STUDYID|DOMAIN|USUBJID|LBSEQ|LBTESTCD|LBTEST|LBCAT|LBORRES|LBORRESU|LBORNRLO|LBORNRHI|LBSTRESC|LBSTRESN|LBSTRESU|LBSTNRLO|LBSTNRHI|LBSTREFC|LBNRIND|LBSPEC|LBSPCCND|LBSPCUFL|LBMETHOD|LBANMETH|LBLOBXFL|LBBLFL|LBFAST|LBDRVFL|VISITNUM|VISIT|VISITDY|TAETORD|EPOCH|LBDTC|LBENDTC|LBDY|LBENDY|LBTPT|LBTPTNUM|LBELTM|LBTPTREF|LBRFTDTC
e|LB|35f5401f-575a-44dc-9141-8084716a5b70|1|APOA5|Apolipoprotein A5|CHEMISTRY|[?]|umol/L/min|[?]|[?]|NEGATIVE|1|mg/kg/day|1|1|[?]|ABNORMAL|BLOOD|THAWED||MICROBIAL CULTURE, SOLID|CKD-EPI CREATININE FORMULA||Y|NA||1|Visit_1|10|7|TREATMENT|2020-10-20|2020-11-22|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|35f5401f-575a-44dc-9141-8084716a5b70|2|INTLK19|Interleukin 19|HEMATOLOGY|||[?]|[?]|TRACE|1|Pack Year|1|1|[?]|ABNORMAL|BUFFY COAT|THAWED||TOLUIDINE BLUE STAIN|FIBROTEST FORMULA|||NA|Y|1|Visit_1|10|7|FOLLOW-UP|2020-10-20|2020-10-29|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|35f5401f-575a-44dc-9141-8084716a5b70|3|TPROTP|Phosphorylated Tau Protein|CHEMISTRY|[?]|/wk|[?]|[?]|POSITIVE|1|g/mol|1|1|[?]|HIGH|SERUM OR PLASMA|SOLIDIFIED||SPECT/CT SCAN|CKD-EPI CYSTATIN C FORMULA|Y||N||2|Visit_2|25|5|TREATMENT|2020-11-04|2020-12-10|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|35f5401f-575a-44dc-9141-8084716a5b70|4|BLASTRUB|Rubriblast|CHEMISTRY|[?]|LB|[?]|[?]|INVALID|1|cpm|1|1|[?]|LOW|TISSUE|ROOM TEMPERATURE||APPLANATION TONOMETRY|GMI MMOL/MOL FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-11-04|2021-01-08|25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|35f5401f-575a-44dc-9141-8084716a5b70|5|C130125|Cat Dander Antigen IgG Antibody|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mOsm/kg|1|1|[?]|HIGH|MUCUS|PARAFFIN-EMBEDDED||DUCTOGRAPHY|MDRD ENZYMATIC FORMULA|||N|Y|3|Visit_3|40|7|FOLLOW-UP|2020-11-19|2020-12-17|40|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|35f5401f-575a-44dc-9141-8084716a5b70|6|C165908|Animal Mix IgG AB RAST Score|HEMATOLOGY|[?]|IU/dL|[?]|[?]|INDETERMINATE|1|g/g/day|1|1|[?]|NORMAL|BREAST MILK|THAWED|N|SLIT LAMP PHOTOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|U||3|Visit_3|40|4|WASHOUT|2020-11-19|2020-12-12|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|35f5401f-575a-44dc-9141-8084716a5b70|7|TESTOSFR|Testosterone, Free|HEMATOLOGY|||[?]|[?]|INVALID|1|Ci/uL|1|1|[?]|ABNORMAL|VITREOUS HUMOR|PARAFFIN-EMBEDDED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|HEPASCORE FORMULA|Y||U|Y|4|Visit_4|65|7|SCREENING|2020-12-14|2021-01-05|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|LB|35f5401f-575a-44dc-9141-8084716a5b70|8|FATACVLC|Fatty Acids, Very Long Chain|URINALYSIS|[?]|Mile|[?]|[?]|POSITIVE|1|CIGAR|1|1|[?]|LOW|GASTRIC FLUID|LIPEMIC||NO INFORMATION|MDRD 6 VARIABLE FORMULA|Y||N||4|Visit_4|65|3|TREATMENT|2020-12-14|2020-12-25|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|LB|35f5401f-575a-44dc-9141-8084716a5b70|9|STROPONI|Skeletal Troponin I|HEMATOLOGY|[?]|mL/beat|[?]|[?]|TRACE|1|U/mmol|1|1|[?]|NORMAL|CERUMEN|AUTOLYZED|N|SINGLE-SLICE SPIRAL CT|CKD-EPI FORMULA||Y|N||5|Visit_5|90|7|TREATMENT|2021-01-08|2021-01-16|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|35f5401f-575a-44dc-9141-8084716a5b70|10|VITD23OH|Vitamin D2 D3 25-OH|HEMATOLOGY|||[?]|[?]|POSITIVE|1|umol/L/min|1|1|[?]|NORMAL|CAPILLARY PLASMA|AUTOLYZED||LYMPHANGIOGRAPHY|FIBROSIS 4 FORMULA|||Y|Y|5|Visit_5|90|6|SCREENING|2021-01-08|2021-01-13|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|8a863a88-67d8-4e50-bafa-c3146591f046|1|INTLK8|Interleukin 8|CHEMISTRY|||[?]|[?]|INVALID|1|usec|1|1|[?]|LOW|CORD SERUM|FROZEN||WRIGHT STAIN|MDRD 4 VARIABLE FORMULA|Y||NA|Y|1|Visit_1|10|3|FOLLOW-UP|2020-12-29|2021-01-03|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|8a863a88-67d8-4e50-bafa-c3146591f046|2|CSMIX|Mixed Casts|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mm/min|1|1|[?]|LOW|LYMPH|THAWED|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|FIBROMETER FORMULA|||U|Y|1|Visit_1|10|4|WASHOUT|2020-12-29|2021-01-23|10|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|8a863a88-67d8-4e50-bafa-c3146591f046|3|BLYMXM|B-lymphocyte Crossmatch|CHEMISTRY|[?]|10^9 CFU|[?]|[?]|POSITIVE|1|SYRINGE|1|1|[?]|ABNORMAL|ABSCESS FLUID|SOLIDIFIED||MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||2|Visit_2|25|5|WASHOUT|2021-01-13|2021-02-05|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|8a863a88-67d8-4e50-bafa-c3146591f046|4|TCHT|Taurocholate|URINALYSIS|[?]|ukat|[?]|[?]|INDETERMINATE|1|/40 HPFs|1|1|[?]|HIGH|ADIPOSE TISSUE|SOLIDIFIED||REVERSE TRANSCRIPTASE PCR|MDRD 4 VARIABLE FORMULA||Y|Y||2|Visit_2|25|3|TREATMENT|2021-01-13|2021-02-04|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|8a863a88-67d8-4e50-bafa-c3146591f046|5|FRTNHC|Ferritin Heavy Chain|HEMATOLOGY|[?]|PNU/mL|[?]|[?]|INDETERMINATE|1|MET|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|LACTESCENT||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|4|TREATMENT|2021-01-28|2021-03-12|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|8a863a88-67d8-4e50-bafa-c3146591f046|6|APOA5|Apolipoprotein A5|URINALYSIS|[?]|VIAL|[?]|[?]|INVALID|1|uV|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|SOLIDIFIED|N|REBOUND TONOMETRY|CKD-EPI FORMULA|Y||U||3|Visit_3|40|7|SCREENING|2021-01-28|2021-03-11|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|8a863a88-67d8-4e50-bafa-c3146591f046|7|ACRNCRNF|Acylcarnitine/Carnitine, Free|HEMATOLOGY|[?]|fraction of 1|[?]|[?]|INVALID|1|mg/kg|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|REFRIGERATED|N|TARGETED GENOME SEQUENCING|CKD-EPI CREATININE FORMULA|||NA||4|Visit_4|65|1|TREATMENT|2021-02-22|2021-03-28|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|8a863a88-67d8-4e50-bafa-c3146591f046|8|CYTYRO|Tyrosine Crystals|CHEMISTRY|[?]|PHERESIS UNIT|[?]|[?]|POSITIVE|1|g/m2|1|1|[?]|LOW|BASAL TEAR|LACTESCENT||MANUAL COUNT|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|4|SCREENING|2021-02-22|2021-03-12|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|8a863a88-67d8-4e50-bafa-c3146591f046|9|DHEAS|Dehydroepiandrosterone Sulfate|URINALYSIS|[?]|Weber|[?]|[?]|TRACE|1|cal|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|FRESH||INDIRECT IMMUNOFLUORESCENCE|COCKCROFT-GAULT FORMULA||Y|U||5|Visit_5|90|1|SCREENING|2021-03-19|2021-03-21|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|8a863a88-67d8-4e50-bafa-c3146591f046|10|CCL21|Chemokine (C-C Motif) Ligand 21|HEMATOLOGY|[?]|ppb|[?]|[?]|NEGATIVE|1|nmol BCE/L|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|REFRIGERATED||SNP ARRAY|GMI MMOL/MOL FORMULA|Y|Y|U||5|Visit_5|90|7|WASHOUT|2021-03-19|2021-03-24|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|1|BILDIRBI|Direct Bilirubin/Bilirubin|HEMATOLOGY|[?]|ohm|[?]|[?]|POSITIVE|1|kg|1|1|[?]|NORMAL|PLEURAL FLUID|UNEXPECTED ODOR||TARGETED GENOME SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-08-03|2020-08-07|10|14|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|2|C130087|English Plantain Pollen IgG4|URINALYSIS|[?]|cmH2O*s/mL|[?]|[?]|INVALID|1|uU/dL|1|1|[?]|ABNORMAL|BONE|CALCIFIED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||Y|Y||1|Visit_1|10|1|TREATMENT|2020-08-03|2020-09-12|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|3|ANGTNS2|Angiotensin II|HEMATOLOGY|||[?]|[?]|POSITIVE|1|Tesla|1|1|[?]|LOW|LAVAGE FLUID|ICTERIC|N|ERGOSPIROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA|Y|2|Visit_2|25|5|TREATMENT|2020-08-18|2020-09-02|25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|4|GLUTAM|Glutamate|CHEMISTRY|[?]|ug/L DDU|[?]|[?]|INDETERMINATE|1|CONTAINER|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|CONCENTRATED||ELECTRICAL IMPEDANCE MYOGRAPHY|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-08-18|2020-08-27|25|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|5|LYMIMLE|Immature Lymphocytes/Leukocytes|CHEMISTRY|[?]|log EID 50/dose|[?]|[?]|POSITIVE|1|DAgU/mL|1|1|[?]|LOW|VITREOUS HUMOR|UNEXPECTED ODOR|N|LIGHT MICROSCOPY|MDRD 4 VARIABLE FORMULA|Y||U||3|Visit_3|40|7|FOLLOW-UP|2020-09-02|2020-10-02|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|6|IBCT|Total Iron Binding Capacity|URINALYSIS|[?]|L/L|[?]|[?]|BORDERLINE|1|dpm/0.5 mL|1|1|[?]|ABNORMAL|BONE MARROW|FROZEN||LANDOLT RING|MDRD 6 VARIABLE FORMULA|||Y||3|Visit_3|40|3|SCREENING|2020-09-02|2020-10-01|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|7|OAS3|2-5-Oligoadenylate Synthase 3|URINALYSIS|[?]|/wk|[?]|[?]|NEGATIVE|1|U/g/h|1|1|[?]|LOW|HAIR FOLLICLE|GELLED||TOTAL BODY RADIOGRAPHY|FIBROMETER FORMULA|||N||4|Visit_4|65|3|FOLLOW-UP|2020-09-27|2020-10-26|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|8|PLSNCE|Neoplastic Plasma Cells|HEMATOLOGY|[?]|mL/dose|[?]|[?]|TRACE|1|10^7 TCID 50/dose|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|REFRIGERATED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|HEPASCORE FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-09-27|2020-10-14|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|9|CHRMTNAB|Chromatin Antibodies|URINALYSIS|[?]|MESF|[?]|[?]|BORDERLINE|1|umol/L/min|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|LIPEMIC||FLUORIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||5|Visit_5|90|5|FOLLOW-UP|2020-10-22|2020-10-26|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|10|CREATCLR|Creatinine Clearance|URINALYSIS|[?]|g/mol|[?]|[?]|NEGATIVE|1|s*kPa|1|1|[?]|NORMAL|BUFFY COAT|FRESH||SINGLE-SLICE SPIRAL CT|CKD-EPI CYSTATIN C FORMULA|Y|Y|Y||5|Visit_5|90|7|WASHOUT|2020-10-22|2020-10-31|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|0558cb35-f542-4f9a-a7e7-18b1d71be69c|1|STOMCY|Stomatocytes|URINALYSIS|[?]|ukat/L|[?]|[?]|NEGATIVE|1|IU/kg/h|1|1|[?]|ABNORMAL|EMESIS|SOLIDIFIED||ELISA|GMI % FORMULA|||N||1|Visit_1|10|1|FOLLOW-UP|2020-12-20|2021-01-17|10|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|0558cb35-f542-4f9a-a7e7-18b1d71be69c|2|SRTONIN|Serotonin|URINALYSIS|[?]|dpm/0.5 mL|[?]|[?]|NEGATIVE|1|10^5/hpf|1|1|[?]|LOW|ARTERIAL CORD BLOOD|CLOTTED||EPSILOMETER|MDRD FORMULA|||U||1|Visit_1|10|4|FOLLOW-UP|2020-12-20|2021-01-10|10|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|0558cb35-f542-4f9a-a7e7-18b1d71be69c|3|LDH5LDH|LDH Isoenzyme 5/LDH|CHEMISTRY|[?]|100 IU/mL|[?]|[?]|POSITIVE|1|10^9 CFU/g|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|REFRIGERATED||FUNDUS PHOTOGRAPHY|HEPASCORE FORMULA|||N||2|Visit_2|25|5|TREATMENT|2021-01-04|2021-03-03|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|0558cb35-f542-4f9a-a7e7-18b1d71be69c|4|RANTES|Reg upon Act Normal T-cell Exprd Secrtd|CHEMISTRY|[?]|/200 HPFs|[?]|[?]|TRACE|1|mV*min|1|1|[?]|NORMAL|ISOLATE|FROZEN|N|AGAR DILUTION|ASH FIBROSURE FORMULA|Y||U||2|Visit_2|25|2|TREATMENT|2021-01-04|2021-03-16|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|0558cb35-f542-4f9a-a7e7-18b1d71be69c|5|CHCNT|Corpuscular Hemoglobin Content|HEMATOLOGY|[?]|FEU|[?]|[?]|TRACE|1|Ejaculate U|1|1|[?]|ABNORMAL|SWABBED MATERIAL|LIPEMIC||DUKE INCISION METHOD|COCKCROFT-GAULT FORMULA||Y|N||3|Visit_3|40|2|TREATMENT|2021-01-19|2021-02-22|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|0558cb35-f542-4f9a-a7e7-18b1d71be69c|6|AFPL2|Alpha Fetoprotein L2|URINALYSIS|||[?]|[?]|INVALID|1|LB|1|1|[?]|NORMAL|SEBUM|UNEXPECTED ODOR|N|SMEAR|GMI % FORMULA|Y||NA|Y|3|Visit_3|40|5|TREATMENT|2021-01-19|2021-03-16|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|0558cb35-f542-4f9a-a7e7-18b1d71be69c|7|HALBAB|Human Albumin Antibody|CHEMISTRY|[?]|PFU|[?]|[?]|TRACE|1|log EID 50/dose|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|CLOTTED|N|FLUORESCENT SPOT TEST|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||4|Visit_4|65|3|TREATMENT|2021-02-13|2021-02-26|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|0558cb35-f542-4f9a-a7e7-18b1d71be69c|8|PRGNENLN|Pregnenolone|URINALYSIS|[?]|PFU/dose|[?]|[?]|NEGATIVE|1|ukat|1|1|[?]|NORMAL|CAPILLARY PLASMA|CONCENTRATED||CLAUSS METHOD|MDRD ENZYMATIC FORMULA|Y||U||4|Visit_4|65|4|FOLLOW-UP|2021-02-13|2021-02-28|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|0558cb35-f542-4f9a-a7e7-18b1d71be69c|9|SPHERO|Spherocytes|HEMATOLOGY|[?]|mL/m2|[?]|[?]|BORDERLINE|1|g/U|1|1|[?]|HIGH|EMESIS|FROZEN||FLOW CYTOMETRY|FIBROSIS 4 FORMULA|||N||5|Visit_5|90|2|FOLLOW-UP|2021-03-10|2021-03-13|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|0558cb35-f542-4f9a-a7e7-18b1d71be69c|10|INR|Prothrombin Intl. Normalized Ratio|HEMATOLOGY|[?]|nmol/day|[?]|[?]|INVALID|1|U/m2|1|1|[?]|NORMAL|SERUM|LACTESCENT||FLAME PHOTOMETRY|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2021-03-10|2021-03-19|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|a9cf4d21-c2a8-4f32-b932-f05d2d317400|1|LCHLCM|Lithocholate Compounds|HEMATOLOGY|[?]|mg/m2/h|[?]|[?]|BORDERLINE|1|U/10^12 RBC|1|1|[?]|HIGH|DISCHARGE|CALCIFIED||PLETHYSMOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||1|Visit_1|10|4|TREATMENT|2020-07-03|2020-09-03|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|a9cf4d21-c2a8-4f32-b932-f05d2d317400|2|PLSCR1|Phospholipid Scramblase 1|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mol|1|1|[?]|LOW|CORD SERUM|CONCENTRATED||SEQUENCING|MDRD ENZYMATIC FORMULA|||N|Y|1|Visit_1|10|6|SCREENING|2020-07-03|2020-07-14|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|a9cf4d21-c2a8-4f32-b932-f05d2d317400|3|PROTSFR|Protein S, Free|HEMATOLOGY|[?]|APL U|[?]|[?]|BORDERLINE|1|IU/mg|1|1|[?]|ABNORMAL|PROSTATIC FLUID|PARAFFIN-EMBEDDED|N|WESTERGREN|GMI % FORMULA|Y||NA||2|Visit_2|25|2|TREATMENT|2020-07-18|2020-09-02|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|LB|a9cf4d21-c2a8-4f32-b932-f05d2d317400|4|GHRELINA|Active Ghrelin|HEMATOLOGY|||[?]|[?]|INVALID|1|Tesla|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|REFRIGERATED||ELECTROCHEMILUMINESCENCE|GMI MMOL/MOL FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2020-07-18|2020-08-19|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|LB|a9cf4d21-c2a8-4f32-b932-f05d2d317400|5|PAI1|Plasminogen Activator Inhibitor-1|URINALYSIS|[?]|cmol/L|[?]|[?]|BORDERLINE|1|cal|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|UNEXPECTED ODOR||CALIPER MEASUREMENT METHOD|HEPASCORE FORMULA|||NA||3|Visit_3|40|4|SCREENING|2020-08-02|2020-09-03|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|LB|a9cf4d21-c2a8-4f32-b932-f05d2d317400|6|ELLIPCY|Elliptocytes|HEMATOLOGY|[?]|Ci/L|[?]|[?]|NEGATIVE|1|10^6/g|1|1|[?]|NORMAL|COLOSTRUM|FRESH||PULSE OXIMETRY|MDRD 5 VARIABLE FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-08-02|2020-08-29|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|LB|a9cf4d21-c2a8-4f32-b932-f05d2d317400|7|BURRCE|Burr Cells|URINALYSIS|[?]|Ci/L|[?]|[?]|INVALID|1|MBP|1|1|[?]|ABNORMAL|SEBUM|PARAFFIN-EMBEDDED||FISH|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|5|TREATMENT|2020-08-27|2020-09-09|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|a9cf4d21-c2a8-4f32-b932-f05d2d317400|8|KRCYMGLE|Megakaryocytes/Leukocytes|URINALYSIS|||[?]|[?]|BORDERLINE|1|PA|1|1|[?]|NORMAL|VITREOUS HUMOR|FROZEN||CALCULATION|MDRD 6 VARIABLE FORMULA||Y|Y|Y|4|Visit_4|65|4|TREATMENT|2020-08-27|2020-09-29|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|a9cf4d21-c2a8-4f32-b932-f05d2d317400|9|PGD2S|Prostaglandin D2 Synthase|URINALYSIS|[?]|IU/kg|[?]|[?]|POSITIVE|1|ug/L|1|1|[?]|HIGH|SERUM OR PLASMA|ICTERIC|N|FUNDUS PHOTOGRAPHY|NASH FIBROSURE FORMULA|Y||NA||5|Visit_5|90|3|FOLLOW-UP|2020-09-21|2020-09-22|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|LB|a9cf4d21-c2a8-4f32-b932-f05d2d317400|10|PLSTCELE|Total Plasma Cells/Leukocytes|HEMATOLOGY|[?]|umol/kg/min|[?]|[?]|NEGATIVE|1|pg|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|SOLIDIFIED||MRI WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-09-21|2020-09-29|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|LB|0389257f-50de-4a05-8f2a-69c068374337|1|ACANT|Acanthocytes|URINALYSIS|||[?]|[?]|TRACE|1|P|1|1|[?]|HIGH|SEMEN|SOLIDIFIED||MICROSCOPY|MDRD 5 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|4|TREATMENT|2020-10-08|2020-11-13|10|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|0389257f-50de-4a05-8f2a-69c068374337|2|HIST2AAB|Histone 2A Antibody|HEMATOLOGY|[?]|ng/dL|[?]|[?]|POSITIVE|1|cmH2O*s2/mL|1|1|[?]|HIGH|BONE MARROW|UNEXPECTED ODOR||IVY INCISION METHOD|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-10-08|2020-12-13|10|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|0389257f-50de-4a05-8f2a-69c068374337|3|DSG1AB|Desmoglein 1 Antibody|HEMATOLOGY|[?]|mol/day|[?]|[?]|BORDERLINE|1|mmol/s|1|1|[?]|HIGH|SWABBED MATERIAL|CONTAMINATED|N|SIZE EXCLUSION CHROMATOGRAPHY|GMI % FORMULA|Y|Y|Y||2|Visit_2|25|4|WASHOUT|2020-10-23|2020-12-30|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|0389257f-50de-4a05-8f2a-69c068374337|4|CHYTRYP|Chymotrypsin|CHEMISTRY|[?]|copies/ug|[?]|[?]|NEGATIVE|1|genEq/mL|1|1|[?]|LOW|SEBUM|FROZEN||IMMUNOFIXATION ELECTROPHORESIS|GMI MMOL/MOL FORMULA|Y||Y||2|Visit_2|25|2|FOLLOW-UP|2020-10-23|2020-12-07|25|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|0389257f-50de-4a05-8f2a-69c068374337|5|IFIT1|Interferon-Induced 56 kDa Protein|URINALYSIS|[?]|dyn|[?]|[?]|NEGATIVE|1|mg/dose|1|1|[?]|LOW|PLASMA|CLOTTED||WHOLE GENOME SEQUENCING|CKD-EPI FORMULA|||U||3|Visit_3|40|6|SCREENING|2020-11-07|2020-12-15|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|0389257f-50de-4a05-8f2a-69c068374337|6|APOA1|Apolipoprotein A1|CHEMISTRY|||[?]|[?]|INVALID|1|kg/mol|1|1|[?]|LOW|SPUTUM|THAWED||CT SCAN WITHOUT CONTRAST|ASH FIBROSURE FORMULA||Y|U|Y|3|Visit_3|40|7|TREATMENT|2020-11-07|2020-11-13|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|0389257f-50de-4a05-8f2a-69c068374337|7|C165917|D. pteronyssinus IgG AB RAST Score|CHEMISTRY|||[?]|[?]|POSITIVE|1|10^5/hpf|1|1|[?]|NORMAL|MENSTRUAL BLOOD|CONTAMINATED||LEAD CITRATE STAIN|CKD-EPI FORMULA|||Y|Y|4|Visit_4|65|2|SCREENING|2020-12-02|2020-12-15|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|0389257f-50de-4a05-8f2a-69c068374337|8|BLASTCE|Blasts/Total Cells|HEMATOLOGY|[?]|keV|[?]|[?]|POSITIVE|1|10^3 DNA copies/mL|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|FRESH|N|PANENDOSCOPY|CKD-EPI FORMULA|Y||Y||4|Visit_4|65|3|TREATMENT|2020-12-02|2020-12-26|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|0389257f-50de-4a05-8f2a-69c068374337|9|ADPNHMW|Adiponectin, High Molecular Weight|CHEMISTRY|||[?]|[?]|POSITIVE|1|oz eq|1|1|[?]|NORMAL|SERUM OR PLASMA|UNEXPECTED ODOR|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD ENZYMATIC FORMULA|Y||N|Y|5|Visit_5|90|4|SCREENING|2020-12-27|2021-01-02|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|0389257f-50de-4a05-8f2a-69c068374337|10|CYAMMOX|Ammonium Oxalate Crystals|CHEMISTRY|||[?]|[?]|POSITIVE|1|mg/L|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|ROOM TEMPERATURE|N|MEDIASTINOSCOPY|MDRD 4 VARIABLE FORMULA||Y|NA|Y|5|Visit_5|90|2|TREATMENT|2020-12-27|2020-12-30|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|1|RETIM|Medium Absorption Reticulocytes|CHEMISTRY|[?]|mg/g/min|[?]|[?]|INVALID|1|pt_br|1|1|[?]|LOW|CALCULUS|AUTOLYZED||SCINTIGRAPHY|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|4|SCREENING|2020-12-15|2020-12-19|10|14|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|2|PRO|Proline|CHEMISTRY|[?]|tsp eq|[?]|[?]|BORDERLINE|1|mg/mL/day|1|1|[?]|ABNORMAL|HAIR FOLLICLE|NON-HEMOLYZED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD 4 VARIABLE FORMULA|Y||U||1|Visit_1|10|4|TREATMENT|2020-12-15|2021-02-17|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|3|NAGCREAT|N-Acetyl Glucosamide/Creatinine|URINALYSIS|||[?]|[?]|POSITIVE|1|fmol|1|1|[?]|HIGH|ABSCESS FLUID|AUTOLYZED||QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROTEST FORMULA||Y|U|Y|2|Visit_2|25|2|FOLLOW-UP|2020-12-30|2021-02-13|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|4|PROTSFR|Protein S, Free|HEMATOLOGY|[?]|U/10^12 RBC|[?]|[?]|POSITIVE|1|INHALATION|1|1|[?]|NORMAL|MECONIUM|AUTOLYZED|N|WHOLE TRANSCRIPTOME SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||2|Visit_2|25|4|WASHOUT|2020-12-30|2021-02-26|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|5|C130111|Mold Mix Antigen IgA Antibody|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mol|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|CONCENTRATED|N|PH METER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA||Y|U|Y|3|Visit_3|40|6|TREATMENT|2021-01-14|2021-01-16|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|6|EOSPSDLE|Pseudo-Eosinophils/Leukocytes|CHEMISTRY|[?]|Gauss|[?]|[?]|TRACE|1|umol/L/h|1|1|[?]|HIGH|NAIL|AUTOLYZED||ICC|CKD-EPI CYSTATIN C FORMULA|Y||NA||3|Visit_3|40|2|FOLLOW-UP|2021-01-14|2021-01-19|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|7|MG|Magnesium|HEMATOLOGY|[?]|nmol/day|[?]|[?]|TRACE|1|ng/L|1|1|[?]|NORMAL|CERUMEN|SOLIDIFIED||QUANTITATIVE COMPUTED TOMOGRAPHY|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|1|TREATMENT|2021-02-08|2021-02-13|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|8|GCDCA|Glycochenodeoxycholate|HEMATOLOGY|[?]|DAgU/mL|[?]|[?]|INVALID|1|dyn|1|1|[?]|LOW|PROSTATIC FLUID|CLOTTED||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|7|SCREENING|2021-02-08|2021-03-05|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|9|MLIGCEBC|Malignant Cells, NOS/Blood Cells|CHEMISTRY|||[?]|[?]|POSITIVE|1|mL*cmH2O|1|1|[?]|NORMAL|BUFFY COAT|HEMOLYZED|N|WHOLE TRANSCRIPTOME SEQUENCING|CKD-EPI CYSTATIN C FORMULA|||N|Y|5|Visit_5|90|4|TREATMENT|2021-03-05|2021-03-13|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|10|FACTVA|Factor V Activity|URINALYSIS|[?]|g/cage/day|[?]|[?]|INDETERMINATE|1|mL/h|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|ROOM TEMPERATURE||SICKLE CELL SOLUBILITY TEST|FIBROSIS 4 FORMULA||Y|N||5|Visit_5|90|3|TREATMENT|2021-03-05|2021-03-09|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|1|CHOLINES|Cholinesterase|URINALYSIS|[?]|damol/L|[?]|[?]|TRACE|1|L/min|1|1|[?]|ABNORMAL|BONE MARROW|CONCENTRATED||CLINICAL EVALUATION|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|1|WASHOUT|2020-12-22|2021-01-29|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|2|PROLYM|Prolymphocytes|URINALYSIS|[?]|U/m2/day|[?]|[?]|POSITIVE|1|mol/day|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|REFRIGERATED||IMMUNOFIXATION ELECTROPHORESIS|MDRD FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-12-22|2021-03-18|10|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|3|TRPCRT|Tryptophan/Creatinine|CHEMISTRY|[?]|mL/cm3/min|[?]|[?]|BORDERLINE|1|Bq|1|1|[?]|HIGH|URINE SEDIMENT|UNEXPECTED ODOR||CORONARY ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U||2|Visit_2|25|1|TREATMENT|2021-01-06|2021-02-18|25|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|4|CCL21|Chemokine (C-C Motif) Ligand 21|HEMATOLOGY|[?]|Log10 ELISA unit/dose|[?]|[?]|INDETERMINATE|1|um|1|1|[?]|NORMAL|MONOCYTE|CLOTTED|N|ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||2|Visit_2|25|4|SCREENING|2021-01-06|2021-02-20|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|5|BTKFR|Bruton's Tyrosine Kinase, Free|URINALYSIS|[?]|/LPF|[?]|[?]|POSITIVE|1|IU/mg|1|1|[?]|HIGH|EPIDERMAL TISSUE|NON-HEMOLYZED||MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|3|SCREENING|2021-01-21|2021-01-23|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|6|LYMMCELY|Lymphoma Cells/Lymphocytes|URINALYSIS|||[?]|[?]|INVALID|1|Ci/g|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|DRIED||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA|Y|3|Visit_3|40|7|TREATMENT|2021-01-21|2021-02-12|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|7|CITCREAT|Citrate/Creatinine|CHEMISTRY|[?]|genEq|[?]|[?]|NEGATIVE|1|IU/mmol|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|GELLED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|||U||4|Visit_4|65|6|WASHOUT|2021-02-15|2021-03-14|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|LB|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|8|INSLNFR|Insulin, Free|URINALYSIS|[?]|um/s|[?]|[?]|INVALID|1|MBq/uL|1|1|[?]|HIGH|INFRANATANT, PLASMA|FROZEN||MODIFIED ACID FAST STAIN|MDRD 5 VARIABLE FORMULA||Y|N||4|Visit_4|65|7|TREATMENT|2021-02-15|2021-02-20|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|LB|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|9|BLSTMKCE|Megakaryoblasts/Total Cells|CHEMISTRY|[?]|DAgU/mL|[?]|[?]|INVALID|1|mol/day|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|CALCIFIED||MACRO BROTH DILUTION|MDRD FORMULA|||U||5|Visit_5|90|2|SCREENING|2021-03-12|2021-03-16|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|LB|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|10|ZINC|Zinc|CHEMISTRY|||[?]|[?]|POSITIVE|1|mL*cmH2O|1|1|[?]|LOW|BLOOD|FROZEN||HEMATOXYLIN AND EOSIN STAIN|COCKCROFT-GAULT FORMULA|||NA|Y|5|Visit_5|90|1|TREATMENT|2021-03-12|2021-03-13|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|LB|ad402b62-0625-431b-9bd7-ffd6124610f3|1|TNFR1B|TNF Receptor 1B|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|10^6/L|1|1|[?]|HIGH|ABSCESS FLUID|CONCENTRATED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|CKD-EPI FORMULA||Y|NA|Y|1|Visit_1|10|4|TREATMENT|2020-09-25|2020-10-01|10|16|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|ad402b62-0625-431b-9bd7-ffd6124610f3|2|C165899|Silver Birch Pollen IgG AB RAST Score|HEMATOLOGY|[?]|BAU|[?]|[?]|TRACE|1|umol/mg/min|1|1|[?]|ABNORMAL|BASAL TEAR|CALCIFIED||CLOT DETECTION|FIBROMETER FORMULA|||NA||1|Visit_1|10|1|FOLLOW-UP|2020-09-25|2020-12-06|10|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|ad402b62-0625-431b-9bd7-ffd6124610f3|3|PGES|Prostaglandin E Synthase|HEMATOLOGY|[?]|anti-Xa IU/mL|[?]|[?]|BORDERLINE|1|log10 TCID 50/uL|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|CONCENTRATED||OLIGO ACGH|FIBROTEST FORMULA|Y|Y|Y||2|Visit_2|25|6|SCREENING|2020-10-10|2020-11-22|25|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|ad402b62-0625-431b-9bd7-ffd6124610f3|4|KETONES|Ketones|CHEMISTRY|||[?]|[?]|INVALID|1|Ci/ug|1|1|[?]|LOW|VENOUS BLOOD|PARAFFIN-EMBEDDED|N|PHOROPTER|HEPASCORE FORMULA|Y||U|Y|2|Visit_2|25|4|SCREENING|2020-10-10|2020-10-11|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|ad402b62-0625-431b-9bd7-ffd6124610f3|5|PYK|Pyruvate Kinase|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ug/g/day|1|1|[?]|NORMAL|DERMAL TISSUE|FRESH|N|LC-FL|CKD-EPI CYSTATIN C FORMULA|Y|Y|Y|Y|3|Visit_3|40|6|SCREENING|2020-10-25|2020-11-20|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|ad402b62-0625-431b-9bd7-ffd6124610f3|6|TRIG|Triglycerides|HEMATOLOGY|[?]|10^3 RNA copies/mL|[?]|[?]|BORDERLINE|1|BOLUS|1|1|[?]|LOW|GASTRIC CONTENTS|LIPEMIC|N|HPLC/MS|MDRD 5 VARIABLE FORMULA|Y||NA||3|Visit_3|40|5|WASHOUT|2020-10-25|2020-11-10|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|ad402b62-0625-431b-9bd7-ffd6124610f3|7|CYCAOXA|Calcium Oxalate Crystals|URINALYSIS|[?]|ug/g/min|[?]|[?]|BORDERLINE|1|ELISA unit/dose|1|1|[?]|LOW|ISOLATE|CONCENTRATED|N|SLOAN LETTER EYE CHART 1.25%|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U||4|Visit_4|65|7|SCREENING|2020-11-19|2020-12-13|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|ad402b62-0625-431b-9bd7-ffd6124610f3|8|WBCCE|Leukocytes/Total Cells|CHEMISTRY|||[?]|[?]|BORDERLINE|1|DIOPTER|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|NASH FIBROSURE FORMULA|||Y|Y|4|Visit_4|65|1|SCREENING|2020-11-19|2020-11-22|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|ad402b62-0625-431b-9bd7-ffd6124610f3|9|C130126|Cat Dander Antigen IgA Antibody|CHEMISTRY|[?]|kBq/uL|[?]|[?]|INDETERMINATE|1|Absorbance U/mL|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|NON-HEMOLYZED||SLIT LAMP|MDRD ENZYMATIC FORMULA||Y|U||5|Visit_5|90|6|WASHOUT|2020-12-14|2020-12-16|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|ad402b62-0625-431b-9bd7-ffd6124610f3|10|MX1|Interferon-Induced Protein p78|HEMATOLOGY|[?]|g/cage/day|[?]|[?]|POSITIVE|1|RNA copies/mL|1|1|[?]|NORMAL|PLASMA|FROZEN|N|WRIGHT-GIEMSA STAIN|HEPASCORE FORMULA|Y||N||5|Visit_5|90|5|TREATMENT|2020-12-14|2020-12-17|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|d76b0f55-541c-491d-9162-4c133c9509f1|1|DCA|Deoxycholate|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mL/100g/min|1|1|[?]|HIGH|BASAL TEAR|HEMOLYZED||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|MDRD 5 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|7|WASHOUT|2020-05-24|2020-05-27|10|13|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|LB|d76b0f55-541c-491d-9162-4c133c9509f1|2|CD161ALY|CD161a/Lymphocytes|CHEMISTRY|[?]|mg/mol|[?]|[?]|INDETERMINATE|1|%(v/v)|1|1|[?]|LOW|DIALYSIS FLUID|FRESH||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|ASH FIBROSURE FORMULA|Y|Y|Y||1|Visit_1|10|3|WASHOUT|2020-05-24|2020-06-29|10|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|LB|d76b0f55-541c-491d-9162-4c133c9509f1|3|HGBA|Hemoglobin A|CHEMISTRY|||[?]|[?]|POSITIVE|1|mL/day|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|GELLED||GRADIENT DIFFUSION|FIBROTEST FORMULA|||N|Y|2|Visit_2|25|5|FOLLOW-UP|2020-06-08|2020-08-04|25|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|d76b0f55-541c-491d-9162-4c133c9509f1|4|GFRBSCRT|GFR from Creatinine Adjusted for BSA|CHEMISTRY|[?]|nmol BCE/nmol|[?]|[?]|POSITIVE|1|nmol BCE/mmol|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|LACTESCENT||DNA MICROARRAY|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-06-08|2020-06-22|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|d76b0f55-541c-491d-9162-4c133c9509f1|5|RNPSMAB|Ribonucleoprotein Smith Complex Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|NFIU|1|1|[?]|NORMAL|NAIL|REFRIGERATED||MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CREATININE FORMULA|Y||Y|Y|3|Visit_3|40|5|TREATMENT|2020-06-23|2020-07-11|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|d76b0f55-541c-491d-9162-4c133c9509f1|6|HBLEPRHB|Hemoglobin Lepore/Total Hemoglobin|CHEMISTRY|[?]|ug/kg/h|[?]|[?]|TRACE|1|Ci|1|1|[?]|LOW|FLUID|HEMOLYZED||HIGH RESOLUTION CT|FIBROSIS 4 FORMULA||Y|Y||3|Visit_3|40|6|TREATMENT|2020-06-23|2020-08-19|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|d76b0f55-541c-491d-9162-4c133c9509f1|7|WBCDIFF|Leukocyte Cell Differential|CHEMISTRY|||[?]|[?]|POSITIVE|1|Tbsp|1|1|[?]|HIGH|PERITONEAL FLUID|FROZEN||CENTRIFUGATION|MDRD 5 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|2|SCREENING|2020-07-18|2020-07-30|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|d76b0f55-541c-491d-9162-4c133c9509f1|8|CXCL3|Chemokine (C-X-C Motif) Ligand 3|CHEMISTRY|[?]|ug/L DDU|[?]|[?]|POSITIVE|1|STEPS|1|1|[?]|LOW|INFRANATANT, SERUM|REFRIGERATED|N|MULTI-SLICE SPIRAL CT|MDRD ENZYMATIC JAPANESE FORMULA|||N||4|Visit_4|65|4|FOLLOW-UP|2020-07-18|2020-07-27|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|d76b0f55-541c-491d-9162-4c133c9509f1|9|RBCGHOST|Erythrocyte Ghosts|HEMATOLOGY|[?]|cm|[?]|[?]|INDETERMINATE|1|uL/kg/day|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|DRIED|N|LANDOLT RING|HEPASCORE FORMULA|Y||N||5|Visit_5|90|3|TREATMENT|2020-08-12|2020-08-21|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|d76b0f55-541c-491d-9162-4c133c9509f1|10|CD4CD8|CD4/CD8|URINALYSIS|[?]|umol/L/min|[?]|[?]|INVALID|1|mL/s/m2|1|1|[?]|NORMAL|BASAL TEAR|SOLIDIFIED||MAPH|MDRD 6 VARIABLE FORMULA|Y|Y|NA||5|Visit_5|90|7|TREATMENT|2020-08-12|2020-08-19|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|146059d8-5652-41cd-b484-c6e5d8ea540f|1|MYBLA|Myeloblasts|CHEMISTRY|||[?]|[?]|TRACE|1|ug/day|1|1|[?]|HIGH|SPERMATOZOON|CONCENTRATED||ZIEHL NEELSEN ACID FAST STAIN|GMI MMOL/MOL FORMULA||Y|U|Y|1|Visit_1|10|5|TREATMENT|2020-08-26|2020-09-05|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|146059d8-5652-41cd-b484-c6e5d8ea540f|2|PDW|Platelet Distribution Width|URINALYSIS|[?]|PACKAGE|[?]|[?]|NEGATIVE|1|ug/L DDU|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|HEMOLYZED||CLIP SEQUENCING|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-08-26|2020-10-13|10|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|146059d8-5652-41cd-b484-c6e5d8ea540f|3|PROGEST|Progesterone|URINALYSIS|[?]|V|[?]|[?]|POSITIVE|1|Bq/mL|1|1|[?]|NORMAL|LEUKOCYTE|ICTERIC||LAPAROSCOPY|MDRD ENZYMATIC FORMULA|Y||Y||2|Visit_2|25|5|TREATMENT|2020-09-10|2020-10-13|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|LB|146059d8-5652-41cd-b484-c6e5d8ea540f|4|THRMPTN|Thrombopoietin|CHEMISTRY|[?]|mEq/g|[?]|[?]|POSITIVE|1|mL/cage/wk|1|1|[?]|LOW|ISOLATE|HEMOLYZED||IN SITU HYBRIDIZATION|MDRD FORMULA|Y||U||2|Visit_2|25|1|SCREENING|2020-09-10|2020-10-01|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|LB|146059d8-5652-41cd-b484-c6e5d8ea540f|5|HAMAB|Human Anti-Mouse Antibody|URINALYSIS|[?]|10^9/dose|[?]|[?]|BORDERLINE|1|mkat|1|1|[?]|NORMAL|PLATELET POOR PLASMA|LACTESCENT||FLUORESCENT SPOT TEST|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-09-25|2020-10-19|40|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|146059d8-5652-41cd-b484-c6e5d8ea540f|6|CLUECE|Clue Cells|URINALYSIS|[?]|LB|[?]|[?]|NEGATIVE|1|BAU/mL|1|1|[?]|ABNORMAL|SPERMATOZOON|REFRIGERATED||DYNAMOMETRY|HEPASCORE FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2020-09-25|2020-11-14|40|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|146059d8-5652-41cd-b484-c6e5d8ea540f|7|NSPMTSPM|Normal Sperm/Total Sperm|HEMATOLOGY|[?]|U/kg/h|[?]|[?]|POSITIVE|1|uCi/kg|1|1|[?]|LOW|VITREOUS HUMOR|CONCENTRATED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|ASH FIBROSURE FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-10-20|2020-11-16|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|146059d8-5652-41cd-b484-c6e5d8ea540f|8|CAPHOS|Calcium/Phosphorus|HEMATOLOGY|[?]|log10 IU/mL|[?]|[?]|TRACE|1|mg/kg/dose|1|1|[?]|HIGH|AQUEOUS HUMOR|LACTESCENT||MICROBIAL CONCENTRATION|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-10-20|2020-10-21|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|146059d8-5652-41cd-b484-c6e5d8ea540f|9|PSAF|Prostate Specific Antigen, Free|HEMATOLOGY|[?]|mJoule/cm2|[?]|[?]|POSITIVE|1|/10^4|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|FRESH||ALCIAN BLUE STAIN|GMI % FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2020-11-14|2020-11-23|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|146059d8-5652-41cd-b484-c6e5d8ea540f|10|MCP1|Monocyte Chemotactic Protein 1|URINALYSIS|[?]|STRIP|[?]|[?]|INDETERMINATE|1|Henry|1|1|[?]|NORMAL|SPUTUM|THAWED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|3|SCREENING|2020-11-14|2020-11-23|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|3d5f1964-b65c-4a0a-bb5b-1689308754d8|1|HCGND|Choriogonadotropin|HEMATOLOGY|||[?]|[?]|INVALID|1|U/g/min|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|FRESH|N|POLYMERASE CHAIN REACTION|MDRD FORMULA|||Y|Y|1|Visit_1|10|1|TREATMENT|2020-11-04|2020-11-16|10|22|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|3d5f1964-b65c-4a0a-bb5b-1689308754d8|2|FLT3L|FMS-like Tyrosine Kinase 3 Ligand|CHEMISTRY|[?]|L/s/kPa|[?]|[?]|NEGATIVE|1|Gravitational Unit|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|ICTERIC||OSCILLOMETRY|ASH FIBROSURE FORMULA|||N||1|Visit_1|10|3|SCREENING|2020-11-04|2020-12-24|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|3d5f1964-b65c-4a0a-bb5b-1689308754d8|3|VOLUME|Volume|CHEMISTRY|[?]|tsp eq|[?]|[?]|BORDERLINE|1|mL/g/h|1|1|[?]|HIGH|PERITONEAL FLUID|AUTOLYZED||MAMMOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||2|Visit_2|25|4|FOLLOW-UP|2020-11-19|2020-11-29|25|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|3d5f1964-b65c-4a0a-bb5b-1689308754d8|4|CELLULAR|Cellularity|URINALYSIS|[?]|TCID 50/dose|[?]|[?]|INDETERMINATE|1|Enzyme U/g Hb|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|FRESH||ENDPOINT DILUTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||2|Visit_2|25|2|TREATMENT|2020-11-19|2020-11-24|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|3d5f1964-b65c-4a0a-bb5b-1689308754d8|5|HDLPL|HDL Phospholipid|URINALYSIS|[?]|cm/min|[?]|[?]|NEGATIVE|1|mL/cage|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|AGGLUTINATED|N|ISHIHARA COLOR PLATES|MDRD 5 VARIABLE FORMULA|||U||3|Visit_3|40|1|TREATMENT|2020-12-04|2021-01-30|40|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|3d5f1964-b65c-4a0a-bb5b-1689308754d8|6|ANA|Antinuclear Antibodies|HEMATOLOGY|[?]|LOZENGE|[?]|[?]|TRACE|1|cs|1|1|[?]|LOW|BLOOD|CONCENTRATED||MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI FORMULA||Y|Y||3|Visit_3|40|4|TREATMENT|2020-12-04|2021-01-16|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|3d5f1964-b65c-4a0a-bb5b-1689308754d8|7|GRANIMLE|Immature Granulocytes/Leukocytes|CHEMISTRY|[?]|cycle/min|[?]|[?]|NEGATIVE|1|mL/day|1|1|[?]|NORMAL|EXUDATE|AGGLUTINATED||CINEANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA||4|Visit_4|65|7|SCREENING|2020-12-29|2021-01-25|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|3d5f1964-b65c-4a0a-bb5b-1689308754d8|8|LPA|Lipoprotein-a|URINALYSIS|[?]|cg|[?]|[?]|POSITIVE|1|g|1|1|[?]|HIGH|SMEGMA|CONCENTRATED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|2|SCREENING|2020-12-29|2021-01-27|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|3d5f1964-b65c-4a0a-bb5b-1689308754d8|9|PCSK9|Proprotein Convertase Subtilisin/Kexin 9|CHEMISTRY|[?]|pmol/L/h|[?]|[?]|POSITIVE|1|Farad|1|1|[?]|HIGH|PERITONEAL FLUID|HEMOLYZED|N|SLOAN LETTER EYE CHART 1.25%|NASH FIBROSURE FORMULA||Y|U||5|Visit_5|90|1|TREATMENT|2021-01-23|2021-01-29|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|3d5f1964-b65c-4a0a-bb5b-1689308754d8|10|INTLK16|Interleukin 16|HEMATOLOGY|[?]|CUP|[?]|[?]|INDETERMINATE|1|mmol/min/kPa|1|1|[?]|LOW|EPITHELIAL CELL|SOLIDIFIED|N|RADIATION DOSIMETRY|MDRD FORMULA|||U||5|Visit_5|90|2|WASHOUT|2021-01-23|2021-01-28|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|129dc836-068a-463e-b789-a0d05c60605d|1|DGNWBC|Degenerated Leukocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|APPLICATION|1|1|[?]|ABNORMAL|PLEURAL TISSUE|DRIED||MRI|FIBROSIS 4 FORMULA||Y|N|Y|1|Visit_1|10|5|FOLLOW-UP|2020-07-06|2020-09-16|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|129dc836-068a-463e-b789-a0d05c60605d|2|GDF8|Growth Differentiation Factor 8|URINALYSIS|||[?]|[?]|INVALID|1|Farad|1|1|[?]|NORMAL|BREAST MILK|CALCIFIED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD ENZYMATIC FORMULA|||Y|Y|1|Visit_1|10|1|TREATMENT|2020-07-06|2020-08-08|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|129dc836-068a-463e-b789-a0d05c60605d|3|NEOPTERN|Neopterin|URINALYSIS|[?]|CCID 50/mL|[?]|[?]|INVALID|1|10^4 CFU|1|1|[?]|ABNORMAL|LYSATE|FRESH||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|GMI MMOL/MOL FORMULA||Y|NA||2|Visit_2|25|6|SCREENING|2020-07-21|2020-09-11|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|129dc836-068a-463e-b789-a0d05c60605d|4|SAA1|Serum Amyloid A1|HEMATOLOGY|[?]|Hz|[?]|[?]|TRACE|1|ng/mol|1|1|[?]|LOW|CAPILLARY PLASMA|PARAFFIN-EMBEDDED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|FIBROMETER FORMULA||Y|Y||2|Visit_2|25|3|FOLLOW-UP|2020-07-21|2020-07-24|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|129dc836-068a-463e-b789-a0d05c60605d|5|APOB48|Apolipoprotein B48|URINALYSIS|[?]|IU|[?]|[?]|BORDERLINE|1|mU/g|1|1|[?]|HIGH|STOOL|DRIED|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|1|SCREENING|2020-08-05|2020-09-15|40|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|129dc836-068a-463e-b789-a0d05c60605d|6|MPM|Mean Platelet Dry Mass|HEMATOLOGY|[?]|IU/day|[?]|[?]|NEGATIVE|1|kV|1|1|[?]|ABNORMAL|EXPIRED AIR|SOLIDIFIED||SCANNING ELECTRON MICROSCOPY|CKD-EPI CREATININE FORMULA|Y||NA||3|Visit_3|40|1|SCREENING|2020-08-05|2020-08-10|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|129dc836-068a-463e-b789-a0d05c60605d|7|FVAAC|Factor V Activity Actual/Control|HEMATOLOGY|[?]|mg/day|[?]|[?]|INDETERMINATE|1|ELISA unit/dose|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|FROZEN|N|CLIP|MDRD ENZYMATIC FORMULA|||U||4|Visit_4|65|6|WASHOUT|2020-08-30|2020-09-19|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|129dc836-068a-463e-b789-a0d05c60605d|8|GFRBSCUA|GFR from Creat,UreaN,Alb Adj BSA|URINALYSIS|||[?]|[?]|BORDERLINE|1|CIGAR|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED||INDIRECT IMMUNOFLUORESCENCE|MDRD FORMULA|||Y|Y|4|Visit_4|65|7|WASHOUT|2020-08-30|2020-09-02|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|129dc836-068a-463e-b789-a0d05c60605d|9|HBOXHGB|Oxyhemoglobin/Total Hemoglobin|HEMATOLOGY|[?]|10^6 CFU/mL|[?]|[?]|NEGATIVE|1|um|1|1|[?]|HIGH|CERUMEN|GELLED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|NASH FIBROSURE FORMULA|||Y||5|Visit_5|90|7|SCREENING|2020-09-24|2020-09-30|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|129dc836-068a-463e-b789-a0d05c60605d|10|C165917|D. pteronyssinus IgG AB RAST Score|CHEMISTRY|[?]|pmol|[?]|[?]|POSITIVE|1|PIPE|1|1|[?]|LOW|SERUM OR PLASMA|FROZEN||NEPHELOMETRY|FIBROSIS 4 FORMULA|Y|Y|NA||5|Visit_5|90|2|FOLLOW-UP|2020-09-24|2020-10-03|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|9ef8a6d4-8326-4050-be85-e9f8983f55c1|1|CHOLATE|Cholate|HEMATOLOGY|[?]|ug|[?]|[?]|INVALID|1|PACKAGE|1|1|[?]|LOW|AMNIOTIC FLUID|CALCIFIED||MODIFIED ACID FAST STAIN|MDRD 4 VARIABLE FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-11-07|2021-01-18|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|9ef8a6d4-8326-4050-be85-e9f8983f55c1|2|DSG1AB|Desmoglein 1 Antibody|CHEMISTRY|[?]|mL*cmH2O|[?]|[?]|TRACE|1|10^9 organisms/mL|1|1|[?]|NORMAL|SUPERNATANT, SERUM|CALCIFIED||FARNSWORTH-MUNSELL 100 HUE TEST|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|1|FOLLOW-UP|2020-11-07|2020-12-27|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|9ef8a6d4-8326-4050-be85-e9f8983f55c1|3|CYAMORPH|Amorphous Crystals|URINALYSIS|||[?]|[?]|NEGATIVE|1|mMU/mL|1|1|[?]|NORMAL|SALIVA|CLOTTED||AUDIOMETRY|FIBROMETER FORMULA|||NA|Y|2|Visit_2|25|7|SCREENING|2020-11-22|2020-12-09|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|9ef8a6d4-8326-4050-be85-e9f8983f55c1|4|C130139|American Cockroach Antigen IgG4 Antibody|HEMATOLOGY|[?]|ng|[?]|[?]|POSITIVE|1|nmol/mL/min|1|1|[?]|LOW|SUPERNATANT, SERUM|SOLIDIFIED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|1|SCREENING|2020-11-22|2021-01-31|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|9ef8a6d4-8326-4050-be85-e9f8983f55c1|5|APOA2|Apolipoprotein AII|URINALYSIS|[?]|10^6 organisms/mL|[?]|[?]|INVALID|1|TCID 50/dose|1|1|[?]|LOW|STOOL|NON-HEMOLYZED|N|CALIPER MEASUREMENT METHOD|GMI MMOL/MOL FORMULA|Y||NA||3|Visit_3|40|6|TREATMENT|2020-12-07|2021-02-04|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|9ef8a6d4-8326-4050-be85-e9f8983f55c1|6|PAF|Platelet Activating Factor|HEMATOLOGY|||[?]|[?]|TRACE|1|/LPF|1|1|[?]|NORMAL|SEMEN|ICTERIC||AUDIOMETRY|HEPASCORE FORMULA|||N|Y|3|Visit_3|40|5|TREATMENT|2020-12-07|2020-12-30|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|9ef8a6d4-8326-4050-be85-e9f8983f55c1|7|ANTHRMAG|Antithrombin Antigen|CHEMISTRY|||[?]|[?]|INVALID|1|cup eq|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|REFRIGERATED||SNELLEN EYE CHART|COCKCROFT-GAULT FORMULA|Y||Y|Y|4|Visit_4|65|6|FOLLOW-UP|2021-01-01|2021-02-04|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|9ef8a6d4-8326-4050-be85-e9f8983f55c1|8|APPA|Amyloid Alpha Precursor Protein|HEMATOLOGY|[?]|ug/m2/day|[?]|[?]|POSITIVE|1|/kg|1|1|[?]|NORMAL|MUCUS|UNEXPECTED ODOR|N|IODINE STAIN|COCKCROFT-GAULT FORMULA|Y||U||4|Visit_4|65|5|FOLLOW-UP|2021-01-01|2021-02-01|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|9ef8a6d4-8326-4050-be85-e9f8983f55c1|9|BLYCELE|B-Lymphocytes/Leukocytes|URINALYSIS|[?]|10^6/Ejaculate U|[?]|[?]|INVALID|1|L/s/kPa|1|1|[?]|NORMAL|STOOL|AGGLUTINATED||CALIPER MEASUREMENT METHOD|GMI % FORMULA|||U||5|Visit_5|90|6|TREATMENT|2021-01-26|2021-02-04|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|9ef8a6d4-8326-4050-be85-e9f8983f55c1|10|IA2AB|Insulinoma-Associated Protein 2 Antibody|URINALYSIS|||[?]|[?]|INDETERMINATE|1|IU/g|1|1|[?]|ABNORMAL|VENOUS BLOOD|ICTERIC||MASS SPECTROMETRY|FIBROSIS 4 FORMULA|||Y|Y|5|Visit_5|90|4|TREATMENT|2021-01-26|2021-02-04|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|b91c4469-b3be-467f-8512-b73cf561e168|1|CMPK2|Cytidine-Uridine Monophosphate Kinase 2|HEMATOLOGY|[?]|min|[?]|[?]|TRACE|1|Arbitrary U|1|1|[?]|HIGH|CAPILLARY PLASMA|LACTESCENT||DIFFUSION WEIGHTED MRI|CKD-EPI CYSTATIN C FORMULA|Y|Y|Y||1|Visit_1|10|6|TREATMENT|2020-05-18|2020-06-15|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|b91c4469-b3be-467f-8512-b73cf561e168|2|C165927|Animal Mix IgE AB RAST Score|URINALYSIS|[?]|ug/dose|[?]|[?]|BORDERLINE|1|titer|1|1|[?]|NORMAL|COLOSTRUM|UNEXPECTED ODOR|N|MALDI|MDRD 5 VARIABLE FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-05-18|2020-06-01|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|b91c4469-b3be-467f-8512-b73cf561e168|3|CASTS|Casts|URINALYSIS|[?]|PNU/mL|[?]|[?]|INDETERMINATE|1|mL/cm H2O|1|1|[?]|LOW|ARTERIAL BLOOD|CALCIFIED||STATIC PERIMETRY|MDRD 5 VARIABLE FORMULA|||N||2|Visit_2|25|4|SCREENING|2020-06-02|2020-06-05|25|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|b91c4469-b3be-467f-8512-b73cf561e168|4|C130071|Bermuda Grass Pollen IgG4|URINALYSIS|[?]|DAgU|[?]|[?]|TRACE|1|s^-1(%O2)^-1|1|1|[?]|NORMAL|CALCULUS|REFRIGERATED||IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD 5 VARIABLE FORMULA||Y|N||2|Visit_2|25|1|FOLLOW-UP|2020-06-02|2020-07-19|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|b91c4469-b3be-467f-8512-b73cf561e168|5|RDCSUB|Reducing Substances|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Siemens|1|1|[?]|HIGH|RETICULOCYTES|CONCENTRATED||WRIGHT-GIEMSA STAIN|MDRD FORMULA||Y|NA|Y|3|Visit_3|40|4|TREATMENT|2020-06-17|2020-07-30|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|b91c4469-b3be-467f-8512-b73cf561e168|6|ECCENTCY|Eccentrocytes|HEMATOLOGY|[?]|ms2|[?]|[?]|NEGATIVE|1|tsp eq|1|1|[?]|ABNORMAL|BREAST MILK|UNEXPECTED ODOR||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y||3|Visit_3|40|5|WASHOUT|2020-06-17|2020-07-25|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|b91c4469-b3be-467f-8512-b73cf561e168|7|NEUTLS|Left Shift Neutrophils|CHEMISTRY|[?]|pg/dL|[?]|[?]|INDETERMINATE|1|log10 CFU/g|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|GELLED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|COCKCROFT-GAULT FORMULA||Y|N||4|Visit_4|65|4|TREATMENT|2020-07-12|2020-07-29|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|b91c4469-b3be-467f-8512-b73cf561e168|8|A2MACG|Alpha-2 Macroglobulin|HEMATOLOGY|[?]|mCi|[?]|[?]|INDETERMINATE|1|GPL U|1|1|[?]|HIGH|PLASMA|UNEXPECTED ODOR|N|PELLI-ROBSON EYE CHART|CKD-EPI CYSTATIN C FORMULA|||Y||4|Visit_4|65|7|FOLLOW-UP|2020-07-12|2020-07-20|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|b91c4469-b3be-467f-8512-b73cf561e168|9|POIKILO|Poikilocytes|CHEMISTRY|[?]|mm/2h|[?]|[?]|INDETERMINATE|1|RING|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|CONCENTRATED||SEQUENCING|FIBROMETER FORMULA|||Y||5|Visit_5|90|2|SCREENING|2020-08-06|2020-08-12|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|b91c4469-b3be-467f-8512-b73cf561e168|10|MYCYLE|Myelocytes/Leukocytes|CHEMISTRY|[?]|IU/g|[?]|[?]|NEGATIVE|1|1/(s*kPa)|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|CONTAMINATED|N|ARTERIAL SPIN LABELING FUNCTIONAL MRI|FIBROMETER FORMULA|||U||5|Visit_5|90|7|TREATMENT|2020-08-06|2020-08-09|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|3637e1e0-8c0c-45cc-b139-e812a589f940|1|BICARB|Bicarbonate|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|10^5/L|1|1|[?]|HIGH|BONE|NON-HEMOLYZED|N|ACCELERATOR MASS SPECTROMETRY|FIBROSIS 4 FORMULA|||N|Y|1|Visit_1|10|6|SCREENING|2020-08-30|2020-09-28|10|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|3637e1e0-8c0c-45cc-b139-e812a589f940|2|PRLYMLE|Prolymphocytes/Leukocytes|HEMATOLOGY|[?]|SUPPOSITORY|[?]|[?]|INDETERMINATE|1|Ci/ug|1|1|[?]|LOW|DIALYSIS FLUID|THAWED||DIGITAL PCR ARRAY|CKD-EPI CREATININE FORMULA|||Y||1|Visit_1|10|2|WASHOUT|2020-08-30|2020-10-24|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|3637e1e0-8c0c-45cc-b139-e812a589f940|3|RAGE|Receptor Advanced Glycation Endproducts|HEMATOLOGY|[?]|L/h/m2|[?]|[?]|INDETERMINATE|1|VIAL|1|1|[?]|NORMAL|BONE MARROW|LIPEMIC|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|HEPASCORE FORMULA||Y|N||2|Visit_2|25|7|TREATMENT|2020-09-14|2020-11-01|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|3637e1e0-8c0c-45cc-b139-e812a589f940|4|ALA|Alanine|CHEMISTRY|||[?]|[?]|TRACE|1|JDF Unit|1|1|[?]|HIGH|TISSUE|NON-HEMOLYZED||HEMAGGLUTINATION INHIBITION ASSAY|FIBROTEST FORMULA||Y|Y|Y|2|Visit_2|25|3|WASHOUT|2020-09-14|2020-11-16|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|3637e1e0-8c0c-45cc-b139-e812a589f940|5|GRWHIH|Growth Hormone Inhibiting Hormone|CHEMISTRY|[?]|nmol|[?]|[?]|INDETERMINATE|1|BOTTLE|1|1|[?]|HIGH|CORD BLOOD|AUTOLYZED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI % FORMULA|Y||U||3|Visit_3|40|1|SCREENING|2020-09-29|2020-10-25|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|3637e1e0-8c0c-45cc-b139-e812a589f940|6|DRVTSCPD|dRVVT Screen to Confirm Pct Difference|CHEMISTRY|[?]|ugEq|[?]|[?]|POSITIVE|1|U/kg/min|1|1|[?]|HIGH|MUCUS|FRESH||KINYOUN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||3|Visit_3|40|7|TREATMENT|2020-09-29|2020-10-24|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|3637e1e0-8c0c-45cc-b139-e812a589f940|7|GFRE|Glomerular Filtration Rate, Estimated|URINALYSIS|[?]|cycle/min|[?]|[?]|INDETERMINATE|1|pkat|1|1|[?]|LOW|HAIR FOLLICLE|AGGLUTINATED||TONOMETRY|CKD-EPI CYSTATIN C FORMULA|Y|Y|N||4|Visit_4|65|6|TREATMENT|2020-10-24|2020-11-26|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|LB|3637e1e0-8c0c-45cc-b139-e812a589f940|8|CCK|Cholecystokinin|URINALYSIS|[?]|10^6 RNA copies/mL|[?]|[?]|INVALID|1|g/dL|1|1|[?]|ABNORMAL|SEBUM|ROOM TEMPERATURE||COMPLEMENT FIXATION|CKD-EPI CREATININE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-10-24|2020-10-26|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|LB|3637e1e0-8c0c-45cc-b139-e812a589f940|9|FVAAC|Factor V Activity Actual/Control|URINALYSIS|||[?]|[?]|BORDERLINE|1|mmol/g|1|1|[?]|LOW|PLATELET|CONCENTRATED||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|5|Visit_5|90|4|TREATMENT|2020-11-18|2020-11-27|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|3637e1e0-8c0c-45cc-b139-e812a589f940|10|FVIIAAC|Factor VII Activity Actual/Control|HEMATOLOGY|[?]|10^12/L|[?]|[?]|INVALID|1|mV/sec|1|1|[?]|LOW|TISSUE|LIPEMIC||ELECTROGASTROGRAPHY|MDRD 6 VARIABLE FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-11-18|2020-11-21|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|23385974-5fcd-4c36-b9fa-2fbb3841f182|1|HGF|Hepatocyte Growth Factor|URINALYSIS|[?]|K|[?]|[?]|INDETERMINATE|1|gtt|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|HEMOLYZED||TOTAL BODY IRRADIATION|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|6|SCREENING|2020-11-27|2020-12-17|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|LB|23385974-5fcd-4c36-b9fa-2fbb3841f182|2|CSGRANC|Granular Coarse Casts|URINALYSIS|[?]|mgEq|[?]|[?]|TRACE|1|AgU/mL|1|1|[?]|LOW|CEREBROSPINAL FLUID|NON-HEMOLYZED||FLUOROSCOPY|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|2|FOLLOW-UP|2020-11-27|2020-12-09|10|22|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|LB|23385974-5fcd-4c36-b9fa-2fbb3841f182|3|LYMATLE|Lymphocytes Atypical/Leukocytes|URINALYSIS|[?]|mL/min|[?]|[?]|INDETERMINATE|1|cP|1|1|[?]|HIGH|EXPIRED AIR|DRIED||PH METER MEASUREMENT METHOD|CKD-EPI CYSTATIN C FORMULA|Y|Y|U||2|Visit_2|25|2|TREATMENT|2020-12-12|2021-02-13|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|23385974-5fcd-4c36-b9fa-2fbb3841f182|4|NEUTNSQE|Neutrophils/Non-Squam Epi Cells|HEMATOLOGY|[?]|min|[?]|[?]|BORDERLINE|1|1/(s*kPa)|1|1|[?]|HIGH|ISOLATE|UNEXPECTED ODOR||AUTOREFRACTION|NASH FIBROSURE FORMULA|||NA||2|Visit_2|25|7|SCREENING|2020-12-12|2021-01-19|25|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|23385974-5fcd-4c36-b9fa-2fbb3841f182|5|SHBG|Sex Hormone Binding Globulin|CHEMISTRY|[?]|dpm/mg|[?]|[?]|TRACE|1|mU/g|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE||KINETIC MICROPARTICLE IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|6|SCREENING|2020-12-27|2020-12-29|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|23385974-5fcd-4c36-b9fa-2fbb3841f182|6|C130128|Dog Dander Antigen IgE Antibody|HEMATOLOGY|[?]|/LPF|[?]|[?]|BORDERLINE|1|Bq/ug|1|1|[?]|ABNORMAL|LYMPH|FROZEN||DYNAMOMETRY|HEPASCORE FORMULA|||Y||3|Visit_3|40|2|FOLLOW-UP|2020-12-27|2021-01-26|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|23385974-5fcd-4c36-b9fa-2fbb3841f182|7|PBGCREAT|Porphobilinogen/Creatinine|URINALYSIS|[?]|mg/m2/min|[?]|[?]|TRACE|1|QUANTITY SUFFICIENT|1|1|[?]|HIGH|EMESIS|AUTOLYZED|N|WRIGHT-GIEMSA STAIN|FIBROTEST FORMULA||Y|NA||4|Visit_4|65|6|TREATMENT|2021-01-21|2021-02-16|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|23385974-5fcd-4c36-b9fa-2fbb3841f182|8|LVFBRSC|Liver Fibrosis Score|URINALYSIS|[?]|Newton|[?]|[?]|NEGATIVE|1|vg/kg|1|1|[?]|LOW|CALCULUS|ROOM TEMPERATURE|N|ANTIMICROBIAL COMBINATION TESTING|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||4|Visit_4|65|1|WASHOUT|2021-01-21|2021-02-11|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|23385974-5fcd-4c36-b9fa-2fbb3841f182|9|LYMA|Lymphocytes Activated|URINALYSIS|||[?]|[?]|NEGATIVE|1|mPa|1|1|[?]|HIGH|PERITONEAL FLUID|THAWED||PERIODIC ACID SCHIFF STAIN|MDRD 5 VARIABLE FORMULA|||U|Y|5|Visit_5|90|3|SCREENING|2021-02-15|2021-02-16|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|23385974-5fcd-4c36-b9fa-2fbb3841f182|10|BASOBLE|Basophils Band Form/Leukocytes|HEMATOLOGY|[?]|mg/L|[?]|[?]|BORDERLINE|1|pptr|1|1|[?]|LOW|INTERSTITIAL FLUID|FRESH||DYNAMIC CONTRAST ENHANCED MRI|MDRD ENZYMATIC FORMULA|Y||U||5|Visit_5|90|7|WASHOUT|2021-02-15|2021-02-24|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|1|IGM|Immunoglobulin M|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mL/sec/1.73m2|1|1|[?]|HIGH|SMEGMA|REFRIGERATED||IMMUNOBLOT|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|1|Visit_1|10|4|WASHOUT|2020-12-06|2021-02-28|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|2|HBA1B|Hemoglobin A1B|URINALYSIS|||[?]|[?]|NEGATIVE|1|cm/s|1|1|[?]|LOW|EPITHELIAL CELL|AUTOLYZED||DIGITAL PCR|GMI MMOL/MOL FORMULA|||U|Y|1|Visit_1|10|3|SCREENING|2020-12-06|2020-12-27|10|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|3|MMP3|Matrix Metalloproteinase 3|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|PIPE|1|1|[?]|NORMAL|MUCUS|THAWED||OLIGO ACGH|FIBROSIS 4 FORMULA|||U|Y|2|Visit_2|25|4|TREATMENT|2020-12-21|2021-01-16|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|4|THYPXDAB|Thyroperoxidase Antibody|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|JAR|1|1|[?]|HIGH|BLOOD|SOLIDIFIED||SPECTROPHOTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|Y|2|Visit_2|25|7|WASHOUT|2020-12-21|2021-02-23|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|5|APLSMA2|Alpha-2 Antiplasmin|CHEMISTRY|[?]|10^6 organisms/g|[?]|[?]|BORDERLINE|1|10^6/Ejaculate U|1|1|[?]|NORMAL|EXPIRED AIR|REFRIGERATED||COMPUTERIZED CORNEAL TOPOGRAPHY|HEPASCORE FORMULA|||NA||3|Visit_3|40|7|SCREENING|2021-01-05|2021-02-10|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|6|OSMRTY|Osmolarity|URINALYSIS|[?]|g/m2/day|[?]|[?]|TRACE|1|U/g/min|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|NON-HEMOLYZED|N|FLOCCULATION, CHARCOAL ENHANCED|FIBROTEST FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2021-01-05|2021-01-17|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|7|C165895|Johnson Grass Pollen IgG4 Antibody|HEMATOLOGY|[?]|h/wk|[?]|[?]|NEGATIVE|1|LB|1|1|[?]|HIGH|SWABBED MATERIAL|SOLIDIFIED||PHOTOMETRY|GMI % FORMULA|Y||Y||4|Visit_4|65|4|TREATMENT|2021-01-30|2021-02-11|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|8|FACTVWMU|von Willebrand Factor Multimers|URINALYSIS|[?]|Bq/g|[?]|[?]|INDETERMINATE|1|kg/L|1|1|[?]|LOW|GASTRIC FLUID|HEMOLYZED||GEL ELECTROPHORESIS|CKD-EPI FORMULA|||N||4|Visit_4|65|2|WASHOUT|2021-01-30|2021-02-08|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|9|ERCEMPOL|Erythroid Maturation Pool|HEMATOLOGY|[?]|10^3 DNA copies/mL|[?]|[?]|POSITIVE|1|BE/mL|1|1|[?]|HIGH|VENOUS BLOOD|THAWED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|2|WASHOUT|2021-02-24|2021-03-04|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|10|ABO|ABO Blood Group|URINALYSIS|[?]|DNA copies/mL|[?]|[?]|BORDERLINE|1|nsec|1|1|[?]|HIGH|DIALYSIS FLUID|LACTESCENT||INTERRUPTER TECHNIQUE|ASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|3|TREATMENT|2021-02-24|2021-03-01|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|f1327e16-08c6-4ef0-852e-13c095a94c00|1|MYCEPIDX|Myeloid Proliferation Index|URINALYSIS|[?]|uCi|[?]|[?]|POSITIVE|1|ug/dose|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|PARAFFIN-EMBEDDED||DNA MICROARRAY|ASH FIBROSURE FORMULA|Y||U||1|Visit_1|10|6|TREATMENT|2020-05-26|2020-06-27|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-20
e|LB|f1327e16-08c6-4ef0-852e-13c095a94c00|2|CAPHOS|Calcium/Phosphorus|CHEMISTRY|||[?]|[?]|BORDERLINE|1|kV|1|1|[?]|ABNORMAL|EPITHELIAL CELL|FRESH||BAC ACGH|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|1|Visit_1|10|3|SCREENING|2020-05-26|2020-07-27|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-20
e|LB|f1327e16-08c6-4ef0-852e-13c095a94c00|3|ADPNCTN|Adiponectin|URINALYSIS|||[?]|[?]|INVALID|1|mOsm|1|1|[?]|NORMAL|SPUTUM|FROZEN||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|GMI % FORMULA|||NA|Y|2|Visit_2|25|2|TREATMENT|2020-06-10|2020-08-12|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|LB|f1327e16-08c6-4ef0-852e-13c095a94c00|4|CALB|Calbindin|URINALYSIS|[?]|g/m2|[?]|[?]|POSITIVE|1|mPa|1|1|[?]|HIGH|HAIR FOLLICLE|GELLED||GIEMSA STAIN|CKD-EPI CREATININE FORMULA||Y|U||2|Visit_2|25|1|TREATMENT|2020-06-10|2020-06-22|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|LB|f1327e16-08c6-4ef0-852e-13c095a94c00|5|ROUNDCE|Round Cells|CHEMISTRY|||[?]|[?]|TRACE|1|g/mol|1|1|[?]|NORMAL|PERSPIRATION|NON-HEMOLYZED|N|WHOLE EXOME SEQUENCING|CKD-EPI CYSTATIN C FORMULA|Y||Y|Y|3|Visit_3|40|6|TREATMENT|2020-06-25|2020-07-02|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|LB|f1327e16-08c6-4ef0-852e-13c095a94c00|6|INSAAB|Insulin Autoantibody|URINALYSIS|[?]|/10^3|[?]|[?]|NEGATIVE|1|SACHET|1|1|[?]|HIGH|VITREOUS HUMOR|THAWED||HEMATOXYLIN AND EOSIN STAIN|GMI % FORMULA|Y||Y||3|Visit_3|40|3|TREATMENT|2020-06-25|2020-07-29|40|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|LB|f1327e16-08c6-4ef0-852e-13c095a94c00|7|METHDN|Methadone|HEMATOLOGY|[?]|10^3 copies/mL|[?]|[?]|NEGATIVE|1|10^8/L|1|1|[?]|HIGH|PLEURAL FLUID|LIPEMIC||PERIPHERAL ANGIOGRAPHY|FIBROMETER FORMULA|||U||4|Visit_4|65|3|FOLLOW-UP|2020-07-20|2020-08-14|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|f1327e16-08c6-4ef0-852e-13c095a94c00|8|FACTXIV|Factor XIV|URINALYSIS|[?]|g/animal/day|[?]|[?]|TRACE|1|mmHg|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED||PH METER MEASUREMENT METHOD|CKD-EPI FORMULA|Y||NA||4|Visit_4|65|7|WASHOUT|2020-07-20|2020-07-22|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|f1327e16-08c6-4ef0-852e-13c095a94c00|9|VLDL|VLDL Cholesterol|URINALYSIS|[?]|CIGAR|[?]|[?]|INDETERMINATE|1|atm|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|LACTESCENT||LC-FL|HEPASCORE FORMULA|Y||U||5|Visit_5|90|3|TREATMENT|2020-08-14|2020-08-21|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|f1327e16-08c6-4ef0-852e-13c095a94c00|10|MUCTHR|Mucous Threads|URINALYSIS|||[?]|[?]|INVALID|1|log10 PFU|1|1|[?]|NORMAL|LAVAGE FLUID|UNEXPECTED ODOR||IMPEDANCE CONDUCTIVITY|FIBROTEST FORMULA|||Y|Y|5|Visit_5|90|4|TREATMENT|2020-08-14|2020-08-19|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|1|BILI|Bilirubin|CHEMISTRY|||[?]|[?]|BORDERLINE|1|g/m2/day|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|CONTAMINATED||PEAK FLOWMETRY|NASH FIBROSURE FORMULA|||N|Y|1|Visit_1|10|6|TREATMENT|2021-01-15|2021-04-13|10|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|2|C147282|White Oak Pollen IgE Antibody|HEMATOLOGY|[?]|10^6 CFU|[?]|[?]|BORDERLINE|1|g/day|1|1|[?]|ABNORMAL|BREAST MILK|FRESH||CELLULAR PROLIFERATION ASSAY|HEPASCORE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2021-01-15|2021-02-26|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|3|HBA1B|Hemoglobin A1B|CHEMISTRY|[?]|g/g/day|[?]|[?]|NEGATIVE|1|nmol/L/h|1|1|[?]|NORMAL|LUNG SURFACTANT|LIPEMIC||ORCHIDOMETERY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||2|Visit_2|25|6|WASHOUT|2021-01-30|2021-02-21|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|4|APPB|Amyloid Beta Precursor Protein|HEMATOLOGY|||[?]|[?]|INVALID|1|s/h|1|1|[?]|HIGH|EMOTIONAL TEAR|CONCENTRATED||MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD ENZYMATIC FORMULA|||N|Y|2|Visit_2|25|6|TREATMENT|2021-01-30|2021-02-23|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|5|IA5OHEXR|5-HydroxyindoleaceticAcid Excretion Rate|URINALYSIS|[?]|umol/mol|[?]|[?]|POSITIVE|1|ppth|1|1|[?]|LOW|LUNG SURFACTANT|NON-HEMOLYZED||ANTIMICROBIAL COMBINATION TESTING|CKD-EPI CYSTATIN C FORMULA|||U||3|Visit_3|40|7|SCREENING|2021-02-14|2021-04-03|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|LB|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|6|LKM1IAAB|Liver Kidney Microsomal Type 1 IgA Ab|URINALYSIS|[?]|deg/s|[?]|[?]|TRACE|1|pmol/dL|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|ROOM TEMPERATURE||BALLPOINT PEN TECHNIQUE|CKD-EPI FORMULA|||Y||3|Visit_3|40|4|TREATMENT|2021-02-14|2021-02-28|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|LB|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|7|CXCL1|Chemokine (C-X-C Motif) Ligand 1|URINALYSIS|[?]|%/s|[?]|[?]|POSITIVE|1|mAmp|1|1|[?]|ABNORMAL|PLEURAL TISSUE|FRESH||MODIFIED ACID FAST STAIN|HEPASCORE FORMULA||Y|U||4|Visit_4|65|6|TREATMENT|2021-03-11|2021-03-21|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|8|RENINA|Renin Activity|HEMATOLOGY|[?]|mg/kg|[?]|[?]|NEGATIVE|1|km/h|1|1|[?]|NORMAL|SPUTUM|FRESH||PERIODIC ACID SCHIFF STAIN|MDRD 6 VARIABLE FORMULA|Y|Y|NA||4|Visit_4|65|4|WASHOUT|2021-03-11|2021-04-01|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|9|CH50|Complement CH50|CHEMISTRY|[?]|ukat|[?]|[?]|BORDERLINE|1|/LPF|1|1|[?]|LOW|HAIR|ICTERIC|N|FARR ASSAY|MDRD FORMULA|||Y||5|Visit_5|90|1|FOLLOW-UP|2021-04-05|2021-04-12|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|10|CBANH9|Carbonic Anhydrase 9|HEMATOLOGY|[?]|mg/cm2|[?]|[?]|NEGATIVE|1|mg/kg/dose|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED|N|FARR ASSAY|MDRD 6 VARIABLE FORMULA||Y|U||5|Visit_5|90|5|TREATMENT|2021-04-05|2021-04-09|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|e8065021-c163-41c8-8a76-5f0c1c3a06c4|1|FLT3L|FMS-like Tyrosine Kinase 3 Ligand|URINALYSIS|[?]|mm3/mm2/year|[?]|[?]|POSITIVE|1|CYLINDER|1|1|[?]|ABNORMAL|MUSCLE TISSUE|PARAFFIN-EMBEDDED|N|PYROSEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||NA||1|Visit_1|10|4|FOLLOW-UP|2020-12-08|2021-01-11|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|e8065021-c163-41c8-8a76-5f0c1c3a06c4|2|GRAN|Granulocytes|CHEMISTRY|[?]|m/sec|[?]|[?]|INVALID|1|%(v/v)|1|1|[?]|ABNORMAL|PROSTATIC FLUID|LIPEMIC||SLOAN LETTER EYE CHART 2.5%|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||1|Visit_1|10|5|TREATMENT|2020-12-08|2021-01-07|10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|e8065021-c163-41c8-8a76-5f0c1c3a06c4|3|HOMOCY|Homocysteine|HEMATOLOGY|||[?]|[?]|POSITIVE|1|g/L|1|1|[?]|LOW|BONE MARROW|PARAFFIN-EMBEDDED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE FORMULA|||U|Y|2|Visit_2|25|3|TREATMENT|2020-12-23|2021-03-01|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|e8065021-c163-41c8-8a76-5f0c1c3a06c4|4|C3A|Complement C3a|CHEMISTRY|||[?]|[?]|POSITIVE|1|CAPLET|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|GELLED|N|NUCLEIC ACID SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|2|Visit_2|25|5|TREATMENT|2020-12-23|2021-02-13|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|e8065021-c163-41c8-8a76-5f0c1c3a06c4|5|FCTVIIIA|Factor VIII Activity|CHEMISTRY|[?]|ug/kg|[?]|[?]|NEGATIVE|1|mm2|1|1|[?]|HIGH|EPIDERMAL TISSUE|HEMOLYZED||OPTICAL COHERENCE TOMOGRAPHY|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|6|TREATMENT|2021-01-07|2021-01-22|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|e8065021-c163-41c8-8a76-5f0c1c3a06c4|6|ASN|Asparagine|CHEMISTRY|[?]|mL/cm|[?]|[?]|INDETERMINATE|1|GLOBULE|1|1|[?]|NORMAL|SEMINAL FLUID|REFRIGERATED||LIGHT MICROSCOPY|NASH FIBROSURE FORMULA||Y|Y||3|Visit_3|40|4|TREATMENT|2021-01-07|2021-02-28|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|e8065021-c163-41c8-8a76-5f0c1c3a06c4|7|LY6E|Lymphocyte Antigen 6E|URINALYSIS|[?]|/10^4|[?]|[?]|INVALID|1|g/dL|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED||MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2021-02-01|2021-02-15|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|e8065021-c163-41c8-8a76-5f0c1c3a06c4|8|OPG|Osteoprotegerin|CHEMISTRY|[?]|ugEq|[?]|[?]|BORDERLINE|1|USP U|1|1|[?]|ABNORMAL|SEBUM|AUTOLYZED||MICROBIAL CULTURE, SOLID|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||4|Visit_4|65|7|FOLLOW-UP|2021-02-01|2021-02-22|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|e8065021-c163-41c8-8a76-5f0c1c3a06c4|9|CYAMORPH|Amorphous Crystals|HEMATOLOGY|||[?]|[?]|POSITIVE|1|kg/cm|1|1|[?]|LOW|ERYTHROCYTES|CONTAMINATED||CT SCAN|FIBROSIS 4 FORMULA|||Y|Y|5|Visit_5|90|4|TREATMENT|2021-02-26|2021-03-01|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|LB|e8065021-c163-41c8-8a76-5f0c1c3a06c4|10|AMMONIA|Ammonia|HEMATOLOGY|[?]|MAC50|[?]|[?]|BORDERLINE|1|ft2|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|ICTERIC||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2021-02-26|2021-02-27|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|LB|854a9218-995e-47f4-87ab-e58d20f56d19|1|IGE|Immunoglobulin E|CHEMISTRY|[?]|JAR|[?]|[?]|NEGATIVE|1|log10 TCID 50/uL|1|1|[?]|NORMAL|BILE|GELLED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA|Y||U||1|Visit_1|10|7|TREATMENT|2020-11-23|2020-12-14|10|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|854a9218-995e-47f4-87ab-e58d20f56d19|2|AMYLASE|Amylase|CHEMISTRY|[?]|PACKAGE|[?]|[?]|INVALID|1|U/L|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|DRIED||NUCLEIC ACID BASED METHOD|HEPASCORE FORMULA||Y|Y||1|Visit_1|10|7|TREATMENT|2020-11-23|2020-12-20|10|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|854a9218-995e-47f4-87ab-e58d20f56d19|3|AMH|Anti-Mullerian Hormone|CHEMISTRY|||[?]|[?]|BORDERLINE|1|10^6 U|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|ROOM TEMPERATURE||PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA|Y|Y|N|Y|2|Visit_2|25|3|TREATMENT|2020-12-08|2021-02-19|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|854a9218-995e-47f4-87ab-e58d20f56d19|4|LPPLA2|Lipoprotein Associated Phospholipase A2|URINALYSIS|[?]|steps/min|[?]|[?]|POSITIVE|1|GBq/ug|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|AGGLUTINATED||TRIPLE-PHASE SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA|Y||U||2|Visit_2|25|1|WASHOUT|2020-12-08|2021-01-16|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|854a9218-995e-47f4-87ab-e58d20f56d19|5|TAT|Thrombin/Antithrombin|HEMATOLOGY|[?]|gMFI|[?]|[?]|INDETERMINATE|1|/month|1|1|[?]|NORMAL|PLEURAL FLUID|ROOM TEMPERATURE||FARR ASSAY|NASH FIBROSURE FORMULA|||NA||3|Visit_3|40|5|FOLLOW-UP|2020-12-23|2021-02-07|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|854a9218-995e-47f4-87ab-e58d20f56d19|6|IOHEXCLR|Iohexol Clearance|CHEMISTRY|[?]|VIAL|[?]|[?]|TRACE|1|Gravitational Unit|1|1|[?]|HIGH|WHITE MATTER TISSUE|LACTESCENT||ELASTOGRAPHY|ASH FIBROSURE FORMULA|||U||3|Visit_3|40|7|TREATMENT|2020-12-23|2021-02-19|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|854a9218-995e-47f4-87ab-e58d20f56d19|7|CD13|CD13|URINALYSIS|[?]|COAT|[?]|[?]|INDETERMINATE|1|ppm|1|1|[?]|LOW|URINE|ROOM TEMPERATURE||IMMUNOCHROMATOGRAPHY|FIBROMETER FORMULA|||N||4|Visit_4|65|6|TREATMENT|2021-01-17|2021-02-13|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|854a9218-995e-47f4-87ab-e58d20f56d19|8|CCL13|Chemokine (C-C Motif) Ligand 13|CHEMISTRY|||[?]|[?]|TRACE|1|TABLET|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|AGGLUTINATED||PHOROPTER|FIBROSIS 4 FORMULA|||NA|Y|4|Visit_4|65|2|FOLLOW-UP|2021-01-17|2021-02-07|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|854a9218-995e-47f4-87ab-e58d20f56d19|9|C165909|Industrial Mix IgG AB RAST Score|CHEMISTRY|||[?]|[?]|NEGATIVE|1|10^7 CFU/mL|1|1|[?]|HIGH|ADIPOSE TISSUE|SOLIDIFIED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|5|Visit_5|90|7|TREATMENT|2021-02-11|2021-02-13|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|854a9218-995e-47f4-87ab-e58d20f56d19|10|SEZCELE|Sezary Cells/Leukocytes|CHEMISTRY|[?]|mol/g|[?]|[?]|TRACE|1|PFU/dose|1|1|[?]|ABNORMAL|CERUMEN|FRESH||SURFACE PLASMON RESONANCE|CKD-EPI CREATININE FORMULA|Y||NA||5|Visit_5|90|1|TREATMENT|2021-02-11|2021-02-14|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|1|HGBB|Hemoglobin B|URINALYSIS|[?]|cd|[?]|[?]|INVALID|1|Ci|1|1|[?]|ABNORMAL|TISSUE|UNEXPECTED ODOR||PATHOLOGICAL EVALUATION|GMI MMOL/MOL FORMULA||Y|U||1|Visit_1|10|1|WASHOUT|2020-06-21|2020-09-09|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|2|NEUTIM|Immature Neutrophils|URINALYSIS|[?]|mg/min|[?]|[?]|INDETERMINATE|1|mL/m2/h|1|1|[?]|LOW|PLATELET POOR PLASMA|CALCIFIED|N|ULTRASOUND|COCKCROFT-GAULT FORMULA|Y||U||1|Visit_1|10|3|FOLLOW-UP|2020-06-21|2020-08-14|10|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|3|HOMOCIT|Homocitrulline|HEMATOLOGY|[?]|g/day|[?]|[?]|POSITIVE|1|uU/dL|1|1|[?]|ABNORMAL|PERSPIRATION|CLOTTED||MS/MS|MDRD 5 VARIABLE FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-07-06|2020-07-31|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|4|BASOIM|Immature Basophils|URINALYSIS|[?]|PIXELS/in|[?]|[?]|TRACE|1|SQU/mL|1|1|[?]|LOW|PLEURAL TISSUE|PARAFFIN-EMBEDDED||QUANTITATIVE ULTRASOUND|NASH FIBROSURE FORMULA|Y|Y|Y||2|Visit_2|25|6|TREATMENT|2020-07-06|2020-07-17|25|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|5|INTLK25|Interleukin 25|URINALYSIS|[?]|U/g/day|[?]|[?]|INVALID|1|ug|1|1|[?]|HIGH|SERUM OR PLASMA|SOLIDIFIED|N|CONTRAST ENHANCED MRI|CKD-EPI CREATININE FORMULA|||U||3|Visit_3|40|6|FOLLOW-UP|2020-07-21|2020-08-23|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|LB|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|6|TNF12S|Soluble TNF Superfamily Member 12|CHEMISTRY|[?]|mm/min|[?]|[?]|POSITIVE|1|umol/dL|1|1|[?]|ABNORMAL|TRANSUDATE|DRIED|N|HPLC/IEX|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-07-21|2020-09-18|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|LB|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|7|ROUNDCE|Round Cells|URINALYSIS|[?]|BISCUIT|[?]|[?]|INVALID|1|genEq|1|1|[?]|NORMAL|AMNIOTIC FLUID|LIPEMIC||CINEANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-08-15|2020-08-28|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|LB|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|8|FXIVAAC|Factor XIV Activity Actual/Control|URINALYSIS|[?]|kg/L|[?]|[?]|BORDERLINE|1|oz eq|1|1|[?]|NORMAL|CELL PELLET|CONTAMINATED|N|HPLC/MS|CKD-EPI CREATININE FORMULA|Y||U||4|Visit_4|65|5|FOLLOW-UP|2020-08-15|2020-08-31|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|LB|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|9|RBCGHOST|Erythrocyte Ghosts|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|MPS U|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|LACTESCENT||ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD FORMULA|||N|Y|5|Visit_5|90|5|TREATMENT|2020-09-09|2020-09-14|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|10|LCHT|Lithocholate|URINALYSIS|[?]|/500 WBC|[?]|[?]|NEGATIVE|1|mL/s|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|GELLED|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA|||Y||5|Visit_5|90|4|WASHOUT|2020-09-09|2020-09-16|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|08944dcd-a62d-4932-bb15-a8f15cc73229|1|PLATAGGR|Platelet Aggregation|URINALYSIS|[?]|U/kg/day|[?]|[?]|NEGATIVE|1|Ci/uL|1|1|[?]|NORMAL|RETICULOCYTES|DRIED||GIEMSA STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||1|Visit_1|10|6|WASHOUT|2020-12-23|2021-02-23|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|08944dcd-a62d-4932-bb15-a8f15cc73229|2|BASOMM|Basophilic Metamyelocytes|HEMATOLOGY|[?]|U/g/day|[?]|[?]|INDETERMINATE|1|beats/min|1|1|[?]|NORMAL|REFLEX TEAR|HEMOLYZED||NUCLEIC ACID SEQUENCING|GMI % FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-12-23|2021-03-20|10|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|08944dcd-a62d-4932-bb15-a8f15cc73229|3|HVA|Homovanillic Acid|CHEMISTRY|[?]|mL/cage/wk|[?]|[?]|BORDERLINE|1|GPS U|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|LACTESCENT|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|HEPASCORE FORMULA|||U||2|Visit_2|25|3|WASHOUT|2021-01-07|2021-01-30|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|08944dcd-a62d-4932-bb15-a8f15cc73229|4|GRAN|Granulocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|EID 50/dose|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED||PET SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U|Y|2|Visit_2|25|6|SCREENING|2021-01-07|2021-01-17|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|08944dcd-a62d-4932-bb15-a8f15cc73229|5|TRICH|Trichomonas|URINALYSIS|[?]|ka_u/dL|[?]|[?]|POSITIVE|1|10^3 copies/mL|1|1|[?]|LOW|EXUDATE|CONCENTRATED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|GMI MMOL/MOL FORMULA|||N||3|Visit_3|40|5|TREATMENT|2021-01-22|2021-03-20|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|08944dcd-a62d-4932-bb15-a8f15cc73229|6|SPGRAV|Specific Gravity|CHEMISTRY|||[?]|[?]|POSITIVE|1|/40 HPFs|1|1|[?]|NORMAL|SEBUM|NON-HEMOLYZED||OBSERVATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|5|TREATMENT|2021-01-22|2021-02-06|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|08944dcd-a62d-4932-bb15-a8f15cc73229|7|BASOIMLE|Immature Basophils/Leukocytes|CHEMISTRY|[?]|uCi/L|[?]|[?]|BORDERLINE|1|mg/L|1|1|[?]|NORMAL|PUS|REFRIGERATED||KLEIHAUER-BETKE|GMI % FORMULA|Y|Y|NA||4|Visit_4|65|4|FOLLOW-UP|2021-02-16|2021-03-03|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|08944dcd-a62d-4932-bb15-a8f15cc73229|8|PCNAG|Proliferating Cell Nuclear Antigen|CHEMISTRY|[?]|km/h|[?]|[?]|INVALID|1|U/10^12 RBC|1|1|[?]|HIGH|MUCUS|SOLIDIFIED||SPECT/CT SCAN|GMI MMOL/MOL FORMULA|Y||Y||4|Visit_4|65|7|FOLLOW-UP|2021-02-16|2021-03-18|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|08944dcd-a62d-4932-bb15-a8f15cc73229|9|CXCL12|Chemokine (C-X-C Motif) Ligand 12|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|log10 copies/mL|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|PARAFFIN-EMBEDDED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|ASH FIBROSURE FORMULA|Y||U|Y|5|Visit_5|90|7|FOLLOW-UP|2021-03-13|2021-03-15|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|08944dcd-a62d-4932-bb15-a8f15cc73229|10|FLUVOXAM|Fluvoxamine|URINALYSIS|[?]|uV2|[?]|[?]|BORDERLINE|1|BAU/mL|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|ICTERIC|N|SPIRAL CT|COCKCROFT-GAULT FORMULA|||N||5|Visit_5|90|2|TREATMENT|2021-03-13|2021-03-16|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|1d7df560-695a-41fe-9226-4cc206b05f48|1|GDA|Guanine Deaminase|URINALYSIS|||[?]|[?]|TRACE|1|dL|1|1|[?]|NORMAL|GASTRIC FLUID|DRIED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|1|Visit_1|10|1|TREATMENT|2020-12-09|2021-01-22|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|1d7df560-695a-41fe-9226-4cc206b05f48|2|LYMATLE|Lymphocytes Atypical/Leukocytes|HEMATOLOGY|[?]|10^4/hpf|[?]|[?]|NEGATIVE|1|U/m2/day|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|REFRIGERATED|N|CLOT DETECTION|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|7|FOLLOW-UP|2020-12-09|2021-02-27|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|1d7df560-695a-41fe-9226-4cc206b05f48|3|HDL2|HDL-Cholesterol Subclass 2|HEMATOLOGY|[?]|10^7/L|[?]|[?]|INDETERMINATE|1|uIU/dL|1|1|[?]|ABNORMAL|BUFFY COAT|AGGLUTINATED|N|REFRACTOMETRY|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-12-24|2021-02-13|25|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|1d7df560-695a-41fe-9226-4cc206b05f48|4|PGAG|Platelet-Granulocyte Agg|URINALYSIS|||[?]|[?]|POSITIVE|1|cm2|1|1|[?]|ABNORMAL|EPITHELIAL CELL|CONCENTRATED||POPULATION SEQUENCING|MDRD 6 VARIABLE FORMULA|||NA|Y|2|Visit_2|25|3|TREATMENT|2020-12-24|2021-01-15|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|1d7df560-695a-41fe-9226-4cc206b05f48|5|ISOPRF2|F2-Isoprostane|HEMATOLOGY|[?]|lm|[?]|[?]|INDETERMINATE|1|MESF|1|1|[?]|NORMAL|NAIL|CALCIFIED||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|5|TREATMENT|2021-01-08|2021-01-24|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|1d7df560-695a-41fe-9226-4cc206b05f48|6|TLCHT|Taurolithocholate|URINALYSIS|[?]|umol/L|[?]|[?]|BORDERLINE|1|IU/mg|1|1|[?]|NORMAL|ALVEOLAR AIR|ROOM TEMPERATURE||ANGIOGRAPHY|MDRD ENZYMATIC FORMULA|Y||U||3|Visit_3|40|7|TREATMENT|2021-01-08|2021-02-24|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|1d7df560-695a-41fe-9226-4cc206b05f48|7|CSRBC|RBC Casts|URINALYSIS|[?]|km/h|[?]|[?]|INDETERMINATE|1|mV|1|1|[?]|HIGH|CORD SERUM|FROZEN||REBOUND TONOMETRY|COCKCROFT-GAULT FORMULA|Y|Y|Y||4|Visit_4|65|2|TREATMENT|2021-02-02|2021-02-08|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|1d7df560-695a-41fe-9226-4cc206b05f48|8|PROMYCE|Promyelocytes/Total Cells|URINALYSIS|[?]|10^6 organisms|[?]|[?]|BORDERLINE|1|cmH2O*s2/mL|1|1|[?]|NORMAL|SMEGMA|AGGLUTINATED|N|FUNCTIONAL MRI|NASH FIBROSURE FORMULA|Y||Y||4|Visit_4|65|1|TREATMENT|2021-02-02|2021-02-23|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|1d7df560-695a-41fe-9226-4cc206b05f48|9|CACRALB|Calcium Corrected for Albumin|HEMATOLOGY|[?]|MBq|[?]|[?]|TRACE|1|/500 WBC|1|1|[?]|HIGH|ARTERIAL BLOOD|LIPEMIC||KINETIC MICROPARTICLE IMMUNOASSAY|ASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|2|FOLLOW-UP|2021-02-27|2021-03-05|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|1d7df560-695a-41fe-9226-4cc206b05f48|10|FACTIII|Factor III|HEMATOLOGY|[?]|mg/mol|[?]|[?]|NEGATIVE|1|ngEq/L|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|ROOM TEMPERATURE||CONTRAST ENHANCED PET SCAN|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||5|Visit_5|90|3|FOLLOW-UP|2021-02-27|2021-03-03|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|12c802a8-862c-45a4-b12c-a6f920772534|1|FACTXIIA|Factor XII Activity|CHEMISTRY|[?]|10^6 organisms/mL|[?]|[?]|INDETERMINATE|1|PFU|1|1|[?]|HIGH|GASTRIC CONTENTS|PARAFFIN-EMBEDDED||MICROPARTICLE ENZYME IMMUNOASSAY|FIBROTEST FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-06-17|2020-07-30|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|12c802a8-862c-45a4-b12c-a6f920772534|2|CYDRUG|Drug Crystals|CHEMISTRY|[?]|10^6 organisms/mg|[?]|[?]|BORDERLINE|1|mEq/day|1|1|[?]|NORMAL|GASTRIC FLUID|REFRIGERATED||HILLMEN COLOR CHART|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-06-17|2020-09-10|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|12c802a8-862c-45a4-b12c-a6f920772534|3|CTOT|Complement Total|URINALYSIS|[?]|10^4/L|[?]|[?]|TRACE|1|EVENTS|1|1|[?]|NORMAL|LUNG SURFACTANT|DRIED|N|HEMATOXYLIN AND EOSIN STAIN|MDRD ENZYMATIC FORMULA|||N||2|Visit_2|25|7|FOLLOW-UP|2020-07-02|2020-08-27|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|12c802a8-862c-45a4-b12c-a6f920772534|4|IGFBP1|Insulin-Like Growth Factor Binding Prot1|URINALYSIS|||[?]|[?]|INVALID|1|mL/kg/h|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|FROZEN|N|NEPHELOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA|Y|2|Visit_2|25|1|TREATMENT|2020-07-02|2020-08-22|25|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|12c802a8-862c-45a4-b12c-a6f920772534|5|DPDCREAT|Deoxypyridinoline/Creatinine|CHEMISTRY|[?]|mg/m2/min|[?]|[?]|INDETERMINATE|1|dram|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|AGGLUTINATED|N|DIRECT SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|2|SCREENING|2020-07-17|2020-08-05|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|12c802a8-862c-45a4-b12c-a6f920772534|6|INTLK18|Interleukin 18|HEMATOLOGY|[?]|uL/kg/day|[?]|[?]|POSITIVE|1|ug/m2/min|1|1|[?]|LOW|PERSPIRATION|AGGLUTINATED||DXA SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||3|Visit_3|40|1|WASHOUT|2020-07-17|2020-09-04|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|12c802a8-862c-45a4-b12c-a6f920772534|7|RHD|RhD Factor|URINALYSIS|[?]|mL/kg|[?]|[?]|NEGATIVE|1|/VF|1|1|[?]|LOW|SOFT TISSUE|CLOTTED||DIFFUSION TENSOR MRI|HEPASCORE FORMULA||Y|Y||4|Visit_4|65|1|FOLLOW-UP|2020-08-11|2020-08-27|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|12c802a8-862c-45a4-b12c-a6f920772534|8|POLYNORM|Polychromatophilic Normoblast|CHEMISTRY|[?]|10^4/hpf|[?]|[?]|NEGATIVE|1|BAR|1|1|[?]|NORMAL|ADIPOSE TISSUE|PARAFFIN-EMBEDDED|N|THIN SMEAR|MDRD 4 VARIABLE FORMULA|||Y||4|Visit_4|65|4|SCREENING|2020-08-11|2020-08-30|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|12c802a8-862c-45a4-b12c-a6f920772534|9|AMPHETD|Dextroamphetamine|CHEMISTRY|[?]|anti-Xa IU|[?]|[?]|INDETERMINATE|1|/VF|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|FRESH||MEDIASTINOSCOPY|FIBROTEST FORMULA|||Y||5|Visit_5|90|2|SCREENING|2020-09-05|2020-09-11|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|12c802a8-862c-45a4-b12c-a6f920772534|10|GGTCREAT|Gamma Glutamyl Transferase/Creatinine|HEMATOLOGY|[?]|cm2|[?]|[?]|NEGATIVE|1|atm|1|1|[?]|LOW|VENOUS BLOOD|REFRIGERATED||NO INFORMATION|MDRD FORMULA|Y||U||5|Visit_5|90|1|TREATMENT|2020-09-05|2020-09-07|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|1|ALUMINUM|Aluminum|CHEMISTRY|[?]|AU/mL|[?]|[?]|BORDERLINE|1|Pa|1|1|[?]|LOW|BUFFY COAT|CALCIFIED||PET/CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-11-23|2020-12-12|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|2|GLN|Glutamine|CHEMISTRY|[?]|min|[?]|[?]|POSITIVE|1|U/dL|1|1|[?]|NORMAL|SERUM OR PLASMA|AGGLUTINATED||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-11-23|2020-11-26|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|3|C165877|Cat Dander IgE AB RAST Score|URINALYSIS|[?]|DAYS|[?]|[?]|NEGATIVE|1|g|1|1|[?]|NORMAL|LYMPH|HEMOLYZED||CT SCAN|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|4|WASHOUT|2020-12-08|2020-12-14|25|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|4|DKK1|Dickkopf WNT Signaling Path Inhibitor 1|URINALYSIS|[?]|YEARS|[?]|[?]|BORDERLINE|1|GBq/ug|1|1|[?]|ABNORMAL|STOOL|DRIED||DIRECT SEQUENCING|ASH FIBROSURE FORMULA|Y|Y|Y||2|Visit_2|25|3|TREATMENT|2020-12-08|2021-01-14|25|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|5|TGFB2|Transforming Growth Factor Beta 2|CHEMISTRY|[?]|U/m2|[?]|[?]|INVALID|1|ELISA unit/mL|1|1|[?]|LOW|MONOCYTE|DRIED||WRIGHT STAIN|FIBROMETER FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-12-23|2021-01-09|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|6|APPT|Total Amyloid Precursor Protein|URINALYSIS|[?]|fmol|[?]|[?]|POSITIVE|1|pmol/10^10 cells|1|1|[?]|LOW|AMNIOTIC FLUID|AUTOLYZED|N|SURFACE PLASMON RESONANCE|FIBROTEST FORMULA|Y||NA||3|Visit_3|40|3|TREATMENT|2020-12-23|2021-02-06|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|7|FACTII|Factor II|CHEMISTRY|[?]|mg/L FEU|[?]|[?]|INDETERMINATE|1|MBq/uL|1|1|[?]|LOW|NAIL|PARAFFIN-EMBEDDED||ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD ENZYMATIC FORMULA|Y||Y||4|Visit_4|65|5|TREATMENT|2021-01-17|2021-02-15|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|8|CYMSU|Monosodium Urate Crystals|HEMATOLOGY|||[?]|[?]|POSITIVE|1|vp/mL|1|1|[?]|ABNORMAL|DISCHARGE|FRESH|N|JAFFE REACTION|FIBROMETER FORMULA|Y|Y|U|Y|4|Visit_4|65|1|SCREENING|2021-01-17|2021-02-15|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|9|FIO2|Fraction of Inspired Oxygen|HEMATOLOGY|[?]|cm|[?]|[?]|INDETERMINATE|1|U/m2/h|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|UNEXPECTED ODOR||ANTIMICROBIAL COMBINATION TESTING|MDRD ENZYMATIC FORMULA|||NA||5|Visit_5|90|7|SCREENING|2021-02-11|2021-02-18|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|10|INSLNFR|Insulin, Free|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|cmH2O*s2/mL|1|1|[?]|NORMAL|SUPERNATANT, SERUM|LIPEMIC||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA|||Y|Y|5|Visit_5|90|7|TREATMENT|2021-02-11|2021-02-16|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|1|HETRPHLE|Heterophils/Leukocytes|URINALYSIS|[?]|SFC/10^6 PBMC|[?]|[?]|INVALID|1|kN/cm2|1|1|[?]|LOW|SKIN TISSUE|REFRIGERATED||DNA MICROARRAY|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|1|TREATMENT|2020-08-16|2020-11-09|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|2|C165900|Orchard Grass Pollen IgG AB RAST Score|CHEMISTRY|[?]|damol/L|[?]|[?]|POSITIVE|1|100 IU/mL|1|1|[?]|NORMAL|BREAST MILK|AGGLUTINATED||DOPPLER ULTRASOUND|CKD-EPI FORMULA||Y|NA||1|Visit_1|10|7|TREATMENT|2020-08-16|2020-11-01|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|3|TTGIGMAB|Tissue Transglutaminase IgM Antibody|CHEMISTRY|||[?]|[?]|TRACE|1|nmol|1|1|[?]|HIGH|AMNIOTIC FLUID|CONCENTRATED||ICC|CKD-EPI CREATININE FORMULA|||Y|Y|2|Visit_2|25|6|WASHOUT|2020-08-31|2020-09-13|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|4|ISOPRF2|F2-Isoprostane|HEMATOLOGY|[?]|Joule|[?]|[?]|TRACE|1|log10 copies/mL|1|1|[?]|ABNORMAL|PUS|ROOM TEMPERATURE|N|ZIEHL NEELSEN ACID FAST STAIN|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-08-31|2020-11-10|25|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|5|GLUC|Glucose|CHEMISTRY|[?]|P|[?]|[?]|NEGATIVE|1|mmol/day|1|1|[?]|LOW|SERUM|DRIED|N|CELLULAR PROLIFERATION ASSAY|ASH FIBROSURE FORMULA||Y|NA||3|Visit_3|40|4|TREATMENT|2020-09-15|2020-10-04|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|6|PLAGGCVT|Platelet Aggregation Curve Type|CHEMISTRY|[?]|mL/(min*100mL)|[?]|[?]|NEGATIVE|1|fL|1|1|[?]|LOW|PERITONEAL FLUID|CLOTTED||PERCUSSION|NASH FIBROSURE FORMULA|Y||Y||3|Visit_3|40|4|SCREENING|2020-09-15|2020-11-01|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|7|BTLBARTL|Butabarbital|HEMATOLOGY|[?]|cmol|[?]|[?]|NEGATIVE|1|cmol/L|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR||MALDI-TOF|MDRD 5 VARIABLE FORMULA|||U||4|Visit_4|65|5|WASHOUT|2020-10-10|2020-10-31|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|8|VITDIT|25-Hydroxyvitamin D|URINALYSIS|||[?]|[?]|NEGATIVE|1|mL/cm|1|1|[?]|ABNORMAL|CORD BLOOD|CONTAMINATED||INTRAVASCULAR ULTRASOUND|MDRD 6 VARIABLE FORMULA|||U|Y|4|Visit_4|65|4|TREATMENT|2020-10-10|2020-10-22|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|9|CARNITAT|Carnitine Acetyl Transferase|URINALYSIS|[?]|10^10/L|[?]|[?]|POSITIVE|1|nmol/L|1|1|[?]|ABNORMAL|LYMPH|AUTOLYZED||IMMUNORADIOMETRIC ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||5|Visit_5|90|1|TREATMENT|2020-11-04|2020-11-09|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|10|KURLOFCE|Kurloff Cells|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mol/g|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|LACTESCENT||LC/MS|ASH FIBROSURE FORMULA|||NA|Y|5|Visit_5|90|1|WASHOUT|2020-11-04|2020-11-11|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|96114171-59a0-4543-b3ec-c7796ae8ee92|1|OSMLTY|Osmolality|HEMATOLOGY|[?]|MdFI|[?]|[?]|NEGATIVE|1|FIU|1|1|[?]|LOW|SERUM OR PLASMA|CALCIFIED||POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||1|Visit_1|10|1|FOLLOW-UP|2020-11-24|2021-02-05|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|96114171-59a0-4543-b3ec-c7796ae8ee92|2|PRORUBCE|Prorubricyte/Total Cells|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|foz_br|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|AGGLUTINATED|N|MRS|FIBROSIS 4 FORMULA|Y||Y|Y|1|Visit_1|10|5|WASHOUT|2020-11-24|2020-12-30|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|96114171-59a0-4543-b3ec-c7796ae8ee92|3|HYPRLN|Hydroxyproline|URINALYSIS|[?]|U/dL|[?]|[?]|TRACE|1|L/day|1|1|[?]|NORMAL|SEMINAL FLUID|CONCENTRATED||SPECT/CT SCAN|MDRD 4 VARIABLE FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-12-09|2021-01-18|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|96114171-59a0-4543-b3ec-c7796ae8ee92|4|HASIGGAB|Human Anti-Sheep IgG Antibody|HEMATOLOGY|[?]|ug/L/h|[?]|[?]|BORDERLINE|1|BEAM BREAKS|1|1|[?]|LOW|CERUMEN|DRIED||DYNAMOMETRY|MDRD 6 VARIABLE FORMULA|Y|Y|U||2|Visit_2|25|2|TREATMENT|2020-12-09|2021-01-05|25|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|96114171-59a0-4543-b3ec-c7796ae8ee92|5|FACTVIIA|Factor VII Activity|CHEMISTRY|[?]|IU/mg|[?]|[?]|BORDERLINE|1|cmH2O*s/mL|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|AGGLUTINATED||POLYSOMNOGRAPHY|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2020-12-24|2021-01-30|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|96114171-59a0-4543-b3ec-c7796ae8ee92|6|APTTSTND|Activated PTT/Standard|HEMATOLOGY|[?]|EID 50/dose|[?]|[?]|BORDERLINE|1|CAPFUL|1|1|[?]|LOW|LAVAGE FLUID|AUTOLYZED||HPLC/MS|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-12-24|2021-02-05|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|96114171-59a0-4543-b3ec-c7796ae8ee92|7|ASYNP|Alpha Synuclein Protein|CHEMISTRY|||[?]|[?]|TRACE|1|mL/s|1|1|[?]|NORMAL|ABSCESS FLUID|ROOM TEMPERATURE||MICROBIAL CULTURE|MDRD 4 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|2|FOLLOW-UP|2021-01-18|2021-02-17|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|96114171-59a0-4543-b3ec-c7796ae8ee92|8|GFR|Glomerular Filtration Rate|HEMATOLOGY|[?]|mEq/day|[?]|[?]|BORDERLINE|1|CAN|1|1|[?]|LOW|ALVEOLAR AIR|AUTOLYZED||TRANSTHORACIC ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA|||NA||4|Visit_4|65|5|WASHOUT|2021-01-18|2021-02-12|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|96114171-59a0-4543-b3ec-c7796ae8ee92|9|FATACVLC|Fatty Acids, Very Long Chain|HEMATOLOGY|[?]|Anson U|[?]|[?]|NEGATIVE|1|mL/animal/wk|1|1|[?]|LOW|SPERMATOZOON|UNEXPECTED ODOR||ULTRASONOGRAPHIC ELASTOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y|Y|U||5|Visit_5|90|7|SCREENING|2021-02-12|2021-02-16|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|96114171-59a0-4543-b3ec-c7796ae8ee92|10|PYDCREAT|Pyridinoline/Creatinine|URINALYSIS|[?]|mL/min/mmHg|[?]|[?]|BORDERLINE|1|MHz|1|1|[?]|NORMAL|NAIL|THAWED||HPLC|HEPASCORE FORMULA|Y||U||5|Visit_5|90|6|TREATMENT|2021-02-12|2021-02-17|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|0070d42d-c864-4a83-a3c9-4c8ca7de51de|1|TSH|Thyrotropin|HEMATOLOGY|[?]|log10 TCID 50/mL|[?]|[?]|INDETERMINATE|1|Bq/L|1|1|[?]|HIGH|PLEURAL FLUID|FRESH|N|HEMATOXYLIN AND EOSIN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||1|Visit_1|10|5|SCREENING|2020-08-15|2020-09-02|10|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|0070d42d-c864-4a83-a3c9-4c8ca7de51de|2|FBNCTPL|Fibronectin, Plasma|CHEMISTRY|[?]|U/m2/h|[?]|[?]|TRACE|1|RNA copies/mL|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|ROOM TEMPERATURE|N|THIN SMEAR|HEPASCORE FORMULA||Y|U||1|Visit_1|10|7|TREATMENT|2020-08-15|2020-10-21|10|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|0070d42d-c864-4a83-a3c9-4c8ca7de51de|3|FECA|Fractional Calcium Excretion|CHEMISTRY|[?]|dpm/mg|[?]|[?]|TRACE|1|Ci|1|1|[?]|HIGH|TRANSUDATE|PARAFFIN-EMBEDDED||PAP STAIN|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-08-30|2020-10-08|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|0070d42d-c864-4a83-a3c9-4c8ca7de51de|4|XNTHCHR|Xanthochromia|HEMATOLOGY|[?]|mmol/day|[?]|[?]|BORDERLINE|1|mCi|1|1|[?]|NORMAL|BLOOD|CLOTTED||DIFFUSION WEIGHTED MRI|MDRD 6 VARIABLE FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2020-08-30|2020-09-10|25|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|0070d42d-c864-4a83-a3c9-4c8ca7de51de|5|STBSEXCS|Standard Base Excess|CHEMISTRY|[?]|ug/m2/h|[?]|[?]|INDETERMINATE|1|mmAL|1|1|[?]|ABNORMAL|TISSUE|LACTESCENT||TEMPLATE INCISION METHOD|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|5|FOLLOW-UP|2020-09-14|2020-10-23|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|0070d42d-c864-4a83-a3c9-4c8ca7de51de|6|HGBAHGB|Hemoglobin A/Total Hemoglobin|URINALYSIS|[?]|10^6 organisms/g|[?]|[?]|INDETERMINATE|1|U/cL|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|CLOTTED||FUNCTIONAL MRI|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||3|Visit_3|40|6|WASHOUT|2020-09-14|2020-10-03|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|0070d42d-c864-4a83-a3c9-4c8ca7de51de|7|HEPCIDIN|Hepcidin|CHEMISTRY|[?]|mL/cm3/min|[?]|[?]|INVALID|1|Bq/L|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|CALCIFIED||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2020-10-09|2020-10-21|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|0070d42d-c864-4a83-a3c9-4c8ca7de51de|8|MDC|Macrophage-Derived Chemokine|URINALYSIS|[?]|BOWL|[?]|[?]|TRACE|1|10^4 CFU/mL|1|1|[?]|ABNORMAL|SPERMATOZOON|CONCENTRATED||CISH|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|7|FOLLOW-UP|2020-10-09|2020-11-12|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|0070d42d-c864-4a83-a3c9-4c8ca7de51de|9|POLYCHR|Polychromasia|CHEMISTRY|[?]|10^6 IU/mL|[?]|[?]|POSITIVE|1|ag|1|1|[?]|HIGH|VENOUS CORD BLOOD|DRIED||PYROSEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||5|Visit_5|90|7|SCREENING|2020-11-03|2020-11-05|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|0070d42d-c864-4a83-a3c9-4c8ca7de51de|10|EPICCE|Epithelial Cells/Total Cells|HEMATOLOGY|||[?]|[?]|POSITIVE|1|Absorbance U|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|HEMOLYZED|N|HEMAGGLUTINATION ASSAY|COCKCROFT-GAULT FORMULA||Y|U|Y|5|Visit_5|90|4|FOLLOW-UP|2020-11-03|2020-11-09|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|a2ec3389-6f5f-44a3-a6dd-f6177a805791|1|C1QAB|Complement C1q Antibody|HEMATOLOGY|[?]|cy/cm|[?]|[?]|NEGATIVE|1|uL/dose|1|1|[?]|HIGH|CELL PELLET|THAWED||TRANSTHORACIC ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||1|Visit_1|10|2|FOLLOW-UP|2020-10-17|2020-11-30|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|a2ec3389-6f5f-44a3-a6dd-f6177a805791|2|GLOBA2PT|Alpha-2 Globulin/Total Protein|URINALYSIS|[?]|fL|[?]|[?]|INVALID|1|breaths/min|1|1|[?]|LOW|STOOL|CALCIFIED||SLOAN LETTER EYE CHART 100%|GMI % FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-10-17|2020-11-10|10|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|a2ec3389-6f5f-44a3-a6dd-f6177a805791|3|C165884|Olive Tree Pollen IgE Antibody|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|U/kg/h|1|1|[?]|ABNORMAL|STOOL|DRIED||SICKLE CELL SOLUBILITY TEST|FIBROSIS 4 FORMULA||Y|U|Y|2|Visit_2|25|3|SCREENING|2020-11-01|2021-01-01|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|a2ec3389-6f5f-44a3-a6dd-f6177a805791|4|FRUCT|Fructosamine|CHEMISTRY|[?]|YEARS|[?]|[?]|BORDERLINE|1|log10 TCID 50/uL|1|1|[?]|LOW|EPITHELIAL CELL|NON-HEMOLYZED|N|TEST STRIP|HEPASCORE FORMULA|||N||2|Visit_2|25|2|SCREENING|2020-11-01|2020-12-26|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|a2ec3389-6f5f-44a3-a6dd-f6177a805791|5|ALBGLOB|Albumin/Globulin|URINALYSIS|[?]|Bq/L|[?]|[?]|NEGATIVE|1|MBq/uL|1|1|[?]|NORMAL|TRANSUDATE|LACTESCENT|N|COLORIMETRY|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2020-11-16|2020-12-08|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|a2ec3389-6f5f-44a3-a6dd-f6177a805791|6|RDWRCV|Ret RDW Coefficient of Variation|CHEMISTRY|[?]|mg/kg|[?]|[?]|INVALID|1|/MBP|1|1|[?]|ABNORMAL|MUSCLE TISSUE|CALCIFIED||AMSLER GRID|CKD-EPI CYSTATIN C FORMULA||Y|N||3|Visit_3|40|6|SCREENING|2020-11-16|2020-12-28|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|a2ec3389-6f5f-44a3-a6dd-f6177a805791|7|VITB7|Vitamin B7|URINALYSIS|[?]|10^3 organisms/g|[?]|[?]|POSITIVE|1|PACK|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|ROOM TEMPERATURE||COMPUTERIZED CORNEAL TOPOGRAPHY|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|5|FOLLOW-UP|2020-12-11|2020-12-12|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|a2ec3389-6f5f-44a3-a6dd-f6177a805791|8|SRTONIN|Serotonin|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ug/kg/day|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED||SCINTIGRAPHY|HEPASCORE FORMULA||Y|NA|Y|4|Visit_4|65|2|TREATMENT|2020-12-11|2021-01-11|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|a2ec3389-6f5f-44a3-a6dd-f6177a805791|9|HPOCROM|Hypochromia|HEMATOLOGY|[?]|ug/cm2|[?]|[?]|BORDERLINE|1|CYLINDER|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|SOLIDIFIED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA|||Y||5|Visit_5|90|4|WASHOUT|2021-01-05|2021-01-07|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|a2ec3389-6f5f-44a3-a6dd-f6177a805791|10|NORMETA|Normetanephrine|HEMATOLOGY|[?]|cmH2O*s2/mL|[?]|[?]|INDETERMINATE|1|AgU/mL|1|1|[?]|ABNORMAL|SPERMATOZOON|SOLIDIFIED|N|WRIGHT STAIN|GMI MMOL/MOL FORMULA|||NA||5|Visit_5|90|5|SCREENING|2021-01-05|2021-01-12|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|cc562042-9641-460d-862e-d6923dd4207d|1|SJSA52AB|Sjogrens SS-A52 Antibody|CHEMISTRY|[?]|mL/s/m2|[?]|[?]|INVALID|1|U/L|1|1|[?]|HIGH|EXPIRED AIR|LACTESCENT||POPULATION SEQUENCING|ASH FIBROSURE FORMULA|||N||1|Visit_1|10|3|SCREENING|2020-05-27|2020-08-15|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|LB|cc562042-9641-460d-862e-d6923dd4207d|2|PLSNCE|Neoplastic Plasma Cells|CHEMISTRY|[?]|ng/L|[?]|[?]|POSITIVE|1|/min|1|1|[?]|ABNORMAL|SEMEN|SOLIDIFIED||PHASE CONTRAST MICROSCOPY|ASH FIBROSURE FORMULA|||Y||1|Visit_1|10|5|WASHOUT|2020-05-27|2020-07-04|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|LB|cc562042-9641-460d-862e-d6923dd4207d|3|C130111|Mold Mix Antigen IgA Antibody|URINALYSIS|[?]|MASK|[?]|[?]|POSITIVE|1|LB|1|1|[?]|LOW|LYSATE|PARAFFIN-EMBEDDED||INTRAVASCULAR ULTRASOUND|MDRD 5 VARIABLE FORMULA||Y|N||2|Visit_2|25|1|TREATMENT|2020-06-11|2020-08-18|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|LB|cc562042-9641-460d-862e-d6923dd4207d|4|C130073|Birch Pollen IgA|CHEMISTRY|[?]|10^11/L|[?]|[?]|NEGATIVE|1|MdFI|1|1|[?]|NORMAL|LUNG SURFACTANT|AGGLUTINATED||CELLULAR PROLIFERATION ASSAY|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|7|SCREENING|2020-06-11|2020-07-23|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|LB|cc562042-9641-460d-862e-d6923dd4207d|5|VITB17|Vitamin B17|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^5/hpf|1|1|[?]|LOW|COLOSTRUM|AUTOLYZED||MALDI-TOF|MDRD 5 VARIABLE FORMULA||Y|N|Y|3|Visit_3|40|4|FOLLOW-UP|2020-06-26|2020-08-18|40|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|LB|cc562042-9641-460d-862e-d6923dd4207d|6|TRH|Thyrotropin Releasing Hormone|CHEMISTRY|[?]|mL/s|[?]|[?]|POSITIVE|1|PLUG|1|1|[?]|HIGH|ARTERIAL BLOOD|FRESH|N|ENDOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||3|Visit_3|40|5|FOLLOW-UP|2020-06-26|2020-07-21|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|LB|cc562042-9641-460d-862e-d6923dd4207d|7|PLSNCE|Neoplastic Plasma Cells|HEMATOLOGY|[?]|uL/dose|[?]|[?]|NEGATIVE|1|ng|1|1|[?]|NORMAL|PLEURAL FLUID|FRESH||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|CKD-EPI CYSTATIN C FORMULA||Y|N||4|Visit_4|65|7|FOLLOW-UP|2020-07-21|2020-08-04|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|cc562042-9641-460d-862e-d6923dd4207d|8|ENDOSTN|Endostatin|HEMATOLOGY|||[?]|[?]|POSITIVE|1|INHALATION|1|1|[?]|ABNORMAL|MUSCLE TISSUE|CONCENTRATED||FLOCCULATION, CHARCOAL ENHANCED|NASH FIBROSURE FORMULA|||U|Y|4|Visit_4|65|6|FOLLOW-UP|2020-07-21|2020-08-06|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|cc562042-9641-460d-862e-d6923dd4207d|9|MPV|Mean Platelet Volume|URINALYSIS|[?]|ug/kg/day|[?]|[?]|NEGATIVE|1|m|1|1|[?]|LOW|SERUM|HEMOLYZED||KLEIHAUER-BETKE|FIBROSIS 4 FORMULA|Y||Y||5|Visit_5|90|3|TREATMENT|2020-08-15|2020-08-19|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|cc562042-9641-460d-862e-d6923dd4207d|10|BTKFR|Bruton's Tyrosine Kinase, Free|HEMATOLOGY|[?]|SCOOPFUL|[?]|[?]|NEGATIVE|1|FIU|1|1|[?]|ABNORMAL|SPUTUM|CONCENTRATED|N|DYNAMIC LIGHT SCATTERING|CKD-EPI FORMULA||Y|Y||5|Visit_5|90|3|FOLLOW-UP|2020-08-15|2020-08-24|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|1|FXIVAC|Factor XIV Actual/Control|URINALYSIS|||[?]|[?]|TRACE|1|mL/g/min|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|HEMOLYZED||THICK SMEAR|MDRD 6 VARIABLE FORMULA||Y|Y|Y|1|Visit_1|10|2|TREATMENT|2020-07-30|2020-10-26|10|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|LB|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|2|TAURINE|Taurine|HEMATOLOGY|[?]|Log10 ELISA unit|[?]|[?]|INDETERMINATE|1|ppm|1|1|[?]|NORMAL|CAPILLARY PLASMA|DRIED||TARGETED GENOME SEQUENCING|CKD-EPI FORMULA|||NA||1|Visit_1|10|5|SCREENING|2020-07-30|2020-09-18|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|LB|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|3|LKM1IGAB|Liver Kidney Microsomal Type 1 IgG Ab|URINALYSIS|[?]|ug/m2/day|[?]|[?]|INVALID|1|QUANTITY SUFFICIENT|1|1|[?]|ABNORMAL|SOFT TISSUE|CALCIFIED||INTRAVASCULAR ULTRASOUND|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|3|FOLLOW-UP|2020-08-14|2020-09-16|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|4|C130108|Weed Mix Pollen Antigen IgA Antibody|HEMATOLOGY|[?]|PLUG|[?]|[?]|BORDERLINE|1|10^9/L|1|1|[?]|NORMAL|PERITONEAL FLUID|DRIED||HPLC|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|7|TREATMENT|2020-08-14|2020-09-21|25|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|5|C165886|White Oak Pollen IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|POSITIVE|1|g/m2|1|1|[?]|LOW|LAVAGE FLUID|ROOM TEMPERATURE|N|CONTRAST ENHANCED PET SCAN|GMI % FORMULA|Y||Y|Y|3|Visit_3|40|6|FOLLOW-UP|2020-08-29|2020-10-02|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|6|GADAB|Glutamic Acid Decarboxylase Antibody|CHEMISTRY|[?]|/ms|[?]|[?]|NEGATIVE|1|%/min|1|1|[?]|NORMAL|SEBUM|ROOM TEMPERATURE||IMMUNOBLOT|CKD-EPI FORMULA|Y||N||3|Visit_3|40|4|FOLLOW-UP|2020-08-29|2020-09-23|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|7|PSP100AB|P100 Polymyositis-scleroderma Autoag Ab|URINALYSIS|||[?]|[?]|INVALID|1|mmol/kg|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|ICTERIC||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|FIBROMETER FORMULA|Y||NA|Y|4|Visit_4|65|6|TREATMENT|2020-09-23|2020-10-18|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|8|GLOBB2|Beta-2 Globulin|URINALYSIS|[?]|DRINK|[?]|[?]|INDETERMINATE|1|pmol/L/h|1|1|[?]|NORMAL|CORD BLOOD|LACTESCENT||PEAK FLOWMETRY|MDRD 4 VARIABLE FORMULA|||N||4|Visit_4|65|7|SCREENING|2020-09-23|2020-09-25|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|9|CYURIAC|Uric Acid Crystals|CHEMISTRY|[?]|log10 TCID 50/uL|[?]|[?]|BORDERLINE|1|mm/2h|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|CLOTTED||FLOW MICROSCOPY|FIBROMETER FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2020-10-18|2020-10-22|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|10|CCL16|Chemokine (C-C Motif) Ligand 16|HEMATOLOGY|[?]|TRANSDUCING UNIT/mL|[?]|[?]|TRACE|1|mg/kg/min|1|1|[?]|ABNORMAL|LUNG SURFACTANT|SOLIDIFIED||GC/MS-EI|GMI MMOL/MOL FORMULA|Y||NA||5|Visit_5|90|6|SCREENING|2020-10-18|2020-10-20|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|d90f2824-692e-403f-b1ca-5b6462c93a75|1|NMP22|Nuclear Matrix Protein 22|HEMATOLOGY|[?]|10^3 CFU|[?]|[?]|BORDERLINE|1|/mm|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|PARAFFIN-EMBEDDED||FLUORESCENT SPOT TEST|MDRD ENZYMATIC JAPANESE FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-07-15|2020-09-23|10|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|d90f2824-692e-403f-b1ca-5b6462c93a75|2|MCSF|Macrophage Colony Stimulating Factor|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mEq|1|1|[?]|LOW|CEREBROSPINAL FLUID|THAWED||MULTI-SLICE SPIRAL CT|HEPASCORE FORMULA|||Y|Y|1|Visit_1|10|1|SCREENING|2020-07-15|2020-08-16|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|d90f2824-692e-403f-b1ca-5b6462c93a75|3|ETHANOL|Ethanol|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|log10 IU/mL|1|1|[?]|LOW|PLASMA|THAWED||MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI CREATININE FORMULA|||N|Y|2|Visit_2|25|3|TREATMENT|2020-07-30|2020-10-10|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|d90f2824-692e-403f-b1ca-5b6462c93a75|4|PCSK9|Proprotein Convertase Subtilisin/Kexin 9|CHEMISTRY|[?]|SBE/mL|[?]|[?]|POSITIVE|1|uL/dose|1|1|[?]|HIGH|MENSTRUAL BLOOD|CONCENTRATED||POLYSOMNOGRAPHY|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|5|FOLLOW-UP|2020-07-30|2020-08-16|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|d90f2824-692e-403f-b1ca-5b6462c93a75|5|IFI27|Interferon Alpha-Inducible Protein 27|HEMATOLOGY|[?]|DROP|[?]|[?]|INDETERMINATE|1|RATIO|1|1|[?]|NORMAL|VITREOUS HUMOR|CONTAMINATED||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|FIBROMETER FORMULA|||U||3|Visit_3|40|3|FOLLOW-UP|2020-08-14|2020-09-24|40|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|d90f2824-692e-403f-b1ca-5b6462c93a75|6|EDTACLR|EDTA Clearance|URINALYSIS|[?]|ug/L/h|[?]|[?]|INVALID|1|s*kPa|1|1|[?]|ABNORMAL|PLEURAL TISSUE|PARAFFIN-EMBEDDED||CORONARY ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-08-14|2020-09-08|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|d90f2824-692e-403f-b1ca-5b6462c93a75|7|CYCHOL|Cholesterol Crystals|URINALYSIS|[?]|FFU|[?]|[?]|INVALID|1|SACHET|1|1|[?]|HIGH|EPITHELIAL CELL|SOLIDIFIED|N|MICROBIAL CULTURE, SOLID|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2020-09-08|2020-10-12|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|d90f2824-692e-403f-b1ca-5b6462c93a75|8|C130109|Mold Mix Antigen IgE Antibody|URINALYSIS|[?]|dpm/100mg|[?]|[?]|BORDERLINE|1|/LPF|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|DRIED||RADIOGRAPHY|FIBROMETER FORMULA|||Y||4|Visit_4|65|5|FOLLOW-UP|2020-09-08|2020-10-10|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|d90f2824-692e-403f-b1ca-5b6462c93a75|9|UREANCRT|Urea Nitrogen/Creatinine|CHEMISTRY|[?]|kcal/day|[?]|[?]|INVALID|1|mL/kg|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|CONCENTRATED||PELLI-ROBSON EYE CHART|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|7|SCREENING|2020-10-03|2020-10-11|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|d90f2824-692e-403f-b1ca-5b6462c93a75|10|ALS|Acid Labile Subunit|CHEMISTRY|||[?]|[?]|INVALID|1|ug/h|1|1|[?]|NORMAL|PERITONEAL FLUID|LIPEMIC||FLUORESCENCE ANGIOGRAPHY|GMI % FORMULA|||NA|Y|5|Visit_5|90|6|FOLLOW-UP|2020-10-03|2020-10-12|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|ee0e55e1-6107-4a3c-85b4-cb48300153e8|1|LDLOXAB|Oxidized LDL Cholesterol Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|AMPULE|1|1|[?]|ABNORMAL|PLASMA|LACTESCENT||TARGETED TRANSCRIPTOME SEQUENCING|GMI MMOL/MOL FORMULA|||U|Y|1|Visit_1|10|4|SCREENING|2020-05-25|2020-07-03|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|ee0e55e1-6107-4a3c-85b4-cb48300153e8|2|BASOLE|Basophils/Leukocytes|HEMATOLOGY|[?]|ug/g/min|[?]|[?]|INDETERMINATE|1|mg/dL|1|1|[?]|HIGH|SERUM|PARAFFIN-EMBEDDED||NO INFORMATION|HEPASCORE FORMULA||Y|NA||1|Visit_1|10|2|TREATMENT|2020-05-25|2020-08-03|10|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|ee0e55e1-6107-4a3c-85b4-cb48300153e8|3|BPIAB|Bactericidal/Permeability-Inc Protein Ab|CHEMISTRY|[?]|nL|[?]|[?]|TRACE|1|10^4/L|1|1|[?]|HIGH|STOOL|UNEXPECTED ODOR||DIRECT SEQUENCING|MDRD 5 VARIABLE FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-06-09|2020-07-18|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|ee0e55e1-6107-4a3c-85b4-cb48300153e8|4|CORTFR|Cortisol, Free|CHEMISTRY|[?]|kcal|[?]|[?]|BORDERLINE|1|L/kg|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|FROZEN||ARTERIAL SPIN LABELING FUNCTIONAL MRI|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|3|SCREENING|2020-06-09|2020-06-18|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|ee0e55e1-6107-4a3c-85b4-cb48300153e8|5|HGBC|Hemoglobin C|HEMATOLOGY|[?]|DISK|[?]|[?]|INDETERMINATE|1|mg2/dL2|1|1|[?]|HIGH|PERSPIRATION|FRESH||ETDRS EYE CHART|CKD-EPI CYSTATIN C FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-06-24|2020-07-10|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|ee0e55e1-6107-4a3c-85b4-cb48300153e8|6|C165908|Animal Mix IgG AB RAST Score|URINALYSIS|[?]|10^6 DNA copies/mL|[?]|[?]|POSITIVE|1|mL/cm3/min|1|1|[?]|ABNORMAL|SPERMATOZOON|ICTERIC||MECHANICAL CLOT DETECTION|COCKCROFT-GAULT FORMULA||Y|NA||3|Visit_3|40|2|SCREENING|2020-06-24|2020-07-12|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|ee0e55e1-6107-4a3c-85b4-cb48300153e8|7|GAD2|Glutamic Acid Decarboxylase 2|HEMATOLOGY|||[?]|[?]|INVALID|1|ECL unit|1|1|[?]|LOW|TRANSUDATE|CALCIFIED||NEURAMINIDASE INHIBITION ASSAY|MDRD FORMULA|Y||NA|Y|4|Visit_4|65|7|SCREENING|2020-07-19|2020-07-27|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|LB|ee0e55e1-6107-4a3c-85b4-cb48300153e8|8|IL2SR|Soluble Interleukin 2 Receptor|URINALYSIS|[?]|U/mL|[?]|[?]|POSITIVE|1|ug/L FEU|1|1|[?]|NORMAL|PLATELET RICH PLASMA|AGGLUTINATED||NON-INVASIVE DIELECTRIC SENSING|HEPASCORE FORMULA||Y|NA||4|Visit_4|65|6|TREATMENT|2020-07-19|2020-08-20|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|LB|ee0e55e1-6107-4a3c-85b4-cb48300153e8|9|MYBLA|Myeloblasts|CHEMISTRY|[?]|rpm|[?]|[?]|TRACE|1|uL|1|1|[?]|LOW|CALCULUS|THAWED||CONTRAST ENHANCED SPIRAL CT SCAN|GMI % FORMULA||Y|Y||5|Visit_5|90|5|SCREENING|2020-08-13|2020-08-16|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|LB|ee0e55e1-6107-4a3c-85b4-cb48300153e8|10|ALPIALP|Alk Phos, Intestinal/Total Alk Phos|CHEMISTRY|[?]|CAPFUL|[?]|[?]|INVALID|1|JAR|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE||MAMMOGRAPHY|CKD-EPI CREATININE FORMULA|||NA||5|Visit_5|90|7|FOLLOW-UP|2020-08-13|2020-08-22|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|LB|6aa37bb3-85aa-427f-9e56-a776257f1548|1|SMTHAB|Smith Antibody|HEMATOLOGY|||[?]|[?]|INVALID|1|kg/cm|1|1|[?]|LOW|SUPERNATANT, SERUM|DRIED||IMMUNORADIOMETRIC ASSAY|MDRD 6 VARIABLE FORMULA|||N|Y|1|Visit_1|10|6|WASHOUT|2020-11-14|2020-11-18|10|14|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|6aa37bb3-85aa-427f-9e56-a776257f1548|2|CYP2C9A|Cytochrome P450 2C9 Activity|URINALYSIS|||[?]|[?]|INDETERMINATE|1|/VF|1|1|[?]|ABNORMAL|BONE MARROW|FRESH||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA||Y|Y|Y|1|Visit_1|10|3|TREATMENT|2020-11-14|2020-11-15|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|6aa37bb3-85aa-427f-9e56-a776257f1548|3|MDC|Macrophage-Derived Chemokine|HEMATOLOGY|[?]|mL/beat|[?]|[?]|POSITIVE|1|cmol/L|1|1|[?]|ABNORMAL|ERYTHROCYTES|AGGLUTINATED||SINGLE-SLICE SPIRAL CT|MDRD 6 VARIABLE FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-11-29|2021-01-10|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|6aa37bb3-85aa-427f-9e56-a776257f1548|4|C165933|American Cockroach IgE AB RAST Score|HEMATOLOGY|[?]|IU/L|[?]|[?]|POSITIVE|1|/ms|1|1|[?]|NORMAL|CAPILLARY PLASMA|THAWED||TARGETED GENOME SEQUENCING|FIBROMETER FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-11-29|2020-12-17|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|6aa37bb3-85aa-427f-9e56-a776257f1548|5|TUDCA|Tauroursodeoxycholate|URINALYSIS|[?]|U/kg/day|[?]|[?]|INDETERMINATE|1|BOWL|1|1|[?]|ABNORMAL|DISCHARGE|AUTOLYZED||TRICHROME STAIN|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-12-14|2021-01-14|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|LB|6aa37bb3-85aa-427f-9e56-a776257f1548|6|INTLK27|Interleukin 27|HEMATOLOGY|[?]|DAgU|[?]|[?]|TRACE|1|nmol/mol|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED||EEG|HEPASCORE FORMULA|Y||N||3|Visit_3|40|1|TREATMENT|2020-12-14|2021-02-05|40|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|LB|6aa37bb3-85aa-427f-9e56-a776257f1548|7|SPMAGGR|Sperm Aggregation|URINALYSIS|||[?]|[?]|POSITIVE|1|nCi|1|1|[?]|HIGH|PLATELET|REFRIGERATED||AGAR PROPORTION|FIBROMETER FORMULA|||N|Y|4|Visit_4|65|4|WASHOUT|2021-01-08|2021-01-10|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|6aa37bb3-85aa-427f-9e56-a776257f1548|8|CITCREAT|Citrate/Creatinine|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|cmol|1|1|[?]|NORMAL|COLOSTRUM|LACTESCENT||ANTIMICROBIAL COMBINATION TESTING|GMI MMOL/MOL FORMULA|||NA|Y|4|Visit_4|65|5|FOLLOW-UP|2021-01-08|2021-01-27|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|6aa37bb3-85aa-427f-9e56-a776257f1548|9|CCL21|Chemokine (C-C Motif) Ligand 21|CHEMISTRY|[?]|mV/sec|[?]|[?]|TRACE|1|ug/L/h|1|1|[?]|HIGH|PLEURAL FLUID|ICTERIC|N|HPLC/MS|MDRD ENZYMATIC JAPANESE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2021-02-02|2021-02-07|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|LB|6aa37bb3-85aa-427f-9e56-a776257f1548|10|MMP9|Matrix Metalloproteinase 9|URINALYSIS|[?]|in|[?]|[?]|NEGATIVE|1|beats/min|1|1|[?]|LOW|SEMEN|FROZEN||SPIRAL CT|GMI % FORMULA|Y||U||5|Visit_5|90|5|TREATMENT|2021-02-02|2021-02-03|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|LB|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|1|FAT|Fat|CHEMISTRY|||[?]|[?]|NEGATIVE|1|amu|1|1|[?]|LOW|ISOLATE|CONTAMINATED||CONTRAST ENHANCED X-RAY|COCKCROFT-GAULT FORMULA|Y||NA|Y|1|Visit_1|10|5|TREATMENT|2020-05-18|2020-06-18|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|2|ANIONG|Anion Gap|CHEMISTRY|[?]|10^4 CFU|[?]|[?]|INVALID|1|DISK|1|1|[?]|LOW|MECONIUM|REFRIGERATED||HIGH RESOLUTION MELT ANALYSIS|MDRD 4 VARIABLE FORMULA|||N||1|Visit_1|10|5|SCREENING|2020-05-18|2020-06-11|10|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|3|WDR26|WD Repeat-Containing Protein 26|CHEMISTRY|[?]|PFU/dose|[?]|[?]|NEGATIVE|1|nkat|1|1|[?]|LOW|MECONIUM|NON-HEMOLYZED||COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI FORMULA|Y|Y|U||2|Visit_2|25|1|SCREENING|2020-06-02|2020-07-05|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-17
e|LB|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|4|TLYCE|T-Lymphocytes|CHEMISTRY|[?]|mg/kg/day|[?]|[?]|TRACE|1|PFU|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|LACTESCENT||SCANNING ELECTRON MICROSCOPY|FIBROSIS 4 FORMULA||Y|U||2|Visit_2|25|1|SCREENING|2020-06-02|2020-06-13|25|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-17
e|LB|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|5|PHOSLPD|Phospholipid|HEMATOLOGY|[?]|kUSP|[?]|[?]|INDETERMINATE|1|ECL unit|1|1|[?]|HIGH|AMNIOTIC FLUID|AGGLUTINATED||TOTAL BODY RADIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||3|Visit_3|40|5|TREATMENT|2020-06-17|2020-08-12|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|6|INTLK10|Interleukin 10|HEMATOLOGY|[?]|mmol/day|[?]|[?]|POSITIVE|1|Bq/L|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED||SANGER SEQUENCING|FIBROMETER FORMULA|||Y||3|Visit_3|40|4|FOLLOW-UP|2020-06-17|2020-07-26|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|7|C165920|White Elm Pollen IgG AB RAST Score|HEMATOLOGY|[?]|m/sec|[?]|[?]|INDETERMINATE|1|mg/kg/h|1|1|[?]|LOW|EMESIS|GELLED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD FORMULA|||Y||4|Visit_4|65|3|FOLLOW-UP|2020-07-12|2020-08-08|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|8|LRG1|Leucine Rich Alpha-2-Glycoprotein 1|HEMATOLOGY|||[?]|[?]|TRACE|1|L/s|1|1|[?]|LOW|HAIR FOLLICLE|HEMOLYZED||PERIODIC ACID SCHIFF STAIN|NASH FIBROSURE FORMULA|||U|Y|4|Visit_4|65|4|FOLLOW-UP|2020-07-12|2020-07-30|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|9|IRF|Immature Reticulocyte Fraction|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mL/dose|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|CLOTTED||MICROBIAL CONCENTRATION|GMI MMOL/MOL FORMULA|||U|Y|5|Visit_5|90|3|TREATMENT|2020-08-06|2020-08-10|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|10|CLNZPM|Clonazepam|URINALYSIS|[?]|F|[?]|[?]|POSITIVE|1|%(v/v)|1|1|[?]|LOW|VENOUS CORD BLOOD|NON-HEMOLYZED||CELLULOSE TAPE|ASH FIBROSURE FORMULA|||N||5|Visit_5|90|2|TREATMENT|2020-08-06|2020-08-13|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|940d4614-b41a-44d3-b878-6e19ee22f24b|1|CLRDZPXD|Chlordiazepoxide|HEMATOLOGY|[?]|mU/g|[?]|[?]|NEGATIVE|1|scm|1|1|[?]|ABNORMAL|MONOCYTE|CLOTTED||RIA|MDRD 6 VARIABLE FORMULA|Y||U||1|Visit_1|10|3|TREATMENT|2020-07-06|2020-08-30|10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|940d4614-b41a-44d3-b878-6e19ee22f24b|2|MASTCE|Mast Cells|URINALYSIS|[?]|GBq|[?]|[?]|POSITIVE|1|MHz|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|DRIED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA|Y||N||1|Visit_1|10|6|WASHOUT|2020-07-06|2020-08-25|10|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|940d4614-b41a-44d3-b878-6e19ee22f24b|3|GLOBB2PT|Beta-2 Globulin/Total Protein|CHEMISTRY|[?]|BE/mL|[?]|[?]|NEGATIVE|1|/sec|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|DRIED||CONTACT SPECULAR MICROSCOPY|FIBROSIS 4 FORMULA|Y||N||2|Visit_2|25|4|SCREENING|2020-07-21|2020-08-01|25|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|940d4614-b41a-44d3-b878-6e19ee22f24b|4|GOLD|Gold|URINALYSIS|||[?]|[?]|TRACE|1|/sec|1|1|[?]|HIGH|SUPERNATANT, PLASMA|CLOTTED||IMMUNOCHEMILUMINOMETRIC ASSAY|ASH FIBROSURE FORMULA|||N|Y|2|Visit_2|25|2|FOLLOW-UP|2020-07-21|2020-08-27|25|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|940d4614-b41a-44d3-b878-6e19ee22f24b|5|GCDCA|Glycochenodeoxycholate|CHEMISTRY|||[?]|[?]|TRACE|1|IU/g Hb|1|1|[?]|NORMAL|VENOUS BLOOD|NON-HEMOLYZED|N|FLUORESCENT MICROSCOPY|GMI % FORMULA|||U|Y|3|Visit_3|40|6|SCREENING|2020-08-05|2020-08-09|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|940d4614-b41a-44d3-b878-6e19ee22f24b|6|PRGNENLN|Pregnenolone|URINALYSIS|[?]|pg|[?]|[?]|BORDERLINE|1|GLOBULE|1|1|[?]|NORMAL|SEMEN|REFRIGERATED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|HEPASCORE FORMULA|Y||NA||3|Visit_3|40|2|FOLLOW-UP|2020-08-05|2020-09-12|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|940d4614-b41a-44d3-b878-6e19ee22f24b|7|HDLPL|HDL Phospholipid|HEMATOLOGY|||[?]|[?]|INVALID|1|U/g/day|1|1|[?]|LOW|VITREOUS HUMOR|FROZEN||PHOTOGRAPHY|FIBROTEST FORMULA||Y|NA|Y|4|Visit_4|65|4|SCREENING|2020-08-30|2020-09-25|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|940d4614-b41a-44d3-b878-6e19ee22f24b|8|C147276|Arachis hypogaea Antigen IgE Antibody|URINALYSIS|[?]|CAPSULE|[?]|[?]|TRACE|1|uEq/L|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|SOLIDIFIED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD FORMULA|||Y||4|Visit_4|65|7|SCREENING|2020-08-30|2020-09-20|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|940d4614-b41a-44d3-b878-6e19ee22f24b|9|GLOBUL|Globulin|HEMATOLOGY|[?]|fmol/L/sec|[?]|[?]|BORDERLINE|1|Coulomb|1|1|[?]|NORMAL|BILE|ICTERIC||BETA LACTAMASE|ASH FIBROSURE FORMULA|Y|Y|Y||5|Visit_5|90|1|TREATMENT|2020-09-24|2020-10-02|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|940d4614-b41a-44d3-b878-6e19ee22f24b|10|KIM1S|Soluble Kidney Injury Molecule-1|HEMATOLOGY|[?]|/MBP|[?]|[?]|INDETERMINATE|1|g/mol|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|SOLIDIFIED|N|THICK SMEAR|CKD-EPI FORMULA|Y||NA||5|Visit_5|90|1|WASHOUT|2020-09-24|2020-09-29|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|e2edd4f0-926b-4514-bf3f-7449f248343f|1|GLOBB1PT|Beta-1 Globulin/Total Protein|CHEMISTRY|[?]|vp/mL|[?]|[?]|INVALID|1|U/L|1|1|[?]|LOW|CAPILLARY BLOOD|GELLED||MAGNETIC RESONANCE ANGIOGRAPHY|GMI MMOL/MOL FORMULA|||NA||1|Visit_1|10|7|FOLLOW-UP|2020-11-01|2020-12-15|10|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|LB|e2edd4f0-926b-4514-bf3f-7449f248343f|2|SMUSCGAB|Smooth Muscle IgG Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|mmHg*min/L|1|1|[?]|ABNORMAL|ISOLATE|LIPEMIC||MICROBIAL CONCENTRATION|FIBROTEST FORMULA|||U|Y|1|Visit_1|10|2|TREATMENT|2020-11-01|2021-01-22|10|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|LB|e2edd4f0-926b-4514-bf3f-7449f248343f|3|ERCEMIDX|Erythroid Maturation Index|URINALYSIS|[?]|mmHg/L/min|[?]|[?]|NEGATIVE|1|mg/g/min|1|1|[?]|HIGH|BUFFY COAT|CALCIFIED||ACCELERATOR MASS SPECTROMETRY|CKD-EPI FORMULA|||U||2|Visit_2|25|4|FOLLOW-UP|2020-11-16|2021-01-14|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|e2edd4f0-926b-4514-bf3f-7449f248343f|4|DCCARNIT|Decanoylcarnitine|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Ci/L|1|1|[?]|ABNORMAL|FLUID|LIPEMIC||PET/CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|2|Visit_2|25|3|TREATMENT|2020-11-16|2020-12-30|25|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|e2edd4f0-926b-4514-bf3f-7449f248343f|5|C130075|Birch Pollen IgG4|CHEMISTRY|||[?]|[?]|TRACE|1|ppb|1|1|[?]|HIGH|MECONIUM|GELLED||MRS|MDRD 4 VARIABLE FORMULA|||U|Y|3|Visit_3|40|1|TREATMENT|2020-12-01|2021-01-01|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|e2edd4f0-926b-4514-bf3f-7449f248343f|6|CD11B|CD11B|CHEMISTRY|[?]|kg/cm2|[?]|[?]|TRACE|1|pmol/10^9 cells|1|1|[?]|HIGH|GASTRIC FLUID|FRESH||PANENDOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||3|Visit_3|40|1|TREATMENT|2020-12-01|2020-12-02|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|e2edd4f0-926b-4514-bf3f-7449f248343f|7|LDH4LDH|LDH Isoenzyme 4/LDH|URINALYSIS|||[?]|[?]|NEGATIVE|1|mEq/day|1|1|[?]|LOW|SEBUM|CALCIFIED|N|BRDU CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE FORMULA|Y||Y|Y|4|Visit_4|65|2|FOLLOW-UP|2020-12-26|2021-01-05|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|e2edd4f0-926b-4514-bf3f-7449f248343f|8|TSP1|Thrombospondin 1|URINALYSIS|||[?]|[?]|POSITIVE|1|uEq|1|1|[?]|HIGH|LOCHIA|GELLED||WESTERN BLOT|COCKCROFT-GAULT FORMULA|||Y|Y|4|Visit_4|65|5|WASHOUT|2020-12-26|2021-01-03|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|e2edd4f0-926b-4514-bf3f-7449f248343f|9|CDCACM|Chenodeoxycholate Compounds|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mmol/mol|1|1|[?]|LOW|PLEURAL TISSUE|AUTOLYZED||COULOMETRIC TITRATION|MDRD 6 VARIABLE FORMULA|Y|Y|NA|Y|5|Visit_5|90|5|TREATMENT|2021-01-20|2021-01-29|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|e2edd4f0-926b-4514-bf3f-7449f248343f|10|MONOBLLE|Monoblasts/Leukocytes|URINALYSIS|[?]|TUBE|[?]|[?]|NEGATIVE|1|mL|1|1|[?]|HIGH|PLATELET|DRIED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2021-01-20|2021-01-27|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|1|INTLK21|Interleukin 21|URINALYSIS|[?]|deg|[?]|[?]|NEGATIVE|1|L/h|1|1|[?]|ABNORMAL|NAIL|CONTAMINATED||PET/SPECT SCAN|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-06-28|2020-09-16|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|2|CYSTATC|Cystatin C|HEMATOLOGY|||[?]|[?]|INVALID|1|ug|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|FRESH||CALIPER MEASUREMENT METHOD|GMI MMOL/MOL FORMULA|Y||Y|Y|1|Visit_1|10|4|SCREENING|2020-06-28|2020-08-29|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|3|BCMAS|Soluble B Cell Maturation Antigen|CHEMISTRY|[?]|log10 TCID 50/uL|[?]|[?]|BORDERLINE|1|mg/min|1|1|[?]|LOW|INFRANATANT, PLASMA|DRIED|N|SMEAR|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2020-07-13|2020-09-11|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|4|RLP|RLP Cholesterol|URINALYSIS|||[?]|[?]|POSITIVE|1|kN/cm2|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|THAWED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|FIBROSIS 4 FORMULA|Y||N|Y|2|Visit_2|25|6|FOLLOW-UP|2020-07-13|2020-08-02|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|5|VOLUME|Volume|CHEMISTRY|[?]|Joule|[?]|[?]|POSITIVE|1|U/g/h|1|1|[?]|LOW|FLUID|CLOTTED||TEMPLATE INCISION METHOD|COCKCROFT-GAULT FORMULA|Y||U||3|Visit_3|40|2|TREATMENT|2020-07-28|2020-08-14|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|6|ARGSAC|Argininosuccinic Acid|CHEMISTRY|[?]|L|[?]|[?]|INVALID|1|dB|1|1|[?]|LOW|VENOUS CORD BLOOD|ICTERIC|N|SMEAR|CKD-EPI CREATININE FORMULA|Y|Y|U||3|Visit_3|40|1|TREATMENT|2020-07-28|2020-09-11|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|7|ASTAG|Aspartate Aminotransferase Antigen|URINALYSIS|[?]|%(w/v)|[?]|[?]|TRACE|1|DAgU/mL|1|1|[?]|NORMAL|EMESIS|CLOTTED||NON-INVASIVE DIELECTRIC SENSING|CKD-EPI FORMULA|Y||U||4|Visit_4|65|1|TREATMENT|2020-08-22|2020-09-22|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|8|BLYMXM|B-lymphocyte Crossmatch|CHEMISTRY|[?]|mV/sec|[?]|[?]|TRACE|1|CAPSULE|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|AUTOLYZED||ANGIOGRAPHY|HEPASCORE FORMULA|Y||NA||4|Visit_4|65|3|FOLLOW-UP|2020-08-22|2020-09-22|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|9|VIP|Vasoactive Intestinal Polypeptide|HEMATOLOGY|||[?]|[?]|INVALID|1|mMU/mL|1|1|[?]|LOW|ADIPOSE TISSUE|REFRIGERATED||CAPILLARY ELECTROPHORESIS|NASH FIBROSURE FORMULA|Y|Y|NA|Y|5|Visit_5|90|3|WASHOUT|2020-09-16|2020-09-22|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|10|S6PHS|Phos-S6 Ribosomal Protein|HEMATOLOGY|[?]|10^3 organisms|[?]|[?]|NEGATIVE|1|DNA copies/mL|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|CLOTTED||DIRECT SEQUENCING|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|5|SCREENING|2020-09-16|2020-09-17|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|493a53ef-01ab-470c-9bbe-7c2aa48b946b|1|CYAMORPH|Amorphous Crystals|HEMATOLOGY|[?]|YEARS|[?]|[?]|TRACE|1|10^6 organisms/mL|1|1|[?]|NORMAL|EPITHELIAL CELL|AUTOLYZED||U-HPLC/MS/MS|COCKCROFT-GAULT FORMULA||Y|Y||1|Visit_1|10|4|TREATMENT|2020-07-13|2020-09-12|10|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|493a53ef-01ab-470c-9bbe-7c2aa48b946b|2|MGBCREAT|Myoglobin/Creatinine|HEMATOLOGY|[?]|Anson U|[?]|[?]|INVALID|1|FEU|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|FROZEN||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CYSTATIN C FORMULA|||U||1|Visit_1|10|2|TREATMENT|2020-07-13|2020-09-14|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|493a53ef-01ab-470c-9bbe-7c2aa48b946b|3|CCL19|Chemokine (C-C Motif) Ligand 19|HEMATOLOGY|[?]|GPL U/mL|[?]|[?]|INDETERMINATE|1|DROP|1|1|[?]|ABNORMAL|CORD SERUM|NON-HEMOLYZED||MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI FORMULA|Y||U||2|Visit_2|25|4|WASHOUT|2020-07-28|2020-08-21|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|493a53ef-01ab-470c-9bbe-7c2aa48b946b|4|HGBTET|Hemoglobin Tetramer|CHEMISTRY|||[?]|[?]|NEGATIVE|1|FIU|1|1|[?]|HIGH|TUMOR TISSUE|DRIED||DXA SCAN|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|2|Visit_2|25|7|TREATMENT|2020-07-28|2020-09-13|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|493a53ef-01ab-470c-9bbe-7c2aa48b946b|5|MMP8|Matrix Metalloproteinase 8|CHEMISTRY|[?]|Ci/mL|[?]|[?]|NEGATIVE|1|pmol/L|1|1|[?]|ABNORMAL|SEBUM|GELLED||DOPPLER ULTRASOUND|MDRD FORMULA|Y||NA||3|Visit_3|40|1|SCREENING|2020-08-12|2020-10-02|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|LB|493a53ef-01ab-470c-9bbe-7c2aa48b946b|6|TNFR1|Tumor Necrosis Factor Receptor 1|URINALYSIS|[?]|Ci/mg|[?]|[?]|POSITIVE|1|IU|1|1|[?]|HIGH|CALCULUS|AGGLUTINATED||CONFOCAL MICROSCOPY|CKD-EPI FORMULA|Y||Y||3|Visit_3|40|6|SCREENING|2020-08-12|2020-08-18|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|LB|493a53ef-01ab-470c-9bbe-7c2aa48b946b|7|GBP1|Guanylate Binding Protein 1|URINALYSIS|[?]|PFU/mL|[?]|[?]|NEGATIVE|1|mg2/dL2|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|LIPEMIC||KINYOUN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||4|Visit_4|65|7|TREATMENT|2020-09-06|2020-09-27|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|LB|493a53ef-01ab-470c-9bbe-7c2aa48b946b|8|MCH|Ery. Mean Corpuscular Hemoglobin|URINALYSIS|[?]|mg/kg/dose|[?]|[?]|TRACE|1|10^6 organisms/mL|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|CALCIFIED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|5|FOLLOW-UP|2020-09-06|2020-10-07|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|LB|493a53ef-01ab-470c-9bbe-7c2aa48b946b|9|MASTCECE|Mast Cells/Total Cells|CHEMISTRY|||[?]|[?]|POSITIVE|1|10^6 organisms/mg|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|HEMOLYZED||VENTILATION PERFUSION LUNG SCAN|FIBROTEST FORMULA|||U|Y|5|Visit_5|90|5|TREATMENT|2020-10-01|2020-10-10|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|493a53ef-01ab-470c-9bbe-7c2aa48b946b|10|PLATSAT|Platelet Satellitism|CHEMISTRY|[?]|keV|[?]|[?]|TRACE|1|min*mg/mL|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|SOLIDIFIED|N|KLEIHAUER-BETKE|GMI MMOL/MOL FORMULA|||Y||5|Visit_5|90|1|FOLLOW-UP|2020-10-01|2020-10-04|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|ba33de14-b676-4389-a863-a7fa3edb8543|1|CPB2|Carboxypeptidase B2|CHEMISTRY|||[?]|[?]|TRACE|1|%(w/w)|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|NON-HEMOLYZED|N|PULSE OXIMETRY|MDRD ENZYMATIC FORMULA|||N|Y|1|Visit_1|10|5|TREATMENT|2020-11-03|2020-11-08|10|15|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|ba33de14-b676-4389-a863-a7fa3edb8543|2|CD11A|CD11A|URINALYSIS|[?]|U/g/h|[?]|[?]|INDETERMINATE|1|Tbsp|1|1|[?]|LOW|ARTERIAL CORD BLOOD|LACTESCENT||CORONARY ANGIOGRAPHY|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-11-03|2020-11-21|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|ba33de14-b676-4389-a863-a7fa3edb8543|3|MAYHEG|May-Hegglin Anomaly|CHEMISTRY|[?]|mPa|[?]|[?]|NEGATIVE|1|%(v/v)|1|1|[?]|LOW|AMNIOTIC FLUID|LACTESCENT|N|TOLUIDINE BLUE STAIN|MDRD FORMULA|Y|Y|NA||2|Visit_2|25|7|WASHOUT|2020-11-18|2020-12-15|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|ba33de14-b676-4389-a863-a7fa3edb8543|4|METARBLE|Metarubricytes/Leukocytes|CHEMISTRY|[?]|nmol/L|[?]|[?]|INVALID|1|umol/L|1|1|[?]|HIGH|SPUTUM|THAWED||MICROBIAL CULTURE, LIQUID|MDRD 5 VARIABLE FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-11-18|2021-01-15|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|ba33de14-b676-4389-a863-a7fa3edb8543|5|HCGFR|Choriogonadotropin Beta, Free|CHEMISTRY|[?]|DPM|[?]|[?]|POSITIVE|1|mmol2/L2|1|1|[?]|HIGH|NAIL|LIPEMIC|N|CORONARY ANGIOGRAPHY|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|5|SCREENING|2020-12-03|2021-01-15|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|ba33de14-b676-4389-a863-a7fa3edb8543|6|ACTH|Adrenocorticotropic Hormone|URINALYSIS|[?]|pt_br|[?]|[?]|NEGATIVE|1|PA|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|HEMOLYZED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD ENZYMATIC JAPANESE FORMULA|||NA||3|Visit_3|40|2|TREATMENT|2020-12-03|2021-01-03|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|ba33de14-b676-4389-a863-a7fa3edb8543|7|RETIHCR|Hematocrit Corrected Reticulocytes|HEMATOLOGY|[?]|mmol/day|[?]|[?]|INDETERMINATE|1|WAFER|1|1|[?]|LOW|SUPERNATANT, PLASMA|ICTERIC||WRIGHT-GIEMSA STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-12-28|2021-01-18|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|ba33de14-b676-4389-a863-a7fa3edb8543|8|GALM|Galactose Mutarotase|HEMATOLOGY|[?]|KALLIKREIN INHIBITOR UNIT|[?]|[?]|BORDERLINE|1|uEq|1|1|[?]|LOW|SEMEN|FRESH||STRESS ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2020-12-28|2021-01-17|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|ba33de14-b676-4389-a863-a7fa3edb8543|9|SMTHAB|Smith Antibody|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|cm/s|1|1|[?]|ABNORMAL|RETICULOCYTES|LIPEMIC||ELISA|MDRD 5 VARIABLE FORMULA|||N|Y|5|Visit_5|90|2|TREATMENT|2021-01-22|2021-01-31|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|ba33de14-b676-4389-a863-a7fa3edb8543|10|CEACAM1|CEA Cell Adhesion Molecule 1|CHEMISTRY|||[?]|[?]|TRACE|1|/ms|1|1|[?]|ABNORMAL|TISSUE|THAWED||RADIAL IMMUNODIFFUSION|CKD-EPI CYSTATIN C FORMULA|||NA|Y|5|Visit_5|90|7|WASHOUT|2021-01-22|2021-01-30|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|24801f05-79be-433d-8124-85580bc14c4f|1|FGF23|Fibroblast Growth Factor 23|HEMATOLOGY|[?]|10^6/g|[?]|[?]|INVALID|1|mEq/uL|1|1|[?]|ABNORMAL|BREAST MILK|DRIED||DROPLET DIGITAL PCR|CKD-EPI FORMULA|Y||U||1|Visit_1|10|5|WASHOUT|2020-09-09|2020-09-18|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|24801f05-79be-433d-8124-85580bc14c4f|2|DNASEBAB|DNase-B Antibody|CHEMISTRY|[?]|pt_br|[?]|[?]|TRACE|1|U/dL|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|FRESH||HEMAGGLUTINATION ASSAY|MDRD 6 VARIABLE FORMULA||Y|Y||1|Visit_1|10|6|TREATMENT|2020-09-09|2020-11-08|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|24801f05-79be-433d-8124-85580bc14c4f|3|FATACVLC|Fatty Acids, Very Long Chain|CHEMISTRY|||[?]|[?]|BORDERLINE|1|/MBP|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|HEMOLYZED||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA|Y||U|Y|2|Visit_2|25|3|TREATMENT|2020-09-24|2020-11-15|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|24801f05-79be-433d-8124-85580bc14c4f|4|TNF12EXR|TNF Superfamily Member 12 Excretion Rate|HEMATOLOGY|[?]|Torr|[?]|[?]|INDETERMINATE|1|steps/min|1|1|[?]|NORMAL|EXUDATE|HEMOLYZED||DISK DIFFUSION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-09-24|2020-10-14|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|24801f05-79be-433d-8124-85580bc14c4f|5|SPERM|Spermatozoa|URINALYSIS|[?]|DNA copies/mL|[?]|[?]|BORDERLINE|1|pg/L|1|1|[?]|HIGH|ERYTHROCYTES|HEMOLYZED||HIGH RESOLUTION CT|GMI % FORMULA|||N||3|Visit_3|40|3|FOLLOW-UP|2020-10-09|2020-11-01|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|24801f05-79be-433d-8124-85580bc14c4f|6|FCTXIIIA|Factor XIII Activity|HEMATOLOGY|[?]|Ci|[?]|[?]|TRACE|1|m/sec|1|1|[?]|NORMAL|SKIN TISSUE|THAWED|N|BRDU CELLULAR PROLIFERATION ASSAY|MDRD 5 VARIABLE FORMULA|Y|Y|Y||3|Visit_3|40|7|TREATMENT|2020-10-09|2020-10-13|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|24801f05-79be-433d-8124-85580bc14c4f|7|IDL|IDL Cholesterol|URINALYSIS|[?]|anti-Xa IU|[?]|[?]|NEGATIVE|1|TABLET|1|1|[?]|LOW|INFRANATANT, SERUM|AGGLUTINATED||KNEMOMETRY|MDRD 4 VARIABLE FORMULA|||Y||4|Visit_4|65|6|FOLLOW-UP|2020-11-03|2020-12-05|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|24801f05-79be-433d-8124-85580bc14c4f|8|TNFR1B|TNF Receptor 1B|HEMATOLOGY|[?]|g/mol|[?]|[?]|INDETERMINATE|1|BU|1|1|[?]|ABNORMAL|RETICULOCYTES|NON-HEMOLYZED||TRICHROME STAIN|HEPASCORE FORMULA|Y||NA||4|Visit_4|65|2|TREATMENT|2020-11-03|2020-11-22|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|24801f05-79be-433d-8124-85580bc14c4f|9|PGF1A|Prostaglandin F1 Alpha|URINALYSIS|[?]|uL/dose|[?]|[?]|INDETERMINATE|1|nmol/kg/day|1|1|[?]|HIGH|INFRANATANT, SERUM|LIPEMIC||IMMUNORADIOMETRIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-11-28|2020-12-06|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|24801f05-79be-433d-8124-85580bc14c4f|10|HBA1C|Hemoglobin A1C|HEMATOLOGY|[?]|DDU|[?]|[?]|BORDERLINE|1|mU/g|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|DRIED|N|IMPEDANCE CONDUCTIVITY|NASH FIBROSURE FORMULA||Y|U||5|Visit_5|90|1|TREATMENT|2020-11-28|2020-12-04|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|02df80f9-2337-4abd-9452-41cd83dec8ba|1|GFRBSCCC|GFR from Cystatin C and Creat Adj BSA|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mL/breath|1|1|[?]|ABNORMAL|SOFT TISSUE|NON-HEMOLYZED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|GMI % FORMULA|||N|Y|1|Visit_1|10|1|TREATMENT|2020-08-04|2020-10-14|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|02df80f9-2337-4abd-9452-41cd83dec8ba|2|OXYCAP|Oxygen Capacity|HEMATOLOGY|[?]|Bq/mL|[?]|[?]|NEGATIVE|1|kUSP|1|1|[?]|LOW|REFLEX TEAR|NON-HEMOLYZED||WRIGHT-GIEMSA STAIN|MDRD 6 VARIABLE FORMULA|Y||Y||1|Visit_1|10|1|FOLLOW-UP|2020-08-04|2020-10-22|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|02df80f9-2337-4abd-9452-41cd83dec8ba|3|UDCACM|Ursodeoxycholate Compounds|CHEMISTRY|[?]|fg|[?]|[?]|POSITIVE|1|VOXEL|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|ROOM TEMPERATURE|N|SINGLE-SLICE SPIRAL CT|COCKCROFT-GAULT FORMULA|||N||2|Visit_2|25|3|WASHOUT|2020-08-19|2020-10-12|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|02df80f9-2337-4abd-9452-41cd83dec8ba|4|COL4|Collagen Type IV|CHEMISTRY|[?]|PELLET|[?]|[?]|INDETERMINATE|1|uOsm|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|ICTERIC||SIZE EXCLUSION CHROMATOGRAPHY|MDRD 6 VARIABLE FORMULA|||NA||2|Visit_2|25|2|SCREENING|2020-08-19|2020-09-25|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|02df80f9-2337-4abd-9452-41cd83dec8ba|5|CD23|CD23|CHEMISTRY|[?]|umol/mg/min|[?]|[?]|INDETERMINATE|1|nmol BCE/L|1|1|[?]|HIGH|STOOL|ICTERIC|N|GC/MS-CI|FIBROTEST FORMULA||Y|N||3|Visit_3|40|4|TREATMENT|2020-09-03|2020-09-28|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|02df80f9-2337-4abd-9452-41cd83dec8ba|6|PERCECE|Proliferating Erythroid/Total Cells|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|vg/mL|1|1|[?]|LOW|DIALYSIS FLUID|FRESH|N|DNA MICROARRAY|MDRD ENZYMATIC FORMULA|||Y|Y|3|Visit_3|40|4|SCREENING|2020-09-03|2020-09-12|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|02df80f9-2337-4abd-9452-41cd83dec8ba|7|BLASTERY|Basophilic Erythroblast|URINALYSIS|[?]|ngEq/L|[?]|[?]|TRACE|1|Sv|1|1|[?]|ABNORMAL|ABSCESS FLUID|THAWED||MRI WITHOUT CONTRAST|MDRD 5 VARIABLE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-09-28|2020-10-17|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|02df80f9-2337-4abd-9452-41cd83dec8ba|8|TRIM38|Tripartite Motif Containing Protein 38|CHEMISTRY|||[?]|[?]|BORDERLINE|1|cd*s/m2|1|1|[?]|LOW|BREAST MILK|UNEXPECTED ODOR||KLEIHAUER-BETKE|MDRD 6 VARIABLE FORMULA|||N|Y|4|Visit_4|65|1|FOLLOW-UP|2020-09-28|2020-10-02|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|02df80f9-2337-4abd-9452-41cd83dec8ba|9|CCL7|Chemokine (C-C Motif) Ligand 7|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|m2|1|1|[?]|HIGH|STOOL|FROZEN||ELECTROPHORESIS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|5|Visit_5|90|5|SCREENING|2020-10-23|2020-10-30|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|LB|02df80f9-2337-4abd-9452-41cd83dec8ba|10|CYURIAC|Uric Acid Crystals|CHEMISTRY|[?]|mm/sec|[?]|[?]|TRACE|1|GBq/mg|1|1|[?]|NORMAL|VENOUS BLOOD|CONTAMINATED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||5|Visit_5|90|7|TREATMENT|2020-10-23|2020-10-26|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|LB|d9eea93b-f9f9-466c-aa8a-a250baff18ef|1|ATHMBAC|Antithrombin Actual/Control|CHEMISTRY|[?]|ft2|[?]|[?]|POSITIVE|1|TRANSDUCING UNIT|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|CALCIFIED||OSCILLOMETRY|CKD-EPI CREATININE FORMULA|Y|Y|Y||1|Visit_1|10|7|TREATMENT|2020-08-03|2020-08-23|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|d9eea93b-f9f9-466c-aa8a-a250baff18ef|2|IGGALB|Immunoglobulin G/Albumin|HEMATOLOGY|[?]|log EID 50/dose|[?]|[?]|POSITIVE|1|nmol/L|1|1|[?]|HIGH|INTERSTITIAL FLUID|HEMOLYZED||HIGH RESOLUTION MELT ANALYSIS|CKD-EPI CYSTATIN C FORMULA|Y||U||1|Visit_1|10|3|WASHOUT|2020-08-03|2020-08-11|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|d9eea93b-f9f9-466c-aa8a-a250baff18ef|3|ENDOTH1|Endothelin-1|CHEMISTRY|[?]|nmol BCE/L|[?]|[?]|NEGATIVE|1|cmol|1|1|[?]|HIGH|EPIDERMAL TISSUE|CALCIFIED||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||2|Visit_2|25|7|TREATMENT|2020-08-18|2020-09-30|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|d9eea93b-f9f9-466c-aa8a-a250baff18ef|4|MMA|Methylmalonic Acid|HEMATOLOGY|[?]|SCOOPFUL|[?]|[?]|BORDERLINE|1|days/month|1|1|[?]|NORMAL|LYMPH|CLOTTED||FARNSWORTH-MUNSELL 100 HUE TEST|FIBROSIS 4 FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-08-18|2020-10-20|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|d9eea93b-f9f9-466c-aa8a-a250baff18ef|5|HGBS|Hemoglobin S|HEMATOLOGY|[?]|mL/mmHg|[?]|[?]|TRACE|1|CAPSULE|1|1|[?]|HIGH|BASAL TEAR|THAWED||SCANNING ELECTRON MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||3|Visit_3|40|4|TREATMENT|2020-09-02|2020-10-02|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|d9eea93b-f9f9-466c-aa8a-a250baff18ef|6|AMBRBTL|Amobarbital|URINALYSIS|[?]|mU|[?]|[?]|POSITIVE|1|PFU/animal|1|1|[?]|LOW|LOCHIA|UNEXPECTED ODOR||FLUOROSCOPY|HEPASCORE FORMULA|Y||Y||3|Visit_3|40|5|TREATMENT|2020-09-02|2020-09-16|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|d9eea93b-f9f9-466c-aa8a-a250baff18ef|7|VENLAFAX|Venlafaxine|HEMATOLOGY|[?]|uL/mL|[?]|[?]|NEGATIVE|1|hr/day|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED||LANDOLT RING|CKD-EPI FORMULA||Y|N||4|Visit_4|65|4|FOLLOW-UP|2020-09-27|2020-09-30|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|d9eea93b-f9f9-466c-aa8a-a250baff18ef|8|C5B9S|Soluble Complement C5b-9|HEMATOLOGY|[?]|dB|[?]|[?]|TRACE|1|U/kg|1|1|[?]|ABNORMAL|SALIVA|AGGLUTINATED||WESTERN BLOT|MDRD 6 VARIABLE FORMULA|||Y||4|Visit_4|65|2|FOLLOW-UP|2020-09-27|2020-10-21|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|d9eea93b-f9f9-466c-aa8a-a250baff18ef|9|LYMNSQE|Lymphocytes/Non-Squam Epi Cells|HEMATOLOGY|[?]|mN|[?]|[?]|TRACE|1|/h|1|1|[?]|ABNORMAL|PROSTATIC FLUID|CONTAMINATED||DC SHEATH FLOW|HEPASCORE FORMULA|Y||U||5|Visit_5|90|6|SCREENING|2020-10-22|2020-10-28|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|d9eea93b-f9f9-466c-aa8a-a250baff18ef|10|CDTTFRN|Carb-Deficient Transferrin/Transferrin|URINALYSIS|[?]|/100 WBC|[?]|[?]|INDETERMINATE|1|DAYS|1|1|[?]|HIGH|KERATINOCYTE|LACTESCENT||ELLA|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||5|Visit_5|90|1|WASHOUT|2020-10-22|2020-10-23|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|35a59f6a-2712-4d1b-a954-f1418d4b9168|1|MACROBLD|Macroscopic Blood|CHEMISTRY|[?]|APL U/mL|[?]|[?]|NEGATIVE|1|PFU|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|PARAFFIN-EMBEDDED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||1|Visit_1|10|2|SCREENING|2020-11-05|2020-11-13|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|35a59f6a-2712-4d1b-a954-f1418d4b9168|2|HEPCIDIN|Hepcidin|HEMATOLOGY|[?]|GPL U/mL|[?]|[?]|NEGATIVE|1|pmol/10^10 cells|1|1|[?]|ABNORMAL|SMEGMA|LACTESCENT||CORONARY ANGIOGRAPHY|HEPASCORE FORMULA|Y||N||1|Visit_1|10|4|WASHOUT|2020-11-05|2020-12-22|10|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|35a59f6a-2712-4d1b-a954-f1418d4b9168|3|INTLK24|Interleukin 24|URINALYSIS|||[?]|[?]|POSITIVE|1|um2|1|1|[?]|LOW|SKIN TISSUE|DRIED||JAEGER EYE CHART|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|2|Visit_2|25|5|TREATMENT|2020-11-20|2021-01-25|25|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|35a59f6a-2712-4d1b-a954-f1418d4b9168|4|PTHI|Parathyroid Hormone, Intact|HEMATOLOGY|[?]|mg/g/min|[?]|[?]|TRACE|1|mm3/mm2/year|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED||GRADIENT DIFFUSION|MDRD 5 VARIABLE FORMULA|||N||2|Visit_2|25|2|SCREENING|2020-11-20|2020-11-23|25|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|35a59f6a-2712-4d1b-a954-f1418d4b9168|5|SJSSBAB|Sjogrens SS-B Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|cmHg|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|N|CONTRAST ENHANCED PET/CT SCAN|MDRD 5 VARIABLE FORMULA|Y||NA|Y|3|Visit_3|40|7|FOLLOW-UP|2020-12-05|2020-12-28|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|35a59f6a-2712-4d1b-a954-f1418d4b9168|6|CFA|Coefficient of Fat Absorption|HEMATOLOGY|[?]|EID 50/dose|[?]|[?]|INDETERMINATE|1|g/L|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|FRESH||MAPH|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|N||3|Visit_3|40|5|TREATMENT|2020-12-05|2020-12-22|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|35a59f6a-2712-4d1b-a954-f1418d4b9168|7|GLOBB1|Beta-1 Globulin|HEMATOLOGY|[?]|umol/mol|[?]|[?]|INVALID|1|CAN|1|1|[?]|LOW|EXPIRED AIR|UNEXPECTED ODOR||POTENTIOMETRY|GMI % FORMULA||Y|Y||4|Visit_4|65|3|TREATMENT|2020-12-30|2021-01-04|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|35a59f6a-2712-4d1b-a954-f1418d4b9168|8|LGUNSCE|Large Unstained Cells|HEMATOLOGY|[?]|uU/dL|[?]|[?]|NEGATIVE|1|VIAL|1|1|[?]|NORMAL|ALVEOLAR AIR|ICTERIC||JAEGER EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||4|Visit_4|65|4|SCREENING|2020-12-30|2021-01-16|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|35a59f6a-2712-4d1b-a954-f1418d4b9168|9|INTLK27|Interleukin 27|HEMATOLOGY|[?]|nU/cL|[?]|[?]|INVALID|1|mL/cm H2O|1|1|[?]|ABNORMAL|LYMPH|AUTOLYZED||POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||5|Visit_5|90|5|TREATMENT|2021-01-24|2021-01-27|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|35a59f6a-2712-4d1b-a954-f1418d4b9168|10|APOA|Apolipoprotein A|CHEMISTRY|[?]|Absorbance U|[?]|[?]|TRACE|1|V/sec|1|1|[?]|NORMAL|MONOCYTE|CALCIFIED|N|CORONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||5|Visit_5|90|7|TREATMENT|2021-01-24|2021-02-02|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|1|NEUTSGNE|Neutrophils, Segmented/Neutrophils|CHEMISTRY|[?]|dram|[?]|[?]|INDETERMINATE|1|nmol BCE/nmol|1|1|[?]|ABNORMAL|SOFT TISSUE|HEMOLYZED||ROMANOWSKY STAIN|FIBROTEST FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-11-10|2020-12-21|10|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|2|ADPNHMW|Adiponectin, High Molecular Weight|HEMATOLOGY|||[?]|[?]|INVALID|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|BONE|THAWED||TURBIDIMETRY|CKD-EPI FORMULA||Y|U|Y|1|Visit_1|10|2|TREATMENT|2020-11-10|2021-01-11|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|3|BLSTRSID|Ringed Sideroblasts|CHEMISTRY|||[?]|[?]|POSITIVE|1|um/day|1|1|[?]|NORMAL|EPIDERMAL TISSUE|THAWED||IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CREATININE FORMULA||Y|N|Y|2|Visit_2|25|1|WASHOUT|2020-11-25|2020-12-12|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|4|MDMA|3,4-methylenedioxymethamphetamine|URINALYSIS|[?]|g/cm2|[?]|[?]|NEGATIVE|1|PFU/mL|1|1|[?]|LOW|SPERMATOZOON|REFRIGERATED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|NASH FIBROSURE FORMULA|||U||2|Visit_2|25|6|FOLLOW-UP|2020-11-25|2020-12-29|25|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|5|HDLPSZ|HDL Particle Size|CHEMISTRY|[?]|KIT|[?]|[?]|BORDERLINE|1|atm|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|FROZEN||FLUORESCENT ENZYME IMMUNOASSAY|COCKCROFT-GAULT FORMULA|Y||NA||3|Visit_3|40|2|SCREENING|2020-12-10|2021-01-14|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|6|RBCGHOST|Erythrocyte Ghosts|URINALYSIS|||[?]|[?]|INVALID|1|pmol/L/h|1|1|[?]|HIGH|PLEURAL TISSUE|CLOTTED||FARNSWORTH-MUNSELL 100 HUE TEST|MDRD 6 VARIABLE FORMULA|||Y|Y|3|Visit_3|40|7|FOLLOW-UP|2020-12-10|2021-01-18|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|7|ERCECE|Erythroid Cells/Total Cells|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|U/m2/day|1|1|[?]|LOW|CORD BLOOD|AGGLUTINATED||FARR ASSAY|NASH FIBROSURE FORMULA|||NA|Y|4|Visit_4|65|1|TREATMENT|2021-01-04|2021-01-29|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|8|PGD2|Prostaglandin D2|CHEMISTRY|[?]|mOsm/L|[?]|[?]|INVALID|1|ms2|1|1|[?]|ABNORMAL|SMEGMA|NON-HEMOLYZED||PEAK FLOWMETRY|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|3|FOLLOW-UP|2021-01-04|2021-01-21|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|9|C130101|Tree Mix Pollen Antigen IgE Antibody|CHEMISTRY|[?]|SFC/10^6 PBMC|[?]|[?]|NEGATIVE|1|mL/min/mmHg|1|1|[?]|NORMAL|TRANSUDATE|DRIED||SPECULAR MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||5|Visit_5|90|7|WASHOUT|2021-01-29|2021-02-02|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|10|PHTRMN|Phentermine|HEMATOLOGY|[?]|mEq|[?]|[?]|INDETERMINATE|1|Gy|1|1|[?]|NORMAL|SPERMATOZOON|AGGLUTINATED||ANTIBIOTIC AGAR SCREEN|NASH FIBROSURE FORMULA||Y|Y||5|Visit_5|90|5|TREATMENT|2021-01-29|2021-01-31|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|1|RBCDIPOP|Dimorphic Erythrocyte Population|HEMATOLOGY|[?]|SACHET|[?]|[?]|TRACE|1|mg/cm2|1|1|[?]|HIGH|RETICULOCYTES|AUTOLYZED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|7|SCREENING|2020-05-13|2020-07-23|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|2|C130119|Dairy Mix Antigen IgG Antibody|URINALYSIS|[?]|usec|[?]|[?]|NEGATIVE|1|/month|1|1|[?]|LOW|INTERSTITIAL FLUID|LIPEMIC||GC/MS-EI|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|5|WASHOUT|2020-05-13|2020-07-02|10|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|3|FEP|Erythrocyte Protoporphyrin, Free|HEMATOLOGY|[?]|nCi|[?]|[?]|INVALID|1|PIXELS/cm|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|AGGLUTINATED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|1|SCREENING|2020-05-28|2020-06-19|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|4|HEINZRBC|Heinz Bodies/Erythrocytes|CHEMISTRY|[?]|kIU|[?]|[?]|POSITIVE|1|APPLICATION|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|FROZEN||IMMUNOASSAY|CKD-EPI CREATININE FORMULA|||U||2|Visit_2|25|2|TREATMENT|2020-05-28|2020-06-30|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|5|NACREAT|Sodium/Creatinine|CHEMISTRY|[?]|EU|[?]|[?]|BORDERLINE|1|nmol/day|1|1|[?]|HIGH|EMOTIONAL TEAR|GELLED|N|DYNAMOMETRY|HEPASCORE FORMULA|Y|Y|U||3|Visit_3|40|5|SCREENING|2020-06-12|2020-08-07|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-14
e|LB|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|6|RUB|Rubricyte|CHEMISTRY|[?]|/MBP|[?]|[?]|NEGATIVE|1|Bq/mg|1|1|[?]|ABNORMAL|BONE|THAWED||NEURAMINIDASE INHIBITION ASSAY|MDRD 6 VARIABLE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-06-12|2020-08-10|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-14
e|LB|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|7|TTGIGAAB|Tissue Transglutaminase IgA Antibody|URINALYSIS|[?]|JAR|[?]|[?]|BORDERLINE|1|Mile|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|REFRIGERATED||TEMPLATE INCISION METHOD|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|6|WASHOUT|2020-07-07|2020-07-27|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-06
e|LB|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|8|C165930|Shellfish Mix IgE AB RAST Score|CHEMISTRY|[?]|g/day|[?]|[?]|INDETERMINATE|1|uV2|1|1|[?]|ABNORMAL|MUCUS|UNEXPECTED ODOR||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|7|TREATMENT|2020-07-07|2020-07-09|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-06
e|LB|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|9|EPITCE|Transitional Epithelial Cells|CHEMISTRY|[?]|umol/h/mmol|[?]|[?]|TRACE|1|dmol|1|1|[?]|LOW|CELL PELLET|REFRIGERATED||TRANSMISSION ELECTRON MICROSCOPY|FIBROSIS 4 FORMULA||Y|Y||5|Visit_5|90|3|TREATMENT|2020-08-01|2020-08-08|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|10|VITC|Vitamin C|CHEMISTRY|[?]|gMFI|[?]|[?]|INVALID|1|uL/kg/day|1|1|[?]|HIGH|CAPILLARY PLASMA|CLOTTED||REVERSE TRANSCRIPTASE PCR|MDRD ENZYMATIC JAPANESE FORMULA|||Y||5|Visit_5|90|1|FOLLOW-UP|2020-08-01|2020-08-02|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|d041952e-4aa6-4b37-9cec-127adce2eabb|1|HGBB|Hemoglobin B|URINALYSIS|||[?]|[?]|INVALID|1|KIT|1|1|[?]|NORMAL|LYSATE|CONTAMINATED||CT SCAN WITHOUT CONTRAST|COCKCROFT-GAULT FORMULA|||NA|Y|1|Visit_1|10|3|FOLLOW-UP|2020-10-09|2020-11-21|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|d041952e-4aa6-4b37-9cec-127adce2eabb|2|TIMP3|Tissue Inhibitor of Metalloproteinase 3|HEMATOLOGY|[?]|L/min|[?]|[?]|BORDERLINE|1|IU/L|1|1|[?]|ABNORMAL|PUS|UNEXPECTED ODOR||DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-10-09|2020-11-01|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|d041952e-4aa6-4b37-9cec-127adce2eabb|3|BAFF|B-Cell Activating Factor|CHEMISTRY|[?]|Gy/min|[?]|[?]|BORDERLINE|1|U/m2|1|1|[?]|ABNORMAL|SALIVA|DRIED||RADIAL IMMUNODIFFUSION|HEPASCORE FORMULA|Y|Y|Y||2|Visit_2|25|5|WASHOUT|2020-10-24|2020-12-27|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|d041952e-4aa6-4b37-9cec-127adce2eabb|4|C130094|Western Ragweed Pollen IgG|HEMATOLOGY|[?]|umol/h/mmol|[?]|[?]|INDETERMINATE|1|PFU/dose|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|AGGLUTINATED|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||N||2|Visit_2|25|1|FOLLOW-UP|2020-10-24|2020-12-09|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|d041952e-4aa6-4b37-9cec-127adce2eabb|5|BNP|Brain Natriuretic Peptide|URINALYSIS|[?]|V/sec|[?]|[?]|POSITIVE|1|foz_br|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|DRIED||SXA SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||Y||3|Visit_3|40|1|SCREENING|2020-11-08|2020-11-30|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|d041952e-4aa6-4b37-9cec-127adce2eabb|6|GLOBG|Gamma Globulin|HEMATOLOGY|[?]|deg|[?]|[?]|TRACE|1|mg/mL/min|1|1|[?]|ABNORMAL|VENOUS BLOOD|CALCIFIED||NUCLEIC ACID SEQUENCING|MDRD ENZYMATIC FORMULA|Y|Y|Y||3|Visit_3|40|3|FOLLOW-UP|2020-11-08|2021-01-06|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|d041952e-4aa6-4b37-9cec-127adce2eabb|7|NEUTGT|Giant Neutrophils|CHEMISTRY|[?]|mL/(min*100mL)|[?]|[?]|INDETERMINATE|1|Bq/mL|1|1|[?]|LOW|EMOTIONAL TEAR|GELLED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD 6 VARIABLE FORMULA|Y||NA||4|Visit_4|65|4|FOLLOW-UP|2020-12-03|2021-01-06|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|d041952e-4aa6-4b37-9cec-127adce2eabb|8|MSTHCELE|Mesothelial Cells/Leukocytes|CHEMISTRY|[?]|U.CARR|[?]|[?]|BORDERLINE|1|mm/h|1|1|[?]|LOW|SERUM|ROOM TEMPERATURE||ELISA|FIBROTEST FORMULA||Y|Y||4|Visit_4|65|1|WASHOUT|2020-12-03|2020-12-26|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|d041952e-4aa6-4b37-9cec-127adce2eabb|9|HRYCELE|Hairy Cells/Leukocytes|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ug/h|1|1|[?]|NORMAL|MONOCYTE|REFRIGERATED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|COCKCROFT-GAULT FORMULA|||U|Y|5|Visit_5|90|1|FOLLOW-UP|2020-12-28|2021-01-05|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|d041952e-4aa6-4b37-9cec-127adce2eabb|10|CYPHOS|Phosphate Crystals|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mOsm/L|1|1|[?]|ABNORMAL|LYMPH|LACTESCENT||LASER CAPTURE MICRODISSECTION|NASH FIBROSURE FORMULA|||N|Y|5|Visit_5|90|3|TREATMENT|2020-12-28|2021-01-01|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|1|TGFA|Transforming Growth Factor Alpha|URINALYSIS|[?]|mol/g|[?]|[?]|BORDERLINE|1|nU/cL|1|1|[?]|HIGH|CAPILLARY BLOOD|AGGLUTINATED|N|ORCHIDOMETERY|GMI MMOL/MOL FORMULA|Y||N||1|Visit_1|10|4|TREATMENT|2020-06-09|2020-08-10|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|2|CYHIPPAC|Hippuric Acid Crystals|CHEMISTRY|[?]|10^3 CFU/mL|[?]|[?]|INDETERMINATE|1|tuberculin unit|1|1|[?]|HIGH|VENOUS PLASMA|LIPEMIC||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI CYSTATIN C FORMULA|||U||1|Visit_1|10|1|TREATMENT|2020-06-09|2020-07-29|10|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|3|TNF10|TNF Superfamily Member 10|URINALYSIS|[?]|pmol/dL|[?]|[?]|INVALID|1|V/sec|1|1|[?]|HIGH|ALVEOLAR AIR|AGGLUTINATED||INFRARED SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|4|FOLLOW-UP|2020-06-24|2020-08-31|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|4|TSIAC|TSI Actual/Control|CHEMISTRY|[?]|DAgU/mL|[?]|[?]|INDETERMINATE|1|mg/kg/day|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|HEMOLYZED||CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-06-24|2020-06-29|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|5|EPICCE|Epithelial Cells/Total Cells|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|L/h|1|1|[?]|ABNORMAL|CORD SERUM|LACTESCENT||AGAR DILUTION|NASH FIBROSURE FORMULA|||Y|Y|3|Visit_3|40|7|FOLLOW-UP|2020-07-09|2020-07-18|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|6|C130142|German Cockroach Antigen IgG Antibody|HEMATOLOGY|[?]|dL|[?]|[?]|POSITIVE|1|PUFF|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|DRIED|N|SCANNING ELECTRON MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|1|WASHOUT|2020-07-09|2020-09-02|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|7|TTGIGMAB|Tissue Transglutaminase IgM Antibody|CHEMISTRY|||[?]|[?]|INVALID|1|mEq/ug|1|1|[?]|NORMAL|CELL PELLET|SOLIDIFIED||ERGOSPIROMETRY|FIBROMETER FORMULA|||U|Y|4|Visit_4|65|4|TREATMENT|2020-08-03|2020-08-10|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|8|A1MICG|Alpha-1 Microglobulin|URINALYSIS|[?]|pmol|[?]|[?]|INVALID|1|tsp|1|1|[?]|LOW|ISOLATE|FRESH||PULSE OXIMETRY|MDRD 6 VARIABLE FORMULA||Y|N||4|Visit_4|65|5|SCREENING|2020-08-03|2020-08-17|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|9|ANGTNS2|Angiotensin II|CHEMISTRY|[?]|%/s|[?]|[?]|INDETERMINATE|1|cm2|1|1|[?]|HIGH|PLEURAL FLUID|FRESH||NEXT GENERATION TARGETED SEQUENCING|FIBROTEST FORMULA|||U||5|Visit_5|90|4|FOLLOW-UP|2020-08-28|2020-09-06|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|10|IGD|Immunoglobulin D|URINALYSIS|[?]|Weber|[?]|[?]|BORDERLINE|1|APS U|1|1|[?]|HIGH|VITREOUS HUMOR|LACTESCENT|N|DYNAMIC LIGHT SCATTERING|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|4|FOLLOW-UP|2020-08-28|2020-09-03|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|9fc393da-4665-4be5-a869-856c45ddcf13|1|CTC|Circulating Tumor Cells|CHEMISTRY|[?]|U/g|[?]|[?]|INDETERMINATE|1|mmol/mol|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|REFRIGERATED||TARGETED TRANSCRIPTOME SEQUENCING|NASH FIBROSURE FORMULA||Y|U||1|Visit_1|10|6|TREATMENT|2020-06-18|2020-08-17|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|9fc393da-4665-4be5-a869-856c45ddcf13|2|AMACR|Alpha-Methylacyl Coenzyme A Racemase|HEMATOLOGY|[?]|mg/mL/day|[?]|[?]|INDETERMINATE|1|ug/g/min|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED||RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI FORMULA|Y||U||1|Visit_1|10|4|TREATMENT|2020-06-18|2020-08-09|10|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|9fc393da-4665-4be5-a869-856c45ddcf13|3|FLUDOUTE|Fluid Output, Estimated|HEMATOLOGY|[?]|umol/L/sec|[?]|[?]|INVALID|1|uEq/L|1|1|[?]|HIGH|HAIR|CONTAMINATED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|CKD-EPI CREATININE FORMULA|||U||2|Visit_2|25|1|FOLLOW-UP|2020-07-03|2020-07-20|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|LB|9fc393da-4665-4be5-a869-856c45ddcf13|4|C130112|Animal Mix Antigen IgE Antibody|URINALYSIS|[?]|mL/m2/day|[?]|[?]|TRACE|1|BOTTLE|1|1|[?]|HIGH|BONE|NON-HEMOLYZED|N|MICROBIAL CONCENTRATION|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|1|SCREENING|2020-07-03|2020-08-05|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|LB|9fc393da-4665-4be5-a869-856c45ddcf13|5|ATHMBAAC|Antithrombin Activity Actual/Control|URINALYSIS|[?]|GPL U|[?]|[?]|POSITIVE|1|breaths/30s|1|1|[?]|LOW|CIRCULATING TUMOR CELL|CLOTTED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||3|Visit_3|40|5|SCREENING|2020-07-18|2020-07-27|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|9fc393da-4665-4be5-a869-856c45ddcf13|6|HLAA|HLA Class IA Antigen|HEMATOLOGY|[?]|fmol|[?]|[?]|NEGATIVE|1|MAC50|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|SOLIDIFIED||SMEAR|CKD-EPI FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-07-18|2020-07-21|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|9fc393da-4665-4be5-a869-856c45ddcf13|7|ISOPRF2|F2-Isoprostane|CHEMISTRY|[?]|mg/m2|[?]|[?]|TRACE|1|NFIU|1|1|[?]|NORMAL|SEMINAL FLUID|ROOM TEMPERATURE||DIGITAL PCR|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|1|TREATMENT|2020-08-12|2020-08-23|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|LB|9fc393da-4665-4be5-a869-856c45ddcf13|8|NTENS|Neurotensin|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|cup eq|1|1|[?]|ABNORMAL|LYMPH|LACTESCENT||SCINTIGRAPHY|MDRD FORMULA|||U|Y|4|Visit_4|65|1|SCREENING|2020-08-12|2020-08-15|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|LB|9fc393da-4665-4be5-a869-856c45ddcf13|9|PGD2|Prostaglandin D2|CHEMISTRY|||[?]|[?]|BORDERLINE|1|L/h|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|LACTESCENT||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y||U|Y|5|Visit_5|90|2|WASHOUT|2020-09-06|2020-09-07|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|9fc393da-4665-4be5-a869-856c45ddcf13|10|TSP1|Thrombospondin 1|CHEMISTRY|[?]|fraction of 1|[?]|[?]|INDETERMINATE|1|titer|1|1|[?]|NORMAL|FLUID|REFRIGERATED||MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||5|Visit_5|90|5|TREATMENT|2020-09-06|2020-09-15|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|cddc1541-4de9-45e7-bb61-15a2d5baca6f|1|CKBB|Creatine Kinase BB|URINALYSIS|||[?]|[?]|TRACE|1|EID 50/dose|1|1|[?]|LOW|ENDOMETRIAL TISSUE|PARAFFIN-EMBEDDED||GC/MS-CI|MDRD FORMULA|||N|Y|1|Visit_1|10|7|TREATMENT|2021-01-19|2021-03-27|10|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|LB|cddc1541-4de9-45e7-bb61-15a2d5baca6f|2|BILI|Bilirubin|URINALYSIS|||[?]|[?]|POSITIVE|1|m/sec|1|1|[?]|HIGH|SUPERNATANT, SERUM|CONCENTRATED||IN SITU HYBRIDIZATION|ASH FIBROSURE FORMULA|||Y|Y|1|Visit_1|10|7|WASHOUT|2021-01-19|2021-03-13|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|LB|cddc1541-4de9-45e7-bb61-15a2d5baca6f|3|BTECERBC|Bite Cells/Erythrocytes|HEMATOLOGY|[?]|CUP|[?]|[?]|INDETERMINATE|1|PA|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|FRESH||MICRODENSITOMETRY|FIBROTEST FORMULA|Y|Y|Y||2|Visit_2|25|2|FOLLOW-UP|2021-02-03|2021-02-22|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|cddc1541-4de9-45e7-bb61-15a2d5baca6f|4|C165918|American Cockroach IgG AB RAST Score|URINALYSIS|[?]|mg/m2|[?]|[?]|TRACE|1|Tesla|1|1|[?]|ABNORMAL|CELL PELLET|GELLED||HIGH RESOLUTION CT|GMI % FORMULA|Y||NA||2|Visit_2|25|5|SCREENING|2021-02-03|2021-02-23|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|cddc1541-4de9-45e7-bb61-15a2d5baca6f|5|OXACREAT|Oxalate/Creatinine|HEMATOLOGY|[?]|min*mg/mL|[?]|[?]|INVALID|1|nmol/L/h|1|1|[?]|ABNORMAL|VITREOUS HUMOR|ICTERIC||REFRACTOMETRY|MDRD 5 VARIABLE FORMULA||Y|N||3|Visit_3|40|7|TREATMENT|2021-02-18|2021-03-07|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|cddc1541-4de9-45e7-bb61-15a2d5baca6f|6|LCN2CREA|Lipocalin-2/Creatinine|CHEMISTRY|[?]|umol/L/sec|[?]|[?]|NEGATIVE|1|nmol/kg/day|1|1|[?]|ABNORMAL|PERSPIRATION|PARAFFIN-EMBEDDED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|CKD-EPI FORMULA|||N||3|Visit_3|40|5|WASHOUT|2021-02-18|2021-02-22|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|cddc1541-4de9-45e7-bb61-15a2d5baca6f|7|EOSIM|Immature Eosinophils|CHEMISTRY|[?]|OI50|[?]|[?]|NEGATIVE|1|10^3 copies/mL|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|FRESH||LC/MS|MDRD FORMULA|||Y||4|Visit_4|65|5|WASHOUT|2021-03-15|2021-04-13|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|LB|cddc1541-4de9-45e7-bb61-15a2d5baca6f|8|TROPONIN|Troponin|CHEMISTRY|||[?]|[?]|POSITIVE|1|nkat/L|1|1|[?]|HIGH|BONE MARROW|HEMOLYZED||ACRIDINE ORANGE STAIN|FIBROSIS 4 FORMULA||Y|N|Y|4|Visit_4|65|5|SCREENING|2021-03-15|2021-03-23|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|LB|cddc1541-4de9-45e7-bb61-15a2d5baca6f|9|KCREAT|Potassium/Creatinine|URINALYSIS|||[?]|[?]|TRACE|1|V|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|CLOTTED||DIFFUSION TENSOR MRI|NASH FIBROSURE FORMULA|||Y|Y|5|Visit_5|90|7|WASHOUT|2021-04-09|2021-04-11|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-18
e|LB|cddc1541-4de9-45e7-bb61-15a2d5baca6f|10|HBGCHTHB|Hemoglobin G Coushatta/Total Hemoglobin|HEMATOLOGY|[?]|mL/g/day|[?]|[?]|INVALID|1|10^3 CFU/mL|1|1|[?]|ABNORMAL|SPUTUM|SOLIDIFIED|N|SIZE EXCLUSION CHROMATOGRAPHY|FIBROMETER FORMULA||Y|Y||5|Visit_5|90|6|TREATMENT|2021-04-09|2021-04-17|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-18
e|LB|303c6dbe-59f9-4016-baa1-8506c0c1ee09|1|CA242AG|Cancer Antigen 242|URINALYSIS|||[?]|[?]|TRACE|1|mol/mol|1|1|[?]|HIGH|TRANSUDATE|CLOTTED||PELLI-ROBSON EYE CHART|FIBROSIS 4 FORMULA|Y|Y|Y|Y|1|Visit_1|10|3|TREATMENT|2020-12-26|2021-01-08|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|303c6dbe-59f9-4016-baa1-8506c0c1ee09|2|TROPONI3|Troponin I Type 3|URINALYSIS|[?]|APPLICATION|[?]|[?]|INVALID|1|Log10 ELISA unit|1|1|[?]|HIGH|WHITE MATTER TISSUE|ROOM TEMPERATURE||FLUORESCENT IMMUNOASSAY|ASH FIBROSURE FORMULA||Y|U||1|Visit_1|10|7|FOLLOW-UP|2020-12-26|2021-03-22|10|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|303c6dbe-59f9-4016-baa1-8506c0c1ee09|3|ALBGLYCA|Glycated Albumin|HEMATOLOGY|[?]|Absorbance U|[?]|[?]|TRACE|1|10^6 IU|1|1|[?]|HIGH|LAVAGE FLUID|FRESH||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|3|FOLLOW-UP|2021-01-10|2021-03-05|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|303c6dbe-59f9-4016-baa1-8506c0c1ee09|4|GFRBSCRT|GFR from Creatinine Adjusted for BSA|HEMATOLOGY|[?]|ks|[?]|[?]|NEGATIVE|1|SFC/10^6 PBMC|1|1|[?]|ABNORMAL|BUFFY COAT|GELLED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|6|SCREENING|2021-01-10|2021-03-11|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|303c6dbe-59f9-4016-baa1-8506c0c1ee09|5|IOTCLR|Iothalamate Clearance|CHEMISTRY|[?]|ug/animal|[?]|[?]|NEGATIVE|1|10^6/Ejaculate U|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|N|TRYPAN BLUE STAIN|HEPASCORE FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2021-01-25|2021-02-08|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|LB|303c6dbe-59f9-4016-baa1-8506c0c1ee09|6|RMNTLP|Remnant Lipoprotein|CHEMISTRY|[?]|nmol/g|[?]|[?]|BORDERLINE|1|ECL unit|1|1|[?]|HIGH|ISOLATE|NON-HEMOLYZED||NEXT GENERATION SEQUENCING|ASH FIBROSURE FORMULA|||N||3|Visit_3|40|6|SCREENING|2021-01-25|2021-03-02|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|LB|303c6dbe-59f9-4016-baa1-8506c0c1ee09|7|APOH|Apolipoprotein H|HEMATOLOGY|[?]|BAU|[?]|[?]|POSITIVE|1|U/g/day|1|1|[?]|NORMAL|CERUMEN|CLOTTED||GEL ELECTROPHORESIS|MDRD 5 VARIABLE FORMULA||Y|Y||4|Visit_4|65|1|FOLLOW-UP|2021-02-19|2021-03-02|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|303c6dbe-59f9-4016-baa1-8506c0c1ee09|8|GSTY1|Glutathione S-Transferase, Y1|URINALYSIS|[?]|Bq|[?]|[?]|INVALID|1|umol/L/h|1|1|[?]|HIGH|AMNIOTIC FLUID|LIPEMIC|N|FARR ASSAY|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|4|WASHOUT|2021-02-19|2021-03-11|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|303c6dbe-59f9-4016-baa1-8506c0c1ee09|9|LTB4|Leukotriene B4|HEMATOLOGY|[?]|OI50|[?]|[?]|INDETERMINATE|1|mOsm/L|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|GELLED||POPULATION SEQUENCING|CKD-EPI CREATININE FORMULA|Y||Y||5|Visit_5|90|4|FOLLOW-UP|2021-03-16|2021-03-21|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|303c6dbe-59f9-4016-baa1-8506c0c1ee09|10|C165910|Bee Mix IgG AB RAST Score|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Enzyme U/L|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|AGGLUTINATED||MICROBIAL CULTURE, SOLID|ASH FIBROSURE FORMULA|||Y|Y|5|Visit_5|90|6|TREATMENT|2021-03-16|2021-03-20|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|fee3c810-3d76-4db4-9272-6b4e8fd14088|1|C130122|Nut Mix Antigen IgE Antibody|HEMATOLOGY|[?]|mL/dL|[?]|[?]|POSITIVE|1|kg|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|ICTERIC||X-RAY|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|7|SCREENING|2020-12-15|2021-02-13|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|LB|fee3c810-3d76-4db4-9272-6b4e8fd14088|2|TIMP3|Tissue Inhibitor of Metalloproteinase 3|HEMATOLOGY|[?]|s/h|[?]|[?]|INDETERMINATE|1|GPS U|1|1|[?]|ABNORMAL|RETICULOCYTES|ROOM TEMPERATURE||MYELOPEROXIDASE STAIN|FIBROSIS 4 FORMULA|Y|Y|Y||1|Visit_1|10|2|TREATMENT|2020-12-15|2021-01-01|10|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|LB|fee3c810-3d76-4db4-9272-6b4e8fd14088|3|IGAGM|IgG IgM IgA Total|CHEMISTRY|[?]|ug/kg|[?]|[?]|POSITIVE|1|cL|1|1|[?]|ABNORMAL|BONE MARROW|CONTAMINATED||MANUAL CLOT DETECTION|MDRD 4 VARIABLE FORMULA|Y|Y|NA||2|Visit_2|25|4|TREATMENT|2020-12-30|2021-01-30|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|fee3c810-3d76-4db4-9272-6b4e8fd14088|4|HBA1C|Hemoglobin A1C|HEMATOLOGY|[?]|nmol/L/min|[?]|[?]|POSITIVE|1|foz_br|1|1|[?]|ABNORMAL|PLEURAL TISSUE|AGGLUTINATED||REFLECTANCE SPECTROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||2|Visit_2|25|3|TREATMENT|2020-12-30|2021-03-09|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|fee3c810-3d76-4db4-9272-6b4e8fd14088|5|MGCREAT|Magnesium/Creatinine|HEMATOLOGY|[?]|ug/g/h|[?]|[?]|BORDERLINE|1|mJoule/cm2|1|1|[?]|NORMAL|SALIVA|CALCIFIED||SLIT LAMP|COCKCROFT-GAULT FORMULA|||N||3|Visit_3|40|3|FOLLOW-UP|2021-01-14|2021-03-11|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|fee3c810-3d76-4db4-9272-6b4e8fd14088|6|HGBFHGB|Hemoglobin F/Total Hemoglobin|CHEMISTRY|[?]|uL/mL|[?]|[?]|TRACE|1|ft|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|NON-HEMOLYZED||CT SCAN|NASH FIBROSURE FORMULA|||U||3|Visit_3|40|6|TREATMENT|2021-01-14|2021-01-18|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|fee3c810-3d76-4db4-9272-6b4e8fd14088|7|DHEAS|Dehydroepiandrosterone Sulfate|URINALYSIS|[?]|mL/g/h|[?]|[?]|TRACE|1|TUBE|1|1|[?]|ABNORMAL|PERITONEAL FLUID|CONTAMINATED||TRANSVAGINAL ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||4|Visit_4|65|5|TREATMENT|2021-02-08|2021-02-18|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|fee3c810-3d76-4db4-9272-6b4e8fd14088|8|HVA|Homovanillic Acid|HEMATOLOGY|[?]|Antibody Unit|[?]|[?]|TRACE|1|mL/m2/h|1|1|[?]|ABNORMAL|HAIR|HEMOLYZED||GRAM STAIN|MDRD ENZYMATIC FORMULA|Y|Y|NA||4|Visit_4|65|3|SCREENING|2021-02-08|2021-03-07|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|fee3c810-3d76-4db4-9272-6b4e8fd14088|9|CCL8|Chemokine (C-C Motif) Ligand 8|HEMATOLOGY|[?]|mg/mol|[?]|[?]|POSITIVE|1|MHz|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|GELLED||FLUORESCENT MICROSCOPY|FIBROTEST FORMULA|||Y||5|Visit_5|90|5|TREATMENT|2021-03-05|2021-03-13|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|fee3c810-3d76-4db4-9272-6b4e8fd14088|10|PLSIMCE|Immature Plasma Cells|URINALYSIS|||[?]|[?]|NEGATIVE|1|CARTRIDGE|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|LACTESCENT||ATOMIC ABSORPTION SPECTROMETRY|MDRD FORMULA|||NA|Y|5|Visit_5|90|6|TREATMENT|2021-03-05|2021-03-12|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|1|BNZLCGN|Benzoylecgonine|CHEMISTRY|[?]|deg/mm|[?]|[?]|TRACE|1|Enzyme U|1|1|[?]|NORMAL|LOCHIA|AGGLUTINATED|N|PALPATION|MDRD FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-07-08|2020-08-29|10|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|2|TROPONI|Troponin I|URINALYSIS|[?]|pm|[?]|[?]|NEGATIVE|1|Log10 ELISA unit|1|1|[?]|ABNORMAL|CORD BLOOD|PARAFFIN-EMBEDDED||IVY INCISION METHOD|NASH FIBROSURE FORMULA|Y||Y||1|Visit_1|10|5|SCREENING|2020-07-08|2020-08-22|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|3|CYUNCLA|Unclassified Crystals|CHEMISTRY|[?]|MET*h|[?]|[?]|BORDERLINE|1|uL/mL|1|1|[?]|HIGH|URINE|LACTESCENT||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|6|WASHOUT|2020-07-23|2020-08-28|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|4|ELA2|Neutrophil Elastase|URINALYSIS|[?]|IU/L|[?]|[?]|INVALID|1|mgEq|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|LACTESCENT||PHOROPTER|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|3|SCREENING|2020-07-23|2020-09-10|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|5|VITB7|Vitamin B7|HEMATOLOGY|[?]|cm2|[?]|[?]|POSITIVE|1|MBP|1|1|[?]|LOW|HAIR FOLLICLE|AUTOLYZED||MULTIPLE BREATH WASHOUT|MDRD FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-08-07|2020-09-29|40|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|6|DHEAS|Dehydroepiandrosterone Sulfate|URINALYSIS|[?]|g/cage|[?]|[?]|INDETERMINATE|1|HOMEOPATHIC DILUTION|1|1|[?]|NORMAL|HAIR|CONCENTRATED||MICROSCOPY|CKD-EPI CREATININE FORMULA||Y|NA||3|Visit_3|40|3|WASHOUT|2020-08-07|2020-09-29|40|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|7|ACPHOS|Acid Phosphatase|HEMATOLOGY|[?]|ug/L FEU|[?]|[?]|BORDERLINE|1|WAFER|1|1|[?]|ABNORMAL|MUSCLE TISSUE|FRESH||ANALYTICAL ULTRACENTRIFUGATION|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-09-01|2020-10-05|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|8|ACHRAB|Acetylcholine Receptor Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|COAT|1|1|[?]|LOW|RETICULOCYTES|FRESH|N|GC/MS-EI|MDRD 6 VARIABLE FORMULA||Y|U|Y|4|Visit_4|65|4|WASHOUT|2020-09-01|2020-09-18|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|9|PSP100AB|P100 Polymyositis-scleroderma Autoag Ab|URINALYSIS|[?]|Joule|[?]|[?]|INVALID|1|% INHIBITION|1|1|[?]|NORMAL|DERMAL TISSUE|ICTERIC|N|LC-FL|MDRD 5 VARIABLE FORMULA|Y||U||5|Visit_5|90|6|WASHOUT|2020-09-26|2020-10-01|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|10|FATBODOV|Fat Bodies, Oval|URINALYSIS|||[?]|[?]|BORDERLINE|1|s/h|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|CLOTTED||MS/MS|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|5|Visit_5|90|6|TREATMENT|2020-09-26|2020-09-29|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|1|NUCSWELL|Nuclear Swelling|HEMATOLOGY|||[?]|[?]|INVALID|1|DNA copies/ug|1|1|[?]|ABNORMAL|VENOUS PLASMA|AUTOLYZED||COLORIMETRY|NASH FIBROSURE FORMULA||Y|U|Y|1|Visit_1|10|5|TREATMENT|2020-08-01|2020-08-06|10|15|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|2|METAMYLE|Metamyelocytes/Leukocytes|HEMATOLOGY|[?]|10^9 CFU/g|[?]|[?]|POSITIVE|1|mL/s/m2|1|1|[?]|LOW|CORD BLOOD|PARAFFIN-EMBEDDED||PULMONARY ANGIOGRAPHY|FIBROMETER FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-08-01|2020-10-18|10|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|3|DZPM|Diazepam|HEMATOLOGY|||[?]|[?]|TRACE|1|mMU/mL|1|1|[?]|ABNORMAL|PLEURAL FLUID|NON-HEMOLYZED||DIRECT SEQUENCING|MDRD 4 VARIABLE FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2020-08-16|2020-10-23|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|4|ERCENC|Erythroid Cells/Nucleated Cells|CHEMISTRY|[?]|mg/animal|[?]|[?]|INVALID|1|Weber|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|HEMOLYZED||WEBER GREEN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-08-16|2020-09-22|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|5|COAGIDX|Coagulation Index|CHEMISTRY|[?]|QUANTITY SUFFICIENT|[?]|[?]|BORDERLINE|1|U/m2/day|1|1|[?]|HIGH|PLEURAL TISSUE|LIPEMIC||WHOLE TRANSCRIPTOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-08-31|2020-10-24|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|6|PSIGAAB|Phosphatidylserine IgA Antibody|URINALYSIS|[?]|U/g|[?]|[?]|POSITIVE|1|mmol/mol|1|1|[?]|NORMAL|TRANSUDATE|LACTESCENT||PHOTOMETRY|FIBROMETER FORMULA|||N||3|Visit_3|40|4|SCREENING|2020-08-31|2020-10-25|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|7|HLADR52A|HLA-DR52 Antibody|CHEMISTRY|[?]|APPLICATION|[?]|[?]|TRACE|1|KALLIKREIN INHIBITOR UNIT|1|1|[?]|NORMAL|WHITE MATTER TISSUE|ICTERIC||SLOAN LETTER EYE CHART 100%|FIBROTEST FORMULA|Y|Y|NA||4|Visit_4|65|6|TREATMENT|2020-09-25|2020-10-01|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|8|ALPRZLM|Alprazolam|HEMATOLOGY|[?]|ug/min|[?]|[?]|NEGATIVE|1|Antibody Unit|1|1|[?]|HIGH|CELL PELLET|NON-HEMOLYZED||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-09-25|2020-10-06|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|9|CAMP|Cyclic Adenosine 3,5-Monophosphate|URINALYSIS|[?]|uIU/dL|[?]|[?]|POSITIVE|1|/100 WBC|1|1|[?]|HIGH|VENOUS BLOOD|CLOTTED||DIGITAL PCR|HEPASCORE FORMULA|||N||5|Visit_5|90|7|FOLLOW-UP|2020-10-20|2020-10-22|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|10|HLADR51A|HLA-DR51 Antibody|CHEMISTRY|[?]|TABLET|[?]|[?]|BORDERLINE|1|KALLIKREIN INHIBITOR UNIT|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|THAWED||FLUORESCENT SPOT TEST|COCKCROFT-GAULT FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-10-20|2020-10-26|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|47fad45a-9a4c-47ee-a863-089d979523b5|1|C130122|Nut Mix Antigen IgE Antibody|CHEMISTRY|[?]|mCi/L|[?]|[?]|BORDERLINE|1|pg/dL|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|REFRIGERATED||TRANSCRIPTION-MEDIATED AMPLIFICATION|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2020-10-07|2020-11-12|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|47fad45a-9a4c-47ee-a863-089d979523b5|2|FACTVL|Factor V Leiden|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|IU/mmol|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|CLOTTED||DYNAMOMETRY|GMI MMOL/MOL FORMULA||Y|Y|Y|1|Visit_1|10|1|TREATMENT|2020-10-07|2020-10-10|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|47fad45a-9a4c-47ee-a863-089d979523b5|3|GLOBBPT|Beta Globulin/Total Protein|HEMATOLOGY|[?]|umol|[?]|[?]|BORDERLINE|1|Weber|1|1|[?]|ABNORMAL|PERITONEAL FLUID|CLOTTED||INCISION-INDUCED BLEEDING METHOD|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|2|TREATMENT|2020-10-22|2020-12-10|25|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|47fad45a-9a4c-47ee-a863-089d979523b5|4|ANCCLSAB|Neutrophil Cytoplasmic Ab, Classic|URINALYSIS|[?]|Henry|[?]|[?]|INDETERMINATE|1|lm|1|1|[?]|HIGH|SYNOVIAL FLUID|ROOM TEMPERATURE||DYNAMIC CONTRAST ENHANCED MRI|NASH FIBROSURE FORMULA|Y||N||2|Visit_2|25|4|TREATMENT|2020-10-22|2020-11-22|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|47fad45a-9a4c-47ee-a863-089d979523b5|5|PLATAGRN|Platelets, Agranular|URINALYSIS|[?]|U/mL|[?]|[?]|INDETERMINATE|1|log10 PFU/mL|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED||TRICHROME STAIN|FIBROTEST FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-11-06|2020-12-19|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|47fad45a-9a4c-47ee-a863-089d979523b5|6|IGFBP7|Insulin-Like Growth Factor Binding Prot7|CHEMISTRY|[?]|mg/kg/min|[?]|[?]|BORDERLINE|1|/10^5|1|1|[?]|HIGH|BONE|AGGLUTINATED||TARGETED GENOME SEQUENCING|MDRD 6 VARIABLE FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-11-06|2020-11-14|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|47fad45a-9a4c-47ee-a863-089d979523b5|7|CA242AG|Cancer Antigen 242|URINALYSIS|[?]|nmol/kg/day|[?]|[?]|INVALID|1|mg/mol|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|AGGLUTINATED||MODIFIED ACID FAST STAIN|CKD-EPI CREATININE FORMULA||Y|U||4|Visit_4|65|6|TREATMENT|2020-12-01|2020-12-18|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|47fad45a-9a4c-47ee-a863-089d979523b5|8|GRWHRH|Growth Hormone Releasing Hormone|CHEMISTRY|[?]|cm|[?]|[?]|POSITIVE|1|kcal|1|1|[?]|LOW|CALCULUS|AUTOLYZED||GEL ELECTROPHORESIS|NASH FIBROSURE FORMULA||Y|N||4|Visit_4|65|2|FOLLOW-UP|2020-12-01|2020-12-07|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|47fad45a-9a4c-47ee-a863-089d979523b5|9|FGF9|Fibroblast Growth Factor 9|HEMATOLOGY|||[?]|[?]|POSITIVE|1|cmH2O/mL|1|1|[?]|HIGH|SYNOVIAL FLUID|CONCENTRATED||COLORIMETRY|MDRD ENZYMATIC FORMULA|||Y|Y|5|Visit_5|90|7|FOLLOW-UP|2020-12-26|2021-01-04|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|47fad45a-9a4c-47ee-a863-089d979523b5|10|C5|Complement C5|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|um/day|1|1|[?]|ABNORMAL|MONOCYTE|GELLED||MICROBIAL CULTURE, SOLID|MDRD FORMULA|Y||N|Y|5|Visit_5|90|4|SCREENING|2020-12-26|2020-12-31|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|317b8b6d-9638-44a3-816f-7f3fca1e01a3|1|THRCREAT|Threonine/Creatinine|CHEMISTRY|[?]|IU/kg|[?]|[?]|INDETERMINATE|1|log10 copies/mL|1|1|[?]|ABNORMAL|LAVAGE FLUID|HEMOLYZED||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||U||1|Visit_1|10|1|TREATMENT|2020-05-23|2020-06-25|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|LB|317b8b6d-9638-44a3-816f-7f3fca1e01a3|2|MLIGCE|Malignant Cells, NOS|URINALYSIS|[?]|tsp eq|[?]|[?]|NEGATIVE|1|/VF|1|1|[?]|LOW|BREAST MILK|DRIED||HPLC-FL|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||1|Visit_1|10|4|WASHOUT|2020-05-23|2020-07-13|10|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|LB|317b8b6d-9638-44a3-816f-7f3fca1e01a3|3|SCF|Stem Cell Factor|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|Hz|1|1|[?]|LOW|SUPERNATANT, SERUM|CONCENTRATED||PYROSEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|2|Visit_2|25|4|TREATMENT|2020-06-07|2020-08-04|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|317b8b6d-9638-44a3-816f-7f3fca1e01a3|4|HLAAAGT|HLA-A Antigen Type|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|DIOPTER|1|1|[?]|LOW|PERSPIRATION|UNEXPECTED ODOR||IRON HEMATOXYLIN STAIN|FIBROTEST FORMULA|||N|Y|2|Visit_2|25|6|FOLLOW-UP|2020-06-07|2020-08-09|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|317b8b6d-9638-44a3-816f-7f3fca1e01a3|5|PAPPA|Pregnancy-Associated Plasma Protein-A|URINALYSIS|||[?]|[?]|NEGATIVE|1|MBq/uL|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|CONCENTRATED||JAEGER EYE CHART|GMI MMOL/MOL FORMULA|||U|Y|3|Visit_3|40|1|SCREENING|2020-06-22|2020-07-26|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|317b8b6d-9638-44a3-816f-7f3fca1e01a3|6|VITB12|Vitamin B12|URINALYSIS|[?]|CFU/g|[?]|[?]|INVALID|1|mIU/L|1|1|[?]|ABNORMAL|PUS|ROOM TEMPERATURE||MICROPARTICLE ENZYME IMMUNOASSAY|ASH FIBROSURE FORMULA|Y||Y||3|Visit_3|40|5|FOLLOW-UP|2020-06-22|2020-07-01|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|317b8b6d-9638-44a3-816f-7f3fca1e01a3|7|AMPHET|Amphetamine|URINALYSIS|||[?]|[?]|TRACE|1|pmol/10^9 cells|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED||X-RAY FLUORESCENCE SPECTROMETRY|GMI % FORMULA|||NA|Y|4|Visit_4|65|4|SCREENING|2020-07-17|2020-08-18|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|317b8b6d-9638-44a3-816f-7f3fca1e01a3|8|MCPHNSQE|Macrophages/Non-Squam Epi Cells|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mEq/dL|1|1|[?]|ABNORMAL|PLEURAL TISSUE|SOLIDIFIED||DIFFUSION TENSOR MRI|GMI % FORMULA|Y||NA|Y|4|Visit_4|65|4|TREATMENT|2020-07-17|2020-07-30|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|317b8b6d-9638-44a3-816f-7f3fca1e01a3|9|LDLP|LDL Particles|URINALYSIS|[?]|nmol BCE/nmol|[?]|[?]|POSITIVE|1|km|1|1|[?]|LOW|DIALYSIS FLUID|THAWED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD 4 VARIABLE FORMULA|||U||5|Visit_5|90|5|FOLLOW-UP|2020-08-11|2020-08-18|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|LB|317b8b6d-9638-44a3-816f-7f3fca1e01a3|10|ACHRAB|Acetylcholine Receptor Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mm3/mm2/year|1|1|[?]|HIGH|PERSPIRATION|DRIED||GEL ELECTROPHORESIS|MDRD ENZYMATIC FORMULA|||U|Y|5|Visit_5|90|1|TREATMENT|2020-08-11|2020-08-12|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|LB|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|1|HRYCECE|Hairy Cells/Total Cells|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mg/kg/dose|1|1|[?]|HIGH|SUPERNATANT, SERUM|CALCIFIED||RULER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA|Y||Y|Y|1|Visit_1|10|7|WASHOUT|2020-07-10|2020-07-26|10|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|2|VITD23OH|Vitamin D2 D3 25-OH|CHEMISTRY|[?]|10^11/L|[?]|[?]|POSITIVE|1|SUPPOSITORY|1|1|[?]|LOW|SEMINAL FLUID|FRESH||LASER CAPTURE MICRODISSECTION|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|1|WASHOUT|2020-07-10|2020-09-07|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|3|ALS|Acid Labile Subunit|CHEMISTRY|[?]|AMPULE|[?]|[?]|TRACE|1|log10 CCID 50/dose|1|1|[?]|NORMAL|DISCHARGE|LACTESCENT||THERMAL IONIZATION MASS SPECTROMETRY|HEPASCORE FORMULA|||N||2|Visit_2|25|3|WASHOUT|2020-07-25|2020-09-16|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|4|PREALB|Prealbumin|CHEMISTRY|[?]|Bq/uL|[?]|[?]|TRACE|1|grain|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|ROOM TEMPERATURE|N|MRI WITHOUT CONTRAST|CKD-EPI CREATININE FORMULA|Y||N||2|Visit_2|25|1|FOLLOW-UP|2020-07-25|2020-07-30|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|5|C130078|Silver Birch Pollen IgG|URINALYSIS|[?]|SFC/10^6 PBMC|[?]|[?]|TRACE|1|mMU/mL|1|1|[?]|LOW|DIALYSIS FLUID|THAWED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD 5 VARIABLE FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-08-09|2020-08-21|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|6|FERRITIN|Ferritin|CHEMISTRY|[?]|ppb|[?]|[?]|INVALID|1|NEBULE|1|1|[?]|NORMAL|SPERMATOZOON|CONTAMINATED||SPIRAL CT SCAN WITHOUT CONTRAST|FIBROMETER FORMULA||Y|NA||3|Visit_3|40|7|SCREENING|2020-08-09|2020-10-06|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|7|PYDCREAT|Pyridinoline/Creatinine|HEMATOLOGY|||[?]|[?]|INVALID|1|cm2|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|LACTESCENT||HEMAGGLUTINATION INHIBITION ASSAY|COCKCROFT-GAULT FORMULA||Y|U|Y|4|Visit_4|65|6|SCREENING|2020-09-03|2020-09-28|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|8|PPTDCALB|Phosphatidylcholine/Albumin|CHEMISTRY|[?]|DRUM|[?]|[?]|INDETERMINATE|1|JDF Unit|1|1|[?]|LOW|VENOUS CORD BLOOD|PARAFFIN-EMBEDDED||PULMONARY ANGIOGRAPHY|FIBROTEST FORMULA|||N||4|Visit_4|65|5|FOLLOW-UP|2020-09-03|2020-10-02|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|9|METARBCE|Metarubricyte/Total Cells|CHEMISTRY|[?]|nmol/kg/day|[?]|[?]|BORDERLINE|1|Ejaculate U|1|1|[?]|NORMAL|BLOOD|LACTESCENT|N|FLOW MICROSCOPY|MDRD ENZYMATIC FORMULA|Y||Y||5|Visit_5|90|1|FOLLOW-UP|2020-09-28|2020-10-02|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|10|ERCECE|Erythroid Cells/Total Cells|CHEMISTRY|[?]|INHALATION|[?]|[?]|BORDERLINE|1|mL|1|1|[?]|HIGH|PUS|NON-HEMOLYZED|N|IMMUNODIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA|||N||5|Visit_5|90|2|WASHOUT|2020-09-28|2020-09-29|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|e7cee930-54f6-482e-b782-01aed0f0db06|1|A73OXC|7-alpha-Hydroxy-4-cholesten-3-one|CHEMISTRY|[?]|umol|[?]|[?]|INDETERMINATE|1|Siemens|1|1|[?]|ABNORMAL|MUSCLE TISSUE|LIPEMIC||ROMANOWSKY STAIN|MDRD ENZYMATIC FORMULA|Y||Y||1|Visit_1|10|5|TREATMENT|2021-01-07|2021-03-26|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|e7cee930-54f6-482e-b782-01aed0f0db06|2|SLTFRNRC|Soluble Transferrin Receptor|URINALYSIS|[?]|10^7 CFU/mL|[?]|[?]|TRACE|1|kg/cm|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|CLOTTED||MANUAL CLOT DETECTION|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||1|Visit_1|10|2|WASHOUT|2021-01-07|2021-03-14|10|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|e7cee930-54f6-482e-b782-01aed0f0db06|3|C5A|Complement C5a|CHEMISTRY|||[?]|[?]|NEGATIVE|1|CAN|1|1|[?]|LOW|EMESIS|CONTAMINATED|N|DARK FIELD MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|||NA|Y|2|Visit_2|25|4|FOLLOW-UP|2021-01-22|2021-04-02|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|LB|e7cee930-54f6-482e-b782-01aed0f0db06|4|VMAEXR|Vanillyl Mandelic Acid Excretion Rate|HEMATOLOGY|[?]|mMU/mL|[?]|[?]|BORDERLINE|1|MESF|1|1|[?]|ABNORMAL|CORD SERUM|CLOTTED||CALCOFLUOR WHITE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|5|FOLLOW-UP|2021-01-22|2021-02-03|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|LB|e7cee930-54f6-482e-b782-01aed0f0db06|5|LYMCE|Lymphocytes/Total Cells|HEMATOLOGY|[?]|cm H2O|[?]|[?]|INDETERMINATE|1|fmol/L|1|1|[?]|ABNORMAL|DISCHARGE|HEMOLYZED||MULTI-SLICE SPIRAL CT|MDRD 5 VARIABLE FORMULA|||NA||3|Visit_3|40|2|TREATMENT|2021-02-06|2021-02-28|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|e7cee930-54f6-482e-b782-01aed0f0db06|6|LACTULOS|Lactulose|URINALYSIS|[?]|g/g/day|[?]|[?]|TRACE|1|umol/mol|1|1|[?]|HIGH|NAIL|CLOTTED||CLAUSS METHOD|CKD-EPI FORMULA||Y|N||3|Visit_3|40|7|SCREENING|2021-02-06|2021-02-11|40|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|e7cee930-54f6-482e-b782-01aed0f0db06|7|MACROCY|Macrocytes|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Log10 ELISA unit|1|1|[?]|NORMAL|INFRANATANT, SERUM|DRIED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI FORMULA||Y|N|Y|4|Visit_4|65|1|TREATMENT|2021-03-03|2021-03-09|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|e7cee930-54f6-482e-b782-01aed0f0db06|8|BETACRTN|Beta Carotene|HEMATOLOGY|[?]|nmol/kg/day|[?]|[?]|BORDERLINE|1|kcal|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|PARAFFIN-EMBEDDED|N|STATIC PERIMETRY|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-03-03|2021-03-05|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|e7cee930-54f6-482e-b782-01aed0f0db06|9|ANDSTNDL|Androstenediol|URINALYSIS|[?]|Linear ft*LB|[?]|[?]|INVALID|1|ug/m2/min|1|1|[?]|NORMAL|VITREOUS HUMOR|FRESH||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROTEST FORMULA|Y||NA||5|Visit_5|90|1|SCREENING|2021-03-28|2021-04-05|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|LB|e7cee930-54f6-482e-b782-01aed0f0db06|10|C165894|D. farinae Antigen IgG4 Antibody|HEMATOLOGY|[?]|uSiemens|[?]|[?]|TRACE|1|mg/dose|1|1|[?]|NORMAL|AQUEOUS HUMOR|CONTAMINATED||CELL OF ORIGIN ASSAY|MDRD 6 VARIABLE FORMULA|||U||5|Visit_5|90|7|WASHOUT|2021-03-28|2021-03-30|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|LB|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|1|OSMRTY|Osmolarity|HEMATOLOGY|[?]|BOTTLE|[?]|[?]|BORDERLINE|1|U/g Hb|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|ROOM TEMPERATURE||FUNDUS PHOTOGRAPHY|MDRD FORMULA|||U||1|Visit_1|10|6|TREATMENT|2021-01-21|2021-04-14|10|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|LB|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|2|NEUTBLE|Neutrophils Band Form/Leukocytes|CHEMISTRY|[?]|WEEKS|[?]|[?]|INVALID|1|cmH2O/mL|1|1|[?]|NORMAL|SEMEN|LACTESCENT||NUCLEIC ACID AMPLIFICATION TEST|MDRD ENZYMATIC JAPANESE FORMULA|||NA||1|Visit_1|10|4|WASHOUT|2021-01-21|2021-02-11|10|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|LB|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|3|TTGIGGAB|Tissue Transglutaminase IgG Antibody|HEMATOLOGY|[?]|SYRINGE|[?]|[?]|INVALID|1|Sv|1|1|[?]|NORMAL|CORD SERUM|DRIED|N|BALLPOINT PEN TECHNIQUE|GMI MMOL/MOL FORMULA||Y|NA||2|Visit_2|25|6|WASHOUT|2021-02-05|2021-03-19|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|4|HLADRMSC|HLA-DR Mismatch Count|HEMATOLOGY|[?]|mmHg|[?]|[?]|POSITIVE|1|pmol/dL|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|CONTAMINATED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD 4 VARIABLE FORMULA|||U||2|Visit_2|25|7|FOLLOW-UP|2021-02-05|2021-04-11|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|5|MTNEPHFR|Metanephrine, Free|HEMATOLOGY|[?]|LB|[?]|[?]|INDETERMINATE|1|HEP|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED||FLUORESCENT SPOT TEST|COCKCROFT-GAULT FORMULA||Y|Y||3|Visit_3|40|3|WASHOUT|2021-02-20|2021-04-12|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|6|CASULPH|Calcium Sulphate|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|10^6 copies/mL|1|1|[?]|NORMAL|DISCHARGE|GELLED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA||Y|U|Y|3|Visit_3|40|4|SCREENING|2021-02-20|2021-03-23|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|7|CYPHOS|Phosphate Crystals|HEMATOLOGY|[?]|/MBP|[?]|[?]|BORDERLINE|1|1/(s*kPa)|1|1|[?]|LOW|EMESIS|FRESH|N|COMPLEMENT FIXATION|CKD-EPI FORMULA||Y|N||4|Visit_4|65|4|FOLLOW-UP|2021-03-17|2021-04-06|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-28
e|LB|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|8|EPSTI1|Epithelial Stromal Interaction Protein 1|CHEMISTRY|[?]|nmol/day|[?]|[?]|INDETERMINATE|1|foz_us|1|1|[?]|HIGH|ARTERIAL BLOOD|AUTOLYZED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|6|FOLLOW-UP|2021-03-17|2021-03-21|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-28
e|LB|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|9|PLG|Plasminogen|URINALYSIS|[?]|copies/ug|[?]|[?]|BORDERLINE|1|titer|1|1|[?]|NORMAL|VENOUS CORD BLOOD|DRIED||EEG|CKD-EPI CREATININE FORMULA|Y|Y|Y||5|Visit_5|90|4|TREATMENT|2021-04-11|2021-04-20|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|10|COCAM|Cocaine Metabolites|CHEMISTRY|[?]|INHALATION|[?]|[?]|NEGATIVE|1|fL|1|1|[?]|NORMAL|COLOSTRUM|CONTAMINATED||ISHIHARA COLOR PLATES|COCKCROFT-GAULT FORMULA||Y|U||5|Visit_5|90|4|TREATMENT|2021-04-11|2021-04-12|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|f754ae7d-0776-41c0-988c-8cf2879d85da|1|HDLCLDLC|HDL Cholesterol/LDL Cholesterol|CHEMISTRY|[?]|ug/animal|[?]|[?]|POSITIVE|1|IU/kg|1|1|[?]|ABNORMAL|BLOOD|GELLED|N|IMMUNORADIOMETRIC ASSAY|MDRD 4 VARIABLE FORMULA|Y||U||1|Visit_1|10|2|SCREENING|2020-09-17|2020-09-19|10|12|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|f754ae7d-0776-41c0-988c-8cf2879d85da|2|NKCEFUNC|Natural Killer Cell Function|URINALYSIS|[?]|10^9/dose|[?]|[?]|TRACE|1|L/min/m2|1|1|[?]|ABNORMAL|LAVAGE FLUID|CONTAMINATED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD FORMULA|Y||N||1|Visit_1|10|1|TREATMENT|2020-09-17|2020-11-08|10|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|f754ae7d-0776-41c0-988c-8cf2879d85da|3|CD79A|CD79A|HEMATOLOGY|[?]|mol/g|[?]|[?]|POSITIVE|1|10^8 PFU|1|1|[?]|NORMAL|DISCHARGE|FROZEN||PHASE-CONTRAST MRI|HEPASCORE FORMULA||Y|N||2|Visit_2|25|2|TREATMENT|2020-10-02|2020-11-05|25|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|f754ae7d-0776-41c0-988c-8cf2879d85da|4|FUNGI|Fungi|URINALYSIS|[?]|10^9 organisms/mg|[?]|[?]|POSITIVE|1|m/sec|1|1|[?]|NORMAL|TRANSUDATE|REFRIGERATED||STRESS ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|3|WASHOUT|2020-10-02|2020-10-20|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|f754ae7d-0776-41c0-988c-8cf2879d85da|5|EOSIMLE|Immature Eosinophils/Leukocytes|HEMATOLOGY|[?]|mMU/mL|[?]|[?]|NEGATIVE|1|mg/kg/h|1|1|[?]|NORMAL|CALCULUS|CALCIFIED|N|IMMUNOFLUORESCENT STAIN|CKD-EPI CYSTATIN C FORMULA|||N||3|Visit_3|40|6|SCREENING|2020-10-17|2020-12-06|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|f754ae7d-0776-41c0-988c-8cf2879d85da|6|MLIGCEBC|Malignant Cells, NOS/Blood Cells|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|DAgU|1|1|[?]|HIGH|TISSUE|ICTERIC||FLUORESCENT LIFETIME IMAGING MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|3|Visit_3|40|5|FOLLOW-UP|2020-10-17|2020-12-05|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|f754ae7d-0776-41c0-988c-8cf2879d85da|7|BETAINES|Betaines|HEMATOLOGY|[?]|mL/mmHg/min/L|[?]|[?]|INDETERMINATE|1|TABLET|1|1|[?]|ABNORMAL|SALIVA|DRIED||LINE PROBE ASSAY|FIBROTEST FORMULA|||Y||4|Visit_4|65|5|FOLLOW-UP|2020-11-11|2020-12-15|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|f754ae7d-0776-41c0-988c-8cf2879d85da|8|PROC6|Pro-C6|URINALYSIS|||[?]|[?]|POSITIVE|1|RNA copies/mL|1|1|[?]|HIGH|SERUM|ROOM TEMPERATURE|N|PHYSICAL EXAMINATION|COCKCROFT-GAULT FORMULA|||NA|Y|4|Visit_4|65|2|TREATMENT|2020-11-11|2020-11-20|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|f754ae7d-0776-41c0-988c-8cf2879d85da|9|FLT3|FMS-like Receptor Tyrosine Kinase 3|HEMATOLOGY|[?]|/HPF|[?]|[?]|INDETERMINATE|1|10^12/L|1|1|[?]|NORMAL|SPUTUM|ROOM TEMPERATURE||POTENTIOMETRY|MDRD FORMULA|||NA||5|Visit_5|90|1|WASHOUT|2020-12-06|2020-12-14|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|f754ae7d-0776-41c0-988c-8cf2879d85da|10|TNFSR|Soluble Tumor Necrosis Factor Receptor|HEMATOLOGY|[?]|cd|[?]|[?]|BORDERLINE|1|mg/g/h|1|1|[?]|LOW|EXUDATE|SOLIDIFIED||HPLC/MS|MDRD 4 VARIABLE FORMULA|||U||5|Visit_5|90|3|FOLLOW-UP|2020-12-06|2020-12-13|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|8a8d8c31-ae36-4a64-90da-ba5eb473e420|1|METANEXR|Metanephrine Excretion Rate|HEMATOLOGY|[?]|nsec|[?]|[?]|INDETERMINATE|1|Bq/uL|1|1|[?]|HIGH|VENOUS CORD BLOOD|CLOTTED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-06-25|2020-08-07|10|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|8a8d8c31-ae36-4a64-90da-ba5eb473e420|2|SJSSAAB|Sjogrens SS-A Antibody|CHEMISTRY|[?]|ng/L|[?]|[?]|POSITIVE|1|ELISA unit|1|1|[?]|ABNORMAL|NAIL|ICTERIC||COULOMETRIC TITRATION|MDRD FORMULA|||NA||1|Visit_1|10|4|SCREENING|2020-06-25|2020-09-21|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|8a8d8c31-ae36-4a64-90da-ba5eb473e420|3|KAPPALC|Kappa Light Chain|CHEMISTRY|||[?]|[?]|BORDERLINE|1|kat|1|1|[?]|HIGH|VENOUS BLOOD|ROOM TEMPERATURE||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA||Y|Y|Y|2|Visit_2|25|1|TREATMENT|2020-07-10|2020-07-11|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|8a8d8c31-ae36-4a64-90da-ba5eb473e420|4|DSVLFXN|Desvenlafaxine|URINALYSIS|[?]|kV|[?]|[?]|INVALID|1|log10 TCID 50/mL|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|AGGLUTINATED||DOPPLER ULTRASOUND|FIBROMETER FORMULA|Y|Y|NA||2|Visit_2|25|7|TREATMENT|2020-07-10|2020-09-12|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|8a8d8c31-ae36-4a64-90da-ba5eb473e420|5|TROPONI|Troponin I|URINALYSIS|[?]|K|[?]|[?]|TRACE|1|V/sec|1|1|[?]|LOW|PLEURAL TISSUE|THAWED|N|TARGETED GENOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||3|Visit_3|40|4|TREATMENT|2020-07-25|2020-09-13|40|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|8a8d8c31-ae36-4a64-90da-ba5eb473e420|6|STAT3|STAT3|CHEMISTRY|[?]|10^6/hpf|[?]|[?]|INVALID|1|h/wk|1|1|[?]|NORMAL|PERITONEAL FLUID|FROZEN||PALM METHOD|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA||3|Visit_3|40|1|FOLLOW-UP|2020-07-25|2020-08-25|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|8a8d8c31-ae36-4a64-90da-ba5eb473e420|7|KETONES|Ketones|HEMATOLOGY|||[?]|[?]|POSITIVE|1|BLOCKS|1|1|[?]|LOW|PLEURAL TISSUE|AUTOLYZED||SIZE EXCLUSION CHROMATOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||U|Y|4|Visit_4|65|3|TREATMENT|2020-08-19|2020-09-05|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|8a8d8c31-ae36-4a64-90da-ba5eb473e420|8|ACT|Activated Coagulation Time|URINALYSIS|[?]|kN/cm2|[?]|[?]|NEGATIVE|1|log10 TCID 50/mL|1|1|[?]|ABNORMAL|MUCUS|CLOTTED||MAGNETIC RESONANCE ANGIOGRAPHY|FIBROMETER FORMULA||Y|NA||4|Visit_4|65|6|SCREENING|2020-08-19|2020-08-22|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|8a8d8c31-ae36-4a64-90da-ba5eb473e420|9|LDH|Lactate Dehydrogenase|CHEMISTRY|||[?]|[?]|INVALID|1|ug/m2/day|1|1|[?]|HIGH|ERYTHROCYTES|SOLIDIFIED||NEURAMINIDASE INHIBITION ASSAY|CKD-EPI CREATININE FORMULA|Y||NA|Y|5|Visit_5|90|6|WASHOUT|2020-09-13|2020-09-21|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|8a8d8c31-ae36-4a64-90da-ba5eb473e420|10|LDH1LDH|LDH Isoenzyme 1/LDH|CHEMISTRY|||[?]|[?]|TRACE|1|cm/s|1|1|[?]|LOW|BUFFY COAT|DRIED||DNA MICROARRAY|MDRD 5 VARIABLE FORMULA||Y|U|Y|5|Visit_5|90|2|TREATMENT|2020-09-13|2020-09-21|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|482e40c9-2908-4269-b93c-61c311e9fde3|1|C165900|Orchard Grass Pollen IgG AB RAST Score|URINALYSIS|[?]|cycle/min|[?]|[?]|TRACE|1|APL U|1|1|[?]|LOW|SWABBED MATERIAL|ICTERIC||AUSCULTATION|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|6|FOLLOW-UP|2020-07-16|2020-08-11|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|482e40c9-2908-4269-b93c-61c311e9fde3|2|BLSTIMLY|Immunoblasts/Lymphocytes|HEMATOLOGY|[?]|ug/g/h|[?]|[?]|BORDERLINE|1|U/g/day|1|1|[?]|NORMAL|EMESIS|AGGLUTINATED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||Y|NA||1|Visit_1|10|6|TREATMENT|2020-07-16|2020-09-16|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|482e40c9-2908-4269-b93c-61c311e9fde3|3|C147282|White Oak Pollen IgE Antibody|URINALYSIS|[?]|amol|[?]|[?]|INVALID|1|Hounsfield Unit|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED||CELL OF ORIGIN ASSAY|MDRD ENZYMATIC FORMULA||Y|Y||2|Visit_2|25|7|TREATMENT|2020-07-31|2020-08-30|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|482e40c9-2908-4269-b93c-61c311e9fde3|4|ANAG|Alpha-N-acetylglucosaminidase|CHEMISTRY|[?]|nmol/L/h|[?]|[?]|BORDERLINE|1|10^9 CFU/g|1|1|[?]|ABNORMAL|URINE SEDIMENT|LACTESCENT||CRYOSCOPY|COCKCROFT-GAULT FORMULA|Y||N||2|Visit_2|25|6|TREATMENT|2020-07-31|2020-09-15|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|482e40c9-2908-4269-b93c-61c311e9fde3|5|CYAMORPH|Amorphous Crystals|CHEMISTRY|||[?]|[?]|INVALID|1|fraction of 1|1|1|[?]|NORMAL|PLATELET|UNEXPECTED ODOR||SPECT/CT SCAN|MDRD FORMULA|||N|Y|3|Visit_3|40|1|FOLLOW-UP|2020-08-15|2020-08-28|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|482e40c9-2908-4269-b93c-61c311e9fde3|6|DRUGSCR|Drug Screen|HEMATOLOGY|[?]|mkat|[?]|[?]|TRACE|1|Torr|1|1|[?]|ABNORMAL|PLEURAL TISSUE|CLOTTED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|CKD-EPI CREATININE FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-08-15|2020-08-31|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|482e40c9-2908-4269-b93c-61c311e9fde3|7|GRAN|Granulocytes|URINALYSIS|[?]|CFU/g|[?]|[?]|INDETERMINATE|1|mg/cm2|1|1|[?]|HIGH|BLOOD|SOLIDIFIED|N|HPLC-FL|GMI MMOL/MOL FORMULA||Y|U||4|Visit_4|65|5|WASHOUT|2020-09-09|2020-09-13|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|482e40c9-2908-4269-b93c-61c311e9fde3|8|EPIN|Epinephrine|HEMATOLOGY|[?]|Bq/kg|[?]|[?]|INDETERMINATE|1|IU/mL|1|1|[?]|LOW|PUS|SOLIDIFIED||ETDRS EYE CHART|MDRD ENZYMATIC JAPANESE FORMULA|||Y||4|Visit_4|65|3|SCREENING|2020-09-09|2020-09-20|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|482e40c9-2908-4269-b93c-61c311e9fde3|9|FPP|Protoporphyrin, Free|HEMATOLOGY|[?]|10^6 IU/mL|[?]|[?]|INDETERMINATE|1|CYLINDER|1|1|[?]|HIGH|INTERSTITIAL FLUID|AUTOLYZED||REFRACTOMETRY|MDRD ENZYMATIC FORMULA|Y||U||5|Visit_5|90|1|TREATMENT|2020-10-04|2020-10-13|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|482e40c9-2908-4269-b93c-61c311e9fde3|10|GSTAL|Alpha Glutathione-S-Transferase|CHEMISTRY|[?]|g/kg|[?]|[?]|INVALID|1|10^7 TCID 50/dose|1|1|[?]|NORMAL|FLUID|HEMOLYZED||ENZYMATIC ULTRACENTRIFUGATION|CKD-EPI CYSTATIN C FORMULA|||Y||5|Visit_5|90|1|WASHOUT|2020-10-04|2020-10-11|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|f7cfb281-0556-4316-9373-65edf63c4b23|1|HLADR51A|HLA-DR51 Antibody|HEMATOLOGY|[?]|Sv|[?]|[?]|TRACE|1|mg2/dL2|1|1|[?]|HIGH|STOOL|LIPEMIC||MANUAL COUNT|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-06-29|2020-08-19|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|LB|f7cfb281-0556-4316-9373-65edf63c4b23|2|GIPI|Glucose-dep Insulinotropic Pep, Intact|HEMATOLOGY|[?]|10^8/L|[?]|[?]|INDETERMINATE|1|CAPFUL|1|1|[?]|LOW|CALCULUS|AGGLUTINATED||DUCTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||1|Visit_1|10|4|TREATMENT|2020-06-29|2020-09-06|10|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|LB|f7cfb281-0556-4316-9373-65edf63c4b23|3|VLDL2|VLDL Cholesterol Subtype 2|CHEMISTRY|||[?]|[?]|TRACE|1|CIGAR|1|1|[?]|LOW|BONE MARROW|ICTERIC||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|FIBROSIS 4 FORMULA|||NA|Y|2|Visit_2|25|4|TREATMENT|2020-07-14|2020-07-25|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|f7cfb281-0556-4316-9373-65edf63c4b23|4|MCV|Ery. Mean Corpuscular Volume|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mL/min|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|UNEXPECTED ODOR||TURBIDIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|2|Visit_2|25|1|FOLLOW-UP|2020-07-14|2020-07-29|25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|f7cfb281-0556-4316-9373-65edf63c4b23|5|PSDEPHD|Pseudoephedrine|HEMATOLOGY|[?]|mV|[?]|[?]|TRACE|1|nU/cL|1|1|[?]|LOW|PUS|CONCENTRATED|N|INFRARED SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-07-29|2020-08-21|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|f7cfb281-0556-4316-9373-65edf63c4b23|6|SCCAG|Squamous Cell Carcinoma Antigen|URINALYSIS|[?]|dpm/0.5 mL|[?]|[?]|BORDERLINE|1|mol|1|1|[?]|HIGH|LOCHIA|PARAFFIN-EMBEDDED||SCINTIGRAPHY|MDRD 5 VARIABLE FORMULA|||N||3|Visit_3|40|7|WASHOUT|2020-07-29|2020-09-19|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|f7cfb281-0556-4316-9373-65edf63c4b23|7|ENDOSTN|Endostatin|HEMATOLOGY|[?]|mJoule/cm2|[?]|[?]|NEGATIVE|1|mL/mmHg|1|1|[?]|ABNORMAL|DIALYSIS FLUID|CLOTTED||ULTRASOUND|FIBROTEST FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2020-08-23|2020-09-18|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|f7cfb281-0556-4316-9373-65edf63c4b23|8|C130094|Western Ragweed Pollen IgG|CHEMISTRY|[?]|m/sec|[?]|[?]|NEGATIVE|1|SFC/10^6 PBMC|1|1|[?]|NORMAL|SEMINAL FLUID|ICTERIC||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|N||4|Visit_4|65|3|TREATMENT|2020-08-23|2020-09-17|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|f7cfb281-0556-4316-9373-65edf63c4b23|9|EUDCA|Epimerized Ursodeoxycholate|HEMATOLOGY|[?]|ft2|[?]|[?]|TRACE|1|mU/L|1|1|[?]|NORMAL|EPITHELIAL CELL|AUTOLYZED||LYMPHANGIOGRAPHY|MDRD 5 VARIABLE FORMULA|||U||5|Visit_5|90|3|WASHOUT|2020-09-17|2020-09-19|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|f7cfb281-0556-4316-9373-65edf63c4b23|10|PGAG|Platelet-Granulocyte Agg|URINALYSIS|[?]|mL/animal|[?]|[?]|TRACE|1|mAnson U/mL|1|1|[?]|LOW|URINE SEDIMENT|CALCIFIED||FLUORESCENT MICROSCOPY|FIBROMETER FORMULA|||Y||5|Visit_5|90|5|WASHOUT|2020-09-17|2020-09-24|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|1|INTLK18|Interleukin 18|URINALYSIS|[?]|%|[?]|[?]|TRACE|1|IU/g Hb|1|1|[?]|HIGH|MUSCLE TISSUE|NON-HEMOLYZED|N|BALLPOINT PEN TECHNIQUE|MDRD 5 VARIABLE FORMULA||Y|N||1|Visit_1|10|1|TREATMENT|2021-01-10|2021-03-19|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|2|CSGRANF|Granular Fine Casts|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|tuberculin unit/mL|1|1|[?]|HIGH|DISCHARGE|SOLIDIFIED||DIFFUSION TENSOR MRI|CKD-EPI CREATININE FORMULA||Y|U|Y|1|Visit_1|10|5|FOLLOW-UP|2021-01-10|2021-03-26|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|3|CRNTESTR|Carnitine Esters|URINALYSIS|||[?]|[?]|POSITIVE|1|log10 IU/mL|1|1|[?]|ABNORMAL|ABSCESS FLUID|CALCIFIED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA|Y||N|Y|2|Visit_2|25|4|TREATMENT|2021-01-25|2021-03-27|25|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|4|IBCT|Total Iron Binding Capacity|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^9/L|1|1|[?]|ABNORMAL|HAIR FOLLICLE|CONCENTRATED||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|COCKCROFT-GAULT FORMULA||Y|NA|Y|2|Visit_2|25|4|SCREENING|2021-01-25|2021-03-12|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|5|NEUTMY|Neutrophilic Myelocytes|URINALYSIS|[?]|SBE/mL|[?]|[?]|TRACE|1|STEPS|1|1|[?]|NORMAL|TISSUE|CONTAMINATED||TOLUIDINE BLUE STAIN|MDRD 6 VARIABLE FORMULA|||NA||3|Visit_3|40|7|SCREENING|2021-02-09|2021-03-22|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|6|C165891|Western Ragweed Pollen IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mEq/uL|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR||PH METER MEASUREMENT METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|3|Visit_3|40|3|SCREENING|2021-02-09|2021-04-01|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|7|PTSAAC|Protein S Activity Actual/Control|URINALYSIS|||[?]|[?]|NEGATIVE|1|BU/mL|1|1|[?]|NORMAL|BUFFY COAT|THAWED|N|FARNSWORTH-MUNSELL 100 HUE TEST|NASH FIBROSURE FORMULA|||NA|Y|4|Visit_4|65|1|TREATMENT|2021-03-06|2021-03-22|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|LB|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|8|CHCM|Corpuscular HGB Concentration Mean|URINALYSIS|[?]|10^6 RNA copies/mL|[?]|[?]|POSITIVE|1|Tesla|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|THAWED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC FORMULA|||U||4|Visit_4|65|1|TREATMENT|2021-03-06|2021-04-08|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|LB|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|9|POIKILO|Poikilocytes|CHEMISTRY|[?]|mL/dL|[?]|[?]|BORDERLINE|1|vg/kg|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|UNEXPECTED ODOR||IN VITRO GENE EXPRESSION ASSAY|ASH FIBROSURE FORMULA|||N||5|Visit_5|90|6|SCREENING|2021-03-31|2021-04-09|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|10|FIBRINOF|Fibrinogen, Functional|CHEMISTRY|[?]|bel|[?]|[?]|INVALID|1|uU/dL|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|NON-HEMOLYZED||ANTIBIOTIC AGAR SCREEN|NASH FIBROSURE FORMULA||Y|N||5|Visit_5|90|1|TREATMENT|2021-03-31|2021-04-07|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|9ed8a578-a82a-423a-81ca-ee87f98d62f7|1|TPROT|Tau Protein|CHEMISTRY|||[?]|[?]|INVALID|1|Absorbance U/mL|1|1|[?]|ABNORMAL|LAVAGE FLUID|LIPEMIC||CONTRAST ENHANCED X-RAY|FIBROMETER FORMULA|||N|Y|1|Visit_1|10|7|FOLLOW-UP|2020-09-02|2020-10-20|10|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|9ed8a578-a82a-423a-81ca-ee87f98d62f7|2|HLAIAB|HLA Class I Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|/7.5 mL|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|ICTERIC||TURBIDIMETRY|MDRD 6 VARIABLE FORMULA|Y|Y|NA|Y|1|Visit_1|10|2|FOLLOW-UP|2020-09-02|2020-10-12|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|9ed8a578-a82a-423a-81ca-ee87f98d62f7|3|DHPG|3,4-Dihydroxyphenylglycol|URINALYSIS|[?]|mm2|[?]|[?]|INVALID|1|mL/kg/min|1|1|[?]|ABNORMAL|LYMPH|CLOTTED||CONGO RED STAIN|MDRD FORMULA|||N||2|Visit_2|25|5|WASHOUT|2020-09-17|2020-11-20|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|9ed8a578-a82a-423a-81ca-ee87f98d62f7|4|RP3IGGAB|RNA Polymerase III IgG Antibody|CHEMISTRY|[?]|mol/mg|[?]|[?]|INVALID|1|psi|1|1|[?]|HIGH|BUFFY COAT|CALCIFIED||TRYPAN BLUE STAIN|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-09-17|2020-10-13|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|9ed8a578-a82a-423a-81ca-ee87f98d62f7|5|GLUCEXR|Glucose Excretion Rate|CHEMISTRY|[?]|nmol BCE/L|[?]|[?]|POSITIVE|1|genEq|1|1|[?]|HIGH|ADIPOSE TISSUE|NON-HEMOLYZED|N|SPECULAR MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||3|Visit_3|40|1|TREATMENT|2020-10-02|2020-11-16|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|9ed8a578-a82a-423a-81ca-ee87f98d62f7|6|PROMYB|Promyeloblasts|URINALYSIS|||[?]|[?]|TRACE|1|kPa|1|1|[?]|ABNORMAL|BONE|PARAFFIN-EMBEDDED||ELISPOT|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA|Y|3|Visit_3|40|2|TREATMENT|2020-10-02|2020-11-10|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|9ed8a578-a82a-423a-81ca-ee87f98d62f7|7|SPWEIGHT|Specimen Weight|HEMATOLOGY|[?]|mL/mmHg/min/L|[?]|[?]|NEGATIVE|1|10^6 IU|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED||LC/MS|COCKCROFT-GAULT FORMULA|||Y||4|Visit_4|65|6|SCREENING|2020-10-27|2020-10-31|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|9ed8a578-a82a-423a-81ca-ee87f98d62f7|8|MMIF|Macrophage Migration Inhibitory Factor|URINALYSIS|[?]|Tbsp|[?]|[?]|POSITIVE|1|/h|1|1|[?]|NORMAL|VENOUS CORD BLOOD|PARAFFIN-EMBEDDED||SPECULAR MICROSCOPY|MDRD 4 VARIABLE FORMULA|||N||4|Visit_4|65|7|WASHOUT|2020-10-27|2020-11-23|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|9ed8a578-a82a-423a-81ca-ee87f98d62f7|9|AFPL2|Alpha Fetoprotein L2|CHEMISTRY|[?]|mJoule/cm2|[?]|[?]|INVALID|1|DDU|1|1|[?]|NORMAL|GASTRIC CONTENTS|NON-HEMOLYZED||MALDI-TOF|MDRD 6 VARIABLE FORMULA|Y||U||5|Visit_5|90|4|WASHOUT|2020-11-21|2020-11-30|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|9ed8a578-a82a-423a-81ca-ee87f98d62f7|10|CHLMCRN|Chylomicrons|URINALYSIS|||[?]|[?]|POSITIVE|1|mg/mL/min|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|REFRIGERATED||FLOW MICROSCOPY|ASH FIBROSURE FORMULA|||N|Y|5|Visit_5|90|1|TREATMENT|2020-11-21|2020-11-30|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|2214af46-1072-4328-bf3d-f4fe9cd97d9b|1|CXCL3|Chemokine (C-X-C Motif) Ligand 3|HEMATOLOGY|[?]|Ci/kg|[?]|[?]|BORDERLINE|1|U/kg/min|1|1|[?]|HIGH|REFLEX TEAR|NON-HEMOLYZED||CAPILLARY ELECTROPHORESIS|ASH FIBROSURE FORMULA||Y|NA||1|Visit_1|10|3|SCREENING|2020-10-18|2021-01-11|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|2214af46-1072-4328-bf3d-f4fe9cd97d9b|2|GSTALEXR|Alpha-GST Excretion Rate|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^9/g|1|1|[?]|ABNORMAL|TRANSUDATE|AUTOLYZED||NUCLEIC ACID BASED METHOD|MDRD 5 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|1|TREATMENT|2020-10-18|2020-11-24|10|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|2214af46-1072-4328-bf3d-f4fe9cd97d9b|3|FLUOXTN|Fluoxetine|URINALYSIS|[?]|MBq|[?]|[?]|NEGATIVE|1|g/kg/day|1|1|[?]|NORMAL|NAIL|ROOM TEMPERATURE||EIA|GMI % FORMULA|Y|Y|NA||2|Visit_2|25|4|TREATMENT|2020-11-02|2020-11-12|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|2214af46-1072-4328-bf3d-f4fe9cd97d9b|4|OVALCY|Ovalocytes|URINALYSIS|[?]|BOX|[?]|[?]|INVALID|1|mV/sec|1|1|[?]|NORMAL|BONE MARROW|LACTESCENT||ENDOSCOPY|MDRD 5 VARIABLE FORMULA|||N||2|Visit_2|25|4|SCREENING|2020-11-02|2020-11-17|25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|2214af46-1072-4328-bf3d-f4fe9cd97d9b|5|SODIUM|Sodium|CHEMISTRY|[?]|TAMPON|[?]|[?]|INVALID|1|deg2|1|1|[?]|HIGH|VITREOUS HUMOR|SOLIDIFIED||ULTRASOUND|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|6|SCREENING|2020-11-17|2020-11-25|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|2214af46-1072-4328-bf3d-f4fe9cd97d9b|6|TNFR1B|TNF Receptor 1B|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|MPL U|1|1|[?]|HIGH|TRANSUDATE|PARAFFIN-EMBEDDED||TELLER ACUITY CARDS|MDRD 4 VARIABLE FORMULA|||U|Y|3|Visit_3|40|6|SCREENING|2020-11-17|2020-12-23|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|2214af46-1072-4328-bf3d-f4fe9cd97d9b|7|C165916|D. farinae IgG AB RAST Score|CHEMISTRY|||[?]|[?]|POSITIVE|1|cd*s/m2|1|1|[?]|HIGH|MIXED VENOUS BLOOD|ICTERIC|N|LISSAMINE GREEN STAIN|MDRD 6 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|4|TREATMENT|2020-12-12|2020-12-15|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|2214af46-1072-4328-bf3d-f4fe9cd97d9b|8|PLAGMAMP|Platelet Aggregation Mean Amplitude|URINALYSIS|||[?]|[?]|NEGATIVE|1|/MBP|1|1|[?]|LOW|RETICULOCYTES|AUTOLYZED||MICROARRAY|COCKCROFT-GAULT FORMULA|||N|Y|4|Visit_4|65|4|TREATMENT|2020-12-12|2021-01-14|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|2214af46-1072-4328-bf3d-f4fe9cd97d9b|9|C165907|Mold Mix IgG AB RAST Score|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mEq/kg|1|1|[?]|HIGH|REFLEX TEAR|GELLED||FREEZING POINT DEPRESSION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N|Y|5|Visit_5|90|6|SCREENING|2021-01-06|2021-01-09|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|2214af46-1072-4328-bf3d-f4fe9cd97d9b|10|PLSCR1|Phospholipid Scramblase 1|HEMATOLOGY|[?]|pg|[?]|[?]|TRACE|1|ECL unit|1|1|[?]|NORMAL|BONE|AUTOLYZED|N|SPIRAL CT|COCKCROFT-GAULT FORMULA|Y||Y||5|Visit_5|90|4|TREATMENT|2021-01-06|2021-01-13|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|7e56eb43-62a6-45ac-9476-1d0655595a04|1|TESTOSFR|Testosterone, Free|CHEMISTRY|||[?]|[?]|BORDERLINE|1|uEq|1|1|[?]|NORMAL|VENOUS PLASMA|UNEXPECTED ODOR|N|THIN SMEAR|MDRD 6 VARIABLE FORMULA|Y||NA|Y|1|Visit_1|10|6|TREATMENT|2021-01-24|2021-03-21|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|7e56eb43-62a6-45ac-9476-1d0655595a04|2|HALPRZLM|Hydroxyalprazolam|CHEMISTRY|[?]|10^12 IU/L|[?]|[?]|NEGATIVE|1|PIXEL|1|1|[?]|NORMAL|ALVEOLAR AIR|NON-HEMOLYZED|N|SLOAN LETTER EYE CHART 1.25%|FIBROSIS 4 FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2021-01-24|2021-02-20|10|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|7e56eb43-62a6-45ac-9476-1d0655595a04|3|MENGL|Meningeal Cells|CHEMISTRY|[?]|Watt|[?]|[?]|INVALID|1|eq|1|1|[?]|NORMAL|CAPILLARY PLASMA|SOLIDIFIED||SCANNING ELECTRON MICROSCOPY|FIBROMETER FORMULA|||U||2|Visit_2|25|7|SCREENING|2021-02-08|2021-03-26|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|7e56eb43-62a6-45ac-9476-1d0655595a04|4|T3|Triiodothyronine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|g/dL|1|1|[?]|HIGH|LOCHIA|ROOM TEMPERATURE||ERGOSPIROMETRY|MDRD ENZYMATIC FORMULA|Y||U|Y|2|Visit_2|25|4|TREATMENT|2021-02-08|2021-02-19|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|7e56eb43-62a6-45ac-9476-1d0655595a04|5|IGGSYNRT|IgG Synthesis Rate|URINALYSIS|||[?]|[?]|NEGATIVE|1|foz_us|1|1|[?]|HIGH|DISCHARGE|PARAFFIN-EMBEDDED||CALCULATION|CKD-EPI CREATININE FORMULA||Y|U|Y|3|Visit_3|40|3|TREATMENT|2021-02-23|2021-03-22|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|7e56eb43-62a6-45ac-9476-1d0655595a04|6|BITECE|Bite Cells|URINALYSIS|[?]|mL/min/1.73m2|[?]|[?]|POSITIVE|1|APPLICATION|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|GELLED|N|SLOAN LETTER EYE CHART 1.25%|GMI % FORMULA||Y|U||3|Visit_3|40|5|TREATMENT|2021-02-23|2021-03-08|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|7e56eb43-62a6-45ac-9476-1d0655595a04|7|INTLK32|Interleukin 32|URINALYSIS|[?]|10^3 copies/mL|[?]|[?]|NEGATIVE|1|ug/m2|1|1|[?]|LOW|DISCHARGE|UNEXPECTED ODOR|N|COMPLEMENT FIXATION|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|7|SCREENING|2021-03-20|2021-04-09|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|LB|7e56eb43-62a6-45ac-9476-1d0655595a04|8|C165888|Russian Thistle Pollen IgE Antibody|URINALYSIS|||[?]|[?]|POSITIVE|1|KALLIKREIN INHIBITOR UNIT|1|1|[?]|HIGH|ADIPOSE TISSUE|GELLED||FLUORESCEIN STAIN|MDRD 6 VARIABLE FORMULA|||U|Y|4|Visit_4|65|3|TREATMENT|2021-03-20|2021-03-25|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|LB|7e56eb43-62a6-45ac-9476-1d0655595a04|9|C165894|D. farinae Antigen IgG4 Antibody|HEMATOLOGY|[?]|mmol/min/kPa/L|[?]|[?]|BORDERLINE|1|Farad|1|1|[?]|HIGH|SMEGMA|DRIED||IN VITRO GENE EXPRESSION ASSAY|FIBROMETER FORMULA|||NA||5|Visit_5|90|6|WASHOUT|2021-04-14|2021-04-21|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|7e56eb43-62a6-45ac-9476-1d0655595a04|10|CK|Creatine Kinase|HEMATOLOGY|[?]|IU/kg|[?]|[?]|NEGATIVE|1|Bq|1|1|[?]|NORMAL|EXPIRED AIR|CONTAMINATED||CELLULAR PROLIFERATION ASSAY|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|2|FOLLOW-UP|2021-04-14|2021-04-19|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|73a8e85a-0b5f-496b-b164-afc4d1f02de2|1|GMCSF|Granulocyte Macrophage Colony Stm Factor|HEMATOLOGY|[?]|mol/mg|[?]|[?]|POSITIVE|1|ukat/L|1|1|[?]|HIGH|HAIR|AUTOLYZED|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|6|WASHOUT|2020-06-29|2020-09-06|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|73a8e85a-0b5f-496b-b164-afc4d1f02de2|2|HBA1C|Hemoglobin A1C|URINALYSIS|[?]|deg/mm|[?]|[?]|NEGATIVE|1|PIXELS/cm|1|1|[?]|ABNORMAL|SEMINAL FLUID|AUTOLYZED||FLUORESCENT SPOT TEST|CKD-EPI CYSTATIN C FORMULA||Y|NA||1|Visit_1|10|4|TREATMENT|2020-06-29|2020-07-22|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|73a8e85a-0b5f-496b-b164-afc4d1f02de2|3|CYHIPPAC|Hippuric Acid Crystals|CHEMISTRY|||[?]|[?]|POSITIVE|1|mL/min/1.73m2|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|UNEXPECTED ODOR||DIGITAL PCR|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|2|Visit_2|25|2|SCREENING|2020-07-14|2020-09-13|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|73a8e85a-0b5f-496b-b164-afc4d1f02de2|4|LTD4|Leukotriene D4|CHEMISTRY|[?]|ug/dL|[?]|[?]|TRACE|1|U/g/day|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|CONTAMINATED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC FORMULA|Y||U||2|Visit_2|25|4|TREATMENT|2020-07-14|2020-08-22|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|73a8e85a-0b5f-496b-b164-afc4d1f02de2|5|FECA|Fractional Calcium Excretion|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|OD Unit|1|1|[?]|LOW|CORD BLOOD|LACTESCENT||MAGNETIC RESONANCE ELASTOGRAPHY|HEPASCORE FORMULA|Y||NA|Y|3|Visit_3|40|4|TREATMENT|2020-07-29|2020-08-19|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|73a8e85a-0b5f-496b-b164-afc4d1f02de2|6|IGFBP2|Insulin-Like Growth Factor Binding Prot2|CHEMISTRY|[?]|ug/day|[?]|[?]|TRACE|1|min/day|1|1|[?]|NORMAL|VENOUS CORD BLOOD|HEMOLYZED|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA|||Y||3|Visit_3|40|5|SCREENING|2020-07-29|2020-07-30|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|73a8e85a-0b5f-496b-b164-afc4d1f02de2|7|TROPONI3|Troponin I Type 3|URINALYSIS|||[?]|[?]|INVALID|1|pg/L|1|1|[?]|ABNORMAL|GASTRIC FLUID|ROOM TEMPERATURE|N|MRI WITHOUT CONTRAST|FIBROTEST FORMULA|||NA|Y|4|Visit_4|65|3|SCREENING|2020-08-23|2020-09-05|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|LB|73a8e85a-0b5f-496b-b164-afc4d1f02de2|8|SPWEIGHT|Specimen Weight|URINALYSIS|[?]|uV|[?]|[?]|INVALID|1|rpm|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|ICTERIC||ORCHIDOMETERY|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|6|TREATMENT|2020-08-23|2020-09-20|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|LB|73a8e85a-0b5f-496b-b164-afc4d1f02de2|9|CRH|Corticotropin Releasing Hormone|HEMATOLOGY|[?]|/100 HPFs|[?]|[?]|BORDERLINE|1|/40 HPFs|1|1|[?]|HIGH|SALIVA|NON-HEMOLYZED|N|THIN SMEAR|MDRD 6 VARIABLE FORMULA||Y|NA||5|Visit_5|90|7|TREATMENT|2020-09-17|2020-09-20|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|73a8e85a-0b5f-496b-b164-afc4d1f02de2|10|PSP100AB|P100 Polymyositis-scleroderma Autoag Ab|HEMATOLOGY|||[?]|[?]|TRACE|1|NEEDLE GAUGE|1|1|[?]|LOW|CIRCULATING TUMOR CELL|HEMOLYZED||AGAR PROPORTION|GMI % FORMULA|||NA|Y|5|Visit_5|90|5|SCREENING|2020-09-17|2020-09-20|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|84f74359-c79b-4f1c-8119-a4993b071973|1|MAYHEG|May-Hegglin Anomaly|HEMATOLOGY|[?]|10^6 copies/mL|[?]|[?]|BORDERLINE|1|Arbitrary U|1|1|[?]|HIGH|PLATELET POOR PLASMA|NON-HEMOLYZED||RAJI CELL EIA|MDRD 6 VARIABLE FORMULA||Y|U||1|Visit_1|10|6|TREATMENT|2020-05-12|2020-07-09|10|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|LB|84f74359-c79b-4f1c-8119-a4993b071973|2|PAH|P-Aminohippurate Sodium|CHEMISTRY|[?]|HEP|[?]|[?]|BORDERLINE|1|WEEKS|1|1|[?]|LOW|SUPERNATANT, PLASMA|CALCIFIED||ATOMIC ABSORPTION SPECTROMETRY|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|4|TREATMENT|2020-05-12|2020-05-29|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|LB|84f74359-c79b-4f1c-8119-a4993b071973|3|LKM1AB|Liver Kidney Microsomal Type 1 Antibody|URINALYSIS|[?]|mg/kg/dose|[?]|[?]|TRACE|1|EIA unit|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|CLOTTED||RADIATION DOSIMETRY|MDRD 6 VARIABLE FORMULA||Y|NA||2|Visit_2|25|6|TREATMENT|2020-05-27|2020-07-07|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|84f74359-c79b-4f1c-8119-a4993b071973|4|HGBFHGB|Hemoglobin F/Total Hemoglobin|URINALYSIS|[?]|mg/kg/day|[?]|[?]|NEGATIVE|1|mAmp|1|1|[?]|ABNORMAL|SEMEN|CLOTTED|N|MOUSE PROTECTION ASSAY|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|4|WASHOUT|2020-05-27|2020-06-27|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|84f74359-c79b-4f1c-8119-a4993b071973|5|FBNCTCE|Fibronectin, Cellular|URINALYSIS|[?]|PELLET|[?]|[?]|POSITIVE|1|IU/mL|1|1|[?]|NORMAL|CAPILLARY PLASMA|CONTAMINATED|N|FLUORESCENCE ANGIOGRAPHY|HEPASCORE FORMULA|Y||NA||3|Visit_3|40|2|TREATMENT|2020-06-11|2020-06-25|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|84f74359-c79b-4f1c-8119-a4993b071973|6|PTSAC|Protein S Actual/Control|CHEMISTRY|[?]|10^3 RNA copies/mL|[?]|[?]|INVALID|1|JAR|1|1|[?]|ABNORMAL|BONE MARROW|SOLIDIFIED||FUNDUS PHOTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||3|Visit_3|40|3|WASHOUT|2020-06-11|2020-07-23|40|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|84f74359-c79b-4f1c-8119-a4993b071973|7|BLASTERY|Basophilic Erythroblast|HEMATOLOGY|||[?]|[?]|INVALID|1|Bq/mL|1|1|[?]|HIGH|TUMOR TISSUE|ROOM TEMPERATURE||PULSE OXIMETRY|COCKCROFT-GAULT FORMULA||Y|U|Y|4|Visit_4|65|1|TREATMENT|2020-07-06|2020-07-19|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|84f74359-c79b-4f1c-8119-a4993b071973|8|TSTSFRPT|Testosterone, Free/Total Protein|URINALYSIS|||[?]|[?]|POSITIVE|1|Enzyme U/L|1|1|[?]|LOW|PLATELET POOR PLASMA|NON-HEMOLYZED||NEXT GENERATION TARGETED SEQUENCING|CKD-EPI CYSTATIN C FORMULA|||Y|Y|4|Visit_4|65|1|TREATMENT|2020-07-06|2020-08-01|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|84f74359-c79b-4f1c-8119-a4993b071973|9|CANNABS|Cannabinoids, Synthetic|CHEMISTRY|[?]|Gravitational Unit|[?]|[?]|POSITIVE|1|ug/kg|1|1|[?]|LOW|STOOL|SOLIDIFIED||IMMUNOPRECIPITATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||5|Visit_5|90|6|SCREENING|2020-07-31|2020-08-07|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|84f74359-c79b-4f1c-8119-a4993b071973|10|LAM|Lipoarabinomannan|URINALYSIS|[?]|DNA copies/mL|[?]|[?]|TRACE|1|L/L|1|1|[?]|NORMAL|URINE SEDIMENT|LACTESCENT||PET/CT SCAN WITHOUT CONTRAST|GMI % FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-07-31|2020-08-02|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|1|TRICH|Trichomonas|CHEMISTRY|[?]|mL/kg/h|[?]|[?]|BORDERLINE|1|SYRINGE|1|1|[?]|LOW|HAIR FOLLICLE|CLOTTED||CALCULATION|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-11-06|2020-11-17|10|21|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|2|ANA|Antinuclear Antibodies|URINALYSIS|||[?]|[?]|BORDERLINE|1|RFU|1|1|[?]|ABNORMAL|HAIR FOLLICLE|SOLIDIFIED||ELISPOT|FIBROTEST FORMULA|||Y|Y|1|Visit_1|10|4|TREATMENT|2020-11-06|2020-12-27|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|3|C130087|English Plantain Pollen IgG4|URINALYSIS|[?]|ug/L FEU|[?]|[?]|INVALID|1|ng|1|1|[?]|NORMAL|CALCULUS|CONTAMINATED||CLINICAL EVALUATION|COCKCROFT-GAULT FORMULA|Y|Y|U||2|Visit_2|25|4|TREATMENT|2020-11-21|2020-12-12|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|4|CHRMTNAB|Chromatin Antibodies|URINALYSIS|[?]|WAFER|[?]|[?]|BORDERLINE|1|aMFI|1|1|[?]|LOW|ABSCESS FLUID|CONCENTRATED||CINEANGIOGRAPHY|FIBROTEST FORMULA|||NA||2|Visit_2|25|3|SCREENING|2020-11-21|2020-12-22|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|5|TSP1|Thrombospondin 1|CHEMISTRY|[?]|Absorbance U/mL|[?]|[?]|TRACE|1|AgU/mL|1|1|[?]|ABNORMAL|CALCULUS|CONCENTRATED||ACID FAST STAIN|GMI % FORMULA|Y|Y|Y||3|Visit_3|40|1|WASHOUT|2020-12-06|2020-12-09|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|6|EPISCECE|Squamous Epithelial Cells/Total Cells|HEMATOLOGY|[?]|L|[?]|[?]|TRACE|1|RFU|1|1|[?]|LOW|EPIDERMAL TISSUE|CONCENTRATED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2020-12-06|2020-12-29|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|7|VITK1|Vitamin K1|URINALYSIS|||[?]|[?]|NEGATIVE|1|uV|1|1|[?]|LOW|BREAST MILK|CONTAMINATED||CALIPER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|7|FOLLOW-UP|2020-12-31|2021-01-20|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|8|LYMMCELY|Lymphoma Cells/Lymphocytes|CHEMISTRY|[?]|mL/(min*100mL)|[?]|[?]|TRACE|1|10^6 CFU|1|1|[?]|NORMAL|PERSPIRATION|LACTESCENT||ELASTOGRAPHY|MDRD 6 VARIABLE FORMULA|Y|Y|N||4|Visit_4|65|2|FOLLOW-UP|2020-12-31|2021-01-04|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|9|FECL|Fractional Chloride Excretion|CHEMISTRY|[?]|ng/dL|[?]|[?]|INVALID|1|%(w/v)|1|1|[?]|HIGH|EXUDATE|CONCENTRATED||STRESS ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2021-01-25|2021-02-03|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|10|HASIGMAB|Human Anti-Sheep IgM Antibody|HEMATOLOGY|[?]|10^12 IU/L|[?]|[?]|BORDERLINE|1|L/L|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED||STATIC PERIMETRY|COCKCROFT-GAULT FORMULA||Y|U||5|Visit_5|90|6|SCREENING|2021-01-25|2021-02-01|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|cd0c969e-61c6-4c65-ac19-4ee247f5009a|1|HGBA|Hemoglobin A|HEMATOLOGY|[?]|10^6 CFU|[?]|[?]|NEGATIVE|1|/MBP|1|1|[?]|LOW|LYSATE|GELLED|N|OPHTHALMOSCOPY|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-09-09|2020-12-01|10|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|cd0c969e-61c6-4c65-ac19-4ee247f5009a|2|PLATAGGR|Platelet Aggregation|HEMATOLOGY|[?]|mm/sec|[?]|[?]|TRACE|1|mmol/min/kPa|1|1|[?]|NORMAL|BLOOD|GELLED|N|LIGHT MICROSCOPY|NASH FIBROSURE FORMULA||Y|NA||1|Visit_1|10|3|SCREENING|2020-09-09|2020-10-10|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|cd0c969e-61c6-4c65-ac19-4ee247f5009a|3|ALP|Alkaline Phosphatase|URINALYSIS|[?]|ohm|[?]|[?]|INDETERMINATE|1|PELLET|1|1|[?]|ABNORMAL|LYSATE|DRIED|N|CT SCAN WITHOUT CONTRAST|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-09-24|2020-09-25|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|cd0c969e-61c6-4c65-ac19-4ee247f5009a|4|MYPCERPC|Myeloid/Erythroid Ratio|CHEMISTRY|[?]|PLUG|[?]|[?]|TRACE|1|m2|1|1|[?]|HIGH|LOCHIA|HEMOLYZED|N|FLUORESCENT SPOT TEST|FIBROTEST FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-09-24|2020-11-22|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|cd0c969e-61c6-4c65-ac19-4ee247f5009a|5|VOLUME|Volume|HEMATOLOGY|[?]|pkat/L|[?]|[?]|NEGATIVE|1|10^4 CFU/mL|1|1|[?]|NORMAL|NAIL|REFRIGERATED|N|MICROARRAY|MDRD 6 VARIABLE FORMULA|||U||3|Visit_3|40|4|TREATMENT|2020-10-09|2020-10-10|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|cd0c969e-61c6-4c65-ac19-4ee247f5009a|6|INTLK25|Interleukin 25|HEMATOLOGY|[?]|breaths/min|[?]|[?]|INVALID|1|10^9 organisms/g|1|1|[?]|ABNORMAL|PROSTATIC FLUID|THAWED|N|CLAUSS METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||3|Visit_3|40|6|TREATMENT|2020-10-09|2020-10-22|40|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|cd0c969e-61c6-4c65-ac19-4ee247f5009a|7|PTHFG|Parathyroid Hormone, Fragmented|URINALYSIS|[?]|HEP|[?]|[?]|INDETERMINATE|1|SUPPOSITORY|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|GELLED||IRON HEMATOXYLIN STAIN|GMI % FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-11-03|2020-11-13|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|cd0c969e-61c6-4c65-ac19-4ee247f5009a|8|LEU|Leucine|URINALYSIS|[?]|oz eq|[?]|[?]|BORDERLINE|1|uCi/kg|1|1|[?]|ABNORMAL|KERATINOCYTE|GELLED||COMPLEMENT FIXATION|FIBROSIS 4 FORMULA|||Y||4|Visit_4|65|7|TREATMENT|2020-11-03|2020-12-05|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|cd0c969e-61c6-4c65-ac19-4ee247f5009a|9|C130136|American Cockroach Antigen IgE Antibody|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^6 IU|1|1|[?]|NORMAL|SKIN TISSUE|LACTESCENT||ULTRASOUND|COCKCROFT-GAULT FORMULA|||N|Y|5|Visit_5|90|2|TREATMENT|2020-11-28|2020-12-07|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|cd0c969e-61c6-4c65-ac19-4ee247f5009a|10|PGES|Prostaglandin E Synthase|HEMATOLOGY|||[?]|[?]|POSITIVE|1|cm H2O|1|1|[?]|NORMAL|TRANSUDATE|CLOTTED||HPLC/MS/MS|HEPASCORE FORMULA|||Y|Y|5|Visit_5|90|4|TREATMENT|2020-11-28|2020-11-30|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|1fff484d-0a68-42cd-8eff-bc4fe4da945c|1|CANNABS|Cannabinoids, Synthetic|URINALYSIS|[?]|CAN|[?]|[?]|POSITIVE|1|nm|1|1|[?]|ABNORMAL|PERSPIRATION|ICTERIC||PHOTOMETRIC CLOT DETECTION|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|6|SCREENING|2021-01-28|2021-02-20|10|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|LB|1fff484d-0a68-42cd-8eff-bc4fe4da945c|2|C165936|Glycine max IgE AB RAST Score|HEMATOLOGY|[?]|nmol BCE/nmol|[?]|[?]|INVALID|1|vg/dose|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR||COULOMETRIC TITRATION|MDRD 5 VARIABLE FORMULA||Y|U||1|Visit_1|10|3|TREATMENT|2021-01-28|2021-03-18|10|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|LB|1fff484d-0a68-42cd-8eff-bc4fe4da945c|3|BLYCELE|B-Lymphocytes/Leukocytes|CHEMISTRY|||[?]|[?]|NEGATIVE|1|oz|1|1|[?]|HIGH|BREAST MILK|THAWED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD FORMULA|Y||Y|Y|2|Visit_2|25|1|TREATMENT|2021-02-12|2021-04-08|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-18
e|LB|1fff484d-0a68-42cd-8eff-bc4fe4da945c|4|GGT|Gamma Glutamyl Transferase|HEMATOLOGY|||[?]|[?]|TRACE|1|CIGARETTE|1|1|[?]|LOW|MUCUS|LACTESCENT||REBOUND TONOMETRY|COCKCROFT-GAULT FORMULA|||Y|Y|2|Visit_2|25|4|TREATMENT|2021-02-12|2021-03-27|25|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-18
e|LB|1fff484d-0a68-42cd-8eff-bc4fe4da945c|5|INSULINR|Insulin Resistance|URINALYSIS|[?]|cm H2O|[?]|[?]|BORDERLINE|1|BOWL|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|REFRIGERATED|N|CONFOCAL MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|||N||3|Visit_3|40|5|FOLLOW-UP|2021-02-27|2021-04-01|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|LB|1fff484d-0a68-42cd-8eff-bc4fe4da945c|6|C130141|German Cockroach Antigen IgA Antibody|CHEMISTRY|[?]|mEq/L|[?]|[?]|BORDERLINE|1|mm3/mm2/year|1|1|[?]|LOW|CAPILLARY PLASMA|CONCENTRATED|N|GC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||3|Visit_3|40|2|TREATMENT|2021-02-27|2021-04-12|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|LB|1fff484d-0a68-42cd-8eff-bc4fe4da945c|7|BLSTLYLE|Lymphoblasts/Leukocytes|HEMATOLOGY|[?]|PHERESIS UNIT|[?]|[?]|INVALID|1|mmol/day|1|1|[?]|ABNORMAL|EMESIS|CONCENTRATED||HPLC|GMI % FORMULA||Y|N||4|Visit_4|65|1|TREATMENT|2021-03-24|2021-04-27|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|LB|1fff484d-0a68-42cd-8eff-bc4fe4da945c|8|CYSTARCH|Starch Crystals|HEMATOLOGY|[?]|mol|[?]|[?]|NEGATIVE|1|vp/mL|1|1|[?]|LOW|ADIPOSE TISSUE|UNEXPECTED ODOR|N|GC/MS|NASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|2|TREATMENT|2021-03-24|2021-04-10|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|LB|1fff484d-0a68-42cd-8eff-bc4fe4da945c|9|CA2729AG|Cancer Antigen 27-29|URINALYSIS|[?]|Absorbance U/min|[?]|[?]|NEGATIVE|1|cd|1|1|[?]|LOW|PERITONEAL FLUID|PARAFFIN-EMBEDDED||HEMAGGLUTINATION INHIBITION ASSAY|FIBROMETER FORMULA|||U||5|Visit_5|90|4|TREATMENT|2021-04-18|2021-04-24|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|1fff484d-0a68-42cd-8eff-bc4fe4da945c|10|HLAB|HLA Class IB Antigen|HEMATOLOGY|[?]|VOXEL|[?]|[?]|BORDERLINE|1|umol/mol|1|1|[?]|LOW|AQUEOUS HUMOR|DRIED||DARK FIELD MICROSCOPY|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2021-04-18|2021-04-26|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|e2c20e9a-0ac5-4907-96de-472bee70bd79|1|CYAMPURT|Amorphous Urate Crystals|URINALYSIS|[?]|10^8 PFU|[?]|[?]|POSITIVE|1|ug/g/h|1|1|[?]|ABNORMAL|BONE|REFRIGERATED||LAPAROSCOPY|FIBROMETER FORMULA|||N||1|Visit_1|10|6|FOLLOW-UP|2020-12-04|2021-02-10|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|e2c20e9a-0ac5-4907-96de-472bee70bd79|2|PCNAG|Proliferating Cell Nuclear Antigen|HEMATOLOGY|[?]|pmol/L|[?]|[?]|NEGATIVE|1|Bq/kg|1|1|[?]|LOW|CELL PELLET|NON-HEMOLYZED||PHASE CONTRAST MICROSCOPY|HEPASCORE FORMULA|Y||U||1|Visit_1|10|1|SCREENING|2020-12-04|2021-02-27|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|e2c20e9a-0ac5-4907-96de-472bee70bd79|3|PLATBIZ|Bizarre Platelets|URINALYSIS|[?]|titer|[?]|[?]|INVALID|1|dpm/0.5 mL|1|1|[?]|LOW|ABSCESS FLUID|CONCENTRATED||RAJI CELL EIA|MDRD ENZYMATIC FORMULA|Y||Y||2|Visit_2|25|1|FOLLOW-UP|2020-12-19|2021-02-20|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|LB|e2c20e9a-0ac5-4907-96de-472bee70bd79|4|ACRNCRNF|Acylcarnitine/Carnitine, Free|CHEMISTRY|[?]|mL/mmHg|[?]|[?]|INVALID|1|AMPULE|1|1|[?]|NORMAL|EPITHELIAL CELL|LACTESCENT|N|TARGETED GENOME SEQUENCING|CKD-EPI FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-12-19|2021-02-07|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|LB|e2c20e9a-0ac5-4907-96de-472bee70bd79|5|RLP|RLP Cholesterol|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|/mm|1|1|[?]|LOW|LEUKOCYTE|CONCENTRATED||CYSTOMETRY|MDRD FORMULA|Y||NA|Y|3|Visit_3|40|6|TREATMENT|2021-01-03|2021-02-28|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|e2c20e9a-0ac5-4907-96de-472bee70bd79|6|RETI|Reticulocytes|URINALYSIS|[?]|BU/mL|[?]|[?]|TRACE|1|g/U|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|FROZEN||WRIGHT-GIEMSA STAIN|CKD-EPI CYSTATIN C FORMULA|||N||3|Visit_3|40|1|SCREENING|2021-01-03|2021-01-04|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|e2c20e9a-0ac5-4907-96de-472bee70bd79|7|ADMA|Asymmetric Dimethylarginine|URINALYSIS|[?]|Henry|[?]|[?]|INDETERMINATE|1|v/v|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|FROZEN||INDIRECT IMMUNOFLUORESCENCE|MDRD 4 VARIABLE FORMULA|||U||4|Visit_4|65|2|WASHOUT|2021-01-28|2021-02-02|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|e2c20e9a-0ac5-4907-96de-472bee70bd79|8|TNFSR1|Soluble TNF Receptor Type I|CHEMISTRY|||[?]|[?]|POSITIVE|1|DAgU/mL|1|1|[?]|HIGH|CEREBROSPINAL FLUID|AGGLUTINATED|N|ELECTROCHEMILUMINESCENCE|FIBROTEST FORMULA||Y|Y|Y|4|Visit_4|65|5|TREATMENT|2021-01-28|2021-02-10|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|e2c20e9a-0ac5-4907-96de-472bee70bd79|9|IGGCREAT|Immunoglobulin G/Creatinine|HEMATOLOGY|[?]|L/h/m2|[?]|[?]|BORDERLINE|1|mmHg*min/L|1|1|[?]|LOW|BUFFY COAT|LACTESCENT|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD FORMULA||Y|Y||5|Visit_5|90|7|TREATMENT|2021-02-22|2021-03-01|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|e2c20e9a-0ac5-4907-96de-472bee70bd79|10|IBCU|Unsaturated Iron Binding Capacity|HEMATOLOGY|[?]|cm/min|[?]|[?]|BORDERLINE|1|/10^4|1|1|[?]|LOW|SERUM OR PLASMA|ICTERIC||HIGH RESOLUTION MELT ANALYSIS|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||5|Visit_5|90|6|FOLLOW-UP|2021-02-22|2021-02-24|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|6064ca8c-b723-4d05-914a-bb547d86fcc5|1|GLDIGGAB|Gliadin IgG Antibody|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|IU/kg|1|1|[?]|NORMAL|BILE|NON-HEMOLYZED||ROMANOWSKY STAIN|MDRD 5 VARIABLE FORMULA|||U|Y|1|Visit_1|10|1|TREATMENT|2020-06-02|2020-07-12|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|6064ca8c-b723-4d05-914a-bb547d86fcc5|2|BLASTRUB|Rubriblast|URINALYSIS|[?]|s^-1(%O2)^-1|[?]|[?]|TRACE|1|damol/L|1|1|[?]|NORMAL|PERITONEAL FLUID|UNEXPECTED ODOR||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|ASH FIBROSURE FORMULA||Y|Y||1|Visit_1|10|2|WASHOUT|2020-06-02|2020-08-16|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|6064ca8c-b723-4d05-914a-bb547d86fcc5|3|A1ANTRYP|Alpha-1 Antitrypsin|CHEMISTRY|[?]|Henry|[?]|[?]|POSITIVE|1|pmol|1|1|[?]|NORMAL|LYMPH|AUTOLYZED||NEPHELOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||2|Visit_2|25|2|TREATMENT|2020-06-17|2020-08-23|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|LB|6064ca8c-b723-4d05-914a-bb547d86fcc5|4|B2MCREAT|Beta-2 Microglobulin/Creatinine|HEMATOLOGY|[?]|CONTAINER|[?]|[?]|INVALID|1|DAYS|1|1|[?]|LOW|EPITHELIAL CELL|DRIED|N|WEBER GREEN STAIN|MDRD FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-06-17|2020-07-30|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|LB|6064ca8c-b723-4d05-914a-bb547d86fcc5|5|ORNITHIN|Ornithine|HEMATOLOGY|[?]|HOMEOPATHIC DILUTION|[?]|[?]|TRACE|1|cmHg|1|1|[?]|HIGH|EXPIRED AIR|UNEXPECTED ODOR||CLINICAL EVALUATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||3|Visit_3|40|7|TREATMENT|2020-07-02|2020-07-07|40|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|6064ca8c-b723-4d05-914a-bb547d86fcc5|6|C130133|D. farinae Antigen IgG Antibody|CHEMISTRY|[?]|C|[?]|[?]|INVALID|1|nmol/mol|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|PARAFFIN-EMBEDDED||LANDOLT RING|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|4|WASHOUT|2020-07-02|2020-08-04|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|6064ca8c-b723-4d05-914a-bb547d86fcc5|7|TAURINE|Taurine|URINALYSIS|||[?]|[?]|POSITIVE|1|g/cage|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|CONTAMINATED||MICROBIAL CULTURE, SOLID|HEPASCORE FORMULA||Y|N|Y|4|Visit_4|65|5|SCREENING|2020-07-27|2020-08-25|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|LB|6064ca8c-b723-4d05-914a-bb547d86fcc5|8|ROULEAUX|Rouleaux Formation|CHEMISTRY|[?]|U/cL|[?]|[?]|NEGATIVE|1|deg2|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED||AUDIOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|6|FOLLOW-UP|2020-07-27|2020-08-29|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|LB|6064ca8c-b723-4d05-914a-bb547d86fcc5|9|APOH|Apolipoprotein H|URINALYSIS|||[?]|[?]|TRACE|1|L/L|1|1|[?]|NORMAL|AQUEOUS HUMOR|DRIED|N|APPLANATION TONOMETRY|FIBROTEST FORMULA|||N|Y|5|Visit_5|90|2|TREATMENT|2020-08-21|2020-08-25|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|6064ca8c-b723-4d05-914a-bb547d86fcc5|10|RETIM|Medium Absorption Reticulocytes|URINALYSIS|[?]|nmol/kg/day|[?]|[?]|POSITIVE|1|/min|1|1|[?]|LOW|DISCHARGE|ROOM TEMPERATURE|N|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CREATININE FORMULA|Y|Y|N||5|Visit_5|90|6|TREATMENT|2020-08-21|2020-08-27|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|8effbbff-acda-4718-89f1-e30a418f6bae|1|INTLK14|Interleukin 14|CHEMISTRY|[?]|FINGERTIP UNIT|[?]|[?]|INDETERMINATE|1|nmol|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|UNEXPECTED ODOR||CONTRAST ENHANCED MRI|NASH FIBROSURE FORMULA|||Y||1|Visit_1|10|6|WASHOUT|2020-11-06|2021-01-16|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|8effbbff-acda-4718-89f1-e30a418f6bae|2|ETPPHR|ETP Peak Height Relative|URINALYSIS|[?]|pmol/L/h|[?]|[?]|POSITIVE|1|ug/L/h|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|THAWED||MUGA|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-11-06|2020-11-20|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|8effbbff-acda-4718-89f1-e30a418f6bae|3|CRTRONE|Corticosterone|URINALYSIS|[?]|uEq/L|[?]|[?]|INVALID|1|mm/2h|1|1|[?]|LOW|MONOCYTE|CONTAMINATED||ENZYMATIC COLORIMETRY|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-11-21|2020-12-05|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|8effbbff-acda-4718-89f1-e30a418f6bae|4|FXIVAAC|Factor XIV Activity Actual/Control|CHEMISTRY|[?]|mg/min|[?]|[?]|INVALID|1|nmol/L/min|1|1|[?]|NORMAL|VENOUS PLASMA|REFRIGERATED|N|APPLANATION TONOMETRY|CKD-EPI CYSTATIN C FORMULA|||U||2|Visit_2|25|2|WASHOUT|2020-11-21|2020-12-22|25|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|8effbbff-acda-4718-89f1-e30a418f6bae|5|PROMYB|Promyeloblasts|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|cy/cm|1|1|[?]|NORMAL|LYMPH|PARAFFIN-EMBEDDED||MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|7|SCREENING|2020-12-06|2020-12-21|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|8effbbff-acda-4718-89f1-e30a418f6bae|6|OXYSAT|Oxygen Saturation|URINALYSIS|||[?]|[?]|NEGATIVE|1|NEEDLE GAUGE|1|1|[?]|LOW|GASTRIC CONTENTS|LACTESCENT||REBOUND TONOMETRY|NASH FIBROSURE FORMULA|Y||N|Y|3|Visit_3|40|7|SCREENING|2020-12-06|2021-01-26|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|8effbbff-acda-4718-89f1-e30a418f6bae|7|CXCL12|Chemokine (C-X-C Motif) Ligand 12|HEMATOLOGY|[?]|10^8 PFU|[?]|[?]|NEGATIVE|1|uIU/dL|1|1|[?]|ABNORMAL|TRANSUDATE|UNEXPECTED ODOR||GC/FID|MDRD ENZYMATIC FORMULA|||U||4|Visit_4|65|4|SCREENING|2020-12-31|2021-02-03|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|8effbbff-acda-4718-89f1-e30a418f6bae|8|ASMACT|Alpha-Smooth Muscle Actin|URINALYSIS|||[?]|[?]|TRACE|1|mPa|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|GELLED||DUCTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|4|Visit_4|65|7|FOLLOW-UP|2020-12-31|2021-01-15|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|8effbbff-acda-4718-89f1-e30a418f6bae|9|VITDBP|Vitamin D Binding Protein|URINALYSIS|[?]|PATCH|[?]|[?]|POSITIVE|1|DAgU|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|ROOM TEMPERATURE|N|DYNAMOMETRY|COCKCROFT-GAULT FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2021-01-25|2021-01-26|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|LB|8effbbff-acda-4718-89f1-e30a418f6bae|10|C165884|Olive Tree Pollen IgE Antibody|CHEMISTRY|[?]|Bq/L|[?]|[?]|TRACE|1|foz_br|1|1|[?]|ABNORMAL|PLEURAL FLUID|CONCENTRATED||DROPLET DIGITAL PCR|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||5|Visit_5|90|3|TREATMENT|2021-01-25|2021-01-27|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|LB|859b16a5-f6a2-40cc-8e01-18c112b1969e|1|IGG1|Immunoglobulin G Subclass 1|CHEMISTRY|[?]|mEq|[?]|[?]|BORDERLINE|1|nmol/g|1|1|[?]|NORMAL|GASTRIC CONTENTS|LIPEMIC|N|GIEMSA STAIN|FIBROMETER FORMULA|Y||N||1|Visit_1|10|4|TREATMENT|2020-08-18|2020-08-29|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|859b16a5-f6a2-40cc-8e01-18c112b1969e|2|CYHGBC|Hemoglobin C Crystals|HEMATOLOGY|[?]|MAC50|[?]|[?]|TRACE|1|C|1|1|[?]|LOW|PLATELET RICH PLASMA|CALCIFIED||LASER CAPTURE MICRODISSECTION|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|4|WASHOUT|2020-08-18|2020-10-17|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|859b16a5-f6a2-40cc-8e01-18c112b1969e|3|PLP|Pyridoxal Phosphate|URINALYSIS|||[?]|[?]|INDETERMINATE|1|10^6 organisms/mg|1|1|[?]|HIGH|SUPERNATANT, PLASMA|HEMOLYZED||CONFOCAL MICROSCOPY|MDRD 6 VARIABLE FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2020-09-02|2020-10-16|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|859b16a5-f6a2-40cc-8e01-18c112b1969e|4|DDIMER|D-Dimer|CHEMISTRY|[?]|BEAM BREAKS|[?]|[?]|INDETERMINATE|1|ug/cm2|1|1|[?]|HIGH|LYSATE|ICTERIC||MICROARRAY|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|7|WASHOUT|2020-09-02|2020-09-27|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|859b16a5-f6a2-40cc-8e01-18c112b1969e|5|MPC|Mean Platelet Component|CHEMISTRY|[?]|10^6 organisms/mg|[?]|[?]|INVALID|1|mAnson U/mL|1|1|[?]|LOW|PROSTATIC FLUID|UNEXPECTED ODOR||LINE PROBE ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-09-17|2020-10-26|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|859b16a5-f6a2-40cc-8e01-18c112b1969e|6|CYLEUC|Leucine Crystals|CHEMISTRY|[?]|dmol|[?]|[?]|NEGATIVE|1|mmol/s|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|CONCENTRATED||SPIRAL CT|HEPASCORE FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-09-17|2020-10-15|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|859b16a5-f6a2-40cc-8e01-18c112b1969e|7|FAI|Free Androgen Index|CHEMISTRY|[?]|msec|[?]|[?]|NEGATIVE|1|mg/mL/min|1|1|[?]|NORMAL|CERUMEN|HEMOLYZED||TRANSCRIPTION-MEDIATED AMPLIFICATION|HEPASCORE FORMULA|Y||Y||4|Visit_4|65|7|TREATMENT|2020-10-12|2020-11-10|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|859b16a5-f6a2-40cc-8e01-18c112b1969e|8|HCGND|Choriogonadotropin|HEMATOLOGY|[?]|grain|[?]|[?]|BORDERLINE|1|Absorbance U/mL|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED||NEURAMINIDASE INHIBITION ASSAY|FIBROSIS 4 FORMULA||Y|Y||4|Visit_4|65|1|FOLLOW-UP|2020-10-12|2020-11-06|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|859b16a5-f6a2-40cc-8e01-18c112b1969e|9|RBCDYSM|Dysmorphic Erythrocytes|URINALYSIS|||[?]|[?]|INVALID|1|ug/dL|1|1|[?]|NORMAL|CORD SERUM|CLOTTED|N|MICROPARTICLE ENZYME IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|5|Visit_5|90|5|FOLLOW-UP|2020-11-06|2020-11-12|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|859b16a5-f6a2-40cc-8e01-18c112b1969e|10|LYMMCELY|Lymphoma Cells/Lymphocytes|HEMATOLOGY|[?]|mJoule/cm2|[?]|[?]|INDETERMINATE|1|Ci/g|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|REFRIGERATED||AGAR PROPORTION|CKD-EPI CYSTATIN C FORMULA|Y||U||5|Visit_5|90|3|TREATMENT|2020-11-06|2020-11-07|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|36b457ef-4cf6-4043-a836-49368ebf3f1c|1|HLZPM|Halazepam|URINALYSIS|[?]|U/m2|[?]|[?]|BORDERLINE|1|P|1|1|[?]|NORMAL|PLATELET RICH PLASMA|AUTOLYZED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y||1|Visit_1|10|2|SCREENING|2020-08-16|2020-10-16|10|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|36b457ef-4cf6-4043-a836-49368ebf3f1c|2|DKK1|Dickkopf WNT Signaling Path Inhibitor 1|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|L|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|PARAFFIN-EMBEDDED|N|CYSTOSCOPY|MDRD ENZYMATIC FORMULA|Y||U|Y|1|Visit_1|10|4|TREATMENT|2020-08-16|2020-11-10|10|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|36b457ef-4cf6-4043-a836-49368ebf3f1c|3|B2G1GMAB|Beta-2 Glycoprotein 1 IgM Antibody|HEMATOLOGY|||[?]|[?]|POSITIVE|1|GLOBULE|1|1|[?]|NORMAL|NAIL|ICTERIC||PHOROPTER|CKD-EPI FORMULA|Y||Y|Y|2|Visit_2|25|4|SCREENING|2020-08-31|2020-10-17|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|36b457ef-4cf6-4043-a836-49368ebf3f1c|4|PLATGNT|Giant Platelets|CHEMISTRY|[?]|dpm/0.5 mL|[?]|[?]|INDETERMINATE|1|mEq/mmol|1|1|[?]|LOW|ENDOTRACHEAL FLUID|LIPEMIC||TRIPLE-PHASE MRI SCAN|FIBROMETER FORMULA|Y|Y|NA||2|Visit_2|25|3|SCREENING|2020-08-31|2020-09-28|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|36b457ef-4cf6-4043-a836-49368ebf3f1c|5|CYTYRO|Tyrosine Crystals|URINALYSIS|[?]|TROCHE|[?]|[?]|INVALID|1|Bq/kg|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|AUTOLYZED||MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-09-15|2020-11-13|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|36b457ef-4cf6-4043-a836-49368ebf3f1c|6|APLSMA2A|Alpha-2 Antiplasmin Activity|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Ci/kg|1|1|[?]|NORMAL|MUCUS|ROOM TEMPERATURE||PATHOLOGICAL EVALUATION|FIBROMETER FORMULA|||NA|Y|3|Visit_3|40|6|WASHOUT|2020-09-15|2020-09-21|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|36b457ef-4cf6-4043-a836-49368ebf3f1c|7|NOREPIN|Norepinephrine|HEMATOLOGY|[?]|Ci/kg|[?]|[?]|TRACE|1|mEq/day|1|1|[?]|HIGH|BREAST MILK|CALCIFIED||CALCOFLUOR WHITE STAIN|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|7|FOLLOW-UP|2020-10-10|2020-10-22|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|36b457ef-4cf6-4043-a836-49368ebf3f1c|8|GLUTAM|Glutamate|HEMATOLOGY|||[?]|[?]|INVALID|1|Watt|1|1|[?]|NORMAL|BONE MARROW|GELLED||CENTRIFUGATION|NASH FIBROSURE FORMULA|||NA|Y|4|Visit_4|65|1|SCREENING|2020-10-10|2020-10-26|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|36b457ef-4cf6-4043-a836-49368ebf3f1c|9|MYCYCE|Myelocytes/Total Cells|HEMATOLOGY|[?]|10^7/L|[?]|[?]|INDETERMINATE|1|PLUG|1|1|[?]|NORMAL|FLUID|CALCIFIED||ANTIBIOTIC AGAR SCREEN|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|3|WASHOUT|2020-11-04|2020-11-12|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|36b457ef-4cf6-4043-a836-49368ebf3f1c|10|CSEPI|Epithelial Casts|CHEMISTRY|[?]|ug/h|[?]|[?]|INDETERMINATE|1|CYLINDER|1|1|[?]|NORMAL|INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|N|STATIC PERIMETRY|MDRD 6 VARIABLE FORMULA|Y||Y||5|Visit_5|90|5|TREATMENT|2020-11-04|2020-11-06|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|31f33e38-bba6-4c8a-b563-14afaabae5d7|1|HALBAB|Human Albumin Antibody|URINALYSIS|[?]|mg/dL|[?]|[?]|INDETERMINATE|1|KALLIKREIN INHIBITOR UNIT|1|1|[?]|LOW|BONE|LACTESCENT||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA|||N||1|Visit_1|10|4|FOLLOW-UP|2020-07-01|2020-08-09|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|31f33e38-bba6-4c8a-b563-14afaabae5d7|2|C130112|Animal Mix Antigen IgE Antibody|URINALYSIS|[?]|Gy|[?]|[?]|BORDERLINE|1|cmH2O*s2/mL|1|1|[?]|ABNORMAL|ABSCESS FLUID|UNEXPECTED ODOR||IMMUNODIFFUSION|MDRD FORMULA|||Y||1|Visit_1|10|4|FOLLOW-UP|2020-07-01|2020-09-25|10|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|31f33e38-bba6-4c8a-b563-14afaabae5d7|3|HALLUC|Hallucinogen|CHEMISTRY|||[?]|[?]|TRACE|1|10^6 CFU|1|1|[?]|HIGH|WHITE MATTER TISSUE|REFRIGERATED||CLAUSS METHOD|GMI % FORMULA||Y|Y|Y|2|Visit_2|25|7|WASHOUT|2020-07-16|2020-09-18|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|31f33e38-bba6-4c8a-b563-14afaabae5d7|4|ESELECT|E-Selectin|HEMATOLOGY|||[?]|[?]|POSITIVE|1|CCID 50/mL|1|1|[?]|HIGH|COLOSTRUM|FRESH||THICK SMEAR|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|2|Visit_2|25|1|TREATMENT|2020-07-16|2020-07-30|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|31f33e38-bba6-4c8a-b563-14afaabae5d7|5|AMMONIA|Ammonia|CHEMISTRY|[?]|10^6 CFU/g|[?]|[?]|NEGATIVE|1|uV2|1|1|[?]|HIGH|TISSUE|DRIED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||3|Visit_3|40|3|FOLLOW-UP|2020-07-31|2020-08-29|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|LB|31f33e38-bba6-4c8a-b563-14afaabae5d7|6|CRTRONE|Corticosterone|URINALYSIS|[?]|mg/dL|[?]|[?]|POSITIVE|1|10^8/L|1|1|[?]|NORMAL|LOCHIA|FROZEN||GC/MS/MS|FIBROMETER FORMULA|Y|Y|Y||3|Visit_3|40|2|TREATMENT|2020-07-31|2020-09-11|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|LB|31f33e38-bba6-4c8a-b563-14afaabae5d7|7|TNFSR2|Soluble TNF Receptor Type II|CHEMISTRY|[?]|mL/beat|[?]|[?]|BORDERLINE|1|uV|1|1|[?]|HIGH|SEBUM|AGGLUTINATED||TURBIDIMETRY|CKD-EPI CYSTATIN C FORMULA||Y|U||4|Visit_4|65|1|TREATMENT|2020-08-25|2020-09-14|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|31f33e38-bba6-4c8a-b563-14afaabae5d7|8|CHOL|Cholesterol|CHEMISTRY|[?]|ug/m2|[?]|[?]|POSITIVE|1|Watt|1|1|[?]|NORMAL|BLOOD|LACTESCENT|N|SPECT/CT SCAN|HEPASCORE FORMULA|Y||N||4|Visit_4|65|4|TREATMENT|2020-08-25|2020-09-02|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|31f33e38-bba6-4c8a-b563-14afaabae5d7|9|PICP|Procollagen Type I Carboxy Term Peptide|CHEMISTRY|[?]|GLOBULE|[?]|[?]|POSITIVE|1|Mile|1|1|[?]|LOW|EPIDERMAL TISSUE|FRESH||TONOMETRY|CKD-EPI CREATININE FORMULA|Y||Y||5|Visit_5|90|4|TREATMENT|2020-09-19|2020-09-21|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|31f33e38-bba6-4c8a-b563-14afaabae5d7|10|GUSA|Glucuronidase, Alpha|URINALYSIS|[?]|mL/s|[?]|[?]|TRACE|1|U/m2/day|1|1|[?]|ABNORMAL|PERSPIRATION|LIPEMIC||HIGH RESOLUTION CT|NASH FIBROSURE FORMULA|Y||Y||5|Visit_5|90|1|TREATMENT|2020-09-19|2020-09-26|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|6794dffe-333b-425b-8883-26f6e5ba0797|1|MONOBLLE|Monoblasts/Leukocytes|HEMATOLOGY|[?]|kBq/uL|[?]|[?]|TRACE|1|fL|1|1|[?]|NORMAL|SEMEN|LACTESCENT|N|KARYOTYPING|GMI % FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-07-09|2020-08-08|10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|6794dffe-333b-425b-8883-26f6e5ba0797|2|GFRBSCUA|GFR from Creat,UreaN,Alb Adj BSA|CHEMISTRY|[?]|kDa|[?]|[?]|INDETERMINATE|1|ugEq|1|1|[?]|HIGH|PUS|LIPEMIC||CORONARY ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA|Y||U||1|Visit_1|10|6|SCREENING|2020-07-09|2020-09-12|10|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|6794dffe-333b-425b-8883-26f6e5ba0797|3|CTLPRM|Citalopram|HEMATOLOGY|[?]|umol/L/sec|[?]|[?]|TRACE|1|km/h|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|ROOM TEMPERATURE|N|GC/MS|MDRD ENZYMATIC FORMULA||Y|U||2|Visit_2|25|3|WASHOUT|2020-07-24|2020-09-05|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|LB|6794dffe-333b-425b-8883-26f6e5ba0797|4|UNSPCECE|Unspecified Cells/Total Cells|URINALYSIS|[?]|U/m2|[?]|[?]|POSITIVE|1|nmol/g|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|CONCENTRATED||PALPATION|MDRD ENZYMATIC FORMULA|Y|Y|N||2|Visit_2|25|6|FOLLOW-UP|2020-07-24|2020-08-05|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|LB|6794dffe-333b-425b-8883-26f6e5ba0797|5|HIST2BAB|Histone 2B Antibody|CHEMISTRY|[?]|DIP|[?]|[?]|TRACE|1|deg|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|CALCIFIED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI FORMULA|Y||N||3|Visit_3|40|6|TREATMENT|2020-08-08|2020-08-30|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|6794dffe-333b-425b-8883-26f6e5ba0797|6|SJSA60AB|Sjogrens SS-A60 Antibody|URINALYSIS|[?]|MESF|[?]|[?]|BORDERLINE|1|kBq/uL|1|1|[?]|LOW|PLATELET POOR PLASMA|FRESH||CELL OF ORIGIN ASSAY|CKD-EPI FORMULA|Y||Y||3|Visit_3|40|4|FOLLOW-UP|2020-08-08|2020-08-14|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|6794dffe-333b-425b-8883-26f6e5ba0797|7|SJSSAAB|Sjogrens SS-A Antibody|HEMATOLOGY|[?]|mmHg/L/min|[?]|[?]|NEGATIVE|1|GBq/g|1|1|[?]|NORMAL|CORD SERUM|CONTAMINATED|N|NUCLEIC ACID BASED METHOD|MDRD ENZYMATIC FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-09-02|2020-09-07|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|6794dffe-333b-425b-8883-26f6e5ba0797|8|C130133|D. farinae Antigen IgG Antibody|URINALYSIS|||[?]|[?]|INVALID|1|GBq|1|1|[?]|LOW|DERMAL TISSUE|SOLIDIFIED||BALLPOINT PEN TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|4|Visit_4|65|3|SCREENING|2020-09-02|2020-09-03|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|6794dffe-333b-425b-8883-26f6e5ba0797|9|CD2|CD2|HEMATOLOGY|[?]|m|[?]|[?]|INVALID|1|mU/L|1|1|[?]|NORMAL|RETICULOCYTES|LIPEMIC||RAJI CELL RIA|HEPASCORE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-09-27|2020-09-29|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|6794dffe-333b-425b-8883-26f6e5ba0797|10|TKG|T-Kininogen|HEMATOLOGY|||[?]|[?]|POSITIVE|1|STEPS|1|1|[?]|NORMAL|STOOL|LACTESCENT||SNELLEN EYE CHART|MDRD ENZYMATIC FORMULA|||Y|Y|5|Visit_5|90|5|FOLLOW-UP|2020-09-27|2020-09-30|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|1|PRCTC|Prostate Circulating Tumor Cells|URINALYSIS|[?]|HOMEOPATHIC DILUTION|[?]|[?]|BORDERLINE|1|mm/min|1|1|[?]|LOW|BILE|ICTERIC||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|FIBROMETER FORMULA|||N||1|Visit_1|10|5|WASHOUT|2020-06-07|2020-08-17|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|2|NEUTCE|Neutrophils/Total Cells|CHEMISTRY|[?]|Enzyme U|[?]|[?]|TRACE|1|mL/breath|1|1|[?]|ABNORMAL|RETICULOCYTES|DRIED||SNELLEN EYE CHART|MDRD 4 VARIABLE FORMULA|||NA||1|Visit_1|10|1|SCREENING|2020-06-07|2020-06-08|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|3|CA72_4AG|Cancer Antigen 72-4|CHEMISTRY|[?]|tsp|[?]|[?]|INDETERMINATE|1|ug/kg/min|1|1|[?]|NORMAL|COLOSTRUM|UNEXPECTED ODOR||MALDI-TOF|FIBROTEST FORMULA|||U||2|Visit_2|25|7|WASHOUT|2020-06-22|2020-09-04|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|4|C5FR|Complement C5, Free|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Gy/min|1|1|[?]|HIGH|BREAST MILK|PARAFFIN-EMBEDDED|N|KARYOTYPING|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|Y|2|Visit_2|25|7|TREATMENT|2020-06-22|2020-08-30|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|5|CARNTEXR|Carnitine Excretion Rate|CHEMISTRY|[?]|vg/mL|[?]|[?]|POSITIVE|1|10^8/L|1|1|[?]|HIGH|CALCULUS|CONTAMINATED||PERIODIC ACID SCHIFF STAIN|FIBROMETER FORMULA|Y|Y|NA||3|Visit_3|40|4|TREATMENT|2020-07-07|2020-08-28|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|6|ALPLALP|Alk Phos, Liver/Total Alk Phos|CHEMISTRY|[?]|EID 50/dose|[?]|[?]|BORDERLINE|1|mmHg/sec|1|1|[?]|ABNORMAL|DIALYSIS FLUID|CONCENTRATED||MAGNETIC RESONANCE ELASTOGRAPHY|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|3|WASHOUT|2020-07-07|2020-07-24|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|7|CYAMPURT|Amorphous Urate Crystals|URINALYSIS|||[?]|[?]|TRACE|1|s/h|1|1|[?]|HIGH|SYNOVIAL FLUID|CONTAMINATED|N|LIGHT SCATTERING SPECTROSCOPY|HEPASCORE FORMULA|Y||U|Y|4|Visit_4|65|5|SCREENING|2020-08-01|2020-08-24|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|8|CD8LY|CD8/Lymphocytes|URINALYSIS|||[?]|[?]|NEGATIVE|1|Gy/min|1|1|[?]|ABNORMAL|BASAL TEAR|CLOTTED||DIFFUSION WEIGHTED MRI|NASH FIBROSURE FORMULA|||NA|Y|4|Visit_4|65|2|TREATMENT|2020-08-01|2020-08-02|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|9|FRTNHC|Ferritin Heavy Chain|URINALYSIS|[?]|ng/mol|[?]|[?]|NEGATIVE|1|in|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED||PHOTOGRAPHY|MDRD FORMULA|Y||N||5|Visit_5|90|4|TREATMENT|2020-08-26|2020-08-30|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|10|PRABC|Calculated Panel Reactive Antibody|HEMATOLOGY|[?]|/10^5|[?]|[?]|INVALID|1|uIU/L|1|1|[?]|NORMAL|SYNOVIAL FLUID|DRIED||CONTACT SPECULAR MICROSCOPY|NASH FIBROSURE FORMULA||Y|U||5|Visit_5|90|5|SCREENING|2020-08-26|2020-08-30|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|45897452-8f5a-458d-9a43-13237460ba48|1|TPAAG|Tissue Plasminogen Activator Antigen|HEMATOLOGY|[?]|ng/mol|[?]|[?]|BORDERLINE|1|mg/m2/day|1|1|[?]|HIGH|CALCULUS|FROZEN||SIZE EXCLUSION CHROMATOGRAPHY|ASH FIBROSURE FORMULA||Y|U||1|Visit_1|10|4|WASHOUT|2020-11-11|2020-11-15|10|14|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|45897452-8f5a-458d-9a43-13237460ba48|2|DCCARNIT|Decanoylcarnitine|URINALYSIS|[?]|IU/kg/h|[?]|[?]|INDETERMINATE|1|mL/cage|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|ROOM TEMPERATURE||HEMAGGLUTINATION ASSAY|GMI % FORMULA||Y|U||1|Visit_1|10|1|TREATMENT|2020-11-11|2020-11-24|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|45897452-8f5a-458d-9a43-13237460ba48|3|CAIONPH|Calcium, Ionized pH Adjusted|HEMATOLOGY|[?]|uV|[?]|[?]|TRACE|1|PACKAGE|1|1|[?]|HIGH|BUFFY COAT|THAWED|N|CLOT DETECTION|MDRD ENZYMATIC FORMULA|||N||2|Visit_2|25|7|SCREENING|2020-11-26|2020-12-16|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|45897452-8f5a-458d-9a43-13237460ba48|4|INTLK6|Interleukin 6|HEMATOLOGY|[?]|MASK|[?]|[?]|NEGATIVE|1|Rad|1|1|[?]|LOW|RETICULOCYTES|CONTAMINATED||MAPH|FIBROSIS 4 FORMULA|||NA||2|Visit_2|25|1|SCREENING|2020-11-26|2020-12-03|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|45897452-8f5a-458d-9a43-13237460ba48|5|VITDIT|25-Hydroxyvitamin D|URINALYSIS|[?]|Ci/mL|[?]|[?]|INVALID|1|/sec|1|1|[?]|LOW|TUMOR TISSUE|ICTERIC|N|DISK DIFFUSION|GMI MMOL/MOL FORMULA|Y||U||3|Visit_3|40|7|TREATMENT|2020-12-11|2021-01-09|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|45897452-8f5a-458d-9a43-13237460ba48|6|LPPLA2|Lipoprotein Associated Phospholipase A2|URINALYSIS|[?]|mL/animal/wk|[?]|[?]|INVALID|1|MPL U/mL|1|1|[?]|ABNORMAL|CELL PELLET|FRESH||ZIEHL NEELSEN ACID FAST STAIN|FIBROSIS 4 FORMULA|Y|Y|Y||3|Visit_3|40|1|SCREENING|2020-12-11|2021-01-20|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|45897452-8f5a-458d-9a43-13237460ba48|7|RBCNURBC|Nucleated Erythrocytes/Erythrocytes|URINALYSIS|[?]|mCi/L|[?]|[?]|TRACE|1|mL/kg|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|AGGLUTINATED||PLETHYSMOGRAPHY|CKD-EPI FORMULA||Y|Y||4|Visit_4|65|1|TREATMENT|2021-01-05|2021-01-17|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|45897452-8f5a-458d-9a43-13237460ba48|8|GLOBBPT|Beta Globulin/Total Protein|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|IU/L|1|1|[?]|ABNORMAL|CERUMEN|ROOM TEMPERATURE|N|LC/MS|CKD-EPI CREATININE FORMULA|Y||NA|Y|4|Visit_4|65|4|TREATMENT|2021-01-05|2021-02-02|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|45897452-8f5a-458d-9a43-13237460ba48|9|C130082|Orchard Grass Pollen IgG|HEMATOLOGY|[?]|TRANSDUCING UNIT/mL|[?]|[?]|INDETERMINATE|1|g/day|1|1|[?]|LOW|BUFFY COAT|CLOTTED|N|MAPH|FIBROMETER FORMULA|Y||U||5|Visit_5|90|2|TREATMENT|2021-01-30|2021-02-06|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|45897452-8f5a-458d-9a43-13237460ba48|10|C130138|American Cockroach Antigen IgG Antibody|CHEMISTRY|[?]|ug/m2/h|[?]|[?]|INVALID|1|PIXEL|1|1|[?]|ABNORMAL|VENOUS PLASMA|CONCENTRATED||GC/MS-CI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||5|Visit_5|90|3|SCREENING|2021-01-30|2021-02-01|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|16eb981f-2118-4658-a83f-93d925c410c9|1|VBCE|Viable Cells|HEMATOLOGY|[?]|HOMEOPATHIC DILUTION|[?]|[?]|INDETERMINATE|1|APL U/mL|1|1|[?]|HIGH|SKIN TISSUE|CONCENTRATED||NON-INVASIVE DIELECTRIC SENSING|HEPASCORE FORMULA||Y|NA||1|Visit_1|10|4|TREATMENT|2020-12-16|2021-01-18|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|16eb981f-2118-4658-a83f-93d925c410c9|2|IL122340|Interleukin 12+23 p40|URINALYSIS|[?]|OD Unit|[?]|[?]|BORDERLINE|1|BISCUIT|1|1|[?]|LOW|GASTRIC FLUID|PARAFFIN-EMBEDDED|N|DC SHEATH FLOW|FIBROTEST FORMULA||Y|U||1|Visit_1|10|1|TREATMENT|2020-12-16|2021-01-26|10|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|16eb981f-2118-4658-a83f-93d925c410c9|3|AFPL2|Alpha Fetoprotein L2|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ug/L|1|1|[?]|LOW|SPERMATOZOON|HEMOLYZED||REFRACTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|2|Visit_2|25|7|TREATMENT|2020-12-31|2021-03-05|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|16eb981f-2118-4658-a83f-93d925c410c9|4|ICAIGGAB|Islet Cell Cytoplasmic IgG Antibody|URINALYSIS|||[?]|[?]|INDETERMINATE|1|MET*h|1|1|[?]|NORMAL|BREAST MILK|LIPEMIC||COULOMETRIC TITRATION|ASH FIBROSURE FORMULA|||NA|Y|2|Visit_2|25|6|TREATMENT|2020-12-31|2021-02-10|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|16eb981f-2118-4658-a83f-93d925c410c9|5|C1INH|Complement C1 Esterase Inhibitor|HEMATOLOGY|[?]|L/min/m2|[?]|[?]|TRACE|1|kPa|1|1|[?]|LOW|VITREOUS HUMOR|CONTAMINATED||DIFFUSION WEIGHTED MRI|FIBROTEST FORMULA||Y|U||3|Visit_3|40|6|FOLLOW-UP|2021-01-15|2021-02-02|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|16eb981f-2118-4658-a83f-93d925c410c9|6|MCPHG|Macrophages|URINALYSIS|[?]|umol/dL|[?]|[?]|INDETERMINATE|1|V|1|1|[?]|NORMAL|SUPERNATANT, SERUM|DRIED||PET/SPECT SCAN|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|3|WASHOUT|2021-01-15|2021-01-28|40|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|16eb981f-2118-4658-a83f-93d925c410c9|7|PHOS|Phosphate|URINALYSIS|[?]|mL/day|[?]|[?]|NEGATIVE|1|mEq/mL|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|AGGLUTINATED||DNA MICROARRAY|GMI % FORMULA|Y|Y|N||4|Visit_4|65|1|SCREENING|2021-02-09|2021-02-10|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|16eb981f-2118-4658-a83f-93d925c410c9|8|PLSPCE|Precursor Plasma Cells|URINALYSIS|||[?]|[?]|NEGATIVE|1|Ci|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|CALCIFIED||DYNAMOMETRY|FIBROTEST FORMULA|Y||Y|Y|4|Visit_4|65|2|SCREENING|2021-02-09|2021-03-03|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|16eb981f-2118-4658-a83f-93d925c410c9|9|RBCFRAG|Erythrocyte Fragment|CHEMISTRY|[?]|CIGARETTE|[?]|[?]|TRACE|1|ag|1|1|[?]|LOW|SMEGMA|UNEXPECTED ODOR|N|CISH|GMI % FORMULA|||U||5|Visit_5|90|4|WASHOUT|2021-03-06|2021-03-12|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|16eb981f-2118-4658-a83f-93d925c410c9|10|LYMMCE|Lymphoma Cells|HEMATOLOGY|[?]|AFU|[?]|[?]|NEGATIVE|1|BEAM BREAKS|1|1|[?]|HIGH|BASAL TEAR|ROOM TEMPERATURE||MOUSE PROTECTION ASSAY|NASH FIBROSURE FORMULA|Y||U||5|Visit_5|90|3|WASHOUT|2021-03-06|2021-03-15|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|1|CARNTEXR|Carnitine Excretion Rate|CHEMISTRY|||[?]|[?]|NEGATIVE|1|genEq/mL|1|1|[?]|HIGH|CAPILLARY BLOOD|ROOM TEMPERATURE||CINEANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|1|Visit_1|10|1|TREATMENT|2021-01-11|2021-03-14|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|2|DALACRT|Delta Aminolevulinate/Creatinine|URINALYSIS|[?]|uL/dose|[?]|[?]|INVALID|1|100 IU/mL|1|1|[?]|HIGH|SEMINAL FLUID|AGGLUTINATED||IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||1|Visit_1|10|4|TREATMENT|2021-01-11|2021-03-13|10|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|3|ANCIGAB|Anti-Neutrophil Cytoplasmic IgG Antibody|URINALYSIS|[?]|kIU|[?]|[?]|BORDERLINE|1|mmol/kg|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|LIPEMIC||INDIRECT IMMUNOFLUORESCENCE|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2021-01-26|2021-02-06|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|4|CRTCREAT|Corticosterone/Creatinine|URINALYSIS|[?]|dyn|[?]|[?]|NEGATIVE|1|ng/mol|1|1|[?]|HIGH|ARTERIAL BLOOD|AUTOLYZED|N|CELLULAR PROLIFERATION ASSAY|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|7|TREATMENT|2021-01-26|2021-01-30|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|5|PROTEXR|Protein Excretion Rate|HEMATOLOGY|[?]|U/m2/h|[?]|[?]|BORDERLINE|1|breaths/30s|1|1|[?]|HIGH|WHITE MATTER TISSUE|CLOTTED||ERGOSPIROMETRY|FIBROMETER FORMULA||Y|Y||3|Visit_3|40|3|TREATMENT|2021-02-10|2021-04-10|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|LB|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|6|CD8|CD8|URINALYSIS|[?]|mmAL|[?]|[?]|INDETERMINATE|1|%/min|1|1|[?]|NORMAL|RETICULOCYTES|CONTAMINATED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|ASH FIBROSURE FORMULA||Y|U||3|Visit_3|40|1|SCREENING|2021-02-10|2021-03-03|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|LB|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|7|COLOR|Color|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|PIXELS/cm|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|CONCENTRATED||ALCIAN BLUE STAIN|HEPASCORE FORMULA|Y||N|Y|4|Visit_4|65|1|TREATMENT|2021-03-07|2021-03-28|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|8|MNC|Mononuclear Cells|HEMATOLOGY|[?]|U/kg|[?]|[?]|POSITIVE|1|Antibody Unit|1|1|[?]|ABNORMAL|ABSCESS FLUID|CLOTTED|N|ACRIDINE ORANGE STAIN|HEPASCORE FORMULA|||Y||4|Visit_4|65|2|WASHOUT|2021-03-07|2021-03-08|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|9|C165931|Nut Mix IgE AB RAST Score|URINALYSIS|[?]|deg2|[?]|[?]|NEGATIVE|1|mL/m2/min|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|DRIED||MALDI-TOF|CKD-EPI CREATININE FORMULA|Y||N||5|Visit_5|90|5|TREATMENT|2021-04-01|2021-04-08|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|10|GRANSGCE|Granulocytes Segmented/Total Cells|URINALYSIS|||[?]|[?]|TRACE|1|Ci/ug|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|LACTESCENT||DYNAMIC LIGHT SCATTERING|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|5|Visit_5|90|5|TREATMENT|2021-04-01|2021-04-10|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|1|LCTHSPGM|Lecithin/Sphingomyelin|HEMATOLOGY|[?]|lm|[?]|[?]|INDETERMINATE|1|IU/mmol|1|1|[?]|HIGH|TRANSUDATE|NON-HEMOLYZED||FLUORESCENT SPOT TEST|HEPASCORE FORMULA|||NA||1|Visit_1|10|1|WASHOUT|2021-01-29|2021-04-13|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|LB|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|2|CCPAB|Cyclic Citrullinated Peptide Antibody|CHEMISTRY|[?]|umol/dL|[?]|[?]|BORDERLINE|1|mg/kg/h|1|1|[?]|ABNORMAL|SPUTUM|LIPEMIC||HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||1|Visit_1|10|2|SCREENING|2021-01-29|2021-02-02|10|14|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|LB|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|3|SPMAGGLU|Sperm Agglutination|CHEMISTRY|[?]|dB|[?]|[?]|INVALID|1|mmHg/L/min|1|1|[?]|ABNORMAL|DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED||NEXT GENERATION TARGETED SEQUENCING|COCKCROFT-GAULT FORMULA|||N||2|Visit_2|25|7|WASHOUT|2021-02-13|2021-04-22|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|4|ANUAB|Anti-Nucleosome Antibody|URINALYSIS|[?]|tsp|[?]|[?]|BORDERLINE|1|pg/cell|1|1|[?]|HIGH|CORD SERUM|THAWED||ENZYMATIC ULTRACENTRIFUGATION|GMI MMOL/MOL FORMULA|Y||N||2|Visit_2|25|7|FOLLOW-UP|2021-02-13|2021-04-01|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|5|GFRBSCRT|GFR from Creatinine Adjusted for BSA|URINALYSIS|||[?]|[?]|INDETERMINATE|1|min*mg/mL|1|1|[?]|HIGH|SWABBED MATERIAL|CALCIFIED||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD FORMULA||Y|Y|Y|3|Visit_3|40|7|WASHOUT|2021-02-28|2021-04-01|40|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|LB|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|6|CSGRANC|Granular Coarse Casts|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|sec|1|1|[?]|HIGH|MENSTRUAL BLOOD|LACTESCENT||CENTRIFUGATION|MDRD 4 VARIABLE FORMULA||Y|U|Y|3|Visit_3|40|7|WASHOUT|2021-02-28|2021-03-14|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|LB|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|7|PROC6|Pro-C6|CHEMISTRY|[?]|mm/sec|[?]|[?]|NEGATIVE|1|ug/L FEU|1|1|[?]|LOW|URINE SEDIMENT|CLOTTED||AUTOMATED COUNT|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2021-03-25|2021-04-20|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-09
e|LB|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|8|AXL|AXL Receptor Tyrosine Kinase|URINALYSIS|[?]|Absorbance U/min|[?]|[?]|INVALID|1|umol/kg/min|1|1|[?]|ABNORMAL|BUFFY COAT|AGGLUTINATED||COULOMETRIC TITRATION|GMI % FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2021-03-25|2021-03-26|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-09
e|LB|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|9|LYMMCELY|Lymphoma Cells/Lymphocytes|CHEMISTRY|[?]|10^8 PFU|[?]|[?]|NEGATIVE|1|aMFI|1|1|[?]|HIGH|VITREOUS HUMOR|FRESH||MEDIASTINOSCOPY|MDRD ENZYMATIC FORMULA||Y|Y||5|Visit_5|90|4|TREATMENT|2021-04-19|2021-04-28|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-26
e|LB|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|10|INTLK22|Interleukin 22|HEMATOLOGY|[?]|mm/min|[?]|[?]|NEGATIVE|1|umol/L|1|1|[?]|NORMAL|URINE SEDIMENT|SOLIDIFIED||MUGA|MDRD ENZYMATIC FORMULA|Y||U||5|Visit_5|90|5|SCREENING|2021-04-19|2021-04-27|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-26
e|LB|874f491c-5d55-4738-86b7-b1200b16d106|1|PGE1|Prostaglandin E1|URINALYSIS|[?]|APL U/mL|[?]|[?]|NEGATIVE|1|vg/mL|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|CONCENTRATED||BRDU CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE FORMULA|||N||1|Visit_1|10|2|FOLLOW-UP|2021-01-08|2021-02-06|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|874f491c-5d55-4738-86b7-b1200b16d106|2|GDIGA1|Galactose-Deficient IgA1|HEMATOLOGY|[?]|ug/m2|[?]|[?]|INVALID|1|mmAL|1|1|[?]|LOW|ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED||ELECTROPHORESIS|MDRD ENZYMATIC FORMULA||Y|U||1|Visit_1|10|1|TREATMENT|2021-01-08|2021-03-20|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|874f491c-5d55-4738-86b7-b1200b16d106|3|ADPNHMW|Adiponectin, High Molecular Weight|CHEMISTRY|[?]|cm|[?]|[?]|NEGATIVE|1|Gravitational Unit|1|1|[?]|ABNORMAL|BUFFY COAT|AGGLUTINATED||DUCTOGRAPHY|CKD-EPI FORMULA|||N||2|Visit_2|25|5|TREATMENT|2021-01-23|2021-02-19|25|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|874f491c-5d55-4738-86b7-b1200b16d106|4|FACTVII|Factor VII|CHEMISTRY|||[?]|[?]|INVALID|1|ohm|1|1|[?]|ABNORMAL|PROSTATIC FLUID|CONCENTRATED||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2021-01-23|2021-04-01|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|874f491c-5d55-4738-86b7-b1200b16d106|5|LH|Luteinizing Hormone|URINALYSIS|[?]|ug/kg/min|[?]|[?]|INDETERMINATE|1|TRACE|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|LIPEMIC||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA|||U||3|Visit_3|40|7|SCREENING|2021-02-07|2021-03-31|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|874f491c-5d55-4738-86b7-b1200b16d106|6|C165909|Industrial Mix IgG AB RAST Score|HEMATOLOGY|[?]|P|[?]|[?]|INDETERMINATE|1|LOZENGE|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|THAWED|N|NEXT GENERATION SEQUENCING|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2021-02-07|2021-02-16|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|874f491c-5d55-4738-86b7-b1200b16d106|7|HGBS|Hemoglobin S|URINALYSIS|||[?]|[?]|INDETERMINATE|1|h/wk|1|1|[?]|NORMAL|PLATELET POOR PLASMA|THAWED||MICROBIAL CULTURE|MDRD 5 VARIABLE FORMULA|||N|Y|4|Visit_4|65|3|TREATMENT|2021-03-04|2021-03-07|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|874f491c-5d55-4738-86b7-b1200b16d106|8|CORTFR|Cortisol, Free|CHEMISTRY|[?]|10^4/L|[?]|[?]|POSITIVE|1|POUCH|1|1|[?]|ABNORMAL|KERATINOCYTE|HEMOLYZED|N|DIGITAL PCR ARRAY|NASH FIBROSURE FORMULA|Y|Y|U||4|Visit_4|65|7|FOLLOW-UP|2021-03-04|2021-03-21|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|874f491c-5d55-4738-86b7-b1200b16d106|9|YEAST|Yeast Cells|URINALYSIS|||[?]|[?]|INVALID|1|/kg|1|1|[?]|HIGH|BILE|AGGLUTINATED||KNEMOMETRY|MDRD 5 VARIABLE FORMULA|||Y|Y|5|Visit_5|90|6|FOLLOW-UP|2021-03-29|2021-03-31|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|LB|874f491c-5d55-4738-86b7-b1200b16d106|10|PAI1|Plasminogen Activator Inhibitor-1|CHEMISTRY|[?]|umol/L/h|[?]|[?]|INDETERMINATE|1|IU/kg/h|1|1|[?]|NORMAL|VITREOUS HUMOR|AUTOLYZED||MANUAL COUNT|FIBROMETER FORMULA||Y|NA||5|Visit_5|90|5|TREATMENT|2021-03-29|2021-04-04|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|LB|281ccdef-794c-49ad-9616-6f6f68dd4543|1|COCBNZEC|Cocaine Benzoylecgonine Ecgonine|CHEMISTRY|[?]|10^9 CFU/g|[?]|[?]|TRACE|1|yd|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|CALCIFIED||X-RAY|MDRD 4 VARIABLE FORMULA||Y|N||1|Visit_1|10|7|TREATMENT|2020-06-04|2020-07-11|10|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|281ccdef-794c-49ad-9616-6f6f68dd4543|2|CHOL|Cholesterol|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mmol2/L2|1|1|[?]|HIGH|ALVEOLAR AIR|CONCENTRATED|N|IMPULSE OSCILLOMETRY|GMI % FORMULA|Y||N|Y|1|Visit_1|10|6|SCREENING|2020-06-04|2020-07-07|10|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|281ccdef-794c-49ad-9616-6f6f68dd4543|3|PO2ADJT|Partial Pressure Oxygen Adj for Temp|HEMATOLOGY|[?]|L/min/m2|[?]|[?]|INDETERMINATE|1|nmol/L|1|1|[?]|LOW|MECONIUM|AGGLUTINATED|N|FLUORESCEIN STAIN|CKD-EPI FORMULA|Y|Y|NA||2|Visit_2|25|5|WASHOUT|2020-06-19|2020-06-27|25|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|281ccdef-794c-49ad-9616-6f6f68dd4543|4|CAPHOS|Calcium/Phosphorus|URINALYSIS|[?]|dmol|[?]|[?]|INDETERMINATE|1|PELLET|1|1|[?]|HIGH|TUMOR TISSUE|DRIED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|COCKCROFT-GAULT FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-06-19|2020-07-30|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|281ccdef-794c-49ad-9616-6f6f68dd4543|5|GRANBCE|Granulocytes Band Form/Total Cells|CHEMISTRY|[?]|mg/L|[?]|[?]|POSITIVE|1|mg/animal|1|1|[?]|NORMAL|TRANSUDATE|THAWED||FLUORESCENT SPOT TEST|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2020-07-04|2020-08-19|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|281ccdef-794c-49ad-9616-6f6f68dd4543|6|DHPG|3,4-Dihydroxyphenylglycol|HEMATOLOGY|[?]|RFU|[?]|[?]|NEGATIVE|1|F|1|1|[?]|NORMAL|CERUMEN|THAWED||GIEMSA STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||3|Visit_3|40|5|WASHOUT|2020-07-04|2020-07-14|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|281ccdef-794c-49ad-9616-6f6f68dd4543|7|APOA5|Apolipoprotein A5|URINALYSIS|||[?]|[?]|POSITIVE|1|HEP|1|1|[?]|LOW|PROSTATIC FLUID|AUTOLYZED||SIZE EXCLUSION CHROMATOGRAPHY|FIBROTEST FORMULA|||NA|Y|4|Visit_4|65|7|TREATMENT|2020-07-29|2020-08-27|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|281ccdef-794c-49ad-9616-6f6f68dd4543|8|TOXVAC|Toxic Vacuolation|URINALYSIS|||[?]|[?]|TRACE|1|mU|1|1|[?]|NORMAL|LUNG SURFACTANT|AUTOLYZED||CELLULOSE TAPE|MDRD 6 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|7|WASHOUT|2020-07-29|2020-08-04|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|281ccdef-794c-49ad-9616-6f6f68dd4543|9|A73OXC|7-alpha-Hydroxy-4-cholesten-3-one|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ug/L DDU|1|1|[?]|NORMAL|STOOL|CONTAMINATED||CENTRIFUGATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|5|Visit_5|90|6|TREATMENT|2020-08-23|2020-08-28|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|281ccdef-794c-49ad-9616-6f6f68dd4543|10|PHTRMN|Phentermine|URINALYSIS|[?]|SFC/10^6 PBMC|[?]|[?]|NEGATIVE|1|10^9 organisms|1|1|[?]|HIGH|CORD SERUM|LACTESCENT|N|AUTOREFRACTION|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||5|Visit_5|90|6|TREATMENT|2020-08-23|2020-09-01|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|b1179e10-e8fe-472c-a511-d6d460571857|1|APRIL|A Proliferation-Inducing Ligand|HEMATOLOGY|[?]|ug/m2/h|[?]|[?]|POSITIVE|1|mEq/g|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|THAWED|N|INCISION-INDUCED BLEEDING METHOD|CKD-EPI CYSTATIN C FORMULA||Y|N||1|Visit_1|10|1|TREATMENT|2020-08-02|2020-10-04|10|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|b1179e10-e8fe-472c-a511-d6d460571857|2|GLUCCLR|Glucose Clearance|CHEMISTRY|[?]|IU/mL|[?]|[?]|POSITIVE|1|uV|1|1|[?]|NORMAL|MUCUS|NON-HEMOLYZED||HEMAGGLUTINATION ASSAY|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|3|FOLLOW-UP|2020-08-02|2020-08-08|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|b1179e10-e8fe-472c-a511-d6d460571857|3|BASOMYL|Basophilic Myelocytes|CHEMISTRY|[?]|Frames/s|[?]|[?]|BORDERLINE|1|Torr|1|1|[?]|ABNORMAL|HAIR FOLLICLE|FROZEN||BAC ACGH|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|5|SCREENING|2020-08-17|2020-09-30|25|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|b1179e10-e8fe-472c-a511-d6d460571857|4|SULFATE|Sulfate|URINALYSIS|[?]|h*%|[?]|[?]|POSITIVE|1|ukat/L|1|1|[?]|NORMAL|CELL PELLET|GELLED||KLEIHAUER-BETKE|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-08-17|2020-09-28|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|b1179e10-e8fe-472c-a511-d6d460571857|5|INULIN|Inulin|HEMATOLOGY|[?]|cpm|[?]|[?]|NEGATIVE|1|ug/m2|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|LACTESCENT||IMMUNE REPERTOIRE DEEP SEQUENCING|CKD-EPI FORMULA|||NA||3|Visit_3|40|6|SCREENING|2020-09-01|2020-09-26|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|b1179e10-e8fe-472c-a511-d6d460571857|6|INTLK4|Interleukin 4|HEMATOLOGY|[?]|ng/L|[?]|[?]|NEGATIVE|1|cd|1|1|[?]|NORMAL|LYMPH|NON-HEMOLYZED||SANGER SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||N||3|Visit_3|40|4|TREATMENT|2020-09-01|2020-09-29|40|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|b1179e10-e8fe-472c-a511-d6d460571857|7|GLDH|Glutamate Dehydrogenase|URINALYSIS|[?]|umol/mol|[?]|[?]|NEGATIVE|1|mL/dose|1|1|[?]|HIGH|SEMEN|CLOTTED||IMMUNOFIXATION ELECTROPHORESIS|CKD-EPI FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-09-26|2020-10-09|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|b1179e10-e8fe-472c-a511-d6d460571857|8|APRI|AST to Platelet Ratio Index|HEMATOLOGY|||[?]|[?]|POSITIVE|1|Ejaculate U|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|THAWED|N|FLUORESCEIN STAIN|CKD-EPI CREATININE FORMULA|||Y|Y|4|Visit_4|65|4|TREATMENT|2020-09-26|2020-10-26|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|b1179e10-e8fe-472c-a511-d6d460571857|9|BASO|Basophils|HEMATOLOGY|[?]|deg/mm|[?]|[?]|TRACE|1|min/day|1|1|[?]|NORMAL|REFLEX TEAR|UNEXPECTED ODOR|N|SPECT/CT SCAN|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-10-21|2020-10-28|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|b1179e10-e8fe-472c-a511-d6d460571857|10|C130103|Grass Mix Pollen Antigen IgE Antibody|HEMATOLOGY|[?]|kDa|[?]|[?]|INDETERMINATE|1|kHz|1|1|[?]|LOW|URINE SEDIMENT|UNEXPECTED ODOR||IMMUNO-PET SCAN|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-10-21|2020-10-22|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|6362cf42-f286-4151-bdf7-38fcc5639eed|1|PGF2AI8|8-Iso-Prostaglandin F2 Alpha|HEMATOLOGY|[?]|U/g/min|[?]|[?]|TRACE|1|PA|1|1|[?]|LOW|URINE SEDIMENT|PARAFFIN-EMBEDDED||NEXT GENERATION SEQUENCING|COCKCROFT-GAULT FORMULA|||NA||1|Visit_1|10|5|SCREENING|2020-09-07|2020-10-17|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|6362cf42-f286-4151-bdf7-38fcc5639eed|2|TROPONIN|Troponin|URINALYSIS|||[?]|[?]|INDETERMINATE|1|PLUG|1|1|[?]|ABNORMAL|PLEURAL FLUID|DRIED||ICP-MS|GMI MMOL/MOL FORMULA|||NA|Y|1|Visit_1|10|3|WASHOUT|2020-09-07|2020-10-06|10|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|6362cf42-f286-4151-bdf7-38fcc5639eed|3|GLOBG|Gamma Globulin|HEMATOLOGY|[?]|g|[?]|[?]|TRACE|1|m/sec2|1|1|[?]|ABNORMAL|VENOUS PLASMA|CLOTTED||SPIRAL CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|7|SCREENING|2020-09-22|2020-10-02|25|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|6362cf42-f286-4151-bdf7-38fcc5639eed|4|CARBXHGB|Carboxyhemoglobin|URINALYSIS|||[?]|[?]|INVALID|1|SPRAY|1|1|[?]|LOW|PUS|LIPEMIC||IMMUNOTURBIDIMETRY|CKD-EPI CYSTATIN C FORMULA|Y|Y|NA|Y|2|Visit_2|25|7|WASHOUT|2020-09-22|2020-10-10|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|6362cf42-f286-4151-bdf7-38fcc5639eed|5|STBSEXCS|Standard Base Excess|URINALYSIS|[?]|/2000 RBC|[?]|[?]|TRACE|1|BEAM BREAKS|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED||BIOIMPEDANCE SPECTROSCOPY|FIBROSIS 4 FORMULA||Y|Y||3|Visit_3|40|3|FOLLOW-UP|2020-10-07|2020-10-19|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|LB|6362cf42-f286-4151-bdf7-38fcc5639eed|6|G6PDA|Glucose-6-Phosphate Dehydrogenase Act|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Bq/g|1|1|[?]|HIGH|LYMPH|AUTOLYZED|N|FUNCTIONAL MRI|FIBROMETER FORMULA|||Y|Y|3|Visit_3|40|5|SCREENING|2020-10-07|2020-11-15|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|LB|6362cf42-f286-4151-bdf7-38fcc5639eed|7|PF2AI8CR|8-Iso-PGF2alpha/Creatinine|CHEMISTRY|[?]|umol|[?]|[?]|INVALID|1|INHALATION|1|1|[?]|LOW|VENOUS CORD BLOOD|CONCENTRATED||BALLPOINT PEN TECHNIQUE|MDRD 5 VARIABLE FORMULA|Y||NA||4|Visit_4|65|7|TREATMENT|2020-11-01|2020-12-04|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|6362cf42-f286-4151-bdf7-38fcc5639eed|8|BHYXBTR|Beta-Hydroxybutyrate|URINALYSIS|||[?]|[?]|INVALID|1|Arbitrary U|1|1|[?]|LOW|CELL PELLET|HEMOLYZED||REFRACTOMETRY|CKD-EPI CYSTATIN C FORMULA|Y|Y|N|Y|4|Visit_4|65|6|TREATMENT|2020-11-01|2020-12-03|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|6362cf42-f286-4151-bdf7-38fcc5639eed|9|PCO2ADJT|Partial Pressure Carbon Dioxide Adj Temp|CHEMISTRY|[?]|mL|[?]|[?]|TRACE|1|10^6/hpf|1|1|[?]|HIGH|EMESIS|GELLED|N|POLYSOMNOGRAPHY|GMI % FORMULA||Y|Y||5|Visit_5|90|1|TREATMENT|2020-11-26|2020-11-28|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|6362cf42-f286-4151-bdf7-38fcc5639eed|10|RNP70AB|Ribonucleoprotein-70 Antibody|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Arbitrary U|1|1|[?]|HIGH|ALVEOLAR AIR|CONTAMINATED||SPECT SCAN|COCKCROFT-GAULT FORMULA|||U|Y|5|Visit_5|90|7|WASHOUT|2020-11-26|2020-12-01|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|8e28e3ab-0060-43f7-b033-c16bd77c0e29|1|A2MACG|Alpha-2 Macroglobulin|URINALYSIS|[?]|MASK|[?]|[?]|INVALID|1|CCID 50/mL|1|1|[?]|HIGH|URINE SEDIMENT|FRESH||TURBIDIMETRY|COCKCROFT-GAULT FORMULA|||U||1|Visit_1|10|1|SCREENING|2020-11-30|2021-02-22|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|8e28e3ab-0060-43f7-b033-c16bd77c0e29|2|CARNIT|Carnitine|CHEMISTRY|[?]|mL/animal|[?]|[?]|POSITIVE|1|mL/mmHg|1|1|[?]|HIGH|SPUTUM|CONCENTRATED||ELISA|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||1|Visit_1|10|4|WASHOUT|2020-11-30|2020-12-02|10|12|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|8e28e3ab-0060-43f7-b033-c16bd77c0e29|3|BLYCELE|B-Lymphocytes/Leukocytes|CHEMISTRY|[?]|mmol/day|[?]|[?]|POSITIVE|1|IU/L|1|1|[?]|LOW|AMNIOTIC FLUID|LIPEMIC||TRIPLE-PHASE SPIRAL CT SCAN|FIBROSIS 4 FORMULA||Y|Y||2|Visit_2|25|1|TREATMENT|2020-12-15|2021-02-25|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|8e28e3ab-0060-43f7-b033-c16bd77c0e29|4|INTLK11|Interleukin 11|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|sec|1|1|[?]|ABNORMAL|STOOL|ROOM TEMPERATURE|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD ENZYMATIC FORMULA||Y|N|Y|2|Visit_2|25|3|TREATMENT|2020-12-15|2021-01-04|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|8e28e3ab-0060-43f7-b033-c16bd77c0e29|5|PROTSFR|Protein S, Free|URINALYSIS|[?]|mg/kg/min|[?]|[?]|TRACE|1|cm/s|1|1|[?]|ABNORMAL|KERATINOCYTE|NON-HEMOLYZED||RADIAL IMMUNODIFFUSION|FIBROTEST FORMULA|Y||Y||3|Visit_3|40|2|TREATMENT|2020-12-30|2021-01-18|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|8e28e3ab-0060-43f7-b033-c16bd77c0e29|6|ETS|Ethyl Sulfate|HEMATOLOGY|[?]|U/kg|[?]|[?]|BORDERLINE|1|dpm/mg|1|1|[?]|LOW|AMNIOTIC FLUID|DRIED||CELL BASED BIOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|4|WASHOUT|2020-12-30|2021-01-25|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|8e28e3ab-0060-43f7-b033-c16bd77c0e29|7|ATHPIDX|Atherogenic Index of Plasma|HEMATOLOGY|[?]|YEARS|[?]|[?]|INVALID|1|tsp eq|1|1|[?]|LOW|GASTRIC FLUID|CONTAMINATED||U-HPLC/MS/MS|MDRD FORMULA|||NA||4|Visit_4|65|6|SCREENING|2021-01-24|2021-02-01|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|8e28e3ab-0060-43f7-b033-c16bd77c0e29|8|OXACREAT|Oxalate/Creatinine|URINALYSIS|[?]|lm|[?]|[?]|INDETERMINATE|1|SYRINGE|1|1|[?]|NORMAL|ALVEOLAR AIR|DRIED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2021-01-24|2021-02-10|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|8e28e3ab-0060-43f7-b033-c16bd77c0e29|9|COCAINE|Cocaine|CHEMISTRY|||[?]|[?]|INVALID|1|mL/animal/day|1|1|[?]|NORMAL|SOFT TISSUE|FROZEN||MICRODENSITOMETRY|MDRD 5 VARIABLE FORMULA|||Y|Y|5|Visit_5|90|3|SCREENING|2021-02-18|2021-02-24|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|8e28e3ab-0060-43f7-b033-c16bd77c0e29|10|CARNITAT|Carnitine Acetyl Transferase|URINALYSIS|[?]|mEq/g|[?]|[?]|BORDERLINE|1|ELISA unit/mL|1|1|[?]|HIGH|PLATELET POOR PLASMA|CLOTTED||AUTOREFRACTION|CKD-EPI CREATININE FORMULA|||N||5|Visit_5|90|6|WASHOUT|2021-02-18|2021-02-26|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|1|TGFB3|Transforming Growth Factor Beta 3|URINALYSIS|[?]|mU|[?]|[?]|NEGATIVE|1|PRESSOR UNITS|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|CLOTTED||MICROBIAL CULTURE, LIQUID|ASH FIBROSURE FORMULA|||N||1|Visit_1|10|4|FOLLOW-UP|2020-06-27|2020-08-31|10|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|2|BLASTERY|Basophilic Erythroblast|URINALYSIS|[?]|damol/L|[?]|[?]|INVALID|1|USP U|1|1|[?]|ABNORMAL|NAIL|REFRIGERATED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-06-27|2020-08-19|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|3|HBCOHGB|Carboxyhemoglobin/Total Hemoglobin|HEMATOLOGY|[?]|mm|[?]|[?]|INDETERMINATE|1|PHERESIS UNIT|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|CONCENTRATED||QUANTITATIVE CORONARY ANGIOGRAPHY|CKD-EPI FORMULA|Y||Y||2|Visit_2|25|3|TREATMENT|2020-07-12|2020-09-03|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|4|HLAMSC|HLA Mismatch Count|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|uEq|1|1|[?]|NORMAL|CERUMEN|NON-HEMOLYZED|N|PHYSICAL EXAMINATION|GMI % FORMULA|||Y|Y|2|Visit_2|25|4|FOLLOW-UP|2020-07-12|2020-07-25|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|5|C165891|Western Ragweed Pollen IgE AB RAST Score|URINALYSIS|[?]|fmol/g|[?]|[?]|INDETERMINATE|1|SCOOPFUL|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|PARAFFIN-EMBEDDED||DARK FIELD MICROSCOPY|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-07-27|2020-09-02|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|6|ROM|Reactive Oxygen Metabolite|URINALYSIS|[?]|days/wk|[?]|[?]|POSITIVE|1|h/wk|1|1|[?]|LOW|VENOUS PLASMA|UNEXPECTED ODOR||PHASE-CONTRAST MRI|CKD-EPI CYSTATIN C FORMULA||Y|Y||3|Visit_3|40|4|TREATMENT|2020-07-27|2020-09-02|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|7|COCAAOM|Cocaine and/or Metabolites|URINALYSIS|[?]|mg/kg/h|[?]|[?]|INVALID|1|genEq|1|1|[?]|LOW|MIXED VENOUS BLOOD|CALCIFIED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||4|Visit_4|65|3|SCREENING|2020-08-21|2020-09-22|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|8|ALBC|Albumin Clearance|URINALYSIS|[?]|km|[?]|[?]|INVALID|1|mol/mg|1|1|[?]|NORMAL|VENOUS CORD BLOOD|REFRIGERATED||MOUSE PROTECTION ASSAY|GMI MMOL/MOL FORMULA||Y|NA||4|Visit_4|65|7|WASHOUT|2020-08-21|2020-08-26|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|9|BNPPRONT|N-Terminal ProB-type Natriuretic Peptide|URINALYSIS|[?]|10^9 organisms/mL|[?]|[?]|POSITIVE|1|IU/day|1|1|[?]|LOW|CALCULUS|NON-HEMOLYZED|N|PHOTOMETRIC CLOT DETECTION|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||5|Visit_5|90|6|WASHOUT|2020-09-15|2020-09-24|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|10|APTT|Activated Partial Thromboplastin Time|CHEMISTRY|[?]|U/dL|[?]|[?]|BORDERLINE|1|/wk|1|1|[?]|ABNORMAL|ALVEOLAR AIR|THAWED||MICROBIAL CULTURE, SOLID|MDRD ENZYMATIC FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-09-15|2020-09-24|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|1|HCHT|Hyocholate|HEMATOLOGY|[?]|beats/min|[?]|[?]|BORDERLINE|1|uL/kg/day|1|1|[?]|NORMAL|SUPERNATANT, SERUM|NON-HEMOLYZED||SLIT LAMP PHOTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-06-22|2020-07-20|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|2|HSP70|Heat Shock Protein 70|URINALYSIS|||[?]|[?]|INVALID|1|breaths/min|1|1|[?]|NORMAL|CALCULUS|UNEXPECTED ODOR||RADIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||NA|Y|1|Visit_1|10|7|TREATMENT|2020-06-22|2020-08-15|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|3|ETS|Ethyl Sulfate|CHEMISTRY|[?]|DDU|[?]|[?]|TRACE|1|fL|1|1|[?]|ABNORMAL|LYSATE|HEMOLYZED||CONTRAST ENHANCED MRI|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|1|WASHOUT|2020-07-07|2020-07-17|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|4|CATNINB|Beta Catenin|HEMATOLOGY|[?]|IU|[?]|[?]|INDETERMINATE|1|cd|1|1|[?]|HIGH|AQUEOUS HUMOR|HEMOLYZED|N|MICRONEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA|Y|Y|N||2|Visit_2|25|5|FOLLOW-UP|2020-07-07|2020-09-13|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|5|C130111|Mold Mix Antigen IgA Antibody|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|L/s|1|1|[?]|HIGH|EMOTIONAL TEAR|AUTOLYZED||TOLUIDINE BLUE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|3|Visit_3|40|3|TREATMENT|2020-07-22|2020-07-24|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|6|CASULPH|Calcium Sulphate|HEMATOLOGY|||[?]|[?]|TRACE|1|%(w/w)|1|1|[?]|LOW|ADIPOSE TISSUE|REFRIGERATED|N|SEQUENCING|GMI % FORMULA||Y|N|Y|3|Visit_3|40|6|SCREENING|2020-07-22|2020-07-31|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|7|RPA1|Renal Papillary Antigen 1|HEMATOLOGY|[?]|P|[?]|[?]|INDETERMINATE|1|kBq/uL|1|1|[?]|LOW|LUNG SURFACTANT|HEMOLYZED||TEST STRIP|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2020-08-16|2020-08-22|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|8|C4A|Complement C4a|URINALYSIS|||[?]|[?]|NEGATIVE|1|DAYS|1|1|[?]|NORMAL|INFRANATANT, SERUM|THAWED||OPHTHALMOSCOPY|CKD-EPI CREATININE FORMULA|||NA|Y|4|Visit_4|65|7|SCREENING|2020-08-16|2020-09-07|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|9|MLATONIN|Melatonin|HEMATOLOGY|[?]|h*%|[?]|[?]|NEGATIVE|1|TAMPON|1|1|[?]|LOW|PUS|CALCIFIED||IRON HEMATOXYLIN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|U||5|Visit_5|90|4|FOLLOW-UP|2020-09-10|2020-09-19|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|10|PAI1|Plasminogen Activator Inhibitor-1|URINALYSIS|[?]|anti-Xa IU|[?]|[?]|BORDERLINE|1|ug/g/min|1|1|[?]|NORMAL|SWABBED MATERIAL|CLOTTED||KINYOUN STAIN|MDRD 5 VARIABLE FORMULA|||U||5|Visit_5|90|3|FOLLOW-UP|2020-09-10|2020-09-16|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|43880587-c397-402d-886b-9b666e3fe455|1|GFR|Glomerular Filtration Rate|HEMATOLOGY|[?]|ELISA unit/dose|[?]|[?]|BORDERLINE|1|umol/L|1|1|[?]|LOW|LOCHIA|CONCENTRATED||ALCIAN BLUE STAIN|CKD-EPI FORMULA||Y|Y||1|Visit_1|10|1|FOLLOW-UP|2020-07-21|2020-08-13|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|43880587-c397-402d-886b-9b666e3fe455|2|IBCT|Total Iron Binding Capacity|URINALYSIS|[?]|pg/dL|[?]|[?]|POSITIVE|1|ug/kg/h|1|1|[?]|LOW|EMOTIONAL TEAR|FRESH|N|TELLER ACUITY CARDS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||1|Visit_1|10|6|FOLLOW-UP|2020-07-21|2020-09-27|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|43880587-c397-402d-886b-9b666e3fe455|3|THROMNUC|Thrombocytes|CHEMISTRY|||[?]|[?]|NEGATIVE|1|pmol/dL|1|1|[?]|LOW|STOOL|NON-HEMOLYZED||CLAUSS METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|2|Visit_2|25|7|FOLLOW-UP|2020-08-05|2020-10-13|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|43880587-c397-402d-886b-9b666e3fe455|4|BARB|Barbiturates|URINALYSIS|[?]|Tbsp|[?]|[?]|NEGATIVE|1|kg/cm|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|CALCIFIED||NUCLEIC ACID BASED METHOD|FIBROMETER FORMULA|Y|Y|NA||2|Visit_2|25|6|TREATMENT|2020-08-05|2020-09-07|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|43880587-c397-402d-886b-9b666e3fe455|5|C130121|Shellfish Mix Antigen IgG Antibody|HEMATOLOGY|[?]|GBq|[?]|[?]|BORDERLINE|1|10^9 CFU|1|1|[?]|NORMAL|WHITE MATTER TISSUE|CLOTTED||CELL BASED BIOASSAY|GMI MMOL/MOL FORMULA|Y||U||3|Visit_3|40|5|FOLLOW-UP|2020-08-20|2020-10-18|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|43880587-c397-402d-886b-9b666e3fe455|6|INLCLR|Inulin Clearance|HEMATOLOGY|[?]|CUP|[?]|[?]|POSITIVE|1|PELLET|1|1|[?]|ABNORMAL|PLATELET|ROOM TEMPERATURE||MULTIPLEXED BEAD BASED IMMUNOASSAY|CKD-EPI FORMULA|Y||U||3|Visit_3|40|1|FOLLOW-UP|2020-08-20|2020-09-05|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|43880587-c397-402d-886b-9b666e3fe455|7|HGBA1HGB|Hemoglobin A1/Total Hemoglobin|URINALYSIS|[?]|Gravitational Unit|[?]|[?]|BORDERLINE|1|Weber|1|1|[?]|NORMAL|CELL PELLET|CLOTTED|N|RYAN BLUE STAIN|CKD-EPI CREATININE FORMULA||Y|U||4|Visit_4|65|2|FOLLOW-UP|2020-09-14|2020-09-17|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|43880587-c397-402d-886b-9b666e3fe455|8|BNZDZPN|Benzodiazepine|HEMATOLOGY|[?]|%|[?]|[?]|BORDERLINE|1|USP U|1|1|[?]|NORMAL|DISCHARGE|CONTAMINATED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|CKD-EPI CREATININE FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-09-14|2020-10-05|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|43880587-c397-402d-886b-9b666e3fe455|9|A1ANTRYP|Alpha-1 Antitrypsin|CHEMISTRY|[?]|PFU/animal|[?]|[?]|INDETERMINATE|1|U/kg/h|1|1|[?]|ABNORMAL|ISOLATE|PARAFFIN-EMBEDDED||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|FIBROMETER FORMULA|Y||U||5|Visit_5|90|6|TREATMENT|2020-10-09|2020-10-12|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|43880587-c397-402d-886b-9b666e3fe455|10|HDL2|HDL-Cholesterol Subclass 2|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|10^4 CFU/mL|1|1|[?]|ABNORMAL|SMEGMA|AGGLUTINATED||IMMUNOFLUORESCENT STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y|Y|5|Visit_5|90|7|FOLLOW-UP|2020-10-09|2020-10-12|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|807f83d2-9364-4ee4-855d-304f3e252555|1|FACTVII|Factor VII|CHEMISTRY|[?]|km|[?]|[?]|POSITIVE|1|mU|1|1|[?]|NORMAL|VENOUS PLASMA|FRESH||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 6 VARIABLE FORMULA|Y|Y|Y||1|Visit_1|10|6|FOLLOW-UP|2020-05-14|2020-07-21|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-12
e|LB|807f83d2-9364-4ee4-855d-304f3e252555|2|RESISTIN|Resistin|URINALYSIS|||[?]|[?]|INVALID|1|CAPSULE|1|1|[?]|ABNORMAL|FLUID|REFRIGERATED||BIOIMPEDANCE SPECTROSCOPY|HEPASCORE FORMULA|||N|Y|1|Visit_1|10|2|WASHOUT|2020-05-14|2020-08-09|10|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-12
e|LB|807f83d2-9364-4ee4-855d-304f3e252555|3|RBCNUCLE|Nucleated Erythrocytes/Leukocytes|URINALYSIS|[?]|IMPLANT|[?]|[?]|TRACE|1|mg/mol|1|1|[?]|HIGH|SEBUM|CONCENTRATED|N|MRI|GMI MMOL/MOL FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-05-29|2020-05-30|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|807f83d2-9364-4ee4-855d-304f3e252555|4|OH8DXG2|8-Hydroxy-2'-Deoxyguanosine|HEMATOLOGY|[?]|TABLET|[?]|[?]|BORDERLINE|1|IU/day|1|1|[?]|NORMAL|EMESIS|AUTOLYZED||FARNSWORTH-MUNSELL 100 HUE TEST|MDRD 5 VARIABLE FORMULA||Y|NA||2|Visit_2|25|2|SCREENING|2020-05-29|2020-06-10|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|807f83d2-9364-4ee4-855d-304f3e252555|5|GLUCCLR|Glucose Clearance|URINALYSIS|[?]|10^3 organisms/mL|[?]|[?]|POSITIVE|1|Bq/ug|1|1|[?]|HIGH|EXUDATE|ROOM TEMPERATURE|N|TRYPAN BLUE STAIN|MDRD 5 VARIABLE FORMULA||Y|U||3|Visit_3|40|1|FOLLOW-UP|2020-06-13|2020-06-28|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|807f83d2-9364-4ee4-855d-304f3e252555|6|HRYCELY|Hairy Cells/Lymphocytes|HEMATOLOGY|[?]|deg/s|[?]|[?]|POSITIVE|1|g/animal|1|1|[?]|HIGH|LYMPH|ROOM TEMPERATURE||ENZYMATIC ULTRACENTRIFUGATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|2|TREATMENT|2020-06-13|2020-07-02|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|807f83d2-9364-4ee4-855d-304f3e252555|7|C130120|Shellfish Mix Antigen IgE Antibody|URINALYSIS|[?]|Bq/mL|[?]|[?]|POSITIVE|1|mg/cm2|1|1|[?]|HIGH|LAVAGE FLUID|FROZEN||CYSTOSCOPY|MDRD 5 VARIABLE FORMULA|Y||Y||4|Visit_4|65|6|WASHOUT|2020-07-08|2020-07-10|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|LB|807f83d2-9364-4ee4-855d-304f3e252555|8|EOSSG|Eosinophils, Segmented|HEMATOLOGY|[?]|QUANTITY SUFFICIENT|[?]|[?]|INDETERMINATE|1|U/kg/h|1|1|[?]|HIGH|EMOTIONAL TEAR|FROZEN||MICROARRAY|MDRD FORMULA|||NA||4|Visit_4|65|2|SCREENING|2020-07-08|2020-07-16|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|LB|807f83d2-9364-4ee4-855d-304f3e252555|9|HGBFR|Hemoglobin, Free|CHEMISTRY|||[?]|[?]|NEGATIVE|1|IU/mmol|1|1|[?]|LOW|WHITE MATTER TISSUE|ROOM TEMPERATURE||INDIA INK STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|5|Visit_5|90|3|FOLLOW-UP|2020-08-02|2020-08-10|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|LB|807f83d2-9364-4ee4-855d-304f3e252555|10|OHF6B|6 Beta-Hydroxycortisol|HEMATOLOGY|[?]|um|[?]|[?]|TRACE|1|cycle/min|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|FROZEN||HPLC/MS/MS|MDRD 6 VARIABLE FORMULA|||Y||5|Visit_5|90|4|FOLLOW-UP|2020-08-02|2020-08-07|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|LB|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|1|CEACAM1|CEA Cell Adhesion Molecule 1|HEMATOLOGY|[?]|/day|[?]|[?]|BORDERLINE|1|MET*h|1|1|[?]|ABNORMAL|PERSPIRATION|NON-HEMOLYZED||FLOW MICROSCOPY|FIBROMETER FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-12-09|2021-01-16|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|2|THYPXD|Thyroperoxidase|HEMATOLOGY|[?]|g/dL|[?]|[?]|TRACE|1|umol/L/sec|1|1|[?]|LOW|CERUMEN|GELLED||MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||1|Visit_1|10|4|WASHOUT|2020-12-09|2021-01-07|10|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|3|C130103|Grass Mix Pollen Antigen IgE Antibody|URINALYSIS|[?]|g/g/day|[?]|[?]|TRACE|1|mEq/g|1|1|[?]|LOW|SEMINAL FLUID|CALCIFIED||MICROBIAL CULTURE|GMI MMOL/MOL FORMULA|Y||N||2|Visit_2|25|6|FOLLOW-UP|2020-12-24|2021-01-18|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|LB|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|4|APTTLAAC|APTT-LA Actual/Control|URINALYSIS|||[?]|[?]|POSITIVE|1|uV|1|1|[?]|NORMAL|RETICULOCYTES|CONTAMINATED||ACCELERATOR MASS SPECTROMETRY|GMI MMOL/MOL FORMULA|||NA|Y|2|Visit_2|25|2|TREATMENT|2020-12-24|2021-01-15|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|LB|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|5|ANIONG3|Anion Gap 3|CHEMISTRY|[?]|deg/mm|[?]|[?]|INDETERMINATE|1|mL/day|1|1|[?]|HIGH|SUPERNATANT, SERUM|CLOTTED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|GMI MMOL/MOL FORMULA|Y||N||3|Visit_3|40|7|TREATMENT|2021-01-08|2021-02-10|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|LB|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|6|MKCMKBMP|Megakaryocyte and Megakaryoblast Morph|HEMATOLOGY|||[?]|[?]|POSITIVE|1|GPL U|1|1|[?]|LOW|BONE|ROOM TEMPERATURE||MECHANICAL CLOT DETECTION|CKD-EPI FORMULA|Y||NA|Y|3|Visit_3|40|6|SCREENING|2021-01-08|2021-01-18|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|LB|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|7|APOB48|Apolipoprotein B48|HEMATOLOGY|[?]|U.CARR|[?]|[?]|POSITIVE|1|TRACE|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|SOLIDIFIED||FUNCTIONAL MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||4|Visit_4|65|4|TREATMENT|2021-02-02|2021-02-03|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|8|DFI|DNA Fragmentation Index|URINALYSIS|[?]|/sec|[?]|[?]|TRACE|1|dram|1|1|[?]|HIGH|CEREBROSPINAL FLUID|DRIED||FLAME PHOTOMETRY|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|7|WASHOUT|2021-02-02|2021-02-27|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|9|TRH|Thyrotropin Releasing Hormone|URINALYSIS|[?]|ppm|[?]|[?]|TRACE|1|L/day|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|DRIED|N|ANALYTICAL ULTRACENTRIFUGATION|FIBROTEST FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2021-02-27|2021-02-28|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|10|MONOPTPT|Monoclonal Protein/Total Protein|URINALYSIS|[?]|cpm|[?]|[?]|INVALID|1|beats/min|1|1|[?]|HIGH|SUPERNATANT, SERUM|PARAFFIN-EMBEDDED||MULTI-SLICE SPIRAL CT|COCKCROFT-GAULT FORMULA|||Y||5|Visit_5|90|4|SCREENING|2021-02-27|2021-03-07|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|81c33633-6ade-45fe-a78e-0e853d8aa9c2|1|AMYLOIDB|Amyloid, Beta|URINALYSIS|[?]|10^8/L|[?]|[?]|INDETERMINATE|1|RFU|1|1|[?]|HIGH|SERUM OR PLASMA|AUTOLYZED||NEPHELOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||1|Visit_1|10|7|TREATMENT|2020-08-15|2020-08-25|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|81c33633-6ade-45fe-a78e-0e853d8aa9c2|2|MCV|Ery. Mean Corpuscular Volume|URINALYSIS|[?]|/kg|[?]|[?]|INVALID|1|Gauss|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED||CALCULATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-08-15|2020-09-23|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|81c33633-6ade-45fe-a78e-0e853d8aa9c2|3|ICTERUSI|Icteric Index|HEMATOLOGY|[?]|anti-Xa IU|[?]|[?]|INVALID|1|mV/sec|1|1|[?]|NORMAL|CORD SERUM|CLOTTED|N|IMMUNORADIOMETRIC ASSAY|MDRD 5 VARIABLE FORMULA|Y|Y|NA||2|Visit_2|25|2|TREATMENT|2020-08-30|2020-09-23|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|81c33633-6ade-45fe-a78e-0e853d8aa9c2|4|IGGSYNRT|IgG Synthesis Rate|URINALYSIS|[?]|BOWL|[?]|[?]|INVALID|1|fraction of 1|1|1|[?]|ABNORMAL|EXPIRED AIR|FRESH||IMMUNORADIOMETRIC ASSAY|MDRD 5 VARIABLE FORMULA||Y|N||2|Visit_2|25|6|TREATMENT|2020-08-30|2020-09-06|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|81c33633-6ade-45fe-a78e-0e853d8aa9c2|5|C165891|Western Ragweed Pollen IgE AB RAST Score|CHEMISTRY|[?]|CCID 50/dose|[?]|[?]|INVALID|1|MPS U|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|LIPEMIC||ERGOSPIROMETRY|GMI % FORMULA|||Y||3|Visit_3|40|4|FOLLOW-UP|2020-09-14|2020-09-24|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|81c33633-6ade-45fe-a78e-0e853d8aa9c2|6|C147285|Common Ragweed Pollen IgE Antibody|CHEMISTRY|[?]|DROP|[?]|[?]|TRACE|1|ug/day|1|1|[?]|NORMAL|LAVAGE FLUID|CLOTTED||COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI CREATININE FORMULA|Y||U||3|Visit_3|40|4|TREATMENT|2020-09-14|2020-11-08|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|81c33633-6ade-45fe-a78e-0e853d8aa9c2|7|ALBGLOB|Albumin/Globulin|CHEMISTRY|[?]|mm/2h|[?]|[?]|TRACE|1|Bq/mg|1|1|[?]|LOW|KERATINOCYTE|CLOTTED||GIEMSA STAIN|CKD-EPI CYSTATIN C FORMULA|||Y||4|Visit_4|65|7|FOLLOW-UP|2020-10-09|2020-10-29|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|81c33633-6ade-45fe-a78e-0e853d8aa9c2|8|IL18EXR|Interleukin 18 Excretion Rate|URINALYSIS|||[?]|[?]|NEGATIVE|1|BLOCKS|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|DRIED||HPLC/MS|GMI % FORMULA|||N|Y|4|Visit_4|65|3|SCREENING|2020-10-09|2020-10-22|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|81c33633-6ade-45fe-a78e-0e853d8aa9c2|9|FABP3|Fatty Acid Binding Protein 3|HEMATOLOGY|||[?]|[?]|INVALID|1|USP U|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|FROZEN||REFLECTANCE SPECTROSCOPY|FIBROTEST FORMULA|Y||NA|Y|5|Visit_5|90|1|TREATMENT|2020-11-03|2020-11-12|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|81c33633-6ade-45fe-a78e-0e853d8aa9c2|10|TDTAG|Terminal Deoxynucleotidyl Transferase Ag|HEMATOLOGY|[?]|10^7 CFU/mL|[?]|[?]|POSITIVE|1|deg/mm|1|1|[?]|ABNORMAL|SPUTUM|NON-HEMOLYZED|N|U-HPLC/MS/MS|NASH FIBROSURE FORMULA|Y||N||5|Visit_5|90|7|TREATMENT|2020-11-03|2020-11-10|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|1|VMA|Vanillyl Mandelic Acid|HEMATOLOGY|[?]|umol/h/mmol|[?]|[?]|INVALID|1|ug/m2/day|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|LACTESCENT||CINEANGIOGRAPHY|COCKCROFT-GAULT FORMULA|Y||N||1|Visit_1|10|6|SCREENING|2020-08-01|2020-08-24|10|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|2|CKMBCK|Creatine Kinase MB/Total Creatine Kinase|CHEMISTRY|[?]|deg2|[?]|[?]|INDETERMINATE|1|MPL U|1|1|[?]|NORMAL|LEUKOCYTE|THAWED||IMMUNO-PET SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|2|FOLLOW-UP|2020-08-01|2020-09-15|10|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|3|LDH4|LDH Isoenzyme 4|URINALYSIS|[?]|10^8 PFU|[?]|[?]|NEGATIVE|1|ELISA unit/dose|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE||COMPUTERIZED CORNEAL TOPOGRAPHY|GMI % FORMULA|Y|Y|U||2|Visit_2|25|4|TREATMENT|2020-08-16|2020-08-26|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|4|TSI|Thyroid Stimulating Immunoglobulin|HEMATOLOGY|[?]|log10 PFU/mL|[?]|[?]|POSITIVE|1|kPa|1|1|[?]|LOW|PLATELET POOR PLASMA|PARAFFIN-EMBEDDED||PH METER MEASUREMENT METHOD|FIBROMETER FORMULA|Y||Y||2|Visit_2|25|3|TREATMENT|2020-08-16|2020-10-07|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|5|ROULEAUX|Rouleaux Formation|HEMATOLOGY|[?]|pg|[?]|[?]|NEGATIVE|1|mL/m2|1|1|[?]|LOW|ABSCESS FLUID|REFRIGERATED||IN SITU HYBRIDIZATION|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|2|FOLLOW-UP|2020-08-31|2020-09-11|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|6|HYPERCHR|Hyperchromia|CHEMISTRY|[?]|tuberculin unit/mL|[?]|[?]|BORDERLINE|1|mg/m2/h|1|1|[?]|NORMAL|SWABBED MATERIAL|CONCENTRATED||REVERSE TRANSCRIPTASE PCR|FIBROTEST FORMULA|Y||U||3|Visit_3|40|1|FOLLOW-UP|2020-08-31|2020-09-11|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|7|CD3LY|CD3/Lymphocytes|HEMATOLOGY|[?]|CIGARETTE|[?]|[?]|INVALID|1|GBq/mg|1|1|[?]|NORMAL|DISCHARGE|AUTOLYZED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|6|TREATMENT|2020-09-25|2020-10-18|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|8|IGGSYNRT|IgG Synthesis Rate|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mU/L|1|1|[?]|NORMAL|ARTERIAL BLOOD|HEMOLYZED||DUCTOGRAPHY|CKD-EPI CREATININE FORMULA|||U|Y|4|Visit_4|65|1|WASHOUT|2020-09-25|2020-10-25|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|9|FGF9|Fibroblast Growth Factor 9|HEMATOLOGY|[?]|cy/cm|[?]|[?]|TRACE|1|IU/mg|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|DRIED||AUSCULTATION|FIBROMETER FORMULA||Y|NA||5|Visit_5|90|3|WASHOUT|2020-10-20|2020-10-25|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|10|C130105|Grass Mix Pollen Antigen IgA Antibody|CHEMISTRY|||[?]|[?]|POSITIVE|1|mmHg/L/min|1|1|[?]|NORMAL|CALCULUS|PARAFFIN-EMBEDDED||FLOCCULATION, CHARCOAL ENHANCED|MDRD 5 VARIABLE FORMULA|Y||NA|Y|5|Visit_5|90|3|FOLLOW-UP|2020-10-20|2020-10-28|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|1|INTLK3|Interleukin 3|CHEMISTRY|[?]|10^9/g|[?]|[?]|INDETERMINATE|1|mEq/g|1|1|[?]|NORMAL|CERUMEN|PARAFFIN-EMBEDDED||OPTICAL DENSITY MEASUREMENT|FIBROTEST FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-09-01|2020-11-13|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|2|FBNCTFT|Fibronectin, Fetal|URINALYSIS|[?]|mL/breath|[?]|[?]|INDETERMINATE|1|10^9/L|1|1|[?]|ABNORMAL|RETICULOCYTES|CALCIFIED||INDIRECT IMMUNOFLUORESCENCE|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||1|Visit_1|10|6|SCREENING|2020-09-01|2020-11-21|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|3|LEUKCRBC|Leuks Corrected for Nucl Erythrocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|APS U|1|1|[?]|ABNORMAL|PUS|ROOM TEMPERATURE|N|CONTRAST ENHANCED SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA|Y||Y|Y|2|Visit_2|25|7|SCREENING|2020-09-16|2020-11-02|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|4|LCHT|Lithocholate|CHEMISTRY|[?]|mL/beat|[?]|[?]|NEGATIVE|1|nmol/L/h|1|1|[?]|NORMAL|SKIN TISSUE|FROZEN|N|ACRIDINE ORANGE STAIN|CKD-EPI FORMULA|||U||2|Visit_2|25|5|TREATMENT|2020-09-16|2020-11-19|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|5|RBCDIPOP|Dimorphic Erythrocyte Population|URINALYSIS|[?]|POUCH|[?]|[?]|INDETERMINATE|1|LB|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|CLOTTED||HEMATOXYLIN AND EOSIN STAIN|CKD-EPI CREATININE FORMULA||Y|N||3|Visit_3|40|4|TREATMENT|2020-10-01|2020-11-01|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|6|HEPCIDIN|Hepcidin|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|Log10 ELISA unit|1|1|[?]|LOW|MENSTRUAL BLOOD|NON-HEMOLYZED||TRANSMISSION ELECTRON MICROSCOPY|NASH FIBROSURE FORMULA|||N|Y|3|Visit_3|40|5|WASHOUT|2020-10-01|2020-11-14|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|7|MMP7|Matrix Metalloproteinase 7|CHEMISTRY|[?]|FIU|[?]|[?]|NEGATIVE|1|nm|1|1|[?]|NORMAL|SPERMATOZOON|CONCENTRATED||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD FORMULA|||NA||4|Visit_4|65|1|WASHOUT|2020-10-26|2020-11-01|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|8|C5|Complement C5|URINALYSIS|[?]|mEq|[?]|[?]|BORDERLINE|1|cmH2O*s2/mL|1|1|[?]|ABNORMAL|FLUID|REFRIGERATED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|4|SCREENING|2020-10-26|2020-11-20|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|9|PSIGAAB|Phosphatidylserine IgA Antibody|HEMATOLOGY|[?]|MONTHS|[?]|[?]|INVALID|1|DRUM|1|1|[?]|NORMAL|DERMAL TISSUE|LIPEMIC||GC/MS-EI|GMI % FORMULA||Y|N||5|Visit_5|90|5|TREATMENT|2020-11-20|2020-11-22|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|10|ACETOAC|Acetoacetic Acid|HEMATOLOGY|[?]|CYLINDER|[?]|[?]|INDETERMINATE|1|log10 PFU/mL|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|REFRIGERATED||IMMUNE REPERTOIRE DEEP SEQUENCING|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-11-20|2020-11-24|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|1|FVAAC|Factor V Activity Actual/Control|URINALYSIS|[?]|mmHg/sec|[?]|[?]|INVALID|1|mJoule/cm2|1|1|[?]|HIGH|MUCUS|REFRIGERATED||TARGETED TRANSCRIPTOME SEQUENCING|FIBROSIS 4 FORMULA|Y||Y||1|Visit_1|10|3|TREATMENT|2021-01-27|2021-04-18|10|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|2|MYPCERPC|Myeloid/Erythroid Ratio|URINALYSIS|[?]|g/m2/day|[?]|[?]|BORDERLINE|1|mV/sec|1|1|[?]|NORMAL|BONE|CLOTTED||OPTICAL COHERENCE TOMOGRAPHY|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2021-01-27|2021-03-03|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|3|FACTXIV|Factor XIV|CHEMISTRY|[?]|h/wk|[?]|[?]|POSITIVE|1|mEq/g|1|1|[?]|HIGH|SEMINAL FLUID|FRESH||CYSTOSCOPY|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|4|TREATMENT|2021-02-11|2021-04-01|25|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|LB|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|4|FACTIII|Factor III|URINALYSIS|[?]|/ms|[?]|[?]|INDETERMINATE|1|umol/min|1|1|[?]|LOW|CORD SERUM|SOLIDIFIED||MYELOPEROXIDASE STAIN|MDRD FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2021-02-11|2021-04-21|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|LB|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|5|HGFR|Hepatocyte Growth Factor Receptor|CHEMISTRY|[?]|km/h|[?]|[?]|NEGATIVE|1|AgU/mL|1|1|[?]|NORMAL|SERUM|FRESH||MODIFIED ACID FAST STAIN|GMI MMOL/MOL FORMULA|||U||3|Visit_3|40|4|FOLLOW-UP|2021-02-26|2021-03-23|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|6|LDH5LDH|LDH Isoenzyme 5/LDH|URINALYSIS|[?]|U/g|[?]|[?]|POSITIVE|1|in|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED|N|CONGO RED STAIN|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|7|SCREENING|2021-02-26|2021-03-23|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|7|CTXICRT|Type I Collagen C-Telopeptides/Creat|HEMATOLOGY|[?]|pt_br|[?]|[?]|POSITIVE|1|APL U|1|1|[?]|NORMAL|GASTRIC FLUID|LACTESCENT||KINYOUN STAIN|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|1|FOLLOW-UP|2021-03-23|2021-04-24|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|8|PHOSCLR|Phosphate Clearance|CHEMISTRY|||[?]|[?]|POSITIVE|1|10^3 organisms|1|1|[?]|NORMAL|BONE MARROW|ROOM TEMPERATURE||ELISA|MDRD 4 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|5|SCREENING|2021-03-23|2021-04-24|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|9|HBLEPRHB|Hemoglobin Lepore/Total Hemoglobin|CHEMISTRY|[?]|ukat/L|[?]|[?]|INVALID|1|Bq/kg|1|1|[?]|NORMAL|CORD BLOOD|AUTOLYZED||MULTIPLEXED BEAD BASED IMMUNOASSAY|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2021-04-17|2021-04-23|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-18
e|LB|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|10|ODMTASE|O-Demethylase|CHEMISTRY|[?]|mm/2h|[?]|[?]|TRACE|1|mL/kg/h|1|1|[?]|HIGH|SUPERNATANT, PLASMA|ICTERIC||SIZE EXCLUSION CHROMATOGRAPHY|NASH FIBROSURE FORMULA|Y||NA||5|Visit_5|90|7|TREATMENT|2021-04-17|2021-04-25|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-18
e|LB|21740641-69bb-49a9-a86d-2444914f6d12|1|FGF19|Fibroblast Growth Factor 19|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|STEPS|1|1|[?]|ABNORMAL|DERMAL TISSUE|GELLED||MOUSE PROTECTION ASSAY|FIBROMETER FORMULA|||Y|Y|1|Visit_1|10|7|TREATMENT|2020-05-17|2020-07-17|10|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|LB|21740641-69bb-49a9-a86d-2444914f6d12|2|NUCSWELL|Nuclear Swelling|HEMATOLOGY|[?]|mL/dL|[?]|[?]|INVALID|1|SBE/mL|1|1|[?]|NORMAL|URINE|CLOTTED|N|SPIRAL CT|GMI % FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-05-17|2020-05-26|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|LB|21740641-69bb-49a9-a86d-2444914f6d12|3|HAMAB|Human Anti-Mouse Antibody|HEMATOLOGY|[?]|g/m2/day|[?]|[?]|INDETERMINATE|1|/wk|1|1|[?]|LOW|INTERSTITIAL FLUID|ICTERIC||QUANTITATIVE COMPUTED TOMOGRAPHY|MDRD FORMULA|||NA||2|Visit_2|25|5|FOLLOW-UP|2020-06-01|2020-06-08|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-24
e|LB|21740641-69bb-49a9-a86d-2444914f6d12|4|PLSPCE|Precursor Plasma Cells|CHEMISTRY|[?]|EU|[?]|[?]|NEGATIVE|1|mg/m2/min|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|LACTESCENT||RAJI CELL EIA|CKD-EPI FORMULA||Y|U||2|Visit_2|25|5|TREATMENT|2020-06-01|2020-07-18|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-24
e|LB|21740641-69bb-49a9-a86d-2444914f6d12|5|FACTIXA|Factor IX Activity|URINALYSIS|[?]|kDa|[?]|[?]|INDETERMINATE|1|L/min/m2|1|1|[?]|NORMAL|FLUID|CONTAMINATED||ELECTRICAL IMPEDANCE MYOGRAPHY|FIBROTEST FORMULA|Y||NA||3|Visit_3|40|7|TREATMENT|2020-06-16|2020-06-20|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|21740641-69bb-49a9-a86d-2444914f6d12|6|CD19LY|CD19/Lymphocytes|URINALYSIS|||[?]|[?]|POSITIVE|1|DIP|1|1|[?]|HIGH|MIXED VENOUS BLOOD|REFRIGERATED||IMMUNORADIOMETRIC ASSAY|CKD-EPI CREATININE FORMULA||Y|NA|Y|3|Visit_3|40|2|FOLLOW-UP|2020-06-16|2020-07-28|40|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|21740641-69bb-49a9-a86d-2444914f6d12|7|MM2IGAB|Mitochondrial M2 IgG Antibody|URINALYSIS|[?]|APL U|[?]|[?]|INDETERMINATE|1|min/day|1|1|[?]|NORMAL|PERITONEAL FLUID|SOLIDIFIED||KINETIC MICROPARTICLE IMMUNOASSAY|MDRD 6 VARIABLE FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2020-07-11|2020-08-03|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|21740641-69bb-49a9-a86d-2444914f6d12|8|IL1RL1|Interleukin 1 Receptor-Like 1|CHEMISTRY|[?]|OD Unit|[?]|[?]|POSITIVE|1|bel|1|1|[?]|HIGH|INFRANATANT, SERUM|CALCIFIED||SLOAN LETTER EYE CHART 2.5%|NASH FIBROSURE FORMULA|||NA||4|Visit_4|65|3|WASHOUT|2020-07-11|2020-08-08|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|21740641-69bb-49a9-a86d-2444914f6d12|9|BASEEXCS|Base Excess|HEMATOLOGY|[?]|mg/g/min|[?]|[?]|BORDERLINE|1|mg/kg/day|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|UNEXPECTED ODOR||FLUORESCENT IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||5|Visit_5|90|7|SCREENING|2020-08-05|2020-08-07|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|21740641-69bb-49a9-a86d-2444914f6d12|10|INTLK25|Interleukin 25|HEMATOLOGY|[?]|m|[?]|[?]|INVALID|1|pL|1|1|[?]|NORMAL|CORD BLOOD|PARAFFIN-EMBEDDED|N|MYELOPEROXIDASE STAIN|GMI % FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2020-08-05|2020-08-06|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|c3984f41-30a0-49a4-a8bd-f36fad4621a8|1|GNRH|Gonadotropin Releasing Hormone|URINALYSIS|[?]|PATCH|[?]|[?]|NEGATIVE|1|mol/mL|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|CALCIFIED||KLEIHAUER-BETKE|CKD-EPI FORMULA|||Y||1|Visit_1|10|4|WASHOUT|2020-06-18|2020-09-14|10|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|c3984f41-30a0-49a4-a8bd-f36fad4621a8|2|BLYCE|B-Lymphocytes|CHEMISTRY|||[?]|[?]|BORDERLINE|1|m3|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|SOLIDIFIED||FLOW MICROSCOPY|MDRD ENZYMATIC FORMULA|||N|Y|1|Visit_1|10|7|WASHOUT|2020-06-18|2020-08-10|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|c3984f41-30a0-49a4-a8bd-f36fad4621a8|3|VITB1|Thiamine|CHEMISTRY|[?]|mmol/min/kPa/L|[?]|[?]|TRACE|1|cs|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|NON-HEMOLYZED|N|ENDOSCOPY|MDRD 5 VARIABLE FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-07-03|2020-08-30|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|LB|c3984f41-30a0-49a4-a8bd-f36fad4621a8|4|ANGPT2|Angiopoietin 2|CHEMISTRY|[?]|mm/2h|[?]|[?]|NEGATIVE|1|cpm|1|1|[?]|NORMAL|CERUMEN|CONCENTRATED||OPTICAL MAPPING|MDRD 6 VARIABLE FORMULA|||Y||2|Visit_2|25|2|FOLLOW-UP|2020-07-03|2020-09-12|25|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|LB|c3984f41-30a0-49a4-a8bd-f36fad4621a8|5|GALM|Galactose Mutarotase|URINALYSIS|[?]|hPa|[?]|[?]|TRACE|1|cmH2O/mL|1|1|[?]|NORMAL|SEMINAL FLUID|CONTAMINATED||CLIP|FIBROMETER FORMULA|||U||3|Visit_3|40|3|SCREENING|2020-07-18|2020-09-15|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|c3984f41-30a0-49a4-a8bd-f36fad4621a8|6|PROINSUL|Proinsulin|CHEMISTRY|[?]|100 IU/mL|[?]|[?]|NEGATIVE|1|lm|1|1|[?]|LOW|MONOCYTE|REFRIGERATED||DIFFUSION TENSOR MRI|MDRD ENZYMATIC FORMULA|||U||3|Visit_3|40|3|WASHOUT|2020-07-18|2020-08-13|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|c3984f41-30a0-49a4-a8bd-f36fad4621a8|7|FGFBF|Fibroblast Growth Factor Basic Form|CHEMISTRY|||[?]|[?]|INVALID|1|DDU|1|1|[?]|ABNORMAL|URINE|DRIED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|4|Visit_4|65|6|SCREENING|2020-08-12|2020-08-17|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|c3984f41-30a0-49a4-a8bd-f36fad4621a8|8|PYK|Pyruvate Kinase|HEMATOLOGY|[?]|fg|[?]|[?]|POSITIVE|1|mmol/day|1|1|[?]|HIGH|URINE|CALCIFIED|N|SPECTROPHOTOMETRY|MDRD 6 VARIABLE FORMULA|Y||NA||4|Visit_4|65|6|WASHOUT|2020-08-12|2020-08-20|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|c3984f41-30a0-49a4-a8bd-f36fad4621a8|9|TSTSFRPT|Testosterone, Free/Total Protein|CHEMISTRY|||[?]|[?]|NEGATIVE|1|nmol/L/h|1|1|[?]|ABNORMAL|PROSTATIC FLUID|GELLED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||Y|Y|Y|5|Visit_5|90|7|WASHOUT|2020-09-06|2020-09-12|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|c3984f41-30a0-49a4-a8bd-f36fad4621a8|10|FIBRINOF|Fibrinogen, Functional|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|U/cL|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|GELLED||FLUOROSCOPY|GMI MMOL/MOL FORMULA|||U|Y|5|Visit_5|90|4|TREATMENT|2020-09-06|2020-09-08|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|1|UREAN|Urea Nitrogen|URINALYSIS|[?]|vp/mL|[?]|[?]|INDETERMINATE|1|10^3 organisms/mL|1|1|[?]|LOW|CERUMEN|THAWED||IMMUNO-PET SCAN|FIBROSIS 4 FORMULA||Y|N||1|Visit_1|10|3|FOLLOW-UP|2021-01-21|2021-04-18|10|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|2|GLCHT|Glycolithocholate|HEMATOLOGY|[?]|Gy|[?]|[?]|BORDERLINE|1|SQU/mL|1|1|[?]|LOW|CORD BLOOD|CLOTTED||CHROMATOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||1|Visit_1|10|5|FOLLOW-UP|2021-01-21|2021-01-25|10|14|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|3|EOSNUCCE|Eosinophils/Nucleated Cells|HEMATOLOGY|[?]|umol/dL|[?]|[?]|BORDERLINE|1|atm|1|1|[?]|LOW|ENDOTRACHEAL FLUID|CLOTTED||LAPAROSCOPY|MDRD ENZYMATIC FORMULA|Y||U||2|Visit_2|25|6|WASHOUT|2021-02-05|2021-03-07|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|4|THBD|Thrombomodulin|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|g/g|1|1|[?]|LOW|MECONIUM|FRESH||ANALYTICAL ULTRACENTRIFUGATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|2|Visit_2|25|2|FOLLOW-UP|2021-02-05|2021-04-15|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|5|PTSAAC|Protein S Activity Actual/Control|URINALYSIS|[?]|Torr|[?]|[?]|TRACE|1|10^6/g|1|1|[?]|NORMAL|HAIR FOLLICLE|AGGLUTINATED|N|SCANNING ELECTRON MICROSCOPY|FIBROMETER FORMULA|Y||Y||3|Visit_3|40|3|SCREENING|2021-02-20|2021-04-07|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|LB|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|6|AMYLOIDP|Amyloid P|HEMATOLOGY|[?]|nmol|[?]|[?]|INVALID|1|mgEq|1|1|[?]|NORMAL|LAVAGE FLUID|AUTOLYZED||SMEAR|HEPASCORE FORMULA|||U||3|Visit_3|40|2|TREATMENT|2021-02-20|2021-02-27|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|LB|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|7|ODMTASE|O-Demethylase|CHEMISTRY|[?]|tuberculin unit/mL|[?]|[?]|INVALID|1|TROCHE|1|1|[?]|ABNORMAL|SPUTUM|DRIED||ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI FORMULA|Y||NA||4|Visit_4|65|6|WASHOUT|2021-03-17|2021-03-22|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|8|INSAB|Insulin Antibody|CHEMISTRY|[?]|ug/L/h|[?]|[?]|TRACE|1|Bq/kg|1|1|[?]|NORMAL|TRANSUDATE|NON-HEMOLYZED||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI CREATININE FORMULA|||N||4|Visit_4|65|2|TREATMENT|2021-03-17|2021-04-19|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|9|SER|Serine|URINALYSIS|[?]|ug/min|[?]|[?]|INDETERMINATE|1|cal|1|1|[?]|HIGH|INTERSTITIAL FLUID|THAWED|N|IN VITRO GENE EXPRESSION ASSAY|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|1|TREATMENT|2021-04-11|2021-04-19|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|10|C130078|Silver Birch Pollen IgG|URINALYSIS|[?]|titer|[?]|[?]|NEGATIVE|1|FFU|1|1|[?]|NORMAL|CORD BLOOD|GELLED|N|CLINICAL EVALUATION|HEPASCORE FORMULA||Y|U||5|Visit_5|90|6|TREATMENT|2021-04-11|2021-04-14|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|0f85b859-187d-4c6b-8873-33c0f18d3e3c|1|PLSIMCE|Immature Plasma Cells|CHEMISTRY|[?]|mOsm/L|[?]|[?]|BORDERLINE|1|mEq/mmol|1|1|[?]|ABNORMAL|FLUID|LACTESCENT||PHOTOGRAPHY|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|1|WASHOUT|2020-07-24|2020-07-29|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|0f85b859-187d-4c6b-8873-33c0f18d3e3c|2|BNPPRONT|N-Terminal ProB-type Natriuretic Peptide|CHEMISTRY|[?]|ECL unit|[?]|[?]|INDETERMINATE|1|ppb|1|1|[?]|HIGH|SEMINAL FLUID|PARAFFIN-EMBEDDED|N|MULTI-SLICE SPIRAL CT|FIBROTEST FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-07-24|2020-10-10|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|0f85b859-187d-4c6b-8873-33c0f18d3e3c|3|BLSTIMLY|Immunoblasts/Lymphocytes|URINALYSIS|[?]|mV/sec|[?]|[?]|NEGATIVE|1|hr/day|1|1|[?]|NORMAL|SMEGMA|UNEXPECTED ODOR||CLIP|MDRD 6 VARIABLE FORMULA|||NA||2|Visit_2|25|3|WASHOUT|2020-08-08|2020-08-25|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|0f85b859-187d-4c6b-8873-33c0f18d3e3c|4|EAGLUC|Glucose, Estimated Average|URINALYSIS|[?]|DIOPTER|[?]|[?]|NEGATIVE|1|mL/dL|1|1|[?]|HIGH|BILE|CONTAMINATED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|FIBROTEST FORMULA|Y||Y||2|Visit_2|25|1|TREATMENT|2020-08-08|2020-08-25|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|0f85b859-187d-4c6b-8873-33c0f18d3e3c|5|APOA4|Apolipoprotein A4|CHEMISTRY|[?]|mL/100g/min|[?]|[?]|INDETERMINATE|1|mEq/kg|1|1|[?]|ABNORMAL|LYSATE|NON-HEMOLYZED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI FORMULA|||U||3|Visit_3|40|7|FOLLOW-UP|2020-08-23|2020-10-03|40|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|0f85b859-187d-4c6b-8873-33c0f18d3e3c|6|MOCYCE|Monocytoid Cells|CHEMISTRY|[?]|/100 WBC|[?]|[?]|TRACE|1|ohm|1|1|[?]|HIGH|SEMEN|REFRIGERATED||INDIA INK STAIN|FIBROMETER FORMULA||Y|U||3|Visit_3|40|7|FOLLOW-UP|2020-08-23|2020-09-08|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|0f85b859-187d-4c6b-8873-33c0f18d3e3c|7|VITDBP|Vitamin D Binding Protein|URINALYSIS|[?]|fg|[?]|[?]|POSITIVE|1|BOWL|1|1|[?]|ABNORMAL|MUSCLE TISSUE|NON-HEMOLYZED||NUCLEIC ACID HYBRIDIZATION|GMI % FORMULA|Y||U||4|Visit_4|65|7|SCREENING|2020-09-17|2020-10-02|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|LB|0f85b859-187d-4c6b-8873-33c0f18d3e3c|8|BASOSG|Basophils, Segmented|HEMATOLOGY|[?]|umol/L/sec|[?]|[?]|INVALID|1|mm/sec|1|1|[?]|LOW|SOFT TISSUE|AGGLUTINATED||RADIOIMMUNOPRECIPITATION ASSAY|HEPASCORE FORMULA|Y||NA||4|Visit_4|65|7|TREATMENT|2020-09-17|2020-10-07|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|LB|0f85b859-187d-4c6b-8873-33c0f18d3e3c|9|IGG2|Immunoglobulin G Subclass 2|URINALYSIS|[?]|BOTTLE|[?]|[?]|TRACE|1|IU/mL|1|1|[?]|HIGH|SERUM OR PLASMA|CONCENTRATED||PEAK FLOWMETRY|MDRD ENZYMATIC FORMULA|Y||N||5|Visit_5|90|3|FOLLOW-UP|2020-10-12|2020-10-18|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|0f85b859-187d-4c6b-8873-33c0f18d3e3c|10|CHRMTNAB|Chromatin Antibodies|CHEMISTRY|[?]|Tesla|[?]|[?]|POSITIVE|1|MPS U|1|1|[?]|NORMAL|SERUM OR PLASMA|AUTOLYZED||SINGLE-SLICE SPIRAL CT|CKD-EPI FORMULA|||NA||5|Visit_5|90|5|WASHOUT|2020-10-12|2020-10-19|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|5e383a9d-dc97-4352-8add-d55a1a566b9f|1|APOJCRT|Apolipoprotein J/Creatinine|CHEMISTRY|[?]|10^12 IU/L|[?]|[?]|NEGATIVE|1|BP|1|1|[?]|LOW|PROSTATIC FLUID|AGGLUTINATED||KINETIC CHROMOGENIC ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-09-27|2020-09-28|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|5e383a9d-dc97-4352-8add-d55a1a566b9f|2|PHOSCRT|Phosphate/Creatinine|URINALYSIS|[?]|JAR|[?]|[?]|INDETERMINATE|1|MET*min|1|1|[?]|ABNORMAL|NAIL|HEMOLYZED||SURFACE PLASMON RESONANCE|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-09-27|2020-12-19|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|5e383a9d-dc97-4352-8add-d55a1a566b9f|3|KIM1|Kidney Injury Molecule-1|URINALYSIS|||[?]|[?]|INDETERMINATE|1|10^3 CFU/mL|1|1|[?]|NORMAL|LYMPH|AUTOLYZED|N|SLOAN LETTER EYE CHART 1.25%|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|2|Visit_2|25|7|TREATMENT|2020-10-12|2020-12-19|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|5e383a9d-dc97-4352-8add-d55a1a566b9f|4|TGFA|Transforming Growth Factor Alpha|CHEMISTRY|[?]|amp|[?]|[?]|BORDERLINE|1|Siemens|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|SOLIDIFIED||PERIPHERAL ANGIOGRAPHY|NASH FIBROSURE FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-10-12|2020-12-22|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|5e383a9d-dc97-4352-8add-d55a1a566b9f|5|C165913|Nut Mix IgG AB RAST Score|CHEMISTRY|[?]|cm2|[?]|[?]|BORDERLINE|1|mmol/min/kPa|1|1|[?]|NORMAL|CALCULUS|CONCENTRATED|N|ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD ENZYMATIC JAPANESE FORMULA|||NA||3|Visit_3|40|5|SCREENING|2020-10-27|2020-11-07|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|5e383a9d-dc97-4352-8add-d55a1a566b9f|6|FIBRINOF|Fibrinogen, Functional|CHEMISTRY|||[?]|[?]|BORDERLINE|1|L/h/m2|1|1|[?]|NORMAL|LOCHIA|THAWED|N|PHASE CONTRAST MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|3|Visit_3|40|4|SCREENING|2020-10-27|2020-11-08|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|5e383a9d-dc97-4352-8add-d55a1a566b9f|7|CAIONPH|Calcium, Ionized pH Adjusted|HEMATOLOGY|[?]|10^4/L|[?]|[?]|POSITIVE|1|EVENTS|1|1|[?]|ABNORMAL|EPITHELIAL CELL|LIPEMIC||HANSEL STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|U||4|Visit_4|65|3|WASHOUT|2020-11-21|2020-12-16|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|5e383a9d-dc97-4352-8add-d55a1a566b9f|8|IMMGLCFR|Immunoglobulin Light Chains, Free|URINALYSIS|[?]|uCi|[?]|[?]|NEGATIVE|1|g/animal|1|1|[?]|LOW|AMNIOTIC FLUID|REFRIGERATED|N|WESTERN BLOT|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||4|Visit_4|65|3|WASHOUT|2020-11-21|2020-11-23|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|5e383a9d-dc97-4352-8add-d55a1a566b9f|9|GLOBBPT|Beta Globulin/Total Protein|HEMATOLOGY|||[?]|[?]|TRACE|1|Gy/h|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED||MICROBIAL BIOCHEMICAL IDENTIFICATION|ASH FIBROSURE FORMULA|||Y|Y|5|Visit_5|90|7|TREATMENT|2020-12-16|2020-12-23|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|5e383a9d-dc97-4352-8add-d55a1a566b9f|10|ERCEPPOL|Erythroid Proliferation Pool|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Tbsp|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|CALCIFIED||HIGH RESOLUTION MELT ANALYSIS|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|5|Visit_5|90|3|TREATMENT|2020-12-16|2020-12-23|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|3eda746b-fb97-4950-a528-1d4ae5d3653a|1|GFRBSB2M|GFR from B-2 Microglobulin Adj for BSA|URINALYSIS|[?]|U/kg/min|[?]|[?]|TRACE|1|ng/L|1|1|[?]|ABNORMAL|MECONIUM|CLOTTED||RADIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|Y||1|Visit_1|10|7|SCREENING|2020-06-13|2020-09-01|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|3eda746b-fb97-4950-a528-1d4ae5d3653a|2|MYCY|Myelocytes|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|/ms|1|1|[?]|HIGH|SMEGMA|AGGLUTINATED|N|HPLC-FL|NASH FIBROSURE FORMULA|||NA|Y|1|Visit_1|10|4|SCREENING|2020-06-13|2020-09-02|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|3eda746b-fb97-4950-a528-1d4ae5d3653a|3|KL6|Krebs von den Lungen-6|HEMATOLOGY|[?]|g/kg|[?]|[?]|TRACE|1|mL/animal/day|1|1|[?]|HIGH|VITREOUS HUMOR|SOLIDIFIED||FLOW CYTOMETRY|GMI % FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-06-28|2020-07-06|25|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|3eda746b-fb97-4950-a528-1d4ae5d3653a|4|MM2IGAB|Mitochondrial M2 IgG Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|/40 HPFs|1|1|[?]|NORMAL|BILE|SOLIDIFIED||WRIGHT STAIN|GMI % FORMULA||Y|NA|Y|2|Visit_2|25|7|TREATMENT|2020-06-28|2020-08-16|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|3eda746b-fb97-4950-a528-1d4ae5d3653a|5|RETIM|Medium Absorption Reticulocytes|HEMATOLOGY|[?]|WAFER|[?]|[?]|TRACE|1|MBP|1|1|[?]|LOW|BONE|PARAFFIN-EMBEDDED||MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI FORMULA||Y|U||3|Visit_3|40|7|SCREENING|2020-07-13|2020-08-27|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|3eda746b-fb97-4950-a528-1d4ae5d3653a|6|CD40|CD40|URINALYSIS|[?]|kV|[?]|[?]|INDETERMINATE|1|ms/mmHg|1|1|[?]|NORMAL|CORD SERUM|HEMOLYZED||NON-CONTACT SPECULAR MICROSCOPY|FIBROTEST FORMULA||Y|U||3|Visit_3|40|1|FOLLOW-UP|2020-07-13|2020-08-30|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|3eda746b-fb97-4950-a528-1d4ae5d3653a|7|A1AGLP|Alpha-1 Acid Glycoprotein|URINALYSIS|[?]|/100 WBC|[?]|[?]|INVALID|1|mL/m2|1|1|[?]|NORMAL|PLASMA|PARAFFIN-EMBEDDED||RYAN BLUE STAIN|GMI MMOL/MOL FORMULA|Y||U||4|Visit_4|65|1|TREATMENT|2020-08-07|2020-08-16|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|3eda746b-fb97-4950-a528-1d4ae5d3653a|8|INSULIN|Insulin|URINALYSIS|||[?]|[?]|TRACE|1|mL/dL|1|1|[?]|LOW|SPUTUM|AUTOLYZED|N|MODIFIED ACID FAST STAIN|CKD-EPI CYSTATIN C FORMULA|||N|Y|4|Visit_4|65|3|SCREENING|2020-08-07|2020-08-11|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|3eda746b-fb97-4950-a528-1d4ae5d3653a|9|CCL19|Chemokine (C-C Motif) Ligand 19|HEMATOLOGY|[?]|TABLET|[?]|[?]|TRACE|1|cm/s|1|1|[?]|LOW|BREAST MILK|NON-HEMOLYZED||AGAR PROPORTION|MDRD 6 VARIABLE FORMULA||Y|NA||5|Visit_5|90|3|TREATMENT|2020-09-01|2020-09-05|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|3eda746b-fb97-4950-a528-1d4ae5d3653a|10|EPO|Erythropoietin|CHEMISTRY|[?]|damol/L|[?]|[?]|POSITIVE|1|Enzyme U|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|LACTESCENT||CISH|GMI % FORMULA|Y|Y|U||5|Visit_5|90|2|TREATMENT|2020-09-01|2020-09-08|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|a3b72841-3401-4dcc-9d06-75438b408d0b|1|T3FR|Triiodothyronine, Free|HEMATOLOGY|||[?]|[?]|INVALID|1|pL|1|1|[?]|LOW|BREAST MILK|AGGLUTINATED||VIRUS PLAQUE ASSAY|CKD-EPI CYSTATIN C FORMULA|Y|Y|Y|Y|1|Visit_1|10|7|FOLLOW-UP|2020-11-05|2021-01-15|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|a3b72841-3401-4dcc-9d06-75438b408d0b|2|C130092|Western Ragweed Pollen IgE|URINALYSIS|[?]|g/g/day|[?]|[?]|BORDERLINE|1|10^8 PFU|1|1|[?]|NORMAL|VENOUS BLOOD|AGGLUTINATED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|2|TREATMENT|2020-11-05|2020-11-26|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|a3b72841-3401-4dcc-9d06-75438b408d0b|3|PSP100AB|P100 Polymyositis-scleroderma Autoag Ab|CHEMISTRY|[?]|kg/cm|[?]|[?]|TRACE|1|10^7 CFU|1|1|[?]|NORMAL|MONOCYTE|THAWED||DNA MICROARRAY|HEPASCORE FORMULA|||U||2|Visit_2|25|1|SCREENING|2020-11-20|2021-01-19|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|a3b72841-3401-4dcc-9d06-75438b408d0b|4|CYHIPPAC|Hippuric Acid Crystals|CHEMISTRY|[?]|ug/min|[?]|[?]|INDETERMINATE|1|10^8 PFU|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|AGGLUTINATED||PH METER MEASUREMENT METHOD|CKD-EPI FORMULA|Y|Y|N||2|Visit_2|25|1|WASHOUT|2020-11-20|2020-11-21|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|a3b72841-3401-4dcc-9d06-75438b408d0b|5|LYMA|Lymphocytes Activated|URINALYSIS|||[?]|[?]|TRACE|1|kg/cm|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|SOLIDIFIED||IODINE STAIN|NASH FIBROSURE FORMULA|||NA|Y|3|Visit_3|40|7|TREATMENT|2020-12-05|2020-12-24|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|a3b72841-3401-4dcc-9d06-75438b408d0b|6|IRON|Iron|URINALYSIS|[?]|ft3|[?]|[?]|NEGATIVE|1|10^6 CFU|1|1|[?]|NORMAL|SERUM|CONTAMINATED|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROMETER FORMULA||Y|U||3|Visit_3|40|2|WASHOUT|2020-12-05|2021-01-24|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|a3b72841-3401-4dcc-9d06-75438b408d0b|7|TNF12S|Soluble TNF Superfamily Member 12|HEMATOLOGY|[?]|10^3 organisms/mL|[?]|[?]|NEGATIVE|1|PRESSOR UNITS|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|ICTERIC||INDIRECT IMMUNOFLUORESCENCE|HEPASCORE FORMULA|||Y||4|Visit_4|65|6|WASHOUT|2020-12-30|2021-01-07|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|a3b72841-3401-4dcc-9d06-75438b408d0b|8|MMIF|Macrophage Migration Inhibitory Factor|HEMATOLOGY|[?]|10^6 IU/mL|[?]|[?]|POSITIVE|1|pptr|1|1|[?]|LOW|SUPERNATANT, PLASMA|REFRIGERATED|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|6|TREATMENT|2020-12-30|2021-02-01|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|a3b72841-3401-4dcc-9d06-75438b408d0b|9|PROMYB|Promyeloblasts|HEMATOLOGY|[?]|U/kg/day|[?]|[?]|NEGATIVE|1|pmol/L|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|CONTAMINATED|N|MANUAL COUNT|CKD-EPI CREATININE FORMULA|Y||NA||5|Visit_5|90|6|WASHOUT|2021-01-24|2021-01-26|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|a3b72841-3401-4dcc-9d06-75438b408d0b|10|BTLBTL|Butalbital|CHEMISTRY|||[?]|[?]|POSITIVE|1|mOsm|1|1|[?]|LOW|TUMOR TISSUE|REFRIGERATED||ZIEHL NEELSEN ACID FAST STAIN|MDRD 5 VARIABLE FORMULA|||N|Y|5|Visit_5|90|5|TREATMENT|2021-01-24|2021-01-31|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|4393406e-bda5-42e4-a752-a8121004b7ef|1|C130124|Cat Dander Antigen IgE Antibody|CHEMISTRY|||[?]|[?]|NEGATIVE|1|pt_br|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|UNEXPECTED ODOR||TRICHROME STAIN|CKD-EPI FORMULA|Y||Y|Y|1|Visit_1|10|2|SCREENING|2020-10-28|2021-01-20|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|4393406e-bda5-42e4-a752-a8121004b7ef|2|TPROTP|Phosphorylated Tau Protein|URINALYSIS|[?]|vg/dose|[?]|[?]|NEGATIVE|1|mm2|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|NON-HEMOLYZED|N|DROPLET DIGITAL PCR|FIBROTEST FORMULA|Y||NA||1|Visit_1|10|3|TREATMENT|2020-10-28|2020-11-23|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|4393406e-bda5-42e4-a752-a8121004b7ef|3|HYPSEGCE|Hypersegmented Cells|CHEMISTRY|[?]|ug/day|[?]|[?]|BORDERLINE|1|aMFI|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|ICTERIC||ROMANOWSKY STAIN|GMI % FORMULA|||NA||2|Visit_2|25|3|FOLLOW-UP|2020-11-12|2020-11-27|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|4393406e-bda5-42e4-a752-a8121004b7ef|4|GSTMU|Mu Glutathione-S-Transferase|URINALYSIS|[?]|nkat/g Hb|[?]|[?]|BORDERLINE|1|/day|1|1|[?]|NORMAL|MUSCLE TISSUE|THAWED||HPLC|GMI % FORMULA|||N||2|Visit_2|25|1|WASHOUT|2020-11-12|2020-12-02|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|4393406e-bda5-42e4-a752-a8121004b7ef|5|ANGPT2|Angiopoietin 2|HEMATOLOGY|[?]|U/10^12 RBC|[?]|[?]|INVALID|1|pmol/L/h|1|1|[?]|NORMAL|CALCULUS|HEMOLYZED||TEST STRIP|FIBROMETER FORMULA||Y|NA||3|Visit_3|40|3|FOLLOW-UP|2020-11-27|2021-01-07|40|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|4393406e-bda5-42e4-a752-a8121004b7ef|6|TRACP5B|Tartrate-Resistant Acid Phosphatase 5b|CHEMISTRY|[?]|foz_us|[?]|[?]|POSITIVE|1|rpm|1|1|[?]|HIGH|SMEGMA|AGGLUTINATED||U-HPLC/MS/MS|GMI % FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-11-27|2020-12-26|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|4393406e-bda5-42e4-a752-a8121004b7ef|7|NEUTSGLE|Neutrophils, Segmented/Leukocytes|HEMATOLOGY|[?]|g/g|[?]|[?]|POSITIVE|1|MnFI|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|SOLIDIFIED||CONTACT SPECULAR MICROSCOPY|FIBROSIS 4 FORMULA||Y|NA||4|Visit_4|65|7|SCREENING|2020-12-22|2021-01-07|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|4393406e-bda5-42e4-a752-a8121004b7ef|8|CAPHOS|Calcium/Phosphorus|URINALYSIS|[?]|SFC/10^6 PBMC|[?]|[?]|TRACE|1|Bq/uL|1|1|[?]|HIGH|INTERSTITIAL FLUID|NON-HEMOLYZED||MICROBIAL CULTURE|FIBROSIS 4 FORMULA|Y||NA||4|Visit_4|65|4|WASHOUT|2020-12-22|2020-12-23|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|4393406e-bda5-42e4-a752-a8121004b7ef|9|ROM|Reactive Oxygen Metabolite|URINALYSIS|[?]|nmol/mol|[?]|[?]|INDETERMINATE|1|sec|1|1|[?]|HIGH|LYMPH|DRIED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|4|WASHOUT|2021-01-16|2021-01-19|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|4393406e-bda5-42e4-a752-a8121004b7ef|10|CD5|CD5|URINALYSIS|[?]|dB|[?]|[?]|INVALID|1|ug/animal|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE||CONTRAST ENHANCED PET/CT SCAN|GMI % FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2021-01-16|2021-01-17|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|d70f5903-3d94-422b-8f69-212f015b54c9|1|TATC|Thrombin Antithrombin Complex|URINALYSIS|||[?]|[?]|POSITIVE|1|10^6/Ejaculate U|1|1|[?]|NORMAL|REFLEX TEAR|ICTERIC|N|DNA MICROARRAY|CKD-EPI CREATININE FORMULA|||N|Y|1|Visit_1|10|2|TREATMENT|2020-05-19|2020-07-03|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|d70f5903-3d94-422b-8f69-212f015b54c9|2|KLCLLC|Kappa Light Chain/Lambda Light Chain|HEMATOLOGY|[?]|kcal/day|[?]|[?]|BORDERLINE|1|APS U|1|1|[?]|LOW|PLEURAL TISSUE|PARAFFIN-EMBEDDED||ERGOSPIROMETRY|COCKCROFT-GAULT FORMULA|Y||NA||1|Visit_1|10|2|WASHOUT|2020-05-19|2020-06-28|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|d70f5903-3d94-422b-8f69-212f015b54c9|3|ABNCECE|Abnormal Cells/Total Cells|URINALYSIS|[?]|DDU|[?]|[?]|POSITIVE|1|km|1|1|[?]|ABNORMAL|LAVAGE FLUID|CALCIFIED||OPTICAL COHERENCE TOMOGRAPHY|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-06-03|2020-06-22|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|d70f5903-3d94-422b-8f69-212f015b54c9|4|TRAP|Total Radical-Trap Antioxidant Potential|URINALYSIS|||[?]|[?]|INVALID|1|ukat|1|1|[?]|NORMAL|HAIR FOLLICLE|LACTESCENT|N|SLIT LAMP PHOTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|2|Visit_2|25|2|TREATMENT|2020-06-03|2020-08-01|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|d70f5903-3d94-422b-8f69-212f015b54c9|5|MCV|Ery. Mean Corpuscular Volume|HEMATOLOGY|[?]|MdFI|[?]|[?]|TRACE|1|Bq/L|1|1|[?]|LOW|KERATINOCYTE|LACTESCENT||LYMPHANGIOGRAPHY|CKD-EPI CREATININE FORMULA||Y|U||3|Visit_3|40|2|SCREENING|2020-06-18|2020-08-02|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|d70f5903-3d94-422b-8f69-212f015b54c9|6|PROT|Protein|URINALYSIS|||[?]|[?]|BORDERLINE|1|BE/mL|1|1|[?]|ABNORMAL|CERUMEN|CALCIFIED|N|SLIT LAMP|FIBROTEST FORMULA|||NA|Y|3|Visit_3|40|6|SCREENING|2020-06-18|2020-08-08|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|d70f5903-3d94-422b-8f69-212f015b54c9|7|CELLSIM|Immature Cells|HEMATOLOGY|[?]|10^8 PFU|[?]|[?]|BORDERLINE|1|MdFI|1|1|[?]|LOW|PLASMA|FRESH||IN VITRO GENE EXPRESSION ASSAY|GMI % FORMULA|Y||NA||4|Visit_4|65|1|WASHOUT|2020-07-13|2020-07-24|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|d70f5903-3d94-422b-8f69-212f015b54c9|8|CD22|CD22|URINALYSIS|[?]|10^12/L|[?]|[?]|BORDERLINE|1|U/kg/day|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|THAWED||ANALYTICAL ULTRACENTRIFUGATION|MDRD 5 VARIABLE FORMULA|Y||N||4|Visit_4|65|3|FOLLOW-UP|2020-07-13|2020-08-08|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|d70f5903-3d94-422b-8f69-212f015b54c9|9|VITA|Vitamin A|URINALYSIS|[?]|SPRAY|[?]|[?]|INVALID|1|g/animal/wk|1|1|[?]|NORMAL|EXUDATE|SOLIDIFIED|N|MUGA|GMI MMOL/MOL FORMULA|||U||5|Visit_5|90|7|SCREENING|2020-08-07|2020-08-11|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|d70f5903-3d94-422b-8f69-212f015b54c9|10|NAGASEXR|NAGASE Excretion Rate|URINALYSIS|[?]|CONTAINER|[?]|[?]|INDETERMINATE|1|BU/mL|1|1|[?]|LOW|EPIDERMAL TISSUE|LIPEMIC||DYNAMIC LIGHT SCATTERING|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|Y||5|Visit_5|90|7|TREATMENT|2020-08-07|2020-08-13|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|ef772266-faf1-4904-8ac3-19cbc3ea7d36|1|PRLYMLE|Prolymphocytes/Leukocytes|CHEMISTRY|[?]|10^9 organisms/mg|[?]|[?]|INVALID|1|/VF|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|CALCIFIED|N|LINE PROBE ASSAY|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|3|TREATMENT|2021-01-06|2021-02-19|10|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|ef772266-faf1-4904-8ac3-19cbc3ea7d36|2|LH|Luteinizing Hormone|URINALYSIS|[?]|/h|[?]|[?]|TRACE|1|mL/mmHg|1|1|[?]|LOW|PLEURAL TISSUE|ROOM TEMPERATURE|N|IMMUNOCHEMILUMINOMETRIC ASSAY|FIBROTEST FORMULA|||Y||1|Visit_1|10|3|SCREENING|2021-01-06|2021-02-13|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|ef772266-faf1-4904-8ac3-19cbc3ea7d36|3|APOA|Apolipoprotein A|HEMATOLOGY|[?]|IU/L|[?]|[?]|NEGATIVE|1|mL/g/h|1|1|[?]|ABNORMAL|DIALYSIS FLUID|AGGLUTINATED||TRANSVAGINAL ULTRASOUND|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2021-01-21|2021-02-15|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|LB|ef772266-faf1-4904-8ac3-19cbc3ea7d36|4|FCTVIIIA|Factor VIII Activity|CHEMISTRY|[?]|PIXELS/cm|[?]|[?]|INDETERMINATE|1|mg/day|1|1|[?]|HIGH|URINE SEDIMENT|THAWED||OLIGO ACGH|FIBROSIS 4 FORMULA|||N||2|Visit_2|25|3|TREATMENT|2021-01-21|2021-03-14|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|LB|ef772266-faf1-4904-8ac3-19cbc3ea7d36|5|CKMT1CK|CK, Macromolecular Type 1/Total CK|CHEMISTRY|[?]|mL/cm H2O|[?]|[?]|INVALID|1|CFU/g|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|NON-HEMOLYZED|N|ELECTROGASTROGRAPHY|GMI MMOL/MOL FORMULA||Y|Y||3|Visit_3|40|5|SCREENING|2021-02-05|2021-04-02|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|ef772266-faf1-4904-8ac3-19cbc3ea7d36|6|AFPL3AFP|A Fetoprotein L3/A Fetoprotein|CHEMISTRY|[?]|nmol/g|[?]|[?]|TRACE|1|dpm/100mg|1|1|[?]|LOW|BONE MARROW|CONCENTRATED||NO INFORMATION|MDRD 6 VARIABLE FORMULA|||U||3|Visit_3|40|1|TREATMENT|2021-02-05|2021-02-22|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|ef772266-faf1-4904-8ac3-19cbc3ea7d36|7|CSFIGIDX|CSF IgG Index|URINALYSIS|[?]|EP U|[?]|[?]|INDETERMINATE|1|mL/s|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|AUTOLYZED||MYELOPEROXIDASE STAIN|FIBROTEST FORMULA||Y|Y||4|Visit_4|65|2|TREATMENT|2021-03-02|2021-03-11|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|ef772266-faf1-4904-8ac3-19cbc3ea7d36|8|VITK|Vitamin K|CHEMISTRY|[?]|ppth|[?]|[?]|INVALID|1|IU|1|1|[?]|ABNORMAL|EXUDATE|ICTERIC||IMMUNOTURBIDIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|1|TREATMENT|2021-03-02|2021-03-08|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|ef772266-faf1-4904-8ac3-19cbc3ea7d36|9|LEUKASE|Leukocyte Esterase|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|/5x10^4 WBC|1|1|[?]|LOW|PERITONEAL FLUID|SOLIDIFIED||PET SCAN|FIBROMETER FORMULA||Y|U|Y|5|Visit_5|90|3|FOLLOW-UP|2021-03-27|2021-04-01|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|ef772266-faf1-4904-8ac3-19cbc3ea7d36|10|C165886|White Oak Pollen IgE AB RAST Score|HEMATOLOGY|[?]|DAgU/mL|[?]|[?]|INVALID|1|mL/beat|1|1|[?]|NORMAL|TRANSUDATE|CLOTTED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 4 VARIABLE FORMULA|Y||U||5|Visit_5|90|3|SCREENING|2021-03-27|2021-04-01|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|c0f9c36c-1ae5-4f80-b936-0afe3f661746|1|ASMACT|Alpha-Smooth Muscle Actin|HEMATOLOGY|[?]|%/min|[?]|[?]|INVALID|1|lx|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|GELLED||CENTRIFUGATION|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-07-14|2020-08-31|10|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|c0f9c36c-1ae5-4f80-b936-0afe3f661746|2|ADH|Antidiuretic Hormone|HEMATOLOGY|[?]|mkat|[?]|[?]|INVALID|1|MdFI|1|1|[?]|NORMAL|TUMOR TISSUE|SOLIDIFIED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-07-14|2020-08-20|10|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|c0f9c36c-1ae5-4f80-b936-0afe3f661746|3|EOSMM|Eosinophilic Metamyelocytes|CHEMISTRY|[?]|C|[?]|[?]|POSITIVE|1|PNU/mL|1|1|[?]|HIGH|RETICULOCYTES|AGGLUTINATED||PATHOLOGICAL EVALUATION|ASH FIBROSURE FORMULA||Y|N||2|Visit_2|25|5|FOLLOW-UP|2020-07-29|2020-08-15|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|c0f9c36c-1ae5-4f80-b936-0afe3f661746|4|INTLK4|Interleukin 4|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|10^12/L|1|1|[?]|NORMAL|MONOCYTE|LIPEMIC||NON-CONTACT SPECULAR MICROSCOPY|FIBROSIS 4 FORMULA|||U|Y|2|Visit_2|25|3|TREATMENT|2020-07-29|2020-08-21|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|c0f9c36c-1ae5-4f80-b936-0afe3f661746|5|C130087|English Plantain Pollen IgG4|HEMATOLOGY|||[?]|[?]|INVALID|1|log10 TCID 50/mL|1|1|[?]|LOW|SERUM OR PLASMA|GELLED||IHC|COCKCROFT-GAULT FORMULA||Y|N|Y|3|Visit_3|40|5|FOLLOW-UP|2020-08-13|2020-09-23|40|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|c0f9c36c-1ae5-4f80-b936-0afe3f661746|6|NITRICOX|Nitric Oxide|URINALYSIS|[?]|Enzyme U/g Hb|[?]|[?]|POSITIVE|1|fg|1|1|[?]|ABNORMAL|TISSUE|HEMOLYZED||MICROBIAL CULTURE, SOLID|CKD-EPI CREATININE FORMULA|Y||NA||3|Visit_3|40|1|SCREENING|2020-08-13|2020-10-01|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|c0f9c36c-1ae5-4f80-b936-0afe3f661746|7|INTLK10|Interleukin 10|HEMATOLOGY|[?]|10^10/L|[?]|[?]|TRACE|1|Siemens|1|1|[?]|LOW|AMNIOTIC FLUID|UNEXPECTED ODOR||OBSERVATION|FIBROMETER FORMULA|Y||Y||4|Visit_4|65|6|WASHOUT|2020-09-07|2020-09-08|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|c0f9c36c-1ae5-4f80-b936-0afe3f661746|8|ECCENTCY|Eccentrocytes|CHEMISTRY|[?]|CAPFUL|[?]|[?]|BORDERLINE|1|nm|1|1|[?]|NORMAL|SYNOVIAL FLUID|AGGLUTINATED||LIQUID SCINTILLATION COUNTING|MDRD 6 VARIABLE FORMULA|||N||4|Visit_4|65|6|TREATMENT|2020-09-07|2020-09-23|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|c0f9c36c-1ae5-4f80-b936-0afe3f661746|9|ACANTRBC|Acanthocytes/Erythrocytes|HEMATOLOGY|[?]|cup eq|[?]|[?]|INVALID|1|uL/kg/day|1|1|[?]|LOW|DERMAL TISSUE|DRIED||PHOTOGRAPHY|MDRD ENZYMATIC FORMULA|Y||NA||5|Visit_5|90|4|TREATMENT|2020-10-02|2020-10-08|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|c0f9c36c-1ae5-4f80-b936-0afe3f661746|10|PROMYLE|Promyelocytes/Leukocytes|URINALYSIS|[?]|g/g/day|[?]|[?]|INDETERMINATE|1|mg|1|1|[?]|NORMAL|VENOUS CORD BLOOD|CLOTTED||IMMUNODIFFUSION|MDRD 6 VARIABLE FORMULA|Y||Y||5|Visit_5|90|1|WASHOUT|2020-10-02|2020-10-10|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|f17b5630-e782-4135-8a50-4a9bb2fe63b1|1|C165908|Animal Mix IgG AB RAST Score|CHEMISTRY|[?]|ug/kg/min|[?]|[?]|TRACE|1|cd*s/m2|1|1|[?]|HIGH|ABSCESS FLUID|NON-HEMOLYZED||HEMATOXYLIN AND EOSIN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|Y||1|Visit_1|10|3|SCREENING|2020-11-29|2020-12-06|10|17|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|LB|f17b5630-e782-4135-8a50-4a9bb2fe63b1|2|NITRITE|Nitrite|CHEMISTRY|[?]|mL/m2|[?]|[?]|INVALID|1|/mm|1|1|[?]|NORMAL|VENOUS CORD BLOOD|ICTERIC||LYMPHANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-11-29|2020-12-29|10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|LB|f17b5630-e782-4135-8a50-4a9bb2fe63b1|3|IGAGM|IgG IgM IgA Total|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|/LPF|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|DRIED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|ASH FIBROSURE FORMULA|Y||Y|Y|2|Visit_2|25|6|TREATMENT|2020-12-14|2021-02-21|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|LB|f17b5630-e782-4135-8a50-4a9bb2fe63b1|4|C147279|Zea mays Antigen IgE Antibody|URINALYSIS|[?]|log10 TCID 50/mL|[?]|[?]|INVALID|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|SEMEN|CLOTTED|N|ENZYMATIC ULTRACENTRIFUGATION|MDRD 6 VARIABLE FORMULA|||NA||2|Visit_2|25|4|SCREENING|2020-12-14|2021-02-13|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|LB|f17b5630-e782-4135-8a50-4a9bb2fe63b1|5|CCL20|Chemokine (C-C Motif) Ligand 20|HEMATOLOGY|[?]|POUCH|[?]|[?]|INDETERMINATE|1|nkat|1|1|[?]|ABNORMAL|PERITONEAL FLUID|AGGLUTINATED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|N||3|Visit_3|40|6|SCREENING|2020-12-29|2021-01-18|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|f17b5630-e782-4135-8a50-4a9bb2fe63b1|6|C130142|German Cockroach Antigen IgG Antibody|URINALYSIS|[?]|mL/g/day|[?]|[?]|POSITIVE|1|beats/min|1|1|[?]|ABNORMAL|SKIN TISSUE|CONTAMINATED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|FIBROTEST FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-12-29|2021-01-16|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|f17b5630-e782-4135-8a50-4a9bb2fe63b1|7|INTLK19|Interleukin 19|HEMATOLOGY|[?]|mEq|[?]|[?]|TRACE|1|mmol/s|1|1|[?]|NORMAL|PLATELET POOR PLASMA|FRESH||PET/CT SCAN WITHOUT CONTRAST|GMI % FORMULA|Y|Y|Y||4|Visit_4|65|1|SCREENING|2021-01-23|2021-01-27|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|LB|f17b5630-e782-4135-8a50-4a9bb2fe63b1|8|PROGESTR|Progesterone Receptor|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mg/h|1|1|[?]|NORMAL|PLEURAL FLUID|AUTOLYZED||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|COCKCROFT-GAULT FORMULA|||N|Y|4|Visit_4|65|2|TREATMENT|2021-01-23|2021-02-08|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|LB|f17b5630-e782-4135-8a50-4a9bb2fe63b1|9|CTOT|Complement Total|CHEMISTRY|[?]|/2000 RBC|[?]|[?]|NEGATIVE|1|PLUG|1|1|[?]|LOW|SUPERNATANT, SERUM|HEMOLYZED||ANALYTICAL ULTRACENTRIFUGATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||5|Visit_5|90|1|SCREENING|2021-02-17|2021-02-24|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|f17b5630-e782-4135-8a50-4a9bb2fe63b1|10|ANPPROMR|Mid-Reg Pro-Atrial Natriuretic Peptide|URINALYSIS|[?]|kcal/day|[?]|[?]|POSITIVE|1|mmol/mol|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|NON-HEMOLYZED||CRYOSCOPY|HEPASCORE FORMULA|||U||5|Visit_5|90|3|TREATMENT|2021-02-17|2021-02-20|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|8bdb40c9-1e44-45ae-bf08-81ea635fd762|1|RBCCLMP|Erythrocyte Cell Clumps|URINALYSIS|[?]|cs|[?]|[?]|INDETERMINATE|1|/day|1|1|[?]|LOW|COLOSTRUM|THAWED||ELISPOT|FIBROMETER FORMULA||Y|N||1|Visit_1|10|6|FOLLOW-UP|2021-01-02|2021-03-23|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|8bdb40c9-1e44-45ae-bf08-81ea635fd762|2|HGBDHGB|Hemoglobin D/Total Hemoglobin|URINALYSIS|||[?]|[?]|TRACE|1|mg/m2/h|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|AUTOLYZED|N|CELLULAR PROLIFERATION ASSAY|ASH FIBROSURE FORMULA|||U|Y|1|Visit_1|10|4|TREATMENT|2021-01-02|2021-01-07|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|8bdb40c9-1e44-45ae-bf08-81ea635fd762|3|GSTTH|Glutathione S-Transferase, Theta|HEMATOLOGY|[?]|CFU/mL|[?]|[?]|INVALID|1|FINGERTIP UNIT|1|1|[?]|NORMAL|GASTRIC CONTENTS|UNEXPECTED ODOR|N|SANGER SEQUENCING|CKD-EPI FORMULA|Y||NA||2|Visit_2|25|2|TREATMENT|2021-01-17|2021-01-26|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|8bdb40c9-1e44-45ae-bf08-81ea635fd762|4|BLSTNMCE|Normoblasts/Total Cells|CHEMISTRY|[?]|ng|[?]|[?]|NEGATIVE|1|10^7 CFU|1|1|[?]|ABNORMAL|COLOSTRUM|ROOM TEMPERATURE||GC/FID|FIBROTEST FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2021-01-17|2021-04-01|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|8bdb40c9-1e44-45ae-bf08-81ea635fd762|5|CXCL12|Chemokine (C-X-C Motif) Ligand 12|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mEq/g|1|1|[?]|NORMAL|SEBUM|ICTERIC||ENZYMATIC ULTRACENTRIFUGATION|MDRD ENZYMATIC FORMULA|Y||Y|Y|3|Visit_3|40|1|TREATMENT|2021-02-01|2021-02-12|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|8bdb40c9-1e44-45ae-bf08-81ea635fd762|6|C165878|German Cockroach IgE AB RAST Score|HEMATOLOGY|[?]|ug/g/day|[?]|[?]|BORDERLINE|1|TAMPON|1|1|[?]|NORMAL|ALVEOLAR AIR|HEMOLYZED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|2|TREATMENT|2021-02-01|2021-03-06|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|8bdb40c9-1e44-45ae-bf08-81ea635fd762|7|BARB|Barbiturates|URINALYSIS|[?]|CCID 50/dose|[?]|[?]|POSITIVE|1|Ci/kg|1|1|[?]|ABNORMAL|LEUKOCYTE|LACTESCENT||MULTI-SLICE SPIRAL CT|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|7|WASHOUT|2021-02-26|2021-03-24|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|8bdb40c9-1e44-45ae-bf08-81ea635fd762|8|GSTY1|Glutathione S-Transferase, Y1|URINALYSIS|[?]|uCi|[?]|[?]|TRACE|1|10^5/hpf|1|1|[?]|NORMAL|MECONIUM|AUTOLYZED|N|PET SCAN|MDRD FORMULA||Y|Y||4|Visit_4|65|6|SCREENING|2021-02-26|2021-03-15|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|8bdb40c9-1e44-45ae-bf08-81ea635fd762|9|IGGCALBC|IgG Clearance/Albumin Clearance|URINALYSIS|[?]|mAnson U/mL|[?]|[?]|INDETERMINATE|1|10^9 organisms|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|UNEXPECTED ODOR||PANENDOSCOPY|GMI MMOL/MOL FORMULA|||Y||5|Visit_5|90|6|TREATMENT|2021-03-23|2021-03-24|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|8bdb40c9-1e44-45ae-bf08-81ea635fd762|10|CXCR3|Chemokine (C-X-C Motif) Receptor 3|URINALYSIS|[?]|uL|[?]|[?]|POSITIVE|1|mmol/min/kPa|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|LIPEMIC|N|FISH|CKD-EPI FORMULA|||N||5|Visit_5|90|4|TREATMENT|2021-03-23|2021-03-28|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|1|LDL|LDL Cholesterol|HEMATOLOGY|[?]|SUPPOSITORY|[?]|[?]|INVALID|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|CERUMEN|PARAFFIN-EMBEDDED||TRICHROME STAIN|MDRD ENZYMATIC FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2021-01-16|2021-03-13|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|2|RAGE|Receptor Advanced Glycation Endproducts|HEMATOLOGY|[?]|ug/day|[?]|[?]|NEGATIVE|1|%|1|1|[?]|HIGH|PLEURAL FLUID|FRESH||ANTIBIOTIC AGAR SCREEN|MDRD 4 VARIABLE FORMULA|Y|Y|NA||1|Visit_1|10|2|WASHOUT|2021-01-16|2021-04-15|10|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|3|DGNWBC|Degenerated Leukocytes|HEMATOLOGY|[?]|CIGAR|[?]|[?]|POSITIVE|1|SQU/mL|1|1|[?]|NORMAL|STOOL|LIPEMIC|N|DROPLET DIGITAL PCR|CKD-EPI CREATININE FORMULA|||NA||2|Visit_2|25|6|FOLLOW-UP|2021-01-31|2021-03-20|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|4|AST|Aspartate Aminotransferase|URINALYSIS|[?]|PIXELS/in|[?]|[?]|INVALID|1|mmol/s|1|1|[?]|HIGH|MECONIUM|ROOM TEMPERATURE||MRS|MDRD 5 VARIABLE FORMULA|||U||2|Visit_2|25|6|FOLLOW-UP|2021-01-31|2021-03-16|25|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|5|INTLK31|Interleukin 31|CHEMISTRY|[?]|10^7 CFU|[?]|[?]|NEGATIVE|1|OD Unit|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED||OBSERVATION|GMI MMOL/MOL FORMULA||Y|NA||3|Visit_3|40|7|SCREENING|2021-02-15|2021-03-12|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|6|PRORUB|Prorubricyte|CHEMISTRY|[?]|min*mg/mL|[?]|[?]|INDETERMINATE|1|Bq/mg|1|1|[?]|HIGH|GASTRIC FLUID|FRESH|N|CORONARY ANGIOGRAPHY|CKD-EPI FORMULA|||Y||3|Visit_3|40|5|WASHOUT|2021-02-15|2021-02-28|40|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|7|SLTFRNRC|Soluble Transferrin Receptor|CHEMISTRY|[?]|/10^5|[?]|[?]|INVALID|1|JAR|1|1|[?]|NORMAL|LAVAGE FLUID|CONTAMINATED||ATOMIC ABSORPTION SPECTROMETRY|GMI MMOL/MOL FORMULA||Y|N||4|Visit_4|65|7|TREATMENT|2021-03-12|2021-04-01|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|8|C165929|Bee Mix IgE AB RAST Score|URINALYSIS|[?]|umol/mol|[?]|[?]|INVALID|1|RATIO|1|1|[?]|NORMAL|BREAST MILK|CALCIFIED||CARDIAC THERMODILUTION|MDRD 5 VARIABLE FORMULA|Y||NA||4|Visit_4|65|3|SCREENING|2021-03-12|2021-03-31|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|9|CD2LY|CD2/Lymphocytes|CHEMISTRY|||[?]|[?]|BORDERLINE|1|cd|1|1|[?]|LOW|BUFFY COAT|ROOM TEMPERATURE||AGAR DILUTION|FIBROTEST FORMULA|Y||NA|Y|5|Visit_5|90|5|SCREENING|2021-04-06|2021-04-14|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|LB|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|10|BLSTSID|Sideroblast|URINALYSIS|[?]|uEq|[?]|[?]|BORDERLINE|1|mg|1|1|[?]|LOW|ABSCESS FLUID|LIPEMIC||CLINICAL EVALUATION|MDRD 5 VARIABLE FORMULA||Y|U||5|Visit_5|90|1|TREATMENT|2021-04-06|2021-04-13|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|LB|296f8314-5a07-47b5-8796-31afe709b379|1|DHPG|3,4-Dihydroxyphenylglycol|HEMATOLOGY|||[?]|[?]|POSITIVE|1|lx|1|1|[?]|HIGH|PERSPIRATION|SOLIDIFIED||RULER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|4|FOLLOW-UP|2020-07-08|2020-07-15|10|17|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|296f8314-5a07-47b5-8796-31afe709b379|2|HBGCHTHB|Hemoglobin G Coushatta/Total Hemoglobin|URINALYSIS|[?]|kg/mol|[?]|[?]|TRACE|1|Ci/g|1|1|[?]|NORMAL|EPITHELIAL CELL|FROZEN||HEMAGGLUTINATION INHIBITION ASSAY|COCKCROFT-GAULT FORMULA||Y|N||1|Visit_1|10|7|WASHOUT|2020-07-08|2020-08-31|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|296f8314-5a07-47b5-8796-31afe709b379|3|MOCYCECE|Monocytoid Cells/Total Cells|HEMATOLOGY|[?]|PUFF|[?]|[?]|INDETERMINATE|1|mL/min|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|FRESH||FUNDUS PHOTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||2|Visit_2|25|2|FOLLOW-UP|2020-07-23|2020-09-18|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|296f8314-5a07-47b5-8796-31afe709b379|4|NCCPTN|Nociceptin|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mEq/uL|1|1|[?]|ABNORMAL|COLOSTRUM|THAWED||OPTICAL COHERENCE TOMOGRAPHY|FIBROSIS 4 FORMULA|||N|Y|2|Visit_2|25|6|SCREENING|2020-07-23|2020-08-30|25|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|296f8314-5a07-47b5-8796-31afe709b379|5|CA|Calcium|CHEMISTRY|[?]|cm H2O|[?]|[?]|INVALID|1|mgEq|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|CONCENTRATED||RADIATION DOSIMETRY|HEPASCORE FORMULA|Y|Y|NA||3|Visit_3|40|3|TREATMENT|2020-08-07|2020-09-27|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|296f8314-5a07-47b5-8796-31afe709b379|6|PROLYM|Prolymphocytes|CHEMISTRY|[?]|mmol/g|[?]|[?]|TRACE|1|PFU/dose|1|1|[?]|LOW|BILE|PARAFFIN-EMBEDDED|N|SPECT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|N||3|Visit_3|40|3|SCREENING|2020-08-07|2020-09-20|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|296f8314-5a07-47b5-8796-31afe709b379|7|THBD|Thrombomodulin|URINALYSIS|[?]|ng/L|[?]|[?]|INDETERMINATE|1|OD Unit|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED||LINE PROBE ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||4|Visit_4|65|7|TREATMENT|2020-09-01|2020-09-17|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|296f8314-5a07-47b5-8796-31afe709b379|8|TRP1TRG1|Trypsin 1 and Trypsinogen 1|HEMATOLOGY|[?]|ug/L DDU|[?]|[?]|INDETERMINATE|1|km|1|1|[?]|LOW|EPITHELIAL CELL|ROOM TEMPERATURE||MANUAL CLOT DETECTION|FIBROMETER FORMULA||Y|N||4|Visit_4|65|3|FOLLOW-UP|2020-09-01|2020-09-09|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|296f8314-5a07-47b5-8796-31afe709b379|9|CYHGBC|Hemoglobin C Crystals|CHEMISTRY|[?]|cpm|[?]|[?]|NEGATIVE|1|mg/kg|1|1|[?]|HIGH|URINE|REFRIGERATED||MRI WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|3|SCREENING|2020-09-26|2020-10-03|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|296f8314-5a07-47b5-8796-31afe709b379|10|CREAT|Creatinine|HEMATOLOGY|[?]|/LPF|[?]|[?]|BORDERLINE|1|pptr|1|1|[?]|ABNORMAL|FLUID|AGGLUTINATED||MOUSE PROTECTION ASSAY|ASH FIBROSURE FORMULA|||N||5|Visit_5|90|7|TREATMENT|2020-09-26|2020-09-28|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|1|BILEAC|Bile Acid|CHEMISTRY|[?]|Shock Wave|[?]|[?]|BORDERLINE|1|log10 CCID 50/dose|1|1|[?]|HIGH|CORD SERUM|CONCENTRATED|N|HIGH RESOLUTION MELT ANALYSIS|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|3|FOLLOW-UP|2020-12-13|2020-12-21|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|2|IFNA|Interferon Alpha|CHEMISTRY|[?]|FEU|[?]|[?]|INVALID|1|10^11/L|1|1|[?]|LOW|SEMEN|FRESH||PATHOLOGICAL EVALUATION|MDRD 5 VARIABLE FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-12-13|2021-03-04|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|3|CLUECE|Clue Cells|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|s/h|1|1|[?]|LOW|PUS|FRESH||VENTILATION PERFUSION LUNG SCAN|CKD-EPI CREATININE FORMULA|||N|Y|2|Visit_2|25|2|TREATMENT|2020-12-28|2021-01-31|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|4|CYSTARCH|Starch Crystals|URINALYSIS|||[?]|[?]|BORDERLINE|1|Anson U|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|CALCIFIED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD ENZYMATIC FORMULA|||NA|Y|2|Visit_2|25|2|FOLLOW-UP|2020-12-28|2021-01-20|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|5|ALDOLASE|Aldolase|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|g/kg|1|1|[?]|HIGH|WHITE MATTER TISSUE|GELLED||FLOW CYTOMETRY|HEPASCORE FORMULA|Y||U|Y|3|Visit_3|40|1|SCREENING|2021-01-12|2021-02-03|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|6|CXCL12|Chemokine (C-X-C Motif) Ligand 12|HEMATOLOGY|[?]|IU/L|[?]|[?]|BORDERLINE|1|fg|1|1|[?]|LOW|DERMAL TISSUE|AGGLUTINATED||RADIATION DOSIMETRY|HEPASCORE FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2021-01-12|2021-02-19|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|7|ADMA|Asymmetric Dimethylarginine|URINALYSIS|[?]|/mm|[?]|[?]|INVALID|1|10^9/g|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|PARAFFIN-EMBEDDED||MULTI-SLICE SPIRAL CT|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|1|TREATMENT|2021-02-06|2021-02-12|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|8|HGBAHGB|Hemoglobin A/Total Hemoglobin|HEMATOLOGY|[?]|BAR|[?]|[?]|INDETERMINATE|1|mAnson U/mL|1|1|[?]|HIGH|ADIPOSE TISSUE|UNEXPECTED ODOR||AGAR PROPORTION|NASH FIBROSURE FORMULA|||NA||4|Visit_4|65|7|FOLLOW-UP|2021-02-06|2021-03-02|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|9|EAGLUC|Glucose, Estimated Average|URINALYSIS|[?]|mg/g/min|[?]|[?]|POSITIVE|1|L/min|1|1|[?]|NORMAL|ARTERIAL BLOOD|THAWED||FLOCCULATION|CKD-EPI CREATININE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2021-03-03|2021-03-09|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|10|APOA|Apolipoprotein A|CHEMISTRY|||[?]|[?]|INVALID|1|U/g/day|1|1|[?]|NORMAL|HAIR|AGGLUTINATED||AUDIOMETRY|CKD-EPI FORMULA|||N|Y|5|Visit_5|90|3|FOLLOW-UP|2021-03-03|2021-03-11|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|b06043ae-8251-4df8-ab6d-0ceb269c1a42|1|MYPCERPC|Myeloid/Erythroid Ratio|CHEMISTRY|[?]|anti-Xa IU/mL|[?]|[?]|BORDERLINE|1|mOsm/kg|1|1|[?]|LOW|NAIL|GELLED||SXA SCAN|CKD-EPI CYSTATIN C FORMULA|Y||U||1|Visit_1|10|3|TREATMENT|2021-01-25|2021-03-08|10|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|b06043ae-8251-4df8-ab6d-0ceb269c1a42|2|PGE1|Prostaglandin E1|URINALYSIS|||[?]|[?]|NEGATIVE|1|CAPLET|1|1|[?]|LOW|WHITE MATTER TISSUE|NON-HEMOLYZED||IMMUNOCHEMILUMINOMETRIC ASSAY|FIBROMETER FORMULA|||Y|Y|1|Visit_1|10|2|TREATMENT|2021-01-25|2021-04-13|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|b06043ae-8251-4df8-ab6d-0ceb269c1a42|3|LEIM|Immature Leukocytes|CHEMISTRY|[?]|PIPE|[?]|[?]|NEGATIVE|1|10^4 CFU|1|1|[?]|ABNORMAL|SMEGMA|CLOTTED|N|HANSEL STAIN|FIBROTEST FORMULA|||N||2|Visit_2|25|1|TREATMENT|2021-02-09|2021-03-04|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|b06043ae-8251-4df8-ab6d-0ceb269c1a42|4|TRP|Tryptophan|CHEMISTRY|[?]|Mile|[?]|[?]|NEGATIVE|1|mOsm/kg|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|GELLED|N|DIGITAL PCR ARRAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||2|Visit_2|25|5|TREATMENT|2021-02-09|2021-04-03|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|b06043ae-8251-4df8-ab6d-0ceb269c1a42|5|ASTALT|AST/ALT|HEMATOLOGY|[?]|Anson U|[?]|[?]|TRACE|1|dmol|1|1|[?]|ABNORMAL|SPUTUM|SOLIDIFIED||MUGA|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|3|WASHOUT|2021-02-24|2021-04-23|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|b06043ae-8251-4df8-ab6d-0ceb269c1a42|6|GCDCA|Glycochenodeoxycholate|URINALYSIS|||[?]|[?]|BORDERLINE|1|deg2|1|1|[?]|LOW|HAIR FOLLICLE|LIPEMIC||DYNAMIC CONTRAST ENHANCED MRI|FIBROSIS 4 FORMULA|Y|Y|NA|Y|3|Visit_3|40|2|TREATMENT|2021-02-24|2021-03-08|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|b06043ae-8251-4df8-ab6d-0ceb269c1a42|7|ACT|Activated Coagulation Time|URINALYSIS|[?]|cGy|[?]|[?]|TRACE|1|titer|1|1|[?]|HIGH|FLUID|LIPEMIC|N|HIGH RESOLUTION MELT ANALYSIS|FIBROTEST FORMULA|||U||4|Visit_4|65|1|TREATMENT|2021-03-21|2021-04-06|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|b06043ae-8251-4df8-ab6d-0ceb269c1a42|8|INTLK21|Interleukin 21|HEMATOLOGY|[?]|MAC50|[?]|[?]|INDETERMINATE|1|g/kg/day|1|1|[?]|NORMAL|HAIR|AGGLUTINATED||LC-FL|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|2|SCREENING|2021-03-21|2021-04-09|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|b06043ae-8251-4df8-ab6d-0ceb269c1a42|9|IGG4|Immunoglobulin G Subclass 4|CHEMISTRY|[?]|/mm|[?]|[?]|BORDERLINE|1|nmol|1|1|[?]|LOW|ALVEOLAR AIR|FRESH||MICROBIAL CONCENTRATION|GMI % FORMULA|Y||N||5|Visit_5|90|3|SCREENING|2021-04-15|2021-04-18|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|LB|b06043ae-8251-4df8-ab6d-0ceb269c1a42|10|FGF9|Fibroblast Growth Factor 9|CHEMISTRY|[?]|mL/(min*100mL)|[?]|[?]|INVALID|1|mmol/min/kPa|1|1|[?]|NORMAL|SWABBED MATERIAL|ROOM TEMPERATURE|N|JAFFE REACTION|MDRD ENZYMATIC FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2021-04-15|2021-04-19|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|LB|d4fb5b9e-e244-4818-be3d-dbb57faacd43|1|MENGL|Meningeal Cells|URINALYSIS|[?]|MONTHS|[?]|[?]|INVALID|1|m|1|1|[?]|LOW|CIRCULATING TUMOR CELL|PARAFFIN-EMBEDDED||OPTICAL COHERENCE TOMOGRAPHY|MDRD ENZYMATIC FORMULA||Y|U||1|Visit_1|10|1|WASHOUT|2020-11-07|2020-11-08|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|d4fb5b9e-e244-4818-be3d-dbb57faacd43|2|PROMY|Promyelocytes|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|h*%|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|FROZEN||ERGOSPIROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|1|Visit_1|10|7|TREATMENT|2020-11-07|2021-01-18|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|d4fb5b9e-e244-4818-be3d-dbb57faacd43|3|BNPPRO|ProB-type Natriuretic Peptide|CHEMISTRY|[?]|s*kPa|[?]|[?]|TRACE|1|nkat|1|1|[?]|HIGH|SWABBED MATERIAL|FROZEN|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA|Y|Y|N||2|Visit_2|25|1|TREATMENT|2020-11-22|2020-12-19|25|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|d4fb5b9e-e244-4818-be3d-dbb57faacd43|4|LTA|Lymphotoxin Alpha|URINALYSIS|[?]|ELISA unit/mL|[?]|[?]|INVALID|1|anti-Xa IU/mL|1|1|[?]|NORMAL|AQUEOUS HUMOR|GELLED||ENZYMATIC SPECTROPHOTOMETRY|GMI % FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2020-11-22|2021-01-16|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|d4fb5b9e-e244-4818-be3d-dbb57faacd43|5|BLSTRBCE|Rubriblast/Total Cells|HEMATOLOGY|[?]|kcal/day|[?]|[?]|TRACE|1|FINGERTIP UNIT|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|UNEXPECTED ODOR||FLUORESCENT MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA||3|Visit_3|40|1|TREATMENT|2020-12-07|2020-12-14|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|d4fb5b9e-e244-4818-be3d-dbb57faacd43|6|CYAMPPH|Amorphous Phosphate Crystals|HEMATOLOGY|||[?]|[?]|INVALID|1|dram|1|1|[?]|ABNORMAL|PUS|AGGLUTINATED||GIEMSA STAIN|MDRD 5 VARIABLE FORMULA|Y||N|Y|3|Visit_3|40|5|WASHOUT|2020-12-07|2021-01-03|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|d4fb5b9e-e244-4818-be3d-dbb57faacd43|7|PRLYMLE|Prolymphocytes/Leukocytes|CHEMISTRY|||[?]|[?]|INVALID|1|IU/mmol|1|1|[?]|NORMAL|SPUTUM|CALCIFIED||FLUORESCENT ENZYME IMMUNOASSAY|CKD-EPI FORMULA|Y||Y|Y|4|Visit_4|65|4|TREATMENT|2021-01-01|2021-01-29|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|d4fb5b9e-e244-4818-be3d-dbb57faacd43|8|CSFIGIDX|CSF IgG Index|CHEMISTRY|[?]|/7.5 mL|[?]|[?]|INDETERMINATE|1|PRESSOR UNITS|1|1|[?]|NORMAL|CAPILLARY PLASMA|CONCENTRATED||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD 5 VARIABLE FORMULA||Y|U||4|Visit_4|65|7|TREATMENT|2021-01-01|2021-01-04|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|d4fb5b9e-e244-4818-be3d-dbb57faacd43|9|INR|Prothrombin Intl. Normalized Ratio|URINALYSIS|||[?]|[?]|INDETERMINATE|1|pmol/L/h|1|1|[?]|LOW|GASTRIC CONTENTS|FRESH||MAMMOGRAPHY|GMI MMOL/MOL FORMULA|||N|Y|5|Visit_5|90|6|SCREENING|2021-01-26|2021-02-04|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|d4fb5b9e-e244-4818-be3d-dbb57faacd43|10|RETICH|Ret. Corpuscular Hemoglobin Content|URINALYSIS|[?]|IU/L|[?]|[?]|TRACE|1|BAU/mL|1|1|[?]|LOW|PLATELET POOR PLASMA|DRIED||ULTRASONOGRAPHIC ELASTOGRAPHY|CKD-EPI FORMULA|||N||5|Visit_5|90|1|FOLLOW-UP|2021-01-26|2021-02-01|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|1|CSEPIRT|Renal Tubular Epithelial Casts|HEMATOLOGY|[?]|mL/day|[?]|[?]|POSITIVE|1|nkat/L|1|1|[?]|LOW|BUFFY COAT|SOLIDIFIED||COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||1|Visit_1|10|2|SCREENING|2020-07-13|2020-10-01|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|2|CCL12|Chemokine (C-C Motif) Ligand 12|URINALYSIS|[?]|umol/kg/min|[?]|[?]|BORDERLINE|1|uL|1|1|[?]|ABNORMAL|GASTRIC FLUID|GELLED||PH METER MEASUREMENT METHOD|MDRD 4 VARIABLE FORMULA||Y|NA||1|Visit_1|10|3|TREATMENT|2020-07-13|2020-07-25|10|22|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|3|EOSCE|Eosinophils/Total Cells|HEMATOLOGY|[?]|ng|[?]|[?]|POSITIVE|1|mL/min/mmHg|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|PARAFFIN-EMBEDDED||HEMATOXYLIN AND EOSIN STAIN|MDRD 5 VARIABLE FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-07-28|2020-09-30|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|4|APOA1|Apolipoprotein A1|HEMATOLOGY|[?]|Ci/mL|[?]|[?]|NEGATIVE|1|/100 HPFs|1|1|[?]|HIGH|REFLEX TEAR|AGGLUTINATED||ANALYTICAL ULTRACENTRIFUGATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||2|Visit_2|25|5|WASHOUT|2020-07-28|2020-09-24|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|5|CA2729AG|Cancer Antigen 27-29|CHEMISTRY|||[?]|[?]|INVALID|1|s^-1(%O2)^-1|1|1|[?]|NORMAL|PLATELET|PARAFFIN-EMBEDDED|N|IMMUNOFLUORESCENT STAIN|MDRD 6 VARIABLE FORMULA|||NA|Y|3|Visit_3|40|4|TREATMENT|2020-08-12|2020-09-18|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|6|P1NP|Procollagen 1 N-Terminal Propeptide|CHEMISTRY|[?]|nmol/kg/day|[?]|[?]|INVALID|1|mPa|1|1|[?]|LOW|BONE MARROW|ICTERIC|N|PH METER MEASUREMENT METHOD|GMI % FORMULA|Y||Y||3|Visit_3|40|5|FOLLOW-UP|2020-08-12|2020-08-31|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|7|NSPMTSPM|Normal Sperm/Total Sperm|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^7 TCID 50/dose|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|GELLED||FLUORESCENT IMMUNOASSAY|MDRD FORMULA||Y|U|Y|4|Visit_4|65|4|TREATMENT|2020-09-06|2020-10-01|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|8|MLR|Mixed Lymphocyte Reaction|CHEMISTRY|||[?]|[?]|TRACE|1|ng/dL|1|1|[?]|LOW|BILE|UNEXPECTED ODOR||PET/CT SCAN WITHOUT CONTRAST|COCKCROFT-GAULT FORMULA|||NA|Y|4|Visit_4|65|7|FOLLOW-UP|2020-09-06|2020-09-22|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|9|NSE|Neuron Specific Enolase|CHEMISTRY|[?]|tsp eq|[?]|[?]|POSITIVE|1|cmH2O*s/mL|1|1|[?]|NORMAL|INFRANATANT, SERUM|SOLIDIFIED||MICROARRAY|FIBROMETER FORMULA|||U||5|Visit_5|90|4|TREATMENT|2020-10-01|2020-10-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|10|CD56|CD56|URINALYSIS|[?]|10^9/L|[?]|[?]|NEGATIVE|1|foz_br|1|1|[?]|LOW|INFRANATANT, SERUM|HEMOLYZED||MASS SPECTROMETRY|COCKCROFT-GAULT FORMULA|Y||Y||5|Visit_5|90|3|TREATMENT|2020-10-01|2020-10-07|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|1|BLASTNCE|Blasts/Nucleated Cells|CHEMISTRY|[?]|10^6 organisms/mL|[?]|[?]|POSITIVE|1|g/m2/day|1|1|[?]|LOW|CALCULUS|UNEXPECTED ODOR||ANTIMICROBIAL COMBINATION TESTING|GMI MMOL/MOL FORMULA|Y||N||1|Visit_1|10|1|FOLLOW-UP|2021-01-14|2021-02-23|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|2|FXIVAC|Factor XIV Actual/Control|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|nmol/mL/min|1|1|[?]|NORMAL|MUCUS|LIPEMIC||MEDIASTINOSCOPY|GMI % FORMULA||Y|NA|Y|1|Visit_1|10|3|TREATMENT|2021-01-14|2021-03-24|10|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|3|LYMIM|Immature Lymphocytes|HEMATOLOGY|[?]|cP|[?]|[?]|INDETERMINATE|1|BAU/mL|1|1|[?]|LOW|BONE|SOLIDIFIED|N|OLIGO ACGH|COCKCROFT-GAULT FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2021-01-29|2021-02-16|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|4|CYP2C9A|Cytochrome P450 2C9 Activity|HEMATOLOGY|[?]|log10 CCID 50/dose|[?]|[?]|BORDERLINE|1|dpm/mL|1|1|[?]|LOW|ALVEOLAR AIR|DRIED||TRIPLE-PHASE SPIRAL CT SCAN|FIBROTEST FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2021-01-29|2021-04-02|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|5|GLUCCRT|Glucose/Creatinine|HEMATOLOGY|[?]|/MBP|[?]|[?]|TRACE|1|IU/kg|1|1|[?]|LOW|CAPILLARY BLOOD|REFRIGERATED||STRESS ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA|Y|Y|Y||3|Visit_3|40|5|TREATMENT|2021-02-13|2021-03-07|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|6|COCAINE|Cocaine|CHEMISTRY|[?]|WEEKS|[?]|[?]|INVALID|1|Frames/s|1|1|[?]|NORMAL|INTERSTITIAL FLUID|AGGLUTINATED||MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD 5 VARIABLE FORMULA|Y||Y||3|Visit_3|40|4|WASHOUT|2021-02-13|2021-03-08|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|7|ROM|Reactive Oxygen Metabolite|HEMATOLOGY|||[?]|[?]|POSITIVE|1|cup eq|1|1|[?]|ABNORMAL|LUNG SURFACTANT|PARAFFIN-EMBEDDED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA|Y||N|Y|4|Visit_4|65|2|TREATMENT|2021-03-10|2021-03-11|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|8|FACTXI|Factor XI|CHEMISTRY|[?]|Ci/mL|[?]|[?]|TRACE|1|dpm/mL|1|1|[?]|NORMAL|SERUM|AUTOLYZED||SURFACE PLASMON RESONANCE|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|7|TREATMENT|2021-03-10|2021-04-05|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|9|RITALAC|Ritalinic Acid|CHEMISTRY|[?]|log10 copies/mL|[?]|[?]|NEGATIVE|1|10^3 RNA copies/mL|1|1|[?]|LOW|SWABBED MATERIAL|FROZEN||TRICHROME STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||5|Visit_5|90|3|TREATMENT|2021-04-04|2021-04-13|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|LB|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|10|PTSFAAC|Protein S Free Activity Actual/Control|URINALYSIS|||[?]|[?]|BORDERLINE|1|uL|1|1|[?]|ABNORMAL|GASTRIC FLUID|CONCENTRATED||NON-INVASIVE DIELECTRIC SENSING|MDRD ENZYMATIC FORMULA|||NA|Y|5|Visit_5|90|2|TREATMENT|2021-04-04|2021-04-11|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|LB|b1215705-4c22-43bd-aa65-58bd8745f081|1|EPINEXR|Epinephrine Excretion Rate|CHEMISTRY|[?]|umol/L|[?]|[?]|INDETERMINATE|1|IU/kg/h|1|1|[?]|ABNORMAL|RETICULOCYTES|ICTERIC|N|DYNAMIC CONTRAST ENHANCED MRI|FIBROMETER FORMULA||Y|U||1|Visit_1|10|1|SCREENING|2020-07-15|2020-09-08|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|b1215705-4c22-43bd-aa65-58bd8745f081|2|CXCL13|Chemokine (C-X-C Motif) Ligand 13|CHEMISTRY|||[?]|[?]|TRACE|1|mol/day|1|1|[?]|LOW|EMESIS|SOLIDIFIED|N|KNEMOMETRY|CKD-EPI CYSTATIN C FORMULA|Y||Y|Y|1|Visit_1|10|4|TREATMENT|2020-07-15|2020-08-26|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|b1215705-4c22-43bd-aa65-58bd8745f081|3|CCL25|Chemokine (C-C Motif) Ligand 25|CHEMISTRY|[?]|/40 HPFs|[?]|[?]|NEGATIVE|1|ug/h|1|1|[?]|LOW|INTERSTITIAL FLUID|ICTERIC||FUNCTIONAL MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-07-30|2020-09-11|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|b1215705-4c22-43bd-aa65-58bd8745f081|4|V25HD2|25-Hydroxyvitamin D2|URINALYSIS|[?]|PACK|[?]|[?]|TRACE|1|10^9 CFU/mL|1|1|[?]|ABNORMAL|BILE|AUTOLYZED||ELISPOT|NASH FIBROSURE FORMULA|||U||2|Visit_2|25|1|SCREENING|2020-07-30|2020-10-05|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|b1215705-4c22-43bd-aa65-58bd8745f081|5|BNP|Brain Natriuretic Peptide|URINALYSIS|[?]|mL/dose|[?]|[?]|BORDERLINE|1|STEPS|1|1|[?]|HIGH|SPERMATOZOON|PARAFFIN-EMBEDDED|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||Y|NA||3|Visit_3|40|2|WASHOUT|2020-08-14|2020-09-01|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|b1215705-4c22-43bd-aa65-58bd8745f081|6|NEUTBLE|Neutrophils Band Form/Leukocytes|CHEMISTRY|||[?]|[?]|BORDERLINE|1|10^6 U|1|1|[?]|HIGH|SPERMATOZOON|CLOTTED||TRICHROME STAIN|CKD-EPI CYSTATIN C FORMULA|||U|Y|3|Visit_3|40|3|TREATMENT|2020-08-14|2020-09-07|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|b1215705-4c22-43bd-aa65-58bd8745f081|7|THYAB|Thyroid Antibodies|CHEMISTRY|||[?]|[?]|POSITIVE|1|pkat|1|1|[?]|NORMAL|INFRANATANT, SERUM|LACTESCENT||HANSEL STAIN|MDRD 6 VARIABLE FORMULA||Y|NA|Y|4|Visit_4|65|4|SCREENING|2020-09-08|2020-10-07|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|b1215705-4c22-43bd-aa65-58bd8745f081|8|HGBDHGB|Hemoglobin D/Total Hemoglobin|CHEMISTRY|||[?]|[?]|INVALID|1|/HPF|1|1|[?]|LOW|ENDOMETRIAL TISSUE|CONTAMINATED|N|AUSCULTATION|FIBROSIS 4 FORMULA|Y|Y|NA|Y|4|Visit_4|65|3|WASHOUT|2020-09-08|2020-10-11|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|b1215705-4c22-43bd-aa65-58bd8745f081|9|PNTBRBTL|Pentobarbital|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|ng/day|1|1|[?]|HIGH|VITREOUS HUMOR|FROZEN||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|5|Visit_5|90|1|SCREENING|2020-10-03|2020-10-06|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|b1215705-4c22-43bd-aa65-58bd8745f081|10|BACT|Bacteria|CHEMISTRY|[?]|Linear ft*LB|[?]|[?]|POSITIVE|1|mg/L FEU|1|1|[?]|NORMAL|CAPILLARY BLOOD|ICTERIC|N|TRICHROME STAIN|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|2|SCREENING|2020-10-03|2020-10-12|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|b99c6528-af4e-42f5-8d2d-18943b57d55a|1|AMPHETD|Dextroamphetamine|HEMATOLOGY|[?]|umol/mg/min|[?]|[?]|INDETERMINATE|1|Absorbance U/mL|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|NON-HEMOLYZED||TOLUIDINE BLUE STAIN|FIBROTEST FORMULA|||N||1|Visit_1|10|4|SCREENING|2020-10-25|2020-12-24|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|b99c6528-af4e-42f5-8d2d-18943b57d55a|2|ERCENC|Erythroid Cells/Nucleated Cells|URINALYSIS|[?]|10^3 DNA copies/mL|[?]|[?]|POSITIVE|1|Bq/L|1|1|[?]|ABNORMAL|SWABBED MATERIAL|AGGLUTINATED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROTEST FORMULA|||N||1|Visit_1|10|1|FOLLOW-UP|2020-10-25|2020-12-08|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|b99c6528-af4e-42f5-8d2d-18943b57d55a|3|RPTLAAC|Reptilase Activity Actual/Control|URINALYSIS|[?]|/mm|[?]|[?]|BORDERLINE|1|FINGERTIP UNIT|1|1|[?]|NORMAL|STOOL|CONCENTRATED||ERGOSPIROMETRY|FIBROMETER FORMULA|||N||2|Visit_2|25|6|SCREENING|2020-11-09|2021-01-09|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|b99c6528-af4e-42f5-8d2d-18943b57d55a|4|NITRATE|Nitrate|CHEMISTRY|[?]|kBq/uL|[?]|[?]|NEGATIVE|1|IU/mg|1|1|[?]|HIGH|SERUM OR PLASMA|CALCIFIED||SMEAR|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-11-09|2021-01-03|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|b99c6528-af4e-42f5-8d2d-18943b57d55a|5|TCDCA|Taurochenodeoxycholate|URINALYSIS|[?]|KIT|[?]|[?]|INVALID|1|gpELISA unit/mL|1|1|[?]|ABNORMAL|SOFT TISSUE|CONCENTRATED||FARNSWORTH-MUNSELL 100 HUE TEST|MDRD 4 VARIABLE FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-11-24|2020-12-30|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|b99c6528-af4e-42f5-8d2d-18943b57d55a|6|BACT|Bacteria|HEMATOLOGY|[?]|% INHIBITION|[?]|[?]|INDETERMINATE|1|10^3 DNA copies/mL|1|1|[?]|ABNORMAL|BREAST MILK|HEMOLYZED||OPTICAL DENSITY MEASUREMENT|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|3|FOLLOW-UP|2020-11-24|2021-01-07|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|b99c6528-af4e-42f5-8d2d-18943b57d55a|7|GSTPIEXR|Pi-GST Excretion Rate|HEMATOLOGY|||[?]|[?]|POSITIVE|1|RNA copies/mL|1|1|[?]|NORMAL|SUPERNATANT, SERUM|PARAFFIN-EMBEDDED||ELECTRONEUROGRAPHY|MDRD 6 VARIABLE FORMULA||Y|U|Y|4|Visit_4|65|2|TREATMENT|2020-12-19|2021-01-12|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|b99c6528-af4e-42f5-8d2d-18943b57d55a|8|PCDW|Platelet Component Distribution Width|HEMATOLOGY|||[?]|[?]|TRACE|1|uCi|1|1|[?]|LOW|EPITHELIAL CELL|LACTESCENT|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|4|Visit_4|65|1|TREATMENT|2020-12-19|2021-01-07|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|b99c6528-af4e-42f5-8d2d-18943b57d55a|9|ELA2|Neutrophil Elastase|CHEMISTRY|||[?]|[?]|TRACE|1|CCID 50/dose|1|1|[?]|NORMAL|PLEURAL TISSUE|FROZEN|N|CLAUSS METHOD|CKD-EPI CYSTATIN C FORMULA|||N|Y|5|Visit_5|90|6|FOLLOW-UP|2021-01-13|2021-01-20|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|b99c6528-af4e-42f5-8d2d-18943b57d55a|10|CSEPIR|Renal Epithelial Casts|CHEMISTRY|||[?]|[?]|TRACE|1|nmol/L/min|1|1|[?]|HIGH|SOFT TISSUE|HEMOLYZED||WESTERGREN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|5|Visit_5|90|2|TREATMENT|2021-01-13|2021-01-14|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|6848e438-51ca-4a7d-8f81-26c375969a64|1|EOSMM|Eosinophilic Metamyelocytes|HEMATOLOGY|[?]|mL/kg/day|[?]|[?]|TRACE|1|log10 TCID 50/mL|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|REFRIGERATED||CARDIAC THERMODILUTION|FIBROSIS 4 FORMULA|Y||N||1|Visit_1|10|5|TREATMENT|2020-11-12|2020-12-13|10|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|6848e438-51ca-4a7d-8f81-26c375969a64|2|T4|Thyroxine|HEMATOLOGY|[?]|NEEDLE GAUGE|[?]|[?]|NEGATIVE|1|OI50|1|1|[?]|ABNORMAL|TISSUE|CLOTTED||KARYOTYPING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-11-12|2021-01-05|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|6848e438-51ca-4a7d-8f81-26c375969a64|3|CDCA|Chenodeoxycholate|URINALYSIS|[?]|g/g/day|[?]|[?]|BORDERLINE|1|mg/mL/day|1|1|[?]|ABNORMAL|SWABBED MATERIAL|PARAFFIN-EMBEDDED|N|DNA MICROARRAY|CKD-EPI FORMULA|Y||N||2|Visit_2|25|5|TREATMENT|2020-11-27|2020-12-22|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|6848e438-51ca-4a7d-8f81-26c375969a64|4|DPDCREAT|Deoxypyridinoline/Creatinine|URINALYSIS|||[?]|[?]|BORDERLINE|1|PFU|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|THAWED||ECHOCARDIOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|U|Y|2|Visit_2|25|3|FOLLOW-UP|2020-11-27|2021-01-25|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|6848e438-51ca-4a7d-8f81-26c375969a64|5|CD1|CD1|HEMATOLOGY|[?]|BOLUS|[?]|[?]|BORDERLINE|1|L/h/m2|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|REFRIGERATED|N|PUPILLOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||3|Visit_3|40|1|SCREENING|2020-12-12|2021-01-31|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|6848e438-51ca-4a7d-8f81-26c375969a64|6|NAK|Sodium/Potassium|HEMATOLOGY|[?]|amp|[?]|[?]|NEGATIVE|1|Anson U|1|1|[?]|HIGH|DISCHARGE|ICTERIC||CARDIAC THERMODILUTION|CKD-EPI FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-12-12|2021-01-25|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|6848e438-51ca-4a7d-8f81-26c375969a64|7|FCTXIIIA|Factor XIII Activity|CHEMISTRY|||[?]|[?]|NEGATIVE|1|L/L|1|1|[?]|HIGH|SWABBED MATERIAL|AGGLUTINATED||CONTRAST ENHANCED X-RAY|NASH FIBROSURE FORMULA|||Y|Y|4|Visit_4|65|4|TREATMENT|2021-01-06|2021-01-17|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|6848e438-51ca-4a7d-8f81-26c375969a64|8|BASO|Basophils|HEMATOLOGY|[?]|VIAL|[?]|[?]|TRACE|1|IU/mg|1|1|[?]|NORMAL|EMOTIONAL TEAR|UNEXPECTED ODOR|N|POLYGRAPHY|MDRD 5 VARIABLE FORMULA|Y|Y|N||4|Visit_4|65|3|WASHOUT|2021-01-06|2021-01-25|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|6848e438-51ca-4a7d-8f81-26c375969a64|9|LDH5|LDH Isoenzyme 5|CHEMISTRY|[?]|uU/dL|[?]|[?]|NEGATIVE|1|log10 TCID 50/dose|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|SOLIDIFIED||CLIP|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2021-01-31|2021-02-01|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|6848e438-51ca-4a7d-8f81-26c375969a64|10|CACREAT|Calcium/Creatinine|CHEMISTRY|[?]|mkat|[?]|[?]|TRACE|1|10^3 CFU/g|1|1|[?]|ABNORMAL|REFLEX TEAR|UNEXPECTED ODOR|N|DIFFUSION TENSOR MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||5|Visit_5|90|2|FOLLOW-UP|2021-01-31|2021-02-01|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|a6e11c33-7905-42d2-bda9-671d756d4c51|1|PHOSEXR|Phosphorus Excretion Rate|CHEMISTRY|[?]|AgU/mL|[?]|[?]|BORDERLINE|1|umol/L/h|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|ROOM TEMPERATURE||TARGETED GENOME SEQUENCING|CKD-EPI FORMULA||Y|Y||1|Visit_1|10|6|WASHOUT|2020-08-06|2020-08-22|10|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|a6e11c33-7905-42d2-bda9-671d756d4c51|2|MPOAB|Myeloperoxidase Antibody|HEMATOLOGY|[?]|kBq|[?]|[?]|NEGATIVE|1|BEAM BREAKS|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|LACTESCENT||HANSEL STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-08-06|2020-09-10|10|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|a6e11c33-7905-42d2-bda9-671d756d4c51|3|RETIM|Medium Absorption Reticulocytes|URINALYSIS|[?]|mm/h|[?]|[?]|BORDERLINE|1|mmol/mol|1|1|[?]|LOW|URINE|CALCIFIED||DOPPLER ULTRASOUND|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|7|TREATMENT|2020-08-21|2020-09-18|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|a6e11c33-7905-42d2-bda9-671d756d4c51|4|GRWHIH|Growth Hormone Inhibiting Hormone|HEMATOLOGY|||[?]|[?]|INVALID|1|Torr|1|1|[?]|HIGH|SWABBED MATERIAL|CONTAMINATED||MULTIPLE BREATH WASHOUT|COCKCROFT-GAULT FORMULA||Y|Y|Y|2|Visit_2|25|6|SCREENING|2020-08-21|2020-10-22|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|a6e11c33-7905-42d2-bda9-671d756d4c51|5|TBG|Thyroxine Binding Globulin|URINALYSIS|||[?]|[?]|POSITIVE|1|ELISA unit|1|1|[?]|LOW|SYNOVIAL FLUID|REFRIGERATED||PET SCAN|HEPASCORE FORMULA|||Y|Y|3|Visit_3|40|4|FOLLOW-UP|2020-09-05|2020-10-03|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|LB|a6e11c33-7905-42d2-bda9-671d756d4c51|6|CSGRANC|Granular Coarse Casts|URINALYSIS|[?]|10^6 CFU|[?]|[?]|NEGATIVE|1|/2500 WBC|1|1|[?]|ABNORMAL|BREAST MILK|GELLED||WEBER GREEN STAIN|CKD-EPI CREATININE FORMULA|||U||3|Visit_3|40|3|WASHOUT|2020-09-05|2020-11-03|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|LB|a6e11c33-7905-42d2-bda9-671d756d4c51|7|ALBGLYCA|Glycated Albumin|CHEMISTRY|[?]|mEq/g|[?]|[?]|NEGATIVE|1|AgU/mL|1|1|[?]|NORMAL|SPERMATOZOON|AUTOLYZED|N|MICRONEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-09-30|2020-10-07|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|a6e11c33-7905-42d2-bda9-671d756d4c51|8|NTRLFAT|Neutral Fats|URINALYSIS|[?]|PA|[?]|[?]|BORDERLINE|1|10^3 RNA copies/mL|1|1|[?]|NORMAL|INFRANATANT, SERUM|CONCENTRATED||GRADIENT DIFFUSION|FIBROTEST FORMULA|||N||4|Visit_4|65|5|FOLLOW-UP|2020-09-30|2020-10-13|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|a6e11c33-7905-42d2-bda9-671d756d4c51|9|TAURINE|Taurine|CHEMISTRY|[?]|log10 copies/mL|[?]|[?]|BORDERLINE|1|g/animal|1|1|[?]|NORMAL|STOOL|AUTOLYZED||FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CREATININE FORMULA|Y||U||5|Visit_5|90|2|WASHOUT|2020-10-25|2020-10-28|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|a6e11c33-7905-42d2-bda9-671d756d4c51|10|ERCEMIDX|Erythroid Maturation Index|CHEMISTRY|[?]|g/cage/day|[?]|[?]|INDETERMINATE|1|kPa|1|1|[?]|HIGH|PLASMA|HEMOLYZED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|CKD-EPI CYSTATIN C FORMULA|||N||5|Visit_5|90|4|TREATMENT|2020-10-25|2020-10-29|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|1|TIMP1|Tissue Inhibitor of Metalloproteinase 1|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mL/g/min|1|1|[?]|LOW|SWABBED MATERIAL|FRESH|N|MAGNETIC RESONANCE ELASTOGRAPHY|FIBROTEST FORMULA||Y|Y|Y|1|Visit_1|10|6|WASHOUT|2020-11-12|2020-12-18|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|2|HEPCIDIN|Hepcidin|HEMATOLOGY|[?]|ug/cm2|[?]|[?]|INVALID|1|mg/cm2|1|1|[?]|LOW|MUCUS|NON-HEMOLYZED||MAGNETIC RESONANCE ELASTOGRAPHY|FIBROMETER FORMULA||Y|NA||1|Visit_1|10|5|TREATMENT|2020-11-12|2020-11-14|10|12|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|3|IL2R|Interleukin 2 Receptor|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mL/beat|1|1|[?]|LOW|COLOSTRUM|REFRIGERATED||GC/MS-EI|MDRD 5 VARIABLE FORMULA|||N|Y|2|Visit_2|25|4|TREATMENT|2020-11-27|2021-01-18|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|4|AMABARAB|ACH Receptor Modulatn Ab/ACH Receptor Ab|CHEMISTRY|||[?]|[?]|POSITIVE|1|fmol/g|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|PARAFFIN-EMBEDDED||PULSE OXIMETRY|CKD-EPI FORMULA|Y||N|Y|2|Visit_2|25|2|FOLLOW-UP|2020-11-27|2020-12-18|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|5|PLAGMCVT|Platelet Aggregation Mean Curve Type|CHEMISTRY|[?]|RNA copies/mL|[?]|[?]|POSITIVE|1|nmol BCE/nmol|1|1|[?]|ABNORMAL|MONOCYTE|HEMOLYZED||FLUORESCENT SPOT TEST|COCKCROFT-GAULT FORMULA|||N||3|Visit_3|40|4|SCREENING|2020-12-12|2021-01-20|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|6|CD5|CD5|URINALYSIS|[?]|in2|[?]|[?]|POSITIVE|1|mL/(min*100mL)|1|1|[?]|HIGH|PLATELET|CLOTTED||FREEZING POINT DEPRESSION|COCKCROFT-GAULT FORMULA|Y||NA||3|Visit_3|40|1|TREATMENT|2020-12-12|2020-12-23|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|7|CBS|Cystathionine Beta-Synthase|HEMATOLOGY|[?]|days/wk|[?]|[?]|INDETERMINATE|1|kPa/L/sec|1|1|[?]|ABNORMAL|PLEURAL TISSUE|PARAFFIN-EMBEDDED||SPECULAR MICROSCOPY|NASH FIBROSURE FORMULA|Y||NA||4|Visit_4|65|5|TREATMENT|2021-01-06|2021-01-18|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|8|MONOPTPT|Monoclonal Protein/Total Protein|HEMATOLOGY|[?]|mol/g|[?]|[?]|BORDERLINE|1|Roentgen|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|ICTERIC|N|IMMUNO-PET SCAN|CKD-EPI CYSTATIN C FORMULA||Y|Y||4|Visit_4|65|7|TREATMENT|2021-01-06|2021-02-02|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|9|PSA|Prostate Specific Antigen|CHEMISTRY|[?]|MET*min|[?]|[?]|INVALID|1|dyn|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE||BRDU CELLULAR PROLIFERATION ASSAY|FIBROTEST FORMULA|||NA||5|Visit_5|90|1|TREATMENT|2021-01-31|2021-02-03|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|10|ETGETS|Ethyl Glucuronide Ethyl Sulfate|CHEMISTRY|[?]|g/kg|[?]|[?]|INDETERMINATE|1|VIAL|1|1|[?]|ABNORMAL|CALCULUS|LIPEMIC||SLOAN LETTER EYE CHART 2.5%|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|NA||5|Visit_5|90|1|TREATMENT|2021-01-31|2021-02-03|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|8ef37b54-b463-43a4-879f-3ad653c4fef4|1|UREANEXR|Urea Nitrogen Excretion Rate|URINALYSIS|||[?]|[?]|TRACE|1|ka_u/dL|1|1|[?]|NORMAL|TRANSUDATE|FRESH||THIN SMEAR|GMI % FORMULA|||U|Y|1|Visit_1|10|4|FOLLOW-UP|2020-09-11|2020-09-16|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|8ef37b54-b463-43a4-879f-3ad653c4fef4|2|AMACR|Alpha-Methylacyl Coenzyme A Racemase|URINALYSIS|[?]|log10 PFU/mL|[?]|[?]|INVALID|1|ng/mol|1|1|[?]|NORMAL|SMEGMA|THAWED||CENTRIFUGATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-09-11|2020-10-11|10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|8ef37b54-b463-43a4-879f-3ad653c4fef4|3|PSDEPHD|Pseudoephedrine|URINALYSIS|[?]|mg/kg/h|[?]|[?]|INDETERMINATE|1|bel|1|1|[?]|LOW|DIALYSIS FLUID|CALCIFIED||ENDPOINT DILUTION ASSAY|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|3|FOLLOW-UP|2020-09-26|2020-12-01|25|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|8ef37b54-b463-43a4-879f-3ad653c4fef4|4|PPA|Phenylpropanolamine|CHEMISTRY|[?]|eq|[?]|[?]|POSITIVE|1|mg|1|1|[?]|LOW|ENDOTRACHEAL FLUID|AUTOLYZED||MICRO BROTH DILUTION|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|N||2|Visit_2|25|3|SCREENING|2020-09-26|2020-11-09|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|8ef37b54-b463-43a4-879f-3ad653c4fef4|5|CCL23|Chemokine (C-C Motif) Ligand 23|CHEMISTRY|[?]|PUFF|[?]|[?]|TRACE|1|Gy/h|1|1|[?]|NORMAL|PLATELET|CALCIFIED|N|IMMUNORADIOMETRIC ASSAY|FIBROSIS 4 FORMULA|Y||NA||3|Visit_3|40|3|TREATMENT|2020-10-11|2020-10-22|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|LB|8ef37b54-b463-43a4-879f-3ad653c4fef4|6|G6PDA|Glucose-6-Phosphate Dehydrogenase Act|CHEMISTRY|[?]|yd|[?]|[?]|BORDERLINE|1|mL|1|1|[?]|HIGH|TISSUE|REFRIGERATED|N|DUKE INCISION METHOD|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|3|FOLLOW-UP|2020-10-11|2020-10-16|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|LB|8ef37b54-b463-43a4-879f-3ad653c4fef4|7|PAPPEN|Pappenheimer Bodies|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|fmol/L/sec|1|1|[?]|ABNORMAL|LYMPH|ICTERIC|N|ERGOSPIROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|4|Visit_4|65|7|TREATMENT|2020-11-05|2020-11-17|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|LB|8ef37b54-b463-43a4-879f-3ad653c4fef4|8|FVIIIAAC|Factor VIII Activity Actual/Control|URINALYSIS|||[?]|[?]|NEGATIVE|1|/mm|1|1|[?]|LOW|ENDOTRACHEAL FLUID|NON-HEMOLYZED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA|||N|Y|4|Visit_4|65|7|WASHOUT|2020-11-05|2020-11-25|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|LB|8ef37b54-b463-43a4-879f-3ad653c4fef4|9|FACTXA|Factor X Activity|HEMATOLOGY|[?]|10^9 organisms/g|[?]|[?]|INDETERMINATE|1|ug/g/min|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|DRIED|N|LASER CAPTURE MICRODISSECTION|HEPASCORE FORMULA|||N||5|Visit_5|90|3|TREATMENT|2020-11-30|2020-12-08|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|8ef37b54-b463-43a4-879f-3ad653c4fef4|10|TATC|Thrombin Antithrombin Complex|HEMATOLOGY|[?]|nmol/day|[?]|[?]|TRACE|1|L|1|1|[?]|ABNORMAL|VENOUS BLOOD|LACTESCENT||MAPH|ASH FIBROSURE FORMULA|||U||5|Visit_5|90|7|TREATMENT|2020-11-30|2020-12-03|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|cf10035c-4d44-4512-810b-c267d1c8821b|1|ATPVITE|Alpha Tocopherol/Vitamin E|HEMATOLOGY|[?]|mPa|[?]|[?]|INDETERMINATE|1|mm/min|1|1|[?]|HIGH|PERSPIRATION|CALCIFIED|N|FLOCCULATION|ASH FIBROSURE FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-05-27|2020-06-02|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|cf10035c-4d44-4512-810b-c267d1c8821b|2|RETI|Reticulocytes|HEMATOLOGY|[?]|s^-1(%O2)^-1|[?]|[?]|INVALID|1|nkat/L|1|1|[?]|HIGH|MECONIUM|REFRIGERATED|N|PLETHYSMOGRAPHY|FIBROMETER FORMULA||Y|Y||1|Visit_1|10|1|TREATMENT|2020-05-27|2020-07-16|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|cf10035c-4d44-4512-810b-c267d1c8821b|3|PHOSLPD|Phospholipid|HEMATOLOGY|[?]|DRINK|[?]|[?]|INVALID|1|CIGARETTE|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|FRESH||MACRO BROTH DILUTION|COCKCROFT-GAULT FORMULA|Y|Y|U||2|Visit_2|25|7|TREATMENT|2020-06-11|2020-08-04|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|cf10035c-4d44-4512-810b-c267d1c8821b|4|ENRAGE|Extracell Newly Ident RAGE Bind Protein|HEMATOLOGY|||[?]|[?]|INVALID|1|mL/breath|1|1|[?]|NORMAL|CERUMEN|UNEXPECTED ODOR||EEG|CKD-EPI FORMULA|||N|Y|2|Visit_2|25|3|TREATMENT|2020-06-11|2020-07-01|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|cf10035c-4d44-4512-810b-c267d1c8821b|5|C165936|Glycine max IgE AB RAST Score|URINALYSIS|||[?]|[?]|INVALID|1|IU/kg/h|1|1|[?]|LOW|CERUMEN|LACTESCENT||FARR ASSAY|MDRD 5 VARIABLE FORMULA|||Y|Y|3|Visit_3|40|1|SCREENING|2020-06-26|2020-06-28|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|cf10035c-4d44-4512-810b-c267d1c8821b|6|ACETOAC|Acetoacetic Acid|HEMATOLOGY|[?]|Bq/mL|[?]|[?]|NEGATIVE|1|cm/s|1|1|[?]|NORMAL|MECONIUM|HEMOLYZED||INDIRECT IMMUNOFLUORESCENCE|CKD-EPI FORMULA|Y|Y|N||3|Visit_3|40|1|TREATMENT|2020-06-26|2020-08-10|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|cf10035c-4d44-4512-810b-c267d1c8821b|7|SLTFRNRC|Soluble Transferrin Receptor|HEMATOLOGY|[?]|BISCUIT|[?]|[?]|INDETERMINATE|1|tsp eq|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|DRIED||LEAD CITRATE STAIN|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|6|SCREENING|2020-07-21|2020-07-29|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|cf10035c-4d44-4512-810b-c267d1c8821b|8|LYMPLLY|Plasmacytoid Lymphocytes/Lymphocytes|HEMATOLOGY|[?]|genEq/mL|[?]|[?]|TRACE|1|10^7 CFU/mL|1|1|[?]|ABNORMAL|LAVAGE FLUID|NON-HEMOLYZED||DUCTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|1|TREATMENT|2020-07-21|2020-07-28|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|cf10035c-4d44-4512-810b-c267d1c8821b|9|MONO|Monocytes|HEMATOLOGY|[?]|log10 TCID 50/dose|[?]|[?]|NEGATIVE|1|VOXEL|1|1|[?]|ABNORMAL|BREAST MILK|DRIED|N|HPLC-FL|GMI MMOL/MOL FORMULA|Y||U||5|Visit_5|90|7|TREATMENT|2020-08-15|2020-08-21|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|cf10035c-4d44-4512-810b-c267d1c8821b|10|PROC6|Pro-C6|HEMATOLOGY|[?]|mL/cm3/min|[?]|[?]|INDETERMINATE|1|uOsm|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|LACTESCENT||POLYSOMNOGRAPHY|CKD-EPI FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2020-08-15|2020-08-24|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|1|C130069|Bermuda Grass Pollen IgA|HEMATOLOGY|[?]|TAMPON|[?]|[?]|INDETERMINATE|1|TUBE|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|AUTOLYZED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|ASH FIBROSURE FORMULA|||U||1|Visit_1|10|3|WASHOUT|2020-08-01|2020-10-29|10|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|2|FCTXIIIA|Factor XIII Activity|HEMATOLOGY|[?]|umol|[?]|[?]|BORDERLINE|1|U/g/day|1|1|[?]|LOW|MUCUS|AUTOLYZED||RULER MEASUREMENT METHOD|MDRD FORMULA|||Y||1|Visit_1|10|3|TREATMENT|2020-08-01|2020-08-20|10|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|3|SDMA|Symmetric Dimethylarginine|URINALYSIS|[?]|L/s|[?]|[?]|POSITIVE|1|mL/g/h|1|1|[?]|ABNORMAL|VENOUS PLASMA|CALCIFIED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD FORMULA|Y||NA||2|Visit_2|25|1|TREATMENT|2020-08-16|2020-08-29|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|4|HGBFHGB|Hemoglobin F/Total Hemoglobin|HEMATOLOGY|[?]|Gauss|[?]|[?]|POSITIVE|1|nmol BCE/nmol|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|ICTERIC||SINGLE-SLICE SPIRAL CT|MDRD ENZYMATIC FORMULA|Y||U||2|Visit_2|25|4|FOLLOW-UP|2020-08-16|2020-10-12|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|5|TRIGHDL|Triglycerides/HDL Cholesterol|HEMATOLOGY|[?]|10^9 organisms/mg|[?]|[?]|INDETERMINATE|1|kg/mol|1|1|[?]|NORMAL|HAIR|AGGLUTINATED|N|TRANSMISSION ELECTRON MICROSCOPY|MDRD FORMULA|Y||Y||3|Visit_3|40|2|SCREENING|2020-08-31|2020-10-28|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|6|C130124|Cat Dander Antigen IgE Antibody|URINALYSIS|[?]|/kg|[?]|[?]|POSITIVE|1|ng/mol|1|1|[?]|HIGH|DIALYSIS FLUID|CALCIFIED|N|LIQUID SCINTILLATION COUNTING|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-08-31|2020-10-07|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|7|IGG1|Immunoglobulin G Subclass 1|URINALYSIS|[?]|10^9 CFU/g|[?]|[?]|POSITIVE|1|/HPF|1|1|[?]|HIGH|PERSPIRATION|LACTESCENT||ENZYMATIC COLORIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||4|Visit_4|65|6|SCREENING|2020-09-25|2020-10-06|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|8|C130093|Western Ragweed Pollen IgA|CHEMISTRY|[?]|mL/animal/wk|[?]|[?]|NEGATIVE|1|CIGARETTE|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|CALCIFIED||MICROBIAL BIOCHEMICAL IDENTIFICATION|GMI MMOL/MOL FORMULA|||U||4|Visit_4|65|2|TREATMENT|2020-09-25|2020-10-26|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|9|CLARITY|Clarity|CHEMISTRY|[?]|10^9/L|[?]|[?]|INDETERMINATE|1|mOsm/kg|1|1|[?]|ABNORMAL|CELL PELLET|PARAFFIN-EMBEDDED||SPIROMETRY|CKD-EPI FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2020-10-20|2020-10-22|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|10|BLASTERY|Basophilic Erythroblast|HEMATOLOGY|[?]|mAmp|[?]|[?]|TRACE|1|copies/uL|1|1|[?]|NORMAL|VENOUS CORD BLOOD|UNEXPECTED ODOR||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD FORMULA|Y||U||5|Visit_5|90|6|TREATMENT|2020-10-20|2020-10-24|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|a1e0035a-3328-4966-8664-82e53a44eb59|1|PMYCECE|Proliferating Myeloid Cells/Total Cells|CHEMISTRY|[?]|Enzyme U|[?]|[?]|INDETERMINATE|1|U/mmol|1|1|[?]|LOW|AQUEOUS HUMOR|DRIED||MICROARRAY|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|4|WASHOUT|2020-08-10|2020-10-19|10|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|a1e0035a-3328-4966-8664-82e53a44eb59|2|CSEPIRT|Renal Tubular Epithelial Casts|URINALYSIS|[?]|/MBP|[?]|[?]|TRACE|1|mmol/g|1|1|[?]|LOW|INFRANATANT, SERUM|THAWED||MICRO BROTH DILUTION|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-08-10|2020-08-11|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|a1e0035a-3328-4966-8664-82e53a44eb59|3|HLAIIPRA|HLA Class II Panel Reactive Antibody|URINALYSIS|[?]|mmol2/L2|[?]|[?]|BORDERLINE|1|bel|1|1|[?]|HIGH|SERUM|CLOTTED|N|DYNAMIC LIGHT SCATTERING|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2020-08-25|2020-10-09|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|a1e0035a-3328-4966-8664-82e53a44eb59|4|RBCDIPOP|Dimorphic Erythrocyte Population|URINALYSIS|[?]|CCID 50/dose|[?]|[?]|INVALID|1|STEPS|1|1|[?]|NORMAL|VENOUS CORD BLOOD|CALCIFIED||AGAR PROPORTION|MDRD ENZYMATIC JAPANESE FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-08-25|2020-09-12|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|a1e0035a-3328-4966-8664-82e53a44eb59|5|DHEAS|Dehydroepiandrosterone Sulfate|HEMATOLOGY|||[?]|[?]|POSITIVE|1|sec|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED||MRI|MDRD 5 VARIABLE FORMULA|Y||Y|Y|3|Visit_3|40|5|FOLLOW-UP|2020-09-09|2020-10-08|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|a1e0035a-3328-4966-8664-82e53a44eb59|6|METHPHEN|Methylphenidate|URINALYSIS|[?]|10^6 CFU/mL|[?]|[?]|INDETERMINATE|1|IU/g|1|1|[?]|HIGH|STOOL|THAWED|N|IODINE STAIN|MDRD ENZYMATIC FORMULA|||Y||3|Visit_3|40|4|FOLLOW-UP|2020-09-09|2020-10-24|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|a1e0035a-3328-4966-8664-82e53a44eb59|7|C130085|English Plantain Pollen IgA|HEMATOLOGY|[?]|mg/m2|[?]|[?]|NEGATIVE|1|mN|1|1|[?]|LOW|SEMEN|AUTOLYZED||ANGIOGRAPHY|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|6|WASHOUT|2020-10-04|2020-10-24|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|a1e0035a-3328-4966-8664-82e53a44eb59|8|EDMIGAAB|Endomysial IgA Antibody|CHEMISTRY|[?]|Gy/min|[?]|[?]|INDETERMINATE|1|MBP|1|1|[?]|ABNORMAL|LAVAGE FLUID|CONCENTRATED||POLYSOMNOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|6|TREATMENT|2020-10-04|2020-10-17|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|a1e0035a-3328-4966-8664-82e53a44eb59|9|BILDIRBI|Direct Bilirubin/Bilirubin|URINALYSIS|[?]|VIAL|[?]|[?]|BORDERLINE|1|mmol/day|1|1|[?]|HIGH|RETICULOCYTES|FRESH|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI MMOL/MOL FORMULA|||U||5|Visit_5|90|6|TREATMENT|2020-10-29|2020-10-30|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|a1e0035a-3328-4966-8664-82e53a44eb59|10|HGF|Hepatocyte Growth Factor|HEMATOLOGY|[?]|km/h|[?]|[?]|INDETERMINATE|1|ng/mol|1|1|[?]|NORMAL|VENOUS PLASMA|HEMOLYZED||CISH|COCKCROFT-GAULT FORMULA||Y|NA||5|Visit_5|90|4|WASHOUT|2020-10-29|2020-11-07|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|771377fd-724f-4056-b2ea-84e1adab1f47|1|C130126|Cat Dander Antigen IgA Antibody|HEMATOLOGY|[?]|deg2|[?]|[?]|POSITIVE|1|vg/kg|1|1|[?]|ABNORMAL|DERMAL TISSUE|ICTERIC||MICRO BROTH DILUTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||1|Visit_1|10|6|FOLLOW-UP|2020-11-08|2021-01-26|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|771377fd-724f-4056-b2ea-84e1adab1f47|2|LCHLCM|Lithocholate Compounds|HEMATOLOGY|||[?]|[?]|INVALID|1|Bq/kg|1|1|[?]|HIGH|CELL PELLET|CLOTTED||IMMUNOBLOT|MDRD FORMULA|||NA|Y|1|Visit_1|10|7|TREATMENT|2020-11-08|2021-01-26|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|771377fd-724f-4056-b2ea-84e1adab1f47|3|UROTHCE|Urothelial Cells|URINALYSIS|[?]|yd|[?]|[?]|POSITIVE|1|10^10/L|1|1|[?]|HIGH|INFRANATANT, PLASMA|ROOM TEMPERATURE||FLAME PHOTOMETRY|CKD-EPI CREATININE FORMULA|||U||2|Visit_2|25|3|SCREENING|2020-11-23|2020-12-11|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|771377fd-724f-4056-b2ea-84e1adab1f47|4|MICA|MHC Class I Chain Related Protein A|HEMATOLOGY|[?]|kg/mol|[?]|[?]|TRACE|1|mEq/g|1|1|[?]|HIGH|BLOOD|FRESH||POLYGRAPHY|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-11-23|2021-02-01|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|771377fd-724f-4056-b2ea-84e1adab1f47|5|NPAP|Non-Prostatic Acid Phosphatase|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|IU/kg/h|1|1|[?]|NORMAL|SEMINAL FLUID|CONCENTRATED||SPECT SCAN|NASH FIBROSURE FORMULA|Y||Y|Y|3|Visit_3|40|2|FOLLOW-UP|2020-12-08|2021-01-20|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|771377fd-724f-4056-b2ea-84e1adab1f47|6|SPLA2II|Type II Secretory Phospholipase A2|URINALYSIS|[?]|cmH2O/mL|[?]|[?]|POSITIVE|1|10^6/Ejaculate U|1|1|[?]|LOW|DISCHARGE|AUTOLYZED||LAPAROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||3|Visit_3|40|1|TREATMENT|2020-12-08|2021-01-09|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|771377fd-724f-4056-b2ea-84e1adab1f47|7|CMPK2|Cytidine-Uridine Monophosphate Kinase 2|CHEMISTRY|[?]|PACKAGE|[?]|[?]|BORDERLINE|1|U/g|1|1|[?]|HIGH|PROSTATIC FLUID|AGGLUTINATED||PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|6|FOLLOW-UP|2021-01-02|2021-01-18|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|771377fd-724f-4056-b2ea-84e1adab1f47|8|HIS|Histidine|CHEMISTRY|[?]|Weber|[?]|[?]|INVALID|1|ng/L|1|1|[?]|HIGH|GASTRIC FLUID|UNEXPECTED ODOR||ELECTROPHORESIS|GMI % FORMULA|Y|Y|N||4|Visit_4|65|3|FOLLOW-UP|2021-01-02|2021-01-13|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|771377fd-724f-4056-b2ea-84e1adab1f47|9|INTLK13|Interleukin 13|URINALYSIS|[?]|POUCH|[?]|[?]|INDETERMINATE|1|U|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|AUTOLYZED||LYMPHANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||5|Visit_5|90|2|TREATMENT|2021-01-27|2021-02-03|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|771377fd-724f-4056-b2ea-84e1adab1f47|10|C165908|Animal Mix IgG AB RAST Score|URINALYSIS|[?]|kg|[?]|[?]|POSITIVE|1|deg/s|1|1|[?]|NORMAL|SMEGMA|NON-HEMOLYZED||MECHANICAL CLOT DETECTION|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|1|SCREENING|2021-01-27|2021-02-04|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|1|LCTHSPGM|Lecithin/Sphingomyelin|HEMATOLOGY|[?]|kg/mol|[?]|[?]|INVALID|1|deg/mm|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|LIPEMIC||OPTICAL COHERENCE TOMOGRAPHY|CKD-EPI CREATININE FORMULA|Y|Y|N||1|Visit_1|10|7|TREATMENT|2020-08-23|2020-10-29|10|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|2|PPA|Phenylpropanolamine|URINALYSIS|[?]|umol|[?]|[?]|POSITIVE|1|cP|1|1|[?]|HIGH|SUPERNATANT, SERUM|CONCENTRATED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|COCKCROFT-GAULT FORMULA||Y|NA||1|Visit_1|10|3|FOLLOW-UP|2020-08-23|2020-09-02|10|20|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|3|CACRTP|Calcium Corrected for Total Protein|HEMATOLOGY|[?]|nmol/kg/day|[?]|[?]|NEGATIVE|1|APPLICATION|1|1|[?]|NORMAL|COLOSTRUM|DRIED|N|CLIP SEQUENCING|GMI MMOL/MOL FORMULA|||Y||2|Visit_2|25|3|FOLLOW-UP|2020-09-07|2020-10-17|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|4|ACETAMIN|Acetaminophen|URINALYSIS|[?]|Rad|[?]|[?]|POSITIVE|1|fraction of 1|1|1|[?]|ABNORMAL|NAIL|CONCENTRATED||ENDPOINT DILUTION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|7|TREATMENT|2020-09-07|2020-11-19|25|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|5|PLSMCELY|Mature Plasma Cells/Lymphocytes|URINALYSIS|[?]|umol/kg/min|[?]|[?]|NEGATIVE|1|PHERESIS UNIT|1|1|[?]|NORMAL|MECONIUM|HEMOLYZED||FLUORESCENT IMMUNOASSAY|COCKCROFT-GAULT FORMULA||Y|NA||3|Visit_3|40|7|TREATMENT|2020-09-22|2020-11-10|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|6|MYCEMPOL|Myeloid Maturation Pool|URINALYSIS|||[?]|[?]|NEGATIVE|1|pg/cell|1|1|[?]|LOW|KERATINOCYTE|CLOTTED||IHC|FIBROMETER FORMULA||Y|N|Y|3|Visit_3|40|7|TREATMENT|2020-09-22|2020-10-17|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|7|PAROXET|Paroxetine|CHEMISTRY|||[?]|[?]|POSITIVE|1|mL/m2/h|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|ICTERIC||CELL BASED BIOASSAY|CKD-EPI FORMULA|Y|Y|Y|Y|4|Visit_4|65|6|FOLLOW-UP|2020-10-17|2020-10-20|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|8|SPMAGGR|Sperm Aggregation|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mol/day|1|1|[?]|ABNORMAL|SKIN TISSUE|ICTERIC||ANTIBIOTIC AGAR SCREEN|CKD-EPI CYSTATIN C FORMULA|||Y|Y|4|Visit_4|65|1|TREATMENT|2020-10-17|2020-11-19|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|9|GDF8|Growth Differentiation Factor 8|HEMATOLOGY|||[?]|[?]|POSITIVE|1|/4.0 mL|1|1|[?]|NORMAL|AQUEOUS HUMOR|FROZEN||ELECTRICAL IMPEDANCE MYOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y|Y|5|Visit_5|90|1|WASHOUT|2020-11-11|2020-11-16|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|10|FBNCTFT|Fibronectin, Fetal|HEMATOLOGY|[?]|/200 HPFs|[?]|[?]|NEGATIVE|1|mg|1|1|[?]|LOW|EMOTIONAL TEAR|CALCIFIED||TURBIDIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA||5|Visit_5|90|3|WASHOUT|2020-11-11|2020-11-17|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|3aea0861-8f67-4717-93ce-c1e322f151d9|1|FVAAC|Factor V Activity Actual/Control|URINALYSIS|[?]|mg/g/min|[?]|[?]|TRACE|1|BAR|1|1|[?]|NORMAL|ALVEOLAR AIR|CLOTTED||POLYSOMNOGRAPHY|FIBROTEST FORMULA||Y|NA||1|Visit_1|10|2|TREATMENT|2020-08-14|2020-10-01|10|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|3aea0861-8f67-4717-93ce-c1e322f151d9|2|LTF|Lactoferrin|URINALYSIS|[?]|Gauss|[?]|[?]|TRACE|1|mL/dL|1|1|[?]|HIGH|SWABBED MATERIAL|CALCIFIED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|NASH FIBROSURE FORMULA||Y|N||1|Visit_1|10|4|WASHOUT|2020-08-14|2020-09-07|10|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|3aea0861-8f67-4717-93ce-c1e322f151d9|3|NHMCELE|Nonhematic Cells/Leukocytes|URINALYSIS|[?]|gtt|[?]|[?]|TRACE|1|U.CARR|1|1|[?]|LOW|FLUID|SOLIDIFIED|N|BIOPSY|FIBROSIS 4 FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-08-29|2020-09-08|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|3aea0861-8f67-4717-93ce-c1e322f151d9|4|MYBLAT3|Type III Myeloblasts|CHEMISTRY|[?]|10^6 CFU/mL|[?]|[?]|INVALID|1|MBq|1|1|[?]|ABNORMAL|PUS|FROZEN||OPHTHALMOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||2|Visit_2|25|6|TREATMENT|2020-08-29|2020-09-10|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|3aea0861-8f67-4717-93ce-c1e322f151d9|5|INTLK15|Interleukin 15|CHEMISTRY|[?]|INHALATION|[?]|[?]|BORDERLINE|1|/cmH2O|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|ICTERIC|N|CELLULAR PROLIFERATION ASSAY|CKD-EPI CYSTATIN C FORMULA|Y||NA||3|Visit_3|40|2|TREATMENT|2020-09-13|2020-11-05|40|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|3aea0861-8f67-4717-93ce-c1e322f151d9|6|FRUMCRTP|Fructosamine Corrected for Total Protein|CHEMISTRY|[?]|kDa|[?]|[?]|TRACE|1|GPL U|1|1|[?]|ABNORMAL|PERSPIRATION|CALCIFIED|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROTEST FORMULA|Y||Y||3|Visit_3|40|5|TREATMENT|2020-09-13|2020-10-10|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|3aea0861-8f67-4717-93ce-c1e322f151d9|7|CD22|CD22|CHEMISTRY|[?]|U/cL|[?]|[?]|POSITIVE|1|amol|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|REFRIGERATED|N|CLIP|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-10-08|2020-10-20|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|3aea0861-8f67-4717-93ce-c1e322f151d9|8|C130075|Birch Pollen IgG4|URINALYSIS|[?]|s/h|[?]|[?]|INDETERMINATE|1|uOsm|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|CALCIFIED|N|AURAMINE STAIN|MDRD FORMULA||Y|U||4|Visit_4|65|7|SCREENING|2020-10-08|2020-11-02|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|3aea0861-8f67-4717-93ce-c1e322f151d9|9|TSP1|Thrombospondin 1|CHEMISTRY|||[?]|[?]|NEGATIVE|1|% INHIBITION|1|1|[?]|HIGH|LEUKOCYTE|FRESH||MICRO BROTH DILUTION|ASH FIBROSURE FORMULA|||Y|Y|5|Visit_5|90|1|TREATMENT|2020-11-02|2020-11-10|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|3aea0861-8f67-4717-93ce-c1e322f151d9|10|NAGASECR|N-acetyl-B-D-glucosaminidase/Creatinine|URINALYSIS|[?]|RFU|[?]|[?]|POSITIVE|1|pkat/L|1|1|[?]|ABNORMAL|REFLEX TEAR|CONTAMINATED||TOTAL BODY RADIOGRAPHY|MDRD FORMULA|||N||5|Visit_5|90|7|FOLLOW-UP|2020-11-02|2020-11-07|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|1|PLATIM|Immature Platelets|HEMATOLOGY|[?]|Bq/kg|[?]|[?]|POSITIVE|1|IU/L|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|FROZEN||GRADIENT DIFFUSION|FIBROSIS 4 FORMULA|Y|Y|N||1|Visit_1|10|2|FOLLOW-UP|2020-10-05|2020-12-16|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|2|INSULINR|Insulin Resistance|HEMATOLOGY|[?]|VIAL|[?]|[?]|INVALID|1|10^3 CFU|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|LIPEMIC||AUSCULTATION|CKD-EPI FORMULA|Y||N||1|Visit_1|10|3|SCREENING|2020-10-05|2020-11-17|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|3|FBNCTPL|Fibronectin, Plasma|CHEMISTRY|||[?]|[?]|TRACE|1|HOURS|1|1|[?]|NORMAL|INFRANATANT, SERUM|CONTAMINATED||DARK FIELD MICROSCOPY|MDRD FORMULA|Y|Y|N|Y|2|Visit_2|25|4|TREATMENT|2020-10-20|2020-11-04|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|4|APRIL|A Proliferation-Inducing Ligand|HEMATOLOGY|[?]|fmol/L|[?]|[?]|TRACE|1|V/sec|1|1|[?]|LOW|SEMEN|CONCENTRATED||COLORIMETRY|GMI % FORMULA|Y||U||2|Visit_2|25|5|TREATMENT|2020-10-20|2020-11-08|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|5|PEPSNGA|Pepsinogen A|URINALYSIS|[?]|FFU|[?]|[?]|NEGATIVE|1|tuberculin unit|1|1|[?]|LOW|INFRANATANT, PLASMA|CLOTTED||MAGNETIC RESONANCE ANGIOGRAPHY|FIBROSIS 4 FORMULA|Y||Y||3|Visit_3|40|6|FOLLOW-UP|2020-11-04|2021-01-01|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|6|IL6SR|Soluble Interleukin 6 Receptor|CHEMISTRY|[?]|nsec|[?]|[?]|POSITIVE|1|mEq|1|1|[?]|LOW|LOCHIA|CALCIFIED||DC SHEATH FLOW|MDRD ENZYMATIC FORMULA|||N||3|Visit_3|40|2|SCREENING|2020-11-04|2020-11-21|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|7|CRTRONE|Corticosterone|HEMATOLOGY|||[?]|[?]|TRACE|1|uSiemens|1|1|[?]|NORMAL|VENOUS CORD BLOOD|AGGLUTINATED|N|GEL ELECTROPHORESIS|GMI MMOL/MOL FORMULA|||N|Y|4|Visit_4|65|2|TREATMENT|2020-11-29|2020-12-21|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|8|PMDW|Platelet Mass Distribution Width|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mL/mmHg|1|1|[?]|NORMAL|BONE|HEMOLYZED|N|NEPHELOMETRY|MDRD 6 VARIABLE FORMULA|||U|Y|4|Visit_4|65|5|TREATMENT|2020-11-29|2020-12-21|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|9|C165907|Mold Mix IgG AB RAST Score|URINALYSIS|[?]|mL/kg/min|[?]|[?]|TRACE|1|/2500 WBC|1|1|[?]|HIGH|LYMPH|LACTESCENT||CT SCAN|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|5|WASHOUT|2020-12-24|2020-12-26|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|LB|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|10|FATACFRU|Free Fatty Acid, Unsaturated|URINALYSIS|[?]|scm|[?]|[?]|INVALID|1|umol/min|1|1|[?]|LOW|SEBUM|THAWED|N|APPLANATION TONOMETRY|MDRD FORMULA|||Y||5|Visit_5|90|6|WASHOUT|2020-12-24|2020-12-31|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|LB|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|1|ESELECT|E-Selectin|HEMATOLOGY|[?]|SBE/mL|[?]|[?]|INDETERMINATE|1|mmol/min/kPa/L|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|AGGLUTINATED||TRYPAN BLUE STAIN|ASH FIBROSURE FORMULA||Y|N||1|Visit_1|10|3|WASHOUT|2020-12-30|2021-01-12|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|2|MOCYCE|Monocytoid Cells|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|APPLICATION|1|1|[?]|HIGH|URINE SEDIMENT|CONCENTRATED||INTRAVASCULAR ULTRASOUND|HEPASCORE FORMULA|||Y|Y|1|Visit_1|10|7|WASHOUT|2020-12-30|2021-01-12|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|3|FGFBF|Fibroblast Growth Factor Basic Form|HEMATOLOGY|[?]|mg/m2/h|[?]|[?]|TRACE|1|Ci/g|1|1|[?]|NORMAL|GASTRIC FLUID|LIPEMIC||COMPLEMENT FIXATION|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|2|WASHOUT|2021-01-14|2021-01-18|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|4|FGF21|Fibroblast Growth Factor 21|HEMATOLOGY|[?]|ks|[?]|[?]|NEGATIVE|1|mol/L|1|1|[?]|HIGH|DISCHARGE|FROZEN||WRIGHT-GIEMSA STAIN|FIBROTEST FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2021-01-14|2021-02-10|25|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|5|MONMPHLE|Monocytes and Macrophages/Leukocytes|URINALYSIS|[?]|/10^5|[?]|[?]|NEGATIVE|1|L/day|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|ROOM TEMPERATURE||MRI WITHOUT CONTRAST|COCKCROFT-GAULT FORMULA||Y|U||3|Visit_3|40|5|FOLLOW-UP|2021-01-29|2021-02-21|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|LB|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|6|TRP|Tryptophan|HEMATOLOGY|[?]|%/s|[?]|[?]|TRACE|1|mmol/mol|1|1|[?]|NORMAL|SUPERNATANT, SERUM|CLOTTED||FREEZING POINT DEPRESSION|MDRD 4 VARIABLE FORMULA||Y|U||3|Visit_3|40|7|TREATMENT|2021-01-29|2021-02-21|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|LB|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|7|VITD2425|24,25-Dihydroxyvitamin D|HEMATOLOGY|[?]|U/kg/day|[?]|[?]|TRACE|1|10^12 IU/L|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED||SPIROMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA||4|Visit_4|65|4|TREATMENT|2021-02-23|2021-03-22|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|8|C165893|Wild Rye Pollen IgE AB RAST Score|URINALYSIS|[?]|Torr|[?]|[?]|INVALID|1|nmol BCE/L|1|1|[?]|HIGH|SPERMATOZOON|NON-HEMOLYZED|N|ELECTROCHEMILUMINESCENCE|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|3|TREATMENT|2021-02-23|2021-03-12|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|9|ATP|Adenosine Triphosphate|URINALYSIS|[?]|umol/mol|[?]|[?]|INDETERMINATE|1|ft3|1|1|[?]|HIGH|SEMEN|ROOM TEMPERATURE||PEAK FLOWMETRY|CKD-EPI CYSTATIN C FORMULA|||U||5|Visit_5|90|4|SCREENING|2021-03-20|2021-03-22|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|10|OH8DXG2|8-Hydroxy-2'-Deoxyguanosine|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|EU|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|LACTESCENT||NEXT GENERATION SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|5|Visit_5|90|2|TREATMENT|2021-03-20|2021-03-24|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|39f51bd8-5edc-4434-92d4-7d8b683a6c32|1|NEUTLS|Left Shift Neutrophils|CHEMISTRY|[?]|mEq/dL|[?]|[?]|INVALID|1|ugEq/L|1|1|[?]|LOW|TRANSUDATE|UNEXPECTED ODOR||MICRO BROTH DILUTION|FIBROSIS 4 FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-09-19|2020-10-02|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|39f51bd8-5edc-4434-92d4-7d8b683a6c32|2|RNPAB|Ribonucleoprotein Antibody|URINALYSIS|[?]|1/(s*kPa)|[?]|[?]|TRACE|1|kcal/day|1|1|[?]|ABNORMAL|SPUTUM|THAWED||HPLC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||1|Visit_1|10|5|FOLLOW-UP|2020-09-19|2020-11-04|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|39f51bd8-5edc-4434-92d4-7d8b683a6c32|3|HGBF|Hemoglobin F|URINALYSIS|[?]|MBP|[?]|[?]|BORDERLINE|1|ug/kg/day|1|1|[?]|NORMAL|VENOUS PLASMA|LACTESCENT|N|CONTRAST ENHANCED PET SCAN|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-10-04|2020-11-20|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|39f51bd8-5edc-4434-92d4-7d8b683a6c32|4|RETCRRBC|HCT Corrected Reticulocytes/Erythrocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|U/g|1|1|[?]|NORMAL|INTERSTITIAL FLUID|UNEXPECTED ODOR|N|MOUSE PROTECTION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|2|Visit_2|25|3|WASHOUT|2020-10-04|2020-11-02|25|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|39f51bd8-5edc-4434-92d4-7d8b683a6c32|5|DKK1|Dickkopf WNT Signaling Path Inhibitor 1|HEMATOLOGY|||[?]|[?]|TRACE|1|GPL U|1|1|[?]|NORMAL|BLOOD|LIPEMIC|N|SPECT SCAN|FIBROSIS 4 FORMULA|||N|Y|3|Visit_3|40|3|SCREENING|2020-10-19|2020-12-09|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|LB|39f51bd8-5edc-4434-92d4-7d8b683a6c32|6|EPISCECE|Squamous Epithelial Cells/Total Cells|HEMATOLOGY|||[?]|[?]|TRACE|1|mkat|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED||CLINICAL EVALUATION|GMI % FORMULA|||NA|Y|3|Visit_3|40|6|TREATMENT|2020-10-19|2020-10-29|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|LB|39f51bd8-5edc-4434-92d4-7d8b683a6c32|7|TPRONP|Non-Phosphorylated Tau Protein|HEMATOLOGY|[?]|TAMPON|[?]|[?]|INVALID|1|DAYS|1|1|[?]|NORMAL|SPUTUM|SOLIDIFIED||IMPULSE OSCILLOMETRY|HEPASCORE FORMULA|Y||NA||4|Visit_4|65|5|TREATMENT|2020-11-13|2020-12-05|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|39f51bd8-5edc-4434-92d4-7d8b683a6c32|8|STAT3P|Phosphorylated STAT3|HEMATOLOGY|[?]|foz_br|[?]|[?]|BORDERLINE|1|GPL U/mL|1|1|[?]|LOW|TRANSUDATE|CALCIFIED||CENTRIFUGATION|NASH FIBROSURE FORMULA|||Y||4|Visit_4|65|2|WASHOUT|2020-11-13|2020-12-09|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|39f51bd8-5edc-4434-92d4-7d8b683a6c32|9|BARB|Barbiturates|URINALYSIS|[?]|mV|[?]|[?]|BORDERLINE|1|mEq/dL|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|CALCIFIED||MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2020-12-08|2020-12-14|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|39f51bd8-5edc-4434-92d4-7d8b683a6c32|10|VEGFR2S|Soluble Vasc Endoth Growth Factor Rec2|URINALYSIS|[?]|pg|[?]|[?]|TRACE|1|um|1|1|[?]|NORMAL|AQUEOUS HUMOR|UNEXPECTED ODOR||DYNAMIC CONTRAST ENHANCED MRI|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|6|TREATMENT|2020-12-08|2020-12-09|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|80565a22-8cec-46a2-abd7-91daf0767035|1|PCDW|Platelet Component Distribution Width|URINALYSIS|||[?]|[?]|BORDERLINE|1|ug/g/h|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|UNEXPECTED ODOR|N|DOUBLE IMMUNODIFFUSION|GMI MMOL/MOL FORMULA|||N|Y|1|Visit_1|10|7|SCREENING|2021-01-28|2021-02-01|10|14|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|LB|80565a22-8cec-46a2-abd7-91daf0767035|2|MLR|Mixed Lymphocyte Reaction|HEMATOLOGY|[?]|pmol/g|[?]|[?]|BORDERLINE|1|EVENTS|1|1|[?]|HIGH|VENOUS CORD BLOOD|ROOM TEMPERATURE||QUANTITATIVE ULTRASOUND|FIBROMETER FORMULA|Y|Y|U||1|Visit_1|10|7|TREATMENT|2021-01-28|2021-02-12|10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|LB|80565a22-8cec-46a2-abd7-91daf0767035|3|HDL|HDL Cholesterol|HEMATOLOGY|[?]|ka_u/dL|[?]|[?]|NEGATIVE|1|JDF Unit|1|1|[?]|NORMAL|CAPILLARY BLOOD|AGGLUTINATED||PERFUSION MRI|GMI % FORMULA|||N||2|Visit_2|25|7|FOLLOW-UP|2021-02-12|2021-02-15|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|80565a22-8cec-46a2-abd7-91daf0767035|4|CIC|Circulating Immune Complexes|CHEMISTRY|[?]|ug/day|[?]|[?]|INDETERMINATE|1|U/m2/h|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|LACTESCENT||TURBIDIMETRY|FIBROMETER FORMULA|||U||2|Visit_2|25|5|TREATMENT|2021-02-12|2021-03-12|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|80565a22-8cec-46a2-abd7-91daf0767035|5|CTXIICRT|Type II Collagen C-Telopeptides/Creat|URINALYSIS|[?]|NFIU|[?]|[?]|NEGATIVE|1|fL|1|1|[?]|LOW|SERUM|DRIED||MICRO BROTH DILUTION|COCKCROFT-GAULT FORMULA|||Y||3|Visit_3|40|3|FOLLOW-UP|2021-02-27|2021-04-06|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|80565a22-8cec-46a2-abd7-91daf0767035|6|SMUSCAB|Smooth Muscle Antibody|CHEMISTRY|[?]|PFU/animal|[?]|[?]|POSITIVE|1|mMU/mL|1|1|[?]|HIGH|PLATELET|NON-HEMOLYZED||FLAME PHOTOMETRY|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2021-02-27|2021-03-21|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|80565a22-8cec-46a2-abd7-91daf0767035|7|HGBSHGB|Hemoglobin S/Total Hemoglobin|HEMATOLOGY|[?]|mmHg/sec|[?]|[?]|NEGATIVE|1|min/day|1|1|[?]|ABNORMAL|BLOOD|LACTESCENT|N|MYELOPEROXIDASE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||4|Visit_4|65|4|SCREENING|2021-03-24|2021-04-14|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|80565a22-8cec-46a2-abd7-91daf0767035|8|TRAMADOL|Tramadol|CHEMISTRY|||[?]|[?]|POSITIVE|1|mEq/kg|1|1|[?]|HIGH|EXPIRED AIR|ROOM TEMPERATURE||IMPEDANCE CONDUCTIVITY|NASH FIBROSURE FORMULA|Y||U|Y|4|Visit_4|65|5|WASHOUT|2021-03-24|2021-03-25|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|80565a22-8cec-46a2-abd7-91daf0767035|9|ICAM3|Intercellular Adhesion Molecule 3|URINALYSIS|[?]|mL/s/m2|[?]|[?]|INVALID|1|ug/kg|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|ICTERIC||FLUORESCENT MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||5|Visit_5|90|1|TREATMENT|2021-04-18|2021-04-23|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|80565a22-8cec-46a2-abd7-91daf0767035|10|ASYNP|Alpha Synuclein Protein|URINALYSIS|[?]|kcal/day|[?]|[?]|TRACE|1|Gy/min|1|1|[?]|ABNORMAL|CORD BLOOD|CONTAMINATED||PERCUSSION|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|2|WASHOUT|2021-04-18|2021-04-19|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|585a254e-c36b-44cf-b8a9-335fb98e0fd2|1|C130119|Dairy Mix Antigen IgG Antibody|CHEMISTRY|[?]|ug/m2|[?]|[?]|INVALID|1|mg/L FEU|1|1|[?]|NORMAL|PLATELET RICH PLASMA|GELLED||CONTRAST ENHANCED MRI|MDRD 6 VARIABLE FORMULA|||N||1|Visit_1|10|6|SCREENING|2020-10-19|2021-01-10|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|585a254e-c36b-44cf-b8a9-335fb98e0fd2|2|C165900|Orchard Grass Pollen IgG AB RAST Score|CHEMISTRY|||[?]|[?]|TRACE|1|kcal|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|DRIED||SLIT LAMP PHOTOGRAPHY|MDRD ENZYMATIC FORMULA|||NA|Y|1|Visit_1|10|5|SCREENING|2020-10-19|2020-11-12|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|585a254e-c36b-44cf-b8a9-335fb98e0fd2|3|CARTP|Cocaine Amphetamine-Reg Transcript Prot|CHEMISTRY|||[?]|[?]|POSITIVE|1|%|1|1|[?]|HIGH|MUCUS|CONTAMINATED||FLUORESCENCE ANGIOGRAPHY|CKD-EPI CREATININE FORMULA|||U|Y|2|Visit_2|25|6|SCREENING|2020-11-03|2020-11-27|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|585a254e-c36b-44cf-b8a9-335fb98e0fd2|4|NPY|Neuropeptide Y|URINALYSIS|[?]|fL|[?]|[?]|NEGATIVE|1|CYLINDER|1|1|[?]|HIGH|MENSTRUAL BLOOD|LACTESCENT||ELECTROMYOGRAPHY|FIBROMETER FORMULA|||N||2|Visit_2|25|5|WASHOUT|2020-11-03|2020-11-29|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|585a254e-c36b-44cf-b8a9-335fb98e0fd2|5|UNSPCECE|Unspecified Cells/Total Cells|URINALYSIS|[?]|BE/mL|[?]|[?]|INDETERMINATE|1|MESF|1|1|[?]|LOW|HAIR FOLLICLE|AGGLUTINATED|N|IN VITRO GENE EXPRESSION ASSAY|HEPASCORE FORMULA||Y|Y||3|Visit_3|40|6|FOLLOW-UP|2020-11-18|2020-12-15|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|585a254e-c36b-44cf-b8a9-335fb98e0fd2|6|CEC|Circulating Endothelial Cells|URINALYSIS|[?]|uOsm|[?]|[?]|INDETERMINATE|1|10^7 PFU|1|1|[?]|ABNORMAL|BONE|CONCENTRATED||AGAR DILUTION|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-11-18|2020-12-20|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|585a254e-c36b-44cf-b8a9-335fb98e0fd2|7|FVIIIAAC|Factor VIII Activity Actual/Control|URINALYSIS|||[?]|[?]|TRACE|1|10^12 IU/L|1|1|[?]|LOW|ALVEOLAR AIR|FROZEN||WRIGHT-GIEMSA STAIN|MDRD ENZYMATIC FORMULA|||U|Y|4|Visit_4|65|2|SCREENING|2020-12-13|2020-12-26|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|585a254e-c36b-44cf-b8a9-335fb98e0fd2|8|TRGTCE|Target Cells|CHEMISTRY|[?]|ug/animal|[?]|[?]|BORDERLINE|1|10^6/Ejaculate U|1|1|[?]|HIGH|EXPIRED AIR|FRESH|N|MAMMOGRAPHY|ASH FIBROSURE FORMULA|||NA||4|Visit_4|65|1|WASHOUT|2020-12-13|2020-12-29|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|585a254e-c36b-44cf-b8a9-335fb98e0fd2|9|CABOT|Cabot Rings|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|BAG|1|1|[?]|HIGH|VENOUS BLOOD|PARAFFIN-EMBEDDED|N|MULTI-SLICE SPIRAL CT|HEPASCORE FORMULA|Y||Y|Y|5|Visit_5|90|1|TREATMENT|2021-01-07|2021-01-09|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|585a254e-c36b-44cf-b8a9-335fb98e0fd2|10|CD10|CD10|URINALYSIS|[?]|sec|[?]|[?]|INDETERMINATE|1|ug|1|1|[?]|NORMAL|BILE|LIPEMIC||SURFACE PLASMON RESONANCE|FIBROTEST FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2021-01-07|2021-01-09|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|9ee3632d-4e99-4a46-b0b9-237467d97ca0|1|UREAN|Urea Nitrogen|HEMATOLOGY|[?]|cup eq|[?]|[?]|BORDERLINE|1|nkat/L|1|1|[?]|LOW|SEMEN|UNEXPECTED ODOR|N|MS/MS|MDRD ENZYMATIC FORMULA|Y||NA||1|Visit_1|10|2|WASHOUT|2020-09-09|2020-10-28|10|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|9ee3632d-4e99-4a46-b0b9-237467d97ca0|2|PTHI|Parathyroid Hormone, Intact|CHEMISTRY|[?]|pt_us|[?]|[?]|INVALID|1|10^10/L|1|1|[?]|NORMAL|TISSUE|CLOTTED||LINE PROBE ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA||1|Visit_1|10|5|TREATMENT|2020-09-09|2020-09-29|10|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|9ee3632d-4e99-4a46-b0b9-237467d97ca0|3|FACTX|Factor X|CHEMISTRY|[?]|fg|[?]|[?]|INVALID|1|BLOCKS|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|HEMOLYZED||PHOTOMETRIC CLOT DETECTION|NASH FIBROSURE FORMULA|Y||NA||2|Visit_2|25|2|TREATMENT|2020-09-24|2020-11-18|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|9ee3632d-4e99-4a46-b0b9-237467d97ca0|4|VEGFA|Vascular Endothelial Growth Factor A|HEMATOLOGY|[?]|ppth|[?]|[?]|INDETERMINATE|1|pmol/dL|1|1|[?]|ABNORMAL|SERUM OR PLASMA|ICTERIC|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|3|FOLLOW-UP|2020-09-24|2020-10-16|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|9ee3632d-4e99-4a46-b0b9-237467d97ca0|5|TPROTP|Phosphorylated Tau Protein|CHEMISTRY|[?]|MPL U|[?]|[?]|BORDERLINE|1|mCi/kg|1|1|[?]|HIGH|PLASMA ULTRAFILTRATE|LACTESCENT|N|RAJI CELL RIA|GMI % FORMULA|Y||U||3|Visit_3|40|6|SCREENING|2020-10-09|2020-11-04|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|9ee3632d-4e99-4a46-b0b9-237467d97ca0|6|SEDEXAM|Sediment Examination|CHEMISTRY|[?]|10^3 organisms/mL|[?]|[?]|INDETERMINATE|1|mEq/mmol|1|1|[?]|NORMAL|LEUKOCYTE|FROZEN|N|NON-CONTACT SPECULAR MICROSCOPY|COCKCROFT-GAULT FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-10-09|2020-10-27|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|9ee3632d-4e99-4a46-b0b9-237467d97ca0|7|GSTPIEXR|Pi-GST Excretion Rate|URINALYSIS|||[?]|[?]|NEGATIVE|1|mg/m2/min|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|CONTAMINATED||CARDIAC THERMODILUTION|MDRD 6 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|3|TREATMENT|2020-11-03|2020-11-15|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|9ee3632d-4e99-4a46-b0b9-237467d97ca0|8|FXAAC|Factor X Activity Actual/Control|HEMATOLOGY|[?]|KIT|[?]|[?]|TRACE|1|10^9 CFU/mL|1|1|[?]|HIGH|CEREBROSPINAL FLUID|AUTOLYZED|N|FARR ASSAY|NASH FIBROSURE FORMULA|Y|Y|Y||4|Visit_4|65|6|WASHOUT|2020-11-03|2020-11-19|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|9ee3632d-4e99-4a46-b0b9-237467d97ca0|9|INSLNFR|Insulin, Free|URINALYSIS|[?]|mm/sec|[?]|[?]|INDETERMINATE|1|ug/g/min|1|1|[?]|LOW|BREAST MILK|UNEXPECTED ODOR||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA|||N||5|Visit_5|90|7|FOLLOW-UP|2020-11-28|2020-12-02|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|9ee3632d-4e99-4a46-b0b9-237467d97ca0|10|MCPHNSQE|Macrophages/Non-Squam Epi Cells|URINALYSIS|[?]|kHz|[?]|[?]|NEGATIVE|1|10^6 CFU/g|1|1|[?]|LOW|CAPILLARY PLASMA|PARAFFIN-EMBEDDED||CLOT DETECTION|MDRD FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-11-28|2020-12-04|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|1|FACTX|Factor X|CHEMISTRY|[?]|10^6/hpf|[?]|[?]|NEGATIVE|1|nmol|1|1|[?]|LOW|INFRANATANT, SERUM|HEMOLYZED||TARGETED TRANSCRIPTOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-06-16|2020-08-25|10|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|2|NOHDLHDL|Non-HDL Cholesterol/HDL Cholesterol|CHEMISTRY|[?]|fL|[?]|[?]|NEGATIVE|1|mL/min|1|1|[?]|LOW|DERMAL TISSUE|SOLIDIFIED|N|HILLMEN COLOR CHART|GMI % FORMULA|||N||1|Visit_1|10|5|SCREENING|2020-06-16|2020-09-07|10|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|3|C165906|Weed Mix Pollen IgG AB RAST Score|HEMATOLOGY|[?]|INHALATION|[?]|[?]|BORDERLINE|1|beats/min|1|1|[?]|HIGH|KERATINOCYTE|CLOTTED||BIOIMPEDANCE SPECTROSCOPY|MDRD ENZYMATIC FORMULA||Y|U||2|Visit_2|25|1|WASHOUT|2020-07-01|2020-07-24|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|4|C130081|Orchard Grass Pollen IgA|URINALYSIS|[?]|kUSP|[?]|[?]|BORDERLINE|1|BOWL|1|1|[?]|NORMAL|VENOUS CORD BLOOD|AUTOLYZED||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA||2|Visit_2|25|2|FOLLOW-UP|2020-07-01|2020-07-15|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|5|ILE|Isoleucine|URINALYSIS|[?]|g/m2|[?]|[?]|TRACE|1|nCi|1|1|[?]|ABNORMAL|FLUID|NON-HEMOLYZED||ICC|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|1|SCREENING|2020-07-16|2020-07-29|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|6|UBQN|Ubiquitin Protein|CHEMISTRY|[?]|nm|[?]|[?]|TRACE|1|PHERESIS UNIT|1|1|[?]|LOW|CORD SERUM|CONTAMINATED||REFRACTOMETRY|FIBROSIS 4 FORMULA||Y|U||3|Visit_3|40|2|SCREENING|2020-07-16|2020-07-19|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|7|ACT|Activated Coagulation Time|URINALYSIS|[?]|nkat/g Hb|[?]|[?]|INDETERMINATE|1|ug/cm2|1|1|[?]|LOW|EMESIS|LIPEMIC||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD ENZYMATIC FORMULA|Y||Y||4|Visit_4|65|7|TREATMENT|2020-08-10|2020-09-05|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|8|PCNAG|Proliferating Cell Nuclear Antigen|CHEMISTRY|[?]|min/day|[?]|[?]|POSITIVE|1|10^6 CFU/mL|1|1|[?]|ABNORMAL|LAVAGE FLUID|ICTERIC|N|CALCULATION|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|4|SCREENING|2020-08-10|2020-09-01|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|9|C130126|Cat Dander Antigen IgA Antibody|URINALYSIS|||[?]|[?]|POSITIVE|1|Ci/mL|1|1|[?]|NORMAL|BONE|AUTOLYZED||MOUSE PROTECTION ASSAY|HEPASCORE FORMULA||Y|N|Y|5|Visit_5|90|7|TREATMENT|2020-09-04|2020-09-05|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|10|SHBG|Sex Hormone Binding Globulin|URINALYSIS|||[?]|[?]|TRACE|1|amol|1|1|[?]|NORMAL|SUPERNATANT, SERUM|THAWED||MICROBIAL CULTURE|GMI MMOL/MOL FORMULA|||Y|Y|5|Visit_5|90|2|WASHOUT|2020-09-04|2020-09-07|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|34b2090b-13ac-4fb2-8d87-eca2839a62f2|1|IGFBP2|Insulin-Like Growth Factor Binding Prot2|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|10^6/hpf|1|1|[?]|LOW|SUPERNATANT, SERUM|ROOM TEMPERATURE||ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD ENZYMATIC FORMULA|Y||Y|Y|1|Visit_1|10|4|SCREENING|2020-06-07|2020-07-18|10|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|34b2090b-13ac-4fb2-8d87-eca2839a62f2|2|PHOS|Phosphate|URINALYSIS|[?]|cmH2O*s/mL|[?]|[?]|BORDERLINE|1|kg/m2|1|1|[?]|NORMAL|PLATELET|ICTERIC||DNA MICROARRAY|GMI % FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-06-07|2020-07-14|10|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|34b2090b-13ac-4fb2-8d87-eca2839a62f2|3|PGE2|Prostaglandin E2|CHEMISTRY|[?]|umol/mg/min|[?]|[?]|TRACE|1|CFU/mL|1|1|[?]|LOW|TUMOR TISSUE|AGGLUTINATED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 6 VARIABLE FORMULA|Y|Y|Y||2|Visit_2|25|7|WASHOUT|2020-06-22|2020-08-28|25|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|34b2090b-13ac-4fb2-8d87-eca2839a62f2|4|GLBCREAT|Globulin/Creatinine|HEMATOLOGY|[?]|min*mg/mL|[?]|[?]|POSITIVE|1|ug/mol|1|1|[?]|HIGH|ISOLATE|UNEXPECTED ODOR||IMMUNOCHEMILUMINOMETRIC ASSAY|FIBROMETER FORMULA|Y||U||2|Visit_2|25|5|TREATMENT|2020-06-22|2020-08-19|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|34b2090b-13ac-4fb2-8d87-eca2839a62f2|5|KETONES|Ketones|HEMATOLOGY|[?]|PNU/mL|[?]|[?]|TRACE|1|IU/day|1|1|[?]|NORMAL|SEMEN|ICTERIC||FUNCTIONAL MRI|FIBROMETER FORMULA||Y|N||3|Visit_3|40|4|WASHOUT|2020-07-07|2020-08-01|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|34b2090b-13ac-4fb2-8d87-eca2839a62f2|6|PPTDCALB|Phosphatidylcholine/Albumin|URINALYSIS|[?]|PLUG|[?]|[?]|BORDERLINE|1|ug/m2/h|1|1|[?]|NORMAL|LUNG SURFACTANT|NON-HEMOLYZED||COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD ENZYMATIC FORMULA|Y||NA||3|Visit_3|40|2|SCREENING|2020-07-07|2020-07-31|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|34b2090b-13ac-4fb2-8d87-eca2839a62f2|7|PO2ADJT|Partial Pressure Oxygen Adj for Temp|HEMATOLOGY|[?]|SQU/mL|[?]|[?]|NEGATIVE|1|U/g|1|1|[?]|HIGH|VENOUS PLASMA|FROZEN||CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI FORMULA|||Y||4|Visit_4|65|4|SCREENING|2020-08-01|2020-09-04|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|34b2090b-13ac-4fb2-8d87-eca2839a62f2|8|AMYLOIDB|Amyloid, Beta|URINALYSIS|[?]|mg/min|[?]|[?]|BORDERLINE|1|mL/breath|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED||ACID FAST STAIN|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|6|TREATMENT|2020-08-01|2020-08-09|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|34b2090b-13ac-4fb2-8d87-eca2839a62f2|9|RBCDYRBC|Dysmorphic Erythrocytes/Erythrocytes|HEMATOLOGY|||[?]|[?]|INVALID|1|mL/mmHg|1|1|[?]|HIGH|ISOLATE|CONTAMINATED||RADIATION DOSIMETRY|FIBROSIS 4 FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2020-08-26|2020-09-04|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|34b2090b-13ac-4fb2-8d87-eca2839a62f2|10|ROUNDCE|Round Cells|CHEMISTRY|[?]|fg|[?]|[?]|TRACE|1|nmol/kg/day|1|1|[?]|LOW|CAPILLARY PLASMA|REFRIGERATED||ELECTROCHEMILUMINESCENCE|NASH FIBROSURE FORMULA|||Y||5|Visit_5|90|6|FOLLOW-UP|2020-08-26|2020-08-28|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|bfc19b4b-51bb-4056-9195-8bd2db53a497|1|FUNGI|Fungi|HEMATOLOGY|[?]|m/sec|[?]|[?]|TRACE|1|Ci/g|1|1|[?]|NORMAL|LAVAGE FLUID|CLOTTED||PH METER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA|Y||U||1|Visit_1|10|6|TREATMENT|2020-07-26|2020-09-01|10|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|bfc19b4b-51bb-4056-9195-8bd2db53a497|2|LYMLG|Large Lymphocytes|URINALYSIS|[?]|mg/min|[?]|[?]|TRACE|1|mL/s/m2|1|1|[?]|HIGH|PROSTATIC FLUID|CONTAMINATED||REFLECTANCE SPECTROSCOPY|COCKCROFT-GAULT FORMULA||Y|Y||1|Visit_1|10|2|WASHOUT|2020-07-26|2020-10-07|10|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|bfc19b4b-51bb-4056-9195-8bd2db53a497|3|HLAIIPRA|HLA Class II Panel Reactive Antibody|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Newton|1|1|[?]|LOW|KERATINOCYTE|REFRIGERATED|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|CKD-EPI FORMULA|||U|Y|2|Visit_2|25|6|SCREENING|2020-08-10|2020-09-13|25|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|bfc19b4b-51bb-4056-9195-8bd2db53a497|4|EOSPSD|Pseudo-Eosinophils|CHEMISTRY|[?]|10^6/Ejaculate U|[?]|[?]|INDETERMINATE|1|gpELISA unit/mL|1|1|[?]|ABNORMAL|SEMEN|THAWED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD ENZYMATIC FORMULA|Y||NA||2|Visit_2|25|4|SCREENING|2020-08-10|2020-09-15|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|bfc19b4b-51bb-4056-9195-8bd2db53a497|5|TXB2_D11|11-Dehydro-Thromboxane B2|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mol/L|1|1|[?]|LOW|ENDOTRACHEAL FLUID|FRESH||POTENTIOMETRY|MDRD 6 VARIABLE FORMULA||Y|N|Y|3|Visit_3|40|5|FOLLOW-UP|2020-08-25|2020-09-09|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|bfc19b4b-51bb-4056-9195-8bd2db53a497|6|PTA|Prothrombin Activity|URINALYSIS|[?]|ag|[?]|[?]|INVALID|1|kcal/day|1|1|[?]|NORMAL|SOFT TISSUE|AUTOLYZED|N|CT SCAN|NASH FIBROSURE FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-08-25|2020-08-30|40|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|bfc19b4b-51bb-4056-9195-8bd2db53a497|7|GAD2|Glutamic Acid Decarboxylase 2|CHEMISTRY|[?]|ug/kg/day|[?]|[?]|TRACE|1|TRACE|1|1|[?]|LOW|SPUTUM|PARAFFIN-EMBEDDED|N|POLYSOMNOGRAPHY|HEPASCORE FORMULA|||NA||4|Visit_4|65|7|WASHOUT|2020-09-19|2020-09-30|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|LB|bfc19b4b-51bb-4056-9195-8bd2db53a497|8|ALDOLASE|Aldolase|URINALYSIS|[?]|g/cage/day|[?]|[?]|INDETERMINATE|1|10^3 CFU/mL|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|GELLED||CYSTOSCOPY|NASH FIBROSURE FORMULA||Y|N||4|Visit_4|65|4|WASHOUT|2020-09-19|2020-09-22|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|LB|bfc19b4b-51bb-4056-9195-8bd2db53a497|9|KLHIGMAB|Keyhole Limpet Hemocyanin IgM Antibody|CHEMISTRY|[?]|/mm2|[?]|[?]|INDETERMINATE|1|U/g/min|1|1|[?]|LOW|PLATELET POOR PLASMA|THAWED|N|HPLC-FL|MDRD 5 VARIABLE FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-10-14|2020-10-20|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|bfc19b4b-51bb-4056-9195-8bd2db53a497|10|HIST1AB|Histone 1 Antibody|URINALYSIS|[?]|/LPF|[?]|[?]|TRACE|1|10^3 organisms/mL|1|1|[?]|ABNORMAL|CORD BLOOD|UNEXPECTED ODOR||ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD 6 VARIABLE FORMULA|Y||NA||5|Visit_5|90|3|SCREENING|2020-10-14|2020-10-17|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|1|FGF21|Fibroblast Growth Factor 21|HEMATOLOGY|||[?]|[?]|INVALID|1|PRESSOR UNITS|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED||ULTRASOUND|MDRD 4 VARIABLE FORMULA|||U|Y|1|Visit_1|10|6|SCREENING|2020-09-21|2020-11-28|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|2|CD4LY|CD4/Lymphocytes|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|nmol BCE/nmol|1|1|[?]|NORMAL|PLATELET POOR PLASMA|DRIED|N|IHC|MDRD 4 VARIABLE FORMULA|Y||NA|Y|1|Visit_1|10|2|FOLLOW-UP|2020-09-21|2020-11-01|10|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|3|C130135|D. pteronyssinus Antigen IgG Antibody|URINALYSIS|[?]|SUPPOSITORY|[?]|[?]|INVALID|1|pkat|1|1|[?]|NORMAL|BASAL TEAR|GELLED|N|ELISPOT|MDRD 5 VARIABLE FORMULA|Y||N||2|Visit_2|25|6|TREATMENT|2020-10-06|2020-10-31|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|4|GSTALCRT|Glutathione S-Transferase, Alpha/Creat|HEMATOLOGY|[?]|JDF Unit|[?]|[?]|TRACE|1|log10 copies/mL|1|1|[?]|NORMAL|GASTRIC FLUID|THAWED||LC-FL|HEPASCORE FORMULA|Y||NA||2|Visit_2|25|6|TREATMENT|2020-10-06|2020-11-20|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|5|RNPAB|Ribonucleoprotein Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|RING|1|1|[?]|LOW|PERSPIRATION|SOLIDIFIED||DIGITAL PCR ARRAY|CKD-EPI CREATININE FORMULA|||Y|Y|3|Visit_3|40|1|TREATMENT|2020-10-21|2020-12-07|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|6|PIVKAII|Protein Induced by Vitamin K Absence-II|HEMATOLOGY|[?]|HOURS|[?]|[?]|INVALID|1|fraction of 1|1|1|[?]|ABNORMAL|BONE MARROW|CLOTTED|N|TEMPLATE INCISION METHOD|COCKCROFT-GAULT FORMULA||Y|Y||3|Visit_3|40|4|SCREENING|2020-10-21|2020-10-22|40|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|7|LLCFR|Lambda Light Chain, Free|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^6 DNA copies/mL|1|1|[?]|ABNORMAL|EXPIRED AIR|GELLED||ENDPOINT DILUTION ASSAY|GMI MMOL/MOL FORMULA||Y|U|Y|4|Visit_4|65|7|TREATMENT|2020-11-15|2020-11-29|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|8|T4FR|Thyroxine, Free|URINALYSIS|[?]|10^7 TCID 50/dose|[?]|[?]|NEGATIVE|1|10^3/L|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|HEMOLYZED||LC-FL|FIBROSIS 4 FORMULA||Y|U||4|Visit_4|65|2|TREATMENT|2020-11-15|2020-12-11|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|9|HGBTET|Hemoglobin Tetramer|URINALYSIS|[?]|IU/mL|[?]|[?]|POSITIVE|1|Watt|1|1|[?]|LOW|EPIDERMAL TISSUE|PARAFFIN-EMBEDDED||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD FORMULA|||NA||5|Visit_5|90|1|FOLLOW-UP|2020-12-10|2020-12-18|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|10|EPHD|Ephedrine|HEMATOLOGY|[?]|10^5/L|[?]|[?]|INVALID|1|MET*h|1|1|[?]|ABNORMAL|SMEGMA|NON-HEMOLYZED|N|IODINE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|3|SCREENING|2020-12-10|2020-12-19|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|64a70103-14bf-42f4-808b-fbdecec8bd4f|1|IOTCLR|Iothalamate Clearance|HEMATOLOGY|[?]|Farad|[?]|[?]|POSITIVE|1|tuberculin unit/mL|1|1|[?]|LOW|LOCHIA|CONCENTRATED||PALPATION|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||1|Visit_1|10|3|WASHOUT|2020-09-09|2020-11-11|10|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|64a70103-14bf-42f4-808b-fbdecec8bd4f|2|VITB7|Vitamin B7|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|dpm/0.5 mL|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|FROZEN||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|CKD-EPI CYSTATIN C FORMULA|||Y|Y|1|Visit_1|10|7|TREATMENT|2020-09-09|2020-11-20|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|64a70103-14bf-42f4-808b-fbdecec8bd4f|3|HASIGEAB|Human Anti-Sheep IgE Antibody|URINALYSIS|[?]|g/g/day|[?]|[?]|POSITIVE|1|mmHg/sec|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|FROZEN||PET/MRI SCAN|COCKCROFT-GAULT FORMULA||Y|N||2|Visit_2|25|7|TREATMENT|2020-09-24|2020-12-05|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|64a70103-14bf-42f4-808b-fbdecec8bd4f|4|HLAAMSC|HLA-A Mismatch Count|HEMATOLOGY|[?]|log10 TCID 50/uL|[?]|[?]|INDETERMINATE|1|deg2|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|ICTERIC||CYSTOSCOPY|CKD-EPI CYSTATIN C FORMULA|||U||2|Visit_2|25|5|TREATMENT|2020-09-24|2020-10-01|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|64a70103-14bf-42f4-808b-fbdecec8bd4f|5|C165891|Western Ragweed Pollen IgE AB RAST Score|CHEMISTRY|[?]|anti-Xa IU/mL|[?]|[?]|INVALID|1|/LSQN|1|1|[?]|LOW|RETICULOCYTES|REFRIGERATED||IMMUNOFLUORESCENT STAIN|MDRD 6 VARIABLE FORMULA||Y|N||3|Visit_3|40|2|TREATMENT|2020-10-09|2020-11-08|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|64a70103-14bf-42f4-808b-fbdecec8bd4f|6|NEUTSGB|Neutrophils, Segmented + Band Form|URINALYSIS|[?]|Henry|[?]|[?]|INDETERMINATE|1|uU/L|1|1|[?]|HIGH|GASTRIC FLUID|CALCIFIED|N|GC/FID|MDRD 4 VARIABLE FORMULA|||Y||3|Visit_3|40|1|SCREENING|2020-10-09|2020-11-17|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|64a70103-14bf-42f4-808b-fbdecec8bd4f|7|LDH4|LDH Isoenzyme 4|URINALYSIS|||[?]|[?]|BORDERLINE|1|/2000 RBC|1|1|[?]|LOW|SKIN TISSUE|NON-HEMOLYZED||CHROMATOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||U|Y|4|Visit_4|65|4|SCREENING|2020-11-03|2020-11-16|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|64a70103-14bf-42f4-808b-fbdecec8bd4f|8|TRYPTASE|Tryptase|HEMATOLOGY|[?]|Hounsfield Unit|[?]|[?]|INDETERMINATE|1|ppb|1|1|[?]|NORMAL|ISOLATE|UNEXPECTED ODOR||LINE PROBE ASSAY|MDRD 6 VARIABLE FORMULA|||N||4|Visit_4|65|2|SCREENING|2020-11-03|2020-11-29|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|64a70103-14bf-42f4-808b-fbdecec8bd4f|9|GLOBA|Alpha Globulin|HEMATOLOGY|[?]|/day|[?]|[?]|BORDERLINE|1|U/dL|1|1|[?]|LOW|CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED||SCANNING ELECTRON MICROSCOPY|MDRD 6 VARIABLE FORMULA||Y|NA||5|Visit_5|90|1|WASHOUT|2020-11-28|2020-12-07|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|64a70103-14bf-42f4-808b-fbdecec8bd4f|10|CGADJMW|Choriogonadotropin Adj for Maternal Wt|URINALYSIS|||[?]|[?]|TRACE|1|/h|1|1|[?]|LOW|BASAL TEAR|CALCIFIED|N|IODINE STAIN|CKD-EPI FORMULA|||U|Y|5|Visit_5|90|3|TREATMENT|2020-11-28|2020-11-29|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|00f3949b-b14a-47c5-942c-2ab71e03e40f|1|TAT|Thrombin/Antithrombin|URINALYSIS|[?]|10^3 organisms/mL|[?]|[?]|POSITIVE|1|s^-1(%O2)^-1|1|1|[?]|HIGH|SEMEN|CLOTTED||SCANNING ELECTRON MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|7|FOLLOW-UP|2021-01-19|2021-03-02|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|00f3949b-b14a-47c5-942c-2ab71e03e40f|2|CD11A|CD11A|HEMATOLOGY|||[?]|[?]|TRACE|1|PA|1|1|[?]|ABNORMAL|SEBUM|PARAFFIN-EMBEDDED||HEMATOXYLIN AND EOSIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA|Y|1|Visit_1|10|4|TREATMENT|2021-01-19|2021-03-18|10|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|00f3949b-b14a-47c5-942c-2ab71e03e40f|3|YEASTBUD|Yeast Budding|CHEMISTRY|[?]|pt_br|[?]|[?]|POSITIVE|1|mgEq|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|GELLED||THERMAL IONIZATION MASS SPECTROMETRY|FIBROTEST FORMULA|Y||Y||2|Visit_2|25|2|FOLLOW-UP|2021-02-03|2021-03-16|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|00f3949b-b14a-47c5-942c-2ab71e03e40f|4|INTLK2|Interleukin 2|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ug/L DDU|1|1|[?]|HIGH|EPITHELIAL CELL|PARAFFIN-EMBEDDED|N|ENDPOINT DILUTION ASSAY|MDRD FORMULA|||Y|Y|2|Visit_2|25|6|TREATMENT|2021-02-03|2021-02-07|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|00f3949b-b14a-47c5-942c-2ab71e03e40f|5|COCBNZEC|Cocaine Benzoylecgonine Ecgonine|CHEMISTRY|[?]|/200 HPFs|[?]|[?]|BORDERLINE|1|/2500 WBC|1|1|[?]|HIGH|PLEURAL TISSUE|THAWED||SLIT LAMP PHOTOGRAPHY|FIBROTEST FORMULA|Y||N||3|Visit_3|40|1|TREATMENT|2021-02-18|2021-02-25|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|LB|00f3949b-b14a-47c5-942c-2ab71e03e40f|6|COCBNZEC|Cocaine Benzoylecgonine Ecgonine|HEMATOLOGY|[?]|mV2/Hz|[?]|[?]|INDETERMINATE|1|mEq/uL|1|1|[?]|HIGH|CAPILLARY PLASMA|SOLIDIFIED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2021-02-18|2021-04-02|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|LB|00f3949b-b14a-47c5-942c-2ab71e03e40f|7|IL1EXR|Interleukin 1 Excretion Rate|HEMATOLOGY|[?]|g/mol|[?]|[?]|INVALID|1|mm/2h|1|1|[?]|NORMAL|PUS|FROZEN|N|HEMAGGLUTINATION ASSAY|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|5|TREATMENT|2021-03-15|2021-04-05|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|LB|00f3949b-b14a-47c5-942c-2ab71e03e40f|8|HGBTET|Hemoglobin Tetramer|HEMATOLOGY|[?]|mg/L|[?]|[?]|NEGATIVE|1|CARTRIDGE|1|1|[?]|LOW|ADIPOSE TISSUE|CALCIFIED||HIGH RESOLUTION CT|MDRD 5 VARIABLE FORMULA|||N||4|Visit_4|65|7|TREATMENT|2021-03-15|2021-04-01|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|LB|00f3949b-b14a-47c5-942c-2ab71e03e40f|9|BILEAC|Bile Acid|URINALYSIS|[?]|scm|[?]|[?]|BORDERLINE|1|g/g/day|1|1|[?]|NORMAL|SEBUM|CLOTTED||ULTRASOUND|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2021-04-09|2021-04-17|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|00f3949b-b14a-47c5-942c-2ab71e03e40f|10|ESTRIOL|Estriol|HEMATOLOGY|[?]|L/h/m2|[?]|[?]|TRACE|1|EIA unit|1|1|[?]|ABNORMAL|DIALYSIS FLUID|AUTOLYZED|N|FLOCCULATION, CHARCOAL ENHANCED|MDRD 4 VARIABLE FORMULA|Y||Y||5|Visit_5|90|4|SCREENING|2021-04-09|2021-04-18|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|1|C130141|German Cockroach Antigen IgA Antibody|URINALYSIS|[?]|10^4/L|[?]|[?]|INDETERMINATE|1|TRANSDUCING UNIT/mL|1|1|[?]|HIGH|SPERMATOZOON|GELLED||MASS SPECTROMETRY|MDRD 5 VARIABLE FORMULA|||NA||1|Visit_1|10|3|FOLLOW-UP|2020-12-27|2021-01-02|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|LB|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|2|C130074|Birch Pollen IgG|CHEMISTRY|[?]|CAN|[?]|[?]|POSITIVE|1|mL/sec/1.73m2|1|1|[?]|HIGH|ARTERIAL BLOOD|CLOTTED|N|PULMONARY ANGIOGRAPHY|NASH FIBROSURE FORMULA||Y|NA||1|Visit_1|10|1|TREATMENT|2020-12-27|2021-03-10|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|LB|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|3|CLEPNSQE|Columnar Epi Cells/Non-Squam Epi Cells|URINALYSIS|||[?]|[?]|POSITIVE|1|Antibody Unit|1|1|[?]|HIGH|ERYTHROCYTES|SOLIDIFIED||POPULATION SEQUENCING|NASH FIBROSURE FORMULA||Y|U|Y|2|Visit_2|25|4|TREATMENT|2021-01-11|2021-02-02|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|4|IAA5OHCR|5-Hydroxyindoleacetic Acid/Creatinine|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mEq/kg|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|CALCIFIED|N|IMMUNOASSAY|CKD-EPI FORMULA|||N|Y|2|Visit_2|25|3|SCREENING|2021-01-11|2021-02-28|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|5|V25HD3|25-Hydroxyvitamin D3|CHEMISTRY|||[?]|[?]|BORDERLINE|1|V|1|1|[?]|LOW|PROSTATIC FLUID|AGGLUTINATED||MANUAL CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|3|Visit_3|40|1|WASHOUT|2021-01-26|2021-03-17|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|6|HIST1AB|Histone 1 Antibody|HEMATOLOGY|[?]|ug/dose|[?]|[?]|INDETERMINATE|1|pmol|1|1|[?]|NORMAL|MENSTRUAL BLOOD|REFRIGERATED||ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2021-01-26|2021-02-16|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|7|TNF5S|Soluble TNF Superfamily Member 5|URINALYSIS|[?]|log10 IU/mL|[?]|[?]|POSITIVE|1|/100 HPFs|1|1|[?]|LOW|TRANSUDATE|CONCENTRATED|N|MICROBIAL CULTURE, SOLID|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|1|TREATMENT|2021-02-20|2021-03-15|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|8|PRCTC|Prostate Circulating Tumor Cells|URINALYSIS|[?]|ngEq/L|[?]|[?]|INDETERMINATE|1|IU/kg|1|1|[?]|NORMAL|SALIVA|ICTERIC||CALIPER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2021-02-20|2021-03-01|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|9|GRANIMLE|Immature Granulocytes/Leukocytes|CHEMISTRY|[?]|fmol/g|[?]|[?]|TRACE|1|DIOPTER|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|ICTERIC|N|HEMATOXYLIN AND EOSIN STAIN|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|4|TREATMENT|2021-03-17|2021-03-26|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|10|C130130|Dog Dander Antigen IgA Antibody|HEMATOLOGY|[?]|mL/kg/day|[?]|[?]|NEGATIVE|1|ELISA unit/dose|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|UNEXPECTED ODOR||PET/CT SCAN|MDRD FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2021-03-17|2021-03-25|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|1|EPINEXR|Epinephrine Excretion Rate|CHEMISTRY|[?]|cg|[?]|[?]|INVALID|1|mg/mL/min|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|AUTOLYZED|N|PHASE CONTRAST MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y||1|Visit_1|10|2|TREATMENT|2020-07-19|2020-08-09|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|2|RETICH|Ret. Corpuscular Hemoglobin Content|HEMATOLOGY|[?]|mL/mmHg|[?]|[?]|NEGATIVE|1|U/g/h|1|1|[?]|LOW|HAIR|UNEXPECTED ODOR||SICKLE CELL SOLUBILITY TEST|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||1|Visit_1|10|1|WASHOUT|2020-07-19|2020-07-28|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|3|ABO|ABO Blood Group|HEMATOLOGY|[?]|mEq/ug|[?]|[?]|INVALID|1|dmol|1|1|[?]|LOW|DIALYSIS FLUID|CLOTTED||ZIEHL NEELSEN ACID FAST STAIN|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|7|WASHOUT|2020-08-03|2020-09-21|25|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|4|PCO2|Partial Pressure Carbon Dioxide|URINALYSIS|[?]|mU/L|[?]|[?]|BORDERLINE|1|BP|1|1|[?]|HIGH|DERMAL TISSUE|UNEXPECTED ODOR|N|PANENDOSCOPY|CKD-EPI CREATININE FORMULA|Y||U||2|Visit_2|25|1|TREATMENT|2020-08-03|2020-08-24|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|5|COQ10|Ubiquinone 10|URINALYSIS|[?]|pg|[?]|[?]|POSITIVE|1|Rad|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|AGGLUTINATED||OSCILLOMETRY|NASH FIBROSURE FORMULA||Y|NA||3|Visit_3|40|5|TREATMENT|2020-08-18|2020-08-29|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|6|PLSIMCCE|Immature Plasma Cells/Total Cells|CHEMISTRY|[?]|FFU|[?]|[?]|BORDERLINE|1|ELISA unit/dose|1|1|[?]|NORMAL|BREAST MILK|THAWED||ALCIAN BLUE STAIN|CKD-EPI FORMULA|||U||3|Visit_3|40|5|FOLLOW-UP|2020-08-18|2020-09-13|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|7|PTAC|Prothrombin Time Actual/Control|URINALYSIS|[?]|ka_u/dL|[?]|[?]|INDETERMINATE|1|10^6 copies/mL|1|1|[?]|LOW|REFLEX TEAR|HEMOLYZED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|FIBROTEST FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-09-12|2020-10-09|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|8|PLSPCE|Precursor Plasma Cells|URINALYSIS|[?]|umol/L|[?]|[?]|BORDERLINE|1|ug/cm2|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|GELLED|N|DIGITAL PCR ARRAY|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|2|SCREENING|2020-09-12|2020-09-19|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|9|TNFSR|Soluble Tumor Necrosis Factor Receptor|CHEMISTRY|[?]|L/h|[?]|[?]|INDETERMINATE|1|DNA copies/ug|1|1|[?]|LOW|SPERMATOZOON|THAWED|N|WHOLE EXOME SEQUENCING|MDRD 6 VARIABLE FORMULA|Y||N||5|Visit_5|90|1|TREATMENT|2020-10-07|2020-10-16|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|10|HBA1CHGB|Hemoglobin A1C/Hemoglobin|CHEMISTRY|||[?]|[?]|INVALID|1|km|1|1|[?]|ABNORMAL|TUMOR TISSUE|LIPEMIC|N|OSCILLOMETRY|CKD-EPI CYSTATIN C FORMULA|||Y|Y|5|Visit_5|90|6|TREATMENT|2020-10-07|2020-10-10|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|44ca1fe6-76d2-4a94-9854-1ddbde638803|1|EPIROCE|Round Epithelial Cells|URINALYSIS|[?]|L/h/m2|[?]|[?]|BORDERLINE|1|mL/animal/day|1|1|[?]|HIGH|ARTERIAL BLOOD|ICTERIC|N|CLIP SEQUENCING|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|6|SCREENING|2020-07-19|2020-09-15|10|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|44ca1fe6-76d2-4a94-9854-1ddbde638803|2|ANAIGGAB|Antinuclear IgG Antibody|HEMATOLOGY|[?]|F|[?]|[?]|BORDERLINE|1|mL/g/day|1|1|[?]|ABNORMAL|SPUTUM|REFRIGERATED||IN VITRO GENE EXPRESSION ASSAY|NASH FIBROSURE FORMULA|Y||U||1|Visit_1|10|7|TREATMENT|2020-07-19|2020-10-03|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|44ca1fe6-76d2-4a94-9854-1ddbde638803|3|POIKRBC|Poikilocytes/Erythrocytes|URINALYSIS|[?]|g/cage|[?]|[?]|TRACE|1|mEq/mmol|1|1|[?]|NORMAL|PUS|CONTAMINATED||POLYGRAPHY|FIBROSIS 4 FORMULA||Y|N||2|Visit_2|25|1|TREATMENT|2020-08-03|2020-09-11|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|44ca1fe6-76d2-4a94-9854-1ddbde638803|4|INTLK3|Interleukin 3|CHEMISTRY|[?]|deg2|[?]|[?]|TRACE|1|TRACE|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|AUTOLYZED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|7|TREATMENT|2020-08-03|2020-10-01|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|44ca1fe6-76d2-4a94-9854-1ddbde638803|5|NGF|Nerve Growth Factor|URINALYSIS|[?]|10^6 organisms/mL|[?]|[?]|TRACE|1|Farad|1|1|[?]|LOW|VENOUS BLOOD|DRIED||DC SHEATH FLOW|MDRD FORMULA|||N||3|Visit_3|40|7|FOLLOW-UP|2020-08-18|2020-10-02|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|44ca1fe6-76d2-4a94-9854-1ddbde638803|6|CYTYRO|Tyrosine Crystals|URINALYSIS|[?]|fL|[?]|[?]|BORDERLINE|1|yd|1|1|[?]|ABNORMAL|TUMOR TISSUE|CLOTTED||ANGIOGRAPHY|NASH FIBROSURE FORMULA|||NA||3|Visit_3|40|2|SCREENING|2020-08-18|2020-08-23|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|44ca1fe6-76d2-4a94-9854-1ddbde638803|7|PLATEST|Platelets, Estimated|HEMATOLOGY|[?]|QUANTITY SUFFICIENT|[?]|[?]|TRACE|1|DDU|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|THAWED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|CKD-EPI CYSTATIN C FORMULA|Y||NA||4|Visit_4|65|5|FOLLOW-UP|2020-09-12|2020-10-06|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|44ca1fe6-76d2-4a94-9854-1ddbde638803|8|CKMMCK|Creatine Kinase MM/Total Creatine Kinase|URINALYSIS|[?]|/cmH2O|[?]|[?]|POSITIVE|1|mL/g/min|1|1|[?]|LOW|CELL PELLET|UNEXPECTED ODOR||RADIOGRAPHY|CKD-EPI FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2020-09-12|2020-10-07|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|44ca1fe6-76d2-4a94-9854-1ddbde638803|9|PLATAGGR|Platelet Aggregation|CHEMISTRY|[?]|uCi/L|[?]|[?]|NEGATIVE|1|deg2|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|AUTOLYZED||RAJI CELL EIA|CKD-EPI FORMULA|||Y||5|Visit_5|90|1|SCREENING|2020-10-07|2020-10-14|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|44ca1fe6-76d2-4a94-9854-1ddbde638803|10|HLADRB1|HLA DR Beta1 Antigen|URINALYSIS|[?]|10^3 copies/mL|[?]|[?]|NEGATIVE|1|mEq/mL|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|UNEXPECTED ODOR|N|DISK DIFFUSION|FIBROTEST FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2020-10-07|2020-10-13|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|edc935ed-3b94-43fa-9b7f-facf6eb6780e|1|INTLK10|Interleukin 10|HEMATOLOGY|[?]|pt_us|[?]|[?]|NEGATIVE|1|ft|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|FRESH|N|ARTERIAL SPIN LABELING FUNCTIONAL MRI|COCKCROFT-GAULT FORMULA|Y||Y||1|Visit_1|10|2|TREATMENT|2020-12-04|2021-03-03|10|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|edc935ed-3b94-43fa-9b7f-facf6eb6780e|2|MSTHCELE|Mesothelial Cells/Leukocytes|HEMATOLOGY|[?]|10^6 DNA copies/mL|[?]|[?]|INDETERMINATE|1|L/min|1|1|[?]|HIGH|CALCULUS|LIPEMIC||BETA LACTAMASE|GMI % FORMULA|Y|Y|N||1|Visit_1|10|1|SCREENING|2020-12-04|2020-12-17|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|edc935ed-3b94-43fa-9b7f-facf6eb6780e|3|BLASTERY|Basophilic Erythroblast|HEMATOLOGY|||[?]|[?]|TRACE|1|log10 CCID 50/dose|1|1|[?]|LOW|MECONIUM|PARAFFIN-EMBEDDED||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI CREATININE FORMULA|||N|Y|2|Visit_2|25|7|TREATMENT|2020-12-19|2021-01-23|25|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|edc935ed-3b94-43fa-9b7f-facf6eb6780e|4|CCPAB|Cyclic Citrullinated Peptide Antibody|URINALYSIS|[?]|10^6 U|[?]|[?]|POSITIVE|1|tsp|1|1|[?]|HIGH|SKIN TISSUE|GELLED||NUCLEIC ACID HYBRIDIZATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|4|WASHOUT|2020-12-19|2021-01-27|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|edc935ed-3b94-43fa-9b7f-facf6eb6780e|5|EPIN|Epinephrine|URINALYSIS|[?]|g/animal/day|[?]|[?]|NEGATIVE|1|SQU/mL|1|1|[?]|NORMAL|BUFFY COAT|CLOTTED||NUCLEIC ACID AMPLIFICATION TEST|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|4|FOLLOW-UP|2021-01-03|2021-02-05|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|edc935ed-3b94-43fa-9b7f-facf6eb6780e|6|C130068|Bermuda Grass Pollen IgE|URINALYSIS|[?]|U/mg|[?]|[?]|NEGATIVE|1|Tbsp|1|1|[?]|LOW|SKIN TISSUE|ICTERIC||POLYGRAPHY|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|5|WASHOUT|2021-01-03|2021-01-08|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|edc935ed-3b94-43fa-9b7f-facf6eb6780e|7|LYMCLFLE|Lymphocytes, Clefted/Leukocytes|HEMATOLOGY|[?]|umol/L/min|[?]|[?]|INDETERMINATE|1|KALLIKREIN INHIBITOR UNIT|1|1|[?]|LOW|URINE|HEMOLYZED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|1|FOLLOW-UP|2021-01-28|2021-02-03|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|LB|edc935ed-3b94-43fa-9b7f-facf6eb6780e|8|HYDMDZ1|1-Hydroxymidazolam|CHEMISTRY|[?]|EP U|[?]|[?]|TRACE|1|10^3 copies/mL|1|1|[?]|ABNORMAL|STOOL|AGGLUTINATED||MAPH|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||4|Visit_4|65|2|TREATMENT|2021-01-28|2021-02-18|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|LB|edc935ed-3b94-43fa-9b7f-facf6eb6780e|9|SMDGCE|Smudge Cells|CHEMISTRY|[?]|BLOCKS|[?]|[?]|BORDERLINE|1|mL/min/mmHg|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR||MECHANICAL CLOT DETECTION|CKD-EPI CYSTATIN C FORMULA|||U||5|Visit_5|90|2|SCREENING|2021-02-22|2021-02-23|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|edc935ed-3b94-43fa-9b7f-facf6eb6780e|10|PKM|Pyruvate Kinase Muscle Isozyme|HEMATOLOGY|[?]|HOMEOPATHIC DILUTION|[?]|[?]|NEGATIVE|1|%/s|1|1|[?]|NORMAL|ARTERIAL BLOOD|UNEXPECTED ODOR|N|TOTAL BODY RADIOGRAPHY|HEPASCORE FORMULA|||N||5|Visit_5|90|1|FOLLOW-UP|2021-02-22|2021-02-27|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|f997ad2a-e9b1-4341-96d5-caef4bcb7196|1|GSTMU|Mu Glutathione-S-Transferase|URINALYSIS|[?]|mEq/mL|[?]|[?]|BORDERLINE|1|APS U|1|1|[?]|ABNORMAL|CORD SERUM|REFRIGERATED||PATHOLOGICAL EVALUATION|ASH FIBROSURE FORMULA|||U||1|Visit_1|10|3|WASHOUT|2020-06-08|2020-07-09|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|f997ad2a-e9b1-4341-96d5-caef4bcb7196|2|ICAM1|Intercellular Adhesion Molecule 1|CHEMISTRY|[?]|C|[?]|[?]|POSITIVE|1|SFC/10^6 PBMC|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|LIPEMIC||WESTERN BLOT|HEPASCORE FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-06-08|2020-08-07|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|f997ad2a-e9b1-4341-96d5-caef4bcb7196|3|AMYLB42|Amyloid Beta 1-42|URINALYSIS|[?]|gpELISA unit/mL|[?]|[?]|NEGATIVE|1|U.CARR|1|1|[?]|LOW|CORD BLOOD|CONCENTRATED||MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-06-23|2020-08-03|25|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|f997ad2a-e9b1-4341-96d5-caef4bcb7196|4|PTHMM|Parathyroid Hormone, Mid-Molecule|URINALYSIS|[?]|copies/ug|[?]|[?]|NEGATIVE|1|mCi|1|1|[?]|NORMAL|CORD SERUM|PARAFFIN-EMBEDDED||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI CYSTATIN C FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-06-23|2020-07-09|25|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|f997ad2a-e9b1-4341-96d5-caef4bcb7196|5|MUCTHR|Mucous Threads|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|g/cage/wk|1|1|[?]|LOW|CAPILLARY PLASMA|ICTERIC||MASS SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|NA|Y|3|Visit_3|40|1|TREATMENT|2020-07-08|2020-08-13|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|f997ad2a-e9b1-4341-96d5-caef4bcb7196|6|HLAAAGT|HLA-A Antigen Type|CHEMISTRY|[?]|POUCH|[?]|[?]|NEGATIVE|1|umol/kg/min|1|1|[?]|NORMAL|BILE|THAWED||ANGIOGRAPHY|FIBROMETER FORMULA|||N||3|Visit_3|40|4|TREATMENT|2020-07-08|2020-08-01|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|f997ad2a-e9b1-4341-96d5-caef4bcb7196|7|ACETOAC|Acetoacetic Acid|URINALYSIS|[?]|pkat/L|[?]|[?]|NEGATIVE|1|U/m2|1|1|[?]|LOW|DIALYSIS FLUID|LACTESCENT||CONTRAST ENHANCED PET SCAN|GMI MMOL/MOL FORMULA|||NA||4|Visit_4|65|3|FOLLOW-UP|2020-08-02|2020-08-18|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|f997ad2a-e9b1-4341-96d5-caef4bcb7196|8|TYR|Tyrosine|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|OI50|1|1|[?]|ABNORMAL|DIALYSIS FLUID|NON-HEMOLYZED||PALM METHOD|GMI % FORMULA|||U|Y|4|Visit_4|65|4|WASHOUT|2020-08-02|2020-08-03|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|f997ad2a-e9b1-4341-96d5-caef4bcb7196|9|ATHMBAC|Antithrombin Actual/Control|CHEMISTRY|||[?]|[?]|POSITIVE|1|ag|1|1|[?]|ABNORMAL|SPERMATOZOON|NON-HEMOLYZED||OLIGO ACGH|ASH FIBROSURE FORMULA|||N|Y|5|Visit_5|90|5|TREATMENT|2020-08-27|2020-09-03|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|f997ad2a-e9b1-4341-96d5-caef4bcb7196|10|TRAMADOL|Tramadol|CHEMISTRY|||[?]|[?]|BORDERLINE|1|10^6 organisms/g|1|1|[?]|HIGH|AQUEOUS HUMOR|SOLIDIFIED||MULTIPLE BREATH WASHOUT|FIBROTEST FORMULA|||U|Y|5|Visit_5|90|1|TREATMENT|2020-08-27|2020-08-31|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|5a56874f-10e4-4cd0-842f-19552a04d1bd|1|INTLK15|Interleukin 15|CHEMISTRY|[?]|CIGARETTE|[?]|[?]|POSITIVE|1|dpm/mg|1|1|[?]|HIGH|TRANSUDATE|REFRIGERATED||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD 6 VARIABLE FORMULA||Y|Y||1|Visit_1|10|2|TREATMENT|2020-06-20|2020-08-15|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|5a56874f-10e4-4cd0-842f-19552a04d1bd|2|GLN|Glutamine|CHEMISTRY|[?]|Enzyme U/g Hb|[?]|[?]|INVALID|1|BOTTLE|1|1|[?]|LOW|STOOL|ROOM TEMPERATURE|N|THERMAL IONIZATION MASS SPECTROMETRY|FIBROSIS 4 FORMULA|Y||U||1|Visit_1|10|4|TREATMENT|2020-06-20|2020-08-16|10|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|5a56874f-10e4-4cd0-842f-19552a04d1bd|3|HRYCECE|Hairy Cells/Total Cells|URINALYSIS|[?]|pptr|[?]|[?]|INVALID|1|ug/m2/h|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|AUTOLYZED||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CREATININE FORMULA|Y||NA||2|Visit_2|25|5|TREATMENT|2020-07-05|2020-07-10|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|5a56874f-10e4-4cd0-842f-19552a04d1bd|4|BILEAC|Bile Acid|URINALYSIS|||[?]|[?]|INVALID|1|WAFER|1|1|[?]|HIGH|VITREOUS HUMOR|FRESH||IN SITU HYBRIDIZATION|NASH FIBROSURE FORMULA||Y|Y|Y|2|Visit_2|25|5|FOLLOW-UP|2020-07-05|2020-09-06|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|5a56874f-10e4-4cd0-842f-19552a04d1bd|5|CA242AG|Cancer Antigen 242|HEMATOLOGY|||[?]|[?]|TRACE|1|uL/dose|1|1|[?]|LOW|EMESIS|LIPEMIC||CHROMATOGRAPHY|MDRD 4 VARIABLE FORMULA|||NA|Y|3|Visit_3|40|1|TREATMENT|2020-07-20|2020-09-16|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|LB|5a56874f-10e4-4cd0-842f-19552a04d1bd|6|ALP|Alkaline Phosphatase|URINALYSIS|||[?]|[?]|POSITIVE|1|BAU/mL|1|1|[?]|LOW|LAVAGE FLUID|AUTOLYZED||CONGO RED STAIN|CKD-EPI CREATININE FORMULA|Y||Y|Y|3|Visit_3|40|3|TREATMENT|2020-07-20|2020-08-21|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|LB|5a56874f-10e4-4cd0-842f-19552a04d1bd|7|COCAM|Cocaine Metabolites|CHEMISTRY|[?]|uU/L|[?]|[?]|BORDERLINE|1|kV|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|NON-HEMOLYZED||OPTICAL MAPPING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||4|Visit_4|65|4|SCREENING|2020-08-14|2020-09-10|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|5a56874f-10e4-4cd0-842f-19552a04d1bd|8|CD14|CD14|HEMATOLOGY|[?]|Ci/mL|[?]|[?]|INDETERMINATE|1|mg/animal|1|1|[?]|HIGH|VENOUS CORD BLOOD|LACTESCENT|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||Y|N||4|Visit_4|65|3|TREATMENT|2020-08-14|2020-09-17|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|5a56874f-10e4-4cd0-842f-19552a04d1bd|9|PGE2|Prostaglandin E2|HEMATOLOGY|[?]|10^11/L|[?]|[?]|BORDERLINE|1|nmol/mL/min|1|1|[?]|HIGH|HAIR FOLLICLE|AGGLUTINATED||SPIRAL CT SCAN WITHOUT CONTRAST|HEPASCORE FORMULA|Y||U||5|Visit_5|90|4|SCREENING|2020-09-08|2020-09-12|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|5a56874f-10e4-4cd0-842f-19552a04d1bd|10|POIKILO|Poikilocytes|HEMATOLOGY|[?]|umol/mol|[?]|[?]|POSITIVE|1|MdFI|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|PARAFFIN-EMBEDDED||ALCIAN BLUE STAIN|COCKCROFT-GAULT FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2020-09-08|2020-09-11|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|f1d4ebe5-fc72-447b-8872-67e971ff471b|1|CLNZPM|Clonazepam|HEMATOLOGY|[?]|Joule|[?]|[?]|INVALID|1|mgEq|1|1|[?]|LOW|AMNIOTIC FLUID|AUTOLYZED||SANGER SEQUENCING|MDRD FORMULA|Y||NA||1|Visit_1|10|6|TREATMENT|2020-11-08|2020-12-30|10|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|f1d4ebe5-fc72-447b-8872-67e971ff471b|2|OH8DXG2|8-Hydroxy-2'-Deoxyguanosine|HEMATOLOGY|[?]|PLUG|[?]|[?]|INDETERMINATE|1|pm|1|1|[?]|HIGH|SOFT TISSUE|AGGLUTINATED||PALM METHOD|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|2|WASHOUT|2020-11-08|2021-01-23|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|f1d4ebe5-fc72-447b-8872-67e971ff471b|3|GFRBSCU|GFR from Creat and UreaN Adj BSA|URINALYSIS|[?]|ka_u/dL|[?]|[?]|NEGATIVE|1|MPL U|1|1|[?]|HIGH|ADIPOSE TISSUE|FROZEN||AMSLER GRID|NASH FIBROSURE FORMULA||Y|NA||2|Visit_2|25|3|TREATMENT|2020-11-23|2021-01-24|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|LB|f1d4ebe5-fc72-447b-8872-67e971ff471b|4|CKMBCK|Creatine Kinase MB/Total Creatine Kinase|HEMATOLOGY|[?]|mm/h|[?]|[?]|INVALID|1|%/min|1|1|[?]|LOW|LYSATE|HEMOLYZED||POTENTIOMETRY|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-11-23|2020-12-14|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|LB|f1d4ebe5-fc72-447b-8872-67e971ff471b|5|HCGFR|Choriogonadotropin Beta, Free|HEMATOLOGY|[?]|kat|[?]|[?]|TRACE|1|gMFI|1|1|[?]|ABNORMAL|MUCUS|DRIED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|GMI % FORMULA|||N||3|Visit_3|40|4|TREATMENT|2020-12-08|2021-02-02|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|f1d4ebe5-fc72-447b-8872-67e971ff471b|6|SMDGCELE|Smudge Cells/Leukocytes|CHEMISTRY|[?]|DRUM|[?]|[?]|INVALID|1|min/day|1|1|[?]|LOW|INTERSTITIAL FLUID|DRIED||IMMUNE REPERTOIRE DEEP SEQUENCING|CKD-EPI CREATININE FORMULA||Y|N||3|Visit_3|40|2|TREATMENT|2020-12-08|2020-12-17|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|f1d4ebe5-fc72-447b-8872-67e971ff471b|7|BETAINES|Betaines|URINALYSIS|[?]|mL/g/day|[?]|[?]|INVALID|1|PACKAGE|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|CALCIFIED||ACID FAST STAIN|FIBROSIS 4 FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2021-01-02|2021-02-01|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|f1d4ebe5-fc72-447b-8872-67e971ff471b|8|GLOBA|Alpha Globulin|CHEMISTRY|[?]|mmol/kg|[?]|[?]|INDETERMINATE|1|deg|1|1|[?]|LOW|SOFT TISSUE|FROZEN|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|5|FOLLOW-UP|2021-01-02|2021-01-20|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|f1d4ebe5-fc72-447b-8872-67e971ff471b|9|LSELS|Soluble L-Selectin|HEMATOLOGY|[?]|deg/mm|[?]|[?]|TRACE|1|oz|1|1|[?]|ABNORMAL|DISCHARGE|ICTERIC|N|SPIROMETRY|MDRD 5 VARIABLE FORMULA||Y|U||5|Visit_5|90|3|FOLLOW-UP|2021-01-27|2021-02-01|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|f1d4ebe5-fc72-447b-8872-67e971ff471b|10|TATC|Thrombin Antithrombin Complex|CHEMISTRY|[?]|pmol/10^9 cells|[?]|[?]|INVALID|1|kg/cm|1|1|[?]|NORMAL|ABSCESS FLUID|NON-HEMOLYZED|N|MAMMOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|N||5|Visit_5|90|7|TREATMENT|2021-01-27|2021-02-02|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|2a141b73-e336-4701-9067-8d51d532596b|1|EOTAXIN2|Eotaxin-2|HEMATOLOGY|[?]|copies/mL|[?]|[?]|NEGATIVE|1|TABLET|1|1|[?]|ABNORMAL|SALIVA|CLOTTED||MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-06-12|2020-06-30|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|2a141b73-e336-4701-9067-8d51d532596b|2|C165901|EnglishPlantain Pollen IgG AB RAST Score|URINALYSIS|[?]|mm/sec|[?]|[?]|INVALID|1|CIGARETTE|1|1|[?]|NORMAL|HAIR|PARAFFIN-EMBEDDED||OPTICAL DENSITY MEASUREMENT|MDRD 4 VARIABLE FORMULA|||Y||1|Visit_1|10|1|FOLLOW-UP|2020-06-12|2020-07-08|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|2a141b73-e336-4701-9067-8d51d532596b|3|C3M|Collagen III Neo-Peptide C3M|CHEMISTRY|[?]|PIXELS/in|[?]|[?]|INDETERMINATE|1|mg/mL/min|1|1|[?]|LOW|PROSTATIC FLUID|HEMOLYZED|N|SPECTROPHOTOMETRY|FIBROTEST FORMULA|Y||Y||2|Visit_2|25|3|WASHOUT|2020-06-27|2020-07-27|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|2a141b73-e336-4701-9067-8d51d532596b|4|C165941|Common Ragweed Pollen IgE AB RAST Score|HEMATOLOGY|[?]|pt_us|[?]|[?]|NEGATIVE|1|BU/mL|1|1|[?]|HIGH|CORD BLOOD|ROOM TEMPERATURE||ELISA|MDRD FORMULA|Y||N||2|Visit_2|25|3|SCREENING|2020-06-27|2020-07-13|25|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|2a141b73-e336-4701-9067-8d51d532596b|5|C130117|Bee Mix Antigen IgG Antibody|CHEMISTRY|[?]|BOWL|[?]|[?]|NEGATIVE|1|s/h|1|1|[?]|LOW|SERUM OR PLASMA|THAWED||LANDOLT RING|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|4|FOLLOW-UP|2020-07-12|2020-08-03|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|LB|2a141b73-e336-4701-9067-8d51d532596b|6|PLSCR1|Phospholipid Scramblase 1|URINALYSIS|[?]|hPa|[?]|[?]|TRACE|1|10^9/L|1|1|[?]|ABNORMAL|BUFFY COAT|PARAFFIN-EMBEDDED|N|CYSTOMETRY|MDRD FORMULA|Y||U||3|Visit_3|40|6|TREATMENT|2020-07-12|2020-09-05|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|LB|2a141b73-e336-4701-9067-8d51d532596b|7|LIPASET|Lipase|URINALYSIS|[?]|U/animal|[?]|[?]|TRACE|1|10^3 CFU|1|1|[?]|HIGH|SPUTUM|CONTAMINATED||ANGIOGRAPHY|MDRD FORMULA||Y|Y||4|Visit_4|65|7|TREATMENT|2020-08-06|2020-08-22|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|2a141b73-e336-4701-9067-8d51d532596b|8|ANGPT1|Angiopoietin 1|URINALYSIS|[?]|10^6 RNA copies/mL|[?]|[?]|INDETERMINATE|1|uEq|1|1|[?]|ABNORMAL|KERATINOCYTE|CLOTTED||TARGETED TRANSCRIPTOME SEQUENCING|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|1|FOLLOW-UP|2020-08-06|2020-08-28|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|2a141b73-e336-4701-9067-8d51d532596b|9|PTAUAB42|Phosphorylated Tau Prot/Amyloid Beta1-42|CHEMISTRY|[?]|cd/m2|[?]|[?]|INVALID|1|FEU|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|HEMOLYZED|N|IMMUNOTURBIDIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|7|SCREENING|2020-08-31|2020-09-05|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|2a141b73-e336-4701-9067-8d51d532596b|10|INTLK29|Interleukin 29|CHEMISTRY|||[?]|[?]|TRACE|1|10^3/L|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|FROZEN||REFRACTOMETRY|MDRD 6 VARIABLE FORMULA||Y|Y|Y|5|Visit_5|90|3|TREATMENT|2020-08-31|2020-09-09|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|4adf9a2c-3c43-4289-8156-1a109791580c|1|WBCCLMP|Leukocyte Cell Clumps|URINALYSIS|[?]|10^6/g|[?]|[?]|INVALID|1|GLOBULE|1|1|[?]|ABNORMAL|PUS|REFRIGERATED|N|WHOLE GENOME SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||NA||1|Visit_1|10|5|SCREENING|2020-11-22|2020-12-22|10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|4adf9a2c-3c43-4289-8156-1a109791580c|2|C165907|Mold Mix IgG AB RAST Score|CHEMISTRY|[?]|L/kg|[?]|[?]|INDETERMINATE|1|IMPLANT|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|SOLIDIFIED||SLIT LAMP|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||1|Visit_1|10|5|WASHOUT|2020-11-22|2021-01-09|10|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|4adf9a2c-3c43-4289-8156-1a109791580c|3|HBLEPRHB|Hemoglobin Lepore/Total Hemoglobin|HEMATOLOGY|[?]|nmol/L/h|[?]|[?]|NEGATIVE|1|pmol/day|1|1|[?]|LOW|MENSTRUAL BLOOD|CONTAMINATED||COULOMETRIC TITRATION|NASH FIBROSURE FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-12-07|2021-01-03|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|4adf9a2c-3c43-4289-8156-1a109791580c|4|OVALCY|Ovalocytes|HEMATOLOGY|[?]|mg/dL|[?]|[?]|POSITIVE|1|grain|1|1|[?]|ABNORMAL|DERMAL TISSUE|AUTOLYZED||RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|6|FOLLOW-UP|2020-12-07|2021-01-09|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|4adf9a2c-3c43-4289-8156-1a109791580c|5|HGBFHGB|Hemoglobin F/Total Hemoglobin|HEMATOLOGY|[?]|pmol/g|[?]|[?]|TRACE|1|Bq/kg|1|1|[?]|NORMAL|INTERSTITIAL FLUID|ROOM TEMPERATURE||WEBER GREEN STAIN|NASH FIBROSURE FORMULA|Y|Y|N||3|Visit_3|40|3|WASHOUT|2020-12-22|2021-01-03|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|4adf9a2c-3c43-4289-8156-1a109791580c|6|C130110|Mold Mix Antigen IgG Antibody|CHEMISTRY|[?]|10^3 CFU/g|[?]|[?]|INDETERMINATE|1|mmol2/L2|1|1|[?]|NORMAL|VENOUS PLASMA|SOLIDIFIED||DYNAMIC CONTRAST ENHANCED MRI|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-12-22|2021-01-08|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|4adf9a2c-3c43-4289-8156-1a109791580c|7|ANDSTNDN|Androstenedione|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^9 CFU/mL|1|1|[?]|NORMAL|ABSCESS FLUID|ICTERIC||TRANSVAGINAL ULTRASOUND|CKD-EPI FORMULA|||U|Y|4|Visit_4|65|5|SCREENING|2021-01-16|2021-02-05|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|4adf9a2c-3c43-4289-8156-1a109791580c|8|PHOS|Phosphate|URINALYSIS|[?]|pt_br|[?]|[?]|NEGATIVE|1|10^6 organisms/mL|1|1|[?]|ABNORMAL|CORD SERUM|CLOTTED||FLUORESCENCE ANGIOGRAPHY|HEPASCORE FORMULA|||N||4|Visit_4|65|7|TREATMENT|2021-01-16|2021-01-22|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|4adf9a2c-3c43-4289-8156-1a109791580c|9|FACTVIII|Factor VIII|HEMATOLOGY|[?]|pg/dL|[?]|[?]|BORDERLINE|1|10^6 CFU|1|1|[?]|ABNORMAL|KERATINOCYTE|ROOM TEMPERATURE||TRANSVAGINAL ULTRASOUND|CKD-EPI CYSTATIN C FORMULA|Y||Y||5|Visit_5|90|6|TREATMENT|2021-02-10|2021-02-17|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|4adf9a2c-3c43-4289-8156-1a109791580c|10|HGBOXY|Oxyhemoglobin|CHEMISTRY|[?]|BEAM BREAKS|[?]|[?]|INDETERMINATE|1|GBq/g|1|1|[?]|LOW|SERUM OR PLASMA|LACTESCENT||CYSTOMETRY|MDRD 6 VARIABLE FORMULA|Y|Y|N||5|Visit_5|90|4|FOLLOW-UP|2021-02-10|2021-02-19|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|1|LYMA|Lymphocytes Activated|CHEMISTRY|||[?]|[?]|POSITIVE|1|nmol/L/min|1|1|[?]|HIGH|EMESIS|HEMOLYZED||MAGNETIC RESONANCE ENTEROGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|1|Visit_1|10|7|SCREENING|2020-05-23|2020-08-01|10|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-15
e|LB|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|2|DTPACLR|DTPA Clearance|HEMATOLOGY|||[?]|[?]|INVALID|1|CIGAR|1|1|[?]|ABNORMAL|TRANSUDATE|REFRIGERATED||KINETIC CHROMOGENIC ASSAY|MDRD FORMULA|||N|Y|1|Visit_1|10|6|TREATMENT|2020-05-23|2020-06-19|10|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-15
e|LB|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|3|ESELS|Soluble E-Selectin|HEMATOLOGY|[?]|g/g|[?]|[?]|TRACE|1|Pa|1|1|[?]|ABNORMAL|PROSTATIC FLUID|CLOTTED||PUPILLOMETRY|ASH FIBROSURE FORMULA|||U||2|Visit_2|25|6|SCREENING|2020-06-07|2020-08-05|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|4|RBCAGGLU|Erythrocyte Agglutination|CHEMISTRY|[?]|MESF|[?]|[?]|INDETERMINATE|1|titer|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|SOLIDIFIED||MYELOPEROXIDASE STAIN|MDRD FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-06-07|2020-07-23|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|5|URATECRT|Urate/Creatinine|HEMATOLOGY|[?]|nmol/L|[?]|[?]|BORDERLINE|1|U/cL|1|1|[?]|LOW|VENOUS BLOOD|CONTAMINATED||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|COCKCROFT-GAULT FORMULA|Y||U||3|Visit_3|40|1|SCREENING|2020-06-22|2020-07-31|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|6|PEPSNGII|Pepsinogen II|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|ug/m2/min|1|1|[?]|ABNORMAL|MUCUS|REFRIGERATED||WHOLE GENOME SEQUENCING|FIBROTEST FORMULA|||NA|Y|3|Visit_3|40|2|TREATMENT|2020-06-22|2020-07-21|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|7|PYDCREAT|Pyridinoline/Creatinine|CHEMISTRY|[?]|PACKAGE|[?]|[?]|INVALID|1|vp/dose|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|REFRIGERATED||MALDI|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2020-07-17|2020-08-02|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|LB|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|8|NAGASECR|N-acetyl-B-D-glucosaminidase/Creatinine|CHEMISTRY|[?]|nmol|[?]|[?]|TRACE|1|breaths/30s|1|1|[?]|HIGH|BLOOD|NON-HEMOLYZED||MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|2|FOLLOW-UP|2020-07-17|2020-08-17|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|LB|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|9|NRP1|Neuropilin-1|CHEMISTRY|[?]|TAMPON|[?]|[?]|INDETERMINATE|1|pmol|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|PARAFFIN-EMBEDDED||ICP-MS|FIBROMETER FORMULA||Y|Y||5|Visit_5|90|3|SCREENING|2020-08-11|2020-08-13|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|10|TPROT|Tau Protein|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mmol/min/kPa/L|1|1|[?]|LOW|SWABBED MATERIAL|CALCIFIED|N|RULER MEASUREMENT METHOD|MDRD ENZYMATIC FORMULA|||U|Y|5|Visit_5|90|2|TREATMENT|2020-08-11|2020-08-20|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|1b2eda86-2d2c-4fdc-a88e-409ea5180603|1|SCF|Stem Cell Factor|URINALYSIS|[?]|Antibody Unit|[?]|[?]|INVALID|1|PIXELS/cm|1|1|[?]|NORMAL|SUPERNATANT, SERUM|CLOTTED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|NASH FIBROSURE FORMULA|Y||U||1|Visit_1|10|6|SCREENING|2020-05-19|2020-07-30|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|1b2eda86-2d2c-4fdc-a88e-409ea5180603|2|PHOS|Phosphate|CHEMISTRY|[?]|mol/g|[?]|[?]|BORDERLINE|1|uV|1|1|[?]|HIGH|PUS|ICTERIC|N|PHOTOMETRIC CLOT DETECTION|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|U||1|Visit_1|10|4|SCREENING|2020-05-19|2020-06-18|10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|1b2eda86-2d2c-4fdc-a88e-409ea5180603|3|MLIGCE|Malignant Cells, NOS|HEMATOLOGY|[?]|ug/day|[?]|[?]|NEGATIVE|1|/cmH2O|1|1|[?]|NORMAL|MUCUS|ROOM TEMPERATURE||LISSAMINE GREEN STAIN|MDRD ENZYMATIC FORMULA|Y||NA||2|Visit_2|25|1|TREATMENT|2020-06-03|2020-06-15|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|1b2eda86-2d2c-4fdc-a88e-409ea5180603|4|CDT|Carbohydrate-Deficient Transferrin|HEMATOLOGY|[?]|ELISA unit/dose|[?]|[?]|TRACE|1|nmol/mol|1|1|[?]|NORMAL|URINE SEDIMENT|THAWED|N|CENTRIFUGATION|MDRD 4 VARIABLE FORMULA|Y||Y||2|Visit_2|25|2|WASHOUT|2020-06-03|2020-06-30|25|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|1b2eda86-2d2c-4fdc-a88e-409ea5180603|5|CTXII|Type II Collagen C-Telopeptides|HEMATOLOGY|[?]|10^3 organisms/mL|[?]|[?]|NEGATIVE|1|mg2/dL2|1|1|[?]|NORMAL|PUS|CALCIFIED||PERFUSION MRI|GMI MMOL/MOL FORMULA|||N||3|Visit_3|40|5|FOLLOW-UP|2020-06-18|2020-07-28|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|1b2eda86-2d2c-4fdc-a88e-409ea5180603|6|PKM1|Pyruvate Kinase Isozyme M1|URINALYSIS|||[?]|[?]|INDETERMINATE|1|ug/h|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|UNEXPECTED ODOR|N|KARYOTYPING|CKD-EPI CREATININE FORMULA||Y|N|Y|3|Visit_3|40|2|WASHOUT|2020-06-18|2020-07-09|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|1b2eda86-2d2c-4fdc-a88e-409ea5180603|7|ESTROGEN|Estrogen|CHEMISTRY|[?]|pmol/L|[?]|[?]|NEGATIVE|1|L/h/m2|1|1|[?]|ABNORMAL|MECONIUM|HEMOLYZED|N|TRICHROME STAIN|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-07-13|2020-07-23|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|LB|1b2eda86-2d2c-4fdc-a88e-409ea5180603|8|GLOBB1|Beta-1 Globulin|CHEMISTRY|[?]|mg/m2/day|[?]|[?]|NEGATIVE|1|BOLUS|1|1|[?]|NORMAL|NAIL|ROOM TEMPERATURE||PULMONARY ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA|||U||4|Visit_4|65|7|SCREENING|2020-07-13|2020-08-15|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|LB|1b2eda86-2d2c-4fdc-a88e-409ea5180603|9|CTLPRM|Citalopram|HEMATOLOGY|[?]|mL/s|[?]|[?]|BORDERLINE|1|Anson U|1|1|[?]|LOW|SWABBED MATERIAL|SOLIDIFIED|N|ENDOSCOPY|CKD-EPI FORMULA||Y|N||5|Visit_5|90|3|TREATMENT|2020-08-07|2020-08-15|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|1b2eda86-2d2c-4fdc-a88e-409ea5180603|10|IGE|Immunoglobulin E|HEMATOLOGY|[?]|mg/kg/h|[?]|[?]|INDETERMINATE|1|cGy|1|1|[?]|NORMAL|NAIL|UNEXPECTED ODOR|N|GRAM STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-08-07|2020-08-13|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|fc02184a-dfba-4964-be3a-cfa5f5d7200e|1|CD11A|CD11A|URINALYSIS|||[?]|[?]|POSITIVE|1|days/wk|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|CALCIFIED||MUGA|CKD-EPI CREATININE FORMULA|||Y|Y|1|Visit_1|10|6|SCREENING|2020-05-26|2020-07-26|10|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|fc02184a-dfba-4964-be3a-cfa5f5d7200e|2|PYK|Pyruvate Kinase|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|g/animal/wk|1|1|[?]|NORMAL|GASTRIC FLUID|HEMOLYZED||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD 6 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|1|FOLLOW-UP|2020-05-26|2020-07-02|10|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|fc02184a-dfba-4964-be3a-cfa5f5d7200e|3|CDCACM|Chenodeoxycholate Compounds|URINALYSIS|||[?]|[?]|BORDERLINE|1|mL/dose|1|1|[?]|NORMAL|PERITONEAL FLUID|HEMOLYZED||RAJI CELL EIA|MDRD 6 VARIABLE FORMULA|Y||NA|Y|2|Visit_2|25|5|FOLLOW-UP|2020-06-10|2020-08-16|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|fc02184a-dfba-4964-be3a-cfa5f5d7200e|4|ELA1PMN|Pancreatic Elastase 1, Polymorphonuclear|CHEMISTRY|||[?]|[?]|INVALID|1|um/s|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|SOLIDIFIED||TOLUIDINE BLUE STAIN|MDRD 6 VARIABLE FORMULA|Y||NA|Y|2|Visit_2|25|1|FOLLOW-UP|2020-06-10|2020-07-28|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|fc02184a-dfba-4964-be3a-cfa5f5d7200e|5|VLDL|VLDL Cholesterol|CHEMISTRY|[?]|GLOBULE|[?]|[?]|BORDERLINE|1|U/m2|1|1|[?]|ABNORMAL|BUFFY COAT|CLOTTED|N|RADIOIMMUNOPRECIPITATION ASSAY|MDRD 6 VARIABLE FORMULA|||Y||3|Visit_3|40|1|FOLLOW-UP|2020-06-25|2020-06-29|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|fc02184a-dfba-4964-be3a-cfa5f5d7200e|6|METARBLE|Metarubricytes/Leukocytes|CHEMISTRY|[?]|breaths/min|[?]|[?]|INDETERMINATE|1|U/mmol|1|1|[?]|LOW|FLUID|UNEXPECTED ODOR||RADIATION DOSIMETRY|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-06-25|2020-07-15|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|fc02184a-dfba-4964-be3a-cfa5f5d7200e|7|STAT3|STAT3|URINALYSIS|[?]|mmHg*min/L|[?]|[?]|NEGATIVE|1|g|1|1|[?]|HIGH|SPUTUM|REFRIGERATED||FREEZING POINT DEPRESSION|CKD-EPI CREATININE FORMULA||Y|N||4|Visit_4|65|2|TREATMENT|2020-07-20|2020-07-24|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|LB|fc02184a-dfba-4964-be3a-cfa5f5d7200e|8|SODIUM|Sodium|CHEMISTRY|[?]|MASK|[?]|[?]|POSITIVE|1|DIOPTER|1|1|[?]|ABNORMAL|URINE|AUTOLYZED||TELLER ACUITY CARDS|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|2|FOLLOW-UP|2020-07-20|2020-07-22|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|LB|fc02184a-dfba-4964-be3a-cfa5f5d7200e|9|HYPGST17|17-Hydroxyprogesterone|URINALYSIS|[?]|vp/mL|[?]|[?]|TRACE|1|U/m2/min|1|1|[?]|NORMAL|URINE SEDIMENT|ICTERIC|N|DIFFUSION WEIGHTED MRI|FIBROSIS 4 FORMULA||Y|N||5|Visit_5|90|2|SCREENING|2020-08-14|2020-08-22|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|LB|fc02184a-dfba-4964-be3a-cfa5f5d7200e|10|TTAC|Thrombin Time Actual/Control|CHEMISTRY|[?]|kHz|[?]|[?]|POSITIVE|1|10^9 CFU/g|1|1|[?]|NORMAL|NAIL|CLOTTED||PHOTOGRAPHY|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-08-14|2020-08-23|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|LB|37c59cfa-b952-4d16-a675-5e3b3a2e0288|1|CD34|CD34|URINALYSIS|[?]|ug/m2|[?]|[?]|POSITIVE|1|tuberculin unit/mL|1|1|[?]|LOW|SYNOVIAL FLUID|CALCIFIED|N|TOLUIDINE BLUE STAIN|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-05-29|2020-06-08|10|20|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|37c59cfa-b952-4d16-a675-5e3b3a2e0288|2|VITK1|Vitamin K1|CHEMISTRY|[?]|mL/cage|[?]|[?]|INVALID|1|U/dL|1|1|[?]|NORMAL|TISSUE|AGGLUTINATED||MULTIPLEXED BEAD BASED IMMUNOASSAY|FIBROSIS 4 FORMULA|||Y||1|Visit_1|10|5|WASHOUT|2020-05-29|2020-06-30|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|37c59cfa-b952-4d16-a675-5e3b3a2e0288|3|ACE|Angiotensin Converting Enzyme|URINALYSIS|[?]|nU/cL|[?]|[?]|INDETERMINATE|1|PUFF|1|1|[?]|NORMAL|KERATINOCYTE|AGGLUTINATED|N|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA|Y||U||2|Visit_2|25|1|SCREENING|2020-06-13|2020-07-08|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|37c59cfa-b952-4d16-a675-5e3b3a2e0288|4|SARCOSIN|Sarcosine|URINALYSIS|[?]|psi|[?]|[?]|NEGATIVE|1|CCID 50/mL|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|FROZEN|N|CORONARY ANGIOGRAPHY|GMI % FORMULA|Y||N||2|Visit_2|25|6|TREATMENT|2020-06-13|2020-07-15|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|37c59cfa-b952-4d16-a675-5e3b3a2e0288|5|HRYCELY|Hairy Cells/Lymphocytes|CHEMISTRY|[?]|K|[?]|[?]|NEGATIVE|1|umol/kg/min|1|1|[?]|HIGH|BUFFY COAT|GELLED||MICROARRAY|MDRD 5 VARIABLE FORMULA||Y|Y||3|Visit_3|40|7|SCREENING|2020-06-28|2020-07-02|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|37c59cfa-b952-4d16-a675-5e3b3a2e0288|6|DRUGSCR|Drug Screen|URINALYSIS|[?]|umol/dL|[?]|[?]|NEGATIVE|1|mg/h|1|1|[?]|HIGH|BASAL TEAR|HEMOLYZED||CARDIAC THERMODILUTION|CKD-EPI CYSTATIN C FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-06-28|2020-07-03|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|37c59cfa-b952-4d16-a675-5e3b3a2e0288|7|BASOIM|Immature Basophils|HEMATOLOGY|[?]|10^3 DNA copies/mL|[?]|[?]|POSITIVE|1|PFU|1|1|[?]|ABNORMAL|BILE|ROOM TEMPERATURE||MRI|FIBROTEST FORMULA|Y||NA||4|Visit_4|65|4|WASHOUT|2020-07-23|2020-07-31|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|LB|37c59cfa-b952-4d16-a675-5e3b3a2e0288|8|NAG|N-Acetyl Glucosamide|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|breaths/30s|1|1|[?]|NORMAL|CALCULUS|LACTESCENT|N|KINETIC MICROPARTICLE IMMUNOASSAY|CKD-EPI FORMULA|||Y|Y|4|Visit_4|65|6|WASHOUT|2020-07-23|2020-07-29|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|LB|37c59cfa-b952-4d16-a675-5e3b3a2e0288|9|CORCREAT|Cortisol/Creatinine|HEMATOLOGY|[?]|in2|[?]|[?]|BORDERLINE|1|mL/kg|1|1|[?]|LOW|MECONIUM|LIPEMIC|N|TOTAL BODY RADIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||5|Visit_5|90|4|TREATMENT|2020-08-17|2020-08-25|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|37c59cfa-b952-4d16-a675-5e3b3a2e0288|10|MYPC|Myeloid Progenitor Cells|CHEMISTRY|[?]|mm/h|[?]|[?]|INDETERMINATE|1|mL/cage/wk|1|1|[?]|HIGH|URINE SEDIMENT|CALCIFIED||ENZYMATIC ULTRACENTRIFUGATION|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|6|TREATMENT|2020-08-17|2020-08-25|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|11130b2c-e9fd-4a50-87ee-5dfa19199eba|1|C3B|Complement C3b|HEMATOLOGY|[?]|Torr|[?]|[?]|POSITIVE|1|cg|1|1|[?]|ABNORMAL|FLUID|CONCENTRATED|N|CELLULAR PROLIFERATION ASSAY|MDRD FORMULA||Y|NA||1|Visit_1|10|7|SCREENING|2020-12-03|2021-01-07|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|11130b2c-e9fd-4a50-87ee-5dfa19199eba|2|C165912|Shellfish Mix IgG AB RAST Score|URINALYSIS|||[?]|[?]|INVALID|1|mL/g/min|1|1|[?]|LOW|CAPILLARY BLOOD|CLOTTED|N|PULMONARY ANGIOGRAPHY|ASH FIBROSURE FORMULA|||U|Y|1|Visit_1|10|7|TREATMENT|2020-12-03|2021-01-01|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|11130b2c-e9fd-4a50-87ee-5dfa19199eba|3|KLHIGGAB|Keyhole Limpet Hemocyanin IgG Antibody|CHEMISTRY|[?]|mEq/mL|[?]|[?]|INVALID|1|BE/mL|1|1|[?]|ABNORMAL|CERUMEN|CONCENTRATED||RYAN BLUE STAIN|GMI MMOL/MOL FORMULA|Y||N||2|Visit_2|25|4|TREATMENT|2020-12-18|2021-01-27|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|11130b2c-e9fd-4a50-87ee-5dfa19199eba|4|RETPALM|Retinyl Palmitate|CHEMISTRY|||[?]|[?]|TRACE|1|EID 50/dose|1|1|[?]|LOW|VENOUS CORD BLOOD|HEMOLYZED||AGAR PROPORTION|MDRD FORMULA|||N|Y|2|Visit_2|25|7|TREATMENT|2020-12-18|2020-12-26|25|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|11130b2c-e9fd-4a50-87ee-5dfa19199eba|5|MEPRDN|Meperidine|URINALYSIS|[?]|Shock Wave|[?]|[?]|BORDERLINE|1|Shock Wave|1|1|[?]|LOW|BILE|FROZEN||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD FORMULA|Y||N||3|Visit_3|40|6|WASHOUT|2021-01-02|2021-01-10|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|11130b2c-e9fd-4a50-87ee-5dfa19199eba|6|MEPRDN|Meperidine|URINALYSIS|||[?]|[?]|POSITIVE|1|POUCH|1|1|[?]|LOW|SUPERNATANT, SERUM|SOLIDIFIED||AUTOMATED COUNT|FIBROMETER FORMULA|||N|Y|3|Visit_3|40|7|TREATMENT|2021-01-02|2021-01-03|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|11130b2c-e9fd-4a50-87ee-5dfa19199eba|7|NEUTVAC|Vacuolated Neutrophils|CHEMISTRY|[?]|TABLET|[?]|[?]|TRACE|1|g/animal|1|1|[?]|ABNORMAL|ISOLATE|CLOTTED||LYMPHANGIOGRAPHY|FIBROTEST FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2021-01-27|2021-02-17|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|11130b2c-e9fd-4a50-87ee-5dfa19199eba|8|LYMLE|Lymphocytes/Leukocytes|URINALYSIS|[?]|POINT|[?]|[?]|INDETERMINATE|1|BU|1|1|[?]|HIGH|PLATELET|NON-HEMOLYZED||LC-FL|FIBROMETER FORMULA|||Y||4|Visit_4|65|4|WASHOUT|2021-01-27|2021-02-24|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|11130b2c-e9fd-4a50-87ee-5dfa19199eba|9|PMDW|Platelet Mass Distribution Width|URINALYSIS|||[?]|[?]|NEGATIVE|1|ms/mmHg|1|1|[?]|NORMAL|DIALYSIS FLUID|PARAFFIN-EMBEDDED||MODIFIED ACID FAST STAIN|MDRD 4 VARIABLE FORMULA|||U|Y|5|Visit_5|90|5|TREATMENT|2021-02-21|2021-03-01|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|11130b2c-e9fd-4a50-87ee-5dfa19199eba|10|GLUCAGON|Glucagon|CHEMISTRY|[?]|ugEq|[?]|[?]|BORDERLINE|1|RFU|1|1|[?]|HIGH|ADIPOSE TISSUE|NON-HEMOLYZED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|4|WASHOUT|2021-02-21|2021-02-22|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|08e4310f-f868-4858-a321-f33a21a771e8|1|A1AGLP|Alpha-1 Acid Glycoprotein|HEMATOLOGY|[?]|DISK|[?]|[?]|INDETERMINATE|1|rpm|1|1|[?]|HIGH|ABSCESS FLUID|THAWED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|COCKCROFT-GAULT FORMULA|||U||1|Visit_1|10|7|SCREENING|2020-05-15|2020-06-18|10|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|08e4310f-f868-4858-a321-f33a21a771e8|2|LDH5LDH|LDH Isoenzyme 5/LDH|HEMATOLOGY|[?]|deg/mm|[?]|[?]|POSITIVE|1|g/cage/day|1|1|[?]|HIGH|VENOUS BLOOD|THAWED||PULSE OXIMETRY|ASH FIBROSURE FORMULA|||N||1|Visit_1|10|1|WASHOUT|2020-05-15|2020-08-06|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|08e4310f-f868-4858-a321-f33a21a771e8|3|INGAPAB|Islet Neogenesis Assoc Protein Antibody|HEMATOLOGY|[?]|mV*min|[?]|[?]|TRACE|1|kg/cm|1|1|[?]|LOW|EXUDATE|NON-HEMOLYZED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-05-30|2020-07-21|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|08e4310f-f868-4858-a321-f33a21a771e8|4|IL2SRA|Soluble Interleukin 2 Receptor Activity|HEMATOLOGY|[?]|U.CARR|[?]|[?]|NEGATIVE|1|FFU|1|1|[?]|NORMAL|HAIR FOLLICLE|GELLED|N|RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI CYSTATIN C FORMULA|||U||2|Visit_2|25|2|FOLLOW-UP|2020-05-30|2020-07-09|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|08e4310f-f868-4858-a321-f33a21a771e8|5|VMAEXR|Vanillyl Mandelic Acid Excretion Rate|URINALYSIS|[?]|U/kg/h|[?]|[?]|NEGATIVE|1|Ejaculate U|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|AUTOLYZED||MANUAL COUNT|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||3|Visit_3|40|2|TREATMENT|2020-06-14|2020-07-14|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|08e4310f-f868-4858-a321-f33a21a771e8|6|PROMYB|Promyeloblasts|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|damol/L|1|1|[?]|NORMAL|LYSATE|CONTAMINATED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD 6 VARIABLE FORMULA||Y|U|Y|3|Visit_3|40|4|FOLLOW-UP|2020-06-14|2020-07-23|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|08e4310f-f868-4858-a321-f33a21a771e8|7|HETRPH|Heterophils|CHEMISTRY|[?]|10^9/dose|[?]|[?]|TRACE|1|LOZENGE|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|FIBROTEST FORMULA||Y|N||4|Visit_4|65|1|SCREENING|2020-07-09|2020-08-05|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-15
e|LB|08e4310f-f868-4858-a321-f33a21a771e8|8|C165925|Weed Mix Pollen IgE AB RAST Score|URINALYSIS|[?]|U/mg|[?]|[?]|POSITIVE|1|Gy|1|1|[?]|HIGH|ALVEOLAR AIR|REFRIGERATED||MICROBIAL CULTURE|FIBROSIS 4 FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2020-07-09|2020-07-19|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-15
e|LB|08e4310f-f868-4858-a321-f33a21a771e8|9|MLIGCEBC|Malignant Cells, NOS/Blood Cells|CHEMISTRY|[?]|RNA copies/mL|[?]|[?]|INVALID|1|min*mg/mL|1|1|[?]|NORMAL|CERUMEN|LACTESCENT||INTRAVASCULAR ULTRASOUND|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA||5|Visit_5|90|7|TREATMENT|2020-08-03|2020-08-06|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|08e4310f-f868-4858-a321-f33a21a771e8|10|PBG|Porphobilinogen|CHEMISTRY|[?]|10^6 CFU/mL|[?]|[?]|INDETERMINATE|1|Gauss|1|1|[?]|NORMAL|PERITONEAL FLUID|AGGLUTINATED||IMMUNOBLOT|CKD-EPI FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-08-03|2020-08-12|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|29edf133-8b5b-46d5-bf7a-f75af4658417|1|CYAMMBIU|Ammonium Biurate Crystals|URINALYSIS|[?]|mol/g|[?]|[?]|INVALID|1|10^6 IU/mL|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|DRIED||CYSTOMETRY|CKD-EPI FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-08-22|2020-10-16|10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|29edf133-8b5b-46d5-bf7a-f75af4658417|2|ACYLCAOX|Acyl Coenzyme A Oxidase|URINALYSIS|[?]|NEBULE|[?]|[?]|TRACE|1|nmol|1|1|[?]|ABNORMAL|NAIL|DRIED||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|2|TREATMENT|2020-08-22|2020-08-29|10|17|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|29edf133-8b5b-46d5-bf7a-f75af4658417|3|INGAPAB|Islet Neogenesis Assoc Protein Antibody|HEMATOLOGY|[?]|PFU/mL|[?]|[?]|BORDERLINE|1|RNA copies/mL|1|1|[?]|ABNORMAL|CELL PELLET|HEMOLYZED|N|CLIP SEQUENCING|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|3|SCREENING|2020-09-06|2020-09-07|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|29edf133-8b5b-46d5-bf7a-f75af4658417|4|CAMP|Cyclic Adenosine 3,5-Monophosphate|CHEMISTRY|[?]|mEq/dL|[?]|[?]|NEGATIVE|1|PELLET|1|1|[?]|ABNORMAL|REFLEX TEAR|CONCENTRATED||POLYMERASE CHAIN REACTION|CKD-EPI FORMULA|Y|Y|NA||2|Visit_2|25|1|TREATMENT|2020-09-06|2020-09-30|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|29edf133-8b5b-46d5-bf7a-f75af4658417|5|PTHRP|Parathyroid Hormone-related Protein|CHEMISTRY|[?]|Bq/ug|[?]|[?]|BORDERLINE|1|10^3 organisms/g|1|1|[?]|NORMAL|LYSATE|FROZEN||HIGH RESOLUTION MELT ANALYSIS|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||3|Visit_3|40|7|WASHOUT|2020-09-21|2020-11-18|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|29edf133-8b5b-46d5-bf7a-f75af4658417|6|DECORIN|Decorin|HEMATOLOGY|[?]|Sv|[?]|[?]|INVALID|1|uCi|1|1|[?]|HIGH|MENSTRUAL BLOOD|DRIED||LIGHT MICROSCOPY|MDRD 5 VARIABLE FORMULA|Y||NA||3|Visit_3|40|7|WASHOUT|2020-09-21|2020-10-19|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|29edf133-8b5b-46d5-bf7a-f75af4658417|7|NAGASECR|N-acetyl-B-D-glucosaminidase/Creatinine|URINALYSIS|[?]|L/day|[?]|[?]|INVALID|1|FIU|1|1|[?]|LOW|LYSATE|FROZEN||AUSCULTATION|MDRD FORMULA|||N||4|Visit_4|65|3|WASHOUT|2020-10-16|2020-11-19|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|29edf133-8b5b-46d5-bf7a-f75af4658417|8|CSGRANF|Granular Fine Casts|CHEMISTRY|||[?]|[?]|TRACE|1|mL/m2|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|DRIED|N|OBSERVATION|GMI MMOL/MOL FORMULA|Y||Y|Y|4|Visit_4|65|6|WASHOUT|2020-10-16|2020-11-04|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|29edf133-8b5b-46d5-bf7a-f75af4658417|9|CXCR3|Chemokine (C-X-C Motif) Receptor 3|URINALYSIS|||[?]|[?]|INVALID|1|Siemens|1|1|[?]|LOW|EPIDERMAL TISSUE|ICTERIC||CLINICAL EVALUATION|FIBROSIS 4 FORMULA|||Y|Y|5|Visit_5|90|4|WASHOUT|2020-11-10|2020-11-14|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|29edf133-8b5b-46d5-bf7a-f75af4658417|10|ANGTNS2|Angiotensin II|CHEMISTRY|[?]|APPLICATION|[?]|[?]|TRACE|1|nCi|1|1|[?]|ABNORMAL|SALIVA|HEMOLYZED|N|IN SITU HYBRIDIZATION|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|2|SCREENING|2020-11-10|2020-11-15|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|49756233-e18f-4187-8d48-3b6b4fa7e5c2|1|PLTAGAMP|Platelet Aggregation Amplitude|HEMATOLOGY|[?]|mg/m2/min|[?]|[?]|TRACE|1|DIP|1|1|[?]|NORMAL|HAIR|CONTAMINATED||MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||Y|N||1|Visit_1|10|1|SCREENING|2020-08-09|2020-09-25|10|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|49756233-e18f-4187-8d48-3b6b4fa7e5c2|2|FACTVWMU|von Willebrand Factor Multimers|HEMATOLOGY|[?]|mEq/dL|[?]|[?]|POSITIVE|1|% INHIBITION|1|1|[?]|NORMAL|EXUDATE|CALCIFIED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2020-08-09|2020-11-05|10|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|49756233-e18f-4187-8d48-3b6b4fa7e5c2|3|ALS|Acid Labile Subunit|CHEMISTRY|[?]|IU/kg|[?]|[?]|INVALID|1|mmol/L|1|1|[?]|ABNORMAL|PUS|FRESH|N|ELECTROGASTROGRAPHY|MDRD FORMULA|||NA||2|Visit_2|25|2|FOLLOW-UP|2020-08-24|2020-09-01|25|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|49756233-e18f-4187-8d48-3b6b4fa7e5c2|4|CCR5|C-C Chemokine Receptor Type 5|URINALYSIS|[?]|kDa|[?]|[?]|NEGATIVE|1|TRANSDUCING UNIT/mL|1|1|[?]|LOW|LAVAGE FLUID|THAWED||ICP-MS|CKD-EPI CYSTATIN C FORMULA||Y|Y||2|Visit_2|25|7|SCREENING|2020-08-24|2020-10-22|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|49756233-e18f-4187-8d48-3b6b4fa7e5c2|5|OPIATE|Opiate|CHEMISTRY|[?]|log10 PFU|[?]|[?]|INDETERMINATE|1|umol/dL|1|1|[?]|LOW|TRANSUDATE|ICTERIC||HEMATOXYLIN AND EOSIN STAIN|GMI MMOL/MOL FORMULA||Y|U||3|Visit_3|40|6|FOLLOW-UP|2020-09-08|2020-09-15|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|49756233-e18f-4187-8d48-3b6b4fa7e5c2|6|NEUTSGB|Neutrophils, Segmented + Band Form|CHEMISTRY|[?]|STEPS|[?]|[?]|INVALID|1|YEARS|1|1|[?]|HIGH|PLATELET RICH PLASMA|GELLED||EPSILOMETER|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||3|Visit_3|40|1|SCREENING|2020-09-08|2020-10-30|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|49756233-e18f-4187-8d48-3b6b4fa7e5c2|7|ANGLOBDR|Antiglobulin Test, Direct|CHEMISTRY|[?]|lm|[?]|[?]|INDETERMINATE|1|mEq/L|1|1|[?]|HIGH|SPUTUM|UNEXPECTED ODOR|N|TRIPLE-PHASE MRI SCAN|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|4|FOLLOW-UP|2020-10-03|2020-10-17|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|49756233-e18f-4187-8d48-3b6b4fa7e5c2|8|PTSAAC|Protein S Activity Actual/Control|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|10^6 organisms/mg|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED||HIGH RESOLUTION CT|FIBROTEST FORMULA|Y||Y|Y|4|Visit_4|65|3|TREATMENT|2020-10-03|2020-10-12|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|49756233-e18f-4187-8d48-3b6b4fa7e5c2|9|GFRBSCU|GFR from Creat and UreaN Adj BSA|CHEMISTRY|[?]|ug/animal|[?]|[?]|INDETERMINATE|1|kPa|1|1|[?]|LOW|PLATELET RICH PLASMA|CONCENTRATED||MALDI-TOF|CKD-EPI CYSTATIN C FORMULA||Y|U||5|Visit_5|90|3|FOLLOW-UP|2020-10-28|2020-10-29|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|49756233-e18f-4187-8d48-3b6b4fa7e5c2|10|CSFAT|Fatty Casts|HEMATOLOGY|[?]|10^8/L|[?]|[?]|INVALID|1|10^3 CFU|1|1|[?]|HIGH|LEUKOCYTE|AUTOLYZED||CYSTOMETRY|MDRD 4 VARIABLE FORMULA|Y||Y||5|Visit_5|90|4|TREATMENT|2020-10-28|2020-10-29|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|7a046104-7215-4708-9d85-66683ceb8fe8|1|FATACVLC|Fatty Acids, Very Long Chain|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mL/breath|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|AGGLUTINATED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|GMI % FORMULA|||U|Y|1|Visit_1|10|1|TREATMENT|2020-10-16|2020-10-17|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|LB|7a046104-7215-4708-9d85-66683ceb8fe8|2|S100B|S100 Calcium-Binding Protein B|HEMATOLOGY|[?]|keV|[?]|[?]|POSITIVE|1|mg/kg/week|1|1|[?]|ABNORMAL|SMEGMA|CONTAMINATED||MULTI-SLICE SPIRAL CT|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-10-16|2021-01-03|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|LB|7a046104-7215-4708-9d85-66683ceb8fe8|3|MCVRETIC|MCV Reticulocytes|URINALYSIS|[?]|WEEKS|[?]|[?]|TRACE|1|Gravitational Unit|1|1|[?]|NORMAL|CERUMEN|THAWED||MANUAL COUNT|MDRD 6 VARIABLE FORMULA|Y||Y||2|Visit_2|25|7|TREATMENT|2020-10-31|2021-01-13|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|7a046104-7215-4708-9d85-66683ceb8fe8|4|FACTXIA|Factor XI Activity|CHEMISTRY|[?]|BOWL|[?]|[?]|POSITIVE|1|ug/mol|1|1|[?]|HIGH|RETICULOCYTES|ROOM TEMPERATURE||MICROPARTICLE ENZYME IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||2|Visit_2|25|7|SCREENING|2020-10-31|2020-11-05|25|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|7a046104-7215-4708-9d85-66683ceb8fe8|5|BNZDZPN|Benzodiazepine|URINALYSIS|[?]|10^9 CFU/mL|[?]|[?]|INDETERMINATE|1|fmol|1|1|[?]|ABNORMAL|CELL PELLET|FRESH||DC SHEATH FLOW|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-11-15|2020-11-17|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|7a046104-7215-4708-9d85-66683ceb8fe8|6|BLSTMBCE|Myeloblasts/Total Cells|URINALYSIS|[?]|aMFI|[?]|[?]|POSITIVE|1|/wk|1|1|[?]|NORMAL|URINE SEDIMENT|CLOTTED|N|CONTRAST ENHANCED SPIRAL CT SCAN|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2020-11-15|2020-12-26|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|7a046104-7215-4708-9d85-66683ceb8fe8|7|MMP8|Matrix Metalloproteinase 8|HEMATOLOGY|||[?]|[?]|INVALID|1|CFU/g|1|1|[?]|NORMAL|CELL PELLET|CALCIFIED||MICROBIAL CULTURE, LIQUID|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y|Y|4|Visit_4|65|7|TREATMENT|2020-12-10|2020-12-13|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|7a046104-7215-4708-9d85-66683ceb8fe8|8|LYMPLLY|Plasmacytoid Lymphocytes/Lymphocytes|CHEMISTRY|[?]|10^3 DNA copies/mL|[?]|[?]|INDETERMINATE|1|mg/animal|1|1|[?]|NORMAL|LEUKOCYTE|LIPEMIC|N|CONTRAST ENHANCED X-RAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|4|SCREENING|2020-12-10|2020-12-30|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|7a046104-7215-4708-9d85-66683ceb8fe8|9|OXALATE|Oxalate|HEMATOLOGY|[?]|/2000 RBC|[?]|[?]|INVALID|1|log10 TCID 50/mL|1|1|[?]|LOW|FLUID|FRESH||PHYSICAL EXAMINATION|MDRD FORMULA|Y||NA||5|Visit_5|90|7|FOLLOW-UP|2021-01-04|2021-01-13|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|7a046104-7215-4708-9d85-66683ceb8fe8|10|C165941|Common Ragweed Pollen IgE AB RAST Score|CHEMISTRY|[?]|RFU|[?]|[?]|POSITIVE|1|L/min/m2|1|1|[?]|NORMAL|BONE MARROW|FRESH||PHOTOMETRY|HEPASCORE FORMULA|||U||5|Visit_5|90|7|SCREENING|2021-01-04|2021-01-08|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|1|ALDEPX|Aldrin Epoxidase|HEMATOLOGY|[?]|mJoule/cm2|[?]|[?]|INDETERMINATE|1|Antibody Unit|1|1|[?]|LOW|BONE MARROW|FRESH||PUPILLOMETRY|CKD-EPI CYSTATIN C FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2021-01-26|2021-03-14|10|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|2|NPAP|Non-Prostatic Acid Phosphatase|CHEMISTRY|[?]|VIRTUAL PIXEL|[?]|[?]|BORDERLINE|1|10^6 U|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|FROZEN|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA|||NA||1|Visit_1|10|5|WASHOUT|2021-01-26|2021-02-13|10|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|3|IBCT|Total Iron Binding Capacity|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|uV*sec|1|1|[?]|LOW|INFRANATANT, SERUM|PARAFFIN-EMBEDDED||FLUORESCENT IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|2|Visit_2|25|5|TREATMENT|2021-02-10|2021-03-21|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|LB|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|4|VTRNCTN|Vitronectin|URINALYSIS|[?]|ms/mmHg|[?]|[?]|INVALID|1|nmol/day|1|1|[?]|LOW|ENDOTRACHEAL FLUID|GELLED||FORCED OSCILLATION TECHNIQUE|NASH FIBROSURE FORMULA|Y||U||2|Visit_2|25|3|TREATMENT|2021-02-10|2021-03-11|25|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|LB|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|5|CA2729AG|Cancer Antigen 27-29|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|dL|1|1|[?]|LOW|LOCHIA|CONTAMINATED||LIGHT SCATTERING SPECTROSCOPY|NASH FIBROSURE FORMULA|||N|Y|3|Visit_3|40|6|SCREENING|2021-02-25|2021-04-03|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|LB|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|6|C165877|Cat Dander IgE AB RAST Score|CHEMISTRY|[?]|mV/sec|[?]|[?]|NEGATIVE|1|Torr|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|CONCENTRATED|N|CISH|FIBROMETER FORMULA|||U||3|Visit_3|40|5|WASHOUT|2021-02-25|2021-04-19|40|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|LB|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|7|MSTHCE|Mesothelial Cells|URINALYSIS|[?]|nmol/L/min|[?]|[?]|POSITIVE|1|ks|1|1|[?]|ABNORMAL|BILE|CONTAMINATED|N|TELLER ACUITY CARDS|FIBROTEST FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2021-03-22|2021-04-21|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|8|BCEFNCTN|Beta-cell Function|URINALYSIS|[?]|TRANSDUCING UNIT/mL|[?]|[?]|BORDERLINE|1|10^6 organisms|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR||SPECTROPHOTOMETRY|CKD-EPI FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2021-03-22|2021-04-19|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|9|LDH2LDH|LDH Isoenzyme 2/LDH|URINALYSIS|[?]|/2500 WBC|[?]|[?]|INVALID|1|ohm|1|1|[?]|LOW|WHITE MATTER TISSUE|ICTERIC||SPECTROPHOTOMETRY|HEPASCORE FORMULA|||N||5|Visit_5|90|2|WASHOUT|2021-04-16|2021-04-18|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-23
e|LB|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|10|C165929|Bee Mix IgE AB RAST Score|CHEMISTRY|[?]|MESF|[?]|[?]|INVALID|1|VIRTUAL PIXEL|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|ICTERIC||MEDIASTINOSCOPY|FIBROMETER FORMULA|||Y||5|Visit_5|90|4|SCREENING|2021-04-16|2021-04-22|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-23
e|LB|bcbe7d50-2ebe-483a-9d71-dce4094f864e|1|GLUCPE|Plasma Equivalent Glucose|HEMATOLOGY|[?]|mm/2h|[?]|[?]|TRACE|1|uOsm|1|1|[?]|NORMAL|ADIPOSE TISSUE|CLOTTED||RYAN BLUE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-05-25|2020-08-05|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|bcbe7d50-2ebe-483a-9d71-dce4094f864e|2|KIM1S|Soluble Kidney Injury Molecule-1|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ug/animal|1|1|[?]|ABNORMAL|ISOLATE|LIPEMIC||TELLER ACUITY CARDS|ASH FIBROSURE FORMULA||Y|U|Y|1|Visit_1|10|4|TREATMENT|2020-05-25|2020-06-22|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|bcbe7d50-2ebe-483a-9d71-dce4094f864e|3|APPA|Amyloid Alpha Precursor Protein|URINALYSIS|[?]|U/g/day|[?]|[?]|POSITIVE|1|atm|1|1|[?]|NORMAL|ABSCESS FLUID|LACTESCENT|N|ICP-MS|MDRD FORMULA|Y||U||2|Visit_2|25|6|WASHOUT|2020-06-09|2020-08-01|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|bcbe7d50-2ebe-483a-9d71-dce4094f864e|4|C3ADARG|Complement C3a DesArg|HEMATOLOGY|[?]|10^7 PFU|[?]|[?]|INDETERMINATE|1|NEEDLE GAUGE|1|1|[?]|NORMAL|PUS|UNEXPECTED ODOR|N|ERGOSPIROMETRY|MDRD 6 VARIABLE FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-06-09|2020-08-08|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|bcbe7d50-2ebe-483a-9d71-dce4094f864e|5|ESELECT|E-Selectin|HEMATOLOGY|[?]|kcal|[?]|[?]|BORDERLINE|1|uCi/L|1|1|[?]|LOW|EXPIRED AIR|SOLIDIFIED||ENZYMATIC ULTRACENTRIFUGATION|ASH FIBROSURE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-06-24|2020-07-04|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|LB|bcbe7d50-2ebe-483a-9d71-dce4094f864e|6|ANA|Antinuclear Antibodies|CHEMISTRY|||[?]|[?]|TRACE|1|hPa|1|1|[?]|LOW|CAPILLARY PLASMA|AGGLUTINATED||DYNAMIC LIGHT SCATTERING|CKD-EPI CYSTATIN C FORMULA|||U|Y|3|Visit_3|40|1|TREATMENT|2020-06-24|2020-08-15|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|LB|bcbe7d50-2ebe-483a-9d71-dce4094f864e|7|FEPI|Fractional Phosphorus Excretion|CHEMISTRY|[?]|log10 PFU/mL|[?]|[?]|BORDERLINE|1|mg/L|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|CONTAMINATED|N|POLYSOMNOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||4|Visit_4|65|5|TREATMENT|2020-07-19|2020-07-28|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|LB|bcbe7d50-2ebe-483a-9d71-dce4094f864e|8|TIMP3|Tissue Inhibitor of Metalloproteinase 3|HEMATOLOGY|||[?]|[?]|INVALID|1|MPS U|1|1|[?]|HIGH|CORD SERUM|GELLED||IODINE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N|Y|4|Visit_4|65|6|TREATMENT|2020-07-19|2020-08-20|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|LB|bcbe7d50-2ebe-483a-9d71-dce4094f864e|9|PAH|P-Aminohippurate Sodium|HEMATOLOGY|[?]|g/cage/day|[?]|[?]|INVALID|1|GPL U/mL|1|1|[?]|LOW|ARTERIAL BLOOD|CALCIFIED||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|GMI % FORMULA|Y||N||5|Visit_5|90|3|SCREENING|2020-08-13|2020-08-22|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|bcbe7d50-2ebe-483a-9d71-dce4094f864e|10|CSCELL|Cellular Casts|URINALYSIS|[?]|10^7 CFU/mL|[?]|[?]|BORDERLINE|1|mEq/mL|1|1|[?]|ABNORMAL|PERITONEAL FLUID|FROZEN||CALCOFLUOR WHITE STAIN|MDRD 4 VARIABLE FORMULA|||U||5|Visit_5|90|3|TREATMENT|2020-08-13|2020-08-15|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|2550ba24-7bcf-41e2-9eae-536e13d4b345|1|SPGRAV|Specific Gravity|CHEMISTRY|[?]|mL/g/min|[?]|[?]|INDETERMINATE|1|TRANSDUCING UNIT|1|1|[?]|LOW|CAPILLARY BLOOD|CONTAMINATED||FLUORIMETRY|CKD-EPI FORMULA|Y||U||1|Visit_1|10|6|SCREENING|2021-01-20|2021-01-23|10|13|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|2550ba24-7bcf-41e2-9eae-536e13d4b345|2|PROMYCE|Promyelocytes/Total Cells|CHEMISTRY|[?]|U.CARR|[?]|[?]|POSITIVE|1|EVENTS|1|1|[?]|ABNORMAL|PLASMA|THAWED||PALM METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||1|Visit_1|10|2|WASHOUT|2021-01-20|2021-04-13|10|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|2550ba24-7bcf-41e2-9eae-536e13d4b345|3|CHCMR|Ret. Corpuscular HGB Concentration Mean|HEMATOLOGY|[?]|AgU/mL|[?]|[?]|TRACE|1|LB|1|1|[?]|HIGH|MECONIUM|FROZEN||CENTRIFUGATION|HEPASCORE FORMULA|Y||U||2|Visit_2|25|1|FOLLOW-UP|2021-02-04|2021-03-08|25|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|LB|2550ba24-7bcf-41e2-9eae-536e13d4b345|4|CRH|Corticotropin Releasing Hormone|HEMATOLOGY|[?]|sec|[?]|[?]|INVALID|1|CCID 50/dose|1|1|[?]|HIGH|ADIPOSE TISSUE|THAWED|N|NO INFORMATION|FIBROMETER FORMULA|||U||2|Visit_2|25|3|FOLLOW-UP|2021-02-04|2021-04-11|25|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|LB|2550ba24-7bcf-41e2-9eae-536e13d4b345|5|BAFF|B-Cell Activating Factor|HEMATOLOGY|[?]|mg/kg/h|[?]|[?]|BORDERLINE|1|ug/kg/min|1|1|[?]|HIGH|SYNOVIAL FLUID|SOLIDIFIED||THERMAL IONIZATION MASS SPECTROMETRY|GMI MMOL/MOL FORMULA|Y||Y||3|Visit_3|40|7|TREATMENT|2021-02-19|2021-03-10|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|2550ba24-7bcf-41e2-9eae-536e13d4b345|6|C147283|White Elm Pollen IgG Antibody|CHEMISTRY|[?]|dB|[?]|[?]|INVALID|1|10^9 CFU|1|1|[?]|ABNORMAL|HAIR|CONCENTRATED|N|SPECULAR MICROSCOPY|GMI MMOL/MOL FORMULA|||U||3|Visit_3|40|4|TREATMENT|2021-02-19|2021-04-09|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|2550ba24-7bcf-41e2-9eae-536e13d4b345|7|SJSSBAB|Sjogrens SS-B Antibody|URINALYSIS|||[?]|[?]|TRACE|1|DNA copies/mL|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|LACTESCENT||BIOPSY|MDRD 6 VARIABLE FORMULA||Y|Y|Y|4|Visit_4|65|3|FOLLOW-UP|2021-03-16|2021-04-16|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|2550ba24-7bcf-41e2-9eae-536e13d4b345|8|WBC|Leukocytes|URINALYSIS|||[?]|[?]|TRACE|1|Ci/ug|1|1|[?]|HIGH|KERATINOCYTE|FRESH|N|LIQUID SCINTILLATION COUNTING|FIBROMETER FORMULA||Y|U|Y|4|Visit_4|65|5|TREATMENT|2021-03-16|2021-04-04|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|2550ba24-7bcf-41e2-9eae-536e13d4b345|9|CCL8|Chemokine (C-C Motif) Ligand 8|URINALYSIS|||[?]|[?]|TRACE|1|pt_us|1|1|[?]|ABNORMAL|PLATELET|REFRIGERATED|N|CONTRAST ENHANCED PET SCAN|MDRD 6 VARIABLE FORMULA|Y|Y|NA|Y|5|Visit_5|90|6|TREATMENT|2021-04-10|2021-04-12|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|2550ba24-7bcf-41e2-9eae-536e13d4b345|10|FABP1|Fatty Acid Binding Protein 1|CHEMISTRY|[?]|foz_br|[?]|[?]|POSITIVE|1|mg/kg/h|1|1|[?]|HIGH|NAIL|CONTAMINATED||KARYOTYPING|FIBROMETER FORMULA|Y||NA||5|Visit_5|90|1|TREATMENT|2021-04-10|2021-04-12|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|1|HEXK|Hexokinase|URINALYSIS|[?]|Bq/mg|[?]|[?]|INDETERMINATE|1|umol/L/sec|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|LACTESCENT||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||1|Visit_1|10|7|TREATMENT|2020-08-14|2020-09-12|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|2|LEAD|Lead|URINALYSIS|||[?]|[?]|TRACE|1|psec|1|1|[?]|HIGH|ISOLATE|SOLIDIFIED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|2|TREATMENT|2020-08-14|2020-09-19|10|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|3|DNASEBAB|DNase-B Antibody|CHEMISTRY|||[?]|[?]|NEGATIVE|1|umol/L|1|1|[?]|LOW|INTERSTITIAL FLUID|LIPEMIC|N|SINGLE-SLICE SPIRAL CT|MDRD 4 VARIABLE FORMULA|||NA|Y|2|Visit_2|25|2|TREATMENT|2020-08-29|2020-09-05|25|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|4|TSIAC|TSI Actual/Control|CHEMISTRY|||[?]|[?]|NEGATIVE|1|GPS U|1|1|[?]|HIGH|NAIL|REFRIGERATED||POTENTIOMETRY|CKD-EPI FORMULA|||N|Y|2|Visit_2|25|7|TREATMENT|2020-08-29|2020-10-29|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|5|AG1_5|1,5-Anhydroglucitol|URINALYSIS|[?]|10^6 U|[?]|[?]|BORDERLINE|1|nmol/mol|1|1|[?]|HIGH|SEMEN|PARAFFIN-EMBEDDED||OPTICAL DENSITY MEASUREMENT|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|7|SCREENING|2020-09-13|2020-11-03|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|LB|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|6|S6PHS|Phos-S6 Ribosomal Protein|CHEMISTRY|[?]|log10 copies/mL|[?]|[?]|INVALID|1|oz eq|1|1|[?]|LOW|CORD SERUM|FROZEN||DIGITAL PCR|MDRD 6 VARIABLE FORMULA||Y|Y||3|Visit_3|40|4|FOLLOW-UP|2020-09-13|2020-11-11|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|LB|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|7|GMI|Glucose Management Indicator|HEMATOLOGY|[?]|ug/L FEU|[?]|[?]|BORDERLINE|1|g/kg|1|1|[?]|NORMAL|SEBUM|PARAFFIN-EMBEDDED||TOLUIDINE BLUE STAIN|GMI MMOL/MOL FORMULA|||U||4|Visit_4|65|6|SCREENING|2020-10-08|2020-10-15|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|8|HIST2AAB|Histone 2A Antibody|URINALYSIS|[?]|100 IU/mL|[?]|[?]|INDETERMINATE|1|10^6/L|1|1|[?]|HIGH|LEUKOCYTE|SOLIDIFIED||JAEGER EYE CHART|GMI % FORMULA|Y||NA||4|Visit_4|65|7|TREATMENT|2020-10-08|2020-10-27|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|9|CYHGBC|Hemoglobin C Crystals|HEMATOLOGY|[?]|ugEq/L|[?]|[?]|INVALID|1|mL/mmHg|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|ICTERIC||CALIPER MEASUREMENT METHOD|FIBROTEST FORMULA||Y|U||5|Visit_5|90|1|FOLLOW-UP|2020-11-02|2020-11-05|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|10|CHYTRYP|Chymotrypsin|HEMATOLOGY|[?]|dpm/0.5 mL|[?]|[?]|BORDERLINE|1|NEEDLE GAUGE|1|1|[?]|LOW|SPERMATOZOON|THAWED||DUCTOGRAPHY|MDRD 6 VARIABLE FORMULA|Y|Y|Y||5|Visit_5|90|1|WASHOUT|2020-11-02|2020-11-08|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|6ec23671-252e-4dc9-b919-88254fce68a5|1|GHRELINA|Active Ghrelin|HEMATOLOGY|[?]|10^6 IU|[?]|[?]|BORDERLINE|1|RATIO|1|1|[?]|LOW|STOOL|UNEXPECTED ODOR|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CREATININE FORMULA|Y||Y||1|Visit_1|10|5|TREATMENT|2020-07-28|2020-08-12|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|6ec23671-252e-4dc9-b919-88254fce68a5|2|SAA1|Serum Amyloid A1|URINALYSIS|[?]|10^9 CFU|[?]|[?]|POSITIVE|1|mCi/L|1|1|[?]|LOW|CORD SERUM|FRESH|N|LIGHT SCATTERING SPECTROSCOPY|FIBROMETER FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-07-28|2020-08-03|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|6ec23671-252e-4dc9-b919-88254fce68a5|3|GFRBSCYC|GFR from Cystatin C Adjusted for BSA|URINALYSIS|||[?]|[?]|TRACE|1|mmol|1|1|[?]|HIGH|BONE MARROW|UNEXPECTED ODOR||MECHANICAL CLOT DETECTION|MDRD 5 VARIABLE FORMULA|Y||U|Y|2|Visit_2|25|2|WASHOUT|2020-08-12|2020-10-18|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|6ec23671-252e-4dc9-b919-88254fce68a5|4|ESTRDIOL|Estradiol|URINALYSIS|[?]|uCi/kg|[?]|[?]|TRACE|1|uCi|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|CONTAMINATED||PHOTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|1|FOLLOW-UP|2020-08-12|2020-10-15|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|6ec23671-252e-4dc9-b919-88254fce68a5|5|CARNTEXR|Carnitine Excretion Rate|CHEMISTRY|||[?]|[?]|TRACE|1|mol/mol|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|ICTERIC||IMMUNOCHROMATOGRAPHY|GMI MMOL/MOL FORMULA|||NA|Y|3|Visit_3|40|1|TREATMENT|2020-08-27|2020-09-21|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|6ec23671-252e-4dc9-b919-88254fce68a5|6|MSPIKER|Monoclonal Protein Spike Region|URINALYSIS|||[?]|[?]|NEGATIVE|1|Pack Year|1|1|[?]|NORMAL|RETICULOCYTES|AUTOLYZED||CONFOCAL MICROSCOPY|FIBROMETER FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2020-08-27|2020-09-24|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|6ec23671-252e-4dc9-b919-88254fce68a5|7|CYAMPPH|Amorphous Phosphate Crystals|CHEMISTRY|||[?]|[?]|TRACE|1|Ci/kg|1|1|[?]|ABNORMAL|SOFT TISSUE|REFRIGERATED||PALM METHOD|FIBROMETER FORMULA|||NA|Y|4|Visit_4|65|1|FOLLOW-UP|2020-09-21|2020-10-19|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|6ec23671-252e-4dc9-b919-88254fce68a5|8|TROPONI|Troponin I|URINALYSIS|[?]|cmol|[?]|[?]|POSITIVE|1|mL|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|FROZEN||HPLC/MS|HEPASCORE FORMULA||Y|NA||4|Visit_4|65|6|WASHOUT|2020-09-21|2020-10-02|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|6ec23671-252e-4dc9-b919-88254fce68a5|9|HDLPL|HDL Phospholipid|URINALYSIS|[?]|log10 PFU|[?]|[?]|INVALID|1|HOURS|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|ROOM TEMPERATURE||DISK DIFFUSION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||5|Visit_5|90|2|TREATMENT|2020-10-16|2020-10-21|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|6ec23671-252e-4dc9-b919-88254fce68a5|10|HLAA2AB|HLA-A2 Antibody|CHEMISTRY|[?]|MET|[?]|[?]|NEGATIVE|1|mg/dose|1|1|[?]|NORMAL|BILE|CONTAMINATED||DROPLET DIGITAL PCR|CKD-EPI CREATININE FORMULA|||U||5|Visit_5|90|3|SCREENING|2020-10-16|2020-10-21|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|db59e5e1-ccda-480b-8955-da5157e16c4a|1|CSHYAL|Hyaline Casts|URINALYSIS|[?]|kg/cm|[?]|[?]|NEGATIVE|1|MPL U/mL|1|1|[?]|NORMAL|PERSPIRATION|NON-HEMOLYZED||X-RAY FLUORESCENCE SPECTROMETRY|GMI % FORMULA||Y|NA||1|Visit_1|10|2|FOLLOW-UP|2020-05-14|2020-05-30|10|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|LB|db59e5e1-ccda-480b-8955-da5157e16c4a|2|ACANTRBC|Acanthocytes/Erythrocytes|URINALYSIS|||[?]|[?]|TRACE|1|cd*s/m2|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|FRESH|N|DOUBLE IMMUNODIFFUSION|GMI % FORMULA||Y|U|Y|1|Visit_1|10|6|SCREENING|2020-05-14|2020-06-29|10|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|LB|db59e5e1-ccda-480b-8955-da5157e16c4a|3|AMYLB42|Amyloid Beta 1-42|URINALYSIS|[?]|g|[?]|[?]|NEGATIVE|1|STRIP|1|1|[?]|LOW|DERMAL TISSUE|THAWED|N|LAPAROSCOPY|FIBROSIS 4 FORMULA|Y|Y|N||2|Visit_2|25|6|TREATMENT|2020-05-29|2020-07-07|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|db59e5e1-ccda-480b-8955-da5157e16c4a|4|LDLPATT|LDL Subtype Pattern|CHEMISTRY|[?]|ug|[?]|[?]|NEGATIVE|1|PIPE|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|REFRIGERATED||NEURAMINIDASE INHIBITION ASSAY|MDRD 6 VARIABLE FORMULA|||N||2|Visit_2|25|2|SCREENING|2020-05-29|2020-07-26|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|db59e5e1-ccda-480b-8955-da5157e16c4a|5|CYAMPURT|Amorphous Urate Crystals|CHEMISTRY|[?]|uV2|[?]|[?]|BORDERLINE|1|IU/day|1|1|[?]|LOW|CORD SERUM|CLOTTED||ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA|Y||Y||3|Visit_3|40|4|TREATMENT|2020-06-13|2020-07-29|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-07
e|LB|db59e5e1-ccda-480b-8955-da5157e16c4a|6|INTLK27|Interleukin 27|HEMATOLOGY|[?]|MESF|[?]|[?]|POSITIVE|1|Ejaculate U|1|1|[?]|ABNORMAL|LYSATE|SOLIDIFIED|N|ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|N||3|Visit_3|40|5|TREATMENT|2020-06-13|2020-06-15|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-07
e|LB|db59e5e1-ccda-480b-8955-da5157e16c4a|7|PECAM|Platelet Endothelial Adhesion Molecule|CHEMISTRY|[?]|MPS U|[?]|[?]|TRACE|1|mL/cage/wk|1|1|[?]|LOW|CAPILLARY BLOOD|ICTERIC||ELECTRONEUROGRAPHY|GMI MMOL/MOL FORMULA|||NA||4|Visit_4|65|1|FOLLOW-UP|2020-07-08|2020-07-15|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|db59e5e1-ccda-480b-8955-da5157e16c4a|8|CSEPI|Epithelial Casts|CHEMISTRY|||[?]|[?]|BORDERLINE|1|U/m2/day|1|1|[?]|HIGH|KERATINOCYTE|LIPEMIC|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD 5 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|1|WASHOUT|2020-07-08|2020-07-17|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|db59e5e1-ccda-480b-8955-da5157e16c4a|9|C165906|Weed Mix Pollen IgG AB RAST Score|URINALYSIS|[?]|Gravitational Unit|[?]|[?]|POSITIVE|1|BP|1|1|[?]|ABNORMAL|BASAL TEAR|ICTERIC|N|DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI FORMULA|Y|Y|U||5|Visit_5|90|5|TREATMENT|2020-08-02|2020-08-04|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|db59e5e1-ccda-480b-8955-da5157e16c4a|10|CKMT1CK|CK, Macromolecular Type 1/Total CK|HEMATOLOGY|[?]|kg/cm|[?]|[?]|INVALID|1|usec|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|GELLED||ICP-MS|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|4|TREATMENT|2020-08-02|2020-08-05|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|1dce856e-b7cb-4899-b27f-87ab8d918df4|1|HEPCIDIN|Hepcidin|URINALYSIS|[?]|mkat|[?]|[?]|BORDERLINE|1|Joule|1|1|[?]|ABNORMAL|TISSUE|CONCENTRATED||SNP ARRAY|NASH FIBROSURE FORMULA|||Y||1|Visit_1|10|1|FOLLOW-UP|2020-09-12|2020-09-24|10|22|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|1dce856e-b7cb-4899-b27f-87ab8d918df4|2|PTHCT|Parathyroid Hormone, C-Terminal|URINALYSIS|[?]|mg/dL|[?]|[?]|INVALID|1|CAPFUL|1|1|[?]|LOW|PERITONEAL FLUID|ICTERIC||HILLMEN COLOR CHART|FIBROTEST FORMULA||Y|U||1|Visit_1|10|6|TREATMENT|2020-09-12|2020-10-06|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|1dce856e-b7cb-4899-b27f-87ab8d918df4|3|MSPIKEPT|Monoclonal Protein Spike/Total Protein|CHEMISTRY|[?]|Arbitrary U|[?]|[?]|NEGATIVE|1|uV|1|1|[?]|NORMAL|REFLEX TEAR|AUTOLYZED|N|CT SCAN|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-09-27|2020-11-22|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|1dce856e-b7cb-4899-b27f-87ab8d918df4|4|CD40L|CD40 Ligand|URINALYSIS|[?]|amu|[?]|[?]|BORDERLINE|1|mmHg|1|1|[?]|NORMAL|SEMEN|THAWED||CELL BASED BIOASSAY|GMI % FORMULA|||Y||2|Visit_2|25|1|WASHOUT|2020-09-27|2020-10-19|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|1dce856e-b7cb-4899-b27f-87ab8d918df4|5|KLHIGGAB|Keyhole Limpet Hemocyanin IgG Antibody|CHEMISTRY|[?]|mmHg/sec|[?]|[?]|TRACE|1|PFU/mL|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|FRESH|N|TOLUIDINE BLUE STAIN|MDRD ENZYMATIC FORMULA|Y||Y||3|Visit_3|40|3|TREATMENT|2020-10-12|2020-12-08|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|1dce856e-b7cb-4899-b27f-87ab8d918df4|6|C130090|Timothy Grass Pollen IgG|CHEMISTRY|[?]|10^6 organisms/mg|[?]|[?]|INVALID|1|MnFI|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|GELLED|N|WESTERN BLOT|MDRD ENZYMATIC FORMULA|||Y||3|Visit_3|40|5|WASHOUT|2020-10-12|2020-11-19|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|1dce856e-b7cb-4899-b27f-87ab8d918df4|7|LH|Luteinizing Hormone|CHEMISTRY|[?]|L/day|[?]|[?]|NEGATIVE|1|mkat|1|1|[?]|LOW|HAIR FOLLICLE|SOLIDIFIED||IMPEDANCE CONDUCTIVITY|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2020-11-06|2020-11-12|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|1dce856e-b7cb-4899-b27f-87ab8d918df4|8|PTSFAC|Protein S, Free Actual/Control|HEMATOLOGY|[?]|APS U|[?]|[?]|BORDERLINE|1|POINT|1|1|[?]|NORMAL|SEMEN|UNEXPECTED ODOR||GC/MS|FIBROMETER FORMULA|||Y||4|Visit_4|65|1|TREATMENT|2020-11-06|2020-11-12|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|1dce856e-b7cb-4899-b27f-87ab8d918df4|9|LDLOXI|Oxidized LDL Cholesterol|HEMATOLOGY|[?]|ppm|[?]|[?]|INDETERMINATE|1|g/cage/day|1|1|[?]|ABNORMAL|EXUDATE|HEMOLYZED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA||Y|N||5|Visit_5|90|6|WASHOUT|2020-12-01|2020-12-09|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|1dce856e-b7cb-4899-b27f-87ab8d918df4|10|PGE1|Prostaglandin E1|CHEMISTRY|[?]|Log10 ELISA unit/dose|[?]|[?]|NEGATIVE|1|ukat/L|1|1|[?]|LOW|SOFT TISSUE|CALCIFIED||EPSILOMETER|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2020-12-01|2020-12-08|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|7449180b-e226-4e97-a059-8760f6523f77|1|INTLK30|Interleukin 30|CHEMISTRY|[?]|Ci/g|[?]|[?]|TRACE|1|umol/day|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|AUTOLYZED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|CKD-EPI CREATININE FORMULA||Y|Y||1|Visit_1|10|2|SCREENING|2020-07-04|2020-07-20|10|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|LB|7449180b-e226-4e97-a059-8760f6523f77|2|PGF2AI8|8-Iso-Prostaglandin F2 Alpha|URINALYSIS|[?]|umol/h/mmol|[?]|[?]|NEGATIVE|1|h*%|1|1|[?]|HIGH|EXPIRED AIR|UNEXPECTED ODOR||MAPH|CKD-EPI CREATININE FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-07-04|2020-07-10|10|16|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|LB|7449180b-e226-4e97-a059-8760f6523f77|3|AMA|Antimitochondrial Antibodies|CHEMISTRY|[?]|Bq|[?]|[?]|NEGATIVE|1|oz eq|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|LACTESCENT||WHOLE EXOME SEQUENCING|MDRD FORMULA|Y|Y|NA||2|Visit_2|25|3|TREATMENT|2020-07-19|2020-08-26|25|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|7449180b-e226-4e97-a059-8760f6523f77|4|MNC|Mononuclear Cells|URINALYSIS|[?]|uV|[?]|[?]|POSITIVE|1|10^3 organisms|1|1|[?]|LOW|LYMPH|FRESH|N|MRS|MDRD FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-07-19|2020-08-04|25|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|7449180b-e226-4e97-a059-8760f6523f77|5|TBG|Thyroxine Binding Globulin|URINALYSIS|[?]|ugEq|[?]|[?]|POSITIVE|1|10^3 CFU/g|1|1|[?]|HIGH|BONE|CLOTTED||PH METER MEASUREMENT METHOD|FIBROTEST FORMULA|||NA||3|Visit_3|40|2|SCREENING|2020-08-03|2020-10-01|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|7449180b-e226-4e97-a059-8760f6523f77|6|GLOBB2|Beta-2 Globulin|URINALYSIS|[?]|mmol/min/kPa|[?]|[?]|INVALID|1|DRUM|1|1|[?]|NORMAL|SALIVA|SOLIDIFIED||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|COCKCROFT-GAULT FORMULA|||NA||3|Visit_3|40|7|SCREENING|2020-08-03|2020-08-14|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|7449180b-e226-4e97-a059-8760f6523f77|7|HOMOCIT|Homocitrulline|CHEMISTRY|[?]|CFU/g|[?]|[?]|INDETERMINATE|1|10^3 DNA copies/mL|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|ROOM TEMPERATURE||COULOMETRIC TITRATION|MDRD 4 VARIABLE FORMULA|||N||4|Visit_4|65|7|FOLLOW-UP|2020-08-28|2020-09-30|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|7449180b-e226-4e97-a059-8760f6523f77|8|COTININE|Cotinine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ug/mol|1|1|[?]|NORMAL|GASTRIC FLUID|UNEXPECTED ODOR|N|CONTRAST ENHANCED X-RAY|GMI % FORMULA||Y|Y|Y|4|Visit_4|65|6|TREATMENT|2020-08-28|2020-09-11|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|7449180b-e226-4e97-a059-8760f6523f77|9|EOSBLE|Eosinophils Band Form/Leukocytes|URINALYSIS|[?]|mL/mmHg|[?]|[?]|TRACE|1|BISCUIT|1|1|[?]|ABNORMAL|CERUMEN|DRIED|N|GC/MS/MS|MDRD ENZYMATIC FORMULA|Y||NA||5|Visit_5|90|1|TREATMENT|2020-09-22|2020-10-01|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|7449180b-e226-4e97-a059-8760f6523f77|10|RFIGMAB|Rheumatoid Factor IgM Antibody|HEMATOLOGY|[?]|HEP|[?]|[?]|NEGATIVE|1|JDF Unit|1|1|[?]|NORMAL|HAIR|DRIED||DXA SCAN|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|5|SCREENING|2020-09-22|2020-09-29|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|f077c497-b0f0-4a20-b448-608b0cc6ab36|1|HBOARBHB|Hemoglobin O-Arab/Total Hemoglobin|URINALYSIS|[?]|mmol2/L2|[?]|[?]|INDETERMINATE|1|fmol|1|1|[?]|ABNORMAL|ABSCESS FLUID|CLOTTED|N|LANDOLT RING|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||1|Visit_1|10|1|TREATMENT|2020-06-08|2020-08-22|10|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|LB|f077c497-b0f0-4a20-b448-608b0cc6ab36|2|ACPHOS|Acid Phosphatase|CHEMISTRY|||[?]|[?]|INVALID|1|mL/dL|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|ICTERIC||DIGITAL PCR|MDRD FORMULA|Y||Y|Y|1|Visit_1|10|6|FOLLOW-UP|2020-06-08|2020-08-31|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|LB|f077c497-b0f0-4a20-b448-608b0cc6ab36|3|FBNCTPL|Fibronectin, Plasma|HEMATOLOGY|[?]|dyn|[?]|[?]|NEGATIVE|1|/mm2|1|1|[?]|HIGH|CELL PELLET|AUTOLYZED||CARDIAC THERMODILUTION|CKD-EPI CYSTATIN C FORMULA|Y|Y|U||2|Visit_2|25|5|TREATMENT|2020-06-23|2020-08-10|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|LB|f077c497-b0f0-4a20-b448-608b0cc6ab36|4|ENRAGE|Extracell Newly Ident RAGE Bind Protein|HEMATOLOGY|[?]|mL/cage/day|[?]|[?]|NEGATIVE|1|sec|1|1|[?]|HIGH|RETICULOCYTES|CALCIFIED||CLINICAL EVALUATION|FIBROSIS 4 FORMULA|||Y||2|Visit_2|25|1|SCREENING|2020-06-23|2020-06-29|25|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|LB|f077c497-b0f0-4a20-b448-608b0cc6ab36|5|C165882|White Elm Pollen IgE AB RAST Score|CHEMISTRY|[?]|mL/breath|[?]|[?]|INVALID|1|g/cage|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|GELLED||REFRACTOMETRY|HEPASCORE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-07-08|2020-07-11|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|f077c497-b0f0-4a20-b448-608b0cc6ab36|6|APOA2|Apolipoprotein AII|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|BOTTLE|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|LACTESCENT|N|TWO-COLOR MICROARRAY|COCKCROFT-GAULT FORMULA|||N|Y|3|Visit_3|40|6|TREATMENT|2020-07-08|2020-08-04|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|f077c497-b0f0-4a20-b448-608b0cc6ab36|7|C130095|Western Ragweed Pollen IgG4|URINALYSIS|[?]|10^6/g|[?]|[?]|TRACE|1|/day|1|1|[?]|LOW|AMNIOTIC FLUID|PARAFFIN-EMBEDDED|N|COULOMETRIC TITRATION|FIBROMETER FORMULA|||N||4|Visit_4|65|6|TREATMENT|2020-08-02|2020-08-19|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|f077c497-b0f0-4a20-b448-608b0cc6ab36|8|EPITUCE|Tubular Epithelial Cells|URINALYSIS|||[?]|[?]|TRACE|1|Ci/L|1|1|[?]|ABNORMAL|COLOSTRUM|ROOM TEMPERATURE||SPIRAL CT|MDRD 6 VARIABLE FORMULA||Y|N|Y|4|Visit_4|65|6|FOLLOW-UP|2020-08-02|2020-09-03|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|f077c497-b0f0-4a20-b448-608b0cc6ab36|9|PO2FIO2|PP Arterial O2/Fraction Inspired O2|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|Osm|1|1|[?]|HIGH|INFRANATANT, SERUM|LIPEMIC||TARGETED TRANSCRIPTOME SEQUENCING|MDRD ENZYMATIC FORMULA|||NA|Y|5|Visit_5|90|5|TREATMENT|2020-08-27|2020-09-02|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|f077c497-b0f0-4a20-b448-608b0cc6ab36|10|PROINSUL|Proinsulin|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mol/L|1|1|[?]|HIGH|COLOSTRUM|LIPEMIC|N|SXA SCAN|COCKCROFT-GAULT FORMULA|||Y|Y|5|Visit_5|90|7|SCREENING|2020-08-27|2020-09-02|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|1|FACTVW|von Willebrand Factor|CHEMISTRY|[?]|pmol|[?]|[?]|INVALID|1|lx|1|1|[?]|LOW|INFRANATANT, SERUM|CLOTTED||MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-06-12|2020-06-27|10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|LB|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|2|MONONSQE|Monocytes/Non-Squam Epi Cells|CHEMISTRY|||[?]|[?]|INVALID|1|/wk|1|1|[?]|LOW|MUSCLE TISSUE|CONCENTRATED|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|COCKCROFT-GAULT FORMULA|||U|Y|1|Visit_1|10|5|TREATMENT|2020-06-12|2020-07-26|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|LB|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|3|INULIN|Inulin|URINALYSIS|[?]|mol|[?]|[?]|INDETERMINATE|1|mL/animal/day|1|1|[?]|HIGH|ABSCESS FLUID|REFRIGERATED||SPIRAL CT SCAN WITHOUT CONTRAST|MDRD FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-06-27|2020-08-24|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|4|DDNAIGAB|Anti-Double Stranded DNA IgG|URINALYSIS|[?]|10^3 organisms|[?]|[?]|TRACE|1|fmol|1|1|[?]|HIGH|BREAST MILK|CONTAMINATED|N|MICROBIAL CULTURE, LIQUID|MDRD 5 VARIABLE FORMULA|||U||2|Visit_2|25|1|FOLLOW-UP|2020-06-27|2020-07-29|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|5|GST|Glutathione S-Transferase, Total|URINALYSIS|||[?]|[?]|INVALID|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|EPITHELIAL CELL|THAWED||TRYPAN BLUE STAIN|MDRD 4 VARIABLE FORMULA|||NA|Y|3|Visit_3|40|4|FOLLOW-UP|2020-07-12|2020-08-12|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|LB|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|6|C130077|Silver Birch Pollen IgA|CHEMISTRY|[?]|KIT|[?]|[?]|INDETERMINATE|1|g/m2/day|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|CONTAMINATED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA|Y||U||3|Visit_3|40|4|FOLLOW-UP|2020-07-12|2020-08-10|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|LB|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|7|PDL1S|Soluble Programmed Death Ligand 1|CHEMISTRY|[?]|ft2|[?]|[?]|POSITIVE|1|NFIU|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC||THICK SMEAR|CKD-EPI CREATININE FORMULA|Y||NA||4|Visit_4|65|3|SCREENING|2020-08-06|2020-08-20|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|8|SER|Serine|URINALYSIS|||[?]|[?]|TRACE|1|mg/day|1|1|[?]|HIGH|LAVAGE FLUID|FROZEN||COULOMETRIC TITRATION|MDRD 5 VARIABLE FORMULA|Y|Y|Y|Y|4|Visit_4|65|3|SCREENING|2020-08-06|2020-08-18|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|9|C4D|Complement C4d|HEMATOLOGY|[?]|g|[?]|[?]|INVALID|1|umol/L/sec|1|1|[?]|HIGH|URINE|AGGLUTINATED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|||U||5|Visit_5|90|4|TREATMENT|2020-08-31|2020-09-06|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|10|ALPEXR|Alkaline Phosphatase Excretion Rate|CHEMISTRY|[?]|umol/min|[?]|[?]|TRACE|1|Bq/mg|1|1|[?]|ABNORMAL|REFLEX TEAR|FRESH||SPECULAR MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||N||5|Visit_5|90|5|WASHOUT|2020-08-31|2020-09-05|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|3f7c46ac-fe30-4ef3-a581-99c064a85efa|1|IRONEXR|Iron Excretion Rate|HEMATOLOGY|[?]|umol/h/mmol|[?]|[?]|INDETERMINATE|1|V|1|1|[?]|HIGH|HAIR|CALCIFIED||CISH|FIBROSIS 4 FORMULA|Y||N||1|Visit_1|10|5|TREATMENT|2021-01-11|2021-02-27|10|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|3f7c46ac-fe30-4ef3-a581-99c064a85efa|2|C165886|White Oak Pollen IgE AB RAST Score|URINALYSIS|[?]|cd/m2|[?]|[?]|TRACE|1|mmol/g|1|1|[?]|NORMAL|URINE|DRIED||OPTICAL COHERENCE TOMOGRAPHY|MDRD ENZYMATIC FORMULA|Y||N||1|Visit_1|10|4|WASHOUT|2021-01-11|2021-02-12|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|3f7c46ac-fe30-4ef3-a581-99c064a85efa|3|INTLK28|Interleukin 28|URINALYSIS|||[?]|[?]|TRACE|1|uL/kg/day|1|1|[?]|ABNORMAL|EPITHELIAL CELL|HEMOLYZED||MACRO BROTH DILUTION|GMI % FORMULA||Y|U|Y|2|Visit_2|25|7|TREATMENT|2021-01-26|2021-01-29|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|3f7c46ac-fe30-4ef3-a581-99c064a85efa|4|MSTHCE|Mesothelial Cells|CHEMISTRY|[?]|Pack Year|[?]|[?]|NEGATIVE|1|U/animal|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|CONTAMINATED|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|FIBROSIS 4 FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2021-01-26|2021-02-25|25|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|3f7c46ac-fe30-4ef3-a581-99c064a85efa|5|HLADRMSC|HLA-DR Mismatch Count|HEMATOLOGY|[?]|Bq|[?]|[?]|POSITIVE|1|umol/mg/min|1|1|[?]|ABNORMAL|CORD SERUM|LIPEMIC||PERIODIC ACID SCHIFF STAIN|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|6|SCREENING|2021-02-10|2021-03-20|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|3f7c46ac-fe30-4ef3-a581-99c064a85efa|6|FXAAC|Factor X Activity Actual/Control|HEMATOLOGY|[?]|Bq/uL|[?]|[?]|INDETERMINATE|1|Gravitational Unit|1|1|[?]|HIGH|COLOSTRUM|UNEXPECTED ODOR|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||3|Visit_3|40|7|TREATMENT|2021-02-10|2021-02-18|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|3f7c46ac-fe30-4ef3-a581-99c064a85efa|7|INTLK1|Interleukin 1|HEMATOLOGY|[?]|ug/g/min|[?]|[?]|TRACE|1|L/s/kPa|1|1|[?]|ABNORMAL|EPITHELIAL CELL|CONTAMINATED||DOPPLER ULTRASOUND|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|6|TREATMENT|2021-03-07|2021-03-21|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|3f7c46ac-fe30-4ef3-a581-99c064a85efa|8|AXL|AXL Receptor Tyrosine Kinase|CHEMISTRY|||[?]|[?]|NEGATIVE|1|RATIO|1|1|[?]|ABNORMAL|SEMINAL FLUID|NON-HEMOLYZED||CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N|Y|4|Visit_4|65|1|TREATMENT|2021-03-07|2021-04-09|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|3f7c46ac-fe30-4ef3-a581-99c064a85efa|9|ACH|Acetylcholine|URINALYSIS|||[?]|[?]|NEGATIVE|1|PIPE|1|1|[?]|HIGH|VENOUS PLASMA|AGGLUTINATED|N|SNP ARRAY|GMI % FORMULA|||NA|Y|5|Visit_5|90|4|TREATMENT|2021-04-01|2021-04-06|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|3f7c46ac-fe30-4ef3-a581-99c064a85efa|10|LCN2CREA|Lipocalin-2/Creatinine|CHEMISTRY|[?]|APS U|[?]|[?]|BORDERLINE|1|pkat/L|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE||SICKLE CELL SOLUBILITY TEST|MDRD 5 VARIABLE FORMULA|||Y||5|Visit_5|90|7|WASHOUT|2021-04-01|2021-04-05|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|8d944400-df75-4ec7-8fb4-239eb0f6de9d|1|B2G1GAAB|Beta-2 Glycoprotein 1 IgA Antibody|HEMATOLOGY|[?]|bel|[?]|[?]|INDETERMINATE|1|Hz|1|1|[?]|ABNORMAL|VENOUS PLASMA|CONTAMINATED||CHROMOGENIC ASSAY|COCKCROFT-GAULT FORMULA|Y|Y|N||1|Visit_1|10|2|TREATMENT|2020-09-22|2020-10-31|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|8d944400-df75-4ec7-8fb4-239eb0f6de9d|2|SCN|Thiocyanate|CHEMISTRY|[?]|U/animal|[?]|[?]|BORDERLINE|1|pkat|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|SOLIDIFIED||EEG|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||1|Visit_1|10|5|FOLLOW-UP|2020-09-22|2020-10-27|10|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|8d944400-df75-4ec7-8fb4-239eb0f6de9d|3|PHENYTN|Phenytoin|CHEMISTRY|[?]|uIU/dL|[?]|[?]|INVALID|1|mkat|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED||BRDU CELLULAR PROLIFERATION ASSAY|COCKCROFT-GAULT FORMULA|Y|Y|U||2|Visit_2|25|2|SCREENING|2020-10-07|2020-10-29|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|8d944400-df75-4ec7-8fb4-239eb0f6de9d|4|SOST|Sclerostin|URINALYSIS|[?]|nmol BCE/nmol|[?]|[?]|BORDERLINE|1|mg/kg/day|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|NON-HEMOLYZED||RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI CREATININE FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-10-07|2020-10-08|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|8d944400-df75-4ec7-8fb4-239eb0f6de9d|5|BASOMYL|Basophilic Myelocytes|URINALYSIS|[?]|HOMEOPATHIC DILUTION|[?]|[?]|INVALID|1|mg/kg/min|1|1|[?]|NORMAL|SOFT TISSUE|DRIED||IRON HEMATOXYLIN STAIN|MDRD 4 VARIABLE FORMULA|||Y||3|Visit_3|40|6|SCREENING|2020-10-22|2020-11-24|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|8d944400-df75-4ec7-8fb4-239eb0f6de9d|6|KAPPALC|Kappa Light Chain|CHEMISTRY|[?]|Newton|[?]|[?]|INVALID|1|MET*h|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|AUTOLYZED||CLINICAL EVALUATION|MDRD FORMULA|||N||3|Visit_3|40|3|FOLLOW-UP|2020-10-22|2020-11-28|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|8d944400-df75-4ec7-8fb4-239eb0f6de9d|7|MYCYCE|Myelocytes/Total Cells|CHEMISTRY|[?]|ng/L|[?]|[?]|INDETERMINATE|1|dmol|1|1|[?]|ABNORMAL|CORD BLOOD|HEMOLYZED||IMMUNOBLOT|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-11-16|2020-11-20|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|8d944400-df75-4ec7-8fb4-239eb0f6de9d|8|INTLK32|Interleukin 32|URINALYSIS|[?]|pmol/g|[?]|[?]|INDETERMINATE|1|C|1|1|[?]|NORMAL|SUPERNATANT, SERUM|CLOTTED||BRDU CELLULAR PROLIFERATION ASSAY|CKD-EPI CYSTATIN C FORMULA|Y||U||4|Visit_4|65|4|WASHOUT|2020-11-16|2020-11-25|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|8d944400-df75-4ec7-8fb4-239eb0f6de9d|9|CHOLOH4B|4-Beta-Hydroxycholesterol|URINALYSIS|[?]|ug/kg|[?]|[?]|INDETERMINATE|1|100 IU/mL|1|1|[?]|LOW|INFRANATANT, SERUM|CONTAMINATED|N|ELISA|FIBROSIS 4 FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-12-11|2020-12-19|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|8d944400-df75-4ec7-8fb4-239eb0f6de9d|10|TPAG|Tissue Polypeptide Antigen|URINALYSIS|[?]|mmol/kg|[?]|[?]|BORDERLINE|1|FIU|1|1|[?]|NORMAL|TRANSUDATE|DRIED||TRIPLE-PHASE MRI SCAN|CKD-EPI FORMULA|Y||N||5|Visit_5|90|7|TREATMENT|2020-12-11|2020-12-18|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|7b201f93-bd8c-4507-a7b7-27a02e364647|1|PSDGLSRF|Phosphatidylglycerol/Lung Surfactant|HEMATOLOGY|[?]|log10 CFU/mL|[?]|[?]|INVALID|1|% INHIBITION|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|SOLIDIFIED||ENDOSCOPY|FIBROMETER FORMULA|Y||NA||1|Visit_1|10|3|WASHOUT|2020-12-23|2021-01-30|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|LB|7b201f93-bd8c-4507-a7b7-27a02e364647|2|APOC2|Apolipoprotein C2|HEMATOLOGY|||[?]|[?]|INVALID|1|IU/mmol|1|1|[?]|ABNORMAL|PUS|GELLED||FLAME PHOTOMETRY|CKD-EPI FORMULA||Y|Y|Y|1|Visit_1|10|7|WASHOUT|2020-12-23|2021-03-08|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|LB|7b201f93-bd8c-4507-a7b7-27a02e364647|3|PG|Prostaglandin|HEMATOLOGY|[?]|umol/h/mmol|[?]|[?]|INDETERMINATE|1|SPRAY|1|1|[?]|LOW|PERITONEAL FLUID|CALCIFIED||ELECTROGASTROGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||2|Visit_2|25|3|TREATMENT|2021-01-07|2021-01-25|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|7b201f93-bd8c-4507-a7b7-27a02e364647|4|CD4LY|CD4/Lymphocytes|CHEMISTRY|[?]|L/s|[?]|[?]|POSITIVE|1|dyn|1|1|[?]|HIGH|INFRANATANT, PLASMA|THAWED||X-RAY|CKD-EPI FORMULA|||NA||2|Visit_2|25|7|TREATMENT|2021-01-07|2021-03-08|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|7b201f93-bd8c-4507-a7b7-27a02e364647|5|C130088|Timothy Grass Pollen IgE|CHEMISTRY|||[?]|[?]|POSITIVE|1|scm|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|DRIED||GRADIENT DIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|3|Visit_3|40|2|TREATMENT|2021-01-22|2021-03-20|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|7b201f93-bd8c-4507-a7b7-27a02e364647|6|PGD2|Prostaglandin D2|URINALYSIS|[?]|cmH2O*s/mL|[?]|[?]|INVALID|1|10^9 CFU/mL|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|CALCIFIED||CONTRAST ENHANCED PET SCAN|MDRD 5 VARIABLE FORMULA|Y|Y|N||3|Visit_3|40|5|TREATMENT|2021-01-22|2021-02-09|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|7b201f93-bd8c-4507-a7b7-27a02e364647|7|THEOPHYL|Theophylline|URINALYSIS|[?]|10^7 CFU|[?]|[?]|POSITIVE|1|mL/mmHg/min/L|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|HEMOLYZED||OPTICAL COHERENCE TOMOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|N||4|Visit_4|65|1|WASHOUT|2021-02-16|2021-03-22|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|7b201f93-bd8c-4507-a7b7-27a02e364647|8|NEUTMY|Neutrophilic Myelocytes|URINALYSIS|[?]|g/U|[?]|[?]|NEGATIVE|1|g/kg|1|1|[?]|NORMAL|VITREOUS HUMOR|CONTAMINATED||BETA LACTAMASE|HEPASCORE FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2021-02-16|2021-03-10|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|7b201f93-bd8c-4507-a7b7-27a02e364647|9|HIST2AAB|Histone 2A Antibody|CHEMISTRY|[?]|mL/day|[?]|[?]|INDETERMINATE|1|CONTAINER|1|1|[?]|LOW|BONE|SOLIDIFIED||DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI FORMULA||Y|N||5|Visit_5|90|5|TREATMENT|2021-03-13|2021-03-22|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|7b201f93-bd8c-4507-a7b7-27a02e364647|10|C5B9|Complement C5b-9|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ug/dose|1|1|[?]|NORMAL|CORD BLOOD|CLOTTED||DC SHEATH FLOW|CKD-EPI CREATININE FORMULA|||U|Y|5|Visit_5|90|4|TREATMENT|2021-03-13|2021-03-20|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|1|PTHW|Parathyroid Hormone, Whole|CHEMISTRY|[?]|dpm/mL|[?]|[?]|TRACE|1|TUBE|1|1|[?]|NORMAL|SWABBED MATERIAL|HEMOLYZED||HEMAGGLUTINATION ASSAY|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-08-05|2020-08-19|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|2|DNPSEPHD|D-Norpseudoephedrine|HEMATOLOGY|[?]|log10 TCID 50/mL|[?]|[?]|INDETERMINATE|1|IU/day|1|1|[?]|HIGH|INTERSTITIAL FLUID|SOLIDIFIED||BALLPOINT PEN TECHNIQUE|NASH FIBROSURE FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-08-05|2020-10-29|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|3|TRIG|Triglycerides|HEMATOLOGY|[?]|DAYS|[?]|[?]|TRACE|1|nmol BCE/nmol|1|1|[?]|HIGH|HAIR|SOLIDIFIED||NEURAMINIDASE INHIBITION ASSAY|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-08-20|2020-09-05|25|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|4|GHRELINA|Active Ghrelin|HEMATOLOGY|[?]|LENS|[?]|[?]|POSITIVE|1|HOMEOPATHIC DILUTION|1|1|[?]|HIGH|INFRANATANT, PLASMA|LACTESCENT||TRANSCRIPTION-MEDIATED AMPLIFICATION|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|3|FOLLOW-UP|2020-08-20|2020-09-03|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|5|CD4|CD4|URINALYSIS|[?]|/LSQN|[?]|[?]|INVALID|1|mol/L|1|1|[?]|ABNORMAL|PERSPIRATION|THAWED|N|INFRARED SPECTROMETRY|CKD-EPI CREATININE FORMULA|Y||Y||3|Visit_3|40|7|TREATMENT|2020-09-04|2020-09-17|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|6|FACTIII|Factor III|CHEMISTRY|[?]|10^6 IU|[?]|[?]|POSITIVE|1|cy/cm|1|1|[?]|NORMAL|TISSUE|ROOM TEMPERATURE|N|ELLA|MDRD ENZYMATIC FORMULA|||Y||3|Visit_3|40|2|SCREENING|2020-09-04|2020-09-06|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|7|AFPL1|Alpha Fetoprotein L1|URINALYSIS|[?]|/day|[?]|[?]|POSITIVE|1|cd*s/m2|1|1|[?]|NORMAL|PERITONEAL FLUID|ROOM TEMPERATURE||TONOMETRY|FIBROTEST FORMULA|Y||Y||4|Visit_4|65|5|TREATMENT|2020-09-29|2020-10-13|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|8|PLATBIZ|Bizarre Platelets|CHEMISTRY|[?]|s^-1(%O2)^-1|[?]|[?]|POSITIVE|1|AFU|1|1|[?]|HIGH|INFRANATANT, SERUM|AUTOLYZED||PHOTOMETRIC CLOT DETECTION|MDRD 5 VARIABLE FORMULA|||NA||4|Visit_4|65|3|SCREENING|2020-09-29|2020-10-31|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|9|AMH|Anti-Mullerian Hormone|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/sec/1.73m2|1|1|[?]|LOW|INTERSTITIAL FLUID|LACTESCENT||MULTIPLEXED BEAD BASED IMMUNOASSAY|COCKCROFT-GAULT FORMULA|Y||NA|Y|5|Visit_5|90|2|TREATMENT|2020-10-24|2020-10-28|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|10|VITB2|Riboflavin|CHEMISTRY|||[?]|[?]|NEGATIVE|1|L/s|1|1|[?]|NORMAL|PLASMA|REFRIGERATED||SPECT/CT SCAN|MDRD 4 VARIABLE FORMULA|Y||NA|Y|5|Visit_5|90|2|TREATMENT|2020-10-24|2020-10-28|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|3611b798-9b3d-4173-b23e-3017939847e0|1|TRIG|Triglycerides|HEMATOLOGY|[?]|MPL U|[?]|[?]|INVALID|1|mAmp|1|1|[?]|ABNORMAL|ERYTHROCYTES|THAWED||MICRONEUTRALIZATION ASSAY|NASH FIBROSURE FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-08-03|2020-10-05|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|3611b798-9b3d-4173-b23e-3017939847e0|2|SLXAG|Sialyl SSEA-1 Antigen|HEMATOLOGY|[?]|U/m2|[?]|[?]|BORDERLINE|1|dL|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|CALCIFIED||HILLMEN COLOR CHART|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-08-03|2020-08-13|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|3611b798-9b3d-4173-b23e-3017939847e0|3|DGNWBC|Degenerated Leukocytes|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|SQU/mL|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|REFRIGERATED||FLUORESCEIN STAIN|MDRD FORMULA||Y|Y|Y|2|Visit_2|25|2|TREATMENT|2020-08-18|2020-10-12|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|3611b798-9b3d-4173-b23e-3017939847e0|4|GLOBB1|Beta-1 Globulin|HEMATOLOGY|[?]|mmol/min/kPa/L|[?]|[?]|BORDERLINE|1|10^3 CFU/g|1|1|[?]|LOW|CAPILLARY BLOOD|LACTESCENT||EEG|MDRD ENZYMATIC FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-08-18|2020-10-10|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|3611b798-9b3d-4173-b23e-3017939847e0|5|INHIBINA|Inhibin A|CHEMISTRY|[?]|mOsm|[?]|[?]|INVALID|1|mL/sec/1.73m2|1|1|[?]|HIGH|ABSCESS FLUID|UNEXPECTED ODOR||NEXT GENERATION SEQUENCING|CKD-EPI CREATININE FORMULA||Y|NA||3|Visit_3|40|3|TREATMENT|2020-09-02|2020-10-05|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|3611b798-9b3d-4173-b23e-3017939847e0|6|TDTAG|Terminal Deoxynucleotidyl Transferase Ag|CHEMISTRY|[?]|scm|[?]|[?]|POSITIVE|1|nmol/mol|1|1|[?]|NORMAL|EPIDERMAL TISSUE|SOLIDIFIED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|4|WASHOUT|2020-09-02|2020-10-09|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|3611b798-9b3d-4173-b23e-3017939847e0|7|APTTLAS|Lupus Anticoagulant Sensitive APTT|CHEMISTRY|||[?]|[?]|BORDERLINE|1|L/min|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|GELLED||WESTERN BLOT|FIBROMETER FORMULA|||NA|Y|4|Visit_4|65|4|TREATMENT|2020-09-27|2020-10-02|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|3611b798-9b3d-4173-b23e-3017939847e0|8|LTE4|Leukotriene E4|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|hPa|1|1|[?]|ABNORMAL|CORD SERUM|FRESH||ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI FORMULA|||NA|Y|4|Visit_4|65|4|TREATMENT|2020-09-27|2020-10-07|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|3611b798-9b3d-4173-b23e-3017939847e0|9|CTLPRM|Citalopram|URINALYSIS|[?]|pmol/10^10 cells|[?]|[?]|POSITIVE|1|BE/mL|1|1|[?]|LOW|ALVEOLAR AIR|LACTESCENT|N|DIFFUSION TENSOR MRI|GMI MMOL/MOL FORMULA|Y||N||5|Visit_5|90|3|TREATMENT|2020-10-22|2020-10-30|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|3611b798-9b3d-4173-b23e-3017939847e0|10|AMYLASE|Amylase|URINALYSIS|||[?]|[?]|INVALID|1|U/mg|1|1|[?]|LOW|WHITE MATTER TISSUE|AUTOLYZED||TONOMETRY|MDRD 4 VARIABLE FORMULA|Y||U|Y|5|Visit_5|90|6|SCREENING|2020-10-22|2020-10-29|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|f651799b-9723-4c2c-88d1-de2f347e9a69|1|EOTAXIN1|Eotaxin-1|CHEMISTRY|[?]|EID 50/dose|[?]|[?]|NEGATIVE|1|mol/mol|1|1|[?]|ABNORMAL|SALIVA|PARAFFIN-EMBEDDED|N|PELLI-ROBSON EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||1|Visit_1|10|6|TREATMENT|2020-06-24|2020-08-07|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|f651799b-9723-4c2c-88d1-de2f347e9a69|2|FRUCTOSE|Fructose|HEMATOLOGY|||[?]|[?]|INVALID|1|dyn|1|1|[?]|NORMAL|PLASMA|AGGLUTINATED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD 5 VARIABLE FORMULA|Y|Y|N|Y|1|Visit_1|10|2|TREATMENT|2020-06-24|2020-09-02|10|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|f651799b-9723-4c2c-88d1-de2f347e9a69|3|METHDN|Methadone|HEMATOLOGY|[?]|mm2|[?]|[?]|TRACE|1|umol/kg/min|1|1|[?]|LOW|CAPILLARY BLOOD|CONCENTRATED||CINEANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||2|Visit_2|25|4|FOLLOW-UP|2020-07-09|2020-09-12|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|f651799b-9723-4c2c-88d1-de2f347e9a69|4|GLCTN3|Galectin-3|URINALYSIS|[?]|Joule|[?]|[?]|TRACE|1|pmol/day|1|1|[?]|LOW|CERUMEN|CLOTTED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|7|WASHOUT|2020-07-09|2020-08-30|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|f651799b-9723-4c2c-88d1-de2f347e9a69|5|CHYTRYP|Chymotrypsin|CHEMISTRY|[?]|ug|[?]|[?]|INDETERMINATE|1|ELISA unit|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|CALCIFIED||PH METER MEASUREMENT METHOD|GMI MMOL/MOL FORMULA|||N||3|Visit_3|40|7|SCREENING|2020-07-24|2020-08-27|40|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|f651799b-9723-4c2c-88d1-de2f347e9a69|6|AFPA|Alpha Fetoprotein Activity|URINALYSIS|[?]|/10^3|[?]|[?]|NEGATIVE|1|PFU/animal|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|ROOM TEMPERATURE|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|HEPASCORE FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-07-24|2020-08-11|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|f651799b-9723-4c2c-88d1-de2f347e9a69|7|IDLVLDL3|IDL+VLDL Cholesterol Subtype 3|URINALYSIS|[?]|10^6 DNA copies/mL|[?]|[?]|INDETERMINATE|1|mm/min|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|FRESH||HIGH RESOLUTION CT|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-08-18|2020-08-28|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|f651799b-9723-4c2c-88d1-de2f347e9a69|8|PLATAGGR|Platelet Aggregation|HEMATOLOGY|[?]|mg/L|[?]|[?]|NEGATIVE|1|BE/mL|1|1|[?]|HIGH|LOCHIA|ICTERIC|N|ENZYMATIC ULTRACENTRIFUGATION|FIBROMETER FORMULA|||N||4|Visit_4|65|2|WASHOUT|2020-08-18|2020-09-17|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|f651799b-9723-4c2c-88d1-de2f347e9a69|9|LPPLA2|Lipoprotein Associated Phospholipase A2|HEMATOLOGY|[?]|atm|[?]|[?]|TRACE|1|mg/L|1|1|[?]|NORMAL|SWABBED MATERIAL|CONTAMINATED||NEPHELOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||5|Visit_5|90|3|TREATMENT|2020-09-12|2020-09-13|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|f651799b-9723-4c2c-88d1-de2f347e9a69|10|NHMCELE|Nonhematic Cells/Leukocytes|URINALYSIS|[?]|WAFER|[?]|[?]|INVALID|1|kg/mol|1|1|[?]|HIGH|BASAL TEAR|ICTERIC||PALM METHOD|MDRD ENZYMATIC FORMULA||Y|U||5|Visit_5|90|2|WASHOUT|2020-09-12|2020-09-21|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|1|C165924|Grass Mix Pollen IgE AB RAST Score|CHEMISTRY|[?]|mm/2h|[?]|[?]|BORDERLINE|1|VOXEL|1|1|[?]|HIGH|FLUID|ROOM TEMPERATURE|N|RAJI CELL RIA|NASH FIBROSURE FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-10-19|2020-12-12|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|2|GMCSF|Granulocyte Macrophage Colony Stm Factor|HEMATOLOGY|[?]|mm/sec|[?]|[?]|TRACE|1|oz eq|1|1|[?]|ABNORMAL|SEMEN|CLOTTED||ELASTOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||Y||1|Visit_1|10|5|TREATMENT|2020-10-19|2020-12-07|10|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|3|C130105|Grass Mix Pollen Antigen IgA Antibody|HEMATOLOGY|[?]|ukat/10^12 RBC|[?]|[?]|NEGATIVE|1|amol|1|1|[?]|NORMAL|CAPILLARY PLASMA|LACTESCENT||TARGETED TRANSCRIPTOME SEQUENCING|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-11-03|2021-01-04|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|4|CCPIGGAB|Cyclic Citrullinated Peptide IgG Ab|URINALYSIS|[?]|DISK|[?]|[?]|INDETERMINATE|1|Absorbance U|1|1|[?]|NORMAL|BONE|FRESH||PHOTOMETRY|MDRD ENZYMATIC FORMULA|||NA||2|Visit_2|25|1|WASHOUT|2020-11-03|2020-12-16|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|5|PAH|P-Aminohippurate Sodium|CHEMISTRY|[?]|dpm/mg|[?]|[?]|TRACE|1|m3|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|LIPEMIC||POPULATION SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|Y||3|Visit_3|40|6|FOLLOW-UP|2020-11-18|2020-11-26|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|6|S6PHS|Phos-S6 Ribosomal Protein|HEMATOLOGY|[?]|uL/mL|[?]|[?]|INVALID|1|mEq/g|1|1|[?]|LOW|PLATELET|AGGLUTINATED||ELISA|GMI % FORMULA||Y|N||3|Visit_3|40|5|SCREENING|2020-11-18|2020-11-20|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|7|C165911|Dairy Mix IgG AB RAST Score|URINALYSIS|||[?]|[?]|BORDERLINE|1|U/g/day|1|1|[?]|NORMAL|PLEURAL TISSUE|LIPEMIC|N|HPLC/IEX|MDRD FORMULA|||U|Y|4|Visit_4|65|3|WASHOUT|2020-12-13|2021-01-02|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|8|ALDSTRN|Aldosterone|URINALYSIS|[?]|Torr|[?]|[?]|INVALID|1|CCID 50/mL|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|GELLED||MYELOPEROXIDASE STAIN|CKD-EPI CREATININE FORMULA|||NA||4|Visit_4|65|7|FOLLOW-UP|2020-12-13|2021-01-02|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|9|ANTHRMA|Antithrombin Activity|HEMATOLOGY|[?]|nkat/L|[?]|[?]|BORDERLINE|1|mL/animal/day|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|FRESH||MICRONEUTRALIZATION ASSAY|FIBROMETER FORMULA|||U||5|Visit_5|90|3|FOLLOW-UP|2021-01-07|2021-01-11|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|10|HTTP|Huntingtin Protein|URINALYSIS|[?]|cy/cm|[?]|[?]|TRACE|1|kIU|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|AUTOLYZED||PET/MRI SCAN|MDRD 6 VARIABLE FORMULA|||Y||5|Visit_5|90|6|SCREENING|2021-01-07|2021-01-14|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|29b16c31-df0e-493c-a777-46113b904879|1|LKM1IMAB|Liver Kidney Microsomal Type 1 IgM Ab|CHEMISTRY|[?]|ug/cm2|[?]|[?]|POSITIVE|1|/LSQN|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|LACTESCENT||CENTRIFUGATION|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-06-07|2020-08-02|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-01
e|LB|29b16c31-df0e-493c-a777-46113b904879|2|NEUTMM|Neutrophilic Metamyelocytes|URINALYSIS|[?]|g/animal|[?]|[?]|NEGATIVE|1|10^7 PFU|1|1|[?]|NORMAL|ISOLATE|GELLED|N|PHOROPTER|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|3|TREATMENT|2020-06-07|2020-07-28|10|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-01
e|LB|29b16c31-df0e-493c-a777-46113b904879|3|STIPBASO|Basophilic Stippling|CHEMISTRY|[?]|nCi|[?]|[?]|TRACE|1|mm/sec|1|1|[?]|NORMAL|CAPILLARY BLOOD|PARAFFIN-EMBEDDED|N|SICKLE CELL SOLUBILITY TEST|FIBROSIS 4 FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-06-22|2020-08-12|25|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|29b16c31-df0e-493c-a777-46113b904879|4|HETRPH|Heterophils|CHEMISTRY|[?]|uL/mL|[?]|[?]|INDETERMINATE|1|/40 HPFs|1|1|[?]|NORMAL|DISCHARGE|FROZEN||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|5|TREATMENT|2020-06-22|2020-06-24|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|29b16c31-df0e-493c-a777-46113b904879|5|PGES|Prostaglandin E Synthase|HEMATOLOGY|[?]|umol/L/sec|[?]|[?]|INDETERMINATE|1|L/kg|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|FRESH||FLUORESCENT ENZYME IMMUNOASSAY|GMI % FORMULA|Y||U||3|Visit_3|40|7|FOLLOW-UP|2020-07-07|2020-08-11|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|29b16c31-df0e-493c-a777-46113b904879|6|PLSCR1|Phospholipid Scramblase 1|URINALYSIS|||[?]|[?]|TRACE|1|nkat|1|1|[?]|HIGH|PUS|PARAFFIN-EMBEDDED||CLAUSS METHOD|MDRD ENZYMATIC FORMULA|||NA|Y|3|Visit_3|40|7|TREATMENT|2020-07-07|2020-08-21|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|29b16c31-df0e-493c-a777-46113b904879|7|GADAB|Glutamic Acid Decarboxylase Antibody|HEMATOLOGY|[?]|IU|[?]|[?]|POSITIVE|1|Weber|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|CONTAMINATED|N|ELASTOGRAPHY|FIBROMETER FORMULA|Y||Y||4|Visit_4|65|6|TREATMENT|2020-08-01|2020-08-08|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|29b16c31-df0e-493c-a777-46113b904879|8|PROC6|Pro-C6|URINALYSIS|[?]|EID 50/mL|[?]|[?]|TRACE|1|mL/animal/day|1|1|[?]|NORMAL|GASTRIC FLUID|NON-HEMOLYZED||ROMANOWSKY STAIN|MDRD 4 VARIABLE FORMULA||Y|NA||4|Visit_4|65|5|TREATMENT|2020-08-01|2020-08-03|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|29b16c31-df0e-493c-a777-46113b904879|9|NTXICRT|T1 Collagen X-link N-Telopeptides/Creat|CHEMISTRY|[?]|kcal|[?]|[?]|NEGATIVE|1|DIP|1|1|[?]|HIGH|MECONIUM|REFRIGERATED||KLEIHAUER-BETKE|FIBROMETER FORMULA|||NA||5|Visit_5|90|4|FOLLOW-UP|2020-08-26|2020-08-30|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|29b16c31-df0e-493c-a777-46113b904879|10|C165891|Western Ragweed Pollen IgE AB RAST Score|CHEMISTRY|[?]|TROCHE|[?]|[?]|BORDERLINE|1|/5x10^4 WBC|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|REFRIGERATED||POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|7|TREATMENT|2020-08-26|2020-08-29|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|1|IGG1|Immunoglobulin G Subclass 1|CHEMISTRY|[?]|IU/g|[?]|[?]|TRACE|1|genEq/mL|1|1|[?]|NORMAL|MUSCLE TISSUE|GELLED||ACID FAST STAIN|CKD-EPI CYSTATIN C FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-07-31|2020-08-14|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|2|CXCL13|Chemokine (C-X-C Motif) Ligand 13|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|/200 HPFs|1|1|[?]|NORMAL|PUS|LACTESCENT||CHROMOGENIC ASSAY|MDRD 5 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|5|TREATMENT|2020-07-31|2020-10-19|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|3|DPPIVA|Dipeptidyl Peptidase-4 Activity|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mL/kg/h|1|1|[?]|LOW|LOCHIA|PARAFFIN-EMBEDDED||CHROMOGENIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA|Y|2|Visit_2|25|3|FOLLOW-UP|2020-08-15|2020-08-17|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|4|COL4|Collagen Type IV|CHEMISTRY|[?]|CIGAR|[?]|[?]|BORDERLINE|1|uIU/dL|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|DRIED|N|INDIRECT IMMUNOFLUORESCENCE|MDRD 6 VARIABLE FORMULA||Y|U||2|Visit_2|25|4|TREATMENT|2020-08-15|2020-09-06|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|5|RNPSMAB|Ribonucleoprotein Smith Complex Antibody|URINALYSIS|[?]|PELLET|[?]|[?]|TRACE|1|Enzyme U/L|1|1|[?]|ABNORMAL|ABSCESS FLUID|LIPEMIC||DIRECT SEQUENCING|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-08-30|2020-09-22|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|6|GDIGA1|Galactose-Deficient IgA1|CHEMISTRY|[?]|pkat/L|[?]|[?]|INVALID|1|RING|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|CALCIFIED|N|REVERSE TRANSCRIPTASE PCR|MDRD 4 VARIABLE FORMULA||Y|NA||3|Visit_3|40|2|TREATMENT|2020-08-30|2020-10-22|40|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|7|C147277|Triticum aestivum Antigen IgE Antibody|HEMATOLOGY|[?]|log10 CCID 50/dose|[?]|[?]|POSITIVE|1|mg/day|1|1|[?]|LOW|INTERSTITIAL FLUID|THAWED|N|FLUORIMETRY|FIBROMETER FORMULA|||Y||4|Visit_4|65|7|WASHOUT|2020-09-24|2020-10-24|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|8|C147285|Common Ragweed Pollen IgE Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|kIU|1|1|[?]|NORMAL|TRANSUDATE|UNEXPECTED ODOR||DROPLET DIGITAL PCR|NASH FIBROSURE FORMULA||Y|N|Y|4|Visit_4|65|6|FOLLOW-UP|2020-09-24|2020-10-22|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|9|INTLK13|Interleukin 13|HEMATOLOGY|[?]|HEP|[?]|[?]|NEGATIVE|1|Ci/L|1|1|[?]|HIGH|URINE|FROZEN||HEMAGGLUTINATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||5|Visit_5|90|5|FOLLOW-UP|2020-10-19|2020-10-21|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|10|C1INH|Complement C1 Esterase Inhibitor|CHEMISTRY|[?]|mEq/g|[?]|[?]|INVALID|1|mg/mol|1|1|[?]|LOW|BONE MARROW|CLOTTED||AGAR PROPORTION|FIBROMETER FORMULA|Y||U||5|Visit_5|90|7|TREATMENT|2020-10-19|2020-10-26|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|118914c8-9f6a-47c8-b427-296a99547756|1|C147276|Arachis hypogaea Antigen IgE Antibody|CHEMISTRY|[?]|Linear ft*LB|[?]|[?]|TRACE|1|PACKET|1|1|[?]|HIGH|VITREOUS HUMOR|AGGLUTINATED||VENTILATION PERFUSION LUNG SCAN|MDRD FORMULA||Y|NA||1|Visit_1|10|3|TREATMENT|2020-10-25|2020-11-03|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|118914c8-9f6a-47c8-b427-296a99547756|2|UROBIL|Urobilinogen|HEMATOLOGY|[?]|CFU/g|[?]|[?]|BORDERLINE|1|mL/mmHg|1|1|[?]|HIGH|VENOUS BLOOD|REFRIGERATED||SLOAN LETTER EYE CHART 100%|CKD-EPI CYSTATIN C FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-10-25|2020-12-05|10|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|118914c8-9f6a-47c8-b427-296a99547756|3|BITECE|Bite Cells|CHEMISTRY|[?]|days/month|[?]|[?]|POSITIVE|1|pmol/L|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|CONTAMINATED||ORCHIDOMETERY|GMI MMOL/MOL FORMULA||Y|Y||2|Visit_2|25|6|SCREENING|2020-11-09|2020-11-13|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|118914c8-9f6a-47c8-b427-296a99547756|4|IMMGLC|Immunoglobulin Light Chains|CHEMISTRY|[?]|mg/kg/dose|[?]|[?]|POSITIVE|1|Ci|1|1|[?]|LOW|TRANSUDATE|AGGLUTINATED||ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|7|TREATMENT|2020-11-09|2020-12-04|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|118914c8-9f6a-47c8-b427-296a99547756|5|APPEAR|Specimen Appearance|HEMATOLOGY|[?]|tuberculin unit|[?]|[?]|BORDERLINE|1|mOsm/L|1|1|[?]|NORMAL|SYNOVIAL FLUID|REFRIGERATED||THIN SMEAR|CKD-EPI CREATININE FORMULA|Y||U||3|Visit_3|40|5|TREATMENT|2020-11-24|2020-11-30|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|118914c8-9f6a-47c8-b427-296a99547756|6|ALPBALP|Alk Phos, Bone/Total Alk Phos|CHEMISTRY|[?]|/mm|[?]|[?]|TRACE|1|10^6/Ejaculate U|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|AUTOLYZED||MS/MS|MDRD FORMULA||Y|Y||3|Visit_3|40|7|FOLLOW-UP|2020-11-24|2021-01-11|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|118914c8-9f6a-47c8-b427-296a99547756|7|A1ANTRYP|Alpha-1 Antitrypsin|URINALYSIS|||[?]|[?]|INDETERMINATE|1|s^-1(%O2)^-1|1|1|[?]|LOW|BASAL TEAR|CONTAMINATED||ZIEHL NEELSEN ACID FAST STAIN|ASH FIBROSURE FORMULA|||U|Y|4|Visit_4|65|5|FOLLOW-UP|2020-12-19|2020-12-20|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|118914c8-9f6a-47c8-b427-296a99547756|8|CYCASULF|Calcium Sulfate Crystals|CHEMISTRY|[?]|mL/min/mmHg|[?]|[?]|TRACE|1|mg/m2/day|1|1|[?]|NORMAL|MONOCYTE|CALCIFIED|N|APPLANATION TONOMETRY|MDRD 6 VARIABLE FORMULA|||Y||4|Visit_4|65|7|FOLLOW-UP|2020-12-19|2021-01-05|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|118914c8-9f6a-47c8-b427-296a99547756|9|RBCCLMP|Erythrocyte Cell Clumps|CHEMISTRY|[?]|tuberculin unit|[?]|[?]|INDETERMINATE|1|Ci/mL|1|1|[?]|HIGH|INFRANATANT, SERUM|UNEXPECTED ODOR||IMMUNOFLUORESCENT STAIN|CKD-EPI CREATININE FORMULA|||N||5|Visit_5|90|5|WASHOUT|2021-01-13|2021-01-16|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|118914c8-9f6a-47c8-b427-296a99547756|10|PLTAGAMP|Platelet Aggregation Amplitude|HEMATOLOGY|||[?]|[?]|POSITIVE|1|MONTHS|1|1|[?]|LOW|EXPIRED AIR|ROOM TEMPERATURE|N|SICKLE CELL SOLUBILITY TEST|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|5|Visit_5|90|7|WASHOUT|2021-01-13|2021-01-16|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|1|HGBEHGB|Hemoglobin E/Total Hemoglobin|HEMATOLOGY|||[?]|[?]|INVALID|1|umol/L/sec|1|1|[?]|HIGH|CORD BLOOD|CONTAMINATED||MRI WITHOUT CONTRAST|GMI % FORMULA|Y||N|Y|1|Visit_1|10|4|FOLLOW-UP|2020-12-09|2020-12-19|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|2|PLATAGGR|Platelet Aggregation|CHEMISTRY|||[?]|[?]|INVALID|1|fg|1|1|[?]|ABNORMAL|ERYTHROCYTES|THAWED||TRIPLE-PHASE MRI SCAN|COCKCROFT-GAULT FORMULA|||NA|Y|1|Visit_1|10|3|TREATMENT|2020-12-09|2020-12-14|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|3|MYBLAT3|Type III Myeloblasts|URINALYSIS|||[?]|[?]|INVALID|1|mL/s|1|1|[?]|NORMAL|VENOUS CORD BLOOD|FROZEN||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|2|Visit_2|25|1|SCREENING|2020-12-24|2021-01-19|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|4|BLSTSID|Sideroblast|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|umol/kg/min|1|1|[?]|HIGH|BASAL TEAR|LIPEMIC||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|NASH FIBROSURE FORMULA|||N|Y|2|Visit_2|25|7|WASHOUT|2020-12-24|2021-01-22|25|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|5|TESTOSWB|Testosterone, Weakly Bound|CHEMISTRY|||[?]|[?]|TRACE|1|v/v|1|1|[?]|HIGH|CELL PELLET|DRIED|N|CINEANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|6|TREATMENT|2021-01-08|2021-02-04|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|6|OH8DXG2|8-Hydroxy-2'-Deoxyguanosine|URINALYSIS|[?]|/100 HPFs|[?]|[?]|INVALID|1|mL/animal|1|1|[?]|HIGH|BLOOD|CLOTTED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|FIBROTEST FORMULA|Y||U||3|Visit_3|40|1|TREATMENT|2021-01-08|2021-03-05|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|7|KL6|Krebs von den Lungen-6|HEMATOLOGY|[?]|mL/kg/day|[?]|[?]|BORDERLINE|1|BU/mL|1|1|[?]|NORMAL|BILE|GELLED||HPLC/MS/MS|NASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|7|FOLLOW-UP|2021-02-02|2021-03-06|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|8|KRCYMGLE|Megakaryocytes/Leukocytes|HEMATOLOGY|[?]|10^9 CFU/g|[?]|[?]|INVALID|1|mL/animal/wk|1|1|[?]|NORMAL|CERUMEN|CLOTTED||PALM METHOD|MDRD FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2021-02-02|2021-02-06|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|9|C165911|Dairy Mix IgG AB RAST Score|HEMATOLOGY|[?]|mU|[?]|[?]|TRACE|1|ug/m2|1|1|[?]|NORMAL|SKIN TISSUE|HEMOLYZED|N|AUTOMATED COUNT|FIBROSIS 4 FORMULA|||NA||5|Visit_5|90|6|WASHOUT|2021-02-27|2021-03-07|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|10|GLCHT|Glycolithocholate|URINALYSIS|[?]|g/day|[?]|[?]|INDETERMINATE|1|deg/mm|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|FROZEN||PEAK FLOWMETRY|FIBROMETER FORMULA|||U||5|Visit_5|90|2|FOLLOW-UP|2021-02-27|2021-02-28|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|1|CRTRONE|Corticosterone|URINALYSIS|[?]|uCi/kg|[?]|[?]|BORDERLINE|1|vg/kg|1|1|[?]|LOW|EMESIS|ICTERIC||PHOTOMETRIC CLOT DETECTION|MDRD 4 VARIABLE FORMULA|Y||NA||1|Visit_1|10|3|WASHOUT|2021-01-08|2021-01-30|10|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|2|PECAM|Platelet Endothelial Adhesion Molecule|CHEMISTRY|[?]|Pack Year|[?]|[?]|NEGATIVE|1|PFU|1|1|[?]|NORMAL|ISOLATE|GELLED||CLINICAL EVALUATION|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|3|FOLLOW-UP|2021-01-08|2021-03-21|10|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|3|THYPXD|Thyroperoxidase|CHEMISTRY|[?]|km/h|[?]|[?]|TRACE|1|PFU|1|1|[?]|NORMAL|URINE|GELLED||HPLC|MDRD 4 VARIABLE FORMULA|||U||2|Visit_2|25|3|TREATMENT|2021-01-23|2021-02-25|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|4|UREA|Urea|HEMATOLOGY|[?]|10^6 copies/mL|[?]|[?]|BORDERLINE|1|mmol/min/kPa|1|1|[?]|ABNORMAL|MONOCYTE|ICTERIC||INTRAVASCULAR ULTRASOUND|HEPASCORE FORMULA||Y|Y||2|Visit_2|25|1|TREATMENT|2021-01-23|2021-03-25|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|5|INTLK13|Interleukin 13|URINALYSIS|[?]|mg/m2/min|[?]|[?]|NEGATIVE|1|ngEq/L|1|1|[?]|NORMAL|SEMEN|PARAFFIN-EMBEDDED||TRANSCRIPTION-MEDIATED AMPLIFICATION|COCKCROFT-GAULT FORMULA|Y||NA||3|Visit_3|40|2|TREATMENT|2021-02-07|2021-04-04|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|6|VITB17|Vitamin B17|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|days/month|1|1|[?]|LOW|KERATINOCYTE|CALCIFIED|N|PALPATION|MDRD ENZYMATIC FORMULA|Y|Y|U|Y|3|Visit_3|40|3|SCREENING|2021-02-07|2021-03-18|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|7|TLYCE|T-Lymphocytes|CHEMISTRY|[?]|ag|[?]|[?]|NEGATIVE|1|ug/kg|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE||JAFFE REACTION|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|2|TREATMENT|2021-03-04|2021-03-12|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|8|LGUNSCE|Large Unstained Cells|CHEMISTRY|[?]|ug/min|[?]|[?]|INVALID|1|gpELISA unit/mL|1|1|[?]|NORMAL|CERUMEN|ICTERIC||ANTIBIOTIC AGAR SCREEN|MDRD 5 VARIABLE FORMULA|Y|Y|Y||4|Visit_4|65|2|SCREENING|2021-03-04|2021-04-03|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|9|HLAMSC|HLA Mismatch Count|CHEMISTRY|[?]|log10 CCID 50/dose|[?]|[?]|TRACE|1|foz_br|1|1|[?]|LOW|SYNOVIAL FLUID|SOLIDIFIED||PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||Y||5|Visit_5|90|1|WASHOUT|2021-03-29|2021-03-31|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|10|CYPHOS|Phosphate Crystals|HEMATOLOGY|[?]|10^6 RNA copies/mL|[?]|[?]|INDETERMINATE|1|mL/animal/day|1|1|[?]|NORMAL|DIALYSIS FLUID|AGGLUTINATED||MICROBIAL CONCENTRATION|CKD-EPI CREATININE FORMULA|Y||NA||5|Visit_5|90|4|SCREENING|2021-03-29|2021-04-02|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|7a5ae465-03b9-4006-a29e-94822ed857aa|1|ALAALB|Apolipoprotein A/Apolipoprotein B|HEMATOLOGY|||[?]|[?]|TRACE|1|ag|1|1|[?]|LOW|PUS|ROOM TEMPERATURE||ELECTROMYOGRAPHY|MDRD 5 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|7|TREATMENT|2020-07-02|2020-08-24|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|7a5ae465-03b9-4006-a29e-94822ed857aa|2|P3NP|Procollagen 3 N-Terminal Propeptide|URINALYSIS|[?]|ft2|[?]|[?]|TRACE|1|kg/cm2|1|1|[?]|LOW|ISOLATE|CALCIFIED||GC/MS-CI|FIBROMETER FORMULA|Y||Y||1|Visit_1|10|4|WASHOUT|2020-07-02|2020-09-19|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|7a5ae465-03b9-4006-a29e-94822ed857aa|3|BASOIMLE|Immature Basophils/Leukocytes|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|cg|1|1|[?]|HIGH|LAVAGE FLUID|LIPEMIC|N|ROMANOWSKY STAIN|FIBROSIS 4 FORMULA|||NA|Y|2|Visit_2|25|4|SCREENING|2020-07-17|2020-08-07|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|7a5ae465-03b9-4006-a29e-94822ed857aa|4|BLYCECE|B-Lymphocytes/Total Cells|URINALYSIS|[?]|ug/L|[?]|[?]|TRACE|1|nCi|1|1|[?]|HIGH|KERATINOCYTE|HEMOLYZED||MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD ENZYMATIC FORMULA|Y||Y||2|Visit_2|25|6|TREATMENT|2020-07-17|2020-08-20|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|7a5ae465-03b9-4006-a29e-94822ed857aa|5|C165922|Mixed Antigen IgE AB RAST Score|HEMATOLOGY|[?]|mU|[?]|[?]|NEGATIVE|1|DIP|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|N|LC/MS|MDRD FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2020-08-01|2020-09-20|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|7a5ae465-03b9-4006-a29e-94822ed857aa|6|VLDL1|VLDL Cholesterol Subtype 1|HEMATOLOGY|[?]|/mm|[?]|[?]|INDETERMINATE|1|mU/L|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|CALCIFIED||MEDIASTINOSCOPY|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2020-08-01|2020-08-02|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|7a5ae465-03b9-4006-a29e-94822ed857aa|7|SLAIGGAB|Soluble Liver Antigen IgG Antibody|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mL/g/min|1|1|[?]|HIGH|MUCUS|UNEXPECTED ODOR||GEL ELECTROPHORESIS|FIBROTEST FORMULA|||N|Y|4|Visit_4|65|5|TREATMENT|2020-08-26|2020-09-29|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|7a5ae465-03b9-4006-a29e-94822ed857aa|8|T3|Triiodothyronine|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^6 organisms|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|REFRIGERATED||EIA|MDRD 5 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|4|SCREENING|2020-08-26|2020-09-24|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|7a5ae465-03b9-4006-a29e-94822ed857aa|9|FUNGYLK|Fungi, Yeast-Like|CHEMISTRY|[?]|kg/L|[?]|[?]|NEGATIVE|1|MONTHS|1|1|[?]|LOW|SMEGMA|CONTAMINATED|N|ULTRASOUND|MDRD 5 VARIABLE FORMULA|||N||5|Visit_5|90|6|TREATMENT|2020-09-20|2020-09-28|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|7a5ae465-03b9-4006-a29e-94822ed857aa|10|GLY|Glycine|URINALYSIS|[?]|RNA copies/mL|[?]|[?]|TRACE|1|Osm|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED||POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA|Y||N||5|Visit_5|90|1|SCREENING|2020-09-20|2020-09-29|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|1|INTLK21|Interleukin 21|CHEMISTRY|[?]|%(v/v)|[?]|[?]|TRACE|1|EID 50/mL|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|AUTOLYZED|N|MICROARRAY|MDRD ENZYMATIC FORMULA|||U||1|Visit_1|10|4|FOLLOW-UP|2020-09-22|2020-11-01|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|2|C147283|White Elm Pollen IgG Antibody|HEMATOLOGY|[?]|U/cL|[?]|[?]|BORDERLINE|1|kIU|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED|N|MICROARRAY|MDRD FORMULA|Y||N||1|Visit_1|10|7|TREATMENT|2020-09-22|2020-12-04|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|3|EUDCA|Epimerized Ursodeoxycholate|URINALYSIS|||[?]|[?]|TRACE|1|kBq/uL|1|1|[?]|LOW|ALVEOLAR AIR|THAWED|N|TARGETED TRANSCRIPTOME SEQUENCING|GMI % FORMULA||Y|N|Y|2|Visit_2|25|4|TREATMENT|2020-10-07|2020-11-17|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|4|BASOMYL|Basophilic Myelocytes|URINALYSIS|[?]|kIU|[?]|[?]|BORDERLINE|1|Hounsfield Unit|1|1|[?]|HIGH|INTERSTITIAL FLUID|GELLED||MICRO BROTH DILUTION|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|3|FOLLOW-UP|2020-10-07|2020-10-29|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|5|CYTYRO|Tyrosine Crystals|CHEMISTRY|[?]|ka_u/dL|[?]|[?]|INDETERMINATE|1|ms/mmHg|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|REFRIGERATED||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-10-22|2020-11-29|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|6|ALBGLOB|Albumin/Globulin|CHEMISTRY|[?]|PIXEL|[?]|[?]|INVALID|1|ug/L|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|UNEXPECTED ODOR||BAC ACGH|COCKCROFT-GAULT FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-10-22|2020-11-09|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|7|CCR5|C-C Chemokine Receptor Type 5|CHEMISTRY|[?]|mOsm/kg|[?]|[?]|INDETERMINATE|1|uU/L|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|REFRIGERATED|N|IN VITRO GENE EXPRESSION ASSAY|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|5|SCREENING|2020-11-16|2020-11-30|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|8|EOSNUCCE|Eosinophils/Nucleated Cells|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mg/dL|1|1|[?]|NORMAL|SKIN TISSUE|CONTAMINATED||KARYOTYPING|MDRD 6 VARIABLE FORMULA|Y||Y|Y|4|Visit_4|65|3|WASHOUT|2020-11-16|2020-11-28|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|9|GLYHLACD|Glycocholic Acid|HEMATOLOGY|[?]|gtt|[?]|[?]|POSITIVE|1|mOsm/L|1|1|[?]|HIGH|BONE MARROW|CLOTTED||PLETHYSMOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||5|Visit_5|90|6|TREATMENT|2020-12-11|2020-12-14|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|10|METHPHEN|Methylphenidate|HEMATOLOGY|[?]|cycle/min|[?]|[?]|POSITIVE|1|CIGAR|1|1|[?]|LOW|PUS|LACTESCENT|N|HPLC/MS/MS|MDRD 5 VARIABLE FORMULA|Y||NA||5|Visit_5|90|2|TREATMENT|2020-12-11|2020-12-14|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|2e4cd860-734a-40b0-bde5-ca08297415a9|1|PTHCT|Parathyroid Hormone, C-Terminal|CHEMISTRY|[?]|log10 CCID 50/dose|[?]|[?]|TRACE|1|Gy/min|1|1|[?]|NORMAL|PLATELET RICH PLASMA|DRIED||CYSTOSCOPY|CKD-EPI FORMULA|||U||1|Visit_1|10|1|FOLLOW-UP|2020-11-25|2020-12-04|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|2e4cd860-734a-40b0-bde5-ca08297415a9|2|FRTNLC|Ferritin Light Chain|HEMATOLOGY|[?]|PA|[?]|[?]|NEGATIVE|1|/mm|1|1|[?]|NORMAL|MONOCYTE|PARAFFIN-EMBEDDED||GC/MS-CI|FIBROMETER FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-11-25|2020-11-29|10|14|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|2e4cd860-734a-40b0-bde5-ca08297415a9|3|RSAD2|Cytomegalovirus-Induced Gene 5 Protein|CHEMISTRY|[?]|10^6 CFU|[?]|[?]|INVALID|1|10^4 CFU|1|1|[?]|NORMAL|SUPERNATANT, SERUM|NON-HEMOLYZED||VIRUS PLAQUE ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|2|FOLLOW-UP|2020-12-10|2020-12-18|25|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|2e4cd860-734a-40b0-bde5-ca08297415a9|4|DZPM|Diazepam|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mCi/kg|1|1|[?]|LOW|HAIR|THAWED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 5 VARIABLE FORMULA|||U|Y|2|Visit_2|25|2|TREATMENT|2020-12-10|2020-12-28|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|2e4cd860-734a-40b0-bde5-ca08297415a9|5|TRICH|Trichomonas|HEMATOLOGY|[?]|PRESSOR UNITS|[?]|[?]|INDETERMINATE|1|pmol/dL|1|1|[?]|NORMAL|SERUM|GELLED||IMMUNOCHROMATOGRAPHY|ASH FIBROSURE FORMULA|Y||Y||3|Visit_3|40|2|FOLLOW-UP|2020-12-25|2021-01-13|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|2e4cd860-734a-40b0-bde5-ca08297415a9|6|HLAB27AG|HLA-B27 Antigen|URINALYSIS|[?]|mL/min|[?]|[?]|TRACE|1|IU/kg|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|DRIED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|FIBROMETER FORMULA|||NA||3|Visit_3|40|7|WASHOUT|2020-12-25|2021-01-27|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|2e4cd860-734a-40b0-bde5-ca08297415a9|7|AMYLASE|Amylase|CHEMISTRY|||[?]|[?]|BORDERLINE|1|pmol/L|1|1|[?]|ABNORMAL|BONE MARROW|GELLED||MECHANICAL CLOT DETECTION|MDRD ENZYMATIC FORMULA|Y||NA|Y|4|Visit_4|65|3|TREATMENT|2021-01-19|2021-01-26|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|2e4cd860-734a-40b0-bde5-ca08297415a9|8|HSP90A|Heat Shock Protein 90 Alpha|URINALYSIS|[?]|Gravitational Unit|[?]|[?]|NEGATIVE|1|nmol/g|1|1|[?]|LOW|PLEURAL FLUID|SOLIDIFIED||BAC ACGH|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|1|FOLLOW-UP|2021-01-19|2021-02-21|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|2e4cd860-734a-40b0-bde5-ca08297415a9|9|ASN|Asparagine|HEMATOLOGY|[?]|/100 HPFs|[?]|[?]|INVALID|1|log10 copies/mL|1|1|[?]|LOW|DIALYSIS FLUID|FRESH||ENZYMATIC ULTRACENTRIFUGATION|MDRD 4 VARIABLE FORMULA|||U||5|Visit_5|90|5|SCREENING|2021-02-13|2021-02-21|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|2e4cd860-734a-40b0-bde5-ca08297415a9|10|C165899|Silver Birch Pollen IgG AB RAST Score|HEMATOLOGY|||[?]|[?]|INVALID|1|Tbsp|1|1|[?]|ABNORMAL|SEMEN|DRIED||PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA|||Y|Y|5|Visit_5|90|5|TREATMENT|2021-02-13|2021-02-17|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|3f1854fb-d14e-4699-888b-d5042fa9327c|1|BETAINES|Betaines|HEMATOLOGY|[?]|AFU|[?]|[?]|NEGATIVE|1|mmHg/L/min|1|1|[?]|NORMAL|CORD SERUM|HEMOLYZED|N|CONGO RED STAIN|FIBROSIS 4 FORMULA|||U||1|Visit_1|10|3|WASHOUT|2020-08-04|2020-10-19|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|3f1854fb-d14e-4699-888b-d5042fa9327c|2|C130074|Birch Pollen IgG|HEMATOLOGY|[?]|mg/g/h|[?]|[?]|TRACE|1|DROP|1|1|[?]|LOW|MUCUS|FROZEN||FARNSWORTH-MUNSELL 100 HUE TEST|MDRD ENZYMATIC FORMULA|||U||1|Visit_1|10|3|TREATMENT|2020-08-04|2020-10-28|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|3f1854fb-d14e-4699-888b-d5042fa9327c|3|P1NP|Procollagen 1 N-Terminal Propeptide|URINALYSIS|[?]|kDa|[?]|[?]|BORDERLINE|1|ug/animal|1|1|[?]|HIGH|PLEURAL FLUID|ICTERIC||EPSILOMETER|CKD-EPI FORMULA|||NA||2|Visit_2|25|7|WASHOUT|2020-08-19|2020-09-02|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|3f1854fb-d14e-4699-888b-d5042fa9327c|4|BALA|Beta Alanine|CHEMISTRY|||[?]|[?]|INVALID|1|SUPPOSITORY|1|1|[?]|NORMAL|SYNOVIAL FLUID|CONCENTRATED|N|DUKE INCISION METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|2|Visit_2|25|6|TREATMENT|2020-08-19|2020-09-21|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|3f1854fb-d14e-4699-888b-d5042fa9327c|5|FGF9|Fibroblast Growth Factor 9|HEMATOLOGY|[?]|U/m2/min|[?]|[?]|BORDERLINE|1|CCID 50/dose|1|1|[?]|LOW|SERUM|LIPEMIC||LANDOLT RING|CKD-EPI CREATININE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-09-03|2020-10-19|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|3f1854fb-d14e-4699-888b-d5042fa9327c|6|LEUKASE|Leukocyte Esterase|HEMATOLOGY|||[?]|[?]|INVALID|1|TABLET|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|CALCIFIED||DUCTOGRAPHY|GMI MMOL/MOL FORMULA|||U|Y|3|Visit_3|40|2|SCREENING|2020-09-03|2020-09-26|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|3f1854fb-d14e-4699-888b-d5042fa9327c|7|CELLS|Cells|CHEMISTRY|[?]|Tesla|[?]|[?]|POSITIVE|1|CAPLET|1|1|[?]|ABNORMAL|PLASMA|CONCENTRATED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|GMI MMOL/MOL FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-09-28|2020-10-30|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|3f1854fb-d14e-4699-888b-d5042fa9327c|8|FVAAC|Factor V Activity Actual/Control|CHEMISTRY|[?]|Absorbance U/mL|[?]|[?]|INVALID|1|um|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|UNEXPECTED ODOR||ERGOSPIROMETRY|FIBROMETER FORMULA|||NA||4|Visit_4|65|3|WASHOUT|2020-09-28|2020-10-25|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|3f1854fb-d14e-4699-888b-d5042fa9327c|9|C165917|D. pteronyssinus IgG AB RAST Score|HEMATOLOGY|[?]|MASK|[?]|[?]|POSITIVE|1|10^7 PFU|1|1|[?]|LOW|AMNIOTIC FLUID|AGGLUTINATED||HPLC-UV|MDRD FORMULA||Y|N||5|Visit_5|90|1|FOLLOW-UP|2020-10-23|2020-10-30|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|3f1854fb-d14e-4699-888b-d5042fa9327c|10|THYPXD|Thyroperoxidase|CHEMISTRY|[?]|s/h|[?]|[?]|BORDERLINE|1|cs|1|1|[?]|ABNORMAL|VITREOUS HUMOR|REFRIGERATED||FLAME PHOTOMETRY|ASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|3|FOLLOW-UP|2020-10-23|2020-10-25|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|f6e37eba-e224-47f3-baa0-59dfdfb47b70|1|BNZDZPN|Benzodiazepine|CHEMISTRY|[?]|Pa|[?]|[?]|BORDERLINE|1|kUSP|1|1|[?]|NORMAL|TISSUE|FROZEN||SINGLE-MOLECULE ARRAY|CKD-EPI CYSTATIN C FORMULA|Y||U||1|Visit_1|10|4|TREATMENT|2020-12-10|2021-03-04|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|f6e37eba-e224-47f3-baa0-59dfdfb47b70|2|HOWJOL|Howell-Jolly Bodies|CHEMISTRY|[?]|mN|[?]|[?]|NEGATIVE|1|SQU/mL|1|1|[?]|HIGH|PLATELET RICH PLASMA|AUTOLYZED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|6|SCREENING|2020-12-10|2020-12-25|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|f6e37eba-e224-47f3-baa0-59dfdfb47b70|3|MONOCE|Monocytes/Total Cells|CHEMISTRY|[?]|Ci/mL|[?]|[?]|TRACE|1|breaths/30s|1|1|[?]|HIGH|CAPILLARY BLOOD|ICTERIC||BIOPSY|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-12-25|2021-01-30|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|f6e37eba-e224-47f3-baa0-59dfdfb47b70|4|HGBEHGB|Hemoglobin E/Total Hemoglobin|CHEMISTRY|[?]|100 IU/mL|[?]|[?]|TRACE|1|cmH2O*s/mL|1|1|[?]|LOW|BONE MARROW|LIPEMIC||NUCLEIC ACID BASED METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||2|Visit_2|25|1|FOLLOW-UP|2020-12-25|2021-03-06|25|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|f6e37eba-e224-47f3-baa0-59dfdfb47b70|5|CTOT|Complement Total|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|10^6 organisms/mL|1|1|[?]|NORMAL|CORD BLOOD|HEMOLYZED|N|WESTERN BLOT|MDRD 5 VARIABLE FORMULA|||N|Y|3|Visit_3|40|7|TREATMENT|2021-01-09|2021-02-04|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|f6e37eba-e224-47f3-baa0-59dfdfb47b70|6|VITB9|Vitamin B9|HEMATOLOGY|||[?]|[?]|INVALID|1|PFU/mL|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|AGGLUTINATED|N|THICK SMEAR|CKD-EPI FORMULA|||Y|Y|3|Visit_3|40|3|FOLLOW-UP|2021-01-09|2021-01-16|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|f6e37eba-e224-47f3-baa0-59dfdfb47b70|7|ICAB|Islet Cell Antibody|HEMATOLOGY|[?]|foz_br|[?]|[?]|NEGATIVE|1|mg/m2/day|1|1|[?]|HIGH|URINE SEDIMENT|PARAFFIN-EMBEDDED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROSIS 4 FORMULA|||NA||4|Visit_4|65|2|WASHOUT|2021-02-03|2021-02-19|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|f6e37eba-e224-47f3-baa0-59dfdfb47b70|8|ANCCLSAB|Neutrophil Cytoplasmic Ab, Classic|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Ejaculate U|1|1|[?]|NORMAL|SKIN TISSUE|NON-HEMOLYZED||GC/MS-EI|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|4|Visit_4|65|1|TREATMENT|2021-02-03|2021-03-08|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|f6e37eba-e224-47f3-baa0-59dfdfb47b70|9|HMOSIDRN|Hemosiderin|HEMATOLOGY|[?]|pmol/L/h|[?]|[?]|BORDERLINE|1|ng/mol|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|AUTOLYZED||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|CKD-EPI CREATININE FORMULA|||N||5|Visit_5|90|3|WASHOUT|2021-02-28|2021-03-06|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|LB|f6e37eba-e224-47f3-baa0-59dfdfb47b70|10|CACLR|Calcium Clearance|CHEMISTRY|[?]|ug/day|[?]|[?]|INVALID|1|GPL U|1|1|[?]|NORMAL|COLOSTRUM|REFRIGERATED||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|GMI % FORMULA||Y|U||5|Visit_5|90|4|TREATMENT|2021-02-28|2021-03-06|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|LB|8298b45d-16ff-42ef-8404-0f3ce628f9e5|1|TRIG|Triglycerides|HEMATOLOGY|[?]|umol/mol|[?]|[?]|INDETERMINATE|1|yd|1|1|[?]|NORMAL|URINE SEDIMENT|ROOM TEMPERATURE||ELECTROCHEMILUMINESCENCE|MDRD ENZYMATIC FORMULA||Y|N||1|Visit_1|10|7|TREATMENT|2020-07-31|2020-08-29|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|8298b45d-16ff-42ef-8404-0f3ce628f9e5|2|CRDIGMAB|Cardiolipin IgM Antibody|HEMATOLOGY|[?]|V/sec|[?]|[?]|INVALID|1|log10 PFU/mL|1|1|[?]|ABNORMAL|PLATELET|SOLIDIFIED|N|MALDI-TOF|GMI % FORMULA|Y||N||1|Visit_1|10|5|TREATMENT|2020-07-31|2020-10-26|10|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|8298b45d-16ff-42ef-8404-0f3ce628f9e5|3|A1MICG|Alpha-1 Microglobulin|CHEMISTRY|||[?]|[?]|NEGATIVE|1|LENS|1|1|[?]|NORMAL|SYNOVIAL FLUID|AGGLUTINATED|N|POPULATION SEQUENCING|MDRD 5 VARIABLE FORMULA|Y||Y|Y|2|Visit_2|25|5|FOLLOW-UP|2020-08-15|2020-09-24|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|8298b45d-16ff-42ef-8404-0f3ce628f9e5|4|C165915|Dog Dander IgG AB RAST Score|HEMATOLOGY|[?]|kg/cm2|[?]|[?]|BORDERLINE|1|Absorbance U/min|1|1|[?]|LOW|ARTERIAL BLOOD|FRESH|N|ANTIBIOTIC AGAR SCREEN|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U||2|Visit_2|25|6|TREATMENT|2020-08-15|2020-09-16|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|8298b45d-16ff-42ef-8404-0f3ce628f9e5|5|GLOBA2|Alpha-2 Globulin|URINALYSIS|||[?]|[?]|POSITIVE|1|% INHIBITION|1|1|[?]|LOW|ALVEOLAR AIR|THAWED|N|GC/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|3|Visit_3|40|1|TREATMENT|2020-08-30|2020-09-10|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|8298b45d-16ff-42ef-8404-0f3ce628f9e5|6|NEUTB|Neutrophils Band Form|CHEMISTRY|[?]|mmHg/sec|[?]|[?]|INDETERMINATE|1|Absorbance U/min|1|1|[?]|LOW|DERMAL TISSUE|CONCENTRATED|N|SPECTROPHOTOMETRY|ASH FIBROSURE FORMULA|||U||3|Visit_3|40|1|TREATMENT|2020-08-30|2020-09-30|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|8298b45d-16ff-42ef-8404-0f3ce628f9e5|7|FGF23I|Fibroblast Growth Factor 23, Intact|HEMATOLOGY|[?]|/LPF|[?]|[?]|NEGATIVE|1|TABLET|1|1|[?]|HIGH|CELL PELLET|ICTERIC|N|LINE PROBE ASSAY|HEPASCORE FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-09-24|2020-10-20|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|8298b45d-16ff-42ef-8404-0f3ce628f9e5|8|NTRLFAT|Neutral Fats|CHEMISTRY|||[?]|[?]|NEGATIVE|1|uU/dL|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|GELLED||OBSERVATION|MDRD 4 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|3|TREATMENT|2020-09-24|2020-09-25|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|8298b45d-16ff-42ef-8404-0f3ce628f9e5|9|BURRCE|Burr Cells|URINALYSIS|[?]|cal|[?]|[?]|TRACE|1|mg/kg/min|1|1|[?]|ABNORMAL|GASTRIC FLUID|LACTESCENT||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|FIBROTEST FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2020-10-19|2020-10-21|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|8298b45d-16ff-42ef-8404-0f3ce628f9e5|10|ALPEXR|Alkaline Phosphatase Excretion Rate|URINALYSIS|||[?]|[?]|INVALID|1|AU/mL|1|1|[?]|HIGH|AMNIOTIC FLUID|CONCENTRATED||ELECTROCHEMILUMINESCENCE|CKD-EPI CREATININE FORMULA|Y||U|Y|5|Visit_5|90|6|TREATMENT|2020-10-19|2020-10-26|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|ee5c6623-5cb4-4f18-99b0-6373328abc1d|1|VITB9|Vitamin B9|HEMATOLOGY|[?]|TAMPON|[?]|[?]|NEGATIVE|1|GBq/g|1|1|[?]|LOW|CORD SERUM|SOLIDIFIED||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|Y||1|Visit_1|10|7|WASHOUT|2020-06-11|2020-06-19|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|ee5c6623-5cb4-4f18-99b0-6373328abc1d|2|METAMYCE|Metamyelocytes/Total Cells|HEMATOLOGY|[?]|/day|[?]|[?]|NEGATIVE|1|uL/kg/day|1|1|[?]|LOW|SERUM OR PLASMA|CALCIFIED||INFRARED SPECTROMETRY|HEPASCORE FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-06-11|2020-08-08|10|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|ee5c6623-5cb4-4f18-99b0-6373328abc1d|3|STIPBASO|Basophilic Stippling|URINALYSIS|[?]|PACK|[?]|[?]|BORDERLINE|1|nmol|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|CALCIFIED||REBOUND TONOMETRY|FIBROSIS 4 FORMULA|Y||NA||2|Visit_2|25|3|SCREENING|2020-06-26|2020-07-16|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|ee5c6623-5cb4-4f18-99b0-6373328abc1d|4|SIXMAM|6-Monoacetylmorphine|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mg/h|1|1|[?]|HIGH|MUCUS|REFRIGERATED|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y|Y|2|Visit_2|25|6|WASHOUT|2020-06-26|2020-08-07|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|ee5c6623-5cb4-4f18-99b0-6373328abc1d|5|MX1|Interferon-Induced Protein p78|HEMATOLOGY|[?]|SUPPOSITORY|[?]|[?]|BORDERLINE|1|mL|1|1|[?]|NORMAL|LYSATE|AUTOLYZED||WHOLE EXOME SEQUENCING|MDRD 4 VARIABLE FORMULA|||Y||3|Visit_3|40|3|SCREENING|2020-07-11|2020-07-31|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|ee5c6623-5cb4-4f18-99b0-6373328abc1d|6|IL122340|Interleukin 12+23 p40|CHEMISTRY|[?]|mg/min|[?]|[?]|INDETERMINATE|1|g/day|1|1|[?]|LOW|SPERMATOZOON|CLOTTED||VENTILATION PERFUSION LUNG SCAN|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-07-11|2020-08-16|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|ee5c6623-5cb4-4f18-99b0-6373328abc1d|7|LIF|Leukemia Inhibitory Factor|URINALYSIS|[?]|10^6 organisms/g|[?]|[?]|BORDERLINE|1|Enzyme U|1|1|[?]|NORMAL|EPITHELIAL CELL|FROZEN||MOUSE PROTECTION ASSAY|FIBROMETER FORMULA||Y|N||4|Visit_4|65|6|TREATMENT|2020-08-05|2020-08-17|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|ee5c6623-5cb4-4f18-99b0-6373328abc1d|8|HGBF|Hemoglobin F|URINALYSIS|||[?]|[?]|POSITIVE|1|mmAL|1|1|[?]|HIGH|URINE|CONTAMINATED||IMMUNO-PET SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||Y|Y|4|Visit_4|65|4|TREATMENT|2020-08-05|2020-08-20|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|ee5c6623-5cb4-4f18-99b0-6373328abc1d|9|C130113|Animal Mix Antigen IgG Antibody|URINALYSIS|[?]|SPRAY|[?]|[?]|INDETERMINATE|1|%(v/v)|1|1|[?]|LOW|REFLEX TEAR|AUTOLYZED||FLUORESCEIN STAIN|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-08-30|2020-09-04|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|ee5c6623-5cb4-4f18-99b0-6373328abc1d|10|CSMIX|Mixed Casts|CHEMISTRY|[?]|mg|[?]|[?]|BORDERLINE|1|lx|1|1|[?]|HIGH|LYMPH|NON-HEMOLYZED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|3|FOLLOW-UP|2020-08-30|2020-09-03|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|f8d6576b-b300-4c5f-8f5a-6bb35250d576|1|CCL20|Chemokine (C-C Motif) Ligand 20|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|NFIU|1|1|[?]|LOW|LYMPH|FROZEN||BETA LACTAMASE|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|2|TREATMENT|2020-06-25|2020-07-27|10|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|f8d6576b-b300-4c5f-8f5a-6bb35250d576|2|KLHIGGAB|Keyhole Limpet Hemocyanin IgG Antibody|CHEMISTRY|[?]|GBq|[?]|[?]|TRACE|1|/mm2|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|DRIED|N|CLINICAL EVALUATION|MDRD 6 VARIABLE FORMULA||Y|U||1|Visit_1|10|5|WASHOUT|2020-06-25|2020-07-10|10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|f8d6576b-b300-4c5f-8f5a-6bb35250d576|3|MM2IGAB|Mitochondrial M2 IgG Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/cage|1|1|[?]|NORMAL|AMNIOTIC FLUID|DRIED||OLIGO ACGH|MDRD 5 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|1|FOLLOW-UP|2020-07-10|2020-07-12|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|f8d6576b-b300-4c5f-8f5a-6bb35250d576|4|LY6E|Lymphocyte Antigen 6E|URINALYSIS|[?]|TABLET|[?]|[?]|NEGATIVE|1|MASK|1|1|[?]|ABNORMAL|CERUMEN|CLOTTED||TARGETED GENOME SEQUENCING|FIBROMETER FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-07-10|2020-08-21|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|f8d6576b-b300-4c5f-8f5a-6bb35250d576|5|FACTVII|Factor VII|HEMATOLOGY|[?]|%(v/v)|[?]|[?]|TRACE|1|10^6 organisms/g|1|1|[?]|ABNORMAL|SOFT TISSUE|DRIED||LISSAMINE GREEN STAIN|GMI MMOL/MOL FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-07-25|2020-07-28|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|f8d6576b-b300-4c5f-8f5a-6bb35250d576|6|ANP|Atrial Natriuretic Peptide|CHEMISTRY|[?]|IU/g|[?]|[?]|POSITIVE|1|GPS U|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|SOLIDIFIED||MASS SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||3|Visit_3|40|5|SCREENING|2020-07-25|2020-09-02|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|f8d6576b-b300-4c5f-8f5a-6bb35250d576|7|MYL3|Myosin Light Chain 3|HEMATOLOGY|[?]|Absorbance U|[?]|[?]|BORDERLINE|1|IU/kg|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED||SLIT LAMP|COCKCROFT-GAULT FORMULA|||Y||4|Visit_4|65|4|SCREENING|2020-08-19|2020-09-07|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|f8d6576b-b300-4c5f-8f5a-6bb35250d576|8|C165876|Birch Pollen IgE AB RAST Score|CHEMISTRY|||[?]|[?]|BORDERLINE|1|vg/kg|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|DRIED||RADIOGRAPHY|MDRD FORMULA|Y|Y|Y|Y|4|Visit_4|65|7|TREATMENT|2020-08-19|2020-08-26|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|f8d6576b-b300-4c5f-8f5a-6bb35250d576|9|APOBAPA1|Apolipoprotein B/Apolipoprotein A1|CHEMISTRY|[?]|BP|[?]|[?]|POSITIVE|1|ug|1|1|[?]|HIGH|KERATINOCYTE|ROOM TEMPERATURE||FISH|COCKCROFT-GAULT FORMULA|Y|Y|NA||5|Visit_5|90|5|TREATMENT|2020-09-13|2020-09-14|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|f8d6576b-b300-4c5f-8f5a-6bb35250d576|10|NICOTINE|Nicotine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|PIXELS/cm|1|1|[?]|HIGH|CALCULUS|CONCENTRATED|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE FORMULA|||NA|Y|5|Visit_5|90|4|SCREENING|2020-09-13|2020-09-15|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|8635a6b3-d16e-432c-90bf-53f1494dbe5e|1|CLCTONN|Calcitonin|CHEMISTRY|[?]|gtt|[?]|[?]|INVALID|1|Osm|1|1|[?]|LOW|AMNIOTIC FLUID|LACTESCENT||SISH|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|6|SCREENING|2020-10-26|2020-10-27|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|8635a6b3-d16e-432c-90bf-53f1494dbe5e|2|AMABARAB|ACH Receptor Modulatn Ab/ACH Receptor Ab|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|dpm/mL|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|AGGLUTINATED||MICROARRAY|GMI MMOL/MOL FORMULA|||N|Y|1|Visit_1|10|3|FOLLOW-UP|2020-10-26|2020-12-16|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|8635a6b3-d16e-432c-90bf-53f1494dbe5e|3|LPL|Lipoprotein Lipase|URINALYSIS|||[?]|[?]|INVALID|1|pkat/L|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|REFRIGERATED|N|GC/MS/MS|MDRD ENZYMATIC FORMULA|Y||Y|Y|2|Visit_2|25|1|TREATMENT|2020-11-10|2020-11-25|25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|8635a6b3-d16e-432c-90bf-53f1494dbe5e|4|NICOTINE|Nicotine|CHEMISTRY|[?]|INHALATION|[?]|[?]|POSITIVE|1|ug/day|1|1|[?]|NORMAL|CALCULUS|UNEXPECTED ODOR||RIA|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|3|WASHOUT|2020-11-10|2020-12-27|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|8635a6b3-d16e-432c-90bf-53f1494dbe5e|5|HBA2PHB|Hemoglobin A2 Prime/Total Hemoglobin|CHEMISTRY|||[?]|[?]|TRACE|1|HEP|1|1|[?]|HIGH|PLEURAL FLUID|ICTERIC|N|HPLC/IEX|GMI MMOL/MOL FORMULA|||Y|Y|3|Visit_3|40|2|TREATMENT|2020-11-25|2021-01-22|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|8635a6b3-d16e-432c-90bf-53f1494dbe5e|6|CODEINE|Codeine|URINALYSIS|[?]|NEBULE|[?]|[?]|NEGATIVE|1|mL/cage/wk|1|1|[?]|ABNORMAL|ISOLATE|SOLIDIFIED|N|TRICHROME STAIN|ASH FIBROSURE FORMULA|||NA||3|Visit_3|40|4|WASHOUT|2020-11-25|2020-12-25|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|8635a6b3-d16e-432c-90bf-53f1494dbe5e|7|EPINEXR|Epinephrine Excretion Rate|HEMATOLOGY|||[?]|[?]|TRACE|1|ukat/L|1|1|[?]|ABNORMAL|BUFFY COAT|CALCIFIED||MRI|ASH FIBROSURE FORMULA|Y||NA|Y|4|Visit_4|65|1|FOLLOW-UP|2020-12-20|2020-12-30|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|8635a6b3-d16e-432c-90bf-53f1494dbe5e|8|APLSMA2|Alpha-2 Antiplasmin|URINALYSIS|[?]|ug/L/h|[?]|[?]|TRACE|1|CAPSULE|1|1|[?]|ABNORMAL|ABSCESS FLUID|GELLED||ISHIHARA COLOR PLATES|MDRD FORMULA||Y|N||4|Visit_4|65|2|WASHOUT|2020-12-20|2020-12-26|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|8635a6b3-d16e-432c-90bf-53f1494dbe5e|9|LYMPLLE|Plasmacytoid Lymphocytes/Leukocytes|HEMATOLOGY|[?]|DNA copies/ug|[?]|[?]|INVALID|1|copies/mL|1|1|[?]|NORMAL|CAPILLARY BLOOD|ICTERIC||NEURAMINIDASE INHIBITION ASSAY|GMI MMOL/MOL FORMULA|Y||U||5|Visit_5|90|6|TREATMENT|2021-01-14|2021-01-17|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|8635a6b3-d16e-432c-90bf-53f1494dbe5e|10|KLHIGMAB|Keyhole Limpet Hemocyanin IgM Antibody|HEMATOLOGY|[?]|cy/cm|[?]|[?]|INVALID|1|BAU|1|1|[?]|HIGH|CORD SERUM|THAWED||GRADIENT DIFFUSION|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|7|WASHOUT|2021-01-14|2021-01-22|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|2cda4297-410a-49e4-949c-deb3dc4c6656|1|MANNITOL|Mannitol|HEMATOLOGY|||[?]|[?]|TRACE|1|PRESSOR UNITS|1|1|[?]|LOW|PROSTATIC FLUID|CALCIFIED||DIGITAL PCR|COCKCROFT-GAULT FORMULA|||Y|Y|1|Visit_1|10|6|FOLLOW-UP|2020-06-20|2020-09-05|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|2cda4297-410a-49e4-949c-deb3dc4c6656|2|PSDEPHD|Pseudoephedrine|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|10^6 CFU/mL|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|CALCIFIED||MALDI-TOF|NASH FIBROSURE FORMULA||Y|Y|Y|1|Visit_1|10|5|FOLLOW-UP|2020-06-20|2020-07-24|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|2cda4297-410a-49e4-949c-deb3dc4c6656|3|ASTALT|AST/ALT|CHEMISTRY|[?]|ug/L FEU|[?]|[?]|INVALID|1|cm|1|1|[?]|ABNORMAL|VENOUS PLASMA|CALCIFIED||ANALYTICAL ULTRACENTRIFUGATION|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-07-05|2020-08-14|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|2cda4297-410a-49e4-949c-deb3dc4c6656|4|AMYLB40|Amyloid Beta 1-40|URINALYSIS|||[?]|[?]|INVALID|1|Mile|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|CONCENTRATED||CLIP SEQUENCING|CKD-EPI CYSTATIN C FORMULA|||U|Y|2|Visit_2|25|7|WASHOUT|2020-07-05|2020-09-07|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|2cda4297-410a-49e4-949c-deb3dc4c6656|5|RP3IGGAB|RNA Polymerase III IgG Antibody|CHEMISTRY|[?]|MASK|[?]|[?]|INDETERMINATE|1|kat|1|1|[?]|ABNORMAL|SKIN TISSUE|CONCENTRATED||NUCLEIC ACID BASED METHOD|MDRD ENZYMATIC FORMULA|||Y||3|Visit_3|40|5|SCREENING|2020-07-20|2020-09-16|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|LB|2cda4297-410a-49e4-949c-deb3dc4c6656|6|VITA|Vitamin A|URINALYSIS|[?]|mg/min|[?]|[?]|TRACE|1|mEq/kg|1|1|[?]|LOW|CAPILLARY BLOOD|CONCENTRATED||COULOMETRIC TITRATION|MDRD ENZYMATIC FORMULA||Y|Y||3|Visit_3|40|2|TREATMENT|2020-07-20|2020-09-03|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|LB|2cda4297-410a-49e4-949c-deb3dc4c6656|7|C165898|Birch Pollen IgG AB RAST Score|HEMATOLOGY|[?]|10^6 organisms/mg|[?]|[?]|INDETERMINATE|1|ng/L|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|HEMOLYZED|N|PATHOLOGICAL EVALUATION|COCKCROFT-GAULT FORMULA|Y||Y||4|Visit_4|65|7|TREATMENT|2020-08-14|2020-08-28|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|2cda4297-410a-49e4-949c-deb3dc4c6656|8|TGFA|Transforming Growth Factor Alpha|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|ug/h|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|REFRIGERATED||IMMUNOASSAY|HEPASCORE FORMULA||Y|NA|Y|4|Visit_4|65|5|TREATMENT|2020-08-14|2020-08-15|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|2cda4297-410a-49e4-949c-deb3dc4c6656|9|CYTRPHOS|Triple Phosphate Crystals|CHEMISTRY|[?]|WEEKS|[?]|[?]|INVALID|1|ag|1|1|[?]|ABNORMAL|LYSATE|AUTOLYZED||GC/FID|FIBROSIS 4 FORMULA||Y|NA||5|Visit_5|90|3|TREATMENT|2020-09-08|2020-09-15|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|LB|2cda4297-410a-49e4-949c-deb3dc4c6656|10|PEPSNGA|Pepsinogen A|HEMATOLOGY|[?]|10^3 CFU/g|[?]|[?]|BORDERLINE|1|mg/day|1|1|[?]|HIGH|SEMINAL FLUID|CONTAMINATED||KLEIHAUER-BETKE|HEPASCORE FORMULA|Y||N||5|Visit_5|90|5|SCREENING|2020-09-08|2020-09-15|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|LB|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|1|VEGFD|Vascular Endothelial Growth Factor D|CHEMISTRY|[?]|Anson U|[?]|[?]|BORDERLINE|1|PNU/mL|1|1|[?]|HIGH|TRANSUDATE|FROZEN|N|PERIPHERAL ANGIOGRAPHY|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|6|SCREENING|2021-01-29|2021-02-27|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|LB|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|2|PEMAB|Pemphigoid Antibodies|URINALYSIS|[?]|ppth|[?]|[?]|POSITIVE|1|L/min|1|1|[?]|HIGH|BLOOD|REFRIGERATED||LC/MS|CKD-EPI FORMULA|||N||1|Visit_1|10|6|TREATMENT|2021-01-29|2021-01-30|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|LB|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|3|IRF|Immature Reticulocyte Fraction|CHEMISTRY|[?]|BOWL|[?]|[?]|TRACE|1|umol/L/min|1|1|[?]|NORMAL|URINE|SOLIDIFIED||CONTACT SPECULAR MICROSCOPY|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2021-02-13|2021-04-06|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|4|NAGASECR|N-acetyl-B-D-glucosaminidase/Creatinine|HEMATOLOGY|[?]|Hz/s|[?]|[?]|POSITIVE|1|Antibody Unit|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA|Y||U||2|Visit_2|25|4|WASHOUT|2021-02-13|2021-04-19|25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|5|VITC|Vitamin C|CHEMISTRY|[?]|/10^4|[?]|[?]|POSITIVE|1|dpm/100mg|1|1|[?]|HIGH|CALCULUS|GELLED|N|TARGETED GENOME SEQUENCING|NASH FIBROSURE FORMULA|||NA||3|Visit_3|40|1|WASHOUT|2021-02-28|2021-04-23|40|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|6|EOS|Eosinophils|URINALYSIS|||[?]|[?]|INDETERMINATE|1|umol/mg/min|1|1|[?]|NORMAL|DERMAL TISSUE|CALCIFIED||COMPLEMENT FIXATION|CKD-EPI FORMULA|||Y|Y|3|Visit_3|40|3|TREATMENT|2021-02-28|2021-04-16|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|7|LIQUFT|Liquefaction Time|URINALYSIS|[?]|kat|[?]|[?]|TRACE|1|deg/s|1|1|[?]|HIGH|PLATELET RICH PLASMA|AGGLUTINATED|N|ETDRS EYE CHART|NASH FIBROSURE FORMULA|Y|Y|NA||4|Visit_4|65|3|TREATMENT|2021-03-25|2021-04-15|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|8|ACETOAC|Acetoacetic Acid|URINALYSIS|[?]|nmol BCE/nmol|[?]|[?]|INDETERMINATE|1|mg/animal|1|1|[?]|HIGH|BONE|UNEXPECTED ODOR||RULER MEASUREMENT METHOD|MDRD 6 VARIABLE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2021-03-25|2021-04-09|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|9|LEIMLE|Immature Leukocytes/Leukocytes|CHEMISTRY|[?]|Enzyme U/m2|[?]|[?]|NEGATIVE|1|CIGAR|1|1|[?]|LOW|FLUID|AGGLUTINATED||RULER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|3|SCREENING|2021-04-19|2021-04-21|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|10|ADPNCTN|Adiponectin|HEMATOLOGY|||[?]|[?]|TRACE|1|rpm|1|1|[?]|LOW|ARTERIAL CORD BLOOD|HEMOLYZED|N|HILLMEN COLOR CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|5|Visit_5|90|1|TREATMENT|2021-04-19|2021-04-26|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|9e82141b-e2b9-42c7-b813-b79bda2bd216|1|BLSTLMLY|Leukemic Blasts/Lymphocytes|HEMATOLOGY|[?]|10^7 TCID 50/dose|[?]|[?]|INVALID|1|tsp eq|1|1|[?]|HIGH|AMNIOTIC FLUID|PARAFFIN-EMBEDDED||NON-INVASIVE DIELECTRIC SENSING|MDRD 4 VARIABLE FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2020-05-31|2020-07-03|10|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|LB|9e82141b-e2b9-42c7-b813-b79bda2bd216|2|GLUCPED|Plasma Equivalent Glucose Distribution|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|CAPFUL|1|1|[?]|ABNORMAL|DISCHARGE|ICTERIC||TRICHROME STAIN|GMI MMOL/MOL FORMULA|||NA|Y|1|Visit_1|10|2|SCREENING|2020-05-31|2020-08-16|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|LB|9e82141b-e2b9-42c7-b813-b79bda2bd216|3|CYP2C9|Cytochrome P450 2C9|HEMATOLOGY|[?]|scm|[?]|[?]|BORDERLINE|1|MASK|1|1|[?]|HIGH|PLASMA|PARAFFIN-EMBEDDED||BALLPOINT PEN TECHNIQUE|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|5|TREATMENT|2020-06-15|2020-08-01|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|9e82141b-e2b9-42c7-b813-b79bda2bd216|4|C147281|Egg White Antigen IgE Antibody|CHEMISTRY|[?]|Ci/mL|[?]|[?]|POSITIVE|1|ug/L/h|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|THAWED|N|PANENDOSCOPY|MDRD 4 VARIABLE FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-06-15|2020-07-05|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|9e82141b-e2b9-42c7-b813-b79bda2bd216|5|SJSSAAB|Sjogrens SS-A Antibody|HEMATOLOGY|[?]|mmHg/sec|[?]|[?]|INVALID|1|10^6 organisms/mL|1|1|[?]|LOW|VENOUS BLOOD|CLOTTED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|FIBROMETER FORMULA|Y||U||3|Visit_3|40|7|TREATMENT|2020-06-30|2020-07-28|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|LB|9e82141b-e2b9-42c7-b813-b79bda2bd216|6|MGB|Myoglobin|CHEMISTRY|[?]|mL/m2|[?]|[?]|INVALID|1|Hz/s|1|1|[?]|ABNORMAL|PLEURAL FLUID|PARAFFIN-EMBEDDED|N|WHOLE EXOME SEQUENCING|FIBROTEST FORMULA||Y|U||3|Visit_3|40|5|SCREENING|2020-06-30|2020-07-07|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|LB|9e82141b-e2b9-42c7-b813-b79bda2bd216|7|CD40|CD40|CHEMISTRY|[?]|10^6 IU|[?]|[?]|INDETERMINATE|1|10^9/g|1|1|[?]|NORMAL|SEBUM|FROZEN||SPECT/CT SCAN|MDRD FORMULA|||U||4|Visit_4|65|4|WASHOUT|2020-07-25|2020-08-11|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|9e82141b-e2b9-42c7-b813-b79bda2bd216|8|PO2|Partial Pressure Oxygen|URINALYSIS|[?]|copies/ug|[?]|[?]|NEGATIVE|1|mL/g/day|1|1|[?]|LOW|VITREOUS HUMOR|LACTESCENT|N|IN SITU HYBRIDIZATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2020-07-25|2020-08-21|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|9e82141b-e2b9-42c7-b813-b79bda2bd216|9|APOB|Apolipoprotein B|HEMATOLOGY|[?]|MBq/uL|[?]|[?]|TRACE|1|RATIO|1|1|[?]|NORMAL|EMOTIONAL TEAR|CONTAMINATED||CLINICAL EVALUATION|CKD-EPI CREATININE FORMULA||Y|U||5|Visit_5|90|5|TREATMENT|2020-08-19|2020-08-23|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|LB|9e82141b-e2b9-42c7-b813-b79bda2bd216|10|ASP|Aspartic Acid|URINALYSIS|[?]|Gauss|[?]|[?]|INDETERMINATE|1|U/g/min|1|1|[?]|HIGH|KERATINOCYTE|LACTESCENT||ELECTROCHEMILUMINESCENCE|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|5|FOLLOW-UP|2020-08-19|2020-08-26|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|LB|4b432c61-c620-4c5e-8aad-411facc0f4db|1|HCGND|Choriogonadotropin|HEMATOLOGY|[?]|m3|[?]|[?]|POSITIVE|1|mm2|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|CONTAMINATED||MANUAL COUNT|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||1|Visit_1|10|2|FOLLOW-UP|2020-09-14|2020-09-17|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|4b432c61-c620-4c5e-8aad-411facc0f4db|2|NEUTHYGR|Hypogranular Neutrophils|HEMATOLOGY|[?]|10^4/L|[?]|[?]|INVALID|1|mL/cm|1|1|[?]|ABNORMAL|SKIN TISSUE|SOLIDIFIED||DNA MICROARRAY|MDRD 5 VARIABLE FORMULA|Y||N||1|Visit_1|10|4|WASHOUT|2020-09-14|2020-10-20|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|4b432c61-c620-4c5e-8aad-411facc0f4db|3|TK2|Thymidine Kinase 2|HEMATOLOGY|[?]|cd*s/m2|[?]|[?]|POSITIVE|1|mEq/kg|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|ROOM TEMPERATURE|N|ELECTROGASTROGRAPHY|FIBROTEST FORMULA|||N||2|Visit_2|25|5|TREATMENT|2020-09-29|2020-10-25|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|4b432c61-c620-4c5e-8aad-411facc0f4db|4|MICROCY|Microcytes|HEMATOLOGY|[?]|%/min|[?]|[?]|INVALID|1|nmol/L/min|1|1|[?]|LOW|LAVAGE FLUID|SOLIDIFIED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||2|Visit_2|25|5|SCREENING|2020-09-29|2020-11-16|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|4b432c61-c620-4c5e-8aad-411facc0f4db|5|OXYSAT|Oxygen Saturation|HEMATOLOGY|||[?]|[?]|INVALID|1|umol/mol|1|1|[?]|ABNORMAL|BILE|CONTAMINATED||PHASE CONTRAST MICROSCOPY|FIBROMETER FORMULA|||Y|Y|3|Visit_3|40|7|TREATMENT|2020-10-14|2020-12-07|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|4b432c61-c620-4c5e-8aad-411facc0f4db|6|C130089|Timothy Grass Pollen IgA|URINALYSIS|[?]|Bq/uL|[?]|[?]|NEGATIVE|1|LENS|1|1|[?]|NORMAL|VITREOUS HUMOR|CALCIFIED||RIA|COCKCROFT-GAULT FORMULA|Y||Y||3|Visit_3|40|1|WASHOUT|2020-10-14|2020-12-05|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|4b432c61-c620-4c5e-8aad-411facc0f4db|7|OSTEOC|Osteocalcin|CHEMISTRY|[?]|PFU/dose|[?]|[?]|INDETERMINATE|1|cmHg|1|1|[?]|ABNORMAL|PUS|AUTOLYZED||SPIRAL CT SCAN WITHOUT CONTRAST|HEPASCORE FORMULA|||U||4|Visit_4|65|7|TREATMENT|2020-11-08|2020-11-21|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|4b432c61-c620-4c5e-8aad-411facc0f4db|8|EOTAXIN3|Eotaxin-3|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mL/cm3/min|1|1|[?]|LOW|MIXED VENOUS BLOOD|CALCIFIED||PERIPHERAL ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||U|Y|4|Visit_4|65|6|TREATMENT|2020-11-08|2020-11-25|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|4b432c61-c620-4c5e-8aad-411facc0f4db|9|INTLK10|Interleukin 10|CHEMISTRY|[?]|mEq|[?]|[?]|TRACE|1|/kg|1|1|[?]|HIGH|HAIR FOLLICLE|SOLIDIFIED||FLUORESCENT ENZYME IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|4|FOLLOW-UP|2020-12-03|2020-12-10|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|4b432c61-c620-4c5e-8aad-411facc0f4db|10|GLUCWBE|Whole Blood Equivalent Glucose|CHEMISTRY|[?]|log10 CFU/g|[?]|[?]|INVALID|1|PUFF|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|PARAFFIN-EMBEDDED|N|CORONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|||Y||5|Visit_5|90|2|SCREENING|2020-12-03|2020-12-08|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|1a1e6863-26da-4b5d-b82a-5703e3e9056e|1|VWFAAC|von Will Factor Act Actual/Control|URINALYSIS|[?]|U/mg|[?]|[?]|BORDERLINE|1|ug/m2/min|1|1|[?]|LOW|SALIVA|LACTESCENT|N|ZIEHL NEELSEN ACID FAST STAIN|GMI MMOL/MOL FORMULA|||Y||1|Visit_1|10|5|FOLLOW-UP|2020-12-26|2021-02-19|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|1a1e6863-26da-4b5d-b82a-5703e3e9056e|2|B2MCREAT|Beta-2 Microglobulin/Creatinine|CHEMISTRY|[?]|h*%|[?]|[?]|TRACE|1|U|1|1|[?]|NORMAL|MENSTRUAL BLOOD|CLOTTED|N|COMPLEMENT FIXATION|HEPASCORE FORMULA|||Y||1|Visit_1|10|7|SCREENING|2020-12-26|2021-02-11|10|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|1a1e6863-26da-4b5d-b82a-5703e3e9056e|3|MGBCREAT|Myoglobin/Creatinine|URINALYSIS|[?]|lx|[?]|[?]|NEGATIVE|1|mCi/kg|1|1|[?]|NORMAL|TRANSUDATE|FROZEN||ACRIDINE ORANGE STAIN|GMI MMOL/MOL FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2021-01-10|2021-02-19|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|1a1e6863-26da-4b5d-b82a-5703e3e9056e|4|LDL|LDL Cholesterol|CHEMISTRY|||[?]|[?]|TRACE|1|mg/g/min|1|1|[?]|ABNORMAL|TRANSUDATE|LACTESCENT||ULTRASONOGRAPHIC ELASTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|2|Visit_2|25|5|FOLLOW-UP|2021-01-10|2021-02-01|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|1a1e6863-26da-4b5d-b82a-5703e3e9056e|5|COCBNZEC|Cocaine Benzoylecgonine Ecgonine|URINALYSIS|[?]|ft|[?]|[?]|INVALID|1|BOTTLE|1|1|[?]|LOW|ISOLATE|CALCIFIED||INTERRUPTER TECHNIQUE|FIBROMETER FORMULA|Y||U||3|Visit_3|40|2|TREATMENT|2021-01-25|2021-01-26|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|LB|1a1e6863-26da-4b5d-b82a-5703e3e9056e|6|AFACTXAA|Anti-Factor Xa Activity|CHEMISTRY|[?]|gpELISA unit/mL|[?]|[?]|NEGATIVE|1|uOsm|1|1|[?]|ABNORMAL|PERSPIRATION|AUTOLYZED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|5|SCREENING|2021-01-25|2021-03-24|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|LB|1a1e6863-26da-4b5d-b82a-5703e3e9056e|7|SPMPSPM|Spermatozoa, Progressive/Spermatozoa|CHEMISTRY|[?]|DIOPTER|[?]|[?]|INVALID|1|mm|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|GELLED||ISHIHARA COLOR PLATES|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2021-02-19|2021-03-17|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|1a1e6863-26da-4b5d-b82a-5703e3e9056e|8|KLHIGMAB|Keyhole Limpet Hemocyanin IgM Antibody|URINALYSIS|[?]|CCID 50/mL|[?]|[?]|NEGATIVE|1|PACKAGE|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED||TURBIDIMETRY|COCKCROFT-GAULT FORMULA|Y|Y|U||4|Visit_4|65|5|FOLLOW-UP|2021-02-19|2021-03-18|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|1a1e6863-26da-4b5d-b82a-5703e3e9056e|9|IGFBP1|Insulin-Like Growth Factor Binding Prot1|URINALYSIS|||[?]|[?]|INVALID|1|DAYS|1|1|[?]|NORMAL|BONE MARROW|ROOM TEMPERATURE||VIRUS PLAQUE ASSAY|FIBROTEST FORMULA|Y||Y|Y|5|Visit_5|90|1|TREATMENT|2021-03-16|2021-03-17|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|LB|1a1e6863-26da-4b5d-b82a-5703e3e9056e|10|OXYCAP|Oxygen Capacity|HEMATOLOGY|[?]|10^6 DNA copies/mL|[?]|[?]|BORDERLINE|1|KIT|1|1|[?]|LOW|SEMINAL FLUID|NON-HEMOLYZED||U-HPLC/MS/MS|GMI MMOL/MOL FORMULA|Y||Y||5|Visit_5|90|7|TREATMENT|2021-03-16|2021-03-24|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|LB|8c8053d1-adae-4d45-870e-cf4ad2475c74|1|THYAB|Thyroid Antibodies|HEMATOLOGY|[?]|CFU/g|[?]|[?]|INVALID|1|APS U|1|1|[?]|ABNORMAL|LAVAGE FLUID|FROZEN|N|SINGLE-SLICE SPIRAL CT|FIBROSIS 4 FORMULA|Y|Y|U||1|Visit_1|10|3|TREATMENT|2020-05-11|2020-07-05|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|8c8053d1-adae-4d45-870e-cf4ad2475c74|2|CD161ALY|CD161a/Lymphocytes|URINALYSIS|||[?]|[?]|BORDERLINE|1|Ejaculate U|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|CLOTTED||KNEMOMETRY|MDRD 4 VARIABLE FORMULA|||U|Y|1|Visit_1|10|2|SCREENING|2020-05-11|2020-06-14|10|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|8c8053d1-adae-4d45-870e-cf4ad2475c74|3|AMYLASES|Amylase, Salivary|HEMATOLOGY|[?]|kDa|[?]|[?]|POSITIVE|1|mOsm/kg|1|1|[?]|NORMAL|MONOCYTE|UNEXPECTED ODOR|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|FIBROTEST FORMULA|Y||N||2|Visit_2|25|6|TREATMENT|2020-05-26|2020-07-17|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|LB|8c8053d1-adae-4d45-870e-cf4ad2475c74|4|CYDRUG|Drug Crystals|CHEMISTRY|||[?]|[?]|TRACE|1|km|1|1|[?]|HIGH|TRANSUDATE|AUTOLYZED|N|OSCILLOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y|Y|2|Visit_2|25|1|TREATMENT|2020-05-26|2020-07-07|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|LB|8c8053d1-adae-4d45-870e-cf4ad2475c74|5|HASIGMAB|Human Anti-Sheep IgM Antibody|HEMATOLOGY|[?]|Ci/g|[?]|[?]|INVALID|1|mMU/mL|1|1|[?]|ABNORMAL|CORD SERUM|NON-HEMOLYZED|N|KINETIC CHROMOGENIC ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-06-10|2020-08-03|40|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-22
e|LB|8c8053d1-adae-4d45-870e-cf4ad2475c74|6|CXCL6|Chemokine (C-X-C Motif) Ligand 6|URINALYSIS|[?]|nmol BCE/nmol|[?]|[?]|POSITIVE|1|CUP|1|1|[?]|HIGH|URINE|HEMOLYZED||LISSAMINE GREEN STAIN|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-06-10|2020-07-29|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-22
e|LB|8c8053d1-adae-4d45-870e-cf4ad2475c74|7|PYK|Pyruvate Kinase|URINALYSIS|[?]|g/animal|[?]|[?]|INVALID|1|fmol|1|1|[?]|HIGH|SMEGMA|GELLED|N|INCISION-INDUCED BLEEDING METHOD|MDRD 4 VARIABLE FORMULA|Y||N||4|Visit_4|65|4|TREATMENT|2020-07-05|2020-07-15|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|8c8053d1-adae-4d45-870e-cf4ad2475c74|8|CD11B|CD11B|HEMATOLOGY|[?]|ug/kg/h|[?]|[?]|BORDERLINE|1|v/v|1|1|[?]|HIGH|LOCHIA|CALCIFIED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|Y||NA||4|Visit_4|65|1|TREATMENT|2020-07-05|2020-08-03|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|8c8053d1-adae-4d45-870e-cf4ad2475c74|9|FRUCTOSE|Fructose|HEMATOLOGY|[?]|dmol|[?]|[?]|BORDERLINE|1|log10 copies/mL|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|CLOTTED||CLAUSS METHOD|NASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|7|SCREENING|2020-07-30|2020-08-07|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|8c8053d1-adae-4d45-870e-cf4ad2475c74|10|IFI27|Interferon Alpha-Inducible Protein 27|CHEMISTRY|[?]|mm|[?]|[?]|NEGATIVE|1|L/kg|1|1|[?]|HIGH|SYNOVIAL FLUID|FRESH||CONTRAST ENHANCED PET/CT SCAN|MDRD ENZYMATIC FORMULA|||N||5|Visit_5|90|7|TREATMENT|2020-07-30|2020-08-02|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|c3b911a8-116e-4940-80a2-7128db004f4a|1|CYSTINE|Cystine|HEMATOLOGY|[?]|km|[?]|[?]|INVALID|1|m/sec|1|1|[?]|ABNORMAL|BLOOD|LACTESCENT||MIGET|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-11-19|2021-02-13|10|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|c3b911a8-116e-4940-80a2-7128db004f4a|2|EPINEXR|Epinephrine Excretion Rate|HEMATOLOGY|[?]|scm|[?]|[?]|NEGATIVE|1|Enzyme U/g Hb|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|AGGLUTINATED|N|MAMMOGRAPHY|MDRD 4 VARIABLE FORMULA|Y||U||1|Visit_1|10|7|WASHOUT|2020-11-19|2020-12-31|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|c3b911a8-116e-4940-80a2-7128db004f4a|3|PGF2A|Prostaglandin F2 Alpha|HEMATOLOGY|[?]|Rad|[?]|[?]|BORDERLINE|1|ug/mol|1|1|[?]|LOW|ISOLATE|FROZEN||QUANTITATIVE CORONARY ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-12-04|2021-01-14|25|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|c3b911a8-116e-4940-80a2-7128db004f4a|4|VLDL|VLDL Cholesterol|URINALYSIS|[?]|USP U|[?]|[?]|INVALID|1|g/L|1|1|[?]|NORMAL|CAPILLARY PLASMA|FRESH||DOPPLER ULTRASOUND|MDRD FORMULA|Y||U||2|Visit_2|25|1|TREATMENT|2020-12-04|2020-12-22|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|c3b911a8-116e-4940-80a2-7128db004f4a|5|RPA1|Renal Papillary Antigen 1|URINALYSIS|||[?]|[?]|NEGATIVE|1|mU|1|1|[?]|ABNORMAL|PERSPIRATION|CALCIFIED|N|CLIP SEQUENCING|FIBROMETER FORMULA||Y|NA|Y|3|Visit_3|40|4|SCREENING|2020-12-19|2020-12-21|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|c3b911a8-116e-4940-80a2-7128db004f4a|6|TPROT|Tau Protein|HEMATOLOGY|[?]|U/dL|[?]|[?]|NEGATIVE|1|umol/kg/min|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|ICTERIC||MRS|FIBROSIS 4 FORMULA|Y||U||3|Visit_3|40|7|WASHOUT|2020-12-19|2021-02-16|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|c3b911a8-116e-4940-80a2-7128db004f4a|7|C165915|Dog Dander IgG AB RAST Score|URINALYSIS|||[?]|[?]|INVALID|1|log10 CFU/g|1|1|[?]|HIGH|MIXED VENOUS BLOOD|DRIED||PLETHYSMOGRAPHY|COCKCROFT-GAULT FORMULA|||NA|Y|4|Visit_4|65|4|FOLLOW-UP|2021-01-13|2021-01-23|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|c3b911a8-116e-4940-80a2-7128db004f4a|8|NEUTHYGR|Hypogranular Neutrophils|HEMATOLOGY|||[?]|[?]|TRACE|1|10^6/Ejaculate U|1|1|[?]|HIGH|SEMEN|GELLED||FREEZING POINT DEPRESSION|COCKCROFT-GAULT FORMULA|||U|Y|4|Visit_4|65|3|WASHOUT|2021-01-13|2021-01-17|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|c3b911a8-116e-4940-80a2-7128db004f4a|9|C130133|D. farinae Antigen IgG Antibody|URINALYSIS|[?]|TROCHE|[?]|[?]|INDETERMINATE|1|steps/min|1|1|[?]|HIGH|SKIN TISSUE|NON-HEMOLYZED||IODINE STAIN|FIBROSIS 4 FORMULA||Y|U||5|Visit_5|90|1|WASHOUT|2021-02-07|2021-02-10|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|c3b911a8-116e-4940-80a2-7128db004f4a|10|CAEXR|Calcium Excretion Rate|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|titer|1|1|[?]|NORMAL|BILE|CONTAMINATED||THERMAL IONIZATION MASS SPECTROMETRY|CKD-EPI CREATININE FORMULA||Y|N|Y|5|Visit_5|90|3|TREATMENT|2021-02-07|2021-02-12|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|401d66ba-bc00-4495-ba5d-796068dd1fd6|1|PRGNENLN|Pregnenolone|URINALYSIS|[?]|DIP|[?]|[?]|INVALID|1|g/cage/day|1|1|[?]|ABNORMAL|RETICULOCYTES|CALCIFIED||MALDI|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|4|SCREENING|2020-06-11|2020-06-28|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|LB|401d66ba-bc00-4495-ba5d-796068dd1fd6|2|ACYLCAOX|Acyl Coenzyme A Oxidase|HEMATOLOGY|[?]|mg/mol|[?]|[?]|INVALID|1|kat|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|AGGLUTINATED||ELECTROPHORESIS|ASH FIBROSURE FORMULA|||U||1|Visit_1|10|2|TREATMENT|2020-06-11|2020-08-12|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|LB|401d66ba-bc00-4495-ba5d-796068dd1fd6|3|DMG|Dimethylglycine|CHEMISTRY|[?]|pmol/L/h|[?]|[?]|INDETERMINATE|1|MET*h|1|1|[?]|HIGH|HAIR|FROZEN||CELL OF ORIGIN ASSAY|ASH FIBROSURE FORMULA|Y|Y|U||2|Visit_2|25|5|TREATMENT|2020-06-26|2020-07-19|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|401d66ba-bc00-4495-ba5d-796068dd1fd6|4|MENGLCE|Meningeal Cells/Total Cells|CHEMISTRY|[?]|log10 PFU/mL|[?]|[?]|POSITIVE|1|cycle/min|1|1|[?]|HIGH|MONOCYTE|CLOTTED||GRAM STAIN|FIBROMETER FORMULA|||N||2|Visit_2|25|2|FOLLOW-UP|2020-06-26|2020-07-19|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|401d66ba-bc00-4495-ba5d-796068dd1fd6|5|CRTRONE|Corticosterone|URINALYSIS|[?]|nmol BCE/mmol|[?]|[?]|INDETERMINATE|1|ug/m2/min|1|1|[?]|ABNORMAL|REFLEX TEAR|FRESH|N|PAP STAIN|MDRD 6 VARIABLE FORMULA|||Y||3|Visit_3|40|7|SCREENING|2020-07-11|2020-08-13|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|LB|401d66ba-bc00-4495-ba5d-796068dd1fd6|6|FACTVWA|von Willebrand Factor Activity|HEMATOLOGY|[?]|ukat|[?]|[?]|TRACE|1|U/m2/h|1|1|[?]|LOW|GASTRIC CONTENTS|PARAFFIN-EMBEDDED|N|REBOUND TONOMETRY|CKD-EPI CREATININE FORMULA|Y||Y||3|Visit_3|40|7|TREATMENT|2020-07-11|2020-07-26|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|LB|401d66ba-bc00-4495-ba5d-796068dd1fd6|7|NEUTB|Neutrophils Band Form|URINALYSIS|||[?]|[?]|INDETERMINATE|1|DRINK|1|1|[?]|NORMAL|CALCULUS|FROZEN|N|CONTRAST ENHANCED SPIRAL CT SCAN|GMI MMOL/MOL FORMULA|Y||N|Y|4|Visit_4|65|1|TREATMENT|2020-08-05|2020-09-03|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|401d66ba-bc00-4495-ba5d-796068dd1fd6|8|CYAMORPH|Amorphous Crystals|HEMATOLOGY|[?]|Hz/s|[?]|[?]|INVALID|1|pmol/dL|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|CONCENTRATED||DOUBLE IMMUNODIFFUSION|FIBROMETER FORMULA|Y||Y||4|Visit_4|65|3|SCREENING|2020-08-05|2020-08-09|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|401d66ba-bc00-4495-ba5d-796068dd1fd6|9|IRONEXR|Iron Excretion Rate|URINALYSIS|[?]|nkat|[?]|[?]|NEGATIVE|1|pt_br|1|1|[?]|LOW|DISCHARGE|LACTESCENT||MECHANICAL CLOT DETECTION|CKD-EPI CREATININE FORMULA|||U||5|Visit_5|90|6|FOLLOW-UP|2020-08-30|2020-09-02|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|401d66ba-bc00-4495-ba5d-796068dd1fd6|10|LIF|Leukemia Inhibitory Factor|HEMATOLOGY|[?]|mm|[?]|[?]|INVALID|1|mL/s/m2|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|CALCIFIED||PEAK FLOWMETRY|CKD-EPI FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-08-30|2020-09-08|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|f8113725-4deb-48a1-876a-ba168a6d2cee|1|OVALCY|Ovalocytes|HEMATOLOGY|[?]|dpm/mg|[?]|[?]|BORDERLINE|1|pt_br|1|1|[?]|ABNORMAL|CERUMEN|CALCIFIED|N|URANYL ACETATE STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||U||1|Visit_1|10|4|TREATMENT|2021-01-22|2021-03-21|10|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|LB|f8113725-4deb-48a1-876a-ba168a6d2cee|2|CIT|Citrulline|HEMATOLOGY|[?]|tuberculin unit/mL|[?]|[?]|BORDERLINE|1|in2|1|1|[?]|LOW|SPERMATOZOON|HEMOLYZED|N|FLAME PHOTOMETRY|FIBROSIS 4 FORMULA|||Y||1|Visit_1|10|7|FOLLOW-UP|2021-01-22|2021-03-04|10|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|LB|f8113725-4deb-48a1-876a-ba168a6d2cee|3|CD45RALY|CD45RA/Lymphocytes|CHEMISTRY|[?]|mL/beat|[?]|[?]|TRACE|1|U/m2/min|1|1|[?]|ABNORMAL|DERMAL TISSUE|HEMOLYZED|N|LIGHT MICROSCOPY|FIBROTEST FORMULA|||NA||2|Visit_2|25|7|FOLLOW-UP|2021-02-06|2021-02-26|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|f8113725-4deb-48a1-876a-ba168a6d2cee|4|PSELECT|P-Selectin|URINALYSIS|[?]|/100 HPFs|[?]|[?]|BORDERLINE|1|ppb|1|1|[?]|LOW|ENDOMETRIAL TISSUE|AGGLUTINATED||INFRARED SPECTROMETRY|COCKCROFT-GAULT FORMULA|||U||2|Visit_2|25|4|TREATMENT|2021-02-06|2021-03-14|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|f8113725-4deb-48a1-876a-ba168a6d2cee|5|RMNTLP|Remnant Lipoprotein|HEMATOLOGY|[?]|FINGERTIP UNIT|[?]|[?]|POSITIVE|1|10^6/Ejaculate U|1|1|[?]|HIGH|STOOL|UNEXPECTED ODOR||TRIPLE-PHASE MRI SCAN|MDRD ENZYMATIC FORMULA|||Y||3|Visit_3|40|1|SCREENING|2021-02-21|2021-04-10|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|f8113725-4deb-48a1-876a-ba168a6d2cee|6|PGD2S|Prostaglandin D2 Synthase|URINALYSIS|[?]|mEq/g|[?]|[?]|INVALID|1|foz_us|1|1|[?]|LOW|ABSCESS FLUID|CONCENTRATED||KARYOTYPING|GMI % FORMULA|Y|Y|N||3|Visit_3|40|2|TREATMENT|2021-02-21|2021-03-10|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|f8113725-4deb-48a1-876a-ba168a6d2cee|7|MONOIMLE|Immature Monocytes/Leukocytes|URINALYSIS|[?]|pmol/10^9 cells|[?]|[?]|BORDERLINE|1|pmol/L/h|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|LACTESCENT||CONGO RED STAIN|MDRD 5 VARIABLE FORMULA||Y|N||4|Visit_4|65|3|WASHOUT|2021-03-18|2021-04-13|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|LB|f8113725-4deb-48a1-876a-ba168a6d2cee|8|C130136|American Cockroach Antigen IgE Antibody|HEMATOLOGY|[?]|10^5/L|[?]|[?]|BORDERLINE|1|MET*min|1|1|[?]|HIGH|CAPILLARY PLASMA|CONTAMINATED||AURAMINE STAIN|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2021-03-18|2021-04-19|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|LB|f8113725-4deb-48a1-876a-ba168a6d2cee|9|INTLK3|Interleukin 3|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ug/animal|1|1|[?]|NORMAL|BONE MARROW|GELLED|N|ACCELERATOR MASS SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2021-04-12|2021-04-13|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|f8113725-4deb-48a1-876a-ba168a6d2cee|10|CD2LY|CD2/Lymphocytes|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Gy/min|1|1|[?]|ABNORMAL|DISCHARGE|DRIED||NUCLEIC ACID SEQUENCING|CKD-EPI CYSTATIN C FORMULA|||NA|Y|5|Visit_5|90|4|TREATMENT|2021-04-12|2021-04-14|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|f056c174-b6da-4df6-bf95-2e31911939fb|1|MYCYLE|Myelocytes/Leukocytes|URINALYSIS|[?]|10^11/L|[?]|[?]|TRACE|1|mL/100g/min|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|N|IMPEDANCE CONDUCTIVITY|NASH FIBROSURE FORMULA||Y|U||1|Visit_1|10|5|TREATMENT|2020-12-16|2021-02-26|10|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|LB|f056c174-b6da-4df6-bf95-2e31911939fb|2|ISG15|Ubiquitin-Like Protein ISG15|CHEMISTRY|[?]|/HPF|[?]|[?]|NEGATIVE|1|mmol/s|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|ICTERIC|N|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y|Y|N||1|Visit_1|10|1|TREATMENT|2020-12-16|2021-01-02|10|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|LB|f056c174-b6da-4df6-bf95-2e31911939fb|3|VLDL|VLDL Cholesterol|HEMATOLOGY|[?]|AgU/mL|[?]|[?]|INVALID|1|mg/dL|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|CALCIFIED||MICROBIAL CONCENTRATION|NASH FIBROSURE FORMULA||Y|NA||2|Visit_2|25|4|TREATMENT|2020-12-31|2021-03-12|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|f056c174-b6da-4df6-bf95-2e31911939fb|4|RENINA|Renin Activity|URINALYSIS|[?]|cP|[?]|[?]|NEGATIVE|1|TRANSDUCING UNIT|1|1|[?]|HIGH|LAVAGE FLUID|FROZEN||HANSEL STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||2|Visit_2|25|5|FOLLOW-UP|2020-12-31|2021-03-15|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|f056c174-b6da-4df6-bf95-2e31911939fb|5|RENIN|Renin|CHEMISTRY|[?]|DIP|[?]|[?]|POSITIVE|1|m3|1|1|[?]|LOW|PROSTATIC FLUID|AUTOLYZED||AURAMINE STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||3|Visit_3|40|2|TREATMENT|2021-01-15|2021-03-09|40|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|f056c174-b6da-4df6-bf95-2e31911939fb|6|C165928|Industrial Mix IgE AB RAST Score|URINALYSIS|[?]|mL/h|[?]|[?]|INVALID|1|ug|1|1|[?]|HIGH|SEBUM|DRIED||CINEANGIOGRAPHY|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|5|FOLLOW-UP|2021-01-15|2021-02-09|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|f056c174-b6da-4df6-bf95-2e31911939fb|7|MX1|Interferon-Induced Protein p78|CHEMISTRY|[?]|amol|[?]|[?]|TRACE|1|pmol/L|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|FROZEN|N|CLINICAL EVALUATION|MDRD 6 VARIABLE FORMULA|||Y||4|Visit_4|65|6|FOLLOW-UP|2021-02-09|2021-03-14|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|LB|f056c174-b6da-4df6-bf95-2e31911939fb|8|EAGLUC|Glucose, Estimated Average|URINALYSIS|[?]|g/kg|[?]|[?]|POSITIVE|1|umol/h/mmol|1|1|[?]|NORMAL|LYSATE|DRIED|N|ENDPOINT DILUTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2021-02-09|2021-02-24|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|LB|f056c174-b6da-4df6-bf95-2e31911939fb|9|LCN2CREA|Lipocalin-2/Creatinine|HEMATOLOGY|[?]|mg/animal|[?]|[?]|INVALID|1|mAmp|1|1|[?]|HIGH|SPERMATOZOON|FRESH||MANUAL COUNT|FIBROSIS 4 FORMULA|Y|Y|U||5|Visit_5|90|7|FOLLOW-UP|2021-03-06|2021-03-13|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|f056c174-b6da-4df6-bf95-2e31911939fb|10|CXCL10|Chemokine (C-X-C Motif) Ligand 10|HEMATOLOGY|[?]|mU|[?]|[?]|POSITIVE|1|SQU/mL|1|1|[?]|LOW|URINE SEDIMENT|LIPEMIC|N|MOUSE PROTECTION ASSAY|CKD-EPI CYSTATIN C FORMULA|Y||U||5|Visit_5|90|3|TREATMENT|2021-03-06|2021-03-07|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|1|FATACFRS|Free Fatty Acid, Saturated|HEMATOLOGY|[?]|PHERESIS UNIT|[?]|[?]|TRACE|1|MBq/uL|1|1|[?]|HIGH|LUNG SURFACTANT|CONCENTRATED|N|INTRAVASCULAR ULTRASOUND|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||1|Visit_1|10|6|SCREENING|2020-09-16|2020-10-26|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|2|NSE|Neuron Specific Enolase|HEMATOLOGY|[?]|BAG|[?]|[?]|INVALID|1|/ms|1|1|[?]|NORMAL|URINE SEDIMENT|HEMOLYZED||CONTRAST ENHANCED PET SCAN|GMI MMOL/MOL FORMULA|||Y||1|Visit_1|10|3|TREATMENT|2020-09-16|2020-09-29|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|3|RDW|Erythrocytes Distribution Width|HEMATOLOGY|[?]|PIXELS/cm|[?]|[?]|BORDERLINE|1|DISK|1|1|[?]|HIGH|LYMPH|FROZEN||KNEMOMETRY|NASH FIBROSURE FORMULA|Y||N||2|Visit_2|25|1|WASHOUT|2020-10-01|2020-10-25|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|4|ANABASN|Anabasine|HEMATOLOGY|[?]|/mm|[?]|[?]|NEGATIVE|1|FFU|1|1|[?]|LOW|URINE|SOLIDIFIED|N|ELISPOT|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-10-01|2020-11-02|25|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|5|PLCGF|Placental Growth Factor|URINALYSIS|[?]|IU/mmol|[?]|[?]|POSITIVE|1|PELLET|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|ICTERIC|N|MOUSE PROTECTION ASSAY|MDRD 6 VARIABLE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-10-16|2020-11-28|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|6|ACE|Angiotensin Converting Enzyme|URINALYSIS|||[?]|[?]|BORDERLINE|1|cm|1|1|[?]|LOW|PLEURAL TISSUE|LACTESCENT|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|CKD-EPI CYSTATIN C FORMULA|||U|Y|3|Visit_3|40|4|TREATMENT|2020-10-16|2020-12-04|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|7|INTLK12|Interleukin 12|CHEMISTRY|[?]|cd*s/m2|[?]|[?]|INDETERMINATE|1|CARTRIDGE|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|HEMOLYZED||MAMMOGRAPHY|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|5|FOLLOW-UP|2020-11-10|2020-12-03|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|8|VITDAT|1, 25-Dihydroxyvitamin D|HEMATOLOGY|[?]|vp/mL|[?]|[?]|INDETERMINATE|1|dmol|1|1|[?]|HIGH|PLATELET RICH PLASMA|SOLIDIFIED|N|ROMANOWSKY STAIN|FIBROSIS 4 FORMULA|||NA||4|Visit_4|65|4|SCREENING|2020-11-10|2020-12-14|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|9|PLSMCELY|Mature Plasma Cells/Lymphocytes|HEMATOLOGY|[?]|ks|[?]|[?]|INVALID|1|mL/kg/day|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|ROOM TEMPERATURE||LASER CAPTURE MICRODISSECTION|HEPASCORE FORMULA||Y|U||5|Visit_5|90|6|TREATMENT|2020-12-05|2020-12-10|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|LB|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|10|EPICCE|Epithelial Cells/Total Cells|HEMATOLOGY|[?]|10^3/hpf|[?]|[?]|BORDERLINE|1|BE/mL|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|AGGLUTINATED||REFLECTANCE SPECTROSCOPY|FIBROSIS 4 FORMULA||Y|Y||5|Visit_5|90|1|TREATMENT|2020-12-05|2020-12-11|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|LB|57b7f30f-5f2a-425d-8bf2-fd5915cac481|1|MONONSQE|Monocytes/Non-Squam Epi Cells|URINALYSIS|[?]|NEEDLE GAUGE|[?]|[?]|INVALID|1|10^3 CFU|1|1|[?]|NORMAL|VITREOUS HUMOR|ICTERIC||DROPLET DIGITAL PCR|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||1|Visit_1|10|4|TREATMENT|2021-01-18|2021-03-09|10|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|57b7f30f-5f2a-425d-8bf2-fd5915cac481|2|COAGIDX|Coagulation Index|URINALYSIS|[?]|umol/L/min|[?]|[?]|INDETERMINATE|1|log10 CFU/mL|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|THAWED|N|CALIPER MEASUREMENT METHOD|MDRD ENZYMATIC FORMULA|||Y||1|Visit_1|10|7|FOLLOW-UP|2021-01-18|2021-04-02|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|57b7f30f-5f2a-425d-8bf2-fd5915cac481|3|MICROCY|Microcytes|CHEMISTRY|[?]|ug/g/min|[?]|[?]|POSITIVE|1|WEEKS|1|1|[?]|ABNORMAL|PLEURAL FLUID|CLOTTED||SIZE EXCLUSION CHROMATOGRAPHY|MDRD 5 VARIABLE FORMULA|Y|Y|NA||2|Visit_2|25|1|WASHOUT|2021-02-02|2021-02-04|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|57b7f30f-5f2a-425d-8bf2-fd5915cac481|4|ELA2PMN|Neutrophil Elastase, Polymorphonuclear|HEMATOLOGY|[?]|10^9/g|[?]|[?]|INVALID|1|PELLET|1|1|[?]|NORMAL|DERMAL TISSUE|LACTESCENT||DUCTOGRAPHY|GMI % FORMULA||Y|NA||2|Visit_2|25|3|WASHOUT|2021-02-02|2021-02-23|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|57b7f30f-5f2a-425d-8bf2-fd5915cac481|5|PDW|Platelet Distribution Width|CHEMISTRY|[?]|fg|[?]|[?]|BORDERLINE|1|log EID 50/dose|1|1|[?]|NORMAL|ARTERIAL BLOOD|CALCIFIED|N|PHOROPTER|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|5|FOLLOW-UP|2021-02-17|2021-02-20|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|57b7f30f-5f2a-425d-8bf2-fd5915cac481|6|VBCE|Viable Cells|URINALYSIS|[?]|atm|[?]|[?]|INVALID|1|log10 PFU/mL|1|1|[?]|LOW|PLEURAL TISSUE|PARAFFIN-EMBEDDED||WRIGHT STAIN|ASH FIBROSURE FORMULA||Y|NA||3|Visit_3|40|7|WASHOUT|2021-02-17|2021-04-02|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|57b7f30f-5f2a-425d-8bf2-fd5915cac481|7|FACTIII|Factor III|HEMATOLOGY|[?]|mEq/dL|[?]|[?]|INVALID|1|10^3 CFU|1|1|[?]|HIGH|VENOUS CORD BLOOD|SOLIDIFIED||SLIT LAMP PHOTOGRAPHY|FIBROTEST FORMULA|Y||N||4|Visit_4|65|1|TREATMENT|2021-03-14|2021-04-12|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|57b7f30f-5f2a-425d-8bf2-fd5915cac481|8|C165937|Zea mays IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|Log10 ELISA unit/dose|1|1|[?]|HIGH|URINE SEDIMENT|ROOM TEMPERATURE||TRANSMISSION ELECTRON MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N|Y|4|Visit_4|65|2|TREATMENT|2021-03-14|2021-04-15|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|57b7f30f-5f2a-425d-8bf2-fd5915cac481|9|VITE|Vitamin E|HEMATOLOGY|[?]|ug/mL/h|[?]|[?]|TRACE|1|PLUG|1|1|[?]|NORMAL|LYSATE|HEMOLYZED||NEXT GENERATION SEQUENCING|MDRD 6 VARIABLE FORMULA|||Y||5|Visit_5|90|3|FOLLOW-UP|2021-04-08|2021-04-16|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|57b7f30f-5f2a-425d-8bf2-fd5915cac481|10|IFIT3|Interferon-Induced 60 kDa Protein|HEMATOLOGY|[?]|WAFER|[?]|[?]|INDETERMINATE|1|PRESSOR UNITS|1|1|[?]|HIGH|BUFFY COAT|LIPEMIC||NEXT GENERATION TARGETED SEQUENCING|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|6|FOLLOW-UP|2021-04-08|2021-04-16|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|02d9a74a-abc8-4b47-a4d4-a196d339f621|1|CLUECE|Clue Cells|CHEMISTRY|||[?]|[?]|NEGATIVE|1|g/animal|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|SOLIDIFIED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|FIBROSIS 4 FORMULA|||Y|Y|1|Visit_1|10|4|FOLLOW-UP|2020-09-14|2020-11-13|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|02d9a74a-abc8-4b47-a4d4-a196d339f621|2|TLYCE|T-Lymphocytes|URINALYSIS|[?]|IU/day|[?]|[?]|INVALID|1|min*mg/mL|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED||ELECTRONEUROGRAPHY|GMI MMOL/MOL FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-09-14|2020-10-24|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|02d9a74a-abc8-4b47-a4d4-a196d339f621|3|ADPNHMW|Adiponectin, High Molecular Weight|CHEMISTRY|||[?]|[?]|INVALID|1|F|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|AGGLUTINATED||REBOUND TONOMETRY|CKD-EPI CREATININE FORMULA|Y||Y|Y|2|Visit_2|25|5|TREATMENT|2020-09-29|2020-10-17|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|02d9a74a-abc8-4b47-a4d4-a196d339f621|4|CLCTRIOL|Calcitriol|HEMATOLOGY|[?]|EID 50/dose|[?]|[?]|NEGATIVE|1|Roentgen|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|ICTERIC||FLOCCULATION|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||2|Visit_2|25|6|TREATMENT|2020-09-29|2020-12-11|25|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|02d9a74a-abc8-4b47-a4d4-a196d339f621|5|ETPPH|ETP Peak Height|HEMATOLOGY|[?]|lm|[?]|[?]|INVALID|1|CYLINDER|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|LIPEMIC||CALCOFLUOR WHITE STAIN|GMI % FORMULA|||U||3|Visit_3|40|4|WASHOUT|2020-10-14|2020-11-10|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|02d9a74a-abc8-4b47-a4d4-a196d339f621|6|LYMMCE|Lymphoma Cells|URINALYSIS|[?]|mmol/min/kPa/L|[?]|[?]|NEGATIVE|1|nU/cL|1|1|[?]|HIGH|INFRANATANT, SERUM|ICTERIC||TARGETED TRANSCRIPTOME SEQUENCING|COCKCROFT-GAULT FORMULA|Y||NA||3|Visit_3|40|6|TREATMENT|2020-10-14|2020-11-03|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|02d9a74a-abc8-4b47-a4d4-a196d339f621|7|CACREAT|Calcium/Creatinine|URINALYSIS|||[?]|[?]|INVALID|1|mL/dose|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|CONTAMINATED||SISH|FIBROMETER FORMULA|||Y|Y|4|Visit_4|65|5|TREATMENT|2020-11-08|2020-12-03|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|LB|02d9a74a-abc8-4b47-a4d4-a196d339f621|8|TLYCE|T-Lymphocytes|URINALYSIS|[?]|copies/uL|[?]|[?]|NEGATIVE|1|BAU|1|1|[?]|ABNORMAL|DIALYSIS FLUID|PARAFFIN-EMBEDDED||AUTOREFRACTION|CKD-EPI FORMULA|Y||Y||4|Visit_4|65|4|TREATMENT|2020-11-08|2020-11-22|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|LB|02d9a74a-abc8-4b47-a4d4-a196d339f621|9|PROTPATN|Protein Pattern|CHEMISTRY|||[?]|[?]|POSITIVE|1|mol/mol|1|1|[?]|HIGH|PUS|FRESH||KARYOTYPING|CKD-EPI CREATININE FORMULA||Y|Y|Y|5|Visit_5|90|3|SCREENING|2020-12-03|2020-12-09|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|02d9a74a-abc8-4b47-a4d4-a196d339f621|10|CEMORPH|Cell Morphology|HEMATOLOGY|[?]|fraction of 1|[?]|[?]|INVALID|1|MONTHS|1|1|[?]|HIGH|LEUKOCYTE|UNEXPECTED ODOR|N|PHOTOMETRY|COCKCROFT-GAULT FORMULA|||N||5|Visit_5|90|3|FOLLOW-UP|2020-12-03|2020-12-07|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|81480f83-206f-40c0-a5a4-f75b31cda363|1|A1MICG|Alpha-1 Microglobulin|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mg/L FEU|1|1|[?]|LOW|MENSTRUAL BLOOD|LIPEMIC||POTENTIOMETRY|GMI MMOL/MOL FORMULA|||U|Y|1|Visit_1|10|6|SCREENING|2020-11-22|2020-12-09|10|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|81480f83-206f-40c0-a5a4-f75b31cda363|2|APPA|Amyloid Alpha Precursor Protein|URINALYSIS|[?]|ng/dL|[?]|[?]|POSITIVE|1|mL/cage/wk|1|1|[?]|ABNORMAL|TUMOR TISSUE|FROZEN|N|PET/SPECT SCAN|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|3|SCREENING|2020-11-22|2021-01-01|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|81480f83-206f-40c0-a5a4-f75b31cda363|3|C3M|Collagen III Neo-Peptide C3M|CHEMISTRY|||[?]|[?]|POSITIVE|1|Pa|1|1|[?]|HIGH|DIALYSIS FLUID|GELLED|N|CONTRAST ENHANCED X-RAY|MDRD 4 VARIABLE FORMULA|||U|Y|2|Visit_2|25|6|TREATMENT|2020-12-07|2021-01-12|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|81480f83-206f-40c0-a5a4-f75b31cda363|4|PLAT|Platelets|URINALYSIS|||[?]|[?]|NEGATIVE|1|SBE/mL|1|1|[?]|ABNORMAL|BONE|FROZEN||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|FIBROMETER FORMULA||Y|NA|Y|2|Visit_2|25|3|SCREENING|2020-12-07|2021-01-23|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|81480f83-206f-40c0-a5a4-f75b31cda363|5|ASMACT|Alpha-Smooth Muscle Actin|URINALYSIS|[?]|Watt|[?]|[?]|TRACE|1|Ci/mg|1|1|[?]|NORMAL|INFRANATANT, SERUM|DRIED||PET/CT SCAN WITHOUT CONTRAST|FIBROSIS 4 FORMULA|Y|Y|U||3|Visit_3|40|5|TREATMENT|2020-12-22|2020-12-25|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|81480f83-206f-40c0-a5a4-f75b31cda363|6|PHNKET|Phenylketones|URINALYSIS|||[?]|[?]|INVALID|1|/mm2|1|1|[?]|HIGH|SOFT TISSUE|ROOM TEMPERATURE||FLUORESCENT IMMUNOASSAY|ASH FIBROSURE FORMULA|Y|Y|Y|Y|3|Visit_3|40|6|SCREENING|2020-12-22|2021-02-17|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|81480f83-206f-40c0-a5a4-f75b31cda363|7|EOSNSQE|Eosinophils/Non-Squam Epi Cells|URINALYSIS|[?]|km/h|[?]|[?]|TRACE|1|Hz|1|1|[?]|LOW|PLEURAL FLUID|CALCIFIED||TOLUIDINE BLUE STAIN|COCKCROFT-GAULT FORMULA|Y||N||4|Visit_4|65|6|TREATMENT|2021-01-16|2021-02-15|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|81480f83-206f-40c0-a5a4-f75b31cda363|8|TEARDCY|Dacryocytes|CHEMISTRY|[?]|min|[?]|[?]|POSITIVE|1|10^3 CFU/mL|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|SOLIDIFIED||FLUORESCENT LIFETIME IMAGING MICROSCOPY|HEPASCORE FORMULA|||NA||4|Visit_4|65|1|TREATMENT|2021-01-16|2021-01-28|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|81480f83-206f-40c0-a5a4-f75b31cda363|9|RH|Rh Factor|CHEMISTRY|||[?]|[?]|POSITIVE|1|mol/mL|1|1|[?]|NORMAL|TUMOR TISSUE|LACTESCENT||MICRONEUTRALIZATION ASSAY|HEPASCORE FORMULA|||N|Y|5|Visit_5|90|7|WASHOUT|2021-02-10|2021-02-16|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|81480f83-206f-40c0-a5a4-f75b31cda363|10|PAI1|Plasminogen Activator Inhibitor-1|URINALYSIS|[?]|% INHIBITION|[?]|[?]|NEGATIVE|1|tsp eq|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|THAWED|N|FUNCTIONAL MRI|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2021-02-10|2021-02-17|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|2b183b69-3ed8-4356-b9e2-0988128de3f2|1|IL1SR1|Soluble Interleukin-1 Receptor Type I|HEMATOLOGY|[?]|10^3 organisms/g|[?]|[?]|INDETERMINATE|1|ft3|1|1|[?]|NORMAL|EXPIRED AIR|THAWED||ANTIBIOTIC AGAR SCREEN|MDRD 5 VARIABLE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-10-16|2020-12-11|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|2b183b69-3ed8-4356-b9e2-0988128de3f2|2|ADPNCTN|Adiponectin|HEMATOLOGY|[?]|Rad|[?]|[?]|INVALID|1|mJoule/cm2|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|CONTAMINATED||SPECT/CT SCAN|HEPASCORE FORMULA|||N||1|Visit_1|10|4|TREATMENT|2020-10-16|2020-11-04|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|2b183b69-3ed8-4356-b9e2-0988128de3f2|3|ROM|Reactive Oxygen Metabolite|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|APL U/mL|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|FRESH|N|MRI WITHOUT CONTRAST|CKD-EPI FORMULA|||U|Y|2|Visit_2|25|3|TREATMENT|2020-10-31|2020-12-30|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|2b183b69-3ed8-4356-b9e2-0988128de3f2|4|NMP22|Nuclear Matrix Protein 22|CHEMISTRY|[?]|MBq/uL|[?]|[?]|NEGATIVE|1|nmol/L|1|1|[?]|NORMAL|BREAST MILK|THAWED||PHOTOMETRIC CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||2|Visit_2|25|7|FOLLOW-UP|2020-10-31|2021-01-10|25|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|2b183b69-3ed8-4356-b9e2-0988128de3f2|5|ALBGALB|Glycated Albumin/Albumin|URINALYSIS|[?]|ug/L DDU|[?]|[?]|BORDERLINE|1|Bq/mg|1|1|[?]|NORMAL|EPIDERMAL TISSUE|REFRIGERATED||CELL OF ORIGIN ASSAY|GMI % FORMULA|||NA||3|Visit_3|40|4|SCREENING|2020-11-15|2020-12-23|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|2b183b69-3ed8-4356-b9e2-0988128de3f2|6|FACTVII|Factor VII|CHEMISTRY|[?]|Gy/min|[?]|[?]|NEGATIVE|1|log10 CCID 50/dose|1|1|[?]|LOW|PLATELET POOR PLASMA|THAWED||HEMOCYTOMETRY|ASH FIBROSURE FORMULA|Y|Y|U||3|Visit_3|40|4|FOLLOW-UP|2020-11-15|2020-12-16|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|2b183b69-3ed8-4356-b9e2-0988128de3f2|7|C165877|Cat Dander IgE AB RAST Score|URINALYSIS|[?]|min*mg/mL|[?]|[?]|POSITIVE|1|Bq/kg|1|1|[?]|HIGH|TUMOR TISSUE|NON-HEMOLYZED|N|EIA|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||4|Visit_4|65|3|TREATMENT|2020-12-10|2020-12-21|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|2b183b69-3ed8-4356-b9e2-0988128de3f2|8|PSELECTS|Soluble P-Selectin|URINALYSIS|[?]|Bq/kg|[?]|[?]|POSITIVE|1|ug/mol|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|CONTAMINATED|N|ICP-MS|COCKCROFT-GAULT FORMULA|||NA||4|Visit_4|65|7|SCREENING|2020-12-10|2021-01-05|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|2b183b69-3ed8-4356-b9e2-0988128de3f2|9|IGFBP1|Insulin-Like Growth Factor Binding Prot1|HEMATOLOGY|[?]|mL/m2/day|[?]|[?]|INDETERMINATE|1|mol/mL|1|1|[?]|ABNORMAL|BLOOD|CLOTTED||ELECTROGASTROGRAPHY|HEPASCORE FORMULA||Y|U||5|Visit_5|90|2|TREATMENT|2021-01-04|2021-01-08|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|2b183b69-3ed8-4356-b9e2-0988128de3f2|10|CD14|CD14|HEMATOLOGY|[?]|mL/m2|[?]|[?]|TRACE|1|CONTAINER|1|1|[?]|ABNORMAL|URINE|UNEXPECTED ODOR||POLYSOMNOGRAPHY|GMI MMOL/MOL FORMULA|Y||Y||5|Visit_5|90|6|FOLLOW-UP|2021-01-04|2021-01-07|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|6ed8a749-81c0-4998-817d-efc86cfaa091|1|KIM1S|Soluble Kidney Injury Molecule-1|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|ug/L DDU|1|1|[?]|LOW|SEBUM|AUTOLYZED||NON-INVASIVE DIELECTRIC SENSING|FIBROMETER FORMULA|||U|Y|1|Visit_1|10|2|TREATMENT|2020-06-05|2020-08-07|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|6ed8a749-81c0-4998-817d-efc86cfaa091|2|FIXAAC|Factor IX Activity Actual/Control|CHEMISTRY|||[?]|[?]|BORDERLINE|1|VOXEL|1|1|[?]|NORMAL|MENSTRUAL BLOOD|REFRIGERATED||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|1|Visit_1|10|3|SCREENING|2020-06-05|2020-08-27|10|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|6ed8a749-81c0-4998-817d-efc86cfaa091|3|FACTVIIA|Factor VII Activity|CHEMISTRY|[?]|g/animal/wk|[?]|[?]|INVALID|1|cm|1|1|[?]|HIGH|MECONIUM|HEMOLYZED|N|ELECTROPHORESIS|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-06-20|2020-07-04|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|6ed8a749-81c0-4998-817d-efc86cfaa091|4|C130126|Cat Dander Antigen IgA Antibody|HEMATOLOGY|[?]|min/day|[?]|[?]|INVALID|1|mg/kg/week|1|1|[?]|ABNORMAL|NAIL|LIPEMIC||THICK SMEAR|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|2|SCREENING|2020-06-20|2020-06-24|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|6ed8a749-81c0-4998-817d-efc86cfaa091|5|HIS|Histidine|URINALYSIS|||[?]|[?]|NEGATIVE|1|VIAL|1|1|[?]|HIGH|SOFT TISSUE|THAWED||MRI WITHOUT CONTRAST|CKD-EPI CREATININE FORMULA|||N|Y|3|Visit_3|40|6|WASHOUT|2020-07-05|2020-07-20|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|6ed8a749-81c0-4998-817d-efc86cfaa091|6|CACR|Calcium Corrected|URINALYSIS|[?]|10^3 RNA copies/mL|[?]|[?]|NEGATIVE|1|nkat|1|1|[?]|HIGH|SEBUM|AUTOLYZED||REBOUND TONOMETRY|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|1|FOLLOW-UP|2020-07-05|2020-09-01|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|6ed8a749-81c0-4998-817d-efc86cfaa091|7|PROGRP|Pro-gastrin Releasing Peptide|URINALYSIS|[?]|Roentgen|[?]|[?]|TRACE|1|g/cage|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|AGGLUTINATED||ROMANOWSKY STAIN|MDRD 5 VARIABLE FORMULA|Y|Y|U||4|Visit_4|65|5|TREATMENT|2020-07-30|2020-08-21|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|6ed8a749-81c0-4998-817d-efc86cfaa091|8|ESR|Erythrocyte Sedimentation Rate|URINALYSIS|[?]|DPM|[?]|[?]|INDETERMINATE|1|pL|1|1|[?]|NORMAL|CORD BLOOD|NON-HEMOLYZED|N|NUCLEIC ACID HYBRIDIZATION|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-07-30|2020-08-01|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|6ed8a749-81c0-4998-817d-efc86cfaa091|9|TCDCA|Taurochenodeoxycholate|CHEMISTRY|[?]|Absorbance U/mL|[?]|[?]|INDETERMINATE|1|Tbsp|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|LIPEMIC||ELISPOT|MDRD FORMULA|||Y||5|Visit_5|90|3|SCREENING|2020-08-24|2020-08-31|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|6ed8a749-81c0-4998-817d-efc86cfaa091|10|CGA|Chromogranin A|URINALYSIS|[?]|g/dL|[?]|[?]|BORDERLINE|1|in|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|CONCENTRATED||GC/MS-CI|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||5|Visit_5|90|3|WASHOUT|2020-08-24|2020-08-28|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|1|ANTHRMA|Antithrombin Activity|CHEMISTRY|[?]|uCi/kg|[?]|[?]|TRACE|1|mL/g/min|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|CALCIFIED||RIA|HEPASCORE FORMULA|||Y||1|Visit_1|10|4|FOLLOW-UP|2021-01-18|2021-03-12|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|2|BLSTLYLE|Lymphoblasts/Leukocytes|HEMATOLOGY|[?]|g/day|[?]|[?]|INVALID|1|mV/sec|1|1|[?]|NORMAL|ISOLATE|LACTESCENT||FLUORESCENT MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||1|Visit_1|10|5|WASHOUT|2021-01-18|2021-03-17|10|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|3|ISOPRF2|F2-Isoprostane|HEMATOLOGY|[?]|FFU|[?]|[?]|TRACE|1|uSiemens|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|LACTESCENT||JAEGER EYE CHART|COCKCROFT-GAULT FORMULA||Y|NA||2|Visit_2|25|3|TREATMENT|2021-02-02|2021-02-15|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|4|GFRBSBTP|GFR from Beta-Trace Protein Adj for BSA|URINALYSIS|[?]|fmol/L/sec|[?]|[?]|INVALID|1|Hz/s|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|GELLED||DIFFUSION WEIGHTED MRI|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|4|WASHOUT|2021-02-02|2021-02-16|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|5|TAT|Thrombin/Antithrombin|CHEMISTRY|[?]|U/kg/day|[?]|[?]|POSITIVE|1|10^4 CFU|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|CONTAMINATED||NEPHELOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||3|Visit_3|40|1|TREATMENT|2021-02-17|2021-03-18|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|6|ETS|Ethyl Sulfate|HEMATOLOGY|[?]|VIAL|[?]|[?]|INDETERMINATE|1|HEP|1|1|[?]|ABNORMAL|CALCULUS|CONCENTRATED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|NASH FIBROSURE FORMULA|Y||NA||3|Visit_3|40|7|SCREENING|2021-02-17|2021-03-29|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|7|SMDGCE|Smudge Cells|CHEMISTRY|[?]|pkat/L|[?]|[?]|NEGATIVE|1|IMPLANT|1|1|[?]|HIGH|CEREBROSPINAL FLUID|CONTAMINATED||PERIODIC ACID SCHIFF STAIN|MDRD 6 VARIABLE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2021-03-14|2021-04-05|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|8|GLUCWBE|Whole Blood Equivalent Glucose|CHEMISTRY|[?]|ELISA unit/mL|[?]|[?]|BORDERLINE|1|IMPLANT|1|1|[?]|ABNORMAL|PERITONEAL FLUID|FROZEN||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|||U||4|Visit_4|65|2|TREATMENT|2021-03-14|2021-04-02|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|9|TRCYANDP|Tricyclic Antidepressants|URINALYSIS|[?]|nkat|[?]|[?]|POSITIVE|1|/MBP|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|HEMOLYZED||FLOCCULATION, CHARCOAL ENHANCED|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|U||5|Visit_5|90|5|SCREENING|2021-04-08|2021-04-14|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|LB|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|10|CTXI|Type I Collagen C-Telopeptides|HEMATOLOGY|[?]|ECL unit|[?]|[?]|INDETERMINATE|1|mg/kg/dose|1|1|[?]|HIGH|VITREOUS HUMOR|SOLIDIFIED|N|SPIROMETRY|CKD-EPI CYSTATIN C FORMULA||Y|N||5|Visit_5|90|4|SCREENING|2021-04-08|2021-04-10|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|LB|e6162980-e240-4924-a13a-dde28b2345cd|1|MLR|Mixed Lymphocyte Reaction|URINALYSIS|||[?]|[?]|BORDERLINE|1|U/g|1|1|[?]|LOW|SWABBED MATERIAL|CONTAMINATED|N|EIA|GMI % FORMULA|||NA|Y|1|Visit_1|10|1|WASHOUT|2020-08-11|2020-09-23|10|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|e6162980-e240-4924-a13a-dde28b2345cd|2|CHCMR|Ret. Corpuscular HGB Concentration Mean|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mU|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|HEMOLYZED||NEXT GENERATION SEQUENCING|GMI MMOL/MOL FORMULA|||Y|Y|1|Visit_1|10|6|FOLLOW-UP|2020-08-11|2020-09-14|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|e6162980-e240-4924-a13a-dde28b2345cd|3|C130114|Industrial Mix Antigen IgE Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ug/L FEU|1|1|[?]|LOW|SUPERNATANT, PLASMA|HEMOLYZED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|2|Visit_2|25|2|SCREENING|2020-08-26|2020-09-08|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|e6162980-e240-4924-a13a-dde28b2345cd|4|LKM1IGAB|Liver Kidney Microsomal Type 1 IgG Ab|HEMATOLOGY|[?]|CAPSULE|[?]|[?]|INVALID|1|PFU|1|1|[?]|LOW|SPERMATOZOON|CLOTTED|N|PYROSEQUENCING|FIBROMETER FORMULA|||U||2|Visit_2|25|6|SCREENING|2020-08-26|2020-10-04|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|e6162980-e240-4924-a13a-dde28b2345cd|5|HDL2|HDL-Cholesterol Subclass 2|HEMATOLOGY|[?]|CUP|[?]|[?]|POSITIVE|1|pmol/day|1|1|[?]|HIGH|COLOSTRUM|HEMOLYZED||QUANTITATIVE COMPUTED TOMOGRAPHY|GMI % FORMULA|||N||3|Visit_3|40|6|WASHOUT|2020-09-10|2020-10-23|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|e6162980-e240-4924-a13a-dde28b2345cd|6|C165930|Shellfish Mix IgE AB RAST Score|HEMATOLOGY|[?]|U/g/day|[?]|[?]|INDETERMINATE|1|Ci/ug|1|1|[?]|LOW|EMESIS|REFRIGERATED||TOLUIDINE BLUE STAIN|HEPASCORE FORMULA|Y||Y||3|Visit_3|40|5|FOLLOW-UP|2020-09-10|2020-10-04|40|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|e6162980-e240-4924-a13a-dde28b2345cd|7|RLP|RLP Cholesterol|CHEMISTRY|[?]|mOsm/L|[?]|[?]|INDETERMINATE|1|mCi/kg|1|1|[?]|NORMAL|LEUKOCYTE|LACTESCENT||CT SCAN WITHOUT CONTRAST|NASH FIBROSURE FORMULA|Y|Y|Y||4|Visit_4|65|6|SCREENING|2020-10-05|2020-10-19|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|LB|e6162980-e240-4924-a13a-dde28b2345cd|8|TAURINE|Taurine|CHEMISTRY|[?]|umol/day|[?]|[?]|TRACE|1|ug/L|1|1|[?]|ABNORMAL|LEUKOCYTE|PARAFFIN-EMBEDDED||ICP-MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|6|WASHOUT|2020-10-05|2020-10-26|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|LB|e6162980-e240-4924-a13a-dde28b2345cd|9|PGAG|Platelet-Granulocyte Agg|HEMATOLOGY|[?]|mmHg/sec|[?]|[?]|POSITIVE|1|nsec|1|1|[?]|NORMAL|EPIDERMAL TISSUE|CONCENTRATED||LYMPHANGIOGRAPHY|HEPASCORE FORMULA||Y|N||5|Visit_5|90|5|TREATMENT|2020-10-30|2020-11-06|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|e6162980-e240-4924-a13a-dde28b2345cd|10|CCL21|Chemokine (C-C Motif) Ligand 21|HEMATOLOGY|[?]|BAU/mL|[?]|[?]|INVALID|1|Bq|1|1|[?]|LOW|SOFT TISSUE|AUTOLYZED||MAGNETIC RESONANCE ELASTOGRAPHY|MDRD FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-10-30|2020-11-07|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|3dc9c666-8be3-4cfa-88d4-b18647e08d00|1|FACTII|Factor II|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mEq/ug|1|1|[?]|LOW|AQUEOUS HUMOR|CONTAMINATED||QUANTITATIVE ULTRASOUND|FIBROSIS 4 FORMULA|Y||U|Y|1|Visit_1|10|1|SCREENING|2020-06-13|2020-08-05|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|3dc9c666-8be3-4cfa-88d4-b18647e08d00|2|THCCOOH|11-Nor-Delta9-THC-9-Carboxylic Acid|HEMATOLOGY|[?]|anti-Xa IU/mL|[?]|[?]|BORDERLINE|1|/100 WBC|1|1|[?]|LOW|PUS|HEMOLYZED|N|U-HPLC/MS/MS|FIBROSIS 4 FORMULA|Y|Y|N||1|Visit_1|10|5|TREATMENT|2020-06-13|2020-07-03|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|3dc9c666-8be3-4cfa-88d4-b18647e08d00|3|VITK|Vitamin K|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mL/m2|1|1|[?]|HIGH|SEBUM|FRESH|N|PALPATION|MDRD ENZYMATIC JAPANESE FORMULA|Y||U|Y|2|Visit_2|25|1|TREATMENT|2020-06-28|2020-06-30|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|3dc9c666-8be3-4cfa-88d4-b18647e08d00|4|BLSTNMCE|Normoblasts/Total Cells|CHEMISTRY|[?]|10^6/Ejaculate U|[?]|[?]|INDETERMINATE|1|10^3 organisms/mL|1|1|[?]|HIGH|SWABBED MATERIAL|DRIED||DIGITAL PCR|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-06-28|2020-06-30|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|3dc9c666-8be3-4cfa-88d4-b18647e08d00|5|NEUTAGR|Agranular Neutrophils|CHEMISTRY|[?]|ppth|[?]|[?]|INVALID|1|TROCHE|1|1|[?]|NORMAL|REFLEX TEAR|CONTAMINATED||MICROSCOPY|COCKCROFT-GAULT FORMULA|||NA||3|Visit_3|40|5|FOLLOW-UP|2020-07-13|2020-07-31|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|3dc9c666-8be3-4cfa-88d4-b18647e08d00|6|GSTPI|Glutathione S-Transferase, Pi|HEMATOLOGY|[?]|tuberculin unit|[?]|[?]|BORDERLINE|1|nmol/mol|1|1|[?]|HIGH|MUSCLE TISSUE|AUTOLYZED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|HEPASCORE FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-07-13|2020-08-14|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|3dc9c666-8be3-4cfa-88d4-b18647e08d00|7|APAPCYS|Acetaminophen-Cysteine Adduct|URINALYSIS|[?]|dpm/0.5 mL|[?]|[?]|TRACE|1|APL U/mL|1|1|[?]|LOW|MUSCLE TISSUE|UNEXPECTED ODOR||SPIRAL CT SCAN WITHOUT CONTRAST|ASH FIBROSURE FORMULA|Y|Y|N||4|Visit_4|65|7|TREATMENT|2020-08-07|2020-08-15|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|3dc9c666-8be3-4cfa-88d4-b18647e08d00|8|IL2R|Interleukin 2 Receptor|HEMATOLOGY|[?]|uV*sec|[?]|[?]|INVALID|1|Osm|1|1|[?]|LOW|ADIPOSE TISSUE|ROOM TEMPERATURE||CONTACT SPECULAR MICROSCOPY|ASH FIBROSURE FORMULA|||N||4|Visit_4|65|5|FOLLOW-UP|2020-08-07|2020-08-09|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|3dc9c666-8be3-4cfa-88d4-b18647e08d00|9|PSAMRNA|Prostate Specific Antigen mRNA|URINALYSIS|[?]|mL/g/h|[?]|[?]|INDETERMINATE|1|uL/mL|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|CLOTTED||MODIFIED ACID FAST STAIN|GMI % FORMULA||Y|N||5|Visit_5|90|6|TREATMENT|2020-09-01|2020-09-07|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|3dc9c666-8be3-4cfa-88d4-b18647e08d00|10|RETIL|Low Absorption Reticulocytes|HEMATOLOGY|[?]|mL/cm H2O|[?]|[?]|BORDERLINE|1|min|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|SOLIDIFIED||INTRAVASCULAR ULTRASOUND|MDRD 6 VARIABLE FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2020-09-01|2020-09-03|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|1|ARGSAC|Argininosuccinic Acid|HEMATOLOGY|[?]|g/animal|[?]|[?]|INVALID|1|gMFI|1|1|[?]|HIGH|KERATINOCYTE|UNEXPECTED ODOR||LIGHT SCATTERING SPECTROSCOPY|CKD-EPI FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2021-01-23|2021-03-21|10|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|2|CALPRO|Calprotectin|CHEMISTRY|[?]|kIU|[?]|[?]|INDETERMINATE|1|mL/kg/h|1|1|[?]|NORMAL|LUNG SURFACTANT|DRIED||TEMPLATE INCISION METHOD|GMI % FORMULA|Y||U||1|Visit_1|10|1|WASHOUT|2021-01-23|2021-04-04|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|3|TNFSR2|Soluble TNF Receptor Type II|CHEMISTRY|[?]|bel|[?]|[?]|TRACE|1|yd|1|1|[?]|ABNORMAL|VENOUS PLASMA|GELLED||SPIRAL CT|GMI % FORMULA||Y|N||2|Visit_2|25|4|SCREENING|2021-02-07|2021-03-21|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|4|HYDMRPHN|Hydromorphone|URINALYSIS|[?]|ugEq/L|[?]|[?]|INVALID|1|10^6/hpf|1|1|[?]|HIGH|MIXED VENOUS BLOOD|PARAFFIN-EMBEDDED|N|APPLANATION TONOMETRY|MDRD FORMULA|Y||NA||2|Visit_2|25|2|TREATMENT|2021-02-07|2021-04-01|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|5|VEGFC|Vascular Endothelial Growth Factor C|URINALYSIS|[?]|g/kg|[?]|[?]|TRACE|1|ugEq|1|1|[?]|HIGH|MUSCLE TISSUE|LIPEMIC||EEG|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|5|WASHOUT|2021-02-22|2021-04-16|40|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|6|DNPSEPHD|D-Norpseudoephedrine|URINALYSIS|[?]|g/cage/day|[?]|[?]|INVALID|1|MBq|1|1|[?]|LOW|LUNG SURFACTANT|LACTESCENT||CORONARY ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2021-02-22|2021-03-23|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|7|TNFAPIA|TNF-a Production Inhibitory Activity|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ug/dL|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|N|GC/MS/MS|ASH FIBROSURE FORMULA|||Y|Y|4|Visit_4|65|3|SCREENING|2021-03-19|2021-03-25|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|8|OH8DXG2|8-Hydroxy-2'-Deoxyguanosine|HEMATOLOGY|[?]|U/dL|[?]|[?]|POSITIVE|1|Linear ft*LB|1|1|[?]|LOW|SEMINAL FLUID|REFRIGERATED||TRIPLE-PHASE SPIRAL CT SCAN|FIBROMETER FORMULA|||NA||4|Visit_4|65|2|FOLLOW-UP|2021-03-19|2021-03-28|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|9|TFERRIN|Transferrin|HEMATOLOGY|||[?]|[?]|POSITIVE|1|dpm/mg|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|CONCENTRATED||CONTRAST ENHANCED PET SCAN|ASH FIBROSURE FORMULA|Y||U|Y|5|Visit_5|90|2|SCREENING|2021-04-13|2021-04-21|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|10|RLP|RLP Cholesterol|URINALYSIS|[?]|steps/min|[?]|[?]|BORDERLINE|1|nmol BCE/L|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||5|Visit_5|90|1|FOLLOW-UP|2021-04-13|2021-04-16|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|1|HELMOV10|Helicase MOV-10 Protein|CHEMISTRY|||[?]|[?]|NEGATIVE|1|/h|1|1|[?]|NORMAL|CELL PELLET|PARAFFIN-EMBEDDED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|COCKCROFT-GAULT FORMULA||Y|Y|Y|1|Visit_1|10|4|SCREENING|2020-11-19|2021-01-10|10|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|2|C130120|Shellfish Mix Antigen IgE Antibody|CHEMISTRY|[?]|COAT|[?]|[?]|POSITIVE|1|mL/kg/min|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|REFRIGERATED||IVY INCISION METHOD|FIBROMETER FORMULA|||N||1|Visit_1|10|7|FOLLOW-UP|2020-11-19|2021-01-13|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|3|HBHIB|Hemoglobin H Inclusion Bodies|HEMATOLOGY|[?]|umol/kg/min|[?]|[?]|TRACE|1|WEEKS|1|1|[?]|ABNORMAL|CORD BLOOD|CLOTTED||TURBIDIMETRY|MDRD FORMULA|Y||Y||2|Visit_2|25|1|FOLLOW-UP|2020-12-04|2021-01-31|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|4|MDA|3,4-methylenedioxyamphetamine|CHEMISTRY|[?]|V/sec|[?]|[?]|NEGATIVE|1|m|1|1|[?]|LOW|LYMPH|THAWED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-12-04|2021-01-21|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|5|IGGCREAT|Immunoglobulin G/Creatinine|HEMATOLOGY|[?]|m/sec2|[?]|[?]|NEGATIVE|1|mCi/kg|1|1|[?]|LOW|BONE|ICTERIC||PULSE OXIMETRY|CKD-EPI FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-12-19|2021-01-23|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|6|PAF|Platelet Activating Factor|URINALYSIS|||[?]|[?]|NEGATIVE|1|ug/cm2|1|1|[?]|NORMAL|DISCHARGE|SOLIDIFIED||PET/SPECT SCAN|GMI MMOL/MOL FORMULA||Y|N|Y|3|Visit_3|40|4|WASHOUT|2020-12-19|2021-02-01|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|7|EPIC|Epithelial Cells|CHEMISTRY|[?]|g/L|[?]|[?]|BORDERLINE|1|log10 TCID 50/uL|1|1|[?]|ABNORMAL|LUNG SURFACTANT|AGGLUTINATED||ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA|Y|Y|Y||4|Visit_4|65|5|WASHOUT|2021-01-13|2021-02-03|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|8|PLSPCELY|Precursor Plasma Cells/Lymphocytes|CHEMISTRY|||[?]|[?]|NEGATIVE|1|fmol/g|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|FRESH||TOTAL BODY RADIOGRAPHY|GMI % FORMULA|||N|Y|4|Visit_4|65|6|TREATMENT|2021-01-13|2021-01-25|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|9|CD22|CD22|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|MPS U|1|1|[?]|NORMAL|SWABBED MATERIAL|PARAFFIN-EMBEDDED||MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|5|Visit_5|90|2|WASHOUT|2021-02-07|2021-02-10|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|10|PCSK9|Proprotein Convertase Subtilisin/Kexin 9|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mL/g/h|1|1|[?]|LOW|DERMAL TISSUE|AGGLUTINATED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|COCKCROFT-GAULT FORMULA|||U|Y|5|Visit_5|90|5|FOLLOW-UP|2021-02-07|2021-02-15|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|2738b933-c71d-4239-a093-6b4aa7cc41df|1|PAI1|Plasminogen Activator Inhibitor-1|CHEMISTRY|[?]|mL/(min*100mL)|[?]|[?]|NEGATIVE|1|breaths/30s|1|1|[?]|NORMAL|URINE|PARAFFIN-EMBEDDED||DOPPLER ULTRASOUND|MDRD 6 VARIABLE FORMULA|||Y||1|Visit_1|10|5|SCREENING|2020-05-28|2020-06-20|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|2738b933-c71d-4239-a093-6b4aa7cc41df|2|GRANLE|Granulocytes/Leukocytes|URINALYSIS|[?]|FIU|[?]|[?]|INVALID|1|mg/kg/min|1|1|[?]|NORMAL|ARTERIAL BLOOD|AGGLUTINATED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||1|Visit_1|10|1|SCREENING|2020-05-28|2020-06-15|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|2738b933-c71d-4239-a093-6b4aa7cc41df|3|INGAPAB|Islet Neogenesis Assoc Protein Antibody|HEMATOLOGY|[?]|ug/kg|[?]|[?]|NEGATIVE|1|damol/L|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|LACTESCENT||COMPUTERIZED CORNEAL TOPOGRAPHY|GMI % FORMULA||Y|Y||2|Visit_2|25|3|WASHOUT|2020-06-12|2020-08-05|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|2738b933-c71d-4239-a093-6b4aa7cc41df|4|BLSTMGK|Megakaryoblasts|URINALYSIS|[?]|10^6 IU|[?]|[?]|TRACE|1|nkat/g Hb|1|1|[?]|NORMAL|NAIL|REFRIGERATED||ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD 5 VARIABLE FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2020-06-12|2020-06-13|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|2738b933-c71d-4239-a093-6b4aa7cc41df|5|CD11B|CD11B|URINALYSIS|[?]|CFU/mL|[?]|[?]|TRACE|1|s/h|1|1|[?]|LOW|VENOUS PLASMA|FROZEN|N|DIFFUSION WEIGHTED MRI|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|2|TREATMENT|2020-06-27|2020-08-04|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|2738b933-c71d-4239-a093-6b4aa7cc41df|6|C165906|Weed Mix Pollen IgG AB RAST Score|HEMATOLOGY|[?]|uL/mL|[?]|[?]|NEGATIVE|1|Bq/ug|1|1|[?]|LOW|FLUID|FROZEN||CELL OF ORIGIN ASSAY|FIBROTEST FORMULA|Y||Y||3|Visit_3|40|3|TREATMENT|2020-06-27|2020-08-01|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|2738b933-c71d-4239-a093-6b4aa7cc41df|7|IMMGLC|Immunoglobulin Light Chains|URINALYSIS|[?]|log10 copies/mL|[?]|[?]|POSITIVE|1|PFU/dose|1|1|[?]|NORMAL|PUS|SOLIDIFIED||REBOUND TONOMETRY|MDRD FORMULA||Y|NA||4|Visit_4|65|1|SCREENING|2020-07-22|2020-08-25|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|2738b933-c71d-4239-a093-6b4aa7cc41df|8|AMPHET|Amphetamine|CHEMISTRY|[?]|tsp|[?]|[?]|POSITIVE|1|fmol/L/sec|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|LACTESCENT||MICROBIAL CONCENTRATION|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|4|FOLLOW-UP|2020-07-22|2020-08-17|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|2738b933-c71d-4239-a093-6b4aa7cc41df|9|C130095|Western Ragweed Pollen IgG4|CHEMISTRY|[?]|Bq/g|[?]|[?]|POSITIVE|1|MET*min|1|1|[?]|HIGH|MUCUS|REFRIGERATED||MANUAL CLOT DETECTION|MDRD ENZYMATIC FORMULA|Y||NA||5|Visit_5|90|6|WASHOUT|2020-08-16|2020-08-24|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|2738b933-c71d-4239-a093-6b4aa7cc41df|10|CLCLR|Chloride Clearance|HEMATOLOGY|[?]|titer|[?]|[?]|TRACE|1|bel|1|1|[?]|ABNORMAL|LOCHIA|UNEXPECTED ODOR||MASS SPECTROMETRY|MDRD FORMULA|Y||Y||5|Visit_5|90|7|SCREENING|2020-08-16|2020-08-18|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|68b9ff4e-9694-4545-a752-4d3ac0e89fda|1|MYCEMIDX|Myeloid Maturation Index|HEMATOLOGY|[?]|nmol BCE/nmol|[?]|[?]|INDETERMINATE|1|pg/dL|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|AGGLUTINATED||FLUOROSCOPY|MDRD 6 VARIABLE FORMULA||Y|Y||1|Visit_1|10|1|TREATMENT|2021-01-08|2021-03-17|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|68b9ff4e-9694-4545-a752-4d3ac0e89fda|2|ALBGLYCA|Glycated Albumin|CHEMISTRY|||[?]|[?]|INVALID|1|nsec|1|1|[?]|HIGH|PLEURAL FLUID|DRIED||ANTIMICROBIAL COMBINATION TESTING|MDRD 6 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|1|SCREENING|2021-01-08|2021-03-02|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|68b9ff4e-9694-4545-a752-4d3ac0e89fda|3|KETONEBD|Ketone Bodies|URINALYSIS|||[?]|[?]|INVALID|1|INHALATION|1|1|[?]|ABNORMAL|DIALYSIS FLUID, PERITONEAL|SOLIDIFIED||EEG|HEPASCORE FORMULA|||U|Y|2|Visit_2|25|6|WASHOUT|2021-01-23|2021-03-21|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|68b9ff4e-9694-4545-a752-4d3ac0e89fda|4|NRP1|Neuropilin-1|CHEMISTRY|[?]|HOMEOPATHIC DILUTION|[?]|[?]|NEGATIVE|1|g/m2/day|1|1|[?]|ABNORMAL|MECONIUM|UNEXPECTED ODOR||PYROSEQUENCING|FIBROTEST FORMULA||Y|Y||2|Visit_2|25|7|FOLLOW-UP|2021-01-23|2021-03-06|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|68b9ff4e-9694-4545-a752-4d3ac0e89fda|5|BARB|Barbiturates|CHEMISTRY|[?]|copies/mL|[?]|[?]|POSITIVE|1|mmol/L|1|1|[?]|LOW|CAPILLARY PLASMA|LIPEMIC|N|HPLC-UV|MDRD 4 VARIABLE FORMULA||Y|NA||3|Visit_3|40|6|WASHOUT|2021-02-07|2021-02-24|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-03
e|LB|68b9ff4e-9694-4545-a752-4d3ac0e89fda|6|STAT3|STAT3|HEMATOLOGY|||[?]|[?]|POSITIVE|1|pkat|1|1|[?]|ABNORMAL|FLUID|UNEXPECTED ODOR||FARR ASSAY|MDRD 6 VARIABLE FORMULA|||NA|Y|3|Visit_3|40|6|WASHOUT|2021-02-07|2021-02-19|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-03
e|LB|68b9ff4e-9694-4545-a752-4d3ac0e89fda|7|TRPTRG|Trypsin and Trypsinogen|HEMATOLOGY|[?]|mmol/mol|[?]|[?]|POSITIVE|1|ELISA unit|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|FROZEN||STATIC PERIMETRY|CKD-EPI CREATININE FORMULA||Y|NA||4|Visit_4|65|7|FOLLOW-UP|2021-03-04|2021-03-11|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|LB|68b9ff4e-9694-4545-a752-4d3ac0e89fda|8|PHE|Phenylalanine|CHEMISTRY|[?]|mL/kg/h|[?]|[?]|POSITIVE|1|Sv|1|1|[?]|HIGH|PLEURAL FLUID|DRIED||SINGLE-SLICE SPIRAL CT|MDRD 5 VARIABLE FORMULA||Y|NA||4|Visit_4|65|5|FOLLOW-UP|2021-03-04|2021-03-30|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|LB|68b9ff4e-9694-4545-a752-4d3ac0e89fda|9|FABP1|Fatty Acid Binding Protein 1|CHEMISTRY|||[?]|[?]|INVALID|1|TUBE|1|1|[?]|LOW|ENDOMETRIAL TISSUE|FROZEN||DUKE INCISION METHOD|NASH FIBROSURE FORMULA|||U|Y|5|Visit_5|90|2|SCREENING|2021-03-29|2021-03-30|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|68b9ff4e-9694-4545-a752-4d3ac0e89fda|10|LEPTIN|Leptin|HEMATOLOGY|[?]|/mm2|[?]|[?]|INVALID|1|10^3 CFU/mL|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|AUTOLYZED||SIZE EXCLUSION CHROMATOGRAPHY|FIBROMETER FORMULA|||N||5|Visit_5|90|2|WASHOUT|2021-03-29|2021-03-31|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|0f0ec179-5100-4a3d-9f93-54140aca7d30|1|SMTHAB|Smith Antibody|URINALYSIS|||[?]|[?]|POSITIVE|1|rpm|1|1|[?]|HIGH|BILE|CONCENTRATED||MICROBIAL CULTURE, LIQUID|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|1|Visit_1|10|3|TREATMENT|2020-08-25|2020-09-19|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|0f0ec179-5100-4a3d-9f93-54140aca7d30|2|NEUTSGLE|Neutrophils, Segmented/Leukocytes|CHEMISTRY|[?]|mPa|[?]|[?]|NEGATIVE|1|mL/g/min|1|1|[?]|HIGH|ADIPOSE TISSUE|ROOM TEMPERATURE||KINETIC MICROPARTICLE IMMUNOASSAY|GMI % FORMULA|Y|Y|N||1|Visit_1|10|2|SCREENING|2020-08-25|2020-11-06|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|0f0ec179-5100-4a3d-9f93-54140aca7d30|3|AMH|Anti-Mullerian Hormone|HEMATOLOGY|[?]|10^3 RNA copies/mL|[?]|[?]|INDETERMINATE|1|10^6 copies/mL|1|1|[?]|LOW|ARTERIAL CORD BLOOD|NON-HEMOLYZED||BRDU CELLULAR PROLIFERATION ASSAY|FIBROMETER FORMULA|||U||2|Visit_2|25|5|TREATMENT|2020-09-09|2020-10-14|25|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|0f0ec179-5100-4a3d-9f93-54140aca7d30|4|T3|Triiodothyronine|URINALYSIS|[?]|10^12/L|[?]|[?]|INVALID|1|Siemens|1|1|[?]|ABNORMAL|SERUM OR PLASMA|AUTOLYZED|N|FARR ASSAY|NASH FIBROSURE FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-09-09|2020-10-27|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|0f0ec179-5100-4a3d-9f93-54140aca7d30|5|TAT|Thrombin/Antithrombin|HEMATOLOGY|||[?]|[?]|POSITIVE|1|uEq/L|1|1|[?]|ABNORMAL|STOOL|CLOTTED||LAPAROSCOPY|MDRD FORMULA|Y||NA|Y|3|Visit_3|40|4|TREATMENT|2020-09-24|2020-11-22|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|0f0ec179-5100-4a3d-9f93-54140aca7d30|6|LYS|Lysine|HEMATOLOGY|[?]|nmol BCE/L|[?]|[?]|BORDERLINE|1|U/kg/min|1|1|[?]|NORMAL|HAIR|GELLED||MANUAL CLOT DETECTION|ASH FIBROSURE FORMULA|Y||U||3|Visit_3|40|2|TREATMENT|2020-09-24|2020-09-25|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|0f0ec179-5100-4a3d-9f93-54140aca7d30|7|PLSMCECE|Mature Plasma Cells/Total Cells|URINALYSIS|||[?]|[?]|INVALID|1|SBE/mL|1|1|[?]|ABNORMAL|VITREOUS HUMOR|PARAFFIN-EMBEDDED||PERIODIC ACID SCHIFF STAIN|HEPASCORE FORMULA|Y||NA|Y|4|Visit_4|65|5|WASHOUT|2020-10-19|2020-10-26|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|0f0ec179-5100-4a3d-9f93-54140aca7d30|8|CLNZPM|Clonazepam|CHEMISTRY|[?]|mol/day|[?]|[?]|TRACE|1|U/m2/day|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|FRESH||TARGETED GENOME SEQUENCING|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|1|SCREENING|2020-10-19|2020-11-22|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|0f0ec179-5100-4a3d-9f93-54140aca7d30|9|HLAIIAB|HLA Class II Antibody|CHEMISTRY|[?]|Roentgen|[?]|[?]|BORDERLINE|1|nsec|1|1|[?]|ABNORMAL|PLATELET|PARAFFIN-EMBEDDED||GEL ELECTROPHORESIS|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||5|Visit_5|90|3|FOLLOW-UP|2020-11-13|2020-11-15|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|0f0ec179-5100-4a3d-9f93-54140aca7d30|10|FCTVIIAA|Factor VIIa Activity|URINALYSIS|||[?]|[?]|INVALID|1|ug/mol|1|1|[?]|HIGH|SUPERNATANT, SERUM|LIPEMIC||MIGET|FIBROMETER FORMULA||Y|NA|Y|5|Visit_5|90|5|TREATMENT|2020-11-13|2020-11-17|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|6affe43d-e455-40af-8478-dc38019e89e1|1|LIPEMIAI|Lipemic Index|CHEMISTRY|[?]|mL/dose|[?]|[?]|POSITIVE|1|NEBULE|1|1|[?]|NORMAL|EPITHELIAL CELL|ICTERIC|N|PULSE OXIMETRY|COCKCROFT-GAULT FORMULA|Y||NA||1|Visit_1|10|2|TREATMENT|2020-06-17|2020-06-29|10|22|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|6affe43d-e455-40af-8478-dc38019e89e1|2|EPIRCE|Renal Epithelial Cells|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|uOsm|1|1|[?]|HIGH|CORD BLOOD|AUTOLYZED|N|NUCLEIC ACID SEQUENCING|MDRD FORMULA|||U|Y|1|Visit_1|10|4|SCREENING|2020-06-17|2020-08-21|10|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|6affe43d-e455-40af-8478-dc38019e89e1|3|TRP1TRG1|Trypsin 1 and Trypsinogen 1|HEMATOLOGY|[?]|fL|[?]|[?]|NEGATIVE|1|cm/min|1|1|[?]|HIGH|CAPILLARY BLOOD|ROOM TEMPERATURE||KINETIC MICROPARTICLE IMMUNOASSAY|ASH FIBROSURE FORMULA|Y|Y|NA||2|Visit_2|25|2|TREATMENT|2020-07-02|2020-09-02|25|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|6affe43d-e455-40af-8478-dc38019e89e1|4|NOHDLHDL|Non-HDL Cholesterol/HDL Cholesterol|HEMATOLOGY|[?]|U/kg/h|[?]|[?]|TRACE|1|10^3 RNA copies/mL|1|1|[?]|ABNORMAL|PLEURAL FLUID|AUTOLYZED||VIRUS PLAQUE ASSAY|MDRD FORMULA|Y|Y|Y||2|Visit_2|25|2|TREATMENT|2020-07-02|2020-08-12|25|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|6affe43d-e455-40af-8478-dc38019e89e1|5|FLT3|FMS-like Receptor Tyrosine Kinase 3|HEMATOLOGY|[?]|ug/L FEU|[?]|[?]|NEGATIVE|1|deg/mm|1|1|[?]|ABNORMAL|FLUID|AGGLUTINATED||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|2|WASHOUT|2020-07-17|2020-09-12|40|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|6affe43d-e455-40af-8478-dc38019e89e1|6|CKMT1CK|CK, Macromolecular Type 1/Total CK|HEMATOLOGY|[?]|mL/mmHg|[?]|[?]|NEGATIVE|1|titer|1|1|[?]|LOW|HAIR|DRIED||GC/FID|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|5|WASHOUT|2020-07-17|2020-07-19|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|6affe43d-e455-40af-8478-dc38019e89e1|7|OVALCY|Ovalocytes|CHEMISTRY|[?]|/day|[?]|[?]|INVALID|1|SBE/mL|1|1|[?]|LOW|TUMOR TISSUE|ICTERIC||MAGNETIC RESONANCE ENTEROGRAPHY|GMI % FORMULA|||NA||4|Visit_4|65|6|SCREENING|2020-08-11|2020-08-14|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|6affe43d-e455-40af-8478-dc38019e89e1|8|PTHI|Parathyroid Hormone, Intact|URINALYSIS|[?]|umol/mol|[?]|[?]|INVALID|1|mL/h|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED||U-HPLC/MS/MS|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-08-11|2020-09-02|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|6affe43d-e455-40af-8478-dc38019e89e1|9|CD45LY|CD45/Lymphocytes|URINALYSIS|[?]|kBq/uL|[?]|[?]|POSITIVE|1|fL|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|ROOM TEMPERATURE||MECHANICAL CLOT DETECTION|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|1|TREATMENT|2020-09-05|2020-09-08|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|6affe43d-e455-40af-8478-dc38019e89e1|10|GLP1|Glucagon-Like Peptide-1|URINALYSIS|||[?]|[?]|INVALID|1|cm/s|1|1|[?]|NORMAL|ABSCESS FLUID|AUTOLYZED||HANSEL STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|5|Visit_5|90|1|TREATMENT|2020-09-05|2020-09-12|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|1|FACTXIVA|Factor XIV Activity|CHEMISTRY|[?]|10^3/hpf|[?]|[?]|POSITIVE|1|cmol/L|1|1|[?]|ABNORMAL|URINE SEDIMENT|THAWED|N|IODINE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|5|FOLLOW-UP|2020-06-07|2020-08-30|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|2|MSPIKEPT|Monoclonal Protein Spike/Total Protein|URINALYSIS|[?]|mL/animal|[?]|[?]|NEGATIVE|1|m2|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|LIPEMIC||NUCLEIC ACID AMPLIFICATION TEST|GMI % FORMULA|||NA||1|Visit_1|10|1|FOLLOW-UP|2020-06-07|2020-08-12|10|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|3|C130133|D. farinae Antigen IgG Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|SBE/mL|1|1|[?]|ABNORMAL|LAVAGE FLUID|CALCIFIED||CLINICAL EVALUATION|MDRD 4 VARIABLE FORMULA||Y|N|Y|2|Visit_2|25|3|TREATMENT|2020-06-22|2020-09-04|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|LB|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|4|BLYCE|B-Lymphocytes|HEMATOLOGY|[?]|COAT|[?]|[?]|TRACE|1|cmH2O/mL|1|1|[?]|HIGH|CAPILLARY PLASMA|LACTESCENT||OPTICAL MAPPING|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-06-22|2020-07-08|25|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|LB|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|5|TRGTCE|Target Cells|HEMATOLOGY|||[?]|[?]|INVALID|1|Ci/mg|1|1|[?]|ABNORMAL|LEUKOCYTE|CLOTTED||IMMUNOCHROMATOGRAPHY|COCKCROFT-GAULT FORMULA|||Y|Y|3|Visit_3|40|7|WASHOUT|2020-07-07|2020-07-20|40|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|6|TIMP1|Tissue Inhibitor of Metalloproteinase 1|URINALYSIS|||[?]|[?]|NEGATIVE|1|uIU/L|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|DRIED||FLUORESCENT IMMUNOASSAY|CKD-EPI FORMULA|||NA|Y|3|Visit_3|40|7|TREATMENT|2020-07-07|2020-08-29|40|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|7|AZURGRAN|Azurophilic Granules|URINALYSIS|||[?]|[?]|BORDERLINE|1|g/kg|1|1|[?]|HIGH|RETICULOCYTES|LIPEMIC|N|PERIODIC ACID SCHIFF STAIN|FIBROSIS 4 FORMULA||Y|N|Y|4|Visit_4|65|6|TREATMENT|2020-08-01|2020-08-28|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|8|P3NP|Procollagen 3 N-Terminal Propeptide|URINALYSIS|||[?]|[?]|TRACE|1|DIOPTER|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|CALCIFIED|N|X-RAY FLUORESCENCE SPECTROMETRY|MDRD 4 VARIABLE FORMULA|||U|Y|4|Visit_4|65|5|TREATMENT|2020-08-01|2020-08-28|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|9|TROPONI1|Troponin I Type 1|CHEMISTRY|||[?]|[?]|INVALID|1|mL/m2/min|1|1|[?]|NORMAL|PERITONEAL FLUID|SOLIDIFIED||HIGH RESOLUTION CT|MDRD 4 VARIABLE FORMULA|||U|Y|5|Visit_5|90|1|WASHOUT|2020-08-26|2020-08-30|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|LB|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|10|NAGASECR|N-acetyl-B-D-glucosaminidase/Creatinine|URINALYSIS|[?]|mg/animal|[?]|[?]|BORDERLINE|1|10^3 DNA copies/mL|1|1|[?]|HIGH|AQUEOUS HUMOR|REFRIGERATED||MRI WITHOUT CONTRAST|CKD-EPI FORMULA|||NA||5|Visit_5|90|2|WASHOUT|2020-08-26|2020-09-03|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|LB|e0258c95-7bcc-4b54-895c-f290a1364b5c|1|C130095|Western Ragweed Pollen IgG4|HEMATOLOGY|[?]|/h|[?]|[?]|BORDERLINE|1|/ms|1|1|[?]|HIGH|ARTERIAL BLOOD|UNEXPECTED ODOR||TRANSVAGINAL ULTRASOUND|CKD-EPI CREATININE FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-12-27|2021-02-26|10|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|LB|e0258c95-7bcc-4b54-895c-f290a1364b5c|2|FGFBF|Fibroblast Growth Factor Basic Form|CHEMISTRY|[?]|/sec|[?]|[?]|TRACE|1|nkat/L|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|UNEXPECTED ODOR||HPLC/IEX|MDRD ENZYMATIC FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-12-27|2021-02-27|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|LB|e0258c95-7bcc-4b54-895c-f290a1364b5c|3|EDMIGAAB|Endomysial IgA Antibody|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|log10 CFU/mL|1|1|[?]|ABNORMAL|SMEGMA|CALCIFIED|N|CONTRAST ENHANCED SPIRAL CT SCAN|MDRD FORMULA|||N|Y|2|Visit_2|25|1|TREATMENT|2021-01-11|2021-03-25|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|e0258c95-7bcc-4b54-895c-f290a1364b5c|4|APOB|Apolipoprotein B|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|/min|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|LIPEMIC|N|NEXT GENERATION TARGETED SEQUENCING|FIBROTEST FORMULA|||Y|Y|2|Visit_2|25|3|FOLLOW-UP|2021-01-11|2021-03-02|25|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|e0258c95-7bcc-4b54-895c-f290a1364b5c|5|BJPROT|Bence-Jones Protein|CHEMISTRY|[?]|Siemens|[?]|[?]|NEGATIVE|1|U/kg/min|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|DRIED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|FIBROMETER FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2021-01-26|2021-03-17|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|e0258c95-7bcc-4b54-895c-f290a1364b5c|6|FABP3|Fatty Acid Binding Protein 3|URINALYSIS|[?]|GBq/mg|[?]|[?]|POSITIVE|1|CFU/g|1|1|[?]|LOW|EPIDERMAL TISSUE|LIPEMIC||HPLC/MS/MS|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|2|FOLLOW-UP|2021-01-26|2021-02-24|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|e0258c95-7bcc-4b54-895c-f290a1364b5c|7|ANDSTNDL|Androstenediol|URINALYSIS|||[?]|[?]|TRACE|1|kcal/day|1|1|[?]|ABNORMAL|LYMPH|REFRIGERATED||WESTERN BLOT|MDRD ENZYMATIC FORMULA|||U|Y|4|Visit_4|65|4|WASHOUT|2021-02-20|2021-02-23|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|e0258c95-7bcc-4b54-895c-f290a1364b5c|8|GFRBSCCC|GFR from Cystatin C and Creat Adj BSA|HEMATOLOGY|[?]|PFU/dose|[?]|[?]|INDETERMINATE|1|10^4 CFU|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|HEMOLYZED||ETDRS EYE CHART|HEPASCORE FORMULA|||NA||4|Visit_4|65|5|WASHOUT|2021-02-20|2021-03-19|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|e0258c95-7bcc-4b54-895c-f290a1364b5c|9|ROULEAUX|Rouleaux Formation|HEMATOLOGY|[?]|uCi/L|[?]|[?]|POSITIVE|1|U/cL|1|1|[?]|HIGH|TUMOR TISSUE|AUTOLYZED||OPTICAL MAPPING|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|1|FOLLOW-UP|2021-03-17|2021-03-22|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|e0258c95-7bcc-4b54-895c-f290a1364b5c|10|TUDCA|Tauroursodeoxycholate|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mg/m2/min|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|CONCENTRATED|N|BALLPOINT PEN TECHNIQUE|MDRD FORMULA|||N|Y|5|Visit_5|90|7|SCREENING|2021-03-17|2021-03-26|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|7218f9ae-0119-4633-a8d3-7d98b2ae1671|1|CYMSU|Monosodium Urate Crystals|URINALYSIS|[?]|DDU|[?]|[?]|INDETERMINATE|1|/mm2|1|1|[?]|ABNORMAL|RETICULOCYTES|AUTOLYZED|N|WESTERGREN|CKD-EPI CREATININE FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2021-01-13|2021-02-13|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|7218f9ae-0119-4633-a8d3-7d98b2ae1671|2|WBCCLMP|Leukocyte Cell Clumps|HEMATOLOGY|[?]|GPL U/mL|[?]|[?]|BORDERLINE|1|Shock Wave|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR||CHROMATOGRAPHY|ASH FIBROSURE FORMULA|||Y||1|Visit_1|10|3|TREATMENT|2021-01-13|2021-04-02|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|7218f9ae-0119-4633-a8d3-7d98b2ae1671|3|HSP70|Heat Shock Protein 70|URINALYSIS|[?]|mph|[?]|[?]|POSITIVE|1|damol/L|1|1|[?]|NORMAL|CORD BLOOD|FRESH||CLIP|CKD-EPI FORMULA||Y|Y||2|Visit_2|25|4|SCREENING|2021-01-28|2021-02-01|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|LB|7218f9ae-0119-4633-a8d3-7d98b2ae1671|4|NEUTSG|Neutrophils, Segmented|HEMATOLOGY|[?]|U/mmol|[?]|[?]|INDETERMINATE|1|NEEDLE GAUGE|1|1|[?]|ABNORMAL|BLOOD|SOLIDIFIED||ICC|GMI % FORMULA|||U||2|Visit_2|25|1|WASHOUT|2021-01-28|2021-03-15|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|LB|7218f9ae-0119-4633-a8d3-7d98b2ae1671|5|CD23|CD23|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|MdFI|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH||RAJI CELL RIA|COCKCROFT-GAULT FORMULA||Y|Y|Y|3|Visit_3|40|4|SCREENING|2021-02-12|2021-03-14|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|LB|7218f9ae-0119-4633-a8d3-7d98b2ae1671|6|CANNAB|Cannabinoids|URINALYSIS|[?]|VOXEL|[?]|[?]|NEGATIVE|1|pg|1|1|[?]|LOW|GASTRIC CONTENTS|HEMOLYZED||DUCTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|7|FOLLOW-UP|2021-02-12|2021-03-27|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|LB|7218f9ae-0119-4633-a8d3-7d98b2ae1671|7|C130118|Bee Mix Antigen IgG4 Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|kPa/L/sec|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|CONTAMINATED||FLAME PHOTOMETRY|MDRD ENZYMATIC FORMULA|||U|Y|4|Visit_4|65|2|WASHOUT|2021-03-09|2021-03-30|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|LB|7218f9ae-0119-4633-a8d3-7d98b2ae1671|8|GDF11|Growth Differentiation Factor 11|CHEMISTRY|[?]|ELISA unit|[?]|[?]|INVALID|1|sec|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|NON-HEMOLYZED||DOPPLER ULTRASOUND|GMI MMOL/MOL FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-03-09|2021-03-25|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|LB|7218f9ae-0119-4633-a8d3-7d98b2ae1671|9|APRI|AST to Platelet Ratio Index|HEMATOLOGY|[?]|Shock Wave|[?]|[?]|TRACE|1|MAC50|1|1|[?]|HIGH|CALCULUS|LIPEMIC||MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 4 VARIABLE FORMULA||Y|Y||5|Visit_5|90|5|FOLLOW-UP|2021-04-03|2021-04-09|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|7218f9ae-0119-4633-a8d3-7d98b2ae1671|10|OXYCAP|Oxygen Capacity|URINALYSIS|[?]|mEq/L|[?]|[?]|POSITIVE|1|CAPLET|1|1|[?]|HIGH|BILE|FRESH||FLUORESCENT IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||Y|N||5|Visit_5|90|2|TREATMENT|2021-04-03|2021-04-05|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|f8c938ff-21c8-4d0b-9335-08d2865543ab|1|FLRZPM|Flurazepam|HEMATOLOGY|[?]|g/m2/day|[?]|[?]|TRACE|1|mEq|1|1|[?]|NORMAL|ERYTHROCYTES|CLOTTED|N|SCINTIGRAPHY|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|6|SCREENING|2020-05-11|2020-06-12|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|f8c938ff-21c8-4d0b-9335-08d2865543ab|2|ARA|Arachidonic Acid|CHEMISTRY|[?]|mg/animal|[?]|[?]|INDETERMINATE|1|IMPLANT|1|1|[?]|NORMAL|LYMPH|CONTAMINATED||CT SCAN|HEPASCORE FORMULA|||Y||1|Visit_1|10|3|TREATMENT|2020-05-11|2020-08-07|10|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|f8c938ff-21c8-4d0b-9335-08d2865543ab|3|TNF12EXR|TNF Superfamily Member 12 Excretion Rate|URINALYSIS|||[?]|[?]|INDETERMINATE|1|PACKET|1|1|[?]|NORMAL|ERYTHROCYTES|FRESH||MAPH|FIBROSIS 4 FORMULA|||Y|Y|2|Visit_2|25|3|TREATMENT|2020-05-26|2020-07-18|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|LB|f8c938ff-21c8-4d0b-9335-08d2865543ab|4|K|Potassium|CHEMISTRY|[?]|mmHg*min/L|[?]|[?]|INVALID|1|pg/dL|1|1|[?]|HIGH|BASAL TEAR|CONCENTRATED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|N||2|Visit_2|25|1|FOLLOW-UP|2020-05-26|2020-05-29|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|LB|f8c938ff-21c8-4d0b-9335-08d2865543ab|5|CACRALB|Calcium Corrected for Albumin|CHEMISTRY|[?]|mgEq|[?]|[?]|TRACE|1|BAU|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|HEMOLYZED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA||Y|N||3|Visit_3|40|6|SCREENING|2020-06-10|2020-08-07|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|f8c938ff-21c8-4d0b-9335-08d2865543ab|6|TLYCE|T-Lymphocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|YEARS|1|1|[?]|NORMAL|SUPERNATANT, SERUM|CONTAMINATED||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|FIBROSIS 4 FORMULA|||Y|Y|3|Visit_3|40|2|WASHOUT|2020-06-10|2020-07-07|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|f8c938ff-21c8-4d0b-9335-08d2865543ab|7|SOST|Sclerostin|CHEMISTRY|[?]|FFU|[?]|[?]|NEGATIVE|1|Gauss|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|DRIED|N|MANUAL COUNT|CKD-EPI CREATININE FORMULA||Y|Y||4|Visit_4|65|6|TREATMENT|2020-07-05|2020-07-23|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|LB|f8c938ff-21c8-4d0b-9335-08d2865543ab|8|CSEPI846|Aggrecan Chondroitin Sulfate Epitope 846|HEMATOLOGY|[?]|Gy/min|[?]|[?]|POSITIVE|1|mOsm/L|1|1|[?]|NORMAL|PLATELET|CONTAMINATED||ENDPOINT DILUTION ASSAY|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-07-05|2020-08-07|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|LB|f8c938ff-21c8-4d0b-9335-08d2865543ab|9|C147279|Zea mays Antigen IgE Antibody|URINALYSIS|[?]|U|[?]|[?]|INVALID|1|foz_us|1|1|[?]|ABNORMAL|ALVEOLAR AIR|AUTOLYZED||DC SHEATH FLOW|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|6|WASHOUT|2020-07-30|2020-07-31|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|LB|f8c938ff-21c8-4d0b-9335-08d2865543ab|10|C130081|Orchard Grass Pollen IgA|HEMATOLOGY|[?]|mEq/L|[?]|[?]|INDETERMINATE|1|Gy/min|1|1|[?]|NORMAL|LOCHIA|CONCENTRATED|N|OPTICAL DENSITY MEASUREMENT|FIBROTEST FORMULA|Y|Y|Y||5|Visit_5|90|5|WASHOUT|2020-07-30|2020-08-07|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|LB|7176f852-7392-4636-800f-3aad48e93065|1|ALA1ALB|Apolipoprotein A1/Apolipoprotein B|HEMATOLOGY|[?]|g/cm2|[?]|[?]|BORDERLINE|1|g/cage/day|1|1|[?]|ABNORMAL|SWABBED MATERIAL|ICTERIC||SPECT/CT SCAN|HEPASCORE FORMULA||Y|N||1|Visit_1|10|4|WASHOUT|2021-01-16|2021-01-27|10|21|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|7176f852-7392-4636-800f-3aad48e93065|2|APOH|Apolipoprotein H|HEMATOLOGY|[?]|oz eq|[?]|[?]|INVALID|1|BLOCKS|1|1|[?]|ABNORMAL|SKIN TISSUE|CONTAMINATED||CISH|FIBROTEST FORMULA|Y||Y||1|Visit_1|10|5|TREATMENT|2021-01-16|2021-01-19|10|13|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|7176f852-7392-4636-800f-3aad48e93065|3|CYCHOL|Cholesterol Crystals|HEMATOLOGY|[?]|/LSQN|[?]|[?]|BORDERLINE|1|breaths/30s|1|1|[?]|LOW|CERUMEN|AGGLUTINATED|N|AUSCULTATION|GMI MMOL/MOL FORMULA|Y||NA||2|Visit_2|25|6|TREATMENT|2021-01-31|2021-03-05|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|7176f852-7392-4636-800f-3aad48e93065|4|CITCREAT|Citrate/Creatinine|URINALYSIS|[?]|g/kg|[?]|[?]|POSITIVE|1|um2|1|1|[?]|ABNORMAL|KERATINOCYTE|NON-HEMOLYZED||ALCIAN BLUE STAIN|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|3|SCREENING|2021-01-31|2021-03-13|25|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|7176f852-7392-4636-800f-3aad48e93065|5|RT3|Triiodothyronine, Reverse|CHEMISTRY|[?]|Bq/mL|[?]|[?]|POSITIVE|1|Siemens|1|1|[?]|HIGH|BILE|THAWED|N|TURBIDIMETRY|CKD-EPI FORMULA||Y|NA||3|Visit_3|40|5|TREATMENT|2021-02-15|2021-03-25|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|7176f852-7392-4636-800f-3aad48e93065|6|INTLK14|Interleukin 14|HEMATOLOGY|[?]|ug/m2/min|[?]|[?]|BORDERLINE|1|pmol/g|1|1|[?]|ABNORMAL|SOFT TISSUE|GELLED|N|ICC|MDRD FORMULA|||Y||3|Visit_3|40|7|SCREENING|2021-02-15|2021-03-30|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|7176f852-7392-4636-800f-3aad48e93065|7|CRTFREXR|Cortisol, Free Excretion Rate|URINALYSIS|||[?]|[?]|INVALID|1|mmHg|1|1|[?]|HIGH|BONE|LIPEMIC||FUNCTIONAL MRI|GMI % FORMULA|||U|Y|4|Visit_4|65|6|TREATMENT|2021-03-12|2021-03-21|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|LB|7176f852-7392-4636-800f-3aad48e93065|8|CSAB|Cathepsin Antibody|HEMATOLOGY|[?]|MET|[?]|[?]|POSITIVE|1|lm|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|SOLIDIFIED|N|TRIPLE-PHASE MRI SCAN|CKD-EPI FORMULA|||N||4|Visit_4|65|2|WASHOUT|2021-03-12|2021-03-24|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|LB|7176f852-7392-4636-800f-3aad48e93065|9|PFCT|Platelet Function Closure Time|CHEMISTRY|[?]|dmol|[?]|[?]|POSITIVE|1|GPL U|1|1|[?]|ABNORMAL|HAIR|CONCENTRATED||TELLER ACUITY CARDS|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|5|FOLLOW-UP|2021-04-06|2021-04-08|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|7176f852-7392-4636-800f-3aad48e93065|10|RETPALM|Retinyl Palmitate|URINALYSIS|[?]|ug/kg/day|[?]|[?]|INDETERMINATE|1|atm|1|1|[?]|NORMAL|SEMEN|LACTESCENT||TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|3|TREATMENT|2021-04-06|2021-04-15|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|1|GLUCPE|Plasma Equivalent Glucose|URINALYSIS|[?]|PFU/animal|[?]|[?]|BORDERLINE|1|V|1|1|[?]|HIGH|PERITONEAL FLUID|REFRIGERATED|N|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CYSTATIN C FORMULA|||U||1|Visit_1|10|6|SCREENING|2020-10-08|2020-12-21|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|LB|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|2|TSTFWTST|Testosterone Free+Weakly Bound/Testost|URINALYSIS|[?]|mL/day|[?]|[?]|TRACE|1|nmol BCE/nmol|1|1|[?]|HIGH|ALVEOLAR AIR|UNEXPECTED ODOR|N|IMMUNOFIXATION ELECTROPHORESIS|GMI MMOL/MOL FORMULA|Y||Y||1|Visit_1|10|5|TREATMENT|2020-10-08|2020-10-21|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|LB|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|3|URATECRT|Urate/Creatinine|HEMATOLOGY|[?]|ft2|[?]|[?]|INVALID|1|EID 50/mL|1|1|[?]|ABNORMAL|PERITONEAL FLUID|LACTESCENT||DROPLET DIGITAL PCR|CKD-EPI CYSTATIN C FORMULA|Y||N||2|Visit_2|25|3|FOLLOW-UP|2020-10-23|2020-11-30|25|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|4|RBCFRAG|Erythrocyte Fragment|URINALYSIS|[?]|ugEq|[?]|[?]|BORDERLINE|1|VOXEL|1|1|[?]|ABNORMAL|SERUM|HEMOLYZED||MICRONEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA|||U||2|Visit_2|25|6|SCREENING|2020-10-23|2020-11-27|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|5|ALBGALB|Glycated Albumin/Albumin|HEMATOLOGY|[?]|vg/kg|[?]|[?]|POSITIVE|1|nkat/L|1|1|[?]|HIGH|PLEURAL FLUID|CONTAMINATED||FLUORESCENT ENZYME IMMUNOASSAY|MDRD FORMULA|Y||NA||3|Visit_3|40|5|WASHOUT|2020-11-07|2020-12-03|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|6|CCL17|Chemokine (C-C Motif) Ligand 17|URINALYSIS|||[?]|[?]|NEGATIVE|1|Enzyme U/g Hb|1|1|[?]|NORMAL|AQUEOUS HUMOR|LIPEMIC||POLYGRAPHY|MDRD 5 VARIABLE FORMULA|||Y|Y|3|Visit_3|40|2|TREATMENT|2020-11-07|2020-11-10|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|7|LYMPLLE|Plasmacytoid Lymphocytes/Leukocytes|CHEMISTRY|[?]|10^6 organisms/mg|[?]|[?]|NEGATIVE|1|CFU/mL|1|1|[?]|NORMAL|PROSTATIC FLUID|HEMOLYZED|N|THICK SMEAR|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|7|TREATMENT|2020-12-02|2021-01-05|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|8|CSWAX|Waxy Casts|HEMATOLOGY|[?]|IMPLANT|[?]|[?]|BORDERLINE|1|U/10^12 RBC|1|1|[?]|HIGH|PERSPIRATION|REFRIGERATED||HPLC/MS/MS|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|5|TREATMENT|2020-12-02|2020-12-16|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|9|HIST4AB|Histone 4 Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|ms2|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR||IMMUNOPRECIPITATION|FIBROMETER FORMULA|||Y|Y|5|Visit_5|90|5|SCREENING|2020-12-27|2020-12-29|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|10|MCH|Ery. Mean Corpuscular Hemoglobin|CHEMISTRY|[?]|CONTAINER|[?]|[?]|NEGATIVE|1|RATIO|1|1|[?]|LOW|MONOCYTE|CLOTTED|N|COLORIMETRY|COCKCROFT-GAULT FORMULA||Y|Y||5|Visit_5|90|2|TREATMENT|2020-12-27|2020-12-31|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|69e41d6b-57f7-48b0-be7a-29fca953f8d9|1|ADSDNA|Anti-Double Stranded DNA|HEMATOLOGY|[?]|pg|[?]|[?]|TRACE|1|10^4 CFU|1|1|[?]|ABNORMAL|LUNG SURFACTANT|HEMOLYZED|N|ORCHIDOMETERY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||1|Visit_1|10|3|TREATMENT|2020-10-28|2020-11-05|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|69e41d6b-57f7-48b0-be7a-29fca953f8d9|2|LDH5|LDH Isoenzyme 5|HEMATOLOGY|[?]|mL/cm3/min|[?]|[?]|INVALID|1|10^9 organisms/g|1|1|[?]|ABNORMAL|MUSCLE TISSUE|ICTERIC|N|BRDU CELLULAR PROLIFERATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||1|Visit_1|10|1|SCREENING|2020-10-28|2020-12-10|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|69e41d6b-57f7-48b0-be7a-29fca953f8d9|3|CD1|CD1|HEMATOLOGY|[?]|ug/m2/day|[?]|[?]|TRACE|1|Bq/ug|1|1|[?]|LOW|INFRANATANT, PLASMA|CONCENTRATED||HEMAGGLUTINATION INHIBITION ASSAY|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|4|FOLLOW-UP|2020-11-12|2020-12-16|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|69e41d6b-57f7-48b0-be7a-29fca953f8d9|4|LYMCLF|Lymphocytes, Clefted|URINALYSIS|[?]|tuberculin unit|[?]|[?]|BORDERLINE|1|CFU/g|1|1|[?]|HIGH|INTERSTITIAL FLUID|ROOM TEMPERATURE||CHROMOGENIC ASSAY|MDRD 6 VARIABLE FORMULA||Y|Y||2|Visit_2|25|1|TREATMENT|2020-11-12|2020-12-24|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|69e41d6b-57f7-48b0-be7a-29fca953f8d9|5|ZINC|Zinc|CHEMISTRY|[?]|ukat|[?]|[?]|INVALID|1|mL/(min*100mL)|1|1|[?]|HIGH|SWABBED MATERIAL|CONCENTRATED||POTENTIOMETRY|ASH FIBROSURE FORMULA||Y|U||3|Visit_3|40|7|TREATMENT|2020-11-27|2021-01-10|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|69e41d6b-57f7-48b0-be7a-29fca953f8d9|6|PC3MPSAM|PCA3 mRNA/PSA mRNA|CHEMISTRY|||[?]|[?]|BORDERLINE|1|INHALATION|1|1|[?]|LOW|PERITONEAL FLUID|NON-HEMOLYZED||MULTIPLE BREATH WASHOUT|GMI % FORMULA|||NA|Y|3|Visit_3|40|1|WASHOUT|2020-11-27|2020-12-17|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|69e41d6b-57f7-48b0-be7a-29fca953f8d9|7|XNTHCHR|Xanthochromia|CHEMISTRY|[?]|mg/kg/week|[?]|[?]|INVALID|1|APL U|1|1|[?]|NORMAL|VENOUS BLOOD|REFRIGERATED|N|ECHOCARDIOGRAPHY|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|5|WASHOUT|2020-12-22|2021-01-02|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|69e41d6b-57f7-48b0-be7a-29fca953f8d9|8|LYMLE|Lymphocytes/Leukocytes|URINALYSIS|[?]|kBq/uL|[?]|[?]|NEGATIVE|1|vg/kg|1|1|[?]|NORMAL|LOCHIA|PARAFFIN-EMBEDDED|N|CALCOFLUOR WHITE STAIN|MDRD FORMULA|||U||4|Visit_4|65|6|WASHOUT|2020-12-22|2020-12-25|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|69e41d6b-57f7-48b0-be7a-29fca953f8d9|9|IC512AB|Islet Cell 512 Antibody|CHEMISTRY|[?]|YEARS|[?]|[?]|NEGATIVE|1|mL/m2/day|1|1|[?]|NORMAL|PROSTATIC FLUID|THAWED||PULSE OXIMETRY|HEPASCORE FORMULA|||Y||5|Visit_5|90|5|WASHOUT|2021-01-16|2021-01-19|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|69e41d6b-57f7-48b0-be7a-29fca953f8d9|10|NAGCREAT|N-Acetyl Glucosamide/Creatinine|URINALYSIS|[?]|ft3|[?]|[?]|POSITIVE|1|pg|1|1|[?]|ABNORMAL|SEMINAL FLUID|THAWED||LANDOLT RING|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|1|WASHOUT|2021-01-16|2021-01-19|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|a38eb4fc-2422-4d4a-a435-58ae9bf42589|1|C147283|White Elm Pollen IgG Antibody|URINALYSIS|[?]|Joule|[?]|[?]|NEGATIVE|1|mL*cmH2O|1|1|[?]|LOW|MONOCYTE|HEMOLYZED|N|POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA|||Y||1|Visit_1|10|3|FOLLOW-UP|2020-11-23|2020-12-04|10|21|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|LB|a38eb4fc-2422-4d4a-a435-58ae9bf42589|2|RLP|RLP Cholesterol|URINALYSIS|[?]|mL/cm3/min|[?]|[?]|NEGATIVE|1|BOTTLE|1|1|[?]|HIGH|MUCUS|LIPEMIC||CONGO RED STAIN|FIBROTEST FORMULA|||Y||1|Visit_1|10|5|FOLLOW-UP|2020-11-23|2020-12-04|10|21|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|LB|a38eb4fc-2422-4d4a-a435-58ae9bf42589|3|CH50|Complement CH50|HEMATOLOGY|||[?]|[?]|TRACE|1|10^6 DNA copies/mL|1|1|[?]|HIGH|BONE MARROW|UNEXPECTED ODOR||APPLANATION TONOMETRY|NASH FIBROSURE FORMULA|||NA|Y|2|Visit_2|25|1|TREATMENT|2020-12-08|2021-02-03|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|a38eb4fc-2422-4d4a-a435-58ae9bf42589|4|FATACVLC|Fatty Acids, Very Long Chain|HEMATOLOGY|[?]|fmol|[?]|[?]|POSITIVE|1|mV*min|1|1|[?]|HIGH|CELL PELLET|PARAFFIN-EMBEDDED||CELLULAR PROLIFERATION ASSAY|CKD-EPI CYSTATIN C FORMULA|||N||2|Visit_2|25|4|SCREENING|2020-12-08|2020-12-24|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|a38eb4fc-2422-4d4a-a435-58ae9bf42589|5|PSAFPSAT|PSA, Free/PSA|CHEMISTRY|[?]|mL/sec/1.73m2|[?]|[?]|INVALID|1|IU/mg|1|1|[?]|ABNORMAL|LAVAGE FLUID|AGGLUTINATED||X-RAY|FIBROSIS 4 FORMULA|||U||3|Visit_3|40|4|SCREENING|2020-12-23|2021-01-02|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|a38eb4fc-2422-4d4a-a435-58ae9bf42589|6|FOLHMRNA|Folate Hydrolase mRNA|URINALYSIS|||[?]|[?]|NEGATIVE|1|dL|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED||LASER CAPTURE MICRODISSECTION|COCKCROFT-GAULT FORMULA|||U|Y|3|Visit_3|40|1|WASHOUT|2020-12-23|2021-02-10|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|a38eb4fc-2422-4d4a-a435-58ae9bf42589|7|MONOIMLE|Immature Monocytes/Leukocytes|CHEMISTRY|[?]|amp|[?]|[?]|POSITIVE|1|cm2|1|1|[?]|LOW|PROSTATIC FLUID|THAWED||ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|N||4|Visit_4|65|5|WASHOUT|2021-01-17|2021-02-02|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|a38eb4fc-2422-4d4a-a435-58ae9bf42589|8|INSAAB|Insulin Autoantibody|CHEMISTRY|[?]|SCOOPFUL|[?]|[?]|POSITIVE|1|Ci/L|1|1|[?]|LOW|URINE SEDIMENT|CONTAMINATED||CHROMOGENIC ASSAY|FIBROMETER FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2021-01-17|2021-01-20|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|a38eb4fc-2422-4d4a-a435-58ae9bf42589|9|INTLK11|Interleukin 11|CHEMISTRY|||[?]|[?]|TRACE|1|SACHET|1|1|[?]|NORMAL|AQUEOUS HUMOR|REFRIGERATED||COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD 5 VARIABLE FORMULA|||Y|Y|5|Visit_5|90|7|SCREENING|2021-02-11|2021-02-15|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|a38eb4fc-2422-4d4a-a435-58ae9bf42589|10|TGFB1|Transforming Growth Factor Beta 1|URINALYSIS|[?]|min|[?]|[?]|BORDERLINE|1|gpELISA unit/mL|1|1|[?]|HIGH|MUCUS|ROOM TEMPERATURE||BRDU CELLULAR PROLIFERATION ASSAY|GMI MMOL/MOL FORMULA||Y|U||5|Visit_5|90|6|SCREENING|2021-02-11|2021-02-13|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|1|PYK|Pyruvate Kinase|CHEMISTRY|[?]|10^9 organisms/mL|[?]|[?]|TRACE|1|DAYS|1|1|[?]|LOW|TUMOR TISSUE|LIPEMIC||RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||1|Visit_1|10|5|FOLLOW-UP|2020-09-26|2020-10-14|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|2|BAMBTAC|Beta-Aminobutyric Acid|URINALYSIS|[?]|CCID 50/mL|[?]|[?]|INVALID|1|RNA copies/mL|1|1|[?]|NORMAL|SPERMATOZOON|LIPEMIC||INFRARED SPECTROMETRY|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-09-26|2020-10-04|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|3|BLYCELE|B-Lymphocytes/Leukocytes|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|CIGARETTE|1|1|[?]|LOW|MONOCYTE|UNEXPECTED ODOR||MAPH|CKD-EPI CYSTATIN C FORMULA|||NA|Y|2|Visit_2|25|6|FOLLOW-UP|2020-10-11|2020-10-30|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|4|CD27|CD27|URINALYSIS|[?]|TCID 50/dose|[?]|[?]|NEGATIVE|1|Joule|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|CLOTTED||FREEZING POINT DEPRESSION|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|2|TREATMENT|2020-10-11|2020-12-17|25|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|5|PBG|Porphobilinogen|CHEMISTRY|||[?]|[?]|POSITIVE|1|ug/g/day|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|AUTOLYZED||DYNAMOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|3|WASHOUT|2020-10-26|2020-11-03|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|6|SOMATRO|Somatotrophin|URINALYSIS|[?]|cmHg|[?]|[?]|NEGATIVE|1|PFU/dose|1|1|[?]|LOW|CERUMEN|CALCIFIED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-10-26|2020-12-19|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|7|AMYLOIDA|Amyloid A|URINALYSIS|[?]|KALLIKREIN INHIBITOR UNIT|[?]|[?]|BORDERLINE|1|copies/ug|1|1|[?]|NORMAL|WHITE MATTER TISSUE|CONTAMINATED||ENZYMATIC COLORIMETRY|COCKCROFT-GAULT FORMULA|Y||Y||4|Visit_4|65|2|SCREENING|2020-11-20|2020-12-22|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|8|ALBCREAT|Albumin/Creatinine|CHEMISTRY|[?]|ft|[?]|[?]|POSITIVE|1|10^10/L|1|1|[?]|LOW|PROSTATIC FLUID|AGGLUTINATED|N|MASS SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||4|Visit_4|65|2|TREATMENT|2020-11-20|2020-12-17|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|9|APOA4|Apolipoprotein A4|URINALYSIS|[?]|mL|[?]|[?]|NEGATIVE|1|10^3 CFU|1|1|[?]|NORMAL|PLATELET|DRIED|N|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2020-12-15|2020-12-24|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|10|K|Potassium|CHEMISTRY|[?]|mg/dose|[?]|[?]|INDETERMINATE|1|mg/mL/day|1|1|[?]|LOW|SOFT TISSUE|HEMOLYZED||IMMUNODIFFUSION|MDRD 6 VARIABLE FORMULA|||U||5|Visit_5|90|5|TREATMENT|2020-12-15|2020-12-22|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|1|ALBC|Albumin Clearance|CHEMISTRY|[?]|Pa|[?]|[?]|POSITIVE|1|Log10 ELISA unit|1|1|[?]|ABNORMAL|PUS|CALCIFIED||LIQUID SCINTILLATION COUNTING|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|6|FOLLOW-UP|2021-01-01|2021-03-26|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|2|GLUCCRT|Glucose/Creatinine|HEMATOLOGY|[?]|BOLUS|[?]|[?]|BORDERLINE|1|CFU/g|1|1|[?]|HIGH|LUNG SURFACTANT|ICTERIC|N|POTENTIOMETRY|MDRD 6 VARIABLE FORMULA|Y||U||1|Visit_1|10|2|TREATMENT|2021-01-01|2021-03-04|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|3|BAFF|B-Cell Activating Factor|CHEMISTRY|[?]|DISK|[?]|[?]|NEGATIVE|1|10^8/L|1|1|[?]|LOW|KERATINOCYTE|ICTERIC||KLEIHAUER-BETKE|MDRD FORMULA||Y|U||2|Visit_2|25|2|TREATMENT|2021-01-16|2021-01-24|25|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|4|PMYCECE|Proliferating Myeloid Cells/Total Cells|CHEMISTRY|[?]|MONTHS|[?]|[?]|INDETERMINATE|1|dpm/mg|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|FRESH||PELLI-ROBSON EYE CHART|CKD-EPI CYSTATIN C FORMULA|Y||U||2|Visit_2|25|7|FOLLOW-UP|2021-01-16|2021-01-17|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|5|C130135|D. pteronyssinus Antigen IgG Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|L/s|1|1|[?]|ABNORMAL|NAIL|REFRIGERATED||MICRODENSITOMETRY|MDRD 4 VARIABLE FORMULA|Y||NA|Y|3|Visit_3|40|1|SCREENING|2021-01-31|2021-03-23|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|LB|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|6|FCTVIIIA|Factor VIII Activity|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|pmol/day|1|1|[?]|HIGH|MONOCYTE|PARAFFIN-EMBEDDED|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|3|Visit_3|40|6|FOLLOW-UP|2021-01-31|2021-03-13|40|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|LB|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|7|GNRH|Gonadotropin Releasing Hormone|HEMATOLOGY|||[?]|[?]|INVALID|1|mmol/g|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|FROZEN||MANUAL CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|4|Visit_4|65|3|WASHOUT|2021-02-25|2021-03-05|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|8|IGG4|Immunoglobulin G Subclass 4|URINALYSIS|[?]|copies/mL|[?]|[?]|INDETERMINATE|1|mPa|1|1|[?]|LOW|ENDOMETRIAL TISSUE|PARAFFIN-EMBEDDED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD 6 VARIABLE FORMULA|||Y||4|Visit_4|65|2|SCREENING|2021-02-25|2021-03-06|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|9|S6PHS|Phos-S6 Ribosomal Protein|HEMATOLOGY|[?]|10^9 organisms/g|[?]|[?]|TRACE|1|PATCH|1|1|[?]|HIGH|TISSUE|REFRIGERATED|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|5|FOLLOW-UP|2021-03-22|2021-03-27|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|LB|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|10|PHE|Phenylalanine|CHEMISTRY|[?]|KIT|[?]|[?]|TRACE|1|pmol/L|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|CLOTTED|N|CELL OF ORIGIN ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||5|Visit_5|90|6|TREATMENT|2021-03-22|2021-03-23|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|LB|dd518f55-0280-445d-a29f-10f09b21fd53|1|KYNURNN|Kynurenine|URINALYSIS|||[?]|[?]|NEGATIVE|1|dpm/mL|1|1|[?]|LOW|NAIL|LACTESCENT||HPLC|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|1|Visit_1|10|5|TREATMENT|2020-05-18|2020-06-08|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|LB|dd518f55-0280-445d-a29f-10f09b21fd53|2|CYSULFA|Sulfa Crystals|CHEMISTRY|[?]|10^3 organisms|[?]|[?]|BORDERLINE|1|mL/h|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|LIPEMIC||CELL BASED BIOASSAY|COCKCROFT-GAULT FORMULA|Y|Y|N||1|Visit_1|10|1|WASHOUT|2020-05-18|2020-06-29|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|LB|dd518f55-0280-445d-a29f-10f09b21fd53|3|AMYLOIDA|Amyloid A|URINALYSIS|[?]|ug/h|[?]|[?]|INVALID|1|mg/L|1|1|[?]|ABNORMAL|PERITONEAL FLUID|NON-HEMOLYZED|N|PYROSEQUENCING|MDRD FORMULA|||U||2|Visit_2|25|2|FOLLOW-UP|2020-06-02|2020-08-10|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-27
e|LB|dd518f55-0280-445d-a29f-10f09b21fd53|4|CYSTHION|Cystathionine|HEMATOLOGY|[?]|mol/day|[?]|[?]|TRACE|1|mg/dL|1|1|[?]|LOW|ENDOMETRIAL TISSUE|CALCIFIED||ELECTROCHEMILUMINESCENCE|MDRD FORMULA|||N||2|Visit_2|25|3|WASHOUT|2020-06-02|2020-08-04|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-27
e|LB|dd518f55-0280-445d-a29f-10f09b21fd53|5|C165913|Nut Mix IgG AB RAST Score|URINALYSIS|[?]|days/wk|[?]|[?]|INDETERMINATE|1|/40 HPFs|1|1|[?]|HIGH|EMOTIONAL TEAR|PARAFFIN-EMBEDDED||APPLANATION TONOMETRY|HEPASCORE FORMULA|||NA||3|Visit_3|40|2|TREATMENT|2020-06-17|2020-07-14|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|dd518f55-0280-445d-a29f-10f09b21fd53|6|CACRALB|Calcium Corrected for Albumin|URINALYSIS|[?]|Antibody Unit|[?]|[?]|NEGATIVE|1|mmHg/L/min|1|1|[?]|ABNORMAL|LYMPH|GELLED||SPECT SCAN|ASH FIBROSURE FORMULA|Y||N||3|Visit_3|40|2|TREATMENT|2020-06-17|2020-06-22|40|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|dd518f55-0280-445d-a29f-10f09b21fd53|7|MCV|Ery. Mean Corpuscular Volume|HEMATOLOGY|[?]|copies/ug|[?]|[?]|INDETERMINATE|1|DISK|1|1|[?]|ABNORMAL|MONOCYTE|NON-HEMOLYZED||FUNDUS PHOTOGRAPHY|COCKCROFT-GAULT FORMULA|Y||U||4|Visit_4|65|5|TREATMENT|2020-07-12|2020-07-23|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|dd518f55-0280-445d-a29f-10f09b21fd53|8|NSE|Neuron Specific Enolase|CHEMISTRY|[?]|RFU|[?]|[?]|INVALID|1|CYLINDER|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|CALCIFIED|N|SPIROMETRY|MDRD 4 VARIABLE FORMULA||Y|U||4|Visit_4|65|3|FOLLOW-UP|2020-07-12|2020-08-03|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|dd518f55-0280-445d-a29f-10f09b21fd53|9|GLY|Glycine|CHEMISTRY|[?]|TAMPON|[?]|[?]|BORDERLINE|1|log10 TCID 50/uL|1|1|[?]|NORMAL|TUMOR TISSUE|REFRIGERATED|N|MAMMOGRAPHY|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-08-06|2020-08-12|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|dd518f55-0280-445d-a29f-10f09b21fd53|10|C130131|Dog Dander Antigen IgG4 Antibody|HEMATOLOGY|[?]|C|[?]|[?]|TRACE|1|/10^3|1|1|[?]|NORMAL|SERUM|DRIED||NUCLEIC ACID BASED METHOD|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|6|SCREENING|2020-08-06|2020-08-09|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|49a972da-dfad-438e-b5bc-26ee6b955a59|1|PLAGMAMP|Platelet Aggregation Mean Amplitude|URINALYSIS|||[?]|[?]|POSITIVE|1|Ci/L|1|1|[?]|HIGH|PLATELET RICH PLASMA|NON-HEMOLYZED||PULSE OXIMETRY|MDRD FORMULA|||Y|Y|1|Visit_1|10|6|FOLLOW-UP|2020-06-24|2020-06-26|10|12|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|49a972da-dfad-438e-b5bc-26ee6b955a59|2|C165912|Shellfish Mix IgG AB RAST Score|HEMATOLOGY|||[?]|[?]|TRACE|1|nL|1|1|[?]|HIGH|EMOTIONAL TEAR|LACTESCENT||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD ENZYMATIC FORMULA|||N|Y|1|Visit_1|10|5|TREATMENT|2020-06-24|2020-07-13|10|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|49a972da-dfad-438e-b5bc-26ee6b955a59|3|PTHMM|Parathyroid Hormone, Mid-Molecule|URINALYSIS|[?]|V|[?]|[?]|BORDERLINE|1|DISK|1|1|[?]|LOW|ENDOMETRIAL TISSUE|CLOTTED||WESTERN BLOT|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-07-09|2020-09-08|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|49a972da-dfad-438e-b5bc-26ee6b955a59|4|PEPSNG|Pepsinogen|HEMATOLOGY|[?]|log10 copies/mL|[?]|[?]|TRACE|1|/200 HPFs|1|1|[?]|NORMAL|CAPILLARY BLOOD|GELLED||CYSTOMETRY|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|1|WASHOUT|2020-07-09|2020-07-29|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|49a972da-dfad-438e-b5bc-26ee6b955a59|5|PROPOX|Propoxyphene|HEMATOLOGY|[?]|TABLET|[?]|[?]|BORDERLINE|1|PATCH|1|1|[?]|NORMAL|PLASMA|PARAFFIN-EMBEDDED||ELLA|HEPASCORE FORMULA|||U||3|Visit_3|40|5|WASHOUT|2020-07-24|2020-08-07|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|49a972da-dfad-438e-b5bc-26ee6b955a59|6|COCAINE|Cocaine|HEMATOLOGY|[?]|mg/dose|[?]|[?]|POSITIVE|1|mm/min|1|1|[?]|HIGH|URINE|SOLIDIFIED||CHROMOGENIC ASSAY|HEPASCORE FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-07-24|2020-09-20|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|49a972da-dfad-438e-b5bc-26ee6b955a59|7|IFNG|Interferon Gamma|CHEMISTRY|||[?]|[?]|BORDERLINE|1|nmol/mol|1|1|[?]|NORMAL|CAPILLARY BLOOD|HEMOLYZED||RADIATION DOSIMETRY|GMI % FORMULA|Y||N|Y|4|Visit_4|65|7|SCREENING|2020-08-18|2020-09-15|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|49a972da-dfad-438e-b5bc-26ee6b955a59|8|MYBLALE|Myeloblasts/Leukocytes|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mm/sec|1|1|[?]|ABNORMAL|TUMOR TISSUE|HEMOLYZED|N|OPHTHALMOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|4|Visit_4|65|4|SCREENING|2020-08-18|2020-09-15|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|49a972da-dfad-438e-b5bc-26ee6b955a59|9|MLR|Mixed Lymphocyte Reaction|HEMATOLOGY|[?]|ug/kg/min|[?]|[?]|POSITIVE|1|g/m2/day|1|1|[?]|HIGH|VITREOUS HUMOR|ICTERIC|N|DOUBLE IMMUNODIFFUSION|FIBROMETER FORMULA|||NA||5|Visit_5|90|6|FOLLOW-UP|2020-09-12|2020-09-16|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|49a972da-dfad-438e-b5bc-26ee6b955a59|10|DHT|Dihydrotestosterone|CHEMISTRY|[?]|ug/kg/day|[?]|[?]|TRACE|1|Roentgen|1|1|[?]|NORMAL|BREAST MILK|CALCIFIED||CELL BASED BIOASSAY|HEPASCORE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-09-12|2020-09-17|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|502a42a7-2ed6-46b9-9b10-728f849334b6|1|FATACVLC|Fatty Acids, Very Long Chain|HEMATOLOGY|[?]|vg/dose|[?]|[?]|POSITIVE|1|/2000 RBC|1|1|[?]|ABNORMAL|PLEURAL FLUID|CONTAMINATED||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|NASH FIBROSURE FORMULA|Y|Y|N||1|Visit_1|10|5|TREATMENT|2020-11-21|2021-02-15|10|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|502a42a7-2ed6-46b9-9b10-728f849334b6|2|GADAB|Glutamic Acid Decarboxylase Antibody|HEMATOLOGY|[?]|U/dL|[?]|[?]|NEGATIVE|1|/VF|1|1|[?]|HIGH|LUNG SURFACTANT|DRIED||MIGET|FIBROMETER FORMULA|||Y||1|Visit_1|10|2|WASHOUT|2020-11-21|2021-01-24|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|502a42a7-2ed6-46b9-9b10-728f849334b6|3|WBCDIFF|Leukocyte Cell Differential|CHEMISTRY|[?]|mmol|[?]|[?]|BORDERLINE|1|ugEq|1|1|[?]|HIGH|LEUKOCYTE|LACTESCENT|N|FLUORESCENT IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|1|FOLLOW-UP|2020-12-06|2020-12-24|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|502a42a7-2ed6-46b9-9b10-728f849334b6|4|CCPAB|Cyclic Citrullinated Peptide Antibody|URINALYSIS|[?]|K|[?]|[?]|NEGATIVE|1|Gy/min|1|1|[?]|LOW|MUSCLE TISSUE|DRIED||FLOCCULATION, CHARCOAL ENHANCED|NASH FIBROSURE FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-12-06|2021-01-15|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|502a42a7-2ed6-46b9-9b10-728f849334b6|5|CRYGLBSR|Cryoglobulin Volume/Serum Volume|HEMATOLOGY|[?]|mV2/Hz|[?]|[?]|INVALID|1|10^3 organisms/mL|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|CONCENTRATED||MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-12-21|2021-01-07|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|LB|502a42a7-2ed6-46b9-9b10-728f849334b6|6|DSVLFXN|Desvenlafaxine|HEMATOLOGY|[?]|mEq/day|[?]|[?]|POSITIVE|1|vp/mL|1|1|[?]|ABNORMAL|MONOCYTE|CLOTTED||NEXT GENERATION TARGETED SEQUENCING|CKD-EPI CREATININE FORMULA||Y|U||3|Visit_3|40|2|FOLLOW-UP|2020-12-21|2021-02-07|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|LB|502a42a7-2ed6-46b9-9b10-728f849334b6|7|IL122340|Interleukin 12+23 p40|URINALYSIS|[?]|mL/cage/day|[?]|[?]|NEGATIVE|1|10^4 CFU/mL|1|1|[?]|NORMAL|TISSUE|CONCENTRATED||DROPLET DIGITAL PCR|NASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|2|TREATMENT|2021-01-15|2021-02-01|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|502a42a7-2ed6-46b9-9b10-728f849334b6|8|FIBRINOF|Fibrinogen, Functional|HEMATOLOGY|[?]|Rad|[?]|[?]|NEGATIVE|1|DRUM|1|1|[?]|LOW|INTERSTITIAL FLUID|NON-HEMOLYZED|N|FARR ASSAY|HEPASCORE FORMULA|||U||4|Visit_4|65|5|TREATMENT|2021-01-15|2021-01-21|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|502a42a7-2ed6-46b9-9b10-728f849334b6|9|ATP|Adenosine Triphosphate|URINALYSIS|[?]|VOXEL|[?]|[?]|BORDERLINE|1|U/kg/min|1|1|[?]|HIGH|URINE SEDIMENT|FRESH||REVERSE TRANSCRIPTASE PCR|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2021-02-09|2021-02-15|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|LB|502a42a7-2ed6-46b9-9b10-728f849334b6|10|CXCL12|Chemokine (C-X-C Motif) Ligand 12|CHEMISTRY|[?]|mg/dL|[?]|[?]|POSITIVE|1|SUPPOSITORY|1|1|[?]|NORMAL|KERATINOCYTE|THAWED||CELL BASED BIOASSAY|CKD-EPI CYSTATIN C FORMULA||Y|Y||5|Visit_5|90|3|TREATMENT|2021-02-09|2021-02-10|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|LB|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|1|ISG15|Ubiquitin-Like Protein ISG15|URINALYSIS|[?]|um2|[?]|[?]|INVALID|1|kat|1|1|[?]|HIGH|EPITHELIAL CELL|REFRIGERATED||FLOCCULATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||1|Visit_1|10|3|FOLLOW-UP|2020-10-26|2020-11-28|10|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|2|ANAIGGAB|Antinuclear IgG Antibody|CHEMISTRY|[?]|dpm/0.5 mL|[?]|[?]|INVALID|1|pmol|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED||PUPILLOMETRY|MDRD FORMULA|Y||N||1|Visit_1|10|3|WASHOUT|2020-10-26|2020-12-09|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|3|ALDOLASE|Aldolase|CHEMISTRY|[?]|U/mg|[?]|[?]|TRACE|1|mL/mmHg|1|1|[?]|ABNORMAL|PLATELET|CONCENTRATED||POTENTIOMETRY|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-11-10|2020-11-28|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|4|HGBS|Hemoglobin S|CHEMISTRY|[?]|Bq/ug|[?]|[?]|INVALID|1|ppm|1|1|[?]|HIGH|DERMAL TISSUE|DRIED|N|SPIRAL CT SCAN WITHOUT CONTRAST|GMI % FORMULA||Y|U||2|Visit_2|25|2|TREATMENT|2020-11-10|2020-11-20|25|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|5|TIMP3|Tissue Inhibitor of Metalloproteinase 3|HEMATOLOGY|[?]|ft2|[?]|[?]|TRACE|1|Ci/mg|1|1|[?]|ABNORMAL|LEUKOCYTE|LIPEMIC||MAMMOGRAPHY|MDRD ENZYMATIC FORMULA||Y|NA||3|Visit_3|40|6|TREATMENT|2020-11-25|2020-12-04|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|6|GFRBSCRT|GFR from Creatinine Adjusted for BSA|CHEMISTRY|[?]|mV*min|[?]|[?]|NEGATIVE|1|log10 CFU/g|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|PARAFFIN-EMBEDDED||SISH|HEPASCORE FORMULA||Y|N||3|Visit_3|40|7|TREATMENT|2020-11-25|2021-01-04|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|7|VEGFR2S|Soluble Vasc Endoth Growth Factor Rec2|CHEMISTRY|[?]|umol/min|[?]|[?]|INVALID|1|EP U|1|1|[?]|LOW|CIRCULATING TUMOR CELL|CONCENTRATED||BALLPOINT PEN TECHNIQUE|HEPASCORE FORMULA||Y|Y||4|Visit_4|65|7|SCREENING|2020-12-20|2021-01-16|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|8|OAS3|2-5-Oligoadenylate Synthase 3|HEMATOLOGY|[?]|AU/mL|[?]|[?]|NEGATIVE|1|nmol/L/min|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|HEMOLYZED||FLUORESCENCE ANGIOGRAPHY|CKD-EPI CREATININE FORMULA|Y||NA||4|Visit_4|65|7|FOLLOW-UP|2020-12-20|2021-01-19|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|9|ERCEPPOL|Erythroid Proliferation Pool|CHEMISTRY|[?]|log EID 50/dose|[?]|[?]|TRACE|1|IMPLANT|1|1|[?]|ABNORMAL|LYSATE|LACTESCENT||PLETHYSMOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||5|Visit_5|90|6|TREATMENT|2021-01-14|2021-01-22|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|10|ERCEMPOL|Erythroid Maturation Pool|HEMATOLOGY|[?]|PHERESIS UNIT|[?]|[?]|TRACE|1|g/L|1|1|[?]|LOW|REFLEX TEAR|FROZEN|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI FORMULA|||U||5|Visit_5|90|7|SCREENING|2021-01-14|2021-01-16|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|40c048ea-d637-426b-8afe-2da3a6961528|1|NORNCTN|Nornicotine|CHEMISTRY|[?]|kDa|[?]|[?]|BORDERLINE|1|um/day|1|1|[?]|NORMAL|ARTERIAL BLOOD|CALCIFIED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|U||1|Visit_1|10|1|TREATMENT|2020-07-13|2020-08-21|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|40c048ea-d637-426b-8afe-2da3a6961528|2|VEGFD|Vascular Endothelial Growth Factor D|CHEMISTRY|[?]|BAU|[?]|[?]|BORDERLINE|1|DPM|1|1|[?]|NORMAL|LOCHIA|HEMOLYZED||ULTRASOUND|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||1|Visit_1|10|1|WASHOUT|2020-07-13|2020-09-09|10|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|40c048ea-d637-426b-8afe-2da3a6961528|3|V25HD3|25-Hydroxyvitamin D3|CHEMISTRY|[?]|ug/animal|[?]|[?]|INVALID|1|mL/day|1|1|[?]|LOW|MONOCYTE|LIPEMIC||VENTILATION PERFUSION LUNG SCAN|MDRD FORMULA|||U||2|Visit_2|25|3|SCREENING|2020-07-28|2020-08-16|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|40c048ea-d637-426b-8afe-2da3a6961528|4|PF2AI8CR|8-Iso-PGF2alpha/Creatinine|URINALYSIS|[?]|IU/mL|[?]|[?]|INDETERMINATE|1|mCi|1|1|[?]|NORMAL|SWABBED MATERIAL|SOLIDIFIED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD ENZYMATIC FORMULA||Y|U||2|Visit_2|25|2|WASHOUT|2020-07-28|2020-08-26|25|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|40c048ea-d637-426b-8afe-2da3a6961528|5|PSP100AB|P100 Polymyositis-scleroderma Autoag Ab|URINALYSIS|[?]|10^9 CFU/g|[?]|[?]|INVALID|1|mV|1|1|[?]|HIGH|HAIR|CALCIFIED|N|URANYL ACETATE STAIN|HEPASCORE FORMULA|||NA||3|Visit_3|40|3|WASHOUT|2020-08-12|2020-09-27|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|40c048ea-d637-426b-8afe-2da3a6961528|6|T4|Thyroxine|URINALYSIS|[?]|min/day|[?]|[?]|POSITIVE|1|uEq/L|1|1|[?]|LOW|DIALYSIS FLUID|SOLIDIFIED||CONTRAST ENHANCED X-RAY|FIBROTEST FORMULA|Y||Y||3|Visit_3|40|7|WASHOUT|2020-08-12|2020-09-14|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|40c048ea-d637-426b-8afe-2da3a6961528|7|ANTHRMAG|Antithrombin Antigen|HEMATOLOGY|[?]|ug/animal|[?]|[?]|NEGATIVE|1|mL/g/min|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|LACTESCENT||CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||4|Visit_4|65|5|FOLLOW-UP|2020-09-06|2020-09-13|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|40c048ea-d637-426b-8afe-2da3a6961528|8|APOB|Apolipoprotein B|CHEMISTRY|[?]|10^9 organisms/g|[?]|[?]|INDETERMINATE|1|KALLIKREIN INHIBITOR UNIT|1|1|[?]|LOW|DIALYSIS FLUID|GELLED||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|FIBROSIS 4 FORMULA|Y|Y|N||4|Visit_4|65|3|TREATMENT|2020-09-06|2020-10-10|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|40c048ea-d637-426b-8afe-2da3a6961528|9|VAL|Valine|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|AgU/mL|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|GELLED||SLIT LAMP PHOTOGRAPHY|GMI % FORMULA|||N|Y|5|Visit_5|90|5|WASHOUT|2020-10-01|2020-10-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|40c048ea-d637-426b-8afe-2da3a6961528|10|FACTXI|Factor XI|HEMATOLOGY|[?]|/10^5|[?]|[?]|POSITIVE|1|ug/kg/h|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|THAWED|N|WHOLE TRANSCRIPTOME SEQUENCING|MDRD 5 VARIABLE FORMULA|Y||NA||5|Visit_5|90|1|WASHOUT|2020-10-01|2020-10-07|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|4d03b209-bd53-47f5-8251-f9fb2074bc38|1|GGTEXR|GammaGlutamyl Transferase Excretion Rate|CHEMISTRY|[?]|BEAM BREAKS|[?]|[?]|BORDERLINE|1|mL/min/mmHg|1|1|[?]|ABNORMAL|EXPIRED AIR|THAWED||DISK DIFFUSION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||1|Visit_1|10|4|TREATMENT|2021-01-02|2021-03-06|10|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|4d03b209-bd53-47f5-8251-f9fb2074bc38|2|C165938|Cow Milk Protein IgE AB RAST Score|CHEMISTRY|[?]|log10 TCID 50/dose|[?]|[?]|INDETERMINATE|1|nmol/mL/min|1|1|[?]|HIGH|CALCULUS|UNEXPECTED ODOR||MANUAL CLOT DETECTION|COCKCROFT-GAULT FORMULA|Y||U||1|Visit_1|10|5|TREATMENT|2021-01-02|2021-01-21|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|4d03b209-bd53-47f5-8251-f9fb2074bc38|3|TAT|Thrombin/Antithrombin|URINALYSIS|[?]|uEq|[?]|[?]|TRACE|1|nkat|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|CONTAMINATED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD 6 VARIABLE FORMULA||Y|N||2|Visit_2|25|2|TREATMENT|2021-01-17|2021-03-21|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|LB|4d03b209-bd53-47f5-8251-f9fb2074bc38|4|BLISTCE|Blister Cell|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mmAL|1|1|[?]|HIGH|BASAL TEAR|CALCIFIED|N|QUANTITATIVE ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2021-01-17|2021-02-22|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|LB|4d03b209-bd53-47f5-8251-f9fb2074bc38|5|APLIGGAB|Anti-Phospholipid IgG Antibody|HEMATOLOGY|[?]|beats/min|[?]|[?]|INVALID|1|ukat/L|1|1|[?]|ABNORMAL|ERYTHROCYTES|ICTERIC||ISHIHARA COLOR PLATES|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|4|TREATMENT|2021-02-01|2021-03-15|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|4d03b209-bd53-47f5-8251-f9fb2074bc38|6|HLADRAGT|HLA-DR Antigen Type|URINALYSIS|||[?]|[?]|NEGATIVE|1|Torr|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|UNEXPECTED ODOR||LIGHT SCATTERING SPECTROSCOPY|HEPASCORE FORMULA||Y|N|Y|3|Visit_3|40|5|WASHOUT|2021-02-01|2021-03-05|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|4d03b209-bd53-47f5-8251-f9fb2074bc38|7|CACR|Calcium Corrected|CHEMISTRY|[?]|U/mg|[?]|[?]|INVALID|1|DNA copies/mL|1|1|[?]|NORMAL|LAVAGE FLUID|GELLED|N|SNP ARRAY|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|1|TREATMENT|2021-02-26|2021-03-29|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|LB|4d03b209-bd53-47f5-8251-f9fb2074bc38|8|DNPSEPHD|D-Norpseudoephedrine|CHEMISTRY|||[?]|[?]|INVALID|1|PIXELS/in|1|1|[?]|HIGH|SALIVA|NON-HEMOLYZED||SNELLEN EYE CHART|CKD-EPI FORMULA|Y||NA|Y|4|Visit_4|65|4|SCREENING|2021-02-26|2021-03-22|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|LB|4d03b209-bd53-47f5-8251-f9fb2074bc38|9|DPD|Deoxypyridinoline|HEMATOLOGY|[?]|IU|[?]|[?]|NEGATIVE|1|Bq/mg|1|1|[?]|ABNORMAL|PUS|GELLED||ANTIMICROBIAL COMBINATION TESTING|FIBROTEST FORMULA|||U||5|Visit_5|90|5|FOLLOW-UP|2021-03-23|2021-03-29|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|4d03b209-bd53-47f5-8251-f9fb2074bc38|10|LYMATLE|Lymphocytes Atypical/Leukocytes|HEMATOLOGY|[?]|log10 CCID 50/dose|[?]|[?]|INVALID|1|mL/cage/wk|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED||DXA SCAN|FIBROTEST FORMULA|||U||5|Visit_5|90|4|FOLLOW-UP|2021-03-23|2021-03-24|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|35f01eda-1acb-4700-8285-c8cd4b69b524|1|PGF2A|Prostaglandin F2 Alpha|HEMATOLOGY|[?]|um/day|[?]|[?]|TRACE|1|ELISA unit/mL|1|1|[?]|NORMAL|BONE MARROW|CONCENTRATED||HIGH RESOLUTION MELT ANALYSIS|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-09-30|2020-11-06|10|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|35f01eda-1acb-4700-8285-c8cd4b69b524|2|LDH|Lactate Dehydrogenase|HEMATOLOGY|[?]|BOX|[?]|[?]|BORDERLINE|1|log10 PFU|1|1|[?]|NORMAL|GASTRIC CONTENTS|CONTAMINATED||COMPLEMENT FIXATION|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-09-30|2020-11-20|10|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|35f01eda-1acb-4700-8285-c8cd4b69b524|3|ELLIPCY|Elliptocytes|CHEMISTRY|[?]|DISK|[?]|[?]|TRACE|1|Ci/kg|1|1|[?]|LOW|ENDOMETRIAL TISSUE|HEMOLYZED||DOUBLE IMMUNODIFFUSION|MDRD ENZYMATIC FORMULA||Y|N||2|Visit_2|25|1|TREATMENT|2020-10-15|2020-12-12|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|35f01eda-1acb-4700-8285-c8cd4b69b524|4|ANGTNSGN|Angiotensinogen|URINALYSIS|[?]|cycle/min|[?]|[?]|BORDERLINE|1|U/g/min|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|CALCIFIED|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||2|Visit_2|25|7|FOLLOW-UP|2020-10-15|2020-12-12|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|35f01eda-1acb-4700-8285-c8cd4b69b524|5|EPITUCE|Tubular Epithelial Cells|CHEMISTRY|[?]|mL/day|[?]|[?]|BORDERLINE|1|mL/(min*100mL)|1|1|[?]|NORMAL|CORD BLOOD|NON-HEMOLYZED||U-HPLC/MS/MS|MDRD FORMULA|Y||NA||3|Visit_3|40|2|TREATMENT|2020-10-30|2020-11-07|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|LB|35f01eda-1acb-4700-8285-c8cd4b69b524|6|CD5|CD5|URINALYSIS|||[?]|[?]|BORDERLINE|1|kV|1|1|[?]|ABNORMAL|SPUTUM|ROOM TEMPERATURE|N|POLYSOMNOGRAPHY|MDRD FORMULA|Y||Y|Y|3|Visit_3|40|7|TREATMENT|2020-10-30|2020-11-21|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|LB|35f01eda-1acb-4700-8285-c8cd4b69b524|7|PHE|Phenylalanine|HEMATOLOGY|[?]|/2500 WBC|[?]|[?]|POSITIVE|1|g/animal/wk|1|1|[?]|HIGH|VENOUS CORD BLOOD|THAWED||GRAM STAIN|NASH FIBROSURE FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2020-11-24|2020-11-30|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|35f01eda-1acb-4700-8285-c8cd4b69b524|8|ACRNCRNF|Acylcarnitine/Carnitine, Free|URINALYSIS|||[?]|[?]|POSITIVE|1|CUP|1|1|[?]|HIGH|CORD BLOOD|CLOTTED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|GMI MMOL/MOL FORMULA|||U|Y|4|Visit_4|65|2|WASHOUT|2020-11-24|2020-12-05|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|35f01eda-1acb-4700-8285-c8cd4b69b524|9|C147282|White Oak Pollen IgE Antibody|HEMATOLOGY|[?]|mEq/g|[?]|[?]|POSITIVE|1|lx|1|1|[?]|NORMAL|LOCHIA|HEMOLYZED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA|||N||5|Visit_5|90|7|WASHOUT|2020-12-19|2020-12-22|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|35f01eda-1acb-4700-8285-c8cd4b69b524|10|APOJ|Apolipoprotein J|HEMATOLOGY|||[?]|[?]|TRACE|1|U/g|1|1|[?]|LOW|MENSTRUAL BLOOD|CALCIFIED||KLEIHAUER-BETKE|CKD-EPI FORMULA|Y||N|Y|5|Visit_5|90|7|TREATMENT|2020-12-19|2020-12-22|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|9df97277-7d07-4020-bae0-dfa982f21c8d|1|C147277|Triticum aestivum Antigen IgE Antibody|CHEMISTRY|||[?]|[?]|POSITIVE|1|10^3 CFU|1|1|[?]|HIGH|INFRANATANT, SERUM|FROZEN||CYSTOMETRY|MDRD 6 VARIABLE FORMULA|||N|Y|1|Visit_1|10|1|WASHOUT|2020-11-02|2020-12-02|10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|9df97277-7d07-4020-bae0-dfa982f21c8d|2|C165899|Silver Birch Pollen IgG AB RAST Score|URINALYSIS|[?]|Gy|[?]|[?]|NEGATIVE|1|Linear ft*LB|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|AGGLUTINATED||MICROBIAL CULTURE|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|NA||1|Visit_1|10|5|FOLLOW-UP|2020-11-02|2021-01-05|10|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|9df97277-7d07-4020-bae0-dfa982f21c8d|3|CARNITF|Carnitine, Free|CHEMISTRY|[?]|pmol/day|[?]|[?]|TRACE|1|mCi/L|1|1|[?]|HIGH|STOOL|CONTAMINATED||PET/CT SCAN|FIBROMETER FORMULA||Y|U||2|Visit_2|25|7|TREATMENT|2020-11-17|2020-12-03|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|9df97277-7d07-4020-bae0-dfa982f21c8d|4|DOPAMINE|Dopamine|HEMATOLOGY|[?]|m2|[?]|[?]|TRACE|1|nmol/L|1|1|[?]|LOW|PERITONEAL FLUID|CALCIFIED|N|ELECTROCHEMILUMINESCENCE|HEPASCORE FORMULA|Y||U||2|Visit_2|25|1|TREATMENT|2020-11-17|2021-01-28|25|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|9df97277-7d07-4020-bae0-dfa982f21c8d|5|INTLK5|Interleukin 5|HEMATOLOGY|||[?]|[?]|INVALID|1|DROP|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|REFRIGERATED|N|TRANSMISSION ELECTRON MICROSCOPY|MDRD ENZYMATIC FORMULA||Y|U|Y|3|Visit_3|40|1|TREATMENT|2020-12-02|2021-01-17|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|9df97277-7d07-4020-bae0-dfa982f21c8d|6|PCSK9|Proprotein Convertase Subtilisin/Kexin 9|URINALYSIS|[?]|Henry|[?]|[?]|TRACE|1|hPa|1|1|[?]|HIGH|BONE MARROW|CONTAMINATED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROMETER FORMULA|||Y||3|Visit_3|40|1|FOLLOW-UP|2020-12-02|2020-12-19|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|9df97277-7d07-4020-bae0-dfa982f21c8d|7|HRYCELY|Hairy Cells/Lymphocytes|CHEMISTRY|[?]|kPa/L/sec|[?]|[?]|POSITIVE|1|s*kPa|1|1|[?]|ABNORMAL|EPITHELIAL CELL|FROZEN||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|NASH FIBROSURE FORMULA||Y|N||4|Visit_4|65|6|FOLLOW-UP|2020-12-27|2020-12-30|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|9df97277-7d07-4020-bae0-dfa982f21c8d|8|AMYLB42|Amyloid Beta 1-42|HEMATOLOGY|[?]|mg/kg/week|[?]|[?]|TRACE|1|uOsm|1|1|[?]|HIGH|PLATELET|GELLED|N|DIGITAL PCR|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-12-27|2021-01-21|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|9df97277-7d07-4020-bae0-dfa982f21c8d|9|C165932|Dog Dander IgE AB RAST Score|CHEMISTRY|||[?]|[?]|POSITIVE|1|SUPPOSITORY|1|1|[?]|LOW|CORD SERUM|UNEXPECTED ODOR||NUCLEIC ACID BASED METHOD|CKD-EPI FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2021-01-21|2021-01-27|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|9df97277-7d07-4020-bae0-dfa982f21c8d|10|CD4CD8|CD4/CD8|HEMATOLOGY|[?]|BOWL|[?]|[?]|INDETERMINATE|1|nmol/day|1|1|[?]|NORMAL|SYNOVIAL FLUID|LACTESCENT||FLAME PHOTOMETRY|MDRD 5 VARIABLE FORMULA|||U||5|Visit_5|90|7|SCREENING|2021-01-21|2021-01-25|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|d1b522d5-557a-4361-a9da-292aa601fbc3|1|IFNB|Interferon Beta|URINALYSIS|||[?]|[?]|INDETERMINATE|1|%(w/w)|1|1|[?]|HIGH|ALVEOLAR AIR|REFRIGERATED|N|IODINE STAIN|ASH FIBROSURE FORMULA|||N|Y|1|Visit_1|10|3|FOLLOW-UP|2020-10-09|2020-12-07|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|d1b522d5-557a-4361-a9da-292aa601fbc3|2|ANCAB|Anti-Neutrophil Cytoplasmic Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mV|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|GELLED||DARK FIELD MICROSCOPY|MDRD 5 VARIABLE FORMULA||Y|N|Y|1|Visit_1|10|7|TREATMENT|2020-10-09|2020-11-02|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|d1b522d5-557a-4361-a9da-292aa601fbc3|3|ALBC|Albumin Clearance|URINALYSIS|||[?]|[?]|TRACE|1|damol/L|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|LIPEMIC|N|LINE PROBE ASSAY|CKD-EPI FORMULA|Y||Y|Y|2|Visit_2|25|3|TREATMENT|2020-10-24|2021-01-02|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|d1b522d5-557a-4361-a9da-292aa601fbc3|4|PSELECT|P-Selectin|HEMATOLOGY|[?]|mL*cmH2O|[?]|[?]|BORDERLINE|1|IU/day|1|1|[?]|NORMAL|BILE|LIPEMIC||OPTICAL DENSITY MEASUREMENT|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-10-24|2020-10-29|25|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|d1b522d5-557a-4361-a9da-292aa601fbc3|5|PDW|Platelet Distribution Width|CHEMISTRY|[?]|ng/day|[?]|[?]|BORDERLINE|1|Hz|1|1|[?]|NORMAL|PERSPIRATION|LIPEMIC||BALLPOINT PEN TECHNIQUE|MDRD 4 VARIABLE FORMULA|Y||N||3|Visit_3|40|3|TREATMENT|2020-11-08|2020-12-17|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|d1b522d5-557a-4361-a9da-292aa601fbc3|6|LYS|Lysine|HEMATOLOGY|[?]|DRINK|[?]|[?]|BORDERLINE|1|lx|1|1|[?]|NORMAL|PLATELET POOR PLASMA|REFRIGERATED||PULSE OXIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|5|FOLLOW-UP|2020-11-08|2020-11-09|40|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|d1b522d5-557a-4361-a9da-292aa601fbc3|7|PG|Prostaglandin|URINALYSIS|[?]|mL/beat|[?]|[?]|NEGATIVE|1|mg/kg/min|1|1|[?]|LOW|VITREOUS HUMOR|CONTAMINATED|N|DUCTOGRAPHY|HEPASCORE FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2020-12-03|2020-12-21|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|d1b522d5-557a-4361-a9da-292aa601fbc3|8|GLYCRL|Glycerol|HEMATOLOGY|[?]|mg/L FEU|[?]|[?]|INVALID|1|U/g/day|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|LACTESCENT||FLAME PHOTOMETRY|MDRD 4 VARIABLE FORMULA||Y|N||4|Visit_4|65|5|TREATMENT|2020-12-03|2020-12-23|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|d1b522d5-557a-4361-a9da-292aa601fbc3|9|CSWAX|Waxy Casts|CHEMISTRY|||[?]|[?]|TRACE|1|mCi/kg|1|1|[?]|LOW|FLUID|UNEXPECTED ODOR|N|MEDIASTINOSCOPY|MDRD FORMULA|Y||NA|Y|5|Visit_5|90|3|SCREENING|2020-12-28|2020-12-31|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|d1b522d5-557a-4361-a9da-292aa601fbc3|10|NONHDL|Non-HDL Cholesterol|URINALYSIS|||[?]|[?]|INDETERMINATE|1|10^6 organisms/mg|1|1|[?]|LOW|FLUID|CONTAMINATED|N|BETA LACTAMASE|MDRD 4 VARIABLE FORMULA|||U|Y|5|Visit_5|90|4|TREATMENT|2020-12-28|2021-01-03|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|1|C130086|English Plantain Pollen IgG|URINALYSIS|[?]|mm|[?]|[?]|INDETERMINATE|1|dpm/0.5 mL|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|GELLED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|7|FOLLOW-UP|2020-07-27|2020-09-02|10|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|2|TPAAG|Tissue Plasminogen Activator Antigen|URINALYSIS|[?]|PIPE|[?]|[?]|NEGATIVE|1|/ms|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|CONCENTRATED||TRICHROME STAIN|MDRD 6 VARIABLE FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-07-27|2020-08-16|10|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|3|ESTRDIOL|Estradiol|URINALYSIS|[?]|damol/L|[?]|[?]|POSITIVE|1|APPLICATION|1|1|[?]|ABNORMAL|EXUDATE|THAWED||REBOUND TONOMETRY|CKD-EPI CREATININE FORMULA||Y|N||2|Visit_2|25|5|TREATMENT|2020-08-11|2020-10-16|25|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|4|GAD2|Glutamic Acid Decarboxylase 2|CHEMISTRY|[?]|U/kg/h|[?]|[?]|POSITIVE|1|/month|1|1|[?]|ABNORMAL|MUCUS|LACTESCENT||ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-08-11|2020-08-15|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|5|URATEEXR|Urate Excretion Rate|HEMATOLOGY|[?]|EP U|[?]|[?]|TRACE|1|RFU|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|HEMOLYZED|N|MICRO BROTH DILUTION|CKD-EPI FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-08-26|2020-09-02|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|6|FACTVL|Factor V Leiden|URINALYSIS|||[?]|[?]|POSITIVE|1|mg/kg/week|1|1|[?]|ABNORMAL|EXUDATE|CLOTTED||KINETIC MICROPARTICLE IMMUNOASSAY|GMI % FORMULA|||NA|Y|3|Visit_3|40|6|SCREENING|2020-08-26|2020-10-24|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|7|METHDN|Methadone|CHEMISTRY|[?]|Weber|[?]|[?]|POSITIVE|1|mL/animal/wk|1|1|[?]|NORMAL|LOCHIA|FRESH||MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI FORMULA|Y||Y||4|Visit_4|65|2|TREATMENT|2020-09-20|2020-09-27|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|8|C130108|Weed Mix Pollen Antigen IgA Antibody|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|BLOCKS|1|1|[?]|NORMAL|TUMOR TISSUE|AUTOLYZED||ANTIBIOTIC AGAR SCREEN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|4|Visit_4|65|1|FOLLOW-UP|2020-09-20|2020-09-23|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|9|TRIM21|Tripartite Motif Containing Protein 21|HEMATOLOGY|[?]|BAU|[?]|[?]|INVALID|1|10^9/L|1|1|[?]|HIGH|BILE|FRESH||NON-INVASIVE DIELECTRIC SENSING|MDRD 5 VARIABLE FORMULA|||U||5|Visit_5|90|6|WASHOUT|2020-10-15|2020-10-22|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|10|CYUNCLA|Unclassified Crystals|URINALYSIS|[?]|PACKET|[?]|[?]|POSITIVE|1|mL/sec/1.73m2|1|1|[?]|HIGH|ABSCESS FLUID|ROOM TEMPERATURE|N|FLUORESCENCE ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-10-15|2020-10-21|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|da2d0844-3608-4927-9103-cb7c52dd2c96|1|COAGIDX|Coagulation Index|CHEMISTRY|[?]|copies/uL|[?]|[?]|TRACE|1|/wk|1|1|[?]|LOW|VENOUS CORD BLOOD|FROZEN||MALDI-TOF|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||1|Visit_1|10|5|FOLLOW-UP|2021-01-26|2021-03-06|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|LB|da2d0844-3608-4927-9103-cb7c52dd2c96|2|APTT|Activated Partial Thromboplastin Time|URINALYSIS|[?]|Pack Year|[?]|[?]|NEGATIVE|1|GBq|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|HEMOLYZED|N|MICRO BROTH DILUTION|FIBROMETER FORMULA|||U||1|Visit_1|10|3|SCREENING|2021-01-26|2021-04-24|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|LB|da2d0844-3608-4927-9103-cb7c52dd2c96|3|PPA|Phenylpropanolamine|CHEMISTRY|||[?]|[?]|POSITIVE|1|CONTAINER|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|THAWED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|2|Visit_2|25|7|WASHOUT|2021-02-10|2021-04-22|25|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|LB|da2d0844-3608-4927-9103-cb7c52dd2c96|4|LKM1IAAB|Liver Kidney Microsomal Type 1 IgA Ab|HEMATOLOGY|[?]|mL/dose|[?]|[?]|POSITIVE|1|ug/mol|1|1|[?]|ABNORMAL|PLASMA|HEMOLYZED|N|SPECT/CT SCAN|FIBROSIS 4 FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2021-02-10|2021-03-05|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|LB|da2d0844-3608-4927-9103-cb7c52dd2c96|5|INTLK12B|Interleukin 12 Beta|HEMATOLOGY|[?]|PHERESIS UNIT|[?]|[?]|INVALID|1|mm|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|PARAFFIN-EMBEDDED||CELLULAR PROLIFERATION ASSAY|CKD-EPI CYSTATIN C FORMULA|Y||N||3|Visit_3|40|2|SCREENING|2021-02-25|2021-03-01|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|da2d0844-3608-4927-9103-cb7c52dd2c96|6|AMYLB42|Amyloid Beta 1-42|HEMATOLOGY|[?]|/LSQN|[?]|[?]|POSITIVE|1|mN|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|LIPEMIC|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|2|FOLLOW-UP|2021-02-25|2021-03-03|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|da2d0844-3608-4927-9103-cb7c52dd2c96|7|HYALUAC|Hyaluronic Acid|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|km|1|1|[?]|NORMAL|FLUID|SOLIDIFIED||PHYSICAL EXAMINATION|CKD-EPI CREATININE FORMULA||Y|NA|Y|4|Visit_4|65|3|FOLLOW-UP|2021-03-22|2021-04-20|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|da2d0844-3608-4927-9103-cb7c52dd2c96|8|AFPL1|Alpha Fetoprotein L1|URINALYSIS|[?]|FEU|[?]|[?]|POSITIVE|1|10^9 organisms/mg|1|1|[?]|HIGH|INFRANATANT, PLASMA|CONCENTRATED|N|ATOMIC ABSORPTION SPECTROMETRY|HEPASCORE FORMULA||Y|U||4|Visit_4|65|3|TREATMENT|2021-03-22|2021-04-07|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|da2d0844-3608-4927-9103-cb7c52dd2c96|9|ESTFR|Estradiol, Free|HEMATOLOGY|[?]|10^6 CFU/g|[?]|[?]|NEGATIVE|1|cm H2O|1|1|[?]|HIGH|PLATELET POOR PLASMA|CLOTTED||COMPLEMENT FIXATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||5|Visit_5|90|4|TREATMENT|2021-04-16|2021-04-25|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-23
e|LB|da2d0844-3608-4927-9103-cb7c52dd2c96|10|T4FR|Thyroxine, Free|CHEMISTRY|[?]|PIXEL|[?]|[?]|TRACE|1|ug/g/day|1|1|[?]|NORMAL|SWABBED MATERIAL|DRIED||REFRACTOMETRY|GMI % FORMULA|Y|Y|U||5|Visit_5|90|2|TREATMENT|2021-04-16|2021-04-17|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-23
e|LB|30b6f8a7-4512-462d-a162-45c3dad853e5|1|RBPCREAT|Retinol Binding Protein/Creatinine|CHEMISTRY|[?]|mg/min|[?]|[?]|BORDERLINE|1|F|1|1|[?]|LOW|ENDOMETRIAL TISSUE|FRESH||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|GMI MMOL/MOL FORMULA|Y||U||1|Visit_1|10|4|SCREENING|2020-12-02|2021-01-02|10|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|30b6f8a7-4512-462d-a162-45c3dad853e5|2|BTK|Bruton's Tyrosine Kinase|URINALYSIS|[?]|Ci/L|[?]|[?]|BORDERLINE|1|mg/kg/day|1|1|[?]|HIGH|MUSCLE TISSUE|CONCENTRATED||PELLI-ROBSON EYE CHART|NASH FIBROSURE FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-12-02|2021-01-16|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|30b6f8a7-4512-462d-a162-45c3dad853e5|3|GLP1|Glucagon-Like Peptide-1|CHEMISTRY|[?]|DROP|[?]|[?]|NEGATIVE|1|fL|1|1|[?]|ABNORMAL|COLOSTRUM|FROZEN||SICKLE CELL SOLUBILITY TEST|ASH FIBROSURE FORMULA||Y|Y||2|Visit_2|25|1|SCREENING|2020-12-17|2021-01-18|25|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|30b6f8a7-4512-462d-a162-45c3dad853e5|4|VITK|Vitamin K|URINALYSIS|[?]|nCi|[?]|[?]|NEGATIVE|1|mmol2/L2|1|1|[?]|ABNORMAL|SPERMATOZOON|FRESH||MICROSCOPY|CKD-EPI FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-12-17|2021-01-28|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|30b6f8a7-4512-462d-a162-45c3dad853e5|5|VAL|Valine|CHEMISTRY|[?]|U/10^12 RBC|[?]|[?]|INVALID|1|10^9 CFU/g|1|1|[?]|ABNORMAL|SALIVA|UNEXPECTED ODOR|N|CONTRAST ENHANCED MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||3|Visit_3|40|5|TREATMENT|2021-01-01|2021-01-10|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|30b6f8a7-4512-462d-a162-45c3dad853e5|6|ATHMBAAC|Antithrombin Activity Actual/Control|URINALYSIS|[?]|mkat|[?]|[?]|INVALID|1|cmH2O*s/mL|1|1|[?]|ABNORMAL|FLUID|ICTERIC|N|LANDOLT RING|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2021-01-01|2021-01-14|40|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|30b6f8a7-4512-462d-a162-45c3dad853e5|7|THMBAAC|Thrombin Activity Actual/Control|HEMATOLOGY|[?]|/month|[?]|[?]|BORDERLINE|1|pmol/L/h|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|PARAFFIN-EMBEDDED||SISH|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y||4|Visit_4|65|3|TREATMENT|2021-01-26|2021-02-14|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|30b6f8a7-4512-462d-a162-45c3dad853e5|8|POLYNORM|Polychromatophilic Normoblast|CHEMISTRY|[?]|ELISA unit|[?]|[?]|TRACE|1|Ejaculate U|1|1|[?]|NORMAL|LOCHIA|DRIED|N|SISH|GMI % FORMULA|Y||Y||4|Visit_4|65|2|WASHOUT|2021-01-26|2021-02-27|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|30b6f8a7-4512-462d-a162-45c3dad853e5|9|DKK1|Dickkopf WNT Signaling Path Inhibitor 1|CHEMISTRY|||[?]|[?]|TRACE|1|ug/g/min|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|CALCIFIED||HPLC-UV|GMI % FORMULA||Y|N|Y|5|Visit_5|90|5|WASHOUT|2021-02-20|2021-02-25|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|30b6f8a7-4512-462d-a162-45c3dad853e5|10|DENSITY|Density|HEMATOLOGY|[?]|kBq/uL|[?]|[?]|POSITIVE|1|vg/kg|1|1|[?]|NORMAL|INFRANATANT, PLASMA|HEMOLYZED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|FIBROMETER FORMULA||Y|N||5|Visit_5|90|6|SCREENING|2021-02-20|2021-02-25|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|1a3808b9-6004-4133-8f59-49905d04655e|1|THBD|Thrombomodulin|HEMATOLOGY|[?]|cm2|[?]|[?]|TRACE|1|g/animal/day|1|1|[?]|LOW|CAPILLARY PLASMA|REFRIGERATED||IMMUNOFIXATION ELECTROPHORESIS|ASH FIBROSURE FORMULA|||N||1|Visit_1|10|7|WASHOUT|2020-11-07|2021-01-20|10|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|1a3808b9-6004-4133-8f59-49905d04655e|2|TXB2|Thromboxane B2|CHEMISTRY|[?]|mol/mL|[?]|[?]|NEGATIVE|1|breaths/min|1|1|[?]|NORMAL|EMESIS|FROZEN||FREEZING POINT DEPRESSION|FIBROMETER FORMULA|Y|Y|NA||1|Visit_1|10|3|WASHOUT|2020-11-07|2021-01-30|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|1a3808b9-6004-4133-8f59-49905d04655e|3|HLADPB1|HLA DP Beta1 Antigen|URINALYSIS|[?]|pg|[?]|[?]|BORDERLINE|1|mEq|1|1|[?]|ABNORMAL|VITREOUS HUMOR|FRESH||OPTICAL COHERENCE TOMOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-11-22|2020-12-10|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|1a3808b9-6004-4133-8f59-49905d04655e|4|VLDLTCT|VLDL Triglyceride + Chylomicron Triglyceride|URINALYSIS|||[?]|[?]|TRACE|1|km|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|FROZEN||KNEMOMETRY|CKD-EPI CYSTATIN C FORMULA|||Y|Y|2|Visit_2|25|6|FOLLOW-UP|2020-11-22|2020-12-19|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|1a3808b9-6004-4133-8f59-49905d04655e|5|BARB|Barbiturates|HEMATOLOGY|[?]|10^7/L|[?]|[?]|BORDERLINE|1|AgU/mL|1|1|[?]|ABNORMAL|LOCHIA|ICTERIC||LEAD CITRATE STAIN|GMI % FORMULA||Y|Y||3|Visit_3|40|3|TREATMENT|2020-12-07|2020-12-24|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|1a3808b9-6004-4133-8f59-49905d04655e|6|CDTTFRN|Carb-Deficient Transferrin/Transferrin|URINALYSIS|[?]|cmH2O*s2/mL|[?]|[?]|INDETERMINATE|1|mg/L|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|CONCENTRATED|N|ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI FORMULA|||Y||3|Visit_3|40|4|SCREENING|2020-12-07|2020-12-13|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|1a3808b9-6004-4133-8f59-49905d04655e|7|CXCL3|Chemokine (C-X-C Motif) Ligand 3|HEMATOLOGY|[?]|10^7 CFU|[?]|[?]|INDETERMINATE|1|uV|1|1|[?]|HIGH|MIXED VENOUS BLOOD|FRESH|N|HILLMEN COLOR CHART|CKD-EPI CYSTATIN C FORMULA|Y||N||4|Visit_4|65|7|TREATMENT|2021-01-01|2021-02-04|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|1a3808b9-6004-4133-8f59-49905d04655e|8|APOB|Apolipoprotein B|CHEMISTRY|[?]|deg|[?]|[?]|POSITIVE|1|Absorbance U/mL|1|1|[?]|ABNORMAL|FLUID|CONCENTRATED|N|COLORIMETRY|NASH FIBROSURE FORMULA|||U||4|Visit_4|65|7|SCREENING|2021-01-01|2021-01-06|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|1a3808b9-6004-4133-8f59-49905d04655e|9|FERRITIN|Ferritin|HEMATOLOGY|[?]|L/s/kPa|[?]|[?]|BORDERLINE|1|10^3 CFU|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|SOLIDIFIED||PHOROPTER|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||5|Visit_5|90|1|FOLLOW-UP|2021-01-26|2021-01-28|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|1a3808b9-6004-4133-8f59-49905d04655e|10|CEMORPH|Cell Morphology|URINALYSIS|[?]|ug/mL/h|[?]|[?]|POSITIVE|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|SMEGMA|REFRIGERATED||PHOROPTER|COCKCROFT-GAULT FORMULA|Y||N||5|Visit_5|90|5|FOLLOW-UP|2021-01-26|2021-02-04|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|5c91894d-c756-4ade-9fc4-2a64d4acc53f|1|HYPERCHR|Hyperchromia|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|L|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|DRIED|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE FORMULA||Y|N|Y|1|Visit_1|10|4|WASHOUT|2021-01-19|2021-01-20|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|5c91894d-c756-4ade-9fc4-2a64d4acc53f|2|LYMVACLE|Vacuolated Lymphocytes/Leukocytes|HEMATOLOGY|[?]|mL/cm3/min|[?]|[?]|POSITIVE|1|BAU/mL|1|1|[?]|ABNORMAL|MUSCLE TISSUE|LACTESCENT||HANSEL STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2021-01-19|2021-02-24|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|5c91894d-c756-4ade-9fc4-2a64d4acc53f|3|CTXIICRT|Type II Collagen C-Telopeptides/Creat|URINALYSIS|[?]|CFU/mL|[?]|[?]|INVALID|1|Antibody Unit|1|1|[?]|NORMAL|LAVAGE FLUID|CLOTTED||PULSE OXIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||2|Visit_2|25|7|SCREENING|2021-02-03|2021-04-13|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|5c91894d-c756-4ade-9fc4-2a64d4acc53f|4|CTXI|Type I Collagen C-Telopeptides|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mg/cm2|1|1|[?]|NORMAL|BREAST MILK|REFRIGERATED||CALCOFLUOR WHITE STAIN|GMI % FORMULA|Y||U|Y|2|Visit_2|25|6|TREATMENT|2021-02-03|2021-03-04|25|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|5c91894d-c756-4ade-9fc4-2a64d4acc53f|5|C165932|Dog Dander IgE AB RAST Score|CHEMISTRY|||[?]|[?]|NEGATIVE|1|TRANSDUCING UNIT|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|CALCIFIED||CLOT DETECTION|HEPASCORE FORMULA|||U|Y|3|Visit_3|40|5|TREATMENT|2021-02-18|2021-04-14|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|5c91894d-c756-4ade-9fc4-2a64d4acc53f|6|C165936|Glycine max IgE AB RAST Score|URINALYSIS|[?]|ug/m2/min|[?]|[?]|TRACE|1|DAYS|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|LACTESCENT||FLOCCULATION|MDRD FORMULA|||NA||3|Visit_3|40|1|FOLLOW-UP|2021-02-18|2021-04-07|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|5c91894d-c756-4ade-9fc4-2a64d4acc53f|7|C165931|Nut Mix IgE AB RAST Score|HEMATOLOGY|[?]|MPS U|[?]|[?]|BORDERLINE|1|mg/dL|1|1|[?]|NORMAL|PROSTATIC FLUID|LACTESCENT||OLIGO ACGH|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y||4|Visit_4|65|7|FOLLOW-UP|2021-03-15|2021-04-17|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|5c91894d-c756-4ade-9fc4-2a64d4acc53f|8|C165912|Shellfish Mix IgG AB RAST Score|URINALYSIS|||[?]|[?]|NEGATIVE|1|log EID 50/dose|1|1|[?]|NORMAL|BREAST MILK|CLOTTED|N|NUCLEIC ACID SEQUENCING|MDRD ENZYMATIC FORMULA|||N|Y|4|Visit_4|65|5|SCREENING|2021-03-15|2021-04-11|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|5c91894d-c756-4ade-9fc4-2a64d4acc53f|9|MMP7|Matrix Metalloproteinase 7|URINALYSIS|[?]|10^9 organisms/mL|[?]|[?]|INDETERMINATE|1|anti-Xa IU|1|1|[?]|LOW|RETICULOCYTES|LIPEMIC||ANTIMICROBIAL COMBINATION TESTING|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||5|Visit_5|90|7|TREATMENT|2021-04-09|2021-04-15|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|5c91894d-c756-4ade-9fc4-2a64d4acc53f|10|DMG|Dimethylglycine|CHEMISTRY|||[?]|[?]|POSITIVE|1|umol/L/min|1|1|[?]|NORMAL|ERYTHROCYTES|REFRIGERATED|N|MECHANICAL CLOT DETECTION|ASH FIBROSURE FORMULA||Y|Y|Y|5|Visit_5|90|5|TREATMENT|2021-04-09|2021-04-17|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|1|TRAP|Total Radical-Trap Antioxidant Potential|URINALYSIS|[?]|mL/dL|[?]|[?]|INVALID|1|10^3 CFU/mL|1|1|[?]|LOW|GASTRIC FLUID|LIPEMIC||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|FIBROTEST FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-07-15|2020-08-04|10|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|LB|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|2|IOTCLR|Iothalamate Clearance|HEMATOLOGY|[?]|ft3|[?]|[?]|INDETERMINATE|1|log10 copies/mL|1|1|[?]|LOW|SPUTUM|UNEXPECTED ODOR||HIGH RESOLUTION MELT ANALYSIS|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|2|TREATMENT|2020-07-15|2020-10-05|10|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|LB|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|3|DCA|Deoxycholate|HEMATOLOGY|[?]|mmol2/L2|[?]|[?]|BORDERLINE|1|FEU|1|1|[?]|HIGH|LUNG SURFACTANT|ICTERIC||ELECTRICAL IMPEDANCE MYOGRAPHY|GMI MMOL/MOL FORMULA||Y|U||2|Visit_2|25|4|SCREENING|2020-07-30|2020-09-03|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|LB|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|4|CPB2|Carboxypeptidase B2|CHEMISTRY|[?]|m2|[?]|[?]|TRACE|1|fg|1|1|[?]|LOW|REFLEX TEAR|CONCENTRATED|N|DISK DIFFUSION|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|6|TREATMENT|2020-07-30|2020-08-22|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|LB|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|5|CFA|Coefficient of Fat Absorption|HEMATOLOGY|[?]|mL/cage|[?]|[?]|TRACE|1|mL/beat|1|1|[?]|NORMAL|PLEURAL TISSUE|SOLIDIFIED|N|ANALYTICAL ULTRACENTRIFUGATION|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-08-14|2020-08-26|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|6|BLYCECE|B-Lymphocytes/Total Cells|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ug/m2/h|1|1|[?]|LOW|BLOOD|AGGLUTINATED||HPLC/MS/MS|FIBROSIS 4 FORMULA|Y||N|Y|3|Visit_3|40|5|TREATMENT|2020-08-14|2020-09-21|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|7|FATDROP|Fat Droplet|URINALYSIS|[?]|/h|[?]|[?]|BORDERLINE|1|dram|1|1|[?]|NORMAL|URINE|ROOM TEMPERATURE|N|SCANNING ELECTRON MICROSCOPY|CKD-EPI CREATININE FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-09-08|2020-09-18|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|8|APOC2|Apolipoprotein C2|HEMATOLOGY|[?]|deg/mm|[?]|[?]|BORDERLINE|1|10^10/L|1|1|[?]|LOW|BASAL TEAR|FRESH|N|PET SCAN|FIBROSIS 4 FORMULA|Y||N||4|Visit_4|65|5|TREATMENT|2020-09-08|2020-09-27|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|9|CYAMPURT|Amorphous Urate Crystals|HEMATOLOGY|[?]|10^8 PFU|[?]|[?]|NEGATIVE|1|ug/dose|1|1|[?]|ABNORMAL|LUNG SURFACTANT|CLOTTED||IMMUNORADIOMETRIC ASSAY|FIBROTEST FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-10-03|2020-10-06|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|10|LYMPHOID|Lymphoid Cells|URINALYSIS|[?]|Ci|[?]|[?]|INVALID|1|10^4 CFU/mL|1|1|[?]|NORMAL|PERITONEAL FLUID|ROOM TEMPERATURE||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|GMI % FORMULA|||NA||5|Visit_5|90|5|WASHOUT|2020-10-03|2020-10-07|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|1|AMYLB40|Amyloid Beta 1-40|HEMATOLOGY|[?]|copies/mL|[?]|[?]|INVALID|1|ka_u/dL|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|FROZEN||AUSCULTATION|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|4|WASHOUT|2020-09-15|2020-10-05|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|2|BARB|Barbiturates|CHEMISTRY|[?]|g/m2/day|[?]|[?]|TRACE|1|Ci/mg|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|SOLIDIFIED||TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD FORMULA|||Y||1|Visit_1|10|6|SCREENING|2020-09-15|2020-11-13|10|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|3|INDICAN|Indican|HEMATOLOGY|[?]|GPL U/mL|[?]|[?]|POSITIVE|1|anti-Xa IU|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|SOLIDIFIED||MICROBIAL CONCENTRATION|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-09-30|2020-11-03|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|4|CSGRANF|Granular Fine Casts|URINALYSIS|||[?]|[?]|BORDERLINE|1|/LPF|1|1|[?]|NORMAL|URINE|HEMOLYZED||SANGER SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|U|Y|2|Visit_2|25|3|TREATMENT|2020-09-30|2020-12-13|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|5|PRAB|Panel Reactive Antibody|CHEMISTRY|[?]|mL/dose|[?]|[?]|INVALID|1|DNA copies/ug|1|1|[?]|ABNORMAL|TISSUE|LACTESCENT||IN VITRO GENE EXPRESSION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||3|Visit_3|40|6|SCREENING|2020-10-15|2020-10-16|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|6|CCR5|C-C Chemokine Receptor Type 5|HEMATOLOGY|[?]|mU/g|[?]|[?]|TRACE|1|QUANTITY SUFFICIENT|1|1|[?]|HIGH|PLATELET POOR PLASMA|CONTAMINATED||ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||3|Visit_3|40|3|TREATMENT|2020-10-15|2020-11-08|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|7|INTLK15|Interleukin 15|HEMATOLOGY|[?]|mmol2/L2|[?]|[?]|TRACE|1|FEU|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|FROZEN||RIA|CKD-EPI CYSTATIN C FORMULA||Y|N||4|Visit_4|65|1|TREATMENT|2020-11-09|2020-11-19|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|8|CD1|CD1|CHEMISTRY|[?]|vg/kg|[?]|[?]|POSITIVE|1|Hz/s|1|1|[?]|ABNORMAL|HAIR FOLLICLE|UNEXPECTED ODOR||PHOTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|Y||4|Visit_4|65|3|WASHOUT|2020-11-09|2020-11-17|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|9|GSTCREAT|Glutathione-S-Transferase/Creatinine|CHEMISTRY|||[?]|[?]|POSITIVE|1|ppm|1|1|[?]|LOW|PROSTATIC FLUID|FRESH||PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA||Y|Y|Y|5|Visit_5|90|2|WASHOUT|2020-12-04|2020-12-05|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|10|C1QAB|Complement C1q Antibody|CHEMISTRY|[?]|10^3 DNA copies/mL|[?]|[?]|INDETERMINATE|1|deg2|1|1|[?]|HIGH|INTERSTITIAL FLUID|LACTESCENT|N|PULSE OXIMETRY|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-12-04|2020-12-08|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|1|TNF12|TNF Superfamily Member 12|HEMATOLOGY|[?]|kUSP|[?]|[?]|INVALID|1|L/kg|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|SOLIDIFIED||CONTRAST ENHANCED PET/CT SCAN|MDRD 5 VARIABLE FORMULA|Y||NA||1|Visit_1|10|4|WASHOUT|2020-06-10|2020-08-24|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|2|MICA|MHC Class I Chain Related Protein A|CHEMISTRY|||[?]|[?]|TRACE|1|oz|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|THAWED||IMMUNOBLOT|MDRD ENZYMATIC FORMULA|||Y|Y|1|Visit_1|10|7|WASHOUT|2020-06-10|2020-06-21|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|3|CHLMCRNT|Chylomicron Triglyceride|CHEMISTRY|[?]|uIU/dL|[?]|[?]|INDETERMINATE|1|IMPLANT|1|1|[?]|ABNORMAL|LEUKOCYTE|REFRIGERATED||HPLC-FL|MDRD 4 VARIABLE FORMULA|||N||2|Visit_2|25|4|FOLLOW-UP|2020-06-25|2020-08-29|25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|4|PPA|Phenylpropanolamine|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/mmHg/min/L|1|1|[?]|NORMAL|PUS|CONCENTRATED||X-RAY FLUORESCENCE SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|2|Visit_2|25|6|WASHOUT|2020-06-25|2020-08-17|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|5|COL4|Collagen Type IV|URINALYSIS|[?]|BOTTLE|[?]|[?]|POSITIVE|1|100 IU/mL|1|1|[?]|HIGH|MIXED VENOUS BLOOD|REFRIGERATED||MAPH|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||3|Visit_3|40|6|TREATMENT|2020-07-10|2020-08-20|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|LB|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|g/cage/day|1|1|[?]|HIGH|CALCULUS|CLOTTED|N|CONGO RED STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|3|Visit_3|40|4|FOLLOW-UP|2020-07-10|2020-07-16|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|LB|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|7|NAGASECR|N-acetyl-B-D-glucosaminidase/Creatinine|CHEMISTRY|[?]|cd|[?]|[?]|BORDERLINE|1|fmol/g|1|1|[?]|NORMAL|SPUTUM|DRIED||TWO-COLOR MICROARRAY|GMI MMOL/MOL FORMULA||Y|U||4|Visit_4|65|5|SCREENING|2020-08-04|2020-08-24|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|LB|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|8|CBA|Complement Ba|HEMATOLOGY|[?]|nmol/day|[?]|[?]|TRACE|1|ohm|1|1|[?]|HIGH|ADIPOSE TISSUE|UNEXPECTED ODOR||ELISA|FIBROMETER FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-08-04|2020-08-15|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|LB|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|9|INDICAN|Indican|HEMATOLOGY|[?]|oz|[?]|[?]|INVALID|1|ugEq|1|1|[?]|HIGH|DERMAL TISSUE|CONCENTRATED||MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|3|TREATMENT|2020-08-29|2020-08-30|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|10|ABNCE|Abnormal Cells|HEMATOLOGY|[?]|nkat|[?]|[?]|BORDERLINE|1|fg|1|1|[?]|LOW|REFLEX TEAR|REFRIGERATED||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|5|SCREENING|2020-08-29|2020-08-30|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|37610314-f803-4ffa-a584-ebfe09267a0d|1|VITB9|Vitamin B9|HEMATOLOGY|[?]|mL/m2/min|[?]|[?]|INVALID|1|mg/L|1|1|[?]|LOW|MECONIUM|CONTAMINATED|N|ZIEHL NEELSEN ACID FAST STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||1|Visit_1|10|7|SCREENING|2020-06-30|2020-08-29|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|LB|37610314-f803-4ffa-a584-ebfe09267a0d|2|ALAALB|Apolipoprotein A/Apolipoprotein B|URINALYSIS|[?]|pmol/day|[?]|[?]|INVALID|1|mmHg/sec|1|1|[?]|ABNORMAL|SOFT TISSUE|DRIED||PET/CT SCAN|CKD-EPI CYSTATIN C FORMULA|||U||1|Visit_1|10|4|WASHOUT|2020-06-30|2020-07-22|10|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|LB|37610314-f803-4ffa-a584-ebfe09267a0d|3|HAIRYCE|Hairy Cells|CHEMISTRY|||[?]|[?]|BORDERLINE|1|IU/day|1|1|[?]|NORMAL|FLUID|CALCIFIED||ROMANOWSKY STAIN|GMI MMOL/MOL FORMULA|||Y|Y|2|Visit_2|25|1|TREATMENT|2020-07-15|2020-09-13|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|37610314-f803-4ffa-a584-ebfe09267a0d|4|MPV|Mean Platelet Volume|CHEMISTRY|[?]|s^-1(%O2)^-1|[?]|[?]|INDETERMINATE|1|mg/animal|1|1|[?]|NORMAL|BONE|NON-HEMOLYZED||LIGHT MICROSCOPY|MDRD 6 VARIABLE FORMULA|||U||2|Visit_2|25|7|TREATMENT|2020-07-15|2020-09-05|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|37610314-f803-4ffa-a584-ebfe09267a0d|5|CYHGBC|Hemoglobin C Crystals|CHEMISTRY|[?]|10^6 organisms/mg|[?]|[?]|BORDERLINE|1|BAU/mL|1|1|[?]|HIGH|GASTRIC FLUID|SOLIDIFIED|N|IMMUNOPRECIPITATION|HEPASCORE FORMULA||Y|N||3|Visit_3|40|1|TREATMENT|2020-07-30|2020-08-31|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|37610314-f803-4ffa-a584-ebfe09267a0d|6|GLOBB2|Beta-2 Globulin|HEMATOLOGY|[?]|U/kg/h|[?]|[?]|BORDERLINE|1|GBq|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|CLOTTED|N|OPTICAL MAPPING|CKD-EPI CREATININE FORMULA|||U||3|Visit_3|40|4|SCREENING|2020-07-30|2020-09-22|40|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|37610314-f803-4ffa-a584-ebfe09267a0d|7|SJSA52AB|Sjogrens SS-A52 Antibody|URINALYSIS|[?]|Bq/L|[?]|[?]|NEGATIVE|1|Watt|1|1|[?]|NORMAL|MUSCLE TISSUE|THAWED||PH METER MEASUREMENT METHOD|FIBROSIS 4 FORMULA|Y||U||4|Visit_4|65|4|TREATMENT|2020-08-24|2020-09-25|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|37610314-f803-4ffa-a584-ebfe09267a0d|8|ANABASN|Anabasine|HEMATOLOGY|[?]|mmol/mol|[?]|[?]|INVALID|1|CYLINDER|1|1|[?]|LOW|PERSPIRATION|DRIED||VENTILATION PERFUSION LUNG SCAN|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2020-08-24|2020-08-31|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|37610314-f803-4ffa-a584-ebfe09267a0d|9|LIPASEP|Lipase, Pancreatic|HEMATOLOGY|[?]|STEPS|[?]|[?]|INVALID|1|dB|1|1|[?]|HIGH|MONOCYTE|CLOTTED||WEBER GREEN STAIN|GMI % FORMULA|Y||U||5|Visit_5|90|3|TREATMENT|2020-09-18|2020-09-23|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|37610314-f803-4ffa-a584-ebfe09267a0d|10|TK1|Thymidine Kinase 1|HEMATOLOGY|[?]|NEBULE|[?]|[?]|TRACE|1|Gravitational Unit|1|1|[?]|HIGH|BREAST MILK|UNEXPECTED ODOR||URANYL ACETATE STAIN|MDRD ENZYMATIC FORMULA|Y||U||5|Visit_5|90|3|WASHOUT|2020-09-18|2020-09-23|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|760ec5ce-3ae7-4268-9f76-b83085ad3754|1|RNA|Ribonucleic Acid|CHEMISTRY|[?]|ug/mL/h|[?]|[?]|NEGATIVE|1|ohm|1|1|[?]|HIGH|PLEURAL FLUID|SOLIDIFIED||DYNAMIC CONTRAST ENHANCED MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|Y||1|Visit_1|10|7|TREATMENT|2020-09-24|2020-11-13|10|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|760ec5ce-3ae7-4268-9f76-b83085ad3754|2|LYMLE|Lymphocytes/Leukocytes|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Enzyme U/g Hb|1|1|[?]|NORMAL|MUSCLE TISSUE|LIPEMIC|N|SXA SCAN|MDRD 5 VARIABLE FORMULA|||U|Y|1|Visit_1|10|7|TREATMENT|2020-09-24|2020-12-06|10|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|760ec5ce-3ae7-4268-9f76-b83085ad3754|3|TRYPSIN|Trypsin|HEMATOLOGY|[?]|ug/kg|[?]|[?]|BORDERLINE|1|umol/day|1|1|[?]|HIGH|SUPERNATANT, PLASMA|CLOTTED||HIGH RESOLUTION MELT ANALYSIS|MDRD 5 VARIABLE FORMULA||Y|NA||2|Visit_2|25|7|WASHOUT|2020-10-09|2020-10-20|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|760ec5ce-3ae7-4268-9f76-b83085ad3754|4|CENTROAB|Centromere B Antibodies|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mL/dL|1|1|[?]|ABNORMAL|VENOUS BLOOD|LACTESCENT||CELL OF ORIGIN ASSAY|CKD-EPI CYSTATIN C FORMULA|||NA|Y|2|Visit_2|25|6|FOLLOW-UP|2020-10-09|2020-10-23|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|760ec5ce-3ae7-4268-9f76-b83085ad3754|5|SCKCERBC|Sickle Cells/Erythrocytes|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/cm H2O|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|NON-HEMOLYZED||POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2020-10-24|2020-11-05|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|760ec5ce-3ae7-4268-9f76-b83085ad3754|6|KLOTHO|Klotho|URINALYSIS|[?]|nU/cL|[?]|[?]|NEGATIVE|1|L/kg|1|1|[?]|ABNORMAL|TISSUE|CONCENTRATED|N|NUCLEIC ACID HYBRIDIZATION|CKD-EPI CYSTATIN C FORMULA||Y|Y||3|Visit_3|40|4|WASHOUT|2020-10-24|2020-11-14|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|760ec5ce-3ae7-4268-9f76-b83085ad3754|7|UNSPCECE|Unspecified Cells/Total Cells|HEMATOLOGY|[?]|Anson U|[?]|[?]|POSITIVE|1|/4.0 mL|1|1|[?]|ABNORMAL|CELL PELLET|LIPEMIC||REBOUND TONOMETRY|MDRD ENZYMATIC FORMULA||Y|NA||4|Visit_4|65|1|TREATMENT|2020-11-18|2020-12-04|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|760ec5ce-3ae7-4268-9f76-b83085ad3754|8|PLATHCT|Platelet Hematocrit|HEMATOLOGY|[?]|g/cage|[?]|[?]|BORDERLINE|1|mL/animal/wk|1|1|[?]|ABNORMAL|TISSUE|UNEXPECTED ODOR||IMMUNOPRECIPITATION|CKD-EPI CREATININE FORMULA|||NA||4|Visit_4|65|5|FOLLOW-UP|2020-11-18|2020-11-24|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|760ec5ce-3ae7-4268-9f76-b83085ad3754|9|PROINSUL|Proinsulin|URINALYSIS|[?]|DROP|[?]|[?]|INVALID|1|tuberculin unit/mL|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|ROOM TEMPERATURE||COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||5|Visit_5|90|6|WASHOUT|2020-12-13|2020-12-16|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|760ec5ce-3ae7-4268-9f76-b83085ad3754|10|IOHEXCLR|Iohexol Clearance|CHEMISTRY|||[?]|[?]|POSITIVE|1|mU|1|1|[?]|NORMAL|BILE|PARAFFIN-EMBEDDED||ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA|||U|Y|5|Visit_5|90|7|TREATMENT|2020-12-13|2020-12-20|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|1|PLATSAT|Platelet Satellitism|URINALYSIS|[?]|cP|[?]|[?]|INDETERMINATE|1|gMFI|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|AUTOLYZED|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-06-15|2020-08-03|10|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|LB|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|2|URATEEXR|Urate Excretion Rate|URINALYSIS|[?]|umol/mol|[?]|[?]|INVALID|1|mg/cm2|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|SOLIDIFIED||CONTRAST ENHANCED PET SCAN|NASH FIBROSURE FORMULA||Y|N||1|Visit_1|10|3|TREATMENT|2020-06-15|2020-07-09|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|LB|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|3|LEUKASE|Leukocyte Esterase|URINALYSIS|[?]|P|[?]|[?]|TRACE|1|10^7 TCID 50/dose|1|1|[?]|HIGH|EXUDATE|CONTAMINATED||BIOPSY|CKD-EPI FORMULA||Y|N||2|Visit_2|25|1|TREATMENT|2020-06-30|2020-07-12|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|4|PHOSCLR|Phosphate Clearance|URINALYSIS|[?]|dpm/100mg|[?]|[?]|NEGATIVE|1|um/day|1|1|[?]|NORMAL|CORD SERUM|CLOTTED||TRICHROME STAIN|MDRD 5 VARIABLE FORMULA||Y|Y||2|Visit_2|25|2|WASHOUT|2020-06-30|2020-07-04|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|5|PROPOX|Propoxyphene|URINALYSIS|[?]|F|[?]|[?]|POSITIVE|1|mph|1|1|[?]|NORMAL|SYNOVIAL FLUID|FRESH|N|MICROBIAL CULTURE, LIQUID|NASH FIBROSURE FORMULA|Y||NA||3|Visit_3|40|1|FOLLOW-UP|2020-07-15|2020-07-23|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|6|PCO2|Partial Pressure Carbon Dioxide|CHEMISTRY|[?]|foz_br|[?]|[?]|INDETERMINATE|1|GBq/ug|1|1|[?]|NORMAL|PLEURAL FLUID|ICTERIC||TARGETED TRANSCRIPTOME SEQUENCING|CKD-EPI CREATININE FORMULA|||U||3|Visit_3|40|7|FOLLOW-UP|2020-07-15|2020-08-08|40|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|7|SJSA52AB|Sjogrens SS-A52 Antibody|CHEMISTRY|[?]|INHALATION|[?]|[?]|TRACE|1|mL/m2/h|1|1|[?]|LOW|LUNG SURFACTANT|CONTAMINATED||LC/MS|MDRD 4 VARIABLE FORMULA|||U||4|Visit_4|65|6|TREATMENT|2020-08-09|2020-08-17|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|8|INTLK15|Interleukin 15|CHEMISTRY|[?]|g/kg/day|[?]|[?]|TRACE|1|MBq|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|REFRIGERATED||RADIOGRAPHY|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|4|FOLLOW-UP|2020-08-09|2020-08-24|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|9|HEXK|Hexokinase|URINALYSIS|[?]|mg/animal|[?]|[?]|TRACE|1|pm|1|1|[?]|LOW|PLATELET RICH PLASMA|AGGLUTINATED||APPLANATION TONOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||5|Visit_5|90|7|TREATMENT|2020-09-03|2020-09-06|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|10|TOXVAC|Toxic Vacuolation|URINALYSIS|[?]|ug/min|[?]|[?]|INDETERMINATE|1|GBq/g|1|1|[?]|HIGH|CALCULUS|UNEXPECTED ODOR||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|7|WASHOUT|2020-09-03|2020-09-06|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|1|DENSITY|Density|CHEMISTRY|[?]|Gy/h|[?]|[?]|TRACE|1|EID 50/mL|1|1|[?]|ABNORMAL|REFLEX TEAR|UNEXPECTED ODOR|N|DIFFUSION WEIGHTED MRI|CKD-EPI CYSTATIN C FORMULA|Y||U||1|Visit_1|10|2|TREATMENT|2021-01-24|2021-02-06|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|2|C165926|Mold Mix IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|POSITIVE|1|PUFF|1|1|[?]|NORMAL|EMOTIONAL TEAR|NON-HEMOLYZED||COULOMETRIC TITRATION|CKD-EPI CYSTATIN C FORMULA|Y|Y|U|Y|1|Visit_1|10|5|TREATMENT|2021-01-24|2021-04-16|10|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|3|INTLK26|Interleukin 26|CHEMISTRY|[?]|mL/breath|[?]|[?]|TRACE|1|mmol/kg|1|1|[?]|LOW|PLATELET POOR PLASMA|CLOTTED|N|DC SHEATH FLOW|ASH FIBROSURE FORMULA|Y||Y||2|Visit_2|25|6|SCREENING|2021-02-08|2021-04-20|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|LB|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|4|CRYGLBSR|Cryoglobulin Volume/Serum Volume|CHEMISTRY|[?]|mEq/mmol|[?]|[?]|TRACE|1|mL/m2/h|1|1|[?]|LOW|INFRANATANT, PLASMA|AUTOLYZED|N|MS/MS|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2021-02-08|2021-02-21|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|LB|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|5|PSDGLSRF|Phosphatidylglycerol/Lung Surfactant|CHEMISTRY|[?]|fraction of 1|[?]|[?]|NEGATIVE|1|sec|1|1|[?]|NORMAL|TRANSUDATE|DRIED|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||U||3|Visit_3|40|4|WASHOUT|2021-02-23|2021-03-24|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|6|CREAT|Creatinine|HEMATOLOGY|[?]|uV|[?]|[?]|TRACE|1|/sec|1|1|[?]|HIGH|INFRANATANT, SERUM|GELLED|N|FARR ASSAY|NASH FIBROSURE FORMULA|||U||3|Visit_3|40|1|TREATMENT|2021-02-23|2021-04-18|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|7|MSTHCE|Mesothelial Cells|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|BAR|1|1|[?]|HIGH|AMNIOTIC FLUID|ROOM TEMPERATURE|N|CENTRIFUGATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|NA|Y|4|Visit_4|65|5|TREATMENT|2021-03-20|2021-04-03|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|8|INTLK21|Interleukin 21|HEMATOLOGY|[?]|cd/m2|[?]|[?]|INDETERMINATE|1|APL U/mL|1|1|[?]|HIGH|URINE SEDIMENT|DRIED||TOLUIDINE BLUE STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||Y||4|Visit_4|65|3|FOLLOW-UP|2021-03-20|2021-04-13|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|9|PTHMM|Parathyroid Hormone, Mid-Molecule|URINALYSIS|||[?]|[?]|INVALID|1|GPL U/mL|1|1|[?]|HIGH|TUMOR TISSUE|CLOTTED|N|PUPILLOMETRY|GMI MMOL/MOL FORMULA|Y|Y|N|Y|5|Visit_5|90|1|SCREENING|2021-04-14|2021-04-21|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|LB|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|10|GLYCRLFR|Free Glycerol|CHEMISTRY|[?]|Enzyme U/m2|[?]|[?]|NEGATIVE|1|/wk|1|1|[?]|LOW|PLEURAL TISSUE|CLOTTED||CHROMATOGRAPHY|MDRD ENZYMATIC FORMULA|Y||U||5|Visit_5|90|4|TREATMENT|2021-04-14|2021-04-21|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|LB|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|1|C130131|Dog Dander Antigen IgG4 Antibody|HEMATOLOGY|[?]|U/kg/h|[?]|[?]|BORDERLINE|1|10^3 RNA copies/mL|1|1|[?]|HIGH|FLUID|REFRIGERATED|N|DIRECT SEQUENCING|FIBROMETER FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-11-13|2021-01-06|10|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|2|HALPRZLM|Hydroxyalprazolam|HEMATOLOGY|[?]|ELISA unit/dose|[?]|[?]|TRACE|1|U/10^12 RBC|1|1|[?]|LOW|EMOTIONAL TEAR|ROOM TEMPERATURE||MANUAL CLOT DETECTION|CKD-EPI CREATININE FORMULA|||Y||1|Visit_1|10|2|WASHOUT|2020-11-13|2020-11-16|10|13|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|3|LDH2|LDH Isoenzyme 2|HEMATOLOGY|[?]|mL/cm H2O|[?]|[?]|NEGATIVE|1|ppm|1|1|[?]|ABNORMAL|HAIR FOLLICLE|REFRIGERATED|N|NON-CONTACT SPECULAR MICROSCOPY|COCKCROFT-GAULT FORMULA|Y||U||2|Visit_2|25|7|SCREENING|2020-11-28|2020-12-13|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|4|ANCAB|Anti-Neutrophil Cytoplasmic Antibody|HEMATOLOGY|[?]|P|[?]|[?]|POSITIVE|1|Absorbance U|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|HEMOLYZED||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|FIBROSIS 4 FORMULA|||U||2|Visit_2|25|4|SCREENING|2020-11-28|2020-12-03|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|5|GLYCRL|Glycerol|HEMATOLOGY|[?]|sec|[?]|[?]|INVALID|1|kg|1|1|[?]|HIGH|CELL PELLET|FROZEN||PELLI-ROBSON EYE CHART|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|1|FOLLOW-UP|2020-12-13|2021-01-06|40|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|6|PSAMRNA|Prostate Specific Antigen mRNA|URINALYSIS|||[?]|[?]|POSITIVE|1|HOURS|1|1|[?]|LOW|PLATELET RICH PLASMA|SOLIDIFIED||MICROBIAL CULTURE, SOLID|COCKCROFT-GAULT FORMULA|||NA|Y|3|Visit_3|40|4|TREATMENT|2020-12-13|2021-01-18|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|7|C165935|Triticum aestivum IgE AB RAST Score|URINALYSIS|[?]|PIXEL|[?]|[?]|INDETERMINATE|1|ng/L|1|1|[?]|NORMAL|CORD BLOOD|CALCIFIED||PET/CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||4|Visit_4|65|6|TREATMENT|2021-01-07|2021-01-28|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|8|LDHEXR|Lactate Dehydrogenase Excretion Rate|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^6 CFU/g|1|1|[?]|NORMAL|PERITONEAL FLUID|NON-HEMOLYZED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD ENZYMATIC FORMULA||Y|N|Y|4|Visit_4|65|2|TREATMENT|2021-01-07|2021-01-12|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|9|DCCARNIT|Decanoylcarnitine|HEMATOLOGY|[?]|Tbsp|[?]|[?]|NEGATIVE|1|uIU/dL|1|1|[?]|NORMAL|PLATELET|REFRIGERATED||QUANTITATIVE CORONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|4|FOLLOW-UP|2021-02-01|2021-02-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|10|TPROT|Tau Protein|CHEMISTRY|[?]|pg/L|[?]|[?]|POSITIVE|1|mL/beat|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|NON-HEMOLYZED||NO INFORMATION|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2021-02-01|2021-02-06|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|d7b41e15-6725-4433-8a35-72629e342b47|1|KAPPALC|Kappa Light Chain|HEMATOLOGY|[?]|L/kg|[?]|[?]|BORDERLINE|1|nmol/L/h|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|REFRIGERATED||PATHOLOGICAL EVALUATION|FIBROTEST FORMULA|||Y||1|Visit_1|10|7|FOLLOW-UP|2020-09-14|2020-10-13|10|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|d7b41e15-6725-4433-8a35-72629e342b47|2|ICTERUSI|Icteric Index|CHEMISTRY|[?]|mL/dose|[?]|[?]|TRACE|1|cL|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|DRIED|N|DYNAMOMETRY|GMI % FORMULA|||U||1|Visit_1|10|4|SCREENING|2020-09-14|2020-11-22|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|d7b41e15-6725-4433-8a35-72629e342b47|3|HGFR|Hepatocyte Growth Factor Receptor|CHEMISTRY|[?]|CCID 50/dose|[?]|[?]|NEGATIVE|1|pmol/10^9 cells|1|1|[?]|ABNORMAL|HAIR FOLLICLE|UNEXPECTED ODOR||GC/FID|MDRD 5 VARIABLE FORMULA|||NA||2|Visit_2|25|5|SCREENING|2020-09-29|2020-11-23|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|d7b41e15-6725-4433-8a35-72629e342b47|4|PTHNT|Parathyroid Hormone, N-Terminal|CHEMISTRY|[?]|breaths/min|[?]|[?]|INDETERMINATE|1|uEq|1|1|[?]|HIGH|URINE|ICTERIC||DUKE INCISION METHOD|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-09-29|2020-12-12|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|d7b41e15-6725-4433-8a35-72629e342b47|5|INTLK17|Interleukin 17|CHEMISTRY|||[?]|[?]|TRACE|1|pt_us|1|1|[?]|ABNORMAL|LOCHIA|CONCENTRATED||COMPLEMENT FIXATION|CKD-EPI CYSTATIN C FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2020-10-14|2020-11-06|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|d7b41e15-6725-4433-8a35-72629e342b47|6|STSA|Steroid Sulfatase Activity|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^6 organisms/mg|1|1|[?]|ABNORMAL|SEBUM|UNEXPECTED ODOR||MS/MS|CKD-EPI CREATININE FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2020-10-14|2020-11-27|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|d7b41e15-6725-4433-8a35-72629e342b47|7|APOE|Apolipoprotein E|CHEMISTRY|[?]|g/U|[?]|[?]|POSITIVE|1|Ejaculate U|1|1|[?]|NORMAL|SWABBED MATERIAL|DRIED||CLIP|GMI % FORMULA|||NA||4|Visit_4|65|1|WASHOUT|2020-11-08|2020-11-28|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|d7b41e15-6725-4433-8a35-72629e342b47|8|TRPCRT|Tryptophan/Creatinine|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|MONTHS|1|1|[?]|LOW|INFRANATANT, PLASMA|SOLIDIFIED|N|IMMUNOPRECIPITATION|FIBROSIS 4 FORMULA|||NA|Y|4|Visit_4|65|3|TREATMENT|2020-11-08|2020-11-20|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|d7b41e15-6725-4433-8a35-72629e342b47|9|IL2RB|Interleukin 2 Receptor Subunit Beta|CHEMISTRY|[?]|kg/cm|[?]|[?]|INVALID|1|um2|1|1|[?]|HIGH|LEUKOCYTE|HEMOLYZED||AGAR PROPORTION|MDRD ENZYMATIC FORMULA||Y|NA||5|Visit_5|90|3|TREATMENT|2020-12-03|2020-12-05|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|d7b41e15-6725-4433-8a35-72629e342b47|10|B2G1GGAB|Beta-2 Glycoprotein 1 IgG Antibody|CHEMISTRY|||[?]|[?]|POSITIVE|1|BOLUS|1|1|[?]|LOW|SEMEN|PARAFFIN-EMBEDDED|N|IMMUNOCHROMATOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA|Y|5|Visit_5|90|1|TREATMENT|2020-12-03|2020-12-06|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|aeddc1ed-545c-405e-b1f7-08131961f5ff|1|IGF2|Insulin-like Growth Factor-2|URINALYSIS|[?]|MET|[?]|[?]|INVALID|1|POUCH|1|1|[?]|HIGH|BASAL TEAR|CONTAMINATED||ELECTROCHEMILUMINESCENCE|FIBROTEST FORMULA|||U||1|Visit_1|10|1|WASHOUT|2020-10-15|2020-11-08|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|aeddc1ed-545c-405e-b1f7-08131961f5ff|2|HLADRMSC|HLA-DR Mismatch Count|CHEMISTRY|[?]|umol/L|[?]|[?]|TRACE|1|MASK|1|1|[?]|HIGH|PLEURAL TISSUE|CONCENTRATED|N|WHOLE GENOME SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|NA||1|Visit_1|10|7|SCREENING|2020-10-15|2020-10-17|10|12|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|aeddc1ed-545c-405e-b1f7-08131961f5ff|3|ACE|Angiotensin Converting Enzyme|CHEMISTRY|[?]|mL/sec/1.73m2|[?]|[?]|BORDERLINE|1|/MBP|1|1|[?]|NORMAL|NAIL|SOLIDIFIED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI FORMULA|Y||Y||2|Visit_2|25|1|FOLLOW-UP|2020-10-30|2020-11-16|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|aeddc1ed-545c-405e-b1f7-08131961f5ff|4|SPERMP|Spermatozoa, Progressive|URINALYSIS|||[?]|[?]|INDETERMINATE|1|umol/day|1|1|[?]|HIGH|INFRANATANT, PLASMA|FROZEN||HIGH RESOLUTION CT|FIBROSIS 4 FORMULA|Y|Y|NA|Y|2|Visit_2|25|2|WASHOUT|2020-10-30|2020-11-03|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|aeddc1ed-545c-405e-b1f7-08131961f5ff|5|APROTCRS|Activated Protein C Resistance|URINALYSIS|[?]|TRANSDUCING UNIT|[?]|[?]|POSITIVE|1|Enzyme U/m2|1|1|[?]|HIGH|SERUM OR PLASMA|FROZEN|N|CRYOSCOPY|MDRD 5 VARIABLE FORMULA|Y||Y||3|Visit_3|40|1|TREATMENT|2020-11-14|2020-12-19|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|aeddc1ed-545c-405e-b1f7-08131961f5ff|6|CLCTRIOL|Calcitriol|HEMATOLOGY|[?]|ug/animal|[?]|[?]|BORDERLINE|1|GBq/mg|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|CONCENTRATED||LAPAROSCOPY|CKD-EPI FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-11-14|2020-12-16|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|aeddc1ed-545c-405e-b1f7-08131961f5ff|7|CA|Calcium|CHEMISTRY|[?]|ohm|[?]|[?]|BORDERLINE|1|breaths/30s|1|1|[?]|HIGH|INTERSTITIAL FLUID|LIPEMIC||PEAK FLOWMETRY|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|5|WASHOUT|2020-12-09|2020-12-15|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|LB|aeddc1ed-545c-405e-b1f7-08131961f5ff|8|BUCHE|Butyrylcholinesterase|HEMATOLOGY|||[?]|[?]|TRACE|1|BOLUS|1|1|[?]|ABNORMAL|COLOSTRUM|AGGLUTINATED|N|TEMPLATE INCISION METHOD|FIBROTEST FORMULA|||U|Y|4|Visit_4|65|2|WASHOUT|2020-12-09|2020-12-22|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|LB|aeddc1ed-545c-405e-b1f7-08131961f5ff|9|PNCTPP|Pancreatic Polypeptide|CHEMISTRY|[?]|10^8 PFU|[?]|[?]|BORDERLINE|1|Gy/min|1|1|[?]|ABNORMAL|SEMEN|CONCENTRATED||MICROSCOPY|HEPASCORE FORMULA||Y|N||5|Visit_5|90|1|WASHOUT|2021-01-03|2021-01-04|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|aeddc1ed-545c-405e-b1f7-08131961f5ff|10|HALBAB|Human Albumin Antibody|HEMATOLOGY|[?]|pg/cell|[?]|[?]|INDETERMINATE|1|10^7 PFU|1|1|[?]|LOW|ARTERIAL CORD BLOOD|NON-HEMOLYZED||SINGLE-MOLECULE ARRAY|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|6|SCREENING|2021-01-03|2021-01-08|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|3effe272-6a68-4163-a4f3-bd269af6061c|1|NITRICOX|Nitric Oxide|HEMATOLOGY|[?]|POUCH|[?]|[?]|BORDERLINE|1|KALLIKREIN INHIBITOR UNIT|1|1|[?]|LOW|AMNIOTIC FLUID|THAWED||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|6|SCREENING|2021-01-15|2021-03-27|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|LB|3effe272-6a68-4163-a4f3-bd269af6061c|2|ALBIDX|Albumin Index|HEMATOLOGY|[?]|uL/dose|[?]|[?]|BORDERLINE|1|VOXEL|1|1|[?]|NORMAL|ALVEOLAR AIR|ROOM TEMPERATURE||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROSIS 4 FORMULA||Y|U||1|Visit_1|10|7|SCREENING|2021-01-15|2021-04-14|10|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|LB|3effe272-6a68-4163-a4f3-bd269af6061c|3|IL1RL1|Interleukin 1 Receptor-Like 1|CHEMISTRY|[?]|vg/mL|[?]|[?]|INVALID|1|tuberculin unit|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|FRESH||THERMAL IONIZATION MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|3|TREATMENT|2021-01-30|2021-03-06|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|3effe272-6a68-4163-a4f3-bd269af6061c|4|PRAB|Panel Reactive Antibody|URINALYSIS|[?]|mph|[?]|[?]|INDETERMINATE|1|Ci|1|1|[?]|HIGH|SPERMATOZOON|SOLIDIFIED||POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||2|Visit_2|25|7|TREATMENT|2021-01-30|2021-03-27|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|3effe272-6a68-4163-a4f3-bd269af6061c|5|P50OXYGN|P50 Oxygen|HEMATOLOGY|||[?]|[?]|TRACE|1|L/day|1|1|[?]|ABNORMAL|EXUDATE|CONCENTRATED||IN VITRO GENE EXPRESSION ASSAY|MDRD 5 VARIABLE FORMULA||Y|U|Y|3|Visit_3|40|7|WASHOUT|2021-02-14|2021-03-08|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|3effe272-6a68-4163-a4f3-bd269af6061c|6|INTLK26|Interleukin 26|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|GBq/mg|1|1|[?]|LOW|KERATINOCYTE|CONTAMINATED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA|Y||N|Y|3|Visit_3|40|6|TREATMENT|2021-02-14|2021-03-05|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|3effe272-6a68-4163-a4f3-bd269af6061c|7|TNF12|TNF Superfamily Member 12|HEMATOLOGY|[?]|Gravitational Unit|[?]|[?]|INVALID|1|JAR|1|1|[?]|NORMAL|SPUTUM|CLOTTED||NEXT GENERATION SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|Y||4|Visit_4|65|6|TREATMENT|2021-03-11|2021-04-05|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|LB|3effe272-6a68-4163-a4f3-bd269af6061c|8|NEUTMM|Neutrophilic Metamyelocytes|URINALYSIS|[?]|U/m2/h|[?]|[?]|INVALID|1|/10^3|1|1|[?]|LOW|HAIR FOLLICLE|PARAFFIN-EMBEDDED|N|IHC|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|7|WASHOUT|2021-03-11|2021-04-06|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|LB|3effe272-6a68-4163-a4f3-bd269af6061c|9|HCGNDI|Choriogonadotropin, Intact|CHEMISTRY|[?]|foz_us|[?]|[?]|INDETERMINATE|1|10^9/L|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|GELLED||LAPAROSCOPY|ASH FIBROSURE FORMULA||Y|Y||5|Visit_5|90|2|TREATMENT|2021-04-05|2021-04-11|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-03
e|LB|3effe272-6a68-4163-a4f3-bd269af6061c|10|MPO|Myeloperoxidase|URINALYSIS|||[?]|[?]|INDETERMINATE|1|DIP|1|1|[?]|LOW|LAVAGE FLUID|GELLED|N|IMMUNORADIOMETRIC ASSAY|CKD-EPI CREATININE FORMULA||Y|Y|Y|5|Visit_5|90|7|TREATMENT|2021-04-05|2021-04-09|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-03
e|LB|8153c765-a92a-4b0f-9ef3-6ca925337f54|1|ETPTP|ETP Time to Peak|CHEMISTRY|[?]|RNA copies/mL|[?]|[?]|INDETERMINATE|1|PFU/mL|1|1|[?]|LOW|MUSCLE TISSUE|THAWED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-09-29|2020-10-22|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|8153c765-a92a-4b0f-9ef3-6ca925337f54|2|BJPROT|Bence-Jones Protein|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|/200 HPFs|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR||TONOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|6|TREATMENT|2020-09-29|2020-12-20|10|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|8153c765-a92a-4b0f-9ef3-6ca925337f54|3|AMYLOIDA|Amyloid A|CHEMISTRY|[?]|IU/day|[?]|[?]|POSITIVE|1|IU/g|1|1|[?]|ABNORMAL|NAIL|PARAFFIN-EMBEDDED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2020-10-14|2020-11-02|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|8153c765-a92a-4b0f-9ef3-6ca925337f54|4|MSTHCE|Mesothelial Cells|HEMATOLOGY|||[?]|[?]|TRACE|1|EP U|1|1|[?]|HIGH|DIALYSIS FLUID|CONCENTRATED||LIQUID SCINTILLATION COUNTING|NASH FIBROSURE FORMULA|||N|Y|2|Visit_2|25|7|FOLLOW-UP|2020-10-14|2020-12-04|25|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|8153c765-a92a-4b0f-9ef3-6ca925337f54|5|CCL8|Chemokine (C-C Motif) Ligand 8|CHEMISTRY|[?]|pmol/L/h|[?]|[?]|INVALID|1|mPa|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|REFRIGERATED||PYROSEQUENCING|FIBROSIS 4 FORMULA|Y||NA||3|Visit_3|40|3|TREATMENT|2020-10-29|2020-12-08|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|8153c765-a92a-4b0f-9ef3-6ca925337f54|6|MKCMKBMP|Megakaryocyte and Megakaryoblast Morph|HEMATOLOGY|[?]|MPL U|[?]|[?]|NEGATIVE|1|uCi/L|1|1|[?]|NORMAL|INTERSTITIAL FLUID|NON-HEMOLYZED||SPIRAL CT SCAN WITHOUT CONTRAST|GMI MMOL/MOL FORMULA|||U||3|Visit_3|40|1|FOLLOW-UP|2020-10-29|2020-11-19|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|8153c765-a92a-4b0f-9ef3-6ca925337f54|7|THYATAB|Thyroid Antithyroglobulin Antibodies|CHEMISTRY|[?]|L/L|[?]|[?]|POSITIVE|1|mg/kg/day|1|1|[?]|HIGH|CAPILLARY BLOOD|ROOM TEMPERATURE||SURFACE PLASMON RESONANCE|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-11-23|2020-12-10|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|8153c765-a92a-4b0f-9ef3-6ca925337f54|8|BASOMYL|Basophilic Myelocytes|CHEMISTRY|[?]|10^7 PFU|[?]|[?]|POSITIVE|1|10^6 organisms|1|1|[?]|LOW|BASAL TEAR|LIPEMIC||NO INFORMATION|GMI % FORMULA|||N||4|Visit_4|65|6|FOLLOW-UP|2020-11-23|2020-11-25|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|8153c765-a92a-4b0f-9ef3-6ca925337f54|9|C130100|Mixed Antigen IgE Antibody|CHEMISTRY|[?]|umol/min|[?]|[?]|POSITIVE|1|pm|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|UNEXPECTED ODOR||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2020-12-18|2020-12-26|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|8153c765-a92a-4b0f-9ef3-6ca925337f54|10|TCHT|Taurocholate|URINALYSIS|[?]|mEq/g|[?]|[?]|TRACE|1|10^6 copies/mL|1|1|[?]|ABNORMAL|LYMPH|FROZEN||MICRONEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA|Y||U||5|Visit_5|90|2|SCREENING|2020-12-18|2020-12-24|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|8d27cdcf-768e-4630-95b5-da554f6f3b56|1|C5|Complement C5|HEMATOLOGY|[?]|um/day|[?]|[?]|TRACE|1|mL/s/m2|1|1|[?]|HIGH|CALCULUS|FROZEN||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2020-10-30|2020-10-31|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|8d27cdcf-768e-4630-95b5-da554f6f3b56|2|VLDL3|VLDL Cholesterol Subtype 3|HEMATOLOGY|[?]|SCOOPFUL|[?]|[?]|NEGATIVE|1|nkat/g Hb|1|1|[?]|NORMAL|BREAST MILK|UNEXPECTED ODOR||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|HEPASCORE FORMULA|Y||NA||1|Visit_1|10|2|TREATMENT|2020-10-30|2021-01-23|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|8d27cdcf-768e-4630-95b5-da554f6f3b56|3|RBCNUC|Nucleated Erythrocytes|CHEMISTRY|[?]|Enzyme U/m2|[?]|[?]|POSITIVE|1|umol/day|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|HEMOLYZED||HPLC/IEX|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|1|SCREENING|2020-11-14|2021-01-21|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|8d27cdcf-768e-4630-95b5-da554f6f3b56|4|BLISTCE|Blister Cell|URINALYSIS|[?]|uU/L|[?]|[?]|INDETERMINATE|1|ft3|1|1|[?]|LOW|URINE SEDIMENT|AUTOLYZED||CLIP|FIBROTEST FORMULA||Y|N||2|Visit_2|25|3|TREATMENT|2020-11-14|2020-12-30|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|8d27cdcf-768e-4630-95b5-da554f6f3b56|5|CD161LY|CD161/Lymphocytes|URINALYSIS|[?]|1/(s*kPa)|[?]|[?]|NEGATIVE|1|mEq/uL|1|1|[?]|HIGH|GASTRIC CONTENTS|PARAFFIN-EMBEDDED||MANUAL CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||3|Visit_3|40|1|TREATMENT|2020-11-29|2020-12-30|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|8d27cdcf-768e-4630-95b5-da554f6f3b56|6|BASOB|Basophils Band Form|HEMATOLOGY|[?]|mJoule/cm2|[?]|[?]|INVALID|1|kHz|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|CALCIFIED||TOTAL BODY IRRADIATION|GMI % FORMULA||Y|Y||3|Visit_3|40|3|SCREENING|2020-11-29|2020-12-27|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|8d27cdcf-768e-4630-95b5-da554f6f3b56|7|INHIBINA|Inhibin A|HEMATOLOGY|[?]|ft3|[?]|[?]|INDETERMINATE|1|ms/mmHg|1|1|[?]|ABNORMAL|BREAST MILK|GELLED||DNA MICROARRAY|HEPASCORE FORMULA|||N||4|Visit_4|65|6|TREATMENT|2020-12-24|2021-01-21|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|8d27cdcf-768e-4630-95b5-da554f6f3b56|8|ANAG|Alpha-N-acetylglucosaminidase|URINALYSIS|[?]|YEARS|[?]|[?]|POSITIVE|1|mOsm/kg|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|AGGLUTINATED||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI CREATININE FORMULA|||N||4|Visit_4|65|3|FOLLOW-UP|2020-12-24|2021-01-17|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|8d27cdcf-768e-4630-95b5-da554f6f3b56|9|TNF12EXR|TNF Superfamily Member 12 Excretion Rate|URINALYSIS|[?]|mL/dL|[?]|[?]|NEGATIVE|1|amol|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|CALCIFIED||TELLER ACUITY CARDS|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|6|TREATMENT|2021-01-18|2021-01-23|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|LB|8d27cdcf-768e-4630-95b5-da554f6f3b56|10|LDH5LDH|LDH Isoenzyme 5/LDH|URINALYSIS|[?]|mEq/ug|[?]|[?]|NEGATIVE|1|10^9 organisms|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|DRIED|N|CONTRAST ENHANCED PET/CT SCAN|GMI MMOL/MOL FORMULA|Y||NA||5|Visit_5|90|3|WASHOUT|2021-01-18|2021-01-22|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|LB|5c2791ff-aaf6-413f-9827-6e97e2273388|1|LIPASEP|Lipase, Pancreatic|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Coulomb|1|1|[?]|ABNORMAL|COLOSTRUM|ROOM TEMPERATURE||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROMETER FORMULA|||Y|Y|1|Visit_1|10|2|SCREENING|2020-09-06|2020-09-09|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|5c2791ff-aaf6-413f-9827-6e97e2273388|2|MDZPM|Medazepam|URINALYSIS|[?]|um2|[?]|[?]|NEGATIVE|1|uSiemens|1|1|[?]|ABNORMAL|CORD SERUM|CONTAMINATED||TRANSTHORACIC ECHOCARDIOGRAPHY|HEPASCORE FORMULA|Y||U||1|Visit_1|10|4|TREATMENT|2020-09-06|2020-11-19|10|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|5c2791ff-aaf6-413f-9827-6e97e2273388|3|INTLK13|Interleukin 13|URINALYSIS|[?]|mmol/g|[?]|[?]|NEGATIVE|1|mg/mol|1|1|[?]|HIGH|SUPERNATANT, SERUM|CALCIFIED||NEXT GENERATION TARGETED SEQUENCING|FIBROMETER FORMULA|||Y||2|Visit_2|25|3|FOLLOW-UP|2020-09-21|2020-10-15|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|5c2791ff-aaf6-413f-9827-6e97e2273388|4|THYPXDAB|Thyroperoxidase Antibody|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|deg/s|1|1|[?]|NORMAL|BONE|THAWED||KINETIC CHROMOGENIC ASSAY|FIBROSIS 4 FORMULA|||NA|Y|2|Visit_2|25|4|TREATMENT|2020-09-21|2020-11-22|25|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|5c2791ff-aaf6-413f-9827-6e97e2273388|5|PLATAGRN|Platelets, Agranular|URINALYSIS|[?]|U/m2/h|[?]|[?]|NEGATIVE|1|mmol/s|1|1|[?]|NORMAL|PLEURAL TISSUE|AGGLUTINATED|N|LYMPHANGIOGRAPHY|MDRD 4 VARIABLE FORMULA|||U||3|Visit_3|40|1|TREATMENT|2020-10-06|2020-11-16|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|5c2791ff-aaf6-413f-9827-6e97e2273388|6|C130120|Shellfish Mix Antigen IgE Antibody|URINALYSIS|[?]|/wk|[?]|[?]|INVALID|1|ug/day|1|1|[?]|LOW|GASTRIC CONTENTS|FRESH|N|SINGLE-MOLECULE ARRAY|FIBROSIS 4 FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-10-06|2020-10-17|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|5c2791ff-aaf6-413f-9827-6e97e2273388|7|P3NP|Procollagen 3 N-Terminal Propeptide|HEMATOLOGY|[?]|BOX|[?]|[?]|BORDERLINE|1|cup eq|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|DRIED||SIZE EXCLUSION CHROMATOGRAPHY|CKD-EPI FORMULA|||Y||4|Visit_4|65|4|SCREENING|2020-10-31|2020-11-13|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|5c2791ff-aaf6-413f-9827-6e97e2273388|8|ANA|Antinuclear Antibodies|CHEMISTRY|[?]|BU/mL|[?]|[?]|NEGATIVE|1|STRIP|1|1|[?]|HIGH|GASTRIC FLUID|CALCIFIED||MEDIASTINOSCOPY|HEPASCORE FORMULA|||U||4|Visit_4|65|2|TREATMENT|2020-10-31|2020-11-07|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|5c2791ff-aaf6-413f-9827-6e97e2273388|9|ALPBALP|Alk Phos, Bone/Total Alk Phos|CHEMISTRY|[?]|uSiemens|[?]|[?]|INDETERMINATE|1|10^8 PFU|1|1|[?]|ABNORMAL|DISCHARGE|AUTOLYZED|N|GRADIENT DIFFUSION|CKD-EPI FORMULA|||N||5|Visit_5|90|2|FOLLOW-UP|2020-11-25|2020-12-04|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|LB|5c2791ff-aaf6-413f-9827-6e97e2273388|10|BLSTSID|Sideroblast|URINALYSIS|[?]|mgEq|[?]|[?]|NEGATIVE|1|cycle/min|1|1|[?]|ABNORMAL|TISSUE|CLOTTED||COULOMETRIC TITRATION|MDRD 5 VARIABLE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-11-25|2020-12-01|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|LB|b336d8c2-7bca-404e-aea3-5148d559ea99|1|VITC|Vitamin C|HEMATOLOGY|[?]|log10 TCID 50/uL|[?]|[?]|INDETERMINATE|1|mmol/min/kPa|1|1|[?]|ABNORMAL|TRANSUDATE|GELLED||SINGLE-MOLECULE ARRAY|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|4|FOLLOW-UP|2020-09-19|2020-11-24|10|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|b336d8c2-7bca-404e-aea3-5148d559ea99|2|INTLK12|Interleukin 12|CHEMISTRY|||[?]|[?]|INVALID|1|10^6 IU/mL|1|1|[?]|HIGH|PLASMA|CALCIFIED|N|ICP-MS|CKD-EPI FORMULA|||Y|Y|1|Visit_1|10|1|TREATMENT|2020-09-19|2020-10-21|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|b336d8c2-7bca-404e-aea3-5148d559ea99|3|GLDIGGAB|Gliadin IgG Antibody|HEMATOLOGY|[?]|umol/h/mmol|[?]|[?]|INVALID|1|mCi|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|DRIED||HPLC-UV|FIBROTEST FORMULA||Y|Y||2|Visit_2|25|3|TREATMENT|2020-10-04|2020-12-06|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|b336d8c2-7bca-404e-aea3-5148d559ea99|4|MYL3|Myosin Light Chain 3|CHEMISTRY|||[?]|[?]|POSITIVE|1|CAN|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED||PHYSICAL EXAMINATION|MDRD ENZYMATIC FORMULA|||U|Y|2|Visit_2|25|2|TREATMENT|2020-10-04|2020-12-07|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|b336d8c2-7bca-404e-aea3-5148d559ea99|5|LACTULOS|Lactulose|CHEMISTRY|[?]|days/month|[?]|[?]|TRACE|1|U/kg|1|1|[?]|NORMAL|ISOLATE|ICTERIC||MICRO BROTH DILUTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||3|Visit_3|40|5|FOLLOW-UP|2020-10-19|2020-11-30|40|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|b336d8c2-7bca-404e-aea3-5148d559ea99|6|AMYLASES|Amylase, Salivary|CHEMISTRY|[?]|C|[?]|[?]|INDETERMINATE|1|km/h|1|1|[?]|ABNORMAL|REFLEX TEAR|ROOM TEMPERATURE|N|INDIRECT IMMUNOFLUORESCENCE|MDRD 6 VARIABLE FORMULA||Y|NA||3|Visit_3|40|6|TREATMENT|2020-10-19|2020-11-03|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|b336d8c2-7bca-404e-aea3-5148d559ea99|7|IL1RL1|Interleukin 1 Receptor-Like 1|HEMATOLOGY|[?]|QUANTITY SUFFICIENT|[?]|[?]|BORDERLINE|1|IU/day|1|1|[?]|HIGH|RETICULOCYTES|PARAFFIN-EMBEDDED|N|MAPH|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|4|SCREENING|2020-11-13|2020-11-23|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|b336d8c2-7bca-404e-aea3-5148d559ea99|8|RETILRTC|Low Absorption Retic/Reticulocytes|CHEMISTRY|[?]|PACKAGE|[?]|[?]|POSITIVE|1|Bq|1|1|[?]|LOW|PROSTATIC FLUID|PARAFFIN-EMBEDDED|N|COMPUTERIZED CORNEAL TOPOGRAPHY|ASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|4|SCREENING|2020-11-13|2020-12-08|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|b336d8c2-7bca-404e-aea3-5148d559ea99|9|PLATLRG|Large Platelets|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|cP|1|1|[?]|ABNORMAL|BILE|THAWED||GC/MS/MS|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|5|Visit_5|90|2|FOLLOW-UP|2020-12-08|2020-12-13|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|b336d8c2-7bca-404e-aea3-5148d559ea99|10|FIBRINO|Fibrinogen|HEMATOLOGY|||[?]|[?]|POSITIVE|1|POUCH|1|1|[?]|ABNORMAL|BONE|CLOTTED||LISSAMINE GREEN STAIN|FIBROMETER FORMULA|||NA|Y|5|Visit_5|90|5|FOLLOW-UP|2020-12-08|2020-12-16|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|702b2f8f-63b9-44c1-a46d-1a41bc837c32|1|GUSB|Glucuronidase, Beta|HEMATOLOGY|[?]|/LPF|[?]|[?]|INDETERMINATE|1|keV|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|SOLIDIFIED||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|HEPASCORE FORMULA|||NA||1|Visit_1|10|2|SCREENING|2020-06-17|2020-08-29|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|702b2f8f-63b9-44c1-a46d-1a41bc837c32|2|CSGRANF|Granular Fine Casts|CHEMISTRY|||[?]|[?]|NEGATIVE|1|/10^5|1|1|[?]|HIGH|TRANSUDATE|REFRIGERATED||RIA|MDRD 6 VARIABLE FORMULA|||U|Y|1|Visit_1|10|6|TREATMENT|2020-06-17|2020-07-25|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|702b2f8f-63b9-44c1-a46d-1a41bc837c32|3|IFI44|Interferon-Induced Protein 44|CHEMISTRY|[?]|mU/L|[?]|[?]|POSITIVE|1|Joule|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|UNEXPECTED ODOR||ENZYMATIC ULTRACENTRIFUGATION|FIBROMETER FORMULA|Y|Y|N||2|Visit_2|25|6|TREATMENT|2020-07-02|2020-07-14|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|LB|702b2f8f-63b9-44c1-a46d-1a41bc837c32|4|CTXIICRT|Type II Collagen C-Telopeptides/Creat|CHEMISTRY|||[?]|[?]|INVALID|1|HOURS|1|1|[?]|NORMAL|PERITONEAL FLUID|GELLED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI % FORMULA|||N|Y|2|Visit_2|25|6|TREATMENT|2020-07-02|2020-07-20|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|LB|702b2f8f-63b9-44c1-a46d-1a41bc837c32|5|PG|Prostaglandin|HEMATOLOGY|[?]|mL/min/1.73m2|[?]|[?]|INVALID|1|U/g|1|1|[?]|HIGH|SEMEN|FROZEN||FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||Y|Y||3|Visit_3|40|3|WASHOUT|2020-07-17|2020-07-23|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|702b2f8f-63b9-44c1-a46d-1a41bc837c32|6|CHLMCRNT|Chylomicron Triglyceride|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|foz_us|1|1|[?]|NORMAL|SMEGMA|CALCIFIED||MICRONEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA||Y|NA|Y|3|Visit_3|40|3|TREATMENT|2020-07-17|2020-08-22|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|702b2f8f-63b9-44c1-a46d-1a41bc837c32|7|MPV|Mean Platelet Volume|CHEMISTRY|||[?]|[?]|NEGATIVE|1|MPL U/mL|1|1|[?]|LOW|SPERMATOZOON|DRIED|N|PALM METHOD|NASH FIBROSURE FORMULA||Y|Y|Y|4|Visit_4|65|2|TREATMENT|2020-08-11|2020-08-28|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|702b2f8f-63b9-44c1-a46d-1a41bc837c32|8|BLASTLM|Leukemic Blasts|CHEMISTRY|[?]|log EID 50/dose|[?]|[?]|NEGATIVE|1|EU|1|1|[?]|HIGH|AMNIOTIC FLUID|LIPEMIC|N|AURAMINE STAIN|MDRD 4 VARIABLE FORMULA|||N||4|Visit_4|65|5|SCREENING|2020-08-11|2020-09-03|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|702b2f8f-63b9-44c1-a46d-1a41bc837c32|9|FCTXIIIA|Factor XIII Activity|HEMATOLOGY|[?]|kDa|[?]|[?]|INDETERMINATE|1|MONTHS|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|LIPEMIC||TOLUIDINE BLUE STAIN|FIBROMETER FORMULA|||N||5|Visit_5|90|7|TREATMENT|2020-09-05|2020-09-14|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|702b2f8f-63b9-44c1-a46d-1a41bc837c32|10|C130108|Weed Mix Pollen Antigen IgA Antibody|URINALYSIS|[?]|gpELISA unit/mL|[?]|[?]|INDETERMINATE|1|DIOPTER|1|1|[?]|NORMAL|CAPILLARY BLOOD|HEMOLYZED||KARYOTYPING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||5|Visit_5|90|2|TREATMENT|2020-09-05|2020-09-11|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|1261eee1-f073-4419-b0b7-28abd0ec1513|1|VITB1|Thiamine|CHEMISTRY|||[?]|[?]|INVALID|1|10^6 IU/mL|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|THAWED||ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|1|Visit_1|10|5|TREATMENT|2020-10-01|2020-10-23|10|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|1261eee1-f073-4419-b0b7-28abd0ec1513|2|C130079|Silver Birch Pollen IgG4|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|/4.0 mL|1|1|[?]|LOW|ARTERIAL BLOOD|AGGLUTINATED||DNA MICROARRAY|MDRD 6 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|1|TREATMENT|2020-10-01|2020-10-22|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|1261eee1-f073-4419-b0b7-28abd0ec1513|3|MONMPHLE|Monocytes and Macrophages/Leukocytes|HEMATOLOGY|[?]|/MBP|[?]|[?]|BORDERLINE|1|/200 HPFs|1|1|[?]|HIGH|EPITHELIAL CELL|CLOTTED||MICROARRAY|CKD-EPI CYSTATIN C FORMULA||Y|U||2|Visit_2|25|1|TREATMENT|2020-10-16|2020-10-17|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|1261eee1-f073-4419-b0b7-28abd0ec1513|4|CD23|CD23|HEMATOLOGY|[?]|mL/cage/wk|[?]|[?]|INDETERMINATE|1|%/min|1|1|[?]|LOW|EXPIRED AIR|FRESH||THERMAL IONIZATION MASS SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||2|Visit_2|25|1|FOLLOW-UP|2020-10-16|2020-11-30|25|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|1261eee1-f073-4419-b0b7-28abd0ec1513|5|IDL|IDL Cholesterol|URINALYSIS|||[?]|[?]|TRACE|1|LOZENGE|1|1|[?]|NORMAL|LYSATE|ROOM TEMPERATURE||IODINE STAIN|ASH FIBROSURE FORMULA||Y|Y|Y|3|Visit_3|40|7|SCREENING|2020-10-31|2020-12-18|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|1261eee1-f073-4419-b0b7-28abd0ec1513|6|METHQLDN|Methaqualone|CHEMISTRY|[?]|cmH2O*s/mL|[?]|[?]|INDETERMINATE|1|ug/kg|1|1|[?]|NORMAL|SWABBED MATERIAL|CONTAMINATED||COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||N||3|Visit_3|40|4|FOLLOW-UP|2020-10-31|2020-12-29|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|1261eee1-f073-4419-b0b7-28abd0ec1513|7|SMUSCGAB|Smooth Muscle IgG Antibody|HEMATOLOGY|[?]|s/h|[?]|[?]|POSITIVE|1|mL/animal/wk|1|1|[?]|NORMAL|BREAST MILK|ICTERIC||TRIPLE-PHASE SPIRAL CT SCAN|MDRD ENZYMATIC FORMULA|Y||NA||4|Visit_4|65|7|SCREENING|2020-11-25|2020-11-26|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|1261eee1-f073-4419-b0b7-28abd0ec1513|8|CORTISOL|Cortisol|CHEMISTRY|[?]|10^3 CFU/g|[?]|[?]|INDETERMINATE|1|MdFI|1|1|[?]|LOW|SEMINAL FLUID|AGGLUTINATED|N|AGAR PROPORTION|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||4|Visit_4|65|2|FOLLOW-UP|2020-11-25|2020-12-18|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|1261eee1-f073-4419-b0b7-28abd0ec1513|9|NOHDLHDL|Non-HDL Cholesterol/HDL Cholesterol|URINALYSIS|||[?]|[?]|POSITIVE|1|nmol/mL/min|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|GELLED||MAPH|GMI % FORMULA|Y||NA|Y|5|Visit_5|90|7|WASHOUT|2020-12-20|2020-12-25|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|1261eee1-f073-4419-b0b7-28abd0ec1513|10|PGAG|Platelet-Granulocyte Agg|CHEMISTRY|[?]|TUBE|[?]|[?]|INVALID|1|CIGAR|1|1|[?]|HIGH|HAIR FOLLICLE|NON-HEMOLYZED||RADIAL IMMUNODIFFUSION|MDRD 6 VARIABLE FORMULA||Y|N||5|Visit_5|90|3|TREATMENT|2020-12-20|2020-12-26|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|46eefdf3-c314-4e61-963c-ce7f48c636e5|1|MYCEPPOL|Myeloid Proliferation Pool|HEMATOLOGY|[?]|10^6 CFU/g|[?]|[?]|INDETERMINATE|1|kBq|1|1|[?]|NORMAL|VENOUS PLASMA|CONCENTRATED|N|CLINICAL EVALUATION|CKD-EPI FORMULA|||U||1|Visit_1|10|1|WASHOUT|2020-12-29|2021-01-24|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|46eefdf3-c314-4e61-963c-ce7f48c636e5|2|AMPHET|Amphetamine|CHEMISTRY|[?]|min/day|[?]|[?]|INDETERMINATE|1|in2|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|UNEXPECTED ODOR||PEAK FLOWMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||1|Visit_1|10|6|FOLLOW-UP|2020-12-29|2021-03-15|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|46eefdf3-c314-4e61-963c-ce7f48c636e5|3|RBCFRAG|Erythrocyte Fragment|URINALYSIS|||[?]|[?]|POSITIVE|1|cd/m2|1|1|[?]|HIGH|LEUKOCYTE|SOLIDIFIED||COULOMETRIC TITRATION|MDRD 5 VARIABLE FORMULA|||NA|Y|2|Visit_2|25|4|WASHOUT|2021-01-13|2021-02-08|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|46eefdf3-c314-4e61-963c-ce7f48c636e5|4|OPIATE|Opiate|CHEMISTRY|[?]|nmol/mL/min|[?]|[?]|INVALID|1|Bq/mL|1|1|[?]|NORMAL|CELL PELLET|HEMOLYZED||HPLC-UV|MDRD ENZYMATIC FORMULA|||NA||2|Visit_2|25|7|TREATMENT|2021-01-13|2021-01-21|25|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|46eefdf3-c314-4e61-963c-ce7f48c636e5|5|C130109|Mold Mix Antigen IgE Antibody|HEMATOLOGY|[?]|mL/(min*100mL)|[?]|[?]|TRACE|1|genEq|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|AGGLUTINATED|N|COULOMETRIC TITRATION|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2021-01-28|2021-03-17|40|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|46eefdf3-c314-4e61-963c-ce7f48c636e5|6|GLUCPE|Plasma Equivalent Glucose|CHEMISTRY|[?]|cm|[?]|[?]|INVALID|1|10^3 DNA copies/mL|1|1|[?]|NORMAL|AQUEOUS HUMOR|CONCENTRATED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||3|Visit_3|40|4|WASHOUT|2021-01-28|2021-03-18|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|46eefdf3-c314-4e61-963c-ce7f48c636e5|7|HSP90A|Heat Shock Protein 90 Alpha|HEMATOLOGY|[?]|mg/kg|[?]|[?]|TRACE|1|g/cage|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|GELLED||CLIP SEQUENCING|GMI MMOL/MOL FORMULA||Y|NA||4|Visit_4|65|7|SCREENING|2021-02-22|2021-03-17|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|46eefdf3-c314-4e61-963c-ce7f48c636e5|8|WBC|Leukocytes|URINALYSIS|[?]|vg/dose|[?]|[?]|POSITIVE|1|g/U|1|1|[?]|LOW|KERATINOCYTE|ICTERIC|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|5|WASHOUT|2021-02-22|2021-03-27|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|46eefdf3-c314-4e61-963c-ce7f48c636e5|9|CETPA|Cholesteryl Ester Transfer Protein Act|URINALYSIS|||[?]|[?]|POSITIVE|1|DIP|1|1|[?]|NORMAL|SEMINAL FLUID|FROZEN||SLOAN LETTER EYE CHART 2.5%|FIBROTEST FORMULA|||U|Y|5|Visit_5|90|2|WASHOUT|2021-03-19|2021-03-26|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|46eefdf3-c314-4e61-963c-ce7f48c636e5|10|GCHT|Glycocholate|HEMATOLOGY|[?]|cP|[?]|[?]|NEGATIVE|1|V|1|1|[?]|HIGH|MECONIUM|ROOM TEMPERATURE||IMMUNORADIOMETRIC ASSAY|CKD-EPI CREATININE FORMULA|||U||5|Visit_5|90|1|TREATMENT|2021-03-19|2021-03-23|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|f632159b-8c91-4f0d-81cb-e5b9195588c9|1|HDLPSZ|HDL Particle Size|CHEMISTRY|||[?]|[?]|NEGATIVE|1|nmol BCE/L|1|1|[?]|NORMAL|LEUKOCYTE|ROOM TEMPERATURE||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD 5 VARIABLE FORMULA||Y|N|Y|1|Visit_1|10|4|WASHOUT|2021-01-12|2021-01-20|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|LB|f632159b-8c91-4f0d-81cb-e5b9195588c9|2|INSULINS|Insulin Sensitivity|HEMATOLOGY|[?]|mol|[?]|[?]|BORDERLINE|1|POINT|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|N|BIOPSY|CKD-EPI FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2021-01-12|2021-02-14|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|LB|f632159b-8c91-4f0d-81cb-e5b9195588c9|3|PTHMM|Parathyroid Hormone, Mid-Molecule|URINALYSIS|[?]|TRACE|[?]|[?]|POSITIVE|1|CARTRIDGE|1|1|[?]|NORMAL|ARTERIAL BLOOD|AUTOLYZED||MICROSCOPY|FIBROTEST FORMULA|Y||Y||2|Visit_2|25|7|TREATMENT|2021-01-27|2021-03-16|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|f632159b-8c91-4f0d-81cb-e5b9195588c9|4|NAGASECR|N-acetyl-B-D-glucosaminidase/Creatinine|HEMATOLOGY|[?]|IMPLANT|[?]|[?]|NEGATIVE|1|mL/kg/min|1|1|[?]|LOW|INFRANATANT, PLASMA|FRESH||MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD ENZYMATIC FORMULA|||N||2|Visit_2|25|1|TREATMENT|2021-01-27|2021-02-27|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|f632159b-8c91-4f0d-81cb-e5b9195588c9|5|CXCL1|Chemokine (C-X-C Motif) Ligand 1|HEMATOLOGY|||[?]|[?]|INVALID|1|mOsm/L|1|1|[?]|NORMAL|MENSTRUAL BLOOD|THAWED||TRANSMISSION ELECTRON MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|3|Visit_3|40|1|TREATMENT|2021-02-11|2021-02-18|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|LB|f632159b-8c91-4f0d-81cb-e5b9195588c9|6|C165893|Wild Rye Pollen IgE AB RAST Score|URINALYSIS|[?]|nmol BCE/nmol|[?]|[?]|BORDERLINE|1|10^6 organisms/mg|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|FROZEN||CLIP|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||3|Visit_3|40|3|FOLLOW-UP|2021-02-11|2021-03-08|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|LB|f632159b-8c91-4f0d-81cb-e5b9195588c9|7|CD34|CD34|URINALYSIS|[?]|mCi/kg|[?]|[?]|BORDERLINE|1|IU/mmol|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|SOLIDIFIED||DIGITAL PCR|FIBROSIS 4 FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2021-03-08|2021-04-06|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|f632159b-8c91-4f0d-81cb-e5b9195588c9|8|PLATHCT|Platelet Hematocrit|URINALYSIS|[?]|10^6/hpf|[?]|[?]|BORDERLINE|1|DRINK|1|1|[?]|NORMAL|INFRANATANT, PLASMA|LIPEMIC||ANGIOGRAPHY|CKD-EPI FORMULA|||U||4|Visit_4|65|3|FOLLOW-UP|2021-03-08|2021-03-20|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|f632159b-8c91-4f0d-81cb-e5b9195588c9|9|PROGRP|Pro-gastrin Releasing Peptide|CHEMISTRY|[?]|uU/dL|[?]|[?]|NEGATIVE|1|kg/L|1|1|[?]|NORMAL|EXPIRED AIR|ICTERIC||ENDOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||U||5|Visit_5|90|5|WASHOUT|2021-04-02|2021-04-10|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|f632159b-8c91-4f0d-81cb-e5b9195588c9|10|INTLK1A|Interleukin 1 Alpha|URINALYSIS|[?]|POINT|[?]|[?]|INDETERMINATE|1|mmol/min/kPa|1|1|[?]|HIGH|CORD BLOOD|CONTAMINATED||MICROARRAY|FIBROMETER FORMULA|||NA||5|Visit_5|90|1|TREATMENT|2021-04-02|2021-04-05|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|898a9d2f-338b-41bf-8ac0-c4a025481349|1|CYDCPHOS|Dicalcium Phosphate Crystals|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|ug/L FEU|1|1|[?]|LOW|CEREBROSPINAL FLUID|AUTOLYZED||LYMPHANGIOGRAPHY|CKD-EPI FORMULA|Y||Y|Y|1|Visit_1|10|2|WASHOUT|2020-05-24|2020-06-11|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|898a9d2f-338b-41bf-8ac0-c4a025481349|2|HIST1AB|Histone 1 Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|cmol/L|1|1|[?]|HIGH|SKIN TISSUE|FRESH||MANUAL COUNT|ASH FIBROSURE FORMULA|Y|Y|NA|Y|1|Visit_1|10|4|TREATMENT|2020-05-24|2020-08-14|10|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|898a9d2f-338b-41bf-8ac0-c4a025481349|3|FATACVLC|Fatty Acids, Very Long Chain|URINALYSIS|[?]|mg/dose|[?]|[?]|INVALID|1|PIPE|1|1|[?]|HIGH|BONE|AUTOLYZED||DC SHEATH FLOW|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-06-08|2020-08-14|25|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|898a9d2f-338b-41bf-8ac0-c4a025481349|4|KLHIGMAB|Keyhole Limpet Hemocyanin IgM Antibody|CHEMISTRY|[?]|kg|[?]|[?]|TRACE|1|FINGERTIP UNIT|1|1|[?]|LOW|STOOL|ICTERIC|N|SLOAN LETTER EYE CHART 100%|CKD-EPI CREATININE FORMULA||Y|U||2|Visit_2|25|4|TREATMENT|2020-06-08|2020-07-02|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|898a9d2f-338b-41bf-8ac0-c4a025481349|5|MONOIMLE|Immature Monocytes/Leukocytes|CHEMISTRY|[?]|GBq/g|[?]|[?]|INDETERMINATE|1|log10 CFU/g|1|1|[?]|HIGH|LYSATE|SOLIDIFIED|N|IMMUNE REPERTOIRE DEEP SEQUENCING|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|1|WASHOUT|2020-06-23|2020-07-08|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|898a9d2f-338b-41bf-8ac0-c4a025481349|6|C130131|Dog Dander Antigen IgG4 Antibody|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|log10 copies/mL|1|1|[?]|HIGH|BUFFY COAT|AUTOLYZED|N|PEAK FLOWMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|2|SCREENING|2020-06-23|2020-07-13|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|898a9d2f-338b-41bf-8ac0-c4a025481349|7|CYP2C9|Cytochrome P450 2C9|URINALYSIS|[?]|BEAM BREAKS|[?]|[?]|TRACE|1|/500 WBC|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|LACTESCENT||MICROARRAY|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|2|WASHOUT|2020-07-18|2020-08-02|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|898a9d2f-338b-41bf-8ac0-c4a025481349|8|CPEPTIDE|C-peptide|URINALYSIS|[?]|mEq/g|[?]|[?]|TRACE|1|V|1|1|[?]|ABNORMAL|CELL PELLET|SOLIDIFIED||ORCHIDOMETERY|MDRD 6 VARIABLE FORMULA|||Y||4|Visit_4|65|1|FOLLOW-UP|2020-07-18|2020-08-05|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|898a9d2f-338b-41bf-8ac0-c4a025481349|9|GHRELINA|Active Ghrelin|URINALYSIS|||[?]|[?]|NEGATIVE|1|PUFF|1|1|[?]|ABNORMAL|SMEGMA|CLOTTED||IMMUNOASSAY|GMI % FORMULA|||NA|Y|5|Visit_5|90|7|WASHOUT|2020-08-12|2020-08-19|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|898a9d2f-338b-41bf-8ac0-c4a025481349|10|CSMIX|Mixed Casts|URINALYSIS|[?]|APL U/mL|[?]|[?]|INDETERMINATE|1|TRACE|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|LACTESCENT||IN VITRO GENE EXPRESSION ASSAY|CKD-EPI FORMULA|||NA||5|Visit_5|90|3|WASHOUT|2020-08-12|2020-08-16|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|db3824aa-375d-4e40-a14b-af0e4460914e|1|OAS2|2-5-Oligoadenylate Synthase 2|URINALYSIS|[?]|nkat/L|[?]|[?]|TRACE|1|JAR|1|1|[?]|HIGH|LYMPH|CONCENTRATED||HEMOCYTOMETRY|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-05-20|2020-07-30|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|db3824aa-375d-4e40-a14b-af0e4460914e|2|MDEA|3,4-methylenedioxy-N-ethylamphetamine|URINALYSIS|[?]|Bq|[?]|[?]|TRACE|1|Ejaculate U|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|FROZEN||FLUORESCENT MICROSCOPY|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-05-20|2020-06-11|10|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|db3824aa-375d-4e40-a14b-af0e4460914e|3|NAGASEXR|NAGASE Excretion Rate|HEMATOLOGY|[?]|PFU|[?]|[?]|TRACE|1|eq|1|1|[?]|NORMAL|PROSTATIC FLUID|SOLIDIFIED||ENDOSCOPY|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|4|FOLLOW-UP|2020-06-04|2020-08-07|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|LB|db3824aa-375d-4e40-a14b-af0e4460914e|4|LIPASEP|Lipase, Pancreatic|CHEMISTRY|[?]|mL/min/1.73m2|[?]|[?]|BORDERLINE|1|Anson U|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|AUTOLYZED||MALDI-TOF|ASH FIBROSURE FORMULA||Y|U||2|Visit_2|25|7|FOLLOW-UP|2020-06-04|2020-07-16|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|LB|db3824aa-375d-4e40-a14b-af0e4460914e|5|ISOPRF2|F2-Isoprostane|HEMATOLOGY|[?]|Mile|[?]|[?]|TRACE|1|g/day|1|1|[?]|ABNORMAL|SKIN TISSUE|FROZEN||FLOW MICROSCOPY|MDRD 6 VARIABLE FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-06-19|2020-08-09|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|db3824aa-375d-4e40-a14b-af0e4460914e|6|INR|Prothrombin Intl. Normalized Ratio|URINALYSIS|[?]|titer|[?]|[?]|TRACE|1|mg/m2/day|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|FROZEN||ICC|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-06-19|2020-08-15|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|db3824aa-375d-4e40-a14b-af0e4460914e|7|AST|Aspartate Aminotransferase|HEMATOLOGY|[?]|ug/mL/h|[?]|[?]|BORDERLINE|1|vg/dose|1|1|[?]|NORMAL|INFRANATANT, PLASMA|AUTOLYZED||JAEGER EYE CHART|ASH FIBROSURE FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-07-14|2020-08-13|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-16
e|LB|db3824aa-375d-4e40-a14b-af0e4460914e|8|MUCTHR|Mucous Threads|HEMATOLOGY|[?]|Enzyme U/L|[?]|[?]|INDETERMINATE|1|10^3 CFU|1|1|[?]|NORMAL|SWABBED MATERIAL|HEMOLYZED||BIOIMPEDANCE SPECTROSCOPY|ASH FIBROSURE FORMULA|Y|Y|NA||4|Visit_4|65|2|WASHOUT|2020-07-14|2020-07-22|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-16
e|LB|db3824aa-375d-4e40-a14b-af0e4460914e|9|TEARDCY|Dacryocytes|HEMATOLOGY|[?]|Newton|[?]|[?]|INVALID|1|dB|1|1|[?]|ABNORMAL|VENOUS BLOOD|LIPEMIC||GC/MS|GMI MMOL/MOL FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2020-08-08|2020-08-16|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|db3824aa-375d-4e40-a14b-af0e4460914e|10|CBA|Complement Ba|URINALYSIS|[?]|MET|[?]|[?]|POSITIVE|1|/MBP|1|1|[?]|NORMAL|SERUM OR PLASMA|AUTOLYZED||HPLC-FL|FIBROSIS 4 FORMULA||Y|Y||5|Visit_5|90|2|FOLLOW-UP|2020-08-08|2020-08-13|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|0ea6be64-32f8-4e10-b993-687ea200e4e9|1|PLTLPLT|Large Platelets/Total Platelets|HEMATOLOGY|[?]|cs|[?]|[?]|INDETERMINATE|1|mg/L FEU|1|1|[?]|NORMAL|PLEURAL TISSUE|GELLED||BIOIMPEDANCE SPECTROSCOPY|MDRD FORMULA|Y||N||1|Visit_1|10|4|TREATMENT|2021-01-28|2021-02-19|10|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-03
e|LB|0ea6be64-32f8-4e10-b993-687ea200e4e9|2|CYCHOL|Cholesterol Crystals|URINALYSIS|[?]|kBq|[?]|[?]|POSITIVE|1|10^3 organisms/g|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|AGGLUTINATED|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA|Y||N||1|Visit_1|10|1|WASHOUT|2021-01-28|2021-02-21|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-03
e|LB|0ea6be64-32f8-4e10-b993-687ea200e4e9|3|GLUCEXR|Glucose Excretion Rate|CHEMISTRY|[?]|ug/kg/min|[?]|[?]|NEGATIVE|1|GPL U/mL|1|1|[?]|ABNORMAL|PLATELET|FRESH||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA|||NA||2|Visit_2|25|1|SCREENING|2021-02-12|2021-02-21|25|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|0ea6be64-32f8-4e10-b993-687ea200e4e9|4|BITECE|Bite Cells|URINALYSIS|[?]|titer|[?]|[?]|BORDERLINE|1|mg/h|1|1|[?]|NORMAL|BONE MARROW|AUTOLYZED||CONTACT SPECULAR MICROSCOPY|CKD-EPI CREATININE FORMULA||Y|N||2|Visit_2|25|3|WASHOUT|2021-02-12|2021-03-29|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|0ea6be64-32f8-4e10-b993-687ea200e4e9|5|C130139|American Cockroach Antigen IgG4 Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|mmHg|1|1|[?]|LOW|EXPIRED AIR|HEMOLYZED||OPHTHALMOSCOPY|MDRD 5 VARIABLE FORMULA|||U|Y|3|Visit_3|40|3|TREATMENT|2021-02-27|2021-03-16|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|0ea6be64-32f8-4e10-b993-687ea200e4e9|6|C165937|Zea mays IgE AB RAST Score|HEMATOLOGY|[?]|MET*min|[?]|[?]|INDETERMINATE|1|10^9 CFU/mL|1|1|[?]|ABNORMAL|BONE|SOLIDIFIED||SLOAN LETTER EYE CHART 1.25%|COCKCROFT-GAULT FORMULA||Y|Y||3|Visit_3|40|2|SCREENING|2021-02-27|2021-03-16|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|0ea6be64-32f8-4e10-b993-687ea200e4e9|7|AMABARAB|ACH Receptor Modulatn Ab/ACH Receptor Ab|URINALYSIS|[?]|10^3 CFU/mL|[?]|[?]|INVALID|1|BAR|1|1|[?]|HIGH|LEUKOCYTE|CONTAMINATED|N|TELLER ACUITY CARDS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||4|Visit_4|65|7|SCREENING|2021-03-24|2021-04-03|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|0ea6be64-32f8-4e10-b993-687ea200e4e9|8|NHMCE|Nonhematic Cells|CHEMISTRY|[?]|DAYS|[?]|[?]|INVALID|1|EVENTS|1|1|[?]|NORMAL|LUNG SURFACTANT|NON-HEMOLYZED||NUCLEAR RADIOLOGY|MDRD ENZYMATIC FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2021-03-24|2021-04-26|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|0ea6be64-32f8-4e10-b993-687ea200e4e9|9|ALBGALB|Glycated Albumin/Albumin|HEMATOLOGY|[?]|DPM|[?]|[?]|BORDERLINE|1|/ms|1|1|[?]|NORMAL|CAPILLARY BLOOD|CONTAMINATED||THICK SMEAR|MDRD FORMULA|||Y||5|Visit_5|90|7|WASHOUT|2021-04-18|2021-04-22|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|0ea6be64-32f8-4e10-b993-687ea200e4e9|10|DRVVT|Dilute Russell's Viper Venom Time|URINALYSIS|||[?]|[?]|TRACE|1|USP U|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|CLOTTED|N|ERGOSPIROMETRY|HEPASCORE FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2021-04-18|2021-04-23|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|18504c4e-41c8-4c1a-a479-d179ccd318e3|1|CCPAB|Cyclic Citrullinated Peptide Antibody|CHEMISTRY|||[?]|[?]|INVALID|1|nmol/L|1|1|[?]|NORMAL|SMEGMA|SOLIDIFIED||RADIOGRAPHY|MDRD FORMULA||Y|N|Y|1|Visit_1|10|3|TREATMENT|2020-06-22|2020-06-25|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|LB|18504c4e-41c8-4c1a-a479-d179ccd318e3|2|CARNITF|Carnitine, Free|URINALYSIS|[?]|mg/mL/min|[?]|[?]|INVALID|1|Anson U|1|1|[?]|ABNORMAL|EPITHELIAL CELL|PARAFFIN-EMBEDDED||TOLUIDINE BLUE STAIN|FIBROTEST FORMULA||Y|U||1|Visit_1|10|6|WASHOUT|2020-06-22|2020-07-22|10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|LB|18504c4e-41c8-4c1a-a479-d179ccd318e3|3|MLIGCE|Malignant Cells, NOS|CHEMISTRY|||[?]|[?]|TRACE|1|ms/mmHg|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|HEMOLYZED||PERFUSION MRI|MDRD 4 VARIABLE FORMULA|||U|Y|2|Visit_2|25|3|TREATMENT|2020-07-07|2020-07-25|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|18504c4e-41c8-4c1a-a479-d179ccd318e3|4|LYMPHOID|Lymphoid Cells|CHEMISTRY|[?]|DRUM|[?]|[?]|POSITIVE|1|U/animal|1|1|[?]|NORMAL|AMNIOTIC FLUID|NON-HEMOLYZED|N|BIOPSY|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|7|FOLLOW-UP|2020-07-07|2020-07-20|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|18504c4e-41c8-4c1a-a479-d179ccd318e3|5|C165885|Olive Tree Pollen IgE AB RAST Score|HEMATOLOGY|[?]|APPLICATION|[?]|[?]|POSITIVE|1|10^6 IU|1|1|[?]|ABNORMAL|MECONIUM|HEMOLYZED||NUCLEIC ACID BASED METHOD|CKD-EPI FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-07-22|2020-08-15|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|18504c4e-41c8-4c1a-a479-d179ccd318e3|6|TLCHT|Taurolithocholate|HEMATOLOGY|[?]|pL|[?]|[?]|BORDERLINE|1|Gauss|1|1|[?]|HIGH|AQUEOUS HUMOR|REFRIGERATED||ELISA|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||3|Visit_3|40|5|WASHOUT|2020-07-22|2020-08-24|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|18504c4e-41c8-4c1a-a479-d179ccd318e3|7|METARBLE|Metarubricytes/Leukocytes|HEMATOLOGY|[?]|mL/dL|[?]|[?]|TRACE|1|Absorbance U|1|1|[?]|LOW|VENOUS PLASMA|CONCENTRATED|N|CYSTOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-08-16|2020-08-25|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|18504c4e-41c8-4c1a-a479-d179ccd318e3|8|VITDBP|Vitamin D Binding Protein|URINALYSIS|[?]|mol/day|[?]|[?]|BORDERLINE|1|mL/m2/h|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|ROOM TEMPERATURE|N|MS/MS|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||4|Visit_4|65|3|SCREENING|2020-08-16|2020-09-16|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|18504c4e-41c8-4c1a-a479-d179ccd318e3|9|HLABAGT|HLA-B Antigen Type|HEMATOLOGY|[?]|CFU/mL|[?]|[?]|INDETERMINATE|1|Sv|1|1|[?]|LOW|EMOTIONAL TEAR|CONTAMINATED|N|WESTERN BLOT|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|7|SCREENING|2020-09-10|2020-09-15|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|18504c4e-41c8-4c1a-a479-d179ccd318e3|10|AFPL3AFP|A Fetoprotein L3/A Fetoprotein|CHEMISTRY|[?]|anti-Xa IU/mL|[?]|[?]|INVALID|1|kg/cm|1|1|[?]|ABNORMAL|DIALYSIS FLUID|GELLED||PULSE OXIMETRY|GMI % FORMULA|||NA||5|Visit_5|90|2|WASHOUT|2020-09-10|2020-09-12|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|7f211d8a-7478-4082-8d95-4ace9ceee919|1|BNZLCGN|Benzoylecgonine|HEMATOLOGY|[?]|cd*s/m2|[?]|[?]|INVALID|1|mL/m2/day|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|DRIED|N|KINYOUN STAIN|MDRD 4 VARIABLE FORMULA|Y|Y|NA||1|Visit_1|10|5|SCREENING|2020-08-19|2020-08-25|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|7f211d8a-7478-4082-8d95-4ace9ceee919|2|BLAST|Blasts|HEMATOLOGY|||[?]|[?]|INVALID|1|APL U|1|1|[?]|ABNORMAL|PLASMA|ROOM TEMPERATURE|N|MAMMOGRAPHY|ASH FIBROSURE FORMULA|||NA|Y|1|Visit_1|10|5|TREATMENT|2020-08-19|2020-08-30|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|7f211d8a-7478-4082-8d95-4ace9ceee919|3|RETIL|Low Absorption Reticulocytes|URINALYSIS|[?]|10^4 CFU|[?]|[?]|POSITIVE|1|cd|1|1|[?]|HIGH|INTERSTITIAL FLUID|HEMOLYZED|N|SCINTIGRAPHY|FIBROSIS 4 FORMULA|||U||2|Visit_2|25|7|TREATMENT|2020-09-03|2020-10-22|25|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|7f211d8a-7478-4082-8d95-4ace9ceee919|4|PPA|Phenylpropanolamine|URINALYSIS|[?]|v/v|[?]|[?]|BORDERLINE|1|10^3 RNA copies/mL|1|1|[?]|NORMAL|SOFT TISSUE|PARAFFIN-EMBEDDED||GRAM STAIN|MDRD ENZYMATIC FORMULA|Y|Y|N||2|Visit_2|25|3|FOLLOW-UP|2020-09-03|2020-09-21|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|7f211d8a-7478-4082-8d95-4ace9ceee919|5|LYM|Lymphocytes|URINALYSIS|[?]|POUCH|[?]|[?]|TRACE|1|MET*min|1|1|[?]|HIGH|PLATELET RICH PLASMA|GELLED|N|CONTRAST ENHANCED X-RAY|MDRD ENZYMATIC FORMULA||Y|NA||3|Visit_3|40|1|TREATMENT|2020-09-18|2020-10-06|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|7f211d8a-7478-4082-8d95-4ace9ceee919|6|GRN|Progranulin|HEMATOLOGY|[?]|mg2/dL2|[?]|[?]|POSITIVE|1|psi|1|1|[?]|NORMAL|SEMINAL FLUID|FRESH||ANTIBIOTIC AGAR SCREEN|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|7|SCREENING|2020-09-18|2020-10-18|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|7f211d8a-7478-4082-8d95-4ace9ceee919|7|CYAMPPH|Amorphous Phosphate Crystals|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|nmol/mol|1|1|[?]|NORMAL|SKIN TISSUE|CLOTTED||NEXT GENERATION TARGETED SEQUENCING|GMI MMOL/MOL FORMULA|||Y|Y|4|Visit_4|65|4|TREATMENT|2020-10-13|2020-11-10|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|7f211d8a-7478-4082-8d95-4ace9ceee919|8|CAFFEINE|Caffeine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|RING|1|1|[?]|LOW|LYMPH|THAWED|N|ENZYMATIC ULTRACENTRIFUGATION|MDRD 6 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|6|TREATMENT|2020-10-13|2020-10-30|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|7f211d8a-7478-4082-8d95-4ace9ceee919|9|APLAB|Antiphospholipid Antibodies|HEMATOLOGY|[?]|L/h|[?]|[?]|INVALID|1|mg/kg/day|1|1|[?]|HIGH|MUSCLE TISSUE|LIPEMIC||FLUORESCENT ENZYME IMMUNOASSAY|MDRD ENZYMATIC FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-11-07|2020-11-15|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|7f211d8a-7478-4082-8d95-4ace9ceee919|10|C165877|Cat Dander IgE AB RAST Score|URINALYSIS|[?]|mEq/g|[?]|[?]|TRACE|1|mL/animal|1|1|[?]|NORMAL|SKIN TISSUE|SOLIDIFIED||BIOPSY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|1|FOLLOW-UP|2020-11-07|2020-11-10|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|0739e140-bcac-4df9-9629-bd0748d1fdd6|1|ESTRDIOL|Estradiol|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|keV|1|1|[?]|LOW|ABSCESS FLUID|FRESH||LC/MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|1|Visit_1|10|3|TREATMENT|2020-10-09|2020-12-02|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|0739e140-bcac-4df9-9629-bd0748d1fdd6|2|BLSTMBCE|Myeloblasts/Total Cells|CHEMISTRY|[?]|cm/s|[?]|[?]|INDETERMINATE|1|Hz|1|1|[?]|LOW|BUFFY COAT|ICTERIC||COLORIMETRY|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|6|WASHOUT|2020-10-09|2020-11-29|10|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|0739e140-bcac-4df9-9629-bd0748d1fdd6|3|CYFRA18|Cytokeratin 18 Fragment|HEMATOLOGY|[?]|LENS|[?]|[?]|INVALID|1|g/cage/day|1|1|[?]|LOW|LOCHIA|GELLED||CELL BASED BIOASSAY|MDRD 6 VARIABLE FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-10-24|2021-01-02|25|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|0739e140-bcac-4df9-9629-bd0748d1fdd6|4|TXB2_D11|11-Dehydro-Thromboxane B2|HEMATOLOGY|[?]|mg/L|[?]|[?]|NEGATIVE|1|eq|1|1|[?]|LOW|VITREOUS HUMOR|FRESH||ELECTRONEUROGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y|Y|N||2|Visit_2|25|6|TREATMENT|2020-10-24|2020-12-26|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|0739e140-bcac-4df9-9629-bd0748d1fdd6|5|C165880|D. pteronyssinus IgE AB RAST Score|CHEMISTRY|[?]|DROP|[?]|[?]|BORDERLINE|1|ug/L DDU|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|CLOTTED||PHOTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|6|WASHOUT|2020-11-08|2020-12-14|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|0739e140-bcac-4df9-9629-bd0748d1fdd6|6|MOCYCECE|Monocytoid Cells/Total Cells|CHEMISTRY|||[?]|[?]|INVALID|1|BLOCKS|1|1|[?]|HIGH|MONOCYTE|CALCIFIED||MULTIPLEXED BEAD BASED IMMUNOASSAY|HEPASCORE FORMULA|Y||U|Y|3|Visit_3|40|1|TREATMENT|2020-11-08|2020-11-12|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|0739e140-bcac-4df9-9629-bd0748d1fdd6|7|CODEINE|Codeine|URINALYSIS|||[?]|[?]|NEGATIVE|1|AMPULE|1|1|[?]|HIGH|DERMAL TISSUE|CONTAMINATED||ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD 6 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|1|SCREENING|2020-12-03|2020-12-24|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|LB|0739e140-bcac-4df9-9629-bd0748d1fdd6|8|ALLOILE|Alloisoleucine|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mL/min/mmHg|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|PARAFFIN-EMBEDDED||GRAM STAIN|FIBROTEST FORMULA|||Y|Y|4|Visit_4|65|6|FOLLOW-UP|2020-12-03|2020-12-27|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|LB|0739e140-bcac-4df9-9629-bd0748d1fdd6|9|ALLOILE|Alloisoleucine|CHEMISTRY|[?]|IU/kg/h|[?]|[?]|POSITIVE|1|nCi|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|SOLIDIFIED||COULOMETRIC TITRATION|MDRD ENZYMATIC FORMULA|Y||U||5|Visit_5|90|4|TREATMENT|2020-12-28|2021-01-01|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|0739e140-bcac-4df9-9629-bd0748d1fdd6|10|FACTXIIA|Factor XII Activity|URINALYSIS|[?]|L/L|[?]|[?]|NEGATIVE|1|10^6 IU|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED||VENTILATION PERFUSION LUNG SCAN|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|5|WASHOUT|2020-12-28|2021-01-03|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|1|HALLUC|Hallucinogen|URINALYSIS|[?]|Ci/kg|[?]|[?]|INDETERMINATE|1|10^6 copies/mL|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED||MICRONEUTRALIZATION ASSAY|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-12-21|2021-01-25|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|2|CD22|CD22|URINALYSIS|[?]|TABLET|[?]|[?]|INVALID|1|kg/cm2|1|1|[?]|HIGH|BASAL TEAR|DRIED||SPECT SCAN|FIBROTEST FORMULA||Y|U||1|Visit_1|10|2|TREATMENT|2020-12-21|2021-03-05|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|3|CD19|CD19|CHEMISTRY|||[?]|[?]|INVALID|1|U/m2/day|1|1|[?]|NORMAL|ERYTHROCYTES|NON-HEMOLYZED||SLIT LAMP PHOTOGRAPHY|GMI % FORMULA|||U|Y|2|Visit_2|25|6|TREATMENT|2021-01-05|2021-02-07|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|LB|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|4|CCR5|C-C Chemokine Receptor Type 5|URINALYSIS|[?]|10^6/g|[?]|[?]|TRACE|1|%/s|1|1|[?]|NORMAL|ISOLATE|PARAFFIN-EMBEDDED||GC/MS/MS|COCKCROFT-GAULT FORMULA||Y|NA||2|Visit_2|25|7|SCREENING|2021-01-05|2021-01-31|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|LB|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|5|INTLK19|Interleukin 19|HEMATOLOGY|[?]|mCi|[?]|[?]|INDETERMINATE|1|uL/kg/day|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|AUTOLYZED||ENZYMATIC COLORIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||3|Visit_3|40|7|TREATMENT|2021-01-20|2021-02-05|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|LB|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|6|PYK|Pyruvate Kinase|HEMATOLOGY|[?]|h*%|[?]|[?]|POSITIVE|1|Ci/kg|1|1|[?]|LOW|HAIR FOLLICLE|PARAFFIN-EMBEDDED||MICROBIAL CULTURE, SOLID|CKD-EPI CREATININE FORMULA|Y||U||3|Visit_3|40|5|TREATMENT|2021-01-20|2021-02-18|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|LB|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|7|FUNGIFIL|Fungi, Filamentous|URINALYSIS|[?]|mol/g|[?]|[?]|POSITIVE|1|HOURS|1|1|[?]|NORMAL|PLATELET RICH PLASMA|UNEXPECTED ODOR||NON-CONTACT SPECULAR MICROSCOPY|NASH FIBROSURE FORMULA|||Y||4|Visit_4|65|7|SCREENING|2021-02-14|2021-03-06|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|8|PLTAGAMP|Platelet Aggregation Amplitude|HEMATOLOGY|[?]|/40 HPFs|[?]|[?]|NEGATIVE|1|mL/h|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|PARAFFIN-EMBEDDED||IHC|FIBROSIS 4 FORMULA|Y||NA||4|Visit_4|65|2|WASHOUT|2021-02-14|2021-03-02|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|9|ALT|Alanine Aminotransferase|URINALYSIS|||[?]|[?]|NEGATIVE|1|mm/sec|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|UNEXPECTED ODOR||IRON HEMATOXYLIN STAIN|FIBROTEST FORMULA||Y|U|Y|5|Visit_5|90|5|TREATMENT|2021-03-11|2021-03-15|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|10|ESTROGEN|Estrogen|CHEMISTRY|[?]|U/cL|[?]|[?]|NEGATIVE|1|nmol/kg/day|1|1|[?]|HIGH|AMNIOTIC FLUID|HEMOLYZED||TOTAL BODY IRRADIATION|MDRD 5 VARIABLE FORMULA||Y|NA||5|Visit_5|90|2|TREATMENT|2021-03-11|2021-03-14|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|f24b931a-2cdd-4432-a1dd-69c7286f4690|1|NHMCELE|Nonhematic Cells/Leukocytes|CHEMISTRY|||[?]|[?]|BORDERLINE|1|uIU/L|1|1|[?]|HIGH|CERUMEN|CALCIFIED||INTRAVASCULAR ULTRASOUND|NASH FIBROSURE FORMULA|Y||NA|Y|1|Visit_1|10|7|WASHOUT|2020-05-15|2020-05-21|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-01
e|LB|f24b931a-2cdd-4432-a1dd-69c7286f4690|2|LDL|LDL Cholesterol|HEMATOLOGY|[?]|kN/cm2|[?]|[?]|BORDERLINE|1|/sec|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|PARAFFIN-EMBEDDED|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|ASH FIBROSURE FORMULA||Y|U||1|Visit_1|10|7|TREATMENT|2020-05-15|2020-08-12|10|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-01
e|LB|f24b931a-2cdd-4432-a1dd-69c7286f4690|3|APLSMA2|Alpha-2 Antiplasmin|URINALYSIS|[?]|pg/L|[?]|[?]|BORDERLINE|1|Weber|1|1|[?]|ABNORMAL|VITREOUS HUMOR|NON-HEMOLYZED||NUCLEIC ACID SEQUENCING|CKD-EPI CYSTATIN C FORMULA|Y|Y|N||2|Visit_2|25|1|SCREENING|2020-05-30|2020-07-26|25|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|f24b931a-2cdd-4432-a1dd-69c7286f4690|4|B2GLYAB|Beta-2 Glycoprotein Antibody|URINALYSIS|[?]|Rad|[?]|[?]|BORDERLINE|1|aMFI|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|REFRIGERATED|N|ELECTROMYOGRAPHY|MDRD FORMULA|||U||2|Visit_2|25|3|SCREENING|2020-05-30|2020-07-31|25|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|f24b931a-2cdd-4432-a1dd-69c7286f4690|5|KLOTHO|Klotho|URINALYSIS|[?]|mm3/mm2/year|[?]|[?]|BORDERLINE|1|WEEKS|1|1|[?]|ABNORMAL|LYMPH|HEMOLYZED||LIGHT MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||3|Visit_3|40|1|TREATMENT|2020-06-14|2020-06-15|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|f24b931a-2cdd-4432-a1dd-69c7286f4690|6|PHOS|Phosphate|CHEMISTRY|[?]|umol|[?]|[?]|INDETERMINATE|1|mg/dL|1|1|[?]|HIGH|MUSCLE TISSUE|UNEXPECTED ODOR||FARR ASSAY|ASH FIBROSURE FORMULA|Y||N||3|Visit_3|40|5|TREATMENT|2020-06-14|2020-06-23|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|f24b931a-2cdd-4432-a1dd-69c7286f4690|7|APTTLAS|Lupus Anticoagulant Sensitive APTT|URINALYSIS|[?]|/day|[?]|[?]|NEGATIVE|1|10^12 IU/L|1|1|[?]|ABNORMAL|SKIN TISSUE|HEMOLYZED||ZIEHL NEELSEN ACID FAST STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-07-09|2020-08-08|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|f24b931a-2cdd-4432-a1dd-69c7286f4690|8|ANIONG|Anion Gap|HEMATOLOGY|[?]|mg/g/min|[?]|[?]|INDETERMINATE|1|Weber|1|1|[?]|NORMAL|DERMAL TISSUE|FROZEN||INTRAVASCULAR ULTRASOUND|FIBROMETER FORMULA||Y|Y||4|Visit_4|65|7|TREATMENT|2020-07-09|2020-08-04|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|f24b931a-2cdd-4432-a1dd-69c7286f4690|9|FLUDOUTE|Fluid Output, Estimated|HEMATOLOGY|[?]|kcal/day|[?]|[?]|INDETERMINATE|1|PUFF|1|1|[?]|NORMAL|HAIR|NON-HEMOLYZED|N|GRADIENT DIFFUSION|FIBROMETER FORMULA|||NA||5|Visit_5|90|5|WASHOUT|2020-08-03|2020-08-07|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-13
e|LB|f24b931a-2cdd-4432-a1dd-69c7286f4690|10|TRP1TRG1|Trypsin 1 and Trypsinogen 1|HEMATOLOGY|[?]|CAPLET|[?]|[?]|INDETERMINATE|1|10^11/L|1|1|[?]|LOW|BONE MARROW|FROZEN|N|IMMUNOBLOT|CKD-EPI FORMULA|||N||5|Visit_5|90|3|TREATMENT|2020-08-03|2020-08-08|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-13
e|LB|d394120d-7630-4fcf-a336-482599d88296|1|NORMETA|Normetanephrine|HEMATOLOGY|[?]|nmol/kg/day|[?]|[?]|BORDERLINE|1|10^7 CFU/mL|1|1|[?]|HIGH|SYNOVIAL FLUID|NON-HEMOLYZED||MAGNETIC RESONANCE ELASTOGRAPHY|MDRD ENZYMATIC FORMULA|Y||NA||1|Visit_1|10|3|SCREENING|2021-01-22|2021-03-27|10|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|d394120d-7630-4fcf-a336-482599d88296|2|GSTALCRT|Glutathione S-Transferase, Alpha/Creat|HEMATOLOGY|[?]|pg/cell|[?]|[?]|POSITIVE|1|mU/g|1|1|[?]|LOW|INTERSTITIAL FLUID|FRESH||REVERSE TRANSCRIPTASE PCR|FIBROTEST FORMULA||Y|N||1|Visit_1|10|7|SCREENING|2021-01-22|2021-02-19|10|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|d394120d-7630-4fcf-a336-482599d88296|3|CRBMZPN|Carbamazepine|URINALYSIS|[?]|mL/100g/min|[?]|[?]|TRACE|1|ug/dose|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC||VIRUS PLAQUE ASSAY|CKD-EPI FORMULA|Y||N||2|Visit_2|25|3|TREATMENT|2021-02-06|2021-03-14|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|d394120d-7630-4fcf-a336-482599d88296|4|GLYCRLFR|Free Glycerol|CHEMISTRY|[?]|g/day|[?]|[?]|NEGATIVE|1|10^3 CFU|1|1|[?]|ABNORMAL|BLOOD|AGGLUTINATED||ELISPOT|FIBROTEST FORMULA||Y|Y||2|Visit_2|25|3|WASHOUT|2021-02-06|2021-03-28|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|d394120d-7630-4fcf-a336-482599d88296|5|PLSPCE|Precursor Plasma Cells|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|10^9 organisms/g|1|1|[?]|HIGH|REFLEX TEAR|LIPEMIC||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2021-02-21|2021-04-02|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|d394120d-7630-4fcf-a336-482599d88296|6|PRLYMLE|Prolymphocytes/Leukocytes|HEMATOLOGY|[?]|kPa|[?]|[?]|INDETERMINATE|1|g/day|1|1|[?]|LOW|EMOTIONAL TEAR|CLOTTED|N|LIGHT SCATTERING SPECTROSCOPY|ASH FIBROSURE FORMULA|||N||3|Visit_3|40|1|TREATMENT|2021-02-21|2021-03-22|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|d394120d-7630-4fcf-a336-482599d88296|7|EPIN|Epinephrine|URINALYSIS|[?]|APS U|[?]|[?]|TRACE|1|foz_br|1|1|[?]|ABNORMAL|STOOL|NON-HEMOLYZED|N|THICK SMEAR|MDRD ENZYMATIC FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2021-03-18|2021-04-01|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|d394120d-7630-4fcf-a336-482599d88296|8|VITD3|Vitamin D3|HEMATOLOGY|[?]|mL/kg/min|[?]|[?]|NEGATIVE|1|damol/L|1|1|[?]|ABNORMAL|LYMPH|LACTESCENT||FLUORIMETRY|CKD-EPI FORMULA||Y|U||4|Visit_4|65|6|FOLLOW-UP|2021-03-18|2021-04-16|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|d394120d-7630-4fcf-a336-482599d88296|9|ANUAB|Anti-Nucleosome Antibody|CHEMISTRY|[?]|s*kPa|[?]|[?]|TRACE|1|mL/cage/wk|1|1|[?]|HIGH|EXUDATE|UNEXPECTED ODOR|N|IMPEDANCE CONDUCTIVITY|MDRD ENZYMATIC FORMULA|||Y||5|Visit_5|90|5|WASHOUT|2021-04-12|2021-04-20|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|d394120d-7630-4fcf-a336-482599d88296|10|ACETONE|Acetone|CHEMISTRY|[?]|ukat|[?]|[?]|INDETERMINATE|1|EID 50/mL|1|1|[?]|NORMAL|DERMAL TISSUE|FROZEN||ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA|||U||5|Visit_5|90|7|TREATMENT|2021-04-12|2021-04-16|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|bcda1d95-58ed-4991-9395-0b98efc1d9a1|1|MMP8|Matrix Metalloproteinase 8|URINALYSIS|[?]|ukat/L|[?]|[?]|TRACE|1|POUCH|1|1|[?]|LOW|EPIDERMAL TISSUE|LIPEMIC||ELASTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-10-21|2020-11-07|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|bcda1d95-58ed-4991-9395-0b98efc1d9a1|2|GDF8|Growth Differentiation Factor 8|URINALYSIS|||[?]|[?]|INDETERMINATE|1|10^4/hpf|1|1|[?]|HIGH|PLATELET POOR PLASMA|SOLIDIFIED||PLETHYSMOGRAPHY|FIBROMETER FORMULA||Y|N|Y|1|Visit_1|10|4|TREATMENT|2020-10-21|2020-12-02|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|bcda1d95-58ed-4991-9395-0b98efc1d9a1|3|HSP70|Heat Shock Protein 70|URINALYSIS|[?]|POUCH|[?]|[?]|INDETERMINATE|1|Linear ft*LB|1|1|[?]|HIGH|INTERSTITIAL FLUID|CONTAMINATED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||2|Visit_2|25|2|TREATMENT|2020-11-05|2020-11-07|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|bcda1d95-58ed-4991-9395-0b98efc1d9a1|4|GASTRIN|Gastrin|CHEMISTRY|[?]|BAU/mL|[?]|[?]|INVALID|1|anti-Xa IU|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|CONCENTRATED||ENDPOINT DILUTION ASSAY|CKD-EPI FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-11-05|2020-11-12|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|bcda1d95-58ed-4991-9395-0b98efc1d9a1|5|ABNCECE|Abnormal Cells/Total Cells|URINALYSIS|||[?]|[?]|INVALID|1|um2|1|1|[?]|HIGH|TRANSUDATE|AGGLUTINATED||IMMUNE REPERTOIRE DEEP SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|3|Visit_3|40|6|SCREENING|2020-11-20|2020-12-01|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|bcda1d95-58ed-4991-9395-0b98efc1d9a1|6|SERTRAL|Sertraline|CHEMISTRY|||[?]|[?]|TRACE|1|TROCHE|1|1|[?]|ABNORMAL|BONE|AUTOLYZED|N|WHOLE EXOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|3|Visit_3|40|7|TREATMENT|2020-11-20|2021-01-03|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|bcda1d95-58ed-4991-9395-0b98efc1d9a1|7|OAS3|2-5-Oligoadenylate Synthase 3|URINALYSIS|[?]|CIGARETTE|[?]|[?]|NEGATIVE|1|Absorbance U|1|1|[?]|LOW|NAIL|LIPEMIC||KINETIC CHROMOGENIC ASSAY|NASH FIBROSURE FORMULA|||U||4|Visit_4|65|7|WASHOUT|2020-12-15|2020-12-29|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|bcda1d95-58ed-4991-9395-0b98efc1d9a1|8|IFNG|Interferon Gamma|CHEMISTRY|[?]|uOsm|[?]|[?]|INVALID|1|mL/g/day|1|1|[?]|LOW|GASTRIC CONTENTS|NON-HEMOLYZED||PELLI-ROBSON EYE CHART|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2020-12-15|2021-01-13|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|bcda1d95-58ed-4991-9395-0b98efc1d9a1|9|BLASTCE|Blasts/Total Cells|HEMATOLOGY|[?]|mL/g/h|[?]|[?]|BORDERLINE|1|MPL U|1|1|[?]|NORMAL|PERITONEAL FLUID|CONCENTRATED||AUSCULTATION|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|7|WASHOUT|2021-01-09|2021-01-13|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|bcda1d95-58ed-4991-9395-0b98efc1d9a1|10|ABO|ABO Blood Group|URINALYSIS|[?]|mmHg|[?]|[?]|BORDERLINE|1|ka_u/dL|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|CONTAMINATED|N|PHOTOGRAPHY|ASH FIBROSURE FORMULA|||N||5|Visit_5|90|3|TREATMENT|2021-01-09|2021-01-13|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|6999bd5c-0790-42b8-a4ff-e538776b0fb0|1|COCBNZEC|Cocaine Benzoylecgonine Ecgonine|URINALYSIS|[?]|/h|[?]|[?]|INVALID|1|10^6 CFU/mL|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|CLOTTED||GC/FID|NASH FIBROSURE FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2020-08-15|2020-11-12|10|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|6999bd5c-0790-42b8-a4ff-e538776b0fb0|2|BLSTNMCE|Normoblasts/Total Cells|URINALYSIS|[?]|cL|[?]|[?]|POSITIVE|1|BU/mL|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|DRIED||NUCLEIC ACID AMPLIFICATION TEST|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|1|WASHOUT|2020-08-15|2020-10-24|10|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|6999bd5c-0790-42b8-a4ff-e538776b0fb0|3|ALBEXR|Albumin Excretion Rate|CHEMISTRY|[?]|SFC/10^6 PBMC|[?]|[?]|POSITIVE|1|10^9 CFU/g|1|1|[?]|HIGH|LUNG SURFACTANT|CALCIFIED||PANENDOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|Y||2|Visit_2|25|5|SCREENING|2020-08-30|2020-11-04|25|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|6999bd5c-0790-42b8-a4ff-e538776b0fb0|4|CYMSU|Monosodium Urate Crystals|URINALYSIS|[?]|U/dL|[?]|[?]|INVALID|1|PIXELS/cm|1|1|[?]|HIGH|CELL PELLET|DRIED|N|REFLECTANCE SPECTROSCOPY|MDRD 4 VARIABLE FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-08-30|2020-09-24|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|6999bd5c-0790-42b8-a4ff-e538776b0fb0|5|APOJ|Apolipoprotein J|HEMATOLOGY|||[?]|[?]|TRACE|1|dpm/mL|1|1|[?]|HIGH|ERYTHROCYTES|THAWED||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|GMI % FORMULA|||U|Y|3|Visit_3|40|6|TREATMENT|2020-09-14|2020-09-21|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|6999bd5c-0790-42b8-a4ff-e538776b0fb0|6|INSAAB|Insulin Autoantibody|HEMATOLOGY|[?]|cy/cm|[?]|[?]|BORDERLINE|1|10^9 organisms/mL|1|1|[?]|HIGH|RETICULOCYTES|CONCENTRATED|N|ELASTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||N||3|Visit_3|40|5|SCREENING|2020-09-14|2020-11-12|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|6999bd5c-0790-42b8-a4ff-e538776b0fb0|7|FABP1|Fatty Acid Binding Protein 1|CHEMISTRY|||[?]|[?]|INVALID|1|10^6 organisms/mL|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|THAWED||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|COCKCROFT-GAULT FORMULA|||U|Y|4|Visit_4|65|6|TREATMENT|2020-10-09|2020-10-20|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|6999bd5c-0790-42b8-a4ff-e538776b0fb0|8|APRI|AST to Platelet Ratio Index|HEMATOLOGY|[?]|log10 copies/mL|[?]|[?]|INDETERMINATE|1|mg/g/min|1|1|[?]|NORMAL|BASAL TEAR|CONCENTRATED||DUKE INCISION METHOD|HEPASCORE FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-10-09|2020-11-05|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|6999bd5c-0790-42b8-a4ff-e538776b0fb0|9|SLTFRNRC|Soluble Transferrin Receptor|URINALYSIS|[?]|nsec|[?]|[?]|INDETERMINATE|1|PIXELS/in|1|1|[?]|HIGH|FLUID|ROOM TEMPERATURE||OPHTHALMOSCOPY|MDRD FORMULA|||U||5|Visit_5|90|4|TREATMENT|2020-11-03|2020-11-06|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|6999bd5c-0790-42b8-a4ff-e538776b0fb0|10|CL|Chloride|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|umol/L/min|1|1|[?]|NORMAL|SOFT TISSUE|CONTAMINATED||MACRO BROTH DILUTION|MDRD ENZYMATIC FORMULA|||N|Y|5|Visit_5|90|7|FOLLOW-UP|2020-11-03|2020-11-10|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|1|VITDAT|1, 25-Dihydroxyvitamin D|CHEMISTRY|||[?]|[?]|TRACE|1|ug/g/h|1|1|[?]|LOW|SMEGMA|NON-HEMOLYZED||DIGITAL PCR ARRAY|HEPASCORE FORMULA|||NA|Y|1|Visit_1|10|3|TREATMENT|2020-12-21|2021-03-11|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|2|SCN|Thiocyanate|URINALYSIS|||[?]|[?]|INVALID|1|mAmp|1|1|[?]|HIGH|MECONIUM|NON-HEMOLYZED||RIA|MDRD 5 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|2|TREATMENT|2020-12-21|2020-12-23|10|12|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|3|C165894|D. farinae Antigen IgG4 Antibody|URINALYSIS|[?]|BAG|[?]|[?]|INVALID|1|AMPULE|1|1|[?]|NORMAL|HAIR FOLLICLE|HEMOLYZED||NON-CONTACT SPECULAR MICROSCOPY|CKD-EPI CREATININE FORMULA|||NA||2|Visit_2|25|7|SCREENING|2021-01-05|2021-03-01|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|LB|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|4|MONOCE|Monocytes/Total Cells|HEMATOLOGY|||[?]|[?]|INVALID|1|log10 CFU/g|1|1|[?]|HIGH|EMOTIONAL TEAR|NON-HEMOLYZED|N|NUCLEIC ACID SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|2|Visit_2|25|5|TREATMENT|2021-01-05|2021-01-29|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|LB|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|5|BASEDEF|Base Deficit|HEMATOLOGY|[?]|10^3 organisms|[?]|[?]|INDETERMINATE|1|dpm/mg|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|DRIED||TEMPLATE INCISION METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||3|Visit_3|40|3|SCREENING|2021-01-20|2021-01-29|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|6|IL1R2|Interleukin 1 Receptor Type 2|HEMATOLOGY|[?]|mIU/L|[?]|[?]|INDETERMINATE|1|uV*sec|1|1|[?]|LOW|DISCHARGE|AGGLUTINATED||SPIROMETRY|CKD-EPI FORMULA|||N||3|Visit_3|40|4|TREATMENT|2021-01-20|2021-01-22|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|7|HGBA2|Hemoglobin A2|CHEMISTRY|[?]|mMU/mL|[?]|[?]|INDETERMINATE|1|10^6 organisms/mL|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|AUTOLYZED|N|FLUORESCENT SPOT TEST|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|4|SCREENING|2021-02-14|2021-02-15|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|8|ASTAG|Aspartate Aminotransferase Antigen|HEMATOLOGY|[?]|TROCHE|[?]|[?]|POSITIVE|1|psi|1|1|[?]|LOW|DIALYSIS FLUID|ROOM TEMPERATURE||ELECTROGASTROGRAPHY|ASH FIBROSURE FORMULA|||NA||4|Visit_4|65|2|FOLLOW-UP|2021-02-14|2021-03-12|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|9|ADSDNA|Anti-Double Stranded DNA|URINALYSIS|[?]|mg/kg/h|[?]|[?]|BORDERLINE|1|PFU|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|AGGLUTINATED||MICROBIAL CONCENTRATION|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|6|TREATMENT|2021-03-11|2021-03-19|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|10|C147276|Arachis hypogaea Antigen IgE Antibody|CHEMISTRY|[?]|mmol/min/kPa/L|[?]|[?]|INDETERMINATE|1|PACKET|1|1|[?]|HIGH|LYMPH|CONTAMINATED|N|HPLC/IEX|MDRD 6 VARIABLE FORMULA|||Y||5|Visit_5|90|1|FOLLOW-UP|2021-03-11|2021-03-19|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|59b0fee3-2294-448e-9837-38bd6b5c794b|1|VITB9|Vitamin B9|CHEMISTRY|[?]|BOWL|[?]|[?]|TRACE|1|pL|1|1|[?]|ABNORMAL|SERUM OR PLASMA|GELLED||INTERRUPTER TECHNIQUE|GMI % FORMULA|Y||U||1|Visit_1|10|2|SCREENING|2021-01-01|2021-01-12|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-23
e|LB|59b0fee3-2294-448e-9837-38bd6b5c794b|2|NORMEEXR|Normetanephrine Excretion Rate|URINALYSIS|||[?]|[?]|NEGATIVE|1|PFU/animal|1|1|[?]|ABNORMAL|EMESIS|NON-HEMOLYZED|N|ELECTROMYOGRAPHY|FIBROMETER FORMULA|Y||NA|Y|1|Visit_1|10|6|TREATMENT|2021-01-01|2021-01-09|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-23
e|LB|59b0fee3-2294-448e-9837-38bd6b5c794b|3|CYFRA18|Cytokeratin 18 Fragment|CHEMISTRY|[?]|g/cage/day|[?]|[?]|INVALID|1|vp/mL|1|1|[?]|NORMAL|MECONIUM|PARAFFIN-EMBEDDED||IMMUNE REPERTOIRE DEEP SEQUENCING|ASH FIBROSURE FORMULA||Y|Y||2|Visit_2|25|2|WASHOUT|2021-01-16|2021-03-10|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|59b0fee3-2294-448e-9837-38bd6b5c794b|4|PLP|Pyridoxal Phosphate|HEMATOLOGY|||[?]|[?]|POSITIVE|1|Log10 ELISA unit/dose|1|1|[?]|HIGH|PERITONEAL FLUID|GELLED||INTRAVASCULAR ULTRASOUND|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|2|Visit_2|25|3|FOLLOW-UP|2021-01-16|2021-03-15|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|59b0fee3-2294-448e-9837-38bd6b5c794b|5|VOLUME|Volume|CHEMISTRY|[?]|MPL U/mL|[?]|[?]|TRACE|1|kcal|1|1|[?]|HIGH|CERUMEN|LIPEMIC||APPLANATION TONOMETRY|FIBROTEST FORMULA||Y|NA||3|Visit_3|40|6|TREATMENT|2021-01-31|2021-03-23|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|59b0fee3-2294-448e-9837-38bd6b5c794b|6|PELGERH|Pelger Huet Anomaly|CHEMISTRY|[?]|mg/mol|[?]|[?]|INVALID|1|ft2|1|1|[?]|LOW|CEREBROSPINAL FLUID|FRESH||ELISPOT|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||3|Visit_3|40|2|TREATMENT|2021-01-31|2021-03-24|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|59b0fee3-2294-448e-9837-38bd6b5c794b|7|CHOLOH4B|4-Beta-Hydroxycholesterol|CHEMISTRY|[?]|Ci/mL|[?]|[?]|NEGATIVE|1|cm2|1|1|[?]|ABNORMAL|PLEURAL FLUID|THAWED||ELECTROGASTROGRAPHY|HEPASCORE FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2021-02-25|2021-03-01|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|59b0fee3-2294-448e-9837-38bd6b5c794b|8|IDLVLDL3|IDL+VLDL Cholesterol Subtype 3|HEMATOLOGY|[?]|IU|[?]|[?]|TRACE|1|IU/mmol|1|1|[?]|HIGH|SWABBED MATERIAL|GELLED|N|CALCULATION|MDRD 4 VARIABLE FORMULA||Y|U||4|Visit_4|65|6|WASHOUT|2021-02-25|2021-03-16|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|59b0fee3-2294-448e-9837-38bd6b5c794b|9|MIP1|Macrophage Inflammatory Protein 1|URINALYSIS|[?]|BISCUIT|[?]|[?]|INVALID|1|MET|1|1|[?]|LOW|ARTERIAL CORD BLOOD|ICTERIC||DYNAMOMETRY|MDRD 4 VARIABLE FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2021-03-22|2021-03-26|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|59b0fee3-2294-448e-9837-38bd6b5c794b|10|ERCECE|Erythroid Cells/Total Cells|URINALYSIS|[?]|BEAM BREAKS|[?]|[?]|NEGATIVE|1|Enzyme U/m2|1|1|[?]|NORMAL|CAPILLARY BLOOD|CALCIFIED|N|MAGNETIC RESONANCE ENTEROGRAPHY|MDRD 6 VARIABLE FORMULA||Y|U||5|Visit_5|90|5|TREATMENT|2021-03-22|2021-03-23|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|d9bdb1e3-4630-423f-be01-4873bce30422|1|RBCDIPOP|Dimorphic Erythrocyte Population|URINALYSIS|||[?]|[?]|NEGATIVE|1|Tbsp|1|1|[?]|ABNORMAL|FLUID|DRIED||MANUAL COUNT|CKD-EPI CREATININE FORMULA||Y|NA|Y|1|Visit_1|10|1|WASHOUT|2020-12-22|2021-03-10|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|d9bdb1e3-4630-423f-be01-4873bce30422|2|PLTAGAMP|Platelet Aggregation Amplitude|CHEMISTRY|[?]|U/g/h|[?]|[?]|BORDERLINE|1|ug/mol|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|CLOTTED|N|DYNAMIC CONTRAST ENHANCED MRI|HEPASCORE FORMULA|||Y||1|Visit_1|10|5|WASHOUT|2020-12-22|2021-02-24|10|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|d9bdb1e3-4630-423f-be01-4873bce30422|3|CK|Creatine Kinase|HEMATOLOGY|[?]|ug/m2/min|[?]|[?]|BORDERLINE|1|DROP|1|1|[?]|LOW|SYNOVIAL FLUID|AGGLUTINATED||CORONARY ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA|||N||2|Visit_2|25|3|FOLLOW-UP|2021-01-06|2021-03-03|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|d9bdb1e3-4630-423f-be01-4873bce30422|4|OXZPM|Oxazepam|URINALYSIS|[?]|MBq|[?]|[?]|BORDERLINE|1|EID 50/mL|1|1|[?]|LOW|KERATINOCYTE|ICTERIC||MICROBIAL CULTURE, LIQUID|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2021-01-06|2021-01-28|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|d9bdb1e3-4630-423f-be01-4873bce30422|5|CYAMMBIU|Ammonium Biurate Crystals|URINALYSIS|||[?]|[?]|INDETERMINATE|1|BISCUIT|1|1|[?]|HIGH|AQUEOUS HUMOR|ICTERIC||THICK SMEAR|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|3|Visit_3|40|2|TREATMENT|2021-01-21|2021-03-17|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|d9bdb1e3-4630-423f-be01-4873bce30422|6|YEAST|Yeast Cells|HEMATOLOGY|[?]|mL/kg/h|[?]|[?]|NEGATIVE|1|hPa|1|1|[?]|NORMAL|SERUM OR PLASMA|GELLED||CRYOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||3|Visit_3|40|1|TREATMENT|2021-01-21|2021-02-10|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|d9bdb1e3-4630-423f-be01-4873bce30422|7|C165903|Western Ragweed Pollen IgG AB RAST Score|CHEMISTRY|||[?]|[?]|INVALID|1|amu|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|CONTAMINATED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|FIBROSIS 4 FORMULA|||N|Y|4|Visit_4|65|1|TREATMENT|2021-02-15|2021-03-20|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|d9bdb1e3-4630-423f-be01-4873bce30422|8|ANABASN|Anabasine|CHEMISTRY|[?]|IU/g|[?]|[?]|INVALID|1|CFU/mL|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|AUTOLYZED|N|KINETIC CHROMOGENIC ASSAY|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|5|WASHOUT|2021-02-15|2021-03-17|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|d9bdb1e3-4630-423f-be01-4873bce30422|9|BLSTMGK|Megakaryoblasts|HEMATOLOGY|[?]|km/h|[?]|[?]|TRACE|1|mL/cage/day|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|SOLIDIFIED|N|DYNAMIC CONTRAST ENHANCED MRI|MDRD 5 VARIABLE FORMULA||Y|Y||5|Visit_5|90|5|TREATMENT|2021-03-12|2021-03-13|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|d9bdb1e3-4630-423f-be01-4873bce30422|10|ECCENTCY|Eccentrocytes|URINALYSIS|[?]|Osm|[?]|[?]|POSITIVE|1|/7.5 mL|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|CALCIFIED|N|DYNAMIC LIGHT SCATTERING|HEPASCORE FORMULA|||U||5|Visit_5|90|1|TREATMENT|2021-03-12|2021-03-21|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|1|LEPTIN|Leptin|HEMATOLOGY|[?]|PA|[?]|[?]|INVALID|1|10^7 TCID 50/dose|1|1|[?]|NORMAL|AQUEOUS HUMOR|CONCENTRATED||OPTICAL DENSITY MEASUREMENT|CKD-EPI FORMULA|Y||N||1|Visit_1|10|2|SCREENING|2020-06-25|2020-07-17|10|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|2|ASSDNA|Anti-Single Stranded DNA IgG|HEMATOLOGY|[?]|deg|[?]|[?]|TRACE|1|AU/mL|1|1|[?]|HIGH|EXPIRED AIR|REFRIGERATED||SLOAN LETTER EYE CHART 100%|FIBROTEST FORMULA|||U||1|Visit_1|10|4|SCREENING|2020-06-25|2020-09-05|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|3|LYSOZYME|Lysozyme|CHEMISTRY|[?]|damol/L|[?]|[?]|INVALID|1|mg/animal|1|1|[?]|HIGH|AQUEOUS HUMOR|UNEXPECTED ODOR||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|7|WASHOUT|2020-07-10|2020-09-04|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|4|MPO|Myeloperoxidase|URINALYSIS|[?]|copies/uL|[?]|[?]|NEGATIVE|1|uL/mL|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|THAWED||REFLECTANCE SPECTROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA||2|Visit_2|25|6|FOLLOW-UP|2020-07-10|2020-09-02|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|5|CARNIT|Carnitine|URINALYSIS|[?]|PLUG|[?]|[?]|INDETERMINATE|1|Tbsp|1|1|[?]|HIGH|COLOSTRUM|SOLIDIFIED||AUSCULTATION|MDRD 5 VARIABLE FORMULA||Y|U||3|Visit_3|40|7|SCREENING|2020-07-25|2020-09-12|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|6|INTLK7|Interleukin 7|HEMATOLOGY|[?]|10^6 U|[?]|[?]|BORDERLINE|1|ug/kg/h|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|NON-HEMOLYZED||LAPAROSCOPY|MDRD 4 VARIABLE FORMULA||Y|Y||3|Visit_3|40|5|WASHOUT|2020-07-25|2020-08-11|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|7|CXCL9|Chemokine (C-X-C Motif) Ligand 9|URINALYSIS|[?]|EVENTS|[?]|[?]|BORDERLINE|1|HOURS|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|CLOTTED||OLIGO ACGH|GMI MMOL/MOL FORMULA|Y||Y||4|Visit_4|65|4|FOLLOW-UP|2020-08-19|2020-08-21|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|8|GRWHRH|Growth Hormone Releasing Hormone|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mPa|1|1|[?]|NORMAL|INTERSTITIAL FLUID|GELLED||LANDOLT RING|ASH FIBROSURE FORMULA|||U|Y|4|Visit_4|65|5|TREATMENT|2020-08-19|2020-09-13|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|9|LEUKCRBC|Leuks Corrected for Nucl Erythrocytes|HEMATOLOGY|[?]|copies/ug|[?]|[?]|NEGATIVE|1|ug/kg/min|1|1|[?]|HIGH|CORD SERUM|UNEXPECTED ODOR|N|TWO-COLOR MICROARRAY|CKD-EPI FORMULA|Y||N||5|Visit_5|90|1|WASHOUT|2020-09-13|2020-09-16|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|LB|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|10|DALACRT|Delta Aminolevulinate/Creatinine|HEMATOLOGY|[?]|10^11/L|[?]|[?]|INDETERMINATE|1|Gy/min|1|1|[?]|HIGH|SEBUM|PARAFFIN-EMBEDDED||PYROSEQUENCING|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-09-13|2020-09-14|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|LB|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|1|IGAGM|IgG IgM IgA Total|URINALYSIS|[?]|U.CARR|[?]|[?]|INDETERMINATE|1|mol/day|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|CONTAMINATED||SLOAN LETTER EYE CHART 2.5%|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||1|Visit_1|10|5|FOLLOW-UP|2020-08-04|2020-09-01|10|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|LB|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|2|IOHEXCLR|Iohexol Clearance|CHEMISTRY|[?]|PNU/mL|[?]|[?]|NEGATIVE|1|10^3 RNA copies/mL|1|1|[?]|HIGH|SYNOVIAL FLUID|ROOM TEMPERATURE||OPTICAL COHERENCE TOMOGRAPHY|CKD-EPI CREATININE FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-08-04|2020-08-07|10|13|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|LB|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|3|TESTOSBA|Bioavailable Testosterone|HEMATOLOGY|[?]|PIPE|[?]|[?]|POSITIVE|1|ug/L|1|1|[?]|NORMAL|LOCHIA|CONCENTRATED||PUPILLOMETRY|FIBROTEST FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-08-19|2020-10-10|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|4|GLY|Glycine|HEMATOLOGY|[?]|cd/m2|[?]|[?]|INDETERMINATE|1|ng/L|1|1|[?]|NORMAL|URINE SEDIMENT|AUTOLYZED||VIRUS PLAQUE ASSAY|COCKCROFT-GAULT FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-08-19|2020-09-25|25|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|5|RETIH|High Absorption Reticulocytes|URINALYSIS|[?]|10^4/hpf|[?]|[?]|INVALID|1|PACKAGE|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|UNEXPECTED ODOR|N|KARYOTYPING|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-09-03|2020-09-24|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|6|PEPSNGII|Pepsinogen II|URINALYSIS|[?]|uSiemens|[?]|[?]|BORDERLINE|1|mol/L|1|1|[?]|LOW|HAIR|CLOTTED||ICC|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-09-03|2020-10-20|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|7|RBCFRAG|Erythrocyte Fragment|CHEMISTRY|[?]|log10 IU/mL|[?]|[?]|BORDERLINE|1|mg/m2|1|1|[?]|LOW|BILE|CONTAMINATED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|GMI % FORMULA|Y||N||4|Visit_4|65|3|TREATMENT|2020-09-28|2020-10-09|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|8|HYPERCHR|Hyperchromia|HEMATOLOGY|[?]|10^3 CFU/mL|[?]|[?]|NEGATIVE|1|10^6 CFU/g|1|1|[?]|NORMAL|VENOUS BLOOD|DRIED|N|DNA MICROARRAY|CKD-EPI CREATININE FORMULA|||U||4|Visit_4|65|1|TREATMENT|2020-09-28|2020-10-22|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|9|ESELS|Soluble E-Selectin|CHEMISTRY|||[?]|[?]|TRACE|1|ECL unit|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|AUTOLYZED||PERIODIC ACID SCHIFF STAIN|CKD-EPI FORMULA|||NA|Y|5|Visit_5|90|6|TREATMENT|2020-10-23|2020-10-30|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|10|IFI44|Interferon-Induced Protein 44|HEMATOLOGY|[?]|ppth|[?]|[?]|NEGATIVE|1|/mm2|1|1|[?]|NORMAL|SMEGMA|THAWED||SPECTROPHOTOMETRY|MDRD ENZYMATIC FORMULA||Y|U||5|Visit_5|90|6|TREATMENT|2020-10-23|2020-10-29|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|933c3a61-59a0-4cfb-ae17-45bc48229323|1|HER2|Human Epidermal Growth Factor Receptor 2|CHEMISTRY|[?]|Enzyme U/L|[?]|[?]|BORDERLINE|1|10^6 U|1|1|[?]|ABNORMAL|TUMOR TISSUE|UNEXPECTED ODOR||MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI CREATININE FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-09-09|2020-09-15|10|16|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|933c3a61-59a0-4cfb-ae17-45bc48229323|2|PROGESTR|Progesterone Receptor|HEMATOLOGY|[?]|ka_u/dL|[?]|[?]|INDETERMINATE|1|kg/m2|1|1|[?]|NORMAL|ARTERIAL BLOOD|HEMOLYZED|N|FLOW CYTOMETRY|CKD-EPI FORMULA|||N||1|Visit_1|10|2|FOLLOW-UP|2020-09-09|2020-10-10|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|933c3a61-59a0-4cfb-ae17-45bc48229323|3|TNF|Tumor Necrosis Factor|HEMATOLOGY|[?]|ug/g/day|[?]|[?]|TRACE|1|SACHET|1|1|[?]|HIGH|PLASMA ULTRAFILTRATE|FRESH||PALM METHOD|GMI % FORMULA||Y|Y||2|Visit_2|25|1|TREATMENT|2020-09-24|2020-10-17|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|933c3a61-59a0-4cfb-ae17-45bc48229323|4|LAP|Leucine Aminopeptidase|CHEMISTRY|[?]|kg/m2|[?]|[?]|BORDERLINE|1|g/cm2|1|1|[?]|NORMAL|MONOCYTE|THAWED||WESTERGREN|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|5|WASHOUT|2020-09-24|2020-11-07|25|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|933c3a61-59a0-4cfb-ae17-45bc48229323|5|ESTRCPT|Estrogen Receptor|CHEMISTRY|||[?]|[?]|INVALID|1|Bq/g|1|1|[?]|NORMAL|PLASMA|CALCIFIED|N|SPIRAL CT|MDRD ENZYMATIC FORMULA||Y|NA|Y|3|Visit_3|40|2|SCREENING|2020-10-09|2020-11-28|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|LB|933c3a61-59a0-4cfb-ae17-45bc48229323|6|ABNCE|Abnormal Cells|CHEMISTRY|[?]|nmol BCE/nmol|[?]|[?]|POSITIVE|1|ukat/10^12 RBC|1|1|[?]|ABNORMAL|BONE|CALCIFIED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|FIBROSIS 4 FORMULA||Y|NA||3|Visit_3|40|4|SCREENING|2020-10-09|2020-11-29|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|LB|933c3a61-59a0-4cfb-ae17-45bc48229323|7|GLDIGGAB|Gliadin IgG Antibody|HEMATOLOGY|[?]|mkat|[?]|[?]|INDETERMINATE|1|kg/L|1|1|[?]|HIGH|CELL PELLET|ICTERIC||SIZE EXCLUSION CHROMATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|3|FOLLOW-UP|2020-11-03|2020-11-14|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|933c3a61-59a0-4cfb-ae17-45bc48229323|8|RDCSUB|Reducing Substances|HEMATOLOGY|[?]|mg/kg/day|[?]|[?]|NEGATIVE|1|/10^3|1|1|[?]|LOW|HAIR FOLLICLE|ICTERIC||IMPULSE OSCILLOMETRY|MDRD FORMULA|||U||4|Visit_4|65|2|TREATMENT|2020-11-03|2020-12-06|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|933c3a61-59a0-4cfb-ae17-45bc48229323|9|TRP1TRG1|Trypsin 1 and Trypsinogen 1|URINALYSIS|||[?]|[?]|TRACE|1|mL/g/day|1|1|[?]|LOW|PLASMA|AUTOLYZED|N|ELECTROMYOGRAPHY|GMI MMOL/MOL FORMULA|||NA|Y|5|Visit_5|90|7|SCREENING|2020-11-28|2020-12-04|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|933c3a61-59a0-4cfb-ae17-45bc48229323|10|STAT3PS3|Phosphorylated STAT3/STAT3|CHEMISTRY|[?]|mmol/mol|[?]|[?]|TRACE|1|g/animal/day|1|1|[?]|LOW|NAIL|HEMOLYZED||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI FORMULA|||N||5|Visit_5|90|2|WASHOUT|2020-11-28|2020-12-03|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|58d871e3-ef99-48da-ab12-fdfdc2e01da6|1|ANGLOBDR|Antiglobulin Test, Direct|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|ELISA unit/dose|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|CLOTTED||HPLC-UV|ASH FIBROSURE FORMULA|||NA|Y|1|Visit_1|10|6|TREATMENT|2020-10-26|2020-11-11|10|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|58d871e3-ef99-48da-ab12-fdfdc2e01da6|2|PAROXET|Paroxetine|HEMATOLOGY|[?]|fraction of 1|[?]|[?]|NEGATIVE|1|cmH2O/mL|1|1|[?]|HIGH|ALVEOLAR AIR|REFRIGERATED||COLORIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||1|Visit_1|10|1|SCREENING|2020-10-26|2020-12-23|10|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|58d871e3-ef99-48da-ab12-fdfdc2e01da6|3|LPPLA2|Lipoprotein Associated Phospholipase A2|HEMATOLOGY|||[?]|[?]|TRACE|1|tuberculin unit|1|1|[?]|HIGH|LYMPH|ROOM TEMPERATURE||HPLC/IEX|CKD-EPI CREATININE FORMULA|||NA|Y|2|Visit_2|25|5|FOLLOW-UP|2020-11-10|2020-12-25|25|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|58d871e3-ef99-48da-ab12-fdfdc2e01da6|4|C130095|Western Ragweed Pollen IgG4|HEMATOLOGY|[?]|Bq|[?]|[?]|POSITIVE|1|10^6 IU|1|1|[?]|ABNORMAL|PLEURAL FLUID|CALCIFIED|N|CONTRAST ENHANCED PET SCAN|GMI % FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-11-10|2020-12-05|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|58d871e3-ef99-48da-ab12-fdfdc2e01da6|5|DHT|Dihydrotestosterone|URINALYSIS|[?]|U/cL|[?]|[?]|POSITIVE|1|mL/kg/day|1|1|[?]|LOW|SPUTUM|CALCIFIED||REVERSE TRANSCRIPTASE PCR|COCKCROFT-GAULT FORMULA||Y|N||3|Visit_3|40|3|FOLLOW-UP|2020-11-25|2021-01-21|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|58d871e3-ef99-48da-ab12-fdfdc2e01da6|6|FLT3L|FMS-like Tyrosine Kinase 3 Ligand|HEMATOLOGY|[?]|EID 50/dose|[?]|[?]|NEGATIVE|1|CIGAR|1|1|[?]|NORMAL|VITREOUS HUMOR|NON-HEMOLYZED||NEURAMINIDASE INHIBITION ASSAY|FIBROSIS 4 FORMULA|Y|Y|U||3|Visit_3|40|4|SCREENING|2020-11-25|2020-12-02|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|58d871e3-ef99-48da-ab12-fdfdc2e01da6|7|DENSITY|Density|CHEMISTRY|[?]|um|[?]|[?]|NEGATIVE|1|PNU/mL|1|1|[?]|LOW|BASAL TEAR|FROZEN||ROMANOWSKY STAIN|FIBROMETER FORMULA|||U||4|Visit_4|65|2|SCREENING|2020-12-20|2020-12-22|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|58d871e3-ef99-48da-ab12-fdfdc2e01da6|8|ALTAST|ALT/AST|CHEMISTRY|[?]|10^6 organisms/mg|[?]|[?]|POSITIVE|1|Absorbance U/mL|1|1|[?]|ABNORMAL|URINE|LACTESCENT||IMPEDANCE CONDUCTIVITY|FIBROTEST FORMULA|||U||4|Visit_4|65|5|TREATMENT|2020-12-20|2021-01-06|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|58d871e3-ef99-48da-ab12-fdfdc2e01da6|9|ACANTRBC|Acanthocytes/Erythrocytes|HEMATOLOGY|[?]|pg/cell|[?]|[?]|INVALID|1|BAG|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|ICTERIC||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||Y|NA||5|Visit_5|90|7|TREATMENT|2021-01-14|2021-01-22|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|58d871e3-ef99-48da-ab12-fdfdc2e01da6|10|OVALCY|Ovalocytes|HEMATOLOGY|[?]|km|[?]|[?]|BORDERLINE|1|mL/cage|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|NON-HEMOLYZED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|CKD-EPI FORMULA|||NA||5|Visit_5|90|7|FOLLOW-UP|2021-01-14|2021-01-17|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|ac66129e-3244-4cd8-a235-43b4bfb7dace|1|FACTXI|Factor XI|URINALYSIS|[?]|U/m2/h|[?]|[?]|TRACE|1|mL/g/min|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED||AGAR PROPORTION|MDRD 4 VARIABLE FORMULA|||NA||1|Visit_1|10|4|WASHOUT|2020-10-29|2020-11-06|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|ac66129e-3244-4cd8-a235-43b4bfb7dace|2|SERTRAL|Sertraline|HEMATOLOGY|[?]|VIRTUAL PIXEL|[?]|[?]|POSITIVE|1|/day|1|1|[?]|LOW|SERUM OR PLASMA|PARAFFIN-EMBEDDED||PULMONARY ANGIOGRAPHY|COCKCROFT-GAULT FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-10-29|2020-12-31|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|ac66129e-3244-4cd8-a235-43b4bfb7dace|3|HYPRLN|Hydroxyproline|HEMATOLOGY|[?]|mg/kg|[?]|[?]|NEGATIVE|1|pmol/10^9 cells|1|1|[?]|NORMAL|SEMEN|AGGLUTINATED||PERIODIC ACID SCHIFF STAIN|GMI % FORMULA||Y|N||2|Visit_2|25|3|TREATMENT|2020-11-13|2020-11-29|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|ac66129e-3244-4cd8-a235-43b4bfb7dace|4|GLDIGGAB|Gliadin IgG Antibody|HEMATOLOGY|[?]|Shock Wave|[?]|[?]|INDETERMINATE|1|L/s|1|1|[?]|LOW|LUNG SURFACTANT|THAWED|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|GMI MMOL/MOL FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-11-13|2020-12-07|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|ac66129e-3244-4cd8-a235-43b4bfb7dace|5|DDNAIGAB|Anti-Double Stranded DNA IgG|CHEMISTRY|[?]|Bq/ug|[?]|[?]|BORDERLINE|1|mL/h|1|1|[?]|NORMAL|NAIL|ICTERIC|N|CONTRAST ENHANCED PET SCAN|MDRD 5 VARIABLE FORMULA|Y|Y|NA||3|Visit_3|40|6|TREATMENT|2020-11-28|2020-12-23|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|ac66129e-3244-4cd8-a235-43b4bfb7dace|6|PLATEST|Platelets, Estimated|URINALYSIS|||[?]|[?]|POSITIVE|1|CAN|1|1|[?]|LOW|DERMAL TISSUE|CALCIFIED||CAPILLARY ELECTROPHORESIS|HEPASCORE FORMULA|||N|Y|3|Visit_3|40|7|TREATMENT|2020-11-28|2021-01-14|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|ac66129e-3244-4cd8-a235-43b4bfb7dace|7|FABP3|Fatty Acid Binding Protein 3|CHEMISTRY|[?]|kV|[?]|[?]|NEGATIVE|1|mL/g/day|1|1|[?]|HIGH|LYSATE|AUTOLYZED||MULTIPLE BREATH WASHOUT|NASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|1|FOLLOW-UP|2020-12-23|2020-12-29|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|ac66129e-3244-4cd8-a235-43b4bfb7dace|8|C165939|Egg White IgE AB RAST Score|CHEMISTRY|[?]|/min|[?]|[?]|BORDERLINE|1|KALLIKREIN INHIBITOR UNIT|1|1|[?]|ABNORMAL|BASAL TEAR|CALCIFIED|N|GC/FID|COCKCROFT-GAULT FORMULA||Y|U||4|Visit_4|65|7|TREATMENT|2020-12-23|2021-01-25|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|ac66129e-3244-4cd8-a235-43b4bfb7dace|9|PTHNT|Parathyroid Hormone, N-Terminal|HEMATOLOGY|[?]|%/min|[?]|[?]|NEGATIVE|1|AMPULE|1|1|[?]|NORMAL|ABSCESS FLUID|GELLED||GC/FID|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||5|Visit_5|90|6|WASHOUT|2021-01-17|2021-01-25|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|ac66129e-3244-4cd8-a235-43b4bfb7dace|10|ZINC|Zinc|URINALYSIS|[?]|Anson U|[?]|[?]|TRACE|1|mEq|1|1|[?]|ABNORMAL|LEUKOCYTE|NON-HEMOLYZED||PHOROPTER|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|4|FOLLOW-UP|2021-01-17|2021-01-24|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|1|MIP1B|Macrophage Inflammatory Protein 1 Beta|URINALYSIS|[?]|10^7 TCID 50/dose|[?]|[?]|BORDERLINE|1|uV*sec|1|1|[?]|LOW|SPERMATOZOON|HEMOLYZED||DIFFUSION TENSOR MRI|HEPASCORE FORMULA||Y|Y||1|Visit_1|10|1|WASHOUT|2020-09-02|2020-11-07|10|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|2|GDF8|Growth Differentiation Factor 8|CHEMISTRY|[?]|ug/L/h|[?]|[?]|NEGATIVE|1|Bq/kg|1|1|[?]|ABNORMAL|PLEURAL FLUID|HEMOLYZED|N|HPLC/MS|MDRD FORMULA|||Y||1|Visit_1|10|4|SCREENING|2020-09-02|2020-11-19|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|3|GLYCREAT|Glycine/Creatinine|URINALYSIS|||[?]|[?]|BORDERLINE|1|10^3 copies/mL|1|1|[?]|HIGH|DIALYSIS FLUID|PARAFFIN-EMBEDDED||SCINTIGRAPHY|CKD-EPI CREATININE FORMULA|Y||N|Y|2|Visit_2|25|5|TREATMENT|2020-09-17|2020-11-13|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|4|LDHCREAT|Lactate Dehydrogenase/Creatinine|URINALYSIS|||[?]|[?]|INVALID|1|log10 copies/mL|1|1|[?]|HIGH|GASTRIC CONTENTS|NON-HEMOLYZED||HEMOCYTOMETRY|GMI MMOL/MOL FORMULA|||Y|Y|2|Visit_2|25|1|FOLLOW-UP|2020-09-17|2020-10-02|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|5|ERCEMIDX|Erythroid Maturation Index|URINALYSIS|[?]|10^9/g|[?]|[?]|BORDERLINE|1|ug/kg/min|1|1|[?]|LOW|CELL PELLET|LACTESCENT||WESTERGREN|MDRD 5 VARIABLE FORMULA|||U||3|Visit_3|40|4|TREATMENT|2020-10-02|2020-10-16|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|6|THYATAB|Thyroid Antithyroglobulin Antibodies|URINALYSIS|[?]|mL/dose|[?]|[?]|INVALID|1|nmol BCE/L|1|1|[?]|LOW|MUCUS|FRESH|N|DUCTOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|Y||3|Visit_3|40|4|SCREENING|2020-10-02|2020-10-14|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|7|MMYCECE|Maturing Myeloid Cells/Total Cells|URINALYSIS|[?]|EP U|[?]|[?]|INDETERMINATE|1|mg/L FEU|1|1|[?]|ABNORMAL|LYMPH|GELLED||AURAMINE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||4|Visit_4|65|2|FOLLOW-UP|2020-10-27|2020-11-30|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|8|HCHT|Hyocholate|URINALYSIS|[?]|pmol/dL|[?]|[?]|BORDERLINE|1|mL/100g/min|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|REFRIGERATED||LINE PROBE ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||4|Visit_4|65|6|FOLLOW-UP|2020-10-27|2020-11-04|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|9|RBP|Retinol Binding Protein|CHEMISTRY|[?]|V|[?]|[?]|INDETERMINATE|1|mL/(min*100mL)|1|1|[?]|LOW|SMEGMA|AUTOLYZED||CHROMOGENIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-11-21|2020-11-28|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|10|CEA|Carcinoembryonic Antigen|CHEMISTRY|||[?]|[?]|POSITIVE|1|/mm|1|1|[?]|LOW|NAIL|LACTESCENT||ICP-MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|5|Visit_5|90|2|WASHOUT|2020-11-21|2020-11-28|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|3d59a754-10bb-4847-93ea-433b43265a2f|1|UREAN|Urea Nitrogen|URINALYSIS|[?]|FINGERTIP UNIT|[?]|[?]|POSITIVE|1|mm3/mm2/year|1|1|[?]|LOW|PERITONEAL FLUID|AGGLUTINATED||PERCUSSION|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-10-24|2020-11-12|10|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|3d59a754-10bb-4847-93ea-433b43265a2f|2|FIBRINO|Fibrinogen|URINALYSIS|[?]|K|[?]|[?]|TRACE|1|atm|1|1|[?]|NORMAL|PLATELET POOR PLASMA|DRIED||POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|4|FOLLOW-UP|2020-10-24|2020-11-27|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|3d59a754-10bb-4847-93ea-433b43265a2f|3|OSTEOC|Osteocalcin|HEMATOLOGY|[?]|cmol|[?]|[?]|BORDERLINE|1|10^6 CFU|1|1|[?]|NORMAL|PERSPIRATION|ICTERIC|N|MICROBIAL CONCENTRATION|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-11-08|2021-01-15|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|3d59a754-10bb-4847-93ea-433b43265a2f|4|C147279|Zea mays Antigen IgE Antibody|CHEMISTRY|[?]|mol|[?]|[?]|BORDERLINE|1|um/s|1|1|[?]|HIGH|DERMAL TISSUE|CONTAMINATED||LIGHT MICROSCOPY|CKD-EPI FORMULA||Y|NA||2|Visit_2|25|4|TREATMENT|2020-11-08|2021-01-12|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|3d59a754-10bb-4847-93ea-433b43265a2f|5|ERCEMPOL|Erythroid Maturation Pool|HEMATOLOGY|[?]|fL|[?]|[?]|POSITIVE|1|ELISA unit/mL|1|1|[?]|ABNORMAL|DIALYSIS FLUID|PARAFFIN-EMBEDDED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI FORMULA|||Y||3|Visit_3|40|2|WASHOUT|2020-11-23|2020-12-29|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|3d59a754-10bb-4847-93ea-433b43265a2f|6|ACANTRBC|Acanthocytes/Erythrocytes|CHEMISTRY|[?]|mEq/g|[?]|[?]|INDETERMINATE|1|uU/dL|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED||ERGOSPIROMETRY|FIBROTEST FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-11-23|2020-12-16|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|3d59a754-10bb-4847-93ea-433b43265a2f|7|OXALATE|Oxalate|HEMATOLOGY|[?]|h/wk|[?]|[?]|NEGATIVE|1|mg/m2/h|1|1|[?]|HIGH|URINE|LACTESCENT||FARR ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-12-18|2021-01-04|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|3d59a754-10bb-4847-93ea-433b43265a2f|8|LDLP|LDL Particles|HEMATOLOGY|[?]|PA|[?]|[?]|TRACE|1|mg/g/h|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|HEMOLYZED||DUCTOGRAPHY|GMI MMOL/MOL FORMULA||Y|U||4|Visit_4|65|6|TREATMENT|2020-12-18|2020-12-25|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|3d59a754-10bb-4847-93ea-433b43265a2f|9|CONDUCTU|Urine Conductivity|HEMATOLOGY|[?]|g/cm2|[?]|[?]|TRACE|1|copies/mL|1|1|[?]|NORMAL|SERUM|FROZEN||SPECT SCAN|MDRD 5 VARIABLE FORMULA||Y|N||5|Visit_5|90|7|WASHOUT|2021-01-12|2021-01-19|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|3d59a754-10bb-4847-93ea-433b43265a2f|10|HDW|Hemoglobin Distribution Width|HEMATOLOGY|[?]|U/m2/h|[?]|[?]|INDETERMINATE|1|atm|1|1|[?]|NORMAL|ALVEOLAR AIR|ROOM TEMPERATURE||DIFFUSION WEIGHTED MRI|COCKCROFT-GAULT FORMULA|Y||Y||5|Visit_5|90|7|WASHOUT|2021-01-12|2021-01-18|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|1|FIBRINOF|Fibrinogen, Functional|HEMATOLOGY|[?]|EIA unit|[?]|[?]|NEGATIVE|1|APS U|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|FRESH||NUCLEIC ACID AMPLIFICATION TEST|GMI % FORMULA|||N||1|Visit_1|10|2|WASHOUT|2021-01-20|2021-03-23|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-15
e|LB|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|2|MTNEPHFR|Metanephrine, Free|HEMATOLOGY|[?]|min*mg/mL|[?]|[?]|BORDERLINE|1|mAmp|1|1|[?]|LOW|EPITHELIAL CELL|REFRIGERATED|N|SISH|FIBROMETER FORMULA|||N||1|Visit_1|10|5|SCREENING|2021-01-20|2021-04-11|10|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-15
e|LB|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|3|LYMVACLE|Vacuolated Lymphocytes/Leukocytes|HEMATOLOGY|[?]|gMFI|[?]|[?]|TRACE|1|msec|1|1|[?]|HIGH|SERUM OR PLASMA|HEMOLYZED||ELECTROPHORESIS|FIBROSIS 4 FORMULA|Y||Y||2|Visit_2|25|3|TREATMENT|2021-02-04|2021-03-22|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|4|PROTS|Protein S|URINALYSIS|[?]|ng/L|[?]|[?]|TRACE|1|BISCUIT|1|1|[?]|NORMAL|VITREOUS HUMOR|AUTOLYZED||PET/SPECT SCAN|FIBROTEST FORMULA|||NA||2|Visit_2|25|1|SCREENING|2021-02-04|2021-02-18|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|5|HAPTOG|Haptoglobin|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|AU/mL|1|1|[?]|LOW|INFRANATANT, SERUM|CONTAMINATED||IMMUNODIFFUSION|CKD-EPI FORMULA||Y|U|Y|3|Visit_3|40|1|FOLLOW-UP|2021-02-19|2021-03-30|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-08
e|LB|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|6|ALDEPX|Aldrin Epoxidase|CHEMISTRY|[?]|ug/g/min|[?]|[?]|NEGATIVE|1|RING|1|1|[?]|NORMAL|BUFFY COAT|LIPEMIC||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|3|WASHOUT|2021-02-19|2021-04-15|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-08
e|LB|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|7|BLASTRUB|Rubriblast|URINALYSIS|[?]|msec|[?]|[?]|TRACE|1|mL/m2/min|1|1|[?]|NORMAL|SOFT TISSUE|CONTAMINATED||ELECTROCHEMILUMINESCENCE|MDRD ENZYMATIC FORMULA|Y||NA||4|Visit_4|65|1|TREATMENT|2021-03-16|2021-04-05|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|8|CXCL7|Chemokine (C-X-C Motif) Ligand 7|CHEMISTRY|[?]|mmol/mol|[?]|[?]|TRACE|1|/10^4|1|1|[?]|NORMAL|MENSTRUAL BLOOD|SOLIDIFIED||ETDRS EYE CHART|GMI MMOL/MOL FORMULA|Y|Y|N||4|Visit_4|65|5|WASHOUT|2021-03-16|2021-03-27|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|9|LDH2LDH|LDH Isoenzyme 2/LDH|CHEMISTRY|[?]|mol/day|[?]|[?]|NEGATIVE|1|pmol/10^10 cells|1|1|[?]|ABNORMAL|SPERMATOZOON|GELLED|N|IMMUNORADIOMETRIC ASSAY|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|1|SCREENING|2021-04-10|2021-04-15|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|LB|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|10|DRUGSCR|Drug Screen|CHEMISTRY|[?]|L/min/m2|[?]|[?]|INDETERMINATE|1|FINGERTIP UNIT|1|1|[?]|LOW|HAIR|THAWED||DYNAMIC LIGHT SCATTERING|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|1|SCREENING|2021-04-10|2021-04-11|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|LB|89209495-c485-4eb7-b858-8dc5490d2b64|1|FACTVA|Factor V Activity|CHEMISTRY|[?]|bel|[?]|[?]|BORDERLINE|1|U/m2/day|1|1|[?]|LOW|CALCULUS|DRIED||IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||Y|Y||1|Visit_1|10|2|TREATMENT|2020-09-07|2020-11-13|10|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|89209495-c485-4eb7-b858-8dc5490d2b64|2|ZPP|Zinc Protoporphyrin|CHEMISTRY|[?]|YEARS|[?]|[?]|NEGATIVE|1|umol/min|1|1|[?]|NORMAL|TISSUE|THAWED||CELL OF ORIGIN ASSAY|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-09-07|2020-11-19|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|89209495-c485-4eb7-b858-8dc5490d2b64|3|METARUB|Metarubricyte|CHEMISTRY|[?]|log10 TCID 50/dose|[?]|[?]|TRACE|1|mEq/g|1|1|[?]|ABNORMAL|FLUID|PARAFFIN-EMBEDDED||WESTERN BLOT|CKD-EPI FORMULA||Y|N||2|Visit_2|25|2|WASHOUT|2020-09-22|2020-10-10|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|89209495-c485-4eb7-b858-8dc5490d2b64|4|VITD2425|24,25-Dihydroxyvitamin D|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|P|1|1|[?]|ABNORMAL|BASAL TEAR|ICTERIC||ENZYMATIC SPECTROPHOTOMETRY|FIBROTEST FORMULA||Y|NA|Y|2|Visit_2|25|2|SCREENING|2020-09-22|2020-10-20|25|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|89209495-c485-4eb7-b858-8dc5490d2b64|5|LDLOXAB|Oxidized LDL Cholesterol Antibody|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|%(w/v)|1|1|[?]|ABNORMAL|TRANSUDATE|CLOTTED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROMETER FORMULA|||N|Y|3|Visit_3|40|4|TREATMENT|2020-10-07|2020-11-21|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|89209495-c485-4eb7-b858-8dc5490d2b64|6|TLYCE|T-Lymphocytes|URINALYSIS|[?]|g/mol|[?]|[?]|TRACE|1|DPM|1|1|[?]|HIGH|INFRANATANT, SERUM|SOLIDIFIED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|ASH FIBROSURE FORMULA|Y||Y||3|Visit_3|40|7|FOLLOW-UP|2020-10-07|2020-11-25|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|89209495-c485-4eb7-b858-8dc5490d2b64|7|GLDIGGAB|Gliadin IgG Antibody|HEMATOLOGY|[?]|10^3 RNA copies/mL|[?]|[?]|NEGATIVE|1|Mile|1|1|[?]|LOW|DIALYSIS FLUID|THAWED|N|KNEMOMETRY|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|4|TREATMENT|2020-11-01|2020-11-05|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|89209495-c485-4eb7-b858-8dc5490d2b64|8|IGF1|Insulin-like Growth Factor-1|HEMATOLOGY|||[?]|[?]|TRACE|1|mmol/g|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|PARAFFIN-EMBEDDED||AGAR PROPORTION|MDRD 6 VARIABLE FORMULA|Y||N|Y|4|Visit_4|65|7|WASHOUT|2020-11-01|2020-11-13|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|89209495-c485-4eb7-b858-8dc5490d2b64|9|HIST1AB|Histone 1 Antibody|HEMATOLOGY|[?]|mL/dL|[?]|[?]|BORDERLINE|1|umol/dL|1|1|[?]|NORMAL|URINE SEDIMENT|SOLIDIFIED||X-RAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||5|Visit_5|90|7|WASHOUT|2020-11-26|2020-11-27|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|89209495-c485-4eb7-b858-8dc5490d2b64|10|PCA3MRNA|Prostate Cancer Antigen 3 mRNA|CHEMISTRY|[?]|APPLICATION|[?]|[?]|BORDERLINE|1|10^6 organisms/mL|1|1|[?]|LOW|MUSCLE TISSUE|AGGLUTINATED|N|PHOTOGRAPHY|FIBROMETER FORMULA||Y|NA||5|Visit_5|90|5|TREATMENT|2020-11-26|2020-11-29|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|d80522bb-f146-4270-a6e1-326fde50d9ca|1|CARBXHGB|Carboxyhemoglobin|CHEMISTRY|||[?]|[?]|INVALID|1|10^9 organisms/mg|1|1|[?]|NORMAL|BLOOD|PARAFFIN-EMBEDDED|N|TRANSMISSION ELECTRON MICROSCOPY|MDRD FORMULA|||Y|Y|1|Visit_1|10|4|TREATMENT|2020-12-31|2021-01-04|10|14|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|d80522bb-f146-4270-a6e1-326fde50d9ca|2|HISTAB|Histone Antibodies|HEMATOLOGY|[?]|mEq/mmol|[?]|[?]|POSITIVE|1|FFU|1|1|[?]|HIGH|TISSUE|LIPEMIC||POPULATION SEQUENCING|MDRD ENZYMATIC FORMULA||Y|U||1|Visit_1|10|5|TREATMENT|2020-12-31|2021-01-08|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|d80522bb-f146-4270-a6e1-326fde50d9ca|3|CSEPI846|Aggrecan Chondroitin Sulfate Epitope 846|CHEMISTRY|[?]|v/v|[?]|[?]|INDETERMINATE|1|MAC50|1|1|[?]|LOW|GASTRIC CONTENTS|PARAFFIN-EMBEDDED||ICC|HEPASCORE FORMULA||Y|U||2|Visit_2|25|1|TREATMENT|2021-01-15|2021-01-31|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|d80522bb-f146-4270-a6e1-326fde50d9ca|4|HTTPM|Huntingtin Protein, Mutant|HEMATOLOGY|[?]|mOsm/L|[?]|[?]|INDETERMINATE|1|nmol/g|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|NON-HEMOLYZED|N|ALCIAN BLUE STAIN|CKD-EPI CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|1|SCREENING|2021-01-15|2021-01-28|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|d80522bb-f146-4270-a6e1-326fde50d9ca|5|C130112|Animal Mix Antigen IgE Antibody|HEMATOLOGY|[?]|deg|[?]|[?]|BORDERLINE|1|EID 50/mL|1|1|[?]|NORMAL|WHITE MATTER TISSUE|AUTOLYZED|N|IMMUNOTURBIDIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||3|Visit_3|40|4|TREATMENT|2021-01-30|2021-02-08|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|d80522bb-f146-4270-a6e1-326fde50d9ca|6|ALPIS|Intestinal Specific Alkaline Phosphatase|CHEMISTRY|[?]|V|[?]|[?]|TRACE|1|log10 PFU|1|1|[?]|LOW|CORD BLOOD|AUTOLYZED|N|OLIGO ACGH|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||3|Visit_3|40|1|FOLLOW-UP|2021-01-30|2021-02-24|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|d80522bb-f146-4270-a6e1-326fde50d9ca|7|C130071|Bermuda Grass Pollen IgG4|URINALYSIS|[?]|Ci/kg|[?]|[?]|BORDERLINE|1|mOsm/L|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED||KINETIC MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC FORMULA|Y||Y||4|Visit_4|65|1|SCREENING|2021-02-24|2021-03-11|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|d80522bb-f146-4270-a6e1-326fde50d9ca|8|LYMPHOID|Lymphoid Cells|URINALYSIS|[?]|WAFER|[?]|[?]|POSITIVE|1|mL/mmHg/min/L|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|REFRIGERATED||OPTICAL DENSITY MEASUREMENT|GMI MMOL/MOL FORMULA||Y|N||4|Visit_4|65|2|TREATMENT|2021-02-24|2021-03-12|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|d80522bb-f146-4270-a6e1-326fde50d9ca|9|CYHGBC|Hemoglobin C Crystals|HEMATOLOGY|[?]|BAU|[?]|[?]|TRACE|1|/2000 RBC|1|1|[?]|NORMAL|FLUID|HEMOLYZED||TRIPLE-PHASE MRI SCAN|MDRD FORMULA|||U||5|Visit_5|90|5|TREATMENT|2021-03-21|2021-03-30|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|d80522bb-f146-4270-a6e1-326fde50d9ca|10|MYCEMPOL|Myeloid Maturation Pool|HEMATOLOGY|[?]|g/cage/wk|[?]|[?]|INVALID|1|umol/L/h|1|1|[?]|NORMAL|BONE MARROW|FRESH|N|CELL BASED BIOASSAY|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|5|TREATMENT|2021-03-21|2021-03-23|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|3982a462-95f6-4e71-93e5-9df777770067|1|VLDL2|VLDL Cholesterol Subtype 2|CHEMISTRY|[?]|DNA copies/ug|[?]|[?]|TRACE|1|IU/mmol|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|ICTERIC||ENZYMATIC SPECTROPHOTOMETRY|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-12-25|2021-03-23|10|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|LB|3982a462-95f6-4e71-93e5-9df777770067|2|ALTAST|ALT/AST|HEMATOLOGY|[?]|mL/g/h|[?]|[?]|INVALID|1|10^8 PFU|1|1|[?]|ABNORMAL|PLATELET|SOLIDIFIED||SURFACE PLASMON RESONANCE|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||1|Visit_1|10|1|SCREENING|2020-12-25|2021-01-16|10|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|LB|3982a462-95f6-4e71-93e5-9df777770067|3|C130073|Birch Pollen IgA|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^7 TCID 50/dose|1|1|[?]|LOW|CORD BLOOD|CALCIFIED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|2|Visit_2|25|5|TREATMENT|2021-01-09|2021-03-13|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|3982a462-95f6-4e71-93e5-9df777770067|4|BLYCECE|B-Lymphocytes/Total Cells|HEMATOLOGY|||[?]|[?]|POSITIVE|1|P|1|1|[?]|NORMAL|LOCHIA|FRESH||ZIEHL NEELSEN ACID FAST STAIN|HEPASCORE FORMULA|||U|Y|2|Visit_2|25|5|TREATMENT|2021-01-09|2021-02-10|25|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|3982a462-95f6-4e71-93e5-9df777770067|5|ALLOILE|Alloisoleucine|URINALYSIS|[?]|/VF|[?]|[?]|NEGATIVE|1|mL/kg/day|1|1|[?]|LOW|VENOUS BLOOD|SOLIDIFIED|N|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|2|TREATMENT|2021-01-24|2021-03-24|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|3982a462-95f6-4e71-93e5-9df777770067|6|LCN2CREA|Lipocalin-2/Creatinine|HEMATOLOGY|[?]|mg/mL/day|[?]|[?]|INDETERMINATE|1|umol/L|1|1|[?]|NORMAL|INFRANATANT, SERUM|CONTAMINATED||CELL BASED BIOASSAY|MDRD 5 VARIABLE FORMULA|||U||3|Visit_3|40|4|TREATMENT|2021-01-24|2021-03-07|40|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|3982a462-95f6-4e71-93e5-9df777770067|7|C165888|Russian Thistle Pollen IgE Antibody|URINALYSIS|[?]|mg/dL|[?]|[?]|NEGATIVE|1|/wk|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|AUTOLYZED||AUDIOMETRY|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|7|SCREENING|2021-02-18|2021-03-14|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|3982a462-95f6-4e71-93e5-9df777770067|8|PLSIMCLY|Immature Plasma Cells/Lymphocytes|HEMATOLOGY|[?]|IU/dL|[?]|[?]|NEGATIVE|1|mg/L FEU|1|1|[?]|NORMAL|DISCHARGE|ICTERIC|N|SANGER SEQUENCING|MDRD ENZYMATIC FORMULA|Y|Y|NA||4|Visit_4|65|6|SCREENING|2021-02-18|2021-03-10|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|3982a462-95f6-4e71-93e5-9df777770067|9|PYRUVATE|Pyruvate|CHEMISTRY|[?]|LB|[?]|[?]|NEGATIVE|1|nkat/g Hb|1|1|[?]|LOW|EPIDERMAL TISSUE|THAWED||FISH|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|4|TREATMENT|2021-03-15|2021-03-21|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|3982a462-95f6-4e71-93e5-9df777770067|10|PROTSFR|Protein S, Free|URINALYSIS|||[?]|[?]|BORDERLINE|1|umol/dL|1|1|[?]|ABNORMAL|PERSPIRATION|NON-HEMOLYZED|N|INDIA INK STAIN|MDRD FORMULA||Y|U|Y|5|Visit_5|90|1|FOLLOW-UP|2021-03-15|2021-03-24|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|f3a3a6ca-2344-4cee-a6a5-59beee9304df|1|EPIROCE|Round Epithelial Cells|URINALYSIS|[?]|mmol/min/kPa/L|[?]|[?]|INDETERMINATE|1|PFU/animal|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED||IMMUNODIFFUSION|NASH FIBROSURE FORMULA||Y|N||1|Visit_1|10|7|FOLLOW-UP|2020-11-09|2021-02-01|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|f3a3a6ca-2344-4cee-a6a5-59beee9304df|2|C165929|Bee Mix IgE AB RAST Score|CHEMISTRY|[?]|ug/h|[?]|[?]|BORDERLINE|1|10^3 copies/mL|1|1|[?]|ABNORMAL|SALIVA|DRIED||MAGNETIC RESONANCE ANGIOGRAPHY|FIBROTEST FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-11-09|2020-11-22|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|f3a3a6ca-2344-4cee-a6a5-59beee9304df|3|ODMTASE|O-Demethylase|URINALYSIS|[?]|cg|[?]|[?]|INVALID|1|Tbsp|1|1|[?]|LOW|ARTERIAL CORD BLOOD|CONCENTRATED||ATOMIC ABSORPTION SPECTROMETRY|FIBROTEST FORMULA|Y||NA||2|Visit_2|25|4|TREATMENT|2020-11-24|2020-12-22|25|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|f3a3a6ca-2344-4cee-a6a5-59beee9304df|4|LEUKCRBC|Leuks Corrected for Nucl Erythrocytes|HEMATOLOGY|[?]|uIU/dL|[?]|[?]|BORDERLINE|1|vg/dose|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|DRIED||DYNAMOMETRY|FIBROMETER FORMULA|||U||2|Visit_2|25|1|WASHOUT|2020-11-24|2020-12-25|25|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|f3a3a6ca-2344-4cee-a6a5-59beee9304df|5|PECAM|Platelet Endothelial Adhesion Molecule|HEMATOLOGY|||[?]|[?]|INVALID|1|DIOPTER|1|1|[?]|NORMAL|PLATELET RICH PLASMA|FRESH||DNA MICROARRAY|COCKCROFT-GAULT FORMULA|Y||N|Y|3|Visit_3|40|1|TREATMENT|2020-12-09|2020-12-17|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|f3a3a6ca-2344-4cee-a6a5-59beee9304df|6|VITB6|Vitamin B6|CHEMISTRY|||[?]|[?]|POSITIVE|1|/wk|1|1|[?]|ABNORMAL|BILE|FROZEN||SPECULAR MICROSCOPY|MDRD ENZYMATIC FORMULA|||Y|Y|3|Visit_3|40|4|FOLLOW-UP|2020-12-09|2021-01-15|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|f3a3a6ca-2344-4cee-a6a5-59beee9304df|7|FLUDOUTE|Fluid Output, Estimated|URINALYSIS|[?]|U|[?]|[?]|POSITIVE|1|PIXEL|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|THAWED||POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||Y|Y||4|Visit_4|65|3|WASHOUT|2021-01-03|2021-01-06|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|f3a3a6ca-2344-4cee-a6a5-59beee9304df|8|GLUC|Glucose|CHEMISTRY|[?]|10^9 organisms|[?]|[?]|TRACE|1|mg/L FEU|1|1|[?]|ABNORMAL|MUCUS|NON-HEMOLYZED||SANGER SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|3|WASHOUT|2021-01-03|2021-01-04|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|f3a3a6ca-2344-4cee-a6a5-59beee9304df|9|ANPPRONT|N-Terminal ProA-type Natriuretic Peptide|CHEMISTRY|||[?]|[?]|BORDERLINE|1|10^7/L|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|ROOM TEMPERATURE|N|ANGIOGRAPHY|FIBROMETER FORMULA|||NA|Y|5|Visit_5|90|1|TREATMENT|2021-01-28|2021-02-05|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|f3a3a6ca-2344-4cee-a6a5-59beee9304df|10|IGGALB|Immunoglobulin G/Albumin|HEMATOLOGY|[?]|mL/h|[?]|[?]|NEGATIVE|1|g/L|1|1|[?]|LOW|GASTRIC CONTENTS|AGGLUTINATED||PHASE-CONTRAST MRI|MDRD 6 VARIABLE FORMULA|Y||Y||5|Visit_5|90|2|WASHOUT|2021-01-28|2021-02-01|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|175cfd82-a6fe-463b-81e5-07ae9e1253db|1|TNF12|TNF Superfamily Member 12|URINALYSIS|[?]|mg/L|[?]|[?]|NEGATIVE|1|nmol BCE/mmol|1|1|[?]|NORMAL|BUFFY COAT|FRESH||PULMONARY ANGIOGRAPHY|MDRD ENZYMATIC FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2020-05-26|2020-08-10|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|LB|175cfd82-a6fe-463b-81e5-07ae9e1253db|2|PHTRMN|Phentermine|HEMATOLOGY|[?]|mL/cage/day|[?]|[?]|INVALID|1|mAnson U/mL|1|1|[?]|ABNORMAL|VENOUS BLOOD|LACTESCENT||FUNCTIONAL MRI|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|7|WASHOUT|2020-05-26|2020-06-12|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|LB|175cfd82-a6fe-463b-81e5-07ae9e1253db|3|KI67|Ki-67|HEMATOLOGY|[?]|VIAL|[?]|[?]|INDETERMINATE|1|pg|1|1|[?]|NORMAL|LAVAGE FLUID|AGGLUTINATED||FLUORESCEIN STAIN|CKD-EPI FORMULA|||N||2|Visit_2|25|1|WASHOUT|2020-06-10|2020-07-05|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|175cfd82-a6fe-463b-81e5-07ae9e1253db|4|MONOBL|Monoblasts|CHEMISTRY|[?]|/min|[?]|[?]|INDETERMINATE|1|g/cage|1|1|[?]|HIGH|SEMEN|THAWED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 4 VARIABLE FORMULA|Y||Y||2|Visit_2|25|4|WASHOUT|2020-06-10|2020-08-01|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|175cfd82-a6fe-463b-81e5-07ae9e1253db|5|INSAB|Insulin Antibody|CHEMISTRY|[?]|min*mg/mL|[?]|[?]|INDETERMINATE|1|/ms|1|1|[?]|LOW|EMESIS|NON-HEMOLYZED||ELLA|GMI MMOL/MOL FORMULA|||U||3|Visit_3|40|1|SCREENING|2020-06-25|2020-07-22|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|175cfd82-a6fe-463b-81e5-07ae9e1253db|6|SPLA2II|Type II Secretory Phospholipase A2|CHEMISTRY|[?]|cpm|[?]|[?]|BORDERLINE|1|10^3 copies/mL|1|1|[?]|HIGH|CORD BLOOD|CLOTTED||HEMATOXYLIN AND EOSIN STAIN|FIBROSIS 4 FORMULA|Y|Y|U||3|Visit_3|40|3|WASHOUT|2020-06-25|2020-08-18|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|175cfd82-a6fe-463b-81e5-07ae9e1253db|7|SAHOMC|S-Adenosylhomocysteine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|h*%|1|1|[?]|ABNORMAL|LEUKOCYTE|REFRIGERATED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NASH FIBROSURE FORMULA|Y|Y|NA|Y|4|Visit_4|65|4|WASHOUT|2020-07-20|2020-07-27|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|175cfd82-a6fe-463b-81e5-07ae9e1253db|8|TAT|Thrombin/Antithrombin|HEMATOLOGY|||[?]|[?]|TRACE|1|mmol2/L2|1|1|[?]|ABNORMAL|PERSPIRATION|FROZEN||MICROBIAL CULTURE, LIQUID|NASH FIBROSURE FORMULA|Y||NA|Y|4|Visit_4|65|2|TREATMENT|2020-07-20|2020-08-13|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|175cfd82-a6fe-463b-81e5-07ae9e1253db|9|MMP9|Matrix Metalloproteinase 9|URINALYSIS|[?]|mg/kg/min|[?]|[?]|BORDERLINE|1|mmol/g|1|1|[?]|NORMAL|STOOL|GELLED||SCINTIGRAPHY|MDRD FORMULA|||NA||5|Visit_5|90|1|SCREENING|2020-08-14|2020-08-15|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|175cfd82-a6fe-463b-81e5-07ae9e1253db|10|C165884|Olive Tree Pollen IgE Antibody|URINALYSIS|[?]|log10 CFU/mL|[?]|[?]|POSITIVE|1|/LSQN|1|1|[?]|HIGH|MUSCLE TISSUE|AGGLUTINATED||FLOW CYTOMETRY|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|7|SCREENING|2020-08-14|2020-08-20|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|e19b469c-40d5-4506-8233-a86bebde880d|1|COPEP|Copeptin|URINALYSIS|[?]|/HPF|[?]|[?]|POSITIVE|1|ug|1|1|[?]|ABNORMAL|ABSCESS FLUID|ROOM TEMPERATURE|N|CONTACT SPECULAR MICROSCOPY|FIBROSIS 4 FORMULA|Y||U||1|Visit_1|10|2|TREATMENT|2021-01-22|2021-04-07|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|e19b469c-40d5-4506-8233-a86bebde880d|2|PTHMM|Parathyroid Hormone, Mid-Molecule|URINALYSIS|[?]|g/g|[?]|[?]|POSITIVE|1|/10^5|1|1|[?]|NORMAL|LYMPH|HEMOLYZED||X-RAY|MDRD FORMULA|Y||N||1|Visit_1|10|2|TREATMENT|2021-01-22|2021-02-06|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|e19b469c-40d5-4506-8233-a86bebde880d|3|GSTMU|Mu Glutathione-S-Transferase|HEMATOLOGY|[?]|DROP|[?]|[?]|BORDERLINE|1|IU|1|1|[?]|ABNORMAL|TRANSUDATE|LIPEMIC||CT SCAN|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2021-02-06|2021-03-13|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|e19b469c-40d5-4506-8233-a86bebde880d|4|APRIL|A Proliferation-Inducing Ligand|URINALYSIS|[?]|SQU/mL|[?]|[?]|INDETERMINATE|1|L/L|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED|N|MICRONEUTRALIZATION ASSAY|HEPASCORE FORMULA|||U||2|Visit_2|25|5|SCREENING|2021-02-06|2021-04-01|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|e19b469c-40d5-4506-8233-a86bebde880d|5|HGBSHGB|Hemoglobin S/Total Hemoglobin|URINALYSIS|[?]|mg/kg/min|[?]|[?]|INVALID|1|pmol/10^9 cells|1|1|[?]|NORMAL|SWABBED MATERIAL|GELLED|N|DIFFUSION TENSOR MRI|MDRD 5 VARIABLE FORMULA||Y|N||3|Visit_3|40|2|SCREENING|2021-02-21|2021-04-04|40|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|e19b469c-40d5-4506-8233-a86bebde880d|6|MGCREAT|Magnesium/Creatinine|URINALYSIS|[?]|BISCUIT|[?]|[?]|INDETERMINATE|1|Bq/mg|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|CALCIFIED||PANENDOSCOPY|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2021-02-21|2021-03-04|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|e19b469c-40d5-4506-8233-a86bebde880d|7|C130095|Western Ragweed Pollen IgG4|URINALYSIS|||[?]|[?]|INDETERMINATE|1|m2|1|1|[?]|LOW|SUPERNATANT, SERUM|NON-HEMOLYZED||OPTICAL COHERENCE TOMOGRAPHY|HEPASCORE FORMULA||Y|U|Y|4|Visit_4|65|5|TREATMENT|2021-03-18|2021-04-15|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|e19b469c-40d5-4506-8233-a86bebde880d|8|ACPHOS|Acid Phosphatase|HEMATOLOGY|[?]|Gy/h|[?]|[?]|POSITIVE|1|anti-Xa IU/mL|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|AGGLUTINATED||REFRACTOMETRY|CKD-EPI FORMULA|||N||4|Visit_4|65|1|WASHOUT|2021-03-18|2021-03-23|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|e19b469c-40d5-4506-8233-a86bebde880d|9|VMAEXR|Vanillyl Mandelic Acid Excretion Rate|HEMATOLOGY|[?]|BP|[?]|[?]|NEGATIVE|1|VIRTUAL PIXEL|1|1|[?]|HIGH|PERITONEAL FLUID|CONTAMINATED|N|IMMUNO-PET SCAN|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|5|TREATMENT|2021-04-12|2021-04-15|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|e19b469c-40d5-4506-8233-a86bebde880d|10|INTLK11|Interleukin 11|CHEMISTRY|[?]|/VF|[?]|[?]|BORDERLINE|1|%(v/v)|1|1|[?]|LOW|SEMINAL FLUID|CLOTTED|N|CONTRAST ENHANCED CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||5|Visit_5|90|6|SCREENING|2021-04-12|2021-04-20|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|f280a4a5-9826-4d77-adf1-992284cb3314|1|ASSDNA|Anti-Single Stranded DNA IgG|HEMATOLOGY|[?]|TRANSDUCING UNIT|[?]|[?]|POSITIVE|1|cm/min|1|1|[?]|HIGH|CALCULUS|REFRIGERATED|N|TARGETED GENOME SEQUENCING|MDRD 6 VARIABLE FORMULA|Y||N||1|Visit_1|10|6|TREATMENT|2020-12-19|2021-01-28|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|LB|f280a4a5-9826-4d77-adf1-992284cb3314|2|CHOLATE|Cholate|URINALYSIS|[?]|ms/mmHg|[?]|[?]|INDETERMINATE|1|Absorbance U/mL|1|1|[?]|LOW|PLEURAL FLUID|LACTESCENT||DNA MICROARRAY|GMI MMOL/MOL FORMULA|Y||NA||1|Visit_1|10|1|FOLLOW-UP|2020-12-19|2021-01-14|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|LB|f280a4a5-9826-4d77-adf1-992284cb3314|3|HGBDOXY|Deoxyhemoglobin|CHEMISTRY|[?]|10^4 CFU|[?]|[?]|NEGATIVE|1|grain|1|1|[?]|LOW|BILE|CALCIFIED||SCINTIGRAPHY|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2021-01-03|2021-02-18|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|f280a4a5-9826-4d77-adf1-992284cb3314|4|THYPXD|Thyroperoxidase|CHEMISTRY|[?]|kg/m2|[?]|[?]|NEGATIVE|1|RING|1|1|[?]|HIGH|VITREOUS HUMOR|HEMOLYZED||LIQUID SCINTILLATION COUNTING|HEPASCORE FORMULA|||U||2|Visit_2|25|6|WASHOUT|2021-01-03|2021-01-24|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|f280a4a5-9826-4d77-adf1-992284cb3314|5|TRGTCE|Target Cells|HEMATOLOGY|[?]|mmHg/sec|[?]|[?]|NEGATIVE|1|vg/kg|1|1|[?]|HIGH|STOOL|ICTERIC||PHASE-CONTRAST MRI|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||3|Visit_3|40|4|SCREENING|2021-01-18|2021-02-09|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|f280a4a5-9826-4d77-adf1-992284cb3314|6|HGBSHGB|Hemoglobin S/Total Hemoglobin|HEMATOLOGY|[?]|/min|[?]|[?]|INDETERMINATE|1|mL/cage/day|1|1|[?]|NORMAL|BREAST MILK|SOLIDIFIED|N|CT SCAN|FIBROMETER FORMULA|Y||N||3|Visit_3|40|5|TREATMENT|2021-01-18|2021-02-24|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|f280a4a5-9826-4d77-adf1-992284cb3314|7|C130134|D. pteronyssinus Antigen IgE Antibody|URINALYSIS|[?]|ft|[?]|[?]|TRACE|1|nmol/L/min|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED||RADIAL IMMUNODIFFUSION|FIBROSIS 4 FORMULA|||Y||4|Visit_4|65|4|SCREENING|2021-02-12|2021-03-15|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|f280a4a5-9826-4d77-adf1-992284cb3314|8|CHOLATE|Cholate|URINALYSIS|[?]|K|[?]|[?]|BORDERLINE|1|/day|1|1|[?]|NORMAL|SERUM OR PLASMA|CALCIFIED||PERIPHERAL ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|U||4|Visit_4|65|1|SCREENING|2021-02-12|2021-02-16|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|f280a4a5-9826-4d77-adf1-992284cb3314|9|ETG|Ethyl Glucuronide|HEMATOLOGY|[?]|ug/L|[?]|[?]|NEGATIVE|1|mm|1|1|[?]|LOW|LYSATE|PARAFFIN-EMBEDDED||IODINE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|6|FOLLOW-UP|2021-03-09|2021-03-13|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|LB|f280a4a5-9826-4d77-adf1-992284cb3314|10|NEUTSG|Neutrophils, Segmented|URINALYSIS|[?]|nmol BCE/mmol|[?]|[?]|INDETERMINATE|1|dpm/mg|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|LACTESCENT||POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||Y|Y||5|Visit_5|90|7|SCREENING|2021-03-09|2021-03-11|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|LB|82840929-7800-4254-b60a-8af4786664f6|1|NRP1|Neuropilin-1|HEMATOLOGY|[?]|U/mmol|[?]|[?]|INDETERMINATE|1|mL/dose|1|1|[?]|HIGH|URINE|PARAFFIN-EMBEDDED||QUANTITATIVE COMPUTED TOMOGRAPHY|CKD-EPI FORMULA|Y||N||1|Visit_1|10|7|TREATMENT|2020-06-04|2020-07-10|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-27
e|LB|82840929-7800-4254-b60a-8af4786664f6|2|CD45LY|CD45/Lymphocytes|HEMATOLOGY|[?]|Bq/L|[?]|[?]|INDETERMINATE|1|DAgU|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|AGGLUTINATED|N|SCINTIGRAPHY|FIBROMETER FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-06-04|2020-06-23|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-27
e|LB|82840929-7800-4254-b60a-8af4786664f6|3|MSPIKER|Monoclonal Protein Spike Region|HEMATOLOGY|[?]|ug/kg/min|[?]|[?]|INVALID|1|PHERESIS UNIT|1|1|[?]|NORMAL|BLOOD|LACTESCENT||IMMUNOFIXATION ELECTROPHORESIS|FIBROTEST FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-06-19|2020-07-13|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|82840929-7800-4254-b60a-8af4786664f6|4|FACTVW|von Willebrand Factor|HEMATOLOGY|||[?]|[?]|INVALID|1|fmol/L/sec|1|1|[?]|LOW|SKIN TISSUE|AGGLUTINATED||HPLC-UV|CKD-EPI FORMULA|||U|Y|2|Visit_2|25|3|TREATMENT|2020-06-19|2020-07-17|25|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|82840929-7800-4254-b60a-8af4786664f6|5|C147284|Boxelder Pollen IgE Antibody|HEMATOLOGY|[?]|/7.5 mL|[?]|[?]|BORDERLINE|1|mg/kg/day|1|1|[?]|NORMAL|LEUKOCYTE|NON-HEMOLYZED||JAFFE REACTION|CKD-EPI CYSTATIN C FORMULA|Y||U||3|Visit_3|40|6|TREATMENT|2020-07-04|2020-08-25|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|82840929-7800-4254-b60a-8af4786664f6|6|SPERMP|Spermatozoa, Progressive|HEMATOLOGY|[?]|U/g/day|[?]|[?]|TRACE|1|10^6/g|1|1|[?]|ABNORMAL|LOCHIA|AGGLUTINATED||PHOROPTER|FIBROSIS 4 FORMULA||Y|N||3|Visit_3|40|7|TREATMENT|2020-07-04|2020-07-21|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|82840929-7800-4254-b60a-8af4786664f6|7|MYBLAT1|Type I Myeloblasts|HEMATOLOGY|[?]|mL/s/m2|[?]|[?]|POSITIVE|1|s*kPa|1|1|[?]|ABNORMAL|LUNG SURFACTANT|CONCENTRATED||REFRACTOMETRY|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-07-29|2020-08-25|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|82840929-7800-4254-b60a-8af4786664f6|8|T3UP|Triiodothyronine Uptake|HEMATOLOGY|[?]|BLOCKS|[?]|[?]|BORDERLINE|1|WAFER|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|N|HANSEL STAIN|CKD-EPI FORMULA|||NA||4|Visit_4|65|1|TREATMENT|2020-07-29|2020-08-10|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|82840929-7800-4254-b60a-8af4786664f6|9|C165899|Silver Birch Pollen IgG AB RAST Score|CHEMISTRY|[?]|Enzyme U|[?]|[?]|POSITIVE|1|USP U|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|THAWED||PERIODIC ACID SCHIFF STAIN|MDRD 5 VARIABLE FORMULA||Y|N||5|Visit_5|90|4|TREATMENT|2020-08-23|2020-09-01|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-29
e|LB|82840929-7800-4254-b60a-8af4786664f6|10|IBCT|Total Iron Binding Capacity|HEMATOLOGY|[?]|QUANTITY SUFFICIENT|[?]|[?]|BORDERLINE|1|mL/(min*100mL)|1|1|[?]|NORMAL|BREAST MILK|THAWED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2020-08-23|2020-08-30|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-29
e|LB|dae25bdb-38fd-4852-9a9a-7627368e9497|1|FERRITIN|Ferritin|URINALYSIS|[?]|kPa|[?]|[?]|NEGATIVE|1|in|1|1|[?]|ABNORMAL|CORD BLOOD|LACTESCENT||CT SCAN|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-09-02|2020-10-24|10|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|dae25bdb-38fd-4852-9a9a-7627368e9497|2|IRONEXR|Iron Excretion Rate|HEMATOLOGY|[?]|IU|[?]|[?]|INVALID|1|msec|1|1|[?]|ABNORMAL|MUCUS|THAWED||ATOMIC ABSORPTION SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-09-02|2020-10-30|10|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|dae25bdb-38fd-4852-9a9a-7627368e9497|3|RENINA|Renin Activity|CHEMISTRY|||[?]|[?]|BORDERLINE|1|vg/mL|1|1|[?]|HIGH|PROSTATIC FLUID|THAWED||CONTRAST ENHANCED CT SCAN|CKD-EPI CYSTATIN C FORMULA|||U|Y|2|Visit_2|25|7|TREATMENT|2020-09-17|2020-10-14|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|LB|dae25bdb-38fd-4852-9a9a-7627368e9497|4|AFPL1|Alpha Fetoprotein L1|HEMATOLOGY|[?]|kg/mol|[?]|[?]|TRACE|1|EIA unit|1|1|[?]|NORMAL|ADIPOSE TISSUE|GELLED||MRS|MDRD ENZYMATIC JAPANESE FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-09-17|2020-10-09|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|LB|dae25bdb-38fd-4852-9a9a-7627368e9497|5|CD11A|CD11A|CHEMISTRY|||[?]|[?]|BORDERLINE|1|pmol/10^9 cells|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|REFRIGERATED||SEQUENCING|MDRD 6 VARIABLE FORMULA|||N|Y|3|Visit_3|40|3|FOLLOW-UP|2020-10-02|2020-11-15|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|dae25bdb-38fd-4852-9a9a-7627368e9497|6|GAD1|Glutamic Acid Decarboxylase 1|CHEMISTRY|[?]|BLOCKS|[?]|[?]|POSITIVE|1|BAR|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|CLOTTED|N|HEMAGGLUTINATION INHIBITION ASSAY|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|1|SCREENING|2020-10-02|2020-11-08|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|dae25bdb-38fd-4852-9a9a-7627368e9497|7|DPPIVA|Dipeptidyl Peptidase-4 Activity|URINALYSIS|[?]|nL|[?]|[?]|NEGATIVE|1|s^-1(%O2)^-1|1|1|[?]|NORMAL|INFRANATANT, SERUM|ROOM TEMPERATURE|N|ACCELERATOR MASS SPECTROMETRY|MDRD 4 VARIABLE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-10-27|2020-11-05|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|dae25bdb-38fd-4852-9a9a-7627368e9497|8|RDCSUG|Reducing Sugars|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ft|1|1|[?]|NORMAL|ALVEOLAR AIR|FROZEN||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|HEPASCORE FORMULA|||N|Y|4|Visit_4|65|3|WASHOUT|2020-10-27|2020-11-14|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|dae25bdb-38fd-4852-9a9a-7627368e9497|9|GLOBA|Alpha Globulin|URINALYSIS|||[?]|[?]|POSITIVE|1|DRUM|1|1|[?]|LOW|HAIR FOLLICLE|HEMOLYZED||CONTRAST ENHANCED SPIRAL CT SCAN|GMI % FORMULA|||N|Y|5|Visit_5|90|5|FOLLOW-UP|2020-11-21|2020-11-24|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|dae25bdb-38fd-4852-9a9a-7627368e9497|10|ALAALB|Apolipoprotein A/Apolipoprotein B|CHEMISTRY|||[?]|[?]|INVALID|1|cGy|1|1|[?]|ABNORMAL|SEMINAL FLUID|AUTOLYZED|N|TRANSMISSION ELECTRON MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA|Y|5|Visit_5|90|3|TREATMENT|2020-11-21|2020-11-29|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|9e009737-cd77-4b96-a4af-e9731ef7e9d0|1|GLOBB1BP|Beta-1 Globulin/Beta Protein|HEMATOLOGY|[?]|cm2|[?]|[?]|INDETERMINATE|1|BOLUS|1|1|[?]|HIGH|INTERSTITIAL FLUID|PARAFFIN-EMBEDDED||OPTICAL COHERENCE TOMOGRAPHY|MDRD ENZYMATIC FORMULA|||NA||1|Visit_1|10|7|SCREENING|2020-10-05|2020-10-28|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|LB|9e009737-cd77-4b96-a4af-e9731ef7e9d0|2|XNTHCHR|Xanthochromia|HEMATOLOGY|[?]|MET*min|[?]|[?]|TRACE|1|mol/mL|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|CALCIFIED||SCINTIGRAPHY|GMI MMOL/MOL FORMULA||Y|U||1|Visit_1|10|1|TREATMENT|2020-10-05|2020-11-03|10|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|LB|9e009737-cd77-4b96-a4af-e9731ef7e9d0|3|EOSNUCCE|Eosinophils/Nucleated Cells|URINALYSIS|[?]|mg/kg/day|[?]|[?]|TRACE|1|L/s|1|1|[?]|LOW|NAIL|UNEXPECTED ODOR||ICP-MS|CKD-EPI FORMULA|Y|Y|Y||2|Visit_2|25|3|FOLLOW-UP|2020-10-20|2020-10-21|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|9e009737-cd77-4b96-a4af-e9731ef7e9d0|4|HLAB27AG|HLA-B27 Antigen|HEMATOLOGY|[?]|km/h|[?]|[?]|TRACE|1|CAPFUL|1|1|[?]|ABNORMAL|ISOLATE|FRESH||DOPPLER ULTRASOUND|FIBROSIS 4 FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-10-20|2020-12-19|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|9e009737-cd77-4b96-a4af-e9731ef7e9d0|5|TUDCA|Tauroursodeoxycholate|CHEMISTRY|[?]|nCi|[?]|[?]|TRACE|1|%(w/v)|1|1|[?]|LOW|CAPILLARY BLOOD|GELLED||MEDIASTINOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-11-04|2020-11-17|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|9e009737-cd77-4b96-a4af-e9731ef7e9d0|6|FCTXIIIA|Factor XIII Activity|HEMATOLOGY|[?]|10^9 organisms/mL|[?]|[?]|TRACE|1|POINT|1|1|[?]|NORMAL|SWABBED MATERIAL|CONTAMINATED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|4|WASHOUT|2020-11-04|2020-12-04|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|9e009737-cd77-4b96-a4af-e9731ef7e9d0|7|A2MACG|Alpha-2 Macroglobulin|CHEMISTRY|[?]|mg/dose|[?]|[?]|BORDERLINE|1|DAgU/mL|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|FROZEN||KINYOUN STAIN|GMI % FORMULA|||N||4|Visit_4|65|2|SCREENING|2020-11-29|2020-12-08|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|9e009737-cd77-4b96-a4af-e9731ef7e9d0|8|HBHIB|Hemoglobin H Inclusion Bodies|HEMATOLOGY|[?]|10^9/dose|[?]|[?]|INDETERMINATE|1|L|1|1|[?]|ABNORMAL|URINE|GELLED||IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y||4|Visit_4|65|3|FOLLOW-UP|2020-11-29|2020-12-25|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|9e009737-cd77-4b96-a4af-e9731ef7e9d0|9|APOB100|Apolipoprotein B100|CHEMISTRY|[?]|cL|[?]|[?]|INVALID|1|/cmH2O|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|ICTERIC||LAPAROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|6|WASHOUT|2020-12-24|2020-12-29|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|9e009737-cd77-4b96-a4af-e9731ef7e9d0|10|BLSTLYLE|Lymphoblasts/Leukocytes|CHEMISTRY|||[?]|[?]|POSITIVE|1|lm|1|1|[?]|LOW|CALCULUS|GELLED||BIOPSY|CKD-EPI CREATININE FORMULA|Y|Y|U|Y|5|Visit_5|90|2|TREATMENT|2020-12-24|2020-12-26|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|e7468d01-71b3-47c4-9715-62fe143364cb|1|EDMAB|Endomysial Antibody|HEMATOLOGY|[?]|10^6 copies/mL|[?]|[?]|NEGATIVE|1|Joule|1|1|[?]|NORMAL|AQUEOUS HUMOR|CONCENTRATED|N|CELLULOSE TAPE|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|1|TREATMENT|2020-10-15|2020-11-08|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|e7468d01-71b3-47c4-9715-62fe143364cb|2|LCTHSPGM|Lecithin/Sphingomyelin|HEMATOLOGY|[?]|IU/kg/h|[?]|[?]|INVALID|1|mL/cm3/min|1|1|[?]|HIGH|PLASMA|CONCENTRATED||MANUAL COUNT|MDRD FORMULA|Y||Y||1|Visit_1|10|7|SCREENING|2020-10-15|2020-11-04|10|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|e7468d01-71b3-47c4-9715-62fe143364cb|3|FECL|Fractional Chloride Excretion|CHEMISTRY|[?]|m3|[?]|[?]|BORDERLINE|1|ug/h|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|GELLED||CALIPER MEASUREMENT METHOD|FIBROTEST FORMULA|Y||Y||2|Visit_2|25|3|SCREENING|2020-10-30|2020-12-27|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|e7468d01-71b3-47c4-9715-62fe143364cb|4|TNFSR1|Soluble TNF Receptor Type I|CHEMISTRY|[?]|Shock Wave|[?]|[?]|NEGATIVE|1|mL/g/day|1|1|[?]|ABNORMAL|EMESIS|HEMOLYZED||MECHANICAL CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||2|Visit_2|25|3|WASHOUT|2020-10-30|2020-12-20|25|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|e7468d01-71b3-47c4-9715-62fe143364cb|5|CD45LY|CD45/Lymphocytes|CHEMISTRY|||[?]|[?]|POSITIVE|1|EP U|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|LIPEMIC|N|MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|3|Visit_3|40|3|TREATMENT|2020-11-14|2020-12-23|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|e7468d01-71b3-47c4-9715-62fe143364cb|6|NOREPIN|Norepinephrine|URINALYSIS|[?]|PFU|[?]|[?]|POSITIVE|1|/month|1|1|[?]|NORMAL|SEMINAL FLUID|REFRIGERATED||NUCLEIC ACID BASED METHOD|COCKCROFT-GAULT FORMULA|Y||N||3|Visit_3|40|4|SCREENING|2020-11-14|2020-11-17|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|e7468d01-71b3-47c4-9715-62fe143364cb|7|UROBIL|Urobilinogen|URINALYSIS|||[?]|[?]|INVALID|1|tuberculin unit/mL|1|1|[?]|HIGH|GASTRIC CONTENTS|AGGLUTINATED||GC/FID|MDRD 5 VARIABLE FORMULA|||U|Y|4|Visit_4|65|4|WASHOUT|2020-12-09|2020-12-14|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|e7468d01-71b3-47c4-9715-62fe143364cb|8|GLOBB1|Beta-1 Globulin|CHEMISTRY|[?]|psec|[?]|[?]|INDETERMINATE|1|mL/beat|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|AUTOLYZED||SINGLE-SLICE SPIRAL CT|MDRD 6 VARIABLE FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2020-12-09|2020-12-14|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|e7468d01-71b3-47c4-9715-62fe143364cb|9|EOSLE|Eosinophils/Leukocytes|CHEMISTRY|||[?]|[?]|TRACE|1|mg/mL/day|1|1|[?]|LOW|LYSATE|CONTAMINATED|N|SPECT SCAN|CKD-EPI CYSTATIN C FORMULA|||Y|Y|5|Visit_5|90|3|TREATMENT|2021-01-03|2021-01-05|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|e7468d01-71b3-47c4-9715-62fe143364cb|10|CYSTATC|Cystatin C|HEMATOLOGY|[?]|gtt|[?]|[?]|BORDERLINE|1|copies/mL|1|1|[?]|NORMAL|TRANSUDATE|REFRIGERATED|N|OBSERVATION|FIBROTEST FORMULA||Y|NA||5|Visit_5|90|6|TREATMENT|2021-01-03|2021-01-07|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|6a021859-1b18-4eb5-9548-0e32c0c1edf7|1|NKCE|Natural Killer Cells|CHEMISTRY|[?]|PELLET|[?]|[?]|POSITIVE|1|/VF|1|1|[?]|HIGH|AMNIOTIC FLUID|LACTESCENT||SINGLE-SLICE SPIRAL CT|MDRD FORMULA|||U||1|Visit_1|10|5|WASHOUT|2020-05-18|2020-06-15|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|6a021859-1b18-4eb5-9548-0e32c0c1edf7|2|C147283|White Elm Pollen IgG Antibody|CHEMISTRY|[?]|mMU/mL|[?]|[?]|NEGATIVE|1|log10 copies/mL|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|REFRIGERATED|N|ORCHIDOMETERY|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-05-18|2020-06-08|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|6a021859-1b18-4eb5-9548-0e32c0c1edf7|3|CATNINB|Beta Catenin|CHEMISTRY|[?]|U/g Hb|[?]|[?]|INDETERMINATE|1|EIA unit|1|1|[?]|LOW|REFLEX TEAR|DRIED|N|ANTIMICROBIAL COMBINATION TESTING|FIBROMETER FORMULA|||NA||2|Visit_2|25|6|FOLLOW-UP|2020-06-02|2020-06-15|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|LB|6a021859-1b18-4eb5-9548-0e32c0c1edf7|4|MCVRETIC|MCV Reticulocytes|CHEMISTRY|[?]|/40 HPFs|[?]|[?]|TRACE|1|SCOOPFUL|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|GELLED||PAP STAIN|GMI % FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-06-02|2020-06-24|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|LB|6a021859-1b18-4eb5-9548-0e32c0c1edf7|5|AMYLASEP|Amylase, Pancreatic|URINALYSIS|[?]|Sv|[?]|[?]|POSITIVE|1|DAYS|1|1|[?]|ABNORMAL|DIALYSIS FLUID, PERITONEAL|HEMOLYZED|N|ACCELERATOR MASS SPECTROMETRY|HEPASCORE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-06-17|2020-07-23|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|6a021859-1b18-4eb5-9548-0e32c0c1edf7|6|RDWSD|RDW Standard Deviation|URINALYSIS|[?]|msec|[?]|[?]|NEGATIVE|1|U/kg|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|GELLED||SLOAN LETTER EYE CHART 2.5%|HEPASCORE FORMULA||Y|Y||3|Visit_3|40|3|TREATMENT|2020-06-17|2020-07-14|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|6a021859-1b18-4eb5-9548-0e32c0c1edf7|7|APRI|AST to Platelet Ratio Index|URINALYSIS|[?]|DIP|[?]|[?]|INDETERMINATE|1|sec|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|SOLIDIFIED||SPECTROPHOTOMETRY|MDRD 6 VARIABLE FORMULA||Y|NA||4|Visit_4|65|3|TREATMENT|2020-07-12|2020-08-10|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|6a021859-1b18-4eb5-9548-0e32c0c1edf7|8|MX1|Interferon-Induced Protein p78|URINALYSIS|[?]|m2|[?]|[?]|POSITIVE|1|log10 PFU|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|DRIED|N|ROMANOWSKY STAIN|CKD-EPI CREATININE FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-07-12|2020-07-19|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|6a021859-1b18-4eb5-9548-0e32c0c1edf7|9|PD1S|Soluble Programmed Death-1|HEMATOLOGY|[?]|POINT|[?]|[?]|NEGATIVE|1|vg/kg|1|1|[?]|NORMAL|FLUID|ICTERIC|N|ACID FAST STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2020-08-06|2020-08-10|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|6a021859-1b18-4eb5-9548-0e32c0c1edf7|10|DHEAS|Dehydroepiandrosterone Sulfate|URINALYSIS|[?]|g/dL|[?]|[?]|NEGATIVE|1|cmol/L|1|1|[?]|HIGH|BONE MARROW|CONCENTRATED||CALCOFLUOR WHITE STAIN|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|2|WASHOUT|2020-08-06|2020-08-15|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|eb409ec5-4c02-41c8-a11f-03d990818c2a|1|DHEA|Dehydroepiandrosterone|URINALYSIS|||[?]|[?]|POSITIVE|1|Hz|1|1|[?]|HIGH|LEUKOCYTE|ICTERIC||IMMUNOPRECIPITATION|MDRD FORMULA|||N|Y|1|Visit_1|10|5|TREATMENT|2020-12-09|2021-01-18|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|eb409ec5-4c02-41c8-a11f-03d990818c2a|2|NICOTINE|Nicotine|HEMATOLOGY|[?]|log10 TCID 50/mL|[?]|[?]|NEGATIVE|1|DRINK|1|1|[?]|NORMAL|FLUID|CLOTTED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-12-09|2021-02-10|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|eb409ec5-4c02-41c8-a11f-03d990818c2a|3|RUBCE|Rubricyte/Total Cells|CHEMISTRY|[?]|EU|[?]|[?]|INVALID|1|10^6 organisms/mg|1|1|[?]|HIGH|SEMINAL FLUID|CONCENTRATED|N|URANYL ACETATE STAIN|GMI % FORMULA|Y||Y||2|Visit_2|25|2|WASHOUT|2020-12-24|2021-01-30|25|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|eb409ec5-4c02-41c8-a11f-03d990818c2a|4|VEGFA|Vascular Endothelial Growth Factor A|CHEMISTRY|[?]|U/dL|[?]|[?]|POSITIVE|1|ug/animal|1|1|[?]|ABNORMAL|COLOSTRUM|GELLED||SIZE EXCLUSION CHROMATOGRAPHY|GMI % FORMULA|||Y||2|Visit_2|25|7|SCREENING|2020-12-24|2021-01-26|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|eb409ec5-4c02-41c8-a11f-03d990818c2a|5|KLCLLC|Kappa Light Chain/Lambda Light Chain|URINALYSIS|[?]|L|[?]|[?]|BORDERLINE|1|10^5/L|1|1|[?]|NORMAL|MUSCLE TISSUE|LIPEMIC||ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2021-01-08|2021-02-10|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|eb409ec5-4c02-41c8-a11f-03d990818c2a|6|FRUCT|Fructosamine|CHEMISTRY|[?]|ft|[?]|[?]|POSITIVE|1|fmol/g|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|CONTAMINATED||ACCELERATOR MASS SPECTROMETRY|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|1|WASHOUT|2021-01-08|2021-02-23|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|eb409ec5-4c02-41c8-a11f-03d990818c2a|7|OXYSAT|Oxygen Saturation|URINALYSIS|[?]|/10^3|[?]|[?]|INVALID|1|IU/g Hb|1|1|[?]|LOW|SWABBED MATERIAL|AUTOLYZED||SLIT LAMP|MDRD ENZYMATIC FORMULA|||NA||4|Visit_4|65|3|TREATMENT|2021-02-02|2021-02-21|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|eb409ec5-4c02-41c8-a11f-03d990818c2a|8|MMA|Methylmalonic Acid|CHEMISTRY|[?]|BOX|[?]|[?]|POSITIVE|1|10^3/L|1|1|[?]|HIGH|LYMPH|UNEXPECTED ODOR||MALDI-TOF|HEPASCORE FORMULA|||Y||4|Visit_4|65|6|WASHOUT|2021-02-02|2021-02-08|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|eb409ec5-4c02-41c8-a11f-03d990818c2a|9|BCMAS|Soluble B Cell Maturation Antigen|URINALYSIS|[?]|10^12/L|[?]|[?]|BORDERLINE|1|ppm|1|1|[?]|NORMAL|FLUID|ROOM TEMPERATURE|N|TELLER ACUITY CARDS|MDRD 6 VARIABLE FORMULA|Y||NA||5|Visit_5|90|6|WASHOUT|2021-02-27|2021-03-06|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|eb409ec5-4c02-41c8-a11f-03d990818c2a|10|PROMONO|Promonocytes|HEMATOLOGY|[?]|10^6 IU|[?]|[?]|BORDERLINE|1|Siemens|1|1|[?]|ABNORMAL|SERUM|NON-HEMOLYZED|N|CELL BASED BIOASSAY|CKD-EPI FORMULA|||N||5|Visit_5|90|4|FOLLOW-UP|2021-02-27|2021-03-08|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|2178f542-809d-4306-84e4-26d3b3b370b0|1|EOSSG|Eosinophils, Segmented|URINALYSIS|||[?]|[?]|POSITIVE|1|V/sec|1|1|[?]|NORMAL|ABSCESS FLUID|LACTESCENT||ELASTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|1|Visit_1|10|4|TREATMENT|2020-11-06|2020-11-15|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|2178f542-809d-4306-84e4-26d3b3b370b0|2|INTLK32|Interleukin 32|URINALYSIS|[?]|min|[?]|[?]|TRACE|1|beats/min|1|1|[?]|HIGH|SUPERNATANT, SERUM|DRIED||FISH|MDRD 4 VARIABLE FORMULA||Y|Y||1|Visit_1|10|5|TREATMENT|2020-11-06|2020-11-23|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|2178f542-809d-4306-84e4-26d3b3b370b0|3|CHCMR|Ret. Corpuscular HGB Concentration Mean|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mMU/mL|1|1|[?]|ABNORMAL|COLOSTRUM|GELLED|N|TRYPAN BLUE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|2|Visit_2|25|6|WASHOUT|2020-11-21|2021-01-27|25|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|2178f542-809d-4306-84e4-26d3b3b370b0|4|OAS3|2-5-Oligoadenylate Synthase 3|CHEMISTRY|||[?]|[?]|TRACE|1|U/kg/day|1|1|[?]|LOW|ADIPOSE TISSUE|REFRIGERATED||ROMANOWSKY STAIN|NASH FIBROSURE FORMULA||Y|N|Y|2|Visit_2|25|4|WASHOUT|2020-11-21|2021-01-25|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|2178f542-809d-4306-84e4-26d3b3b370b0|5|PTHCT|Parathyroid Hormone, C-Terminal|URINALYSIS|[?]|g/cage/day|[?]|[?]|INVALID|1|CYLINDER|1|1|[?]|NORMAL|BILE|ICTERIC|N|EIA|MDRD ENZYMATIC FORMULA|Y||NA||3|Visit_3|40|6|TREATMENT|2020-12-06|2021-01-26|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|2178f542-809d-4306-84e4-26d3b3b370b0|6|OXMORPHN|Oxymorphone|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mmol/kg|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|GELLED|N|FLUORESCENT SPOT TEST|FIBROTEST FORMULA|Y||N|Y|3|Visit_3|40|6|SCREENING|2020-12-06|2021-01-09|40|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|2178f542-809d-4306-84e4-26d3b3b370b0|7|HELMOV10|Helicase MOV-10 Protein|URINALYSIS|[?]|10^7 PFU|[?]|[?]|INDETERMINATE|1|dB|1|1|[?]|LOW|HAIR|THAWED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|GMI MMOL/MOL FORMULA||Y|U||4|Visit_4|65|1|TREATMENT|2020-12-31|2021-01-28|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|2178f542-809d-4306-84e4-26d3b3b370b0|8|CD13|CD13|URINALYSIS|[?]|NEBULE|[?]|[?]|BORDERLINE|1|mOsm/kg|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|AGGLUTINATED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD FORMULA|||NA||4|Visit_4|65|4|WASHOUT|2020-12-31|2021-01-13|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|2178f542-809d-4306-84e4-26d3b3b370b0|9|TPRONP|Non-Phosphorylated Tau Protein|CHEMISTRY|||[?]|[?]|POSITIVE|1|mL/100g/min|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|FROZEN||NUCLEIC ACID BASED METHOD|GMI MMOL/MOL FORMULA|||U|Y|5|Visit_5|90|7|FOLLOW-UP|2021-01-25|2021-02-01|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|2178f542-809d-4306-84e4-26d3b3b370b0|10|METARUB|Metarubricyte|HEMATOLOGY|[?]|min/day|[?]|[?]|INDETERMINATE|1|nmol BCE/mmol|1|1|[?]|LOW|ARTERIAL CORD BLOOD|ICTERIC||MODIFIED ACID FAST STAIN|CKD-EPI CYSTATIN C FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2021-01-25|2021-01-27|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|da7423fb-461e-43a6-bcb9-aa87051bda0a|1|A73OXC|7-alpha-Hydroxy-4-cholesten-3-one|URINALYSIS|[?]|RNA copies/mL|[?]|[?]|TRACE|1|mmHg/L/min|1|1|[?]|ABNORMAL|EPITHELIAL CELL|AUTOLYZED||ACCELERATOR MASS SPECTROMETRY|GMI MMOL/MOL FORMULA|Y|Y|Y||1|Visit_1|10|6|FOLLOW-UP|2020-10-04|2020-10-31|10|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|da7423fb-461e-43a6-bcb9-aa87051bda0a|2|C165905|Grass Mix Pollen IgG AB RAST Score|CHEMISTRY|[?]|10^6 organisms|[?]|[?]|NEGATIVE|1|ukat/10^12 RBC|1|1|[?]|LOW|LYSATE|FRESH||LC/MS/MS|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|5|FOLLOW-UP|2020-10-04|2020-12-23|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|da7423fb-461e-43a6-bcb9-aa87051bda0a|3|OHDG8|8-Hydroxydeoxyguanosine|URINALYSIS|||[?]|[?]|NEGATIVE|1|cmH2O*s/mL|1|1|[?]|LOW|TRANSUDATE|FROZEN||FLUORESCENCE ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|1|WASHOUT|2020-10-19|2020-11-23|25|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|da7423fb-461e-43a6-bcb9-aa87051bda0a|4|CYSULFA|Sulfa Crystals|URINALYSIS|[?]|uL/dose|[?]|[?]|INDETERMINATE|1|AFU|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|LIPEMIC||MULTI-SLICE SPIRAL CT|CKD-EPI CYSTATIN C FORMULA|||NA||2|Visit_2|25|4|FOLLOW-UP|2020-10-19|2021-01-01|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|da7423fb-461e-43a6-bcb9-aa87051bda0a|5|NEUTSGNE|Neutrophils, Segmented/Neutrophils|URINALYSIS|||[?]|[?]|BORDERLINE|1|fg|1|1|[?]|NORMAL|HAIR|PARAFFIN-EMBEDDED||IVY INCISION METHOD|MDRD 5 VARIABLE FORMULA|Y||NA|Y|3|Visit_3|40|4|FOLLOW-UP|2020-11-03|2020-11-10|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|LB|da7423fb-461e-43a6-bcb9-aa87051bda0a|6|PRORUB|Prorubricyte|HEMATOLOGY|[?]|kat|[?]|[?]|BORDERLINE|1|cP|1|1|[?]|ABNORMAL|MUSCLE TISSUE|LIPEMIC|N|ELASTOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-11-03|2020-12-31|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|LB|da7423fb-461e-43a6-bcb9-aa87051bda0a|7|FIO2|Fraction of Inspired Oxygen|CHEMISTRY|||[?]|[?]|POSITIVE|1|BAR|1|1|[?]|ABNORMAL|MECONIUM|FRESH||ANALYTICAL ULTRACENTRIFUGATION|MDRD 5 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|5|TREATMENT|2020-11-28|2020-12-15|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|da7423fb-461e-43a6-bcb9-aa87051bda0a|8|LCHLCM|Lithocholate Compounds|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mL/cage/wk|1|1|[?]|HIGH|AQUEOUS HUMOR|ROOM TEMPERATURE|N|CONTRAST ENHANCED MRI|GMI MMOL/MOL FORMULA||Y|N|Y|4|Visit_4|65|1|SCREENING|2020-11-28|2020-12-28|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|da7423fb-461e-43a6-bcb9-aa87051bda0a|9|APOA5|Apolipoprotein A5|HEMATOLOGY|[?]|Ci|[?]|[?]|INVALID|1|%(w/w)|1|1|[?]|LOW|SOFT TISSUE|SOLIDIFIED||INTERRUPTER TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||5|Visit_5|90|2|TREATMENT|2020-12-23|2020-12-31|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|da7423fb-461e-43a6-bcb9-aa87051bda0a|10|RDWRCV|Ret RDW Coefficient of Variation|HEMATOLOGY|[?]|DRINK|[?]|[?]|BORDERLINE|1|kat|1|1|[?]|ABNORMAL|GASTRIC FLUID|AUTOLYZED|N|OPTICAL MAPPING|CKD-EPI CYSTATIN C FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-12-23|2020-12-27|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|40e4c69f-6115-4f0e-8555-45b12b222801|1|NRDZPM|Nordazepam|CHEMISTRY|[?]|vp/dose|[?]|[?]|INDETERMINATE|1|mm2|1|1|[?]|HIGH|LUNG SURFACTANT|AUTOLYZED|N|ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|7|TREATMENT|2021-01-30|2021-02-09|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|40e4c69f-6115-4f0e-8555-45b12b222801|2|BNPPRO|ProB-type Natriuretic Peptide|HEMATOLOGY|[?]|Ci|[?]|[?]|INVALID|1|MdFI|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|GELLED||IVY INCISION METHOD|CKD-EPI FORMULA|||U||1|Visit_1|10|6|TREATMENT|2021-01-30|2021-04-23|10|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|40e4c69f-6115-4f0e-8555-45b12b222801|3|LCTHSPGM|Lecithin/Sphingomyelin|CHEMISTRY|[?]|in2|[?]|[?]|BORDERLINE|1|cmH2O/mL|1|1|[?]|LOW|MUSCLE TISSUE|FRESH||IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2021-02-14|2021-04-26|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|LB|40e4c69f-6115-4f0e-8555-45b12b222801|4|ADH|Antidiuretic Hormone|URINALYSIS|[?]|amu|[?]|[?]|TRACE|1|HOURS|1|1|[?]|HIGH|CEREBROSPINAL FLUID|CLOTTED||THICK SMEAR|FIBROTEST FORMULA|||Y||2|Visit_2|25|7|WASHOUT|2021-02-14|2021-04-02|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|LB|40e4c69f-6115-4f0e-8555-45b12b222801|5|C1QAB|Complement C1q Antibody|URINALYSIS|[?]|U/m2|[?]|[?]|TRACE|1|ELISA unit|1|1|[?]|HIGH|SEMINAL FLUID|LACTESCENT||PH METER MEASUREMENT METHOD|MDRD ENZYMATIC FORMULA|||U||3|Visit_3|40|5|TREATMENT|2021-03-01|2021-03-07|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|40e4c69f-6115-4f0e-8555-45b12b222801|6|O2CT|Oxygen Content|CHEMISTRY|[?]|PRESSOR UNITS|[?]|[?]|INDETERMINATE|1|WAFER|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|GELLED||SPECT SCAN|CKD-EPI FORMULA|||NA||3|Visit_3|40|4|SCREENING|2021-03-01|2021-03-05|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|40e4c69f-6115-4f0e-8555-45b12b222801|7|MYCEMIDX|Myeloid Maturation Index|URINALYSIS|||[?]|[?]|TRACE|1|mmol/L|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|SOLIDIFIED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROMETER FORMULA|||U|Y|4|Visit_4|65|4|TREATMENT|2021-03-26|2021-04-15|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|LB|40e4c69f-6115-4f0e-8555-45b12b222801|8|INTLK18|Interleukin 18|CHEMISTRY|[?]|kg/L|[?]|[?]|BORDERLINE|1|ug/animal|1|1|[?]|ABNORMAL|SOFT TISSUE|CONTAMINATED||INDIRECT IMMUNOFLUORESCENCE|GMI % FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2021-03-26|2021-04-07|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|LB|40e4c69f-6115-4f0e-8555-45b12b222801|9|CCL20|Chemokine (C-C Motif) Ligand 20|HEMATOLOGY|[?]|DDU|[?]|[?]|INDETERMINATE|1|GLOBULE|1|1|[?]|NORMAL|ARTERIAL BLOOD|GELLED||ISHIHARA COLOR PLATES|GMI % FORMULA|||N||5|Visit_5|90|4|TREATMENT|2021-04-20|2021-04-25|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|LB|40e4c69f-6115-4f0e-8555-45b12b222801|10|CCL23|Chemokine (C-C Motif) Ligand 23|CHEMISTRY|[?]|ug/L DDU|[?]|[?]|TRACE|1|FFU|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|REFRIGERATED||FLUORESCENT MICROSCOPY|MDRD 4 VARIABLE FORMULA|Y||NA||5|Visit_5|90|2|TREATMENT|2021-04-20|2021-04-23|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|LB|1307d7f6-acb6-4096-a907-08345548a82b|1|TROPONI3|Troponin I Type 3|URINALYSIS|||[?]|[?]|INDETERMINATE|1|dram|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED||LYMPHANGIOGRAPHY|FIBROTEST FORMULA|||NA|Y|1|Visit_1|10|2|WASHOUT|2020-05-28|2020-07-01|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|LB|1307d7f6-acb6-4096-a907-08345548a82b|2|GSTALCRT|Glutathione S-Transferase, Alpha/Creat|URINALYSIS|[?]|10^3/L|[?]|[?]|INDETERMINATE|1|in2|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|UNEXPECTED ODOR|N|SISH|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|N||1|Visit_1|10|6|TREATMENT|2020-05-28|2020-08-17|10|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|LB|1307d7f6-acb6-4096-a907-08345548a82b|3|DSG3AB|Desmoglein 3 Antibody|HEMATOLOGY|||[?]|[?]|INVALID|1|kg/cm2|1|1|[?]|NORMAL|PERSPIRATION|SOLIDIFIED||X-RAY|FIBROSIS 4 FORMULA|Y||U|Y|2|Visit_2|25|6|FOLLOW-UP|2020-06-12|2020-06-25|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|LB|1307d7f6-acb6-4096-a907-08345548a82b|4|PAROXET|Paroxetine|URINALYSIS|||[?]|[?]|INVALID|1|mL/cage/wk|1|1|[?]|HIGH|LUNG SURFACTANT|LIPEMIC|N|OPTICAL DENSITY MEASUREMENT|MDRD FORMULA|Y||U|Y|2|Visit_2|25|7|WASHOUT|2020-06-12|2020-08-11|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|LB|1307d7f6-acb6-4096-a907-08345548a82b|5|GFRBSCYC|GFR from Cystatin C Adjusted for BSA|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|SPRAY|1|1|[?]|HIGH|SERUM OR PLASMA|FROZEN||KLEIHAUER-BETKE|MDRD FORMULA||Y|Y|Y|3|Visit_3|40|6|TREATMENT|2020-06-27|2020-07-24|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|1307d7f6-acb6-4096-a907-08345548a82b|6|CYHGBC|Hemoglobin C Crystals|CHEMISTRY|||[?]|[?]|INVALID|1|ug/kg/min|1|1|[?]|ABNORMAL|EXUDATE|CONCENTRATED||AGAR DILUTION|FIBROMETER FORMULA|||NA|Y|3|Visit_3|40|1|TREATMENT|2020-06-27|2020-06-29|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|1307d7f6-acb6-4096-a907-08345548a82b|7|FIO2|Fraction of Inspired Oxygen|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|10^6 organisms|1|1|[?]|ABNORMAL|MECONIUM|ROOM TEMPERATURE||VENTILATION PERFUSION LUNG SCAN|MDRD 4 VARIABLE FORMULA|||N|Y|4|Visit_4|65|4|WASHOUT|2020-07-22|2020-07-31|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|LB|1307d7f6-acb6-4096-a907-08345548a82b|8|DHEAS|Dehydroepiandrosterone Sulfate|CHEMISTRY|[?]|g/U|[?]|[?]|NEGATIVE|1|mmol/s|1|1|[?]|NORMAL|DERMAL TISSUE|ICTERIC||KINYOUN STAIN|GMI % FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-07-22|2020-07-29|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|LB|1307d7f6-acb6-4096-a907-08345548a82b|9|PGES|Prostaglandin E Synthase|HEMATOLOGY|[?]|cm|[?]|[?]|POSITIVE|1|Sv|1|1|[?]|HIGH|SALIVA|ICTERIC||MICROBIAL CULTURE, SOLID|MDRD FORMULA|Y||NA||5|Visit_5|90|4|TREATMENT|2020-08-16|2020-08-24|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|1307d7f6-acb6-4096-a907-08345548a82b|10|MONOLE|Monocytes/Leukocytes|HEMATOLOGY|[?]|ugEq/L|[?]|[?]|INVALID|1|PIXELS/cm|1|1|[?]|LOW|EXPIRED AIR|AGGLUTINATED|N|NUCLEIC ACID HYBRIDIZATION|MDRD FORMULA|Y||Y||5|Visit_5|90|1|SCREENING|2020-08-16|2020-08-22|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|bac23835-1120-43b2-9d99-694bef97f44b|1|VITE|Vitamin E|CHEMISTRY|[?]|mOsm/kg|[?]|[?]|TRACE|1|ug/kg|1|1|[?]|ABNORMAL|URINE|LIPEMIC||HEMAGGLUTINATION ASSAY|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-05-21|2020-06-25|10|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-14
e|LB|bac23835-1120-43b2-9d99-694bef97f44b|2|TSTFTSTT|Testosterone, Free/Testosterone|CHEMISTRY|[?]|pkat/L|[?]|[?]|INVALID|1|mg/day|1|1|[?]|LOW|PLEURAL FLUID|AGGLUTINATED||MAGNETIC RESONANCE ELASTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||1|Visit_1|10|2|TREATMENT|2020-05-21|2020-07-15|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-14
e|LB|bac23835-1120-43b2-9d99-694bef97f44b|3|PRORUBCE|Prorubricyte/Total Cells|CHEMISTRY|[?]|10^7 CFU|[?]|[?]|POSITIVE|1|mg/m2/day|1|1|[?]|LOW|GASTRIC CONTENTS|AGGLUTINATED|N|CALIPER MEASUREMENT METHOD|FIBROTEST FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2020-06-05|2020-08-13|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|bac23835-1120-43b2-9d99-694bef97f44b|4|CA125AG|Cancer Antigen 125|URINALYSIS|[?]|Ci/L|[?]|[?]|INVALID|1|10^6/hpf|1|1|[?]|LOW|ENDOMETRIAL TISSUE|CALCIFIED|N|MAGNETIC RESONANCE ELASTOGRAPHY|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|7|FOLLOW-UP|2020-06-05|2020-07-24|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|bac23835-1120-43b2-9d99-694bef97f44b|5|C130079|Silver Birch Pollen IgG4|HEMATOLOGY|[?]|Gy/min|[?]|[?]|POSITIVE|1|pg/dL|1|1|[?]|ABNORMAL|LOCHIA|ROOM TEMPERATURE|N|DIFFUSION TENSOR MRI|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|1|WASHOUT|2020-06-20|2020-07-14|40|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|bac23835-1120-43b2-9d99-694bef97f44b|6|NKINA|Neurokinin A|HEMATOLOGY|||[?]|[?]|INVALID|1|MdFI|1|1|[?]|NORMAL|CAPILLARY BLOOD|THAWED||NEPHELOMETRY|CKD-EPI FORMULA|Y||Y|Y|3|Visit_3|40|4|WASHOUT|2020-06-20|2020-08-14|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|bac23835-1120-43b2-9d99-694bef97f44b|7|C130125|Cat Dander Antigen IgG Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|Watt|1|1|[?]|NORMAL|DERMAL TISSUE|LACTESCENT||IN VITRO GENE EXPRESSION ASSAY|MDRD 5 VARIABLE FORMULA||Y|Y|Y|4|Visit_4|65|5|TREATMENT|2020-07-15|2020-08-18|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|bac23835-1120-43b2-9d99-694bef97f44b|8|FLUOXTN|Fluoxetine|HEMATOLOGY|[?]|g/cm2|[?]|[?]|INVALID|1|10^6 CFU/g|1|1|[?]|NORMAL|COLOSTRUM|CLOTTED||SPIRAL CT SCAN WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|5|FOLLOW-UP|2020-07-15|2020-08-06|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|bac23835-1120-43b2-9d99-694bef97f44b|9|MIP1|Macrophage Inflammatory Protein 1|URINALYSIS|[?]|lm|[?]|[?]|INDETERMINATE|1|v/v|1|1|[?]|NORMAL|LYSATE|CONTAMINATED||PET/CT SCAN WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA||Y|Y||5|Visit_5|90|6|TREATMENT|2020-08-09|2020-08-16|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|bac23835-1120-43b2-9d99-694bef97f44b|10|NTRLFAT|Neutral Fats|HEMATOLOGY|[?]|Sv|[?]|[?]|NEGATIVE|1|ELISA unit/dose|1|1|[?]|LOW|MONOCYTE|CONTAMINATED||AUTOREFRACTION|MDRD 4 VARIABLE FORMULA|||Y||5|Visit_5|90|7|FOLLOW-UP|2020-08-09|2020-08-13|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|1|LYMPLLY|Plasmacytoid Lymphocytes/Lymphocytes|CHEMISTRY|[?]|mEq/uL|[?]|[?]|NEGATIVE|1|cmH2O/mL|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|AUTOLYZED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROMETER FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-09-24|2020-11-27|10|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|2|PAH|P-Aminohippurate Sodium|URINALYSIS|[?]|dmol|[?]|[?]|INDETERMINATE|1|P|1|1|[?]|HIGH|NAIL|ROOM TEMPERATURE||DXA SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|3|SCREENING|2020-09-24|2020-11-05|10|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|3|C130075|Birch Pollen IgG4|HEMATOLOGY|[?]|pmol/10^10 cells|[?]|[?]|POSITIVE|1|um2|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|GELLED||MULTI-SLICE SPIRAL CT|CKD-EPI FORMULA|||U||2|Visit_2|25|5|SCREENING|2020-10-09|2020-12-03|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|4|OSM|Oncostatin M|CHEMISTRY|[?]|log10 TCID 50/uL|[?]|[?]|TRACE|1|Ci/mL|1|1|[?]|LOW|COLOSTRUM|UNEXPECTED ODOR||DNA MICROARRAY|FIBROSIS 4 FORMULA|||U||2|Visit_2|25|2|WASHOUT|2020-10-09|2020-12-08|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|5|MYBLAT3|Type III Myeloblasts|URINALYSIS|||[?]|[?]|INVALID|1|ug/g/min|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|GELLED||IMMUNOFIXATION ELECTROPHORESIS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|3|Visit_3|40|5|TREATMENT|2020-10-24|2020-11-08|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|6|GHRELINA|Active Ghrelin|CHEMISTRY|[?]|/mm2|[?]|[?]|BORDERLINE|1|lm|1|1|[?]|NORMAL|EMESIS|LACTESCENT|N|TEST STRIP|MDRD 6 VARIABLE FORMULA|||NA||3|Visit_3|40|3|FOLLOW-UP|2020-10-24|2020-11-01|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|7|AMYLASES|Amylase, Salivary|URINALYSIS|[?]|breaths/30s|[?]|[?]|INDETERMINATE|1|U/g Hb|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|AUTOLYZED||CISH|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-11-18|2020-12-17|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|8|ENRAGE|Extracell Newly Ident RAGE Bind Protein|CHEMISTRY|[?]|CAPFUL|[?]|[?]|BORDERLINE|1|PACK|1|1|[?]|LOW|LYMPH|CLOTTED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROSIS 4 FORMULA|||NA||4|Visit_4|65|1|TREATMENT|2020-11-18|2020-12-17|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|9|CYURIAC|Uric Acid Crystals|HEMATOLOGY|[?]|/7.5 mL|[?]|[?]|INDETERMINATE|1|mL/day|1|1|[?]|HIGH|SUPERNATANT, PLASMA|LACTESCENT||ICC|COCKCROFT-GAULT FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2020-12-13|2020-12-19|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|10|IBCU|Unsaturated Iron Binding Capacity|URINALYSIS|[?]|dmol|[?]|[?]|POSITIVE|1|LOZENGE|1|1|[?]|LOW|TISSUE|CALCIFIED||IMMUNOPRECIPITATION|HEPASCORE FORMULA|Y|Y|N||5|Visit_5|90|6|FOLLOW-UP|2020-12-13|2020-12-14|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|14cd64f5-f3c8-47a4-b40e-9c5090890870|1|C165882|White Elm Pollen IgE AB RAST Score|HEMATOLOGY|[?]|vg/mL|[?]|[?]|INVALID|1|mmol/min/kPa/L|1|1|[?]|ABNORMAL|VITREOUS HUMOR|LACTESCENT||DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI CYSTATIN C FORMULA|Y|Y|U||1|Visit_1|10|1|SCREENING|2020-09-24|2020-11-02|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|14cd64f5-f3c8-47a4-b40e-9c5090890870|2|OPIATE|Opiate|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Enzyme U/g Hb|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|CALCIFIED||MEDIASTINOSCOPY|COCKCROFT-GAULT FORMULA|||Y|Y|1|Visit_1|10|6|TREATMENT|2020-09-24|2020-09-26|10|12|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|14cd64f5-f3c8-47a4-b40e-9c5090890870|3|DHEA|Dehydroepiandrosterone|URINALYSIS|||[?]|[?]|INDETERMINATE|1|ug/kg|1|1|[?]|NORMAL|PLEURAL TISSUE|DRIED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA|||N|Y|2|Visit_2|25|2|TREATMENT|2020-10-09|2020-12-14|25|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|14cd64f5-f3c8-47a4-b40e-9c5090890870|4|GHRELIN|Ghrelin|URINALYSIS|[?]|beats/min|[?]|[?]|INVALID|1|/100 HPFs|1|1|[?]|ABNORMAL|BONE MARROW|UNEXPECTED ODOR||PHOROPTER|NASH FIBROSURE FORMULA|||U||2|Visit_2|25|6|SCREENING|2020-10-09|2020-11-24|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|14cd64f5-f3c8-47a4-b40e-9c5090890870|5|INTLK23|Interleukin 23|CHEMISTRY|[?]|g/g|[?]|[?]|POSITIVE|1|nkat/g Hb|1|1|[?]|HIGH|CERUMEN|PARAFFIN-EMBEDDED||CARDIAC THERMODILUTION|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-10-24|2020-12-09|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|14cd64f5-f3c8-47a4-b40e-9c5090890870|6|MBP|Myelin Basic Protein|HEMATOLOGY|[?]|nmol/L/min|[?]|[?]|INDETERMINATE|1|U/10^12 RBC|1|1|[?]|HIGH|VENOUS CORD BLOOD|AUTOLYZED||MRI WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||3|Visit_3|40|4|TREATMENT|2020-10-24|2020-12-22|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|14cd64f5-f3c8-47a4-b40e-9c5090890870|7|PARICEAB|Parietal Cell Antibody|CHEMISTRY|[?]|/LSQN|[?]|[?]|INDETERMINATE|1|cpm|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|CONTAMINATED|N|POTENTIOMETRY|GMI % FORMULA||Y|Y||4|Visit_4|65|6|TREATMENT|2020-11-18|2020-12-15|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|14cd64f5-f3c8-47a4-b40e-9c5090890870|8|FCT8INH|Factor VIII Inhibitor|HEMATOLOGY|[?]|mL/m2|[?]|[?]|BORDERLINE|1|ft2|1|1|[?]|NORMAL|HAIR|FROZEN||RAJI CELL RIA|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|3|SCREENING|2020-11-18|2020-11-28|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|14cd64f5-f3c8-47a4-b40e-9c5090890870|9|CRTCLRE|Creatinine Clearance, Estimated|HEMATOLOGY|[?]|INHALATION|[?]|[?]|INVALID|1|m3|1|1|[?]|HIGH|HAIR|AGGLUTINATED||DYNAMIC CONTRAST ENHANCED MRI|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|4|FOLLOW-UP|2020-12-13|2020-12-20|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|14cd64f5-f3c8-47a4-b40e-9c5090890870|10|CTXII|Type II Collagen C-Telopeptides|URINALYSIS|[?]|Bq/kg|[?]|[?]|INDETERMINATE|1|APS U|1|1|[?]|ABNORMAL|CORD SERUM|ICTERIC||RIA|FIBROMETER FORMULA||Y|N||5|Visit_5|90|5|TREATMENT|2020-12-13|2020-12-22|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|ca4a06be-5e6a-4220-9854-e5fe02b384af|1|DSG1AB|Desmoglein 1 Antibody|URINALYSIS|||[?]|[?]|INDETERMINATE|1|ug/mol|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|HEMOLYZED||URANYL ACETATE STAIN|FIBROMETER FORMULA|||N|Y|1|Visit_1|10|7|TREATMENT|2020-10-03|2020-10-17|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|ca4a06be-5e6a-4220-9854-e5fe02b384af|2|ANCAB|Anti-Neutrophil Cytoplasmic Antibody|URINALYSIS|[?]|JDF Unit|[?]|[?]|NEGATIVE|1|IU/kg|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|LIPEMIC||MIGET|CKD-EPI FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-10-03|2020-12-19|10|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|ca4a06be-5e6a-4220-9854-e5fe02b384af|3|NTXII|Type II Collagen N-Telopeptides|CHEMISTRY|[?]|ms2|[?]|[?]|POSITIVE|1|CAPSULE|1|1|[?]|NORMAL|CELL PELLET|AUTOLYZED|N|VIRUS PLAQUE ASSAY|FIBROTEST FORMULA|Y||N||2|Visit_2|25|1|TREATMENT|2020-10-18|2020-10-27|25|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|ca4a06be-5e6a-4220-9854-e5fe02b384af|4|CYMSU|Monosodium Urate Crystals|HEMATOLOGY|[?]|ng/day|[?]|[?]|POSITIVE|1|ukat/10^12 RBC|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE|N|ENZYMATIC ULTRACENTRIFUGATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||2|Visit_2|25|2|TREATMENT|2020-10-18|2020-12-02|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|ca4a06be-5e6a-4220-9854-e5fe02b384af|5|BLASTLE|Blasts/Leukocytes|URINALYSIS|[?]|GPL U|[?]|[?]|INDETERMINATE|1|fg|1|1|[?]|ABNORMAL|BILE|CALCIFIED||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|CKD-EPI FORMULA|Y||N||3|Visit_3|40|5|SCREENING|2020-11-02|2020-11-11|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|ca4a06be-5e6a-4220-9854-e5fe02b384af|6|TNFR1B|TNF Receptor 1B|CHEMISTRY|[?]|mV2/Hz|[?]|[?]|INDETERMINATE|1|DDU|1|1|[?]|NORMAL|MUSCLE TISSUE|THAWED||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|FIBROTEST FORMULA|Y||N||3|Visit_3|40|5|FOLLOW-UP|2020-11-02|2020-12-07|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|ca4a06be-5e6a-4220-9854-e5fe02b384af|7|GRWHIH|Growth Hormone Inhibiting Hormone|CHEMISTRY|[?]|kPa/L/sec|[?]|[?]|TRACE|1|g/animal/wk|1|1|[?]|HIGH|MIXED VENOUS BLOOD|UNEXPECTED ODOR|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|FIBROMETER FORMULA|||NA||4|Visit_4|65|2|WASHOUT|2020-11-27|2020-12-16|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|ca4a06be-5e6a-4220-9854-e5fe02b384af|8|INDICAN|Indican|URINALYSIS|||[?]|[?]|INVALID|1|GBq/mg|1|1|[?]|HIGH|SEMINAL FLUID|CLOTTED|N|FUNCTIONAL MRI|NASH FIBROSURE FORMULA|Y||NA|Y|4|Visit_4|65|5|TREATMENT|2020-11-27|2020-12-27|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|ca4a06be-5e6a-4220-9854-e5fe02b384af|9|CXCL6|Chemokine (C-X-C Motif) Ligand 6|CHEMISTRY|[?]|Sv|[?]|[?]|INVALID|1|dB|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|REFRIGERATED||X-RAY FLUORESCENCE SPECTROMETRY|MDRD ENZYMATIC FORMULA|Y||N||5|Visit_5|90|3|TREATMENT|2020-12-22|2020-12-28|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|ca4a06be-5e6a-4220-9854-e5fe02b384af|10|PEPSNGI|Pepsinogen I|CHEMISTRY|||[?]|[?]|INVALID|1|mL/g/h|1|1|[?]|HIGH|EPITHELIAL CELL|LIPEMIC||ETDRS EYE CHART|MDRD 4 VARIABLE FORMULA|||N|Y|5|Visit_5|90|1|TREATMENT|2020-12-22|2020-12-28|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|55504c69-a659-402b-a0cb-95ab4e08c086|1|IAA5OH|5-Hydroxyindoleacetic Acid|URINALYSIS|[?]|mg/m2|[?]|[?]|POSITIVE|1|mg/m2/day|1|1|[?]|NORMAL|GASTRIC CONTENTS|THAWED||TEST STRIP|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|2|WASHOUT|2021-01-14|2021-03-29|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|55504c69-a659-402b-a0cb-95ab4e08c086|2|NEUTSGBP|Neutrophils, Seg + Band Form + Precursor|URINALYSIS|[?]|10^9 organisms/g|[?]|[?]|INVALID|1|10^5/hpf|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|CLOTTED||WHOLE TRANSCRIPTOME SEQUENCING|GMI % FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2021-01-14|2021-03-11|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|55504c69-a659-402b-a0cb-95ab4e08c086|3|C147276|Arachis hypogaea Antigen IgE Antibody|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|nU/cL|1|1|[?]|ABNORMAL|NAIL|UNEXPECTED ODOR||LC/MS|FIBROSIS 4 FORMULA|||U|Y|2|Visit_2|25|4|SCREENING|2021-01-29|2021-03-24|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|55504c69-a659-402b-a0cb-95ab4e08c086|4|APPEAR|Specimen Appearance|HEMATOLOGY|[?]|BAU|[?]|[?]|INDETERMINATE|1|Hz/s|1|1|[?]|NORMAL|BONE|CONCENTRATED||U-HPLC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2021-01-29|2021-04-04|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|55504c69-a659-402b-a0cb-95ab4e08c086|5|NFHP|Phosphorylated Neurofilament Heavy Chain|CHEMISTRY|[?]|IU/g Hb|[?]|[?]|BORDERLINE|1|ms/mmHg|1|1|[?]|HIGH|URINE SEDIMENT|FROZEN||TRANSVAGINAL ULTRASOUND|FIBROMETER FORMULA|Y|Y|N||3|Visit_3|40|4|SCREENING|2021-02-13|2021-02-22|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-12
e|LB|55504c69-a659-402b-a0cb-95ab4e08c086|6|HEPCIDIN|Hepcidin|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|nmol BCE/nmol|1|1|[?]|NORMAL|VENOUS BLOOD|PARAFFIN-EMBEDDED||CALIPER MEASUREMENT METHOD|CKD-EPI FORMULA|||Y|Y|3|Visit_3|40|2|TREATMENT|2021-02-13|2021-04-12|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-12
e|LB|55504c69-a659-402b-a0cb-95ab4e08c086|7|IL2RA|Interleukin 2 Receptor Subunit Alpha|HEMATOLOGY|||[?]|[?]|TRACE|1|/HPF|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|REFRIGERATED||MUGA|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|4|Visit_4|65|1|WASHOUT|2021-03-10|2021-03-31|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|55504c69-a659-402b-a0cb-95ab4e08c086|8|LKM1AB|Liver Kidney Microsomal Type 1 Antibody|HEMATOLOGY|[?]|mg/kg/week|[?]|[?]|INVALID|1|mm|1|1|[?]|NORMAL|LAVAGE FLUID|CLOTTED|N|IMMUNORADIOMETRIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||4|Visit_4|65|7|TREATMENT|2021-03-10|2021-03-31|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|55504c69-a659-402b-a0cb-95ab4e08c086|9|C5B9S|Soluble Complement C5b-9|CHEMISTRY|||[?]|[?]|POSITIVE|1|log10 copies/mL|1|1|[?]|LOW|INTERSTITIAL FLUID|CONCENTRATED|N|PET/MRI SCAN|MDRD 4 VARIABLE FORMULA|||U|Y|5|Visit_5|90|7|WASHOUT|2021-04-04|2021-04-10|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|LB|55504c69-a659-402b-a0cb-95ab4e08c086|10|FIO2|Fraction of Inspired Oxygen|URINALYSIS|[?]|Hz|[?]|[?]|TRACE|1|dmol|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|FROZEN||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|FIBROSIS 4 FORMULA|||Y||5|Visit_5|90|4|WASHOUT|2021-04-04|2021-04-12|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|LB|bffa468a-a27b-4e87-a60d-b5787a03c6f6|1|CLCLR|Chloride Clearance|HEMATOLOGY|[?]|ugEq|[?]|[?]|NEGATIVE|1|TRACE|1|1|[?]|NORMAL|MONOCYTE|AGGLUTINATED||PHOROPTER|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|3|SCREENING|2020-11-30|2021-01-18|10|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|bffa468a-a27b-4e87-a60d-b5787a03c6f6|2|MIP1A|Macrophage Inflammatory Protein 1 Alpha|URINALYSIS|[?]|LENS|[?]|[?]|TRACE|1|10^3 copies/mL|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|AUTOLYZED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|GMI % FORMULA|Y||N||1|Visit_1|10|3|TREATMENT|2020-11-30|2021-01-15|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|bffa468a-a27b-4e87-a60d-b5787a03c6f6|3|BAMBTAC|Beta-Aminobutyric Acid|URINALYSIS|||[?]|[?]|POSITIVE|1|kat|1|1|[?]|NORMAL|DISCHARGE|FRESH|N|GEL ELECTROPHORESIS|GMI MMOL/MOL FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2020-12-15|2020-12-18|25|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|bffa468a-a27b-4e87-a60d-b5787a03c6f6|4|PRO|Proline|URINALYSIS|[?]|ug/L FEU|[?]|[?]|BORDERLINE|1|cpm|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED||AURAMINE STAIN|COCKCROFT-GAULT FORMULA|||U||2|Visit_2|25|2|TREATMENT|2020-12-15|2021-02-08|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|bffa468a-a27b-4e87-a60d-b5787a03c6f6|5|NEUTB|Neutrophils Band Form|HEMATOLOGY|[?]|mV|[?]|[?]|BORDERLINE|1|pg/L|1|1|[?]|HIGH|SMEGMA|AUTOLYZED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2020-12-30|2021-02-03|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|bffa468a-a27b-4e87-a60d-b5787a03c6f6|6|INTLK12B|Interleukin 12 Beta|HEMATOLOGY|||[?]|[?]|TRACE|1|MASK|1|1|[?]|HIGH|PLATELET|GELLED||DARK FIELD MICROSCOPY|HEPASCORE FORMULA|||N|Y|3|Visit_3|40|6|TREATMENT|2020-12-30|2021-01-05|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|bffa468a-a27b-4e87-a60d-b5787a03c6f6|7|RETIHCR|Hematocrit Corrected Reticulocytes|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|pg|1|1|[?]|ABNORMAL|ABSCESS FLUID|SOLIDIFIED||ROMANOWSKY STAIN|NASH FIBROSURE FORMULA||Y|Y|Y|4|Visit_4|65|4|SCREENING|2021-01-24|2021-02-07|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|bffa468a-a27b-4e87-a60d-b5787a03c6f6|8|POLYNORM|Polychromatophilic Normoblast|HEMATOLOGY|[?]|deg/s|[?]|[?]|POSITIVE|1|TABLET|1|1|[?]|ABNORMAL|SKIN TISSUE|GELLED||CINEANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|||Y||4|Visit_4|65|3|FOLLOW-UP|2021-01-24|2021-02-14|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|bffa468a-a27b-4e87-a60d-b5787a03c6f6|9|PLTMORPH|Platelet Morphology|HEMATOLOGY|[?]|/min|[?]|[?]|TRACE|1|/40 HPFs|1|1|[?]|LOW|INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|N|CYSTOMETRY|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2021-02-18|2021-02-20|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|bffa468a-a27b-4e87-a60d-b5787a03c6f6|10|CXCL11|Chemokine (C-X-C Motif) Ligand 11|HEMATOLOGY|[?]|Ci/L|[?]|[?]|BORDERLINE|1|10^6 RNA copies/mL|1|1|[?]|NORMAL|MUSCLE TISSUE|ROOM TEMPERATURE||TRIPLE-PHASE MRI SCAN|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|1|TREATMENT|2021-02-18|2021-02-23|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|2e25aa76-914f-41e3-82ce-7c56ba2f6271|1|ECT|Ecarin Clotting Time|URINALYSIS|[?]|VOXEL|[?]|[?]|POSITIVE|1|PIXELS/cm|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|SOLIDIFIED||NUCLEIC ACID SEQUENCING|GMI % FORMULA|Y||NA||1|Visit_1|10|4|TREATMENT|2020-12-11|2021-03-10|10|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|2e25aa76-914f-41e3-82ce-7c56ba2f6271|2|DRVTSCPD|dRVVT Screen to Confirm Pct Difference|HEMATOLOGY|[?]|10^7 CFU/mL|[?]|[?]|NEGATIVE|1|ug/g/day|1|1|[?]|NORMAL|ADIPOSE TISSUE|CONCENTRATED||FISH|MDRD FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-12-11|2021-02-03|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|2e25aa76-914f-41e3-82ce-7c56ba2f6271|3|BAMBTAC|Beta-Aminobutyric Acid|URINALYSIS|[?]|amol|[?]|[?]|NEGATIVE|1|uCi|1|1|[?]|NORMAL|KERATINOCYTE|CONTAMINATED||MAPH|MDRD FORMULA||Y|Y||2|Visit_2|25|2|TREATMENT|2020-12-26|2021-02-05|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|2e25aa76-914f-41e3-82ce-7c56ba2f6271|4|MMIF|Macrophage Migration Inhibitory Factor|URINALYSIS|||[?]|[?]|NEGATIVE|1|pmol/dL|1|1|[?]|LOW|BREAST MILK|NON-HEMOLYZED|N|KLEIHAUER-BETKE|ASH FIBROSURE FORMULA|||U|Y|2|Visit_2|25|2|WASHOUT|2020-12-26|2021-02-14|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|2e25aa76-914f-41e3-82ce-7c56ba2f6271|5|DENSITY|Density|HEMATOLOGY|[?]|eq|[?]|[?]|INVALID|1|FFU|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|CLOTTED||GC/MS-EI|MDRD 6 VARIABLE FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2021-01-10|2021-01-17|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|LB|2e25aa76-914f-41e3-82ce-7c56ba2f6271|6|MUCTHR|Mucous Threads|URINALYSIS|||[?]|[?]|INVALID|1|Ci/kg|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR||MRS|MDRD FORMULA|||U|Y|3|Visit_3|40|5|FOLLOW-UP|2021-01-10|2021-02-14|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|LB|2e25aa76-914f-41e3-82ce-7c56ba2f6271|7|DRVTSCPD|dRVVT Screen to Confirm Pct Difference|URINALYSIS|[?]|PFU/dose|[?]|[?]|BORDERLINE|1|titer|1|1|[?]|ABNORMAL|LYMPH|FROZEN|N|IODINE STAIN|MDRD 4 VARIABLE FORMULA||Y|NA||4|Visit_4|65|7|TREATMENT|2021-02-04|2021-03-08|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|2e25aa76-914f-41e3-82ce-7c56ba2f6271|8|ALB|Albumin|CHEMISTRY|[?]|mol/mg|[?]|[?]|POSITIVE|1|pg/L|1|1|[?]|HIGH|BUFFY COAT|HEMOLYZED||PERIPHERAL ANGIOGRAPHY|GMI MMOL/MOL FORMULA|Y|Y|U||4|Visit_4|65|6|WASHOUT|2021-02-04|2021-03-02|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|2e25aa76-914f-41e3-82ce-7c56ba2f6271|9|VLDLPSZ|VLDL Particle Size|HEMATOLOGY|||[?]|[?]|TRACE|1|mOsm/L|1|1|[?]|LOW|SWABBED MATERIAL|FRESH|N|TOTAL BODY IRRADIATION|NASH FIBROSURE FORMULA|||Y|Y|5|Visit_5|90|5|FOLLOW-UP|2021-03-01|2021-03-09|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|LB|2e25aa76-914f-41e3-82ce-7c56ba2f6271|10|CREATEXR|Creatinine Excretion Rate|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|ug/L|1|1|[?]|NORMAL|PLASMA|DRIED||MANUAL CLOT DETECTION|GMI % FORMULA|||NA|Y|5|Visit_5|90|1|WASHOUT|2021-03-01|2021-03-08|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|LB|12c24fff-080b-4889-a455-ff55d5c0536c|1|EPO|Erythropoietin|CHEMISTRY|||[?]|[?]|POSITIVE|1|GLOBULE|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|LACTESCENT||IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|1|Visit_1|10|1|TREATMENT|2021-01-27|2021-02-01|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|12c24fff-080b-4889-a455-ff55d5c0536c|2|TCHT|Taurocholate|URINALYSIS|[?]|PIXEL|[?]|[?]|INVALID|1|ug/g/min|1|1|[?]|ABNORMAL|KERATINOCYTE|FRESH||TRANSVAGINAL ULTRASOUND|FIBROSIS 4 FORMULA|||NA||1|Visit_1|10|7|FOLLOW-UP|2021-01-27|2021-02-15|10|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|12c24fff-080b-4889-a455-ff55d5c0536c|3|THYPXD|Thyroperoxidase|URINALYSIS|[?]|Ci/ug|[?]|[?]|POSITIVE|1|mm/min|1|1|[?]|ABNORMAL|EMESIS|PARAFFIN-EMBEDDED||ORCHIDOMETERY|MDRD ENZYMATIC FORMULA||Y|N||2|Visit_2|25|4|TREATMENT|2021-02-11|2021-03-19|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|12c24fff-080b-4889-a455-ff55d5c0536c|4|PROTEXR|Protein Excretion Rate|HEMATOLOGY|[?]|mEq/g|[?]|[?]|BORDERLINE|1|g/cage/wk|1|1|[?]|NORMAL|CORD SERUM|AGGLUTINATED||TEST STRIP|MDRD FORMULA|Y||U||2|Visit_2|25|1|WASHOUT|2021-02-11|2021-03-31|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|12c24fff-080b-4889-a455-ff55d5c0536c|5|GAD2AB|Glutamic Acid Decarboxylase 2 Antibody|CHEMISTRY|[?]|10^8/L|[?]|[?]|INVALID|1|Bq|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|THAWED||COLORIMETRY|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2021-02-26|2021-03-02|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-21
e|LB|12c24fff-080b-4889-a455-ff55d5c0536c|6|INSLNFR|Insulin, Free|HEMATOLOGY|[?]|Bq/ug|[?]|[?]|INVALID|1|pmol/g|1|1|[?]|ABNORMAL|SEBUM|LIPEMIC|N|DC SHEATH FLOW|COCKCROFT-GAULT FORMULA|||U||3|Visit_3|40|4|FOLLOW-UP|2021-02-26|2021-03-23|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-21
e|LB|12c24fff-080b-4889-a455-ff55d5c0536c|7|C165888|Russian Thistle Pollen IgE Antibody|CHEMISTRY|[?]|10^12 IU/L|[?]|[?]|INDETERMINATE|1|MPL U/mL|1|1|[?]|NORMAL|BILE|AGGLUTINATED||ISHIHARA COLOR PLATES|FIBROSIS 4 FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-03-23|2021-04-21|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|12c24fff-080b-4889-a455-ff55d5c0536c|8|CREATEXR|Creatinine Excretion Rate|URINALYSIS|[?]|cL|[?]|[?]|INDETERMINATE|1|nsec|1|1|[?]|HIGH|CELL PELLET|PARAFFIN-EMBEDDED|N|SANGER SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||4|Visit_4|65|6|TREATMENT|2021-03-23|2021-03-26|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|12c24fff-080b-4889-a455-ff55d5c0536c|9|INTLK2|Interleukin 2|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mg/kg/day|1|1|[?]|NORMAL|BASAL TEAR|NON-HEMOLYZED||ELECTROMYOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N|Y|5|Visit_5|90|4|SCREENING|2021-04-17|2021-04-23|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|12c24fff-080b-4889-a455-ff55d5c0536c|10|TK|Thymidine Kinase|HEMATOLOGY|[?]|PFU/dose|[?]|[?]|NEGATIVE|1|mmol/kg|1|1|[?]|NORMAL|RETICULOCYTES|CONTAMINATED||WESTERGREN|FIBROMETER FORMULA|||Y||5|Visit_5|90|1|SCREENING|2021-04-17|2021-04-24|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|aecfe062-4e0d-4c91-8b67-1f304c5765ae|1|CITRTEXR|Citrate Excretion Rate|URINALYSIS|||[?]|[?]|BORDERLINE|1|Linear ft*LB|1|1|[?]|ABNORMAL|VENOUS BLOOD|REFRIGERATED||DIFFUSION WEIGHTED MRI|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|Y|1|Visit_1|10|6|FOLLOW-UP|2021-01-21|2021-02-05|10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|LB|aecfe062-4e0d-4c91-8b67-1f304c5765ae|2|NMH|N-methylhistamine|CHEMISTRY|[?]|s/h|[?]|[?]|INVALID|1|deg/mm|1|1|[?]|HIGH|CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|N|BAC ACGH|FIBROMETER FORMULA||Y|Y||1|Visit_1|10|3|TREATMENT|2021-01-21|2021-04-14|10|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|LB|aecfe062-4e0d-4c91-8b67-1f304c5765ae|3|BTLBTL|Butalbital|HEMATOLOGY|[?]|DRUM|[?]|[?]|NEGATIVE|1|Osm|1|1|[?]|LOW|LYMPH|CALCIFIED||SNELLEN EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||2|Visit_2|25|1|TREATMENT|2021-02-05|2021-04-09|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|LB|aecfe062-4e0d-4c91-8b67-1f304c5765ae|4|VCAM1|Vascular Cell Adhesion Molecule 1|HEMATOLOGY|[?]|PIXELS/cm|[?]|[?]|INVALID|1|uCi|1|1|[?]|LOW|LYMPH|ICTERIC||HIGH RESOLUTION MELT ANALYSIS|HEPASCORE FORMULA||Y|N||2|Visit_2|25|6|FOLLOW-UP|2021-02-05|2021-02-08|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|LB|aecfe062-4e0d-4c91-8b67-1f304c5765ae|5|APOE|Apolipoprotein E|CHEMISTRY|[?]|uL/mL|[?]|[?]|POSITIVE|1|Ci|1|1|[?]|ABNORMAL|BREAST MILK|AGGLUTINATED|N|GC/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||3|Visit_3|40|7|TREATMENT|2021-02-20|2021-04-18|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|LB|aecfe062-4e0d-4c91-8b67-1f304c5765ae|6|HCGNDI|Choriogonadotropin, Intact|CHEMISTRY|[?]|nL|[?]|[?]|POSITIVE|1|/mm2|1|1|[?]|NORMAL|ALVEOLAR AIR|LACTESCENT|N|AUSCULTATION|MDRD 5 VARIABLE FORMULA|Y|Y|Y||3|Visit_3|40|2|TREATMENT|2021-02-20|2021-03-21|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|LB|aecfe062-4e0d-4c91-8b67-1f304c5765ae|7|LDLPSZ|LDL Particle Size|URINALYSIS|[?]|cycle/min|[?]|[?]|TRACE|1|U/kg/min|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|AUTOLYZED||AUSCULTATION|FIBROTEST FORMULA|Y||U||4|Visit_4|65|7|TREATMENT|2021-03-17|2021-04-08|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|LB|aecfe062-4e0d-4c91-8b67-1f304c5765ae|8|ARA|Arachidonic Acid|HEMATOLOGY|[?]|mmol/min/kPa/L|[?]|[?]|INVALID|1|rpm|1|1|[?]|LOW|EMESIS|ROOM TEMPERATURE||MEDIASTINOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|5|SCREENING|2021-03-17|2021-03-24|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|LB|aecfe062-4e0d-4c91-8b67-1f304c5765ae|9|TSH|Thyrotropin|CHEMISTRY|[?]|mCi|[?]|[?]|INDETERMINATE|1|MPS U|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|FRESH||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD ENZYMATIC FORMULA|Y|Y|U||5|Visit_5|90|5|TREATMENT|2021-04-11|2021-04-15|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|aecfe062-4e0d-4c91-8b67-1f304c5765ae|10|OSM|Oncostatin M|HEMATOLOGY|[?]|DIP|[?]|[?]|NEGATIVE|1|mol/mg|1|1|[?]|HIGH|TRANSUDATE|SOLIDIFIED||ELECTROCHEMILUMINESCENCE|GMI % FORMULA|Y||Y||5|Visit_5|90|5|SCREENING|2021-04-11|2021-04-14|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|05a142dc-a779-44cb-ab2e-f961676a3940|1|CHLMCRNT|Chylomicron Triglyceride|URINALYSIS|[?]|/100 WBC|[?]|[?]|INVALID|1|nmol/day|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|FROZEN|N|ENZYMATIC SPECTROPHOTOMETRY|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|6|WASHOUT|2020-11-18|2020-11-29|10|21|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|05a142dc-a779-44cb-ab2e-f961676a3940|2|C147284|Boxelder Pollen IgE Antibody|URINALYSIS|[?]|mol/day|[?]|[?]|POSITIVE|1|CUP|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|PARAFFIN-EMBEDDED|N|CARDIAC THERMODILUTION|MDRD 5 VARIABLE FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2020-11-18|2021-01-20|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|05a142dc-a779-44cb-ab2e-f961676a3940|3|YEASTHYP|Yeast Hyphae|HEMATOLOGY|[?]|10^3 CFU/mL|[?]|[?]|TRACE|1|mg/L|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|LACTESCENT||REFLECTANCE SPECTROSCOPY|MDRD 5 VARIABLE FORMULA||Y|U||2|Visit_2|25|7|WASHOUT|2020-12-03|2020-12-27|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|05a142dc-a779-44cb-ab2e-f961676a3940|4|HBGCHTHB|Hemoglobin G Coushatta/Total Hemoglobin|CHEMISTRY|[?]|cmH2O/mL|[?]|[?]|POSITIVE|1|ug/m2/h|1|1|[?]|ABNORMAL|KERATINOCYTE|CONTAMINATED||OPTICAL DENSITY MEASUREMENT|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|1|SCREENING|2020-12-03|2020-12-19|25|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|05a142dc-a779-44cb-ab2e-f961676a3940|5|VITD2|Vitamin D2|HEMATOLOGY|[?]|U|[?]|[?]|INVALID|1|U/animal|1|1|[?]|HIGH|AMNIOTIC FLUID|PARAFFIN-EMBEDDED|N|TRANSMISSION ELECTRON MICROSCOPY|GMI % FORMULA|Y||N||3|Visit_3|40|7|TREATMENT|2020-12-18|2021-02-01|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|05a142dc-a779-44cb-ab2e-f961676a3940|6|IGM|Immunoglobulin M|CHEMISTRY|[?]|mgEq|[?]|[?]|INDETERMINATE|1|Hounsfield Unit|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|ROOM TEMPERATURE|N|SNELLEN EYE CHART|GMI MMOL/MOL FORMULA|||N||3|Visit_3|40|7|FOLLOW-UP|2020-12-18|2020-12-28|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|05a142dc-a779-44cb-ab2e-f961676a3940|7|HCGNDI|Choriogonadotropin, Intact|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/m2/h|1|1|[?]|NORMAL|EPITHELIAL CELL|FROZEN||CARDIAC THERMODILUTION|MDRD 5 VARIABLE FORMULA|Y||N|Y|4|Visit_4|65|4|TREATMENT|2021-01-12|2021-01-14|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|05a142dc-a779-44cb-ab2e-f961676a3940|8|C165899|Silver Birch Pollen IgG AB RAST Score|HEMATOLOGY|[?]|Weber|[?]|[?]|POSITIVE|1|ms/mmHg|1|1|[?]|HIGH|VENOUS BLOOD|ICTERIC||FLUORESCENT ENZYME IMMUNOASSAY|CKD-EPI CREATININE FORMULA||Y|Y||4|Visit_4|65|6|TREATMENT|2021-01-12|2021-01-28|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|05a142dc-a779-44cb-ab2e-f961676a3940|9|C130118|Bee Mix Antigen IgG4 Antibody|URINALYSIS|[?]|genEq/mL|[?]|[?]|INVALID|1|mg/L FEU|1|1|[?]|NORMAL|PERSPIRATION|FRESH||WRIGHT STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||N||5|Visit_5|90|5|FOLLOW-UP|2021-02-06|2021-02-14|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|LB|05a142dc-a779-44cb-ab2e-f961676a3940|10|SPLA2II|Type II Secretory Phospholipase A2|URINALYSIS|[?]|mg/m2|[?]|[?]|INDETERMINATE|1|HOMEOPATHIC DILUTION|1|1|[?]|LOW|LUNG SURFACTANT|UNEXPECTED ODOR||EEG|GMI MMOL/MOL FORMULA|||Y||5|Visit_5|90|1|FOLLOW-UP|2021-02-06|2021-02-11|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|LB|498524c5-08c4-41a4-af81-876ab2452f64|1|PCA3MRNA|Prostate Cancer Antigen 3 mRNA|URINALYSIS|[?]|Siemens|[?]|[?]|INVALID|1|/10^4|1|1|[?]|HIGH|ARTERIAL BLOOD|AGGLUTINATED|N|ROMANOWSKY STAIN|CKD-EPI FORMULA||Y|U||1|Visit_1|10|1|TREATMENT|2020-12-09|2021-02-13|10|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|498524c5-08c4-41a4-af81-876ab2452f64|2|FUNGIFIL|Fungi, Filamentous|HEMATOLOGY|[?]|VIAL|[?]|[?]|INDETERMINATE|1|ng/dL|1|1|[?]|NORMAL|SWABBED MATERIAL|ROOM TEMPERATURE||WEBER GREEN STAIN|MDRD 6 VARIABLE FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-12-09|2021-03-02|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|498524c5-08c4-41a4-af81-876ab2452f64|3|INTLK28|Interleukin 28|URINALYSIS|[?]|mL/dose|[?]|[?]|INDETERMINATE|1|Roentgen|1|1|[?]|LOW|RETICULOCYTES|THAWED||MODIFIED ACID FAST STAIN|CKD-EPI CYSTATIN C FORMULA|Y|Y|Y||2|Visit_2|25|5|TREATMENT|2020-12-24|2021-02-11|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|498524c5-08c4-41a4-af81-876ab2452f64|4|ESTRCPT|Estrogen Receptor|CHEMISTRY|[?]|Bq/g|[?]|[?]|INVALID|1|mL/day|1|1|[?]|LOW|BONE MARROW|AGGLUTINATED|N|CELLULOSE TAPE|COCKCROFT-GAULT FORMULA|||U||2|Visit_2|25|4|WASHOUT|2020-12-24|2021-01-10|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|498524c5-08c4-41a4-af81-876ab2452f64|5|PYY|Peptide YY|HEMATOLOGY|[?]|KALLIKREIN INHIBITOR UNIT|[?]|[?]|INVALID|1|Frames/s|1|1|[?]|ABNORMAL|MECONIUM|FRESH||GC/MS-CI|CKD-EPI FORMULA|||U||3|Visit_3|40|1|TREATMENT|2021-01-08|2021-01-31|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|498524c5-08c4-41a4-af81-876ab2452f64|6|MONO|Monocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|JDF Unit|1|1|[?]|NORMAL|BUFFY COAT|PARAFFIN-EMBEDDED||CONTRAST ENHANCED X-RAY|NASH FIBROSURE FORMULA|||Y|Y|3|Visit_3|40|1|WASHOUT|2021-01-08|2021-02-28|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|498524c5-08c4-41a4-af81-876ab2452f64|7|HLAAMSC|HLA-A Mismatch Count|URINALYSIS|[?]|/10^3|[?]|[?]|POSITIVE|1|U/mmol|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|THAWED||PET/MRI SCAN|FIBROTEST FORMULA|||U||4|Visit_4|65|3|TREATMENT|2021-02-02|2021-02-04|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|498524c5-08c4-41a4-af81-876ab2452f64|8|HALPRZLM|Hydroxyalprazolam|URINALYSIS|||[?]|[?]|BORDERLINE|1|EID 50/dose|1|1|[?]|ABNORMAL|ISOLATE|THAWED||AUDIOMETRY|MDRD FORMULA|||Y|Y|4|Visit_4|65|1|TREATMENT|2021-02-02|2021-02-16|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|498524c5-08c4-41a4-af81-876ab2452f64|9|C1INH|Complement C1 Esterase Inhibitor|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Bq/mL|1|1|[?]|NORMAL|PUS|FRESH|N|APPLANATION TONOMETRY|MDRD ENZYMATIC FORMULA|Y||U|Y|5|Visit_5|90|2|SCREENING|2021-02-27|2021-03-06|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|498524c5-08c4-41a4-af81-876ab2452f64|10|APLAB|Antiphospholipid Antibodies|CHEMISTRY|[?]|10^9 CFU/g|[?]|[?]|NEGATIVE|1|nCi|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|AGGLUTINATED||AUTOREFRACTION|FIBROSIS 4 FORMULA|||N||5|Visit_5|90|5|TREATMENT|2021-02-27|2021-03-03|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|93490930-01cd-470e-81a3-bcd7a140ccc1|1|TROPONI1|Troponin I Type 1|CHEMISTRY|[?]|vp/mL|[?]|[?]|NEGATIVE|1|uL/dose|1|1|[?]|HIGH|CALCULUS|AUTOLYZED||PET/CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|1|TREATMENT|2020-11-17|2020-12-25|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|93490930-01cd-470e-81a3-bcd7a140ccc1|2|C130081|Orchard Grass Pollen IgA|CHEMISTRY|[?]|mg/dL|[?]|[?]|TRACE|1|psec|1|1|[?]|HIGH|DISCHARGE|LACTESCENT||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|COCKCROFT-GAULT FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-11-17|2021-01-19|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|93490930-01cd-470e-81a3-bcd7a140ccc1|3|AAMBTAC|Alpha-Aminobutyric Acid|CHEMISTRY|[?]|ppth|[?]|[?]|POSITIVE|1|mg/h|1|1|[?]|HIGH|LOCHIA|SOLIDIFIED||RAJI CELL RIA|MDRD ENZYMATIC JAPANESE FORMULA|||Y||2|Visit_2|25|2|FOLLOW-UP|2020-12-02|2021-01-05|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|93490930-01cd-470e-81a3-bcd7a140ccc1|4|HDL|HDL Cholesterol|URINALYSIS|[?]|cmol|[?]|[?]|INVALID|1|MASK|1|1|[?]|ABNORMAL|LUNG SURFACTANT|REFRIGERATED|N|SINGLE-MOLECULE ARRAY|CKD-EPI CREATININE FORMULA|||NA||2|Visit_2|25|7|WASHOUT|2020-12-02|2020-12-21|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|93490930-01cd-470e-81a3-bcd7a140ccc1|5|LEPTIN|Leptin|CHEMISTRY|[?]|PACKAGE|[?]|[?]|BORDERLINE|1|nmol/L/h|1|1|[?]|HIGH|VENOUS CORD BLOOD|CALCIFIED||CONTACT SPECULAR MICROSCOPY|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-12-17|2021-02-08|40|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|93490930-01cd-470e-81a3-bcd7a140ccc1|6|NEUTB|Neutrophils Band Form|CHEMISTRY|||[?]|[?]|NEGATIVE|1|PATCH|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|DRIED|N|CLIP|FIBROSIS 4 FORMULA|Y||NA|Y|3|Visit_3|40|5|TREATMENT|2020-12-17|2020-12-21|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|93490930-01cd-470e-81a3-bcd7a140ccc1|7|KETONEBD|Ketone Bodies|URINALYSIS|||[?]|[?]|BORDERLINE|1|yd|1|1|[?]|LOW|SUPERNATANT, SERUM|CALCIFIED|N|GEL ELECTROPHORESIS|NASH FIBROSURE FORMULA||Y|NA|Y|4|Visit_4|65|6|TREATMENT|2021-01-11|2021-01-31|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|93490930-01cd-470e-81a3-bcd7a140ccc1|8|ETS|Ethyl Sulfate|URINALYSIS|[?]|uOsm|[?]|[?]|NEGATIVE|1|/10^4|1|1|[?]|LOW|EXPIRED AIR|PARAFFIN-EMBEDDED||CISH|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|4|FOLLOW-UP|2021-01-11|2021-02-06|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|93490930-01cd-470e-81a3-bcd7a140ccc1|9|MONONSQE|Monocytes/Non-Squam Epi Cells|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|g/kg/day|1|1|[?]|LOW|SEMINAL FLUID|DRIED||OSCILLOMETRY|COCKCROFT-GAULT FORMULA|||Y|Y|5|Visit_5|90|2|SCREENING|2021-02-05|2021-02-13|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|93490930-01cd-470e-81a3-bcd7a140ccc1|10|CLEXR|Chloride Excretion Rate|CHEMISTRY|[?]|vg/dose|[?]|[?]|BORDERLINE|1|m2|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|ICTERIC||OBSERVATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|NA||5|Visit_5|90|2|WASHOUT|2021-02-05|2021-02-09|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|fd588c97-c57f-432f-81a0-a116a017c5dd|1|C1INH|Complement C1 Esterase Inhibitor|URINALYSIS|[?]|mmol/mol|[?]|[?]|TRACE|1|ug/kg/day|1|1|[?]|NORMAL|PERSPIRATION|REFRIGERATED||ICC|COCKCROFT-GAULT FORMULA||Y|N||1|Visit_1|10|7|WASHOUT|2020-06-03|2020-06-29|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|fd588c97-c57f-432f-81a0-a116a017c5dd|2|TIMP3|Tissue Inhibitor of Metalloproteinase 3|HEMATOLOGY|[?]|Hounsfield Unit|[?]|[?]|TRACE|1|%(w/w)|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|CONCENTRATED||AURAMINE STAIN|MDRD 4 VARIABLE FORMULA|Y|Y|Y||1|Visit_1|10|6|FOLLOW-UP|2020-06-03|2020-08-10|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|fd588c97-c57f-432f-81a0-a116a017c5dd|3|CGADJMW|Choriogonadotropin Adj for Maternal Wt|URINALYSIS|||[?]|[?]|POSITIVE|1|atm|1|1|[?]|ABNORMAL|TUMOR TISSUE|AGGLUTINATED||MAGNETIC RESONANCE ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N|Y|2|Visit_2|25|1|WASHOUT|2020-06-18|2020-08-10|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|fd588c97-c57f-432f-81a0-a116a017c5dd|4|C130092|Western Ragweed Pollen IgE|URINALYSIS|[?]|nmol/g|[?]|[?]|BORDERLINE|1|Enzyme U/m2|1|1|[?]|NORMAL|CORD BLOOD|ICTERIC|N|TRIPLE-PHASE SPIRAL CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||2|Visit_2|25|3|WASHOUT|2020-06-18|2020-07-15|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|fd588c97-c57f-432f-81a0-a116a017c5dd|5|CHDWR|Ret Corpuscular HGB Conc Distr Width|URINALYSIS|[?]|MET*min|[?]|[?]|INDETERMINATE|1|10^4 CFU/mL|1|1|[?]|ABNORMAL|REFLEX TEAR|HEMOLYZED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|1|WASHOUT|2020-07-03|2020-08-09|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|LB|fd588c97-c57f-432f-81a0-a116a017c5dd|6|FGFBF|Fibroblast Growth Factor Basic Form|URINALYSIS|[?]|GBq/g|[?]|[?]|BORDERLINE|1|anti-Xa IU/mL|1|1|[?]|LOW|EMESIS|LACTESCENT||MULTI-SLICE SPIRAL CT|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||3|Visit_3|40|5|TREATMENT|2020-07-03|2020-08-21|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|LB|fd588c97-c57f-432f-81a0-a116a017c5dd|7|NORNCTN|Nornicotine|CHEMISTRY|[?]|AMPULE|[?]|[?]|NEGATIVE|1|TUBE|1|1|[?]|HIGH|GASTRIC FLUID|LIPEMIC|N|THICK SMEAR|MDRD FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-07-28|2020-08-29|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|LB|fd588c97-c57f-432f-81a0-a116a017c5dd|8|CAMP|Cyclic Adenosine 3,5-Monophosphate|HEMATOLOGY|[?]|TRANSDUCING UNIT|[?]|[?]|INVALID|1|mL/100g/min|1|1|[?]|HIGH|CORD BLOOD|NON-HEMOLYZED||ISHIHARA COLOR PLATES|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|1|TREATMENT|2020-07-28|2020-08-13|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|LB|fd588c97-c57f-432f-81a0-a116a017c5dd|9|RBCDYRBC|Dysmorphic Erythrocytes/Erythrocytes|URINALYSIS|[?]|mEq/g|[?]|[?]|BORDERLINE|1|mg/kg/week|1|1|[?]|HIGH|URINE|HEMOLYZED||FUNCTIONAL MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||5|Visit_5|90|5|TREATMENT|2020-08-22|2020-08-23|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|LB|fd588c97-c57f-432f-81a0-a116a017c5dd|10|CDCA|Chenodeoxycholate|CHEMISTRY|||[?]|[?]|NEGATIVE|1|MBq/uL|1|1|[?]|LOW|PLATELET RICH PLASMA|FRESH|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|COCKCROFT-GAULT FORMULA|||NA|Y|5|Visit_5|90|6|TREATMENT|2020-08-22|2020-08-26|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|LB|18028efc-33b9-4741-a47a-8fdac0a90e6e|1|PGD2S|Prostaglandin D2 Synthase|HEMATOLOGY|[?]|tsp eq|[?]|[?]|POSITIVE|1|FEU|1|1|[?]|NORMAL|PLATELET RICH PLASMA|REFRIGERATED|N|HPLC/MS|CKD-EPI CYSTATIN C FORMULA|||Y||1|Visit_1|10|3|FOLLOW-UP|2020-12-22|2021-02-28|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|18028efc-33b9-4741-a47a-8fdac0a90e6e|2|EOSIMLE|Immature Eosinophils/Leukocytes|URINALYSIS|[?]|PACKAGE|[?]|[?]|NEGATIVE|1|10^5/L|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|ICTERIC|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI FORMULA|||N||1|Visit_1|10|6|SCREENING|2020-12-22|2021-02-07|10|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|18028efc-33b9-4741-a47a-8fdac0a90e6e|3|ALPISOE|Alkaline Phosphatase Isoenzyme|URINALYSIS|[?]|bel|[?]|[?]|NEGATIVE|1|DROP|1|1|[?]|ABNORMAL|RETICULOCYTES|CONCENTRATED|N|DIFFUSION WEIGHTED MRI|MDRD FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2021-01-06|2021-01-27|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|18028efc-33b9-4741-a47a-8fdac0a90e6e|4|IGSOL|Soluble Immunoglobulin|URINALYSIS|[?]|MPL U|[?]|[?]|NEGATIVE|1|HOURS|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|THAWED||FLUORESCENT MICROSCOPY|CKD-EPI FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2021-01-06|2021-01-15|25|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|18028efc-33b9-4741-a47a-8fdac0a90e6e|5|CHLMCRNT|Chylomicron Triglyceride|URINALYSIS|[?]|mol/day|[?]|[?]|POSITIVE|1|DIOPTER|1|1|[?]|ABNORMAL|BASAL TEAR|GELLED||DISK DIFFUSION|MDRD 6 VARIABLE FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2021-01-21|2021-03-08|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|LB|18028efc-33b9-4741-a47a-8fdac0a90e6e|6|ACYGLYCN|Acylglycine|CHEMISTRY|[?]|APL U/mL|[?]|[?]|BORDERLINE|1|PUFF|1|1|[?]|ABNORMAL|NAIL|THAWED||CT SCAN|MDRD 6 VARIABLE FORMULA|Y||NA||3|Visit_3|40|2|TREATMENT|2021-01-21|2021-03-06|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|LB|18028efc-33b9-4741-a47a-8fdac0a90e6e|7|PKM2|Pyruvate Kinase Isozyme M2|URINALYSIS|[?]|Ci/L|[?]|[?]|TRACE|1|nsec|1|1|[?]|NORMAL|HAIR|ICTERIC||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||4|Visit_4|65|3|WASHOUT|2021-02-15|2021-03-12|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|18028efc-33b9-4741-a47a-8fdac0a90e6e|8|PLAGMAMP|Platelet Aggregation Mean Amplitude|HEMATOLOGY|[?]|Bq/uL|[?]|[?]|TRACE|1|ug/g/day|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED||PH METER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|4|WASHOUT|2021-02-15|2021-03-05|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|18028efc-33b9-4741-a47a-8fdac0a90e6e|9|LPA|Lipoprotein-a|URINALYSIS|[?]|ngEq/L|[?]|[?]|INDETERMINATE|1|Arbitrary U|1|1|[?]|LOW|PERSPIRATION|LACTESCENT|N|OPTICAL MAPPING|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|1|WASHOUT|2021-03-12|2021-03-13|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|18028efc-33b9-4741-a47a-8fdac0a90e6e|10|CCL17|Chemokine (C-C Motif) Ligand 17|CHEMISTRY|||[?]|[?]|NEGATIVE|1|ug/dL|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|CLOTTED|N|SNP ARRAY|FIBROTEST FORMULA|||U|Y|5|Visit_5|90|2|FOLLOW-UP|2021-03-12|2021-03-13|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|1|RBCGHOST|Erythrocyte Ghosts|URINALYSIS|[?]|SPRAY|[?]|[?]|INDETERMINATE|1|HEP|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|NON-HEMOLYZED||GC/MS-EI|COCKCROFT-GAULT FORMULA|Y||NA||1|Visit_1|10|4|FOLLOW-UP|2020-06-04|2020-07-05|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|2|MICROCY|Microcytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|g/m2/day|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|CALCIFIED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI FORMULA|||N|Y|1|Visit_1|10|1|TREATMENT|2020-06-04|2020-08-30|10|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|3|LIPID|Lipid|CHEMISTRY|[?]|/2500 WBC|[?]|[?]|BORDERLINE|1|kIU|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|CONCENTRATED|N|PHYSICAL EXAMINATION|CKD-EPI FORMULA||Y|Y||2|Visit_2|25|6|TREATMENT|2020-06-19|2020-08-16|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|4|AMYLASEM|Macroamylase|HEMATOLOGY|[?]|FFU|[?]|[?]|BORDERLINE|1|mmHg/L/min|1|1|[?]|ABNORMAL|SOFT TISSUE|THAWED||NUCLEIC ACID HYBRIDIZATION|CKD-EPI CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|2|SCREENING|2020-06-19|2020-07-14|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|5|C130118|Bee Mix Antigen IgG4 Antibody|URINALYSIS|[?]|MPS U|[?]|[?]|BORDERLINE|1|U.CARR|1|1|[?]|ABNORMAL|EXUDATE|SOLIDIFIED|N|DUCTOGRAPHY|COCKCROFT-GAULT FORMULA|||Y||3|Visit_3|40|7|SCREENING|2020-07-04|2020-08-18|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|LB|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|6|TRP|Tryptophan|HEMATOLOGY|[?]|s/h|[?]|[?]|INDETERMINATE|1|kcal/day|1|1|[?]|HIGH|URINE SEDIMENT|ICTERIC||RADIAL IMMUNODIFFUSION|ASH FIBROSURE FORMULA|Y||NA||3|Visit_3|40|4|TREATMENT|2020-07-04|2020-07-05|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|LB|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|7|HASIGGAB|Human Anti-Sheep IgG Antibody|HEMATOLOGY|[?]|DAYS|[?]|[?]|INDETERMINATE|1|dyn|1|1|[?]|ABNORMAL|CELL PELLET|CLOTTED|N|FLUORESCENT IMMUNOASSAY|CKD-EPI CREATININE FORMULA||Y|U||4|Visit_4|65|3|SCREENING|2020-07-29|2020-08-30|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|8|CSUNCLA|Unclassified Casts|HEMATOLOGY|[?]|Pa|[?]|[?]|TRACE|1|Ci/ug|1|1|[?]|NORMAL|LAVAGE FLUID|LIPEMIC|N|VENTILATION PERFUSION LUNG SCAN|HEPASCORE FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-07-29|2020-08-13|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|9|CD14|CD14|HEMATOLOGY|[?]|ft3|[?]|[?]|NEGATIVE|1|amu|1|1|[?]|ABNORMAL|DERMAL TISSUE|THAWED||SPECT SCAN|FIBROTEST FORMULA|||Y||5|Visit_5|90|7|FOLLOW-UP|2020-08-23|2020-08-31|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|LB|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|10|MCPHG|Macrophages|CHEMISTRY|[?]|EIA unit|[?]|[?]|BORDERLINE|1|BAU|1|1|[?]|ABNORMAL|TUMOR TISSUE|FROZEN|N|HANSEL STAIN|CKD-EPI FORMULA|||U||5|Visit_5|90|6|FOLLOW-UP|2020-08-23|2020-08-25|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|LB|08fccce4-64bf-431e-81b0-a96566e77df6|1|MMP3|Matrix Metalloproteinase 3|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|/10^3|1|1|[?]|ABNORMAL|ABSCESS FLUID|CALCIFIED|N|LC-FL|MDRD 4 VARIABLE FORMULA|Y|Y|NA|Y|1|Visit_1|10|4|WASHOUT|2021-01-20|2021-04-02|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|08fccce4-64bf-431e-81b0-a96566e77df6|2|FIO2|Fraction of Inspired Oxygen|HEMATOLOGY|||[?]|[?]|TRACE|1|APS U|1|1|[?]|NORMAL|ALVEOLAR AIR|PARAFFIN-EMBEDDED|N|DC SHEATH FLOW|CKD-EPI CREATININE FORMULA|||N|Y|1|Visit_1|10|3|FOLLOW-UP|2021-01-20|2021-02-27|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|08fccce4-64bf-431e-81b0-a96566e77df6|3|GSTALCRT|Glutathione S-Transferase, Alpha/Creat|HEMATOLOGY|[?]|CARTRIDGE|[?]|[?]|NEGATIVE|1|kg/cm|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED||DARK FIELD MICROSCOPY|HEPASCORE FORMULA||Y|Y||2|Visit_2|25|1|TREATMENT|2021-02-04|2021-03-15|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|08fccce4-64bf-431e-81b0-a96566e77df6|4|INLCLR|Inulin Clearance|HEMATOLOGY|[?]|mL/min/mmHg|[?]|[?]|TRACE|1|dpm/0.5 mL|1|1|[?]|LOW|SOFT TISSUE|AGGLUTINATED||IMPEDANCE CONDUCTIVITY|FIBROMETER FORMULA|Y||Y||2|Visit_2|25|3|TREATMENT|2021-02-04|2021-03-24|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|08fccce4-64bf-431e-81b0-a96566e77df6|5|CIC|Circulating Immune Complexes|CHEMISTRY|||[?]|[?]|TRACE|1|Gy|1|1|[?]|LOW|SALIVA|NON-HEMOLYZED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD FORMULA||Y|U|Y|3|Visit_3|40|4|TREATMENT|2021-02-19|2021-04-08|40|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|08fccce4-64bf-431e-81b0-a96566e77df6|6|RETPALM|Retinyl Palmitate|URINALYSIS|||[?]|[?]|INVALID|1|PIPE|1|1|[?]|HIGH|CAPILLARY PLASMA|ROOM TEMPERATURE||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|ASH FIBROSURE FORMULA||Y|Y|Y|3|Visit_3|40|7|SCREENING|2021-02-19|2021-03-13|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|08fccce4-64bf-431e-81b0-a96566e77df6|7|FCT8INH|Factor VIII Inhibitor|URINALYSIS|[?]|mmol2/L2|[?]|[?]|INVALID|1|Ci/kg|1|1|[?]|LOW|LUNG SURFACTANT|HEMOLYZED||PAP STAIN|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|7|FOLLOW-UP|2021-03-16|2021-03-28|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|LB|08fccce4-64bf-431e-81b0-a96566e77df6|8|ICAIGGAB|Islet Cell Cytoplasmic IgG Antibody|URINALYSIS|[?]|log EID 50/dose|[?]|[?]|TRACE|1|DIP|1|1|[?]|HIGH|EPITHELIAL CELL|DRIED|N|CINEANGIOGRAPHY|MDRD ENZYMATIC FORMULA|Y||N||4|Visit_4|65|3|TREATMENT|2021-03-16|2021-03-29|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|LB|08fccce4-64bf-431e-81b0-a96566e77df6|9|LCHT|Lithocholate|HEMATOLOGY|[?]|mL/min/1.73m2|[?]|[?]|INDETERMINATE|1|mOsm/kg|1|1|[?]|LOW|CERUMEN|REFRIGERATED||PERIPHERAL ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|N||5|Visit_5|90|6|TREATMENT|2021-04-10|2021-04-19|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|08fccce4-64bf-431e-81b0-a96566e77df6|10|GDIGA1|Galactose-Deficient IgA1|CHEMISTRY|||[?]|[?]|POSITIVE|1|10^3 organisms/mL|1|1|[?]|NORMAL|PLEURAL TISSUE|UNEXPECTED ODOR|N|OPTICAL MAPPING|CKD-EPI CREATININE FORMULA|||N|Y|5|Visit_5|90|2|FOLLOW-UP|2021-04-10|2021-04-17|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|0354fab5-5636-4504-8345-af060ad4c90c|1|C165895|Johnson Grass Pollen IgG4 Antibody|URINALYSIS|[?]|CFU/mL|[?]|[?]|NEGATIVE|1|umol/day|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|AGGLUTINATED||CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||1|Visit_1|10|7|TREATMENT|2021-01-23|2021-02-26|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|LB|0354fab5-5636-4504-8345-af060ad4c90c|2|MLIGCE|Malignant Cells, NOS|CHEMISTRY|[?]|ug/day|[?]|[?]|INDETERMINATE|1|PUFF|1|1|[?]|LOW|ENDOMETRIAL TISSUE|NON-HEMOLYZED||CYSTOMETRY|MDRD FORMULA|Y|Y|Y||1|Visit_1|10|6|WASHOUT|2021-01-23|2021-04-12|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|LB|0354fab5-5636-4504-8345-af060ad4c90c|3|RNPSMAB|Ribonucleoprotein Smith Complex Antibody|URINALYSIS|[?]|ug/L DDU|[?]|[?]|POSITIVE|1|SPRAY|1|1|[?]|LOW|MUCUS|FRESH||CONTRAST ENHANCED PET/CT SCAN|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|7|FOLLOW-UP|2021-02-07|2021-03-26|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-20
e|LB|0354fab5-5636-4504-8345-af060ad4c90c|4|CLCTONN|Calcitonin|URINALYSIS|||[?]|[?]|NEGATIVE|1|GLOBULE|1|1|[?]|HIGH|BUFFY COAT|ICTERIC|N|OBSERVATION|FIBROTEST FORMULA|||U|Y|2|Visit_2|25|1|FOLLOW-UP|2021-02-07|2021-03-31|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-20
e|LB|0354fab5-5636-4504-8345-af060ad4c90c|5|IDLVLDL3|IDL+VLDL Cholesterol Subtype 3|CHEMISTRY|[?]|log10 TCID 50/dose|[?]|[?]|INVALID|1|RATIO|1|1|[?]|HIGH|SEBUM|CALCIFIED|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD ENZYMATIC FORMULA|Y|Y|Y||3|Visit_3|40|4|SCREENING|2021-02-22|2021-03-23|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|0354fab5-5636-4504-8345-af060ad4c90c|6|ACYCRNTN|Acylcarnitine|HEMATOLOGY|[?]|SBE/mL|[?]|[?]|NEGATIVE|1|mg/dose|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|FROZEN||CRYOSCOPY|MDRD ENZYMATIC FORMULA|||N||3|Visit_3|40|5|SCREENING|2021-02-22|2021-04-13|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|0354fab5-5636-4504-8345-af060ad4c90c|7|ALTAST|ALT/AST|CHEMISTRY|[?]|cm2|[?]|[?]|INDETERMINATE|1|PA|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|REFRIGERATED||U-HPLC/MS/MS|FIBROTEST FORMULA|Y|Y|NA||4|Visit_4|65|4|WASHOUT|2021-03-19|2021-04-01|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-17
e|LB|0354fab5-5636-4504-8345-af060ad4c90c|8|DALA|Delta Aminolevulinate|CHEMISTRY|[?]|pkat/L|[?]|[?]|BORDERLINE|1|keV|1|1|[?]|NORMAL|DERMAL TISSUE|LIPEMIC||ALCIAN BLUE STAIN|MDRD 5 VARIABLE FORMULA|Y||Y||4|Visit_4|65|7|FOLLOW-UP|2021-03-19|2021-03-22|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-17
e|LB|0354fab5-5636-4504-8345-af060ad4c90c|9|CSEPI|Epithelial Casts|URINALYSIS|||[?]|[?]|BORDERLINE|1|IU/mg|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE||FLAME PHOTOMETRY|MDRD 4 VARIABLE FORMULA|||NA|Y|5|Visit_5|90|6|SCREENING|2021-04-13|2021-04-20|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|0354fab5-5636-4504-8345-af060ad4c90c|10|PTA|Prothrombin Activity|URINALYSIS|[?]|kV|[?]|[?]|NEGATIVE|1|mg/day|1|1|[?]|HIGH|TUMOR TISSUE|FROZEN||IN SITU HYBRIDIZATION|FIBROMETER FORMULA|||N||5|Visit_5|90|4|TREATMENT|2021-04-13|2021-04-22|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|f4f1a53a-d621-4f75-b44e-96b959aed03d|1|C147285|Common Ragweed Pollen IgE Antibody|HEMATOLOGY|[?]|Enzyme U|[?]|[?]|INVALID|1|10^8/L|1|1|[?]|LOW|ARTERIAL BLOOD|FROZEN||MICRO BROTH DILUTION|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|4|TREATMENT|2021-01-09|2021-03-21|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|f4f1a53a-d621-4f75-b44e-96b959aed03d|2|TGFB1|Transforming Growth Factor Beta 1|URINALYSIS|[?]|ohm|[?]|[?]|INVALID|1|mL/100g/min|1|1|[?]|HIGH|REFLEX TEAR|AUTOLYZED||FLAME PHOTOMETRY|FIBROMETER FORMULA|Y||U||1|Visit_1|10|5|FOLLOW-UP|2021-01-09|2021-02-19|10|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|f4f1a53a-d621-4f75-b44e-96b959aed03d|3|MCHC|Ery. Mean Corpuscular HGB Concentration|HEMATOLOGY|||[?]|[?]|INVALID|1|BAG|1|1|[?]|HIGH|SEBUM|UNEXPECTED ODOR||BIOIMPEDANCE SPECTROSCOPY|MDRD 4 VARIABLE FORMULA|||NA|Y|2|Visit_2|25|2|TREATMENT|2021-01-24|2021-02-15|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|LB|f4f1a53a-d621-4f75-b44e-96b959aed03d|4|CCPAB|Cyclic Citrullinated Peptide Antibody|HEMATOLOGY|[?]|mAnson U/mL|[?]|[?]|BORDERLINE|1|USP U|1|1|[?]|NORMAL|ALVEOLAR AIR|NON-HEMOLYZED||AGAR PROPORTION|FIBROTEST FORMULA|||N||2|Visit_2|25|5|TREATMENT|2021-01-24|2021-02-21|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|LB|f4f1a53a-d621-4f75-b44e-96b959aed03d|5|GFRBSCRT|GFR from Creatinine Adjusted for BSA|CHEMISTRY|[?]|Ejaculate U|[?]|[?]|POSITIVE|1|10^9 organisms/mg|1|1|[?]|HIGH|BUFFY COAT|DRIED|N|MICROARRAY|HEPASCORE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2021-02-08|2021-03-08|40|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|f4f1a53a-d621-4f75-b44e-96b959aed03d|6|GGTCREAT|Gamma Glutamyl Transferase/Creatinine|URINALYSIS|[?]|pmol/10^9 cells|[?]|[?]|INVALID|1|Shock Wave|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|FROZEN||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|NASH FIBROSURE FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2021-02-08|2021-04-03|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|f4f1a53a-d621-4f75-b44e-96b959aed03d|7|GLYHLACD|Glycocholic Acid|CHEMISTRY|[?]|vg/dose|[?]|[?]|INVALID|1|nmol/g|1|1|[?]|NORMAL|CELL PELLET|AUTOLYZED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|GMI MMOL/MOL FORMULA|Y||Y||4|Visit_4|65|6|TREATMENT|2021-03-05|2021-03-28|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|f4f1a53a-d621-4f75-b44e-96b959aed03d|8|ANTHRMAG|Antithrombin Antigen|CHEMISTRY|[?]|TCID 50/dose|[?]|[?]|BORDERLINE|1|genEq/mL|1|1|[?]|LOW|BUFFY COAT|ROOM TEMPERATURE||HILLMEN COLOR CHART|GMI % FORMULA|||NA||4|Visit_4|65|7|FOLLOW-UP|2021-03-05|2021-03-28|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|f4f1a53a-d621-4f75-b44e-96b959aed03d|9|KIM1S|Soluble Kidney Injury Molecule-1|CHEMISTRY|[?]|GBq/g|[?]|[?]|NEGATIVE|1|YEARS|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|CONTAMINATED||DOPPLER ULTRASOUND|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|5|SCREENING|2021-03-30|2021-04-04|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|f4f1a53a-d621-4f75-b44e-96b959aed03d|10|CATNINB|Beta Catenin|URINALYSIS|[?]|PACKET|[?]|[?]|BORDERLINE|1|DROP|1|1|[?]|NORMAL|BUFFY COAT|GELLED||POLYSOMNOGRAPHY|MDRD 4 VARIABLE FORMULA|Y|Y|N||5|Visit_5|90|1|TREATMENT|2021-03-30|2021-04-05|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|1|CARNIT|Carnitine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|g/g/day|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|NON-HEMOLYZED|N|JAEGER EYE CHART|FIBROTEST FORMULA|||NA|Y|1|Visit_1|10|1|TREATMENT|2020-10-01|2020-12-11|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|2|PROINSUL|Proinsulin|URINALYSIS|||[?]|[?]|INVALID|1|BOWL|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|PARAFFIN-EMBEDDED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CREATININE FORMULA|Y||Y|Y|1|Visit_1|10|6|TREATMENT|2020-10-01|2020-10-08|10|17|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|3|IGGCALBC|IgG Clearance/Albumin Clearance|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Hounsfield Unit|1|1|[?]|HIGH|SUPERNATANT, PLASMA|AUTOLYZED||MAMMOGRAPHY|NASH FIBROSURE FORMULA|||U|Y|2|Visit_2|25|2|WASHOUT|2020-10-16|2020-10-28|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|4|T4FRIDX|Thyroxine, Free Index|URINALYSIS|[?]|vg/dose|[?]|[?]|INVALID|1|mL/animal/day|1|1|[?]|HIGH|SEMEN|THAWED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2020-10-16|2020-11-23|25|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|5|KLHIGMAB|Keyhole Limpet Hemocyanin IgM Antibody|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mmol/mol|1|1|[?]|HIGH|SOFT TISSUE|CONTAMINATED||PLAQUE REDUCTION NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA|Y||U|Y|3|Visit_3|40|4|SCREENING|2020-10-31|2020-11-09|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|6|PELGERH|Pelger Huet Anomaly|HEMATOLOGY|[?]|mg/min|[?]|[?]|POSITIVE|1|dpm/mL|1|1|[?]|NORMAL|MUCUS|ICTERIC||NUCLEIC ACID SEQUENCING|GMI % FORMULA|Y|Y|Y||3|Visit_3|40|7|TREATMENT|2020-10-31|2020-11-16|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|7|THYAB|Thyroid Antibodies|URINALYSIS|[?]|COAT|[?]|[?]|POSITIVE|1|eq|1|1|[?]|LOW|GASTRIC FLUID|UNEXPECTED ODOR||ANTIMICROBIAL COMBINATION TESTING|MDRD 5 VARIABLE FORMULA|||U||4|Visit_4|65|6|FOLLOW-UP|2020-11-25|2020-12-13|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|8|ESTFREST|Estradiol, Free/Estradiol|CHEMISTRY|[?]|kg/m2|[?]|[?]|INVALID|1|umol/mol|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|AGGLUTINATED||DXA SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-11-25|2020-12-16|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|9|EOSCE|Eosinophils/Total Cells|HEMATOLOGY|[?]|copies/ug|[?]|[?]|INDETERMINATE|1|PFU/animal|1|1|[?]|LOW|GASTRIC CONTENTS|GELLED||WHOLE EXOME SEQUENCING|GMI % FORMULA|||NA||5|Visit_5|90|2|SCREENING|2020-12-20|2020-12-29|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|10|CAMP|Cyclic Adenosine 3,5-Monophosphate|HEMATOLOGY|||[?]|[?]|TRACE|1|AU/mL|1|1|[?]|HIGH|GASTRIC FLUID|CALCIFIED||MRS|COCKCROFT-GAULT FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2020-12-20|2020-12-29|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|679423a4-92cf-4a93-8277-282f9b43f2ed|1|C130075|Birch Pollen IgG4|URINALYSIS|[?]|10^4/hpf|[?]|[?]|INDETERMINATE|1|PA|1|1|[?]|LOW|ARTERIAL BLOOD|NON-HEMOLYZED||MEDIASTINOSCOPY|MDRD ENZYMATIC FORMULA|Y||U||1|Visit_1|10|7|FOLLOW-UP|2020-08-03|2020-09-17|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|679423a4-92cf-4a93-8277-282f9b43f2ed|2|CD13|CD13|URINALYSIS|[?]|ug/m2|[?]|[?]|NEGATIVE|1|dpm/mg|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|UNEXPECTED ODOR||HEMAGGLUTINATION ASSAY|CKD-EPI CREATININE FORMULA|Y|Y|N||1|Visit_1|10|1|SCREENING|2020-08-03|2020-09-18|10|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|679423a4-92cf-4a93-8277-282f9b43f2ed|3|TIMP1|Tissue Inhibitor of Metalloproteinase 1|CHEMISTRY|[?]|L/min/m2|[?]|[?]|POSITIVE|1|MET*h|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|UNEXPECTED ODOR|N|IN SITU HYBRIDIZATION|NASH FIBROSURE FORMULA|Y||Y||2|Visit_2|25|4|SCREENING|2020-08-18|2020-09-10|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|679423a4-92cf-4a93-8277-282f9b43f2ed|4|GNRH|Gonadotropin Releasing Hormone|URINALYSIS|[?]|mm3/mm2/year|[?]|[?]|TRACE|1|mm/h|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|ROOM TEMPERATURE|N|PELLI-ROBSON EYE CHART|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||2|Visit_2|25|4|FOLLOW-UP|2020-08-18|2020-09-06|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|679423a4-92cf-4a93-8277-282f9b43f2ed|5|THRCREAT|Threonine/Creatinine|HEMATOLOGY|[?]|pg/dL|[?]|[?]|INVALID|1|nmol/L|1|1|[?]|HIGH|PLATELET POOR PLASMA|NON-HEMOLYZED||AUSCULTATION|HEPASCORE FORMULA|||Y||3|Visit_3|40|4|TREATMENT|2020-09-02|2020-09-22|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|679423a4-92cf-4a93-8277-282f9b43f2ed|6|FGF21|Fibroblast Growth Factor 21|URINALYSIS|[?]|PFU/animal|[?]|[?]|POSITIVE|1|U/kg/h|1|1|[?]|HIGH|EXPIRED AIR|LIPEMIC||NEURAMINIDASE INHIBITION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||3|Visit_3|40|1|WASHOUT|2020-09-02|2020-09-25|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|679423a4-92cf-4a93-8277-282f9b43f2ed|7|GBP2|Guanylate Binding Protein 2|HEMATOLOGY|[?]|nmol|[?]|[?]|INDETERMINATE|1|PA|1|1|[?]|HIGH|LUNG SURFACTANT|ROOM TEMPERATURE||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|ASH FIBROSURE FORMULA|Y||U||4|Visit_4|65|3|SCREENING|2020-09-27|2020-10-07|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|679423a4-92cf-4a93-8277-282f9b43f2ed|8|C165882|White Elm Pollen IgE AB RAST Score|CHEMISTRY|[?]|ELISA unit/dose|[?]|[?]|INDETERMINATE|1|cs|1|1|[?]|NORMAL|TISSUE|LACTESCENT||MIGET|ASH FIBROSURE FORMULA|||N||4|Visit_4|65|4|SCREENING|2020-09-27|2020-10-12|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|679423a4-92cf-4a93-8277-282f9b43f2ed|9|PHENYTN|Phenytoin|CHEMISTRY|[?]|lx|[?]|[?]|POSITIVE|1|lx|1|1|[?]|NORMAL|LAVAGE FLUID|DRIED|N|ELECTRICAL IMPEDANCE MYOGRAPHY|FIBROMETER FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2020-10-22|2020-10-31|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|679423a4-92cf-4a93-8277-282f9b43f2ed|10|PSAMRNA|Prostate Specific Antigen mRNA|URINALYSIS|[?]|umol/L/sec|[?]|[?]|INDETERMINATE|1|IU/dL|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|DRIED|N|LC-FL|GMI % FORMULA||Y|N||5|Visit_5|90|4|TREATMENT|2020-10-22|2020-10-28|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|fb686cda-337b-46aa-b67b-790414201d9a|1|ESTRCPT|Estrogen Receptor|URINALYSIS|[?]|EVENTS|[?]|[?]|NEGATIVE|1|m/sec|1|1|[?]|HIGH|BONE|SOLIDIFIED||PET SCAN|MDRD FORMULA||Y|NA||1|Visit_1|10|2|TREATMENT|2020-05-26|2020-05-27|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|fb686cda-337b-46aa-b67b-790414201d9a|2|FLRZPM|Flurazepam|HEMATOLOGY|[?]|/10^5|[?]|[?]|BORDERLINE|1|mg/m2|1|1|[?]|NORMAL|SALIVA|ROOM TEMPERATURE||CELL OF ORIGIN ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||1|Visit_1|10|2|FOLLOW-UP|2020-05-26|2020-07-04|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|fb686cda-337b-46aa-b67b-790414201d9a|3|EPSTI1|Epithelial Stromal Interaction Protein 1|URINALYSIS|||[?]|[?]|BORDERLINE|1|U/g/min|1|1|[?]|LOW|BLOOD|NON-HEMOLYZED||PERIODIC ACID SCHIFF STAIN|MDRD 4 VARIABLE FORMULA||Y|NA|Y|2|Visit_2|25|3|TREATMENT|2020-06-10|2020-07-28|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|LB|fb686cda-337b-46aa-b67b-790414201d9a|4|ACRNCRNF|Acylcarnitine/Carnitine, Free|CHEMISTRY|[?]|/LSQN|[?]|[?]|TRACE|1|IU/mg|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|AGGLUTINATED||SANGER SEQUENCING|FIBROSIS 4 FORMULA|||Y||2|Visit_2|25|2|WASHOUT|2020-06-10|2020-07-05|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|LB|fb686cda-337b-46aa-b67b-790414201d9a|5|EOSPSD|Pseudo-Eosinophils|HEMATOLOGY|[?]|uL/dose|[?]|[?]|POSITIVE|1|log10 TCID 50/uL|1|1|[?]|LOW|CALCULUS|DRIED||MODIFIED ACID FAST STAIN|FIBROMETER FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-06-25|2020-06-28|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|fb686cda-337b-46aa-b67b-790414201d9a|6|MMP9|Matrix Metalloproteinase 9|CHEMISTRY|[?]|cs|[?]|[?]|INDETERMINATE|1|10^3 RNA copies/mL|1|1|[?]|HIGH|PROSTATIC FLUID|ROOM TEMPERATURE|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|FIBROMETER FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2020-06-25|2020-08-02|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|fb686cda-337b-46aa-b67b-790414201d9a|7|RH|Rh Factor|URINALYSIS|[?]|BLOCKS|[?]|[?]|TRACE|1|kIU|1|1|[?]|HIGH|ISOLATE|LACTESCENT||U-HPLC/MS/MS|GMI % FORMULA|Y|Y|N||4|Visit_4|65|1|TREATMENT|2020-07-20|2020-08-09|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|LB|fb686cda-337b-46aa-b67b-790414201d9a|8|LYMPHOTC|Lymphotactin|URINALYSIS|[?]|tsp eq|[?]|[?]|NEGATIVE|1|APL U|1|1|[?]|HIGH|KERATINOCYTE|FROZEN||SINGLE-SLICE SPIRAL CT|GMI MMOL/MOL FORMULA||Y|U||4|Visit_4|65|5|TREATMENT|2020-07-20|2020-07-27|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|LB|fb686cda-337b-46aa-b67b-790414201d9a|9|GLTRCE|Glitter Cells|URINALYSIS|[?]|BEAM BREAKS|[?]|[?]|NEGATIVE|1|ms2|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|N|OSCILLOMETRY|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-08-14|2020-08-23|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|LB|fb686cda-337b-46aa-b67b-790414201d9a|10|FAS|Fas Cell Surface Death Receptor|URINALYSIS|[?]|Gy/h|[?]|[?]|INDETERMINATE|1|vg/kg|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|CLOTTED||FLOCCULATION, CHARCOAL ENHANCED|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|1|FOLLOW-UP|2020-08-14|2020-08-19|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|LB|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|1|INGAPAB|Islet Neogenesis Assoc Protein Antibody|CHEMISTRY|[?]|DROP|[?]|[?]|INVALID|1|g/cage/day|1|1|[?]|LOW|MIXED VENOUS BLOOD|UNEXPECTED ODOR|N|TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROTEST FORMULA|||NA||1|Visit_1|10|6|SCREENING|2020-10-05|2020-11-21|10|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|2|GLUCAGON|Glucagon|URINALYSIS|[?]|kg|[?]|[?]|TRACE|1|mL/cage/wk|1|1|[?]|LOW|SOFT TISSUE|REFRIGERATED||NEURAMINIDASE INHIBITION ASSAY|FIBROMETER FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-10-05|2020-12-30|10|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|3|KRCYMGLE|Megakaryocytes/Leukocytes|HEMATOLOGY|[?]|10^3 CFU|[?]|[?]|BORDERLINE|1|mV*min|1|1|[?]|LOW|AMNIOTIC FLUID|FRESH||MANUAL CLOT DETECTION|ASH FIBROSURE FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-10-20|2020-11-20|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|4|HLZPM|Halazepam|URINALYSIS|[?]|10^6/L|[?]|[?]|INDETERMINATE|1|/MBP|1|1|[?]|ABNORMAL|PROSTATIC FLUID|LIPEMIC|N|TOTAL BODY IRRADIATION|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|6|TREATMENT|2020-10-20|2020-10-22|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|5|APAPCYS|Acetaminophen-Cysteine Adduct|CHEMISTRY|||[?]|[?]|NEGATIVE|1|GBq/g|1|1|[?]|HIGH|ARTERIAL BLOOD|DRIED||QUANTITATIVE ULTRASOUND|ASH FIBROSURE FORMULA|||U|Y|3|Visit_3|40|7|TREATMENT|2020-11-04|2020-11-07|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|6|ETPPH|ETP Peak Height|CHEMISTRY|[?]|ppb|[?]|[?]|POSITIVE|1|mL/m2/h|1|1|[?]|LOW|MIXED VENOUS BLOOD|NON-HEMOLYZED||NUCLEIC ACID AMPLIFICATION TEST|FIBROMETER FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-11-04|2020-11-18|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|7|MORPHINE|Morphine|HEMATOLOGY|[?]|HOURS|[?]|[?]|INDETERMINATE|1|um/day|1|1|[?]|HIGH|MENSTRUAL BLOOD|AUTOLYZED|N|LC-FL|ASH FIBROSURE FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2020-11-29|2020-12-31|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|8|C3DAB|Complement C3d Antibody|CHEMISTRY|[?]|DNA copies/mL|[?]|[?]|NEGATIVE|1|TRANSDUCING UNIT/mL|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|PARAFFIN-EMBEDDED|N|X-RAY FLUORESCENCE SPECTROMETRY|CKD-EPI CREATININE FORMULA||Y|Y||4|Visit_4|65|7|TREATMENT|2020-11-29|2020-12-18|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|9|GLOBA1|Alpha-1 Globulin|HEMATOLOGY|[?]|10^3/L|[?]|[?]|TRACE|1|ft3|1|1|[?]|HIGH|SKIN TISSUE|DRIED||MICRONEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA|Y||N||5|Visit_5|90|4|SCREENING|2020-12-24|2020-12-31|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|LB|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|10|TXB2_D11|11-Dehydro-Thromboxane B2|HEMATOLOGY|[?]|nmol/g|[?]|[?]|INDETERMINATE|1|mL/cage/day|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|REFRIGERATED|N|IMMUNOTURBIDIMETRY|CKD-EPI CYSTATIN C FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2020-12-24|2020-12-31|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|LB|92d7a180-9353-41f8-93e2-ebcee32a1c63|1|LYMPHOID|Lymphoid Cells|URINALYSIS|[?]|mg2/dL2|[?]|[?]|NEGATIVE|1|BOTTLE|1|1|[?]|HIGH|MUSCLE TISSUE|AGGLUTINATED||CINEANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||Y||1|Visit_1|10|5|FOLLOW-UP|2020-12-06|2021-01-11|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|92d7a180-9353-41f8-93e2-ebcee32a1c63|2|MYCEPIDX|Myeloid Proliferation Index|HEMATOLOGY|[?]|mL/breath|[?]|[?]|INDETERMINATE|1|AU/mL|1|1|[?]|NORMAL|ARTERIAL BLOOD|CONCENTRATED||TARGETED TRANSCRIPTOME SEQUENCING|MDRD 4 VARIABLE FORMULA|||NA||1|Visit_1|10|1|SCREENING|2020-12-06|2021-01-24|10|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|92d7a180-9353-41f8-93e2-ebcee32a1c63|3|PGE1|Prostaglandin E1|URINALYSIS|[?]|MHz|[?]|[?]|NEGATIVE|1|mL/h|1|1|[?]|NORMAL|SEBUM|CALCIFIED||LANDOLT RING|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|7|FOLLOW-UP|2020-12-21|2020-12-24|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|92d7a180-9353-41f8-93e2-ebcee32a1c63|4|TOXVAC|Toxic Vacuolation|HEMATOLOGY|[?]|nmol/g|[?]|[?]|INVALID|1|Torr|1|1|[?]|NORMAL|LEUKOCYTE|CONCENTRATED||ENZYMATIC COLORIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||2|Visit_2|25|5|TREATMENT|2020-12-21|2021-02-09|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|92d7a180-9353-41f8-93e2-ebcee32a1c63|5|CHLMCRN|Chylomicrons|CHEMISTRY|[?]|mL/100g/min|[?]|[?]|TRACE|1|ka_u/dL|1|1|[?]|LOW|DERMAL TISSUE|UNEXPECTED ODOR||LIQUID SCINTILLATION COUNTING|GMI % FORMULA|||NA||3|Visit_3|40|6|FOLLOW-UP|2021-01-05|2021-02-08|40|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|92d7a180-9353-41f8-93e2-ebcee32a1c63|6|CHDW|Corpuscular HGB Conc Distribution Width|HEMATOLOGY|[?]|psi|[?]|[?]|NEGATIVE|1|ukat/L|1|1|[?]|NORMAL|BREAST MILK|UNEXPECTED ODOR||ENDOSCOPY|CKD-EPI CYSTATIN C FORMULA|||U||3|Visit_3|40|2|WASHOUT|2021-01-05|2021-01-23|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|92d7a180-9353-41f8-93e2-ebcee32a1c63|7|CD161ALY|CD161a/Lymphocytes|CHEMISTRY|[?]|/2000 RBC|[?]|[?]|TRACE|1|OI50|1|1|[?]|LOW|EPIDERMAL TISSUE|DRIED|N|MALDI-TOF|MDRD ENZYMATIC JAPANESE FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2021-01-30|2021-02-12|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|92d7a180-9353-41f8-93e2-ebcee32a1c63|8|EOSPSD|Pseudo-Eosinophils|HEMATOLOGY|[?]|10^8/L|[?]|[?]|TRACE|1|10^6 organisms/mL|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|LACTESCENT||OPTICAL MAPPING|GMI % FORMULA||Y|U||4|Visit_4|65|2|WASHOUT|2021-01-30|2021-02-13|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|92d7a180-9353-41f8-93e2-ebcee32a1c63|9|RPPAB|Ribosomal P Protein Antibody|URINALYSIS|[?]|ELISA unit/dose|[?]|[?]|POSITIVE|1|Arbitrary U|1|1|[?]|ABNORMAL|LAVAGE FLUID|SOLIDIFIED||SANGER SEQUENCING|HEPASCORE FORMULA|Y||N||5|Visit_5|90|4|FOLLOW-UP|2021-02-24|2021-03-04|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|92d7a180-9353-41f8-93e2-ebcee32a1c63|10|HEXK|Hexokinase|CHEMISTRY|[?]|in2|[?]|[?]|BORDERLINE|1|mL/cm|1|1|[?]|HIGH|STOOL|AUTOLYZED||BIOIMPEDANCE SPECTROSCOPY|FIBROMETER FORMULA|||U||5|Visit_5|90|7|SCREENING|2021-02-24|2021-03-02|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|5da18fbc-1274-4cb3-bb6b-b57872b9815b|1|RNPAB|Ribonucleoprotein Antibody|URINALYSIS|||[?]|[?]|INVALID|1|tuberculin unit/mL|1|1|[?]|LOW|CAPILLARY BLOOD|ICTERIC||PHYSICAL EXAMINATION|NASH FIBROSURE FORMULA|||NA|Y|1|Visit_1|10|7|TREATMENT|2020-10-17|2020-11-28|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|5da18fbc-1274-4cb3-bb6b-b57872b9815b|2|INTLK29|Interleukin 29|CHEMISTRY|[?]|U/10^12 RBC|[?]|[?]|NEGATIVE|1|mol/mL|1|1|[?]|NORMAL|SERUM|UNEXPECTED ODOR||RIA|MDRD FORMULA|||U||1|Visit_1|10|7|SCREENING|2020-10-17|2020-12-02|10|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|5da18fbc-1274-4cb3-bb6b-b57872b9815b|3|CONDUCTU|Urine Conductivity|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|BP|1|1|[?]|HIGH|PERITONEAL FLUID|CLOTTED||PET/MRI SCAN|NASH FIBROSURE FORMULA|Y||N|Y|2|Visit_2|25|7|SCREENING|2020-11-01|2020-12-19|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|5da18fbc-1274-4cb3-bb6b-b57872b9815b|4|OXACREAT|Oxalate/Creatinine|CHEMISTRY|[?]|uL/kg/day|[?]|[?]|BORDERLINE|1|RNA copies/mL|1|1|[?]|HIGH|LOCHIA|THAWED|N|AUDIOMETRY|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|3|FOLLOW-UP|2020-11-01|2020-12-15|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|5da18fbc-1274-4cb3-bb6b-b57872b9815b|5|GRANIMLE|Immature Granulocytes/Leukocytes|URINALYSIS|[?]|breaths/30s|[?]|[?]|BORDERLINE|1|ukat/L|1|1|[?]|LOW|PERSPIRATION|LACTESCENT||WHOLE EXOME SEQUENCING|GMI % FORMULA|||N||3|Visit_3|40|1|TREATMENT|2020-11-16|2020-12-31|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|5da18fbc-1274-4cb3-bb6b-b57872b9815b|6|URATECRT|Urate/Creatinine|HEMATOLOGY|[?]|BAU|[?]|[?]|INDETERMINATE|1|PNU/mL|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|N|ELECTROCHEMILUMINESCENCE|GMI % FORMULA|||Y||3|Visit_3|40|4|TREATMENT|2020-11-16|2020-12-10|40|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|5da18fbc-1274-4cb3-bb6b-b57872b9815b|7|FLUVOXAM|Fluvoxamine|URINALYSIS|[?]|U/mmol|[?]|[?]|POSITIVE|1|s/h|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|REFRIGERATED|N|NEXT GENERATION SEQUENCING|MDRD 4 VARIABLE FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-12-11|2020-12-28|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|5da18fbc-1274-4cb3-bb6b-b57872b9815b|8|MERCURY|Mercury|CHEMISTRY|[?]|bel|[?]|[?]|BORDERLINE|1|g/animal|1|1|[?]|HIGH|BLOOD|NON-HEMOLYZED|N|TOLUIDINE BLUE STAIN|MDRD FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2020-12-11|2021-01-14|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|5da18fbc-1274-4cb3-bb6b-b57872b9815b|9|NEUTIM|Immature Neutrophils|URINALYSIS|||[?]|[?]|INDETERMINATE|1|Hz|1|1|[?]|LOW|PLEURAL TISSUE|CALCIFIED||SXA SCAN|CKD-EPI CREATININE FORMULA|Y||NA|Y|5|Visit_5|90|5|FOLLOW-UP|2021-01-05|2021-01-12|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|5da18fbc-1274-4cb3-bb6b-b57872b9815b|10|C165887|EnglishPlantain Pollen IgE AB RAST Score|CHEMISTRY|[?]|log10 PFU/mL|[?]|[?]|TRACE|1|DAgU|1|1|[?]|NORMAL|CORD SERUM|FROZEN||MAGNETIC RESONANCE ANGIOGRAPHY|HEPASCORE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2021-01-05|2021-01-11|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|1|C147278|Glycine max Antigen IgE Antibody|HEMATOLOGY|[?]|mg/g/h|[?]|[?]|BORDERLINE|1|cL|1|1|[?]|ABNORMAL|LYMPH|HEMOLYZED||AUTOREFRACTION|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|2|SCREENING|2020-11-21|2020-12-27|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|2|AMYLOIDB|Amyloid, Beta|CHEMISTRY|[?]|mg/L|[?]|[?]|INVALID|1|Shock Wave|1|1|[?]|LOW|SWABBED MATERIAL|UNEXPECTED ODOR||LISSAMINE GREEN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|5|SCREENING|2020-11-21|2021-02-08|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|3|SAHOMC|S-Adenosylhomocysteine|CHEMISTRY|[?]|breaths/30s|[?]|[?]|POSITIVE|1|10^6 organisms/mg|1|1|[?]|ABNORMAL|NAIL|THAWED|N|HPLC/MS|NASH FIBROSURE FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-12-06|2020-12-19|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|4|GALM|Galactose Mutarotase|HEMATOLOGY|[?]|U/m2/h|[?]|[?]|INVALID|1|deg|1|1|[?]|LOW|GASTRIC FLUID|PARAFFIN-EMBEDDED||GC/MS-CI|ASH FIBROSURE FORMULA|Y||N||2|Visit_2|25|3|SCREENING|2020-12-06|2020-12-18|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|5|CYSULFA|Sulfa Crystals|URINALYSIS|||[?]|[?]|INDETERMINATE|1|SBE/mL|1|1|[?]|LOW|SERUM|GELLED||DIFFUSION TENSOR MRI|GMI MMOL/MOL FORMULA|||Y|Y|3|Visit_3|40|2|FOLLOW-UP|2020-12-21|2021-01-08|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|6|RETILRTC|Low Absorption Retic/Reticulocytes|CHEMISTRY|[?]|GPS U|[?]|[?]|TRACE|1|psec|1|1|[?]|NORMAL|URINE|CONTAMINATED||X-RAY|FIBROMETER FORMULA|Y||U||3|Visit_3|40|5|TREATMENT|2020-12-21|2021-01-30|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|7|B2MICG|Beta-2 Microglobulin|CHEMISTRY|[?]|mL/m2/min|[?]|[?]|INDETERMINATE|1|g/U|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|AUTOLYZED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||4|Visit_4|65|4|TREATMENT|2021-01-15|2021-02-11|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|8|HYDCDN|Hydrocodone|CHEMISTRY|||[?]|[?]|TRACE|1|ppm|1|1|[?]|ABNORMAL|PERSPIRATION|CONTAMINATED|N|BIOPSY|GMI MMOL/MOL FORMULA|||U|Y|4|Visit_4|65|6|SCREENING|2021-01-15|2021-02-07|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|9|BASOBLE|Basophils Band Form/Leukocytes|URINALYSIS|||[?]|[?]|NEGATIVE|1|L/h/m2|1|1|[?]|LOW|TISSUE|CONCENTRATED||TRANSVAGINAL ULTRASOUND|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|5|Visit_5|90|3|TREATMENT|2021-02-09|2021-02-11|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|10|CCR5|C-C Chemokine Receptor Type 5|HEMATOLOGY|[?]|uU/L|[?]|[?]|POSITIVE|1|mol|1|1|[?]|HIGH|BONE MARROW|CONCENTRATED||ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD ENZYMATIC FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2021-02-09|2021-02-14|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|4a195822-d646-4b22-a3b9-f6642442474d|1|CXCL3|Chemokine (C-X-C Motif) Ligand 3|URINALYSIS|||[?]|[?]|NEGATIVE|1|BOTTLE|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|SOLIDIFIED|N|HIGH LEVEL AMINOGLYCOSIDE SCREEN|COCKCROFT-GAULT FORMULA|||U|Y|1|Visit_1|10|5|FOLLOW-UP|2020-07-25|2020-09-05|10|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|4a195822-d646-4b22-a3b9-f6642442474d|2|LGLUCLE|Large Unstained Cells/Leukocytes|CHEMISTRY|[?]|pmol/L/h|[?]|[?]|NEGATIVE|1|Rad|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|AGGLUTINATED|N|SEQUENCING|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|1|FOLLOW-UP|2020-07-25|2020-10-19|10|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|4a195822-d646-4b22-a3b9-f6642442474d|3|LKM1IGAB|Liver Kidney Microsomal Type 1 IgG Ab|CHEMISTRY|[?]|U/mL|[?]|[?]|INDETERMINATE|1|mL/beat|1|1|[?]|NORMAL|VENOUS BLOOD|CONTAMINATED||JAEGER EYE CHART|FIBROMETER FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-08-09|2020-09-12|25|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|4a195822-d646-4b22-a3b9-f6642442474d|4|LVFBRSC|Liver Fibrosis Score|URINALYSIS|||[?]|[?]|INVALID|1|VIRTUAL PIXEL|1|1|[?]|HIGH|PLATELET POOR PLASMA|HEMOLYZED|N|QUANTITATIVE ULTRASOUND|MDRD FORMULA|||N|Y|2|Visit_2|25|7|TREATMENT|2020-08-09|2020-08-29|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|4a195822-d646-4b22-a3b9-f6642442474d|5|LYMCE|Lymphocytes/Total Cells|HEMATOLOGY|[?]|DPM|[?]|[?]|NEGATIVE|1|mL/kg|1|1|[?]|HIGH|EPIDERMAL TISSUE|ICTERIC|N|EPSILOMETER|MDRD FORMULA|Y||N||3|Visit_3|40|7|WASHOUT|2020-08-24|2020-09-27|40|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|4a195822-d646-4b22-a3b9-f6642442474d|6|SMUSCAB|Smooth Muscle Antibody|HEMATOLOGY|[?]|in2|[?]|[?]|POSITIVE|1|CFU/g|1|1|[?]|ABNORMAL|DIALYSIS FLUID, PERITONEAL|REFRIGERATED|N|HPLC-FL|GMI % FORMULA|||N||3|Visit_3|40|1|TREATMENT|2020-08-24|2020-10-19|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|4a195822-d646-4b22-a3b9-f6642442474d|7|PROTCRT|Protein/Creatinine|CHEMISTRY|[?]|U/mL|[?]|[?]|POSITIVE|1|mg/kg/week|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|CALCIFIED||OPTICAL DENSITY MEASUREMENT|ASH FIBROSURE FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-09-18|2020-10-09|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|4a195822-d646-4b22-a3b9-f6642442474d|8|GLUTAM|Glutamate|HEMATOLOGY|[?]|mL/m2/day|[?]|[?]|INVALID|1|ug/animal|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|LACTESCENT||FLUORESCENT SPOT TEST|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|3|FOLLOW-UP|2020-09-18|2020-10-21|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|4a195822-d646-4b22-a3b9-f6642442474d|9|VTD2D3IT|25-Hydroxyvit D2 + 25-Hydroxyvit D3|HEMATOLOGY|[?]|FINGERTIP UNIT|[?]|[?]|POSITIVE|1|10^5/hpf|1|1|[?]|NORMAL|CORD BLOOD|ICTERIC|N|OPTICAL COHERENCE TOMOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||5|Visit_5|90|2|TREATMENT|2020-10-13|2020-10-15|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|4a195822-d646-4b22-a3b9-f6642442474d|10|APOBAPA1|Apolipoprotein B/Apolipoprotein A1|URINALYSIS|[?]|PFU/mL|[?]|[?]|INDETERMINATE|1|IU/g|1|1|[?]|HIGH|SERUM|GELLED||FREEZING POINT DEPRESSION|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||5|Visit_5|90|2|TREATMENT|2020-10-13|2020-10-15|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|515808c1-fda7-43bb-91dc-28e2d4e308cd|1|INTLK32|Interleukin 32|HEMATOLOGY|[?]|10^12 IU/L|[?]|[?]|BORDERLINE|1|/sec|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|AUTOLYZED||REBOUND TONOMETRY|MDRD 5 VARIABLE FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-09-07|2020-10-10|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|515808c1-fda7-43bb-91dc-28e2d4e308cd|2|MCSF|Macrophage Colony Stimulating Factor|HEMATOLOGY|[?]|BEAM BREAKS|[?]|[?]|BORDERLINE|1|grain|1|1|[?]|LOW|CORD BLOOD|FROZEN||COMPLEMENT FIXATION|CKD-EPI CREATININE FORMULA|Y||Y||1|Visit_1|10|2|FOLLOW-UP|2020-09-07|2020-11-06|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|515808c1-fda7-43bb-91dc-28e2d4e308cd|3|CL|Chloride|HEMATOLOGY|[?]|Gy|[?]|[?]|POSITIVE|1|mL/cm|1|1|[?]|NORMAL|VITREOUS HUMOR|CONTAMINATED||POPULATION SEQUENCING|FIBROTEST FORMULA|||U||2|Visit_2|25|4|FOLLOW-UP|2020-09-22|2020-10-06|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|515808c1-fda7-43bb-91dc-28e2d4e308cd|4|GFR|Glomerular Filtration Rate|CHEMISTRY|[?]|CCID 50/dose|[?]|[?]|INVALID|1|mEq/mL|1|1|[?]|NORMAL|CALCULUS|HEMOLYZED|N|ELECTROPHORESIS|HEPASCORE FORMULA||Y|N||2|Visit_2|25|4|FOLLOW-UP|2020-09-22|2020-10-26|25|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|515808c1-fda7-43bb-91dc-28e2d4e308cd|5|C130117|Bee Mix Antigen IgG Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|PFU/dose|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|GELLED||WHOLE EXOME SEQUENCING|MDRD 6 VARIABLE FORMULA||Y|N|Y|3|Visit_3|40|5|FOLLOW-UP|2020-10-07|2020-11-26|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|515808c1-fda7-43bb-91dc-28e2d4e308cd|6|IFI44|Interferon-Induced Protein 44|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|GBq/g|1|1|[?]|NORMAL|SALIVA|ICTERIC|N|CT SCAN|CKD-EPI FORMULA|||N|Y|3|Visit_3|40|7|TREATMENT|2020-10-07|2020-10-22|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|515808c1-fda7-43bb-91dc-28e2d4e308cd|7|PLAGMCVT|Platelet Aggregation Mean Curve Type|HEMATOLOGY|[?]|mm|[?]|[?]|TRACE|1|U/mL|1|1|[?]|NORMAL|BONE MARROW|ROOM TEMPERATURE||ENDOSCOPY|CKD-EPI CREATININE FORMULA||Y|U||4|Visit_4|65|5|WASHOUT|2020-11-01|2020-11-07|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|515808c1-fda7-43bb-91dc-28e2d4e308cd|8|MONOIM|Immature Monocytes|HEMATOLOGY|[?]|/40 HPFs|[?]|[?]|POSITIVE|1|nmol/L/h|1|1|[?]|LOW|EMESIS|SOLIDIFIED||HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|4|FOLLOW-UP|2020-11-01|2020-12-02|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|515808c1-fda7-43bb-91dc-28e2d4e308cd|9|PNTBRBTL|Pentobarbital|CHEMISTRY|||[?]|[?]|POSITIVE|1|ug/kg/h|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|UNEXPECTED ODOR||SPECT SCAN|FIBROSIS 4 FORMULA||Y|NA|Y|5|Visit_5|90|6|TREATMENT|2020-11-26|2020-12-01|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|LB|515808c1-fda7-43bb-91dc-28e2d4e308cd|10|CD45LY|CD45/Lymphocytes|URINALYSIS|||[?]|[?]|TRACE|1|amu|1|1|[?]|ABNORMAL|BONE MARROW|THAWED|N|GRADIENT DIFFUSION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|5|Visit_5|90|2|FOLLOW-UP|2020-11-26|2020-12-01|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|LB|18461665-388d-403b-90e4-2b42fcb4a01a|1|STAT3P|Phosphorylated STAT3|HEMATOLOGY|[?]|gMFI|[?]|[?]|TRACE|1|TRACE|1|1|[?]|LOW|LEUKOCYTE|CONTAMINATED|N|ISHIHARA COLOR PLATES|FIBROMETER FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-10-03|2020-11-23|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|18461665-388d-403b-90e4-2b42fcb4a01a|2|C130095|Western Ragweed Pollen IgG4|HEMATOLOGY|[?]|umol/L/min|[?]|[?]|INDETERMINATE|1|nmol/mol|1|1|[?]|HIGH|ADIPOSE TISSUE|DRIED||WRIGHT-GIEMSA STAIN|MDRD ENZYMATIC FORMULA|||NA||1|Visit_1|10|2|SCREENING|2020-10-03|2020-12-18|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|18461665-388d-403b-90e4-2b42fcb4a01a|3|VTRNCTN|Vitronectin|URINALYSIS|[?]|mg/m2/min|[?]|[?]|BORDERLINE|1|/2000 RBC|1|1|[?]|HIGH|FLUID|DRIED||SIZE EXCLUSION CHROMATOGRAPHY|GMI MMOL/MOL FORMULA|Y||NA||2|Visit_2|25|6|TREATMENT|2020-10-18|2020-11-08|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|18461665-388d-403b-90e4-2b42fcb4a01a|4|FPP|Protoporphyrin, Free|CHEMISTRY|||[?]|[?]|INVALID|1|LB|1|1|[?]|NORMAL|STOOL|FROZEN||ELECTROMYOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||N|Y|2|Visit_2|25|2|SCREENING|2020-10-18|2020-11-12|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|18461665-388d-403b-90e4-2b42fcb4a01a|5|ILE|Isoleucine|URINALYSIS|[?]|Hz/s|[?]|[?]|BORDERLINE|1|cm/s|1|1|[?]|LOW|DERMAL TISSUE|CONCENTRATED|N|DROPLET DIGITAL PCR|FIBROSIS 4 FORMULA|Y||NA||3|Visit_3|40|4|TREATMENT|2020-11-02|2020-12-24|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|18461665-388d-403b-90e4-2b42fcb4a01a|6|FATACVLC|Fatty Acids, Very Long Chain|CHEMISTRY|[?]|%|[?]|[?]|POSITIVE|1|MBq/uL|1|1|[?]|LOW|BILE|LIPEMIC||IMPULSE OSCILLOMETRY|CKD-EPI CYSTATIN C FORMULA|Y||N||3|Visit_3|40|1|WASHOUT|2020-11-02|2020-11-26|40|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|18461665-388d-403b-90e4-2b42fcb4a01a|7|CXCL13|Chemokine (C-X-C Motif) Ligand 13|HEMATOLOGY|[?]|mAmp|[?]|[?]|INDETERMINATE|1|mg/min|1|1|[?]|HIGH|MECONIUM|CONCENTRATED|N|CONTRAST ENHANCED SPIRAL CT SCAN|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2020-11-27|2020-12-20|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|18461665-388d-403b-90e4-2b42fcb4a01a|8|PROLYMLY|Prolymphocytes/Lymphocytes|CHEMISTRY|[?]|ug/kg|[?]|[?]|INVALID|1|g/mol|1|1|[?]|LOW|BLOOD|SOLIDIFIED||CORONARY ANGIOGRAPHY|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|1|FOLLOW-UP|2020-11-27|2020-12-23|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|18461665-388d-403b-90e4-2b42fcb4a01a|9|RESISTIN|Resistin|CHEMISTRY|[?]|kg/cm2|[?]|[?]|BORDERLINE|1|mL/animal|1|1|[?]|NORMAL|RETICULOCYTES|FROZEN|N|DROPLET DIGITAL PCR|COCKCROFT-GAULT FORMULA|Y||Y||5|Visit_5|90|4|TREATMENT|2020-12-22|2020-12-28|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|18461665-388d-403b-90e4-2b42fcb4a01a|10|CTXI|Type I Collagen C-Telopeptides|HEMATOLOGY|[?]|ug/m2|[?]|[?]|INDETERMINATE|1|L/s|1|1|[?]|NORMAL|LYMPH|AGGLUTINATED||OBSERVATION|MDRD 4 VARIABLE FORMULA||Y|NA||5|Visit_5|90|7|TREATMENT|2020-12-22|2020-12-23|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|1|DCCARNIT|Decanoylcarnitine|CHEMISTRY|[?]|in2|[?]|[?]|POSITIVE|1|cd*s/m2|1|1|[?]|LOW|SEMEN|AUTOLYZED||FISH|MDRD 6 VARIABLE FORMULA||Y|N||1|Visit_1|10|5|TREATMENT|2020-08-14|2020-11-07|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|2|RPTLTIME|Reptilase Time|URINALYSIS|[?]|mg/g/h|[?]|[?]|INVALID|1|log10 PFU|1|1|[?]|NORMAL|LYSATE|AUTOLYZED|N|IMPEDANCE CONDUCTIVITY|GMI MMOL/MOL FORMULA|Y||U||1|Visit_1|10|5|TREATMENT|2020-08-14|2020-10-01|10|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|3|GLOBGPT|Gamma Globulin/Total Protein|HEMATOLOGY|[?]|BAG|[?]|[?]|INVALID|1|g/mol|1|1|[?]|ABNORMAL|BLOOD|GELLED||CONTRAST ENHANCED PET/CT SCAN|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|2|WASHOUT|2020-08-29|2020-09-19|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|4|CHLMCRNT|Chylomicron Triglyceride|HEMATOLOGY|[?]|C|[?]|[?]|BORDERLINE|1|BU/mL|1|1|[?]|HIGH|ERYTHROCYTES|DRIED||FLUORIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||2|Visit_2|25|3|WASHOUT|2020-08-29|2020-09-17|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|5|TIMP1|Tissue Inhibitor of Metalloproteinase 1|CHEMISTRY|[?]|MBP|[?]|[?]|POSITIVE|1|ng/mol|1|1|[?]|NORMAL|CALCULUS|SOLIDIFIED||PET/MRI SCAN|CKD-EPI CYSTATIN C FORMULA||Y|N||3|Visit_3|40|4|FOLLOW-UP|2020-09-13|2020-11-03|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|6|UBQN|Ubiquitin Protein|HEMATOLOGY|[?]|Enzyme U/g Hb|[?]|[?]|INVALID|1|cm|1|1|[?]|LOW|VENOUS CORD BLOOD|LACTESCENT||IMMUNOCHROMATOGRAPHY|COCKCROFT-GAULT FORMULA|Y|Y|NA||3|Visit_3|40|5|SCREENING|2020-09-13|2020-09-15|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|7|ANISO|Anisocytes|CHEMISTRY|||[?]|[?]|NEGATIVE|1|cm|1|1|[?]|HIGH|LEUKOCYTE|CONTAMINATED||WHOLE TRANSCRIPTOME SEQUENCING|GMI % FORMULA|||Y|Y|4|Visit_4|65|4|TREATMENT|2020-10-08|2020-10-21|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|8|T3|Triiodothyronine|URINALYSIS|[?]|nmol BCE/mmol|[?]|[?]|INDETERMINATE|1|umol/mol|1|1|[?]|HIGH|EMOTIONAL TEAR|GELLED|N|CHROMATOGRAPHY|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-10-08|2020-11-05|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|9|C130141|German Cockroach Antigen IgA Antibody|HEMATOLOGY|[?]|ka_u/dL|[?]|[?]|INVALID|1|FEU|1|1|[?]|LOW|BONE|UNEXPECTED ODOR||TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD ENZYMATIC JAPANESE FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2020-11-02|2020-11-05|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|LB|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|10|IGHG4|Immunoglobulin Heavy Constant Gamma 4|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|kg/m2|1|1|[?]|NORMAL|BREAST MILK|GELLED||LASER CAPTURE MICRODISSECTION|COCKCROFT-GAULT FORMULA|||U|Y|5|Visit_5|90|1|TREATMENT|2020-11-02|2020-11-10|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|LB|e3ce1661-1b72-4835-88d1-5a6d3655b674|1|EPO|Erythropoietin|CHEMISTRY|[?]|Ci|[?]|[?]|NEGATIVE|1|uL/kg/day|1|1|[?]|ABNORMAL|SALIVA|AUTOLYZED|N|DOUBLE IMMUNODIFFUSION|CKD-EPI FORMULA|||U||1|Visit_1|10|4|FOLLOW-UP|2020-08-12|2020-10-13|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|e3ce1661-1b72-4835-88d1-5a6d3655b674|2|LTD4|Leukotriene D4|HEMATOLOGY|[?]|L/kg|[?]|[?]|NEGATIVE|1|g/cage|1|1|[?]|ABNORMAL|PUS|THAWED||PET/CT SCAN WITHOUT CONTRAST|GMI MMOL/MOL FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-08-12|2020-09-25|10|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|e3ce1661-1b72-4835-88d1-5a6d3655b674|3|C130094|Western Ragweed Pollen IgG|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Hz|1|1|[?]|ABNORMAL|SPERMATOZOON|GELLED||DOPPLER ULTRASOUND|CKD-EPI CREATININE FORMULA|Y|Y|U|Y|2|Visit_2|25|5|TREATMENT|2020-08-27|2020-09-05|25|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|e3ce1661-1b72-4835-88d1-5a6d3655b674|4|XNTHCHR|Xanthochromia|CHEMISTRY|[?]|s^-1(%O2)^-1|[?]|[?]|INVALID|1|PIXEL|1|1|[?]|HIGH|PLATELET|NON-HEMOLYZED||FLUORESCEIN STAIN|GMI MMOL/MOL FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2020-08-27|2020-10-10|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|e3ce1661-1b72-4835-88d1-5a6d3655b674|5|NICOTINE|Nicotine|CHEMISTRY|[?]|mmol/day|[?]|[?]|TRACE|1|CUP|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|AGGLUTINATED|N|DC SHEATH FLOW|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||3|Visit_3|40|2|TREATMENT|2020-09-11|2020-10-24|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|e3ce1661-1b72-4835-88d1-5a6d3655b674|6|OVALCY|Ovalocytes|CHEMISTRY|[?]|mg/g/min|[?]|[?]|INVALID|1|mCi|1|1|[?]|NORMAL|PLASMA|FRESH||TRANSCRIPTION-MEDIATED AMPLIFICATION|ASH FIBROSURE FORMULA|||NA||3|Visit_3|40|2|SCREENING|2020-09-11|2020-10-12|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|e3ce1661-1b72-4835-88d1-5a6d3655b674|7|MERCECE|Maturing Erythroid Cells/Total Cells|CHEMISTRY|[?]|VIAL|[?]|[?]|INDETERMINATE|1|days/wk|1|1|[?]|HIGH|SALIVA|LACTESCENT||TARGETED TRANSCRIPTOME SEQUENCING|FIBROMETER FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-10-06|2020-11-05|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|e3ce1661-1b72-4835-88d1-5a6d3655b674|8|IGGALB|Immunoglobulin G/Albumin|CHEMISTRY|[?]|cd*s/m2|[?]|[?]|NEGATIVE|1|Torr|1|1|[?]|NORMAL|SWABBED MATERIAL|PARAFFIN-EMBEDDED|N|CONTRAST ENHANCED PET/CT SCAN|MDRD 5 VARIABLE FORMULA|Y|Y|N||4|Visit_4|65|3|FOLLOW-UP|2020-10-06|2020-11-03|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|e3ce1661-1b72-4835-88d1-5a6d3655b674|9|SRTONIN|Serotonin|CHEMISTRY|||[?]|[?]|TRACE|1|CFU/mL|1|1|[?]|LOW|BASAL TEAR|REFRIGERATED|N|KARYOTYPING|FIBROMETER FORMULA|||NA|Y|5|Visit_5|90|1|TREATMENT|2020-10-31|2020-11-07|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|e3ce1661-1b72-4835-88d1-5a6d3655b674|10|APROTCRS|Activated Protein C Resistance|CHEMISTRY|||[?]|[?]|INVALID|1|Enzyme U|1|1|[?]|HIGH|VENOUS CORD BLOOD|CALCIFIED||CLIP|MDRD 5 VARIABLE FORMULA||Y|N|Y|5|Visit_5|90|7|WASHOUT|2020-10-31|2020-11-04|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|240844e9-3dda-438e-81b2-8f6aa4e0427e|1|EOSIM|Immature Eosinophils|URINALYSIS|[?]|PFU/animal|[?]|[?]|NEGATIVE|1|breaths/min|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|FRESH||FLOW CYTOMETRY|CKD-EPI CREATININE FORMULA|||N||1|Visit_1|10|7|SCREENING|2020-12-09|2020-12-28|10|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|240844e9-3dda-438e-81b2-8f6aa4e0427e|2|CARTP|Cocaine Amphetamine-Reg Transcript Prot|HEMATOLOGY|[?]|mL/cage/wk|[?]|[?]|INVALID|1|IU|1|1|[?]|NORMAL|LEUKOCYTE|AUTOLYZED|N|KNEMOMETRY|MDRD 4 VARIABLE FORMULA|||N||1|Visit_1|10|1|WASHOUT|2020-12-09|2021-02-13|10|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|240844e9-3dda-438e-81b2-8f6aa4e0427e|3|CITRATE|Citrate|HEMATOLOGY|[?]|mmol/day|[?]|[?]|POSITIVE|1|ug/m2/min|1|1|[?]|LOW|EXUDATE|CALCIFIED||TURBIDIMETRY|GMI MMOL/MOL FORMULA|Y||N||2|Visit_2|25|1|SCREENING|2020-12-24|2021-01-31|25|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|240844e9-3dda-438e-81b2-8f6aa4e0427e|4|CFA|Coefficient of Fat Absorption|URINALYSIS|[?]|mmol/kg|[?]|[?]|POSITIVE|1|RING|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|THAWED||SPECT SCAN|CKD-EPI FORMULA|||Y||2|Visit_2|25|3|FOLLOW-UP|2020-12-24|2020-12-29|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|240844e9-3dda-438e-81b2-8f6aa4e0427e|5|HGBS|Hemoglobin S|URINALYSIS|[?]|mV2/Hz|[?]|[?]|TRACE|1|10^3 CFU|1|1|[?]|NORMAL|URINE SEDIMENT|UNEXPECTED ODOR||LINE PROBE ASSAY|MDRD 4 VARIABLE FORMULA|Y|Y|N||3|Visit_3|40|4|TREATMENT|2021-01-08|2021-02-19|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|240844e9-3dda-438e-81b2-8f6aa4e0427e|6|VLDLTCT|VLDL Triglyceride + Chylomicron Triglyceride|HEMATOLOGY|[?]|mmol/min/kPa|[?]|[?]|NEGATIVE|1|100 IU/mL|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED||MICROBIAL BIOCHEMICAL IDENTIFICATION|FIBROMETER FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2021-01-08|2021-01-27|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|240844e9-3dda-438e-81b2-8f6aa4e0427e|7|CLARITY|Clarity|CHEMISTRY|[?]|mg/m2/day|[?]|[?]|INDETERMINATE|1|mmol/kg|1|1|[?]|HIGH|ERYTHROCYTES|FRESH||RYAN BLUE STAIN|FIBROSIS 4 FORMULA||Y|NA||4|Visit_4|65|4|TREATMENT|2021-02-02|2021-02-06|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|240844e9-3dda-438e-81b2-8f6aa4e0427e|8|LCN2|Lipocalin-2|URINALYSIS|[?]|fmol/L/sec|[?]|[?]|TRACE|1|cy/cm|1|1|[?]|NORMAL|AMNIOTIC FLUID|CONCENTRATED|N|RIA|FIBROMETER FORMULA|||Y||4|Visit_4|65|5|SCREENING|2021-02-02|2021-02-05|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|240844e9-3dda-438e-81b2-8f6aa4e0427e|9|MYCY|Myelocytes|CHEMISTRY|||[?]|[?]|BORDERLINE|1|/LPF|1|1|[?]|LOW|VENOUS CORD BLOOD|FRESH||DARK FIELD MICROSCOPY|MDRD 5 VARIABLE FORMULA||Y|N|Y|5|Visit_5|90|2|TREATMENT|2021-02-27|2021-03-04|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|240844e9-3dda-438e-81b2-8f6aa4e0427e|10|FCTVIIIA|Factor VIII Activity|HEMATOLOGY|[?]|log10 TCID 50/mL|[?]|[?]|POSITIVE|1|mol/mol|1|1|[?]|LOW|BLOOD|GELLED|N|GC/MS/MS|ASH FIBROSURE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2021-02-27|2021-03-01|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|fccf5c5d-deb6-4f13-a485-afcda3556578|1|IL6SR|Soluble Interleukin 6 Receptor|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mL/breath|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|ICTERIC||PELLI-ROBSON EYE CHART|MDRD 4 VARIABLE FORMULA|||U|Y|1|Visit_1|10|4|FOLLOW-UP|2020-08-04|2020-10-17|10|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|fccf5c5d-deb6-4f13-a485-afcda3556578|2|EUDCA|Epimerized Ursodeoxycholate|URINALYSIS|[?]|mmol/kg|[?]|[?]|BORDERLINE|1|g/day|1|1|[?]|ABNORMAL|URINE|DRIED|N|RYAN BLUE STAIN|FIBROSIS 4 FORMULA|Y||NA||1|Visit_1|10|7|WASHOUT|2020-08-04|2020-09-19|10|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|fccf5c5d-deb6-4f13-a485-afcda3556578|3|LY6E|Lymphocyte Antigen 6E|CHEMISTRY|||[?]|[?]|POSITIVE|1|nL|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|ROOM TEMPERATURE||MALDI|MDRD 4 VARIABLE FORMULA|||NA|Y|2|Visit_2|25|5|TREATMENT|2020-08-19|2020-10-05|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|fccf5c5d-deb6-4f13-a485-afcda3556578|4|MMIF|Macrophage Migration Inhibitory Factor|HEMATOLOGY|[?]|fmol/g|[?]|[?]|INDETERMINATE|1|Ci|1|1|[?]|NORMAL|TUMOR TISSUE|HEMOLYZED||ETDRS EYE CHART|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|5|TREATMENT|2020-08-19|2020-09-21|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|fccf5c5d-deb6-4f13-a485-afcda3556578|5|NEUTGT|Giant Neutrophils|URINALYSIS|[?]|Ci|[?]|[?]|BORDERLINE|1|Coulomb|1|1|[?]|HIGH|URINE SEDIMENT|AGGLUTINATED||EPSILOMETER|CKD-EPI FORMULA|Y||NA||3|Visit_3|40|2|WASHOUT|2020-09-03|2020-09-13|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|fccf5c5d-deb6-4f13-a485-afcda3556578|6|C130108|Weed Mix Pollen Antigen IgA Antibody|URINALYSIS|[?]|kg|[?]|[?]|INVALID|1|10^6 IU|1|1|[?]|NORMAL|RETICULOCYTES|LIPEMIC||DUCTOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-09-03|2020-09-14|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|fccf5c5d-deb6-4f13-a485-afcda3556578|7|CD45LY|CD45/Lymphocytes|URINALYSIS|||[?]|[?]|BORDERLINE|1|STEPS|1|1|[?]|ABNORMAL|BLOOD|REFRIGERATED||FLUORESCENCE ANGIOGRAPHY|MDRD FORMULA||Y|Y|Y|4|Visit_4|65|5|TREATMENT|2020-09-28|2020-10-29|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|fccf5c5d-deb6-4f13-a485-afcda3556578|8|SEDEXAM|Sediment Examination|CHEMISTRY|[?]|10^9/L|[?]|[?]|INDETERMINATE|1|L/h/m2|1|1|[?]|NORMAL|GASTRIC FLUID|ICTERIC||TRICHROME STAIN|CKD-EPI CREATININE FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-09-28|2020-10-24|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|fccf5c5d-deb6-4f13-a485-afcda3556578|9|NAGASEXR|NAGASE Excretion Rate|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Bq/g|1|1|[?]|NORMAL|SOFT TISSUE|SOLIDIFIED|N|GC/MS/MS|NASH FIBROSURE FORMULA|||Y|Y|5|Visit_5|90|5|WASHOUT|2020-10-23|2020-10-31|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|fccf5c5d-deb6-4f13-a485-afcda3556578|10|PTA|Prothrombin Activity|CHEMISTRY|[?]|/10^4|[?]|[?]|TRACE|1|HEP|1|1|[?]|LOW|URINE SEDIMENT|NON-HEMOLYZED|N|ULTRASOUND|GMI % FORMULA|Y||U||5|Visit_5|90|4|SCREENING|2020-10-23|2020-11-01|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|94620ed0-1ae8-4fa5-a629-9210860b0be9|1|CCL18|Chemokine (C-C Motif) Ligand 18|URINALYSIS|[?]|10^6 CFU|[?]|[?]|BORDERLINE|1|mm/sec|1|1|[?]|ABNORMAL|SKIN TISSUE|CONCENTRATED|N|FLUOROSCOPY|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|1|WASHOUT|2020-08-04|2020-10-15|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|94620ed0-1ae8-4fa5-a629-9210860b0be9|2|SMUSCAB|Smooth Muscle Antibody|HEMATOLOGY|[?]|kUSP|[?]|[?]|POSITIVE|1|ug/m2/day|1|1|[?]|LOW|BILE|LACTESCENT|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|4|WASHOUT|2020-08-04|2020-10-29|10|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|94620ed0-1ae8-4fa5-a629-9210860b0be9|3|MCH|Ery. Mean Corpuscular Hemoglobin|HEMATOLOGY|[?]|bel|[?]|[?]|NEGATIVE|1|nmol/g|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|SOLIDIFIED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|FIBROSIS 4 FORMULA|||Y||2|Visit_2|25|7|SCREENING|2020-08-19|2020-10-08|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|94620ed0-1ae8-4fa5-a629-9210860b0be9|4|FATBODOV|Fat Bodies, Oval|HEMATOLOGY|[?]|JDF Unit|[?]|[?]|POSITIVE|1|TABLET|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|DRIED|N|PHASE-CONTRAST MRI|MDRD ENZYMATIC FORMULA|Y|Y|N||2|Visit_2|25|1|FOLLOW-UP|2020-08-19|2020-08-25|25|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|94620ed0-1ae8-4fa5-a629-9210860b0be9|5|BGTCPHRL|Beta+Gamma Tocopherol|URINALYSIS|[?]|mol/mol|[?]|[?]|INDETERMINATE|1|dpm/0.5 mL|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED||NEURAMINIDASE INHIBITION ASSAY|FIBROMETER FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-09-03|2020-10-06|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|LB|94620ed0-1ae8-4fa5-a629-9210860b0be9|6|NORMEEXR|Normetanephrine Excretion Rate|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|U/L|1|1|[?]|NORMAL|SERUM OR PLASMA|PARAFFIN-EMBEDDED||FREEZING POINT DEPRESSION|MDRD ENZYMATIC FORMULA|Y|Y|Y|Y|3|Visit_3|40|7|TREATMENT|2020-09-03|2020-09-28|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|LB|94620ed0-1ae8-4fa5-a629-9210860b0be9|7|CTXICRT|Type I Collagen C-Telopeptides/Creat|CHEMISTRY|[?]|10^5/hpf|[?]|[?]|BORDERLINE|1|kN/cm2|1|1|[?]|LOW|ADIPOSE TISSUE|AGGLUTINATED||FLUORESCEIN STAIN|MDRD 6 VARIABLE FORMULA||Y|Y||4|Visit_4|65|5|TREATMENT|2020-09-28|2020-10-11|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|94620ed0-1ae8-4fa5-a629-9210860b0be9|8|LYMIMLE|Immature Lymphocytes/Leukocytes|URINALYSIS|||[?]|[?]|BORDERLINE|1|10^6 IU/mL|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED||ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI FORMULA|Y||Y|Y|4|Visit_4|65|1|FOLLOW-UP|2020-09-28|2020-10-07|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|94620ed0-1ae8-4fa5-a629-9210860b0be9|9|MYCYCE|Myelocytes/Total Cells|CHEMISTRY|||[?]|[?]|BORDERLINE|1|10^3 organisms/mL|1|1|[?]|HIGH|CERUMEN|LACTESCENT||HIGH RESOLUTION MELT ANALYSIS|FIBROSIS 4 FORMULA|||U|Y|5|Visit_5|90|4|TREATMENT|2020-10-23|2020-10-28|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|94620ed0-1ae8-4fa5-a629-9210860b0be9|10|C165890|Timothy Grass Pollen IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|INVALID|1|g/dL|1|1|[?]|NORMAL|LEUKOCYTE|FROZEN||PERIODIC ACID SCHIFF STAIN|CKD-EPI FORMULA|Y||NA|Y|5|Visit_5|90|3|WASHOUT|2020-10-23|2020-10-27|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|9c3b6912-19be-435c-87fc-781a08efb847|1|LYMPLLE|Plasmacytoid Lymphocytes/Leukocytes|HEMATOLOGY|[?]|BOX|[?]|[?]|BORDERLINE|1|ELISA unit|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|CONCENTRATED||SANGER SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|Y||1|Visit_1|10|5|WASHOUT|2021-01-22|2021-04-10|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|9c3b6912-19be-435c-87fc-781a08efb847|2|FLUIDOUT|Fluid Output|HEMATOLOGY|[?]|/4.0 mL|[?]|[?]|NEGATIVE|1|U/m2/h|1|1|[?]|ABNORMAL|BASAL TEAR|FROZEN|N|SPECT SCAN|MDRD 6 VARIABLE FORMULA|Y||Y||1|Visit_1|10|2|WASHOUT|2021-01-22|2021-02-11|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|9c3b6912-19be-435c-87fc-781a08efb847|3|AFP|Alpha Fetoprotein|URINALYSIS|[?]|mL/kg|[?]|[?]|NEGATIVE|1|log10 TCID 50/mL|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|HEMOLYZED||MIGET|CKD-EPI FORMULA||Y|Y||2|Visit_2|25|1|WASHOUT|2021-02-06|2021-02-07|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-16
e|LB|9c3b6912-19be-435c-87fc-781a08efb847|4|NEUTB|Neutrophils Band Form|HEMATOLOGY|[?]|10^9/g|[?]|[?]|POSITIVE|1|IU/L|1|1|[?]|HIGH|SYNOVIAL FLUID|AGGLUTINATED||PET SCAN|HEPASCORE FORMULA|||NA||2|Visit_2|25|5|FOLLOW-UP|2021-02-06|2021-02-15|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-16
e|LB|9c3b6912-19be-435c-87fc-781a08efb847|5|DMG|Dimethylglycine|URINALYSIS|[?]|mg/m2/day|[?]|[?]|POSITIVE|1|tuberculin unit|1|1|[?]|HIGH|SPERMATOZOON|CLOTTED|N|U-HPLC/MS/MS|COCKCROFT-GAULT FORMULA|Y||U||3|Visit_3|40|6|FOLLOW-UP|2021-02-21|2021-03-16|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|9c3b6912-19be-435c-87fc-781a08efb847|6|C165918|American Cockroach IgG AB RAST Score|URINALYSIS|[?]|/cmH2O|[?]|[?]|BORDERLINE|1|copies/ug|1|1|[?]|LOW|KERATINOCYTE|PARAFFIN-EMBEDDED|N|DOUBLE IMMUNODIFFUSION|ASH FIBROSURE FORMULA|||U||3|Visit_3|40|6|TREATMENT|2021-02-21|2021-03-14|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|9c3b6912-19be-435c-87fc-781a08efb847|7|TAURCRT|Taurine/Creatinine|HEMATOLOGY|[?]|mm3/mm2/year|[?]|[?]|INDETERMINATE|1|pt_us|1|1|[?]|ABNORMAL|VENOUS PLASMA|LIPEMIC||PUPILLOMETRY|CKD-EPI FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2021-03-18|2021-04-10|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|9c3b6912-19be-435c-87fc-781a08efb847|8|LCTHSPGM|Lecithin/Sphingomyelin|CHEMISTRY|||[?]|[?]|BORDERLINE|1|10^6 DNA copies/mL|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|CLOTTED||SPECTROPHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|N|Y|4|Visit_4|65|5|WASHOUT|2021-03-18|2021-03-25|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|9c3b6912-19be-435c-87fc-781a08efb847|9|MDZPM|Medazepam|HEMATOLOGY|[?]|MBq/uL|[?]|[?]|INVALID|1|ug/h|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CONTAMINATED||RYAN BLUE STAIN|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|5|WASHOUT|2021-04-12|2021-04-17|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|9c3b6912-19be-435c-87fc-781a08efb847|10|RDCSUG|Reducing Sugars|HEMATOLOGY|[?]|10^3 DNA copies/mL|[?]|[?]|NEGATIVE|1|cd/m2|1|1|[?]|LOW|SKIN TISSUE|FROZEN||SMEAR|FIBROMETER FORMULA|||N||5|Visit_5|90|4|FOLLOW-UP|2021-04-12|2021-04-15|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|171a6d85-ba2e-45da-b31b-01651b26e890|1|CXCL13|Chemokine (C-X-C Motif) Ligand 13|CHEMISTRY|[?]|dpm/mL|[?]|[?]|NEGATIVE|1|STEPS|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|ICTERIC||VENTILATION PERFUSION LUNG SCAN|FIBROMETER FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-08-02|2020-08-11|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|171a6d85-ba2e-45da-b31b-01651b26e890|2|EOSNUCCE|Eosinophils/Nucleated Cells|CHEMISTRY|||[?]|[?]|NEGATIVE|1|kN/cm2|1|1|[?]|ABNORMAL|MECONIUM|AUTOLYZED||TONOMETRY|NASH FIBROSURE FORMULA|||N|Y|1|Visit_1|10|6|TREATMENT|2020-08-02|2020-09-25|10|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|171a6d85-ba2e-45da-b31b-01651b26e890|3|LTFAB|Lactoferrin Antibody|URINALYSIS|[?]|cpm|[?]|[?]|TRACE|1|pm|1|1|[?]|NORMAL|SPUTUM|FROZEN||PEAK FLOWMETRY|CKD-EPI FORMULA||Y|U||2|Visit_2|25|4|TREATMENT|2020-08-17|2020-10-18|25|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|171a6d85-ba2e-45da-b31b-01651b26e890|4|SPMAGGR|Sperm Aggregation|CHEMISTRY|[?]|mEq/ug|[?]|[?]|NEGATIVE|1|g/cage|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR||PHOTOGRAPHY|ASH FIBROSURE FORMULA||Y|NA||2|Visit_2|25|5|TREATMENT|2020-08-17|2020-08-26|25|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|171a6d85-ba2e-45da-b31b-01651b26e890|5|HCHT|Hyocholate|URINALYSIS|[?]|mEq/ug|[?]|[?]|TRACE|1|BAG|1|1|[?]|ABNORMAL|DIALYSIS FLUID|AGGLUTINATED||TOLUIDINE BLUE STAIN|MDRD FORMULA|||NA||3|Visit_3|40|7|WASHOUT|2020-09-01|2020-09-10|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|171a6d85-ba2e-45da-b31b-01651b26e890|6|GLP1IAC|Glucagon-Like Peptide-1, Inactive Form|URINALYSIS|[?]|BU/mL|[?]|[?]|TRACE|1|10^11/L|1|1|[?]|HIGH|PROSTATIC FLUID|CALCIFIED||SCANNING ELECTRON MICROSCOPY|CKD-EPI CREATININE FORMULA|||U||3|Visit_3|40|7|FOLLOW-UP|2020-09-01|2020-09-23|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|171a6d85-ba2e-45da-b31b-01651b26e890|7|MLATONIN|Melatonin|HEMATOLOGY|[?]|/mm|[?]|[?]|POSITIVE|1|kg/cm|1|1|[?]|ABNORMAL|MECONIUM|GELLED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|NASH FIBROSURE FORMULA|||U||4|Visit_4|65|7|TREATMENT|2020-09-26|2020-10-22|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|LB|171a6d85-ba2e-45da-b31b-01651b26e890|8|INTLK14|Interleukin 14|URINALYSIS|[?]|Linear ft*LB|[?]|[?]|POSITIVE|1|mg/mL/min|1|1|[?]|LOW|CAPILLARY PLASMA|LACTESCENT||GC/FID|CKD-EPI CREATININE FORMULA||Y|U||4|Visit_4|65|6|SCREENING|2020-09-26|2020-10-28|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|LB|171a6d85-ba2e-45da-b31b-01651b26e890|9|HDLCLDLC|HDL Cholesterol/LDL Cholesterol|URINALYSIS|[?]|RING|[?]|[?]|BORDERLINE|1|uSiemens|1|1|[?]|LOW|BONE|HEMOLYZED||ANGIOGRAPHY|GMI % FORMULA|Y||N||5|Visit_5|90|5|WASHOUT|2020-10-21|2020-10-24|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|171a6d85-ba2e-45da-b31b-01651b26e890|10|NTXII|Type II Collagen N-Telopeptides|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|log10 TCID 50/mL|1|1|[?]|LOW|LOCHIA|ICTERIC|N|CT SCAN WITHOUT CONTRAST|MDRD 4 VARIABLE FORMULA||Y|Y|Y|5|Visit_5|90|3|FOLLOW-UP|2020-10-21|2020-10-22|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|a8338164-1bb5-4474-9432-4d5a81ab30d8|1|VTD2D3IT|25-Hydroxyvit D2 + 25-Hydroxyvit D3|URINALYSIS|[?]|mL/cage/wk|[?]|[?]|INDETERMINATE|1|PACKAGE|1|1|[?]|ABNORMAL|SEMEN|REFRIGERATED||HEMOCYTOMETRY|FIBROTEST FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-12-10|2021-02-14|10|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|a8338164-1bb5-4474-9432-4d5a81ab30d8|2|C130072|Birch Pollen IgE|URINALYSIS|[?]|vg/dose|[?]|[?]|INDETERMINATE|1|10^4 CFU/mL|1|1|[?]|LOW|SERUM|CALCIFIED||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|FIBROMETER FORMULA||Y|NA||1|Visit_1|10|7|TREATMENT|2020-12-10|2021-02-11|10|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|a8338164-1bb5-4474-9432-4d5a81ab30d8|3|SAMETH|S-Adenosylmethionine|CHEMISTRY|[?]|Bq|[?]|[?]|INVALID|1|U.CARR|1|1|[?]|LOW|BONE|NON-HEMOLYZED|N|CALIPER MEASUREMENT METHOD|MDRD ENZYMATIC FORMULA|Y|Y|NA||2|Visit_2|25|5|TREATMENT|2020-12-25|2021-02-05|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|a8338164-1bb5-4474-9432-4d5a81ab30d8|4|DPD|Deoxypyridinoline|HEMATOLOGY|||[?]|[?]|INVALID|1|ft3|1|1|[?]|LOW|SOFT TISSUE|FROZEN||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|2|Visit_2|25|2|TREATMENT|2020-12-25|2021-01-03|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|a8338164-1bb5-4474-9432-4d5a81ab30d8|5|IA2AB|Insulinoma-Associated Protein 2 Antibody|URINALYSIS|[?]|mg/mol|[?]|[?]|BORDERLINE|1|10^10/L|1|1|[?]|LOW|SPUTUM|CLOTTED||SANGER SEQUENCING|CKD-EPI CREATININE FORMULA|||U||3|Visit_3|40|2|TREATMENT|2021-01-09|2021-01-31|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|a8338164-1bb5-4474-9432-4d5a81ab30d8|6|CACRALB|Calcium Corrected for Albumin|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|cm2|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|CLOTTED||KINYOUN STAIN|NASH FIBROSURE FORMULA||Y|NA|Y|3|Visit_3|40|3|TREATMENT|2021-01-09|2021-02-24|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|a8338164-1bb5-4474-9432-4d5a81ab30d8|7|MGCREAT|Magnesium/Creatinine|URINALYSIS|[?]|L/s/kPa|[?]|[?]|BORDERLINE|1|nsec|1|1|[?]|HIGH|AQUEOUS HUMOR|CALCIFIED||BETA LACTAMASE|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|Y||4|Visit_4|65|3|SCREENING|2021-02-03|2021-02-26|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|a8338164-1bb5-4474-9432-4d5a81ab30d8|8|TNFAPIA|TNF-a Production Inhibitory Activity|URINALYSIS|[?]|U/m2/day|[?]|[?]|INVALID|1|10^9 organisms|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|LIPEMIC||CALIPER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA|Y|Y|Y||4|Visit_4|65|6|SCREENING|2021-02-03|2021-02-28|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|a8338164-1bb5-4474-9432-4d5a81ab30d8|9|ALB|Albumin|URINALYSIS|||[?]|[?]|INVALID|1|min/day|1|1|[?]|LOW|VITREOUS HUMOR|CALCIFIED||ULTRASONOGRAPHIC ELASTOGRAPHY|GMI MMOL/MOL FORMULA|Y||U|Y|5|Visit_5|90|1|TREATMENT|2021-02-28|2021-03-07|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|a8338164-1bb5-4474-9432-4d5a81ab30d8|10|EPIRCE|Renal Epithelial Cells|URINALYSIS|[?]|10^6 RNA copies/mL|[?]|[?]|NEGATIVE|1|ppth|1|1|[?]|HIGH|GASTRIC FLUID|AGGLUTINATED||HPLC/MS|CKD-EPI FORMULA|Y|Y|U||5|Visit_5|90|2|TREATMENT|2021-02-28|2021-03-09|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|6d64077e-1f18-4bd6-ba86-53d90121f7a9|1|LSELS|Soluble L-Selectin|HEMATOLOGY|[?]|GLOBULE|[?]|[?]|INDETERMINATE|1|L/day|1|1|[?]|NORMAL|KERATINOCYTE|AUTOLYZED|N|MICRONEUTRALIZATION ASSAY|MDRD ENZYMATIC FORMULA|||U||1|Visit_1|10|3|SCREENING|2020-06-17|2020-07-18|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|6d64077e-1f18-4bd6-ba86-53d90121f7a9|2|GRANIMLE|Immature Granulocytes/Leukocytes|URINALYSIS|[?]|nmol/L|[?]|[?]|BORDERLINE|1|kN/cm2|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|CLOTTED||PALM METHOD|HEPASCORE FORMULA|||N||1|Visit_1|10|4|SCREENING|2020-06-17|2020-09-12|10|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|6d64077e-1f18-4bd6-ba86-53d90121f7a9|3|LKM1IMAB|Liver Kidney Microsomal Type 1 IgM Ab|URINALYSIS|[?]|BAG|[?]|[?]|NEGATIVE|1|10^10/L|1|1|[?]|NORMAL|LYSATE|CONTAMINATED|N|WESTERN BLOT|COCKCROFT-GAULT FORMULA|Y||NA||2|Visit_2|25|3|SCREENING|2020-07-02|2020-09-08|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|LB|6d64077e-1f18-4bd6-ba86-53d90121f7a9|4|LKM1IMAB|Liver Kidney Microsomal Type 1 IgM Ab|HEMATOLOGY|[?]|g/U|[?]|[?]|POSITIVE|1|cL|1|1|[?]|ABNORMAL|PUS|ICTERIC||CYSTOSCOPY|CKD-EPI CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|1|TREATMENT|2020-07-02|2020-08-15|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|LB|6d64077e-1f18-4bd6-ba86-53d90121f7a9|5|CRTFREXR|Cortisol, Free Excretion Rate|CHEMISTRY|||[?]|[?]|TRACE|1|10^6 organisms/mL|1|1|[?]|LOW|CALCULUS|CONCENTRATED||MS/MS|GMI MMOL/MOL FORMULA|||U|Y|3|Visit_3|40|5|TREATMENT|2020-07-17|2020-08-10|40|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|6d64077e-1f18-4bd6-ba86-53d90121f7a9|6|FACTII|Factor II|URINALYSIS|[?]|pg/dL|[?]|[?]|INDETERMINATE|1|L/s/kPa|1|1|[?]|LOW|EMOTIONAL TEAR|THAWED||IMMUNOFLUORESCENT STAIN|FIBROMETER FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2020-07-17|2020-08-02|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|6d64077e-1f18-4bd6-ba86-53d90121f7a9|7|CD34|CD34|HEMATOLOGY|[?]|mL/s|[?]|[?]|POSITIVE|1|ug/min|1|1|[?]|ABNORMAL|LUNG SURFACTANT|DRIED||FLUORESCEIN STAIN|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|1|SCREENING|2020-08-11|2020-08-16|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|6d64077e-1f18-4bd6-ba86-53d90121f7a9|8|BLSTMKCE|Megakaryoblasts/Total Cells|URINALYSIS|[?]|log10 PFU/mL|[?]|[?]|TRACE|1|mEq/mmol|1|1|[?]|ABNORMAL|DIALYSIS FLUID|GELLED||CLOT DETECTION|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-08-11|2020-08-21|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|6d64077e-1f18-4bd6-ba86-53d90121f7a9|9|VITE|Vitamin E|URINALYSIS|||[?]|[?]|TRACE|1|fraction of 1|1|1|[?]|LOW|URINE|ROOM TEMPERATURE||ELLA|MDRD 4 VARIABLE FORMULA||Y|Y|Y|5|Visit_5|90|2|TREATMENT|2020-09-05|2020-09-12|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|6d64077e-1f18-4bd6-ba86-53d90121f7a9|10|HIST4AB|Histone 4 Antibody|CHEMISTRY|[?]|uEq|[?]|[?]|INVALID|1|cGy|1|1|[?]|HIGH|VITREOUS HUMOR|HEMOLYZED||IMPEDANCE CONDUCTIVITY|MDRD FORMULA||Y|U||5|Visit_5|90|6|TREATMENT|2020-09-05|2020-09-12|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|91d08486-3db7-4c71-a63f-fd060f4ae1a4|1|VEGFD|Vascular Endothelial Growth Factor D|URINALYSIS|[?]|cGy|[?]|[?]|POSITIVE|1|min/day|1|1|[?]|LOW|MENSTRUAL BLOOD|CONCENTRATED||AUDIOMETRY|FIBROMETER FORMULA|||Y||1|Visit_1|10|7|FOLLOW-UP|2020-12-25|2021-01-11|10|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|91d08486-3db7-4c71-a63f-fd060f4ae1a4|2|PLAT|Platelets|HEMATOLOGY|[?]|gtt|[?]|[?]|NEGATIVE|1|keV|1|1|[?]|ABNORMAL|SEBUM|HEMOLYZED|N|ELISA|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||1|Visit_1|10|1|SCREENING|2020-12-25|2021-02-18|10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|91d08486-3db7-4c71-a63f-fd060f4ae1a4|3|OXMORPHN|Oxymorphone|URINALYSIS|||[?]|[?]|POSITIVE|1|foz_us|1|1|[?]|HIGH|ARTERIAL BLOOD|CONTAMINATED||PAP STAIN|HEPASCORE FORMULA|||U|Y|2|Visit_2|25|7|TREATMENT|2021-01-09|2021-03-22|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|91d08486-3db7-4c71-a63f-fd060f4ae1a4|4|ANTHRMAG|Antithrombin Antigen|URINALYSIS|[?]|Gy/min|[?]|[?]|NEGATIVE|1|mV/sec|1|1|[?]|ABNORMAL|DERMAL TISSUE|NON-HEMOLYZED||CONTRAST ENHANCED SPIRAL CT SCAN|FIBROMETER FORMULA|||N||2|Visit_2|25|1|FOLLOW-UP|2021-01-09|2021-02-24|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|91d08486-3db7-4c71-a63f-fd060f4ae1a4|5|C130068|Bermuda Grass Pollen IgE|URINALYSIS|[?]|nmol BCE/nmol|[?]|[?]|BORDERLINE|1|g/L|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|LACTESCENT|N|SXA SCAN|MDRD 4 VARIABLE FORMULA|Y||N||3|Visit_3|40|1|WASHOUT|2021-01-24|2021-03-22|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|91d08486-3db7-4c71-a63f-fd060f4ae1a4|6|LKM1AB|Liver Kidney Microsomal Type 1 Antibody|URINALYSIS|[?]|mL/h|[?]|[?]|INDETERMINATE|1|10^9 organisms/g|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|REFRIGERATED||KARYOTYPING|FIBROTEST FORMULA|Y||U||3|Visit_3|40|4|SCREENING|2021-01-24|2021-03-08|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|91d08486-3db7-4c71-a63f-fd060f4ae1a4|7|PLATCLMP|Platelet Clumps|URINALYSIS|[?]|10^6/hpf|[?]|[?]|INDETERMINATE|1|10^3 copies/mL|1|1|[?]|NORMAL|CAPILLARY PLASMA|CALCIFIED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U||4|Visit_4|65|2|FOLLOW-UP|2021-02-18|2021-03-15|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|91d08486-3db7-4c71-a63f-fd060f4ae1a4|8|OXYTOCIN|Oxytocin|URINALYSIS|[?]|cd/m2|[?]|[?]|INDETERMINATE|1|10^4/L|1|1|[?]|HIGH|VENOUS BLOOD|DRIED|N|KARYOTYPING|CKD-EPI CREATININE FORMULA|||U||4|Visit_4|65|6|FOLLOW-UP|2021-02-18|2021-03-21|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|91d08486-3db7-4c71-a63f-fd060f4ae1a4|9|LPL|Lipoprotein Lipase|URINALYSIS|[?]|Enzyme U/L|[?]|[?]|TRACE|1|foz_br|1|1|[?]|ABNORMAL|TUMOR TISSUE|HEMOLYZED||NEXT GENERATION TARGETED SEQUENCING|CKD-EPI FORMULA|||Y||5|Visit_5|90|5|TREATMENT|2021-03-15|2021-03-20|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|LB|91d08486-3db7-4c71-a63f-fd060f4ae1a4|10|FENA|Fractional Sodium Excretion|CHEMISTRY|[?]|mCi/kg|[?]|[?]|TRACE|1|BAU/mL|1|1|[?]|NORMAL|SOFT TISSUE|FRESH||IMMUNOCHROMATOGRAPHY|GMI MMOL/MOL FORMULA|Y|Y|N||5|Visit_5|90|5|TREATMENT|2021-03-15|2021-03-16|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|LB|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|1|APOA5|Apolipoprotein A5|HEMATOLOGY|[?]|mol/mg|[?]|[?]|INVALID|1|cd*s/m2|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|LACTESCENT||MICROARRAY|MDRD FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-08-14|2020-08-27|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|2|INTLK16|Interleukin 16|CHEMISTRY|[?]|mm3/mm2/year|[?]|[?]|TRACE|1|foz_us|1|1|[?]|ABNORMAL|TRANSUDATE|AUTOLYZED||NEPHELOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|2|FOLLOW-UP|2020-08-14|2020-10-24|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|3|AFPL1|Alpha Fetoprotein L1|URINALYSIS|[?]|g/kg/day|[?]|[?]|TRACE|1|ng/L|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|HEMOLYZED||WESTERN BLOT|CKD-EPI CYSTATIN C FORMULA|Y||N||2|Visit_2|25|7|TREATMENT|2020-08-29|2020-10-08|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|4|HLAB27AG|HLA-B27 Antigen|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Hz|1|1|[?]|LOW|SEBUM|AUTOLYZED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC FORMULA|||N|Y|2|Visit_2|25|1|TREATMENT|2020-08-29|2020-10-06|25|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|5|HDL|HDL Cholesterol|HEMATOLOGY|[?]|mol/mL|[?]|[?]|TRACE|1|g/g|1|1|[?]|NORMAL|SKIN TISSUE|GELLED|N|JAEGER EYE CHART|GMI MMOL/MOL FORMULA|||N||3|Visit_3|40|5|WASHOUT|2020-09-13|2020-09-23|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|6|VITB7|Vitamin B7|CHEMISTRY|||[?]|[?]|NEGATIVE|1|cd*s/m2|1|1|[?]|LOW|LYSATE|AGGLUTINATED||SINGLE-MOLECULE ARRAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|3|Visit_3|40|4|TREATMENT|2020-09-13|2020-09-14|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|7|HTTPM|Huntingtin Protein, Mutant|CHEMISTRY|||[?]|[?]|TRACE|1|10^6 organisms/g|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|HEMOLYZED|N|MRS|MDRD 4 VARIABLE FORMULA||Y|U|Y|4|Visit_4|65|6|TREATMENT|2020-10-08|2020-10-15|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|8|TROPONI|Troponin I|HEMATOLOGY|[?]|ukat/L|[?]|[?]|INVALID|1|nmol/kg/day|1|1|[?]|NORMAL|LAVAGE FLUID|PARAFFIN-EMBEDDED||PHOTOMETRIC CLOT DETECTION|FIBROMETER FORMULA|||U||4|Visit_4|65|1|TREATMENT|2020-10-08|2020-10-27|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|9|ENA78|Epith Neutrophil-Activating Peptide 78|HEMATOLOGY|[?]|BOX|[?]|[?]|POSITIVE|1|vg/dose|1|1|[?]|LOW|CERUMEN|FROZEN||LC/MS/MS|MDRD ENZYMATIC FORMULA|Y|Y|Y||5|Visit_5|90|5|FOLLOW-UP|2020-11-02|2020-11-08|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|10|PHADJT|pH Adjusted for Body Temp|CHEMISTRY|[?]|OD Unit|[?]|[?]|NEGATIVE|1|COAT|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|SOLIDIFIED||IHC|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2020-11-02|2020-11-11|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|1|ENDOTH1|Endothelin-1|HEMATOLOGY|[?]|mg/m2/min|[?]|[?]|INVALID|1|m/sec2|1|1|[?]|LOW|BLOOD|AUTOLYZED||DXA SCAN|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|7|TREATMENT|2021-01-09|2021-01-20|10|21|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|2|BILI|Bilirubin|URINALYSIS|[?]|psi|[?]|[?]|BORDERLINE|1|mg/kg/dose|1|1|[?]|LOW|ARTERIAL CORD BLOOD|FRESH||JAFFE REACTION|FIBROTEST FORMULA|||NA||1|Visit_1|10|5|SCREENING|2021-01-09|2021-04-07|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|3|C130076|Silver Birch Pollen IgE|HEMATOLOGY|[?]|Bq|[?]|[?]|POSITIVE|1|ft2|1|1|[?]|HIGH|AQUEOUS HUMOR|ICTERIC||PYROSEQUENCING|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|1|TREATMENT|2021-01-24|2021-02-13|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|4|INTLK8|Interleukin 8|HEMATOLOGY|[?]|Bq|[?]|[?]|TRACE|1|%/s|1|1|[?]|ABNORMAL|LYMPH|THAWED||CLIP SEQUENCING|MDRD 5 VARIABLE FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2021-01-24|2021-02-18|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|5|FGFBF|Fibroblast Growth Factor Basic Form|CHEMISTRY|[?]|s^-1(%O2)^-1|[?]|[?]|INDETERMINATE|1|atm|1|1|[?]|NORMAL|TUMOR TISSUE|HEMOLYZED||NUCLEIC ACID HYBRIDIZATION|CKD-EPI FORMULA||Y|Y||3|Visit_3|40|3|WASHOUT|2021-02-08|2021-02-19|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|6|ACTH|Adrenocorticotropic Hormone|HEMATOLOGY|[?]|MESF|[?]|[?]|POSITIVE|1|/HPF|1|1|[?]|LOW|BREAST MILK|FRESH||DIFFUSION TENSOR MRI|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2021-02-08|2021-03-06|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|7|SEDEXAM|Sediment Examination|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|g/day|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|CONTAMINATED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|N|Y|4|Visit_4|65|7|WASHOUT|2021-03-05|2021-03-07|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|LB|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|8|NEUTCYBS|Cytoplasmic Basophilia Neutrophil|CHEMISTRY|[?]|GBq/g|[?]|[?]|INDETERMINATE|1|kg|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|LACTESCENT|N|POLYSOMNOGRAPHY|FIBROTEST FORMULA|Y||Y||4|Visit_4|65|2|TREATMENT|2021-03-05|2021-03-08|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|LB|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|9|PO2|Partial Pressure Oxygen|URINALYSIS|[?]|DIP|[?]|[?]|POSITIVE|1|mL/mmHg/min/L|1|1|[?]|HIGH|FLUID|THAWED||ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD 5 VARIABLE FORMULA|||Y||5|Visit_5|90|6|FOLLOW-UP|2021-03-30|2021-04-07|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|10|SEZCE|Sezary Cells|URINALYSIS|[?]|TROCHE|[?]|[?]|INDETERMINATE|1|dpm/0.5 mL|1|1|[?]|LOW|SUPERNATANT, PLASMA|LIPEMIC||REBOUND TONOMETRY|FIBROTEST FORMULA|||N||5|Visit_5|90|4|FOLLOW-UP|2021-03-30|2021-04-01|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|87998e13-813a-464d-935c-d5513cd0db5e|1|ALPISOE|Alkaline Phosphatase Isoenzyme|HEMATOLOGY|[?]|FEU|[?]|[?]|INVALID|1|oz eq|1|1|[?]|LOW|SUPERNATANT, PLASMA|SOLIDIFIED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 4 VARIABLE FORMULA||Y|N||1|Visit_1|10|1|TREATMENT|2020-08-31|2020-10-26|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|87998e13-813a-464d-935c-d5513cd0db5e|2|CAEXR|Calcium Excretion Rate|HEMATOLOGY|[?]|mEq/uL|[?]|[?]|BORDERLINE|1|10^3 CFU/g|1|1|[?]|HIGH|URINE SEDIMENT|CALCIFIED||PATHOLOGICAL EVALUATION|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|3|SCREENING|2020-08-31|2020-10-27|10|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|87998e13-813a-464d-935c-d5513cd0db5e|3|RBCDYSM|Dysmorphic Erythrocytes|URINALYSIS|[?]|DISK|[?]|[?]|INDETERMINATE|1|mEq/dL|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|FROZEN|N|HILLMEN COLOR CHART|FIBROTEST FORMULA||Y|Y||2|Visit_2|25|3|TREATMENT|2020-09-15|2020-10-26|25|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|87998e13-813a-464d-935c-d5513cd0db5e|4|OHF6B|6 Beta-Hydroxycortisol|HEMATOLOGY|[?]|%/min|[?]|[?]|BORDERLINE|1|/LSQN|1|1|[?]|ABNORMAL|DERMAL TISSUE|ICTERIC||SPECULAR MICROSCOPY|MDRD 5 VARIABLE FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-09-15|2020-10-31|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|87998e13-813a-464d-935c-d5513cd0db5e|5|PFCT|Platelet Function Closure Time|URINALYSIS|[?]|ug/m2/h|[?]|[?]|NEGATIVE|1|dmol|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|FROZEN||EIA|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-09-30|2020-10-10|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|87998e13-813a-464d-935c-d5513cd0db5e|6|HEXK|Hexokinase|HEMATOLOGY|[?]|in|[?]|[?]|NEGATIVE|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|NAIL|PARAFFIN-EMBEDDED|N|INTERRUPTER TECHNIQUE|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|2|TREATMENT|2020-09-30|2020-11-21|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|87998e13-813a-464d-935c-d5513cd0db5e|7|PLATHCT|Platelet Hematocrit|CHEMISTRY|||[?]|[?]|POSITIVE|1|pg/L|1|1|[?]|HIGH|SERUM|ROOM TEMPERATURE||GEL ELECTROPHORESIS|HEPASCORE FORMULA|||NA|Y|4|Visit_4|65|7|TREATMENT|2020-10-25|2020-11-26|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|87998e13-813a-464d-935c-d5513cd0db5e|8|ESELECT|E-Selectin|HEMATOLOGY|[?]|DAgU/mL|[?]|[?]|NEGATIVE|1|10^6 organisms/g|1|1|[?]|HIGH|BONE MARROW|UNEXPECTED ODOR||LC/MS|HEPASCORE FORMULA||Y|Y||4|Visit_4|65|4|TREATMENT|2020-10-25|2020-11-02|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|87998e13-813a-464d-935c-d5513cd0db5e|9|TTGIGGAB|Tissue Transglutaminase IgG Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|ppb|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|CALCIFIED||RAJI CELL RIA|HEPASCORE FORMULA||Y|NA|Y|5|Visit_5|90|3|TREATMENT|2020-11-19|2020-11-21|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|87998e13-813a-464d-935c-d5513cd0db5e|10|TFRRNSAT|Transferrin Saturation|CHEMISTRY|[?]|fmol/g|[?]|[?]|INDETERMINATE|1|mm/2h|1|1|[?]|LOW|PROSTATIC FLUID|CLOTTED|N|TEMPLATE INCISION METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|1|FOLLOW-UP|2020-11-19|2020-11-28|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|7812e96e-ea53-4eb0-8160-d4118c567c9d|1|IL122340|Interleukin 12+23 p40|URINALYSIS|[?]|hr/day|[?]|[?]|BORDERLINE|1|10^9/dose|1|1|[?]|NORMAL|CAPILLARY PLASMA|LACTESCENT||AUTOMATED COUNT|NASH FIBROSURE FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2021-01-27|2021-03-28|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|7812e96e-ea53-4eb0-8160-d4118c567c9d|2|CYBILI|Bilirubin Crystals|URINALYSIS|[?]|BLOCKS|[?]|[?]|TRACE|1|HOMEOPATHIC DILUTION|1|1|[?]|NORMAL|SEBUM|FRESH|N|PATHOLOGICAL EVALUATION|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|2|TREATMENT|2021-01-27|2021-03-07|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|7812e96e-ea53-4eb0-8160-d4118c567c9d|3|BLASTIMM|Immunoblasts|HEMATOLOGY|[?]|PFU|[?]|[?]|BORDERLINE|1|ug/kg|1|1|[?]|HIGH|INFRANATANT, SERUM|AUTOLYZED||FLUORESCENT LIFETIME IMAGING MICROSCOPY|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|6|SCREENING|2021-02-11|2021-02-27|25|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|7812e96e-ea53-4eb0-8160-d4118c567c9d|4|PRCTC|Prostate Circulating Tumor Cells|URINALYSIS|[?]|mL/animal|[?]|[?]|POSITIVE|1|ugEq/L|1|1|[?]|NORMAL|EPIDERMAL TISSUE|DRIED|N|CLINICAL EVALUATION|COCKCROFT-GAULT FORMULA|||U||2|Visit_2|25|4|TREATMENT|2021-02-11|2021-04-08|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|7812e96e-ea53-4eb0-8160-d4118c567c9d|5|LTB4|Leukotriene B4|CHEMISTRY|[?]|MPS U|[?]|[?]|NEGATIVE|1|kBq/uL|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|DRIED||ORCHIDOMETERY|FIBROSIS 4 FORMULA|||U||3|Visit_3|40|6|TREATMENT|2021-02-26|2021-04-25|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|7812e96e-ea53-4eb0-8160-d4118c567c9d|6|CRP|C Reactive Protein|URINALYSIS|||[?]|[?]|BORDERLINE|1|mL/g/day|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|GELLED||RAJI CELL RIA|COCKCROFT-GAULT FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2021-02-26|2021-03-17|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|7812e96e-ea53-4eb0-8160-d4118c567c9d|7|CYP2C9|Cytochrome P450 2C9|HEMATOLOGY|[?]|10^5/L|[?]|[?]|POSITIVE|1|L/s|1|1|[?]|ABNORMAL|SMEGMA|CONCENTRATED||FARNSWORTH-MUNSELL 100 HUE TEST|COCKCROFT-GAULT FORMULA|Y||NA||4|Visit_4|65|5|WASHOUT|2021-03-23|2021-04-24|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|7812e96e-ea53-4eb0-8160-d4118c567c9d|8|BASOIMLE|Immature Basophils/Leukocytes|HEMATOLOGY|[?]|Coulomb|[?]|[?]|TRACE|1|U/kg/day|1|1|[?]|LOW|ISOLATE|LIPEMIC||AUTOREFRACTION|CKD-EPI CREATININE FORMULA|||N||4|Visit_4|65|6|SCREENING|2021-03-23|2021-04-06|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|7812e96e-ea53-4eb0-8160-d4118c567c9d|9|ASYNP|Alpha Synuclein Protein|URINALYSIS|[?]|cmHg|[?]|[?]|BORDERLINE|1|Ci/ug|1|1|[?]|ABNORMAL|PLATELET|CONCENTRATED||PHASE-CONTRAST MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||5|Visit_5|90|7|SCREENING|2021-04-17|2021-04-23|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|7812e96e-ea53-4eb0-8160-d4118c567c9d|10|METAMYLE|Metamyelocytes/Leukocytes|URINALYSIS|[?]|BAU/mL|[?]|[?]|INVALID|1|10^9 organisms/g|1|1|[?]|HIGH|PERITONEAL FLUID|AGGLUTINATED||SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||5|Visit_5|90|6|SCREENING|2021-04-17|2021-04-21|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|f9c6c448-0e3d-421f-a63f-be4aeb965256|1|INTLK20|Interleukin 20|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ft3|1|1|[?]|LOW|VITREOUS HUMOR|AUTOLYZED|N|AUTOREFRACTION|CKD-EPI CYSTATIN C FORMULA|||Y|Y|1|Visit_1|10|3|TREATMENT|2020-11-08|2021-01-12|10|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|f9c6c448-0e3d-421f-a63f-be4aeb965256|2|CBB|Complement Bb|CHEMISTRY|[?]|pm|[?]|[?]|INDETERMINATE|1|ug/m2|1|1|[?]|LOW|ERYTHROCYTES|UNEXPECTED ODOR||IMMUNO-PET SCAN|CKD-EPI FORMULA||Y|N||1|Visit_1|10|4|FOLLOW-UP|2020-11-08|2021-01-07|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|f9c6c448-0e3d-421f-a63f-be4aeb965256|3|FLT3|FMS-like Receptor Tyrosine Kinase 3|CHEMISTRY|[?]|CAN|[?]|[?]|INDETERMINATE|1|BP|1|1|[?]|LOW|DISCHARGE|THAWED|N|KINETIC MICROPARTICLE IMMUNOASSAY|MDRD FORMULA|Y||U||2|Visit_2|25|1|FOLLOW-UP|2020-11-23|2020-12-21|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|f9c6c448-0e3d-421f-a63f-be4aeb965256|4|AFPA|Alpha Fetoprotein Activity|HEMATOLOGY|[?]|10^7 PFU|[?]|[?]|INVALID|1|mmol/s|1|1|[?]|LOW|VITREOUS HUMOR|HEMOLYZED||TRANSTHORACIC ECHOCARDIOGRAPHY|GMI % FORMULA||Y|NA||2|Visit_2|25|1|FOLLOW-UP|2020-11-23|2020-12-23|25|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|f9c6c448-0e3d-421f-a63f-be4aeb965256|5|KLCFR|Kappa Light Chain, Free|CHEMISTRY|||[?]|[?]|INVALID|1|ug/m2/min|1|1|[?]|HIGH|ALVEOLAR AIR|DRIED|N|IMMUNOASSAY|MDRD 4 VARIABLE FORMULA||Y|Y|Y|3|Visit_3|40|2|WASHOUT|2020-12-08|2020-12-22|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|f9c6c448-0e3d-421f-a63f-be4aeb965256|6|INTLK17|Interleukin 17|URINALYSIS|||[?]|[?]|INDETERMINATE|1|10^11/L|1|1|[?]|LOW|TISSUE|LIPEMIC|N|TURBIDIMETRY|COCKCROFT-GAULT FORMULA|||U|Y|3|Visit_3|40|4|TREATMENT|2020-12-08|2020-12-19|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|f9c6c448-0e3d-421f-a63f-be4aeb965256|7|VEGFD|Vascular Endothelial Growth Factor D|HEMATOLOGY|[?]|TABLET|[?]|[?]|INVALID|1|pkat|1|1|[?]|LOW|ABSCESS FLUID|AUTOLYZED||PET/CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE FORMULA||Y|Y||4|Visit_4|65|1|TREATMENT|2021-01-02|2021-01-04|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|f9c6c448-0e3d-421f-a63f-be4aeb965256|8|TNFR1B|TNF Receptor 1B|CHEMISTRY|[?]|GBq/g|[?]|[?]|TRACE|1|DRUM|1|1|[?]|LOW|EMESIS|NON-HEMOLYZED|N|AUDIOMETRY|HEPASCORE FORMULA|||N||4|Visit_4|65|7|FOLLOW-UP|2021-01-02|2021-01-30|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|f9c6c448-0e3d-421f-a63f-be4aeb965256|9|ATHMBAAC|Antithrombin Activity Actual/Control|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|ag|1|1|[?]|HIGH|EMOTIONAL TEAR|AUTOLYZED||MRI|ASH FIBROSURE FORMULA||Y|N|Y|5|Visit_5|90|2|WASHOUT|2021-01-27|2021-02-01|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|f9c6c448-0e3d-421f-a63f-be4aeb965256|10|RDWSD|RDW Standard Deviation|CHEMISTRY|[?]|mg/h|[?]|[?]|BORDERLINE|1|mL/g/min|1|1|[?]|ABNORMAL|ERYTHROCYTES|CALCIFIED|N|MECHANICAL CLOT DETECTION|CKD-EPI CYSTATIN C FORMULA|Y||U||5|Visit_5|90|3|WASHOUT|2021-01-27|2021-01-29|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|e8da815a-b53c-46f4-a546-e8553152719f|1|ICTERUSI|Icteric Index|HEMATOLOGY|[?]|TRANSDUCING UNIT|[?]|[?]|INDETERMINATE|1|Ejaculate U|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|LIPEMIC||LIGHT MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|NA||1|Visit_1|10|5|FOLLOW-UP|2020-12-27|2021-03-17|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|e8da815a-b53c-46f4-a546-e8553152719f|2|CRYSTALS|Crystals|CHEMISTRY|[?]|copies/uL|[?]|[?]|INVALID|1|GPL U|1|1|[?]|HIGH|PLATELET POOR PLASMA|AGGLUTINATED||CONTRAST ENHANCED PET SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||1|Visit_1|10|2|TREATMENT|2020-12-27|2021-02-06|10|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|e8da815a-b53c-46f4-a546-e8553152719f|3|C165926|Mold Mix IgE AB RAST Score|CHEMISTRY|[?]|10^6 CFU/mL|[?]|[?]|POSITIVE|1|CYLINDER|1|1|[?]|HIGH|INFRANATANT, SERUM|ICTERIC||LC/MS/MS|MDRD FORMULA|||N||2|Visit_2|25|1|SCREENING|2021-01-11|2021-01-28|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|e8da815a-b53c-46f4-a546-e8553152719f|4|TSTFTSTT|Testosterone, Free/Testosterone|CHEMISTRY|[?]|mg/mL/min|[?]|[?]|INVALID|1|mU|1|1|[?]|HIGH|LYMPH|LACTESCENT|N|PAP STAIN|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2021-01-11|2021-03-11|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|e8da815a-b53c-46f4-a546-e8553152719f|5|ANTIDPRS|Antidepressants|CHEMISTRY|||[?]|[?]|INVALID|1|10^3 DNA copies/mL|1|1|[?]|HIGH|AMNIOTIC FLUID|THAWED||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|ASH FIBROSURE FORMULA||Y|N|Y|3|Visit_3|40|7|TREATMENT|2021-01-26|2021-01-30|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|e8da815a-b53c-46f4-a546-e8553152719f|6|MERCURY|Mercury|CHEMISTRY|[?]|IU/L|[?]|[?]|INDETERMINATE|1|/min|1|1|[?]|ABNORMAL|VITREOUS HUMOR|CALCIFIED||FLUORESCENT SPOT TEST|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|4|WASHOUT|2021-01-26|2021-03-06|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|e8da815a-b53c-46f4-a546-e8553152719f|7|CD11A|CD11A|URINALYSIS|||[?]|[?]|TRACE|1|OI50|1|1|[?]|HIGH|EXUDATE|ROOM TEMPERATURE||HEMOCYTOMETRY|MDRD 6 VARIABLE FORMULA|Y||NA|Y|4|Visit_4|65|1|TREATMENT|2021-02-20|2021-03-19|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|e8da815a-b53c-46f4-a546-e8553152719f|8|PRZPM|Prazepam|CHEMISTRY|[?]|/LSQN|[?]|[?]|BORDERLINE|1|uV*sec|1|1|[?]|HIGH|VENOUS CORD BLOOD|SOLIDIFIED||GC/MS|MDRD 4 VARIABLE FORMULA|Y|Y|Y||4|Visit_4|65|6|TREATMENT|2021-02-20|2021-03-21|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|e8da815a-b53c-46f4-a546-e8553152719f|9|HGBA2|Hemoglobin A2|CHEMISTRY|||[?]|[?]|TRACE|1|mmHg*min/L|1|1|[?]|ABNORMAL|LYMPH|CONCENTRATED||FLUORESCENT IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|||NA|Y|5|Visit_5|90|3|TREATMENT|2021-03-17|2021-03-19|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|LB|e8da815a-b53c-46f4-a546-e8553152719f|10|FACTVW|von Willebrand Factor|URINALYSIS|[?]|cmHg|[?]|[?]|TRACE|1|ECL unit|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|AUTOLYZED|N|SANGER SEQUENCING|CKD-EPI FORMULA|||Y||5|Visit_5|90|2|WASHOUT|2021-03-17|2021-03-26|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|LB|701d794b-07b4-4394-a2a4-d31a9f5b743a|1|LDLPSZ|LDL Particle Size|CHEMISTRY|[?]|umol/day|[?]|[?]|BORDERLINE|1|pmol/L/h|1|1|[?]|ABNORMAL|TRANSUDATE|NON-HEMOLYZED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD ENZYMATIC FORMULA|||NA||1|Visit_1|10|1|WASHOUT|2021-01-29|2021-04-15|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|LB|701d794b-07b4-4394-a2a4-d31a9f5b743a|2|AMYLB38|Amyloid Beta 1-38|CHEMISTRY|[?]|h*%|[?]|[?]|POSITIVE|1|mEq/uL|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|LIPEMIC|N|FLOCCULATION|COCKCROFT-GAULT FORMULA|Y||Y||1|Visit_1|10|1|WASHOUT|2021-01-29|2021-03-18|10|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|LB|701d794b-07b4-4394-a2a4-d31a9f5b743a|3|CARTP|Cocaine Amphetamine-Reg Transcript Prot|HEMATOLOGY|[?]|ug/L FEU|[?]|[?]|BORDERLINE|1|min*mg/mL|1|1|[?]|HIGH|PROSTATIC FLUID|REFRIGERATED||SNELLEN EYE CHART|FIBROTEST FORMULA|Y|Y|NA||2|Visit_2|25|5|TREATMENT|2021-02-13|2021-03-07|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|LB|701d794b-07b4-4394-a2a4-d31a9f5b743a|4|TRAMADOL|Tramadol|URINALYSIS|[?]|/10^3|[?]|[?]|TRACE|1|1/(s*kPa)|1|1|[?]|HIGH|LAVAGE FLUID|NON-HEMOLYZED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA|||Y||2|Visit_2|25|1|FOLLOW-UP|2021-02-13|2021-03-11|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|LB|701d794b-07b4-4394-a2a4-d31a9f5b743a|5|C5A|Complement C5a|HEMATOLOGY|||[?]|[?]|INVALID|1|BAR|1|1|[?]|HIGH|PERITONEAL FLUID|GELLED|N|CONTRAST ENHANCED SPIRAL CT SCAN|FIBROSIS 4 FORMULA|||Y|Y|3|Visit_3|40|1|FOLLOW-UP|2021-02-28|2021-04-22|40|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|701d794b-07b4-4394-a2a4-d31a9f5b743a|6|FATACFR|Free Fatty Acid|URINALYSIS|[?]|CCID 50/mL|[?]|[?]|INVALID|1|nkat/g Hb|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|AGGLUTINATED||URANYL ACETATE STAIN|MDRD ENZYMATIC FORMULA|||U||3|Visit_3|40|1|FOLLOW-UP|2021-02-28|2021-04-12|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|701d794b-07b4-4394-a2a4-d31a9f5b743a|7|NEUTLE|Neutrophils/Leukocytes|HEMATOLOGY|[?]|GPL U|[?]|[?]|NEGATIVE|1|mAnson U/mL|1|1|[?]|NORMAL|DIALYSIS FLUID|PARAFFIN-EMBEDDED||PET/MRI SCAN|FIBROTEST FORMULA|Y||NA||4|Visit_4|65|7|TREATMENT|2021-03-25|2021-04-12|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-19
e|LB|701d794b-07b4-4394-a2a4-d31a9f5b743a|8|PHOS|Phosphate|URINALYSIS|[?]|hr/day|[?]|[?]|INDETERMINATE|1|dpm/mg|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|FRESH||COMPUTERIZED CORNEAL TOPOGRAPHY|GMI MMOL/MOL FORMULA||Y|N||4|Visit_4|65|7|TREATMENT|2021-03-25|2021-04-09|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-19
e|LB|701d794b-07b4-4394-a2a4-d31a9f5b743a|9|BLASTNCE|Blasts/Nucleated Cells|HEMATOLOGY|[?]|10^6 CFU|[?]|[?]|POSITIVE|1|mL/cm3/min|1|1|[?]|HIGH|PLEURAL TISSUE|ROOM TEMPERATURE|N|FARR ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||5|Visit_5|90|6|TREATMENT|2021-04-19|2021-04-27|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|LB|701d794b-07b4-4394-a2a4-d31a9f5b743a|10|FACTIXA|Factor IX Activity|CHEMISTRY|[?]|PRESSOR UNITS|[?]|[?]|INVALID|1|um/day|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|N|PHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||5|Visit_5|90|7|TREATMENT|2021-04-19|2021-04-26|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|LB|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|1|C165892|Wild Rye Pollen IgE Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|dpm/mg|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|UNEXPECTED ODOR|N|SCINTIGRAPHY|GMI MMOL/MOL FORMULA||Y|NA|Y|1|Visit_1|10|5|SCREENING|2020-12-25|2021-02-16|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|2|BASOBLE|Basophils Band Form/Leukocytes|CHEMISTRY|[?]|ug/m2/h|[?]|[?]|BORDERLINE|1|ukat/L|1|1|[?]|NORMAL|SEBUM|ICTERIC||TRYPAN BLUE STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||1|Visit_1|10|5|FOLLOW-UP|2020-12-25|2021-02-27|10|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|3|PEPSNG|Pepsinogen|CHEMISTRY|[?]|ppm|[?]|[?]|TRACE|1|mg/g/min|1|1|[?]|LOW|TRANSUDATE|GELLED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI FORMULA|Y|Y|U||2|Visit_2|25|1|TREATMENT|2021-01-09|2021-02-08|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|4|ERCENC|Erythroid Cells/Nucleated Cells|URINALYSIS|[?]|cd*s/m2|[?]|[?]|BORDERLINE|1|m/sec|1|1|[?]|ABNORMAL|BREAST MILK|PARAFFIN-EMBEDDED|N|BALLPOINT PEN TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||2|Visit_2|25|5|TREATMENT|2021-01-09|2021-02-27|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|5|HLAA23A|HLA-A23 Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mmol/L|1|1|[?]|LOW|LAVAGE FLUID|HEMOLYZED||ELECTROPHORESIS|MDRD 6 VARIABLE FORMULA|||NA|Y|3|Visit_3|40|5|SCREENING|2021-01-24|2021-03-20|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|6|NPY|Neuropeptide Y|URINALYSIS|[?]|cmHg|[?]|[?]|BORDERLINE|1|uU/dL|1|1|[?]|HIGH|ALVEOLAR AIR|DRIED||CONTRAST ENHANCED PET/CT SCAN|MDRD FORMULA||Y|NA||3|Visit_3|40|1|WASHOUT|2021-01-24|2021-03-24|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|7|FPP|Protoporphyrin, Free|CHEMISTRY|||[?]|[?]|INVALID|1|ukat|1|1|[?]|ABNORMAL|LYSATE|CALCIFIED|N|ORCHIDOMETERY|NASH FIBROSURE FORMULA|||NA|Y|4|Visit_4|65|4|SCREENING|2021-02-18|2021-03-19|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|8|HGBA|Hemoglobin A|HEMATOLOGY|||[?]|[?]|TRACE|1|mm/sec|1|1|[?]|HIGH|EXPIRED AIR|FRESH||NEXT GENERATION SEQUENCING|MDRD 4 VARIABLE FORMULA|||U|Y|4|Visit_4|65|7|TREATMENT|2021-02-18|2021-02-28|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|9|INTLK23|Interleukin 23|URINALYSIS|[?]|CARTRIDGE|[?]|[?]|INVALID|1|APL U|1|1|[?]|LOW|INFRANATANT, SERUM|THAWED|N|DYNAMIC CONTRAST ENHANCED MRI|GMI % FORMULA|||NA||5|Visit_5|90|4|WASHOUT|2021-03-15|2021-03-20|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|LB|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|10|INTLK1RA|Interleukin 1 Receptor Antagonist|CHEMISTRY|[?]|DIOPTER|[?]|[?]|BORDERLINE|1|10^4 CFU|1|1|[?]|ABNORMAL|BONE MARROW|ROOM TEMPERATURE||NEXT GENERATION SEQUENCING|GMI % FORMULA|Y||U||5|Visit_5|90|5|TREATMENT|2021-03-15|2021-03-17|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|LB|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|1|SPMAGGLU|Sperm Agglutination|URINALYSIS|||[?]|[?]|TRACE|1|mV*min|1|1|[?]|ABNORMAL|REFLEX TEAR|CONCENTRATED||DIGITAL PCR ARRAY|CKD-EPI CREATININE FORMULA|||Y|Y|1|Visit_1|10|7|FOLLOW-UP|2020-08-10|2020-10-19|10|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|2|RETICH|Ret. Corpuscular Hemoglobin Content|CHEMISTRY|||[?]|[?]|INVALID|1|mm|1|1|[?]|LOW|RETICULOCYTES|FROZEN||CONTRAST ENHANCED SPIRAL CT SCAN|FIBROMETER FORMULA|||N|Y|1|Visit_1|10|1|FOLLOW-UP|2020-08-10|2020-10-10|10|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|3|PLSMCECE|Mature Plasma Cells/Total Cells|URINALYSIS|[?]|BE/mL|[?]|[?]|POSITIVE|1|mg/kg/h|1|1|[?]|NORMAL|PLATELET RICH PLASMA|AUTOLYZED||OPTICAL DENSITY MEASUREMENT|CKD-EPI CYSTATIN C FORMULA|Y||U||2|Visit_2|25|5|TREATMENT|2020-08-25|2020-08-29|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|4|NOREPIN|Norepinephrine|URINALYSIS|[?]|log10 CFU/g|[?]|[?]|INVALID|1|VOXEL|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|UNEXPECTED ODOR||ELISA|CKD-EPI CREATININE FORMULA|Y||N||2|Visit_2|25|7|TREATMENT|2020-08-25|2020-10-01|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|5|ANGPT2|Angiopoietin 2|HEMATOLOGY|[?]|deg2|[?]|[?]|BORDERLINE|1|10^9/dose|1|1|[?]|ABNORMAL|SEMINAL FLUID|CONTAMINATED||MAPH|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|4|SCREENING|2020-09-09|2020-09-28|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|6|NCCPTN|Nociceptin|HEMATOLOGY|[?]|g/cm2|[?]|[?]|NEGATIVE|1|Bq/kg|1|1|[?]|HIGH|VENOUS PLASMA|HEMOLYZED||X-RAY FLUORESCENCE SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||3|Visit_3|40|6|TREATMENT|2020-09-09|2020-09-16|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|7|C5A|Complement C5a|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|cmol|1|1|[?]|HIGH|ABSCESS FLUID|NON-HEMOLYZED|N|DARK FIELD MICROSCOPY|FIBROSIS 4 FORMULA|Y||U|Y|4|Visit_4|65|4|FOLLOW-UP|2020-10-04|2020-10-25|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|8|C165919|German Cockroach IgG AB RAST Score|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|L/min|1|1|[?]|LOW|AMNIOTIC FLUID|CALCIFIED||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|4|Visit_4|65|2|TREATMENT|2020-10-04|2020-11-07|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|9|C165888|Russian Thistle Pollen IgE Antibody|URINALYSIS|[?]|ug/kg/day|[?]|[?]|TRACE|1|mmol2/L2|1|1|[?]|HIGH|EMOTIONAL TEAR|THAWED||IMPEDANCE CONDUCTIVITY|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|6|FOLLOW-UP|2020-10-29|2020-11-01|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|10|C130094|Western Ragweed Pollen IgG|URINALYSIS|[?]|U/cL|[?]|[?]|NEGATIVE|1|DROP|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR||LC-FL|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||5|Visit_5|90|6|FOLLOW-UP|2020-10-29|2020-11-01|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|1|CSMIX|Mixed Casts|URINALYSIS|[?]|Ci/g|[?]|[?]|BORDERLINE|1|L/h/m2|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|FRESH||DXA SCAN|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||1|Visit_1|10|1|FOLLOW-UP|2021-01-02|2021-01-28|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|2|CD4|CD4|URINALYSIS|||[?]|[?]|BORDERLINE|1|NEBULE|1|1|[?]|HIGH|EMESIS|LIPEMIC|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|ASH FIBROSURE FORMULA|||N|Y|1|Visit_1|10|7|FOLLOW-UP|2021-01-02|2021-02-22|10|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|3|LIF|Leukemia Inhibitory Factor|HEMATOLOGY|[?]|10^7 CFU|[?]|[?]|BORDERLINE|1|g/animal/day|1|1|[?]|NORMAL|HAIR FOLLICLE|CLOTTED||ACRIDINE ORANGE STAIN|MDRD FORMULA|||N||2|Visit_2|25|6|TREATMENT|2021-01-17|2021-01-29|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|4|HIST2BAB|Histone 2B Antibody|HEMATOLOGY|[?]|mg/day|[?]|[?]|INVALID|1|10^9 organisms/g|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|NON-HEMOLYZED||POPULATION SEQUENCING|FIBROTEST FORMULA||Y|NA||2|Visit_2|25|4|TREATMENT|2021-01-17|2021-03-05|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|5|NEUTLE|Neutrophils/Leukocytes|HEMATOLOGY|[?]|s*kPa|[?]|[?]|INDETERMINATE|1|QUANTITY SUFFICIENT|1|1|[?]|ABNORMAL|CERUMEN|ROOM TEMPERATURE||SIZE EXCLUSION CHROMATOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||3|Visit_3|40|6|TREATMENT|2021-02-01|2021-03-28|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|6|ANTHRMAG|Antithrombin Antigen|CHEMISTRY|[?]|foz_us|[?]|[?]|NEGATIVE|1|DAgU|1|1|[?]|LOW|LYSATE|UNEXPECTED ODOR||IRON HEMATOXYLIN STAIN|MDRD 4 VARIABLE FORMULA|Y||U||3|Visit_3|40|1|TREATMENT|2021-02-01|2021-02-23|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|7|NEUTAGR|Agranular Neutrophils|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|uEq|1|1|[?]|HIGH|CEREBROSPINAL FLUID|CONTAMINATED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE FORMULA||Y|Y|Y|4|Visit_4|65|2|TREATMENT|2021-02-26|2021-03-26|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|8|INTLK9|Interleukin 9|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|m/sec|1|1|[?]|HIGH|PLASMA|REFRIGERATED||LIGHT MICROSCOPY|MDRD 5 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|5|SCREENING|2021-02-26|2021-03-29|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|9|BLASTNCE|Blasts/Nucleated Cells|CHEMISTRY|[?]|L/h/m2|[?]|[?]|NEGATIVE|1|pmol/day|1|1|[?]|HIGH|SEBUM|FROZEN||IN SITU HYBRIDIZATION|ASH FIBROSURE FORMULA||Y|Y||5|Visit_5|90|6|TREATMENT|2021-03-23|2021-03-31|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|10|SCHISTO|Schistocytes|HEMATOLOGY|[?]|%/min|[?]|[?]|POSITIVE|1|umol/mol|1|1|[?]|HIGH|MUCUS|HEMOLYZED||HPLC/MS/MS|HEPASCORE FORMULA|Y|Y|NA||5|Visit_5|90|6|TREATMENT|2021-03-23|2021-03-29|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|bb2487c3-cc05-48f8-9031-0e433c07e3d6|1|VITECHOL|Vitamin E/Cholesterol|CHEMISTRY|[?]|Enzyme U/g Hb|[?]|[?]|INDETERMINATE|1|ug/h|1|1|[?]|LOW|AQUEOUS HUMOR|NON-HEMOLYZED||CHROMOGENIC ASSAY|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|5|FOLLOW-UP|2020-11-29|2021-01-12|10|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|bb2487c3-cc05-48f8-9031-0e433c07e3d6|2|ASMACT|Alpha-Smooth Muscle Actin|CHEMISTRY|[?]|cup eq|[?]|[?]|NEGATIVE|1|AMPULE|1|1|[?]|HIGH|COLOSTRUM|HEMOLYZED||HEMAGGLUTINATION INHIBITION ASSAY|GMI MMOL/MOL FORMULA|Y||U||1|Visit_1|10|4|TREATMENT|2020-11-29|2021-01-05|10|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|bb2487c3-cc05-48f8-9031-0e433c07e3d6|3|NEUTTOXC|Neutrophilic Toxic Change|CHEMISTRY|[?]|10^4/L|[?]|[?]|TRACE|1|mol|1|1|[?]|LOW|LYMPH|ROOM TEMPERATURE||COMPLEMENT FIXATION|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|7|FOLLOW-UP|2020-12-14|2021-02-08|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|bb2487c3-cc05-48f8-9031-0e433c07e3d6|4|FLT3L|FMS-like Tyrosine Kinase 3 Ligand|URINALYSIS|[?]|10^9 CFU/g|[?]|[?]|INDETERMINATE|1|nmol/L/min|1|1|[?]|ABNORMAL|PLEURAL FLUID|UNEXPECTED ODOR||MICRO BROTH DILUTION|FIBROSIS 4 FORMULA||Y|N||2|Visit_2|25|1|TREATMENT|2020-12-14|2021-02-18|25|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|bb2487c3-cc05-48f8-9031-0e433c07e3d6|5|CTXII|Type II Collagen C-Telopeptides|CHEMISTRY|[?]|mL/kg/h|[?]|[?]|POSITIVE|1|mL/cm|1|1|[?]|HIGH|AQUEOUS HUMOR|UNEXPECTED ODOR|N|FARR ASSAY|GMI % FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-12-29|2021-02-13|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|LB|bb2487c3-cc05-48f8-9031-0e433c07e3d6|6|CYFRA18|Cytokeratin 18 Fragment|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mg/mol|1|1|[?]|HIGH|INTERSTITIAL FLUID|PARAFFIN-EMBEDDED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI % FORMULA|||Y|Y|3|Visit_3|40|3|TREATMENT|2020-12-29|2021-02-26|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|LB|bb2487c3-cc05-48f8-9031-0e433c07e3d6|7|HDLPL|HDL Phospholipid|CHEMISTRY|[?]|USP U|[?]|[?]|INVALID|1|ug/L/h|1|1|[?]|LOW|SPUTUM|LIPEMIC|N|GC/MS|MDRD ENZYMATIC FORMULA|||N||4|Visit_4|65|5|TREATMENT|2021-01-23|2021-02-03|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|bb2487c3-cc05-48f8-9031-0e433c07e3d6|8|PERIOSTN|Periostin|URINALYSIS|||[?]|[?]|TRACE|1|mEq/dL|1|1|[?]|ABNORMAL|CORD BLOOD|FRESH||EEG|CKD-EPI FORMULA|||U|Y|4|Visit_4|65|6|TREATMENT|2021-01-23|2021-02-05|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|bb2487c3-cc05-48f8-9031-0e433c07e3d6|9|CETP|Cholesteryl Ester Transfer Protein|CHEMISTRY|[?]|ug/L|[?]|[?]|NEGATIVE|1|TABLET|1|1|[?]|NORMAL|BONE MARROW|ROOM TEMPERATURE||MRS|CKD-EPI CYSTATIN C FORMULA|Y||Y||5|Visit_5|90|4|SCREENING|2021-02-17|2021-02-22|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|bb2487c3-cc05-48f8-9031-0e433c07e3d6|10|ANIONG4|Anion Gap 4|HEMATOLOGY|||[?]|[?]|TRACE|1|mm3/mm2/year|1|1|[?]|HIGH|ERYTHROCYTES|SOLIDIFIED|N|ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI FORMULA|||Y|Y|5|Visit_5|90|2|TREATMENT|2021-02-17|2021-02-18|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|2661da18-b539-49d8-ac80-9da03c127d21|1|MYELINAB|Myelin Antibodies|URINALYSIS|||[?]|[?]|TRACE|1|10^9/L|1|1|[?]|ABNORMAL|PLASMA|CONCENTRATED||IN SITU HYBRIDIZATION|GMI % FORMULA|||Y|Y|1|Visit_1|10|2|SCREENING|2020-07-26|2020-07-29|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|2661da18-b539-49d8-ac80-9da03c127d21|2|RBCDIPOP|Dimorphic Erythrocyte Population|CHEMISTRY|[?]|Newton|[?]|[?]|NEGATIVE|1|MBP|1|1|[?]|HIGH|TISSUE|LACTESCENT||TRANSCRIPTION-MEDIATED AMPLIFICATION|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-07-26|2020-09-24|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|2661da18-b539-49d8-ac80-9da03c127d21|3|HER2|Human Epidermal Growth Factor Receptor 2|URINALYSIS|[?]|10^3 CFU/mL|[?]|[?]|NEGATIVE|1|mL/s|1|1|[?]|HIGH|GASTRIC CONTENTS|SOLIDIFIED||GC/MS|FIBROTEST FORMULA|||U||2|Visit_2|25|2|SCREENING|2020-08-10|2020-09-12|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|2661da18-b539-49d8-ac80-9da03c127d21|4|CARNTEXR|Carnitine Excretion Rate|URINALYSIS|[?]|/HPF|[?]|[?]|TRACE|1|mg/kg/day|1|1|[?]|ABNORMAL|LOCHIA|FRESH|N|DIGITAL PCR ARRAY|FIBROTEST FORMULA|Y||NA||2|Visit_2|25|1|WASHOUT|2020-08-10|2020-10-22|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|2661da18-b539-49d8-ac80-9da03c127d21|5|ATHMBAAC|Antithrombin Activity Actual/Control|CHEMISTRY|[?]|ukat|[?]|[?]|BORDERLINE|1|mmol/kg|1|1|[?]|ABNORMAL|REFLEX TEAR|CONTAMINATED|N|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI FORMULA|||Y||3|Visit_3|40|3|FOLLOW-UP|2020-08-25|2020-09-21|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|2661da18-b539-49d8-ac80-9da03c127d21|6|OSTEOC|Osteocalcin|CHEMISTRY|[?]|BOX|[?]|[?]|BORDERLINE|1|MESF|1|1|[?]|HIGH|TUMOR TISSUE|GELLED||PEAK FLOWMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|4|TREATMENT|2020-08-25|2020-10-19|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|2661da18-b539-49d8-ac80-9da03c127d21|7|PAP|Prostatic Acid Phosphatase|CHEMISTRY|[?]|mmol/L|[?]|[?]|NEGATIVE|1|genEq|1|1|[?]|LOW|TUMOR TISSUE|NON-HEMOLYZED||CAPILLARY ELECTROPHORESIS|HEPASCORE FORMULA|||Y||4|Visit_4|65|1|TREATMENT|2020-09-19|2020-09-24|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|2661da18-b539-49d8-ac80-9da03c127d21|8|MCH|Ery. Mean Corpuscular Hemoglobin|CHEMISTRY|||[?]|[?]|POSITIVE|1|kPa|1|1|[?]|HIGH|BILE|ROOM TEMPERATURE||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD ENZYMATIC JAPANESE FORMULA|Y||N|Y|4|Visit_4|65|1|TREATMENT|2020-09-19|2020-09-21|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|2661da18-b539-49d8-ac80-9da03c127d21|9|NORMBASO|Basophilic Normoblast|URINALYSIS|[?]|Joule|[?]|[?]|INDETERMINATE|1|Pack Year|1|1|[?]|LOW|VENOUS PLASMA|AUTOLYZED|N|PET/SPECT SCAN|CKD-EPI CYSTATIN C FORMULA|Y||U||5|Visit_5|90|1|FOLLOW-UP|2020-10-14|2020-10-21|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|2661da18-b539-49d8-ac80-9da03c127d21|10|PNCTPP|Pancreatic Polypeptide|URINALYSIS|[?]|mEq/ug|[?]|[?]|INDETERMINATE|1|ppm|1|1|[?]|NORMAL|PLATELET RICH PLASMA|FRESH|N|MAGNETIC RESONANCE ANGIOGRAPHY|FIBROSIS 4 FORMULA||Y|N||5|Visit_5|90|5|TREATMENT|2020-10-14|2020-10-20|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|f1835786-c567-4235-9bd1-f7ffcec12741|1|CHOLCM|Cholate Compounds|URINALYSIS|[?]|/mm|[?]|[?]|TRACE|1|10^10/L|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|HEMOLYZED|N|WESTERGREN|CKD-EPI CREATININE FORMULA|||N||1|Visit_1|10|4|TREATMENT|2020-08-06|2020-09-01|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|f1835786-c567-4235-9bd1-f7ffcec12741|2|MMP8|Matrix Metalloproteinase 8|HEMATOLOGY|[?]|MBq/uL|[?]|[?]|INDETERMINATE|1|kPa|1|1|[?]|ABNORMAL|DERMAL TISSUE|LIPEMIC||CELL BASED BIOASSAY|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-08-06|2020-09-01|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|f1835786-c567-4235-9bd1-f7ffcec12741|3|ETPLT|ETP Lag Time|CHEMISTRY|||[?]|[?]|BORDERLINE|1|U/dL|1|1|[?]|ABNORMAL|SKIN TISSUE|PARAFFIN-EMBEDDED|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI FORMULA||Y|Y|Y|2|Visit_2|25|6|TREATMENT|2020-08-21|2020-09-12|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|f1835786-c567-4235-9bd1-f7ffcec12741|4|ANGPT2|Angiopoietin 2|HEMATOLOGY|[?]|cL|[?]|[?]|INVALID|1|mph|1|1|[?]|HIGH|KERATINOCYTE|LACTESCENT||DC SHEATH FLOW|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||2|Visit_2|25|5|TREATMENT|2020-08-21|2020-10-20|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|f1835786-c567-4235-9bd1-f7ffcec12741|5|VEGFD|Vascular Endothelial Growth Factor D|URINALYSIS|[?]|kUSP|[?]|[?]|POSITIVE|1|nL|1|1|[?]|LOW|SWABBED MATERIAL|CLOTTED||IMMUNOBLOT|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|6|FOLLOW-UP|2020-09-05|2020-10-05|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|f1835786-c567-4235-9bd1-f7ffcec12741|6|ASN|Asparagine|HEMATOLOGY|[?]|L/day|[?]|[?]|INVALID|1|mEq/g|1|1|[?]|HIGH|DIALYSIS FLUID|SOLIDIFIED|N|ARTERIAL SPIN LABELING FUNCTIONAL MRI|FIBROTEST FORMULA|||NA||3|Visit_3|40|1|WASHOUT|2020-09-05|2020-10-11|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|f1835786-c567-4235-9bd1-f7ffcec12741|7|OXZPM|Oxazepam|CHEMISTRY|[?]|Bq/mg|[?]|[?]|NEGATIVE|1|DROP|1|1|[?]|ABNORMAL|EXPIRED AIR|REFRIGERATED||FLUORESCENT SPOT TEST|MDRD 6 VARIABLE FORMULA|Y||N||4|Visit_4|65|1|TREATMENT|2020-09-30|2020-10-28|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|f1835786-c567-4235-9bd1-f7ffcec12741|8|LYMPHOTC|Lymphotactin|HEMATOLOGY|[?]|BOTTLE|[?]|[?]|POSITIVE|1|U/mL|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|AGGLUTINATED||MEDIASTINOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-09-30|2020-10-25|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|f1835786-c567-4235-9bd1-f7ffcec12741|9|ANA|Antinuclear Antibodies|URINALYSIS|[?]|IU/day|[?]|[?]|POSITIVE|1|mmol/mol|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|AUTOLYZED||COLORIMETRY|MDRD 6 VARIABLE FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2020-10-25|2020-11-01|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|f1835786-c567-4235-9bd1-f7ffcec12741|10|MICROCY|Microcytes|HEMATOLOGY|[?]|PFU/animal|[?]|[?]|BORDERLINE|1|VIAL|1|1|[?]|NORMAL|CAPILLARY PLASMA|FROZEN||KINETIC MICROPARTICLE IMMUNOASSAY|HEPASCORE FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-10-25|2020-10-31|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|019eb415-1da3-40fa-b4ba-b1f381ec3cac|1|EAGLUC|Glucose, Estimated Average|HEMATOLOGY|[?]|CAN|[?]|[?]|INDETERMINATE|1|mmol/mol|1|1|[?]|NORMAL|AQUEOUS HUMOR|ROOM TEMPERATURE|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROMETER FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-07-10|2020-08-07|10|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|019eb415-1da3-40fa-b4ba-b1f381ec3cac|2|GLUCPE|Plasma Equivalent Glucose|CHEMISTRY|[?]|U/kg/day|[?]|[?]|TRACE|1|SYRINGE|1|1|[?]|ABNORMAL|PROSTATIC FLUID|FROZEN||TOTAL BODY RADIOGRAPHY|FIBROTEST FORMULA||Y|N||1|Visit_1|10|1|TREATMENT|2020-07-10|2020-08-09|10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|019eb415-1da3-40fa-b4ba-b1f381ec3cac|3|PTAC|Prothrombin Time Actual/Control|HEMATOLOGY|[?]|ng/mol|[?]|[?]|INVALID|1|mm|1|1|[?]|NORMAL|LOCHIA|ICTERIC|N|OPTICAL COHERENCE TOMOGRAPHY|MDRD ENZYMATIC FORMULA||Y|NA||2|Visit_2|25|3|TREATMENT|2020-07-25|2020-09-17|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|019eb415-1da3-40fa-b4ba-b1f381ec3cac|4|APPEAR|Specimen Appearance|CHEMISTRY|[?]|U/g/min|[?]|[?]|BORDERLINE|1|log10 CFU/g|1|1|[?]|HIGH|URINE|ICTERIC||TURBIDIMETRY|MDRD FORMULA|||N||2|Visit_2|25|2|SCREENING|2020-07-25|2020-09-16|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|019eb415-1da3-40fa-b4ba-b1f381ec3cac|5|LYMPHOID|Lymphoid Cells|HEMATOLOGY|[?]|NEBULE|[?]|[?]|INDETERMINATE|1|PIXELS/in|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|AUTOLYZED||U-HPLC/MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|5|WASHOUT|2020-08-09|2020-08-16|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|019eb415-1da3-40fa-b4ba-b1f381ec3cac|6|LEU|Leucine|URINALYSIS|[?]|cm/min|[?]|[?]|INVALID|1|ug/kg/day|1|1|[?]|NORMAL|PROSTATIC FLUID|FROZEN||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA||Y|Y||3|Visit_3|40|5|TREATMENT|2020-08-09|2020-08-14|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|019eb415-1da3-40fa-b4ba-b1f381ec3cac|7|RETCRRBC|HCT Corrected Reticulocytes/Erythrocytes|HEMATOLOGY|[?]|g/animal/wk|[?]|[?]|INVALID|1|DRINK|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|FRESH||RADIATION DOSIMETRY|HEPASCORE FORMULA|||NA||4|Visit_4|65|5|FOLLOW-UP|2020-09-03|2020-09-24|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|019eb415-1da3-40fa-b4ba-b1f381ec3cac|8|LDH1|LDH Isoenzyme 1|HEMATOLOGY|[?]|mOsm/kg|[?]|[?]|INVALID|1|mg/kg|1|1|[?]|LOW|ARTERIAL BLOOD|PARAFFIN-EMBEDDED||FLOW CYTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|6|FOLLOW-UP|2020-09-03|2020-09-19|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|019eb415-1da3-40fa-b4ba-b1f381ec3cac|9|PHENTHZ|Phenothiazine|HEMATOLOGY|||[?]|[?]|INVALID|1|mmol/kg|1|1|[?]|LOW|DERMAL TISSUE|CLOTTED||LANDOLT RING|FIBROSIS 4 FORMULA|Y||NA|Y|5|Visit_5|90|2|WASHOUT|2020-09-28|2020-10-03|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|019eb415-1da3-40fa-b4ba-b1f381ec3cac|10|INTLK1A|Interleukin 1 Alpha|CHEMISTRY|[?]|/100 WBC|[?]|[?]|TRACE|1|mm3/mm2/year|1|1|[?]|LOW|LAVAGE FLUID|GELLED||ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD 4 VARIABLE FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2020-09-28|2020-10-06|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|2506c6e2-018f-4300-b3b5-44ff8d6e13df|1|C130100|Mixed Antigen IgE Antibody|HEMATOLOGY|[?]|U/kg/min|[?]|[?]|INDETERMINATE|1|m|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC||DUKE INCISION METHOD|COCKCROFT-GAULT FORMULA||Y|Y||1|Visit_1|10|4|TREATMENT|2020-07-23|2020-08-11|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|2506c6e2-018f-4300-b3b5-44ff8d6e13df|2|CRYGLBSR|Cryoglobulin Volume/Serum Volume|HEMATOLOGY|[?]|damol/L|[?]|[?]|INDETERMINATE|1|mL/cage|1|1|[?]|HIGH|SUPERNATANT, PLASMA|ICTERIC|N|NEXT GENERATION TARGETED SEQUENCING|CKD-EPI FORMULA||Y|U||1|Visit_1|10|7|SCREENING|2020-07-23|2020-09-11|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|2506c6e2-018f-4300-b3b5-44ff8d6e13df|3|LRG1|Leucine Rich Alpha-2-Glycoprotein 1|HEMATOLOGY|[?]|scm|[?]|[?]|NEGATIVE|1|ms/mmHg|1|1|[?]|LOW|EMOTIONAL TEAR|THAWED|N|TEST STRIP|FIBROTEST FORMULA|Y|Y|Y||2|Visit_2|25|3|WASHOUT|2020-08-07|2020-08-16|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|2506c6e2-018f-4300-b3b5-44ff8d6e13df|4|IGHG2|Immunoglobulin Heavy Constant Gamma 2|CHEMISTRY|||[?]|[?]|TRACE|1|PA|1|1|[?]|NORMAL|CALCULUS|LACTESCENT|N|ELECTROGASTROGRAPHY|COCKCROFT-GAULT FORMULA|Y||Y|Y|2|Visit_2|25|4|FOLLOW-UP|2020-08-07|2020-09-29|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|2506c6e2-018f-4300-b3b5-44ff8d6e13df|5|ANAG|Alpha-N-acetylglucosaminidase|CHEMISTRY|[?]|GBq/mg|[?]|[?]|BORDERLINE|1|g/animal|1|1|[?]|LOW|URINE|AGGLUTINATED|N|NEXT GENERATION SEQUENCING|CKD-EPI CREATININE FORMULA|||U||3|Visit_3|40|2|TREATMENT|2020-08-22|2020-10-04|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|2506c6e2-018f-4300-b3b5-44ff8d6e13df|6|NORMEEXR|Normetanephrine Excretion Rate|HEMATOLOGY|[?]|mL/min/mmHg|[?]|[?]|INVALID|1|mL/animal|1|1|[?]|LOW|ARTERIAL BLOOD|CLOTTED||RAJI CELL RIA|MDRD FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-08-22|2020-10-08|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|2506c6e2-018f-4300-b3b5-44ff8d6e13df|7|PLTAGAMP|Platelet Aggregation Amplitude|CHEMISTRY|||[?]|[?]|NEGATIVE|1|ug/L FEU|1|1|[?]|ABNORMAL|MUSCLE TISSUE|REFRIGERATED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|4|Visit_4|65|7|TREATMENT|2020-09-16|2020-09-26|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|2506c6e2-018f-4300-b3b5-44ff8d6e13df|8|B2G1GGAB|Beta-2 Glycoprotein 1 IgG Antibody|HEMATOLOGY|[?]|10^6/Ejaculate U|[?]|[?]|NEGATIVE|1|uL/dose|1|1|[?]|LOW|CELL PELLET|UNEXPECTED ODOR||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|FIBROMETER FORMULA||Y|U||4|Visit_4|65|3|TREATMENT|2020-09-16|2020-09-29|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|2506c6e2-018f-4300-b3b5-44ff8d6e13df|9|HGBDOXY|Deoxyhemoglobin|HEMATOLOGY|[?]|kPa|[?]|[?]|NEGATIVE|1|mol/g|1|1|[?]|LOW|MONOCYTE|NON-HEMOLYZED||LC/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||5|Visit_5|90|6|FOLLOW-UP|2020-10-11|2020-10-15|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|2506c6e2-018f-4300-b3b5-44ff8d6e13df|10|LRZPM|Lorazepam|URINALYSIS|||[?]|[?]|POSITIVE|1|ukat/L|1|1|[?]|HIGH|MUSCLE TISSUE|SOLIDIFIED||FLOCCULATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U|Y|5|Visit_5|90|3|WASHOUT|2020-10-11|2020-10-14|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|65c439f8-9658-4ac5-9eae-0837182a90fd|1|KRCYMGCE|Megakaryocytes/Total Cells|HEMATOLOGY|[?]|mg/kg/dose|[?]|[?]|NEGATIVE|1|mL/dL|1|1|[?]|ABNORMAL|TUMOR TISSUE|CALCIFIED||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-06-04|2020-08-09|10|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|65c439f8-9658-4ac5-9eae-0837182a90fd|2|LDLOXAB|Oxidized LDL Cholesterol Antibody|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|/LPF|1|1|[?]|NORMAL|SOFT TISSUE|CALCIFIED|N|SPECT SCAN|MDRD 5 VARIABLE FORMULA|Y|Y|U|Y|1|Visit_1|10|6|FOLLOW-UP|2020-06-04|2020-07-24|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|65c439f8-9658-4ac5-9eae-0837182a90fd|3|G6PDRBC|G6PD-Deficient Erythrocytes|URINALYSIS|||[?]|[?]|POSITIVE|1|Joule|1|1|[?]|NORMAL|CORD BLOOD|FROZEN||LIGHT SCATTERING SPECTROSCOPY|HEPASCORE FORMULA|||N|Y|2|Visit_2|25|7|SCREENING|2020-06-19|2020-08-31|25|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|65c439f8-9658-4ac5-9eae-0837182a90fd|4|BNPPRONT|N-Terminal ProB-type Natriuretic Peptide|CHEMISTRY|[?]|10^7 PFU|[?]|[?]|NEGATIVE|1|kg/cm2|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|AGGLUTINATED|N|HEMATOXYLIN AND EOSIN STAIN|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-06-19|2020-07-18|25|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|65c439f8-9658-4ac5-9eae-0837182a90fd|5|MYBLAT3|Type III Myeloblasts|CHEMISTRY|[?]|ohm|[?]|[?]|INVALID|1|U/mmol|1|1|[?]|LOW|CAPILLARY PLASMA|LIPEMIC|N|TOLUIDINE BLUE STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA||3|Visit_3|40|2|WASHOUT|2020-07-04|2020-08-04|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|LB|65c439f8-9658-4ac5-9eae-0837182a90fd|6|PTHW|Parathyroid Hormone, Whole|URINALYSIS|[?]|AFU|[?]|[?]|INVALID|1|cm/min|1|1|[?]|ABNORMAL|TISSUE|DRIED||TEST STRIP|FIBROTEST FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-07-04|2020-07-20|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|LB|65c439f8-9658-4ac5-9eae-0837182a90fd|7|LDH1LDH|LDH Isoenzyme 1/LDH|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|Bq/uL|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|GELLED||KARYOTYPING|GMI % FORMULA||Y|N|Y|4|Visit_4|65|4|TREATMENT|2020-07-29|2020-08-06|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|LB|65c439f8-9658-4ac5-9eae-0837182a90fd|8|MBP|Myelin Basic Protein|HEMATOLOGY|[?]|EVENTS|[?]|[?]|BORDERLINE|1|/HPF|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|CONCENTRATED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|FIBROTEST FORMULA|Y|Y|N||4|Visit_4|65|1|FOLLOW-UP|2020-07-29|2020-08-09|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|LB|65c439f8-9658-4ac5-9eae-0837182a90fd|9|C165930|Shellfish Mix IgE AB RAST Score|CHEMISTRY|||[?]|[?]|TRACE|1|PACKAGE|1|1|[?]|ABNORMAL|KERATINOCYTE|GELLED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA|Y||U|Y|5|Visit_5|90|6|TREATMENT|2020-08-23|2020-08-24|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|65c439f8-9658-4ac5-9eae-0837182a90fd|10|PHOSLPD|Phospholipid|HEMATOLOGY|[?]|10^3 RNA copies/mL|[?]|[?]|INDETERMINATE|1|g/cm2|1|1|[?]|ABNORMAL|HAIR FOLLICLE|CONCENTRATED||ANTIBIOTIC AGAR SCREEN|FIBROMETER FORMULA|Y|Y|NA||5|Visit_5|90|1|WASHOUT|2020-08-23|2020-08-31|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|5b73ad4c-bb28-47d1-a2f6-8508444059a5|1|FATACFRS|Free Fatty Acid, Saturated|URINALYSIS|||[?]|[?]|NEGATIVE|1|uL/kg/day|1|1|[?]|HIGH|HAIR|LIPEMIC||ARTERIAL SPIN LABELING FUNCTIONAL MRI|CKD-EPI FORMULA||Y|U|Y|1|Visit_1|10|5|WASHOUT|2020-06-12|2020-07-10|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|5b73ad4c-bb28-47d1-a2f6-8508444059a5|2|DENSITY|Density|CHEMISTRY|[?]|breaths/min|[?]|[?]|POSITIVE|1|genEq|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|REFRIGERATED||IHC|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||1|Visit_1|10|4|TREATMENT|2020-06-12|2020-08-10|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|5b73ad4c-bb28-47d1-a2f6-8508444059a5|3|HIST1AB|Histone 1 Antibody|HEMATOLOGY|[?]|/2500 WBC|[?]|[?]|INDETERMINATE|1|PACKAGE|1|1|[?]|NORMAL|BUFFY COAT|SOLIDIFIED||KARYOTYPING|ASH FIBROSURE FORMULA||Y|U||2|Visit_2|25|2|TREATMENT|2020-06-27|2020-08-17|25|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|5b73ad4c-bb28-47d1-a2f6-8508444059a5|4|EPSTI1|Epithelial Stromal Interaction Protein 1|URINALYSIS|[?]|nmol|[?]|[?]|INVALID|1|mL/dose|1|1|[?]|LOW|MIXED VENOUS BLOOD|NON-HEMOLYZED|N|CAPILLARY ELECTROPHORESIS|HEPASCORE FORMULA|Y||Y||2|Visit_2|25|4|WASHOUT|2020-06-27|2020-09-07|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|5b73ad4c-bb28-47d1-a2f6-8508444059a5|5|CASULPH|Calcium Sulphate|CHEMISTRY|[?]|CIGARETTE|[?]|[?]|BORDERLINE|1|APL U|1|1|[?]|HIGH|URINE|LACTESCENT|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|ASH FIBROSURE FORMULA|||U||3|Visit_3|40|3|TREATMENT|2020-07-12|2020-09-01|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|5b73ad4c-bb28-47d1-a2f6-8508444059a5|6|INTLK22|Interleukin 22|CHEMISTRY|[?]|uU/L|[?]|[?]|INDETERMINATE|1|mg/h|1|1|[?]|NORMAL|SPERMATOZOON|PARAFFIN-EMBEDDED|N|PHOTOMETRIC CLOT DETECTION|CKD-EPI CYSTATIN C FORMULA|Y||U||3|Visit_3|40|1|TREATMENT|2020-07-12|2020-08-16|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|5b73ad4c-bb28-47d1-a2f6-8508444059a5|7|AAMAPAC|Alpha-Aminoadipic Acid|HEMATOLOGY|||[?]|[?]|POSITIVE|1|WEEKS|1|1|[?]|NORMAL|VENOUS BLOOD|NON-HEMOLYZED|N|POPULATION SEQUENCING|HEPASCORE FORMULA|Y|Y|U|Y|4|Visit_4|65|7|TREATMENT|2020-08-06|2020-08-24|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|5b73ad4c-bb28-47d1-a2f6-8508444059a5|8|RENINA|Renin Activity|HEMATOLOGY|||[?]|[?]|INVALID|1|WAFER|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|CONCENTRATED|N|NUCLEIC ACID HYBRIDIZATION|FIBROTEST FORMULA|||N|Y|4|Visit_4|65|2|TREATMENT|2020-08-06|2020-08-08|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|5b73ad4c-bb28-47d1-a2f6-8508444059a5|9|CA242AG|Cancer Antigen 242|CHEMISTRY|[?]|uOsm|[?]|[?]|INDETERMINATE|1|PFU/mL|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|NON-HEMOLYZED|N|LINE PROBE ASSAY|GMI % FORMULA||Y|U||5|Visit_5|90|7|TREATMENT|2020-08-31|2020-09-07|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|5b73ad4c-bb28-47d1-a2f6-8508444059a5|10|MAYHEG|May-Hegglin Anomaly|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Bq/g|1|1|[?]|HIGH|LOCHIA|ROOM TEMPERATURE|N|NEXT GENERATION TARGETED SEQUENCING|MDRD 6 VARIABLE FORMULA|Y||NA|Y|5|Visit_5|90|4|FOLLOW-UP|2020-08-31|2020-09-02|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|16dcaefa-701c-4863-b010-8ac640aeb55a|1|TRACP5B|Tartrate-Resistant Acid Phosphatase 5b|HEMATOLOGY|[?]|CCID 50/dose|[?]|[?]|TRACE|1|ELISA unit|1|1|[?]|LOW|CEREBROSPINAL FLUID|AGGLUTINATED|N|ELECTROMYOGRAPHY|CKD-EPI FORMULA|Y||NA||1|Visit_1|10|3|TREATMENT|2020-06-17|2020-09-05|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|16dcaefa-701c-4863-b010-8ac640aeb55a|2|MYBLALE|Myeloblasts/Leukocytes|URINALYSIS|||[?]|[?]|TRACE|1|Gy/min|1|1|[?]|HIGH|INTERSTITIAL FLUID|THAWED|N|CELLULOSE TAPE|GMI MMOL/MOL FORMULA|||Y|Y|1|Visit_1|10|4|TREATMENT|2020-06-17|2020-06-26|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|16dcaefa-701c-4863-b010-8ac640aeb55a|3|CD45RALY|CD45RA/Lymphocytes|HEMATOLOGY|||[?]|[?]|INVALID|1|mg/m2/day|1|1|[?]|NORMAL|PLEURAL FLUID|CLOTTED||IMMUNOCHROMATOGRAPHY|COCKCROFT-GAULT FORMULA|||U|Y|2|Visit_2|25|4|TREATMENT|2020-07-02|2020-09-10|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|16dcaefa-701c-4863-b010-8ac640aeb55a|4|CYSTHION|Cystathionine|URINALYSIS|[?]|U/m2|[?]|[?]|POSITIVE|1|ug|1|1|[?]|HIGH|COLOSTRUM|CALCIFIED||TELLER ACUITY CARDS|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-07-02|2020-07-14|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|16dcaefa-701c-4863-b010-8ac640aeb55a|5|PYOCYTES|Pyocytes|URINALYSIS|[?]|L/min/m2|[?]|[?]|TRACE|1|ugEq/L|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|DRIED||CONTRAST ENHANCED CT SCAN|MDRD FORMULA|||NA||3|Visit_3|40|4|WASHOUT|2020-07-17|2020-08-08|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|16dcaefa-701c-4863-b010-8ac640aeb55a|6|CA|Calcium|CHEMISTRY|[?]|%(w/v)|[?]|[?]|INVALID|1|scm|1|1|[?]|NORMAL|STOOL|FROZEN|N|OBSERVATION|GMI % FORMULA|Y||N||3|Visit_3|40|7|FOLLOW-UP|2020-07-17|2020-07-23|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|16dcaefa-701c-4863-b010-8ac640aeb55a|7|GDIGA1|Galactose-Deficient IgA1|URINALYSIS|[?]|DAgU/mL|[?]|[?]|INDETERMINATE|1|uEq/L|1|1|[?]|ABNORMAL|CORD SERUM|GELLED||ERGOSPIROMETRY|FIBROMETER FORMULA|Y||U||4|Visit_4|65|6|TREATMENT|2020-08-11|2020-09-05|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|16dcaefa-701c-4863-b010-8ac640aeb55a|8|DOPAMINE|Dopamine|HEMATOLOGY|[?]|U/kg/min|[?]|[?]|INVALID|1|min|1|1|[?]|ABNORMAL|URINE SEDIMENT|NON-HEMOLYZED||MRS|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|1|TREATMENT|2020-08-11|2020-09-11|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|16dcaefa-701c-4863-b010-8ac640aeb55a|9|CHCNT|Corpuscular Hemoglobin Content|URINALYSIS|[?]|APL U|[?]|[?]|BORDERLINE|1|10^12/L|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|AGGLUTINATED||CARDIAC THERMODILUTION|MDRD 6 VARIABLE FORMULA||Y|N||5|Visit_5|90|2|WASHOUT|2020-09-05|2020-09-08|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|16dcaefa-701c-4863-b010-8ac640aeb55a|10|RETIM|Medium Absorption Reticulocytes|URINALYSIS|||[?]|[?]|TRACE|1|s*kPa|1|1|[?]|HIGH|ADIPOSE TISSUE|SOLIDIFIED||TRIPLE-PHASE MRI SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|5|Visit_5|90|6|SCREENING|2020-09-05|2020-09-12|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|4c19e870-9195-41d8-9c8a-8a54bb428732|1|BALA|Beta Alanine|URINALYSIS|[?]|Shock Wave|[?]|[?]|INVALID|1|ug/h|1|1|[?]|LOW|MUSCLE TISSUE|PARAFFIN-EMBEDDED|N|HEMOCYTOMETRY|FIBROTEST FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-08-03|2020-09-25|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|4c19e870-9195-41d8-9c8a-8a54bb428732|2|METHQLDN|Methaqualone|HEMATOLOGY|[?]|ng|[?]|[?]|INVALID|1|mg/cm2|1|1|[?]|LOW|SMEGMA|AGGLUTINATED||GEL ELECTROPHORESIS|FIBROTEST FORMULA||Y|NA||1|Visit_1|10|7|TREATMENT|2020-08-03|2020-08-04|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|4c19e870-9195-41d8-9c8a-8a54bb428732|3|SCCAG|Squamous Cell Carcinoma Antigen|HEMATOLOGY|[?]|FINGERTIP UNIT|[?]|[?]|NEGATIVE|1|AU/mL|1|1|[?]|NORMAL|SERUM OR PLASMA|DRIED||CONGO RED STAIN|MDRD 4 VARIABLE FORMULA||Y|U||2|Visit_2|25|2|TREATMENT|2020-08-18|2020-08-19|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|4c19e870-9195-41d8-9c8a-8a54bb428732|4|HALLUC|Hallucinogen|CHEMISTRY|||[?]|[?]|INVALID|1|DIOPTER|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|AUTOLYZED||FLUORESCENCE ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|4|TREATMENT|2020-08-18|2020-09-09|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|4c19e870-9195-41d8-9c8a-8a54bb428732|5|OXZPM|Oxazepam|CHEMISTRY|[?]|DIP|[?]|[?]|INDETERMINATE|1|GPS U|1|1|[?]|NORMAL|VITREOUS HUMOR|UNEXPECTED ODOR||LIQUID SCINTILLATION COUNTING|FIBROTEST FORMULA|||Y||3|Visit_3|40|1|SCREENING|2020-09-02|2020-09-24|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|4c19e870-9195-41d8-9c8a-8a54bb428732|6|C1INH|Complement C1 Esterase Inhibitor|HEMATOLOGY|[?]|Ci/kg|[?]|[?]|INVALID|1|P|1|1|[?]|HIGH|PUS|PARAFFIN-EMBEDDED||IMMUNE REPERTOIRE DEEP SEQUENCING|CKD-EPI FORMULA||Y|Y||3|Visit_3|40|1|WASHOUT|2020-09-02|2020-10-04|40|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|4c19e870-9195-41d8-9c8a-8a54bb428732|7|T4FR|Thyroxine, Free|URINALYSIS|[?]|log EID 50/dose|[?]|[?]|INVALID|1|DAYS|1|1|[?]|HIGH|MIXED VENOUS BLOOD|GELLED|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-09-27|2020-10-31|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|4c19e870-9195-41d8-9c8a-8a54bb428732|8|C130082|Orchard Grass Pollen IgG|URINALYSIS|[?]|nCi|[?]|[?]|TRACE|1|Gy/min|1|1|[?]|LOW|HAIR FOLLICLE|LACTESCENT||NUCLEIC ACID BASED METHOD|CKD-EPI FORMULA||Y|NA||4|Visit_4|65|2|TREATMENT|2020-09-27|2020-10-09|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|4c19e870-9195-41d8-9c8a-8a54bb428732|9|MASTCE|Mast Cells|CHEMISTRY|[?]|uU/L|[?]|[?]|INVALID|1|g/U|1|1|[?]|NORMAL|LYMPH|AGGLUTINATED||ELECTRICAL IMPEDANCE MYOGRAPHY|FIBROMETER FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-10-22|2020-10-29|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|4c19e870-9195-41d8-9c8a-8a54bb428732|10|RNPSMAB|Ribonucleoprotein Smith Complex Antibody|HEMATOLOGY|[?]|mEq|[?]|[?]|INDETERMINATE|1|g/mol|1|1|[?]|ABNORMAL|SERUM|CALCIFIED|N|PHOTOMETRIC CLOT DETECTION|FIBROTEST FORMULA|||U||5|Visit_5|90|6|FOLLOW-UP|2020-10-22|2020-10-25|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|7682184f-0801-4315-9c5f-116f7321a2b0|1|VLDL2|VLDL Cholesterol Subtype 2|CHEMISTRY|[?]|cup eq|[?]|[?]|NEGATIVE|1|mol|1|1|[?]|ABNORMAL|LYMPH|HEMOLYZED||LEAD CITRATE STAIN|NASH FIBROSURE FORMULA|Y|Y|U||1|Visit_1|10|2|FOLLOW-UP|2020-12-22|2020-12-23|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|LB|7682184f-0801-4315-9c5f-116f7321a2b0|2|MYCEMPOL|Myeloid Maturation Pool|CHEMISTRY|[?]|IU/mL|[?]|[?]|INVALID|1|Farad|1|1|[?]|NORMAL|CORD SERUM|PARAFFIN-EMBEDDED||CONTACT SPECULAR MICROSCOPY|MDRD FORMULA|Y|Y|U||1|Visit_1|10|3|TREATMENT|2020-12-22|2021-02-20|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|LB|7682184f-0801-4315-9c5f-116f7321a2b0|3|LSD|Lysergic Acid Diethylamide|URINALYSIS|[?]|mol/mL|[?]|[?]|POSITIVE|1|COAT|1|1|[?]|ABNORMAL|HAIR FOLLICLE|CALCIFIED|N|SPECTROPHOTOMETRY|MDRD FORMULA|||N||2|Visit_2|25|1|WASHOUT|2021-01-06|2021-02-10|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|7682184f-0801-4315-9c5f-116f7321a2b0|4|VITE|Vitamin E|HEMATOLOGY|||[?]|[?]|INVALID|1|10^6 organisms/mL|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|DRIED|N|NUCLEIC ACID AMPLIFICATION TEST|MDRD 5 VARIABLE FORMULA|||U|Y|2|Visit_2|25|3|FOLLOW-UP|2021-01-06|2021-03-04|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|7682184f-0801-4315-9c5f-116f7321a2b0|5|GLY|Glycine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Absorbance U/mL|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|CLOTTED|N|COULOMETRIC TITRATION|COCKCROFT-GAULT FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2021-01-21|2021-03-03|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|7682184f-0801-4315-9c5f-116f7321a2b0|6|FACTVA|Factor V Activity|CHEMISTRY|[?]|P|[?]|[?]|TRACE|1|yd|1|1|[?]|ABNORMAL|BONE MARROW|NON-HEMOLYZED||ENZYMATIC SPECTROPHOTOMETRY|MDRD 5 VARIABLE FORMULA||Y|U||3|Visit_3|40|4|SCREENING|2021-01-21|2021-03-21|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|7682184f-0801-4315-9c5f-116f7321a2b0|7|CLUECE|Clue Cells|CHEMISTRY|[?]|copies/uL|[?]|[?]|INVALID|1|fmol/L|1|1|[?]|ABNORMAL|CELL PELLET|GELLED||STATIC PERIMETRY|MDRD 4 VARIABLE FORMULA|||U||4|Visit_4|65|4|TREATMENT|2021-02-15|2021-02-22|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|LB|7682184f-0801-4315-9c5f-116f7321a2b0|8|CD79A|CD79A|CHEMISTRY|[?]|cm/min|[?]|[?]|TRACE|1|10^3 organisms/mL|1|1|[?]|NORMAL|SMEGMA|CONTAMINATED||PEAK FLOWMETRY|ASH FIBROSURE FORMULA||Y|N||4|Visit_4|65|7|SCREENING|2021-02-15|2021-03-18|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|LB|7682184f-0801-4315-9c5f-116f7321a2b0|9|TPROTFR|Tau Protein, Free|CHEMISTRY|[?]|PFU|[?]|[?]|BORDERLINE|1|U/mL|1|1|[?]|ABNORMAL|SALIVA|FRESH||NUCLEIC ACID BASED METHOD|NASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|6|TREATMENT|2021-03-12|2021-03-14|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|7682184f-0801-4315-9c5f-116f7321a2b0|10|STBSEXCS|Standard Base Excess|URINALYSIS|[?]|TRANSDUCING UNIT|[?]|[?]|POSITIVE|1|10^10/L|1|1|[?]|ABNORMAL|BUFFY COAT|PARAFFIN-EMBEDDED|N|NO INFORMATION|CKD-EPI CREATININE FORMULA|||N||5|Visit_5|90|1|FOLLOW-UP|2021-03-12|2021-03-19|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|c40f9cb3-b597-4614-8ba5-d40849030ff9|1|LPPLA2|Lipoprotein Associated Phospholipase A2|HEMATOLOGY|[?]|sec|[?]|[?]|INDETERMINATE|1|nmol/L|1|1|[?]|LOW|PLEURAL TISSUE|SOLIDIFIED||PELLI-ROBSON EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|NA||1|Visit_1|10|4|TREATMENT|2020-12-12|2021-02-03|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|c40f9cb3-b597-4614-8ba5-d40849030ff9|2|PGAG|Platelet-Granulocyte Agg|HEMATOLOGY|[?]|mL/m2|[?]|[?]|BORDERLINE|1|TRANSDUCING UNIT/mL|1|1|[?]|ABNORMAL|PLEURAL TISSUE|DRIED|N|ULTRASOUND|CKD-EPI FORMULA|||U||1|Visit_1|10|1|SCREENING|2020-12-12|2021-02-08|10|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|c40f9cb3-b597-4614-8ba5-d40849030ff9|3|BPIAB|Bactericidal/Permeability-Inc Protein Ab|HEMATOLOGY|[?]|TRANSDUCING UNIT/mL|[?]|[?]|NEGATIVE|1|10^9 organisms/g|1|1|[?]|NORMAL|LYMPH|CLOTTED|N|SNP ARRAY|CKD-EPI CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|4|TREATMENT|2020-12-27|2021-02-05|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|c40f9cb3-b597-4614-8ba5-d40849030ff9|4|ANABASN|Anabasine|HEMATOLOGY|[?]|cmH2O*s/mL|[?]|[?]|TRACE|1|WAFER|1|1|[?]|ABNORMAL|HAIR|SOLIDIFIED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-12-27|2021-03-01|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|c40f9cb3-b597-4614-8ba5-d40849030ff9|5|SJSSAAB|Sjogrens SS-A Antibody|URINALYSIS|[?]|tsp eq|[?]|[?]|TRACE|1|pmol/g|1|1|[?]|NORMAL|COLOSTRUM|CONCENTRATED||MAGNETIC RESONANCE ANGIOGRAPHY|COCKCROFT-GAULT FORMULA|||NA||3|Visit_3|40|4|SCREENING|2021-01-11|2021-02-27|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|c40f9cb3-b597-4614-8ba5-d40849030ff9|6|C147283|White Elm Pollen IgG Antibody|URINALYSIS|[?]|10^5/L|[?]|[?]|INDETERMINATE|1|Weber|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|FROZEN||NUCLEIC ACID BASED METHOD|FIBROSIS 4 FORMULA|Y|Y|N||3|Visit_3|40|1|WASHOUT|2021-01-11|2021-01-21|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|c40f9cb3-b597-4614-8ba5-d40849030ff9|7|IGG3|Immunoglobulin G Subclass 3|HEMATOLOGY|[?]|VOXEL|[?]|[?]|INDETERMINATE|1|TCID 50/dose|1|1|[?]|NORMAL|LUNG SURFACTANT|CALCIFIED||CELLULAR PROLIFERATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||4|Visit_4|65|1|FOLLOW-UP|2021-02-05|2021-03-08|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|c40f9cb3-b597-4614-8ba5-d40849030ff9|8|CYFRA18|Cytokeratin 18 Fragment|CHEMISTRY|||[?]|[?]|POSITIVE|1|BOLUS|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|AUTOLYZED||HEMAGGLUTINATION ASSAY|COCKCROFT-GAULT FORMULA|||N|Y|4|Visit_4|65|7|WASHOUT|2021-02-05|2021-03-02|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|c40f9cb3-b597-4614-8ba5-d40849030ff9|9|GLOBG|Gamma Globulin|URINALYSIS|[?]|BEAM BREAKS|[?]|[?]|NEGATIVE|1|lx|1|1|[?]|LOW|INFRANATANT, PLASMA|CONCENTRATED|N|EEG|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||5|Visit_5|90|5|TREATMENT|2021-03-02|2021-03-09|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|c40f9cb3-b597-4614-8ba5-d40849030ff9|10|ANTIDPRS|Antidepressants|HEMATOLOGY|[?]|10^6 U|[?]|[?]|INVALID|1|dpm/mg|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|ICTERIC||ENDPOINT DILUTION ASSAY|FIBROTEST FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2021-03-02|2021-03-09|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|1|BLISTCE|Blister Cell|URINALYSIS|||[?]|[?]|INVALID|1|ug/mol|1|1|[?]|ABNORMAL|PLASMA|SOLIDIFIED||PERIODIC ACID SCHIFF STAIN|MDRD 4 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|4|TREATMENT|2020-09-09|2020-12-07|10|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|2|LPL|Lipoprotein Lipase|HEMATOLOGY|[?]|log10 CFU/g|[?]|[?]|POSITIVE|1|fmol|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|FROZEN||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|CKD-EPI FORMULA|Y||NA||1|Visit_1|10|5|TREATMENT|2020-09-09|2020-12-05|10|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|3|VITB7|Vitamin B7|URINALYSIS|[?]|Pa|[?]|[?]|POSITIVE|1|nsec|1|1|[?]|ABNORMAL|ALVEOLAR AIR|REFRIGERATED|N|GEL ELECTROPHORESIS|GMI MMOL/MOL FORMULA||Y|NA||2|Visit_2|25|7|FOLLOW-UP|2020-09-24|2020-10-13|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|4|NAK|Sodium/Potassium|URINALYSIS|[?]|mOsm/kg|[?]|[?]|INDETERMINATE|1|TUBE|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|HEMOLYZED||PHOTOMETRIC CLOT DETECTION|FIBROTEST FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-09-24|2020-11-23|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|5|LEUKASE|Leukocyte Esterase|URINALYSIS|[?]|SQU/mL|[?]|[?]|INVALID|1|eq|1|1|[?]|NORMAL|HAIR FOLLICLE|CONCENTRATED|N|DOUBLE IMMUNODIFFUSION|CKD-EPI FORMULA||Y|Y||3|Visit_3|40|3|TREATMENT|2020-10-09|2020-10-12|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|6|APOH|Apolipoprotein H|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|10^12/L|1|1|[?]|NORMAL|LOCHIA|SOLIDIFIED||GC/MS-CI|MDRD FORMULA|Y||U|Y|3|Visit_3|40|1|FOLLOW-UP|2020-10-09|2020-11-30|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|7|KURLOFCE|Kurloff Cells|HEMATOLOGY|[?]|mmol/min/kPa/L|[?]|[?]|BORDERLINE|1|/7.5 mL|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|AUTOLYZED|N|DIFFUSION TENSOR MRI|FIBROTEST FORMULA|||Y||4|Visit_4|65|7|TREATMENT|2020-11-03|2020-11-07|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|8|C130143|German Cockroach Antigen IgG4 Antibody|HEMATOLOGY|||[?]|[?]|POSITIVE|1|uU/dL|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|HEMOLYZED||AMSLER GRID|FIBROSIS 4 FORMULA|||U|Y|4|Visit_4|65|5|TREATMENT|2020-11-03|2020-11-20|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|9|ESELS|Soluble E-Selectin|URINALYSIS|||[?]|[?]|BORDERLINE|1|BP|1|1|[?]|HIGH|CERUMEN|GELLED||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|5|Visit_5|90|1|TREATMENT|2020-11-28|2020-12-07|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|10|ZPP|Zinc Protoporphyrin|HEMATOLOGY|[?]|mmol/g|[?]|[?]|NEGATIVE|1|nmol BCE/L|1|1|[?]|NORMAL|BONE|LACTESCENT||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|CKD-EPI CREATININE FORMULA|Y|Y|Y||5|Visit_5|90|6|WASHOUT|2020-11-28|2020-12-03|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|c9308aa7-f38f-4b54-a919-d3f893b18cd1|1|C165895|Johnson Grass Pollen IgG4 Antibody|URINALYSIS|[?]|L/s/kPa|[?]|[?]|INVALID|1|g/kg/day|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|CONTAMINATED||FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI FORMULA||Y|Y||1|Visit_1|10|6|SCREENING|2020-11-07|2021-01-29|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|LB|c9308aa7-f38f-4b54-a919-d3f893b18cd1|2|PEPSNGII|Pepsinogen II|URINALYSIS|[?]|F|[?]|[?]|BORDERLINE|1|vp/dose|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|REFRIGERATED||MACRO BROTH DILUTION|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|2|FOLLOW-UP|2020-11-07|2021-02-02|10|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|LB|c9308aa7-f38f-4b54-a919-d3f893b18cd1|3|MTNEPHFR|Metanephrine, Free|URINALYSIS|[?]|mL/min|[?]|[?]|INVALID|1|mV2/Hz|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|CONCENTRATED|N|ELECTROCHEMILUMINESCENCE|HEPASCORE FORMULA|||U||2|Visit_2|25|5|WASHOUT|2020-11-22|2021-01-16|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|LB|c9308aa7-f38f-4b54-a919-d3f893b18cd1|4|IFNB|Interferon Beta|URINALYSIS|[?]|L/s/kPa|[?]|[?]|NEGATIVE|1|mL/sec/1.73m2|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|ICTERIC||ROMANOWSKY STAIN|GMI MMOL/MOL FORMULA|||NA||2|Visit_2|25|4|FOLLOW-UP|2020-11-22|2020-12-03|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|LB|c9308aa7-f38f-4b54-a919-d3f893b18cd1|5|FSH|Follicle Stimulating Hormone|CHEMISTRY|[?]|mU|[?]|[?]|TRACE|1|g/kg|1|1|[?]|HIGH|BILE|THAWED|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|Y||3|Visit_3|40|1|WASHOUT|2020-12-07|2021-01-04|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|c9308aa7-f38f-4b54-a919-d3f893b18cd1|6|BLSTNMCE|Normoblasts/Total Cells|CHEMISTRY|||[?]|[?]|POSITIVE|1|cm2|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|SOLIDIFIED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|HEPASCORE FORMULA|||N|Y|3|Visit_3|40|6|SCREENING|2020-12-07|2021-01-30|40|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|c9308aa7-f38f-4b54-a919-d3f893b18cd1|7|BLSTLMLY|Leukemic Blasts/Lymphocytes|HEMATOLOGY|[?]|DPM|[?]|[?]|TRACE|1|kIU|1|1|[?]|ABNORMAL|PROSTATIC FLUID|FROZEN||LYMPHANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||4|Visit_4|65|3|FOLLOW-UP|2021-01-01|2021-01-19|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|c9308aa7-f38f-4b54-a919-d3f893b18cd1|8|HAIRYCE|Hairy Cells|URINALYSIS|[?]|cd/m2|[?]|[?]|INVALID|1|10^6 IU/mL|1|1|[?]|NORMAL|SUPERNATANT, SERUM|LIPEMIC||ICC|CKD-EPI FORMULA|||U||4|Visit_4|65|3|SCREENING|2021-01-01|2021-02-04|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|c9308aa7-f38f-4b54-a919-d3f893b18cd1|9|C5B9|Complement C5b-9|HEMATOLOGY|||[?]|[?]|INVALID|1|SYRINGE|1|1|[?]|LOW|PLEURAL TISSUE|THAWED||SINGLE-MOLECULE ARRAY|ASH FIBROSURE FORMULA||Y|Y|Y|5|Visit_5|90|7|SCREENING|2021-01-26|2021-01-30|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|c9308aa7-f38f-4b54-a919-d3f893b18cd1|10|HISTAB|Histone Antibodies|CHEMISTRY|[?]|log10 TCID 50/uL|[?]|[?]|TRACE|1|PRESSOR UNITS|1|1|[?]|NORMAL|CAPILLARY PLASMA|NON-HEMOLYZED||PET SCAN|FIBROTEST FORMULA||Y|U||5|Visit_5|90|3|SCREENING|2021-01-26|2021-02-04|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|1|C165902|Timothy Grass Pollen IgG AB RAST Score|HEMATOLOGY|||[?]|[?]|TRACE|1|mg2/dL2|1|1|[?]|LOW|SALIVA|GELLED||THIN SMEAR|ASH FIBROSURE FORMULA|Y||NA|Y|1|Visit_1|10|7|SCREENING|2020-08-22|2020-11-03|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|2|ADMA|Asymmetric Dimethylarginine|URINALYSIS|||[?]|[?]|INVALID|1|mOsm/L|1|1|[?]|ABNORMAL|HAIR|NON-HEMOLYZED||RAJI CELL RIA|CKD-EPI CYSTATIN C FORMULA|||U|Y|1|Visit_1|10|3|TREATMENT|2020-08-22|2020-09-17|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|3|RNA|Ribonucleic Acid|URINALYSIS|[?]|mCi|[?]|[?]|BORDERLINE|1|g/mol|1|1|[?]|HIGH|SPUTUM|ROOM TEMPERATURE|N|POTENTIOMETRY|MDRD 5 VARIABLE FORMULA|Y||NA||2|Visit_2|25|7|SCREENING|2020-09-06|2020-09-23|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|4|IGFBP3|Insulin-Like Growth Factor Binding Prot3|HEMATOLOGY|[?]|kBq/uL|[?]|[?]|BORDERLINE|1|U/kg/min|1|1|[?]|HIGH|EPITHELIAL CELL|THAWED||MAPH|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|7|WASHOUT|2020-09-06|2020-11-04|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|5|THROMNUC|Thrombocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|kDa|1|1|[?]|HIGH|BONE|UNEXPECTED ODOR||MRI|FIBROTEST FORMULA|||Y|Y|3|Visit_3|40|7|FOLLOW-UP|2020-09-21|2020-10-31|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|6|C165933|American Cockroach IgE AB RAST Score|CHEMISTRY|[?]|um2|[?]|[?]|INDETERMINATE|1|fraction of 1|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROTEST FORMULA|Y||NA||3|Visit_3|40|3|TREATMENT|2020-09-21|2020-10-02|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|7|CHOLCM|Cholate Compounds|URINALYSIS|[?]|damol/L|[?]|[?]|TRACE|1|% INHIBITION|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|CONCENTRATED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-10-16|2020-10-20|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|8|LDLOXI|Oxidized LDL Cholesterol|URINALYSIS|[?]|mL/(min*100mL)|[?]|[?]|TRACE|1|s/h|1|1|[?]|ABNORMAL|LOCHIA|UNEXPECTED ODOR|N|HIGH RESOLUTION MELT ANALYSIS|FIBROMETER FORMULA|Y||NA||4|Visit_4|65|4|TREATMENT|2020-10-16|2020-10-23|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|9|APOH|Apolipoprotein H|URINALYSIS|[?]|h/wk|[?]|[?]|TRACE|1|pt_br|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|HEMOLYZED||SXA SCAN|CKD-EPI CREATININE FORMULA|||U||5|Visit_5|90|6|FOLLOW-UP|2020-11-10|2020-11-13|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|LB|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|10|HBOXHGB|Oxyhemoglobin/Total Hemoglobin|URINALYSIS|||[?]|[?]|BORDERLINE|1|1/(s*kPa)|1|1|[?]|NORMAL|ARTERIAL BLOOD|THAWED||MAPH|MDRD FORMULA|||NA|Y|5|Visit_5|90|3|FOLLOW-UP|2020-11-10|2020-11-11|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|LB|3da865e8-9680-4112-b6d3-1f5763cfdaae|1|SPMAGGR|Sperm Aggregation|CHEMISTRY|[?]|PNU/mL|[?]|[?]|BORDERLINE|1|IU/kg|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|AUTOLYZED||SISH|HEPASCORE FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2021-01-20|2021-02-12|10|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|3da865e8-9680-4112-b6d3-1f5763cfdaae|2|C130141|German Cockroach Antigen IgA Antibody|HEMATOLOGY|||[?]|[?]|POSITIVE|1|pt_us|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|DRIED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD ENZYMATIC FORMULA|||U|Y|1|Visit_1|10|7|FOLLOW-UP|2021-01-20|2021-03-03|10|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|3da865e8-9680-4112-b6d3-1f5763cfdaae|3|MYBLAT3|Type III Myeloblasts|CHEMISTRY|[?]|log10 copies/mL|[?]|[?]|INDETERMINATE|1|lx|1|1|[?]|LOW|SMEGMA|DRIED||DIGITAL PCR ARRAY|NASH FIBROSURE FORMULA|||U||2|Visit_2|25|7|TREATMENT|2021-02-04|2021-03-07|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|3da865e8-9680-4112-b6d3-1f5763cfdaae|4|MYCEPPOL|Myeloid Proliferation Pool|HEMATOLOGY|[?]|fmol/L|[?]|[?]|TRACE|1|BOX|1|1|[?]|LOW|EMESIS|AUTOLYZED|N|ATOMIC ABSORPTION SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA||Y|Y||2|Visit_2|25|3|SCREENING|2021-02-04|2021-02-09|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|3da865e8-9680-4112-b6d3-1f5763cfdaae|5|NSE|Neuron Specific Enolase|CHEMISTRY|[?]|cm/s|[?]|[?]|NEGATIVE|1|U/m2/day|1|1|[?]|NORMAL|CELL PELLET|AGGLUTINATED||WHOLE EXOME SEQUENCING|CKD-EPI CREATININE FORMULA|Y|Y|U||3|Visit_3|40|6|FOLLOW-UP|2021-02-19|2021-02-21|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|LB|3da865e8-9680-4112-b6d3-1f5763cfdaae|6|GUSA|Glucuronidase, Alpha|HEMATOLOGY|[?]|IU/mmol|[?]|[?]|TRACE|1|Shock Wave|1|1|[?]|LOW|ARTERIAL CORD BLOOD|GELLED||IMPEDANCE CONDUCTIVITY|FIBROSIS 4 FORMULA||Y|NA||3|Visit_3|40|7|TREATMENT|2021-02-19|2021-03-09|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|LB|3da865e8-9680-4112-b6d3-1f5763cfdaae|7|ANDSTNDN|Androstenedione|HEMATOLOGY|[?]|mg2/dL2|[?]|[?]|TRACE|1|pmol/10^9 cells|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|CONCENTRATED||DROPLET DIGITAL PCR|HEPASCORE FORMULA|Y||Y||4|Visit_4|65|4|SCREENING|2021-03-16|2021-04-08|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-16
e|LB|3da865e8-9680-4112-b6d3-1f5763cfdaae|8|MNC|Mononuclear Cells|URINALYSIS|[?]|vg/mL|[?]|[?]|NEGATIVE|1|IU/dL|1|1|[?]|HIGH|ARTERIAL BLOOD|THAWED||SPIRAL CT SCAN WITHOUT CONTRAST|NASH FIBROSURE FORMULA|||U||4|Visit_4|65|5|FOLLOW-UP|2021-03-16|2021-04-13|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-16
e|LB|3da865e8-9680-4112-b6d3-1f5763cfdaae|9|SO2|Sulfur Dioxide|URINALYSIS|[?]|mL/g/h|[?]|[?]|TRACE|1|mV/sec|1|1|[?]|LOW|INFRANATANT, PLASMA|PARAFFIN-EMBEDDED|N|OPHTHALMOSCOPY|MDRD 4 VARIABLE FORMULA|Y||U||5|Visit_5|90|6|TREATMENT|2021-04-10|2021-04-12|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|3da865e8-9680-4112-b6d3-1f5763cfdaae|10|A1MICG|Alpha-1 Microglobulin|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mL/h|1|1|[?]|LOW|BILE|FRESH||PYROSEQUENCING|COCKCROFT-GAULT FORMULA|Y|Y|NA|Y|5|Visit_5|90|3|SCREENING|2021-04-10|2021-04-14|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|60afc3a3-56b7-4988-9006-e12f3bc1097c|1|IFIT3|Interferon-Induced 60 kDa Protein|URINALYSIS|[?]|LENS|[?]|[?]|BORDERLINE|1|mg/m2/min|1|1|[?]|NORMAL|PLEURAL FLUID|PARAFFIN-EMBEDDED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROTEST FORMULA|Y||NA||1|Visit_1|10|7|TREATMENT|2020-08-16|2020-10-16|10|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|60afc3a3-56b7-4988-9006-e12f3bc1097c|2|ESTRCPT|Estrogen Receptor|URINALYSIS|[?]|Bq/g|[?]|[?]|INDETERMINATE|1|INHALATION|1|1|[?]|LOW|MONOCYTE|FROZEN||ISHIHARA COLOR PLATES|MDRD ENZYMATIC FORMULA|Y||N||1|Visit_1|10|7|SCREENING|2020-08-16|2020-09-25|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|60afc3a3-56b7-4988-9006-e12f3bc1097c|3|CYFRA18|Cytokeratin 18 Fragment|CHEMISTRY|[?]|mmAL|[?]|[?]|INDETERMINATE|1|genEq/mL|1|1|[?]|ABNORMAL|ABSCESS FLUID|LIPEMIC||POLYSOMNOGRAPHY|NASH FIBROSURE FORMULA||Y|N||2|Visit_2|25|3|SCREENING|2020-08-31|2020-09-17|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|60afc3a3-56b7-4988-9006-e12f3bc1097c|4|A2MACG|Alpha-2 Macroglobulin|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Log10 ELISA unit/dose|1|1|[?]|LOW|MUCUS|DRIED||PH METER MEASUREMENT METHOD|MDRD ENZYMATIC FORMULA|||Y|Y|2|Visit_2|25|7|TREATMENT|2020-08-31|2020-10-02|25|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|60afc3a3-56b7-4988-9006-e12f3bc1097c|5|C130085|English Plantain Pollen IgA|HEMATOLOGY|[?]|uEq|[?]|[?]|INDETERMINATE|1|BISCUIT|1|1|[?]|LOW|SEBUM|CONTAMINATED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD FORMULA|||U||3|Visit_3|40|1|FOLLOW-UP|2020-09-15|2020-10-11|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|60afc3a3-56b7-4988-9006-e12f3bc1097c|6|GDIGA1|Galactose-Deficient IgA1|URINALYSIS|[?]|Ci|[?]|[?]|TRACE|1|anti-Xa IU|1|1|[?]|LOW|PROSTATIC FLUID|AUTOLYZED||FLUORESCENT SPOT TEST|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-09-15|2020-11-05|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|60afc3a3-56b7-4988-9006-e12f3bc1097c|7|EPINSQCE|Non-Squamous Epithelial Cells|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|/h|1|1|[?]|HIGH|BONE MARROW|REFRIGERATED||CYSTOMETRY|CKD-EPI FORMULA||Y|N|Y|4|Visit_4|65|2|TREATMENT|2020-10-10|2020-10-26|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|60afc3a3-56b7-4988-9006-e12f3bc1097c|8|KLOTHO|Klotho|HEMATOLOGY|[?]|mL|[?]|[?]|BORDERLINE|1|mmol/min/kPa|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|AUTOLYZED||HEMAGGLUTINATION ASSAY|MDRD 5 VARIABLE FORMULA|Y||NA||4|Visit_4|65|6|TREATMENT|2020-10-10|2020-11-07|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|60afc3a3-56b7-4988-9006-e12f3bc1097c|9|APLIGGAB|Anti-Phospholipid IgG Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|nkat/L|1|1|[?]|LOW|AQUEOUS HUMOR|AGGLUTINATED||BAC ACGH|MDRD 6 VARIABLE FORMULA||Y|U|Y|5|Visit_5|90|3|TREATMENT|2020-11-04|2020-11-06|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|60afc3a3-56b7-4988-9006-e12f3bc1097c|10|CHCNT|Corpuscular Hemoglobin Content|CHEMISTRY|||[?]|[?]|BORDERLINE|1|BLOCKS|1|1|[?]|ABNORMAL|STOOL|SOLIDIFIED||PHOTOGRAPHY|FIBROTEST FORMULA|||N|Y|5|Visit_5|90|6|TREATMENT|2020-11-04|2020-11-10|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|440119fb-ad46-4348-b236-8e2979c7bf2e|1|C130076|Silver Birch Pollen IgE|URINALYSIS|[?]|uU/dL|[?]|[?]|INVALID|1|10^6 organisms|1|1|[?]|HIGH|BONE MARROW|ROOM TEMPERATURE|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA|Y||Y||1|Visit_1|10|4|SCREENING|2020-12-16|2021-01-28|10|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|LB|440119fb-ad46-4348-b236-8e2979c7bf2e|2|GSTY1|Glutathione S-Transferase, Y1|CHEMISTRY|[?]|ft2|[?]|[?]|INDETERMINATE|1|CAPLET|1|1|[?]|LOW|EMOTIONAL TEAR|FROZEN|N|LISSAMINE GREEN STAIN|GMI MMOL/MOL FORMULA|||Y||1|Visit_1|10|6|SCREENING|2020-12-16|2021-02-10|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|LB|440119fb-ad46-4348-b236-8e2979c7bf2e|3|CEIMCE|Immature Cells/Total Cells|HEMATOLOGY|[?]|BOLUS|[?]|[?]|TRACE|1|mCi/L|1|1|[?]|ABNORMAL|CORD BLOOD|LIPEMIC||INDIRECT IMMUNOFLUORESCENCE|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|4|SCREENING|2020-12-31|2021-02-03|25|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|LB|440119fb-ad46-4348-b236-8e2979c7bf2e|4|PLSNCE|Neoplastic Plasma Cells|URINALYSIS|||[?]|[?]|BORDERLINE|1|U/g|1|1|[?]|NORMAL|PLEURAL FLUID|CALCIFIED||TOLUIDINE BLUE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|2|Visit_2|25|3|TREATMENT|2020-12-31|2021-01-22|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|LB|440119fb-ad46-4348-b236-8e2979c7bf2e|5|LYMCE|Lymphocytes/Total Cells|CHEMISTRY|||[?]|[?]|TRACE|1|/100 WBC|1|1|[?]|HIGH|MECONIUM|LACTESCENT||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|GMI % FORMULA|Y||N|Y|3|Visit_3|40|7|TREATMENT|2021-01-15|2021-01-17|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|LB|440119fb-ad46-4348-b236-8e2979c7bf2e|6|HYALUAC|Hyaluronic Acid|HEMATOLOGY|[?]|tuberculin unit|[?]|[?]|NEGATIVE|1|uIU/dL|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|THAWED|N|ELECTROMYOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||U||3|Visit_3|40|1|TREATMENT|2021-01-15|2021-02-05|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|LB|440119fb-ad46-4348-b236-8e2979c7bf2e|7|PF4HCIAB|Platelet Fctr 4 Heparin Cmplx Induced Ab|HEMATOLOGY|[?]|uV*sec|[?]|[?]|NEGATIVE|1|log10 TCID 50/mL|1|1|[?]|HIGH|DIALYSIS FLUID|DRIED||ELISPOT|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||4|Visit_4|65|1|TREATMENT|2021-02-09|2021-02-20|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|440119fb-ad46-4348-b236-8e2979c7bf2e|8|C130122|Nut Mix Antigen IgE Antibody|HEMATOLOGY|[?]|ng/L|[?]|[?]|NEGATIVE|1|kN/cm2|1|1|[?]|ABNORMAL|LAVAGE FLUID|HEMOLYZED|N|PALPATION|HEPASCORE FORMULA|||NA||4|Visit_4|65|3|FOLLOW-UP|2021-02-09|2021-03-08|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|440119fb-ad46-4348-b236-8e2979c7bf2e|9|C165907|Mold Mix IgG AB RAST Score|HEMATOLOGY|[?]|Gy/min|[?]|[?]|POSITIVE|1|s/h|1|1|[?]|NORMAL|AMNIOTIC FLUID|AGGLUTINATED||CELLULOSE TAPE|GMI MMOL/MOL FORMULA|Y||U||5|Visit_5|90|4|FOLLOW-UP|2021-03-06|2021-03-14|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|440119fb-ad46-4348-b236-8e2979c7bf2e|10|PF2AI8CR|8-Iso-PGF2alpha/Creatinine|URINALYSIS|||[?]|[?]|POSITIVE|1|mEq/mmol|1|1|[?]|HIGH|REFLEX TEAR|HEMOLYZED|N|GC/MS-CI|FIBROMETER FORMULA|||Y|Y|5|Visit_5|90|3|SCREENING|2021-03-06|2021-03-10|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|af45a9de-c8aa-4602-8e3b-d16998740ebd|1|ESTRIOLF|Estriol, Free|HEMATOLOGY|[?]|hr/day|[?]|[?]|BORDERLINE|1|DNA copies/mL|1|1|[?]|NORMAL|CALCULUS|HEMOLYZED||CHROMATOGRAPHY|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-06-15|2020-08-13|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|af45a9de-c8aa-4602-8e3b-d16998740ebd|2|TMZPM|Temazepam|CHEMISTRY|||[?]|[?]|TRACE|1|mL/g/h|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|DRIED|N|MACRO BROTH DILUTION|MDRD FORMULA|||NA|Y|1|Visit_1|10|3|TREATMENT|2020-06-15|2020-08-16|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|af45a9de-c8aa-4602-8e3b-d16998740ebd|3|C130110|Mold Mix Antigen IgG Antibody|CHEMISTRY|[?]|BOLUS|[?]|[?]|POSITIVE|1|uV|1|1|[?]|HIGH|SKIN TISSUE|DRIED|N|CYSTOMETRY|CKD-EPI CYSTATIN C FORMULA|Y|Y|Y||2|Visit_2|25|6|TREATMENT|2020-06-30|2020-07-14|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|af45a9de-c8aa-4602-8e3b-d16998740ebd|4|ICAIGGAB|Islet Cell Cytoplasmic IgG Antibody|URINALYSIS|[?]|ft2|[?]|[?]|TRACE|1|cm H2O|1|1|[?]|LOW|BONE MARROW|THAWED|N|RADIAL IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA|Y|Y|U||2|Visit_2|25|6|SCREENING|2020-06-30|2020-07-10|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|af45a9de-c8aa-4602-8e3b-d16998740ebd|5|ADAM8|ADAM Metallopeptidase Domain 8|URINALYSIS|||[?]|[?]|TRACE|1|EID 50/mL|1|1|[?]|NORMAL|EMOTIONAL TEAR|ROOM TEMPERATURE||CAPILLARY ELECTROPHORESIS|MDRD 6 VARIABLE FORMULA||Y|N|Y|3|Visit_3|40|3|TREATMENT|2020-07-15|2020-07-25|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|af45a9de-c8aa-4602-8e3b-d16998740ebd|6|CH100|Complement CH100|URINALYSIS|[?]|cm2|[?]|[?]|TRACE|1|mol|1|1|[?]|NORMAL|TRANSUDATE|HEMOLYZED|N|X-RAY FLUORESCENCE SPECTROMETRY|FIBROSIS 4 FORMULA||Y|U||3|Visit_3|40|4|TREATMENT|2020-07-15|2020-08-29|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|af45a9de-c8aa-4602-8e3b-d16998740ebd|7|COTININE|Cotinine|CHEMISTRY|[?]|/mm|[?]|[?]|INDETERMINATE|1|um/s|1|1|[?]|HIGH|VENOUS PLASMA|CONCENTRATED||TOLUIDINE BLUE STAIN|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|7|SCREENING|2020-08-09|2020-08-28|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|af45a9de-c8aa-4602-8e3b-d16998740ebd|8|ANA|Antinuclear Antibodies|URINALYSIS|||[?]|[?]|INDETERMINATE|1|PFU/animal|1|1|[?]|ABNORMAL|MECONIUM|FRESH|N|ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|N|Y|4|Visit_4|65|3|FOLLOW-UP|2020-08-09|2020-09-08|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|af45a9de-c8aa-4602-8e3b-d16998740ebd|9|PLATAGRN|Platelets, Agranular|URINALYSIS|[?]|VIRTUAL PIXEL|[?]|[?]|INDETERMINATE|1|mN|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC||CENTRIFUGATION|MDRD 4 VARIABLE FORMULA|Y||NA||5|Visit_5|90|1|SCREENING|2020-09-03|2020-09-04|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|LB|af45a9de-c8aa-4602-8e3b-d16998740ebd|10|CDTTFRN|Carb-Deficient Transferrin/Transferrin|URINALYSIS|||[?]|[?]|INDETERMINATE|1|ug/L FEU|1|1|[?]|HIGH|SPUTUM|AUTOLYZED||TEMPLATE INCISION METHOD|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|5|Visit_5|90|3|FOLLOW-UP|2020-09-03|2020-09-07|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|LB|23306866-3fcb-418d-861b-de3bd779260d|1|HDLCCHOL|HDL Cholesterol/Total Cholesterol|CHEMISTRY|||[?]|[?]|POSITIVE|1|g/m2|1|1|[?]|NORMAL|LOCHIA|GELLED||HEMAGGLUTINATION INHIBITION ASSAY|FIBROSIS 4 FORMULA|Y|Y|N|Y|1|Visit_1|10|1|WASHOUT|2020-07-25|2020-09-09|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|23306866-3fcb-418d-861b-de3bd779260d|2|SO2|Sulfur Dioxide|URINALYSIS|[?]|umol/mg/min|[?]|[?]|INVALID|1|uV*sec|1|1|[?]|HIGH|SYNOVIAL FLUID|FROZEN||WHOLE TRANSCRIPTOME SEQUENCING|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|4|TREATMENT|2020-07-25|2020-10-22|10|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|23306866-3fcb-418d-861b-de3bd779260d|3|MENGLCE|Meningeal Cells/Total Cells|HEMATOLOGY|[?]|BOX|[?]|[?]|INVALID|1|ng|1|1|[?]|HIGH|ARTERIAL BLOOD|UNEXPECTED ODOR||PHOTOGRAPHY|NASH FIBROSURE FORMULA|Y||N||2|Visit_2|25|7|FOLLOW-UP|2020-08-09|2020-08-21|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|23306866-3fcb-418d-861b-de3bd779260d|4|AMH|Anti-Mullerian Hormone|URINALYSIS|[?]|/LPF|[?]|[?]|POSITIVE|1|g/animal|1|1|[?]|NORMAL|STOOL|HEMOLYZED||ELECTRICAL IMPEDANCE MYOGRAPHY|ASH FIBROSURE FORMULA||Y|N||2|Visit_2|25|5|WASHOUT|2020-08-09|2020-09-28|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|23306866-3fcb-418d-861b-de3bd779260d|5|VLDL2|VLDL Cholesterol Subtype 2|HEMATOLOGY|[?]|breaths/min|[?]|[?]|INVALID|1|MnFI|1|1|[?]|NORMAL|AQUEOUS HUMOR|CLOTTED||PULSE OXIMETRY|HEPASCORE FORMULA||Y|N||3|Visit_3|40|5|SCREENING|2020-08-24|2020-10-14|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|23306866-3fcb-418d-861b-de3bd779260d|6|GSTCREAT|Glutathione-S-Transferase/Creatinine|URINALYSIS|[?]|U/kg/day|[?]|[?]|BORDERLINE|1|10^6 IU/mL|1|1|[?]|HIGH|ISOLATE|ICTERIC||MALDI-TOF|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-08-24|2020-10-20|40|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|23306866-3fcb-418d-861b-de3bd779260d|7|SO2|Sulfur Dioxide|URINALYSIS|||[?]|[?]|POSITIVE|1|ukat|1|1|[?]|NORMAL|WHITE MATTER TISSUE|THAWED||SLIT LAMP PHOTOGRAPHY|HEPASCORE FORMULA||Y|Y|Y|4|Visit_4|65|7|WASHOUT|2020-09-18|2020-09-23|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|23306866-3fcb-418d-861b-de3bd779260d|8|ANTHRMA|Antithrombin Activity|CHEMISTRY|[?]|1/(s*kPa)|[?]|[?]|TRACE|1|Ci/mL|1|1|[?]|HIGH|NAIL|CONCENTRATED||RIA|FIBROTEST FORMULA|||U||4|Visit_4|65|4|SCREENING|2020-09-18|2020-10-03|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|23306866-3fcb-418d-861b-de3bd779260d|9|SMDGCELE|Smudge Cells/Leukocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|pkat/L|1|1|[?]|HIGH|PERSPIRATION|PARAFFIN-EMBEDDED|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|HEPASCORE FORMULA||Y|Y|Y|5|Visit_5|90|1|TREATMENT|2020-10-13|2020-10-20|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|23306866-3fcb-418d-861b-de3bd779260d|10|MGB|Myoglobin|HEMATOLOGY|[?]|FIU|[?]|[?]|POSITIVE|1|mL/cm|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED||MICRO BROTH DILUTION|GMI % FORMULA||Y|Y||5|Visit_5|90|1|WASHOUT|2020-10-13|2020-10-21|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|144d2eb9-d79a-4a61-91f5-6a807832d8ca|1|TROPONT|Troponin T|CHEMISTRY|[?]|km/h|[?]|[?]|INDETERMINATE|1|ug/g/day|1|1|[?]|LOW|LOCHIA|AUTOLYZED||OPTICAL COHERENCE TOMOGRAPHY|COCKCROFT-GAULT FORMULA|Y||N||1|Visit_1|10|3|FOLLOW-UP|2020-08-04|2020-10-27|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|LB|144d2eb9-d79a-4a61-91f5-6a807832d8ca|2|BLSTRSID|Ringed Sideroblasts|URINALYSIS|[?]|anti-Xa IU|[?]|[?]|NEGATIVE|1|hr/day|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|CALCIFIED||MICROBIAL CULTURE|HEPASCORE FORMULA||Y|N||1|Visit_1|10|5|TREATMENT|2020-08-04|2020-09-09|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|LB|144d2eb9-d79a-4a61-91f5-6a807832d8ca|3|GLUTAM|Glutamate|URINALYSIS|[?]|mEq/L|[?]|[?]|INDETERMINATE|1|mg/L FEU|1|1|[?]|LOW|HAIR FOLLICLE|GELLED||DOUBLE IMMUNODIFFUSION|FIBROSIS 4 FORMULA|||NA||2|Visit_2|25|7|FOLLOW-UP|2020-08-19|2020-09-04|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|144d2eb9-d79a-4a61-91f5-6a807832d8ca|4|FUNGI|Fungi|HEMATOLOGY|[?]|/mm|[?]|[?]|BORDERLINE|1|pmol/10^10 cells|1|1|[?]|LOW|INFRANATANT, PLASMA|REFRIGERATED||ETDRS EYE CHART|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA||2|Visit_2|25|2|FOLLOW-UP|2020-08-19|2020-09-24|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|144d2eb9-d79a-4a61-91f5-6a807832d8ca|5|APOE|Apolipoprotein E|HEMATOLOGY|[?]|pkat/L|[?]|[?]|TRACE|1|/kg|1|1|[?]|LOW|SPERMATOZOON|LIPEMIC|N|RADIOIMMUNOPRECIPITATION ASSAY|MDRD FORMULA|||N||3|Visit_3|40|5|SCREENING|2020-09-03|2020-10-31|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|144d2eb9-d79a-4a61-91f5-6a807832d8ca|6|FAS|Fas Cell Surface Death Receptor|URINALYSIS|[?]|dB|[?]|[?]|NEGATIVE|1|/10^3|1|1|[?]|LOW|PERITONEAL FLUID|AUTOLYZED||ULTRASONOGRAPHIC ELASTOGRAPHY|ASH FIBROSURE FORMULA|||N||3|Visit_3|40|6|FOLLOW-UP|2020-09-03|2020-10-30|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|144d2eb9-d79a-4a61-91f5-6a807832d8ca|7|PRINSINS|Proinsulin/Insulin Ratio|URINALYSIS|[?]|mOsm/L|[?]|[?]|NEGATIVE|1|Log10 ELISA unit|1|1|[?]|NORMAL|TISSUE|CALCIFIED||GIEMSA STAIN|CKD-EPI CYSTATIN C FORMULA|Y||Y||4|Visit_4|65|4|TREATMENT|2020-09-28|2020-10-24|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|144d2eb9-d79a-4a61-91f5-6a807832d8ca|8|ANCPNCAB|Neutrophil Cytoplasmic Ab, Perinuclear|URINALYSIS|[?]|tsp eq|[?]|[?]|TRACE|1|km/h|1|1|[?]|LOW|PERITONEAL FLUID|CALCIFIED|N|DISK DIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA|||Y||4|Visit_4|65|2|SCREENING|2020-09-28|2020-10-25|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|144d2eb9-d79a-4a61-91f5-6a807832d8ca|9|FLUIDOUT|Fluid Output|URINALYSIS|[?]|10^4/L|[?]|[?]|POSITIVE|1|/cmH2O|1|1|[?]|NORMAL|TISSUE|CONCENTRATED||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|ASH FIBROSURE FORMULA|Y||Y||5|Visit_5|90|1|SCREENING|2020-10-23|2020-10-31|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|144d2eb9-d79a-4a61-91f5-6a807832d8ca|10|KCLR|Potassium Clearance|URINALYSIS|[?]|ugEq/L|[?]|[?]|TRACE|1|POINT|1|1|[?]|LOW|HAIR|HEMOLYZED|N|SIZE EXCLUSION CHROMATOGRAPHY|HEPASCORE FORMULA|||Y||5|Visit_5|90|7|SCREENING|2020-10-23|2020-10-27|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|92855d33-eee6-449f-a9e6-c06a1532571f|1|MCPHGLE|Macrophages/Leukocytes|URINALYSIS|||[?]|[?]|BORDERLINE|1|PFU/dose|1|1|[?]|LOW|PROSTATIC FLUID|CALCIFIED||SPIROMETRY|FIBROMETER FORMULA||Y|N|Y|1|Visit_1|10|1|SCREENING|2020-11-29|2020-12-26|10|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|92855d33-eee6-449f-a9e6-c06a1532571f|2|MYL3|Myosin Light Chain 3|CHEMISTRY|[?]|nCi|[?]|[?]|INDETERMINATE|1|/h|1|1|[?]|HIGH|EPITHELIAL CELL|PARAFFIN-EMBEDDED||PULMONARY ANGIOGRAPHY|FIBROSIS 4 FORMULA|Y|Y|Y||1|Visit_1|10|2|WASHOUT|2020-11-29|2021-02-09|10|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|92855d33-eee6-449f-a9e6-c06a1532571f|3|CARNTEXR|Carnitine Excretion Rate|CHEMISTRY|||[?]|[?]|TRACE|1|mol/mol|1|1|[?]|HIGH|SPUTUM|ROOM TEMPERATURE||HEMAGGLUTINATION INHIBITION ASSAY|MDRD ENZYMATIC FORMULA||Y|U|Y|2|Visit_2|25|2|TREATMENT|2020-12-14|2021-02-09|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|92855d33-eee6-449f-a9e6-c06a1532571f|4|TRIGHDL|Triglycerides/HDL Cholesterol|CHEMISTRY|[?]|CONTAINER|[?]|[?]|INDETERMINATE|1|ug/dL|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|AGGLUTINATED||RADIAL IMMUNODIFFUSION|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|4|WASHOUT|2020-12-14|2020-12-19|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|92855d33-eee6-449f-a9e6-c06a1532571f|5|KI67|Ki-67|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Bq/L|1|1|[?]|LOW|MIXED VENOUS BLOOD|ICTERIC||ENZYMATIC ULTRACENTRIFUGATION|MDRD 6 VARIABLE FORMULA||Y|NA|Y|3|Visit_3|40|2|SCREENING|2020-12-29|2021-01-20|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|92855d33-eee6-449f-a9e6-c06a1532571f|6|TNF5S|Soluble TNF Superfamily Member 5|URINALYSIS|||[?]|[?]|POSITIVE|1|U/mL|1|1|[?]|HIGH|CELL PELLET|NON-HEMOLYZED||BAC ACGH|CKD-EPI FORMULA||Y|U|Y|3|Visit_3|40|3|WASHOUT|2020-12-29|2021-01-22|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|92855d33-eee6-449f-a9e6-c06a1532571f|7|C165929|Bee Mix IgE AB RAST Score|CHEMISTRY|[?]|mg/g/min|[?]|[?]|POSITIVE|1|Ci/g|1|1|[?]|LOW|SUPERNATANT, PLASMA|NON-HEMOLYZED||MICROBIAL CULTURE, LIQUID|NASH FIBROSURE FORMULA|Y||Y||4|Visit_4|65|3|TREATMENT|2021-01-23|2021-02-14|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|92855d33-eee6-449f-a9e6-c06a1532571f|8|CHDW|Corpuscular HGB Conc Distribution Width|HEMATOLOGY|||[?]|[?]|INVALID|1|mg/L|1|1|[?]|ABNORMAL|GASTRIC FLUID|FROZEN|N|IMMUNO-PET SCAN|COCKCROFT-GAULT FORMULA|||Y|Y|4|Visit_4|65|6|WASHOUT|2021-01-23|2021-01-24|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|92855d33-eee6-449f-a9e6-c06a1532571f|9|MPXI|Myeloperoxidase Index|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mg/L|1|1|[?]|ABNORMAL|CELL PELLET|AUTOLYZED||INFRARED SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|5|Visit_5|90|2|TREATMENT|2021-02-17|2021-02-24|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|92855d33-eee6-449f-a9e6-c06a1532571f|10|GLOBUL|Globulin|CHEMISTRY|[?]|mol/day|[?]|[?]|INDETERMINATE|1|10^4 CFU/mL|1|1|[?]|HIGH|MIXED VENOUS BLOOD|NON-HEMOLYZED|N|ISHIHARA COLOR PLATES|COCKCROFT-GAULT FORMULA|||N||5|Visit_5|90|5|TREATMENT|2021-02-17|2021-02-25|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|1|C165934|Arachis hypogaea IgE AB RAST Score|CHEMISTRY|[?]|AMPULE|[?]|[?]|NEGATIVE|1|U/m2|1|1|[?]|LOW|SERUM|LACTESCENT||OLIGO ACGH|NASH FIBROSURE FORMULA||Y|NA||1|Visit_1|10|1|FOLLOW-UP|2021-01-29|2021-02-17|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-19
e|LB|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|2|VITB6|Vitamin B6|CHEMISTRY|||[?]|[?]|TRACE|1|10^6 IU|1|1|[?]|NORMAL|REFLEX TEAR|CONCENTRATED|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|MDRD ENZYMATIC FORMULA|Y|Y|Y|Y|1|Visit_1|10|5|WASHOUT|2021-01-29|2021-03-18|10|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-19
e|LB|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|3|C130079|Silver Birch Pollen IgG4|CHEMISTRY|[?]|ug/m2|[?]|[?]|BORDERLINE|1|cm/min|1|1|[?]|LOW|GASTRIC CONTENTS|THAWED||GEL ELECTROPHORESIS|MDRD FORMULA|||U||2|Visit_2|25|4|FOLLOW-UP|2021-02-13|2021-03-23|25|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|4|IGGSYNRT|IgG Synthesis Rate|CHEMISTRY|[?]|10^3/hpf|[?]|[?]|TRACE|1|lm|1|1|[?]|HIGH|PERSPIRATION|AUTOLYZED||REBOUND TONOMETRY|HEPASCORE FORMULA|Y||N||2|Visit_2|25|6|FOLLOW-UP|2021-02-13|2021-03-16|25|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|5|HGBOXY|Oxyhemoglobin|CHEMISTRY|[?]|mL/100g/min|[?]|[?]|NEGATIVE|1|V/sec|1|1|[?]|NORMAL|MUSCLE TISSUE|AUTOLYZED|N|MOUSE PROTECTION ASSAY|GMI % FORMULA|||N||3|Visit_3|40|7|FOLLOW-UP|2021-02-28|2021-03-20|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|LB|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|6|C165910|Bee Mix IgG AB RAST Score|URINALYSIS|[?]|mL/s/m2|[?]|[?]|INVALID|1|10^8/L|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|DRIED|N|MALDI|MDRD 5 VARIABLE FORMULA|||N||3|Visit_3|40|5|TREATMENT|2021-02-28|2021-04-13|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|LB|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|7|TYR|Tyrosine|URINALYSIS|||[?]|[?]|TRACE|1|10^3/L|1|1|[?]|NORMAL|SEMEN|FROZEN|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|4|Visit_4|65|7|TREATMENT|2021-03-25|2021-04-25|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|8|FACTVIIA|Factor VII Activity|CHEMISTRY|||[?]|[?]|TRACE|1|pL|1|1|[?]|ABNORMAL|URINE|SOLIDIFIED||MS/MS|CKD-EPI FORMULA|||U|Y|4|Visit_4|65|5|TREATMENT|2021-03-25|2021-04-20|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|9|THYAB|Thyroid Antibodies|URINALYSIS|[?]|dpm/mL|[?]|[?]|POSITIVE|1|USP U|1|1|[?]|NORMAL|CERUMEN|REFRIGERATED||ORCHIDOMETERY|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|5|SCREENING|2021-04-19|2021-04-22|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|10|ALPISOE|Alkaline Phosphatase Isoenzyme|CHEMISTRY|[?]|mm/sec|[?]|[?]|POSITIVE|1|cd/m2|1|1|[?]|HIGH|MUCUS|CALCIFIED||COLORIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA||5|Visit_5|90|2|FOLLOW-UP|2021-04-19|2021-04-20|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|40cb9bc3-abec-4158-bdee-becdeceba727|1|SJSA52AB|Sjogrens SS-A52 Antibody|URINALYSIS|[?]|GBq/ug|[?]|[?]|TRACE|1|Gravitational Unit|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|ROOM TEMPERATURE||SIZE EXCLUSION CHROMATOGRAPHY|ASH FIBROSURE FORMULA||Y|NA||1|Visit_1|10|2|FOLLOW-UP|2020-10-19|2020-11-01|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|40cb9bc3-abec-4158-bdee-becdeceba727|2|HLAMSC|HLA Mismatch Count|URINALYSIS|[?]|kHz|[?]|[?]|TRACE|1|amp|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|ROOM TEMPERATURE||CINEANGIOGRAPHY|FIBROSIS 4 FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-10-19|2020-12-22|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|40cb9bc3-abec-4158-bdee-becdeceba727|3|CYDRUG|Drug Crystals|CHEMISTRY|[?]|Absorbance U/min|[?]|[?]|INVALID|1|mL/kg/h|1|1|[?]|NORMAL|FLUID|THAWED||ERGOSPIROMETRY|CKD-EPI CREATININE FORMULA||Y|Y||2|Visit_2|25|7|TREATMENT|2020-11-03|2020-11-22|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|40cb9bc3-abec-4158-bdee-becdeceba727|4|PYK|Pyruvate Kinase|URINALYSIS|[?]|/min|[?]|[?]|TRACE|1|CCID 50/mL|1|1|[?]|LOW|SMEGMA|LACTESCENT||DARK FIELD MICROSCOPY|FIBROMETER FORMULA||Y|N||2|Visit_2|25|2|SCREENING|2020-11-03|2020-12-07|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|40cb9bc3-abec-4158-bdee-becdeceba727|5|PRABC|Calculated Panel Reactive Antibody|CHEMISTRY|[?]|/10^5|[?]|[?]|BORDERLINE|1|v/v|1|1|[?]|NORMAL|LYMPH|DRIED||MRS|COCKCROFT-GAULT FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2020-11-18|2020-11-30|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|40cb9bc3-abec-4158-bdee-becdeceba727|6|SPMMSPM|Motile Sperm/Total Sperm|URINALYSIS|[?]|log10 CCID 50/dose|[?]|[?]|INVALID|1|umol/kg/min|1|1|[?]|HIGH|SUPERNATANT, SERUM|LACTESCENT||IHC|GMI MMOL/MOL FORMULA|Y||N||3|Visit_3|40|4|TREATMENT|2020-11-18|2021-01-12|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|40cb9bc3-abec-4158-bdee-becdeceba727|7|GIPI|Glucose-dep Insulinotropic Pep, Intact|HEMATOLOGY|[?]|%(w/v)|[?]|[?]|NEGATIVE|1|nsec|1|1|[?]|NORMAL|INFRANATANT, PLASMA|CALCIFIED|N|CONTACT SPECULAR MICROSCOPY|FIBROTEST FORMULA|Y||Y||4|Visit_4|65|3|TREATMENT|2020-12-13|2020-12-25|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|40cb9bc3-abec-4158-bdee-becdeceba727|8|FDP|Fibrin Degradation Products|URINALYSIS|[?]|Gy|[?]|[?]|BORDERLINE|1|ug/g/min|1|1|[?]|LOW|STOOL|PARAFFIN-EMBEDDED|N|FLUORESCENCE ANGIOGRAPHY|MDRD FORMULA|||N||4|Visit_4|65|4|TREATMENT|2020-12-13|2021-01-16|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|40cb9bc3-abec-4158-bdee-becdeceba727|9|GAMBTAC|Gamma-Aminobutyric Acid|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mg/animal|1|1|[?]|HIGH|BASAL TEAR|HEMOLYZED||FARNSWORTH-MUNSELL 100 HUE TEST|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|5|Visit_5|90|3|WASHOUT|2021-01-07|2021-01-12|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|40cb9bc3-abec-4158-bdee-becdeceba727|10|MONOMA|Monocytes/Macrocytes|HEMATOLOGY|[?]|cm/min|[?]|[?]|INVALID|1|IU/dL|1|1|[?]|ABNORMAL|RETICULOCYTES|CLOTTED||AURAMINE STAIN|NASH FIBROSURE FORMULA|Y||N||5|Visit_5|90|5|TREATMENT|2021-01-07|2021-01-14|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|1|AMMONIA|Ammonia|URINALYSIS|[?]|/2000 RBC|[?]|[?]|BORDERLINE|1|INHALATION|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|CONCENTRATED||DUCTOGRAPHY|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|5|SCREENING|2020-10-17|2020-10-18|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|2|EPIROCE|Round Epithelial Cells|CHEMISTRY|[?]|10^3/hpf|[?]|[?]|POSITIVE|1|10^7 PFU|1|1|[?]|HIGH|BONE|DRIED|N|LYMPHANGIOGRAPHY|GMI % FORMULA|||N||1|Visit_1|10|3|FOLLOW-UP|2020-10-17|2020-11-09|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|3|INSULINS|Insulin Sensitivity|HEMATOLOGY|[?]|nsec|[?]|[?]|INVALID|1|%|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|FRESH|N|LIGHT MICROSCOPY|MDRD ENZYMATIC FORMULA|||N||2|Visit_2|25|1|SCREENING|2020-11-01|2020-12-28|25|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|4|NEUTB|Neutrophils Band Form|HEMATOLOGY|[?]|ug/kg|[?]|[?]|BORDERLINE|1|PFU|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|DRIED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI FORMULA|||U||2|Visit_2|25|7|TREATMENT|2020-11-01|2020-12-18|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|5|OXYTOCIN|Oxytocin|URINALYSIS|||[?]|[?]|TRACE|1|vp/mL|1|1|[?]|LOW|DISCHARGE|FRESH||PALPATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|3|Visit_3|40|4|TREATMENT|2020-11-16|2020-12-01|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|6|NHMCE|Nonhematic Cells|CHEMISTRY|[?]|10^6/Ejaculate U|[?]|[?]|POSITIVE|1|10^3 DNA copies/mL|1|1|[?]|LOW|EMOTIONAL TEAR|GELLED||IHC|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|7|WASHOUT|2020-11-16|2020-12-19|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|7|OLIGBAND|Oligoclonal Bands|URINALYSIS|||[?]|[?]|POSITIVE|1|mL/g/min|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|LACTESCENT||CLAUSS METHOD|MDRD 6 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|2|WASHOUT|2020-12-11|2021-01-03|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|8|MLR|Mixed Lymphocyte Reaction|URINALYSIS|[?]|kg/mol|[?]|[?]|INVALID|1|IU/mmol|1|1|[?]|HIGH|SEMEN|AGGLUTINATED||QUANTITATIVE ULTRASOUND|ASH FIBROSURE FORMULA||Y|NA||4|Visit_4|65|7|TREATMENT|2020-12-11|2021-01-10|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|9|VITB17|Vitamin B17|HEMATOLOGY|[?]|ug/m2/min|[?]|[?]|TRACE|1|BU/mL|1|1|[?]|HIGH|EPITHELIAL CELL|LIPEMIC||RYAN BLUE STAIN|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|2|TREATMENT|2021-01-05|2021-01-09|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|10|INHIBINA|Inhibin A|HEMATOLOGY|[?]|fmol/L|[?]|[?]|INDETERMINATE|1|cup eq|1|1|[?]|HIGH|GASTRIC CONTENTS|AGGLUTINATED||ICP-MS|CKD-EPI CYSTATIN C FORMULA||Y|U||5|Visit_5|90|2|FOLLOW-UP|2021-01-05|2021-01-11|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|616b284a-3fed-4009-bafe-7da10acd537e|1|B2G1GMAB|Beta-2 Glycoprotein 1 IgM Antibody|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mL/s/m2|1|1|[?]|HIGH|CELL PELLET|CONCENTRATED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|GMI MMOL/MOL FORMULA|Y||NA|Y|1|Visit_1|10|6|TREATMENT|2020-09-03|2020-11-20|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|616b284a-3fed-4009-bafe-7da10acd537e|2|CD161LY|CD161/Lymphocytes|CHEMISTRY|[?]|10^9 CFU/mL|[?]|[?]|INVALID|1|mL/mmHg|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|AGGLUTINATED|N|SCANNING ELECTRON MICROSCOPY|MDRD 4 VARIABLE FORMULA||Y|Y||1|Visit_1|10|3|WASHOUT|2020-09-03|2020-11-19|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|616b284a-3fed-4009-bafe-7da10acd537e|3|C165929|Bee Mix IgE AB RAST Score|HEMATOLOGY|[?]|/4.0 mL|[?]|[?]|BORDERLINE|1|oz eq|1|1|[?]|ABNORMAL|TRANSUDATE|CONTAMINATED||RULER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-09-18|2020-10-18|25|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|616b284a-3fed-4009-bafe-7da10acd537e|4|INTLK29|Interleukin 29|URINALYSIS|[?]|nmol/day|[?]|[?]|NEGATIVE|1|%(w/w)|1|1|[?]|ABNORMAL|CORD BLOOD|FRESH|N|CLOT DETECTION|MDRD 6 VARIABLE FORMULA||Y|U||2|Visit_2|25|2|WASHOUT|2020-09-18|2020-11-01|25|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|616b284a-3fed-4009-bafe-7da10acd537e|5|STBSEXCS|Standard Base Excess|CHEMISTRY|[?]|mMU/mL|[?]|[?]|NEGATIVE|1|uIU/L|1|1|[?]|HIGH|TRANSUDATE|FRESH||DIGITAL PCR|GMI % FORMULA|Y||Y||3|Visit_3|40|1|FOLLOW-UP|2020-10-03|2020-11-04|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|616b284a-3fed-4009-bafe-7da10acd537e|6|UROTHCE|Urothelial Cells|URINALYSIS|[?]|U/g|[?]|[?]|INDETERMINATE|1|tsp|1|1|[?]|ABNORMAL|BASAL TEAR|UNEXPECTED ODOR||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|3|SCREENING|2020-10-03|2020-11-29|40|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|616b284a-3fed-4009-bafe-7da10acd537e|7|V25HD3|25-Hydroxyvitamin D3|CHEMISTRY|[?]|mIU/L|[?]|[?]|NEGATIVE|1|mg/kg|1|1|[?]|LOW|ABSCESS FLUID|CONCENTRATED|N|ELECTRONEUROGRAPHY|MDRD ENZYMATIC FORMULA||Y|N||4|Visit_4|65|3|FOLLOW-UP|2020-10-28|2020-11-15|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|616b284a-3fed-4009-bafe-7da10acd537e|8|TGFB3|Transforming Growth Factor Beta 3|URINALYSIS|[?]|V/sec|[?]|[?]|INVALID|1|mL/h|1|1|[?]|ABNORMAL|KERATINOCYTE|AGGLUTINATED||CENTRIFUGATION|CKD-EPI FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2020-10-28|2020-11-17|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|616b284a-3fed-4009-bafe-7da10acd537e|9|OXZPM|Oxazepam|HEMATOLOGY|[?]|kUSP|[?]|[?]|BORDERLINE|1|mL/kg/min|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|LIPEMIC|N|ICC|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-11-22|2020-11-28|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|LB|616b284a-3fed-4009-bafe-7da10acd537e|10|INTLK31|Interleukin 31|CHEMISTRY|[?]|DIP|[?]|[?]|NEGATIVE|1|Arbitrary U|1|1|[?]|NORMAL|BILE|ROOM TEMPERATURE||PET/CT SCAN|CKD-EPI FORMULA|Y|Y|Y||5|Visit_5|90|1|SCREENING|2020-11-22|2020-12-01|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|LB|d39b53da-187f-4da6-9614-2bd301e9ad05|1|PNCTPP|Pancreatic Polypeptide|CHEMISTRY|[?]|DAgU/mL|[?]|[?]|NEGATIVE|1|nmol/L/h|1|1|[?]|LOW|TUMOR TISSUE|DRIED||SLIT LAMP|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|3|TREATMENT|2020-10-02|2020-11-04|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|d39b53da-187f-4da6-9614-2bd301e9ad05|2|PLSTCE|Total Plasma Cells|CHEMISTRY|[?]|cmH2O/mL|[?]|[?]|INVALID|1|10^6 organisms/mL|1|1|[?]|LOW|EXPIRED AIR|ROOM TEMPERATURE||NEXT GENERATION SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||1|Visit_1|10|7|SCREENING|2020-10-02|2020-11-03|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|d39b53da-187f-4da6-9614-2bd301e9ad05|3|ATHMBAAC|Antithrombin Activity Actual/Control|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mEq|1|1|[?]|NORMAL|CORD SERUM|FRESH||FARNSWORTH-MUNSELL 100 HUE TEST|MDRD ENZYMATIC JAPANESE FORMULA|Y||N|Y|2|Visit_2|25|3|SCREENING|2020-10-17|2020-11-21|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|d39b53da-187f-4da6-9614-2bd301e9ad05|4|IGG|Immunoglobulin G|HEMATOLOGY|[?]|nL|[?]|[?]|BORDERLINE|1|/cmH2O|1|1|[?]|NORMAL|SUPERNATANT, SERUM|FRESH|N|IMMUNORADIOMETRIC ASSAY|CKD-EPI CREATININE FORMULA|Y|Y|U||2|Visit_2|25|6|TREATMENT|2020-10-17|2020-11-05|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|d39b53da-187f-4da6-9614-2bd301e9ad05|5|CSCYL|Cylindroid Casts|HEMATOLOGY|[?]|BOWL|[?]|[?]|INVALID|1|hr/day|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|LIPEMIC|N|LANDOLT RING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-11-01|2020-11-06|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|d39b53da-187f-4da6-9614-2bd301e9ad05|6|FATBODOV|Fat Bodies, Oval|HEMATOLOGY|[?]|mL/m2|[?]|[?]|INDETERMINATE|1|ug/min|1|1|[?]|LOW|BASAL TEAR|AUTOLYZED|N|MECHANICAL CLOT DETECTION|GMI MMOL/MOL FORMULA||Y|Y||3|Visit_3|40|3|SCREENING|2020-11-01|2020-12-15|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|d39b53da-187f-4da6-9614-2bd301e9ad05|7|LSD|Lysergic Acid Diethylamide|URINALYSIS|||[?]|[?]|POSITIVE|1|mg/cm2|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|AGGLUTINATED||X-RAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|NA|Y|4|Visit_4|65|2|WASHOUT|2020-11-26|2020-12-21|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|d39b53da-187f-4da6-9614-2bd301e9ad05|8|NEOPTERN|Neopterin|HEMATOLOGY|[?]|m2|[?]|[?]|BORDERLINE|1|PACK|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED||GRAM STAIN|CKD-EPI FORMULA|Y||Y||4|Visit_4|65|6|WASHOUT|2020-11-26|2020-12-26|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|d39b53da-187f-4da6-9614-2bd301e9ad05|9|PT|Prothrombin Time|URINALYSIS|[?]|mL/sec/1.73m2|[?]|[?]|NEGATIVE|1|/day|1|1|[?]|ABNORMAL|DIALYSIS FLUID|THAWED||CONTRAST ENHANCED PET SCAN|FIBROMETER FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2020-12-21|2020-12-24|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|d39b53da-187f-4da6-9614-2bd301e9ad05|10|PHOSLPD|Phospholipid|URINALYSIS|[?]|mg/animal|[?]|[?]|TRACE|1|ug/m2/min|1|1|[?]|HIGH|LYMPH|HEMOLYZED||OPTICAL MAPPING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||5|Visit_5|90|7|SCREENING|2020-12-21|2020-12-28|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|1|CREAT|Creatinine|CHEMISTRY|||[?]|[?]|TRACE|1|PACKAGE|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED|N|SICKLE CELL SOLUBILITY TEST|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|1|Visit_1|10|2|WASHOUT|2020-12-04|2021-01-13|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|LB|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|2|C3A|Complement C3a|URINALYSIS|[?]|L/min|[?]|[?]|INDETERMINATE|1|NEEDLE GAUGE|1|1|[?]|LOW|BLOOD|HEMOLYZED|N|IMMUNO-PET SCAN|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-12-04|2021-02-27|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|LB|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|3|THRCREAT|Threonine/Creatinine|URINALYSIS|[?]|IU/mmol|[?]|[?]|INVALID|1|ng/mol|1|1|[?]|HIGH|MECONIUM|DRIED||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|GMI % FORMULA|||NA||2|Visit_2|25|1|SCREENING|2020-12-19|2021-01-11|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|4|CCPAB|Cyclic Citrullinated Peptide Antibody|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Siemens|1|1|[?]|LOW|SUPERNATANT, PLASMA|CLOTTED||FLUORESCENT MICROSCOPY|MDRD 4 VARIABLE FORMULA|||N|Y|2|Visit_2|25|1|TREATMENT|2020-12-19|2021-01-29|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|5|RETCRRBC|HCT Corrected Reticulocytes/Erythrocytes|URINALYSIS|[?]|U/10^12 RBC|[?]|[?]|INVALID|1|uIU/dL|1|1|[?]|HIGH|SERUM OR PLASMA|HEMOLYZED||AUDIOMETRY|CKD-EPI FORMULA||Y|N||3|Visit_3|40|1|TREATMENT|2021-01-03|2021-02-01|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|6|C165905|Grass Mix Pollen IgG AB RAST Score|HEMATOLOGY|[?]|10^6 organisms|[?]|[?]|INVALID|1|kcal|1|1|[?]|HIGH|DERMAL TISSUE|REFRIGERATED||MS/MS|HEPASCORE FORMULA|||U||3|Visit_3|40|7|SCREENING|2021-01-03|2021-01-16|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|7|RENIN|Renin|CHEMISTRY|[?]|kPa|[?]|[?]|TRACE|1|mAnson U/mL|1|1|[?]|NORMAL|LOCHIA|CALCIFIED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|4|WASHOUT|2021-01-28|2021-02-11|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|8|PHOS|Phosphate|CHEMISTRY|||[?]|[?]|BORDERLINE|1|/cmH2O|1|1|[?]|HIGH|WHITE MATTER TISSUE|ICTERIC||EPSILOMETER|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|4|Visit_4|65|7|FOLLOW-UP|2021-01-28|2021-03-01|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|9|IDL|IDL Cholesterol|HEMATOLOGY|[?]|PIXEL|[?]|[?]|NEGATIVE|1|10^6 CFU/mL|1|1|[?]|ABNORMAL|CERUMEN|REFRIGERATED||MYELOPEROXIDASE STAIN|ASH FIBROSURE FORMULA|||U||5|Visit_5|90|7|TREATMENT|2021-02-22|2021-02-24|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|10|PRINSINS|Proinsulin/Insulin Ratio|URINALYSIS|[?]|mU/L|[?]|[?]|NEGATIVE|1|g/kg|1|1|[?]|HIGH|PLASMA ULTRAFILTRATE|LACTESCENT||DC SHEATH FLOW|FIBROMETER FORMULA|Y||N||5|Visit_5|90|7|FOLLOW-UP|2021-02-22|2021-03-02|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|e51cf168-af89-44d9-9e56-14785071f6b0|1|FGF19|Fibroblast Growth Factor 19|HEMATOLOGY|[?]|ug/g/h|[?]|[?]|INVALID|1|L/h/m2|1|1|[?]|LOW|TISSUE|CALCIFIED||ACRIDINE ORANGE STAIN|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-11-27|2020-12-15|10|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|e51cf168-af89-44d9-9e56-14785071f6b0|2|INHIBINB|Inhibin B|HEMATOLOGY|[?]|nm|[?]|[?]|BORDERLINE|1|mL/g/day|1|1|[?]|LOW|ENDOMETRIAL TISSUE|CLOTTED|N|TELLER ACUITY CARDS|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-11-27|2021-02-03|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|e51cf168-af89-44d9-9e56-14785071f6b0|3|MMYCECE|Maturing Myeloid Cells/Total Cells|HEMATOLOGY|||[?]|[?]|POSITIVE|1|Gy/h|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|GELLED||MRI WITHOUT CONTRAST|CKD-EPI FORMULA|||NA|Y|2|Visit_2|25|3|TREATMENT|2020-12-12|2021-02-03|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|e51cf168-af89-44d9-9e56-14785071f6b0|4|GSTMU|Mu Glutathione-S-Transferase|CHEMISTRY|||[?]|[?]|INVALID|1|PFU/dose|1|1|[?]|NORMAL|PERSPIRATION|REFRIGERATED||SPIRAL CT|FIBROMETER FORMULA|Y||U|Y|2|Visit_2|25|4|TREATMENT|2020-12-12|2020-12-14|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|e51cf168-af89-44d9-9e56-14785071f6b0|5|CD27|CD27|CHEMISTRY|[?]|ug/mL/h|[?]|[?]|NEGATIVE|1|10^3 CFU|1|1|[?]|LOW|KERATINOCYTE|GELLED||NUCLEIC ACID HYBRIDIZATION|MDRD 4 VARIABLE FORMULA|Y||U||3|Visit_3|40|5|WASHOUT|2020-12-27|2021-02-14|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|LB|e51cf168-af89-44d9-9e56-14785071f6b0|6|AMYLASES|Amylase, Salivary|CHEMISTRY|[?]|U/mmol|[?]|[?]|BORDERLINE|1|10^6/Ejaculate U|1|1|[?]|HIGH|LOCHIA|SOLIDIFIED||DOPPLER ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||3|Visit_3|40|2|FOLLOW-UP|2020-12-27|2021-01-16|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|LB|e51cf168-af89-44d9-9e56-14785071f6b0|7|LYMPHOTC|Lymphotactin|CHEMISTRY|[?]|uV*sec|[?]|[?]|TRACE|1|Bq/g|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|SOLIDIFIED||ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA|||U||4|Visit_4|65|4|TREATMENT|2021-01-21|2021-01-22|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|e51cf168-af89-44d9-9e56-14785071f6b0|8|ESTROGEN|Estrogen|HEMATOLOGY|[?]|beats/min|[?]|[?]|INVALID|1|fL|1|1|[?]|LOW|TISSUE|AUTOLYZED||IVY INCISION METHOD|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-01-21|2021-02-06|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|e51cf168-af89-44d9-9e56-14785071f6b0|9|INTLK29|Interleukin 29|HEMATOLOGY|[?]|10^9 organisms/g|[?]|[?]|NEGATIVE|1|pL|1|1|[?]|ABNORMAL|BONE MARROW|HEMOLYZED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|2|WASHOUT|2021-02-15|2021-02-21|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|e51cf168-af89-44d9-9e56-14785071f6b0|10|C165933|American Cockroach IgE AB RAST Score|CHEMISTRY|[?]|log10 copies/mL|[?]|[?]|INVALID|1|kg/L|1|1|[?]|NORMAL|RETICULOCYTES|PARAFFIN-EMBEDDED|N|ZIEHL NEELSEN ACID FAST STAIN|MDRD 4 VARIABLE FORMULA|Y||U||5|Visit_5|90|2|TREATMENT|2021-02-15|2021-02-18|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|8416f8c6-d0e4-43fc-9a66-6a916e853e87|1|ALBGLOB|Albumin/Globulin|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|/10^5|1|1|[?]|LOW|PROSTATIC FLUID|FROZEN||ELECTROGASTROGRAPHY|ASH FIBROSURE FORMULA|Y||N|Y|1|Visit_1|10|2|SCREENING|2020-06-13|2020-06-29|10|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|LB|8416f8c6-d0e4-43fc-9a66-6a916e853e87|2|HISTAMIN|Histamine|CHEMISTRY|[?]|fmol/L|[?]|[?]|NEGATIVE|1|ug/L|1|1|[?]|HIGH|CEREBROSPINAL FLUID|NON-HEMOLYZED|N|MALDI-TOF|HEPASCORE FORMULA|Y|Y|Y||1|Visit_1|10|7|TREATMENT|2020-06-13|2020-09-04|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|LB|8416f8c6-d0e4-43fc-9a66-6a916e853e87|3|C130117|Bee Mix Antigen IgG Antibody|URINALYSIS|[?]|min/day|[?]|[?]|TRACE|1|dpm/mg|1|1|[?]|HIGH|SOFT TISSUE|DRIED|N|MICROBIAL CULTURE|CKD-EPI CYSTATIN C FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-06-28|2020-08-10|25|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|8416f8c6-d0e4-43fc-9a66-6a916e853e87|4|CSGRANF|Granular Fine Casts|HEMATOLOGY|[?]|EID 50/mL|[?]|[?]|TRACE|1|10^8/L|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|CONCENTRATED||IMMUNOFIXATION ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA||Y|N||2|Visit_2|25|5|WASHOUT|2020-06-28|2020-08-14|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|8416f8c6-d0e4-43fc-9a66-6a916e853e87|5|ECT|Ecarin Clotting Time|CHEMISTRY|[?]|APL U|[?]|[?]|NEGATIVE|1|TRANSDUCING UNIT|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|LACTESCENT|N|ELECTROCHEMILUMINESCENCE|MDRD 4 VARIABLE FORMULA||Y|NA||3|Visit_3|40|5|TREATMENT|2020-07-13|2020-08-21|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|8416f8c6-d0e4-43fc-9a66-6a916e853e87|6|CSEPI846|Aggrecan Chondroitin Sulfate Epitope 846|CHEMISTRY|[?]|cP|[?]|[?]|INDETERMINATE|1|MnFI|1|1|[?]|LOW|EXPIRED AIR|ROOM TEMPERATURE|N|LIGHT MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||3|Visit_3|40|5|SCREENING|2020-07-13|2020-07-27|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|8416f8c6-d0e4-43fc-9a66-6a916e853e87|7|MENGLCE|Meningeal Cells/Total Cells|URINALYSIS|[?]|ug/g/min|[?]|[?]|TRACE|1|ug/L DDU|1|1|[?]|LOW|FLUID|ROOM TEMPERATURE||PERIPHERAL ANGIOGRAPHY|ASH FIBROSURE FORMULA|Y||N||4|Visit_4|65|5|TREATMENT|2020-08-07|2020-08-19|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|8416f8c6-d0e4-43fc-9a66-6a916e853e87|8|SEDEXAM|Sediment Examination|URINALYSIS|||[?]|[?]|NEGATIVE|1|LB|1|1|[?]|HIGH|CERUMEN|THAWED||AUSCULTATION|MDRD ENZYMATIC FORMULA|||NA|Y|4|Visit_4|65|7|TREATMENT|2020-08-07|2020-08-30|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|8416f8c6-d0e4-43fc-9a66-6a916e853e87|9|CEC|Circulating Endothelial Cells|CHEMISTRY|[?]|pkat|[?]|[?]|BORDERLINE|1|mEq/mL|1|1|[?]|NORMAL|LEUKOCYTE|NON-HEMOLYZED||PERFUSION MRI|FIBROMETER FORMULA|Y||Y||5|Visit_5|90|5|WASHOUT|2020-09-01|2020-09-03|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|8416f8c6-d0e4-43fc-9a66-6a916e853e87|10|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|URINALYSIS|[?]|pm|[?]|[?]|INDETERMINATE|1|s^-1(%O2)^-1|1|1|[?]|HIGH|EPITHELIAL CELL|FRESH||EIA|HEPASCORE FORMULA|||N||5|Visit_5|90|2|FOLLOW-UP|2020-09-01|2020-09-10|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|a110e924-90a1-4e84-b47a-410f800fa201|1|ALB|Albumin|HEMATOLOGY|[?]|/500 WBC|[?]|[?]|NEGATIVE|1|mmol/min/kPa/L|1|1|[?]|HIGH|DERMAL TISSUE|NON-HEMOLYZED||CONTRAST ENHANCED X-RAY|MDRD FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-10-29|2020-12-23|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|a110e924-90a1-4e84-b47a-410f800fa201|2|CD14|CD14|URINALYSIS|||[?]|[?]|BORDERLINE|1|pkat|1|1|[?]|LOW|BONE MARROW|AUTOLYZED||ACID FAST STAIN|MDRD 4 VARIABLE FORMULA|Y||N|Y|1|Visit_1|10|7|FOLLOW-UP|2020-10-29|2020-12-09|10|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|a110e924-90a1-4e84-b47a-410f800fa201|3|INTLK7|Interleukin 7|URINALYSIS|[?]|bel|[?]|[?]|NEGATIVE|1|cg|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|LIPEMIC|N|CELL BASED BIOASSAY|MDRD 6 VARIABLE FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-11-13|2021-01-23|25|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|a110e924-90a1-4e84-b47a-410f800fa201|4|LKM1IGAB|Liver Kidney Microsomal Type 1 IgG Ab|URINALYSIS|[?]|cs|[?]|[?]|BORDERLINE|1|/mm2|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED||DIGITAL PCR ARRAY|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|2|FOLLOW-UP|2020-11-13|2021-01-18|25|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|a110e924-90a1-4e84-b47a-410f800fa201|5|C130123|Nut Mix Antigen IgG Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|/40 HPFs|1|1|[?]|ABNORMAL|MUSCLE TISSUE|HEMOLYZED||URANYL ACETATE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|3|Visit_3|40|4|FOLLOW-UP|2020-11-28|2020-12-21|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|a110e924-90a1-4e84-b47a-410f800fa201|6|EOSSG|Eosinophils, Segmented|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|YEARS|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|CONTAMINATED|N|DISK DIFFUSION|FIBROTEST FORMULA|Y|Y|Y|Y|3|Visit_3|40|3|TREATMENT|2020-11-28|2020-12-30|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|a110e924-90a1-4e84-b47a-410f800fa201|7|CA2729AG|Cancer Antigen 27-29|HEMATOLOGY|[?]|cm|[?]|[?]|INDETERMINATE|1|pmol/10^10 cells|1|1|[?]|HIGH|ALVEOLAR AIR|AUTOLYZED|N|APPLANATION TONOMETRY|COCKCROFT-GAULT FORMULA|||NA||4|Visit_4|65|2|WASHOUT|2020-12-23|2021-01-03|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|a110e924-90a1-4e84-b47a-410f800fa201|8|IL18EXR|Interleukin 18 Excretion Rate|CHEMISTRY|[?]|log10 PFU/mL|[?]|[?]|INDETERMINATE|1|/h|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|SOLIDIFIED||PULMONARY ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|U||4|Visit_4|65|5|TREATMENT|2020-12-23|2020-12-26|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|a110e924-90a1-4e84-b47a-410f800fa201|9|PLATIM|Immature Platelets|URINALYSIS|||[?]|[?]|BORDERLINE|1|ELISA unit/mL|1|1|[?]|ABNORMAL|ALVEOLAR AIR|AGGLUTINATED||CYSTOSCOPY|FIBROMETER FORMULA|||NA|Y|5|Visit_5|90|2|WASHOUT|2021-01-17|2021-01-22|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|a110e924-90a1-4e84-b47a-410f800fa201|10|APOB|Apolipoprotein B|URINALYSIS|[?]|vg/kg|[?]|[?]|TRACE|1|DRINK|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|CONTAMINATED|N|IODINE STAIN|MDRD 5 VARIABLE FORMULA|||U||5|Visit_5|90|7|TREATMENT|2021-01-17|2021-01-20|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|40681cb8-5d49-4e1d-b893-f5fad62a0885|1|C130081|Orchard Grass Pollen IgA|URINALYSIS|[?]|in|[?]|[?]|TRACE|1|10^8 PFU|1|1|[?]|LOW|CAPILLARY BLOOD|AGGLUTINATED||HANSEL STAIN|MDRD 4 VARIABLE FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-08-08|2020-10-13|10|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|40681cb8-5d49-4e1d-b893-f5fad62a0885|2|MOCYCE|Monocytoid Cells|URINALYSIS|[?]|nmol BCE/nmol|[?]|[?]|BORDERLINE|1|msec|1|1|[?]|NORMAL|TISSUE|THAWED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|GMI % FORMULA|||U||1|Visit_1|10|6|SCREENING|2020-08-08|2020-08-16|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|40681cb8-5d49-4e1d-b893-f5fad62a0885|3|TATC|Thrombin Antithrombin Complex|HEMATOLOGY|[?]|mIU/L|[?]|[?]|INVALID|1|KIT|1|1|[?]|LOW|CAPILLARY PLASMA|PARAFFIN-EMBEDDED||REVERSE TRANSCRIPTASE PCR|MDRD FORMULA|Y|Y|NA||2|Visit_2|25|5|FOLLOW-UP|2020-08-23|2020-09-06|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|40681cb8-5d49-4e1d-b893-f5fad62a0885|4|EOSLE|Eosinophils/Leukocytes|CHEMISTRY|[?]|cal|[?]|[?]|INDETERMINATE|1|Coulomb|1|1|[?]|ABNORMAL|VENOUS BLOOD|DRIED||DIFFUSION WEIGHTED MRI|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|4|SCREENING|2020-08-23|2020-09-28|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|40681cb8-5d49-4e1d-b893-f5fad62a0885|5|NEUTCE|Neutrophils/Total Cells|CHEMISTRY|||[?]|[?]|INVALID|1|10^4/L|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|DRIED|N|AUSCULTATION|ASH FIBROSURE FORMULA|||NA|Y|3|Visit_3|40|7|TREATMENT|2020-09-07|2020-10-31|40|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|40681cb8-5d49-4e1d-b893-f5fad62a0885|6|MONOBL|Monoblasts|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mmol|1|1|[?]|LOW|FLUID|DRIED||IODINE STAIN|MDRD 5 VARIABLE FORMULA||Y|N|Y|3|Visit_3|40|2|WASHOUT|2020-09-07|2020-09-16|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|40681cb8-5d49-4e1d-b893-f5fad62a0885|7|OXYCAP|Oxygen Capacity|CHEMISTRY|[?]|mg/h|[?]|[?]|POSITIVE|1|kPa/L/sec|1|1|[?]|HIGH|VENOUS CORD BLOOD|DRIED||IMMUNO-PET SCAN|MDRD FORMULA|Y||U||4|Visit_4|65|4|FOLLOW-UP|2020-10-02|2020-10-06|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|40681cb8-5d49-4e1d-b893-f5fad62a0885|8|INLCLR|Inulin Clearance|CHEMISTRY|[?]|/10^3|[?]|[?]|POSITIVE|1|m2|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|AGGLUTINATED||PET SCAN|HEPASCORE FORMULA|||NA||4|Visit_4|65|2|SCREENING|2020-10-02|2020-10-10|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|40681cb8-5d49-4e1d-b893-f5fad62a0885|9|INTLK26|Interleukin 26|URINALYSIS|[?]|pmol/10^9 cells|[?]|[?]|BORDERLINE|1|nkat/g Hb|1|1|[?]|LOW|CORD SERUM|AUTOLYZED|N|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|GMI % FORMULA|||N||5|Visit_5|90|4|WASHOUT|2020-10-27|2020-10-29|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|40681cb8-5d49-4e1d-b893-f5fad62a0885|10|SCL70GAB|Scl-70 IgG Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|L/s|1|1|[?]|ABNORMAL|HAIR FOLLICLE|FROZEN||PUPILLOMETRY|MDRD 4 VARIABLE FORMULA|||Y|Y|5|Visit_5|90|4|TREATMENT|2020-10-27|2020-10-28|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|1|IL1R2|Interleukin 1 Receptor Type 2|URINALYSIS|||[?]|[?]|BORDERLINE|1|kPa/L/sec|1|1|[?]|HIGH|SYNOVIAL FLUID|AGGLUTINATED||ATOMIC ABSORPTION SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA|Y|1|Visit_1|10|4|TREATMENT|2020-12-17|2021-01-11|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|2|RNP70AB|Ribonucleoprotein-70 Antibody|CHEMISTRY|[?]|VIAL|[?]|[?]|TRACE|1|PIXELS/cm|1|1|[?]|HIGH|WHITE MATTER TISSUE|AGGLUTINATED|N|PHOROPTER|FIBROTEST FORMULA|Y||U||1|Visit_1|10|6|FOLLOW-UP|2020-12-17|2021-02-08|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|3|PTSAC|Protein S Actual/Control|URINALYSIS|||[?]|[?]|NEGATIVE|1|ukat/L|1|1|[?]|ABNORMAL|PLASMA|NON-HEMOLYZED||DC SHEATH FLOW|MDRD ENZYMATIC JAPANESE FORMULA|||Y|Y|2|Visit_2|25|1|SCREENING|2021-01-01|2021-03-08|25|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|4|ALBCREAT|Albumin/Creatinine|HEMATOLOGY|[?]|cg|[?]|[?]|BORDERLINE|1|EP U|1|1|[?]|HIGH|VITREOUS HUMOR|LIPEMIC||X-RAY FLUORESCENCE SPECTROMETRY|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2021-01-01|2021-01-05|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|5|HLADRAGT|HLA-DR Antigen Type|HEMATOLOGY|[?]|PFU/animal|[?]|[?]|BORDERLINE|1|LB|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|LIPEMIC||SLOAN LETTER EYE CHART 100%|CKD-EPI CREATININE FORMULA|Y||U||3|Visit_3|40|5|WASHOUT|2021-01-16|2021-02-01|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|LB|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|6|IMMGLC|Immunoglobulin Light Chains|URINALYSIS|[?]|um/s|[?]|[?]|INDETERMINATE|1|nmol BCE/mmol|1|1|[?]|HIGH|PLASMA|THAWED||RADIATION DOSIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2021-01-16|2021-02-04|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|LB|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|7|HGBFR|Hemoglobin, Free|CHEMISTRY|[?]|ug/L|[?]|[?]|NEGATIVE|1|mkat|1|1|[?]|NORMAL|BREAST MILK|GELLED||IRON HEMATOXYLIN STAIN|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|2|TREATMENT|2021-02-10|2021-02-24|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|8|EOTAXIN2|Eotaxin-2|HEMATOLOGY|[?]|mL|[?]|[?]|TRACE|1|kBq|1|1|[?]|HIGH|TRANSUDATE|ICTERIC|N|WRIGHT STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||4|Visit_4|65|5|SCREENING|2021-02-10|2021-03-05|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|9|BLSTIMLY|Immunoblasts/Lymphocytes|CHEMISTRY|[?]|/10^5|[?]|[?]|INVALID|1|umol/L/min|1|1|[?]|NORMAL|COLOSTRUM|GELLED||ISHIHARA COLOR PLATES|ASH FIBROSURE FORMULA||Y|N||5|Visit_5|90|4|WASHOUT|2021-03-07|2021-03-16|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|LB|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|10|APPB|Amyloid Beta Precursor Protein|CHEMISTRY|[?]|ppb|[?]|[?]|POSITIVE|1|ug/L DDU|1|1|[?]|ABNORMAL|PERSPIRATION|FROZEN||SNELLEN EYE CHART|MDRD 5 VARIABLE FORMULA|||Y||5|Visit_5|90|4|WASHOUT|2021-03-07|2021-03-10|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|LB|96e65c5c-723c-42d9-8e88-0bcb600e9f88|1|OHF6B|6 Beta-Hydroxycortisol|URINALYSIS|[?]|U/m2/h|[?]|[?]|BORDERLINE|1|mol/day|1|1|[?]|HIGH|BASAL TEAR|SOLIDIFIED||COLORIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-09-10|2020-10-12|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|96e65c5c-723c-42d9-8e88-0bcb600e9f88|2|FACTV|Factor V|URINALYSIS|||[?]|[?]|TRACE|1|10^3 CFU/g|1|1|[?]|LOW|MECONIUM|HEMOLYZED||ICC|GMI MMOL/MOL FORMULA|||N|Y|1|Visit_1|10|5|TREATMENT|2020-09-10|2020-10-10|10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|96e65c5c-723c-42d9-8e88-0bcb600e9f88|3|C130137|American Cockroach Antigen IgA Antibody|CHEMISTRY|[?]|10^3 CFU/g|[?]|[?]|POSITIVE|1|umol/min|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|CONCENTRATED||OPHTHALMOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-09-25|2020-10-05|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|96e65c5c-723c-42d9-8e88-0bcb600e9f88|4|POLYCHR|Polychromasia|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|umol/L/sec|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|PARAFFIN-EMBEDDED||CONTACT SPECULAR MICROSCOPY|HEPASCORE FORMULA|||U|Y|2|Visit_2|25|6|TREATMENT|2020-09-25|2020-10-28|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|96e65c5c-723c-42d9-8e88-0bcb600e9f88|5|C165895|Johnson Grass Pollen IgG4 Antibody|URINALYSIS|[?]|INHALATION|[?]|[?]|INVALID|1|mm/h|1|1|[?]|ABNORMAL|EXPIRED AIR|CLOTTED||SURFACE PLASMON RESONANCE|FIBROTEST FORMULA|||U||3|Visit_3|40|3|TREATMENT|2020-10-10|2020-11-28|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|96e65c5c-723c-42d9-8e88-0bcb600e9f88|6|GLOBB1|Beta-1 Globulin|URINALYSIS|||[?]|[?]|INVALID|1|mL/cm|1|1|[?]|ABNORMAL|LUNG SURFACTANT|AGGLUTINATED|N|STRESS ECHOCARDIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||NA|Y|3|Visit_3|40|1|TREATMENT|2020-10-10|2020-11-18|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|96e65c5c-723c-42d9-8e88-0bcb600e9f88|7|HYALUAC|Hyaluronic Acid|HEMATOLOGY|[?]|mmol|[?]|[?]|INDETERMINATE|1|10^6 CFU/g|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|CLOTTED||IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-11-04|2020-11-22|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|96e65c5c-723c-42d9-8e88-0bcb600e9f88|8|CONDUCTU|Urine Conductivity|CHEMISTRY|[?]|Frames/s|[?]|[?]|TRACE|1|CYLINDER|1|1|[?]|NORMAL|CAPILLARY BLOOD|AUTOLYZED||SICKLE CELL SOLUBILITY TEST|FIBROTEST FORMULA|||NA||4|Visit_4|65|1|WASHOUT|2020-11-04|2020-11-25|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|96e65c5c-723c-42d9-8e88-0bcb600e9f88|9|HGB|Hemoglobin|HEMATOLOGY|[?]|mEq/mmol|[?]|[?]|INDETERMINATE|1|U/g Hb|1|1|[?]|LOW|GASTRIC FLUID|DRIED||TARGETED TRANSCRIPTOME SEQUENCING|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|3|WASHOUT|2020-11-29|2020-12-04|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|96e65c5c-723c-42d9-8e88-0bcb600e9f88|10|HGF|Hepatocyte Growth Factor|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|LENS|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|THAWED||INFRARED SPECTROMETRY|MDRD 6 VARIABLE FORMULA|||U|Y|5|Visit_5|90|4|TREATMENT|2020-11-29|2020-12-06|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|1|C165936|Glycine max IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|INVALID|1|U/g/min|1|1|[?]|LOW|EXUDATE|SOLIDIFIED||DOUBLE IMMUNODIFFUSION|COCKCROFT-GAULT FORMULA|||U|Y|1|Visit_1|10|7|FOLLOW-UP|2020-07-12|2020-08-01|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|2|DRVTSCPD|dRVVT Screen to Confirm Pct Difference|HEMATOLOGY|[?]|kPa|[?]|[?]|NEGATIVE|1|mV2/Hz|1|1|[?]|LOW|COLOSTRUM|LIPEMIC||ELASTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||1|Visit_1|10|4|FOLLOW-UP|2020-07-12|2020-09-04|10|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|3|PYOCYTES|Pyocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mL|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE||AURAMINE STAIN|GMI % FORMULA|||U|Y|2|Visit_2|25|2|TREATMENT|2020-07-27|2020-09-19|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|4|CRENCE|Crenated Cells|HEMATOLOGY|[?]|mg/mL/day|[?]|[?]|NEGATIVE|1|Gy/min|1|1|[?]|HIGH|LYMPH|CALCIFIED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|6|FOLLOW-UP|2020-07-27|2020-08-07|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|5|RBCGHOST|Erythrocyte Ghosts|URINALYSIS|||[?]|[?]|NEGATIVE|1|mg/kg/dose|1|1|[?]|NORMAL|SUPERNATANT, SERUM|LACTESCENT||WHOLE TRANSCRIPTOME SEQUENCING|ASH FIBROSURE FORMULA|||U|Y|3|Visit_3|40|4|TREATMENT|2020-08-11|2020-08-31|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|LB|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|6|TURB|Turbidity|CHEMISTRY|||[?]|[?]|NEGATIVE|1|min|1|1|[?]|ABNORMAL|CELL PELLET|HEMOLYZED||DUCTOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||Y|Y|3|Visit_3|40|1|TREATMENT|2020-08-11|2020-08-15|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|LB|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|7|EGF|Epidermal Growth Factor|CHEMISTRY|||[?]|[?]|NEGATIVE|1|CIGARETTE|1|1|[?]|NORMAL|TRANSUDATE|CALCIFIED||ORCHIDOMETERY|COCKCROFT-GAULT FORMULA|Y|Y|N|Y|4|Visit_4|65|5|FOLLOW-UP|2020-09-05|2020-09-14|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|8|TSH|Thyrotropin|CHEMISTRY|[?]|FEU|[?]|[?]|TRACE|1|mL/min/mmHg|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|GELLED|N|MICRODENSITOMETRY|FIBROMETER FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-09-05|2020-09-17|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|9|EOSPSDLE|Pseudo-Eosinophils/Leukocytes|CHEMISTRY|[?]|uL/kg/day|[?]|[?]|INVALID|1|OI50|1|1|[?]|LOW|ABSCESS FLUID|HEMOLYZED||RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI FORMULA||Y|Y||5|Visit_5|90|7|FOLLOW-UP|2020-09-30|2020-10-08|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|10|HOMOCIT|Homocitrulline|HEMATOLOGY|[?]|POINT|[?]|[?]|INVALID|1|mm|1|1|[?]|HIGH|GASTRIC CONTENTS|UNEXPECTED ODOR||RYAN BLUE STAIN|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-09-30|2020-10-01|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|f81742a2-5250-43d7-a6e2-8fcb1625a114|1|MERCECE|Maturing Erythroid Cells/Total Cells|URINALYSIS|||[?]|[?]|POSITIVE|1|10^9 organisms/g|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|ICTERIC||RADIOIMMUNOPRECIPITATION ASSAY|MDRD 4 VARIABLE FORMULA||Y|U|Y|1|Visit_1|10|5|TREATMENT|2020-05-30|2020-07-09|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|LB|f81742a2-5250-43d7-a6e2-8fcb1625a114|2|TK1|Thymidine Kinase 1|CHEMISTRY|||[?]|[?]|POSITIVE|1|Ci/L|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|ROOM TEMPERATURE||SPECULAR MICROSCOPY|GMI % FORMULA|Y|Y|Y|Y|1|Visit_1|10|2|TREATMENT|2020-05-30|2020-06-20|10|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|LB|f81742a2-5250-43d7-a6e2-8fcb1625a114|3|TGLOBRR|Thyroglobulin Recovery Rate|URINALYSIS|[?]|dB|[?]|[?]|TRACE|1|log10 IU/mL|1|1|[?]|NORMAL|TRANSUDATE|PARAFFIN-EMBEDDED||COMPLEMENT FIXATION|MDRD 4 VARIABLE FORMULA|||N||2|Visit_2|25|7|WASHOUT|2020-06-14|2020-06-25|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|LB|f81742a2-5250-43d7-a6e2-8fcb1625a114|4|PLATCLMP|Platelet Clumps|CHEMISTRY|[?]|copies/ug|[?]|[?]|TRACE|1|EID 50/mL|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|FRESH||DXA SCAN|FIBROSIS 4 FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2020-06-14|2020-07-26|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|LB|f81742a2-5250-43d7-a6e2-8fcb1625a114|5|NKCEFUNC|Natural Killer Cell Function|HEMATOLOGY|[?]|mL/mmHg/min/L|[?]|[?]|INDETERMINATE|1|nmol/kg/day|1|1|[?]|NORMAL|LYSATE|NON-HEMOLYZED||KLEIHAUER-BETKE|HEPASCORE FORMULA|||U||3|Visit_3|40|6|SCREENING|2020-06-29|2020-08-10|40|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|f81742a2-5250-43d7-a6e2-8fcb1625a114|6|CLEXR|Chloride Excretion Rate|URINALYSIS|||[?]|[?]|POSITIVE|1|IU/mg|1|1|[?]|NORMAL|URINE|DRIED||DYNAMIC CONTRAST ENHANCED MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|6|FOLLOW-UP|2020-06-29|2020-07-16|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|f81742a2-5250-43d7-a6e2-8fcb1625a114|7|NAGASECR|N-acetyl-B-D-glucosaminidase/Creatinine|URINALYSIS|||[?]|[?]|INVALID|1|10^6 DNA copies/mL|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|CONTAMINATED||ELISPOT|CKD-EPI CYSTATIN C FORMULA|||N|Y|4|Visit_4|65|2|TREATMENT|2020-07-24|2020-08-20|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|f81742a2-5250-43d7-a6e2-8fcb1625a114|8|SCKCERBC|Sickle Cells/Erythrocytes|CHEMISTRY|[?]|mL/cm|[?]|[?]|BORDERLINE|1|cy/cm|1|1|[?]|HIGH|SPUTUM|AUTOLYZED|N|ROMANOWSKY STAIN|MDRD 5 VARIABLE FORMULA|Y||N||4|Visit_4|65|5|WASHOUT|2020-07-24|2020-08-26|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|f81742a2-5250-43d7-a6e2-8fcb1625a114|9|BLSTLY|Lymphoblasts|CHEMISTRY|||[?]|[?]|TRACE|1|g/cage|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|THAWED||URANYL ACETATE STAIN|CKD-EPI CYSTATIN C FORMULA|||Y|Y|5|Visit_5|90|2|TREATMENT|2020-08-18|2020-08-26|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|f81742a2-5250-43d7-a6e2-8fcb1625a114|10|PH|pH|HEMATOLOGY|||[?]|[?]|POSITIVE|1|%/s|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|CONTAMINATED||ENDOSCOPY|NASH FIBROSURE FORMULA|Y||NA|Y|5|Visit_5|90|6|WASHOUT|2020-08-18|2020-08-19|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|c6bad1d0-3514-4f98-b229-d093a94dfbc4|1|B2MICG|Beta-2 Microglobulin|HEMATOLOGY|||[?]|[?]|POSITIVE|1|min/day|1|1|[?]|ABNORMAL|LYMPH|ROOM TEMPERATURE||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|1|Visit_1|10|4|WASHOUT|2020-06-24|2020-08-14|10|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|c6bad1d0-3514-4f98-b229-d093a94dfbc4|2|NORMETA|Normetanephrine|CHEMISTRY|||[?]|[?]|TRACE|1|mm/sec|1|1|[?]|LOW|PLASMA|ICTERIC||MRI WITHOUT CONTRAST|FIBROSIS 4 FORMULA|Y||U|Y|1|Visit_1|10|4|SCREENING|2020-06-24|2020-08-02|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|c6bad1d0-3514-4f98-b229-d093a94dfbc4|3|APPT|Total Amyloid Precursor Protein|URINALYSIS|[?]|10^5/L|[?]|[?]|INDETERMINATE|1|umol/min|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|GELLED||PULMONARY ANGIOGRAPHY|FIBROSIS 4 FORMULA|Y||NA||2|Visit_2|25|1|TREATMENT|2020-07-09|2020-07-23|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|c6bad1d0-3514-4f98-b229-d093a94dfbc4|4|EPISQCE|Squamous Epithelial Cells|URINALYSIS|||[?]|[?]|POSITIVE|1|usec|1|1|[?]|HIGH|ERYTHROCYTES|LACTESCENT||STATIC PERIMETRY|MDRD ENZYMATIC FORMULA|Y||Y|Y|2|Visit_2|25|6|FOLLOW-UP|2020-07-09|2020-08-22|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|c6bad1d0-3514-4f98-b229-d093a94dfbc4|5|HYDMDZ1|1-Hydroxymidazolam|URINALYSIS|[?]|/7.5 mL|[?]|[?]|INDETERMINATE|1|MPS U|1|1|[?]|NORMAL|MECONIUM|SOLIDIFIED||ENDOSCOPY|HEPASCORE FORMULA|||U||3|Visit_3|40|3|FOLLOW-UP|2020-07-24|2020-09-01|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|c6bad1d0-3514-4f98-b229-d093a94dfbc4|6|ABNCELE|Abnormal Cells/Leukocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|g/L|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|CONTAMINATED|N|FLOCCULATION, CHARCOAL ENHANCED|MDRD ENZYMATIC FORMULA|||NA|Y|3|Visit_3|40|7|TREATMENT|2020-07-24|2020-09-16|40|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|c6bad1d0-3514-4f98-b229-d093a94dfbc4|7|CHOLATE|Cholate|CHEMISTRY|||[?]|[?]|TRACE|1|/100 WBC|1|1|[?]|HIGH|MIXED VENOUS BLOOD|CALCIFIED||SANGER SEQUENCING|HEPASCORE FORMULA|Y||Y|Y|4|Visit_4|65|3|FOLLOW-UP|2020-08-18|2020-09-21|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|c6bad1d0-3514-4f98-b229-d093a94dfbc4|8|C147284|Boxelder Pollen IgE Antibody|CHEMISTRY|[?]|amu|[?]|[?]|POSITIVE|1|mV*min|1|1|[?]|ABNORMAL|PROSTATIC FLUID|NON-HEMOLYZED|N|MANUAL COUNT|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|1|SCREENING|2020-08-18|2020-09-02|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|c6bad1d0-3514-4f98-b229-d093a94dfbc4|9|CACLR|Calcium Clearance|URINALYSIS|[?]|cm H2O|[?]|[?]|POSITIVE|1|umol/day|1|1|[?]|ABNORMAL|PLATELET|GELLED||CALCULATION|FIBROTEST FORMULA|Y|Y|NA||5|Visit_5|90|7|TREATMENT|2020-09-12|2020-09-20|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|LB|c6bad1d0-3514-4f98-b229-d093a94dfbc4|10|GFRBSB2M|GFR from B-2 Microglobulin Adj for BSA|URINALYSIS|[?]|mL/g/min|[?]|[?]|TRACE|1|EU|1|1|[?]|ABNORMAL|SPERMATOZOON|ICTERIC||GC/FID|ASH FIBROSURE FORMULA|||U||5|Visit_5|90|6|TREATMENT|2020-09-12|2020-09-21|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|LB|84d68bcc-dc7a-4366-9630-40ce8885351d|1|CKMMCK|Creatine Kinase MM/Total Creatine Kinase|URINALYSIS|[?]|U/g/min|[?]|[?]|BORDERLINE|1|mg/m2/h|1|1|[?]|ABNORMAL|EPITHELIAL CELL|HEMOLYZED|N|SPECTROPHOTOMETRY|CKD-EPI FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-06-16|2020-08-08|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|LB|84d68bcc-dc7a-4366-9630-40ce8885351d|2|LDLOXAB|Oxidized LDL Cholesterol Antibody|URINALYSIS|[?]|uU/dL|[?]|[?]|INVALID|1|log10 PFU/mL|1|1|[?]|LOW|LOCHIA|ROOM TEMPERATURE||PANENDOSCOPY|MDRD 5 VARIABLE FORMULA||Y|Y||1|Visit_1|10|3|TREATMENT|2020-06-16|2020-07-03|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|LB|84d68bcc-dc7a-4366-9630-40ce8885351d|3|INTLK1|Interleukin 1|HEMATOLOGY|[?]|h*%|[?]|[?]|POSITIVE|1|Bq/g|1|1|[?]|ABNORMAL|BASAL TEAR|FROZEN||SPECTROPHOTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|U||2|Visit_2|25|5|FOLLOW-UP|2020-07-01|2020-09-02|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|LB|84d68bcc-dc7a-4366-9630-40ce8885351d|4|COPPER|Copper|HEMATOLOGY|||[?]|[?]|TRACE|1|ug/L/h|1|1|[?]|HIGH|CEREBROSPINAL FLUID|ROOM TEMPERATURE||SCINTIGRAPHY|FIBROMETER FORMULA|Y||Y|Y|2|Visit_2|25|4|SCREENING|2020-07-01|2020-07-14|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|LB|84d68bcc-dc7a-4366-9630-40ce8885351d|5|C130129|Dog Dander Antigen IgG Antibody|URINALYSIS|[?]|TROCHE|[?]|[?]|TRACE|1|pg|1|1|[?]|HIGH|VENOUS BLOOD|REFRIGERATED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NASH FIBROSURE FORMULA|Y||Y||3|Visit_3|40|2|TREATMENT|2020-07-16|2020-08-25|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|84d68bcc-dc7a-4366-9630-40ce8885351d|6|FOLHMRNA|Folate Hydrolase mRNA|HEMATOLOGY|[?]|g/g/day|[?]|[?]|POSITIVE|1|umol/dL|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|DRIED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|FIBROTEST FORMULA|||U||3|Visit_3|40|7|SCREENING|2020-07-16|2020-08-06|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|84d68bcc-dc7a-4366-9630-40ce8885351d|7|C165878|German Cockroach IgE AB RAST Score|HEMATOLOGY|[?]|mol/mg|[?]|[?]|INVALID|1|10^9 CFU|1|1|[?]|ABNORMAL|CALCULUS|PARAFFIN-EMBEDDED||QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD FORMULA||Y|N||4|Visit_4|65|3|SCREENING|2020-08-10|2020-08-23|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|84d68bcc-dc7a-4366-9630-40ce8885351d|8|VLDLTCT|VLDL Triglyceride + Chylomicron Triglyceride|URINALYSIS|[?]|kBq|[?]|[?]|NEGATIVE|1|vg/dose|1|1|[?]|NORMAL|PROSTATIC FLUID|GELLED||IMMUNO-PET SCAN|FIBROSIS 4 FORMULA||Y|NA||4|Visit_4|65|3|WASHOUT|2020-08-10|2020-08-17|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|84d68bcc-dc7a-4366-9630-40ce8885351d|9|KLHIGGAB|Keyhole Limpet Hemocyanin IgG Antibody|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ohm|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|ICTERIC||DROPLET DIGITAL PCR|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|5|Visit_5|90|6|TREATMENT|2020-09-04|2020-09-12|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|84d68bcc-dc7a-4366-9630-40ce8885351d|10|CD161LY|CD161/Lymphocytes|CHEMISTRY|[?]|ug/cm2|[?]|[?]|TRACE|1|ug/mol|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|CALCIFIED||MRS|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-09-04|2020-09-09|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|517f3930-5202-4e0a-b3e1-85ed4bd7e117|1|PCP|Phencyclidine|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|nmol/day|1|1|[?]|ABNORMAL|BREAST MILK|UNEXPECTED ODOR||DIFFUSION TENSOR MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|1|Visit_1|10|3|FOLLOW-UP|2021-01-08|2021-01-14|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|LB|517f3930-5202-4e0a-b3e1-85ed4bd7e117|2|CTXICRT|Type I Collagen C-Telopeptides/Creat|HEMATOLOGY|||[?]|[?]|POSITIVE|1|uIU/dL|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|AUTOLYZED||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|HEPASCORE FORMULA|Y||NA|Y|1|Visit_1|10|2|FOLLOW-UP|2021-01-08|2021-01-23|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|LB|517f3930-5202-4e0a-b3e1-85ed4bd7e117|3|MYCYLE|Myelocytes/Leukocytes|HEMATOLOGY|[?]|mg/m2/day|[?]|[?]|BORDERLINE|1|mU/L|1|1|[?]|LOW|SEMINAL FLUID|PARAFFIN-EMBEDDED||PULMONARY ANGIOGRAPHY|MDRD FORMULA|||Y||2|Visit_2|25|5|FOLLOW-UP|2021-01-23|2021-02-07|25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|LB|517f3930-5202-4e0a-b3e1-85ed4bd7e117|4|LDH4LDH|LDH Isoenzyme 4/LDH|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|umol/mg/min|1|1|[?]|LOW|EPITHELIAL CELL|CALCIFIED||TRYPAN BLUE STAIN|MDRD 5 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|6|TREATMENT|2021-01-23|2021-03-27|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|LB|517f3930-5202-4e0a-b3e1-85ed4bd7e117|5|AFPL2|Alpha Fetoprotein L2|HEMATOLOGY|[?]|gMFI|[?]|[?]|BORDERLINE|1|10^3 organisms|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|UNEXPECTED ODOR||HEMATOXYLIN AND EOSIN STAIN|ASH FIBROSURE FORMULA|||NA||3|Visit_3|40|1|FOLLOW-UP|2021-02-07|2021-03-12|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|LB|517f3930-5202-4e0a-b3e1-85ed4bd7e117|6|CTLPRM|Citalopram|CHEMISTRY|[?]|PIXELS/in|[?]|[?]|INDETERMINATE|1|ug/g/day|1|1|[?]|HIGH|ALVEOLAR AIR|GELLED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|GMI % FORMULA|||N||3|Visit_3|40|7|SCREENING|2021-02-07|2021-03-22|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|LB|517f3930-5202-4e0a-b3e1-85ed4bd7e117|7|SCL70GAB|Scl-70 IgG Antibody|HEMATOLOGY|[?]|FFU|[?]|[?]|TRACE|1|10^6 CFU|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC|N|ULTRASONOGRAPHIC ELASTOGRAPHY|FIBROMETER FORMULA|||NA||4|Visit_4|65|5|SCREENING|2021-03-04|2021-03-05|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|517f3930-5202-4e0a-b3e1-85ed4bd7e117|8|CHOLINES|Cholinesterase|CHEMISTRY|||[?]|[?]|BORDERLINE|1|gpELISA unit/mL|1|1|[?]|HIGH|SERUM|REFRIGERATED||ANTIMICROBIAL COMBINATION TESTING|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|U|Y|4|Visit_4|65|3|SCREENING|2021-03-04|2021-03-06|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|517f3930-5202-4e0a-b3e1-85ed4bd7e117|9|TROPONT|Troponin T|HEMATOLOGY|[?]|g/cage/day|[?]|[?]|NEGATIVE|1|log10 TCID 50/dose|1|1|[?]|LOW|PLATELET RICH PLASMA|CONTAMINATED||OSCILLOMETRY|CKD-EPI CREATININE FORMULA|||N||5|Visit_5|90|4|SCREENING|2021-03-29|2021-04-04|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|517f3930-5202-4e0a-b3e1-85ed4bd7e117|10|LYMPLLY|Plasmacytoid Lymphocytes/Lymphocytes|HEMATOLOGY|||[?]|[?]|POSITIVE|1|SFC/10^6 PBMC|1|1|[?]|ABNORMAL|SWABBED MATERIAL|ROOM TEMPERATURE||CT SCAN WITHOUT CONTRAST|FIBROSIS 4 FORMULA||Y|U|Y|5|Visit_5|90|7|FOLLOW-UP|2021-03-29|2021-04-03|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|edd73650-27bb-474f-bab7-d2c3d57b2dc4|1|NAK|Sodium/Potassium|HEMATOLOGY|||[?]|[?]|POSITIVE|1|Frames/s|1|1|[?]|ABNORMAL|DIALYSIS FLUID|FRESH||CONFOCAL MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|Y|1|Visit_1|10|6|TREATMENT|2020-12-21|2021-01-23|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|edd73650-27bb-474f-bab7-d2c3d57b2dc4|2|IDLP|IDL Particles|URINALYSIS|[?]|ug/m2/day|[?]|[?]|INVALID|1|%/min|1|1|[?]|LOW|CALCULUS|THAWED||NUCLEIC ACID AMPLIFICATION TEST|MDRD 6 VARIABLE FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-12-21|2021-01-24|10|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|edd73650-27bb-474f-bab7-d2c3d57b2dc4|3|MORPHINE|Morphine|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|cm|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|THAWED||IMMUNO-PET SCAN|MDRD 4 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|3|TREATMENT|2021-01-05|2021-01-20|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|edd73650-27bb-474f-bab7-d2c3d57b2dc4|4|GAMBTAC|Gamma-Aminobutyric Acid|HEMATOLOGY|||[?]|[?]|INVALID|1|breaths/min|1|1|[?]|ABNORMAL|VITREOUS HUMOR|GELLED||MULTIPLEXED BEAD BASED IMMUNOASSAY|ASH FIBROSURE FORMULA|Y||NA|Y|2|Visit_2|25|1|TREATMENT|2021-01-05|2021-01-09|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|edd73650-27bb-474f-bab7-d2c3d57b2dc4|5|AFPADJBW|Alpha Fetoprotein Adj for Body Weight|URINALYSIS|||[?]|[?]|NEGATIVE|1|TUBE|1|1|[?]|ABNORMAL|HAIR|CALCIFIED||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|FIBROTEST FORMULA|||U|Y|3|Visit_3|40|3|TREATMENT|2021-01-20|2021-02-11|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|LB|edd73650-27bb-474f-bab7-d2c3d57b2dc4|6|BASOMYL|Basophilic Myelocytes|URINALYSIS|[?]|SCOOPFUL|[?]|[?]|NEGATIVE|1|VIAL|1|1|[?]|NORMAL|ADIPOSE TISSUE|NON-HEMOLYZED||AURAMINE STAIN|ASH FIBROSURE FORMULA|||NA||3|Visit_3|40|7|SCREENING|2021-01-20|2021-03-08|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|LB|edd73650-27bb-474f-bab7-d2c3d57b2dc4|7|CYSULFA|Sulfa Crystals|CHEMISTRY|[?]|lm|[?]|[?]|INVALID|1|yd|1|1|[?]|HIGH|SYNOVIAL FLUID|CALCIFIED||RAJI CELL EIA|GMI MMOL/MOL FORMULA||Y|NA||4|Visit_4|65|2|TREATMENT|2021-02-14|2021-02-17|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|edd73650-27bb-474f-bab7-d2c3d57b2dc4|8|METAMYCE|Metamyelocytes/Total Cells|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|steps/min|1|1|[?]|LOW|PROSTATIC FLUID|AUTOLYZED||CHROMATOGRAPHY|MDRD 5 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|5|TREATMENT|2021-02-14|2021-03-08|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|edd73650-27bb-474f-bab7-d2c3d57b2dc4|9|MYCEPPOL|Myeloid Proliferation Pool|URINALYSIS|[?]|10^3 CFU|[?]|[?]|BORDERLINE|1|pg/dL|1|1|[?]|HIGH|AQUEOUS HUMOR|THAWED||CYSTOMETRY|MDRD FORMULA|||N||5|Visit_5|90|5|SCREENING|2021-03-11|2021-03-15|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|edd73650-27bb-474f-bab7-d2c3d57b2dc4|10|KYNURNN|Kynurenine|URINALYSIS|[?]|mmol|[?]|[?]|TRACE|1|PACKAGE|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|UNEXPECTED ODOR|N|IHC|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|3|WASHOUT|2021-03-11|2021-03-20|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|98737dfa-0058-4420-a515-38526f01f90d|1|COLOR|Color|URINALYSIS|[?]|10^6/hpf|[?]|[?]|NEGATIVE|1|/h|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|REFRIGERATED||POPULATION SEQUENCING|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-09-09|2020-09-13|10|14|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|98737dfa-0058-4420-a515-38526f01f90d|2|MSTHCE|Mesothelial Cells|HEMATOLOGY|[?]|10^9/g|[?]|[?]|INDETERMINATE|1|10^6 copies/mL|1|1|[?]|NORMAL|INFRANATANT, PLASMA|GELLED||SLOAN LETTER EYE CHART 1.25%|MDRD FORMULA|||U||1|Visit_1|10|5|WASHOUT|2020-09-09|2020-11-27|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|98737dfa-0058-4420-a515-38526f01f90d|3|CD14|CD14|URINALYSIS|[?]|SBE/mL|[?]|[?]|POSITIVE|1|Shock Wave|1|1|[?]|NORMAL|FLUID|CONCENTRATED|N|WHOLE GENOME SEQUENCING|FIBROTEST FORMULA||Y|Y||2|Visit_2|25|1|TREATMENT|2020-09-24|2020-10-20|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|98737dfa-0058-4420-a515-38526f01f90d|4|MUG|Murinoglobulin|URINALYSIS|[?]|nmol/day|[?]|[?]|INVALID|1|mph|1|1|[?]|HIGH|REFLEX TEAR|LIPEMIC|N|DUCTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-09-24|2020-12-06|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|98737dfa-0058-4420-a515-38526f01f90d|5|NITRICOX|Nitric Oxide|CHEMISTRY|[?]|min*mg/mL|[?]|[?]|TRACE|1|g/day|1|1|[?]|HIGH|ABSCESS FLUID|PARAFFIN-EMBEDDED||IODINE STAIN|MDRD FORMULA|||N||3|Visit_3|40|5|SCREENING|2020-10-09|2020-11-30|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|98737dfa-0058-4420-a515-38526f01f90d|6|C165933|American Cockroach IgE AB RAST Score|CHEMISTRY|[?]|IU/mL|[?]|[?]|BORDERLINE|1|ug/g/h|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|PARAFFIN-EMBEDDED||AUTOREFRACTION|GMI MMOL/MOL FORMULA|Y||Y||3|Visit_3|40|4|TREATMENT|2020-10-09|2020-10-17|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|98737dfa-0058-4420-a515-38526f01f90d|7|SJSA52AB|Sjogrens SS-A52 Antibody|URINALYSIS|||[?]|[?]|TRACE|1|TCID 50/dose|1|1|[?]|HIGH|STOOL|DRIED||PULSE OXIMETRY|MDRD FORMULA|||NA|Y|4|Visit_4|65|2|SCREENING|2020-11-03|2020-11-18|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|98737dfa-0058-4420-a515-38526f01f90d|8|PLATGNT|Giant Platelets|CHEMISTRY|[?]|10^9 organisms|[?]|[?]|NEGATIVE|1|ug/cm2|1|1|[?]|HIGH|CORD BLOOD|LIPEMIC||MECHANICAL CLOT DETECTION|FIBROTEST FORMULA||Y|NA||4|Visit_4|65|1|WASHOUT|2020-11-03|2020-11-26|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|98737dfa-0058-4420-a515-38526f01f90d|9|GLN|Glutamine|HEMATOLOGY|[?]|mm|[?]|[?]|INDETERMINATE|1|/LPF|1|1|[?]|HIGH|CAPILLARY PLASMA|LACTESCENT|N|MICROBIAL CULTURE|ASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|6|TREATMENT|2020-11-28|2020-12-01|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|98737dfa-0058-4420-a515-38526f01f90d|10|HLAB|HLA Class IB Antigen|HEMATOLOGY|[?]|CIGAR|[?]|[?]|POSITIVE|1|ugEq/L|1|1|[?]|ABNORMAL|ISOLATE|AGGLUTINATED|N|CONTRAST ENHANCED PET/CT SCAN|ASH FIBROSURE FORMULA|||U||5|Visit_5|90|7|TREATMENT|2020-11-28|2020-12-02|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|e713c631-cdd8-428f-a3a6-0195f6fb80b4|1|PLATSAT|Platelet Satellitism|URINALYSIS|||[?]|[?]|INDETERMINATE|1|IU/kg/h|1|1|[?]|HIGH|SWABBED MATERIAL|UNEXPECTED ODOR||MICROARRAY|GMI MMOL/MOL FORMULA|||N|Y|1|Visit_1|10|1|TREATMENT|2020-10-03|2020-12-23|10|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|e713c631-cdd8-428f-a3a6-0195f6fb80b4|2|PROTS|Protein S|URINALYSIS|[?]|mol/L|[?]|[?]|POSITIVE|1|mL/kg|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|REFRIGERATED|N|SLOAN LETTER EYE CHART 2.5%|ASH FIBROSURE FORMULA||Y|Y||1|Visit_1|10|7|TREATMENT|2020-10-03|2020-11-21|10|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|e713c631-cdd8-428f-a3a6-0195f6fb80b4|3|PTHMM|Parathyroid Hormone, Mid-Molecule|URINALYSIS|[?]|10^3 organisms/mL|[?]|[?]|POSITIVE|1|Anson U|1|1|[?]|HIGH|ERYTHROCYTES|ICTERIC||DYNAMIC LIGHT SCATTERING|CKD-EPI FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-10-18|2020-11-05|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|e713c631-cdd8-428f-a3a6-0195f6fb80b4|4|APTT|Activated Partial Thromboplastin Time|URINALYSIS|||[?]|[?]|INVALID|1|ug/g/h|1|1|[?]|NORMAL|DERMAL TISSUE|FRESH|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|2|Visit_2|25|4|WASHOUT|2020-10-18|2020-12-15|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|e713c631-cdd8-428f-a3a6-0195f6fb80b4|5|CARNITAT|Carnitine Acetyl Transferase|CHEMISTRY|[?]|m|[?]|[?]|BORDERLINE|1|ag|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|CKD-EPI CREATININE FORMULA||Y|N||3|Visit_3|40|2|SCREENING|2020-11-02|2020-12-15|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|e713c631-cdd8-428f-a3a6-0195f6fb80b4|6|CEA|Carcinoembryonic Antigen|CHEMISTRY|[?]|mg/m2|[?]|[?]|BORDERLINE|1|tsp|1|1|[?]|LOW|ABSCESS FLUID|DRIED||REBOUND TONOMETRY|CKD-EPI CREATININE FORMULA||Y|NA||3|Visit_3|40|3|TREATMENT|2020-11-02|2020-11-30|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|e713c631-cdd8-428f-a3a6-0195f6fb80b4|7|NTXICRT|T1 Collagen X-link N-Telopeptides/Creat|HEMATOLOGY|[?]|10^12/L|[?]|[?]|INVALID|1|cm/s|1|1|[?]|LOW|HAIR FOLLICLE|FROZEN||SINGLE-SLICE SPIRAL CT|MDRD FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2020-11-27|2020-11-28|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|e713c631-cdd8-428f-a3a6-0195f6fb80b4|8|TESTOS|Testosterone|HEMATOLOGY|[?]|keV|[?]|[?]|POSITIVE|1|Enzyme U/L|1|1|[?]|ABNORMAL|BILE|THAWED||COLORIMETRY|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|5|FOLLOW-UP|2020-11-27|2020-12-04|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|e713c631-cdd8-428f-a3a6-0195f6fb80b4|9|FACTIII|Factor III|URINALYSIS|[?]|genEq/mL|[?]|[?]|POSITIVE|1|sec|1|1|[?]|ABNORMAL|TUMOR TISSUE|THAWED||PET/CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|2|FOLLOW-UP|2020-12-22|2020-12-28|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|e713c631-cdd8-428f-a3a6-0195f6fb80b4|10|FABP1|Fatty Acid Binding Protein 1|HEMATOLOGY|[?]|ng/day|[?]|[?]|TRACE|1|Arbitrary U|1|1|[?]|LOW|LUNG SURFACTANT|AGGLUTINATED||PALM METHOD|FIBROMETER FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2020-12-22|2020-12-27|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|a3964bed-1273-4bce-bbb4-b8d768b30aa3|1|HBA1B|Hemoglobin A1B|HEMATOLOGY|[?]|ug/h|[?]|[?]|INVALID|1|umol/h/mmol|1|1|[?]|ABNORMAL|SPUTUM|AUTOLYZED|N|DOUBLE IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA||Y|U||1|Visit_1|10|1|FOLLOW-UP|2020-09-20|2020-12-09|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|a3964bed-1273-4bce-bbb4-b8d768b30aa3|2|MONO|Monocytes|HEMATOLOGY|[?]|Bq/mL|[?]|[?]|BORDERLINE|1|mMU/mL|1|1|[?]|LOW|SUPERNATANT, SERUM|CONCENTRATED|N|SPIROMETRY|CKD-EPI FORMULA|||N||1|Visit_1|10|1|FOLLOW-UP|2020-09-20|2020-10-28|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|a3964bed-1273-4bce-bbb4-b8d768b30aa3|3|LYMCLF|Lymphocytes, Clefted|HEMATOLOGY|[?]|mph|[?]|[?]|INVALID|1|PLUG|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|ROOM TEMPERATURE||CINEANGIOGRAPHY|MDRD ENZYMATIC FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2020-10-05|2020-10-26|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|a3964bed-1273-4bce-bbb4-b8d768b30aa3|4|DSG3AB|Desmoglein 3 Antibody|URINALYSIS|[?]|OI50|[?]|[?]|NEGATIVE|1|/wk|1|1|[?]|HIGH|TUMOR TISSUE|DRIED||SCINTIGRAPHY|MDRD FORMULA|Y||N||2|Visit_2|25|5|SCREENING|2020-10-05|2020-10-18|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|a3964bed-1273-4bce-bbb4-b8d768b30aa3|5|APRI|AST to Platelet Ratio Index|HEMATOLOGY|[?]|Roentgen|[?]|[?]|POSITIVE|1|damol/L|1|1|[?]|LOW|AMNIOTIC FLUID|CLOTTED|N|DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI FORMULA|||NA||3|Visit_3|40|2|WASHOUT|2020-10-20|2020-12-10|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|a3964bed-1273-4bce-bbb4-b8d768b30aa3|6|INTLK1|Interleukin 1|URINALYSIS|[?]|CAPLET|[?]|[?]|INVALID|1|umol/L|1|1|[?]|HIGH|CALCULUS|NON-HEMOLYZED||ACCELERATOR MASS SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||3|Visit_3|40|6|TREATMENT|2020-10-20|2020-10-30|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|a3964bed-1273-4bce-bbb4-b8d768b30aa3|7|GLP1AC|Glucagon-Like Peptide-1, Active Form|CHEMISTRY|[?]|foz_us|[?]|[?]|NEGATIVE|1|mL/cage/wk|1|1|[?]|HIGH|PERSPIRATION|REFRIGERATED||HEMATOXYLIN AND EOSIN STAIN|ASH FIBROSURE FORMULA||Y|U||4|Visit_4|65|2|TREATMENT|2020-11-14|2020-12-01|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|a3964bed-1273-4bce-bbb4-b8d768b30aa3|8|HBCOHGB|Carboxyhemoglobin/Total Hemoglobin|URINALYSIS|||[?]|[?]|INDETERMINATE|1|umol/mg/min|1|1|[?]|ABNORMAL|LOCHIA|ROOM TEMPERATURE||RADIOIMMUNOPRECIPITATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|U|Y|4|Visit_4|65|6|TREATMENT|2020-11-14|2020-12-18|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|a3964bed-1273-4bce-bbb4-b8d768b30aa3|9|CYTRPHOS|Triple Phosphate Crystals|URINALYSIS|[?]|nL|[?]|[?]|POSITIVE|1|L/kg|1|1|[?]|ABNORMAL|GASTRIC FLUID|SOLIDIFIED|N|AUTOREFRACTION|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y||5|Visit_5|90|2|WASHOUT|2020-12-09|2020-12-14|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|a3964bed-1273-4bce-bbb4-b8d768b30aa3|10|HRYCECE|Hairy Cells/Total Cells|URINALYSIS|[?]|yd|[?]|[?]|POSITIVE|1|%(w/w)|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR|N|PERCUSSION|FIBROSIS 4 FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-12-09|2020-12-18|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|1|CORTFR|Cortisol, Free|URINALYSIS|[?]|C|[?]|[?]|TRACE|1|10^3/L|1|1|[?]|NORMAL|KERATINOCYTE|ICTERIC||HPLC/IEX|GMI MMOL/MOL FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-12-21|2021-03-03|10|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|LB|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|2|CASTS|Casts|URINALYSIS|[?]|deg|[?]|[?]|BORDERLINE|1|10^6 organisms/mL|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|AUTOLYZED|N|ANTIBIOTIC AGAR SCREEN|FIBROSIS 4 FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-12-21|2021-03-02|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|LB|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|3|G6PDA|Glucose-6-Phosphate Dehydrogenase Act|CHEMISTRY|[?]|mm/min|[?]|[?]|BORDERLINE|1|mg/animal|1|1|[?]|NORMAL|SPUTUM|SOLIDIFIED||SPIRAL CT|COCKCROFT-GAULT FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2021-01-05|2021-01-26|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|4|URATE|Urate|HEMATOLOGY|[?]|umol/min|[?]|[?]|BORDERLINE|1|10^9/dose|1|1|[?]|HIGH|BUFFY COAT|GELLED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA|||U||2|Visit_2|25|4|TREATMENT|2021-01-05|2021-02-08|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|5|FBRTST|FibroTest Score|CHEMISTRY|[?]|uIU/L|[?]|[?]|INVALID|1|CYLINDER|1|1|[?]|NORMAL|VENOUS CORD BLOOD|CLOTTED||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2021-01-20|2021-02-06|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|6|HAMAB|Human Anti-Mouse Antibody|HEMATOLOGY|[?]|dram|[?]|[?]|TRACE|1|%(v/v)|1|1|[?]|LOW|WHITE MATTER TISSUE|FRESH||SMEAR|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|5|TREATMENT|2021-01-20|2021-01-22|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|7|HASIGGAB|Human Anti-Sheep IgG Antibody|CHEMISTRY|[?]|GLOBULE|[?]|[?]|BORDERLINE|1|Enzyme U/L|1|1|[?]|NORMAL|MECONIUM|ROOM TEMPERATURE||GC/MS|FIBROSIS 4 FORMULA||Y|Y||4|Visit_4|65|1|WASHOUT|2021-02-14|2021-02-23|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|8|PROTSFR|Protein S, Free|URINALYSIS|||[?]|[?]|INDETERMINATE|1|umol/kg/min|1|1|[?]|NORMAL|PERSPIRATION|FROZEN||ICC|NASH FIBROSURE FORMULA|||N|Y|4|Visit_4|65|7|TREATMENT|2021-02-14|2021-02-19|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|9|LACTULOS|Lactulose|URINALYSIS|[?]|kN/cm2|[?]|[?]|BORDERLINE|1|10^3 DNA copies/mL|1|1|[?]|LOW|TRANSUDATE|THAWED||SICKLE CELL SOLUBILITY TEST|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||5|Visit_5|90|6|TREATMENT|2021-03-11|2021-03-13|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|10|S100A8|S100 Calcium Binding Protein A8|CHEMISTRY|[?]|Pa|[?]|[?]|NEGATIVE|1|v/v|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|GELLED|N|SURFACE PLASMON RESONANCE|FIBROTEST FORMULA|Y||N||5|Visit_5|90|6|TREATMENT|2021-03-11|2021-03-17|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|1|CDCACM|Chenodeoxycholate Compounds|URINALYSIS|||[?]|[?]|BORDERLINE|1|10^9 organisms|1|1|[?]|ABNORMAL|STOOL|CALCIFIED||GC/FID|FIBROSIS 4 FORMULA|Y|Y|N|Y|1|Visit_1|10|6|SCREENING|2020-06-09|2020-08-27|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|2|RBCCLMP|Erythrocyte Cell Clumps|HEMATOLOGY|[?]|vg/mL|[?]|[?]|INDETERMINATE|1|Absorbance U/min|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|REFRIGERATED||MASS SPECTROMETRY|MDRD 5 VARIABLE FORMULA|Y||NA||1|Visit_1|10|3|WASHOUT|2020-06-09|2020-07-16|10|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|3|HBOARBHB|Hemoglobin O-Arab/Total Hemoglobin|CHEMISTRY|||[?]|[?]|INVALID|1|uEq|1|1|[?]|NORMAL|SMEGMA|AGGLUTINATED|N|HPLC/MS/MS|CKD-EPI CREATININE FORMULA|||Y|Y|2|Visit_2|25|5|SCREENING|2020-06-24|2020-08-16|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|4|MYCYLE|Myelocytes/Leukocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|Hounsfield Unit|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|2|Visit_2|25|2|TREATMENT|2020-06-24|2020-07-27|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|5|OXACREAT|Oxalate/Creatinine|URINALYSIS|||[?]|[?]|INVALID|1|log10 TCID 50/uL|1|1|[?]|HIGH|LAVAGE FLUID|PARAFFIN-EMBEDDED||ENDPOINT DILUTION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N|Y|3|Visit_3|40|4|TREATMENT|2020-07-09|2020-09-01|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|6|APOA|Apolipoprotein A|URINALYSIS|||[?]|[?]|POSITIVE|1|mL/m2/h|1|1|[?]|LOW|SEBUM|CONTAMINATED||COMPLEMENT FIXATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|3|Visit_3|40|4|TREATMENT|2020-07-09|2020-07-28|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|7|PLSNCE|Neoplastic Plasma Cells|HEMATOLOGY|[?]|mg/L FEU|[?]|[?]|INVALID|1|/min|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|CONCENTRATED||IMMUNOFIXATION ELECTROPHORESIS|FIBROTEST FORMULA|||U||4|Visit_4|65|7|TREATMENT|2020-08-03|2020-08-25|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|8|VAL|Valine|HEMATOLOGY|[?]|Coulomb|[?]|[?]|TRACE|1|SFC/10^6 PBMC|1|1|[?]|NORMAL|FLUID|ICTERIC||DARK FIELD MICROSCOPY|MDRD ENZYMATIC FORMULA||Y|U||4|Visit_4|65|1|TREATMENT|2020-08-03|2020-08-16|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|9|DNAAB|Anti-DNA Antibodies|URINALYSIS|[?]|mL/kg/h|[?]|[?]|TRACE|1|PELLET|1|1|[?]|NORMAL|BASAL TEAR|PARAFFIN-EMBEDDED|N|THICK SMEAR|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||5|Visit_5|90|3|TREATMENT|2020-08-28|2020-08-30|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|10|RUB|Rubricyte|CHEMISTRY|[?]|mL/min/mmHg|[?]|[?]|POSITIVE|1|Absorbance U/mL|1|1|[?]|NORMAL|AMNIOTIC FLUID|SOLIDIFIED||MICROBIAL CULTURE, LIQUID|MDRD FORMULA|||NA||5|Visit_5|90|7|WASHOUT|2020-08-28|2020-08-31|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|597ff319-c16e-4aae-a7d9-ed2bc25684dc|1|DRUGSCR|Drug Screen|URINALYSIS|||[?]|[?]|INVALID|1|FFU|1|1|[?]|LOW|URINE|PARAFFIN-EMBEDDED|N|WHOLE EXOME SEQUENCING|FIBROTEST FORMULA|||Y|Y|1|Visit_1|10|7|SCREENING|2020-05-28|2020-08-15|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|597ff319-c16e-4aae-a7d9-ed2bc25684dc|2|MDC|Macrophage-Derived Chemokine|HEMATOLOGY|[?]|uU/dL|[?]|[?]|BORDERLINE|1|kg/mol|1|1|[?]|ABNORMAL|GASTRIC FLUID|FRESH||MICROBIAL CULTURE, LIQUID|FIBROTEST FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-05-28|2020-08-04|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|597ff319-c16e-4aae-a7d9-ed2bc25684dc|3|HGB|Hemoglobin|HEMATOLOGY|||[?]|[?]|INVALID|1|uIU/dL|1|1|[?]|LOW|NAIL|UNEXPECTED ODOR|N|NUCLEIC ACID HYBRIDIZATION|GMI % FORMULA||Y|NA|Y|2|Visit_2|25|5|TREATMENT|2020-06-12|2020-06-26|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|597ff319-c16e-4aae-a7d9-ed2bc25684dc|4|LYMIMLE|Immature Lymphocytes/Leukocytes|URINALYSIS|[?]|mg/L|[?]|[?]|BORDERLINE|1|U/mg|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|HEMOLYZED||CAPILLARY ELECTROPHORESIS|CKD-EPI FORMULA|||NA||2|Visit_2|25|4|WASHOUT|2020-06-12|2020-07-11|25|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|597ff319-c16e-4aae-a7d9-ed2bc25684dc|5|TRIM38|Tripartite Motif Containing Protein 38|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|nL|1|1|[?]|ABNORMAL|BREAST MILK|AUTOLYZED||LEAD CITRATE STAIN|CKD-EPI CYSTATIN C FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2020-06-27|2020-07-11|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|597ff319-c16e-4aae-a7d9-ed2bc25684dc|6|PTAUAB42|Phosphorylated Tau Prot/Amyloid Beta1-42|URINALYSIS|[?]|CAN|[?]|[?]|POSITIVE|1|10^6 IU/mL|1|1|[?]|NORMAL|PERSPIRATION|LIPEMIC||FLOCCULATION|CKD-EPI CYSTATIN C FORMULA|||U||3|Visit_3|40|7|WASHOUT|2020-06-27|2020-08-02|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|597ff319-c16e-4aae-a7d9-ed2bc25684dc|7|A1ANTRYP|Alpha-1 Antitrypsin|URINALYSIS|[?]|km|[?]|[?]|BORDERLINE|1|K|1|1|[?]|ABNORMAL|MUSCLE TISSUE|CONTAMINATED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA|Y||Y||4|Visit_4|65|5|FOLLOW-UP|2020-07-22|2020-08-03|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-29
e|LB|597ff319-c16e-4aae-a7d9-ed2bc25684dc|8|CXCL12|Chemokine (C-X-C Motif) Ligand 12|CHEMISTRY|[?]|fmol/g|[?]|[?]|BORDERLINE|1|BE/mL|1|1|[?]|HIGH|PLASMA ULTRAFILTRATE|GELLED|N|INCISION-INDUCED BLEEDING METHOD|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2020-07-22|2020-07-31|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-29
e|LB|597ff319-c16e-4aae-a7d9-ed2bc25684dc|9|AMORPHSD|Amorphous Sediment|CHEMISTRY|[?]|cup eq|[?]|[?]|INVALID|1|mL/h|1|1|[?]|LOW|STOOL|LACTESCENT||PAP STAIN|FIBROTEST FORMULA|Y||U||5|Visit_5|90|7|SCREENING|2020-08-16|2020-08-22|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-25
e|LB|597ff319-c16e-4aae-a7d9-ed2bc25684dc|10|PELGERH|Pelger Huet Anomaly|URINALYSIS|||[?]|[?]|NEGATIVE|1|GBq/g|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|UNEXPECTED ODOR||POLYGRAPHY|MDRD 4 VARIABLE FORMULA|||NA|Y|5|Visit_5|90|2|SCREENING|2020-08-16|2020-08-19|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-25
e|LB|7d845e3e-8bd1-4647-a3e8-352a52b585cb|1|BLSTRSID|Ringed Sideroblasts|URINALYSIS|[?]|g/U|[?]|[?]|BORDERLINE|1|10^3 CFU/g|1|1|[?]|LOW|HAIR FOLLICLE|PARAFFIN-EMBEDDED||DROPLET DIGITAL PCR|GMI MMOL/MOL FORMULA|||NA||1|Visit_1|10|4|SCREENING|2020-11-08|2020-12-31|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|7d845e3e-8bd1-4647-a3e8-352a52b585cb|2|CITRTEXR|Citrate Excretion Rate|URINALYSIS|[?]|nmol/L/min|[?]|[?]|POSITIVE|1|cm|1|1|[?]|LOW|MONOCYTE|ROOM TEMPERATURE||HIGH LEVEL AMINOGLYCOSIDE SCREEN|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|7|WASHOUT|2020-11-08|2020-12-19|10|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|7d845e3e-8bd1-4647-a3e8-352a52b585cb|3|IGFBP3|Insulin-Like Growth Factor Binding Prot3|CHEMISTRY|[?]|m3|[?]|[?]|POSITIVE|1|10^9 CFU/mL|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|CONCENTRATED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|GMI MMOL/MOL FORMULA||Y|U||2|Visit_2|25|7|TREATMENT|2020-11-23|2021-01-19|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|7d845e3e-8bd1-4647-a3e8-352a52b585cb|4|EPINSQE|Epi Cells/Non-Squam Epi Cells|URINALYSIS|[?]|mL/s/m2|[?]|[?]|TRACE|1|10^9/dose|1|1|[?]|HIGH|STOOL|THAWED||MALDI-TOF|CKD-EPI CYSTATIN C FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-11-23|2021-01-19|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|7d845e3e-8bd1-4647-a3e8-352a52b585cb|5|THCCOOH|11-Nor-Delta9-THC-9-Carboxylic Acid|CHEMISTRY|[?]|cg|[?]|[?]|NEGATIVE|1|10^9 CFU/mL|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|CALCIFIED|N|LASER CAPTURE MICRODISSECTION|CKD-EPI FORMULA|||NA||3|Visit_3|40|4|FOLLOW-UP|2020-12-08|2021-01-05|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|7d845e3e-8bd1-4647-a3e8-352a52b585cb|6|WBC|Leukocytes|CHEMISTRY|[?]|mL/kg/h|[?]|[?]|INDETERMINATE|1|C|1|1|[?]|HIGH|CEREBROSPINAL FLUID|HEMOLYZED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|GMI MMOL/MOL FORMULA||Y|U||3|Visit_3|40|5|FOLLOW-UP|2020-12-08|2021-01-29|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|7d845e3e-8bd1-4647-a3e8-352a52b585cb|7|RETCRRBC|HCT Corrected Reticulocytes/Erythrocytes|URINALYSIS|||[?]|[?]|TRACE|1|g/dL|1|1|[?]|LOW|PLATELET RICH PLASMA|LACTESCENT||SMEAR|GMI % FORMULA|||U|Y|4|Visit_4|65|2|FOLLOW-UP|2021-01-02|2021-01-13|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|LB|7d845e3e-8bd1-4647-a3e8-352a52b585cb|8|CRTCREAT|Corticosterone/Creatinine|URINALYSIS|[?]|Watt|[?]|[?]|INDETERMINATE|1|Enzyme U/L|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|SOLIDIFIED||MOUSE PROTECTION ASSAY|COCKCROFT-GAULT FORMULA|||NA||4|Visit_4|65|6|SCREENING|2021-01-02|2021-01-06|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|LB|7d845e3e-8bd1-4647-a3e8-352a52b585cb|9|RANKL|Receptor Activator Nuclear KappaB Ligand|URINALYSIS|[?]|U/g|[?]|[?]|INVALID|1|pmol/10^10 cells|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|LIPEMIC|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA|Y|Y|U||5|Visit_5|90|7|TREATMENT|2021-01-27|2021-01-30|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|7d845e3e-8bd1-4647-a3e8-352a52b585cb|10|CD1|CD1|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mL/sec/1.73m2|1|1|[?]|HIGH|SERUM OR PLASMA|ICTERIC||MAMMOGRAPHY|CKD-EPI CREATININE FORMULA|||Y|Y|5|Visit_5|90|1|TREATMENT|2021-01-27|2021-01-30|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|7e9f4283-f90b-4f74-939c-b42648e8373c|1|CRDIGAAB|Cardiolipin IgA Antibody|CHEMISTRY|[?]|g/animal/wk|[?]|[?]|INDETERMINATE|1|uU/L|1|1|[?]|HIGH|EMOTIONAL TEAR|ROOM TEMPERATURE||COMPLEMENT FIXATION|CKD-EPI CREATININE FORMULA||Y|N||1|Visit_1|10|5|TREATMENT|2020-12-15|2021-03-02|10|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|7e9f4283-f90b-4f74-939c-b42648e8373c|2|IL6SR|Soluble Interleukin 6 Receptor|HEMATOLOGY|[?]|ug/L FEU|[?]|[?]|INDETERMINATE|1|beats/min|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|CALCIFIED||IMMUNOCHEMILUMINOMETRIC ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||1|Visit_1|10|4|TREATMENT|2020-12-15|2021-02-07|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|7e9f4283-f90b-4f74-939c-b42648e8373c|3|CXCL1|Chemokine (C-X-C Motif) Ligand 1|HEMATOLOGY|[?]|U/m2/h|[?]|[?]|TRACE|1|mg/kg/week|1|1|[?]|HIGH|EPITHELIAL CELL|ICTERIC||PHOTOMETRY|MDRD 6 VARIABLE FORMULA|Y||Y||2|Visit_2|25|6|TREATMENT|2020-12-30|2021-01-04|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|7e9f4283-f90b-4f74-939c-b42648e8373c|4|V25HD2|25-Hydroxyvitamin D2|CHEMISTRY|||[?]|[?]|INVALID|1|GBq|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|UNEXPECTED ODOR||SLOAN LETTER EYE CHART 2.5%|GMI MMOL/MOL FORMULA|Y||Y|Y|2|Visit_2|25|6|FOLLOW-UP|2020-12-30|2021-02-16|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|7e9f4283-f90b-4f74-939c-b42648e8373c|5|FATACFRS|Free Fatty Acid, Saturated|URINALYSIS|||[?]|[?]|TRACE|1|GBq/ug|1|1|[?]|LOW|SMEGMA|FRESH||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|FIBROTEST FORMULA|Y||U|Y|3|Visit_3|40|4|TREATMENT|2021-01-14|2021-02-12|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|7e9f4283-f90b-4f74-939c-b42648e8373c|6|PMYCECE|Proliferating Myeloid Cells/Total Cells|CHEMISTRY|||[?]|[?]|BORDERLINE|1|PACKAGE|1|1|[?]|LOW|ADIPOSE TISSUE|ROOM TEMPERATURE||POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|3|Visit_3|40|7|SCREENING|2021-01-14|2021-03-12|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|7e9f4283-f90b-4f74-939c-b42648e8373c|7|TOXGRAN|Toxic Granulation|URINALYSIS|[?]|mg/m2/min|[?]|[?]|INVALID|1|MPL U/mL|1|1|[?]|LOW|SERUM OR PLASMA|DRIED||PET/CT SCAN WITHOUT CONTRAST|NASH FIBROSURE FORMULA||Y|N||4|Visit_4|65|6|WASHOUT|2021-02-08|2021-03-06|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|7e9f4283-f90b-4f74-939c-b42648e8373c|8|INTLK12B|Interleukin 12 Beta|HEMATOLOGY|[?]|IU/g|[?]|[?]|INDETERMINATE|1|MPL U|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|FRESH||MALDI|CKD-EPI FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2021-02-08|2021-03-03|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|7e9f4283-f90b-4f74-939c-b42648e8373c|9|TESTOSBA|Bioavailable Testosterone|URINALYSIS|[?]|mg/dL|[?]|[?]|NEGATIVE|1|mL/mmHg|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|AUTOLYZED||DOUBLE IMMUNODIFFUSION|ASH FIBROSURE FORMULA|Y||N||5|Visit_5|90|7|TREATMENT|2021-03-05|2021-03-09|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|7e9f4283-f90b-4f74-939c-b42648e8373c|10|C165922|Mixed Antigen IgE AB RAST Score|CHEMISTRY|[?]|U/10^12 RBC|[?]|[?]|TRACE|1|cm H2O|1|1|[?]|ABNORMAL|BUFFY COAT|LACTESCENT|N|CELL BASED BIOASSAY|MDRD 5 VARIABLE FORMULA||Y|U||5|Visit_5|90|1|SCREENING|2021-03-05|2021-03-14|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|20a637e6-83d2-4a86-9ecc-8ddb0523997f|1|HLADPB1|HLA DP Beta1 Antigen|CHEMISTRY|[?]|mmol2/L2|[?]|[?]|BORDERLINE|1|mEq/kg|1|1|[?]|LOW|FLUID|LACTESCENT||PHOTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-10-31|2021-01-22|10|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|20a637e6-83d2-4a86-9ecc-8ddb0523997f|2|ETPTPR|ETP Time to Peak Relative|URINALYSIS|||[?]|[?]|POSITIVE|1|mL/kg/h|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|REFRIGERATED||MICROSCOPY|FIBROSIS 4 FORMULA|||U|Y|1|Visit_1|10|6|SCREENING|2020-10-31|2020-12-27|10|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|20a637e6-83d2-4a86-9ecc-8ddb0523997f|3|CREAT|Creatinine|URINALYSIS|||[?]|[?]|NEGATIVE|1|PRESSOR UNITS|1|1|[?]|HIGH|EPIDERMAL TISSUE|SOLIDIFIED||CAPILLARY ELECTROPHORESIS|HEPASCORE FORMULA|||Y|Y|2|Visit_2|25|3|TREATMENT|2020-11-15|2021-01-14|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|20a637e6-83d2-4a86-9ecc-8ddb0523997f|4|TURB|Turbidity|CHEMISTRY|[?]|mL/kg/day|[?]|[?]|INVALID|1|mg/mL/min|1|1|[?]|HIGH|MUSCLE TISSUE|REFRIGERATED||CONTRAST ENHANCED SPIRAL CT SCAN|MDRD 6 VARIABLE FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-11-15|2020-12-11|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|20a637e6-83d2-4a86-9ecc-8ddb0523997f|5|GLOBA2PT|Alpha-2 Globulin/Total Protein|URINALYSIS|[?]|10^5/L|[?]|[?]|INDETERMINATE|1|Rad|1|1|[?]|LOW|TISSUE|NON-HEMOLYZED|N|DIFFUSION TENSOR MRI|MDRD 6 VARIABLE FORMULA|||NA||3|Visit_3|40|5|FOLLOW-UP|2020-11-30|2021-01-15|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|20a637e6-83d2-4a86-9ecc-8ddb0523997f|6|A1AGLP|Alpha-1 Acid Glycoprotein|URINALYSIS|[?]|FINGERTIP UNIT|[?]|[?]|TRACE|1|breaths/min|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|FROZEN||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-11-30|2021-01-22|40|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|20a637e6-83d2-4a86-9ecc-8ddb0523997f|7|TPROTFR|Tau Protein, Free|URINALYSIS|||[?]|[?]|NEGATIVE|1|mmol/kg|1|1|[?]|HIGH|SYNOVIAL FLUID|ICTERIC|N|GIEMSA STAIN|FIBROMETER FORMULA|||Y|Y|4|Visit_4|65|1|TREATMENT|2020-12-25|2020-12-29|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|20a637e6-83d2-4a86-9ecc-8ddb0523997f|8|BICARB|Bicarbonate|HEMATOLOGY|[?]|LB|[?]|[?]|BORDERLINE|1|ukat/10^12 RBC|1|1|[?]|NORMAL|AQUEOUS HUMOR|SOLIDIFIED|N|TARGETED GENOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||4|Visit_4|65|2|SCREENING|2020-12-25|2021-01-10|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|20a637e6-83d2-4a86-9ecc-8ddb0523997f|9|C130140|German Cockroach Antigen IgE Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|MdFI|1|1|[?]|ABNORMAL|REFLEX TEAR|NON-HEMOLYZED|N|GRAM STAIN|ASH FIBROSURE FORMULA|||U|Y|5|Visit_5|90|7|TREATMENT|2021-01-19|2021-01-20|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|20a637e6-83d2-4a86-9ecc-8ddb0523997f|10|CACRALB|Calcium Corrected for Albumin|HEMATOLOGY|[?]|CAPSULE|[?]|[?]|INDETERMINATE|1|DRINK|1|1|[?]|LOW|STOOL|NON-HEMOLYZED||BAC ACGH|FIBROTEST FORMULA|||Y||5|Visit_5|90|6|FOLLOW-UP|2021-01-19|2021-01-28|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|1|CMPK2|Cytidine-Uridine Monophosphate Kinase 2|HEMATOLOGY|[?]|dram|[?]|[?]|INDETERMINATE|1|Siemens|1|1|[?]|LOW|GASTRIC CONTENTS|REFRIGERATED||THICK SMEAR|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|3|TREATMENT|2020-05-16|2020-06-14|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|LB|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|2|APAPCYS|Acetaminophen-Cysteine Adduct|CHEMISTRY|[?]|log10 IU/mL|[?]|[?]|BORDERLINE|1|IU/dL|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|CALCIFIED|N|FREEZING POINT DEPRESSION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-05-16|2020-07-22|10|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|LB|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|3|ANIONG3|Anion Gap 3|HEMATOLOGY|||[?]|[?]|TRACE|1|/10^5|1|1|[?]|LOW|ADIPOSE TISSUE|FRESH|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD 6 VARIABLE FORMULA|||NA|Y|2|Visit_2|25|1|TREATMENT|2020-05-31|2020-06-10|25|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|4|CACR|Calcium Corrected|HEMATOLOGY|[?]|kg|[?]|[?]|INVALID|1|BAG|1|1|[?]|ABNORMAL|MUCUS|CONCENTRATED||CENTRIFUGATION|FIBROMETER FORMULA|Y||Y||2|Visit_2|25|1|TREATMENT|2020-05-31|2020-07-06|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|5|C165934|Arachis hypogaea IgE AB RAST Score|CHEMISTRY|[?]|Bq|[?]|[?]|NEGATIVE|1|GBq|1|1|[?]|ABNORMAL|EXUDATE|FRESH|N|GC/MS-EI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||3|Visit_3|40|2|FOLLOW-UP|2020-06-15|2020-08-04|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|LB|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|6|GLY|Glycine|URINALYSIS|[?]|um2|[?]|[?]|POSITIVE|1|10^6/Ejaculate U|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|PARAFFIN-EMBEDDED||IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||3|Visit_3|40|2|TREATMENT|2020-06-15|2020-06-18|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|LB|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|7|ORNITHIN|Ornithine|URINALYSIS|[?]|mV*min|[?]|[?]|INDETERMINATE|1|GPS U|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|CLOTTED||GIEMSA STAIN|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|1|TREATMENT|2020-07-10|2020-08-07|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|8|NUCSWELL|Nuclear Swelling|URINALYSIS|[?]|ug/L/h|[?]|[?]|INVALID|1|10^5/L|1|1|[?]|ABNORMAL|BASAL TEAR|LIPEMIC|N|ELISPOT|ASH FIBROSURE FORMULA|||NA||4|Visit_4|65|5|SCREENING|2020-07-10|2020-08-12|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|9|HGBTET|Hemoglobin Tetramer|URINALYSIS|[?]|10^8/L|[?]|[?]|TRACE|1|cmHg|1|1|[?]|NORMAL|BREAST MILK|REFRIGERATED||LC/MS/MS|CKD-EPI CREATININE FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-08-04|2020-08-11|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|10|CAPHOS|Calcium/Phosphorus|CHEMISTRY|[?]|uEq/L|[?]|[?]|INDETERMINATE|1|L/s|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|LIPEMIC||TELLER ACUITY CARDS|CKD-EPI FORMULA||Y|U||5|Visit_5|90|3|FOLLOW-UP|2020-08-04|2020-08-08|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|595aa95c-4378-47c1-96e9-5512d08fb653|1|FAT|Fat|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|MPS U|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|CONTAMINATED||PAP STAIN|HEPASCORE FORMULA||Y|Y|Y|1|Visit_1|10|4|FOLLOW-UP|2020-08-23|2020-09-15|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|595aa95c-4378-47c1-96e9-5512d08fb653|2|CTXI|Type I Collagen C-Telopeptides|CHEMISTRY|||[?]|[?]|NEGATIVE|1|HEP|1|1|[?]|LOW|SYNOVIAL FLUID|HEMOLYZED||SPIRAL CT SCAN WITHOUT CONTRAST|NASH FIBROSURE FORMULA||Y|Y|Y|1|Visit_1|10|3|TREATMENT|2020-08-23|2020-11-04|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|595aa95c-4378-47c1-96e9-5512d08fb653|3|EOSCE|Eosinophils/Total Cells|HEMATOLOGY|[?]|dpm/0.5 mL|[?]|[?]|TRACE|1|DAgU/mL|1|1|[?]|HIGH|LOCHIA|CLOTTED|N|SPIRAL CT SCAN WITHOUT CONTRAST|MDRD 4 VARIABLE FORMULA|||N||2|Visit_2|25|5|TREATMENT|2020-09-07|2020-11-20|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|595aa95c-4378-47c1-96e9-5512d08fb653|4|CDCACM|Chenodeoxycholate Compounds|URINALYSIS|[?]|Ci/mg|[?]|[?]|NEGATIVE|1|/40 HPFs|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|AUTOLYZED||VENTILATION PERFUSION LUNG SCAN|FIBROSIS 4 FORMULA|||NA||2|Visit_2|25|1|FOLLOW-UP|2020-09-07|2020-09-25|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|595aa95c-4378-47c1-96e9-5512d08fb653|5|GATCPHRL|Gamma Tocopherol|CHEMISTRY|[?]|mmol/min/kPa/L|[?]|[?]|INVALID|1|hr/day|1|1|[?]|NORMAL|BONE MARROW|CLOTTED||HPLC-UV|MDRD 6 VARIABLE FORMULA|Y||Y||3|Visit_3|40|3|FOLLOW-UP|2020-09-22|2020-10-25|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|LB|595aa95c-4378-47c1-96e9-5512d08fb653|6|ALBEXR|Albumin Excretion Rate|HEMATOLOGY|||[?]|[?]|INVALID|1|um2|1|1|[?]|NORMAL|BASAL TEAR|CONTAMINATED|N|TELLER ACUITY CARDS|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|3|Visit_3|40|4|SCREENING|2020-09-22|2020-10-29|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|LB|595aa95c-4378-47c1-96e9-5512d08fb653|7|MDMA|3,4-methylenedioxymethamphetamine|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mol/mg|1|1|[?]|NORMAL|EMESIS|CLOTTED||WESTERGREN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA|Y|4|Visit_4|65|4|TREATMENT|2020-10-17|2020-11-15|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|595aa95c-4378-47c1-96e9-5512d08fb653|8|CXCL12|Chemokine (C-X-C Motif) Ligand 12|CHEMISTRY|[?]|CYLINDER|[?]|[?]|TRACE|1|atm|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|PARAFFIN-EMBEDDED||IMPEDANCE CONDUCTIVITY|FIBROTEST FORMULA||Y|U||4|Visit_4|65|4|WASHOUT|2020-10-17|2020-11-13|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|595aa95c-4378-47c1-96e9-5512d08fb653|9|BNP|Brain Natriuretic Peptide|CHEMISTRY|[?]|FIU|[?]|[?]|BORDERLINE|1|HOURS|1|1|[?]|HIGH|EPIDERMAL TISSUE|LACTESCENT||KARYOTYPING|CKD-EPI FORMULA|||U||5|Visit_5|90|3|FOLLOW-UP|2020-11-11|2020-11-20|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|595aa95c-4378-47c1-96e9-5512d08fb653|10|CAFFEINE|Caffeine|HEMATOLOGY|[?]|10^4/hpf|[?]|[?]|BORDERLINE|1|%(w/w)|1|1|[?]|LOW|SPUTUM|CONCENTRATED||PERIODIC ACID SCHIFF STAIN|MDRD FORMULA||Y|Y||5|Visit_5|90|5|TREATMENT|2020-11-11|2020-11-18|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|b528dc24-e791-41b1-95b3-fc0be18da47f|1|HBA2PHB|Hemoglobin A2 Prime/Total Hemoglobin|CHEMISTRY|[?]|/10^3|[?]|[?]|TRACE|1|% INHIBITION|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|LACTESCENT||THIN SMEAR|GMI MMOL/MOL FORMULA|Y|Y|NA||1|Visit_1|10|6|SCREENING|2020-12-27|2021-03-11|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|LB|b528dc24-e791-41b1-95b3-fc0be18da47f|2|INTLK28|Interleukin 28|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ug/g/day|1|1|[?]|NORMAL|VITREOUS HUMOR|PARAFFIN-EMBEDDED||DUKE INCISION METHOD|MDRD 6 VARIABLE FORMULA|||U|Y|1|Visit_1|10|2|TREATMENT|2020-12-27|2021-02-19|10|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|LB|b528dc24-e791-41b1-95b3-fc0be18da47f|3|IC512AG|Islet Cell 512 Antigen|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mg/mL/day|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|CLOTTED|N|ELECTROMYOGRAPHY|CKD-EPI FORMULA|Y||NA|Y|2|Visit_2|25|1|TREATMENT|2021-01-11|2021-03-16|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|b528dc24-e791-41b1-95b3-fc0be18da47f|4|EOSB|Eosinophils Band Form|URINALYSIS|[?]|/5x10^4 WBC|[?]|[?]|BORDERLINE|1|mMU/mL|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|ICTERIC||SISH|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||2|Visit_2|25|4|TREATMENT|2021-01-11|2021-02-07|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|b528dc24-e791-41b1-95b3-fc0be18da47f|5|MONOPTPT|Monoclonal Protein/Total Protein|CHEMISTRY|[?]|nkat/L|[?]|[?]|BORDERLINE|1|10^9 organisms/mg|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|CONCENTRATED||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|2|FOLLOW-UP|2021-01-26|2021-02-15|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|b528dc24-e791-41b1-95b3-fc0be18da47f|6|OXALATE|Oxalate|CHEMISTRY|||[?]|[?]|POSITIVE|1|pg/dL|1|1|[?]|LOW|WHITE MATTER TISSUE|ROOM TEMPERATURE||LIGHT SCATTERING SPECTROSCOPY|ASH FIBROSURE FORMULA|Y||N|Y|3|Visit_3|40|1|WASHOUT|2021-01-26|2021-02-07|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|b528dc24-e791-41b1-95b3-fc0be18da47f|7|IRON|Iron|CHEMISTRY|[?]|MBP|[?]|[?]|POSITIVE|1|tsp eq|1|1|[?]|HIGH|FLUID|CLOTTED||FUNCTIONAL MRI|FIBROMETER FORMULA|||N||4|Visit_4|65|1|TREATMENT|2021-02-20|2021-02-22|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|b528dc24-e791-41b1-95b3-fc0be18da47f|8|MSPIKEPT|Monoclonal Protein Spike/Total Protein|CHEMISTRY|||[?]|[?]|NEGATIVE|1|ks|1|1|[?]|LOW|BREAST MILK|SOLIDIFIED||PET/CT SCAN WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA||Y|N|Y|4|Visit_4|65|4|SCREENING|2021-02-20|2021-03-15|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|b528dc24-e791-41b1-95b3-fc0be18da47f|9|IAPP|Islet Amyloid Polypeptide|URINALYSIS|[?]|mU|[?]|[?]|INVALID|1|mmHg/sec|1|1|[?]|HIGH|CEREBROSPINAL FLUID|FRESH||CALIPER MEASUREMENT METHOD|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|3|TREATMENT|2021-03-17|2021-03-22|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|b528dc24-e791-41b1-95b3-fc0be18da47f|10|OXYSAT|Oxygen Saturation|CHEMISTRY|[?]|pg/cell|[?]|[?]|BORDERLINE|1|umol/min|1|1|[?]|ABNORMAL|LUNG SURFACTANT|FRESH||WHOLE TRANSCRIPTOME SEQUENCING|MDRD 6 VARIABLE FORMULA||Y|Y||5|Visit_5|90|6|TREATMENT|2021-03-17|2021-03-26|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|7a43c892-0e7f-4f33-9130-e175e475531f|1|LDH4LDH|LDH Isoenzyme 4/LDH|HEMATOLOGY|[?]|uV|[?]|[?]|TRACE|1|mAmp|1|1|[?]|LOW|SUPERNATANT, SERUM|THAWED|N|LC-FL|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-05-17|2020-06-18|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|7a43c892-0e7f-4f33-9130-e175e475531f|2|LAP|Leucine Aminopeptidase|HEMATOLOGY|[?]|L/s/kPa|[?]|[?]|TRACE|1|TUBE|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|THAWED||MANUAL CLOT DETECTION|GMI MMOL/MOL FORMULA||Y|NA||1|Visit_1|10|7|SCREENING|2020-05-17|2020-07-01|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|7a43c892-0e7f-4f33-9130-e175e475531f|3|SJSSBAB|Sjogrens SS-B Antibody|CHEMISTRY|[?]|mL/cm3/min|[?]|[?]|TRACE|1|m/sec2|1|1|[?]|ABNORMAL|KERATINOCYTE|AUTOLYZED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|4|FOLLOW-UP|2020-06-01|2020-06-24|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|7a43c892-0e7f-4f33-9130-e175e475531f|4|ESTFR|Estradiol, Free|URINALYSIS|[?]|U/10^12 RBC|[?]|[?]|POSITIVE|1|cg|1|1|[?]|NORMAL|URINE|UNEXPECTED ODOR||CONFOCAL MICROSCOPY|MDRD 5 VARIABLE FORMULA|Y||Y||2|Visit_2|25|5|WASHOUT|2020-06-01|2020-07-04|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|7a43c892-0e7f-4f33-9130-e175e475531f|5|HBA1C|Hemoglobin A1C|CHEMISTRY|[?]|Rad|[?]|[?]|INVALID|1|yd|1|1|[?]|ABNORMAL|CERUMEN|AGGLUTINATED||WEBER GREEN STAIN|MDRD FORMULA|||N||3|Visit_3|40|4|TREATMENT|2020-06-16|2020-06-28|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|7a43c892-0e7f-4f33-9130-e175e475531f|6|BLSTLYLE|Lymphoblasts/Leukocytes|URINALYSIS|[?]|%(v/v)|[?]|[?]|TRACE|1|U/mg|1|1|[?]|NORMAL|LOCHIA|HEMOLYZED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|4|WASHOUT|2020-06-16|2020-07-14|40|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|7a43c892-0e7f-4f33-9130-e175e475531f|7|TGFB2|Transforming Growth Factor Beta 2|URINALYSIS|[?]|dpm/0.5 mL|[?]|[?]|POSITIVE|1|umol/day|1|1|[?]|ABNORMAL|PROSTATIC FLUID|PARAFFIN-EMBEDDED|N|OBSERVATION|GMI MMOL/MOL FORMULA||Y|N||4|Visit_4|65|3|TREATMENT|2020-07-11|2020-08-08|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|LB|7a43c892-0e7f-4f33-9130-e175e475531f|8|ATHMBAAC|Antithrombin Activity Actual/Control|CHEMISTRY|[?]|/day|[?]|[?]|POSITIVE|1|cmH2O/mL|1|1|[?]|ABNORMAL|VITREOUS HUMOR|DRIED|N|IMMUNOPRECIPITATION|HEPASCORE FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-07-11|2020-08-09|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|LB|7a43c892-0e7f-4f33-9130-e175e475531f|9|CSGRAN|Granular Casts|CHEMISTRY|[?]|ug/mol|[?]|[?]|TRACE|1|Bq/g|1|1|[?]|HIGH|SUPERNATANT, SERUM|FRESH||COMPLEMENT FIXATION|HEPASCORE FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-08-05|2020-08-07|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|7a43c892-0e7f-4f33-9130-e175e475531f|10|VCAM1|Vascular Cell Adhesion Molecule 1|URINALYSIS|||[?]|[?]|NEGATIVE|1|mm/2h|1|1|[?]|NORMAL|ABSCESS FLUID|CLOTTED||MYELOPEROXIDASE STAIN|GMI MMOL/MOL FORMULA|Y||Y|Y|5|Visit_5|90|6|FOLLOW-UP|2020-08-05|2020-08-08|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|1|SAA1|Serum Amyloid A1|CHEMISTRY|[?]|%(w/w)|[?]|[?]|NEGATIVE|1|mL/g/min|1|1|[?]|HIGH|AMNIOTIC FLUID|CONTAMINATED||FLOW CYTOMETRY|HEPASCORE FORMULA||Y|N||1|Visit_1|10|5|TREATMENT|2020-12-10|2021-01-16|10|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|2|SECRETIN|Secretin|HEMATOLOGY|[?]|MET|[?]|[?]|BORDERLINE|1|nmol/mL/min|1|1|[?]|LOW|GASTRIC FLUID|AUTOLYZED||ACRIDINE ORANGE STAIN|CKD-EPI FORMULA|||U||1|Visit_1|10|2|FOLLOW-UP|2020-12-10|2021-02-09|10|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|3|ANCIGAB|Anti-Neutrophil Cytoplasmic IgG Antibody|CHEMISTRY|[?]|QUANTITY SUFFICIENT|[?]|[?]|TRACE|1|U/m2/h|1|1|[?]|HIGH|AQUEOUS HUMOR|AUTOLYZED|N|FUNDUS PHOTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA||2|Visit_2|25|7|TREATMENT|2020-12-25|2021-01-20|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|4|KRCYMGLE|Megakaryocytes/Leukocytes|CHEMISTRY|[?]|EVENTS|[?]|[?]|INVALID|1|10^5/L|1|1|[?]|NORMAL|PUS|ROOM TEMPERATURE||X-RAY FLUORESCENCE SPECTROMETRY|MDRD 4 VARIABLE FORMULA||Y|Y||2|Visit_2|25|4|TREATMENT|2020-12-25|2021-03-05|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|5|PRO|Proline|HEMATOLOGY|[?]|CARTRIDGE|[?]|[?]|NEGATIVE|1|IU/L|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|GELLED||CALCOFLUOR WHITE STAIN|FIBROMETER FORMULA|||Y||3|Visit_3|40|1|SCREENING|2021-01-09|2021-01-12|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|6|MMA|Methylmalonic Acid|CHEMISTRY|[?]|CIGARETTE|[?]|[?]|INVALID|1|10^3 DNA copies/mL|1|1|[?]|LOW|ADIPOSE TISSUE|CONTAMINATED|N|LC-FL|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2021-01-09|2021-03-07|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|7|ETPAUC|ETP Area Under Curve|URINALYSIS|[?]|pL|[?]|[?]|NEGATIVE|1|U/10^12 RBC|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|HEMOLYZED|N|SNELLEN EYE CHART|CKD-EPI CYSTATIN C FORMULA|||Y||4|Visit_4|65|2|FOLLOW-UP|2021-02-03|2021-02-09|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|8|ESTROGEN|Estrogen|HEMATOLOGY|[?]|BOWL|[?]|[?]|POSITIVE|1|mmol/g|1|1|[?]|LOW|PLEURAL TISSUE|SOLIDIFIED|N|BRDU CELLULAR PROLIFERATION ASSAY|MDRD 6 VARIABLE FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2021-02-03|2021-02-21|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|9|MCHC|Ery. Mean Corpuscular HGB Concentration|CHEMISTRY|[?]|scm|[?]|[?]|INVALID|1|pL|1|1|[?]|NORMAL|COLOSTRUM|SOLIDIFIED||HIGH RESOLUTION CT|FIBROTEST FORMULA|||NA||5|Visit_5|90|2|SCREENING|2021-02-28|2021-03-07|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|10|HLAIAB|HLA Class I Antibody|URINALYSIS|[?]|mm/2h|[?]|[?]|INVALID|1|L/min/m2|1|1|[?]|NORMAL|SALIVA|CONCENTRATED||LIGHT SCATTERING SPECTROSCOPY|HEPASCORE FORMULA||Y|Y||5|Visit_5|90|4|FOLLOW-UP|2021-02-28|2021-03-01|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|bde9096e-9ab9-45fe-8e96-1ec9762824a0|1|NMH|N-methylhistamine|HEMATOLOGY|[?]|mV/sec|[?]|[?]|INVALID|1|MBq|1|1|[?]|NORMAL|SPUTUM|DRIED||FUNCTIONAL MRI|FIBROMETER FORMULA|||Y||1|Visit_1|10|3|TREATMENT|2020-08-27|2020-10-03|10|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|bde9096e-9ab9-45fe-8e96-1ec9762824a0|2|CD8|CD8|URINALYSIS|||[?]|[?]|POSITIVE|1|g/mol|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|ROOM TEMPERATURE||IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD 6 VARIABLE FORMULA||Y|U|Y|1|Visit_1|10|3|FOLLOW-UP|2020-08-27|2020-11-19|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|bde9096e-9ab9-45fe-8e96-1ec9762824a0|3|PTA|Prothrombin Activity|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|/4.0 mL|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|CLOTTED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI FORMULA|||U|Y|2|Visit_2|25|7|TREATMENT|2020-09-11|2020-09-26|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|bde9096e-9ab9-45fe-8e96-1ec9762824a0|4|ANIONG4|Anion Gap 4|HEMATOLOGY|[?]|pg/L|[?]|[?]|TRACE|1|/100 HPFs|1|1|[?]|ABNORMAL|CALCULUS|AUTOLYZED||HEMAGGLUTINATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|5|WASHOUT|2020-09-11|2020-10-25|25|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|bde9096e-9ab9-45fe-8e96-1ec9762824a0|5|FXAC|Factor X Actual/Control|URINALYSIS|[?]|10^6 CFU|[?]|[?]|NEGATIVE|1|MONTHS|1|1|[?]|HIGH|SERUM|ROOM TEMPERATURE||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CREATININE FORMULA|||N||3|Visit_3|40|3|FOLLOW-UP|2020-09-26|2020-10-16|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|bde9096e-9ab9-45fe-8e96-1ec9762824a0|6|VTRNCTN|Vitronectin|HEMATOLOGY|[?]|100 IU/mL|[?]|[?]|POSITIVE|1|10^3 DNA copies/mL|1|1|[?]|LOW|LOCHIA|FRESH||POLYMERASE CHAIN REACTION|HEPASCORE FORMULA|||U||3|Visit_3|40|2|TREATMENT|2020-09-26|2020-11-05|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|bde9096e-9ab9-45fe-8e96-1ec9762824a0|7|RP3IGGAB|RNA Polymerase III IgG Antibody|URINALYSIS|[?]|DROP|[?]|[?]|NEGATIVE|1|mmol/min/kPa/L|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|THAWED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-10-21|2020-11-19|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|bde9096e-9ab9-45fe-8e96-1ec9762824a0|8|NCTD5P|5 Prime Nucleotidase|CHEMISTRY|||[?]|[?]|BORDERLINE|1|in2|1|1|[?]|ABNORMAL|SERUM OR PLASMA|NON-HEMOLYZED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|4|Visit_4|65|5|WASHOUT|2020-10-21|2020-11-16|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|bde9096e-9ab9-45fe-8e96-1ec9762824a0|9|HERC5|Hect Domain and RLD 5|HEMATOLOGY|||[?]|[?]|TRACE|1|cd|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|HEMOLYZED||CLOT DETECTION|NASH FIBROSURE FORMULA|||NA|Y|5|Visit_5|90|7|TREATMENT|2020-11-15|2020-11-16|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|bde9096e-9ab9-45fe-8e96-1ec9762824a0|10|S6PHS|Phos-S6 Ribosomal Protein|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|Anson U|1|1|[?]|LOW|BASAL TEAR|PARAFFIN-EMBEDDED||IODINE STAIN|ASH FIBROSURE FORMULA|Y||Y|Y|5|Visit_5|90|6|FOLLOW-UP|2020-11-15|2020-11-16|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|ea7907aa-811e-48ec-9fc6-ab8affde8913|1|CD2|CD2|HEMATOLOGY|[?]|/mm|[?]|[?]|BORDERLINE|1|Absorbance U|1|1|[?]|LOW|CORD BLOOD|FROZEN||MICROBIAL CULTURE, SOLID|NASH FIBROSURE FORMULA|||Y||1|Visit_1|10|1|SCREENING|2020-06-28|2020-07-21|10|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|ea7907aa-811e-48ec-9fc6-ab8affde8913|2|ANIONG4|Anion Gap 4|CHEMISTRY|[?]|10^3 organisms|[?]|[?]|INVALID|1|/h|1|1|[?]|NORMAL|SALIVA|AGGLUTINATED||LIQUID SCINTILLATION COUNTING|FIBROMETER FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-06-28|2020-09-16|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|ea7907aa-811e-48ec-9fc6-ab8affde8913|3|PMDW|Platelet Mass Distribution Width|CHEMISTRY|||[?]|[?]|TRACE|1|ug/kg/min|1|1|[?]|LOW|VENOUS BLOOD|THAWED||COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD 4 VARIABLE FORMULA|Y||Y|Y|2|Visit_2|25|2|TREATMENT|2020-07-13|2020-07-30|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|ea7907aa-811e-48ec-9fc6-ab8affde8913|4|DENSITY|Density|HEMATOLOGY|[?]|kHz|[?]|[?]|INDETERMINATE|1|cmH2O*s/mL|1|1|[?]|LOW|DIALYSIS FLUID|REFRIGERATED|N|URANYL ACETATE STAIN|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|7|SCREENING|2020-07-13|2020-08-31|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|ea7907aa-811e-48ec-9fc6-ab8affde8913|5|VITB12|Vitamin B12|URINALYSIS|[?]|mg/kg/week|[?]|[?]|POSITIVE|1|U|1|1|[?]|ABNORMAL|PLASMA|GELLED||SPIROMETRY|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|4|WASHOUT|2020-07-28|2020-08-15|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|ea7907aa-811e-48ec-9fc6-ab8affde8913|6|IGF1|Insulin-like Growth Factor-1|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mEq/L|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|CONCENTRATED||IHC|ASH FIBROSURE FORMULA||Y|Y|Y|3|Visit_3|40|2|TREATMENT|2020-07-28|2020-09-21|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|ea7907aa-811e-48ec-9fc6-ab8affde8913|7|EOSB|Eosinophils Band Form|HEMATOLOGY|[?]|DIP|[?]|[?]|BORDERLINE|1|ukat|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|LACTESCENT||CHROMATOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-08-22|2020-08-24|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|ea7907aa-811e-48ec-9fc6-ab8affde8913|8|DRVTSCPD|dRVVT Screen to Confirm Pct Difference|HEMATOLOGY|[?]|Farad|[?]|[?]|NEGATIVE|1|PACK|1|1|[?]|LOW|PLEURAL FLUID|SOLIDIFIED||MAMMOGRAPHY|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|2|SCREENING|2020-08-22|2020-09-13|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|ea7907aa-811e-48ec-9fc6-ab8affde8913|9|ALDEPX|Aldrin Epoxidase|HEMATOLOGY|[?]|cmH2O/mL|[?]|[?]|TRACE|1|gMFI|1|1|[?]|NORMAL|SERUM|PARAFFIN-EMBEDDED||THERMAL IONIZATION MASS SPECTROMETRY|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|5|SCREENING|2020-09-16|2020-09-24|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|LB|ea7907aa-811e-48ec-9fc6-ab8affde8913|10|EPINSQCE|Non-Squamous Epithelial Cells|URINALYSIS|||[?]|[?]|POSITIVE|1|um|1|1|[?]|ABNORMAL|SKIN TISSUE|THAWED||PHOTOMETRIC CLOT DETECTION|MDRD 4 VARIABLE FORMULA|Y||Y|Y|5|Visit_5|90|6|FOLLOW-UP|2020-09-16|2020-09-22|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|LB|3aa9935c-943d-406a-bb6e-fc067fa8a487|1|ATHPIDX|Atherogenic Index of Plasma|URINALYSIS|[?]|nU/cL|[?]|[?]|INDETERMINATE|1|fg|1|1|[?]|HIGH|MECONIUM|THAWED||DYNAMIC LIGHT SCATTERING|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|6|FOLLOW-UP|2020-08-27|2020-10-29|10|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|3aa9935c-943d-406a-bb6e-fc067fa8a487|2|BASOMYL|Basophilic Myelocytes|CHEMISTRY|||[?]|[?]|INVALID|1|10^9 CFU|1|1|[?]|LOW|CIRCULATING TUMOR CELL|FROZEN|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD 5 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|2|TREATMENT|2020-08-27|2020-11-24|10|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|3aa9935c-943d-406a-bb6e-fc067fa8a487|3|INTLK1A|Interleukin 1 Alpha|CHEMISTRY|[?]|nmol BCE/nmol|[?]|[?]|POSITIVE|1|mL/kg/h|1|1|[?]|LOW|HAIR|SOLIDIFIED||DUKE INCISION METHOD|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|3|SCREENING|2020-09-11|2020-10-10|25|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|3aa9935c-943d-406a-bb6e-fc067fa8a487|4|BLYMXM|B-lymphocyte Crossmatch|CHEMISTRY|[?]|Bq/g|[?]|[?]|POSITIVE|1|10^7 PFU|1|1|[?]|ABNORMAL|SMEGMA|REFRIGERATED||FREEZING POINT DEPRESSION|HEPASCORE FORMULA||Y|Y||2|Visit_2|25|3|FOLLOW-UP|2020-09-11|2020-10-15|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|3aa9935c-943d-406a-bb6e-fc067fa8a487|5|IA2AB|Insulinoma-Associated Protein 2 Antibody|CHEMISTRY|[?]|WEEKS|[?]|[?]|INDETERMINATE|1|WAFER|1|1|[?]|ABNORMAL|PERSPIRATION|NON-HEMOLYZED|N|ISHIHARA COLOR PLATES|MDRD ENZYMATIC FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-09-26|2020-11-07|40|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|3aa9935c-943d-406a-bb6e-fc067fa8a487|6|CYUNCLA|Unclassified Crystals|CHEMISTRY|[?]|mL/cm|[?]|[?]|POSITIVE|1|log10 CFU/g|1|1|[?]|HIGH|SWABBED MATERIAL|REFRIGERATED|N|TELLER ACUITY CARDS|CKD-EPI FORMULA|||N||3|Visit_3|40|4|WASHOUT|2020-09-26|2020-10-03|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|3aa9935c-943d-406a-bb6e-fc067fa8a487|7|IMMGLB|Immunoglobulin|CHEMISTRY|[?]|vg/kg|[?]|[?]|POSITIVE|1|vg/dose|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|DRIED||PHYSICAL EXAMINATION|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|4|WASHOUT|2020-10-21|2020-10-24|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|LB|3aa9935c-943d-406a-bb6e-fc067fa8a487|8|TGFB3|Transforming Growth Factor Beta 3|CHEMISTRY|[?]|copies/ug|[?]|[?]|INVALID|1|Linear ft*LB|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|GELLED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||4|Visit_4|65|5|TREATMENT|2020-10-21|2020-11-08|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|LB|3aa9935c-943d-406a-bb6e-fc067fa8a487|9|UREANEXR|Urea Nitrogen Excretion Rate|CHEMISTRY|[?]|log10 copies/mL|[?]|[?]|TRACE|1|10^3 organisms/g|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|CONTAMINATED||MIGET|MDRD 6 VARIABLE FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2020-11-15|2020-11-21|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|3aa9935c-943d-406a-bb6e-fc067fa8a487|10|CXCL13|Chemokine (C-X-C Motif) Ligand 13|URINALYSIS|[?]|V|[?]|[?]|INDETERMINATE|1|BU/mL|1|1|[?]|NORMAL|PUS|FRESH||TWO-COLOR MICROARRAY|MDRD ENZYMATIC JAPANESE FORMULA|||U||5|Visit_5|90|6|SCREENING|2020-11-15|2020-11-23|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|0cac2007-ca12-45ba-9b1c-70f753232f05|1|ASP|Aspartic Acid|CHEMISTRY|||[?]|[?]|POSITIVE|1|IU/mL|1|1|[?]|LOW|GASTRIC FLUID|THAWED||MICROBIAL CULTURE, LIQUID|CKD-EPI FORMULA|||N|Y|1|Visit_1|10|6|TREATMENT|2020-12-01|2021-01-16|10|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|0cac2007-ca12-45ba-9b1c-70f753232f05|2|ATHPIDX|Atherogenic Index of Plasma|CHEMISTRY|[?]|pmol/L/h|[?]|[?]|NEGATIVE|1|kg/L|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|THAWED||CT SCAN|FIBROSIS 4 FORMULA|||NA||1|Visit_1|10|7|WASHOUT|2020-12-01|2021-01-03|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|0cac2007-ca12-45ba-9b1c-70f753232f05|3|CHCMR|Ret. Corpuscular HGB Concentration Mean|URINALYSIS|[?]|Log10 ELISA unit/dose|[?]|[?]|INDETERMINATE|1|ug/L|1|1|[?]|NORMAL|SPUTUM|FRESH||KNEMOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||2|Visit_2|25|3|SCREENING|2020-12-16|2021-01-30|25|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|0cac2007-ca12-45ba-9b1c-70f753232f05|4|BLYCELY|B-Lymphocytes/Lymphocytes|CHEMISTRY|[?]|mV*min|[?]|[?]|NEGATIVE|1|mL/(min*100mL)|1|1|[?]|ABNORMAL|URINE|ROOM TEMPERATURE||NUCLEIC ACID SEQUENCING|MDRD 5 VARIABLE FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-12-16|2021-01-11|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|0cac2007-ca12-45ba-9b1c-70f753232f05|5|TBG|Thyroxine Binding Globulin|CHEMISTRY|||[?]|[?]|BORDERLINE|1|IU/mL|1|1|[?]|ABNORMAL|VENOUS BLOOD|CONTAMINATED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI FORMULA|||U|Y|3|Visit_3|40|3|TREATMENT|2020-12-31|2021-02-07|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|0cac2007-ca12-45ba-9b1c-70f753232f05|6|PICP|Procollagen Type I Carboxy Term Peptide|CHEMISTRY|[?]|fL|[?]|[?]|POSITIVE|1|ft2|1|1|[?]|ABNORMAL|SMEGMA|FRESH||MAPH|MDRD 5 VARIABLE FORMULA|||NA||3|Visit_3|40|7|SCREENING|2020-12-31|2021-01-09|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|0cac2007-ca12-45ba-9b1c-70f753232f05|7|FLUORIDE|Fluoride|URINALYSIS|||[?]|[?]|TRACE|1|ug/mol|1|1|[?]|NORMAL|SKIN TISSUE|CONCENTRATED|N|EEG|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|4|Visit_4|65|5|TREATMENT|2021-01-25|2021-01-27|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|0cac2007-ca12-45ba-9b1c-70f753232f05|8|HALBAB|Human Albumin Antibody|HEMATOLOGY|[?]|DRUM|[?]|[?]|INVALID|1|nmol|1|1|[?]|LOW|LOCHIA|CONCENTRATED|N|ELISPOT|HEPASCORE FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2021-01-25|2021-02-16|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|0cac2007-ca12-45ba-9b1c-70f753232f05|9|IRON|Iron|CHEMISTRY|[?]|cmol|[?]|[?]|INDETERMINATE|1|ft2|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|DRIED||MICRO BROTH DILUTION|CKD-EPI CYSTATIN C FORMULA||Y|U||5|Visit_5|90|7|TREATMENT|2021-02-19|2021-02-26|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|0cac2007-ca12-45ba-9b1c-70f753232f05|10|UDCA|Ursodeoxycholate|URINALYSIS|[?]|mL/s|[?]|[?]|INVALID|1|10^6 organisms|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|HEMOLYZED||PHASE CONTRAST MICROSCOPY|FIBROMETER FORMULA|||Y||5|Visit_5|90|7|FOLLOW-UP|2021-02-19|2021-02-28|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|2339e91a-b93e-426f-9b60-3d3b6969268d|1|ASTALT|AST/ALT|HEMATOLOGY|[?]|kPa|[?]|[?]|TRACE|1|kDa|1|1|[?]|LOW|PLEURAL TISSUE|GELLED|N|IRON HEMATOXYLIN STAIN|FIBROSIS 4 FORMULA|Y||N||1|Visit_1|10|6|FOLLOW-UP|2020-07-07|2020-09-01|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|2339e91a-b93e-426f-9b60-3d3b6969268d|2|RPTLAAC|Reptilase Activity Actual/Control|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mEq/mL|1|1|[?]|ABNORMAL|SEMEN|NON-HEMOLYZED|N|HEMOCYTOMETRY|MDRD FORMULA|||Y|Y|1|Visit_1|10|6|FOLLOW-UP|2020-07-07|2020-08-20|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|2339e91a-b93e-426f-9b60-3d3b6969268d|3|CARNIT|Carnitine|URINALYSIS|[?]|Ci/ug|[?]|[?]|INDETERMINATE|1|U/m2/min|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|SOLIDIFIED||PHOROPTER|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-07-22|2020-10-03|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|2339e91a-b93e-426f-9b60-3d3b6969268d|4|VCAM1|Vascular Cell Adhesion Molecule 1|URINALYSIS|[?]|mL/100g/min|[?]|[?]|INDETERMINATE|1|eq|1|1|[?]|HIGH|ABSCESS FLUID|PARAFFIN-EMBEDDED||HIGH RESOLUTION MELT ANALYSIS|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||2|Visit_2|25|4|TREATMENT|2020-07-22|2020-08-03|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|2339e91a-b93e-426f-9b60-3d3b6969268d|5|TLCHT|Taurolithocholate|HEMATOLOGY|[?]|MPL U|[?]|[?]|POSITIVE|1|foz_us|1|1|[?]|LOW|HAIR FOLLICLE|PARAFFIN-EMBEDDED||COMPLEMENT FIXATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-08-06|2020-08-24|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|2339e91a-b93e-426f-9b60-3d3b6969268d|6|CD19LY|CD19/Lymphocytes|HEMATOLOGY|[?]|MnFI|[?]|[?]|INDETERMINATE|1|PACKAGE|1|1|[?]|LOW|SUPERNATANT, PLASMA|SOLIDIFIED||PHASE-CONTRAST MRI|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|1|TREATMENT|2020-08-06|2020-09-30|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|2339e91a-b93e-426f-9b60-3d3b6969268d|7|ENRAGE|Extracell Newly Ident RAGE Bind Protein|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mg/mL/day|1|1|[?]|ABNORMAL|TUMOR TISSUE|CALCIFIED||FREEZING POINT DEPRESSION|GMI MMOL/MOL FORMULA|||U|Y|4|Visit_4|65|3|TREATMENT|2020-08-31|2020-09-11|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|2339e91a-b93e-426f-9b60-3d3b6969268d|8|NEUTGT|Giant Neutrophils|CHEMISTRY|||[?]|[?]|NEGATIVE|1|/LSQN|1|1|[?]|NORMAL|SKIN TISSUE|CLOTTED||ELISA|FIBROSIS 4 FORMULA||Y|U|Y|4|Visit_4|65|1|TREATMENT|2020-08-31|2020-09-06|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|2339e91a-b93e-426f-9b60-3d3b6969268d|9|FGF21|Fibroblast Growth Factor 21|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mL/(min*100mL)|1|1|[?]|ABNORMAL|DIALYSIS FLUID|SOLIDIFIED|N|DYNAMIC CONTRAST ENHANCED MRI|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|Y|5|Visit_5|90|4|WASHOUT|2020-09-25|2020-09-27|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|2339e91a-b93e-426f-9b60-3d3b6969268d|10|PT|Prothrombin Time|URINALYSIS|[?]|nU/cL|[?]|[?]|INDETERMINATE|1|DPM|1|1|[?]|HIGH|ARTERIAL BLOOD|CALCIFIED||WHOLE EXOME SEQUENCING|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-09-25|2020-09-30|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|0d09e35b-e864-4492-a341-21c71d92b551|1|HAMAB|Human Anti-Mouse Antibody|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|CAN|1|1|[?]|ABNORMAL|TUMOR TISSUE|CALCIFIED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD FORMULA|||U|Y|1|Visit_1|10|4|TREATMENT|2020-10-30|2021-01-19|10|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|0d09e35b-e864-4492-a341-21c71d92b551|2|HGBOXY|Oxyhemoglobin|HEMATOLOGY|[?]|mU/L|[?]|[?]|INDETERMINATE|1|PIXELS/in|1|1|[?]|HIGH|BILE|THAWED|N|ZIEHL NEELSEN ACID FAST STAIN|MDRD 5 VARIABLE FORMULA||Y|NA||1|Visit_1|10|4|SCREENING|2020-10-30|2020-12-14|10|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|0d09e35b-e864-4492-a341-21c71d92b551|3|ANP|Atrial Natriuretic Peptide|HEMATOLOGY|[?]|kg/L|[?]|[?]|NEGATIVE|1|vp/dose|1|1|[?]|HIGH|MIXED VENOUS BLOOD|NON-HEMOLYZED||MRS|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||2|Visit_2|25|7|SCREENING|2020-11-14|2021-01-12|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|LB|0d09e35b-e864-4492-a341-21c71d92b551|4|MG|Magnesium|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ug/m2/h|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|FRESH||ELECTROMYOGRAPHY|CKD-EPI FORMULA|||Y|Y|2|Visit_2|25|6|FOLLOW-UP|2020-11-14|2020-11-16|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|LB|0d09e35b-e864-4492-a341-21c71d92b551|5|LYMMCE|Lymphoma Cells|CHEMISTRY|||[?]|[?]|TRACE|1|lm|1|1|[?]|NORMAL|PERITONEAL FLUID|UNEXPECTED ODOR||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U|Y|3|Visit_3|40|2|FOLLOW-UP|2020-11-29|2021-01-24|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|0d09e35b-e864-4492-a341-21c71d92b551|6|TROPONI3|Troponin I Type 3|CHEMISTRY|[?]|log EID 50/dose|[?]|[?]|INVALID|1|KALLIKREIN INHIBITOR UNIT|1|1|[?]|NORMAL|CELL PELLET|CLOTTED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|GMI MMOL/MOL FORMULA|Y||Y||3|Visit_3|40|2|TREATMENT|2020-11-29|2021-01-21|40|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|0d09e35b-e864-4492-a341-21c71d92b551|7|URATE|Urate|CHEMISTRY|||[?]|[?]|POSITIVE|1|tsp eq|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|LACTESCENT||CHROMATOGRAPHY|CKD-EPI CREATININE FORMULA|Y||NA|Y|4|Visit_4|65|7|SCREENING|2020-12-24|2021-01-10|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|0d09e35b-e864-4492-a341-21c71d92b551|8|ETPTPR|ETP Time to Peak Relative|HEMATOLOGY|[?]|m3|[?]|[?]|INVALID|1|Antibody Unit|1|1|[?]|ABNORMAL|COLOSTRUM|GELLED|N|SLIT LAMP PHOTOGRAPHY|GMI MMOL/MOL FORMULA|Y|Y|N||4|Visit_4|65|3|TREATMENT|2020-12-24|2021-01-22|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|0d09e35b-e864-4492-a341-21c71d92b551|9|WBCCE|Leukocytes/Total Cells|CHEMISTRY|[?]|SCOOPFUL|[?]|[?]|NEGATIVE|1|DIOPTER|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR||IVY INCISION METHOD|FIBROTEST FORMULA|Y||NA||5|Visit_5|90|7|WASHOUT|2021-01-18|2021-01-26|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|0d09e35b-e864-4492-a341-21c71d92b551|10|CAEXR|Calcium Excretion Rate|CHEMISTRY|[?]|10^6 DNA copies/mL|[?]|[?]|NEGATIVE|1|in2|1|1|[?]|NORMAL|SMEGMA|HEMOLYZED||MECHANICAL CLOT DETECTION|FIBROMETER FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2021-01-18|2021-01-21|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|1|CYCASULF|Calcium Sulfate Crystals|HEMATOLOGY|[?]|amol|[?]|[?]|TRACE|1|%(w/w)|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|LIPEMIC||OLIGO ACGH|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||1|Visit_1|10|4|FOLLOW-UP|2020-06-05|2020-07-10|10|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|2|VCAM1|Vascular Cell Adhesion Molecule 1|CHEMISTRY|[?]|kUSP|[?]|[?]|TRACE|1|log10 PFU/mL|1|1|[?]|LOW|ENDOTRACHEAL FLUID|CONTAMINATED||HEMAGGLUTINATION INHIBITION ASSAY|NASH FIBROSURE FORMULA|Y||N||1|Visit_1|10|1|FOLLOW-UP|2020-06-05|2020-08-09|10|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|3|MYELINAB|Myelin Antibodies|CHEMISTRY|||[?]|[?]|POSITIVE|1|TCID 50/dose|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT|N|TOTAL BODY IRRADIATION|MDRD 5 VARIABLE FORMULA|Y||NA|Y|2|Visit_2|25|3|SCREENING|2020-06-20|2020-08-24|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|LB|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|4|APRIL|A Proliferation-Inducing Ligand|URINALYSIS|[?]|/MBP|[?]|[?]|BORDERLINE|1|/100 WBC|1|1|[?]|HIGH|MONOCYTE|FRESH||ELISPOT|MDRD ENZYMATIC FORMULA|Y||N||2|Visit_2|25|1|TREATMENT|2020-06-20|2020-09-02|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|LB|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|5|C130135|D. pteronyssinus Antigen IgG Antibody|HEMATOLOGY|[?]|PHERESIS UNIT|[?]|[?]|POSITIVE|1|APL U|1|1|[?]|LOW|PERITONEAL FLUID|REFRIGERATED||SANGER SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|NA||3|Visit_3|40|7|TREATMENT|2020-07-05|2020-08-19|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-07
e|LB|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|6|GSTPI|Glutathione S-Transferase, Pi|HEMATOLOGY|[?]|U/g Hb|[?]|[?]|TRACE|1|mmHg/sec|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|AUTOLYZED||POLYGRAPHY|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-07-05|2020-07-11|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-07
e|LB|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|7|NEUTCYBS|Cytoplasmic Basophilia Neutrophil|URINALYSIS|[?]|Arbitrary U|[?]|[?]|INVALID|1|ug/mL/h|1|1|[?]|LOW|SALIVA|AGGLUTINATED||SLIT LAMP PHOTOGRAPHY|FIBROTEST FORMULA||Y|N||4|Visit_4|65|7|TREATMENT|2020-07-30|2020-08-23|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|8|RHD|RhD Factor|URINALYSIS|[?]|uEq|[?]|[?]|NEGATIVE|1|Log10 ELISA unit|1|1|[?]|HIGH|TISSUE|HEMOLYZED||COULOMETRIC TITRATION|MDRD 4 VARIABLE FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2020-07-30|2020-08-29|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|9|BUCHE|Butyrylcholinesterase|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|nmol/mL/min|1|1|[?]|ABNORMAL|SWABBED MATERIAL|CONTAMINATED||MICROBIAL CULTURE|ASH FIBROSURE FORMULA|||N|Y|5|Visit_5|90|5|TREATMENT|2020-08-24|2020-09-02|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|LB|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|10|C130093|Western Ragweed Pollen IgA|CHEMISTRY|||[?]|[?]|POSITIVE|1|fraction of 1|1|1|[?]|ABNORMAL|COLOSTRUM|PARAFFIN-EMBEDDED||COMPLEMENT FIXATION|FIBROMETER FORMULA|||U|Y|5|Visit_5|90|4|TREATMENT|2020-08-24|2020-09-01|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|LB|0a5b1036-cd00-4221-b218-ee2664e5a43e|1|LYMIMLE|Immature Lymphocytes/Leukocytes|CHEMISTRY|[?]|ukat|[?]|[?]|TRACE|1|g/U|1|1|[?]|HIGH|COLOSTRUM|AUTOLYZED|N|INTRAVASCULAR ULTRASOUND|CKD-EPI CREATININE FORMULA|Y||N||1|Visit_1|10|1|TREATMENT|2021-01-02|2021-01-12|10|20|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|0a5b1036-cd00-4221-b218-ee2664e5a43e|2|NEUTBNE|Neutrophils Band Form/ Neutrophils|HEMATOLOGY|[?]|in2|[?]|[?]|POSITIVE|1|Ci/uL|1|1|[?]|LOW|HAIR FOLLICLE|UNEXPECTED ODOR||MICROSCOPY|MDRD FORMULA||Y|NA||1|Visit_1|10|3|TREATMENT|2021-01-02|2021-01-27|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|0a5b1036-cd00-4221-b218-ee2664e5a43e|3|OXYCAP|Oxygen Capacity|URINALYSIS|||[?]|[?]|POSITIVE|1|g/cm2|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|DRIED||PALM METHOD|MDRD 6 VARIABLE FORMULA||Y|U|Y|2|Visit_2|25|1|WASHOUT|2021-01-17|2021-03-20|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|0a5b1036-cd00-4221-b218-ee2664e5a43e|4|CREATCLR|Creatinine Clearance|HEMATOLOGY|[?]|g/animal|[?]|[?]|NEGATIVE|1|hPa|1|1|[?]|LOW|SPUTUM|CONCENTRATED||NUCLEIC ACID AMPLIFICATION TEST|COCKCROFT-GAULT FORMULA|Y||NA||2|Visit_2|25|2|TREATMENT|2021-01-17|2021-01-27|25|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|0a5b1036-cd00-4221-b218-ee2664e5a43e|5|C130086|English Plantain Pollen IgG|CHEMISTRY|||[?]|[?]|INVALID|1|POINT|1|1|[?]|ABNORMAL|ISOLATE|CONCENTRATED||CLINICAL EVALUATION|GMI % FORMULA|||N|Y|3|Visit_3|40|2|SCREENING|2021-02-01|2021-02-17|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|LB|0a5b1036-cd00-4221-b218-ee2664e5a43e|6|EOSIM|Immature Eosinophils|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^12/L|1|1|[?]|NORMAL|LYMPH|SOLIDIFIED||PALPATION|FIBROMETER FORMULA|Y|Y|U|Y|3|Visit_3|40|4|SCREENING|2021-02-01|2021-02-27|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|LB|0a5b1036-cd00-4221-b218-ee2664e5a43e|7|GOLD|Gold|URINALYSIS|||[?]|[?]|INDETERMINATE|1|SUPPOSITORY|1|1|[?]|LOW|PERSPIRATION|SOLIDIFIED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD ENZYMATIC FORMULA|||NA|Y|4|Visit_4|65|6|TREATMENT|2021-02-26|2021-02-28|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|0a5b1036-cd00-4221-b218-ee2664e5a43e|8|CHOLINES|Cholinesterase|CHEMISTRY|[?]|ELISA unit|[?]|[?]|TRACE|1|pptr|1|1|[?]|LOW|URINE SEDIMENT|UNEXPECTED ODOR||ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||4|Visit_4|65|6|TREATMENT|2021-02-26|2021-03-18|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|0a5b1036-cd00-4221-b218-ee2664e5a43e|9|IGGCREAT|Immunoglobulin G/Creatinine|URINALYSIS|[?]|Gravitational Unit|[?]|[?]|BORDERLINE|1|cm H2O|1|1|[?]|NORMAL|CORD BLOOD|CALCIFIED||LIGHT SCATTERING SPECTROSCOPY|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|1|SCREENING|2021-03-23|2021-03-27|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|0a5b1036-cd00-4221-b218-ee2664e5a43e|10|COQ10|Ubiquinone 10|CHEMISTRY|[?]|U/m2/h|[?]|[?]|INDETERMINATE|1|MONTHS|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|FROZEN||FLOW CYTOMETRY|ASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|2|TREATMENT|2021-03-23|2021-03-30|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|a4f74465-7abc-4cc2-a0be-25d1c802af8c|1|LDH1|LDH Isoenzyme 1|CHEMISTRY|[?]|/2500 WBC|[?]|[?]|POSITIVE|1|100 IU/mL|1|1|[?]|ABNORMAL|SMEGMA|SOLIDIFIED|N|WRIGHT-GIEMSA STAIN|MDRD FORMULA||Y|Y||1|Visit_1|10|2|WASHOUT|2020-09-30|2020-10-10|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|a4f74465-7abc-4cc2-a0be-25d1c802af8c|2|GAD2|Glutamic Acid Decarboxylase 2|CHEMISTRY|||[?]|[?]|NEGATIVE|1|nmol BCE/nmol|1|1|[?]|ABNORMAL|PERSPIRATION|REFRIGERATED||FLOCCULATION|MDRD 4 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|5|WASHOUT|2020-09-30|2020-10-23|10|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|a4f74465-7abc-4cc2-a0be-25d1c802af8c|3|SPMAGGR|Sperm Aggregation|HEMATOLOGY|[?]|mL/dose|[?]|[?]|BORDERLINE|1|umol/mol|1|1|[?]|HIGH|BLOOD|UNEXPECTED ODOR||AGAR PROPORTION|MDRD ENZYMATIC FORMULA|||N||2|Visit_2|25|2|SCREENING|2020-10-15|2020-12-15|25|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|a4f74465-7abc-4cc2-a0be-25d1c802af8c|4|C147281|Egg White Antigen IgE Antibody|URINALYSIS|[?]|10^9/L|[?]|[?]|INDETERMINATE|1|mL/beat|1|1|[?]|ABNORMAL|TUMOR TISSUE|NON-HEMOLYZED|N|COULOMETRIC TITRATION|CKD-EPI CYSTATIN C FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-10-15|2020-12-02|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|a4f74465-7abc-4cc2-a0be-25d1c802af8c|5|MDC|Macrophage-Derived Chemokine|HEMATOLOGY|[?]|s*kPa|[?]|[?]|BORDERLINE|1|CIGARETTE|1|1|[?]|HIGH|PERITONEAL FLUID|ROOM TEMPERATURE|N|INTERRUPTER TECHNIQUE|FIBROSIS 4 FORMULA|Y||NA||3|Visit_3|40|4|TREATMENT|2020-10-30|2020-12-08|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|a4f74465-7abc-4cc2-a0be-25d1c802af8c|6|C165910|Bee Mix IgG AB RAST Score|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|TAMPON|1|1|[?]|NORMAL|GASTRIC CONTENTS|DRIED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI CYSTATIN C FORMULA|Y||U|Y|3|Visit_3|40|3|TREATMENT|2020-10-30|2020-12-23|40|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|a4f74465-7abc-4cc2-a0be-25d1c802af8c|7|HLAIAB|HLA Class I Antibody|HEMATOLOGY|[?]|TABLET|[?]|[?]|TRACE|1|WEEKS|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|DRIED||WEBER GREEN STAIN|CKD-EPI FORMULA|||NA||4|Visit_4|65|3|SCREENING|2020-11-24|2020-12-06|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|a4f74465-7abc-4cc2-a0be-25d1c802af8c|8|LDLPSZ|LDL Particle Size|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mEq/kg|1|1|[?]|HIGH|PLATELET|UNEXPECTED ODOR||FARNSWORTH-MUNSELL 100 HUE TEST|MDRD FORMULA|Y|Y|U|Y|4|Visit_4|65|6|FOLLOW-UP|2020-11-24|2020-12-16|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|a4f74465-7abc-4cc2-a0be-25d1c802af8c|9|C165934|Arachis hypogaea IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|INVALID|1|PHERESIS UNIT|1|1|[?]|HIGH|VENOUS CORD BLOOD|CALCIFIED||SXA SCAN|COCKCROFT-GAULT FORMULA|||N|Y|5|Visit_5|90|6|TREATMENT|2020-12-19|2020-12-28|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|a4f74465-7abc-4cc2-a0be-25d1c802af8c|10|CONSIST|Consistency|CHEMISTRY|[?]|mmol/mol|[?]|[?]|INDETERMINATE|1|mm3/mm2/year|1|1|[?]|LOW|MUCUS|AUTOLYZED||TOLUIDINE BLUE STAIN|COCKCROFT-GAULT FORMULA|||Y||5|Visit_5|90|4|SCREENING|2020-12-19|2020-12-23|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|1|AMABARAB|ACH Receptor Modulatn Ab/ACH Receptor Ab|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mL/animal/day|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|LACTESCENT||NEURAMINIDASE INHIBITION ASSAY|GMI % FORMULA||Y|U|Y|1|Visit_1|10|4|TREATMENT|2020-11-12|2021-01-04|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|2|FATACFRS|Free Fatty Acid, Saturated|URINALYSIS|[?]|IU/day|[?]|[?]|POSITIVE|1|TUBE|1|1|[?]|NORMAL|BLOOD|CONCENTRATED||SINGLE-MOLECULE ARRAY|GMI % FORMULA|Y||Y||1|Visit_1|10|5|SCREENING|2020-11-12|2021-01-04|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|3|ANCIGAB|Anti-Neutrophil Cytoplasmic IgG Antibody|CHEMISTRY|[?]|g/m2/day|[?]|[?]|BORDERLINE|1|umol/kg/min|1|1|[?]|HIGH|AQUEOUS HUMOR|AUTOLYZED|N|CELLULAR PROLIFERATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||2|Visit_2|25|3|SCREENING|2020-11-27|2020-12-11|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|4|ATP|Adenosine Triphosphate|HEMATOLOGY|||[?]|[?]|TRACE|1|U/kg|1|1|[?]|NORMAL|BREAST MILK|UNEXPECTED ODOR||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD 6 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|5|TREATMENT|2020-11-27|2021-01-01|25|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|5|B2MICG|Beta-2 Microglobulin|URINALYSIS|||[?]|[?]|POSITIVE|1|cm|1|1|[?]|LOW|MUCUS|LIPEMIC||RADIAL IMMUNODIFFUSION|MDRD 6 VARIABLE FORMULA||Y|U|Y|3|Visit_3|40|3|TREATMENT|2020-12-12|2021-01-01|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|6|ESTRCPT|Estrogen Receptor|CHEMISTRY|[?]|BAU|[?]|[?]|NEGATIVE|1|cmHg|1|1|[?]|NORMAL|EMOTIONAL TEAR|FRESH|N|CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC FORMULA||Y|Y||3|Visit_3|40|1|TREATMENT|2020-12-12|2020-12-27|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|7|ALLOILE|Alloisoleucine|HEMATOLOGY|[?]|keV|[?]|[?]|NEGATIVE|1|BOWL|1|1|[?]|HIGH|HAIR FOLLICLE|NON-HEMOLYZED|N|MICROBIAL CULTURE, SOLID|NASH FIBROSURE FORMULA|||NA||4|Visit_4|65|1|SCREENING|2021-01-06|2021-01-24|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|8|GHB|Gamma-Hydroxybutyrate|URINALYSIS|||[?]|[?]|TRACE|1|mL/dL|1|1|[?]|LOW|KERATINOCYTE|LACTESCENT||ACID FAST STAIN|FIBROMETER FORMULA||Y|N|Y|4|Visit_4|65|4|TREATMENT|2021-01-06|2021-01-11|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|9|PBGCREAT|Porphobilinogen/Creatinine|CHEMISTRY|[?]|IMPLANT|[?]|[?]|INVALID|1|PHERESIS UNIT|1|1|[?]|LOW|SUPERNATANT, SERUM|AGGLUTINATED|N|RYAN BLUE STAIN|MDRD 5 VARIABLE FORMULA||Y|U||5|Visit_5|90|2|FOLLOW-UP|2021-01-31|2021-02-02|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|10|LEUKCE|Leukemic Cells|CHEMISTRY|[?]|mPa|[?]|[?]|INVALID|1|MHz|1|1|[?]|NORMAL|AQUEOUS HUMOR|ROOM TEMPERATURE|N|AUTOMATED COUNT|FIBROSIS 4 FORMULA|||Y||5|Visit_5|90|2|WASHOUT|2021-01-31|2021-02-03|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|e7262592-01e8-4cb3-b967-ec1037505e81|1|C165880|D. pteronyssinus IgE AB RAST Score|CHEMISTRY|||[?]|[?]|POSITIVE|1|in|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|DRIED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|1|TREATMENT|2020-09-12|2020-09-27|10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|e7262592-01e8-4cb3-b967-ec1037505e81|2|RANTES|Reg upon Act Normal T-cell Exprd Secrtd|HEMATOLOGY|[?]|ug/L/h|[?]|[?]|INVALID|1|km/h|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|HEMOLYZED||TRIPLE-PHASE MRI SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-09-12|2020-09-24|10|22|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|e7262592-01e8-4cb3-b967-ec1037505e81|3|HGBFHGB|Hemoglobin F/Total Hemoglobin|URINALYSIS|[?]|genEq/mL|[?]|[?]|BORDERLINE|1|GPL U/mL|1|1|[?]|LOW|EPIDERMAL TISSUE|AUTOLYZED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-09-27|2020-10-31|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|e7262592-01e8-4cb3-b967-ec1037505e81|4|MICA|MHC Class I Chain Related Protein A|HEMATOLOGY|[?]|10^6 RNA copies/mL|[?]|[?]|POSITIVE|1|Watt|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|CLOTTED||MULTIPLE BREATH WASHOUT|CKD-EPI CREATININE FORMULA||Y|Y||2|Visit_2|25|7|TREATMENT|2020-09-27|2020-11-27|25|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|e7262592-01e8-4cb3-b967-ec1037505e81|5|GLOBA1|Alpha-1 Globulin|CHEMISTRY|||[?]|[?]|POSITIVE|1|/cmH2O|1|1|[?]|ABNORMAL|LEUKOCYTE|DRIED||MEDIASTINOSCOPY|FIBROMETER FORMULA|Y||N|Y|3|Visit_3|40|5|TREATMENT|2020-10-12|2020-10-28|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|e7262592-01e8-4cb3-b967-ec1037505e81|6|URATECRT|Urate/Creatinine|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|DDU|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED||SURFACE PLASMON RESONANCE|MDRD 4 VARIABLE FORMULA|||Y|Y|3|Visit_3|40|3|TREATMENT|2020-10-12|2020-11-14|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|e7262592-01e8-4cb3-b967-ec1037505e81|7|VITA|Vitamin A|URINALYSIS|[?]|mL/m2/day|[?]|[?]|POSITIVE|1|mg/animal|1|1|[?]|ABNORMAL|CALCULUS|LIPEMIC||PERIPHERAL ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||4|Visit_4|65|4|SCREENING|2020-11-06|2020-11-25|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|e7262592-01e8-4cb3-b967-ec1037505e81|8|HYPGST17|17-Hydroxyprogesterone|CHEMISTRY|[?]|mg/h|[?]|[?]|POSITIVE|1|pm|1|1|[?]|NORMAL|EXUDATE|AGGLUTINATED||GRADIENT DIFFUSION|MDRD 5 VARIABLE FORMULA|||NA||4|Visit_4|65|3|FOLLOW-UP|2020-11-06|2020-11-29|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|e7262592-01e8-4cb3-b967-ec1037505e81|9|AMMONIA|Ammonia|CHEMISTRY|[?]|min*mg/mL|[?]|[?]|BORDERLINE|1|ag|1|1|[?]|ABNORMAL|SKIN TISSUE|ICTERIC||HPLC-FL|MDRD 5 VARIABLE FORMULA||Y|Y||5|Visit_5|90|5|TREATMENT|2020-12-01|2020-12-08|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|e7262592-01e8-4cb3-b967-ec1037505e81|10|CSRBC|RBC Casts|URINALYSIS|||[?]|[?]|NEGATIVE|1|SQU/mL|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|ICTERIC||CHROMATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|5|Visit_5|90|7|FOLLOW-UP|2020-12-01|2020-12-03|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|bf150829-1b25-418a-9bc6-61716984387c|1|CLCTONN|Calcitonin|URINALYSIS|[?]|cP|[?]|[?]|INVALID|1|PFU/animal|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|FRESH||HPLC-UV|ASH FIBROSURE FORMULA|||Y||1|Visit_1|10|1|FOLLOW-UP|2020-06-15|2020-07-19|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|LB|bf150829-1b25-418a-9bc6-61716984387c|2|VITB9|Vitamin B9|URINALYSIS|[?]|PACKET|[?]|[?]|INVALID|1|U|1|1|[?]|HIGH|NAIL|CLOTTED||ACRIDINE ORANGE STAIN|MDRD ENZYMATIC FORMULA|Y|Y|U||1|Visit_1|10|5|TREATMENT|2020-06-15|2020-07-21|10|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|LB|bf150829-1b25-418a-9bc6-61716984387c|3|TRAMADOL|Tramadol|HEMATOLOGY|[?]|uSiemens|[?]|[?]|BORDERLINE|1|mEq/dL|1|1|[?]|NORMAL|INFRANATANT, SERUM|CALCIFIED||AGAR PROPORTION|FIBROSIS 4 FORMULA|||NA||2|Visit_2|25|7|FOLLOW-UP|2020-06-30|2020-07-18|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|bf150829-1b25-418a-9bc6-61716984387c|4|EPINSQCE|Non-Squamous Epithelial Cells|CHEMISTRY|[?]|mOsm|[?]|[?]|INDETERMINATE|1|10^12 IU/L|1|1|[?]|HIGH|HAIR|UNEXPECTED ODOR||MODIFIED ACID FAST STAIN|FIBROSIS 4 FORMULA||Y|Y||2|Visit_2|25|4|TREATMENT|2020-06-30|2020-08-16|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|bf150829-1b25-418a-9bc6-61716984387c|5|GLUCPED|Plasma Equivalent Glucose Distribution|URINALYSIS|||[?]|[?]|POSITIVE|1|kcal/day|1|1|[?]|LOW|EMOTIONAL TEAR|UNEXPECTED ODOR||ACCELERATOR MASS SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|3|Visit_3|40|1|FOLLOW-UP|2020-07-15|2020-07-22|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|bf150829-1b25-418a-9bc6-61716984387c|6|TAURINE|Taurine|CHEMISTRY|||[?]|[?]|INVALID|1|F|1|1|[?]|LOW|MECONIUM|CONTAMINATED|N|THIN SMEAR|CKD-EPI CYSTATIN C FORMULA|||U|Y|3|Visit_3|40|3|TREATMENT|2020-07-15|2020-08-27|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|bf150829-1b25-418a-9bc6-61716984387c|7|PGF1A|Prostaglandin F1 Alpha|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|umol/min|1|1|[?]|ABNORMAL|SPERMATOZOON|CLOTTED|N|HPLC/IEX|MDRD 6 VARIABLE FORMULA|||U|Y|4|Visit_4|65|4|WASHOUT|2020-08-09|2020-08-27|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|bf150829-1b25-418a-9bc6-61716984387c|8|BLASTIMM|Immunoblasts|HEMATOLOGY|[?]|g/animal/wk|[?]|[?]|BORDERLINE|1|g/kg|1|1|[?]|HIGH|VITREOUS HUMOR|LACTESCENT||OPTICAL COHERENCE TOMOGRAPHY|COCKCROFT-GAULT FORMULA|Y||Y||4|Visit_4|65|4|TREATMENT|2020-08-09|2020-08-31|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|bf150829-1b25-418a-9bc6-61716984387c|9|ANUAB|Anti-Nucleosome Antibody|CHEMISTRY|[?]|fraction of 1|[?]|[?]|INVALID|1|U/g/day|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|REFRIGERATED||SNELLEN EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||5|Visit_5|90|5|WASHOUT|2020-09-03|2020-09-11|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|bf150829-1b25-418a-9bc6-61716984387c|10|CKMBCK|Creatine Kinase MB/Total Creatine Kinase|URINALYSIS|[?]|PACKAGE|[?]|[?]|INDETERMINATE|1|g/mol|1|1|[?]|ABNORMAL|VENOUS BLOOD|ROOM TEMPERATURE||ELISPOT|CKD-EPI CYSTATIN C FORMULA||Y|N||5|Visit_5|90|1|WASHOUT|2020-09-03|2020-09-05|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|5c1cc260-97a0-493c-bc11-57f31ffd7455|1|UREACRT|Urea/Creatinine|URINALYSIS|[?]|km|[?]|[?]|INDETERMINATE|1|mmol/min/kPa|1|1|[?]|NORMAL|SALIVA|PARAFFIN-EMBEDDED||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||1|Visit_1|10|2|WASHOUT|2020-09-06|2020-11-13|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|5c1cc260-97a0-493c-bc11-57f31ffd7455|2|LAG3S|Soluble Lymphocyte Activation Gene-3|URINALYSIS|[?]|mOsm/L|[?]|[?]|BORDERLINE|1|mL/cm|1|1|[?]|NORMAL|EXPIRED AIR|LACTESCENT||ZIEHL NEELSEN ACID FAST STAIN|MDRD FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-09-06|2020-09-21|10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|5c1cc260-97a0-493c-bc11-57f31ffd7455|3|CD161ALY|CD161a/Lymphocytes|HEMATOLOGY|||[?]|[?]|POSITIVE|1|vg/kg|1|1|[?]|HIGH|SERUM OR PLASMA|NON-HEMOLYZED||LC-FL|CKD-EPI CREATININE FORMULA||Y|U|Y|2|Visit_2|25|3|FOLLOW-UP|2020-09-21|2020-11-06|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|5c1cc260-97a0-493c-bc11-57f31ffd7455|4|C130070|Bermuda Grass Pollen IgG|HEMATOLOGY|[?]|Coulomb|[?]|[?]|INDETERMINATE|1|DNA copies/ug|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|REFRIGERATED|N|RADIOIMMUNOPRECIPITATION ASSAY|MDRD 4 VARIABLE FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-09-21|2020-11-04|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|5c1cc260-97a0-493c-bc11-57f31ffd7455|5|CAPHOSPD|Calcium - Phosphorus Product|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|MAC50|1|1|[?]|HIGH|SUPERNATANT, SERUM|SOLIDIFIED||DISK DIFFUSION|CKD-EPI CYSTATIN C FORMULA|||N|Y|3|Visit_3|40|4|FOLLOW-UP|2020-10-06|2020-10-08|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|LB|5c1cc260-97a0-493c-bc11-57f31ffd7455|6|HDLCCHOL|HDL Cholesterol/Total Cholesterol|HEMATOLOGY|[?]|g/kg|[?]|[?]|TRACE|1|fmol/g|1|1|[?]|HIGH|SPERMATOZOON|LACTESCENT||SLOAN LETTER EYE CHART 100%|HEPASCORE FORMULA|||N||3|Visit_3|40|3|FOLLOW-UP|2020-10-06|2020-10-24|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|LB|5c1cc260-97a0-493c-bc11-57f31ffd7455|7|VEGFR2S|Soluble Vasc Endoth Growth Factor Rec2|CHEMISTRY|||[?]|[?]|BORDERLINE|1|deg2|1|1|[?]|HIGH|TRANSUDATE|UNEXPECTED ODOR|N|REBOUND TONOMETRY|HEPASCORE FORMULA|||NA|Y|4|Visit_4|65|3|TREATMENT|2020-10-31|2020-11-05|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|5c1cc260-97a0-493c-bc11-57f31ffd7455|8|OSTEOC|Osteocalcin|CHEMISTRY|||[?]|[?]|BORDERLINE|1|hPa|1|1|[?]|HIGH|ALVEOLAR AIR|DRIED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|4|Visit_4|65|5|TREATMENT|2020-10-31|2020-11-27|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|5c1cc260-97a0-493c-bc11-57f31ffd7455|9|FACTXII|Factor XII|CHEMISTRY|[?]|dL|[?]|[?]|INDETERMINATE|1|U/animal|1|1|[?]|LOW|BLOOD|LACTESCENT||INDIRECT IMMUNOFLUORESCENCE|GMI MMOL/MOL FORMULA|Y||N||5|Visit_5|90|2|TREATMENT|2020-11-25|2020-12-02|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|5c1cc260-97a0-493c-bc11-57f31ffd7455|10|FACTV|Factor V|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|uCi|1|1|[?]|NORMAL|PERSPIRATION|FROZEN||IMMUNOFIXATION ELECTROPHORESIS|FIBROMETER FORMULA|Y||NA|Y|5|Visit_5|90|5|FOLLOW-UP|2020-11-25|2020-12-02|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|cca2835b-ca8d-4db6-89b4-9f2855968a8a|1|HMOSIDRN|Hemosiderin|CHEMISTRY|||[?]|[?]|NEGATIVE|1|L/day|1|1|[?]|LOW|PLASMA|NON-HEMOLYZED||PHASE CONTRAST MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|6|TREATMENT|2020-07-19|2020-09-06|10|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|cca2835b-ca8d-4db6-89b4-9f2855968a8a|2|TNF|Tumor Necrosis Factor|URINALYSIS|[?]|10^6 IU/mL|[?]|[?]|POSITIVE|1|10^12/L|1|1|[?]|NORMAL|BONE|PARAFFIN-EMBEDDED|N|DXA SCAN|MDRD ENZYMATIC FORMULA|||NA||1|Visit_1|10|6|FOLLOW-UP|2020-07-19|2020-08-23|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|cca2835b-ca8d-4db6-89b4-9f2855968a8a|3|LCTHSPGM|Lecithin/Sphingomyelin|URINALYSIS|[?]|Ci/L|[?]|[?]|BORDERLINE|1|ug/g/min|1|1|[?]|HIGH|TRANSUDATE|CALCIFIED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-08-03|2020-09-13|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|cca2835b-ca8d-4db6-89b4-9f2855968a8a|4|WDR26|WD Repeat-Containing Protein 26|CHEMISTRY|[?]|genEq|[?]|[?]|BORDERLINE|1|1/(s*kPa)|1|1|[?]|LOW|LYMPH|LACTESCENT||CLINICAL EVALUATION|MDRD FORMULA|Y|Y|Y||2|Visit_2|25|6|FOLLOW-UP|2020-08-03|2020-09-25|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|cca2835b-ca8d-4db6-89b4-9f2855968a8a|5|HGBA|Hemoglobin A|CHEMISTRY|[?]|BP|[?]|[?]|INDETERMINATE|1|TRANSDUCING UNIT/mL|1|1|[?]|LOW|WHITE MATTER TISSUE|CONCENTRATED||FLOCCULATION|HEPASCORE FORMULA|||U||3|Visit_3|40|7|FOLLOW-UP|2020-08-18|2020-08-26|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|cca2835b-ca8d-4db6-89b4-9f2855968a8a|6|ARR|Aldosterone/Renin Activity|HEMATOLOGY|||[?]|[?]|POSITIVE|1|/10^4|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|GELLED|N|MANUAL COUNT|COCKCROFT-GAULT FORMULA||Y|N|Y|3|Visit_3|40|5|FOLLOW-UP|2020-08-18|2020-10-06|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|cca2835b-ca8d-4db6-89b4-9f2855968a8a|7|CX3CL1|Chemokine (C-X3-C Motif) Ligand 1|URINALYSIS|[?]|ug/kg/h|[?]|[?]|INDETERMINATE|1|Roentgen|1|1|[?]|LOW|ADIPOSE TISSUE|FROZEN||CELLULOSE TAPE|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA||4|Visit_4|65|3|TREATMENT|2020-09-12|2020-10-08|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|cca2835b-ca8d-4db6-89b4-9f2855968a8a|8|CREATCLR|Creatinine Clearance|HEMATOLOGY|||[?]|[?]|INVALID|1|um|1|1|[?]|NORMAL|EPITHELIAL CELL|LIPEMIC|N|SLOAN LETTER EYE CHART 100%|FIBROTEST FORMULA|||N|Y|4|Visit_4|65|4|WASHOUT|2020-09-12|2020-09-26|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|cca2835b-ca8d-4db6-89b4-9f2855968a8a|9|BASOIM|Immature Basophils|URINALYSIS|[?]|/month|[?]|[?]|NEGATIVE|1|mL/animal/day|1|1|[?]|NORMAL|SEMEN|CONCENTRATED|N|IHC|MDRD FORMULA|Y|Y|Y||5|Visit_5|90|6|FOLLOW-UP|2020-10-07|2020-10-13|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|cca2835b-ca8d-4db6-89b4-9f2855968a8a|10|C165882|White Elm Pollen IgE AB RAST Score|HEMATOLOGY|[?]|uU/L|[?]|[?]|BORDERLINE|1|10^12 IU/L|1|1|[?]|HIGH|SWABBED MATERIAL|GELLED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA|Y||NA||5|Visit_5|90|1|SCREENING|2020-10-07|2020-10-10|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|1|DIHYDCDN|Dihydrocodeine|CHEMISTRY|[?]|L/min|[?]|[?]|NEGATIVE|1|mL/cm|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|FROZEN||ELLA|ASH FIBROSURE FORMULA||Y|Y||1|Visit_1|10|6|FOLLOW-UP|2020-10-07|2020-11-11|10|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|2|NEUTSGNE|Neutrophils, Segmented/Neutrophils|URINALYSIS|||[?]|[?]|TRACE|1|mL/100g/min|1|1|[?]|LOW|BILE|CONTAMINATED||TARGETED GENOME SEQUENCING|MDRD ENZYMATIC FORMULA|Y|Y|Y|Y|1|Visit_1|10|5|FOLLOW-UP|2020-10-07|2020-10-28|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|3|EPISQCE|Squamous Epithelial Cells|HEMATOLOGY|[?]|STRIP|[?]|[?]|INDETERMINATE|1|min|1|1|[?]|LOW|AQUEOUS HUMOR|CLOTTED||TELLER ACUITY CARDS|FIBROTEST FORMULA|||N||2|Visit_2|25|4|WASHOUT|2020-10-22|2020-12-31|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|4|C165890|Timothy Grass Pollen IgE AB RAST Score|CHEMISTRY|[?]|mmHg/sec|[?]|[?]|INVALID|1|g/L|1|1|[?]|LOW|SEBUM|ICTERIC|N|CALCOFLUOR WHITE STAIN|CKD-EPI FORMULA||Y|U||2|Visit_2|25|6|FOLLOW-UP|2020-10-22|2020-12-07|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|5|B2MCREAT|Beta-2 Microglobulin/Creatinine|URINALYSIS|[?]|mm/sec|[?]|[?]|NEGATIVE|1|U|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|CLOTTED||FLOW CYTOMETRY|MDRD 6 VARIABLE FORMULA|Y||U||3|Visit_3|40|5|TREATMENT|2020-11-06|2020-12-25|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|6|THYAB|Thyroid Antibodies|CHEMISTRY|[?]|/mm|[?]|[?]|INVALID|1|kDa|1|1|[?]|NORMAL|HAIR|THAWED|N|IMPEDANCE CONDUCTIVITY|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|4|WASHOUT|2020-11-06|2020-11-21|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|7|FGF23C|Fibroblast Growth Factor 23, C-Terminal|HEMATOLOGY|[?]|nmol/mol|[?]|[?]|INVALID|1|10^9 CFU|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|REFRIGERATED||TWO-COLOR MICROARRAY|GMI MMOL/MOL FORMULA|Y||U||4|Visit_4|65|2|TREATMENT|2020-12-01|2021-01-02|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|8|NEUTLS|Left Shift Neutrophils|CHEMISTRY|[?]|WEEKS|[?]|[?]|BORDERLINE|1|DAYS|1|1|[?]|NORMAL|CORD BLOOD|CALCIFIED|N|PET SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||4|Visit_4|65|6|WASHOUT|2020-12-01|2020-12-07|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|9|CIC|Circulating Immune Complexes|URINALYSIS|[?]|IU/mg|[?]|[?]|BORDERLINE|1|Torr|1|1|[?]|ABNORMAL|DIALYSIS FLUID|REFRIGERATED|N|PHOTOGRAPHY|MDRD 6 VARIABLE FORMULA|Y||N||5|Visit_5|90|7|SCREENING|2020-12-26|2021-01-04|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|10|RDCSUG|Reducing Sugars|HEMATOLOGY|[?]|IU/mL|[?]|[?]|POSITIVE|1|10^9 CFU/g|1|1|[?]|LOW|SYNOVIAL FLUID|LIPEMIC|N|DUKE INCISION METHOD|ASH FIBROSURE FORMULA|||N||5|Visit_5|90|1|WASHOUT|2020-12-26|2021-01-03|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|74cd0a4f-f9fe-4df9-93b8-7832512d0828|1|PPA|Phenylpropanolamine|HEMATOLOGY|||[?]|[?]|POSITIVE|1|IU/dL|1|1|[?]|ABNORMAL|PLEURAL TISSUE|CALCIFIED||ELECTROGASTROGRAPHY|ASH FIBROSURE FORMULA|Y|Y|U|Y|1|Visit_1|10|7|TREATMENT|2020-05-15|2020-06-15|10|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|LB|74cd0a4f-f9fe-4df9-93b8-7832512d0828|2|PAH|P-Aminohippurate Sodium|CHEMISTRY|[?]|BEAM BREAKS|[?]|[?]|INDETERMINATE|1|mg|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|CONCENTRATED||APPLANATION TONOMETRY|HEPASCORE FORMULA|||U||1|Visit_1|10|1|FOLLOW-UP|2020-05-15|2020-06-12|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|LB|74cd0a4f-f9fe-4df9-93b8-7832512d0828|3|C130128|Dog Dander Antigen IgE Antibody|URINALYSIS|[?]|aMFI|[?]|[?]|INVALID|1|/4.0 mL|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|SOLIDIFIED||MICRONEUTRALIZATION ASSAY|FIBROMETER FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-05-30|2020-07-15|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|74cd0a4f-f9fe-4df9-93b8-7832512d0828|4|BLSTRSID|Ringed Sideroblasts|URINALYSIS|[?]|Sv|[?]|[?]|POSITIVE|1|amu|1|1|[?]|ABNORMAL|VENOUS BLOOD|FROZEN||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI MMOL/MOL FORMULA||Y|NA||2|Visit_2|25|6|WASHOUT|2020-05-30|2020-06-21|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|74cd0a4f-f9fe-4df9-93b8-7832512d0828|5|CYFRA18|Cytokeratin 18 Fragment|CHEMISTRY|[?]|L/s|[?]|[?]|NEGATIVE|1|Anson U|1|1|[?]|ABNORMAL|LEUKOCYTE|DRIED||CONTRAST ENHANCED PET SCAN|CKD-EPI CREATININE FORMULA|Y||NA||3|Visit_3|40|6|FOLLOW-UP|2020-06-14|2020-07-01|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|LB|74cd0a4f-f9fe-4df9-93b8-7832512d0828|6|VLDL3|VLDL Cholesterol Subtype 3|CHEMISTRY|[?]|CAPFUL|[?]|[?]|INDETERMINATE|1|RING|1|1|[?]|LOW|MUCUS|ROOM TEMPERATURE||PELLI-ROBSON EYE CHART|GMI % FORMULA|||NA||3|Visit_3|40|3|FOLLOW-UP|2020-06-14|2020-07-10|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|LB|74cd0a4f-f9fe-4df9-93b8-7832512d0828|7|CONDUCTU|Urine Conductivity|HEMATOLOGY|[?]|10^12 IU/L|[?]|[?]|TRACE|1|mL/s|1|1|[?]|LOW|MENSTRUAL BLOOD|GELLED||LEAD CITRATE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-07-09|2020-08-07|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|74cd0a4f-f9fe-4df9-93b8-7832512d0828|8|PAPPEN|Pappenheimer Bodies|HEMATOLOGY|[?]|kg/m2|[?]|[?]|BORDERLINE|1|%(v/v)|1|1|[?]|LOW|TUMOR TISSUE|HEMOLYZED||CELLULOSE TAPE|GMI MMOL/MOL FORMULA|Y|Y|Y||4|Visit_4|65|3|WASHOUT|2020-07-09|2020-07-17|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|74cd0a4f-f9fe-4df9-93b8-7832512d0828|9|C130141|German Cockroach Antigen IgA Antibody|HEMATOLOGY|[?]|mL/sec/1.73m2|[?]|[?]|NEGATIVE|1|uEq|1|1|[?]|LOW|NAIL|AGGLUTINATED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||5|Visit_5|90|6|SCREENING|2020-08-03|2020-08-08|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|74cd0a4f-f9fe-4df9-93b8-7832512d0828|10|RF|Rheumatoid Factor|HEMATOLOGY|[?]|cd*s/m2|[?]|[?]|POSITIVE|1|CAPSULE|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED|N|DOUBLE IMMUNODIFFUSION|GMI % FORMULA||Y|N||5|Visit_5|90|3|TREATMENT|2020-08-03|2020-08-10|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|09238251-feaf-45a9-b295-dfed9a75fbb2|1|ALBEXR|Albumin Excretion Rate|URINALYSIS|[?]|DISK|[?]|[?]|POSITIVE|1|steps/min|1|1|[?]|NORMAL|BILE|REFRIGERATED||ETDRS EYE CHART|FIBROMETER FORMULA|||U||1|Visit_1|10|1|WASHOUT|2020-06-26|2020-07-05|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|09238251-feaf-45a9-b295-dfed9a75fbb2|2|GLCHT|Glycolithocholate|CHEMISTRY|[?]|BAG|[?]|[?]|BORDERLINE|1|vg/mL|1|1|[?]|ABNORMAL|SEMINAL FLUID|CLOTTED||BIOPSY|FIBROSIS 4 FORMULA||Y|U||1|Visit_1|10|5|FOLLOW-UP|2020-06-26|2020-06-27|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|09238251-feaf-45a9-b295-dfed9a75fbb2|3|PDGFAB|Platelet Derived Growth Factor IsoformAB|URINALYSIS|[?]|gtt|[?]|[?]|NEGATIVE|1|pmol/day|1|1|[?]|HIGH|HAIR FOLLICLE|GELLED||LC-FL|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||2|Visit_2|25|6|SCREENING|2020-07-11|2020-07-15|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|09238251-feaf-45a9-b295-dfed9a75fbb2|4|MLIGCE|Malignant Cells, NOS|HEMATOLOGY|[?]|kg/L|[?]|[?]|INDETERMINATE|1|MET*min|1|1|[?]|ABNORMAL|SMEGMA|HEMOLYZED||LC/MS|MDRD 6 VARIABLE FORMULA|||Y||2|Visit_2|25|3|SCREENING|2020-07-11|2020-08-17|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|09238251-feaf-45a9-b295-dfed9a75fbb2|5|C130095|Western Ragweed Pollen IgG4|CHEMISTRY|||[?]|[?]|NEGATIVE|1|BU|1|1|[?]|HIGH|PLEURAL FLUID|CONCENTRATED||MICROBIAL CULTURE|COCKCROFT-GAULT FORMULA|||Y|Y|3|Visit_3|40|1|TREATMENT|2020-07-26|2020-08-03|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|LB|09238251-feaf-45a9-b295-dfed9a75fbb2|6|TESTOSFR|Testosterone, Free|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|EU|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|AUTOLYZED||TRANSCRIPTION-MEDIATED AMPLIFICATION|NASH FIBROSURE FORMULA||Y|U|Y|3|Visit_3|40|3|TREATMENT|2020-07-26|2020-09-12|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|LB|09238251-feaf-45a9-b295-dfed9a75fbb2|7|PEPSNGI|Pepsinogen I|URINALYSIS|[?]|mV|[?]|[?]|INDETERMINATE|1|Antibody Unit|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|THAWED||ZIEHL NEELSEN ACID FAST STAIN|MDRD ENZYMATIC FORMULA|||N||4|Visit_4|65|5|SCREENING|2020-08-20|2020-08-24|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|LB|09238251-feaf-45a9-b295-dfed9a75fbb2|8|CYCHOL|Cholesterol Crystals|URINALYSIS|||[?]|[?]|POSITIVE|1|kg/mol|1|1|[?]|NORMAL|ABSCESS FLUID|DRIED||WESTERGREN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|4|Visit_4|65|3|SCREENING|2020-08-20|2020-09-23|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|LB|09238251-feaf-45a9-b295-dfed9a75fbb2|9|DTPACLR|DTPA Clearance|HEMATOLOGY|[?]|vp/dose|[?]|[?]|BORDERLINE|1|AFU|1|1|[?]|LOW|COLOSTRUM|DRIED||URANYL ACETATE STAIN|MDRD ENZYMATIC FORMULA|Y||N||5|Visit_5|90|3|TREATMENT|2020-09-14|2020-09-22|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|09238251-feaf-45a9-b295-dfed9a75fbb2|10|IGG1|Immunoglobulin G Subclass 1|URINALYSIS|[?]|uEq/L|[?]|[?]|POSITIVE|1|TRACE|1|1|[?]|HIGH|CELL PELLET|LACTESCENT|N|ACID FAST STAIN|FIBROMETER FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2020-09-14|2020-09-21|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|3e896568-85dc-4a14-ba41-eb3575940a9d|1|PLAT|Platelets|HEMATOLOGY|[?]|TAMPON|[?]|[?]|INVALID|1|dyn|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|CONTAMINATED||NUCLEIC ACID SEQUENCING|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|5|WASHOUT|2021-01-26|2021-02-03|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|3e896568-85dc-4a14-ba41-eb3575940a9d|2|TRGTCE|Target Cells|URINALYSIS|[?]|mm/min|[?]|[?]|TRACE|1|mL/dL|1|1|[?]|HIGH|ISOLATE|FROZEN||EPSILOMETER|GMI % FORMULA|Y||U||1|Visit_1|10|2|SCREENING|2021-01-26|2021-03-29|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|3e896568-85dc-4a14-ba41-eb3575940a9d|3|ALPIS|Intestinal Specific Alkaline Phosphatase|CHEMISTRY|[?]|g/cage|[?]|[?]|TRACE|1|log10 TCID 50/dose|1|1|[?]|LOW|SYNOVIAL FLUID|NON-HEMOLYZED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|HEPASCORE FORMULA|||Y||2|Visit_2|25|6|WASHOUT|2021-02-10|2021-04-18|25|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|3e896568-85dc-4a14-ba41-eb3575940a9d|4|PROLCTN|Prolactin|HEMATOLOGY|[?]|10^6 CFU|[?]|[?]|TRACE|1|min/day|1|1|[?]|NORMAL|LYSATE|CLOTTED||OPTICAL MAPPING|MDRD 5 VARIABLE FORMULA|Y|Y|NA||2|Visit_2|25|5|FOLLOW-UP|2021-02-10|2021-03-23|25|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|3e896568-85dc-4a14-ba41-eb3575940a9d|5|RENIN|Renin|CHEMISTRY|[?]|Ci|[?]|[?]|TRACE|1|mU|1|1|[?]|NORMAL|GASTRIC FLUID|ICTERIC||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI % FORMULA||Y|NA||3|Visit_3|40|6|TREATMENT|2021-02-25|2021-03-06|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|3e896568-85dc-4a14-ba41-eb3575940a9d|6|YEASTBUD|Yeast Budding|URINALYSIS|[?]|IU/mg|[?]|[?]|POSITIVE|1|U/animal|1|1|[?]|ABNORMAL|HAIR FOLLICLE|SOLIDIFIED||GC/FID|MDRD 5 VARIABLE FORMULA||Y|NA||3|Visit_3|40|4|TREATMENT|2021-02-25|2021-03-11|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|3e896568-85dc-4a14-ba41-eb3575940a9d|7|TNF5S|Soluble TNF Superfamily Member 5|URINALYSIS|[?]|F|[?]|[?]|POSITIVE|1|mEq/ug|1|1|[?]|ABNORMAL|PLASMA|ICTERIC||THERMAL IONIZATION MASS SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2021-03-22|2021-04-08|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|LB|3e896568-85dc-4a14-ba41-eb3575940a9d|8|CRP|C Reactive Protein|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/m2/min|1|1|[?]|NORMAL|CALCULUS|REFRIGERATED||TARGETED GENOME SEQUENCING|ASH FIBROSURE FORMULA|||Y|Y|4|Visit_4|65|1|SCREENING|2021-03-22|2021-03-31|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|LB|3e896568-85dc-4a14-ba41-eb3575940a9d|9|VEGFA|Vascular Endothelial Growth Factor A|CHEMISTRY|||[?]|[?]|NEGATIVE|1|ug/kg/h|1|1|[?]|NORMAL|DERMAL TISSUE|LACTESCENT||AMSLER GRID|NASH FIBROSURE FORMULA|Y||N|Y|5|Visit_5|90|1|TREATMENT|2021-04-16|2021-04-22|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|LB|3e896568-85dc-4a14-ba41-eb3575940a9d|10|DIHYDCDN|Dihydrocodeine|URINALYSIS|[?]|mL/kg|[?]|[?]|INDETERMINATE|1|Gy/h|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|SOLIDIFIED|N|MACRO BROTH DILUTION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||5|Visit_5|90|7|FOLLOW-UP|2021-04-16|2021-04-19|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|LB|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|1|BLYCECE|B-Lymphocytes/Total Cells|URINALYSIS|[?]|mkat|[?]|[?]|BORDERLINE|1|CUP|1|1|[?]|NORMAL|BILE|REFRIGERATED|N|HPLC/IEX|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||1|Visit_1|10|6|FOLLOW-UP|2020-10-22|2021-01-02|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|2|PEPSNGC|Pepsinogen C|URINALYSIS|[?]|LOZENGE|[?]|[?]|INVALID|1|mU/g|1|1|[?]|LOW|FLUID|LIPEMIC|N|PHOROPTER|FIBROMETER FORMULA|||U||1|Visit_1|10|2|TREATMENT|2020-10-22|2020-10-25|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|3|MMP9|Matrix Metalloproteinase 9|CHEMISTRY|[?]|kV|[?]|[?]|NEGATIVE|1|mg/m2/min|1|1|[?]|ABNORMAL|REFLEX TEAR|CONTAMINATED||REFRACTOMETRY|CKD-EPI FORMULA||Y|NA||2|Visit_2|25|4|WASHOUT|2020-11-06|2020-12-31|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|4|STAT3P|Phosphorylated STAT3|URINALYSIS|[?]|mm2|[?]|[?]|INVALID|1|keV|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|SOLIDIFIED||ELISA|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-11-06|2020-12-22|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|5|HDL2|HDL-Cholesterol Subclass 2|HEMATOLOGY|[?]|anti-Xa IU|[?]|[?]|NEGATIVE|1|FEU|1|1|[?]|NORMAL|CELL PELLET|UNEXPECTED ODOR|N|CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-11-21|2021-01-06|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|6|CRTCREAT|Corticosterone/Creatinine|CHEMISTRY|[?]|scm|[?]|[?]|INVALID|1|mol/L|1|1|[?]|ABNORMAL|URINE|UNEXPECTED ODOR||PHOTOMETRY|FIBROMETER FORMULA|||N||3|Visit_3|40|6|WASHOUT|2020-11-21|2021-01-11|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|7|C165930|Shellfish Mix IgE AB RAST Score|HEMATOLOGY|[?]|mAnson U/mL|[?]|[?]|BORDERLINE|1|10^3 CFU/g|1|1|[?]|HIGH|ARTERIAL BLOOD|PARAFFIN-EMBEDDED|N|MAGNETIC RESONANCE ENTEROGRAPHY|FIBROMETER FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2020-12-16|2021-01-13|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|8|VITA|Vitamin A|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|10^6/hpf|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|NON-HEMOLYZED||NUCLEIC ACID HYBRIDIZATION|COCKCROFT-GAULT FORMULA||Y|Y|Y|4|Visit_4|65|3|FOLLOW-UP|2020-12-16|2021-01-06|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|9|AFACTXAA|Anti-Factor Xa Activity|HEMATOLOGY|[?]|L/s|[?]|[?]|POSITIVE|1|atm|1|1|[?]|NORMAL|MONOCYTE|NON-HEMOLYZED|N|GC/MS|CKD-EPI FORMULA|Y||NA||5|Visit_5|90|6|SCREENING|2021-01-10|2021-01-18|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|10|HETRPHLE|Heterophils/Leukocytes|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^3 CFU|1|1|[?]|HIGH|INFRANATANT, PLASMA|CALCIFIED|N|DUCTOGRAPHY|MDRD FORMULA|Y||NA|Y|5|Visit_5|90|3|FOLLOW-UP|2021-01-10|2021-01-19|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|725c5a91-72b0-4b2c-a51a-d1006303373e|1|TRGTCE|Target Cells|CHEMISTRY|[?]|%(v/v)|[?]|[?]|INVALID|1|g/cage/day|1|1|[?]|HIGH|TUMOR TISSUE|LACTESCENT|N|INTERRUPTER TECHNIQUE|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|6|WASHOUT|2020-11-23|2020-12-26|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|725c5a91-72b0-4b2c-a51a-d1006303373e|2|WBCDIFF|Leukocyte Cell Differential|URINALYSIS|[?]|anti-Xa IU/mL|[?]|[?]|INDETERMINATE|1|g/dL|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|LACTESCENT||SICKLE CELL SOLUBILITY TEST|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-11-23|2020-12-14|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|725c5a91-72b0-4b2c-a51a-d1006303373e|3|ESTRIOL|Estriol|CHEMISTRY|[?]|gtt|[?]|[?]|INDETERMINATE|1|POUCH|1|1|[?]|LOW|GASTRIC FLUID|CONTAMINATED||FLUORESCENT ENZYME IMMUNOASSAY|HEPASCORE FORMULA||Y|Y||2|Visit_2|25|7|TREATMENT|2020-12-08|2021-01-19|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|725c5a91-72b0-4b2c-a51a-d1006303373e|4|ANAIGGAB|Antinuclear IgG Antibody|HEMATOLOGY|[?]|ugEq/L|[?]|[?]|TRACE|1|mL/h|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|CALCIFIED||JAEGER EYE CHART|NASH FIBROSURE FORMULA|||NA||2|Visit_2|25|4|WASHOUT|2020-12-08|2021-01-09|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|725c5a91-72b0-4b2c-a51a-d1006303373e|5|MMP7|Matrix Metalloproteinase 7|HEMATOLOGY|[?]|mL/kg/day|[?]|[?]|TRACE|1|ELISA unit/dose|1|1|[?]|HIGH|PLASMA|CLOTTED|N|CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||3|Visit_3|40|3|TREATMENT|2020-12-23|2021-01-31|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|725c5a91-72b0-4b2c-a51a-d1006303373e|6|LH|Luteinizing Hormone|CHEMISTRY|[?]|g/kg/day|[?]|[?]|BORDERLINE|1|kN/cm2|1|1|[?]|ABNORMAL|FLUID|FROZEN|N|CORONARY ANGIOGRAPHY|CKD-EPI FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-12-23|2021-01-15|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|725c5a91-72b0-4b2c-a51a-d1006303373e|7|FCTVIIAA|Factor VIIa Activity|HEMATOLOGY|[?]|g/L|[?]|[?]|INDETERMINATE|1|dL|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|LACTESCENT||IMPEDANCE CONDUCTIVITY|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|7|WASHOUT|2021-01-17|2021-02-19|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|725c5a91-72b0-4b2c-a51a-d1006303373e|8|ETPPHR|ETP Peak Height Relative|URINALYSIS|[?]|RFU|[?]|[?]|INDETERMINATE|1|mL/min/mmHg|1|1|[?]|NORMAL|GASTRIC CONTENTS|LIPEMIC||SMEAR|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|5|WASHOUT|2021-01-17|2021-01-25|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|725c5a91-72b0-4b2c-a51a-d1006303373e|9|INSULIN|Insulin|URINALYSIS|[?]|copies/uL|[?]|[?]|POSITIVE|1|BP|1|1|[?]|HIGH|CELL PELLET|SOLIDIFIED||PERIPHERAL ANGIOGRAPHY|FIBROMETER FORMULA|||NA||5|Visit_5|90|7|FOLLOW-UP|2021-02-11|2021-02-19|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|LB|725c5a91-72b0-4b2c-a51a-d1006303373e|10|FERRITIN|Ferritin|CHEMISTRY|[?]|U/m2/min|[?]|[?]|TRACE|1|Farad|1|1|[?]|HIGH|CELL PELLET|FROZEN|N|LEAD CITRATE STAIN|ASH FIBROSURE FORMULA|||N||5|Visit_5|90|5|SCREENING|2021-02-11|2021-02-13|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|LB|5bf5b31d-a59d-46b7-8f8f-97919d449565|1|C165934|Arachis hypogaea IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|FEU|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|LIPEMIC||PERIODIC ACID SCHIFF STAIN|MDRD 5 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|7|WASHOUT|2021-01-01|2021-01-26|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|LB|5bf5b31d-a59d-46b7-8f8f-97919d449565|2|TRICH|Trichomonas|URINALYSIS|||[?]|[?]|POSITIVE|1|10^3 organisms/g|1|1|[?]|ABNORMAL|FLUID|HEMOLYZED||MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|Y||N|Y|1|Visit_1|10|6|TREATMENT|2021-01-01|2021-03-14|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|LB|5bf5b31d-a59d-46b7-8f8f-97919d449565|3|RETCRRBC|HCT Corrected Reticulocytes/Erythrocytes|URINALYSIS|[?]|MPS U|[?]|[?]|TRACE|1|lx|1|1|[?]|NORMAL|REFLEX TEAR|FROZEN|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI % FORMULA||Y|NA||2|Visit_2|25|5|SCREENING|2021-01-16|2021-03-26|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|5bf5b31d-a59d-46b7-8f8f-97919d449565|4|C165937|Zea mays IgE AB RAST Score|CHEMISTRY|[?]|mV|[?]|[?]|INVALID|1|cm/min|1|1|[?]|LOW|HAIR|PARAFFIN-EMBEDDED||PYROSEQUENCING|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|6|TREATMENT|2021-01-16|2021-02-15|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|5bf5b31d-a59d-46b7-8f8f-97919d449565|5|C165892|Wild Rye Pollen IgE Antibody|HEMATOLOGY|[?]|10^6 organisms/g|[?]|[?]|POSITIVE|1|mL/m2/day|1|1|[?]|NORMAL|AQUEOUS HUMOR|SOLIDIFIED||PHOROPTER|MDRD ENZYMATIC JAPANESE FORMULA|||N||3|Visit_3|40|2|WASHOUT|2021-01-31|2021-02-06|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|5bf5b31d-a59d-46b7-8f8f-97919d449565|6|ARR|Aldosterone/Renin Activity|CHEMISTRY|||[?]|[?]|NEGATIVE|1|TAMPON|1|1|[?]|HIGH|SKIN TISSUE|SOLIDIFIED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROTEST FORMULA|||N|Y|3|Visit_3|40|3|SCREENING|2021-01-31|2021-02-24|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|5bf5b31d-a59d-46b7-8f8f-97919d449565|7|SPERM|Spermatozoa|CHEMISTRY|[?]|APL U/mL|[?]|[?]|BORDERLINE|1|10^6 IU/mL|1|1|[?]|LOW|WHITE MATTER TISSUE|REFRIGERATED||MAGNETIC RESONANCE ENTEROGRAPHY|FIBROMETER FORMULA|Y|Y|Y||4|Visit_4|65|2|WASHOUT|2021-02-25|2021-03-23|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|5bf5b31d-a59d-46b7-8f8f-97919d449565|8|ABNCECE|Abnormal Cells/Total Cells|HEMATOLOGY|[?]|/100 HPFs|[?]|[?]|NEGATIVE|1|/40 HPFs|1|1|[?]|LOW|KERATINOCYTE|ICTERIC||LC/MS/MS|FIBROSIS 4 FORMULA||Y|N||4|Visit_4|65|5|FOLLOW-UP|2021-02-25|2021-03-26|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|5bf5b31d-a59d-46b7-8f8f-97919d449565|9|VEGFC|Vascular Endothelial Growth Factor C|URINALYSIS|||[?]|[?]|NEGATIVE|1|kcal|1|1|[?]|LOW|VENOUS PLASMA|DRIED|N|SLIT LAMP PHOTOGRAPHY|FIBROMETER FORMULA|||N|Y|5|Visit_5|90|7|FOLLOW-UP|2021-03-22|2021-03-23|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|5bf5b31d-a59d-46b7-8f8f-97919d449565|10|GLUCEXR|Glucose Excretion Rate|CHEMISTRY|[?]|/10^4|[?]|[?]|INVALID|1|sec|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|CALCIFIED||MICROBIAL CULTURE, LIQUID|GMI % FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2021-03-22|2021-03-30|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|7fc35880-1672-4e64-ba3b-aa3f1e42764b|1|C130076|Silver Birch Pollen IgE|CHEMISTRY|[?]|POUCH|[?]|[?]|NEGATIVE|1|Siemens|1|1|[?]|NORMAL|HAIR|AUTOLYZED||INFRARED SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA|||Y||1|Visit_1|10|6|FOLLOW-UP|2020-05-26|2020-06-14|10|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|LB|7fc35880-1672-4e64-ba3b-aa3f1e42764b|2|PYRIDNLN|Pyridinoline|URINALYSIS|[?]|DROP|[?]|[?]|INVALID|1|fmol/g|1|1|[?]|HIGH|MUSCLE TISSUE|ICTERIC|N|CAPILLARY ELECTROPHORESIS|MDRD ENZYMATIC FORMULA|||NA||1|Visit_1|10|3|SCREENING|2020-05-26|2020-07-05|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|LB|7fc35880-1672-4e64-ba3b-aa3f1e42764b|3|ADSDNA|Anti-Double Stranded DNA|URINALYSIS|||[?]|[?]|POSITIVE|1|ug/kg/min|1|1|[?]|LOW|EPIDERMAL TISSUE|LACTESCENT||ACID FAST STAIN|NASH FIBROSURE FORMULA|||Y|Y|2|Visit_2|25|6|WASHOUT|2020-06-10|2020-08-09|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|7fc35880-1672-4e64-ba3b-aa3f1e42764b|4|WBCCE|Leukocytes/Total Cells|CHEMISTRY|[?]|Ci/ug|[?]|[?]|NEGATIVE|1|mL/sec/1.73m2|1|1|[?]|ABNORMAL|EXPIRED AIR|ICTERIC||RADIATION DOSIMETRY|CKD-EPI FORMULA|Y||NA||2|Visit_2|25|5|TREATMENT|2020-06-10|2020-07-17|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|7fc35880-1672-4e64-ba3b-aa3f1e42764b|5|MCVRETIC|MCV Reticulocytes|HEMATOLOGY|[?]|g/animal|[?]|[?]|POSITIVE|1|ohm|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|CONTAMINATED||GC/MS-CI|HEPASCORE FORMULA|||NA||3|Visit_3|40|1|SCREENING|2020-06-25|2020-07-26|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|LB|7fc35880-1672-4e64-ba3b-aa3f1e42764b|6|BETAINES|Betaines|CHEMISTRY|[?]|APL U/mL|[?]|[?]|INDETERMINATE|1|PACK|1|1|[?]|NORMAL|STOOL|HEMOLYZED||HEMATOXYLIN AND EOSIN STAIN|FIBROTEST FORMULA|||U||3|Visit_3|40|7|TREATMENT|2020-06-25|2020-08-09|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|LB|7fc35880-1672-4e64-ba3b-aa3f1e42764b|7|PRTN3AB|Proteinase 3 Antibody|HEMATOLOGY|[?]|uCi/kg|[?]|[?]|INDETERMINATE|1|g/mol|1|1|[?]|LOW|MECONIUM|SOLIDIFIED|N|RAJI CELL RIA|GMI MMOL/MOL FORMULA|||NA||4|Visit_4|65|1|TREATMENT|2020-07-20|2020-08-13|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|7fc35880-1672-4e64-ba3b-aa3f1e42764b|8|AMYLASES|Amylase, Salivary|CHEMISTRY|[?]|Weber|[?]|[?]|POSITIVE|1|Watt|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|CLOTTED|N|NUCLEAR RADIOLOGY|FIBROTEST FORMULA|Y||U||4|Visit_4|65|4|TREATMENT|2020-07-20|2020-08-06|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|7fc35880-1672-4e64-ba3b-aa3f1e42764b|9|VITB7|Vitamin B7|CHEMISTRY|[?]|10^12/L|[?]|[?]|INVALID|1|AFU|1|1|[?]|NORMAL|HAIR|LIPEMIC|N|MRI WITHOUT CONTRAST|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-08-14|2020-08-22|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|7fc35880-1672-4e64-ba3b-aa3f1e42764b|10|MONOBL|Monoblasts|HEMATOLOGY|[?]|keV|[?]|[?]|NEGATIVE|1|PIXEL|1|1|[?]|LOW|LOCHIA|CONTAMINATED||OBSERVATION|MDRD 5 VARIABLE FORMULA|Y||Y||5|Visit_5|90|4|TREATMENT|2020-08-14|2020-08-17|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|1|RNA|Ribonucleic Acid|HEMATOLOGY|[?]|mg/animal|[?]|[?]|NEGATIVE|1|fmol/g|1|1|[?]|HIGH|STOOL|AUTOLYZED||PET/CT SCAN WITHOUT CONTRAST|FIBROMETER FORMULA|||N||1|Visit_1|10|4|TREATMENT|2020-10-14|2020-11-07|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|2|LIPASEG|Lipase, Gastric|HEMATOLOGY|[?]|cL|[?]|[?]|POSITIVE|1|lm|1|1|[?]|LOW|SWABBED MATERIAL|UNEXPECTED ODOR||REFLECTANCE SPECTROSCOPY|FIBROMETER FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-10-14|2020-12-15|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|3|PHADJT|pH Adjusted for Body Temp|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mmHg/sec|1|1|[?]|LOW|RETICULOCYTES|REFRIGERATED||SNELLEN EYE CHART|FIBROTEST FORMULA|||U|Y|2|Visit_2|25|6|SCREENING|2020-10-29|2020-11-10|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|4|HGBCS|Hemoglobin Casts|HEMATOLOGY|[?]|cm H2O|[?]|[?]|INDETERMINATE|1|foz_br|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|SOLIDIFIED||NUCLEIC ACID SEQUENCING|GMI % FORMULA||Y|NA||2|Visit_2|25|3|SCREENING|2020-10-29|2020-12-12|25|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|5|RPPAB|Ribosomal P Protein Antibody|HEMATOLOGY|[?]|mol/L|[?]|[?]|INVALID|1|pL|1|1|[?]|HIGH|PERITONEAL FLUID|AGGLUTINATED|N|ULTRASOUND|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|4|SCREENING|2020-11-13|2020-11-17|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|6|MPO|Myeloperoxidase|URINALYSIS|[?]|nmol/mol|[?]|[?]|INVALID|1|RATIO|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|ROOM TEMPERATURE||OPTICAL MAPPING|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||3|Visit_3|40|1|TREATMENT|2020-11-13|2020-12-15|40|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|7|ACT|Activated Coagulation Time|HEMATOLOGY|[?]|KALLIKREIN INHIBITOR UNIT|[?]|[?]|INDETERMINATE|1|mJoule/cm2|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|NON-HEMOLYZED||GRADIENT DIFFUSION|CKD-EPI CREATININE FORMULA||Y|U||4|Visit_4|65|2|TREATMENT|2020-12-08|2020-12-29|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|8|C165897|Bermuda Grass Pollen IgG AB RAST Score|URINALYSIS|[?]|mmHg|[?]|[?]|TRACE|1|g/U|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|HEMOLYZED||CONGO RED STAIN|GMI MMOL/MOL FORMULA|Y|Y|NA||4|Visit_4|65|6|FOLLOW-UP|2020-12-08|2020-12-17|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|9|KRCYMG|Megakaryocytes|URINALYSIS|[?]|DRINK|[?]|[?]|BORDERLINE|1|tsp eq|1|1|[?]|LOW|LEUKOCYTE|NON-HEMOLYZED||SXA SCAN|MDRD 5 VARIABLE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2021-01-02|2021-01-04|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|10|ANABASN|Anabasine|HEMATOLOGY|[?]|cd|[?]|[?]|TRACE|1|Mile|1|1|[?]|LOW|REFLEX TEAR|AGGLUTINATED||WHOLE TRANSCRIPTOME SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|U||5|Visit_5|90|6|TREATMENT|2021-01-02|2021-01-10|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|f8878ffd-67af-414c-b346-596dbec640cf|1|TK2|Thymidine Kinase 2|HEMATOLOGY|[?]|mmol/g|[?]|[?]|NEGATIVE|1|ug/mol|1|1|[?]|LOW|EPITHELIAL CELL|FRESH||CONTACT SPECULAR MICROSCOPY|MDRD FORMULA|||NA||1|Visit_1|10|7|FOLLOW-UP|2021-01-04|2021-01-08|10|14|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|LB|f8878ffd-67af-414c-b346-596dbec640cf|2|INTLK32|Interleukin 32|CHEMISTRY|[?]|/2000 RBC|[?]|[?]|BORDERLINE|1|in2|1|1|[?]|NORMAL|ABSCESS FLUID|FRESH|N|IN SITU HYBRIDIZATION|FIBROSIS 4 FORMULA|Y||Y||1|Visit_1|10|7|FOLLOW-UP|2021-01-04|2021-03-01|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|LB|f8878ffd-67af-414c-b346-596dbec640cf|3|RNPSMAB|Ribonucleoprotein Smith Complex Antibody|URINALYSIS|[?]|Joule|[?]|[?]|TRACE|1|vp/dose|1|1|[?]|ABNORMAL|EXUDATE|GELLED|N|POLYMERASE CHAIN REACTION|FIBROTEST FORMULA|||N||2|Visit_2|25|6|FOLLOW-UP|2021-01-19|2021-01-26|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|LB|f8878ffd-67af-414c-b346-596dbec640cf|4|PO2|Partial Pressure Oxygen|URINALYSIS|[?]|Henry|[?]|[?]|NEGATIVE|1|ug/mol|1|1|[?]|LOW|STOOL|ICTERIC||CONTRAST ENHANCED X-RAY|FIBROTEST FORMULA|||N||2|Visit_2|25|5|TREATMENT|2021-01-19|2021-01-26|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|LB|f8878ffd-67af-414c-b346-596dbec640cf|5|MYBLAT1|Type I Myeloblasts|URINALYSIS|||[?]|[?]|BORDERLINE|1|mV|1|1|[?]|LOW|LOCHIA|LACTESCENT||PHYSICAL EXAMINATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|3|WASHOUT|2021-02-03|2021-03-07|40|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|f8878ffd-67af-414c-b346-596dbec640cf|6|PLSMCE|Mature Plasma Cells|CHEMISTRY|[?]|g/cage|[?]|[?]|INDETERMINATE|1|mkat|1|1|[?]|NORMAL|REFLEX TEAR|FRESH||NUCLEIC ACID SEQUENCING|CKD-EPI FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2021-02-03|2021-04-01|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|f8878ffd-67af-414c-b346-596dbec640cf|7|LRZPM|Lorazepam|CHEMISTRY|||[?]|[?]|BORDERLINE|1|PIXELS/in|1|1|[?]|HIGH|INTERSTITIAL FLUID|UNEXPECTED ODOR||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|4|Visit_4|65|6|TREATMENT|2021-02-28|2021-03-03|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|f8878ffd-67af-414c-b346-596dbec640cf|8|MENGL|Meningeal Cells|CHEMISTRY|[?]|ug/dose|[?]|[?]|TRACE|1|gpELISA unit/mL|1|1|[?]|ABNORMAL|BILE|AUTOLYZED||NON-INVASIVE DIELECTRIC SENSING|CKD-EPI CREATININE FORMULA|||N||4|Visit_4|65|6|TREATMENT|2021-02-28|2021-03-31|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|f8878ffd-67af-414c-b346-596dbec640cf|9|THRMPTN|Thrombopoietin|HEMATOLOGY|[?]|CAPLET|[?]|[?]|TRACE|1|IU/mL|1|1|[?]|NORMAL|LYSATE|UNEXPECTED ODOR||CALCULATION|CKD-EPI FORMULA||Y|N||5|Visit_5|90|7|SCREENING|2021-03-25|2021-03-31|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|f8878ffd-67af-414c-b346-596dbec640cf|10|PLSTCELE|Total Plasma Cells/Leukocytes|URINALYSIS|[?]|pmol/10^10 cells|[?]|[?]|POSITIVE|1|dpm/0.5 mL|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|GELLED||AUTOMATED COUNT|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2021-03-25|2021-04-02|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|d8212248-cd8c-4404-8ad8-2c89c05bee9e|1|ASTCREAT|Aspartate Aminotransferase/Creatinine|URINALYSIS|||[?]|[?]|TRACE|1|umol/L/sec|1|1|[?]|ABNORMAL|SOFT TISSUE|UNEXPECTED ODOR||EIA|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y|Y|1|Visit_1|10|2|TREATMENT|2020-05-11|2020-05-20|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|LB|d8212248-cd8c-4404-8ad8-2c89c05bee9e|2|C130105|Grass Mix Pollen Antigen IgA Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|log10 PFU/mL|1|1|[?]|LOW|PLATELET RICH PLASMA|FRESH||ELECTROCHEMILUMINESCENCE|COCKCROFT-GAULT FORMULA|||N|Y|1|Visit_1|10|5|SCREENING|2020-05-11|2020-07-26|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|LB|d8212248-cd8c-4404-8ad8-2c89c05bee9e|3|BLSTIMLY|Immunoblasts/Lymphocytes|URINALYSIS|[?]|TRANSDUCING UNIT/mL|[?]|[?]|BORDERLINE|1|TUBE|1|1|[?]|LOW|KERATINOCYTE|LACTESCENT||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2020-05-26|2020-06-09|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|LB|d8212248-cd8c-4404-8ad8-2c89c05bee9e|4|TNFR5S|Soluble TNF Receptor Superfamily Mem 5|HEMATOLOGY|[?]|tuberculin unit|[?]|[?]|INDETERMINATE|1|JAR|1|1|[?]|LOW|ARTERIAL CORD BLOOD|AUTOLYZED||PAP STAIN|CKD-EPI FORMULA|Y||NA||2|Visit_2|25|1|TREATMENT|2020-05-26|2020-07-19|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|LB|d8212248-cd8c-4404-8ad8-2c89c05bee9e|5|IL18EXR|Interleukin 18 Excretion Rate|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ukat/10^12 RBC|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|LACTESCENT|N|OBSERVATION|MDRD ENZYMATIC JAPANESE FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2020-06-10|2020-06-11|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|LB|d8212248-cd8c-4404-8ad8-2c89c05bee9e|6|TNFSR|Soluble Tumor Necrosis Factor Receptor|CHEMISTRY|[?]|10^3 CFU/g|[?]|[?]|BORDERLINE|1|POINT|1|1|[?]|NORMAL|CAPILLARY BLOOD|PARAFFIN-EMBEDDED||LYMPHANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||N||3|Visit_3|40|3|TREATMENT|2020-06-10|2020-06-26|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|LB|d8212248-cd8c-4404-8ad8-2c89c05bee9e|7|CRTCREAT|Corticosterone/Creatinine|URINALYSIS|[?]|10^3 CFU/g|[?]|[?]|BORDERLINE|1|log10 TCID 50/uL|1|1|[?]|ABNORMAL|DISCHARGE|HEMOLYZED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD 6 VARIABLE FORMULA|Y||U||4|Visit_4|65|7|WASHOUT|2020-07-05|2020-07-17|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|d8212248-cd8c-4404-8ad8-2c89c05bee9e|8|GLTRCE|Glitter Cells|URINALYSIS|||[?]|[?]|INVALID|1|amol|1|1|[?]|LOW|URINE|GELLED||IHC|GMI % FORMULA|||Y|Y|4|Visit_4|65|1|FOLLOW-UP|2020-07-05|2020-08-08|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|d8212248-cd8c-4404-8ad8-2c89c05bee9e|9|CD34|CD34|CHEMISTRY|[?]|nmol/kg/day|[?]|[?]|POSITIVE|1|Joule|1|1|[?]|LOW|BREAST MILK|LACTESCENT||FISH|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|4|FOLLOW-UP|2020-07-30|2020-08-07|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-25
e|LB|d8212248-cd8c-4404-8ad8-2c89c05bee9e|10|IOHEXOL|Iohexol|HEMATOLOGY|[?]|mmAL|[?]|[?]|NEGATIVE|1|ng/dL|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|CONCENTRATED||MICRODENSITOMETRY|MDRD FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-07-30|2020-07-31|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-25
e|LB|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|1|MPM|Mean Platelet Dry Mass|CHEMISTRY|[?]|SYRINGE|[?]|[?]|POSITIVE|1|nmol/L/min|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|LIPEMIC||AUTOREFRACTION|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-07-02|2020-07-17|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|2|HGB|Hemoglobin|CHEMISTRY|[?]|DAgU/mL|[?]|[?]|POSITIVE|1|BAG|1|1|[?]|HIGH|VENOUS CORD BLOOD|FRESH||FUNCTIONAL MRI|MDRD 4 VARIABLE FORMULA|Y|Y|U||1|Visit_1|10|7|WASHOUT|2020-07-02|2020-09-21|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|3|HSP70|Heat Shock Protein 70|CHEMISTRY|[?]|10^6 CFU|[?]|[?]|TRACE|1|mg/m2/h|1|1|[?]|HIGH|WHITE MATTER TISSUE|LIPEMIC|N|JAFFE REACTION|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|1|FOLLOW-UP|2020-07-17|2020-09-04|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|LB|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|4|RDCSUB|Reducing Substances|HEMATOLOGY|[?]|10^6/Ejaculate U|[?]|[?]|NEGATIVE|1|uL/dose|1|1|[?]|HIGH|PLATELET RICH PLASMA|GELLED||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|CKD-EPI CYSTATIN C FORMULA||Y|N||2|Visit_2|25|2|TREATMENT|2020-07-17|2020-09-17|25|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|LB|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|5|CD1|CD1|URINALYSIS|[?]|RNA copies/mL|[?]|[?]|BORDERLINE|1|BOLUS|1|1|[?]|HIGH|DIALYSIS FLUID|REFRIGERATED||NUCLEIC ACID HYBRIDIZATION|CKD-EPI FORMULA|Y||Y||3|Visit_3|40|2|TREATMENT|2020-08-01|2020-08-16|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|6|HIST2BAB|Histone 2B Antibody|HEMATOLOGY|[?]|Gauss|[?]|[?]|TRACE|1|pkat|1|1|[?]|LOW|MIXED VENOUS BLOOD|HEMOLYZED|N|MASS SPECTROMETRY|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|7|WASHOUT|2020-08-01|2020-08-27|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|7|CORTFR|Cortisol, Free|HEMATOLOGY|[?]|mg/L FEU|[?]|[?]|INVALID|1|%/s|1|1|[?]|ABNORMAL|SWABBED MATERIAL|NON-HEMOLYZED||MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|GMI % FORMULA|||Y||4|Visit_4|65|7|SCREENING|2020-08-26|2020-09-24|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|8|NEUTHYGR|Hypogranular Neutrophils|URINALYSIS|[?]|Shock Wave|[?]|[?]|NEGATIVE|1|BLOCKS|1|1|[?]|ABNORMAL|PERITONEAL FLUID|CONTAMINATED||ELECTROMYOGRAPHY|MDRD 6 VARIABLE FORMULA|||Y||4|Visit_4|65|1|TREATMENT|2020-08-26|2020-08-30|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|9|CCL8|Chemokine (C-C Motif) Ligand 8|HEMATOLOGY|[?]|MPL U/mL|[?]|[?]|NEGATIVE|1|LOZENGE|1|1|[?]|ABNORMAL|MECONIUM|ICTERIC|N|MAPH|FIBROSIS 4 FORMULA||Y|N||5|Visit_5|90|6|SCREENING|2020-09-20|2020-09-21|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|10|CRLPLSMN|Ceruloplasmin|URINALYSIS|[?]|mg/h|[?]|[?]|TRACE|1|mol/L|1|1|[?]|ABNORMAL|BONE MARROW|AGGLUTINATED|N|LYMPHANGIOGRAPHY|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-09-20|2020-09-28|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|b832144e-88c4-4ad6-b173-abac7802a36c|1|PYK|Pyruvate Kinase|URINALYSIS|[?]|mL/100g/min|[?]|[?]|TRACE|1|tuberculin unit|1|1|[?]|HIGH|EXUDATE|CLOTTED||ACID FAST STAIN|COCKCROFT-GAULT FORMULA||Y|Y||1|Visit_1|10|4|TREATMENT|2021-01-14|2021-01-16|10|12|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|b832144e-88c4-4ad6-b173-abac7802a36c|2|NEUTAGR|Agranular Neutrophils|CHEMISTRY|[?]|Farad|[?]|[?]|TRACE|1|mL/mmHg|1|1|[?]|LOW|MIXED VENOUS BLOOD|THAWED|N|IN VITRO GENE EXPRESSION ASSAY|NASH FIBROSURE FORMULA|||Y||1|Visit_1|10|2|SCREENING|2021-01-14|2021-03-28|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|b832144e-88c4-4ad6-b173-abac7802a36c|3|PRZPM|Prazepam|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|Coulomb|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|CLOTTED|N|RAJI CELL RIA|COCKCROFT-GAULT FORMULA|||U|Y|2|Visit_2|25|6|WASHOUT|2021-01-29|2021-02-01|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|b832144e-88c4-4ad6-b173-abac7802a36c|4|PROTPATN|Protein Pattern|HEMATOLOGY|[?]|10^7 TCID 50/dose|[?]|[?]|INVALID|1|/mm|1|1|[?]|NORMAL|PERITONEAL FLUID|CONCENTRATED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|FIBROSIS 4 FORMULA||Y|NA||2|Visit_2|25|2|TREATMENT|2021-01-29|2021-02-12|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|b832144e-88c4-4ad6-b173-abac7802a36c|5|FACTXIIA|Factor XII Activity|HEMATOLOGY|[?]|U/kg|[?]|[?]|POSITIVE|1|BU/mL|1|1|[?]|ABNORMAL|MONOCYTE|CONTAMINATED||CYSTOMETRY|GMI % FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2021-02-13|2021-03-19|40|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|LB|b832144e-88c4-4ad6-b173-abac7802a36c|6|AMORPHSD|Amorphous Sediment|CHEMISTRY|[?]|ug/min|[?]|[?]|BORDERLINE|1|mL/g/day|1|1|[?]|NORMAL|URINE SEDIMENT|UNEXPECTED ODOR||MICROSCOPY|HEPASCORE FORMULA|||NA||3|Visit_3|40|6|WASHOUT|2021-02-13|2021-02-17|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|LB|b832144e-88c4-4ad6-b173-abac7802a36c|7|LACTICAC|Lactic Acid|CHEMISTRY|[?]|titer|[?]|[?]|INVALID|1|PACKET|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|HEMOLYZED||MAGNETIC RESONANCE ENTEROGRAPHY|FIBROSIS 4 FORMULA|||Y||4|Visit_4|65|7|FOLLOW-UP|2021-03-10|2021-03-30|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|b832144e-88c4-4ad6-b173-abac7802a36c|8|TSTSFRPT|Testosterone, Free/Total Protein|URINALYSIS|[?]|ft|[?]|[?]|POSITIVE|1|10^6 IU/mL|1|1|[?]|HIGH|CALCULUS|AUTOLYZED||OBSERVATION|GMI % FORMULA|||U||4|Visit_4|65|7|TREATMENT|2021-03-10|2021-03-22|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|b832144e-88c4-4ad6-b173-abac7802a36c|9|GLOBUL|Globulin|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|IU/kg/h|1|1|[?]|HIGH|MONOCYTE|ICTERIC||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|CKD-EPI CYSTATIN C FORMULA||Y|U|Y|5|Visit_5|90|6|TREATMENT|2021-04-04|2021-04-10|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|b832144e-88c4-4ad6-b173-abac7802a36c|10|LIPASEG|Lipase, Gastric|HEMATOLOGY|[?]|mL/animal/wk|[?]|[?]|INDETERMINATE|1|HOURS|1|1|[?]|LOW|VITREOUS HUMOR|FRESH||WESTERGREN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||5|Visit_5|90|4|SCREENING|2021-04-04|2021-04-07|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|6acacd87-c487-401c-8888-76ccf97b640d|1|C130127|Cat Dander Antigen IgG4 Antibody|URINALYSIS|[?]|IMPLANT|[?]|[?]|TRACE|1|g/L|1|1|[?]|NORMAL|MUSCLE TISSUE|DRIED||DIFFUSION TENSOR MRI|FIBROMETER FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-05-25|2020-06-03|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|6acacd87-c487-401c-8888-76ccf97b640d|2|DSVLFXN|Desvenlafaxine|URINALYSIS|[?]|DROP|[?]|[?]|BORDERLINE|1|JAR|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|LIPEMIC|N|WHOLE EXOME SEQUENCING|MDRD FORMULA|||Y||1|Visit_1|10|1|WASHOUT|2020-05-25|2020-07-08|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|6acacd87-c487-401c-8888-76ccf97b640d|3|C130093|Western Ragweed Pollen IgA|URINALYSIS|[?]|g/U|[?]|[?]|TRACE|1|mg/m2/h|1|1|[?]|ABNORMAL|SOFT TISSUE|ICTERIC|N|LC/MS|HEPASCORE FORMULA||Y|NA||2|Visit_2|25|2|WASHOUT|2020-06-09|2020-08-02|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|6acacd87-c487-401c-8888-76ccf97b640d|4|NEUTAGR|Agranular Neutrophils|HEMATOLOGY|[?]|mEq/ug|[?]|[?]|INVALID|1|PLUG|1|1|[?]|LOW|AQUEOUS HUMOR|CONTAMINATED||LANDOLT RING|HEPASCORE FORMULA|||N||2|Visit_2|25|5|WASHOUT|2020-06-09|2020-07-28|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|6acacd87-c487-401c-8888-76ccf97b640d|5|TRACP5B|Tartrate-Resistant Acid Phosphatase 5b|CHEMISTRY|[?]|Tesla|[?]|[?]|POSITIVE|1|mN|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|LACTESCENT|N|HEMAGGLUTINATION ASSAY|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|4|SCREENING|2020-06-24|2020-08-15|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|6acacd87-c487-401c-8888-76ccf97b640d|6|BLASTLE|Blasts/Leukocytes|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Anson U|1|1|[?]|HIGH|BLOOD|CONCENTRATED||SPIRAL CT|CKD-EPI CYSTATIN C FORMULA|||NA|Y|3|Visit_3|40|2|TREATMENT|2020-06-24|2020-08-06|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|6acacd87-c487-401c-8888-76ccf97b640d|7|LPPLA2|Lipoprotein Associated Phospholipase A2|URINALYSIS|||[?]|[?]|NEGATIVE|1|ug/day|1|1|[?]|NORMAL|INTERSTITIAL FLUID|LACTESCENT||DXA SCAN|FIBROSIS 4 FORMULA|||N|Y|4|Visit_4|65|5|WASHOUT|2020-07-19|2020-08-11|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|6acacd87-c487-401c-8888-76ccf97b640d|8|MG|Magnesium|CHEMISTRY|[?]|uL/dose|[?]|[?]|TRACE|1|CONTAINER|1|1|[?]|NORMAL|PLASMA|FRESH||LANDOLT RING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|1|WASHOUT|2020-07-19|2020-07-28|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|6acacd87-c487-401c-8888-76ccf97b640d|9|CX3CL1|Chemokine (C-X3-C Motif) Ligand 1|CHEMISTRY|||[?]|[?]|BORDERLINE|1|nmol/mL/min|1|1|[?]|ABNORMAL|EXUDATE|CLOTTED|N|HPLC|ASH FIBROSURE FORMULA||Y|U|Y|5|Visit_5|90|3|WASHOUT|2020-08-13|2020-08-15|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|6acacd87-c487-401c-8888-76ccf97b640d|10|INTLK1B|Interleukin 1 Beta|CHEMISTRY|[?]|mg/kg/dose|[?]|[?]|POSITIVE|1|USP U|1|1|[?]|LOW|SUPERNATANT, SERUM|PARAFFIN-EMBEDDED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|7|SCREENING|2020-08-13|2020-08-20|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|1|CTOT|Complement Total|CHEMISTRY|[?]|GPS U|[?]|[?]|TRACE|1|uV2|1|1|[?]|HIGH|BILE|SOLIDIFIED|N|ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-07-16|2020-09-05|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|2|LAG3S|Soluble Lymphocyte Activation Gene-3|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|/wk|1|1|[?]|ABNORMAL|LUNG SURFACTANT|LIPEMIC||PH METER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA|Y||N|Y|1|Visit_1|10|7|TREATMENT|2020-07-16|2020-08-15|10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|3|IAPP|Islet Amyloid Polypeptide|URINALYSIS|[?]|mol/mg|[?]|[?]|INDETERMINATE|1|Watt|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|UNEXPECTED ODOR||POTENTIOMETRY|HEPASCORE FORMULA|Y|Y|Y||2|Visit_2|25|6|TREATMENT|2020-07-31|2020-09-19|25|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|4|C130132|D. farinae Antigen IgE Antibody|HEMATOLOGY|[?]|g/cage/day|[?]|[?]|INVALID|1|JAR|1|1|[?]|LOW|PLATELET POOR PLASMA|NON-HEMOLYZED||BIOPSY|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|6|SCREENING|2020-07-31|2020-10-07|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|5|IGGCREAT|Immunoglobulin G/Creatinine|URINALYSIS|[?]|psi|[?]|[?]|NEGATIVE|1|cm H2O|1|1|[?]|ABNORMAL|HAIR|ICTERIC||IMPEDANCE CONDUCTIVITY|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-08-15|2020-08-18|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|6|GFRBSCCC|GFR from Cystatin C and Creat Adj BSA|HEMATOLOGY|[?]|deg/mm|[?]|[?]|TRACE|1|foz_br|1|1|[?]|HIGH|DERMAL TISSUE|ROOM TEMPERATURE||WEBER GREEN STAIN|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|3|FOLLOW-UP|2020-08-15|2020-10-07|40|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|7|PLSPCELY|Precursor Plasma Cells/Lymphocytes|URINALYSIS|[?]|pmol|[?]|[?]|INVALID|1|FINGERTIP UNIT|1|1|[?]|NORMAL|SKIN TISSUE|AGGLUTINATED||FLUORESCENT MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-09-09|2020-10-08|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|8|DOPAMEXR|Dopamine Excretion Rate|HEMATOLOGY|[?]|10^9 CFU/mL|[?]|[?]|TRACE|1|mol/L|1|1|[?]|LOW|REFLEX TEAR|GELLED||PULMONARY ANGIOGRAPHY|ASH FIBROSURE FORMULA|Y||N||4|Visit_4|65|6|SCREENING|2020-09-09|2020-10-07|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|9|APPA|Amyloid Alpha Precursor Protein|HEMATOLOGY|[?]|PIPE|[?]|[?]|INDETERMINATE|1|mEq/mL|1|1|[?]|LOW|STOOL|UNEXPECTED ODOR||LIGHT SCATTERING SPECTROSCOPY|MDRD 5 VARIABLE FORMULA|||Y||5|Visit_5|90|5|TREATMENT|2020-10-04|2020-10-09|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|10|CXCL7|Chemokine (C-X-C Motif) Ligand 7|URINALYSIS|[?]|mg/m2|[?]|[?]|NEGATIVE|1|atm|1|1|[?]|NORMAL|PROSTATIC FLUID|FROZEN||DYNAMIC CONTRAST ENHANCED MRI|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|2|FOLLOW-UP|2020-10-04|2020-10-10|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|73988e01-56c0-4b31-84e2-c23ce0bac5ac|1|MPOAB|Myeloperoxidase Antibody|CHEMISTRY|[?]|mEq/mL|[?]|[?]|INDETERMINATE|1|10^5/L|1|1|[?]|ABNORMAL|ALVEOLAR AIR|NON-HEMOLYZED||URANYL ACETATE STAIN|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|2|WASHOUT|2021-01-03|2021-01-28|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|LB|73988e01-56c0-4b31-84e2-c23ce0bac5ac|2|PROINSUL|Proinsulin|CHEMISTRY|[?]|10^8 PFU|[?]|[?]|BORDERLINE|1|hPa|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|ROOM TEMPERATURE|N|AGAR PROPORTION|FIBROSIS 4 FORMULA|||U||1|Visit_1|10|4|TREATMENT|2021-01-03|2021-03-23|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|LB|73988e01-56c0-4b31-84e2-c23ce0bac5ac|3|GRANIMLE|Immature Granulocytes/Leukocytes|HEMATOLOGY|[?]|mL/cage|[?]|[?]|INVALID|1|U/g|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|REFRIGERATED||LINE PROBE ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||2|Visit_2|25|3|TREATMENT|2021-01-18|2021-03-26|25|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|73988e01-56c0-4b31-84e2-c23ce0bac5ac|4|C165927|Animal Mix IgE AB RAST Score|CHEMISTRY|||[?]|[?]|TRACE|1|APL U/mL|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|CONTAMINATED|N|PULSE OXIMETRY|FIBROSIS 4 FORMULA|||U|Y|2|Visit_2|25|6|FOLLOW-UP|2021-01-18|2021-03-14|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|73988e01-56c0-4b31-84e2-c23ce0bac5ac|5|ESTRIOL|Estriol|URINALYSIS|[?]|10^3/L|[?]|[?]|TRACE|1|mU/L|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|ROOM TEMPERATURE|N|HPLC/MS|FIBROMETER FORMULA|||N||3|Visit_3|40|7|SCREENING|2021-02-02|2021-03-26|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|73988e01-56c0-4b31-84e2-c23ce0bac5ac|6|ABNCE|Abnormal Cells|CHEMISTRY|[?]|IU/kg|[?]|[?]|BORDERLINE|1|MONTHS|1|1|[?]|ABNORMAL|SEBUM|UNEXPECTED ODOR|N|POTENTIOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|6|TREATMENT|2021-02-02|2021-02-09|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|73988e01-56c0-4b31-84e2-c23ce0bac5ac|7|C165906|Weed Mix Pollen IgG AB RAST Score|URINALYSIS|[?]|mL/cm H2O|[?]|[?]|INVALID|1|m2|1|1|[?]|LOW|BONE MARROW|DRIED|N|TONOMETRY|MDRD 4 VARIABLE FORMULA|Y|Y|U||4|Visit_4|65|7|TREATMENT|2021-02-27|2021-03-08|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|73988e01-56c0-4b31-84e2-c23ce0bac5ac|8|C147282|White Oak Pollen IgE Antibody|CHEMISTRY|[?]|CUP|[?]|[?]|BORDERLINE|1|IU/dL|1|1|[?]|LOW|VENOUS BLOOD|DRIED|N|NON-CONTACT SPECULAR MICROSCOPY|FIBROSIS 4 FORMULA|Y|Y|Y||4|Visit_4|65|2|TREATMENT|2021-02-27|2021-03-04|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|73988e01-56c0-4b31-84e2-c23ce0bac5ac|9|PRGNENLN|Pregnenolone|HEMATOLOGY|[?]|umol/L/min|[?]|[?]|POSITIVE|1|gpELISA unit/mL|1|1|[?]|HIGH|CORD BLOOD|SOLIDIFIED|N|CELL BASED BIOASSAY|COCKCROFT-GAULT FORMULA||Y|N||5|Visit_5|90|7|TREATMENT|2021-03-24|2021-03-26|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|LB|73988e01-56c0-4b31-84e2-c23ce0bac5ac|10|FATDROP|Fat Droplet|HEMATOLOGY|[?]|PIXELS/in|[?]|[?]|INDETERMINATE|1|uOsm|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|FRESH||CYSTOSCOPY|GMI MMOL/MOL FORMULA|Y||Y||5|Visit_5|90|4|FOLLOW-UP|2021-03-24|2021-03-28|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|LB|0670f6a3-18c9-4027-91c1-56f5555589a8|1|MUG|Murinoglobulin|CHEMISTRY|||[?]|[?]|NEGATIVE|1|10^6 U|1|1|[?]|HIGH|SUPERNATANT, PLASMA|CONCENTRATED||MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|1|TREATMENT|2020-05-13|2020-08-09|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|LB|0670f6a3-18c9-4027-91c1-56f5555589a8|2|SRTONIN|Serotonin|CHEMISTRY|[?]|mOsm/L|[?]|[?]|BORDERLINE|1|mPa|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|HEMOLYZED|N|STATIC PERIMETRY|GMI % FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-05-13|2020-06-28|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|LB|0670f6a3-18c9-4027-91c1-56f5555589a8|3|UBQN|Ubiquitin Protein|HEMATOLOGY|||[?]|[?]|INVALID|1|Linear ft*LB|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|CONCENTRATED||MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD 6 VARIABLE FORMULA|||N|Y|2|Visit_2|25|6|TREATMENT|2020-05-28|2020-07-26|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|0670f6a3-18c9-4027-91c1-56f5555589a8|4|CMPK2|Cytidine-Uridine Monophosphate Kinase 2|URINALYSIS|[?]|mV*min|[?]|[?]|BORDERLINE|1|BU|1|1|[?]|ABNORMAL|CORD SERUM|ROOM TEMPERATURE||WRIGHT-GIEMSA STAIN|HEPASCORE FORMULA||Y|Y||2|Visit_2|25|3|TREATMENT|2020-05-28|2020-07-18|25|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|0670f6a3-18c9-4027-91c1-56f5555589a8|5|APRIL|A Proliferation-Inducing Ligand|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mL/s/m2|1|1|[?]|HIGH|CAPILLARY PLASMA|PARAFFIN-EMBEDDED||DYNAMIC CONTRAST ENHANCED MRI|ASH FIBROSURE FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2020-06-12|2020-07-01|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|0670f6a3-18c9-4027-91c1-56f5555589a8|6|HELMOV10|Helicase MOV-10 Protein|CHEMISTRY|[?]|Anson U|[?]|[?]|BORDERLINE|1|mL/g/h|1|1|[?]|LOW|DERMAL TISSUE|ROOM TEMPERATURE|N|AUTOREFRACTION|CKD-EPI CREATININE FORMULA|Y||N||3|Visit_3|40|1|FOLLOW-UP|2020-06-12|2020-08-06|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|0670f6a3-18c9-4027-91c1-56f5555589a8|7|DTPACLR|DTPA Clearance|URINALYSIS|[?]|ug/mL/h|[?]|[?]|TRACE|1|/2500 WBC|1|1|[?]|ABNORMAL|SERUM|CONTAMINATED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||4|Visit_4|65|7|TREATMENT|2020-07-07|2020-07-31|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|0670f6a3-18c9-4027-91c1-56f5555589a8|8|GSTPIEXR|Pi-GST Excretion Rate|HEMATOLOGY|[?]|PFU|[?]|[?]|INDETERMINATE|1|mph|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|GELLED||DIGITAL PCR|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||4|Visit_4|65|1|SCREENING|2020-07-07|2020-07-22|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|0670f6a3-18c9-4027-91c1-56f5555589a8|9|MSTHCELE|Mesothelial Cells/Leukocytes|HEMATOLOGY|[?]|umol/kg/min|[?]|[?]|INDETERMINATE|1|mg/day|1|1|[?]|ABNORMAL|URINE SEDIMENT|CALCIFIED||SLIT LAMP PHOTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA||5|Visit_5|90|6|FOLLOW-UP|2020-08-01|2020-08-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|LB|0670f6a3-18c9-4027-91c1-56f5555589a8|10|LDLHDL|LDL Cholesterol/HDL Cholesterol|URINALYSIS|[?]|10^3 CFU/mL|[?]|[?]|TRACE|1|EP U|1|1|[?]|NORMAL|BLOOD|ROOM TEMPERATURE||DNA MICROARRAY|FIBROTEST FORMULA|||NA||5|Visit_5|90|7|FOLLOW-UP|2020-08-01|2020-08-10|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|LB|59179734-8784-4a88-aa6b-51b6082ffc1b|1|FCTVIIIA|Factor VIII Activity|CHEMISTRY|[?]|Bq|[?]|[?]|POSITIVE|1|mL/min/mmHg|1|1|[?]|NORMAL|KERATINOCYTE|PARAFFIN-EMBEDDED||POTENTIOMETRY|CKD-EPI CYSTATIN C FORMULA|Y||Y||1|Visit_1|10|4|TREATMENT|2020-08-11|2020-08-12|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|59179734-8784-4a88-aa6b-51b6082ffc1b|2|STAT3PS3|Phosphorylated STAT3/STAT3|URINALYSIS|[?]|EID 50/dose|[?]|[?]|NEGATIVE|1|10^6 organisms/g|1|1|[?]|HIGH|LAVAGE FLUID|ICTERIC||ELECTROCHEMILUMINESCENCE|FIBROSIS 4 FORMULA|Y||U||1|Visit_1|10|4|TREATMENT|2020-08-11|2020-09-01|10|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|59179734-8784-4a88-aa6b-51b6082ffc1b|3|GLUCPE|Plasma Equivalent Glucose|HEMATOLOGY|[?]|mm3/mm2/year|[?]|[?]|BORDERLINE|1|%(w/v)|1|1|[?]|HIGH|TUMOR TISSUE|NON-HEMOLYZED||MRI|FIBROTEST FORMULA||Y|N||2|Visit_2|25|4|FOLLOW-UP|2020-08-26|2020-10-25|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|59179734-8784-4a88-aa6b-51b6082ffc1b|4|HALBAB|Human Albumin Antibody|CHEMISTRY|[?]|MHz|[?]|[?]|INVALID|1|LB|1|1|[?]|LOW|PLATELET POOR PLASMA|CONCENTRATED||HEMATOXYLIN AND EOSIN STAIN|ASH FIBROSURE FORMULA||Y|NA||2|Visit_2|25|6|SCREENING|2020-08-26|2020-09-23|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|59179734-8784-4a88-aa6b-51b6082ffc1b|5|OXYSAT|Oxygen Saturation|URINALYSIS|[?]|ugEq|[?]|[?]|NEGATIVE|1|ms/mmHg|1|1|[?]|HIGH|PUS|CONTAMINATED||MS/MS|FIBROMETER FORMULA|||N||3|Visit_3|40|1|SCREENING|2020-09-10|2020-09-15|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|59179734-8784-4a88-aa6b-51b6082ffc1b|6|MENGL|Meningeal Cells|HEMATOLOGY|||[?]|[?]|TRACE|1|ng/L|1|1|[?]|NORMAL|LYSATE|ROOM TEMPERATURE||GC/MS-EI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|3|Visit_3|40|3|TREATMENT|2020-09-10|2020-09-24|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|59179734-8784-4a88-aa6b-51b6082ffc1b|7|NEUT|Neutrophils|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Pack Year|1|1|[?]|NORMAL|CALCULUS|THAWED||MICRO BROTH DILUTION|MDRD ENZYMATIC JAPANESE FORMULA|||Y|Y|4|Visit_4|65|3|TREATMENT|2020-10-05|2020-10-23|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|59179734-8784-4a88-aa6b-51b6082ffc1b|8|C165937|Zea mays IgE AB RAST Score|CHEMISTRY|[?]|Antibody Unit|[?]|[?]|TRACE|1|dpm/mL|1|1|[?]|LOW|CEREBROSPINAL FLUID|FROZEN||MS/MS|FIBROMETER FORMULA|||NA||4|Visit_4|65|4|WASHOUT|2020-10-05|2020-11-01|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|59179734-8784-4a88-aa6b-51b6082ffc1b|9|HGBFPATN|Hemoglobin Fraction Pattern|URINALYSIS|[?]|cm/s|[?]|[?]|TRACE|1|DIP|1|1|[?]|ABNORMAL|SPUTUM|ICTERIC||NEXT GENERATION SEQUENCING|CKD-EPI CREATININE FORMULA||Y|N||5|Visit_5|90|4|FOLLOW-UP|2020-10-30|2020-11-02|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|59179734-8784-4a88-aa6b-51b6082ffc1b|10|ALPLS|Liver Specific Alkaline Phosphatase|URINALYSIS|[?]|MAC50|[?]|[?]|POSITIVE|1|ukat/L|1|1|[?]|ABNORMAL|SERUM OR PLASMA|LIPEMIC||ACID FAST STAIN|FIBROTEST FORMULA|||NA||5|Visit_5|90|3|WASHOUT|2020-10-30|2020-11-07|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|1|CARNITAT|Carnitine Acetyl Transferase|CHEMISTRY|[?]|mL/animal/day|[?]|[?]|TRACE|1|sec|1|1|[?]|NORMAL|BREAST MILK|GELLED||QUANTITATIVE COMPUTED TOMOGRAPHY|CKD-EPI CREATININE FORMULA|Y||Y||1|Visit_1|10|5|TREATMENT|2020-08-22|2020-09-14|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|2|T4FRIDX|Thyroxine, Free Index|URINALYSIS|[?]|uL/dose|[?]|[?]|INDETERMINATE|1|F|1|1|[?]|NORMAL|SEBUM|THAWED||DIGITAL PCR ARRAY|NASH FIBROSURE FORMULA||Y|N||1|Visit_1|10|7|WASHOUT|2020-08-22|2020-09-02|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|3|PPA|Phenylpropanolamine|CHEMISTRY|[?]|mIU/L|[?]|[?]|INDETERMINATE|1|TAMPON|1|1|[?]|HIGH|ARTERIAL BLOOD|CLOTTED||ELECTRICAL IMPEDANCE MYOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||U||2|Visit_2|25|3|WASHOUT|2020-09-06|2020-10-29|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|4|HEPCIDIN|Hepcidin|CHEMISTRY|[?]|CAPSULE|[?]|[?]|BORDERLINE|1|Gy/h|1|1|[?]|NORMAL|REFLEX TEAR|CONTAMINATED|N|PERIPHERAL ANGIOGRAPHY|MDRD ENZYMATIC FORMULA|Y||NA||2|Visit_2|25|7|TREATMENT|2020-09-06|2020-09-30|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|5|ANIONG3|Anion Gap 3|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^5/hpf|1|1|[?]|LOW|ADIPOSE TISSUE|DRIED|N|STRESS ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|3|Visit_3|40|5|TREATMENT|2020-09-21|2020-10-14|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|6|ANGPT1|Angiopoietin 1|HEMATOLOGY|[?]|/10^4|[?]|[?]|INVALID|1|PFU/dose|1|1|[?]|ABNORMAL|URINE|ROOM TEMPERATURE|N|ELECTRONEUROGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-09-21|2020-09-29|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|7|IFI44|Interferon-Induced Protein 44|URINALYSIS|[?]|cd*s/m2|[?]|[?]|POSITIVE|1|mg/m2/day|1|1|[?]|LOW|BILE|DRIED||WHOLE TRANSCRIPTOME SEQUENCING|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2020-10-16|2020-11-09|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|8|ANGTNS2|Angiotensin II|HEMATOLOGY|[?]|INHALATION|[?]|[?]|TRACE|1|lx|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|DRIED|N|PET/CT SCAN WITHOUT CONTRAST|GMI % FORMULA||Y|N||4|Visit_4|65|3|TREATMENT|2020-10-16|2020-11-03|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|9|C165939|Egg White IgE AB RAST Score|CHEMISTRY|[?]|mg/m2/day|[?]|[?]|INDETERMINATE|1|PHERESIS UNIT|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|LACTESCENT||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|1|TREATMENT|2020-11-10|2020-11-16|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|10|PYK|Pyruvate Kinase|URINALYSIS|||[?]|[?]|INDETERMINATE|1|SYRINGE|1|1|[?]|LOW|BREAST MILK|CLOTTED||PAP STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|5|Visit_5|90|7|FOLLOW-UP|2020-11-10|2020-11-14|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|01c642f8-48ef-4375-aa2b-d0940b74e580|1|CD5|CD5|URINALYSIS|[?]|ks|[?]|[?]|TRACE|1|rpm|1|1|[?]|ABNORMAL|SERUM|UNEXPECTED ODOR|N|PELLI-ROBSON EYE CHART|FIBROMETER FORMULA|||Y||1|Visit_1|10|5|FOLLOW-UP|2020-09-19|2020-10-23|10|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|01c642f8-48ef-4375-aa2b-d0940b74e580|2|GNRH|Gonadotropin Releasing Hormone|CHEMISTRY|[?]|mm2|[?]|[?]|INVALID|1|AMPULE|1|1|[?]|ABNORMAL|URINE SEDIMENT|LIPEMIC||SPIRAL CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|3|WASHOUT|2020-09-19|2020-10-26|10|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|01c642f8-48ef-4375-aa2b-d0940b74e580|3|APLIGGAB|Anti-Phospholipid IgG Antibody|URINALYSIS|[?]|cpm|[?]|[?]|POSITIVE|1|TUBE|1|1|[?]|LOW|BASAL TEAR|GELLED||ACCELERATOR MASS SPECTROMETRY|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2020-10-04|2020-11-21|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|01c642f8-48ef-4375-aa2b-d0940b74e580|4|ERCENC|Erythroid Cells/Nucleated Cells|HEMATOLOGY|[?]|uCi/L|[?]|[?]|NEGATIVE|1|GBq|1|1|[?]|ABNORMAL|SEMINAL FLUID|ROOM TEMPERATURE||CHROMATOGRAPHY|GMI % FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-10-04|2020-10-17|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|01c642f8-48ef-4375-aa2b-d0940b74e580|5|NSE|Neuron Specific Enolase|HEMATOLOGY|[?]|10^4/L|[?]|[?]|TRACE|1|mEq/kg|1|1|[?]|ABNORMAL|SERUM OR PLASMA|GELLED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD FORMULA|Y||Y||3|Visit_3|40|4|TREATMENT|2020-10-19|2020-10-20|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|01c642f8-48ef-4375-aa2b-d0940b74e580|6|FACTIXA|Factor IX Activity|CHEMISTRY|[?]|QUANTITY SUFFICIENT|[?]|[?]|NEGATIVE|1|vg/kg|1|1|[?]|NORMAL|ABSCESS FLUID|LACTESCENT||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|MDRD ENZYMATIC FORMULA|Y||NA||3|Visit_3|40|5|WASHOUT|2020-10-19|2020-11-02|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|01c642f8-48ef-4375-aa2b-d0940b74e580|7|HOMOCIT|Homocitrulline|URINALYSIS|||[?]|[?]|INDETERMINATE|1|kg|1|1|[?]|NORMAL|LUNG SURFACTANT|LIPEMIC||IMPULSE OSCILLOMETRY|MDRD 4 VARIABLE FORMULA|||N|Y|4|Visit_4|65|6|WASHOUT|2020-11-13|2020-12-05|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|01c642f8-48ef-4375-aa2b-d0940b74e580|8|ALTCPHRL|Alpha Tocopherol|CHEMISTRY|[?]|Sv|[?]|[?]|INVALID|1|usec|1|1|[?]|NORMAL|DIALYSIS FLUID|SOLIDIFIED||HANSEL STAIN|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|1|TREATMENT|2020-11-13|2020-12-07|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|01c642f8-48ef-4375-aa2b-d0940b74e580|9|CLCREAT|Chloride/Creatinine|URINALYSIS|[?]|mmol/kg|[?]|[?]|POSITIVE|1|EP U|1|1|[?]|LOW|RETICULOCYTES|AGGLUTINATED||ELISA|CKD-EPI FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2020-12-08|2020-12-15|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|01c642f8-48ef-4375-aa2b-d0940b74e580|10|C3B|Complement C3b|HEMATOLOGY|[?]|mg/kg/dose|[?]|[?]|BORDERLINE|1|cs|1|1|[?]|ABNORMAL|ALVEOLAR AIR|PARAFFIN-EMBEDDED|N|MALDI-TOF|HEPASCORE FORMULA|||NA||5|Visit_5|90|5|SCREENING|2020-12-08|2020-12-09|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|c0e7028c-6f5c-410a-afde-e56af2177983|1|GLP1IAC|Glucagon-Like Peptide-1, Inactive Form|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^6/g|1|1|[?]|ABNORMAL|EXUDATE|LACTESCENT||PALPATION|FIBROSIS 4 FORMULA|||N|Y|1|Visit_1|10|5|SCREENING|2020-07-06|2020-09-12|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|c0e7028c-6f5c-410a-afde-e56af2177983|2|LYMPHOTC|Lymphotactin|HEMATOLOGY|[?]|ug/m2|[?]|[?]|INVALID|1|in|1|1|[?]|HIGH|NAIL|FROZEN||PERIPHERAL ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||1|Visit_1|10|2|WASHOUT|2020-07-06|2020-08-21|10|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|c0e7028c-6f5c-410a-afde-e56af2177983|3|CCL18|Chemokine (C-C Motif) Ligand 18|URINALYSIS|[?]|copies/uL|[?]|[?]|BORDERLINE|1|10^6 organisms/g|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|AUTOLYZED||PHYSICAL EXAMINATION|FIBROSIS 4 FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-07-21|2020-08-29|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|c0e7028c-6f5c-410a-afde-e56af2177983|4|LAM|Lipoarabinomannan|URINALYSIS|[?]|U/mmol|[?]|[?]|BORDERLINE|1|ukat/L|1|1|[?]|LOW|EPITHELIAL CELL|HEMOLYZED||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CREATININE FORMULA|||U||2|Visit_2|25|6|TREATMENT|2020-07-21|2020-09-30|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|c0e7028c-6f5c-410a-afde-e56af2177983|5|CACRTP|Calcium Corrected for Total Protein|CHEMISTRY|[?]|g/animal/wk|[?]|[?]|INVALID|1|CCID 50/dose|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|HEMOLYZED||RULER MEASUREMENT METHOD|ASH FIBROSURE FORMULA|Y||Y||3|Visit_3|40|6|SCREENING|2020-08-05|2020-08-27|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|c0e7028c-6f5c-410a-afde-e56af2177983|6|RBP|Retinol Binding Protein|URINALYSIS|||[?]|[?]|INDETERMINATE|1|10^3 organisms/mL|1|1|[?]|HIGH|INTERSTITIAL FLUID|NON-HEMOLYZED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD FORMULA|||N|Y|3|Visit_3|40|2|TREATMENT|2020-08-05|2020-08-22|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|c0e7028c-6f5c-410a-afde-e56af2177983|7|CABOT|Cabot Rings|CHEMISTRY|[?]|yd|[?]|[?]|NEGATIVE|1|EP U|1|1|[?]|NORMAL|SERUM|GELLED||QUANTITATIVE ULTRASOUND|MDRD FORMULA||Y|NA||4|Visit_4|65|3|TREATMENT|2020-08-30|2020-09-06|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|c0e7028c-6f5c-410a-afde-e56af2177983|8|ACANT|Acanthocytes|CHEMISTRY|[?]|Absorbance U|[?]|[?]|BORDERLINE|1|Ci|1|1|[?]|LOW|RETICULOCYTES|ICTERIC||CONTRAST ENHANCED X-RAY|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|6|WASHOUT|2020-08-30|2020-09-01|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|c0e7028c-6f5c-410a-afde-e56af2177983|9|KEXR|Potassium Excretion Rate|URINALYSIS|[?]|cGy|[?]|[?]|POSITIVE|1|10^8/L|1|1|[?]|HIGH|MENSTRUAL BLOOD|NON-HEMOLYZED||MS/MS|FIBROTEST FORMULA||Y|U||5|Visit_5|90|1|FOLLOW-UP|2020-09-24|2020-10-03|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|c0e7028c-6f5c-410a-afde-e56af2177983|10|C165919|German Cockroach IgG AB RAST Score|HEMATOLOGY|[?]|mg/dL|[?]|[?]|BORDERLINE|1|ft3|1|1|[?]|HIGH|RETICULOCYTES|FRESH||SIZE EXCLUSION CHROMATOGRAPHY|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|3|TREATMENT|2020-09-24|2020-09-28|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|eba928ed-9434-4e75-b49d-169298f966e1|1|TTGIGGAB|Tissue Transglutaminase IgG Antibody|HEMATOLOGY|[?]|mg/g/min|[?]|[?]|NEGATIVE|1|uIU/L|1|1|[?]|ABNORMAL|PLEURAL TISSUE|FROZEN|N|CONFOCAL MICROSCOPY|COCKCROFT-GAULT FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-08-12|2020-08-29|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|eba928ed-9434-4e75-b49d-169298f966e1|2|INTLK19|Interleukin 19|HEMATOLOGY|[?]|/40 HPFs|[?]|[?]|INDETERMINATE|1|10^6 CFU|1|1|[?]|NORMAL|EMESIS|REFRIGERATED|N|ERGOSPIROMETRY|MDRD 5 VARIABLE FORMULA|Y|Y|Y||1|Visit_1|10|7|TREATMENT|2020-08-12|2020-11-07|10|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|eba928ed-9434-4e75-b49d-169298f966e1|3|UNSPCELE|Unspecified Cells/Leukocytes|CHEMISTRY|[?]|U|[?]|[?]|BORDERLINE|1|fmol/g|1|1|[?]|NORMAL|INFRANATANT, PLASMA|ROOM TEMPERATURE||OPTICAL MAPPING|ASH FIBROSURE FORMULA|||U||2|Visit_2|25|6|SCREENING|2020-08-27|2020-10-20|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|eba928ed-9434-4e75-b49d-169298f966e1|4|RETIH|High Absorption Reticulocytes|HEMATOLOGY|[?]|MHz|[?]|[?]|INDETERMINATE|1|BP|1|1|[?]|HIGH|DIALYSIS FLUID|PARAFFIN-EMBEDDED||ELASTOGRAPHY|MDRD 5 VARIABLE FORMULA|Y|Y|Y||2|Visit_2|25|3|WASHOUT|2020-08-27|2020-10-15|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|eba928ed-9434-4e75-b49d-169298f966e1|5|BUCHE|Butyrylcholinesterase|HEMATOLOGY|[?]|mol/g|[?]|[?]|POSITIVE|1|L/s/kPa|1|1|[?]|ABNORMAL|ALVEOLAR AIR|CALCIFIED|N|KINETIC MICROPARTICLE IMMUNOASSAY|FIBROMETER FORMULA|||N||3|Visit_3|40|4|WASHOUT|2020-09-11|2020-10-26|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|eba928ed-9434-4e75-b49d-169298f966e1|6|PROLYM|Prolymphocytes|CHEMISTRY|[?]|L/h|[?]|[?]|POSITIVE|1|umol/L/sec|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|GELLED||LC/MS|MDRD 5 VARIABLE FORMULA|||U||3|Visit_3|40|4|WASHOUT|2020-09-11|2020-10-16|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|eba928ed-9434-4e75-b49d-169298f966e1|7|TGFB|Transforming Growth Factor Beta|URINALYSIS|||[?]|[?]|BORDERLINE|1|s^-1(%O2)^-1|1|1|[?]|NORMAL|DISCHARGE|ICTERIC||DIFFUSION WEIGHTED MRI|MDRD FORMULA||Y|Y|Y|4|Visit_4|65|6|FOLLOW-UP|2020-10-06|2020-10-15|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|eba928ed-9434-4e75-b49d-169298f966e1|8|C165936|Glycine max IgE AB RAST Score|CHEMISTRY|[?]|DISK|[?]|[?]|INDETERMINATE|1|oz eq|1|1|[?]|HIGH|ALVEOLAR AIR|AGGLUTINATED|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|1|TREATMENT|2020-10-06|2020-11-05|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|eba928ed-9434-4e75-b49d-169298f966e1|9|ABOA1|ABO A1 Subtype|URINALYSIS|[?]|CIGAR|[?]|[?]|NEGATIVE|1|/LSQN|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR||KLEIHAUER-BETKE|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||5|Visit_5|90|7|SCREENING|2020-10-31|2020-11-04|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|eba928ed-9434-4e75-b49d-169298f966e1|10|C147276|Arachis hypogaea Antigen IgE Antibody|HEMATOLOGY|[?]|g/L|[?]|[?]|INDETERMINATE|1|pkat/L|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|UNEXPECTED ODOR|N|TRYPAN BLUE STAIN|CKD-EPI CYSTATIN C FORMULA||Y|U||5|Visit_5|90|4|WASHOUT|2020-10-31|2020-11-02|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|4772aa80-2097-4867-a549-b6f9b140f141|1|GSTALCRT|Glutathione S-Transferase, Alpha/Creat|CHEMISTRY|||[?]|[?]|INVALID|1|nmol/g|1|1|[?]|HIGH|SWABBED MATERIAL|CALCIFIED||DIGITAL PCR ARRAY|MDRD 4 VARIABLE FORMULA|||N|Y|1|Visit_1|10|6|SCREENING|2020-07-12|2020-09-21|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|4772aa80-2097-4867-a549-b6f9b140f141|2|PLAGGCVT|Platelet Aggregation Curve Type|URINALYSIS|||[?]|[?]|NEGATIVE|1|VOXEL|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|CLOTTED||CLIP|MDRD FORMULA|Y|Y|Y|Y|1|Visit_1|10|3|SCREENING|2020-07-12|2020-09-06|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|4772aa80-2097-4867-a549-b6f9b140f141|3|DIHYDCDN|Dihydrocodeine|HEMATOLOGY|[?]|mol/L|[?]|[?]|BORDERLINE|1|mol/g|1|1|[?]|LOW|EPITHELIAL CELL|FRESH||CRYOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|6|TREATMENT|2020-07-27|2020-09-29|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|4772aa80-2097-4867-a549-b6f9b140f141|4|KRCYMGLE|Megakaryocytes/Leukocytes|URINALYSIS|[?]|g/mol|[?]|[?]|INVALID|1|mU/g|1|1|[?]|LOW|SERUM OR PLASMA|ICTERIC||TRANSMISSION ELECTRON MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-07-27|2020-08-15|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|4772aa80-2097-4867-a549-b6f9b140f141|5|C3B|Complement C3b|URINALYSIS|[?]|NFIU|[?]|[?]|BORDERLINE|1|IU/dL|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|DRIED||RAJI CELL EIA|MDRD ENZYMATIC FORMULA||Y|U||3|Visit_3|40|2|TREATMENT|2020-08-11|2020-09-26|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|4772aa80-2097-4867-a549-b6f9b140f141|6|SULFATE|Sulfate|URINALYSIS|[?]|10^6 CFU/g|[?]|[?]|INDETERMINATE|1|Shock Wave|1|1|[?]|NORMAL|NAIL|LACTESCENT|N|PERFUSION MRI|MDRD FORMULA|Y|Y|N||3|Visit_3|40|4|TREATMENT|2020-08-11|2020-08-15|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|4772aa80-2097-4867-a549-b6f9b140f141|7|CALPRO|Calprotectin|URINALYSIS|[?]|mEq/uL|[?]|[?]|TRACE|1|mEq/dL|1|1|[?]|HIGH|COLOSTRUM|PARAFFIN-EMBEDDED||OLIGO ACGH|CKD-EPI CREATININE FORMULA|Y||NA||4|Visit_4|65|7|TREATMENT|2020-09-05|2020-09-26|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|4772aa80-2097-4867-a549-b6f9b140f141|8|G6PD|Glucose-6-Phosphate Dehydrogenase|URINALYSIS|[?]|steps/min|[?]|[?]|BORDERLINE|1|Gy/h|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|THAWED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|NASH FIBROSURE FORMULA|Y||N||4|Visit_4|65|5|SCREENING|2020-09-05|2020-09-16|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|4772aa80-2097-4867-a549-b6f9b140f141|9|DOPAC|3,4-Dihydroxyphenylacetic Acid|HEMATOLOGY|[?]|U/kg|[?]|[?]|INVALID|1|L/min|1|1|[?]|LOW|GASTRIC FLUID|CONTAMINATED||RULER MEASUREMENT METHOD|HEPASCORE FORMULA|||Y||5|Visit_5|90|5|TREATMENT|2020-09-30|2020-10-05|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|4772aa80-2097-4867-a549-b6f9b140f141|10|HAMAB|Human Anti-Mouse Antibody|CHEMISTRY|[?]|uL/mL|[?]|[?]|INVALID|1|Ci/mg|1|1|[?]|NORMAL|LAVAGE FLUID|CONTAMINATED||CISH|FIBROTEST FORMULA|||NA||5|Visit_5|90|2|FOLLOW-UP|2020-09-30|2020-10-06|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|1|KETONEBD|Ketone Bodies|CHEMISTRY|[?]|10^6 organisms|[?]|[?]|INVALID|1|genEq/mL|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|HEMOLYZED||TARGETED GENOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||1|Visit_1|10|7|WASHOUT|2020-06-07|2020-07-13|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|LB|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|2|MACROCY|Macrocytes|HEMATOLOGY|||[?]|[?]|POSITIVE|1|copies/mL|1|1|[?]|HIGH|TISSUE|CONCENTRATED|N|TARGETED TRANSCRIPTOME SEQUENCING|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|1|Visit_1|10|1|SCREENING|2020-06-07|2020-07-17|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|LB|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|3|PCSK9|Proprotein Convertase Subtilisin/Kexin 9|CHEMISTRY|[?]|mm/min|[?]|[?]|INDETERMINATE|1|BAR|1|1|[?]|NORMAL|MUSCLE TISSUE|GELLED||DYNAMIC LIGHT SCATTERING|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|5|WASHOUT|2020-06-22|2020-08-25|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|4|HGBC|Hemoglobin C|CHEMISTRY|||[?]|[?]|NEGATIVE|1|ms2|1|1|[?]|NORMAL|SALIVA|AUTOLYZED||CALCULATION|CKD-EPI CREATININE FORMULA||Y|N|Y|2|Visit_2|25|4|SCREENING|2020-06-22|2020-07-22|25|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|5|MCV|Ery. Mean Corpuscular Volume|URINALYSIS|||[?]|[?]|INVALID|1|s/h|1|1|[?]|ABNORMAL|BILE|LACTESCENT||LASER CAPTURE MICRODISSECTION|MDRD FORMULA|||U|Y|3|Visit_3|40|2|TREATMENT|2020-07-07|2020-08-18|40|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|6|ALP|Alkaline Phosphatase|URINALYSIS|[?]|tsp eq|[?]|[?]|INVALID|1|cGy|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|ICTERIC||ULTRASOUND|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|2|FOLLOW-UP|2020-07-07|2020-09-01|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|7|CRH|Corticotropin Releasing Hormone|URINALYSIS|||[?]|[?]|POSITIVE|1|SFC/10^6 PBMC|1|1|[?]|ABNORMAL|SALIVA|HEMOLYZED||LC-FL|NASH FIBROSURE FORMULA|Y||Y|Y|4|Visit_4|65|7|SCREENING|2020-08-01|2020-08-28|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|8|EOSLE|Eosinophils/Leukocytes|URINALYSIS|[?]|ms2|[?]|[?]|POSITIVE|1|Joule|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CONTAMINATED||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD FORMULA||Y|N||4|Visit_4|65|4|TREATMENT|2020-08-01|2020-08-21|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|9|TRP|Tryptophan|CHEMISTRY|[?]|kcal/day|[?]|[?]|INVALID|1|ng/day|1|1|[?]|NORMAL|CAPILLARY BLOOD|DRIED|N|KINETIC CHROMOGENIC ASSAY|NASH FIBROSURE FORMULA|Y||NA||5|Visit_5|90|5|TREATMENT|2020-08-26|2020-09-01|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|10|C130139|American Cockroach Antigen IgG4 Antibody|CHEMISTRY|[?]|V|[?]|[?]|POSITIVE|1|Absorbance U|1|1|[?]|HIGH|LEUKOCYTE|CONTAMINATED||MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD FORMULA||Y|Y||5|Visit_5|90|4|WASHOUT|2020-08-26|2020-08-29|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|4d8dd0d0-407d-4374-8345-c11f30603273|1|CYDCPHOS|Dicalcium Phosphate Crystals|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|s*kPa|1|1|[?]|LOW|PUS|CLOTTED|N|CONTRAST ENHANCED X-RAY|CKD-EPI CREATININE FORMULA|Y||Y|Y|1|Visit_1|10|6|TREATMENT|2021-01-01|2021-03-27|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|4d8dd0d0-407d-4374-8345-c11f30603273|2|FBNCTPL|Fibronectin, Plasma|HEMATOLOGY|[?]|umol/L|[?]|[?]|POSITIVE|1|Ci/kg|1|1|[?]|ABNORMAL|DIALYSIS FLUID|GELLED||ENDPOINT DILUTION ASSAY|MDRD ENZYMATIC FORMULA|||Y||1|Visit_1|10|4|WASHOUT|2021-01-01|2021-02-28|10|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|4d8dd0d0-407d-4374-8345-c11f30603273|3|GFRBSCCC|GFR from Cystatin C and Creat Adj BSA|HEMATOLOGY|[?]|IU|[?]|[?]|POSITIVE|1|IU/day|1|1|[?]|ABNORMAL|ISOLATE|SOLIDIFIED||TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA|Y||N||2|Visit_2|25|3|TREATMENT|2021-01-16|2021-01-23|25|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|4d8dd0d0-407d-4374-8345-c11f30603273|4|CA72_4AG|Cancer Antigen 72-4|URINALYSIS|||[?]|[?]|BORDERLINE|1|BOLUS|1|1|[?]|ABNORMAL|FLUID|FRESH|N|LAPAROSCOPY|NASH FIBROSURE FORMULA|Y|Y|U|Y|2|Visit_2|25|6|TREATMENT|2021-01-16|2021-02-10|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|4d8dd0d0-407d-4374-8345-c11f30603273|5|NEUTBNE|Neutrophils Band Form/ Neutrophils|CHEMISTRY|[?]|mL/cage|[?]|[?]|INDETERMINATE|1|Rad|1|1|[?]|ABNORMAL|PLATELET|LIPEMIC||CONTRAST ENHANCED SPIRAL CT SCAN|FIBROMETER FORMULA|Y|Y|U||3|Visit_3|40|7|WASHOUT|2021-01-31|2021-03-18|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|4d8dd0d0-407d-4374-8345-c11f30603273|6|CYAMMOX|Ammonium Oxalate Crystals|HEMATOLOGY|[?]|mL/breath|[?]|[?]|INVALID|1|pg|1|1|[?]|LOW|CEREBROSPINAL FLUID|SOLIDIFIED||SINGLE-SLICE SPIRAL CT|GMI MMOL/MOL FORMULA||Y|N||3|Visit_3|40|4|TREATMENT|2021-01-31|2021-02-16|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|4d8dd0d0-407d-4374-8345-c11f30603273|7|SCL70GAB|Scl-70 IgG Antibody|CHEMISTRY|||[?]|[?]|INVALID|1|STRIP|1|1|[?]|ABNORMAL|SEMINAL FLUID|AUTOLYZED||MODIFIED ACID FAST STAIN|CKD-EPI CYSTATIN C FORMULA|||NA|Y|4|Visit_4|65|2|FOLLOW-UP|2021-02-25|2021-03-10|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|LB|4d8dd0d0-407d-4374-8345-c11f30603273|8|HLZPM|Halazepam|CHEMISTRY|[?]|cm/s|[?]|[?]|POSITIVE|1|m3|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|FROZEN||ANGIOGRAPHY|FIBROSIS 4 FORMULA||Y|NA||4|Visit_4|65|7|TREATMENT|2021-02-25|2021-03-27|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|LB|4d8dd0d0-407d-4374-8345-c11f30603273|9|THMBAAC|Thrombin Activity Actual/Control|CHEMISTRY|[?]|g/cage/day|[?]|[?]|INVALID|1|pkat/L|1|1|[?]|HIGH|MUCUS|REFRIGERATED||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|1|FOLLOW-UP|2021-03-22|2021-03-31|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|4d8dd0d0-407d-4374-8345-c11f30603273|10|PBGCREAT|Porphobilinogen/Creatinine|HEMATOLOGY|[?]|mm/h|[?]|[?]|INVALID|1|MHz|1|1|[?]|HIGH|BASAL TEAR|THAWED||AUTOMATED COUNT|HEPASCORE FORMULA||Y|U||5|Visit_5|90|4|SCREENING|2021-03-22|2021-03-23|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|6996077b-556a-47b9-bbff-20c1b4df35ea|1|BTECERBC|Bite Cells/Erythrocytes|CHEMISTRY|[?]|mCi|[?]|[?]|INDETERMINATE|1|Ci/kg|1|1|[?]|ABNORMAL|ERYTHROCYTES|FROZEN||LISSAMINE GREEN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-06-08|2020-07-31|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|6996077b-556a-47b9-bbff-20c1b4df35ea|2|ASN|Asparagine|CHEMISTRY|[?]|nkat|[?]|[?]|INDETERMINATE|1|/day|1|1|[?]|LOW|CAPILLARY PLASMA|REFRIGERATED||DUCTOGRAPHY|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|5|WASHOUT|2020-06-08|2020-06-29|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|6996077b-556a-47b9-bbff-20c1b4df35ea|3|OXZPM|Oxazepam|HEMATOLOGY|[?]|/2500 WBC|[?]|[?]|TRACE|1|MdFI|1|1|[?]|NORMAL|PLATELET|ROOM TEMPERATURE||MICRONEUTRALIZATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||2|Visit_2|25|1|TREATMENT|2020-06-23|2020-07-16|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|6996077b-556a-47b9-bbff-20c1b4df35ea|4|SPWEIGHT|Specimen Weight|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|U/g/h|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|ICTERIC||INTRAVASCULAR ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|Y|2|Visit_2|25|6|WASHOUT|2020-06-23|2020-07-11|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|6996077b-556a-47b9-bbff-20c1b4df35ea|5|TRIGHDL|Triglycerides/HDL Cholesterol|HEMATOLOGY|[?]|IU/L|[?]|[?]|NEGATIVE|1|cmH2O*s2/mL|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|NON-HEMOLYZED|N|PHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-07-08|2020-08-14|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|6996077b-556a-47b9-bbff-20c1b4df35ea|6|LIPASLAL|Lipase, Lysosomal Acid|CHEMISTRY|[?]|mL/animal/wk|[?]|[?]|INVALID|1|BAU|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|FRESH||AUSCULTATION|FIBROTEST FORMULA|||U||3|Visit_3|40|3|SCREENING|2020-07-08|2020-08-06|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|6996077b-556a-47b9-bbff-20c1b4df35ea|7|HDLPSZ|HDL Particle Size|CHEMISTRY|[?]|s/h|[?]|[?]|TRACE|1|damol/L|1|1|[?]|NORMAL|SUPERNATANT, SERUM|THAWED||MODIFIED ACID FAST STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|7|SCREENING|2020-08-02|2020-08-21|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|6996077b-556a-47b9-bbff-20c1b4df35ea|8|HCGND|Choriogonadotropin|CHEMISTRY|[?]|U/L|[?]|[?]|INDETERMINATE|1|DRINK|1|1|[?]|LOW|CERUMEN|AUTOLYZED||HANSEL STAIN|NASH FIBROSURE FORMULA|Y||N||4|Visit_4|65|4|TREATMENT|2020-08-02|2020-08-31|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|6996077b-556a-47b9-bbff-20c1b4df35ea|9|C165912|Shellfish Mix IgG AB RAST Score|HEMATOLOGY|[?]|SFC/10^6 PBMC|[?]|[?]|BORDERLINE|1|ks|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|ICTERIC||WESTERN BLOT|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||5|Visit_5|90|1|FOLLOW-UP|2020-08-27|2020-08-28|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|6996077b-556a-47b9-bbff-20c1b4df35ea|10|CLCREAT|Chloride/Creatinine|CHEMISTRY|[?]|pg/L|[?]|[?]|INVALID|1|100 IU/mL|1|1|[?]|LOW|NAIL|LIPEMIC|N|MICROBIAL CULTURE, LIQUID|HEPASCORE FORMULA|||NA||5|Visit_5|90|2|SCREENING|2020-08-27|2020-08-28|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|d79d31c5-d51a-46a7-b22c-20d6d483f46e|1|C130114|Industrial Mix Antigen IgE Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|BEAM BREAKS|1|1|[?]|LOW|CIRCULATING TUMOR CELL|REFRIGERATED|N|MICROBIAL CULTURE, SOLID|FIBROMETER FORMULA|Y|Y|N|Y|1|Visit_1|10|7|TREATMENT|2020-10-23|2020-11-26|10|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|d79d31c5-d51a-46a7-b22c-20d6d483f46e|2|GRANIM|Immature Granulocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|LB|1|1|[?]|HIGH|AMNIOTIC FLUID|AUTOLYZED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA|||NA|Y|1|Visit_1|10|3|TREATMENT|2020-10-23|2021-01-03|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|d79d31c5-d51a-46a7-b22c-20d6d483f46e|3|CLRDZPXD|Chlordiazepoxide|HEMATOLOGY|[?]|/LPF|[?]|[?]|INDETERMINATE|1|mL/h|1|1|[?]|ABNORMAL|REFLEX TEAR|UNEXPECTED ODOR||PLETHYSMOGRAPHY|NASH FIBROSURE FORMULA|||NA||2|Visit_2|25|3|WASHOUT|2020-11-07|2020-12-29|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|d79d31c5-d51a-46a7-b22c-20d6d483f46e|4|C165927|Animal Mix IgE AB RAST Score|HEMATOLOGY|[?]|10^9 organisms/mL|[?]|[?]|TRACE|1|nkat/g Hb|1|1|[?]|HIGH|EMOTIONAL TEAR|LACTESCENT||RAJI CELL EIA|MDRD ENZYMATIC FORMULA||Y|Y||2|Visit_2|25|4|TREATMENT|2020-11-07|2021-01-04|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|d79d31c5-d51a-46a7-b22c-20d6d483f46e|5|DCCARNIT|Decanoylcarnitine|URINALYSIS|[?]|10^9 CFU|[?]|[?]|INDETERMINATE|1|K|1|1|[?]|LOW|TUMOR TISSUE|CONCENTRATED||STRESS ECHOCARDIOGRAPHY|CKD-EPI FORMULA|||N||3|Visit_3|40|7|FOLLOW-UP|2020-11-22|2021-01-08|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|d79d31c5-d51a-46a7-b22c-20d6d483f46e|6|ANCAB|Anti-Neutrophil Cytoplasmic Antibody|URINALYSIS|||[?]|[?]|INDETERMINATE|1|pkat/L|1|1|[?]|NORMAL|BLOOD|UNEXPECTED ODOR||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA|||NA|Y|3|Visit_3|40|2|WASHOUT|2020-11-22|2021-01-14|40|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|d79d31c5-d51a-46a7-b22c-20d6d483f46e|7|CHLMCRN|Chylomicrons|CHEMISTRY|[?]|mmAL|[?]|[?]|INDETERMINATE|1|IU/kg|1|1|[?]|HIGH|INFRANATANT, SERUM|DRIED||MICROBIAL CULTURE, LIQUID|GMI % FORMULA||Y|Y||4|Visit_4|65|1|SCREENING|2020-12-17|2021-01-04|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|d79d31c5-d51a-46a7-b22c-20d6d483f46e|8|ACH|Acetylcholine|CHEMISTRY|[?]|L/day|[?]|[?]|BORDERLINE|1|cm/s|1|1|[?]|LOW|DIALYSIS FLUID|UNEXPECTED ODOR|N|INFRARED SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-12-17|2021-01-01|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|d79d31c5-d51a-46a7-b22c-20d6d483f46e|9|VITB7|Vitamin B7|HEMATOLOGY|[?]|IU/kg/h|[?]|[?]|TRACE|1|nmol BCE/L|1|1|[?]|LOW|ADIPOSE TISSUE|CLOTTED|N|DIFFUSION WEIGHTED MRI|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|1|TREATMENT|2021-01-11|2021-01-16|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|d79d31c5-d51a-46a7-b22c-20d6d483f46e|10|NORMEEXR|Normetanephrine Excretion Rate|HEMATOLOGY|[?]|10^7 CFU/mL|[?]|[?]|POSITIVE|1|kDa|1|1|[?]|NORMAL|MUCUS|AUTOLYZED||MODIFIED ACID FAST STAIN|FIBROMETER FORMULA|||U||5|Visit_5|90|3|SCREENING|2021-01-11|2021-01-17|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|738d539e-a810-4207-8904-fc6a5d055424|1|PDGFAA|Platelet Derived Growth Factor IsoformAA|CHEMISTRY|[?]|mCi/kg|[?]|[?]|INVALID|1|nmol BCE/nmol|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|ROOM TEMPERATURE||PERIPHERAL ANGIOGRAPHY|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|2|SCREENING|2021-01-08|2021-03-29|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|738d539e-a810-4207-8904-fc6a5d055424|2|C130073|Birch Pollen IgA|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Bq/kg|1|1|[?]|NORMAL|GASTRIC FLUID|AGGLUTINATED||X-RAY|FIBROMETER FORMULA||Y|U|Y|1|Visit_1|10|2|WASHOUT|2021-01-08|2021-02-24|10|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|738d539e-a810-4207-8904-fc6a5d055424|3|VISC|Viscosity|CHEMISTRY|[?]|log10 PFU|[?]|[?]|BORDERLINE|1|PACK|1|1|[?]|HIGH|WHITE MATTER TISSUE|HEMOLYZED||ATOMIC ABSORPTION SPECTROMETRY|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|5|WASHOUT|2021-01-23|2021-01-31|25|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|738d539e-a810-4207-8904-fc6a5d055424|4|HIST4AB|Histone 4 Antibody|HEMATOLOGY|[?]|dL|[?]|[?]|INVALID|1|STEPS|1|1|[?]|HIGH|SKIN TISSUE|CONTAMINATED||FUNDUS PHOTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|6|TREATMENT|2021-01-23|2021-03-01|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|738d539e-a810-4207-8904-fc6a5d055424|5|HASIGEAB|Human Anti-Sheep IgE Antibody|CHEMISTRY|[?]|10^8 PFU|[?]|[?]|INVALID|1|mCi/kg|1|1|[?]|HIGH|CAPILLARY BLOOD|NON-HEMOLYZED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|FIBROTEST FORMULA||Y|U||3|Visit_3|40|7|SCREENING|2021-02-07|2021-03-05|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|738d539e-a810-4207-8904-fc6a5d055424|6|WDR26|WD Repeat-Containing Protein 26|CHEMISTRY|[?]|log10 TCID 50/uL|[?]|[?]|TRACE|1|mol/mg|1|1|[?]|ABNORMAL|EXPIRED AIR|LACTESCENT||INDIRECT IMMUNOFLUORESCENCE|HEPASCORE FORMULA|||NA||3|Visit_3|40|5|FOLLOW-UP|2021-02-07|2021-02-14|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|738d539e-a810-4207-8904-fc6a5d055424|7|TOXVAC|Toxic Vacuolation|URINALYSIS|[?]|LOZENGE|[?]|[?]|POSITIVE|1|MONTHS|1|1|[?]|LOW|LAVAGE FLUID|DRIED||PYROSEQUENCING|NASH FIBROSURE FORMULA|||U||4|Visit_4|65|2|TREATMENT|2021-03-04|2021-03-22|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|738d539e-a810-4207-8904-fc6a5d055424|8|CD40|CD40|HEMATOLOGY|[?]|10^4 CFU/mL|[?]|[?]|NEGATIVE|1|mEq|1|1|[?]|LOW|PLASMA|FROZEN|N|NEURAMINIDASE INHIBITION ASSAY|CKD-EPI CREATININE FORMULA|||U||4|Visit_4|65|4|SCREENING|2021-03-04|2021-04-04|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|738d539e-a810-4207-8904-fc6a5d055424|9|CHDW|Corpuscular HGB Conc Distribution Width|URINALYSIS|[?]|U/g/day|[?]|[?]|NEGATIVE|1|g/U|1|1|[?]|LOW|SERUM|AUTOLYZED|N|SXA SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2021-03-29|2021-03-30|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|738d539e-a810-4207-8904-fc6a5d055424|10|MKCMKBMP|Megakaryocyte and Megakaryoblast Morph|HEMATOLOGY|[?]|ug/m2|[?]|[?]|BORDERLINE|1|pL|1|1|[?]|NORMAL|HAIR|FRESH||ALCIAN BLUE STAIN|FIBROMETER FORMULA|||NA||5|Visit_5|90|1|FOLLOW-UP|2021-03-29|2021-04-04|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|1|IGGSYNRT|IgG Synthesis Rate|CHEMISTRY|||[?]|[?]|TRACE|1|umol/mol|1|1|[?]|NORMAL|ALVEOLAR AIR|CLOTTED||SEQUENCING|MDRD 4 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|4|TREATMENT|2020-08-11|2020-10-06|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|2|INHIBINB|Inhibin B|HEMATOLOGY|[?]|cm H2O|[?]|[?]|TRACE|1|kg/cm2|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|LACTESCENT||PALPATION|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|Y||1|Visit_1|10|7|TREATMENT|2020-08-11|2020-09-19|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|3|A1ANTRYP|Alpha-1 Antitrypsin|HEMATOLOGY|[?]|CARTRIDGE|[?]|[?]|NEGATIVE|1|BOX|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|AGGLUTINATED|N|ISHIHARA COLOR PLATES|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||2|Visit_2|25|7|WASHOUT|2020-08-26|2020-09-20|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|4|CYSTARCH|Starch Crystals|HEMATOLOGY|[?]|cm/s|[?]|[?]|NEGATIVE|1|10^7/L|1|1|[?]|NORMAL|SPERMATOZOON|UNEXPECTED ODOR||SPIRAL CT SCAN WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA|Y||Y||2|Visit_2|25|7|SCREENING|2020-08-26|2020-10-01|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|5|EPSTI1|Epithelial Stromal Interaction Protein 1|URINALYSIS|[?]|GPL U/mL|[?]|[?]|INDETERMINATE|1|% INHIBITION|1|1|[?]|LOW|TUMOR TISSUE|LACTESCENT||DIGITAL PCR ARRAY|MDRD 5 VARIABLE FORMULA|Y|Y|U||3|Visit_3|40|6|SCREENING|2020-09-10|2020-09-24|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|6|OLIGBAND|Oligoclonal Bands|CHEMISTRY|[?]|SACHET|[?]|[?]|INDETERMINATE|1|um2|1|1|[?]|NORMAL|ERYTHROCYTES|REFRIGERATED||HANSEL STAIN|FIBROTEST FORMULA||Y|Y||3|Visit_3|40|1|TREATMENT|2020-09-10|2020-10-16|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|7|OSM|Oncostatin M|CHEMISTRY|||[?]|[?]|BORDERLINE|1|pm|1|1|[?]|NORMAL|INFRANATANT, PLASMA|AGGLUTINATED||IMMUNOTURBIDIMETRY|FIBROTEST FORMULA|||N|Y|4|Visit_4|65|2|TREATMENT|2020-10-05|2020-10-23|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|8|TROPONT|Troponin T|URINALYSIS|[?]|mL/h|[?]|[?]|TRACE|1|mL/kg/day|1|1|[?]|ABNORMAL|VENOUS BLOOD|LIPEMIC|N|OPTICAL COHERENCE TOMOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-10-05|2020-11-08|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|9|EOSLE|Eosinophils/Leukocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|10^6 CFU/mL|1|1|[?]|HIGH|LYMPH|SOLIDIFIED||ELECTRONEUROGRAPHY|FIBROSIS 4 FORMULA|Y||NA|Y|5|Visit_5|90|6|WASHOUT|2020-10-30|2020-11-06|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|10|SPWEIGHT|Specimen Weight|URINALYSIS|||[?]|[?]|BORDERLINE|1|Tesla|1|1|[?]|NORMAL|LAVAGE FLUID|ROOM TEMPERATURE||ELECTRICAL IMPEDANCE MYOGRAPHY|CKD-EPI FORMULA|||Y|Y|5|Visit_5|90|3|WASHOUT|2020-10-30|2020-11-05|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|20841d37-0444-4d1d-b934-1e805cdacdaf|1|CD4|CD4|HEMATOLOGY|[?]|mkat|[?]|[?]|BORDERLINE|1|ug/dose|1|1|[?]|NORMAL|EPIDERMAL TISSUE|AUTOLYZED||SPIRAL CT|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|4|SCREENING|2020-11-22|2021-01-23|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|20841d37-0444-4d1d-b934-1e805cdacdaf|2|HAMAB|Human Anti-Mouse Antibody|URINALYSIS|[?]|kN/cm2|[?]|[?]|INVALID|1|kg/L|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED||DC SHEATH FLOW|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-11-22|2020-12-10|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|20841d37-0444-4d1d-b934-1e805cdacdaf|3|PCDW|Platelet Component Distribution Width|HEMATOLOGY|[?]|MASK|[?]|[?]|POSITIVE|1|mg/kg/dose|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|FIBROTEST FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-12-07|2021-02-08|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|20841d37-0444-4d1d-b934-1e805cdacdaf|4|TRIGHDL|Triglycerides/HDL Cholesterol|CHEMISTRY|[?]|kg|[?]|[?]|NEGATIVE|1|mL/cage|1|1|[?]|ABNORMAL|CALCULUS|HEMOLYZED|N|FREEZING POINT DEPRESSION|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-12-07|2021-01-12|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|20841d37-0444-4d1d-b934-1e805cdacdaf|5|C165878|German Cockroach IgE AB RAST Score|CHEMISTRY|||[?]|[?]|POSITIVE|1|damol/L|1|1|[?]|HIGH|CEREBROSPINAL FLUID|DRIED||FLUORESCEIN STAIN|GMI % FORMULA|||U|Y|3|Visit_3|40|5|TREATMENT|2020-12-22|2020-12-29|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|20841d37-0444-4d1d-b934-1e805cdacdaf|6|CITRTEXR|Citrate Excretion Rate|HEMATOLOGY|[?]|10^3 organisms/g|[?]|[?]|INVALID|1|CUP|1|1|[?]|HIGH|BONE MARROW|LIPEMIC||SINGLE-MOLECULE ARRAY|FIBROMETER FORMULA||Y|NA||3|Visit_3|40|5|SCREENING|2020-12-22|2021-01-17|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|20841d37-0444-4d1d-b934-1e805cdacdaf|7|IOHEXCLR|Iohexol Clearance|HEMATOLOGY|||[?]|[?]|POSITIVE|1|cmol/L|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|FRESH|N|SINGLE-MOLECULE ARRAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|N|Y|4|Visit_4|65|1|SCREENING|2021-01-16|2021-01-19|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|20841d37-0444-4d1d-b934-1e805cdacdaf|8|ANDSTNDN|Androstenedione|CHEMISTRY|||[?]|[?]|BORDERLINE|1|fmol|1|1|[?]|LOW|TUMOR TISSUE|NON-HEMOLYZED|N|STATIC PERIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|4|Visit_4|65|3|TREATMENT|2021-01-16|2021-02-05|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|20841d37-0444-4d1d-b934-1e805cdacdaf|9|TGLOBRR|Thyroglobulin Recovery Rate|HEMATOLOGY|[?]|log10 CFU/g|[?]|[?]|NEGATIVE|1|nmol/day|1|1|[?]|LOW|LOCHIA|LACTESCENT||ICP-MS|FIBROTEST FORMULA||Y|U||5|Visit_5|90|3|SCREENING|2021-02-10|2021-02-18|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|LB|20841d37-0444-4d1d-b934-1e805cdacdaf|10|PROC6|Pro-C6|CHEMISTRY|||[?]|[?]|INVALID|1|Torr|1|1|[?]|LOW|CALCULUS|UNEXPECTED ODOR||CT SCAN|MDRD FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2021-02-10|2021-02-15|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|LB|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|1|FACTII|Factor II|CHEMISTRY|[?]|/2000 RBC|[?]|[?]|NEGATIVE|1|U/g/day|1|1|[?]|ABNORMAL|MUSCLE TISSUE|DRIED|N|ENDOSCOPY|CKD-EPI CYSTATIN C FORMULA|Y||Y||1|Visit_1|10|3|TREATMENT|2020-11-01|2020-12-25|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|2|SECRETIN|Secretin|HEMATOLOGY|[?]|PNU/mL|[?]|[?]|INDETERMINATE|1|ug/m2/day|1|1|[?]|ABNORMAL|BONE MARROW|AUTOLYZED||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|FIBROTEST FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-11-01|2020-12-03|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|3|FEMG|Fractional Magnesium Excretion|URINALYSIS|[?]|IU/kg|[?]|[?]|POSITIVE|1|cs|1|1|[?]|HIGH|URINE SEDIMENT|GELLED|N|WRIGHT STAIN|NASH FIBROSURE FORMULA||Y|U||2|Visit_2|25|2|TREATMENT|2020-11-16|2020-11-21|25|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|4|RBCDIPOP|Dimorphic Erythrocyte Population|URINALYSIS|[?]|Weber|[?]|[?]|NEGATIVE|1|MET|1|1|[?]|HIGH|FLUID|GELLED||MOUSE PROTECTION ASSAY|MDRD 5 VARIABLE FORMULA||Y|U||2|Visit_2|25|3|TREATMENT|2020-11-16|2021-01-16|25|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|5|THYPXD|Thyroperoxidase|CHEMISTRY|||[?]|[?]|INVALID|1|lx|1|1|[?]|NORMAL|DISCHARGE|PARAFFIN-EMBEDDED||RADIOIMMUNOPRECIPITATION ASSAY|HEPASCORE FORMULA|||U|Y|3|Visit_3|40|6|TREATMENT|2020-12-01|2021-01-03|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|6|PROLYMLY|Prolymphocytes/Lymphocytes|URINALYSIS|||[?]|[?]|TRACE|1|mOsm|1|1|[?]|HIGH|LEUKOCYTE|LIPEMIC|N|ACRIDINE ORANGE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|2|TREATMENT|2020-12-01|2021-01-16|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|7|SMTHAB|Smith Antibody|CHEMISTRY|||[?]|[?]|TRACE|1|Gy|1|1|[?]|HIGH|PERITONEAL FLUID|NON-HEMOLYZED||MUGA|GMI % FORMULA|Y||Y|Y|4|Visit_4|65|1|WASHOUT|2020-12-26|2021-01-29|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|8|CANNAB|Cannabinoids|URINALYSIS|[?]|h*%|[?]|[?]|NEGATIVE|1|10^7 CFU|1|1|[?]|LOW|PLEURAL FLUID|THAWED|N|WRIGHT STAIN|NASH FIBROSURE FORMULA|Y|Y|NA||4|Visit_4|65|1|TREATMENT|2020-12-26|2021-01-17|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|9|PDL1S|Soluble Programmed Death Ligand 1|CHEMISTRY|[?]|CFU/mL|[?]|[?]|POSITIVE|1|min|1|1|[?]|LOW|EMESIS|CLOTTED||IMMUNOPRECIPITATION|FIBROSIS 4 FORMULA|Y||U||5|Visit_5|90|5|TREATMENT|2021-01-20|2021-01-29|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|10|TOXVAC|Toxic Vacuolation|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mL/m2/min|1|1|[?]|NORMAL|BUFFY COAT|PARAFFIN-EMBEDDED||PHOROPTER|GMI % FORMULA|Y||NA|Y|5|Visit_5|90|6|SCREENING|2021-01-20|2021-01-27|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|d74682f1-824e-449d-bdf1-db517d8fdf2e|1|SODIUM|Sodium|CHEMISTRY|||[?]|[?]|POSITIVE|1|pg/cell|1|1|[?]|LOW|COLOSTRUM|DRIED||CINEANGIOGRAPHY|HEPASCORE FORMULA|||Y|Y|1|Visit_1|10|6|WASHOUT|2020-08-08|2020-09-26|10|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|d74682f1-824e-449d-bdf1-db517d8fdf2e|2|HISTAB|Histone Antibodies|URINALYSIS|||[?]|[?]|INVALID|1|mL/day|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|THAWED||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|NASH FIBROSURE FORMULA|||N|Y|1|Visit_1|10|7|TREATMENT|2020-08-08|2020-08-15|10|17|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|d74682f1-824e-449d-bdf1-db517d8fdf2e|3|NEUTB|Neutrophils Band Form|HEMATOLOGY|[?]|g/animal|[?]|[?]|TRACE|1|dpm/mg|1|1|[?]|NORMAL|LEUKOCYTE|REFRIGERATED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|HEPASCORE FORMULA|Y||N||2|Visit_2|25|5|TREATMENT|2020-08-23|2020-09-12|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|d74682f1-824e-449d-bdf1-db517d8fdf2e|4|FACTIII|Factor III|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|10^6 RNA copies/mL|1|1|[?]|LOW|CORD BLOOD|PARAFFIN-EMBEDDED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD 4 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|7|TREATMENT|2020-08-23|2020-10-09|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|d74682f1-824e-449d-bdf1-db517d8fdf2e|5|INTLK31|Interleukin 31|HEMATOLOGY|[?]|CAPLET|[?]|[?]|NEGATIVE|1|g/animal/day|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|FROZEN||MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|Y||U||3|Visit_3|40|4|WASHOUT|2020-09-07|2020-10-08|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|d74682f1-824e-449d-bdf1-db517d8fdf2e|6|HYXLYS|Hydroxylysine|HEMATOLOGY|[?]|%(w/w)|[?]|[?]|TRACE|1|h/wk|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|AUTOLYZED||DYNAMIC LIGHT SCATTERING|CKD-EPI FORMULA|||U||3|Visit_3|40|4|TREATMENT|2020-09-07|2020-10-17|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|d74682f1-824e-449d-bdf1-db517d8fdf2e|7|CD4|CD4|CHEMISTRY|[?]|mL/m2|[?]|[?]|TRACE|1|/7.5 mL|1|1|[?]|NORMAL|SERUM|FROZEN||PHOROPTER|ASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|1|WASHOUT|2020-10-02|2020-10-26|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|d74682f1-824e-449d-bdf1-db517d8fdf2e|8|NEUT|Neutrophils|HEMATOLOGY|[?]|Tesla|[?]|[?]|TRACE|1|uV*sec|1|1|[?]|LOW|NAIL|REFRIGERATED||SCINTIGRAPHY|MDRD 6 VARIABLE FORMULA||Y|N||4|Visit_4|65|3|FOLLOW-UP|2020-10-02|2020-11-01|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|d74682f1-824e-449d-bdf1-db517d8fdf2e|9|MCPHGLE|Macrophages/Leukocytes|CHEMISTRY|||[?]|[?]|INVALID|1|AU/mL|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|LACTESCENT|N|ULTRASOUND|MDRD 5 VARIABLE FORMULA|Y|Y|NA|Y|5|Visit_5|90|3|TREATMENT|2020-10-27|2020-10-28|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|d74682f1-824e-449d-bdf1-db517d8fdf2e|10|TRGTCE|Target Cells|URINALYSIS|||[?]|[?]|TRACE|1|mL/cm H2O|1|1|[?]|NORMAL|CAPILLARY PLASMA|CONCENTRATED||PHOROPTER|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|Y|5|Visit_5|90|2|TREATMENT|2020-10-27|2020-11-03|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|1|PROC6|Pro-C6|HEMATOLOGY|[?]|10^4/hpf|[?]|[?]|NEGATIVE|1|ka_u/dL|1|1|[?]|LOW|ERYTHROCYTES|LACTESCENT|N|LC/MS|CKD-EPI CYSTATIN C FORMULA|Y||Y||1|Visit_1|10|3|TREATMENT|2020-12-07|2020-12-10|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|2|HBA1B|Hemoglobin A1B|URINALYSIS|[?]|10^3 CFU/mL|[?]|[?]|NEGATIVE|1|Absorbance U/mL|1|1|[?]|LOW|SKIN TISSUE|GELLED||OBSERVATION|MDRD FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-12-07|2021-02-12|10|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|3|HAPTOG|Haptoglobin|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|U/L|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|AGGLUTINATED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|GMI % FORMULA|||NA|Y|2|Visit_2|25|2|SCREENING|2020-12-22|2020-12-24|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|4|TSHRAB|Thyrotropin Receptor Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|BE/mL|1|1|[?]|HIGH|PLATELET RICH PLASMA|CONTAMINATED||MAGNETIC RESONANCE ELASTOGRAPHY|MDRD FORMULA|||U|Y|2|Visit_2|25|7|TREATMENT|2020-12-22|2021-01-19|25|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|5|ABOA1|ABO A1 Subtype|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|Henry|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|CALCIFIED|N|MAMMOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N|Y|3|Visit_3|40|4|TREATMENT|2021-01-06|2021-01-22|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|6|IGG3|Immunoglobulin G Subclass 3|HEMATOLOGY|[?]|mL/cm H2O|[?]|[?]|POSITIVE|1|g|1|1|[?]|HIGH|TRANSUDATE|CALCIFIED||CALCULATION|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||3|Visit_3|40|3|TREATMENT|2021-01-06|2021-01-18|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|7|ANDSTNDN|Androstenedione|CHEMISTRY|[?]|mol/mL|[?]|[?]|INVALID|1|mg/day|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|AUTOLYZED||NON-INVASIVE DIELECTRIC SENSING|HEPASCORE FORMULA|Y|Y|Y||4|Visit_4|65|4|WASHOUT|2021-01-31|2021-02-10|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|8|RANTES|Reg upon Act Normal T-cell Exprd Secrtd|CHEMISTRY|[?]|nkat|[?]|[?]|BORDERLINE|1|Ci/kg|1|1|[?]|NORMAL|PLATELET POOR PLASMA|CLOTTED||SINGLE-SLICE SPIRAL CT|HEPASCORE FORMULA|Y||U||4|Visit_4|65|2|TREATMENT|2021-01-31|2021-02-18|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|9|MERCECE|Maturing Erythroid Cells/Total Cells|HEMATOLOGY|[?]|mEq/kg|[?]|[?]|INVALID|1|APL U|1|1|[?]|HIGH|INTERSTITIAL FLUID|FRESH||FLUORESCEIN STAIN|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|4|FOLLOW-UP|2021-02-25|2021-03-01|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|10|C165896|D. pteronyssinus Antigen IgG4 Antibody|HEMATOLOGY|[?]|g/cage/day|[?]|[?]|NEGATIVE|1|Bq|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|LACTESCENT||CAPILLARY ELECTROPHORESIS|CKD-EPI CYSTATIN C FORMULA|Y||U||5|Visit_5|90|5|SCREENING|2021-02-25|2021-03-06|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|1|C1INH|Complement C1 Esterase Inhibitor|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|Hz/s|1|1|[?]|ABNORMAL|SERUM|SOLIDIFIED||TOLUIDINE BLUE STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y|Y|1|Visit_1|10|3|TREATMENT|2020-07-02|2020-07-26|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|2|LKM1IAAB|Liver Kidney Microsomal Type 1 IgA Ab|URINALYSIS|[?]|PIXELS/in|[?]|[?]|INDETERMINATE|1|10^6 U|1|1|[?]|NORMAL|EPIDERMAL TISSUE|CLOTTED||APPLANATION TONOMETRY|FIBROTEST FORMULA|Y||Y||1|Visit_1|10|7|WASHOUT|2020-07-02|2020-09-08|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|3|ERCEPIDX|Erythroid Proliferation Index|HEMATOLOGY|||[?]|[?]|INVALID|1|PIXELS/in|1|1|[?]|HIGH|GASTRIC CONTENTS|GELLED||GC/MS/MS|MDRD ENZYMATIC FORMULA|Y||Y|Y|2|Visit_2|25|5|FOLLOW-UP|2020-07-17|2020-08-25|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|4|LYMATLE|Lymphocytes Atypical/Leukocytes|URINALYSIS|[?]|aMFI|[?]|[?]|POSITIVE|1|/40 HPFs|1|1|[?]|ABNORMAL|SMEGMA|FRESH|N|COMPLEMENT FIXATION|CKD-EPI CREATININE FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-07-17|2020-09-20|25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|5|TESTOSFR|Testosterone, Free|URINALYSIS|||[?]|[?]|POSITIVE|1|L/h|1|1|[?]|HIGH|HAIR FOLLICLE|UNEXPECTED ODOR||POLYSOMNOGRAPHY|ASH FIBROSURE FORMULA||Y|U|Y|3|Visit_3|40|3|WASHOUT|2020-08-01|2020-08-31|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|6|ATHPIDX|Atherogenic Index of Plasma|HEMATOLOGY|[?]|SACHET|[?]|[?]|NEGATIVE|1|10^5/L|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|UNEXPECTED ODOR||RAJI CELL EIA|MDRD ENZYMATIC FORMULA|||Y||3|Visit_3|40|4|TREATMENT|2020-08-01|2020-08-05|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|7|HGBDOXY|Deoxyhemoglobin|URINALYSIS|[?]|dpm/mg|[?]|[?]|INDETERMINATE|1|log10 CFU/g|1|1|[?]|LOW|EXPIRED AIR|CONCENTRATED||ANTIBIOTIC AGAR SCREEN|MDRD FORMULA|Y||Y||4|Visit_4|65|2|WASHOUT|2020-08-26|2020-09-02|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|8|CARNITF|Carnitine, Free|CHEMISTRY|||[?]|[?]|NEGATIVE|1|uL/kg/day|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|THAWED||WRIGHT STAIN|HEPASCORE FORMULA|||Y|Y|4|Visit_4|65|6|SCREENING|2020-08-26|2020-09-26|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|9|C165919|German Cockroach IgG AB RAST Score|URINALYSIS|[?]|ng/day|[?]|[?]|NEGATIVE|1|fL|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|LIPEMIC||FARNSWORTH-MUNSELL 100 HUE TEST|ASH FIBROSURE FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-09-20|2020-09-22|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|10|OH8DXG2|8-Hydroxy-2'-Deoxyguanosine|CHEMISTRY|[?]|BAU|[?]|[?]|TRACE|1|nmol/L/min|1|1|[?]|HIGH|MECONIUM|AUTOLYZED||CONTACT SPECULAR MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||5|Visit_5|90|6|WASHOUT|2020-09-20|2020-09-24|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|1|FACTVA|Factor V Activity|CHEMISTRY|[?]|BISCUIT|[?]|[?]|NEGATIVE|1|L|1|1|[?]|HIGH|KERATINOCYTE|ICTERIC||TOLUIDINE BLUE STAIN|GMI % FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-11-17|2020-12-15|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|2|AMBRBTL|Amobarbital|CHEMISTRY|[?]|kg|[?]|[?]|TRACE|1|mol/mg|1|1|[?]|HIGH|ISOLATE|CONTAMINATED|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|GMI MMOL/MOL FORMULA||Y|NA||1|Visit_1|10|7|FOLLOW-UP|2020-11-17|2020-11-18|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|3|TCDCA|Taurochenodeoxycholate|HEMATOLOGY|||[?]|[?]|INVALID|1|mL/day|1|1|[?]|LOW|ARTERIAL CORD BLOOD|ICTERIC||NEXT GENERATION SEQUENCING|MDRD 6 VARIABLE FORMULA|||U|Y|2|Visit_2|25|1|FOLLOW-UP|2020-12-02|2021-01-23|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|4|BICARB|Bicarbonate|CHEMISTRY|[?]|mEq/L|[?]|[?]|NEGATIVE|1|genEq|1|1|[?]|NORMAL|DISCHARGE|AUTOLYZED|N|IMPULSE OSCILLOMETRY|MDRD 4 VARIABLE FORMULA|Y||U||2|Visit_2|25|3|TREATMENT|2020-12-02|2021-01-24|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|5|LIPASLAL|Lipase, Lysosomal Acid|CHEMISTRY|[?]|mmol2/L2|[?]|[?]|BORDERLINE|1|Gy/min|1|1|[?]|HIGH|BLOOD|SOLIDIFIED||OSCILLOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||U||3|Visit_3|40|3|SCREENING|2020-12-17|2021-01-20|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|6|C3B|Complement C3b|URINALYSIS|[?]|g/cm2|[?]|[?]|TRACE|1|cmH2O/mL|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|CONTAMINATED||BAC ACGH|MDRD FORMULA||Y|N||3|Visit_3|40|5|SCREENING|2020-12-17|2021-02-14|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|7|C147277|Triticum aestivum Antigen IgE Antibody|CHEMISTRY|[?]|beats/min|[?]|[?]|INDETERMINATE|1|ng/L|1|1|[?]|HIGH|PLASMA|FRESH||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|CKD-EPI CYSTATIN C FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2021-01-11|2021-01-26|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|8|PROTPATN|Protein Pattern|CHEMISTRY|[?]|LENS|[?]|[?]|TRACE|1|uV|1|1|[?]|ABNORMAL|GASTRIC FLUID|AUTOLYZED||CHROMOGENIC ASSAY|FIBROTEST FORMULA|||NA||4|Visit_4|65|4|SCREENING|2021-01-11|2021-01-23|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|9|ADPNHMW|Adiponectin, High Molecular Weight|HEMATOLOGY|[?]|LENS|[?]|[?]|INDETERMINATE|1|ag|1|1|[?]|LOW|CELL PELLET|CONCENTRATED|N|PALM METHOD|FIBROTEST FORMULA|||U||5|Visit_5|90|7|FOLLOW-UP|2021-02-05|2021-02-11|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|LB|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|10|IGHG2|Immunoglobulin Heavy Constant Gamma 2|HEMATOLOGY|||[?]|[?]|POSITIVE|1|cmH2O*s/mL|1|1|[?]|LOW|AMNIOTIC FLUID|FRESH||DYNAMIC LIGHT SCATTERING|FIBROTEST FORMULA|||U|Y|5|Visit_5|90|6|TREATMENT|2021-02-05|2021-02-11|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|LB|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|1|GLOBA1|Alpha-1 Globulin|HEMATOLOGY|[?]|ug/mL/h|[?]|[?]|POSITIVE|1|mm/min|1|1|[?]|HIGH|AQUEOUS HUMOR|GELLED|N|CELLULOSE TAPE|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||1|Visit_1|10|1|SCREENING|2020-10-27|2021-01-03|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|2|DECORIN|Decorin|HEMATOLOGY|[?]|10^3 organisms|[?]|[?]|POSITIVE|1|mmHg/sec|1|1|[?]|LOW|CORD BLOOD|FROZEN||PET SCAN|COCKCROFT-GAULT FORMULA|||NA||1|Visit_1|10|2|WASHOUT|2020-10-27|2020-11-24|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|3|PROLYM|Prolymphocytes|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|10^3 organisms|1|1|[?]|ABNORMAL|EMESIS|ROOM TEMPERATURE||TRANSMISSION ELECTRON MICROSCOPY|FIBROMETER FORMULA|||U|Y|2|Visit_2|25|4|WASHOUT|2020-11-11|2020-11-13|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|4|ASMACT|Alpha-Smooth Muscle Actin|URINALYSIS|[?]|FIU|[?]|[?]|TRACE|1|mL/m2/min|1|1|[?]|NORMAL|MECONIUM|AUTOLYZED||RAJI CELL RIA|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||2|Visit_2|25|7|WASHOUT|2020-11-11|2021-01-02|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|5|TGFA|Transforming Growth Factor Alpha|HEMATOLOGY|[?]|dL|[?]|[?]|BORDERLINE|1|/MBP|1|1|[?]|LOW|ARTERIAL CORD BLOOD|HEMOLYZED|N|WESTERN BLOT|MDRD FORMULA|Y||N||3|Visit_3|40|2|FOLLOW-UP|2020-11-26|2021-01-13|40|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|6|AFPADJBW|Alpha Fetoprotein Adj for Body Weight|HEMATOLOGY|[?]|/100 HPFs|[?]|[?]|NEGATIVE|1|deg2|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|FROZEN||PANENDOSCOPY|COCKCROFT-GAULT FORMULA|||Y||3|Visit_3|40|7|SCREENING|2020-11-26|2020-12-01|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|7|PTA|Prothrombin Activity|URINALYSIS|[?]|L/s|[?]|[?]|NEGATIVE|1|RNA copies/mL|1|1|[?]|LOW|KERATINOCYTE|REFRIGERATED||HPLC/MS|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||4|Visit_4|65|3|SCREENING|2020-12-21|2020-12-28|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|8|FABP3|Fatty Acid Binding Protein 3|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|L|1|1|[?]|ABNORMAL|DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED||GC/MS|CKD-EPI CREATININE FORMULA|||N|Y|4|Visit_4|65|5|TREATMENT|2020-12-21|2020-12-25|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|9|CACRTP|Calcium Corrected for Total Protein|HEMATOLOGY|[?]|mg/L|[?]|[?]|NEGATIVE|1|titer|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|ICTERIC||PHASE-CONTRAST MRI|NASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|6|WASHOUT|2021-01-15|2021-01-24|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|10|T4FR|Thyroxine, Free|HEMATOLOGY|[?]|uU/dL|[?]|[?]|BORDERLINE|1|fmol/L|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|CLOTTED||LC/MS/MS|HEPASCORE FORMULA|||N||5|Visit_5|90|3|WASHOUT|2021-01-15|2021-01-18|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|b5644705-65e9-4d9b-9f5c-f8f62d26e257|1|PECAM|Platelet Endothelial Adhesion Molecule|HEMATOLOGY|[?]|PACKET|[?]|[?]|INVALID|1|mg/mL/min|1|1|[?]|NORMAL|CELL PELLET|CALCIFIED||IMPULSE OSCILLOMETRY|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-12-24|2021-01-10|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|b5644705-65e9-4d9b-9f5c-f8f62d26e257|2|UNSPCE|Unspecified Cells|URINALYSIS|[?]|mm/sec|[?]|[?]|BORDERLINE|1|BISCUIT|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|UNEXPECTED ODOR||MOUSE PROTECTION ASSAY|NASH FIBROSURE FORMULA||Y|U||1|Visit_1|10|1|WASHOUT|2020-12-24|2021-01-04|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|b5644705-65e9-4d9b-9f5c-f8f62d26e257|3|HAPTOG|Haptoglobin|CHEMISTRY|||[?]|[?]|TRACE|1|MBq/uL|1|1|[?]|HIGH|VITREOUS HUMOR|FROZEN||ETDRS EYE CHART|FIBROTEST FORMULA|||U|Y|2|Visit_2|25|6|WASHOUT|2021-01-08|2021-02-01|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|b5644705-65e9-4d9b-9f5c-f8f62d26e257|4|C130073|Birch Pollen IgA|CHEMISTRY|[?]|in2|[?]|[?]|INDETERMINATE|1|nmol/mL/min|1|1|[?]|HIGH|PLATELET|HEMOLYZED||CENTRIFUGATION|MDRD 6 VARIABLE FORMULA|||U||2|Visit_2|25|5|TREATMENT|2021-01-08|2021-01-29|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|b5644705-65e9-4d9b-9f5c-f8f62d26e257|5|ERCECE|Erythroid Cells/Total Cells|URINALYSIS|[?]|log10 TCID 50/dose|[?]|[?]|TRACE|1|IU/kg|1|1|[?]|LOW|SEBUM|CONCENTRATED||LANDOLT RING|FIBROTEST FORMULA||Y|Y||3|Visit_3|40|5|SCREENING|2021-01-23|2021-03-09|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|b5644705-65e9-4d9b-9f5c-f8f62d26e257|6|COAGIDX|Coagulation Index|URINALYSIS|[?]|mmol|[?]|[?]|TRACE|1|/2000 RBC|1|1|[?]|NORMAL|VENOUS PLASMA|LACTESCENT|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||3|Visit_3|40|2|TREATMENT|2021-01-23|2021-03-09|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|b5644705-65e9-4d9b-9f5c-f8f62d26e257|7|PORPH|Porphyrin|URINALYSIS|||[?]|[?]|TRACE|1|mg/m2|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|AUTOLYZED||BIOPSY|HEPASCORE FORMULA|||NA|Y|4|Visit_4|65|6|SCREENING|2021-02-17|2021-03-15|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|b5644705-65e9-4d9b-9f5c-f8f62d26e257|8|NKCE|Natural Killer Cells|URINALYSIS|[?]|um/day|[?]|[?]|INVALID|1|BOLUS|1|1|[?]|ABNORMAL|STOOL|GELLED||IN VITRO GENE EXPRESSION ASSAY|MDRD 6 VARIABLE FORMULA||Y|Y||4|Visit_4|65|1|TREATMENT|2021-02-17|2021-03-12|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|b5644705-65e9-4d9b-9f5c-f8f62d26e257|9|GSTY1|Glutathione S-Transferase, Y1|URINALYSIS|[?]|uL|[?]|[?]|INDETERMINATE|1|100 IU/mL|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|FROZEN||PUPILLOMETRY|HEPASCORE FORMULA|||NA||5|Visit_5|90|4|SCREENING|2021-03-14|2021-03-22|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|b5644705-65e9-4d9b-9f5c-f8f62d26e257|10|NEUTLE|Neutrophils/Leukocytes|CHEMISTRY|[?]|BU|[?]|[?]|POSITIVE|1|DIOPTER|1|1|[?]|LOW|PERSPIRATION|AUTOLYZED||POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA|Y||Y||5|Visit_5|90|4|FOLLOW-UP|2021-03-14|2021-03-21|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|ec82f59b-197a-4ccc-b5e5-d91627a86a27|1|PLSMCE|Mature Plasma Cells|HEMATOLOGY|[?]|kHz|[?]|[?]|INDETERMINATE|1|10^9/dose|1|1|[?]|HIGH|CERUMEN|REFRIGERATED||ANTIMICROBIAL COMBINATION TESTING|MDRD 5 VARIABLE FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-05-16|2020-06-10|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|ec82f59b-197a-4ccc-b5e5-d91627a86a27|2|MBP|Myelin Basic Protein|HEMATOLOGY|[?]|10^3 RNA copies/mL|[?]|[?]|BORDERLINE|1|EID 50/dose|1|1|[?]|NORMAL|LOCHIA|CONCENTRATED|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-05-16|2020-07-27|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|ec82f59b-197a-4ccc-b5e5-d91627a86a27|3|BILDIR|Direct Bilirubin|CHEMISTRY|[?]|10^6 U|[?]|[?]|POSITIVE|1|deg/s|1|1|[?]|NORMAL|TRANSUDATE|HEMOLYZED||DXA SCAN|MDRD 6 VARIABLE FORMULA|Y||U||2|Visit_2|25|4|SCREENING|2020-05-31|2020-06-11|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|ec82f59b-197a-4ccc-b5e5-d91627a86a27|4|FACTIII|Factor III|URINALYSIS|[?]|oz eq|[?]|[?]|INVALID|1|min/day|1|1|[?]|LOW|HAIR|ICTERIC||IMPEDANCE CONDUCTIVITY|MDRD 4 VARIABLE FORMULA|Y|Y|N||2|Visit_2|25|3|FOLLOW-UP|2020-05-31|2020-06-13|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|ec82f59b-197a-4ccc-b5e5-d91627a86a27|5|ACETONE|Acetone|URINALYSIS|[?]|ug/m2/day|[?]|[?]|TRACE|1|VIRTUAL PIXEL|1|1|[?]|NORMAL|DIALYSIS FLUID|LACTESCENT|N|WESTERN BLOT|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2020-06-15|2020-06-20|40|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|LB|ec82f59b-197a-4ccc-b5e5-d91627a86a27|6|ASP|Aspartic Acid|URINALYSIS|||[?]|[?]|BORDERLINE|1|nmol/g|1|1|[?]|NORMAL|LOCHIA|AGGLUTINATED||SNELLEN EYE CHART|MDRD 4 VARIABLE FORMULA|||Y|Y|3|Visit_3|40|2|SCREENING|2020-06-15|2020-07-24|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|LB|ec82f59b-197a-4ccc-b5e5-d91627a86a27|7|CAIONPH|Calcium, Ionized pH Adjusted|URINALYSIS|[?]|WEEKS|[?]|[?]|NEGATIVE|1|AU/mL|1|1|[?]|ABNORMAL|KERATINOCYTE|HEMOLYZED||AUTOREFRACTION|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|4|SCREENING|2020-07-10|2020-07-11|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|LB|ec82f59b-197a-4ccc-b5e5-d91627a86a27|8|EOSNSQE|Eosinophils/Non-Squam Epi Cells|HEMATOLOGY|[?]|scm|[?]|[?]|BORDERLINE|1|g/day|1|1|[?]|NORMAL|CERUMEN|AGGLUTINATED||PET SCAN|MDRD FORMULA||Y|N||4|Visit_4|65|2|TREATMENT|2020-07-10|2020-08-11|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|LB|ec82f59b-197a-4ccc-b5e5-d91627a86a27|9|MGB|Myoglobin|HEMATOLOGY|||[?]|[?]|INVALID|1|kcal/day|1|1|[?]|ABNORMAL|CORD SERUM|PARAFFIN-EMBEDDED||ACCELERATOR MASS SPECTROMETRY|MDRD 5 VARIABLE FORMULA|||U|Y|5|Visit_5|90|6|WASHOUT|2020-08-04|2020-08-08|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|ec82f59b-197a-4ccc-b5e5-d91627a86a27|10|AZURGRAN|Azurophilic Granules|URINALYSIS|||[?]|[?]|BORDERLINE|1|ukat/10^12 RBC|1|1|[?]|ABNORMAL|DIALYSIS FLUID|FRESH||CONTRAST ENHANCED PET/CT SCAN|MDRD 4 VARIABLE FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2020-08-04|2020-08-05|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|527fd604-110f-47b1-bd8b-b1de2f5b0d29|1|ESTRCPT|Estrogen Receptor|HEMATOLOGY|||[?]|[?]|POSITIVE|1|/2000 RBC|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|DRIED||EIA|GMI MMOL/MOL FORMULA|Y||Y|Y|1|Visit_1|10|5|WASHOUT|2020-11-29|2021-01-22|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|527fd604-110f-47b1-bd8b-b1de2f5b0d29|2|ELA2PMN|Neutrophil Elastase, Polymorphonuclear|URINALYSIS|[?]|CAPSULE|[?]|[?]|NEGATIVE|1|RING|1|1|[?]|NORMAL|LYSATE|SOLIDIFIED||CELL OF ORIGIN ASSAY|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-11-29|2020-12-06|10|17|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|527fd604-110f-47b1-bd8b-b1de2f5b0d29|3|INTLK14|Interleukin 14|HEMATOLOGY|[?]|Absorbance U/min|[?]|[?]|POSITIVE|1|/cmH2O|1|1|[?]|ABNORMAL|VENOUS PLASMA|GELLED|N|MICROBIAL CULTURE|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-12-14|2021-01-08|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|527fd604-110f-47b1-bd8b-b1de2f5b0d29|4|HIST4AB|Histone 4 Antibody|CHEMISTRY|[?]|log10 CCID 50/dose|[?]|[?]|NEGATIVE|1|ug/animal|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|AUTOLYZED||DNA MICROARRAY|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|3|FOLLOW-UP|2020-12-14|2021-02-04|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|527fd604-110f-47b1-bd8b-b1de2f5b0d29|5|PTA|Prothrombin Activity|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^3 copies/mL|1|1|[?]|LOW|PLEURAL FLUID|CONTAMINATED|N|ENDOSCOPY|MDRD ENZYMATIC FORMULA|||Y|Y|3|Visit_3|40|5|WASHOUT|2020-12-29|2021-01-19|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|527fd604-110f-47b1-bd8b-b1de2f5b0d29|6|C165934|Arachis hypogaea IgE AB RAST Score|CHEMISTRY|[?]|/mm|[?]|[?]|BORDERLINE|1|/500 WBC|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|LIPEMIC|N|PET/CT SCAN WITHOUT CONTRAST|FIBROMETER FORMULA||Y|N||3|Visit_3|40|7|FOLLOW-UP|2020-12-29|2021-01-24|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|527fd604-110f-47b1-bd8b-b1de2f5b0d29|7|FUNGIFIL|Fungi, Filamentous|CHEMISTRY|[?]|/month|[?]|[?]|NEGATIVE|1|MASK|1|1|[?]|NORMAL|BLOOD|AUTOLYZED|N|SPECULAR MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||4|Visit_4|65|4|FOLLOW-UP|2021-01-23|2021-02-14|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|527fd604-110f-47b1-bd8b-b1de2f5b0d29|8|RDW|Erythrocytes Distribution Width|HEMATOLOGY|[?]|mm/2h|[?]|[?]|NEGATIVE|1|ug/L|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|UNEXPECTED ODOR|N|TONOMETRY|MDRD 6 VARIABLE FORMULA||Y|U||4|Visit_4|65|2|WASHOUT|2021-01-23|2021-02-11|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|527fd604-110f-47b1-bd8b-b1de2f5b0d29|9|PLAGMCVT|Platelet Aggregation Mean Curve Type|URINALYSIS|||[?]|[?]|BORDERLINE|1|Bq/L|1|1|[?]|HIGH|PLASMA|AUTOLYZED||INDIRECT IMMUNOFLUORESCENCE|CKD-EPI CYSTATIN C FORMULA|||U|Y|5|Visit_5|90|2|TREATMENT|2021-02-17|2021-02-24|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|527fd604-110f-47b1-bd8b-b1de2f5b0d29|10|EOSSG|Eosinophils, Segmented|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|kUSP|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|REFRIGERATED||WHOLE TRANSCRIPTOME SEQUENCING|MDRD ENZYMATIC FORMULA|||U|Y|5|Visit_5|90|7|SCREENING|2021-02-17|2021-02-25|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|1e1de453-920a-4132-b2f7-6335ee81ec83|1|BD2|Beta-defensin 2|CHEMISTRY|[?]|mL/animal|[?]|[?]|BORDERLINE|1|mN|1|1|[?]|HIGH|SYNOVIAL FLUID|HEMOLYZED|N|SPIROMETRY|FIBROMETER FORMULA|||NA||1|Visit_1|10|3|SCREENING|2020-10-22|2021-01-06|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|1e1de453-920a-4132-b2f7-6335ee81ec83|2|LYMNSQE|Lymphocytes/Non-Squam Epi Cells|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|IMPLANT|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|AUTOLYZED||PLAQUE REDUCTION NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA|||Y|Y|1|Visit_1|10|2|TREATMENT|2020-10-22|2020-12-29|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|1e1de453-920a-4132-b2f7-6335ee81ec83|3|APTTLAS|Lupus Anticoagulant Sensitive APTT|CHEMISTRY|||[?]|[?]|TRACE|1|DRINK|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|UNEXPECTED ODOR||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|COCKCROFT-GAULT FORMULA|||N|Y|2|Visit_2|25|1|TREATMENT|2020-11-06|2020-11-12|25|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|1e1de453-920a-4132-b2f7-6335ee81ec83|4|C130137|American Cockroach Antigen IgA Antibody|CHEMISTRY|[?]|Absorbance U/mL|[?]|[?]|INDETERMINATE|1|s/h|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|CALCIFIED||MOUSE PROTECTION ASSAY|FIBROTEST FORMULA|||N||2|Visit_2|25|5|SCREENING|2020-11-06|2020-11-20|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|1e1de453-920a-4132-b2f7-6335ee81ec83|5|URATECRT|Urate/Creatinine|HEMATOLOGY|[?]|/day|[?]|[?]|INVALID|1|g/kg|1|1|[?]|NORMAL|DIALYSIS FLUID|NON-HEMOLYZED||NEXT GENERATION SEQUENCING|CKD-EPI CYSTATIN C FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-11-21|2020-12-15|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|1e1de453-920a-4132-b2f7-6335ee81ec83|6|PLAGMCVT|Platelet Aggregation Mean Curve Type|CHEMISTRY|[?]|log10 TCID 50/uL|[?]|[?]|POSITIVE|1|umol/dL|1|1|[?]|LOW|REFLEX TEAR|GELLED||LEAD CITRATE STAIN|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2020-11-21|2020-12-06|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|1e1de453-920a-4132-b2f7-6335ee81ec83|7|CD13|CD13|HEMATOLOGY|[?]|ug/dL|[?]|[?]|INDETERMINATE|1|10^7 PFU|1|1|[?]|ABNORMAL|ALVEOLAR AIR|UNEXPECTED ODOR||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|1|FOLLOW-UP|2020-12-16|2020-12-24|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|1e1de453-920a-4132-b2f7-6335ee81ec83|8|RT3|Triiodothyronine, Reverse|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ppth|1|1|[?]|ABNORMAL|ALVEOLAR AIR|CONCENTRATED||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|NASH FIBROSURE FORMULA||Y|Y|Y|4|Visit_4|65|3|SCREENING|2020-12-16|2021-01-16|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|1e1de453-920a-4132-b2f7-6335ee81ec83|9|GLUBD13|1,3-Beta-D-Glucan|HEMATOLOGY|[?]|Gy|[?]|[?]|INVALID|1|fraction of 1|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|CONTAMINATED||GC/MS|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2021-01-10|2021-01-16|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|1e1de453-920a-4132-b2f7-6335ee81ec83|10|SICAM1|Soluble Intercell Adhesion Molecule 1|CHEMISTRY|||[?]|[?]|BORDERLINE|1|g/animal|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|LACTESCENT||NEURAMINIDASE INHIBITION ASSAY|MDRD FORMULA|||N|Y|5|Visit_5|90|4|WASHOUT|2021-01-10|2021-01-14|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|e553ad8e-96f4-4cb0-a005-51e9b64513b7|1|GADAB|Glutamic Acid Decarboxylase Antibody|CHEMISTRY|[?]|mEq/dL|[?]|[?]|INVALID|1|U/cL|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|CONCENTRATED||NEURAMINIDASE INHIBITION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U||1|Visit_1|10|3|WASHOUT|2020-06-29|2020-09-22|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|e553ad8e-96f4-4cb0-a005-51e9b64513b7|2|PREALB|Prealbumin|HEMATOLOGY|[?]|mL/cage/wk|[?]|[?]|BORDERLINE|1|mEq/dL|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|REFRIGERATED||FLUORESCENCE ANGIOGRAPHY|ASH FIBROSURE FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-06-29|2020-08-19|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|e553ad8e-96f4-4cb0-a005-51e9b64513b7|3|CD22|CD22|HEMATOLOGY|[?]|10^6/g|[?]|[?]|INVALID|1|g/m2/day|1|1|[?]|ABNORMAL|URINE|HEMOLYZED||ACCELERATOR MASS SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||2|Visit_2|25|6|TREATMENT|2020-07-14|2020-08-09|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|LB|e553ad8e-96f4-4cb0-a005-51e9b64513b7|4|FLUDOUTE|Fluid Output, Estimated|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|10^6 organisms/mL|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|FROZEN||CENTRIFUGATION|GMI MMOL/MOL FORMULA|||Y|Y|2|Visit_2|25|1|WASHOUT|2020-07-14|2020-09-16|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|LB|e553ad8e-96f4-4cb0-a005-51e9b64513b7|5|PLSIMCLY|Immature Plasma Cells/Lymphocytes|CHEMISTRY|[?]|mol/day|[?]|[?]|INDETERMINATE|1|mL/animal/day|1|1|[?]|NORMAL|AQUEOUS HUMOR|AGGLUTINATED||CAPILLARY ELECTROPHORESIS|MDRD 6 VARIABLE FORMULA|Y|Y|NA||3|Visit_3|40|2|TREATMENT|2020-07-29|2020-08-14|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|e553ad8e-96f4-4cb0-a005-51e9b64513b7|6|C130112|Animal Mix Antigen IgE Antibody|HEMATOLOGY|[?]|mL/mmHg/min/L|[?]|[?]|BORDERLINE|1|TRACE|1|1|[?]|HIGH|MONOCYTE|AUTOLYZED|N|CALIPER MEASUREMENT METHOD|CKD-EPI CYSTATIN C FORMULA||Y|U||3|Visit_3|40|2|TREATMENT|2020-07-29|2020-08-09|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|e553ad8e-96f4-4cb0-a005-51e9b64513b7|7|MYCEMIDX|Myeloid Maturation Index|URINALYSIS|[?]|Absorbance U|[?]|[?]|INVALID|1|KIT|1|1|[?]|HIGH|SMEGMA|SOLIDIFIED|N|LISSAMINE GREEN STAIN|GMI % FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-08-23|2020-09-05|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|e553ad8e-96f4-4cb0-a005-51e9b64513b7|8|CCPAB|Cyclic Citrullinated Peptide Antibody|HEMATOLOGY|[?]|mm/h|[?]|[?]|BORDERLINE|1|GPL U|1|1|[?]|LOW|MUSCLE TISSUE|AGGLUTINATED||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|COCKCROFT-GAULT FORMULA||Y|U||4|Visit_4|65|5|FOLLOW-UP|2020-08-23|2020-09-23|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|e553ad8e-96f4-4cb0-a005-51e9b64513b7|9|CD4|CD4|CHEMISTRY|[?]|cal|[?]|[?]|NEGATIVE|1|FFU|1|1|[?]|LOW|SERUM|FRESH||CINEANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|Y||U||5|Visit_5|90|4|FOLLOW-UP|2020-09-17|2020-09-24|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|e553ad8e-96f4-4cb0-a005-51e9b64513b7|10|B2GLYAB|Beta-2 Glycoprotein Antibody|CHEMISTRY|[?]|MET*h|[?]|[?]|INVALID|1|mL/cm3/min|1|1|[?]|NORMAL|ABSCESS FLUID|ROOM TEMPERATURE||PHASE CONTRAST MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA||5|Visit_5|90|1|TREATMENT|2020-09-17|2020-09-20|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|1|EOSIMLE|Immature Eosinophils/Leukocytes|URINALYSIS|[?]|10^7 CFU/mL|[?]|[?]|POSITIVE|1|/MBP|1|1|[?]|NORMAL|BUFFY COAT|LIPEMIC|N|MULTI-SLICE SPIRAL CT|MDRD ENZYMATIC FORMULA||Y|Y||1|Visit_1|10|2|WASHOUT|2020-12-16|2021-02-18|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|2|FLT3|FMS-like Receptor Tyrosine Kinase 3|HEMATOLOGY|[?]|/MBP|[?]|[?]|NEGATIVE|1|fmol/g|1|1|[?]|LOW|EPITHELIAL CELL|AUTOLYZED||PHASE CONTRAST MICROSCOPY|MDRD 5 VARIABLE FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-12-16|2021-01-11|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|3|PAROXET|Paroxetine|URINALYSIS|[?]|10^6 organisms/mg|[?]|[?]|NEGATIVE|1|uL/mL|1|1|[?]|NORMAL|TUMOR TISSUE|UNEXPECTED ODOR|N|FLUORESCEIN STAIN|CKD-EPI CYSTATIN C FORMULA|||U||2|Visit_2|25|5|TREATMENT|2020-12-31|2021-01-12|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|4|HOMOCIT|Homocitrulline|URINALYSIS|||[?]|[?]|INVALID|1|mU|1|1|[?]|NORMAL|HAIR FOLLICLE|ICTERIC|N|NON-INVASIVE DIELECTRIC SENSING|GMI % FORMULA||Y|N|Y|2|Visit_2|25|6|TREATMENT|2020-12-31|2021-01-23|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|5|AFPL3AFP|A Fetoprotein L3/A Fetoprotein|URINALYSIS|[?]|mL/g/h|[?]|[?]|TRACE|1|amu|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|ICTERIC||BIOIMPEDANCE SPECTROSCOPY|FIBROMETER FORMULA|Y|Y|NA||3|Visit_3|40|4|TREATMENT|2021-01-15|2021-02-15|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|6|RBCDYSM|Dysmorphic Erythrocytes|CHEMISTRY|[?]|MPS U|[?]|[?]|NEGATIVE|1|MBq|1|1|[?]|LOW|PERSPIRATION|HEMOLYZED||TRANSVAGINAL ULTRASOUND|HEPASCORE FORMULA|||U||3|Visit_3|40|4|TREATMENT|2021-01-15|2021-02-18|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|7|KEXR|Potassium Excretion Rate|CHEMISTRY|[?]|vg/mL|[?]|[?]|BORDERLINE|1|GPL U|1|1|[?]|ABNORMAL|SPERMATOZOON|THAWED|N|POTENTIOMETRY|HEPASCORE FORMULA||Y|N||4|Visit_4|65|6|TREATMENT|2021-02-09|2021-02-10|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|8|FIXAAC|Factor IX Activity Actual/Control|CHEMISTRY|[?]|mEq/mL|[?]|[?]|POSITIVE|1|DNA copies/mL|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|CONTAMINATED|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||Y|NA||4|Visit_4|65|2|FOLLOW-UP|2021-02-09|2021-02-26|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|9|HDLPL|HDL Phospholipid|CHEMISTRY|[?]|pL|[?]|[?]|TRACE|1|Mile|1|1|[?]|HIGH|BLOOD|CLOTTED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA|Y||N||5|Visit_5|90|3|SCREENING|2021-03-06|2021-03-13|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|10|FEK|Fractional Potassium Excretion|URINALYSIS|[?]|pg/cell|[?]|[?]|NEGATIVE|1|ugEq|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|FROZEN|N|THERMAL IONIZATION MASS SPECTROMETRY|HEPASCORE FORMULA|||U||5|Visit_5|90|6|TREATMENT|2021-03-06|2021-03-13|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|1|PTHFG|Parathyroid Hormone, Fragmented|URINALYSIS|[?]|STEPS|[?]|[?]|BORDERLINE|1|mm/h|1|1|[?]|HIGH|SEBUM|CONCENTRATED||IMMUNE REPERTOIRE DEEP SEQUENCING|FIBROMETER FORMULA|Y||NA||1|Visit_1|10|2|WASHOUT|2020-06-09|2020-08-07|10|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|2|CAIONPH|Calcium, Ionized pH Adjusted|HEMATOLOGY|[?]|CAPLET|[?]|[?]|BORDERLINE|1|mV*min|1|1|[?]|HIGH|PERSPIRATION|SOLIDIFIED||PALM METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|N||1|Visit_1|10|4|WASHOUT|2020-06-09|2020-08-09|10|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|3|PCP|Phencyclidine|URINALYSIS|[?]|mm|[?]|[?]|INDETERMINATE|1|POINT|1|1|[?]|HIGH|SPERMATOZOON|CONCENTRATED||WESTERGREN|MDRD FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-06-24|2020-08-12|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|4|BUCHE|Butyrylcholinesterase|URINALYSIS|[?]|10^6 organisms|[?]|[?]|TRACE|1|Bq|1|1|[?]|HIGH|AMNIOTIC FLUID|THAWED||INDIRECT IMMUNOFLUORESCENCE|ASH FIBROSURE FORMULA|||U||2|Visit_2|25|7|TREATMENT|2020-06-24|2020-07-14|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|5|C147285|Common Ragweed Pollen IgE Antibody|URINALYSIS|[?]|Anson U|[?]|[?]|TRACE|1|SBE/mL|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|CALCIFIED||MAGNETIC RESONANCE ELASTOGRAPHY|MDRD 4 VARIABLE FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-07-09|2020-07-24|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|6|CKMM|Creatine Kinase MM|CHEMISTRY|[?]|PA|[?]|[?]|NEGATIVE|1|mL/(min*100mL)|1|1|[?]|HIGH|LAVAGE FLUID|AGGLUTINATED|N|CALCOFLUOR WHITE STAIN|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|1|WASHOUT|2020-07-09|2020-07-20|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|7|POIKRBC|Poikilocytes/Erythrocytes|URINALYSIS|[?]|nmol BCE/mmol|[?]|[?]|INDETERMINATE|1|km/h|1|1|[?]|ABNORMAL|SMEGMA|PARAFFIN-EMBEDDED||MS/MS|FIBROMETER FORMULA|||Y||4|Visit_4|65|3|WASHOUT|2020-08-03|2020-08-22|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|8|GSTMUCRT|Mu Glutathione-S-Transferase/Creatinine|HEMATOLOGY|[?]|10^3 DNA copies/mL|[?]|[?]|BORDERLINE|1|log10 copies/mL|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED||IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD 6 VARIABLE FORMULA|Y||NA||4|Visit_4|65|3|WASHOUT|2020-08-03|2020-08-05|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|9|GLTRCE|Glitter Cells|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ngEq/L|1|1|[?]|ABNORMAL|DIALYSIS FLUID, PERITONEAL|HEMOLYZED|N|LC-FL|MDRD 6 VARIABLE FORMULA|||NA|Y|5|Visit_5|90|3|FOLLOW-UP|2020-08-28|2020-09-04|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|LB|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|10|ANGLOBDR|Antiglobulin Test, Direct|URINALYSIS|[?]|BOTTLE|[?]|[?]|INVALID|1|mL/s|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|NON-HEMOLYZED|N|MICROARRAY|MDRD 6 VARIABLE FORMULA||Y|NA||5|Visit_5|90|6|TREATMENT|2020-08-28|2020-09-05|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|LB|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|1|GAD2AB|Glutamic Acid Decarboxylase 2 Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|TRACE|1|1|[?]|HIGH|LEUKOCYTE|DRIED||CLOT DETECTION|NASH FIBROSURE FORMULA|||N|Y|1|Visit_1|10|2|SCREENING|2020-10-29|2021-01-21|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|2|PD1S|Soluble Programmed Death-1|URINALYSIS|[?]|mol/day|[?]|[?]|INVALID|1|ug/mL/h|1|1|[?]|HIGH|CAPILLARY PLASMA|AUTOLYZED||BIOIMPEDANCE SPECTROSCOPY|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-10-29|2021-01-24|10|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|3|NEUTSGBP|Neutrophils, Seg + Band Form + Precursor|CHEMISTRY|[?]|mOsm|[?]|[?]|INDETERMINATE|1|HOMEOPATHIC DILUTION|1|1|[?]|LOW|LAVAGE FLUID|LIPEMIC||CLIP SEQUENCING|MDRD 4 VARIABLE FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-11-13|2021-01-02|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|4|HEINZRBC|Heinz Bodies/Erythrocytes|HEMATOLOGY|||[?]|[?]|INVALID|1|g/L|1|1|[?]|HIGH|INFRANATANT, SERUM|NON-HEMOLYZED||SPIRAL CT SCAN WITHOUT CONTRAST|FIBROTEST FORMULA|||Y|Y|2|Visit_2|25|1|WASHOUT|2020-11-13|2021-01-02|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|5|HALLUC|Hallucinogen|HEMATOLOGY|[?]|APS U|[?]|[?]|INDETERMINATE|1|U/kg/min|1|1|[?]|HIGH|BONE|AUTOLYZED||CONTRAST ENHANCED SPIRAL CT SCAN|FIBROMETER FORMULA||Y|NA||3|Visit_3|40|7|TREATMENT|2020-11-28|2021-01-06|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|LB|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|6|RETIL|Low Absorption Reticulocytes|HEMATOLOGY|[?]|WAFER|[?]|[?]|TRACE|1|anti-Xa IU|1|1|[?]|LOW|DIALYSIS FLUID|FRESH||NUCLEIC ACID AMPLIFICATION TEST|MDRD 5 VARIABLE FORMULA|Y||Y||3|Visit_3|40|4|WASHOUT|2020-11-28|2020-12-20|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|LB|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|7|RPPAB|Ribosomal P Protein Antibody|HEMATOLOGY|[?]|Ci/mL|[?]|[?]|NEGATIVE|1|Shock Wave|1|1|[?]|NORMAL|LEUKOCYTE|ICTERIC||CALIPER MEASUREMENT METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2020-12-23|2021-01-25|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|8|ICTERUSI|Icteric Index|URINALYSIS|||[?]|[?]|NEGATIVE|1|kN/cm2|1|1|[?]|HIGH|SEMINAL FLUID|THAWED||ISHIHARA COLOR PLATES|FIBROSIS 4 FORMULA|||N|Y|4|Visit_4|65|4|WASHOUT|2020-12-23|2021-01-16|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|9|AMORPHSD|Amorphous Sediment|URINALYSIS|||[?]|[?]|INVALID|1|BISCUIT|1|1|[?]|ABNORMAL|HAIR|DRIED||CAPILLARY ELECTROPHORESIS|MDRD 6 VARIABLE FORMULA||Y|NA|Y|5|Visit_5|90|1|FOLLOW-UP|2021-01-17|2021-01-20|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|10|CGADJMW|Choriogonadotropin Adj for Maternal Wt|HEMATOLOGY|[?]|NEEDLE GAUGE|[?]|[?]|NEGATIVE|1|MET*h|1|1|[?]|NORMAL|SPUTUM|AGGLUTINATED||TEMPLATE INCISION METHOD|GMI MMOL/MOL FORMULA||Y|NA||5|Visit_5|90|5|TREATMENT|2021-01-17|2021-01-23|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|1|SAA1|Serum Amyloid A1|URINALYSIS|||[?]|[?]|NEGATIVE|1|kHz|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|CALCIFIED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI CREATININE FORMULA||Y|N|Y|1|Visit_1|10|4|TREATMENT|2020-12-24|2021-01-19|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|LB|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|2|IL1R2|Interleukin 1 Receptor Type 2|CHEMISTRY|||[?]|[?]|INVALID|1|mEq/g|1|1|[?]|HIGH|SYNOVIAL FLUID|UNEXPECTED ODOR||CHROMOGENIC ASSAY|HEPASCORE FORMULA|||NA|Y|1|Visit_1|10|7|TREATMENT|2020-12-24|2021-01-20|10|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|LB|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|3|CHCNT|Corpuscular Hemoglobin Content|URINALYSIS|[?]|MONTHS|[?]|[?]|POSITIVE|1|umol/mg/min|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|CONCENTRATED||CONTRAST ENHANCED MRI|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|1|SCREENING|2021-01-08|2021-01-29|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|4|PROMYB|Promyeloblasts|CHEMISTRY|||[?]|[?]|NEGATIVE|1|1/(s*kPa)|1|1|[?]|ABNORMAL|SPERMATOZOON|THAWED||FLAME PHOTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|2|Visit_2|25|7|WASHOUT|2021-01-08|2021-03-23|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|5|AMPHET|Amphetamine|URINALYSIS|||[?]|[?]|INDETERMINATE|1|MESF|1|1|[?]|NORMAL|SPUTUM|NON-HEMOLYZED||NUCLEIC ACID BASED METHOD|CKD-EPI FORMULA|||U|Y|3|Visit_3|40|5|TREATMENT|2021-01-23|2021-02-09|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|6|CAEXR|Calcium Excretion Rate|HEMATOLOGY|[?]|gpELISA unit/mL|[?]|[?]|INDETERMINATE|1|10^3/hpf|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|AGGLUTINATED||FLUORESCENT ENZYME IMMUNOASSAY|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|5|SCREENING|2021-01-23|2021-02-25|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|7|APTT|Activated Partial Thromboplastin Time|HEMATOLOGY|[?]|days/wk|[?]|[?]|BORDERLINE|1|Gauss|1|1|[?]|LOW|EPIDERMAL TISSUE|ROOM TEMPERATURE|N|MACRO BROTH DILUTION|MDRD ENZYMATIC FORMULA|Y||NA||4|Visit_4|65|7|TREATMENT|2021-02-17|2021-03-15|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|8|PIVKAII|Protein Induced by Vitamin K Absence-II|URINALYSIS|[?]|CCID 50/dose|[?]|[?]|INVALID|1|h/wk|1|1|[?]|LOW|DERMAL TISSUE|LIPEMIC||RAJI CELL EIA|MDRD ENZYMATIC JAPANESE FORMULA|||N||4|Visit_4|65|6|WASHOUT|2021-02-17|2021-03-05|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|9|PHOSCRT|Phosphate/Creatinine|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|10^7 PFU|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|HEMOLYZED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|COCKCROFT-GAULT FORMULA|Y||N|Y|5|Visit_5|90|3|TREATMENT|2021-03-14|2021-03-18|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|10|PLTAGAMP|Platelet Aggregation Amplitude|CHEMISTRY|[?]|PLUG|[?]|[?]|INVALID|1|OI50|1|1|[?]|LOW|SERUM OR PLASMA|HEMOLYZED|N|HEMAGGLUTINATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||5|Visit_5|90|7|TREATMENT|2021-03-14|2021-03-19|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|ad04ec90-9fd5-49f2-ae23-264273eb0a24|1|ZPP|Zinc Protoporphyrin|HEMATOLOGY|[?]|cmH2O/mL|[?]|[?]|INDETERMINATE|1|GBq/mg|1|1|[?]|NORMAL|SKIN TISSUE|LACTESCENT|N|REFRACTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-10-17|2020-11-16|10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|ad04ec90-9fd5-49f2-ae23-264273eb0a24|2|NAK|Sodium/Potassium|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|RATIO|1|1|[?]|ABNORMAL|LYMPH|GELLED||HPLC/IEX|MDRD 5 VARIABLE FORMULA|||U|Y|1|Visit_1|10|6|TREATMENT|2020-10-17|2020-11-17|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|ad04ec90-9fd5-49f2-ae23-264273eb0a24|3|VLDL1|VLDL Cholesterol Subtype 1|HEMATOLOGY|[?]|MBq/uL|[?]|[?]|TRACE|1|Anson U|1|1|[?]|NORMAL|BREAST MILK|THAWED||NO INFORMATION|FIBROTEST FORMULA||Y|Y||2|Visit_2|25|1|SCREENING|2020-11-01|2020-12-05|25|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|ad04ec90-9fd5-49f2-ae23-264273eb0a24|4|ICAB|Islet Cell Antibody|CHEMISTRY|||[?]|[?]|TRACE|1|L/s/kPa|1|1|[?]|LOW|VENOUS CORD BLOOD|DRIED|N|DOUBLE IMMUNODIFFUSION|CKD-EPI FORMULA|Y||NA|Y|2|Visit_2|25|4|SCREENING|2020-11-01|2020-12-02|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|ad04ec90-9fd5-49f2-ae23-264273eb0a24|5|HYPRLN|Hydroxyproline|URINALYSIS|||[?]|[?]|NEGATIVE|1|cP|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|HEMOLYZED||ICC|MDRD ENZYMATIC FORMULA|Y||NA|Y|3|Visit_3|40|6|WASHOUT|2020-11-16|2020-12-11|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|ad04ec90-9fd5-49f2-ae23-264273eb0a24|6|PLAT|Platelets|HEMATOLOGY|[?]|g/cage/wk|[?]|[?]|POSITIVE|1|mmHg*min/L|1|1|[?]|NORMAL|LYMPH|LIPEMIC|N|MAPH|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2020-11-16|2020-12-31|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|ad04ec90-9fd5-49f2-ae23-264273eb0a24|7|PHOSCLR|Phosphate Clearance|URINALYSIS|[?]|RFU|[?]|[?]|NEGATIVE|1|nCi|1|1|[?]|LOW|SEMEN|PARAFFIN-EMBEDDED||CONTRAST ENHANCED X-RAY|MDRD 5 VARIABLE FORMULA|Y||NA||4|Visit_4|65|4|FOLLOW-UP|2020-12-11|2020-12-16|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|ad04ec90-9fd5-49f2-ae23-264273eb0a24|8|FLUDOUTE|Fluid Output, Estimated|CHEMISTRY|[?]|Ci/g|[?]|[?]|INVALID|1|/ms|1|1|[?]|LOW|BASAL TEAR|CALCIFIED||TRANSVAGINAL ULTRASOUND|NASH FIBROSURE FORMULA|Y||Y||4|Visit_4|65|1|WASHOUT|2020-12-11|2021-01-12|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|ad04ec90-9fd5-49f2-ae23-264273eb0a24|9|ARR|Aldosterone/Renin Activity|HEMATOLOGY|[?]|uSiemens|[?]|[?]|BORDERLINE|1|APL U|1|1|[?]|NORMAL|KERATINOCYTE|SOLIDIFIED|N|TONOMETRY|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2021-01-05|2021-01-10|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|ad04ec90-9fd5-49f2-ae23-264273eb0a24|10|UREANEXR|Urea Nitrogen Excretion Rate|URINALYSIS|[?]|uCi|[?]|[?]|TRACE|1|TABLET|1|1|[?]|NORMAL|TISSUE|CLOTTED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA||5|Visit_5|90|5|FOLLOW-UP|2021-01-05|2021-01-13|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|a1d203ef-7ee1-4373-988a-370532bae2b1|1|ADMA|Asymmetric Dimethylarginine|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^7 PFU|1|1|[?]|HIGH|CAPILLARY BLOOD|ROOM TEMPERATURE||DARK FIELD MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|1|Visit_1|10|1|TREATMENT|2021-01-28|2021-02-23|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-17
e|LB|a1d203ef-7ee1-4373-988a-370532bae2b1|2|HELMOV10|Helicase MOV-10 Protein|URINALYSIS|[?]|vg/mL|[?]|[?]|INVALID|1|min/day|1|1|[?]|NORMAL|SOFT TISSUE|ROOM TEMPERATURE||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|3|TREATMENT|2021-01-28|2021-04-10|10|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-17
e|LB|a1d203ef-7ee1-4373-988a-370532bae2b1|3|VEGFR1S|Soluble Vasc Endoth Growth Factor Rec1|URINALYSIS|||[?]|[?]|INVALID|1|PHERESIS UNIT|1|1|[?]|NORMAL|CAPILLARY BLOOD|LACTESCENT||CHROMOGENIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|2|Visit_2|25|3|SCREENING|2021-02-12|2021-04-21|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|a1d203ef-7ee1-4373-988a-370532bae2b1|4|KETONEBD|Ketone Bodies|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mEq/kg|1|1|[?]|HIGH|EXPIRED AIR|FRESH||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|GMI % FORMULA||Y|U|Y|2|Visit_2|25|3|TREATMENT|2021-02-12|2021-04-01|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|a1d203ef-7ee1-4373-988a-370532bae2b1|5|HCGNDI|Choriogonadotropin, Intact|CHEMISTRY|[?]|km/h|[?]|[?]|BORDERLINE|1|RATIO|1|1|[?]|ABNORMAL|PLASMA|UNEXPECTED ODOR||ANALYTICAL ULTRACENTRIFUGATION|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2021-02-27|2021-04-25|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|a1d203ef-7ee1-4373-988a-370532bae2b1|6|CYSTHION|Cystathionine|URINALYSIS|[?]|PIXELS/in|[?]|[?]|TRACE|1|mmol/min/kPa|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|NON-HEMOLYZED||HPLC|MDRD FORMULA|||N||3|Visit_3|40|1|TREATMENT|2021-02-27|2021-03-02|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|a1d203ef-7ee1-4373-988a-370532bae2b1|7|HASIGMAB|Human Anti-Sheep IgM Antibody|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|MHz|1|1|[?]|ABNORMAL|DIALYSIS FLUID, PERITONEAL|GELLED||SLOAN LETTER EYE CHART 1.25%|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|4|Visit_4|65|1|WASHOUT|2021-03-24|2021-04-27|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|a1d203ef-7ee1-4373-988a-370532bae2b1|8|HYPERCHR|Hyperchromia|HEMATOLOGY|[?]|U/m2/day|[?]|[?]|NEGATIVE|1|ug/min|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|FROZEN||WHOLE EXOME SEQUENCING|CKD-EPI CYSTATIN C FORMULA|||N||4|Visit_4|65|2|TREATMENT|2021-03-24|2021-03-31|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|a1d203ef-7ee1-4373-988a-370532bae2b1|9|TSP1|Thrombospondin 1|CHEMISTRY|[?]|mIU/L|[?]|[?]|POSITIVE|1|DNA copies/ug|1|1|[?]|HIGH|AQUEOUS HUMOR|ICTERIC|N|ELLA|CKD-EPI FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2021-04-18|2021-04-26|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|LB|a1d203ef-7ee1-4373-988a-370532bae2b1|10|CHOL|Cholesterol|CHEMISTRY|[?]|10^6 DNA copies/mL|[?]|[?]|NEGATIVE|1|oz|1|1|[?]|NORMAL|URINE SEDIMENT|THAWED||ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI FORMULA|||N||5|Visit_5|90|5|SCREENING|2021-04-18|2021-04-24|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|LB|4389d158-cb51-4779-b19a-f38dbef0806a|1|CSCYL|Cylindroid Casts|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Ejaculate U|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED||DOUBLE IMMUNODIFFUSION|MDRD 6 VARIABLE FORMULA|||N|Y|1|Visit_1|10|4|SCREENING|2020-06-22|2020-07-29|10|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|4389d158-cb51-4779-b19a-f38dbef0806a|2|PLATCLMP|Platelet Clumps|HEMATOLOGY|[?]|deg|[?]|[?]|TRACE|1|Frames/s|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|AUTOLYZED||REVERSE TRANSCRIPTASE PCR|FIBROTEST FORMULA|Y||N||1|Visit_1|10|3|FOLLOW-UP|2020-06-22|2020-09-08|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|4389d158-cb51-4779-b19a-f38dbef0806a|3|THBD|Thrombomodulin|CHEMISTRY|[?]|umol/L/min|[?]|[?]|NEGATIVE|1|NEBULE|1|1|[?]|LOW|PERITONEAL FLUID|AUTOLYZED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|FIBROMETER FORMULA|||Y||2|Visit_2|25|3|SCREENING|2020-07-07|2020-09-19|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|4389d158-cb51-4779-b19a-f38dbef0806a|4|HEMOLYSI|Hemolytic Index|URINALYSIS|[?]|uL/kg/day|[?]|[?]|BORDERLINE|1|nmol/day|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|SOLIDIFIED||NUCLEAR RADIOLOGY|GMI MMOL/MOL FORMULA|Y||U||2|Visit_2|25|7|TREATMENT|2020-07-07|2020-09-06|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|4389d158-cb51-4779-b19a-f38dbef0806a|5|HGBA2HGB|Hemoglobin A2/Total Hemoglobin|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ng/L|1|1|[?]|HIGH|PERITONEAL FLUID|AUTOLYZED||IMMUNE REPERTOIRE DEEP SEQUENCING|FIBROMETER FORMULA|||N|Y|3|Visit_3|40|1|WASHOUT|2020-07-22|2020-09-12|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|4389d158-cb51-4779-b19a-f38dbef0806a|6|NAGASE|N-acetyl-beta-D-glucosaminidase|HEMATOLOGY|[?]|uV*sec|[?]|[?]|TRACE|1|/200 HPFs|1|1|[?]|NORMAL|PLEURAL TISSUE|NON-HEMOLYZED||TRICHROME STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-07-22|2020-08-03|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|4389d158-cb51-4779-b19a-f38dbef0806a|7|ESTFREST|Estradiol, Free/Estradiol|URINALYSIS|[?]|mg/min|[?]|[?]|INDETERMINATE|1|msec|1|1|[?]|LOW|ISOLATE|AUTOLYZED|N|IMMUNODIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA||4|Visit_4|65|4|SCREENING|2020-08-16|2020-09-06|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|4389d158-cb51-4779-b19a-f38dbef0806a|8|NMH|N-methylhistamine|HEMATOLOGY|||[?]|[?]|TRACE|1|/2000 RBC|1|1|[?]|HIGH|SYNOVIAL FLUID|LACTESCENT||TRYPAN BLUE STAIN|HEPASCORE FORMULA||Y|Y|Y|4|Visit_4|65|3|WASHOUT|2020-08-16|2020-09-03|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|4389d158-cb51-4779-b19a-f38dbef0806a|9|IGGCALBC|IgG Clearance/Albumin Clearance|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mg/mol|1|1|[?]|HIGH|VENOUS BLOOD|LIPEMIC||FLUORESCENT IMMUNOASSAY|CKD-EPI CREATININE FORMULA||Y|NA|Y|5|Visit_5|90|6|FOLLOW-UP|2020-09-10|2020-09-19|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|4389d158-cb51-4779-b19a-f38dbef0806a|10|IL2SRA|Soluble Interleukin 2 Receptor Activity|HEMATOLOGY|||[?]|[?]|INVALID|1|pmol/10^9 cells|1|1|[?]|ABNORMAL|DERMAL TISSUE|DRIED||THICK SMEAR|MDRD 6 VARIABLE FORMULA|Y||U|Y|5|Visit_5|90|3|TREATMENT|2020-09-10|2020-09-16|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|3a973b7a-3583-4383-b59e-3dab51b511bd|1|CORTISOL|Cortisol|CHEMISTRY|[?]|kPa|[?]|[?]|INVALID|1|ELISA unit|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|FROZEN||SIZE EXCLUSION CHROMATOGRAPHY|NASH FIBROSURE FORMULA|Y||NA||1|Visit_1|10|4|SCREENING|2021-01-19|2021-04-06|10|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|3a973b7a-3583-4383-b59e-3dab51b511bd|2|FLNTRZPM|Flunitrazepam|HEMATOLOGY|[?]|g/m2/day|[?]|[?]|NEGATIVE|1|PACKAGE|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|CALCIFIED||TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD 6 VARIABLE FORMULA|Y||U||1|Visit_1|10|3|TREATMENT|2021-01-19|2021-03-12|10|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|3a973b7a-3583-4383-b59e-3dab51b511bd|3|DMG|Dimethylglycine|URINALYSIS|[?]|U/g/min|[?]|[?]|BORDERLINE|1|mL/kg/day|1|1|[?]|HIGH|SUPERNATANT, SERUM|SOLIDIFIED||ENDOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|Y||2|Visit_2|25|7|TREATMENT|2021-02-03|2021-03-06|25|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|3a973b7a-3583-4383-b59e-3dab51b511bd|4|IGG2|Immunoglobulin G Subclass 2|HEMATOLOGY|[?]|lx|[?]|[?]|INDETERMINATE|1|10^3 organisms/g|1|1|[?]|NORMAL|CELL PELLET|CALCIFIED||TWO-COLOR MICROARRAY|HEPASCORE FORMULA|||U||2|Visit_2|25|5|TREATMENT|2021-02-03|2021-04-04|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|3a973b7a-3583-4383-b59e-3dab51b511bd|5|LYMATLE|Lymphocytes Atypical/Leukocytes|HEMATOLOGY|[?]|h*%|[?]|[?]|INDETERMINATE|1|dpm/mg|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED||ELECTROMYOGRAPHY|ASH FIBROSURE FORMULA|Y|Y|U||3|Visit_3|40|1|WASHOUT|2021-02-18|2021-03-26|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|3a973b7a-3583-4383-b59e-3dab51b511bd|6|OAS2|2-5-Oligoadenylate Synthase 2|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|VOXEL|1|1|[?]|LOW|RETICULOCYTES|HEMOLYZED||IMPEDANCE CONDUCTIVITY|FIBROMETER FORMULA|||NA|Y|3|Visit_3|40|6|WASHOUT|2021-02-18|2021-02-26|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|3a973b7a-3583-4383-b59e-3dab51b511bd|7|FECL|Fractional Chloride Excretion|CHEMISTRY|[?]|10^6 organisms/g|[?]|[?]|TRACE|1|CAPLET|1|1|[?]|NORMAL|CERUMEN|SOLIDIFIED||WHOLE EXOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||4|Visit_4|65|7|FOLLOW-UP|2021-03-15|2021-03-18|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|3a973b7a-3583-4383-b59e-3dab51b511bd|8|VITB17|Vitamin B17|CHEMISTRY|[?]|L/s|[?]|[?]|BORDERLINE|1|fmol/L|1|1|[?]|LOW|PUS|CONTAMINATED|N|IMMUNOFIXATION ELECTROPHORESIS|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|5|WASHOUT|2021-03-15|2021-03-16|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|3a973b7a-3583-4383-b59e-3dab51b511bd|9|PTF1_2|Prothrombin Fragments 1 + 2|CHEMISTRY|[?]|HOURS|[?]|[?]|TRACE|1|pg/cell|1|1|[?]|LOW|EPITHELIAL CELL|PARAFFIN-EMBEDDED||MYELOPEROXIDASE STAIN|MDRD ENZYMATIC FORMULA|||Y||5|Visit_5|90|5|FOLLOW-UP|2021-04-09|2021-04-15|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|3a973b7a-3583-4383-b59e-3dab51b511bd|10|HBA2PHB|Hemoglobin A2 Prime/Total Hemoglobin|CHEMISTRY|||[?]|[?]|NEGATIVE|1|CAN|1|1|[?]|LOW|CORD SERUM|UNEXPECTED ODOR||PET/SPECT SCAN|MDRD FORMULA|||U|Y|5|Visit_5|90|3|TREATMENT|2021-04-09|2021-04-13|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|d283591c-2085-459e-94f2-d3eb6b81aea7|1|ANCIGAB|Anti-Neutrophil Cytoplasmic IgG Antibody|URINALYSIS|||[?]|[?]|INDETERMINATE|1|Joule|1|1|[?]|NORMAL|EPIDERMAL TISSUE|THAWED||INCISION-INDUCED BLEEDING METHOD|ASH FIBROSURE FORMULA|||NA|Y|1|Visit_1|10|2|TREATMENT|2020-09-28|2020-11-24|10|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|d283591c-2085-459e-94f2-d3eb6b81aea7|2|C130107|Weed Mix Pollen Antigen IgG Antibody|CHEMISTRY|[?]|ms/mmHg|[?]|[?]|NEGATIVE|1|10^3/hpf|1|1|[?]|LOW|LOCHIA|AUTOLYZED||REVERSE TRANSCRIPTASE PCR|HEPASCORE FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-09-28|2020-10-01|10|13|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|d283591c-2085-459e-94f2-d3eb6b81aea7|3|LIPASLAL|Lipase, Lysosomal Acid|CHEMISTRY|[?]|10^3 organisms/mL|[?]|[?]|BORDERLINE|1|V|1|1|[?]|ABNORMAL|SEBUM|PARAFFIN-EMBEDDED|N|TRIPLE-PHASE SPIRAL CT SCAN|MDRD ENZYMATIC FORMULA|Y||N||2|Visit_2|25|5|TREATMENT|2020-10-13|2020-12-26|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|d283591c-2085-459e-94f2-d3eb6b81aea7|4|ALPIALP|Alk Phos, Intestinal/Total Alk Phos|URINALYSIS|||[?]|[?]|NEGATIVE|1|IU/dL|1|1|[?]|HIGH|SKIN TISSUE|FRESH||ICP-MS|MDRD 4 VARIABLE FORMULA|||U|Y|2|Visit_2|25|7|WASHOUT|2020-10-13|2020-11-14|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|d283591c-2085-459e-94f2-d3eb6b81aea7|5|TSP1|Thrombospondin 1|CHEMISTRY|[?]|log10 TCID 50/mL|[?]|[?]|POSITIVE|1|%/min|1|1|[?]|LOW|BONE MARROW|LACTESCENT||ELISPOT|FIBROSIS 4 FORMULA||Y|U||3|Visit_3|40|4|TREATMENT|2020-10-28|2020-11-24|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|d283591c-2085-459e-94f2-d3eb6b81aea7|6|IGA|Immunoglobulin A|HEMATOLOGY|[?]|YEARS|[?]|[?]|NEGATIVE|1|kV|1|1|[?]|HIGH|BONE|CONTAMINATED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-10-28|2020-12-12|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|d283591c-2085-459e-94f2-d3eb6b81aea7|7|C165878|German Cockroach IgE AB RAST Score|CHEMISTRY|||[?]|[?]|POSITIVE|1|mL|1|1|[?]|ABNORMAL|BONE|CLOTTED||HIGH RESOLUTION CT|GMI MMOL/MOL FORMULA|||Y|Y|4|Visit_4|65|1|SCREENING|2020-11-22|2020-12-19|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|d283591c-2085-459e-94f2-d3eb6b81aea7|8|GSTMUCRT|Mu Glutathione-S-Transferase/Creatinine|URINALYSIS|||[?]|[?]|INVALID|1|mL/m2/day|1|1|[?]|NORMAL|URINE|DRIED||SCANNING ELECTRON MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|4|Visit_4|65|3|TREATMENT|2020-11-22|2020-12-14|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|d283591c-2085-459e-94f2-d3eb6b81aea7|9|VEGFD|Vascular Endothelial Growth Factor D|HEMATOLOGY|[?]|DAgU|[?]|[?]|INVALID|1|10^4 CFU|1|1|[?]|NORMAL|SEBUM|THAWED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD 5 VARIABLE FORMULA|||N||5|Visit_5|90|3|TREATMENT|2020-12-17|2020-12-24|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|d283591c-2085-459e-94f2-d3eb6b81aea7|10|C130068|Bermuda Grass Pollen IgE|URINALYSIS|[?]|cGy|[?]|[?]|TRACE|1|um2|1|1|[?]|LOW|SKIN TISSUE|CONCENTRATED||PEAK FLOWMETRY|CKD-EPI CREATININE FORMULA|Y||NA||5|Visit_5|90|1|TREATMENT|2020-12-17|2020-12-22|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|da31f695-9f6a-46b2-8002-5c1c21b55cf3|1|EOSPSD|Pseudo-Eosinophils|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|CFU/mL|1|1|[?]|ABNORMAL|BLOOD|CLOTTED|N|AURAMINE STAIN|GMI MMOL/MOL FORMULA|||Y|Y|1|Visit_1|10|5|SCREENING|2020-10-01|2020-10-28|10|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|da31f695-9f6a-46b2-8002-5c1c21b55cf3|2|NTXICRT|T1 Collagen X-link N-Telopeptides/Creat|URINALYSIS|[?]|aMFI|[?]|[?]|INDETERMINATE|1|g/kg/day|1|1|[?]|HIGH|EXUDATE|NON-HEMOLYZED|N|U-HPLC/MS/MS|HEPASCORE FORMULA|||N||1|Visit_1|10|4|SCREENING|2020-10-01|2020-12-03|10|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|da31f695-9f6a-46b2-8002-5c1c21b55cf3|3|C165924|Grass Mix Pollen IgE AB RAST Score|HEMATOLOGY|[?]|EIA unit|[?]|[?]|TRACE|1|pkat|1|1|[?]|HIGH|KERATINOCYTE|AUTOLYZED||MICROBIAL BIOCHEMICAL IDENTIFICATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|2|WASHOUT|2020-10-16|2020-12-15|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|da31f695-9f6a-46b2-8002-5c1c21b55cf3|4|CSUNCLA|Unclassified Casts|URINALYSIS|[?]|mL/kg/min|[?]|[?]|TRACE|1|U/kg/day|1|1|[?]|HIGH|LYSATE|LIPEMIC||APPLANATION TONOMETRY|FIBROSIS 4 FORMULA|Y||Y||2|Visit_2|25|7|TREATMENT|2020-10-16|2020-10-21|25|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|da31f695-9f6a-46b2-8002-5c1c21b55cf3|5|LDH3LDH|LDH Isoenzyme 3/LDH|HEMATOLOGY|[?]|genEq|[?]|[?]|TRACE|1|gpELISA unit/mL|1|1|[?]|LOW|PLASMA|CLOTTED||MIGET|FIBROMETER FORMULA|Y||N||3|Visit_3|40|2|TREATMENT|2020-10-31|2020-12-25|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|da31f695-9f6a-46b2-8002-5c1c21b55cf3|6|COPEP|Copeptin|CHEMISTRY|[?]|mCi|[?]|[?]|POSITIVE|1|nmol/kg/day|1|1|[?]|LOW|BREAST MILK|NON-HEMOLYZED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|CKD-EPI FORMULA|||U||3|Visit_3|40|2|TREATMENT|2020-10-31|2020-12-16|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|da31f695-9f6a-46b2-8002-5c1c21b55cf3|7|RDWR|Ret Volume Distribution Width|URINALYSIS|||[?]|[?]|INVALID|1|10^6 CFU|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|THAWED||NON-INVASIVE DIELECTRIC SENSING|MDRD 6 VARIABLE FORMULA||Y|U|Y|4|Visit_4|65|3|SCREENING|2020-11-25|2020-12-24|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|da31f695-9f6a-46b2-8002-5c1c21b55cf3|8|HLADRB1|HLA DR Beta1 Antigen|URINALYSIS|[?]|mL/m2|[?]|[?]|POSITIVE|1|10^9 organisms/g|1|1|[?]|HIGH|PLEURAL TISSUE|LACTESCENT||ANTIMICROBIAL COMBINATION TESTING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|4|TREATMENT|2020-11-25|2020-12-08|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|da31f695-9f6a-46b2-8002-5c1c21b55cf3|9|ACHE|Acetylcholinesterase|HEMATOLOGY|[?]|m2|[?]|[?]|NEGATIVE|1|EU|1|1|[?]|HIGH|ARTERIAL BLOOD|HEMOLYZED||CISH|MDRD 6 VARIABLE FORMULA|||U||5|Visit_5|90|4|TREATMENT|2020-12-20|2020-12-29|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|da31f695-9f6a-46b2-8002-5c1c21b55cf3|10|VBCE|Viable Cells|URINALYSIS|||[?]|[?]|INDETERMINATE|1|BLOCKS|1|1|[?]|LOW|PLASMA|AUTOLYZED||LEAD CITRATE STAIN|CKD-EPI CREATININE FORMULA||Y|N|Y|5|Visit_5|90|3|TREATMENT|2020-12-20|2020-12-28|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|4cd63e56-3d93-403a-8011-3b4fcf26e445|1|THYAB|Thyroid Antibodies|HEMATOLOGY|[?]|m/sec|[?]|[?]|INDETERMINATE|1|GBq/mg|1|1|[?]|ABNORMAL|URINE|GELLED||MALDI|CKD-EPI CYSTATIN C FORMULA||Y|Y||1|Visit_1|10|5|WASHOUT|2020-12-27|2021-02-18|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|4cd63e56-3d93-403a-8011-3b4fcf26e445|2|STROPONI|Skeletal Troponin I|URINALYSIS|[?]|/kg|[?]|[?]|POSITIVE|1|mol|1|1|[?]|LOW|BLOOD|AGGLUTINATED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-12-27|2021-03-10|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|4cd63e56-3d93-403a-8011-3b4fcf26e445|3|GLOBB1BP|Beta-1 Globulin/Beta Protein|HEMATOLOGY|[?]|cd|[?]|[?]|TRACE|1|mg/animal|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|DRIED|N|DIFFUSION TENSOR MRI|FIBROTEST FORMULA|||NA||2|Visit_2|25|3|SCREENING|2021-01-11|2021-03-20|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|4cd63e56-3d93-403a-8011-3b4fcf26e445|4|IRONEXR|Iron Excretion Rate|CHEMISTRY|[?]|Shock Wave|[?]|[?]|INVALID|1|L/L|1|1|[?]|HIGH|GASTRIC CONTENTS|THAWED||PERCUSSION|COCKCROFT-GAULT FORMULA|||N||2|Visit_2|25|7|TREATMENT|2021-01-11|2021-03-04|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|4cd63e56-3d93-403a-8011-3b4fcf26e445|5|CHOLHDL|Cholesterol/HDL-Cholesterol|CHEMISTRY|||[?]|[?]|INVALID|1|AU/mL|1|1|[?]|ABNORMAL|MECONIUM|FRESH|N|SNP ARRAY|MDRD ENZYMATIC JAPANESE FORMULA|||Y|Y|3|Visit_3|40|2|WASHOUT|2021-01-26|2021-02-25|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|4cd63e56-3d93-403a-8011-3b4fcf26e445|6|HIST2AAB|Histone 2A Antibody|CHEMISTRY|||[?]|[?]|POSITIVE|1|um/day|1|1|[?]|HIGH|GASTRIC CONTENTS|FROZEN||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|NASH FIBROSURE FORMULA|||N|Y|3|Visit_3|40|2|TREATMENT|2021-01-26|2021-02-10|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|4cd63e56-3d93-403a-8011-3b4fcf26e445|7|ANCATYAB|Neutrophil Cytoplasmic Ab, Atypical|URINALYSIS|[?]|usec|[?]|[?]|INVALID|1|Rad|1|1|[?]|ABNORMAL|CORD BLOOD|PARAFFIN-EMBEDDED|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROSIS 4 FORMULA|Y|Y|N||4|Visit_4|65|4|TREATMENT|2021-02-20|2021-03-07|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|4cd63e56-3d93-403a-8011-3b4fcf26e445|8|IFI44|Interferon-Induced Protein 44|HEMATOLOGY|[?]|g/animal/wk|[?]|[?]|NEGATIVE|1|Anson U|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|AGGLUTINATED||ERGOSPIROMETRY|MDRD 5 VARIABLE FORMULA|Y||NA||4|Visit_4|65|5|TREATMENT|2021-02-20|2021-03-17|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|4cd63e56-3d93-403a-8011-3b4fcf26e445|9|ESTRCPT|Estrogen Receptor|CHEMISTRY|[?]|WEEKS|[?]|[?]|INVALID|1|V/sec|1|1|[?]|HIGH|SUPERNATANT, PLASMA|NON-HEMOLYZED||PET/SPECT SCAN|FIBROMETER FORMULA|||NA||5|Visit_5|90|2|SCREENING|2021-03-17|2021-03-24|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|4cd63e56-3d93-403a-8011-3b4fcf26e445|10|CSMIX|Mixed Casts|HEMATOLOGY|[?]|BOWL|[?]|[?]|TRACE|1|IU/dL|1|1|[?]|ABNORMAL|ERYTHROCYTES|DRIED||URANYL ACETATE STAIN|CKD-EPI FORMULA|||N||5|Visit_5|90|2|TREATMENT|2021-03-17|2021-03-20|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|1|ERCEPPOL|Erythroid Proliferation Pool|CHEMISTRY|[?]|uIU/dL|[?]|[?]|INVALID|1|10^6 IU/mL|1|1|[?]|LOW|SWABBED MATERIAL|GELLED||PHOTOMETRIC CLOT DETECTION|ASH FIBROSURE FORMULA||Y|NA||1|Visit_1|10|7|WASHOUT|2020-05-23|2020-06-13|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|2|LYMCLF|Lymphocytes, Clefted|HEMATOLOGY|[?]|deg/s|[?]|[?]|POSITIVE|1|TCID 50/dose|1|1|[?]|LOW|AQUEOUS HUMOR|GELLED||MICROBIAL CULTURE, SOLID|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-05-23|2020-07-26|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|3|FLT3|FMS-like Receptor Tyrosine Kinase 3|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mEq|1|1|[?]|ABNORMAL|BONE|CLOTTED||IHC|FIBROMETER FORMULA|||Y|Y|2|Visit_2|25|6|TREATMENT|2020-06-07|2020-07-09|25|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|LB|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|4|FACTIX|Factor IX|HEMATOLOGY|[?]|uSiemens|[?]|[?]|BORDERLINE|1|DNA copies/mL|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|PARAFFIN-EMBEDDED||FLUOROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||2|Visit_2|25|6|TREATMENT|2020-06-07|2020-07-04|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|LB|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|5|SOST|Sclerostin|URINALYSIS|||[?]|[?]|TRACE|1|umol/L/h|1|1|[?]|LOW|CEREBROSPINAL FLUID|DRIED||MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|3|Visit_3|40|6|WASHOUT|2020-06-22|2020-07-22|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-22
e|LB|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|6|ASSDNA|Anti-Single Stranded DNA IgG|URINALYSIS|[?]|cL|[?]|[?]|INVALID|1|mol/mol|1|1|[?]|LOW|EPITHELIAL CELL|THAWED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-06-22|2020-07-07|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-22
e|LB|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|7|AST|Aspartate Aminotransferase|HEMATOLOGY|[?]|GPL U|[?]|[?]|TRACE|1|Hz/s|1|1|[?]|ABNORMAL|SOFT TISSUE|AUTOLYZED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|CKD-EPI CREATININE FORMULA||Y|Y||4|Visit_4|65|1|TREATMENT|2020-07-17|2020-07-19|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|8|MNC|Mononuclear Cells|CHEMISTRY|[?]|mL/s|[?]|[?]|INDETERMINATE|1|mg/kg|1|1|[?]|ABNORMAL|ABSCESS FLUID|REFRIGERATED||DIFFUSION TENSOR MRI|FIBROMETER FORMULA||Y|U||4|Visit_4|65|6|WASHOUT|2020-07-17|2020-08-11|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|9|ALTAST|ALT/AST|CHEMISTRY|[?]|fmol/L|[?]|[?]|INDETERMINATE|1|U/m2/h|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|ROOM TEMPERATURE||INCISION-INDUCED BLEEDING METHOD|COCKCROFT-GAULT FORMULA||Y|N||5|Visit_5|90|3|FOLLOW-UP|2020-08-11|2020-08-13|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|10|VEGF|Vascular Endothelial Growth Factor|URINALYSIS|||[?]|[?]|TRACE|1|U/m2/day|1|1|[?]|LOW|MECONIUM|AGGLUTINATED||MICROBIAL CULTURE|GMI MMOL/MOL FORMULA|Y||U|Y|5|Visit_5|90|1|WASHOUT|2020-08-11|2020-08-17|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|f31bab3b-3624-44a5-a62f-f8cf9055eec4|1|NEUTHYGR|Hypogranular Neutrophils|URINALYSIS|[?]|m|[?]|[?]|NEGATIVE|1|10^9 CFU/mL|1|1|[?]|ABNORMAL|CORD BLOOD|LIPEMIC||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|1|TREATMENT|2020-08-09|2020-09-02|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|f31bab3b-3624-44a5-a62f-f8cf9055eec4|2|ERCEMIDX|Erythroid Maturation Index|URINALYSIS|||[?]|[?]|INVALID|1|10^6 U|1|1|[?]|NORMAL|ERYTHROCYTES|AUTOLYZED||TOTAL BODY IRRADIATION|COCKCROFT-GAULT FORMULA|Y||Y|Y|1|Visit_1|10|2|TREATMENT|2020-08-09|2020-08-15|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|f31bab3b-3624-44a5-a62f-f8cf9055eec4|3|CRDIGAAB|Cardiolipin IgA Antibody|HEMATOLOGY|[?]|nsec|[?]|[?]|INVALID|1|mL/kg/h|1|1|[?]|ABNORMAL|VENOUS BLOOD|REFRIGERATED||CORONARY ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||2|Visit_2|25|2|SCREENING|2020-08-24|2020-11-04|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|f31bab3b-3624-44a5-a62f-f8cf9055eec4|4|ACETOAC|Acetoacetic Acid|HEMATOLOGY|[?]|nmol|[?]|[?]|POSITIVE|1|EID 50/mL|1|1|[?]|NORMAL|EMESIS|ICTERIC||RADIAL IMMUNODIFFUSION|HEPASCORE FORMULA||Y|Y||2|Visit_2|25|7|TREATMENT|2020-08-24|2020-08-26|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|f31bab3b-3624-44a5-a62f-f8cf9055eec4|5|CBS|Cystathionine Beta-Synthase|HEMATOLOGY|[?]|PIXELS/in|[?]|[?]|NEGATIVE|1|ug/kg/min|1|1|[?]|LOW|PLASMA|NON-HEMOLYZED||DOPPLER ULTRASOUND|GMI MMOL/MOL FORMULA||Y|N||3|Visit_3|40|2|SCREENING|2020-09-08|2020-10-15|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|f31bab3b-3624-44a5-a62f-f8cf9055eec4|6|CYSTHION|Cystathionine|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mg/animal|1|1|[?]|NORMAL|REFLEX TEAR|UNEXPECTED ODOR||CLIP|MDRD 4 VARIABLE FORMULA|Y||U|Y|3|Visit_3|40|1|TREATMENT|2020-09-08|2020-09-29|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|f31bab3b-3624-44a5-a62f-f8cf9055eec4|7|P1NP|Procollagen 1 N-Terminal Propeptide|HEMATOLOGY|[?]|dpm/100mg|[?]|[?]|INVALID|1|ppb|1|1|[?]|LOW|MONOCYTE|CLOTTED|N|LIGHT MICROSCOPY|COCKCROFT-GAULT FORMULA|||Y||4|Visit_4|65|6|FOLLOW-UP|2020-10-03|2020-10-31|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|f31bab3b-3624-44a5-a62f-f8cf9055eec4|8|C5|Complement C5|URINALYSIS|||[?]|[?]|TRACE|1|%/s|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|AUTOLYZED|N|CALCULATION|MDRD FORMULA|Y||Y|Y|4|Visit_4|65|6|SCREENING|2020-10-03|2020-10-07|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|f31bab3b-3624-44a5-a62f-f8cf9055eec4|9|POIKRBC|Poikilocytes/Erythrocytes|CHEMISTRY|[?]|tuberculin unit/mL|[?]|[?]|POSITIVE|1|mL/cage/wk|1|1|[?]|HIGH|SEMEN|GELLED||PALM METHOD|CKD-EPI CYSTATIN C FORMULA||Y|NA||5|Visit_5|90|1|TREATMENT|2020-10-28|2020-10-31|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|LB|f31bab3b-3624-44a5-a62f-f8cf9055eec4|10|C165882|White Elm Pollen IgE AB RAST Score|HEMATOLOGY|[?]|mL/m2/min|[?]|[?]|NEGATIVE|1|cm|1|1|[?]|ABNORMAL|VENOUS PLASMA|AGGLUTINATED||NO INFORMATION|FIBROTEST FORMULA|Y||NA||5|Visit_5|90|4|TREATMENT|2020-10-28|2020-10-30|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|LB|0b5675aa-4ec0-4548-9a0b-a13f8de89883|1|MG|Magnesium|CHEMISTRY|||[?]|[?]|TRACE|1|g/animal/wk|1|1|[?]|NORMAL|URINE SEDIMENT|THAWED||GEL ELECTROPHORESIS|GMI % FORMULA||Y|U|Y|1|Visit_1|10|7|FOLLOW-UP|2020-06-28|2020-07-07|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|0b5675aa-4ec0-4548-9a0b-a13f8de89883|2|PRORUBCE|Prorubricyte/Total Cells|URINALYSIS|[?]|g/kg|[?]|[?]|INDETERMINATE|1|kat|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|CONTAMINATED||WHOLE EXOME SEQUENCING|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|6|SCREENING|2020-06-28|2020-07-19|10|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|0b5675aa-4ec0-4548-9a0b-a13f8de89883|3|VIP|Vasoactive Intestinal Polypeptide|CHEMISTRY|[?]|Bq/kg|[?]|[?]|TRACE|1|MBq|1|1|[?]|NORMAL|PROSTATIC FLUID|HEMOLYZED||DYNAMOMETRY|MDRD 4 VARIABLE FORMULA|Y||NA||2|Visit_2|25|5|TREATMENT|2020-07-13|2020-09-13|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|0b5675aa-4ec0-4548-9a0b-a13f8de89883|4|PLSTCELE|Total Plasma Cells/Leukocytes|CHEMISTRY|[?]|COAT|[?]|[?]|INVALID|1|cmol|1|1|[?]|LOW|PLEURAL FLUID|CONTAMINATED|N|CALCOFLUOR WHITE STAIN|COCKCROFT-GAULT FORMULA||Y|U||2|Visit_2|25|6|FOLLOW-UP|2020-07-13|2020-08-12|25|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|0b5675aa-4ec0-4548-9a0b-a13f8de89883|5|FAI|Free Androgen Index|URINALYSIS|[?]|PACKET|[?]|[?]|INDETERMINATE|1|mm3/mm2/year|1|1|[?]|NORMAL|INFRANATANT, PLASMA|SOLIDIFIED|N|DIFFUSION WEIGHTED MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|6|WASHOUT|2020-07-28|2020-08-26|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|0b5675aa-4ec0-4548-9a0b-a13f8de89883|6|DDNAIGAB|Anti-Double Stranded DNA IgG|HEMATOLOGY|[?]|cmH2O*s/mL|[?]|[?]|POSITIVE|1|MPL U/mL|1|1|[?]|HIGH|MENSTRUAL BLOOD|LIPEMIC||FLUORIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||3|Visit_3|40|6|SCREENING|2020-07-28|2020-08-05|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|0b5675aa-4ec0-4548-9a0b-a13f8de89883|7|PTAUAB42|Phosphorylated Tau Prot/Amyloid Beta1-42|HEMATOLOGY|[?]|Ci/uL|[?]|[?]|NEGATIVE|1|MET*min|1|1|[?]|NORMAL|SPUTUM|GELLED||HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI FORMULA|||N||4|Visit_4|65|4|TREATMENT|2020-08-22|2020-09-05|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|0b5675aa-4ec0-4548-9a0b-a13f8de89883|8|FEP|Erythrocyte Protoporphyrin, Free|URINALYSIS|[?]|pt_us|[?]|[?]|BORDERLINE|1|U/g/h|1|1|[?]|LOW|NAIL|ICTERIC||MAPH|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||4|Visit_4|65|1|WASHOUT|2020-08-22|2020-09-10|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|0b5675aa-4ec0-4548-9a0b-a13f8de89883|9|APROTCRS|Activated Protein C Resistance|URINALYSIS|[?]|g/m2|[?]|[?]|POSITIVE|1|10^9 CFU|1|1|[?]|HIGH|PLATELET RICH PLASMA|THAWED||CLAUSS METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-09-16|2020-09-17|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|0b5675aa-4ec0-4548-9a0b-a13f8de89883|10|P3NP|Procollagen 3 N-Terminal Propeptide|URINALYSIS|[?]|IMPLANT|[?]|[?]|INDETERMINATE|1|P|1|1|[?]|HIGH|DERMAL TISSUE|REFRIGERATED||OPTICAL COHERENCE TOMOGRAPHY|FIBROTEST FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-09-16|2020-09-23|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|9bdf9856-3b2a-43db-b369-3e13868ef413|1|FXAC|Factor X Actual/Control|CHEMISTRY|||[?]|[?]|BORDERLINE|1|um/s|1|1|[?]|NORMAL|CORD BLOOD|SOLIDIFIED|N|CORONARY ANGIOGRAPHY|NASH FIBROSURE FORMULA|||Y|Y|1|Visit_1|10|4|TREATMENT|2021-01-23|2021-04-13|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|9bdf9856-3b2a-43db-b369-3e13868ef413|2|ALA|Alanine|URINALYSIS|[?]|L|[?]|[?]|NEGATIVE|1|U/dL|1|1|[?]|ABNORMAL|GASTRIC FLUID|CONCENTRATED||PET SCAN|MDRD 4 VARIABLE FORMULA|Y||NA||1|Visit_1|10|2|SCREENING|2021-01-23|2021-04-13|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|9bdf9856-3b2a-43db-b369-3e13868ef413|3|TRANK1|TPR-Ankyrin Repeat-Containing Protein 1|HEMATOLOGY|[?]|nmol/L|[?]|[?]|INVALID|1|cP|1|1|[?]|HIGH|DIALYSIS FLUID|ROOM TEMPERATURE||CONTRAST ENHANCED X-RAY|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|1|TREATMENT|2021-02-07|2021-03-05|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|9bdf9856-3b2a-43db-b369-3e13868ef413|4|OXYCAP|Oxygen Capacity|HEMATOLOGY|||[?]|[?]|POSITIVE|1|g/day|1|1|[?]|LOW|EXUDATE|AUTOLYZED||DC SHEATH FLOW|GMI % FORMULA|||Y|Y|2|Visit_2|25|6|TREATMENT|2021-02-07|2021-02-10|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|9bdf9856-3b2a-43db-b369-3e13868ef413|5|METHPHEN|Methylphenidate|URINALYSIS|[?]|mg/m2/h|[?]|[?]|INVALID|1|g/cage|1|1|[?]|HIGH|PERITONEAL FLUID|CLOTTED||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|FIBROMETER FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2021-02-22|2021-04-04|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|9bdf9856-3b2a-43db-b369-3e13868ef413|6|C165913|Nut Mix IgG AB RAST Score|CHEMISTRY|||[?]|[?]|TRACE|1|ug/g/min|1|1|[?]|ABNORMAL|PLASMA|UNEXPECTED ODOR|N|THICK SMEAR|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|U|Y|3|Visit_3|40|1|TREATMENT|2021-02-22|2021-04-02|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|9bdf9856-3b2a-43db-b369-3e13868ef413|7|FERRITIN|Ferritin|URINALYSIS|[?]|Ci/kg|[?]|[?]|BORDERLINE|1|CAPSULE|1|1|[?]|HIGH|EPIDERMAL TISSUE|LACTESCENT||ACID FAST STAIN|FIBROMETER FORMULA||Y|N||4|Visit_4|65|5|TREATMENT|2021-03-19|2021-03-21|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|LB|9bdf9856-3b2a-43db-b369-3e13868ef413|8|ANAIGGAB|Antinuclear IgG Antibody|HEMATOLOGY|[?]|BAR|[?]|[?]|TRACE|1|fmol/g|1|1|[?]|HIGH|LAVAGE FLUID|GELLED||SXA SCAN|HEPASCORE FORMULA|||Y||4|Visit_4|65|7|TREATMENT|2021-03-19|2021-04-06|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|LB|9bdf9856-3b2a-43db-b369-3e13868ef413|9|TTGIGGAB|Tissue Transglutaminase IgG Antibody|HEMATOLOGY|[?]|msec|[?]|[?]|INVALID|1|mL/m2/min|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|REFRIGERATED||FLUORESCENT ENZYME IMMUNOASSAY|FIBROMETER FORMULA|||U||5|Visit_5|90|5|TREATMENT|2021-04-13|2021-04-18|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|9bdf9856-3b2a-43db-b369-3e13868ef413|10|FRUCT|Fructosamine|CHEMISTRY|[?]|Bq|[?]|[?]|BORDERLINE|1|mL/min/1.73m2|1|1|[?]|NORMAL|SPERMATOZOON|FRESH||ATOMIC ABSORPTION SPECTROMETRY|CKD-EPI CREATININE FORMULA||Y|NA||5|Visit_5|90|3|TREATMENT|2021-04-13|2021-04-20|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|5cc53922-60c0-4bce-8d4a-bc59e9203d63|1|COAGIDX|Coagulation Index|HEMATOLOGY|[?]|mmol/g|[?]|[?]|BORDERLINE|1|ks|1|1|[?]|NORMAL|KERATINOCYTE|GELLED||X-RAY FLUORESCENCE SPECTROMETRY|COCKCROFT-GAULT FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2020-12-28|2021-03-09|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|5cc53922-60c0-4bce-8d4a-bc59e9203d63|2|SAMETH|S-Adenosylmethionine|HEMATOLOGY|[?]|10^6/Ejaculate U|[?]|[?]|INDETERMINATE|1|umol/h/mmol|1|1|[?]|NORMAL|TISSUE|NON-HEMOLYZED|N|CONTRAST ENHANCED PET SCAN|MDRD 4 VARIABLE FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-12-28|2021-01-03|10|16|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|5cc53922-60c0-4bce-8d4a-bc59e9203d63|3|FEPI|Fractional Phosphorus Excretion|HEMATOLOGY|[?]|ng|[?]|[?]|TRACE|1|mL/cage/wk|1|1|[?]|ABNORMAL|DIALYSIS FLUID, PERITONEAL|FROZEN||LEAD CITRATE STAIN|MDRD 6 VARIABLE FORMULA|||U||2|Visit_2|25|7|FOLLOW-UP|2021-01-12|2021-02-08|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|5cc53922-60c0-4bce-8d4a-bc59e9203d63|4|HGBC|Hemoglobin C|CHEMISTRY|[?]|g/U|[?]|[?]|TRACE|1|mL/h|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|CONTAMINATED||IMMUNO-PET SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2021-01-12|2021-03-14|25|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|5cc53922-60c0-4bce-8d4a-bc59e9203d63|5|C130069|Bermuda Grass Pollen IgA|CHEMISTRY|[?]|Watt|[?]|[?]|INDETERMINATE|1|NEEDLE GAUGE|1|1|[?]|LOW|SALIVA|DRIED||CRYOSCOPY|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|3|FOLLOW-UP|2021-01-27|2021-02-25|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|5cc53922-60c0-4bce-8d4a-bc59e9203d63|6|TROPONI3|Troponin I Type 3|CHEMISTRY|[?]|EP U|[?]|[?]|POSITIVE|1|10^6 CFU|1|1|[?]|HIGH|EMOTIONAL TEAR|AGGLUTINATED||COMPLEMENT FIXATION|COCKCROFT-GAULT FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2021-01-27|2021-03-12|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|5cc53922-60c0-4bce-8d4a-bc59e9203d63|7|APOA4|Apolipoprotein A4|URINALYSIS|||[?]|[?]|POSITIVE|1|bel|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|THAWED|N|PET/SPECT SCAN|CKD-EPI CYSTATIN C FORMULA|||N|Y|4|Visit_4|65|1|SCREENING|2021-02-21|2021-03-10|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|LB|5cc53922-60c0-4bce-8d4a-bc59e9203d63|8|PLATBIZ|Bizarre Platelets|URINALYSIS|[?]|mL/mmHg/min/L|[?]|[?]|NEGATIVE|1|KIT|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|CONTAMINATED||STATIC PERIMETRY|ASH FIBROSURE FORMULA|Y||Y||4|Visit_4|65|6|SCREENING|2021-02-21|2021-03-01|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|LB|5cc53922-60c0-4bce-8d4a-bc59e9203d63|9|C165897|Bermuda Grass Pollen IgG AB RAST Score|URINALYSIS|||[?]|[?]|INDETERMINATE|1|10^3 RNA copies/mL|1|1|[?]|HIGH|ABSCESS FLUID|AUTOLYZED|N|NEPHELOMETRY|GMI % FORMULA|||Y|Y|5|Visit_5|90|4|TREATMENT|2021-03-18|2021-03-27|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|LB|5cc53922-60c0-4bce-8d4a-bc59e9203d63|10|CKMT2CK|CK, Macromolecular Type 2/Total CK|HEMATOLOGY|[?]|/40 HPFs|[?]|[?]|INDETERMINATE|1|Bq/L|1|1|[?]|HIGH|PERITONEAL FLUID|AGGLUTINATED|N|POLYGRAPHY|COCKCROFT-GAULT FORMULA||Y|Y||5|Visit_5|90|6|TREATMENT|2021-03-18|2021-03-27|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|LB|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|1|C130134|D. pteronyssinus Antigen IgE Antibody|CHEMISTRY|[?]|/min|[?]|[?]|TRACE|1|ug/min|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|ROOM TEMPERATURE||EIA|CKD-EPI CREATININE FORMULA||Y|NA||1|Visit_1|10|6|TREATMENT|2020-12-29|2021-03-22|10|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|LB|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|2|PLSTCELE|Total Plasma Cells/Leukocytes|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|MASK|1|1|[?]|HIGH|SEBUM|CONCENTRATED|N|GC/FID|GMI MMOL/MOL FORMULA||Y|N|Y|1|Visit_1|10|6|SCREENING|2020-12-29|2021-03-24|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|LB|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|3|GLOBA1PT|Alpha-1 Globulin/Total Protein|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mL/mmHg|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|ICTERIC||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|2|Visit_2|25|1|FOLLOW-UP|2021-01-13|2021-02-17|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|4|C130088|Timothy Grass Pollen IgE|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|/VF|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|AUTOLYZED||WEBER GREEN STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|2|Visit_2|25|4|TREATMENT|2021-01-13|2021-02-26|25|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|5|C165892|Wild Rye Pollen IgE Antibody|CHEMISTRY|||[?]|[?]|POSITIVE|1|mmAL|1|1|[?]|LOW|PROSTATIC FLUID|DRIED||TRANSVAGINAL ULTRASOUND|MDRD 6 VARIABLE FORMULA|||Y|Y|3|Visit_3|40|7|SCREENING|2021-01-28|2021-01-31|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|6|IGG4|Immunoglobulin G Subclass 4|CHEMISTRY|[?]|CCID 50/dose|[?]|[?]|TRACE|1|SUPPOSITORY|1|1|[?]|HIGH|PLATELET POOR PLASMA|ICTERIC|N|COULOMETRIC TITRATION|FIBROMETER FORMULA|Y||Y||3|Visit_3|40|2|FOLLOW-UP|2021-01-28|2021-03-26|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|7|LCHLCM|Lithocholate Compounds|CHEMISTRY|[?]|ug/mol|[?]|[?]|INVALID|1|mEq/L|1|1|[?]|LOW|PERSPIRATION|SOLIDIFIED||CARDIAC THERMODILUTION|MDRD 6 VARIABLE FORMULA|||N||4|Visit_4|65|6|FOLLOW-UP|2021-02-22|2021-02-23|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|8|PO2|Partial Pressure Oxygen|CHEMISTRY|[?]|VOXEL|[?]|[?]|BORDERLINE|1|BAR|1|1|[?]|HIGH|ALVEOLAR AIR|CONCENTRATED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2021-02-22|2021-03-24|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|9|PGF2A|Prostaglandin F2 Alpha|URINALYSIS|[?]|IU/L|[?]|[?]|TRACE|1|mL/min/1.73m2|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|GELLED||ENDOSCOPY|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|2|WASHOUT|2021-03-19|2021-03-20|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|10|PROGESTR|Progesterone Receptor|URINALYSIS|[?]|/200 HPFs|[?]|[?]|NEGATIVE|1|/5x10^4 WBC|1|1|[?]|LOW|PERSPIRATION|GELLED||SCINTIGRAPHY|MDRD FORMULA|||N||5|Visit_5|90|1|TREATMENT|2021-03-19|2021-03-25|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|066281d3-27b8-439f-8340-f59115f646ef|1|UREA|Urea|URINALYSIS|[?]|VIRTUAL PIXEL|[?]|[?]|INDETERMINATE|1|pmol/10^10 cells|1|1|[?]|HIGH|PLATELET|AUTOLYZED|N|WESTERN BLOT|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-10-21|2020-10-29|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|066281d3-27b8-439f-8340-f59115f646ef|2|C130142|German Cockroach Antigen IgG Antibody|URINALYSIS|[?]|AFU|[?]|[?]|INDETERMINATE|1|mmol2/L2|1|1|[?]|LOW|INTERSTITIAL FLUID|CONTAMINATED||TWO-COLOR MICROARRAY|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-10-21|2020-11-24|10|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|066281d3-27b8-439f-8340-f59115f646ef|3|IFNA|Interferon Alpha|HEMATOLOGY|[?]|amol|[?]|[?]|POSITIVE|1|Rad|1|1|[?]|LOW|INFRANATANT, PLASMA|FROZEN||PET/CT SCAN WITHOUT CONTRAST|MDRD FORMULA||Y|Y||2|Visit_2|25|7|WASHOUT|2020-11-05|2021-01-04|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|066281d3-27b8-439f-8340-f59115f646ef|4|NEUTIMLE|Immature Neutrophils/Leukocytes|CHEMISTRY|[?]|PLUG|[?]|[?]|TRACE|1|BOWL|1|1|[?]|LOW|GASTRIC CONTENTS|GELLED||HANSEL STAIN|FIBROSIS 4 FORMULA||Y|U||2|Visit_2|25|7|WASHOUT|2020-11-05|2020-12-31|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|066281d3-27b8-439f-8340-f59115f646ef|5|BTLBTL|Butalbital|URINALYSIS|||[?]|[?]|INVALID|1|mmol2/L2|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|ICTERIC|N|ELASTOGRAPHY|MDRD ENZYMATIC FORMULA|||N|Y|3|Visit_3|40|4|SCREENING|2020-11-20|2021-01-14|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|066281d3-27b8-439f-8340-f59115f646ef|6|RBCDYRBC|Dysmorphic Erythrocytes/Erythrocytes|URINALYSIS|||[?]|[?]|NEGATIVE|1|EP U|1|1|[?]|HIGH|CERUMEN|CONTAMINATED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|GMI % FORMULA|||N|Y|3|Visit_3|40|5|WASHOUT|2020-11-20|2020-12-21|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|066281d3-27b8-439f-8340-f59115f646ef|7|PLSNCE|Neoplastic Plasma Cells|URINALYSIS|||[?]|[?]|TRACE|1|10^6 IU/mL|1|1|[?]|LOW|AMNIOTIC FLUID|AGGLUTINATED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|HEPASCORE FORMULA|Y||Y|Y|4|Visit_4|65|6|WASHOUT|2020-12-15|2020-12-17|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|066281d3-27b8-439f-8340-f59115f646ef|8|PHENTHZ|Phenothiazine|URINALYSIS|[?]|pg/dL|[?]|[?]|POSITIVE|1|/kg|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|HEMOLYZED||ANTIMICROBIAL COMBINATION TESTING|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-12-15|2020-12-20|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|066281d3-27b8-439f-8340-f59115f646ef|9|MYCEPIDX|Myeloid Proliferation Index|URINALYSIS|[?]|mOsm|[?]|[?]|BORDERLINE|1|PIXELS/cm|1|1|[?]|HIGH|LUNG SURFACTANT|FRESH|N|WRIGHT STAIN|FIBROTEST FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2021-01-09|2021-01-10|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|066281d3-27b8-439f-8340-f59115f646ef|10|DNAAB|Anti-DNA Antibodies|HEMATOLOGY|[?]|TUBE|[?]|[?]|INVALID|1|damol/L|1|1|[?]|HIGH|PERSPIRATION|CONTAMINATED||HEMOCYTOMETRY|CKD-EPI CYSTATIN C FORMULA|||N||5|Visit_5|90|2|TREATMENT|2021-01-09|2021-01-17|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|d23cc47e-da96-4042-a69f-60097beaef0e|1|TDTAG|Terminal Deoxynucleotidyl Transferase Ag|URINALYSIS|[?]|MET*min|[?]|[?]|NEGATIVE|1|mg/cm2|1|1|[?]|HIGH|EPIDERMAL TISSUE|CONCENTRATED|N|NON-INVASIVE DIELECTRIC SENSING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2021-01-21|2021-02-10|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|d23cc47e-da96-4042-a69f-60097beaef0e|2|BETACRTN|Beta Carotene|URINALYSIS|[?]|/500 WBC|[?]|[?]|TRACE|1|ukat|1|1|[?]|NORMAL|DIALYSIS FLUID|CONTAMINATED||GC/FID|FIBROSIS 4 FORMULA|||U||1|Visit_1|10|5|FOLLOW-UP|2021-01-21|2021-02-03|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|d23cc47e-da96-4042-a69f-60097beaef0e|3|HCGNDI|Choriogonadotropin, Intact|CHEMISTRY|[?]|mU/L|[?]|[?]|BORDERLINE|1|g/cm2|1|1|[?]|LOW|SKIN TISSUE|SOLIDIFIED||AUDIOMETRY|GMI % FORMULA|||U||2|Visit_2|25|5|TREATMENT|2021-02-05|2021-03-15|25|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|d23cc47e-da96-4042-a69f-60097beaef0e|4|CACRALB|Calcium Corrected for Albumin|HEMATOLOGY|[?]|Watt|[?]|[?]|INDETERMINATE|1|fmol/g|1|1|[?]|HIGH|MONOCYTE|FROZEN||OSCILLOMETRY|HEPASCORE FORMULA||Y|U||2|Visit_2|25|7|TREATMENT|2021-02-05|2021-04-01|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|d23cc47e-da96-4042-a69f-60097beaef0e|5|PHADJT|pH Adjusted for Body Temp|CHEMISTRY|[?]|vg/mL|[?]|[?]|POSITIVE|1|U/g/h|1|1|[?]|LOW|EXUDATE|PARAFFIN-EMBEDDED||RADIAL IMMUNODIFFUSION|COCKCROFT-GAULT FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2021-02-20|2021-04-01|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|LB|d23cc47e-da96-4042-a69f-60097beaef0e|6|BLSTLMLY|Leukemic Blasts/Lymphocytes|CHEMISTRY|[?]|DRUM|[?]|[?]|INVALID|1|mEq/mmol|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|CONCENTRATED||SLIT LAMP|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|3|SCREENING|2021-02-20|2021-03-29|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|LB|d23cc47e-da96-4042-a69f-60097beaef0e|7|CYHIPPAC|Hippuric Acid Crystals|HEMATOLOGY|[?]|g/mol|[?]|[?]|INDETERMINATE|1|APPLICATION|1|1|[?]|NORMAL|TRANSUDATE|CONCENTRATED||AURAMINE STAIN|FIBROSIS 4 FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2021-03-17|2021-04-08|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-03
e|LB|d23cc47e-da96-4042-a69f-60097beaef0e|8|DIHYDCDN|Dihydrocodeine|HEMATOLOGY|[?]|POINT|[?]|[?]|BORDERLINE|1|ng/day|1|1|[?]|HIGH|LEUKOCYTE|HEMOLYZED||SNP ARRAY|FIBROTEST FORMULA||Y|N||4|Visit_4|65|4|SCREENING|2021-03-17|2021-03-22|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-03
e|LB|d23cc47e-da96-4042-a69f-60097beaef0e|9|GLUBD13|1,3-Beta-D-Glucan|HEMATOLOGY|||[?]|[?]|TRACE|1|tuberculin unit/mL|1|1|[?]|LOW|DERMAL TISSUE|LACTESCENT||CONTRAST ENHANCED PET SCAN|MDRD 5 VARIABLE FORMULA|||Y|Y|5|Visit_5|90|6|TREATMENT|2021-04-11|2021-04-19|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|d23cc47e-da96-4042-a69f-60097beaef0e|10|TRIM38|Tripartite Motif Containing Protein 38|HEMATOLOGY|[?]|MBq|[?]|[?]|NEGATIVE|1|g/kg/day|1|1|[?]|HIGH|PUS|AGGLUTINATED|N|SIZE EXCLUSION CHROMATOGRAPHY|MDRD ENZYMATIC FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2021-04-11|2021-04-13|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|b896c679-87d0-4e29-ad27-3944cf09b3ec|1|SCHISTO|Schistocytes|HEMATOLOGY|[?]|mol/day|[?]|[?]|INVALID|1|pmol/L|1|1|[?]|LOW|SEMINAL FLUID|PARAFFIN-EMBEDDED||ENDOSCOPY|ASH FIBROSURE FORMULA|Y|Y|Y||1|Visit_1|10|7|TREATMENT|2021-01-02|2021-02-02|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|LB|b896c679-87d0-4e29-ad27-3944cf09b3ec|2|C165907|Mold Mix IgG AB RAST Score|URINALYSIS|||[?]|[?]|NEGATIVE|1|EP U|1|1|[?]|NORMAL|EPIDERMAL TISSUE|FROZEN||FLUORESCEIN STAIN|MDRD 5 VARIABLE FORMULA||Y|N|Y|1|Visit_1|10|1|WASHOUT|2021-01-02|2021-01-26|10|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|LB|b896c679-87d0-4e29-ad27-3944cf09b3ec|3|GRWHIH|Growth Hormone Inhibiting Hormone|URINALYSIS|[?]|JAR|[?]|[?]|INVALID|1|psi|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|GELLED||DIFFUSION TENSOR MRI|MDRD ENZYMATIC FORMULA||Y|Y||2|Visit_2|25|4|FOLLOW-UP|2021-01-17|2021-01-26|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|b896c679-87d0-4e29-ad27-3944cf09b3ec|4|C130068|Bermuda Grass Pollen IgE|URINALYSIS|[?]|dB|[?]|[?]|BORDERLINE|1|Newton|1|1|[?]|LOW|MUSCLE TISSUE|UNEXPECTED ODOR||OLIGO ACGH|GMI % FORMULA|||N||2|Visit_2|25|6|FOLLOW-UP|2021-01-17|2021-01-31|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|b896c679-87d0-4e29-ad27-3944cf09b3ec|5|C165896|D. pteronyssinus Antigen IgG4 Antibody|CHEMISTRY|[?]|amol|[?]|[?]|BORDERLINE|1|% INHIBITION|1|1|[?]|ABNORMAL|EXUDATE|UNEXPECTED ODOR||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|3|TREATMENT|2021-02-01|2021-03-11|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|b896c679-87d0-4e29-ad27-3944cf09b3ec|6|CTXICRT|Type I Collagen C-Telopeptides/Creat|URINALYSIS|[?]|Log10 ELISA unit/dose|[?]|[?]|POSITIVE|1|Antibody Unit|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|AGGLUTINATED||GRADIENT DIFFUSION|MDRD 6 VARIABLE FORMULA|||Y||3|Visit_3|40|6|FOLLOW-UP|2021-02-01|2021-03-08|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|b896c679-87d0-4e29-ad27-3944cf09b3ec|7|DFI|DNA Fragmentation Index|CHEMISTRY|[?]|mL/g/min|[?]|[?]|INDETERMINATE|1|sec|1|1|[?]|HIGH|SYNOVIAL FLUID|THAWED||BETA LACTAMASE|HEPASCORE FORMULA||Y|Y||4|Visit_4|65|1|TREATMENT|2021-02-26|2021-03-29|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|b896c679-87d0-4e29-ad27-3944cf09b3ec|8|BAFF|B-Cell Activating Factor|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mmHg*min/L|1|1|[?]|LOW|SKIN TISSUE|NON-HEMOLYZED||GC/MS-CI|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|N|Y|4|Visit_4|65|3|WASHOUT|2021-02-26|2021-03-23|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|b896c679-87d0-4e29-ad27-3944cf09b3ec|9|CELLSIM|Immature Cells|HEMATOLOGY|[?]|ug/L DDU|[?]|[?]|BORDERLINE|1|DDU|1|1|[?]|LOW|VITREOUS HUMOR|GELLED||SPECT SCAN|CKD-EPI CYSTATIN C FORMULA|||N||5|Visit_5|90|6|FOLLOW-UP|2021-03-23|2021-04-01|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|b896c679-87d0-4e29-ad27-3944cf09b3ec|10|INTLK33|Interleukin 33|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|IU/kg/h|1|1|[?]|HIGH|INFRANATANT, PLASMA|AUTOLYZED||JAEGER EYE CHART|ASH FIBROSURE FORMULA|Y||Y|Y|5|Visit_5|90|6|WASHOUT|2021-03-23|2021-03-24|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|6d0ec221-6eb6-4fed-806e-2bc700968333|1|CMPK2|Cytidine-Uridine Monophosphate Kinase 2|URINALYSIS|[?]|10^3 CFU/g|[?]|[?]|TRACE|1|MPS U|1|1|[?]|LOW|INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|N|SPECULAR MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|Y||Y||1|Visit_1|10|5|TREATMENT|2020-07-27|2020-09-12|10|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|6d0ec221-6eb6-4fed-806e-2bc700968333|2|ESTRIOL|Estriol|CHEMISTRY|[?]|Hounsfield Unit|[?]|[?]|NEGATIVE|1|10^4/L|1|1|[?]|NORMAL|VENOUS PLASMA|AUTOLYZED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-07-27|2020-08-28|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|6d0ec221-6eb6-4fed-806e-2bc700968333|3|RANTES|Reg upon Act Normal T-cell Exprd Secrtd|URINALYSIS|[?]|/mm|[?]|[?]|INVALID|1|mg/kg/h|1|1|[?]|HIGH|EPIDERMAL TISSUE|CONTAMINATED||PULMONARY ANGIOGRAPHY|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|7|TREATMENT|2020-08-11|2020-08-31|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|6d0ec221-6eb6-4fed-806e-2bc700968333|4|THC|Tetrahydrocannabinol|URINALYSIS|[?]|cm2|[?]|[?]|POSITIVE|1|U/kg|1|1|[?]|LOW|DIALYSIS FLUID|AGGLUTINATED|N|CHROMOGENIC ASSAY|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-08-11|2020-10-18|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|6d0ec221-6eb6-4fed-806e-2bc700968333|5|HRYCECE|Hairy Cells/Total Cells|CHEMISTRY|[?]|log10 PFU/mL|[?]|[?]|BORDERLINE|1|Log10 ELISA unit/dose|1|1|[?]|LOW|BILE|LACTESCENT|N|MAGNETIC RESONANCE ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA|Y||NA||3|Visit_3|40|6|WASHOUT|2020-08-26|2020-09-02|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|6d0ec221-6eb6-4fed-806e-2bc700968333|6|CALPRO|Calprotectin|CHEMISTRY|[?]|pt_br|[?]|[?]|INDETERMINATE|1|HOMEOPATHIC DILUTION|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|DRIED||AUTOMATED COUNT|MDRD FORMULA|Y|Y|Y||3|Visit_3|40|3|FOLLOW-UP|2020-08-26|2020-09-03|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|6d0ec221-6eb6-4fed-806e-2bc700968333|7|PSELECT|P-Selectin|URINALYSIS|||[?]|[?]|INVALID|1|Torr|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|REFRIGERATED||NEXT GENERATION SEQUENCING|ASH FIBROSURE FORMULA|||Y|Y|4|Visit_4|65|7|TREATMENT|2020-09-20|2020-10-06|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|6d0ec221-6eb6-4fed-806e-2bc700968333|8|RANKL|Receptor Activator Nuclear KappaB Ligand|URINALYSIS|||[?]|[?]|INVALID|1|yd|1|1|[?]|NORMAL|FLUID|PARAFFIN-EMBEDDED||NEPHELOMETRY|CKD-EPI CREATININE FORMULA|Y|Y|N|Y|4|Visit_4|65|1|WASHOUT|2020-09-20|2020-10-14|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|6d0ec221-6eb6-4fed-806e-2bc700968333|9|AMPHETD|Dextroamphetamine|URINALYSIS|[?]|mol|[?]|[?]|POSITIVE|1|DIP|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|SOLIDIFIED||MICRODENSITOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||5|Visit_5|90|1|TREATMENT|2020-10-15|2020-10-22|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|6d0ec221-6eb6-4fed-806e-2bc700968333|10|CYAMPPH|Amorphous Phosphate Crystals|URINALYSIS|[?]|log10 PFU/mL|[?]|[?]|POSITIVE|1|vg/kg|1|1|[?]|NORMAL|COLOSTRUM|THAWED|N|LANDOLT RING|HEPASCORE FORMULA|Y||NA||5|Visit_5|90|2|TREATMENT|2020-10-15|2020-10-18|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|1|INTLK29|Interleukin 29|URINALYSIS|[?]|Absorbance U/min|[?]|[?]|INVALID|1|WEEKS|1|1|[?]|LOW|LYMPH|AGGLUTINATED|N|TWO-COLOR MICROARRAY|HEPASCORE FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-10-03|2020-10-09|10|16|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|2|CXCL13|Chemokine (C-X-C Motif) Ligand 13|URINALYSIS|[?]|Torr|[?]|[?]|INVALID|1|DIOPTER|1|1|[?]|LOW|AMNIOTIC FLUID|FRESH|N|PYROSEQUENCING|MDRD 4 VARIABLE FORMULA|||NA||1|Visit_1|10|3|SCREENING|2020-10-03|2020-12-12|10|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|LB|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|3|C130125|Cat Dander Antigen IgG Antibody|CHEMISTRY|[?]|10^6/L|[?]|[?]|INVALID|1|log EID 50/dose|1|1|[?]|ABNORMAL|EMESIS|CONTAMINATED||ALCIAN BLUE STAIN|MDRD ENZYMATIC FORMULA|Y||NA||2|Visit_2|25|4|WASHOUT|2020-10-18|2020-11-20|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|4|MCPHGLE|Macrophages/Leukocytes|URINALYSIS|[?]|um/s|[?]|[?]|INDETERMINATE|1|Antibody Unit|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|NON-HEMOLYZED||LASER CAPTURE MICRODISSECTION|FIBROTEST FORMULA|||NA||2|Visit_2|25|3|WASHOUT|2020-10-18|2020-10-23|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|5|PO2|Partial Pressure Oxygen|URINALYSIS|[?]|dram|[?]|[?]|POSITIVE|1|HOMEOPATHIC DILUTION|1|1|[?]|ABNORMAL|DERMAL TISSUE|FRESH|N|ATOMIC ABSORPTION SPECTROMETRY|FIBROMETER FORMULA|||U||3|Visit_3|40|5|FOLLOW-UP|2020-11-02|2020-12-15|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|6|FBNCTCE|Fibronectin, Cellular|URINALYSIS|||[?]|[?]|TRACE|1|/10^3|1|1|[?]|HIGH|SPERMATOZOON|LACTESCENT||CELLULOSE TAPE|COCKCROFT-GAULT FORMULA|||NA|Y|3|Visit_3|40|3|WASHOUT|2020-11-02|2020-12-05|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|7|HALLUC|Hallucinogen|HEMATOLOGY|[?]|U/g/min|[?]|[?]|NEGATIVE|1|L/s/kPa|1|1|[?]|NORMAL|BLOOD|ICTERIC||LC-FL|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-11-27|2020-12-02|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|8|CEACAM1|CEA Cell Adhesion Molecule 1|URINALYSIS|[?]|IU/day|[?]|[?]|INVALID|1|ms2|1|1|[?]|ABNORMAL|TUMOR TISSUE|PARAFFIN-EMBEDDED|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||Y|U||4|Visit_4|65|5|SCREENING|2020-11-27|2020-12-03|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|9|PLATIM|Immature Platelets|HEMATOLOGY|[?]|PELLET|[?]|[?]|NEGATIVE|1|ag|1|1|[?]|NORMAL|PLATELET RICH PLASMA|LACTESCENT|N|SPIRAL CT|ASH FIBROSURE FORMULA||Y|N||5|Visit_5|90|7|FOLLOW-UP|2020-12-22|2020-12-24|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|10|PLAGMAMP|Platelet Aggregation Mean Amplitude|CHEMISTRY|[?]|nmol/kg/day|[?]|[?]|INDETERMINATE|1|10^5/L|1|1|[?]|HIGH|DISCHARGE|AUTOLYZED||GRADIENT DIFFUSION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||5|Visit_5|90|7|TREATMENT|2020-12-22|2020-12-23|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|15e5e7ca-b832-450c-a20c-b21585086328|1|KRCYMG|Megakaryocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mL/m2/min|1|1|[?]|ABNORMAL|SERUM|DRIED||DIGITAL PCR ARRAY|MDRD 6 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|7|TREATMENT|2021-01-05|2021-02-13|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|15e5e7ca-b832-450c-a20c-b21585086328|2|SULFATE|Sulfate|HEMATOLOGY|[?]|%(w/v)|[?]|[?]|TRACE|1|tsp|1|1|[?]|NORMAL|PUS|LIPEMIC||CLOT DETECTION|HEPASCORE FORMULA|||NA||1|Visit_1|10|1|SCREENING|2021-01-05|2021-01-24|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|15e5e7ca-b832-450c-a20c-b21585086328|3|PSDEPHD|Pseudoephedrine|HEMATOLOGY|[?]|MnFI|[?]|[?]|TRACE|1|10^9 organisms/mL|1|1|[?]|NORMAL|HAIR FOLLICLE|HEMOLYZED||WEBER GREEN STAIN|FIBROMETER FORMULA|||N||2|Visit_2|25|3|WASHOUT|2021-01-20|2021-03-13|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|15e5e7ca-b832-450c-a20c-b21585086328|4|NCCPTN|Nociceptin|URINALYSIS|[?]|Linear ft*LB|[?]|[?]|BORDERLINE|1|GPS U|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|SOLIDIFIED||CALIPER MEASUREMENT METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|7|TREATMENT|2021-01-20|2021-02-03|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|15e5e7ca-b832-450c-a20c-b21585086328|5|ESTRIOLF|Estriol, Free|HEMATOLOGY|[?]|10^6 organisms/mL|[?]|[?]|INVALID|1|U.CARR|1|1|[?]|HIGH|AMNIOTIC FLUID|SOLIDIFIED|N|MALDI|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2021-02-04|2021-03-27|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|15e5e7ca-b832-450c-a20c-b21585086328|6|NEUTGT|Giant Neutrophils|CHEMISTRY|[?]|L/L|[?]|[?]|POSITIVE|1|U/kg|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|THAWED||BALLPOINT PEN TECHNIQUE|MDRD 4 VARIABLE FORMULA|||U||3|Visit_3|40|2|WASHOUT|2021-02-04|2021-02-05|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|15e5e7ca-b832-450c-a20c-b21585086328|7|DOPAC|3,4-Dihydroxyphenylacetic Acid|URINALYSIS|||[?]|[?]|POSITIVE|1|P|1|1|[?]|LOW|LYSATE|CALCIFIED||CELLULAR PROLIFERATION ASSAY|MDRD ENZYMATIC FORMULA|||Y|Y|4|Visit_4|65|5|TREATMENT|2021-03-01|2021-03-16|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|LB|15e5e7ca-b832-450c-a20c-b21585086328|8|ALBIDX|Albumin Index|URINALYSIS|[?]|km/h|[?]|[?]|NEGATIVE|1|umol|1|1|[?]|NORMAL|TUMOR TISSUE|ICTERIC||SIZE EXCLUSION CHROMATOGRAPHY|HEPASCORE FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-03-01|2021-03-12|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|LB|15e5e7ca-b832-450c-a20c-b21585086328|9|RBCNUCLE|Nucleated Erythrocytes/Leukocytes|HEMATOLOGY|[?]|/cmH2O|[?]|[?]|INVALID|1|mEq/mmol|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|AUTOLYZED||SMEAR|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|1|WASHOUT|2021-03-26|2021-04-04|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|15e5e7ca-b832-450c-a20c-b21585086328|10|PKM1|Pyruvate Kinase Isozyme M1|URINALYSIS|||[?]|[?]|POSITIVE|1|10^6 CFU/mL|1|1|[?]|ABNORMAL|STOOL|FROZEN||REFLECTANCE SPECTROSCOPY|NASH FIBROSURE FORMULA||Y|U|Y|5|Visit_5|90|1|SCREENING|2021-03-26|2021-03-31|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|b46ff3a2-f257-4803-8064-e29bd1114bfc|1|PROC6|Pro-C6|HEMATOLOGY|[?]|m|[?]|[?]|INDETERMINATE|1|HOMEOPATHIC DILUTION|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|AGGLUTINATED||MEDIASTINOSCOPY|GMI MMOL/MOL FORMULA|||Y||1|Visit_1|10|7|FOLLOW-UP|2020-10-13|2020-12-16|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|b46ff3a2-f257-4803-8064-e29bd1114bfc|2|RDWR|Ret Volume Distribution Width|CHEMISTRY|||[?]|[?]|POSITIVE|1|APS U|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|SOLIDIFIED|N|REVERSE TRANSCRIPTASE PCR|CKD-EPI CYSTATIN C FORMULA|Y||U|Y|1|Visit_1|10|5|TREATMENT|2020-10-13|2020-10-26|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|b46ff3a2-f257-4803-8064-e29bd1114bfc|3|PYRUVATE|Pyruvate|URINALYSIS|[?]|Bq/kg|[?]|[?]|INDETERMINATE|1|mg/dL|1|1|[?]|LOW|HAIR|SOLIDIFIED||ANTIBIOTIC AGAR SCREEN|MDRD 6 VARIABLE FORMULA|Y||U||2|Visit_2|25|6|FOLLOW-UP|2020-10-28|2020-12-17|25|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|b46ff3a2-f257-4803-8064-e29bd1114bfc|4|CYCAPHOS|Calcium Phosphate Crystals|HEMATOLOGY|[?]|mL/kg/h|[?]|[?]|TRACE|1|g/cage/wk|1|1|[?]|LOW|GASTRIC FLUID|ROOM TEMPERATURE||MICROBIAL CULTURE, LIQUID|MDRD ENZYMATIC FORMULA||Y|Y||2|Visit_2|25|1|WASHOUT|2020-10-28|2020-12-24|25|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|b46ff3a2-f257-4803-8064-e29bd1114bfc|5|MSPIKER|Monoclonal Protein Spike Region|HEMATOLOGY|[?]|mL/min|[?]|[?]|NEGATIVE|1|umol/min|1|1|[?]|NORMAL|BONE MARROW|FROZEN||GC/MS|CKD-EPI CYSTATIN C FORMULA|Y||Y||3|Visit_3|40|3|TREATMENT|2020-11-12|2020-12-13|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|b46ff3a2-f257-4803-8064-e29bd1114bfc|6|CACRTP|Calcium Corrected for Total Protein|URINALYSIS|[?]|sec|[?]|[?]|NEGATIVE|1|mL/animal/wk|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|REFRIGERATED||CONTRAST ENHANCED PET SCAN|GMI MMOL/MOL FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-11-12|2020-12-19|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|b46ff3a2-f257-4803-8064-e29bd1114bfc|7|ESTRDIOL|Estradiol|URINALYSIS|||[?]|[?]|POSITIVE|1|mg/min|1|1|[?]|HIGH|SEMEN|LACTESCENT||OBSERVATION|FIBROMETER FORMULA|||Y|Y|4|Visit_4|65|1|WASHOUT|2020-12-07|2021-01-07|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|b46ff3a2-f257-4803-8064-e29bd1114bfc|8|IDL|IDL Cholesterol|HEMATOLOGY|[?]|deg/mm|[?]|[?]|TRACE|1|/mm2|1|1|[?]|NORMAL|INTERSTITIAL FLUID|REFRIGERATED||INTERRUPTER TECHNIQUE|FIBROSIS 4 FORMULA|Y||Y||4|Visit_4|65|5|TREATMENT|2020-12-07|2020-12-13|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|b46ff3a2-f257-4803-8064-e29bd1114bfc|9|LTD4|Leukotriene D4|URINALYSIS|[?]|MET*h|[?]|[?]|INVALID|1|/sec|1|1|[?]|ABNORMAL|LYSATE|SOLIDIFIED||MAMMOGRAPHY|CKD-EPI FORMULA||Y|Y||5|Visit_5|90|7|SCREENING|2021-01-01|2021-01-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|b46ff3a2-f257-4803-8064-e29bd1114bfc|10|HLAIPRA|HLA Class I Panel Reactive Antibody|HEMATOLOGY|[?]|RFU|[?]|[?]|INVALID|1|POUCH|1|1|[?]|NORMAL|VENOUS CORD BLOOD|SOLIDIFIED|N|DIFFUSION WEIGHTED MRI|ASH FIBROSURE FORMULA|||N||5|Visit_5|90|4|SCREENING|2021-01-01|2021-01-08|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|1|GRWHIH|Growth Hormone Inhibiting Hormone|URINALYSIS|[?]|10^9/L|[?]|[?]|INVALID|1|vg/mL|1|1|[?]|ABNORMAL|MONOCYTE|CALCIFIED||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-12-06|2021-02-27|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|2|FACTXA|Factor X Activity|URINALYSIS|[?]|CARTRIDGE|[?]|[?]|BORDERLINE|1|mg/L FEU|1|1|[?]|HIGH|DISCHARGE|DRIED||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD 5 VARIABLE FORMULA||Y|Y||1|Visit_1|10|3|TREATMENT|2020-12-06|2020-12-15|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|3|AFPADJBW|Alpha Fetoprotein Adj for Body Weight|HEMATOLOGY|[?]|10^3/hpf|[?]|[?]|POSITIVE|1|AgU/mL|1|1|[?]|NORMAL|ALVEOLAR AIR|LACTESCENT||PLETHYSMOGRAPHY|MDRD 6 VARIABLE FORMULA|||U||2|Visit_2|25|3|WASHOUT|2020-12-21|2021-01-19|25|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|4|INTLK15|Interleukin 15|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^3 DNA copies/mL|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|CLOTTED||HILLMEN COLOR CHART|CKD-EPI CREATININE FORMULA|Y||N|Y|2|Visit_2|25|6|TREATMENT|2020-12-21|2021-02-18|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|5|CLEXR|Chloride Excretion Rate|HEMATOLOGY|[?]|kPa/L/sec|[?]|[?]|BORDERLINE|1|Joule|1|1|[?]|LOW|KERATINOCYTE|FRESH||LISSAMINE GREEN STAIN|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|3|WASHOUT|2021-01-05|2021-02-08|40|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|LB|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|6|C130091|Timothy Grass Pollen IgG4|URINALYSIS|||[?]|[?]|NEGATIVE|1|mg/L|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|CALCIFIED|N|PULMONARY ANGIOGRAPHY|ASH FIBROSURE FORMULA||Y|Y|Y|3|Visit_3|40|1|TREATMENT|2021-01-05|2021-02-15|40|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|LB|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|7|LCHLCM|Lithocholate Compounds|CHEMISTRY|[?]|mg/day|[?]|[?]|INDETERMINATE|1|log10 CFU/g|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|SOLIDIFIED||TRYPAN BLUE STAIN|MDRD 5 VARIABLE FORMULA|Y||Y||4|Visit_4|65|7|SCREENING|2021-01-30|2021-02-06|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|8|VCAM1|Vascular Cell Adhesion Molecule 1|URINALYSIS|[?]|10^7 TCID 50/dose|[?]|[?]|INVALID|1|fraction of 1|1|1|[?]|HIGH|TUMOR TISSUE|ROOM TEMPERATURE||TOTAL BODY IRRADIATION|CKD-EPI CYSTATIN C FORMULA||Y|Y||4|Visit_4|65|4|TREATMENT|2021-01-30|2021-02-02|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|9|C130095|Western Ragweed Pollen IgG4|CHEMISTRY|[?]|/7.5 mL|[?]|[?]|POSITIVE|1|log10 IU/mL|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|CALCIFIED||REBOUND TONOMETRY|HEPASCORE FORMULA|||Y||5|Visit_5|90|5|SCREENING|2021-02-24|2021-03-01|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|10|PTHNT|Parathyroid Hormone, N-Terminal|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^3/L|1|1|[?]|LOW|LYMPH|SOLIDIFIED||TOLUIDINE BLUE STAIN|MDRD 6 VARIABLE FORMULA|||NA|Y|5|Visit_5|90|3|FOLLOW-UP|2021-02-24|2021-02-27|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|a5c667d1-d2ac-49f7-ad44-bf9a44762025|1|APAPCYS|Acetaminophen-Cysteine Adduct|HEMATOLOGY|[?]|10^7 CFU|[?]|[?]|NEGATIVE|1|cg|1|1|[?]|ABNORMAL|SERUM|FRESH|N|DIFFUSION WEIGHTED MRI|MDRD ENZYMATIC FORMULA||Y|U||1|Visit_1|10|1|TREATMENT|2020-10-06|2021-01-02|10|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|a5c667d1-d2ac-49f7-ad44-bf9a44762025|2|DRVTSCPD|dRVVT Screen to Confirm Pct Difference|URINALYSIS|[?]|SFC/10^6 PBMC|[?]|[?]|POSITIVE|1|kg/cm2|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|FRESH||REFRACTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|N||1|Visit_1|10|5|WASHOUT|2020-10-06|2020-10-20|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|a5c667d1-d2ac-49f7-ad44-bf9a44762025|3|ELA2|Neutrophil Elastase|CHEMISTRY|[?]|RATIO|[?]|[?]|NEGATIVE|1|mL*cmH2O|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED||WESTERGREN|GMI MMOL/MOL FORMULA||Y|NA||2|Visit_2|25|6|TREATMENT|2020-10-21|2020-12-31|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|a5c667d1-d2ac-49f7-ad44-bf9a44762025|4|APPA|Amyloid Alpha Precursor Protein|CHEMISTRY|[?]|U/mg|[?]|[?]|BORDERLINE|1|cycle/min|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|AUTOLYZED||DNA MICROARRAY|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-10-21|2021-01-01|25|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|a5c667d1-d2ac-49f7-ad44-bf9a44762025|5|KIM1S|Soluble Kidney Injury Molecule-1|CHEMISTRY|[?]|pt_br|[?]|[?]|INDETERMINATE|1|Absorbance U/min|1|1|[?]|NORMAL|KERATINOCYTE|LACTESCENT||PHOTOMETRY|MDRD ENZYMATIC FORMULA||Y|NA||3|Visit_3|40|2|TREATMENT|2020-11-05|2020-11-07|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|LB|a5c667d1-d2ac-49f7-ad44-bf9a44762025|6|DTPACLR|DTPA Clearance|URINALYSIS|[?]|mg/dL|[?]|[?]|BORDERLINE|1|nkat/g Hb|1|1|[?]|HIGH|VITREOUS HUMOR|THAWED||TRIPLE-PHASE SPIRAL CT SCAN|GMI % FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-11-05|2020-11-08|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|LB|a5c667d1-d2ac-49f7-ad44-bf9a44762025|7|GAD2AB|Glutamic Acid Decarboxylase 2 Antibody|URINALYSIS|[?]|um/day|[?]|[?]|POSITIVE|1|mEq/day|1|1|[?]|LOW|EXUDATE|NON-HEMOLYZED||BIOIMPEDANCE SPECTROSCOPY|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|4|WASHOUT|2020-11-30|2020-12-16|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|a5c667d1-d2ac-49f7-ad44-bf9a44762025|8|ANGLOBDR|Antiglobulin Test, Direct|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|ft|1|1|[?]|NORMAL|CAPILLARY BLOOD|ICTERIC||IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA|||Y|Y|4|Visit_4|65|7|TREATMENT|2020-11-30|2020-12-26|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|a5c667d1-d2ac-49f7-ad44-bf9a44762025|9|TNF|Tumor Necrosis Factor|CHEMISTRY|[?]|GBq/g|[?]|[?]|INVALID|1|DAgU|1|1|[?]|NORMAL|HAIR|CONTAMINATED||MIGET|GMI MMOL/MOL FORMULA||Y|Y||5|Visit_5|90|5|FOLLOW-UP|2020-12-25|2020-12-26|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|a5c667d1-d2ac-49f7-ad44-bf9a44762025|10|IGG2|Immunoglobulin G Subclass 2|CHEMISTRY|[?]|WAFER|[?]|[?]|TRACE|1|FIU|1|1|[?]|LOW|TUMOR TISSUE|CONTAMINATED||HILLMEN COLOR CHART|FIBROSIS 4 FORMULA|||N||5|Visit_5|90|3|TREATMENT|2020-12-25|2020-12-26|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|944a2627-13f1-4ecf-9545-8819a1327138|1|PO2ADJT|Partial Pressure Oxygen Adj for Temp|HEMATOLOGY|[?]|mL/h|[?]|[?]|TRACE|1|g/g|1|1|[?]|LOW|BILE|FRESH|N|CT SCAN|CKD-EPI FORMULA|||N||1|Visit_1|10|3|TREATMENT|2021-01-17|2021-04-07|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|944a2627-13f1-4ecf-9545-8819a1327138|2|APRI|AST to Platelet Ratio Index|CHEMISTRY|[?]|PACK|[?]|[?]|NEGATIVE|1|mL/cage|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|UNEXPECTED ODOR||BETA LACTAMASE|MDRD FORMULA|||N||1|Visit_1|10|1|TREATMENT|2021-01-17|2021-02-12|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|944a2627-13f1-4ecf-9545-8819a1327138|3|CKBB|Creatine Kinase BB|CHEMISTRY|[?]|Ci|[?]|[?]|BORDERLINE|1|sec|1|1|[?]|HIGH|DIALYSIS FLUID|ICTERIC||IMMUNOBLOT|NASH FIBROSURE FORMULA|||U||2|Visit_2|25|6|FOLLOW-UP|2021-02-01|2021-03-06|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|944a2627-13f1-4ecf-9545-8819a1327138|4|WBCCLMP|Leukocyte Cell Clumps|URINALYSIS|||[?]|[?]|NEGATIVE|1|log10 PFU|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|CONTAMINATED||HEMOCYTOMETRY|MDRD ENZYMATIC FORMULA||Y|N|Y|2|Visit_2|25|4|SCREENING|2021-02-01|2021-04-02|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|944a2627-13f1-4ecf-9545-8819a1327138|5|INHIBINA|Inhibin A|CHEMISTRY|[?]|mL/m2|[?]|[?]|INDETERMINATE|1|10^7 PFU|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|COCKCROFT-GAULT FORMULA||Y|U||3|Visit_3|40|1|WASHOUT|2021-02-16|2021-02-25|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-09
e|LB|944a2627-13f1-4ecf-9545-8819a1327138|6|NAGASEXR|NAGASE Excretion Rate|HEMATOLOGY|[?]|BOTTLE|[?]|[?]|POSITIVE|1|g/kg|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED||PHYSICAL EXAMINATION|FIBROSIS 4 FORMULA|Y|Y|N||3|Visit_3|40|4|WASHOUT|2021-02-16|2021-03-26|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-09
e|LB|944a2627-13f1-4ecf-9545-8819a1327138|7|C130094|Western Ragweed Pollen IgG|CHEMISTRY|[?]|VOXEL|[?]|[?]|TRACE|1|mL/s/m2|1|1|[?]|HIGH|LYMPH|SOLIDIFIED|N|SICKLE CELL SOLUBILITY TEST|CKD-EPI CREATININE FORMULA|||NA||4|Visit_4|65|1|SCREENING|2021-03-13|2021-03-14|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|944a2627-13f1-4ecf-9545-8819a1327138|8|GAD2|Glutamic Acid Decarboxylase 2|CHEMISTRY|[?]|umol/L/sec|[?]|[?]|INVALID|1|ug/kg/h|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|ROOM TEMPERATURE||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|CKD-EPI CYSTATIN C FORMULA|Y||Y||4|Visit_4|65|1|SCREENING|2021-03-13|2021-03-30|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|944a2627-13f1-4ecf-9545-8819a1327138|9|MOCYCE|Monocytoid Cells|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|CIGARETTE|1|1|[?]|NORMAL|SERUM OR PLASMA|LACTESCENT||GC/MS-CI|MDRD 4 VARIABLE FORMULA|Y|Y|Y|Y|5|Visit_5|90|1|SCREENING|2021-04-07|2021-04-09|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|944a2627-13f1-4ecf-9545-8819a1327138|10|GLOBA|Alpha Globulin|URINALYSIS|[?]|SCOOPFUL|[?]|[?]|INDETERMINATE|1|mL/cm3/min|1|1|[?]|LOW|TUMOR TISSUE|REFRIGERATED|N|SMEAR|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|1|SCREENING|2021-04-07|2021-04-08|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|7902955a-6336-45e5-a15d-7c368a28ac4f|1|PDL1S|Soluble Programmed Death Ligand 1|HEMATOLOGY|||[?]|[?]|INVALID|1|ug/kg/day|1|1|[?]|NORMAL|HAIR|CLOTTED||ORCHIDOMETERY|ASH FIBROSURE FORMULA|Y|Y|NA|Y|1|Visit_1|10|7|TREATMENT|2020-06-01|2020-07-06|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-27
e|LB|7902955a-6336-45e5-a15d-7c368a28ac4f|2|NORMEEXR|Normetanephrine Excretion Rate|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|10^3 RNA copies/mL|1|1|[?]|HIGH|DIALYSIS FLUID|GELLED||CORONARY ANGIOGRAPHY|CKD-EPI CREATININE FORMULA|||NA|Y|1|Visit_1|10|4|TREATMENT|2020-06-01|2020-07-26|10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-27
e|LB|7902955a-6336-45e5-a15d-7c368a28ac4f|3|CREATCLR|Creatinine Clearance|URINALYSIS|[?]|mL/kg|[?]|[?]|POSITIVE|1|copies/ug|1|1|[?]|HIGH|FLUID|THAWED||PYROSEQUENCING|ASH FIBROSURE FORMULA||Y|Y||2|Visit_2|25|4|WASHOUT|2020-06-16|2020-07-25|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|7902955a-6336-45e5-a15d-7c368a28ac4f|4|CFA|Coefficient of Fat Absorption|CHEMISTRY|[?]|tsp eq|[?]|[?]|POSITIVE|1|10^3 RNA copies/mL|1|1|[?]|NORMAL|NAIL|CALCIFIED|N|PULSE OXIMETRY|COCKCROFT-GAULT FORMULA||Y|U||2|Visit_2|25|1|TREATMENT|2020-06-16|2020-06-19|25|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|7902955a-6336-45e5-a15d-7c368a28ac4f|5|SJSSAAB|Sjogrens SS-A Antibody|URINALYSIS|[?]|10^12/L|[?]|[?]|BORDERLINE|1|Bq/mg|1|1|[?]|LOW|TUMOR TISSUE|DRIED||MICROSCOPY|MDRD 6 VARIABLE FORMULA|Y||NA||3|Visit_3|40|2|TREATMENT|2020-07-01|2020-07-17|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|LB|7902955a-6336-45e5-a15d-7c368a28ac4f|6|C165875|Bermuda Grass Pollen IgE AB RAST Score|URINALYSIS|[?]|MnFI|[?]|[?]|NEGATIVE|1|ug/dL|1|1|[?]|HIGH|SMEGMA|CLOTTED|N|CLIP|CKD-EPI CYSTATIN C FORMULA|||N||3|Visit_3|40|4|TREATMENT|2020-07-01|2020-08-03|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|LB|7902955a-6336-45e5-a15d-7c368a28ac4f|7|PSP100AB|P100 Polymyositis-scleroderma Autoag Ab|URINALYSIS|[?]|ks|[?]|[?]|TRACE|1|kDa|1|1|[?]|HIGH|COLOSTRUM|ICTERIC|N|HILLMEN COLOR CHART|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2020-07-26|2020-08-07|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|LB|7902955a-6336-45e5-a15d-7c368a28ac4f|8|HLAAAGT|HLA-A Antigen Type|HEMATOLOGY|[?]|nmol/L/h|[?]|[?]|NEGATIVE|1|m/sec|1|1|[?]|HIGH|SPERMATOZOON|NON-HEMOLYZED||HANSEL STAIN|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|5|WASHOUT|2020-07-26|2020-08-22|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|LB|7902955a-6336-45e5-a15d-7c368a28ac4f|9|TESTOSWB|Testosterone, Weakly Bound|HEMATOLOGY|[?]|DNA copies/mL|[?]|[?]|BORDERLINE|1|deg2|1|1|[?]|HIGH|CAPILLARY PLASMA|REFRIGERATED||SLOAN LETTER EYE CHART 1.25%|MDRD FORMULA|||N||5|Visit_5|90|3|SCREENING|2020-08-20|2020-08-28|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|LB|7902955a-6336-45e5-a15d-7c368a28ac4f|10|ISOPRF2|F2-Isoprostane|URINALYSIS|[?]|Ci/ug|[?]|[?]|NEGATIVE|1|/4.0 mL|1|1|[?]|HIGH|SOFT TISSUE|ROOM TEMPERATURE|N|PULMONARY ANGIOGRAPHY|ASH FIBROSURE FORMULA|Y||N||5|Visit_5|90|4|TREATMENT|2020-08-20|2020-08-22|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|LB|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|1|INTLK33|Interleukin 33|HEMATOLOGY|[?]|10^7 PFU|[?]|[?]|POSITIVE|1|cmH2O/mL|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|REFRIGERATED|N|COULOMETRIC TITRATION|MDRD ENZYMATIC FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-12-20|2021-03-18|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|2|INTLK7|Interleukin 7|HEMATOLOGY|||[?]|[?]|INVALID|1|uCi|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|FROZEN||CHROMATOGRAPHY|NASH FIBROSURE FORMULA|||Y|Y|1|Visit_1|10|2|SCREENING|2020-12-20|2021-02-14|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|3|CCL19|Chemokine (C-C Motif) Ligand 19|CHEMISTRY|||[?]|[?]|INVALID|1|Weber|1|1|[?]|LOW|BONE MARROW|THAWED||DOUBLE IMMUNODIFFUSION|GMI MMOL/MOL FORMULA|Y||N|Y|2|Visit_2|25|5|TREATMENT|2021-01-04|2021-03-10|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|4|MYBLAT3|Type III Myeloblasts|CHEMISTRY|[?]|10^9/g|[?]|[?]|POSITIVE|1|CAPLET|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|CONTAMINATED||COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD FORMULA|||Y||2|Visit_2|25|6|WASHOUT|2021-01-04|2021-02-13|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|5|BASOBLE|Basophils Band Form/Leukocytes|CHEMISTRY|[?]|ohm|[?]|[?]|NEGATIVE|1|GPS U|1|1|[?]|NORMAL|DIALYSIS FLUID|CALCIFIED|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|CKD-EPI FORMULA|||Y||3|Visit_3|40|6|SCREENING|2021-01-19|2021-01-24|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|6|COCBNZEC|Cocaine Benzoylecgonine Ecgonine|URINALYSIS|[?]|anti-Xa IU/mL|[?]|[?]|INDETERMINATE|1|MdFI|1|1|[?]|HIGH|SERUM OR PLASMA|CLOTTED||MICROBIAL CULTURE, SOLID|HEPASCORE FORMULA|Y||Y||3|Visit_3|40|1|TREATMENT|2021-01-19|2021-01-22|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|7|BPIAB|Bactericidal/Permeability-Inc Protein Ab|URINALYSIS|[?]|IU/day|[?]|[?]|NEGATIVE|1|PLUG|1|1|[?]|ABNORMAL|SWABBED MATERIAL|DRIED||FLAME PHOTOMETRY|GMI MMOL/MOL FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-02-13|2021-03-04|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|8|ALPRZLM|Alprazolam|URINALYSIS|[?]|Gy/min|[?]|[?]|NEGATIVE|1|IU/dL|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|LACTESCENT||CISH|CKD-EPI CYSTATIN C FORMULA||Y|N||4|Visit_4|65|4|TREATMENT|2021-02-13|2021-03-15|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|9|B2G1GGAB|Beta-2 Glycoprotein 1 IgG Antibody|URINALYSIS|[?]|fraction of 1|[?]|[?]|TRACE|1|10^9 CFU|1|1|[?]|NORMAL|GASTRIC CONTENTS|FRESH||PHOROPTER|GMI % FORMULA||Y|Y||5|Visit_5|90|2|SCREENING|2021-03-10|2021-03-13|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|10|GLDIGGAB|Gliadin IgG Antibody|URINALYSIS|[?]|10^9/L|[?]|[?]|TRACE|1|Tbsp|1|1|[?]|LOW|EPIDERMAL TISSUE|CONCENTRATED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||5|Visit_5|90|7|TREATMENT|2021-03-10|2021-03-11|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|6071d81f-2f38-414f-90ca-4ad80c971054|1|FACTIII|Factor III|HEMATOLOGY|[?]|cd*s/m2|[?]|[?]|INDETERMINATE|1|Bq/mg|1|1|[?]|ABNORMAL|URINE|REFRIGERATED|N|LIQUID SCINTILLATION COUNTING|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-09-07|2020-09-27|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|6071d81f-2f38-414f-90ca-4ad80c971054|2|C165876|Birch Pollen IgE AB RAST Score|CHEMISTRY|||[?]|[?]|BORDERLINE|1|deg/mm|1|1|[?]|HIGH|MUCUS|CLOTTED||LAPAROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA|Y|1|Visit_1|10|1|SCREENING|2020-09-07|2020-11-11|10|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|6071d81f-2f38-414f-90ca-4ad80c971054|3|T4FRIDX|Thyroxine, Free Index|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^6/Ejaculate U|1|1|[?]|NORMAL|NAIL|AUTOLYZED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 4 VARIABLE FORMULA|||N|Y|2|Visit_2|25|6|SCREENING|2020-09-22|2020-12-01|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|6071d81f-2f38-414f-90ca-4ad80c971054|4|PROLYMLY|Prolymphocytes/Lymphocytes|CHEMISTRY|[?]|PIXEL|[?]|[?]|TRACE|1|IU/g|1|1|[?]|LOW|SMEGMA|CLOTTED|N|FISH|CKD-EPI CYSTATIN C FORMULA|||N||2|Visit_2|25|5|SCREENING|2020-09-22|2020-09-29|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|6071d81f-2f38-414f-90ca-4ad80c971054|5|MYCEMIDX|Myeloid Maturation Index|URINALYSIS|[?]|ug/m2/day|[?]|[?]|TRACE|1|GPL U|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|FROZEN||OPTICAL DENSITY MEASUREMENT|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2020-10-07|2020-10-19|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|6071d81f-2f38-414f-90ca-4ad80c971054|6|ARR|Aldosterone/Renin Activity|URINALYSIS|[?]|MBq|[?]|[?]|TRACE|1|DIOPTER|1|1|[?]|ABNORMAL|CALCULUS|THAWED||HIGH RESOLUTION MELT ANALYSIS|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-10-07|2020-11-20|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|6071d81f-2f38-414f-90ca-4ad80c971054|7|SER|Serine|URINALYSIS|||[?]|[?]|NEGATIVE|1|psec|1|1|[?]|ABNORMAL|SERUM OR PLASMA|CALCIFIED|N|IHC|CKD-EPI CYSTATIN C FORMULA|Y||U|Y|4|Visit_4|65|5|TREATMENT|2020-11-01|2020-11-29|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|6071d81f-2f38-414f-90ca-4ad80c971054|8|HGBCHGB|Hemoglobin C/Total Hemoglobin|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|umol/L|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|CONCENTRATED|N|PERIPHERAL ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|4|Visit_4|65|2|TREATMENT|2020-11-01|2020-11-14|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|6071d81f-2f38-414f-90ca-4ad80c971054|9|COL4|Collagen Type IV|CHEMISTRY|[?]|Absorbance U|[?]|[?]|INDETERMINATE|1|10^7 CFU/mL|1|1|[?]|HIGH|AMNIOTIC FLUID|NON-HEMOLYZED||ELASTOGRAPHY|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|6|WASHOUT|2020-11-26|2020-12-04|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|6071d81f-2f38-414f-90ca-4ad80c971054|10|PCA3MRNA|Prostate Cancer Antigen 3 mRNA|URINALYSIS|[?]|CFU/g|[?]|[?]|INDETERMINATE|1|mL/100g/min|1|1|[?]|ABNORMAL|MONOCYTE|CLOTTED||PHOROPTER|GMI MMOL/MOL FORMULA||Y|U||5|Visit_5|90|7|SCREENING|2020-11-26|2020-11-30|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|1|GRANBCE|Granulocytes Band Form/Total Cells|CHEMISTRY|[?]|ug/cm2|[?]|[?]|BORDERLINE|1|Gy/h|1|1|[?]|ABNORMAL|DIALYSIS FLUID, PERITONEAL|CONCENTRATED||AUSCULTATION|NASH FIBROSURE FORMULA||Y|N||1|Visit_1|10|4|TREATMENT|2020-09-28|2020-10-11|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|2|GUSB|Glucuronidase, Beta|CHEMISTRY|[?]|fmol|[?]|[?]|BORDERLINE|1|mL/breath|1|1|[?]|ABNORMAL|PROSTATIC FLUID|THAWED||CHROMOGENIC ASSAY|MDRD ENZYMATIC FORMULA|||U||1|Visit_1|10|6|WASHOUT|2020-09-28|2020-11-30|10|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|3|HGBCS|Hemoglobin Casts|CHEMISTRY|[?]|Joule|[?]|[?]|BORDERLINE|1|mmHg/sec|1|1|[?]|ABNORMAL|NAIL|REFRIGERATED||SISH|CKD-EPI CYSTATIN C FORMULA||Y|Y||2|Visit_2|25|6|TREATMENT|2020-10-13|2020-10-21|25|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|4|BD2|Beta-defensin 2|HEMATOLOGY|[?]|RING|[?]|[?]|NEGATIVE|1|DISK|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|CONCENTRATED|N|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-10-13|2020-11-25|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|5|LYMCE|Lymphocytes/Total Cells|URINALYSIS|[?]|mL/m2/day|[?]|[?]|POSITIVE|1|fmol/g|1|1|[?]|LOW|GASTRIC FLUID|FROZEN||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||3|Visit_3|40|3|SCREENING|2020-10-28|2020-11-05|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|6|INHIBINA|Inhibin A|URINALYSIS|[?]|mmol/g|[?]|[?]|INVALID|1|10^12/L|1|1|[?]|LOW|PLATELET|LACTESCENT||X-RAY FLUORESCENCE SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA|Y||Y||3|Visit_3|40|4|WASHOUT|2020-10-28|2020-11-29|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|7|PLSIMCLY|Immature Plasma Cells/Lymphocytes|CHEMISTRY|[?]|PELLET|[?]|[?]|NEGATIVE|1|min*mg/mL|1|1|[?]|HIGH|ISOLATE|GELLED|N|IN SITU HYBRIDIZATION|NASH FIBROSURE FORMULA|||U||4|Visit_4|65|5|TREATMENT|2020-11-22|2020-12-01|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|8|COCAETH|Cocaethylene|HEMATOLOGY|[?]|mEq/kg|[?]|[?]|NEGATIVE|1|cycle/min|1|1|[?]|LOW|PUS|ROOM TEMPERATURE||FLUORIMETRY|FIBROSIS 4 FORMULA||Y|Y||4|Visit_4|65|3|WASHOUT|2020-11-22|2020-12-16|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|9|GLDIGGAB|Gliadin IgG Antibody|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mL/cm H2O|1|1|[?]|HIGH|HAIR FOLLICLE|CONCENTRATED|N|PERFUSION MRI|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|5|Visit_5|90|5|TREATMENT|2020-12-17|2020-12-24|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|10|RITALAC|Ritalinic Acid|CHEMISTRY|[?]|Bq/g|[?]|[?]|TRACE|1|CYLINDER|1|1|[?]|LOW|SMEGMA|FROZEN||CONTRAST ENHANCED PET SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||5|Visit_5|90|1|WASHOUT|2020-12-17|2020-12-23|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|a046d48d-b1fa-4d46-902e-3984aed00ec7|1|THYAB|Thyroid Antibodies|HEMATOLOGY|[?]|MnFI|[?]|[?]|NEGATIVE|1|kg/cm|1|1|[?]|HIGH|SUPERNATANT, SERUM|NON-HEMOLYZED||ACRIDINE ORANGE STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|2|FOLLOW-UP|2020-08-01|2020-09-04|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|a046d48d-b1fa-4d46-902e-3984aed00ec7|2|RETIH|High Absorption Reticulocytes|URINALYSIS|[?]|min/day|[?]|[?]|NEGATIVE|1|hPa|1|1|[?]|HIGH|SEMINAL FLUID|LACTESCENT||IMMUNOBLOT|CKD-EPI FORMULA|Y||U||1|Visit_1|10|3|TREATMENT|2020-08-01|2020-10-17|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|a046d48d-b1fa-4d46-902e-3984aed00ec7|3|MMIF|Macrophage Migration Inhibitory Factor|CHEMISTRY|[?]|umol/mg/min|[?]|[?]|BORDERLINE|1|mmol/kg|1|1|[?]|ABNORMAL|PERSPIRATION|HEMOLYZED||DIRECT SEQUENCING|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|4|WASHOUT|2020-08-16|2020-09-17|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|a046d48d-b1fa-4d46-902e-3984aed00ec7|4|VEGFR2S|Soluble Vasc Endoth Growth Factor Rec2|URINALYSIS|[?]|gtt|[?]|[?]|BORDERLINE|1|Ci/L|1|1|[?]|LOW|CELL PELLET|PARAFFIN-EMBEDDED||BAC ACGH|FIBROMETER FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-08-16|2020-10-27|25|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|a046d48d-b1fa-4d46-902e-3984aed00ec7|5|PLSTCE|Total Plasma Cells|URINALYSIS|||[?]|[?]|INDETERMINATE|1|/4.0 mL|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|REFRIGERATED||JAFFE REACTION|GMI % FORMULA||Y|Y|Y|3|Visit_3|40|5|FOLLOW-UP|2020-08-31|2020-09-01|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|a046d48d-b1fa-4d46-902e-3984aed00ec7|6|SECRETIN|Secretin|URINALYSIS|[?]|uL/dose|[?]|[?]|BORDERLINE|1|10^3 organisms/mL|1|1|[?]|NORMAL|BASAL TEAR|AUTOLYZED||ICP-MS|FIBROSIS 4 FORMULA||Y|Y||3|Visit_3|40|2|WASHOUT|2020-08-31|2020-09-12|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|a046d48d-b1fa-4d46-902e-3984aed00ec7|7|BLEEDT|Bleeding Time|CHEMISTRY|[?]|IU/g|[?]|[?]|NEGATIVE|1|ka_u/dL|1|1|[?]|ABNORMAL|HAIR FOLLICLE|DRIED|N|GC/MS-EI|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|7|TREATMENT|2020-09-25|2020-09-27|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|a046d48d-b1fa-4d46-902e-3984aed00ec7|8|GALM|Galactose Mutarotase|CHEMISTRY|||[?]|[?]|BORDERLINE|1|CCID 50/mL|1|1|[?]|NORMAL|INFRANATANT, PLASMA|PARAFFIN-EMBEDDED||FARR ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|4|Visit_4|65|2|FOLLOW-UP|2020-09-25|2020-10-26|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|a046d48d-b1fa-4d46-902e-3984aed00ec7|9|GFR|Glomerular Filtration Rate|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mL/cm3/min|1|1|[?]|NORMAL|SERUM|FROZEN||EIA|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|N|Y|5|Visit_5|90|5|FOLLOW-UP|2020-10-20|2020-10-27|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|a046d48d-b1fa-4d46-902e-3984aed00ec7|10|FLUVOXAM|Fluvoxamine|HEMATOLOGY|[?]|g/L|[?]|[?]|TRACE|1|USP U|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|CONTAMINATED||SINGLE-MOLECULE ARRAY|MDRD 6 VARIABLE FORMULA|||Y||5|Visit_5|90|3|FOLLOW-UP|2020-10-20|2020-10-21|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|8b60e1b0-2cd9-419d-b345-9006af042932|1|C165925|Weed Mix Pollen IgE AB RAST Score|HEMATOLOGY|[?]|MONTHS|[?]|[?]|TRACE|1|GPL U/mL|1|1|[?]|HIGH|INTERSTITIAL FLUID|SOLIDIFIED||ACID FAST STAIN|MDRD FORMULA|||N||1|Visit_1|10|4|WASHOUT|2020-12-16|2021-01-31|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|8b60e1b0-2cd9-419d-b345-9006af042932|2|NMP22|Nuclear Matrix Protein 22|URINALYSIS|[?]|mm/2h|[?]|[?]|TRACE|1|PIPE|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|CONCENTRATED||PULMONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|||N||1|Visit_1|10|4|FOLLOW-UP|2020-12-16|2021-02-28|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|8b60e1b0-2cd9-419d-b345-9006af042932|3|SCBRBTL|Secobarbital|URINALYSIS|[?]|log EID 50/dose|[?]|[?]|BORDERLINE|1|10^7 CFU|1|1|[?]|NORMAL|VENOUS CORD BLOOD|DRIED||ANALYTICAL ULTRACENTRIFUGATION|NASH FIBROSURE FORMULA|Y||U||2|Visit_2|25|5|WASHOUT|2020-12-31|2021-02-22|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|8b60e1b0-2cd9-419d-b345-9006af042932|4|RT3|Triiodothyronine, Reverse|HEMATOLOGY|[?]|mg/animal|[?]|[?]|INDETERMINATE|1|cal|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|DRIED||PHASE-CONTRAST MRI|GMI MMOL/MOL FORMULA|Y||N||2|Visit_2|25|6|TREATMENT|2020-12-31|2021-03-05|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|8b60e1b0-2cd9-419d-b345-9006af042932|5|PROGRP|Pro-gastrin Releasing Peptide|URINALYSIS|||[?]|[?]|NEGATIVE|1|MONTHS|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|GELLED||ETDRS EYE CHART|HEPASCORE FORMULA|||N|Y|3|Visit_3|40|1|TREATMENT|2021-01-15|2021-03-07|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|8b60e1b0-2cd9-419d-b345-9006af042932|6|KYNURNN|Kynurenine|URINALYSIS|[?]|/MBP|[?]|[?]|TRACE|1|mEq/day|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|SOLIDIFIED||COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD 4 VARIABLE FORMULA|Y||Y||3|Visit_3|40|5|SCREENING|2021-01-15|2021-01-25|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|8b60e1b0-2cd9-419d-b345-9006af042932|7|CD33|CD33|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|kg/L|1|1|[?]|NORMAL|EPITHELIAL CELL|PARAFFIN-EMBEDDED||TELLER ACUITY CARDS|MDRD 4 VARIABLE FORMULA|||U|Y|4|Visit_4|65|2|WASHOUT|2021-02-09|2021-02-11|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|8b60e1b0-2cd9-419d-b345-9006af042932|8|FACTV|Factor V|URINALYSIS|[?]|10^11/L|[?]|[?]|INVALID|1|10^7 CFU|1|1|[?]|NORMAL|GASTRIC FLUID|PARAFFIN-EMBEDDED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 4 VARIABLE FORMULA|||U||4|Visit_4|65|3|TREATMENT|2021-02-09|2021-03-01|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|8b60e1b0-2cd9-419d-b345-9006af042932|9|C147279|Zea mays Antigen IgE Antibody|URINALYSIS|[?]|g/kg|[?]|[?]|BORDERLINE|1|mg/mL/day|1|1|[?]|HIGH|VENOUS PLASMA|FRESH||NEPHELOMETRY|GMI % FORMULA|||Y||5|Visit_5|90|6|TREATMENT|2021-03-06|2021-03-10|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|8b60e1b0-2cd9-419d-b345-9006af042932|10|FABP3|Fatty Acid Binding Protein 3|CHEMISTRY|[?]|nmol/L/h|[?]|[?]|BORDERLINE|1|uL|1|1|[?]|NORMAL|TUMOR TISSUE|THAWED||MICROBIAL CULTURE, LIQUID|FIBROSIS 4 FORMULA||Y|U||5|Visit_5|90|7|FOLLOW-UP|2021-03-06|2021-03-12|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|712029bc-471a-4e3d-9123-e38b3c38bc6c|1|KIM1EXR|Kidney Injury Molecule-1 Excretion Rate|HEMATOLOGY|[?]|g/animal/day|[?]|[?]|NEGATIVE|1|L|1|1|[?]|HIGH|BUFFY COAT|AUTOLYZED||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|FIBROMETER FORMULA|Y||N||1|Visit_1|10|1|TREATMENT|2021-01-24|2021-01-29|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-21
e|LB|712029bc-471a-4e3d-9123-e38b3c38bc6c|2|RDWRCV|Ret RDW Coefficient of Variation|URINALYSIS|[?]|mL/cm H2O|[?]|[?]|BORDERLINE|1|cmol|1|1|[?]|LOW|SEBUM|LACTESCENT||PET/CT SCAN WITHOUT CONTRAST|FIBROTEST FORMULA|||N||1|Visit_1|10|4|TREATMENT|2021-01-24|2021-02-24|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-21
e|LB|712029bc-471a-4e3d-9123-e38b3c38bc6c|3|PLATAGGR|Platelet Aggregation|CHEMISTRY|[?]|Henry|[?]|[?]|TRACE|1|kg|1|1|[?]|HIGH|BONE MARROW|CONCENTRATED||NUCLEIC ACID HYBRIDIZATION|MDRD FORMULA|Y||NA||2|Visit_2|25|4|WASHOUT|2021-02-08|2021-02-12|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|712029bc-471a-4e3d-9123-e38b3c38bc6c|4|FLNTRZPM|Flunitrazepam|CHEMISTRY|[?]|m2|[?]|[?]|INDETERMINATE|1|umol/h/mmol|1|1|[?]|ABNORMAL|DIALYSIS FLUID, PERITONEAL|AGGLUTINATED||IMMUNORADIOMETRIC ASSAY|GMI % FORMULA||Y|NA||2|Visit_2|25|1|SCREENING|2021-02-08|2021-03-20|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|712029bc-471a-4e3d-9123-e38b3c38bc6c|5|DFI|DNA Fragmentation Index|URINALYSIS|[?]|nmol/L/min|[?]|[?]|INVALID|1|mV*min|1|1|[?]|HIGH|EXPIRED AIR|CLOTTED||SINGLE-MOLECULE ARRAY|CKD-EPI FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2021-02-23|2021-03-03|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|712029bc-471a-4e3d-9123-e38b3c38bc6c|6|TRIGHDL|Triglycerides/HDL Cholesterol|CHEMISTRY|[?]|pmol|[?]|[?]|POSITIVE|1|CUP|1|1|[?]|HIGH|DISCHARGE|HEMOLYZED||PET/MRI SCAN|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2021-02-23|2021-03-01|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|712029bc-471a-4e3d-9123-e38b3c38bc6c|7|SCBRBTL|Secobarbital|URINALYSIS|[?]|umol/h/mmol|[?]|[?]|INDETERMINATE|1|PIPE|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|HEMOLYZED|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2021-03-20|2021-04-11|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|LB|712029bc-471a-4e3d-9123-e38b3c38bc6c|8|C130083|Orchard Grass Pollen IgG4|HEMATOLOGY|[?]|MPS U|[?]|[?]|INDETERMINATE|1|mm3/mm2/year|1|1|[?]|ABNORMAL|SERUM OR PLASMA|FRESH|N|TRANSTHORACIC ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||4|Visit_4|65|2|SCREENING|2021-03-20|2021-04-15|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|LB|712029bc-471a-4e3d-9123-e38b3c38bc6c|9|PHTRMN|Phentermine|URINALYSIS|[?]|PATCH|[?]|[?]|BORDERLINE|1|mg/day|1|1|[?]|HIGH|BONE|LIPEMIC||CALCULATION|MDRD 4 VARIABLE FORMULA|Y||Y||5|Visit_5|90|5|FOLLOW-UP|2021-04-14|2021-04-17|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|LB|712029bc-471a-4e3d-9123-e38b3c38bc6c|10|GATCPHRL|Gamma Tocopherol|CHEMISTRY|||[?]|[?]|INVALID|1|SBE/mL|1|1|[?]|NORMAL|CORD SERUM|UNEXPECTED ODOR||TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD FORMULA|||NA|Y|5|Visit_5|90|5|WASHOUT|2021-04-14|2021-04-19|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|LB|92c0183d-5704-45ad-9aec-e24bc5777b80|1|HLAA|HLA Class IA Antigen|CHEMISTRY|[?]|copies/ug|[?]|[?]|POSITIVE|1|mEq/dL|1|1|[?]|LOW|AQUEOUS HUMOR|REFRIGERATED||MICROBIAL CULTURE, SOLID|FIBROSIS 4 FORMULA|||NA||1|Visit_1|10|2|SCREENING|2021-01-20|2021-04-13|10|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|92c0183d-5704-45ad-9aec-e24bc5777b80|2|C165937|Zea mays IgE AB RAST Score|CHEMISTRY|[?]|kg|[?]|[?]|TRACE|1|LOZENGE|1|1|[?]|HIGH|SERUM OR PLASMA|AGGLUTINATED||COMPUTERIZED CORNEAL TOPOGRAPHY|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|5|FOLLOW-UP|2021-01-20|2021-04-05|10|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|92c0183d-5704-45ad-9aec-e24bc5777b80|3|PTSAAC|Protein S Activity Actual/Control|URINALYSIS|[?]|mmHg*min/L|[?]|[?]|INVALID|1|ppth|1|1|[?]|HIGH|PLASMA ULTRAFILTRATE|THAWED|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA|||NA||2|Visit_2|25|5|WASHOUT|2021-02-04|2021-04-02|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|92c0183d-5704-45ad-9aec-e24bc5777b80|4|LKM1IGAB|Liver Kidney Microsomal Type 1 IgG Ab|URINALYSIS|[?]|uU/dL|[?]|[?]|INDETERMINATE|1|/LPF|1|1|[?]|HIGH|NAIL|ICTERIC|N|COMPLEMENT FIXATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||2|Visit_2|25|7|TREATMENT|2021-02-04|2021-04-03|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|92c0183d-5704-45ad-9aec-e24bc5777b80|5|UREACRT|Urea/Creatinine|CHEMISTRY|[?]|Gy/min|[?]|[?]|POSITIVE|1|umol/kg/min|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|GELLED|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|CKD-EPI FORMULA|||NA||3|Visit_3|40|4|SCREENING|2021-02-19|2021-03-01|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|LB|92c0183d-5704-45ad-9aec-e24bc5777b80|6|KRCYMGLE|Megakaryocytes/Leukocytes|URINALYSIS|[?]|COAT|[?]|[?]|POSITIVE|1|kg/cm2|1|1|[?]|NORMAL|BASAL TEAR|UNEXPECTED ODOR||DYNAMIC CONTRAST ENHANCED MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2021-02-19|2021-04-12|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|LB|92c0183d-5704-45ad-9aec-e24bc5777b80|7|HBLEPRHB|Hemoglobin Lepore/Total Hemoglobin|URINALYSIS|||[?]|[?]|TRACE|1|L/L|1|1|[?]|ABNORMAL|NAIL|CONTAMINATED||SPIROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|4|Visit_4|65|7|TREATMENT|2021-03-16|2021-03-25|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|LB|92c0183d-5704-45ad-9aec-e24bc5777b80|8|EPITCE|Transitional Epithelial Cells|CHEMISTRY|[?]|anti-Xa IU/mL|[?]|[?]|INDETERMINATE|1|RING|1|1|[?]|LOW|SPUTUM|SOLIDIFIED||CENTRIFUGATION|CKD-EPI FORMULA|||U||4|Visit_4|65|6|TREATMENT|2021-03-16|2021-04-04|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|LB|92c0183d-5704-45ad-9aec-e24bc5777b80|9|SO2|Sulfur Dioxide|HEMATOLOGY|[?]|mg/mol|[?]|[?]|NEGATIVE|1|/h|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|CALCIFIED||MICROBIAL CULTURE|CKD-EPI FORMULA|||N||5|Visit_5|90|2|WASHOUT|2021-04-10|2021-04-18|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|92c0183d-5704-45ad-9aec-e24bc5777b80|10|ANCAB|Anti-Neutrophil Cytoplasmic Antibody|CHEMISTRY|[?]|mol/mol|[?]|[?]|INDETERMINATE|1|ug|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR|N|X-RAY FLUORESCENCE SPECTROMETRY|FIBROMETER FORMULA|Y||NA||5|Visit_5|90|6|SCREENING|2021-04-10|2021-04-14|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|52ce3b1f-9500-4323-861d-73c8b96f59de|1|BLSTNMCE|Normoblasts/Total Cells|URINALYSIS|[?]|L/min/m2|[?]|[?]|BORDERLINE|1|Log10 ELISA unit/dose|1|1|[?]|NORMAL|PLEURAL TISSUE|CLOTTED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||Y|U||1|Visit_1|10|6|SCREENING|2020-10-26|2020-12-13|10|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|52ce3b1f-9500-4323-861d-73c8b96f59de|2|ELA1|Pancreatic Elastase 1|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mg/m2/day|1|1|[?]|LOW|STOOL|AGGLUTINATED|N|CLOT DETECTION|MDRD FORMULA|Y||NA|Y|1|Visit_1|10|5|WASHOUT|2020-10-26|2020-12-17|10|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|52ce3b1f-9500-4323-861d-73c8b96f59de|3|FIO2|Fraction of Inspired Oxygen|HEMATOLOGY|||[?]|[?]|TRACE|1|mol/L|1|1|[?]|NORMAL|VENOUS PLASMA|FROZEN||INDIRECT IMMUNOFLUORESCENCE|GMI % FORMULA||Y|U|Y|2|Visit_2|25|1|TREATMENT|2020-11-10|2020-12-13|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|52ce3b1f-9500-4323-861d-73c8b96f59de|4|PLSTCELE|Total Plasma Cells/Leukocytes|HEMATOLOGY|[?]|ohm|[?]|[?]|INVALID|1|mL/animal/wk|1|1|[?]|LOW|VENOUS BLOOD|UNEXPECTED ODOR||PHASE-CONTRAST MRI|MDRD FORMULA|Y||NA||2|Visit_2|25|2|FOLLOW-UP|2020-11-10|2021-01-20|25|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|52ce3b1f-9500-4323-861d-73c8b96f59de|5|HOMOCIT|Homocitrulline|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|PLUG|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|FROZEN||RADIATION DOSIMETRY|GMI MMOL/MOL FORMULA|||NA|Y|3|Visit_3|40|2|TREATMENT|2020-11-25|2020-12-20|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|52ce3b1f-9500-4323-861d-73c8b96f59de|6|WBCCE|Leukocytes/Total Cells|URINALYSIS|||[?]|[?]|NEGATIVE|1|lx|1|1|[?]|LOW|FLUID|AUTOLYZED|N|BAC ACGH|FIBROTEST FORMULA||Y|N|Y|3|Visit_3|40|1|SCREENING|2020-11-25|2020-12-26|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|52ce3b1f-9500-4323-861d-73c8b96f59de|7|GHRELINA|Active Ghrelin|HEMATOLOGY|[?]|L/day|[?]|[?]|INVALID|1|ug/dL|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|CONTAMINATED|N|MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||Y|N||4|Visit_4|65|4|SCREENING|2020-12-20|2021-01-16|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|52ce3b1f-9500-4323-861d-73c8b96f59de|8|CD33|CD33|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mL/100g/min|1|1|[?]|ABNORMAL|LEUKOCYTE|LIPEMIC||IRON HEMATOXYLIN STAIN|MDRD 4 VARIABLE FORMULA|||U|Y|4|Visit_4|65|3|TREATMENT|2020-12-20|2020-12-31|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|52ce3b1f-9500-4323-861d-73c8b96f59de|9|FXIVAAC|Factor XIV Activity Actual/Control|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ELISA unit|1|1|[?]|LOW|MUSCLE TISSUE|NON-HEMOLYZED||MULTIPLE BREATH WASHOUT|MDRD FORMULA|||U|Y|5|Visit_5|90|2|TREATMENT|2021-01-14|2021-01-15|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|52ce3b1f-9500-4323-861d-73c8b96f59de|10|LYMLG|Large Lymphocytes|CHEMISTRY|[?]|10^5/hpf|[?]|[?]|POSITIVE|1|DRINK|1|1|[?]|NORMAL|VENOUS CORD BLOOD|DRIED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|CKD-EPI CREATININE FORMULA||Y|N||5|Visit_5|90|4|TREATMENT|2021-01-14|2021-01-23|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|3655d198-2e7e-419e-8337-d7eea7d795ca|1|MPC|Mean Platelet Component|URINALYSIS|||[?]|[?]|TRACE|1|pm|1|1|[?]|LOW|VENOUS BLOOD|CONTAMINATED|N|WEBER GREEN STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||Y|Y|1|Visit_1|10|6|TREATMENT|2020-11-23|2021-01-30|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|3655d198-2e7e-419e-8337-d7eea7d795ca|2|CTXI|Type I Collagen C-Telopeptides|HEMATOLOGY|[?]|EID 50/dose|[?]|[?]|INDETERMINATE|1|PFU/mL|1|1|[?]|LOW|LYMPH|NON-HEMOLYZED|N|MYELOPEROXIDASE STAIN|FIBROMETER FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-11-23|2020-12-31|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|3655d198-2e7e-419e-8337-d7eea7d795ca|3|HYPSEGCE|Hypersegmented Cells|URINALYSIS|[?]|APPLICATION|[?]|[?]|INVALID|1|dram|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|LACTESCENT||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD FORMULA||Y|U||2|Visit_2|25|6|FOLLOW-UP|2020-12-08|2020-12-18|25|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|3655d198-2e7e-419e-8337-d7eea7d795ca|4|GLOBB1PT|Beta-1 Globulin/Total Protein|URINALYSIS|[?]|mg/kg/min|[?]|[?]|TRACE|1|s*kPa|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|SOLIDIFIED||MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-12-08|2020-12-10|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|3655d198-2e7e-419e-8337-d7eea7d795ca|5|EPITUCE|Tubular Epithelial Cells|URINALYSIS|[?]|mL/m2/min|[?]|[?]|INVALID|1|Joule|1|1|[?]|ABNORMAL|BILE|DRIED|N|DIRECT SEQUENCING|MDRD FORMULA||Y|NA||3|Visit_3|40|7|TREATMENT|2020-12-23|2020-12-31|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|3655d198-2e7e-419e-8337-d7eea7d795ca|6|CYP2C9|Cytochrome P450 2C9|HEMATOLOGY|[?]|umol/L|[?]|[?]|BORDERLINE|1|ug/g/min|1|1|[?]|NORMAL|TRANSUDATE|GELLED||NUCLEIC ACID AMPLIFICATION TEST|CKD-EPI FORMULA|Y||N||3|Visit_3|40|2|TREATMENT|2020-12-23|2021-02-10|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|3655d198-2e7e-419e-8337-d7eea7d795ca|7|C165877|Cat Dander IgE AB RAST Score|CHEMISTRY|[?]|L/h|[?]|[?]|TRACE|1|vg/kg|1|1|[?]|ABNORMAL|FLUID|LIPEMIC||SLOAN LETTER EYE CHART 100%|HEPASCORE FORMULA|||Y||4|Visit_4|65|6|WASHOUT|2021-01-17|2021-02-04|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|3655d198-2e7e-419e-8337-d7eea7d795ca|8|FSH|Follicle Stimulating Hormone|URINALYSIS|||[?]|[?]|INVALID|1|mm2|1|1|[?]|NORMAL|PLASMA|NON-HEMOLYZED||FLOW CYTOMETRY|CKD-EPI CREATININE FORMULA|||N|Y|4|Visit_4|65|2|FOLLOW-UP|2021-01-17|2021-02-04|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|3655d198-2e7e-419e-8337-d7eea7d795ca|9|TNFSR|Soluble Tumor Necrosis Factor Receptor|URINALYSIS|||[?]|[?]|POSITIVE|1|uEq|1|1|[?]|LOW|CORD SERUM|LACTESCENT||CLAUSS METHOD|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA|Y|5|Visit_5|90|3|FOLLOW-UP|2021-02-11|2021-02-13|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|3655d198-2e7e-419e-8337-d7eea7d795ca|10|CA125AG|Cancer Antigen 125|URINALYSIS|[?]|STRIP|[?]|[?]|INVALID|1|km|1|1|[?]|ABNORMAL|SEMEN|UNEXPECTED ODOR|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|HEPASCORE FORMULA||Y|NA||5|Visit_5|90|1|TREATMENT|2021-02-11|2021-02-18|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|d47da6bf-8abf-4b62-8bb8-797155981158|1|BLASTNCE|Blasts/Nucleated Cells|CHEMISTRY|||[?]|[?]|TRACE|1|umol/h/mmol|1|1|[?]|NORMAL|COLOSTRUM|NON-HEMOLYZED|N|PERCUSSION|FIBROTEST FORMULA||Y|U|Y|1|Visit_1|10|4|SCREENING|2020-09-10|2020-11-28|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|d47da6bf-8abf-4b62-8bb8-797155981158|2|IL1R2|Interleukin 1 Receptor Type 2|CHEMISTRY|[?]|h/wk|[?]|[?]|POSITIVE|1|g/cm2|1|1|[?]|NORMAL|TISSUE|THAWED||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|GMI MMOL/MOL FORMULA|||NA||1|Visit_1|10|3|SCREENING|2020-09-10|2020-11-01|10|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|d47da6bf-8abf-4b62-8bb8-797155981158|3|ADH|Antidiuretic Hormone|HEMATOLOGY|[?]|10^9 CFU/g|[?]|[?]|TRACE|1|cd/m2|1|1|[?]|LOW|CAPILLARY BLOOD|FRESH|N|FLUOROSCOPY|MDRD FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-09-25|2020-10-20|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|d47da6bf-8abf-4b62-8bb8-797155981158|4|DTPACLR|DTPA Clearance|CHEMISTRY|[?]|mm/min|[?]|[?]|NEGATIVE|1|/MBP|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|GELLED||PHASE-CONTRAST MRI|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2020-09-25|2020-10-28|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|d47da6bf-8abf-4b62-8bb8-797155981158|5|STIPBASO|Basophilic Stippling|CHEMISTRY|[?]|10^9 organisms/mL|[?]|[?]|BORDERLINE|1|umol/kg/min|1|1|[?]|LOW|CORD BLOOD|SOLIDIFIED||DYNAMIC CONTRAST ENHANCED MRI|MDRD FORMULA|||N||3|Visit_3|40|5|SCREENING|2020-10-10|2020-11-04|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|d47da6bf-8abf-4b62-8bb8-797155981158|6|GGTEXR|GammaGlutamyl Transferase Excretion Rate|CHEMISTRY|||[?]|[?]|TRACE|1|Ci/L|1|1|[?]|NORMAL|EXPIRED AIR|REFRIGERATED||PULMONARY ANGIOGRAPHY|GMI % FORMULA||Y|NA|Y|3|Visit_3|40|6|TREATMENT|2020-10-10|2020-11-12|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|d47da6bf-8abf-4b62-8bb8-797155981158|7|AAP|Alanine Aminopeptidase|CHEMISTRY|[?]|mIU/L|[?]|[?]|TRACE|1|dpm/mL|1|1|[?]|HIGH|SEBUM|CALCIFIED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI FORMULA|Y||U||4|Visit_4|65|7|TREATMENT|2020-11-04|2020-11-14|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|d47da6bf-8abf-4b62-8bb8-797155981158|8|ANCCLSAB|Neutrophil Cytoplasmic Ab, Classic|CHEMISTRY|[?]|mL/beat|[?]|[?]|INDETERMINATE|1|/HPF|1|1|[?]|ABNORMAL|FLUID|AUTOLYZED||ANTIBIOTIC AGAR SCREEN|MDRD ENZYMATIC FORMULA|Y|Y|Y||4|Visit_4|65|6|TREATMENT|2020-11-04|2020-11-10|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|d47da6bf-8abf-4b62-8bb8-797155981158|9|FACTXI|Factor XI|URINALYSIS|||[?]|[?]|INDETERMINATE|1|TABLET|1|1|[?]|NORMAL|TISSUE|HEMOLYZED|N|MUGA|FIBROSIS 4 FORMULA|Y||Y|Y|5|Visit_5|90|7|WASHOUT|2020-11-29|2020-12-08|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|d47da6bf-8abf-4b62-8bb8-797155981158|10|VITDIT|25-Hydroxyvitamin D|CHEMISTRY|[?]|umol/day|[?]|[?]|TRACE|1|mEq/mL|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|DRIED||BIOPSY|CKD-EPI CYSTATIN C FORMULA||Y|N||5|Visit_5|90|4|TREATMENT|2020-11-29|2020-12-01|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|25e81c81-8c23-4c9e-be79-35247384dd1f|1|FRUCT|Fructosamine|HEMATOLOGY|[?]|nU/cL|[?]|[?]|INDETERMINATE|1|um/day|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|AGGLUTINATED||AGAR DILUTION|MDRD 4 VARIABLE FORMULA|||Y||1|Visit_1|10|3|TREATMENT|2020-08-08|2020-10-23|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|25e81c81-8c23-4c9e-be79-35247384dd1f|2|ADH|Antidiuretic Hormone|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|nkat/g Hb|1|1|[?]|ABNORMAL|LEUKOCYTE|FROZEN||MALDI-TOF|GMI MMOL/MOL FORMULA||Y|Y|Y|1|Visit_1|10|6|SCREENING|2020-08-08|2020-10-18|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|25e81c81-8c23-4c9e-be79-35247384dd1f|3|FBNCTPL|Fibronectin, Plasma|URINALYSIS|[?]|IU/kg/h|[?]|[?]|INVALID|1|/2000 RBC|1|1|[?]|HIGH|CAPILLARY BLOOD|ROOM TEMPERATURE|N|ELISPOT|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|5|FOLLOW-UP|2020-08-23|2020-10-04|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|25e81c81-8c23-4c9e-be79-35247384dd1f|4|FUNGI|Fungi|URINALYSIS|[?]|keV|[?]|[?]|TRACE|1|ug|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|REFRIGERATED||ANTIMICROBIAL COMBINATION TESTING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-08-23|2020-10-19|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|25e81c81-8c23-4c9e-be79-35247384dd1f|5|BLSTLY|Lymphoblasts|URINALYSIS|[?]|log10 PFU|[?]|[?]|INDETERMINATE|1|PFU|1|1|[?]|HIGH|INFRANATANT, PLASMA|FROZEN||HEMATOXYLIN AND EOSIN STAIN|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2020-09-07|2020-10-26|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|25e81c81-8c23-4c9e-be79-35247384dd1f|6|APLAB|Antiphospholipid Antibodies|HEMATOLOGY|||[?]|[?]|POSITIVE|1|kIU|1|1|[?]|ABNORMAL|COLOSTRUM|FROZEN||ETDRS EYE CHART|CKD-EPI CREATININE FORMULA|||NA|Y|3|Visit_3|40|7|TREATMENT|2020-09-07|2020-09-13|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|25e81c81-8c23-4c9e-be79-35247384dd1f|7|IGF1|Insulin-like Growth Factor-1|HEMATOLOGY|[?]|Arbitrary U|[?]|[?]|INDETERMINATE|1|TRACE|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|GELLED||CALIPER MEASUREMENT METHOD|ASH FIBROSURE FORMULA|||NA||4|Visit_4|65|5|FOLLOW-UP|2020-10-02|2020-10-18|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|25e81c81-8c23-4c9e-be79-35247384dd1f|8|MICROCY|Microcytes|HEMATOLOGY|[?]|m/sec|[?]|[?]|NEGATIVE|1|mg/mL/day|1|1|[?]|HIGH|BASAL TEAR|SOLIDIFIED|N|LINE PROBE ASSAY|CKD-EPI CREATININE FORMULA|Y|Y|N||4|Visit_4|65|7|TREATMENT|2020-10-02|2020-10-16|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|25e81c81-8c23-4c9e-be79-35247384dd1f|9|MSTHCELE|Mesothelial Cells/Leukocytes|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|nkat/L|1|1|[?]|LOW|BILE|CONCENTRATED||SNP ARRAY|GMI % FORMULA|Y||U|Y|5|Visit_5|90|1|TREATMENT|2020-10-27|2020-10-28|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|25e81c81-8c23-4c9e-be79-35247384dd1f|10|TRGTCE|Target Cells|HEMATOLOGY|[?]|U/mg|[?]|[?]|POSITIVE|1|mL/m2|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|DRIED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|HEPASCORE FORMULA|Y||N||5|Visit_5|90|4|TREATMENT|2020-10-27|2020-10-31|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|1|GRANCE|Granulocytes/Total Cells|URINALYSIS|[?]|IU/kg/h|[?]|[?]|POSITIVE|1|/sec|1|1|[?]|LOW|URINE SEDIMENT|PARAFFIN-EMBEDDED||CORONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||1|Visit_1|10|4|SCREENING|2020-07-27|2020-09-10|10|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|2|EOSBLE|Eosinophils Band Form/Leukocytes|URINALYSIS|[?]|CAPLET|[?]|[?]|INDETERMINATE|1|ug/day|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|ROOM TEMPERATURE||KARYOTYPING|FIBROTEST FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-07-27|2020-09-17|10|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|3|ANPPROMR|Mid-Reg Pro-Atrial Natriuretic Peptide|HEMATOLOGY|[?]|DAgU/mL|[?]|[?]|BORDERLINE|1|BISCUIT|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|FROZEN|N|LIQUID SCINTILLATION COUNTING|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|5|SCREENING|2020-08-11|2020-09-07|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|4|MOCYCECE|Monocytoid Cells/Total Cells|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|KIT|1|1|[?]|NORMAL|CAPILLARY PLASMA|REFRIGERATED||IMMUNOTURBIDIMETRY|MDRD FORMULA|||N|Y|2|Visit_2|25|3|TREATMENT|2020-08-11|2020-09-01|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|5|GRWHIH|Growth Hormone Inhibiting Hormone|HEMATOLOGY|[?]|IMPLANT|[?]|[?]|BORDERLINE|1|rpm|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|ICTERIC|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-08-26|2020-10-14|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|6|BASO|Basophils|CHEMISTRY|[?]|uV2|[?]|[?]|INDETERMINATE|1|TRACE|1|1|[?]|HIGH|BASAL TEAR|CLOTTED||AMSLER GRID|NASH FIBROSURE FORMULA||Y|N||3|Visit_3|40|7|FOLLOW-UP|2020-08-26|2020-09-11|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|7|C165902|Timothy Grass Pollen IgG AB RAST Score|CHEMISTRY|[?]|/HPF|[?]|[?]|INVALID|1|U/kg/day|1|1|[?]|LOW|BASAL TEAR|CALCIFIED||DIRECT SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||4|Visit_4|65|2|TREATMENT|2020-09-20|2020-09-29|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|8|SFTPD|Surfactant Protein D|CHEMISTRY|[?]|nU/cL|[?]|[?]|NEGATIVE|1|mV/sec|1|1|[?]|HIGH|CEREBROSPINAL FLUID|CONTAMINATED||WRIGHT STAIN|ASH FIBROSURE FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-09-20|2020-09-24|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|9|T4|Thyroxine|HEMATOLOGY|[?]|IU|[?]|[?]|TRACE|1|g/cm2|1|1|[?]|NORMAL|EMOTIONAL TEAR|NON-HEMOLYZED||NO INFORMATION|FIBROMETER FORMULA||Y|N||5|Visit_5|90|5|FOLLOW-UP|2020-10-15|2020-10-17|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|10|VITD2|Vitamin D2|HEMATOLOGY|[?]|DIOPTER|[?]|[?]|TRACE|1|amu|1|1|[?]|NORMAL|COLOSTRUM|ICTERIC||MALDI-TOF|CKD-EPI CYSTATIN C FORMULA|||N||5|Visit_5|90|3|SCREENING|2020-10-15|2020-10-20|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|1|VEGFR2|Vasc Endothelial Growth Factor Rec 2|URINALYSIS|[?]|kg|[?]|[?]|POSITIVE|1|Absorbance U|1|1|[?]|NORMAL|CORD BLOOD|ICTERIC||NO INFORMATION|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|6|FOLLOW-UP|2020-11-12|2021-01-21|10|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|2|GLYHLACD|Glycocholic Acid|URINALYSIS|[?]|10^6 CFU/mL|[?]|[?]|BORDERLINE|1|POINT|1|1|[?]|NORMAL|EXPIRED AIR|LACTESCENT|N|PAP STAIN|MDRD FORMULA||Y|Y||1|Visit_1|10|4|WASHOUT|2020-11-12|2021-01-29|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|3|INGAPAB|Islet Neogenesis Assoc Protein Antibody|HEMATOLOGY|[?]|MBP|[?]|[?]|INVALID|1|mL/animal/day|1|1|[?]|HIGH|PLEURAL TISSUE|CONTAMINATED||OSCILLOMETRY|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|5|WASHOUT|2020-11-27|2020-12-26|25|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|4|C165913|Nut Mix IgG AB RAST Score|HEMATOLOGY|||[?]|[?]|INVALID|1|ug/g/h|1|1|[?]|HIGH|STOOL|LACTESCENT||IMMUNOFLUORESCENT STAIN|MDRD ENZYMATIC FORMULA||Y|Y|Y|2|Visit_2|25|1|SCREENING|2020-11-27|2020-12-19|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|5|NPY|Neuropeptide Y|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Ejaculate U|1|1|[?]|ABNORMAL|SERUM OR PLASMA|LACTESCENT||LISSAMINE GREEN STAIN|MDRD ENZYMATIC FORMULA||Y|NA|Y|3|Visit_3|40|1|SCREENING|2020-12-12|2021-01-10|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|6|CH50|Complement CH50|CHEMISTRY|[?]|g/kg|[?]|[?]|INVALID|1|EP U|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|LIPEMIC||TRIPLE-PHASE SPIRAL CT SCAN|CKD-EPI CREATININE FORMULA|Y||N||3|Visit_3|40|1|TREATMENT|2020-12-12|2020-12-31|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|7|HDW|Hemoglobin Distribution Width|URINALYSIS|[?]|mg/day|[?]|[?]|NEGATIVE|1|cGy|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|HEMOLYZED||ACRIDINE ORANGE STAIN|GMI MMOL/MOL FORMULA|||U||4|Visit_4|65|4|TREATMENT|2021-01-06|2021-01-28|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|8|GLOBB2|Beta-2 Globulin|URINALYSIS|[?]|mmol2/L2|[?]|[?]|INVALID|1|log10 TCID 50/dose|1|1|[?]|ABNORMAL|NAIL|FROZEN||SCINTIGRAPHY|NASH FIBROSURE FORMULA|Y|Y|Y||4|Visit_4|65|1|TREATMENT|2021-01-06|2021-01-16|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|9|TSP1|Thrombospondin 1|HEMATOLOGY|[?]|EID 50/mL|[?]|[?]|INVALID|1|hPa|1|1|[?]|ABNORMAL|LAVAGE FLUID|SOLIDIFIED||PHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||5|Visit_5|90|3|FOLLOW-UP|2021-01-31|2021-02-02|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|10|PHE|Phenylalanine|HEMATOLOGY|[?]|BLOCKS|[?]|[?]|NEGATIVE|1|/h|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|NON-HEMOLYZED|N|MEDIASTINOSCOPY|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|7|FOLLOW-UP|2021-01-31|2021-02-09|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|5ba70148-c29b-47af-9280-10d1a942380a|1|IBCT|Total Iron Binding Capacity|HEMATOLOGY|[?]|ukat/L|[?]|[?]|TRACE|1|RATIO|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED||DYNAMIC CONTRAST ENHANCED MRI|MDRD ENZYMATIC FORMULA||Y|NA||1|Visit_1|10|4|WASHOUT|2020-11-28|2021-01-20|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|5ba70148-c29b-47af-9280-10d1a942380a|2|C165924|Grass Mix Pollen IgE AB RAST Score|URINALYSIS|||[?]|[?]|POSITIVE|1|ug/m2/h|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|SOLIDIFIED||TRANSCRIPTION-MEDIATED AMPLIFICATION|HEPASCORE FORMULA||Y|N|Y|1|Visit_1|10|6|SCREENING|2020-11-28|2021-02-05|10|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|5ba70148-c29b-47af-9280-10d1a942380a|3|V25HD2|25-Hydroxyvitamin D2|CHEMISTRY|[?]|/min|[?]|[?]|TRACE|1|mg/m2|1|1|[?]|LOW|LYSATE|ICTERIC||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD ENZYMATIC FORMULA||Y|U||2|Visit_2|25|3|TREATMENT|2020-12-13|2021-01-25|25|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|5ba70148-c29b-47af-9280-10d1a942380a|4|LKM1IAAB|Liver Kidney Microsomal Type 1 IgA Ab|HEMATOLOGY|[?]|JDF Unit|[?]|[?]|NEGATIVE|1|pg/dL|1|1|[?]|NORMAL|SWABBED MATERIAL|PARAFFIN-EMBEDDED||FARNSWORTH-MUNSELL 100 HUE TEST|GMI % FORMULA|||Y||2|Visit_2|25|4|SCREENING|2020-12-13|2021-01-28|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|5ba70148-c29b-47af-9280-10d1a942380a|5|TUDCA|Tauroursodeoxycholate|URINALYSIS|||[?]|[?]|TRACE|1|dpm/100mg|1|1|[?]|HIGH|HAIR FOLLICLE|REFRIGERATED|N|ELISA|NASH FIBROSURE FORMULA|||N|Y|3|Visit_3|40|2|TREATMENT|2020-12-28|2021-02-04|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|5ba70148-c29b-47af-9280-10d1a942380a|6|CYP2C9|Cytochrome P450 2C9|URINALYSIS|||[?]|[?]|NEGATIVE|1|ft2|1|1|[?]|ABNORMAL|VENOUS BLOOD|LACTESCENT||MICROBIAL CULTURE, SOLID|COCKCROFT-GAULT FORMULA|||U|Y|3|Visit_3|40|4|TREATMENT|2020-12-28|2021-01-06|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|5ba70148-c29b-47af-9280-10d1a942380a|7|O2CT|Oxygen Content|HEMATOLOGY|[?]|Enzyme U/L|[?]|[?]|POSITIVE|1|/10^5|1|1|[?]|ABNORMAL|SOFT TISSUE|NON-HEMOLYZED||GC/MS/MS|HEPASCORE FORMULA|||U||4|Visit_4|65|3|FOLLOW-UP|2021-01-22|2021-02-18|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|5ba70148-c29b-47af-9280-10d1a942380a|8|CD8|CD8|CHEMISTRY|||[?]|[?]|TRACE|1|mmol/min/kPa/L|1|1|[?]|ABNORMAL|SPUTUM|LACTESCENT||APPLANATION TONOMETRY|GMI % FORMULA|||Y|Y|4|Visit_4|65|7|TREATMENT|2021-01-22|2021-02-08|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|5ba70148-c29b-47af-9280-10d1a942380a|9|AMYLOIDP|Amyloid P|CHEMISTRY|||[?]|[?]|POSITIVE|1|uCi|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|PARAFFIN-EMBEDDED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|5|Visit_5|90|4|TREATMENT|2021-02-16|2021-02-20|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|5ba70148-c29b-47af-9280-10d1a942380a|10|HDLPSZ|HDL Particle Size|URINALYSIS|[?]|mL/animal|[?]|[?]|NEGATIVE|1|/500 WBC|1|1|[?]|ABNORMAL|URINE|PARAFFIN-EMBEDDED||AGAR PROPORTION|FIBROTEST FORMULA|||N||5|Visit_5|90|2|TREATMENT|2021-02-16|2021-02-19|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|1|TSHRAB|Thyrotropin Receptor Antibody|HEMATOLOGY|[?]|ug/L DDU|[?]|[?]|POSITIVE|1|Ci/ug|1|1|[?]|ABNORMAL|TRANSUDATE|HEMOLYZED||FREEZING POINT DEPRESSION|NASH FIBROSURE FORMULA||Y|N||1|Visit_1|10|1|WASHOUT|2020-05-27|2020-08-20|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|2|ASTCK|AST/Creatine Kinase|URINALYSIS|[?]|umol/L|[?]|[?]|INDETERMINATE|1|mPa|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|DRIED||DUKE INCISION METHOD|CKD-EPI FORMULA||Y|NA||1|Visit_1|10|6|TREATMENT|2020-05-27|2020-07-20|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|3|LKM1IGAB|Liver Kidney Microsomal Type 1 IgG Ab|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|PFU|1|1|[?]|NORMAL|WHITE MATTER TISSUE|ICTERIC|N|GC/MS|FIBROSIS 4 FORMULA|||Y|Y|2|Visit_2|25|6|TREATMENT|2020-06-11|2020-06-13|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|4|MYBLAT2|Type II Myeloblasts|HEMATOLOGY|[?]|dpm/mg|[?]|[?]|BORDERLINE|1|DAYS|1|1|[?]|NORMAL|TRANSUDATE|HEMOLYZED||DYNAMOMETRY|HEPASCORE FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-06-11|2020-07-21|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|5|CONDUCTU|Urine Conductivity|URINALYSIS|[?]|mU/g|[?]|[?]|NEGATIVE|1|mOsm/L|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED||PET SCAN|MDRD ENZYMATIC FORMULA|Y|Y|NA||3|Visit_3|40|1|WASHOUT|2020-06-26|2020-07-05|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|6|BASOBLE|Basophils Band Form/Leukocytes|HEMATOLOGY|[?]|/40 HPFs|[?]|[?]|BORDERLINE|1|/LPF|1|1|[?]|LOW|EMOTIONAL TEAR|FROZEN|N|FISH|MDRD FORMULA|Y|Y|U||3|Visit_3|40|2|SCREENING|2020-06-26|2020-08-11|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|7|CHOLHDL|Cholesterol/HDL-Cholesterol|CHEMISTRY|[?]|kg/m2|[?]|[?]|BORDERLINE|1|Absorbance U/min|1|1|[?]|LOW|FLUID|AUTOLYZED||WHOLE EXOME SEQUENCING|CKD-EPI FORMULA|||Y||4|Visit_4|65|1|SCREENING|2020-07-21|2020-08-11|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|LB|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|8|VITD|Vitamin D|HEMATOLOGY|[?]|TRACE|[?]|[?]|NEGATIVE|1|mm/2h|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|ICTERIC|N|DIFFUSION TENSOR MRI|NASH FIBROSURE FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2020-07-21|2020-08-14|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|LB|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|9|ACYCRNTN|Acylcarnitine|URINALYSIS|||[?]|[?]|BORDERLINE|1|Coulomb|1|1|[?]|HIGH|ABSCESS FLUID|AGGLUTINATED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROMETER FORMULA|||NA|Y|5|Visit_5|90|3|TREATMENT|2020-08-15|2020-08-16|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|10|PCNAG|Proliferating Cell Nuclear Antigen|URINALYSIS|||[?]|[?]|BORDERLINE|1|mol/mol|1|1|[?]|NORMAL|LYMPH|THAWED||ICC|NASH FIBROSURE FORMULA|Y|Y|N|Y|5|Visit_5|90|2|TREATMENT|2020-08-15|2020-08-23|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|2d8f8b1e-7914-400b-afc5-8dc23a626d76|1|PLSIMCE|Immature Plasma Cells|CHEMISTRY|[?]|10^3/hpf|[?]|[?]|POSITIVE|1|mm/min|1|1|[?]|NORMAL|LEUKOCYTE|HEMOLYZED||POPULATION SEQUENCING|FIBROMETER FORMULA||Y|NA||1|Visit_1|10|5|FOLLOW-UP|2020-06-19|2020-07-07|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|2d8f8b1e-7914-400b-afc5-8dc23a626d76|2|ALBGLOB|Albumin/Globulin|CHEMISTRY|||[?]|[?]|INVALID|1|10^7/L|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|LACTESCENT||OPTICAL COHERENCE TOMOGRAPHY|MDRD 4 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|3|WASHOUT|2020-06-19|2020-09-15|10|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|2d8f8b1e-7914-400b-afc5-8dc23a626d76|3|CXCL4|Chemokine (C-X-C Motif) Ligand 4|HEMATOLOGY|[?]|mL/min/1.73m2|[?]|[?]|TRACE|1|kHz|1|1|[?]|LOW|HAIR|LIPEMIC||CONGO RED STAIN|CKD-EPI FORMULA|||U||2|Visit_2|25|7|TREATMENT|2020-07-04|2020-08-27|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|2d8f8b1e-7914-400b-afc5-8dc23a626d76|4|SIXMAM|6-Monoacetylmorphine|CHEMISTRY|[?]|mL*cmH2O|[?]|[?]|INVALID|1|Enzyme U/L|1|1|[?]|ABNORMAL|SEMINAL FLUID|LACTESCENT|N|WESTERN BLOT|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|NA||2|Visit_2|25|2|TREATMENT|2020-07-04|2020-08-27|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|2d8f8b1e-7914-400b-afc5-8dc23a626d76|5|HBLEPRHB|Hemoglobin Lepore/Total Hemoglobin|CHEMISTRY|[?]|10^6 organisms|[?]|[?]|NEGATIVE|1|mol/mol|1|1|[?]|LOW|LOCHIA|CLOTTED||ISHIHARA COLOR PLATES|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||3|Visit_3|40|2|WASHOUT|2020-07-19|2020-09-11|40|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|2d8f8b1e-7914-400b-afc5-8dc23a626d76|6|HBA1CHGB|Hemoglobin A1C/Hemoglobin|HEMATOLOGY|[?]|mL/mmHg|[?]|[?]|INDETERMINATE|1|PLUG|1|1|[?]|NORMAL|LOCHIA|THAWED||ELECTROCHEMILUMINESCENCE|FIBROTEST FORMULA|Y||Y||3|Visit_3|40|2|WASHOUT|2020-07-19|2020-09-04|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|2d8f8b1e-7914-400b-afc5-8dc23a626d76|7|MAYHEG|May-Hegglin Anomaly|URINALYSIS|||[?]|[?]|BORDERLINE|1|s/h|1|1|[?]|ABNORMAL|BONE|ROOM TEMPERATURE||AUTOREFRACTION|HEPASCORE FORMULA||Y|N|Y|4|Visit_4|65|7|TREATMENT|2020-08-13|2020-08-18|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|2d8f8b1e-7914-400b-afc5-8dc23a626d76|8|AMYLASEP|Amylase, Pancreatic|HEMATOLOGY|||[?]|[?]|POSITIVE|1|uCi/L|1|1|[?]|NORMAL|BILE|FRESH||GRAM STAIN|MDRD ENZYMATIC FORMULA||Y|N|Y|4|Visit_4|65|7|TREATMENT|2020-08-13|2020-08-15|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|2d8f8b1e-7914-400b-afc5-8dc23a626d76|9|C130103|Grass Mix Pollen Antigen IgE Antibody|CHEMISTRY|[?]|mL/mmHg/min/L|[?]|[?]|BORDERLINE|1|MnFI|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|THAWED|N|SPIRAL CT|MDRD 5 VARIABLE FORMULA|Y|Y|Y||5|Visit_5|90|3|FOLLOW-UP|2020-09-07|2020-09-10|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|2d8f8b1e-7914-400b-afc5-8dc23a626d76|10|PGD2|Prostaglandin D2|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mL/m2/min|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|AGGLUTINATED||SNELLEN EYE CHART|MDRD FORMULA|||Y|Y|5|Visit_5|90|7|WASHOUT|2020-09-07|2020-09-14|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|1|APOB|Apolipoprotein B|URINALYSIS|[?]|mol/g|[?]|[?]|TRACE|1|10^7/L|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|REFRIGERATED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||1|Visit_1|10|3|SCREENING|2020-08-20|2020-08-30|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|2|IFI44|Interferon-Induced Protein 44|CHEMISTRY|[?]|mEq|[?]|[?]|INDETERMINATE|1|10^6/Ejaculate U|1|1|[?]|LOW|ABSCESS FLUID|LIPEMIC||RADIOGRAPHY|CKD-EPI FORMULA|Y||U||1|Visit_1|10|6|TREATMENT|2020-08-20|2020-10-06|10|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|3|EOSMYL|Eosinophilic Myelocytes|URINALYSIS|[?]|/40 HPFs|[?]|[?]|BORDERLINE|1|nmol/L/h|1|1|[?]|ABNORMAL|SMEGMA|THAWED||PUPILLOMETRY|HEPASCORE FORMULA|Y||NA||2|Visit_2|25|3|TREATMENT|2020-09-04|2020-11-12|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|4|ETPTPR|ETP Time to Peak Relative|URINALYSIS|[?]|ugEq|[?]|[?]|NEGATIVE|1|BEAM BREAKS|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|REFRIGERATED||AUTOREFRACTION|CKD-EPI FORMULA|||Y||2|Visit_2|25|7|WASHOUT|2020-09-04|2020-09-17|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|5|INULIN|Inulin|CHEMISTRY|||[?]|[?]|POSITIVE|1|kg/cm2|1|1|[?]|ABNORMAL|BREAST MILK|ICTERIC||CELL OF ORIGIN ASSAY|MDRD ENZYMATIC FORMULA|||NA|Y|3|Visit_3|40|1|TREATMENT|2020-09-19|2020-11-14|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|6|TNFSR2|Soluble TNF Receptor Type II|URINALYSIS|[?]|IU/day|[?]|[?]|INVALID|1|ELISA unit|1|1|[?]|HIGH|BASAL TEAR|REFRIGERATED|N|DC SHEATH FLOW|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||3|Visit_3|40|2|FOLLOW-UP|2020-09-19|2020-10-26|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|7|IL1SR1|Soluble Interleukin-1 Receptor Type I|HEMATOLOGY|[?]|10^7/L|[?]|[?]|TRACE|1|mL/beat|1|1|[?]|HIGH|CORD BLOOD|PARAFFIN-EMBEDDED||DIGITAL PCR ARRAY|CKD-EPI CREATININE FORMULA|Y|Y|NA||4|Visit_4|65|2|TREATMENT|2020-10-14|2020-11-15|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|8|DZPM|Diazepam|CHEMISTRY|[?]|Arbitrary U|[?]|[?]|NEGATIVE|1|mMU/mL|1|1|[?]|NORMAL|MUSCLE TISSUE|REFRIGERATED||IMMUNODIFFUSION|CKD-EPI FORMULA||Y|Y||4|Visit_4|65|1|WASHOUT|2020-10-14|2020-11-04|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|9|C165927|Animal Mix IgE AB RAST Score|CHEMISTRY|[?]|cmH2O*s/mL|[?]|[?]|INDETERMINATE|1|mMU/mL|1|1|[?]|NORMAL|VENOUS BLOOD|LIPEMIC||HEMOCYTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||5|Visit_5|90|6|TREATMENT|2020-11-08|2020-11-10|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|10|G6PDRBRB|G6PD-Deficient Erythrocytes/Erythrocytes|URINALYSIS|||[?]|[?]|POSITIVE|1|EID 50/mL|1|1|[?]|NORMAL|LOCHIA|CONTAMINATED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD 5 VARIABLE FORMULA||Y|Y|Y|5|Visit_5|90|3|TREATMENT|2020-11-08|2020-11-14|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|a73142e4-e34b-4144-b95f-7a5562574c1b|1|GSTMUCRT|Mu Glutathione-S-Transferase/Creatinine|URINALYSIS|[?]|CYLINDER|[?]|[?]|POSITIVE|1|mOsm/kg|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|FROZEN||PALPATION|CKD-EPI CYSTATIN C FORMULA||Y|Y||1|Visit_1|10|1|TREATMENT|2020-08-08|2020-10-05|10|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|a73142e4-e34b-4144-b95f-7a5562574c1b|2|SDH|Sorbitol Dehydrogenase|URINALYSIS|||[?]|[?]|BORDERLINE|1|AU/mL|1|1|[?]|LOW|LUNG SURFACTANT|SOLIDIFIED||QUANTITATIVE ULTRASOUND|COCKCROFT-GAULT FORMULA|Y||NA|Y|1|Visit_1|10|5|SCREENING|2020-08-08|2020-09-15|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|a73142e4-e34b-4144-b95f-7a5562574c1b|3|HALPRZLM|Hydroxyalprazolam|CHEMISTRY|[?]|Absorbance U/mL|[?]|[?]|INVALID|1|kPa/L/sec|1|1|[?]|HIGH|PLATELET|AUTOLYZED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA|Y||U||2|Visit_2|25|7|SCREENING|2020-08-23|2020-10-26|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|LB|a73142e4-e34b-4144-b95f-7a5562574c1b|4|CAPHOSPD|Calcium - Phosphorus Product|CHEMISTRY|[?]|V/sec|[?]|[?]|BORDERLINE|1|U/g|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|ROOM TEMPERATURE|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-08-23|2020-10-01|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|LB|a73142e4-e34b-4144-b95f-7a5562574c1b|5|OAS1|2-5-Oligoadenylate Synthase 1|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|Newton|1|1|[?]|NORMAL|PLATELET|CLOTTED||LIQUID SCINTILLATION COUNTING|NASH FIBROSURE FORMULA|||U|Y|3|Visit_3|40|7|WASHOUT|2020-09-07|2020-09-17|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|a73142e4-e34b-4144-b95f-7a5562574c1b|6|PLATHCT|Platelet Hematocrit|URINALYSIS|[?]|MBq|[?]|[?]|INDETERMINATE|1|Coulomb|1|1|[?]|LOW|INFRANATANT, PLASMA|LIPEMIC||ENZYMATIC ULTRACENTRIFUGATION|HEPASCORE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-09-07|2020-09-26|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|a73142e4-e34b-4144-b95f-7a5562574c1b|7|ANCAB|Anti-Neutrophil Cytoplasmic Antibody|CHEMISTRY|[?]|ug/min|[?]|[?]|NEGATIVE|1|/month|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|THAWED||SCINTIGRAPHY|NASH FIBROSURE FORMULA|Y||N||4|Visit_4|65|3|TREATMENT|2020-10-02|2020-11-04|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|a73142e4-e34b-4144-b95f-7a5562574c1b|8|HDWR|Ret Hemoglobin Distribution Width|CHEMISTRY|[?]|PIXELS/in|[?]|[?]|BORDERLINE|1|BOLUS|1|1|[?]|ABNORMAL|REFLEX TEAR|HEMOLYZED||WESTERGREN|FIBROSIS 4 FORMULA|||Y||4|Visit_4|65|6|WASHOUT|2020-10-02|2020-10-15|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|a73142e4-e34b-4144-b95f-7a5562574c1b|9|NEUTMM|Neutrophilic Metamyelocytes|URINALYSIS|[?]|/MBP|[?]|[?]|BORDERLINE|1|BOWL|1|1|[?]|LOW|PLEURAL TISSUE|AUTOLYZED|N|HPLC-FL|MDRD FORMULA|||N||5|Visit_5|90|6|SCREENING|2020-10-27|2020-10-31|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|a73142e4-e34b-4144-b95f-7a5562574c1b|10|BACT|Bacteria|HEMATOLOGY|[?]|Log10 ELISA unit|[?]|[?]|INDETERMINATE|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|CORD BLOOD|CLOTTED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|ASH FIBROSURE FORMULA|Y||U||5|Visit_5|90|3|TREATMENT|2020-10-27|2020-10-31|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|1|TIMP1CRE|TIMP1/Creatinine|CHEMISTRY|[?]|JDF Unit|[?]|[?]|POSITIVE|1|mEq/uL|1|1|[?]|HIGH|GASTRIC CONTENTS|HEMOLYZED||TARGETED TRANSCRIPTOME SEQUENCING|ASH FIBROSURE FORMULA||Y|U||1|Visit_1|10|1|FOLLOW-UP|2020-06-03|2020-08-22|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|2|MCPHGCE|Macrophages/Total Cells|HEMATOLOGY|[?]|FFU|[?]|[?]|INDETERMINATE|1|BU/mL|1|1|[?]|LOW|PLEURAL FLUID|PARAFFIN-EMBEDDED||ERGOSPIROMETRY|MDRD ENZYMATIC FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-06-03|2020-06-22|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|3|C130115|Industrial Mix Antigen IgG Antibody|HEMATOLOGY|[?]|days/month|[?]|[?]|TRACE|1|U/g/h|1|1|[?]|NORMAL|CORD BLOOD|AGGLUTINATED||MRS|FIBROMETER FORMULA|Y||Y||2|Visit_2|25|1|TREATMENT|2020-06-18|2020-08-16|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|LB|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|4|GFRBSCUA|GFR from Creat,UreaN,Alb Adj BSA|URINALYSIS|[?]|uIU/L|[?]|[?]|INDETERMINATE|1|CFU/g|1|1|[?]|HIGH|PLEURAL TISSUE|GELLED||NUCLEAR RADIOLOGY|FIBROMETER FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-06-18|2020-07-13|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|LB|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|5|C130075|Birch Pollen IgG4|CHEMISTRY|[?]|POUCH|[?]|[?]|INVALID|1|pL|1|1|[?]|HIGH|CAPILLARY BLOOD|CONTAMINATED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|FIBROTEST FORMULA|||Y||3|Visit_3|40|6|SCREENING|2020-07-03|2020-07-08|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|6|DNA|Deoxyribonucleic Acid|HEMATOLOGY|||[?]|[?]|INVALID|1|mL*cmH2O|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|FRESH||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA|||N|Y|3|Visit_3|40|5|TREATMENT|2020-07-03|2020-07-14|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|7|BICARB|Bicarbonate|HEMATOLOGY|[?]|kg/cm2|[?]|[?]|TRACE|1|BU/mL|1|1|[?]|NORMAL|INTERSTITIAL FLUID|SOLIDIFIED||FLUORESCENT ENZYME IMMUNOASSAY|FIBROMETER FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-07-28|2020-08-24|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|LB|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|8|LCHLCM|Lithocholate Compounds|HEMATOLOGY|[?]|F|[?]|[?]|INDETERMINATE|1|mg/m2/day|1|1|[?]|LOW|DIALYSIS FLUID|REFRIGERATED|N|POPULATION SEQUENCING|MDRD 5 VARIABLE FORMULA|||NA||4|Visit_4|65|1|SCREENING|2020-07-28|2020-08-06|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|LB|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|9|DRVVTRT|Dilute Russell's Viper Venom Time Ratio|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|Ci/uL|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|GELLED||MECHANICAL CLOT DETECTION|MDRD 4 VARIABLE FORMULA||Y|N|Y|5|Visit_5|90|5|TREATMENT|2020-08-22|2020-08-31|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|10|C130080|Orchard Grass Pollen IgE|URINALYSIS|[?]|cycle/min|[?]|[?]|BORDERLINE|1|kg/cm|1|1|[?]|NORMAL|LUNG SURFACTANT|GELLED||WHOLE TRANSCRIPTOME SEQUENCING|COCKCROFT-GAULT FORMULA|Y|Y|Y||5|Visit_5|90|6|WASHOUT|2020-08-22|2020-08-23|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|0f682806-b63c-4c3f-9fda-1e59befbd3a3|1|V25HD2|25-Hydroxyvitamin D2|URINALYSIS|[?]|steps/min|[?]|[?]|INVALID|1|U/g/h|1|1|[?]|LOW|PUS|AUTOLYZED||PHOTOMETRIC CLOT DETECTION|FIBROTEST FORMULA|Y|Y|N||1|Visit_1|10|7|TREATMENT|2020-05-29|2020-07-08|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|0f682806-b63c-4c3f-9fda-1e59befbd3a3|2|CAFFEINE|Caffeine|HEMATOLOGY|[?]|tsp|[?]|[?]|INDETERMINATE|1|dpm/0.5 mL|1|1|[?]|NORMAL|ALVEOLAR AIR|DRIED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|HEPASCORE FORMULA||Y|U||1|Visit_1|10|4|SCREENING|2020-05-29|2020-07-29|10|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|0f682806-b63c-4c3f-9fda-1e59befbd3a3|3|AMPHETD|Dextroamphetamine|URINALYSIS|[?]|L/kg|[?]|[?]|INVALID|1|10^4/hpf|1|1|[?]|LOW|EXPIRED AIR|FRESH||ATOMIC ABSORPTION SPECTROMETRY|HEPASCORE FORMULA|||Y||2|Visit_2|25|5|FOLLOW-UP|2020-06-13|2020-06-15|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|0f682806-b63c-4c3f-9fda-1e59befbd3a3|4|ASTCREAT|Aspartate Aminotransferase/Creatinine|HEMATOLOGY|[?]|DRINK|[?]|[?]|INDETERMINATE|1|ug/mol|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|AGGLUTINATED||CT SCAN|COCKCROFT-GAULT FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-06-13|2020-07-31|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|0f682806-b63c-4c3f-9fda-1e59befbd3a3|5|TLYMXM|T-lymphocyte Crossmatch|HEMATOLOGY|||[?]|[?]|TRACE|1|m2|1|1|[?]|NORMAL|PLATELET|GELLED|N|OPTICAL MAPPING|NASH FIBROSURE FORMULA|Y||N|Y|3|Visit_3|40|4|TREATMENT|2020-06-28|2020-07-11|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|LB|0f682806-b63c-4c3f-9fda-1e59befbd3a3|6|CRYOGLBN|Cryoglobulin|URINALYSIS|||[?]|[?]|INDETERMINATE|1|log10 PFU|1|1|[?]|LOW|TUMOR TISSUE|CONCENTRATED||IMMUNOTURBIDIMETRY|MDRD 4 VARIABLE FORMULA||Y|Y|Y|3|Visit_3|40|4|SCREENING|2020-06-28|2020-08-12|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|LB|0f682806-b63c-4c3f-9fda-1e59befbd3a3|7|BHYXBTR|Beta-Hydroxybutyrate|CHEMISTRY|[?]|Gauss|[?]|[?]|INVALID|1|APL U|1|1|[?]|HIGH|SUPERNATANT, SERUM|AUTOLYZED||PULSE OXIMETRY|HEPASCORE FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-07-23|2020-08-10|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|0f682806-b63c-4c3f-9fda-1e59befbd3a3|8|MACROCY|Macrocytes|CHEMISTRY|[?]|/2500 WBC|[?]|[?]|TRACE|1|mU|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|CLOTTED||HPLC-FL|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|5|WASHOUT|2020-07-23|2020-08-16|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|0f682806-b63c-4c3f-9fda-1e59befbd3a3|9|ALDEPX|Aldrin Epoxidase|CHEMISTRY|[?]|10^6 copies/mL|[?]|[?]|NEGATIVE|1|uEq|1|1|[?]|NORMAL|CORD SERUM|SOLIDIFIED||IN SITU HYBRIDIZATION|GMI % FORMULA||Y|N||5|Visit_5|90|5|TREATMENT|2020-08-17|2020-08-25|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|0f682806-b63c-4c3f-9fda-1e59befbd3a3|10|BLSTSID|Sideroblast|HEMATOLOGY|[?]|1/(s*kPa)|[?]|[?]|INDETERMINATE|1|min/day|1|1|[?]|HIGH|DIALYSIS FLUID|NON-HEMOLYZED|N|ROMANOWSKY STAIN|FIBROTEST FORMULA|Y||Y||5|Visit_5|90|1|TREATMENT|2020-08-17|2020-08-25|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|1d8aba56-f62e-4116-b447-899dedd3d4df|1|LYS|Lysine|CHEMISTRY|[?]|CFU/g|[?]|[?]|POSITIVE|1|nmol/mol|1|1|[?]|ABNORMAL|CORD BLOOD|AGGLUTINATED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|HEPASCORE FORMULA||Y|Y||1|Visit_1|10|5|TREATMENT|2020-09-29|2020-11-25|10|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|1d8aba56-f62e-4116-b447-899dedd3d4df|2|GLUCPED|Plasma Equivalent Glucose Distribution|HEMATOLOGY|[?]|v/v|[?]|[?]|INVALID|1|hPa|1|1|[?]|HIGH|BONE|GELLED||REFLECTANCE SPECTROSCOPY|FIBROTEST FORMULA||Y|Y||1|Visit_1|10|3|FOLLOW-UP|2020-09-29|2020-11-08|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|1d8aba56-f62e-4116-b447-899dedd3d4df|3|RPTLTIME|Reptilase Time|HEMATOLOGY|||[?]|[?]|INVALID|1|vp/dose|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|PARAFFIN-EMBEDDED||ENZYMATIC SPECTROPHOTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N|Y|2|Visit_2|25|1|SCREENING|2020-10-14|2020-12-21|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|1d8aba56-f62e-4116-b447-899dedd3d4df|4|LDLP|LDL Particles|URINALYSIS|||[?]|[?]|BORDERLINE|1|/2000 RBC|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|CLOTTED||VENTILATION PERFUSION LUNG SCAN|FIBROMETER FORMULA||Y|Y|Y|2|Visit_2|25|3|TREATMENT|2020-10-14|2020-11-28|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|1d8aba56-f62e-4116-b447-899dedd3d4df|5|LEU|Leucine|URINALYSIS|[?]|10^6/Ejaculate U|[?]|[?]|INDETERMINATE|1|L/min|1|1|[?]|NORMAL|PLASMA|GELLED|N|MANUAL CLOT DETECTION|FIBROTEST FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-10-29|2020-11-12|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|1d8aba56-f62e-4116-b447-899dedd3d4df|6|EOSIM|Immature Eosinophils|HEMATOLOGY|[?]|nkat/g Hb|[?]|[?]|BORDERLINE|1|nmol/day|1|1|[?]|LOW|REFLEX TEAR|NON-HEMOLYZED||FARR ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|NA||3|Visit_3|40|7|WASHOUT|2020-10-29|2020-11-08|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|1d8aba56-f62e-4116-b447-899dedd3d4df|7|BASOB|Basophils Band Form|CHEMISTRY|[?]|CONTAINER|[?]|[?]|INDETERMINATE|1|pmol/L|1|1|[?]|LOW|TISSUE|HEMOLYZED||KINETIC MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|4|SCREENING|2020-11-23|2020-12-08|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|1d8aba56-f62e-4116-b447-899dedd3d4df|8|MIDCEF|Mid Cell Fraction|URINALYSIS|[?]|mmol2/L2|[?]|[?]|POSITIVE|1|in|1|1|[?]|HIGH|BILE|THAWED||HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-11-23|2020-12-03|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|1d8aba56-f62e-4116-b447-899dedd3d4df|9|CYCASULF|Calcium Sulfate Crystals|HEMATOLOGY|[?]|mL/mmHg/min/L|[?]|[?]|INVALID|1|km|1|1|[?]|LOW|SEMEN|AGGLUTINATED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|FIBROMETER FORMULA|||Y||5|Visit_5|90|4|WASHOUT|2020-12-18|2020-12-22|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|1d8aba56-f62e-4116-b447-899dedd3d4df|10|CRP|C Reactive Protein|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|kg/cm|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED|N|ELECTROGASTROGRAPHY|FIBROSIS 4 FORMULA|Y|Y|Y|Y|5|Visit_5|90|6|TREATMENT|2020-12-18|2020-12-19|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|1|ELLIPCY|Elliptocytes|URINALYSIS|[?]|C|[?]|[?]|INVALID|1|PIPE|1|1|[?]|HIGH|BILE|ICTERIC||HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI CREATININE FORMULA|||Y||1|Visit_1|10|3|WASHOUT|2020-08-14|2020-10-01|10|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|2|LDL|LDL Cholesterol|URINALYSIS|[?]|/HPF|[?]|[?]|NEGATIVE|1|umol/L|1|1|[?]|ABNORMAL|MECONIUM|GELLED||AUSCULTATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||1|Visit_1|10|7|WASHOUT|2020-08-14|2020-09-08|10|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|3|C130123|Nut Mix Antigen IgG Antibody|URINALYSIS|[?]|mL/m2/min|[?]|[?]|INDETERMINATE|1|10^9 CFU/g|1|1|[?]|NORMAL|LOCHIA|FROZEN||MECHANICAL CLOT DETECTION|COCKCROFT-GAULT FORMULA||Y|N||2|Visit_2|25|7|SCREENING|2020-08-29|2020-10-03|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|4|GMI|Glucose Management Indicator|HEMATOLOGY|[?]|mmol2/L2|[?]|[?]|INDETERMINATE|1|mEq/ug|1|1|[?]|ABNORMAL|ISOLATE|CLOTTED||ACCELERATOR MASS SPECTROMETRY|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-08-29|2020-10-07|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|5|HCT|Hematocrit|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|TRACE|1|1|[?]|HIGH|SPUTUM|REFRIGERATED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|COCKCROFT-GAULT FORMULA|||U|Y|3|Visit_3|40|7|FOLLOW-UP|2020-09-13|2020-10-27|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|6|CD161ALY|CD161a/Lymphocytes|HEMATOLOGY|[?]|mol/mol|[?]|[?]|BORDERLINE|1|uIU/L|1|1|[?]|LOW|SEMINAL FLUID|LACTESCENT||CELLULAR PROLIFERATION ASSAY|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-09-13|2020-11-10|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|7|NEUTVAC|Vacuolated Neutrophils|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|umol/mg/min|1|1|[?]|HIGH|LYSATE|DRIED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA|Y|Y|NA|Y|4|Visit_4|65|5|SCREENING|2020-10-08|2020-11-09|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|8|PBG|Porphobilinogen|HEMATOLOGY|[?]|ECL unit|[?]|[?]|NEGATIVE|1|INHALATION|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|HEMOLYZED||ENZYMATIC SPECTROPHOTOMETRY|ASH FIBROSURE FORMULA||Y|NA||4|Visit_4|65|2|SCREENING|2020-10-08|2020-11-04|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|9|HPOCROM|Hypochromia|CHEMISTRY|[?]|Rad|[?]|[?]|POSITIVE|1|mmol/s|1|1|[?]|LOW|AMNIOTIC FLUID|LACTESCENT||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|GMI % FORMULA|Y||NA||5|Visit_5|90|3|SCREENING|2020-11-02|2020-11-10|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|10|CCL16|Chemokine (C-C Motif) Ligand 16|URINALYSIS|[?]|Osm|[?]|[?]|INDETERMINATE|1|Joule|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|CONTAMINATED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROTEST FORMULA|Y||U||5|Visit_5|90|3|SCREENING|2020-11-02|2020-11-11|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|LB|383d3f30-14b7-48c3-b1a8-0f481ef37a50|1|CYCYSTIN|Cystine Crystals|HEMATOLOGY|[?]|L/s/kPa|[?]|[?]|INVALID|1|ELISA unit/dose|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|LIPEMIC||ALCIAN BLUE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||1|Visit_1|10|4|WASHOUT|2020-06-07|2020-09-01|10|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|383d3f30-14b7-48c3-b1a8-0f481ef37a50|2|PTSFAAC|Protein S Free Activity Actual/Control|HEMATOLOGY|[?]|mm/sec|[?]|[?]|POSITIVE|1|ms2|1|1|[?]|LOW|TRANSUDATE|CLOTTED||IMMUNOCHROMATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|NA||1|Visit_1|10|6|FOLLOW-UP|2020-06-07|2020-07-12|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|383d3f30-14b7-48c3-b1a8-0f481ef37a50|3|HCGND|Choriogonadotropin|HEMATOLOGY|[?]|kg/cm2|[?]|[?]|INDETERMINATE|1|U/kg/day|1|1|[?]|ABNORMAL|HAIR FOLLICLE|ICTERIC|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-06-22|2020-07-26|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|383d3f30-14b7-48c3-b1a8-0f481ef37a50|4|IGHG4|Immunoglobulin Heavy Constant Gamma 4|CHEMISTRY|[?]|kDa|[?]|[?]|INDETERMINATE|1|bel|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|REFRIGERATED||HIGH RESOLUTION CT|HEPASCORE FORMULA||Y|N||2|Visit_2|25|2|SCREENING|2020-06-22|2020-07-14|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|383d3f30-14b7-48c3-b1a8-0f481ef37a50|5|CDCACM|Chenodeoxycholate Compounds|URINALYSIS|[?]|km/h|[?]|[?]|BORDERLINE|1|vg/dose|1|1|[?]|ABNORMAL|VITREOUS HUMOR|FRESH||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA|Y||Y||3|Visit_3|40|6|TREATMENT|2020-07-07|2020-09-01|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|LB|383d3f30-14b7-48c3-b1a8-0f481ef37a50|6|HYDMDZ4|4-Hydroxymidazolam|URINALYSIS|[?]|10^3 organisms/g|[?]|[?]|INVALID|1|mN|1|1|[?]|NORMAL|DIALYSIS FLUID|HEMOLYZED||SPIRAL CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|2|TREATMENT|2020-07-07|2020-07-29|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|LB|383d3f30-14b7-48c3-b1a8-0f481ef37a50|7|VIP|Vasoactive Intestinal Polypeptide|URINALYSIS|[?]|Sv|[?]|[?]|INVALID|1|mIU/L|1|1|[?]|NORMAL|REFLEX TEAR|NON-HEMOLYZED||NEXT GENERATION TARGETED SEQUENCING|HEPASCORE FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2020-08-01|2020-08-04|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|LB|383d3f30-14b7-48c3-b1a8-0f481ef37a50|8|ANUAB|Anti-Nucleosome Antibody|URINALYSIS|[?]|Enzyme U|[?]|[?]|BORDERLINE|1|mV*min|1|1|[?]|LOW|SOFT TISSUE|REFRIGERATED|N|ENDOSCOPY|NASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|2|TREATMENT|2020-08-01|2020-08-23|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|LB|383d3f30-14b7-48c3-b1a8-0f481ef37a50|9|PKM|Pyruvate Kinase Muscle Isozyme|URINALYSIS|[?]|DPM|[?]|[?]|INVALID|1|PA|1|1|[?]|LOW|LOCHIA|CALCIFIED||ELISPOT|ASH FIBROSURE FORMULA|Y||N||5|Visit_5|90|6|TREATMENT|2020-08-26|2020-08-27|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|383d3f30-14b7-48c3-b1a8-0f481ef37a50|10|BACT|Bacteria|HEMATOLOGY|[?]|10^3 organisms/mL|[?]|[?]|TRACE|1|mg/g/h|1|1|[?]|ABNORMAL|LOCHIA|LIPEMIC||IMPEDANCE CONDUCTIVITY|MDRD FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-08-26|2020-09-01|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|b4f81b74-fee9-4544-9404-206d931ed8e5|1|FATACFR|Free Fatty Acid|CHEMISTRY|[?]|copies/ug|[?]|[?]|POSITIVE|1|Weber|1|1|[?]|HIGH|VENOUS PLASMA|AGGLUTINATED||AMSLER GRID|HEPASCORE FORMULA|||N||1|Visit_1|10|2|SCREENING|2020-10-18|2020-12-05|10|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|b4f81b74-fee9-4544-9404-206d931ed8e5|2|OXYCAP|Oxygen Capacity|URINALYSIS|||[?]|[?]|BORDERLINE|1|ukat|1|1|[?]|ABNORMAL|CORD BLOOD|LIPEMIC||GRAM STAIN|HEPASCORE FORMULA|||U|Y|1|Visit_1|10|4|TREATMENT|2020-10-18|2020-10-19|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|b4f81b74-fee9-4544-9404-206d931ed8e5|3|TNF12|TNF Superfamily Member 12|HEMATOLOGY|||[?]|[?]|TRACE|1|fmol/L|1|1|[?]|ABNORMAL|SEMINAL FLUID|CONTAMINATED|N|ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA|Y||U|Y|2|Visit_2|25|2|SCREENING|2020-11-02|2020-12-02|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|b4f81b74-fee9-4544-9404-206d931ed8e5|4|LYMMCE|Lymphoma Cells|CHEMISTRY|||[?]|[?]|TRACE|1|CAPLET|1|1|[?]|NORMAL|INFRANATANT, PLASMA|THAWED||ACCELERATOR MASS SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA|||NA|Y|2|Visit_2|25|7|TREATMENT|2020-11-02|2020-12-21|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|b4f81b74-fee9-4544-9404-206d931ed8e5|5|CXCL4|Chemokine (C-X-C Motif) Ligand 4|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|cmol|1|1|[?]|HIGH|COLOSTRUM|ICTERIC||MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|3|Visit_3|40|7|SCREENING|2020-11-17|2020-12-04|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|b4f81b74-fee9-4544-9404-206d931ed8e5|6|CARNITF|Carnitine, Free|CHEMISTRY|[?]|Rad|[?]|[?]|BORDERLINE|1|min/day|1|1|[?]|NORMAL|CAPILLARY PLASMA|AUTOLYZED||TOTAL BODY RADIOGRAPHY|FIBROSIS 4 FORMULA|||U||3|Visit_3|40|2|FOLLOW-UP|2020-11-17|2020-11-20|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|b4f81b74-fee9-4544-9404-206d931ed8e5|7|RLP|RLP Cholesterol|CHEMISTRY|[?]|g/g/day|[?]|[?]|NEGATIVE|1|gtt|1|1|[?]|NORMAL|LYMPH|CONCENTRATED||NON-CONTACT SPECULAR MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-12-12|2020-12-25|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|b4f81b74-fee9-4544-9404-206d931ed8e5|8|IGHG2|Immunoglobulin Heavy Constant Gamma 2|HEMATOLOGY|[?]|tsp eq|[?]|[?]|TRACE|1|V|1|1|[?]|LOW|PLATELET RICH PLASMA|ROOM TEMPERATURE||WHOLE GENOME SEQUENCING|MDRD FORMULA||Y|N||4|Visit_4|65|7|TREATMENT|2020-12-12|2020-12-15|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|b4f81b74-fee9-4544-9404-206d931ed8e5|9|TRP1TRG1|Trypsin 1 and Trypsinogen 1|CHEMISTRY|[?]|nmol/g|[?]|[?]|BORDERLINE|1|/4.0 mL|1|1|[?]|LOW|CAPILLARY PLASMA|REFRIGERATED|N|NO INFORMATION|MDRD 6 VARIABLE FORMULA|||N||5|Visit_5|90|3|TREATMENT|2021-01-06|2021-01-08|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|b4f81b74-fee9-4544-9404-206d931ed8e5|10|ELA2PMN|Neutrophil Elastase, Polymorphonuclear|URINALYSIS|[?]|mL/kg|[?]|[?]|BORDERLINE|1|uEq/L|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE|N|MAGNETIC RESONANCE ELASTOGRAPHY|FIBROTEST FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2021-01-06|2021-01-09|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|9e69b457-20db-45e5-a535-0cd8ac102fea|1|CBA|Complement Ba|CHEMISTRY|[?]|anti-Xa IU|[?]|[?]|INVALID|1|Ci|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|FROZEN||WRIGHT-GIEMSA STAIN|GMI % FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-06-07|2020-08-26|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|9e69b457-20db-45e5-a535-0cd8ac102fea|2|BLSTMKCE|Megakaryoblasts/Total Cells|CHEMISTRY|[?]|TROCHE|[?]|[?]|INVALID|1|10^3 organisms/g|1|1|[?]|NORMAL|ISOLATE|ROOM TEMPERATURE||LC-FL|MDRD FORMULA|||N||1|Visit_1|10|6|FOLLOW-UP|2020-06-07|2020-06-11|10|14|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|9e69b457-20db-45e5-a535-0cd8ac102fea|3|CKMBCK|Creatine Kinase MB/Total Creatine Kinase|HEMATOLOGY|[?]|g/g/day|[?]|[?]|NEGATIVE|1|g/animal/wk|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|REFRIGERATED||OLIGO ACGH|FIBROSIS 4 FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-06-22|2020-08-17|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|LB|9e69b457-20db-45e5-a535-0cd8ac102fea|4|IL2RA|Interleukin 2 Receptor Subunit Alpha|CHEMISTRY|[?]|DDU|[?]|[?]|INVALID|1|PLUG|1|1|[?]|LOW|ADIPOSE TISSUE|CALCIFIED|N|AUTOREFRACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-06-22|2020-08-23|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|LB|9e69b457-20db-45e5-a535-0cd8ac102fea|5|ESTRIOL|Estriol|URINALYSIS|[?]|fraction of 1|[?]|[?]|TRACE|1|grain|1|1|[?]|LOW|CELL PELLET|CONCENTRATED|N|SMEAR|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||3|Visit_3|40|7|SCREENING|2020-07-07|2020-07-21|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|9e69b457-20db-45e5-a535-0cd8ac102fea|6|LYMVACLE|Vacuolated Lymphocytes/Leukocytes|CHEMISTRY|[?]|cm2|[?]|[?]|INVALID|1|BAG|1|1|[?]|LOW|PLATELET|DRIED|N|SLIT LAMP|CKD-EPI CREATININE FORMULA|||U||3|Visit_3|40|5|SCREENING|2020-07-07|2020-08-09|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|9e69b457-20db-45e5-a535-0cd8ac102fea|7|APOC3|Apolipoprotein CIII|CHEMISTRY|||[?]|[?]|INVALID|1|nm|1|1|[?]|ABNORMAL|CALCULUS|DRIED|N|PHASE-CONTRAST MRI|FIBROTEST FORMULA|||U|Y|4|Visit_4|65|5|TREATMENT|2020-08-01|2020-08-17|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|9e69b457-20db-45e5-a535-0cd8ac102fea|8|ACYLCAOX|Acyl Coenzyme A Oxidase|URINALYSIS|[?]|EID 50/dose|[?]|[?]|TRACE|1|Bq/L|1|1|[?]|HIGH|PLATELET RICH PLASMA|LACTESCENT|N|SPIRAL CT SCAN WITHOUT CONTRAST|FIBROTEST FORMULA|||N||4|Visit_4|65|2|WASHOUT|2020-08-01|2020-08-24|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|9e69b457-20db-45e5-a535-0cd8ac102fea|9|CD161ALY|CD161a/Lymphocytes|HEMATOLOGY|||[?]|[?]|POSITIVE|1|g/L|1|1|[?]|HIGH|KERATINOCYTE|THAWED||PET/CT SCAN|FIBROSIS 4 FORMULA|||U|Y|5|Visit_5|90|3|TREATMENT|2020-08-26|2020-08-29|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|9e69b457-20db-45e5-a535-0cd8ac102fea|10|ALTCPHRL|Alpha Tocopherol|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ugEq|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|SOLIDIFIED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|5|Visit_5|90|1|TREATMENT|2020-08-26|2020-08-31|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|14211798-ddf6-47c8-bd9d-056d95bad8ff|1|AMPHETD|Dextroamphetamine|HEMATOLOGY|[?]|/40 HPFs|[?]|[?]|POSITIVE|1|DIOPTER|1|1|[?]|HIGH|PLATELET POOR PLASMA|LACTESCENT||CT SCAN WITHOUT CONTRAST|MDRD FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-09-26|2020-11-26|10|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|14211798-ddf6-47c8-bd9d-056d95bad8ff|2|INTLK7|Interleukin 7|URINALYSIS|[?]|scm|[?]|[?]|NEGATIVE|1|mL*cmH2O|1|1|[?]|ABNORMAL|BLOOD|AUTOLYZED|N|CELLULAR PROLIFERATION ASSAY|GMI % FORMULA|||N||1|Visit_1|10|4|FOLLOW-UP|2020-09-26|2020-12-10|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|14211798-ddf6-47c8-bd9d-056d95bad8ff|3|ODMTASE|O-Demethylase|CHEMISTRY|[?]|gpELISA unit/mL|[?]|[?]|INDETERMINATE|1|EIA unit|1|1|[?]|LOW|LYMPH|CLOTTED|N|TEST STRIP|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|4|SCREENING|2020-10-11|2020-11-26|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|14211798-ddf6-47c8-bd9d-056d95bad8ff|4|PLATSAT|Platelet Satellitism|URINALYSIS|[?]|mL/g/h|[?]|[?]|INVALID|1|TABLET|1|1|[?]|ABNORMAL|DERMAL TISSUE|CALCIFIED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROSIS 4 FORMULA|Y||NA||2|Visit_2|25|7|FOLLOW-UP|2020-10-11|2020-12-21|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|14211798-ddf6-47c8-bd9d-056d95bad8ff|5|C130072|Birch Pollen IgE|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mL/min/mmHg|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|HEMOLYZED|N|DOUBLE IMMUNODIFFUSION|MDRD 6 VARIABLE FORMULA|||U|Y|3|Visit_3|40|4|TREATMENT|2020-10-26|2020-11-26|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|14211798-ddf6-47c8-bd9d-056d95bad8ff|6|NRP1|Neuropilin-1|CHEMISTRY|[?]|PIXELS/cm|[?]|[?]|BORDERLINE|1|10^4/L|1|1|[?]|HIGH|EMOTIONAL TEAR|SOLIDIFIED||HANSEL STAIN|GMI MMOL/MOL FORMULA|Y||N||3|Visit_3|40|7|WASHOUT|2020-10-26|2020-11-29|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|14211798-ddf6-47c8-bd9d-056d95bad8ff|7|APTTLAS|Lupus Anticoagulant Sensitive APTT|CHEMISTRY|[?]|mL/cm3/min|[?]|[?]|INDETERMINATE|1|Hz/s|1|1|[?]|NORMAL|LAVAGE FLUID|SOLIDIFIED|N|CAPILLARY ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|4|SCREENING|2020-11-20|2020-12-24|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|14211798-ddf6-47c8-bd9d-056d95bad8ff|8|CABOT|Cabot Rings|CHEMISTRY|[?]|fraction of 1|[?]|[?]|INVALID|1|/HPF|1|1|[?]|ABNORMAL|LYSATE|GELLED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|GMI MMOL/MOL FORMULA|Y||Y||4|Visit_4|65|7|SCREENING|2020-11-20|2020-12-01|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|14211798-ddf6-47c8-bd9d-056d95bad8ff|9|FLRZPM|Flurazepam|URINALYSIS|[?]|PNU/mL|[?]|[?]|INDETERMINATE|1|IU/mmol|1|1|[?]|NORMAL|SEMINAL FLUID|GELLED|N|DROPLET DIGITAL PCR|MDRD 6 VARIABLE FORMULA||Y|Y||5|Visit_5|90|2|WASHOUT|2020-12-15|2020-12-23|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|LB|14211798-ddf6-47c8-bd9d-056d95bad8ff|10|SFTPD|Surfactant Protein D|HEMATOLOGY|[?]|10^3 CFU/g|[?]|[?]|INVALID|1|mm/min|1|1|[?]|NORMAL|LEUKOCYTE|REFRIGERATED|N|ROMANOWSKY STAIN|CKD-EPI CYSTATIN C FORMULA|Y||U||5|Visit_5|90|7|WASHOUT|2020-12-15|2020-12-21|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|LB|63f3194e-9b88-491a-9a68-19109ed86e2b|1|KCLR|Potassium Clearance|HEMATOLOGY|[?]|Bq/L|[?]|[?]|BORDERLINE|1|mEq/day|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|CALCIFIED||DIFFUSION TENSOR MRI|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||1|Visit_1|10|2|TREATMENT|2020-06-10|2020-06-13|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|LB|63f3194e-9b88-491a-9a68-19109ed86e2b|2|FLUOXTN|Fluoxetine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ohm|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|CONCENTRATED|N|POLYMERASE CHAIN REACTION|FIBROTEST FORMULA|||Y|Y|1|Visit_1|10|3|SCREENING|2020-06-10|2020-06-17|10|17|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|LB|63f3194e-9b88-491a-9a68-19109ed86e2b|3|CD163S|Soluble CD163|CHEMISTRY|||[?]|[?]|POSITIVE|1|U/g|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|CALCIFIED||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|FIBROMETER FORMULA||Y|NA|Y|2|Visit_2|25|7|TREATMENT|2020-06-25|2020-08-23|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-06
e|LB|63f3194e-9b88-491a-9a68-19109ed86e2b|4|FLRZPM|Flurazepam|HEMATOLOGY|[?]|AMPULE|[?]|[?]|BORDERLINE|1|mCi|1|1|[?]|HIGH|HAIR FOLLICLE|ROOM TEMPERATURE||SPECULAR MICROSCOPY|FIBROMETER FORMULA|Y|Y|Y||2|Visit_2|25|6|SCREENING|2020-06-25|2020-07-17|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-06
e|LB|63f3194e-9b88-491a-9a68-19109ed86e2b|5|CYCHOL|Cholesterol Crystals|URINALYSIS|||[?]|[?]|POSITIVE|1|Absorbance U/mL|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR||NUCLEIC ACID HYBRIDIZATION|GMI MMOL/MOL FORMULA|Y||N|Y|3|Visit_3|40|6|WASHOUT|2020-07-10|2020-08-20|40|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|63f3194e-9b88-491a-9a68-19109ed86e2b|6|ECCENTCY|Eccentrocytes|CHEMISTRY|[?]|mU|[?]|[?]|INDETERMINATE|1|mg/cm2|1|1|[?]|NORMAL|SOFT TISSUE|ROOM TEMPERATURE||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|NASH FIBROSURE FORMULA|Y||NA||3|Visit_3|40|5|TREATMENT|2020-07-10|2020-08-21|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|63f3194e-9b88-491a-9a68-19109ed86e2b|7|HDL|HDL Cholesterol|HEMATOLOGY|[?]|uU/L|[?]|[?]|INDETERMINATE|1|mkat|1|1|[?]|LOW|SPUTUM|LACTESCENT|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA||4|Visit_4|65|6|TREATMENT|2020-08-04|2020-08-17|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|63f3194e-9b88-491a-9a68-19109ed86e2b|8|THC|Tetrahydrocannabinol|URINALYSIS|[?]|IU/mg|[?]|[?]|TRACE|1|mOsm/kg|1|1|[?]|HIGH|VENOUS BLOOD|CONTAMINATED||PHASE CONTRAST MICROSCOPY|ASH FIBROSURE FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-08-04|2020-08-10|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|63f3194e-9b88-491a-9a68-19109ed86e2b|9|C130108|Weed Mix Pollen Antigen IgA Antibody|URINALYSIS|||[?]|[?]|TRACE|1|kIU|1|1|[?]|HIGH|ABSCESS FLUID|CONTAMINATED||WESTERGREN|NASH FIBROSURE FORMULA|||N|Y|5|Visit_5|90|4|FOLLOW-UP|2020-08-29|2020-09-07|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|LB|63f3194e-9b88-491a-9a68-19109ed86e2b|10|NORMBASO|Basophilic Normoblast|HEMATOLOGY|[?]|mg/h|[?]|[?]|TRACE|1|dpm/100mg|1|1|[?]|ABNORMAL|SWABBED MATERIAL|LIPEMIC||MICROBIAL CULTURE, LIQUID|FIBROMETER FORMULA||Y|N||5|Visit_5|90|5|FOLLOW-UP|2020-08-29|2020-09-01|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|LB|b6208258-d7c2-4dde-addf-4677946ab165|1|PSELECTS|Soluble P-Selectin|CHEMISTRY|[?]|10^9 CFU/mL|[?]|[?]|INDETERMINATE|1|tuberculin unit/mL|1|1|[?]|ABNORMAL|LEUKOCYTE|UNEXPECTED ODOR|N|RAJI CELL RIA|MDRD ENZYMATIC FORMULA||Y|N||1|Visit_1|10|4|TREATMENT|2020-09-20|2020-09-28|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|b6208258-d7c2-4dde-addf-4677946ab165|2|INTLK1A|Interleukin 1 Alpha|URINALYSIS|||[?]|[?]|BORDERLINE|1|mmol2/L2|1|1|[?]|NORMAL|LUNG SURFACTANT|FROZEN||DUKE INCISION METHOD|CKD-EPI FORMULA|||U|Y|1|Visit_1|10|1|TREATMENT|2020-09-20|2020-09-29|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|b6208258-d7c2-4dde-addf-4677946ab165|3|ACANTRBC|Acanthocytes/Erythrocytes|CHEMISTRY|[?]|umol/L/h|[?]|[?]|INDETERMINATE|1|POINT|1|1|[?]|LOW|SPERMATOZOON|REFRIGERATED||NUCLEIC ACID HYBRIDIZATION|MDRD FORMULA|Y||N||2|Visit_2|25|2|TREATMENT|2020-10-05|2020-11-14|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|b6208258-d7c2-4dde-addf-4677946ab165|4|BASOMYL|Basophilic Myelocytes|URINALYSIS|[?]|kcal|[?]|[?]|TRACE|1|umol/mg/min|1|1|[?]|NORMAL|EMESIS|GELLED||SANGER SEQUENCING|COCKCROFT-GAULT FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-10-05|2020-12-05|25|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|b6208258-d7c2-4dde-addf-4677946ab165|5|EOSPSD|Pseudo-Eosinophils|URINALYSIS|[?]|10^3/hpf|[?]|[?]|BORDERLINE|1|pmol/L/h|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|LACTESCENT||PALPATION|NASH FIBROSURE FORMULA|||U||3|Visit_3|40|1|TREATMENT|2020-10-20|2020-10-30|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|b6208258-d7c2-4dde-addf-4677946ab165|6|ALDEPX|Aldrin Epoxidase|CHEMISTRY|[?]|10^12/L|[?]|[?]|BORDERLINE|1|PHERESIS UNIT|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|LACTESCENT||PHASE CONTRAST MICROSCOPY|CKD-EPI FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2020-10-20|2020-11-19|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|b6208258-d7c2-4dde-addf-4677946ab165|7|CRTFREXR|Cortisol, Free Excretion Rate|URINALYSIS|[?]|IU/g|[?]|[?]|BORDERLINE|1|Ci/mg|1|1|[?]|HIGH|TRANSUDATE|AGGLUTINATED||FLUORESCENT SPOT TEST|CKD-EPI CREATININE FORMULA|Y||U||4|Visit_4|65|1|FOLLOW-UP|2020-11-14|2020-11-21|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|b6208258-d7c2-4dde-addf-4677946ab165|8|CSWBC|WBC Casts|HEMATOLOGY|[?]|Pa|[?]|[?]|BORDERLINE|1|POUCH|1|1|[?]|LOW|COLOSTRUM|ICTERIC||DYNAMIC LIGHT SCATTERING|MDRD ENZYMATIC FORMULA||Y|N||4|Visit_4|65|6|FOLLOW-UP|2020-11-14|2020-12-09|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|b6208258-d7c2-4dde-addf-4677946ab165|9|IGG3|Immunoglobulin G Subclass 3|CHEMISTRY|[?]|mL/kg|[?]|[?]|INDETERMINATE|1|um/s|1|1|[?]|HIGH|MONOCYTE|ICTERIC||PEAK FLOWMETRY|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|2|FOLLOW-UP|2020-12-09|2020-12-13|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|b6208258-d7c2-4dde-addf-4677946ab165|10|ERCENC|Erythroid Cells/Nucleated Cells|URINALYSIS|[?]|TAMPON|[?]|[?]|INDETERMINATE|1|TCID 50/dose|1|1|[?]|HIGH|SKIN TISSUE|ROOM TEMPERATURE||MAMMOGRAPHY|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-12-09|2020-12-11|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|a669a7b9-2034-4bca-aa80-0371c5fb46d3|1|CYCASULF|Calcium Sulfate Crystals|CHEMISTRY|[?]|PFU/mL|[?]|[?]|TRACE|1|h/wk|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|CLOTTED||KLEIHAUER-BETKE|FIBROMETER FORMULA|||NA||1|Visit_1|10|6|FOLLOW-UP|2021-01-26|2021-01-30|10|14|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|a669a7b9-2034-4bca-aa80-0371c5fb46d3|2|HLABAGT|HLA-B Antigen Type|URINALYSIS|[?]|mg/h|[?]|[?]|TRACE|1|BEAM BREAKS|1|1|[?]|NORMAL|LYSATE|REFRIGERATED|N|CONTRAST ENHANCED CT SCAN|ASH FIBROSURE FORMULA|Y||U||1|Visit_1|10|7|WASHOUT|2021-01-26|2021-03-03|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|a669a7b9-2034-4bca-aa80-0371c5fb46d3|3|ALBCREAT|Albumin/Creatinine|URINALYSIS|[?]|TROCHE|[?]|[?]|BORDERLINE|1|10^6 RNA copies/mL|1|1|[?]|LOW|PLEURAL TISSUE|ICTERIC||MODIFIED ACID FAST STAIN|GMI % FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2021-02-10|2021-04-06|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|a669a7b9-2034-4bca-aa80-0371c5fb46d3|4|CIC|Circulating Immune Complexes|CHEMISTRY|||[?]|[?]|TRACE|1|mL/kg/day|1|1|[?]|ABNORMAL|BONE|PARAFFIN-EMBEDDED||FLOCCULATION|FIBROTEST FORMULA|||N|Y|2|Visit_2|25|1|TREATMENT|2021-02-10|2021-03-18|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|a669a7b9-2034-4bca-aa80-0371c5fb46d3|5|ALBGLYCA|Glycated Albumin|URINALYSIS|[?]|uEq/L|[?]|[?]|NEGATIVE|1|PUFF|1|1|[?]|ABNORMAL|KERATINOCYTE|NON-HEMOLYZED|N|MAGNETIC RESONANCE ELASTOGRAPHY|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|6|TREATMENT|2021-02-25|2021-03-01|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|a669a7b9-2034-4bca-aa80-0371c5fb46d3|6|PEPSNGI|Pepsinogen I|HEMATOLOGY|[?]|Coulomb|[?]|[?]|BORDERLINE|1|g/cm2|1|1|[?]|LOW|LUNG SURFACTANT|CLOTTED||CLOT DETECTION|MDRD 4 VARIABLE FORMULA|Y||NA||3|Visit_3|40|6|TREATMENT|2021-02-25|2021-03-17|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|a669a7b9-2034-4bca-aa80-0371c5fb46d3|7|LDH3LDH|LDH Isoenzyme 3/LDH|CHEMISTRY|[?]|FEU|[?]|[?]|NEGATIVE|1|10^6 RNA copies/mL|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|LACTESCENT||HPLC-UV|FIBROTEST FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-03-22|2021-04-21|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|LB|a669a7b9-2034-4bca-aa80-0371c5fb46d3|8|MX1|Interferon-Induced Protein p78|HEMATOLOGY|[?]|ppm|[?]|[?]|INVALID|1|mmol/mol|1|1|[?]|NORMAL|ALVEOLAR AIR|DRIED||POLYGRAPHY|COCKCROFT-GAULT FORMULA|Y|Y|N||4|Visit_4|65|4|SCREENING|2021-03-22|2021-04-23|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|LB|a669a7b9-2034-4bca-aa80-0371c5fb46d3|9|NEUTSGNE|Neutrophils, Segmented/Neutrophils|URINALYSIS|[?]|10^4 CFU/mL|[?]|[?]|BORDERLINE|1|uCi|1|1|[?]|LOW|EPIDERMAL TISSUE|AUTOLYZED||TOTAL BODY IRRADIATION|CKD-EPI FORMULA||Y|N||5|Visit_5|90|1|SCREENING|2021-04-16|2021-04-24|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|a669a7b9-2034-4bca-aa80-0371c5fb46d3|10|OSMLTY|Osmolality|URINALYSIS|[?]|g/animal/day|[?]|[?]|POSITIVE|1|PLUG|1|1|[?]|HIGH|PLATELET|NON-HEMOLYZED||DISK DIFFUSION|GMI MMOL/MOL FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2021-04-16|2021-04-20|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|e148c13d-ee41-4503-a7e5-397dd6155f04|1|VLDLPSZ|VLDL Particle Size|CHEMISTRY|[?]|uU/dL|[?]|[?]|INDETERMINATE|1|pg/dL|1|1|[?]|HIGH|SEMINAL FLUID|PARAFFIN-EMBEDDED||FLUORESCENCE ANGIOGRAPHY|GMI % FORMULA|Y|Y|NA||1|Visit_1|10|4|TREATMENT|2020-07-18|2020-08-10|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|e148c13d-ee41-4503-a7e5-397dd6155f04|2|GCHT|Glycocholate|HEMATOLOGY|[?]|pptr|[?]|[?]|TRACE|1|GLOBULE|1|1|[?]|ABNORMAL|EXPIRED AIR|LIPEMIC||MULTIPLEXED BEAD BASED IMMUNOASSAY|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|5|WASHOUT|2020-07-18|2020-08-05|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|e148c13d-ee41-4503-a7e5-397dd6155f04|3|GHRELINA|Active Ghrelin|URINALYSIS|[?]|CARTRIDGE|[?]|[?]|BORDERLINE|1|g/g|1|1|[?]|HIGH|SALIVA|LIPEMIC|N|TEST STRIP|MDRD FORMULA|||U||2|Visit_2|25|7|WASHOUT|2020-08-02|2020-08-28|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|e148c13d-ee41-4503-a7e5-397dd6155f04|4|BTLBARTL|Butabarbital|CHEMISTRY|[?]|nmol/L/h|[?]|[?]|INDETERMINATE|1|U/m2|1|1|[?]|NORMAL|PROSTATIC FLUID|LIPEMIC|N|PET/MRI SCAN|FIBROTEST FORMULA||Y|Y||2|Visit_2|25|3|SCREENING|2020-08-02|2020-08-25|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|e148c13d-ee41-4503-a7e5-397dd6155f04|5|IGE|Immunoglobulin E|CHEMISTRY|[?]|ug/min|[?]|[?]|INVALID|1|10^3 organisms/g|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|REFRIGERATED||AGAR DILUTION|MDRD ENZYMATIC FORMULA||Y|Y||3|Visit_3|40|1|TREATMENT|2020-08-17|2020-09-29|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|e148c13d-ee41-4503-a7e5-397dd6155f04|6|NEUTHYGR|Hypogranular Neutrophils|CHEMISTRY|[?]|C|[?]|[?]|INVALID|1|uV*sec|1|1|[?]|LOW|DISCHARGE|NON-HEMOLYZED||IN VITRO GENE EXPRESSION ASSAY|CKD-EPI FORMULA|Y|Y|N||3|Visit_3|40|7|FOLLOW-UP|2020-08-17|2020-09-29|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|e148c13d-ee41-4503-a7e5-397dd6155f04|7|IFNB|Interferon Beta|CHEMISTRY|[?]|AU/mL|[?]|[?]|BORDERLINE|1|Enzyme U/m2|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE||PHOTOMETRY|CKD-EPI CYSTATIN C FORMULA|Y||Y||4|Visit_4|65|5|FOLLOW-UP|2020-09-11|2020-09-21|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|LB|e148c13d-ee41-4503-a7e5-397dd6155f04|8|TRIM21|Tripartite Motif Containing Protein 21|CHEMISTRY|[?]|log10 CCID 50/dose|[?]|[?]|TRACE|1|nL|1|1|[?]|HIGH|MONOCYTE|CONTAMINATED||RAJI CELL EIA|GMI % FORMULA|Y||Y||4|Visit_4|65|2|TREATMENT|2020-09-11|2020-10-08|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|LB|e148c13d-ee41-4503-a7e5-397dd6155f04|9|CYSTATC|Cystatin C|CHEMISTRY|[?]|uCi/L|[?]|[?]|BORDERLINE|1|mEq/mL|1|1|[?]|LOW|PERITONEAL FLUID|HEMOLYZED|N|BIOIMPEDANCE SPECTROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||5|Visit_5|90|3|FOLLOW-UP|2020-10-06|2020-10-08|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|e148c13d-ee41-4503-a7e5-397dd6155f04|10|PYRUVATE|Pyruvate|CHEMISTRY|[?]|K|[?]|[?]|INVALID|1|gMFI|1|1|[?]|LOW|LAVAGE FLUID|CLOTTED|N|FORCED OSCILLATION TECHNIQUE|GMI % FORMULA||Y|U||5|Visit_5|90|1|WASHOUT|2020-10-06|2020-10-15|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|815de94a-f259-41ee-8951-8df150184a25|1|NEUTNSQE|Neutrophils/Non-Squam Epi Cells|URINALYSIS|[?]|damol/L|[?]|[?]|POSITIVE|1|ug/animal|1|1|[?]|ABNORMAL|TUMOR TISSUE|AGGLUTINATED||NON-CONTACT SPECULAR MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-07-07|2020-07-12|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|815de94a-f259-41ee-8951-8df150184a25|2|PLSMCECE|Mature Plasma Cells/Total Cells|HEMATOLOGY|[?]|v/v|[?]|[?]|INDETERMINATE|1|ug/g/h|1|1|[?]|ABNORMAL|DISCHARGE|HEMOLYZED||AUTOREFRACTION|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|4|SCREENING|2020-07-07|2020-09-04|10|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|815de94a-f259-41ee-8951-8df150184a25|3|FACTV|Factor V|URINALYSIS|||[?]|[?]|POSITIVE|1|mg/L|1|1|[?]|LOW|TISSUE|PARAFFIN-EMBEDDED||ACRIDINE ORANGE STAIN|CKD-EPI CYSTATIN C FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2020-07-22|2020-08-08|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|815de94a-f259-41ee-8951-8df150184a25|4|GRANCE|Granulocytes/Total Cells|HEMATOLOGY|[?]|mm2|[?]|[?]|TRACE|1|dpm/100mg|1|1|[?]|LOW|CAPILLARY BLOOD|CLOTTED|N|SPECT SCAN|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-07-22|2020-08-01|25|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|815de94a-f259-41ee-8951-8df150184a25|5|HDLPL|HDL Phospholipid|HEMATOLOGY|[?]|%(v/v)|[?]|[?]|INVALID|1|APL U/mL|1|1|[?]|NORMAL|GASTRIC FLUID|LIPEMIC||MICROARRAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|N||3|Visit_3|40|4|WASHOUT|2020-08-06|2020-09-08|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|815de94a-f259-41ee-8951-8df150184a25|6|FACTIX|Factor IX|CHEMISTRY|||[?]|[?]|INVALID|1|fL|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|GELLED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD FORMULA|||N|Y|3|Visit_3|40|6|TREATMENT|2020-08-06|2020-09-01|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|815de94a-f259-41ee-8951-8df150184a25|7|SER|Serine|URINALYSIS|[?]|mL/cm|[?]|[?]|TRACE|1|mol/mL|1|1|[?]|LOW|ABSCESS FLUID|FRESH||THERMAL IONIZATION MASS SPECTROMETRY|HEPASCORE FORMULA|Y||N||4|Visit_4|65|1|WASHOUT|2020-08-31|2020-09-24|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|815de94a-f259-41ee-8951-8df150184a25|8|TK|Thymidine Kinase|CHEMISTRY|[?]|fmol|[?]|[?]|TRACE|1|BE/mL|1|1|[?]|LOW|VENOUS CORD BLOOD|ICTERIC||INDIA INK STAIN|CKD-EPI CREATININE FORMULA||Y|Y||4|Visit_4|65|6|FOLLOW-UP|2020-08-31|2020-09-04|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|815de94a-f259-41ee-8951-8df150184a25|9|OPIATE|Opiate|CHEMISTRY|[?]|cmH2O*s/mL|[?]|[?]|TRACE|1|mL/kg|1|1|[?]|HIGH|VENOUS BLOOD|FROZEN||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|5|WASHOUT|2020-09-25|2020-10-01|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|815de94a-f259-41ee-8951-8df150184a25|10|LDH3LDH|LDH Isoenzyme 3/LDH|URINALYSIS|[?]|Enzyme U/g Hb|[?]|[?]|POSITIVE|1|mmol/day|1|1|[?]|NORMAL|SMEGMA|FRESH||SLOAN LETTER EYE CHART 1.25%|CKD-EPI CREATININE FORMULA|Y||N||5|Visit_5|90|5|TREATMENT|2020-09-25|2020-09-26|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|1|PICP|Procollagen Type I Carboxy Term Peptide|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|breaths/30s|1|1|[?]|NORMAL|LEUKOCYTE|AGGLUTINATED||MICROBIAL CULTURE, LIQUID|COCKCROFT-GAULT FORMULA|||N|Y|1|Visit_1|10|2|WASHOUT|2020-05-16|2020-05-28|10|22|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|2|RFIGGAB|Rheumatoid Factor IgG Antibody|HEMATOLOGY|[?]|log10 TCID 50/uL|[?]|[?]|INDETERMINATE|1|U/g|1|1|[?]|LOW|URINE SEDIMENT|LACTESCENT||DYNAMOMETRY|HEPASCORE FORMULA|||NA||1|Visit_1|10|1|FOLLOW-UP|2020-05-16|2020-06-02|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|3|C130135|D. pteronyssinus Antigen IgG Antibody|URINALYSIS|||[?]|[?]|POSITIVE|1|/LSQN|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|ROOM TEMPERATURE|N|FLOCCULATION|MDRD 6 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|2|TREATMENT|2020-05-31|2020-07-26|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|LB|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|4|POIKRBC|Poikilocytes/Erythrocytes|CHEMISTRY|[?]|log10 IU/mL|[?]|[?]|NEGATIVE|1|TRANSDUCING UNIT/mL|1|1|[?]|ABNORMAL|CORD SERUM|FRESH||SCINTIGRAPHY|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|4|FOLLOW-UP|2020-05-31|2020-08-12|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|LB|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|5|DCCARNIT|Decanoylcarnitine|CHEMISTRY|[?]|10^7/L|[?]|[?]|INVALID|1|mg/kg/day|1|1|[?]|LOW|SERUM OR PLASMA|DRIED|N|BIOPSY|FIBROMETER FORMULA|||Y||3|Visit_3|40|6|FOLLOW-UP|2020-06-15|2020-07-03|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-29
e|LB|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|6|IGHG4|Immunoglobulin Heavy Constant Gamma 4|CHEMISTRY|[?]|AFU|[?]|[?]|INDETERMINATE|1|mmHg|1|1|[?]|ABNORMAL|SERUM|FROZEN||COLORIMETRY|MDRD FORMULA|Y||NA||3|Visit_3|40|3|FOLLOW-UP|2020-06-15|2020-07-20|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-29
e|LB|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|7|RETPALM|Retinyl Palmitate|URINALYSIS|[?]|mL/m2/h|[?]|[?]|INVALID|1|Bq/kg|1|1|[?]|HIGH|EMOTIONAL TEAR|HEMOLYZED||HPLC|MDRD FORMULA|||U||4|Visit_4|65|1|TREATMENT|2020-07-10|2020-08-05|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-11
e|LB|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|8|SCCAG|Squamous Cell Carcinoma Antigen|CHEMISTRY|[?]|foz_br|[?]|[?]|INDETERMINATE|1|mm/h|1|1|[?]|LOW|URINE|AGGLUTINATED||NEXT GENERATION SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||4|Visit_4|65|2|SCREENING|2020-07-10|2020-07-18|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-11
e|LB|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|9|CSGRANF|Granular Fine Casts|URINALYSIS|[?]|Antibody Unit|[?]|[?]|POSITIVE|1|ng/L|1|1|[?]|ABNORMAL|CERUMEN|ICTERIC||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA|||NA||5|Visit_5|90|7|WASHOUT|2020-08-04|2020-08-13|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|10|HLAIAB|HLA Class I Antibody|HEMATOLOGY|[?]|10^3 CFU/mL|[?]|[?]|BORDERLINE|1|log10 TCID 50/uL|1|1|[?]|NORMAL|SEMEN|ICTERIC||JAEGER EYE CHART|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-08-04|2020-08-13|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|1|MPC|Mean Platelet Component|HEMATOLOGY|[?]|deg|[?]|[?]|NEGATIVE|1|/10^3|1|1|[?]|NORMAL|TRANSUDATE|AGGLUTINATED|N|PERFUSION MRI|MDRD 4 VARIABLE FORMULA||Y|N||1|Visit_1|10|2|TREATMENT|2021-01-25|2021-04-04|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|2|BILIND|Indirect Bilirubin|CHEMISTRY|||[?]|[?]|POSITIVE|1|mL/cage/wk|1|1|[?]|LOW|SUPERNATANT, SERUM|FROZEN||X-RAY FLUORESCENCE SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|1|Visit_1|10|2|TREATMENT|2021-01-25|2021-03-20|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|3|TOXGRAN|Toxic Granulation|CHEMISTRY|[?]|ppth|[?]|[?]|POSITIVE|1|umol/mg/min|1|1|[?]|NORMAL|AQUEOUS HUMOR|CONTAMINATED||MICROSCOPY|MDRD FORMULA|Y||N||2|Visit_2|25|2|TREATMENT|2021-02-09|2021-03-29|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|4|ETPTPR|ETP Time to Peak Relative|HEMATOLOGY|[?]|g/g/day|[?]|[?]|NEGATIVE|1|IMPLANT|1|1|[?]|ABNORMAL|PLASMA|ICTERIC|N|IMMUNO-PET SCAN|MDRD 6 VARIABLE FORMULA|||U||2|Visit_2|25|4|SCREENING|2021-02-09|2021-03-27|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|5|C130125|Cat Dander Antigen IgG Antibody|CHEMISTRY|||[?]|[?]|TRACE|1|ks|1|1|[?]|HIGH|CALCULUS|CALCIFIED|N|FLAME PHOTOMETRY|HEPASCORE FORMULA|||Y|Y|3|Visit_3|40|5|TREATMENT|2021-02-24|2021-03-12|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|6|CXCL7|Chemokine (C-X-C Motif) Ligand 7|CHEMISTRY|[?]|KIT|[?]|[?]|INVALID|1|vp/mL|1|1|[?]|ABNORMAL|EPITHELIAL CELL|LACTESCENT||LC/MS|MDRD FORMULA||Y|N||3|Visit_3|40|6|TREATMENT|2021-02-24|2021-03-27|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|7|LDH1|LDH Isoenzyme 1|CHEMISTRY|[?]|JAR|[?]|[?]|TRACE|1|um/s|1|1|[?]|ABNORMAL|PUS|PARAFFIN-EMBEDDED||ATOMIC ABSORPTION SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|5|SCREENING|2021-03-21|2021-04-01|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|8|HDW|Hemoglobin Distribution Width|CHEMISTRY|[?]|kPa/L/sec|[?]|[?]|INDETERMINATE|1|kg/cm|1|1|[?]|NORMAL|ABSCESS FLUID|FROZEN|N|PEAK FLOWMETRY|MDRD ENZYMATIC FORMULA||Y|Y||4|Visit_4|65|1|FOLLOW-UP|2021-03-21|2021-03-25|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|9|ETPTP|ETP Time to Peak|CHEMISTRY|[?]|Ci/mL|[?]|[?]|NEGATIVE|1|BOX|1|1|[?]|NORMAL|MECONIUM|DRIED||ANALYTICAL ULTRACENTRIFUGATION|GMI MMOL/MOL FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2021-04-15|2021-04-18|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|LB|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|10|G6PD|Glucose-6-Phosphate Dehydrogenase|URINALYSIS|[?]|dyn|[?]|[?]|INDETERMINATE|1|10^6 organisms|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|GELLED||CELL OF ORIGIN ASSAY|MDRD 6 VARIABLE FORMULA|Y||N||5|Visit_5|90|4|WASHOUT|2021-04-15|2021-04-17|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|LB|a616ef00-05d6-459a-8474-06ab3eb493b1|1|SCKLCE|Sickle Cells|HEMATOLOGY|||[?]|[?]|INVALID|1|/min|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|THAWED||FLUORESCENT ENZYME IMMUNOASSAY|NASH FIBROSURE FORMULA||Y|Y|Y|1|Visit_1|10|6|WASHOUT|2020-09-25|2020-10-30|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|a616ef00-05d6-459a-8474-06ab3eb493b1|2|CRLPLSMN|Ceruloplasmin|URINALYSIS|||[?]|[?]|NEGATIVE|1|/10^4|1|1|[?]|ABNORMAL|BREAST MILK|AUTOLYZED||IMMUNO-PET SCAN|ASH FIBROSURE FORMULA|||Y|Y|1|Visit_1|10|3|WASHOUT|2020-09-25|2020-11-04|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|a616ef00-05d6-459a-8474-06ab3eb493b1|3|DOPAMEXR|Dopamine Excretion Rate|HEMATOLOGY|[?]|/7.5 mL|[?]|[?]|NEGATIVE|1|tuberculin unit|1|1|[?]|LOW|DISCHARGE|ICTERIC|N|CLAUSS METHOD|MDRD FORMULA|||U||2|Visit_2|25|2|WASHOUT|2020-10-10|2020-11-26|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|a616ef00-05d6-459a-8474-06ab3eb493b1|4|TRCYANDP|Tricyclic Antidepressants|HEMATOLOGY|||[?]|[?]|INVALID|1|cP|1|1|[?]|HIGH|EXPIRED AIR|HEMOLYZED|N|BIOPSY|GMI MMOL/MOL FORMULA|||Y|Y|2|Visit_2|25|1|TREATMENT|2020-10-10|2020-10-31|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|a616ef00-05d6-459a-8474-06ab3eb493b1|5|MACROBLD|Macroscopic Blood|HEMATOLOGY|||[?]|[?]|INVALID|1|Enzyme U|1|1|[?]|LOW|BILE|UNEXPECTED ODOR||MICROBIAL CONCENTRATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|3|Visit_3|40|2|TREATMENT|2020-10-25|2020-12-23|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|a616ef00-05d6-459a-8474-06ab3eb493b1|6|RH|Rh Factor|HEMATOLOGY|[?]|mV2/Hz|[?]|[?]|POSITIVE|1|/200 HPFs|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|SOLIDIFIED||TRICHROME STAIN|NASH FIBROSURE FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-10-25|2020-12-07|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|a616ef00-05d6-459a-8474-06ab3eb493b1|7|EOSNUCCE|Eosinophils/Nucleated Cells|URINALYSIS|[?]|ppb|[?]|[?]|INDETERMINATE|1|mEq|1|1|[?]|LOW|WHITE MATTER TISSUE|AUTOLYZED|N|ZIEHL NEELSEN ACID FAST STAIN|FIBROMETER FORMULA|||N||4|Visit_4|65|3|FOLLOW-UP|2020-11-19|2020-11-23|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|a616ef00-05d6-459a-8474-06ab3eb493b1|8|INCLBRBC|Erythrocyte Inclusion Bodies|CHEMISTRY|[?]|cycle/min|[?]|[?]|BORDERLINE|1|cg|1|1|[?]|LOW|SEMINAL FLUID|SOLIDIFIED||TRIPLE-PHASE SPIRAL CT SCAN|MDRD ENZYMATIC FORMULA|||N||4|Visit_4|65|1|TREATMENT|2020-11-19|2020-11-26|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|a616ef00-05d6-459a-8474-06ab3eb493b1|9|C130120|Shellfish Mix Antigen IgE Antibody|HEMATOLOGY|[?]|nmol/L|[?]|[?]|TRACE|1|cmol/L|1|1|[?]|ABNORMAL|DERMAL TISSUE|LIPEMIC|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA|Y|Y|NA||5|Visit_5|90|5|FOLLOW-UP|2020-12-14|2020-12-16|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|a616ef00-05d6-459a-8474-06ab3eb493b1|10|CETP|Cholesteryl Ester Transfer Protein|CHEMISTRY|[?]|10^12 IU/L|[?]|[?]|TRACE|1|damol/L|1|1|[?]|ABNORMAL|CELL PELLET|NON-HEMOLYZED||SICKLE CELL SOLUBILITY TEST|MDRD 6 VARIABLE FORMULA||Y|U||5|Visit_5|90|2|TREATMENT|2020-12-14|2020-12-18|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|1|RPTLAAC|Reptilase Activity Actual/Control|HEMATOLOGY|[?]|mL/s|[?]|[?]|NEGATIVE|1|10^11/L|1|1|[?]|HIGH|MUSCLE TISSUE|FRESH||HPLC/MS/MS|FIBROMETER FORMULA|||NA||1|Visit_1|10|5|FOLLOW-UP|2020-08-20|2020-09-07|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|2|NEUTGT|Giant Neutrophils|URINALYSIS|[?]|umol/min|[?]|[?]|BORDERLINE|1|CCID 50/dose|1|1|[?]|NORMAL|BONE MARROW|AUTOLYZED||HIGH RESOLUTION MELT ANALYSIS|ASH FIBROSURE FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-08-20|2020-10-28|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|3|FPP|Protoporphyrin, Free|URINALYSIS|[?]|um|[?]|[?]|POSITIVE|1|Torr|1|1|[?]|LOW|SYNOVIAL FLUID|SOLIDIFIED|N|TOTAL BODY RADIOGRAPHY|MDRD 6 VARIABLE FORMULA|||Y||2|Visit_2|25|1|FOLLOW-UP|2020-09-04|2020-10-01|25|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|4|CENTROAB|Centromere B Antibodies|CHEMISTRY|||[?]|[?]|INVALID|1|nCi|1|1|[?]|ABNORMAL|PLEURAL FLUID|SOLIDIFIED||THICK SMEAR|GMI MMOL/MOL FORMULA|Y|Y|Y|Y|2|Visit_2|25|5|FOLLOW-UP|2020-09-04|2020-10-27|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|5|PELGERH|Pelger Huet Anomaly|URINALYSIS|||[?]|[?]|INVALID|1|TABLET|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|NON-HEMOLYZED||TWO-COLOR MICROARRAY|ASH FIBROSURE FORMULA||Y|NA|Y|3|Visit_3|40|7|SCREENING|2020-09-19|2020-11-16|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|6|OSMRTY|Osmolarity|CHEMISTRY|[?]|tsp eq|[?]|[?]|POSITIVE|1|U/kg/min|1|1|[?]|NORMAL|ARTERIAL BLOOD|REFRIGERATED||HPLC/MS/MS|MDRD ENZYMATIC FORMULA|||N||3|Visit_3|40|7|SCREENING|2020-09-19|2020-11-15|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|7|IGG4|Immunoglobulin G Subclass 4|CHEMISTRY|[?]|10^3 organisms/mL|[?]|[?]|INVALID|1|IU/mmol|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|PARAFFIN-EMBEDDED|N|KINYOUN STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||4|Visit_4|65|1|TREATMENT|2020-10-14|2020-11-11|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|8|COCBNZEC|Cocaine Benzoylecgonine Ecgonine|CHEMISTRY|[?]|BOTTLE|[?]|[?]|BORDERLINE|1|amol|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|CONTAMINATED||COULOMETRIC TITRATION|FIBROSIS 4 FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-10-14|2020-11-10|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|9|C5B9|Complement C5b-9|URINALYSIS|||[?]|[?]|TRACE|1|10^7 PFU|1|1|[?]|ABNORMAL|CORD BLOOD|HEMOLYZED||SPIRAL CT|GMI MMOL/MOL FORMULA|Y|Y|NA|Y|5|Visit_5|90|3|WASHOUT|2020-11-08|2020-11-16|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|10|POLYCHR|Polychromasia|URINALYSIS|||[?]|[?]|NEGATIVE|1|ft3|1|1|[?]|HIGH|FLUID|HEMOLYZED||LC-FL|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|5|Visit_5|90|6|TREATMENT|2020-11-08|2020-11-16|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|1|TROPONIN|Troponin|CHEMISTRY|[?]|mL/mmHg/min/L|[?]|[?]|INVALID|1|mg2/dL2|1|1|[?]|ABNORMAL|DERMAL TISSUE|PARAFFIN-EMBEDDED|N|PERFUSION MRI|FIBROSIS 4 FORMULA|Y||U||1|Visit_1|10|2|SCREENING|2020-10-21|2020-11-19|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|2|SPMPSPM|Spermatozoa, Progressive/Spermatozoa|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|cd/m2|1|1|[?]|ABNORMAL|ABSCESS FLUID|AUTOLYZED|N|CALCULATION|MDRD 4 VARIABLE FORMULA||Y|N|Y|1|Visit_1|10|3|FOLLOW-UP|2020-10-21|2020-12-25|10|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|3|TMZPM|Temazepam|CHEMISTRY|[?]|/ms|[?]|[?]|TRACE|1|mEq|1|1|[?]|NORMAL|BILE|CONCENTRATED||NEPHELOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|7|WASHOUT|2020-11-05|2020-11-26|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|4|V25HD3|25-Hydroxyvitamin D3|HEMATOLOGY|[?]|h/wk|[?]|[?]|INVALID|1|Bq|1|1|[?]|ABNORMAL|BILE|FRESH|N|ENZYMATIC COLORIMETRY|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|1|WASHOUT|2020-11-05|2020-12-29|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|5|GFRBSA|Glomerular Filtration Rate Adj for BSA|HEMATOLOGY|[?]|mIU/L|[?]|[?]|TRACE|1|deg/s|1|1|[?]|ABNORMAL|LEUKOCYTE|LACTESCENT||POPULATION SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|Y||3|Visit_3|40|1|TREATMENT|2020-11-20|2020-12-28|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|LB|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|6|BASO|Basophils|HEMATOLOGY|[?]|mg/animal|[?]|[?]|POSITIVE|1|GBq|1|1|[?]|LOW|RETICULOCYTES|CONTAMINATED||CONGO RED STAIN|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-11-20|2021-01-03|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|LB|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|7|FATACVLC|Fatty Acids, Very Long Chain|CHEMISTRY|[?]|mJoule/cm2|[?]|[?]|NEGATIVE|1|PA|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|HEMOLYZED||RAJI CELL RIA|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2020-12-15|2021-01-04|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|8|ORNITHIN|Ornithine|URINALYSIS|||[?]|[?]|INDETERMINATE|1|ELISA unit/mL|1|1|[?]|ABNORMAL|HAIR FOLLICLE|CONCENTRATED|N|PHOTOGRAPHY|FIBROTEST FORMULA|||NA|Y|4|Visit_4|65|3|FOLLOW-UP|2020-12-15|2021-01-14|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|9|SAHOMC|S-Adenosylhomocysteine|CHEMISTRY|[?]|mmol/kg|[?]|[?]|NEGATIVE|1|PIXEL|1|1|[?]|LOW|MUSCLE TISSUE|THAWED|N|NEXT GENERATION TARGETED SEQUENCING|FIBROSIS 4 FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2021-01-09|2021-01-13|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|10|DNPSEPHD|D-Norpseudoephedrine|URINALYSIS|||[?]|[?]|TRACE|1|Ci/L|1|1|[?]|NORMAL|REFLEX TEAR|ROOM TEMPERATURE||TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA|||N|Y|5|Visit_5|90|2|TREATMENT|2021-01-09|2021-01-15|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|1|EOTAXIN1|Eotaxin-1|CHEMISTRY|[?]|m/sec|[?]|[?]|TRACE|1|/2000 RBC|1|1|[?]|HIGH|INFRANATANT, SERUM|CALCIFIED|N|U-HPLC/MS/MS|FIBROSIS 4 FORMULA|||U||1|Visit_1|10|6|SCREENING|2020-07-04|2020-08-14|10|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|2|PROGRP|Pro-gastrin Releasing Peptide|CHEMISTRY|[?]|IU/mmol|[?]|[?]|INDETERMINATE|1|DRUM|1|1|[?]|NORMAL|BLOOD|GELLED||PLETHYSMOGRAPHY|FIBROSIS 4 FORMULA|||Y||1|Visit_1|10|5|SCREENING|2020-07-04|2020-09-04|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|3|CREATEXR|Creatinine Excretion Rate|HEMATOLOGY|[?]|mL/animal/wk|[?]|[?]|NEGATIVE|1|uCi|1|1|[?]|LOW|CIRCULATING TUMOR CELL|REFRIGERATED||KINETIC MICROPARTICLE IMMUNOASSAY|FIBROTEST FORMULA|||U||2|Visit_2|25|6|TREATMENT|2020-07-19|2020-09-26|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|4|GSTPIEXR|Pi-GST Excretion Rate|URINALYSIS|||[?]|[?]|BORDERLINE|1|mg2/dL2|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|ICTERIC|N|ACCELERATOR MASS SPECTROMETRY|COCKCROFT-GAULT FORMULA|Y|Y|NA|Y|2|Visit_2|25|2|WASHOUT|2020-07-19|2020-08-30|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|5|PHNBRBTL|Phenobarbital|CHEMISTRY|[?]|EIA unit|[?]|[?]|NEGATIVE|1|GPL U|1|1|[?]|LOW|INFRANATANT, SERUM|FROZEN||OPTICAL DENSITY MEASUREMENT|GMI MMOL/MOL FORMULA||Y|U||3|Visit_3|40|1|WASHOUT|2020-08-03|2020-09-11|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|6|ALDSTRN|Aldosterone|HEMATOLOGY|[?]|scm|[?]|[?]|BORDERLINE|1|mL/mmHg/min/L|1|1|[?]|ABNORMAL|CORD BLOOD|NON-HEMOLYZED||MALDI-TOF|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||3|Visit_3|40|2|TREATMENT|2020-08-03|2020-09-14|40|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|7|C130110|Mold Mix Antigen IgG Antibody|HEMATOLOGY|[?]|mol/mL|[?]|[?]|POSITIVE|1|mph|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|LACTESCENT|N|TURBIDIMETRY|MDRD 5 VARIABLE FORMULA|||NA||4|Visit_4|65|5|SCREENING|2020-08-28|2020-09-17|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|8|AMYLASES|Amylase, Salivary|CHEMISTRY|[?]|10^12/L|[?]|[?]|INVALID|1|WEEKS|1|1|[?]|LOW|COLOSTRUM|DRIED||SINGLE-SLICE SPIRAL CT|NASH FIBROSURE FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-08-28|2020-09-03|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|9|NEUTCE|Neutrophils/Total Cells|CHEMISTRY|[?]|mL/(min*100mL)|[?]|[?]|INDETERMINATE|1|PACKAGE|1|1|[?]|ABNORMAL|LOCHIA|CLOTTED||ULTRASONOGRAPHIC ELASTOGRAPHY|FIBROSIS 4 FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2020-09-22|2020-09-29|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|10|NITRICOX|Nitric Oxide|CHEMISTRY|[?]|/month|[?]|[?]|TRACE|1|uV*sec|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|NON-HEMOLYZED||ZIEHL NEELSEN ACID FAST STAIN|MDRD 6 VARIABLE FORMULA|Y|Y|N||5|Visit_5|90|7|TREATMENT|2020-09-22|2020-09-23|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|2014bcd0-1430-4096-87f5-650a01dae626|1|MMP1|Matrix Metalloproteinase 1|URINALYSIS|||[?]|[?]|POSITIVE|1|/LPF|1|1|[?]|NORMAL|DIALYSIS FLUID|PARAFFIN-EMBEDDED|N|ALCIAN BLUE STAIN|MDRD 5 VARIABLE FORMULA|Y||NA|Y|1|Visit_1|10|6|SCREENING|2020-05-31|2020-06-05|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|2014bcd0-1430-4096-87f5-650a01dae626|2|CGADJMW|Choriogonadotropin Adj for Maternal Wt|HEMATOLOGY|[?]|L/kg|[?]|[?]|POSITIVE|1|10^3 organisms/g|1|1|[?]|NORMAL|KERATINOCYTE|PARAFFIN-EMBEDDED||ENDPOINT DILUTION ASSAY|MDRD 6 VARIABLE FORMULA|Y||Y||1|Visit_1|10|7|TREATMENT|2020-05-31|2020-07-14|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|2014bcd0-1430-4096-87f5-650a01dae626|3|RLP|RLP Cholesterol|URINALYSIS|||[?]|[?]|INVALID|1|Ci/mg|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|CLOTTED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE FORMULA|||U|Y|2|Visit_2|25|5|TREATMENT|2020-06-15|2020-07-11|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|LB|2014bcd0-1430-4096-87f5-650a01dae626|4|NKCE|Natural Killer Cells|CHEMISTRY|[?]|Shock Wave|[?]|[?]|INDETERMINATE|1|mAnson U/mL|1|1|[?]|LOW|PLEURAL TISSUE|LACTESCENT|N|ATOMIC ABSORPTION SPECTROMETRY|MDRD FORMULA|||U||2|Visit_2|25|6|WASHOUT|2020-06-15|2020-07-05|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|LB|2014bcd0-1430-4096-87f5-650a01dae626|5|TXB2D11R|11-Dehydro-Thromboxane B2 Excretion Rate|CHEMISTRY|[?]|10^3 organisms/g|[?]|[?]|INDETERMINATE|1|mL/cm|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|HEMOLYZED|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD FORMULA|Y||Y||3|Visit_3|40|2|TREATMENT|2020-06-30|2020-07-23|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|LB|2014bcd0-1430-4096-87f5-650a01dae626|6|LDH5|LDH Isoenzyme 5|CHEMISTRY|[?]|uL/kg/day|[?]|[?]|INVALID|1|10^6 IU|1|1|[?]|HIGH|GASTRIC CONTENTS|REFRIGERATED||ELECTRONEUROGRAPHY|ASH FIBROSURE FORMULA||Y|Y||3|Visit_3|40|2|WASHOUT|2020-06-30|2020-07-06|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|LB|2014bcd0-1430-4096-87f5-650a01dae626|7|MDZPM|Medazepam|HEMATOLOGY|[?]|L|[?]|[?]|TRACE|1|10^9 CFU/mL|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|ICTERIC||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||4|Visit_4|65|6|TREATMENT|2020-07-25|2020-07-30|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|2014bcd0-1430-4096-87f5-650a01dae626|8|INSLNFR|Insulin, Free|HEMATOLOGY|[?]|mL/s/m2|[?]|[?]|POSITIVE|1|GBq/mg|1|1|[?]|HIGH|INTERSTITIAL FLUID|HEMOLYZED||QUANTITATIVE COMPUTED TOMOGRAPHY|GMI MMOL/MOL FORMULA|||NA||4|Visit_4|65|1|FOLLOW-UP|2020-07-25|2020-08-11|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|2014bcd0-1430-4096-87f5-650a01dae626|9|C130078|Silver Birch Pollen IgG|URINALYSIS|[?]|10^6 organisms/mL|[?]|[?]|BORDERLINE|1|pmol|1|1|[?]|HIGH|BLOOD|AGGLUTINATED|N|DUCTOGRAPHY|GMI % FORMULA|||U||5|Visit_5|90|4|TREATMENT|2020-08-19|2020-08-24|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|LB|2014bcd0-1430-4096-87f5-650a01dae626|10|HLAC|HLA Class IC Antigen|URINALYSIS|[?]|mEq|[?]|[?]|BORDERLINE|1|GBq/mg|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|GELLED||INTRAVASCULAR ULTRASOUND|MDRD ENZYMATIC FORMULA|Y||Y||5|Visit_5|90|5|SCREENING|2020-08-19|2020-08-24|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|LB|e043f1b3-6b65-45c0-bdae-eb783406c263|1|APOC3|Apolipoprotein CIII|HEMATOLOGY|[?]|mg/kg/day|[?]|[?]|INDETERMINATE|1|pm|1|1|[?]|HIGH|BREAST MILK|SOLIDIFIED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-11-11|2021-01-03|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|e043f1b3-6b65-45c0-bdae-eb783406c263|2|MMA|Methylmalonic Acid|CHEMISTRY|[?]|IU/kg/h|[?]|[?]|POSITIVE|1|mm/h|1|1|[?]|HIGH|CORD SERUM|SOLIDIFIED||QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|Y||NA||1|Visit_1|10|5|WASHOUT|2020-11-11|2020-11-25|10|24|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|e043f1b3-6b65-45c0-bdae-eb783406c263|3|A1AGLP|Alpha-1 Acid Glycoprotein|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^3 copies/mL|1|1|[?]|LOW|VENOUS CORD BLOOD|AGGLUTINATED||ANGIOGRAPHY|HEPASCORE FORMULA|Y||NA|Y|2|Visit_2|25|7|TREATMENT|2020-11-26|2020-12-19|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|e043f1b3-6b65-45c0-bdae-eb783406c263|4|C165893|Wild Rye Pollen IgE AB RAST Score|HEMATOLOGY|[?]|ug/L FEU|[?]|[?]|INVALID|1|DROP|1|1|[?]|NORMAL|ISOLATE|CALCIFIED||MASS SPECTROMETRY|MDRD FORMULA|||Y||2|Visit_2|25|6|FOLLOW-UP|2020-11-26|2020-12-03|25|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|e043f1b3-6b65-45c0-bdae-eb783406c263|5|PKM2|Pyruvate Kinase Isozyme M2|HEMATOLOGY|[?]|dyn|[?]|[?]|BORDERLINE|1|PACKAGE|1|1|[?]|LOW|INFRANATANT, SERUM|FRESH|N|OBSERVATION|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|3|FOLLOW-UP|2020-12-11|2021-01-03|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|e043f1b3-6b65-45c0-bdae-eb783406c263|6|TNF12EXR|TNF Superfamily Member 12 Excretion Rate|URINALYSIS|||[?]|[?]|TRACE|1|foz_us|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|DRIED||TEMPLATE INCISION METHOD|MDRD ENZYMATIC FORMULA||Y|NA|Y|3|Visit_3|40|6|TREATMENT|2020-12-11|2021-01-09|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|e043f1b3-6b65-45c0-bdae-eb783406c263|7|DPD|Deoxypyridinoline|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^3 copies/mL|1|1|[?]|LOW|MECONIUM|AGGLUTINATED||CALCULATION|MDRD ENZYMATIC JAPANESE FORMULA|Y||U|Y|4|Visit_4|65|7|TREATMENT|2021-01-05|2021-01-28|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|e043f1b3-6b65-45c0-bdae-eb783406c263|8|BHYXBTR|Beta-Hydroxybutyrate|HEMATOLOGY|[?]|log10 CCID 50/dose|[?]|[?]|POSITIVE|1|U/g/min|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|ROOM TEMPERATURE|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|HEPASCORE FORMULA|||N||4|Visit_4|65|2|TREATMENT|2021-01-05|2021-02-02|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|e043f1b3-6b65-45c0-bdae-eb783406c263|9|CHOL|Cholesterol|URINALYSIS|[?]|ag|[?]|[?]|POSITIVE|1|/10^5|1|1|[?]|LOW|PUS|ICTERIC||FUNCTIONAL MRI|MDRD 5 VARIABLE FORMULA|||Y||5|Visit_5|90|4|FOLLOW-UP|2021-01-30|2021-02-07|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|e043f1b3-6b65-45c0-bdae-eb783406c263|10|CD161ALY|CD161a/Lymphocytes|CHEMISTRY|[?]|mg/m2|[?]|[?]|BORDERLINE|1|pmol/10^9 cells|1|1|[?]|LOW|TUMOR TISSUE|CALCIFIED||CLAUSS METHOD|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||5|Visit_5|90|4|SCREENING|2021-01-30|2021-02-02|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|45623c39-86de-4b2f-bf2d-998d0e941e92|1|PPTDCALB|Phosphatidylcholine/Albumin|URINALYSIS|||[?]|[?]|TRACE|1|GBq/g|1|1|[?]|LOW|LUNG SURFACTANT|AGGLUTINATED|N|FORCED OSCILLATION TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|1|Visit_1|10|5|TREATMENT|2020-07-22|2020-08-15|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|45623c39-86de-4b2f-bf2d-998d0e941e92|2|CTC|Circulating Tumor Cells|HEMATOLOGY|[?]|Absorbance U/min|[?]|[?]|NEGATIVE|1|BAU|1|1|[?]|NORMAL|CAPILLARY BLOOD|ICTERIC|N|MAGNETIC RESONANCE ANGIOGRAPHY|FIBROTEST FORMULA||Y|N||1|Visit_1|10|4|TREATMENT|2020-07-22|2020-10-13|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|45623c39-86de-4b2f-bf2d-998d0e941e92|3|PDGFAB|Platelet Derived Growth Factor IsoformAB|URINALYSIS|[?]|mmHg*min/L|[?]|[?]|BORDERLINE|1|BAU/mL|1|1|[?]|LOW|FLUID|ICTERIC||RAJI CELL RIA|GMI MMOL/MOL FORMULA|||Y||2|Visit_2|25|6|FOLLOW-UP|2020-08-06|2020-09-24|25|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|45623c39-86de-4b2f-bf2d-998d0e941e92|4|MPOAB|Myeloperoxidase Antibody|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|JAR|1|1|[?]|LOW|PERITONEAL FLUID|AGGLUTINATED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA|||Y|Y|2|Visit_2|25|1|TREATMENT|2020-08-06|2020-08-30|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|45623c39-86de-4b2f-bf2d-998d0e941e92|5|PYRUVATE|Pyruvate|HEMATOLOGY|||[?]|[?]|POSITIVE|1|Bq/g|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED||INTERRUPTER TECHNIQUE|GMI MMOL/MOL FORMULA|Y|Y|N|Y|3|Visit_3|40|5|SCREENING|2020-08-21|2020-10-01|40|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|45623c39-86de-4b2f-bf2d-998d0e941e92|6|CLNZPM|Clonazepam|CHEMISTRY|[?]|ugEq/L|[?]|[?]|NEGATIVE|1|nkat/g Hb|1|1|[?]|HIGH|ABSCESS FLUID|CONCENTRATED||FLUOROSCOPY|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-08-21|2020-10-16|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|45623c39-86de-4b2f-bf2d-998d0e941e92|7|MYCEPPOL|Myeloid Proliferation Pool|HEMATOLOGY|[?]|/100 WBC|[?]|[?]|TRACE|1|min|1|1|[?]|HIGH|PLEURAL TISSUE|NON-HEMOLYZED|N|BETA LACTAMASE|MDRD 5 VARIABLE FORMULA|Y||N||4|Visit_4|65|4|TREATMENT|2020-09-15|2020-09-16|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|45623c39-86de-4b2f-bf2d-998d0e941e92|8|CYSTINE|Cystine|CHEMISTRY|[?]|s*kPa|[?]|[?]|NEGATIVE|1|MBq|1|1|[?]|HIGH|VENOUS CORD BLOOD|AGGLUTINATED||ELECTROCHEMILUMINESCENCE|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|7|SCREENING|2020-09-15|2020-09-20|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|45623c39-86de-4b2f-bf2d-998d0e941e92|9|FATACFRU|Free Fatty Acid, Unsaturated|CHEMISTRY|[?]|mmol/min/kPa/L|[?]|[?]|INVALID|1|anti-Xa IU/mL|1|1|[?]|NORMAL|EMOTIONAL TEAR|CONCENTRATED||CONGO RED STAIN|NASH FIBROSURE FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2020-10-10|2020-10-16|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|45623c39-86de-4b2f-bf2d-998d0e941e92|10|FLNTRZPM|Flunitrazepam|HEMATOLOGY|[?]|/10^3|[?]|[?]|NEGATIVE|1|ft|1|1|[?]|ABNORMAL|SALIVA|FRESH||ACID FAST STAIN|HEPASCORE FORMULA|||U||5|Visit_5|90|7|WASHOUT|2020-10-10|2020-10-15|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|1|NTXII|Type II Collagen N-Telopeptides|CHEMISTRY|[?]|ELISA unit/dose|[?]|[?]|BORDERLINE|1|U.CARR|1|1|[?]|ABNORMAL|EXUDATE|PARAFFIN-EMBEDDED||IN VITRO GENE EXPRESSION ASSAY|COCKCROFT-GAULT FORMULA|||NA||1|Visit_1|10|3|FOLLOW-UP|2020-10-18|2020-12-08|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|2|BLASTCE|Blasts/Total Cells|URINALYSIS|[?]|PHERESIS UNIT|[?]|[?]|INDETERMINATE|1|10^9 organisms/g|1|1|[?]|ABNORMAL|ERYTHROCYTES|AGGLUTINATED||INFRARED SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||1|Visit_1|10|7|WASHOUT|2020-10-18|2020-10-23|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|3|OHF6B|6 Beta-Hydroxycortisol|HEMATOLOGY|[?]|uSiemens|[?]|[?]|INVALID|1|tuberculin unit/mL|1|1|[?]|HIGH|SYNOVIAL FLUID|AGGLUTINATED|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|NASH FIBROSURE FORMULA|||NA||2|Visit_2|25|6|SCREENING|2020-11-02|2021-01-07|25|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|4|FGF9|Fibroblast Growth Factor 9|CHEMISTRY|[?]|10^6/L|[?]|[?]|BORDERLINE|1|BP|1|1|[?]|ABNORMAL|EPITHELIAL CELL|NON-HEMOLYZED||SNELLEN EYE CHART|CKD-EPI FORMULA|||Y||2|Visit_2|25|7|SCREENING|2020-11-02|2020-11-28|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|5|IL1R2|Interleukin 1 Receptor Type 2|URINALYSIS|||[?]|[?]|TRACE|1|%(w/v)|1|1|[?]|NORMAL|INFRANATANT, SERUM|CALCIFIED||APPLANATION TONOMETRY|HEPASCORE FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2020-11-17|2020-11-22|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|6|NEUTSG|Neutrophils, Segmented|HEMATOLOGY|[?]|mmHg|[?]|[?]|POSITIVE|1|mmHg*min/L|1|1|[?]|LOW|SEBUM|PARAFFIN-EMBEDDED||CHROMOGENIC ASSAY|MDRD 4 VARIABLE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-11-17|2020-12-04|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|7|TLYMXM|T-lymphocyte Crossmatch|URINALYSIS|[?]|10^12/L|[?]|[?]|NEGATIVE|1|dB|1|1|[?]|HIGH|DERMAL TISSUE|GELLED||THERMAL IONIZATION MASS SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||4|Visit_4|65|1|TREATMENT|2020-12-12|2021-01-04|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|8|ASTALT|AST/ALT|CHEMISTRY|[?]|log10 TCID 50/mL|[?]|[?]|INDETERMINATE|1|TRACE|1|1|[?]|NORMAL|LUNG SURFACTANT|AGGLUTINATED||ELISPOT|FIBROSIS 4 FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-12-12|2021-01-08|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|9|C130091|Timothy Grass Pollen IgG4|HEMATOLOGY|[?]|kV|[?]|[?]|INDETERMINATE|1|psi|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|SOLIDIFIED||IMMUNOFIXATION ELECTROPHORESIS|COCKCROFT-GAULT FORMULA|||N||5|Visit_5|90|5|TREATMENT|2021-01-06|2021-01-11|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|10|MSPIKE|Monoclonal Protein Spike|HEMATOLOGY|||[?]|[?]|TRACE|1|mg/m2|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED||MRI WITHOUT CONTRAST|FIBROMETER FORMULA|||NA|Y|5|Visit_5|90|3|TREATMENT|2021-01-06|2021-01-12|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|e5a105f7-38ac-4f19-aace-4149ed9b1100|1|CYUNCLA|Unclassified Crystals|CHEMISTRY|[?]|CFU/mL|[?]|[?]|NEGATIVE|1|ms/mmHg|1|1|[?]|HIGH|LOCHIA|REFRIGERATED||X-RAY|CKD-EPI CREATININE FORMULA|Y|Y|NA||1|Visit_1|10|4|SCREENING|2020-09-03|2020-10-18|10|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|e5a105f7-38ac-4f19-aace-4149ed9b1100|2|BASO|Basophils|CHEMISTRY|[?]|MPL U/mL|[?]|[?]|INVALID|1|mL/cage|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|CALCIFIED|N|OPTICAL DENSITY MEASUREMENT|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-09-03|2020-11-08|10|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|e5a105f7-38ac-4f19-aace-4149ed9b1100|3|BASOMM|Basophilic Metamyelocytes|CHEMISTRY|[?]|pL|[?]|[?]|TRACE|1|10^9/dose|1|1|[?]|LOW|SERUM OR PLASMA|CONTAMINATED||FLOCCULATION|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-09-18|2020-10-23|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|e5a105f7-38ac-4f19-aace-4149ed9b1100|4|C130080|Orchard Grass Pollen IgE|HEMATOLOGY|[?]|Osm|[?]|[?]|NEGATIVE|1|10^9 organisms|1|1|[?]|HIGH|PERITONEAL FLUID|NON-HEMOLYZED||CT SCAN WITHOUT CONTRAST|MDRD FORMULA|Y||NA||2|Visit_2|25|4|SCREENING|2020-09-18|2020-09-20|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|e5a105f7-38ac-4f19-aace-4149ed9b1100|5|MM2IGAB|Mitochondrial M2 IgG Antibody|CHEMISTRY|[?]|U|[?]|[?]|POSITIVE|1|Frames/s|1|1|[?]|NORMAL|DISCHARGE|REFRIGERATED||FUNCTIONAL MRI|CKD-EPI FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-10-03|2020-10-15|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|e5a105f7-38ac-4f19-aace-4149ed9b1100|6|BLASTERY|Basophilic Erythroblast|HEMATOLOGY|[?]|pg|[?]|[?]|INDETERMINATE|1|RING|1|1|[?]|ABNORMAL|VENOUS BLOOD|HEMOLYZED|N|ULTRASOUND|GMI MMOL/MOL FORMULA||Y|NA||3|Visit_3|40|7|WASHOUT|2020-10-03|2020-11-27|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|e5a105f7-38ac-4f19-aace-4149ed9b1100|7|TNF12|TNF Superfamily Member 12|CHEMISTRY|[?]|%(w/v)|[?]|[?]|BORDERLINE|1|ag|1|1|[?]|LOW|GASTRIC CONTENTS|REFRIGERATED||WHOLE EXOME SEQUENCING|MDRD FORMULA|||NA||4|Visit_4|65|1|SCREENING|2020-10-28|2020-11-28|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|e5a105f7-38ac-4f19-aace-4149ed9b1100|8|GLOBA2|Alpha-2 Globulin|CHEMISTRY|[?]|IU/mg|[?]|[?]|BORDERLINE|1|mL/dose|1|1|[?]|NORMAL|PLEURAL TISSUE|ROOM TEMPERATURE||PULSE OXIMETRY|GMI % FORMULA|||U||4|Visit_4|65|1|WASHOUT|2020-10-28|2020-11-08|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|e5a105f7-38ac-4f19-aace-4149ed9b1100|9|MX1|Interferon-Induced Protein p78|HEMATOLOGY|[?]|10^7 PFU|[?]|[?]|POSITIVE|1|km|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|AUTOLYZED||TRYPAN BLUE STAIN|MDRD 4 VARIABLE FORMULA|Y||NA||5|Visit_5|90|4|FOLLOW-UP|2020-11-22|2020-11-29|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|e5a105f7-38ac-4f19-aace-4149ed9b1100|10|FGF9|Fibroblast Growth Factor 9|CHEMISTRY|[?]|OI50|[?]|[?]|NEGATIVE|1|Watt|1|1|[?]|LOW|VENOUS CORD BLOOD|PARAFFIN-EMBEDDED||FLOW CYTOMETRY|MDRD 5 VARIABLE FORMULA|||N||5|Visit_5|90|5|SCREENING|2020-11-22|2020-11-26|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|c568ab93-8e7f-4e4e-9685-f0c13f293606|1|C165930|Shellfish Mix IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mPa|1|1|[?]|ABNORMAL|PROSTATIC FLUID|AUTOLYZED||TRANSMISSION ELECTRON MICROSCOPY|MDRD ENZYMATIC FORMULA|||NA|Y|1|Visit_1|10|2|TREATMENT|2021-01-14|2021-03-29|10|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|c568ab93-8e7f-4e4e-9685-f0c13f293606|2|PARICEAB|Parietal Cell Antibody|URINALYSIS|[?]|bel|[?]|[?]|NEGATIVE|1|vg/dose|1|1|[?]|ABNORMAL|DIALYSIS FLUID|NON-HEMOLYZED|N|SPECT/CT SCAN|GMI MMOL/MOL FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2021-01-14|2021-04-06|10|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|c568ab93-8e7f-4e4e-9685-f0c13f293606|3|C130126|Cat Dander Antigen IgA Antibody|HEMATOLOGY|[?]|Rad|[?]|[?]|INDETERMINATE|1|mL/breath|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|REFRIGERATED||ALCIAN BLUE STAIN|NASH FIBROSURE FORMULA||Y|NA||2|Visit_2|25|6|TREATMENT|2021-01-29|2021-02-23|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-08
e|LB|c568ab93-8e7f-4e4e-9685-f0c13f293606|4|MM2IGAB|Mitochondrial M2 IgG Antibody|HEMATOLOGY|[?]|/500 WBC|[?]|[?]|INDETERMINATE|1|mol/mol|1|1|[?]|HIGH|LYMPH|AUTOLYZED||NEXT GENERATION SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||2|Visit_2|25|6|SCREENING|2021-01-29|2021-03-27|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-08
e|LB|c568ab93-8e7f-4e4e-9685-f0c13f293606|5|C165931|Nut Mix IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|ukat/L|1|1|[?]|LOW|SPERMATOZOON|ROOM TEMPERATURE||FLUORESCENT SPOT TEST|GMI % FORMULA|||Y|Y|3|Visit_3|40|1|TREATMENT|2021-02-13|2021-03-25|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|c568ab93-8e7f-4e4e-9685-f0c13f293606|6|FUNGI|Fungi|CHEMISTRY|[?]|mEq/ug|[?]|[?]|INDETERMINATE|1|HEP|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|CONCENTRATED||AUTOREFRACTION|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2021-02-13|2021-03-18|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|c568ab93-8e7f-4e4e-9685-f0c13f293606|7|HRYCELE|Hairy Cells/Leukocytes|CHEMISTRY|[?]|kUSP|[?]|[?]|NEGATIVE|1|L/s/kPa|1|1|[?]|NORMAL|BONE|FROZEN||IMMUNODIFFUSION|GMI % FORMULA|Y|Y|Y||4|Visit_4|65|4|TREATMENT|2021-03-10|2021-03-27|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|c568ab93-8e7f-4e4e-9685-f0c13f293606|8|MOCYCE|Monocytoid Cells|URINALYSIS|||[?]|[?]|BORDERLINE|1|nkat|1|1|[?]|ABNORMAL|PROSTATIC FLUID|LIPEMIC||MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI CREATININE FORMULA|||N|Y|4|Visit_4|65|5|SCREENING|2021-03-10|2021-03-13|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|c568ab93-8e7f-4e4e-9685-f0c13f293606|9|CYSTATC|Cystatin C|CHEMISTRY|[?]|mV2/Hz|[?]|[?]|BORDERLINE|1|log10 CFU/mL|1|1|[?]|NORMAL|BUFFY COAT|CLOTTED||PET SCAN|FIBROMETER FORMULA|||N||5|Visit_5|90|5|TREATMENT|2021-04-04|2021-04-13|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|c568ab93-8e7f-4e4e-9685-f0c13f293606|10|SJSSAAB|Sjogrens SS-A Antibody|CHEMISTRY|||[?]|[?]|TRACE|1|ugEq/L|1|1|[?]|NORMAL|DERMAL TISSUE|ICTERIC|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|CKD-EPI FORMULA|||Y|Y|5|Visit_5|90|2|SCREENING|2021-04-04|2021-04-09|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|bccd8af0-2ecf-4091-92e4-681597b57ca4|1|ESTRIOLF|Estriol, Free|CHEMISTRY|||[?]|[?]|INVALID|1|IU/dL|1|1|[?]|ABNORMAL|SEMINAL FLUID|PARAFFIN-EMBEDDED|N|FLUORESCENT IMMUNOASSAY|GMI MMOL/MOL FORMULA|Y||NA|Y|1|Visit_1|10|7|SCREENING|2020-09-30|2020-12-01|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|bccd8af0-2ecf-4091-92e4-681597b57ca4|2|CPEPCRT|C-peptide/Creatinine|URINALYSIS|[?]|10^7 CFU/mL|[?]|[?]|INVALID|1|IU/kg|1|1|[?]|NORMAL|CORD BLOOD|PARAFFIN-EMBEDDED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|6|WASHOUT|2020-09-30|2020-11-29|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|bccd8af0-2ecf-4091-92e4-681597b57ca4|3|AFPA|Alpha Fetoprotein Activity|URINALYSIS|[?]|keV|[?]|[?]|INVALID|1|genEq|1|1|[?]|LOW|AMNIOTIC FLUID|FRESH||DIGITAL PCR ARRAY|FIBROMETER FORMULA|Y|Y|Y||2|Visit_2|25|7|TREATMENT|2020-10-15|2020-10-31|25|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|bccd8af0-2ecf-4091-92e4-681597b57ca4|4|CCL20|Chemokine (C-C Motif) Ligand 20|URINALYSIS|[?]|HOURS|[?]|[?]|INDETERMINATE|1|pmol/day|1|1|[?]|NORMAL|LEUKOCYTE|SOLIDIFIED||HEMOCYTOMETRY|COCKCROFT-GAULT FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2020-10-15|2020-11-30|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|bccd8af0-2ecf-4091-92e4-681597b57ca4|5|CAEXR|Calcium Excretion Rate|CHEMISTRY|[?]|BOWL|[?]|[?]|POSITIVE|1|DAYS|1|1|[?]|LOW|SMEGMA|GELLED||ACCELERATOR MASS SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA|Y||NA||3|Visit_3|40|6|WASHOUT|2020-10-30|2020-11-25|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|bccd8af0-2ecf-4091-92e4-681597b57ca4|6|LMBDLC|Lambda Light Chain|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/s/m2|1|1|[?]|LOW|PLATELET POOR PLASMA|AUTOLYZED||MICRO BROTH DILUTION|MDRD ENZYMATIC FORMULA|Y|Y|U|Y|3|Visit_3|40|2|TREATMENT|2020-10-30|2020-12-27|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|bccd8af0-2ecf-4091-92e4-681597b57ca4|7|MUCTHR|Mucous Threads|URINALYSIS|[?]|cmH2O/mL|[?]|[?]|INDETERMINATE|1|IU/day|1|1|[?]|HIGH|URINE|FROZEN|N|CAPILLARY ELECTROPHORESIS|MDRD FORMULA||Y|N||4|Visit_4|65|3|TREATMENT|2020-11-24|2020-11-26|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|bccd8af0-2ecf-4091-92e4-681597b57ca4|8|GRANCE|Granulocytes/Total Cells|URINALYSIS|[?]|mL/s|[?]|[?]|NEGATIVE|1|mL/g/h|1|1|[?]|HIGH|REFLEX TEAR|GELLED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA|Y||Y||4|Visit_4|65|3|WASHOUT|2020-11-24|2020-12-06|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|bccd8af0-2ecf-4091-92e4-681597b57ca4|9|VITD3|Vitamin D3|URINALYSIS|[?]|mL/sec/1.73m2|[?]|[?]|POSITIVE|1|aMFI|1|1|[?]|LOW|PLEURAL FLUID|THAWED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||5|Visit_5|90|1|FOLLOW-UP|2020-12-19|2020-12-21|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|bccd8af0-2ecf-4091-92e4-681597b57ca4|10|MASTCE|Mast Cells|CHEMISTRY|[?]|mg/kg/h|[?]|[?]|INVALID|1|uU/dL|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|HEMOLYZED|N|ELISA|GMI % FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-12-19|2020-12-23|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|bf069a02-03a6-4013-b16d-d7c954a6cc3d|1|THMBAAC|Thrombin Activity Actual/Control|HEMATOLOGY|[?]|Hz|[?]|[?]|INDETERMINATE|1|cmH2O*s2/mL|1|1|[?]|NORMAL|MUSCLE TISSUE|LIPEMIC|N|AUTOREFRACTION|MDRD 5 VARIABLE FORMULA|Y|Y|Y||1|Visit_1|10|7|SCREENING|2020-08-06|2020-09-01|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|bf069a02-03a6-4013-b16d-d7c954a6cc3d|2|GMCSF|Granulocyte Macrophage Colony Stm Factor|URINALYSIS|||[?]|[?]|POSITIVE|1|uCi/kg|1|1|[?]|HIGH|INFRANATANT, SERUM|NON-HEMOLYZED||RIA|COCKCROFT-GAULT FORMULA|||NA|Y|1|Visit_1|10|1|SCREENING|2020-08-06|2020-10-14|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|bf069a02-03a6-4013-b16d-d7c954a6cc3d|3|PO2FIO2|PP Arterial O2/Fraction Inspired O2|HEMATOLOGY|[?]|log10 CCID 50/dose|[?]|[?]|INDETERMINATE|1|10^6 copies/mL|1|1|[?]|HIGH|SEMEN|UNEXPECTED ODOR||MULTI-SLICE SPIRAL CT|MDRD ENZYMATIC FORMULA|Y||U||2|Visit_2|25|7|SCREENING|2020-08-21|2020-08-25|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|bf069a02-03a6-4013-b16d-d7c954a6cc3d|4|C3|Complement C3|CHEMISTRY|[?]|OI50|[?]|[?]|TRACE|1|deg2|1|1|[?]|NORMAL|LEUKOCYTE|NON-HEMOLYZED||HANSEL STAIN|CKD-EPI FORMULA|Y||Y||2|Visit_2|25|2|TREATMENT|2020-08-21|2020-09-12|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|bf069a02-03a6-4013-b16d-d7c954a6cc3d|5|VITD|Vitamin D|HEMATOLOGY|[?]|Hounsfield Unit|[?]|[?]|INVALID|1|U/mmol|1|1|[?]|NORMAL|MUSCLE TISSUE|FRESH||MALDI-TOF|MDRD 6 VARIABLE FORMULA|Y||NA||3|Visit_3|40|4|TREATMENT|2020-09-05|2020-10-31|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|bf069a02-03a6-4013-b16d-d7c954a6cc3d|6|POLYERY|Polychromatophilic Erythroblast|HEMATOLOGY|[?]|10^7 PFU|[?]|[?]|NEGATIVE|1|umol/mol|1|1|[?]|ABNORMAL|CERUMEN|AUTOLYZED||MASS SPECTROMETRY|ASH FIBROSURE FORMULA|||NA||3|Visit_3|40|5|WASHOUT|2020-09-05|2020-10-15|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|bf069a02-03a6-4013-b16d-d7c954a6cc3d|7|CYDRUG|Drug Crystals|URINALYSIS|[?]|10^3 CFU|[?]|[?]|POSITIVE|1|m/sec2|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|CLOTTED||CORONARY ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||4|Visit_4|65|2|SCREENING|2020-09-30|2020-10-18|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|bf069a02-03a6-4013-b16d-d7c954a6cc3d|8|CSEPI846|Aggrecan Chondroitin Sulfate Epitope 846|HEMATOLOGY|[?]|pptr|[?]|[?]|BORDERLINE|1|umol/L/h|1|1|[?]|HIGH|KERATINOCYTE|GELLED||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD ENZYMATIC FORMULA|Y|Y|NA||4|Visit_4|65|7|TREATMENT|2020-09-30|2020-10-25|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|bf069a02-03a6-4013-b16d-d7c954a6cc3d|9|MONMPHLE|Monocytes and Macrophages/Leukocytes|URINALYSIS|[?]|g/g|[?]|[?]|INDETERMINATE|1|kUSP|1|1|[?]|LOW|LYMPH|SOLIDIFIED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 4 VARIABLE FORMULA||Y|NA||5|Visit_5|90|7|TREATMENT|2020-10-25|2020-10-29|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|bf069a02-03a6-4013-b16d-d7c954a6cc3d|10|HYDMDZ1|1-Hydroxymidazolam|CHEMISTRY|[?]|VOXEL|[?]|[?]|POSITIVE|1|SBE/mL|1|1|[?]|HIGH|SMEGMA|CALCIFIED||ELISA|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||5|Visit_5|90|7|SCREENING|2020-10-25|2020-11-01|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|c40fc52b-2668-4fab-b051-5b258da72f2c|1|FRTNLC|Ferritin Light Chain|HEMATOLOGY|[?]|g/g|[?]|[?]|BORDERLINE|1|fmol/L|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|LIPEMIC||CISH|FIBROMETER FORMULA|||U||1|Visit_1|10|1|TREATMENT|2020-10-11|2020-11-22|10|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|c40fc52b-2668-4fab-b051-5b258da72f2c|2|C130136|American Cockroach Antigen IgE Antibody|CHEMISTRY|[?]|U/m2/h|[?]|[?]|INDETERMINATE|1|RFU|1|1|[?]|LOW|DIALYSIS FLUID|ICTERIC||SLOAN LETTER EYE CHART 2.5%|GMI % FORMULA||Y|NA||1|Visit_1|10|7|TREATMENT|2020-10-11|2020-11-12|10|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|c40fc52b-2668-4fab-b051-5b258da72f2c|3|NACLR|Sodium Clearance|URINALYSIS|[?]|MPL U/mL|[?]|[?]|NEGATIVE|1|10^5/L|1|1|[?]|LOW|INTERSTITIAL FLUID|GELLED||NON-CONTACT SPECULAR MICROSCOPY|GMI % FORMULA|Y|Y|U||2|Visit_2|25|2|TREATMENT|2020-10-26|2020-11-01|25|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|c40fc52b-2668-4fab-b051-5b258da72f2c|4|INCLBOD|Inclusion Bodies|URINALYSIS|[?]|L/min|[?]|[?]|INVALID|1|SCOOPFUL|1|1|[?]|NORMAL|CORD BLOOD|CALCIFIED||MICROBIAL CULTURE, SOLID|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-10-26|2020-11-02|25|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|c40fc52b-2668-4fab-b051-5b258da72f2c|5|BLSTMGK|Megakaryoblasts|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mEq/g|1|1|[?]|NORMAL|EPIDERMAL TISSUE|ROOM TEMPERATURE|N|PANENDOSCOPY|CKD-EPI FORMULA|||Y|Y|3|Visit_3|40|7|TREATMENT|2020-11-10|2020-11-23|40|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|c40fc52b-2668-4fab-b051-5b258da72f2c|6|B1BGLP|Beta-1B Glycoprotein|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|CCID 50/dose|1|1|[?]|LOW|LOCHIA|PARAFFIN-EMBEDDED|N|TURBIDIMETRY|GMI MMOL/MOL FORMULA||Y|N|Y|3|Visit_3|40|3|TREATMENT|2020-11-10|2020-11-16|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|c40fc52b-2668-4fab-b051-5b258da72f2c|7|MBP|Myelin Basic Protein|HEMATOLOGY|[?]|pm|[?]|[?]|NEGATIVE|1|10^9 organisms/mL|1|1|[?]|LOW|BLOOD|UNEXPECTED ODOR|N|DOPPLER ULTRASOUND|MDRD 6 VARIABLE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-12-05|2021-01-03|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|c40fc52b-2668-4fab-b051-5b258da72f2c|8|IRON|Iron|CHEMISTRY|||[?]|[?]|BORDERLINE|1|g/L|1|1|[?]|ABNORMAL|SMEGMA|LACTESCENT||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA|||N|Y|4|Visit_4|65|4|TREATMENT|2020-12-05|2020-12-11|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|c40fc52b-2668-4fab-b051-5b258da72f2c|9|C5|Complement C5|HEMATOLOGY|[?]|DROP|[?]|[?]|INVALID|1|APL U|1|1|[?]|NORMAL|EXUDATE|CONCENTRATED||KINETIC MICROPARTICLE IMMUNOASSAY|COCKCROFT-GAULT FORMULA||Y|U||5|Visit_5|90|2|SCREENING|2020-12-30|2021-01-01|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|c40fc52b-2668-4fab-b051-5b258da72f2c|10|PCSK9|Proprotein Convertase Subtilisin/Kexin 9|HEMATOLOGY|||[?]|[?]|POSITIVE|1|SQU/mL|1|1|[?]|LOW|TISSUE|UNEXPECTED ODOR||GRADIENT DIFFUSION|MDRD ENZYMATIC FORMULA|Y||U|Y|5|Visit_5|90|7|TREATMENT|2020-12-30|2021-01-04|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|d7c792d8-fc98-41ab-8a9e-59de1e186a06|1|C130125|Cat Dander Antigen IgG Antibody|HEMATOLOGY|[?]|ug/day|[?]|[?]|NEGATIVE|1|deg|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|NON-HEMOLYZED||ACRIDINE ORANGE STAIN|COCKCROFT-GAULT FORMULA|||NA||1|Visit_1|10|7|WASHOUT|2020-07-28|2020-09-23|10|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|d7c792d8-fc98-41ab-8a9e-59de1e186a06|2|LYMPLLY|Plasmacytoid Lymphocytes/Lymphocytes|HEMATOLOGY|[?]|lm|[?]|[?]|INVALID|1|CAN|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|AUTOLYZED||OPTICAL DENSITY MEASUREMENT|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-07-28|2020-10-16|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|d7c792d8-fc98-41ab-8a9e-59de1e186a06|3|CSBROAD|Broad Casts|URINALYSIS|[?]|/40 HPFs|[?]|[?]|NEGATIVE|1|mEq/mL|1|1|[?]|LOW|VITREOUS HUMOR|FROZEN||CORONARY ANGIOGRAPHY|FIBROSIS 4 FORMULA|Y||N||2|Visit_2|25|1|SCREENING|2020-08-12|2020-09-09|25|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|d7c792d8-fc98-41ab-8a9e-59de1e186a06|4|C130122|Nut Mix Antigen IgE Antibody|URINALYSIS|[?]|mEq/uL|[?]|[?]|TRACE|1|/10^3|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|SOLIDIFIED||MAGNETIC RESONANCE ENTEROGRAPHY|MDRD FORMULA|Y||N||2|Visit_2|25|1|WASHOUT|2020-08-12|2020-08-28|25|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|d7c792d8-fc98-41ab-8a9e-59de1e186a06|5|ALBGALB|Glycated Albumin/Albumin|URINALYSIS|[?]|cg|[?]|[?]|INVALID|1|PACKAGE|1|1|[?]|ABNORMAL|SKIN TISSUE|UNEXPECTED ODOR||INTERRUPTER TECHNIQUE|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||3|Visit_3|40|5|FOLLOW-UP|2020-08-27|2020-09-26|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|d7c792d8-fc98-41ab-8a9e-59de1e186a06|6|DRVVTSCR|DRVVT Screen to Confirm Ratio|HEMATOLOGY|[?]|uL/mL|[?]|[?]|INDETERMINATE|1|HOURS|1|1|[?]|LOW|SERUM|THAWED||TARGETED GENOME SEQUENCING|MDRD FORMULA|||N||3|Visit_3|40|1|TREATMENT|2020-08-27|2020-09-19|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|d7c792d8-fc98-41ab-8a9e-59de1e186a06|7|EOSNSQE|Eosinophils/Non-Squam Epi Cells|HEMATOLOGY|[?]|breaths/min|[?]|[?]|INVALID|1|FINGERTIP UNIT|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|ICTERIC||SPECT SCAN|CKD-EPI FORMULA|||N||4|Visit_4|65|4|TREATMENT|2020-09-21|2020-09-30|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|d7c792d8-fc98-41ab-8a9e-59de1e186a06|8|GDA|Guanine Deaminase|HEMATOLOGY|[?]|IMPLANT|[?]|[?]|NEGATIVE|1|10^9/L|1|1|[?]|NORMAL|PLEURAL TISSUE|ROOM TEMPERATURE|N|MAGNETIC RESONANCE ANGIOGRAPHY|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|5|WASHOUT|2020-09-21|2020-09-28|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|d7c792d8-fc98-41ab-8a9e-59de1e186a06|9|PRABC|Calculated Panel Reactive Antibody|URINALYSIS|||[?]|[?]|INVALID|1|nU/cL|1|1|[?]|ABNORMAL|PROSTATIC FLUID|CONCENTRATED|N|KNEMOMETRY|FIBROMETER FORMULA|||NA|Y|5|Visit_5|90|3|TREATMENT|2020-10-16|2020-10-24|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|d7c792d8-fc98-41ab-8a9e-59de1e186a06|10|S100B|S100 Calcium-Binding Protein B|URINALYSIS|||[?]|[?]|NEGATIVE|1|mkat|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|REFRIGERATED||FLUORESCENT ENZYME IMMUNOASSAY|NASH FIBROSURE FORMULA||Y|NA|Y|5|Visit_5|90|4|WASHOUT|2020-10-16|2020-10-19|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|f7773659-f207-4b29-8389-3aa766a6337a|1|GFRBSCU|GFR from Creat and UreaN Adj BSA|HEMATOLOGY|[?]|IU/L|[?]|[?]|POSITIVE|1|mm/h|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|PARAFFIN-EMBEDDED||KINETIC MICROPARTICLE IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||Y|Y||1|Visit_1|10|7|WASHOUT|2020-10-19|2021-01-03|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|f7773659-f207-4b29-8389-3aa766a6337a|2|GFRBSCYC|GFR from Cystatin C Adjusted for BSA|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|/100 WBC|1|1|[?]|LOW|SKIN TISSUE|CONTAMINATED||WESTERGREN|ASH FIBROSURE FORMULA||Y|NA|Y|1|Visit_1|10|6|TREATMENT|2020-10-19|2020-12-10|10|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|f7773659-f207-4b29-8389-3aa766a6337a|3|PO2ADJT|Partial Pressure Oxygen Adj for Temp|URINALYSIS|[?]|BAU/mL|[?]|[?]|INDETERMINATE|1|mL/animal/wk|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|CLOTTED||LC/MS|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|3|SCREENING|2020-11-03|2020-12-06|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|f7773659-f207-4b29-8389-3aa766a6337a|4|HDLPL|HDL Phospholipid|HEMATOLOGY|||[?]|[?]|INVALID|1|atm|1|1|[?]|ABNORMAL|SEMINAL FLUID|ICTERIC|N|RADIATION DOSIMETRY|CKD-EPI CREATININE FORMULA||Y|N|Y|2|Visit_2|25|7|TREATMENT|2020-11-03|2021-01-11|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|f7773659-f207-4b29-8389-3aa766a6337a|5|LCN2|Lipocalin-2|URINALYSIS|[?]|g|[?]|[?]|NEGATIVE|1|nmol/mol|1|1|[?]|NORMAL|SMEGMA|ICTERIC||MACRO BROTH DILUTION|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-11-18|2021-01-01|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|f7773659-f207-4b29-8389-3aa766a6337a|6|WBCDIFF|Leukocyte Cell Differential|URINALYSIS|[?]|mL*cmH2O|[?]|[?]|TRACE|1|POINT|1|1|[?]|LOW|URINE SEDIMENT|AUTOLYZED||MALDI-TOF|CKD-EPI CREATININE FORMULA||Y|Y||3|Visit_3|40|5|TREATMENT|2020-11-18|2020-12-09|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|f7773659-f207-4b29-8389-3aa766a6337a|7|C130077|Silver Birch Pollen IgA|URINALYSIS|||[?]|[?]|BORDERLINE|1|kPa/L/sec|1|1|[?]|LOW|URINE|LACTESCENT||MICROPARTICLE ENZYME IMMUNOASSAY|HEPASCORE FORMULA||Y|Y|Y|4|Visit_4|65|2|FOLLOW-UP|2020-12-13|2020-12-27|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|f7773659-f207-4b29-8389-3aa766a6337a|8|CSAB|Cathepsin Antibody|URINALYSIS|||[?]|[?]|INVALID|1|min|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|FROZEN|N|GC/MS-CI|FIBROTEST FORMULA||Y|NA|Y|4|Visit_4|65|3|TREATMENT|2020-12-13|2020-12-29|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|f7773659-f207-4b29-8389-3aa766a6337a|9|COPEP|Copeptin|CHEMISTRY|[?]|U/g/min|[?]|[?]|NEGATIVE|1|mL/cage/wk|1|1|[?]|LOW|CEREBROSPINAL FLUID|UNEXPECTED ODOR||THERMAL IONIZATION MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA|||N||5|Visit_5|90|1|SCREENING|2021-01-07|2021-01-08|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|f7773659-f207-4b29-8389-3aa766a6337a|10|SPGRAV|Specific Gravity|CHEMISTRY|[?]|Ci|[?]|[?]|INVALID|1|10^9 organisms/g|1|1|[?]|NORMAL|SOFT TISSUE|NON-HEMOLYZED||CLOT DETECTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||5|Visit_5|90|2|TREATMENT|2021-01-07|2021-01-13|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|1|CRDIGMAB|Cardiolipin IgM Antibody|HEMATOLOGY|[?]|Bq/mg|[?]|[?]|POSITIVE|1|log EID 50/dose|1|1|[?]|NORMAL|REFLEX TEAR|CONTAMINATED|N|LIGHT SCATTERING SPECTROSCOPY|ASH FIBROSURE FORMULA||Y|NA||1|Visit_1|10|2|TREATMENT|2021-01-07|2021-03-04|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|2|GSTMUCRT|Mu Glutathione-S-Transferase/Creatinine|URINALYSIS|[?]|gpELISA unit/mL|[?]|[?]|NEGATIVE|1|%/min|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|LACTESCENT|N|VENTILATION PERFUSION LUNG SCAN|CKD-EPI FORMULA|||NA||1|Visit_1|10|7|FOLLOW-UP|2021-01-07|2021-03-01|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|3|CRDIGGAB|Cardiolipin IgG Antibody|HEMATOLOGY|[?]|log10 CFU/g|[?]|[?]|NEGATIVE|1|umol/mol|1|1|[?]|LOW|MENSTRUAL BLOOD|PARAFFIN-EMBEDDED|N|MUGA|CKD-EPI CREATININE FORMULA||Y|Y||2|Visit_2|25|3|TREATMENT|2021-01-22|2021-03-10|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|4|PPI|Inorganic Pyrophosphate|HEMATOLOGY|[?]|pmol/day|[?]|[?]|POSITIVE|1|USP U|1|1|[?]|ABNORMAL|BILE|UNEXPECTED ODOR||BIOPSY|CKD-EPI CREATININE FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2021-01-22|2021-02-24|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|5|CELLSIM|Immature Cells|URINALYSIS|[?]|um/s|[?]|[?]|INDETERMINATE|1|mmol/L|1|1|[?]|ABNORMAL|REFLEX TEAR|AGGLUTINATED||ENZYMATIC COLORIMETRY|FIBROMETER FORMULA|||U||3|Visit_3|40|4|TREATMENT|2021-02-06|2021-02-26|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|6|IC512AG|Islet Cell 512 Antigen|URINALYSIS|[?]|g/animal/day|[?]|[?]|INVALID|1|Gauss|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|GELLED||INTRAVASCULAR ULTRASOUND|GMI % FORMULA|||N||3|Visit_3|40|6|FOLLOW-UP|2021-02-06|2021-03-17|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|7|CRTCLRE|Creatinine Clearance, Estimated|HEMATOLOGY|||[?]|[?]|POSITIVE|1|kPa/L/sec|1|1|[?]|LOW|ENDOTRACHEAL FLUID|CONCENTRATED||CYSTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|4|Visit_4|65|3|WASHOUT|2021-03-03|2021-03-09|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|8|IGF2|Insulin-like Growth Factor-2|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|cd|1|1|[?]|NORMAL|BONE|PARAFFIN-EMBEDDED||ELECTROGASTROGRAPHY|MDRD ENZYMATIC FORMULA|||NA|Y|4|Visit_4|65|7|TREATMENT|2021-03-03|2021-03-19|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|9|EPIROCE|Round Epithelial Cells|CHEMISTRY|[?]|V/sec|[?]|[?]|TRACE|1|g/cage/wk|1|1|[?]|ABNORMAL|ALVEOLAR AIR|CALCIFIED||DIFFUSION TENSOR MRI|ASH FIBROSURE FORMULA||Y|N||5|Visit_5|90|7|TREATMENT|2021-03-28|2021-04-03|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|10|C130083|Orchard Grass Pollen IgG4|CHEMISTRY|[?]|mmol/s|[?]|[?]|POSITIVE|1|mL/s|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|CLOTTED||WHOLE TRANSCRIPTOME SEQUENCING|ASH FIBROSURE FORMULA||Y|U||5|Visit_5|90|3|WASHOUT|2021-03-28|2021-03-31|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|1|THYPXDAB|Thyroperoxidase Antibody|URINALYSIS|||[?]|[?]|TRACE|1|ug/kg/min|1|1|[?]|LOW|CAPILLARY PLASMA|CONTAMINATED||DYNAMOMETRY|MDRD ENZYMATIC FORMULA|||NA|Y|1|Visit_1|10|5|TREATMENT|2021-01-26|2021-01-27|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|2|GRWHRH|Growth Hormone Releasing Hormone|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|BAU/mL|1|1|[?]|HIGH|DISCHARGE|UNEXPECTED ODOR||ENDOSCOPY|MDRD ENZYMATIC FORMULA|||N|Y|1|Visit_1|10|1|WASHOUT|2021-01-26|2021-04-20|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|3|PROGESTR|Progesterone Receptor|CHEMISTRY|||[?]|[?]|POSITIVE|1|CONTAINER|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|CALCIFIED||KNEMOMETRY|GMI % FORMULA||Y|NA|Y|2|Visit_2|25|2|SCREENING|2021-02-10|2021-03-24|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|LB|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|4|LH|Luteinizing Hormone|HEMATOLOGY|[?]|mg|[?]|[?]|NEGATIVE|1|mg/m2|1|1|[?]|ABNORMAL|HAIR|LACTESCENT||ULTRASOUND|MDRD FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2021-02-10|2021-02-15|25|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|LB|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|5|CD45LY|CD45/Lymphocytes|CHEMISTRY|[?]|deg/s|[?]|[?]|INVALID|1|PATCH|1|1|[?]|LOW|REFLEX TEAR|ICTERIC|N|POPULATION SEQUENCING|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|2|SCREENING|2021-02-25|2021-03-26|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|6|PEPSNGA|Pepsinogen A|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|min/day|1|1|[?]|LOW|INFRANATANT, SERUM|NON-HEMOLYZED||OSCILLOMETRY|CKD-EPI CREATININE FORMULA|Y||NA|Y|3|Visit_3|40|2|SCREENING|2021-02-25|2021-03-22|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|7|TPROTFR|Tau Protein, Free|CHEMISTRY|[?]|umol/mol|[?]|[?]|NEGATIVE|1|min|1|1|[?]|ABNORMAL|SERUM|SOLIDIFIED|N|MICRODENSITOMETRY|MDRD 4 VARIABLE FORMULA|Y||NA||4|Visit_4|65|4|TREATMENT|2021-03-22|2021-04-11|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|LB|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|8|LYMPL|Plasmacytoid Lymphocytes|CHEMISTRY|[?]|STRIP|[?]|[?]|POSITIVE|1|umol|1|1|[?]|ABNORMAL|RETICULOCYTES|UNEXPECTED ODOR||SLIT LAMP PHOTOGRAPHY|MDRD FORMULA|||Y||4|Visit_4|65|1|WASHOUT|2021-03-22|2021-04-10|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|LB|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|9|CD79A|CD79A|CHEMISTRY|[?]|Ci/L|[?]|[?]|INVALID|1|BISCUIT|1|1|[?]|HIGH|BUFFY COAT|UNEXPECTED ODOR|N|FLUORESCEIN STAIN|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|2|FOLLOW-UP|2021-04-16|2021-04-18|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|10|ALBGLYCA|Glycated Albumin|HEMATOLOGY|[?]|ukat/L|[?]|[?]|INDETERMINATE|1|nCi|1|1|[?]|HIGH|ALVEOLAR AIR|HEMOLYZED|N|WHOLE GENOME SEQUENCING|FIBROMETER FORMULA|Y||NA||5|Visit_5|90|1|TREATMENT|2021-04-16|2021-04-19|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|700049a2-ef66-466b-b1d8-f0800bcfde43|1|HOWJOL|Howell-Jolly Bodies|HEMATOLOGY|[?]|mL/animal/day|[?]|[?]|POSITIVE|1|ug/m2|1|1|[?]|NORMAL|KERATINOCYTE|LIPEMIC||AURAMINE STAIN|HEPASCORE FORMULA|Y||Y||1|Visit_1|10|2|TREATMENT|2020-06-27|2020-08-06|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|700049a2-ef66-466b-b1d8-f0800bcfde43|2|PROMYCE|Promyelocytes/Total Cells|CHEMISTRY|||[?]|[?]|POSITIVE|1|SFC/10^6 PBMC|1|1|[?]|HIGH|BONE|LACTESCENT||MAGNETIC RESONANCE ANGIOGRAPHY|FIBROSIS 4 FORMULA|Y||NA|Y|1|Visit_1|10|6|TREATMENT|2020-06-27|2020-07-26|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|700049a2-ef66-466b-b1d8-f0800bcfde43|3|FACTVWA|von Willebrand Factor Activity|URINALYSIS|[?]|U/g/min|[?]|[?]|TRACE|1|JAR|1|1|[?]|LOW|INFRANATANT, SERUM|PARAFFIN-EMBEDDED||CONTRAST ENHANCED MRI|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||2|Visit_2|25|2|SCREENING|2020-07-12|2020-07-28|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|700049a2-ef66-466b-b1d8-f0800bcfde43|4|SPMPSPM|Spermatozoa, Progressive/Spermatozoa|URINALYSIS|[?]|TRANSDUCING UNIT|[?]|[?]|NEGATIVE|1|Linear ft*LB|1|1|[?]|HIGH|PLATELET POOR PLASMA|ROOM TEMPERATURE||URANYL ACETATE STAIN|MDRD FORMULA||Y|Y||2|Visit_2|25|1|FOLLOW-UP|2020-07-12|2020-07-25|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|700049a2-ef66-466b-b1d8-f0800bcfde43|5|METAMYCE|Metamyelocytes/Total Cells|CHEMISTRY|[?]|eq|[?]|[?]|INVALID|1|BE/mL|1|1|[?]|ABNORMAL|ISOLATE|CONCENTRATED||MICROBIAL CULTURE|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||3|Visit_3|40|1|SCREENING|2020-07-27|2020-09-23|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|700049a2-ef66-466b-b1d8-f0800bcfde43|6|GALM|Galactose Mutarotase|URINALYSIS|[?]|PACKAGE|[?]|[?]|TRACE|1|min/day|1|1|[?]|LOW|MECONIUM|UNEXPECTED ODOR||DYNAMIC CONTRAST ENHANCED MRI|MDRD FORMULA|||NA||3|Visit_3|40|1|WASHOUT|2020-07-27|2020-07-30|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|700049a2-ef66-466b-b1d8-f0800bcfde43|7|CD27|CD27|HEMATOLOGY|[?]|mEq/mmol|[?]|[?]|INVALID|1|FIU|1|1|[?]|LOW|CORD BLOOD|FRESH||POPULATION SEQUENCING|FIBROSIS 4 FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2020-08-21|2020-09-13|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|700049a2-ef66-466b-b1d8-f0800bcfde43|8|GFRBSCCC|GFR from Cystatin C and Creat Adj BSA|CHEMISTRY|[?]|10^6/Ejaculate U|[?]|[?]|INDETERMINATE|1|mL/g/min|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|UNEXPECTED ODOR|N|VENTILATION PERFUSION LUNG SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-08-21|2020-09-17|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|700049a2-ef66-466b-b1d8-f0800bcfde43|9|OPG|Osteoprotegerin|HEMATOLOGY|[?]|Pack Year|[?]|[?]|TRACE|1|pmol/dL|1|1|[?]|NORMAL|GASTRIC FLUID|FROZEN|N|OPHTHALMOSCOPY|MDRD FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-09-15|2020-09-21|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|700049a2-ef66-466b-b1d8-f0800bcfde43|10|C165920|White Elm Pollen IgG AB RAST Score|CHEMISTRY|[?]|gtt|[?]|[?]|POSITIVE|1|breaths/min|1|1|[?]|HIGH|BONE|LACTESCENT||HIGH RESOLUTION MELT ANALYSIS|MDRD 6 VARIABLE FORMULA||Y|U||5|Visit_5|90|7|SCREENING|2020-09-15|2020-09-22|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|00d906a6-2d14-4199-aff9-524388c5117f|1|CD10|CD10|HEMATOLOGY|[?]|BOWL|[?]|[?]|TRACE|1|EID 50/dose|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|THAWED|N|HPLC/IEX|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||1|Visit_1|10|1|TREATMENT|2020-11-24|2020-12-25|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|00d906a6-2d14-4199-aff9-524388c5117f|2|LACTICAC|Lactic Acid|URINALYSIS|[?]|mIU/L|[?]|[?]|TRACE|1|BU|1|1|[?]|LOW|PUS|LIPEMIC||FARNSWORTH-MUNSELL 100 HUE TEST|MDRD 4 VARIABLE FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-11-24|2021-01-26|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|00d906a6-2d14-4199-aff9-524388c5117f|3|GBP1|Guanylate Binding Protein 1|CHEMISTRY|[?]|MASK|[?]|[?]|TRACE|1|/sec|1|1|[?]|HIGH|PROSTATIC FLUID|ROOM TEMPERATURE|N|REVERSE TRANSCRIPTASE PCR|CKD-EPI FORMULA|Y||U||2|Visit_2|25|7|TREATMENT|2020-12-09|2020-12-31|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|00d906a6-2d14-4199-aff9-524388c5117f|4|VLDL|VLDL Cholesterol|CHEMISTRY|[?]|Farad|[?]|[?]|NEGATIVE|1|DROP|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|ICTERIC||OPTICAL MAPPING|CKD-EPI FORMULA|Y||U||2|Visit_2|25|6|FOLLOW-UP|2020-12-09|2021-02-07|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|00d906a6-2d14-4199-aff9-524388c5117f|5|NITRITE|Nitrite|URINALYSIS|[?]|JDF Unit|[?]|[?]|INVALID|1|ms2|1|1|[?]|ABNORMAL|ERYTHROCYTES|CONCENTRATED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA|Y||N||3|Visit_3|40|6|TREATMENT|2020-12-24|2021-01-20|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|00d906a6-2d14-4199-aff9-524388c5117f|6|FABP1|Fatty Acid Binding Protein 1|HEMATOLOGY|[?]|mol/day|[?]|[?]|POSITIVE|1|umol/h/mmol|1|1|[?]|LOW|ARTERIAL CORD BLOOD|SOLIDIFIED||LANDOLT RING|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|U||3|Visit_3|40|2|SCREENING|2020-12-24|2021-02-12|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|00d906a6-2d14-4199-aff9-524388c5117f|7|RETIHCR|Hematocrit Corrected Reticulocytes|CHEMISTRY|[?]|Joule|[?]|[?]|POSITIVE|1|L/s|1|1|[?]|NORMAL|LAVAGE FLUID|REFRIGERATED||PEAK FLOWMETRY|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2021-01-18|2021-02-17|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|00d906a6-2d14-4199-aff9-524388c5117f|8|LYMVAC|Vacuolated Lymphocytes|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mmol/kg|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|LACTESCENT||OSCILLOMETRY|COCKCROFT-GAULT FORMULA|||U|Y|4|Visit_4|65|6|SCREENING|2021-01-18|2021-02-20|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|00d906a6-2d14-4199-aff9-524388c5117f|9|TLCHT|Taurolithocholate|URINALYSIS|[?]|kN/cm2|[?]|[?]|NEGATIVE|1|mmol/kg|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|GELLED||GC/FID|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|5|TREATMENT|2021-02-12|2021-02-15|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|LB|00d906a6-2d14-4199-aff9-524388c5117f|10|P50OXYGN|P50 Oxygen|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^7 CFU|1|1|[?]|LOW|LYSATE|REFRIGERATED||ELISPOT|FIBROSIS 4 FORMULA|||N|Y|5|Visit_5|90|7|SCREENING|2021-02-12|2021-02-19|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|LB|2fcc5910-bce0-4510-b17e-3925850d6d32|1|IGAGM|IgG IgM IgA Total|HEMATOLOGY|[?]|Newton|[?]|[?]|BORDERLINE|1|CAPLET|1|1|[?]|HIGH|NAIL|ROOM TEMPERATURE||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI CYSTATIN C FORMULA|Y||N||1|Visit_1|10|4|TREATMENT|2020-12-16|2021-02-03|10|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|LB|2fcc5910-bce0-4510-b17e-3925850d6d32|2|COPPER|Copper|URINALYSIS|||[?]|[?]|POSITIVE|1|nmol BCE/mmol|1|1|[?]|NORMAL|MONOCYTE|NON-HEMOLYZED||IMMUNOTURBIDIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||Y|Y|1|Visit_1|10|3|TREATMENT|2020-12-16|2021-01-22|10|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|LB|2fcc5910-bce0-4510-b17e-3925850d6d32|3|ANAIGGAB|Antinuclear IgG Antibody|HEMATOLOGY|[?]|mL/cage|[?]|[?]|INVALID|1|cy/cm|1|1|[?]|HIGH|INTERSTITIAL FLUID|AUTOLYZED||GIEMSA STAIN|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-12-31|2021-01-27|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|2fcc5910-bce0-4510-b17e-3925850d6d32|4|LDH4LDH|LDH Isoenzyme 4/LDH|CHEMISTRY|[?]|Ci/g|[?]|[?]|INDETERMINATE|1|GLOBULE|1|1|[?]|HIGH|ABSCESS FLUID|ICTERIC||LEAD CITRATE STAIN|HEPASCORE FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-12-31|2021-02-03|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|2fcc5910-bce0-4510-b17e-3925850d6d32|5|STAT3P|Phosphorylated STAT3|CHEMISTRY|[?]|IU/day|[?]|[?]|INDETERMINATE|1|/10^5|1|1|[?]|HIGH|ERYTHROCYTES|LIPEMIC||MICRONEUTRALIZATION ASSAY|CKD-EPI FORMULA|||N||3|Visit_3|40|2|TREATMENT|2021-01-15|2021-02-03|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|2fcc5910-bce0-4510-b17e-3925850d6d32|6|TNFSR|Soluble Tumor Necrosis Factor Receptor|URINALYSIS|[?]|uOsm|[?]|[?]|BORDERLINE|1|mL/beat|1|1|[?]|ABNORMAL|DISCHARGE|THAWED||GRADIENT DIFFUSION|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2021-01-15|2021-02-07|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|2fcc5910-bce0-4510-b17e-3925850d6d32|7|THC|Tetrahydrocannabinol|URINALYSIS|||[?]|[?]|NEGATIVE|1|kIU|1|1|[?]|HIGH|MECONIUM|REFRIGERATED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|4|Visit_4|65|5|TREATMENT|2021-02-09|2021-02-24|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|2fcc5910-bce0-4510-b17e-3925850d6d32|8|LDHCREAT|Lactate Dehydrogenase/Creatinine|HEMATOLOGY|[?]|Arbitrary U|[?]|[?]|INVALID|1|mCi/L|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|PARAFFIN-EMBEDDED||MICRODENSITOMETRY|CKD-EPI CREATININE FORMULA|||NA||4|Visit_4|65|3|TREATMENT|2021-02-09|2021-03-06|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|2fcc5910-bce0-4510-b17e-3925850d6d32|9|GLTRCE|Glitter Cells|HEMATOLOGY|[?]|gtt|[?]|[?]|NEGATIVE|1|CIGARETTE|1|1|[?]|HIGH|KERATINOCYTE|UNEXPECTED ODOR|N|COULOMETRIC TITRATION|MDRD ENZYMATIC FORMULA|Y||NA||5|Visit_5|90|2|FOLLOW-UP|2021-03-06|2021-03-10|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|2fcc5910-bce0-4510-b17e-3925850d6d32|10|MTNEPHFR|Metanephrine, Free|URINALYSIS|[?]|CUP|[?]|[?]|INDETERMINATE|1|U/mL|1|1|[?]|LOW|EMESIS|PARAFFIN-EMBEDDED|N|ANTIBIOTIC AGAR SCREEN|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|1|SCREENING|2021-03-06|2021-03-15|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|1|FCT8INH|Factor VIII Inhibitor|URINALYSIS|[?]|ug/h|[?]|[?]|POSITIVE|1|ELISA unit|1|1|[?]|ABNORMAL|LEUKOCYTE|SOLIDIFIED||ANTIMICROBIAL COMBINATION TESTING|FIBROTEST FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-08-31|2020-10-05|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|2|TGFB1|Transforming Growth Factor Beta 1|HEMATOLOGY|[?]|Bq/L|[?]|[?]|INVALID|1|mmol/min/kPa/L|1|1|[?]|HIGH|SPERMATOZOON|AGGLUTINATED||MACRO BROTH DILUTION|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||1|Visit_1|10|5|TREATMENT|2020-08-31|2020-10-28|10|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|3|ANISO|Anisocytes|HEMATOLOGY|[?]|10^11/L|[?]|[?]|POSITIVE|1|oz|1|1|[?]|NORMAL|PLATELET RICH PLASMA|CLOTTED||MUGA|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||2|Visit_2|25|6|TREATMENT|2020-09-15|2020-11-06|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|4|RH|Rh Factor|HEMATOLOGY|[?]|10^8 PFU|[?]|[?]|INDETERMINATE|1|mAmp|1|1|[?]|HIGH|REFLEX TEAR|FRESH||DOPPLER ULTRASOUND|HEPASCORE FORMULA||Y|Y||2|Visit_2|25|3|TREATMENT|2020-09-15|2020-10-02|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|5|CA72_4AG|Cancer Antigen 72-4|URINALYSIS|[?]|mol/mL|[?]|[?]|BORDERLINE|1|mL/breath|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|THAWED||FLOCCULATION, CHARCOAL ENHANCED|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||3|Visit_3|40|5|FOLLOW-UP|2020-09-30|2020-10-27|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|6|PF2AI8CR|8-Iso-PGF2alpha/Creatinine|HEMATOLOGY|[?]|titer|[?]|[?]|BORDERLINE|1|SPRAY|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|FROZEN|N|EEG|NASH FIBROSURE FORMULA|Y||U||3|Visit_3|40|3|SCREENING|2020-09-30|2020-10-26|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|7|LDH4LDH|LDH Isoenzyme 4/LDH|HEMATOLOGY|||[?]|[?]|POSITIVE|1|psec|1|1|[?]|ABNORMAL|EXPIRED AIR|REFRIGERATED||JAEGER EYE CHART|CKD-EPI CREATININE FORMULA|||Y|Y|4|Visit_4|65|3|FOLLOW-UP|2020-10-25|2020-11-05|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|8|CX3CL1|Chemokine (C-X3-C Motif) Ligand 1|HEMATOLOGY|[?]|mAmp|[?]|[?]|NEGATIVE|1|kIU|1|1|[?]|ABNORMAL|STOOL|CLOTTED||MICROSCOPY|GMI % FORMULA||Y|U||4|Visit_4|65|6|SCREENING|2020-10-25|2020-10-27|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|9|LYMMCE|Lymphoma Cells|URINALYSIS|||[?]|[?]|POSITIVE|1|uEq/L|1|1|[?]|ABNORMAL|DIALYSIS FLUID|NON-HEMOLYZED||POPULATION SEQUENCING|GMI % FORMULA|||U|Y|5|Visit_5|90|1|TREATMENT|2020-11-19|2020-11-24|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|10|TEARDCY|Dacryocytes|CHEMISTRY|[?]|mol/day|[?]|[?]|TRACE|1|mg/dose|1|1|[?]|ABNORMAL|PUS|FRESH||PALM METHOD|MDRD 5 VARIABLE FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-11-19|2020-11-23|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|1|MLR|Mixed Lymphocyte Reaction|URINALYSIS|[?]|min*mg/mL|[?]|[?]|BORDERLINE|1|PELLET|1|1|[?]|LOW|LOCHIA|SOLIDIFIED||FLUOROSCOPY|GMI % FORMULA||Y|U||1|Visit_1|10|7|FOLLOW-UP|2020-07-26|2020-09-18|10|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|2|NITRATE|Nitrate|URINALYSIS|[?]|10^6/Ejaculate U|[?]|[?]|INVALID|1|g/g/day|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|REFRIGERATED|N|COULOMETRIC TITRATION|MDRD ENZYMATIC FORMULA|Y||Y||1|Visit_1|10|1|FOLLOW-UP|2020-07-26|2020-08-03|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|3|C165899|Silver Birch Pollen IgG AB RAST Score|HEMATOLOGY|[?]|breaths/30s|[?]|[?]|BORDERLINE|1|eq|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|UNEXPECTED ODOR||SISH|GMI % FORMULA|Y||Y||2|Visit_2|25|4|TREATMENT|2020-08-10|2020-09-11|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|4|INTLK12|Interleukin 12|HEMATOLOGY|[?]|HEP|[?]|[?]|INVALID|1|PIXELS/cm|1|1|[?]|NORMAL|URINE|LIPEMIC||TWO-COLOR MICROARRAY|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-08-10|2020-10-03|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|5|MIP1B|Macrophage Inflammatory Protein 1 Beta|URINALYSIS|||[?]|[?]|INVALID|1|/cmH2O|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|SOLIDIFIED|N|DARK FIELD MICROSCOPY|MDRD ENZYMATIC FORMULA|Y||U|Y|3|Visit_3|40|1|FOLLOW-UP|2020-08-25|2020-10-09|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|6|TXB2|Thromboxane B2|URINALYSIS|[?]|mg/mL/min|[?]|[?]|POSITIVE|1|L/L|1|1|[?]|ABNORMAL|SPERMATOZOON|UNEXPECTED ODOR|N|SISH|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||3|Visit_3|40|3|SCREENING|2020-08-25|2020-09-14|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|7|PT|Prothrombin Time|HEMATOLOGY|[?]|Weber|[?]|[?]|NEGATIVE|1|IU|1|1|[?]|HIGH|TUMOR TISSUE|FROZEN||ELASTOGRAPHY|COCKCROFT-GAULT FORMULA|||Y||4|Visit_4|65|2|SCREENING|2020-09-19|2020-10-08|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|8|BASOSG|Basophils, Segmented|CHEMISTRY|[?]|cycle/min|[?]|[?]|TRACE|1|gpELISA unit/mL|1|1|[?]|NORMAL|CAPILLARY BLOOD|THAWED||PAP STAIN|CKD-EPI CYSTATIN C FORMULA|||Y||4|Visit_4|65|4|WASHOUT|2020-09-19|2020-10-12|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|9|CHYTRYP|Chymotrypsin|URINALYSIS|[?]|mL/sec/1.73m2|[?]|[?]|INDETERMINATE|1|vp/dose|1|1|[?]|HIGH|ABSCESS FLUID|AUTOLYZED|N|JAEGER EYE CHART|FIBROTEST FORMULA|Y||U||5|Visit_5|90|3|TREATMENT|2020-10-14|2020-10-22|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|10|MDA|3,4-methylenedioxyamphetamine|CHEMISTRY|[?]|Weber|[?]|[?]|NEGATIVE|1|pmol/L/h|1|1|[?]|NORMAL|TRANSUDATE|HEMOLYZED||NON-CONTACT SPECULAR MICROSCOPY|GMI MMOL/MOL FORMULA|Y||Y||5|Visit_5|90|3|SCREENING|2020-10-14|2020-10-22|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|1|FACTXIVA|Factor XIV Activity|HEMATOLOGY|[?]|mL/animal/day|[?]|[?]|NEGATIVE|1|SBE/mL|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|REFRIGERATED||DIFFUSION TENSOR MRI|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-10-28|2020-12-06|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|LB|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|2|TXB2|Thromboxane B2|HEMATOLOGY|||[?]|[?]|POSITIVE|1|nL|1|1|[?]|ABNORMAL|PLEURAL FLUID|FROZEN|N|FUNCTIONAL MRI|GMI % FORMULA|||U|Y|1|Visit_1|10|3|FOLLOW-UP|2020-10-28|2020-11-06|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|LB|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|3|GLDH|Glutamate Dehydrogenase|CHEMISTRY|[?]|AgU/mL|[?]|[?]|POSITIVE|1|uIU/dL|1|1|[?]|LOW|ENDOTRACHEAL FLUID|ICTERIC||WHOLE TRANSCRIPTOME SEQUENCING|FIBROSIS 4 FORMULA|Y|Y|Y||2|Visit_2|25|1|FOLLOW-UP|2020-11-12|2021-01-21|25|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|4|C130071|Bermuda Grass Pollen IgG4|URINALYSIS|||[?]|[?]|BORDERLINE|1|s^-1(%O2)^-1|1|1|[?]|NORMAL|HAIR FOLLICLE|GELLED||APPLANATION TONOMETRY|FIBROSIS 4 FORMULA|||N|Y|2|Visit_2|25|2|WASHOUT|2020-11-12|2021-01-02|25|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|5|GGTEXR|GammaGlutamyl Transferase Excretion Rate|HEMATOLOGY|[?]|g|[?]|[?]|BORDERLINE|1|Bq/g|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|LACTESCENT||PET/CT SCAN|HEPASCORE FORMULA|||N||3|Visit_3|40|2|FOLLOW-UP|2020-11-27|2021-01-09|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|6|PLATSAT|Platelet Satellitism|URINALYSIS|[?]|RATIO|[?]|[?]|INVALID|1|mL/kg/h|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|AUTOLYZED||MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|4|TREATMENT|2020-11-27|2020-11-30|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|7|NEUTSGB|Neutrophils, Segmented + Band Form|HEMATOLOGY|[?]|MPS U|[?]|[?]|INDETERMINATE|1|OD Unit|1|1|[?]|HIGH|URINE SEDIMENT|AGGLUTINATED|N|RAJI CELL EIA|MDRD FORMULA|||U||4|Visit_4|65|4|WASHOUT|2020-12-22|2020-12-28|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|8|LYMPLLY|Plasmacytoid Lymphocytes/Lymphocytes|HEMATOLOGY|[?]|V|[?]|[?]|INDETERMINATE|1|kBq|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|ROOM TEMPERATURE||CALIPER MEASUREMENT METHOD|HEPASCORE FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-12-22|2020-12-26|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|9|HELMOV10|Helicase MOV-10 Protein|URINALYSIS|||[?]|[?]|POSITIVE|1|nU/cL|1|1|[?]|HIGH|SWABBED MATERIAL|ICTERIC|N|ELECTRICAL IMPEDANCE MYOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|5|Visit_5|90|7|TREATMENT|2021-01-16|2021-01-19|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|10|LEUKASE|Leukocyte Esterase|HEMATOLOGY|||[?]|[?]|INVALID|1|/ms|1|1|[?]|HIGH|NAIL|LIPEMIC||CAPILLARY ELECTROPHORESIS|GMI % FORMULA|Y||N|Y|5|Visit_5|90|7|TREATMENT|2021-01-16|2021-01-25|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|ff163542-abec-4260-b257-f15a11e580ee|1|CITRATE|Citrate|URINALYSIS|[?]|uV2|[?]|[?]|TRACE|1|nmol/L/min|1|1|[?]|LOW|LUNG SURFACTANT|NON-HEMOLYZED||OPHTHALMOSCOPY|FIBROTEST FORMULA||Y|U||1|Visit_1|10|4|TREATMENT|2020-08-16|2020-09-23|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|ff163542-abec-4260-b257-f15a11e580ee|2|BITECE|Bite Cells|CHEMISTRY|[?]|uIU/L|[?]|[?]|TRACE|1|ks|1|1|[?]|LOW|ARTERIAL BLOOD|REFRIGERATED||PEAK FLOWMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||1|Visit_1|10|5|WASHOUT|2020-08-16|2020-10-09|10|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|ff163542-abec-4260-b257-f15a11e580ee|3|DCA|Deoxycholate|CHEMISTRY|||[?]|[?]|INVALID|1|mg/L FEU|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|AUTOLYZED||ISHIHARA COLOR PLATES|COCKCROFT-GAULT FORMULA|||U|Y|2|Visit_2|25|4|FOLLOW-UP|2020-08-31|2020-11-07|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|ff163542-abec-4260-b257-f15a11e580ee|4|FCTXIIIA|Factor XIII Activity|HEMATOLOGY|||[?]|[?]|POSITIVE|1|U/mL|1|1|[?]|ABNORMAL|BASAL TEAR|PARAFFIN-EMBEDDED||SPECTROPHOTOMETRY|CKD-EPI CREATININE FORMULA|||U|Y|2|Visit_2|25|7|SCREENING|2020-08-31|2020-10-23|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|ff163542-abec-4260-b257-f15a11e580ee|5|RUB|Rubricyte|URINALYSIS|||[?]|[?]|NEGATIVE|1|dpm/mg|1|1|[?]|NORMAL|EPIDERMAL TISSUE|CONTAMINATED||LIQUID SCINTILLATION COUNTING|HEPASCORE FORMULA|||U|Y|3|Visit_3|40|6|TREATMENT|2020-09-15|2020-10-01|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|ff163542-abec-4260-b257-f15a11e580ee|6|RETIHCR|Hematocrit Corrected Reticulocytes|HEMATOLOGY|[?]|CYLINDER|[?]|[?]|TRACE|1|U/animal|1|1|[?]|LOW|SALIVA|CLOTTED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 4 VARIABLE FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-09-15|2020-09-30|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|ff163542-abec-4260-b257-f15a11e580ee|7|PTF1_2|Prothrombin Fragments 1 + 2|URINALYSIS|[?]|Frames/s|[?]|[?]|BORDERLINE|1|Roentgen|1|1|[?]|ABNORMAL|SPUTUM|LIPEMIC|N|PERFUSION MRI|COCKCROFT-GAULT FORMULA||Y|Y||4|Visit_4|65|7|SCREENING|2020-10-10|2020-11-05|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|ff163542-abec-4260-b257-f15a11e580ee|8|HYALUAC|Hyaluronic Acid|HEMATOLOGY|||[?]|[?]|POSITIVE|1|DROP|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|SOLIDIFIED|N|FUNDUS PHOTOGRAPHY|CKD-EPI CREATININE FORMULA|Y||NA|Y|4|Visit_4|65|6|SCREENING|2020-10-10|2020-11-03|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|ff163542-abec-4260-b257-f15a11e580ee|9|DRVVTSCR|DRVVT Screen to Confirm Ratio|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^6 organisms|1|1|[?]|NORMAL|SEMINAL FLUID|LIPEMIC||LINE PROBE ASSAY|FIBROTEST FORMULA||Y|NA|Y|5|Visit_5|90|5|WASHOUT|2020-11-04|2020-11-13|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|ff163542-abec-4260-b257-f15a11e580ee|10|INTLK32|Interleukin 32|HEMATOLOGY|[?]|10^3 copies/mL|[?]|[?]|NEGATIVE|1|mol/g|1|1|[?]|NORMAL|PROSTATIC FLUID|GELLED||BALLPOINT PEN TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|3|WASHOUT|2020-11-04|2020-11-08|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|bb73f732-a52f-4013-9ae6-60ff23b9c224|1|MSPIKEPT|Monoclonal Protein Spike/Total Protein|HEMATOLOGY|[?]|g/cage|[?]|[?]|INVALID|1|mg/m2/h|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|THAWED|N|ANTIMICROBIAL COMBINATION TESTING|HEPASCORE FORMULA|||NA||1|Visit_1|10|4|FOLLOW-UP|2020-08-05|2020-09-29|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|bb73f732-a52f-4013-9ae6-60ff23b9c224|2|TRYPSIN|Trypsin|CHEMISTRY|[?]|mL/(min*100mL)|[?]|[?]|TRACE|1|ug/mol|1|1|[?]|ABNORMAL|LEUKOCYTE|CALCIFIED|N|ULTRASONOGRAPHIC ELASTOGRAPHY|FIBROSIS 4 FORMULA||Y|Y||1|Visit_1|10|7|WASHOUT|2020-08-05|2020-10-14|10|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|bb73f732-a52f-4013-9ae6-60ff23b9c224|3|MYBLAT1|Type I Myeloblasts|CHEMISTRY|[?]|Bq/mg|[?]|[?]|NEGATIVE|1|MBq|1|1|[?]|LOW|PLEURAL FLUID|PARAFFIN-EMBEDDED||LIGHT SCATTERING SPECTROSCOPY|GMI % FORMULA|Y|Y|Y||2|Visit_2|25|2|FOLLOW-UP|2020-08-20|2020-09-06|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|bb73f732-a52f-4013-9ae6-60ff23b9c224|4|BLASTNCE|Blasts/Nucleated Cells|CHEMISTRY|[?]|GBq/mg|[?]|[?]|INDETERMINATE|1|ng/day|1|1|[?]|LOW|LUNG SURFACTANT|FRESH||IMMUNOBLOT|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||2|Visit_2|25|4|FOLLOW-UP|2020-08-20|2020-09-26|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|bb73f732-a52f-4013-9ae6-60ff23b9c224|5|C3A|Complement C3a|HEMATOLOGY|[?]|GPL U|[?]|[?]|BORDERLINE|1|fg|1|1|[?]|LOW|PUS|CLOTTED||SLOAN LETTER EYE CHART 1.25%|CKD-EPI FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-09-04|2020-10-20|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|bb73f732-a52f-4013-9ae6-60ff23b9c224|6|ETPLT|ETP Lag Time|CHEMISTRY|[?]|/day|[?]|[?]|TRACE|1|LB|1|1|[?]|HIGH|LOCHIA|CALCIFIED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|4|WASHOUT|2020-09-04|2020-09-17|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|bb73f732-a52f-4013-9ae6-60ff23b9c224|7|C165933|American Cockroach IgE AB RAST Score|CHEMISTRY|[?]|mIU/L|[?]|[?]|TRACE|1|deg/mm|1|1|[?]|NORMAL|SOFT TISSUE|CONTAMINATED|N|PET/CT SCAN|NASH FIBROSURE FORMULA||Y|U||4|Visit_4|65|4|TREATMENT|2020-09-29|2020-10-13|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|bb73f732-a52f-4013-9ae6-60ff23b9c224|8|WBCCLMP|Leukocyte Cell Clumps|HEMATOLOGY|[?]|U/cL|[?]|[?]|INVALID|1|%/min|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED||DYNAMIC LIGHT SCATTERING|CKD-EPI FORMULA|Y||Y||4|Visit_4|65|4|FOLLOW-UP|2020-09-29|2020-11-01|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|bb73f732-a52f-4013-9ae6-60ff23b9c224|9|MMIF|Macrophage Migration Inhibitory Factor|URINALYSIS|[?]|K|[?]|[?]|TRACE|1|uCi/kg|1|1|[?]|ABNORMAL|ALVEOLAR AIR|ROOM TEMPERATURE||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|CKD-EPI CYSTATIN C FORMULA||Y|NA||5|Visit_5|90|7|TREATMENT|2020-10-24|2020-10-26|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|bb73f732-a52f-4013-9ae6-60ff23b9c224|10|RBCNUC|Nucleated Erythrocytes|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|fmol|1|1|[?]|HIGH|BLOOD|THAWED||SPECT SCAN|FIBROMETER FORMULA|Y||U|Y|5|Visit_5|90|2|TREATMENT|2020-10-24|2020-10-27|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|1|UREA|Urea|URINALYSIS|[?]|nmol/L|[?]|[?]|INDETERMINATE|1|CAPFUL|1|1|[?]|HIGH|SERUM OR PLASMA|UNEXPECTED ODOR||PALPATION|HEPASCORE FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-07-21|2020-08-11|10|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|2|TRGTCE|Target Cells|HEMATOLOGY|[?]|10^6 IU/mL|[?]|[?]|INDETERMINATE|1|Bq/ug|1|1|[?]|ABNORMAL|BONE MARROW|CLOTTED||NUCLEIC ACID AMPLIFICATION TEST|FIBROSIS 4 FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-07-21|2020-07-27|10|16|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|3|GADAB|Glutamic Acid Decarboxylase Antibody|HEMATOLOGY|[?]|tsp eq|[?]|[?]|POSITIVE|1|Ci/ug|1|1|[?]|LOW|BASAL TEAR|CLOTTED||LC-FL|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|2|WASHOUT|2020-08-05|2020-10-10|25|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|4|CCL21|Chemokine (C-C Motif) Ligand 21|URINALYSIS|[?]|Ci|[?]|[?]|POSITIVE|1|RFU|1|1|[?]|ABNORMAL|PUS|LIPEMIC|N|CONTRAST ENHANCED PET/CT SCAN|MDRD 6 VARIABLE FORMULA|Y||N||2|Visit_2|25|4|TREATMENT|2020-08-05|2020-10-02|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|5|EPICCE|Epithelial Cells/Total Cells|HEMATOLOGY|[?]|foz_us|[?]|[?]|INVALID|1|umol|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|HEMOLYZED||PULSE OXIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||3|Visit_3|40|2|TREATMENT|2020-08-20|2020-09-04|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|6|IL1R2|Interleukin 1 Receptor Type 2|URINALYSIS|[?]|kPa|[?]|[?]|INVALID|1|/h|1|1|[?]|ABNORMAL|REFLEX TEAR|PARAFFIN-EMBEDDED||FLUORESCENT LIFETIME IMAGING MICROSCOPY|FIBROMETER FORMULA|||N||3|Visit_3|40|3|FOLLOW-UP|2020-08-20|2020-09-17|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|7|KRCYMG|Megakaryocytes|HEMATOLOGY|||[?]|[?]|TRACE|1|ELISA unit/mL|1|1|[?]|LOW|EPIDERMAL TISSUE|SOLIDIFIED||TONOMETRY|FIBROMETER FORMULA|||Y|Y|4|Visit_4|65|4|SCREENING|2020-09-14|2020-10-16|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|8|ARSENIC|Arsenic|URINALYSIS|[?]|SFC/10^6 PBMC|[?]|[?]|NEGATIVE|1|cmol/L|1|1|[?]|ABNORMAL|MONOCYTE|FRESH||IRON HEMATOXYLIN STAIN|MDRD ENZYMATIC FORMULA|Y|Y|U||4|Visit_4|65|3|SCREENING|2020-09-14|2020-09-22|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|9|HOMOCIT|Homocitrulline|HEMATOLOGY|[?]|IMPLANT|[?]|[?]|POSITIVE|1|ug/kg|1|1|[?]|ABNORMAL|URINE SEDIMENT|SOLIDIFIED|N|HPLC|MDRD 5 VARIABLE FORMULA|||U||5|Visit_5|90|4|WASHOUT|2020-10-09|2020-10-12|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|10|HGBA2HGB|Hemoglobin A2/Total Hemoglobin|CHEMISTRY|[?]|Gravitational Unit|[?]|[?]|INVALID|1|SUPPOSITORY|1|1|[?]|HIGH|PLASMA|UNEXPECTED ODOR||CELL OF ORIGIN ASSAY|GMI % FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2020-10-09|2020-10-11|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|8e056558-ffd2-4c43-bbfa-40914b38af34|1|GLOBB2PT|Beta-2 Globulin/Total Protein|CHEMISTRY|||[?]|[?]|NEGATIVE|1|TABLET|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|REFRIGERATED||CYSTOSCOPY|FIBROTEST FORMULA|Y||Y|Y|1|Visit_1|10|2|TREATMENT|2021-01-29|2021-02-15|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|8e056558-ffd2-4c43-bbfa-40914b38af34|2|SCN|Thiocyanate|CHEMISTRY|[?]|cm/s|[?]|[?]|POSITIVE|1|cmHg|1|1|[?]|HIGH|SPERMATOZOON|ROOM TEMPERATURE||IMMUNOFLUORESCENT STAIN|FIBROSIS 4 FORMULA||Y|NA||1|Visit_1|10|5|TREATMENT|2021-01-29|2021-01-30|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|8e056558-ffd2-4c43-bbfa-40914b38af34|3|TPAAG|Tissue Plasminogen Activator Antigen|URINALYSIS|[?]|mg/mol|[?]|[?]|INDETERMINATE|1|U|1|1|[?]|ABNORMAL|BLOOD|CONTAMINATED||TARGETED GENOME SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|Y||2|Visit_2|25|2|TREATMENT|2021-02-13|2021-04-19|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|8e056558-ffd2-4c43-bbfa-40914b38af34|4|PAROXET|Paroxetine|HEMATOLOGY|||[?]|[?]|INVALID|1|cm H2O|1|1|[?]|NORMAL|INTERSTITIAL FLUID|FRESH||WHOLE TRANSCRIPTOME SEQUENCING|MDRD 4 VARIABLE FORMULA|Y||U|Y|2|Visit_2|25|2|FOLLOW-UP|2021-02-13|2021-03-04|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|8e056558-ffd2-4c43-bbfa-40914b38af34|5|GLOBB2|Beta-2 Globulin|URINALYSIS|[?]|tsp|[?]|[?]|NEGATIVE|1|mol/g|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|NON-HEMOLYZED||RYAN BLUE STAIN|GMI MMOL/MOL FORMULA|Y||U||3|Visit_3|40|7|TREATMENT|2021-02-28|2021-03-10|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|LB|8e056558-ffd2-4c43-bbfa-40914b38af34|6|TNF12S|Soluble TNF Superfamily Member 12|HEMATOLOGY|[?]|U|[?]|[?]|INVALID|1|10^9/dose|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|CALCIFIED||SINGLE-SLICE SPIRAL CT|CKD-EPI FORMULA|||N||3|Visit_3|40|4|WASHOUT|2021-02-28|2021-03-30|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|LB|8e056558-ffd2-4c43-bbfa-40914b38af34|7|HGBFR|Hemoglobin, Free|HEMATOLOGY|[?]|/h|[?]|[?]|POSITIVE|1|steps/min|1|1|[?]|LOW|MIXED VENOUS BLOOD|FROZEN||BAC ACGH|FIBROSIS 4 FORMULA|||NA||4|Visit_4|65|3|WASHOUT|2021-03-25|2021-04-11|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|8e056558-ffd2-4c43-bbfa-40914b38af34|8|APLIGMAB|Anti-Phospholipid IgM Antibody|HEMATOLOGY|[?]|mg/m2|[?]|[?]|INVALID|1|CYLINDER|1|1|[?]|NORMAL|HAIR|PARAFFIN-EMBEDDED|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|CKD-EPI CREATININE FORMULA|||NA||4|Visit_4|65|3|TREATMENT|2021-03-25|2021-03-27|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|8e056558-ffd2-4c43-bbfa-40914b38af34|9|CXCL6|Chemokine (C-X-C Motif) Ligand 6|URINALYSIS|[?]|/10^4|[?]|[?]|BORDERLINE|1|L/day|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|REFRIGERATED|N|MICRO BROTH DILUTION|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|6|SCREENING|2021-04-19|2021-04-27|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|8e056558-ffd2-4c43-bbfa-40914b38af34|10|PROT|Protein|CHEMISTRY|||[?]|[?]|POSITIVE|1|umol/kg/min|1|1|[?]|LOW|SPUTUM|CONTAMINATED||CENTRIFUGATION|CKD-EPI CYSTATIN C FORMULA|Y|Y|Y|Y|5|Visit_5|90|5|SCREENING|2021-04-19|2021-04-26|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|1|LDH|Lactate Dehydrogenase|URINALYSIS|[?]|/10^3|[?]|[?]|NEGATIVE|1|mEq/g|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|DRIED||MAGNETIC RESONANCE ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-05-29|2020-08-16|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|2|C3ADARG|Complement C3a DesArg|CHEMISTRY|[?]|ELISA unit/dose|[?]|[?]|NEGATIVE|1|nmol/L|1|1|[?]|HIGH|BONE MARROW|REFRIGERATED|N|MACRO BROTH DILUTION|GMI MMOL/MOL FORMULA|||Y||1|Visit_1|10|5|WASHOUT|2020-05-29|2020-06-24|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|3|C165900|Orchard Grass Pollen IgG AB RAST Score|URINALYSIS|[?]|1/(s*kPa)|[?]|[?]|TRACE|1|um/day|1|1|[?]|NORMAL|SEMINAL FLUID|LACTESCENT||PERCUSSION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||2|Visit_2|25|3|TREATMENT|2020-06-13|2020-06-14|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|LB|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|4|STOMCY|Stomatocytes|CHEMISTRY|[?]|IU/L|[?]|[?]|NEGATIVE|1|/10^3|1|1|[?]|LOW|EXUDATE|FROZEN||IMPEDANCE CONDUCTIVITY|MDRD 6 VARIABLE FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-06-13|2020-07-09|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|LB|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|5|RETIH|High Absorption Reticulocytes|CHEMISTRY|||[?]|[?]|BORDERLINE|1|nL|1|1|[?]|LOW|WHITE MATTER TISSUE|CALCIFIED|N|SLIT LAMP PHOTOGRAPHY|CKD-EPI CREATININE FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2020-06-28|2020-08-13|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|LB|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|6|IC512AG|Islet Cell 512 Antigen|URINALYSIS|[?]|PACKAGE|[?]|[?]|NEGATIVE|1|CIGARETTE|1|1|[?]|LOW|DISCHARGE|NON-HEMOLYZED|N|TARGETED TRANSCRIPTOME SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||U||3|Visit_3|40|4|WASHOUT|2020-06-28|2020-08-18|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|LB|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|7|C165926|Mold Mix IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|INVALID|1|titer|1|1|[?]|LOW|CALCULUS|DRIED|N|OPTICAL COHERENCE TOMOGRAPHY|NASH FIBROSURE FORMULA|||Y|Y|4|Visit_4|65|2|FOLLOW-UP|2020-07-23|2020-08-11|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|8|BLASTCE|Blasts/Total Cells|URINALYSIS|[?]|grain|[?]|[?]|INVALID|1|deg/mm|1|1|[?]|LOW|SPERMATOZOON|UNEXPECTED ODOR||EEG|FIBROMETER FORMULA||Y|N||4|Visit_4|65|6|TREATMENT|2020-07-23|2020-08-07|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|9|VITB3|Niacin|URINALYSIS|[?]|mph|[?]|[?]|POSITIVE|1|VIAL|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED||PHOTOGRAPHY|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|2|TREATMENT|2020-08-17|2020-08-24|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|10|BASEDEF|Base Deficit|CHEMISTRY|[?]|cup eq|[?]|[?]|NEGATIVE|1|10^5/L|1|1|[?]|LOW|SUPERNATANT, PLASMA|PARAFFIN-EMBEDDED||DIRECT SEQUENCING|ASH FIBROSURE FORMULA|Y|Y|NA||5|Visit_5|90|5|TREATMENT|2020-08-17|2020-08-22|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|624c1353-347a-417d-9aab-7f1e7077ba7f|1|C165894|D. farinae Antigen IgG4 Antibody|CHEMISTRY|||[?]|[?]|POSITIVE|1|% INHIBITION|1|1|[?]|HIGH|ALVEOLAR AIR|LIPEMIC|N|MALDI|GMI MMOL/MOL FORMULA|||Y|Y|1|Visit_1|10|3|FOLLOW-UP|2020-08-28|2020-09-10|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|624c1353-347a-417d-9aab-7f1e7077ba7f|2|UREAN|Urea Nitrogen|HEMATOLOGY|[?]|ukat/L|[?]|[?]|INVALID|1|mmol/L|1|1|[?]|ABNORMAL|URINE SEDIMENT|CLOTTED||RADIOIMMUNOPRECIPITATION ASSAY|MDRD 6 VARIABLE FORMULA|||Y||1|Visit_1|10|1|FOLLOW-UP|2020-08-28|2020-10-05|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|624c1353-347a-417d-9aab-7f1e7077ba7f|3|RBCGHOST|Erythrocyte Ghosts|HEMATOLOGY|[?]|MBP|[?]|[?]|NEGATIVE|1|mJoule/cm2|1|1|[?]|LOW|EMOTIONAL TEAR|UNEXPECTED ODOR||CONFOCAL MICROSCOPY|FIBROMETER FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2020-09-12|2020-11-09|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|624c1353-347a-417d-9aab-7f1e7077ba7f|4|LDH3|LDH Isoenzyme 3|CHEMISTRY|[?]|ug/cm2|[?]|[?]|NEGATIVE|1|BAR|1|1|[?]|ABNORMAL|PLEURAL FLUID|CLOTTED|N|DOPPLER ULTRASOUND|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|4|SCREENING|2020-09-12|2020-11-18|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|624c1353-347a-417d-9aab-7f1e7077ba7f|5|C165905|Grass Mix Pollen IgG AB RAST Score|URINALYSIS|[?]|BU|[?]|[?]|INDETERMINATE|1|cd*s/m2|1|1|[?]|NORMAL|PLASMA|FRESH||DNA MICROARRAY|FIBROTEST FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2020-09-27|2020-11-24|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|624c1353-347a-417d-9aab-7f1e7077ba7f|6|NEUTLE|Neutrophils/Leukocytes|URINALYSIS|[?]|10^9 CFU|[?]|[?]|INDETERMINATE|1|mmAL|1|1|[?]|LOW|CORD SERUM|CONCENTRATED||FLOW MICROSCOPY|GMI % FORMULA||Y|NA||3|Visit_3|40|7|TREATMENT|2020-09-27|2020-10-14|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|624c1353-347a-417d-9aab-7f1e7077ba7f|7|GLUCWBE|Whole Blood Equivalent Glucose|URINALYSIS|[?]|Gy|[?]|[?]|NEGATIVE|1|dpm/100mg|1|1|[?]|HIGH|VENOUS CORD BLOOD|ROOM TEMPERATURE||CRYOSCOPY|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|2|FOLLOW-UP|2020-10-22|2020-10-26|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|624c1353-347a-417d-9aab-7f1e7077ba7f|8|CHOLATE|Cholate|CHEMISTRY|[?]|s/h|[?]|[?]|NEGATIVE|1|ms2|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|ICTERIC||CELLULOSE TAPE|FIBROSIS 4 FORMULA|Y|Y|U||4|Visit_4|65|7|TREATMENT|2020-10-22|2020-11-01|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|624c1353-347a-417d-9aab-7f1e7077ba7f|9|CYMSU|Monosodium Urate Crystals|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|DDU|1|1|[?]|NORMAL|VENOUS PLASMA|CONTAMINATED|N|GRADIENT DIFFUSION|CKD-EPI CREATININE FORMULA|||NA|Y|5|Visit_5|90|1|SCREENING|2020-11-16|2020-11-19|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|624c1353-347a-417d-9aab-7f1e7077ba7f|10|IGD|Immunoglobulin D|CHEMISTRY|[?]|nm|[?]|[?]|INVALID|1|/month|1|1|[?]|HIGH|EMOTIONAL TEAR|THAWED||NON-CONTACT SPECULAR MICROSCOPY|FIBROTEST FORMULA|||N||5|Visit_5|90|2|TREATMENT|2020-11-16|2020-11-21|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|ef1cddb8-f4ce-45c4-8671-32fe95f00993|1|KI67|Ki-67|URINALYSIS|[?]|Absorbance U/min|[?]|[?]|INVALID|1|gpELISA unit/mL|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|THAWED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||1|Visit_1|10|4|FOLLOW-UP|2020-08-02|2020-09-20|10|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|ef1cddb8-f4ce-45c4-8671-32fe95f00993|2|MET|Methionine|HEMATOLOGY|[?]|kHz|[?]|[?]|NEGATIVE|1|kN/cm2|1|1|[?]|LOW|MIXED VENOUS BLOOD|CALCIFIED||KARYOTYPING|MDRD 6 VARIABLE FORMULA|Y||Y||1|Visit_1|10|5|SCREENING|2020-08-02|2020-10-20|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|ef1cddb8-f4ce-45c4-8671-32fe95f00993|3|CSBROAD|Broad Casts|URINALYSIS|[?]|ugEq|[?]|[?]|NEGATIVE|1|Bq/mg|1|1|[?]|NORMAL|TISSUE|GELLED||TRANSVAGINAL ULTRASOUND|FIBROTEST FORMULA|||U||2|Visit_2|25|7|FOLLOW-UP|2020-08-17|2020-10-21|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|ef1cddb8-f4ce-45c4-8671-32fe95f00993|4|OAS3|2-5-Oligoadenylate Synthase 3|CHEMISTRY|||[?]|[?]|POSITIVE|1|10^4 CFU/mL|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|ROOM TEMPERATURE||SMEAR|HEPASCORE FORMULA|||Y|Y|2|Visit_2|25|5|WASHOUT|2020-08-17|2020-10-25|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|ef1cddb8-f4ce-45c4-8671-32fe95f00993|5|HIST2BAB|Histone 2B Antibody|CHEMISTRY|||[?]|[?]|NEGATIVE|1|pkat/L|1|1|[?]|NORMAL|VENOUS PLASMA|CLOTTED|N|POTENTIOMETRY|CKD-EPI CYSTATIN C FORMULA|||Y|Y|3|Visit_3|40|7|WASHOUT|2020-09-01|2020-09-19|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|ef1cddb8-f4ce-45c4-8671-32fe95f00993|6|AMYLB40|Amyloid Beta 1-40|HEMATOLOGY|[?]|Hounsfield Unit|[?]|[?]|BORDERLINE|1|mEq|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|HEMOLYZED|N|WESTERN BLOT|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||3|Visit_3|40|7|FOLLOW-UP|2020-09-01|2020-10-20|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|ef1cddb8-f4ce-45c4-8671-32fe95f00993|7|METAMYLE|Metamyelocytes/Leukocytes|URINALYSIS|[?]|nmol BCE/mmol|[?]|[?]|INDETERMINATE|1|BOWL|1|1|[?]|HIGH|PUS|PARAFFIN-EMBEDDED||SINGLE-MOLECULE ARRAY|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|5|FOLLOW-UP|2020-09-26|2020-10-26|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|ef1cddb8-f4ce-45c4-8671-32fe95f00993|8|POIKRBC|Poikilocytes/Erythrocytes|URINALYSIS|[?]|IU/kg|[?]|[?]|TRACE|1|NFIU|1|1|[?]|HIGH|LYMPH|CONCENTRATED||IMMUNOFLUORESCENT STAIN|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|7|FOLLOW-UP|2020-09-26|2020-10-06|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|ef1cddb8-f4ce-45c4-8671-32fe95f00993|9|BLASTIMM|Immunoblasts|URINALYSIS|[?]|EID 50/dose|[?]|[?]|BORDERLINE|1|log10 CFU/mL|1|1|[?]|LOW|EMOTIONAL TEAR|LACTESCENT||INTRAVASCULAR ULTRASOUND|GMI % FORMULA|Y||U||5|Visit_5|90|6|FOLLOW-UP|2020-10-21|2020-10-27|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|ef1cddb8-f4ce-45c4-8671-32fe95f00993|10|OXMORPHN|Oxymorphone|HEMATOLOGY|[?]|g/animal/day|[?]|[?]|INDETERMINATE|1|CYLINDER|1|1|[?]|HIGH|GASTRIC FLUID|LACTESCENT||FLUORESCENCE ANGIOGRAPHY|FIBROSIS 4 FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-10-21|2020-10-28|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|da6294b5-de91-4bf7-b160-55d22fefcb07|1|ANGPT1|Angiopoietin 1|CHEMISTRY|[?]|mol/mL|[?]|[?]|BORDERLINE|1|ks|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|REFRIGERATED||LIGHT MICROSCOPY|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-06-28|2020-08-03|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|LB|da6294b5-de91-4bf7-b160-55d22fefcb07|2|LLCFR|Lambda Light Chain, Free|URINALYSIS|[?]|ECL unit|[?]|[?]|POSITIVE|1|Bq|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|CONTAMINATED||SNELLEN EYE CHART|HEPASCORE FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-06-28|2020-07-06|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|LB|da6294b5-de91-4bf7-b160-55d22fefcb07|3|GDF11|Growth Differentiation Factor 11|CHEMISTRY|[?]|10^3 organisms|[?]|[?]|NEGATIVE|1|BP|1|1|[?]|LOW|NAIL|FROZEN||HEMOCYTOMETRY|MDRD 5 VARIABLE FORMULA|Y||U||2|Visit_2|25|2|TREATMENT|2020-07-13|2020-09-10|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|da6294b5-de91-4bf7-b160-55d22fefcb07|4|VITA|Vitamin A|CHEMISTRY|||[?]|[?]|POSITIVE|1|cmHg|1|1|[?]|NORMAL|SALIVA|NON-HEMOLYZED||MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 6 VARIABLE FORMULA|Y||Y|Y|2|Visit_2|25|2|WASHOUT|2020-07-13|2020-07-18|25|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|da6294b5-de91-4bf7-b160-55d22fefcb07|5|RETICH|Ret. Corpuscular Hemoglobin Content|CHEMISTRY|[?]|U/kg|[?]|[?]|INDETERMINATE|1|MET*min|1|1|[?]|LOW|TISSUE|LIPEMIC|N|ANTIBIOTIC AGAR SCREEN|COCKCROFT-GAULT FORMULA|Y|Y|NA||3|Visit_3|40|4|TREATMENT|2020-07-28|2020-08-31|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|LB|da6294b5-de91-4bf7-b160-55d22fefcb07|6|AMYLB38|Amyloid Beta 1-38|CHEMISTRY|[?]|mol/mg|[?]|[?]|NEGATIVE|1|mg/dL|1|1|[?]|LOW|SPUTUM|CONTAMINATED|N|HEMAGGLUTINATION INHIBITION ASSAY|COCKCROFT-GAULT FORMULA|Y||N||3|Visit_3|40|5|SCREENING|2020-07-28|2020-08-17|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|LB|da6294b5-de91-4bf7-b160-55d22fefcb07|7|MYCYLE|Myelocytes/Leukocytes|CHEMISTRY|[?]|pL|[?]|[?]|INVALID|1|IU/kg/h|1|1|[?]|HIGH|ABSCESS FLUID|FROZEN||FISH|HEPASCORE FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2020-08-22|2020-09-21|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|da6294b5-de91-4bf7-b160-55d22fefcb07|8|CYSTEINE|Cysteine|CHEMISTRY|[?]|cal|[?]|[?]|NEGATIVE|1|eq|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA|||U||4|Visit_4|65|3|FOLLOW-UP|2020-08-22|2020-09-09|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|da6294b5-de91-4bf7-b160-55d22fefcb07|9|IGGCALBC|IgG Clearance/Albumin Clearance|CHEMISTRY|[?]|JAR|[?]|[?]|INVALID|1|JAR|1|1|[?]|NORMAL|ERYTHROCYTES|REFRIGERATED||COLORIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||U||5|Visit_5|90|1|FOLLOW-UP|2020-09-16|2020-09-25|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|da6294b5-de91-4bf7-b160-55d22fefcb07|10|MDMA|3,4-methylenedioxymethamphetamine|CHEMISTRY|[?]|mg/kg/min|[?]|[?]|INDETERMINATE|1|CFU/g|1|1|[?]|ABNORMAL|PLEURAL TISSUE|GELLED||NEXT GENERATION TARGETED SEQUENCING|MDRD FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-09-16|2020-09-17|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|c01c16d4-7a37-421d-9191-1874eba6a1e3|1|AMYLB42|Amyloid Beta 1-42|URINALYSIS|[?]|kUSP|[?]|[?]|INVALID|1|log10 copies/mL|1|1|[?]|LOW|PLEURAL TISSUE|CALCIFIED||POLYGRAPHY|FIBROTEST FORMULA||Y|Y||1|Visit_1|10|7|TREATMENT|2020-10-09|2020-10-18|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|c01c16d4-7a37-421d-9191-1874eba6a1e3|2|POLYERY|Polychromatophilic Erythroblast|CHEMISTRY|[?]|/100 WBC|[?]|[?]|BORDERLINE|1|mol/mg|1|1|[?]|LOW|BASAL TEAR|HEMOLYZED||FLUORIMETRY|MDRD 6 VARIABLE FORMULA||Y|U||1|Visit_1|10|2|TREATMENT|2020-10-09|2020-10-14|10|15|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|c01c16d4-7a37-421d-9191-1874eba6a1e3|3|OVALCY|Ovalocytes|CHEMISTRY|[?]|mMU/mL|[?]|[?]|TRACE|1|L|1|1|[?]|NORMAL|KERATINOCYTE|AGGLUTINATED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|FIBROTEST FORMULA||Y|N||2|Visit_2|25|5|TREATMENT|2020-10-24|2021-01-02|25|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|c01c16d4-7a37-421d-9191-1874eba6a1e3|4|MKCMKBMP|Megakaryocyte and Megakaryoblast Morph|HEMATOLOGY|[?]|ng/mol|[?]|[?]|BORDERLINE|1|PFU/dose|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|REFRIGERATED||AUSCULTATION|CKD-EPI CREATININE FORMULA||Y|Y||2|Visit_2|25|2|TREATMENT|2020-10-24|2020-11-25|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|c01c16d4-7a37-421d-9191-1874eba6a1e3|5|FCTXIIIA|Factor XIII Activity|HEMATOLOGY|[?]|EU|[?]|[?]|INDETERMINATE|1|DNA copies/ug|1|1|[?]|ABNORMAL|SALIVA|FROZEN||CYSTOSCOPY|CKD-EPI FORMULA|Y||Y||3|Visit_3|40|6|TREATMENT|2020-11-08|2020-11-12|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|c01c16d4-7a37-421d-9191-1874eba6a1e3|6|MDZLM|Midazolam|URINALYSIS|||[?]|[?]|INVALID|1|tsp|1|1|[?]|HIGH|LUNG SURFACTANT|CLOTTED||CONTACT SPECULAR MICROSCOPY|MDRD FORMULA||Y|NA|Y|3|Visit_3|40|7|TREATMENT|2020-11-08|2020-12-10|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|c01c16d4-7a37-421d-9191-1874eba6a1e3|7|TRPTRG|Trypsin and Trypsinogen|URINALYSIS|[?]|/LPF|[?]|[?]|INDETERMINATE|1|umol/day|1|1|[?]|ABNORMAL|DERMAL TISSUE|FROZEN||DROPLET DIGITAL PCR|NASH FIBROSURE FORMULA|Y||U||4|Visit_4|65|2|TREATMENT|2020-12-03|2020-12-19|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|c01c16d4-7a37-421d-9191-1874eba6a1e3|8|GSTTH|Glutathione S-Transferase, Theta|URINALYSIS|[?]|vg/kg|[?]|[?]|TRACE|1|Ci/mL|1|1|[?]|LOW|ARTERIAL BLOOD|AUTOLYZED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA||Y|NA||4|Visit_4|65|4|TREATMENT|2020-12-03|2020-12-23|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|c01c16d4-7a37-421d-9191-1874eba6a1e3|9|CRYSTALS|Crystals|HEMATOLOGY|||[?]|[?]|INVALID|1|POUCH|1|1|[?]|HIGH|SPUTUM|LIPEMIC||CAPILLARY ELECTROPHORESIS|MDRD ENZYMATIC FORMULA|||N|Y|5|Visit_5|90|3|FOLLOW-UP|2020-12-28|2021-01-05|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|c01c16d4-7a37-421d-9191-1874eba6a1e3|10|C147281|Egg White Antigen IgE Antibody|CHEMISTRY|[?]|ppth|[?]|[?]|TRACE|1|kDa|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|CLOTTED||SLIT LAMP PHOTOGRAPHY|FIBROTEST FORMULA|||U||5|Visit_5|90|1|FOLLOW-UP|2020-12-28|2021-01-06|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|6036407d-5ac8-400d-91f7-afd63f3cab88|1|CD161LY|CD161/Lymphocytes|CHEMISTRY|[?]|m3|[?]|[?]|INDETERMINATE|1|mg/L FEU|1|1|[?]|ABNORMAL|LEUKOCYTE|LIPEMIC||POTENTIOMETRY|CKD-EPI CYSTATIN C FORMULA|||U||1|Visit_1|10|3|FOLLOW-UP|2020-06-22|2020-07-01|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|6036407d-5ac8-400d-91f7-afd63f3cab88|2|TCDCA|Taurochenodeoxycholate|URINALYSIS|[?]|mEq/dL|[?]|[?]|INDETERMINATE|1|mg/kg/day|1|1|[?]|LOW|SEBUM|HEMOLYZED||AUTOMATED COUNT|CKD-EPI FORMULA|Y|Y|N||1|Visit_1|10|5|TREATMENT|2020-06-22|2020-09-18|10|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|6036407d-5ac8-400d-91f7-afd63f3cab88|3|C130135|D. pteronyssinus Antigen IgG Antibody|HEMATOLOGY|[?]|FINGERTIP UNIT|[?]|[?]|BORDERLINE|1|K|1|1|[?]|HIGH|SERUM OR PLASMA|THAWED|N|MASS SPECTROMETRY|MDRD 4 VARIABLE FORMULA|||U||2|Visit_2|25|6|TREATMENT|2020-07-07|2020-07-28|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|6036407d-5ac8-400d-91f7-afd63f3cab88|4|CYCHOL|Cholesterol Crystals|HEMATOLOGY|[?]|ka_u/dL|[?]|[?]|NEGATIVE|1|/200 HPFs|1|1|[?]|NORMAL|EXPIRED AIR|CONTAMINATED||WHOLE EXOME SEQUENCING|MDRD FORMULA|Y||U||2|Visit_2|25|7|FOLLOW-UP|2020-07-07|2020-08-15|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|6036407d-5ac8-400d-91f7-afd63f3cab88|5|DHPG|3,4-Dihydroxyphenylglycol|HEMATOLOGY|[?]|km|[?]|[?]|BORDERLINE|1|uL/mL|1|1|[?]|ABNORMAL|CALCULUS|FRESH||CONTRAST ENHANCED PET SCAN|MDRD FORMULA|||NA||3|Visit_3|40|6|FOLLOW-UP|2020-07-22|2020-07-26|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|6036407d-5ac8-400d-91f7-afd63f3cab88|6|ALPEXR|Alkaline Phosphatase Excretion Rate|HEMATOLOGY|[?]|10^5/L|[?]|[?]|INVALID|1|uU/L|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|CLOTTED||MICROARRAY|FIBROTEST FORMULA||Y|U||3|Visit_3|40|4|FOLLOW-UP|2020-07-22|2020-09-08|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|6036407d-5ac8-400d-91f7-afd63f3cab88|7|PARICEAB|Parietal Cell Antibody|CHEMISTRY|[?]|mg/kg/day|[?]|[?]|NEGATIVE|1|ug/kg|1|1|[?]|LOW|SUPERNATANT, SERUM|AGGLUTINATED|N|KINETIC MICROPARTICLE IMMUNOASSAY|FIBROTEST FORMULA|||NA||4|Visit_4|65|7|WASHOUT|2020-08-16|2020-09-05|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|6036407d-5ac8-400d-91f7-afd63f3cab88|8|FCT8INH|Factor VIII Inhibitor|HEMATOLOGY|[?]|IU/dL|[?]|[?]|POSITIVE|1|nmol/L/min|1|1|[?]|NORMAL|VENOUS CORD BLOOD|ICTERIC|N|TOTAL BODY IRRADIATION|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2020-08-16|2020-08-19|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|6036407d-5ac8-400d-91f7-afd63f3cab88|9|INLCLR|Inulin Clearance|HEMATOLOGY|[?]|Bq/kg|[?]|[?]|INDETERMINATE|1|U.CARR|1|1|[?]|ABNORMAL|PERSPIRATION|REFRIGERATED||AUDIOMETRY|CKD-EPI CYSTATIN C FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2020-09-10|2020-09-18|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|6036407d-5ac8-400d-91f7-afd63f3cab88|10|VITB6|Vitamin B6|CHEMISTRY|||[?]|[?]|NEGATIVE|1|100 IU/mL|1|1|[?]|NORMAL|SEMEN|THAWED||HEMATOXYLIN AND EOSIN STAIN|NASH FIBROSURE FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2020-09-10|2020-09-15|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|69cf0c4b-13f6-4955-8046-72a333059d6e|1|MYCEPPOL|Myeloid Proliferation Pool|HEMATOLOGY|[?]|mgEq|[?]|[?]|INVALID|1|10^7/L|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|DRIED||DROPLET DIGITAL PCR|MDRD 5 VARIABLE FORMULA||Y|Y||1|Visit_1|10|7|TREATMENT|2020-12-16|2021-01-09|10|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|69cf0c4b-13f6-4955-8046-72a333059d6e|2|TRYPSIN|Trypsin|HEMATOLOGY|[?]|JDF Unit|[?]|[?]|BORDERLINE|1|DIP|1|1|[?]|HIGH|BASAL TEAR|ROOM TEMPERATURE||ELECTROCHEMILUMINESCENCE|MDRD FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-12-16|2021-01-13|10|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|69cf0c4b-13f6-4955-8046-72a333059d6e|3|CLUECE|Clue Cells|CHEMISTRY|||[?]|[?]|POSITIVE|1|mU/L|1|1|[?]|ABNORMAL|SWABBED MATERIAL|ROOM TEMPERATURE||HEMATOXYLIN AND EOSIN STAIN|CKD-EPI CREATININE FORMULA|Y||N|Y|2|Visit_2|25|2|TREATMENT|2020-12-31|2021-02-24|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|69cf0c4b-13f6-4955-8046-72a333059d6e|4|CDTTFRN|Carb-Deficient Transferrin/Transferrin|CHEMISTRY|[?]|10^9/g|[?]|[?]|POSITIVE|1|kPa|1|1|[?]|HIGH|CORD SERUM|CONCENTRATED||SLOAN LETTER EYE CHART 1.25%|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||2|Visit_2|25|6|FOLLOW-UP|2020-12-31|2021-02-22|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|69cf0c4b-13f6-4955-8046-72a333059d6e|5|CYCAPHOS|Calcium Phosphate Crystals|URINALYSIS|||[?]|[?]|TRACE|1|min|1|1|[?]|HIGH|MUSCLE TISSUE|CONCENTRATED||FARNSWORTH-MUNSELL 100 HUE TEST|FIBROSIS 4 FORMULA|Y||U|Y|3|Visit_3|40|3|SCREENING|2021-01-15|2021-02-24|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|69cf0c4b-13f6-4955-8046-72a333059d6e|6|ICAM|Intercellular Adhesion Molecule|URINALYSIS|||[?]|[?]|INVALID|1|ug/kg|1|1|[?]|LOW|ADIPOSE TISSUE|THAWED||CALCULATION|MDRD ENZYMATIC FORMULA|Y||NA|Y|3|Visit_3|40|2|TREATMENT|2021-01-15|2021-01-26|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|69cf0c4b-13f6-4955-8046-72a333059d6e|7|FACTXA|Factor X Activity|HEMATOLOGY|[?]|scm|[?]|[?]|BORDERLINE|1|SBE/mL|1|1|[?]|ABNORMAL|URINE|FRESH||IN VITRO GENE EXPRESSION ASSAY|CKD-EPI FORMULA|||NA||4|Visit_4|65|3|TREATMENT|2021-02-09|2021-02-27|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|69cf0c4b-13f6-4955-8046-72a333059d6e|8|LDLP|LDL Particles|URINALYSIS|[?]|V|[?]|[?]|POSITIVE|1|log10 CFU/g|1|1|[?]|NORMAL|MONOCYTE|HEMOLYZED||OLIGO ACGH|HEPASCORE FORMULA|||U||4|Visit_4|65|4|FOLLOW-UP|2021-02-09|2021-03-11|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|69cf0c4b-13f6-4955-8046-72a333059d6e|9|CCL16|Chemokine (C-C Motif) Ligand 16|URINALYSIS|[?]|mL/animal/wk|[?]|[?]|INVALID|1|STRIP|1|1|[?]|HIGH|LAVAGE FLUID|GELLED||FLUORESCENT ENZYME IMMUNOASSAY|MDRD ENZYMATIC FORMULA|||Y||5|Visit_5|90|6|TREATMENT|2021-03-06|2021-03-08|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|69cf0c4b-13f6-4955-8046-72a333059d6e|10|EPHD|Ephedrine|CHEMISTRY|[?]|10^6 IU|[?]|[?]|BORDERLINE|1|ukat/L|1|1|[?]|LOW|CEREBROSPINAL FLUID|CONTAMINATED||IMMUNOASSAY|MDRD 6 VARIABLE FORMULA|||NA||5|Visit_5|90|4|WASHOUT|2021-03-06|2021-03-15|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|19829028-595c-4811-90e3-0ca696a04ba3|1|CGA|Chromogranin A|CHEMISTRY|[?]|LB|[?]|[?]|INDETERMINATE|1|mV2/Hz|1|1|[?]|HIGH|BUFFY COAT|ICTERIC||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|ASH FIBROSURE FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-07-15|2020-08-09|10|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|19829028-595c-4811-90e3-0ca696a04ba3|2|HEINZRBC|Heinz Bodies/Erythrocytes|HEMATOLOGY|||[?]|[?]|TRACE|1|oz|1|1|[?]|NORMAL|URINE SEDIMENT|CONTAMINATED||FLUORIMETRY|MDRD 4 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|4|WASHOUT|2020-07-15|2020-10-01|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|LB|19829028-595c-4811-90e3-0ca696a04ba3|3|MET|Methionine|CHEMISTRY|[?]|10^4/hpf|[?]|[?]|TRACE|1|IU/dL|1|1|[?]|LOW|NAIL|SOLIDIFIED||OPTICAL MAPPING|MDRD FORMULA||Y|Y||2|Visit_2|25|5|TREATMENT|2020-07-30|2020-08-13|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|19829028-595c-4811-90e3-0ca696a04ba3|4|CLARITY|Clarity|HEMATOLOGY|||[?]|[?]|POSITIVE|1|fraction of 1|1|1|[?]|NORMAL|GASTRIC CONTENTS|CALCIFIED||FLAME PHOTOMETRY|NASH FIBROSURE FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2020-07-30|2020-09-02|25|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|19829028-595c-4811-90e3-0ca696a04ba3|5|C165888|Russian Thistle Pollen IgE Antibody|CHEMISTRY|[?]|/10^4|[?]|[?]|INVALID|1|DPM|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|GELLED||TELLER ACUITY CARDS|CKD-EPI CYSTATIN C FORMULA|||U||3|Visit_3|40|1|TREATMENT|2020-08-14|2020-09-28|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|19829028-595c-4811-90e3-0ca696a04ba3|6|EOTAXIN3|Eotaxin-3|URINALYSIS|[?]|ug/g/min|[?]|[?]|NEGATIVE|1|breaths/min|1|1|[?]|ABNORMAL|BILE|LIPEMIC||FLAME PHOTOMETRY|MDRD 6 VARIABLE FORMULA|Y||Y||3|Visit_3|40|2|TREATMENT|2020-08-14|2020-09-13|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|19829028-595c-4811-90e3-0ca696a04ba3|7|ENRAGE|Extracell Newly Ident RAGE Bind Protein|HEMATOLOGY|[?]|ug/kg|[?]|[?]|POSITIVE|1|breaths/min|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|GELLED|N|THICK SMEAR|FIBROMETER FORMULA||Y|NA||4|Visit_4|65|1|WASHOUT|2020-09-08|2020-09-17|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|19829028-595c-4811-90e3-0ca696a04ba3|8|ALPBALP|Alk Phos, Bone/Total Alk Phos|HEMATOLOGY|||[?]|[?]|INVALID|1|mmol/day|1|1|[?]|LOW|CAPILLARY PLASMA|AGGLUTINATED||ELISPOT|NASH FIBROSURE FORMULA|||N|Y|4|Visit_4|65|7|TREATMENT|2020-09-08|2020-09-11|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|19829028-595c-4811-90e3-0ca696a04ba3|9|OPG|Osteoprotegerin|CHEMISTRY|[?]|10^12 IU/L|[?]|[?]|NEGATIVE|1|dmol|1|1|[?]|ABNORMAL|LEUKOCYTE|ROOM TEMPERATURE||DYNAMIC LIGHT SCATTERING|MDRD 6 VARIABLE FORMULA||Y|NA||5|Visit_5|90|6|WASHOUT|2020-10-03|2020-10-12|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|19829028-595c-4811-90e3-0ca696a04ba3|10|CYSTARCH|Starch Crystals|URINALYSIS|[?]|hr/day|[?]|[?]|BORDERLINE|1|vp/mL|1|1|[?]|LOW|MONOCYTE|ICTERIC||GC/MS/MS|NASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|4|TREATMENT|2020-10-03|2020-10-05|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|562a8182-8e9b-4a68-9b95-bc52df58ed46|1|A2MACG|Alpha-2 Macroglobulin|URINALYSIS|[?]|% INHIBITION|[?]|[?]|BORDERLINE|1|Hounsfield Unit|1|1|[?]|NORMAL|SPERMATOZOON|LIPEMIC|N|MANUAL CLOT DETECTION|FIBROMETER FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-09-05|2020-10-15|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|562a8182-8e9b-4a68-9b95-bc52df58ed46|2|NTENS|Neurotensin|HEMATOLOGY|[?]|Ejaculate U|[?]|[?]|TRACE|1|hr/day|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|HEMOLYZED|N|AMSLER GRID|MDRD 5 VARIABLE FORMULA|||N||1|Visit_1|10|6|FOLLOW-UP|2020-09-05|2020-11-12|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|562a8182-8e9b-4a68-9b95-bc52df58ed46|3|CD13|CD13|CHEMISTRY|[?]|Henry|[?]|[?]|TRACE|1|VIAL|1|1|[?]|NORMAL|MECONIUM|CONTAMINATED||ENZYMATIC SPECTROPHOTOMETRY|MDRD 6 VARIABLE FORMULA|||N||2|Visit_2|25|5|FOLLOW-UP|2020-09-20|2020-10-15|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|562a8182-8e9b-4a68-9b95-bc52df58ed46|4|TSTFTSTT|Testosterone, Free/Testosterone|CHEMISTRY|||[?]|[?]|TRACE|1|BAU/mL|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|REFRIGERATED||CELLULAR PROLIFERATION ASSAY|MDRD 5 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|5|TREATMENT|2020-09-20|2020-09-25|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|562a8182-8e9b-4a68-9b95-bc52df58ed46|5|VEGFR3S|Soluble Vasc Endoth Growth Factor Rec3|HEMATOLOGY|[?]|ug/m2/day|[?]|[?]|TRACE|1|RING|1|1|[?]|NORMAL|MONOCYTE|FRESH||U-HPLC/MS/MS|MDRD ENZYMATIC FORMULA||Y|NA||3|Visit_3|40|6|SCREENING|2020-10-05|2020-11-06|40|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|562a8182-8e9b-4a68-9b95-bc52df58ed46|6|LEU|Leucine|HEMATOLOGY|[?]|Tesla|[?]|[?]|POSITIVE|1|amp|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|AUTOLYZED||PET SCAN|GMI % FORMULA|||U||3|Visit_3|40|2|FOLLOW-UP|2020-10-05|2020-11-12|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|562a8182-8e9b-4a68-9b95-bc52df58ed46|7|ETHANOL|Ethanol|HEMATOLOGY|[?]|MBq|[?]|[?]|NEGATIVE|1|IMPLANT|1|1|[?]|HIGH|LOCHIA|LIPEMIC||PUPILLOMETRY|MDRD FORMULA|||N||4|Visit_4|65|1|TREATMENT|2020-10-30|2020-11-13|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|562a8182-8e9b-4a68-9b95-bc52df58ed46|8|C165891|Western Ragweed Pollen IgE AB RAST Score|HEMATOLOGY|[?]|mL/cm3/min|[?]|[?]|TRACE|1|PNU/mL|1|1|[?]|HIGH|AQUEOUS HUMOR|DRIED|N|ELASTOGRAPHY|HEPASCORE FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-10-30|2020-11-22|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|562a8182-8e9b-4a68-9b95-bc52df58ed46|9|ELA1|Pancreatic Elastase 1|HEMATOLOGY|[?]|/100 WBC|[?]|[?]|NEGATIVE|1|fg|1|1|[?]|ABNORMAL|CERUMEN|FROZEN||MANUAL CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA||5|Visit_5|90|2|SCREENING|2020-11-24|2020-12-01|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|562a8182-8e9b-4a68-9b95-bc52df58ed46|10|SOMATRO|Somatotrophin|CHEMISTRY|||[?]|[?]|TRACE|1|CARTRIDGE|1|1|[?]|NORMAL|CELL PELLET|CLOTTED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|FIBROSIS 4 FORMULA|Y|Y|Y|Y|5|Visit_5|90|4|TREATMENT|2020-11-24|2020-11-25|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|LB|b29e6912-42f4-471b-ad90-1ec446f89ac0|1|BLSTRSID|Ringed Sideroblasts|URINALYSIS|[?]|U/m2/h|[?]|[?]|BORDERLINE|1|mL/cm3/min|1|1|[?]|NORMAL|MECONIUM|AGGLUTINATED||OPTICAL COHERENCE TOMOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2021-01-19|2021-02-13|10|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|b29e6912-42f4-471b-ad90-1ec446f89ac0|2|C130093|Western Ragweed Pollen IgA|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|PFU/dose|1|1|[?]|HIGH|SUPERNATANT, SERUM|THAWED||ISHIHARA COLOR PLATES|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|5|WASHOUT|2021-01-19|2021-02-16|10|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|b29e6912-42f4-471b-ad90-1ec446f89ac0|3|CX3CL1|Chemokine (C-X3-C Motif) Ligand 1|HEMATOLOGY|[?]|nmol/kg/day|[?]|[?]|INVALID|1|genEq|1|1|[?]|LOW|NAIL|ROOM TEMPERATURE||MAGNETIC RESONANCE ENTEROGRAPHY|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|2|SCREENING|2021-02-03|2021-03-18|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|b29e6912-42f4-471b-ad90-1ec446f89ac0|4|TESTOSFR|Testosterone, Free|URINALYSIS|[?]|Enzyme U/m2|[?]|[?]|INDETERMINATE|1|titer|1|1|[?]|NORMAL|VENOUS CORD BLOOD|FRESH||IMMUNOTURBIDIMETRY|ASH FIBROSURE FORMULA||Y|NA||2|Visit_2|25|7|TREATMENT|2021-02-03|2021-03-16|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|b29e6912-42f4-471b-ad90-1ec446f89ac0|5|LEUKCE|Leukemic Cells|CHEMISTRY|[?]|log10 CFU/g|[?]|[?]|INDETERMINATE|1|DAYS|1|1|[?]|ABNORMAL|SERUM OR PLASMA|THAWED|N|PHOTOMETRIC CLOT DETECTION|MDRD ENZYMATIC FORMULA|Y||Y||3|Visit_3|40|7|TREATMENT|2021-02-18|2021-02-22|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|b29e6912-42f4-471b-ad90-1ec446f89ac0|6|CKMBCK|Creatine Kinase MB/Total Creatine Kinase|URINALYSIS|||[?]|[?]|TRACE|1|10^7 TCID 50/dose|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|DRIED||MICROBIAL CONCENTRATION|CKD-EPI CYSTATIN C FORMULA|Y|Y|NA|Y|3|Visit_3|40|4|FOLLOW-UP|2021-02-18|2021-02-22|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|b29e6912-42f4-471b-ad90-1ec446f89ac0|7|INTLK6|Interleukin 6|HEMATOLOGY|[?]|BEAM BREAKS|[?]|[?]|BORDERLINE|1|U/mmol|1|1|[?]|NORMAL|URINE|GELLED||MALDI-TOF|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|1|WASHOUT|2021-03-15|2021-03-23|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|b29e6912-42f4-471b-ad90-1ec446f89ac0|8|PYDCREAT|Pyridinoline/Creatinine|URINALYSIS|||[?]|[?]|NEGATIVE|1|mm2|1|1|[?]|LOW|SEMEN|GELLED||WRIGHT STAIN|COCKCROFT-GAULT FORMULA||Y|N|Y|4|Visit_4|65|4|TREATMENT|2021-03-15|2021-04-17|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|b29e6912-42f4-471b-ad90-1ec446f89ac0|9|CYAMMOX|Ammonium Oxalate Crystals|HEMATOLOGY|[?]|kHz|[?]|[?]|NEGATIVE|1|pmol/dL|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|CALCIFIED||ELECTRICAL IMPEDANCE MYOGRAPHY|GMI % FORMULA||Y|U||5|Visit_5|90|6|TREATMENT|2021-04-09|2021-04-18|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|b29e6912-42f4-471b-ad90-1ec446f89ac0|10|HLAC|HLA Class IC Antigen|CHEMISTRY|[?]|gtt|[?]|[?]|BORDERLINE|1|GLOBULE|1|1|[?]|LOW|CALCULUS|LACTESCENT||X-RAY|GMI % FORMULA|||NA||5|Visit_5|90|5|WASHOUT|2021-04-09|2021-04-17|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|1|PLSPCELY|Precursor Plasma Cells/Lymphocytes|HEMATOLOGY|[?]|ug/dose|[?]|[?]|INVALID|1|/5x10^4 WBC|1|1|[?]|LOW|SYNOVIAL FLUID|UNEXPECTED ODOR|N|ELECTROGASTROGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||1|Visit_1|10|3|FOLLOW-UP|2020-06-09|2020-08-06|10|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|2|MLIGCEBC|Malignant Cells, NOS/Blood Cells|URINALYSIS|[?]|U/animal|[?]|[?]|BORDERLINE|1|L/min/m2|1|1|[?]|LOW|GASTRIC CONTENTS|FROZEN||SLIT LAMP|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|1|WASHOUT|2020-06-09|2020-08-04|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|3|THEOPHYL|Theophylline|URINALYSIS|[?]|10^3 copies/mL|[?]|[?]|NEGATIVE|1|mL/kg|1|1|[?]|HIGH|TUMOR TISSUE|CALCIFIED||MECHANICAL CLOT DETECTION|FIBROMETER FORMULA||Y|NA||2|Visit_2|25|7|SCREENING|2020-06-24|2020-08-17|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-01
e|LB|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|4|METANEPH|Metanephrine|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mL/h|1|1|[?]|HIGH|PLASMA|CONTAMINATED||POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA|Y||N|Y|2|Visit_2|25|7|SCREENING|2020-06-24|2020-09-04|25|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-01
e|LB|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|5|LACTULOS|Lactulose|CHEMISTRY|[?]|ft|[?]|[?]|BORDERLINE|1|ug/g/h|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|FROZEN||PAP STAIN|GMI MMOL/MOL FORMULA||Y|Y||3|Visit_3|40|6|SCREENING|2020-07-09|2020-07-24|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|LB|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|6|LDH2LDH|LDH Isoenzyme 2/LDH|HEMATOLOGY|[?]|mg/m2/h|[?]|[?]|BORDERLINE|1|rpm|1|1|[?]|HIGH|TUMOR TISSUE|AGGLUTINATED||FLAME PHOTOMETRY|HEPASCORE FORMULA||Y|N||3|Visit_3|40|6|FOLLOW-UP|2020-07-09|2020-07-20|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|LB|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|7|IGGCREAT|Immunoglobulin G/Creatinine|URINALYSIS|[?]|kIU|[?]|[?]|BORDERLINE|1|Gauss|1|1|[?]|ABNORMAL|PUS|PARAFFIN-EMBEDDED||GC/MS|MDRD 5 VARIABLE FORMULA|Y|Y|NA||4|Visit_4|65|7|FOLLOW-UP|2020-08-03|2020-08-27|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|8|IBCT|Total Iron Binding Capacity|CHEMISTRY|[?]|pg|[?]|[?]|POSITIVE|1|umol/h/mmol|1|1|[?]|LOW|MIXED VENOUS BLOOD|DRIED||PHOTOMETRIC CLOT DETECTION|MDRD 5 VARIABLE FORMULA||Y|U||4|Visit_4|65|2|SCREENING|2020-08-03|2020-08-04|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|9|NUCSWELL|Nuclear Swelling|HEMATOLOGY|[?]|WAFER|[?]|[?]|BORDERLINE|1|EIA unit|1|1|[?]|LOW|LUNG SURFACTANT|CONCENTRATED||WRIGHT-GIEMSA STAIN|ASH FIBROSURE FORMULA|Y||Y||5|Visit_5|90|6|SCREENING|2020-08-28|2020-08-29|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|10|BUPREN|Buprenorphine|HEMATOLOGY|||[?]|[?]|POSITIVE|1|g/animal/day|1|1|[?]|LOW|ABSCESS FLUID|CLOTTED|N|CAPILLARY ELECTROPHORESIS|COCKCROFT-GAULT FORMULA|||NA|Y|5|Visit_5|90|5|FOLLOW-UP|2020-08-28|2020-09-02|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|396295ba-9f4c-4689-88c2-f80cb28b567a|1|RNA|Ribonucleic Acid|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|cal|1|1|[?]|LOW|URINE SEDIMENT|ROOM TEMPERATURE||SLOAN LETTER EYE CHART 2.5%|MDRD 5 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|7|FOLLOW-UP|2020-12-31|2021-01-20|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|396295ba-9f4c-4689-88c2-f80cb28b567a|2|B2G1GAAB|Beta-2 Glycoprotein 1 IgA Antibody|CHEMISTRY|[?]|10^9 organisms/g|[?]|[?]|INDETERMINATE|1|mmHg|1|1|[?]|NORMAL|PLEURAL TISSUE|THAWED||BETA LACTAMASE|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||1|Visit_1|10|7|SCREENING|2020-12-31|2021-02-04|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|396295ba-9f4c-4689-88c2-f80cb28b567a|3|TGLOB|Thyroglobulin|URINALYSIS|||[?]|[?]|INVALID|1|mg/g/min|1|1|[?]|NORMAL|PERITONEAL FLUID|FRESH||MALDI|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|2|Visit_2|25|2|TREATMENT|2021-01-15|2021-03-07|25|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-28
e|LB|396295ba-9f4c-4689-88c2-f80cb28b567a|4|HGB|Hemoglobin|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^6 DNA copies/mL|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|CONTAMINATED||EPSILOMETER|FIBROTEST FORMULA|||U|Y|2|Visit_2|25|6|FOLLOW-UP|2021-01-15|2021-01-25|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-28
e|LB|396295ba-9f4c-4689-88c2-f80cb28b567a|5|C130135|D. pteronyssinus Antigen IgG Antibody|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|v/v|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|LIPEMIC||CONTRAST ENHANCED PET/CT SCAN|HEPASCORE FORMULA|||NA|Y|3|Visit_3|40|7|SCREENING|2021-01-30|2021-03-04|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|396295ba-9f4c-4689-88c2-f80cb28b567a|6|NAGASECR|N-acetyl-B-D-glucosaminidase/Creatinine|HEMATOLOGY|[?]|kg/mol|[?]|[?]|INVALID|1|10^9/g|1|1|[?]|NORMAL|INFRANATANT, PLASMA|THAWED|N|ELECTROCHEMILUMINESCENCE|MDRD FORMULA||Y|U||3|Visit_3|40|2|WASHOUT|2021-01-30|2021-02-10|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|396295ba-9f4c-4689-88c2-f80cb28b567a|7|DHT|Dihydrotestosterone|CHEMISTRY|||[?]|[?]|NEGATIVE|1|umol/L|1|1|[?]|HIGH|NAIL|HEMOLYZED||CLIP SEQUENCING|NASH FIBROSURE FORMULA|||N|Y|4|Visit_4|65|1|TREATMENT|2021-02-24|2021-03-13|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|396295ba-9f4c-4689-88c2-f80cb28b567a|8|SECRETIN|Secretin|HEMATOLOGY|[?]|KIT|[?]|[?]|INVALID|1|SPRAY|1|1|[?]|HIGH|CEREBROSPINAL FLUID|SOLIDIFIED|N|PUPILLOMETRY|NASH FIBROSURE FORMULA||Y|U||4|Visit_4|65|7|TREATMENT|2021-02-24|2021-03-04|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|396295ba-9f4c-4689-88c2-f80cb28b567a|9|TESTOSWB|Testosterone, Weakly Bound|URINALYSIS|[?]|10^6 copies/mL|[?]|[?]|BORDERLINE|1|cmH2O*s2/mL|1|1|[?]|ABNORMAL|DIALYSIS FLUID|LIPEMIC|N|MRI|MDRD FORMULA|||U||5|Visit_5|90|3|WASHOUT|2021-03-21|2021-03-30|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|396295ba-9f4c-4689-88c2-f80cb28b567a|10|SPERM|Spermatozoa|URINALYSIS|||[?]|[?]|TRACE|1|EID 50/mL|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|AUTOLYZED||NUCLEIC ACID AMPLIFICATION TEST|HEPASCORE FORMULA||Y|U|Y|5|Visit_5|90|3|TREATMENT|2021-03-21|2021-03-28|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|56072c44-67c3-4c93-8db7-2d1570b2bbbc|1|VOLUME|Volume|CHEMISTRY|[?]|uL|[?]|[?]|INDETERMINATE|1|10^6 organisms|1|1|[?]|LOW|FLUID|UNEXPECTED ODOR||IMMUNOPRECIPITATION|HEPASCORE FORMULA|||N||1|Visit_1|10|4|WASHOUT|2020-08-26|2020-09-04|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|56072c44-67c3-4c93-8db7-2d1570b2bbbc|2|S100A8|S100 Calcium Binding Protein A8|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mg/m2/h|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|THAWED|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|4|WASHOUT|2020-08-26|2020-11-16|10|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|56072c44-67c3-4c93-8db7-2d1570b2bbbc|3|HGBA|Hemoglobin A|HEMATOLOGY|[?]|ug/kg/min|[?]|[?]|NEGATIVE|1|10^11/L|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 5 VARIABLE FORMULA||Y|N||2|Visit_2|25|3|TREATMENT|2020-09-10|2020-10-05|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|56072c44-67c3-4c93-8db7-2d1570b2bbbc|4|LTFAB|Lactoferrin Antibody|URINALYSIS|||[?]|[?]|TRACE|1|Bq/uL|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|DRIED|N|ELECTRONEUROGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|NA|Y|2|Visit_2|25|3|TREATMENT|2020-09-10|2020-10-29|25|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|56072c44-67c3-4c93-8db7-2d1570b2bbbc|5|NEUTSG|Neutrophils, Segmented|URINALYSIS|||[?]|[?]|TRACE|1|Tesla|1|1|[?]|LOW|AQUEOUS HUMOR|CALCIFIED||TARGETED GENOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|3|Visit_3|40|4|SCREENING|2020-09-25|2020-10-30|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|56072c44-67c3-4c93-8db7-2d1570b2bbbc|6|TESTOS|Testosterone|URINALYSIS|[?]|mCi|[?]|[?]|INDETERMINATE|1|pt_br|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|CONTAMINATED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROMETER FORMULA|||U||3|Visit_3|40|3|SCREENING|2020-09-25|2020-11-03|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|56072c44-67c3-4c93-8db7-2d1570b2bbbc|7|FENA|Fractional Sodium Excretion|CHEMISTRY|[?]|ng|[?]|[?]|BORDERLINE|1|TUBE|1|1|[?]|HIGH|CELL PELLET|NON-HEMOLYZED||IMMUNO-PET SCAN|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y||4|Visit_4|65|5|SCREENING|2020-10-20|2020-10-22|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|56072c44-67c3-4c93-8db7-2d1570b2bbbc|8|OH8DXG2|8-Hydroxy-2'-Deoxyguanosine|CHEMISTRY|[?]|%/min|[?]|[?]|INVALID|1|CARTRIDGE|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|CLOTTED||DC SHEATH FLOW|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA||4|Visit_4|65|7|WASHOUT|2020-10-20|2020-11-21|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|56072c44-67c3-4c93-8db7-2d1570b2bbbc|9|INTLK10|Interleukin 10|URINALYSIS|[?]|ug/L/h|[?]|[?]|TRACE|1|/LPF|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|THAWED||CELLULOSE TAPE|HEPASCORE FORMULA|||N||5|Visit_5|90|2|TREATMENT|2020-11-14|2020-11-15|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|56072c44-67c3-4c93-8db7-2d1570b2bbbc|10|NEUTB|Neutrophils Band Form|CHEMISTRY|[?]|U/m2/day|[?]|[?]|BORDERLINE|1|pkat/L|1|1|[?]|HIGH|VENOUS BLOOD|NON-HEMOLYZED|N|RAJI CELL EIA|COCKCROFT-GAULT FORMULA||Y|Y||5|Visit_5|90|1|TREATMENT|2020-11-14|2020-11-18|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|55b23180-01f2-498e-a0af-cb9cd7d81750|1|NFLP|Neurofilament Light Chain Protein|URINALYSIS|||[?]|[?]|NEGATIVE|1|mAnson U/mL|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|CALCIFIED||PET/CT SCAN WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA|Y||N|Y|1|Visit_1|10|3|FOLLOW-UP|2020-07-01|2020-07-11|10|20|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|55b23180-01f2-498e-a0af-cb9cd7d81750|2|PGES|Prostaglandin E Synthase|HEMATOLOGY|||[?]|[?]|TRACE|1|m3|1|1|[?]|NORMAL|SWABBED MATERIAL|AUTOLYZED||GRADIENT DIFFUSION|FIBROSIS 4 FORMULA|Y|Y|U|Y|1|Visit_1|10|1|TREATMENT|2020-07-01|2020-08-27|10|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|55b23180-01f2-498e-a0af-cb9cd7d81750|3|CKMB|Creatine Kinase MB|URINALYSIS|||[?]|[?]|BORDERLINE|1|/HPF|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|PARAFFIN-EMBEDDED||IMMUNOFLUORESCENT STAIN|FIBROTEST FORMULA|Y|Y|N|Y|2|Visit_2|25|1|WASHOUT|2020-07-16|2020-08-08|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|55b23180-01f2-498e-a0af-cb9cd7d81750|4|CH50|Complement CH50|URINALYSIS|||[?]|[?]|POSITIVE|1|AgU/mL|1|1|[?]|LOW|CORD BLOOD|UNEXPECTED ODOR|N|QUANTITATIVE CORONARY ANGIOGRAPHY|GMI MMOL/MOL FORMULA|Y||U|Y|2|Visit_2|25|4|SCREENING|2020-07-16|2020-09-14|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|55b23180-01f2-498e-a0af-cb9cd7d81750|5|BASOB|Basophils Band Form|CHEMISTRY|[?]|RING|[?]|[?]|BORDERLINE|1|MET*h|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE||LC/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||3|Visit_3|40|4|TREATMENT|2020-07-31|2020-09-12|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|55b23180-01f2-498e-a0af-cb9cd7d81750|6|OAS1|2-5-Oligoadenylate Synthase 1|CHEMISTRY|[?]|mg/kg|[?]|[?]|TRACE|1|10^6 CFU/g|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|REFRIGERATED||PHOTOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-07-31|2020-09-25|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|55b23180-01f2-498e-a0af-cb9cd7d81750|7|HIST1AB|Histone 1 Antibody|CHEMISTRY|[?]|mCi/kg|[?]|[?]|INDETERMINATE|1|U/m2/day|1|1|[?]|NORMAL|ADIPOSE TISSUE|DRIED|N|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CYSTATIN C FORMULA||Y|Y||4|Visit_4|65|4|FOLLOW-UP|2020-08-25|2020-09-16|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|55b23180-01f2-498e-a0af-cb9cd7d81750|8|CD40L|CD40 Ligand|CHEMISTRY|||[?]|[?]|BORDERLINE|1|BAG|1|1|[?]|LOW|INFRANATANT, SERUM|FROZEN||ACRIDINE ORANGE STAIN|GMI MMOL/MOL FORMULA|||N|Y|4|Visit_4|65|3|WASHOUT|2020-08-25|2020-09-04|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|55b23180-01f2-498e-a0af-cb9cd7d81750|9|FLT3L|FMS-like Tyrosine Kinase 3 Ligand|CHEMISTRY|[?]|log10 CCID 50/dose|[?]|[?]|INDETERMINATE|1|TRACE|1|1|[?]|NORMAL|EMOTIONAL TEAR|CONCENTRATED||DROPLET DIGITAL PCR|GMI % FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-09-19|2020-09-21|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|55b23180-01f2-498e-a0af-cb9cd7d81750|10|K|Potassium|HEMATOLOGY|[?]|fg|[?]|[?]|BORDERLINE|1|genEq/mL|1|1|[?]|HIGH|PLATELET|CLOTTED||AUTOMATED COUNT|COCKCROFT-GAULT FORMULA|Y|Y|NA||5|Visit_5|90|4|SCREENING|2020-09-19|2020-09-27|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|1|SH2D1A|SH2 Domain Containing 1A Protein|CHEMISTRY|[?]|umol/mol|[?]|[?]|TRACE|1|uL/dose|1|1|[?]|LOW|SUPERNATANT, SERUM|FROZEN||WRIGHT STAIN|FIBROSIS 4 FORMULA|Y||Y||1|Visit_1|10|2|SCREENING|2020-11-09|2020-11-14|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|2|GHBP|Growth Hormone Binding Protein|CHEMISTRY|||[?]|[?]|TRACE|1|cm H2O|1|1|[?]|HIGH|SERUM|SOLIDIFIED||FLUORESCEIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|1|Visit_1|10|7|TREATMENT|2020-11-09|2021-01-16|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|3|CYHIPPAC|Hippuric Acid Crystals|HEMATOLOGY|||[?]|[?]|TRACE|1|genEq/mL|1|1|[?]|HIGH|DISCHARGE|FROZEN||NEXT GENERATION TARGETED SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|2|Visit_2|25|6|SCREENING|2020-11-24|2021-01-12|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|4|CEIMCE|Immature Cells/Total Cells|CHEMISTRY|[?]|10^7 CFU|[?]|[?]|TRACE|1|mg/kg/dose|1|1|[?]|HIGH|ISOLATE|FROZEN||FLOW MICROSCOPY|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-11-24|2021-01-09|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|5|JO1AB|Jo-1 Antibody|CHEMISTRY|[?]|g/dL|[?]|[?]|BORDERLINE|1|nmol BCE/nmol|1|1|[?]|ABNORMAL|CORD BLOOD|CONCENTRATED|N|IN VITRO GENE EXPRESSION ASSAY|HEPASCORE FORMULA||Y|NA||3|Visit_3|40|7|WASHOUT|2020-12-09|2021-01-27|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|6|PROLYM|Prolymphocytes|HEMATOLOGY|[?]|10^5/L|[?]|[?]|POSITIVE|1|GBq/g|1|1|[?]|LOW|SYNOVIAL FLUID|SOLIDIFIED||ALCIAN BLUE STAIN|HEPASCORE FORMULA|||NA||3|Visit_3|40|4|FOLLOW-UP|2020-12-09|2021-01-05|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|7|IL1EXR|Interleukin 1 Excretion Rate|HEMATOLOGY|[?]|Hz/s|[?]|[?]|INDETERMINATE|1|ug/kg/min|1|1|[?]|HIGH|SKIN TISSUE|HEMOLYZED|N|SPIROMETRY|MDRD 6 VARIABLE FORMULA||Y|N||4|Visit_4|65|2|TREATMENT|2021-01-03|2021-01-27|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|8|BPIAB|Bactericidal/Permeability-Inc Protein Ab|URINALYSIS|||[?]|[?]|BORDERLINE|1|STEPS|1|1|[?]|ABNORMAL|EMESIS|ICTERIC||TONOMETRY|MDRD 5 VARIABLE FORMULA|Y||U|Y|4|Visit_4|65|3|TREATMENT|2021-01-03|2021-01-06|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|9|TRH|Thyrotropin Releasing Hormone|URINALYSIS|[?]|nmol|[?]|[?]|INDETERMINATE|1|/10^3|1|1|[?]|HIGH|URINE|UNEXPECTED ODOR||MICROBIAL CULTURE, LIQUID|MDRD 6 VARIABLE FORMULA|Y||N||5|Visit_5|90|3|SCREENING|2021-01-28|2021-01-29|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|10|CD163S|Soluble CD163|HEMATOLOGY|[?]|cL|[?]|[?]|BORDERLINE|1|mL/dose|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|FROZEN||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|COCKCROFT-GAULT FORMULA|Y||N||5|Visit_5|90|6|WASHOUT|2021-01-28|2021-02-05|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|940e4aef-5648-46b3-9c3e-7c40f7930030|1|AMPHET|Amphetamine|URINALYSIS|||[?]|[?]|POSITIVE|1|KIT|1|1|[?]|NORMAL|ABSCESS FLUID|CALCIFIED||ENZYMATIC ULTRACENTRIFUGATION|GMI MMOL/MOL FORMULA|Y|Y|N|Y|1|Visit_1|10|1|FOLLOW-UP|2020-11-15|2020-12-19|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|940e4aef-5648-46b3-9c3e-7c40f7930030|2|ACANTRBC|Acanthocytes/Erythrocytes|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^6 organisms/mg|1|1|[?]|NORMAL|EMOTIONAL TEAR|SOLIDIFIED||MACRO BROTH DILUTION|CKD-EPI CREATININE FORMULA|||U|Y|1|Visit_1|10|1|FOLLOW-UP|2020-11-15|2021-01-31|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|940e4aef-5648-46b3-9c3e-7c40f7930030|3|ANGTNSGN|Angiotensinogen|URINALYSIS|[?]|mm3/mm2/year|[?]|[?]|NEGATIVE|1|in|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|ICTERIC|N|ORCHIDOMETERY|FIBROTEST FORMULA|Y||N||2|Visit_2|25|5|WASHOUT|2020-11-30|2020-12-18|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|940e4aef-5648-46b3-9c3e-7c40f7930030|4|LAP|Leucine Aminopeptidase|URINALYSIS|||[?]|[?]|NEGATIVE|1|Enzyme U/g Hb|1|1|[?]|ABNORMAL|URINE SEDIMENT|ROOM TEMPERATURE|N|SPECTROPHOTOMETRY|FIBROTEST FORMULA|Y||N|Y|2|Visit_2|25|7|TREATMENT|2020-11-30|2021-01-24|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|940e4aef-5648-46b3-9c3e-7c40f7930030|5|C130085|English Plantain Pollen IgA|HEMATOLOGY|[?]|U|[?]|[?]|TRACE|1|OD Unit|1|1|[?]|NORMAL|BREAST MILK|CONCENTRATED||DYNAMIC CONTRAST ENHANCED MRI|GMI MMOL/MOL FORMULA|Y||Y||3|Visit_3|40|6|FOLLOW-UP|2020-12-15|2021-01-08|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|940e4aef-5648-46b3-9c3e-7c40f7930030|6|NAG|N-Acetyl Glucosamide|URINALYSIS|[?]|ug/L|[?]|[?]|TRACE|1|ukat/L|1|1|[?]|HIGH|CORD SERUM|NON-HEMOLYZED||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|NASH FIBROSURE FORMULA|||NA||3|Visit_3|40|1|FOLLOW-UP|2020-12-15|2021-01-17|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|940e4aef-5648-46b3-9c3e-7c40f7930030|7|FLUIDOUT|Fluid Output|CHEMISTRY|[?]|pmol/g|[?]|[?]|INVALID|1|LENS|1|1|[?]|NORMAL|BLOOD|FRESH||FLUORESCENT MICROSCOPY|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2021-01-09|2021-01-29|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|940e4aef-5648-46b3-9c3e-7c40f7930030|8|PSDEPHD|Pseudoephedrine|CHEMISTRY|[?]|10^4 CFU/mL|[?]|[?]|TRACE|1|nmol/L|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|REFRIGERATED||APPLANATION TONOMETRY|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2021-01-09|2021-01-15|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|940e4aef-5648-46b3-9c3e-7c40f7930030|9|HAPTOG|Haptoglobin|HEMATOLOGY|[?]|uCi/kg|[?]|[?]|BORDERLINE|1|YEARS|1|1|[?]|ABNORMAL|KERATINOCYTE|LIPEMIC||PERCUSSION|MDRD ENZYMATIC JAPANESE FORMULA|||N||5|Visit_5|90|6|FOLLOW-UP|2021-02-03|2021-02-04|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|940e4aef-5648-46b3-9c3e-7c40f7930030|10|URATEEXR|Urate Excretion Rate|URINALYSIS|[?]|Gy/h|[?]|[?]|TRACE|1|Weber|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|ICTERIC||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|FIBROTEST FORMULA|||Y||5|Visit_5|90|6|FOLLOW-UP|2021-02-03|2021-02-04|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|e4bece1e-6672-4b55-824f-56aa923e60f9|1|MYBLA|Myeloblasts|HEMATOLOGY|[?]|g/cm2|[?]|[?]|NEGATIVE|1|mg/L|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|CONTAMINATED||PELLI-ROBSON EYE CHART|GMI % FORMULA||Y|Y||1|Visit_1|10|1|TREATMENT|2020-06-22|2020-09-17|10|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|e4bece1e-6672-4b55-824f-56aa923e60f9|2|CKMMCK|Creatine Kinase MM/Total Creatine Kinase|URINALYSIS|[?]|mU/L|[?]|[?]|BORDERLINE|1|log10 TCID 50/uL|1|1|[?]|LOW|LYMPH|AUTOLYZED||ANTIMICROBIAL COMBINATION TESTING|GMI % FORMULA|Y|Y|Y||1|Visit_1|10|3|WASHOUT|2020-06-22|2020-08-12|10|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|e4bece1e-6672-4b55-824f-56aa923e60f9|3|IAA5OH|5-Hydroxyindoleacetic Acid|CHEMISTRY|[?]|Bq/kg|[?]|[?]|POSITIVE|1|L/s/kPa|1|1|[?]|ABNORMAL|FLUID|ICTERIC||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD 6 VARIABLE FORMULA|Y||N||2|Visit_2|25|5|WASHOUT|2020-07-07|2020-07-26|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|e4bece1e-6672-4b55-824f-56aa923e60f9|4|FLT3L|FMS-like Tyrosine Kinase 3 Ligand|HEMATOLOGY|[?]|umol/mg/min|[?]|[?]|NEGATIVE|1|pkat/L|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|CONCENTRATED||POLYSOMNOGRAPHY|GMI % FORMULA||Y|Y||2|Visit_2|25|6|SCREENING|2020-07-07|2020-07-22|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|e4bece1e-6672-4b55-824f-56aa923e60f9|5|LSD|Lysergic Acid Diethylamide|HEMATOLOGY|[?]|VIAL|[?]|[?]|TRACE|1|fmol|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|SOLIDIFIED||TRYPAN BLUE STAIN|MDRD FORMULA|Y||N||3|Visit_3|40|3|FOLLOW-UP|2020-07-22|2020-08-07|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|e4bece1e-6672-4b55-824f-56aa923e60f9|6|GAD2AB|Glutamic Acid Decarboxylase 2 Antibody|URINALYSIS|[?]|L/h/m2|[?]|[?]|BORDERLINE|1|mg/dL|1|1|[?]|NORMAL|ERYTHROCYTES|CONCENTRATED||PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD FORMULA||Y|N||3|Visit_3|40|6|WASHOUT|2020-07-22|2020-09-02|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|e4bece1e-6672-4b55-824f-56aa923e60f9|7|CRH|Corticotropin Releasing Hormone|URINALYSIS|[?]|cmH2O/mL|[?]|[?]|NEGATIVE|1|mg/kg/day|1|1|[?]|ABNORMAL|SPERMATOZOON|FROZEN||IN VITRO GENE EXPRESSION ASSAY|MDRD 6 VARIABLE FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-08-16|2020-09-19|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|e4bece1e-6672-4b55-824f-56aa923e60f9|8|GST|Glutathione S-Transferase, Total|URINALYSIS|[?]|/10^5|[?]|[?]|POSITIVE|1|Hz/s|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|HEMOLYZED||BIOIMPEDANCE SPECTROSCOPY|CKD-EPI CYSTATIN C FORMULA||Y|Y||4|Visit_4|65|4|FOLLOW-UP|2020-08-16|2020-09-13|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|e4bece1e-6672-4b55-824f-56aa923e60f9|9|CD45RALY|CD45RA/Lymphocytes|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|ft|1|1|[?]|HIGH|SPUTUM|FROZEN||NEXT GENERATION TARGETED SEQUENCING|ASH FIBROSURE FORMULA||Y|NA|Y|5|Visit_5|90|5|TREATMENT|2020-09-10|2020-09-19|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|e4bece1e-6672-4b55-824f-56aa923e60f9|10|GAD2|Glutamic Acid Decarboxylase 2|HEMATOLOGY|[?]|OI50|[?]|[?]|TRACE|1|steps/min|1|1|[?]|HIGH|REFLEX TEAR|FRESH||TARGETED TRANSCRIPTOME SEQUENCING|COCKCROFT-GAULT FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2020-09-10|2020-09-19|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|12e607da-f53c-4078-9742-23a111db6f54|1|GGTEXR|GammaGlutamyl Transferase Excretion Rate|URINALYSIS|[?]|ug/L FEU|[?]|[?]|POSITIVE|1|ng/mol|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|CLOTTED||TELLER ACUITY CARDS|MDRD FORMULA|||N||1|Visit_1|10|1|FOLLOW-UP|2020-10-03|2020-12-30|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|12e607da-f53c-4078-9742-23a111db6f54|2|INTLK33|Interleukin 33|URINALYSIS|[?]|kcal/day|[?]|[?]|TRACE|1|JDF Unit|1|1|[?]|HIGH|FLUID|HEMOLYZED||SPIRAL CT SCAN WITHOUT CONTRAST|MDRD 4 VARIABLE FORMULA||Y|N||1|Visit_1|10|1|WASHOUT|2020-10-03|2020-12-03|10|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|12e607da-f53c-4078-9742-23a111db6f54|3|IGHG4|Immunoglobulin Heavy Constant Gamma 4|URINALYSIS|[?]|g/cm2|[?]|[?]|NEGATIVE|1|10^11/L|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|CLOTTED||ERGOSPIROMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-10-18|2020-12-10|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|12e607da-f53c-4078-9742-23a111db6f54|4|C130080|Orchard Grass Pollen IgE|URINALYSIS|[?]|dB|[?]|[?]|BORDERLINE|1|mAmp|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|ICTERIC|N|COLORIMETRY|CKD-EPI CREATININE FORMULA|Y||U||2|Visit_2|25|2|FOLLOW-UP|2020-10-18|2020-11-30|25|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|12e607da-f53c-4078-9742-23a111db6f54|5|LSD|Lysergic Acid Diethylamide|URINALYSIS|[?]|ug/g/min|[?]|[?]|TRACE|1|ug/kg|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|REFRIGERATED||SXA SCAN|NASH FIBROSURE FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2020-11-02|2020-12-02|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|12e607da-f53c-4078-9742-23a111db6f54|6|IL1R2|Interleukin 1 Receptor Type 2|HEMATOLOGY|[?]|km|[?]|[?]|NEGATIVE|1|fmol|1|1|[?]|NORMAL|PUS|HEMOLYZED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA|Y||Y||3|Visit_3|40|7|SCREENING|2020-11-02|2020-11-07|40|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|12e607da-f53c-4078-9742-23a111db6f54|7|AFPA|Alpha Fetoprotein Activity|URINALYSIS|||[?]|[?]|POSITIVE|1|ug/kg|1|1|[?]|NORMAL|PLEURAL TISSUE|AUTOLYZED||NON-INVASIVE DIELECTRIC SENSING|MDRD 5 VARIABLE FORMULA|||U|Y|4|Visit_4|65|3|SCREENING|2020-11-27|2020-11-30|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|LB|12e607da-f53c-4078-9742-23a111db6f54|8|C165906|Weed Mix Pollen IgG AB RAST Score|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|nCi|1|1|[?]|LOW|EPIDERMAL TISSUE|CALCIFIED||PHASE-CONTRAST MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|4|Visit_4|65|3|SCREENING|2020-11-27|2020-12-18|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|LB|12e607da-f53c-4078-9742-23a111db6f54|9|PRLYMLE|Prolymphocytes/Leukocytes|HEMATOLOGY|[?]|BU/mL|[?]|[?]|BORDERLINE|1|Arbitrary U|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED||LISSAMINE GREEN STAIN|CKD-EPI CYSTATIN C FORMULA|Y|Y|NA||5|Visit_5|90|7|TREATMENT|2020-12-22|2020-12-29|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|12e607da-f53c-4078-9742-23a111db6f54|10|BLSTLYLE|Lymphoblasts/Leukocytes|URINALYSIS|||[?]|[?]|BORDERLINE|1|mL/min|1|1|[?]|LOW|PLEURAL TISSUE|GELLED||JAEGER EYE CHART|MDRD 4 VARIABLE FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2020-12-22|2020-12-24|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|1|LKM1IAAB|Liver Kidney Microsomal Type 1 IgA Ab|HEMATOLOGY|[?]|mg/g/min|[?]|[?]|INDETERMINATE|1|TROCHE|1|1|[?]|HIGH|PLATELET RICH PLASMA|REFRIGERATED|N|PET SCAN|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2021-01-26|2021-02-27|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|2|PLCGF|Placental Growth Factor|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|pm|1|1|[?]|HIGH|SEMINAL FLUID|NON-HEMOLYZED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|1|Visit_1|10|1|TREATMENT|2021-01-26|2021-03-09|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|3|BASOSG|Basophils, Segmented|HEMATOLOGY|[?]|s/h|[?]|[?]|TRACE|1|Gy/min|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|AUTOLYZED|N|PHASE-CONTRAST MRI|MDRD FORMULA|Y||U||2|Visit_2|25|1|WASHOUT|2021-02-10|2021-02-20|25|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|4|CMPK2|Cytidine-Uridine Monophosphate Kinase 2|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|nmol/L/h|1|1|[?]|LOW|URINE SEDIMENT|PARAFFIN-EMBEDDED||TURBIDIMETRY|FIBROTEST FORMULA||Y|U|Y|2|Visit_2|25|6|FOLLOW-UP|2021-02-10|2021-03-07|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|5|LIPEMIAI|Lipemic Index|URINALYSIS|||[?]|[?]|POSITIVE|1|ug/L|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|CLOTTED||MECHANICAL CLOT DETECTION|ASH FIBROSURE FORMULA||Y|NA|Y|3|Visit_3|40|2|SCREENING|2021-02-25|2021-04-06|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|LB|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|6|NOREPEXR|Norepinephrine Excretion Rate|HEMATOLOGY|[?]|dB|[?]|[?]|NEGATIVE|1|U/kg/min|1|1|[?]|ABNORMAL|SEMEN|SOLIDIFIED|N|PALPATION|MDRD ENZYMATIC FORMULA|Y||NA||3|Visit_3|40|1|WASHOUT|2021-02-25|2021-04-06|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|LB|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|7|TATC|Thrombin Antithrombin Complex|URINALYSIS|[?]|kg/cm|[?]|[?]|TRACE|1|mL/s|1|1|[?]|LOW|ISOLATE|ICTERIC||IMMUNODIFFUSION|NASH FIBROSURE FORMULA|||NA||4|Visit_4|65|4|WASHOUT|2021-03-22|2021-03-30|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|8|CH50|Complement CH50|URINALYSIS|||[?]|[?]|INVALID|1|mL/kg/h|1|1|[?]|LOW|WHITE MATTER TISSUE|AUTOLYZED||MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|U|Y|4|Visit_4|65|6|WASHOUT|2021-03-22|2021-04-13|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|9|CHOLCM|Cholate Compounds|HEMATOLOGY|[?]|CIGARETTE|[?]|[?]|TRACE|1|PACK|1|1|[?]|LOW|EXUDATE|HEMOLYZED||AUTOMATED COUNT|HEPASCORE FORMULA|||Y||5|Visit_5|90|4|FOLLOW-UP|2021-04-16|2021-04-17|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|10|BASOMM|Basophilic Metamyelocytes|URINALYSIS|[?]|PRESSOR UNITS|[?]|[?]|INDETERMINATE|1|lm|1|1|[?]|LOW|SWABBED MATERIAL|HEMOLYZED||MICRONEUTRALIZATION ASSAY|MDRD FORMULA|||N||5|Visit_5|90|7|FOLLOW-UP|2021-04-16|2021-04-22|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|1|O2CT|Oxygen Content|CHEMISTRY|||[?]|[?]|POSITIVE|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|PARAFFIN-EMBEDDED|N|IMMUNE REPERTOIRE DEEP SEQUENCING|NASH FIBROSURE FORMULA|||NA|Y|1|Visit_1|10|3|TREATMENT|2020-07-16|2020-08-11|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|2|CLUECE|Clue Cells|URINALYSIS|[?]|10^8 PFU|[?]|[?]|TRACE|1|ug/cm2|1|1|[?]|NORMAL|SWABBED MATERIAL|LIPEMIC||DOPPLER ULTRASOUND|MDRD 6 VARIABLE FORMULA||Y|NA||1|Visit_1|10|5|SCREENING|2020-07-16|2020-07-26|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|3|MDZLM|Midazolam|URINALYSIS|||[?]|[?]|INDETERMINATE|1|MHz|1|1|[?]|LOW|MONOCYTE|ROOM TEMPERATURE||PHYSICAL EXAMINATION|MDRD 5 VARIABLE FORMULA|Y||NA|Y|2|Visit_2|25|4|FOLLOW-UP|2020-07-31|2020-08-12|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|4|GLYCREAT|Glycine/Creatinine|CHEMISTRY|[?]|10^8 PFU|[?]|[?]|POSITIVE|1|deg/s|1|1|[?]|ABNORMAL|SEMEN|FROZEN|N|NON-INVASIVE DIELECTRIC SENSING|FIBROTEST FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-07-31|2020-09-02|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|5|GFR|Glomerular Filtration Rate|URINALYSIS|||[?]|[?]|TRACE|1|copies/mL|1|1|[?]|HIGH|LEUKOCYTE|HEMOLYZED||OSCILLOMETRY|FIBROTEST FORMULA|||NA|Y|3|Visit_3|40|3|WASHOUT|2020-08-15|2020-10-10|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|6|MMP9|Matrix Metalloproteinase 9|URINALYSIS|[?]|CONTAINER|[?]|[?]|TRACE|1|10^9 organisms|1|1|[?]|NORMAL|LYSATE|ICTERIC|N|DOPPLER ULTRASOUND|FIBROMETER FORMULA||Y|N||3|Visit_3|40|7|TREATMENT|2020-08-15|2020-10-06|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|7|LDH5|LDH Isoenzyme 5|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|rpm|1|1|[?]|ABNORMAL|BUFFY COAT|FRESH||ARTERIAL SPIN LABELING FUNCTIONAL MRI|CKD-EPI FORMULA||Y|Y|Y|4|Visit_4|65|2|WASHOUT|2020-09-09|2020-10-03|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|8|RETIMRTC|Medium Absorption Retic/Reticulocytes|URINALYSIS|[?]|mEq/g|[?]|[?]|BORDERLINE|1|nCi|1|1|[?]|NORMAL|MONOCYTE|DRIED||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|HEPASCORE FORMULA|||U||4|Visit_4|65|5|WASHOUT|2020-09-09|2020-10-11|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|9|NEUTCYBS|Cytoplasmic Basophilia Neutrophil|CHEMISTRY|[?]|mmol/kg|[?]|[?]|POSITIVE|1|uCi|1|1|[?]|HIGH|LEUKOCYTE|CALCIFIED||OLIGO ACGH|FIBROMETER FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2020-10-04|2020-10-11|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|10|FXIVAC|Factor XIV Actual/Control|CHEMISTRY|[?]|PFU/dose|[?]|[?]|INDETERMINATE|1|mg/h|1|1|[?]|NORMAL|EPITHELIAL CELL|LIPEMIC||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||5|Visit_5|90|5|FOLLOW-UP|2020-10-04|2020-10-12|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|3260122d-3bf4-45ff-a026-2379158721d0|1|HAHA|Human Anti-Human Antibody|URINALYSIS|[?]|HEP|[?]|[?]|POSITIVE|1|BAU|1|1|[?]|HIGH|SPUTUM|ICTERIC||CISH|HEPASCORE FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-06-04|2020-08-04|10|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|LB|3260122d-3bf4-45ff-a026-2379158721d0|2|CALPRO|Calprotectin|HEMATOLOGY|[?]|10^9/dose|[?]|[?]|POSITIVE|1|U/kg/min|1|1|[?]|ABNORMAL|PERITONEAL FLUID|THAWED||GRADIENT DIFFUSION|GMI % FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-06-04|2020-07-16|10|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|LB|3260122d-3bf4-45ff-a026-2379158721d0|3|NITRICOX|Nitric Oxide|HEMATOLOGY|[?]|/MBP|[?]|[?]|POSITIVE|1|mg/day|1|1|[?]|LOW|PLEURAL FLUID|DRIED||HANSEL STAIN|GMI % FORMULA|||NA||2|Visit_2|25|2|FOLLOW-UP|2020-06-19|2020-06-30|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|3260122d-3bf4-45ff-a026-2379158721d0|4|AAP|Alanine Aminopeptidase|URINALYSIS|||[?]|[?]|TRACE|1|NEBULE|1|1|[?]|NORMAL|RETICULOCYTES|GELLED||NEXT GENERATION TARGETED SEQUENCING|CKD-EPI CYSTATIN C FORMULA|||Y|Y|2|Visit_2|25|6|FOLLOW-UP|2020-06-19|2020-07-29|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|3260122d-3bf4-45ff-a026-2379158721d0|5|FGF21|Fibroblast Growth Factor 21|CHEMISTRY|[?]|10^7 PFU|[?]|[?]|INVALID|1|DROP|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|CONTAMINATED||LIQUID SCINTILLATION COUNTING|GMI % FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-07-04|2020-07-10|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|LB|3260122d-3bf4-45ff-a026-2379158721d0|6|HGBC|Hemoglobin C|HEMATOLOGY|[?]|GBq/ug|[?]|[?]|TRACE|1|umol/dL|1|1|[?]|LOW|STOOL|AUTOLYZED||VIRUS PLAQUE ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-07-04|2020-07-31|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|LB|3260122d-3bf4-45ff-a026-2379158721d0|7|PBGCREAT|Porphobilinogen/Creatinine|CHEMISTRY|||[?]|[?]|TRACE|1|U/kg/min|1|1|[?]|ABNORMAL|DIALYSIS FLUID|FRESH||AUDIOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|4|Visit_4|65|4|TREATMENT|2020-07-29|2020-08-07|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|3260122d-3bf4-45ff-a026-2379158721d0|8|FGF21|Fibroblast Growth Factor 21|URINALYSIS|[?]|MBP|[?]|[?]|TRACE|1|100 IU/mL|1|1|[?]|HIGH|URINE SEDIMENT|AUTOLYZED||FUNDUS PHOTOGRAPHY|COCKCROFT-GAULT FORMULA|||NA||4|Visit_4|65|4|SCREENING|2020-07-29|2020-08-21|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|3260122d-3bf4-45ff-a026-2379158721d0|9|TIMP1|Tissue Inhibitor of Metalloproteinase 1|HEMATOLOGY|[?]|days/wk|[?]|[?]|TRACE|1|CFU/g|1|1|[?]|LOW|PLATELET RICH PLASMA|CLOTTED|N|DIRECT SEQUENCING|GMI MMOL/MOL FORMULA||Y|N||5|Visit_5|90|3|TREATMENT|2020-08-23|2020-08-24|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|LB|3260122d-3bf4-45ff-a026-2379158721d0|10|APTTLAS|Lupus Anticoagulant Sensitive APTT|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/mmHg|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|CLOTTED||DUCTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|5|Visit_5|90|7|TREATMENT|2020-08-23|2020-08-28|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|LB|05eb4e29-887e-4cdb-8854-49939a8a13d1|1|VWFAAC|von Will Factor Act Actual/Control|HEMATOLOGY|[?]|ppth|[?]|[?]|POSITIVE|1|/10^4|1|1|[?]|LOW|URINE|CONTAMINATED||MANUAL COUNT|NASH FIBROSURE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-11-05|2020-12-29|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|05eb4e29-887e-4cdb-8854-49939a8a13d1|2|C130084|English Plantain Pollen IgE|HEMATOLOGY|[?]|mEq/dL|[?]|[?]|POSITIVE|1|nsec|1|1|[?]|HIGH|PLATELET POOR PLASMA|PARAFFIN-EMBEDDED||TEST STRIP|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||1|Visit_1|10|7|SCREENING|2020-11-05|2020-12-14|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|05eb4e29-887e-4cdb-8854-49939a8a13d1|3|EPIC|Epithelial Cells|CHEMISTRY|[?]|nkat/g Hb|[?]|[?]|BORDERLINE|1|grain|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|CONCENTRATED||ENZYMATIC SPECTROPHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|5|TREATMENT|2020-11-20|2020-11-23|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|05eb4e29-887e-4cdb-8854-49939a8a13d1|4|ANTHRMAG|Antithrombin Antigen|HEMATOLOGY|[?]|U/L|[?]|[?]|INDETERMINATE|1|umol/day|1|1|[?]|ABNORMAL|EXUDATE|ICTERIC||ANGIOGRAPHY|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|3|SCREENING|2020-11-20|2021-01-03|25|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|05eb4e29-887e-4cdb-8854-49939a8a13d1|5|ALBIDX|Albumin Index|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|ug/m2|1|1|[?]|ABNORMAL|PERITONEAL FLUID|CLOTTED||HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI CYSTATIN C FORMULA|||N|Y|3|Visit_3|40|4|FOLLOW-UP|2020-12-05|2021-02-01|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|05eb4e29-887e-4cdb-8854-49939a8a13d1|6|URATE|Urate|URINALYSIS|[?]|MPL U/mL|[?]|[?]|BORDERLINE|1|10^12 IU/L|1|1|[?]|HIGH|ADIPOSE TISSUE|PARAFFIN-EMBEDDED||AMSLER GRID|FIBROSIS 4 FORMULA|Y||Y||3|Visit_3|40|3|TREATMENT|2020-12-05|2021-01-25|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|05eb4e29-887e-4cdb-8854-49939a8a13d1|7|ANCAB|Anti-Neutrophil Cytoplasmic Antibody|URINALYSIS|[?]|BAG|[?]|[?]|TRACE|1|fg|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|CALCIFIED|N|CISH|GMI % FORMULA|||NA||4|Visit_4|65|3|TREATMENT|2020-12-30|2021-01-23|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|05eb4e29-887e-4cdb-8854-49939a8a13d1|8|RETILRTC|Low Absorption Retic/Reticulocytes|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|PATCH|1|1|[?]|LOW|WHITE MATTER TISSUE|ROOM TEMPERATURE|N|DUCTOGRAPHY|GMI % FORMULA||Y|Y|Y|4|Visit_4|65|7|FOLLOW-UP|2020-12-30|2021-01-06|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|05eb4e29-887e-4cdb-8854-49939a8a13d1|9|TOXGRAN|Toxic Granulation|HEMATOLOGY|[?]|10^3 organisms|[?]|[?]|TRACE|1|uEq/L|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|UNEXPECTED ODOR||HILLMEN COLOR CHART|HEPASCORE FORMULA|||NA||5|Visit_5|90|7|SCREENING|2021-01-24|2021-01-29|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|05eb4e29-887e-4cdb-8854-49939a8a13d1|10|LRZPM|Lorazepam|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|PHERESIS UNIT|1|1|[?]|HIGH|VENOUS PLASMA|THAWED||FARR ASSAY|CKD-EPI CYSTATIN C FORMULA|||N|Y|5|Visit_5|90|6|FOLLOW-UP|2021-01-24|2021-02-01|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|c8390c70-766d-4252-9356-39591651bcdf|1|ZPP|Zinc Protoporphyrin|HEMATOLOGY|[?]|cpm|[?]|[?]|POSITIVE|1|Watt|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|ICTERIC|N|URANYL ACETATE STAIN|MDRD FORMULA|Y||NA||1|Visit_1|10|6|SCREENING|2020-08-11|2020-08-21|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|c8390c70-766d-4252-9356-39591651bcdf|2|LEUKCE|Leukemic Cells|HEMATOLOGY|[?]|uL/kg/day|[?]|[?]|POSITIVE|1|ug/kg/min|1|1|[?]|NORMAL|TISSUE|UNEXPECTED ODOR||WRIGHT STAIN|MDRD FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-08-11|2020-08-31|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|c8390c70-766d-4252-9356-39591651bcdf|3|GRAN|Granulocytes|HEMATOLOGY|[?]|km|[?]|[?]|NEGATIVE|1|MPL U/mL|1|1|[?]|NORMAL|BREAST MILK|FRESH||MICROSCOPY|HEPASCORE FORMULA||Y|U||2|Visit_2|25|1|SCREENING|2020-08-26|2020-10-13|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|c8390c70-766d-4252-9356-39591651bcdf|4|SCCAG|Squamous Cell Carcinoma Antigen|URINALYSIS|[?]|aMFI|[?]|[?]|BORDERLINE|1|/10^5|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|CALCIFIED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|CKD-EPI FORMULA|Y||U||2|Visit_2|25|7|WASHOUT|2020-08-26|2020-10-30|25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|c8390c70-766d-4252-9356-39591651bcdf|5|CHYTRYP|Chymotrypsin|CHEMISTRY|[?]|IU/g|[?]|[?]|INVALID|1|pptr|1|1|[?]|LOW|MENSTRUAL BLOOD|SOLIDIFIED||OPHTHALMOSCOPY|CKD-EPI CREATININE FORMULA|Y||Y||3|Visit_3|40|6|WASHOUT|2020-09-10|2020-11-08|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|c8390c70-766d-4252-9356-39591651bcdf|6|C165900|Orchard Grass Pollen IgG AB RAST Score|HEMATOLOGY|[?]|dpm/mL|[?]|[?]|INVALID|1|PACKAGE|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|REFRIGERATED|N|X-RAY FLUORESCENCE SPECTROMETRY|FIBROSIS 4 FORMULA|||U||3|Visit_3|40|7|TREATMENT|2020-09-10|2020-09-17|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|c8390c70-766d-4252-9356-39591651bcdf|7|CPEPCRT|C-peptide/Creatinine|CHEMISTRY|[?]|deg|[?]|[?]|INDETERMINATE|1|uL/mL|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|DRIED||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-10-05|2020-10-07|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|c8390c70-766d-4252-9356-39591651bcdf|8|OSMRTY|Osmolarity|URINALYSIS|[?]|/100 HPFs|[?]|[?]|TRACE|1|mEq/uL|1|1|[?]|HIGH|SUPERNATANT, SERUM|UNEXPECTED ODOR||HPLC/IEX|FIBROTEST FORMULA|||U||4|Visit_4|65|6|FOLLOW-UP|2020-10-05|2020-11-06|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|c8390c70-766d-4252-9356-39591651bcdf|9|CD40L|CD40 Ligand|HEMATOLOGY|||[?]|[?]|INVALID|1|BE/mL|1|1|[?]|HIGH|INFRANATANT, SERUM|REFRIGERATED|N|IMMUNODIFFUSION|MDRD FORMULA||Y|Y|Y|5|Visit_5|90|2|WASHOUT|2020-10-30|2020-11-07|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|c8390c70-766d-4252-9356-39591651bcdf|10|HGBFHGB|Hemoglobin F/Total Hemoglobin|CHEMISTRY|[?]|ngEq/L|[?]|[?]|NEGATIVE|1|U/g/day|1|1|[?]|NORMAL|ARTERIAL BLOOD|PARAFFIN-EMBEDDED||ELECTROCHEMILUMINESCENCE|CKD-EPI FORMULA||Y|N||5|Visit_5|90|2|TREATMENT|2020-10-30|2020-11-07|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|a40bf877-c070-40b3-89df-d566b942246e|1|HMOSIDRN|Hemosiderin|CHEMISTRY|[?]|anti-Xa IU/mL|[?]|[?]|TRACE|1|pmol/day|1|1|[?]|HIGH|KERATINOCYTE|GELLED||REVERSE TRANSCRIPTASE PCR|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-06-16|2020-07-10|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|a40bf877-c070-40b3-89df-d566b942246e|2|AFP|Alpha Fetoprotein|URINALYSIS|||[?]|[?]|NEGATIVE|1|mL/kg/min|1|1|[?]|ABNORMAL|BREAST MILK|HEMOLYZED||IMMUNORADIOMETRIC ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y|Y|1|Visit_1|10|6|TREATMENT|2020-06-16|2020-09-11|10|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|a40bf877-c070-40b3-89df-d566b942246e|3|VLDLT|VLDL Triglyceride|HEMATOLOGY|[?]|SQU/mL|[?]|[?]|BORDERLINE|1|mOsm/L|1|1|[?]|LOW|HAIR FOLLICLE|FRESH||MODIFIED ACID FAST STAIN|FIBROTEST FORMULA||Y|NA||2|Visit_2|25|3|SCREENING|2020-07-01|2020-07-15|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|a40bf877-c070-40b3-89df-d566b942246e|4|INTLK20|Interleukin 20|URINALYSIS|[?]|m/sec2|[?]|[?]|TRACE|1|10^7 PFU|1|1|[?]|HIGH|MONOCYTE|LACTESCENT|N|U-HPLC/MS/MS|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-07-01|2020-07-05|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|a40bf877-c070-40b3-89df-d566b942246e|5|RANKL|Receptor Activator Nuclear KappaB Ligand|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mmol/kg|1|1|[?]|HIGH|AMNIOTIC FLUID|DRIED||OBSERVATION|MDRD 6 VARIABLE FORMULA|||NA|Y|3|Visit_3|40|1|WASHOUT|2020-07-16|2020-09-06|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|a40bf877-c070-40b3-89df-d566b942246e|6|MMA|Methylmalonic Acid|CHEMISTRY|[?]|/10^3|[?]|[?]|TRACE|1|mg/dose|1|1|[?]|HIGH|SOFT TISSUE|CLOTTED|N|BALLPOINT PEN TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2020-07-16|2020-08-18|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|a40bf877-c070-40b3-89df-d566b942246e|7|AAP|Alanine Aminopeptidase|HEMATOLOGY|[?]|/kg|[?]|[?]|INVALID|1|mmol/min/kPa/L|1|1|[?]|LOW|ADIPOSE TISSUE|AUTOLYZED||PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE FORMULA|Y|Y|Y||4|Visit_4|65|2|TREATMENT|2020-08-10|2020-09-11|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|a40bf877-c070-40b3-89df-d566b942246e|8|PSIGAAB|Phosphatidylserine IgA Antibody|URINALYSIS|[?]|10^9/L|[?]|[?]|BORDERLINE|1|Bq/mL|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|THAWED||TARGETED TRANSCRIPTOME SEQUENCING|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|5|SCREENING|2020-08-10|2020-08-27|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|a40bf877-c070-40b3-89df-d566b942246e|9|PLTLPLT|Large Platelets/Total Platelets|HEMATOLOGY|[?]|10^3/hpf|[?]|[?]|TRACE|1|U|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|CLOTTED|N|DIRECT SEQUENCING|MDRD FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-09-04|2020-09-05|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|a40bf877-c070-40b3-89df-d566b942246e|10|GSTPIEXR|Pi-GST Excretion Rate|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|MdFI|1|1|[?]|LOW|ALVEOLAR AIR|FRESH||GC/FID|COCKCROFT-GAULT FORMULA|||Y|Y|5|Visit_5|90|2|FOLLOW-UP|2020-09-04|2020-09-07|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|e9633621-3d08-4b47-b394-5bd3fa47c07f|1|PEMAB|Pemphigoid Antibodies|URINALYSIS|[?]|Bq/uL|[?]|[?]|NEGATIVE|1|/mm|1|1|[?]|HIGH|DIALYSIS FLUID|AGGLUTINATED||LISSAMINE GREEN STAIN|ASH FIBROSURE FORMULA||Y|NA||1|Visit_1|10|3|TREATMENT|2021-01-16|2021-02-12|10|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|e9633621-3d08-4b47-b394-5bd3fa47c07f|2|BLYCE|B-Lymphocytes|URINALYSIS|[?]|breaths/30s|[?]|[?]|TRACE|1|mkat|1|1|[?]|NORMAL|AQUEOUS HUMOR|THAWED||SPIRAL CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||1|Visit_1|10|6|WASHOUT|2021-01-16|2021-03-22|10|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|e9633621-3d08-4b47-b394-5bd3fa47c07f|3|C130128|Dog Dander Antigen IgE Antibody|HEMATOLOGY|[?]|mkat|[?]|[?]|BORDERLINE|1|%(w/v)|1|1|[?]|LOW|ISOLATE|REFRIGERATED||DISK DIFFUSION|HEPASCORE FORMULA|||Y||2|Visit_2|25|2|SCREENING|2021-01-31|2021-02-04|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|e9633621-3d08-4b47-b394-5bd3fa47c07f|4|MERCURY|Mercury|HEMATOLOGY|[?]|TRANSDUCING UNIT|[?]|[?]|BORDERLINE|1|scm|1|1|[?]|NORMAL|MONOCYTE|CALCIFIED||IRON HEMATOXYLIN STAIN|MDRD ENZYMATIC FORMULA|||N||2|Visit_2|25|3|FOLLOW-UP|2021-01-31|2021-02-01|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|e9633621-3d08-4b47-b394-5bd3fa47c07f|5|URATECRT|Urate/Creatinine|CHEMISTRY|[?]|ug/dose|[?]|[?]|BORDERLINE|1|Hz/s|1|1|[?]|HIGH|PLEURAL FLUID|ICTERIC|N|TOTAL BODY IRRADIATION|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|2|FOLLOW-UP|2021-02-15|2021-03-25|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|e9633621-3d08-4b47-b394-5bd3fa47c07f|6|P1NP|Procollagen 1 N-Terminal Propeptide|URINALYSIS|[?]|g/g|[?]|[?]|NEGATIVE|1|oz|1|1|[?]|NORMAL|DIALYSIS FLUID|FROZEN||ELASTOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|N||3|Visit_3|40|6|TREATMENT|2021-02-15|2021-02-21|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|e9633621-3d08-4b47-b394-5bd3fa47c07f|7|BLASTIMM|Immunoblasts|URINALYSIS|[?]|mN|[?]|[?]|TRACE|1|mL/day|1|1|[?]|LOW|EPIDERMAL TISSUE|HEMOLYZED||MICROBIAL CULTURE, LIQUID|ASH FIBROSURE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2021-03-12|2021-04-04|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|e9633621-3d08-4b47-b394-5bd3fa47c07f|8|PSELECT|P-Selectin|CHEMISTRY|[?]|mm2|[?]|[?]|INDETERMINATE|1|pg/cell|1|1|[?]|ABNORMAL|CERUMEN|AGGLUTINATED|N|BIOIMPEDANCE SPECTROSCOPY|ASH FIBROSURE FORMULA|Y||N||4|Visit_4|65|2|TREATMENT|2021-03-12|2021-03-24|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|e9633621-3d08-4b47-b394-5bd3fa47c07f|9|C165892|Wild Rye Pollen IgE Antibody|CHEMISTRY|[?]|U/10^12 RBC|[?]|[?]|TRACE|1|mg/h|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|FRESH||NUCLEIC ACID BASED METHOD|CKD-EPI CREATININE FORMULA||Y|NA||5|Visit_5|90|1|TREATMENT|2021-04-06|2021-04-13|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|e9633621-3d08-4b47-b394-5bd3fa47c07f|10|CSWBC|WBC Casts|URINALYSIS|||[?]|[?]|INDETERMINATE|1|dB|1|1|[?]|LOW|PROSTATIC FLUID|ICTERIC||CT SCAN WITHOUT CONTRAST|ASH FIBROSURE FORMULA|||Y|Y|5|Visit_5|90|4|TREATMENT|2021-04-06|2021-04-08|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|1|GFR|Glomerular Filtration Rate|HEMATOLOGY|[?]|BP|[?]|[?]|INVALID|1|fmol/L|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|UNEXPECTED ODOR||TELLER ACUITY CARDS|MDRD 4 VARIABLE FORMULA|Y||U||1|Visit_1|10|3|TREATMENT|2020-06-08|2020-07-01|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|2|LYMMCELY|Lymphoma Cells/Lymphocytes|URINALYSIS|||[?]|[?]|NEGATIVE|1|ukat/L|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|AGGLUTINATED||LIGHT MICROSCOPY|COCKCROFT-GAULT FORMULA|Y||NA|Y|1|Visit_1|10|6|WASHOUT|2020-06-08|2020-06-26|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|3|TSIAC|TSI Actual/Control|CHEMISTRY|[?]|s*kPa|[?]|[?]|INDETERMINATE|1|uV2|1|1|[?]|ABNORMAL|CORD SERUM|ROOM TEMPERATURE||LIGHT MICROSCOPY|GMI MMOL/MOL FORMULA|||NA||2|Visit_2|25|7|FOLLOW-UP|2020-06-23|2020-09-01|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|4|FRTNLC|Ferritin Light Chain|HEMATOLOGY|[?]|U/kg|[?]|[?]|INDETERMINATE|1|Absorbance U|1|1|[?]|NORMAL|ISOLATE|UNEXPECTED ODOR|N|BAC ACGH|NASH FIBROSURE FORMULA|Y||NA||2|Visit_2|25|4|TREATMENT|2020-06-23|2020-07-11|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|5|C147285|Common Ragweed Pollen IgE Antibody|HEMATOLOGY|[?]|Osm|[?]|[?]|NEGATIVE|1|pg/cell|1|1|[?]|HIGH|EXUDATE|ROOM TEMPERATURE||TRIPLE-PHASE SPIRAL CT SCAN|CKD-EPI CYSTATIN C FORMULA|||N||3|Visit_3|40|1|TREATMENT|2020-07-08|2020-07-21|40|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|LB|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|6|FUNGYLK|Fungi, Yeast-Like|CHEMISTRY|[?]|TRANSDUCING UNIT/mL|[?]|[?]|POSITIVE|1|U/g|1|1|[?]|NORMAL|BASAL TEAR|ICTERIC||PANENDOSCOPY|MDRD 6 VARIABLE FORMULA|||NA||3|Visit_3|40|4|SCREENING|2020-07-08|2020-08-23|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|LB|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|7|GRANCE|Granulocytes/Total Cells|URINALYSIS|[?]|yd|[?]|[?]|POSITIVE|1|JDF Unit|1|1|[?]|NORMAL|WHITE MATTER TISSUE|FROZEN|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|COCKCROFT-GAULT FORMULA||Y|N||4|Visit_4|65|6|SCREENING|2020-08-02|2020-08-10|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|8|CITCREAT|Citrate/Creatinine|CHEMISTRY|[?]|log10 CCID 50/dose|[?]|[?]|INVALID|1|Bq/ug|1|1|[?]|LOW|INFRANATANT, PLASMA|NON-HEMOLYZED||DROPLET DIGITAL PCR|MDRD 5 VARIABLE FORMULA||Y|U||4|Visit_4|65|1|TREATMENT|2020-08-02|2020-08-26|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|9|BLYMXM|B-lymphocyte Crossmatch|URINALYSIS|[?]|CCID 50/mL|[?]|[?]|INDETERMINATE|1|vp/mL|1|1|[?]|NORMAL|CERUMEN|CALCIFIED||ZIEHL NEELSEN ACID FAST STAIN|GMI % FORMULA||Y|Y||5|Visit_5|90|4|TREATMENT|2020-08-27|2020-08-29|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|10|FACTVWA|von Willebrand Factor Activity|CHEMISTRY|[?]|DAgU|[?]|[?]|INVALID|1|titer|1|1|[?]|HIGH|STOOL|ICTERIC||PERFUSION MRI|GMI % FORMULA|Y||NA||5|Visit_5|90|5|TREATMENT|2020-08-27|2020-09-03|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|1|AMYLB40|Amyloid Beta 1-40|CHEMISTRY|[?]|pkat|[?]|[?]|BORDERLINE|1|PNU/mL|1|1|[?]|HIGH|MUCUS|CONTAMINATED||PHASE-CONTRAST MRI|FIBROTEST FORMULA||Y|U||1|Visit_1|10|7|SCREENING|2020-07-16|2020-08-11|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|2|SIXMAM|6-Monoacetylmorphine|URINALYSIS|[?]|umol/day|[?]|[?]|INDETERMINATE|1|psi|1|1|[?]|NORMAL|CORD SERUM|REFRIGERATED|N|DIGITAL PCR|COCKCROFT-GAULT FORMULA|Y||U||1|Visit_1|10|1|TREATMENT|2020-07-16|2020-08-20|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|3|BLSTMBCE|Myeloblasts/Total Cells|URINALYSIS|[?]|mL/dose|[?]|[?]|POSITIVE|1|SPRAY|1|1|[?]|HIGH|CELL PELLET|THAWED||MRI|GMI % FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-07-31|2020-08-24|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|4|BTK|Bruton's Tyrosine Kinase|HEMATOLOGY|||[?]|[?]|INVALID|1|days/wk|1|1|[?]|NORMAL|GASTRIC FLUID|UNEXPECTED ODOR|N|MRI WITHOUT CONTRAST|MDRD 5 VARIABLE FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2020-07-31|2020-09-09|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|5|CBA|Complement Ba|CHEMISTRY|||[?]|[?]|POSITIVE|1|Enzyme U/m2|1|1|[?]|HIGH|MUCUS|FROZEN||GRADIENT DIFFUSION|FIBROSIS 4 FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2020-08-15|2020-08-26|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|6|IOTCLRBS|Iothalamate Clearance Adjusted for BSA|URINALYSIS|||[?]|[?]|POSITIVE|1|copies/mL|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|3|Visit_3|40|4|FOLLOW-UP|2020-08-15|2020-09-22|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|7|PNTBRBTL|Pentobarbital|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|dB|1|1|[?]|HIGH|STOOL|LACTESCENT||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||Y|U|Y|4|Visit_4|65|3|FOLLOW-UP|2020-09-09|2020-10-07|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|8|FIBRINO|Fibrinogen|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|g/U|1|1|[?]|LOW|NAIL|UNEXPECTED ODOR||RIA|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|Y|4|Visit_4|65|7|WASHOUT|2020-09-09|2020-10-13|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|9|CRENCE|Crenated Cells|HEMATOLOGY|[?]|BAG|[?]|[?]|TRACE|1|ug/animal|1|1|[?]|NORMAL|ABSCESS FLUID|LIPEMIC||OPHTHALMOSCOPY|CKD-EPI CREATININE FORMULA|||U||5|Visit_5|90|3|TREATMENT|2020-10-04|2020-10-07|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|10|FOLHMRNA|Folate Hydrolase mRNA|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mV2/Hz|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|DRIED||LIGHT SCATTERING SPECTROSCOPY|CKD-EPI CYSTATIN C FORMULA|Y||Y|Y|5|Visit_5|90|2|TREATMENT|2020-10-04|2020-10-07|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|63f43990-e56e-440c-a445-76e7d114cf26|1|GLUCAGON|Glucagon|CHEMISTRY|[?]|tsp eq|[?]|[?]|TRACE|1|IU/g|1|1|[?]|LOW|PLATELET|LIPEMIC||ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||1|Visit_1|10|5|FOLLOW-UP|2020-10-02|2020-10-22|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|63f43990-e56e-440c-a445-76e7d114cf26|2|BUCHE|Butyrylcholinesterase|URINALYSIS|[?]|mg/mL/min|[?]|[?]|NEGATIVE|1|MET*h|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|PARAFFIN-EMBEDDED||FLUORESCENT SPOT TEST|NASH FIBROSURE FORMULA||Y|Y||1|Visit_1|10|6|TREATMENT|2020-10-02|2020-12-20|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|63f43990-e56e-440c-a445-76e7d114cf26|3|BACT|Bacteria|CHEMISTRY|[?]|10^6 copies/mL|[?]|[?]|BORDERLINE|1|APL U|1|1|[?]|ABNORMAL|PERSPIRATION|ICTERIC||EPSILOMETER|GMI % FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-10-17|2020-11-04|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|63f43990-e56e-440c-a445-76e7d114cf26|4|INTLK13|Interleukin 13|URINALYSIS|[?]|uOsm|[?]|[?]|INDETERMINATE|1|uV2|1|1|[?]|ABNORMAL|BONE|ICTERIC||ENZYMATIC SPECTROPHOTOMETRY|COCKCROFT-GAULT FORMULA||Y|N||2|Visit_2|25|5|TREATMENT|2020-10-17|2020-11-08|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|63f43990-e56e-440c-a445-76e7d114cf26|5|ATHMBAAC|Antithrombin Activity Actual/Control|HEMATOLOGY|[?]|ug/m2/day|[?]|[?]|BORDERLINE|1|psec|1|1|[?]|HIGH|SEBUM|HEMOLYZED|N|POLYGRAPHY|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-11-01|2020-12-29|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|63f43990-e56e-440c-a445-76e7d114cf26|6|LTB4|Leukotriene B4|CHEMISTRY|[?]|V/sec|[?]|[?]|BORDERLINE|1|NEEDLE GAUGE|1|1|[?]|HIGH|TISSUE|LACTESCENT||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI CREATININE FORMULA|||N||3|Visit_3|40|3|WASHOUT|2020-11-01|2020-11-13|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|63f43990-e56e-440c-a445-76e7d114cf26|7|MMP3|Matrix Metalloproteinase 3|URINALYSIS|[?]|umol/L/h|[?]|[?]|INDETERMINATE|1|tsp eq|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|CONTAMINATED|N|HPLC|GMI MMOL/MOL FORMULA||Y|NA||4|Visit_4|65|1|TREATMENT|2020-11-26|2020-12-27|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|63f43990-e56e-440c-a445-76e7d114cf26|8|MIP1B|Macrophage Inflammatory Protein 1 Beta|HEMATOLOGY|[?]|10^9/dose|[?]|[?]|INVALID|1|tuberculin unit|1|1|[?]|HIGH|SUPERNATANT, SERUM|THAWED||MICRONEUTRALIZATION ASSAY|MDRD FORMULA|||U||4|Visit_4|65|1|TREATMENT|2020-11-26|2020-12-03|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|63f43990-e56e-440c-a445-76e7d114cf26|9|PHOSEXR|Phosphorus Excretion Rate|CHEMISTRY|[?]|umol/min|[?]|[?]|NEGATIVE|1|DROP|1|1|[?]|ABNORMAL|ERYTHROCYTES|FROZEN||IODINE STAIN|ASH FIBROSURE FORMULA|||U||5|Visit_5|90|3|SCREENING|2020-12-21|2020-12-24|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|63f43990-e56e-440c-a445-76e7d114cf26|10|GFRE|Glomerular Filtration Rate, Estimated|CHEMISTRY|[?]|PACK|[?]|[?]|INDETERMINATE|1|MASK|1|1|[?]|HIGH|EMOTIONAL TEAR|CALCIFIED||SURFACE PLASMON RESONANCE|FIBROTEST FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2020-12-21|2020-12-28|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|380c89f4-2650-4a54-92f5-5e1278b9a91e|1|C165918|American Cockroach IgG AB RAST Score|URINALYSIS|||[?]|[?]|TRACE|1|pL|1|1|[?]|NORMAL|SEMEN|AGGLUTINATED||CONTRAST ENHANCED PET SCAN|HEPASCORE FORMULA||Y|Y|Y|1|Visit_1|10|2|TREATMENT|2020-10-22|2020-12-06|10|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|380c89f4-2650-4a54-92f5-5e1278b9a91e|2|GLYCRLFR|Free Glycerol|CHEMISTRY|||[?]|[?]|POSITIVE|1|cmol/L|1|1|[?]|ABNORMAL|SKIN TISSUE|THAWED||MECHANICAL CLOT DETECTION|FIBROMETER FORMULA|Y||NA|Y|1|Visit_1|10|6|TREATMENT|2020-10-22|2021-01-18|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|380c89f4-2650-4a54-92f5-5e1278b9a91e|3|FDP|Fibrin Degradation Products|CHEMISTRY|||[?]|[?]|INVALID|1|RFU|1|1|[?]|ABNORMAL|ISOLATE|CLOTTED||MICROSCOPY|MDRD ENZYMATIC FORMULA|||U|Y|2|Visit_2|25|6|TREATMENT|2020-11-06|2020-11-27|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|380c89f4-2650-4a54-92f5-5e1278b9a91e|4|ANAB|Anti-Neutrophil Antibody|URINALYSIS|||[?]|[?]|POSITIVE|1|mIU/L|1|1|[?]|NORMAL|LEUKOCYTE|DRIED|N|MYELOPEROXIDASE STAIN|MDRD 5 VARIABLE FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2020-11-06|2020-12-25|25|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|380c89f4-2650-4a54-92f5-5e1278b9a91e|5|CSEPIRT|Renal Tubular Epithelial Casts|CHEMISTRY|[?]|PHERESIS UNIT|[?]|[?]|TRACE|1|BOWL|1|1|[?]|ABNORMAL|STOOL|FRESH||SXA SCAN|CKD-EPI CYSTATIN C FORMULA||Y|N||3|Visit_3|40|4|TREATMENT|2020-11-21|2020-11-29|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|380c89f4-2650-4a54-92f5-5e1278b9a91e|6|C130122|Nut Mix Antigen IgE Antibody|CHEMISTRY|[?]|MnFI|[?]|[?]|INVALID|1|DIOPTER|1|1|[?]|ABNORMAL|PLEURAL FLUID|HEMOLYZED||CLINICAL EVALUATION|MDRD ENZYMATIC FORMULA|||Y||3|Visit_3|40|3|FOLLOW-UP|2020-11-21|2020-12-20|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|380c89f4-2650-4a54-92f5-5e1278b9a91e|7|ROM|Reactive Oxygen Metabolite|URINALYSIS|[?]|10^6 organisms/mg|[?]|[?]|TRACE|1|%(v/v)|1|1|[?]|LOW|CELL PELLET|ROOM TEMPERATURE|N|EIA|MDRD FORMULA|||U||4|Visit_4|65|2|TREATMENT|2020-12-16|2021-01-09|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|380c89f4-2650-4a54-92f5-5e1278b9a91e|8|EOSB|Eosinophils Band Form|URINALYSIS|[?]|KIT|[?]|[?]|POSITIVE|1|Log10 ELISA unit|1|1|[?]|LOW|BUFFY COAT|NON-HEMOLYZED||CONTRAST ENHANCED SPIRAL CT SCAN|MDRD FORMULA|||N||4|Visit_4|65|5|WASHOUT|2020-12-16|2020-12-24|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|380c89f4-2650-4a54-92f5-5e1278b9a91e|9|RPPAB|Ribosomal P Protein Antibody|HEMATOLOGY|[?]|BEAM BREAKS|[?]|[?]|NEGATIVE|1|Antibody Unit|1|1|[?]|HIGH|BONE MARROW|FRESH|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|U||5|Visit_5|90|5|SCREENING|2021-01-10|2021-01-13|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|380c89f4-2650-4a54-92f5-5e1278b9a91e|10|ALBCREAT|Albumin/Creatinine|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|CYLINDER|1|1|[?]|LOW|URINE|NON-HEMOLYZED||MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|5|Visit_5|90|4|WASHOUT|2021-01-10|2021-01-17|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|84c1f5f4-6415-49d8-b854-22e7529d65b6|1|ANGTNSGN|Angiotensinogen|CHEMISTRY|[?]|mEq/mL|[?]|[?]|INDETERMINATE|1|10^4 CFU/mL|1|1|[?]|HIGH|BUFFY COAT|CLOTTED||DYNAMOMETRY|FIBROMETER FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-12-05|2021-02-14|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|84c1f5f4-6415-49d8-b854-22e7529d65b6|2|CGA|Chromogranin A|URINALYSIS|[?]|MPS U|[?]|[?]|BORDERLINE|1|ukat/L|1|1|[?]|HIGH|LAVAGE FLUID|CLOTTED||INFRARED SPECTROMETRY|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-12-05|2021-02-19|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|84c1f5f4-6415-49d8-b854-22e7529d65b6|3|VITB17|Vitamin B17|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mU|1|1|[?]|ABNORMAL|SOFT TISSUE|HEMOLYZED|N|IMMUNO-PET SCAN|GMI % FORMULA||Y|NA|Y|2|Visit_2|25|1|WASHOUT|2020-12-20|2021-02-15|25|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|84c1f5f4-6415-49d8-b854-22e7529d65b6|4|CD11B|CD11B|CHEMISTRY|[?]|cycle/min|[?]|[?]|NEGATIVE|1|ks|1|1|[?]|HIGH|PERSPIRATION|THAWED||BRDU CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|7|WASHOUT|2020-12-20|2021-02-16|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|84c1f5f4-6415-49d8-b854-22e7529d65b6|5|CYSTATC|Cystatin C|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|dpm/100mg|1|1|[?]|NORMAL|LYSATE|FROZEN||IHC|MDRD 6 VARIABLE FORMULA|Y|Y|NA|Y|3|Visit_3|40|3|TREATMENT|2021-01-04|2021-02-28|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|84c1f5f4-6415-49d8-b854-22e7529d65b6|6|C130071|Bermuda Grass Pollen IgG4|HEMATOLOGY|[?]|log10 PFU/mL|[?]|[?]|BORDERLINE|1|nkat|1|1|[?]|LOW|CIRCULATING TUMOR CELL|CLOTTED||FLUORIMETRY|COCKCROFT-GAULT FORMULA|Y||NA||3|Visit_3|40|6|TREATMENT|2021-01-04|2021-01-30|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|84c1f5f4-6415-49d8-b854-22e7529d65b6|7|LEIMLE|Immature Leukocytes/Leukocytes|CHEMISTRY|[?]|INHALATION|[?]|[?]|BORDERLINE|1|10^3 RNA copies/mL|1|1|[?]|NORMAL|BONE|DRIED||IMMUNOFIXATION ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-01-29|2021-02-22|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|84c1f5f4-6415-49d8-b854-22e7529d65b6|8|MMP8|Matrix Metalloproteinase 8|URINALYSIS|[?]|CCID 50/dose|[?]|[?]|TRACE|1|MBP|1|1|[?]|ABNORMAL|PLEURAL TISSUE|CALCIFIED||CARDIAC THERMODILUTION|FIBROMETER FORMULA||Y|N||4|Visit_4|65|7|FOLLOW-UP|2021-01-29|2021-03-04|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|84c1f5f4-6415-49d8-b854-22e7529d65b6|9|SIXMAM|6-Monoacetylmorphine|URINALYSIS|||[?]|[?]|BORDERLINE|1|/min|1|1|[?]|HIGH|SUPERNATANT, SERUM|REFRIGERATED||AUDIOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|5|Visit_5|90|4|WASHOUT|2021-02-23|2021-02-25|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|84c1f5f4-6415-49d8-b854-22e7529d65b6|10|CEC|Circulating Endothelial Cells|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|TAMPON|1|1|[?]|LOW|ERYTHROCYTES|DRIED||DARK FIELD MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|N|Y|5|Visit_5|90|1|TREATMENT|2021-02-23|2021-02-26|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|77c26a0c-0c84-44d7-8351-a50f3236e59a|1|PMDW|Platelet Mass Distribution Width|CHEMISTRY|[?]|mL/mmHg/min/L|[?]|[?]|BORDERLINE|1|g/mol|1|1|[?]|LOW|CAPILLARY BLOOD|CALCIFIED||IMMUNOCHROMATOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|N||1|Visit_1|10|6|FOLLOW-UP|2020-05-14|2020-06-26|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-27
e|LB|77c26a0c-0c84-44d7-8351-a50f3236e59a|2|IL18BP|Interleukin 18 Binding Protein|URINALYSIS|[?]|IU|[?]|[?]|BORDERLINE|1|cm/min|1|1|[?]|NORMAL|NAIL|AUTOLYZED||WHOLE GENOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||1|Visit_1|10|7|FOLLOW-UP|2020-05-14|2020-05-28|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-27
e|LB|77c26a0c-0c84-44d7-8351-a50f3236e59a|3|INHIBINB|Inhibin B|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|v/v|1|1|[?]|LOW|PLATELET RICH PLASMA|ROOM TEMPERATURE|N|ARTERIAL SPIN LABELING FUNCTIONAL MRI|COCKCROFT-GAULT FORMULA|||NA|Y|2|Visit_2|25|3|WASHOUT|2020-05-29|2020-07-12|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|77c26a0c-0c84-44d7-8351-a50f3236e59a|4|RBCNUC|Nucleated Erythrocytes|HEMATOLOGY|[?]|U/g/day|[?]|[?]|INDETERMINATE|1|um/s|1|1|[?]|NORMAL|SEBUM|FROZEN|N|GC/MS-CI|COCKCROFT-GAULT FORMULA|||NA||2|Visit_2|25|6|SCREENING|2020-05-29|2020-07-13|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|77c26a0c-0c84-44d7-8351-a50f3236e59a|5|GFRBSA|Glomerular Filtration Rate Adj for BSA|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|pg/L|1|1|[?]|ABNORMAL|SWABBED MATERIAL|GELLED||PERCUSSION|CKD-EPI CREATININE FORMULA|||NA|Y|3|Visit_3|40|7|SCREENING|2020-06-13|2020-07-02|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|77c26a0c-0c84-44d7-8351-a50f3236e59a|6|CO2|Carbon Dioxide|CHEMISTRY|[?]|mg/kg/day|[?]|[?]|INDETERMINATE|1|tuberculin unit/mL|1|1|[?]|NORMAL|EPIDERMAL TISSUE|CONCENTRATED||NO INFORMATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|NA||3|Visit_3|40|1|TREATMENT|2020-06-13|2020-08-04|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|77c26a0c-0c84-44d7-8351-a50f3236e59a|7|LYMNSQE|Lymphocytes/Non-Squam Epi Cells|HEMATOLOGY|||[?]|[?]|INVALID|1|DAYS|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|CONCENTRATED||KLEIHAUER-BETKE|MDRD ENZYMATIC FORMULA||Y|U|Y|4|Visit_4|65|6|FOLLOW-UP|2020-07-08|2020-07-29|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|77c26a0c-0c84-44d7-8351-a50f3236e59a|8|BASOIMLE|Immature Basophils/Leukocytes|HEMATOLOGY|[?]|IU|[?]|[?]|TRACE|1|CCID 50/mL|1|1|[?]|LOW|BLOOD|REFRIGERATED|N|TONOMETRY|MDRD ENZYMATIC FORMULA|Y|Y|NA||4|Visit_4|65|7|TREATMENT|2020-07-08|2020-08-09|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|77c26a0c-0c84-44d7-8351-a50f3236e59a|9|INTLK19|Interleukin 19|CHEMISTRY|[?]|mV|[?]|[?]|BORDERLINE|1|mg/dose|1|1|[?]|HIGH|ALVEOLAR AIR|SOLIDIFIED||CLIP SEQUENCING|FIBROMETER FORMULA|Y|Y|Y||5|Visit_5|90|5|TREATMENT|2020-08-02|2020-08-07|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|LB|77c26a0c-0c84-44d7-8351-a50f3236e59a|10|PLSTCELE|Total Plasma Cells/Leukocytes|URINALYSIS|[?]|10^9 CFU/g|[?]|[?]|TRACE|1|mMU/mL|1|1|[?]|ABNORMAL|URINE|FRESH||WESTERN BLOT|NASH FIBROSURE FORMULA||Y|Y||5|Visit_5|90|6|FOLLOW-UP|2020-08-02|2020-08-09|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|LB|a201c78a-e826-4f42-a997-7c6a019e2c91|1|CO2|Carbon Dioxide|HEMATOLOGY|[?]|ks|[?]|[?]|INVALID|1|10^7/L|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|LIPEMIC||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|2|FOLLOW-UP|2020-08-03|2020-10-12|10|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|a201c78a-e826-4f42-a997-7c6a019e2c91|2|YEAST|Yeast Cells|URINALYSIS|||[?]|[?]|INDETERMINATE|1|NEEDLE GAUGE|1|1|[?]|LOW|MONOCYTE|UNEXPECTED ODOR||CHROMOGENIC ASSAY|CKD-EPI FORMULA|||NA|Y|1|Visit_1|10|7|WASHOUT|2020-08-03|2020-09-16|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|a201c78a-e826-4f42-a997-7c6a019e2c91|3|EGF|Epidermal Growth Factor|CHEMISTRY|[?]|U/kg/min|[?]|[?]|INDETERMINATE|1|10^9 organisms|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|CALCIFIED||MECHANICAL CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|5|WASHOUT|2020-08-18|2020-09-29|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|a201c78a-e826-4f42-a997-7c6a019e2c91|4|CHDWR|Ret Corpuscular HGB Conc Distr Width|HEMATOLOGY|[?]|mg/h|[?]|[?]|INVALID|1|L/h|1|1|[?]|NORMAL|PLEURAL TISSUE|THAWED||ROMANOWSKY STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|2|FOLLOW-UP|2020-08-18|2020-09-07|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|a201c78a-e826-4f42-a997-7c6a019e2c91|5|INTLK9|Interleukin 9|URINALYSIS|[?]|MnFI|[?]|[?]|INVALID|1|m|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|AGGLUTINATED|N|HPLC|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|7|FOLLOW-UP|2020-09-02|2020-10-30|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|a201c78a-e826-4f42-a997-7c6a019e2c91|6|C165932|Dog Dander IgE AB RAST Score|URINALYSIS|||[?]|[?]|INVALID|1|K|1|1|[?]|LOW|SEMINAL FLUID|AGGLUTINATED||CORONARY ANGIOGRAPHY|COCKCROFT-GAULT FORMULA||Y|Y|Y|3|Visit_3|40|4|TREATMENT|2020-09-02|2020-09-06|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|a201c78a-e826-4f42-a997-7c6a019e2c91|7|C5|Complement C5|CHEMISTRY|[?]|P|[?]|[?]|INVALID|1|cL|1|1|[?]|LOW|ALVEOLAR AIR|PARAFFIN-EMBEDDED||CORONARY ANGIOGRAPHY|FIBROMETER FORMULA||Y|U||4|Visit_4|65|3|WASHOUT|2020-09-27|2020-10-16|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|a201c78a-e826-4f42-a997-7c6a019e2c91|8|HLADRMSC|HLA-DR Mismatch Count|URINALYSIS|[?]|ELISA unit|[?]|[?]|POSITIVE|1|mL/kg/day|1|1|[?]|ABNORMAL|LYSATE|ROOM TEMPERATURE|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA|||Y||4|Visit_4|65|3|WASHOUT|2020-09-27|2020-10-13|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|a201c78a-e826-4f42-a997-7c6a019e2c91|9|PTSAAC|Protein S Activity Actual/Control|URINALYSIS|[?]|mmAL|[?]|[?]|POSITIVE|1|Linear ft*LB|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|ICTERIC||FARNSWORTH-MUNSELL 100 HUE TEST|FIBROTEST FORMULA|Y|Y|NA||5|Visit_5|90|7|SCREENING|2020-10-22|2020-10-29|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|a201c78a-e826-4f42-a997-7c6a019e2c91|10|FRFEABS|Fractional Iron Absorption|URINALYSIS|[?]|mg/kg/min|[?]|[?]|BORDERLINE|1|g/mol|1|1|[?]|HIGH|EXUDATE|DRIED||TRANSVAGINAL ULTRASOUND|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-10-22|2020-10-31|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|c41880bd-1e29-4961-b74d-bb0d979ab00f|1|CHYTRYP|Chymotrypsin|CHEMISTRY|[?]|cmol/L|[?]|[?]|NEGATIVE|1|vg/mL|1|1|[?]|ABNORMAL|VENOUS PLASMA|AUTOLYZED|N|SPECT SCAN|GMI MMOL/MOL FORMULA||Y|N||1|Visit_1|10|3|TREATMENT|2020-09-11|2020-09-25|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|c41880bd-1e29-4961-b74d-bb0d979ab00f|2|THR|Threonine|HEMATOLOGY|||[?]|[?]|TRACE|1|IU/g Hb|1|1|[?]|ABNORMAL|DISCHARGE|CALCIFIED|N|HANSEL STAIN|MDRD 4 VARIABLE FORMULA||Y|N|Y|1|Visit_1|10|7|SCREENING|2020-09-11|2020-10-16|10|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|c41880bd-1e29-4961-b74d-bb0d979ab00f|3|CARNITAT|Carnitine Acetyl Transferase|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mol/g|1|1|[?]|HIGH|SWABBED MATERIAL|AGGLUTINATED|N|RULER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA|Y||NA|Y|2|Visit_2|25|1|TREATMENT|2020-09-26|2020-09-27|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|c41880bd-1e29-4961-b74d-bb0d979ab00f|4|ERCEMPOL|Erythroid Maturation Pool|URINALYSIS|[?]|fmol/g|[?]|[?]|INVALID|1|10^6 DNA copies/mL|1|1|[?]|HIGH|SEMINAL FLUID|NON-HEMOLYZED|N|SCINTIGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|7|SCREENING|2020-09-26|2020-10-30|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|c41880bd-1e29-4961-b74d-bb0d979ab00f|5|SVCAM1|Soluble Vasc Cell Adhesion Molecule 1|URINALYSIS|[?]|PA|[?]|[?]|TRACE|1|mg/L FEU|1|1|[?]|ABNORMAL|MUSCLE TISSUE|ICTERIC||IMMUNOPRECIPITATION|MDRD ENZYMATIC FORMULA|Y||Y||3|Visit_3|40|6|TREATMENT|2020-10-11|2020-10-27|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|c41880bd-1e29-4961-b74d-bb0d979ab00f|6|PTHCT|Parathyroid Hormone, C-Terminal|HEMATOLOGY|[?]|mg/mol|[?]|[?]|INDETERMINATE|1|MPL U/mL|1|1|[?]|LOW|AMNIOTIC FLUID|FROZEN||SLOAN LETTER EYE CHART 100%|CKD-EPI CREATININE FORMULA|Y||U||3|Visit_3|40|7|WASHOUT|2020-10-11|2020-11-04|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|c41880bd-1e29-4961-b74d-bb0d979ab00f|7|CSFAT|Fatty Casts|URINALYSIS|||[?]|[?]|NEGATIVE|1|U/10^12 RBC|1|1|[?]|ABNORMAL|GASTRIC FLUID|UNEXPECTED ODOR||TRICHROME STAIN|FIBROTEST FORMULA||Y|U|Y|4|Visit_4|65|7|TREATMENT|2020-11-05|2020-11-19|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|c41880bd-1e29-4961-b74d-bb0d979ab00f|8|MONOMA|Monocytes/Macrocytes|CHEMISTRY|[?]|m|[?]|[?]|BORDERLINE|1|mg/mol|1|1|[?]|LOW|VENOUS CORD BLOOD|LIPEMIC||ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|3|WASHOUT|2020-11-05|2020-11-28|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|c41880bd-1e29-4961-b74d-bb0d979ab00f|9|RNP70AB|Ribonucleoprotein-70 Antibody|CHEMISTRY|[?]|MPL U/mL|[?]|[?]|INVALID|1|/day|1|1|[?]|HIGH|MUSCLE TISSUE|ROOM TEMPERATURE||CLIP|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||5|Visit_5|90|4|TREATMENT|2020-11-30|2020-12-01|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|c41880bd-1e29-4961-b74d-bb0d979ab00f|10|LDH1LDH|LDH Isoenzyme 1/LDH|HEMATOLOGY|[?]|Henry|[?]|[?]|TRACE|1|psi|1|1|[?]|NORMAL|BONE MARROW|SOLIDIFIED|N|HEMATOXYLIN AND EOSIN STAIN|FIBROSIS 4 FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-11-30|2020-12-08|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|7de60015-fa9d-4a39-bd19-51c718a624e6|1|IAA5OH|5-Hydroxyindoleacetic Acid|HEMATOLOGY|[?]|10^11/L|[?]|[?]|POSITIVE|1|g/cage/day|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|THAWED||PAP STAIN|MDRD FORMULA|Y|Y|Y||1|Visit_1|10|6|TREATMENT|2020-10-24|2020-11-04|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|7de60015-fa9d-4a39-bd19-51c718a624e6|2|CCL12|Chemokine (C-C Motif) Ligand 12|HEMATOLOGY|[?]|mg/animal|[?]|[?]|NEGATIVE|1|10^3 CFU|1|1|[?]|NORMAL|URINE|UNEXPECTED ODOR||PHASE CONTRAST MICROSCOPY|MDRD 5 VARIABLE FORMULA|Y|Y|Y||1|Visit_1|10|6|TREATMENT|2020-10-24|2021-01-12|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|LB|7de60015-fa9d-4a39-bd19-51c718a624e6|3|WBC|Leukocytes|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^7 CFU/mL|1|1|[?]|HIGH|WHITE MATTER TISSUE|CLOTTED|N|INCISION-INDUCED BLEEDING METHOD|NASH FIBROSURE FORMULA|||NA|Y|2|Visit_2|25|5|FOLLOW-UP|2020-11-08|2020-12-21|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|7de60015-fa9d-4a39-bd19-51c718a624e6|4|LDLOXAB|Oxidized LDL Cholesterol Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|pmol/10^10 cells|1|1|[?]|LOW|PLEURAL TISSUE|SOLIDIFIED|N|BAC ACGH|NASH FIBROSURE FORMULA|||Y|Y|2|Visit_2|25|4|TREATMENT|2020-11-08|2021-01-04|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|7de60015-fa9d-4a39-bd19-51c718a624e6|5|TESTOSBA|Bioavailable Testosterone|HEMATOLOGY|[?]|cm2|[?]|[?]|INVALID|1|vg/mL|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|CONTAMINATED||LAPAROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||3|Visit_3|40|5|WASHOUT|2020-11-23|2020-12-05|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|7de60015-fa9d-4a39-bd19-51c718a624e6|6|C5B9|Complement C5b-9|URINALYSIS|[?]|MBq|[?]|[?]|POSITIVE|1|nmol/mol|1|1|[?]|HIGH|CAPILLARY BLOOD|CONCENTRATED||PYROSEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|5|SCREENING|2020-11-23|2020-12-12|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|7de60015-fa9d-4a39-bd19-51c718a624e6|7|TNFR5S|Soluble TNF Receptor Superfamily Mem 5|CHEMISTRY|[?]|QUANTITY SUFFICIENT|[?]|[?]|BORDERLINE|1|ug/g/h|1|1|[?]|NORMAL|PLATELET POOR PLASMA|GELLED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD FORMULA|||U||4|Visit_4|65|5|FOLLOW-UP|2020-12-18|2021-01-21|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|7de60015-fa9d-4a39-bd19-51c718a624e6|8|T4FRIDX|Thyroxine, Free Index|URINALYSIS|||[?]|[?]|POSITIVE|1|ft3|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED||WHOLE GENOME SEQUENCING|MDRD 6 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|7|WASHOUT|2020-12-18|2021-01-07|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|7de60015-fa9d-4a39-bd19-51c718a624e6|9|TNF5S|Soluble TNF Superfamily Member 5|HEMATOLOGY|[?]|EP U|[?]|[?]|INVALID|1|mg/animal|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|FROZEN||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||5|Visit_5|90|6|FOLLOW-UP|2021-01-12|2021-01-18|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|7de60015-fa9d-4a39-bd19-51c718a624e6|10|CXCL6|Chemokine (C-X-C Motif) Ligand 6|HEMATOLOGY|[?]|mL/cm|[?]|[?]|NEGATIVE|1|mEq/dL|1|1|[?]|LOW|ABSCESS FLUID|ICTERIC|N|ZIEHL NEELSEN ACID FAST STAIN|HEPASCORE FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2021-01-12|2021-01-17|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|34d03f58-155a-4908-bba3-aa979be84610|1|SPERMP|Spermatozoa, Progressive|CHEMISTRY|[?]|mg/m2|[?]|[?]|NEGATIVE|1|ft|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|HEMOLYZED|N|CONTACT SPECULAR MICROSCOPY|HEPASCORE FORMULA||Y|N||1|Visit_1|10|2|TREATMENT|2020-06-29|2020-09-23|10|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|34d03f58-155a-4908-bba3-aa979be84610|2|UBQN|Ubiquitin Protein|URINALYSIS|[?]|g|[?]|[?]|NEGATIVE|1|mm/min|1|1|[?]|ABNORMAL|SOFT TISSUE|THAWED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA|Y||N||1|Visit_1|10|4|WASHOUT|2020-06-29|2020-08-19|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|34d03f58-155a-4908-bba3-aa979be84610|3|INCLBRBC|Erythrocyte Inclusion Bodies|HEMATOLOGY|[?]|OI50|[?]|[?]|INVALID|1|Siemens|1|1|[?]|ABNORMAL|COLOSTRUM|FRESH||KARYOTYPING|HEPASCORE FORMULA|Y||NA||2|Visit_2|25|1|TREATMENT|2020-07-14|2020-08-05|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|34d03f58-155a-4908-bba3-aa979be84610|4|SPERMMTL|Sperm Motility|CHEMISTRY|[?]|Hz|[?]|[?]|POSITIVE|1|uOsm|1|1|[?]|ABNORMAL|SPERMATOZOON|DRIED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROMETER FORMULA|Y||Y||2|Visit_2|25|5|WASHOUT|2020-07-14|2020-09-19|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|34d03f58-155a-4908-bba3-aa979be84610|5|ESTFR|Estradiol, Free|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|v/v|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|DRIED||MUGA|NASH FIBROSURE FORMULA|||U|Y|3|Visit_3|40|2|TREATMENT|2020-07-29|2020-08-24|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|LB|34d03f58-155a-4908-bba3-aa979be84610|6|LDH5LDH|LDH Isoenzyme 5/LDH|CHEMISTRY|[?]|L/min/m2|[?]|[?]|BORDERLINE|1|DPM|1|1|[?]|ABNORMAL|LEUKOCYTE|CONCENTRATED||BETA LACTAMASE|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|6|WASHOUT|2020-07-29|2020-08-17|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|LB|34d03f58-155a-4908-bba3-aa979be84610|7|FGF19|Fibroblast Growth Factor 19|URINALYSIS|||[?]|[?]|TRACE|1|umol/L|1|1|[?]|LOW|AMNIOTIC FLUID|CONTAMINATED|N|FORCED OSCILLATION TECHNIQUE|MDRD ENZYMATIC FORMULA|Y||NA|Y|4|Visit_4|65|2|FOLLOW-UP|2020-08-23|2020-08-27|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|34d03f58-155a-4908-bba3-aa979be84610|8|PCNAG|Proliferating Cell Nuclear Antigen|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mOsm/L|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|CLOTTED||BALLPOINT PEN TECHNIQUE|GMI % FORMULA|Y|Y|U|Y|4|Visit_4|65|2|TREATMENT|2020-08-23|2020-09-12|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|34d03f58-155a-4908-bba3-aa979be84610|9|CANNAB|Cannabinoids|URINALYSIS|||[?]|[?]|TRACE|1|mCi|1|1|[?]|LOW|SOFT TISSUE|CALCIFIED||TOTAL BODY RADIOGRAPHY|HEPASCORE FORMULA|||NA|Y|5|Visit_5|90|7|FOLLOW-UP|2020-09-17|2020-09-25|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|34d03f58-155a-4908-bba3-aa979be84610|10|VAL|Valine|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mg/L FEU|1|1|[?]|HIGH|CAPILLARY PLASMA|PARAFFIN-EMBEDDED|N|DIRECT SEQUENCING|MDRD FORMULA|||NA|Y|5|Visit_5|90|3|TREATMENT|2020-09-17|2020-09-19|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|3818424f-cbc9-4e79-94b8-7edbc706bdbc|1|PRCTC|Prostate Circulating Tumor Cells|HEMATOLOGY|[?]|10^4/L|[?]|[?]|INDETERMINATE|1|log10 TCID 50/uL|1|1|[?]|NORMAL|SPERMATOZOON|ICTERIC||SIZE EXCLUSION CHROMATOGRAPHY|GMI MMOL/MOL FORMULA||Y|N||1|Visit_1|10|3|TREATMENT|2020-08-23|2020-08-24|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|3818424f-cbc9-4e79-94b8-7edbc706bdbc|2|TMZPM|Temazepam|URINALYSIS|[?]|yd|[?]|[?]|INDETERMINATE|1|AgU/mL|1|1|[?]|NORMAL|ALVEOLAR AIR|THAWED||DYNAMOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-08-23|2020-10-08|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|3818424f-cbc9-4e79-94b8-7edbc706bdbc|3|C147285|Common Ragweed Pollen IgE Antibody|URINALYSIS|[?]|copies/uL|[?]|[?]|BORDERLINE|1|mmol/day|1|1|[?]|HIGH|BLOOD|CLOTTED|N|SANGER SEQUENCING|FIBROSIS 4 FORMULA|Y|Y|N||2|Visit_2|25|3|TREATMENT|2020-09-07|2020-09-28|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|3818424f-cbc9-4e79-94b8-7edbc706bdbc|4|CETPA|Cholesteryl Ester Transfer Protein Act|CHEMISTRY|[?]|IU/day|[?]|[?]|NEGATIVE|1|CYLINDER|1|1|[?]|ABNORMAL|CALCULUS|UNEXPECTED ODOR||QUANTITATIVE CORONARY ANGIOGRAPHY|HEPASCORE FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2020-09-07|2020-11-16|25|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|3818424f-cbc9-4e79-94b8-7edbc706bdbc|5|VAL|Valine|CHEMISTRY|[?]|L/kg|[?]|[?]|TRACE|1|ag|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|FRESH||ELECTROGASTROGRAPHY|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2020-09-22|2020-09-30|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|3818424f-cbc9-4e79-94b8-7edbc706bdbc|6|CYDRUG|Drug Crystals|HEMATOLOGY|[?]|log10 PFU/mL|[?]|[?]|BORDERLINE|1|10^9 CFU/mL|1|1|[?]|HIGH|DISCHARGE|FRESH|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-09-22|2020-10-06|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|3818424f-cbc9-4e79-94b8-7edbc706bdbc|7|CYSTHION|Cystathionine|CHEMISTRY|[?]|vp/dose|[?]|[?]|INDETERMINATE|1|MnFI|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE||CELL OF ORIGIN ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|2|FOLLOW-UP|2020-10-17|2020-10-21|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|3818424f-cbc9-4e79-94b8-7edbc706bdbc|8|RPA1|Renal Papillary Antigen 1|URINALYSIS|[?]|MnFI|[?]|[?]|NEGATIVE|1|PACK|1|1|[?]|HIGH|BREAST MILK|HEMOLYZED||CT SCAN WITHOUT CONTRAST|FIBROTEST FORMULA|||U||4|Visit_4|65|1|SCREENING|2020-10-17|2020-11-20|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|3818424f-cbc9-4e79-94b8-7edbc706bdbc|9|ARR|Aldosterone/Renin Activity|HEMATOLOGY|[?]|10^6 organisms/g|[?]|[?]|TRACE|1|U.CARR|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|CONCENTRATED||IMMUNOPRECIPITATION|MDRD 6 VARIABLE FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-11-11|2020-11-20|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|3818424f-cbc9-4e79-94b8-7edbc706bdbc|10|CHCNT|Corpuscular Hemoglobin Content|CHEMISTRY|[?]|10^6 U|[?]|[?]|BORDERLINE|1|mL/g/min|1|1|[?]|LOW|MENSTRUAL BLOOD|LACTESCENT||RADIOGRAPHY|GMI MMOL/MOL FORMULA|||NA||5|Visit_5|90|3|FOLLOW-UP|2020-11-11|2020-11-14|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|4191788e-b2dc-4885-87d8-da9feb6deea5|1|STROPONI|Skeletal Troponin I|URINALYSIS|[?]|%|[?]|[?]|NEGATIVE|1|uIU/L|1|1|[?]|NORMAL|SERUM OR PLASMA|HEMOLYZED|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-09-11|2020-10-25|10|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|4191788e-b2dc-4885-87d8-da9feb6deea5|2|GBP1|Guanylate Binding Protein 1|CHEMISTRY|[?]|10^3 CFU/mL|[?]|[?]|INVALID|1|log10 CFU/g|1|1|[?]|LOW|SPERMATOZOON|NON-HEMOLYZED|N|LC/MS/MS|CKD-EPI CREATININE FORMULA||Y|N||1|Visit_1|10|5|FOLLOW-UP|2020-09-11|2020-10-02|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|LB|4191788e-b2dc-4885-87d8-da9feb6deea5|3|C130080|Orchard Grass Pollen IgE|HEMATOLOGY|[?]|ug/kg/day|[?]|[?]|NEGATIVE|1|Bq/L|1|1|[?]|NORMAL|PERSPIRATION|THAWED||FLAME PHOTOMETRY|FIBROMETER FORMULA|||U||2|Visit_2|25|5|FOLLOW-UP|2020-09-26|2020-10-11|25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|4191788e-b2dc-4885-87d8-da9feb6deea5|4|CKBB|Creatine Kinase BB|HEMATOLOGY|[?]|SFC/10^6 PBMC|[?]|[?]|TRACE|1|MET*h|1|1|[?]|ABNORMAL|DERMAL TISSUE|LIPEMIC||IMMUNE REPERTOIRE DEEP SEQUENCING|FIBROSIS 4 FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-09-26|2020-11-11|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|4191788e-b2dc-4885-87d8-da9feb6deea5|5|GCHT|Glycocholate|HEMATOLOGY|[?]|grain|[?]|[?]|NEGATIVE|1|MAC50|1|1|[?]|LOW|SWABBED MATERIAL|THAWED||ICP-MS|HEPASCORE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-10-11|2020-11-09|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|4191788e-b2dc-4885-87d8-da9feb6deea5|6|BASO|Basophils|URINALYSIS|||[?]|[?]|BORDERLINE|1|g/cage/day|1|1|[?]|LOW|BONE|ICTERIC||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA|||Y|Y|3|Visit_3|40|3|SCREENING|2020-10-11|2020-11-29|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|4191788e-b2dc-4885-87d8-da9feb6deea5|7|ANCAB|Anti-Neutrophil Cytoplasmic Antibody|HEMATOLOGY|[?]|U/m2/day|[?]|[?]|BORDERLINE|1|10^3 organisms/mL|1|1|[?]|LOW|BILE|AGGLUTINATED|N|MUGA|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||4|Visit_4|65|5|TREATMENT|2020-11-05|2020-11-09|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|4191788e-b2dc-4885-87d8-da9feb6deea5|8|MYBLAT3|Type III Myeloblasts|CHEMISTRY|[?]|EID 50/mL|[?]|[?]|INDETERMINATE|1|uEq|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|AUTOLYZED|N|HIGH RESOLUTION CT|CKD-EPI FORMULA||Y|Y||4|Visit_4|65|6|SCREENING|2020-11-05|2020-11-10|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|4191788e-b2dc-4885-87d8-da9feb6deea5|9|MIP1B|Macrophage Inflammatory Protein 1 Beta|URINALYSIS|||[?]|[?]|INDETERMINATE|1|nmol/kg/day|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|CLOTTED||SCINTIGRAPHY|CKD-EPI FORMULA|Y||Y|Y|5|Visit_5|90|3|TREATMENT|2020-11-30|2020-12-08|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|4191788e-b2dc-4885-87d8-da9feb6deea5|10|ALLOILE|Alloisoleucine|CHEMISTRY|[?]|PIPE|[?]|[?]|POSITIVE|1|/5x10^4 WBC|1|1|[?]|NORMAL|PLEURAL FLUID|LIPEMIC||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 4 VARIABLE FORMULA|||U||5|Visit_5|90|3|TREATMENT|2020-11-30|2020-12-07|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|8572a9c4-eb87-4745-81b9-8316bc8de69e|1|C130069|Bermuda Grass Pollen IgA|URINALYSIS|||[?]|[?]|INVALID|1|10^8 PFU|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|CONTAMINATED||MAGNETIC RESONANCE ENTEROGRAPHY|MDRD FORMULA|||N|Y|1|Visit_1|10|5|TREATMENT|2020-12-24|2021-03-19|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|8572a9c4-eb87-4745-81b9-8316bc8de69e|2|CTOT|Complement Total|CHEMISTRY|||[?]|[?]|NEGATIVE|1|DRINK|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|LACTESCENT||INCISION-INDUCED BLEEDING METHOD|MDRD 5 VARIABLE FORMULA|Y|Y|N|Y|1|Visit_1|10|2|TREATMENT|2020-12-24|2020-12-25|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|8572a9c4-eb87-4745-81b9-8316bc8de69e|3|HAPTOG|Haptoglobin|HEMATOLOGY|[?]|/10^5|[?]|[?]|TRACE|1|Frames/s|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|AUTOLYZED||KNEMOMETRY|FIBROMETER FORMULA|||U||2|Visit_2|25|4|WASHOUT|2021-01-08|2021-02-18|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|8572a9c4-eb87-4745-81b9-8316bc8de69e|4|VOLUME|Volume|URINALYSIS|[?]|CYLINDER|[?]|[?]|INVALID|1|POUCH|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|FRESH||TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|3|SCREENING|2021-01-08|2021-03-17|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|8572a9c4-eb87-4745-81b9-8316bc8de69e|5|TGFB1|Transforming Growth Factor Beta 1|CHEMISTRY|[?]|/h|[?]|[?]|TRACE|1|cm|1|1|[?]|ABNORMAL|TUMOR TISSUE|FROZEN||SLIT LAMP|NASH FIBROSURE FORMULA|||U||3|Visit_3|40|4|FOLLOW-UP|2021-01-23|2021-02-02|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|8572a9c4-eb87-4745-81b9-8316bc8de69e|6|SCN|Thiocyanate|HEMATOLOGY|[?]|dB|[?]|[?]|INVALID|1|Gy|1|1|[?]|ABNORMAL|SPUTUM|AUTOLYZED||MYELOPEROXIDASE STAIN|MDRD 6 VARIABLE FORMULA||Y|Y||3|Visit_3|40|4|WASHOUT|2021-01-23|2021-03-13|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|8572a9c4-eb87-4745-81b9-8316bc8de69e|7|AXL|AXL Receptor Tyrosine Kinase|HEMATOLOGY|[?]|uCi/kg|[?]|[?]|NEGATIVE|1|ug/h|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|FROZEN|N|FARNSWORTH-MUNSELL 100 HUE TEST|GMI MMOL/MOL FORMULA|Y||U||4|Visit_4|65|2|WASHOUT|2021-02-17|2021-03-21|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|8572a9c4-eb87-4745-81b9-8316bc8de69e|8|APOA5|Apolipoprotein A5|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|ELISA unit|1|1|[?]|LOW|BASAL TEAR|HEMOLYZED|N|WHOLE GENOME SEQUENCING|MDRD ENZYMATIC FORMULA|||NA|Y|4|Visit_4|65|1|TREATMENT|2021-02-17|2021-03-02|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|8572a9c4-eb87-4745-81b9-8316bc8de69e|9|PGD2|Prostaglandin D2|CHEMISTRY|[?]|ft2|[?]|[?]|TRACE|1|mL/kg/min|1|1|[?]|LOW|MUSCLE TISSUE|HEMOLYZED|N|DUKE INCISION METHOD|FIBROTEST FORMULA|||NA||5|Visit_5|90|4|FOLLOW-UP|2021-03-14|2021-03-21|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|8572a9c4-eb87-4745-81b9-8316bc8de69e|10|STAT3|STAT3|HEMATOLOGY|[?]|100 IU/mL|[?]|[?]|INVALID|1|fmol/L/sec|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|THAWED||NEURAMINIDASE INHIBITION ASSAY|GMI MMOL/MOL FORMULA|Y||Y||5|Visit_5|90|4|FOLLOW-UP|2021-03-14|2021-03-17|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|1|CCL8|Chemokine (C-C Motif) Ligand 8|CHEMISTRY|||[?]|[?]|NEGATIVE|1|gMFI|1|1|[?]|NORMAL|ARTERIAL BLOOD|FROZEN||STATIC PERIMETRY|MDRD 5 VARIABLE FORMULA||Y|NA|Y|1|Visit_1|10|5|TREATMENT|2020-11-26|2021-02-10|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|2|THRCREAT|Threonine/Creatinine|CHEMISTRY|||[?]|[?]|POSITIVE|1|U/animal|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|NON-HEMOLYZED||COMPLEMENT FIXATION|GMI % FORMULA|||N|Y|1|Visit_1|10|3|TREATMENT|2020-11-26|2021-02-04|10|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|3|PHNKET|Phenylketones|HEMATOLOGY|[?]|10^11/L|[?]|[?]|INDETERMINATE|1|nkat/L|1|1|[?]|HIGH|STOOL|GELLED|N|THIN SMEAR|MDRD ENZYMATIC FORMULA|||N||2|Visit_2|25|2|FOLLOW-UP|2020-12-11|2021-01-28|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|4|IL1SR1|Soluble Interleukin-1 Receptor Type I|URINALYSIS|||[?]|[?]|POSITIVE|1|dram|1|1|[?]|ABNORMAL|PERSPIRATION|AUTOLYZED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|ASH FIBROSURE FORMULA|||N|Y|2|Visit_2|25|7|TREATMENT|2020-12-11|2021-01-04|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|5|TNF5S|Soluble TNF Superfamily Member 5|CHEMISTRY|||[?]|[?]|INVALID|1|/40 HPFs|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|GELLED|N|PET/CT SCAN WITHOUT CONTRAST|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|N|Y|3|Visit_3|40|6|FOLLOW-UP|2020-12-26|2021-02-14|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|6|NEUTTOXC|Neutrophilic Toxic Change|URINALYSIS|[?]|AFU|[?]|[?]|NEGATIVE|1|log10 copies/mL|1|1|[?]|LOW|URINE|REFRIGERATED||PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA|Y||N||3|Visit_3|40|6|WASHOUT|2020-12-26|2021-01-17|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|7|APOA2|Apolipoprotein AII|HEMATOLOGY|||[?]|[?]|POSITIVE|1|IU/kg|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|DRIED||IMMUNO-PET SCAN|FIBROMETER FORMULA|||NA|Y|4|Visit_4|65|3|FOLLOW-UP|2021-01-20|2021-02-16|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|8|VITD|Vitamin D|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mL/g/min|1|1|[?]|NORMAL|PLATELET|FROZEN||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|GMI % FORMULA|Y||NA|Y|4|Visit_4|65|2|SCREENING|2021-01-20|2021-02-14|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|9|CKMMCK|Creatine Kinase MM/Total Creatine Kinase|CHEMISTRY|[?]|CCID 50/dose|[?]|[?]|BORDERLINE|1|10^7 TCID 50/dose|1|1|[?]|ABNORMAL|PLASMA|THAWED||NUCLEIC ACID BASED METHOD|HEPASCORE FORMULA|Y|Y|U||5|Visit_5|90|7|TREATMENT|2021-02-14|2021-02-15|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|10|MMP8|Matrix Metalloproteinase 8|HEMATOLOGY|[?]|MdFI|[?]|[?]|POSITIVE|1|mL/beat|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|CONCENTRATED|N|CLAUSS METHOD|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|6|WASHOUT|2021-02-14|2021-02-21|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|3eceae61-a4a0-49fd-964b-9f142e0da067|1|C165920|White Elm Pollen IgG AB RAST Score|CHEMISTRY|||[?]|[?]|NEGATIVE|1|%/s|1|1|[?]|NORMAL|EMESIS|UNEXPECTED ODOR||ERGOSPIROMETRY|HEPASCORE FORMULA|||U|Y|1|Visit_1|10|2|FOLLOW-UP|2020-08-28|2020-10-24|10|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|3eceae61-a4a0-49fd-964b-9f142e0da067|2|PLATEST|Platelets, Estimated|CHEMISTRY|[?]|ug/min|[?]|[?]|TRACE|1|APL U/mL|1|1|[?]|LOW|URINE SEDIMENT|AUTOLYZED||ENDPOINT DILUTION ASSAY|GMI % FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-08-28|2020-10-17|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|LB|3eceae61-a4a0-49fd-964b-9f142e0da067|3|PLSNCE|Neoplastic Plasma Cells|URINALYSIS|[?]|10^9 organisms/g|[?]|[?]|INVALID|1|10^6 U|1|1|[?]|HIGH|SPERMATOZOON|CLOTTED||SANGER SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|5|WASHOUT|2020-09-12|2020-10-07|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|3eceae61-a4a0-49fd-964b-9f142e0da067|4|LYMIMLE|Immature Lymphocytes/Leukocytes|CHEMISTRY|[?]|mg/kg|[?]|[?]|TRACE|1|m/sec2|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|LIPEMIC||ANGIOGRAPHY|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|5|SCREENING|2020-09-12|2020-11-07|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|3eceae61-a4a0-49fd-964b-9f142e0da067|5|CORCREAT|Cortisol/Creatinine|URINALYSIS|[?]|10^6 CFU/mL|[?]|[?]|NEGATIVE|1|uL|1|1|[?]|HIGH|SWABBED MATERIAL|AUTOLYZED||THICK SMEAR|FIBROMETER FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-09-27|2020-11-22|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|3eceae61-a4a0-49fd-964b-9f142e0da067|6|PTHW|Parathyroid Hormone, Whole|URINALYSIS|||[?]|[?]|TRACE|1|Ci/mL|1|1|[?]|LOW|AMNIOTIC FLUID|AGGLUTINATED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA|||Y|Y|3|Visit_3|40|3|FOLLOW-UP|2020-09-27|2020-11-19|40|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|3eceae61-a4a0-49fd-964b-9f142e0da067|7|G6PD|Glucose-6-Phosphate Dehydrogenase|URINALYSIS|[?]|s*kPa|[?]|[?]|POSITIVE|1|DDU|1|1|[?]|LOW|TRANSUDATE|THAWED||PERIODIC ACID SCHIFF STAIN|GMI MMOL/MOL FORMULA|||U||4|Visit_4|65|3|SCREENING|2020-10-22|2020-11-09|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|3eceae61-a4a0-49fd-964b-9f142e0da067|8|P50OXYGN|P50 Oxygen|CHEMISTRY|||[?]|[?]|TRACE|1|10^6/g|1|1|[?]|ABNORMAL|SOFT TISSUE|LIPEMIC||ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CREATININE FORMULA|||U|Y|4|Visit_4|65|3|SCREENING|2020-10-22|2020-11-17|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|3eceae61-a4a0-49fd-964b-9f142e0da067|9|C130127|Cat Dander Antigen IgG4 Antibody|HEMATOLOGY|[?]|lx|[?]|[?]|BORDERLINE|1|JDF Unit|1|1|[?]|NORMAL|REFLEX TEAR|LIPEMIC|N|INTERRUPTER TECHNIQUE|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|6|FOLLOW-UP|2020-11-16|2020-11-24|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|3eceae61-a4a0-49fd-964b-9f142e0da067|10|ANCAB|Anti-Neutrophil Cytoplasmic Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|mEq/day|1|1|[?]|ABNORMAL|SEBUM|SOLIDIFIED||PELLI-ROBSON EYE CHART|MDRD ENZYMATIC FORMULA|||NA|Y|5|Visit_5|90|5|TREATMENT|2020-11-16|2020-11-17|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|fe7ad71c-601d-4909-b56a-401c9a10f00c|1|RDWRCV|Ret RDW Coefficient of Variation|URINALYSIS|[?]|mL/beat|[?]|[?]|TRACE|1|10^6/L|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|DRIED||CELLULAR PROLIFERATION ASSAY|FIBROTEST FORMULA|||U||1|Visit_1|10|3|TREATMENT|2020-05-21|2020-05-22|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|fe7ad71c-601d-4909-b56a-401c9a10f00c|2|HLAMSC|HLA Mismatch Count|URINALYSIS|[?]|10^11/L|[?]|[?]|INDETERMINATE|1|ugEq/L|1|1|[?]|ABNORMAL|EMESIS|CONCENTRATED|N|LIGHT MICROSCOPY|FIBROTEST FORMULA|||Y||1|Visit_1|10|2|SCREENING|2020-05-21|2020-05-25|10|14|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|fe7ad71c-601d-4909-b56a-401c9a10f00c|3|MONO|Monocytes|CHEMISTRY|[?]|beats/min|[?]|[?]|INDETERMINATE|1|mL/animal/day|1|1|[?]|HIGH|VENOUS CORD BLOOD|THAWED||MECHANICAL CLOT DETECTION|MDRD 5 VARIABLE FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-06-05|2020-06-19|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|fe7ad71c-601d-4909-b56a-401c9a10f00c|4|ANGTNS2|Angiotensin II|URINALYSIS|[?]|kg/L|[?]|[?]|TRACE|1|v/v|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|UNEXPECTED ODOR|N|AUTOMATED COUNT|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|4|SCREENING|2020-06-05|2020-08-08|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|fe7ad71c-601d-4909-b56a-401c9a10f00c|5|MYCYLE|Myelocytes/Leukocytes|URINALYSIS|[?]|m3|[?]|[?]|TRACE|1|mg/m2/h|1|1|[?]|NORMAL|COLOSTRUM|LIPEMIC|N|HIGH RESOLUTION CT|FIBROMETER FORMULA|||Y||3|Visit_3|40|6|SCREENING|2020-06-20|2020-07-28|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|LB|fe7ad71c-601d-4909-b56a-401c9a10f00c|6|CMPK2|Cytidine-Uridine Monophosphate Kinase 2|HEMATOLOGY|[?]|kPa|[?]|[?]|POSITIVE|1|umol/mol|1|1|[?]|ABNORMAL|PROSTATIC FLUID|GELLED|N|FLUORESCENT ENZYME IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-06-20|2020-07-07|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|LB|fe7ad71c-601d-4909-b56a-401c9a10f00c|7|C4D|Complement C4d|URINALYSIS|[?]|U|[?]|[?]|NEGATIVE|1|mL/g/h|1|1|[?]|ABNORMAL|BASAL TEAR|CALCIFIED||IMMUNOTURBIDIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||4|Visit_4|65|2|FOLLOW-UP|2020-07-15|2020-07-31|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-27
e|LB|fe7ad71c-601d-4909-b56a-401c9a10f00c|8|HLAIPRA|HLA Class I Panel Reactive Antibody|URINALYSIS|[?]|PRESSOR UNITS|[?]|[?]|INVALID|1|U/m2/h|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|ICTERIC|N|IMMUNOCHEMILUMINOMETRIC ASSAY|CKD-EPI FORMULA|Y||U||4|Visit_4|65|6|TREATMENT|2020-07-15|2020-07-29|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-27
e|LB|fe7ad71c-601d-4909-b56a-401c9a10f00c|9|C165877|Cat Dander IgE AB RAST Score|URINALYSIS|[?]|cL|[?]|[?]|INVALID|1|/2500 WBC|1|1|[?]|ABNORMAL|ISOLATE|AUTOLYZED||MICROBIAL CULTURE|COCKCROFT-GAULT FORMULA|Y||NA||5|Visit_5|90|6|TREATMENT|2020-08-09|2020-08-18|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-18
e|LB|fe7ad71c-601d-4909-b56a-401c9a10f00c|10|EOSCE|Eosinophils/Total Cells|URINALYSIS|[?]|ag|[?]|[?]|NEGATIVE|1|dpm/100mg|1|1|[?]|HIGH|ADIPOSE TISSUE|GELLED||SXA SCAN|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|7|TREATMENT|2020-08-09|2020-08-18|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-18
e|LB|cc52d895-5819-46c0-b8e6-b948f1cd2408|1|CYTRPHOS|Triple Phosphate Crystals|URINALYSIS|[?]|TROCHE|[?]|[?]|POSITIVE|1|min|1|1|[?]|LOW|URINE SEDIMENT|LIPEMIC|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|CKD-EPI FORMULA|||N||1|Visit_1|10|2|WASHOUT|2020-07-06|2020-09-25|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|LB|cc52d895-5819-46c0-b8e6-b948f1cd2408|2|CA125AG|Cancer Antigen 125|URINALYSIS|[?]|mL/s/m2|[?]|[?]|TRACE|1|genEq/mL|1|1|[?]|LOW|SOFT TISSUE|CLOTTED|N|FLOCCULATION, CHARCOAL ENHANCED|MDRD ENZYMATIC FORMULA|||U||1|Visit_1|10|2|FOLLOW-UP|2020-07-06|2020-09-11|10|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|LB|cc52d895-5819-46c0-b8e6-b948f1cd2408|3|C130086|English Plantain Pollen IgG|HEMATOLOGY|||[?]|[?]|TRACE|1|POINT|1|1|[?]|NORMAL|PLEURAL TISSUE|LIPEMIC||AMSLER GRID|CKD-EPI FORMULA||Y|N|Y|2|Visit_2|25|7|WASHOUT|2020-07-21|2020-08-16|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|cc52d895-5819-46c0-b8e6-b948f1cd2408|4|C130141|German Cockroach Antigen IgA Antibody|CHEMISTRY|[?]|10^9/g|[?]|[?]|BORDERLINE|1|ug/mol|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|GELLED||SLIT LAMP PHOTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|3|WASHOUT|2020-07-21|2020-08-08|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|cc52d895-5819-46c0-b8e6-b948f1cd2408|5|V25HD2|25-Hydroxyvitamin D2|URINALYSIS|[?]|mIU/L|[?]|[?]|INDETERMINATE|1|kPa|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|PARAFFIN-EMBEDDED||CALIPER MEASUREMENT METHOD|MDRD ENZYMATIC JAPANESE FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-08-05|2020-08-31|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|cc52d895-5819-46c0-b8e6-b948f1cd2408|6|C165902|Timothy Grass Pollen IgG AB RAST Score|CHEMISTRY|[?]|mU|[?]|[?]|TRACE|1|Joule|1|1|[?]|ABNORMAL|DISCHARGE|DRIED||ISHIHARA COLOR PLATES|MDRD 6 VARIABLE FORMULA||Y|U||3|Visit_3|40|5|WASHOUT|2020-08-05|2020-08-21|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|cc52d895-5819-46c0-b8e6-b948f1cd2408|7|MONOIMLE|Immature Monocytes/Leukocytes|HEMATOLOGY|[?]|mV2/Hz|[?]|[?]|BORDERLINE|1|HOURS|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|HEMOLYZED|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-08-30|2020-09-06|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|cc52d895-5819-46c0-b8e6-b948f1cd2408|8|CD38|CD38|URINALYSIS|[?]|DISK|[?]|[?]|INDETERMINATE|1|pg/L|1|1|[?]|HIGH|INFRANATANT, SERUM|LACTESCENT||AUDIOMETRY|CKD-EPI FORMULA|||NA||4|Visit_4|65|4|SCREENING|2020-08-30|2020-08-31|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|cc52d895-5819-46c0-b8e6-b948f1cd2408|9|C165892|Wild Rye Pollen IgE Antibody|HEMATOLOGY|||[?]|[?]|POSITIVE|1|cmol/L|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|NON-HEMOLYZED||KINYOUN STAIN|CKD-EPI FORMULA||Y|Y|Y|5|Visit_5|90|2|SCREENING|2020-09-24|2020-09-26|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|cc52d895-5819-46c0-b8e6-b948f1cd2408|10|METHDN|Methadone|URINALYSIS|[?]|MnFI|[?]|[?]|POSITIVE|1|mg/kg/h|1|1|[?]|LOW|ENDOTRACHEAL FLUID|AGGLUTINATED|N|PHOTOMETRIC CLOT DETECTION|FIBROMETER FORMULA|||N||5|Visit_5|90|3|SCREENING|2020-09-24|2020-09-25|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|1|LGUNSCE|Large Unstained Cells|HEMATOLOGY|||[?]|[?]|INVALID|1|ft|1|1|[?]|LOW|EPITHELIAL CELL|CLOTTED||BRDU CELLULAR PROLIFERATION ASSAY|MDRD 5 VARIABLE FORMULA|||N|Y|1|Visit_1|10|7|TREATMENT|2021-01-29|2021-03-23|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|2|CACRTP|Calcium Corrected for Total Protein|CHEMISTRY|[?]|uL|[?]|[?]|TRACE|1|IU/L|1|1|[?]|LOW|LYSATE|CONCENTRATED||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 5 VARIABLE FORMULA|Y|Y|NA||1|Visit_1|10|1|SCREENING|2021-01-29|2021-02-26|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|3|C130107|Weed Mix Pollen Antigen IgG Antibody|HEMATOLOGY|[?]|LOZENGE|[?]|[?]|INDETERMINATE|1|BOWL|1|1|[?]|LOW|REFLEX TEAR|CONCENTRATED||POTENTIOMETRY|CKD-EPI CYSTATIN C FORMULA|Y|Y|Y||2|Visit_2|25|7|TREATMENT|2021-02-13|2021-03-22|25|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|4|PLG|Plasminogen|HEMATOLOGY|[?]|/100 HPFs|[?]|[?]|INVALID|1|mm2|1|1|[?]|HIGH|CAPILLARY PLASMA|LACTESCENT||IMMUNOCHROMATOGRAPHY|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2021-02-13|2021-04-09|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|5|MITOM2AB|Mitochondrial M2 Antibody|CHEMISTRY|[?]|QUANTITY SUFFICIENT|[?]|[?]|INVALID|1|fmol|1|1|[?]|LOW|BREAST MILK|SOLIDIFIED||PET/SPECT SCAN|CKD-EPI FORMULA|||U||3|Visit_3|40|7|TREATMENT|2021-02-28|2021-04-02|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|LB|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|6|FEP|Erythrocyte Protoporphyrin, Free|HEMATOLOGY|[?]|Ci/ug|[?]|[?]|BORDERLINE|1|copies/mL|1|1|[?]|ABNORMAL|BASAL TEAR|LIPEMIC|N|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|7|WASHOUT|2021-02-28|2021-03-18|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|LB|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|7|LTF|Lactoferrin|URINALYSIS|[?]|mN|[?]|[?]|INDETERMINATE|1|MdFI|1|1|[?]|HIGH|SUPERNATANT, PLASMA|NON-HEMOLYZED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|ASH FIBROSURE FORMULA|Y|Y|U||4|Visit_4|65|3|SCREENING|2021-03-25|2021-04-10|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|8|HGBA1HGB|Hemoglobin A1/Total Hemoglobin|URINALYSIS|[?]|nkat/L|[?]|[?]|TRACE|1|nmol/day|1|1|[?]|ABNORMAL|EXUDATE|HEMOLYZED|N|CELL OF ORIGIN ASSAY|FIBROTEST FORMULA|||NA||4|Visit_4|65|2|FOLLOW-UP|2021-03-25|2021-04-23|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|9|FACTVWA|von Willebrand Factor Activity|URINALYSIS|[?]|CAPSULE|[?]|[?]|POSITIVE|1|IU/kg|1|1|[?]|LOW|INFRANATANT, SERUM|AUTOLYZED||POPULATION SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||5|Visit_5|90|6|FOLLOW-UP|2021-04-19|2021-04-21|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|LB|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|10|CREAT|Creatinine|URINALYSIS|[?]|Ci|[?]|[?]|BORDERLINE|1|h*%|1|1|[?]|NORMAL|EMESIS|GELLED||RADIAL IMMUNODIFFUSION|CKD-EPI CYSTATIN C FORMULA|Y|Y|U||5|Visit_5|90|3|FOLLOW-UP|2021-04-19|2021-04-22|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|LB|1409edea-a372-4938-889b-df6ee93b8543|1|GEC|Galactose Elimination Capacity|CHEMISTRY|||[?]|[?]|BORDERLINE|1|U/mg|1|1|[?]|NORMAL|SUPERNATANT, SERUM|GELLED||HPLC/MS/MS|FIBROSIS 4 FORMULA||Y|Y|Y|1|Visit_1|10|3|TREATMENT|2020-08-27|2020-09-10|10|24|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|1409edea-a372-4938-889b-df6ee93b8543|2|CSBROAD|Broad Casts|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|U/mg|1|1|[?]|ABNORMAL|SEMINAL FLUID|REFRIGERATED||OPHTHALMOSCOPY|GMI % FORMULA||Y|U|Y|1|Visit_1|10|1|WASHOUT|2020-08-27|2020-11-09|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|1409edea-a372-4938-889b-df6ee93b8543|3|GLP1|Glucagon-Like Peptide-1|CHEMISTRY|[?]|g/cage/day|[?]|[?]|INDETERMINATE|1|L/h|1|1|[?]|LOW|INTERSTITIAL FLUID|CONTAMINATED||MOUSE PROTECTION ASSAY|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-09-11|2020-10-18|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|LB|1409edea-a372-4938-889b-df6ee93b8543|4|FGF19|Fibroblast Growth Factor 19|CHEMISTRY|||[?]|[?]|NEGATIVE|1|HEP|1|1|[?]|NORMAL|GASTRIC CONTENTS|DRIED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD FORMULA|||U|Y|2|Visit_2|25|6|TREATMENT|2020-09-11|2020-09-26|25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|LB|1409edea-a372-4938-889b-df6ee93b8543|5|SPHERO|Spherocytes|CHEMISTRY|[?]|Ci|[?]|[?]|BORDERLINE|1|pmol/10^9 cells|1|1|[?]|LOW|ISOLATE|SOLIDIFIED||ERGOSPIROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-09-26|2020-11-08|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|1409edea-a372-4938-889b-df6ee93b8543|6|ADMA|Asymmetric Dimethylarginine|HEMATOLOGY|||[?]|[?]|TRACE|1|10^6 organisms/mL|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|AUTOLYZED||BIOIMPEDANCE SPECTROSCOPY|FIBROMETER FORMULA|||N|Y|3|Visit_3|40|1|WASHOUT|2020-09-26|2020-10-06|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|1409edea-a372-4938-889b-df6ee93b8543|7|MGB|Myoglobin|CHEMISTRY|[?]|PFU/mL|[?]|[?]|INDETERMINATE|1|mmHg/L/min|1|1|[?]|ABNORMAL|PLATELET|UNEXPECTED ODOR||GIEMSA STAIN|HEPASCORE FORMULA|Y||N||4|Visit_4|65|3|TREATMENT|2020-10-21|2020-11-18|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|1409edea-a372-4938-889b-df6ee93b8543|8|LLCFR|Lambda Light Chain, Free|CHEMISTRY|[?]|pmol/10^9 cells|[?]|[?]|POSITIVE|1|pt_us|1|1|[?]|NORMAL|ABSCESS FLUID|CLOTTED||TRICHROME STAIN|MDRD 6 VARIABLE FORMULA|Y||Y||4|Visit_4|65|3|TREATMENT|2020-10-21|2020-11-03|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|1409edea-a372-4938-889b-df6ee93b8543|9|PCA3MRNA|Prostate Cancer Antigen 3 mRNA|URINALYSIS|[?]|cL|[?]|[?]|INDETERMINATE|1|copies/uL|1|1|[?]|LOW|NAIL|LIPEMIC||PET/CT SCAN|HEPASCORE FORMULA|||NA||5|Visit_5|90|1|SCREENING|2020-11-15|2020-11-16|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|1409edea-a372-4938-889b-df6ee93b8543|10|PNTBRBTL|Pentobarbital|URINALYSIS|[?]|Bq/mL|[?]|[?]|BORDERLINE|1|Absorbance U/mL|1|1|[?]|HIGH|CORD BLOOD|ROOM TEMPERATURE|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROTEST FORMULA|Y|Y|U||5|Visit_5|90|7|SCREENING|2020-11-15|2020-11-19|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|3dc16ad2-d49d-4fad-9823-d0197fb57a42|1|FUNGI|Fungi|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mgEq|1|1|[?]|NORMAL|LUNG SURFACTANT|CLOTTED||SPECT SCAN|MDRD FORMULA|Y||Y|Y|1|Visit_1|10|7|TREATMENT|2020-09-04|2020-09-22|10|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|3dc16ad2-d49d-4fad-9823-d0197fb57a42|2|SHBG|Sex Hormone Binding Globulin|CHEMISTRY|[?]|ug|[?]|[?]|NEGATIVE|1|pg/dL|1|1|[?]|HIGH|ISOLATE|CONTAMINATED||HPLC-FL|FIBROMETER FORMULA|Y|Y|N||1|Visit_1|10|3|WASHOUT|2020-09-04|2020-10-19|10|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|3dc16ad2-d49d-4fad-9823-d0197fb57a42|3|RESISTIN|Resistin|HEMATOLOGY|[?]|%(v/v)|[?]|[?]|INDETERMINATE|1|U/mg|1|1|[?]|LOW|INFRANATANT, SERUM|THAWED||KINETIC CHROMOGENIC ASSAY|FIBROTEST FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2020-09-19|2020-10-12|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|3dc16ad2-d49d-4fad-9823-d0197fb57a42|4|CARNITF|Carnitine, Free|URINALYSIS|[?]|mV2/Hz|[?]|[?]|INVALID|1|min/day|1|1|[?]|ABNORMAL|SMEGMA|SOLIDIFIED||CHROMOGENIC ASSAY|CKD-EPI FORMULA||Y|U||2|Visit_2|25|7|TREATMENT|2020-09-19|2020-11-22|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|3dc16ad2-d49d-4fad-9823-d0197fb57a42|5|FRTNHC|Ferritin Heavy Chain|CHEMISTRY|||[?]|[?]|NEGATIVE|1|lx|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|CLOTTED||ELISA|CKD-EPI CYSTATIN C FORMULA|||N|Y|3|Visit_3|40|1|TREATMENT|2020-10-04|2020-11-18|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|3dc16ad2-d49d-4fad-9823-d0197fb57a42|6|MMP7|Matrix Metalloproteinase 7|HEMATOLOGY|[?]|cm H2O|[?]|[?]|NEGATIVE|1|MPS U|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|CONCENTRATED||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|NASH FIBROSURE FORMULA|||U||3|Visit_3|40|2|WASHOUT|2020-10-04|2020-11-03|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|3dc16ad2-d49d-4fad-9823-d0197fb57a42|7|INCLBRBC|Erythrocyte Inclusion Bodies|HEMATOLOGY|[?]|MET*h|[?]|[?]|BORDERLINE|1|cd*s/m2|1|1|[?]|ABNORMAL|CALCULUS|AUTOLYZED||DOPPLER ULTRASOUND|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2020-10-29|2020-11-09|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|3dc16ad2-d49d-4fad-9823-d0197fb57a42|8|ISG15|Ubiquitin-Like Protein ISG15|HEMATOLOGY|[?]|nmol/L/h|[?]|[?]|NEGATIVE|1|umol/mg/min|1|1|[?]|NORMAL|ADIPOSE TISSUE|HEMOLYZED||FLUOROSCOPY|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|5|TREATMENT|2020-10-29|2020-11-14|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|3dc16ad2-d49d-4fad-9823-d0197fb57a42|9|CYSCREAT|Cystatin C/Creatinine|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mol/day|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|LACTESCENT||DIFFUSION TENSOR MRI|HEPASCORE FORMULA||Y|Y|Y|5|Visit_5|90|3|SCREENING|2020-11-23|2020-11-25|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|3dc16ad2-d49d-4fad-9823-d0197fb57a42|10|VLDL3|VLDL Cholesterol Subtype 3|CHEMISTRY|[?]|ft3|[?]|[?]|INDETERMINATE|1|HOMEOPATHIC DILUTION|1|1|[?]|ABNORMAL|PLEURAL TISSUE|ICTERIC||ELECTRICAL IMPEDANCE MYOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-11-23|2020-11-26|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|7c244128-0508-422f-88ba-ecce68cec054|1|LEU|Leucine|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|uCi|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|FRESH|N|ACRIDINE ORANGE STAIN|COCKCROFT-GAULT FORMULA|||U|Y|1|Visit_1|10|2|SCREENING|2020-08-05|2020-08-14|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|7c244128-0508-422f-88ba-ecce68cec054|2|AMA|Antimitochondrial Antibodies|HEMATOLOGY|[?]|MET|[?]|[?]|INDETERMINATE|1|10^4/hpf|1|1|[?]|LOW|CORD BLOOD|CONCENTRATED||NEXT GENERATION TARGETED SEQUENCING|ASH FIBROSURE FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-08-05|2020-09-26|10|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|7c244128-0508-422f-88ba-ecce68cec054|3|LKM1IAAB|Liver Kidney Microsomal Type 1 IgA Ab|URINALYSIS|[?]|U/g Hb|[?]|[?]|TRACE|1|mmol2/L2|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|ROOM TEMPERATURE||MICROBIAL CULTURE, LIQUID|MDRD 6 VARIABLE FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-08-20|2020-09-23|25|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|LB|7c244128-0508-422f-88ba-ecce68cec054|4|C165904|Tree Mix Pollen IgG AB RAST Score|CHEMISTRY|[?]|mL/animal/day|[?]|[?]|INDETERMINATE|1|gMFI|1|1|[?]|HIGH|PLEURAL FLUID|ROOM TEMPERATURE||BAC ACGH|MDRD 5 VARIABLE FORMULA|||NA||2|Visit_2|25|4|FOLLOW-UP|2020-08-20|2020-08-23|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|LB|7c244128-0508-422f-88ba-ecce68cec054|5|LEIM|Immature Leukocytes|HEMATOLOGY|[?]|um/s|[?]|[?]|POSITIVE|1|log10 CFU/g|1|1|[?]|HIGH|SEMEN|AUTOLYZED||HANSEL STAIN|MDRD ENZYMATIC FORMULA||Y|Y||3|Visit_3|40|2|TREATMENT|2020-09-04|2020-09-18|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|7c244128-0508-422f-88ba-ecce68cec054|6|CHCM|Corpuscular HGB Concentration Mean|URINALYSIS|[?]|mL/kg|[?]|[?]|POSITIVE|1|L/h/m2|1|1|[?]|NORMAL|SMEGMA|NON-HEMOLYZED||BALLPOINT PEN TECHNIQUE|GMI % FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-09-04|2020-10-20|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|7c244128-0508-422f-88ba-ecce68cec054|7|C165878|German Cockroach IgE AB RAST Score|HEMATOLOGY|[?]|10^3 organisms/g|[?]|[?]|POSITIVE|1|kV|1|1|[?]|LOW|ENDOMETRIAL TISSUE|HEMOLYZED|N|POTENTIOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||4|Visit_4|65|6|TREATMENT|2020-09-29|2020-10-22|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|7c244128-0508-422f-88ba-ecce68cec054|8|STBSEXCS|Standard Base Excess|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Gauss|1|1|[?]|ABNORMAL|SEBUM|UNEXPECTED ODOR||THIN SMEAR|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|4|Visit_4|65|6|TREATMENT|2020-09-29|2020-10-27|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|7c244128-0508-422f-88ba-ecce68cec054|9|ENA78|Epith Neutrophil-Activating Peptide 78|CHEMISTRY|[?]|log10 CCID 50/dose|[?]|[?]|INDETERMINATE|1|/100 HPFs|1|1|[?]|NORMAL|PUS|DRIED||MULTIPLE BREATH WASHOUT|COCKCROFT-GAULT FORMULA|Y||N||5|Visit_5|90|5|FOLLOW-UP|2020-10-24|2020-10-31|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|7c244128-0508-422f-88ba-ecce68cec054|10|GFRBSCRT|GFR from Creatinine Adjusted for BSA|CHEMISTRY|||[?]|[?]|BORDERLINE|1|L/L|1|1|[?]|HIGH|ADIPOSE TISSUE|HEMOLYZED||PHASE CONTRAST MICROSCOPY|MDRD 4 VARIABLE FORMULA|||N|Y|5|Visit_5|90|6|SCREENING|2020-10-24|2020-11-02|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|247814c7-9fb3-43f2-9e0a-db70b27b3d95|1|HVA|Homovanillic Acid|CHEMISTRY|[?]|EU|[?]|[?]|NEGATIVE|1|ukat/10^12 RBC|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|CONCENTRATED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|CKD-EPI FORMULA||Y|U||1|Visit_1|10|2|SCREENING|2020-12-16|2021-02-25|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|247814c7-9fb3-43f2-9e0a-db70b27b3d95|2|TNFSR2|Soluble TNF Receptor Type II|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mmol/min/kPa/L|1|1|[?]|NORMAL|VITREOUS HUMOR|LIPEMIC||FLUORIMETRY|MDRD 4 VARIABLE FORMULA|Y||N|Y|1|Visit_1|10|7|TREATMENT|2020-12-16|2021-02-13|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|247814c7-9fb3-43f2-9e0a-db70b27b3d95|3|TSI|Thyroid Stimulating Immunoglobulin|CHEMISTRY|[?]|atm|[?]|[?]|BORDERLINE|1|DIP|1|1|[?]|NORMAL|SALIVA|NON-HEMOLYZED||TRIPLE-PHASE SPIRAL CT SCAN|CKD-EPI CYSTATIN C FORMULA|Y|Y|N||2|Visit_2|25|6|TREATMENT|2020-12-31|2021-01-19|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|247814c7-9fb3-43f2-9e0a-db70b27b3d95|4|DENSITY|Density|CHEMISTRY|||[?]|[?]|INVALID|1|nmol/kg/day|1|1|[?]|HIGH|DERMAL TISSUE|FROZEN||SIZE EXCLUSION CHROMATOGRAPHY|MDRD 4 VARIABLE FORMULA|Y||NA|Y|2|Visit_2|25|2|SCREENING|2020-12-31|2021-02-25|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|247814c7-9fb3-43f2-9e0a-db70b27b3d95|5|VITK|Vitamin K|CHEMISTRY|[?]|10^3 CFU|[?]|[?]|TRACE|1|PIPE|1|1|[?]|HIGH|SALIVA|LACTESCENT|N|DIFFUSION WEIGHTED MRI|MDRD ENZYMATIC JAPANESE FORMULA|||N||3|Visit_3|40|4|FOLLOW-UP|2021-01-15|2021-03-01|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|247814c7-9fb3-43f2-9e0a-db70b27b3d95|6|PGAG|Platelet-Granulocyte Agg|CHEMISTRY|||[?]|[?]|NEGATIVE|1|IMPLANT|1|1|[?]|NORMAL|INFRANATANT, PLASMA|HEMOLYZED|N|HEMAGGLUTINATION INHIBITION ASSAY|FIBROTEST FORMULA||Y|U|Y|3|Visit_3|40|3|FOLLOW-UP|2021-01-15|2021-01-29|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|247814c7-9fb3-43f2-9e0a-db70b27b3d95|7|LYMVAC|Vacuolated Lymphocytes|URINALYSIS|[?]|10^6 IU/mL|[?]|[?]|INDETERMINATE|1|log10 IU/mL|1|1|[?]|LOW|AQUEOUS HUMOR|PARAFFIN-EMBEDDED||SPECT/CT SCAN|MDRD 4 VARIABLE FORMULA|||N||4|Visit_4|65|4|SCREENING|2021-02-09|2021-02-26|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|247814c7-9fb3-43f2-9e0a-db70b27b3d95|8|IMMGLCFR|Immunoglobulin Light Chains, Free|HEMATOLOGY|[?]|mEq/L|[?]|[?]|INVALID|1|MET*h|1|1|[?]|NORMAL|SKIN TISSUE|ICTERIC||SURFACE PLASMON RESONANCE|GMI % FORMULA|Y||N||4|Visit_4|65|2|WASHOUT|2021-02-09|2021-02-27|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|247814c7-9fb3-43f2-9e0a-db70b27b3d95|9|TGFB2|Transforming Growth Factor Beta 2|URINALYSIS|[?]|nmol/L/min|[?]|[?]|INVALID|1|Tbsp|1|1|[?]|NORMAL|SYNOVIAL FLUID|CONTAMINATED||PERIODIC ACID SCHIFF STAIN|COCKCROFT-GAULT FORMULA|||N||5|Visit_5|90|3|TREATMENT|2021-03-06|2021-03-15|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|247814c7-9fb3-43f2-9e0a-db70b27b3d95|10|ANAB|Anti-Neutrophil Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|uIU/dL|1|1|[?]|ABNORMAL|LUNG SURFACTANT|FRESH|N|ANGIOGRAPHY|MDRD FORMULA|Y||Y|Y|5|Visit_5|90|1|TREATMENT|2021-03-06|2021-03-14|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|e870fe2f-b08c-41d9-a672-07da09fe2b99|1|BLEEDT|Bleeding Time|URINALYSIS|[?]|mg/day|[?]|[?]|BORDERLINE|1|DRUM|1|1|[?]|HIGH|MECONIUM|DRIED|N|CONTRAST ENHANCED SPIRAL CT SCAN|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-08-12|2020-11-06|10|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|e870fe2f-b08c-41d9-a672-07da09fe2b99|2|FGF23|Fibroblast Growth Factor 23|URINALYSIS|[?]|U/mmol|[?]|[?]|POSITIVE|1|%(w/w)|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|PARAFFIN-EMBEDDED||HEMATOXYLIN AND EOSIN STAIN|COCKCROFT-GAULT FORMULA||Y|U||1|Visit_1|10|2|TREATMENT|2020-08-12|2020-09-11|10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|e870fe2f-b08c-41d9-a672-07da09fe2b99|3|CHOLOH4B|4-Beta-Hydroxycholesterol|CHEMISTRY|[?]|POUCH|[?]|[?]|POSITIVE|1|uV2|1|1|[?]|ABNORMAL|BASAL TEAR|LACTESCENT|N|SPIROMETRY|HEPASCORE FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-08-27|2020-09-18|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|LB|e870fe2f-b08c-41d9-a672-07da09fe2b99|4|NKCEFUNC|Natural Killer Cell Function|URINALYSIS|[?]|Watt|[?]|[?]|TRACE|1|10^3/hpf|1|1|[?]|HIGH|VITREOUS HUMOR|SOLIDIFIED||OPTICAL MAPPING|CKD-EPI FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2020-08-27|2020-10-05|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|LB|e870fe2f-b08c-41d9-a672-07da09fe2b99|5|CCPAB|Cyclic Citrullinated Peptide Antibody|URINALYSIS|[?]|PFU/mL|[?]|[?]|BORDERLINE|1|ug/cm2|1|1|[?]|NORMAL|WHITE MATTER TISSUE|THAWED|N|ANTIBIOTIC AGAR SCREEN|COCKCROFT-GAULT FORMULA|Y||N||3|Visit_3|40|1|SCREENING|2020-09-11|2020-10-06|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|e870fe2f-b08c-41d9-a672-07da09fe2b99|6|CORTFR|Cortisol, Free|URINALYSIS|[?]|Absorbance U/min|[?]|[?]|TRACE|1|L/h|1|1|[?]|ABNORMAL|BREAST MILK|SOLIDIFIED|N|MANUAL COUNT|MDRD 4 VARIABLE FORMULA|Y||U||3|Visit_3|40|2|TREATMENT|2020-09-11|2020-10-09|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|e870fe2f-b08c-41d9-a672-07da09fe2b99|7|C5FR|Complement C5, Free|URINALYSIS|[?]|PFU/mL|[?]|[?]|NEGATIVE|1|U/m2/h|1|1|[?]|HIGH|BASAL TEAR|LACTESCENT|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|U||4|Visit_4|65|6|TREATMENT|2020-10-06|2020-10-31|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|LB|e870fe2f-b08c-41d9-a672-07da09fe2b99|8|PSAF|Prostate Specific Antigen, Free|HEMATOLOGY|[?]|ug/L DDU|[?]|[?]|BORDERLINE|1|10^6 organisms|1|1|[?]|ABNORMAL|CELL PELLET|CALCIFIED||DUCTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|3|TREATMENT|2020-10-06|2020-10-10|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|LB|e870fe2f-b08c-41d9-a672-07da09fe2b99|9|RP3IGGAB|RNA Polymerase III IgG Antibody|CHEMISTRY|[?]|kPa|[?]|[?]|BORDERLINE|1|10^6 CFU/mL|1|1|[?]|HIGH|LUNG SURFACTANT|FRESH|N|RADIAL IMMUNODIFFUSION|MDRD FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-10-31|2020-11-07|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|e870fe2f-b08c-41d9-a672-07da09fe2b99|10|INCLBRBC|Erythrocyte Inclusion Bodies|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|CAN|1|1|[?]|LOW|SEMINAL FLUID|NON-HEMOLYZED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI FORMULA|Y|Y|Y|Y|5|Visit_5|90|5|TREATMENT|2020-10-31|2020-11-09|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|32979638-fb88-4cbb-a110-a4d2016e9bc5|1|FXIVAAC|Factor XIV Activity Actual/Control|CHEMISTRY|[?]|mL/s/m2|[?]|[?]|TRACE|1|mgEq|1|1|[?]|ABNORMAL|URINE SEDIMENT|SOLIDIFIED|N|SLIT LAMP PHOTOGRAPHY|FIBROSIS 4 FORMULA|Y||Y||1|Visit_1|10|3|FOLLOW-UP|2020-07-15|2020-09-10|10|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|32979638-fb88-4cbb-a110-a4d2016e9bc5|2|C165914|Cat Dander IgG AB RAST Score|URINALYSIS|||[?]|[?]|POSITIVE|1|SBE/mL|1|1|[?]|ABNORMAL|DERMAL TISSUE|PARAFFIN-EMBEDDED||LIGHT MICROSCOPY|NASH FIBROSURE FORMULA|||Y|Y|1|Visit_1|10|1|SCREENING|2020-07-15|2020-09-12|10|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|32979638-fb88-4cbb-a110-a4d2016e9bc5|3|C130143|German Cockroach Antigen IgG4 Antibody|URINALYSIS|[?]|POUCH|[?]|[?]|INDETERMINATE|1|tsp eq|1|1|[?]|NORMAL|SPERMATOZOON|FROZEN||CONFOCAL MICROSCOPY|GMI MMOL/MOL FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2020-07-30|2020-09-06|25|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|32979638-fb88-4cbb-a110-a4d2016e9bc5|4|C165914|Cat Dander IgG AB RAST Score|CHEMISTRY|[?]|mOsm/L|[?]|[?]|TRACE|1|ug/kg|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|LIPEMIC||THIN SMEAR|FIBROSIS 4 FORMULA|Y||Y||2|Visit_2|25|3|FOLLOW-UP|2020-07-30|2020-09-19|25|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|32979638-fb88-4cbb-a110-a4d2016e9bc5|5|FENTANYL|Fentanyl|URINALYSIS|||[?]|[?]|BORDERLINE|1|uV2|1|1|[?]|LOW|PROSTATIC FLUID|DRIED||AUSCULTATION|GMI % FORMULA|Y||N|Y|3|Visit_3|40|7|TREATMENT|2020-08-14|2020-09-17|40|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|32979638-fb88-4cbb-a110-a4d2016e9bc5|6|MECONIUM|Meconium|HEMATOLOGY|[?]|ug/mL/h|[?]|[?]|INVALID|1|nL|1|1|[?]|NORMAL|LEUKOCYTE|HEMOLYZED||PHOTOMETRIC CLOT DETECTION|FIBROMETER FORMULA|Y||U||3|Visit_3|40|7|TREATMENT|2020-08-14|2020-09-22|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|32979638-fb88-4cbb-a110-a4d2016e9bc5|7|INSLNFR|Insulin, Free|URINALYSIS|[?]|foz_br|[?]|[?]|POSITIVE|1|/ms|1|1|[?]|HIGH|RETICULOCYTES|UNEXPECTED ODOR||HPLC/IEX|FIBROSIS 4 FORMULA|||NA||4|Visit_4|65|3|TREATMENT|2020-09-08|2020-09-11|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|32979638-fb88-4cbb-a110-a4d2016e9bc5|8|CA1AG|Cancer Antigen 1|HEMATOLOGY|[?]|log10 TCID 50/mL|[?]|[?]|INDETERMINATE|1|OD Unit|1|1|[?]|ABNORMAL|NAIL|GELLED||NUCLEIC ACID HYBRIDIZATION|MDRD ENZYMATIC JAPANESE FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2020-09-08|2020-09-27|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|32979638-fb88-4cbb-a110-a4d2016e9bc5|9|BLASTRUB|Rubriblast|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|nm|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|ROOM TEMPERATURE||AURAMINE STAIN|NASH FIBROSURE FORMULA|||NA|Y|5|Visit_5|90|5|FOLLOW-UP|2020-10-03|2020-10-08|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|32979638-fb88-4cbb-a110-a4d2016e9bc5|10|CDT|Carbohydrate-Deficient Transferrin|URINALYSIS|[?]|log10 PFU|[?]|[?]|POSITIVE|1|ELISA unit/dose|1|1|[?]|NORMAL|AQUEOUS HUMOR|SOLIDIFIED||AUDIOMETRY|CKD-EPI CREATININE FORMULA||Y|U||5|Visit_5|90|5|FOLLOW-UP|2020-10-03|2020-10-04|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|39b8db88-810b-4402-9ca3-c2bab1939c1c|1|EOS|Eosinophils|CHEMISTRY|[?]|in|[?]|[?]|NEGATIVE|1|mU|1|1|[?]|LOW|DERMAL TISSUE|AGGLUTINATED||FLUORESCEIN STAIN|GMI % FORMULA|Y||Y||1|Visit_1|10|3|SCREENING|2020-11-15|2021-01-28|10|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|39b8db88-810b-4402-9ca3-c2bab1939c1c|2|UREANCRT|Urea Nitrogen/Creatinine|CHEMISTRY|[?]|cmH2O*s/mL|[?]|[?]|INDETERMINATE|1|mJoule/cm2|1|1|[?]|ABNORMAL|PERITONEAL FLUID|FRESH||THIN SMEAR|ASH FIBROSURE FORMULA|Y||N||1|Visit_1|10|4|SCREENING|2020-11-15|2021-01-18|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|39b8db88-810b-4402-9ca3-c2bab1939c1c|3|CCL19|Chemokine (C-C Motif) Ligand 19|URINALYSIS|[?]|breaths/30s|[?]|[?]|INVALID|1|MBq/uL|1|1|[?]|HIGH|AMNIOTIC FLUID|THAWED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|GMI MMOL/MOL FORMULA|Y||Y||2|Visit_2|25|4|SCREENING|2020-11-30|2020-12-08|25|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|LB|39b8db88-810b-4402-9ca3-c2bab1939c1c|4|C165910|Bee Mix IgG AB RAST Score|CHEMISTRY|[?]|mL/min/mmHg|[?]|[?]|INDETERMINATE|1|copies/uL|1|1|[?]|ABNORMAL|LOCHIA|FROZEN|N|ELECTROGASTROGRAPHY|GMI % FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-11-30|2021-02-11|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|LB|39b8db88-810b-4402-9ca3-c2bab1939c1c|5|FAT|Fat|URINALYSIS|[?]|nCi|[?]|[?]|NEGATIVE|1|ms2|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|FROZEN||GIEMSA STAIN|HEPASCORE FORMULA|||Y||3|Visit_3|40|6|FOLLOW-UP|2020-12-15|2021-01-29|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|39b8db88-810b-4402-9ca3-c2bab1939c1c|6|NTELOP|N-telopeptide|URINALYSIS|||[?]|[?]|NEGATIVE|1|nCi|1|1|[?]|HIGH|PLEURAL FLUID|AGGLUTINATED||CONGO RED STAIN|ASH FIBROSURE FORMULA|||N|Y|3|Visit_3|40|6|TREATMENT|2020-12-15|2020-12-18|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|39b8db88-810b-4402-9ca3-c2bab1939c1c|7|GALANIN|Galanin|HEMATOLOGY|[?]|tsp eq|[?]|[?]|NEGATIVE|1|uCi/kg|1|1|[?]|HIGH|PLATELET RICH PLASMA|UNEXPECTED ODOR|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|HEPASCORE FORMULA||Y|U||4|Visit_4|65|2|FOLLOW-UP|2021-01-09|2021-01-19|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|39b8db88-810b-4402-9ca3-c2bab1939c1c|8|OXACREAT|Oxalate/Creatinine|URINALYSIS|[?]|cpm|[?]|[?]|POSITIVE|1|10^9 CFU/g|1|1|[?]|NORMAL|ADIPOSE TISSUE|AGGLUTINATED||DIGITAL PCR|FIBROTEST FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2021-01-09|2021-01-16|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|39b8db88-810b-4402-9ca3-c2bab1939c1c|9|C130085|English Plantain Pollen IgA|HEMATOLOGY|[?]|Log10 ELISA unit/dose|[?]|[?]|POSITIVE|1|CAPLET|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|AGGLUTINATED||SISH|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2021-02-03|2021-02-06|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|39b8db88-810b-4402-9ca3-c2bab1939c1c|10|OSM|Oncostatin M|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|/100 WBC|1|1|[?]|HIGH|MIXED VENOUS BLOOD|FROZEN||ANTIMICROBIAL COMBINATION TESTING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|5|Visit_5|90|7|WASHOUT|2021-02-03|2021-02-08|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|1|FEP|Erythrocyte Protoporphyrin, Free|URINALYSIS|[?]|ug/m2|[?]|[?]|NEGATIVE|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|STOOL|LIPEMIC||NUCLEAR RADIOLOGY|MDRD FORMULA|Y||U||1|Visit_1|10|5|SCREENING|2020-07-27|2020-10-09|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|2|CALPRO|Calprotectin|HEMATOLOGY|[?]|IU/mL|[?]|[?]|BORDERLINE|1|BAG|1|1|[?]|NORMAL|PLATELET RICH PLASMA|ICTERIC||CHROMATOGRAPHY|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-07-27|2020-08-05|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|3|PLTLPLT|Large Platelets/Total Platelets|HEMATOLOGY|[?]|Arbitrary U|[?]|[?]|INDETERMINATE|1|Bq/mL|1|1|[?]|HIGH|INFRANATANT, SERUM|AUTOLYZED|N|SLOAN LETTER EYE CHART 2.5%|COCKCROFT-GAULT FORMULA|Y||U||2|Visit_2|25|6|FOLLOW-UP|2020-08-11|2020-10-20|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|4|VLDL|VLDL Cholesterol|HEMATOLOGY|||[?]|[?]|TRACE|1|mEq/dL|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|ROOM TEMPERATURE||SNELLEN EYE CHART|FIBROMETER FORMULA||Y|NA|Y|2|Visit_2|25|3|TREATMENT|2020-08-11|2020-08-12|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|5|KLCLLCFR|Kappa Lt Chain,Free/Lambda Lt Chain,Free|CHEMISTRY|[?]|AFU|[?]|[?]|BORDERLINE|1|SCOOPFUL|1|1|[?]|LOW|TUMOR TISSUE|SOLIDIFIED|N|IMMUNOPRECIPITATION|FIBROTEST FORMULA||Y|NA||3|Visit_3|40|5|TREATMENT|2020-08-26|2020-09-11|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|6|FVIIAAC|Factor VII Activity Actual/Control|URINALYSIS|[?]|kPa|[?]|[?]|BORDERLINE|1|g/animal|1|1|[?]|ABNORMAL|BONE MARROW|DRIED|N|MULTI-SLICE SPIRAL CT|HEPASCORE FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-08-26|2020-10-20|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|7|LYMCE|Lymphocytes/Total Cells|URINALYSIS|[?]|STRIP|[?]|[?]|INVALID|1|g|1|1|[?]|ABNORMAL|CORD SERUM|FROZEN||CAPILLARY ELECTROPHORESIS|MDRD ENZYMATIC FORMULA|Y||NA||4|Visit_4|65|7|TREATMENT|2020-09-20|2020-10-15|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|8|ALPBALP|Alk Phos, Bone/Total Alk Phos|HEMATOLOGY|[?]|ug/mol|[?]|[?]|NEGATIVE|1|10^3 organisms/mL|1|1|[?]|ABNORMAL|SMEGMA|LACTESCENT|N|OSCILLOMETRY|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|7|SCREENING|2020-09-20|2020-09-25|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|9|GDA|Guanine Deaminase|HEMATOLOGY|||[?]|[?]|TRACE|1|COAT|1|1|[?]|LOW|EMESIS|NON-HEMOLYZED||IHC|NASH FIBROSURE FORMULA|Y|Y|NA|Y|5|Visit_5|90|6|SCREENING|2020-10-15|2020-10-16|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|10|MCVRETIC|MCV Reticulocytes|CHEMISTRY|[?]|deg2|[?]|[?]|BORDERLINE|1|POINT|1|1|[?]|LOW|BILE|FROZEN||CORONARY ANGIOGRAPHY|FIBROTEST FORMULA||Y|N||5|Visit_5|90|4|TREATMENT|2020-10-15|2020-10-21|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|bca1f50d-04e6-46f5-afb3-e48aaea1069d|1|C165911|Dairy Mix IgG AB RAST Score|HEMATOLOGY|[?]|mL/m2/day|[?]|[?]|POSITIVE|1|pmol|1|1|[?]|NORMAL|ISOLATE|DRIED|N|POLYSOMNOGRAPHY|MDRD 6 VARIABLE FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-11-03|2020-12-25|10|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|bca1f50d-04e6-46f5-afb3-e48aaea1069d|2|MCPHGCE|Macrophages/Total Cells|URINALYSIS|[?]|mg|[?]|[?]|TRACE|1|ug|1|1|[?]|ABNORMAL|VENOUS BLOOD|CONCENTRATED||JAFFE REACTION|FIBROMETER FORMULA||Y|NA||1|Visit_1|10|4|TREATMENT|2020-11-03|2020-12-10|10|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|bca1f50d-04e6-46f5-afb3-e48aaea1069d|3|INTLK2|Interleukin 2|HEMATOLOGY|||[?]|[?]|TRACE|1|10^6 IU/mL|1|1|[?]|LOW|AQUEOUS HUMOR|ROOM TEMPERATURE||LC-FL|GMI MMOL/MOL FORMULA|||U|Y|2|Visit_2|25|4|FOLLOW-UP|2020-11-18|2021-01-28|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|bca1f50d-04e6-46f5-afb3-e48aaea1069d|4|HDWR|Ret Hemoglobin Distribution Width|HEMATOLOGY|[?]|mL/m2|[?]|[?]|INVALID|1|Watt|1|1|[?]|HIGH|COLOSTRUM|CALCIFIED||COLORIMETRY|FIBROTEST FORMULA|||N||2|Visit_2|25|6|SCREENING|2020-11-18|2021-01-14|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|bca1f50d-04e6-46f5-afb3-e48aaea1069d|5|ALTCPHRL|Alpha Tocopherol|HEMATOLOGY|[?]|LOZENGE|[?]|[?]|NEGATIVE|1|s/h|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|AUTOLYZED||MICROBIAL BIOCHEMICAL IDENTIFICATION|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|4|TREATMENT|2020-12-03|2020-12-09|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|bca1f50d-04e6-46f5-afb3-e48aaea1069d|6|CYAMORPH|Amorphous Crystals|CHEMISTRY|[?]|DPM|[?]|[?]|TRACE|1|dpm/mL|1|1|[?]|HIGH|PLASMA ULTRAFILTRATE|AGGLUTINATED||EIA|FIBROSIS 4 FORMULA|||U||3|Visit_3|40|1|TREATMENT|2020-12-03|2020-12-05|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|bca1f50d-04e6-46f5-afb3-e48aaea1069d|7|MUG|Murinoglobulin|CHEMISTRY|||[?]|[?]|INVALID|1|OD Unit|1|1|[?]|HIGH|BILE|SOLIDIFIED||ELECTROPHORESIS|GMI MMOL/MOL FORMULA|Y||Y|Y|4|Visit_4|65|3|SCREENING|2020-12-28|2021-01-18|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|bca1f50d-04e6-46f5-afb3-e48aaea1069d|8|CYDCPHOS|Dicalcium Phosphate Crystals|URINALYSIS|||[?]|[?]|BORDERLINE|1|fraction of 1|1|1|[?]|ABNORMAL|GASTRIC FLUID|AGGLUTINATED||PALPATION|FIBROMETER FORMULA|||N|Y|4|Visit_4|65|7|WASHOUT|2020-12-28|2021-01-04|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|bca1f50d-04e6-46f5-afb3-e48aaea1069d|9|ALBGLOB|Albumin/Globulin|URINALYSIS|||[?]|[?]|BORDERLINE|1|pt_br|1|1|[?]|NORMAL|LYMPH|AGGLUTINATED||ATOMIC ABSORPTION SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N|Y|5|Visit_5|90|6|SCREENING|2021-01-22|2021-01-24|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|bca1f50d-04e6-46f5-afb3-e48aaea1069d|10|GGT|Gamma Glutamyl Transferase|CHEMISTRY|[?]|cd|[?]|[?]|INVALID|1|Bq/kg|1|1|[?]|LOW|CAPILLARY BLOOD|PARAFFIN-EMBEDDED||RYAN BLUE STAIN|CKD-EPI FORMULA|Y|Y|N||5|Visit_5|90|5|WASHOUT|2021-01-22|2021-01-24|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|6bddadef-13fb-4fab-b281-aa33aa97aa8f|1|EOTAXIN2|Eotaxin-2|URINALYSIS|[?]|ug/dose|[?]|[?]|POSITIVE|1|mL/s/m2|1|1|[?]|HIGH|MENSTRUAL BLOOD|REFRIGERATED||HPLC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||1|Visit_1|10|6|TREATMENT|2020-05-24|2020-08-16|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|6bddadef-13fb-4fab-b281-aa33aa97aa8f|2|MSPIKEXR|Monoclonal Protein Spike Excretion Rate|CHEMISTRY|[?]|STEPS|[?]|[?]|INVALID|1|kg/mol|1|1|[?]|ABNORMAL|BONE MARROW|LIPEMIC|N|APPLANATION TONOMETRY|CKD-EPI CREATININE FORMULA||Y|U||1|Visit_1|10|1|SCREENING|2020-05-24|2020-08-07|10|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|6bddadef-13fb-4fab-b281-aa33aa97aa8f|3|NKCE|Natural Killer Cells|URINALYSIS|[?]|um2|[?]|[?]|INVALID|1|CIGAR|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|FRESH||FREEZING POINT DEPRESSION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|7|FOLLOW-UP|2020-06-08|2020-07-21|25|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|6bddadef-13fb-4fab-b281-aa33aa97aa8f|4|ANCPNCAB|Neutrophil Cytoplasmic Ab, Perinuclear|CHEMISTRY|[?]|MONTHS|[?]|[?]|NEGATIVE|1|STRIP|1|1|[?]|LOW|CIRCULATING TUMOR CELL|DRIED||ELISA|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||2|Visit_2|25|6|FOLLOW-UP|2020-06-08|2020-07-25|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|6bddadef-13fb-4fab-b281-aa33aa97aa8f|5|C165898|Birch Pollen IgG AB RAST Score|URINALYSIS|[?]|cd*s/m2|[?]|[?]|POSITIVE|1|foz_us|1|1|[?]|ABNORMAL|TISSUE|FRESH||TRYPAN BLUE STAIN|FIBROMETER FORMULA|||N||3|Visit_3|40|2|WASHOUT|2020-06-23|2020-07-27|40|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|6bddadef-13fb-4fab-b281-aa33aa97aa8f|6|GLOBA1|Alpha-1 Globulin|URINALYSIS|[?]|PIXELS/cm|[?]|[?]|INDETERMINATE|1|Coulomb|1|1|[?]|NORMAL|BONE MARROW|CONCENTRATED||CELLULAR PROLIFERATION ASSAY|MDRD FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-06-23|2020-07-30|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|LB|6bddadef-13fb-4fab-b281-aa33aa97aa8f|7|RANKL|Receptor Activator Nuclear KappaB Ligand|CHEMISTRY|||[?]|[?]|BORDERLINE|1|/VF|1|1|[?]|ABNORMAL|LYSATE|CONTAMINATED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|5|TREATMENT|2020-07-18|2020-08-02|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|LB|6bddadef-13fb-4fab-b281-aa33aa97aa8f|8|BURRCE|Burr Cells|URINALYSIS|||[?]|[?]|INDETERMINATE|1|deg/s|1|1|[?]|ABNORMAL|MUCUS|NON-HEMOLYZED||ANTIMICROBIAL COMBINATION TESTING|FIBROSIS 4 FORMULA||Y|Y|Y|4|Visit_4|65|4|WASHOUT|2020-07-18|2020-08-18|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|LB|6bddadef-13fb-4fab-b281-aa33aa97aa8f|9|ATHPIDX|Atherogenic Index of Plasma|URINALYSIS|[?]|SPRAY|[?]|[?]|TRACE|1|amp|1|1|[?]|ABNORMAL|TISSUE|CONCENTRATED||NUCLEIC ACID HYBRIDIZATION|FIBROSIS 4 FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2020-08-12|2020-08-15|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|6bddadef-13fb-4fab-b281-aa33aa97aa8f|10|GCHT|Glycocholate|HEMATOLOGY|||[?]|[?]|INVALID|1|/h|1|1|[?]|ABNORMAL|TRANSUDATE|AUTOLYZED||EEG|MDRD ENZYMATIC FORMULA|||U|Y|5|Visit_5|90|7|SCREENING|2020-08-12|2020-08-21|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|6edb7414-d8f4-44da-8483-504b93a7e705|1|PDL1S|Soluble Programmed Death Ligand 1|CHEMISTRY|[?]|MPL U|[?]|[?]|NEGATIVE|1|ug/kg/min|1|1|[?]|HIGH|BLOOD|CALCIFIED|N|GEL ELECTROPHORESIS|GMI % FORMULA|||U||1|Visit_1|10|3|FOLLOW-UP|2020-06-07|2020-08-01|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|LB|6edb7414-d8f4-44da-8483-504b93a7e705|2|CLARITY|Clarity|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mL/dL|1|1|[?]|HIGH|VENOUS CORD BLOOD|FRESH||SPECT/CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA|Y|1|Visit_1|10|3|FOLLOW-UP|2020-06-07|2020-07-27|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|LB|6edb7414-d8f4-44da-8483-504b93a7e705|3|NCCPTN|Nociceptin|HEMATOLOGY|[?]|mg/kg/week|[?]|[?]|POSITIVE|1|hr/day|1|1|[?]|HIGH|CORD SERUM|UNEXPECTED ODOR||CISH|MDRD 5 VARIABLE FORMULA||Y|U||2|Visit_2|25|4|WASHOUT|2020-06-22|2020-07-20|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|6edb7414-d8f4-44da-8483-504b93a7e705|4|EOSIMLE|Immature Eosinophils/Leukocytes|URINALYSIS|[?]|mmHg*min/L|[?]|[?]|INDETERMINATE|1|ug/kg/h|1|1|[?]|HIGH|REFLEX TEAR|AUTOLYZED||LIGHT MICROSCOPY|MDRD 4 VARIABLE FORMULA||Y|Y||2|Visit_2|25|5|FOLLOW-UP|2020-06-22|2020-08-26|25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|6edb7414-d8f4-44da-8483-504b93a7e705|5|GLN|Glutamine|CHEMISTRY|[?]|10^3/L|[?]|[?]|NEGATIVE|1|mL/h|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|ICTERIC||ELECTROCHEMILUMINESCENCE|HEPASCORE FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-07-07|2020-09-01|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|6edb7414-d8f4-44da-8483-504b93a7e705|6|INTLK26|Interleukin 26|HEMATOLOGY|[?]|MBP|[?]|[?]|NEGATIVE|1|Frames/s|1|1|[?]|NORMAL|GASTRIC FLUID|CONTAMINATED||AURAMINE STAIN|ASH FIBROSURE FORMULA||Y|Y||3|Visit_3|40|1|FOLLOW-UP|2020-07-07|2020-08-09|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|6edb7414-d8f4-44da-8483-504b93a7e705|7|ENDOSTN|Endostatin|URINALYSIS|[?]|WEEKS|[?]|[?]|BORDERLINE|1|uL/mL|1|1|[?]|LOW|ENDOMETRIAL TISSUE|NON-HEMOLYZED||GC/MS/MS|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|2|WASHOUT|2020-08-01|2020-08-06|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|LB|6edb7414-d8f4-44da-8483-504b93a7e705|8|MBP|Myelin Basic Protein|CHEMISTRY|[?]|DRINK|[?]|[?]|INDETERMINATE|1|DAYS|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|ICTERIC||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|GMI % FORMULA||Y|NA||4|Visit_4|65|6|FOLLOW-UP|2020-08-01|2020-09-03|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|LB|6edb7414-d8f4-44da-8483-504b93a7e705|9|ALPRZLM|Alprazolam|URINALYSIS|[?]|uOsm|[?]|[?]|NEGATIVE|1|Siemens|1|1|[?]|HIGH|ERYTHROCYTES|LACTESCENT||ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD 4 VARIABLE FORMULA|||Y||5|Visit_5|90|5|TREATMENT|2020-08-26|2020-08-30|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|LB|6edb7414-d8f4-44da-8483-504b93a7e705|10|CALB|Calbindin|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mg/kg/min|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED||HPLC/MS/MS|ASH FIBROSURE FORMULA|Y||U|Y|5|Visit_5|90|1|WASHOUT|2020-08-26|2020-08-29|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|LB|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|1|MASTCE|Mast Cells|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|PHERESIS UNIT|1|1|[?]|HIGH|CAPILLARY BLOOD|HEMOLYZED|N|MAPH|NASH FIBROSURE FORMULA|||N|Y|1|Visit_1|10|7|TREATMENT|2020-05-16|2020-05-31|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|2|HPOCROM|Hypochromia|URINALYSIS|[?]|cmol|[?]|[?]|POSITIVE|1|mL/sec/1.73m2|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|GELLED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|FIBROSIS 4 FORMULA|||U||1|Visit_1|10|5|FOLLOW-UP|2020-05-16|2020-06-24|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|3|FATACFRU|Free Fatty Acid, Unsaturated|CHEMISTRY|[?]|HEP|[?]|[?]|POSITIVE|1|mV2/Hz|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|THAWED||MICROBIAL CULTURE, SOLID|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|7|WASHOUT|2020-05-31|2020-06-17|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|LB|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|4|ETPTP|ETP Time to Peak|CHEMISTRY|[?]|PIXELS/in|[?]|[?]|BORDERLINE|1|ug/m2/min|1|1|[?]|LOW|LUNG SURFACTANT|THAWED||FLUORESCENT IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||2|Visit_2|25|1|WASHOUT|2020-05-31|2020-06-03|25|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|LB|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|5|ICAM1|Intercellular Adhesion Molecule 1|URINALYSIS|[?]|MAC50|[?]|[?]|INDETERMINATE|1|umol/h/mmol|1|1|[?]|ABNORMAL|GASTRIC FLUID|REFRIGERATED||ZIEHL NEELSEN ACID FAST STAIN|MDRD FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2020-06-15|2020-07-29|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|6|TOXVAC|Toxic Vacuolation|URINALYSIS|[?]|ug/g/min|[?]|[?]|NEGATIVE|1|mg/m2|1|1|[?]|HIGH|PLATELET|PARAFFIN-EMBEDDED|N|LAPAROSCOPY|GMI MMOL/MOL FORMULA|Y||N||3|Visit_3|40|3|WASHOUT|2020-06-15|2020-06-23|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|7|TNFR1|Tumor Necrosis Factor Receptor 1|CHEMISTRY|[?]|ms/mmHg|[?]|[?]|TRACE|1|uCi/kg|1|1|[?]|HIGH|CELL PELLET|THAWED||INFRARED SPECTROMETRY|CKD-EPI FORMULA|||NA||4|Visit_4|65|7|FOLLOW-UP|2020-07-10|2020-08-11|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|8|AMYLB38|Amyloid Beta 1-38|URINALYSIS|||[?]|[?]|INDETERMINATE|1|L/min/m2|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|SOLIDIFIED||MEDIASTINOSCOPY|CKD-EPI CYSTATIN C FORMULA|||Y|Y|4|Visit_4|65|5|SCREENING|2020-07-10|2020-07-29|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|9|IDLVLDL3|IDL+VLDL Cholesterol Subtype 3|URINALYSIS|[?]|ELISA unit/dose|[?]|[?]|INDETERMINATE|1|Bq/mL|1|1|[?]|HIGH|DISCHARGE|CONCENTRATED||SEQUENCING|ASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|6|TREATMENT|2020-08-04|2020-08-11|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|LB|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|10|B2MICG|Beta-2 Microglobulin|CHEMISTRY|[?]|log10 PFU|[?]|[?]|INVALID|1|CONTAINER|1|1|[?]|NORMAL|HAIR FOLLICLE|GELLED||PHYSICAL EXAMINATION|MDRD ENZYMATIC FORMULA|||NA||5|Visit_5|90|6|SCREENING|2020-08-04|2020-08-06|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|LB|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|1|SDH|Sorbitol Dehydrogenase|CHEMISTRY|[?]|ng/day|[?]|[?]|BORDERLINE|1|titer|1|1|[?]|NORMAL|VENOUS PLASMA|ROOM TEMPERATURE||SINGLE-MOLECULE ARRAY|ASH FIBROSURE FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-05-18|2020-08-02|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|LB|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|2|LYMVAC|Vacuolated Lymphocytes|HEMATOLOGY|[?]|Enzyme U/L|[?]|[?]|TRACE|1|ELISA unit|1|1|[?]|NORMAL|KERATINOCYTE|LIPEMIC||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 6 VARIABLE FORMULA|||Y||1|Visit_1|10|2|FOLLOW-UP|2020-05-18|2020-05-30|10|22|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|LB|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|3|CD13|CD13|URINALYSIS|[?]|cm/s|[?]|[?]|INDETERMINATE|1|s^-1(%O2)^-1|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|CONCENTRATED|N|HIGH RESOLUTION MELT ANALYSIS|MDRD FORMULA||Y|Y||2|Visit_2|25|2|TREATMENT|2020-06-02|2020-07-01|25|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|4|COPEP|Copeptin|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|ug/m2/min|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|LIPEMIC||JAFFE REACTION|FIBROTEST FORMULA|||U|Y|2|Visit_2|25|7|TREATMENT|2020-06-02|2020-08-14|25|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|5|C130083|Orchard Grass Pollen IgG4|HEMATOLOGY|||[?]|[?]|INVALID|1|mg/kg/h|1|1|[?]|HIGH|ISOLATE|PARAFFIN-EMBEDDED||MICROBIAL CONCENTRATION|MDRD 6 VARIABLE FORMULA|Y||N|Y|3|Visit_3|40|3|FOLLOW-UP|2020-06-17|2020-06-29|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|6|WBC|Leukocytes|HEMATOLOGY|[?]|kIU|[?]|[?]|NEGATIVE|1|ugEq|1|1|[?]|HIGH|EXUDATE|LACTESCENT||IMMUNOCHROMATOGRAPHY|GMI % FORMULA|||U||3|Visit_3|40|1|TREATMENT|2020-06-17|2020-06-29|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|7|LKM1IGAB|Liver Kidney Microsomal Type 1 IgG Ab|URINALYSIS|||[?]|[?]|INDETERMINATE|1|Ci/kg|1|1|[?]|HIGH|BUFFY COAT|CONTAMINATED||VIRUS PLAQUE ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|4|Visit_4|65|3|SCREENING|2020-07-12|2020-08-05|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|8|SCCAG|Squamous Cell Carcinoma Antigen|CHEMISTRY|[?]|mkat|[?]|[?]|BORDERLINE|1|ag|1|1|[?]|HIGH|LYMPH|CONTAMINATED|N|THIN SMEAR|MDRD 6 VARIABLE FORMULA||Y|U||4|Visit_4|65|5|TREATMENT|2020-07-12|2020-08-01|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|9|PKM2|Pyruvate Kinase Isozyme M2|CHEMISTRY|[?]|Linear ft*LB|[?]|[?]|NEGATIVE|1|mL/cm3/min|1|1|[?]|HIGH|EPIDERMAL TISSUE|CLOTTED||JAFFE REACTION|CKD-EPI CYSTATIN C FORMULA|||NA||5|Visit_5|90|2|FOLLOW-UP|2020-08-06|2020-08-07|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|LB|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|10|C165937|Zea mays IgE AB RAST Score|URINALYSIS|||[?]|[?]|BORDERLINE|1|CFU/mL|1|1|[?]|HIGH|BLOOD|DRIED||ULTRASOUND|COCKCROFT-GAULT FORMULA||Y|NA|Y|5|Visit_5|90|4|WASHOUT|2020-08-06|2020-08-14|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|LB|47d55e87-e559-424d-a6ad-d533a0d77f39|1|UDCA|Ursodeoxycholate|CHEMISTRY|[?]|dL|[?]|[?]|POSITIVE|1|ukat|1|1|[?]|HIGH|EPIDERMAL TISSUE|LIPEMIC|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|2|TREATMENT|2021-01-12|2021-02-10|10|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|47d55e87-e559-424d-a6ad-d533a0d77f39|2|UREAN|Urea Nitrogen|HEMATOLOGY|[?]|cpm|[?]|[?]|INDETERMINATE|1|10^6/g|1|1|[?]|LOW|SEBUM|FROZEN||CORONARY ANGIOGRAPHY|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|6|FOLLOW-UP|2021-01-12|2021-04-01|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|47d55e87-e559-424d-a6ad-d533a0d77f39|3|V25HD3|25-Hydroxyvitamin D3|URINALYSIS|[?]|mEq/mmol|[?]|[?]|NEGATIVE|1|Rad|1|1|[?]|HIGH|SKIN TISSUE|NON-HEMOLYZED||MICROBIAL CULTURE|CKD-EPI FORMULA||Y|NA||2|Visit_2|25|1|WASHOUT|2021-01-27|2021-04-02|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|LB|47d55e87-e559-424d-a6ad-d533a0d77f39|4|PLSIMCLY|Immature Plasma Cells/Lymphocytes|HEMATOLOGY|[?]|EVENTS|[?]|[?]|INVALID|1|uL/dose|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|DRIED||MYELOPEROXIDASE STAIN|MDRD ENZYMATIC FORMULA||Y|NA||2|Visit_2|25|5|WASHOUT|2021-01-27|2021-03-06|25|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|LB|47d55e87-e559-424d-a6ad-d533a0d77f39|5|ARA|Arachidonic Acid|URINALYSIS|[?]|ug|[?]|[?]|INDETERMINATE|1|rpm|1|1|[?]|LOW|PERSPIRATION|CONCENTRATED||EIA|FIBROMETER FORMULA|||U||3|Visit_3|40|4|TREATMENT|2021-02-11|2021-03-25|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|47d55e87-e559-424d-a6ad-d533a0d77f39|6|CBANH9|Carbonic Anhydrase 9|URINALYSIS|[?]|10^9 CFU/g|[?]|[?]|NEGATIVE|1|10^3 CFU/mL|1|1|[?]|NORMAL|CERUMEN|LIPEMIC||GC/MS|GMI MMOL/MOL FORMULA|||U||3|Visit_3|40|4|FOLLOW-UP|2021-02-11|2021-03-23|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|47d55e87-e559-424d-a6ad-d533a0d77f39|7|GFR|Glomerular Filtration Rate|URINALYSIS|[?]|ng|[?]|[?]|BORDERLINE|1|mEq/dL|1|1|[?]|LOW|SUPERNATANT, PLASMA|SOLIDIFIED||TRIPLE-PHASE MRI SCAN|GMI MMOL/MOL FORMULA|Y||U||4|Visit_4|65|5|WASHOUT|2021-03-08|2021-03-10|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|47d55e87-e559-424d-a6ad-d533a0d77f39|8|PAPPEN|Pappenheimer Bodies|URINALYSIS|[?]|ug/L DDU|[?]|[?]|NEGATIVE|1|tuberculin unit|1|1|[?]|ABNORMAL|BLOOD|CLOTTED|N|SXA SCAN|GMI MMOL/MOL FORMULA||Y|N||4|Visit_4|65|4|TREATMENT|2021-03-08|2021-03-10|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|LB|47d55e87-e559-424d-a6ad-d533a0d77f39|9|CENTROAB|Centromere B Antibodies|URINALYSIS|[?]|mg/kg/dose|[?]|[?]|INVALID|1|SFC/10^6 PBMC|1|1|[?]|NORMAL|SOFT TISSUE|DRIED||PHYSICAL EXAMINATION|GMI % FORMULA|||Y||5|Visit_5|90|6|TREATMENT|2021-04-02|2021-04-06|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|47d55e87-e559-424d-a6ad-d533a0d77f39|10|IFI27|Interferon Alpha-Inducible Protein 27|CHEMISTRY|[?]|U/m2/day|[?]|[?]|INVALID|1|Gy/min|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|CONTAMINATED||REBOUND TONOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||5|Visit_5|90|5|WASHOUT|2021-04-02|2021-04-06|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|f89c08df-2e24-4c97-a451-1980cecebf14|1|PLATAGGR|Platelet Aggregation|URINALYSIS|[?]|PELLET|[?]|[?]|TRACE|1|Gauss|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|PARAFFIN-EMBEDDED||IODINE STAIN|FIBROMETER FORMULA|||N||1|Visit_1|10|3|FOLLOW-UP|2020-12-18|2021-01-13|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|LB|f89c08df-2e24-4c97-a451-1980cecebf14|2|GLUC|Glucose|HEMATOLOGY|[?]|nCi|[?]|[?]|TRACE|1|log10 CCID 50/dose|1|1|[?]|LOW|HAIR|ROOM TEMPERATURE||GC/MS/MS|CKD-EPI CYSTATIN C FORMULA|||U||1|Visit_1|10|1|TREATMENT|2020-12-18|2021-02-08|10|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|LB|f89c08df-2e24-4c97-a451-1980cecebf14|3|FRFEABS|Fractional Iron Absorption|HEMATOLOGY|[?]|AU/mL|[?]|[?]|TRACE|1|uIU/L|1|1|[?]|ABNORMAL|MECONIUM|CLOTTED||DISK DIFFUSION|GMI % FORMULA|||U||2|Visit_2|25|2|FOLLOW-UP|2021-01-02|2021-01-23|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|f89c08df-2e24-4c97-a451-1980cecebf14|4|ESTRIOLF|Estriol, Free|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mL/breath|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|CALCIFIED||WRIGHT-GIEMSA STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|2|Visit_2|25|4|TREATMENT|2021-01-02|2021-02-19|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|f89c08df-2e24-4c97-a451-1980cecebf14|5|HAMAB|Human Anti-Mouse Antibody|URINALYSIS|[?]|nmol BCE/L|[?]|[?]|BORDERLINE|1|mEq/mL|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|DRIED|N|INDIA INK STAIN|GMI MMOL/MOL FORMULA|Y||N||3|Visit_3|40|6|TREATMENT|2021-01-17|2021-02-28|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|f89c08df-2e24-4c97-a451-1980cecebf14|6|CSGRANC|Granular Coarse Casts|URINALYSIS|[?]|%/s|[?]|[?]|POSITIVE|1|log EID 50/dose|1|1|[?]|LOW|EXPIRED AIR|CALCIFIED||DISK DIFFUSION|MDRD 5 VARIABLE FORMULA|||N||3|Visit_3|40|1|TREATMENT|2021-01-17|2021-02-11|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|f89c08df-2e24-4c97-a451-1980cecebf14|7|GLOBA|Alpha Globulin|HEMATOLOGY|||[?]|[?]|TRACE|1|Coulomb|1|1|[?]|ABNORMAL|LYMPH|LIPEMIC|N|TRICHROME STAIN|GMI % FORMULA||Y|NA|Y|4|Visit_4|65|4|TREATMENT|2021-02-11|2021-02-18|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|LB|f89c08df-2e24-4c97-a451-1980cecebf14|8|LDH1|LDH Isoenzyme 1|URINALYSIS|[?]|m/sec|[?]|[?]|BORDERLINE|1|deg|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|AUTOLYZED||MYELOPEROXIDASE STAIN|GMI % FORMULA|||Y||4|Visit_4|65|7|TREATMENT|2021-02-11|2021-02-25|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|LB|f89c08df-2e24-4c97-a451-1980cecebf14|9|CACR|Calcium Corrected|HEMATOLOGY|[?]|g/animal/wk|[?]|[?]|INVALID|1|10^4 CFU/mL|1|1|[?]|HIGH|EPITHELIAL CELL|CALCIFIED||NEXT GENERATION SEQUENCING|CKD-EPI CYSTATIN C FORMULA|Y||U||5|Visit_5|90|2|FOLLOW-UP|2021-03-08|2021-03-09|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|f89c08df-2e24-4c97-a451-1980cecebf14|10|CD4CD8|CD4/CD8|CHEMISTRY|[?]|yd|[?]|[?]|TRACE|1|/10^3|1|1|[?]|LOW|PUS|FROZEN||IMPEDANCE CONDUCTIVITY|MDRD ENZYMATIC FORMULA|Y||N||5|Visit_5|90|6|TREATMENT|2021-03-08|2021-03-11|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|dbb225ed-e322-4946-a60a-0fafd7e22953|1|IDLP|IDL Particles|CHEMISTRY|||[?]|[?]|INVALID|1|CARTRIDGE|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|GELLED||VENTILATION PERFUSION LUNG SCAN|MDRD 5 VARIABLE FORMULA|||N|Y|1|Visit_1|10|2|WASHOUT|2021-01-24|2021-04-13|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|LB|dbb225ed-e322-4946-a60a-0fafd7e22953|2|EPINEXR|Epinephrine Excretion Rate|URINALYSIS|||[?]|[?]|NEGATIVE|1|IMPLANT|1|1|[?]|LOW|REFLEX TEAR|LACTESCENT||CARDIAC THERMODILUTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|5|WASHOUT|2021-01-24|2021-02-28|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|LB|dbb225ed-e322-4946-a60a-0fafd7e22953|3|IGGSYNRT|IgG Synthesis Rate|HEMATOLOGY|[?]|Antibody Unit|[?]|[?]|TRACE|1|BP|1|1|[?]|ABNORMAL|LYMPH|AUTOLYZED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|CKD-EPI CYSTATIN C FORMULA|Y||NA||2|Visit_2|25|6|SCREENING|2021-02-08|2021-04-14|25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|LB|dbb225ed-e322-4946-a60a-0fafd7e22953|4|RDWRSD|Ret RDW Standard Deviation|URINALYSIS|[?]|mU/g|[?]|[?]|BORDERLINE|1|Ci/kg|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|REFRIGERATED||TRANSCRIPTION-MEDIATED AMPLIFICATION|CKD-EPI CREATININE FORMULA|||U||2|Visit_2|25|4|TREATMENT|2021-02-08|2021-02-16|25|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|LB|dbb225ed-e322-4946-a60a-0fafd7e22953|5|MYBLA|Myeloblasts|URINALYSIS|[?]|10^4/hpf|[?]|[?]|POSITIVE|1|mg/kg/dose|1|1|[?]|HIGH|COLOSTRUM|ICTERIC|N|COMPUTERIZED CORNEAL TOPOGRAPHY|NASH FIBROSURE FORMULA||Y|U||3|Visit_3|40|7|TREATMENT|2021-02-23|2021-04-02|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|dbb225ed-e322-4946-a60a-0fafd7e22953|6|SLAIGGAB|Soluble Liver Antigen IgG Antibody|CHEMISTRY|[?]|cy/cm|[?]|[?]|INVALID|1|mEq/mmol|1|1|[?]|NORMAL|SALIVA|DRIED||CINEANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||3|Visit_3|40|2|TREATMENT|2021-02-23|2021-03-12|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|dbb225ed-e322-4946-a60a-0fafd7e22953|7|OAS2|2-5-Oligoadenylate Synthase 2|HEMATOLOGY|[?]|foz_us|[?]|[?]|TRACE|1|kcal/day|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|CLOTTED||DIGITAL PCR ARRAY|GMI % FORMULA|||Y||4|Visit_4|65|2|FOLLOW-UP|2021-03-20|2021-03-22|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|dbb225ed-e322-4946-a60a-0fafd7e22953|8|BNPPRO|ProB-type Natriuretic Peptide|CHEMISTRY|[?]|FIU|[?]|[?]|INDETERMINATE|1|dmol|1|1|[?]|NORMAL|FLUID|CONCENTRATED||TOLUIDINE BLUE STAIN|MDRD 5 VARIABLE FORMULA|Y|Y|Y||4|Visit_4|65|1|TREATMENT|2021-03-20|2021-03-29|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|dbb225ed-e322-4946-a60a-0fafd7e22953|9|EOSIM|Immature Eosinophils|URINALYSIS|[?]|NEBULE|[?]|[?]|INDETERMINATE|1|mU|1|1|[?]|NORMAL|PERSPIRATION|AGGLUTINATED||BAC ACGH|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|N||5|Visit_5|90|3|FOLLOW-UP|2021-04-14|2021-04-23|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|LB|dbb225ed-e322-4946-a60a-0fafd7e22953|10|CABOT|Cabot Rings|HEMATOLOGY|||[?]|[?]|POSITIVE|1|GLOBULE|1|1|[?]|NORMAL|DIALYSIS FLUID|UNEXPECTED ODOR|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA|||U|Y|5|Visit_5|90|5|SCREENING|2021-04-14|2021-04-21|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|LB|95e61698-43f7-4cc5-aafa-06dac7870743|1|CENTROAB|Centromere B Antibodies|CHEMISTRY|[?]|ugEq/L|[?]|[?]|INVALID|1|days/wk|1|1|[?]|ABNORMAL|SERUM OR PLASMA|DRIED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA||Y|U||1|Visit_1|10|3|WASHOUT|2020-12-25|2021-02-17|10|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|95e61698-43f7-4cc5-aafa-06dac7870743|2|BLASTLM|Leukemic Blasts|URINALYSIS|[?]|mEq/mL|[?]|[?]|TRACE|1|CAPLET|1|1|[?]|ABNORMAL|PLEURAL FLUID|CONTAMINATED||TRANSMISSION ELECTRON MICROSCOPY|HEPASCORE FORMULA||Y|U||1|Visit_1|10|1|TREATMENT|2020-12-25|2021-01-03|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|95e61698-43f7-4cc5-aafa-06dac7870743|3|LPA|Lipoprotein-a|HEMATOLOGY|[?]|cm/s|[?]|[?]|BORDERLINE|1|nmol/g|1|1|[?]|ABNORMAL|SPERMATOZOON|THAWED||DXA SCAN|FIBROSIS 4 FORMULA|||NA||2|Visit_2|25|7|FOLLOW-UP|2021-01-09|2021-02-22|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|95e61698-43f7-4cc5-aafa-06dac7870743|4|CLCTRIOL|Calcitriol|CHEMISTRY|[?]|10^6/Ejaculate U|[?]|[?]|TRACE|1|Linear ft*LB|1|1|[?]|NORMAL|ABSCESS FLUID|CONCENTRATED||FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||2|Visit_2|25|3|TREATMENT|2021-01-09|2021-02-21|25|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|95e61698-43f7-4cc5-aafa-06dac7870743|5|VLDL1|VLDL Cholesterol Subtype 1|CHEMISTRY|[?]|uOsm|[?]|[?]|INVALID|1|ngEq/L|1|1|[?]|LOW|GASTRIC CONTENTS|LIPEMIC||CONTRAST ENHANCED SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA|Y||N||3|Visit_3|40|2|TREATMENT|2021-01-24|2021-03-20|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|95e61698-43f7-4cc5-aafa-06dac7870743|6|LEPTIN|Leptin|HEMATOLOGY|[?]|ugEq/L|[?]|[?]|INVALID|1|/LPF|1|1|[?]|LOW|BONE|THAWED||FLAME PHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||3|Visit_3|40|5|TREATMENT|2021-01-24|2021-03-12|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|95e61698-43f7-4cc5-aafa-06dac7870743|7|LIPEMIAI|Lipemic Index|URINALYSIS|[?]|mCi/L|[?]|[?]|NEGATIVE|1|mOsm/L|1|1|[?]|ABNORMAL|VITREOUS HUMOR|FROZEN||QUANTITATIVE COMPUTED TOMOGRAPHY|MDRD 4 VARIABLE FORMULA|||U||4|Visit_4|65|3|TREATMENT|2021-02-18|2021-02-24|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|95e61698-43f7-4cc5-aafa-06dac7870743|8|ETHANOL|Ethanol|HEMATOLOGY|[?]|LB|[?]|[?]|NEGATIVE|1|10^9/g|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|LIPEMIC||FARNSWORTH-MUNSELL 100 HUE TEST|NASH FIBROSURE FORMULA||Y|N||4|Visit_4|65|6|TREATMENT|2021-02-18|2021-02-25|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|95e61698-43f7-4cc5-aafa-06dac7870743|9|NEUTLE|Neutrophils/Leukocytes|CHEMISTRY|[?]|GBq/g|[?]|[?]|POSITIVE|1|ms/mmHg|1|1|[?]|ABNORMAL|URINE|FRESH||MUGA|CKD-EPI FORMULA||Y|U||5|Visit_5|90|4|TREATMENT|2021-03-15|2021-03-24|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|95e61698-43f7-4cc5-aafa-06dac7870743|10|SLXAG|Sialyl SSEA-1 Antigen|HEMATOLOGY|[?]|mmol/g|[?]|[?]|NEGATIVE|1|10^3 organisms|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|AGGLUTINATED|N|ENDPOINT DILUTION ASSAY|CKD-EPI CYSTATIN C FORMULA|||N||5|Visit_5|90|4|TREATMENT|2021-03-15|2021-03-18|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|151308c7-03aa-4a0b-b13f-9838edb218ef|1|HGBB|Hemoglobin B|HEMATOLOGY|[?]|10^3 DNA copies/mL|[?]|[?]|INDETERMINATE|1|/HPF|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|UNEXPECTED ODOR||SICKLE CELL SOLUBILITY TEST|MDRD FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-09-13|2020-12-06|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|151308c7-03aa-4a0b-b13f-9838edb218ef|2|CH100|Complement CH100|HEMATOLOGY|[?]|mol/L|[?]|[?]|BORDERLINE|1|TABLET|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|AGGLUTINATED||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-09-13|2020-11-06|10|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|151308c7-03aa-4a0b-b13f-9838edb218ef|3|TTGIGAAB|Tissue Transglutaminase IgA Antibody|URINALYSIS|[?]|mL/min/mmHg|[?]|[?]|BORDERLINE|1|10^4/hpf|1|1|[?]|NORMAL|HAIR|CONTAMINATED||PET SCAN|CKD-EPI CREATININE FORMULA|Y||N||2|Visit_2|25|1|WASHOUT|2020-09-28|2020-11-19|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|151308c7-03aa-4a0b-b13f-9838edb218ef|4|RDWSD|RDW Standard Deviation|URINALYSIS|[?]|U/kg|[?]|[?]|BORDERLINE|1|gMFI|1|1|[?]|HIGH|HAIR|CONCENTRATED||OPHTHALMOSCOPY|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|5|SCREENING|2020-09-28|2020-10-22|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|LB|151308c7-03aa-4a0b-b13f-9838edb218ef|5|TSTSFRPT|Testosterone, Free/Total Protein|URINALYSIS|||[?]|[?]|INVALID|1|CFU/mL|1|1|[?]|NORMAL|PLATELET POOR PLASMA|THAWED||SNELLEN EYE CHART|HEPASCORE FORMULA|||N|Y|3|Visit_3|40|5|SCREENING|2020-10-13|2020-11-06|40|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|151308c7-03aa-4a0b-b13f-9838edb218ef|6|CYP2C9|Cytochrome P450 2C9|CHEMISTRY|[?]|POINT|[?]|[?]|INDETERMINATE|1|cmol/L|1|1|[?]|LOW|SWABBED MATERIAL|LIPEMIC||LIGHT SCATTERING SPECTROSCOPY|NASH FIBROSURE FORMULA|Y||NA||3|Visit_3|40|2|WASHOUT|2020-10-13|2020-11-16|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|151308c7-03aa-4a0b-b13f-9838edb218ef|7|LACTICAC|Lactic Acid|CHEMISTRY|||[?]|[?]|NEGATIVE|1|umol/kg/min|1|1|[?]|NORMAL|SKIN TISSUE|CONCENTRATED|N|MUGA|CKD-EPI CYSTATIN C FORMULA||Y|U|Y|4|Visit_4|65|3|FOLLOW-UP|2020-11-07|2020-11-30|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|151308c7-03aa-4a0b-b13f-9838edb218ef|8|HER2S|Soluble HER2|URINALYSIS|[?]|yd|[?]|[?]|INDETERMINATE|1|cpm|1|1|[?]|NORMAL|PLATELET POOR PLASMA|THAWED|N|HEMAGGLUTINATION INHIBITION ASSAY|HEPASCORE FORMULA|Y||N||4|Visit_4|65|2|TREATMENT|2020-11-07|2020-12-05|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|151308c7-03aa-4a0b-b13f-9838edb218ef|9|WBC|Leukocytes|CHEMISTRY|||[?]|[?]|TRACE|1|BLOCKS|1|1|[?]|ABNORMAL|SALIVA|CALCIFIED||SIZE EXCLUSION CHROMATOGRAPHY|FIBROMETER FORMULA|||N|Y|5|Visit_5|90|6|TREATMENT|2020-12-02|2020-12-10|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|151308c7-03aa-4a0b-b13f-9838edb218ef|10|TNFSR2|Soluble TNF Receptor Type II|URINALYSIS|||[?]|[?]|INDETERMINATE|1|/100 HPFs|1|1|[?]|ABNORMAL|PLASMA|LACTESCENT||ATOMIC ABSORPTION SPECTROMETRY|FIBROTEST FORMULA|Y||Y|Y|5|Visit_5|90|6|TREATMENT|2020-12-02|2020-12-05|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|1|LIPASEG|Lipase, Gastric|URINALYSIS|[?]|/mm|[?]|[?]|TRACE|1|mg/m2|1|1|[?]|HIGH|SALIVA|FROZEN||PHASE-CONTRAST MRI|CKD-EPI CREATININE FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-06-15|2020-08-26|10|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|LB|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|2|SMUSCAB|Smooth Muscle Antibody|CHEMISTRY|[?]|/MBP|[?]|[?]|TRACE|1|ug/m2/min|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|ICTERIC||NO INFORMATION|FIBROTEST FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-06-15|2020-09-01|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|LB|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|3|C130071|Bermuda Grass Pollen IgG4|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|in2|1|1|[?]|LOW|SEBUM|LACTESCENT||ELECTROMYOGRAPHY|COCKCROFT-GAULT FORMULA|||NA|Y|2|Visit_2|25|5|TREATMENT|2020-06-30|2020-08-17|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|4|COCBNZEC|Cocaine Benzoylecgonine Ecgonine|HEMATOLOGY|[?]|10^9 organisms/g|[?]|[?]|POSITIVE|1|cd*s/m2|1|1|[?]|HIGH|ARTERIAL BLOOD|PARAFFIN-EMBEDDED|N|BALLPOINT PEN TECHNIQUE|CKD-EPI CREATININE FORMULA|Y||NA||2|Visit_2|25|7|WASHOUT|2020-06-30|2020-07-12|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|5|CKMMCK|Creatine Kinase MM/Total Creatine Kinase|HEMATOLOGY|[?]|log10 TCID 50/uL|[?]|[?]|INDETERMINATE|1|U/mL|1|1|[?]|LOW|ALVEOLAR AIR|FROZEN|N|ZIEHL NEELSEN ACID FAST STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||3|Visit_3|40|1|TREATMENT|2020-07-15|2020-07-29|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|6|BLYCECE|B-Lymphocytes/Total Cells|URINALYSIS|[?]|/200 HPFs|[?]|[?]|INVALID|1|NEBULE|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|CLOTTED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA|||U||3|Visit_3|40|4|TREATMENT|2020-07-15|2020-08-03|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|7|CGA|Chromogranin A|CHEMISTRY|||[?]|[?]|TRACE|1|m/sec|1|1|[?]|ABNORMAL|SPERMATOZOON|NON-HEMOLYZED||SMEAR|GMI MMOL/MOL FORMULA||Y|U|Y|4|Visit_4|65|4|FOLLOW-UP|2020-08-09|2020-09-04|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|8|GRANIM|Immature Granulocytes|URINALYSIS|[?]|nU/cL|[?]|[?]|INVALID|1|nmol/g|1|1|[?]|ABNORMAL|BREAST MILK|NON-HEMOLYZED||FLOCCULATION, CHARCOAL ENHANCED|CKD-EPI CREATININE FORMULA||Y|Y||4|Visit_4|65|3|FOLLOW-UP|2020-08-09|2020-08-25|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|9|C130118|Bee Mix Antigen IgG4 Antibody|CHEMISTRY|[?]|hr/day|[?]|[?]|NEGATIVE|1|TAMPON|1|1|[?]|LOW|DIALYSIS FLUID|DRIED||TARGETED GENOME SEQUENCING|NASH FIBROSURE FORMULA|Y||N||5|Visit_5|90|4|TREATMENT|2020-09-03|2020-09-11|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|LB|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|10|NUCCE|Nucleated Cells|CHEMISTRY|||[?]|[?]|BORDERLINE|1|umol/mol|1|1|[?]|NORMAL|MUSCLE TISSUE|GELLED|N|PYROSEQUENCING|CKD-EPI FORMULA|Y||Y|Y|5|Visit_5|90|2|TREATMENT|2020-09-03|2020-09-11|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|LB|23605586-1b30-4f05-bb15-417dd3a79994|1|CKBB|Creatine Kinase BB|HEMATOLOGY|[?]|10^9/dose|[?]|[?]|INDETERMINATE|1|10^9 CFU/g|1|1|[?]|HIGH|MIXED VENOUS BLOOD|GELLED|N|DIGITAL PCR ARRAY|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-10-31|2020-11-20|10|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|23605586-1b30-4f05-bb15-417dd3a79994|2|BALA|Beta Alanine|CHEMISTRY|[?]|g/cage|[?]|[?]|BORDERLINE|1|mg/dose|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|LACTESCENT|N|IMPEDANCE CONDUCTIVITY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||1|Visit_1|10|4|SCREENING|2020-10-31|2021-01-24|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|23605586-1b30-4f05-bb15-417dd3a79994|3|OAS2|2-5-Oligoadenylate Synthase 2|URINALYSIS|[?]|10^9 organisms/mg|[?]|[?]|INVALID|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|FROZEN||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|NASH FIBROSURE FORMULA|||U||2|Visit_2|25|6|WASHOUT|2020-11-15|2021-01-26|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|23605586-1b30-4f05-bb15-417dd3a79994|4|OVALCY|Ovalocytes|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mL/min|1|1|[?]|HIGH|INFRANATANT, PLEURAL FLUID|SOLIDIFIED||SLOAN LETTER EYE CHART 100%|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA|Y|2|Visit_2|25|3|FOLLOW-UP|2020-11-15|2021-01-01|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|23605586-1b30-4f05-bb15-417dd3a79994|5|SARCOSIN|Sarcosine|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|CCID 50/dose|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|HEMOLYZED||ELASTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2020-11-30|2020-12-22|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|23605586-1b30-4f05-bb15-417dd3a79994|6|LDH1|LDH Isoenzyme 1|CHEMISTRY|[?]|ug/L FEU|[?]|[?]|NEGATIVE|1|mg/m2/h|1|1|[?]|ABNORMAL|PLATELET|CONCENTRATED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|ASH FIBROSURE FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2020-11-30|2020-12-23|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|23605586-1b30-4f05-bb15-417dd3a79994|7|VLDLTCT|VLDL Triglyceride + Chylomicron Triglyceride|CHEMISTRY|[?]|Watt|[?]|[?]|INVALID|1|ug/m2/h|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|CONTAMINATED||DUKE INCISION METHOD|GMI MMOL/MOL FORMULA||Y|U||4|Visit_4|65|7|SCREENING|2020-12-25|2021-01-05|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|23605586-1b30-4f05-bb15-417dd3a79994|8|ALDEPX|Aldrin Epoxidase|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|MET*min|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|DRIED|N|WHOLE EXOME SEQUENCING|HEPASCORE FORMULA|Y||U|Y|4|Visit_4|65|4|TREATMENT|2020-12-25|2021-01-24|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|23605586-1b30-4f05-bb15-417dd3a79994|9|ASYNP|Alpha Synuclein Protein|HEMATOLOGY|[?]|10^4/hpf|[?]|[?]|NEGATIVE|1|MHz|1|1|[?]|NORMAL|EPITHELIAL CELL|CALCIFIED|N|PATHOLOGICAL EVALUATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2021-01-19|2021-01-23|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|23605586-1b30-4f05-bb15-417dd3a79994|10|PCSK9|Proprotein Convertase Subtilisin/Kexin 9|URINALYSIS|[?]|g/kg|[?]|[?]|POSITIVE|1|MPL U/mL|1|1|[?]|NORMAL|SUPERNATANT, SERUM|UNEXPECTED ODOR|N|LISSAMINE GREEN STAIN|CKD-EPI FORMULA|Y||Y||5|Visit_5|90|3|WASHOUT|2021-01-19|2021-01-28|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|57d15ac0-06a6-40e0-9201-4d947651c9b0|1|LYMNSQE|Lymphocytes/Non-Squam Epi Cells|URINALYSIS|[?]|IU/mL|[?]|[?]|NEGATIVE|1|deg/mm|1|1|[?]|NORMAL|BILE|HEMOLYZED||LIQUID SCINTILLATION COUNTING|ASH FIBROSURE FORMULA|Y|Y|NA||1|Visit_1|10|7|TREATMENT|2020-08-28|2020-11-07|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|57d15ac0-06a6-40e0-9201-4d947651c9b0|2|HALPRZLM|Hydroxyalprazolam|URINALYSIS|[?]|kPa|[?]|[?]|NEGATIVE|1|U/g|1|1|[?]|HIGH|HAIR FOLLICLE|AGGLUTINATED||X-RAY FLUORESCENCE SPECTROMETRY|FIBROSIS 4 FORMULA|||U||1|Visit_1|10|3|FOLLOW-UP|2020-08-28|2020-09-05|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|57d15ac0-06a6-40e0-9201-4d947651c9b0|3|INDICAN|Indican|URINALYSIS|[?]|min|[?]|[?]|TRACE|1|ukat|1|1|[?]|LOW|VENOUS PLASMA|FRESH||SPIRAL CT|HEPASCORE FORMULA|Y||U||2|Visit_2|25|2|WASHOUT|2020-09-12|2020-10-07|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|57d15ac0-06a6-40e0-9201-4d947651c9b0|4|TIMM10|Translocase Inner Mitochondrial Membr 10|CHEMISTRY|[?]|IU/g|[?]|[?]|INVALID|1|dpm/0.5 mL|1|1|[?]|ABNORMAL|FLUID|CLOTTED||NEXT GENERATION TARGETED SEQUENCING|ASH FIBROSURE FORMULA|Y||NA||2|Visit_2|25|5|SCREENING|2020-09-12|2020-09-27|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|57d15ac0-06a6-40e0-9201-4d947651c9b0|5|VLDLPSZ|VLDL Particle Size|CHEMISTRY|[?]|DROP|[?]|[?]|NEGATIVE|1|CIGAR|1|1|[?]|NORMAL|ALVEOLAR AIR|NON-HEMOLYZED|N|ANGIOGRAPHY|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|4|SCREENING|2020-09-27|2020-10-09|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|57d15ac0-06a6-40e0-9201-4d947651c9b0|6|PROTCRT|Protein/Creatinine|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mU/L|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|CONCENTRATED|N|POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA|Y||U|Y|3|Visit_3|40|1|TREATMENT|2020-09-27|2020-10-10|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|57d15ac0-06a6-40e0-9201-4d947651c9b0|7|MYBLAT2|Type II Myeloblasts|URINALYSIS|||[?]|[?]|BORDERLINE|1|10^3 copies/mL|1|1|[?]|ABNORMAL|FLUID|ICTERIC||FREEZING POINT DEPRESSION|MDRD ENZYMATIC JAPANESE FORMULA|||Y|Y|4|Visit_4|65|3|SCREENING|2020-10-22|2020-11-20|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|57d15ac0-06a6-40e0-9201-4d947651c9b0|8|ADPNCTN|Adiponectin|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|s/h|1|1|[?]|NORMAL|PLATELET RICH PLASMA|DRIED||SLIT LAMP PHOTOGRAPHY|NASH FIBROSURE FORMULA|||N|Y|4|Visit_4|65|4|WASHOUT|2020-10-22|2020-10-29|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|57d15ac0-06a6-40e0-9201-4d947651c9b0|9|C3DAB|Complement C3d Antibody|HEMATOLOGY|[?]|log10 IU/mL|[?]|[?]|POSITIVE|1|uEq|1|1|[?]|LOW|DIALYSIS FLUID|FROZEN||IMMUNOBLOT|HEPASCORE FORMULA|||Y||5|Visit_5|90|5|FOLLOW-UP|2020-11-16|2020-11-24|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|57d15ac0-06a6-40e0-9201-4d947651c9b0|10|APOB|Apolipoprotein B|URINALYSIS|||[?]|[?]|NEGATIVE|1|Absorbance U/min|1|1|[?]|ABNORMAL|CALCULUS|PARAFFIN-EMBEDDED||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|HEPASCORE FORMULA|Y||Y|Y|5|Visit_5|90|2|FOLLOW-UP|2020-11-16|2020-11-22|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|1|ETHANOL|Ethanol|HEMATOLOGY|[?]|days/month|[?]|[?]|POSITIVE|1|U/g|1|1|[?]|NORMAL|STOOL|AUTOLYZED||TRYPAN BLUE STAIN|MDRD 5 VARIABLE FORMULA|Y||NA||1|Visit_1|10|2|TREATMENT|2020-08-12|2020-10-17|10|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|2|PLAGGCVT|Platelet Aggregation Curve Type|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|Gy/h|1|1|[?]|LOW|CIRCULATING TUMOR CELL|NON-HEMOLYZED||FORCED OSCILLATION TECHNIQUE|HEPASCORE FORMULA|||N|Y|1|Visit_1|10|7|WASHOUT|2020-08-12|2020-10-05|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|3|IL2RB|Interleukin 2 Receptor Subunit Beta|CHEMISTRY|||[?]|[?]|TRACE|1|pmol/L/h|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|ICTERIC||FLOW CYTOMETRY|MDRD 4 VARIABLE FORMULA||Y|N|Y|2|Visit_2|25|5|WASHOUT|2020-08-27|2020-10-25|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|4|ENA78|Epith Neutrophil-Activating Peptide 78|URINALYSIS|[?]|10^6 organisms/g|[?]|[?]|NEGATIVE|1|U/m2/day|1|1|[?]|LOW|SERUM|LACTESCENT||CONTRAST ENHANCED CT SCAN|MDRD FORMULA|Y||Y||2|Visit_2|25|5|FOLLOW-UP|2020-08-27|2020-08-31|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|5|GST|Glutathione S-Transferase, Total|HEMATOLOGY|[?]|ug/L DDU|[?]|[?]|INDETERMINATE|1|cy/cm|1|1|[?]|LOW|SALIVA|CONCENTRATED||SPECT SCAN|HEPASCORE FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-09-11|2020-09-23|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|6|C130121|Shellfish Mix Antigen IgG Antibody|CHEMISTRY|[?]|10^9/g|[?]|[?]|TRACE|1|nmol BCE/nmol|1|1|[?]|ABNORMAL|URINE SEDIMENT|CALCIFIED|N|LIQUID SCINTILLATION COUNTING|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-09-11|2020-10-06|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|7|CSWAX|Waxy Casts|CHEMISTRY|[?]|nCi|[?]|[?]|INVALID|1|kUSP|1|1|[?]|ABNORMAL|SERUM|NON-HEMOLYZED||PAP STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|4|FOLLOW-UP|2020-10-06|2020-10-10|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|8|METHDN|Methadone|CHEMISTRY|[?]|mm2|[?]|[?]|TRACE|1|mL/g/h|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|CONTAMINATED||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA|Y||N||4|Visit_4|65|5|TREATMENT|2020-10-06|2020-10-22|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|9|PLSPCELY|Precursor Plasma Cells/Lymphocytes|URINALYSIS|||[?]|[?]|NEGATIVE|1|log10 copies/mL|1|1|[?]|LOW|CEREBROSPINAL FLUID|FROZEN||AUTOMATED COUNT|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|5|Visit_5|90|7|FOLLOW-UP|2020-10-31|2020-11-02|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|10|CETP|Cholesteryl Ester Transfer Protein|URINALYSIS|||[?]|[?]|INDETERMINATE|1|kV|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED||CALCULATION|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|5|Visit_5|90|2|FOLLOW-UP|2020-10-31|2020-11-05|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|1|CKMB|Creatine Kinase MB|URINALYSIS|[?]|in|[?]|[?]|TRACE|1|%(w/v)|1|1|[?]|NORMAL|NAIL|ICTERIC||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|HEPASCORE FORMULA||Y|NA||1|Visit_1|10|3|TREATMENT|2020-08-31|2020-10-01|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|2|APOA2|Apolipoprotein AII|URINALYSIS|[?]|10^6 CFU|[?]|[?]|BORDERLINE|1|m/sec|1|1|[?]|LOW|ADIPOSE TISSUE|GELLED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|5|FOLLOW-UP|2020-08-31|2020-09-22|10|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|3|LIPEMIAI|Lipemic Index|CHEMISTRY|[?]|FIU|[?]|[?]|BORDERLINE|1|CYLINDER|1|1|[?]|LOW|PLATELET|UNEXPECTED ODOR||PERCUSSION|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||2|Visit_2|25|4|TREATMENT|2020-09-15|2020-10-14|25|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|4|CSGRANC|Granular Coarse Casts|HEMATOLOGY|[?]|ukat|[?]|[?]|BORDERLINE|1|mg/mL/day|1|1|[?]|HIGH|SUPERNATANT, PLASMA|LACTESCENT|N|PUPILLOMETRY|MDRD ENZYMATIC FORMULA|||NA||2|Visit_2|25|1|SCREENING|2020-09-15|2020-10-21|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|5|ANISO|Anisocytes|CHEMISTRY|[?]|10^9 organisms/mL|[?]|[?]|BORDERLINE|1|nL|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|FRESH|N|FLUOROSCOPY|MDRD ENZYMATIC FORMULA||Y|Y||3|Visit_3|40|2|FOLLOW-UP|2020-09-30|2020-10-16|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|6|OH8DXG2|8-Hydroxy-2'-Deoxyguanosine|HEMATOLOGY|[?]|ug/cm2|[?]|[?]|INDETERMINATE|1|genEq|1|1|[?]|HIGH|MUCUS|PARAFFIN-EMBEDDED||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|NASH FIBROSURE FORMULA||Y|N||3|Visit_3|40|7|TREATMENT|2020-09-30|2020-11-27|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|7|LYMLE|Lymphocytes/Leukocytes|CHEMISTRY|[?]|SACHET|[?]|[?]|POSITIVE|1|ohm|1|1|[?]|HIGH|MENSTRUAL BLOOD|GELLED||FLUORIMETRY|GMI % FORMULA|||U||4|Visit_4|65|2|FOLLOW-UP|2020-10-25|2020-11-07|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|8|LCHLCM|Lithocholate Compounds|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mm/min|1|1|[?]|LOW|PUS|DRIED||AUTOREFRACTION|MDRD 4 VARIABLE FORMULA|||N|Y|4|Visit_4|65|1|FOLLOW-UP|2020-10-25|2020-11-04|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|9|AMYLB38|Amyloid Beta 1-38|HEMATOLOGY|[?]|mm/sec|[?]|[?]|TRACE|1|pm|1|1|[?]|LOW|VENOUS CORD BLOOD|THAWED||ELISPOT|MDRD FORMULA|||Y||5|Visit_5|90|4|FOLLOW-UP|2020-11-19|2020-11-26|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|10|C130136|American Cockroach Antigen IgE Antibody|URINALYSIS|[?]|CAPFUL|[?]|[?]|POSITIVE|1|Enzyme U/g Hb|1|1|[?]|HIGH|ISOLATE|FRESH|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|NASH FIBROSURE FORMULA|||Y||5|Visit_5|90|3|SCREENING|2020-11-19|2020-11-26|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|1|TPROTP|Phosphorylated Tau Protein|HEMATOLOGY|||[?]|[?]|POSITIVE|1|gpELISA unit/mL|1|1|[?]|NORMAL|LUNG SURFACTANT|SOLIDIFIED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROMETER FORMULA|Y|Y|Y|Y|1|Visit_1|10|4|SCREENING|2020-12-24|2021-01-14|10|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|2|CETPA|Cholesteryl Ester Transfer Protein Act|CHEMISTRY|[?]|10^9/dose|[?]|[?]|NEGATIVE|1|mgEq|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|AUTOLYZED||DYNAMIC CONTRAST ENHANCED MRI|COCKCROFT-GAULT FORMULA||Y|U||1|Visit_1|10|5|SCREENING|2020-12-24|2021-03-15|10|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|3|MIP1G|Macrophage Inflammatory Protein 1 Gamma|URINALYSIS|[?]|kBq/uL|[?]|[?]|TRACE|1|/100 HPFs|1|1|[?]|HIGH|PLATELET RICH PLASMA|UNEXPECTED ODOR||MALDI-TOF|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|5|TREATMENT|2021-01-08|2021-02-22|25|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|4|ACETOAC|Acetoacetic Acid|HEMATOLOGY|[?]|cP|[?]|[?]|INDETERMINATE|1|TUBE|1|1|[?]|ABNORMAL|PERSPIRATION|LACTESCENT||FLUOROSCOPY|FIBROSIS 4 FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2021-01-08|2021-03-07|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|5|ACANTRBC|Acanthocytes/Erythrocytes|URINALYSIS|[?]|CFU/g|[?]|[?]|POSITIVE|1|10^3 CFU/mL|1|1|[?]|LOW|PLEURAL FLUID|REFRIGERATED||AUDIOMETRY|MDRD ENZYMATIC FORMULA|Y||NA||3|Visit_3|40|3|TREATMENT|2021-01-23|2021-03-11|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|6|HYPERCHR|Hyperchromia|CHEMISTRY|||[?]|[?]|INVALID|1|BOTTLE|1|1|[?]|ABNORMAL|PROSTATIC FLUID|NON-HEMOLYZED||WHOLE TRANSCRIPTOME SEQUENCING|CKD-EPI CREATININE FORMULA|Y||N|Y|3|Visit_3|40|1|WASHOUT|2021-01-23|2021-03-10|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|7|GLP1|Glucagon-Like Peptide-1|CHEMISTRY|[?]|BAU|[?]|[?]|INVALID|1|/10^5|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|LIPEMIC|N|CLINICAL EVALUATION|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|3|FOLLOW-UP|2021-02-17|2021-02-20|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|8|ESTFREST|Estradiol, Free/Estradiol|HEMATOLOGY|[?]|MESF|[?]|[?]|NEGATIVE|1|mAmp|1|1|[?]|ABNORMAL|VITREOUS HUMOR|HEMOLYZED||OSCILLOMETRY|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2021-02-17|2021-03-06|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|9|RDCSUG|Reducing Sugars|CHEMISTRY|[?]|Henry|[?]|[?]|POSITIVE|1|CYLINDER|1|1|[?]|ABNORMAL|SEMINAL FLUID|ICTERIC||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|FIBROMETER FORMULA||Y|N||5|Visit_5|90|7|TREATMENT|2021-03-14|2021-03-23|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|10|FRUCTOSE|Fructose|URINALYSIS|[?]|/LSQN|[?]|[?]|INVALID|1|Siemens|1|1|[?]|LOW|CAPILLARY BLOOD|CONCENTRATED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|Y||5|Visit_5|90|1|SCREENING|2021-03-14|2021-03-22|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|1|LVFBRSC|Liver Fibrosis Score|URINALYSIS|[?]|mV2/Hz|[?]|[?]|INVALID|1|V/sec|1|1|[?]|HIGH|VENOUS PLASMA|GELLED|N|RULER MEASUREMENT METHOD|CKD-EPI CYSTATIN C FORMULA|Y||NA||1|Visit_1|10|3|SCREENING|2020-07-02|2020-08-02|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|2|BLYMXM|B-lymphocyte Crossmatch|CHEMISTRY|||[?]|[?]|POSITIVE|1|mgEq|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|ICTERIC||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|2|TREATMENT|2020-07-02|2020-07-19|10|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|3|ENA78|Epith Neutrophil-Activating Peptide 78|URINALYSIS|[?]|IU/mL|[?]|[?]|INVALID|1|CCID 50/dose|1|1|[?]|ABNORMAL|CALCULUS|DRIED||MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|2|TREATMENT|2020-07-17|2020-08-09|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|4|AMMONIA|Ammonia|URINALYSIS|[?]|cs|[?]|[?]|BORDERLINE|1|/100 WBC|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED|N|CONFOCAL MICROSCOPY|GMI % FORMULA|Y||Y||2|Visit_2|25|3|FOLLOW-UP|2020-07-17|2020-08-04|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|5|DHT|Dihydrotestosterone|CHEMISTRY|[?]|STRIP|[?]|[?]|INDETERMINATE|1|nmol/kg/day|1|1|[?]|HIGH|MONOCYTE|GELLED||SPECT SCAN|HEPASCORE FORMULA||Y|NA||3|Visit_3|40|3|SCREENING|2020-08-01|2020-08-03|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|6|METANEPH|Metanephrine|CHEMISTRY|[?]|um|[?]|[?]|INVALID|1|U/g/min|1|1|[?]|LOW|CERUMEN|CALCIFIED|N|WESTERGREN|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-08-01|2020-08-21|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|7|HEPARIN|Heparin|CHEMISTRY|||[?]|[?]|NEGATIVE|1|/2000 RBC|1|1|[?]|ABNORMAL|URINE|FRESH||HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI CYSTATIN C FORMULA|Y||U|Y|4|Visit_4|65|5|SCREENING|2020-08-26|2020-09-19|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|8|PKM2|Pyruvate Kinase Isozyme M2|CHEMISTRY|[?]|Enzyme U/L|[?]|[?]|NEGATIVE|1|OD Unit|1|1|[?]|LOW|SUPERNATANT, PLASMA|FRESH||HPLC-UV|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-08-26|2020-08-27|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|9|C130131|Dog Dander Antigen IgG4 Antibody|HEMATOLOGY|||[?]|[?]|POSITIVE|1|APPLICATION|1|1|[?]|HIGH|ISOLATE|CONCENTRATED||CAPILLARY ELECTROPHORESIS|GMI % FORMULA|||Y|Y|5|Visit_5|90|6|TREATMENT|2020-09-20|2020-09-29|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|10|RDWRCV|Ret RDW Coefficient of Variation|URINALYSIS|[?]|g/kg|[?]|[?]|TRACE|1|ug/day|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|HEMOLYZED|N|SCINTIGRAPHY|CKD-EPI FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-09-20|2020-09-27|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|81f62132-123e-4888-abbe-8e289599e965|1|CODEINE|Codeine|HEMATOLOGY|[?]|HOURS|[?]|[?]|BORDERLINE|1|WAFER|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|HEMOLYZED|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD FORMULA|Y||NA||1|Visit_1|10|4|TREATMENT|2020-12-04|2021-02-02|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|81f62132-123e-4888-abbe-8e289599e965|2|APOA2|Apolipoprotein AII|HEMATOLOGY|||[?]|[?]|TRACE|1|kg/mol|1|1|[?]|HIGH|BLOOD|UNEXPECTED ODOR||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|Y|Y|Y|Y|1|Visit_1|10|3|TREATMENT|2020-12-04|2021-01-15|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|81f62132-123e-4888-abbe-8e289599e965|3|CAN|Coefficient of Nitrogen Absorption|CHEMISTRY|[?]|mm3/mm2/year|[?]|[?]|INVALID|1|ug/mol|1|1|[?]|HIGH|SMEGMA|LIPEMIC||IMMUNOASSAY|NASH FIBROSURE FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2020-12-19|2021-01-12|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|81f62132-123e-4888-abbe-8e289599e965|4|APPEAR|Specimen Appearance|CHEMISTRY|||[?]|[?]|TRACE|1|cmH2O*s2/mL|1|1|[?]|ABNORMAL|KERATINOCYTE|DRIED||AUTOMATED COUNT|ASH FIBROSURE FORMULA||Y|N|Y|2|Visit_2|25|5|TREATMENT|2020-12-19|2021-02-21|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|81f62132-123e-4888-abbe-8e289599e965|5|RDWRSD|Ret RDW Standard Deviation|URINALYSIS|[?]|pt_us|[?]|[?]|INVALID|1|mL/m2/day|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|ICTERIC||HPLC/IEX|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|6|FOLLOW-UP|2021-01-03|2021-03-03|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|81f62132-123e-4888-abbe-8e289599e965|6|LDHEXR|Lactate Dehydrogenase Excretion Rate|URINALYSIS|[?]|ug/kg/h|[?]|[?]|BORDERLINE|1|TRANSDUCING UNIT|1|1|[?]|HIGH|PLATELET RICH PLASMA|FROZEN||ENDPOINT DILUTION ASSAY|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2021-01-03|2021-01-07|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|81f62132-123e-4888-abbe-8e289599e965|7|EOSPSD|Pseudo-Eosinophils|HEMATOLOGY|[?]|Enzyme U/m2|[?]|[?]|INDETERMINATE|1|/2500 WBC|1|1|[?]|LOW|SMEGMA|LACTESCENT|N|MALDI|MDRD FORMULA||Y|Y||4|Visit_4|65|5|TREATMENT|2021-01-28|2021-02-20|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|81f62132-123e-4888-abbe-8e289599e965|8|INTLK21|Interleukin 21|URINALYSIS|[?]|g|[?]|[?]|POSITIVE|1|nm|1|1|[?]|HIGH|COLOSTRUM|LACTESCENT||VENTILATION PERFUSION LUNG SCAN|MDRD 5 VARIABLE FORMULA||Y|NA||4|Visit_4|65|4|SCREENING|2021-01-28|2021-02-15|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|81f62132-123e-4888-abbe-8e289599e965|9|C130105|Grass Mix Pollen Antigen IgA Antibody|URINALYSIS|[?]|ng/day|[?]|[?]|NEGATIVE|1|km/h|1|1|[?]|ABNORMAL|SKIN TISSUE|FROZEN|N|WHOLE GENOME SEQUENCING|FIBROMETER FORMULA|Y||U||5|Visit_5|90|3|TREATMENT|2021-02-22|2021-03-02|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|81f62132-123e-4888-abbe-8e289599e965|10|INTLK23|Interleukin 23|URINALYSIS|||[?]|[?]|TRACE|1|cmH2O*s2/mL|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|DRIED||PERCUSSION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|5|Visit_5|90|1|SCREENING|2021-02-22|2021-02-25|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|1|LIQUFT|Liquefaction Time|CHEMISTRY|[?]|10^3/L|[?]|[?]|POSITIVE|1|/2000 RBC|1|1|[?]|ABNORMAL|SOFT TISSUE|HEMOLYZED||HIGH RESOLUTION MELT ANALYSIS|FIBROTEST FORMULA|Y||U||1|Visit_1|10|3|TREATMENT|2020-05-16|2020-06-21|10|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|2|MOCYCECE|Monocytoid Cells/Total Cells|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^9 CFU/g|1|1|[?]|LOW|BONE|NON-HEMOLYZED||LEAD CITRATE STAIN|NASH FIBROSURE FORMULA|||NA|Y|1|Visit_1|10|4|TREATMENT|2020-05-16|2020-06-18|10|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|3|PTSFAC|Protein S, Free Actual/Control|HEMATOLOGY|[?]|dram|[?]|[?]|POSITIVE|1|mCi/L|1|1|[?]|ABNORMAL|STOOL|FROZEN||MAMMOGRAPHY|ASH FIBROSURE FORMULA|Y||NA||2|Visit_2|25|4|TREATMENT|2020-05-31|2020-08-04|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|4|POLYCHR|Polychromasia|URINALYSIS|[?]|10^6 organisms/mL|[?]|[?]|INDETERMINATE|1|U/m2/h|1|1|[?]|NORMAL|SWABBED MATERIAL|AUTOLYZED|N|SLOAN LETTER EYE CHART 100%|CKD-EPI CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|5|TREATMENT|2020-05-31|2020-07-10|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|5|TKG|T-Kininogen|HEMATOLOGY|[?]|mV|[?]|[?]|INVALID|1|g/cage|1|1|[?]|HIGH|MIXED VENOUS BLOOD|AUTOLYZED|N|ENDPOINT DILUTION ASSAY|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|4|WASHOUT|2020-06-15|2020-07-02|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|LB|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|6|RBCNURBC|Nucleated Erythrocytes/Erythrocytes|URINALYSIS|[?]|cmol|[?]|[?]|TRACE|1|uL/kg/day|1|1|[?]|HIGH|VITREOUS HUMOR|SOLIDIFIED||IVY INCISION METHOD|MDRD FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-06-15|2020-07-04|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|LB|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|7|SICAM1|Soluble Intercell Adhesion Molecule 1|URINALYSIS|[?]|uCi/L|[?]|[?]|INDETERMINATE|1|PUFF|1|1|[?]|LOW|AMNIOTIC FLUID|REFRIGERATED||FARR ASSAY|CKD-EPI FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-07-10|2020-07-20|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|8|HGBA|Hemoglobin A|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|uV2|1|1|[?]|HIGH|INFRANATANT, PLASMA|UNEXPECTED ODOR||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROTEST FORMULA|||N|Y|4|Visit_4|65|4|WASHOUT|2020-07-10|2020-08-12|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|9|HLAA23A|HLA-A23 Antibody|CHEMISTRY|[?]|nmol BCE/mmol|[?]|[?]|POSITIVE|1|CUP|1|1|[?]|LOW|CORD BLOOD|GELLED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROTEST FORMULA|||U||5|Visit_5|90|6|SCREENING|2020-08-04|2020-08-06|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|LB|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|10|PCT|Procalcitonin|CHEMISTRY|[?]|kg|[?]|[?]|POSITIVE|1|Ci/mL|1|1|[?]|ABNORMAL|LUNG SURFACTANT|CLOTTED||ACRIDINE ORANGE STAIN|FIBROMETER FORMULA||Y|N||5|Visit_5|90|6|FOLLOW-UP|2020-08-04|2020-08-12|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|LB|49282406-97ec-4108-adf9-e01c18ce59c6|1|CSRBC|RBC Casts|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|BE/mL|1|1|[?]|NORMAL|MECONIUM|LACTESCENT||SLIT LAMP PHOTOGRAPHY|MDRD 6 VARIABLE FORMULA|Y||N|Y|1|Visit_1|10|1|TREATMENT|2020-05-17|2020-06-25|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-10
e|LB|49282406-97ec-4108-adf9-e01c18ce59c6|2|CYAMPPH|Amorphous Phosphate Crystals|URINALYSIS|[?]|RING|[?]|[?]|INVALID|1|PACK|1|1|[?]|NORMAL|STOOL|PARAFFIN-EMBEDDED|N|POPULATION SEQUENCING|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-05-17|2020-06-16|10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-10
e|LB|49282406-97ec-4108-adf9-e01c18ce59c6|3|PLATAGGR|Platelet Aggregation|HEMATOLOGY|[?]|mg/kg|[?]|[?]|INVALID|1|Watt|1|1|[?]|LOW|BONE|ICTERIC||HPLC-FL|CKD-EPI FORMULA|||N||2|Visit_2|25|1|WASHOUT|2020-06-01|2020-07-17|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|49282406-97ec-4108-adf9-e01c18ce59c6|4|MPO|Myeloperoxidase|CHEMISTRY|[?]|Ci/kg|[?]|[?]|BORDERLINE|1|tuberculin unit/mL|1|1|[?]|ABNORMAL|MECONIUM|ROOM TEMPERATURE||SLIT LAMP PHOTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|4|FOLLOW-UP|2020-06-01|2020-08-12|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|49282406-97ec-4108-adf9-e01c18ce59c6|5|GLP1AC|Glucagon-Like Peptide-1, Active Form|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ft3|1|1|[?]|NORMAL|SEBUM|PARAFFIN-EMBEDDED||TRIPLE-PHASE MRI SCAN|CKD-EPI FORMULA|Y||NA|Y|3|Visit_3|40|2|FOLLOW-UP|2020-06-16|2020-07-08|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|LB|49282406-97ec-4108-adf9-e01c18ce59c6|6|C165941|Common Ragweed Pollen IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|INVALID|1|genEq/mL|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|DRIED||PALPATION|FIBROSIS 4 FORMULA|||Y|Y|3|Visit_3|40|1|TREATMENT|2020-06-16|2020-07-21|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|LB|49282406-97ec-4108-adf9-e01c18ce59c6|7|IFNB|Interferon Beta|URINALYSIS|[?]|gMFI|[?]|[?]|INDETERMINATE|1|cpm|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|CALCIFIED||IODINE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2020-07-11|2020-07-31|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|LB|49282406-97ec-4108-adf9-e01c18ce59c6|8|ACYLCAOX|Acyl Coenzyme A Oxidase|CHEMISTRY|[?]|days/month|[?]|[?]|POSITIVE|1|10^6/g|1|1|[?]|ABNORMAL|EPITHELIAL CELL|AUTOLYZED|N|DUCTOGRAPHY|MDRD 5 VARIABLE FORMULA|||N||4|Visit_4|65|6|WASHOUT|2020-07-11|2020-08-10|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|LB|49282406-97ec-4108-adf9-e01c18ce59c6|9|PGF1A|Prostaglandin F1 Alpha|URINALYSIS|[?]|nU/cL|[?]|[?]|INDETERMINATE|1|TABLET|1|1|[?]|NORMAL|LEUKOCYTE|CLOTTED||TRIPLE-PHASE MRI SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||5|Visit_5|90|2|SCREENING|2020-08-05|2020-08-07|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|49282406-97ec-4108-adf9-e01c18ce59c6|10|EOSNUCCE|Eosinophils/Nucleated Cells|HEMATOLOGY|[?]|ug/L DDU|[?]|[?]|TRACE|1|foz_br|1|1|[?]|HIGH|PLATELET POOR PLASMA|CALCIFIED||STATIC PERIMETRY|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|6|FOLLOW-UP|2020-08-05|2020-08-08|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|310936c8-7d24-4eea-9892-1cd8bb675421|1|MANNITOL|Mannitol|CHEMISTRY|[?]|mg/kg/day|[?]|[?]|NEGATIVE|1|mAmp|1|1|[?]|NORMAL|TRANSUDATE|LIPEMIC|N|SPECT/CT SCAN|CKD-EPI FORMULA|||Y||1|Visit_1|10|1|SCREENING|2020-07-06|2020-07-28|10|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|310936c8-7d24-4eea-9892-1cd8bb675421|2|HLAA|HLA Class IA Antigen|HEMATOLOGY|[?]|PELLET|[?]|[?]|INVALID|1|pmol/day|1|1|[?]|ABNORMAL|CALCULUS|HEMOLYZED|N|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|GMI % FORMULA|||Y||1|Visit_1|10|7|FOLLOW-UP|2020-07-06|2020-08-22|10|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|310936c8-7d24-4eea-9892-1cd8bb675421|3|DOPAC|3,4-Dihydroxyphenylacetic Acid|URINALYSIS|[?]|deg/s|[?]|[?]|POSITIVE|1|TROCHE|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|THAWED||FUNDUS PHOTOGRAPHY|CKD-EPI CREATININE FORMULA|Y||Y||2|Visit_2|25|5|TREATMENT|2020-07-21|2020-10-02|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|310936c8-7d24-4eea-9892-1cd8bb675421|4|PSAFPSAT|PSA, Free/PSA|HEMATOLOGY|[?]|pg/L|[?]|[?]|INVALID|1|Anson U|1|1|[?]|ABNORMAL|BONE|ROOM TEMPERATURE||FUNDUS PHOTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|5|SCREENING|2020-07-21|2020-08-20|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|310936c8-7d24-4eea-9892-1cd8bb675421|5|KCLR|Potassium Clearance|HEMATOLOGY|[?]|/mm|[?]|[?]|BORDERLINE|1|ug/mol|1|1|[?]|HIGH|PLASMA|AUTOLYZED|N|PH METER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA|Y||NA||3|Visit_3|40|6|WASHOUT|2020-08-05|2020-09-17|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|LB|310936c8-7d24-4eea-9892-1cd8bb675421|6|MONOBL|Monoblasts|URINALYSIS|||[?]|[?]|INVALID|1|kg/cm|1|1|[?]|LOW|PLEURAL TISSUE|LIPEMIC||CHROMATOGRAPHY|FIBROTEST FORMULA|||U|Y|3|Visit_3|40|5|FOLLOW-UP|2020-08-05|2020-08-15|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|LB|310936c8-7d24-4eea-9892-1cd8bb675421|7|CXCL3|Chemokine (C-X-C Motif) Ligand 3|URINALYSIS|[?]|days/wk|[?]|[?]|NEGATIVE|1|CUP|1|1|[?]|ABNORMAL|LEUKOCYTE|LACTESCENT||ETDRS EYE CHART|GMI % FORMULA|Y||N||4|Visit_4|65|1|FOLLOW-UP|2020-08-30|2020-09-06|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|310936c8-7d24-4eea-9892-1cd8bb675421|8|PLAGGCVT|Platelet Aggregation Curve Type|URINALYSIS|[?]|mU/g|[?]|[?]|INDETERMINATE|1|ug/day|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|ROOM TEMPERATURE||CELL BASED BIOASSAY|HEPASCORE FORMULA|Y||U||4|Visit_4|65|7|FOLLOW-UP|2020-08-30|2020-09-29|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|310936c8-7d24-4eea-9892-1cd8bb675421|9|CHOLOH4B|4-Beta-Hydroxycholesterol|CHEMISTRY|[?]|/LSQN|[?]|[?]|POSITIVE|1|g/day|1|1|[?]|ABNORMAL|ISOLATE|REFRIGERATED|N|MICROBIAL CULTURE, SOLID|CKD-EPI CREATININE FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2020-09-24|2020-09-29|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|310936c8-7d24-4eea-9892-1cd8bb675421|10|AST|Aspartate Aminotransferase|CHEMISTRY|[?]|%|[?]|[?]|NEGATIVE|1|Ejaculate U|1|1|[?]|NORMAL|PLASMA|FRESH||GC/MS/MS|NASH FIBROSURE FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2020-09-24|2020-10-02|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|034e303b-5675-4188-bcea-fc2e53b155d6|1|CENTROAB|Centromere B Antibodies|HEMATOLOGY|[?]|Ci|[?]|[?]|TRACE|1|CONTAINER|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|AUTOLYZED||MAGNETIC RESONANCE ELASTOGRAPHY|NASH FIBROSURE FORMULA|Y||U||1|Visit_1|10|2|TREATMENT|2020-06-01|2020-08-06|10|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|034e303b-5675-4188-bcea-fc2e53b155d6|2|NMP22|Nuclear Matrix Protein 22|CHEMISTRY|[?]|ng/day|[?]|[?]|POSITIVE|1|10^6 IU/mL|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|CALCIFIED||GC/MS/MS|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-06-01|2020-08-03|10|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|034e303b-5675-4188-bcea-fc2e53b155d6|3|ADAM8|ADAM Metallopeptidase Domain 8|CHEMISTRY|[?]|mmol/min/kPa/L|[?]|[?]|BORDERLINE|1|dmol|1|1|[?]|NORMAL|PLATELET POOR PLASMA|DRIED||MICRODENSITOMETRY|CKD-EPI CREATININE FORMULA|||U||2|Visit_2|25|7|TREATMENT|2020-06-16|2020-07-16|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|034e303b-5675-4188-bcea-fc2e53b155d6|4|MAYHEG|May-Hegglin Anomaly|CHEMISTRY|[?]|dpm/0.5 mL|[?]|[?]|NEGATIVE|1|MHz|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|FRESH||AUTOMATED COUNT|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|4|WASHOUT|2020-06-16|2020-08-23|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|034e303b-5675-4188-bcea-fc2e53b155d6|5|HAHA|Human Anti-Human Antibody|URINALYSIS|[?]|kPa/L/sec|[?]|[?]|POSITIVE|1|IU/kg|1|1|[?]|HIGH|TRANSUDATE|AUTOLYZED|N|NEPHELOMETRY|MDRD FORMULA|||N||3|Visit_3|40|7|WASHOUT|2020-07-01|2020-08-18|40|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|034e303b-5675-4188-bcea-fc2e53b155d6|6|EOTAXIN3|Eotaxin-3|URINALYSIS|[?]|umol/mol|[?]|[?]|INDETERMINATE|1|fmol/L|1|1|[?]|NORMAL|AMNIOTIC FLUID|NON-HEMOLYZED|N|IMMUNOFLUORESCENT STAIN|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|5|WASHOUT|2020-07-01|2020-08-05|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|034e303b-5675-4188-bcea-fc2e53b155d6|7|PLATSAT|Platelet Satellitism|CHEMISTRY|[?]|mL/min/1.73m2|[?]|[?]|INDETERMINATE|1|mL/g/day|1|1|[?]|HIGH|SPERMATOZOON|CLOTTED||U-HPLC/MS/MS|GMI MMOL/MOL FORMULA||Y|NA||4|Visit_4|65|6|WASHOUT|2020-07-26|2020-08-24|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|034e303b-5675-4188-bcea-fc2e53b155d6|8|FATDROP|Fat Droplet|HEMATOLOGY|[?]|/5x10^4 WBC|[?]|[?]|TRACE|1|fg|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED||OPTICAL COHERENCE TOMOGRAPHY|GMI % FORMULA|||N||4|Visit_4|65|3|SCREENING|2020-07-26|2020-08-25|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|034e303b-5675-4188-bcea-fc2e53b155d6|9|TNFSR|Soluble Tumor Necrosis Factor Receptor|HEMATOLOGY|[?]|ug/mol|[?]|[?]|BORDERLINE|1|MdFI|1|1|[?]|NORMAL|NAIL|ROOM TEMPERATURE||PHOTOGRAPHY|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|5|TREATMENT|2020-08-20|2020-08-21|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|034e303b-5675-4188-bcea-fc2e53b155d6|10|CX3CL1|Chemokine (C-X3-C Motif) Ligand 1|CHEMISTRY|[?]|log10 PFU/mL|[?]|[?]|NEGATIVE|1|damol/L|1|1|[?]|LOW|EXPIRED AIR|CONTAMINATED||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|GMI % FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-08-20|2020-08-28|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|1|BLEEDT|Bleeding Time|HEMATOLOGY|[?]|VIAL|[?]|[?]|INDETERMINATE|1|mmol/mol|1|1|[?]|ABNORMAL|EXPIRED AIR|SOLIDIFIED||CORONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|NA||1|Visit_1|10|4|TREATMENT|2020-07-07|2020-09-27|10|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|LB|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|2|C147276|Arachis hypogaea Antigen IgE Antibody|URINALYSIS|[?]|mL/g/min|[?]|[?]|TRACE|1|mmHg|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|REFRIGERATED||ELISPOT|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|4|FOLLOW-UP|2020-07-07|2020-09-25|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|LB|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|3|BLASTIMM|Immunoblasts|HEMATOLOGY|[?]|nL|[?]|[?]|NEGATIVE|1|kBq|1|1|[?]|LOW|ERYTHROCYTES|THAWED||SPECT SCAN|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-07-22|2020-09-09|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|4|AMYLOIDP|Amyloid P|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^3/hpf|1|1|[?]|LOW|BONE MARROW|LIPEMIC||POLYMERASE CHAIN REACTION|CKD-EPI FORMULA|Y|Y|N|Y|2|Visit_2|25|5|SCREENING|2020-07-22|2020-08-28|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|5|PTHCT|Parathyroid Hormone, C-Terminal|URINALYSIS|[?]|nmol/L/h|[?]|[?]|INVALID|1|foz_br|1|1|[?]|ABNORMAL|SEMINAL FLUID|CONTAMINATED||NEPHELOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||3|Visit_3|40|6|TREATMENT|2020-08-06|2020-08-27|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|6|C130116|Bee Mix Antigen IgE Antibody|HEMATOLOGY|[?]|ug/kg/min|[?]|[?]|POSITIVE|1|fmol/L|1|1|[?]|LOW|MUCUS|NON-HEMOLYZED||COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|1|SCREENING|2020-08-06|2020-08-26|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|LB|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|7|GASTRIN|Gastrin|HEMATOLOGY|||[?]|[?]|TRACE|1|10^6 organisms/g|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|CLOTTED||ELISPOT|CKD-EPI FORMULA|Y|Y|U|Y|4|Visit_4|65|2|FOLLOW-UP|2020-08-31|2020-10-03|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|8|CLRDZPXD|Chlordiazepoxide|HEMATOLOGY|[?]|OD Unit|[?]|[?]|INVALID|1|/mm|1|1|[?]|NORMAL|LYSATE|HEMOLYZED||SIZE EXCLUSION CHROMATOGRAPHY|MDRD FORMULA|||U||4|Visit_4|65|1|FOLLOW-UP|2020-08-31|2020-09-20|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|9|HE4|Human Epididymis Protein 4|HEMATOLOGY|[?]|oz eq|[?]|[?]|INDETERMINATE|1|Newton|1|1|[?]|ABNORMAL|VENOUS BLOOD|ICTERIC||CHROMATOGRAPHY|HEPASCORE FORMULA|||N||5|Visit_5|90|7|FOLLOW-UP|2020-09-25|2020-09-29|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|10|CLEXR|Chloride Excretion Rate|URINALYSIS|||[?]|[?]|POSITIVE|1|um/s|1|1|[?]|NORMAL|ADIPOSE TISSUE|SOLIDIFIED||ENDOSCOPY|MDRD 5 VARIABLE FORMULA|||Y|Y|5|Visit_5|90|5|TREATMENT|2020-09-25|2020-09-29|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|c912affb-cbc2-4919-81b4-ecaa03908261|1|VITB1|Thiamine|HEMATOLOGY|[?]|SACHET|[?]|[?]|POSITIVE|1|kg/cm|1|1|[?]|ABNORMAL|PROSTATIC FLUID|FRESH||FLUOROSCOPY|HEPASCORE FORMULA||Y|Y||1|Visit_1|10|1|TREATMENT|2020-07-12|2020-08-10|10|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|c912affb-cbc2-4919-81b4-ecaa03908261|2|LYMPLLE|Plasmacytoid Lymphocytes/Leukocytes|CHEMISTRY|[?]|10^7 PFU|[?]|[?]|POSITIVE|1|/2000 RBC|1|1|[?]|LOW|RETICULOCYTES|FROZEN||FLUORESCENT SPOT TEST|FIBROMETER FORMULA|||Y||1|Visit_1|10|6|SCREENING|2020-07-12|2020-07-20|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|c912affb-cbc2-4919-81b4-ecaa03908261|3|FVAAC|Factor V Activity Actual/Control|URINALYSIS|[?]|TROCHE|[?]|[?]|INVALID|1|Watt|1|1|[?]|LOW|ABSCESS FLUID|ICTERIC||QUANTITATIVE COMPUTED TOMOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||2|Visit_2|25|5|TREATMENT|2020-07-27|2020-09-13|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|c912affb-cbc2-4919-81b4-ecaa03908261|4|C130118|Bee Mix Antigen IgG4 Antibody|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|pg|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|DRIED||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 5 VARIABLE FORMULA|||NA|Y|2|Visit_2|25|4|TREATMENT|2020-07-27|2020-07-31|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|c912affb-cbc2-4919-81b4-ecaa03908261|5|BLSTLY|Lymphoblasts|URINALYSIS|[?]|tuberculin unit/mL|[?]|[?]|INVALID|1|CFU/g|1|1|[?]|HIGH|LOCHIA|CONTAMINATED|N|IN SITU HYBRIDIZATION|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|5|SCREENING|2020-08-11|2020-08-22|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|c912affb-cbc2-4919-81b4-ecaa03908261|6|CLUECE|Clue Cells|URINALYSIS|||[?]|[?]|BORDERLINE|1|PATCH|1|1|[?]|ABNORMAL|SALIVA|AGGLUTINATED||BIOIMPEDANCE SPECTROSCOPY|MDRD 6 VARIABLE FORMULA|Y|Y|N|Y|3|Visit_3|40|2|FOLLOW-UP|2020-08-11|2020-09-28|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|c912affb-cbc2-4919-81b4-ecaa03908261|7|RDCSUG|Reducing Sugars|CHEMISTRY|[?]|mmol/min/kPa/L|[?]|[?]|INVALID|1|um/s|1|1|[?]|LOW|PLATELET RICH PLASMA|FRESH|N|TWO-COLOR MICROARRAY|FIBROSIS 4 FORMULA|Y||NA||4|Visit_4|65|1|TREATMENT|2020-09-05|2020-09-12|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|c912affb-cbc2-4919-81b4-ecaa03908261|8|NGF|Nerve Growth Factor|CHEMISTRY|[?]|cd|[?]|[?]|TRACE|1|PFU/mL|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|GELLED||GC/FID|ASH FIBROSURE FORMULA|Y||N||4|Visit_4|65|5|WASHOUT|2020-09-05|2020-09-07|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|c912affb-cbc2-4919-81b4-ecaa03908261|9|ABO|ABO Blood Group|CHEMISTRY|[?]|mL/g/h|[?]|[?]|TRACE|1|L/h/m2|1|1|[?]|NORMAL|PROSTATIC FLUID|CALCIFIED||TEMPLATE INCISION METHOD|MDRD 4 VARIABLE FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-09-30|2020-10-08|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|c912affb-cbc2-4919-81b4-ecaa03908261|10|IGGSYNRT|IgG Synthesis Rate|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ug/mol|1|1|[?]|ABNORMAL|BASAL TEAR|NON-HEMOLYZED||COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|5|Visit_5|90|2|TREATMENT|2020-09-30|2020-10-01|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|5af817f0-5dfb-4046-ac7c-4bae16a90036|1|PLSPCE|Precursor Plasma Cells|HEMATOLOGY|[?]|10^3 CFU/mL|[?]|[?]|POSITIVE|1|Tesla|1|1|[?]|ABNORMAL|REFLEX TEAR|CONTAMINATED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|7|FOLLOW-UP|2020-07-06|2020-07-11|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|5af817f0-5dfb-4046-ac7c-4bae16a90036|2|DHPG|3,4-Dihydroxyphenylglycol|CHEMISTRY|[?]|nmol/day|[?]|[?]|BORDERLINE|1|10^3 copies/mL|1|1|[?]|HIGH|MUCUS|CLOTTED||STATIC PERIMETRY|HEPASCORE FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-07-06|2020-09-30|10|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|5af817f0-5dfb-4046-ac7c-4bae16a90036|3|CKMBCK|Creatine Kinase MB/Total Creatine Kinase|HEMATOLOGY|[?]|ECL unit|[?]|[?]|POSITIVE|1|MONTHS|1|1|[?]|LOW|PROSTATIC FLUID|FROZEN||TELLER ACUITY CARDS|MDRD ENZYMATIC JAPANESE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-07-21|2020-07-25|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|LB|5af817f0-5dfb-4046-ac7c-4bae16a90036|4|GFRBSBTP|GFR from Beta-Trace Protein Adj for BSA|CHEMISTRY|[?]|Enzyme U|[?]|[?]|INVALID|1|deg/mm|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|ICTERIC||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-07-21|2020-08-18|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|LB|5af817f0-5dfb-4046-ac7c-4bae16a90036|5|GLP1IAC|Glucagon-Like Peptide-1, Inactive Form|HEMATOLOGY|[?]|10^12/L|[?]|[?]|NEGATIVE|1|cm2|1|1|[?]|NORMAL|PERSPIRATION|CONCENTRATED||HEMAGGLUTINATION INHIBITION ASSAY|MDRD FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-08-05|2020-09-21|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|5af817f0-5dfb-4046-ac7c-4bae16a90036|6|FACTVA|Factor V Activity|CHEMISTRY|[?]|10^9 organisms/mL|[?]|[?]|POSITIVE|1|BE/mL|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|ICTERIC||PET/CT SCAN WITHOUT CONTRAST|GMI % FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-08-05|2020-08-07|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|5af817f0-5dfb-4046-ac7c-4bae16a90036|7|CMPK2|Cytidine-Uridine Monophosphate Kinase 2|URINALYSIS|[?]|pmol/day|[?]|[?]|BORDERLINE|1|Ci/mL|1|1|[?]|NORMAL|MECONIUM|GELLED||SPECT SCAN|GMI % FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-08-30|2020-09-08|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|5af817f0-5dfb-4046-ac7c-4bae16a90036|8|NEUTGT|Giant Neutrophils|HEMATOLOGY|[?]|Bq/ug|[?]|[?]|INVALID|1|mg/dL|1|1|[?]|ABNORMAL|ISOLATE|UNEXPECTED ODOR|N|LYMPHANGIOGRAPHY|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2020-08-30|2020-09-28|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|LB|5af817f0-5dfb-4046-ac7c-4bae16a90036|9|MMA|Methylmalonic Acid|URINALYSIS|||[?]|[?]|INVALID|1|log10 CFU/mL|1|1|[?]|NORMAL|ARTERIAL BLOOD|DRIED|N|HEMATOXYLIN AND EOSIN STAIN|CKD-EPI CREATININE FORMULA|Y||NA|Y|5|Visit_5|90|6|SCREENING|2020-09-24|2020-09-28|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|5af817f0-5dfb-4046-ac7c-4bae16a90036|10|CCL19|Chemokine (C-C Motif) Ligand 19|CHEMISTRY|[?]|anti-Xa IU|[?]|[?]|INDETERMINATE|1|tsp|1|1|[?]|NORMAL|SOFT TISSUE|CLOTTED||CARDIAC THERMODILUTION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||5|Visit_5|90|6|SCREENING|2020-09-24|2020-09-25|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|dcefd656-a59a-4b71-9260-efcbcecd2132|1|BILDIRBI|Direct Bilirubin/Bilirubin|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|EP U|1|1|[?]|NORMAL|LAVAGE FLUID|REFRIGERATED|N|SNELLEN EYE CHART|FIBROMETER FORMULA|||U|Y|1|Visit_1|10|1|TREATMENT|2020-06-04|2020-07-09|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|dcefd656-a59a-4b71-9260-efcbcecd2132|2|CMONOX|Carbon Monoxide|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|ft|1|1|[?]|LOW|ISOLATE|GELLED||DIGITAL PCR ARRAY|CKD-EPI CYSTATIN C FORMULA|||Y|Y|1|Visit_1|10|6|TREATMENT|2020-06-04|2020-08-06|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|dcefd656-a59a-4b71-9260-efcbcecd2132|3|CRTCREAT|Corticosterone/Creatinine|CHEMISTRY|[?]|Coulomb|[?]|[?]|TRACE|1|/200 HPFs|1|1|[?]|LOW|MENSTRUAL BLOOD|PARAFFIN-EMBEDDED||LC/MS/MS|FIBROMETER FORMULA|Y||N||2|Visit_2|25|4|TREATMENT|2020-06-19|2020-08-27|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|LB|dcefd656-a59a-4b71-9260-efcbcecd2132|4|CRDIGMAB|Cardiolipin IgM Antibody|URINALYSIS|[?]|mol/mL|[?]|[?]|INDETERMINATE|1|ug/m2/day|1|1|[?]|ABNORMAL|PROSTATIC FLUID|HEMOLYZED||MIGET|FIBROTEST FORMULA|Y|Y|N||2|Visit_2|25|4|WASHOUT|2020-06-19|2020-07-07|25|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|LB|dcefd656-a59a-4b71-9260-efcbcecd2132|5|MIP1G|Macrophage Inflammatory Protein 1 Gamma|HEMATOLOGY|[?]|10^9 organisms/g|[?]|[?]|POSITIVE|1|mg/dose|1|1|[?]|NORMAL|LAVAGE FLUID|ROOM TEMPERATURE||ELECTROMYOGRAPHY|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-07-04|2020-08-17|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|dcefd656-a59a-4b71-9260-efcbcecd2132|6|ESTRONE|Estrone|URINALYSIS|[?]|U/g Hb|[?]|[?]|INDETERMINATE|1|SPRAY|1|1|[?]|LOW|PROSTATIC FLUID|NON-HEMOLYZED||MALDI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|5|SCREENING|2020-07-04|2020-07-15|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|dcefd656-a59a-4b71-9260-efcbcecd2132|7|TSIAC|TSI Actual/Control|URINALYSIS|[?]|nkat|[?]|[?]|TRACE|1|log10 PFU|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|CALCIFIED||REFLECTANCE SPECTROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|3|SCREENING|2020-07-29|2020-08-29|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|dcefd656-a59a-4b71-9260-efcbcecd2132|8|LKM1AB|Liver Kidney Microsomal Type 1 Antibody|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|10^3 organisms|1|1|[?]|HIGH|BASAL TEAR|SOLIDIFIED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|COCKCROFT-GAULT FORMULA|Y||Y|Y|4|Visit_4|65|7|TREATMENT|2020-07-29|2020-08-11|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|dcefd656-a59a-4b71-9260-efcbcecd2132|9|PC3MPSAM|PCA3 mRNA/PSA mRNA|URINALYSIS|[?]|mmol/day|[?]|[?]|NEGATIVE|1|PIXEL|1|1|[?]|LOW|PUS|LIPEMIC|N|MAGNETIC RESONANCE ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-08-23|2020-08-27|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|dcefd656-a59a-4b71-9260-efcbcecd2132|10|PEPSNG|Pepsinogen|HEMATOLOGY|[?]|10^7 CFU/mL|[?]|[?]|TRACE|1|deg/s|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|LIPEMIC||HEMOCYTOMETRY|GMI % FORMULA|Y|Y|NA||5|Visit_5|90|2|TREATMENT|2020-08-23|2020-08-27|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|641c8067-941a-4f1a-a7b1-4eea0242f1d7|1|BLSTMBCE|Myeloblasts/Total Cells|HEMATOLOGY|[?]|kcal/day|[?]|[?]|TRACE|1|BEAM BREAKS|1|1|[?]|HIGH|CALCULUS|ICTERIC||TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROMETER FORMULA|||Y||1|Visit_1|10|5|SCREENING|2020-12-22|2021-01-08|10|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|LB|641c8067-941a-4f1a-a7b1-4eea0242f1d7|2|GFRBSCRT|GFR from Creatinine Adjusted for BSA|CHEMISTRY|[?]|/7.5 mL|[?]|[?]|BORDERLINE|1|U/L|1|1|[?]|ABNORMAL|BASAL TEAR|THAWED||MAGNETIC RESONANCE ELASTOGRAPHY|MDRD ENZYMATIC FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-12-22|2021-03-06|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|LB|641c8067-941a-4f1a-a7b1-4eea0242f1d7|3|GSTMUCRT|Mu Glutathione-S-Transferase/Creatinine|URINALYSIS|||[?]|[?]|POSITIVE|1|g/animal|1|1|[?]|ABNORMAL|COLOSTRUM|CONTAMINATED||PATHOLOGICAL EVALUATION|FIBROTEST FORMULA|||NA|Y|2|Visit_2|25|4|FOLLOW-UP|2021-01-06|2021-03-13|25|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|641c8067-941a-4f1a-a7b1-4eea0242f1d7|4|FXIVAC|Factor XIV Actual/Control|URINALYSIS|[?]|%(v/v)|[?]|[?]|TRACE|1|mL/min/mmHg|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|REFRIGERATED||ICP-MS|HEPASCORE FORMULA||Y|NA||2|Visit_2|25|7|TREATMENT|2021-01-06|2021-01-10|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|641c8067-941a-4f1a-a7b1-4eea0242f1d7|5|PHADJT|pH Adjusted for Body Temp|CHEMISTRY|[?]|mL/cm3/min|[?]|[?]|TRACE|1|Pack Year|1|1|[?]|HIGH|SALIVA|FROZEN|N|MALDI-TOF|MDRD 4 VARIABLE FORMULA|||U||3|Visit_3|40|7|SCREENING|2021-01-21|2021-02-20|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|641c8067-941a-4f1a-a7b1-4eea0242f1d7|6|HGBEHGB|Hemoglobin E/Total Hemoglobin|CHEMISTRY|[?]|IU/kg/h|[?]|[?]|INVALID|1|10^6 CFU/mL|1|1|[?]|NORMAL|ISOLATE|UNEXPECTED ODOR||MUGA|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|4|SCREENING|2021-01-21|2021-01-27|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|641c8067-941a-4f1a-a7b1-4eea0242f1d7|7|NOREPEXR|Norepinephrine Excretion Rate|URINALYSIS|||[?]|[?]|TRACE|1|kBq|1|1|[?]|NORMAL|INTERSTITIAL FLUID|SOLIDIFIED|N|AUTOREFRACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|4|Visit_4|65|7|TREATMENT|2021-02-15|2021-02-19|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|641c8067-941a-4f1a-a7b1-4eea0242f1d7|8|APLAB|Antiphospholipid Antibodies|URINALYSIS|[?]|mL/kg/min|[?]|[?]|INDETERMINATE|1|BEAM BREAKS|1|1|[?]|NORMAL|SALIVA|LACTESCENT||ENDPOINT DILUTION ASSAY|MDRD 6 VARIABLE FORMULA||Y|Y||4|Visit_4|65|1|FOLLOW-UP|2021-02-15|2021-02-18|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|641c8067-941a-4f1a-a7b1-4eea0242f1d7|9|INSULINR|Insulin Resistance|URINALYSIS|[?]|BU|[?]|[?]|POSITIVE|1|mm2|1|1|[?]|NORMAL|NAIL|NON-HEMOLYZED||WRIGHT-GIEMSA STAIN|MDRD FORMULA|||N||5|Visit_5|90|1|SCREENING|2021-03-12|2021-03-17|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|641c8067-941a-4f1a-a7b1-4eea0242f1d7|10|C165876|Birch Pollen IgE AB RAST Score|URINALYSIS|[?]|pL|[?]|[?]|INVALID|1|10^6 organisms|1|1|[?]|HIGH|CERUMEN|LIPEMIC||CLOT DETECTION|MDRD 4 VARIABLE FORMULA|||U||5|Visit_5|90|3|SCREENING|2021-03-12|2021-03-16|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|1|TROPONT|Troponin T|URINALYSIS|[?]|mg/cm2|[?]|[?]|INDETERMINATE|1|mm/2h|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|FROZEN||SINGLE-SLICE SPIRAL CT|MDRD 5 VARIABLE FORMULA|Y||Y||1|Visit_1|10|6|WASHOUT|2020-09-24|2020-11-05|10|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|2|CYSCREAT|Cystatin C/Creatinine|HEMATOLOGY|[?]|/VF|[?]|[?]|TRACE|1|cm|1|1|[?]|LOW|MENSTRUAL BLOOD|NON-HEMOLYZED||OPTICAL MAPPING|MDRD ENZYMATIC JAPANESE FORMULA|||U||1|Visit_1|10|2|SCREENING|2020-09-24|2020-09-26|10|12|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|3|CD11B|CD11B|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|nsec|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|THAWED||CT SCAN WITHOUT CONTRAST|HEPASCORE FORMULA||Y|U|Y|2|Visit_2|25|2|TREATMENT|2020-10-09|2020-11-04|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|4|HLAMSC|HLA Mismatch Count|HEMATOLOGY|[?]|dpm/0.5 mL|[?]|[?]|BORDERLINE|1|U/L|1|1|[?]|ABNORMAL|BUFFY COAT|REFRIGERATED||CELLULAR PROLIFERATION ASSAY|MDRD FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-10-09|2020-11-27|25|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|5|C165887|EnglishPlantain Pollen IgE AB RAST Score|URINALYSIS|[?]|MAC50|[?]|[?]|BORDERLINE|1|10^3 DNA copies/mL|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|CONTAMINATED||ACCELERATOR MASS SPECTROMETRY|HEPASCORE FORMULA|Y|Y|Y||3|Visit_3|40|3|SCREENING|2020-10-24|2020-11-09|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|6|PEPSNG|Pepsinogen|HEMATOLOGY|[?]|EU|[?]|[?]|NEGATIVE|1|nmol/day|1|1|[?]|NORMAL|SEBUM|CONCENTRATED||ANTIBIOTIC AGAR SCREEN|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||3|Visit_3|40|5|SCREENING|2020-10-24|2020-11-01|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|7|NTELOCRT|N-telopeptide/Creatinine|URINALYSIS|[?]|Tbsp|[?]|[?]|TRACE|1|m/sec|1|1|[?]|NORMAL|MONOCYTE|REFRIGERATED|N|FLUORESCENT SPOT TEST|MDRD 6 VARIABLE FORMULA|Y||U||4|Visit_4|65|7|TREATMENT|2020-11-18|2020-11-26|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|8|HEMOLYSI|Hemolytic Index|CHEMISTRY|[?]|K|[?]|[?]|TRACE|1|kN/cm2|1|1|[?]|LOW|CORD BLOOD|CLOTTED|N|PHOTOGRAPHY|ASH FIBROSURE FORMULA|||N||4|Visit_4|65|6|WASHOUT|2020-11-18|2020-12-04|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|9|INTLK28|Interleukin 28|HEMATOLOGY|[?]|IU/g Hb|[?]|[?]|INDETERMINATE|1|cm/s|1|1|[?]|ABNORMAL|PLASMA|GELLED||FLOCCULATION|CKD-EPI CREATININE FORMULA|||U||5|Visit_5|90|6|SCREENING|2020-12-13|2020-12-15|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|LB|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|10|C130120|Shellfish Mix Antigen IgE Antibody|CHEMISTRY|[?]|bel|[?]|[?]|NEGATIVE|1|hr/day|1|1|[?]|ABNORMAL|KERATINOCYTE|LIPEMIC|N|ACRIDINE ORANGE STAIN|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-12-13|2020-12-21|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|LB|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|1|HPOCROM|Hypochromia|URINALYSIS|[?]|10^6 organisms/g|[?]|[?]|INVALID|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|LACTESCENT|N|IMMUNODIFFUSION|FIBROTEST FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2020-10-31|2020-12-06|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|2|GAD2|Glutamic Acid Decarboxylase 2|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Arbitrary U|1|1|[?]|NORMAL|LUNG SURFACTANT|ICTERIC||DUKE INCISION METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|1|Visit_1|10|7|TREATMENT|2020-10-31|2020-12-24|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|3|INLCLR|Inulin Clearance|HEMATOLOGY|[?]|Absorbance U/mL|[?]|[?]|BORDERLINE|1|g/L|1|1|[?]|LOW|SEBUM|CONCENTRATED||CLOT DETECTION|GMI % FORMULA|Y||Y||2|Visit_2|25|4|SCREENING|2020-11-15|2020-11-19|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|4|STBSEXCS|Standard Base Excess|CHEMISTRY|[?]|GBq/mg|[?]|[?]|NEGATIVE|1|titer|1|1|[?]|ABNORMAL|BREAST MILK|AUTOLYZED||MICROBIAL CULTURE, LIQUID|GMI % FORMULA|||NA||2|Visit_2|25|4|WASHOUT|2020-11-15|2020-11-27|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|5|ALA|Alanine|HEMATOLOGY|[?]|log10 copies/mL|[?]|[?]|BORDERLINE|1|uL/mL|1|1|[?]|LOW|PLATELET|GELLED||NUCLEIC ACID HYBRIDIZATION|FIBROTEST FORMULA||Y|U||3|Visit_3|40|2|TREATMENT|2020-11-30|2021-01-02|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|6|PTA|Prothrombin Activity|CHEMISTRY|[?]|ug/g/h|[?]|[?]|BORDERLINE|1|mL/min/mmHg|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|SOLIDIFIED|N|MICROBIAL CULTURE|CKD-EPI CYSTATIN C FORMULA|||U||3|Visit_3|40|4|TREATMENT|2020-11-30|2020-12-15|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|7|RETICH|Ret. Corpuscular Hemoglobin Content|HEMATOLOGY|[?]|dB|[?]|[?]|POSITIVE|1|10^6 DNA copies/mL|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|SOLIDIFIED||DNA MICROARRAY|GMI % FORMULA|Y||U||4|Visit_4|65|4|SCREENING|2020-12-25|2021-01-14|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|8|EDTACLR|EDTA Clearance|HEMATOLOGY|[?]|10^3 organisms/g|[?]|[?]|BORDERLINE|1|10^7 TCID 50/dose|1|1|[?]|NORMAL|MONOCYTE|LIPEMIC||MULTIPLE BREATH WASHOUT|FIBROMETER FORMULA|||Y||4|Visit_4|65|7|FOLLOW-UP|2020-12-25|2021-01-18|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|LB|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|9|LCTHSPGM|Lecithin/Sphingomyelin|CHEMISTRY|[?]|kHz|[?]|[?]|INVALID|1|Gravitational Unit|1|1|[?]|ABNORMAL|MECONIUM|CONTAMINATED||HPLC-UV|FIBROTEST FORMULA|Y|Y|N||5|Visit_5|90|5|FOLLOW-UP|2021-01-19|2021-01-20|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|10|INSAB|Insulin Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|umol/mg/min|1|1|[?]|NORMAL|CORD SERUM|DRIED|N|TONOMETRY|MDRD FORMULA|||Y|Y|5|Visit_5|90|1|TREATMENT|2021-01-19|2021-01-20|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|LB|46304edd-0b05-4819-8fcb-35cf9c02764d|1|INDICAN|Indican|HEMATOLOGY|[?]|deg2|[?]|[?]|POSITIVE|1|cg|1|1|[?]|HIGH|EMESIS|FRESH||ELECTROGASTROGRAPHY|CKD-EPI CREATININE FORMULA|||Y||1|Visit_1|10|7|WASHOUT|2020-12-03|2021-02-08|10|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|LB|46304edd-0b05-4819-8fcb-35cf9c02764d|2|ARR|Aldosterone/Renin Activity|CHEMISTRY|[?]|cpm|[?]|[?]|INDETERMINATE|1|PNU/mL|1|1|[?]|LOW|REFLEX TEAR|LIPEMIC||TEMPLATE INCISION METHOD|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y||1|Visit_1|10|4|WASHOUT|2020-12-03|2021-02-07|10|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|LB|46304edd-0b05-4819-8fcb-35cf9c02764d|3|CARNIT|Carnitine|CHEMISTRY|[?]|deg|[?]|[?]|TRACE|1|SBE/mL|1|1|[?]|NORMAL|EXPIRED AIR|CONCENTRATED||ELECTROMYOGRAPHY|CKD-EPI CREATININE FORMULA||Y|Y||2|Visit_2|25|6|TREATMENT|2020-12-18|2021-02-01|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|46304edd-0b05-4819-8fcb-35cf9c02764d|4|PCSK9|Proprotein Convertase Subtilisin/Kexin 9|URINALYSIS|||[?]|[?]|POSITIVE|1|lm|1|1|[?]|ABNORMAL|STOOL|FRESH|N|MANUAL CLOT DETECTION|CKD-EPI CREATININE FORMULA|Y||N|Y|2|Visit_2|25|5|FOLLOW-UP|2020-12-18|2021-02-02|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|46304edd-0b05-4819-8fcb-35cf9c02764d|5|TKG|T-Kininogen|CHEMISTRY|[?]|days/wk|[?]|[?]|INVALID|1|log10 IU/mL|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|LIPEMIC||ENZYMATIC SPECTROPHOTOMETRY|ASH FIBROSURE FORMULA|||U||3|Visit_3|40|4|TREATMENT|2021-01-02|2021-02-21|40|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|46304edd-0b05-4819-8fcb-35cf9c02764d|6|HALLUC|Hallucinogen|CHEMISTRY|[?]|deg/mm|[?]|[?]|BORDERLINE|1|pt_br|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED||STRESS ECHOCARDIOGRAPHY|CKD-EPI FORMULA|Y||N||3|Visit_3|40|7|SCREENING|2021-01-02|2021-02-27|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|46304edd-0b05-4819-8fcb-35cf9c02764d|7|CETP|Cholesteryl Ester Transfer Protein|HEMATOLOGY|[?]|AFU|[?]|[?]|NEGATIVE|1|mg|1|1|[?]|NORMAL|INFRANATANT, SERUM|CALCIFIED||PET/MRI SCAN|NASH FIBROSURE FORMULA||Y|N||4|Visit_4|65|2|FOLLOW-UP|2021-01-27|2021-02-24|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|46304edd-0b05-4819-8fcb-35cf9c02764d|8|IGF2|Insulin-like Growth Factor-2|CHEMISTRY|[?]|ELISA unit/dose|[?]|[?]|INVALID|1|10^8 PFU|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED||IMPULSE OSCILLOMETRY|FIBROTEST FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2021-01-27|2021-01-28|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|46304edd-0b05-4819-8fcb-35cf9c02764d|9|FIXAAC|Factor IX Activity Actual/Control|HEMATOLOGY|[?]|vp/mL|[?]|[?]|TRACE|1|ug/L FEU|1|1|[?]|HIGH|CAPILLARY BLOOD|NON-HEMOLYZED||LISSAMINE GREEN STAIN|MDRD 6 VARIABLE FORMULA|||N||5|Visit_5|90|6|SCREENING|2021-02-21|2021-02-26|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|46304edd-0b05-4819-8fcb-35cf9c02764d|10|ALBGLOB|Albumin/Globulin|CHEMISTRY|[?]|Bq/kg|[?]|[?]|TRACE|1|NFIU|1|1|[?]|NORMAL|VITREOUS HUMOR|NON-HEMOLYZED||LIGHT SCATTERING SPECTROSCOPY|MDRD 6 VARIABLE FORMULA|||NA||5|Visit_5|90|5|FOLLOW-UP|2021-02-21|2021-02-22|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|3fd6dab2-b35f-4cc5-88dd-b507583d9539|1|TNF12S|Soluble TNF Superfamily Member 12|HEMATOLOGY|[?]|log10 CFU/mL|[?]|[?]|POSITIVE|1|Enzyme U|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|LACTESCENT||TRIPLE-PHASE MRI SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||1|Visit_1|10|5|SCREENING|2020-05-26|2020-08-03|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|3fd6dab2-b35f-4cc5-88dd-b507583d9539|2|ANGPT2|Angiopoietin 2|HEMATOLOGY|[?]|mL/kg/day|[?]|[?]|NEGATIVE|1|kIU|1|1|[?]|NORMAL|VENOUS PLASMA|PARAFFIN-EMBEDDED||CONTRAST ENHANCED PET SCAN|GMI % FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-05-26|2020-07-13|10|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|3fd6dab2-b35f-4cc5-88dd-b507583d9539|3|C165892|Wild Rye Pollen IgE Antibody|CHEMISTRY|[?]|ng/dL|[?]|[?]|INDETERMINATE|1|hPa|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|GELLED||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD ENZYMATIC FORMULA||Y|NA||2|Visit_2|25|3|TREATMENT|2020-06-10|2020-08-10|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|3fd6dab2-b35f-4cc5-88dd-b507583d9539|4|PLAT|Platelets|URINALYSIS|||[?]|[?]|POSITIVE|1|ms2|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|LACTESCENT||COMPLEMENT FIXATION|CKD-EPI FORMULA|||N|Y|2|Visit_2|25|1|WASHOUT|2020-06-10|2020-06-29|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|3fd6dab2-b35f-4cc5-88dd-b507583d9539|5|CD3LY|CD3/Lymphocytes|CHEMISTRY|[?]|1/(s*kPa)|[?]|[?]|POSITIVE|1|hr/day|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|AGGLUTINATED|N|SNELLEN EYE CHART|FIBROTEST FORMULA|Y||U||3|Visit_3|40|1|WASHOUT|2020-06-25|2020-08-12|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|3fd6dab2-b35f-4cc5-88dd-b507583d9539|6|VEGFA|Vascular Endothelial Growth Factor A|CHEMISTRY|||[?]|[?]|TRACE|1|Hz/s|1|1|[?]|HIGH|PLATELET|REFRIGERATED|N|COMPLEMENT FIXATION|MDRD 4 VARIABLE FORMULA||Y|N|Y|3|Visit_3|40|6|TREATMENT|2020-06-25|2020-07-30|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|3fd6dab2-b35f-4cc5-88dd-b507583d9539|7|MCSF|Macrophage Colony Stimulating Factor|CHEMISTRY|[?]|eq|[?]|[?]|POSITIVE|1|RATIO|1|1|[?]|NORMAL|FLUID|NON-HEMOLYZED|N|ELECTROCHEMILUMINESCENCE|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|6|SCREENING|2020-07-20|2020-08-19|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-18
e|LB|3fd6dab2-b35f-4cc5-88dd-b507583d9539|8|GLYHLACD|Glycocholic Acid|HEMATOLOGY|[?]|10^6 CFU/mL|[?]|[?]|TRACE|1|Ci/uL|1|1|[?]|NORMAL|CORD BLOOD|LIPEMIC||CT SCAN WITHOUT CONTRAST|CKD-EPI FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-07-20|2020-08-19|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-18
e|LB|3fd6dab2-b35f-4cc5-88dd-b507583d9539|9|ALB|Albumin|URINALYSIS|||[?]|[?]|INVALID|1|IMPLANT|1|1|[?]|HIGH|CELL PELLET|NON-HEMOLYZED||AUSCULTATION|GMI MMOL/MOL FORMULA|||Y|Y|5|Visit_5|90|2|SCREENING|2020-08-14|2020-08-22|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|3fd6dab2-b35f-4cc5-88dd-b507583d9539|10|INTLK8|Interleukin 8|URINALYSIS|[?]|WAFER|[?]|[?]|INDETERMINATE|1|Gauss|1|1|[?]|LOW|PROSTATIC FLUID|ROOM TEMPERATURE||TOLUIDINE BLUE STAIN|GMI % FORMULA|||N||5|Visit_5|90|4|TREATMENT|2020-08-14|2020-08-17|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|daa3b89e-637a-43de-86c1-d0db93f00430|1|CD14|CD14|HEMATOLOGY|[?]|10^3 CFU/g|[?]|[?]|NEGATIVE|1|Bq/ug|1|1|[?]|LOW|REFLEX TEAR|CONTAMINATED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|FIBROTEST FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-10-11|2020-12-07|10|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|daa3b89e-637a-43de-86c1-d0db93f00430|2|ASTAG|Aspartate Aminotransferase Antigen|HEMATOLOGY|[?]|U/m2/min|[?]|[?]|INVALID|1|vp/mL|1|1|[?]|NORMAL|PLEURAL FLUID|FROZEN||IMMUNO-PET SCAN|CKD-EPI CREATININE FORMULA|||Y||1|Visit_1|10|6|FOLLOW-UP|2020-10-11|2020-11-13|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|daa3b89e-637a-43de-86c1-d0db93f00430|3|RNPSMAB|Ribonucleoprotein Smith Complex Antibody|HEMATOLOGY|[?]|psi|[?]|[?]|TRACE|1|CFU/mL|1|1|[?]|NORMAL|INTERSTITIAL FLUID|SOLIDIFIED||WEBER GREEN STAIN|COCKCROFT-GAULT FORMULA|||N||2|Visit_2|25|7|SCREENING|2020-10-26|2020-11-27|25|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|daa3b89e-637a-43de-86c1-d0db93f00430|4|COCAETH|Cocaethylene|URINALYSIS|[?]|dpm/mg|[?]|[?]|NEGATIVE|1|cy/cm|1|1|[?]|ABNORMAL|LYMPH|LIPEMIC|N|NEPHELOMETRY|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|5|TREATMENT|2020-10-26|2020-12-05|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|daa3b89e-637a-43de-86c1-d0db93f00430|5|MCP1|Monocyte Chemotactic Protein 1|CHEMISTRY|||[?]|[?]|INVALID|1|U/animal|1|1|[?]|ABNORMAL|URINE SEDIMENT|CONCENTRATED||MACRO BROTH DILUTION|MDRD 6 VARIABLE FORMULA||Y|N|Y|3|Visit_3|40|6|TREATMENT|2020-11-10|2020-12-19|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|daa3b89e-637a-43de-86c1-d0db93f00430|6|C3DAB|Complement C3d Antibody|HEMATOLOGY|||[?]|[?]|INVALID|1|mol/L|1|1|[?]|NORMAL|CORD BLOOD|CALCIFIED||PHOTOMETRIC CLOT DETECTION|NASH FIBROSURE FORMULA|Y||N|Y|3|Visit_3|40|5|TREATMENT|2020-11-10|2020-12-05|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|daa3b89e-637a-43de-86c1-d0db93f00430|7|RNPAB|Ribonucleoprotein Antibody|URINALYSIS|||[?]|[?]|POSITIVE|1|mg/kg/day|1|1|[?]|LOW|SEMEN|DRIED|N|PHOTOMETRIC CLOT DETECTION|GMI MMOL/MOL FORMULA|||N|Y|4|Visit_4|65|6|TREATMENT|2020-12-05|2021-01-06|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|daa3b89e-637a-43de-86c1-d0db93f00430|8|MMP8|Matrix Metalloproteinase 8|CHEMISTRY|[?]|umol/L|[?]|[?]|INDETERMINATE|1|RATIO|1|1|[?]|NORMAL|CERUMEN|ROOM TEMPERATURE||IMMUNOFIXATION ELECTROPHORESIS|CKD-EPI CREATININE FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-12-05|2020-12-22|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|daa3b89e-637a-43de-86c1-d0db93f00430|9|FBNCTPL|Fibronectin, Plasma|CHEMISTRY|[?]|mmol/kg|[?]|[?]|POSITIVE|1|/200 HPFs|1|1|[?]|NORMAL|PLATELET|SOLIDIFIED|N|IMMUNOFLUORESCENT STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-12-30|2021-01-01|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|daa3b89e-637a-43de-86c1-d0db93f00430|10|PEPSNGC|Pepsinogen C|URINALYSIS|[?]|mN|[?]|[?]|TRACE|1|lx|1|1|[?]|NORMAL|MUSCLE TISSUE|FRESH||SPIRAL CT SCAN WITHOUT CONTRAST|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|7|FOLLOW-UP|2020-12-30|2021-01-04|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|1|ANIONG4|Anion Gap 4|CHEMISTRY|||[?]|[?]|BORDERLINE|1|HOMEOPATHIC DILUTION|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE||GC/MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|2|TREATMENT|2020-07-04|2020-07-24|10|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|2|DPD|Deoxypyridinoline|CHEMISTRY|||[?]|[?]|TRACE|1|cpm|1|1|[?]|ABNORMAL|MUSCLE TISSUE|CONTAMINATED||IRON HEMATOXYLIN STAIN|MDRD 5 VARIABLE FORMULA|||U|Y|1|Visit_1|10|1|WASHOUT|2020-07-04|2020-08-21|10|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|3|C4A|Complement C4a|URINALYSIS|[?]|YEARS|[?]|[?]|BORDERLINE|1|CCID 50/dose|1|1|[?]|ABNORMAL|SPUTUM|ICTERIC|N|ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||2|Visit_2|25|6|TREATMENT|2020-07-19|2020-09-08|25|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|4|TUDCA|Tauroursodeoxycholate|CHEMISTRY|[?]|mg/m2/min|[?]|[?]|INVALID|1|anti-Xa IU/mL|1|1|[?]|NORMAL|REFLEX TEAR|LIPEMIC||FREEZING POINT DEPRESSION|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|2|WASHOUT|2020-07-19|2020-09-11|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|5|VITE|Vitamin E|URINALYSIS|[?]|mL/m2/min|[?]|[?]|POSITIVE|1|mg|1|1|[?]|LOW|CAPILLARY PLASMA|AGGLUTINATED||ENZYMATIC ULTRACENTRIFUGATION|FIBROTEST FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-08-03|2020-09-12|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|6|UREA|Urea|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|AU/mL|1|1|[?]|HIGH|VENOUS BLOOD|FROZEN||SISH|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|3|Visit_3|40|6|SCREENING|2020-08-03|2020-08-16|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|7|HPOCROM|Hypochromia|URINALYSIS|[?]|uIU/L|[?]|[?]|BORDERLINE|1|K|1|1|[?]|HIGH|INFRANATANT, SERUM|CLOTTED||REFRACTOMETRY|CKD-EPI CYSTATIN C FORMULA|Y||U||4|Visit_4|65|7|FOLLOW-UP|2020-08-28|2020-09-19|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|8|BASOIMLE|Immature Basophils/Leukocytes|HEMATOLOGY|[?]|CYLINDER|[?]|[?]|NEGATIVE|1|min*mg/mL|1|1|[?]|HIGH|BONE|ICTERIC||ELISPOT|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|1|TREATMENT|2020-08-28|2020-09-17|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|9|HEMOLYSI|Hemolytic Index|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mg/animal|1|1|[?]|HIGH|PUS|CONTAMINATED||TOTAL BODY IRRADIATION|MDRD 6 VARIABLE FORMULA||Y|NA|Y|5|Visit_5|90|7|TREATMENT|2020-09-22|2020-09-29|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|10|CSAB|Cathepsin Antibody|URINALYSIS|||[?]|[?]|TRACE|1|10^6 organisms/mL|1|1|[?]|HIGH|PERITONEAL FLUID|CONTAMINATED||SISH|MDRD 5 VARIABLE FORMULA||Y|NA|Y|5|Visit_5|90|6|FOLLOW-UP|2020-09-22|2020-10-01|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|c22014f2-2d7b-4897-8ad5-e46785e51837|1|APOB|Apolipoprotein B|HEMATOLOGY|[?]|mL*cmH2O|[?]|[?]|INDETERMINATE|1|rpm|1|1|[?]|NORMAL|PLEURAL TISSUE|PARAFFIN-EMBEDDED|N|BETA LACTAMASE|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-08-13|2020-11-06|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|c22014f2-2d7b-4897-8ad5-e46785e51837|2|AMYLASEP|Amylase, Pancreatic|URINALYSIS|[?]|DISK|[?]|[?]|TRACE|1|Gy/h|1|1|[?]|LOW|SOFT TISSUE|ROOM TEMPERATURE||NUCLEIC ACID BASED METHOD|MDRD 6 VARIABLE FORMULA|Y||NA||1|Visit_1|10|2|TREATMENT|2020-08-13|2020-09-20|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|c22014f2-2d7b-4897-8ad5-e46785e51837|3|NRP1|Neuropilin-1|CHEMISTRY|[?]|TABLET|[?]|[?]|INDETERMINATE|1|Bq|1|1|[?]|HIGH|BONE|LIPEMIC||IVY INCISION METHOD|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-08-28|2020-10-28|25|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|c22014f2-2d7b-4897-8ad5-e46785e51837|4|PLATBIZ|Bizarre Platelets|URINALYSIS|[?]|ngEq/L|[?]|[?]|TRACE|1|Bq/L|1|1|[?]|ABNORMAL|SOFT TISSUE|HEMOLYZED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD FORMULA|Y||Y||2|Visit_2|25|1|TREATMENT|2020-08-28|2020-09-14|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|c22014f2-2d7b-4897-8ad5-e46785e51837|5|HAIRYCE|Hairy Cells|URINALYSIS|[?]|ft|[?]|[?]|TRACE|1|mg|1|1|[?]|HIGH|URINE SEDIMENT|REFRIGERATED||PHOROPTER|HEPASCORE FORMULA|||U||3|Visit_3|40|4|TREATMENT|2020-09-12|2020-10-30|40|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|LB|c22014f2-2d7b-4897-8ad5-e46785e51837|6|TRH|Thyrotropin Releasing Hormone|HEMATOLOGY|[?]|SYRINGE|[?]|[?]|INDETERMINATE|1|pmol/L/h|1|1|[?]|NORMAL|CELL PELLET|ROOM TEMPERATURE||PULMONARY ANGIOGRAPHY|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|2|FOLLOW-UP|2020-09-12|2020-10-12|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|LB|c22014f2-2d7b-4897-8ad5-e46785e51837|7|NEUTIMLE|Immature Neutrophils/Leukocytes|URINALYSIS|[?]|USP U|[?]|[?]|INVALID|1|cmHg|1|1|[?]|NORMAL|EXPIRED AIR|GELLED|N|STRESS ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|6|SCREENING|2020-10-07|2020-10-18|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|c22014f2-2d7b-4897-8ad5-e46785e51837|8|GAD2|Glutamic Acid Decarboxylase 2|CHEMISTRY|[?]|10^9 CFU/g|[?]|[?]|POSITIVE|1|VOXEL|1|1|[?]|HIGH|VITREOUS HUMOR|SOLIDIFIED||HPLC/MS|COCKCROFT-GAULT FORMULA||Y|N||4|Visit_4|65|5|TREATMENT|2020-10-07|2020-10-30|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|c22014f2-2d7b-4897-8ad5-e46785e51837|9|INTLK25|Interleukin 25|URINALYSIS|[?]|Absorbance U/mL|[?]|[?]|TRACE|1|PFU|1|1|[?]|ABNORMAL|PLEURAL TISSUE|UNEXPECTED ODOR||RAJI CELL EIA|CKD-EPI CREATININE FORMULA|||N||5|Visit_5|90|4|TREATMENT|2020-11-01|2020-11-09|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|LB|c22014f2-2d7b-4897-8ad5-e46785e51837|10|C147278|Glycine max Antigen IgE Antibody|HEMATOLOGY|||[?]|[?]|INVALID|1|10^9 organisms/mL|1|1|[?]|LOW|MUSCLE TISSUE|REFRIGERATED||OPTICAL DENSITY MEASUREMENT|CKD-EPI FORMULA||Y|U|Y|5|Visit_5|90|3|SCREENING|2020-11-01|2020-11-09|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|LB|987102b2-fe2f-4d72-b8dc-14a71bf034b5|1|MYBLAT2|Type II Myeloblasts|URINALYSIS|||[?]|[?]|INDETERMINATE|1|10^3/L|1|1|[?]|LOW|MECONIUM|NON-HEMOLYZED||GC/MS-CI|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|1|Visit_1|10|5|TREATMENT|2020-10-11|2020-12-27|10|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|987102b2-fe2f-4d72-b8dc-14a71bf034b5|2|DRVVTSCR|DRVVT Screen to Confirm Ratio|HEMATOLOGY|[?]|L/s/kPa|[?]|[?]|BORDERLINE|1|SPRAY|1|1|[?]|ABNORMAL|PUS|THAWED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD FORMULA|Y||U||1|Visit_1|10|1|WASHOUT|2020-10-11|2020-12-29|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|987102b2-fe2f-4d72-b8dc-14a71bf034b5|3|TNFR5S|Soluble TNF Receptor Superfamily Mem 5|URINALYSIS|[?]|RATIO|[?]|[?]|INDETERMINATE|1|/10^4|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|UNEXPECTED ODOR||ICC|MDRD 6 VARIABLE FORMULA|||N||2|Visit_2|25|1|SCREENING|2020-10-26|2021-01-05|25|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|987102b2-fe2f-4d72-b8dc-14a71bf034b5|4|RBCNURBC|Nucleated Erythrocytes/Erythrocytes|HEMATOLOGY|||[?]|[?]|INVALID|1|ug/kg|1|1|[?]|NORMAL|TUMOR TISSUE|CLOTTED||TOLUIDINE BLUE STAIN|CKD-EPI CREATININE FORMULA|||NA|Y|2|Visit_2|25|2|TREATMENT|2020-10-26|2020-11-29|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|987102b2-fe2f-4d72-b8dc-14a71bf034b5|5|FGF19|Fibroblast Growth Factor 19|CHEMISTRY|[?]|ukat|[?]|[?]|POSITIVE|1|DRINK|1|1|[?]|HIGH|SEMINAL FLUID|FROZEN||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||3|Visit_3|40|5|SCREENING|2020-11-10|2020-11-25|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|LB|987102b2-fe2f-4d72-b8dc-14a71bf034b5|6|INR|Prothrombin Intl. Normalized Ratio|URINALYSIS|[?]|nmol/L/min|[?]|[?]|INDETERMINATE|1|ng|1|1|[?]|HIGH|GASTRIC CONTENTS|CLOTTED|N|RAJI CELL RIA|GMI MMOL/MOL FORMULA|Y||N||3|Visit_3|40|6|TREATMENT|2020-11-10|2020-12-26|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|LB|987102b2-fe2f-4d72-b8dc-14a71bf034b5|7|NACLR|Sodium Clearance|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ug/mol|1|1|[?]|LOW|SPUTUM|CALCIFIED|N|FUNCTIONAL MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y|Y|4|Visit_4|65|7|SCREENING|2020-12-05|2020-12-23|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|987102b2-fe2f-4d72-b8dc-14a71bf034b5|8|CYAMMOX|Ammonium Oxalate Crystals|URINALYSIS|||[?]|[?]|NEGATIVE|1|cm/min|1|1|[?]|LOW|AMNIOTIC FLUID|AGGLUTINATED||BIOPSY|MDRD 4 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|6|TREATMENT|2020-12-05|2020-12-16|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|987102b2-fe2f-4d72-b8dc-14a71bf034b5|9|GFRBSCUA|GFR from Creat,UreaN,Alb Adj BSA|CHEMISTRY|[?]|mL/kg|[?]|[?]|NEGATIVE|1|Ci/kg|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|FRESH||CONFOCAL MICROSCOPY|MDRD 5 VARIABLE FORMULA||Y|U||5|Visit_5|90|6|FOLLOW-UP|2020-12-30|2021-01-05|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|987102b2-fe2f-4d72-b8dc-14a71bf034b5|10|IRONEXR|Iron Excretion Rate|CHEMISTRY|[?]|/100 WBC|[?]|[?]|POSITIVE|1|ug/kg/day|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|FROZEN||PHASE-CONTRAST MRI|COCKCROFT-GAULT FORMULA||Y|N||5|Visit_5|90|6|FOLLOW-UP|2020-12-30|2021-01-03|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|24ce0c77-1921-4b87-91da-3627e2afd399|1|C3B|Complement C3b|CHEMISTRY|||[?]|[?]|NEGATIVE|1|g/g/day|1|1|[?]|NORMAL|SOFT TISSUE|ICTERIC||CONTRAST ENHANCED PET SCAN|GMI MMOL/MOL FORMULA|||U|Y|1|Visit_1|10|1|TREATMENT|2021-01-29|2021-04-26|10|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-15
e|LB|24ce0c77-1921-4b87-91da-3627e2afd399|2|PC3MPSAM|PCA3 mRNA/PSA mRNA|URINALYSIS|[?]|pt_us|[?]|[?]|INVALID|1|log10 IU/mL|1|1|[?]|HIGH|SMEGMA|THAWED||MYELOPEROXIDASE STAIN|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|5|TREATMENT|2021-01-29|2021-03-08|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-15
e|LB|24ce0c77-1921-4b87-91da-3627e2afd399|3|ESELECT|E-Selectin|CHEMISTRY|[?]|/kg|[?]|[?]|POSITIVE|1|U/kg|1|1|[?]|NORMAL|PROSTATIC FLUID|LACTESCENT||BALLPOINT PEN TECHNIQUE|MDRD 4 VARIABLE FORMULA||Y|N||2|Visit_2|25|3|SCREENING|2021-02-13|2021-03-13|25|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-13
e|LB|24ce0c77-1921-4b87-91da-3627e2afd399|4|UREACRT|Urea/Creatinine|URINALYSIS|||[?]|[?]|NEGATIVE|1|Newton|1|1|[?]|HIGH|ERYTHROCYTES|NON-HEMOLYZED||LANDOLT RING|MDRD FORMULA|||N|Y|2|Visit_2|25|1|SCREENING|2021-02-13|2021-04-18|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-13
e|LB|24ce0c77-1921-4b87-91da-3627e2afd399|5|VITB3|Niacin|CHEMISTRY|[?]|MnFI|[?]|[?]|BORDERLINE|1|mEq/g|1|1|[?]|HIGH|BONE MARROW|FRESH||OBSERVATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2021-02-28|2021-04-16|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|LB|24ce0c77-1921-4b87-91da-3627e2afd399|6|VEGFA|Vascular Endothelial Growth Factor A|CHEMISTRY|[?]|V|[?]|[?]|TRACE|1|cm/min|1|1|[?]|NORMAL|NAIL|ICTERIC||PANENDOSCOPY|CKD-EPI FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2021-02-28|2021-04-10|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|LB|24ce0c77-1921-4b87-91da-3627e2afd399|7|MYBLAT3|Type III Myeloblasts|CHEMISTRY|[?]|10^3/hpf|[?]|[?]|TRACE|1|mL/animal/wk|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|ROOM TEMPERATURE||WEBER GREEN STAIN|HEPASCORE FORMULA|Y||N||4|Visit_4|65|1|WASHOUT|2021-03-25|2021-04-01|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|24ce0c77-1921-4b87-91da-3627e2afd399|8|OXYSAT|Oxygen Saturation|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|C|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|DRIED||CYSTOSCOPY|MDRD FORMULA|||NA|Y|4|Visit_4|65|6|WASHOUT|2021-03-25|2021-04-14|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|24ce0c77-1921-4b87-91da-3627e2afd399|9|FACTIII|Factor III|URINALYSIS|[?]|10^9/g|[?]|[?]|POSITIVE|1|Bq/mL|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|REFRIGERATED||REFRACTOMETRY|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2021-04-19|2021-04-27|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|24ce0c77-1921-4b87-91da-3627e2afd399|10|MYCEMPOL|Myeloid Maturation Pool|URINALYSIS|[?]|cg|[?]|[?]|INVALID|1|Bq/kg|1|1|[?]|HIGH|BONE MARROW|HEMOLYZED||IRON HEMATOXYLIN STAIN|CKD-EPI CYSTATIN C FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2021-04-19|2021-04-25|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|1|CANNAB|Cannabinoids|URINALYSIS|||[?]|[?]|TRACE|1|POUCH|1|1|[?]|NORMAL|DISCHARGE|DRIED|N|NEURAMINIDASE INHIBITION ASSAY|ASH FIBROSURE FORMULA|||N|Y|1|Visit_1|10|2|FOLLOW-UP|2020-08-20|2020-10-10|10|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|2|TLYCE|T-Lymphocytes|CHEMISTRY|[?]|Hounsfield Unit|[?]|[?]|TRACE|1|uOsm|1|1|[?]|HIGH|PROSTATIC FLUID|CONTAMINATED||EEG|GMI % FORMULA||Y|N||1|Visit_1|10|4|TREATMENT|2020-08-20|2020-09-18|10|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|3|ALPCREAT|Alkaline Phosphatase/Creatinine|CHEMISTRY|[?]|BOLUS|[?]|[?]|TRACE|1|nmol/L/min|1|1|[?]|NORMAL|DIALYSIS FLUID|REFRIGERATED||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|NA||2|Visit_2|25|6|TREATMENT|2020-09-04|2020-10-23|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|4|PLATSAT|Platelet Satellitism|URINALYSIS|[?]|kN/cm2|[?]|[?]|BORDERLINE|1|uL|1|1|[?]|LOW|REFLEX TEAR|UNEXPECTED ODOR||CONTRAST ENHANCED X-RAY|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-09-04|2020-11-01|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|5|BNZDZPN|Benzodiazepine|HEMATOLOGY|||[?]|[?]|INVALID|1|mmol/mol|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|FROZEN||MEDIASTINOSCOPY|GMI MMOL/MOL FORMULA|||N|Y|3|Visit_3|40|6|SCREENING|2020-09-19|2020-09-26|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|6|PHNBRBTL|Phenobarbital|HEMATOLOGY|[?]|kN/cm2|[?]|[?]|TRACE|1|SYRINGE|1|1|[?]|NORMAL|HAIR|GELLED||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA|Y|Y|N||3|Visit_3|40|1|SCREENING|2020-09-19|2020-10-21|40|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|7|NSPMTSPM|Normal Sperm/Total Sperm|URINALYSIS|[?]|kg/cm2|[?]|[?]|POSITIVE|1|BOLUS|1|1|[?]|LOW|NAIL|NON-HEMOLYZED||DUKE INCISION METHOD|FIBROMETER FORMULA|||Y||4|Visit_4|65|3|SCREENING|2020-10-14|2020-10-23|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|8|CD3LY|CD3/Lymphocytes|HEMATOLOGY|[?]|log10 TCID 50/uL|[?]|[?]|NEGATIVE|1|BP|1|1|[?]|ABNORMAL|LUNG SURFACTANT|CLOTTED|N|ORCHIDOMETERY|MDRD 4 VARIABLE FORMULA|||U||4|Visit_4|65|7|TREATMENT|2020-10-14|2020-10-15|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|9|TMZPM|Temazepam|HEMATOLOGY|||[?]|[?]|INVALID|1|kPa/L/sec|1|1|[?]|HIGH|ADIPOSE TISSUE|CONTAMINATED||HEMAGGLUTINATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|5|Visit_5|90|6|TREATMENT|2020-11-08|2020-11-17|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|10|STIPBASO|Basophilic Stippling|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|dyn|1|1|[?]|LOW|CIRCULATING TUMOR CELL|FROZEN||PELLI-ROBSON EYE CHART|MDRD 4 VARIABLE FORMULA||Y|N|Y|5|Visit_5|90|5|SCREENING|2020-11-08|2020-11-10|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|f4b83a72-7cde-4e02-8883-05e789c617a8|1|GSTMUCRT|Mu Glutathione-S-Transferase/Creatinine|URINALYSIS|[?]|U/animal|[?]|[?]|BORDERLINE|1|mL/cm H2O|1|1|[?]|HIGH|PLATELET RICH PLASMA|AGGLUTINATED||JAFFE REACTION|MDRD ENZYMATIC FORMULA|||U||1|Visit_1|10|6|SCREENING|2020-12-25|2021-03-04|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|LB|f4b83a72-7cde-4e02-8883-05e789c617a8|2|ADH|Antidiuretic Hormone|URINALYSIS|[?]|dpm/mL|[?]|[?]|INVALID|1|IU|1|1|[?]|HIGH|KERATINOCYTE|CONTAMINATED|N|MEDIASTINOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|7|SCREENING|2020-12-25|2021-01-17|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|LB|f4b83a72-7cde-4e02-8883-05e789c617a8|3|METHPHEN|Methylphenidate|HEMATOLOGY|[?]|Siemens|[?]|[?]|TRACE|1|JDF Unit|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|SOLIDIFIED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||Y|N||2|Visit_2|25|3|TREATMENT|2021-01-09|2021-01-24|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|f4b83a72-7cde-4e02-8883-05e789c617a8|4|FACTXIII|Factor XIII|CHEMISTRY|||[?]|[?]|INVALID|1|FEU|1|1|[?]|LOW|FLUID|CONTAMINATED||SPIRAL CT SCAN WITHOUT CONTRAST|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|2|Visit_2|25|3|SCREENING|2021-01-09|2021-03-12|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|f4b83a72-7cde-4e02-8883-05e789c617a8|5|ROUNDCE|Round Cells|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|cm H2O|1|1|[?]|NORMAL|LYMPH|PARAFFIN-EMBEDDED||BIOPSY|FIBROMETER FORMULA|Y||N|Y|3|Visit_3|40|4|TREATMENT|2021-01-24|2021-02-15|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|f4b83a72-7cde-4e02-8883-05e789c617a8|6|DRVVT|Dilute Russell's Viper Venom Time|CHEMISTRY|[?]|DROP|[?]|[?]|POSITIVE|1|/sec|1|1|[?]|NORMAL|PLATELET POOR PLASMA|SOLIDIFIED||AUSCULTATION|MDRD 4 VARIABLE FORMULA|Y||N||3|Visit_3|40|2|SCREENING|2021-01-24|2021-02-19|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|f4b83a72-7cde-4e02-8883-05e789c617a8|7|ASTCREAT|Aspartate Aminotransferase/Creatinine|URINALYSIS|[?]|/LPF|[?]|[?]|POSITIVE|1|PIXELS/in|1|1|[?]|LOW|BONE|LIPEMIC||NUCLEIC ACID SEQUENCING|MDRD 5 VARIABLE FORMULA|||U||4|Visit_4|65|5|SCREENING|2021-02-18|2021-03-11|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|f4b83a72-7cde-4e02-8883-05e789c617a8|8|EUDCA|Epimerized Ursodeoxycholate|URINALYSIS|||[?]|[?]|BORDERLINE|1|U/animal|1|1|[?]|HIGH|EPIDERMAL TISSUE|AUTOLYZED||KINYOUN STAIN|GMI % FORMULA|||N|Y|4|Visit_4|65|7|TREATMENT|2021-02-18|2021-03-11|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|f4b83a72-7cde-4e02-8883-05e789c617a8|9|PCNAG|Proliferating Cell Nuclear Antigen|URINALYSIS|||[?]|[?]|TRACE|1|ug/kg/min|1|1|[?]|LOW|ENDOMETRIAL TISSUE|THAWED|N|NEXT GENERATION SEQUENCING|CKD-EPI CREATININE FORMULA|||NA|Y|5|Visit_5|90|2|TREATMENT|2021-03-15|2021-03-17|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|f4b83a72-7cde-4e02-8883-05e789c617a8|10|HEINZ|Heinz Bodies|URINALYSIS|[?]|ukat|[?]|[?]|NEGATIVE|1|Pa|1|1|[?]|ABNORMAL|HAIR|ICTERIC|N|PHASE CONTRAST MICROSCOPY|FIBROMETER FORMULA|||NA||5|Visit_5|90|5|WASHOUT|2021-03-15|2021-03-20|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|LB|c4087538-422a-4bcf-af25-ed4aab36ed4b|1|IGFBP1|Insulin-Like Growth Factor Binding Prot1|HEMATOLOGY|[?]|L/s|[?]|[?]|NEGATIVE|1|mg/kg/min|1|1|[?]|ABNORMAL|ISOLATE|CLOTTED||CYSTOSCOPY|FIBROTEST FORMULA|||U||1|Visit_1|10|3|SCREENING|2021-01-09|2021-01-20|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|c4087538-422a-4bcf-af25-ed4aab36ed4b|2|BD2|Beta-defensin 2|CHEMISTRY|||[?]|[?]|TRACE|1|ft3|1|1|[?]|NORMAL|DERMAL TISSUE|UNEXPECTED ODOR||DOUBLE IMMUNODIFFUSION|ASH FIBROSURE FORMULA||Y|N|Y|1|Visit_1|10|5|TREATMENT|2021-01-09|2021-03-04|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|c4087538-422a-4bcf-af25-ed4aab36ed4b|3|V25HD2|25-Hydroxyvitamin D2|CHEMISTRY|[?]|Shock Wave|[?]|[?]|INDETERMINATE|1|nkat/L|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|FROZEN|N|TARGETED GENOME SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||2|Visit_2|25|3|TREATMENT|2021-01-24|2021-03-13|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|c4087538-422a-4bcf-af25-ed4aab36ed4b|4|ESTRIOLF|Estriol, Free|URINALYSIS|[?]|beats/min|[?]|[?]|NEGATIVE|1|1/(s*kPa)|1|1|[?]|ABNORMAL|TISSUE|UNEXPECTED ODOR||CALIPER MEASUREMENT METHOD|NASH FIBROSURE FORMULA|Y||U||2|Visit_2|25|2|FOLLOW-UP|2021-01-24|2021-02-18|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|c4087538-422a-4bcf-af25-ed4aab36ed4b|5|DSG1AB|Desmoglein 1 Antibody|CHEMISTRY|[?]|GLOBULE|[?]|[?]|BORDERLINE|1|uU/dL|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR||SMEAR|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||3|Visit_3|40|7|TREATMENT|2021-02-08|2021-03-31|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|LB|c4087538-422a-4bcf-af25-ed4aab36ed4b|6|NFLP|Neurofilament Light Chain Protein|HEMATOLOGY|[?]|ug/kg/h|[?]|[?]|INDETERMINATE|1|fmol/L|1|1|[?]|NORMAL|MENSTRUAL BLOOD|FRESH|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|NASH FIBROSURE FORMULA||Y|N||3|Visit_3|40|3|FOLLOW-UP|2021-02-08|2021-03-20|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|LB|c4087538-422a-4bcf-af25-ed4aab36ed4b|7|NORMETA|Normetanephrine|CHEMISTRY|[?]|mOsm/kg|[?]|[?]|INDETERMINATE|1|10^3/hpf|1|1|[?]|ABNORMAL|PROSTATIC FLUID|FROZEN||LANDOLT RING|GMI MMOL/MOL FORMULA|Y||Y||4|Visit_4|65|1|SCREENING|2021-03-05|2021-04-01|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|c4087538-422a-4bcf-af25-ed4aab36ed4b|8|TRP1TRG1|Trypsin 1 and Trypsinogen 1|URINALYSIS|[?]|Torr|[?]|[?]|TRACE|1|IU|1|1|[?]|LOW|SERUM|ROOM TEMPERATURE||TOTAL BODY RADIOGRAPHY|GMI % FORMULA|||N||4|Visit_4|65|3|FOLLOW-UP|2021-03-05|2021-04-07|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|c4087538-422a-4bcf-af25-ed4aab36ed4b|9|NEOPTERN|Neopterin|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|U/mg|1|1|[?]|ABNORMAL|DERMAL TISSUE|ROOM TEMPERATURE||DIFFUSION WEIGHTED MRI|MDRD ENZYMATIC FORMULA|||U|Y|5|Visit_5|90|2|FOLLOW-UP|2021-03-30|2021-04-05|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|c4087538-422a-4bcf-af25-ed4aab36ed4b|10|WDR26|WD Repeat-Containing Protein 26|HEMATOLOGY|[?]|ohm|[?]|[?]|BORDERLINE|1|/LPF|1|1|[?]|HIGH|SUPERNATANT, PLASMA|LIPEMIC||CLINICAL EVALUATION|MDRD FORMULA|Y||U||5|Visit_5|90|1|TREATMENT|2021-03-30|2021-04-02|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|947aefaf-20c7-47fc-ac56-140f9b6f38f3|1|CRYOFBRN|Cryofibrinogen|CHEMISTRY|[?]|ug/kg/min|[?]|[?]|BORDERLINE|1|BOX|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|AUTOLYZED||PULSE OXIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA||1|Visit_1|10|3|WASHOUT|2020-11-06|2020-12-15|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|947aefaf-20c7-47fc-ac56-140f9b6f38f3|2|C130074|Birch Pollen IgG|CHEMISTRY|[?]|F|[?]|[?]|INDETERMINATE|1|DNA copies/mL|1|1|[?]|LOW|PLATELET|DRIED||HPLC-FL|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||1|Visit_1|10|7|TREATMENT|2020-11-06|2020-11-09|10|13|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|947aefaf-20c7-47fc-ac56-140f9b6f38f3|3|EOTAXIN2|Eotaxin-2|HEMATOLOGY|[?]|10^4 CFU|[?]|[?]|INVALID|1|U/m2/min|1|1|[?]|HIGH|GASTRIC FLUID|AGGLUTINATED|N|IVY INCISION METHOD|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|3|FOLLOW-UP|2020-11-21|2020-12-12|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|947aefaf-20c7-47fc-ac56-140f9b6f38f3|4|CX3CL1|Chemokine (C-X3-C Motif) Ligand 1|URINALYSIS|[?]|g/day|[?]|[?]|TRACE|1|mmol|1|1|[?]|HIGH|MENSTRUAL BLOOD|REFRIGERATED||LIGHT SCATTERING SPECTROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|2|TREATMENT|2020-11-21|2020-12-11|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|947aefaf-20c7-47fc-ac56-140f9b6f38f3|5|SULFATE|Sulfate|CHEMISTRY|[?]|log10 copies/mL|[?]|[?]|POSITIVE|1|dL|1|1|[?]|HIGH|LYSATE|LACTESCENT||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|FIBROSIS 4 FORMULA|||U||3|Visit_3|40|4|TREATMENT|2020-12-06|2021-01-11|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|947aefaf-20c7-47fc-ac56-140f9b6f38f3|6|LPA|Lipoprotein-a|URINALYSIS|[?]|PFU/dose|[?]|[?]|BORDERLINE|1|km|1|1|[?]|ABNORMAL|VENOUS BLOOD|UNEXPECTED ODOR||PHASE-CONTRAST MRI|ASH FIBROSURE FORMULA||Y|U||3|Visit_3|40|2|TREATMENT|2020-12-06|2021-01-29|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|947aefaf-20c7-47fc-ac56-140f9b6f38f3|7|NEUTVAC|Vacuolated Neutrophils|HEMATOLOGY|[?]|cmol|[?]|[?]|POSITIVE|1|BEAM BREAKS|1|1|[?]|LOW|SERUM|AGGLUTINATED|N|LIGHT MICROSCOPY|GMI MMOL/MOL FORMULA|||U||4|Visit_4|65|4|WASHOUT|2020-12-31|2021-01-03|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|947aefaf-20c7-47fc-ac56-140f9b6f38f3|8|C130140|German Cockroach Antigen IgE Antibody|CHEMISTRY|[?]|CAPLET|[?]|[?]|INVALID|1|ug/kg/day|1|1|[?]|HIGH|MIXED VENOUS BLOOD|GELLED||MIGET|CKD-EPI FORMULA||Y|NA||4|Visit_4|65|6|FOLLOW-UP|2020-12-31|2021-01-21|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|LB|947aefaf-20c7-47fc-ac56-140f9b6f38f3|9|PRAB|Panel Reactive Antibody|CHEMISTRY|[?]|CCID 50/dose|[?]|[?]|INVALID|1|amol|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|SOLIDIFIED|N|MAPH|FIBROTEST FORMULA|Y||Y||5|Visit_5|90|5|FOLLOW-UP|2021-01-25|2021-01-31|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|947aefaf-20c7-47fc-ac56-140f9b6f38f3|10|STBSEXCS|Standard Base Excess|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|ug/mol|1|1|[?]|LOW|SUPERNATANT, SERUM|CALCIFIED|N|ANGIOGRAPHY|COCKCROFT-GAULT FORMULA|||N|Y|5|Visit_5|90|2|TREATMENT|2021-01-25|2021-01-29|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|3a0c00eb-5614-4053-844d-6bdb71efb1cd|1|PYY|Peptide YY|CHEMISTRY|[?]|DNA copies/ug|[?]|[?]|POSITIVE|1|pmol/day|1|1|[?]|LOW|SKIN TISSUE|PARAFFIN-EMBEDDED||REBOUND TONOMETRY|GMI % FORMULA||Y|Y||1|Visit_1|10|7|SCREENING|2020-08-11|2020-08-31|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|3a0c00eb-5614-4053-844d-6bdb71efb1cd|2|INR|Prothrombin Intl. Normalized Ratio|CHEMISTRY|[?]|SYRINGE|[?]|[?]|NEGATIVE|1|Log10 ELISA unit|1|1|[?]|ABNORMAL|DIALYSIS FLUID|GELLED|N|DYNAMIC CONTRAST ENHANCED MRI|GMI % FORMULA||Y|Y||1|Visit_1|10|2|FOLLOW-UP|2020-08-11|2020-10-13|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|3a0c00eb-5614-4053-844d-6bdb71efb1cd|3|GLOBA2|Alpha-2 Globulin|URINALYSIS|[?]|g/m2|[?]|[?]|BORDERLINE|1|mg/kg/min|1|1|[?]|ABNORMAL|SEBUM|LACTESCENT||SICKLE CELL SOLUBILITY TEST|COCKCROFT-GAULT FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-08-26|2020-10-09|25|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|3a0c00eb-5614-4053-844d-6bdb71efb1cd|4|A2MACG|Alpha-2 Macroglobulin|HEMATOLOGY|[?]|mEq/kg|[?]|[?]|NEGATIVE|1|/cmH2O|1|1|[?]|LOW|MENSTRUAL BLOOD|THAWED||MRI|COCKCROFT-GAULT FORMULA|||U||2|Visit_2|25|6|FOLLOW-UP|2020-08-26|2020-09-04|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|3a0c00eb-5614-4053-844d-6bdb71efb1cd|5|MIDCEF|Mid Cell Fraction|HEMATOLOGY|[?]|damol/L|[?]|[?]|INDETERMINATE|1|10^7 CFU/mL|1|1|[?]|LOW|COLOSTRUM|PARAFFIN-EMBEDDED||CENTRIFUGATION|MDRD 4 VARIABLE FORMULA|Y||U||3|Visit_3|40|2|TREATMENT|2020-09-10|2020-10-07|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|3a0c00eb-5614-4053-844d-6bdb71efb1cd|6|GADAB|Glutamic Acid Decarboxylase Antibody|HEMATOLOGY|[?]|10^7 TCID 50/dose|[?]|[?]|BORDERLINE|1|mL/animal|1|1|[?]|LOW|VENOUS BLOOD|AGGLUTINATED|N|ORCHIDOMETERY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U||3|Visit_3|40|4|WASHOUT|2020-09-10|2020-11-03|40|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|3a0c00eb-5614-4053-844d-6bdb71efb1cd|7|OPIATE|Opiate|HEMATOLOGY|[?]|BP|[?]|[?]|INDETERMINATE|1|/LSQN|1|1|[?]|NORMAL|CERUMEN|LIPEMIC||PATHOLOGICAL EVALUATION|FIBROTEST FORMULA|||Y||4|Visit_4|65|6|FOLLOW-UP|2020-10-05|2020-11-06|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|3a0c00eb-5614-4053-844d-6bdb71efb1cd|8|MG|Magnesium|URINALYSIS|||[?]|[?]|INDETERMINATE|1|pg/L|1|1|[?]|NORMAL|EPIDERMAL TISSUE|NON-HEMOLYZED||GIEMSA STAIN|CKD-EPI CREATININE FORMULA|||U|Y|4|Visit_4|65|5|WASHOUT|2020-10-05|2020-10-16|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|3a0c00eb-5614-4053-844d-6bdb71efb1cd|9|MMP1|Matrix Metalloproteinase 1|HEMATOLOGY|[?]|mL/mmHg|[?]|[?]|BORDERLINE|1|dpm/100mg|1|1|[?]|NORMAL|CELL PELLET|AGGLUTINATED||MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-10-30|2020-11-05|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|3a0c00eb-5614-4053-844d-6bdb71efb1cd|10|BTK|Bruton's Tyrosine Kinase|CHEMISTRY|[?]|m3|[?]|[?]|BORDERLINE|1|10^7/L|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|LIPEMIC||MALDI-TOF|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-10-30|2020-11-03|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|dc3ce247-24dd-4255-85a8-ec7a58d30c86|1|GUSB|Glucuronidase, Beta|HEMATOLOGY|[?]|INHALATION|[?]|[?]|INDETERMINATE|1|CFU/g|1|1|[?]|LOW|LUNG SURFACTANT|GELLED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-10-11|2020-10-13|10|12|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|dc3ce247-24dd-4255-85a8-ec7a58d30c86|2|CTC|Circulating Tumor Cells|CHEMISTRY|[?]|umol|[?]|[?]|INVALID|1|CAPLET|1|1|[?]|NORMAL|EPIDERMAL TISSUE|FRESH||FREEZING POINT DEPRESSION|GMI MMOL/MOL FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-10-11|2020-11-14|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|dc3ce247-24dd-4255-85a8-ec7a58d30c86|3|NACLR|Sodium Clearance|URINALYSIS|[?]|mL/mmHg/min/L|[?]|[?]|TRACE|1|Log10 ELISA unit|1|1|[?]|ABNORMAL|HAIR FOLLICLE|AGGLUTINATED||QUANTITATIVE COMPUTED TOMOGRAPHY|GMI MMOL/MOL FORMULA|Y||NA||2|Visit_2|25|1|TREATMENT|2020-10-26|2020-11-12|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|dc3ce247-24dd-4255-85a8-ec7a58d30c86|4|CDCA|Chenodeoxycholate|CHEMISTRY|[?]|10^9/L|[?]|[?]|BORDERLINE|1|L/h/m2|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|GELLED||PULMONARY ANGIOGRAPHY|HEPASCORE FORMULA|Y||U||2|Visit_2|25|5|WASHOUT|2020-10-26|2020-11-15|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|dc3ce247-24dd-4255-85a8-ec7a58d30c86|5|AMYLASEM|Macroamylase|URINALYSIS|[?]|Ci/ug|[?]|[?]|POSITIVE|1|usec|1|1|[?]|LOW|EXPIRED AIR|REFRIGERATED||IMMUNOPRECIPITATION|FIBROTEST FORMULA|Y|Y|N||3|Visit_3|40|3|TREATMENT|2020-11-10|2020-12-07|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|dc3ce247-24dd-4255-85a8-ec7a58d30c86|6|HLADR51A|HLA-DR51 Antibody|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|DAgU|1|1|[?]|ABNORMAL|RETICULOCYTES|THAWED||STATIC PERIMETRY|FIBROSIS 4 FORMULA||Y|U|Y|3|Visit_3|40|6|WASHOUT|2020-11-10|2020-12-01|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|dc3ce247-24dd-4255-85a8-ec7a58d30c86|7|MCV|Ery. Mean Corpuscular Volume|CHEMISTRY|[?]|/4.0 mL|[?]|[?]|INDETERMINATE|1|U/m2/h|1|1|[?]|NORMAL|PERITONEAL FLUID|ICTERIC||SLOAN LETTER EYE CHART 2.5%|CKD-EPI CREATININE FORMULA|Y||Y||4|Visit_4|65|6|SCREENING|2020-12-05|2021-01-08|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|dc3ce247-24dd-4255-85a8-ec7a58d30c86|8|LYMCLF|Lymphocytes, Clefted|HEMATOLOGY|[?]|ELISA unit|[?]|[?]|INDETERMINATE|1|ELISA unit/mL|1|1|[?]|ABNORMAL|NAIL|GELLED|N|TOTAL BODY IRRADIATION|CKD-EPI FORMULA|||U||4|Visit_4|65|3|SCREENING|2020-12-05|2020-12-06|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|dc3ce247-24dd-4255-85a8-ec7a58d30c86|9|KERAT|Keratocyte|CHEMISTRY|||[?]|[?]|POSITIVE|1|mmHg*min/L|1|1|[?]|LOW|MUCUS|LIPEMIC||CORONARY ANGIOGRAPHY|MDRD FORMULA||Y|NA|Y|5|Visit_5|90|5|FOLLOW-UP|2020-12-30|2021-01-03|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|dc3ce247-24dd-4255-85a8-ec7a58d30c86|10|NGF|Nerve Growth Factor|CHEMISTRY|[?]|MdFI|[?]|[?]|INVALID|1|IU/kg|1|1|[?]|LOW|PLATELET|FRESH||MS/MS|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2020-12-30|2021-01-01|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|61c19f94-bdfc-456d-ba7a-c9097ca1c645|1|C3|Complement C3|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mmol/kg|1|1|[?]|LOW|ARTERIAL BLOOD|CLOTTED||MICROBIAL CULTURE, SOLID|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|1|Visit_1|10|5|WASHOUT|2020-07-04|2020-08-18|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|61c19f94-bdfc-456d-ba7a-c9097ca1c645|2|GMI|Glucose Management Indicator|URINALYSIS|[?]|SFC/10^6 PBMC|[?]|[?]|INDETERMINATE|1|10^9 organisms/mL|1|1|[?]|NORMAL|DISCHARGE|PARAFFIN-EMBEDDED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|GMI % FORMULA|||N||1|Visit_1|10|1|WASHOUT|2020-07-04|2020-07-16|10|22|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|61c19f94-bdfc-456d-ba7a-c9097ca1c645|3|C130109|Mold Mix Antigen IgE Antibody|HEMATOLOGY|[?]|steps/min|[?]|[?]|NEGATIVE|1|Hz/s|1|1|[?]|HIGH|CEREBROSPINAL FLUID|FRESH||WESTERN BLOT|FIBROMETER FORMULA|||U||2|Visit_2|25|4|WASHOUT|2020-07-19|2020-09-06|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|61c19f94-bdfc-456d-ba7a-c9097ca1c645|4|CYAMPPH|Amorphous Phosphate Crystals|HEMATOLOGY|[?]|10^9 organisms/g|[?]|[?]|TRACE|1|umol/L/min|1|1|[?]|LOW|HAIR FOLLICLE|LACTESCENT||PET/CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-07-19|2020-08-19|25|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|61c19f94-bdfc-456d-ba7a-c9097ca1c645|5|C165891|Western Ragweed Pollen IgE AB RAST Score|HEMATOLOGY|[?]|PFU|[?]|[?]|POSITIVE|1|Bq/g|1|1|[?]|NORMAL|PERSPIRATION|REFRIGERATED|N|RIA|MDRD 5 VARIABLE FORMULA|||N||3|Visit_3|40|3|FOLLOW-UP|2020-08-03|2020-08-15|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|61c19f94-bdfc-456d-ba7a-c9097ca1c645|6|FATACFR|Free Fatty Acid|CHEMISTRY|[?]|JAR|[?]|[?]|BORDERLINE|1|kcal|1|1|[?]|NORMAL|BASAL TEAR|FROZEN||MULTIPLE BREATH WASHOUT|COCKCROFT-GAULT FORMULA|Y||N||3|Visit_3|40|3|FOLLOW-UP|2020-08-03|2020-09-22|40|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|61c19f94-bdfc-456d-ba7a-c9097ca1c645|7|IRON|Iron|URINALYSIS|||[?]|[?]|POSITIVE|1|10^6 copies/mL|1|1|[?]|HIGH|AMNIOTIC FLUID|SOLIDIFIED|N|KINETIC MICROPARTICLE IMMUNOASSAY|FIBROSIS 4 FORMULA|||NA|Y|4|Visit_4|65|2|FOLLOW-UP|2020-08-28|2020-09-20|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|61c19f94-bdfc-456d-ba7a-c9097ca1c645|8|PIVKAII|Protein Induced by Vitamin K Absence-II|CHEMISTRY|[?]|ug/min|[?]|[?]|NEGATIVE|1|pt_us|1|1|[?]|LOW|LYSATE|DRIED||PET/SPECT SCAN|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|4|FOLLOW-UP|2020-08-28|2020-09-27|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|61c19f94-bdfc-456d-ba7a-c9097ca1c645|9|C5FR|Complement C5, Free|URINALYSIS|[?]|JAR|[?]|[?]|BORDERLINE|1|kIU|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|DRIED||PERCUSSION|GMI MMOL/MOL FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2020-09-22|2020-09-29|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|61c19f94-bdfc-456d-ba7a-c9097ca1c645|10|NAGASECR|N-acetyl-B-D-glucosaminidase/Creatinine|URINALYSIS|[?]|Ci|[?]|[?]|INDETERMINATE|1|10^6/g|1|1|[?]|ABNORMAL|SALIVA|GELLED||ICP-MS|MDRD 6 VARIABLE FORMULA|||N||5|Visit_5|90|4|FOLLOW-UP|2020-09-22|2020-09-30|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|1e577f2d-2c45-477d-b74f-af24b81d6d20|1|INTLK14|Interleukin 14|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|%/s|1|1|[?]|ABNORMAL|TUMOR TISSUE|UNEXPECTED ODOR|N|CELLULAR PROLIFERATION ASSAY|ASH FIBROSURE FORMULA|||NA|Y|1|Visit_1|10|1|TREATMENT|2020-09-23|2020-11-14|10|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|1e577f2d-2c45-477d-b74f-af24b81d6d20|2|URATEEXR|Urate Excretion Rate|CHEMISTRY|||[?]|[?]|POSITIVE|1|mL/h|1|1|[?]|NORMAL|DERMAL TISSUE|PARAFFIN-EMBEDDED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA|Y||U|Y|1|Visit_1|10|3|WASHOUT|2020-09-23|2020-12-10|10|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|LB|1e577f2d-2c45-477d-b74f-af24b81d6d20|3|C130084|English Plantain Pollen IgE|HEMATOLOGY|[?]|PIPE|[?]|[?]|INVALID|1|umol/kg/min|1|1|[?]|LOW|BONE MARROW|NON-HEMOLYZED||SPECULAR MICROSCOPY|ASH FIBROSURE FORMULA||Y|NA||2|Visit_2|25|4|TREATMENT|2020-10-08|2020-11-23|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|1e577f2d-2c45-477d-b74f-af24b81d6d20|4|GCSF|Granulocyte Colony Stimulating Factor|HEMATOLOGY|||[?]|[?]|TRACE|1|cd|1|1|[?]|NORMAL|SALIVA|CONCENTRATED|N|RULER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA|Y|Y|Y|Y|2|Visit_2|25|6|FOLLOW-UP|2020-10-08|2020-11-13|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|1e577f2d-2c45-477d-b74f-af24b81d6d20|5|POLYERY|Polychromatophilic Erythroblast|URINALYSIS|[?]|nmol BCE/nmol|[?]|[?]|BORDERLINE|1|ft2|1|1|[?]|ABNORMAL|COLOSTRUM|AGGLUTINATED||COMPLEMENT FIXATION|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-10-23|2020-11-22|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|1e577f2d-2c45-477d-b74f-af24b81d6d20|6|ALT|Alanine Aminotransferase|URINALYSIS|[?]|BISCUIT|[?]|[?]|POSITIVE|1|ms2|1|1|[?]|LOW|SEMEN|CALCIFIED||WHOLE GENOME SEQUENCING|COCKCROFT-GAULT FORMULA||Y|Y||3|Visit_3|40|7|SCREENING|2020-10-23|2020-12-03|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|1e577f2d-2c45-477d-b74f-af24b81d6d20|7|MGCREAT|Magnesium/Creatinine|URINALYSIS|[?]|10^6 IU|[?]|[?]|INVALID|1|genEq|1|1|[?]|NORMAL|URINE|ROOM TEMPERATURE||NEURAMINIDASE INHIBITION ASSAY|HEPASCORE FORMULA||Y|N||4|Visit_4|65|1|FOLLOW-UP|2020-11-17|2020-11-19|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|1e577f2d-2c45-477d-b74f-af24b81d6d20|8|ERCEPIDX|Erythroid Proliferation Index|URINALYSIS|[?]|CAPFUL|[?]|[?]|INVALID|1|BAU/mL|1|1|[?]|LOW|SPUTUM|CALCIFIED||REBOUND TONOMETRY|MDRD ENZYMATIC FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-11-17|2020-12-05|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|1e577f2d-2c45-477d-b74f-af24b81d6d20|9|CANNABM|Cannabinoid Metabolites|CHEMISTRY|[?]|/min|[?]|[?]|INVALID|1|mL/animal/day|1|1|[?]|NORMAL|SEMINAL FLUID|FROZEN|N|AUTOREFRACTION|HEPASCORE FORMULA|||N||5|Visit_5|90|4|SCREENING|2020-12-12|2020-12-16|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|1e577f2d-2c45-477d-b74f-af24b81d6d20|10|HYPGST17|17-Hydroxyprogesterone|URINALYSIS|[?]|POUCH|[?]|[?]|INVALID|1|mmol2/L2|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR||AGAR PROPORTION|NASH FIBROSURE FORMULA|Y||NA||5|Visit_5|90|1|TREATMENT|2020-12-12|2020-12-15|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|f845101e-c057-4f84-94b3-6043afb42ac7|1|GLOBB1BP|Beta-1 Globulin/Beta Protein|URINALYSIS|[?]|tuberculin unit/mL|[?]|[?]|BORDERLINE|1|pkat/L|1|1|[?]|ABNORMAL|URINE SEDIMENT|NON-HEMOLYZED||IVY INCISION METHOD|CKD-EPI FORMULA|Y|Y|U||1|Visit_1|10|6|TREATMENT|2020-10-27|2021-01-10|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|f845101e-c057-4f84-94b3-6043afb42ac7|2|APPEAR|Specimen Appearance|CHEMISTRY|[?]|mg/kg/min|[?]|[?]|INVALID|1|Pa|1|1|[?]|LOW|VENOUS BLOOD|CLOTTED||ENZYMATIC COLORIMETRY|MDRD 6 VARIABLE FORMULA|||N||1|Visit_1|10|4|TREATMENT|2020-10-27|2020-11-11|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|f845101e-c057-4f84-94b3-6043afb42ac7|3|LDH4LDH|LDH Isoenzyme 4/LDH|HEMATOLOGY|[?]|F|[?]|[?]|INVALID|1|m2|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|SOLIDIFIED||LYMPHANGIOGRAPHY|FIBROMETER FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2020-11-11|2021-01-05|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|f845101e-c057-4f84-94b3-6043afb42ac7|4|EDTACLR|EDTA Clearance|CHEMISTRY|[?]|BU/mL|[?]|[?]|INDETERMINATE|1|LB|1|1|[?]|HIGH|WHITE MATTER TISSUE|SOLIDIFIED||THERMAL IONIZATION MASS SPECTROMETRY|CKD-EPI CREATININE FORMULA|||NA||2|Visit_2|25|3|WASHOUT|2020-11-11|2021-01-02|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|f845101e-c057-4f84-94b3-6043afb42ac7|5|PYOCYTES|Pyocytes|HEMATOLOGY|[?]|umol/mg/min|[?]|[?]|TRACE|1|TCID 50/dose|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|FRESH||LANDOLT RING|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-11-26|2020-12-17|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|f845101e-c057-4f84-94b3-6043afb42ac7|6|C165908|Animal Mix IgG AB RAST Score|CHEMISTRY|[?]|sec|[?]|[?]|INVALID|1|RNA copies/mL|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|AGGLUTINATED||NEXT GENERATION SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|U||3|Visit_3|40|5|SCREENING|2020-11-26|2021-01-18|40|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|f845101e-c057-4f84-94b3-6043afb42ac7|7|CRTFREXR|Cortisol, Free Excretion Rate|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ug/kg|1|1|[?]|ABNORMAL|BREAST MILK|FROZEN||ELISA|MDRD 4 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|1|TREATMENT|2020-12-21|2021-01-01|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|f845101e-c057-4f84-94b3-6043afb42ac7|8|NCTD5P|5 Prime Nucleotidase|URINALYSIS|||[?]|[?]|INVALID|1|10^6 IU|1|1|[?]|HIGH|URINE SEDIMENT|AUTOLYZED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|Y||Y|Y|4|Visit_4|65|7|TREATMENT|2020-12-21|2020-12-30|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|f845101e-c057-4f84-94b3-6043afb42ac7|9|CFA|Coefficient of Fat Absorption|CHEMISTRY|[?]|g/dL|[?]|[?]|BORDERLINE|1|hr/day|1|1|[?]|NORMAL|TUMOR TISSUE|REFRIGERATED||MALDI|MDRD FORMULA||Y|Y||5|Visit_5|90|7|TREATMENT|2021-01-15|2021-01-23|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|f845101e-c057-4f84-94b3-6043afb42ac7|10|TPROTFR|Tau Protein, Free|HEMATOLOGY|[?]|ft3|[?]|[?]|TRACE|1|TRANSDUCING UNIT/mL|1|1|[?]|NORMAL|MONOCYTE|REFRIGERATED||RULER MEASUREMENT METHOD|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA||5|Visit_5|90|7|FOLLOW-UP|2021-01-15|2021-01-16|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|4ddb2076-6837-4028-81bc-3e8057475977|1|GRANBCE|Granulocytes Band Form/Total Cells|URINALYSIS|[?]|ug/kg/min|[?]|[?]|BORDERLINE|1|Coulomb|1|1|[?]|ABNORMAL|DISCHARGE|REFRIGERATED||PH METER MEASUREMENT METHOD|ASH FIBROSURE FORMULA|||U||1|Visit_1|10|6|FOLLOW-UP|2020-12-27|2021-02-20|10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|4ddb2076-6837-4028-81bc-3e8057475977|2|ARSENIC|Arsenic|URINALYSIS|[?]|mg/dL|[?]|[?]|INDETERMINATE|1|ug/day|1|1|[?]|ABNORMAL|LEUKOCYTE|FRESH|N|FLUORESCENT SPOT TEST|CKD-EPI CREATININE FORMULA||Y|N||1|Visit_1|10|7|WASHOUT|2020-12-27|2021-02-10|10|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|4ddb2076-6837-4028-81bc-3e8057475977|3|LAP|Leucine Aminopeptidase|URINALYSIS|[?]|vg/dose|[?]|[?]|TRACE|1|IMPLANT|1|1|[?]|LOW|BONE MARROW|GELLED|N|BIOPSY|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2021-01-11|2021-03-17|25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|LB|4ddb2076-6837-4028-81bc-3e8057475977|4|PRZPM|Prazepam|URINALYSIS|||[?]|[?]|INVALID|1|PIXEL|1|1|[?]|ABNORMAL|DERMAL TISSUE|THAWED||MUGA|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|2|Visit_2|25|7|WASHOUT|2021-01-11|2021-01-14|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|LB|4ddb2076-6837-4028-81bc-3e8057475977|5|RETIRBC|Reticulocytes/Erythrocytes|URINALYSIS|[?]|mL/s/m2|[?]|[?]|TRACE|1|g/cage|1|1|[?]|ABNORMAL|CERUMEN|GELLED||URANYL ACETATE STAIN|FIBROMETER FORMULA|||Y||3|Visit_3|40|2|SCREENING|2021-01-26|2021-03-19|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|4ddb2076-6837-4028-81bc-3e8057475977|6|IC512AG|Islet Cell 512 Antigen|HEMATOLOGY|||[?]|[?]|INVALID|1|10^3 organisms/g|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|AUTOLYZED||JAEGER EYE CHART|CKD-EPI CREATININE FORMULA|Y||Y|Y|3|Visit_3|40|2|WASHOUT|2021-01-26|2021-02-25|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|4ddb2076-6837-4028-81bc-3e8057475977|7|APPB|Amyloid Beta Precursor Protein|CHEMISTRY|[?]|MBP|[?]|[?]|BORDERLINE|1|MBq|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED||U-HPLC/MS/MS|CKD-EPI CREATININE FORMULA|||N||4|Visit_4|65|6|TREATMENT|2021-02-20|2021-03-14|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|4ddb2076-6837-4028-81bc-3e8057475977|8|AMYLASEP|Amylase, Pancreatic|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|GLOBULE|1|1|[?]|NORMAL|ABSCESS FLUID|ICTERIC|N|QUANTITATIVE ULTRASOUND|ASH FIBROSURE FORMULA|||NA|Y|4|Visit_4|65|1|SCREENING|2021-02-20|2021-02-21|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|4ddb2076-6837-4028-81bc-3e8057475977|9|OXAEXR|Oxalate Excretion Rate|CHEMISTRY|[?]|/h|[?]|[?]|POSITIVE|1|dB|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|DRIED||CT SCAN|MDRD 6 VARIABLE FORMULA|||U||5|Visit_5|90|7|FOLLOW-UP|2021-03-17|2021-03-20|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|4ddb2076-6837-4028-81bc-3e8057475977|10|IGD|Immunoglobulin D|HEMATOLOGY|[?]|STEPS|[?]|[?]|BORDERLINE|1|pL|1|1|[?]|NORMAL|SOFT TISSUE|AUTOLYZED||CELLULAR PROLIFERATION ASSAY|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|6|TREATMENT|2021-03-17|2021-03-21|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|c165c69c-2ab2-495c-a190-e32d1204bc4e|1|HLADRAGT|HLA-DR Antigen Type|HEMATOLOGY|[?]|pkat|[?]|[?]|INVALID|1|U/kg/h|1|1|[?]|LOW|NAIL|CLOTTED||MICROARRAY|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2021-01-01|2021-02-22|10|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|c165c69c-2ab2-495c-a190-e32d1204bc4e|2|FACTVWA|von Willebrand Factor Activity|URINALYSIS|[?]|/40 HPFs|[?]|[?]|BORDERLINE|1|U|1|1|[?]|HIGH|ABSCESS FLUID|FROZEN||THERMAL IONIZATION MASS SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA||Y|N||1|Visit_1|10|4|TREATMENT|2021-01-01|2021-03-07|10|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|c165c69c-2ab2-495c-a190-e32d1204bc4e|3|HASIGEAB|Human Anti-Sheep IgE Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|kHz|1|1|[?]|ABNORMAL|COLOSTRUM|NON-HEMOLYZED||SLOAN LETTER EYE CHART 100%|MDRD FORMULA|||NA|Y|2|Visit_2|25|5|WASHOUT|2021-01-16|2021-01-26|25|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|c165c69c-2ab2-495c-a190-e32d1204bc4e|4|OAS1|2-5-Oligoadenylate Synthase 1|CHEMISTRY|[?]|10^6 U|[?]|[?]|POSITIVE|1|U/animal|1|1|[?]|ABNORMAL|SWABBED MATERIAL|NON-HEMOLYZED||FLAME PHOTOMETRY|CKD-EPI FORMULA||Y|N||2|Visit_2|25|1|FOLLOW-UP|2021-01-16|2021-02-20|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|c165c69c-2ab2-495c-a190-e32d1204bc4e|5|PTHRP|Parathyroid Hormone-related Protein|CHEMISTRY|[?]|mg/kg|[?]|[?]|INDETERMINATE|1|mg/mL/min|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|THAWED||FLUORESCENCE ANGIOGRAPHY|FIBROTEST FORMULA|||N||3|Visit_3|40|5|TREATMENT|2021-01-31|2021-02-27|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|c165c69c-2ab2-495c-a190-e32d1204bc4e|6|C130083|Orchard Grass Pollen IgG4|CHEMISTRY|[?]|nmol/L|[?]|[?]|INDETERMINATE|1|U/kg/min|1|1|[?]|NORMAL|MONOCYTE|FRESH|N|ETDRS EYE CHART|FIBROSIS 4 FORMULA||Y|Y||3|Visit_3|40|1|WASHOUT|2021-01-31|2021-02-19|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|c165c69c-2ab2-495c-a190-e32d1204bc4e|7|ANISOCHR|Anisochromia|URINALYSIS|[?]|MPL U/mL|[?]|[?]|POSITIVE|1|10^6 organisms/mL|1|1|[?]|HIGH|PLEURAL FLUID|NON-HEMOLYZED||CONTRAST ENHANCED PET SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||Y||4|Visit_4|65|2|SCREENING|2021-02-25|2021-03-21|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|c165c69c-2ab2-495c-a190-e32d1204bc4e|8|CKMBCK|Creatine Kinase MB/Total Creatine Kinase|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|nmol BCE/L|1|1|[?]|HIGH|SUPERNATANT, SERUM|CONTAMINATED||MUGA|CKD-EPI FORMULA|||N|Y|4|Visit_4|65|6|TREATMENT|2021-02-25|2021-03-12|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|c165c69c-2ab2-495c-a190-e32d1204bc4e|9|CPB2|Carboxypeptidase B2|HEMATOLOGY|[?]|bel|[?]|[?]|INVALID|1|umol/day|1|1|[?]|LOW|SKIN TISSUE|AGGLUTINATED||EPSILOMETER|CKD-EPI FORMULA|Y|Y|NA||5|Visit_5|90|2|TREATMENT|2021-03-22|2021-03-23|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|c165c69c-2ab2-495c-a190-e32d1204bc4e|10|CD161LY|CD161/Lymphocytes|URINALYSIS|[?]|pm|[?]|[?]|TRACE|1|10^5/hpf|1|1|[?]|NORMAL|HAIR FOLLICLE|SOLIDIFIED||SPECULAR MICROSCOPY|GMI MMOL/MOL FORMULA|Y||U||5|Visit_5|90|4|FOLLOW-UP|2021-03-22|2021-03-26|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|1|NTELOP|N-telopeptide|URINALYSIS|||[?]|[?]|TRACE|1|U/m2/h|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|ICTERIC|N|MICROSCOPY|FIBROSIS 4 FORMULA|||N|Y|1|Visit_1|10|6|TREATMENT|2020-12-29|2021-02-17|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|2|MCV|Ery. Mean Corpuscular Volume|HEMATOLOGY|[?]|mmol/kg|[?]|[?]|INDETERMINATE|1|mm/sec|1|1|[?]|LOW|ISOLATE|AUTOLYZED||SLIT LAMP PHOTOGRAPHY|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2020-12-29|2021-02-23|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|3|RF|Rheumatoid Factor|CHEMISTRY|[?]|ug/m2/min|[?]|[?]|BORDERLINE|1|deg|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|CALCIFIED||MRS|FIBROMETER FORMULA|Y||U||2|Visit_2|25|3|TREATMENT|2021-01-13|2021-02-18|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|4|CYMSU|Monosodium Urate Crystals|URINALYSIS|[?]|amu|[?]|[?]|TRACE|1|mol/g|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|CALCIFIED|N|OLIGO ACGH|CKD-EPI FORMULA|Y||U||2|Visit_2|25|5|WASHOUT|2021-01-13|2021-03-04|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|5|APOC3|Apolipoprotein CIII|HEMATOLOGY|[?]|ug/kg/h|[?]|[?]|POSITIVE|1|Rad|1|1|[?]|LOW|BONE MARROW|CONCENTRATED||EEG|COCKCROFT-GAULT FORMULA|||N||3|Visit_3|40|1|SCREENING|2021-01-28|2021-02-22|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|6|ANGTNS1|Angiotensin I|HEMATOLOGY|[?]|10^6 CFU/g|[?]|[?]|POSITIVE|1|umol/kg/min|1|1|[?]|LOW|PLEURAL TISSUE|GELLED|N|MICROBIAL CONCENTRATION|MDRD 6 VARIABLE FORMULA|||U||3|Visit_3|40|6|SCREENING|2021-01-28|2021-02-17|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|7|SMUSCGAB|Smooth Muscle IgG Antibody|HEMATOLOGY|[?]|ms/mmHg|[?]|[?]|BORDERLINE|1|INHALATION|1|1|[?]|ABNORMAL|BONE|CONTAMINATED||URANYL ACETATE STAIN|MDRD FORMULA|||NA||4|Visit_4|65|7|SCREENING|2021-02-22|2021-03-19|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|LB|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|8|NFHP|Phosphorylated Neurofilament Heavy Chain|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|SYRINGE|1|1|[?]|NORMAL|INTERSTITIAL FLUID|SOLIDIFIED|N|MALDI|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|4|Visit_4|65|7|SCREENING|2021-02-22|2021-02-25|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|LB|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|9|FACTXA|Factor X Activity|CHEMISTRY|[?]|/200 HPFs|[?]|[?]|INDETERMINATE|1|mmol|1|1|[?]|HIGH|DERMAL TISSUE|SOLIDIFIED|N|CONTRAST ENHANCED PET/CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||5|Visit_5|90|7|TREATMENT|2021-03-19|2021-03-23|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|10|NOREPEXR|Norepinephrine Excretion Rate|CHEMISTRY|[?]|dmol|[?]|[?]|TRACE|1|s/h|1|1|[?]|ABNORMAL|LAVAGE FLUID|THAWED||HPLC/MS/MS|CKD-EPI CYSTATIN C FORMULA|Y||Y||5|Visit_5|90|6|TREATMENT|2021-03-19|2021-03-28|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|024a9f6d-4ff1-4673-8617-3790f831fce7|1|METHQLDN|Methaqualone|URINALYSIS|[?]|Joule|[?]|[?]|BORDERLINE|1|foz_br|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|AUTOLYZED||FREEZING POINT DEPRESSION|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|1|TREATMENT|2020-06-13|2020-08-02|10|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|024a9f6d-4ff1-4673-8617-3790f831fce7|2|OXZPM|Oxazepam|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mEq/dL|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|AUTOLYZED||TURBIDIMETRY|COCKCROFT-GAULT FORMULA|Y||Y|Y|1|Visit_1|10|2|WASHOUT|2020-06-13|2020-07-05|10|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|024a9f6d-4ff1-4673-8617-3790f831fce7|3|CD4CD8|CD4/CD8|HEMATOLOGY|[?]|mL/g/h|[?]|[?]|POSITIVE|1|U/mmol|1|1|[?]|HIGH|LYSATE|GELLED|N|IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-06-28|2020-07-26|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|024a9f6d-4ff1-4673-8617-3790f831fce7|4|IGG3|Immunoglobulin G Subclass 3|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|g/animal|1|1|[?]|LOW|URINE SEDIMENT|CONCENTRATED||STRESS ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA|Y|Y|N|Y|2|Visit_2|25|1|TREATMENT|2020-06-28|2020-08-11|25|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|024a9f6d-4ff1-4673-8617-3790f831fce7|5|ANCPNCAB|Neutrophil Cytoplasmic Ab, Perinuclear|HEMATOLOGY|[?]|DROP|[?]|[?]|NEGATIVE|1|10^3 CFU|1|1|[?]|ABNORMAL|SPUTUM|DRIED||TRIPLE-PHASE SPIRAL CT SCAN|MDRD 6 VARIABLE FORMULA|||U||3|Visit_3|40|2|TREATMENT|2020-07-13|2020-08-14|40|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|024a9f6d-4ff1-4673-8617-3790f831fce7|6|NAG|N-Acetyl Glucosamide|CHEMISTRY|||[?]|[?]|INVALID|1|NEBULE|1|1|[?]|NORMAL|EXUDATE|UNEXPECTED ODOR||CARDIAC THERMODILUTION|FIBROSIS 4 FORMULA|Y|Y|NA|Y|3|Visit_3|40|5|TREATMENT|2020-07-13|2020-08-01|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|024a9f6d-4ff1-4673-8617-3790f831fce7|7|KLCLLC|Kappa Light Chain/Lambda Light Chain|CHEMISTRY|[?]|mg/L FEU|[?]|[?]|POSITIVE|1|genEq|1|1|[?]|LOW|PERITONEAL FLUID|CONCENTRATED||FLUORESCENT LIFETIME IMAGING MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||4|Visit_4|65|3|SCREENING|2020-08-07|2020-08-16|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|024a9f6d-4ff1-4673-8617-3790f831fce7|8|IC512AG|Islet Cell 512 Antigen|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|NFIU|1|1|[?]|ABNORMAL|LUNG SURFACTANT|THAWED|N|SNP ARRAY|CKD-EPI FORMULA|||Y|Y|4|Visit_4|65|3|TREATMENT|2020-08-07|2020-08-21|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|024a9f6d-4ff1-4673-8617-3790f831fce7|9|CXCL10|Chemokine (C-X-C Motif) Ligand 10|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mL/animal|1|1|[?]|HIGH|ERYTHROCYTES|REFRIGERATED||FLOCCULATION, CHARCOAL ENHANCED|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|5|Visit_5|90|3|SCREENING|2020-09-01|2020-09-07|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|024a9f6d-4ff1-4673-8617-3790f831fce7|10|CCL21|Chemokine (C-C Motif) Ligand 21|CHEMISTRY|[?]|10^9/g|[?]|[?]|NEGATIVE|1|U/m2/day|1|1|[?]|HIGH|LAVAGE FLUID|CLOTTED||FLUORESCENT IMMUNOASSAY|HEPASCORE FORMULA|||Y||5|Visit_5|90|4|FOLLOW-UP|2020-09-01|2020-09-10|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|40936fc6-251d-4a17-ae9d-3bd1150f8d20|1|IC512AB|Islet Cell 512 Antibody|HEMATOLOGY|[?]|mL/min/1.73m2|[?]|[?]|POSITIVE|1|g/U|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|LIPEMIC||WEBER GREEN STAIN|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|7|WASHOUT|2020-11-18|2020-12-10|10|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|40936fc6-251d-4a17-ae9d-3bd1150f8d20|2|G6PDRBRB|G6PD-Deficient Erythrocytes/Erythrocytes|URINALYSIS|[?]|in2|[?]|[?]|INDETERMINATE|1|L|1|1|[?]|HIGH|TRANSUDATE|FROZEN|N|PATHOLOGICAL EVALUATION|MDRD ENZYMATIC FORMULA|||Y||1|Visit_1|10|2|FOLLOW-UP|2020-11-18|2020-11-25|10|17|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|40936fc6-251d-4a17-ae9d-3bd1150f8d20|3|GRANIMLE|Immature Granulocytes/Leukocytes|URINALYSIS|||[?]|[?]|BORDERLINE|1|TUBE|1|1|[?]|NORMAL|SKIN TISSUE|AUTOLYZED||CAPILLARY ELECTROPHORESIS|CKD-EPI CYSTATIN C FORMULA|Y||U|Y|2|Visit_2|25|6|TREATMENT|2020-12-03|2021-01-08|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|40936fc6-251d-4a17-ae9d-3bd1150f8d20|4|SEZCELE|Sezary Cells/Leukocytes|URINALYSIS|[?]|COAT|[?]|[?]|BORDERLINE|1|10^3 CFU/mL|1|1|[?]|HIGH|SUPERNATANT, PLASMA|CLOTTED||FLAME PHOTOMETRY|MDRD 5 VARIABLE FORMULA||Y|NA||2|Visit_2|25|3|FOLLOW-UP|2020-12-03|2021-02-11|25|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|40936fc6-251d-4a17-ae9d-3bd1150f8d20|5|C130070|Bermuda Grass Pollen IgG|URINALYSIS|[?]|10^6/L|[?]|[?]|TRACE|1|NEBULE|1|1|[?]|LOW|AQUEOUS HUMOR|HEMOLYZED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROTEST FORMULA|Y||U||3|Visit_3|40|5|WASHOUT|2020-12-18|2021-02-07|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|40936fc6-251d-4a17-ae9d-3bd1150f8d20|6|TSHRAB|Thyrotropin Receptor Antibody|HEMATOLOGY|[?]|BAU/mL|[?]|[?]|INVALID|1|uCi|1|1|[?]|HIGH|EXUDATE|GELLED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|GMI % FORMULA|Y||U||3|Visit_3|40|7|TREATMENT|2020-12-18|2020-12-28|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|40936fc6-251d-4a17-ae9d-3bd1150f8d20|7|MONO|Monocytes|URINALYSIS|[?]|scm|[?]|[?]|BORDERLINE|1|mmHg/L/min|1|1|[?]|NORMAL|VENOUS PLASMA|GELLED||INTRAVASCULAR ULTRASOUND|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|7|WASHOUT|2021-01-12|2021-02-02|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|40936fc6-251d-4a17-ae9d-3bd1150f8d20|8|AMH|Anti-Mullerian Hormone|URINALYSIS|[?]|VIRTUAL PIXEL|[?]|[?]|NEGATIVE|1|mV*min|1|1|[?]|LOW|PLATELET POOR PLASMA|PARAFFIN-EMBEDDED|N|PERCUSSION|COCKCROFT-GAULT FORMULA||Y|N||4|Visit_4|65|5|TREATMENT|2021-01-12|2021-01-29|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|40936fc6-251d-4a17-ae9d-3bd1150f8d20|9|ANGLOBDR|Antiglobulin Test, Direct|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|m/sec|1|1|[?]|NORMAL|ADIPOSE TISSUE|SOLIDIFIED||DIRECT SEQUENCING|MDRD 6 VARIABLE FORMULA|Y|Y|U|Y|5|Visit_5|90|3|WASHOUT|2021-02-06|2021-02-08|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|40936fc6-251d-4a17-ae9d-3bd1150f8d20|10|ANCPNCAB|Neutrophil Cytoplasmic Ab, Perinuclear|CHEMISTRY|[?]|s^-1(%O2)^-1|[?]|[?]|TRACE|1|ukat/L|1|1|[?]|NORMAL|NAIL|AGGLUTINATED||IMMUNOASSAY|MDRD ENZYMATIC FORMULA|||N||5|Visit_5|90|1|TREATMENT|2021-02-06|2021-02-07|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|17b9fa7a-f15d-423a-9671-99cd0cbbd362|1|FGFBF|Fibroblast Growth Factor Basic Form|HEMATOLOGY|[?]|Newton|[?]|[?]|NEGATIVE|1|ng/L|1|1|[?]|NORMAL|BONE|UNEXPECTED ODOR|N|GRADIENT DIFFUSION|MDRD 4 VARIABLE FORMULA||Y|Y||1|Visit_1|10|7|TREATMENT|2020-11-11|2020-11-25|10|24|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|17b9fa7a-f15d-423a-9671-99cd0cbbd362|2|GUSA|Glucuronidase, Alpha|URINALYSIS|[?]|10^4 CFU|[?]|[?]|NEGATIVE|1|MBq/uL|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|CONTAMINATED|N|ALCIAN BLUE STAIN|ASH FIBROSURE FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2020-11-11|2020-12-27|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|17b9fa7a-f15d-423a-9671-99cd0cbbd362|3|NDMTASE|N-Demethylase|URINALYSIS|[?]|APL U/mL|[?]|[?]|INVALID|1|mmol/s|1|1|[?]|HIGH|CAPILLARY PLASMA|HEMOLYZED||NON-CONTACT SPECULAR MICROSCOPY|MDRD 6 VARIABLE FORMULA|||Y||2|Visit_2|25|1|WASHOUT|2020-11-26|2020-11-29|25|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|17b9fa7a-f15d-423a-9671-99cd0cbbd362|4|TROPONIN|Troponin|URINALYSIS|[?]|kHz|[?]|[?]|TRACE|1|pmol/10^10 cells|1|1|[?]|NORMAL|SYNOVIAL FLUID|NON-HEMOLYZED||TARGETED TRANSCRIPTOME SEQUENCING|MDRD 4 VARIABLE FORMULA|Y||NA||2|Visit_2|25|4|SCREENING|2020-11-26|2021-01-16|25|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|17b9fa7a-f15d-423a-9671-99cd0cbbd362|5|TNFAPIA|TNF-a Production Inhibitory Activity|HEMATOLOGY|||[?]|[?]|TRACE|1|mCi/kg|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|THAWED|N|MRS|FIBROTEST FORMULA|||Y|Y|3|Visit_3|40|7|TREATMENT|2020-12-11|2021-01-29|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|17b9fa7a-f15d-423a-9671-99cd0cbbd362|6|HDLPL|HDL Phospholipid|CHEMISTRY|[?]|mmHg/L/min|[?]|[?]|INDETERMINATE|1|10^6 IU|1|1|[?]|NORMAL|BREAST MILK|PARAFFIN-EMBEDDED|N|HPLC-FL|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-12-11|2020-12-22|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|17b9fa7a-f15d-423a-9671-99cd0cbbd362|7|C165882|White Elm Pollen IgE AB RAST Score|URINALYSIS|[?]|GBq/mg|[?]|[?]|POSITIVE|1|10^3/L|1|1|[?]|LOW|SERUM OR PLASMA|LIPEMIC||PYROSEQUENCING|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|3|FOLLOW-UP|2021-01-05|2021-01-21|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|17b9fa7a-f15d-423a-9671-99cd0cbbd362|8|EOSB|Eosinophils Band Form|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|JDF Unit|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|DRIED|N|FUNCTIONAL MRI|MDRD 5 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|4|SCREENING|2021-01-05|2021-01-13|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|17b9fa7a-f15d-423a-9671-99cd0cbbd362|9|HCG|Choriogonadotropin Beta|CHEMISTRY|[?]|mL/cage|[?]|[?]|NEGATIVE|1|WEEKS|1|1|[?]|HIGH|BREAST MILK|CONCENTRATED||MODIFIED ACID FAST STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||5|Visit_5|90|4|TREATMENT|2021-01-30|2021-02-03|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|17b9fa7a-f15d-423a-9671-99cd0cbbd362|10|C165938|Cow Milk Protein IgE AB RAST Score|HEMATOLOGY|[?]|um/day|[?]|[?]|POSITIVE|1|Tesla|1|1|[?]|HIGH|VITREOUS HUMOR|CLOTTED||SLIT LAMP PHOTOGRAPHY|GMI % FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2021-01-30|2021-02-06|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|95c4465b-162a-433d-83c9-6d67dd729c9e|1|CH50|Complement CH50|URINALYSIS|[?]|ug/day|[?]|[?]|INVALID|1|PFU|1|1|[?]|NORMAL|MECONIUM|NON-HEMOLYZED||FLOW MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|4|WASHOUT|2020-10-22|2021-01-06|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|95c4465b-162a-433d-83c9-6d67dd729c9e|2|MGBCREAT|Myoglobin/Creatinine|URINALYSIS|||[?]|[?]|INVALID|1|mmol/kg|1|1|[?]|NORMAL|LYMPH|FROZEN||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|FIBROMETER FORMULA|Y|Y|U|Y|1|Visit_1|10|3|TREATMENT|2020-10-22|2020-12-01|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|95c4465b-162a-433d-83c9-6d67dd729c9e|3|IAA5OHCR|5-Hydroxyindoleacetic Acid/Creatinine|HEMATOLOGY|[?]|cs|[?]|[?]|INVALID|1|PA|1|1|[?]|ABNORMAL|NAIL|ROOM TEMPERATURE|N|CALCULATION|MDRD FORMULA|||N||2|Visit_2|25|7|FOLLOW-UP|2020-11-06|2020-11-25|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|95c4465b-162a-433d-83c9-6d67dd729c9e|4|AAMAPAC|Alpha-Aminoadipic Acid|URINALYSIS|[?]|MPS U|[?]|[?]|BORDERLINE|1|MPL U|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|CONCENTRATED||FISH|MDRD 4 VARIABLE FORMULA||Y|NA||2|Visit_2|25|5|TREATMENT|2020-11-06|2020-12-25|25|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|95c4465b-162a-433d-83c9-6d67dd729c9e|5|MDMA|3,4-methylenedioxymethamphetamine|CHEMISTRY|[?]|10^6 U|[?]|[?]|INVALID|1|umol/dL|1|1|[?]|LOW|SEBUM|PARAFFIN-EMBEDDED||PERCUSSION|MDRD ENZYMATIC JAPANESE FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-11-21|2021-01-03|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|95c4465b-162a-433d-83c9-6d67dd729c9e|6|THMBAAC|Thrombin Activity Actual/Control|CHEMISTRY|[?]|mL/breath|[?]|[?]|NEGATIVE|1|log10 IU/mL|1|1|[?]|ABNORMAL|MUCUS|ROOM TEMPERATURE||SINGLE-MOLECULE ARRAY|MDRD FORMULA||Y|NA||3|Visit_3|40|4|SCREENING|2020-11-21|2020-11-23|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|95c4465b-162a-433d-83c9-6d67dd729c9e|7|C165876|Birch Pollen IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|kBq|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|NON-HEMOLYZED||MICROBIAL CONCENTRATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|4|Visit_4|65|3|TREATMENT|2020-12-16|2021-01-17|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|95c4465b-162a-433d-83c9-6d67dd729c9e|8|TSTSFRPT|Testosterone, Free/Total Protein|URINALYSIS|||[?]|[?]|TRACE|1|Ci/uL|1|1|[?]|HIGH|INFRANATANT, SERUM|UNEXPECTED ODOR||PERIPHERAL ANGIOGRAPHY|ASH FIBROSURE FORMULA|||U|Y|4|Visit_4|65|6|WASHOUT|2020-12-16|2021-01-05|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|95c4465b-162a-433d-83c9-6d67dd729c9e|9|PROLCTN|Prolactin|HEMATOLOGY|[?]|oz eq|[?]|[?]|INVALID|1|PUFF|1|1|[?]|LOW|PLEURAL FLUID|PARAFFIN-EMBEDDED||FUNDUS PHOTOGRAPHY|MDRD 6 VARIABLE FORMULA|Y||Y||5|Visit_5|90|4|TREATMENT|2021-01-10|2021-01-12|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|95c4465b-162a-433d-83c9-6d67dd729c9e|10|PHENTHZ|Phenothiazine|URINALYSIS|[?]|mL/sec/1.73m2|[?]|[?]|INDETERMINATE|1|ukat/L|1|1|[?]|HIGH|PLATELET|AGGLUTINATED||POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||Y|Y||5|Visit_5|90|1|TREATMENT|2021-01-10|2021-01-15|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|LB|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|1|NUCSWELL|Nuclear Swelling|CHEMISTRY|[?]|MnFI|[?]|[?]|BORDERLINE|1|uCi|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|LACTESCENT|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||1|Visit_1|10|2|WASHOUT|2020-06-27|2020-08-07|10|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|2|C130134|D. pteronyssinus Antigen IgE Antibody|URINALYSIS|[?]|mCi/kg|[?]|[?]|NEGATIVE|1|min/day|1|1|[?]|ABNORMAL|CELL PELLET|ROOM TEMPERATURE|N|COULOMETRIC TITRATION|FIBROMETER FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-06-27|2020-07-08|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|3|MONONSQE|Monocytes/Non-Squam Epi Cells|CHEMISTRY|||[?]|[?]|TRACE|1|mmol/min/kPa/L|1|1|[?]|ABNORMAL|PERITONEAL FLUID|THAWED||PULSE OXIMETRY|COCKCROFT-GAULT FORMULA||Y|N|Y|2|Visit_2|25|1|TREATMENT|2020-07-12|2020-09-09|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|4|HGBF|Hemoglobin F|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|vg/dose|1|1|[?]|ABNORMAL|VITREOUS HUMOR|AGGLUTINATED||TEMPLATE INCISION METHOD|MDRD 6 VARIABLE FORMULA|||N|Y|2|Visit_2|25|5|WASHOUT|2020-07-12|2020-07-20|25|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|LB|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|5|CD13|CD13|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^3 CFU/g|1|1|[?]|ABNORMAL|RETICULOCYTES|NON-HEMOLYZED||IMMUNOASSAY|GMI % FORMULA||Y|U|Y|3|Visit_3|40|1|TREATMENT|2020-07-27|2020-08-04|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|6|RFIGGAB|Rheumatoid Factor IgG Antibody|CHEMISTRY|[?]|GPS U|[?]|[?]|BORDERLINE|1|U/10^12 RBC|1|1|[?]|LOW|GASTRIC FLUID|AGGLUTINATED||FUNCTIONAL MRI|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|2|TREATMENT|2020-07-27|2020-09-16|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|7|ANIONG3|Anion Gap 3|CHEMISTRY|[?]|mm/h|[?]|[?]|POSITIVE|1|log10 CFU/g|1|1|[?]|NORMAL|HAIR FOLLICLE|THAWED|N|FARR ASSAY|FIBROSIS 4 FORMULA||Y|NA||4|Visit_4|65|1|TREATMENT|2020-08-21|2020-09-01|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|8|THYPXDAB|Thyroperoxidase Antibody|URINALYSIS|[?]|/month|[?]|[?]|INVALID|1|kPa|1|1|[?]|HIGH|AMNIOTIC FLUID|UNEXPECTED ODOR||PET/CT SCAN|MDRD 6 VARIABLE FORMULA|||Y||4|Visit_4|65|1|SCREENING|2020-08-21|2020-09-17|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|9|TBG|Thyroxine Binding Globulin|CHEMISTRY|[?]|Bq/g|[?]|[?]|NEGATIVE|1|oz|1|1|[?]|NORMAL|ABSCESS FLUID|CONCENTRATED|N|FLUORESCENT IMMUNOASSAY|GMI % FORMULA|Y|Y|Y||5|Visit_5|90|3|TREATMENT|2020-09-15|2020-09-22|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|10|NUCSWELL|Nuclear Swelling|URINALYSIS|[?]|ng|[?]|[?]|NEGATIVE|1|ug/m2|1|1|[?]|HIGH|BILE|REFRIGERATED||MICRODENSITOMETRY|FIBROMETER FORMULA|||N||5|Visit_5|90|6|TREATMENT|2020-09-15|2020-09-16|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|beb6b1ab-1264-456a-bf2b-81e28493301d|1|RITALAC|Ritalinic Acid|URINALYSIS|[?]|LOZENGE|[?]|[?]|NEGATIVE|1|% INHIBITION|1|1|[?]|HIGH|INTERSTITIAL FLUID|AUTOLYZED|N|CHROMOGENIC ASSAY|FIBROTEST FORMULA|||Y||1|Visit_1|10|5|SCREENING|2020-06-10|2020-06-17|10|17|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|beb6b1ab-1264-456a-bf2b-81e28493301d|2|CYTYRO|Tyrosine Crystals|CHEMISTRY|[?]|cm/s|[?]|[?]|NEGATIVE|1|ug/dose|1|1|[?]|LOW|BLOOD|AUTOLYZED||PET SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-06-10|2020-06-19|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|beb6b1ab-1264-456a-bf2b-81e28493301d|3|C130073|Birch Pollen IgA|HEMATOLOGY|[?]|mg/dL|[?]|[?]|POSITIVE|1|10^6 CFU|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|REFRIGERATED||TRICHROME STAIN|CKD-EPI FORMULA|||N||2|Visit_2|25|2|FOLLOW-UP|2020-06-25|2020-08-05|25|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|beb6b1ab-1264-456a-bf2b-81e28493301d|4|TTGIGGAB|Tissue Transglutaminase IgG Antibody|URINALYSIS|[?]|LB|[?]|[?]|INDETERMINATE|1|Log10 ELISA unit|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED||QUANTITATIVE ULTRASOUND|CKD-EPI CREATININE FORMULA||Y|U||2|Visit_2|25|2|FOLLOW-UP|2020-06-25|2020-07-18|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|beb6b1ab-1264-456a-bf2b-81e28493301d|5|LYMAT|Lymphocytes Atypical|CHEMISTRY|||[?]|[?]|INVALID|1|10^6 CFU|1|1|[?]|LOW|EXPIRED AIR|HEMOLYZED||ERGOSPIROMETRY|MDRD 4 VARIABLE FORMULA||Y|N|Y|3|Visit_3|40|6|TREATMENT|2020-07-10|2020-08-08|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|beb6b1ab-1264-456a-bf2b-81e28493301d|6|GFRBSCUA|GFR from Creat,UreaN,Alb Adj BSA|HEMATOLOGY|[?]|Anson U|[?]|[?]|POSITIVE|1|hr/day|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|THAWED||WHOLE TRANSCRIPTOME SEQUENCING|MDRD FORMULA|||NA||3|Visit_3|40|5|WASHOUT|2020-07-10|2020-07-23|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|beb6b1ab-1264-456a-bf2b-81e28493301d|7|RAGE|Receptor Advanced Glycation Endproducts|URINALYSIS|[?]|GBq/g|[?]|[?]|INDETERMINATE|1|g/m2/day|1|1|[?]|HIGH|SUPERNATANT, PLASMA|UNEXPECTED ODOR||PAP STAIN|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-08-04|2020-08-29|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|beb6b1ab-1264-456a-bf2b-81e28493301d|8|NTELOP|N-telopeptide|URINALYSIS|[?]|10^8/L|[?]|[?]|POSITIVE|1|ugEq|1|1|[?]|NORMAL|INTERSTITIAL FLUID|CONCENTRATED|N|CONTACT SPECULAR MICROSCOPY|FIBROMETER FORMULA|||NA||4|Visit_4|65|6|SCREENING|2020-08-04|2020-08-25|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|beb6b1ab-1264-456a-bf2b-81e28493301d|9|HRYCELY|Hairy Cells/Lymphocytes|URINALYSIS|[?]|FIU|[?]|[?]|POSITIVE|1|ug/L FEU|1|1|[?]|NORMAL|LEUKOCYTE|PARAFFIN-EMBEDDED||VENTILATION PERFUSION LUNG SCAN|NASH FIBROSURE FORMULA|Y||NA||5|Visit_5|90|7|TREATMENT|2020-08-29|2020-09-02|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|beb6b1ab-1264-456a-bf2b-81e28493301d|10|FACTIII|Factor III|HEMATOLOGY|[?]|/200 HPFs|[?]|[?]|TRACE|1|g/mol|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|DRIED||DISK DIFFUSION|CKD-EPI FORMULA|Y|Y|N||5|Visit_5|90|6|WASHOUT|2020-08-29|2020-08-31|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|4292c06d-044e-4dff-aea0-830178a6e220|1|APRI|AST to Platelet Ratio Index|URINALYSIS|[?]|um/s|[?]|[?]|NEGATIVE|1|BOLUS|1|1|[?]|NORMAL|MUCUS|UNEXPECTED ODOR||PERIODIC ACID SCHIFF STAIN|FIBROTEST FORMULA|||N||1|Visit_1|10|4|WASHOUT|2020-12-02|2021-02-21|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|4292c06d-044e-4dff-aea0-830178a6e220|2|CANNABS|Cannabinoids, Synthetic|HEMATOLOGY|||[?]|[?]|INVALID|1|g/cage|1|1|[?]|LOW|ALVEOLAR AIR|FRESH||LIGHT SCATTERING SPECTROSCOPY|HEPASCORE FORMULA||Y|N|Y|1|Visit_1|10|3|TREATMENT|2020-12-02|2021-01-01|10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|4292c06d-044e-4dff-aea0-830178a6e220|3|BCMAS|Soluble B Cell Maturation Antigen|CHEMISTRY|||[?]|[?]|BORDERLINE|1|CONTAINER|1|1|[?]|HIGH|AMNIOTIC FLUID|NON-HEMOLYZED||MUGA|GMI % FORMULA|||U|Y|2|Visit_2|25|4|TREATMENT|2020-12-17|2020-12-19|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|4292c06d-044e-4dff-aea0-830178a6e220|4|HIST3AB|Histone 3 Antibody|URINALYSIS|[?]|PFU|[?]|[?]|INVALID|1|uSiemens|1|1|[?]|NORMAL|INTERSTITIAL FLUID|DRIED||CYSTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|2|FOLLOW-UP|2020-12-17|2021-02-08|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|4292c06d-044e-4dff-aea0-830178a6e220|5|HER2|Human Epidermal Growth Factor Receptor 2|CHEMISTRY|[?]|MET*h|[?]|[?]|POSITIVE|1|uU/dL|1|1|[?]|LOW|EMOTIONAL TEAR|REFRIGERATED||GC/MS-CI|CKD-EPI FORMULA|Y||U||3|Visit_3|40|3|TREATMENT|2021-01-01|2021-02-01|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|4292c06d-044e-4dff-aea0-830178a6e220|6|GRWHRH|Growth Hormone Releasing Hormone|CHEMISTRY|[?]|uU/L|[?]|[?]|BORDERLINE|1|10^6 organisms/mL|1|1|[?]|NORMAL|CORD BLOOD|NON-HEMOLYZED||LEAD CITRATE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||3|Visit_3|40|6|TREATMENT|2021-01-01|2021-01-10|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|4292c06d-044e-4dff-aea0-830178a6e220|7|GLDIGAAB|Gliadin IgA Antibody|URINALYSIS|[?]|10^4 CFU/mL|[?]|[?]|INDETERMINATE|1|SYRINGE|1|1|[?]|LOW|VENOUS PLASMA|AUTOLYZED||CONTACT SPECULAR MICROSCOPY|CKD-EPI CREATININE FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2021-01-26|2021-02-08|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|4292c06d-044e-4dff-aea0-830178a6e220|8|APPB|Amyloid Beta Precursor Protein|CHEMISTRY|[?]|pmol/10^9 cells|[?]|[?]|BORDERLINE|1|Bq/L|1|1|[?]|ABNORMAL|CORD SERUM|THAWED||SMEAR|HEPASCORE FORMULA|Y||Y||4|Visit_4|65|5|SCREENING|2021-01-26|2021-02-08|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|4292c06d-044e-4dff-aea0-830178a6e220|9|FRUCTOSE|Fructose|HEMATOLOGY|[?]|kIU|[?]|[?]|INDETERMINATE|1|mg/kg/day|1|1|[?]|HIGH|PLEURAL FLUID|SOLIDIFIED||PHASE-CONTRAST MRI|FIBROMETER FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2021-02-20|2021-02-22|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|4292c06d-044e-4dff-aea0-830178a6e220|10|CMPK2|Cytidine-Uridine Monophosphate Kinase 2|CHEMISTRY|||[?]|[?]|NEGATIVE|1|cmol|1|1|[?]|NORMAL|BREAST MILK|FRESH||ENZYMATIC COLORIMETRY|FIBROMETER FORMULA||Y|Y|Y|5|Visit_5|90|7|TREATMENT|2021-02-20|2021-02-24|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|050c12d2-cf9f-402b-9332-d6a9771ed115|1|HLAMSC|HLA Mismatch Count|URINALYSIS|[?]|mL/mmHg|[?]|[?]|INDETERMINATE|1|/HPF|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|THAWED||BIOPSY|COCKCROFT-GAULT FORMULA|Y||Y||1|Visit_1|10|6|FOLLOW-UP|2020-08-18|2020-10-06|10|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|050c12d2-cf9f-402b-9332-d6a9771ed115|2|TEARDCY|Dacryocytes|CHEMISTRY|[?]|mg/min|[?]|[?]|POSITIVE|1|PIXEL|1|1|[?]|NORMAL|ADIPOSE TISSUE|PARAFFIN-EMBEDDED|N|IMMUNOASSAY|HEPASCORE FORMULA||Y|N||1|Visit_1|10|3|TREATMENT|2020-08-18|2020-10-31|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|050c12d2-cf9f-402b-9332-d6a9771ed115|3|PAI1|Plasminogen Activator Inhibitor-1|URINALYSIS|[?]|ng|[?]|[?]|INDETERMINATE|1|oz eq|1|1|[?]|NORMAL|ALVEOLAR AIR|CALCIFIED||SEQUENCING|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|3|FOLLOW-UP|2020-09-02|2020-10-12|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|050c12d2-cf9f-402b-9332-d6a9771ed115|4|PLSIMCCE|Immature Plasma Cells/Total Cells|CHEMISTRY|[?]|titer|[?]|[?]|INDETERMINATE|1|EID 50/mL|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED|N|CARDIAC THERMODILUTION|MDRD FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-09-02|2020-09-08|25|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|050c12d2-cf9f-402b-9332-d6a9771ed115|5|YEASTHYP|Yeast Hyphae|CHEMISTRY|||[?]|[?]|POSITIVE|1|log10 PFU/mL|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|AGGLUTINATED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|NASH FIBROSURE FORMULA|Y|Y|NA|Y|3|Visit_3|40|5|FOLLOW-UP|2020-09-17|2020-09-26|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|050c12d2-cf9f-402b-9332-d6a9771ed115|6|TRAP|Total Radical-Trap Antioxidant Potential|HEMATOLOGY|[?]|mCi/L|[?]|[?]|TRACE|1|cd|1|1|[?]|NORMAL|DIALYSIS FLUID|CALCIFIED||INCISION-INDUCED BLEEDING METHOD|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|2|FOLLOW-UP|2020-09-17|2020-10-25|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|050c12d2-cf9f-402b-9332-d6a9771ed115|7|GFRBSCUA|GFR from Creat,UreaN,Alb Adj BSA|HEMATOLOGY|[?]|mL/(min*100mL)|[?]|[?]|NEGATIVE|1|mol/g|1|1|[?]|NORMAL|EMOTIONAL TEAR|AUTOLYZED||PET/CT SCAN|MDRD 5 VARIABLE FORMULA|Y|Y|Y||4|Visit_4|65|2|WASHOUT|2020-10-12|2020-10-25|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|050c12d2-cf9f-402b-9332-d6a9771ed115|8|S100A8|S100 Calcium Binding Protein A8|CHEMISTRY|[?]|JDF Unit|[?]|[?]|INVALID|1|uL/kg/day|1|1|[?]|LOW|URINE SEDIMENT|CALCIFIED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 5 VARIABLE FORMULA|||U||4|Visit_4|65|5|SCREENING|2020-10-12|2020-10-29|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|050c12d2-cf9f-402b-9332-d6a9771ed115|9|FUNGI|Fungi|CHEMISTRY|[?]|U/L|[?]|[?]|NEGATIVE|1|/2500 WBC|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|PARAFFIN-EMBEDDED||TRANSCRIPTION-MEDIATED AMPLIFICATION|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2020-11-06|2020-11-13|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|050c12d2-cf9f-402b-9332-d6a9771ed115|10|CRENCE|Crenated Cells|HEMATOLOGY|[?]|g/kg|[?]|[?]|POSITIVE|1|nmol/mol|1|1|[?]|LOW|LYSATE|FROZEN||IMMUNE REPERTOIRE DEEP SEQUENCING|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|6|FOLLOW-UP|2020-11-06|2020-11-08|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|2f1073e4-607f-423f-a5de-f531b828e2d3|1|OXYCDN|Oxycodone|HEMATOLOGY|[?]|TUBE|[?]|[?]|BORDERLINE|1|um|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|GELLED||FLOCCULATION, CHARCOAL ENHANCED|CKD-EPI CREATININE FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-10-15|2020-11-29|10|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|2f1073e4-607f-423f-a5de-f531b828e2d3|2|ICAIGGAB|Islet Cell Cytoplasmic IgG Antibody|HEMATOLOGY|[?]|ug/dose|[?]|[?]|NEGATIVE|1|uEq|1|1|[?]|LOW|BREAST MILK|GELLED||LC-FL|NASH FIBROSURE FORMULA|Y||NA||1|Visit_1|10|7|WASHOUT|2020-10-15|2020-11-18|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|2f1073e4-607f-423f-a5de-f531b828e2d3|3|VITB3|Niacin|CHEMISTRY|[?]|pptr|[?]|[?]|BORDERLINE|1|mL/cm H2O|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|LACTESCENT||IVY INCISION METHOD|FIBROSIS 4 FORMULA|||N||2|Visit_2|25|5|SCREENING|2020-10-30|2020-12-27|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|2f1073e4-607f-423f-a5de-f531b828e2d3|4|PAF|Platelet Activating Factor|HEMATOLOGY|[?]|pmol/L/h|[?]|[?]|INVALID|1|nmol/L|1|1|[?]|ABNORMAL|BUFFY COAT|LACTESCENT||ANTIBIOTIC AGAR SCREEN|MDRD FORMULA|Y||Y||2|Visit_2|25|7|TREATMENT|2020-10-30|2020-11-15|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|2f1073e4-607f-423f-a5de-f531b828e2d3|5|ALPCREAT|Alkaline Phosphatase/Creatinine|URINALYSIS|[?]|ka_u/dL|[?]|[?]|TRACE|1|anti-Xa IU/mL|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|LIPEMIC|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|HEPASCORE FORMULA|||N||3|Visit_3|40|6|SCREENING|2020-11-14|2021-01-01|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|2f1073e4-607f-423f-a5de-f531b828e2d3|6|C165901|EnglishPlantain Pollen IgG AB RAST Score|HEMATOLOGY|||[?]|[?]|TRACE|1|U/m2/min|1|1|[?]|HIGH|VITREOUS HUMOR|REFRIGERATED||PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|Y|3|Visit_3|40|1|WASHOUT|2020-11-14|2021-01-12|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|2f1073e4-607f-423f-a5de-f531b828e2d3|7|HERC5|Hect Domain and RLD 5|URINALYSIS|[?]|cmol/L|[?]|[?]|POSITIVE|1|cm/s|1|1|[?]|LOW|ENDOTRACHEAL FLUID|AGGLUTINATED||PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|U||4|Visit_4|65|4|TREATMENT|2020-12-09|2020-12-22|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|2f1073e4-607f-423f-a5de-f531b828e2d3|8|GLOBA1|Alpha-1 Globulin|HEMATOLOGY|[?]|cpm|[?]|[?]|POSITIVE|1|deg2|1|1|[?]|HIGH|SUPERNATANT, PLASMA|ICTERIC||PERFUSION MRI|HEPASCORE FORMULA|||Y||4|Visit_4|65|7|TREATMENT|2020-12-09|2020-12-30|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|2f1073e4-607f-423f-a5de-f531b828e2d3|9|C147282|White Oak Pollen IgE Antibody|URINALYSIS|[?]|BAU|[?]|[?]|POSITIVE|1|genEq|1|1|[?]|LOW|VITREOUS HUMOR|UNEXPECTED ODOR||RADIATION DOSIMETRY|GMI MMOL/MOL FORMULA|||U||5|Visit_5|90|7|TREATMENT|2021-01-03|2021-01-10|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|2f1073e4-607f-423f-a5de-f531b828e2d3|10|NTXII|Type II Collagen N-Telopeptides|HEMATOLOGY|[?]|U/g|[?]|[?]|POSITIVE|1|cd*s/m2|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|LIPEMIC||NEXT GENERATION SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|2|FOLLOW-UP|2021-01-03|2021-01-04|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|df466903-3212-4e73-bff0-a183447c7408|1|C147282|White Oak Pollen IgE Antibody|URINALYSIS|[?]|DNA copies/mL|[?]|[?]|INDETERMINATE|1|GBq/ug|1|1|[?]|HIGH|INTERSTITIAL FLUID|FROZEN||SPECT SCAN|MDRD 6 VARIABLE FORMULA|Y||Y||1|Visit_1|10|5|WASHOUT|2020-11-01|2021-01-03|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|LB|df466903-3212-4e73-bff0-a183447c7408|2|HIST3AB|Histone 3 Antibody|URINALYSIS|[?]|nkat/L|[?]|[?]|INVALID|1|umol/dL|1|1|[?]|NORMAL|SEMINAL FLUID|HEMOLYZED||ERGOSPIROMETRY|ASH FIBROSURE FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-11-01|2020-11-09|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|LB|df466903-3212-4e73-bff0-a183447c7408|3|SCL70AB|Scl-70 Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|mL/cm H2O|1|1|[?]|NORMAL|LEUKOCYTE|SOLIDIFIED|N|FLUORESCENT MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA|Y|2|Visit_2|25|7|FOLLOW-UP|2020-11-16|2020-11-21|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|df466903-3212-4e73-bff0-a183447c7408|4|GHRELIN|Ghrelin|URINALYSIS|||[?]|[?]|NEGATIVE|1|mL/day|1|1|[?]|ABNORMAL|ALVEOLAR AIR|CLOTTED||GC/MS-EI|MDRD FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2020-11-16|2021-01-25|25|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|df466903-3212-4e73-bff0-a183447c7408|5|TPAG|Tissue Polypeptide Antigen|URINALYSIS|[?]|scm|[?]|[?]|BORDERLINE|1|fmol/L/sec|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|REFRIGERATED|N|ANALYTICAL ULTRACENTRIFUGATION|MDRD 6 VARIABLE FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-12-01|2021-01-29|40|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|LB|df466903-3212-4e73-bff0-a183447c7408|6|P1NP|Procollagen 1 N-Terminal Propeptide|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Coulomb|1|1|[?]|HIGH|VENOUS BLOOD|ICTERIC||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROTEST FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2020-12-01|2020-12-24|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|LB|df466903-3212-4e73-bff0-a183447c7408|7|ELA2|Neutrophil Elastase|URINALYSIS|[?]|mL/s/m2|[?]|[?]|INVALID|1|mAnson U/mL|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT||DIGITAL PCR|MDRD 6 VARIABLE FORMULA||Y|N||4|Visit_4|65|3|WASHOUT|2020-12-26|2021-01-10|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|df466903-3212-4e73-bff0-a183447c7408|8|C130116|Bee Mix Antigen IgE Antibody|CHEMISTRY|[?]|PELLET|[?]|[?]|BORDERLINE|1|mgEq|1|1|[?]|HIGH|CELL PELLET|CALCIFIED||INTERRUPTER TECHNIQUE|GMI % FORMULA|Y||NA||4|Visit_4|65|7|TREATMENT|2020-12-26|2021-01-16|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|df466903-3212-4e73-bff0-a183447c7408|9|MCSF|Macrophage Colony Stimulating Factor|HEMATOLOGY|[?]|mol/mol|[?]|[?]|INVALID|1|pmol/10^9 cells|1|1|[?]|LOW|ADIPOSE TISSUE|LACTESCENT||ELECTROCHEMILUMINESCENCE|ASH FIBROSURE FORMULA|||U||5|Visit_5|90|4|SCREENING|2021-01-20|2021-01-21|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|df466903-3212-4e73-bff0-a183447c7408|10|EPINSQCE|Non-Squamous Epithelial Cells|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mV2/Hz|1|1|[?]|ABNORMAL|BASAL TEAR|AUTOLYZED||DUCTOGRAPHY|GMI MMOL/MOL FORMULA|||N|Y|5|Visit_5|90|4|WASHOUT|2021-01-20|2021-01-27|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|1|MSTHCE|Mesothelial Cells|CHEMISTRY|[?]|LOZENGE|[?]|[?]|NEGATIVE|1|rpm|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|CALCIFIED||STRESS ECHOCARDIOGRAPHY|ASH FIBROSURE FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-07-13|2020-08-09|10|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|2|IGGALB|Immunoglobulin G/Albumin|CHEMISTRY|[?]|s*kPa|[?]|[?]|POSITIVE|1|10^6 organisms/mL|1|1|[?]|NORMAL|ABSCESS FLUID|AUTOLYZED|N|FLUORIMETRY|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|7|FOLLOW-UP|2020-07-13|2020-08-17|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|LB|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|3|DRVVTSCR|DRVVT Screen to Confirm Ratio|URINALYSIS|[?]|vg/mL|[?]|[?]|BORDERLINE|1|DAYS|1|1|[?]|ABNORMAL|VENOUS PLASMA|LIPEMIC||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|6|FOLLOW-UP|2020-07-28|2020-08-07|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|4|PLSIMCCE|Immature Plasma Cells/Total Cells|HEMATOLOGY|[?]|nkat/g Hb|[?]|[?]|INVALID|1|tuberculin unit|1|1|[?]|LOW|SALIVA|SOLIDIFIED||OPHTHALMOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||2|Visit_2|25|5|TREATMENT|2020-07-28|2020-09-27|25|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|5|MPO|Myeloperoxidase|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mgEq|1|1|[?]|LOW|LYMPH|CONTAMINATED|N|GC/MS|MDRD 6 VARIABLE FORMULA|Y|Y|U|Y|3|Visit_3|40|5|FOLLOW-UP|2020-08-12|2020-08-16|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|6|TNFAPIA|TNF-a Production Inhibitory Activity|CHEMISTRY|[?]|MPL U|[?]|[?]|NEGATIVE|1|/cmH2O|1|1|[?]|ABNORMAL|SOFT TISSUE|AGGLUTINATED||WESTERGREN|MDRD FORMULA||Y|NA||3|Visit_3|40|6|SCREENING|2020-08-12|2020-10-09|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|7|HYPRLN|Hydroxyproline|HEMATOLOGY|[?]|dmol|[?]|[?]|BORDERLINE|1|10^6/L|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|LIPEMIC||BALLPOINT PEN TECHNIQUE|CKD-EPI CREATININE FORMULA|Y||NA||4|Visit_4|65|6|FOLLOW-UP|2020-09-06|2020-09-18|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|8|CSHYAL|Hyaline Casts|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mmol/kg|1|1|[?]|NORMAL|FLUID|GELLED||PERCUSSION|FIBROSIS 4 FORMULA|||NA|Y|4|Visit_4|65|2|WASHOUT|2020-09-06|2020-09-08|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|9|ARSENIC|Arsenic|HEMATOLOGY|[?]|mmol|[?]|[?]|INVALID|1|Hz|1|1|[?]|NORMAL|LUNG SURFACTANT|CLOTTED||LINE PROBE ASSAY|MDRD 6 VARIABLE FORMULA|||U||5|Visit_5|90|6|WASHOUT|2020-10-01|2020-10-10|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|10|DNPSEPHD|D-Norpseudoephedrine|HEMATOLOGY|||[?]|[?]|POSITIVE|1|g/m2|1|1|[?]|NORMAL|SEBUM|THAWED|N|CONTRAST ENHANCED PET/CT SCAN|CKD-EPI CYSTATIN C FORMULA|||U|Y|5|Visit_5|90|1|TREATMENT|2020-10-01|2020-10-09|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|c37df2f6-be8a-4709-b97d-061ab9754e0d|1|CRTCLRE|Creatinine Clearance, Estimated|CHEMISTRY|[?]|10^6 organisms|[?]|[?]|NEGATIVE|1|SFC/10^6 PBMC|1|1|[?]|ABNORMAL|PLEURAL FLUID|GELLED|N|TRANSVAGINAL ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-08-01|2020-10-14|10|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|c37df2f6-be8a-4709-b97d-061ab9754e0d|2|BILEAC|Bile Acid|CHEMISTRY|[?]|Farad|[?]|[?]|NEGATIVE|1|g/day|1|1|[?]|NORMAL|DERMAL TISSUE|SOLIDIFIED||QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROSIS 4 FORMULA|Y|Y|U||1|Visit_1|10|3|FOLLOW-UP|2020-08-01|2020-10-03|10|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|c37df2f6-be8a-4709-b97d-061ab9754e0d|3|CDTTFRN|Carb-Deficient Transferrin/Transferrin|CHEMISTRY|[?]|s/h|[?]|[?]|INDETERMINATE|1|%(w/w)|1|1|[?]|LOW|MENSTRUAL BLOOD|CONCENTRATED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD FORMULA||Y|N||2|Visit_2|25|1|TREATMENT|2020-08-16|2020-09-24|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|c37df2f6-be8a-4709-b97d-061ab9754e0d|4|CSEPI846|Aggrecan Chondroitin Sulfate Epitope 846|URINALYSIS|[?]|CIGARETTE|[?]|[?]|POSITIVE|1|Pa|1|1|[?]|NORMAL|BONE MARROW|LIPEMIC|N|CONTRAST ENHANCED CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|5|WASHOUT|2020-08-16|2020-09-02|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|c37df2f6-be8a-4709-b97d-061ab9754e0d|5|APOA4|Apolipoprotein A4|URINALYSIS|[?]|%|[?]|[?]|INDETERMINATE|1|L/min/m2|1|1|[?]|HIGH|INTERSTITIAL FLUID|CALCIFIED||BIOPSY|CKD-EPI FORMULA||Y|NA||3|Visit_3|40|4|TREATMENT|2020-08-31|2020-10-17|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|c37df2f6-be8a-4709-b97d-061ab9754e0d|6|ANAG|Alpha-N-acetylglucosaminidase|URINALYSIS|[?]|pg/cell|[?]|[?]|TRACE|1|Newton|1|1|[?]|HIGH|EMESIS|LACTESCENT|N|AUTOREFRACTION|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||3|Visit_3|40|3|FOLLOW-UP|2020-08-31|2020-09-07|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|c37df2f6-be8a-4709-b97d-061ab9754e0d|7|MSPIKE|Monoclonal Protein Spike|URINALYSIS|||[?]|[?]|TRACE|1|mL/cage/day|1|1|[?]|LOW|SYNOVIAL FLUID|FROZEN|N|CLAUSS METHOD|HEPASCORE FORMULA|||NA|Y|4|Visit_4|65|5|SCREENING|2020-09-25|2020-10-08|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|c37df2f6-be8a-4709-b97d-061ab9754e0d|8|CYTYRO|Tyrosine Crystals|CHEMISTRY|[?]|ag|[?]|[?]|TRACE|1|10^5/hpf|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|SOLIDIFIED||MICROSCOPY|MDRD ENZYMATIC FORMULA||Y|N||4|Visit_4|65|7|TREATMENT|2020-09-25|2020-10-01|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|c37df2f6-be8a-4709-b97d-061ab9754e0d|9|C130091|Timothy Grass Pollen IgG4|HEMATOLOGY|[?]|amu|[?]|[?]|TRACE|1|10^3 CFU/g|1|1|[?]|ABNORMAL|DERMAL TISSUE|LIPEMIC||SPIROMETRY|MDRD FORMULA|||NA||5|Visit_5|90|1|TREATMENT|2020-10-20|2020-10-29|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|c37df2f6-be8a-4709-b97d-061ab9754e0d|10|ARSENIC|Arsenic|URINALYSIS|||[?]|[?]|NEGATIVE|1|/7.5 mL|1|1|[?]|ABNORMAL|PLEURAL FLUID|SOLIDIFIED||AUSCULTATION|GMI MMOL/MOL FORMULA|||U|Y|5|Visit_5|90|6|SCREENING|2020-10-20|2020-10-24|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|1|CBB|Complement Bb|HEMATOLOGY|||[?]|[?]|POSITIVE|1|nmol/L/min|1|1|[?]|LOW|CELL PELLET|THAWED||MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD ENZYMATIC FORMULA|||Y|Y|1|Visit_1|10|7|TREATMENT|2020-05-13|2020-08-07|10|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|LB|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|2|FATBODOV|Fat Bodies, Oval|CHEMISTRY|||[?]|[?]|NEGATIVE|1|ng/day|1|1|[?]|NORMAL|SERUM OR PLASMA|REFRIGERATED||SICKLE CELL SOLUBILITY TEST|MDRD 6 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|6|SCREENING|2020-05-13|2020-06-08|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|LB|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|3|MCVRETIC|MCV Reticulocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ugEq/L|1|1|[?]|ABNORMAL|DISCHARGE|LACTESCENT||MICROBIAL CULTURE, SOLID|CKD-EPI FORMULA|||NA|Y|2|Visit_2|25|2|TREATMENT|2020-05-28|2020-06-20|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-05
e|LB|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|4|C5FR|Complement C5, Free|URINALYSIS|[?]|L/h|[?]|[?]|INDETERMINATE|1|Rad|1|1|[?]|LOW|COLOSTRUM|UNEXPECTED ODOR||OBSERVATION|GMI MMOL/MOL FORMULA|||NA||2|Visit_2|25|3|WASHOUT|2020-05-28|2020-07-14|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-05
e|LB|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|5|BLSTNMCE|Normoblasts/Total Cells|HEMATOLOGY|[?]|Tbsp|[?]|[?]|INVALID|1|mg/g/min|1|1|[?]|LOW|SUPERNATANT, PLASMA|NON-HEMOLYZED|N|SPECTROPHOTOMETRY|FIBROTEST FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-06-12|2020-07-18|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-11
e|LB|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|6|HETRPHLE|Heterophils/Leukocytes|HEMATOLOGY|||[?]|[?]|INVALID|1|mmol/mol|1|1|[?]|NORMAL|SPERMATOZOON|PARAFFIN-EMBEDDED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA|Y||N|Y|3|Visit_3|40|3|TREATMENT|2020-06-12|2020-06-21|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-11
e|LB|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|7|IDL|IDL Cholesterol|CHEMISTRY|[?]|cg|[?]|[?]|TRACE|1|mV*min|1|1|[?]|LOW|BILE|NON-HEMOLYZED||LYMPHANGIOGRAPHY|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|6|FOLLOW-UP|2020-07-07|2020-07-21|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|LB|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|8|NAK|Sodium/Potassium|URINALYSIS|[?]|g/animal|[?]|[?]|POSITIVE|1|g/cage/day|1|1|[?]|NORMAL|ABSCESS FLUID|CONCENTRATED||SICKLE CELL SOLUBILITY TEST|CKD-EPI CYSTATIN C FORMULA|Y||NA||4|Visit_4|65|2|TREATMENT|2020-07-07|2020-08-02|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|LB|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|9|PTHRP|Parathyroid Hormone-related Protein|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|DNA copies/ug|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|CLOTTED||GC/MS-CI|MDRD ENZYMATIC JAPANESE FORMULA|Y||U|Y|5|Visit_5|90|4|TREATMENT|2020-08-01|2020-08-05|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-20
e|LB|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|10|THC|Tetrahydrocannabinol|HEMATOLOGY|[?]|mOsm/L|[?]|[?]|INDETERMINATE|1|MBP|1|1|[?]|NORMAL|SUPERNATANT, SERUM|NON-HEMOLYZED||PELLI-ROBSON EYE CHART|NASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|1|TREATMENT|2020-08-01|2020-08-04|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-20
e|LB|cec9e0ce-4d09-470c-9c26-df661d316a69|1|GHBP|Growth Hormone Binding Protein|HEMATOLOGY|[?]|mol/mL|[?]|[?]|POSITIVE|1|DRINK|1|1|[?]|HIGH|EMESIS|CONTAMINATED||CYSTOSCOPY|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|7|TREATMENT|2021-01-05|2021-03-20|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|cec9e0ce-4d09-470c-9c26-df661d316a69|2|C130133|D. farinae Antigen IgG Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/m2/h|1|1|[?]|LOW|EXUDATE|DRIED||DISK DIFFUSION|HEPASCORE FORMULA||Y|NA|Y|1|Visit_1|10|1|FOLLOW-UP|2021-01-05|2021-01-06|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|cec9e0ce-4d09-470c-9c26-df661d316a69|3|C130086|English Plantain Pollen IgG|HEMATOLOGY|[?]|mg/L FEU|[?]|[?]|INVALID|1|BISCUIT|1|1|[?]|LOW|RETICULOCYTES|UNEXPECTED ODOR|N|TRIPLE-PHASE MRI SCAN|FIBROTEST FORMULA|||U||2|Visit_2|25|3|TREATMENT|2021-01-20|2021-02-24|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|cec9e0ce-4d09-470c-9c26-df661d316a69|4|AMORPHSD|Amorphous Sediment|HEMATOLOGY|[?]|mkat|[?]|[?]|NEGATIVE|1|10^6 organisms/mg|1|1|[?]|HIGH|PLASMA ULTRAFILTRATE|CALCIFIED|N|GEL ELECTROPHORESIS|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2021-01-20|2021-02-22|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|cec9e0ce-4d09-470c-9c26-df661d316a69|5|SJSA52AB|Sjogrens SS-A52 Antibody|CHEMISTRY|[?]|U.CARR|[?]|[?]|POSITIVE|1|pmol/10^10 cells|1|1|[?]|LOW|DERMAL TISSUE|UNEXPECTED ODOR||CARDIAC THERMODILUTION|FIBROTEST FORMULA|||Y||3|Visit_3|40|2|FOLLOW-UP|2021-02-04|2021-03-28|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|LB|cec9e0ce-4d09-470c-9c26-df661d316a69|6|ICAB|Islet Cell Antibody|HEMATOLOGY|[?]|s^-1(%O2)^-1|[?]|[?]|INDETERMINATE|1|uL/mL|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED||BETA LACTAMASE|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||3|Visit_3|40|2|SCREENING|2021-02-04|2021-02-05|40|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|LB|cec9e0ce-4d09-470c-9c26-df661d316a69|7|TRGTCE|Target Cells|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|U/kg/day|1|1|[?]|NORMAL|SYNOVIAL FLUID|GELLED||DC SHEATH FLOW|ASH FIBROSURE FORMULA|||U|Y|4|Visit_4|65|3|WASHOUT|2021-03-01|2021-03-25|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|cec9e0ce-4d09-470c-9c26-df661d316a69|8|RFIGGAB|Rheumatoid Factor IgG Antibody|HEMATOLOGY|[?]|LOZENGE|[?]|[?]|INVALID|1|mmHg/sec|1|1|[?]|LOW|SERUM OR PLASMA|ICTERIC||MRS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|4|WASHOUT|2021-03-01|2021-03-10|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|cec9e0ce-4d09-470c-9c26-df661d316a69|9|ESTROGEN|Estrogen|URINALYSIS|||[?]|[?]|POSITIVE|1|L/h|1|1|[?]|HIGH|PLEURAL FLUID|THAWED|N|TRIPLE-PHASE MRI SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|5|Visit_5|90|5|TREATMENT|2021-03-26|2021-03-27|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|LB|cec9e0ce-4d09-470c-9c26-df661d316a69|10|LDHCREAT|Lactate Dehydrogenase/Creatinine|HEMATOLOGY|[?]|umol/kg/min|[?]|[?]|BORDERLINE|1|pg|1|1|[?]|HIGH|DIALYSIS FLUID|FRESH||POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA|Y||Y||5|Visit_5|90|1|TREATMENT|2021-03-26|2021-03-29|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|LB|b98b4e19-51ac-40cc-80d5-cb6d8000c112|1|HGBCHGB|Hemoglobin C/Total Hemoglobin|CHEMISTRY|[?]|um/s|[?]|[?]|NEGATIVE|1|U/kg|1|1|[?]|NORMAL|SEMEN|PARAFFIN-EMBEDDED|N|DIGITAL PCR ARRAY|MDRD ENZYMATIC FORMULA|||U||1|Visit_1|10|3|WASHOUT|2021-01-17|2021-03-22|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-03
e|LB|b98b4e19-51ac-40cc-80d5-cb6d8000c112|2|C165885|Olive Tree Pollen IgE AB RAST Score|URINALYSIS|[?]|dL|[?]|[?]|POSITIVE|1|10^3/L|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|AGGLUTINATED|N|HPLC/IEX|HEPASCORE FORMULA|||N||1|Visit_1|10|1|FOLLOW-UP|2021-01-17|2021-04-06|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-03
e|LB|b98b4e19-51ac-40cc-80d5-cb6d8000c112|3|LKM1IGAB|Liver Kidney Microsomal Type 1 IgG Ab|HEMATOLOGY|[?]|PLUG|[?]|[?]|POSITIVE|1|mg/kg/h|1|1|[?]|NORMAL|AMNIOTIC FLUID|REFRIGERATED||ANALYTICAL ULTRACENTRIFUGATION|FIBROMETER FORMULA|||NA||2|Visit_2|25|6|SCREENING|2021-02-01|2021-02-14|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|b98b4e19-51ac-40cc-80d5-cb6d8000c112|4|KLCLLCFR|Kappa Lt Chain,Free/Lambda Lt Chain,Free|CHEMISTRY|[?]|mm/h|[?]|[?]|POSITIVE|1|10^6/hpf|1|1|[?]|HIGH|URINE SEDIMENT|NON-HEMOLYZED||IMMUNE REPERTOIRE DEEP SEQUENCING|COCKCROFT-GAULT FORMULA||Y|N||2|Visit_2|25|5|FOLLOW-UP|2021-02-01|2021-02-20|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|b98b4e19-51ac-40cc-80d5-cb6d8000c112|5|ABNCELE|Abnormal Cells/Leukocytes|URINALYSIS|||[?]|[?]|TRACE|1|amol|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|THAWED|N|STATIC PERIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|3|Visit_3|40|5|TREATMENT|2021-02-16|2021-04-04|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|b98b4e19-51ac-40cc-80d5-cb6d8000c112|6|MIP1B|Macrophage Inflammatory Protein 1 Beta|URINALYSIS|[?]|/month|[?]|[?]|INVALID|1|kg/L|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|THAWED||INTRAVASCULAR ULTRASOUND|CKD-EPI FORMULA|||U||3|Visit_3|40|1|TREATMENT|2021-02-16|2021-03-22|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|b98b4e19-51ac-40cc-80d5-cb6d8000c112|7|C3B|Complement C3b|URINALYSIS|[?]|ug/m2/min|[?]|[?]|INDETERMINATE|1|g/U|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|AUTOLYZED||WHOLE EXOME SEQUENCING|FIBROMETER FORMULA||Y|N||4|Visit_4|65|6|TREATMENT|2021-03-13|2021-03-18|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|b98b4e19-51ac-40cc-80d5-cb6d8000c112|8|BLSTNMCE|Normoblasts/Total Cells|HEMATOLOGY|||[?]|[?]|INVALID|1|POINT|1|1|[?]|ABNORMAL|DIALYSIS FLUID|PARAFFIN-EMBEDDED||HIGH RESOLUTION MELT ANALYSIS|FIBROTEST FORMULA|||U|Y|4|Visit_4|65|4|TREATMENT|2021-03-13|2021-04-04|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|b98b4e19-51ac-40cc-80d5-cb6d8000c112|9|C165887|EnglishPlantain Pollen IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|HOURS|1|1|[?]|HIGH|VITREOUS HUMOR|CLOTTED||RIA|GMI MMOL/MOL FORMULA|||Y|Y|5|Visit_5|90|4|TREATMENT|2021-04-07|2021-04-08|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|b98b4e19-51ac-40cc-80d5-cb6d8000c112|10|RBCCLMP|Erythrocyte Cell Clumps|HEMATOLOGY|[?]|PFU/mL|[?]|[?]|INVALID|1|VIRTUAL PIXEL|1|1|[?]|LOW|AQUEOUS HUMOR|DRIED|N|CONTRAST ENHANCED X-RAY|MDRD FORMULA|||NA||5|Visit_5|90|6|FOLLOW-UP|2021-04-07|2021-04-11|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|1|NEUTLS|Left Shift Neutrophils|HEMATOLOGY|[?]|mL/kg|[?]|[?]|NEGATIVE|1|dpm/mg|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|CLOTTED||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|HEPASCORE FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-07-07|2020-09-22|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|2|DENSITY|Density|URINALYSIS|[?]|Antibody Unit|[?]|[?]|INDETERMINATE|1|DROP|1|1|[?]|ABNORMAL|BASAL TEAR|CLOTTED|N|AURAMINE STAIN|CKD-EPI FORMULA||Y|Y||1|Visit_1|10|1|SCREENING|2020-07-07|2020-07-23|10|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|3|SODMEXR|Sodium Excretion Rate|CHEMISTRY|[?]|uL/kg/day|[?]|[?]|TRACE|1|10^7 PFU|1|1|[?]|HIGH|SUPERNATANT, PLASMA|ICTERIC||IMMUNO-PET SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-07-22|2020-08-20|25|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|4|SMTHAB|Smith Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|log10 PFU/mL|1|1|[?]|HIGH|PLATELET RICH PLASMA|SOLIDIFIED||MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 6 VARIABLE FORMULA|Y||N|Y|2|Visit_2|25|2|TREATMENT|2020-07-22|2020-09-13|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|5|HYPSEGCE|Hypersegmented Cells|CHEMISTRY|[?]|DRUM|[?]|[?]|INVALID|1|IU/mmol|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|THAWED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||3|Visit_3|40|3|WASHOUT|2020-08-06|2020-09-10|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|6|ESTROGEN|Estrogen|HEMATOLOGY|[?]|g/animal|[?]|[?]|TRACE|1|gpELISA unit/mL|1|1|[?]|ABNORMAL|GASTRIC FLUID|CALCIFIED||SLOAN LETTER EYE CHART 1.25%|GMI % FORMULA||Y|Y||3|Visit_3|40|2|TREATMENT|2020-08-06|2020-08-07|40|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|7|LYMVAC|Vacuolated Lymphocytes|CHEMISTRY|[?]|g/g|[?]|[?]|TRACE|1|IU|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|UNEXPECTED ODOR||FLUOROSCOPY|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|1|TREATMENT|2020-08-31|2020-09-27|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|8|PSAFPSAT|PSA, Free/PSA|URINALYSIS|[?]|amp|[?]|[?]|NEGATIVE|1|mL/min/mmHg|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|AGGLUTINATED|N|AUDIOMETRY|ASH FIBROSURE FORMULA|Y|Y|U||4|Visit_4|65|2|TREATMENT|2020-08-31|2020-09-10|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|9|CSFAT|Fatty Casts|CHEMISTRY|[?]|Osm|[?]|[?]|INDETERMINATE|1|SCOOPFUL|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|GELLED||TRANSVAGINAL ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||5|Visit_5|90|3|WASHOUT|2020-09-25|2020-09-27|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|10|LGLUCLE|Large Unstained Cells/Leukocytes|HEMATOLOGY|||[?]|[?]|TRACE|1|GPS U|1|1|[?]|HIGH|COLOSTRUM|ICTERIC|N|CINEANGIOGRAPHY|MDRD ENZYMATIC FORMULA|||Y|Y|5|Visit_5|90|7|TREATMENT|2020-09-25|2020-10-04|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|4bc30b18-c8d8-41a3-91d5-33b8b064087b|1|PAPPA|Pregnancy-Associated Plasma Protein-A|URINALYSIS|[?]|in2|[?]|[?]|POSITIVE|1|amp|1|1|[?]|LOW|LUNG SURFACTANT|LIPEMIC||FLAME PHOTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||1|Visit_1|10|4|SCREENING|2020-07-12|2020-08-02|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|4bc30b18-c8d8-41a3-91d5-33b8b064087b|2|FACTX|Factor X|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mL/sec/1.73m2|1|1|[?]|HIGH|MUSCLE TISSUE|ROOM TEMPERATURE||RYAN BLUE STAIN|GMI MMOL/MOL FORMULA||Y|N|Y|1|Visit_1|10|5|TREATMENT|2020-07-12|2020-09-19|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|4bc30b18-c8d8-41a3-91d5-33b8b064087b|3|PH|pH|CHEMISTRY|[?]|cmH2O*s/mL|[?]|[?]|INVALID|1|10^7 CFU/mL|1|1|[?]|HIGH|MONOCYTE|PARAFFIN-EMBEDDED||SLOAN LETTER EYE CHART 2.5%|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|6|SCREENING|2020-07-27|2020-08-03|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|4bc30b18-c8d8-41a3-91d5-33b8b064087b|4|CEIMCE|Immature Cells/Total Cells|CHEMISTRY|[?]|ug/L FEU|[?]|[?]|INVALID|1|kat|1|1|[?]|LOW|NAIL|CALCIFIED||WHOLE TRANSCRIPTOME SEQUENCING|FIBROSIS 4 FORMULA|Y|Y|N||2|Visit_2|25|2|TREATMENT|2020-07-27|2020-10-05|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|4bc30b18-c8d8-41a3-91d5-33b8b064087b|5|ACT|Activated Coagulation Time|CHEMISTRY|||[?]|[?]|POSITIVE|1|mL/breath|1|1|[?]|HIGH|MECONIUM|LIPEMIC|N|SPECT/CT SCAN|CKD-EPI CYSTATIN C FORMULA|Y||U|Y|3|Visit_3|40|3|TREATMENT|2020-08-11|2020-09-25|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|4bc30b18-c8d8-41a3-91d5-33b8b064087b|6|HLAA23A|HLA-A23 Antibody|URINALYSIS|[?]|Enzyme U/L|[?]|[?]|BORDERLINE|1|/10^3|1|1|[?]|LOW|MIXED VENOUS BLOOD|CALCIFIED||SPIROMETRY|MDRD 6 VARIABLE FORMULA|||NA||3|Visit_3|40|4|WASHOUT|2020-08-11|2020-08-13|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|4bc30b18-c8d8-41a3-91d5-33b8b064087b|7|PRZPM|Prazepam|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|/mm2|1|1|[?]|HIGH|EXUDATE|AGGLUTINATED|N|LISSAMINE GREEN STAIN|MDRD 6 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|5|TREATMENT|2020-09-05|2020-10-04|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|4bc30b18-c8d8-41a3-91d5-33b8b064087b|8|ANP|Atrial Natriuretic Peptide|URINALYSIS|[?]|Ejaculate U|[?]|[?]|NEGATIVE|1|mmAL|1|1|[?]|NORMAL|TRANSUDATE|REFRIGERATED||MANUAL COUNT|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-09-05|2020-09-17|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|LB|4bc30b18-c8d8-41a3-91d5-33b8b064087b|9|FLUOXTN|Fluoxetine|URINALYSIS|||[?]|[?]|BORDERLINE|1|MBq/uL|1|1|[?]|HIGH|LYMPH|GELLED||SLIT LAMP PHOTOGRAPHY|CKD-EPI CREATININE FORMULA|||U|Y|5|Visit_5|90|5|FOLLOW-UP|2020-09-30|2020-10-07|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|4bc30b18-c8d8-41a3-91d5-33b8b064087b|10|INTLK19|Interleukin 19|HEMATOLOGY|[?]|pkat/L|[?]|[?]|BORDERLINE|1|kPa/L/sec|1|1|[?]|LOW|TRANSUDATE|LACTESCENT||QUANTITATIVE ULTRASOUND|CKD-EPI FORMULA|||NA||5|Visit_5|90|5|WASHOUT|2020-09-30|2020-10-03|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|7ff27a70-0472-4cc1-b057-6b161ab29568|1|MDC|Macrophage-Derived Chemokine|URINALYSIS|[?]|Hz/s|[?]|[?]|TRACE|1|mL/h|1|1|[?]|NORMAL|CORD SERUM|HEMOLYZED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|||NA||1|Visit_1|10|6|FOLLOW-UP|2020-11-19|2021-01-09|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|7ff27a70-0472-4cc1-b057-6b161ab29568|2|KETONES|Ketones|CHEMISTRY|[?]|ugEq/L|[?]|[?]|BORDERLINE|1|/7.5 mL|1|1|[?]|LOW|REFLEX TEAR|CONCENTRATED||FLUORESCENT LIFETIME IMAGING MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||1|Visit_1|10|3|WASHOUT|2020-11-19|2020-12-27|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|7ff27a70-0472-4cc1-b057-6b161ab29568|3|TK|Thymidine Kinase|URINALYSIS|||[?]|[?]|TRACE|1|mol|1|1|[?]|ABNORMAL|PUS|AGGLUTINATED||AUDIOMETRY|CKD-EPI CREATININE FORMULA|||N|Y|2|Visit_2|25|4|TREATMENT|2020-12-04|2021-02-08|25|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|7ff27a70-0472-4cc1-b057-6b161ab29568|4|C165940|Boxelder Pollen IgE AB RAST Score|URINALYSIS|||[?]|[?]|INVALID|1|IU|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|FRESH||X-RAY|ASH FIBROSURE FORMULA|||N|Y|2|Visit_2|25|4|TREATMENT|2020-12-04|2020-12-20|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|7ff27a70-0472-4cc1-b057-6b161ab29568|5|PRTN3AB|Proteinase 3 Antibody|CHEMISTRY|[?]|/day|[?]|[?]|NEGATIVE|1|Gauss|1|1|[?]|LOW|FLUID|REFRIGERATED||INDIRECT IMMUNOFLUORESCENCE|COCKCROFT-GAULT FORMULA||Y|Y||3|Visit_3|40|5|WASHOUT|2020-12-19|2021-01-23|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|7ff27a70-0472-4cc1-b057-6b161ab29568|6|VTD2D3IT|25-Hydroxyvit D2 + 25-Hydroxyvit D3|URINALYSIS|[?]|gpELISA unit/mL|[?]|[?]|BORDERLINE|1|DAYS|1|1|[?]|HIGH|FLUID|HEMOLYZED||POLYGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||3|Visit_3|40|3|SCREENING|2020-12-19|2020-12-26|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|7ff27a70-0472-4cc1-b057-6b161ab29568|7|IRF|Immature Reticulocyte Fraction|URINALYSIS|[?]|CAPSULE|[?]|[?]|NEGATIVE|1|kDa|1|1|[?]|ABNORMAL|PLEURAL TISSUE|CONCENTRATED||DC SHEATH FLOW|MDRD ENZYMATIC JAPANESE FORMULA|||Y||4|Visit_4|65|1|FOLLOW-UP|2021-01-13|2021-02-02|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|7ff27a70-0472-4cc1-b057-6b161ab29568|8|AFPL3|Alpha Fetoprotein L3|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|EID 50/mL|1|1|[?]|NORMAL|LUNG SURFACTANT|AUTOLYZED||IMMUNOCHEMILUMINOMETRIC ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|U|Y|4|Visit_4|65|6|FOLLOW-UP|2021-01-13|2021-02-04|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|7ff27a70-0472-4cc1-b057-6b161ab29568|9|HGBFHGB|Hemoglobin F/Total Hemoglobin|CHEMISTRY|[?]|VIRTUAL PIXEL|[?]|[?]|INDETERMINATE|1|ug/m2/day|1|1|[?]|LOW|PLASMA|LACTESCENT||CRYOSCOPY|MDRD FORMULA||Y|NA||5|Visit_5|90|2|TREATMENT|2021-02-07|2021-02-09|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|7ff27a70-0472-4cc1-b057-6b161ab29568|10|ARSENIC|Arsenic|CHEMISTRY|[?]|GPL U|[?]|[?]|POSITIVE|1|Ci/ug|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|ICTERIC|N|HEMAGGLUTINATION ASSAY|GMI MMOL/MOL FORMULA|||Y||5|Visit_5|90|2|SCREENING|2021-02-07|2021-02-12|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|40529b01-9a80-4ada-a8df-96eec0e65043|1|LEUKCRBC|Leuks Corrected for Nucl Erythrocytes|URINALYSIS|[?]|10^7 CFU/mL|[?]|[?]|BORDERLINE|1|KIT|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|THAWED|N|POLYGRAPHY|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|5|FOLLOW-UP|2020-06-17|2020-08-18|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|LB|40529b01-9a80-4ada-a8df-96eec0e65043|2|DDIMER|D-Dimer|URINALYSIS|||[?]|[?]|TRACE|1|mL/s|1|1|[?]|NORMAL|ADIPOSE TISSUE|CONTAMINATED||DYNAMOMETRY|FIBROMETER FORMULA|||NA|Y|1|Visit_1|10|7|TREATMENT|2020-06-17|2020-08-09|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|LB|40529b01-9a80-4ada-a8df-96eec0e65043|3|C165919|German Cockroach IgG AB RAST Score|CHEMISTRY|[?]|umol/min|[?]|[?]|NEGATIVE|1|Bq/mL|1|1|[?]|NORMAL|BONE MARROW|GELLED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI FORMULA|Y||N||2|Visit_2|25|6|TREATMENT|2020-07-02|2020-08-22|25|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|40529b01-9a80-4ada-a8df-96eec0e65043|4|TRANK1|TPR-Ankyrin Repeat-Containing Protein 1|CHEMISTRY|[?]|cL|[?]|[?]|POSITIVE|1|s/h|1|1|[?]|NORMAL|INFRANATANT, PLASMA|LIPEMIC||SPIRAL CT SCAN WITHOUT CONTRAST|MDRD FORMULA|||N||2|Visit_2|25|7|FOLLOW-UP|2020-07-02|2020-08-29|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|LB|40529b01-9a80-4ada-a8df-96eec0e65043|5|HLADPB1|HLA DP Beta1 Antigen|HEMATOLOGY|[?]|uIU/L|[?]|[?]|INDETERMINATE|1|mL/g/h|1|1|[?]|HIGH|ABSCESS FLUID|UNEXPECTED ODOR||ELECTROGASTROGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||3|Visit_3|40|5|TREATMENT|2020-07-17|2020-08-06|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|40529b01-9a80-4ada-a8df-96eec0e65043|6|B2G1GAAB|Beta-2 Glycoprotein 1 IgA Antibody|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mmol/min/kPa/L|1|1|[?]|LOW|SMEGMA|THAWED||FLUORIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U|Y|3|Visit_3|40|3|FOLLOW-UP|2020-07-17|2020-08-19|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|40529b01-9a80-4ada-a8df-96eec0e65043|7|VITC|Vitamin C|URINALYSIS|[?]|IU/kg|[?]|[?]|TRACE|1|atm|1|1|[?]|NORMAL|VENOUS BLOOD|DRIED||PELLI-ROBSON EYE CHART|COCKCROFT-GAULT FORMULA|||NA||4|Visit_4|65|5|SCREENING|2020-08-11|2020-08-13|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|LB|40529b01-9a80-4ada-a8df-96eec0e65043|8|AXL|AXL Receptor Tyrosine Kinase|URINALYSIS|[?]|ug/mL/h|[?]|[?]|BORDERLINE|1|g/kg|1|1|[?]|LOW|URINE SEDIMENT|HEMOLYZED||NON-CONTACT SPECULAR MICROSCOPY|FIBROMETER FORMULA|||N||4|Visit_4|65|4|WASHOUT|2020-08-11|2020-09-13|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|LB|40529b01-9a80-4ada-a8df-96eec0e65043|9|HPOCROM|Hypochromia|HEMATOLOGY|[?]|ppth|[?]|[?]|INVALID|1|10^6 organisms|1|1|[?]|LOW|BASAL TEAR|DRIED||FARR ASSAY|NASH FIBROSURE FORMULA|Y||Y||5|Visit_5|90|2|SCREENING|2020-09-05|2020-09-13|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|LB|40529b01-9a80-4ada-a8df-96eec0e65043|10|RETIM|Medium Absorption Reticulocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|nmol/mol|1|1|[?]|ABNORMAL|BREAST MILK|AGGLUTINATED||CONTRAST ENHANCED X-RAY|CKD-EPI CREATININE FORMULA||Y|Y|Y|5|Visit_5|90|6|TREATMENT|2020-09-05|2020-09-14|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|LB|f3e22efc-0948-4c6e-9173-8e284d342d33|1|MECONIUM|Meconium|CHEMISTRY|[?]|pg/cell|[?]|[?]|BORDERLINE|1|mph|1|1|[?]|ABNORMAL|SKIN TISSUE|CONTAMINATED||GC/MS/MS|MDRD 6 VARIABLE FORMULA|Y||N||1|Visit_1|10|3|SCREENING|2020-12-06|2021-01-09|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|f3e22efc-0948-4c6e-9173-8e284d342d33|2|LAP|Leucine Aminopeptidase|URINALYSIS|[?]|m|[?]|[?]|TRACE|1|Ci/mg|1|1|[?]|LOW|EMOTIONAL TEAR|SOLIDIFIED|N|IN VITRO GENE EXPRESSION ASSAY|FIBROMETER FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2020-12-06|2021-02-21|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|f3e22efc-0948-4c6e-9173-8e284d342d33|3|CXCL7|Chemokine (C-X-C Motif) Ligand 7|HEMATOLOGY|[?]|BAU/mL|[?]|[?]|POSITIVE|1|AU/mL|1|1|[?]|HIGH|HAIR FOLLICLE|CALCIFIED||PET SCAN|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-12-21|2021-02-25|25|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|LB|f3e22efc-0948-4c6e-9173-8e284d342d33|4|FVIIIAAC|Factor VIII Activity Actual/Control|HEMATOLOGY|[?]|mAnson U/mL|[?]|[?]|NEGATIVE|1|ug/m2/h|1|1|[?]|HIGH|INTERSTITIAL FLUID|LACTESCENT||BIOIMPEDANCE SPECTROSCOPY|CKD-EPI FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-12-21|2021-02-10|25|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|LB|f3e22efc-0948-4c6e-9173-8e284d342d33|5|KRCYMGLE|Megakaryocytes/Leukocytes|URINALYSIS|||[?]|[?]|BORDERLINE|1|MET|1|1|[?]|HIGH|TUMOR TISSUE|CONTAMINATED||IODINE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|2|TREATMENT|2021-01-05|2021-01-27|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|f3e22efc-0948-4c6e-9173-8e284d342d33|6|EOSMM|Eosinophilic Metamyelocytes|URINALYSIS|[?]|ugEq/L|[?]|[?]|INDETERMINATE|1|PIXELS/in|1|1|[?]|HIGH|SUPERNATANT, PLASMA|THAWED||OPTICAL DENSITY MEASUREMENT|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||3|Visit_3|40|1|TREATMENT|2021-01-05|2021-01-11|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|f3e22efc-0948-4c6e-9173-8e284d342d33|7|NITRITE|Nitrite|HEMATOLOGY|[?]|v/v|[?]|[?]|INVALID|1|/mm2|1|1|[?]|NORMAL|LOCHIA|HEMOLYZED||U-HPLC/MS/MS|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|2|FOLLOW-UP|2021-01-30|2021-02-14|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|f3e22efc-0948-4c6e-9173-8e284d342d33|8|C165891|Western Ragweed Pollen IgE AB RAST Score|CHEMISTRY|[?]|SPRAY|[?]|[?]|TRACE|1|% INHIBITION|1|1|[?]|ABNORMAL|VENOUS PLASMA|ROOM TEMPERATURE||POPULATION SEQUENCING|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|1|WASHOUT|2021-01-30|2021-02-16|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|f3e22efc-0948-4c6e-9173-8e284d342d33|9|C165906|Weed Mix Pollen IgG AB RAST Score|HEMATOLOGY|[?]|10^9 CFU/g|[?]|[?]|TRACE|1|mL/dL|1|1|[?]|ABNORMAL|SKIN TISSUE|CALCIFIED||AUSCULTATION|CKD-EPI CYSTATIN C FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2021-02-24|2021-03-02|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|f3e22efc-0948-4c6e-9173-8e284d342d33|10|GEC|Galactose Elimination Capacity|URINALYSIS|[?]|mol/g|[?]|[?]|INDETERMINATE|1|MBq/uL|1|1|[?]|HIGH|REFLEX TEAR|CONCENTRATED||MULTIPLE BREATH WASHOUT|NASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|1|TREATMENT|2021-02-24|2021-02-25|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|919eb5b4-a3df-41c6-86f7-c78501bb4335|1|CYTYRO|Tyrosine Crystals|CHEMISTRY|||[?]|[?]|TRACE|1|/100 HPFs|1|1|[?]|HIGH|LUNG SURFACTANT|UNEXPECTED ODOR||X-RAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|1|Visit_1|10|2|WASHOUT|2020-10-01|2020-10-25|10|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|919eb5b4-a3df-41c6-86f7-c78501bb4335|2|UROBIL|Urobilinogen|URINALYSIS|[?]|IU/day|[?]|[?]|INVALID|1|EVENTS|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|SOLIDIFIED||HPLC/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||1|Visit_1|10|6|TREATMENT|2020-10-01|2020-10-17|10|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|919eb5b4-a3df-41c6-86f7-c78501bb4335|3|RPA1|Renal Papillary Antigen 1|HEMATOLOGY|||[?]|[?]|POSITIVE|1|POUCH|1|1|[?]|ABNORMAL|PLEURAL TISSUE|ICTERIC||AMSLER GRID|FIBROTEST FORMULA|||NA|Y|2|Visit_2|25|2|FOLLOW-UP|2020-10-16|2020-12-24|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|919eb5b4-a3df-41c6-86f7-c78501bb4335|4|PROLYMLY|Prolymphocytes/Lymphocytes|CHEMISTRY|[?]|m/sec|[?]|[?]|INVALID|1|foz_us|1|1|[?]|LOW|VENOUS CORD BLOOD|AGGLUTINATED||PALPATION|COCKCROFT-GAULT FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-10-16|2020-11-04|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|919eb5b4-a3df-41c6-86f7-c78501bb4335|5|FXIVAC|Factor XIV Actual/Control|CHEMISTRY|[?]|LOZENGE|[?]|[?]|BORDERLINE|1|uCi|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|HEMOLYZED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROTEST FORMULA|||N||3|Visit_3|40|7|FOLLOW-UP|2020-10-31|2020-11-21|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|919eb5b4-a3df-41c6-86f7-c78501bb4335|6|MCP1|Monocyte Chemotactic Protein 1|CHEMISTRY|[?]|mg/dL|[?]|[?]|POSITIVE|1|mU/L|1|1|[?]|ABNORMAL|SERUM|ROOM TEMPERATURE||DUCTOGRAPHY|NASH FIBROSURE FORMULA||Y|NA||3|Visit_3|40|5|SCREENING|2020-10-31|2020-11-13|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|919eb5b4-a3df-41c6-86f7-c78501bb4335|7|GUSA|Glucuronidase, Alpha|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|fg|1|1|[?]|ABNORMAL|EXPIRED AIR|CONCENTRATED||TARGETED GENOME SEQUENCING|FIBROTEST FORMULA|||U|Y|4|Visit_4|65|2|FOLLOW-UP|2020-11-25|2020-12-20|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|919eb5b4-a3df-41c6-86f7-c78501bb4335|8|ANGTNS1|Angiotensin I|URINALYSIS|[?]|uL/mL|[?]|[?]|NEGATIVE|1|BOWL|1|1|[?]|LOW|EPITHELIAL CELL|AGGLUTINATED||PHOTOMETRIC CLOT DETECTION|GMI MMOL/MOL FORMULA|||U||4|Visit_4|65|6|FOLLOW-UP|2020-11-25|2020-12-19|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|919eb5b4-a3df-41c6-86f7-c78501bb4335|9|C165887|EnglishPlantain Pollen IgE AB RAST Score|URINALYSIS|[?]|mg/mL/min|[?]|[?]|INDETERMINATE|1|nmol/mL/min|1|1|[?]|NORMAL|PLATELET POOR PLASMA|SOLIDIFIED||FLUORESCEIN STAIN|CKD-EPI CREATININE FORMULA|Y||Y||5|Visit_5|90|2|FOLLOW-UP|2020-12-20|2020-12-23|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|919eb5b4-a3df-41c6-86f7-c78501bb4335|10|GLOBGPT|Gamma Globulin/Total Protein|CHEMISTRY|[?]|nmol|[?]|[?]|TRACE|1|pptr|1|1|[?]|ABNORMAL|EPITHELIAL CELL|THAWED|N|MYELOPEROXIDASE STAIN|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-12-20|2020-12-22|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|f918d6e0-6fc2-4303-b323-521c5d531773|1|NAGASE|N-acetyl-beta-D-glucosaminidase|CHEMISTRY|[?]|IMPLANT|[?]|[?]|INVALID|1|m|1|1|[?]|NORMAL|BLOOD|THAWED||IMMUNOFLUORESCENT STAIN|MDRD ENZYMATIC FORMULA|||U||1|Visit_1|10|6|WASHOUT|2020-07-31|2020-09-16|10|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|f918d6e0-6fc2-4303-b323-521c5d531773|2|ALBC|Albumin Clearance|HEMATOLOGY|[?]|um/day|[?]|[?]|NEGATIVE|1|PA|1|1|[?]|ABNORMAL|ALVEOLAR AIR|AUTOLYZED|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|NASH FIBROSURE FORMULA|Y||N||1|Visit_1|10|1|SCREENING|2020-07-31|2020-08-05|10|15|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|f918d6e0-6fc2-4303-b323-521c5d531773|3|LYMMCELE|Lymphoma Cells/Leukocytes|HEMATOLOGY|[?]|cup eq|[?]|[?]|BORDERLINE|1|10^12 IU/L|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|REFRIGERATED||FUNDUS PHOTOGRAPHY|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-08-15|2020-10-07|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|f918d6e0-6fc2-4303-b323-521c5d531773|4|C130087|English Plantain Pollen IgG4|CHEMISTRY|[?]|JDF Unit|[?]|[?]|INVALID|1|foz_br|1|1|[?]|NORMAL|SOFT TISSUE|NON-HEMOLYZED||DROPLET DIGITAL PCR|FIBROTEST FORMULA|||NA||2|Visit_2|25|5|SCREENING|2020-08-15|2020-09-22|25|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|f918d6e0-6fc2-4303-b323-521c5d531773|5|CHYTRYP|Chymotrypsin|HEMATOLOGY|||[?]|[?]|TRACE|1|h/wk|1|1|[?]|LOW|CORD SERUM|SOLIDIFIED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA|||Y|Y|3|Visit_3|40|1|SCREENING|2020-08-30|2020-10-08|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|f918d6e0-6fc2-4303-b323-521c5d531773|6|PTSFAC|Protein S, Free Actual/Control|URINALYSIS|[?]|mg/kg|[?]|[?]|BORDERLINE|1|dpm/mL|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|SOLIDIFIED|N|IMMUNODIFFUSION|FIBROTEST FORMULA|||NA||3|Visit_3|40|3|SCREENING|2020-08-30|2020-09-29|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|f918d6e0-6fc2-4303-b323-521c5d531773|7|CRLPLSMN|Ceruloplasmin|URINALYSIS|||[?]|[?]|BORDERLINE|1|fL|1|1|[?]|ABNORMAL|EXPIRED AIR|HEMOLYZED||RADIAL IMMUNODIFFUSION|MDRD FORMULA|Y||U|Y|4|Visit_4|65|7|TREATMENT|2020-09-24|2020-10-27|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|f918d6e0-6fc2-4303-b323-521c5d531773|8|DALA|Delta Aminolevulinate|HEMATOLOGY|[?]|min/day|[?]|[?]|TRACE|1|/40 HPFs|1|1|[?]|LOW|ENDOMETRIAL TISSUE|UNEXPECTED ODOR||NEXT GENERATION SEQUENCING|NASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|3|TREATMENT|2020-09-24|2020-10-04|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|f918d6e0-6fc2-4303-b323-521c5d531773|9|HEINZRBC|Heinz Bodies/Erythrocytes|HEMATOLOGY|[?]|MPS U|[?]|[?]|NEGATIVE|1|SUPPOSITORY|1|1|[?]|ABNORMAL|REFLEX TEAR|CALCIFIED|N|RIA|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2020-10-19|2020-10-23|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|f918d6e0-6fc2-4303-b323-521c5d531773|10|HLAIIPRA|HLA Class II Panel Reactive Antibody|CHEMISTRY|[?]|mmol/kg|[?]|[?]|INDETERMINATE|1|BAR|1|1|[?]|LOW|BILE|ICTERIC|N|RIA|GMI % FORMULA|Y||NA||5|Visit_5|90|2|WASHOUT|2020-10-19|2020-10-25|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|1|ETGETS|Ethyl Glucuronide Ethyl Sulfate|CHEMISTRY|[?]|MPL U/mL|[?]|[?]|POSITIVE|1|U/g/h|1|1|[?]|NORMAL|SERUM|FROZEN||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|2|SCREENING|2020-11-24|2021-02-12|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|2|CSCYL|Cylindroid Casts|URINALYSIS|[?]|ug/cm2|[?]|[?]|NEGATIVE|1|%(v/v)|1|1|[?]|LOW|VENOUS BLOOD|ICTERIC|N|MICROSCOPY|MDRD 4 VARIABLE FORMULA|Y||N||1|Visit_1|10|4|WASHOUT|2020-11-24|2021-02-16|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|3|NITRATE|Nitrate|CHEMISTRY|[?]|SACHET|[?]|[?]|BORDERLINE|1|10^9 organisms/mg|1|1|[?]|HIGH|PLATELET POOR PLASMA|CALCIFIED||PET/SPECT SCAN|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-12-09|2021-01-19|25|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|4|FIXAAC|Factor IX Activity Actual/Control|HEMATOLOGY|[?]|GPS U|[?]|[?]|INVALID|1|mL/g/min|1|1|[?]|HIGH|RETICULOCYTES|DRIED||ENDOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||2|Visit_2|25|7|TREATMENT|2020-12-09|2021-02-15|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|5|ISG15|Ubiquitin-Like Protein ISG15|URINALYSIS|[?]|days/wk|[?]|[?]|TRACE|1|PFU/animal|1|1|[?]|NORMAL|BASAL TEAR|SOLIDIFIED||MULTIPLEXED BEAD BASED IMMUNOASSAY|CKD-EPI FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-12-24|2021-02-11|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|6|OHF6B|6 Beta-Hydroxycortisol|HEMATOLOGY|[?]|mL/mmHg|[?]|[?]|TRACE|1|BOLUS|1|1|[?]|NORMAL|SERUM|CONCENTRATED||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|NASH FIBROSURE FORMULA||Y|U||3|Visit_3|40|4|TREATMENT|2020-12-24|2021-01-04|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|7|HE4|Human Epididymis Protein 4|CHEMISTRY|||[?]|[?]|NEGATIVE|1|IU/mg|1|1|[?]|LOW|ENDOMETRIAL TISSUE|LIPEMIC|N|SPECT SCAN|HEPASCORE FORMULA|||NA|Y|4|Visit_4|65|5|FOLLOW-UP|2021-01-18|2021-02-13|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|LB|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|8|IGFBP7|Insulin-Like Growth Factor Binding Prot7|CHEMISTRY|[?]|100 IU/mL|[?]|[?]|POSITIVE|1|uOsm|1|1|[?]|HIGH|CAPILLARY BLOOD|UNEXPECTED ODOR||FLOCCULATION, CHARCOAL ENHANCED|CKD-EPI FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2021-01-18|2021-02-17|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|LB|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|9|SCCAG|Squamous Cell Carcinoma Antigen|HEMATOLOGY|||[?]|[?]|TRACE|1|dmol|1|1|[?]|LOW|NAIL|FRESH||CAPILLARY ELECTROPHORESIS|ASH FIBROSURE FORMULA|||NA|Y|5|Visit_5|90|6|TREATMENT|2021-02-12|2021-02-16|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|10|YEASTBUD|Yeast Budding|URINALYSIS|[?]|tsp|[?]|[?]|TRACE|1|vp/mL|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED||DARK FIELD MICROSCOPY|FIBROTEST FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2021-02-12|2021-02-20|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|4b1e011f-a16d-4ff6-902d-451d5d13ee97|1|COCAAOM|Cocaine and/or Metabolites|CHEMISTRY|[?]|V/sec|[?]|[?]|INDETERMINATE|1|MASK|1|1|[?]|HIGH|GASTRIC CONTENTS|UNEXPECTED ODOR||DYNAMIC LIGHT SCATTERING|MDRD FORMULA|||Y||1|Visit_1|10|1|WASHOUT|2020-06-21|2020-06-25|10|14|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|LB|4b1e011f-a16d-4ff6-902d-451d5d13ee97|2|LDLOXI|Oxidized LDL Cholesterol|CHEMISTRY|||[?]|[?]|BORDERLINE|1|kat|1|1|[?]|ABNORMAL|DISCHARGE|HEMOLYZED||NUCLEAR RADIOLOGY|HEPASCORE FORMULA|||U|Y|1|Visit_1|10|4|TREATMENT|2020-06-21|2020-08-18|10|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|LB|4b1e011f-a16d-4ff6-902d-451d5d13ee97|3|ESTRONE|Estrone|HEMATOLOGY|[?]|MPS U|[?]|[?]|POSITIVE|1|ug/m2/day|1|1|[?]|HIGH|WHITE MATTER TISSUE|THAWED|N|MICRODENSITOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||2|Visit_2|25|6|TREATMENT|2020-07-06|2020-09-17|25|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|4b1e011f-a16d-4ff6-902d-451d5d13ee97|4|AFPL1|Alpha Fetoprotein L1|HEMATOLOGY|[?]|ug/kg/day|[?]|[?]|TRACE|1|10^6/hpf|1|1|[?]|LOW|SERUM OR PLASMA|GELLED||OLIGO ACGH|MDRD 4 VARIABLE FORMULA|||N||2|Visit_2|25|2|WASHOUT|2020-07-06|2020-07-30|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|4b1e011f-a16d-4ff6-902d-451d5d13ee97|5|PNCTPP|Pancreatic Polypeptide|CHEMISTRY|[?]|pmol|[?]|[?]|TRACE|1|BOWL|1|1|[?]|LOW|SUPERNATANT, SERUM|LIPEMIC||IMMUNOBLOT|HEPASCORE FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-07-21|2020-08-28|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|4b1e011f-a16d-4ff6-902d-451d5d13ee97|6|PCO2|Partial Pressure Carbon Dioxide|CHEMISTRY|[?]|10^3 CFU/g|[?]|[?]|INDETERMINATE|1|msec|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|THAWED||HPLC/MS/MS|MDRD 4 VARIABLE FORMULA|Y||U||3|Visit_3|40|7|SCREENING|2020-07-21|2020-09-11|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|4b1e011f-a16d-4ff6-902d-451d5d13ee97|7|C165940|Boxelder Pollen IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|WAFER|1|1|[?]|LOW|URINE SEDIMENT|LIPEMIC||ACID FAST STAIN|NASH FIBROSURE FORMULA|Y|Y|U|Y|4|Visit_4|65|7|WASHOUT|2020-08-15|2020-08-16|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|4b1e011f-a16d-4ff6-902d-451d5d13ee97|8|PHNBRBTL|Phenobarbital|CHEMISTRY|||[?]|[?]|INVALID|1|umol/L|1|1|[?]|NORMAL|URINE|ICTERIC|N|REBOUND TONOMETRY|GMI % FORMULA|||U|Y|4|Visit_4|65|1|FOLLOW-UP|2020-08-15|2020-08-19|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|4b1e011f-a16d-4ff6-902d-451d5d13ee97|9|HEINZRBC|Heinz Bodies/Erythrocytes|URINALYSIS|[?]|pmol|[?]|[?]|BORDERLINE|1|mL/kg/min|1|1|[?]|ABNORMAL|LYMPH|NON-HEMOLYZED||ELLA|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|2|SCREENING|2020-09-09|2020-09-16|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|4b1e011f-a16d-4ff6-902d-451d5d13ee97|10|FERRITIN|Ferritin|HEMATOLOGY|[?]|cP|[?]|[?]|NEGATIVE|1|%|1|1|[?]|HIGH|PLASMA ULTRAFILTRATE|SOLIDIFIED||ELISA|HEPASCORE FORMULA|Y||N||5|Visit_5|90|4|TREATMENT|2020-09-09|2020-09-11|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|1|PROMONO|Promonocytes|HEMATOLOGY|[?]|L/kg|[?]|[?]|INDETERMINATE|1|deg2|1|1|[?]|ABNORMAL|LUNG SURFACTANT|LIPEMIC||WHOLE EXOME SEQUENCING|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-07-19|2020-09-04|10|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|2|ERCEMIDX|Erythroid Maturation Index|CHEMISTRY|[?]|umol/h/mmol|[?]|[?]|BORDERLINE|1|uIU/dL|1|1|[?]|ABNORMAL|BILE|SOLIDIFIED||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||1|Visit_1|10|6|SCREENING|2020-07-19|2020-07-23|10|14|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|3|THMBAAC|Thrombin Activity Actual/Control|HEMATOLOGY|[?]|Joule|[?]|[?]|BORDERLINE|1|cup eq|1|1|[?]|NORMAL|SPUTUM|SOLIDIFIED||FLUORIMETRY|MDRD 5 VARIABLE FORMULA|Y||U||2|Visit_2|25|6|WASHOUT|2020-08-03|2020-08-27|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|4|SEDEXAM|Sediment Examination|URINALYSIS|[?]|RFU|[?]|[?]|POSITIVE|1|PNU/mL|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|GELLED|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|FIBROTEST FORMULA|||NA||2|Visit_2|25|6|SCREENING|2020-08-03|2020-08-12|25|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|5|EOTAXIN2|Eotaxin-2|CHEMISTRY|||[?]|[?]|NEGATIVE|1|10^6/hpf|1|1|[?]|ABNORMAL|DISCHARGE|CLOTTED|N|ISHIHARA COLOR PLATES|CKD-EPI FORMULA|||N|Y|3|Visit_3|40|1|SCREENING|2020-08-18|2020-08-24|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|6|LKM1IGAB|Liver Kidney Microsomal Type 1 IgG Ab|URINALYSIS|[?]|mph|[?]|[?]|NEGATIVE|1|PRESSOR UNITS|1|1|[?]|LOW|URINE SEDIMENT|CONCENTRATED||PHOTOGRAPHY|FIBROTEST FORMULA|||N||3|Visit_3|40|7|WASHOUT|2020-08-18|2020-09-29|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|7|C165884|Olive Tree Pollen IgE Antibody|CHEMISTRY|[?]|cmH2O/mL|[?]|[?]|INVALID|1|kPa|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|GELLED||BALLPOINT PEN TECHNIQUE|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|7|WASHOUT|2020-09-12|2020-10-15|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|8|DNAAB|Anti-DNA Antibodies|URINALYSIS|[?]|cpm|[?]|[?]|TRACE|1|kg/mol|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|ICTERIC|N|HANSEL STAIN|GMI MMOL/MOL FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-09-12|2020-09-20|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|9|INTLK8|Interleukin 8|HEMATOLOGY|[?]|10^3 CFU/mL|[?]|[?]|TRACE|1|foz_br|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|NON-HEMOLYZED||SISH|MDRD FORMULA|||N||5|Visit_5|90|3|SCREENING|2020-10-07|2020-10-15|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|10|STAT3|STAT3|URINALYSIS|[?]|mg/mL/day|[?]|[?]|NEGATIVE|1|kIU|1|1|[?]|LOW|BREAST MILK|AGGLUTINATED||DNA MICROARRAY|COCKCROFT-GAULT FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-10-07|2020-10-13|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|1|PROTS|Protein S|CHEMISTRY|[?]|ug/kg/h|[?]|[?]|NEGATIVE|1|10^9 organisms/mL|1|1|[?]|ABNORMAL|GASTRIC FLUID|CONTAMINATED||MICROSCOPY|GMI % FORMULA|Y||Y||1|Visit_1|10|7|TREATMENT|2020-11-27|2020-12-05|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|2|TROPONT|Troponin T|HEMATOLOGY|[?]|um|[?]|[?]|NEGATIVE|1|m|1|1|[?]|LOW|MONOCYTE|CONTAMINATED||LIQUID SCINTILLATION COUNTING|MDRD 6 VARIABLE FORMULA||Y|NA||1|Visit_1|10|3|TREATMENT|2020-11-27|2021-02-19|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|3|BILDIR|Direct Bilirubin|URINALYSIS|||[?]|[?]|BORDERLINE|1|cmHg|1|1|[?]|LOW|FLUID|NON-HEMOLYZED||CLIP|CKD-EPI CREATININE FORMULA|Y||U|Y|2|Visit_2|25|4|FOLLOW-UP|2020-12-12|2021-02-09|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|4|ERCEPIDX|Erythroid Proliferation Index|URINALYSIS|[?]|HEP|[?]|[?]|INDETERMINATE|1|um|1|1|[?]|HIGH|PERSPIRATION|AUTOLYZED||SXA SCAN|FIBROTEST FORMULA||Y|Y||2|Visit_2|25|5|WASHOUT|2020-12-12|2021-02-24|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|5|MONMPHLE|Monocytes and Macrophages/Leukocytes|HEMATOLOGY|[?]|mL/m2|[?]|[?]|POSITIVE|1|msec|1|1|[?]|HIGH|AQUEOUS HUMOR|LACTESCENT||FISH|ASH FIBROSURE FORMULA||Y|NA||3|Visit_3|40|4|TREATMENT|2020-12-27|2021-01-20|40|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|6|CCL20|Chemokine (C-C Motif) Ligand 20|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|ng/L|1|1|[?]|NORMAL|URINE SEDIMENT|FRESH|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|CKD-EPI CREATININE FORMULA|Y|Y|U|Y|3|Visit_3|40|2|TREATMENT|2020-12-27|2021-01-01|40|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|7|ANDSTNDL|Androstenediol|HEMATOLOGY|||[?]|[?]|TRACE|1|BOX|1|1|[?]|LOW|MONOCYTE|ICTERIC||CONTRAST ENHANCED MRI|NASH FIBROSURE FORMULA|||U|Y|4|Visit_4|65|1|WASHOUT|2021-01-21|2021-01-25|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|8|CSGRAN|Granular Casts|CHEMISTRY|[?]|vp/dose|[?]|[?]|BORDERLINE|1|kBq|1|1|[?]|LOW|GASTRIC CONTENTS|CALCIFIED||CONTRAST ENHANCED X-RAY|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|5|TREATMENT|2021-01-21|2021-02-13|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|9|NAGASECR|N-acetyl-B-D-glucosaminidase/Creatinine|URINALYSIS|[?]|g/cm2|[?]|[?]|POSITIVE|1|umol/mg/min|1|1|[?]|NORMAL|MUCUS|LACTESCENT||MODIFIED ACID FAST STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|7|SCREENING|2021-02-15|2021-02-17|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|10|C165926|Mold Mix IgE AB RAST Score|HEMATOLOGY|[?]|U/g|[?]|[?]|INVALID|1|days/wk|1|1|[?]|HIGH|SPUTUM|CONCENTRATED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|1|TREATMENT|2021-02-15|2021-02-23|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|1|LDH1LDH|LDH Isoenzyme 1/LDH|CHEMISTRY|[?]|10^6/hpf|[?]|[?]|NEGATIVE|1|MET*min|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|CONTAMINATED||LISSAMINE GREEN STAIN|MDRD 5 VARIABLE FORMULA|||NA||1|Visit_1|10|7|WASHOUT|2020-12-09|2020-12-14|10|15|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|2|C130068|Bermuda Grass Pollen IgE|HEMATOLOGY|[?]|DRINK|[?]|[?]|POSITIVE|1|nmol|1|1|[?]|HIGH|INTERSTITIAL FLUID|CONTAMINATED|N|CONTRAST ENHANCED X-RAY|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-12-09|2021-02-13|10|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|3|NITRITE|Nitrite|CHEMISTRY|[?]|V/sec|[?]|[?]|INVALID|1|U.CARR|1|1|[?]|NORMAL|PUS|FROZEN||ELISPOT|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|Y||2|Visit_2|25|4|TREATMENT|2020-12-24|2020-12-27|25|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|4|PDGFAB|Platelet Derived Growth Factor IsoformAB|URINALYSIS|[?]|mg/kg/h|[?]|[?]|NEGATIVE|1|LENS|1|1|[?]|ABNORMAL|NAIL|CLOTTED||CLAUSS METHOD|MDRD 5 VARIABLE FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-12-24|2021-02-25|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|5|MASTCE|Mast Cells|HEMATOLOGY|[?]|mL/100g/min|[?]|[?]|POSITIVE|1|Henry|1|1|[?]|ABNORMAL|EXPIRED AIR|REFRIGERATED|N|KINETIC MICROPARTICLE IMMUNOASSAY|MDRD FORMULA|||NA||3|Visit_3|40|3|FOLLOW-UP|2021-01-08|2021-01-25|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|6|PBGCREAT|Porphobilinogen/Creatinine|CHEMISTRY|[?]|MPL U/mL|[?]|[?]|POSITIVE|1|umol/min|1|1|[?]|ABNORMAL|PUS|CALCIFIED|N|ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD 4 VARIABLE FORMULA|Y||NA||3|Visit_3|40|6|FOLLOW-UP|2021-01-08|2021-01-30|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|7|LDLOXI|Oxidized LDL Cholesterol|URINALYSIS|[?]|cmHg|[?]|[?]|INVALID|1|MHz|1|1|[?]|LOW|LYSATE|SOLIDIFIED|N|FARNSWORTH-MUNSELL 100 HUE TEST|FIBROTEST FORMULA||Y|Y||4|Visit_4|65|5|TREATMENT|2021-02-02|2021-03-02|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|8|TRPTRG|Trypsin and Trypsinogen|CHEMISTRY|[?]|nmol/L|[?]|[?]|POSITIVE|1|copies/uL|1|1|[?]|ABNORMAL|EXPIRED AIR|FROZEN|N|IMMUNOCHEMILUMINOMETRIC ASSAY|CKD-EPI FORMULA|Y|Y|Y||4|Visit_4|65|4|TREATMENT|2021-02-02|2021-02-10|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|9|PHNKET|Phenylketones|CHEMISTRY|[?]|LB|[?]|[?]|BORDERLINE|1|Sv|1|1|[?]|LOW|ARTERIAL BLOOD|GELLED||GRAM STAIN|MDRD 5 VARIABLE FORMULA||Y|Y||5|Visit_5|90|1|WASHOUT|2021-02-27|2021-03-05|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|10|CRDIGMAB|Cardiolipin IgM Antibody|HEMATOLOGY|[?]|IU/day|[?]|[?]|NEGATIVE|1|BOTTLE|1|1|[?]|NORMAL|EPITHELIAL CELL|CONCENTRATED||CENTRIFUGATION|CKD-EPI CREATININE FORMULA||Y|Y||5|Visit_5|90|2|WASHOUT|2021-02-27|2021-03-08|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|1|KLOTHO|Klotho|HEMATOLOGY|[?]|pg/dL|[?]|[?]|INVALID|1|CFU/g|1|1|[?]|LOW|ISOLATE|AUTOLYZED||IMMUNOCHROMATOGRAPHY|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-07-06|2020-09-03|10|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|2|LYMIM|Immature Lymphocytes|HEMATOLOGY|[?]|PNU/mL|[?]|[?]|INVALID|1|Bq/L|1|1|[?]|LOW|AQUEOUS HUMOR|ROOM TEMPERATURE||DIFFUSION WEIGHTED MRI|ASH FIBROSURE FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-07-06|2020-09-25|10|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|3|ANTHRMAG|Antithrombin Antigen|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|SYRINGE|1|1|[?]|ABNORMAL|MECONIUM|ROOM TEMPERATURE||KLEIHAUER-BETKE|CKD-EPI FORMULA|||Y|Y|2|Visit_2|25|4|TREATMENT|2020-07-21|2020-08-31|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|4|TLYCE|T-Lymphocytes|URINALYSIS|||[?]|[?]|POSITIVE|1|Newton|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|CALCIFIED|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y|Y|2|Visit_2|25|1|SCREENING|2020-07-21|2020-09-20|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|5|APTT|Activated Partial Thromboplastin Time|CHEMISTRY|||[?]|[?]|INVALID|1|TROCHE|1|1|[?]|ABNORMAL|LYSATE|DRIED||SLOAN LETTER EYE CHART 2.5%|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|3|Visit_3|40|4|SCREENING|2020-08-05|2020-08-10|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|6|OXYSAT|Oxygen Saturation|CHEMISTRY|[?]|BAR|[?]|[?]|TRACE|1|10^7 TCID 50/dose|1|1|[?]|LOW|PLASMA|FRESH||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-08-05|2020-09-14|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|7|MYBLA|Myeloblasts|HEMATOLOGY|[?]|mg/m2/min|[?]|[?]|BORDERLINE|1|mmol/mol|1|1|[?]|ABNORMAL|PLEURAL TISSUE|CONCENTRATED||MAGNETIC RESONANCE ENTEROGRAPHY|MDRD 5 VARIABLE FORMULA||Y|NA||4|Visit_4|65|7|TREATMENT|2020-08-30|2020-09-23|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|8|CHYTRYP|Chymotrypsin|HEMATOLOGY|[?]|BP|[?]|[?]|NEGATIVE|1|10^3 CFU|1|1|[?]|NORMAL|ISOLATE|LIPEMIC||INDIRECT IMMUNOFLUORESCENCE|COCKCROFT-GAULT FORMULA||Y|N||4|Visit_4|65|4|WASHOUT|2020-08-30|2020-09-27|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|9|MSPIKEXR|Monoclonal Protein Spike Excretion Rate|URINALYSIS|[?]|10^4 CFU/mL|[?]|[?]|BORDERLINE|1|Enzyme U/L|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|SOLIDIFIED||PUPILLOMETRY|FIBROSIS 4 FORMULA|Y||NA||5|Visit_5|90|3|SCREENING|2020-09-24|2020-09-30|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|10|DDIMER|D-Dimer|HEMATOLOGY|[?]|ug/L DDU|[?]|[?]|TRACE|1|Bq/ug|1|1|[?]|NORMAL|SEMEN|THAWED||ACCELERATOR MASS SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA|Y||N||5|Visit_5|90|7|FOLLOW-UP|2020-09-24|2020-10-02|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|7f1e0661-ebbd-4abd-9031-cb6b424977e2|1|PSAMRNA|Prostate Specific Antigen mRNA|URINALYSIS|[?]|BOWL|[?]|[?]|INVALID|1|ug/g/h|1|1|[?]|NORMAL|ABSCESS FLUID|LIPEMIC||HANSEL STAIN|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|3|SCREENING|2020-12-13|2021-02-23|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|LB|7f1e0661-ebbd-4abd-9031-cb6b424977e2|2|SFTPD|Surfactant Protein D|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|RNA copies/mL|1|1|[?]|LOW|EPITHELIAL CELL|CONCENTRATED||CONGO RED STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|1|Visit_1|10|4|SCREENING|2020-12-13|2020-12-15|10|12|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|LB|7f1e0661-ebbd-4abd-9031-cb6b424977e2|3|IOHEXCLR|Iohexol Clearance|URINALYSIS|[?]|kcal/day|[?]|[?]|POSITIVE|1|10^6/Ejaculate U|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED||WESTERGREN|FIBROSIS 4 FORMULA|Y||N||2|Visit_2|25|2|SCREENING|2020-12-28|2021-01-03|25|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|7f1e0661-ebbd-4abd-9031-cb6b424977e2|4|ISG15|Ubiquitin-Like Protein ISG15|HEMATOLOGY|[?]|mL/m2/day|[?]|[?]|TRACE|1|mmol/kg|1|1|[?]|ABNORMAL|ERYTHROCYTES|LIPEMIC||AMSLER GRID|COCKCROFT-GAULT FORMULA||Y|U||2|Visit_2|25|7|TREATMENT|2020-12-28|2021-01-17|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|7f1e0661-ebbd-4abd-9031-cb6b424977e2|5|HASIGEAB|Human Anti-Sheep IgE Antibody|CHEMISTRY|[?]|tsp eq|[?]|[?]|INDETERMINATE|1|Log10 ELISA unit|1|1|[?]|ABNORMAL|BLOOD|FRESH||ACRIDINE ORANGE STAIN|NASH FIBROSURE FORMULA||Y|N||3|Visit_3|40|4|TREATMENT|2021-01-12|2021-02-08|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|LB|7f1e0661-ebbd-4abd-9031-cb6b424977e2|6|C147282|White Oak Pollen IgE Antibody|HEMATOLOGY|[?]|foz_br|[?]|[?]|INVALID|1|amp|1|1|[?]|ABNORMAL|EXUDATE|LIPEMIC||SINGLE-MOLECULE ARRAY|HEPASCORE FORMULA|||U||3|Visit_3|40|1|WASHOUT|2021-01-12|2021-02-14|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|LB|7f1e0661-ebbd-4abd-9031-cb6b424977e2|7|INTLK12|Interleukin 12|CHEMISTRY|||[?]|[?]|BORDERLINE|1|eq|1|1|[?]|ABNORMAL|BASAL TEAR|CONCENTRATED||LANDOLT RING|NASH FIBROSURE FORMULA|||N|Y|4|Visit_4|65|6|TREATMENT|2021-02-06|2021-02-11|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|7f1e0661-ebbd-4abd-9031-cb6b424977e2|8|LRG1|Leucine Rich Alpha-2-Glycoprotein 1|HEMATOLOGY|[?]|IU|[?]|[?]|NEGATIVE|1|ug/L/h|1|1|[?]|NORMAL|BONE|UNEXPECTED ODOR||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI FORMULA||Y|Y||4|Visit_4|65|7|FOLLOW-UP|2021-02-06|2021-02-08|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|7f1e0661-ebbd-4abd-9031-cb6b424977e2|9|RPTLTIME|Reptilase Time|CHEMISTRY|[?]|mL/cage/wk|[?]|[?]|BORDERLINE|1|lx|1|1|[?]|ABNORMAL|PUS|AUTOLYZED||AMSLER GRID|GMI % FORMULA||Y|Y||5|Visit_5|90|6|TREATMENT|2021-03-03|2021-03-05|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|7f1e0661-ebbd-4abd-9031-cb6b424977e2|10|ENAAB|Extractable Nuclear Antigen Antibody|CHEMISTRY|||[?]|[?]|TRACE|1|mEq/mL|1|1|[?]|HIGH|SALIVA|REFRIGERATED||FLOCCULATION|COCKCROFT-GAULT FORMULA|||NA|Y|5|Visit_5|90|3|SCREENING|2021-03-03|2021-03-08|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|324a2c67-4802-4806-aff2-04fb9c7394d4|1|C130080|Orchard Grass Pollen IgE|HEMATOLOGY|||[?]|[?]|POSITIVE|1|Ci|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|AUTOLYZED|N|NUCLEIC ACID HYBRIDIZATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|NA|Y|1|Visit_1|10|3|FOLLOW-UP|2020-05-27|2020-07-04|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|324a2c67-4802-4806-aff2-04fb9c7394d4|2|APTTLAAC|APTT-LA Actual/Control|URINALYSIS|[?]|nmol/L|[?]|[?]|POSITIVE|1|g/cage/wk|1|1|[?]|NORMAL|NAIL|UNEXPECTED ODOR||FLOW CYTOMETRY|ASH FIBROSURE FORMULA|||U||1|Visit_1|10|4|WASHOUT|2020-05-27|2020-07-25|10|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|324a2c67-4802-4806-aff2-04fb9c7394d4|3|C165901|EnglishPlantain Pollen IgG AB RAST Score|URINALYSIS|[?]|%(w/w)|[?]|[?]|BORDERLINE|1|mm|1|1|[?]|HIGH|SALIVA|NON-HEMOLYZED||THICK SMEAR|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|5|SCREENING|2020-06-11|2020-07-20|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|324a2c67-4802-4806-aff2-04fb9c7394d4|4|HERC5|Hect Domain and RLD 5|URINALYSIS|||[?]|[?]|NEGATIVE|1|OI50|1|1|[?]|NORMAL|SWABBED MATERIAL|LACTESCENT|N|CLINICAL EVALUATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|2|Visit_2|25|6|TREATMENT|2020-06-11|2020-06-13|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|324a2c67-4802-4806-aff2-04fb9c7394d4|5|IL2SRA|Soluble Interleukin 2 Receptor Activity|HEMATOLOGY|[?]|mL/100g/min|[?]|[?]|BORDERLINE|1|L/h|1|1|[?]|LOW|SERUM OR PLASMA|CALCIFIED|N|CELL BASED BIOASSAY|GMI % FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-06-26|2020-08-12|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|324a2c67-4802-4806-aff2-04fb9c7394d4|6|INTLK12|Interleukin 12|URINALYSIS|[?]|ukat/10^12 RBC|[?]|[?]|BORDERLINE|1|kg/L|1|1|[?]|NORMAL|MENSTRUAL BLOOD|AGGLUTINATED||CYSTOSCOPY|MDRD FORMULA||Y|N||3|Visit_3|40|5|SCREENING|2020-06-26|2020-07-10|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|324a2c67-4802-4806-aff2-04fb9c7394d4|7|CANNAB|Cannabinoids|URINALYSIS|[?]|km/h|[?]|[?]|TRACE|1|PLUG|1|1|[?]|NORMAL|MECONIUM|GELLED||TELLER ACUITY CARDS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||4|Visit_4|65|7|FOLLOW-UP|2020-07-21|2020-08-17|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|324a2c67-4802-4806-aff2-04fb9c7394d4|8|C165921|Silver Birch Pollen IgE AB RAST Score|CHEMISTRY|[?]|g/m2|[?]|[?]|NEGATIVE|1|fraction of 1|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|AUTOLYZED||FREEZING POINT DEPRESSION|CKD-EPI CREATININE FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-07-21|2020-07-24|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|324a2c67-4802-4806-aff2-04fb9c7394d4|9|IL2RB|Interleukin 2 Receptor Subunit Beta|CHEMISTRY|[?]|L|[?]|[?]|TRACE|1|Shock Wave|1|1|[?]|HIGH|SALIVA|FRESH||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA|Y||U||5|Visit_5|90|7|TREATMENT|2020-08-15|2020-08-19|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|324a2c67-4802-4806-aff2-04fb9c7394d4|10|CA15_3AG|Cancer Antigen 15-3|URINALYSIS|[?]|mol/day|[?]|[?]|POSITIVE|1|mN|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE|N|INDIA INK STAIN|CKD-EPI FORMULA||Y|U||5|Visit_5|90|2|SCREENING|2020-08-15|2020-08-23|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|1|FGF23|Fibroblast Growth Factor 23|URINALYSIS|[?]|PACKET|[?]|[?]|POSITIVE|1|anti-Xa IU|1|1|[?]|LOW|EPIDERMAL TISSUE|UNEXPECTED ODOR||PHOROPTER|HEPASCORE FORMULA|Y|Y|N||1|Visit_1|10|7|TREATMENT|2020-12-19|2020-12-24|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|2|NAGASE|N-acetyl-beta-D-glucosaminidase|URINALYSIS|||[?]|[?]|INVALID|1|g/dL|1|1|[?]|NORMAL|STOOL|LACTESCENT||THICK SMEAR|CKD-EPI FORMULA|||Y|Y|1|Visit_1|10|2|TREATMENT|2020-12-19|2021-03-09|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|3|PRGNENLN|Pregnenolone|HEMATOLOGY|[?]|/LSQN|[?]|[?]|BORDERLINE|1|mg/mL/min|1|1|[?]|NORMAL|HAIR|FRESH||DIGITAL PCR|MDRD 6 VARIABLE FORMULA|||Y||2|Visit_2|25|6|WASHOUT|2021-01-03|2021-01-26|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|4|AMH|Anti-Mullerian Hormone|CHEMISTRY|[?]|BAG|[?]|[?]|BORDERLINE|1|ug/kg/h|1|1|[?]|LOW|MECONIUM|PARAFFIN-EMBEDDED|N|IMMUNOFLUORESCENT STAIN|MDRD 5 VARIABLE FORMULA|||N||2|Visit_2|25|2|SCREENING|2021-01-03|2021-01-25|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|5|PRO|Proline|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|umol|1|1|[?]|ABNORMAL|SEMEN|FRESH||MYELOPEROXIDASE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|3|Visit_3|40|6|TREATMENT|2021-01-18|2021-01-28|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|6|TNF|Tumor Necrosis Factor|CHEMISTRY|[?]|breaths/min|[?]|[?]|POSITIVE|1|JDF Unit|1|1|[?]|LOW|SPUTUM|UNEXPECTED ODOR|N|DISK DIFFUSION|FIBROMETER FORMULA|||U||3|Visit_3|40|6|WASHOUT|2021-01-18|2021-02-08|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|7|METHQLDN|Methaqualone|HEMATOLOGY|||[?]|[?]|POSITIVE|1|cL|1|1|[?]|HIGH|BUFFY COAT|LACTESCENT||SPECT SCAN|HEPASCORE FORMULA|||Y|Y|4|Visit_4|65|2|TREATMENT|2021-02-12|2021-03-15|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|8|AST|Aspartate Aminotransferase|URINALYSIS|[?]|oz eq|[?]|[?]|POSITIVE|1|L/s|1|1|[?]|ABNORMAL|FLUID|GELLED||FLUORIMETRY|FIBROMETER FORMULA|||N||4|Visit_4|65|3|TREATMENT|2021-02-12|2021-02-13|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|9|COMP|Cartilage Oligomeric Matrix Protein|URINALYSIS|[?]|10^3 organisms|[?]|[?]|INDETERMINATE|1|Bq|1|1|[?]|HIGH|AQUEOUS HUMOR|PARAFFIN-EMBEDDED||NON-INVASIVE DIELECTRIC SENSING|FIBROMETER FORMULA|||Y||5|Visit_5|90|5|FOLLOW-UP|2021-03-09|2021-03-14|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|10|FIBRINO|Fibrinogen|CHEMISTRY|||[?]|[?]|INVALID|1|MET*h|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|PARAFFIN-EMBEDDED||MICROBIAL CULTURE, SOLID|GMI MMOL/MOL FORMULA|||N|Y|5|Visit_5|90|4|TREATMENT|2021-03-09|2021-03-18|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|1|FATACFRS|Free Fatty Acid, Saturated|URINALYSIS|[?]|ugEq|[?]|[?]|BORDERLINE|1|uCi|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|NON-HEMOLYZED|N|ANGIOGRAPHY|GMI % FORMULA||Y|NA||1|Visit_1|10|3|TREATMENT|2020-08-24|2020-09-02|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|2|AMYLOIDA|Amyloid A|HEMATOLOGY|[?]|/2500 WBC|[?]|[?]|TRACE|1|nsec|1|1|[?]|LOW|SPUTUM|CLOTTED||ATOMIC ABSORPTION SPECTROMETRY|NASH FIBROSURE FORMULA|||Y||1|Visit_1|10|4|SCREENING|2020-08-24|2020-08-27|10|13|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|3|PLATAGRN|Platelets, Agranular|CHEMISTRY|||[?]|[?]|TRACE|1|/10^4|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|DRIED||PET SCAN|GMI MMOL/MOL FORMULA|||N|Y|2|Visit_2|25|6|SCREENING|2020-09-08|2020-10-03|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|4|KCREAT|Potassium/Creatinine|HEMATOLOGY|[?]|ug|[?]|[?]|NEGATIVE|1|Coulomb|1|1|[?]|NORMAL|CORD BLOOD|SOLIDIFIED||KINETIC MICROPARTICLE IMMUNOASSAY|ASH FIBROSURE FORMULA||Y|U||2|Visit_2|25|5|TREATMENT|2020-09-08|2020-11-06|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|5|C4D|Complement C4d|HEMATOLOGY|[?]|genEq/mL|[?]|[?]|BORDERLINE|1|uCi/kg|1|1|[?]|LOW|TUMOR TISSUE|FRESH||MICROSCOPY|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-09-23|2020-10-11|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|6|TRACP5B|Tartrate-Resistant Acid Phosphatase 5b|HEMATOLOGY|[?]|umol/day|[?]|[?]|INVALID|1|pmol/g|1|1|[?]|HIGH|INTERSTITIAL FLUID|LIPEMIC||MODIFIED ACID FAST STAIN|GMI % FORMULA|||NA||3|Visit_3|40|6|SCREENING|2020-09-23|2020-11-11|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|7|DGNWBC|Degenerated Leukocytes|HEMATOLOGY|[?]|%/min|[?]|[?]|BORDERLINE|1|U/L|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED||CONFOCAL MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||4|Visit_4|65|4|TREATMENT|2020-10-18|2020-11-14|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|8|EPIN|Epinephrine|CHEMISTRY|||[?]|[?]|INVALID|1|breaths/min|1|1|[?]|HIGH|SWABBED MATERIAL|UNEXPECTED ODOR||LC/MS|MDRD FORMULA|Y|Y|U|Y|4|Visit_4|65|6|SCREENING|2020-10-18|2020-10-21|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|9|CAPHOS|Calcium/Phosphorus|CHEMISTRY|[?]|mmol/mol|[?]|[?]|TRACE|1|cd|1|1|[?]|HIGH|MUCUS|PARAFFIN-EMBEDDED||PERIPHERAL ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||N||5|Visit_5|90|4|WASHOUT|2020-11-12|2020-11-13|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|10|NONHDL|Non-HDL Cholesterol|CHEMISTRY|||[?]|[?]|INVALID|1|Newton|1|1|[?]|LOW|DIALYSIS FLUID|THAWED|N|SLIT LAMP|MDRD 5 VARIABLE FORMULA|Y|Y|Y|Y|5|Visit_5|90|3|WASHOUT|2020-11-12|2020-11-17|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|911dc297-91cb-42b1-8a26-18f6c83c32a6|1|SECRETIN|Secretin|CHEMISTRY|[?]|kg|[?]|[?]|INVALID|1|kg/m2|1|1|[?]|LOW|ALVEOLAR AIR|CONTAMINATED||EIA|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-12-01|2021-02-26|10|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|911dc297-91cb-42b1-8a26-18f6c83c32a6|2|BLASTCE|Blasts/Total Cells|URINALYSIS|[?]|CAPFUL|[?]|[?]|INDETERMINATE|1|m2|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|LACTESCENT||ALCIAN BLUE STAIN|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-12-01|2021-02-02|10|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|911dc297-91cb-42b1-8a26-18f6c83c32a6|3|C165918|American Cockroach IgG AB RAST Score|CHEMISTRY|[?]|DPM|[?]|[?]|INVALID|1|Ejaculate U|1|1|[?]|HIGH|MECONIUM|CONCENTRATED||NEXT GENERATION SEQUENCING|FIBROMETER FORMULA||Y|NA||2|Visit_2|25|2|SCREENING|2020-12-16|2021-02-20|25|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|911dc297-91cb-42b1-8a26-18f6c83c32a6|4|FATACVLC|Fatty Acids, Very Long Chain|CHEMISTRY|||[?]|[?]|POSITIVE|1|L/h|1|1|[?]|LOW|HAIR|PARAFFIN-EMBEDDED||SISH|ASH FIBROSURE FORMULA||Y|N|Y|2|Visit_2|25|3|TREATMENT|2020-12-16|2021-02-07|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|911dc297-91cb-42b1-8a26-18f6c83c32a6|5|C5B9|Complement C5b-9|URINALYSIS|[?]|/LPF|[?]|[?]|INVALID|1|mEq/mL|1|1|[?]|ABNORMAL|PLEURAL FLUID|ICTERIC||TRANSCRIPTION-MEDIATED AMPLIFICATION|HEPASCORE FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-12-31|2021-02-18|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|911dc297-91cb-42b1-8a26-18f6c83c32a6|6|PSAMRNA|Prostate Specific Antigen mRNA|URINALYSIS|[?]|ng|[?]|[?]|INVALID|1|10^4 CFU|1|1|[?]|LOW|ENDOTRACHEAL FLUID|LIPEMIC||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|CKD-EPI FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-12-31|2021-02-07|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|911dc297-91cb-42b1-8a26-18f6c83c32a6|7|FVIIIAAC|Factor VIII Activity Actual/Control|CHEMISTRY|||[?]|[?]|TRACE|1|mg/dL|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|CALCIFIED|N|MANUAL CLOT DETECTION|GMI MMOL/MOL FORMULA|Y||Y|Y|4|Visit_4|65|7|TREATMENT|2021-01-25|2021-02-23|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|911dc297-91cb-42b1-8a26-18f6c83c32a6|8|FBNCTFT|Fibronectin, Fetal|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mL/h|1|1|[?]|ABNORMAL|GASTRIC FLUID|CLOTTED||NUCLEIC ACID SEQUENCING|COCKCROFT-GAULT FORMULA|||N|Y|4|Visit_4|65|5|TREATMENT|2021-01-25|2021-02-09|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|911dc297-91cb-42b1-8a26-18f6c83c32a6|9|CKMT1CK|CK, Macromolecular Type 1/Total CK|HEMATOLOGY|[?]|ppm|[?]|[?]|BORDERLINE|1|mg/kg/min|1|1|[?]|NORMAL|ADIPOSE TISSUE|NON-HEMOLYZED|N|FUNCTIONAL MRI|CKD-EPI CREATININE FORMULA|||U||5|Visit_5|90|7|TREATMENT|2021-02-19|2021-02-25|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|911dc297-91cb-42b1-8a26-18f6c83c32a6|10|SCL70GAB|Scl-70 IgG Antibody|CHEMISTRY|[?]|CIGAR|[?]|[?]|POSITIVE|1|uCi/kg|1|1|[?]|HIGH|BILE|ROOM TEMPERATURE||ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD 6 VARIABLE FORMULA|||U||5|Visit_5|90|2|TREATMENT|2021-02-19|2021-02-26|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|1|THC|Tetrahydrocannabinol|CHEMISTRY|[?]|ukat/L|[?]|[?]|NEGATIVE|1|Bq/kg|1|1|[?]|NORMAL|HAIR FOLLICLE|LACTESCENT|N|GRAM STAIN|MDRD FORMULA|||NA||1|Visit_1|10|5|FOLLOW-UP|2020-11-25|2020-12-01|10|16|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|2|SFTPD|Surfactant Protein D|URINALYSIS|[?]|log10 CFU/g|[?]|[?]|INDETERMINATE|1|GPS U|1|1|[?]|ABNORMAL|BILE|CALCIFIED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|GMI MMOL/MOL FORMULA|Y|Y|U||1|Visit_1|10|6|WASHOUT|2020-11-25|2021-01-02|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|LB|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|3|AMPHETD|Dextroamphetamine|URINALYSIS|||[?]|[?]|INVALID|1|Enzyme U/g Hb|1|1|[?]|ABNORMAL|MUCUS|AUTOLYZED||HIGH RESOLUTION MELT ANALYSIS|MDRD 5 VARIABLE FORMULA|||N|Y|2|Visit_2|25|5|TREATMENT|2020-12-10|2021-02-19|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|4|VWFAAC|von Will Factor Act Actual/Control|URINALYSIS|[?]|dpm/0.5 mL|[?]|[?]|NEGATIVE|1|10^6 CFU|1|1|[?]|NORMAL|HAIR|THAWED||TONOMETRY|ASH FIBROSURE FORMULA|||U||2|Visit_2|25|3|WASHOUT|2020-12-10|2021-02-01|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|5|NONHDL|Non-HDL Cholesterol|HEMATOLOGY|[?]|Pack Year|[?]|[?]|POSITIVE|1|mkat|1|1|[?]|ABNORMAL|LAVAGE FLUID|CLOTTED||FLAME PHOTOMETRY|MDRD ENZYMATIC FORMULA|||N||3|Visit_3|40|2|SCREENING|2020-12-25|2021-01-01|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|6|TESTOSFR|Testosterone, Free|CHEMISTRY|[?]|uIU/dL|[?]|[?]|INVALID|1|mPa|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|SOLIDIFIED||IMMUNORADIOMETRIC ASSAY|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-12-25|2020-12-28|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|7|TGFB|Transforming Growth Factor Beta|CHEMISTRY|[?]|FFU|[?]|[?]|INVALID|1|ug/kg|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|CONTAMINATED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI MMOL/MOL FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-01-19|2021-01-22|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|LB|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|8|GLYCREAT|Glycine/Creatinine|HEMATOLOGY|||[?]|[?]|INVALID|1|nU/cL|1|1|[?]|HIGH|HAIR|UNEXPECTED ODOR||SNELLEN EYE CHART|CKD-EPI CYSTATIN C FORMULA|||Y|Y|4|Visit_4|65|7|SCREENING|2021-01-19|2021-02-15|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|LB|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|9|C130081|Orchard Grass Pollen IgA|URINALYSIS|[?]|hr/day|[?]|[?]|NEGATIVE|1|P|1|1|[?]|LOW|BUFFY COAT|LIPEMIC||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|1|TREATMENT|2021-02-13|2021-02-15|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|10|METARBCE|Metarubricyte/Total Cells|CHEMISTRY|[?]|amol|[?]|[?]|TRACE|1|DIP|1|1|[?]|HIGH|SEMEN|SOLIDIFIED||RADIATION DOSIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||5|Visit_5|90|5|SCREENING|2021-02-13|2021-02-21|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|9bfcd733-2233-4e54-a6cd-641a59fc8a01|1|AMPEA|Alpha-Methylphenethylamine|HEMATOLOGY|[?]|1/(s*kPa)|[?]|[?]|INDETERMINATE|1|mL/animal/day|1|1|[?]|LOW|PLATELET|HEMOLYZED||PAP STAIN|FIBROSIS 4 FORMULA|Y||N||1|Visit_1|10|4|WASHOUT|2020-08-15|2020-11-01|10|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|9bfcd733-2233-4e54-a6cd-641a59fc8a01|2|NEUTSG|Neutrophils, Segmented|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mg/m2|1|1|[?]|HIGH|PLASMA|GELLED||CALCOFLUOR WHITE STAIN|CKD-EPI CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|3|TREATMENT|2020-08-15|2020-09-30|10|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|9bfcd733-2233-4e54-a6cd-641a59fc8a01|3|INTLK1RA|Interleukin 1 Receptor Antagonist|CHEMISTRY|[?]|POUCH|[?]|[?]|POSITIVE|1|kV|1|1|[?]|LOW|SERUM OR PLASMA|AGGLUTINATED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|ASH FIBROSURE FORMULA|Y||Y||2|Visit_2|25|5|TREATMENT|2020-08-30|2020-11-11|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|LB|9bfcd733-2233-4e54-a6cd-641a59fc8a01|4|LYMCE|Lymphocytes/Total Cells|CHEMISTRY|||[?]|[?]|BORDERLINE|1|U/kg|1|1|[?]|HIGH|VENOUS PLASMA|AUTOLYZED||FARR ASSAY|MDRD 5 VARIABLE FORMULA|||N|Y|2|Visit_2|25|5|TREATMENT|2020-08-30|2020-10-29|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|LB|9bfcd733-2233-4e54-a6cd-641a59fc8a01|5|LDLOXAB|Oxidized LDL Cholesterol Antibody|URINALYSIS|||[?]|[?]|TRACE|1|CONTAINER|1|1|[?]|LOW|BILE|DRIED||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|CKD-EPI FORMULA|Y||N|Y|3|Visit_3|40|3|SCREENING|2020-09-14|2020-10-15|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|9bfcd733-2233-4e54-a6cd-641a59fc8a01|6|MMP8|Matrix Metalloproteinase 8|HEMATOLOGY|||[?]|[?]|POSITIVE|1|Pa|1|1|[?]|NORMAL|SPERMATOZOON|REFRIGERATED||ALCIAN BLUE STAIN|ASH FIBROSURE FORMULA|||Y|Y|3|Visit_3|40|1|TREATMENT|2020-09-14|2020-10-05|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|9bfcd733-2233-4e54-a6cd-641a59fc8a01|7|TSH|Thyrotropin|HEMATOLOGY|[?]|SBE/mL|[?]|[?]|POSITIVE|1|IU/kg/h|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|REFRIGERATED||PHASE-CONTRAST MRI|FIBROTEST FORMULA|||U||4|Visit_4|65|6|SCREENING|2020-10-09|2020-10-21|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|9bfcd733-2233-4e54-a6cd-641a59fc8a01|8|TTAC|Thrombin Time Actual/Control|CHEMISTRY|[?]|/h|[?]|[?]|INVALID|1|kg|1|1|[?]|LOW|ALVEOLAR AIR|CALCIFIED|N|LISSAMINE GREEN STAIN|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|5|TREATMENT|2020-10-09|2020-11-06|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|9bfcd733-2233-4e54-a6cd-641a59fc8a01|9|VITB6|Vitamin B6|URINALYSIS|[?]|mL/animal/day|[?]|[?]|INDETERMINATE|1|ug/L FEU|1|1|[?]|HIGH|TUMOR TISSUE|LIPEMIC||AUTOREFRACTION|CKD-EPI CREATININE FORMULA|Y||N||5|Visit_5|90|3|TREATMENT|2020-11-03|2020-11-11|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|9bfcd733-2233-4e54-a6cd-641a59fc8a01|10|TURB|Turbidity|CHEMISTRY|[?]|/LSQN|[?]|[?]|BORDERLINE|1|U/m2/day|1|1|[?]|LOW|CAPILLARY PLASMA|UNEXPECTED ODOR||CYSTOSCOPY|CKD-EPI CYSTATIN C FORMULA|||N||5|Visit_5|90|3|TREATMENT|2020-11-03|2020-11-05|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|7eb97152-173c-4923-8604-5dad3140cc25|1|PSELECT|P-Selectin|CHEMISTRY|||[?]|[?]|INVALID|1|log10 copies/mL|1|1|[?]|ABNORMAL|MECONIUM|NON-HEMOLYZED|N|TRIPLE-PHASE MRI SCAN|CKD-EPI CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|1|SCREENING|2020-09-05|2020-09-18|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|7eb97152-173c-4923-8604-5dad3140cc25|2|KYNURNN|Kynurenine|URINALYSIS|||[?]|[?]|NEGATIVE|1|CAPLET|1|1|[?]|HIGH|PROSTATIC FLUID|CONCENTRATED||POLYSOMNOGRAPHY|HEPASCORE FORMULA|||Y|Y|1|Visit_1|10|4|WASHOUT|2020-09-05|2020-10-10|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|7eb97152-173c-4923-8604-5dad3140cc25|3|PO2ADJT|Partial Pressure Oxygen Adj for Temp|CHEMISTRY|[?]|10^5/L|[?]|[?]|INVALID|1|HOMEOPATHIC DILUTION|1|1|[?]|ABNORMAL|PROSTATIC FLUID|CONTAMINATED||REFLECTANCE SPECTROSCOPY|CKD-EPI CREATININE FORMULA||Y|Y||2|Visit_2|25|4|TREATMENT|2020-09-20|2020-11-12|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|7eb97152-173c-4923-8604-5dad3140cc25|4|TGFB1|Transforming Growth Factor Beta 1|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mkat|1|1|[?]|LOW|DIALYSIS FLUID|PARAFFIN-EMBEDDED|N|SPECT/CT SCAN|MDRD 6 VARIABLE FORMULA|||NA|Y|2|Visit_2|25|2|WASHOUT|2020-09-20|2020-10-19|25|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|7eb97152-173c-4923-8604-5dad3140cc25|5|APOC1|Apolipoprotein CI|CHEMISTRY|[?]|EID 50/dose|[?]|[?]|INVALID|1|TABLET|1|1|[?]|LOW|PLATELET RICH PLASMA|ROOM TEMPERATURE||WRIGHT-GIEMSA STAIN|MDRD 5 VARIABLE FORMULA|Y||Y||3|Visit_3|40|3|TREATMENT|2020-10-05|2020-11-05|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|7eb97152-173c-4923-8604-5dad3140cc25|6|LDH4|LDH Isoenzyme 4|CHEMISTRY|[?]|TAMPON|[?]|[?]|NEGATIVE|1|mol|1|1|[?]|NORMAL|PLEURAL TISSUE|HEMOLYZED||VIRUS PLAQUE ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|6|FOLLOW-UP|2020-10-05|2020-11-22|40|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|7eb97152-173c-4923-8604-5dad3140cc25|7|CAPHOSPD|Calcium - Phosphorus Product|CHEMISTRY|[?]|nmol BCE/L|[?]|[?]|INDETERMINATE|1|ks|1|1|[?]|ABNORMAL|DISCHARGE|SOLIDIFIED|N|NEXT GENERATION SEQUENCING|NASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|3|FOLLOW-UP|2020-10-30|2020-11-25|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|7eb97152-173c-4923-8604-5dad3140cc25|8|FVIIIAAC|Factor VIII Activity Actual/Control|URINALYSIS|||[?]|[?]|INVALID|1|ngEq/L|1|1|[?]|ABNORMAL|TUMOR TISSUE|UNEXPECTED ODOR||SPIROMETRY|MDRD ENZYMATIC FORMULA|||Y|Y|4|Visit_4|65|5|WASHOUT|2020-10-30|2020-11-23|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|7eb97152-173c-4923-8604-5dad3140cc25|9|CD5|CD5|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|deg2|1|1|[?]|NORMAL|PLEURAL FLUID|NON-HEMOLYZED|N|REVERSE TRANSCRIPTASE PCR|GMI % FORMULA|Y||NA|Y|5|Visit_5|90|7|TREATMENT|2020-11-24|2020-11-30|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|7eb97152-173c-4923-8604-5dad3140cc25|10|C165940|Boxelder Pollen IgE AB RAST Score|HEMATOLOGY|[?]|umol/min|[?]|[?]|BORDERLINE|1|ug/m2|1|1|[?]|ABNORMAL|CORD SERUM|PARAFFIN-EMBEDDED||CONTRAST ENHANCED PET/CT SCAN|CKD-EPI FORMULA|||N||5|Visit_5|90|4|TREATMENT|2020-11-24|2020-12-02|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|0b2104d0-e1e3-4516-8c4b-de5d42f82784|1|CD56|CD56|URINALYSIS|||[?]|[?]|INVALID|1|mol/mg|1|1|[?]|ABNORMAL|URINE|CALCIFIED||OLIGO ACGH|ASH FIBROSURE FORMULA|||Y|Y|1|Visit_1|10|3|TREATMENT|2020-08-08|2020-10-19|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|0b2104d0-e1e3-4516-8c4b-de5d42f82784|2|KIM1S|Soluble Kidney Injury Molecule-1|HEMATOLOGY|[?]|mJoule/cm2|[?]|[?]|NEGATIVE|1|oz eq|1|1|[?]|HIGH|ABSCESS FLUID|LIPEMIC||QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-08-08|2020-10-30|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|0b2104d0-e1e3-4516-8c4b-de5d42f82784|3|INCLBOD|Inclusion Bodies|CHEMISTRY|[?]|mEq/day|[?]|[?]|INDETERMINATE|1|uL/dose|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|SOLIDIFIED||SPECULAR MICROSCOPY|GMI MMOL/MOL FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-08-23|2020-09-28|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|0b2104d0-e1e3-4516-8c4b-de5d42f82784|4|DNAAB|Anti-DNA Antibodies|HEMATOLOGY|[?]|uEq/L|[?]|[?]|BORDERLINE|1|GPL U/mL|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|LACTESCENT||TRANSVAGINAL ULTRASOUND|FIBROTEST FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-08-23|2020-09-25|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|0b2104d0-e1e3-4516-8c4b-de5d42f82784|5|C130075|Birch Pollen IgG4|CHEMISTRY|[?]|10^9/g|[?]|[?]|INVALID|1|EID 50/dose|1|1|[?]|NORMAL|FLUID|REFRIGERATED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2020-09-07|2020-10-10|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|0b2104d0-e1e3-4516-8c4b-de5d42f82784|6|PLATAGRN|Platelets, Agranular|HEMATOLOGY|[?]|/VF|[?]|[?]|POSITIVE|1|s^-1(%O2)^-1|1|1|[?]|ABNORMAL|LUNG SURFACTANT|SOLIDIFIED||MOUSE PROTECTION ASSAY|FIBROTEST FORMULA|||Y||3|Visit_3|40|4|TREATMENT|2020-09-07|2020-10-23|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|0b2104d0-e1e3-4516-8c4b-de5d42f82784|7|VAL|Valine|HEMATOLOGY|[?]|IU/mmol|[?]|[?]|TRACE|1|mL/s|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|THAWED||SPIRAL CT|ASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|4|WASHOUT|2020-10-02|2020-10-29|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|0b2104d0-e1e3-4516-8c4b-de5d42f82784|8|GEC|Galactose Elimination Capacity|URINALYSIS|[?]|MPL U|[?]|[?]|BORDERLINE|1|mph|1|1|[?]|HIGH|SOFT TISSUE|LACTESCENT||ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-10-02|2020-10-20|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|0b2104d0-e1e3-4516-8c4b-de5d42f82784|9|SPERMMTL|Sperm Motility|URINALYSIS|[?]|uU/dL|[?]|[?]|NEGATIVE|1|mg/kg/dose|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED|N|HEMAGGLUTINATION ASSAY|CKD-EPI CREATININE FORMULA|||N||5|Visit_5|90|6|TREATMENT|2020-10-27|2020-11-02|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|0b2104d0-e1e3-4516-8c4b-de5d42f82784|10|TNFR5S|Soluble TNF Receptor Superfamily Mem 5|URINALYSIS|[?]|L/min/m2|[?]|[?]|TRACE|1|AMPULE|1|1|[?]|LOW|BUFFY COAT|NON-HEMOLYZED||IMMUNOFLUORESCENT STAIN|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2020-10-27|2020-10-30|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|96f68979-6869-403b-a8bd-78c8f965f98a|1|RBCNUCLE|Nucleated Erythrocytes/Leukocytes|HEMATOLOGY|[?]|ppth|[?]|[?]|INVALID|1|vg/mL|1|1|[?]|LOW|SUPERNATANT, SERUM|HEMOLYZED|N|WESTERN BLOT|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|3|FOLLOW-UP|2020-05-26|2020-08-07|10|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|96f68979-6869-403b-a8bd-78c8f965f98a|2|PYY|Peptide YY|URINALYSIS|[?]|cm2|[?]|[?]|POSITIVE|1|IU/g Hb|1|1|[?]|NORMAL|PUS|AGGLUTINATED||ENZYMATIC COLORIMETRY|FIBROSIS 4 FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-05-26|2020-07-31|10|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|96f68979-6869-403b-a8bd-78c8f965f98a|3|CHOLATE|Cholate|HEMATOLOGY|[?]|um/s|[?]|[?]|NEGATIVE|1|mm2|1|1|[?]|LOW|CAPILLARY PLASMA|LIPEMIC||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA|Y||NA||2|Visit_2|25|5|TREATMENT|2020-06-10|2020-07-25|25|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|96f68979-6869-403b-a8bd-78c8f965f98a|4|ACH|Acetylcholine|HEMATOLOGY|||[?]|[?]|TRACE|1|genEq/mL|1|1|[?]|ABNORMAL|LUNG SURFACTANT|LIPEMIC|N|SLOAN LETTER EYE CHART 100%|COCKCROFT-GAULT FORMULA||Y|NA|Y|2|Visit_2|25|6|SCREENING|2020-06-10|2020-07-18|25|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|96f68979-6869-403b-a8bd-78c8f965f98a|5|BD2|Beta-defensin 2|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|10^9/dose|1|1|[?]|NORMAL|NAIL|REFRIGERATED|N|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD 5 VARIABLE FORMULA|Y||N|Y|3|Visit_3|40|1|SCREENING|2020-06-25|2020-07-17|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|96f68979-6869-403b-a8bd-78c8f965f98a|6|T4FRIDX|Thyroxine, Free Index|URINALYSIS|[?]|ka_u/dL|[?]|[?]|INVALID|1|mN|1|1|[?]|ABNORMAL|GASTRIC FLUID|UNEXPECTED ODOR||CONTRAST ENHANCED PET/CT SCAN|MDRD FORMULA|Y|Y|U||3|Visit_3|40|1|SCREENING|2020-06-25|2020-07-22|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|96f68979-6869-403b-a8bd-78c8f965f98a|7|SEZCELY|Sezary Cells/Lymphocytes|HEMATOLOGY|[?]|v/v|[?]|[?]|TRACE|1|U/kg|1|1|[?]|NORMAL|TUMOR TISSUE|AGGLUTINATED||STATIC PERIMETRY|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2020-07-20|2020-08-17|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|96f68979-6869-403b-a8bd-78c8f965f98a|8|IDLP|IDL Particles|HEMATOLOGY|[?]|mmol2/L2|[?]|[?]|BORDERLINE|1|fmol|1|1|[?]|LOW|CAPILLARY BLOOD|FRESH||LAPAROSCOPY|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-07-20|2020-08-05|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|96f68979-6869-403b-a8bd-78c8f965f98a|9|TRYPTASE|Tryptase|CHEMISTRY|[?]|nm|[?]|[?]|NEGATIVE|1|10^11/L|1|1|[?]|NORMAL|BILE|AGGLUTINATED|N|MULTI-SLICE SPIRAL CT|FIBROMETER FORMULA|||Y||5|Visit_5|90|6|TREATMENT|2020-08-14|2020-08-23|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|LB|96f68979-6869-403b-a8bd-78c8f965f98a|10|CTXIICRT|Type II Collagen C-Telopeptides/Creat|CHEMISTRY|||[?]|[?]|INVALID|1|10^6/hpf|1|1|[?]|ABNORMAL|PROSTATIC FLUID|AUTOLYZED||MRS|MDRD ENZYMATIC FORMULA|||U|Y|5|Visit_5|90|6|TREATMENT|2020-08-14|2020-08-15|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|LB|e0f67610-b86a-4f5a-88eb-905b1e0aa609|1|HGF|Hepatocyte Growth Factor|HEMATOLOGY|[?]|mL/beat|[?]|[?]|NEGATIVE|1|uU/dL|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|THAWED||NON-INVASIVE DIELECTRIC SENSING|FIBROSIS 4 FORMULA|||U||1|Visit_1|10|3|SCREENING|2020-10-16|2021-01-05|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|e0f67610-b86a-4f5a-88eb-905b1e0aa609|2|CXCL1|Chemokine (C-X-C Motif) Ligand 1|CHEMISTRY|||[?]|[?]|TRACE|1|kg/cm2|1|1|[?]|NORMAL|REFLEX TEAR|LACTESCENT||ANTIMICROBIAL COMBINATION TESTING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|1|Visit_1|10|7|SCREENING|2020-10-16|2020-11-21|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|e0f67610-b86a-4f5a-88eb-905b1e0aa609|3|S6PHS|Phos-S6 Ribosomal Protein|URINALYSIS|[?]|mEq/dL|[?]|[?]|BORDERLINE|1|mEq/kg|1|1|[?]|HIGH|PLEURAL TISSUE|UNEXPECTED ODOR|N|OPTICAL COHERENCE TOMOGRAPHY|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|2|SCREENING|2020-10-31|2020-11-19|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|e0f67610-b86a-4f5a-88eb-905b1e0aa609|4|MSTHCELE|Mesothelial Cells/Leukocytes|HEMATOLOGY|[?]|10^9 organisms|[?]|[?]|INDETERMINATE|1|L/min|1|1|[?]|NORMAL|SERUM|CLOTTED||DUCTOGRAPHY|MDRD FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2020-10-31|2020-11-08|25|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|e0f67610-b86a-4f5a-88eb-905b1e0aa609|5|SVCAM1|Soluble Vasc Cell Adhesion Molecule 1|CHEMISTRY|[?]|P|[?]|[?]|INDETERMINATE|1|MESF|1|1|[?]|NORMAL|SPUTUM|REFRIGERATED||PET/CT SCAN|MDRD 6 VARIABLE FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2020-11-15|2020-11-17|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|e0f67610-b86a-4f5a-88eb-905b1e0aa609|6|HVA|Homovanillic Acid|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Henry|1|1|[?]|LOW|REFLEX TEAR|AUTOLYZED||ORCHIDOMETERY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|3|Visit_3|40|5|TREATMENT|2020-11-15|2021-01-08|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|e0f67610-b86a-4f5a-88eb-905b1e0aa609|7|HALBAB|Human Albumin Antibody|CHEMISTRY|[?]|GLOBULE|[?]|[?]|NEGATIVE|1|PFU/dose|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|GELLED||WEBER GREEN STAIN|GMI % FORMULA|Y||NA||4|Visit_4|65|4|TREATMENT|2020-12-10|2020-12-31|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|e0f67610-b86a-4f5a-88eb-905b1e0aa609|8|TUDCA|Tauroursodeoxycholate|URINALYSIS|[?]|ug/L|[?]|[?]|TRACE|1|ugEq/L|1|1|[?]|HIGH|SPUTUM|DRIED||FLUORESCENT LIFETIME IMAGING MICROSCOPY|FIBROTEST FORMULA||Y|U||4|Visit_4|65|2|FOLLOW-UP|2020-12-10|2021-01-13|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|e0f67610-b86a-4f5a-88eb-905b1e0aa609|9|STAT3PS3|Phosphorylated STAT3/STAT3|CHEMISTRY|[?]|mEq/mL|[?]|[?]|NEGATIVE|1|mg/L|1|1|[?]|NORMAL|BONE|THAWED||HPLC|MDRD 4 VARIABLE FORMULA|Y||Y||5|Visit_5|90|5|TREATMENT|2021-01-04|2021-01-09|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|e0f67610-b86a-4f5a-88eb-905b1e0aa609|10|APOA2|Apolipoprotein AII|HEMATOLOGY|[?]|mV|[?]|[?]|POSITIVE|1|MBP|1|1|[?]|NORMAL|SWABBED MATERIAL|THAWED|N|LIGHT MICROSCOPY|FIBROSIS 4 FORMULA|Y||U||5|Visit_5|90|5|TREATMENT|2021-01-04|2021-01-07|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|d62dc655-8865-4592-af0b-744524d9a24c|1|PTHW|Parathyroid Hormone, Whole|URINALYSIS|||[?]|[?]|TRACE|1|U/g|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|N|WHOLE TRANSCRIPTOME SEQUENCING|MDRD ENZYMATIC FORMULA|||Y|Y|1|Visit_1|10|3|WASHOUT|2020-09-29|2020-10-04|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|d62dc655-8865-4592-af0b-744524d9a24c|2|IGSOL|Soluble Immunoglobulin|HEMATOLOGY|[?]|mL/breath|[?]|[?]|INVALID|1|mEq/L|1|1|[?]|LOW|TRANSUDATE|UNEXPECTED ODOR||SEQUENCING|HEPASCORE FORMULA||Y|N||1|Visit_1|10|4|TREATMENT|2020-09-29|2020-11-20|10|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|d62dc655-8865-4592-af0b-744524d9a24c|3|C130107|Weed Mix Pollen Antigen IgG Antibody|HEMATOLOGY|[?]|cm|[?]|[?]|INVALID|1|ukat|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|THAWED||ENZYMATIC COLORIMETRY|MDRD 6 VARIABLE FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-10-14|2020-11-10|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|d62dc655-8865-4592-af0b-744524d9a24c|4|KRCYMGLE|Megakaryocytes/Leukocytes|CHEMISTRY|||[?]|[?]|NEGATIVE|1|DNA copies/mL|1|1|[?]|LOW|SPUTUM|FROZEN|N|MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI CREATININE FORMULA||Y|Y|Y|2|Visit_2|25|3|TREATMENT|2020-10-14|2020-11-02|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|d62dc655-8865-4592-af0b-744524d9a24c|5|ADP|Adenosine Diphosphate|CHEMISTRY|||[?]|[?]|INVALID|1|%(v/v)|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD 4 VARIABLE FORMULA||Y|U|Y|3|Visit_3|40|4|TREATMENT|2020-10-29|2020-11-03|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|d62dc655-8865-4592-af0b-744524d9a24c|6|APOH|Apolipoprotein H|CHEMISTRY|||[?]|[?]|INVALID|1|/day|1|1|[?]|HIGH|PERSPIRATION|SOLIDIFIED||INDIA INK STAIN|GMI % FORMULA|Y||NA|Y|3|Visit_3|40|6|WASHOUT|2020-10-29|2020-11-14|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|d62dc655-8865-4592-af0b-744524d9a24c|7|PELGERH|Pelger Huet Anomaly|HEMATOLOGY|[?]|m2|[?]|[?]|POSITIVE|1|/2500 WBC|1|1|[?]|HIGH|INFRANATANT, SERUM|CONTAMINATED|N|PERCUSSION|CKD-EPI CYSTATIN C FORMULA|||Y||4|Visit_4|65|2|WASHOUT|2020-11-23|2020-12-23|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|d62dc655-8865-4592-af0b-744524d9a24c|8|PYRUVATE|Pyruvate|URINALYSIS|[?]|BU/mL|[?]|[?]|BORDERLINE|1|Bq/mL|1|1|[?]|HIGH|ARTERIAL BLOOD|FRESH|N|MYELOPEROXIDASE STAIN|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|5|TREATMENT|2020-11-23|2020-12-07|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|d62dc655-8865-4592-af0b-744524d9a24c|9|GLUBD13|1,3-Beta-D-Glucan|CHEMISTRY|||[?]|[?]|POSITIVE|1|10^12 IU/L|1|1|[?]|NORMAL|SALIVA|CLOTTED||MOUSE PROTECTION ASSAY|MDRD ENZYMATIC FORMULA|||U|Y|5|Visit_5|90|2|SCREENING|2020-12-18|2020-12-26|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|d62dc655-8865-4592-af0b-744524d9a24c|10|MLATONIN|Melatonin|CHEMISTRY|[?]|vp/dose|[?]|[?]|POSITIVE|1|pmol/L|1|1|[?]|NORMAL|TUMOR TISSUE|CLOTTED||SICKLE CELL SOLUBILITY TEST|CKD-EPI CREATININE FORMULA||Y|U||5|Visit_5|90|4|TREATMENT|2020-12-18|2020-12-22|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|1|ANCCLSAB|Neutrophil Cytoplasmic Ab, Classic|HEMATOLOGY|[?]|amol|[?]|[?]|BORDERLINE|1|TRANSDUCING UNIT|1|1|[?]|HIGH|CERUMEN|CLOTTED||PEAK FLOWMETRY|HEPASCORE FORMULA||Y|U||1|Visit_1|10|4|TREATMENT|2021-01-08|2021-01-31|10|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|2|T4FRIDX|Thyroxine, Free Index|CHEMISTRY|[?]|10^6 RNA copies/mL|[?]|[?]|NEGATIVE|1|10^3 DNA copies/mL|1|1|[?]|LOW|ENDOMETRIAL TISSUE|CONTAMINATED|N|AUSCULTATION|FIBROMETER FORMULA|||N||1|Visit_1|10|7|TREATMENT|2021-01-08|2021-03-15|10|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|3|FATDROP|Fat Droplet|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|deg/s|1|1|[?]|NORMAL|WHITE MATTER TISSUE|CALCIFIED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA||Y|U|Y|2|Visit_2|25|4|FOLLOW-UP|2021-01-23|2021-02-16|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|4|MYBLAT1|Type I Myeloblasts|HEMATOLOGY|[?]|pt_us|[?]|[?]|TRACE|1|log10 TCID 50/uL|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CONTAMINATED|N|INTRAVASCULAR ULTRASOUND|CKD-EPI CREATININE FORMULA|Y||NA||2|Visit_2|25|5|SCREENING|2021-01-23|2021-03-15|25|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|5|BASOMYL|Basophilic Myelocytes|CHEMISTRY|[?]|10^9 CFU/g|[?]|[?]|INVALID|1|uEq|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|NON-HEMOLYZED||ACCELERATOR MASS SPECTROMETRY|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2021-02-07|2021-02-15|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|6|TSI|Thyroid Stimulating Immunoglobulin|CHEMISTRY|[?]|POUCH|[?]|[?]|INDETERMINATE|1|DNA copies/ug|1|1|[?]|NORMAL|FLUID|FROZEN||BAC ACGH|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||3|Visit_3|40|5|TREATMENT|2021-02-07|2021-02-22|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|7|VITE|Vitamin E|HEMATOLOGY|[?]|kV|[?]|[?]|INVALID|1|cmH2O/mL|1|1|[?]|ABNORMAL|EXPIRED AIR|SOLIDIFIED||OPHTHALMOSCOPY|FIBROTEST FORMULA||Y|N||4|Visit_4|65|2|TREATMENT|2021-03-04|2021-04-05|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|8|ATHMBAAC|Antithrombin Activity Actual/Control|HEMATOLOGY|[?]|Enzyme U/g Hb|[?]|[?]|POSITIVE|1|kIU|1|1|[?]|NORMAL|CORD SERUM|CLOTTED||WHOLE TRANSCRIPTOME SEQUENCING|HEPASCORE FORMULA|Y||U||4|Visit_4|65|7|TREATMENT|2021-03-04|2021-03-07|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|9|ETPAUC|ETP Area Under Curve|CHEMISTRY|[?]|Arbitrary U|[?]|[?]|NEGATIVE|1|10^8/L|1|1|[?]|NORMAL|SERUM|THAWED|N|MRI WITHOUT CONTRAST|MDRD ENZYMATIC FORMULA|Y||NA||5|Visit_5|90|4|SCREENING|2021-03-29|2021-04-01|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|10|CRYOFBRN|Cryofibrinogen|URINALYSIS|[?]|m|[?]|[?]|POSITIVE|1|SBE/mL|1|1|[?]|HIGH|SPERMATOZOON|FRESH||ARTERIAL SPIN LABELING FUNCTIONAL MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||5|Visit_5|90|3|TREATMENT|2021-03-29|2021-03-30|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|8005bd56-3bd6-477a-a466-b9a3bd189770|1|ASTALT|AST/ALT|CHEMISTRY|||[?]|[?]|POSITIVE|1|CUP|1|1|[?]|ABNORMAL|BASAL TEAR|ROOM TEMPERATURE||MAMMOGRAPHY|MDRD FORMULA|||U|Y|1|Visit_1|10|1|FOLLOW-UP|2020-12-23|2021-03-03|10|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|8005bd56-3bd6-477a-a466-b9a3bd189770|2|ASMACT|Alpha-Smooth Muscle Actin|URINALYSIS|[?]|usec|[?]|[?]|NEGATIVE|1|umol/L/sec|1|1|[?]|ABNORMAL|TUMOR TISSUE|THAWED||PHOROPTER|MDRD FORMULA|Y||NA||1|Visit_1|10|4|TREATMENT|2020-12-23|2021-03-17|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|8005bd56-3bd6-477a-a466-b9a3bd189770|3|INSLNFR|Insulin, Free|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|U/mL|1|1|[?]|HIGH|CORD BLOOD|AUTOLYZED||MICROARRAY|ASH FIBROSURE FORMULA|Y||Y|Y|2|Visit_2|25|3|SCREENING|2021-01-07|2021-01-10|25|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|8005bd56-3bd6-477a-a466-b9a3bd189770|4|VBCE|Viable Cells|URINALYSIS|[?]|Ci/L|[?]|[?]|BORDERLINE|1|mL/cage|1|1|[?]|HIGH|PLATELET|LACTESCENT|N|MAGNETIC RESONANCE ELASTOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|1|WASHOUT|2021-01-07|2021-03-14|25|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|8005bd56-3bd6-477a-a466-b9a3bd189770|5|SPHERO|Spherocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|kBq|1|1|[?]|HIGH|SKIN TISSUE|CALCIFIED||MICROBIAL CULTURE, LIQUID|CKD-EPI CYSTATIN C FORMULA|Y||Y|Y|3|Visit_3|40|5|TREATMENT|2021-01-22|2021-02-10|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|LB|8005bd56-3bd6-477a-a466-b9a3bd189770|6|BLASTRUB|Rubriblast|CHEMISTRY|[?]|Weber|[?]|[?]|NEGATIVE|1|FINGERTIP UNIT|1|1|[?]|LOW|ISOLATE|FROZEN|N|HEMATOXYLIN AND EOSIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||3|Visit_3|40|3|SCREENING|2021-01-22|2021-03-08|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|LB|8005bd56-3bd6-477a-a466-b9a3bd189770|7|CANNAB|Cannabinoids|CHEMISTRY|[?]|cm/s|[?]|[?]|POSITIVE|1|SCOOPFUL|1|1|[?]|HIGH|COLOSTRUM|SOLIDIFIED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI MMOL/MOL FORMULA||Y|N||4|Visit_4|65|7|SCREENING|2021-02-16|2021-03-03|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|8005bd56-3bd6-477a-a466-b9a3bd189770|8|GFRBSB2M|GFR from B-2 Microglobulin Adj for BSA|URINALYSIS|||[?]|[?]|INVALID|1|10^4/hpf|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|ICTERIC||FLUORESCENT ENZYME IMMUNOASSAY|ASH FIBROSURE FORMULA|||Y|Y|4|Visit_4|65|7|FOLLOW-UP|2021-02-16|2021-02-28|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|8005bd56-3bd6-477a-a466-b9a3bd189770|9|ESTROGEN|Estrogen|URINALYSIS|[?]|Frames/s|[?]|[?]|INVALID|1|Bq/g|1|1|[?]|LOW|SEBUM|CLOTTED||SNP ARRAY|MDRD ENZYMATIC FORMULA||Y|NA||5|Visit_5|90|7|FOLLOW-UP|2021-03-13|2021-03-14|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|8005bd56-3bd6-477a-a466-b9a3bd189770|10|SPERM|Spermatozoa|HEMATOLOGY|[?]|ug/m2/h|[?]|[?]|POSITIVE|1|/2000 RBC|1|1|[?]|NORMAL|CELL PELLET|ROOM TEMPERATURE|N|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD FORMULA|Y|Y|N||5|Visit_5|90|3|WASHOUT|2021-03-13|2021-03-14|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|078ea33d-4114-4320-9116-740b8385a94e|1|GUSB|Glucuronidase, Beta|URINALYSIS|[?]|amol|[?]|[?]|BORDERLINE|1|ng/mol|1|1|[?]|HIGH|ERYTHROCYTES|REFRIGERATED||OLIGO ACGH|NASH FIBROSURE FORMULA||Y|Y||1|Visit_1|10|6|TREATMENT|2020-07-26|2020-09-10|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|078ea33d-4114-4320-9116-740b8385a94e|2|C165920|White Elm Pollen IgG AB RAST Score|URINALYSIS|||[?]|[?]|TRACE|1|OD Unit|1|1|[?]|ABNORMAL|EXPIRED AIR|ICTERIC||GC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|1|Visit_1|10|2|FOLLOW-UP|2020-07-26|2020-09-21|10|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|078ea33d-4114-4320-9116-740b8385a94e|3|SIXMAM|6-Monoacetylmorphine|HEMATOLOGY|[?]|kN/cm2|[?]|[?]|POSITIVE|1|um|1|1|[?]|LOW|PLATELET POOR PLASMA|AGGLUTINATED||MODIFIED ACID FAST STAIN|COCKCROFT-GAULT FORMULA|||U||2|Visit_2|25|1|SCREENING|2020-08-10|2020-10-13|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|078ea33d-4114-4320-9116-740b8385a94e|4|MGBCREAT|Myoglobin/Creatinine|URINALYSIS|||[?]|[?]|INVALID|1|NEEDLE GAUGE|1|1|[?]|LOW|PLATELET|DRIED|N|ANGIOGRAPHY|GMI % FORMULA|Y||NA|Y|2|Visit_2|25|2|TREATMENT|2020-08-10|2020-08-20|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|078ea33d-4114-4320-9116-740b8385a94e|5|BUCHE|Butyrylcholinesterase|HEMATOLOGY|||[?]|[?]|INVALID|1|mg/kg/min|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|ROOM TEMPERATURE|N|ELASTOGRAPHY|MDRD FORMULA|||Y|Y|3|Visit_3|40|5|SCREENING|2020-08-25|2020-10-13|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|LB|078ea33d-4114-4320-9116-740b8385a94e|6|PIVKAII|Protein Induced by Vitamin K Absence-II|HEMATOLOGY|[?]|IU/dL|[?]|[?]|TRACE|1|%|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED||MRI WITHOUT CONTRAST|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|1|TREATMENT|2020-08-25|2020-10-20|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|LB|078ea33d-4114-4320-9116-740b8385a94e|7|PEPSNGI|Pepsinogen I|HEMATOLOGY|[?]|gMFI|[?]|[?]|BORDERLINE|1|ug/m2|1|1|[?]|LOW|SUPERNATANT, SERUM|CALCIFIED||ELECTRONEUROGRAPHY|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|5|TREATMENT|2020-09-19|2020-09-28|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|078ea33d-4114-4320-9116-740b8385a94e|8|INTLK24|Interleukin 24|HEMATOLOGY|[?]|ug/kg/min|[?]|[?]|NEGATIVE|1|ug/g/day|1|1|[?]|HIGH|GASTRIC FLUID|NON-HEMOLYZED||MAMMOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||4|Visit_4|65|4|TREATMENT|2020-09-19|2020-10-16|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|078ea33d-4114-4320-9116-740b8385a94e|9|AMYLASEP|Amylase, Pancreatic|HEMATOLOGY|[?]|fmol/g|[?]|[?]|TRACE|1|mm/2h|1|1|[?]|LOW|DIALYSIS FLUID|LIPEMIC||FLUORIMETRY|CKD-EPI CYSTATIN C FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-10-14|2020-10-16|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|078ea33d-4114-4320-9116-740b8385a94e|10|RETPALM|Retinyl Palmitate|HEMATOLOGY|[?]|umol/h/mmol|[?]|[?]|INVALID|1|um/s|1|1|[?]|ABNORMAL|SPUTUM|DRIED|N|IN SITU HYBRIDIZATION|MDRD 6 VARIABLE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-10-14|2020-10-17|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|1ca91975-9a42-4f4d-9c55-53f7561d82fa|1|P50OXYGN|P50 Oxygen|URINALYSIS|||[?]|[?]|NEGATIVE|1|IU/mmol|1|1|[?]|LOW|SPUTUM|LIPEMIC|N|INFRARED SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|1|Visit_1|10|7|TREATMENT|2020-06-03|2020-06-28|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|LB|1ca91975-9a42-4f4d-9c55-53f7561d82fa|2|HGBFR|Hemoglobin, Free|CHEMISTRY|[?]|ug/min|[?]|[?]|BORDERLINE|1|Tesla|1|1|[?]|HIGH|MUCUS|CALCIFIED|N|IVY INCISION METHOD|FIBROSIS 4 FORMULA||Y|U||1|Visit_1|10|7|TREATMENT|2020-06-03|2020-06-17|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|LB|1ca91975-9a42-4f4d-9c55-53f7561d82fa|3|TSP1|Thrombospondin 1|CHEMISTRY|[?]|GBq/ug|[?]|[?]|INDETERMINATE|1|10^6/g|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|SOLIDIFIED|N|PHOROPTER|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-06-18|2020-08-31|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|1ca91975-9a42-4f4d-9c55-53f7561d82fa|4|IGHG4|Immunoglobulin Heavy Constant Gamma 4|HEMATOLOGY|[?]|Ci|[?]|[?]|BORDERLINE|1|Gy/h|1|1|[?]|LOW|ENDOMETRIAL TISSUE|ICTERIC||PALPATION|FIBROSIS 4 FORMULA|Y|Y|N||2|Visit_2|25|6|TREATMENT|2020-06-18|2020-08-14|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|1ca91975-9a42-4f4d-9c55-53f7561d82fa|5|TNF12EXR|TNF Superfamily Member 12 Excretion Rate|CHEMISTRY|||[?]|[?]|POSITIVE|1|cmol/L|1|1|[?]|HIGH|AMNIOTIC FLUID|FRESH||GIEMSA STAIN|NASH FIBROSURE FORMULA|||NA|Y|3|Visit_3|40|1|TREATMENT|2020-07-03|2020-07-11|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|1ca91975-9a42-4f4d-9c55-53f7561d82fa|6|KLCFR|Kappa Light Chain, Free|CHEMISTRY|[?]|DNA copies/ug|[?]|[?]|INDETERMINATE|1|/day|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|AGGLUTINATED||PHASE-CONTRAST MRI|MDRD ENZYMATIC FORMULA|||N||3|Visit_3|40|1|TREATMENT|2020-07-03|2020-08-15|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|1ca91975-9a42-4f4d-9c55-53f7561d82fa|7|MBP|Myelin Basic Protein|URINALYSIS|[?]|L/s/kPa|[?]|[?]|INVALID|1|TRANSDUCING UNIT|1|1|[?]|NORMAL|BONE|SOLIDIFIED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA|||Y||4|Visit_4|65|1|TREATMENT|2020-07-28|2020-08-09|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|1ca91975-9a42-4f4d-9c55-53f7561d82fa|8|PROMYCE|Promyelocytes/Total Cells|HEMATOLOGY|[?]|10^4 CFU|[?]|[?]|INDETERMINATE|1|mL/min/1.73m2|1|1|[?]|HIGH|BONE|NON-HEMOLYZED||DUKE INCISION METHOD|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2020-07-28|2020-08-30|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|1ca91975-9a42-4f4d-9c55-53f7561d82fa|9|CALB|Calbindin|URINALYSIS|[?]|10^6 RNA copies/mL|[?]|[?]|POSITIVE|1|Bq/g|1|1|[?]|ABNORMAL|DIALYSIS FLUID|GELLED|N|FREEZING POINT DEPRESSION|GMI % FORMULA|||Y||5|Visit_5|90|7|SCREENING|2020-08-22|2020-08-29|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|1ca91975-9a42-4f4d-9c55-53f7561d82fa|10|NONHDL|Non-HDL Cholesterol|CHEMISTRY|||[?]|[?]|POSITIVE|1|g/L|1|1|[?]|HIGH|BUFFY COAT|NON-HEMOLYZED||HPLC-FL|MDRD FORMULA|||U|Y|5|Visit_5|90|5|TREATMENT|2020-08-22|2020-08-29|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|c5f292ad-1729-402b-820f-83ecd29ba00d|1|SEZCELY|Sezary Cells/Lymphocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|ug/day|1|1|[?]|ABNORMAL|ERYTHROCYTES|FROZEN||LIGHT MICROSCOPY|MDRD FORMULA|Y|Y|NA|Y|1|Visit_1|10|1|TREATMENT|2020-06-08|2020-08-31|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|c5f292ad-1729-402b-820f-83ecd29ba00d|2|C165902|Timothy Grass Pollen IgG AB RAST Score|URINALYSIS|[?]|nmol BCE/L|[?]|[?]|TRACE|1|AFU|1|1|[?]|ABNORMAL|SERUM|FRESH||MICRODENSITOMETRY|FIBROMETER FORMULA|||NA||1|Visit_1|10|5|WASHOUT|2020-06-08|2020-07-17|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|c5f292ad-1729-402b-820f-83ecd29ba00d|3|HAPTOG|Haptoglobin|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ug/L FEU|1|1|[?]|NORMAL|VITREOUS HUMOR|CLOTTED||FLUORESCENT IMMUNOASSAY|FIBROTEST FORMULA|Y||U|Y|2|Visit_2|25|5|TREATMENT|2020-06-23|2020-07-06|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|c5f292ad-1729-402b-820f-83ecd29ba00d|4|CXCL4|Chemokine (C-X-C Motif) Ligand 4|HEMATOLOGY|[?]|cs|[?]|[?]|NEGATIVE|1|umol/L/h|1|1|[?]|HIGH|SPERMATOZOON|FROZEN||PUPILLOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||2|Visit_2|25|3|FOLLOW-UP|2020-06-23|2020-08-14|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|c5f292ad-1729-402b-820f-83ecd29ba00d|5|EPSTI1|Epithelial Stromal Interaction Protein 1|URINALYSIS|[?]|mU/g|[?]|[?]|TRACE|1|cmHg|1|1|[?]|HIGH|PROSTATIC FLUID|PARAFFIN-EMBEDDED||CINEANGIOGRAPHY|MDRD ENZYMATIC FORMULA|||U||3|Visit_3|40|2|FOLLOW-UP|2020-07-08|2020-08-13|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|c5f292ad-1729-402b-820f-83ecd29ba00d|6|C165930|Shellfish Mix IgE AB RAST Score|CHEMISTRY|[?]|mEq/L|[?]|[?]|INDETERMINATE|1|MBP|1|1|[?]|ABNORMAL|CERUMEN|CONCENTRATED||IMMUNOBLOT|FIBROTEST FORMULA|||NA||3|Visit_3|40|5|SCREENING|2020-07-08|2020-08-21|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|c5f292ad-1729-402b-820f-83ecd29ba00d|7|DOPAC|3,4-Dihydroxyphenylacetic Acid|CHEMISTRY|[?]|10^6/L|[?]|[?]|INVALID|1|L|1|1|[?]|LOW|MIXED VENOUS BLOOD|PARAFFIN-EMBEDDED||IMMUNOBLOT|MDRD 4 VARIABLE FORMULA||Y|U||4|Visit_4|65|2|TREATMENT|2020-08-02|2020-08-09|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-05
e|LB|c5f292ad-1729-402b-820f-83ecd29ba00d|8|LDLPATT|LDL Subtype Pattern|URINALYSIS|[?]|CIGARETTE|[?]|[?]|INVALID|1|ks|1|1|[?]|LOW|MIXED VENOUS BLOOD|PARAFFIN-EMBEDDED|N|INDIRECT IMMUNOFLUORESCENCE|FIBROMETER FORMULA|||Y||4|Visit_4|65|2|FOLLOW-UP|2020-08-02|2020-08-14|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-05
e|LB|c5f292ad-1729-402b-820f-83ecd29ba00d|9|ACANTRBC|Acanthocytes/Erythrocytes|HEMATOLOGY|[?]|cmol|[?]|[?]|NEGATIVE|1|mg|1|1|[?]|NORMAL|TISSUE|THAWED||TOTAL BODY IRRADIATION|FIBROMETER FORMULA|Y||U||5|Visit_5|90|3|WASHOUT|2020-08-27|2020-08-31|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|c5f292ad-1729-402b-820f-83ecd29ba00d|10|HOMOCIT|Homocitrulline|CHEMISTRY|[?]|Enzyme U/g Hb|[?]|[?]|TRACE|1|kN/cm2|1|1|[?]|HIGH|VENOUS CORD BLOOD|CONCENTRATED|N|FARNSWORTH-MUNSELL 100 HUE TEST|GMI % FORMULA||Y|U||5|Visit_5|90|1|SCREENING|2020-08-27|2020-09-01|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|a746aefb-16c8-43db-a0c4-8e9a4efdb244|1|NEUTB|Neutrophils Band Form|URINALYSIS|[?]|pkat|[?]|[?]|POSITIVE|1|km/h|1|1|[?]|NORMAL|INFRANATANT, SERUM|AGGLUTINATED||TARGETED GENOME SEQUENCING|MDRD ENZYMATIC FORMULA||Y|Y||1|Visit_1|10|2|TREATMENT|2020-06-27|2020-07-08|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|a746aefb-16c8-43db-a0c4-8e9a4efdb244|2|CARTP|Cocaine Amphetamine-Reg Transcript Prot|URINALYSIS|[?]|mg/mol|[?]|[?]|NEGATIVE|1|%(w/v)|1|1|[?]|ABNORMAL|PLATELET|AGGLUTINATED||PHYSICAL EXAMINATION|ASH FIBROSURE FORMULA|||U||1|Visit_1|10|4|FOLLOW-UP|2020-06-27|2020-09-21|10|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|a746aefb-16c8-43db-a0c4-8e9a4efdb244|3|HEPARIN|Heparin|CHEMISTRY|[?]|nmol/L/min|[?]|[?]|NEGATIVE|1|mEq/g|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|GELLED||CONTRAST ENHANCED X-RAY|FIBROSIS 4 FORMULA|Y||Y||2|Visit_2|25|6|WASHOUT|2020-07-12|2020-07-22|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|a746aefb-16c8-43db-a0c4-8e9a4efdb244|4|VITD2|Vitamin D2|URINALYSIS|[?]|Mile|[?]|[?]|INDETERMINATE|1|Ci/g|1|1|[?]|HIGH|ENDOMETRIAL TISSUE|LIPEMIC|N|CALCULATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||2|Visit_2|25|6|TREATMENT|2020-07-12|2020-09-19|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|a746aefb-16c8-43db-a0c4-8e9a4efdb244|5|LYMATLY|Atypical Lymphocytes/Lymphocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|U/g|1|1|[?]|ABNORMAL|REFLEX TEAR|NON-HEMOLYZED|N|TARGETED TRANSCRIPTOME SEQUENCING|FIBROSIS 4 FORMULA|||NA|Y|3|Visit_3|40|2|TREATMENT|2020-07-27|2020-08-01|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|a746aefb-16c8-43db-a0c4-8e9a4efdb244|6|VITD|Vitamin D|CHEMISTRY|[?]|MAC50|[?]|[?]|BORDERLINE|1|ugEq/L|1|1|[?]|ABNORMAL|VENOUS PLASMA|AGGLUTINATED||IMMUNOFLUORESCENT STAIN|MDRD 5 VARIABLE FORMULA|Y||Y||3|Visit_3|40|3|TREATMENT|2020-07-27|2020-08-01|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|a746aefb-16c8-43db-a0c4-8e9a4efdb244|7|RT3|Triiodothyronine, Reverse|URINALYSIS|[?]|kUSP|[?]|[?]|INVALID|1|kHz|1|1|[?]|LOW|GASTRIC CONTENTS|HEMOLYZED||LAPAROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||4|Visit_4|65|7|WASHOUT|2020-08-21|2020-09-16|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|a746aefb-16c8-43db-a0c4-8e9a4efdb244|8|INTLK1|Interleukin 1|URINALYSIS|[?]|pmol/L|[?]|[?]|INDETERMINATE|1|mph|1|1|[?]|LOW|MONOCYTE|FRESH||LC-FL|MDRD 5 VARIABLE FORMULA|Y||U||4|Visit_4|65|5|WASHOUT|2020-08-21|2020-09-03|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|a746aefb-16c8-43db-a0c4-8e9a4efdb244|9|CHOLATE|Cholate|HEMATOLOGY|[?]|h/wk|[?]|[?]|INVALID|1|mU/L|1|1|[?]|ABNORMAL|GASTRIC FLUID|DRIED||ISHIHARA COLOR PLATES|MDRD FORMULA||Y|N||5|Visit_5|90|4|TREATMENT|2020-09-15|2020-09-20|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|a746aefb-16c8-43db-a0c4-8e9a4efdb244|10|STAT3|STAT3|CHEMISTRY|[?]|PFU|[?]|[?]|NEGATIVE|1|tuberculin unit/mL|1|1|[?]|NORMAL|CAPILLARY PLASMA|GELLED||EEG|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||5|Visit_5|90|3|SCREENING|2020-09-15|2020-09-19|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|7f95b9c0-3b77-4c60-8890-ecc955f97122|1|BARB|Barbiturates|HEMATOLOGY|[?]|log10 TCID 50/dose|[?]|[?]|POSITIVE|1|nmol BCE/L|1|1|[?]|HIGH|GASTRIC FLUID|UNEXPECTED ODOR||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|6|FOLLOW-UP|2020-09-25|2020-12-12|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|7f95b9c0-3b77-4c60-8890-ecc955f97122|2|C165925|Weed Mix Pollen IgE AB RAST Score|HEMATOLOGY|[?]|uU/dL|[?]|[?]|POSITIVE|1|mmol2/L2|1|1|[?]|HIGH|LYMPH|CONCENTRATED||SISH|FIBROSIS 4 FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-09-25|2020-12-21|10|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|7f95b9c0-3b77-4c60-8890-ecc955f97122|3|RANTES|Reg upon Act Normal T-cell Exprd Secrtd|URINALYSIS|[?]|mIU/L|[?]|[?]|POSITIVE|1|pg/cell|1|1|[?]|HIGH|PROSTATIC FLUID|FRESH||PET/SPECT SCAN|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-10-10|2020-10-27|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|7f95b9c0-3b77-4c60-8890-ecc955f97122|4|FRUCT|Fructosamine|URINALYSIS|[?]|Bq/mL|[?]|[?]|POSITIVE|1|uEq/L|1|1|[?]|HIGH|TRANSUDATE|CLOTTED||CORONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-10-10|2020-11-15|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|7f95b9c0-3b77-4c60-8890-ecc955f97122|5|IMMGLCFR|Immunoglobulin Light Chains, Free|HEMATOLOGY|[?]|mg/m2/min|[?]|[?]|INVALID|1|g/cage/day|1|1|[?]|NORMAL|SOFT TISSUE|DRIED||SANGER SEQUENCING|CKD-EPI FORMULA||Y|Y||3|Visit_3|40|4|FOLLOW-UP|2020-10-25|2020-11-10|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|7f95b9c0-3b77-4c60-8890-ecc955f97122|6|C4D|Complement C4d|CHEMISTRY|[?]|10^9 CFU/mL|[?]|[?]|INDETERMINATE|1|atm|1|1|[?]|ABNORMAL|TRANSUDATE|REFRIGERATED||NO INFORMATION|CKD-EPI FORMULA|||N||3|Visit_3|40|4|TREATMENT|2020-10-25|2020-10-29|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|7f95b9c0-3b77-4c60-8890-ecc955f97122|7|C130093|Western Ragweed Pollen IgA|URINALYSIS|||[?]|[?]|NEGATIVE|1|APL U/mL|1|1|[?]|HIGH|BILE|HEMOLYZED||TELLER ACUITY CARDS|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|4|Visit_4|65|1|TREATMENT|2020-11-19|2020-11-23|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|7f95b9c0-3b77-4c60-8890-ecc955f97122|8|EOSBLE|Eosinophils Band Form/Leukocytes|URINALYSIS|[?]|/40 HPFs|[?]|[?]|INVALID|1|BOWL|1|1|[?]|NORMAL|ISOLATE|LIPEMIC|N|LINE PROBE ASSAY|MDRD 4 VARIABLE FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2020-11-19|2020-11-21|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|7f95b9c0-3b77-4c60-8890-ecc955f97122|9|UNSPCE|Unspecified Cells|URINALYSIS|[?]|10^5/hpf|[?]|[?]|INVALID|1|Ci/g|1|1|[?]|LOW|CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|N|RAJI CELL RIA|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|4|TREATMENT|2020-12-14|2020-12-18|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|7f95b9c0-3b77-4c60-8890-ecc955f97122|10|DPPIVA|Dipeptidyl Peptidase-4 Activity|HEMATOLOGY|[?]|Gravitational Unit|[?]|[?]|INDETERMINATE|1|kg/L|1|1|[?]|LOW|SOFT TISSUE|AGGLUTINATED||FLOCCULATION, CHARCOAL ENHANCED|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|1|SCREENING|2020-12-14|2020-12-16|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|2be43c56-83f3-4148-9cb1-97c6d191d20e|1|AFPA|Alpha Fetoprotein Activity|CHEMISTRY|[?]|mL/animal|[?]|[?]|NEGATIVE|1|ukat/L|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|DRIED||MASS SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||1|Visit_1|10|2|TREATMENT|2020-10-03|2020-10-11|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|2be43c56-83f3-4148-9cb1-97c6d191d20e|2|VITB9|Vitamin B9|URINALYSIS|[?]|mEq/mmol|[?]|[?]|NEGATIVE|1|Gy/h|1|1|[?]|NORMAL|SUPERNATANT, SERUM|HEMOLYZED||IMMUNOFIXATION ELECTROPHORESIS|FIBROSIS 4 FORMULA|||U||1|Visit_1|10|4|FOLLOW-UP|2020-10-03|2020-12-11|10|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|2be43c56-83f3-4148-9cb1-97c6d191d20e|3|CTXICRT|Type I Collagen C-Telopeptides/Creat|URINALYSIS|[?]|ug/kg/day|[?]|[?]|INDETERMINATE|1|BP|1|1|[?]|LOW|SEBUM|UNEXPECTED ODOR||VIRUS PLAQUE ASSAY|MDRD 5 VARIABLE FORMULA||Y|U||2|Visit_2|25|7|SCREENING|2020-10-18|2020-10-22|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|2be43c56-83f3-4148-9cb1-97c6d191d20e|4|IL18BP|Interleukin 18 Binding Protein|CHEMISTRY|[?]|ug/m2/h|[?]|[?]|INDETERMINATE|1|min*mg/mL|1|1|[?]|HIGH|WHITE MATTER TISSUE|ROOM TEMPERATURE|N|MECHANICAL CLOT DETECTION|GMI % FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-10-18|2020-11-02|25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|2be43c56-83f3-4148-9cb1-97c6d191d20e|5|NOHDLHDL|Non-HDL Cholesterol/HDL Cholesterol|CHEMISTRY|[?]|TRANSDUCING UNIT|[?]|[?]|BORDERLINE|1|bel|1|1|[?]|LOW|RETICULOCYTES|PARAFFIN-EMBEDDED||INTERRUPTER TECHNIQUE|COCKCROFT-GAULT FORMULA|Y|Y|NA||3|Visit_3|40|1|TREATMENT|2020-11-02|2020-12-28|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|2be43c56-83f3-4148-9cb1-97c6d191d20e|6|MENGLCE|Meningeal Cells/Total Cells|URINALYSIS|[?]|uEq|[?]|[?]|NEGATIVE|1|Torr|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|N|PALPATION|MDRD FORMULA|||NA||3|Visit_3|40|5|FOLLOW-UP|2020-11-02|2020-12-29|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|2be43c56-83f3-4148-9cb1-97c6d191d20e|7|OSMRTY|Osmolarity|HEMATOLOGY|[?]|mm/2h|[?]|[?]|BORDERLINE|1|km|1|1|[?]|LOW|SPUTUM|DRIED||MOUSE PROTECTION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||4|Visit_4|65|7|FOLLOW-UP|2020-11-27|2020-12-30|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|2be43c56-83f3-4148-9cb1-97c6d191d20e|8|CYURIAC|Uric Acid Crystals|URINALYSIS|[?]|%(w/w)|[?]|[?]|BORDERLINE|1|umol/day|1|1|[?]|NORMAL|PLASMA|FRESH|N|LANDOLT RING|ASH FIBROSURE FORMULA|Y|Y|Y||4|Visit_4|65|5|WASHOUT|2020-11-27|2020-12-18|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|2be43c56-83f3-4148-9cb1-97c6d191d20e|9|C130128|Dog Dander Antigen IgE Antibody|URINALYSIS|[?]|U|[?]|[?]|BORDERLINE|1|mol/g|1|1|[?]|LOW|SEMEN|CONCENTRATED|N|MS/MS|FIBROMETER FORMULA|||U||5|Visit_5|90|4|TREATMENT|2020-12-22|2020-12-25|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|2be43c56-83f3-4148-9cb1-97c6d191d20e|10|IGD|Immunoglobulin D|CHEMISTRY|[?]|ug/kg|[?]|[?]|BORDERLINE|1|mg/kg|1|1|[?]|HIGH|SPUTUM|LACTESCENT|N|IMMUNO-PET SCAN|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|5|WASHOUT|2020-12-22|2020-12-25|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|e27e0325-5fbe-46c0-8264-982d83124203|1|PROTPATN|Protein Pattern|HEMATOLOGY|[?]|MPS U|[?]|[?]|POSITIVE|1|/mm|1|1|[?]|LOW|MECONIUM|AUTOLYZED||SPIROMETRY|NASH FIBROSURE FORMULA|Y||N||1|Visit_1|10|4|FOLLOW-UP|2020-07-07|2020-08-01|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|e27e0325-5fbe-46c0-8264-982d83124203|2|METARBCE|Metarubricyte/Total Cells|CHEMISTRY|||[?]|[?]|BORDERLINE|1|EIA unit|1|1|[?]|LOW|EPIDERMAL TISSUE|UNEXPECTED ODOR||INTERRUPTER TECHNIQUE|HEPASCORE FORMULA|Y||N|Y|1|Visit_1|10|2|SCREENING|2020-07-07|2020-08-21|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|e27e0325-5fbe-46c0-8264-982d83124203|3|VITB2|Riboflavin|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|U/m2|1|1|[?]|NORMAL|VENOUS PLASMA|CLOTTED||RAJI CELL EIA|FIBROTEST FORMULA||Y|Y|Y|2|Visit_2|25|3|TREATMENT|2020-07-22|2020-08-27|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|e27e0325-5fbe-46c0-8264-982d83124203|4|STOMCY|Stomatocytes|URINALYSIS|[?]|mL/kg/min|[?]|[?]|POSITIVE|1|10^3 RNA copies/mL|1|1|[?]|NORMAL|PLATELET RICH PLASMA|AGGLUTINATED|N|INTERRUPTER TECHNIQUE|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||2|Visit_2|25|6|TREATMENT|2020-07-22|2020-09-22|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|e27e0325-5fbe-46c0-8264-982d83124203|5|NOREPIN|Norepinephrine|URINALYSIS|[?]|MPS U|[?]|[?]|NEGATIVE|1|DNA copies/mL|1|1|[?]|NORMAL|ADIPOSE TISSUE|CONTAMINATED||KLEIHAUER-BETKE|HEPASCORE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-08-06|2020-08-15|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|e27e0325-5fbe-46c0-8264-982d83124203|6|FBRTST|FibroTest Score|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|SCOOPFUL|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|HEMOLYZED||FARNSWORTH-MUNSELL 100 HUE TEST|FIBROTEST FORMULA|||U|Y|3|Visit_3|40|3|TREATMENT|2020-08-06|2020-09-02|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|e27e0325-5fbe-46c0-8264-982d83124203|7|FACTVIIA|Factor VII Activity|HEMATOLOGY|[?]|ppm|[?]|[?]|NEGATIVE|1|mEq/ug|1|1|[?]|LOW|PERSPIRATION|FROZEN||MAPH|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||4|Visit_4|65|1|WASHOUT|2020-08-31|2020-09-09|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|LB|e27e0325-5fbe-46c0-8264-982d83124203|8|PLG|Plasminogen|URINALYSIS|[?]|ug/mol|[?]|[?]|NEGATIVE|1|mU|1|1|[?]|NORMAL|DISCHARGE|HEMOLYZED|N|FORCED OSCILLATION TECHNIQUE|FIBROMETER FORMULA|||Y||4|Visit_4|65|6|SCREENING|2020-08-31|2020-09-07|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|LB|e27e0325-5fbe-46c0-8264-982d83124203|9|CXCL4|Chemokine (C-X-C Motif) Ligand 4|URINALYSIS|||[?]|[?]|TRACE|1|s^-1(%O2)^-1|1|1|[?]|LOW|PERITONEAL FLUID|HEMOLYZED|N|FLUORESCENT SPOT TEST|FIBROSIS 4 FORMULA||Y|N|Y|5|Visit_5|90|6|WASHOUT|2020-09-25|2020-09-27|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|e27e0325-5fbe-46c0-8264-982d83124203|10|ENRAGE|Extracell Newly Ident RAGE Bind Protein|HEMATOLOGY|[?]|mmol2/L2|[?]|[?]|TRACE|1|ft2|1|1|[?]|NORMAL|WHITE MATTER TISSUE|HEMOLYZED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|FIBROMETER FORMULA|||U||5|Visit_5|90|6|FOLLOW-UP|2020-09-25|2020-10-02|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|1|AMCRMRNA|AMACR mRNA|URINALYSIS|||[?]|[?]|BORDERLINE|1|/40 HPFs|1|1|[?]|HIGH|LYSATE|THAWED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|FIBROTEST FORMULA|||N|Y|1|Visit_1|10|4|SCREENING|2020-12-19|2020-12-25|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|2|LYMATLY|Atypical Lymphocytes/Lymphocytes|URINALYSIS|[?]|10^6 U|[?]|[?]|TRACE|1|Roentgen|1|1|[?]|NORMAL|ARTERIAL BLOOD|CALCIFIED||DIFFUSION TENSOR MRI|CKD-EPI CREATININE FORMULA||Y|Y||1|Visit_1|10|7|WASHOUT|2020-12-19|2021-01-18|10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|3|RBCNUC|Nucleated Erythrocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|L/min|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|AGGLUTINATED||CALCOFLUOR WHITE STAIN|MDRD ENZYMATIC FORMULA|||Y|Y|2|Visit_2|25|1|FOLLOW-UP|2021-01-03|2021-02-25|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|4|LH|Luteinizing Hormone|URINALYSIS|[?]|ug/m2/day|[?]|[?]|BORDERLINE|1|PFU/mL|1|1|[?]|LOW|HAIR FOLLICLE|UNEXPECTED ODOR|N|FISH|FIBROMETER FORMULA||Y|NA||2|Visit_2|25|2|TREATMENT|2021-01-03|2021-02-11|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|5|HEINZRBC|Heinz Bodies/Erythrocytes|HEMATOLOGY|[?]|Absorbance U|[?]|[?]|INDETERMINATE|1|g/L|1|1|[?]|NORMAL|KERATINOCYTE|CONTAMINATED||CONTRAST ENHANCED SPIRAL CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||3|Visit_3|40|7|TREATMENT|2021-01-18|2021-03-17|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|6|PSDEPHD|Pseudoephedrine|CHEMISTRY|[?]|ug/mL/h|[?]|[?]|INDETERMINATE|1|MAC50|1|1|[?]|LOW|AMNIOTIC FLUID|DRIED|N|ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD 6 VARIABLE FORMULA|||U||3|Visit_3|40|5|TREATMENT|2021-01-18|2021-03-14|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|7|C130102|Tree Mix Pollen Antigen IgG Antibody|CHEMISTRY|||[?]|[?]|NEGATIVE|1|DIOPTER|1|1|[?]|ABNORMAL|BILE|LIPEMIC|N|SLIT LAMP|GMI MMOL/MOL FORMULA|Y||Y|Y|4|Visit_4|65|2|FOLLOW-UP|2021-02-12|2021-03-15|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|8|PHOSEXR|Phosphorus Excretion Rate|URINALYSIS|[?]|mg/kg/dose|[?]|[?]|BORDERLINE|1|log10 PFU|1|1|[?]|LOW|SOFT TISSUE|ICTERIC||FLUORESCENT SPOT TEST|CKD-EPI CREATININE FORMULA|||U||4|Visit_4|65|1|FOLLOW-UP|2021-02-12|2021-03-07|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|9|IOHEXCLR|Iohexol Clearance|CHEMISTRY|[?]|kcal/day|[?]|[?]|POSITIVE|1|log10 TCID 50/uL|1|1|[?]|LOW|PLASMA|HEMOLYZED||SICKLE CELL SOLUBILITY TEST|NASH FIBROSURE FORMULA|Y||U||5|Visit_5|90|5|FOLLOW-UP|2021-03-09|2021-03-14|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|10|PNTBRBTL|Pentobarbital|CHEMISTRY|[?]|/month|[?]|[?]|NEGATIVE|1|10^5/hpf|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|FROZEN||MICROBIAL CONCENTRATION|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|3|SCREENING|2021-03-09|2021-03-17|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|29e08650-9eae-461f-981e-f2a20d8d4492|1|ANCIGAB|Anti-Neutrophil Cytoplasmic IgG Antibody|HEMATOLOGY|[?]|mU|[?]|[?]|POSITIVE|1|um/day|1|1|[?]|NORMAL|DIALYSIS FLUID|LIPEMIC||ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|2|SCREENING|2020-11-17|2021-02-01|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|29e08650-9eae-461f-981e-f2a20d8d4492|2|CD2LY|CD2/Lymphocytes|HEMATOLOGY|||[?]|[?]|TRACE|1|FINGERTIP UNIT|1|1|[?]|ABNORMAL|LEUKOCYTE|SOLIDIFIED||PET/CT SCAN WITHOUT CONTRAST|FIBROTEST FORMULA|||U|Y|1|Visit_1|10|5|TREATMENT|2020-11-17|2021-01-14|10|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|29e08650-9eae-461f-981e-f2a20d8d4492|3|APOBAPA1|Apolipoprotein B/Apolipoprotein A1|HEMATOLOGY|[?]|CAN|[?]|[?]|POSITIVE|1|mL/kg/day|1|1|[?]|NORMAL|GASTRIC FLUID|CALCIFIED||SXA SCAN|CKD-EPI FORMULA|||Y||2|Visit_2|25|2|WASHOUT|2020-12-02|2021-01-07|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|29e08650-9eae-461f-981e-f2a20d8d4492|4|ASMACT|Alpha-Smooth Muscle Actin|CHEMISTRY|[?]|mOsm/L|[?]|[?]|INVALID|1|JDF Unit|1|1|[?]|NORMAL|PLEURAL FLUID|AUTOLYZED||IMMUNOTURBIDIMETRY|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|3|FOLLOW-UP|2020-12-02|2020-12-11|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|29e08650-9eae-461f-981e-f2a20d8d4492|5|C165917|D. pteronyssinus IgG AB RAST Score|URINALYSIS|[?]|mV2/Hz|[?]|[?]|INDETERMINATE|1|damol/L|1|1|[?]|ABNORMAL|BLOOD|PARAFFIN-EMBEDDED||GEL ELECTROPHORESIS|MDRD ENZYMATIC FORMULA|||U||3|Visit_3|40|5|SCREENING|2020-12-17|2021-01-08|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|29e08650-9eae-461f-981e-f2a20d8d4492|6|VEGFD|Vascular Endothelial Growth Factor D|HEMATOLOGY|[?]|cmH2O*s/mL|[?]|[?]|TRACE|1|mCi/L|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|FROZEN|N|FLUORIMETRY|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-12-17|2020-12-29|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|29e08650-9eae-461f-981e-f2a20d8d4492|7|TROPONI3|Troponin I Type 3|URINALYSIS|[?]|mL/s/m2|[?]|[?]|TRACE|1|ukat/L|1|1|[?]|NORMAL|PLATELET|LIPEMIC|N|HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||4|Visit_4|65|3|TREATMENT|2021-01-11|2021-01-30|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|29e08650-9eae-461f-981e-f2a20d8d4492|8|SPMAGGLU|Sperm Agglutination|CHEMISTRY|[?]|10^9 organisms/g|[?]|[?]|TRACE|1|10^3 DNA copies/mL|1|1|[?]|LOW|EMOTIONAL TEAR|NON-HEMOLYZED||DNA MICROARRAY|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2021-01-11|2021-02-08|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|29e08650-9eae-461f-981e-f2a20d8d4492|9|INTLK5|Interleukin 5|URINALYSIS|[?]|10^8 PFU|[?]|[?]|INDETERMINATE|1|VIAL|1|1|[?]|LOW|SUPERNATANT, SERUM|HEMOLYZED||RADIAL IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA|Y|Y|U||5|Visit_5|90|7|TREATMENT|2021-02-05|2021-02-13|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|29e08650-9eae-461f-981e-f2a20d8d4492|10|BLSTMKCE|Megakaryoblasts/Total Cells|HEMATOLOGY|[?]|10^6 organisms|[?]|[?]|INDETERMINATE|1|g/animal|1|1|[?]|NORMAL|EPITHELIAL CELL|FROZEN||JAFFE REACTION|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|2|TREATMENT|2021-02-05|2021-02-11|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|2b944a62-10bc-475e-a90d-da3f07a2c4df|1|GAMBTAC|Gamma-Aminobutyric Acid|HEMATOLOGY|[?]|pkat/L|[?]|[?]|POSITIVE|1|mL/m2|1|1|[?]|HIGH|SPERMATOZOON|CONTAMINATED||SICKLE CELL SOLUBILITY TEST|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|3|WASHOUT|2020-09-01|2020-10-05|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|2b944a62-10bc-475e-a90d-da3f07a2c4df|2|HISTAB|Histone Antibodies|HEMATOLOGY|[?]|cd*s/m2|[?]|[?]|INVALID|1|Hz/s|1|1|[?]|LOW|HAIR|FRESH||NON-INVASIVE DIELECTRIC SENSING|MDRD 6 VARIABLE FORMULA|||Y||1|Visit_1|10|3|TREATMENT|2020-09-01|2020-11-08|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|LB|2b944a62-10bc-475e-a90d-da3f07a2c4df|3|C130127|Cat Dander Antigen IgG4 Antibody|HEMATOLOGY|||[?]|[?]|INVALID|1|mV/sec|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|LIPEMIC|N|TRIPLE-PHASE SPIRAL CT SCAN|HEPASCORE FORMULA||Y|Y|Y|2|Visit_2|25|1|TREATMENT|2020-09-16|2020-09-17|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|2b944a62-10bc-475e-a90d-da3f07a2c4df|4|SLTFRNRC|Soluble Transferrin Receptor|CHEMISTRY|[?]|copies/mL|[?]|[?]|TRACE|1|mmol/mol|1|1|[?]|ABNORMAL|PERSPIRATION|PARAFFIN-EMBEDDED||CALCULATION|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2020-09-16|2020-10-26|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|2b944a62-10bc-475e-a90d-da3f07a2c4df|5|GLCHT|Glycolithocholate|URINALYSIS|[?]|K|[?]|[?]|NEGATIVE|1|genEq|1|1|[?]|ABNORMAL|BUFFY COAT|FROZEN||ANGIOGRAPHY|ASH FIBROSURE FORMULA|Y|Y|Y||3|Visit_3|40|3|TREATMENT|2020-10-01|2020-10-16|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|2b944a62-10bc-475e-a90d-da3f07a2c4df|6|PRLYMLE|Prolymphocytes/Leukocytes|HEMATOLOGY|[?]|EU|[?]|[?]|NEGATIVE|1|mg/dose|1|1|[?]|NORMAL|DERMAL TISSUE|ICTERIC||INDIA INK STAIN|ASH FIBROSURE FORMULA|Y||U||3|Visit_3|40|4|TREATMENT|2020-10-01|2020-11-05|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|2b944a62-10bc-475e-a90d-da3f07a2c4df|7|LDH2|LDH Isoenzyme 2|URINALYSIS|[?]|U/mL|[?]|[?]|BORDERLINE|1|g/cage|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|THAWED||VIRUS PLAQUE ASSAY|HEPASCORE FORMULA|Y||Y||4|Visit_4|65|6|TREATMENT|2020-10-26|2020-11-14|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|2b944a62-10bc-475e-a90d-da3f07a2c4df|8|HYDMRPHN|Hydromorphone|CHEMISTRY|[?]|ppb|[?]|[?]|POSITIVE|1|mEq/mmol|1|1|[?]|LOW|SPERMATOZOON|FROZEN|N|CONTRAST ENHANCED MRI|MDRD 5 VARIABLE FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2020-10-26|2020-11-26|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|2b944a62-10bc-475e-a90d-da3f07a2c4df|9|PLATIM|Immature Platelets|HEMATOLOGY|[?]|mg/min|[?]|[?]|BORDERLINE|1|EID 50/dose|1|1|[?]|ABNORMAL|SPERMATOZOON|GELLED||ELECTROGASTROGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||N||5|Visit_5|90|2|TREATMENT|2020-11-20|2020-11-21|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|2b944a62-10bc-475e-a90d-da3f07a2c4df|10|CD27|CD27|CHEMISTRY|[?]|COAT|[?]|[?]|NEGATIVE|1|/2500 WBC|1|1|[?]|ABNORMAL|SOFT TISSUE|SOLIDIFIED||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI CREATININE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2020-11-20|2020-11-28|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|1|FAT|Fat|CHEMISTRY|[?]|mL/(min*100mL)|[?]|[?]|NEGATIVE|1|log10 TCID 50/mL|1|1|[?]|ABNORMAL|BUFFY COAT|HEMOLYZED|N|GEL ELECTROPHORESIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||1|Visit_1|10|3|FOLLOW-UP|2020-09-09|2020-10-31|10|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|2|SPMAGGR|Sperm Aggregation|HEMATOLOGY|||[?]|[?]|TRACE|1|EID 50/mL|1|1|[?]|HIGH|EPIDERMAL TISSUE|CONCENTRATED|N|URANYL ACETATE STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA|Y|1|Visit_1|10|7|TREATMENT|2020-09-09|2020-09-23|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|3|CHOLINES|Cholinesterase|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|L/h/m2|1|1|[?]|ABNORMAL|CELL PELLET|CLOTTED||ICP-MS|MDRD FORMULA|||N|Y|2|Visit_2|25|4|WASHOUT|2020-09-24|2020-11-18|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|4|WDR26|WD Repeat-Containing Protein 26|HEMATOLOGY|[?]|Weber|[?]|[?]|POSITIVE|1|Coulomb|1|1|[?]|HIGH|GASTRIC FLUID|CLOTTED||CONTRAST ENHANCED X-RAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||2|Visit_2|25|4|FOLLOW-UP|2020-09-24|2020-11-10|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|5|CITCREAT|Citrate/Creatinine|URINALYSIS|[?]|mg/mL/day|[?]|[?]|BORDERLINE|1|aMFI|1|1|[?]|NORMAL|ISOLATE|CLOTTED||PET SCAN|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|4|FOLLOW-UP|2020-10-09|2020-10-13|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|6|MOCYCE|Monocytoid Cells|URINALYSIS|[?]|pkat/L|[?]|[?]|INDETERMINATE|1|TRACE|1|1|[?]|NORMAL|LEUKOCYTE|DRIED|N|ENDPOINT DILUTION ASSAY|FIBROTEST FORMULA|||N||3|Visit_3|40|6|WASHOUT|2020-10-09|2020-11-08|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|7|CD19LY|CD19/Lymphocytes|HEMATOLOGY|[?]|CCID 50/dose|[?]|[?]|TRACE|1|MET|1|1|[?]|LOW|MECONIUM|CONTAMINATED||AMSLER GRID|MDRD 4 VARIABLE FORMULA|Y||U||4|Visit_4|65|5|FOLLOW-UP|2020-11-03|2020-11-22|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|8|C130103|Grass Mix Pollen Antigen IgE Antibody|HEMATOLOGY|[?]|dram|[?]|[?]|BORDERLINE|1|U/m2/h|1|1|[?]|NORMAL|TISSUE|AGGLUTINATED||SICKLE CELL SOLUBILITY TEST|FIBROTEST FORMULA|Y||N||4|Visit_4|65|3|FOLLOW-UP|2020-11-03|2020-11-22|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|9|IGGCREAT|Immunoglobulin G/Creatinine|HEMATOLOGY|[?]|kcal|[?]|[?]|INVALID|1|MBq/uL|1|1|[?]|HIGH|PERITONEAL FLUID|FRESH|N|GRADIENT DIFFUSION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||5|Visit_5|90|5|WASHOUT|2020-11-28|2020-11-29|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|10|CCL2EXR|Chemokine (C-C Motif) Ligand 2 Excr Rate|HEMATOLOGY|[?]|ka_u/dL|[?]|[?]|BORDERLINE|1|10^3 organisms|1|1|[?]|NORMAL|AMNIOTIC FLUID|NON-HEMOLYZED||ICP-MS|MDRD ENZYMATIC JAPANESE FORMULA|||U||5|Visit_5|90|4|SCREENING|2020-11-28|2020-12-03|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|8aa77db3-b078-4073-a7f3-9b9a7fb14570|1|IL2SRA|Soluble Interleukin 2 Receptor Activity|CHEMISTRY|[?]|Siemens|[?]|[?]|TRACE|1|ug/h|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|HEMOLYZED||WEBER GREEN STAIN|COCKCROFT-GAULT FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-11-12|2021-01-22|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|8aa77db3-b078-4073-a7f3-9b9a7fb14570|2|IMMGLC|Immunoglobulin Light Chains|HEMATOLOGY|[?]|pt_us|[?]|[?]|POSITIVE|1|mEq/uL|1|1|[?]|ABNORMAL|CELL PELLET|PARAFFIN-EMBEDDED||IMMUNOBLOT|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-11-12|2020-12-02|10|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|8aa77db3-b078-4073-a7f3-9b9a7fb14570|3|CSCELL|Cellular Casts|CHEMISTRY|[?]|kV|[?]|[?]|TRACE|1|RFU|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE||WHOLE GENOME SEQUENCING|FIBROSIS 4 FORMULA|Y||N||2|Visit_2|25|5|FOLLOW-UP|2020-11-27|2021-01-30|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|8aa77db3-b078-4073-a7f3-9b9a7fb14570|4|BASOLE|Basophils/Leukocytes|HEMATOLOGY|[?]|EID 50/dose|[?]|[?]|NEGATIVE|1|CYLINDER|1|1|[?]|LOW|REFLEX TEAR|AUTOLYZED||OBSERVATION|COCKCROFT-GAULT FORMULA||Y|Y||2|Visit_2|25|3|TREATMENT|2020-11-27|2020-12-26|25|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|LB|8aa77db3-b078-4073-a7f3-9b9a7fb14570|5|SEZCELY|Sezary Cells/Lymphocytes|HEMATOLOGY|[?]|10^3 CFU/g|[?]|[?]|BORDERLINE|1|DIOPTER|1|1|[?]|HIGH|URINE SEDIMENT|LACTESCENT||APPLANATION TONOMETRY|FIBROTEST FORMULA||Y|NA||3|Visit_3|40|4|FOLLOW-UP|2020-12-12|2021-01-27|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|8aa77db3-b078-4073-a7f3-9b9a7fb14570|6|ALP|Alkaline Phosphatase|CHEMISTRY|[?]|mm/min|[?]|[?]|INDETERMINATE|1|10^6/hpf|1|1|[?]|LOW|SKIN TISSUE|THAWED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|COCKCROFT-GAULT FORMULA|Y||N||3|Visit_3|40|2|TREATMENT|2020-12-12|2021-01-07|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|8aa77db3-b078-4073-a7f3-9b9a7fb14570|7|EOS|Eosinophils|HEMATOLOGY|[?]|10^9 organisms/mg|[?]|[?]|NEGATIVE|1|mL/cm3/min|1|1|[?]|ABNORMAL|NAIL|DRIED|N|DYNAMOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2021-01-06|2021-01-29|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|8aa77db3-b078-4073-a7f3-9b9a7fb14570|8|BTLBTL|Butalbital|URINALYSIS|[?]|mg/L FEU|[?]|[?]|BORDERLINE|1|mg/dL|1|1|[?]|ABNORMAL|STOOL|GELLED|N|FLOCCULATION|GMI MMOL/MOL FORMULA||Y|Y||4|Visit_4|65|1|SCREENING|2021-01-06|2021-02-02|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|8aa77db3-b078-4073-a7f3-9b9a7fb14570|9|COCAAOM|Cocaine and/or Metabolites|HEMATOLOGY|[?]|amu|[?]|[?]|INVALID|1|mL/sec/1.73m2|1|1|[?]|HIGH|PLATELET|AGGLUTINATED||TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD FORMULA|Y||Y||5|Visit_5|90|3|TREATMENT|2021-01-31|2021-02-03|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|8aa77db3-b078-4073-a7f3-9b9a7fb14570|10|CSFIGIDX|CSF IgG Index|CHEMISTRY|[?]|GBq/ug|[?]|[?]|BORDERLINE|1|ng/L|1|1|[?]|HIGH|TUMOR TISSUE|AGGLUTINATED||WRIGHT-GIEMSA STAIN|CKD-EPI CYSTATIN C FORMULA|Y|Y|U||5|Visit_5|90|1|SCREENING|2021-01-31|2021-02-02|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|1fce031b-680b-414f-9b74-d6383e10091d|1|CKBBCK|Creatine Kinase BB/Total Creatine Kinase|HEMATOLOGY|[?]|mmHg/sec|[?]|[?]|BORDERLINE|1|/sec|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|CALCIFIED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD FORMULA||Y|N||1|Visit_1|10|3|FOLLOW-UP|2020-05-31|2020-06-06|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|1fce031b-680b-414f-9b74-d6383e10091d|2|C165880|D. pteronyssinus IgE AB RAST Score|URINALYSIS|[?]|cg|[?]|[?]|INDETERMINATE|1|kat|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|AGGLUTINATED||SLOAN LETTER EYE CHART 1.25%|CKD-EPI CYSTATIN C FORMULA|Y||N||1|Visit_1|10|6|SCREENING|2020-05-31|2020-08-03|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|1fce031b-680b-414f-9b74-d6383e10091d|3|C4|Complement C4|CHEMISTRY|[?]|mmol/min/kPa/L|[?]|[?]|BORDERLINE|1|umol/mg/min|1|1|[?]|NORMAL|SERUM|LACTESCENT|N|MRI|CKD-EPI CREATININE FORMULA|||U||2|Visit_2|25|6|TREATMENT|2020-06-15|2020-08-21|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|1fce031b-680b-414f-9b74-d6383e10091d|4|OXALATE|Oxalate|URINALYSIS|||[?]|[?]|INVALID|1|cd/m2|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|LACTESCENT|N|HPLC/IEX|MDRD FORMULA|||U|Y|2|Visit_2|25|7|SCREENING|2020-06-15|2020-08-13|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|1fce031b-680b-414f-9b74-d6383e10091d|5|LY6E|Lymphocyte Antigen 6E|URINALYSIS|[?]|mCi/kg|[?]|[?]|TRACE|1|copies/ug|1|1|[?]|ABNORMAL|SPERMATOZOON|LIPEMIC||MICROBIAL CONCENTRATION|CKD-EPI CREATININE FORMULA|Y||N||3|Visit_3|40|5|TREATMENT|2020-06-30|2020-07-12|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|LB|1fce031b-680b-414f-9b74-d6383e10091d|6|IRONEXR|Iron Excretion Rate|HEMATOLOGY|[?]|/100 HPFs|[?]|[?]|NEGATIVE|1|10^10/L|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|AGGLUTINATED||AGAR PROPORTION|MDRD 6 VARIABLE FORMULA||Y|Y||3|Visit_3|40|2|SCREENING|2020-06-30|2020-08-25|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|LB|1fce031b-680b-414f-9b74-d6383e10091d|7|CANNAB|Cannabinoids|URINALYSIS|[?]|kHz|[?]|[?]|INDETERMINATE|1|RATIO|1|1|[?]|NORMAL|SEMEN|ROOM TEMPERATURE||VENTILATION PERFUSION LUNG SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||N||4|Visit_4|65|7|WASHOUT|2020-07-25|2020-08-22|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|LB|1fce031b-680b-414f-9b74-d6383e10091d|8|IFNA|Interferon Alpha|HEMATOLOGY|[?]|10^6/hpf|[?]|[?]|INDETERMINATE|1|umol/L/sec|1|1|[?]|NORMAL|ERYTHROCYTES|DRIED||FORCED OSCILLATION TECHNIQUE|HEPASCORE FORMULA|Y|Y|Y||4|Visit_4|65|3|TREATMENT|2020-07-25|2020-08-14|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|LB|1fce031b-680b-414f-9b74-d6383e10091d|9|PERCECE|Proliferating Erythroid/Total Cells|URINALYSIS|||[?]|[?]|TRACE|1|ohm|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|CALCIFIED||HANSEL STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|5|Visit_5|90|6|TREATMENT|2020-08-19|2020-08-21|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|1fce031b-680b-414f-9b74-d6383e10091d|10|FCTVIIIA|Factor VIII Activity|CHEMISTRY|||[?]|[?]|TRACE|1|CIGAR|1|1|[?]|ABNORMAL|BONE MARROW|SOLIDIFIED||FLUOROSCOPY|HEPASCORE FORMULA|Y||NA|Y|5|Visit_5|90|6|TREATMENT|2020-08-19|2020-08-24|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|dcc67696-e91a-4cef-81dd-f2d2711363ae|1|TNFSR2|Soluble TNF Receptor Type II|HEMATOLOGY|[?]|mU|[?]|[?]|POSITIVE|1|Enzyme U/L|1|1|[?]|LOW|LYMPH|FRESH||OBSERVATION|MDRD 6 VARIABLE FORMULA||Y|N||1|Visit_1|10|1|TREATMENT|2020-12-28|2021-02-13|10|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|dcc67696-e91a-4cef-81dd-f2d2711363ae|2|LRZPM|Lorazepam|HEMATOLOGY|[?]|PIXEL|[?]|[?]|NEGATIVE|1|KIT|1|1|[?]|NORMAL|PLEURAL TISSUE|NON-HEMOLYZED|N|INFRARED SPECTROMETRY|GMI MMOL/MOL FORMULA||Y|NA||1|Visit_1|10|1|SCREENING|2020-12-28|2021-01-23|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|dcc67696-e91a-4cef-81dd-f2d2711363ae|3|TGLOB|Thyroglobulin|URINALYSIS|[?]|Mile|[?]|[?]|NEGATIVE|1|mL/cage/wk|1|1|[?]|HIGH|PLATELET|UNEXPECTED ODOR||CLIP SEQUENCING|COCKCROFT-GAULT FORMULA|Y||NA||2|Visit_2|25|3|TREATMENT|2021-01-12|2021-03-21|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|LB|dcc67696-e91a-4cef-81dd-f2d2711363ae|4|NAGCREAT|N-Acetyl Glucosamide/Creatinine|HEMATOLOGY|[?]|Roentgen|[?]|[?]|POSITIVE|1|Farad|1|1|[?]|NORMAL|SPUTUM|THAWED||FLOW MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||2|Visit_2|25|6|WASHOUT|2021-01-12|2021-02-01|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|LB|dcc67696-e91a-4cef-81dd-f2d2711363ae|5|KLCFR|Kappa Light Chain, Free|CHEMISTRY|||[?]|[?]|TRACE|1|log10 CFU/g|1|1|[?]|LOW|STOOL|CONTAMINATED||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|ASH FIBROSURE FORMULA|||Y|Y|3|Visit_3|40|1|WASHOUT|2021-01-27|2021-02-04|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|dcc67696-e91a-4cef-81dd-f2d2711363ae|6|GATCPHRL|Gamma Tocopherol|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|/min|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED||POTENTIOMETRY|CKD-EPI CYSTATIN C FORMULA|||N|Y|3|Visit_3|40|1|FOLLOW-UP|2021-01-27|2021-03-07|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|dcc67696-e91a-4cef-81dd-f2d2711363ae|7|APOB|Apolipoprotein B|URINALYSIS|[?]|IU/kg/h|[?]|[?]|TRACE|1|s/h|1|1|[?]|LOW|CAPILLARY PLASMA|NON-HEMOLYZED||WHOLE EXOME SEQUENCING|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|4|TREATMENT|2021-02-21|2021-03-06|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|dcc67696-e91a-4cef-81dd-f2d2711363ae|8|CA125AG|Cancer Antigen 125|HEMATOLOGY|[?]|10^3 RNA copies/mL|[?]|[?]|INVALID|1|BE/mL|1|1|[?]|NORMAL|RETICULOCYTES|SOLIDIFIED||TRIPLE-PHASE SPIRAL CT SCAN|MDRD 6 VARIABLE FORMULA|Y||NA||4|Visit_4|65|3|TREATMENT|2021-02-21|2021-03-09|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|dcc67696-e91a-4cef-81dd-f2d2711363ae|9|G6PDRBRB|G6PD-Deficient Erythrocytes/Erythrocytes|HEMATOLOGY|[?]|OI50|[?]|[?]|TRACE|1|IU/mL|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|AGGLUTINATED||LAPAROSCOPY|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|5|WASHOUT|2021-03-18|2021-03-20|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|dcc67696-e91a-4cef-81dd-f2d2711363ae|10|HGBMET|Methemoglobin|URINALYSIS|[?]|pmol/10^9 cells|[?]|[?]|INVALID|1|BAR|1|1|[?]|NORMAL|DIALYSIS FLUID|FROZEN||CORONARY ANGIOGRAPHY|NASH FIBROSURE FORMULA|||Y||5|Visit_5|90|2|SCREENING|2021-03-18|2021-03-23|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|91e83d7a-186a-4fed-8750-af796d77d356|1|IOHEXCLR|Iohexol Clearance|CHEMISTRY|||[?]|[?]|POSITIVE|1|/mm2|1|1|[?]|HIGH|PLASMA|DRIED||LEAD CITRATE STAIN|CKD-EPI CYSTATIN C FORMULA|Y||Y|Y|1|Visit_1|10|6|FOLLOW-UP|2020-06-02|2020-06-20|10|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|91e83d7a-186a-4fed-8750-af796d77d356|2|PEPSNGI|Pepsinogen I|URINALYSIS|[?]|log10 TCID 50/uL|[?]|[?]|TRACE|1|PUFF|1|1|[?]|ABNORMAL|SPERMATOZOON|CLOTTED||CLINICAL EVALUATION|GMI % FORMULA||Y|U||1|Visit_1|10|6|FOLLOW-UP|2020-06-02|2020-08-01|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|91e83d7a-186a-4fed-8750-af796d77d356|3|ALBPROT|Albumin/Total Protein|CHEMISTRY|[?]|DPM|[?]|[?]|TRACE|1|dL|1|1|[?]|NORMAL|CORD SERUM|CALCIFIED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||NA||2|Visit_2|25|4|WASHOUT|2020-06-17|2020-08-30|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|91e83d7a-186a-4fed-8750-af796d77d356|4|OSM|Oncostatin M|HEMATOLOGY|[?]|mL/min|[?]|[?]|POSITIVE|1|MET*h|1|1|[?]|ABNORMAL|BUFFY COAT|LACTESCENT||INDIA INK STAIN|FIBROMETER FORMULA|Y|Y|NA||2|Visit_2|25|5|FOLLOW-UP|2020-06-17|2020-08-19|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|91e83d7a-186a-4fed-8750-af796d77d356|5|B2G1GMAB|Beta-2 Glycoprotein 1 IgM Antibody|URINALYSIS|[?]|dB|[?]|[?]|NEGATIVE|1|10^6 CFU/mL|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|THAWED||SIZE EXCLUSION CHROMATOGRAPHY|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|5|FOLLOW-UP|2020-07-02|2020-08-19|40|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|91e83d7a-186a-4fed-8750-af796d77d356|6|OXACREAT|Oxalate/Creatinine|HEMATOLOGY|[?]|pkat/L|[?]|[?]|INDETERMINATE|1|MBq|1|1|[?]|ABNORMAL|PROSTATIC FLUID|PARAFFIN-EMBEDDED||MIGET|COCKCROFT-GAULT FORMULA||Y|N||3|Visit_3|40|7|TREATMENT|2020-07-02|2020-07-08|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|91e83d7a-186a-4fed-8750-af796d77d356|7|SCKCERBC|Sickle Cells/Erythrocytes|HEMATOLOGY|[?]|DRINK|[?]|[?]|BORDERLINE|1|mEq/L|1|1|[?]|LOW|SEMEN|AGGLUTINATED|N|MODIFIED ACID FAST STAIN|CKD-EPI CREATININE FORMULA||Y|NA||4|Visit_4|65|1|WASHOUT|2020-07-27|2020-08-24|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-29
e|LB|91e83d7a-186a-4fed-8750-af796d77d356|8|CSEPI|Epithelial Casts|CHEMISTRY|[?]|CIGARETTE|[?]|[?]|TRACE|1|SBE/mL|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|FROZEN||TOTAL BODY RADIOGRAPHY|NASH FIBROSURE FORMULA|||Y||4|Visit_4|65|2|SCREENING|2020-07-27|2020-07-30|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-29
e|LB|91e83d7a-186a-4fed-8750-af796d77d356|9|ECCENTCY|Eccentrocytes|HEMATOLOGY|[?]|kHz|[?]|[?]|INVALID|1|mol/L|1|1|[?]|HIGH|DISCHARGE|AGGLUTINATED|N|MACRO BROTH DILUTION|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|2|WASHOUT|2020-08-21|2020-08-25|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-25
e|LB|91e83d7a-186a-4fed-8750-af796d77d356|10|RNP70AB|Ribonucleoprotein-70 Antibody|CHEMISTRY|[?]|DRINK|[?]|[?]|POSITIVE|1|DAgU/mL|1|1|[?]|LOW|NAIL|FROZEN||FLUORIMETRY|FIBROMETER FORMULA||Y|Y||5|Visit_5|90|5|TREATMENT|2020-08-21|2020-08-26|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-25
e|LB|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|1|ISOPRF2|F2-Isoprostane|CHEMISTRY|[?]|s^-1(%O2)^-1|[?]|[?]|POSITIVE|1|U/dL|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|NON-HEMOLYZED||COMPLEMENT FIXATION|MDRD 4 VARIABLE FORMULA|||NA||1|Visit_1|10|3|FOLLOW-UP|2020-05-13|2020-08-03|10|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|2|SCL70AB|Scl-70 Antibody|URINALYSIS|[?]|10^3 organisms/g|[?]|[?]|POSITIVE|1|copies/uL|1|1|[?]|HIGH|HAIR FOLLICLE|LIPEMIC||KINETIC CHROMOGENIC ASSAY|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|1|FOLLOW-UP|2020-05-13|2020-06-27|10|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|3|ESTFREST|Estradiol, Free/Estradiol|HEMATOLOGY|[?]|log10 PFU/mL|[?]|[?]|INDETERMINATE|1|fraction of 1|1|1|[?]|NORMAL|BLOOD|GELLED|N|POLYSOMNOGRAPHY|MDRD FORMULA||Y|N||2|Visit_2|25|6|FOLLOW-UP|2020-05-28|2020-07-30|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|LB|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|4|PLATEST|Platelets, Estimated|URINALYSIS|[?]|mg/dose|[?]|[?]|POSITIVE|1|PFU/animal|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|GELLED|N|DARK FIELD MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|6|TREATMENT|2020-05-28|2020-06-28|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|LB|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|5|PG|Prostaglandin|CHEMISTRY|[?]|WEEKS|[?]|[?]|NEGATIVE|1|uU/dL|1|1|[?]|HIGH|LYSATE|THAWED||MICROPARTICLE ENZYME IMMUNOASSAY|MDRD ENZYMATIC FORMULA|Y||NA||3|Visit_3|40|7|WASHOUT|2020-06-12|2020-06-23|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|6|PCO2|Partial Pressure Carbon Dioxide|URINALYSIS|||[?]|[?]|NEGATIVE|1|MONTHS|1|1|[?]|NORMAL|RETICULOCYTES|HEMOLYZED||OPTICAL DENSITY MEASUREMENT|CKD-EPI FORMULA|||NA|Y|3|Visit_3|40|4|TREATMENT|2020-06-12|2020-07-28|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|7|PROMYB|Promyeloblasts|CHEMISTRY|||[?]|[?]|INVALID|1|10^7 CFU|1|1|[?]|LOW|LEUKOCYTE|THAWED||POPULATION SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|4|Visit_4|65|4|SCREENING|2020-07-07|2020-08-05|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|LB|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|8|NONHDL|Non-HDL Cholesterol|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|kBq|1|1|[?]|NORMAL|EMOTIONAL TEAR|HEMOLYZED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA|||U|Y|4|Visit_4|65|7|TREATMENT|2020-07-07|2020-07-17|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|LB|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|9|CALPRO|Calprotectin|URINALYSIS|[?]|FFU|[?]|[?]|INDETERMINATE|1|mU/L|1|1|[?]|ABNORMAL|BLOOD|FRESH||THIN SMEAR|ASH FIBROSURE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-08-01|2020-08-06|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-06
e|LB|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|10|GST|Glutathione S-Transferase, Total|CHEMISTRY|[?]|ugEq/L|[?]|[?]|POSITIVE|1|/HPF|1|1|[?]|NORMAL|SPERMATOZOON|ROOM TEMPERATURE||MRI WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA|||NA||5|Visit_5|90|1|SCREENING|2020-08-01|2020-08-09|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-06
e|LB|0145dfac-a107-4368-b358-bcd136e1ecb3|1|HASIGEAB|Human Anti-Sheep IgE Antibody|HEMATOLOGY|||[?]|[?]|INVALID|1|oz eq|1|1|[?]|NORMAL|REFLEX TEAR|CALCIFIED||PHOTOGRAPHY|FIBROSIS 4 FORMULA|||N|Y|1|Visit_1|10|3|SCREENING|2021-01-08|2021-02-16|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|0145dfac-a107-4368-b358-bcd136e1ecb3|2|BLISTCE|Blister Cell|HEMATOLOGY|[?]|TRANSDUCING UNIT|[?]|[?]|INVALID|1|NEBULE|1|1|[?]|HIGH|PUS|HEMOLYZED||STATIC PERIMETRY|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2021-01-08|2021-01-28|10|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|LB|0145dfac-a107-4368-b358-bcd136e1ecb3|3|GRAN|Granulocytes|URINALYSIS|||[?]|[?]|POSITIVE|1|grain|1|1|[?]|LOW|TUMOR TISSUE|FROZEN||PLETHYSMOGRAPHY|ASH FIBROSURE FORMULA||Y|N|Y|2|Visit_2|25|2|TREATMENT|2021-01-23|2021-03-11|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|0145dfac-a107-4368-b358-bcd136e1ecb3|4|PEPSNG|Pepsinogen|URINALYSIS|[?]|uSiemens|[?]|[?]|POSITIVE|1|log10 CFU/g|1|1|[?]|HIGH|VENOUS PLASMA|FROZEN||ENZYMATIC COLORIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||2|Visit_2|25|7|TREATMENT|2021-01-23|2021-03-21|25|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|LB|0145dfac-a107-4368-b358-bcd136e1ecb3|5|PLAGMCVT|Platelet Aggregation Mean Curve Type|CHEMISTRY|[?]|PFU/mL|[?]|[?]|NEGATIVE|1|IU|1|1|[?]|NORMAL|SMEGMA|LACTESCENT||FLUORESCENT SPOT TEST|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|1|SCREENING|2021-02-07|2021-03-12|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|0145dfac-a107-4368-b358-bcd136e1ecb3|6|PROTCRT|Protein/Creatinine|CHEMISTRY|[?]|% INHIBITION|[?]|[?]|INDETERMINATE|1|U/dL|1|1|[?]|ABNORMAL|LAVAGE FLUID|PARAFFIN-EMBEDDED||THERMAL IONIZATION MASS SPECTROMETRY|HEPASCORE FORMULA|||Y||3|Visit_3|40|5|SCREENING|2021-02-07|2021-02-18|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|0145dfac-a107-4368-b358-bcd136e1ecb3|7|T3|Triiodothyronine|CHEMISTRY|[?]|log10 IU/mL|[?]|[?]|TRACE|1|10^7 CFU/mL|1|1|[?]|NORMAL|URINE SEDIMENT|HEMOLYZED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|GMI % FORMULA|||U||4|Visit_4|65|4|FOLLOW-UP|2021-03-04|2021-03-21|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|0145dfac-a107-4368-b358-bcd136e1ecb3|8|EPISQTCE|Squamous Transitional Epithelial Cells|CHEMISTRY|[?]|U/m2|[?]|[?]|TRACE|1|Gy/h|1|1|[?]|LOW|EPITHELIAL CELL|PARAFFIN-EMBEDDED|N|ICC|GMI % FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2021-03-04|2021-04-04|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|0145dfac-a107-4368-b358-bcd136e1ecb3|9|DGNWBC|Degenerated Leukocytes|CHEMISTRY|||[?]|[?]|TRACE|1|m2|1|1|[?]|ABNORMAL|URINE|UNEXPECTED ODOR||GRAM STAIN|MDRD 5 VARIABLE FORMULA|||Y|Y|5|Visit_5|90|7|TREATMENT|2021-03-29|2021-04-02|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|0145dfac-a107-4368-b358-bcd136e1ecb3|10|CCL21|Chemokine (C-C Motif) Ligand 21|URINALYSIS|[?]|Anson U|[?]|[?]|BORDERLINE|1|mg/kg/h|1|1|[?]|HIGH|REFLEX TEAR|THAWED||TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD ENZYMATIC FORMULA||Y|NA||5|Visit_5|90|3|TREATMENT|2021-03-29|2021-03-30|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|1|EOSNSQE|Eosinophils/Non-Squam Epi Cells|URINALYSIS|||[?]|[?]|INVALID|1|Ci/g|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|AGGLUTINATED||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI CREATININE FORMULA|||U|Y|1|Visit_1|10|5|FOLLOW-UP|2020-12-29|2021-02-17|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|2|BDNF|Brain-Derived Neurotrophic Factor|HEMATOLOGY|[?]|kg|[?]|[?]|POSITIVE|1|10^6 U|1|1|[?]|NORMAL|PERSPIRATION|CLOTTED||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|2|SCREENING|2020-12-29|2021-03-16|10|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|3|HLZPM|Halazepam|HEMATOLOGY|[?]|ukat|[?]|[?]|NEGATIVE|1|PACKET|1|1|[?]|NORMAL|ERYTHROCYTES|DRIED|N|CISH|MDRD 4 VARIABLE FORMULA|||N||2|Visit_2|25|3|TREATMENT|2021-01-13|2021-02-08|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|LB|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|4|MYBLAT1|Type I Myeloblasts|HEMATOLOGY|[?]|damol/L|[?]|[?]|NEGATIVE|1|anti-Xa IU|1|1|[?]|ABNORMAL|KERATINOCYTE|THAWED||SLOAN LETTER EYE CHART 1.25%|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||2|Visit_2|25|3|SCREENING|2021-01-13|2021-01-24|25|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|LB|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|5|C130068|Bermuda Grass Pollen IgE|CHEMISTRY|[?]|mL/cm|[?]|[?]|BORDERLINE|1|mg/m2/day|1|1|[?]|NORMAL|SMEGMA|CALCIFIED|N|SISH|ASH FIBROSURE FORMULA|Y||U||3|Visit_3|40|2|TREATMENT|2021-01-28|2021-02-23|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|LB|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|6|C165940|Boxelder Pollen IgE AB RAST Score|URINALYSIS|[?]|U/cL|[?]|[?]|TRACE|1|mol/day|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|AGGLUTINATED||LIQUID SCINTILLATION COUNTING|CKD-EPI FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2021-01-28|2021-02-25|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|LB|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|7|SPMMSPM|Motile Sperm/Total Sperm|CHEMISTRY|[?]|keV|[?]|[?]|TRACE|1|/mm2|1|1|[?]|HIGH|EPITHELIAL CELL|FROZEN||MEDIASTINOSCOPY|GMI % FORMULA|||NA||4|Visit_4|65|5|FOLLOW-UP|2021-02-22|2021-03-07|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|8|FSH|Follicle Stimulating Hormone|URINALYSIS|[?]|Absorbance U/min|[?]|[?]|NEGATIVE|1|ug/L FEU|1|1|[?]|ABNORMAL|MUCUS|CALCIFIED||PET/SPECT SCAN|CKD-EPI CYSTATIN C FORMULA|Y||Y||4|Visit_4|65|1|FOLLOW-UP|2021-02-22|2021-03-05|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|9|KLCLLCFR|Kappa Lt Chain,Free/Lambda Lt Chain,Free|HEMATOLOGY|[?]|Tesla|[?]|[?]|NEGATIVE|1|MBP|1|1|[?]|NORMAL|ARTERIAL BLOOD|SOLIDIFIED|N|ELECTROPHORESIS|HEPASCORE FORMULA|Y|Y|NA||5|Visit_5|90|5|WASHOUT|2021-03-19|2021-03-21|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|10|ANGPT1|Angiopoietin 1|HEMATOLOGY|[?]|umol/dL|[?]|[?]|POSITIVE|1|log EID 50/dose|1|1|[?]|LOW|BONE|DRIED||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|CKD-EPI CYSTATIN C FORMULA|||U||5|Visit_5|90|5|WASHOUT|2021-03-19|2021-03-27|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|d4d79f6a-ba90-4503-934b-8a86286d83d3|1|PTHI|Parathyroid Hormone, Intact|CHEMISTRY|[?]|IU|[?]|[?]|INDETERMINATE|1|oz eq|1|1|[?]|ABNORMAL|VENOUS BLOOD|SOLIDIFIED|N|ACCELERATOR MASS SPECTROMETRY|ASH FIBROSURE FORMULA|Y||N||1|Visit_1|10|7|TREATMENT|2020-11-17|2020-12-04|10|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|d4d79f6a-ba90-4503-934b-8a86286d83d3|2|APOH|Apolipoprotein H|URINALYSIS|[?]|Newton|[?]|[?]|BORDERLINE|1|BOWL|1|1|[?]|NORMAL|GASTRIC CONTENTS|DRIED|N|X-RAY FLUORESCENCE SPECTROMETRY|GMI % FORMULA|Y||U||1|Visit_1|10|6|TREATMENT|2020-11-17|2021-01-27|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|d4d79f6a-ba90-4503-934b-8a86286d83d3|3|PKM|Pyruvate Kinase Muscle Isozyme|CHEMISTRY|[?]|mL/m2|[?]|[?]|INDETERMINATE|1|Farad|1|1|[?]|NORMAL|FLUID|REFRIGERATED|N|DIGITAL PCR ARRAY|FIBROSIS 4 FORMULA|Y|Y|Y||2|Visit_2|25|1|WASHOUT|2020-12-02|2020-12-12|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|d4d79f6a-ba90-4503-934b-8a86286d83d3|4|FACTVIIA|Factor VII Activity|HEMATOLOGY|[?]|cg|[?]|[?]|BORDERLINE|1|Tbsp|1|1|[?]|NORMAL|ADIPOSE TISSUE|SOLIDIFIED||NUCLEIC ACID BASED METHOD|CKD-EPI FORMULA|Y||NA||2|Visit_2|25|4|SCREENING|2020-12-02|2020-12-03|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|LB|d4d79f6a-ba90-4503-934b-8a86286d83d3|5|LTD4|Leukotriene D4|CHEMISTRY|[?]|10^6 CFU|[?]|[?]|POSITIVE|1|pt_us|1|1|[?]|LOW|TUMOR TISSUE|REFRIGERATED|N|MICROBIAL CULTURE|MDRD ENZYMATIC JAPANESE FORMULA|||N||3|Visit_3|40|3|FOLLOW-UP|2020-12-17|2021-01-03|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|d4d79f6a-ba90-4503-934b-8a86286d83d3|6|SOST|Sclerostin|CHEMISTRY|||[?]|[?]|POSITIVE|1|g/g|1|1|[?]|NORMAL|VENOUS PLASMA|THAWED||WESTERN BLOT|NASH FIBROSURE FORMULA|||U|Y|3|Visit_3|40|6|TREATMENT|2020-12-17|2021-01-07|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|d4d79f6a-ba90-4503-934b-8a86286d83d3|7|LYMA|Lymphocytes Activated|URINALYSIS|[?]|cy/cm|[?]|[?]|INDETERMINATE|1|VOXEL|1|1|[?]|NORMAL|SPERMATOZOON|CONTAMINATED||INTRAVASCULAR ULTRASOUND|MDRD 4 VARIABLE FORMULA|Y||NA||4|Visit_4|65|2|FOLLOW-UP|2021-01-11|2021-01-23|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|d4d79f6a-ba90-4503-934b-8a86286d83d3|8|HDL|HDL Cholesterol|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mOsm|1|1|[?]|ABNORMAL|URINE SEDIMENT|AUTOLYZED||MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|NASH FIBROSURE FORMULA|||NA|Y|4|Visit_4|65|4|TREATMENT|2021-01-11|2021-02-07|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|d4d79f6a-ba90-4503-934b-8a86286d83d3|9|COCAETH|Cocaethylene|HEMATOLOGY|[?]|mL/g/min|[?]|[?]|POSITIVE|1|DPM|1|1|[?]|NORMAL|LYMPH|FROZEN|N|ICP-MS|MDRD 4 VARIABLE FORMULA||Y|Y||5|Visit_5|90|6|SCREENING|2021-02-05|2021-02-11|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|d4d79f6a-ba90-4503-934b-8a86286d83d3|10|SJSA52AB|Sjogrens SS-A52 Antibody|HEMATOLOGY|[?]|/200 HPFs|[?]|[?]|BORDERLINE|1|mg/kg/week|1|1|[?]|ABNORMAL|BUFFY COAT|REFRIGERATED|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD FORMULA||Y|Y||5|Visit_5|90|4|WASHOUT|2021-02-05|2021-02-12|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|a329c350-49e2-415d-ba3c-e1ee929aec86|1|PLTMORPH|Platelet Morphology|URINALYSIS|||[?]|[?]|POSITIVE|1|mm/h|1|1|[?]|LOW|ABSCESS FLUID|NON-HEMOLYZED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|1|Visit_1|10|6|SCREENING|2020-08-15|2020-09-28|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|a329c350-49e2-415d-ba3c-e1ee929aec86|2|AAMAPAC|Alpha-Aminoadipic Acid|HEMATOLOGY|[?]|10^3/L|[?]|[?]|POSITIVE|1|U/g|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|THAWED|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD 5 VARIABLE FORMULA||Y|U||1|Visit_1|10|6|TREATMENT|2020-08-15|2020-11-12|10|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|a329c350-49e2-415d-ba3c-e1ee929aec86|3|METHAMPH|Methamphetamine|URINALYSIS|[?]|mL/min|[?]|[?]|BORDERLINE|1|10^3 copies/mL|1|1|[?]|ABNORMAL|LOCHIA|AGGLUTINATED||ELISA|MDRD 4 VARIABLE FORMULA||Y|Y||2|Visit_2|25|3|FOLLOW-UP|2020-08-30|2020-09-18|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|a329c350-49e2-415d-ba3c-e1ee929aec86|4|CYLEUC|Leucine Crystals|HEMATOLOGY|[?]|IU|[?]|[?]|POSITIVE|1|Mile|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|LIPEMIC||IMMUNOBLOT|GMI MMOL/MOL FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-08-30|2020-10-08|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|a329c350-49e2-415d-ba3c-e1ee929aec86|5|PSIGMAB|Phosphatidylserine IgM Antibody|CHEMISTRY|[?]|10^11/L|[?]|[?]|INDETERMINATE|1|HOMEOPATHIC DILUTION|1|1|[?]|NORMAL|ADIPOSE TISSUE|CONCENTRATED||EPSILOMETER|ASH FIBROSURE FORMULA|Y|Y|NA||3|Visit_3|40|4|WASHOUT|2020-09-14|2020-10-27|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|a329c350-49e2-415d-ba3c-e1ee929aec86|6|C130072|Birch Pollen IgE|URINALYSIS|[?]|ng/dL|[?]|[?]|POSITIVE|1|log10 CCID 50/dose|1|1|[?]|HIGH|EPITHELIAL CELL|CALCIFIED||MULTIPLE BREATH WASHOUT|MDRD 4 VARIABLE FORMULA|||U||3|Visit_3|40|5|WASHOUT|2020-09-14|2020-10-17|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|a329c350-49e2-415d-ba3c-e1ee929aec86|7|GDF11|Growth Differentiation Factor 11|CHEMISTRY|[?]|10^6 organisms/mL|[?]|[?]|NEGATIVE|1|pptr|1|1|[?]|NORMAL|MUSCLE TISSUE|DRIED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|COCKCROFT-GAULT FORMULA|Y|Y|NA||4|Visit_4|65|5|FOLLOW-UP|2020-10-09|2020-11-10|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|a329c350-49e2-415d-ba3c-e1ee929aec86|8|BETACRTN|Beta Carotene|URINALYSIS|[?]|U/g/h|[?]|[?]|POSITIVE|1|mmol/min/kPa|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|ROOM TEMPERATURE||VENTILATION PERFUSION LUNG SCAN|FIBROMETER FORMULA|||N||4|Visit_4|65|1|SCREENING|2020-10-09|2020-11-10|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|a329c350-49e2-415d-ba3c-e1ee929aec86|9|GLUTAM|Glutamate|HEMATOLOGY|[?]|10^6 organisms/g|[?]|[?]|INDETERMINATE|1|mol/day|1|1|[?]|LOW|PLEURAL FLUID|THAWED||CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|2|FOLLOW-UP|2020-11-03|2020-11-10|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|a329c350-49e2-415d-ba3c-e1ee929aec86|10|KLCLLC|Kappa Light Chain/Lambda Light Chain|HEMATOLOGY|[?]|umol|[?]|[?]|POSITIVE|1|cmol|1|1|[?]|NORMAL|DIALYSIS FLUID|CLOTTED|N|BAC ACGH|FIBROTEST FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-11-03|2020-11-05|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|ff0e3543-c1f3-47f8-987f-7b00a4a33704|1|INTLK28|Interleukin 28|URINALYSIS|[?]|nm|[?]|[?]|BORDERLINE|1|mEq/L|1|1|[?]|HIGH|SWABBED MATERIAL|NON-HEMOLYZED||IMMUNOFIXATION ELECTROPHORESIS|CKD-EPI FORMULA||Y|N||1|Visit_1|10|7|SCREENING|2020-10-01|2020-12-09|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|ff0e3543-c1f3-47f8-987f-7b00a4a33704|2|C165879|D. farinae IgE AB RAST Score|URINALYSIS|||[?]|[?]|INDETERMINATE|1|pmol/dL|1|1|[?]|HIGH|EPIDERMAL TISSUE|GELLED||SPIRAL CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|1|Visit_1|10|1|WASHOUT|2020-10-01|2020-11-30|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|ff0e3543-c1f3-47f8-987f-7b00a4a33704|3|ATHPIDX|Atherogenic Index of Plasma|CHEMISTRY|[?]|WEEKS|[?]|[?]|INDETERMINATE|1|QUANTITY SUFFICIENT|1|1|[?]|HIGH|PLATELET POOR PLASMA|HEMOLYZED||PHOTOGRAPHY|GMI % FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-10-16|2020-12-05|25|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|ff0e3543-c1f3-47f8-987f-7b00a4a33704|4|PHE|Phenylalanine|HEMATOLOGY|[?]|YEARS|[?]|[?]|TRACE|1|um|1|1|[?]|LOW|TISSUE|CLOTTED||INDIRECT IMMUNOFLUORESCENCE|FIBROTEST FORMULA|||Y||2|Visit_2|25|5|WASHOUT|2020-10-16|2020-12-05|25|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|ff0e3543-c1f3-47f8-987f-7b00a4a33704|5|HVA|Homovanillic Acid|CHEMISTRY|[?]|TUBE|[?]|[?]|TRACE|1|ohm|1|1|[?]|LOW|SPERMATOZOON|CALCIFIED||ANGIOGRAPHY|MDRD FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-10-31|2020-12-14|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|ff0e3543-c1f3-47f8-987f-7b00a4a33704|6|ANDSTNDN|Androstenedione|CHEMISTRY|[?]|ug/day|[?]|[?]|INDETERMINATE|1|umol/dL|1|1|[?]|NORMAL|PLATELET POOR PLASMA|CALCIFIED||CRYOSCOPY|MDRD 5 VARIABLE FORMULA||Y|N||3|Visit_3|40|4|FOLLOW-UP|2020-10-31|2020-11-10|40|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|ff0e3543-c1f3-47f8-987f-7b00a4a33704|7|CCL19|Chemokine (C-C Motif) Ligand 19|HEMATOLOGY|||[?]|[?]|TRACE|1|PATCH|1|1|[?]|ABNORMAL|BILE|CLOTTED||LC-FL|GMI MMOL/MOL FORMULA|||Y|Y|4|Visit_4|65|7|TREATMENT|2020-11-25|2020-12-08|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|ff0e3543-c1f3-47f8-987f-7b00a4a33704|8|VLDLTCT|VLDL Triglyceride + Chylomicron Triglyceride|CHEMISTRY|[?]|mL/animal/day|[?]|[?]|INVALID|1|MHz|1|1|[?]|ABNORMAL|BUFFY COAT|DRIED|N|WEBER GREEN STAIN|MDRD ENZYMATIC FORMULA|Y||U||4|Visit_4|65|4|SCREENING|2020-11-25|2020-12-09|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|ff0e3543-c1f3-47f8-987f-7b00a4a33704|9|PBG|Porphobilinogen|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|/day|1|1|[?]|HIGH|MUCUS|ICTERIC||MULTI-SLICE SPIRAL CT|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|5|Visit_5|90|3|FOLLOW-UP|2020-12-20|2020-12-25|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|LB|ff0e3543-c1f3-47f8-987f-7b00a4a33704|10|VIP|Vasoactive Intestinal Polypeptide|HEMATOLOGY|[?]|dmol|[?]|[?]|NEGATIVE|1|mEq/mL|1|1|[?]|HIGH|BLOOD|CONCENTRATED||COMPUTERIZED CORNEAL TOPOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||5|Visit_5|90|2|FOLLOW-UP|2020-12-20|2020-12-27|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|LB|128153ce-7bee-4f8d-bb60-fb1776370b6d|1|ALPBS|Bone Specific Alkaline Phosphatase|CHEMISTRY|[?]|SFC/10^6 PBMC|[?]|[?]|POSITIVE|1|BOLUS|1|1|[?]|HIGH|ALVEOLAR AIR|AGGLUTINATED||TWO-COLOR MICROARRAY|GMI MMOL/MOL FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2021-01-11|2021-01-19|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|LB|128153ce-7bee-4f8d-bb60-fb1776370b6d|2|CBANH9|Carbonic Anhydrase 9|CHEMISTRY|||[?]|[?]|INVALID|1|U/m2/min|1|1|[?]|NORMAL|SWABBED MATERIAL|HEMOLYZED|N|COMPUTERIZED CORNEAL TOPOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|1|Visit_1|10|1|TREATMENT|2021-01-11|2021-01-24|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|LB|128153ce-7bee-4f8d-bb60-fb1776370b6d|3|NHMCELE|Nonhematic Cells/Leukocytes|CHEMISTRY|[?]|mL*cmH2O|[?]|[?]|INVALID|1|titer|1|1|[?]|LOW|ARTERIAL CORD BLOOD|UNEXPECTED ODOR||IMMUNOFIXATION ELECTROPHORESIS|FIBROTEST FORMULA|||N||2|Visit_2|25|2|TREATMENT|2021-01-26|2021-02-05|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|128153ce-7bee-4f8d-bb60-fb1776370b6d|4|CALB|Calbindin|HEMATOLOGY|[?]|mEq|[?]|[?]|INDETERMINATE|1|10^9 organisms|1|1|[?]|NORMAL|CELL PELLET|AGGLUTINATED|N|PLETHYSMOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|N||2|Visit_2|25|4|SCREENING|2021-01-26|2021-03-08|25|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|128153ce-7bee-4f8d-bb60-fb1776370b6d|5|GNRH|Gonadotropin Releasing Hormone|HEMATOLOGY|[?]|/40 HPFs|[?]|[?]|TRACE|1|fraction of 1|1|1|[?]|NORMAL|TUMOR TISSUE|THAWED||TARGETED GENOME SEQUENCING|MDRD 5 VARIABLE FORMULA|||N||3|Visit_3|40|2|SCREENING|2021-02-10|2021-04-07|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|128153ce-7bee-4f8d-bb60-fb1776370b6d|6|HYDMDZ4|4-Hydroxymidazolam|CHEMISTRY|[?]|vp/dose|[?]|[?]|TRACE|1|U/g|1|1|[?]|NORMAL|STOOL|GELLED||GC/MS-CI|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||3|Visit_3|40|7|TREATMENT|2021-02-10|2021-03-30|40|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|128153ce-7bee-4f8d-bb60-fb1776370b6d|7|C165892|Wild Rye Pollen IgE Antibody|URINALYSIS|[?]|APPLICATION|[?]|[?]|NEGATIVE|1|%(w/w)|1|1|[?]|LOW|SEMINAL FLUID|ICTERIC||CHROMOGENIC ASSAY|MDRD 4 VARIABLE FORMULA|Y|Y|U||4|Visit_4|65|2|TREATMENT|2021-03-07|2021-03-10|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|LB|128153ce-7bee-4f8d-bb60-fb1776370b6d|8|ALPCREAT|Alkaline Phosphatase/Creatinine|URINALYSIS|[?]|v/v|[?]|[?]|POSITIVE|1|titer|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|HEMOLYZED|N|MAMMOGRAPHY|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|5|SCREENING|2021-03-07|2021-03-24|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|LB|128153ce-7bee-4f8d-bb60-fb1776370b6d|9|EOSPSDLE|Pseudo-Eosinophils/Leukocytes|CHEMISTRY|[?]|ug/kg/min|[?]|[?]|POSITIVE|1|/10^5|1|1|[?]|NORMAL|PUS|UNEXPECTED ODOR||LINE PROBE ASSAY|MDRD FORMULA|||U||5|Visit_5|90|7|WASHOUT|2021-04-01|2021-04-08|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|128153ce-7bee-4f8d-bb60-fb1776370b6d|10|GLOBA2PT|Alpha-2 Globulin/Total Protein|CHEMISTRY|||[?]|[?]|NEGATIVE|1|fg|1|1|[?]|HIGH|INTERSTITIAL FLUID|UNEXPECTED ODOR|N|SPIROMETRY|NASH FIBROSURE FORMULA|||U|Y|5|Visit_5|90|1|TREATMENT|2021-04-01|2021-04-06|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|22ee2f20-4a66-458f-a153-9d7e871e1db2|1|CLCLR|Chloride Clearance|HEMATOLOGY|[?]|ft2|[?]|[?]|INDETERMINATE|1|uEq/L|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|CALCIFIED||IMPULSE OSCILLOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||U||1|Visit_1|10|2|TREATMENT|2020-06-17|2020-09-09|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|22ee2f20-4a66-458f-a153-9d7e871e1db2|2|HPOCROM|Hypochromia|URINALYSIS|||[?]|[?]|BORDERLINE|1|cd|1|1|[?]|ABNORMAL|EMESIS|UNEXPECTED ODOR|N|ELECTRONEUROGRAPHY|MDRD ENZYMATIC FORMULA|||N|Y|1|Visit_1|10|7|TREATMENT|2020-06-17|2020-06-30|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|22ee2f20-4a66-458f-a153-9d7e871e1db2|3|HBCOHGB|Carboxyhemoglobin/Total Hemoglobin|HEMATOLOGY|[?]|cy/cm|[?]|[?]|INDETERMINATE|1|/40 HPFs|1|1|[?]|HIGH|CORD BLOOD|ROOM TEMPERATURE||DOUBLE IMMUNODIFFUSION|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-07-02|2020-08-27|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|22ee2f20-4a66-458f-a153-9d7e871e1db2|4|C130107|Weed Mix Pollen Antigen IgG Antibody|URINALYSIS|[?]|USP U|[?]|[?]|BORDERLINE|1|U/g/day|1|1|[?]|NORMAL|GASTRIC FLUID|AGGLUTINATED||GRAM STAIN|MDRD 6 VARIABLE FORMULA|||N||2|Visit_2|25|3|WASHOUT|2020-07-02|2020-09-01|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|22ee2f20-4a66-458f-a153-9d7e871e1db2|5|BLASTNCE|Blasts/Nucleated Cells|HEMATOLOGY|[?]|10^8/L|[?]|[?]|NEGATIVE|1|10^9 organisms|1|1|[?]|ABNORMAL|CALCULUS|FRESH||NEXT GENERATION SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|2|SCREENING|2020-07-17|2020-07-31|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|22ee2f20-4a66-458f-a153-9d7e871e1db2|6|VLDLT|VLDL Triglyceride|CHEMISTRY|[?]|atm|[?]|[?]|INDETERMINATE|1|ft3|1|1|[?]|HIGH|SERUM OR PLASMA|LIPEMIC|N|MACRO BROTH DILUTION|CKD-EPI FORMULA|||NA||3|Visit_3|40|2|FOLLOW-UP|2020-07-17|2020-07-22|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|22ee2f20-4a66-458f-a153-9d7e871e1db2|7|MYPCERPC|Myeloid/Erythroid Ratio|CHEMISTRY|[?]|DNA copies/mL|[?]|[?]|POSITIVE|1|mm/h|1|1|[?]|ABNORMAL|SPUTUM|REFRIGERATED||PULMONARY ANGIOGRAPHY|GMI % FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-08-11|2020-08-18|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|22ee2f20-4a66-458f-a153-9d7e871e1db2|8|CSBROAD|Broad Casts|HEMATOLOGY|[?]|FINGERTIP UNIT|[?]|[?]|BORDERLINE|1|PIXEL|1|1|[?]|LOW|ADIPOSE TISSUE|HEMOLYZED||ZIEHL NEELSEN ACID FAST STAIN|MDRD FORMULA||Y|U||4|Visit_4|65|1|TREATMENT|2020-08-11|2020-09-14|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|22ee2f20-4a66-458f-a153-9d7e871e1db2|9|ASTALT|AST/ALT|URINALYSIS|[?]|mMU/mL|[?]|[?]|INDETERMINATE|1|10^6 RNA copies/mL|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|CONCENTRATED||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI FORMULA||Y|Y||5|Visit_5|90|5|SCREENING|2020-09-05|2020-09-12|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|22ee2f20-4a66-458f-a153-9d7e871e1db2|10|FEP|Erythrocyte Protoporphyrin, Free|URINALYSIS|||[?]|[?]|TRACE|1|L/h|1|1|[?]|ABNORMAL|PLEURAL FLUID|AUTOLYZED|N|TOTAL BODY RADIOGRAPHY|FIBROSIS 4 FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2020-09-05|2020-09-07|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|b7caaa04-bcc7-4350-ad98-85670a19778f|1|ELA2PMN|Neutrophil Elastase, Polymorphonuclear|CHEMISTRY|[?]|mol/g|[?]|[?]|NEGATIVE|1|Bq/L|1|1|[?]|NORMAL|MENSTRUAL BLOOD|DRIED||LIGHT MICROSCOPY|MDRD 4 VARIABLE FORMULA|Y||U||1|Visit_1|10|7|FOLLOW-UP|2020-07-06|2020-07-14|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|b7caaa04-bcc7-4350-ad98-85670a19778f|2|VTD2D3IT|25-Hydroxyvit D2 + 25-Hydroxyvit D3|CHEMISTRY|[?]|keV|[?]|[?]|TRACE|1|ng/mol|1|1|[?]|NORMAL|EPITHELIAL CELL|DRIED||SEQUENCING|MDRD FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-07-06|2020-08-12|10|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|b7caaa04-bcc7-4350-ad98-85670a19778f|3|MICA|MHC Class I Chain Related Protein A|CHEMISTRY|[?]|Enzyme U/L|[?]|[?]|INVALID|1|mL/animal/day|1|1|[?]|LOW|MUSCLE TISSUE|UNEXPECTED ODOR||MAGNETIC RESONANCE ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|Y||U||2|Visit_2|25|2|TREATMENT|2020-07-21|2020-09-24|25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|b7caaa04-bcc7-4350-ad98-85670a19778f|4|ESTRDIOL|Estradiol|HEMATOLOGY|[?]|CIGAR|[?]|[?]|POSITIVE|1|dpm/0.5 mL|1|1|[?]|LOW|ADIPOSE TISSUE|REFRIGERATED||FORCED OSCILLATION TECHNIQUE|MDRD ENZYMATIC JAPANESE FORMULA|||Y||2|Visit_2|25|7|WASHOUT|2020-07-21|2020-07-28|25|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|b7caaa04-bcc7-4350-ad98-85670a19778f|5|IGHG4|Immunoglobulin Heavy Constant Gamma 4|URINALYSIS|[?]|mol/g|[?]|[?]|BORDERLINE|1|Sv|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE|N|GC/FID|FIBROMETER FORMULA|Y||NA||3|Visit_3|40|6|SCREENING|2020-08-05|2020-08-31|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|b7caaa04-bcc7-4350-ad98-85670a19778f|6|LDH4|LDH Isoenzyme 4|HEMATOLOGY|[?]|gtt|[?]|[?]|INVALID|1|PIXELS/cm|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|CALCIFIED||TARGETED TRANSCRIPTOME SEQUENCING|MDRD 5 VARIABLE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-08-05|2020-09-20|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|b7caaa04-bcc7-4350-ad98-85670a19778f|7|C130116|Bee Mix Antigen IgE Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|dpm/0.5 mL|1|1|[?]|HIGH|VITREOUS HUMOR|LIPEMIC|N|SINGLE-MOLECULE ARRAY|MDRD FORMULA||Y|NA|Y|4|Visit_4|65|6|WASHOUT|2020-08-30|2020-09-11|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|b7caaa04-bcc7-4350-ad98-85670a19778f|8|PLSIMCCE|Immature Plasma Cells/Total Cells|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|F|1|1|[?]|LOW|MONOCYTE|CALCIFIED||APPLANATION TONOMETRY|ASH FIBROSURE FORMULA|||Y|Y|4|Visit_4|65|3|WASHOUT|2020-08-30|2020-09-26|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|b7caaa04-bcc7-4350-ad98-85670a19778f|9|RPTLTIME|Reptilase Time|URINALYSIS|[?]|pmol/g|[?]|[?]|INVALID|1|g/animal|1|1|[?]|LOW|AMNIOTIC FLUID|REFRIGERATED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|6|TREATMENT|2020-09-24|2020-09-29|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|b7caaa04-bcc7-4350-ad98-85670a19778f|10|C165890|Timothy Grass Pollen IgE AB RAST Score|CHEMISTRY|[?]|ug/kg|[?]|[?]|TRACE|1|lx|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|GELLED||AUTOMATED COUNT|MDRD 4 VARIABLE FORMULA|||U||5|Visit_5|90|5|SCREENING|2020-09-24|2020-10-03|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|2b58d5fd-3ec8-415b-bb53-a252049f228a|1|MIP1G|Macrophage Inflammatory Protein 1 Gamma|CHEMISTRY|[?]|Ci|[?]|[?]|NEGATIVE|1|PFU|1|1|[?]|ABNORMAL|VENOUS PLASMA|NON-HEMOLYZED||EPSILOMETER|MDRD 4 VARIABLE FORMULA|||Y||1|Visit_1|10|2|WASHOUT|2020-12-17|2021-02-22|10|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|2b58d5fd-3ec8-415b-bb53-a252049f228a|2|TAP1|Peptide Transporter TAP1|HEMATOLOGY|[?]|CAPSULE|[?]|[?]|INVALID|1|kPa/L/sec|1|1|[?]|ABNORMAL|PLEURAL TISSUE|SOLIDIFIED||SPIRAL CT|FIBROMETER FORMULA|Y||U||1|Visit_1|10|7|TREATMENT|2020-12-17|2021-02-08|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|2b58d5fd-3ec8-415b-bb53-a252049f228a|3|C5FR|Complement C5, Free|HEMATOLOGY|||[?]|[?]|POSITIVE|1|PIXEL|1|1|[?]|NORMAL|DIALYSIS FLUID|CONCENTRATED||IODINE STAIN|MDRD 6 VARIABLE FORMULA||Y|Y|Y|2|Visit_2|25|4|SCREENING|2021-01-01|2021-02-01|25|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|2b58d5fd-3ec8-415b-bb53-a252049f228a|4|NUCCE|Nucleated Cells|HEMATOLOGY|[?]|dyn|[?]|[?]|INVALID|1|mL/m2|1|1|[?]|LOW|BLOOD|THAWED|N|TONOMETRY|NASH FIBROSURE FORMULA|Y||U||2|Visit_2|25|5|TREATMENT|2021-01-01|2021-01-14|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|2b58d5fd-3ec8-415b-bb53-a252049f228a|5|CD56|CD56|URINALYSIS|[?]|mJoule/cm2|[?]|[?]|INVALID|1|log10 TCID 50/mL|1|1|[?]|HIGH|CAPILLARY BLOOD|CLOTTED||CHROMOGENIC ASSAY|MDRD 6 VARIABLE FORMULA|Y||N||3|Visit_3|40|4|SCREENING|2021-01-16|2021-01-31|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|2b58d5fd-3ec8-415b-bb53-a252049f228a|6|PGD2S|Prostaglandin D2 Synthase|CHEMISTRY|[?]|log10 TCID 50/mL|[?]|[?]|INVALID|1|dyn|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|AUTOLYZED|N|NUCLEIC ACID SEQUENCING|MDRD 4 VARIABLE FORMULA|||U||3|Visit_3|40|2|TREATMENT|2021-01-16|2021-02-05|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|2b58d5fd-3ec8-415b-bb53-a252049f228a|7|MDMA|3,4-methylenedioxymethamphetamine|HEMATOLOGY|[?]|10^3 organisms|[?]|[?]|POSITIVE|1|BP|1|1|[?]|HIGH|CORD SERUM|CALCIFIED||MODIFIED ACID FAST STAIN|FIBROTEST FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2021-02-10|2021-02-12|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|2b58d5fd-3ec8-415b-bb53-a252049f228a|8|C165917|D. pteronyssinus IgG AB RAST Score|HEMATOLOGY|[?]|s/h|[?]|[?]|BORDERLINE|1|mEq/mmol|1|1|[?]|LOW|PUS|AGGLUTINATED||DC SHEATH FLOW|CKD-EPI CREATININE FORMULA|Y|Y|NA||4|Visit_4|65|2|FOLLOW-UP|2021-02-10|2021-02-22|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|2b58d5fd-3ec8-415b-bb53-a252049f228a|9|UNSPCE|Unspecified Cells|CHEMISTRY|[?]|g/kg/day|[?]|[?]|INDETERMINATE|1|TRANSDUCING UNIT|1|1|[?]|HIGH|BONE MARROW|SOLIDIFIED||MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI CREATININE FORMULA|||N||5|Visit_5|90|3|TREATMENT|2021-03-07|2021-03-12|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|2b58d5fd-3ec8-415b-bb53-a252049f228a|10|ESTRIOLF|Estriol, Free|HEMATOLOGY|||[?]|[?]|POSITIVE|1|Roentgen|1|1|[?]|LOW|STOOL|CLOTTED||SXA SCAN|MDRD FORMULA|Y||Y|Y|5|Visit_5|90|5|SCREENING|2021-03-07|2021-03-14|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|60b23345-43f6-42eb-9225-5a674456c9b9|1|ELA1|Pancreatic Elastase 1|HEMATOLOGY|[?]|/month|[?]|[?]|BORDERLINE|1|mL/m2/day|1|1|[?]|LOW|EPIDERMAL TISSUE|LIPEMIC||PERIODIC ACID SCHIFF STAIN|MDRD 6 VARIABLE FORMULA|||N||1|Visit_1|10|3|TREATMENT|2021-01-15|2021-03-10|10|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|LB|60b23345-43f6-42eb-9225-5a674456c9b9|2|IGFBP7|Insulin-Like Growth Factor Binding Prot7|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ppth|1|1|[?]|ABNORMAL|CORD SERUM|LACTESCENT||MICRO BROTH DILUTION|CKD-EPI CYSTATIN C FORMULA|Y||Y|Y|1|Visit_1|10|2|TREATMENT|2021-01-15|2021-02-02|10|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|LB|60b23345-43f6-42eb-9225-5a674456c9b9|3|C130125|Cat Dander Antigen IgG Antibody|CHEMISTRY|[?]|Anson U|[?]|[?]|BORDERLINE|1|Tbsp|1|1|[?]|NORMAL|LEUKOCYTE|NON-HEMOLYZED|N|PERIPHERAL ANGIOGRAPHY|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|5|FOLLOW-UP|2021-01-30|2021-02-24|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|60b23345-43f6-42eb-9225-5a674456c9b9|4|BNP|Brain Natriuretic Peptide|HEMATOLOGY|||[?]|[?]|POSITIVE|1|pkat|1|1|[?]|NORMAL|ARTERIAL BLOOD|ICTERIC|N|INDIRECT IMMUNOFLUORESCENCE|FIBROTEST FORMULA|||NA|Y|2|Visit_2|25|2|TREATMENT|2021-01-30|2021-03-02|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|60b23345-43f6-42eb-9225-5a674456c9b9|5|HGBS|Hemoglobin S|CHEMISTRY|[?]|HOURS|[?]|[?]|INDETERMINATE|1|mL*cmH2O|1|1|[?]|HIGH|MUSCLE TISSUE|REFRIGERATED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||3|Visit_3|40|3|SCREENING|2021-02-14|2021-03-11|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|60b23345-43f6-42eb-9225-5a674456c9b9|6|GLOBA2|Alpha-2 Globulin|HEMATOLOGY|[?]|g/L|[?]|[?]|INVALID|1|SYRINGE|1|1|[?]|HIGH|CEREBROSPINAL FLUID|ICTERIC||TARGETED GENOME SEQUENCING|FIBROMETER FORMULA|Y||N||3|Visit_3|40|2|WASHOUT|2021-02-14|2021-03-17|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|60b23345-43f6-42eb-9225-5a674456c9b9|7|MPOAB|Myeloperoxidase Antibody|HEMATOLOGY|[?]|aMFI|[?]|[?]|INVALID|1|10^12/L|1|1|[?]|LOW|ALVEOLAR AIR|CONTAMINATED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|FIBROTEST FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2021-03-11|2021-03-27|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|60b23345-43f6-42eb-9225-5a674456c9b9|8|NPAP|Non-Prostatic Acid Phosphatase|CHEMISTRY|[?]|nL|[?]|[?]|NEGATIVE|1|pkat/L|1|1|[?]|HIGH|SKIN TISSUE|NON-HEMOLYZED||MICROBIAL BIOCHEMICAL IDENTIFICATION|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2021-03-11|2021-04-01|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|60b23345-43f6-42eb-9225-5a674456c9b9|9|C130141|German Cockroach Antigen IgA Antibody|CHEMISTRY|[?]|cmH2O*s/mL|[?]|[?]|NEGATIVE|1|Ci/mg|1|1|[?]|NORMAL|NAIL|REFRIGERATED||FLUORESCENT SPOT TEST|MDRD ENZYMATIC FORMULA|Y||U||5|Visit_5|90|6|WASHOUT|2021-04-05|2021-04-13|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|60b23345-43f6-42eb-9225-5a674456c9b9|10|APTTSTND|Activated PTT/Standard|URINALYSIS|[?]|mEq/kg|[?]|[?]|POSITIVE|1|Weber|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|CALCIFIED||PAP STAIN|CKD-EPI CYSTATIN C FORMULA|Y||N||5|Visit_5|90|2|WASHOUT|2021-04-05|2021-04-06|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|7979239e-2a6b-48e3-9d11-41c97b33d229|1|NKCE|Natural Killer Cells|CHEMISTRY|[?]|tsp|[?]|[?]|BORDERLINE|1|V/sec|1|1|[?]|HIGH|BILE|GELLED||HPLC-FL|CKD-EPI FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2021-01-15|2021-02-03|10|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|7979239e-2a6b-48e3-9d11-41c97b33d229|2|TXB2_D11|11-Dehydro-Thromboxane B2|URINALYSIS|||[?]|[?]|BORDERLINE|1|mEq/g|1|1|[?]|ABNORMAL|CELL PELLET|CALCIFIED|N|ELECTRONEUROGRAPHY|CKD-EPI FORMULA||Y|U|Y|1|Visit_1|10|4|TREATMENT|2021-01-15|2021-04-02|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|7979239e-2a6b-48e3-9d11-41c97b33d229|3|HASIGEAB|Human Anti-Sheep IgE Antibody|URINALYSIS|[?]|PRESSOR UNITS|[?]|[?]|INDETERMINATE|1|mL/cm|1|1|[?]|LOW|ARTERIAL CORD BLOOD|HEMOLYZED||PH METER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|7|WASHOUT|2021-01-30|2021-04-09|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|7979239e-2a6b-48e3-9d11-41c97b33d229|4|GAD2AB|Glutamic Acid Decarboxylase 2 Antibody|HEMATOLOGY|[?]|mg/mL/min|[?]|[?]|INVALID|1|10^6 organisms/mg|1|1|[?]|HIGH|GASTRIC CONTENTS|REFRIGERATED||FLUOROSCOPY|CKD-EPI FORMULA|Y|Y|NA||2|Visit_2|25|7|FOLLOW-UP|2021-01-30|2021-03-10|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|7979239e-2a6b-48e3-9d11-41c97b33d229|5|CRDIGGAB|Cardiolipin IgG Antibody|HEMATOLOGY|[?]|10^6 DNA copies/mL|[?]|[?]|BORDERLINE|1|MnFI|1|1|[?]|NORMAL|AMNIOTIC FLUID|HEMOLYZED||IMMUNODIFFUSION|GMI MMOL/MOL FORMULA|Y||Y||3|Visit_3|40|4|TREATMENT|2021-02-14|2021-02-22|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|7979239e-2a6b-48e3-9d11-41c97b33d229|6|RBCNUC|Nucleated Erythrocytes|URINALYSIS|||[?]|[?]|NEGATIVE|1|/200 HPFs|1|1|[?]|NORMAL|TRANSUDATE|CONTAMINATED||NUCLEIC ACID HYBRIDIZATION|ASH FIBROSURE FORMULA|||Y|Y|3|Visit_3|40|6|SCREENING|2021-02-14|2021-02-20|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|7979239e-2a6b-48e3-9d11-41c97b33d229|7|LVFBRSC|Liver Fibrosis Score|CHEMISTRY|[?]|amol|[?]|[?]|NEGATIVE|1|U/g/h|1|1|[?]|NORMAL|DISCHARGE|LACTESCENT|N|SNELLEN EYE CHART|FIBROSIS 4 FORMULA||Y|NA||4|Visit_4|65|3|SCREENING|2021-03-11|2021-03-21|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|7979239e-2a6b-48e3-9d11-41c97b33d229|8|STAT3PS3|Phosphorylated STAT3/STAT3|URINALYSIS|[?]|mIU/L|[?]|[?]|NEGATIVE|1|cmHg|1|1|[?]|NORMAL|LUNG SURFACTANT|CONTAMINATED||RAJI CELL EIA|COCKCROFT-GAULT FORMULA|Y|Y|N||4|Visit_4|65|6|TREATMENT|2021-03-11|2021-03-22|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|7979239e-2a6b-48e3-9d11-41c97b33d229|9|PSA|Prostate Specific Antigen|HEMATOLOGY|[?]|m2|[?]|[?]|TRACE|1|fraction of 1|1|1|[?]|HIGH|SOFT TISSUE|SOLIDIFIED|N|MANUAL COUNT|FIBROTEST FORMULA|||U||5|Visit_5|90|2|TREATMENT|2021-04-05|2021-04-12|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|7979239e-2a6b-48e3-9d11-41c97b33d229|10|HCGND|Choriogonadotropin|HEMATOLOGY|[?]|umol/min|[?]|[?]|INDETERMINATE|1|um2|1|1|[?]|NORMAL|MONOCYTE|CONCENTRATED||FUNCTIONAL MRI|MDRD 5 VARIABLE FORMULA|Y||U||5|Visit_5|90|4|TREATMENT|2021-04-05|2021-04-11|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|1|PDW|Platelet Distribution Width|URINALYSIS|[?]|Osm|[?]|[?]|POSITIVE|1|uV|1|1|[?]|LOW|SEBUM|ICTERIC||FLOCCULATION|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|3|FOLLOW-UP|2020-08-06|2020-09-04|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|2|GBP1|Guanylate Binding Protein 1|CHEMISTRY|[?]|TRANSDUCING UNIT/mL|[?]|[?]|INDETERMINATE|1|foz_us|1|1|[?]|LOW|INTERSTITIAL FLUID|FROZEN|N|SEQUENCING|CKD-EPI CREATININE FORMULA|Y||U||1|Visit_1|10|3|FOLLOW-UP|2020-08-06|2020-10-16|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|3|C130105|Grass Mix Pollen Antigen IgA Antibody|URINALYSIS|||[?]|[?]|INVALID|1|g/g|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|CONCENTRATED||NON-CONTACT SPECULAR MICROSCOPY|COCKCROFT-GAULT FORMULA|Y||U|Y|2|Visit_2|25|2|TREATMENT|2020-08-21|2020-10-19|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|4|S100A8|S100 Calcium Binding Protein A8|URINALYSIS|[?]|U|[?]|[?]|INDETERMINATE|1|lx|1|1|[?]|LOW|CORD SERUM|CONCENTRATED||APPLANATION TONOMETRY|MDRD ENZYMATIC FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-08-21|2020-10-15|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|5|HBA2PHB|Hemoglobin A2 Prime/Total Hemoglobin|HEMATOLOGY|||[?]|[?]|INVALID|1|vp/dose|1|1|[?]|ABNORMAL|SWABBED MATERIAL|ICTERIC||CALCOFLUOR WHITE STAIN|FIBROMETER FORMULA|Y|Y|U|Y|3|Visit_3|40|7|FOLLOW-UP|2020-09-05|2020-10-12|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|6|CAIONPH|Calcium, Ionized pH Adjusted|URINALYSIS|||[?]|[?]|INDETERMINATE|1|ELISA unit/dose|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|ICTERIC||CLIP SEQUENCING|MDRD 5 VARIABLE FORMULA|Y|Y|U|Y|3|Visit_3|40|5|TREATMENT|2020-09-05|2020-10-07|40|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|LB|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|7|LCTHSPGM|Lecithin/Sphingomyelin|URINALYSIS|[?]|dram|[?]|[?]|NEGATIVE|1|mm/sec|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|AUTOLYZED||HPLC|MDRD 4 VARIABLE FORMULA|||U||4|Visit_4|65|2|TREATMENT|2020-09-30|2020-10-03|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|8|C130101|Tree Mix Pollen Antigen IgE Antibody|URINALYSIS|[?]|10^6 RNA copies/mL|[?]|[?]|BORDERLINE|1|DISK|1|1|[?]|LOW|ERYTHROCYTES|CONTAMINATED|N|IMMUNODIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-09-30|2020-10-12|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|9|SPHERO|Spherocytes|CHEMISTRY|[?]|cm2|[?]|[?]|INDETERMINATE|1|mm|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|FROZEN||HIGH LEVEL AMINOGLYCOSIDE SCREEN|FIBROTEST FORMULA||Y|N||5|Visit_5|90|3|TREATMENT|2020-10-25|2020-10-30|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|10|NMH|N-methylhistamine|URINALYSIS|[?]|LB|[?]|[?]|TRACE|1|10^3 organisms/mL|1|1|[?]|HIGH|MENSTRUAL BLOOD|PARAFFIN-EMBEDDED|N|ELASTOGRAPHY|MDRD 5 VARIABLE FORMULA|Y||Y||5|Visit_5|90|1|SCREENING|2020-10-25|2020-11-01|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|LB|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|1|HLAIPRA|HLA Class I Panel Reactive Antibody|HEMATOLOGY|[?]|MBq/uL|[?]|[?]|BORDERLINE|1|Bq/mg|1|1|[?]|HIGH|KERATINOCYTE|CONTAMINATED||INCISION-INDUCED BLEEDING METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2021-01-05|2021-03-04|10|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|LB|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|2|CGA|Chromogranin A|CHEMISTRY|||[?]|[?]|INVALID|1|OD Unit|1|1|[?]|LOW|SUPERNATANT, PLASMA|UNEXPECTED ODOR||ICP-MS|FIBROTEST FORMULA||Y|U|Y|1|Visit_1|10|3|SCREENING|2021-01-05|2021-04-04|10|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|LB|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|3|CSFAT|Fatty Casts|URINALYSIS|||[?]|[?]|BORDERLINE|1|mg/kg/day|1|1|[?]|LOW|BONE|CONCENTRATED||SPIROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|2|Visit_2|25|1|WASHOUT|2021-01-20|2021-01-21|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|4|C130104|Grass Mix Pollen Antigen IgG Antibody|URINALYSIS|[?]|10^4/hpf|[?]|[?]|INVALID|1|ug/g/h|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|NON-HEMOLYZED||FLOCCULATION, CHARCOAL ENHANCED|CKD-EPI CYSTATIN C FORMULA|||U||2|Visit_2|25|7|TREATMENT|2021-01-20|2021-03-22|25|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|5|CCL12|Chemokine (C-C Motif) Ligand 12|URINALYSIS|[?]|mU|[?]|[?]|NEGATIVE|1|/day|1|1|[?]|ABNORMAL|KERATINOCYTE|UNEXPECTED ODOR|N|NUCLEIC ACID AMPLIFICATION TEST|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||3|Visit_3|40|1|TREATMENT|2021-02-04|2021-03-14|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|LB|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|6|C130074|Birch Pollen IgG|URINALYSIS|[?]|vg/mL|[?]|[?]|TRACE|1|mol/L|1|1|[?]|HIGH|LOCHIA|SOLIDIFIED|N|PANENDOSCOPY|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|1|FOLLOW-UP|2021-02-04|2021-03-16|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|LB|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|7|DHEAS|Dehydroepiandrosterone Sulfate|CHEMISTRY|[?]|Ejaculate U|[?]|[?]|INDETERMINATE|1|fg|1|1|[?]|ABNORMAL|URINE|GELLED||SNP ARRAY|COCKCROFT-GAULT FORMULA|Y||U||4|Visit_4|65|7|TREATMENT|2021-03-01|2021-03-06|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|8|ALTAST|ALT/AST|CHEMISTRY|[?]|10^3 organisms|[?]|[?]|POSITIVE|1|Bq/g|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|CONCENTRATED|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROMETER FORMULA|||U||4|Visit_4|65|2|SCREENING|2021-03-01|2021-03-02|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|9|C1INH|Complement C1 Esterase Inhibitor|HEMATOLOGY|[?]|/2500 WBC|[?]|[?]|INVALID|1|uCi/kg|1|1|[?]|LOW|MENSTRUAL BLOOD|FRESH|N|TARGETED GENOME SEQUENCING|MDRD FORMULA|Y||U||5|Visit_5|90|7|SCREENING|2021-03-26|2021-03-29|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|10|HGFR|Hepatocyte Growth Factor Receptor|CHEMISTRY|[?]|ag|[?]|[?]|POSITIVE|1|ppb|1|1|[?]|ABNORMAL|CALCULUS|CLOTTED||TRIPLE-PHASE SPIRAL CT SCAN|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2021-03-26|2021-03-29|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|da35fc01-4258-4e4d-99d9-4172e84c46e8|1|AMH|Anti-Mullerian Hormone|HEMATOLOGY|[?]|Enzyme U|[?]|[?]|NEGATIVE|1|kat|1|1|[?]|LOW|SPERMATOZOON|CALCIFIED|N|SPECULAR MICROSCOPY|MDRD 6 VARIABLE FORMULA|||N||1|Visit_1|10|4|TREATMENT|2020-07-22|2020-10-07|10|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|da35fc01-4258-4e4d-99d9-4172e84c46e8|2|FATACFRU|Free Fatty Acid, Unsaturated|URINALYSIS|||[?]|[?]|BORDERLINE|1|mL/kg/min|1|1|[?]|LOW|PROSTATIC FLUID|ICTERIC||SLIT LAMP PHOTOGRAPHY|MDRD 4 VARIABLE FORMULA|Y||N|Y|1|Visit_1|10|2|TREATMENT|2020-07-22|2020-09-20|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|da35fc01-4258-4e4d-99d9-4172e84c46e8|3|CLEPNSQE|Columnar Epi Cells/Non-Squam Epi Cells|URINALYSIS|[?]|IU/mL|[?]|[?]|INVALID|1|g/day|1|1|[?]|HIGH|NAIL|CONTAMINATED||INTERRUPTER TECHNIQUE|MDRD 6 VARIABLE FORMULA|Y||U||2|Visit_2|25|6|FOLLOW-UP|2020-08-06|2020-10-13|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|da35fc01-4258-4e4d-99d9-4172e84c46e8|4|CODEINE|Codeine|URINALYSIS|[?]|GBq/g|[?]|[?]|POSITIVE|1|Enzyme U|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|PARAFFIN-EMBEDDED|N|POTENTIOMETRY|FIBROTEST FORMULA|Y|Y|Y||2|Visit_2|25|7|WASHOUT|2020-08-06|2020-08-29|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|da35fc01-4258-4e4d-99d9-4172e84c46e8|5|INSULINR|Insulin Resistance|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^3 copies/mL|1|1|[?]|HIGH|EPIDERMAL TISSUE|LIPEMIC||NUCLEIC ACID SEQUENCING|NASH FIBROSURE FORMULA|||Y|Y|3|Visit_3|40|2|TREATMENT|2020-08-21|2020-09-21|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|da35fc01-4258-4e4d-99d9-4172e84c46e8|6|PCA3MRNA|Prostate Cancer Antigen 3 mRNA|CHEMISTRY|||[?]|[?]|INVALID|1|mL/s/m2|1|1|[?]|ABNORMAL|BONE|SOLIDIFIED||DYNAMOMETRY|CKD-EPI FORMULA|||U|Y|3|Visit_3|40|2|TREATMENT|2020-08-21|2020-09-09|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|da35fc01-4258-4e4d-99d9-4172e84c46e8|7|TRGTCE|Target Cells|URINALYSIS|||[?]|[?]|INDETERMINATE|1|10^3 organisms/mL|1|1|[?]|HIGH|CELL PELLET|FROZEN||POTENTIOMETRY|FIBROMETER FORMULA|Y||U|Y|4|Visit_4|65|4|TREATMENT|2020-09-15|2020-10-04|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|da35fc01-4258-4e4d-99d9-4172e84c46e8|8|CSWAX|Waxy Casts|URINALYSIS|[?]|pg/L|[?]|[?]|INVALID|1|log10 CFU/g|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|REFRIGERATED||FLUORESCENT IMMUNOASSAY|ASH FIBROSURE FORMULA|||N||4|Visit_4|65|5|FOLLOW-UP|2020-09-15|2020-09-22|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|da35fc01-4258-4e4d-99d9-4172e84c46e8|9|BASOLE|Basophils/Leukocytes|URINALYSIS|[?]|mph|[?]|[?]|INDETERMINATE|1|cd/m2|1|1|[?]|HIGH|HAIR|CALCIFIED||COMPLEMENT FIXATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||5|Visit_5|90|3|TREATMENT|2020-10-10|2020-10-17|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|da35fc01-4258-4e4d-99d9-4172e84c46e8|10|CKMM|Creatine Kinase MM|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mEq/kg|1|1|[?]|LOW|CEREBROSPINAL FLUID|HEMOLYZED||MICROBIAL CULTURE, SOLID|GMI MMOL/MOL FORMULA|Y||Y|Y|5|Visit_5|90|6|WASHOUT|2020-10-10|2020-10-16|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|1|TCHT|Taurocholate|HEMATOLOGY|[?]|mg|[?]|[?]|TRACE|1|P|1|1|[?]|ABNORMAL|URINE SEDIMENT|FRESH||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|3|FOLLOW-UP|2020-08-04|2020-10-22|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|LB|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|2|ALS|Acid Labile Subunit|CHEMISTRY|[?]|mEq/L|[?]|[?]|NEGATIVE|1|/sec|1|1|[?]|HIGH|PLEURAL TISSUE|AGGLUTINATED||ELECTROPHORESIS|MDRD FORMULA|Y||N||1|Visit_1|10|4|TREATMENT|2020-08-04|2020-10-04|10|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|LB|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|3|RBC|Erythrocytes|URINALYSIS|||[?]|[?]|INVALID|1|CAPSULE|1|1|[?]|NORMAL|GASTRIC CONTENTS|ICTERIC||TRIPLE-PHASE SPIRAL CT SCAN|COCKCROFT-GAULT FORMULA|||NA|Y|2|Visit_2|25|7|TREATMENT|2020-08-19|2020-10-17|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|4|ANCATYAB|Neutrophil Cytoplasmic Ab, Atypical|HEMATOLOGY|[?]|Hz|[?]|[?]|BORDERLINE|1|TCID 50/dose|1|1|[?]|ABNORMAL|LYMPH|LACTESCENT||SIZE EXCLUSION CHROMATOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2020-08-19|2020-08-28|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|5|CD13|CD13|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|deg/s|1|1|[?]|NORMAL|BASAL TEAR|LIPEMIC|N|KINYOUN STAIN|HEPASCORE FORMULA|||U|Y|3|Visit_3|40|1|FOLLOW-UP|2020-09-03|2020-10-04|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|6|PHADJT|pH Adjusted for Body Temp|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|nmol/L/min|1|1|[?]|NORMAL|TRANSUDATE|DRIED|N|SLOAN LETTER EYE CHART 1.25%|MDRD ENZYMATIC FORMULA|||N|Y|3|Visit_3|40|4|TREATMENT|2020-09-03|2020-09-19|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|7|ANDSTNDN|Androstenedione|HEMATOLOGY|[?]|kcal|[?]|[?]|INDETERMINATE|1|LB|1|1|[?]|ABNORMAL|MONOCYTE|FRESH||IMPULSE OSCILLOMETRY|CKD-EPI FORMULA||Y|Y||4|Visit_4|65|3|TREATMENT|2020-09-28|2020-10-16|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|8|VITC|Vitamin C|HEMATOLOGY|[?]|dpm/mL|[?]|[?]|TRACE|1|keV|1|1|[?]|LOW|CELL PELLET|CLOTTED|N|SINGLE-MOLECULE ARRAY|COCKCROFT-GAULT FORMULA|||NA||4|Visit_4|65|4|FOLLOW-UP|2020-09-28|2020-10-13|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|9|CD8|CD8|URINALYSIS|[?]|foz_br|[?]|[?]|NEGATIVE|1|VOXEL|1|1|[?]|NORMAL|CAPILLARY PLASMA|SOLIDIFIED||PH METER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA|||N||5|Visit_5|90|7|FOLLOW-UP|2020-10-23|2020-10-25|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|10|UREA|Urea|CHEMISTRY|[?]|nU/cL|[?]|[?]|POSITIVE|1|Bq/uL|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|PARAFFIN-EMBEDDED||ELISA|GMI % FORMULA|||NA||5|Visit_5|90|7|SCREENING|2020-10-23|2020-11-01|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|1|PSDGLSRF|Phosphatidylglycerol/Lung Surfactant|URINALYSIS|[?]|cd|[?]|[?]|NEGATIVE|1|mmHg*min/L|1|1|[?]|HIGH|ARTERIAL BLOOD|UNEXPECTED ODOR||ELECTRONEUROGRAPHY|HEPASCORE FORMULA|Y|Y|Y||1|Visit_1|10|5|SCREENING|2020-12-14|2021-02-28|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|2|SEDEXAM|Sediment Examination|HEMATOLOGY|||[?]|[?]|INVALID|1|v/v|1|1|[?]|HIGH|PROSTATIC FLUID|LIPEMIC||EPSILOMETER|CKD-EPI FORMULA|||N|Y|1|Visit_1|10|1|WASHOUT|2020-12-14|2021-01-19|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|3|PGAG|Platelet-Granulocyte Agg|CHEMISTRY|||[?]|[?]|POSITIVE|1|GBq/ug|1|1|[?]|LOW|CERUMEN|GELLED|N|SISH|NASH FIBROSURE FORMULA||Y|N|Y|2|Visit_2|25|3|TREATMENT|2020-12-29|2021-01-02|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|4|PLTLPLT|Large Platelets/Total Platelets|HEMATOLOGY|[?]|PIPE|[?]|[?]|INVALID|1|copies/mL|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|DRIED||WRIGHT-GIEMSA STAIN|MDRD 6 VARIABLE FORMULA|||U||2|Visit_2|25|6|FOLLOW-UP|2020-12-29|2021-01-18|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|LB|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|5|NAGCREAT|N-Acetyl Glucosamide/Creatinine|CHEMISTRY|[?]|nL|[?]|[?]|POSITIVE|1|PIPE|1|1|[?]|ABNORMAL|NAIL|DRIED||IN SITU HYBRIDIZATION|MDRD ENZYMATIC JAPANESE FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2021-01-13|2021-02-28|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|LB|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|6|GLOBB|Beta Globulin|URINALYSIS|[?]|umol/dL|[?]|[?]|NEGATIVE|1|CAN|1|1|[?]|NORMAL|PERSPIRATION|CONCENTRATED||WHOLE GENOME SEQUENCING|ASH FIBROSURE FORMULA|||NA||3|Visit_3|40|1|WASHOUT|2021-01-13|2021-02-27|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|LB|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|7|BLSTLY|Lymphoblasts|HEMATOLOGY|[?]|nsec|[?]|[?]|BORDERLINE|1|mL/animal/day|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|LACTESCENT||MICROARRAY|MDRD 6 VARIABLE FORMULA|Y|Y|N||4|Visit_4|65|5|TREATMENT|2021-02-07|2021-02-26|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|8|GCSF|Granulocyte Colony Stimulating Factor|URINALYSIS|[?]|ag|[?]|[?]|BORDERLINE|1|Gy/h|1|1|[?]|HIGH|LOCHIA|REFRIGERATED||MS/MS|CKD-EPI FORMULA|||N||4|Visit_4|65|1|TREATMENT|2021-02-07|2021-03-13|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|9|BUCHE|Butyrylcholinesterase|CHEMISTRY|[?]|NFIU|[?]|[?]|INDETERMINATE|1|sec|1|1|[?]|NORMAL|PLEURAL FLUID|CALCIFIED|N|HPLC/MS/MS|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2021-03-04|2021-03-10|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|10|INTLK4|Interleukin 4|HEMATOLOGY|[?]|nmol/L|[?]|[?]|NEGATIVE|1|mL/dL|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|CONCENTRATED||MACRO BROTH DILUTION|MDRD 6 VARIABLE FORMULA||Y|U||5|Visit_5|90|5|TREATMENT|2021-03-04|2021-03-09|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|1|GUDCA|Glycoursodeoxycholate|HEMATOLOGY|[?]|IU/mL|[?]|[?]|INDETERMINATE|1|DDU|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|UNEXPECTED ODOR||FISH|FIBROMETER FORMULA|||NA||1|Visit_1|10|5|SCREENING|2020-06-09|2020-08-15|10|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|2|PLAGMCVT|Platelet Aggregation Mean Curve Type|CHEMISTRY|[?]|ukat|[?]|[?]|POSITIVE|1|EID 50/mL|1|1|[?]|NORMAL|CERUMEN|AUTOLYZED||AUDIOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|7|SCREENING|2020-06-09|2020-06-20|10|21|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|3|TATC|Thrombin Antithrombin Complex|URINALYSIS|||[?]|[?]|BORDERLINE|1|/MBP|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|SOLIDIFIED||ICC|GMI MMOL/MOL FORMULA|||U|Y|2|Visit_2|25|4|SCREENING|2020-06-24|2020-07-19|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|4|MYPC|Myeloid Progenitor Cells|CHEMISTRY|||[?]|[?]|INVALID|1|mol/L|1|1|[?]|HIGH|CELL PELLET|REFRIGERATED||SPECT SCAN|FIBROMETER FORMULA|||NA|Y|2|Visit_2|25|5|FOLLOW-UP|2020-06-24|2020-07-22|25|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|5|RDCSUG|Reducing Sugars|HEMATOLOGY|[?]|10^9 organisms/mL|[?]|[?]|BORDERLINE|1|dpm/mL|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|LACTESCENT||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|7|TREATMENT|2020-07-09|2020-08-01|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|6|ASSDNA|Anti-Single Stranded DNA IgG|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|CFU/g|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|CLOTTED|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|CKD-EPI FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2020-07-09|2020-08-13|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|7|CX3CL1|Chemokine (C-X3-C Motif) Ligand 1|URINALYSIS|[?]|uEq|[?]|[?]|BORDERLINE|1|%/min|1|1|[?]|HIGH|URINE|GELLED||NUCLEIC ACID AMPLIFICATION TEST|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|2|FOLLOW-UP|2020-08-03|2020-08-14|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|8|MMA|Methylmalonic Acid|URINALYSIS|||[?]|[?]|BORDERLINE|1|mmol/mol|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|NON-HEMOLYZED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD ENZYMATIC FORMULA|||NA|Y|4|Visit_4|65|2|TREATMENT|2020-08-03|2020-09-05|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|9|PAH|P-Aminohippurate Sodium|HEMATOLOGY|[?]|mol/L|[?]|[?]|POSITIVE|1|log10 TCID 50/uL|1|1|[?]|LOW|ENDOMETRIAL TISSUE|CLOTTED||MULTIPLE BREATH WASHOUT|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||5|Visit_5|90|4|TREATMENT|2020-08-28|2020-08-30|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|10|PRGNENLN|Pregnenolone|URINALYSIS|[?]|pkat/L|[?]|[?]|INDETERMINATE|1|ug/L FEU|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|CALCIFIED|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROMETER FORMULA|||Y||5|Visit_5|90|7|FOLLOW-UP|2020-08-28|2020-08-30|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|LB|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|1|RUBCE|Rubricyte/Total Cells|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|m/sec2|1|1|[?]|HIGH|PLASMA|THAWED||MICROBIAL CULTURE, SOLID|FIBROSIS 4 FORMULA||Y|NA|Y|1|Visit_1|10|3|TREATMENT|2020-05-24|2020-06-17|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|LB|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|2|APOBAPA1|Apolipoprotein B/Apolipoprotein A1|HEMATOLOGY|[?]|Gy/min|[?]|[?]|NEGATIVE|1|mU/L|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|ROOM TEMPERATURE||SNELLEN EYE CHART|MDRD 6 VARIABLE FORMULA|||Y||1|Visit_1|10|6|SCREENING|2020-05-24|2020-06-21|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|LB|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|3|HOWJOL|Howell-Jolly Bodies|CHEMISTRY|[?]|/month|[?]|[?]|NEGATIVE|1|Tbsp|1|1|[?]|LOW|ERYTHROCYTES|CONCENTRATED||ROMANOWSKY STAIN|GMI MMOL/MOL FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-06-08|2020-08-20|25|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|4|GFRBSA|Glomerular Filtration Rate Adj for BSA|HEMATOLOGY|[?]|tuberculin unit/mL|[?]|[?]|INVALID|1|mm/min|1|1|[?]|ABNORMAL|COLOSTRUM|UNEXPECTED ODOR||MAGNETIC RESONANCE ANGIOGRAPHY|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2020-06-08|2020-07-05|25|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|5|B2MICG|Beta-2 Microglobulin|CHEMISTRY|||[?]|[?]|POSITIVE|1|in2|1|1|[?]|LOW|SUPERNATANT, SERUM|HEMOLYZED||ATOMIC ABSORPTION SPECTROMETRY|FIBROMETER FORMULA|Y||Y|Y|3|Visit_3|40|5|FOLLOW-UP|2020-06-23|2020-07-08|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|6|C165930|Shellfish Mix IgE AB RAST Score|HEMATOLOGY|[?]|mg/kg/h|[?]|[?]|BORDERLINE|1|JAR|1|1|[?]|ABNORMAL|CERUMEN|FRESH|N|KINETIC CHROMOGENIC ASSAY|COCKCROFT-GAULT FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-06-23|2020-07-31|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|7|METHQLDN|Methaqualone|CHEMISTRY|[?]|SFC/10^6 PBMC|[?]|[?]|INDETERMINATE|1|MET*min|1|1|[?]|NORMAL|INFRANATANT, SERUM|FROZEN|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||4|Visit_4|65|5|TREATMENT|2020-07-18|2020-08-14|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|LB|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|8|ALTCPHRL|Alpha Tocopherol|HEMATOLOGY|[?]|uL/kg/day|[?]|[?]|NEGATIVE|1|mm|1|1|[?]|LOW|HAIR|UNEXPECTED ODOR||WESTERGREN|MDRD 4 VARIABLE FORMULA||Y|N||4|Visit_4|65|1|TREATMENT|2020-07-18|2020-08-18|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|LB|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|9|DSG3AB|Desmoglein 3 Antibody|CHEMISTRY|[?]|Osm|[?]|[?]|INVALID|1|10^9 CFU/g|1|1|[?]|NORMAL|INTERSTITIAL FLUID|CALCIFIED||NON-INVASIVE DIELECTRIC SENSING|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2020-08-12|2020-08-19|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-24
e|LB|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|10|FACTXII|Factor XII|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|GPL U|1|1|[?]|LOW|GASTRIC CONTENTS|LIPEMIC||GRAM STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|5|Visit_5|90|3|TREATMENT|2020-08-12|2020-08-17|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-24
e|LB|136d59c6-9645-447a-a047-68d33dbb708e|1|CRLPLSMN|Ceruloplasmin|CHEMISTRY|[?]|ug/m2/h|[?]|[?]|NEGATIVE|1|damol/L|1|1|[?]|HIGH|TISSUE|CLOTTED||SCINTIGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||1|Visit_1|10|2|FOLLOW-UP|2020-09-24|2020-11-13|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|136d59c6-9645-447a-a047-68d33dbb708e|2|LDH1LDH|LDH Isoenzyme 1/LDH|HEMATOLOGY|[?]|MASK|[?]|[?]|POSITIVE|1|PFU/dose|1|1|[?]|LOW|ISOLATE|REFRIGERATED||ANALYTICAL ULTRACENTRIFUGATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||1|Visit_1|10|2|TREATMENT|2020-09-24|2020-11-22|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|136d59c6-9645-447a-a047-68d33dbb708e|3|C130114|Industrial Mix Antigen IgE Antibody|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|vp/mL|1|1|[?]|ABNORMAL|SEMEN|CONTAMINATED||PERIODIC ACID SCHIFF STAIN|FIBROMETER FORMULA|||N|Y|2|Visit_2|25|4|WASHOUT|2020-10-09|2020-11-05|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|136d59c6-9645-447a-a047-68d33dbb708e|4|BLISTCE|Blister Cell|HEMATOLOGY|[?]|mEq/mL|[?]|[?]|TRACE|1|m/sec2|1|1|[?]|LOW|EXPIRED AIR|DRIED|N|COLORIMETRY|COCKCROFT-GAULT FORMULA|Y||NA||2|Visit_2|25|6|WASHOUT|2020-10-09|2020-10-11|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|LB|136d59c6-9645-447a-a047-68d33dbb708e|5|APLSMA2A|Alpha-2 Antiplasmin Activity|URINALYSIS|[?]|IU/kg|[?]|[?]|NEGATIVE|1|U/m2|1|1|[?]|HIGH|BILE|SOLIDIFIED||NON-INVASIVE DIELECTRIC SENSING|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|7|FOLLOW-UP|2020-10-24|2020-12-02|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|136d59c6-9645-447a-a047-68d33dbb708e|6|ERCEPPOL|Erythroid Proliferation Pool|CHEMISTRY|||[?]|[?]|NEGATIVE|1|PACKAGE|1|1|[?]|HIGH|SPERMATOZOON|UNEXPECTED ODOR|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|ASH FIBROSURE FORMULA|Y|Y|N|Y|3|Visit_3|40|4|TREATMENT|2020-10-24|2020-11-07|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|136d59c6-9645-447a-a047-68d33dbb708e|7|PMYCECE|Proliferating Myeloid Cells/Total Cells|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mL/cm|1|1|[?]|LOW|PLASMA|REFRIGERATED||CELLULAR PROLIFERATION ASSAY|CKD-EPI CYSTATIN C FORMULA|||N|Y|4|Visit_4|65|2|TREATMENT|2020-11-18|2020-11-28|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|136d59c6-9645-447a-a047-68d33dbb708e|8|THC|Tetrahydrocannabinol|URINALYSIS|[?]|mm|[?]|[?]|INVALID|1|ug/m2/h|1|1|[?]|LOW|SEMEN|ROOM TEMPERATURE|N|INCISION-INDUCED BLEEDING METHOD|FIBROSIS 4 FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2020-11-18|2020-12-07|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|136d59c6-9645-447a-a047-68d33dbb708e|9|CRYGLBSR|Cryoglobulin Volume/Serum Volume|HEMATOLOGY|[?]|pL|[?]|[?]|INVALID|1|nmol/mL/min|1|1|[?]|ABNORMAL|MUCUS|GELLED||SPECT/CT SCAN|MDRD 6 VARIABLE FORMULA|Y||NA||5|Visit_5|90|6|SCREENING|2020-12-13|2020-12-14|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|LB|136d59c6-9645-447a-a047-68d33dbb708e|10|LDLOXAB|Oxidized LDL Cholesterol Antibody|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|umol/day|1|1|[?]|HIGH|ERYTHROCYTES|ICTERIC||PLAQUE REDUCTION NEUTRALIZATION ASSAY|CKD-EPI CYSTATIN C FORMULA|Y||Y|Y|5|Visit_5|90|2|TREATMENT|2020-12-13|2020-12-19|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|LB|2e393b90-213c-4661-ad55-cabb2008bf14|1|LDLPSZ|LDL Particle Size|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|L/h/m2|1|1|[?]|NORMAL|ALVEOLAR AIR|LIPEMIC|N|EPSILOMETER|NASH FIBROSURE FORMULA|||N|Y|1|Visit_1|10|2|TREATMENT|2020-06-26|2020-07-22|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|2e393b90-213c-4661-ad55-cabb2008bf14|2|ANTIDPRS|Antidepressants|URINALYSIS|[?]|/h|[?]|[?]|TRACE|1|dpm/0.5 mL|1|1|[?]|LOW|VITREOUS HUMOR|LIPEMIC||DIGITAL PCR|NASH FIBROSURE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-06-26|2020-09-22|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|2e393b90-213c-4661-ad55-cabb2008bf14|3|PTHFG|Parathyroid Hormone, Fragmented|URINALYSIS|[?]|TCID 50/dose|[?]|[?]|NEGATIVE|1|10^9/g|1|1|[?]|ABNORMAL|ALVEOLAR AIR|LIPEMIC|N|WRIGHT-GIEMSA STAIN|CKD-EPI FORMULA||Y|NA||2|Visit_2|25|2|FOLLOW-UP|2020-07-11|2020-08-10|25|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|2e393b90-213c-4661-ad55-cabb2008bf14|4|CAMP|Cyclic Adenosine 3,5-Monophosphate|HEMATOLOGY|[?]|uV*sec|[?]|[?]|TRACE|1|PACK|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|DRIED|N|JAFFE REACTION|FIBROTEST FORMULA|Y||Y||2|Visit_2|25|4|WASHOUT|2020-07-11|2020-07-20|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|2e393b90-213c-4661-ad55-cabb2008bf14|5|HLAA23A|HLA-A23 Antibody|CHEMISTRY|[?]|pg/dL|[?]|[?]|INDETERMINATE|1|mL/g/h|1|1|[?]|LOW|PROSTATIC FLUID|CONCENTRATED||IMPEDANCE CONDUCTIVITY|HEPASCORE FORMULA|||NA||3|Visit_3|40|7|SCREENING|2020-07-26|2020-09-20|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|2e393b90-213c-4661-ad55-cabb2008bf14|6|APRIL|A Proliferation-Inducing Ligand|URINALYSIS|[?]|IU/kg/h|[?]|[?]|NEGATIVE|1|foz_br|1|1|[?]|LOW|EPITHELIAL CELL|PARAFFIN-EMBEDDED||FLUORESCENT ENZYME IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||3|Visit_3|40|6|WASHOUT|2020-07-26|2020-09-23|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|2e393b90-213c-4661-ad55-cabb2008bf14|7|RANKL|Receptor Activator Nuclear KappaB Ligand|URINALYSIS|[?]|eq|[?]|[?]|BORDERLINE|1|m3|1|1|[?]|ABNORMAL|LOCHIA|PARAFFIN-EMBEDDED||IODINE STAIN|FIBROTEST FORMULA||Y|Y||4|Visit_4|65|2|TREATMENT|2020-08-20|2020-09-13|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|2e393b90-213c-4661-ad55-cabb2008bf14|8|INTLK1A|Interleukin 1 Alpha|CHEMISTRY|[?]|BOWL|[?]|[?]|TRACE|1|damol/L|1|1|[?]|ABNORMAL|PLATELET|ROOM TEMPERATURE||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|CKD-EPI FORMULA|Y||U||4|Visit_4|65|7|FOLLOW-UP|2020-08-20|2020-09-22|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|2e393b90-213c-4661-ad55-cabb2008bf14|9|POLYNORM|Polychromatophilic Normoblast|CHEMISTRY|[?]|umol/L|[?]|[?]|BORDERLINE|1|MONTHS|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|DRIED||SPIROMETRY|FIBROSIS 4 FORMULA|||NA||5|Visit_5|90|1|WASHOUT|2020-09-14|2020-09-15|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|2e393b90-213c-4661-ad55-cabb2008bf14|10|VITK1|Vitamin K1|CHEMISTRY|[?]|PIXELS/in|[?]|[?]|INDETERMINATE|1|g/m2|1|1|[?]|HIGH|PUS|ICTERIC||LC-FL|GMI MMOL/MOL FORMULA|Y||N||5|Visit_5|90|2|TREATMENT|2020-09-14|2020-09-23|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|f72002d8-262b-49da-84a4-42e6011286f0|1|ABNCELE|Abnormal Cells/Leukocytes|CHEMISTRY|[?]|uSiemens|[?]|[?]|INDETERMINATE|1|RNA copies/mL|1|1|[?]|NORMAL|TISSUE|ICTERIC||BRDU CELLULAR PROLIFERATION ASSAY|FIBROSIS 4 FORMULA||Y|U||1|Visit_1|10|2|TREATMENT|2020-10-14|2020-11-06|10|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|f72002d8-262b-49da-84a4-42e6011286f0|2|PROTSFR|Protein S, Free|URINALYSIS|[?]|tuberculin unit|[?]|[?]|POSITIVE|1|L/min|1|1|[?]|ABNORMAL|PLEURAL TISSUE|DRIED||POTENTIOMETRY|MDRD ENZYMATIC FORMULA|Y||NA||1|Visit_1|10|6|SCREENING|2020-10-14|2020-12-19|10|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|f72002d8-262b-49da-84a4-42e6011286f0|3|HER2|Human Epidermal Growth Factor Receptor 2|CHEMISTRY|[?]|ng/day|[?]|[?]|TRACE|1|deg2|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|ICTERIC|N|FLUORESCEIN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||2|Visit_2|25|3|TREATMENT|2020-10-29|2020-11-17|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|LB|f72002d8-262b-49da-84a4-42e6011286f0|4|NMH|N-methylhistamine|URINALYSIS|[?]|10^3/hpf|[?]|[?]|POSITIVE|1|mCi|1|1|[?]|HIGH|INFRANATANT, SERUM|CONTAMINATED|N|NUCLEAR RADIOLOGY|MDRD 4 VARIABLE FORMULA|Y||NA||2|Visit_2|25|4|SCREENING|2020-10-29|2020-11-23|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|LB|f72002d8-262b-49da-84a4-42e6011286f0|5|PSA|Prostate Specific Antigen|CHEMISTRY|[?]|cd/m2|[?]|[?]|INVALID|1|mL/g/min|1|1|[?]|HIGH|URINE SEDIMENT|AGGLUTINATED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD FORMULA|||U||3|Visit_3|40|3|TREATMENT|2020-11-13|2020-12-18|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|f72002d8-262b-49da-84a4-42e6011286f0|6|TESTOSBA|Bioavailable Testosterone|CHEMISTRY|[?]|10^6 IU/mL|[?]|[?]|BORDERLINE|1|g/m2/day|1|1|[?]|ABNORMAL|ERYTHROCYTES|REFRIGERATED||URANYL ACETATE STAIN|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|1|SCREENING|2020-11-13|2021-01-11|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|f72002d8-262b-49da-84a4-42e6011286f0|7|BGTCPHRL|Beta+Gamma Tocopherol|URINALYSIS|||[?]|[?]|INDETERMINATE|1|pmol/dL|1|1|[?]|LOW|NAIL|LIPEMIC||SANGER SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|Y||U|Y|4|Visit_4|65|6|TREATMENT|2020-12-08|2020-12-17|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|f72002d8-262b-49da-84a4-42e6011286f0|8|LEUKASE|Leukocyte Esterase|CHEMISTRY|[?]|cs|[?]|[?]|NEGATIVE|1|Tbsp|1|1|[?]|LOW|BILE|LACTESCENT||WESTERN BLOT|MDRD ENZYMATIC FORMULA|Y||Y||4|Visit_4|65|7|WASHOUT|2020-12-08|2021-01-08|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|f72002d8-262b-49da-84a4-42e6011286f0|9|TSP1|Thrombospondin 1|HEMATOLOGY|[?]|10^6 U|[?]|[?]|BORDERLINE|1|mg/L|1|1|[?]|HIGH|PERSPIRATION|AUTOLYZED||CLINICAL EVALUATION|MDRD FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2021-01-02|2021-01-04|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|f72002d8-262b-49da-84a4-42e6011286f0|10|COTININE|Cotinine|HEMATOLOGY|[?]|/100 WBC|[?]|[?]|BORDERLINE|1|um|1|1|[?]|ABNORMAL|SWABBED MATERIAL|LIPEMIC||THERMAL IONIZATION MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA||Y|NA||5|Visit_5|90|4|TREATMENT|2021-01-02|2021-01-08|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|68869dda-531d-4218-b2b0-4f5f46825569|1|APOB48|Apolipoprotein B48|URINALYSIS|||[?]|[?]|POSITIVE|1|nsec|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|LACTESCENT||ANTIMICROBIAL COMBINATION TESTING|CKD-EPI FORMULA||Y|Y|Y|1|Visit_1|10|3|FOLLOW-UP|2020-12-08|2021-02-27|10|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|68869dda-531d-4218-b2b0-4f5f46825569|2|IFNB|Interferon Beta|HEMATOLOGY|[?]|log10 CFU/mL|[?]|[?]|INVALID|1|mL/min/1.73m2|1|1|[?]|ABNORMAL|URINE SEDIMENT|DRIED||FLUORESCENT MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||1|Visit_1|10|1|SCREENING|2020-12-08|2020-12-30|10|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|68869dda-531d-4218-b2b0-4f5f46825569|3|VOLUME|Volume|URINALYSIS|||[?]|[?]|NEGATIVE|1|tuberculin unit/mL|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|CALCIFIED|N|ELECTRONEUROGRAPHY|GMI MMOL/MOL FORMULA|||N|Y|2|Visit_2|25|4|TREATMENT|2020-12-23|2021-02-03|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|68869dda-531d-4218-b2b0-4f5f46825569|4|ISG15|Ubiquitin-Like Protein ISG15|CHEMISTRY|[?]|U/g|[?]|[?]|INDETERMINATE|1|kg/cm2|1|1|[?]|ABNORMAL|CERUMEN|FROZEN|N|STRESS ECHOCARDIOGRAPHY|MDRD FORMULA|||U||2|Visit_2|25|2|WASHOUT|2020-12-23|2021-02-15|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|LB|68869dda-531d-4218-b2b0-4f5f46825569|5|EDMIGAAB|Endomysial IgA Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|mL/min|1|1|[?]|ABNORMAL|VENOUS BLOOD|NON-HEMOLYZED||FLAME PHOTOMETRY|HEPASCORE FORMULA|Y||N|Y|3|Visit_3|40|6|TREATMENT|2021-01-07|2021-01-26|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|68869dda-531d-4218-b2b0-4f5f46825569|6|FACTX|Factor X|CHEMISTRY|[?]|rpm|[?]|[?]|TRACE|1|g/kg/day|1|1|[?]|ABNORMAL|CORD BLOOD|PARAFFIN-EMBEDDED|N|IVY INCISION METHOD|MDRD 4 VARIABLE FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2021-01-07|2021-01-20|40|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|68869dda-531d-4218-b2b0-4f5f46825569|7|IL1SR1|Soluble Interleukin-1 Receptor Type I|URINALYSIS|[?]|SQU/mL|[?]|[?]|INVALID|1|/day|1|1|[?]|HIGH|ARTERIAL BLOOD|GELLED||DIFFUSION WEIGHTED MRI|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|6|WASHOUT|2021-02-01|2021-02-06|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|68869dda-531d-4218-b2b0-4f5f46825569|8|NEUTBLE|Neutrophils Band Form/Leukocytes|HEMATOLOGY|[?]|uEq|[?]|[?]|POSITIVE|1|Bq/mg|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|CALCIFIED||CORONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|Y||U||4|Visit_4|65|1|FOLLOW-UP|2021-02-01|2021-02-25|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|68869dda-531d-4218-b2b0-4f5f46825569|9|IFIT3|Interferon-Induced 60 kDa Protein|URINALYSIS|||[?]|[?]|INDETERMINATE|1|10^12/L|1|1|[?]|NORMAL|LYMPH|FRESH||ROMANOWSKY STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|Y|5|Visit_5|90|4|WASHOUT|2021-02-26|2021-03-05|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|LB|68869dda-531d-4218-b2b0-4f5f46825569|10|CCL17|Chemokine (C-C Motif) Ligand 17|CHEMISTRY|[?]|eq|[?]|[?]|INDETERMINATE|1|mmHg/sec|1|1|[?]|NORMAL|EXPIRED AIR|LIPEMIC||ETDRS EYE CHART|HEPASCORE FORMULA|Y||U||5|Visit_5|90|3|TREATMENT|2021-02-26|2021-03-03|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|LB|68888445-1819-4f4c-bd0c-a445906476fb|1|TROPONI2|Troponin I Type 2|URINALYSIS|[?]|g/m2|[?]|[?]|POSITIVE|1|mm|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|CLOTTED||WEBER GREEN STAIN|CKD-EPI CYSTATIN C FORMULA||Y|NA||1|Visit_1|10|5|FOLLOW-UP|2021-01-14|2021-04-02|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|LB|68888445-1819-4f4c-bd0c-a445906476fb|2|CX3CL1|Chemokine (C-X3-C Motif) Ligand 1|CHEMISTRY|[?]|ug/cm2|[?]|[?]|POSITIVE|1|anti-Xa IU|1|1|[?]|NORMAL|INTERSTITIAL FLUID|LIPEMIC|N|OPTICAL COHERENCE TOMOGRAPHY|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|4|SCREENING|2021-01-14|2021-03-12|10|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|LB|68888445-1819-4f4c-bd0c-a445906476fb|3|CSHYAL|Hyaline Casts|HEMATOLOGY|||[?]|[?]|TRACE|1|10^9 organisms/mg|1|1|[?]|ABNORMAL|LOCHIA|FRESH|N|ELASTOGRAPHY|MDRD 5 VARIABLE FORMULA|Y|Y|U|Y|2|Visit_2|25|2|FOLLOW-UP|2021-01-29|2021-04-09|25|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|68888445-1819-4f4c-bd0c-a445906476fb|4|IL1R2|Interleukin 1 Receptor Type 2|HEMATOLOGY|[?]|pg/dL|[?]|[?]|TRACE|1|ng/mol|1|1|[?]|LOW|LYMPH|LIPEMIC||TARGETED TRANSCRIPTOME SEQUENCING|MDRD 4 VARIABLE FORMULA|Y|Y|N||2|Visit_2|25|1|TREATMENT|2021-01-29|2021-02-01|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|68888445-1819-4f4c-bd0c-a445906476fb|5|RETIL|Low Absorption Reticulocytes|CHEMISTRY|[?]|log10 CFU/g|[?]|[?]|NEGATIVE|1|BAU/mL|1|1|[?]|HIGH|LYMPH|PARAFFIN-EMBEDDED||ENZYMATIC SPECTROPHOTOMETRY|FIBROTEST FORMULA|||U||3|Visit_3|40|4|TREATMENT|2021-02-13|2021-02-22|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|68888445-1819-4f4c-bd0c-a445906476fb|6|AMH|Anti-Mullerian Hormone|CHEMISTRY|[?]|tuberculin unit/mL|[?]|[?]|INDETERMINATE|1|g/g/day|1|1|[?]|NORMAL|PERITONEAL FLUID|UNEXPECTED ODOR||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||3|Visit_3|40|3|TREATMENT|2021-02-13|2021-03-05|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|68888445-1819-4f4c-bd0c-a445906476fb|7|INSULIN|Insulin|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|10^6 RNA copies/mL|1|1|[?]|NORMAL|SOFT TISSUE|FROZEN||QUANTITATIVE ULTRASOUND|MDRD ENZYMATIC FORMULA|||Y|Y|4|Visit_4|65|1|WASHOUT|2021-03-10|2021-04-04|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|68888445-1819-4f4c-bd0c-a445906476fb|8|EPICCE|Epithelial Cells/Total Cells|URINALYSIS|||[?]|[?]|INVALID|1|beats/min|1|1|[?]|LOW|ABSCESS FLUID|FRESH||BAC ACGH|CKD-EPI FORMULA|Y||Y|Y|4|Visit_4|65|3|TREATMENT|2021-03-10|2021-03-16|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|68888445-1819-4f4c-bd0c-a445906476fb|9|LGLUCLE|Large Unstained Cells/Leukocytes|URINALYSIS|[?]|pmol/g|[?]|[?]|INDETERMINATE|1|Antibody Unit|1|1|[?]|ABNORMAL|RETICULOCYTES|FRESH|N|MICROBIAL CULTURE|MDRD 5 VARIABLE FORMULA|||N||5|Visit_5|90|2|TREATMENT|2021-04-04|2021-04-12|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|LB|68888445-1819-4f4c-bd0c-a445906476fb|10|CLRDZPXD|Chlordiazepoxide|URINALYSIS|[?]|Bq/kg|[?]|[?]|NEGATIVE|1|oz|1|1|[?]|NORMAL|BILE|AUTOLYZED||REFLECTANCE SPECTROSCOPY|CKD-EPI CYSTATIN C FORMULA|||U||5|Visit_5|90|5|WASHOUT|2021-04-04|2021-04-06|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|LB|b2ce31a0-513a-449a-aa2c-7c9668fde275|1|GOLD|Gold|URINALYSIS|[?]|mL/mmHg|[?]|[?]|NEGATIVE|1|HOURS|1|1|[?]|ABNORMAL|CORD BLOOD|DRIED||KLEIHAUER-BETKE|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||1|Visit_1|10|7|FOLLOW-UP|2020-06-24|2020-08-07|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|b2ce31a0-513a-449a-aa2c-7c9668fde275|2|ISOPRF2|F2-Isoprostane|HEMATOLOGY|[?]|Ci/L|[?]|[?]|INDETERMINATE|1|10^5/hpf|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|NON-HEMOLYZED||HIGH RESOLUTION MELT ANALYSIS|GMI % FORMULA|||U||1|Visit_1|10|2|FOLLOW-UP|2020-06-24|2020-07-23|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|b2ce31a0-513a-449a-aa2c-7c9668fde275|3|VITD3|Vitamin D3|URINALYSIS|||[?]|[?]|INVALID|1|10^6/L|1|1|[?]|ABNORMAL|LOCHIA|GELLED|N|DOUBLE IMMUNODIFFUSION|GMI MMOL/MOL FORMULA|||U|Y|2|Visit_2|25|4|WASHOUT|2020-07-09|2020-08-09|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|LB|b2ce31a0-513a-449a-aa2c-7c9668fde275|4|SPMAGGR|Sperm Aggregation|HEMATOLOGY|[?]|log10 PFU|[?]|[?]|TRACE|1|QUANTITY SUFFICIENT|1|1|[?]|LOW|ADIPOSE TISSUE|CALCIFIED|N|CELLULAR PROLIFERATION ASSAY|HEPASCORE FORMULA|Y|Y|U||2|Visit_2|25|7|WASHOUT|2020-07-09|2020-07-16|25|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|LB|b2ce31a0-513a-449a-aa2c-7c9668fde275|5|VLDL|VLDL Cholesterol|URINALYSIS|[?]|LOZENGE|[?]|[?]|NEGATIVE|1|mL/min/mmHg|1|1|[?]|LOW|INTERSTITIAL FLUID|DRIED||TOLUIDINE BLUE STAIN|MDRD 4 VARIABLE FORMULA|||U||3|Visit_3|40|4|FOLLOW-UP|2020-07-24|2020-09-19|40|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|b2ce31a0-513a-449a-aa2c-7c9668fde275|6|GAD2|Glutamic Acid Decarboxylase 2|HEMATOLOGY|||[?]|[?]|TRACE|1|ELISA unit|1|1|[?]|LOW|AQUEOUS HUMOR|SOLIDIFIED||RULER MEASUREMENT METHOD|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U|Y|3|Visit_3|40|2|WASHOUT|2020-07-24|2020-09-08|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|b2ce31a0-513a-449a-aa2c-7c9668fde275|7|BASEEXCS|Base Excess|CHEMISTRY|||[?]|[?]|POSITIVE|1|cpm|1|1|[?]|HIGH|URINE SEDIMENT|ICTERIC||IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U|Y|4|Visit_4|65|1|FOLLOW-UP|2020-08-18|2020-09-02|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|b2ce31a0-513a-449a-aa2c-7c9668fde275|8|HRYCECE|Hairy Cells/Total Cells|HEMATOLOGY|[?]|dyn|[?]|[?]|POSITIVE|1|/40 HPFs|1|1|[?]|NORMAL|EPIDERMAL TISSUE|AUTOLYZED|N|ORCHIDOMETERY|CKD-EPI FORMULA||Y|U||4|Visit_4|65|4|WASHOUT|2020-08-18|2020-09-06|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|b2ce31a0-513a-449a-aa2c-7c9668fde275|9|HEINZ|Heinz Bodies|HEMATOLOGY|[?]|AFU|[?]|[?]|INDETERMINATE|1|g/animal/day|1|1|[?]|HIGH|ERYTHROCYTES|CALCIFIED|N|FLUORESCENT SPOT TEST|CKD-EPI CREATININE FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-09-12|2020-09-13|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|b2ce31a0-513a-449a-aa2c-7c9668fde275|10|AHBDH|Alpha Hydroxybutyrate Dehydrogenase|CHEMISTRY|||[?]|[?]|BORDERLINE|1|10^6 organisms/mg|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|ICTERIC|N|FLUORESCENT MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|Y|5|Visit_5|90|7|FOLLOW-UP|2020-09-12|2020-09-15|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|6c1d481b-985a-4be0-97ca-ecd06a81b456|1|SMUSCAB|Smooth Muscle Antibody|HEMATOLOGY|[?]|mg/g/h|[?]|[?]|TRACE|1|10^9 organisms|1|1|[?]|NORMAL|EPITHELIAL CELL|CALCIFIED||DOPPLER ULTRASOUND|CKD-EPI FORMULA||Y|Y||1|Visit_1|10|6|TREATMENT|2020-10-05|2020-10-22|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|6c1d481b-985a-4be0-97ca-ecd06a81b456|2|HIST3AB|Histone 3 Antibody|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|uL/dose|1|1|[?]|HIGH|SERUM OR PLASMA|SOLIDIFIED||NEURAMINIDASE INHIBITION ASSAY|CKD-EPI FORMULA|||N|Y|1|Visit_1|10|1|SCREENING|2020-10-05|2020-11-02|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|6c1d481b-985a-4be0-97ca-ecd06a81b456|3|DPD|Deoxypyridinoline|CHEMISTRY|[?]|IU/dL|[?]|[?]|POSITIVE|1|log10 PFU|1|1|[?]|NORMAL|VENOUS CORD BLOOD|AUTOLYZED||MANUAL CLOT DETECTION|MDRD 5 VARIABLE FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-10-20|2020-11-27|25|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|6c1d481b-985a-4be0-97ca-ecd06a81b456|4|LDL|LDL Cholesterol|CHEMISTRY|[?]|PIXEL|[?]|[?]|POSITIVE|1|m|1|1|[?]|ABNORMAL|SMEGMA|AUTOLYZED||IMMUNOFLUORESCENT STAIN|MDRD FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-10-20|2020-10-28|25|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|LB|6c1d481b-985a-4be0-97ca-ecd06a81b456|5|CH100|Complement CH100|URINALYSIS|[?]|CYLINDER|[?]|[?]|INDETERMINATE|1|mm|1|1|[?]|ABNORMAL|HAIR|REFRIGERATED||IRON HEMATOXYLIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA||3|Visit_3|40|7|TREATMENT|2020-11-04|2020-12-11|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|6c1d481b-985a-4be0-97ca-ecd06a81b456|6|P50OXYGN|P50 Oxygen|CHEMISTRY|[?]|hr/day|[?]|[?]|NEGATIVE|1|ug/mol|1|1|[?]|HIGH|PLATELET POOR PLASMA|NON-HEMOLYZED||IMMUNORADIOMETRIC ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||3|Visit_3|40|5|WASHOUT|2020-11-04|2020-11-17|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|6c1d481b-985a-4be0-97ca-ecd06a81b456|7|NAGASEXR|NAGASE Excretion Rate|HEMATOLOGY|[?]|mL/g/min|[?]|[?]|NEGATIVE|1|/200 HPFs|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|FROZEN||HEMATOXYLIN AND EOSIN STAIN|GMI MMOL/MOL FORMULA|||U||4|Visit_4|65|5|TREATMENT|2020-11-29|2020-12-09|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|6c1d481b-985a-4be0-97ca-ecd06a81b456|8|C165919|German Cockroach IgG AB RAST Score|URINALYSIS|[?]|FFU|[?]|[?]|BORDERLINE|1|cm H2O|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|SOLIDIFIED|N|FREEZING POINT DEPRESSION|CKD-EPI CREATININE FORMULA|Y||NA||4|Visit_4|65|4|FOLLOW-UP|2020-11-29|2020-12-05|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|LB|6c1d481b-985a-4be0-97ca-ecd06a81b456|9|LDH5LDH|LDH Isoenzyme 5/LDH|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|TRANSDUCING UNIT|1|1|[?]|LOW|ISOLATE|DRIED||MOUSE PROTECTION ASSAY|FIBROMETER FORMULA|Y||Y|Y|5|Visit_5|90|1|FOLLOW-UP|2020-12-24|2020-12-30|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|6c1d481b-985a-4be0-97ca-ecd06a81b456|10|SPERMMTL|Sperm Motility|URINALYSIS|[?]|deg/mm|[?]|[?]|NEGATIVE|1|uV2|1|1|[?]|ABNORMAL|SWABBED MATERIAL|SOLIDIFIED||LIGHT MICROSCOPY|FIBROTEST FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2020-12-24|2020-12-26|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|645a9247-efcb-4641-9514-58d6e28560e0|1|CHRMTNAB|Chromatin Antibodies|URINALYSIS|[?]|genEq|[?]|[?]|BORDERLINE|1|L/s|1|1|[?]|NORMAL|MUSCLE TISSUE|CLOTTED|N|POTENTIOMETRY|MDRD FORMULA||Y|N||1|Visit_1|10|2|FOLLOW-UP|2020-12-21|2021-02-14|10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|645a9247-efcb-4641-9514-58d6e28560e0|2|HOWJOL|Howell-Jolly Bodies|CHEMISTRY|[?]|%(w/v)|[?]|[?]|NEGATIVE|1|mL/h|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|REFRIGERATED||SISH|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||1|Visit_1|10|7|WASHOUT|2020-12-21|2021-02-02|10|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|LB|645a9247-efcb-4641-9514-58d6e28560e0|3|HDLPSZ|HDL Particle Size|CHEMISTRY|[?]|mV2/Hz|[?]|[?]|POSITIVE|1|CCID 50/mL|1|1|[?]|NORMAL|ERYTHROCYTES|ICTERIC|N|NEPHELOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2021-01-05|2021-03-12|25|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|645a9247-efcb-4641-9514-58d6e28560e0|4|PNCTPP|Pancreatic Polypeptide|URINALYSIS|[?]|/cmH2O|[?]|[?]|TRACE|1|uL|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR||PAP STAIN|NASH FIBROSURE FORMULA||Y|N||2|Visit_2|25|4|TREATMENT|2021-01-05|2021-03-08|25|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|645a9247-efcb-4641-9514-58d6e28560e0|5|BAFF|B-Cell Activating Factor|URINALYSIS|||[?]|[?]|POSITIVE|1|log10 PFU/mL|1|1|[?]|NORMAL|EPIDERMAL TISSUE|GELLED||GC/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U|Y|3|Visit_3|40|5|FOLLOW-UP|2021-01-20|2021-02-19|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|645a9247-efcb-4641-9514-58d6e28560e0|6|SPMPSPM|Spermatozoa, Progressive/Spermatozoa|CHEMISTRY|[?]|Hz/s|[?]|[?]|TRACE|1|P|1|1|[?]|HIGH|ABSCESS FLUID|DRIED||HPLC/MS|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2021-01-20|2021-02-23|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|645a9247-efcb-4641-9514-58d6e28560e0|7|HCGNDI|Choriogonadotropin, Intact|CHEMISTRY|[?]|Ejaculate U|[?]|[?]|POSITIVE|1|uL|1|1|[?]|LOW|KERATINOCYTE|SOLIDIFIED||CYSTOMETRY|CKD-EPI FORMULA|Y||NA||4|Visit_4|65|5|FOLLOW-UP|2021-02-14|2021-03-16|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|645a9247-efcb-4641-9514-58d6e28560e0|8|C130106|Weed Mix Pollen Antigen IgE Antibody|URINALYSIS|||[?]|[?]|TRACE|1|ng/mol|1|1|[?]|LOW|TUMOR TISSUE|SOLIDIFIED||GRAM STAIN|MDRD 4 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|6|TREATMENT|2021-02-14|2021-03-11|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|645a9247-efcb-4641-9514-58d6e28560e0|9|MPC|Mean Platelet Component|CHEMISTRY|[?]|uL|[?]|[?]|INDETERMINATE|1|kg/cm|1|1|[?]|HIGH|PLASMA ULTRAFILTRATE|HEMOLYZED||SPIROMETRY|CKD-EPI CREATININE FORMULA|||NA||5|Visit_5|90|4|WASHOUT|2021-03-11|2021-03-19|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|645a9247-efcb-4641-9514-58d6e28560e0|10|CGMP|Cyclic Guanosine Monophosphate|CHEMISTRY|[?]|COAT|[?]|[?]|TRACE|1|GBq/g|1|1|[?]|HIGH|SKIN TISSUE|CALCIFIED||KINETIC CHROMOGENIC ASSAY|FIBROMETER FORMULA||Y|N||5|Visit_5|90|6|TREATMENT|2021-03-11|2021-03-19|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|1|COPPER|Copper|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|kg|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|FRESH||PANENDOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|1|Visit_1|10|6|SCREENING|2020-09-15|2020-10-09|10|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|2|TROPONT|Troponin T|CHEMISTRY|[?]|MBq|[?]|[?]|TRACE|1|/min|1|1|[?]|LOW|PLATELET POOR PLASMA|CALCIFIED||MEDIASTINOSCOPY|MDRD 6 VARIABLE FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-09-15|2020-10-29|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|LB|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|3|TIMP1|Tissue Inhibitor of Metalloproteinase 1|CHEMISTRY|[?]|/10^3|[?]|[?]|POSITIVE|1|fL|1|1|[?]|LOW|PLASMA|CALCIFIED||AUSCULTATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|7|FOLLOW-UP|2020-09-30|2020-12-11|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|4|CITRTEXR|Citrate Excretion Rate|CHEMISTRY|[?]|kBq/uL|[?]|[?]|NEGATIVE|1|mU/g|1|1|[?]|ABNORMAL|BASAL TEAR|LACTESCENT||HEMAGGLUTINATION ASSAY|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|7|SCREENING|2020-09-30|2020-11-14|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|5|TROPONI1|Troponin I Type 1|URINALYSIS|[?]|kV|[?]|[?]|BORDERLINE|1|mL/kg/h|1|1|[?]|LOW|BILE|FROZEN||HPLC-UV|FIBROMETER FORMULA|||U||3|Visit_3|40|5|WASHOUT|2020-10-15|2020-12-09|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|6|RUB|Rubricyte|URINALYSIS|[?]|LB|[?]|[?]|NEGATIVE|1|mL*cmH2O|1|1|[?]|LOW|LEUKOCYTE|ICTERIC||PHASE-CONTRAST MRI|FIBROMETER FORMULA|Y||NA||3|Visit_3|40|6|WASHOUT|2020-10-15|2020-10-29|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|7|LDLHDL|LDL Cholesterol/HDL Cholesterol|URINALYSIS|||[?]|[?]|BORDERLINE|1|BP|1|1|[?]|LOW|ISOLATE|CONTAMINATED||MICROARRAY|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y|Y|4|Visit_4|65|6|TREATMENT|2020-11-09|2020-11-28|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|8|COCAINE|Cocaine|URINALYSIS|[?]|nmol/L/min|[?]|[?]|TRACE|1|Absorbance U/mL|1|1|[?]|LOW|MONOCYTE|LACTESCENT||X-RAY FLUORESCENCE SPECTROMETRY|GMI MMOL/MOL FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-11-09|2020-12-01|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|9|PYY|Peptide YY|CHEMISTRY|||[?]|[?]|TRACE|1|ppth|1|1|[?]|HIGH|BUFFY COAT|PARAFFIN-EMBEDDED||FARR ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N|Y|5|Visit_5|90|1|FOLLOW-UP|2020-12-04|2020-12-12|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|10|ROULEAUX|Rouleaux Formation|URINALYSIS|[?]|BE/mL|[?]|[?]|NEGATIVE|1|U/g/day|1|1|[?]|HIGH|ARTERIAL BLOOD|THAWED||CONTRAST ENHANCED CT SCAN|MDRD 4 VARIABLE FORMULA||Y|NA||5|Visit_5|90|1|WASHOUT|2020-12-04|2020-12-09|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|05b05951-b1ba-4c51-b50f-9c842532bc4e|1|FXAAC|Factor X Activity Actual/Control|URINALYSIS|[?]|/HPF|[?]|[?]|NEGATIVE|1|VIAL|1|1|[?]|LOW|RETICULOCYTES|CALCIFIED||GC/MS-CI|HEPASCORE FORMULA|||Y||1|Visit_1|10|5|WASHOUT|2020-07-28|2020-10-21|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|05b05951-b1ba-4c51-b50f-9c842532bc4e|2|INTLK20|Interleukin 20|HEMATOLOGY|[?]|%/s|[?]|[?]|POSITIVE|1|umol/min|1|1|[?]|ABNORMAL|ERYTHROCYTES|CLOTTED|N|KINETIC MICROPARTICLE IMMUNOASSAY|CKD-EPI FORMULA|||NA||1|Visit_1|10|4|WASHOUT|2020-07-28|2020-10-17|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|05b05951-b1ba-4c51-b50f-9c842532bc4e|3|CD1|CD1|CHEMISTRY|[?]|HEP|[?]|[?]|TRACE|1|min|1|1|[?]|ABNORMAL|TISSUE|PARAFFIN-EMBEDDED||HIGH RESOLUTION CT|CKD-EPI FORMULA||Y|Y||2|Visit_2|25|2|SCREENING|2020-08-12|2020-10-24|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|05b05951-b1ba-4c51-b50f-9c842532bc4e|4|HGBA2HGB|Hemoglobin A2/Total Hemoglobin|HEMATOLOGY|[?]|POUCH|[?]|[?]|NEGATIVE|1|cal|1|1|[?]|NORMAL|INFRANATANT, PLASMA|LACTESCENT||DYNAMIC LIGHT SCATTERING|GMI % FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-08-12|2020-09-17|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|05b05951-b1ba-4c51-b50f-9c842532bc4e|5|KYNURNN|Kynurenine|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|cGy|1|1|[?]|ABNORMAL|ISOLATE|HEMOLYZED||MODIFIED ACID FAST STAIN|NASH FIBROSURE FORMULA|||U|Y|3|Visit_3|40|1|SCREENING|2020-08-27|2020-09-06|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|05b05951-b1ba-4c51-b50f-9c842532bc4e|6|ARG|Arginine|HEMATOLOGY|[?]|mmHg/sec|[?]|[?]|INDETERMINATE|1|cycle/min|1|1|[?]|NORMAL|PERSPIRATION|CLOTTED|N|MICROBIAL CULTURE, SOLID|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|4|SCREENING|2020-08-27|2020-10-19|40|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|05b05951-b1ba-4c51-b50f-9c842532bc4e|7|HAHA|Human Anti-Human Antibody|CHEMISTRY|[?]|Gravitational Unit|[?]|[?]|TRACE|1|Ci/ug|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|HEMOLYZED|N|IMMUNOFIXATION ELECTROPHORESIS|GMI % FORMULA|Y|Y|U||4|Visit_4|65|5|TREATMENT|2020-09-21|2020-09-24|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|05b05951-b1ba-4c51-b50f-9c842532bc4e|8|PLG|Plasminogen|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|ug/kg/day|1|1|[?]|LOW|CORD SERUM|NON-HEMOLYZED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|Y|Y|U|Y|4|Visit_4|65|4|WASHOUT|2020-09-21|2020-10-05|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|05b05951-b1ba-4c51-b50f-9c842532bc4e|9|PTSAC|Protein S Actual/Control|URINALYSIS|[?]|GBq/ug|[?]|[?]|INDETERMINATE|1|U/g/min|1|1|[?]|NORMAL|SERUM|LIPEMIC|N|GRADIENT DIFFUSION|MDRD 4 VARIABLE FORMULA||Y|NA||5|Visit_5|90|6|TREATMENT|2020-10-16|2020-10-25|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|05b05951-b1ba-4c51-b50f-9c842532bc4e|10|INULIN|Inulin|CHEMISTRY|||[?]|[?]|INVALID|1|MBq/uL|1|1|[?]|ABNORMAL|VITREOUS HUMOR|CONTAMINATED||ORCHIDOMETERY|CKD-EPI CREATININE FORMULA|||U|Y|5|Visit_5|90|4|SCREENING|2020-10-16|2020-10-24|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|ab38e976-8c2b-48ff-bdba-5a056637ecdd|1|C3|Complement C3|CHEMISTRY|[?]|keV|[?]|[?]|POSITIVE|1|BAG|1|1|[?]|LOW|CALCULUS|LIPEMIC||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD FORMULA|||Y||1|Visit_1|10|2|FOLLOW-UP|2020-10-23|2021-01-14|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|ab38e976-8c2b-48ff-bdba-5a056637ecdd|2|IRF|Immature Reticulocyte Fraction|CHEMISTRY|[?]|Bq/kg|[?]|[?]|TRACE|1|mL/kg/min|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|CONCENTRATED||IMMUNORADIOMETRIC ASSAY|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-10-23|2020-11-27|10|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|ab38e976-8c2b-48ff-bdba-5a056637ecdd|3|CSBROAD|Broad Casts|HEMATOLOGY|[?]|g/cage/wk|[?]|[?]|INDETERMINATE|1|PLUG|1|1|[?]|NORMAL|MENSTRUAL BLOOD|FRESH||TURBIDIMETRY|MDRD 6 VARIABLE FORMULA||Y|N||2|Visit_2|25|5|TREATMENT|2020-11-07|2021-01-02|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|ab38e976-8c2b-48ff-bdba-5a056637ecdd|4|CYURIAC|Uric Acid Crystals|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|IU/day|1|1|[?]|NORMAL|LEUKOCYTE|PARAFFIN-EMBEDDED||THICK SMEAR|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|2|Visit_2|25|4|TREATMENT|2020-11-07|2020-12-02|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|ab38e976-8c2b-48ff-bdba-5a056637ecdd|5|UREACRT|Urea/Creatinine|URINALYSIS|||[?]|[?]|NEGATIVE|1|pmol/day|1|1|[?]|HIGH|URINE|CALCIFIED||GC/MS-EI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|3|Visit_3|40|1|FOLLOW-UP|2020-11-22|2021-01-08|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|ab38e976-8c2b-48ff-bdba-5a056637ecdd|6|FABP3|Fatty Acid Binding Protein 3|HEMATOLOGY|[?]|umol/L/sec|[?]|[?]|BORDERLINE|1|mL/kg|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|CALCIFIED||FLUORESCENCE ANGIOGRAPHY|FIBROSIS 4 FORMULA|||U||3|Visit_3|40|1|FOLLOW-UP|2020-11-22|2020-12-26|40|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|ab38e976-8c2b-48ff-bdba-5a056637ecdd|7|C165901|EnglishPlantain Pollen IgG AB RAST Score|CHEMISTRY|[?]|Ci/L|[?]|[?]|BORDERLINE|1|CCID 50/mL|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|ICTERIC|N|IMMUNOPRECIPITATION|CKD-EPI CYSTATIN C FORMULA|||N||4|Visit_4|65|6|TREATMENT|2020-12-17|2020-12-29|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|ab38e976-8c2b-48ff-bdba-5a056637ecdd|8|DNA|Deoxyribonucleic Acid|URINALYSIS|[?]|RING|[?]|[?]|INDETERMINATE|1|mEq/dL|1|1|[?]|LOW|SEBUM|AGGLUTINATED||BETA LACTAMASE|HEPASCORE FORMULA|Y|Y|U||4|Visit_4|65|2|FOLLOW-UP|2020-12-17|2021-01-14|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|ab38e976-8c2b-48ff-bdba-5a056637ecdd|9|SDMA|Symmetric Dimethylarginine|CHEMISTRY|[?]|uV*sec|[?]|[?]|BORDERLINE|1|mg/animal|1|1|[?]|NORMAL|SERUM OR PLASMA|LACTESCENT||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2021-01-11|2021-01-20|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|ab38e976-8c2b-48ff-bdba-5a056637ecdd|10|INTLK21|Interleukin 21|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ELISA unit/dose|1|1|[?]|LOW|LEUKOCYTE|ROOM TEMPERATURE||PH METER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA|Y||N|Y|5|Visit_5|90|7|TREATMENT|2021-01-11|2021-01-14|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|1|THYATAB|Thyroid Antithyroglobulin Antibodies|CHEMISTRY|[?]|CAPFUL|[?]|[?]|INDETERMINATE|1|SYRINGE|1|1|[?]|LOW|MECONIUM|LACTESCENT||ELECTROGASTROGRAPHY|MDRD 5 VARIABLE FORMULA|Y||U||1|Visit_1|10|7|TREATMENT|2020-08-31|2020-09-09|10|19|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|2|C165894|D. farinae Antigen IgG4 Antibody|CHEMISTRY|[?]|ks|[?]|[?]|BORDERLINE|1|Ci/mg|1|1|[?]|NORMAL|BLOOD|THAWED||RAJI CELL EIA|ASH FIBROSURE FORMULA|||U||1|Visit_1|10|3|WASHOUT|2020-08-31|2020-09-27|10|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|3|VLDLTCT|VLDL Triglyceride + Chylomicron Triglyceride|CHEMISTRY|[?]|MBq/uL|[?]|[?]|INVALID|1|kDa|1|1|[?]|LOW|EMOTIONAL TEAR|AGGLUTINATED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 5 VARIABLE FORMULA|Y||U||2|Visit_2|25|4|WASHOUT|2020-09-15|2020-10-17|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|4|TCDCA|Taurochenodeoxycholate|CHEMISTRY|[?]|mmol/min/kPa|[?]|[?]|BORDERLINE|1|uOsm|1|1|[?]|NORMAL|PLASMA|FRESH|N|TURBIDIMETRY|MDRD FORMULA|Y||N||2|Visit_2|25|3|SCREENING|2020-09-15|2020-10-28|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|5|STOMCY|Stomatocytes|CHEMISTRY|[?]|ug/kg|[?]|[?]|INVALID|1|/month|1|1|[?]|ABNORMAL|BREAST MILK|UNEXPECTED ODOR||FREEZING POINT DEPRESSION|ASH FIBROSURE FORMULA|||N||3|Visit_3|40|7|WASHOUT|2020-09-30|2020-10-09|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|6|OXAEXR|Oxalate Excretion Rate|URINALYSIS|||[?]|[?]|POSITIVE|1|umol/min|1|1|[?]|HIGH|CORD BLOOD|AUTOLYZED||CHROMATOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||Y|Y|3|Visit_3|40|1|SCREENING|2020-09-30|2020-11-21|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|7|DHEAS|Dehydroepiandrosterone Sulfate|HEMATOLOGY|[?]|mg/min|[?]|[?]|BORDERLINE|1|SYRINGE|1|1|[?]|NORMAL|EPITHELIAL CELL|GELLED||LAPAROSCOPY|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|3|FOLLOW-UP|2020-10-25|2020-10-27|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|8|IGFBP2|Insulin-Like Growth Factor Binding Prot2|URINALYSIS|[?]|ug/day|[?]|[?]|INDETERMINATE|1|10^3/L|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|LIPEMIC||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD FORMULA|||U||4|Visit_4|65|7|SCREENING|2020-10-25|2020-11-22|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|9|ANCATYAB|Neutrophil Cytoplasmic Ab, Atypical|CHEMISTRY|||[?]|[?]|TRACE|1|VOXEL|1|1|[?]|NORMAL|SKIN TISSUE|UNEXPECTED ODOR|N|WESTERGREN|CKD-EPI FORMULA|Y|Y|N|Y|5|Visit_5|90|2|TREATMENT|2020-11-19|2020-11-25|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|10|AAMAPAC|Alpha-Aminoadipic Acid|URINALYSIS|[?]|NEBULE|[?]|[?]|NEGATIVE|1|g/cage|1|1|[?]|ABNORMAL|SMEGMA|FROZEN|N|BIOIMPEDANCE SPECTROSCOPY|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|4|SCREENING|2020-11-19|2020-11-20|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|51a49847-6405-4842-b549-0e2ab99f61b2|1|CORTFR|Cortisol, Free|CHEMISTRY|||[?]|[?]|NEGATIVE|1|10^6/g|1|1|[?]|ABNORMAL|FLUID|NON-HEMOLYZED||TOLUIDINE BLUE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|1|Visit_1|10|3|SCREENING|2021-01-16|2021-02-20|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|LB|51a49847-6405-4842-b549-0e2ab99f61b2|2|C130107|Weed Mix Pollen Antigen IgG Antibody|URINALYSIS|[?]|Ci/mg|[?]|[?]|NEGATIVE|1|U/g/min|1|1|[?]|NORMAL|PLEURAL TISSUE|FROZEN|N|ENDPOINT DILUTION ASSAY|ASH FIBROSURE FORMULA||Y|Y||1|Visit_1|10|7|TREATMENT|2021-01-16|2021-03-21|10|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|LB|51a49847-6405-4842-b549-0e2ab99f61b2|3|C165933|American Cockroach IgE AB RAST Score|HEMATOLOGY|[?]|fmol/L|[?]|[?]|POSITIVE|1|SCOOPFUL|1|1|[?]|HIGH|LUNG SURFACTANT|FRESH||MAPH|CKD-EPI CYSTATIN C FORMULA|||U||2|Visit_2|25|1|WASHOUT|2021-01-31|2021-02-04|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-15
e|LB|51a49847-6405-4842-b549-0e2ab99f61b2|4|PTA|Prothrombin Activity|CHEMISTRY|[?]|nU/cL|[?]|[?]|INVALID|1|mL/kg|1|1|[?]|LOW|PLEURAL FLUID|PARAFFIN-EMBEDDED||ORCHIDOMETERY|MDRD 5 VARIABLE FORMULA|||U||2|Visit_2|25|5|TREATMENT|2021-01-31|2021-04-06|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-15
e|LB|51a49847-6405-4842-b549-0e2ab99f61b2|5|HALLUC|Hallucinogen|URINALYSIS|[?]|BLOCKS|[?]|[?]|POSITIVE|1|mL/g/h|1|1|[?]|ABNORMAL|EXUDATE|AGGLUTINATED|N|ELLA|GMI % FORMULA|||Y||3|Visit_3|40|1|WASHOUT|2021-02-15|2021-03-17|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|51a49847-6405-4842-b549-0e2ab99f61b2|6|LIPEMIAI|Lipemic Index|URINALYSIS|[?]|U/m2|[?]|[?]|POSITIVE|1|nkat|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED||CINEANGIOGRAPHY|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2021-02-15|2021-02-25|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|51a49847-6405-4842-b549-0e2ab99f61b2|7|TRANK1|TPR-Ankyrin Repeat-Containing Protein 1|HEMATOLOGY|[?]|INHALATION|[?]|[?]|POSITIVE|1|uOsm|1|1|[?]|ABNORMAL|TUMOR TISSUE|HEMOLYZED|N|HIGH RESOLUTION CT|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|7|WASHOUT|2021-03-12|2021-03-18|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|LB|51a49847-6405-4842-b549-0e2ab99f61b2|8|FVIIIAAC|Factor VIII Activity Actual/Control|HEMATOLOGY|[?]|mg/kg|[?]|[?]|POSITIVE|1|U/dL|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|FROZEN|N|PAP STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|3|TREATMENT|2021-03-12|2021-03-15|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|LB|51a49847-6405-4842-b549-0e2ab99f61b2|9|CYSTINE|Cystine|CHEMISTRY|||[?]|[?]|TRACE|1|mph|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|HEMOLYZED||QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROTEST FORMULA|Y||U|Y|5|Visit_5|90|7|WASHOUT|2021-04-06|2021-04-08|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|LB|51a49847-6405-4842-b549-0e2ab99f61b2|10|MCHC|Ery. Mean Corpuscular HGB Concentration|HEMATOLOGY|[?]|Bq/kg|[?]|[?]|INDETERMINATE|1|F|1|1|[?]|LOW|SEMINAL FLUID|CONTAMINATED||DARK FIELD MICROSCOPY|CKD-EPI FORMULA|||U||5|Visit_5|90|3|SCREENING|2021-04-06|2021-04-07|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|LB|44dcfb9a-c590-4826-a28c-b5e9f83129d5|1|INTLK26|Interleukin 26|HEMATOLOGY|[?]|10^9 organisms/mg|[?]|[?]|TRACE|1|CIGARETTE|1|1|[?]|ABNORMAL|SERUM OR PLASMA|AUTOLYZED||PELLI-ROBSON EYE CHART|MDRD ENZYMATIC FORMULA||Y|U||1|Visit_1|10|2|WASHOUT|2020-05-21|2020-06-03|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|LB|44dcfb9a-c590-4826-a28c-b5e9f83129d5|2|TPAG|Tissue Polypeptide Antigen|CHEMISTRY|[?]|mol/day|[?]|[?]|INDETERMINATE|1|nL|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|AUTOLYZED|N|IMMUNOBLOT|MDRD FORMULA|||NA||1|Visit_1|10|6|WASHOUT|2020-05-21|2020-07-13|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|LB|44dcfb9a-c590-4826-a28c-b5e9f83129d5|3|RBPCREAT|Retinol Binding Protein/Creatinine|CHEMISTRY|[?]|Enzyme U|[?]|[?]|BORDERLINE|1|m/sec2|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|UNEXPECTED ODOR|N|NEURAMINIDASE INHIBITION ASSAY|COCKCROFT-GAULT FORMULA||Y|NA||2|Visit_2|25|7|TREATMENT|2020-06-05|2020-06-09|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-20
e|LB|44dcfb9a-c590-4826-a28c-b5e9f83129d5|4|PREALB|Prealbumin|HEMATOLOGY|[?]|nmol/day|[?]|[?]|POSITIVE|1|mg/m2/h|1|1|[?]|HIGH|LYMPH|AGGLUTINATED||RADIAL IMMUNODIFFUSION|NASH FIBROSURE FORMULA||Y|U||2|Visit_2|25|5|TREATMENT|2020-06-05|2020-08-13|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-20
e|LB|44dcfb9a-c590-4826-a28c-b5e9f83129d5|5|LEAD|Lead|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|kcal/day|1|1|[?]|LOW|BILE|GELLED|N|FLOCCULATION, CHARCOAL ENHANCED|MDRD 6 VARIABLE FORMULA|Y||NA|Y|3|Visit_3|40|5|TREATMENT|2020-06-20|2020-07-16|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|LB|44dcfb9a-c590-4826-a28c-b5e9f83129d5|6|DENSITY|Density|URINALYSIS|[?]|Log10 ELISA unit/dose|[?]|[?]|INVALID|1|tsp eq|1|1|[?]|ABNORMAL|LEUKOCYTE|FRESH||IN SITU HYBRIDIZATION|ASH FIBROSURE FORMULA|||U||3|Visit_3|40|2|FOLLOW-UP|2020-06-20|2020-06-25|40|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|LB|44dcfb9a-c590-4826-a28c-b5e9f83129d5|7|MORPHINE|Morphine|URINALYSIS|||[?]|[?]|TRACE|1|cd/m2|1|1|[?]|HIGH|SOFT TISSUE|UNEXPECTED ODOR||SXA SCAN|GMI MMOL/MOL FORMULA|||Y|Y|4|Visit_4|65|3|TREATMENT|2020-07-15|2020-08-18|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|44dcfb9a-c590-4826-a28c-b5e9f83129d5|8|MERCURY|Mercury|CHEMISTRY|||[?]|[?]|TRACE|1|beats/min|1|1|[?]|LOW|INFRANATANT, SERUM|LACTESCENT||WHOLE GENOME SEQUENCING|GMI % FORMULA|Y|Y|N|Y|4|Visit_4|65|5|SCREENING|2020-07-15|2020-08-16|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|44dcfb9a-c590-4826-a28c-b5e9f83129d5|9|PTAUAB42|Phosphorylated Tau Prot/Amyloid Beta1-42|HEMATOLOGY|||[?]|[?]|INVALID|1|TRACE|1|1|[?]|HIGH|BREAST MILK|SOLIDIFIED||PUPILLOMETRY|FIBROSIS 4 FORMULA|||Y|Y|5|Visit_5|90|2|FOLLOW-UP|2020-08-09|2020-08-13|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|44dcfb9a-c590-4826-a28c-b5e9f83129d5|10|EOSIMLE|Immature Eosinophils/Leukocytes|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|BE/mL|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|N|CONTACT SPECULAR MICROSCOPY|FIBROTEST FORMULA|Y||N|Y|5|Visit_5|90|3|TREATMENT|2020-08-09|2020-08-11|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|98166d74-caa7-4693-a817-b2cbae947ff8|1|CXCR3|Chemokine (C-X-C Motif) Receptor 3|CHEMISTRY|[?]|g/mol|[?]|[?]|INVALID|1|cup eq|1|1|[?]|NORMAL|MUSCLE TISSUE|UNEXPECTED ODOR||NUCLEIC ACID HYBRIDIZATION|CKD-EPI FORMULA|||U||1|Visit_1|10|2|WASHOUT|2021-01-11|2021-02-01|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|98166d74-caa7-4693-a817-b2cbae947ff8|2|HBA2PHB|Hemoglobin A2 Prime/Total Hemoglobin|HEMATOLOGY|[?]|mL/sec/1.73m2|[?]|[?]|INVALID|1|fmol|1|1|[?]|NORMAL|SALIVA|DRIED|N|LIGHT MICROSCOPY|MDRD FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2021-01-11|2021-02-19|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|98166d74-caa7-4693-a817-b2cbae947ff8|3|PGES|Prostaglandin E Synthase|URINALYSIS|[?]|TRACE|[?]|[?]|POSITIVE|1|uEq/L|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|AUTOLYZED||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|7|FOLLOW-UP|2021-01-26|2021-02-01|25|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|98166d74-caa7-4693-a817-b2cbae947ff8|4|RENINA|Renin Activity|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|10^6 organisms/mL|1|1|[?]|ABNORMAL|EXPIRED AIR|ROOM TEMPERATURE||PERIODIC ACID SCHIFF STAIN|ASH FIBROSURE FORMULA|||NA|Y|2|Visit_2|25|5|FOLLOW-UP|2021-01-26|2021-03-11|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|98166d74-caa7-4693-a817-b2cbae947ff8|5|C165939|Egg White IgE AB RAST Score|HEMATOLOGY|[?]|BU/mL|[?]|[?]|INVALID|1|PACK|1|1|[?]|LOW|SPUTUM|CALCIFIED|N|ACRIDINE ORANGE STAIN|GMI MMOL/MOL FORMULA|Y||U||3|Visit_3|40|6|TREATMENT|2021-02-10|2021-03-12|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|98166d74-caa7-4693-a817-b2cbae947ff8|6|ALLOILE|Alloisoleucine|HEMATOLOGY|[?]|EVENTS|[?]|[?]|NEGATIVE|1|deg|1|1|[?]|ABNORMAL|HAIR|GELLED||MICROPARTICLE ENZYME IMMUNOASSAY|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|1|TREATMENT|2021-02-10|2021-02-21|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|98166d74-caa7-4693-a817-b2cbae947ff8|7|APAPCYS|Acetaminophen-Cysteine Adduct|URINALYSIS|[?]|10^7/L|[?]|[?]|INDETERMINATE|1|kg/L|1|1|[?]|LOW|INTERSTITIAL FLUID|PARAFFIN-EMBEDDED||MRS|CKD-EPI CREATININE FORMULA|Y||N||4|Visit_4|65|1|FOLLOW-UP|2021-03-07|2021-03-11|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|LB|98166d74-caa7-4693-a817-b2cbae947ff8|8|MNC|Mononuclear Cells|URINALYSIS|[?]|cmH2O*s2/mL|[?]|[?]|POSITIVE|1|km/h|1|1|[?]|ABNORMAL|PERSPIRATION|ICTERIC||AURAMINE STAIN|FIBROSIS 4 FORMULA|Y||U||4|Visit_4|65|5|WASHOUT|2021-03-07|2021-03-10|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|LB|98166d74-caa7-4693-a817-b2cbae947ff8|9|KIM1S|Soluble Kidney Injury Molecule-1|CHEMISTRY|[?]|IU/dL|[?]|[?]|POSITIVE|1|cmol/L|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|DRIED||IMPULSE OSCILLOMETRY|CKD-EPI FORMULA|||Y||5|Visit_5|90|2|WASHOUT|2021-04-01|2021-04-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-03
e|LB|98166d74-caa7-4693-a817-b2cbae947ff8|10|RBC|Erythrocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|fmol/L/sec|1|1|[?]|HIGH|CALCULUS|CALCIFIED||BIOPSY|FIBROSIS 4 FORMULA|Y|Y|U|Y|5|Visit_5|90|5|TREATMENT|2021-04-01|2021-04-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-03
e|LB|cb07675a-2042-44da-a1f9-8b7783347e88|1|C165880|D. pteronyssinus IgE AB RAST Score|CHEMISTRY|[?]|BU|[?]|[?]|INVALID|1|mL/breath|1|1|[?]|NORMAL|LYSATE|PARAFFIN-EMBEDDED|N|CLINICAL EVALUATION|MDRD 5 VARIABLE FORMULA||Y|Y||1|Visit_1|10|6|FOLLOW-UP|2020-12-05|2021-02-18|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|cb07675a-2042-44da-a1f9-8b7783347e88|2|GSTTH|Glutathione S-Transferase, Theta|URINALYSIS|||[?]|[?]|NEGATIVE|1|TAMPON|1|1|[?]|LOW|EXUDATE|CLOTTED|N|DYNAMOMETRY|MDRD 6 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|3|TREATMENT|2020-12-05|2020-12-20|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|cb07675a-2042-44da-a1f9-8b7783347e88|3|CKBB|Creatine Kinase BB|CHEMISTRY|[?]|pmol/L|[?]|[?]|INDETERMINATE|1|BOX|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|FRESH||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|CKD-EPI CREATININE FORMULA|Y||NA||2|Visit_2|25|1|TREATMENT|2020-12-20|2020-12-22|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|cb07675a-2042-44da-a1f9-8b7783347e88|4|MYBLA|Myeloblasts|HEMATOLOGY|[?]|mL/cage/wk|[?]|[?]|BORDERLINE|1|ELISA unit|1|1|[?]|LOW|ADIPOSE TISSUE|REFRIGERATED|N|DOPPLER ULTRASOUND|CKD-EPI CREATININE FORMULA|Y|Y|U||2|Visit_2|25|2|TREATMENT|2020-12-20|2021-01-15|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|cb07675a-2042-44da-a1f9-8b7783347e88|5|C165920|White Elm Pollen IgG AB RAST Score|URINALYSIS|[?]|mg/mL/min|[?]|[?]|BORDERLINE|1|MBq/uL|1|1|[?]|NORMAL|SMEGMA|CLOTTED||FUNCTIONAL MRI|MDRD FORMULA||Y|U||3|Visit_3|40|5|TREATMENT|2021-01-04|2021-02-14|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|cb07675a-2042-44da-a1f9-8b7783347e88|6|CLCLR|Chloride Clearance|URINALYSIS|[?]|10^6 DNA copies/mL|[?]|[?]|POSITIVE|1|cpm|1|1|[?]|HIGH|SEBUM|UNEXPECTED ODOR|N|OPTICAL COHERENCE TOMOGRAPHY|MDRD FORMULA|||U||3|Visit_3|40|2|WASHOUT|2021-01-04|2021-01-26|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|cb07675a-2042-44da-a1f9-8b7783347e88|7|UNSPCE|Unspecified Cells|HEMATOLOGY|[?]|U/mL|[?]|[?]|NEGATIVE|1|ug/L FEU|1|1|[?]|HIGH|INFRANATANT, PLASMA|ICTERIC|N|ELECTROCHEMILUMINESCENCE|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|3|TREATMENT|2021-01-29|2021-02-23|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|cb07675a-2042-44da-a1f9-8b7783347e88|8|HLABMSC|HLA-B Mismatch Count|URINALYSIS|[?]|g/animal/wk|[?]|[?]|INDETERMINATE|1|kcal|1|1|[?]|LOW|PLASMA|FROZEN|N|DIRECT SEQUENCING|MDRD ENZYMATIC FORMULA|||U||4|Visit_4|65|2|SCREENING|2021-01-29|2021-02-11|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|cb07675a-2042-44da-a1f9-8b7783347e88|9|GGTCREAT|Gamma Glutamyl Transferase/Creatinine|URINALYSIS|[?]|%/min|[?]|[?]|INVALID|1|INHALATION|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|UNEXPECTED ODOR|N|ANTIBIOTIC AGAR SCREEN|MDRD FORMULA|||N||5|Visit_5|90|7|TREATMENT|2021-02-23|2021-02-27|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|cb07675a-2042-44da-a1f9-8b7783347e88|10|ASTCREAT|Aspartate Aminotransferase/Creatinine|URINALYSIS|[?]|ug/dL|[?]|[?]|NEGATIVE|1|fmol/g|1|1|[?]|ABNORMAL|TUMOR TISSUE|AUTOLYZED||FLOCCULATION, CHARCOAL ENHANCED|HEPASCORE FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2021-02-23|2021-03-02|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|a8a14aa1-4484-4bbc-86bf-c44257146a26|1|LYMPLLE|Plasmacytoid Lymphocytes/Leukocytes|HEMATOLOGY|[?]|pg/cell|[?]|[?]|INDETERMINATE|1|mJoule/cm2|1|1|[?]|HIGH|PLATELET POOR PLASMA|CLOTTED||EPSILOMETER|CKD-EPI CYSTATIN C FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-07-01|2020-07-08|10|17|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|a8a14aa1-4484-4bbc-86bf-c44257146a26|2|FIBRINO|Fibrinogen|URINALYSIS|||[?]|[?]|POSITIVE|1|kg/m2|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|CALCIFIED||IMMUNOASSAY|NASH FIBROSURE FORMULA|||Y|Y|1|Visit_1|10|1|TREATMENT|2020-07-01|2020-08-17|10|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|a8a14aa1-4484-4bbc-86bf-c44257146a26|3|P3NP|Procollagen 3 N-Terminal Propeptide|HEMATOLOGY|[?]|m/sec2|[?]|[?]|BORDERLINE|1|NFIU|1|1|[?]|HIGH|LYSATE|CALCIFIED||TRICHROME STAIN|CKD-EPI FORMULA|||NA||2|Visit_2|25|2|FOLLOW-UP|2020-07-16|2020-08-12|25|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|a8a14aa1-4484-4bbc-86bf-c44257146a26|4|BLASTLE|Blasts/Leukocytes|HEMATOLOGY|[?]|MONTHS|[?]|[?]|BORDERLINE|1|oz|1|1|[?]|NORMAL|SEMINAL FLUID|DRIED||AUTOMATED COUNT|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-07-16|2020-08-07|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|a8a14aa1-4484-4bbc-86bf-c44257146a26|5|LIF|Leukemia Inhibitory Factor|CHEMISTRY|[?]|10^7 CFU/mL|[?]|[?]|TRACE|1|SCOOPFUL|1|1|[?]|NORMAL|HAIR|AUTOLYZED||POLYSOMNOGRAPHY|FIBROTEST FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-07-31|2020-08-04|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|LB|a8a14aa1-4484-4bbc-86bf-c44257146a26|6|LCHT|Lithocholate|CHEMISTRY|[?]|dpm/0.5 mL|[?]|[?]|BORDERLINE|1|ng/L|1|1|[?]|HIGH|INTERSTITIAL FLUID|REFRIGERATED||TRIPLE-PHASE MRI SCAN|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||3|Visit_3|40|6|SCREENING|2020-07-31|2020-09-01|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|LB|a8a14aa1-4484-4bbc-86bf-c44257146a26|7|APOJCRT|Apolipoprotein J/Creatinine|CHEMISTRY|||[?]|[?]|POSITIVE|1|Enzyme U/L|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|AUTOLYZED||MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|4|Visit_4|65|3|TREATMENT|2020-08-25|2020-09-23|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|a8a14aa1-4484-4bbc-86bf-c44257146a26|8|TSTSFRPT|Testosterone, Free/Total Protein|CHEMISTRY|[?]|/2500 WBC|[?]|[?]|INDETERMINATE|1|fmol/L|1|1|[?]|HIGH|CORD SERUM|CALCIFIED|N|ALCIAN BLUE STAIN|MDRD 6 VARIABLE FORMULA|Y||NA||4|Visit_4|65|1|SCREENING|2020-08-25|2020-09-20|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|a8a14aa1-4484-4bbc-86bf-c44257146a26|9|C130089|Timothy Grass Pollen IgA|CHEMISTRY|[?]|Hz|[?]|[?]|INDETERMINATE|1|umol/mol|1|1|[?]|NORMAL|EPIDERMAL TISSUE|THAWED|N|IMMUNO-PET SCAN|GMI % FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2020-09-19|2020-09-28|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|a8a14aa1-4484-4bbc-86bf-c44257146a26|10|TPROTFR|Tau Protein, Free|URINALYSIS|||[?]|[?]|INVALID|1|grain|1|1|[?]|NORMAL|CAPILLARY BLOOD|ICTERIC||SPECT/CT SCAN|CKD-EPI CREATININE FORMULA||Y|Y|Y|5|Visit_5|90|2|TREATMENT|2020-09-19|2020-09-25|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|dfa4c661-9317-4bec-b307-a31eeadcaba6|1|FACTXIIA|Factor XII Activity|HEMATOLOGY|[?]|U/m2/day|[?]|[?]|INVALID|1|RATIO|1|1|[?]|NORMAL|LUNG SURFACTANT|CLOTTED||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|CKD-EPI CYSTATIN C FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-06-04|2020-06-18|10|24|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|dfa4c661-9317-4bec-b307-a31eeadcaba6|2|NEUTVAC|Vacuolated Neutrophils|HEMATOLOGY|[?]|fmol/L|[?]|[?]|INDETERMINATE|1|pmol|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|SOLIDIFIED|N|PET/SPECT SCAN|COCKCROFT-GAULT FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-06-04|2020-07-23|10|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|dfa4c661-9317-4bec-b307-a31eeadcaba6|3|FXAAC|Factor X Activity Actual/Control|CHEMISTRY|[?]|/kg|[?]|[?]|TRACE|1|YEARS|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|NON-HEMOLYZED||NUCLEIC ACID AMPLIFICATION TEST|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|7|SCREENING|2020-06-19|2020-07-11|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-06
e|LB|dfa4c661-9317-4bec-b307-a31eeadcaba6|4|APRI|AST to Platelet Ratio Index|HEMATOLOGY|[?]|ELISA unit/dose|[?]|[?]|TRACE|1|mL/cm H2O|1|1|[?]|ABNORMAL|URINE|ICTERIC|N|AUDIOMETRY|MDRD 6 VARIABLE FORMULA|||NA||2|Visit_2|25|5|WASHOUT|2020-06-19|2020-08-19|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-06
e|LB|dfa4c661-9317-4bec-b307-a31eeadcaba6|5|EDMAB|Endomysial Antibody|URINALYSIS|[?]|/4.0 mL|[?]|[?]|INVALID|1|cmH2O*s/mL|1|1|[?]|NORMAL|LYSATE|ROOM TEMPERATURE||SINGLE-SLICE SPIRAL CT|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA||3|Visit_3|40|4|FOLLOW-UP|2020-07-04|2020-08-03|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|LB|dfa4c661-9317-4bec-b307-a31eeadcaba6|6|CYAMMBIU|Ammonium Biurate Crystals|HEMATOLOGY|[?]|10^3 CFU|[?]|[?]|INVALID|1|ugEq/L|1|1|[?]|HIGH|VENOUS CORD BLOOD|FRESH||OPTICAL COHERENCE TOMOGRAPHY|MDRD ENZYMATIC FORMULA|Y|Y|N||3|Visit_3|40|5|TREATMENT|2020-07-04|2020-07-30|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|LB|dfa4c661-9317-4bec-b307-a31eeadcaba6|7|STAT3|STAT3|HEMATOLOGY|[?]|10^9 organisms|[?]|[?]|POSITIVE|1|mJoule/cm2|1|1|[?]|LOW|MUSCLE TISSUE|CLOTTED||IMMUNOCHROMATOGRAPHY|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|1|TREATMENT|2020-07-29|2020-08-27|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|dfa4c661-9317-4bec-b307-a31eeadcaba6|8|CEMORPH|Cell Morphology|HEMATOLOGY|||[?]|[?]|TRACE|1|Ci/ug|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|AGGLUTINATED||ICP-MS|MDRD 4 VARIABLE FORMULA|Y||NA|Y|4|Visit_4|65|4|WASHOUT|2020-07-29|2020-09-01|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|dfa4c661-9317-4bec-b307-a31eeadcaba6|9|AMYLOIDP|Amyloid P|HEMATOLOGY|||[?]|[?]|INVALID|1|BOWL|1|1|[?]|NORMAL|TUMOR TISSUE|FRESH||CHROMATOGRAPHY|ASH FIBROSURE FORMULA||Y|Y|Y|5|Visit_5|90|4|SCREENING|2020-08-23|2020-08-26|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|LB|dfa4c661-9317-4bec-b307-a31eeadcaba6|10|AST|Aspartate Aminotransferase|CHEMISTRY|||[?]|[?]|NEGATIVE|1|APL U/mL|1|1|[?]|NORMAL|BILE|UNEXPECTED ODOR|N|HPLC/MS/MS|CKD-EPI CREATININE FORMULA|||N|Y|5|Visit_5|90|7|FOLLOW-UP|2020-08-23|2020-08-30|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|LB|9ed984a9-c153-4729-9dc9-3bb3d9059919|1|GLYCRLFR|Free Glycerol|CHEMISTRY|[?]|ug/kg/day|[?]|[?]|BORDERLINE|1|FIU|1|1|[?]|NORMAL|SUPERNATANT, SERUM|LACTESCENT||PET/SPECT SCAN|CKD-EPI FORMULA|||U||1|Visit_1|10|7|FOLLOW-UP|2020-09-01|2020-09-28|10|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|9ed984a9-c153-4729-9dc9-3bb3d9059919|2|S100A8|S100 Calcium Binding Protein A8|HEMATOLOGY|[?]|INHALATION|[?]|[?]|TRACE|1|oz|1|1|[?]|ABNORMAL|PLASMA|LIPEMIC||MRI WITHOUT CONTRAST|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|6|FOLLOW-UP|2020-09-01|2020-10-01|10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|9ed984a9-c153-4729-9dc9-3bb3d9059919|3|SO2|Sulfur Dioxide|URINALYSIS|[?]|%(v/v)|[?]|[?]|POSITIVE|1|g/cage/wk|1|1|[?]|HIGH|LAVAGE FLUID|ICTERIC|N|LAPAROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||2|Visit_2|25|7|TREATMENT|2020-09-16|2020-10-08|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|9ed984a9-c153-4729-9dc9-3bb3d9059919|4|SCHISTO|Schistocytes|CHEMISTRY|[?]|10^6/g|[?]|[?]|INVALID|1|IU|1|1|[?]|NORMAL|PLATELET|CONCENTRATED||HPLC/IEX|FIBROSIS 4 FORMULA||Y|NA||2|Visit_2|25|5|TREATMENT|2020-09-16|2020-09-27|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|9ed984a9-c153-4729-9dc9-3bb3d9059919|5|CYSTATC|Cystatin C|HEMATOLOGY|[?]|uIU/dL|[?]|[?]|INVALID|1|ug/L|1|1|[?]|NORMAL|LOCHIA|REFRIGERATED||HIGH RESOLUTION MELT ANALYSIS|GMI MMOL/MOL FORMULA|||N||3|Visit_3|40|1|FOLLOW-UP|2020-10-01|2020-11-12|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|9ed984a9-c153-4729-9dc9-3bb3d9059919|6|PLSMCELY|Mature Plasma Cells/Lymphocytes|URINALYSIS|[?]|BLOCKS|[?]|[?]|POSITIVE|1|Siemens|1|1|[?]|HIGH|BREAST MILK|HEMOLYZED||CHROMOGENIC ASSAY|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-10-01|2020-11-09|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|9ed984a9-c153-4729-9dc9-3bb3d9059919|7|VBCE|Viable Cells|HEMATOLOGY|[?]|mL/animal|[?]|[?]|INDETERMINATE|1|BEAM BREAKS|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|CONCENTRATED||BRDU CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||4|Visit_4|65|2|TREATMENT|2020-10-26|2020-11-09|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|9ed984a9-c153-4729-9dc9-3bb3d9059919|8|THRCREAT|Threonine/Creatinine|CHEMISTRY|[?]|min*mg/mL|[?]|[?]|POSITIVE|1|mL/kg|1|1|[?]|ABNORMAL|PLASMA|HEMOLYZED||INFRARED SPECTROMETRY|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-10-26|2020-10-28|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|9ed984a9-c153-4729-9dc9-3bb3d9059919|9|SERTRAL|Sertraline|CHEMISTRY|[?]|VIAL|[?]|[?]|POSITIVE|1|cd|1|1|[?]|ABNORMAL|PLEURAL FLUID|PARAFFIN-EMBEDDED||DARK FIELD MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2020-11-20|2020-11-21|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|9ed984a9-c153-4729-9dc9-3bb3d9059919|10|IFNB|Interferon Beta|HEMATOLOGY|[?]|ug/animal|[?]|[?]|TRACE|1|FINGERTIP UNIT|1|1|[?]|NORMAL|PERITONEAL FLUID|LIPEMIC||WESTERN BLOT|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|4|TREATMENT|2020-11-20|2020-11-22|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|fb234b67-3c81-4d55-bc63-2389a23d67b2|1|GFRBSCRT|GFR from Creatinine Adjusted for BSA|URINALYSIS|[?]|PIXEL|[?]|[?]|NEGATIVE|1|mmol/g|1|1|[?]|ABNORMAL|SOFT TISSUE|THAWED||TARGETED GENOME SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|4|TREATMENT|2021-01-11|2021-02-26|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|fb234b67-3c81-4d55-bc63-2389a23d67b2|2|LKM1AB|Liver Kidney Microsomal Type 1 Antibody|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mol|1|1|[?]|LOW|MUSCLE TISSUE|CONCENTRATED||LIGHT MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|1|Visit_1|10|2|TREATMENT|2021-01-11|2021-03-15|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|fb234b67-3c81-4d55-bc63-2389a23d67b2|3|C165876|Birch Pollen IgE AB RAST Score|HEMATOLOGY|[?]|lm|[?]|[?]|NEGATIVE|1|log10 CFU/g|1|1|[?]|NORMAL|TUMOR TISSUE|PARAFFIN-EMBEDDED||BETA LACTAMASE|FIBROSIS 4 FORMULA|Y||N||2|Visit_2|25|2|WASHOUT|2021-01-26|2021-03-03|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|LB|fb234b67-3c81-4d55-bc63-2389a23d67b2|4|EOTAXIN1|Eotaxin-1|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|U/g/h|1|1|[?]|LOW|BLOOD|UNEXPECTED ODOR||CENTRIFUGATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|NA|Y|2|Visit_2|25|5|TREATMENT|2021-01-26|2021-02-16|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|LB|fb234b67-3c81-4d55-bc63-2389a23d67b2|5|VISC|Viscosity|URINALYSIS|[?]|L/kg|[?]|[?]|POSITIVE|1|uOsm|1|1|[?]|NORMAL|SYNOVIAL FLUID|GELLED||PERIPHERAL ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2021-02-10|2021-03-24|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|LB|fb234b67-3c81-4d55-bc63-2389a23d67b2|6|PTHI|Parathyroid Hormone, Intact|URINALYSIS|[?]|fraction of 1|[?]|[?]|NEGATIVE|1|Hz|1|1|[?]|HIGH|SERUM OR PLASMA|ROOM TEMPERATURE||X-RAY FLUORESCENCE SPECTROMETRY|MDRD 4 VARIABLE FORMULA|Y||U||3|Visit_3|40|4|WASHOUT|2021-02-10|2021-04-02|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|LB|fb234b67-3c81-4d55-bc63-2389a23d67b2|7|TOXGRAN|Toxic Granulation|URINALYSIS|[?]|% INHIBITION|[?]|[?]|INVALID|1|APL U/mL|1|1|[?]|HIGH|WHITE MATTER TISSUE|CALCIFIED||FLOCCULATION|ASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|6|TREATMENT|2021-03-07|2021-03-21|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|fb234b67-3c81-4d55-bc63-2389a23d67b2|8|MYELINAB|Myelin Antibodies|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|L/kg|1|1|[?]|NORMAL|VENOUS BLOOD|GELLED||FLUORESCENT MICROSCOPY|GMI % FORMULA|||U|Y|4|Visit_4|65|2|TREATMENT|2021-03-07|2021-03-31|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|fb234b67-3c81-4d55-bc63-2389a23d67b2|9|IL1RL1|Interleukin 1 Receptor-Like 1|HEMATOLOGY|[?]|ug/L FEU|[?]|[?]|INDETERMINATE|1|mL/g/min|1|1|[?]|HIGH|HAIR FOLLICLE|NON-HEMOLYZED||IRON HEMATOXYLIN STAIN|MDRD FORMULA||Y|U||5|Visit_5|90|1|TREATMENT|2021-04-01|2021-04-05|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|fb234b67-3c81-4d55-bc63-2389a23d67b2|10|PEPSNGA|Pepsinogen A|HEMATOLOGY|[?]|umol/mol|[?]|[?]|INDETERMINATE|1|v/v|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|CONTAMINATED||VENTILATION PERFUSION LUNG SCAN|CKD-EPI CYSTATIN C FORMULA|||U||5|Visit_5|90|6|WASHOUT|2021-04-01|2021-04-02|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|84d7ff44-cbe2-446f-b667-5bc539de519b|1|CL|Chloride|CHEMISTRY|[?]|pmol|[?]|[?]|BORDERLINE|1|mg/m2/min|1|1|[?]|ABNORMAL|URINE|CONCENTRATED||HIGH RESOLUTION CT|MDRD 5 VARIABLE FORMULA|Y|Y|N||1|Visit_1|10|6|WASHOUT|2020-07-06|2020-09-26|10|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|84d7ff44-cbe2-446f-b667-5bc539de519b|2|OXAEXR|Oxalate Excretion Rate|CHEMISTRY|[?]|MBP|[?]|[?]|BORDERLINE|1|L|1|1|[?]|LOW|BUFFY COAT|AUTOLYZED|N|PEAK FLOWMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|1|WASHOUT|2020-07-06|2020-07-09|10|13|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|84d7ff44-cbe2-446f-b667-5bc539de519b|3|ATHMBAAC|Antithrombin Activity Actual/Control|CHEMISTRY|[?]|log10 PFU|[?]|[?]|INDETERMINATE|1|ug|1|1|[?]|HIGH|PERITONEAL FLUID|CONTAMINATED||SLOAN LETTER EYE CHART 100%|HEPASCORE FORMULA||Y|NA||2|Visit_2|25|2|TREATMENT|2020-07-21|2020-09-19|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|84d7ff44-cbe2-446f-b667-5bc539de519b|4|MGCREAT|Magnesium/Creatinine|CHEMISTRY|||[?]|[?]|INVALID|1|g/g/day|1|1|[?]|NORMAL|CAPILLARY PLASMA|THAWED|N|MICRODENSITOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|2|Visit_2|25|4|TREATMENT|2020-07-21|2020-08-13|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|84d7ff44-cbe2-446f-b667-5bc539de519b|5|RDWSD|RDW Standard Deviation|CHEMISTRY|[?]|beats/min|[?]|[?]|BORDERLINE|1|nm|1|1|[?]|NORMAL|EPITHELIAL CELL|CONCENTRATED||IMMUNODIFFUSION|CKD-EPI FORMULA|||Y||3|Visit_3|40|1|FOLLOW-UP|2020-08-05|2020-08-24|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|84d7ff44-cbe2-446f-b667-5bc539de519b|6|POLYNORM|Polychromatophilic Normoblast|CHEMISTRY|[?]|eq|[?]|[?]|INDETERMINATE|1|tuberculin unit|1|1|[?]|ABNORMAL|SMEGMA|GELLED|N|DROPLET DIGITAL PCR|MDRD 5 VARIABLE FORMULA|||U||3|Visit_3|40|2|SCREENING|2020-08-05|2020-09-26|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|84d7ff44-cbe2-446f-b667-5bc539de519b|7|MOCYCE|Monocytoid Cells|URINALYSIS|[?]|U/kg/day|[?]|[?]|POSITIVE|1|DDU|1|1|[?]|HIGH|SUPERNATANT, PLASMA|NON-HEMOLYZED||ANALYTICAL ULTRACENTRIFUGATION|FIBROSIS 4 FORMULA||Y|Y||4|Visit_4|65|3|TREATMENT|2020-08-30|2020-09-04|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|84d7ff44-cbe2-446f-b667-5bc539de519b|8|MIP1G|Macrophage Inflammatory Protein 1 Gamma|URINALYSIS|||[?]|[?]|POSITIVE|1|fmol/L|1|1|[?]|HIGH|EMOTIONAL TEAR|HEMOLYZED||OSCILLOMETRY|MDRD ENZYMATIC FORMULA|||U|Y|4|Visit_4|65|4|TREATMENT|2020-08-30|2020-09-09|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|84d7ff44-cbe2-446f-b667-5bc539de519b|9|TNFSR1|Soluble TNF Receptor Type I|CHEMISTRY|[?]|mV/sec|[?]|[?]|POSITIVE|1|cm|1|1|[?]|HIGH|ERYTHROCYTES|LIPEMIC||TURBIDIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||5|Visit_5|90|5|TREATMENT|2020-09-24|2020-09-29|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|84d7ff44-cbe2-446f-b667-5bc539de519b|10|C130109|Mold Mix Antigen IgE Antibody|CHEMISTRY|[?]|copies/uL|[?]|[?]|TRACE|1|VOXEL|1|1|[?]|NORMAL|MECONIUM|DRIED||COMPLEMENT FIXATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||5|Visit_5|90|6|WASHOUT|2020-09-24|2020-09-30|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|c96e4485-4aff-4c18-9c65-5f1a800cc6db|1|THBD|Thrombomodulin|CHEMISTRY|[?]|Ejaculate U|[?]|[?]|NEGATIVE|1|mL/cm|1|1|[?]|HIGH|ABSCESS FLUID|ICTERIC||MICRODENSITOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-09-24|2020-11-07|10|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|c96e4485-4aff-4c18-9c65-5f1a800cc6db|2|FIBRINO|Fibrinogen|HEMATOLOGY|[?]|psec|[?]|[?]|INVALID|1|Joule|1|1|[?]|NORMAL|SALIVA|THAWED||STRESS ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||Y|NA||1|Visit_1|10|4|TREATMENT|2020-09-24|2020-10-19|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|c96e4485-4aff-4c18-9c65-5f1a800cc6db|3|LDH5|LDH Isoenzyme 5|CHEMISTRY|[?]|mol/g|[?]|[?]|INVALID|1|IU/day|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|FRESH||X-RAY FLUORESCENCE SPECTROMETRY|MDRD 5 VARIABLE FORMULA|||U||2|Visit_2|25|2|WASHOUT|2020-10-09|2020-11-24|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|c96e4485-4aff-4c18-9c65-5f1a800cc6db|4|PT|Prothrombin Time|URINALYSIS|[?]|pmol/day|[?]|[?]|TRACE|1|Weber|1|1|[?]|LOW|BILE|GELLED||OPTICAL MAPPING|CKD-EPI CYSTATIN C FORMULA||Y|Y||2|Visit_2|25|7|FOLLOW-UP|2020-10-09|2020-11-05|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|c96e4485-4aff-4c18-9c65-5f1a800cc6db|5|BICARB|Bicarbonate|CHEMISTRY|||[?]|[?]|BORDERLINE|1|CAPLET|1|1|[?]|HIGH|KERATINOCYTE|FROZEN|N|CONGO RED STAIN|CKD-EPI CYSTATIN C FORMULA|||NA|Y|3|Visit_3|40|4|TREATMENT|2020-10-24|2020-12-10|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|c96e4485-4aff-4c18-9c65-5f1a800cc6db|6|VLDL3|VLDL Cholesterol Subtype 3|HEMATOLOGY|[?]|oz eq|[?]|[?]|INDETERMINATE|1|mmol/g|1|1|[?]|LOW|PERITONEAL FLUID|ROOM TEMPERATURE|N|MECHANICAL CLOT DETECTION|FIBROTEST FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-10-24|2020-10-25|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|c96e4485-4aff-4c18-9c65-5f1a800cc6db|7|CSHYAL|Hyaline Casts|CHEMISTRY|[?]|kBq/uL|[?]|[?]|BORDERLINE|1|mEq/dL|1|1|[?]|ABNORMAL|MUSCLE TISSUE|ICTERIC|N|CINEANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-11-18|2020-12-14|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|c96e4485-4aff-4c18-9c65-5f1a800cc6db|8|APLAB|Antiphospholipid Antibodies|URINALYSIS|||[?]|[?]|NEGATIVE|1|GPS U|1|1|[?]|LOW|URINE SEDIMENT|SOLIDIFIED|N|FISH|COCKCROFT-GAULT FORMULA||Y|N|Y|4|Visit_4|65|3|TREATMENT|2020-11-18|2020-12-22|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|c96e4485-4aff-4c18-9c65-5f1a800cc6db|9|PGD2|Prostaglandin D2|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|100 IU/mL|1|1|[?]|ABNORMAL|MUCUS|HEMOLYZED||FLUOROSCOPY|MDRD 6 VARIABLE FORMULA|Y||U|Y|5|Visit_5|90|4|WASHOUT|2020-12-13|2020-12-16|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|c96e4485-4aff-4c18-9c65-5f1a800cc6db|10|PGE1|Prostaglandin E1|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|kcal/day|1|1|[?]|LOW|RETICULOCYTES|FROZEN||CONTRAST ENHANCED PET/CT SCAN|GMI MMOL/MOL FORMULA|Y||Y|Y|5|Visit_5|90|6|TREATMENT|2020-12-13|2020-12-16|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|955188f1-b434-40ab-94c8-0c0fb7f23e84|1|URATE|Urate|CHEMISTRY|||[?]|[?]|NEGATIVE|1|/7.5 mL|1|1|[?]|HIGH|TRANSUDATE|SOLIDIFIED||RYAN BLUE STAIN|MDRD 4 VARIABLE FORMULA|||N|Y|1|Visit_1|10|1|FOLLOW-UP|2020-12-14|2021-01-14|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|955188f1-b434-40ab-94c8-0c0fb7f23e84|2|IAA5OH|5-Hydroxyindoleacetic Acid|CHEMISTRY|[?]|WAFER|[?]|[?]|TRACE|1|Joule|1|1|[?]|LOW|NAIL|HEMOLYZED||ERGOSPIROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-12-14|2020-12-29|10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|955188f1-b434-40ab-94c8-0c0fb7f23e84|3|OSMRTY|Osmolarity|URINALYSIS|[?]|GLOBULE|[?]|[?]|POSITIVE|1|in|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|FROZEN|N|FLOW MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|6|FOLLOW-UP|2020-12-29|2021-02-25|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|955188f1-b434-40ab-94c8-0c0fb7f23e84|4|GLTRCE|Glitter Cells|URINALYSIS|||[?]|[?]|NEGATIVE|1|nCi|1|1|[?]|ABNORMAL|SKIN TISSUE|AUTOLYZED||SPECULAR MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|2|Visit_2|25|2|FOLLOW-UP|2020-12-29|2021-01-26|25|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|955188f1-b434-40ab-94c8-0c0fb7f23e84|5|SPLA2II|Type II Secretory Phospholipase A2|HEMATOLOGY|[?]|pmol|[?]|[?]|INVALID|1|10^9 CFU/mL|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|DRIED||TEST STRIP|CKD-EPI FORMULA|||N||3|Visit_3|40|3|FOLLOW-UP|2021-01-13|2021-02-17|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|955188f1-b434-40ab-94c8-0c0fb7f23e84|6|ARSENIC|Arsenic|CHEMISTRY|[?]|mL*cmH2O|[?]|[?]|BORDERLINE|1|cmHg|1|1|[?]|NORMAL|RETICULOCYTES|HEMOLYZED||DOUBLE IMMUNODIFFUSION|GMI % FORMULA||Y|U||3|Visit_3|40|4|TREATMENT|2021-01-13|2021-02-05|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|955188f1-b434-40ab-94c8-0c0fb7f23e84|7|C130113|Animal Mix Antigen IgG Antibody|HEMATOLOGY|[?]|MnFI|[?]|[?]|NEGATIVE|1|km|1|1|[?]|HIGH|SPERMATOZOON|GELLED||AUSCULTATION|ASH FIBROSURE FORMULA|Y||Y||4|Visit_4|65|3|WASHOUT|2021-02-07|2021-02-09|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|955188f1-b434-40ab-94c8-0c0fb7f23e84|8|HGBA1HGB|Hemoglobin A1/Total Hemoglobin|HEMATOLOGY|[?]|Siemens|[?]|[?]|TRACE|1|BISCUIT|1|1|[?]|HIGH|REFLEX TEAR|SOLIDIFIED||CONTRAST ENHANCED MRI|HEPASCORE FORMULA|||NA||4|Visit_4|65|5|SCREENING|2021-02-07|2021-02-21|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|955188f1-b434-40ab-94c8-0c0fb7f23e84|9|TRIM38|Tripartite Motif Containing Protein 38|CHEMISTRY|[?]|GPL U|[?]|[?]|INDETERMINATE|1|/5x10^4 WBC|1|1|[?]|LOW|KERATINOCYTE|CONTAMINATED||MULTIPLE BREATH WASHOUT|MDRD 6 VARIABLE FORMULA|Y||U||5|Visit_5|90|5|TREATMENT|2021-03-04|2021-03-08|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|955188f1-b434-40ab-94c8-0c0fb7f23e84|10|FBNCTCE|Fibronectin, Cellular|HEMATOLOGY|[?]|mkat|[?]|[?]|NEGATIVE|1|kcal/day|1|1|[?]|LOW|ERYTHROCYTES|SOLIDIFIED||SLOAN LETTER EYE CHART 100%|FIBROSIS 4 FORMULA||Y|Y||5|Visit_5|90|3|WASHOUT|2021-03-04|2021-03-12|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|5a384b5e-954c-4af9-bd60-96aadc72ca44|1|VITB3|Niacin|URINALYSIS|[?]|cycle/min|[?]|[?]|POSITIVE|1|ng|1|1|[?]|HIGH|PLEURAL TISSUE|GELLED||KINYOUN STAIN|GMI % FORMULA||Y|U||1|Visit_1|10|2|WASHOUT|2020-10-09|2020-12-08|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|5a384b5e-954c-4af9-bd60-96aadc72ca44|2|EPINSQCE|Non-Squamous Epithelial Cells|URINALYSIS|||[?]|[?]|BORDERLINE|1|mCi/kg|1|1|[?]|LOW|PERITONEAL FLUID|SOLIDIFIED||QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROSIS 4 FORMULA|||Y|Y|1|Visit_1|10|1|TREATMENT|2020-10-09|2020-12-10|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|5a384b5e-954c-4af9-bd60-96aadc72ca44|3|HGBB|Hemoglobin B|URINALYSIS|[?]|mm3/mm2/year|[?]|[?]|BORDERLINE|1|g/animal|1|1|[?]|HIGH|CELL PELLET|CLOTTED|N|LYMPHANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||U||2|Visit_2|25|1|SCREENING|2020-10-24|2020-12-08|25|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|5a384b5e-954c-4af9-bd60-96aadc72ca44|4|CXCL7|Chemokine (C-X-C Motif) Ligand 7|CHEMISTRY|[?]|nCi|[?]|[?]|NEGATIVE|1|mL/m2/day|1|1|[?]|ABNORMAL|TISSUE|GELLED||COMPUTERIZED CORNEAL TOPOGRAPHY|HEPASCORE FORMULA|||U||2|Visit_2|25|1|SCREENING|2020-10-24|2020-12-27|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|5a384b5e-954c-4af9-bd60-96aadc72ca44|5|NKCE|Natural Killer Cells|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|NFIU|1|1|[?]|NORMAL|AQUEOUS HUMOR|SOLIDIFIED||MS/MS|GMI % FORMULA|||U|Y|3|Visit_3|40|1|FOLLOW-UP|2020-11-08|2020-11-29|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|LB|5a384b5e-954c-4af9-bd60-96aadc72ca44|6|GMCSF|Granulocyte Macrophage Colony Stm Factor|CHEMISTRY|||[?]|[?]|TRACE|1|kDa|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|DRIED||LAPAROSCOPY|MDRD ENZYMATIC FORMULA|||Y|Y|3|Visit_3|40|2|TREATMENT|2020-11-08|2020-11-30|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|LB|5a384b5e-954c-4af9-bd60-96aadc72ca44|7|LIPEMIAI|Lipemic Index|HEMATOLOGY|[?]|pmol|[?]|[?]|BORDERLINE|1|umol/L/h|1|1|[?]|LOW|MONOCYTE|SOLIDIFIED|N|PEAK FLOWMETRY|FIBROMETER FORMULA|Y||Y||4|Visit_4|65|7|TREATMENT|2020-12-03|2020-12-11|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|5a384b5e-954c-4af9-bd60-96aadc72ca44|8|CRYGLBSR|Cryoglobulin Volume/Serum Volume|URINALYSIS|[?]|ft3|[?]|[?]|BORDERLINE|1|10^6/L|1|1|[?]|NORMAL|REFLEX TEAR|THAWED|N|RADIOIMMUNOPRECIPITATION ASSAY|MDRD ENZYMATIC FORMULA|Y||NA||4|Visit_4|65|2|FOLLOW-UP|2020-12-03|2020-12-12|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|5a384b5e-954c-4af9-bd60-96aadc72ca44|9|CRLPLSMN|Ceruloplasmin|HEMATOLOGY|[?]|/100 HPFs|[?]|[?]|NEGATIVE|1|mmol/min/kPa|1|1|[?]|LOW|ERYTHROCYTES|CALCIFIED||LC-FL|GMI MMOL/MOL FORMULA||Y|Y||5|Visit_5|90|1|WASHOUT|2020-12-28|2020-12-30|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|5a384b5e-954c-4af9-bd60-96aadc72ca44|10|HGBFR|Hemoglobin, Free|CHEMISTRY|[?]|in|[?]|[?]|INVALID|1|uV|1|1|[?]|NORMAL|SERUM|CONCENTRATED||IMPULSE OSCILLOMETRY|CKD-EPI CREATININE FORMULA|||N||5|Visit_5|90|7|TREATMENT|2020-12-28|2020-12-31|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|1|PAPPA|Pregnancy-Associated Plasma Protein-A|CHEMISTRY|[?]|ug/kg/h|[?]|[?]|TRACE|1|amol|1|1|[?]|NORMAL|STOOL|HEMOLYZED|N|PH METER MEASUREMENT METHOD|FIBROTEST FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-07-02|2020-07-04|10|12|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|2|EPISCECE|Squamous Epithelial Cells/Total Cells|URINALYSIS|[?]|mm/min|[?]|[?]|INDETERMINATE|1|nkat/g Hb|1|1|[?]|LOW|SEBUM|HEMOLYZED||CLIP|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-07-02|2020-08-11|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|3|PYK|Pyruvate Kinase|URINALYSIS|[?]|g/day|[?]|[?]|BORDERLINE|1|mEq/dL|1|1|[?]|LOW|VITREOUS HUMOR|UNEXPECTED ODOR|N|ELASTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|3|FOLLOW-UP|2020-07-17|2020-07-28|25|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|4|METAMYCE|Metamyelocytes/Total Cells|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Watt|1|1|[?]|NORMAL|PUS|ICTERIC||CYSTOSCOPY|GMI MMOL/MOL FORMULA|Y||Y|Y|2|Visit_2|25|4|WASHOUT|2020-07-17|2020-08-01|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|5|MKCMKBMP|Megakaryocyte and Megakaryoblast Morph|URINALYSIS|||[?]|[?]|INDETERMINATE|1|EID 50/mL|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|REFRIGERATED||SXA SCAN|MDRD 4 VARIABLE FORMULA|||N|Y|3|Visit_3|40|3|FOLLOW-UP|2020-08-01|2020-09-08|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|6|RPTLAAC|Reptilase Activity Actual/Control|URINALYSIS|||[?]|[?]|NEGATIVE|1|kg/m2|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|FROZEN||MEDIASTINOSCOPY|GMI MMOL/MOL FORMULA|Y||N|Y|3|Visit_3|40|4|TREATMENT|2020-08-01|2020-08-25|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|7|CYCASULF|Calcium Sulfate Crystals|HEMATOLOGY|[?]|OI50|[?]|[?]|BORDERLINE|1|umol|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|CALCIFIED||FLUORESCEIN STAIN|NASH FIBROSURE FORMULA||Y|U||4|Visit_4|65|5|SCREENING|2020-08-26|2020-09-15|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|8|CHDWR|Ret Corpuscular HGB Conc Distr Width|CHEMISTRY|[?]|L/min|[?]|[?]|BORDERLINE|1|msec|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|PARAFFIN-EMBEDDED|N|LANDOLT RING|GMI MMOL/MOL FORMULA||Y|N||4|Visit_4|65|7|WASHOUT|2020-08-26|2020-09-15|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|9|CGA|Chromogranin A|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|days/wk|1|1|[?]|HIGH|CORD BLOOD|CONCENTRATED|N|HEMAGGLUTINATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|5|Visit_5|90|3|WASHOUT|2020-09-20|2020-09-23|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|10|CCL21|Chemokine (C-C Motif) Ligand 21|URINALYSIS|[?]|kg/L|[?]|[?]|NEGATIVE|1|mL/kg/min|1|1|[?]|HIGH|ADIPOSE TISSUE|LACTESCENT|N|LEAD CITRATE STAIN|MDRD FORMULA|||NA||5|Visit_5|90|3|TREATMENT|2020-09-20|2020-09-29|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|f9432d72-f7d7-4cdf-a173-2e2029258474|1|GHB|Gamma-Hydroxybutyrate|HEMATOLOGY|[?]|Log10 ELISA unit/dose|[?]|[?]|NEGATIVE|1|umol/day|1|1|[?]|LOW|PLATELET|CONCENTRATED|N|ANALYTICAL ULTRACENTRIFUGATION|NASH FIBROSURE FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-11-20|2020-11-22|10|12|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|f9432d72-f7d7-4cdf-a173-2e2029258474|2|NEUTTOXC|Neutrophilic Toxic Change|CHEMISTRY|[?]|umol/L/min|[?]|[?]|INVALID|1|tsp|1|1|[?]|NORMAL|LYMPH|FROZEN||PERIPHERAL ANGIOGRAPHY|ASH FIBROSURE FORMULA|Y||Y||1|Visit_1|10|4|FOLLOW-UP|2020-11-20|2020-12-16|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|f9432d72-f7d7-4cdf-a173-2e2029258474|3|GIPI|Glucose-dep Insulinotropic Pep, Intact|HEMATOLOGY|[?]|10^7 TCID 50/dose|[?]|[?]|NEGATIVE|1|g/animal/wk|1|1|[?]|HIGH|SERUM OR PLASMA|HEMOLYZED||DNA MICROARRAY|HEPASCORE FORMULA|||Y||2|Visit_2|25|1|WASHOUT|2020-12-05|2020-12-11|25|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|f9432d72-f7d7-4cdf-a173-2e2029258474|4|IGE|Immunoglobulin E|URINALYSIS|[?]|ppb|[?]|[?]|BORDERLINE|1|oz|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|FRESH||DXA SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-12-05|2021-02-17|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|f9432d72-f7d7-4cdf-a173-2e2029258474|5|PLSPCELY|Precursor Plasma Cells/Lymphocytes|HEMATOLOGY|[?]|BOLUS|[?]|[?]|BORDERLINE|1|mL*cmH2O|1|1|[?]|HIGH|PUS|ROOM TEMPERATURE|N|NEXT GENERATION SEQUENCING|CKD-EPI FORMULA|||NA||3|Visit_3|40|3|FOLLOW-UP|2020-12-20|2021-01-07|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|f9432d72-f7d7-4cdf-a173-2e2029258474|6|PDGFAA|Platelet Derived Growth Factor IsoformAA|CHEMISTRY|[?]|mL/g/h|[?]|[?]|TRACE|1|Ci/ug|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|CLOTTED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|Y||3|Visit_3|40|2|FOLLOW-UP|2020-12-20|2021-01-26|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|f9432d72-f7d7-4cdf-a173-2e2029258474|7|BALA|Beta Alanine|CHEMISTRY|[?]|KIT|[?]|[?]|INVALID|1|Anson U|1|1|[?]|LOW|AMNIOTIC FLUID|LIPEMIC||FLUORIMETRY|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|5|FOLLOW-UP|2021-01-14|2021-02-04|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|f9432d72-f7d7-4cdf-a173-2e2029258474|8|HRYCECE|Hairy Cells/Total Cells|URINALYSIS|[?]|mL/100g/min|[?]|[?]|TRACE|1|uL/kg/day|1|1|[?]|NORMAL|INFRANATANT, SERUM|AGGLUTINATED||ENZYMATIC SPECTROPHOTOMETRY|MDRD 4 VARIABLE FORMULA|||U||4|Visit_4|65|5|WASHOUT|2021-01-14|2021-02-14|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|f9432d72-f7d7-4cdf-a173-2e2029258474|9|CXCL9|Chemokine (C-X-C Motif) Ligand 9|HEMATOLOGY|[?]|log10 TCID 50/uL|[?]|[?]|INVALID|1|g/day|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|FRESH||ISHIHARA COLOR PLATES|GMI MMOL/MOL FORMULA||Y|Y||5|Visit_5|90|3|FOLLOW-UP|2021-02-08|2021-02-11|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|f9432d72-f7d7-4cdf-a173-2e2029258474|10|CDT|Carbohydrate-Deficient Transferrin|CHEMISTRY|[?]|MAC50|[?]|[?]|TRACE|1|psec|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|PARAFFIN-EMBEDDED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI FORMULA|Y|Y|N||5|Visit_5|90|3|SCREENING|2021-02-08|2021-02-14|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|1|DNASEBAB|DNase-B Antibody|HEMATOLOGY|[?]|DDU|[?]|[?]|NEGATIVE|1|TCID 50/dose|1|1|[?]|LOW|EMESIS|AGGLUTINATED|N|QUANTITATIVE ULTRASOUND|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-12-19|2021-01-19|10|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|2|HGBTET|Hemoglobin Tetramer|HEMATOLOGY|[?]|pmol/g|[?]|[?]|TRACE|1|log10 CCID 50/dose|1|1|[?]|HIGH|URINE|ROOM TEMPERATURE||IN VITRO GENE EXPRESSION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||1|Visit_1|10|5|WASHOUT|2020-12-19|2021-01-27|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|3|CENTROAB|Centromere B Antibodies|HEMATOLOGY|[?]|L/min|[?]|[?]|NEGATIVE|1|msec|1|1|[?]|LOW|BONE|CONTAMINATED||COMPLEMENT FIXATION|MDRD 6 VARIABLE FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2021-01-03|2021-02-02|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|4|INTLK28|Interleukin 28|CHEMISTRY|||[?]|[?]|POSITIVE|1|V|1|1|[?]|HIGH|PLEURAL FLUID|LACTESCENT||KINETIC CHROMOGENIC ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|2|Visit_2|25|5|TREATMENT|2021-01-03|2021-03-13|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|5|TAURCRT|Taurine/Creatinine|CHEMISTRY|[?]|U/g|[?]|[?]|INVALID|1|Enzyme U|1|1|[?]|NORMAL|CAPILLARY PLASMA|FRESH|N|MACRO BROTH DILUTION|MDRD 4 VARIABLE FORMULA||Y|Y||3|Visit_3|40|7|WASHOUT|2021-01-18|2021-03-01|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|6|TSP1|Thrombospondin 1|URINALYSIS|||[?]|[?]|INVALID|1|PIXEL|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|CONCENTRATED|N|ELECTROCHEMILUMINESCENCE|COCKCROFT-GAULT FORMULA|||N|Y|3|Visit_3|40|5|SCREENING|2021-01-18|2021-03-01|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|7|METHAMPH|Methamphetamine|CHEMISTRY|[?]|nL|[?]|[?]|TRACE|1|Absorbance U|1|1|[?]|LOW|DISCHARGE|NON-HEMOLYZED|N|AURAMINE STAIN|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|6|WASHOUT|2021-02-12|2021-03-02|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|8|METARUB|Metarubricyte|HEMATOLOGY|[?]|cy/cm|[?]|[?]|TRACE|1|U/10^12 RBC|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|LACTESCENT||ICC|CKD-EPI CREATININE FORMULA||Y|NA||4|Visit_4|65|7|TREATMENT|2021-02-12|2021-03-06|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|9|EOSBLE|Eosinophils Band Form/Leukocytes|URINALYSIS|[?]|Bq/ug|[?]|[?]|INVALID|1|days/wk|1|1|[?]|HIGH|MUCUS|CONTAMINATED||MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||5|Visit_5|90|7|TREATMENT|2021-03-09|2021-03-17|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|10|CD38|CD38|CHEMISTRY|[?]|BP|[?]|[?]|NEGATIVE|1|mg/m2/min|1|1|[?]|HIGH|WHITE MATTER TISSUE|SOLIDIFIED||REFLECTANCE SPECTROSCOPY|MDRD 4 VARIABLE FORMULA||Y|Y||5|Visit_5|90|6|WASHOUT|2021-03-09|2021-03-14|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|0fc0650f-ed95-422d-b407-dcee93178780|1|NEUTHYGR|Hypogranular Neutrophils|CHEMISTRY|[?]|EVENTS|[?]|[?]|TRACE|1|BOLUS|1|1|[?]|NORMAL|EMOTIONAL TEAR|CLOTTED||MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|ASH FIBROSURE FORMULA|Y||U||1|Visit_1|10|2|FOLLOW-UP|2020-08-23|2020-11-09|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|0fc0650f-ed95-422d-b407-dcee93178780|2|C165892|Wild Rye Pollen IgE Antibody|HEMATOLOGY|[?]|V|[?]|[?]|INDETERMINATE|1|mOsm/L|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|ICTERIC|N|LYMPHANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|7|FOLLOW-UP|2020-08-23|2020-09-04|10|22|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|0fc0650f-ed95-422d-b407-dcee93178780|3|NORNCTN|Nornicotine|HEMATOLOGY|[?]|mL/cm|[?]|[?]|TRACE|1|mV2/Hz|1|1|[?]|HIGH|GASTRIC FLUID|SOLIDIFIED|N|EPSILOMETER|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||2|Visit_2|25|3|SCREENING|2020-09-07|2020-10-11|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|0fc0650f-ed95-422d-b407-dcee93178780|4|SERTRAL|Sertraline|CHEMISTRY|||[?]|[?]|TRACE|1|DRINK|1|1|[?]|NORMAL|COLOSTRUM|CALCIFIED||NEPHELOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|2|Visit_2|25|5|TREATMENT|2020-09-07|2020-10-17|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|0fc0650f-ed95-422d-b407-dcee93178780|5|C130130|Dog Dander Antigen IgA Antibody|URINALYSIS|[?]|m/sec2|[?]|[?]|TRACE|1|ag|1|1|[?]|LOW|BUFFY COAT|LACTESCENT||ICP-MS|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|4|TREATMENT|2020-09-22|2020-09-25|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|0fc0650f-ed95-422d-b407-dcee93178780|6|PAPPA|Pregnancy-Associated Plasma Protein-A|CHEMISTRY|[?]|psec|[?]|[?]|BORDERLINE|1|mL/mmHg|1|1|[?]|HIGH|VENOUS BLOOD|FRESH||BRDU CELLULAR PROLIFERATION ASSAY|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-09-22|2020-10-10|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|0fc0650f-ed95-422d-b407-dcee93178780|7|VEGFR1S|Soluble Vasc Endoth Growth Factor Rec1|HEMATOLOGY|[?]|cd|[?]|[?]|INVALID|1|DRUM|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|FROZEN|N|COULOMETRIC TITRATION|MDRD 5 VARIABLE FORMULA|Y||N||4|Visit_4|65|3|TREATMENT|2020-10-17|2020-11-12|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|0fc0650f-ed95-422d-b407-dcee93178780|8|APOH|Apolipoprotein H|CHEMISTRY|[?]|Weber|[?]|[?]|INVALID|1|F|1|1|[?]|LOW|ALVEOLAR AIR|CONCENTRATED||POLYMERASE CHAIN REACTION|GMI % FORMULA|||NA||4|Visit_4|65|2|FOLLOW-UP|2020-10-17|2020-11-12|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|0fc0650f-ed95-422d-b407-dcee93178780|9|INTLK6|Interleukin 6|CHEMISTRY|[?]|umol/mg/min|[?]|[?]|BORDERLINE|1|10^9 CFU/mL|1|1|[?]|HIGH|PROSTATIC FLUID|FRESH|N|WESTERGREN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||5|Visit_5|90|4|FOLLOW-UP|2020-11-11|2020-11-16|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|0fc0650f-ed95-422d-b407-dcee93178780|10|ICTERUSI|Icteric Index|HEMATOLOGY|[?]|TRACE|[?]|[?]|TRACE|1|kg/L|1|1|[?]|LOW|PERITONEAL FLUID|LIPEMIC||EIA|MDRD ENZYMATIC FORMULA|Y||NA||5|Visit_5|90|5|SCREENING|2020-11-11|2020-11-13|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|1|CYCHOL|Cholesterol Crystals|URINALYSIS|[?]|ug/animal|[?]|[?]|NEGATIVE|1|umol/min|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|REFRIGERATED||SINGLE-SLICE SPIRAL CT|MDRD 6 VARIABLE FORMULA|Y||U||1|Visit_1|10|3|FOLLOW-UP|2020-06-03|2020-08-09|10|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|LB|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|2|TFERRIN|Transferrin|URINALYSIS|[?]|/5x10^4 WBC|[?]|[?]|TRACE|1|mL/g/min|1|1|[?]|LOW|SPUTUM|HEMOLYZED||JAEGER EYE CHART|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2020-06-03|2020-07-24|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|LB|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|3|THYATAB|Thyroid Antithyroglobulin Antibodies|CHEMISTRY|[?]|%/min|[?]|[?]|BORDERLINE|1|amu|1|1|[?]|NORMAL|WHITE MATTER TISSUE|CALCIFIED||COULOMETRIC TITRATION|ASH FIBROSURE FORMULA|||U||2|Visit_2|25|7|WASHOUT|2020-06-18|2020-06-21|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-01
e|LB|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|4|DALA|Delta Aminolevulinate|HEMATOLOGY|[?]|g/g|[?]|[?]|INDETERMINATE|1|/LSQN|1|1|[?]|LOW|ARTERIAL CORD BLOOD|UNEXPECTED ODOR|N|MICRONEUTRALIZATION ASSAY|MDRD ENZYMATIC FORMULA|||N||2|Visit_2|25|5|SCREENING|2020-06-18|2020-07-31|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-01
e|LB|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|5|PREALB|Prealbumin|CHEMISTRY|||[?]|[?]|TRACE|1|nkat/g Hb|1|1|[?]|NORMAL|TRANSUDATE|ICTERIC||REBOUND TONOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||Y|Y|3|Visit_3|40|5|WASHOUT|2020-07-03|2020-07-17|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|6|CD4CD8|CD4/CD8|URINALYSIS|[?]|g/m2|[?]|[?]|INVALID|1|MONTHS|1|1|[?]|ABNORMAL|VENOUS PLASMA|ROOM TEMPERATURE|N|EPSILOMETER|MDRD 5 VARIABLE FORMULA|Y||NA||3|Visit_3|40|3|TREATMENT|2020-07-03|2020-08-04|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|7|HYDCDN|Hydrocodone|CHEMISTRY|[?]|keV|[?]|[?]|BORDERLINE|1|Ci/kg|1|1|[?]|NORMAL|DERMAL TISSUE|ROOM TEMPERATURE||CT SCAN|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|1|FOLLOW-UP|2020-07-28|2020-08-12|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|LB|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|8|C165914|Cat Dander IgG AB RAST Score|URINALYSIS|[?]|mmHg/sec|[?]|[?]|POSITIVE|1|U/mmol|1|1|[?]|HIGH|DERMAL TISSUE|HEMOLYZED||CELL BASED BIOASSAY|MDRD 5 VARIABLE FORMULA|Y||N||4|Visit_4|65|7|WASHOUT|2020-07-28|2020-07-29|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|LB|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|9|HGBFHGB|Hemoglobin F/Total Hemoglobin|CHEMISTRY|||[?]|[?]|INVALID|1|10^7 PFU|1|1|[?]|HIGH|URINE SEDIMENT|AGGLUTINATED||QUANTITATIVE COMPUTED TOMOGRAPHY|COCKCROFT-GAULT FORMULA||Y|N|Y|5|Visit_5|90|3|TREATMENT|2020-08-22|2020-08-24|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|LB|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|10|LYS|Lysine|URINALYSIS|[?]|mg/L FEU|[?]|[?]|BORDERLINE|1|/40 HPFs|1|1|[?]|HIGH|URINE|AGGLUTINATED||PHOROPTER|CKD-EPI CYSTATIN C FORMULA|||NA||5|Visit_5|90|3|SCREENING|2020-08-22|2020-08-27|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|LB|a6f48290-787a-46ad-bee1-ae263ad3c121|1|CD19LY|CD19/Lymphocytes|HEMATOLOGY|[?]|BOTTLE|[?]|[?]|NEGATIVE|1|g/animal|1|1|[?]|NORMAL|CAPILLARY BLOOD|DRIED||AGAR DILUTION|HEPASCORE FORMULA||Y|U||1|Visit_1|10|3|TREATMENT|2021-01-19|2021-03-15|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|a6f48290-787a-46ad-bee1-ae263ad3c121|2|CCPIGGAB|Cyclic Citrullinated Peptide IgG Ab|URINALYSIS|[?]|pmol/10^10 cells|[?]|[?]|POSITIVE|1|L/s|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|CLOTTED|N|MICRO BROTH DILUTION|ASH FIBROSURE FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2021-01-19|2021-03-31|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|LB|a6f48290-787a-46ad-bee1-ae263ad3c121|3|APTTSTND|Activated PTT/Standard|URINALYSIS|||[?]|[?]|TRACE|1|m/sec|1|1|[?]|ABNORMAL|LAVAGE FLUID|HEMOLYZED||SCANNING ELECTRON MICROSCOPY|COCKCROFT-GAULT FORMULA|Y||NA|Y|2|Visit_2|25|1|FOLLOW-UP|2021-02-03|2021-04-11|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|a6f48290-787a-46ad-bee1-ae263ad3c121|4|INDICAN|Indican|URINALYSIS|[?]|IU/mmol|[?]|[?]|INDETERMINATE|1|psi|1|1|[?]|NORMAL|INTERSTITIAL FLUID|PARAFFIN-EMBEDDED||MYELOPEROXIDASE STAIN|FIBROTEST FORMULA|||N||2|Visit_2|25|1|SCREENING|2021-02-03|2021-02-23|25|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|a6f48290-787a-46ad-bee1-ae263ad3c121|5|CSEPI846|Aggrecan Chondroitin Sulfate Epitope 846|CHEMISTRY|[?]|log10 PFU|[?]|[?]|BORDERLINE|1|ug/L DDU|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|FRESH||CRYOSCOPY|MDRD ENZYMATIC FORMULA|||U||3|Visit_3|40|1|TREATMENT|2021-02-18|2021-03-10|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|a6f48290-787a-46ad-bee1-ae263ad3c121|6|FACTVWA|von Willebrand Factor Activity|CHEMISTRY|[?]|umol/h/mmol|[?]|[?]|NEGATIVE|1|C|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|CLOTTED||CONGO RED STAIN|GMI % FORMULA|||N||3|Visit_3|40|3|WASHOUT|2021-02-18|2021-04-09|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|a6f48290-787a-46ad-bee1-ae263ad3c121|7|HGBTET|Hemoglobin Tetramer|HEMATOLOGY|[?]|mm2|[?]|[?]|TRACE|1|uU/dL|1|1|[?]|HIGH|SMEGMA|REFRIGERATED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|CKD-EPI CYSTATIN C FORMULA|Y||N||4|Visit_4|65|1|WASHOUT|2021-03-15|2021-03-30|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|a6f48290-787a-46ad-bee1-ae263ad3c121|8|IGGSYNRT|IgG Synthesis Rate|HEMATOLOGY|[?]|/5x10^4 WBC|[?]|[?]|NEGATIVE|1|RATIO|1|1|[?]|ABNORMAL|RETICULOCYTES|NON-HEMOLYZED||PET/CT SCAN|GMI % FORMULA|||NA||4|Visit_4|65|1|SCREENING|2021-03-15|2021-04-11|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|a6f48290-787a-46ad-bee1-ae263ad3c121|9|INTLK24|Interleukin 24|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|kg/mol|1|1|[?]|NORMAL|MECONIUM|AUTOLYZED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|HEPASCORE FORMULA|||Y|Y|5|Visit_5|90|7|WASHOUT|2021-04-09|2021-04-10|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|LB|a6f48290-787a-46ad-bee1-ae263ad3c121|10|CA125AG|Cancer Antigen 125|URINALYSIS|[?]|m|[?]|[?]|BORDERLINE|1|ug/g/min|1|1|[?]|HIGH|PLATELET|CONCENTRATED||FREEZING POINT DEPRESSION|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2021-04-09|2021-04-16|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|LB|565e5c83-9c67-4718-bd54-af34be936427|1|MBP|Myelin Basic Protein|HEMATOLOGY|[?]|log10 PFU/mL|[?]|[?]|NEGATIVE|1|10^6 organisms/mg|1|1|[?]|NORMAL|KERATINOCYTE|LIPEMIC|N|SPECT SCAN|CKD-EPI CYSTATIN C FORMULA|||U||1|Visit_1|10|3|TREATMENT|2020-06-09|2020-08-21|10|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|565e5c83-9c67-4718-bd54-af34be936427|2|C147284|Boxelder Pollen IgE Antibody|URINALYSIS|||[?]|[?]|TRACE|1|log10 CFU/g|1|1|[?]|LOW|EXPIRED AIR|SOLIDIFIED|N|MUGA|GMI % FORMULA|||U|Y|1|Visit_1|10|2|TREATMENT|2020-06-09|2020-09-04|10|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|LB|565e5c83-9c67-4718-bd54-af34be936427|3|RHD|RhD Factor|HEMATOLOGY|[?]|log10 TCID 50/mL|[?]|[?]|TRACE|1|U/g/min|1|1|[?]|LOW|SKIN TISSUE|FROZEN||MS/MS|MDRD ENZYMATIC FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-06-24|2020-07-30|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|565e5c83-9c67-4718-bd54-af34be936427|4|AFP|Alpha Fetoprotein|CHEMISTRY|[?]|log10 CFU/mL|[?]|[?]|INVALID|1|L/h/m2|1|1|[?]|LOW|URINE SEDIMENT|CONTAMINATED|N|POPULATION SEQUENCING|FIBROTEST FORMULA||Y|NA||2|Visit_2|25|1|TREATMENT|2020-06-24|2020-08-06|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|565e5c83-9c67-4718-bd54-af34be936427|5|BLYMXM|B-lymphocyte Crossmatch|CHEMISTRY|[?]|Gravitational Unit|[?]|[?]|INVALID|1|L/h/m2|1|1|[?]|NORMAL|SALIVA|ROOM TEMPERATURE||THICK SMEAR|FIBROTEST FORMULA||Y|U||3|Visit_3|40|1|FOLLOW-UP|2020-07-09|2020-08-25|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|565e5c83-9c67-4718-bd54-af34be936427|6|ALB|Albumin|HEMATOLOGY|[?]|10^12 IU/L|[?]|[?]|INDETERMINATE|1|PACK|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|CALCIFIED|N|LINE PROBE ASSAY|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-07-09|2020-07-20|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|565e5c83-9c67-4718-bd54-af34be936427|7|LIQUFT|Liquefaction Time|CHEMISTRY|[?]|mEq/kg|[?]|[?]|TRACE|1|10^3 organisms/mL|1|1|[?]|NORMAL|TUMOR TISSUE|SOLIDIFIED||MAPH|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|2|TREATMENT|2020-08-03|2020-08-26|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|565e5c83-9c67-4718-bd54-af34be936427|8|INGAPAB|Islet Neogenesis Assoc Protein Antibody|CHEMISTRY|[?]|umol/L|[?]|[?]|NEGATIVE|1|mL/kg|1|1|[?]|NORMAL|BREAST MILK|LACTESCENT||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|FIBROMETER FORMULA|||N||4|Visit_4|65|2|WASHOUT|2020-08-03|2020-08-25|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|565e5c83-9c67-4718-bd54-af34be936427|9|GDIGA1|Galactose-Deficient IgA1|CHEMISTRY|[?]|copies/ug|[?]|[?]|BORDERLINE|1|USP U|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA|||Y||5|Visit_5|90|4|FOLLOW-UP|2020-08-28|2020-09-06|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|565e5c83-9c67-4718-bd54-af34be936427|10|CD5|CD5|CHEMISTRY|[?]|10^6 IU/mL|[?]|[?]|NEGATIVE|1|mmol|1|1|[?]|LOW|LAVAGE FLUID|LIPEMIC||HIGH LEVEL AMINOGLYCOSIDE SCREEN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-08-28|2020-09-05|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|LB|b238304c-15ef-4c6e-a32c-9cd583a233a9|1|ELA1|Pancreatic Elastase 1|HEMATOLOGY|||[?]|[?]|POSITIVE|1|L/min|1|1|[?]|NORMAL|DISCHARGE|NON-HEMOLYZED||RADIAL IMMUNODIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|1|Visit_1|10|2|TREATMENT|2021-01-07|2021-03-29|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|b238304c-15ef-4c6e-a32c-9cd583a233a9|2|LKM1IMAB|Liver Kidney Microsomal Type 1 IgM Ab|URINALYSIS|[?]|POINT|[?]|[?]|INVALID|1|cd|1|1|[?]|ABNORMAL|BUFFY COAT|UNEXPECTED ODOR|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2021-01-07|2021-03-21|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|b238304c-15ef-4c6e-a32c-9cd583a233a9|3|PG|Prostaglandin|CHEMISTRY|[?]|ug/cm2|[?]|[?]|TRACE|1|10^9 organisms|1|1|[?]|NORMAL|VITREOUS HUMOR|AUTOLYZED||GC/MS-CI|MDRD FORMULA|Y||Y||2|Visit_2|25|3|TREATMENT|2021-01-22|2021-03-24|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|b238304c-15ef-4c6e-a32c-9cd583a233a9|4|LYMPHOTC|Lymphotactin|URINALYSIS|[?]|mEq/dL|[?]|[?]|BORDERLINE|1|mL/m2/min|1|1|[?]|HIGH|SPUTUM|ICTERIC|N|SCANNING ELECTRON MICROSCOPY|CKD-EPI CREATININE FORMULA|||NA||2|Visit_2|25|7|WASHOUT|2021-01-22|2021-02-27|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|b238304c-15ef-4c6e-a32c-9cd583a233a9|5|C147281|Egg White Antigen IgE Antibody|CHEMISTRY|[?]|APL U/mL|[?]|[?]|NEGATIVE|1|Anson U|1|1|[?]|HIGH|STOOL|UNEXPECTED ODOR||FLUORESCENT SPOT TEST|MDRD ENZYMATIC FORMULA|||Y||3|Visit_3|40|6|FOLLOW-UP|2021-02-06|2021-02-25|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|LB|b238304c-15ef-4c6e-a32c-9cd583a233a9|6|C130085|English Plantain Pollen IgA|CHEMISTRY|[?]|/10^4|[?]|[?]|BORDERLINE|1|ug/L DDU|1|1|[?]|HIGH|SEMINAL FLUID|FROZEN||PERCUSSION|ASH FIBROSURE FORMULA|||U||3|Visit_3|40|3|WASHOUT|2021-02-06|2021-03-24|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|LB|b238304c-15ef-4c6e-a32c-9cd583a233a9|7|MDZLM|Midazolam|CHEMISTRY|[?]|cP|[?]|[?]|TRACE|1|10^9 CFU|1|1|[?]|HIGH|LEUKOCYTE|PARAFFIN-EMBEDDED|N|MASS SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||4|Visit_4|65|5|WASHOUT|2021-03-03|2021-03-07|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|b238304c-15ef-4c6e-a32c-9cd583a233a9|8|BLASTNCE|Blasts/Nucleated Cells|URINALYSIS|[?]|m/sec|[?]|[?]|BORDERLINE|1|umol/mg/min|1|1|[?]|LOW|PLEURAL TISSUE|ROOM TEMPERATURE|N|NEXT GENERATION SEQUENCING|GMI % FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2021-03-03|2021-03-09|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|b238304c-15ef-4c6e-a32c-9cd583a233a9|9|BASOCE|Basophils/Total Cells|CHEMISTRY|[?]|dpm/0.5 mL|[?]|[?]|INDETERMINATE|1|L/h/m2|1|1|[?]|ABNORMAL|BONE MARROW|THAWED|N|CONTRAST ENHANCED PET/CT SCAN|MDRD FORMULA|||NA||5|Visit_5|90|5|SCREENING|2021-03-28|2021-04-03|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|b238304c-15ef-4c6e-a32c-9cd583a233a9|10|PLATGNT|Giant Platelets|HEMATOLOGY|[?]|Bq/mg|[?]|[?]|TRACE|1|genEq|1|1|[?]|ABNORMAL|EXUDATE|HEMOLYZED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA||Y|Y||5|Visit_5|90|2|FOLLOW-UP|2021-03-28|2021-03-29|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|c273f039-bca9-4d55-8620-5c5db32a6c4b|1|TTAC|Thrombin Time Actual/Control|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mEq/ug|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|AUTOLYZED||IMPULSE OSCILLOMETRY|MDRD 6 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|2|WASHOUT|2020-09-23|2020-11-21|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|c273f039-bca9-4d55-8620-5c5db32a6c4b|2|IL2RB|Interleukin 2 Receptor Subunit Beta|CHEMISTRY|[?]|uIU/L|[?]|[?]|BORDERLINE|1|10^4/hpf|1|1|[?]|NORMAL|PERSPIRATION|DRIED|N|ENDPOINT DILUTION ASSAY|MDRD ENZYMATIC FORMULA|Y||N||1|Visit_1|10|4|WASHOUT|2020-09-23|2020-11-27|10|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|LB|c273f039-bca9-4d55-8620-5c5db32a6c4b|3|ANISOCHR|Anisochromia|URINALYSIS|[?]|damol/L|[?]|[?]|TRACE|1|mL/cage|1|1|[?]|LOW|HAIR|DRIED||ZIEHL NEELSEN ACID FAST STAIN|ASH FIBROSURE FORMULA|Y|Y|Y||2|Visit_2|25|4|TREATMENT|2020-10-08|2020-11-10|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|c273f039-bca9-4d55-8620-5c5db32a6c4b|4|NEUTMY|Neutrophilic Myelocytes|HEMATOLOGY|[?]|tuberculin unit|[?]|[?]|INVALID|1|mol/mg|1|1|[?]|ABNORMAL|FLUID|DRIED||WRIGHT STAIN|FIBROTEST FORMULA|||U||2|Visit_2|25|6|TREATMENT|2020-10-08|2020-10-19|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|c273f039-bca9-4d55-8620-5c5db32a6c4b|5|BASO|Basophils|URINALYSIS|[?]|yd|[?]|[?]|INVALID|1|mg/g/min|1|1|[?]|NORMAL|CERUMEN|ROOM TEMPERATURE||KARYOTYPING|FIBROTEST FORMULA||Y|N||3|Visit_3|40|1|TREATMENT|2020-10-23|2020-11-12|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|c273f039-bca9-4d55-8620-5c5db32a6c4b|6|C130069|Bermuda Grass Pollen IgA|CHEMISTRY|[?]|HOURS|[?]|[?]|TRACE|1|cmH2O/mL|1|1|[?]|ABNORMAL|PERSPIRATION|NON-HEMOLYZED||FLUORIMETRY|NASH FIBROSURE FORMULA|Y|Y|NA||3|Visit_3|40|4|TREATMENT|2020-10-23|2020-12-04|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|c273f039-bca9-4d55-8620-5c5db32a6c4b|7|VIP|Vasoactive Intestinal Polypeptide|URINALYSIS|[?]|KIT|[?]|[?]|BORDERLINE|1|nCi|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|AGGLUTINATED||AUTOMATED COUNT|MDRD FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2020-11-17|2020-11-24|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|c273f039-bca9-4d55-8620-5c5db32a6c4b|8|DSVLFXN|Desvenlafaxine|HEMATOLOGY|[?]|nCi|[?]|[?]|TRACE|1|10^3 copies/mL|1|1|[?]|LOW|VENOUS PLASMA|GELLED||PET SCAN|MDRD ENZYMATIC FORMULA|Y||NA||4|Visit_4|65|3|FOLLOW-UP|2020-11-17|2020-11-21|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|c273f039-bca9-4d55-8620-5c5db32a6c4b|9|C165902|Timothy Grass Pollen IgG AB RAST Score|CHEMISTRY|[?]|mL/min/mmHg|[?]|[?]|BORDERLINE|1|Henry|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|UNEXPECTED ODOR||QUANTITATIVE ULTRASOUND|GMI MMOL/MOL FORMULA|Y||Y||5|Visit_5|90|6|WASHOUT|2020-12-12|2020-12-13|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|c273f039-bca9-4d55-8620-5c5db32a6c4b|10|AMPHET|Amphetamine|URINALYSIS|[?]|kV|[?]|[?]|BORDERLINE|1|CAPLET|1|1|[?]|NORMAL|WHITE MATTER TISSUE|LIPEMIC||CT SCAN WITHOUT CONTRAST|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||5|Visit_5|90|7|WASHOUT|2020-12-12|2020-12-20|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|2cdb5053-2108-4f50-8906-8afabc855a36|1|ENAAB|Extractable Nuclear Antigen Antibody|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mg2/dL2|1|1|[?]|HIGH|SKIN TISSUE|LIPEMIC|N|PALPATION|CKD-EPI CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|1|WASHOUT|2020-08-28|2020-09-07|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|2cdb5053-2108-4f50-8906-8afabc855a36|2|CD161ALY|CD161a/Lymphocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|/2500 WBC|1|1|[?]|LOW|WHITE MATTER TISSUE|AUTOLYZED||SXA SCAN|CKD-EPI FORMULA|||N|Y|1|Visit_1|10|5|TREATMENT|2020-08-28|2020-10-06|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|2cdb5053-2108-4f50-8906-8afabc855a36|3|EPISCECE|Squamous Epithelial Cells/Total Cells|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|yd|1|1|[?]|NORMAL|SEBUM|AUTOLYZED||TARGETED GENOME SEQUENCING|FIBROMETER FORMULA|Y|Y|NA|Y|2|Visit_2|25|7|FOLLOW-UP|2020-09-12|2020-10-23|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|2cdb5053-2108-4f50-8906-8afabc855a36|4|C165895|Johnson Grass Pollen IgG4 Antibody|CHEMISTRY|[?]|/LSQN|[?]|[?]|TRACE|1|g/cm2|1|1|[?]|NORMAL|LYMPH|LACTESCENT||PHASE CONTRAST MICROSCOPY|FIBROTEST FORMULA||Y|Y||2|Visit_2|25|4|SCREENING|2020-09-12|2020-11-18|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|2cdb5053-2108-4f50-8906-8afabc855a36|5|CA125AG|Cancer Antigen 125|URINALYSIS|[?]|mg/dose|[?]|[?]|INVALID|1|MET*min|1|1|[?]|HIGH|LYMPH|FRESH|N|PHASE-CONTRAST MRI|FIBROTEST FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-09-27|2020-11-16|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|2cdb5053-2108-4f50-8906-8afabc855a36|6|LYMPHOTC|Lymphotactin|CHEMISTRY|[?]|kPa/L/sec|[?]|[?]|BORDERLINE|1|uV|1|1|[?]|HIGH|COLOSTRUM|DRIED||REVERSE TRANSCRIPTASE PCR|MDRD 4 VARIABLE FORMULA|Y||Y||3|Visit_3|40|7|TREATMENT|2020-09-27|2020-10-09|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|2cdb5053-2108-4f50-8906-8afabc855a36|7|HOMOCIT|Homocitrulline|CHEMISTRY|||[?]|[?]|TRACE|1|mmol/L|1|1|[?]|HIGH|VITREOUS HUMOR|FROZEN|N|IRON HEMATOXYLIN STAIN|NASH FIBROSURE FORMULA|Y||NA|Y|4|Visit_4|65|3|FOLLOW-UP|2020-10-22|2020-11-11|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|2cdb5053-2108-4f50-8906-8afabc855a36|8|MICROCY|Microcytes|URINALYSIS|[?]|ELISA unit/mL|[?]|[?]|INVALID|1|U/m2/min|1|1|[?]|LOW|PERITONEAL FLUID|HEMOLYZED||GRADIENT DIFFUSION|COCKCROFT-GAULT FORMULA|||Y||4|Visit_4|65|2|SCREENING|2020-10-22|2020-11-13|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|2cdb5053-2108-4f50-8906-8afabc855a36|9|CD14|CD14|URINALYSIS|[?]|uL/mL|[?]|[?]|INDETERMINATE|1|U/10^12 RBC|1|1|[?]|LOW|BREAST MILK|THAWED||ELECTROPHORESIS|MDRD 6 VARIABLE FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2020-11-16|2020-11-24|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|2cdb5053-2108-4f50-8906-8afabc855a36|10|PMYCECE|Proliferating Myeloid Cells/Total Cells|URINALYSIS|[?]|DNA copies/ug|[?]|[?]|POSITIVE|1|ukat/L|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|CALCIFIED||WRIGHT-GIEMSA STAIN|FIBROMETER FORMULA|||U||5|Visit_5|90|7|TREATMENT|2020-11-16|2020-11-18|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|fce7149a-503e-4209-8c62-8044a2ad1c1c|1|NKCE|Natural Killer Cells|CHEMISTRY|||[?]|[?]|TRACE|1|CIGARETTE|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|PARAFFIN-EMBEDDED|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NASH FIBROSURE FORMULA|||N|Y|1|Visit_1|10|4|FOLLOW-UP|2020-08-06|2020-09-15|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|fce7149a-503e-4209-8c62-8044a2ad1c1c|2|NCCPTN|Nociceptin|HEMATOLOGY|[?]|L/kg|[?]|[?]|TRACE|1|mg/kg/day|1|1|[?]|ABNORMAL|STOOL|CLOTTED||MICROBIAL BIOCHEMICAL IDENTIFICATION|GMI MMOL/MOL FORMULA|Y||U||1|Visit_1|10|6|TREATMENT|2020-08-06|2020-10-15|10|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|fce7149a-503e-4209-8c62-8044a2ad1c1c|3|FXIVAAC|Factor XIV Activity Actual/Control|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|sec|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|UNEXPECTED ODOR||DROPLET DIGITAL PCR|FIBROTEST FORMULA|Y||Y|Y|2|Visit_2|25|3|TREATMENT|2020-08-21|2020-09-08|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|fce7149a-503e-4209-8c62-8044a2ad1c1c|4|TRIGHDL|Triglycerides/HDL Cholesterol|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mL/cage/wk|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|FROZEN|N|JAEGER EYE CHART|MDRD ENZYMATIC FORMULA||Y|N|Y|2|Visit_2|25|4|TREATMENT|2020-08-21|2020-10-20|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|fce7149a-503e-4209-8c62-8044a2ad1c1c|5|MMP8|Matrix Metalloproteinase 8|CHEMISTRY|[?]|um/s|[?]|[?]|TRACE|1|titer|1|1|[?]|HIGH|CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED||DOPPLER ULTRASOUND|CKD-EPI FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-09-05|2020-10-08|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|fce7149a-503e-4209-8c62-8044a2ad1c1c|6|ATPVITE|Alpha Tocopherol/Vitamin E|URINALYSIS|[?]|BOWL|[?]|[?]|INVALID|1|BE/mL|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|REFRIGERATED||HPLC/IEX|MDRD ENZYMATIC JAPANESE FORMULA|||N||3|Visit_3|40|3|SCREENING|2020-09-05|2020-10-12|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|fce7149a-503e-4209-8c62-8044a2ad1c1c|7|THYATAB|Thyroid Antithyroglobulin Antibodies|CHEMISTRY|[?]|10^7 CFU|[?]|[?]|TRACE|1|FINGERTIP UNIT|1|1|[?]|ABNORMAL|SERUM|FROZEN||PERIODIC ACID SCHIFF STAIN|CKD-EPI FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-09-30|2020-10-20|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|fce7149a-503e-4209-8c62-8044a2ad1c1c|8|MPO|Myeloperoxidase|HEMATOLOGY|[?]|MPS U|[?]|[?]|POSITIVE|1|nmol|1|1|[?]|NORMAL|MUCUS|CONTAMINATED||NON-CONTACT SPECULAR MICROSCOPY|MDRD FORMULA|||N||4|Visit_4|65|4|TREATMENT|2020-09-30|2020-10-25|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|fce7149a-503e-4209-8c62-8044a2ad1c1c|9|PO2ADJT|Partial Pressure Oxygen Adj for Temp|CHEMISTRY|[?]|nmol/L|[?]|[?]|TRACE|1|RATIO|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|FRESH|N|BIOPSY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||5|Visit_5|90|3|TREATMENT|2020-10-25|2020-10-28|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|fce7149a-503e-4209-8c62-8044a2ad1c1c|10|B2G1GAAB|Beta-2 Glycoprotein 1 IgA Antibody|URINALYSIS|[?]|Absorbance U|[?]|[?]|INVALID|1|/500 WBC|1|1|[?]|LOW|PLASMA|REFRIGERATED||POTENTIOMETRY|CKD-EPI CYSTATIN C FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-10-25|2020-10-31|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|c8aad550-11a1-4473-8b35-79b7dfb08122|1|C130095|Western Ragweed Pollen IgG4|URINALYSIS|[?]|g/cm2|[?]|[?]|NEGATIVE|1|mg/kg/dose|1|1|[?]|HIGH|EMESIS|FROZEN||RADIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||1|Visit_1|10|2|TREATMENT|2020-06-09|2020-07-29|10|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|LB|c8aad550-11a1-4473-8b35-79b7dfb08122|2|PHADJT|pH Adjusted for Body Temp|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|ks|1|1|[?]|ABNORMAL|GASTRIC FLUID|ICTERIC||FLUORESCENT IMMUNOASSAY|FIBROSIS 4 FORMULA|Y||Y|Y|1|Visit_1|10|3|TREATMENT|2020-06-09|2020-08-11|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|LB|c8aad550-11a1-4473-8b35-79b7dfb08122|3|FVIIAAC|Factor VII Activity Actual/Control|URINALYSIS|[?]|IU|[?]|[?]|INDETERMINATE|1|10^3 organisms/g|1|1|[?]|HIGH|CEREBROSPINAL FLUID|SOLIDIFIED||HPLC/IEX|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||2|Visit_2|25|1|SCREENING|2020-06-24|2020-09-02|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|c8aad550-11a1-4473-8b35-79b7dfb08122|4|BGTCPHRL|Beta+Gamma Tocopherol|HEMATOLOGY|[?]|Osm|[?]|[?]|NEGATIVE|1|PIPE|1|1|[?]|NORMAL|VENOUS BLOOD|CALCIFIED||ALCIAN BLUE STAIN|NASH FIBROSURE FORMULA||Y|NA||2|Visit_2|25|7|SCREENING|2020-06-24|2020-07-23|25|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|c8aad550-11a1-4473-8b35-79b7dfb08122|5|FENTANYL|Fentanyl|CHEMISTRY|[?]|uL/kg/day|[?]|[?]|INDETERMINATE|1|pkat/L|1|1|[?]|HIGH|RETICULOCYTES|HEMOLYZED||LIGHT SCATTERING SPECTROSCOPY|MDRD FORMULA||Y|Y||3|Visit_3|40|1|TREATMENT|2020-07-09|2020-08-04|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|c8aad550-11a1-4473-8b35-79b7dfb08122|6|HGBSHGB|Hemoglobin S/Total Hemoglobin|URINALYSIS|[?]|C|[?]|[?]|POSITIVE|1|uU/L|1|1|[?]|ABNORMAL|DERMAL TISSUE|FROZEN||RADIATION DOSIMETRY|COCKCROFT-GAULT FORMULA|||NA||3|Visit_3|40|1|FOLLOW-UP|2020-07-09|2020-07-30|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|c8aad550-11a1-4473-8b35-79b7dfb08122|7|TEARDCY|Dacryocytes|CHEMISTRY|[?]|mL/g/min|[?]|[?]|TRACE|1|ukat/10^12 RBC|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|CLOTTED||ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI FORMULA|||U||4|Visit_4|65|3|FOLLOW-UP|2020-08-03|2020-08-23|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|LB|c8aad550-11a1-4473-8b35-79b7dfb08122|8|HER2|Human Epidermal Growth Factor Receptor 2|URINALYSIS|[?]|nmol/day|[?]|[?]|INVALID|1|10^6 CFU/mL|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|DRIED||ELLA|FIBROMETER FORMULA|Y|Y|U||4|Visit_4|65|7|TREATMENT|2020-08-03|2020-09-02|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|LB|c8aad550-11a1-4473-8b35-79b7dfb08122|9|PLATGNT|Giant Platelets|HEMATOLOGY|[?]|beats/min|[?]|[?]|TRACE|1|Gy/min|1|1|[?]|NORMAL|PUS|LACTESCENT||SEQUENCING|MDRD 4 VARIABLE FORMULA|||U||5|Visit_5|90|1|SCREENING|2020-08-28|2020-09-02|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|c8aad550-11a1-4473-8b35-79b7dfb08122|10|CD14|CD14|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mCi/L|1|1|[?]|LOW|GASTRIC CONTENTS|FRESH||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI % FORMULA|Y||N|Y|5|Visit_5|90|6|TREATMENT|2020-08-28|2020-09-03|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|f1967c6e-c520-4482-be7e-01ada4380d87|1|GLYHLACD|Glycocholic Acid|URINALYSIS|||[?]|[?]|TRACE|1|amu|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|CLOTTED||TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD 4 VARIABLE FORMULA|||N|Y|1|Visit_1|10|4|SCREENING|2021-01-05|2021-03-22|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|f1967c6e-c520-4482-be7e-01ada4380d87|2|PD1S|Soluble Programmed Death-1|URINALYSIS|[?]|mg/m2/day|[?]|[?]|POSITIVE|1|log EID 50/dose|1|1|[?]|NORMAL|STOOL|CLOTTED|N|IMMUNORADIOMETRIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2021-01-05|2021-01-23|10|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|f1967c6e-c520-4482-be7e-01ada4380d87|3|HGBTET|Hemoglobin Tetramer|CHEMISTRY|[?]|mL|[?]|[?]|TRACE|1|%(v/v)|1|1|[?]|HIGH|INFRANATANT, SERUM|AUTOLYZED|N|MICROBIAL CULTURE, SOLID|GMI MMOL/MOL FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2021-01-20|2021-03-14|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|LB|f1967c6e-c520-4482-be7e-01ada4380d87|4|GLOBA2PT|Alpha-2 Globulin/Total Protein|HEMATOLOGY|[?]|ug/kg/day|[?]|[?]|TRACE|1|kg/L|1|1|[?]|LOW|KERATINOCYTE|CONTAMINATED||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|CKD-EPI CREATININE FORMULA||Y|U||2|Visit_2|25|2|TREATMENT|2021-01-20|2021-02-14|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|LB|f1967c6e-c520-4482-be7e-01ada4380d87|5|HGBEHGB|Hemoglobin E/Total Hemoglobin|HEMATOLOGY|[?]|10^4/L|[?]|[?]|POSITIVE|1|nCi|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|NON-HEMOLYZED|N|INTERRUPTER TECHNIQUE|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|3|WASHOUT|2021-02-04|2021-02-06|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|f1967c6e-c520-4482-be7e-01ada4380d87|6|RFIGAAB|Rheumatoid Factor IgA Antibody|HEMATOLOGY|[?]|ms2|[?]|[?]|TRACE|1|Ci/uL|1|1|[?]|LOW|PUS|CLOTTED||THERMAL IONIZATION MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA||Y|U||3|Visit_3|40|6|TREATMENT|2021-02-04|2021-02-11|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|f1967c6e-c520-4482-be7e-01ada4380d87|7|AZURGRAN|Azurophilic Granules|HEMATOLOGY|[?]|umol/L/sec|[?]|[?]|INDETERMINATE|1|in|1|1|[?]|NORMAL|REFLEX TEAR|FROZEN||ELECTROMYOGRAPHY|CKD-EPI FORMULA|||N||4|Visit_4|65|5|FOLLOW-UP|2021-03-01|2021-04-02|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|f1967c6e-c520-4482-be7e-01ada4380d87|8|KERAT|Keratocyte|HEMATOLOGY|[?]|IU/g Hb|[?]|[?]|INVALID|1|mg/cm2|1|1|[?]|LOW|SOFT TISSUE|NON-HEMOLYZED||DNA MICROARRAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||4|Visit_4|65|3|WASHOUT|2021-03-01|2021-03-13|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|f1967c6e-c520-4482-be7e-01ada4380d87|9|SLTFRNRC|Soluble Transferrin Receptor|URINALYSIS|||[?]|[?]|INVALID|1|BISCUIT|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|REFRIGERATED||THIN SMEAR|HEPASCORE FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2021-03-26|2021-04-01|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|f1967c6e-c520-4482-be7e-01ada4380d87|10|BAFF|B-Cell Activating Factor|CHEMISTRY|||[?]|[?]|POSITIVE|1|10^9 organisms|1|1|[?]|HIGH|MONOCYTE|FROZEN||TRANSMISSION ELECTRON MICROSCOPY|MDRD 6 VARIABLE FORMULA|||N|Y|5|Visit_5|90|5|TREATMENT|2021-03-26|2021-03-31|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|2a5a1c03-f54e-47da-8dda-2104c9423e94|1|HGBB|Hemoglobin B|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|SCOOPFUL|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|NON-HEMOLYZED||TRYPAN BLUE STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|1|Visit_1|10|5|WASHOUT|2021-01-01|2021-03-03|10|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|2a5a1c03-f54e-47da-8dda-2104c9423e94|2|LYMNSQE|Lymphocytes/Non-Squam Epi Cells|URINALYSIS|[?]|ELISA unit|[?]|[?]|NEGATIVE|1|PACK|1|1|[?]|LOW|INFRANATANT, SERUM|FROZEN||SLIT LAMP|GMI MMOL/MOL FORMULA|||Y||1|Visit_1|10|4|WASHOUT|2021-01-01|2021-02-23|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|LB|2a5a1c03-f54e-47da-8dda-2104c9423e94|3|ENAAB|Extractable Nuclear Antigen Antibody|HEMATOLOGY|[?]|U/m2/h|[?]|[?]|TRACE|1|ppm|1|1|[?]|ABNORMAL|ERYTHROCYTES|LACTESCENT|N|CALIPER MEASUREMENT METHOD|FIBROSIS 4 FORMULA|Y|Y|U||2|Visit_2|25|1|SCREENING|2021-01-16|2021-02-21|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|2a5a1c03-f54e-47da-8dda-2104c9423e94|4|LDLOXI|Oxidized LDL Cholesterol|HEMATOLOGY|||[?]|[?]|INVALID|1|RATIO|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|CLOTTED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|COCKCROFT-GAULT FORMULA|Y||N|Y|2|Visit_2|25|6|TREATMENT|2021-01-16|2021-03-17|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|2a5a1c03-f54e-47da-8dda-2104c9423e94|5|BTECERBC|Bite Cells/Erythrocytes|CHEMISTRY|[?]|10^11/L|[?]|[?]|TRACE|1|mm|1|1|[?]|LOW|CORD BLOOD|PARAFFIN-EMBEDDED|N|SLOAN LETTER EYE CHART 1.25%|MDRD 4 VARIABLE FORMULA|Y|Y|U||3|Visit_3|40|2|FOLLOW-UP|2021-01-31|2021-03-20|40|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|2a5a1c03-f54e-47da-8dda-2104c9423e94|6|FLT3|FMS-like Receptor Tyrosine Kinase 3|HEMATOLOGY|[?]|MdFI|[?]|[?]|POSITIVE|1|PELLET|1|1|[?]|LOW|TUMOR TISSUE|CLOTTED||VIRUS PLAQUE ASSAY|GMI % FORMULA||Y|U||3|Visit_3|40|3|FOLLOW-UP|2021-01-31|2021-02-08|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|2a5a1c03-f54e-47da-8dda-2104c9423e94|7|PHOSEXR|Phosphorus Excretion Rate|HEMATOLOGY|[?]|cy/cm|[?]|[?]|NEGATIVE|1|h/wk|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|GELLED||SPIRAL CT SCAN WITHOUT CONTRAST|MDRD FORMULA|Y||Y||4|Visit_4|65|4|TREATMENT|2021-02-25|2021-03-25|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|2a5a1c03-f54e-47da-8dda-2104c9423e94|8|MYCEMPOL|Myeloid Maturation Pool|URINALYSIS|[?]|MdFI|[?]|[?]|TRACE|1|mg/dL|1|1|[?]|ABNORMAL|LYSATE|AUTOLYZED||IMMUNORADIOMETRIC ASSAY|ASH FIBROSURE FORMULA|Y||U||4|Visit_4|65|4|TREATMENT|2021-02-25|2021-02-28|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|2a5a1c03-f54e-47da-8dda-2104c9423e94|9|ISG15|Ubiquitin-Like Protein ISG15|HEMATOLOGY|||[?]|[?]|TRACE|1|IU/g Hb|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|FROZEN||RAJI CELL EIA|CKD-EPI CREATININE FORMULA||Y|NA|Y|5|Visit_5|90|7|TREATMENT|2021-03-22|2021-03-30|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|LB|2a5a1c03-f54e-47da-8dda-2104c9423e94|10|BTK|Bruton's Tyrosine Kinase|URINALYSIS|[?]|BISCUIT|[?]|[?]|TRACE|1|BISCUIT|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|LIPEMIC||HIGH RESOLUTION MELT ANALYSIS|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|4|SCREENING|2021-03-22|2021-03-26|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|LB|8f98bac3-8010-4902-8ae1-783dc5fea72d|1|WBCCLMP|Leukocyte Cell Clumps|URINALYSIS|[?]|mMU/mL|[?]|[?]|INVALID|1|%(v/v)|1|1|[?]|HIGH|SEMINAL FLUID|REFRIGERATED|N|JAEGER EYE CHART|GMI % FORMULA|Y||U||1|Visit_1|10|3|WASHOUT|2020-06-29|2020-09-17|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|8f98bac3-8010-4902-8ae1-783dc5fea72d|2|MDEA|3,4-methylenedioxy-N-ethylamphetamine|CHEMISTRY|[?]|MET*min|[?]|[?]|BORDERLINE|1|10^3/hpf|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|DRIED||CELL OF ORIGIN ASSAY|GMI % FORMULA|Y||U||1|Visit_1|10|3|TREATMENT|2020-06-29|2020-09-16|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|8f98bac3-8010-4902-8ae1-783dc5fea72d|3|ALTAST|ALT/AST|URINALYSIS|[?]|U/10^12 RBC|[?]|[?]|TRACE|1|gpELISA unit/mL|1|1|[?]|HIGH|LOCHIA|AUTOLYZED|N|FLUOROSCOPY|CKD-EPI FORMULA||Y|U||2|Visit_2|25|5|FOLLOW-UP|2020-07-14|2020-07-27|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|8f98bac3-8010-4902-8ae1-783dc5fea72d|4|OCCBLD|Occult Blood|URINALYSIS|[?]|Farad|[?]|[?]|BORDERLINE|1|U.CARR|1|1|[?]|HIGH|CEREBROSPINAL FLUID|NON-HEMOLYZED||PH METER MEASUREMENT METHOD|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|4|FOLLOW-UP|2020-07-14|2020-08-23|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|8f98bac3-8010-4902-8ae1-783dc5fea72d|5|IMMGLC|Immunoglobulin Light Chains|HEMATOLOGY|[?]|pt_br|[?]|[?]|POSITIVE|1|MET*h|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|AGGLUTINATED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROMETER FORMULA|||N||3|Visit_3|40|2|FOLLOW-UP|2020-07-29|2020-08-07|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|8f98bac3-8010-4902-8ae1-783dc5fea72d|6|C165880|D. pteronyssinus IgE AB RAST Score|CHEMISTRY|[?]|/5x10^4 WBC|[?]|[?]|NEGATIVE|1|log10 CCID 50/dose|1|1|[?]|HIGH|LYSATE|ICTERIC|N|X-RAY FLUORESCENCE SPECTROMETRY|MDRD 6 VARIABLE FORMULA|Y||NA||3|Visit_3|40|2|FOLLOW-UP|2020-07-29|2020-08-03|40|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|8f98bac3-8010-4902-8ae1-783dc5fea72d|7|GLOBBPT|Beta Globulin/Total Protein|URINALYSIS|||[?]|[?]|NEGATIVE|1|RATIO|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|NON-HEMOLYZED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 4 VARIABLE FORMULA||Y|Y|Y|4|Visit_4|65|4|TREATMENT|2020-08-23|2020-09-16|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|8f98bac3-8010-4902-8ae1-783dc5fea72d|8|RNPAB|Ribonucleoprotein Antibody|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|log EID 50/dose|1|1|[?]|HIGH|SWABBED MATERIAL|AGGLUTINATED||NEPHELOMETRY|FIBROMETER FORMULA|Y|Y|NA|Y|4|Visit_4|65|5|TREATMENT|2020-08-23|2020-08-25|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|8f98bac3-8010-4902-8ae1-783dc5fea72d|9|NKCE|Natural Killer Cells|CHEMISTRY|[?]|mL/mmHg/min/L|[?]|[?]|INVALID|1|Newton|1|1|[?]|ABNORMAL|LAVAGE FLUID|AGGLUTINATED|N|GC/FID|NASH FIBROSURE FORMULA|||Y||5|Visit_5|90|5|TREATMENT|2020-09-17|2020-09-20|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|8f98bac3-8010-4902-8ae1-783dc5fea72d|10|TIMM10|Translocase Inner Mitochondrial Membr 10|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mN|1|1|[?]|ABNORMAL|BILE|CALCIFIED||COLORIMETRY|MDRD FORMULA||Y|NA|Y|5|Visit_5|90|3|FOLLOW-UP|2020-09-17|2020-09-19|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|0fd7cece-4d9d-4d8c-82e0-df0c75613888|1|HBA1CHGB|Hemoglobin A1C/Hemoglobin|URINALYSIS|[?]|cg|[?]|[?]|NEGATIVE|1|kg/m2|1|1|[?]|NORMAL|SEBUM|UNEXPECTED ODOR||DYNAMOMETRY|MDRD FORMULA||Y|Y||1|Visit_1|10|2|SCREENING|2020-12-11|2021-01-31|10|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|0fd7cece-4d9d-4d8c-82e0-df0c75613888|2|BAMBTAC|Beta-Aminobutyric Acid|CHEMISTRY|[?]|/VF|[?]|[?]|TRACE|1|log10 copies/mL|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|LIPEMIC|N|NUCLEIC ACID BASED METHOD|MDRD ENZYMATIC JAPANESE FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-12-11|2021-02-04|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|0fd7cece-4d9d-4d8c-82e0-df0c75613888|3|C165933|American Cockroach IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mL/g/h|1|1|[?]|NORMAL|SOFT TISSUE|FROZEN||CONTRAST ENHANCED X-RAY|CKD-EPI FORMULA|||U|Y|2|Visit_2|25|5|SCREENING|2020-12-26|2021-01-17|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|LB|0fd7cece-4d9d-4d8c-82e0-df0c75613888|4|ARR|Aldosterone/Renin Activity|URINALYSIS|[?]|uV*sec|[?]|[?]|POSITIVE|1|mL/m2/day|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|CLOTTED||ERGOSPIROMETRY|MDRD 6 VARIABLE FORMULA||Y|Y||2|Visit_2|25|2|WASHOUT|2020-12-26|2021-02-13|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|LB|0fd7cece-4d9d-4d8c-82e0-df0c75613888|5|MPO|Myeloperoxidase|HEMATOLOGY|[?]|LENS|[?]|[?]|INDETERMINATE|1|RFU|1|1|[?]|ABNORMAL|URINE|CONTAMINATED||ETDRS EYE CHART|MDRD FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2021-01-10|2021-02-16|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|0fd7cece-4d9d-4d8c-82e0-df0c75613888|6|CENTROAB|Centromere B Antibodies|HEMATOLOGY|[?]|mAnson U/mL|[?]|[?]|BORDERLINE|1|genEq|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|REFRIGERATED||WRIGHT STAIN|GMI % FORMULA|||N||3|Visit_3|40|4|WASHOUT|2021-01-10|2021-01-31|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|0fd7cece-4d9d-4d8c-82e0-df0c75613888|7|SLXAG|Sialyl SSEA-1 Antigen|URINALYSIS|||[?]|[?]|BORDERLINE|1|uCi|1|1|[?]|ABNORMAL|MUSCLE TISSUE|GELLED||PLETHYSMOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N|Y|4|Visit_4|65|4|SCREENING|2021-02-04|2021-02-19|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|0fd7cece-4d9d-4d8c-82e0-df0c75613888|8|IRON|Iron|HEMATOLOGY|[?]|cd|[?]|[?]|POSITIVE|1|IU/kg|1|1|[?]|NORMAL|MUCUS|LIPEMIC||CYSTOSCOPY|MDRD FORMULA||Y|Y||4|Visit_4|65|5|TREATMENT|2021-02-04|2021-02-14|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|LB|0fd7cece-4d9d-4d8c-82e0-df0c75613888|9|AFACTXAA|Anti-Factor Xa Activity|CHEMISTRY|[?]|Enzyme U/g Hb|[?]|[?]|NEGATIVE|1|beats/min|1|1|[?]|ABNORMAL|HAIR|CALCIFIED||DOPPLER ULTRASOUND|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|2|SCREENING|2021-03-01|2021-03-02|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|0fd7cece-4d9d-4d8c-82e0-df0c75613888|10|TPAAG|Tissue Plasminogen Activator Antigen|HEMATOLOGY|[?]|mg/mol|[?]|[?]|BORDERLINE|1|U/g/day|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|N|ELISPOT|GMI % FORMULA||Y|NA||5|Visit_5|90|5|FOLLOW-UP|2021-03-01|2021-03-07|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|LB|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|1|ANIONG3|Anion Gap 3|HEMATOLOGY|[?]|DAgU/mL|[?]|[?]|INDETERMINATE|1|/40 HPFs|1|1|[?]|HIGH|CEREBROSPINAL FLUID|GELLED||FLUORESCENCE ANGIOGRAPHY|ASH FIBROSURE FORMULA||Y|N||1|Visit_1|10|2|WASHOUT|2020-06-13|2020-07-21|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|2|IL6SR|Soluble Interleukin 6 Receptor|URINALYSIS|||[?]|[?]|TRACE|1|10^4 CFU|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|CALCIFIED||IN VITRO GENE EXPRESSION ASSAY|FIBROMETER FORMULA||Y|NA|Y|1|Visit_1|10|6|SCREENING|2020-06-13|2020-06-26|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|3|CKMBCK|Creatine Kinase MB/Total Creatine Kinase|URINALYSIS|||[?]|[?]|POSITIVE|1|SPRAY|1|1|[?]|HIGH|INFRANATANT, PLASMA|ICTERIC||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|2|Visit_2|25|1|SCREENING|2020-06-28|2020-08-13|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|4|IGFBP3|Insulin-Like Growth Factor Binding Prot3|CHEMISTRY|[?]|bel|[?]|[?]|BORDERLINE|1|GLOBULE|1|1|[?]|NORMAL|SEBUM|THAWED||NUCLEIC ACID SEQUENCING|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|5|WASHOUT|2020-06-28|2020-07-18|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|5|NEUTTOXC|Neutrophilic Toxic Change|CHEMISTRY|[?]|GPS U|[?]|[?]|BORDERLINE|1|10^7/L|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|THAWED||DISK DIFFUSION|CKD-EPI FORMULA||Y|Y||3|Visit_3|40|5|WASHOUT|2020-07-13|2020-09-10|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|6|BILDIRBI|Direct Bilirubin/Bilirubin|CHEMISTRY|[?]|L/min/m2|[?]|[?]|INVALID|1|pg/L|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|ROOM TEMPERATURE||TOTAL BODY IRRADIATION|COCKCROFT-GAULT FORMULA|Y||N||3|Visit_3|40|7|WASHOUT|2020-07-13|2020-08-29|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|7|PLAGMCVT|Platelet Aggregation Mean Curve Type|CHEMISTRY|[?]|mm/2h|[?]|[?]|POSITIVE|1|mm3/mm2/year|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|FROZEN||DOPPLER ULTRASOUND|GMI % FORMULA|||NA||4|Visit_4|65|6|FOLLOW-UP|2020-08-07|2020-09-09|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|8|LIPEMIAI|Lipemic Index|URINALYSIS|[?]|kg|[?]|[?]|TRACE|1|mg|1|1|[?]|NORMAL|GASTRIC CONTENTS|FRESH|N|ULTRASONOGRAPHIC ELASTOGRAPHY|HEPASCORE FORMULA|Y||Y||4|Visit_4|65|5|FOLLOW-UP|2020-08-07|2020-08-09|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|LB|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|9|PARICEAB|Parietal Cell Antibody|URINALYSIS|[?]|kg/cm|[?]|[?]|INDETERMINATE|1|/wk|1|1|[?]|LOW|SALIVA|REFRIGERATED||CALCULATION|FIBROTEST FORMULA||Y|NA||5|Visit_5|90|6|TREATMENT|2020-09-01|2020-09-09|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|10|HLAB27AG|HLA-B27 Antigen|URINALYSIS|[?]|Shock Wave|[?]|[?]|POSITIVE|1|PATCH|1|1|[?]|HIGH|PROSTATIC FLUID|CONTAMINATED|N|CYSTOMETRY|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|1|TREATMENT|2020-09-01|2020-09-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|4be1ea69-9baf-45b4-873b-13a879544d9c|1|TAURINE|Taurine|CHEMISTRY|[?]|uIU/dL|[?]|[?]|TRACE|1|ug/g/day|1|1|[?]|HIGH|SEMINAL FLUID|ICTERIC||NEXT GENERATION SEQUENCING|MDRD 6 VARIABLE FORMULA||Y|Y||1|Visit_1|10|1|SCREENING|2021-01-26|2021-03-07|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|LB|4be1ea69-9baf-45b4-873b-13a879544d9c|2|INTLK12|Interleukin 12|URINALYSIS|[?]|mL/g/min|[?]|[?]|BORDERLINE|1|ug/day|1|1|[?]|LOW|LUNG SURFACTANT|FRESH||PERFUSION MRI|MDRD FORMULA|||NA||1|Visit_1|10|3|SCREENING|2021-01-26|2021-04-24|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|LB|4be1ea69-9baf-45b4-873b-13a879544d9c|3|SLXAG|Sialyl SSEA-1 Antigen|URINALYSIS|[?]|log10 PFU/mL|[?]|[?]|BORDERLINE|1|mL/kg/day|1|1|[?]|NORMAL|ERYTHROCYTES|DRIED|N|TOLUIDINE BLUE STAIN|MDRD 6 VARIABLE FORMULA|||U||2|Visit_2|25|1|TREATMENT|2021-02-10|2021-02-26|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-22
e|LB|4be1ea69-9baf-45b4-873b-13a879544d9c|4|C1QAB|Complement C1q Antibody|HEMATOLOGY|[?]|uIU/L|[?]|[?]|POSITIVE|1|cpm|1|1|[?]|HIGH|BUFFY COAT|CONCENTRATED||HEMATOXYLIN AND EOSIN STAIN|GMI % FORMULA|Y|Y|U||2|Visit_2|25|1|TREATMENT|2021-02-10|2021-04-15|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-22
e|LB|4be1ea69-9baf-45b4-873b-13a879544d9c|5|LSD|Lysergic Acid Diethylamide|HEMATOLOGY|[?]|mg/kg/week|[?]|[?]|INVALID|1|Hounsfield Unit|1|1|[?]|LOW|INTERSTITIAL FLUID|THAWED||HEMAGGLUTINATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||3|Visit_3|40|6|FOLLOW-UP|2021-02-25|2021-03-30|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|4be1ea69-9baf-45b4-873b-13a879544d9c|6|CODEINE|Codeine|CHEMISTRY|[?]|ks|[?]|[?]|NEGATIVE|1|ppth|1|1|[?]|NORMAL|SEBUM|CONTAMINATED||X-RAY FLUORESCENCE SPECTROMETRY|MDRD FORMULA|||Y||3|Visit_3|40|4|TREATMENT|2021-02-25|2021-04-17|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|4be1ea69-9baf-45b4-873b-13a879544d9c|7|TPAAG|Tissue Plasminogen Activator Antigen|HEMATOLOGY|[?]|ug/m2/day|[?]|[?]|TRACE|1|Linear ft*LB|1|1|[?]|ABNORMAL|VENOUS BLOOD|HEMOLYZED||CENTRIFUGATION|GMI % FORMULA|||U||4|Visit_4|65|6|TREATMENT|2021-03-22|2021-04-18|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-09
e|LB|4be1ea69-9baf-45b4-873b-13a879544d9c|8|OXMORPHN|Oxymorphone|HEMATOLOGY|||[?]|[?]|INVALID|1|10^7 PFU|1|1|[?]|NORMAL|PLATELET POOR PLASMA|ROOM TEMPERATURE|N|DUKE INCISION METHOD|COCKCROFT-GAULT FORMULA|||NA|Y|4|Visit_4|65|2|TREATMENT|2021-03-22|2021-04-02|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-09
e|LB|4be1ea69-9baf-45b4-873b-13a879544d9c|9|GALANIN|Galanin|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|OD Unit|1|1|[?]|LOW|GASTRIC FLUID|CALCIFIED||HPLC-UV|CKD-EPI CREATININE FORMULA||Y|NA|Y|5|Visit_5|90|1|SCREENING|2021-04-16|2021-04-24|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|4be1ea69-9baf-45b4-873b-13a879544d9c|10|CPEPTIDE|C-peptide|CHEMISTRY|[?]|BAU|[?]|[?]|POSITIVE|1|10^9/g|1|1|[?]|LOW|MIXED VENOUS BLOOD|NON-HEMOLYZED||AUDIOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2021-04-16|2021-04-23|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|1|CRTFREXR|Cortisol, Free Excretion Rate|CHEMISTRY|[?]|vg/kg|[?]|[?]|INDETERMINATE|1|mEq/day|1|1|[?]|NORMAL|ADIPOSE TISSUE|CONCENTRATED|N|TONOMETRY|MDRD 4 VARIABLE FORMULA||Y|N||1|Visit_1|10|7|TREATMENT|2020-10-29|2020-11-27|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|2|GLDH|Glutamate Dehydrogenase|URINALYSIS|[?]|FINGERTIP UNIT|[?]|[?]|TRACE|1|dL|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR||BRDU CELLULAR PROLIFERATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2020-10-29|2021-01-04|10|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|3|C165888|Russian Thistle Pollen IgE Antibody|HEMATOLOGY|[?]|EID 50/dose|[?]|[?]|INDETERMINATE|1|g/animal|1|1|[?]|HIGH|SPERMATOZOON|HEMOLYZED||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|GMI MMOL/MOL FORMULA|||Y||2|Visit_2|25|3|SCREENING|2020-11-13|2020-12-05|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|4|CSFAT|Fatty Casts|CHEMISTRY|[?]|U/mg|[?]|[?]|NEGATIVE|1|mmol2/L2|1|1|[?]|HIGH|ISOLATE|CONTAMINATED||PET/MRI SCAN|CKD-EPI FORMULA||Y|N||2|Visit_2|25|1|TREATMENT|2020-11-13|2021-01-04|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|5|CKBB|Creatine Kinase BB|CHEMISTRY|[?]|10^3 DNA copies/mL|[?]|[?]|TRACE|1|cd*s/m2|1|1|[?]|LOW|MUCUS|AUTOLYZED||TONOMETRY|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|4|FOLLOW-UP|2020-11-28|2020-12-31|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|6|C130092|Western Ragweed Pollen IgE|URINALYSIS|||[?]|[?]|TRACE|1|PLUG|1|1|[?]|LOW|STOOL|FRESH||POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA||Y|U|Y|3|Visit_3|40|3|WASHOUT|2020-11-28|2020-12-19|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|7|MPV|Mean Platelet Volume|HEMATOLOGY|||[?]|[?]|POSITIVE|1|pptr|1|1|[?]|HIGH|SMEGMA|ICTERIC||GEL ELECTROPHORESIS|FIBROMETER FORMULA|||NA|Y|4|Visit_4|65|4|TREATMENT|2020-12-23|2021-01-19|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|8|ETS|Ethyl Sulfate|HEMATOLOGY|[?]|mEq/g|[?]|[?]|NEGATIVE|1|ukat/L|1|1|[?]|HIGH|URINE SEDIMENT|PARAFFIN-EMBEDDED|N|JAEGER EYE CHART|MDRD ENZYMATIC JAPANESE FORMULA|||N||4|Visit_4|65|6|WASHOUT|2020-12-23|2021-01-24|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|9|GLCTN3|Galectin-3|HEMATOLOGY|[?]|mg/dose|[?]|[?]|POSITIVE|1|COAT|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|CONTAMINATED|N|FISH|MDRD 6 VARIABLE FORMULA|Y||Y||5|Visit_5|90|3|TREATMENT|2021-01-17|2021-01-20|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|10|SJSA60AB|Sjogrens SS-A60 Antibody|CHEMISTRY|[?]|log10 CFU/mL|[?]|[?]|TRACE|1|pg/L|1|1|[?]|HIGH|FLUID|CALCIFIED|N|DOPPLER ULTRASOUND|CKD-EPI FORMULA|Y||Y||5|Visit_5|90|1|WASHOUT|2021-01-17|2021-01-22|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|16720f71-55b5-478f-b041-00b61ae19ac9|1|AMYLOIDB|Amyloid, Beta|URINALYSIS|[?]|APL U/mL|[?]|[?]|BORDERLINE|1|NEBULE|1|1|[?]|HIGH|MONOCYTE|CLOTTED||PHOROPTER|MDRD 6 VARIABLE FORMULA|Y|Y|NA||1|Visit_1|10|3|TREATMENT|2021-01-10|2021-02-06|10|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|16720f71-55b5-478f-b041-00b61ae19ac9|2|CTXICRT|Type I Collagen C-Telopeptides/Creat|HEMATOLOGY|[?]|MPS U|[?]|[?]|POSITIVE|1|uV2|1|1|[?]|LOW|URINE SEDIMENT|ICTERIC|N|LAPAROSCOPY|CKD-EPI CYSTATIN C FORMULA|Y||Y||1|Visit_1|10|6|WASHOUT|2021-01-10|2021-03-10|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|16720f71-55b5-478f-b041-00b61ae19ac9|3|MDZPM|Medazepam|CHEMISTRY|[?]|10^7 CFU|[?]|[?]|TRACE|1|deg2|1|1|[?]|HIGH|HAIR FOLLICLE|UNEXPECTED ODOR||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|5|TREATMENT|2021-01-25|2021-01-27|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|16720f71-55b5-478f-b041-00b61ae19ac9|4|PLATAGGR|Platelet Aggregation|CHEMISTRY|[?]|NFIU|[?]|[?]|BORDERLINE|1|GBq/g|1|1|[?]|LOW|ARTERIAL BLOOD|CONTAMINATED||NEPHELOMETRY|FIBROMETER FORMULA|||NA||2|Visit_2|25|6|SCREENING|2021-01-25|2021-02-10|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|16720f71-55b5-478f-b041-00b61ae19ac9|5|IA2AB|Insulinoma-Associated Protein 2 Antibody|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|TROCHE|1|1|[?]|NORMAL|INFRANATANT, PLASMA|CALCIFIED|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|3|Visit_3|40|4|TREATMENT|2021-02-09|2021-03-15|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|16720f71-55b5-478f-b041-00b61ae19ac9|6|KIM1|Kidney Injury Molecule-1|HEMATOLOGY|[?]|WAFER|[?]|[?]|INDETERMINATE|1|m/sec|1|1|[?]|NORMAL|SEBUM|THAWED||MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|4|FOLLOW-UP|2021-02-09|2021-03-10|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|16720f71-55b5-478f-b041-00b61ae19ac9|7|CKMMCK|Creatine Kinase MM/Total Creatine Kinase|CHEMISTRY|[?]|mL/kg/day|[?]|[?]|POSITIVE|1|g/kg|1|1|[?]|LOW|ADIPOSE TISSUE|AGGLUTINATED|N|LAPAROSCOPY|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|3|TREATMENT|2021-03-06|2021-04-03|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|16720f71-55b5-478f-b041-00b61ae19ac9|8|NEUTIMLE|Immature Neutrophils/Leukocytes|URINALYSIS|||[?]|[?]|POSITIVE|1|/100 HPFs|1|1|[?]|HIGH|RETICULOCYTES|ROOM TEMPERATURE||BRDU CELLULAR PROLIFERATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|4|Visit_4|65|1|WASHOUT|2021-03-06|2021-04-04|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|16720f71-55b5-478f-b041-00b61ae19ac9|9|TROPONIN|Troponin|URINALYSIS|[?]|pkat|[?]|[?]|INDETERMINATE|1|ms2|1|1|[?]|ABNORMAL|LUNG SURFACTANT|REFRIGERATED||TELLER ACUITY CARDS|GMI MMOL/MOL FORMULA||Y|NA||5|Visit_5|90|6|SCREENING|2021-03-31|2021-04-02|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|16720f71-55b5-478f-b041-00b61ae19ac9|10|BLSTLY|Lymphoblasts|URINALYSIS|[?]|PIXELS/in|[?]|[?]|TRACE|1|pg/dL|1|1|[?]|NORMAL|SPUTUM|GELLED||ERGOSPIROMETRY|MDRD 5 VARIABLE FORMULA|Y|Y|NA||5|Visit_5|90|5|TREATMENT|2021-03-31|2021-04-09|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|LB|4349f45e-f18b-4606-9a72-fd45e64e17dc|1|ALBPROT|Albumin/Total Protein|URINALYSIS|[?]|pg/dL|[?]|[?]|TRACE|1|/mm2|1|1|[?]|HIGH|SEMEN|DRIED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|7|TREATMENT|2021-01-11|2021-03-05|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|4349f45e-f18b-4606-9a72-fd45e64e17dc|2|GLOBUL|Globulin|HEMATOLOGY|[?]|BAU/mL|[?]|[?]|INVALID|1|tuberculin unit|1|1|[?]|HIGH|PLATELET|FROZEN||DOUBLE IMMUNODIFFUSION|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|6|TREATMENT|2021-01-11|2021-03-16|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|4349f45e-f18b-4606-9a72-fd45e64e17dc|3|FACTIII|Factor III|HEMATOLOGY|[?]|U/g/day|[?]|[?]|TRACE|1|ukat|1|1|[?]|LOW|EMESIS|DRIED||SPECTROPHOTOMETRY|CKD-EPI CYSTATIN C FORMULA|Y|Y|U||2|Visit_2|25|6|TREATMENT|2021-01-26|2021-03-23|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|4349f45e-f18b-4606-9a72-fd45e64e17dc|4|METARBCE|Metarubricyte/Total Cells|CHEMISTRY|[?]|gtt|[?]|[?]|POSITIVE|1|fmol/L|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|PARAFFIN-EMBEDDED||ZIEHL NEELSEN ACID FAST STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|1|SCREENING|2021-01-26|2021-03-12|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|4349f45e-f18b-4606-9a72-fd45e64e17dc|5|BLSTLY|Lymphoblasts|URINALYSIS|[?]|mL/beat|[?]|[?]|POSITIVE|1|L/s/kPa|1|1|[?]|NORMAL|WHITE MATTER TISSUE|HEMOLYZED||AUTOMATED COUNT|MDRD 4 VARIABLE FORMULA|Y||NA||3|Visit_3|40|6|WASHOUT|2021-02-10|2021-03-22|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|LB|4349f45e-f18b-4606-9a72-fd45e64e17dc|6|SODIUM|Sodium|URINALYSIS|[?]|umol|[?]|[?]|INVALID|1|Gy|1|1|[?]|ABNORMAL|TUMOR TISSUE|CALCIFIED||TONOMETRY|FIBROMETER FORMULA||Y|N||3|Visit_3|40|2|FOLLOW-UP|2021-02-10|2021-03-11|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|LB|4349f45e-f18b-4606-9a72-fd45e64e17dc|7|CA1AG|Cancer Antigen 1|CHEMISTRY|[?]|K|[?]|[?]|NEGATIVE|1|nmol|1|1|[?]|NORMAL|INFRANATANT, SERUM|GELLED||NUCLEIC ACID HYBRIDIZATION|HEPASCORE FORMULA|||N||4|Visit_4|65|7|TREATMENT|2021-03-07|2021-04-05|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|LB|4349f45e-f18b-4606-9a72-fd45e64e17dc|8|ABNCECE|Abnormal Cells/Total Cells|CHEMISTRY|[?]|ug/m2|[?]|[?]|INDETERMINATE|1|damol/L|1|1|[?]|HIGH|LEUKOCYTE|UNEXPECTED ODOR||PYROSEQUENCING|HEPASCORE FORMULA|Y|Y|N||4|Visit_4|65|6|SCREENING|2021-03-07|2021-03-25|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|LB|4349f45e-f18b-4606-9a72-fd45e64e17dc|9|METARBLE|Metarubricytes/Leukocytes|URINALYSIS|[?]|umol/kg/min|[?]|[?]|BORDERLINE|1|ug/kg/h|1|1|[?]|NORMAL|BONE|CONCENTRATED|N|SLOAN LETTER EYE CHART 2.5%|NASH FIBROSURE FORMULA|Y||N||5|Visit_5|90|4|WASHOUT|2021-04-01|2021-04-10|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|LB|4349f45e-f18b-4606-9a72-fd45e64e17dc|10|RETIH|High Absorption Reticulocytes|URINALYSIS|[?]|mol|[?]|[?]|TRACE|1|DAYS|1|1|[?]|ABNORMAL|ERYTHROCYTES|LIPEMIC|N|CLOT DETECTION|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|2|SCREENING|2021-04-01|2021-04-07|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|LB|32e36ec1-6895-42ff-bf33-52977e72b338|1|C165932|Dog Dander IgE AB RAST Score|HEMATOLOGY|[?]|U/mg|[?]|[?]|INDETERMINATE|1|IU/mmol|1|1|[?]|LOW|CAPILLARY BLOOD|CONTAMINATED||PHASE CONTRAST MICROSCOPY|NASH FIBROSURE FORMULA|||NA||1|Visit_1|10|4|FOLLOW-UP|2020-09-05|2020-10-11|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|32e36ec1-6895-42ff-bf33-52977e72b338|2|AMNOACID|Amino Acids|HEMATOLOGY|[?]|10^3/hpf|[?]|[?]|INVALID|1|/ms|1|1|[?]|HIGH|INTERSTITIAL FLUID|ICTERIC||DYNAMIC CONTRAST ENHANCED MRI|GMI MMOL/MOL FORMULA|||NA||1|Visit_1|10|6|SCREENING|2020-09-05|2020-11-09|10|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|32e36ec1-6895-42ff-bf33-52977e72b338|3|LYMCE|Lymphocytes/Total Cells|HEMATOLOGY|[?]|10^9 organisms/mg|[?]|[?]|TRACE|1|m/sec|1|1|[?]|LOW|KERATINOCYTE|AUTOLYZED||ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA|Y|Y|Y||2|Visit_2|25|4|WASHOUT|2020-09-20|2020-11-08|25|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|32e36ec1-6895-42ff-bf33-52977e72b338|4|RENINA|Renin Activity|URINALYSIS|[?]|mg/animal|[?]|[?]|INDETERMINATE|1|HEP|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|LACTESCENT|N|TARGETED GENOME SEQUENCING|CKD-EPI FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-09-20|2020-11-13|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|LB|32e36ec1-6895-42ff-bf33-52977e72b338|5|GST|Glutathione S-Transferase, Total|URINALYSIS|[?]|/100 WBC|[?]|[?]|INVALID|1|TRANSDUCING UNIT/mL|1|1|[?]|HIGH|SMEGMA|SOLIDIFIED||WHOLE EXOME SEQUENCING|CKD-EPI CREATININE FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-10-05|2020-11-12|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|32e36ec1-6895-42ff-bf33-52977e72b338|6|GLUCPE|Plasma Equivalent Glucose|HEMATOLOGY|[?]|10^9 organisms/mL|[?]|[?]|NEGATIVE|1|DAYS|1|1|[?]|HIGH|MENSTRUAL BLOOD|AUTOLYZED|N|CLIP SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-10-05|2020-11-21|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|32e36ec1-6895-42ff-bf33-52977e72b338|7|GRAN|Granulocytes|CHEMISTRY|[?]|10^3 CFU/mL|[?]|[?]|POSITIVE|1|/10^5|1|1|[?]|LOW|PLATELET|LACTESCENT|N|PALPATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||4|Visit_4|65|1|WASHOUT|2020-10-30|2020-11-22|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|32e36ec1-6895-42ff-bf33-52977e72b338|8|HER2|Human Epidermal Growth Factor Receptor 2|URINALYSIS|[?]|NFIU|[?]|[?]|INDETERMINATE|1|DAYS|1|1|[?]|NORMAL|VENOUS BLOOD|UNEXPECTED ODOR||RYAN BLUE STAIN|MDRD ENZYMATIC FORMULA|||NA||4|Visit_4|65|7|SCREENING|2020-10-30|2020-11-01|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|32e36ec1-6895-42ff-bf33-52977e72b338|9|MIP1G|Macrophage Inflammatory Protein 1 Gamma|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|oz|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|NON-HEMOLYZED||SPECT/CT SCAN|CKD-EPI CREATININE FORMULA|||NA|Y|5|Visit_5|90|7|SCREENING|2020-11-24|2020-11-26|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|32e36ec1-6895-42ff-bf33-52977e72b338|10|FXIVAC|Factor XIV Actual/Control|URINALYSIS|[?]|L/h/m2|[?]|[?]|BORDERLINE|1|kat|1|1|[?]|NORMAL|CAPILLARY PLASMA|HEMOLYZED||IVY INCISION METHOD|GMI MMOL/MOL FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-11-24|2020-12-02|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|e546f2d8-baea-4a6e-93cb-c7ec7292b423|1|PAF|Platelet Activating Factor|URINALYSIS|[?]|/200 HPFs|[?]|[?]|BORDERLINE|1|kBq/uL|1|1|[?]|LOW|BILE|CALCIFIED||PATHOLOGICAL EVALUATION|COCKCROFT-GAULT FORMULA||Y|Y||1|Visit_1|10|7|SCREENING|2020-10-25|2020-12-09|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|e546f2d8-baea-4a6e-93cb-c7ec7292b423|2|CD40|CD40|URINALYSIS|[?]|Enzyme U/L|[?]|[?]|TRACE|1|tuberculin unit|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED||CRYOSCOPY|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|4|SCREENING|2020-10-25|2021-01-22|10|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|e546f2d8-baea-4a6e-93cb-c7ec7292b423|3|HLAA|HLA Class IA Antigen|URINALYSIS|[?]|mAnson U/mL|[?]|[?]|NEGATIVE|1|APPLICATION|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|THAWED||CONTRAST ENHANCED CT SCAN|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|1|FOLLOW-UP|2020-11-09|2021-01-07|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|e546f2d8-baea-4a6e-93cb-c7ec7292b423|4|PROMYB|Promyeloblasts|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|TABLET|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|AUTOLYZED|N|IMMUNOTURBIDIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|2|Visit_2|25|1|WASHOUT|2020-11-09|2020-11-15|25|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|e546f2d8-baea-4a6e-93cb-c7ec7292b423|5|PTAUAB42|Phosphorylated Tau Prot/Amyloid Beta1-42|CHEMISTRY|[?]|Arbitrary U|[?]|[?]|NEGATIVE|1|uL/dose|1|1|[?]|ABNORMAL|SPUTUM|CONTAMINATED||QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROTEST FORMULA|||NA||3|Visit_3|40|5|WASHOUT|2020-11-24|2020-12-19|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|e546f2d8-baea-4a6e-93cb-c7ec7292b423|6|C130132|D. farinae Antigen IgE Antibody|HEMATOLOGY|[?]|mEq/L|[?]|[?]|BORDERLINE|1|10^6 organisms/mL|1|1|[?]|ABNORMAL|SOFT TISSUE|DRIED||WRIGHT STAIN|COCKCROFT-GAULT FORMULA|||N||3|Visit_3|40|3|SCREENING|2020-11-24|2020-12-13|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|e546f2d8-baea-4a6e-93cb-c7ec7292b423|7|SLXAG|Sialyl SSEA-1 Antigen|URINALYSIS|[?]|log10 IU/mL|[?]|[?]|TRACE|1|10^8/L|1|1|[?]|HIGH|SERUM|LIPEMIC||OPTICAL DENSITY MEASUREMENT|MDRD FORMULA|||U||4|Visit_4|65|7|TREATMENT|2020-12-19|2020-12-22|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|e546f2d8-baea-4a6e-93cb-c7ec7292b423|8|ETHANOL|Ethanol|URINALYSIS|[?]|IU/dL|[?]|[?]|POSITIVE|1|mm/min|1|1|[?]|LOW|BUFFY COAT|CLOTTED||AURAMINE STAIN|MDRD FORMULA|||Y||4|Visit_4|65|1|TREATMENT|2020-12-19|2020-12-23|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|e546f2d8-baea-4a6e-93cb-c7ec7292b423|9|SOMATRO|Somatotrophin|HEMATOLOGY|[?]|min*mg/mL|[?]|[?]|NEGATIVE|1|Weber|1|1|[?]|NORMAL|FLUID|THAWED||FLOW MICROSCOPY|CKD-EPI FORMULA|||NA||5|Visit_5|90|4|FOLLOW-UP|2021-01-13|2021-01-14|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|e546f2d8-baea-4a6e-93cb-c7ec7292b423|10|GLOBB2|Beta-2 Globulin|HEMATOLOGY|||[?]|[?]|INVALID|1|MPL U|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH||RAJI CELL EIA|GMI % FORMULA|||NA|Y|5|Visit_5|90|4|TREATMENT|2021-01-13|2021-01-19|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|0329de16-fc7a-4941-900c-b390dac637aa|1|DOHLE|Dohle Bodies|HEMATOLOGY|[?]|10^3/L|[?]|[?]|TRACE|1|Henry|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|HEMOLYZED|N|X-RAY|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA||1|Visit_1|10|7|SCREENING|2020-09-27|2020-10-14|10|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|0329de16-fc7a-4941-900c-b390dac637aa|2|PLTLPLT|Large Platelets/Total Platelets|URINALYSIS|[?]|U/g/h|[?]|[?]|POSITIVE|1|mV|1|1|[?]|LOW|ENDOMETRIAL TISSUE|REFRIGERATED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI FORMULA||Y|Y||1|Visit_1|10|4|TREATMENT|2020-09-27|2020-12-21|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|0329de16-fc7a-4941-900c-b390dac637aa|3|PAP|Prostatic Acid Phosphatase|URINALYSIS|[?]|10^9 CFU/g|[?]|[?]|INVALID|1|kV|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|FROZEN|N|MAPH|MDRD 4 VARIABLE FORMULA|||N||2|Visit_2|25|5|WASHOUT|2020-10-12|2020-11-09|25|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|0329de16-fc7a-4941-900c-b390dac637aa|4|CAEXR|Calcium Excretion Rate|HEMATOLOGY|[?]|DDU|[?]|[?]|TRACE|1|% INHIBITION|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|SOLIDIFIED||AURAMINE STAIN|CKD-EPI FORMULA|||U||2|Visit_2|25|3|SCREENING|2020-10-12|2020-11-29|25|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|0329de16-fc7a-4941-900c-b390dac637aa|5|CD22|CD22|URINALYSIS|[?]|10^8 PFU|[?]|[?]|INDETERMINATE|1|10^3 organisms|1|1|[?]|LOW|ENDOTRACHEAL FLUID|HEMOLYZED||WHOLE EXOME SEQUENCING|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-10-27|2020-11-24|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|0329de16-fc7a-4941-900c-b390dac637aa|6|BAMBTAC|Beta-Aminobutyric Acid|HEMATOLOGY|[?]|GBq/ug|[?]|[?]|INVALID|1|gtt|1|1|[?]|HIGH|EXUDATE|AGGLUTINATED||RADIATION DOSIMETRY|MDRD 6 VARIABLE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-10-27|2020-12-06|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|0329de16-fc7a-4941-900c-b390dac637aa|7|VITA|Vitamin A|HEMATOLOGY|[?]|ug/L|[?]|[?]|POSITIVE|1|Ci/ug|1|1|[?]|ABNORMAL|BILE|CALCIFIED||IMPEDANCE CONDUCTIVITY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||4|Visit_4|65|5|FOLLOW-UP|2020-11-21|2020-12-16|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|0329de16-fc7a-4941-900c-b390dac637aa|8|NAG|N-Acetyl Glucosamide|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|days/month|1|1|[?]|NORMAL|ERYTHROCYTES|DRIED||MAGNETIC RESONANCE ENTEROGRAPHY|MDRD 6 VARIABLE FORMULA|||N|Y|4|Visit_4|65|2|TREATMENT|2020-11-21|2020-12-12|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|0329de16-fc7a-4941-900c-b390dac637aa|9|GHBP|Growth Hormone Binding Protein|CHEMISTRY|||[?]|[?]|NEGATIVE|1|U/g/h|1|1|[?]|ABNORMAL|PLASMA|AGGLUTINATED||ACID FAST STAIN|FIBROSIS 4 FORMULA|Y||U|Y|5|Visit_5|90|5|TREATMENT|2020-12-16|2020-12-25|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|0329de16-fc7a-4941-900c-b390dac637aa|10|LEIMLE|Immature Leukocytes/Leukocytes|CHEMISTRY|[?]|mg2/dL2|[?]|[?]|BORDERLINE|1|log10 CFU/mL|1|1|[?]|HIGH|ARTERIAL BLOOD|GELLED||CALIPER MEASUREMENT METHOD|MDRD 6 VARIABLE FORMULA||Y|NA||5|Visit_5|90|5|TREATMENT|2020-12-16|2020-12-18|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|89d364c9-1338-472b-af0b-19280e45508b|1|T4FR|Thyroxine, Free|HEMATOLOGY|[?]|lm|[?]|[?]|INVALID|1|TROCHE|1|1|[?]|ABNORMAL|EPITHELIAL CELL|PARAFFIN-EMBEDDED||MIGET|FIBROMETER FORMULA||Y|U||1|Visit_1|10|6|TREATMENT|2020-10-15|2021-01-07|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|89d364c9-1338-472b-af0b-19280e45508b|2|IGAGM|IgG IgM IgA Total|URINALYSIS|||[?]|[?]|TRACE|1|MBP|1|1|[?]|HIGH|RETICULOCYTES|PARAFFIN-EMBEDDED||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|GMI MMOL/MOL FORMULA|||N|Y|1|Visit_1|10|1|WASHOUT|2020-10-15|2020-10-19|10|14|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|89d364c9-1338-472b-af0b-19280e45508b|3|APLIGMAB|Anti-Phospholipid IgM Antibody|URINALYSIS|[?]|ELISA unit|[?]|[?]|INDETERMINATE|1|BAG|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED||OPHTHALMOSCOPY|MDRD FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-10-30|2020-11-14|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|89d364c9-1338-472b-af0b-19280e45508b|4|CYSTINE|Cystine|CHEMISTRY|[?]|log10 PFU|[?]|[?]|INDETERMINATE|1|amp|1|1|[?]|LOW|LEUKOCYTE|CLOTTED||ERGOSPIROMETRY|MDRD 6 VARIABLE FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-10-30|2020-12-02|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|LB|89d364c9-1338-472b-af0b-19280e45508b|5|TGFB2|Transforming Growth Factor Beta 2|HEMATOLOGY|[?]|U/kg|[?]|[?]|POSITIVE|1|mg/L|1|1|[?]|ABNORMAL|HAIR|DRIED|N|MANUAL COUNT|GMI MMOL/MOL FORMULA|Y|Y|U||3|Visit_3|40|4|TREATMENT|2020-11-14|2020-11-15|40|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|89d364c9-1338-472b-af0b-19280e45508b|6|ERCEMPOL|Erythroid Maturation Pool|HEMATOLOGY|[?]|DAYS|[?]|[?]|NEGATIVE|1|IU/mmol|1|1|[?]|HIGH|AMNIOTIC FLUID|LIPEMIC||STATIC PERIMETRY|FIBROTEST FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-11-14|2020-11-19|40|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|89d364c9-1338-472b-af0b-19280e45508b|7|ACH|Acetylcholine|URINALYSIS|[?]|mL/(min*100mL)|[?]|[?]|BORDERLINE|1|umol/dL|1|1|[?]|LOW|SEBUM|FROZEN|N|GC/FID|HEPASCORE FORMULA|Y||NA||4|Visit_4|65|5|TREATMENT|2020-12-09|2020-12-24|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|LB|89d364c9-1338-472b-af0b-19280e45508b|8|HGBOXY|Oxyhemoglobin|URINALYSIS|[?]|Bq/mL|[?]|[?]|INVALID|1|mL/cm|1|1|[?]|LOW|ERYTHROCYTES|UNEXPECTED ODOR|N|INDIA INK STAIN|NASH FIBROSURE FORMULA|Y|Y|N||4|Visit_4|65|2|SCREENING|2020-12-09|2020-12-14|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|LB|89d364c9-1338-472b-af0b-19280e45508b|9|NEUTLS|Left Shift Neutrophils|HEMATOLOGY|[?]|Enzyme U|[?]|[?]|NEGATIVE|1|nmol/L/h|1|1|[?]|HIGH|PERSPIRATION|CALCIFIED||IHC|FIBROSIS 4 FORMULA|||N||5|Visit_5|90|1|SCREENING|2021-01-03|2021-01-11|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|89d364c9-1338-472b-af0b-19280e45508b|10|RPPAB|Ribosomal P Protein Antibody|CHEMISTRY|[?]|VOXEL|[?]|[?]|POSITIVE|1|nmol BCE/mmol|1|1|[?]|LOW|BONE MARROW|FRESH||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|FIBROSIS 4 FORMULA|||N||5|Visit_5|90|2|TREATMENT|2021-01-03|2021-01-11|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|1|CSGRANF|Granular Fine Casts|HEMATOLOGY|[?]|10^3/hpf|[?]|[?]|BORDERLINE|1|10^3 organisms/mL|1|1|[?]|ABNORMAL|SEBUM|AUTOLYZED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-05-27|2020-07-25|10|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|LB|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|2|C130070|Bermuda Grass Pollen IgG|HEMATOLOGY|[?]|log10 TCID 50/dose|[?]|[?]|NEGATIVE|1|dpm/mg|1|1|[?]|LOW|SPERMATOZOON|UNEXPECTED ODOR||CENTRIFUGATION|FIBROSIS 4 FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-05-27|2020-07-19|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|LB|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|3|FACTIII|Factor III|URINALYSIS|[?]|EIA unit|[?]|[?]|POSITIVE|1|PFU/mL|1|1|[?]|NORMAL|LAVAGE FLUID|ICTERIC||MECHANICAL CLOT DETECTION|ASH FIBROSURE FORMULA|||U||2|Visit_2|25|7|WASHOUT|2020-06-11|2020-07-03|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|4|GNRH|Gonadotropin Releasing Hormone|CHEMISTRY|[?]|ng|[?]|[?]|INVALID|1|mCi/kg|1|1|[?]|NORMAL|SWABBED MATERIAL|LACTESCENT||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|1|SCREENING|2020-06-11|2020-07-31|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|5|TRPTRG|Trypsin and Trypsinogen|CHEMISTRY|||[?]|[?]|INVALID|1|mL/kg/day|1|1|[?]|HIGH|SPERMATOZOON|LIPEMIC||MAGNETIC RESONANCE ENTEROGRAPHY|MDRD ENZYMATIC FORMULA|||Y|Y|3|Visit_3|40|7|TREATMENT|2020-06-26|2020-07-14|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|6|CD22|CD22|CHEMISTRY|||[?]|[?]|NEGATIVE|1|DDU|1|1|[?]|NORMAL|VENOUS BLOOD|THAWED||STATIC PERIMETRY|HEPASCORE FORMULA|Y||U|Y|3|Visit_3|40|6|FOLLOW-UP|2020-06-26|2020-07-18|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|7|CHCMR|Ret. Corpuscular HGB Concentration Mean|HEMATOLOGY|||[?]|[?]|INVALID|1|GBq/g|1|1|[?]|HIGH|VENOUS PLASMA|CONTAMINATED|N|MICROBIAL CULTURE, LIQUID|GMI MMOL/MOL FORMULA|||Y|Y|4|Visit_4|65|2|TREATMENT|2020-07-21|2020-08-02|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-27
e|LB|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|8|VITB6|Vitamin B6|HEMATOLOGY|||[?]|[?]|TRACE|1|cm/s|1|1|[?]|ABNORMAL|GASTRIC FLUID|SOLIDIFIED||PULSE OXIMETRY|MDRD 5 VARIABLE FORMULA|||U|Y|4|Visit_4|65|1|SCREENING|2020-07-21|2020-08-18|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-27
e|LB|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|9|FDP|Fibrin Degradation Products|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|PELLET|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|ICTERIC||MRI WITHOUT CONTRAST|CKD-EPI CREATININE FORMULA|Y||U|Y|5|Visit_5|90|5|FOLLOW-UP|2020-08-15|2020-08-18|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|10|CFA|Coefficient of Fat Absorption|URINALYSIS|||[?]|[?]|POSITIVE|1|MPS U|1|1|[?]|LOW|AMNIOTIC FLUID|NON-HEMOLYZED|N|MICROBIAL CONCENTRATION|NASH FIBROSURE FORMULA|||NA|Y|5|Visit_5|90|1|SCREENING|2020-08-15|2020-08-17|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|1|IAA5OH|5-Hydroxyindoleacetic Acid|URINALYSIS|[?]|cd/m2|[?]|[?]|TRACE|1|pg/cell|1|1|[?]|ABNORMAL|VENOUS BLOOD|ICTERIC||U-HPLC/MS/MS|CKD-EPI FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2020-10-12|2021-01-08|10|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|2|EOSIMLE|Immature Eosinophils/Leukocytes|CHEMISTRY|[?]|LB|[?]|[?]|INDETERMINATE|1|pL|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|FRESH||LEAD CITRATE STAIN|MDRD 4 VARIABLE FORMULA||Y|NA||1|Visit_1|10|1|FOLLOW-UP|2020-10-12|2020-11-24|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|3|ANGPT2|Angiopoietin 2|URINALYSIS|[?]|kHz|[?]|[?]|INVALID|1|uL/kg/day|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|THAWED||SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||2|Visit_2|25|4|SCREENING|2020-10-27|2020-12-26|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|4|CORCREAT|Cortisol/Creatinine|CHEMISTRY|[?]|U/animal|[?]|[?]|INDETERMINATE|1|L/L|1|1|[?]|NORMAL|MECONIUM|CLOTTED||FLOCCULATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-10-27|2021-01-01|25|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|5|C147281|Egg White Antigen IgE Antibody|CHEMISTRY|[?]|kUSP|[?]|[?]|POSITIVE|1|TRANSDUCING UNIT|1|1|[?]|ABNORMAL|BASAL TEAR|NON-HEMOLYZED||PELLI-ROBSON EYE CHART|MDRD 4 VARIABLE FORMULA|Y||U||3|Visit_3|40|7|TREATMENT|2020-11-11|2021-01-08|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|6|PROGEST|Progesterone|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|PACK|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|DRIED||PET/CT SCAN WITHOUT CONTRAST|FIBROSIS 4 FORMULA|||Y|Y|3|Visit_3|40|2|TREATMENT|2020-11-11|2021-01-01|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|7|TRACP5B|Tartrate-Resistant Acid Phosphatase 5b|HEMATOLOGY|[?]|pmol/10^9 cells|[?]|[?]|INDETERMINATE|1|ug/g/h|1|1|[?]|NORMAL|BONE|NON-HEMOLYZED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA|Y|Y|NA||4|Visit_4|65|2|TREATMENT|2020-12-06|2020-12-10|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|8|BASOBLE|Basophils Band Form/Leukocytes|HEMATOLOGY|[?]|nmol/kg/day|[?]|[?]|NEGATIVE|1|10^9/dose|1|1|[?]|NORMAL|PUS|FROZEN||WHOLE TRANSCRIPTOME SEQUENCING|MDRD FORMULA|||N||4|Visit_4|65|7|WASHOUT|2020-12-06|2020-12-22|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|9|AMPHETD|Dextroamphetamine|HEMATOLOGY|[?]|U/L|[?]|[?]|INDETERMINATE|1|U/g/h|1|1|[?]|NORMAL|PLASMA|CONCENTRATED|N|AURAMINE STAIN|FIBROTEST FORMULA|||Y||5|Visit_5|90|4|SCREENING|2020-12-31|2021-01-06|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|10|FSH|Follicle Stimulating Hormone|CHEMISTRY|[?]|mg/animal|[?]|[?]|INDETERMINATE|1|umol/L/h|1|1|[?]|NORMAL|DISCHARGE|SOLIDIFIED||PHOTOMETRIC CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|6|TREATMENT|2020-12-31|2021-01-05|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|0c103005-efae-48ed-91e3-35d38fa1d359|1|PLSMCELY|Mature Plasma Cells/Lymphocytes|HEMATOLOGY|[?]|min|[?]|[?]|INVALID|1|days/month|1|1|[?]|LOW|SALIVA|ICTERIC|N|PET/MRI SCAN|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-05-28|2020-08-23|10|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|0c103005-efae-48ed-91e3-35d38fa1d359|2|WBCCLMP|Leukocyte Cell Clumps|CHEMISTRY|[?]|ugEq/L|[?]|[?]|BORDERLINE|1|U/cL|1|1|[?]|LOW|AMNIOTIC FLUID|GELLED|N|THERMAL IONIZATION MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA||Y|N||1|Visit_1|10|3|SCREENING|2020-05-28|2020-06-21|10|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|LB|0c103005-efae-48ed-91e3-35d38fa1d359|3|IGSOL|Soluble Immunoglobulin|URINALYSIS|[?]|mg/mL/day|[?]|[?]|INDETERMINATE|1|Ci/g|1|1|[?]|HIGH|PUS|ROOM TEMPERATURE||TOLUIDINE BLUE STAIN|ASH FIBROSURE FORMULA|Y||Y||2|Visit_2|25|6|TREATMENT|2020-06-12|2020-08-04|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|0c103005-efae-48ed-91e3-35d38fa1d359|4|LEUKCRBC|Leuks Corrected for Nucl Erythrocytes|HEMATOLOGY|[?]|mol/L|[?]|[?]|TRACE|1|/5x10^4 WBC|1|1|[?]|ABNORMAL|SPUTUM|FROZEN||RIA|CKD-EPI CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|4|TREATMENT|2020-06-12|2020-08-07|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|0c103005-efae-48ed-91e3-35d38fa1d359|5|ACETAMIN|Acetaminophen|HEMATOLOGY|||[?]|[?]|POSITIVE|1|nmol BCE/mmol|1|1|[?]|NORMAL|CORD SERUM|FRESH||IMMUNOTURBIDIMETRY|HEPASCORE FORMULA|Y||NA|Y|3|Visit_3|40|3|TREATMENT|2020-06-27|2020-07-28|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|0c103005-efae-48ed-91e3-35d38fa1d359|6|VITD23OH|Vitamin D2 D3 25-OH|HEMATOLOGY|[?]|cycle/min|[?]|[?]|BORDERLINE|1|10^5/hpf|1|1|[?]|NORMAL|EXPIRED AIR|NON-HEMOLYZED||FISH|MDRD ENZYMATIC FORMULA||Y|U||3|Visit_3|40|7|TREATMENT|2020-06-27|2020-08-03|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|0c103005-efae-48ed-91e3-35d38fa1d359|7|ANDSTNDN|Androstenedione|CHEMISTRY|[?]|pmol/10^10 cells|[?]|[?]|POSITIVE|1|ug/min|1|1|[?]|LOW|DIALYSIS FLUID|SOLIDIFIED|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROMETER FORMULA|Y|Y|Y||4|Visit_4|65|3|WASHOUT|2020-07-22|2020-07-23|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|0c103005-efae-48ed-91e3-35d38fa1d359|8|CA15_3AG|Cancer Antigen 15-3|HEMATOLOGY|[?]|ug/g/min|[?]|[?]|TRACE|1|umol/mg/min|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|CALCIFIED||SNP ARRAY|CKD-EPI CYSTATIN C FORMULA|||N||4|Visit_4|65|1|SCREENING|2020-07-22|2020-08-06|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|0c103005-efae-48ed-91e3-35d38fa1d359|9|ZPP|Zinc Protoporphyrin|HEMATOLOGY|[?]|pmol/L/h|[?]|[?]|TRACE|1|PFU/mL|1|1|[?]|ABNORMAL|TRANSUDATE|CLOTTED||ICP-MS|MDRD ENZYMATIC JAPANESE FORMULA|||Y||5|Visit_5|90|6|TREATMENT|2020-08-16|2020-08-23|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|0c103005-efae-48ed-91e3-35d38fa1d359|10|RBCDIPOP|Dimorphic Erythrocyte Population|HEMATOLOGY|[?]|in|[?]|[?]|NEGATIVE|1|/7.5 mL|1|1|[?]|HIGH|LEUKOCYTE|CONTAMINATED||HEMAGGLUTINATION ASSAY|FIBROMETER FORMULA|Y||Y||5|Visit_5|90|5|TREATMENT|2020-08-16|2020-08-23|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|c9808184-3432-448c-a5e5-50176715effa|1|C130095|Western Ragweed Pollen IgG4|URINALYSIS|[?]|U/mmol|[?]|[?]|INVALID|1|BAR|1|1|[?]|NORMAL|SEBUM|PARAFFIN-EMBEDDED||HIGH RESOLUTION CT|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||1|Visit_1|10|5|SCREENING|2020-12-29|2021-03-23|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|c9808184-3432-448c-a5e5-50176715effa|2|PLSPCE|Precursor Plasma Cells|URINALYSIS|||[?]|[?]|BORDERLINE|1|CCID 50/dose|1|1|[?]|HIGH|LAVAGE FLUID|REFRIGERATED|N|URANYL ACETATE STAIN|ASH FIBROSURE FORMULA|Y||N|Y|1|Visit_1|10|4|TREATMENT|2020-12-29|2021-01-30|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|c9808184-3432-448c-a5e5-50176715effa|3|AMYLOIDP|Amyloid P|CHEMISTRY|||[?]|[?]|POSITIVE|1|cg|1|1|[?]|NORMAL|PROSTATIC FLUID|AGGLUTINATED||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 4 VARIABLE FORMULA|Y||Y|Y|2|Visit_2|25|3|SCREENING|2021-01-13|2021-03-07|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|c9808184-3432-448c-a5e5-50176715effa|4|PAF|Platelet Activating Factor|URINALYSIS|[?]|ag|[?]|[?]|TRACE|1|uSiemens|1|1|[?]|NORMAL|EPITHELIAL CELL|FRESH|N|MICROBIAL CULTURE|FIBROSIS 4 FORMULA|||N||2|Visit_2|25|2|FOLLOW-UP|2021-01-13|2021-03-11|25|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|c9808184-3432-448c-a5e5-50176715effa|5|NSPMTSPM|Normal Sperm/Total Sperm|CHEMISTRY|[?]|g/cage/day|[?]|[?]|POSITIVE|1|CIGARETTE|1|1|[?]|HIGH|LUNG SURFACTANT|LIPEMIC|N|PHASE-CONTRAST MRI|MDRD ENZYMATIC FORMULA||Y|Y||3|Visit_3|40|5|TREATMENT|2021-01-28|2021-01-31|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|c9808184-3432-448c-a5e5-50176715effa|6|NORMETA|Normetanephrine|HEMATOLOGY|[?]|TUBE|[?]|[?]|INDETERMINATE|1|nmol BCE/L|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|PARAFFIN-EMBEDDED||DOUBLE IMMUNODIFFUSION|FIBROMETER FORMULA|Y|Y|N||3|Visit_3|40|4|WASHOUT|2021-01-28|2021-02-08|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|c9808184-3432-448c-a5e5-50176715effa|7|FUNGIFIL|Fungi, Filamentous|CHEMISTRY|[?]|GPL U/mL|[?]|[?]|TRACE|1|MONTHS|1|1|[?]|LOW|SPUTUM|CONCENTRATED||OSCILLOMETRY|COCKCROFT-GAULT FORMULA|Y|Y|N||4|Visit_4|65|3|TREATMENT|2021-02-22|2021-03-07|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|LB|c9808184-3432-448c-a5e5-50176715effa|8|VITD3|Vitamin D3|HEMATOLOGY|[?]|PUFF|[?]|[?]|POSITIVE|1|/day|1|1|[?]|LOW|DERMAL TISSUE|ROOM TEMPERATURE||ERGOSPIROMETRY|COCKCROFT-GAULT FORMULA|Y||NA||4|Visit_4|65|6|SCREENING|2021-02-22|2021-03-17|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|LB|c9808184-3432-448c-a5e5-50176715effa|9|LDH|Lactate Dehydrogenase|HEMATOLOGY|[?]|log10 PFU/mL|[?]|[?]|INVALID|1|mL/cage/day|1|1|[?]|LOW|CIRCULATING TUMOR CELL|CONCENTRATED|N|ERGOSPIROMETRY|MDRD 5 VARIABLE FORMULA|||U||5|Visit_5|90|6|TREATMENT|2021-03-19|2021-03-24|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|c9808184-3432-448c-a5e5-50176715effa|10|CCL12|Chemokine (C-C Motif) Ligand 12|CHEMISTRY|[?]|ug/L/h|[?]|[?]|INVALID|1|GPL U|1|1|[?]|LOW|URINE SEDIMENT|THAWED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI % FORMULA|Y||NA||5|Visit_5|90|6|TREATMENT|2021-03-19|2021-03-22|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|c3d7d293-975f-44de-bd35-0168eec40ac9|1|TPROTP|Phosphorylated Tau Protein|URINALYSIS|[?]|ELISA unit/mL|[?]|[?]|INVALID|1|mL/(min*100mL)|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|NON-HEMOLYZED|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD 4 VARIABLE FORMULA|Y||N||1|Visit_1|10|7|TREATMENT|2021-01-04|2021-02-28|10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|c3d7d293-975f-44de-bd35-0168eec40ac9|2|LH|Luteinizing Hormone|URINALYSIS|[?]|nmol/day|[?]|[?]|BORDERLINE|1|deg/s|1|1|[?]|HIGH|URINE SEDIMENT|CONCENTRATED|N|MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|7|SCREENING|2021-01-04|2021-02-20|10|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|LB|c3d7d293-975f-44de-bd35-0168eec40ac9|3|TTAC|Thrombin Time Actual/Control|URINALYSIS|[?]|nkat/L|[?]|[?]|POSITIVE|1|ug/L FEU|1|1|[?]|NORMAL|SPUTUM|DRIED||RIA|FIBROTEST FORMULA|||U||2|Visit_2|25|2|TREATMENT|2021-01-19|2021-03-20|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|c3d7d293-975f-44de-bd35-0168eec40ac9|4|LYMPHOID|Lymphoid Cells|URINALYSIS|[?]|10^7 TCID 50/dose|[?]|[?]|NEGATIVE|1|NEEDLE GAUGE|1|1|[?]|HIGH|BREAST MILK|GELLED||X-RAY FLUORESCENCE SPECTROMETRY|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|5|FOLLOW-UP|2021-01-19|2021-03-16|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|c3d7d293-975f-44de-bd35-0168eec40ac9|5|INHIBINB|Inhibin B|HEMATOLOGY|[?]|10^9 organisms/mL|[?]|[?]|POSITIVE|1|uL/mL|1|1|[?]|ABNORMAL|PLASMA|AUTOLYZED||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI FORMULA|||U||3|Visit_3|40|2|FOLLOW-UP|2021-02-03|2021-03-17|40|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|c3d7d293-975f-44de-bd35-0168eec40ac9|6|APLASCPD|APTT-LA Screen to Confirm Pct Difference|HEMATOLOGY|[?]|U/m2|[?]|[?]|POSITIVE|1|VIRTUAL PIXEL|1|1|[?]|ABNORMAL|PERSPIRATION|ROOM TEMPERATURE||GC/MS-CI|GMI % FORMULA||Y|Y||3|Visit_3|40|4|TREATMENT|2021-02-03|2021-02-07|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|LB|c3d7d293-975f-44de-bd35-0168eec40ac9|7|C130131|Dog Dander Antigen IgG4 Antibody|CHEMISTRY|[?]|ug/m2/min|[?]|[?]|NEGATIVE|1|mL/h|1|1|[?]|NORMAL|NAIL|SOLIDIFIED||SPECT/CT SCAN|GMI % FORMULA||Y|NA||4|Visit_4|65|1|TREATMENT|2021-02-28|2021-03-02|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|c3d7d293-975f-44de-bd35-0168eec40ac9|8|C4D|Complement C4d|CHEMISTRY|[?]|Shock Wave|[?]|[?]|NEGATIVE|1|mg/mL/day|1|1|[?]|NORMAL|EMOTIONAL TEAR|CONTAMINATED||PET SCAN|ASH FIBROSURE FORMULA|||N||4|Visit_4|65|3|SCREENING|2021-02-28|2021-03-26|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|c3d7d293-975f-44de-bd35-0168eec40ac9|9|PCT|Procalcitonin|HEMATOLOGY|[?]|umol/h/mmol|[?]|[?]|TRACE|1|g/L|1|1|[?]|LOW|SALIVA|PARAFFIN-EMBEDDED||MICROBIAL CULTURE|MDRD ENZYMATIC FORMULA|Y||U||5|Visit_5|90|4|TREATMENT|2021-03-25|2021-04-03|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|c3d7d293-975f-44de-bd35-0168eec40ac9|10|HYPSEGCE|Hypersegmented Cells|HEMATOLOGY|[?]|/mm2|[?]|[?]|TRACE|1|uIU/L|1|1|[?]|NORMAL|BREAST MILK|FROZEN||PUPILLOMETRY|MDRD 5 VARIABLE FORMULA||Y|N||5|Visit_5|90|4|FOLLOW-UP|2021-03-25|2021-03-26|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|2db1f07d-a7db-4cc3-8943-536e24378f08|1|CTXI|Type I Collagen C-Telopeptides|HEMATOLOGY|[?]|ppm|[?]|[?]|INDETERMINATE|1|mkat|1|1|[?]|ABNORMAL|MUCUS|CONCENTRATED|N|PHOTOMETRY|FIBROTEST FORMULA|||NA||1|Visit_1|10|5|SCREENING|2020-06-12|2020-08-21|10|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|LB|2db1f07d-a7db-4cc3-8943-536e24378f08|2|MCPHGCE|Macrophages/Total Cells|HEMATOLOGY|[?]|g/mol|[?]|[?]|INDETERMINATE|1|Ci/ug|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|THAWED||ELASTOGRAPHY|GMI MMOL/MOL FORMULA|Y||NA||1|Visit_1|10|1|FOLLOW-UP|2020-06-12|2020-08-07|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|LB|2db1f07d-a7db-4cc3-8943-536e24378f08|3|HLADRMSC|HLA-DR Mismatch Count|URINALYSIS|[?]|Gravitational Unit|[?]|[?]|INVALID|1|uOsm|1|1|[?]|NORMAL|INTERSTITIAL FLUID|AGGLUTINATED||SXA SCAN|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|2|SCREENING|2020-06-27|2020-08-19|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|LB|2db1f07d-a7db-4cc3-8943-536e24378f08|4|CRDIGGAB|Cardiolipin IgG Antibody|CHEMISTRY|||[?]|[?]|INVALID|1|pt_us|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|THAWED|N|AUSCULTATION|CKD-EPI CYSTATIN C FORMULA|Y|Y|Y|Y|2|Visit_2|25|4|SCREENING|2020-06-27|2020-08-21|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|LB|2db1f07d-a7db-4cc3-8943-536e24378f08|5|VITB1|Thiamine|HEMATOLOGY|[?]|PELLET|[?]|[?]|POSITIVE|1|10^3/L|1|1|[?]|LOW|SUPERNATANT, PLASMA|LACTESCENT||SPECTROPHOTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|3|WASHOUT|2020-07-12|2020-08-10|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|LB|2db1f07d-a7db-4cc3-8943-536e24378f08|6|NAGASEXR|NAGASE Excretion Rate|CHEMISTRY|[?]|cL|[?]|[?]|INVALID|1|pg|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED||KINETIC CHROMOGENIC ASSAY|MDRD 4 VARIABLE FORMULA|||Y||3|Visit_3|40|7|WASHOUT|2020-07-12|2020-09-06|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|LB|2db1f07d-a7db-4cc3-8943-536e24378f08|7|BNPPRO|ProB-type Natriuretic Peptide|CHEMISTRY|||[?]|[?]|TRACE|1|ug/min|1|1|[?]|NORMAL|LAVAGE FLUID|ICTERIC||MICRONEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|U|Y|4|Visit_4|65|7|TREATMENT|2020-08-06|2020-08-19|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|2db1f07d-a7db-4cc3-8943-536e24378f08|8|IDLVLDL3|IDL+VLDL Cholesterol Subtype 3|URINALYSIS|[?]|mU/g|[?]|[?]|POSITIVE|1|mmol2/L2|1|1|[?]|LOW|AQUEOUS HUMOR|THAWED||STATIC PERIMETRY|ASH FIBROSURE FORMULA|Y||NA||4|Visit_4|65|3|TREATMENT|2020-08-06|2020-09-08|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|2db1f07d-a7db-4cc3-8943-536e24378f08|9|PROC6|Pro-C6|URINALYSIS|[?]|Ci/mL|[?]|[?]|BORDERLINE|1|TAMPON|1|1|[?]|NORMAL|EPITHELIAL CELL|LIPEMIC|N|AGAR PROPORTION|FIBROMETER FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2020-08-31|2020-09-03|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|2db1f07d-a7db-4cc3-8943-536e24378f08|10|DFI|DNA Fragmentation Index|URINALYSIS|||[?]|[?]|NEGATIVE|1|nmol/L/min|1|1|[?]|NORMAL|TRANSUDATE|ICTERIC||PUPILLOMETRY|CKD-EPI CREATININE FORMULA|||Y|Y|5|Visit_5|90|2|WASHOUT|2020-08-31|2020-09-02|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|c343ba98-87d7-40bc-b0e8-b866e42d3a21|1|LYMA|Lymphocytes Activated|URINALYSIS|[?]|mL*cmH2O|[?]|[?]|POSITIVE|1|kUSP|1|1|[?]|ABNORMAL|SPUTUM|CONCENTRATED|N|RADIOIMMUNOPRECIPITATION ASSAY|MDRD 5 VARIABLE FORMULA||Y|NA||1|Visit_1|10|6|TREATMENT|2020-12-15|2021-02-20|10|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|c343ba98-87d7-40bc-b0e8-b866e42d3a21|2|RETICH|Ret. Corpuscular Hemoglobin Content|HEMATOLOGY|[?]|CYLINDER|[?]|[?]|INVALID|1|PA|1|1|[?]|LOW|LEUKOCYTE|HEMOLYZED||CALIPER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|3|WASHOUT|2020-12-15|2021-03-01|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|c343ba98-87d7-40bc-b0e8-b866e42d3a21|3|PELGERH|Pelger Huet Anomaly|URINALYSIS|||[?]|[?]|POSITIVE|1|mL/m2|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|LACTESCENT||MULTIPLEXED BEAD BASED IMMUNOASSAY|CKD-EPI CREATININE FORMULA|Y||NA|Y|2|Visit_2|25|4|FOLLOW-UP|2020-12-30|2021-01-23|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|c343ba98-87d7-40bc-b0e8-b866e42d3a21|4|MONOBL|Monoblasts|HEMATOLOGY|[?]|IU/mg|[?]|[?]|NEGATIVE|1|IU/g Hb|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|THAWED||SLOAN LETTER EYE CHART 1.25%|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|6|FOLLOW-UP|2020-12-30|2021-02-24|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|c343ba98-87d7-40bc-b0e8-b866e42d3a21|5|LDHEXR|Lactate Dehydrogenase Excretion Rate|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Enzyme U/L|1|1|[?]|HIGH|SEBUM|NON-HEMOLYZED||DROPLET DIGITAL PCR|ASH FIBROSURE FORMULA|||NA|Y|3|Visit_3|40|1|SCREENING|2021-01-14|2021-01-29|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|LB|c343ba98-87d7-40bc-b0e8-b866e42d3a21|6|SCHISTO|Schistocytes|CHEMISTRY|[?]|m/sec2|[?]|[?]|POSITIVE|1|mg|1|1|[?]|NORMAL|ADIPOSE TISSUE|THAWED||ANALYTICAL ULTRACENTRIFUGATION|MDRD 5 VARIABLE FORMULA|Y|Y|U||3|Visit_3|40|3|TREATMENT|2021-01-14|2021-01-23|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|LB|c343ba98-87d7-40bc-b0e8-b866e42d3a21|7|ETS|Ethyl Sulfate|URINALYSIS|[?]|pm|[?]|[?]|POSITIVE|1|Rad|1|1|[?]|LOW|SERUM OR PLASMA|CALCIFIED||PEAK FLOWMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||4|Visit_4|65|4|TREATMENT|2021-02-08|2021-02-18|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|c343ba98-87d7-40bc-b0e8-b866e42d3a21|8|KRCYMGCE|Megakaryocytes/Total Cells|CHEMISTRY|[?]|Hz|[?]|[?]|POSITIVE|1|kUSP|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|THAWED||IVY INCISION METHOD|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2021-02-08|2021-02-18|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|LB|c343ba98-87d7-40bc-b0e8-b866e42d3a21|9|PHADJT|pH Adjusted for Body Temp|URINALYSIS|||[?]|[?]|INVALID|1|CIGAR|1|1|[?]|NORMAL|SEMEN|ICTERIC||SIZE EXCLUSION CHROMATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|Y|5|Visit_5|90|7|TREATMENT|2021-03-05|2021-03-11|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|c343ba98-87d7-40bc-b0e8-b866e42d3a21|10|S100B|S100 Calcium-Binding Protein B|URINALYSIS|||[?]|[?]|INDETERMINATE|1|m2|1|1|[?]|NORMAL|ISOLATE|LIPEMIC||FLUORESCENT IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U|Y|5|Visit_5|90|3|TREATMENT|2021-03-05|2021-03-08|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|LB|d2b31ba9-9718-43ce-82ca-3276c28ac42a|1|BLISTCE|Blister Cell|URINALYSIS|[?]|mL/kg/day|[?]|[?]|BORDERLINE|1|cGy|1|1|[?]|NORMAL|ERYTHROCYTES|THAWED||FARNSWORTH-MUNSELL 100 HUE TEST|GMI % FORMULA||Y|NA||1|Visit_1|10|2|WASHOUT|2020-12-04|2021-01-16|10|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|d2b31ba9-9718-43ce-82ca-3276c28ac42a|2|TSTSFRPT|Testosterone, Free/Total Protein|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^3/L|1|1|[?]|HIGH|BASAL TEAR|HEMOLYZED|N|MIGET|ASH FIBROSURE FORMULA|Y||U|Y|1|Visit_1|10|3|WASHOUT|2020-12-04|2020-12-27|10|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|d2b31ba9-9718-43ce-82ca-3276c28ac42a|3|IFNA|Interferon Alpha|URINALYSIS|[?]|DDU|[?]|[?]|TRACE|1|GBq|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|ICTERIC||CT SCAN WITHOUT CONTRAST|FIBROSIS 4 FORMULA|Y|Y|Y||2|Visit_2|25|7|WASHOUT|2020-12-19|2021-02-08|25|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|d2b31ba9-9718-43ce-82ca-3276c28ac42a|4|HYXLYS|Hydroxylysine|URINALYSIS|[?]|ECL unit|[?]|[?]|TRACE|1|LOZENGE|1|1|[?]|ABNORMAL|SWABBED MATERIAL|LACTESCENT||LASER CAPTURE MICRODISSECTION|MDRD 4 VARIABLE FORMULA||Y|NA||2|Visit_2|25|6|TREATMENT|2020-12-19|2021-01-12|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|d2b31ba9-9718-43ce-82ca-3276c28ac42a|5|IFI6|Interferon Alpha-Inducible Protein 6|CHEMISTRY|[?]|PIPE|[?]|[?]|INDETERMINATE|1|Coulomb|1|1|[?]|HIGH|ALVEOLAR AIR|DRIED||MRI|CKD-EPI FORMULA|||U||3|Visit_3|40|4|FOLLOW-UP|2021-01-03|2021-01-19|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|d2b31ba9-9718-43ce-82ca-3276c28ac42a|6|MICROCY|Microcytes|CHEMISTRY|[?]|U/kg/h|[?]|[?]|BORDERLINE|1|pm|1|1|[?]|NORMAL|SALIVA|REFRIGERATED||SPECTROPHOTOMETRY|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2021-01-03|2021-02-12|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|d2b31ba9-9718-43ce-82ca-3276c28ac42a|7|PCO2|Partial Pressure Carbon Dioxide|HEMATOLOGY|[?]|U/L|[?]|[?]|BORDERLINE|1|bel|1|1|[?]|NORMAL|PERITONEAL FLUID|ROOM TEMPERATURE||POLYSOMNOGRAPHY|CKD-EPI CREATININE FORMULA||Y|NA||4|Visit_4|65|6|TREATMENT|2021-01-28|2021-03-03|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|d2b31ba9-9718-43ce-82ca-3276c28ac42a|8|TOXVAC|Toxic Vacuolation|CHEMISTRY|[?]|lm|[?]|[?]|INDETERMINATE|1|10^12 IU/L|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|DRIED||BRDU CELLULAR PROLIFERATION ASSAY|CKD-EPI FORMULA|||U||4|Visit_4|65|4|TREATMENT|2021-01-28|2021-02-17|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|d2b31ba9-9718-43ce-82ca-3276c28ac42a|9|NTXII|Type II Collagen N-Telopeptides|HEMATOLOGY|||[?]|[?]|POSITIVE|1|/HPF|1|1|[?]|ABNORMAL|BREAST MILK|ICTERIC||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA|||Y|Y|5|Visit_5|90|3|TREATMENT|2021-02-22|2021-02-23|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|d2b31ba9-9718-43ce-82ca-3276c28ac42a|10|AUERRODS|Auer Rods|CHEMISTRY|[?]|sec|[?]|[?]|NEGATIVE|1|uSiemens|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|AUTOLYZED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|5|TREATMENT|2021-02-22|2021-02-27|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|1|ROM|Reactive Oxygen Metabolite|CHEMISTRY|[?]|BOX|[?]|[?]|BORDERLINE|1|PACKET|1|1|[?]|HIGH|TRANSUDATE|NON-HEMOLYZED||AGAR DILUTION|GMI MMOL/MOL FORMULA|Y||U||1|Visit_1|10|2|TREATMENT|2020-07-23|2020-08-26|10|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|2|CTXICRT|Type I Collagen C-Telopeptides/Creat|CHEMISTRY|[?]|BU|[?]|[?]|POSITIVE|1|mg/kg/week|1|1|[?]|ABNORMAL|MUSCLE TISSUE|CLOTTED||MAGNETIC RESONANCE ELASTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||1|Visit_1|10|2|TREATMENT|2020-07-23|2020-09-02|10|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|3|LMBDLC|Lambda Light Chain|CHEMISTRY|[?]|mV*min|[?]|[?]|NEGATIVE|1|ngEq/L|1|1|[?]|NORMAL|MUCUS|THAWED||HPLC/IEX|FIBROTEST FORMULA|||U||2|Visit_2|25|6|FOLLOW-UP|2020-08-07|2020-09-09|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|4|UREA|Urea|CHEMISTRY|[?]|EID 50/dose|[?]|[?]|INDETERMINATE|1|ng/mol|1|1|[?]|NORMAL|COLOSTRUM|CLOTTED||OSCILLOMETRY|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2020-08-07|2020-10-20|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|5|CACREAT|Calcium/Creatinine|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|m/sec|1|1|[?]|NORMAL|CERUMEN|NON-HEMOLYZED||PAP STAIN|MDRD 5 VARIABLE FORMULA|||U|Y|3|Visit_3|40|5|SCREENING|2020-08-22|2020-09-30|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|6|C165935|Triticum aestivum IgE AB RAST Score|CHEMISTRY|[?]|kcal|[?]|[?]|BORDERLINE|1|10^5/hpf|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR||ANGIOGRAPHY|CKD-EPI FORMULA|||N||3|Visit_3|40|4|WASHOUT|2020-08-22|2020-09-14|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|7|LDHCREAT|Lactate Dehydrogenase/Creatinine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|10^6 IU/mL|1|1|[?]|NORMAL|BONE|CONCENTRATED||ENZYMATIC ULTRACENTRIFUGATION|HEPASCORE FORMULA|||Y|Y|4|Visit_4|65|4|SCREENING|2020-09-16|2020-09-29|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|8|APOC3|Apolipoprotein CIII|URINALYSIS|||[?]|[?]|INVALID|1|kHz|1|1|[?]|LOW|SUPERNATANT, SERUM|REFRIGERATED||TEST STRIP|CKD-EPI CREATININE FORMULA||Y|U|Y|4|Visit_4|65|1|FOLLOW-UP|2020-09-16|2020-09-28|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|9|EOTAXIN3|Eotaxin-3|HEMATOLOGY|[?]|/100 HPFs|[?]|[?]|INVALID|1|10^6/g|1|1|[?]|HIGH|VENOUS BLOOD|THAWED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD FORMULA||Y|U||5|Visit_5|90|7|TREATMENT|2020-10-11|2020-10-17|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|10|PLSIMCCE|Immature Plasma Cells/Total Cells|CHEMISTRY|[?]|DRINK|[?]|[?]|BORDERLINE|1|nCi|1|1|[?]|ABNORMAL|VITREOUS HUMOR|AGGLUTINATED||FUNDUS PHOTOGRAPHY|MDRD FORMULA|||N||5|Visit_5|90|4|SCREENING|2020-10-11|2020-10-13|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|0a42f96a-49c3-492f-a272-bf9989e53e9d|1|KRCYMG|Megakaryocytes|CHEMISTRY|[?]|BAU|[?]|[?]|BORDERLINE|1|deg/s|1|1|[?]|LOW|DIALYSIS FLUID|THAWED||TWO-COLOR MICROARRAY|CKD-EPI CREATININE FORMULA|||N||1|Visit_1|10|5|TREATMENT|2021-01-26|2021-03-16|10|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|0a42f96a-49c3-492f-a272-bf9989e53e9d|2|MET|Methionine|HEMATOLOGY|[?]|U/dL|[?]|[?]|TRACE|1|L/day|1|1|[?]|LOW|VENOUS BLOOD|FRESH|N|IRON HEMATOXYLIN STAIN|HEPASCORE FORMULA|Y||NA||1|Visit_1|10|1|TREATMENT|2021-01-26|2021-04-15|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|0a42f96a-49c3-492f-a272-bf9989e53e9d|3|THCCOOH|11-Nor-Delta9-THC-9-Carboxylic Acid|HEMATOLOGY|||[?]|[?]|TRACE|1|MBP|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|PARAFFIN-EMBEDDED||INDIA INK STAIN|MDRD 6 VARIABLE FORMULA|Y||NA|Y|2|Visit_2|25|3|WASHOUT|2021-02-10|2021-04-24|25|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|LB|0a42f96a-49c3-492f-a272-bf9989e53e9d|4|APAPCYS|Acetaminophen-Cysteine Adduct|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|JAR|1|1|[?]|ABNORMAL|DERMAL TISSUE|CONCENTRATED||PULMONARY ANGIOGRAPHY|GMI % FORMULA|Y||Y|Y|2|Visit_2|25|7|TREATMENT|2021-02-10|2021-03-18|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|LB|0a42f96a-49c3-492f-a272-bf9989e53e9d|5|MACROCY|Macrocytes|HEMATOLOGY|[?]|Arbitrary U|[?]|[?]|NEGATIVE|1|mCi|1|1|[?]|LOW|SUPERNATANT, SERUM|AUTOLYZED|N|EIA|GMI MMOL/MOL FORMULA||Y|NA||3|Visit_3|40|6|TREATMENT|2021-02-25|2021-04-13|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|0a42f96a-49c3-492f-a272-bf9989e53e9d|6|ACHRAB|Acetylcholine Receptor Antibody|CHEMISTRY|[?]|/100 HPFs|[?]|[?]|TRACE|1|nmol/L/min|1|1|[?]|HIGH|EXUDATE|CLOTTED|N|DC SHEATH FLOW|MDRD FORMULA||Y|N||3|Visit_3|40|6|WASHOUT|2021-02-25|2021-04-14|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|0a42f96a-49c3-492f-a272-bf9989e53e9d|7|GLOBA1PT|Alpha-1 Globulin/Total Protein|HEMATOLOGY|||[?]|[?]|INVALID|1|Bq|1|1|[?]|NORMAL|BREAST MILK|ICTERIC|N|IVY INCISION METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y|Y|4|Visit_4|65|2|FOLLOW-UP|2021-03-22|2021-04-24|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|0a42f96a-49c3-492f-a272-bf9989e53e9d|8|HLAMSC|HLA Mismatch Count|HEMATOLOGY|||[?]|[?]|POSITIVE|1|ks|1|1|[?]|HIGH|EMOTIONAL TEAR|CLOTTED||TRANSMISSION ELECTRON MICROSCOPY|MDRD 5 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|3|SCREENING|2021-03-22|2021-04-10|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|0a42f96a-49c3-492f-a272-bf9989e53e9d|9|MPXI|Myeloperoxidase Index|URINALYSIS|[?]|vp/mL|[?]|[?]|POSITIVE|1|ft|1|1|[?]|HIGH|SEMEN|AUTOLYZED||SNELLEN EYE CHART|GMI MMOL/MOL FORMULA|||NA||5|Visit_5|90|1|FOLLOW-UP|2021-04-16|2021-04-21|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|0a42f96a-49c3-492f-a272-bf9989e53e9d|10|ERCEMPOL|Erythroid Maturation Pool|URINALYSIS|[?]|g/L|[?]|[?]|TRACE|1|uCi|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|AGGLUTINATED|N|CRYOSCOPY|GMI MMOL/MOL FORMULA|||U||5|Visit_5|90|3|WASHOUT|2021-04-16|2021-04-19|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|a78e7287-581c-4bf2-b3ca-ad2476c010cd|1|IMMGLC|Immunoglobulin Light Chains|URINALYSIS|[?]|ug/kg/min|[?]|[?]|BORDERLINE|1|/mm|1|1|[?]|ABNORMAL|GASTRIC FLUID|SOLIDIFIED||ORCHIDOMETERY|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|1|SCREENING|2021-01-08|2021-01-31|10|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|a78e7287-581c-4bf2-b3ca-ad2476c010cd|2|C130122|Nut Mix Antigen IgE Antibody|CHEMISTRY|||[?]|[?]|TRACE|1|Osm|1|1|[?]|LOW|KERATINOCYTE|ROOM TEMPERATURE||CONTRAST ENHANCED X-RAY|COCKCROFT-GAULT FORMULA|||NA|Y|1|Visit_1|10|6|TREATMENT|2021-01-08|2021-03-11|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|a78e7287-581c-4bf2-b3ca-ad2476c010cd|3|COL4|Collagen Type IV|URINALYSIS|||[?]|[?]|BORDERLINE|1|mV/sec|1|1|[?]|NORMAL|VENOUS BLOOD|DRIED||HPLC|FIBROSIS 4 FORMULA|||U|Y|2|Visit_2|25|2|SCREENING|2021-01-23|2021-02-06|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|a78e7287-581c-4bf2-b3ca-ad2476c010cd|4|B2G1GAAB|Beta-2 Glycoprotein 1 IgA Antibody|HEMATOLOGY|[?]|GLOBULE|[?]|[?]|NEGATIVE|1|ng/day|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|DRIED||ENZYMATIC ULTRACENTRIFUGATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||2|Visit_2|25|6|TREATMENT|2021-01-23|2021-02-20|25|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|a78e7287-581c-4bf2-b3ca-ad2476c010cd|5|ELA2PMN|Neutrophil Elastase, Polymorphonuclear|URINALYSIS|||[?]|[?]|INDETERMINATE|1|ug/m2/min|1|1|[?]|NORMAL|MECONIUM|FROZEN|N|MAGNETIC RESONANCE ELASTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y|Y|3|Visit_3|40|3|TREATMENT|2021-02-07|2021-02-26|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-02
e|LB|a78e7287-581c-4bf2-b3ca-ad2476c010cd|6|HGBOXY|Oxyhemoglobin|CHEMISTRY|[?]|h/wk|[?]|[?]|NEGATIVE|1|Log10 ELISA unit|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|THAWED||TEST STRIP|CKD-EPI FORMULA|Y||NA||3|Visit_3|40|7|FOLLOW-UP|2021-02-07|2021-02-15|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-02
e|LB|a78e7287-581c-4bf2-b3ca-ad2476c010cd|7|VOLUME|Volume|HEMATOLOGY|[?]|ug/min|[?]|[?]|INDETERMINATE|1|kg/m2|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|GELLED|N|IMMUNE REPERTOIRE DEEP SEQUENCING|GMI MMOL/MOL FORMULA||Y|NA||4|Visit_4|65|2|TREATMENT|2021-03-04|2021-03-31|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|a78e7287-581c-4bf2-b3ca-ad2476c010cd|8|AMA|Antimitochondrial Antibodies|CHEMISTRY|[?]|PLUG|[?]|[?]|POSITIVE|1|USP U|1|1|[?]|LOW|VENOUS BLOOD|ROOM TEMPERATURE||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD 5 VARIABLE FORMULA|Y||U||4|Visit_4|65|7|WASHOUT|2021-03-04|2021-03-18|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|a78e7287-581c-4bf2-b3ca-ad2476c010cd|9|T4FRIND|Thyroxine, Free, Indirect|URINALYSIS|[?]|GLOBULE|[?]|[?]|NEGATIVE|1|foz_us|1|1|[?]|HIGH|CALCULUS|AGGLUTINATED||CISH|CKD-EPI CYSTATIN C FORMULA|Y|Y|N||5|Visit_5|90|2|WASHOUT|2021-03-29|2021-03-30|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|LB|a78e7287-581c-4bf2-b3ca-ad2476c010cd|10|ERCEPIDX|Erythroid Proliferation Index|HEMATOLOGY|[?]|PLUG|[?]|[?]|TRACE|1|RATIO|1|1|[?]|HIGH|KERATINOCYTE|FROZEN||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|NASH FIBROSURE FORMULA|Y||N||5|Visit_5|90|6|TREATMENT|2021-03-29|2021-04-02|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|LB|d3651e5f-bc38-4c96-afbf-5a65873ff306|1|C165887|EnglishPlantain Pollen IgE AB RAST Score|HEMATOLOGY|[?]|10^10/L|[?]|[?]|NEGATIVE|1|nsec|1|1|[?]|LOW|SWABBED MATERIAL|AGGLUTINATED||DIGITAL PCR|MDRD 5 VARIABLE FORMULA||Y|U||1|Visit_1|10|2|SCREENING|2020-07-28|2020-10-16|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|d3651e5f-bc38-4c96-afbf-5a65873ff306|2|TPAG|Tissue Polypeptide Antigen|CHEMISTRY|[?]|10^4/L|[?]|[?]|INVALID|1|AgU/mL|1|1|[?]|LOW|SERUM OR PLASMA|SOLIDIFIED||MAGNETIC RESONANCE ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA|Y||U||1|Visit_1|10|7|TREATMENT|2020-07-28|2020-09-11|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|d3651e5f-bc38-4c96-afbf-5a65873ff306|3|FATACFR|Free Fatty Acid|CHEMISTRY|[?]|U/kg/min|[?]|[?]|INDETERMINATE|1|nkat/g Hb|1|1|[?]|LOW|TUMOR TISSUE|THAWED|N|FLUORESCEIN STAIN|HEPASCORE FORMULA|||U||2|Visit_2|25|7|FOLLOW-UP|2020-08-12|2020-09-29|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|d3651e5f-bc38-4c96-afbf-5a65873ff306|4|PTAUAB42|Phosphorylated Tau Prot/Amyloid Beta1-42|CHEMISTRY|[?]|mEq/L|[?]|[?]|TRACE|1|MdFI|1|1|[?]|LOW|URINE|AUTOLYZED||RADIOIMMUNOPRECIPITATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|4|FOLLOW-UP|2020-08-12|2020-10-04|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|d3651e5f-bc38-4c96-afbf-5a65873ff306|5|PAI1|Plasminogen Activator Inhibitor-1|HEMATOLOGY|[?]|GPL U/mL|[?]|[?]|POSITIVE|1|L/min|1|1|[?]|LOW|KERATINOCYTE|HEMOLYZED||HPLC/MS/MS|MDRD 6 VARIABLE FORMULA|Y||U||3|Visit_3|40|3|SCREENING|2020-08-27|2020-09-17|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|d3651e5f-bc38-4c96-afbf-5a65873ff306|6|HGBDHGB|Hemoglobin D/Total Hemoglobin|HEMATOLOGY|[?]|cd|[?]|[?]|BORDERLINE|1|10^5/L|1|1|[?]|NORMAL|SALIVA|UNEXPECTED ODOR||DOPPLER ULTRASOUND|FIBROMETER FORMULA|Y||NA||3|Visit_3|40|3|WASHOUT|2020-08-27|2020-08-28|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|d3651e5f-bc38-4c96-afbf-5a65873ff306|7|GLDIGGAB|Gliadin IgG Antibody|URINALYSIS|[?]|10^9 CFU/mL|[?]|[?]|NEGATIVE|1|m3|1|1|[?]|ABNORMAL|BLOOD|AUTOLYZED||PH METER MEASUREMENT METHOD|MDRD 4 VARIABLE FORMULA|Y||U||4|Visit_4|65|6|WASHOUT|2020-09-21|2020-10-03|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|d3651e5f-bc38-4c96-afbf-5a65873ff306|8|SJSA60AB|Sjogrens SS-A60 Antibody|CHEMISTRY|||[?]|[?]|INVALID|1|U/mmol|1|1|[?]|HIGH|SWABBED MATERIAL|DRIED||PERFUSION MRI|GMI % FORMULA|Y||U|Y|4|Visit_4|65|6|TREATMENT|2020-09-21|2020-10-12|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|d3651e5f-bc38-4c96-afbf-5a65873ff306|9|STAT3|STAT3|URINALYSIS|[?]|ms2|[?]|[?]|BORDERLINE|1|IU/g|1|1|[?]|NORMAL|BASAL TEAR|SOLIDIFIED||SICKLE CELL SOLUBILITY TEST|MDRD ENZYMATIC JAPANESE FORMULA|||N||5|Visit_5|90|5|FOLLOW-UP|2020-10-16|2020-10-19|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|d3651e5f-bc38-4c96-afbf-5a65873ff306|10|INTLK1|Interleukin 1|HEMATOLOGY|[?]|mkat|[?]|[?]|BORDERLINE|1|km/h|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|CLOTTED||IMMUNODIFFUSION|FIBROTEST FORMULA|||Y||5|Visit_5|90|6|SCREENING|2020-10-16|2020-10-24|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|1|C5B9|Complement C5b-9|CHEMISTRY|[?]|pg/cell|[?]|[?]|INVALID|1|anti-Xa IU/mL|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|FROZEN||IODINE STAIN|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-06-11|2020-06-20|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|2|GGTCREAT|Gamma Glutamyl Transferase/Creatinine|CHEMISTRY|[?]|Newton|[?]|[?]|INVALID|1|/wk|1|1|[?]|HIGH|DERMAL TISSUE|HEMOLYZED|N|FISH|CKD-EPI CREATININE FORMULA|Y|Y|Y||1|Visit_1|10|5|TREATMENT|2020-06-11|2020-07-02|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|3|LDH5LDH|LDH Isoenzyme 5/LDH|HEMATOLOGY|[?]|C|[?]|[?]|NEGATIVE|1|mol/L|1|1|[?]|LOW|RETICULOCYTES|ROOM TEMPERATURE||LIQUID SCINTILLATION COUNTING|MDRD 6 VARIABLE FORMULA|Y||U||2|Visit_2|25|1|TREATMENT|2020-06-26|2020-07-11|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|4|HASIGEAB|Human Anti-Sheep IgE Antibody|URINALYSIS|[?]|mg/kg/h|[?]|[?]|POSITIVE|1|10^9 organisms/mg|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|CONCENTRATED||PH METER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA|Y||Y||2|Visit_2|25|4|WASHOUT|2020-06-26|2020-08-21|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|LB|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|5|HDL|HDL Cholesterol|CHEMISTRY|[?]|uCi|[?]|[?]|INDETERMINATE|1|mU/g|1|1|[?]|LOW|URINE|ROOM TEMPERATURE||EIA|FIBROMETER FORMULA|Y||N||3|Visit_3|40|3|WASHOUT|2020-07-11|2020-07-29|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|6|C130106|Weed Mix Pollen Antigen IgE Antibody|URINALYSIS|[?]|mAmp|[?]|[?]|NEGATIVE|1|lx|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|CLOTTED||QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-07-11|2020-07-21|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|LB|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|7|PTF1_2|Prothrombin Fragments 1 + 2|CHEMISTRY|[?]|BAU|[?]|[?]|BORDERLINE|1|log10 TCID 50/uL|1|1|[?]|LOW|URINE SEDIMENT|NON-HEMOLYZED||PHOTOMETRY|CKD-EPI CREATININE FORMULA|Y||N||4|Visit_4|65|6|WASHOUT|2020-08-05|2020-08-19|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|LB|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|8|CYFRA211|Cytokeratin 19 Fragment 21-1|HEMATOLOGY|[?]|mg|[?]|[?]|INDETERMINATE|1|ukat/L|1|1|[?]|LOW|HAIR FOLLICLE|FROZEN||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-08-05|2020-08-20|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|LB|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|9|DDX58|DEAD Box Protein 58|URINALYSIS|||[?]|[?]|BORDERLINE|1|g|1|1|[?]|ABNORMAL|TUMOR TISSUE|CALCIFIED||NON-INVASIVE DIELECTRIC SENSING|FIBROMETER FORMULA|||N|Y|5|Visit_5|90|6|TREATMENT|2020-08-30|2020-09-04|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|10|THRCREAT|Threonine/Creatinine|URINALYSIS|[?]|%|[?]|[?]|NEGATIVE|1|MASK|1|1|[?]|NORMAL|BREAST MILK|FROZEN||FUNDUS PHOTOGRAPHY|FIBROMETER FORMULA|||N||5|Visit_5|90|3|TREATMENT|2020-08-30|2020-09-07|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|f50537d2-e098-4dae-8f91-16f2357d709c|1|ALBC|Albumin Clearance|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^7 PFU|1|1|[?]|HIGH|LEUKOCYTE|LIPEMIC||PH METER MEASUREMENT METHOD|FIBROTEST FORMULA|||Y|Y|1|Visit_1|10|2|TREATMENT|2020-12-07|2021-01-16|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|f50537d2-e098-4dae-8f91-16f2357d709c|2|ARGSAC|Argininosuccinic Acid|CHEMISTRY|||[?]|[?]|NEGATIVE|1|MnFI|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|CONCENTRATED||BETA LACTAMASE|COCKCROFT-GAULT FORMULA|||Y|Y|1|Visit_1|10|4|SCREENING|2020-12-07|2020-12-30|10|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|f50537d2-e098-4dae-8f91-16f2357d709c|3|NOREPIN|Norepinephrine|CHEMISTRY|[?]|mOsm/L|[?]|[?]|POSITIVE|1|log10 PFU/mL|1|1|[?]|HIGH|GASTRIC CONTENTS|PARAFFIN-EMBEDDED||CINEANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||2|Visit_2|25|5|TREATMENT|2020-12-22|2021-02-13|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|f50537d2-e098-4dae-8f91-16f2357d709c|4|DCCARNIT|Decanoylcarnitine|URINALYSIS|[?]|10^12 IU/L|[?]|[?]|NEGATIVE|1|dyn|1|1|[?]|HIGH|EPITHELIAL CELL|CALCIFIED||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-12-22|2021-01-12|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|f50537d2-e098-4dae-8f91-16f2357d709c|5|BASOIM|Immature Basophils|URINALYSIS|||[?]|[?]|TRACE|1|DROP|1|1|[?]|HIGH|EMOTIONAL TEAR|UNEXPECTED ODOR||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|FIBROTEST FORMULA|||N|Y|3|Visit_3|40|5|FOLLOW-UP|2021-01-06|2021-03-04|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|f50537d2-e098-4dae-8f91-16f2357d709c|6|HYPERCHR|Hyperchromia|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/cage/day|1|1|[?]|LOW|GASTRIC FLUID|GELLED|N|WESTERGREN|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|3|Visit_3|40|4|TREATMENT|2021-01-06|2021-02-16|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|f50537d2-e098-4dae-8f91-16f2357d709c|7|LIPEMIAI|Lipemic Index|HEMATOLOGY|[?]|MdFI|[?]|[?]|INVALID|1|mL/min/1.73m2|1|1|[?]|LOW|EXUDATE|REFRIGERATED||AUTOMATED COUNT|ASH FIBROSURE FORMULA||Y|NA||4|Visit_4|65|7|WASHOUT|2021-01-31|2021-03-05|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|LB|f50537d2-e098-4dae-8f91-16f2357d709c|8|CD4|CD4|HEMATOLOGY|[?]|mg/m2/day|[?]|[?]|BORDERLINE|1|DROP|1|1|[?]|NORMAL|CERUMEN|CONTAMINATED||OLIGO ACGH|CKD-EPI CYSTATIN C FORMULA|Y||Y||4|Visit_4|65|2|TREATMENT|2021-01-31|2021-02-15|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|LB|f50537d2-e098-4dae-8f91-16f2357d709c|9|HASIGGAB|Human Anti-Sheep IgG Antibody|HEMATOLOGY|[?]|uEq|[?]|[?]|NEGATIVE|1|BLOCKS|1|1|[?]|LOW|SWABBED MATERIAL|LACTESCENT||MICRO BROTH DILUTION|COCKCROFT-GAULT FORMULA||Y|Y||5|Visit_5|90|3|TREATMENT|2021-02-25|2021-03-01|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|f50537d2-e098-4dae-8f91-16f2357d709c|10|ANCCLSAB|Neutrophil Cytoplasmic Ab, Classic|HEMATOLOGY|[?]|Antibody Unit|[?]|[?]|POSITIVE|1|mg/m2/h|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|LACTESCENT||NEXT GENERATION SEQUENCING|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|2|SCREENING|2021-02-25|2021-03-06|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|1|INTLK15|Interleukin 15|URINALYSIS|[?]|USP U|[?]|[?]|INVALID|1|Enzyme U/g Hb|1|1|[?]|LOW|INFRANATANT, PLASMA|CALCIFIED||CONTRAST ENHANCED SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA|Y||Y||1|Visit_1|10|6|SCREENING|2020-07-19|2020-10-09|10|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|2|FACTVII|Factor VII|CHEMISTRY|[?]|sec|[?]|[?]|INDETERMINATE|1|Coulomb|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|SOLIDIFIED||RAJI CELL EIA|FIBROMETER FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-07-19|2020-09-02|10|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|3|ALPLS|Liver Specific Alkaline Phosphatase|CHEMISTRY|[?]|Gy|[?]|[?]|INDETERMINATE|1|BAR|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE|N|STATIC PERIMETRY|ASH FIBROSURE FORMULA||Y|NA||2|Visit_2|25|1|WASHOUT|2020-08-03|2020-08-20|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|4|MNC|Mononuclear Cells|URINALYSIS|[?]|ag|[?]|[?]|INDETERMINATE|1|uL/kg/day|1|1|[?]|LOW|SERUM|ROOM TEMPERATURE||ELECTROCHEMILUMINESCENCE|ASH FIBROSURE FORMULA||Y|N||2|Visit_2|25|6|WASHOUT|2020-08-03|2020-08-22|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|5|FACTVIII|Factor VIII|CHEMISTRY|||[?]|[?]|NEGATIVE|1|OD Unit|1|1|[?]|NORMAL|MONOCYTE|CONCENTRATED||ANTIBIOTIC AGAR SCREEN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y|Y|3|Visit_3|40|5|TREATMENT|2020-08-18|2020-10-03|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|6|INCLBRBC|Erythrocyte Inclusion Bodies|HEMATOLOGY|||[?]|[?]|INVALID|1|mL/kg/min|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|UNEXPECTED ODOR|N|ROMANOWSKY STAIN|ASH FIBROSURE FORMULA||Y|Y|Y|3|Visit_3|40|6|TREATMENT|2020-08-18|2020-08-31|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|7|CCL17|Chemokine (C-C Motif) Ligand 17|CHEMISTRY|[?]|nmol BCE/nmol|[?]|[?]|INVALID|1|mEq/dL|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|CONCENTRATED||MAGNETIC RESONANCE ENTEROGRAPHY|ASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|7|FOLLOW-UP|2020-09-12|2020-09-20|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|8|RETI|Reticulocytes|HEMATOLOGY|[?]|ug/L|[?]|[?]|TRACE|1|nmol/L/h|1|1|[?]|NORMAL|SWABBED MATERIAL|NON-HEMOLYZED|N|PHASE CONTRAST MICROSCOPY|MDRD ENZYMATIC FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2020-09-12|2020-09-20|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|9|TROPONT|Troponin T|HEMATOLOGY|[?]|/2000 RBC|[?]|[?]|TRACE|1|log10 IU/mL|1|1|[?]|ABNORMAL|BILE|CONTAMINATED||MICRODENSITOMETRY|FIBROTEST FORMULA|||N||5|Visit_5|90|7|FOLLOW-UP|2020-10-07|2020-10-08|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|10|FPP|Protoporphyrin, Free|CHEMISTRY|[?]|v/v|[?]|[?]|BORDERLINE|1|CFU/mL|1|1|[?]|ABNORMAL|PERSPIRATION|PARAFFIN-EMBEDDED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|6|SCREENING|2020-10-07|2020-10-13|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|489870ed-9da5-4df6-a5ef-17821c449c84|1|RPPAB|Ribosomal P Protein Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|VOXEL|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|FROZEN||DIGITAL PCR|FIBROTEST FORMULA||Y|U|Y|1|Visit_1|10|1|SCREENING|2020-07-30|2020-09-11|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|489870ed-9da5-4df6-a5ef-17821c449c84|2|C1INH|Complement C1 Esterase Inhibitor|CHEMISTRY|[?]|pg/dL|[?]|[?]|BORDERLINE|1|PIXELS/in|1|1|[?]|LOW|SUPERNATANT, PLASMA|CALCIFIED||ENDPOINT DILUTION ASSAY|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-07-30|2020-08-06|10|17|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|LB|489870ed-9da5-4df6-a5ef-17821c449c84|3|MENGL|Meningeal Cells|HEMATOLOGY|[?]|/4.0 mL|[?]|[?]|POSITIVE|1|Antibody Unit|1|1|[?]|HIGH|CORD SERUM|LIPEMIC||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|3|FOLLOW-UP|2020-08-14|2020-08-27|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|489870ed-9da5-4df6-a5ef-17821c449c84|4|LGLUCLE|Large Unstained Cells/Leukocytes|HEMATOLOGY|[?]|mL/cm3/min|[?]|[?]|BORDERLINE|1|SACHET|1|1|[?]|HIGH|GASTRIC FLUID|AUTOLYZED|N|PEAK FLOWMETRY|COCKCROFT-GAULT FORMULA|||U||2|Visit_2|25|7|TREATMENT|2020-08-14|2020-10-07|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|489870ed-9da5-4df6-a5ef-17821c449c84|5|C130129|Dog Dander Antigen IgG Antibody|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|PHERESIS UNIT|1|1|[?]|NORMAL|LOCHIA|LACTESCENT||GC/FID|CKD-EPI CREATININE FORMULA|Y||Y|Y|3|Visit_3|40|6|FOLLOW-UP|2020-08-29|2020-08-31|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|489870ed-9da5-4df6-a5ef-17821c449c84|6|PEMAB|Pemphigoid Antibodies|URINALYSIS|[?]|cmH2O*s2/mL|[?]|[?]|NEGATIVE|1|Absorbance U/mL|1|1|[?]|NORMAL|SEMEN|LIPEMIC||MIGET|MDRD ENZYMATIC JAPANESE FORMULA|||U||3|Visit_3|40|3|TREATMENT|2020-08-29|2020-10-22|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|489870ed-9da5-4df6-a5ef-17821c449c84|7|ESTFREST|Estradiol, Free/Estradiol|HEMATOLOGY|[?]|MPL U|[?]|[?]|INVALID|1|deg/mm|1|1|[?]|HIGH|SEMEN|GELLED||RADIOGRAPHY|GMI % FORMULA|Y||Y||4|Visit_4|65|4|WASHOUT|2020-09-23|2020-10-27|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|LB|489870ed-9da5-4df6-a5ef-17821c449c84|8|PGD2S|Prostaglandin D2 Synthase|CHEMISTRY|[?]|Watt|[?]|[?]|POSITIVE|1|mgEq|1|1|[?]|NORMAL|SYNOVIAL FLUID|GELLED|N|FLUORESCENT ENZYME IMMUNOASSAY|FIBROTEST FORMULA|||NA||4|Visit_4|65|2|SCREENING|2020-09-23|2020-09-28|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|LB|489870ed-9da5-4df6-a5ef-17821c449c84|9|CRNTESTR|Carnitine Esters|CHEMISTRY|[?]|IU/g Hb|[?]|[?]|BORDERLINE|1|cpm|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|GELLED||ENZYMATIC SPECTROPHOTOMETRY|FIBROMETER FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-10-18|2020-10-23|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|489870ed-9da5-4df6-a5ef-17821c449c84|10|MG|Magnesium|HEMATOLOGY|[?]|10^6 organisms/g|[?]|[?]|BORDERLINE|1|BISCUIT|1|1|[?]|HIGH|LOCHIA|LACTESCENT||HIGH RESOLUTION CT|GMI MMOL/MOL FORMULA|Y|Y|N||5|Visit_5|90|4|TREATMENT|2020-10-18|2020-10-21|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|90fe992f-5a11-4829-b3b0-1c8314f53012|1|PREALB|Prealbumin|URINALYSIS|||[?]|[?]|TRACE|1|cP|1|1|[?]|ABNORMAL|CORD BLOOD|LIPEMIC||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD FORMULA|Y||NA|Y|1|Visit_1|10|5|TREATMENT|2020-09-23|2020-10-29|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|90fe992f-5a11-4829-b3b0-1c8314f53012|2|DSVLFXN|Desvenlafaxine|URINALYSIS|[?]|cd*s/m2|[?]|[?]|POSITIVE|1|mm/h|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|CLOTTED||IN VITRO GENE EXPRESSION ASSAY|COCKCROFT-GAULT FORMULA|Y||N||1|Visit_1|10|2|TREATMENT|2020-09-23|2020-10-01|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|90fe992f-5a11-4829-b3b0-1c8314f53012|3|LEIMLE|Immature Leukocytes/Leukocytes|HEMATOLOGY|||[?]|[?]|POSITIVE|1|Enzyme U/m2|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT||ELASTOGRAPHY|MDRD 6 VARIABLE FORMULA|||U|Y|2|Visit_2|25|1|FOLLOW-UP|2020-10-08|2020-12-19|25|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|90fe992f-5a11-4829-b3b0-1c8314f53012|4|HCT|Hematocrit|URINALYSIS|||[?]|[?]|INVALID|1|CAPSULE|1|1|[?]|NORMAL|MUCUS|SOLIDIFIED||WRIGHT STAIN|MDRD FORMULA|Y||U|Y|2|Visit_2|25|7|TREATMENT|2020-10-08|2020-10-31|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|LB|90fe992f-5a11-4829-b3b0-1c8314f53012|5|ASSDNA|Anti-Single Stranded DNA IgG|CHEMISTRY|[?]|Ci/uL|[?]|[?]|INDETERMINATE|1|ug/kg|1|1|[?]|ABNORMAL|GASTRIC FLUID|LIPEMIC||EEG|FIBROTEST FORMULA|Y|Y|Y||3|Visit_3|40|1|WASHOUT|2020-10-23|2020-12-21|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|90fe992f-5a11-4829-b3b0-1c8314f53012|6|PHNKET|Phenylketones|URINALYSIS|[?]|mg2/dL2|[?]|[?]|INDETERMINATE|1|steps/min|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|CLOTTED||DIFFUSION TENSOR MRI|MDRD ENZYMATIC JAPANESE FORMULA|||N||3|Visit_3|40|7|FOLLOW-UP|2020-10-23|2020-11-07|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|90fe992f-5a11-4829-b3b0-1c8314f53012|7|ALBGALB|Glycated Albumin/Albumin|URINALYSIS|[?]|kPa|[?]|[?]|BORDERLINE|1|mL/min/1.73m2|1|1|[?]|NORMAL|FLUID|DRIED|N|IN VITRO GENE EXPRESSION ASSAY|CKD-EPI FORMULA||Y|U||4|Visit_4|65|1|SCREENING|2020-11-17|2020-12-07|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|90fe992f-5a11-4829-b3b0-1c8314f53012|8|FSH|Follicle Stimulating Hormone|CHEMISTRY|[?]|eq|[?]|[?]|NEGATIVE|1|mg/kg/min|1|1|[?]|NORMAL|VENOUS PLASMA|GELLED||TWO-COLOR MICROARRAY|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|3|SCREENING|2020-11-17|2020-11-22|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|90fe992f-5a11-4829-b3b0-1c8314f53012|9|GIPI|Glucose-dep Insulinotropic Pep, Intact|CHEMISTRY|[?]|mg/kg/min|[?]|[?]|BORDERLINE|1|ug/g/day|1|1|[?]|NORMAL|TISSUE|DRIED||HEMATOXYLIN AND EOSIN STAIN|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|7|WASHOUT|2020-12-12|2020-12-18|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|90fe992f-5a11-4829-b3b0-1c8314f53012|10|CD40L|CD40 Ligand|URINALYSIS|||[?]|[?]|TRACE|1|kat|1|1|[?]|LOW|INFRANATANT, SERUM|LACTESCENT||MS/MS|MDRD 4 VARIABLE FORMULA|Y|Y|N|Y|5|Visit_5|90|6|TREATMENT|2020-12-12|2020-12-21|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|74be8de0-3307-4cc3-9044-05068b60f7e0|1|HBCOHGB|Carboxyhemoglobin/Total Hemoglobin|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|dB|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|NON-HEMOLYZED||MUGA|FIBROTEST FORMULA|Y||Y|Y|1|Visit_1|10|1|SCREENING|2020-10-20|2020-12-22|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|74be8de0-3307-4cc3-9044-05068b60f7e0|2|TMZPM|Temazepam|HEMATOLOGY|[?]|Linear ft*LB|[?]|[?]|NEGATIVE|1|pm|1|1|[?]|LOW|LYSATE|CALCIFIED||CELL OF ORIGIN ASSAY|MDRD 6 VARIABLE FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-10-20|2021-01-09|10|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|74be8de0-3307-4cc3-9044-05068b60f7e0|3|HYDMDZ4|4-Hydroxymidazolam|CHEMISTRY|[?]|10^6 U|[?]|[?]|TRACE|1|ug|1|1|[?]|LOW|CAPILLARY PLASMA|HEMOLYZED||IVY INCISION METHOD|COCKCROFT-GAULT FORMULA|Y||U||2|Visit_2|25|2|TREATMENT|2020-11-04|2020-12-07|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|74be8de0-3307-4cc3-9044-05068b60f7e0|4|COLOR|Color|HEMATOLOGY|[?]|U/kg/min|[?]|[?]|TRACE|1|10^6/L|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|REFRIGERATED|N|LISSAMINE GREEN STAIN|FIBROMETER FORMULA|||Y||2|Visit_2|25|6|FOLLOW-UP|2020-11-04|2020-12-14|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|74be8de0-3307-4cc3-9044-05068b60f7e0|5|CHOLCM|Cholate Compounds|HEMATOLOGY|[?]|mg/g/min|[?]|[?]|BORDERLINE|1|cm/s|1|1|[?]|LOW|GASTRIC CONTENTS|SOLIDIFIED||TRANSVAGINAL ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||3|Visit_3|40|7|WASHOUT|2020-11-19|2020-12-29|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|74be8de0-3307-4cc3-9044-05068b60f7e0|6|MONOBLLE|Monoblasts/Leukocytes|HEMATOLOGY|[?]|10^3 RNA copies/mL|[?]|[?]|BORDERLINE|1|IU/kg/h|1|1|[?]|ABNORMAL|PLASMA|CONCENTRATED||REFRACTOMETRY|GMI % FORMULA||Y|N||3|Visit_3|40|5|TREATMENT|2020-11-19|2020-12-14|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|LB|74be8de0-3307-4cc3-9044-05068b60f7e0|7|LKM1IAAB|Liver Kidney Microsomal Type 1 IgA Ab|HEMATOLOGY|[?]|nmol/L/min|[?]|[?]|INDETERMINATE|1|ug/m2/day|1|1|[?]|NORMAL|VENOUS CORD BLOOD|CALCIFIED||BIOPSY|ASH FIBROSURE FORMULA||Y|NA||4|Visit_4|65|6|TREATMENT|2020-12-14|2020-12-22|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|74be8de0-3307-4cc3-9044-05068b60f7e0|8|BGTCPHRL|Beta+Gamma Tocopherol|CHEMISTRY|[?]|L/day|[?]|[?]|INVALID|1|AU/mL|1|1|[?]|ABNORMAL|MUSCLE TISSUE|DRIED||INDIRECT IMMUNOFLUORESCENCE|MDRD FORMULA|||NA||4|Visit_4|65|5|SCREENING|2020-12-14|2021-01-01|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|74be8de0-3307-4cc3-9044-05068b60f7e0|9|ADPNHMW|Adiponectin, High Molecular Weight|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|TABLET|1|1|[?]|NORMAL|HAIR FOLLICLE|LACTESCENT||INCISION-INDUCED BLEEDING METHOD|HEPASCORE FORMULA||Y|N|Y|5|Visit_5|90|3|SCREENING|2021-01-08|2021-01-17|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|74be8de0-3307-4cc3-9044-05068b60f7e0|10|HDL3|HDL-Cholesterol Subclass 3|URINALYSIS|[?]|cmH2O*s/mL|[?]|[?]|BORDERLINE|1|MASK|1|1|[?]|HIGH|TRANSUDATE|ICTERIC||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|1|SCREENING|2021-01-08|2021-01-16|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|LB|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|1|VITDBP|Vitamin D Binding Protein|URINALYSIS|[?]|10^6 organisms/mL|[?]|[?]|INVALID|1|g/m2/day|1|1|[?]|LOW|ERYTHROCYTES|GELLED||LIQUID SCINTILLATION COUNTING|FIBROTEST FORMULA|||NA||1|Visit_1|10|1|SCREENING|2020-06-11|2020-08-05|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|2|INTLK32|Interleukin 32|CHEMISTRY|[?]|mol/mL|[?]|[?]|BORDERLINE|1|Newton|1|1|[?]|NORMAL|KERATINOCYTE|NON-HEMOLYZED||TOTAL BODY IRRADIATION|GMI % FORMULA|||NA||1|Visit_1|10|6|SCREENING|2020-06-11|2020-06-30|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|3|PO2ADJT|Partial Pressure Oxygen Adj for Temp|URINALYSIS|[?]|Sv|[?]|[?]|INVALID|1|cL|1|1|[?]|HIGH|FLUID|GELLED|N|VENTILATION PERFUSION LUNG SCAN|MDRD 6 VARIABLE FORMULA||Y|NA||2|Visit_2|25|1|TREATMENT|2020-06-26|2020-07-07|25|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|4|SPMAGGR|Sperm Aggregation|HEMATOLOGY|[?]|U/m2/day|[?]|[?]|POSITIVE|1|PFU/dose|1|1|[?]|NORMAL|GASTRIC FLUID|THAWED|N|MICRO BROTH DILUTION|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-06-26|2020-07-25|25|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|5|CCL13|Chemokine (C-C Motif) Ligand 13|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|U/g|1|1|[?]|ABNORMAL|SEMINAL FLUID|THAWED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|3|Visit_3|40|4|TREATMENT|2020-07-11|2020-08-31|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|6|HGF|Hepatocyte Growth Factor|URINALYSIS|[?]|nL|[?]|[?]|INVALID|1|Absorbance U/mL|1|1|[?]|NORMAL|COLOSTRUM|CONCENTRATED||ELECTROCHEMILUMINESCENCE|MDRD ENZYMATIC JAPANESE FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2020-07-11|2020-08-17|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|7|PSIGGAB|Phosphatidylserine IgG Antibody|CHEMISTRY|[?]|Linear ft*LB|[?]|[?]|POSITIVE|1|ng/day|1|1|[?]|HIGH|BILE|CALCIFIED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA|||N||4|Visit_4|65|5|WASHOUT|2020-08-05|2020-08-18|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|8|C165927|Animal Mix IgE AB RAST Score|CHEMISTRY|[?]|cm H2O|[?]|[?]|INVALID|1|log10 PFU|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|GELLED||TWO-COLOR MICROARRAY|CKD-EPI FORMULA|Y||U||4|Visit_4|65|5|TREATMENT|2020-08-05|2020-09-02|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|9|G6PD|Glucose-6-Phosphate Dehydrogenase|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mL/min/mmHg|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|CALCIFIED||AURAMINE STAIN|CKD-EPI CYSTATIN C FORMULA|Y||N|Y|5|Visit_5|90|2|TREATMENT|2020-08-30|2020-09-04|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|10|C1QAB|Complement C1q Antibody|CHEMISTRY|[?]|Absorbance U/min|[?]|[?]|INDETERMINATE|1|BAG|1|1|[?]|LOW|SYNOVIAL FLUID|LIPEMIC|N|FLOW CYTOMETRY|COCKCROFT-GAULT FORMULA|Y||U||5|Visit_5|90|7|WASHOUT|2020-08-30|2020-09-01|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|8825b806-fa76-49d7-b281-d36fc42fee1e|1|ACETOAC|Acetoacetic Acid|URINALYSIS|[?]|nkat/L|[?]|[?]|NEGATIVE|1|nkat/g Hb|1|1|[?]|LOW|FLUID|HEMOLYZED||IMMUNOFLUORESCENT STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-08-29|2020-10-08|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|8825b806-fa76-49d7-b281-d36fc42fee1e|2|LTFAB|Lactoferrin Antibody|HEMATOLOGY|[?]|EID 50/mL|[?]|[?]|TRACE|1|um|1|1|[?]|LOW|PUS|FROZEN||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|CKD-EPI FORMULA|||N||1|Visit_1|10|2|FOLLOW-UP|2020-08-29|2020-11-22|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|8825b806-fa76-49d7-b281-d36fc42fee1e|3|CO2|Carbon Dioxide|HEMATOLOGY|[?]|g/U|[?]|[?]|NEGATIVE|1|nkat/L|1|1|[?]|LOW|ISOLATE|CONTAMINATED|N|MULTIPLE BREATH WASHOUT|COCKCROFT-GAULT FORMULA|||U||2|Visit_2|25|7|TREATMENT|2020-09-13|2020-11-17|25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|8825b806-fa76-49d7-b281-d36fc42fee1e|4|NEUTTOXC|Neutrophilic Toxic Change|HEMATOLOGY|||[?]|[?]|POSITIVE|1|umol|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|AUTOLYZED||MRS|GMI % FORMULA|||Y|Y|2|Visit_2|25|2|TREATMENT|2020-09-13|2020-11-06|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|8825b806-fa76-49d7-b281-d36fc42fee1e|5|NEUTCE|Neutrophils/Total Cells|URINALYSIS|||[?]|[?]|TRACE|1|COAT|1|1|[?]|ABNORMAL|CELL PELLET|UNEXPECTED ODOR|N|HPLC-FL|MDRD FORMULA|||NA|Y|3|Visit_3|40|4|WASHOUT|2020-09-28|2020-10-26|40|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|8825b806-fa76-49d7-b281-d36fc42fee1e|6|GLDAB|Gliadin Antibody|CHEMISTRY|[?]|MASK|[?]|[?]|INDETERMINATE|1|10^3 organisms/g|1|1|[?]|LOW|SKIN TISSUE|AUTOLYZED||ENDOSCOPY|MDRD 4 VARIABLE FORMULA|||U||3|Visit_3|40|1|TREATMENT|2020-09-28|2020-09-29|40|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|8825b806-fa76-49d7-b281-d36fc42fee1e|7|TRACP5B|Tartrate-Resistant Acid Phosphatase 5b|URINALYSIS|[?]|cal|[?]|[?]|INVALID|1|pL|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|SOLIDIFIED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|NASH FIBROSURE FORMULA|Y||U||4|Visit_4|65|5|WASHOUT|2020-10-23|2020-11-06|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|8825b806-fa76-49d7-b281-d36fc42fee1e|8|APLIGMAB|Anti-Phospholipid IgM Antibody|HEMATOLOGY|[?]|V/sec|[?]|[?]|TRACE|1|mL/m2/h|1|1|[?]|LOW|TISSUE|THAWED||SPECTROPHOTOMETRY|CKD-EPI CREATININE FORMULA|Y||Y||4|Visit_4|65|1|TREATMENT|2020-10-23|2020-11-09|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|8825b806-fa76-49d7-b281-d36fc42fee1e|9|HGBEHGB|Hemoglobin E/Total Hemoglobin|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mg/day|1|1|[?]|NORMAL|DIALYSIS FLUID|CONTAMINATED||GC/MS-CI|GMI MMOL/MOL FORMULA|Y|Y|Y|Y|5|Visit_5|90|1|FOLLOW-UP|2020-11-17|2020-11-25|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|8825b806-fa76-49d7-b281-d36fc42fee1e|10|PGD2S|Prostaglandin D2 Synthase|HEMATOLOGY|[?]|ug/m2/h|[?]|[?]|TRACE|1|g/mol|1|1|[?]|HIGH|BILE|THAWED||HPLC/IEX|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2020-11-17|2020-11-24|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|1|VITD3|Vitamin D3|HEMATOLOGY|[?]|%/min|[?]|[?]|TRACE|1|NFIU|1|1|[?]|ABNORMAL|PLEURAL TISSUE|CONCENTRATED||HPLC/MS|FIBROSIS 4 FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-05-19|2020-06-19|10|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|2|PCO2ADJT|Partial Pressure Carbon Dioxide Adj Temp|CHEMISTRY|||[?]|[?]|BORDERLINE|1|CUP|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|REFRIGERATED|N|ETDRS EYE CHART|MDRD 5 VARIABLE FORMULA|Y|Y|N|Y|1|Visit_1|10|2|SCREENING|2020-05-19|2020-07-25|10|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|3|GLUCPE|Plasma Equivalent Glucose|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^6 organisms|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|FROZEN||TARGETED GENOME SEQUENCING|MDRD ENZYMATIC FORMULA|||N|Y|2|Visit_2|25|7|FOLLOW-UP|2020-06-03|2020-06-18|25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|4|INTLK4|Interleukin 4|CHEMISTRY|[?]|g/mol|[?]|[?]|TRACE|1|nmol/day|1|1|[?]|LOW|MENSTRUAL BLOOD|AUTOLYZED||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-06-03|2020-07-26|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|5|METARBCE|Metarubricyte/Total Cells|HEMATOLOGY|[?]|10^3/L|[?]|[?]|INVALID|1|nmol|1|1|[?]|NORMAL|SERUM OR PLASMA|HEMOLYZED||RULER MEASUREMENT METHOD|MDRD ENZYMATIC JAPANESE FORMULA|||U||3|Visit_3|40|3|TREATMENT|2020-06-18|2020-07-26|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|6|BLASTERY|Basophilic Erythroblast|CHEMISTRY|[?]|mV/sec|[?]|[?]|POSITIVE|1|mg/m2|1|1|[?]|LOW|CAPILLARY PLASMA|UNEXPECTED ODOR||ULTRASOUND|FIBROMETER FORMULA|Y|Y|Y||3|Visit_3|40|5|TREATMENT|2020-06-18|2020-07-09|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|7|AMA|Antimitochondrial Antibodies|CHEMISTRY|[?]|ft|[?]|[?]|NEGATIVE|1|ug/dL|1|1|[?]|NORMAL|SWABBED MATERIAL|PARAFFIN-EMBEDDED||IMMUNOCHROMATOGRAPHY|MDRD ENZYMATIC FORMULA||Y|N||4|Visit_4|65|6|FOLLOW-UP|2020-07-13|2020-08-12|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|8|METARBCE|Metarubricyte/Total Cells|HEMATOLOGY|[?]|10^6 U|[?]|[?]|BORDERLINE|1|ng/day|1|1|[?]|ABNORMAL|BONE|CONTAMINATED||GRADIENT DIFFUSION|MDRD 5 VARIABLE FORMULA|Y||NA||4|Visit_4|65|1|TREATMENT|2020-07-13|2020-07-23|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|LB|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|9|INDICAN|Indican|HEMATOLOGY|[?]|log10 CCID 50/dose|[?]|[?]|BORDERLINE|1|Coulomb|1|1|[?]|HIGH|MIXED VENOUS BLOOD|GELLED||IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|2|FOLLOW-UP|2020-08-07|2020-08-13|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|10|ECT|Ecarin Clotting Time|CHEMISTRY|[?]|Absorbance U|[?]|[?]|INDETERMINATE|1|dpm/100mg|1|1|[?]|HIGH|DISCHARGE|LIPEMIC||RADIAL IMMUNODIFFUSION|MDRD 5 VARIABLE FORMULA|||N||5|Visit_5|90|7|TREATMENT|2020-08-07|2020-08-12|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|1|TRGTCE|Target Cells|HEMATOLOGY|[?]|ug/mol|[?]|[?]|BORDERLINE|1|/VF|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|Y||Y||1|Visit_1|10|6|TREATMENT|2021-01-14|2021-03-16|10|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|LB|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|2|GALM|Galactose Mutarotase|CHEMISTRY|[?]|10^8/L|[?]|[?]|TRACE|1|msec|1|1|[?]|ABNORMAL|SKIN TISSUE|REFRIGERATED|N|ELECTRONEUROGRAPHY|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|6|TREATMENT|2021-01-14|2021-02-10|10|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|LB|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|3|FPP|Protoporphyrin, Free|CHEMISTRY|[?]|log10 TCID 50/uL|[?]|[?]|INDETERMINATE|1|ag|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|NON-HEMOLYZED||IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA||Y|N||2|Visit_2|25|7|TREATMENT|2021-01-29|2021-03-26|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|4|CONDUCTU|Urine Conductivity|URINALYSIS|[?]|ug/L DDU|[?]|[?]|INDETERMINATE|1|h*%|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED||ERGOSPIROMETRY|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2021-01-29|2021-02-16|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|LB|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|5|PROT|Protein|CHEMISTRY|[?]|10^6/g|[?]|[?]|NEGATIVE|1|cd|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH||WRIGHT-GIEMSA STAIN|FIBROMETER FORMULA||Y|U||3|Visit_3|40|7|TREATMENT|2021-02-13|2021-03-29|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|LB|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|6|B2G1GMAB|Beta-2 Glycoprotein 1 IgM Antibody|HEMATOLOGY|[?]|10^3 organisms/g|[?]|[?]|BORDERLINE|1|anti-Xa IU|1|1|[?]|HIGH|MENSTRUAL BLOOD|FRESH||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD FORMULA||Y|U||3|Visit_3|40|3|TREATMENT|2021-02-13|2021-03-10|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|LB|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|7|MCPHNSQE|Macrophages/Non-Squam Epi Cells|CHEMISTRY|[?]|pptr|[?]|[?]|TRACE|1|U/mmol|1|1|[?]|HIGH|SERUM OR PLASMA|CONTAMINATED|N|IODINE STAIN|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|5|TREATMENT|2021-03-10|2021-04-11|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|LB|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|8|CANNABM|Cannabinoid Metabolites|URINALYSIS|[?]|mOsm/kg|[?]|[?]|INDETERMINATE|1|AFU|1|1|[?]|HIGH|VENOUS PLASMA|FROZEN||JAFFE REACTION|NASH FIBROSURE FORMULA||Y|NA||4|Visit_4|65|2|TREATMENT|2021-03-10|2021-03-28|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|LB|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|9|AAP|Alanine Aminopeptidase|URINALYSIS|||[?]|[?]|BORDERLINE|1|nmol/L|1|1|[?]|ABNORMAL|CALCULUS|PARAFFIN-EMBEDDED|N|IMPULSE OSCILLOMETRY|COCKCROFT-GAULT FORMULA|Y||NA|Y|5|Visit_5|90|7|FOLLOW-UP|2021-04-04|2021-04-13|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|10|CXCL7|Chemokine (C-X-C Motif) Ligand 7|CHEMISTRY|[?]|amol|[?]|[?]|NEGATIVE|1|anti-Xa IU/mL|1|1|[?]|NORMAL|INFRANATANT, PLASMA|PARAFFIN-EMBEDDED||FLOCCULATION|NASH FIBROSURE FORMULA|Y||Y||5|Visit_5|90|6|SCREENING|2021-04-04|2021-04-07|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|b36220d8-c129-48bf-8c41-542a954b819a|1|CYCYSTIN|Cystine Crystals|HEMATOLOGY|[?]|Bq|[?]|[?]|BORDERLINE|1|10^9/L|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR||AGAR PROPORTION|CKD-EPI CREATININE FORMULA|Y|Y|NA||1|Visit_1|10|5|WASHOUT|2020-05-24|2020-07-16|10|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|b36220d8-c129-48bf-8c41-542a954b819a|2|G6PDRBRB|G6PD-Deficient Erythrocytes/Erythrocytes|URINALYSIS|||[?]|[?]|NEGATIVE|1|ug/L DDU|1|1|[?]|HIGH|CAPILLARY BLOOD|DRIED||ACCELERATOR MASS SPECTROMETRY|ASH FIBROSURE FORMULA|Y|Y|N|Y|1|Visit_1|10|7|TREATMENT|2020-05-24|2020-08-18|10|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|b36220d8-c129-48bf-8c41-542a954b819a|3|CEMORPH|Cell Morphology|URINALYSIS|||[?]|[?]|POSITIVE|1|mmol/s|1|1|[?]|ABNORMAL|TUMOR TISSUE|THAWED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|CKD-EPI FORMULA||Y|U|Y|2|Visit_2|25|6|TREATMENT|2020-06-08|2020-07-20|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|b36220d8-c129-48bf-8c41-542a954b819a|4|INTLK1RA|Interleukin 1 Receptor Antagonist|CHEMISTRY|[?]|GPL U|[?]|[?]|BORDERLINE|1|log10 CCID 50/dose|1|1|[?]|NORMAL|SKIN TISSUE|ICTERIC||OPTICAL COHERENCE TOMOGRAPHY|HEPASCORE FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-06-08|2020-08-09|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|b36220d8-c129-48bf-8c41-542a954b819a|5|AMYLASES|Amylase, Salivary|URINALYSIS|[?]|log10 CCID 50/dose|[?]|[?]|NEGATIVE|1|L/min|1|1|[?]|NORMAL|HAIR FOLLICLE|ICTERIC||IMMUNOFLUORESCENT STAIN|CKD-EPI CREATININE FORMULA|Y||Y||3|Visit_3|40|2|SCREENING|2020-06-23|2020-07-19|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|b36220d8-c129-48bf-8c41-542a954b819a|6|WBCDIFF|Leukocyte Cell Differential|CHEMISTRY|[?]|uCi/kg|[?]|[?]|INDETERMINATE|1|mAnson U/mL|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|N|PERCUSSION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|1|TREATMENT|2020-06-23|2020-08-11|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|b36220d8-c129-48bf-8c41-542a954b819a|7|ACHRAB|Acetylcholine Receptor Antibody|URINALYSIS|[?]|10^6 CFU/mL|[?]|[?]|POSITIVE|1|nmol/kg/day|1|1|[?]|NORMAL|CELL PELLET|HEMOLYZED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|3|FOLLOW-UP|2020-07-18|2020-08-05|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|LB|b36220d8-c129-48bf-8c41-542a954b819a|8|ANISO|Anisocytes|URINALYSIS|[?]|10^12/L|[?]|[?]|BORDERLINE|1|mL/h|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|AUTOLYZED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|5|FOLLOW-UP|2020-07-18|2020-08-15|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|LB|b36220d8-c129-48bf-8c41-542a954b819a|9|NEUTVAC|Vacuolated Neutrophils|URINALYSIS|[?]|mg/mol|[?]|[?]|NEGATIVE|1|ELISA unit|1|1|[?]|HIGH|INFRANATANT, SERUM|CALCIFIED||BRDU CELLULAR PROLIFERATION ASSAY|GMI % FORMULA|||U||5|Visit_5|90|1|SCREENING|2020-08-12|2020-08-17|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|LB|b36220d8-c129-48bf-8c41-542a954b819a|10|LTE4|Leukotriene E4|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|U/m2/day|1|1|[?]|ABNORMAL|EXUDATE|DRIED||INFRARED SPECTROMETRY|CKD-EPI FORMULA|||Y|Y|5|Visit_5|90|5|TREATMENT|2020-08-12|2020-08-16|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|LB|92d3477b-7460-4ce8-b237-38ca4c55fc91|1|C4|Complement C4|CHEMISTRY|[?]|mJoule/cm2|[?]|[?]|INVALID|1|uCi|1|1|[?]|LOW|PLATELET|AUTOLYZED||ENZYMATIC COLORIMETRY|FIBROMETER FORMULA|||N||1|Visit_1|10|4|TREATMENT|2020-08-14|2020-10-25|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|LB|92d3477b-7460-4ce8-b237-38ca4c55fc91|2|MEPRDN|Meperidine|HEMATOLOGY|[?]|Bq/mg|[?]|[?]|INVALID|1|BEAM BREAKS|1|1|[?]|LOW|EXPIRED AIR|CALCIFIED|N|IMMUNODIFFUSION|HEPASCORE FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-08-14|2020-09-16|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|LB|92d3477b-7460-4ce8-b237-38ca4c55fc91|3|IGG3|Immunoglobulin G Subclass 3|URINALYSIS|[?]|umol/kg/min|[?]|[?]|TRACE|1|keV|1|1|[?]|LOW|DIALYSIS FLUID|GELLED||CONTRAST ENHANCED PET SCAN|COCKCROFT-GAULT FORMULA|Y||N||2|Visit_2|25|6|SCREENING|2020-08-29|2020-09-20|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|92d3477b-7460-4ce8-b237-38ca4c55fc91|4|CLRDZPXD|Chlordiazepoxide|URINALYSIS|||[?]|[?]|NEGATIVE|1|CCID 50/dose|1|1|[?]|HIGH|CORD SERUM|CONTAMINATED||RADIOIMMUNOPRECIPITATION ASSAY|GMI % FORMULA|||N|Y|2|Visit_2|25|7|TREATMENT|2020-08-29|2020-09-12|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|92d3477b-7460-4ce8-b237-38ca4c55fc91|5|TNF5S|Soluble TNF Superfamily Member 5|CHEMISTRY|[?]|km|[?]|[?]|NEGATIVE|1|10^11/L|1|1|[?]|NORMAL|AQUEOUS HUMOR|REFRIGERATED|N|LIQUID SCINTILLATION COUNTING|COCKCROFT-GAULT FORMULA|Y||U||3|Visit_3|40|5|TREATMENT|2020-09-13|2020-09-16|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|92d3477b-7460-4ce8-b237-38ca4c55fc91|6|HGBCHGB|Hemoglobin C/Total Hemoglobin|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mL/cage/wk|1|1|[?]|NORMAL|CERUMEN|THAWED|N|HPLC-UV|MDRD ENZYMATIC FORMULA|Y||NA|Y|3|Visit_3|40|1|SCREENING|2020-09-13|2020-10-30|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|LB|92d3477b-7460-4ce8-b237-38ca4c55fc91|7|DCCARNIT|Decanoylcarnitine|HEMATOLOGY|[?]|pm|[?]|[?]|INDETERMINATE|1|genEq/mL|1|1|[?]|HIGH|ALVEOLAR AIR|ICTERIC||CLIP|COCKCROFT-GAULT FORMULA||Y|U||4|Visit_4|65|3|TREATMENT|2020-10-08|2020-11-08|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|92d3477b-7460-4ce8-b237-38ca4c55fc91|8|FENTANYL|Fentanyl|CHEMISTRY|[?]|DAgU/mL|[?]|[?]|BORDERLINE|1|nL|1|1|[?]|LOW|BASAL TEAR|UNEXPECTED ODOR||INCISION-INDUCED BLEEDING METHOD|MDRD 5 VARIABLE FORMULA|Y||Y||4|Visit_4|65|2|WASHOUT|2020-10-08|2020-11-04|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|92d3477b-7460-4ce8-b237-38ca4c55fc91|9|CCL16|Chemokine (C-C Motif) Ligand 16|HEMATOLOGY|[?]|mmHg/L/min|[?]|[?]|NEGATIVE|1|mmol2/L2|1|1|[?]|NORMAL|EXPIRED AIR|NON-HEMOLYZED||AGAR PROPORTION|GMI % FORMULA|Y||U||5|Visit_5|90|1|TREATMENT|2020-11-02|2020-11-09|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|LB|92d3477b-7460-4ce8-b237-38ca4c55fc91|10|AMABARAB|ACH Receptor Modulatn Ab/ACH Receptor Ab|HEMATOLOGY|[?]|LB|[?]|[?]|NEGATIVE|1|s/h|1|1|[?]|NORMAL|PLEURAL TISSUE|FROZEN||QUANTITATIVE COMPUTED TOMOGRAPHY|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|2|FOLLOW-UP|2020-11-02|2020-11-04|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|LB|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|1|CHCNT|Corpuscular Hemoglobin Content|CHEMISTRY|[?]|PFU/dose|[?]|[?]|TRACE|1|mg/m2/min|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|THAWED||MALDI|MDRD ENZYMATIC FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2020-12-16|2021-03-07|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|2|ALPLALP|Alk Phos, Liver/Total Alk Phos|HEMATOLOGY|[?]|pt_us|[?]|[?]|INVALID|1|ug/m2/day|1|1|[?]|LOW|MUSCLE TISSUE|FRESH||ACRIDINE ORANGE STAIN|FIBROMETER FORMULA|||NA||1|Visit_1|10|1|WASHOUT|2020-12-16|2021-02-21|10|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|3|CD56|CD56|CHEMISTRY|[?]|10^3 organisms/mL|[?]|[?]|TRACE|1|Enzyme U/L|1|1|[?]|LOW|LUNG SURFACTANT|LACTESCENT||BIOIMPEDANCE SPECTROSCOPY|MDRD ENZYMATIC FORMULA|Y||Y||2|Visit_2|25|4|TREATMENT|2020-12-31|2021-03-07|25|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|4|DALA|Delta Aminolevulinate|CHEMISTRY|||[?]|[?]|TRACE|1|g/animal/wk|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|THAWED||MRI|NASH FIBROSURE FORMULA|||N|Y|2|Visit_2|25|5|SCREENING|2020-12-31|2021-02-12|25|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|5|C130107|Weed Mix Pollen Antigen IgG Antibody|HEMATOLOGY|[?]|DROP|[?]|[?]|BORDERLINE|1|DISK|1|1|[?]|ABNORMAL|ISOLATE|THAWED||DC SHEATH FLOW|MDRD ENZYMATIC FORMULA|||N||3|Visit_3|40|4|SCREENING|2021-01-15|2021-02-04|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|6|APOA5|Apolipoprotein A5|CHEMISTRY|[?]|Joule|[?]|[?]|BORDERLINE|1|fL|1|1|[?]|HIGH|EPITHELIAL CELL|AUTOLYZED||SNP ARRAY|FIBROMETER FORMULA|||U||3|Visit_3|40|3|WASHOUT|2021-01-15|2021-01-23|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|7|DOPAC|3,4-Dihydroxyphenylacetic Acid|CHEMISTRY|[?]|sec|[?]|[?]|NEGATIVE|1|CYLINDER|1|1|[?]|HIGH|AMNIOTIC FLUID|FRESH||RAJI CELL RIA|GMI MMOL/MOL FORMULA||Y|NA||4|Visit_4|65|7|TREATMENT|2021-02-09|2021-03-05|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|8|SCKLCE|Sickle Cells|HEMATOLOGY|[?]|min/day|[?]|[?]|BORDERLINE|1|uU/dL|1|1|[?]|HIGH|LYSATE|ICTERIC||BALLPOINT PEN TECHNIQUE|MDRD 5 VARIABLE FORMULA|||N||4|Visit_4|65|5|TREATMENT|2021-02-09|2021-02-11|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|9|LYMCLF|Lymphocytes, Clefted|URINALYSIS|[?]|Watt|[?]|[?]|POSITIVE|1|/100 HPFs|1|1|[?]|LOW|PLEURAL TISSUE|HEMOLYZED||WRIGHT STAIN|MDRD FORMULA||Y|Y||5|Visit_5|90|4|WASHOUT|2021-03-06|2021-03-08|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|10|MACROCY|Macrocytes|URINALYSIS|||[?]|[?]|NEGATIVE|1|PFU/dose|1|1|[?]|ABNORMAL|MUCUS|PARAFFIN-EMBEDDED||RIA|CKD-EPI CREATININE FORMULA|Y||U|Y|5|Visit_5|90|2|TREATMENT|2021-03-06|2021-03-14|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|db13afe0-14f6-445b-869a-b0d9fe87e5b9|1|PROINSUL|Proinsulin|HEMATOLOGY|[?]|RING|[?]|[?]|INVALID|1|tsp|1|1|[?]|LOW|SEBUM|LACTESCENT||CELL OF ORIGIN ASSAY|MDRD 6 VARIABLE FORMULA|Y|Y|NA||1|Visit_1|10|5|TREATMENT|2020-08-22|2020-11-08|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|db13afe0-14f6-445b-869a-b0d9fe87e5b9|2|ASTAG|Aspartate Aminotransferase Antigen|HEMATOLOGY|[?]|SBE/mL|[?]|[?]|NEGATIVE|1|nsec|1|1|[?]|LOW|HAIR|GELLED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||Y|N||1|Visit_1|10|2|WASHOUT|2020-08-22|2020-10-10|10|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|db13afe0-14f6-445b-869a-b0d9fe87e5b9|3|CYCYSTIN|Cystine Crystals|CHEMISTRY|[?]|mg/mol|[?]|[?]|TRACE|1|ppb|1|1|[?]|LOW|LUNG SURFACTANT|LIPEMIC||CORONARY ANGIOGRAPHY|FIBROTEST FORMULA||Y|NA||2|Visit_2|25|3|TREATMENT|2020-09-06|2020-09-22|25|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|db13afe0-14f6-445b-869a-b0d9fe87e5b9|4|DDIMER|D-Dimer|URINALYSIS|[?]|amu|[?]|[?]|POSITIVE|1|IU/g Hb|1|1|[?]|HIGH|SALIVA|DRIED||MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI FORMULA|||U||2|Visit_2|25|6|WASHOUT|2020-09-06|2020-11-19|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|LB|db13afe0-14f6-445b-869a-b0d9fe87e5b9|5|ANPPROMR|Mid-Reg Pro-Atrial Natriuretic Peptide|CHEMISTRY|||[?]|[?]|POSITIVE|1|breaths/min|1|1|[?]|HIGH|PLEURAL FLUID|ROOM TEMPERATURE||FLUORESCENT SPOT TEST|MDRD 4 VARIABLE FORMULA|||U|Y|3|Visit_3|40|2|TREATMENT|2020-09-21|2020-10-23|40|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|db13afe0-14f6-445b-869a-b0d9fe87e5b9|6|INLCLR|Inulin Clearance|URINALYSIS|[?]|INHALATION|[?]|[?]|BORDERLINE|1|grain|1|1|[?]|LOW|PLEURAL TISSUE|PARAFFIN-EMBEDDED||ULTRASONOGRAPHIC ELASTOGRAPHY|ASH FIBROSURE FORMULA|Y||U||3|Visit_3|40|7|TREATMENT|2020-09-21|2020-10-09|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|db13afe0-14f6-445b-869a-b0d9fe87e5b9|7|FSH|Follicle Stimulating Hormone|URINALYSIS|[?]|yd|[?]|[?]|NEGATIVE|1|10^3 DNA copies/mL|1|1|[?]|ABNORMAL|LYMPH|LACTESCENT||SCANNING ELECTRON MICROSCOPY|GMI MMOL/MOL FORMULA|Y|Y|N||4|Visit_4|65|4|TREATMENT|2020-10-16|2020-11-04|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|db13afe0-14f6-445b-869a-b0d9fe87e5b9|8|SCKCERBC|Sickle Cells/Erythrocytes|URINALYSIS|[?]|Pack Year|[?]|[?]|INDETERMINATE|1|ELISA unit|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|LIPEMIC||CONTRAST ENHANCED X-RAY|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|1|SCREENING|2020-10-16|2020-10-26|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|LB|db13afe0-14f6-445b-869a-b0d9fe87e5b9|9|IA5OHEXR|5-HydroxyindoleaceticAcid Excretion Rate|CHEMISTRY|[?]|MnFI|[?]|[?]|INVALID|1|nkat/g Hb|1|1|[?]|ABNORMAL|SMEGMA|THAWED||ZIEHL NEELSEN ACID FAST STAIN|ASH FIBROSURE FORMULA|Y||U||5|Visit_5|90|6|SCREENING|2020-11-10|2020-11-14|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|db13afe0-14f6-445b-869a-b0d9fe87e5b9|10|G6PDRBC|G6PD-Deficient Erythrocytes|HEMATOLOGY|[?]|ug/kg|[?]|[?]|INDETERMINATE|1|/500 WBC|1|1|[?]|NORMAL|SYNOVIAL FLUID|FRESH||NUCLEIC ACID HYBRIDIZATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||5|Visit_5|90|7|SCREENING|2020-11-10|2020-11-16|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|3f75a463-1348-4c7f-8b29-7472d29628c8|1|HGBA1HGB|Hemoglobin A1/Total Hemoglobin|URINALYSIS|[?]|Ci/uL|[?]|[?]|BORDERLINE|1|g/kg|1|1|[?]|HIGH|VENOUS PLASMA|LACTESCENT||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-07-12|2020-08-20|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|3f75a463-1348-4c7f-8b29-7472d29628c8|2|CLCTONN|Calcitonin|CHEMISTRY|||[?]|[?]|BORDERLINE|1|% INHIBITION|1|1|[?]|ABNORMAL|REFLEX TEAR|GELLED||GC/MS|MDRD 4 VARIABLE FORMULA|||U|Y|1|Visit_1|10|7|TREATMENT|2020-07-12|2020-08-27|10|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|3f75a463-1348-4c7f-8b29-7472d29628c8|3|CCL8|Chemokine (C-C Motif) Ligand 8|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mCi|1|1|[?]|NORMAL|TUMOR TISSUE|LACTESCENT||NEXT GENERATION TARGETED SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|N|Y|2|Visit_2|25|6|FOLLOW-UP|2020-07-27|2020-09-09|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|3f75a463-1348-4c7f-8b29-7472d29628c8|4|EPIN|Epinephrine|HEMATOLOGY|[?]|mg/day|[?]|[?]|NEGATIVE|1|nkat/L|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|REFRIGERATED|N|SPIRAL CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC FORMULA||Y|N||2|Visit_2|25|1|TREATMENT|2020-07-27|2020-08-07|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|3f75a463-1348-4c7f-8b29-7472d29628c8|5|GLOBGPT|Gamma Globulin/Total Protein|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|umol/L|1|1|[?]|NORMAL|LOCHIA|THAWED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|GMI MMOL/MOL FORMULA|||Y|Y|3|Visit_3|40|1|FOLLOW-UP|2020-08-11|2020-09-03|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|3f75a463-1348-4c7f-8b29-7472d29628c8|6|NEUTBLE|Neutrophils Band Form/Leukocytes|HEMATOLOGY|[?]|g/kg/day|[?]|[?]|POSITIVE|1|PFU/dose|1|1|[?]|LOW|DERMAL TISSUE|CALCIFIED||SLOAN LETTER EYE CHART 100%|NASH FIBROSURE FORMULA|||U||3|Visit_3|40|3|TREATMENT|2020-08-11|2020-09-22|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|3f75a463-1348-4c7f-8b29-7472d29628c8|7|PHNKET|Phenylketones|HEMATOLOGY|[?]|cd|[?]|[?]|INVALID|1|kg|1|1|[?]|LOW|CORD SERUM|ICTERIC|N|FLUORESCENT MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||4|Visit_4|65|7|FOLLOW-UP|2020-09-05|2020-09-22|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|3f75a463-1348-4c7f-8b29-7472d29628c8|8|BASOB|Basophils Band Form|HEMATOLOGY|[?]|deg2|[?]|[?]|POSITIVE|1|mL/mmHg/min/L|1|1|[?]|LOW|CEREBROSPINAL FLUID|FRESH|N|ERGOSPIROMETRY|CKD-EPI CYSTATIN C FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-09-05|2020-09-16|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|LB|3f75a463-1348-4c7f-8b29-7472d29628c8|9|BTLBARTL|Butabarbital|CHEMISTRY|[?]|ELISA unit/dose|[?]|[?]|INVALID|1|m3|1|1|[?]|LOW|LUNG SURFACTANT|CONCENTRATED|N|CLIP|CKD-EPI CYSTATIN C FORMULA|||N||5|Visit_5|90|4|TREATMENT|2020-09-30|2020-10-01|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|3f75a463-1348-4c7f-8b29-7472d29628c8|10|HLADQB1|HLA DQ Beta1 Antigen|URINALYSIS|||[?]|[?]|POSITIVE|1|um|1|1|[?]|LOW|SERUM OR PLASMA|SOLIDIFIED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA|||N|Y|5|Visit_5|90|3|WASHOUT|2020-09-30|2020-10-01|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|1|CHLMCRN|Chylomicrons|CHEMISTRY|[?]|ukat/L|[?]|[?]|POSITIVE|1|DNA copies/ug|1|1|[?]|LOW|DISCHARGE|PARAFFIN-EMBEDDED|N|PALPATION|MDRD ENZYMATIC FORMULA|Y||Y||1|Visit_1|10|3|TREATMENT|2021-01-30|2021-04-17|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-02
e|LB|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|2|INTLK1B|Interleukin 1 Beta|URINALYSIS|||[?]|[?]|POSITIVE|1|mmol/mol|1|1|[?]|LOW|CORD SERUM|THAWED|N|SINGLE-SLICE SPIRAL CT|CKD-EPI FORMULA|||NA|Y|1|Visit_1|10|3|SCREENING|2021-01-30|2021-03-12|10|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-02
e|LB|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|3|TLYMXM|T-lymphocyte Crossmatch|URINALYSIS|[?]|genEq/mL|[?]|[?]|INVALID|1|days/wk|1|1|[?]|LOW|SWABBED MATERIAL|GELLED|N|IMMUNORADIOMETRIC ASSAY|CKD-EPI CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|7|SCREENING|2021-02-14|2021-03-25|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|LB|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|4|KLK2|Kallikrein-2|CHEMISTRY|[?]|10^3 copies/mL|[?]|[?]|INVALID|1|beats/min|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|REFRIGERATED||CARDIAC THERMODILUTION|FIBROTEST FORMULA||Y|U||2|Visit_2|25|4|TREATMENT|2021-02-14|2021-02-17|25|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|LB|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|5|ANIONG3|Anion Gap 3|URINALYSIS|[?]|10^7/L|[?]|[?]|POSITIVE|1|ms2|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|THAWED|N|HPLC/MS|CKD-EPI FORMULA||Y|Y||3|Visit_3|40|3|TREATMENT|2021-03-01|2021-04-13|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|6|B2G1GMAB|Beta-2 Glycoprotein 1 IgM Antibody|HEMATOLOGY|[?]|VIRTUAL PIXEL|[?]|[?]|BORDERLINE|1|uEq/L|1|1|[?]|LOW|SKIN TISSUE|CONCENTRATED||FLUORESCENT LIFETIME IMAGING MICROSCOPY|HEPASCORE FORMULA||Y|N||3|Visit_3|40|2|WASHOUT|2021-03-01|2021-03-18|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|7|FACTXI|Factor XI|CHEMISTRY|[?]|CAPFUL|[?]|[?]|NEGATIVE|1|IU|1|1|[?]|NORMAL|COLOSTRUM|CALCIFIED||CARDIAC THERMODILUTION|MDRD ENZYMATIC FORMULA||Y|N||4|Visit_4|65|6|TREATMENT|2021-03-26|2021-03-29|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|8|TESTOSFR|Testosterone, Free|HEMATOLOGY|[?]|uV*sec|[?]|[?]|TRACE|1|pm|1|1|[?]|HIGH|LEUKOCYTE|REFRIGERATED||ENZYMATIC ULTRACENTRIFUGATION|CKD-EPI CYSTATIN C FORMULA|Y||N||4|Visit_4|65|5|TREATMENT|2021-03-26|2021-04-22|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|LB|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|9|PT|Prothrombin Time|CHEMISTRY|[?]|HEP|[?]|[?]|NEGATIVE|1|/100 WBC|1|1|[?]|LOW|SPUTUM|CONTAMINATED||MRS|CKD-EPI FORMULA||Y|NA||5|Visit_5|90|5|TREATMENT|2021-04-20|2021-04-29|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|LB|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|10|CTOT|Complement Total|HEMATOLOGY|[?]|mL/animal/day|[?]|[?]|INDETERMINATE|1|BAG|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|DRIED||SLIT LAMP|MDRD ENZYMATIC FORMULA|Y||NA||5|Visit_5|90|1|TREATMENT|2021-04-20|2021-04-27|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|LB|4b00b9ef-ddc3-4669-8a73-f69c73743bce|1|HIST2BAB|Histone 2B Antibody|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Roentgen|1|1|[?]|LOW|ENDOTRACHEAL FLUID|LIPEMIC|N|URANYL ACETATE STAIN|CKD-EPI CREATININE FORMULA|Y||Y|Y|1|Visit_1|10|2|WASHOUT|2020-07-23|2020-09-14|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|4b00b9ef-ddc3-4669-8a73-f69c73743bce|2|CD19LY|CD19/Lymphocytes|URINALYSIS|||[?]|[?]|TRACE|1|ug/h|1|1|[?]|NORMAL|BONE|ROOM TEMPERATURE||CONFOCAL MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|||NA|Y|1|Visit_1|10|4|SCREENING|2020-07-23|2020-07-26|10|13|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|LB|4b00b9ef-ddc3-4669-8a73-f69c73743bce|3|P50OXYGN|P50 Oxygen|CHEMISTRY|||[?]|[?]|TRACE|1|mL/s/m2|1|1|[?]|LOW|MIXED VENOUS BLOOD|HEMOLYZED||FLUORESCENCE ANGIOGRAPHY|GMI MMOL/MOL FORMULA|||NA|Y|2|Visit_2|25|6|FOLLOW-UP|2020-08-07|2020-09-02|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|4b00b9ef-ddc3-4669-8a73-f69c73743bce|4|TKG|T-Kininogen|HEMATOLOGY|[?]|EIA unit|[?]|[?]|NEGATIVE|1|dram|1|1|[?]|NORMAL|INFRANATANT, PLASMA|REFRIGERATED||OPTICAL MAPPING|CKD-EPI FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-08-07|2020-08-20|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|4b00b9ef-ddc3-4669-8a73-f69c73743bce|5|VLDL1|VLDL Cholesterol Subtype 1|HEMATOLOGY|[?]|/VF|[?]|[?]|INDETERMINATE|1|kN/cm2|1|1|[?]|ABNORMAL|NAIL|GELLED||ICC|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|7|FOLLOW-UP|2020-08-22|2020-10-07|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|4b00b9ef-ddc3-4669-8a73-f69c73743bce|6|FACTXIII|Factor XIII|CHEMISTRY|[?]|JAR|[?]|[?]|BORDERLINE|1|IU/mL|1|1|[?]|LOW|EMESIS|UNEXPECTED ODOR||MAPH|CKD-EPI CREATININE FORMULA|Y||NA||3|Visit_3|40|6|TREATMENT|2020-08-22|2020-08-31|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|4b00b9ef-ddc3-4669-8a73-f69c73743bce|7|C147280|Cow Milk Protein Antigen IgE Antibody|CHEMISTRY|[?]|mJoule/cm2|[?]|[?]|NEGATIVE|1|lx|1|1|[?]|NORMAL|PERSPIRATION|PARAFFIN-EMBEDDED|N|CYSTOMETRY|FIBROMETER FORMULA|||Y||4|Visit_4|65|3|SCREENING|2020-09-16|2020-10-18|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|4b00b9ef-ddc3-4669-8a73-f69c73743bce|8|PROMY|Promyelocytes|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|cmH2O*s/mL|1|1|[?]|HIGH|PLEURAL FLUID|REFRIGERATED||DIRECT SEQUENCING|ASH FIBROSURE FORMULA|||Y|Y|4|Visit_4|65|5|TREATMENT|2020-09-16|2020-10-13|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|LB|4b00b9ef-ddc3-4669-8a73-f69c73743bce|9|NCTD5P|5 Prime Nucleotidase|CHEMISTRY|[?]|ug/dose|[?]|[?]|BORDERLINE|1|mm/sec|1|1|[?]|HIGH|TISSUE|CALCIFIED||PET SCAN|FIBROTEST FORMULA|||U||5|Visit_5|90|4|FOLLOW-UP|2020-10-11|2020-10-14|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|4b00b9ef-ddc3-4669-8a73-f69c73743bce|10|LDLOXI|Oxidized LDL Cholesterol|HEMATOLOGY|[?]|DRINK|[?]|[?]|TRACE|1|ft3|1|1|[?]|HIGH|PLATELET POOR PLASMA|UNEXPECTED ODOR||CALCOFLUOR WHITE STAIN|CKD-EPI CYSTATIN C FORMULA|||U||5|Visit_5|90|4|TREATMENT|2020-10-11|2020-10-12|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|a125efdf-aec8-47a1-b492-cdaf8b619a78|1|ANABASN|Anabasine|URINALYSIS|[?]|mm3/mm2/year|[?]|[?]|POSITIVE|1|mg/kg/day|1|1|[?]|LOW|SUPERNATANT, SERUM|CONTAMINATED||DYNAMIC CONTRAST ENHANCED MRI|MDRD ENZYMATIC FORMULA|||Y||1|Visit_1|10|1|WASHOUT|2020-09-30|2020-11-13|10|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|a125efdf-aec8-47a1-b492-cdaf8b619a78|2|C130095|Western Ragweed Pollen IgG4|HEMATOLOGY|[?]|ukat/L|[?]|[?]|TRACE|1|BOX|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|CONCENTRATED|N|CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|1|WASHOUT|2020-09-30|2020-11-05|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|a125efdf-aec8-47a1-b492-cdaf8b619a78|3|GLOBB2PT|Beta-2 Globulin/Total Protein|URINALYSIS|[?]|rpm|[?]|[?]|TRACE|1|10^8/L|1|1|[?]|NORMAL|SMEGMA|GELLED||POLYSOMNOGRAPHY|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-10-15|2020-12-17|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|a125efdf-aec8-47a1-b492-cdaf8b619a78|4|VITB1|Thiamine|HEMATOLOGY|[?]|pg/dL|[?]|[?]|NEGATIVE|1|ug/animal|1|1|[?]|ABNORMAL|ERYTHROCYTES|UNEXPECTED ODOR||APPLANATION TONOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|N||2|Visit_2|25|4|TREATMENT|2020-10-15|2020-11-16|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|a125efdf-aec8-47a1-b492-cdaf8b619a78|5|CD33|CD33|CHEMISTRY|[?]|cpm|[?]|[?]|TRACE|1|10^6 organisms/g|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|NON-HEMOLYZED||CALCOFLUOR WHITE STAIN|MDRD 6 VARIABLE FORMULA||Y|U||3|Visit_3|40|7|TREATMENT|2020-10-30|2020-12-02|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|a125efdf-aec8-47a1-b492-cdaf8b619a78|6|IGFBP3|Insulin-Like Growth Factor Binding Prot3|CHEMISTRY|[?]|L/s/kPa|[?]|[?]|TRACE|1|log10 CCID 50/dose|1|1|[?]|ABNORMAL|SERUM|AUTOLYZED||CONTRAST ENHANCED PET/CT SCAN|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|5|FOLLOW-UP|2020-10-30|2020-10-31|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|a125efdf-aec8-47a1-b492-cdaf8b619a78|7|DTPACLR|DTPA Clearance|CHEMISTRY|[?]|U/kg|[?]|[?]|INDETERMINATE|1|cP|1|1|[?]|ABNORMAL|TRANSUDATE|CONTAMINATED||IMMUNORADIOMETRIC ASSAY|FIBROMETER FORMULA|Y||U||4|Visit_4|65|4|FOLLOW-UP|2020-11-24|2020-12-06|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|a125efdf-aec8-47a1-b492-cdaf8b619a78|8|RBCDYSM|Dysmorphic Erythrocytes|CHEMISTRY|[?]|NEEDLE GAUGE|[?]|[?]|NEGATIVE|1|mg/g/min|1|1|[?]|NORMAL|CELL PELLET|LACTESCENT||JAEGER EYE CHART|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-11-24|2020-12-13|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|a125efdf-aec8-47a1-b492-cdaf8b619a78|9|MONOPTPT|Monoclonal Protein/Total Protein|CHEMISTRY|[?]|mg/m2/day|[?]|[?]|POSITIVE|1|s/h|1|1|[?]|ABNORMAL|REFLEX TEAR|LIPEMIC||ROMANOWSKY STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|4|SCREENING|2020-12-19|2020-12-22|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|a125efdf-aec8-47a1-b492-cdaf8b619a78|10|ALAALB|Apolipoprotein A/Apolipoprotein B|URINALYSIS|[?]|Arbitrary U|[?]|[?]|TRACE|1|tuberculin unit|1|1|[?]|LOW|WHITE MATTER TISSUE|AUTOLYZED||CELLULOSE TAPE|ASH FIBROSURE FORMULA|Y||Y||5|Visit_5|90|3|TREATMENT|2020-12-19|2020-12-26|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|9171362e-0166-46f2-ab2d-2748d8c291d5|1|EOSMM|Eosinophilic Metamyelocytes|CHEMISTRY|[?]|m/sec2|[?]|[?]|NEGATIVE|1|Gy/min|1|1|[?]|ABNORMAL|PERITONEAL FLUID|DRIED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|HEPASCORE FORMULA|||U||1|Visit_1|10|3|WASHOUT|2021-01-12|2021-03-13|10|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|9171362e-0166-46f2-ab2d-2748d8c291d5|2|RUB|Rubricyte|URINALYSIS|[?]|Joule|[?]|[?]|NEGATIVE|1|EVENTS|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|UNEXPECTED ODOR||DYNAMIC CONTRAST ENHANCED MRI|GMI MMOL/MOL FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2021-01-12|2021-02-26|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|9171362e-0166-46f2-ab2d-2748d8c291d5|3|MEPRDN|Meperidine|URINALYSIS|[?]|SYRINGE|[?]|[?]|BORDERLINE|1|U/kg/h|1|1|[?]|LOW|MUSCLE TISSUE|GELLED|N|FUNCTIONAL MRI|GMI % FORMULA|Y||U||2|Visit_2|25|3|SCREENING|2021-01-27|2021-02-15|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-10
e|LB|9171362e-0166-46f2-ab2d-2748d8c291d5|4|SPWEIGHT|Specimen Weight|CHEMISTRY|||[?]|[?]|TRACE|1|mOsm|1|1|[?]|HIGH|CAPILLARY BLOOD|LIPEMIC||HPLC|CKD-EPI CREATININE FORMULA|Y||NA|Y|2|Visit_2|25|1|SCREENING|2021-01-27|2021-03-20|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-10
e|LB|9171362e-0166-46f2-ab2d-2748d8c291d5|5|NEUTSGNE|Neutrophils, Segmented/Neutrophils|CHEMISTRY|[?]|mol/g|[?]|[?]|POSITIVE|1|PFU|1|1|[?]|HIGH|PUS|ROOM TEMPERATURE|N|AGAR DILUTION|CKD-EPI FORMULA|Y||U||3|Visit_3|40|4|TREATMENT|2021-02-11|2021-03-21|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|9171362e-0166-46f2-ab2d-2748d8c291d5|6|NEUTBLE|Neutrophils Band Form/Leukocytes|URINALYSIS|||[?]|[?]|INVALID|1|nm|1|1|[?]|HIGH|EPITHELIAL CELL|REFRIGERATED||NUCLEIC ACID SEQUENCING|FIBROSIS 4 FORMULA||Y|N|Y|3|Visit_3|40|5|WASHOUT|2021-02-11|2021-02-22|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|9171362e-0166-46f2-ab2d-2748d8c291d5|7|SERTRAL|Sertraline|CHEMISTRY|[?]|h/wk|[?]|[?]|NEGATIVE|1|mL/kg|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|GELLED|N|ENZYMATIC COLORIMETRY|FIBROMETER FORMULA|||N||4|Visit_4|65|1|FOLLOW-UP|2021-03-08|2021-04-11|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|9171362e-0166-46f2-ab2d-2748d8c291d5|8|CD11A|CD11A|CHEMISTRY|||[?]|[?]|NEGATIVE|1|/100 WBC|1|1|[?]|LOW|GASTRIC CONTENTS|ICTERIC|N|MIGET|GMI % FORMULA|||Y|Y|4|Visit_4|65|5|TREATMENT|2021-03-08|2021-04-11|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|9171362e-0166-46f2-ab2d-2748d8c291d5|9|FLUIDOUT|Fluid Output|URINALYSIS|||[?]|[?]|INVALID|1|mg|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|FRESH||IMMUNODIFFUSION|MDRD ENZYMATIC FORMULA|Y||Y|Y|5|Visit_5|90|6|TREATMENT|2021-04-02|2021-04-05|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|9171362e-0166-46f2-ab2d-2748d8c291d5|10|CANNABM|Cannabinoid Metabolites|CHEMISTRY|||[?]|[?]|INVALID|1|10^6 organisms/g|1|1|[?]|ABNORMAL|ERYTHROCYTES|GELLED||CYSTOMETRY|FIBROSIS 4 FORMULA|||U|Y|5|Visit_5|90|4|TREATMENT|2021-04-02|2021-04-07|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|9b150e38-dc85-4a28-aad3-43f7620be460|1|FBNCTCE|Fibronectin, Cellular|URINALYSIS|||[?]|[?]|TRACE|1|CIGAR|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|UNEXPECTED ODOR|N|TELLER ACUITY CARDS|GMI MMOL/MOL FORMULA|||Y|Y|1|Visit_1|10|1|TREATMENT|2020-07-22|2020-10-15|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|9b150e38-dc85-4a28-aad3-43f7620be460|2|CD19LY|CD19/Lymphocytes|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mgEq|1|1|[?]|HIGH|EMOTIONAL TEAR|ICTERIC||POTENTIOMETRY|CKD-EPI FORMULA|||NA|Y|1|Visit_1|10|2|TREATMENT|2020-07-22|2020-08-15|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|9b150e38-dc85-4a28-aad3-43f7620be460|3|CAION|Calcium, Ionized|HEMATOLOGY|[?]|10^6 CFU/g|[?]|[?]|INDETERMINATE|1|mL/breath|1|1|[?]|NORMAL|ERYTHROCYTES|ICTERIC||LISSAMINE GREEN STAIN|CKD-EPI FORMULA||Y|N||2|Visit_2|25|6|FOLLOW-UP|2020-08-06|2020-09-12|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|9b150e38-dc85-4a28-aad3-43f7620be460|4|MASTCECE|Mast Cells/Total Cells|HEMATOLOGY|||[?]|[?]|POSITIVE|1|DIOPTER|1|1|[?]|ABNORMAL|SEBUM|CONTAMINATED||HEMATOXYLIN AND EOSIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|2|Visit_2|25|3|FOLLOW-UP|2020-08-06|2020-09-09|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|9b150e38-dc85-4a28-aad3-43f7620be460|5|GLOBA|Alpha Globulin|CHEMISTRY|[?]|log10 PFU/mL|[?]|[?]|POSITIVE|1|m|1|1|[?]|HIGH|SPERMATOZOON|LIPEMIC||WHOLE TRANSCRIPTOME SEQUENCING|COCKCROFT-GAULT FORMULA|||N||3|Visit_3|40|3|SCREENING|2020-08-21|2020-08-25|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|9b150e38-dc85-4a28-aad3-43f7620be460|6|CYAMPURT|Amorphous Urate Crystals|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Roentgen|1|1|[?]|NORMAL|EMESIS|AGGLUTINATED||DNA MICROARRAY|CKD-EPI CREATININE FORMULA|||N|Y|3|Visit_3|40|1|TREATMENT|2020-08-21|2020-09-30|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|9b150e38-dc85-4a28-aad3-43f7620be460|7|THYAB|Thyroid Antibodies|URINALYSIS|[?]|U/m2/min|[?]|[?]|INDETERMINATE|1|cGy|1|1|[?]|LOW|SALIVA|DRIED|N|AURAMINE STAIN|MDRD 5 VARIABLE FORMULA||Y|Y||4|Visit_4|65|4|FOLLOW-UP|2020-09-15|2020-10-12|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|9b150e38-dc85-4a28-aad3-43f7620be460|8|CYSCREAT|Cystatin C/Creatinine|HEMATOLOGY|[?]|mmol/min/kPa|[?]|[?]|INVALID|1|/mm|1|1|[?]|HIGH|PERITONEAL FLUID|FRESH||PHOTOMETRIC CLOT DETECTION|MDRD 6 VARIABLE FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-09-15|2020-09-27|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|9b150e38-dc85-4a28-aad3-43f7620be460|9|PLP|Pyridoxal Phosphate|HEMATOLOGY|[?]|mol/g|[?]|[?]|POSITIVE|1|uSiemens|1|1|[?]|LOW|AQUEOUS HUMOR|THAWED||SPECT/CT SCAN|GMI MMOL/MOL FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2020-10-10|2020-10-17|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|9b150e38-dc85-4a28-aad3-43f7620be460|10|LKM1IAAB|Liver Kidney Microsomal Type 1 IgA Ab|CHEMISTRY|[?]|nL|[?]|[?]|INVALID|1|fmol/L/sec|1|1|[?]|LOW|ARTERIAL CORD BLOOD|AGGLUTINATED||LANDOLT RING|FIBROSIS 4 FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2020-10-10|2020-10-16|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|2a595fc0-7621-4ec9-bd77-74444886052e|1|PHTRMN|Phentermine|URINALYSIS|[?]|mEq/kg|[?]|[?]|NEGATIVE|1|min*mg/mL|1|1|[?]|NORMAL|SEMINAL FLUID|NON-HEMOLYZED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|||Y||1|Visit_1|10|2|SCREENING|2020-10-25|2020-10-27|10|12|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|2a595fc0-7621-4ec9-bd77-74444886052e|2|VITA|Vitamin A|CHEMISTRY|[?]|mg/kg/h|[?]|[?]|INDETERMINATE|1|tuberculin unit/mL|1|1|[?]|LOW|EPITHELIAL CELL|LIPEMIC|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROTEST FORMULA|||N||1|Visit_1|10|1|WASHOUT|2020-10-25|2021-01-14|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|2a595fc0-7621-4ec9-bd77-74444886052e|3|OSM|Oncostatin M|URINALYSIS|[?]|mg/mL/day|[?]|[?]|NEGATIVE|1|TUBE|1|1|[?]|NORMAL|SEBUM|PARAFFIN-EMBEDDED||IMMUNOTURBIDIMETRY|GMI % FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-11-09|2020-11-25|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|2a595fc0-7621-4ec9-bd77-74444886052e|4|GLUCCRT|Glucose/Creatinine|URINALYSIS|[?]|DAgU/mL|[?]|[?]|BORDERLINE|1|Siemens|1|1|[?]|NORMAL|AMNIOTIC FLUID|UNEXPECTED ODOR|N|FLUORESCENCE ANGIOGRAPHY|FIBROTEST FORMULA||Y|N||2|Visit_2|25|5|FOLLOW-UP|2020-11-09|2020-11-14|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|2a595fc0-7621-4ec9-bd77-74444886052e|5|S6PHS|Phos-S6 Ribosomal Protein|URINALYSIS|||[?]|[?]|TRACE|1|QUANTITY SUFFICIENT|1|1|[?]|ABNORMAL|BONE|GELLED||PUPILLOMETRY|FIBROMETER FORMULA|||NA|Y|3|Visit_3|40|1|WASHOUT|2020-11-24|2020-12-23|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|2a595fc0-7621-4ec9-bd77-74444886052e|6|ARGSAC|Argininosuccinic Acid|URINALYSIS|[?]|U/g Hb|[?]|[?]|TRACE|1|BAU/mL|1|1|[?]|LOW|COLOSTRUM|CALCIFIED||GC/MS-EI|MDRD 5 VARIABLE FORMULA||Y|U||3|Visit_3|40|1|SCREENING|2020-11-24|2020-12-21|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|2a595fc0-7621-4ec9-bd77-74444886052e|7|NFLP|Neurofilament Light Chain Protein|HEMATOLOGY|[?]|mol/g|[?]|[?]|TRACE|1|CARTRIDGE|1|1|[?]|ABNORMAL|MUCUS|ICTERIC||PULMONARY ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA|Y||NA||4|Visit_4|65|3|TREATMENT|2020-12-19|2021-01-07|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|2a595fc0-7621-4ec9-bd77-74444886052e|8|EOTAXIN1|Eotaxin-1|CHEMISTRY|[?]|mol/mol|[?]|[?]|NEGATIVE|1|HOURS|1|1|[?]|LOW|MUCUS|FROZEN||IMMUNOPRECIPITATION|CKD-EPI CREATININE FORMULA|||NA||4|Visit_4|65|1|TREATMENT|2020-12-19|2021-01-19|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|2a595fc0-7621-4ec9-bd77-74444886052e|9|O2CT|Oxygen Content|CHEMISTRY|[?]|min/day|[?]|[?]|NEGATIVE|1|aMFI|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|SOLIDIFIED|N|MAGNETIC RESONANCE ANGIOGRAPHY|FIBROTEST FORMULA||Y|U||5|Visit_5|90|4|TREATMENT|2021-01-13|2021-01-19|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|2a595fc0-7621-4ec9-bd77-74444886052e|10|C3M|Collagen III Neo-Peptide C3M|HEMATOLOGY|[?]|mg/h|[?]|[?]|INDETERMINATE|1|copies/uL|1|1|[?]|LOW|ENDOMETRIAL TISSUE|SOLIDIFIED||SNELLEN EYE CHART|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|2|TREATMENT|2021-01-13|2021-01-19|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|0bab89c8-cf57-4d19-9b95-884a2e9da523|1|VTD2D3IT|25-Hydroxyvit D2 + 25-Hydroxyvit D3|HEMATOLOGY|[?]|g/animal/wk|[?]|[?]|INDETERMINATE|1|uV|1|1|[?]|HIGH|HAIR|HEMOLYZED||TEST STRIP|GMI % FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-12-20|2020-12-26|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|0bab89c8-cf57-4d19-9b95-884a2e9da523|2|GFRBSB2M|GFR from B-2 Microglobulin Adj for BSA|URINALYSIS|[?]|s^-1(%O2)^-1|[?]|[?]|INDETERMINATE|1|log10 TCID 50/uL|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|PARAFFIN-EMBEDDED||WHOLE GENOME SEQUENCING|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|2|FOLLOW-UP|2020-12-20|2021-01-04|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|0bab89c8-cf57-4d19-9b95-884a2e9da523|3|CIT|Citrulline|HEMATOLOGY|[?]|PUFF|[?]|[?]|POSITIVE|1|vg/dose|1|1|[?]|LOW|KERATINOCYTE|DRIED||PERIPHERAL ANGIOGRAPHY|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|6|TREATMENT|2021-01-04|2021-01-30|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|0bab89c8-cf57-4d19-9b95-884a2e9da523|4|TPRONP|Non-Phosphorylated Tau Protein|CHEMISTRY|[?]|VOXEL|[?]|[?]|BORDERLINE|1|MET|1|1|[?]|HIGH|DISCHARGE|CONTAMINATED||IMMUNOFIXATION ELECTROPHORESIS|MDRD FORMULA|||N||2|Visit_2|25|2|TREATMENT|2021-01-04|2021-02-06|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|0bab89c8-cf57-4d19-9b95-884a2e9da523|5|CGMP|Cyclic Guanosine Monophosphate|HEMATOLOGY|[?]|oz|[?]|[?]|BORDERLINE|1|BU|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|GELLED|N|SPIRAL CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2021-01-19|2021-02-04|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|0bab89c8-cf57-4d19-9b95-884a2e9da523|6|CPEPCRT|C-peptide/Creatinine|CHEMISTRY|||[?]|[?]|TRACE|1|10^6 RNA copies/mL|1|1|[?]|NORMAL|LYSATE|HEMOLYZED||TRICHROME STAIN|GMI MMOL/MOL FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2021-01-19|2021-02-25|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|0bab89c8-cf57-4d19-9b95-884a2e9da523|7|IA2AB|Insulinoma-Associated Protein 2 Antibody|HEMATOLOGY|[?]|pg/L|[?]|[?]|BORDERLINE|1|mm/h|1|1|[?]|NORMAL|LEUKOCYTE|THAWED||SURFACE PLASMON RESONANCE|MDRD FORMULA|Y||U||4|Visit_4|65|5|WASHOUT|2021-02-13|2021-02-20|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|0bab89c8-cf57-4d19-9b95-884a2e9da523|8|METAMYCE|Metamyelocytes/Total Cells|CHEMISTRY|[?]|anti-Xa IU|[?]|[?]|BORDERLINE|1|mU|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|DRIED||URANYL ACETATE STAIN|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|6|TREATMENT|2021-02-13|2021-02-28|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|0bab89c8-cf57-4d19-9b95-884a2e9da523|9|ANGTNS1|Angiotensin I|URINALYSIS|||[?]|[?]|INDETERMINATE|1|ft2|1|1|[?]|ABNORMAL|URINE|LIPEMIC||FLUORESCENT IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|Y||U|Y|5|Visit_5|90|5|TREATMENT|2021-03-10|2021-03-17|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|0bab89c8-cf57-4d19-9b95-884a2e9da523|10|DDIMER|D-Dimer|URINALYSIS|||[?]|[?]|BORDERLINE|1|pg|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|ICTERIC|N|OSCILLOMETRY|ASH FIBROSURE FORMULA|||N|Y|5|Visit_5|90|5|TREATMENT|2021-03-10|2021-03-19|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|84edaa9d-ce48-4866-ab43-af91bee126ae|1|MPM|Mean Platelet Dry Mass|HEMATOLOGY|[?]|10^9/dose|[?]|[?]|TRACE|1|LOZENGE|1|1|[?]|NORMAL|ERYTHROCYTES|PARAFFIN-EMBEDDED||STATIC PERIMETRY|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-05-11|2020-07-22|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|84edaa9d-ce48-4866-ab43-af91bee126ae|2|GSTCREAT|Glutathione-S-Transferase/Creatinine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|10^6 organisms/g|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|DRIED|N|MRS|HEPASCORE FORMULA|Y||N|Y|1|Visit_1|10|6|TREATMENT|2020-05-11|2020-06-20|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|84edaa9d-ce48-4866-ab43-af91bee126ae|3|RENINA|Renin Activity|CHEMISTRY|[?]|Roentgen|[?]|[?]|POSITIVE|1|uU/L|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|ROOM TEMPERATURE||CONTRAST ENHANCED CT SCAN|FIBROMETER FORMULA|||NA||2|Visit_2|25|4|SCREENING|2020-05-26|2020-06-29|25|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|84edaa9d-ce48-4866-ab43-af91bee126ae|4|MSPIKER|Monoclonal Protein Spike Region|URINALYSIS|[?]|DIP|[?]|[?]|POSITIVE|1|pmol/L/h|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|CALCIFIED||LIQUID SCINTILLATION COUNTING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||2|Visit_2|25|6|WASHOUT|2020-05-26|2020-07-05|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|84edaa9d-ce48-4866-ab43-af91bee126ae|5|TOXVAC|Toxic Vacuolation|CHEMISTRY|[?]|APS U|[?]|[?]|NEGATIVE|1|mL/kg/day|1|1|[?]|HIGH|CAPILLARY PLASMA|FROZEN||SLOAN LETTER EYE CHART 100%|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-06-10|2020-07-12|40|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|84edaa9d-ce48-4866-ab43-af91bee126ae|6|BASEEXCS|Base Excess|HEMATOLOGY|[?]|ELISA unit/mL|[?]|[?]|POSITIVE|1|mmol/day|1|1|[?]|HIGH|PROSTATIC FLUID|FRESH||PULMONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|5|FOLLOW-UP|2020-06-10|2020-06-26|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|84edaa9d-ce48-4866-ab43-af91bee126ae|7|BLSTRSID|Ringed Sideroblasts|CHEMISTRY|||[?]|[?]|NEGATIVE|1|cy/cm|1|1|[?]|HIGH|VENOUS CORD BLOOD|PARAFFIN-EMBEDDED||TOTAL BODY RADIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|4|Visit_4|65|5|TREATMENT|2020-07-05|2020-07-26|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|LB|84edaa9d-ce48-4866-ab43-af91bee126ae|8|HBA1B|Hemoglobin A1B|HEMATOLOGY|[?]|AU/mL|[?]|[?]|INVALID|1|mCi/L|1|1|[?]|HIGH|ARTERIAL BLOOD|AUTOLYZED||RYAN BLUE STAIN|MDRD 4 VARIABLE FORMULA|||N||4|Visit_4|65|1|TREATMENT|2020-07-05|2020-07-23|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|LB|84edaa9d-ce48-4866-ab43-af91bee126ae|9|C165916|D. farinae IgG AB RAST Score|CHEMISTRY|[?]|mL/kg|[?]|[?]|TRACE|1|/7.5 mL|1|1|[?]|ABNORMAL|SMEGMA|PARAFFIN-EMBEDDED|N|ELASTOGRAPHY|FIBROTEST FORMULA||Y|Y||5|Visit_5|90|5|TREATMENT|2020-07-30|2020-08-08|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-11
e|LB|84edaa9d-ce48-4866-ab43-af91bee126ae|10|UNSPCECE|Unspecified Cells/Total Cells|CHEMISTRY|||[?]|[?]|INVALID|1|days/month|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED||IMMUNE REPERTOIRE DEEP SEQUENCING|CKD-EPI CREATININE FORMULA|||N|Y|5|Visit_5|90|7|TREATMENT|2020-07-30|2020-08-05|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-11
e|LB|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|1|OPIATE|Opiate|CHEMISTRY|||[?]|[?]|INVALID|1|Rad|1|1|[?]|LOW|ARTERIAL BLOOD|UNEXPECTED ODOR||FLOCCULATION, CHARCOAL ENHANCED|CKD-EPI CREATININE FORMULA|Y|Y|N|Y|1|Visit_1|10|6|FOLLOW-UP|2020-08-03|2020-10-13|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|2|LDH|Lactate Dehydrogenase|URINALYSIS|[?]|ka_u/dL|[?]|[?]|TRACE|1|mg/dL|1|1|[?]|LOW|SKIN TISSUE|CLOTTED||QUANTITATIVE COMPUTED TOMOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|U||1|Visit_1|10|7|TREATMENT|2020-08-03|2020-10-23|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|3|PYOCYTES|Pyocytes|CHEMISTRY|[?]|Coulomb|[?]|[?]|BORDERLINE|1|dB|1|1|[?]|LOW|URINE SEDIMENT|ICTERIC|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|HEPASCORE FORMULA|Y|Y|NA||2|Visit_2|25|5|FOLLOW-UP|2020-08-18|2020-09-10|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|4|MPV|Mean Platelet Volume|HEMATOLOGY|[?]|cmHg|[?]|[?]|BORDERLINE|1|L/s|1|1|[?]|ABNORMAL|LUNG SURFACTANT|CALCIFIED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|5|TREATMENT|2020-08-18|2020-09-18|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|5|LDH5|LDH Isoenzyme 5|HEMATOLOGY|[?]|breaths/min|[?]|[?]|NEGATIVE|1|g/m2|1|1|[?]|LOW|MECONIUM|UNEXPECTED ODOR||ACCELERATOR MASS SPECTROMETRY|FIBROSIS 4 FORMULA|Y||Y||3|Visit_3|40|3|WASHOUT|2020-09-02|2020-09-20|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|6|KETONEBD|Ketone Bodies|CHEMISTRY|[?]|10^3 CFU/mL|[?]|[?]|INVALID|1|mMU/mL|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|ROOM TEMPERATURE||HEMOCYTOMETRY|MDRD ENZYMATIC FORMULA|||Y||3|Visit_3|40|7|SCREENING|2020-09-02|2020-09-15|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|7|ALBGLOB|Albumin/Globulin|URINALYSIS|[?]|g/g/day|[?]|[?]|BORDERLINE|1|U/g/day|1|1|[?]|LOW|BUFFY COAT|CONCENTRATED||SLOAN LETTER EYE CHART 1.25%|CKD-EPI CREATININE FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-09-27|2020-10-01|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|8|DNPSEPHD|D-Norpseudoephedrine|URINALYSIS|[?]|DDU|[?]|[?]|POSITIVE|1|SBE/mL|1|1|[?]|ABNORMAL|MECONIUM|LIPEMIC|N|SPECTROPHOTOMETRY|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-09-27|2020-10-04|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|9|THRMPTN|Thrombopoietin|URINALYSIS|[?]|cmol/L|[?]|[?]|TRACE|1|PFU/mL|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|DRIED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|ASH FIBROSURE FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-10-22|2020-10-30|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|LB|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|10|IA2AB|Insulinoma-Associated Protein 2 Antibody|URINALYSIS|[?]|mOsm/L|[?]|[?]|POSITIVE|1|ng/day|1|1|[?]|LOW|COLOSTRUM|HEMOLYZED||CRYOSCOPY|GMI MMOL/MOL FORMULA|||Y||5|Visit_5|90|4|TREATMENT|2020-10-22|2020-10-31|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|LB|9734ec2a-d06b-43e1-82a5-37764af17890|1|INTLK24|Interleukin 24|CHEMISTRY|[?]|mV|[?]|[?]|NEGATIVE|1|mL/min/1.73m2|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|LACTESCENT||ELISPOT|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|1|WASHOUT|2020-09-29|2020-12-01|10|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|9734ec2a-d06b-43e1-82a5-37764af17890|2|SFTPD|Surfactant Protein D|CHEMISTRY|[?]|mL/m2/h|[?]|[?]|BORDERLINE|1|U/mmol|1|1|[?]|HIGH|EPIDERMAL TISSUE|CLOTTED||CLAUSS METHOD|FIBROTEST FORMULA||Y|U||1|Visit_1|10|1|TREATMENT|2020-09-29|2020-12-19|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|LB|9734ec2a-d06b-43e1-82a5-37764af17890|3|ETPPH|ETP Peak Height|URINALYSIS|[?]|mEq/uL|[?]|[?]|NEGATIVE|1|mg/m2/day|1|1|[?]|ABNORMAL|CALCULUS|REFRIGERATED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U||2|Visit_2|25|7|FOLLOW-UP|2020-10-14|2020-12-10|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|9734ec2a-d06b-43e1-82a5-37764af17890|4|CITRTEXR|Citrate Excretion Rate|URINALYSIS|[?]|dpm/mL|[?]|[?]|NEGATIVE|1|CCID 50/mL|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|ICTERIC||X-RAY FLUORESCENCE SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|3|SCREENING|2020-10-14|2020-11-13|25|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|9734ec2a-d06b-43e1-82a5-37764af17890|5|HBA2PHB|Hemoglobin A2 Prime/Total Hemoglobin|CHEMISTRY|[?]|U/m2|[?]|[?]|NEGATIVE|1|PRESSOR UNITS|1|1|[?]|ABNORMAL|RETICULOCYTES|HEMOLYZED|N|TEMPLATE INCISION METHOD|CKD-EPI FORMULA|||NA||3|Visit_3|40|3|WASHOUT|2020-10-29|2020-12-25|40|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|LB|9734ec2a-d06b-43e1-82a5-37764af17890|6|OXACREAT|Oxalate/Creatinine|CHEMISTRY|||[?]|[?]|POSITIVE|1|mL/g/day|1|1|[?]|LOW|PLATELET RICH PLASMA|FROZEN||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||Y|Y|Y|3|Visit_3|40|3|SCREENING|2020-10-29|2020-12-08|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|LB|9734ec2a-d06b-43e1-82a5-37764af17890|7|NORNCTN|Nornicotine|HEMATOLOGY|[?]|ug/kg/day|[?]|[?]|INVALID|1|mL/100g/min|1|1|[?]|LOW|ARTERIAL CORD BLOOD|THAWED||NUCLEIC ACID HYBRIDIZATION|MDRD ENZYMATIC JAPANESE FORMULA|||N||4|Visit_4|65|7|FOLLOW-UP|2020-11-23|2020-12-21|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|LB|9734ec2a-d06b-43e1-82a5-37764af17890|8|CYHIPPAC|Hippuric Acid Crystals|CHEMISTRY|[?]|mg/mL/min|[?]|[?]|POSITIVE|1|mPa|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|FROZEN||LC/MS|MDRD ENZYMATIC FORMULA||Y|Y||4|Visit_4|65|1|WASHOUT|2020-11-23|2020-12-13|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|LB|9734ec2a-d06b-43e1-82a5-37764af17890|9|PHENYTN|Phenytoin|URINALYSIS|[?]|v/v|[?]|[?]|NEGATIVE|1|BLOCKS|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|CONCENTRATED||ENZYMATIC COLORIMETRY|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-12-18|2020-12-21|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|9734ec2a-d06b-43e1-82a5-37764af17890|10|BPIAB|Bactericidal/Permeability-Inc Protein Ab|CHEMISTRY|[?]|Gravitational Unit|[?]|[?]|POSITIVE|1|mL/m2/h|1|1|[?]|LOW|CAPILLARY PLASMA|AUTOLYZED||FLOW CYTOMETRY|ASH FIBROSURE FORMULA|||U||5|Visit_5|90|1|TREATMENT|2020-12-18|2020-12-24|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|9a0ce525-7f10-4651-885a-f64bd9c8925e|1|NEUTAGR|Agranular Neutrophils|HEMATOLOGY|[?]|mg/m2|[?]|[?]|INDETERMINATE|1|nmol/g|1|1|[?]|LOW|CAPILLARY PLASMA|FRESH||PUPILLOMETRY|COCKCROFT-GAULT FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-11-28|2021-01-21|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|9a0ce525-7f10-4651-885a-f64bd9c8925e|2|VLDL|VLDL Cholesterol|HEMATOLOGY|[?]|fraction of 1|[?]|[?]|TRACE|1|10^6 organisms/mL|1|1|[?]|NORMAL|PUS|REFRIGERATED||INDIRECT IMMUNOFLUORESCENCE|HEPASCORE FORMULA|Y|Y|Y||1|Visit_1|10|5|TREATMENT|2020-11-28|2021-01-10|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|9a0ce525-7f10-4651-885a-f64bd9c8925e|3|SO2|Sulfur Dioxide|HEMATOLOGY|[?]|kg/cm2|[?]|[?]|INVALID|1|CYLINDER|1|1|[?]|HIGH|DERMAL TISSUE|AUTOLYZED||MICROBIAL CULTURE|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA||2|Visit_2|25|1|TREATMENT|2020-12-13|2021-01-08|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|LB|9a0ce525-7f10-4651-885a-f64bd9c8925e|4|MONOMA|Monocytes/Macrocytes|URINALYSIS|[?]|mL/m2/day|[?]|[?]|NEGATIVE|1|10^3 RNA copies/mL|1|1|[?]|LOW|SYNOVIAL FLUID|CALCIFIED||DOUBLE IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-12-13|2021-01-12|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|LB|9a0ce525-7f10-4651-885a-f64bd9c8925e|5|TTGIGAAB|Tissue Transglutaminase IgA Antibody|HEMATOLOGY|[?]|Ci/mL|[?]|[?]|INDETERMINATE|1|10^6 IU|1|1|[?]|HIGH|PLEURAL TISSUE|AGGLUTINATED||COMPLEMENT FIXATION|FIBROMETER FORMULA|||N||3|Visit_3|40|4|TREATMENT|2020-12-28|2021-02-20|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|9a0ce525-7f10-4651-885a-f64bd9c8925e|6|PARICEAB|Parietal Cell Antibody|CHEMISTRY|[?]|dyn|[?]|[?]|NEGATIVE|1|um2|1|1|[?]|ABNORMAL|BILE|REFRIGERATED|N|VIRUS PLAQUE ASSAY|HEPASCORE FORMULA|Y||U||3|Visit_3|40|6|SCREENING|2020-12-28|2021-02-01|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|LB|9a0ce525-7f10-4651-885a-f64bd9c8925e|7|GLDAB|Gliadin Antibody|URINALYSIS|[?]|dpm/100mg|[?]|[?]|BORDERLINE|1|/mm|1|1|[?]|LOW|URINE|FRESH||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||4|Visit_4|65|4|TREATMENT|2021-01-22|2021-02-10|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|9a0ce525-7f10-4651-885a-f64bd9c8925e|8|CKMMCK|Creatine Kinase MM/Total Creatine Kinase|CHEMISTRY|[?]|mOsm/L|[?]|[?]|TRACE|1|U/kg/min|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED||SMEAR|FIBROMETER FORMULA|Y|Y|N||4|Visit_4|65|5|TREATMENT|2021-01-22|2021-02-09|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|9a0ce525-7f10-4651-885a-f64bd9c8925e|9|C165882|White Elm Pollen IgE AB RAST Score|URINALYSIS|[?]|min/day|[?]|[?]|INDETERMINATE|1|mL/breath|1|1|[?]|LOW|EXUDATE|THAWED||SPECULAR MICROSCOPY|CKD-EPI CREATININE FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2021-02-16|2021-02-22|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|9a0ce525-7f10-4651-885a-f64bd9c8925e|10|LDH4|LDH Isoenzyme 4|URINALYSIS|[?]|vp/mL|[?]|[?]|INDETERMINATE|1|fmol|1|1|[?]|NORMAL|KERATINOCYTE|CALCIFIED||SINGLE-SLICE SPIRAL CT|GMI % FORMULA|Y||N||5|Visit_5|90|2|TREATMENT|2021-02-16|2021-02-20|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|1|INTLK3|Interleukin 3|HEMATOLOGY|[?]|/2000 RBC|[?]|[?]|NEGATIVE|1|mL/g/day|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|UNEXPECTED ODOR||PET/CT SCAN|MDRD ENZYMATIC FORMULA||Y|U||1|Visit_1|10|2|TREATMENT|2020-07-15|2020-10-03|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|2|APOB48|Apolipoprotein B48|HEMATOLOGY|[?]|GPL U|[?]|[?]|BORDERLINE|1|KIT|1|1|[?]|HIGH|ADIPOSE TISSUE|ICTERIC||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA|||Y||1|Visit_1|10|3|FOLLOW-UP|2020-07-15|2020-08-31|10|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|3|HIST2BAB|Histone 2B Antibody|CHEMISTRY|[?]|C|[?]|[?]|NEGATIVE|1|uU/dL|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|AUTOLYZED||MRI|CKD-EPI CYSTATIN C FORMULA|Y|Y|NA||2|Visit_2|25|5|TREATMENT|2020-07-30|2020-09-25|25|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|4|VLDLT|VLDL Triglyceride|URINALYSIS|[?]|uEq/L|[?]|[?]|BORDERLINE|1|mg|1|1|[?]|LOW|EPIDERMAL TISSUE|SOLIDIFIED|N|SNELLEN EYE CHART|FIBROMETER FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-07-30|2020-08-23|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|5|CCR5|C-C Chemokine Receptor Type 5|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mg/kg/week|1|1|[?]|HIGH|BLOOD|LIPEMIC||SPIRAL CT SCAN WITHOUT CONTRAST|NASH FIBROSURE FORMULA|Y|Y|NA|Y|3|Visit_3|40|2|TREATMENT|2020-08-14|2020-10-10|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|6|FBNCTFT|Fibronectin, Fetal|URINALYSIS|[?]|10^9 organisms/g|[?]|[?]|POSITIVE|1|mol/g|1|1|[?]|LOW|URINE|CONTAMINATED||FLUOROSCOPY|FIBROMETER FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-08-14|2020-09-23|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|7|LYMNSQE|Lymphocytes/Non-Squam Epi Cells|URINALYSIS|[?]|10^4 CFU/mL|[?]|[?]|BORDERLINE|1|pmol/g|1|1|[?]|NORMAL|PUS|UNEXPECTED ODOR||JAEGER EYE CHART|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|7|WASHOUT|2020-09-08|2020-10-11|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|8|PTSAC|Protein S Actual/Control|CHEMISTRY|||[?]|[?]|TRACE|1|10^3 CFU/g|1|1|[?]|NORMAL|INTERSTITIAL FLUID|CONCENTRATED||CLIP SEQUENCING|NASH FIBROSURE FORMULA||Y|Y|Y|4|Visit_4|65|6|WASHOUT|2020-09-08|2020-10-07|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|9|PF2AI8CR|8-Iso-PGF2alpha/Creatinine|CHEMISTRY|[?]|DPM|[?]|[?]|INVALID|1|%|1|1|[?]|LOW|PLATELET RICH PLASMA|CLOTTED||HANSEL STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||5|Visit_5|90|1|TREATMENT|2020-10-03|2020-10-12|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|10|KLHIGGAB|Keyhole Limpet Hemocyanin IgG Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|copies/ug|1|1|[?]|ABNORMAL|SMEGMA|HEMOLYZED||MIGET|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|5|Visit_5|90|5|TREATMENT|2020-10-03|2020-10-06|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|LB|4ba88073-0003-461a-a950-4504ef7680e7|1|RETIHRTC|High Absorption Retic/Reticulocytes|URINALYSIS|[?]|U.CARR|[?]|[?]|POSITIVE|1|PACK|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED||INTERRUPTER TECHNIQUE|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-09-02|2020-10-05|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|4ba88073-0003-461a-a950-4504ef7680e7|2|CTXICRT|Type I Collagen C-Telopeptides/Creat|CHEMISTRY|[?]|IU/day|[?]|[?]|BORDERLINE|1|mg/g/h|1|1|[?]|NORMAL|PLEURAL FLUID|THAWED||CAPILLARY ELECTROPHORESIS|CKD-EPI CYSTATIN C FORMULA|Y||U||1|Visit_1|10|6|TREATMENT|2020-09-02|2020-10-06|10|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|4ba88073-0003-461a-a950-4504ef7680e7|3|MUG|Murinoglobulin|CHEMISTRY|[?]|10^4 CFU|[?]|[?]|BORDERLINE|1|fg|1|1|[?]|ABNORMAL|SKIN TISSUE|NON-HEMOLYZED||HIGH RESOLUTION CT|GMI % FORMULA|Y|Y|NA||2|Visit_2|25|3|TREATMENT|2020-09-17|2020-11-29|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|4ba88073-0003-461a-a950-4504ef7680e7|4|ANPPROMR|Mid-Reg Pro-Atrial Natriuretic Peptide|CHEMISTRY|[?]|RNA copies/mL|[?]|[?]|POSITIVE|1|TUBE|1|1|[?]|LOW|TRANSUDATE|HEMOLYZED||BETA LACTAMASE|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||2|Visit_2|25|4|WASHOUT|2020-09-17|2020-11-12|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|4ba88073-0003-461a-a950-4504ef7680e7|5|LYMMCELE|Lymphoma Cells/Leukocytes|HEMATOLOGY|[?]|PELLET|[?]|[?]|BORDERLINE|1|gpELISA unit/mL|1|1|[?]|ABNORMAL|FLUID|NON-HEMOLYZED||DISK DIFFUSION|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|2|TREATMENT|2020-10-02|2020-11-06|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|4ba88073-0003-461a-a950-4504ef7680e7|6|GUSB|Glucuronidase, Beta|URINALYSIS|[?]|Torr|[?]|[?]|INDETERMINATE|1|Ci/mg|1|1|[?]|ABNORMAL|COLOSTRUM|THAWED||MASS SPECTROMETRY|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|4|TREATMENT|2020-10-02|2020-10-18|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|4ba88073-0003-461a-a950-4504ef7680e7|7|ANDSTNDN|Androstenedione|HEMATOLOGY|[?]|mL/cage|[?]|[?]|POSITIVE|1|10^9 CFU|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|CALCIFIED|N|WRIGHT STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||4|Visit_4|65|5|TREATMENT|2020-10-27|2020-11-20|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|4ba88073-0003-461a-a950-4504ef7680e7|8|DECORIN|Decorin|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|U/kg/day|1|1|[?]|NORMAL|AMNIOTIC FLUID|FROZEN||CRYOSCOPY|GMI % FORMULA|||NA|Y|4|Visit_4|65|7|TREATMENT|2020-10-27|2020-11-03|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|4ba88073-0003-461a-a950-4504ef7680e7|9|TXB2D11R|11-Dehydro-Thromboxane B2 Excretion Rate|HEMATOLOGY|[?]|U/L|[?]|[?]|INVALID|1|cmHg|1|1|[?]|HIGH|MUCUS|THAWED||CELLULOSE TAPE|NASH FIBROSURE FORMULA|Y||U||5|Visit_5|90|3|FOLLOW-UP|2020-11-21|2020-11-25|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|4ba88073-0003-461a-a950-4504ef7680e7|10|PLATAGGR|Platelet Aggregation|URINALYSIS|||[?]|[?]|NEGATIVE|1|ug/m2|1|1|[?]|NORMAL|CELL PELLET|NON-HEMOLYZED||TEMPLATE INCISION METHOD|FIBROSIS 4 FORMULA||Y|NA|Y|5|Visit_5|90|4|TREATMENT|2020-11-21|2020-11-22|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|1|C130085|English Plantain Pollen IgA|URINALYSIS|||[?]|[?]|INVALID|1|mV/sec|1|1|[?]|NORMAL|SERUM|NON-HEMOLYZED|N|OPTICAL DENSITY MEASUREMENT|MDRD 6 VARIABLE FORMULA||Y|Y|Y|1|Visit_1|10|5|TREATMENT|2020-09-01|2020-10-11|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|2|ALA1ALB|Apolipoprotein A1/Apolipoprotein B|URINALYSIS|[?]|FINGERTIP UNIT|[?]|[?]|INVALID|1|fmol/L|1|1|[?]|NORMAL|LEUKOCYTE|HEMOLYZED|N|X-RAY|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-09-01|2020-09-29|10|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|3|ANGTNS1|Angiotensin I|URINALYSIS|[?]|FIU|[?]|[?]|TRACE|1|MET|1|1|[?]|LOW|COLOSTRUM|LACTESCENT||AUSCULTATION|FIBROTEST FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-09-16|2020-10-08|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|4|DOHLE|Dohle Bodies|URINALYSIS|[?]|nmol/L/h|[?]|[?]|INVALID|1|umol/day|1|1|[?]|LOW|RETICULOCYTES|ROOM TEMPERATURE||IMMUNO-PET SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||2|Visit_2|25|2|WASHOUT|2020-09-16|2020-09-20|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|5|INSULINS|Insulin Sensitivity|HEMATOLOGY|[?]|OI50|[?]|[?]|INVALID|1|log10 TCID 50/mL|1|1|[?]|HIGH|SPERMATOZOON|CALCIFIED|N|CALCULATION|CKD-EPI CYSTATIN C FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-10-01|2020-10-07|40|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|6|TPROTP|Phosphorylated Tau Protein|CHEMISTRY|[?]|mg/mol|[?]|[?]|NEGATIVE|1|ug/L DDU|1|1|[?]|HIGH|SEMEN|CONCENTRATED||MULTI-SLICE SPIRAL CT|MDRD 4 VARIABLE FORMULA|Y|Y|Y||3|Visit_3|40|3|TREATMENT|2020-10-01|2020-11-29|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|7|ADPNCTN|Adiponectin|URINALYSIS|||[?]|[?]|INVALID|1|uIU/dL|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|AUTOLYZED||ULTRASONOGRAPHIC ELASTOGRAPHY|ASH FIBROSURE FORMULA|Y||N|Y|4|Visit_4|65|4|WASHOUT|2020-10-26|2020-11-10|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|8|CD161LY|CD161/Lymphocytes|URINALYSIS|[?]|min|[?]|[?]|NEGATIVE|1|g|1|1|[?]|NORMAL|AMNIOTIC FLUID|CALCIFIED|N|PERFUSION MRI|FIBROTEST FORMULA|||NA||4|Visit_4|65|7|WASHOUT|2020-10-26|2020-11-07|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|9|CLNZPM|Clonazepam|URINALYSIS|[?]|v/v|[?]|[?]|NEGATIVE|1|AFU|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|REFRIGERATED||FLOW CYTOMETRY|MDRD 5 VARIABLE FORMULA|Y||NA||5|Visit_5|90|4|TREATMENT|2020-11-20|2020-11-23|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|10|C5B9S|Soluble Complement C5b-9|CHEMISTRY|[?]|g/animal|[?]|[?]|POSITIVE|1|Absorbance U|1|1|[?]|NORMAL|MONOCYTE|ROOM TEMPERATURE||SIZE EXCLUSION CHROMATOGRAPHY|CKD-EPI FORMULA|Y||NA||5|Visit_5|90|6|WASHOUT|2020-11-20|2020-11-25|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|f552fa78-d78f-44c5-9590-30a737e6652d|1|MONOBL|Monoblasts|URINALYSIS|||[?]|[?]|NEGATIVE|1|BOLUS|1|1|[?]|NORMAL|PLEURAL FLUID|FROZEN|N|CONFOCAL MICROSCOPY|MDRD 4 VARIABLE FORMULA|||N|Y|1|Visit_1|10|3|FOLLOW-UP|2020-10-05|2020-11-12|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|f552fa78-d78f-44c5-9590-30a737e6652d|2|DHEAS|Dehydroepiandrosterone Sulfate|CHEMISTRY|[?]|%/min|[?]|[?]|TRACE|1|pg|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|CLOTTED|N|SLIT LAMP|FIBROMETER FORMULA|||N||1|Visit_1|10|2|WASHOUT|2020-10-05|2020-11-09|10|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|LB|f552fa78-d78f-44c5-9590-30a737e6652d|3|PHNKET|Phenylketones|CHEMISTRY|||[?]|[?]|BORDERLINE|1|g/dL|1|1|[?]|LOW|STOOL|ICTERIC||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CYSTATIN C FORMULA|||U|Y|2|Visit_2|25|2|FOLLOW-UP|2020-10-20|2020-11-13|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|f552fa78-d78f-44c5-9590-30a737e6652d|4|CD163S|Soluble CD163|URINALYSIS|[?]|10^9 CFU/g|[?]|[?]|POSITIVE|1|Bq/kg|1|1|[?]|ABNORMAL|TISSUE|HEMOLYZED||ELECTROCHEMILUMINESCENCE|MDRD 6 VARIABLE FORMULA|Y||NA||2|Visit_2|25|3|FOLLOW-UP|2020-10-20|2020-11-14|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|f552fa78-d78f-44c5-9590-30a737e6652d|5|SOMATRO|Somatotrophin|CHEMISTRY|[?]|10^3 DNA copies/mL|[?]|[?]|INDETERMINATE|1|U/dL|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|LACTESCENT||TONOMETRY|MDRD ENZYMATIC FORMULA|Y|Y|N||3|Visit_3|40|7|TREATMENT|2020-11-04|2020-11-19|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|f552fa78-d78f-44c5-9590-30a737e6652d|6|GADAB|Glutamic Acid Decarboxylase Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|g/L|1|1|[?]|LOW|TRANSUDATE|HEMOLYZED||CONGO RED STAIN|HEPASCORE FORMULA|Y||N|Y|3|Visit_3|40|2|WASHOUT|2020-11-04|2020-12-31|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|f552fa78-d78f-44c5-9590-30a737e6652d|7|B2MICG|Beta-2 Microglobulin|HEMATOLOGY|[?]|mm/h|[?]|[?]|TRACE|1|ppth|1|1|[?]|HIGH|BLOOD|AGGLUTINATED||RADIAL IMMUNODIFFUSION|FIBROMETER FORMULA||Y|NA||4|Visit_4|65|1|TREATMENT|2020-11-29|2020-12-24|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|f552fa78-d78f-44c5-9590-30a737e6652d|8|GLUBD13|1,3-Beta-D-Glucan|URINALYSIS|[?]|/2000 RBC|[?]|[?]|NEGATIVE|1|/2500 WBC|1|1|[?]|LOW|PLATELET RICH PLASMA|SOLIDIFIED|N|APPLANATION TONOMETRY|MDRD 5 VARIABLE FORMULA|Y||N||4|Visit_4|65|6|TREATMENT|2020-11-29|2020-12-02|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|LB|f552fa78-d78f-44c5-9590-30a737e6652d|9|MCPROT|Monoclonal Protein|HEMATOLOGY|[?]|anti-Xa IU/mL|[?]|[?]|INVALID|1|g/U|1|1|[?]|HIGH|LUNG SURFACTANT|FRESH||SLIT LAMP PHOTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||5|Visit_5|90|1|FOLLOW-UP|2020-12-24|2020-12-29|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|f552fa78-d78f-44c5-9590-30a737e6652d|10|HGBA1HGB|Hemoglobin A1/Total Hemoglobin|URINALYSIS|[?]|Joule|[?]|[?]|NEGATIVE|1|nmol/mol|1|1|[?]|LOW|SUPERNATANT, SERUM|CONCENTRATED||CONTRAST ENHANCED PET/CT SCAN|CKD-EPI CREATININE FORMULA|||NA||5|Visit_5|90|6|SCREENING|2020-12-24|2020-12-30|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|38d83f86-d8ce-461a-a288-95aebe498d22|1|INTLK19|Interleukin 19|CHEMISTRY|[?]|BAU/mL|[?]|[?]|TRACE|1|uEq|1|1|[?]|NORMAL|CAPILLARY PLASMA|ROOM TEMPERATURE||CAPILLARY ELECTROPHORESIS|HEPASCORE FORMULA|Y||Y||1|Visit_1|10|7|SCREENING|2020-08-25|2020-09-23|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|38d83f86-d8ce-461a-a288-95aebe498d22|2|K|Potassium|CHEMISTRY|[?]|mL/cm|[?]|[?]|POSITIVE|1|Pack Year|1|1|[?]|LOW|URINE|AUTOLYZED|N|SPECT SCAN|NASH FIBROSURE FORMULA|||NA||1|Visit_1|10|1|TREATMENT|2020-08-25|2020-11-09|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|38d83f86-d8ce-461a-a288-95aebe498d22|3|PROLYM|Prolymphocytes|CHEMISTRY|||[?]|[?]|TRACE|1|tuberculin unit/mL|1|1|[?]|LOW|REFLEX TEAR|THAWED|N|STATIC PERIMETRY|MDRD 6 VARIABLE FORMULA|Y||Y|Y|2|Visit_2|25|4|TREATMENT|2020-09-09|2020-11-06|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|LB|38d83f86-d8ce-461a-a288-95aebe498d22|4|ANIONG4|Anion Gap 4|CHEMISTRY|||[?]|[?]|BORDERLINE|1|% INHIBITION|1|1|[?]|HIGH|VENOUS BLOOD|CLOTTED||SPECT SCAN|MDRD 5 VARIABLE FORMULA|||U|Y|2|Visit_2|25|1|TREATMENT|2020-09-09|2020-10-21|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|LB|38d83f86-d8ce-461a-a288-95aebe498d22|5|C130113|Animal Mix Antigen IgG Antibody|CHEMISTRY|||[?]|[?]|INVALID|1|mmol/min/kPa/L|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|AUTOLYZED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2020-09-24|2020-10-24|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|38d83f86-d8ce-461a-a288-95aebe498d22|6|MCPHNSQE|Macrophages/Non-Squam Epi Cells|CHEMISTRY|[?]|10^3 copies/mL|[?]|[?]|POSITIVE|1|hPa|1|1|[?]|HIGH|PLATELET POOR PLASMA|ROOM TEMPERATURE||ANGIOGRAPHY|MDRD FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-09-24|2020-10-15|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|LB|38d83f86-d8ce-461a-a288-95aebe498d22|7|ODMTASE|O-Demethylase|HEMATOLOGY|[?]|FIU|[?]|[?]|POSITIVE|1|L/h/m2|1|1|[?]|NORMAL|TISSUE|CONCENTRATED||LYMPHANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|U||4|Visit_4|65|6|TREATMENT|2020-10-19|2020-11-09|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|38d83f86-d8ce-461a-a288-95aebe498d22|8|HLAAAGT|HLA-A Antigen Type|HEMATOLOGY|[?]|tsp eq|[?]|[?]|NEGATIVE|1|10^4 CFU|1|1|[?]|HIGH|EMOTIONAL TEAR|NON-HEMOLYZED||SNELLEN EYE CHART|GMI % FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-10-19|2020-11-07|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|38d83f86-d8ce-461a-a288-95aebe498d22|9|IFIT1|Interferon-Induced 56 kDa Protein|CHEMISTRY|[?]|P|[?]|[?]|POSITIVE|1|mL/cage/wk|1|1|[?]|HIGH|INTERSTITIAL FLUID|GELLED||MAGNETIC RESONANCE ENTEROGRAPHY|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|6|TREATMENT|2020-11-13|2020-11-17|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|38d83f86-d8ce-461a-a288-95aebe498d22|10|NGF|Nerve Growth Factor|CHEMISTRY|[?]|U/cL|[?]|[?]|INDETERMINATE|1|mL/h|1|1|[?]|LOW|BUFFY COAT|DRIED||WESTERGREN|GMI MMOL/MOL FORMULA||Y|N||5|Visit_5|90|5|TREATMENT|2020-11-13|2020-11-19|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|b31e8820-cc17-4ce5-af30-358dbeb12ba2|1|CXCL9|Chemokine (C-X-C Motif) Ligand 9|URINALYSIS|[?]|ng/L|[?]|[?]|BORDERLINE|1|km|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR||CONFOCAL MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-08-13|2020-09-09|10|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|b31e8820-cc17-4ce5-af30-358dbeb12ba2|2|KLCFR|Kappa Light Chain, Free|URINALYSIS|[?]|10^6 RNA copies/mL|[?]|[?]|INVALID|1|cm2|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|UNEXPECTED ODOR||CONTRAST ENHANCED PET SCAN|HEPASCORE FORMULA||Y|NA||1|Visit_1|10|5|TREATMENT|2020-08-13|2020-10-30|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|b31e8820-cc17-4ce5-af30-358dbeb12ba2|3|ANTHRMA|Antithrombin Activity|CHEMISTRY|[?]|ug/day|[?]|[?]|POSITIVE|1|VOXEL|1|1|[?]|ABNORMAL|VENOUS PLASMA|CONTAMINATED|N|MUGA|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||2|Visit_2|25|3|TREATMENT|2020-08-28|2020-10-20|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|b31e8820-cc17-4ce5-af30-358dbeb12ba2|4|RUBCE|Rubricyte/Total Cells|URINALYSIS|[?]|APL U|[?]|[?]|INVALID|1|uU/dL|1|1|[?]|HIGH|VITREOUS HUMOR|REFRIGERATED|N|WESTERGREN|FIBROMETER FORMULA|Y|Y|NA||2|Visit_2|25|5|WASHOUT|2020-08-28|2020-09-08|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|b31e8820-cc17-4ce5-af30-358dbeb12ba2|5|C165909|Industrial Mix IgG AB RAST Score|URINALYSIS|[?]|ng/day|[?]|[?]|NEGATIVE|1|mL/cm3/min|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|CALCIFIED||KARYOTYPING|GMI % FORMULA|Y||N||3|Visit_3|40|2|FOLLOW-UP|2020-09-12|2020-10-04|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|b31e8820-cc17-4ce5-af30-358dbeb12ba2|6|LSD|Lysergic Acid Diethylamide|CHEMISTRY|[?]|ag|[?]|[?]|TRACE|1|g/m2|1|1|[?]|HIGH|MIXED VENOUS BLOOD|FROZEN||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI FORMULA|||U||3|Visit_3|40|4|TREATMENT|2020-09-12|2020-10-02|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|b31e8820-cc17-4ce5-af30-358dbeb12ba2|7|HVA|Homovanillic Acid|URINALYSIS|[?]|nU/cL|[?]|[?]|POSITIVE|1|MESF|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|REFRIGERATED||AGAR PROPORTION|CKD-EPI CYSTATIN C FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-10-07|2020-11-10|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|b31e8820-cc17-4ce5-af30-358dbeb12ba2|8|SPMAGGR|Sperm Aggregation|URINALYSIS|[?]|C|[?]|[?]|INDETERMINATE|1|PFU/mL|1|1|[?]|LOW|GASTRIC FLUID|REFRIGERATED|N|TRICHROME STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||4|Visit_4|65|2|TREATMENT|2020-10-07|2020-10-17|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|b31e8820-cc17-4ce5-af30-358dbeb12ba2|9|SCCAG|Squamous Cell Carcinoma Antigen|HEMATOLOGY|[?]|dram|[?]|[?]|INVALID|1|mV/sec|1|1|[?]|LOW|MUCUS|CONCENTRATED|N|NEURAMINIDASE INHIBITION ASSAY|FIBROSIS 4 FORMULA|Y||Y||5|Visit_5|90|4|SCREENING|2020-11-01|2020-11-04|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|b31e8820-cc17-4ce5-af30-358dbeb12ba2|10|DRVVTSCR|DRVVT Screen to Confirm Ratio|CHEMISTRY|[?]|PFU/mL|[?]|[?]|INVALID|1|g/animal/wk|1|1|[?]|NORMAL|SEMINAL FLUID|FRESH||HPLC/MS|CKD-EPI CYSTATIN C FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2020-11-01|2020-11-05|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|LB|cf39d5bd-7682-4546-8495-5bcf48600a69|1|OSTEOC|Osteocalcin|HEMATOLOGY|[?]|RING|[?]|[?]|TRACE|1|PFU|1|1|[?]|NORMAL|PLATELET RICH PLASMA|NON-HEMOLYZED||SLIT LAMP|ASH FIBROSURE FORMULA|Y||Y||1|Visit_1|10|3|TREATMENT|2021-01-20|2021-03-12|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|cf39d5bd-7682-4546-8495-5bcf48600a69|2|ALPBALP|Alk Phos, Bone/Total Alk Phos|HEMATOLOGY|[?]|SCOOPFUL|[?]|[?]|TRACE|1|PACK|1|1|[?]|LOW|ARTERIAL BLOOD|THAWED||FISH|HEPASCORE FORMULA|Y||Y||1|Visit_1|10|7|TREATMENT|2021-01-20|2021-02-24|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|cf39d5bd-7682-4546-8495-5bcf48600a69|3|ALBCREAT|Albumin/Creatinine|CHEMISTRY|[?]|m|[?]|[?]|TRACE|1|IU/mmol|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|THAWED||SISH|MDRD ENZYMATIC FORMULA|Y||NA||2|Visit_2|25|1|TREATMENT|2021-02-04|2021-03-20|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|cf39d5bd-7682-4546-8495-5bcf48600a69|4|CPEPCRT|C-peptide/Creatinine|URINALYSIS|||[?]|[?]|POSITIVE|1|MPS U|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|AUTOLYZED||GIEMSA STAIN|NASH FIBROSURE FORMULA|||N|Y|2|Visit_2|25|7|TREATMENT|2021-02-04|2021-03-04|25|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|cf39d5bd-7682-4546-8495-5bcf48600a69|5|HYXLYS|Hydroxylysine|HEMATOLOGY|[?]|log EID 50/dose|[?]|[?]|INVALID|1|10^9/L|1|1|[?]|HIGH|SKIN TISSUE|NON-HEMOLYZED|N|CLIP SEQUENCING|CKD-EPI FORMULA|||Y||3|Visit_3|40|7|WASHOUT|2021-02-19|2021-02-21|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|LB|cf39d5bd-7682-4546-8495-5bcf48600a69|6|AFPADJBW|Alpha Fetoprotein Adj for Body Weight|HEMATOLOGY|[?]|deg|[?]|[?]|NEGATIVE|1|g/animal/day|1|1|[?]|NORMAL|SUPERNATANT, SERUM|FROZEN||CRYOSCOPY|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|1|FOLLOW-UP|2021-02-19|2021-03-07|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|LB|cf39d5bd-7682-4546-8495-5bcf48600a69|7|EOSMYL|Eosinophilic Myelocytes|URINALYSIS|[?]|mg/kg/dose|[?]|[?]|POSITIVE|1|umol/L/h|1|1|[?]|HIGH|ARTERIAL BLOOD|CONCENTRATED||CONTRAST ENHANCED X-RAY|HEPASCORE FORMULA||Y|N||4|Visit_4|65|6|WASHOUT|2021-03-16|2021-03-26|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|cf39d5bd-7682-4546-8495-5bcf48600a69|8|IGA|Immunoglobulin A|URINALYSIS|[?]|L/h|[?]|[?]|INVALID|1|/kg|1|1|[?]|LOW|PLASMA|NON-HEMOLYZED||MICROBIAL BIOCHEMICAL IDENTIFICATION|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|6|TREATMENT|2021-03-16|2021-04-01|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|cf39d5bd-7682-4546-8495-5bcf48600a69|9|CBB|Complement Bb|HEMATOLOGY|[?]|mAmp|[?]|[?]|INDETERMINATE|1|BLOCKS|1|1|[?]|LOW|MIXED VENOUS BLOOD|NON-HEMOLYZED|N|ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||5|Visit_5|90|2|TREATMENT|2021-04-10|2021-04-18|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|cf39d5bd-7682-4546-8495-5bcf48600a69|10|PF4HCIAB|Platelet Fctr 4 Heparin Cmplx Induced Ab|URINALYSIS|[?]|dpm/mg|[?]|[?]|BORDERLINE|1|mL*cmH2O|1|1|[?]|HIGH|PUS|AGGLUTINATED||TRYPAN BLUE STAIN|HEPASCORE FORMULA|||NA||5|Visit_5|90|3|SCREENING|2021-04-10|2021-04-17|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|84c17e7b-8d56-4726-96a5-9ca41fb9d894|1|NORMBASO|Basophilic Normoblast|CHEMISTRY|[?]|mV2/Hz|[?]|[?]|POSITIVE|1|DPM|1|1|[?]|HIGH|GASTRIC CONTENTS|UNEXPECTED ODOR|N|ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|||NA||1|Visit_1|10|4|FOLLOW-UP|2020-11-24|2020-12-05|10|21|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|84c17e7b-8d56-4726-96a5-9ca41fb9d894|2|NAG|N-Acetyl Glucosamide|URINALYSIS|[?]|U/cL|[?]|[?]|POSITIVE|1|Absorbance U/min|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT||MODIFIED ACID FAST STAIN|MDRD FORMULA|Y||N||1|Visit_1|10|4|FOLLOW-UP|2020-11-24|2020-11-28|10|14|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|84c17e7b-8d56-4726-96a5-9ca41fb9d894|3|EOSCE|Eosinophils/Total Cells|HEMATOLOGY|[?]|Ci/ug|[?]|[?]|INDETERMINATE|1|mL/m2/h|1|1|[?]|LOW|WHITE MATTER TISSUE|DRIED||FLOW CYTOMETRY|HEPASCORE FORMULA|||N||2|Visit_2|25|4|WASHOUT|2020-12-09|2020-12-26|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|84c17e7b-8d56-4726-96a5-9ca41fb9d894|4|CGMP|Cyclic Guanosine Monophosphate|HEMATOLOGY|[?]|ug/mol|[?]|[?]|BORDERLINE|1|mL/m2/h|1|1|[?]|LOW|ENDOTRACHEAL FLUID|LACTESCENT||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|FIBROTEST FORMULA|||NA||2|Visit_2|25|7|TREATMENT|2020-12-09|2021-02-10|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|84c17e7b-8d56-4726-96a5-9ca41fb9d894|5|AMYLASES|Amylase, Salivary|CHEMISTRY|[?]|mol/mg|[?]|[?]|BORDERLINE|1|CONTAINER|1|1|[?]|HIGH|TISSUE|REFRIGERATED||OPTICAL MAPPING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-12-24|2021-01-03|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|84c17e7b-8d56-4726-96a5-9ca41fb9d894|6|HOWJOL|Howell-Jolly Bodies|URINALYSIS|[?]|/5x10^4 WBC|[?]|[?]|TRACE|1|Tbsp|1|1|[?]|HIGH|TISSUE|DRIED||MALDI|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|6|WASHOUT|2020-12-24|2021-01-30|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|84c17e7b-8d56-4726-96a5-9ca41fb9d894|7|ANIONG4|Anion Gap 4|URINALYSIS|||[?]|[?]|TRACE|1|10^6/hpf|1|1|[?]|NORMAL|KERATINOCYTE|UNEXPECTED ODOR||PERCUSSION|FIBROTEST FORMULA|||N|Y|4|Visit_4|65|7|TREATMENT|2021-01-18|2021-01-28|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|84c17e7b-8d56-4726-96a5-9ca41fb9d894|8|TOXGRAN|Toxic Granulation|HEMATOLOGY|[?]|%(w/w)|[?]|[?]|POSITIVE|1|uOsm|1|1|[?]|HIGH|SWABBED MATERIAL|HEMOLYZED|N|ANALYTICAL ULTRACENTRIFUGATION|COCKCROFT-GAULT FORMULA||Y|U||4|Visit_4|65|7|TREATMENT|2021-01-18|2021-02-08|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|84c17e7b-8d56-4726-96a5-9ca41fb9d894|9|SPERMP|Spermatozoa, Progressive|URINALYSIS|[?]|nmol/kg/day|[?]|[?]|NEGATIVE|1|ks|1|1|[?]|HIGH|VENOUS CORD BLOOD|AUTOLYZED||PULMONARY ANGIOGRAPHY|GMI MMOL/MOL FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2021-02-12|2021-02-17|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|84c17e7b-8d56-4726-96a5-9ca41fb9d894|10|EOSMM|Eosinophilic Metamyelocytes|CHEMISTRY|[?]|mL/cage/day|[?]|[?]|BORDERLINE|1|dpm/mg|1|1|[?]|LOW|FLUID|NON-HEMOLYZED||ELECTROPHORESIS|MDRD ENZYMATIC FORMULA|||N||5|Visit_5|90|4|TREATMENT|2021-02-12|2021-02-16|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|6e557fd7-efaf-4c86-806d-9bd66c7de7da|1|PMYCECE|Proliferating Myeloid Cells/Total Cells|HEMATOLOGY|[?]|uIU/dL|[?]|[?]|INVALID|1|copies/ug|1|1|[?]|HIGH|ABSCESS FLUID|THAWED||NUCLEIC ACID HYBRIDIZATION|FIBROTEST FORMULA|||N||1|Visit_1|10|5|TREATMENT|2021-01-27|2021-03-22|10|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|6e557fd7-efaf-4c86-806d-9bd66c7de7da|2|GLYCRLFR|Free Glycerol|URINALYSIS|||[?]|[?]|INVALID|1|ug/L|1|1|[?]|HIGH|SMEGMA|HEMOLYZED|N|ORCHIDOMETERY|FIBROMETER FORMULA|Y||U|Y|1|Visit_1|10|1|TREATMENT|2021-01-27|2021-03-24|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|6e557fd7-efaf-4c86-806d-9bd66c7de7da|3|IGFBP2|Insulin-Like Growth Factor Binding Prot2|CHEMISTRY|[?]|L/s/kPa|[?]|[?]|INVALID|1|cmH2O*s2/mL|1|1|[?]|NORMAL|GASTRIC CONTENTS|ICTERIC||SXA SCAN|CKD-EPI FORMULA||Y|N||2|Visit_2|25|4|WASHOUT|2021-02-11|2021-03-20|25|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|6e557fd7-efaf-4c86-806d-9bd66c7de7da|4|INTLK21|Interleukin 21|URINALYSIS|[?]|uCi/L|[?]|[?]|POSITIVE|1|10^12/L|1|1|[?]|HIGH|PERSPIRATION|GELLED||CENTRIFUGATION|MDRD 6 VARIABLE FORMULA||Y|NA||2|Visit_2|25|4|TREATMENT|2021-02-11|2021-02-25|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|6e557fd7-efaf-4c86-806d-9bd66c7de7da|5|TROPONI3|Troponin I Type 3|URINALYSIS|[?]|g/animal/wk|[?]|[?]|INVALID|1|cd|1|1|[?]|ABNORMAL|LAVAGE FLUID|PARAFFIN-EMBEDDED||QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROSIS 4 FORMULA||Y|NA||3|Visit_3|40|1|FOLLOW-UP|2021-02-26|2021-04-24|40|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|6e557fd7-efaf-4c86-806d-9bd66c7de7da|6|ADH|Antidiuretic Hormone|URINALYSIS|[?]|PRESSOR UNITS|[?]|[?]|NEGATIVE|1|CIGAR|1|1|[?]|HIGH|VENOUS BLOOD|UNEXPECTED ODOR||PET SCAN|MDRD FORMULA|Y||N||3|Visit_3|40|6|TREATMENT|2021-02-26|2021-03-25|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|6e557fd7-efaf-4c86-806d-9bd66c7de7da|7|KLK2|Kallikrein-2|HEMATOLOGY|[?]|CIGARETTE|[?]|[?]|INVALID|1|mL/kg/day|1|1|[?]|HIGH|MONOCYTE|SOLIDIFIED||CALCULATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||4|Visit_4|65|3|SCREENING|2021-03-23|2021-03-29|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|LB|6e557fd7-efaf-4c86-806d-9bd66c7de7da|8|ABNCE|Abnormal Cells|CHEMISTRY|[?]|10^8/L|[?]|[?]|POSITIVE|1|cup eq|1|1|[?]|ABNORMAL|BREAST MILK|FROZEN||NON-INVASIVE DIELECTRIC SENSING|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|2|FOLLOW-UP|2021-03-23|2021-04-06|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|LB|6e557fd7-efaf-4c86-806d-9bd66c7de7da|9|AMYLASES|Amylase, Salivary|URINALYSIS|[?]|TABLET|[?]|[?]|POSITIVE|1|g/cm2|1|1|[?]|LOW|CAPILLARY PLASMA|DRIED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA|Y||NA||5|Visit_5|90|1|TREATMENT|2021-04-17|2021-04-22|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|6e557fd7-efaf-4c86-806d-9bd66c7de7da|10|TGLOB|Thyroglobulin|HEMATOLOGY|[?]|uEq/L|[?]|[?]|INVALID|1|BOX|1|1|[?]|LOW|PLATELET POOR PLASMA|THAWED||SLIT LAMP PHOTOGRAPHY|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|6|SCREENING|2021-04-17|2021-04-18|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|LB|2b25e1f9-929c-4bdc-8758-79f33b832026|1|NEUTCE|Neutrophils/Total Cells|URINALYSIS|||[?]|[?]|INVALID|1|s*kPa|1|1|[?]|HIGH|ABSCESS FLUID|SOLIDIFIED||DIFFUSION TENSOR MRI|GMI % FORMULA|Y||N|Y|1|Visit_1|10|7|TREATMENT|2020-10-19|2020-11-12|10|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|2b25e1f9-929c-4bdc-8758-79f33b832026|2|GFRBSCYC|GFR from Cystatin C Adjusted for BSA|CHEMISTRY|[?]|pL|[?]|[?]|INDETERMINATE|1|10^4/L|1|1|[?]|HIGH|PLEURAL TISSUE|AGGLUTINATED||OPTICAL DENSITY MEASUREMENT|GMI MMOL/MOL FORMULA|Y||U||1|Visit_1|10|7|TREATMENT|2020-10-19|2020-12-04|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|LB|2b25e1f9-929c-4bdc-8758-79f33b832026|3|NMH|N-methylhistamine|URINALYSIS|[?]|uCi|[?]|[?]|TRACE|1|CIGARETTE|1|1|[?]|LOW|URINE|SOLIDIFIED||ZIEHL NEELSEN ACID FAST STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y||2|Visit_2|25|4|TREATMENT|2020-11-03|2021-01-09|25|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|2b25e1f9-929c-4bdc-8758-79f33b832026|4|SPMAGGLU|Sperm Agglutination|URINALYSIS|||[?]|[?]|BORDERLINE|1|COAT|1|1|[?]|NORMAL|CORD SERUM|HEMOLYZED||CELL OF ORIGIN ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|2|Visit_2|25|3|TREATMENT|2020-11-03|2020-11-26|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|2b25e1f9-929c-4bdc-8758-79f33b832026|5|HDLCCHOL|HDL Cholesterol/Total Cholesterol|URINALYSIS|[?]|NEEDLE GAUGE|[?]|[?]|BORDERLINE|1|mV/sec|1|1|[?]|LOW|PLATELET|DRIED||X-RAY FLUORESCENCE SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-11-18|2020-11-29|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|2b25e1f9-929c-4bdc-8758-79f33b832026|6|VEGFR1S|Soluble Vasc Endoth Growth Factor Rec1|HEMATOLOGY|[?]|tsp eq|[?]|[?]|NEGATIVE|1|s/h|1|1|[?]|HIGH|CALCULUS|CALCIFIED|N|HIGH RESOLUTION MELT ANALYSIS|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-11-18|2021-01-02|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|2b25e1f9-929c-4bdc-8758-79f33b832026|7|C165931|Nut Mix IgE AB RAST Score|HEMATOLOGY|[?]|cy/cm|[?]|[?]|INDETERMINATE|1|gMFI|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED||HPLC/MS/MS|HEPASCORE FORMULA|Y||U||4|Visit_4|65|6|TREATMENT|2020-12-13|2020-12-26|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|2b25e1f9-929c-4bdc-8758-79f33b832026|8|NEUTMM|Neutrophilic Metamyelocytes|CHEMISTRY|[?]|mg/m2|[?]|[?]|TRACE|1|/LPF|1|1|[?]|HIGH|KERATINOCYTE|NON-HEMOLYZED||CONTRAST ENHANCED X-RAY|HEPASCORE FORMULA|Y||NA||4|Visit_4|65|1|WASHOUT|2020-12-13|2020-12-19|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|2b25e1f9-929c-4bdc-8758-79f33b832026|9|EOSSG|Eosinophils, Segmented|URINALYSIS|[?]|g/m2/day|[?]|[?]|TRACE|1|Bq/uL|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|CONCENTRATED||IMMUNOCHROMATOGRAPHY|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|6|TREATMENT|2021-01-07|2021-01-11|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|2b25e1f9-929c-4bdc-8758-79f33b832026|10|ACTH|Adrenocorticotropic Hormone|CHEMISTRY|[?]|cal|[?]|[?]|NEGATIVE|1|vp/mL|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|LIPEMIC||OSCILLOMETRY|MDRD 5 VARIABLE FORMULA|||U||5|Visit_5|90|3|TREATMENT|2021-01-07|2021-01-13|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|d02c7553-17f5-44ec-8c24-469234d080e8|1|IGSOL|Soluble Immunoglobulin|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|CIGARETTE|1|1|[?]|LOW|STOOL|LIPEMIC|N|MALDI-TOF|HEPASCORE FORMULA|||N|Y|1|Visit_1|10|4|TREATMENT|2021-01-26|2021-03-03|10|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|d02c7553-17f5-44ec-8c24-469234d080e8|2|PLSMCE|Mature Plasma Cells|URINALYSIS|[?]|CONTAINER|[?]|[?]|TRACE|1|mL/s/m2|1|1|[?]|HIGH|SPUTUM|GELLED||BETA LACTAMASE|MDRD 6 VARIABLE FORMULA|Y||NA||1|Visit_1|10|5|FOLLOW-UP|2021-01-26|2021-04-15|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|d02c7553-17f5-44ec-8c24-469234d080e8|3|SRTONIN|Serotonin|CHEMISTRY|[?]|10^6 copies/mL|[?]|[?]|POSITIVE|1|10^7 TCID 50/dose|1|1|[?]|HIGH|PERITONEAL FLUID|ROOM TEMPERATURE||PET/CT SCAN|MDRD 6 VARIABLE FORMULA||Y|U||2|Visit_2|25|3|TREATMENT|2021-02-10|2021-03-23|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|d02c7553-17f5-44ec-8c24-469234d080e8|4|ANTHRMA|Antithrombin Activity|URINALYSIS|[?]|BEAM BREAKS|[?]|[?]|TRACE|1|/HPF|1|1|[?]|HIGH|PLEURAL FLUID|AGGLUTINATED||PERCUSSION|HEPASCORE FORMULA|Y||Y||2|Visit_2|25|7|FOLLOW-UP|2021-02-10|2021-03-24|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|d02c7553-17f5-44ec-8c24-469234d080e8|5|MSPIKEPT|Monoclonal Protein Spike/Total Protein|CHEMISTRY|[?]|m3|[?]|[?]|NEGATIVE|1|10^3 organisms|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|REFRIGERATED|N|BIOIMPEDANCE SPECTROSCOPY|MDRD FORMULA|Y|Y|NA||3|Visit_3|40|5|SCREENING|2021-02-25|2021-04-20|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|LB|d02c7553-17f5-44ec-8c24-469234d080e8|6|IFI6|Interferon Alpha-Inducible Protein 6|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|BOLUS|1|1|[?]|NORMAL|TRANSUDATE|ICTERIC|N|RADIATION DOSIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2021-02-25|2021-04-17|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|LB|d02c7553-17f5-44ec-8c24-469234d080e8|7|CANNABS|Cannabinoids, Synthetic|URINALYSIS|[?]|Bq|[?]|[?]|POSITIVE|1|/day|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|ICTERIC||TRIPLE-PHASE MRI SCAN|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|2|WASHOUT|2021-03-22|2021-03-25|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|LB|d02c7553-17f5-44ec-8c24-469234d080e8|8|CD8LY|CD8/Lymphocytes|URINALYSIS|||[?]|[?]|POSITIVE|1|RFU|1|1|[?]|LOW|EXPIRED AIR|SOLIDIFIED||FREEZING POINT DEPRESSION|MDRD ENZYMATIC FORMULA|||U|Y|4|Visit_4|65|2|FOLLOW-UP|2021-03-22|2021-04-13|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|LB|d02c7553-17f5-44ec-8c24-469234d080e8|9|MCPHGLE|Macrophages/Leukocytes|HEMATOLOGY|||[?]|[?]|POSITIVE|1|oz eq|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|AGGLUTINATED|N|CT SCAN WITHOUT CONTRAST|GMI % FORMULA|||Y|Y|5|Visit_5|90|4|TREATMENT|2021-04-16|2021-04-22|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|d02c7553-17f5-44ec-8c24-469234d080e8|10|NPY|Neuropeptide Y|HEMATOLOGY|[?]|10^12/L|[?]|[?]|NEGATIVE|1|10^9/L|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|AUTOLYZED||FLUORESCENT MICROSCOPY|COCKCROFT-GAULT FORMULA|Y|Y|Y||5|Visit_5|90|4|SCREENING|2021-04-16|2021-04-23|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|LB|e819939e-548d-4e05-83e3-7976790de7e1|1|ALTAST|ALT/AST|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|MPS U|1|1|[?]|ABNORMAL|BILE|GELLED||ICP-MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|1|Visit_1|10|4|TREATMENT|2020-09-07|2020-11-08|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|e819939e-548d-4e05-83e3-7976790de7e1|2|MONOCE|Monocytes/Total Cells|CHEMISTRY|[?]|pt_us|[?]|[?]|NEGATIVE|1|%(w/w)|1|1|[?]|LOW|MECONIUM|LIPEMIC|N|CARDIAC THERMODILUTION|MDRD FORMULA|||N||1|Visit_1|10|1|WASHOUT|2020-09-07|2020-11-19|10|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|e819939e-548d-4e05-83e3-7976790de7e1|3|LEAD|Lead|CHEMISTRY|[?]|mm|[?]|[?]|INVALID|1|10^6 organisms|1|1|[?]|ABNORMAL|VITREOUS HUMOR|CONTAMINATED|N|ROMANOWSKY STAIN|FIBROMETER FORMULA|||Y||2|Visit_2|25|1|WASHOUT|2020-09-22|2020-09-24|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|e819939e-548d-4e05-83e3-7976790de7e1|4|FXIVAAC|Factor XIV Activity Actual/Control|CHEMISTRY|[?]|cal|[?]|[?]|INVALID|1|Bq/mg|1|1|[?]|NORMAL|SPERMATOZOON|FRESH||NEURAMINIDASE INHIBITION ASSAY|COCKCROFT-GAULT FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-09-22|2020-10-02|25|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|e819939e-548d-4e05-83e3-7976790de7e1|5|INTLK7|Interleukin 7|HEMATOLOGY|||[?]|[?]|POSITIVE|1|/10^3|1|1|[?]|HIGH|KERATINOCYTE|CONCENTRATED||HPLC/IEX|NASH FIBROSURE FORMULA|||N|Y|3|Visit_3|40|2|TREATMENT|2020-10-07|2020-11-14|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|e819939e-548d-4e05-83e3-7976790de7e1|6|C165925|Weed Mix Pollen IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|RING|1|1|[?]|ABNORMAL|LYMPH|SOLIDIFIED||MICRONEUTRALIZATION ASSAY|FIBROMETER FORMULA||Y|Y|Y|3|Visit_3|40|5|FOLLOW-UP|2020-10-07|2020-10-27|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|e819939e-548d-4e05-83e3-7976790de7e1|7|RT3|Triiodothyronine, Reverse|HEMATOLOGY|[?]|Absorbance U/mL|[?]|[?]|TRACE|1|mol/day|1|1|[?]|LOW|RETICULOCYTES|DRIED||KNEMOMETRY|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-11-01|2020-12-04|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|e819939e-548d-4e05-83e3-7976790de7e1|8|CD10|CD10|URINALYSIS|[?]|vg/mL|[?]|[?]|INDETERMINATE|1|IU/mmol|1|1|[?]|LOW|CORD BLOOD|FRESH||HPLC/MS|GMI MMOL/MOL FORMULA||Y|U||4|Visit_4|65|2|TREATMENT|2020-11-01|2020-11-19|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|e819939e-548d-4e05-83e3-7976790de7e1|9|HAPTOG|Haptoglobin|HEMATOLOGY|[?]|Antibody Unit|[?]|[?]|POSITIVE|1|RING|1|1|[?]|NORMAL|BONE|FROZEN||SNP ARRAY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||5|Visit_5|90|6|SCREENING|2020-11-26|2020-12-04|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|e819939e-548d-4e05-83e3-7976790de7e1|10|PTAC|Prothrombin Time Actual/Control|URINALYSIS|[?]|IMPLANT|[?]|[?]|BORDERLINE|1|dpm/0.5 mL|1|1|[?]|NORMAL|SUPERNATANT, SERUM|AUTOLYZED|N|MOUSE PROTECTION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||5|Visit_5|90|7|SCREENING|2020-11-26|2020-11-29|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|1|LEUKCE|Leukemic Cells|URINALYSIS|[?]|10^6 organisms/mL|[?]|[?]|NEGATIVE|1|ft2|1|1|[?]|HIGH|LEUKOCYTE|NON-HEMOLYZED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD FORMULA|||N||1|Visit_1|10|4|SCREENING|2020-08-18|2020-09-09|10|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|2|LIQUFT|Liquefaction Time|URINALYSIS|[?]|g/animal|[?]|[?]|TRACE|1|cycle/min|1|1|[?]|ABNORMAL|DERMAL TISSUE|GELLED|N|HPLC-FL|GMI % FORMULA|||N||1|Visit_1|10|4|SCREENING|2020-08-18|2020-11-12|10|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|3|CA1AG|Cancer Antigen 1|HEMATOLOGY|[?]|pL|[?]|[?]|POSITIVE|1|GBq|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED||SINGLE-MOLECULE ARRAY|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|2|FOLLOW-UP|2020-09-02|2020-09-08|25|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|4|HETRPH|Heterophils|CHEMISTRY|||[?]|[?]|POSITIVE|1|mEq/kg|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|THAWED|N|DYNAMIC CONTRAST ENHANCED MRI|MDRD FORMULA|||Y|Y|2|Visit_2|25|5|SCREENING|2020-09-02|2020-09-04|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|5|NEUTBLE|Neutrophils Band Form/Leukocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|vg/dose|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR||NON-INVASIVE DIELECTRIC SENSING|COCKCROFT-GAULT FORMULA||Y|N|Y|3|Visit_3|40|5|SCREENING|2020-09-17|2020-10-16|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|6|FACTXIV|Factor XIV|CHEMISTRY|[?]|TABLET|[?]|[?]|BORDERLINE|1|mg/m2/day|1|1|[?]|ABNORMAL|VITREOUS HUMOR|FROZEN||X-RAY FLUORESCENCE SPECTROMETRY|GMI MMOL/MOL FORMULA||Y|NA||3|Visit_3|40|7|TREATMENT|2020-09-17|2020-10-22|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|LB|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|7|HIST3AB|Histone 3 Antibody|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|uSiemens|1|1|[?]|LOW|EPITHELIAL CELL|CONCENTRATED||SEQUENCING|GMI MMOL/MOL FORMULA||Y|U|Y|4|Visit_4|65|1|WASHOUT|2020-10-12|2020-11-11|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|8|SPHERO|Spherocytes|CHEMISTRY|[?]|Weber|[?]|[?]|NEGATIVE|1|MPS U|1|1|[?]|ABNORMAL|SERUM|THAWED||SLIT LAMP PHOTOGRAPHY|MDRD 5 VARIABLE FORMULA|Y||NA||4|Visit_4|65|3|TREATMENT|2020-10-12|2020-10-30|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|9|B1BGLP|Beta-1B Glycoprotein|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Watt|1|1|[?]|NORMAL|MUSCLE TISSUE|FROZEN||MRI|COCKCROFT-GAULT FORMULA||Y|Y|Y|5|Visit_5|90|1|TREATMENT|2020-11-06|2020-11-14|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|10|PRO|Proline|CHEMISTRY|[?]|cd/m2|[?]|[?]|INVALID|1|log10 PFU|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|PARAFFIN-EMBEDDED||IMMUNOFIXATION ELECTROPHORESIS|COCKCROFT-GAULT FORMULA||Y|Y||5|Visit_5|90|1|TREATMENT|2020-11-06|2020-11-10|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|LB|ea5229ad-6469-4147-be40-546d27c04c4c|1|INSLNFR|Insulin, Free|HEMATOLOGY|[?]|kcal|[?]|[?]|POSITIVE|1|min|1|1|[?]|LOW|VENOUS PLASMA|GELLED||STRESS ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA||Y|NA||1|Visit_1|10|1|WASHOUT|2020-06-09|2020-06-21|10|22|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|ea5229ad-6469-4147-be40-546d27c04c4c|2|LYS|Lysine|URINALYSIS|[?]|grain|[?]|[?]|BORDERLINE|1|10^7 CFU/mL|1|1|[?]|ABNORMAL|EMESIS|FRESH||PHOTOMETRIC CLOT DETECTION|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|2|TREATMENT|2020-06-09|2020-08-10|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|ea5229ad-6469-4147-be40-546d27c04c4c|3|CSEPIRT|Renal Tubular Epithelial Casts|URINALYSIS|[?]|cP|[?]|[?]|POSITIVE|1|NEEDLE GAUGE|1|1|[?]|ABNORMAL|LYSATE|ROOM TEMPERATURE||PYROSEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2020-06-24|2020-07-19|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|ea5229ad-6469-4147-be40-546d27c04c4c|4|INSAB|Insulin Antibody|HEMATOLOGY|[?]|OI50|[?]|[?]|POSITIVE|1|PIPE|1|1|[?]|NORMAL|SEBUM|FRESH|N|NON-INVASIVE DIELECTRIC SENSING|MDRD 5 VARIABLE FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-06-24|2020-07-17|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|ea5229ad-6469-4147-be40-546d27c04c4c|5|TPAAG|Tissue Plasminogen Activator Antigen|URINALYSIS|[?]|Bq|[?]|[?]|NEGATIVE|1|DRINK|1|1|[?]|HIGH|SWABBED MATERIAL|SOLIDIFIED||MUGA|COCKCROFT-GAULT FORMULA|Y|Y|U||3|Visit_3|40|5|TREATMENT|2020-07-09|2020-08-21|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|ea5229ad-6469-4147-be40-546d27c04c4c|6|MACROCY|Macrocytes|HEMATOLOGY|[?]|ukat/10^12 RBC|[?]|[?]|INVALID|1|mEq|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|FROZEN||JAEGER EYE CHART|CKD-EPI FORMULA|||Y||3|Visit_3|40|5|WASHOUT|2020-07-09|2020-07-27|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|ea5229ad-6469-4147-be40-546d27c04c4c|7|KLOTHO|Klotho|CHEMISTRY|[?]|SFC/10^6 PBMC|[?]|[?]|INDETERMINATE|1|uU/dL|1|1|[?]|NORMAL|SALIVA|HEMOLYZED|N|SURFACE PLASMON RESONANCE|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|5|WASHOUT|2020-08-03|2020-08-15|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|LB|ea5229ad-6469-4147-be40-546d27c04c4c|8|SOST|Sclerostin|URINALYSIS|||[?]|[?]|TRACE|1|EID 50/dose|1|1|[?]|HIGH|HAIR|AGGLUTINATED||GEL ELECTROPHORESIS|CKD-EPI CREATININE FORMULA|||N|Y|4|Visit_4|65|4|TREATMENT|2020-08-03|2020-08-04|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|LB|ea5229ad-6469-4147-be40-546d27c04c4c|9|FGFBF|Fibroblast Growth Factor Basic Form|URINALYSIS|||[?]|[?]|BORDERLINE|1|Ci/mL|1|1|[?]|ABNORMAL|SEBUM|UNEXPECTED ODOR|N|FLOW CYTOMETRY|HEPASCORE FORMULA|||Y|Y|5|Visit_5|90|2|TREATMENT|2020-08-28|2020-08-29|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|LB|ea5229ad-6469-4147-be40-546d27c04c4c|10|CCPIGGAB|Cyclic Citrullinated Peptide IgG Ab|URINALYSIS|[?]|mg/dose|[?]|[?]|BORDERLINE|1|min/day|1|1|[?]|ABNORMAL|BREAST MILK|AUTOLYZED||PHOTOMETRIC CLOT DETECTION|CKD-EPI CYSTATIN C FORMULA|Y||Y||5|Visit_5|90|6|WASHOUT|2020-08-28|2020-09-03|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|LB|0a566742-0f71-4603-85f0-875e2c3395e7|1|NHMCELE|Nonhematic Cells/Leukocytes|CHEMISTRY|[?]|fmol/L|[?]|[?]|INVALID|1|mL/kg|1|1|[?]|LOW|SALIVA|ROOM TEMPERATURE||SLIT LAMP|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|3|WASHOUT|2021-01-08|2021-04-07|10|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|LB|0a566742-0f71-4603-85f0-875e2c3395e7|2|AMMONIA|Ammonia|CHEMISTRY|[?]|TABLET|[?]|[?]|INVALID|1|vg/kg|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|FROZEN||SCANNING ELECTRON MICROSCOPY|CKD-EPI CREATININE FORMULA|Y||NA||1|Visit_1|10|7|WASHOUT|2021-01-08|2021-02-19|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|LB|0a566742-0f71-4603-85f0-875e2c3395e7|3|TNF|Tumor Necrosis Factor|URINALYSIS|[?]|ELISA unit/mL|[?]|[?]|POSITIVE|1|mmol/g|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|FROZEN||MICRO BROTH DILUTION|FIBROMETER FORMULA|||N||2|Visit_2|25|7|TREATMENT|2021-01-23|2021-04-04|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|0a566742-0f71-4603-85f0-875e2c3395e7|4|GLDIGGAB|Gliadin IgG Antibody|URINALYSIS|||[?]|[?]|INVALID|1|log10 CFU/g|1|1|[?]|HIGH|SPUTUM|FROZEN||LIGHT MICROSCOPY|MDRD 6 VARIABLE FORMULA|||U|Y|2|Visit_2|25|7|FOLLOW-UP|2021-01-23|2021-03-04|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|LB|0a566742-0f71-4603-85f0-875e2c3395e7|5|COQ10|Ubiquinone 10|HEMATOLOGY|[?]|PNU/mL|[?]|[?]|INDETERMINATE|1|ugEq/L|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|LACTESCENT|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE FORMULA|Y||Y||3|Visit_3|40|1|TREATMENT|2021-02-07|2021-02-23|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|0a566742-0f71-4603-85f0-875e2c3395e7|6|HGBA1HGB|Hemoglobin A1/Total Hemoglobin|HEMATOLOGY|[?]|dB|[?]|[?]|POSITIVE|1|NEEDLE GAUGE|1|1|[?]|HIGH|URINE SEDIMENT|CLOTTED||MICRODENSITOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||3|Visit_3|40|5|TREATMENT|2021-02-07|2021-02-28|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|LB|0a566742-0f71-4603-85f0-875e2c3395e7|7|BLSTRSID|Ringed Sideroblasts|HEMATOLOGY|[?]|deg/s|[?]|[?]|INVALID|1|CFU/mL|1|1|[?]|ABNORMAL|ABSCESS FLUID|CONTAMINATED||ELISA|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|6|SCREENING|2021-03-04|2021-03-21|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|0a566742-0f71-4603-85f0-875e2c3395e7|8|T4FRIND|Thyroxine, Free, Indirect|HEMATOLOGY|[?]|ug/dL|[?]|[?]|INDETERMINATE|1|10^6 CFU|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|LIPEMIC||CONTRAST ENHANCED MRI|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2021-03-04|2021-03-28|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|0a566742-0f71-4603-85f0-875e2c3395e7|9|HDLPL|HDL Phospholipid|HEMATOLOGY|||[?]|[?]|TRACE|1|BU|1|1|[?]|NORMAL|EXUDATE|ROOM TEMPERATURE||ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||N|Y|5|Visit_5|90|2|FOLLOW-UP|2021-03-29|2021-04-04|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|0a566742-0f71-4603-85f0-875e2c3395e7|10|S100A8|S100 Calcium Binding Protein A8|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|DIP|1|1|[?]|HIGH|CEREBROSPINAL FLUID|AUTOLYZED||CONTRAST ENHANCED X-RAY|HEPASCORE FORMULA|||Y|Y|5|Visit_5|90|3|WASHOUT|2021-03-29|2021-04-07|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|LB|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|1|PTSAAC|Protein S Activity Actual/Control|HEMATOLOGY|[?]|ug/mL/h|[?]|[?]|POSITIVE|1|ug/g/day|1|1|[?]|NORMAL|LYSATE|CLOTTED|N|ELECTRONEUROGRAPHY|CKD-EPI FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-05-14|2020-05-26|10|22|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|2|DNPSEPHD|D-Norpseudoephedrine|HEMATOLOGY|[?]|Ci/kg|[?]|[?]|INDETERMINATE|1|CUP|1|1|[?]|NORMAL|ISOLATE|HEMOLYZED||GC/MS-EI|FIBROMETER FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-05-14|2020-06-21|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|3|NACLR|Sodium Clearance|URINALYSIS|[?]|cm/min|[?]|[?]|NEGATIVE|1|um/day|1|1|[?]|NORMAL|CERUMEN|CONCENTRATED|N|ANGIOGRAPHY|NASH FIBROSURE FORMULA|Y||N||2|Visit_2|25|6|TREATMENT|2020-05-29|2020-06-21|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|4|PHOSCRT|Phosphate/Creatinine|URINALYSIS|||[?]|[?]|TRACE|1|Torr|1|1|[?]|NORMAL|PROSTATIC FLUID|SOLIDIFIED||COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|2|Visit_2|25|4|WASHOUT|2020-05-29|2020-07-02|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|5|TNFSR1|Soluble TNF Receptor Type I|HEMATOLOGY|[?]|Bq/g|[?]|[?]|INVALID|1|DDU|1|1|[?]|HIGH|TISSUE|DRIED||TRIPLE-PHASE MRI SCAN|NASH FIBROSURE FORMULA||Y|NA||3|Visit_3|40|7|TREATMENT|2020-06-13|2020-07-18|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|6|DENSITY|Density|CHEMISTRY|[?]|Enzyme U|[?]|[?]|BORDERLINE|1|nmol|1|1|[?]|NORMAL|COLOSTRUM|CALCIFIED||ENDOSCOPY|MDRD FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-06-13|2020-08-03|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|LB|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|7|RETIHRTC|High Absorption Retic/Reticulocytes|HEMATOLOGY|[?]|min*mg/mL|[?]|[?]|INVALID|1|ugEq|1|1|[?]|LOW|PLATELET|THAWED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|GMI MMOL/MOL FORMULA|Y||U||4|Visit_4|65|6|TREATMENT|2020-07-08|2020-07-22|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-09
e|LB|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|8|TTGIGMAB|Tissue Transglutaminase IgM Antibody|CHEMISTRY|[?]|10^3 organisms/g|[?]|[?]|INVALID|1|ft2|1|1|[?]|ABNORMAL|LAVAGE FLUID|REFRIGERATED||SURFACE PLASMON RESONANCE|CKD-EPI FORMULA|Y||U||4|Visit_4|65|3|FOLLOW-UP|2020-07-08|2020-07-22|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-09
e|LB|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|9|C165897|Bermuda Grass Pollen IgG AB RAST Score|CHEMISTRY|[?]|K|[?]|[?]|TRACE|1|mEq/kg|1|1|[?]|NORMAL|SKIN TISSUE|FROZEN|N|NEURAMINIDASE INHIBITION ASSAY|FIBROSIS 4 FORMULA||Y|U||5|Visit_5|90|5|WASHOUT|2020-08-02|2020-08-03|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|10|CCL21|Chemokine (C-C Motif) Ligand 21|CHEMISTRY|[?]|nmol/L/h|[?]|[?]|BORDERLINE|1|min*mg/mL|1|1|[?]|HIGH|VITREOUS HUMOR|THAWED|N|ALCIAN BLUE STAIN|FIBROMETER FORMULA|||Y||5|Visit_5|90|7|SCREENING|2020-08-02|2020-08-07|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|48103500-0f3d-4108-9167-6afee1098773|1|EOSMYL|Eosinophilic Myelocytes|HEMATOLOGY|[?]|BAU|[?]|[?]|INVALID|1|amol|1|1|[?]|HIGH|LUNG SURFACTANT|LIPEMIC|N|NUCLEIC ACID AMPLIFICATION TEST|HEPASCORE FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-05-15|2020-06-27|10|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|48103500-0f3d-4108-9167-6afee1098773|2|HRYCELE|Hairy Cells/Leukocytes|CHEMISTRY|[?]|CAN|[?]|[?]|TRACE|1|JAR|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|CLOTTED||LIGHT SCATTERING SPECTROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||1|Visit_1|10|4|SCREENING|2020-05-15|2020-05-16|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|LB|48103500-0f3d-4108-9167-6afee1098773|3|TSI|Thyroid Stimulating Immunoglobulin|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^6/g|1|1|[?]|ABNORMAL|TUMOR TISSUE|REFRIGERATED||HPLC-FL|ASH FIBROSURE FORMULA|||N|Y|2|Visit_2|25|1|TREATMENT|2020-05-30|2020-06-26|25|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|LB|48103500-0f3d-4108-9167-6afee1098773|4|RETIHCR|Hematocrit Corrected Reticulocytes|HEMATOLOGY|[?]|L|[?]|[?]|POSITIVE|1|mU|1|1|[?]|LOW|CAPILLARY PLASMA|PARAFFIN-EMBEDDED||IODINE STAIN|MDRD 4 VARIABLE FORMULA||Y|NA||2|Visit_2|25|4|TREATMENT|2020-05-30|2020-07-23|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|LB|48103500-0f3d-4108-9167-6afee1098773|5|PIVKAII|Protein Induced by Vitamin K Absence-II|HEMATOLOGY|[?]|hr/day|[?]|[?]|POSITIVE|1|vg/kg|1|1|[?]|LOW|SUPERNATANT, PLASMA|CLOTTED|N|SLIT LAMP|GMI MMOL/MOL FORMULA|||N||3|Visit_3|40|2|FOLLOW-UP|2020-06-14|2020-07-08|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|48103500-0f3d-4108-9167-6afee1098773|6|PICP|Procollagen Type I Carboxy Term Peptide|HEMATOLOGY|||[?]|[?]|INVALID|1|10^9 organisms/g|1|1|[?]|ABNORMAL|ENDOMETRIAL TISSUE|THAWED|N|ENDOSCOPY|FIBROTEST FORMULA|||Y|Y|3|Visit_3|40|4|TREATMENT|2020-06-14|2020-06-29|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|LB|48103500-0f3d-4108-9167-6afee1098773|7|MIP1B|Macrophage Inflammatory Protein 1 Beta|HEMATOLOGY|[?]|PACKAGE|[?]|[?]|POSITIVE|1|CAPLET|1|1|[?]|LOW|WHITE MATTER TISSUE|FROZEN|N|PET/SPECT SCAN|MDRD ENZYMATIC FORMULA|Y||N||4|Visit_4|65|6|SCREENING|2020-07-09|2020-08-01|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|LB|48103500-0f3d-4108-9167-6afee1098773|8|GMCSF|Granulocyte Macrophage Colony Stm Factor|URINALYSIS|[?]|ng|[?]|[?]|TRACE|1|GPL U|1|1|[?]|HIGH|SERUM|CONCENTRATED||TEST STRIP|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||4|Visit_4|65|4|FOLLOW-UP|2020-07-09|2020-07-31|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|LB|48103500-0f3d-4108-9167-6afee1098773|9|PLATHCT|Platelet Hematocrit|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|ng|1|1|[?]|LOW|INFRANATANT, PLASMA|CALCIFIED|N|FLUORESCENT SPOT TEST|MDRD ENZYMATIC FORMULA||Y|Y|Y|5|Visit_5|90|3|WASHOUT|2020-08-03|2020-08-08|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|LB|48103500-0f3d-4108-9167-6afee1098773|10|MPM|Mean Platelet Dry Mass|CHEMISTRY|[?]|um/s|[?]|[?]|BORDERLINE|1|mEq/day|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|SOLIDIFIED|N|IMMUNOFIXATION ELECTROPHORESIS|NASH FIBROSURE FORMULA||Y|U||5|Visit_5|90|2|TREATMENT|2020-08-03|2020-08-11|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|LB|9855fc59-f162-48ba-8c51-e8c6c54b72f3|1|VITD2425|24,25-Dihydroxyvitamin D|CHEMISTRY|[?]|Bq/L|[?]|[?]|INDETERMINATE|1|ng|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|CALCIFIED||SIZE EXCLUSION CHROMATOGRAPHY|NASH FIBROSURE FORMULA|||NA||1|Visit_1|10|7|FOLLOW-UP|2020-07-25|2020-09-24|10|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|9855fc59-f162-48ba-8c51-e8c6c54b72f3|2|C3DAB|Complement C3d Antibody|HEMATOLOGY|||[?]|[?]|POSITIVE|1|cm2|1|1|[?]|HIGH|CORD SERUM|LACTESCENT||DARK FIELD MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|Y||U|Y|1|Visit_1|10|7|WASHOUT|2020-07-25|2020-10-01|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|9855fc59-f162-48ba-8c51-e8c6c54b72f3|3|IC512AB|Islet Cell 512 Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Ci/g|1|1|[?]|ABNORMAL|SEBUM|PARAFFIN-EMBEDDED|N|ACRIDINE ORANGE STAIN|CKD-EPI FORMULA||Y|Y|Y|2|Visit_2|25|4|SCREENING|2020-08-09|2020-09-14|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|9855fc59-f162-48ba-8c51-e8c6c54b72f3|4|CD56|CD56|URINALYSIS|||[?]|[?]|INVALID|1|10^8 PFU|1|1|[?]|ABNORMAL|SALIVA|THAWED||MANUAL COUNT|FIBROSIS 4 FORMULA||Y|N|Y|2|Visit_2|25|2|WASHOUT|2020-08-09|2020-09-24|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|9855fc59-f162-48ba-8c51-e8c6c54b72f3|5|CSAB|Cathepsin Antibody|HEMATOLOGY|[?]|uV2|[?]|[?]|TRACE|1|CIGARETTE|1|1|[?]|ABNORMAL|MUSCLE TISSUE|CONCENTRATED|N|NUCLEIC ACID SEQUENCING|MDRD 5 VARIABLE FORMULA|||U||3|Visit_3|40|7|TREATMENT|2020-08-24|2020-10-15|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|9855fc59-f162-48ba-8c51-e8c6c54b72f3|6|CARNIT|Carnitine|CHEMISTRY|[?]|mol/mol|[?]|[?]|INDETERMINATE|1|cm/s|1|1|[?]|ABNORMAL|LUNG SURFACTANT|AUTOLYZED||CALCULATION|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-08-24|2020-09-23|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|9855fc59-f162-48ba-8c51-e8c6c54b72f3|7|LDH1|LDH Isoenzyme 1|HEMATOLOGY|[?]|uEq/L|[?]|[?]|NEGATIVE|1|Henry|1|1|[?]|NORMAL|BONE MARROW|NON-HEMOLYZED||CONFOCAL MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|2|WASHOUT|2020-09-18|2020-10-03|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|9855fc59-f162-48ba-8c51-e8c6c54b72f3|8|BLSTLY|Lymphoblasts|HEMATOLOGY|[?]|PACKAGE|[?]|[?]|INDETERMINATE|1|uV2|1|1|[?]|NORMAL|PERSPIRATION|DRIED|N|MRI WITHOUT CONTRAST|GMI % FORMULA|Y||Y||4|Visit_4|65|7|TREATMENT|2020-09-18|2020-09-19|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|9855fc59-f162-48ba-8c51-e8c6c54b72f3|9|URATEEXR|Urate Excretion Rate|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|uOsm|1|1|[?]|LOW|ALVEOLAR AIR|GELLED||FREEZING POINT DEPRESSION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|5|Visit_5|90|6|SCREENING|2020-10-13|2020-10-20|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|9855fc59-f162-48ba-8c51-e8c6c54b72f3|10|GLDIGAAB|Gliadin IgA Antibody|CHEMISTRY|[?]|EVENTS|[?]|[?]|INVALID|1|ug/m2/min|1|1|[?]|HIGH|PLATELET RICH PLASMA|CONCENTRATED|N|LEAD CITRATE STAIN|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|3|SCREENING|2020-10-13|2020-10-17|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|ceab42b0-3a7e-4aad-b599-5da311398148|1|BTK|Bruton's Tyrosine Kinase|CHEMISTRY|[?]|10^9 CFU|[?]|[?]|INDETERMINATE|1|mg/mol|1|1|[?]|HIGH|EXUDATE|REFRIGERATED|N|MOUSE PROTECTION ASSAY|CKD-EPI FORMULA|Y||Y||1|Visit_1|10|7|SCREENING|2020-06-21|2020-07-11|10|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|ceab42b0-3a7e-4aad-b599-5da311398148|2|CSEPI846|Aggrecan Chondroitin Sulfate Epitope 846|HEMATOLOGY|[?]|TROCHE|[?]|[?]|POSITIVE|1|APS U|1|1|[?]|LOW|KERATINOCYTE|ICTERIC||DYNAMOMETRY|GMI % FORMULA|||NA||1|Visit_1|10|6|WASHOUT|2020-06-21|2020-09-01|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|ceab42b0-3a7e-4aad-b599-5da311398148|3|TAT|Thrombin/Antithrombin|CHEMISTRY|||[?]|[?]|BORDERLINE|1|nmol BCE/mmol|1|1|[?]|ABNORMAL|SEBUM|AGGLUTINATED||SLIT LAMP|FIBROSIS 4 FORMULA||Y|NA|Y|2|Visit_2|25|3|TREATMENT|2020-07-06|2020-08-29|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|ceab42b0-3a7e-4aad-b599-5da311398148|4|CSWAX|Waxy Casts|HEMATOLOGY|[?]|breaths/min|[?]|[?]|TRACE|1|10^6 organisms/mL|1|1|[?]|HIGH|URINE SEDIMENT|AGGLUTINATED||SLIT LAMP|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-07-06|2020-09-03|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|ceab42b0-3a7e-4aad-b599-5da311398148|5|TRAP|Total Radical-Trap Antioxidant Potential|URINALYSIS|[?]|steps/min|[?]|[?]|INVALID|1|g/m2|1|1|[?]|NORMAL|PLATELET|THAWED||WESTERN BLOT|GMI MMOL/MOL FORMULA|||U||3|Visit_3|40|6|FOLLOW-UP|2020-07-21|2020-08-10|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|ceab42b0-3a7e-4aad-b599-5da311398148|6|HALPRZLM|Hydroxyalprazolam|HEMATOLOGY|[?]|/VF|[?]|[?]|TRACE|1|mmHg/sec|1|1|[?]|HIGH|CAPILLARY PLASMA|THAWED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|GMI % FORMULA|||NA||3|Visit_3|40|6|SCREENING|2020-07-21|2020-08-25|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|ceab42b0-3a7e-4aad-b599-5da311398148|7|MACROCY|Macrocytes|HEMATOLOGY|[?]|Bq/kg|[?]|[?]|BORDERLINE|1|RNA copies/mL|1|1|[?]|HIGH|CEREBROSPINAL FLUID|FROZEN|N|X-RAY|FIBROMETER FORMULA||Y|NA||4|Visit_4|65|4|TREATMENT|2020-08-15|2020-08-28|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|ceab42b0-3a7e-4aad-b599-5da311398148|8|KIM1EXR|Kidney Injury Molecule-1 Excretion Rate|URINALYSIS|[?]|mg/mL/min|[?]|[?]|TRACE|1|cs|1|1|[?]|NORMAL|BONE|CLOTTED||TONOMETRY|CKD-EPI CYSTATIN C FORMULA|Y|Y|Y||4|Visit_4|65|4|TREATMENT|2020-08-15|2020-09-03|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|ceab42b0-3a7e-4aad-b599-5da311398148|9|FENTANYL|Fentanyl|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|pg|1|1|[?]|LOW|NAIL|CLOTTED||PEAK FLOWMETRY|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|5|Visit_5|90|4|TREATMENT|2020-09-09|2020-09-14|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|ceab42b0-3a7e-4aad-b599-5da311398148|10|OHDG8|8-Hydroxydeoxyguanosine|CHEMISTRY|[?]|U/dL|[?]|[?]|TRACE|1|CCID 50/mL|1|1|[?]|LOW|CAPILLARY PLASMA|CALCIFIED|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|ASH FIBROSURE FORMULA||Y|Y||5|Visit_5|90|1|WASHOUT|2020-09-09|2020-09-15|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|1|GLOBA1PT|Alpha-1 Globulin/Total Protein|HEMATOLOGY|[?]|mol/mg|[?]|[?]|POSITIVE|1|mL/m2/h|1|1|[?]|NORMAL|LOCHIA|AGGLUTINATED||FORCED OSCILLATION TECHNIQUE|CKD-EPI CYSTATIN C FORMULA|Y||N||1|Visit_1|10|6|WASHOUT|2020-07-09|2020-10-02|10|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|2|IL18EXR|Interleukin 18 Excretion Rate|URINALYSIS|[?]|INHALATION|[?]|[?]|BORDERLINE|1|Ci/g|1|1|[?]|LOW|LYSATE|SOLIDIFIED||MYELOPEROXIDASE STAIN|HEPASCORE FORMULA||Y|N||1|Visit_1|10|4|SCREENING|2020-07-09|2020-09-23|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|3|CBS|Cystathionine Beta-Synthase|CHEMISTRY|[?]|kg/m2|[?]|[?]|TRACE|1|g/cage/day|1|1|[?]|LOW|KERATINOCYTE|CLOTTED||OPTICAL COHERENCE TOMOGRAPHY|NASH FIBROSURE FORMULA||Y|U||2|Visit_2|25|7|TREATMENT|2020-07-24|2020-09-09|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|4|AMYLASES|Amylase, Salivary|URINALYSIS|[?]|Hz|[?]|[?]|TRACE|1|BISCUIT|1|1|[?]|NORMAL|PERITONEAL FLUID|FROZEN||IMMUNOTURBIDIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||2|Visit_2|25|6|WASHOUT|2020-07-24|2020-09-17|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|5|LYMPLLY|Plasmacytoid Lymphocytes/Lymphocytes|HEMATOLOGY|[?]|g/L|[?]|[?]|TRACE|1|mph|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|HEMOLYZED||FLOW MICROSCOPY|NASH FIBROSURE FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-08-08|2020-08-19|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|LB|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|6|ENA78|Epith Neutrophil-Activating Peptide 78|HEMATOLOGY|[?]|BP|[?]|[?]|TRACE|1|10^4/L|1|1|[?]|NORMAL|BLOOD|SOLIDIFIED||HPLC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|7|SCREENING|2020-08-08|2020-09-30|40|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|LB|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|7|ARA|Arachidonic Acid|CHEMISTRY|||[?]|[?]|POSITIVE|1|/40 HPFs|1|1|[?]|HIGH|ALVEOLAR AIR|PARAFFIN-EMBEDDED||LANDOLT RING|CKD-EPI FORMULA|||NA|Y|4|Visit_4|65|2|TREATMENT|2020-09-02|2020-09-04|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|8|HBLEPRHB|Hemoglobin Lepore/Total Hemoglobin|CHEMISTRY|[?]|10^6 copies/mL|[?]|[?]|BORDERLINE|1|Enzyme U|1|1|[?]|ABNORMAL|GASTRIC FLUID|ICTERIC||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD 5 VARIABLE FORMULA|Y||N||4|Visit_4|65|4|TREATMENT|2020-09-02|2020-09-19|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|9|INTLK2|Interleukin 2|HEMATOLOGY|[?]|CAPFUL|[?]|[?]|BORDERLINE|1|mL/day|1|1|[?]|HIGH|ABSCESS FLUID|NON-HEMOLYZED||FLUORESCENT IMMUNOASSAY|HEPASCORE FORMULA|||Y||5|Visit_5|90|2|WASHOUT|2020-09-27|2020-10-01|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|10|URATE|Urate|URINALYSIS|[?]|dyn|[?]|[?]|INVALID|1|mCi/L|1|1|[?]|HIGH|EMOTIONAL TEAR|AGGLUTINATED|N|POPULATION SEQUENCING|CKD-EPI CREATININE FORMULA|Y||Y||5|Visit_5|90|1|TREATMENT|2020-09-27|2020-09-29|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|1|SPERMP|Spermatozoa, Progressive|HEMATOLOGY|[?]|U/g/day|[?]|[?]|NEGATIVE|1|ng/dL|1|1|[?]|ABNORMAL|DERMAL TISSUE|LIPEMIC||X-RAY|MDRD 5 VARIABLE FORMULA||Y|U||1|Visit_1|10|3|TREATMENT|2020-07-10|2020-08-04|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|2|WDR26|WD Repeat-Containing Protein 26|HEMATOLOGY|[?]|Ci/g|[?]|[?]|TRACE|1|K|1|1|[?]|HIGH|URINE SEDIMENT|ROOM TEMPERATURE||KINETIC CHROMOGENIC ASSAY|CKD-EPI CREATININE FORMULA|Y||U||1|Visit_1|10|4|TREATMENT|2020-07-10|2020-07-28|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|3|LYMIMLE|Immature Lymphocytes/Leukocytes|CHEMISTRY|[?]|IMPLANT|[?]|[?]|INVALID|1|1/(s*kPa)|1|1|[?]|ABNORMAL|ABSCESS FLUID|NON-HEMOLYZED||TONOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|5|TREATMENT|2020-07-25|2020-09-24|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|4|BITECE|Bite Cells|CHEMISTRY|[?]|U/L|[?]|[?]|INDETERMINATE|1|bel|1|1|[?]|LOW|ENDOMETRIAL TISSUE|CLOTTED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|GMI % FORMULA|Y||U||2|Visit_2|25|1|TREATMENT|2020-07-25|2020-09-03|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|LB|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|5|HCT|Hematocrit|CHEMISTRY|[?]|10^5/hpf|[?]|[?]|INDETERMINATE|1|uV|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|DRIED||DC SHEATH FLOW|ASH FIBROSURE FORMULA|Y||U||3|Visit_3|40|7|TREATMENT|2020-08-09|2020-08-29|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|6|PYK|Pyruvate Kinase|URINALYSIS|[?]|L/min/m2|[?]|[?]|INDETERMINATE|1|cs|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|CLOTTED||REFLECTANCE SPECTROSCOPY|GMI % FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-08-09|2020-09-24|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|7|CD23|CD23|CHEMISTRY|[?]|kg/cm2|[?]|[?]|INDETERMINATE|1|h*%|1|1|[?]|HIGH|PROSTATIC FLUID|NON-HEMOLYZED|N|ELLA|FIBROMETER FORMULA|||Y||4|Visit_4|65|1|TREATMENT|2020-09-03|2020-09-05|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|LB|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|8|CD56|CD56|CHEMISTRY|[?]|kcal/day|[?]|[?]|BORDERLINE|1|SCOOPFUL|1|1|[?]|LOW|MENSTRUAL BLOOD|DRIED||TEST STRIP|CKD-EPI CREATININE FORMULA|||NA||4|Visit_4|65|3|WASHOUT|2020-09-03|2020-09-09|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|LB|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|9|RUBCE|Rubricyte/Total Cells|URINALYSIS|[?]|mCi|[?]|[?]|NEGATIVE|1|ug/kg/h|1|1|[?]|NORMAL|NAIL|HEMOLYZED|N|CYSTOMETRY|MDRD ENZYMATIC FORMULA|||N||5|Visit_5|90|4|TREATMENT|2020-09-28|2020-10-07|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|10|NCCPTN|Nociceptin|HEMATOLOGY|||[?]|[?]|INVALID|1|10^6 CFU|1|1|[?]|ABNORMAL|ISOLATE|THAWED||PULMONARY ANGIOGRAPHY|ASH FIBROSURE FORMULA|||U|Y|5|Visit_5|90|7|TREATMENT|2020-09-28|2020-09-29|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|36a54b72-6368-460e-ab4c-952923e0fd14|1|PLG|Plasminogen|HEMATOLOGY|[?]|mol/mg|[?]|[?]|NEGATIVE|1|ug/day|1|1|[?]|LOW|BASAL TEAR|REFRIGERATED|N|CENTRIFUGATION|CKD-EPI CYSTATIN C FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-05-15|2020-06-03|10|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|36a54b72-6368-460e-ab4c-952923e0fd14|2|C130133|D. farinae Antigen IgG Antibody|CHEMISTRY|[?]|PRESSOR UNITS|[?]|[?]|BORDERLINE|1|mL/kg|1|1|[?]|NORMAL|SUPERNATANT, SERUM|HEMOLYZED||NUCLEAR RADIOLOGY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||1|Visit_1|10|2|TREATMENT|2020-05-15|2020-06-20|10|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|36a54b72-6368-460e-ab4c-952923e0fd14|3|NSPMTSPM|Normal Sperm/Total Sperm|CHEMISTRY|[?]|km|[?]|[?]|INVALID|1|IU/kg|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|AUTOLYZED||FLUORESCENCE ANGIOGRAPHY|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-05-30|2020-07-22|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|36a54b72-6368-460e-ab4c-952923e0fd14|4|PLG|Plasminogen|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|dmol|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|REFRIGERATED||MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI CREATININE FORMULA|||N|Y|2|Visit_2|25|3|TREATMENT|2020-05-30|2020-06-05|25|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|36a54b72-6368-460e-ab4c-952923e0fd14|5|INTLK1RA|Interleukin 1 Receptor Antagonist|CHEMISTRY|[?]|10^6 CFU|[?]|[?]|TRACE|1|Bq|1|1|[?]|ABNORMAL|EPITHELIAL CELL|THAWED||AUDIOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2020-06-14|2020-07-02|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|36a54b72-6368-460e-ab4c-952923e0fd14|6|CD79A|CD79A|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mg/kg/min|1|1|[?]|HIGH|BONE MARROW|ICTERIC||SINGLE-SLICE SPIRAL CT|HEPASCORE FORMULA||Y|N|Y|3|Visit_3|40|1|SCREENING|2020-06-14|2020-07-29|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|36a54b72-6368-460e-ab4c-952923e0fd14|7|METARBLE|Metarubricytes/Leukocytes|CHEMISTRY|[?]|PELLET|[?]|[?]|POSITIVE|1|/40 HPFs|1|1|[?]|LOW|LUNG SURFACTANT|UNEXPECTED ODOR||IMPEDANCE CONDUCTIVITY|FIBROMETER FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-07-09|2020-07-15|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|36a54b72-6368-460e-ab4c-952923e0fd14|8|VITDAT|1, 25-Dihydroxyvitamin D|HEMATOLOGY|[?]|PLUG|[?]|[?]|POSITIVE|1|ug/mL/h|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|ICTERIC||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-07-09|2020-07-25|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|36a54b72-6368-460e-ab4c-952923e0fd14|9|CSEPI|Epithelial Casts|URINALYSIS|||[?]|[?]|BORDERLINE|1|mL/cage|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|LIPEMIC||LISSAMINE GREEN STAIN|GMI MMOL/MOL FORMULA|Y||Y|Y|5|Visit_5|90|3|SCREENING|2020-08-03|2020-08-11|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|36a54b72-6368-460e-ab4c-952923e0fd14|10|APROTCRS|Activated Protein C Resistance|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|MET|1|1|[?]|NORMAL|CALCULUS|THAWED||CINEANGIOGRAPHY|NASH FIBROSURE FORMULA||Y|Y|Y|5|Visit_5|90|5|TREATMENT|2020-08-03|2020-08-04|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|LB|84e56692-9a33-472a-9ddc-545d3342da34|1|CYCASULF|Calcium Sulfate Crystals|URINALYSIS|[?]|ug/min|[?]|[?]|INVALID|1|BAU|1|1|[?]|NORMAL|PLATELET POOR PLASMA|THAWED||PERCUSSION|MDRD FORMULA|||N||1|Visit_1|10|3|WASHOUT|2020-12-19|2021-03-18|10|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|84e56692-9a33-472a-9ddc-545d3342da34|2|MONO|Monocytes|CHEMISTRY|[?]|U/dL|[?]|[?]|TRACE|1|mPa|1|1|[?]|HIGH|BONE|PARAFFIN-EMBEDDED||OPHTHALMOSCOPY|MDRD 6 VARIABLE FORMULA||Y|N||1|Visit_1|10|4|TREATMENT|2020-12-19|2021-01-02|10|24|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|84e56692-9a33-472a-9ddc-545d3342da34|3|C165887|EnglishPlantain Pollen IgE AB RAST Score|CHEMISTRY|[?]|ppth|[?]|[?]|TRACE|1|/kg|1|1|[?]|LOW|ALVEOLAR AIR|SOLIDIFIED||KINETIC MICROPARTICLE IMMUNOASSAY|GMI % FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2021-01-03|2021-03-04|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|84e56692-9a33-472a-9ddc-545d3342da34|4|ESTRDIOL|Estradiol|URINALYSIS|||[?]|[?]|BORDERLINE|1|ug/animal|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|CLOTTED||SPIROMETRY|CKD-EPI FORMULA|||U|Y|2|Visit_2|25|7|SCREENING|2021-01-03|2021-02-10|25|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|LB|84e56692-9a33-472a-9ddc-545d3342da34|5|SCKLCE|Sickle Cells|URINALYSIS|[?]|nkat/g Hb|[?]|[?]|BORDERLINE|1|pkat|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|THAWED||AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2021-01-18|2021-01-22|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|84e56692-9a33-472a-9ddc-545d3342da34|6|THR|Threonine|HEMATOLOGY|[?]|10^7 CFU|[?]|[?]|POSITIVE|1|Absorbance U|1|1|[?]|ABNORMAL|LUNG SURFACTANT|AGGLUTINATED||REFRACTOMETRY|FIBROTEST FORMULA|Y||NA||3|Visit_3|40|2|TREATMENT|2021-01-18|2021-03-06|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|LB|84e56692-9a33-472a-9ddc-545d3342da34|7|C165927|Animal Mix IgE AB RAST Score|URINALYSIS|[?]|mmHg*min/L|[?]|[?]|INDETERMINATE|1|10^6 organisms/mg|1|1|[?]|HIGH|SALIVA|AGGLUTINATED|N|IMPULSE OSCILLOMETRY|GMI % FORMULA|||U||4|Visit_4|65|3|TREATMENT|2021-02-12|2021-03-12|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|84e56692-9a33-472a-9ddc-545d3342da34|8|VEGFR3S|Soluble Vasc Endoth Growth Factor Rec3|URINALYSIS|[?]|/4.0 mL|[?]|[?]|INVALID|1|WAFER|1|1|[?]|NORMAL|INTERSTITIAL FLUID|FRESH||DUKE INCISION METHOD|FIBROMETER FORMULA|||Y||4|Visit_4|65|1|SCREENING|2021-02-12|2021-03-01|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|84e56692-9a33-472a-9ddc-545d3342da34|9|C130073|Birch Pollen IgA|CHEMISTRY|[?]|/HPF|[?]|[?]|NEGATIVE|1|SPRAY|1|1|[?]|NORMAL|SOFT TISSUE|AUTOLYZED||CONTRAST ENHANCED CT SCAN|MDRD 4 VARIABLE FORMULA|||U||5|Visit_5|90|4|WASHOUT|2021-03-09|2021-03-13|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|84e56692-9a33-472a-9ddc-545d3342da34|10|ABO|ABO Blood Group|URINALYSIS|[?]|ug/dL|[?]|[?]|INDETERMINATE|1|Enzyme U/m2|1|1|[?]|NORMAL|CORD BLOOD|AUTOLYZED|N|ACRIDINE ORANGE STAIN|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2021-03-09|2021-03-16|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|1|IFI27|Interferon Alpha-Inducible Protein 27|URINALYSIS|||[?]|[?]|POSITIVE|1|IU/kg|1|1|[?]|LOW|MIXED VENOUS BLOOD|FROZEN||CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA|Y||N|Y|1|Visit_1|10|2|WASHOUT|2020-05-31|2020-08-01|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|LB|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|2|OXACREAT|Oxalate/Creatinine|CHEMISTRY|[?]|mol/L|[?]|[?]|BORDERLINE|1|umol/kg/min|1|1|[?]|HIGH|MONOCYTE|FROZEN||SPECULAR MICROSCOPY|NASH FIBROSURE FORMULA||Y|Y||1|Visit_1|10|4|WASHOUT|2020-05-31|2020-06-06|10|16|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|LB|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|3|HOWJOL|Howell-Jolly Bodies|URINALYSIS|[?]|cm/min|[?]|[?]|INVALID|1|cL|1|1|[?]|LOW|DIALYSIS FLUID|CALCIFIED||STATIC PERIMETRY|CKD-EPI FORMULA||Y|N||2|Visit_2|25|3|SCREENING|2020-06-15|2020-06-16|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|4|FGFBF|Fibroblast Growth Factor Basic Form|CHEMISTRY|[?]|uSiemens|[?]|[?]|TRACE|1|mAnson U/mL|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|THAWED||ENZYMATIC ULTRACENTRIFUGATION|MDRD 4 VARIABLE FORMULA||Y|U||2|Visit_2|25|1|SCREENING|2020-06-15|2020-06-20|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|5|SCL70GAB|Scl-70 IgG Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|mL/100g/min|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|LACTESCENT||PET/SPECT SCAN|MDRD 4 VARIABLE FORMULA||Y|N|Y|3|Visit_3|40|2|WASHOUT|2020-06-30|2020-08-03|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|6|RNA|Ribonucleic Acid|CHEMISTRY|[?]|mEq/kg|[?]|[?]|NEGATIVE|1|umol/L/min|1|1|[?]|HIGH|URINE|CLOTTED|N|KLEIHAUER-BETKE|MDRD 4 VARIABLE FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-06-30|2020-08-27|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|7|C165925|Weed Mix Pollen IgE AB RAST Score|CHEMISTRY|[?]|DROP|[?]|[?]|POSITIVE|1|GBq/g|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|LACTESCENT|N|BALLPOINT PEN TECHNIQUE|MDRD FORMULA|Y|Y|Y||4|Visit_4|65|3|WASHOUT|2020-07-25|2020-08-16|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-23
e|LB|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|8|CRDIGAAB|Cardiolipin IgA Antibody|CHEMISTRY|[?]|ng/L|[?]|[?]|POSITIVE|1|U/mg|1|1|[?]|ABNORMAL|SPUTUM|CALCIFIED||MICROBIAL CULTURE, LIQUID|MDRD 6 VARIABLE FORMULA|||N||4|Visit_4|65|3|SCREENING|2020-07-25|2020-08-14|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-23
e|LB|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|9|IGFBP1|Insulin-Like Growth Factor Binding Prot1|URINALYSIS|[?]|ngEq/L|[?]|[?]|TRACE|1|mL/mmHg/min/L|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|FRESH||IMMUNOFLUORESCENT STAIN|MDRD FORMULA|||Y||5|Visit_5|90|6|SCREENING|2020-08-19|2020-08-27|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|10|MCPHG|Macrophages|HEMATOLOGY|[?]|Siemens|[?]|[?]|POSITIVE|1|mCi/L|1|1|[?]|NORMAL|VENOUS PLASMA|FRESH||PET SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|3|TREATMENT|2020-08-19|2020-08-25|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|1|VEGFC|Vascular Endothelial Growth Factor C|URINALYSIS|[?]|RATIO|[?]|[?]|NEGATIVE|1|FINGERTIP UNIT|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|CALCIFIED||MUGA|MDRD ENZYMATIC FORMULA|||NA||1|Visit_1|10|7|SCREENING|2020-06-10|2020-06-29|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|LB|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|2|OPN|Osteopontin|CHEMISTRY|[?]|mL/cm|[?]|[?]|TRACE|1|umol/day|1|1|[?]|ABNORMAL|SERUM OR PLASMA|SOLIDIFIED|N|MICRO BROTH DILUTION|COCKCROFT-GAULT FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-06-10|2020-08-01|10|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|LB|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|3|CD22|CD22|URINALYSIS|[?]|GLOBULE|[?]|[?]|INDETERMINATE|1|AU/mL|1|1|[?]|NORMAL|PLATELET POOR PLASMA|CONCENTRATED||SPECTROPHOTOMETRY|GMI MMOL/MOL FORMULA||Y|NA||2|Visit_2|25|7|TREATMENT|2020-06-25|2020-07-23|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|4|YEASTBUD|Yeast Budding|CHEMISTRY|[?]|STRIP|[?]|[?]|INDETERMINATE|1|APL U/mL|1|1|[?]|HIGH|PLASMA|SOLIDIFIED||MALDI-TOF|CKD-EPI CREATININE FORMULA|Y|Y|U||2|Visit_2|25|4|FOLLOW-UP|2020-06-25|2020-08-03|25|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|5|TXB2D11R|11-Dehydro-Thromboxane B2 Excretion Rate|CHEMISTRY|[?]|kg/m2|[?]|[?]|NEGATIVE|1|Bq/g|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|FRESH||IMMUNODIFFUSION|MDRD FORMULA||Y|Y||3|Visit_3|40|2|TREATMENT|2020-07-10|2020-08-10|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|6|C130109|Mold Mix Antigen IgE Antibody|CHEMISTRY|[?]|ug/kg/min|[?]|[?]|INVALID|1|% INHIBITION|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|ROOM TEMPERATURE||DIGITAL PCR ARRAY|FIBROMETER FORMULA||Y|NA||3|Visit_3|40|7|SCREENING|2020-07-10|2020-07-23|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|7|MCSF|Macrophage Colony Stimulating Factor|CHEMISTRY|[?]|Gy|[?]|[?]|BORDERLINE|1|mL/min/mmHg|1|1|[?]|HIGH|LUNG SURFACTANT|CONTAMINATED|N|MULTI-SLICE SPIRAL CT|CKD-EPI CREATININE FORMULA|Y|Y|U||4|Visit_4|65|2|FOLLOW-UP|2020-08-04|2020-08-22|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|8|CRYOGLBN|Cryoglobulin|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|NEEDLE GAUGE|1|1|[?]|NORMAL|TRANSUDATE|UNEXPECTED ODOR||ORCHIDOMETERY|ASH FIBROSURE FORMULA||Y|N|Y|4|Visit_4|65|3|TREATMENT|2020-08-04|2020-08-20|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|9|NONHDL|Non-HDL Cholesterol|HEMATOLOGY|[?]|NEBULE|[?]|[?]|TRACE|1|pmol/g|1|1|[?]|NORMAL|PUS|THAWED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA|Y||Y||5|Visit_5|90|6|TREATMENT|2020-08-29|2020-09-02|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|LB|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|10|EPINSQCE|Non-Squamous Epithelial Cells|HEMATOLOGY|[?]|10^12/L|[?]|[?]|POSITIVE|1|amu|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|FRESH||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|FIBROSIS 4 FORMULA|Y||U||5|Visit_5|90|4|TREATMENT|2020-08-29|2020-08-31|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|LB|ae0e05c1-3953-4406-bfae-299295c1fa4c|1|MCHC|Ery. Mean Corpuscular HGB Concentration|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mg/mol|1|1|[?]|ABNORMAL|SMEGMA|CALCIFIED||REBOUND TONOMETRY|GMI MMOL/MOL FORMULA||Y|U|Y|1|Visit_1|10|6|TREATMENT|2021-01-12|2021-02-03|10|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|LB|ae0e05c1-3953-4406-bfae-299295c1fa4c|2|LSELS|Soluble L-Selectin|URINALYSIS|[?]|SFC/10^6 PBMC|[?]|[?]|NEGATIVE|1|CONTAINER|1|1|[?]|HIGH|INFRANATANT, SERUM|PARAFFIN-EMBEDDED||CINEANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||1|Visit_1|10|4|TREATMENT|2021-01-12|2021-03-11|10|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|LB|ae0e05c1-3953-4406-bfae-299295c1fa4c|3|BLASTRUB|Rubriblast|URINALYSIS|[?]|ug/m2|[?]|[?]|POSITIVE|1|Ci|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|FROZEN||GC/FID|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2021-01-27|2021-02-12|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|ae0e05c1-3953-4406-bfae-299295c1fa4c|4|GLUCPED|Plasma Equivalent Glucose Distribution|URINALYSIS|[?]|mg/g/min|[?]|[?]|TRACE|1|fg|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|FROZEN||IHC|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||2|Visit_2|25|7|FOLLOW-UP|2021-01-27|2021-03-14|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|ae0e05c1-3953-4406-bfae-299295c1fa4c|5|PD1S|Soluble Programmed Death-1|URINALYSIS|[?]|fmol/L|[?]|[?]|TRACE|1|kg/mol|1|1|[?]|NORMAL|INFRANATANT, PLASMA|ICTERIC||MULTI-SLICE SPIRAL CT|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|6|SCREENING|2021-02-11|2021-02-20|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|ae0e05c1-3953-4406-bfae-299295c1fa4c|6|APPEAR|Specimen Appearance|HEMATOLOGY|[?]|%/s|[?]|[?]|INDETERMINATE|1|U/g/h|1|1|[?]|HIGH|BASAL TEAR|FRESH||TURBIDIMETRY|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|5|FOLLOW-UP|2021-02-11|2021-04-07|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|ae0e05c1-3953-4406-bfae-299295c1fa4c|7|HYDMDZ4|4-Hydroxymidazolam|URINALYSIS|[?]|mg/cm2|[?]|[?]|NEGATIVE|1|10^6 organisms/mL|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|DRIED|N|OPHTHALMOSCOPY|COCKCROFT-GAULT FORMULA|Y||Y||4|Visit_4|65|3|FOLLOW-UP|2021-03-08|2021-03-09|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|ae0e05c1-3953-4406-bfae-299295c1fa4c|8|C1INH|Complement C1 Esterase Inhibitor|HEMATOLOGY|[?]|PATCH|[?]|[?]|INDETERMINATE|1|Ci/L|1|1|[?]|LOW|BLOOD|CALCIFIED||MALDI-TOF|MDRD 4 VARIABLE FORMULA||Y|N||4|Visit_4|65|4|WASHOUT|2021-03-08|2021-03-19|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|LB|ae0e05c1-3953-4406-bfae-299295c1fa4c|9|TRAP|Total Radical-Trap Antioxidant Potential|URINALYSIS|||[?]|[?]|NEGATIVE|1|mm/sec|1|1|[?]|HIGH|PLEURAL FLUID|CALCIFIED||ELECTRONEUROGRAPHY|MDRD ENZYMATIC FORMULA||Y|U|Y|5|Visit_5|90|1|TREATMENT|2021-04-02|2021-04-08|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|ae0e05c1-3953-4406-bfae-299295c1fa4c|10|KLHIGGAB|Keyhole Limpet Hemocyanin IgG Antibody|CHEMISTRY|||[?]|[?]|INVALID|1|Enzyme U/L|1|1|[?]|LOW|URINE|REFRIGERATED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|HEPASCORE FORMULA|||NA|Y|5|Visit_5|90|5|TREATMENT|2021-04-02|2021-04-06|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|LB|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|1|TNF10|TNF Superfamily Member 10|HEMATOLOGY|[?]|mL/animal|[?]|[?]|TRACE|1|10^9 organisms/mg|1|1|[?]|LOW|EPITHELIAL CELL|GELLED||NON-CONTACT SPECULAR MICROSCOPY|MDRD 6 VARIABLE FORMULA|||U||1|Visit_1|10|5|WASHOUT|2021-01-16|2021-02-05|10|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|2|ETS|Ethyl Sulfate|URINALYSIS|[?]|uL/kg/day|[?]|[?]|BORDERLINE|1|mOsm/L|1|1|[?]|NORMAL|ARTERIAL BLOOD|THAWED|N|PH METER MEASUREMENT METHOD|CKD-EPI CYSTATIN C FORMULA||Y|U||1|Visit_1|10|5|TREATMENT|2021-01-16|2021-03-07|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|LB|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|3|ACYCRNTN|Acylcarnitine|HEMATOLOGY|[?]|CAPSULE|[?]|[?]|INVALID|1|U/mL|1|1|[?]|LOW|SMEGMA|CALCIFIED||ENDOSCOPY|NASH FIBROSURE FORMULA|||U||2|Visit_2|25|3|FOLLOW-UP|2021-01-31|2021-02-02|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|LB|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|4|MMYCECE|Maturing Myeloid Cells/Total Cells|HEMATOLOGY|[?]|mL/s/m2|[?]|[?]|INDETERMINATE|1|BAR|1|1|[?]|ABNORMAL|SERUM OR PLASMA|NON-HEMOLYZED|N|SEQUENCING|GMI % FORMULA|||Y||2|Visit_2|25|3|WASHOUT|2021-01-31|2021-02-02|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|LB|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|5|HIST1AB|Histone 1 Antibody|CHEMISTRY|[?]|U|[?]|[?]|POSITIVE|1|umol|1|1|[?]|HIGH|PERITONEAL FLUID|REFRIGERATED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|7|SCREENING|2021-02-15|2021-03-15|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|6|FENA|Fractional Sodium Excretion|CHEMISTRY|[?]|gtt|[?]|[?]|POSITIVE|1|/2000 RBC|1|1|[?]|ABNORMAL|LEUKOCYTE|CALCIFIED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA|||Y||3|Visit_3|40|4|WASHOUT|2021-02-15|2021-04-13|40|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|LB|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|7|TSIAC|TSI Actual/Control|URINALYSIS|[?]|g/animal/day|[?]|[?]|TRACE|1|10^3/L|1|1|[?]|NORMAL|PERITONEAL FLUID|GELLED|N|GRAM STAIN|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|1|TREATMENT|2021-03-12|2021-04-11|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|8|HSP90A|Heat Shock Protein 90 Alpha|CHEMISTRY|[?]|%|[?]|[?]|POSITIVE|1|%(w/w)|1|1|[?]|NORMAL|ALVEOLAR AIR|CLOTTED||JAEGER EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2021-03-12|2021-04-14|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|9|CXCL7|Chemokine (C-X-C Motif) Ligand 7|URINALYSIS|||[?]|[?]|POSITIVE|1|%|1|1|[?]|LOW|PROSTATIC FLUID|PARAFFIN-EMBEDDED||REFLECTANCE SPECTROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|5|Visit_5|90|2|TREATMENT|2021-04-06|2021-04-10|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|10|ERCEMIDX|Erythroid Maturation Index|CHEMISTRY|[?]|vg/mL|[?]|[?]|BORDERLINE|1|mL/animal/day|1|1|[?]|LOW|ARTERIAL CORD BLOOD|SOLIDIFIED||VIRUS PLAQUE ASSAY|MDRD ENZYMATIC FORMULA||Y|U||5|Visit_5|90|1|FOLLOW-UP|2021-04-06|2021-04-15|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|LB|ab09e76d-8bbf-4126-a60d-08d6b5292836|1|CYAMMOX|Ammonium Oxalate Crystals|URINALYSIS|[?]|cP|[?]|[?]|INVALID|1|/5x10^4 WBC|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|CONTAMINATED|N|MIGET|CKD-EPI CYSTATIN C FORMULA|Y||N||1|Visit_1|10|1|WASHOUT|2020-12-25|2021-02-06|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|ab09e76d-8bbf-4126-a60d-08d6b5292836|2|BTK|Bruton's Tyrosine Kinase|CHEMISTRY|||[?]|[?]|NEGATIVE|1|OI50|1|1|[?]|NORMAL|MECONIUM|HEMOLYZED|N|KINETIC CHROMOGENIC ASSAY|MDRD ENZYMATIC FORMULA|||Y|Y|1|Visit_1|10|1|FOLLOW-UP|2020-12-25|2021-02-21|10|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|ab09e76d-8bbf-4126-a60d-08d6b5292836|3|FLUOXTN|Fluoxetine|HEMATOLOGY|[?]|10^6 organisms/mg|[?]|[?]|INDETERMINATE|1|10^6 U|1|1|[?]|LOW|DERMAL TISSUE|LACTESCENT||SPIRAL CT|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2021-01-09|2021-03-05|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|LB|ab09e76d-8bbf-4126-a60d-08d6b5292836|4|C4A|Complement C4a|CHEMISTRY|[?]|/200 HPFs|[?]|[?]|INVALID|1|10^6/L|1|1|[?]|ABNORMAL|PERITONEAL FLUID|FROZEN||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|GMI MMOL/MOL FORMULA|Y||Y||2|Visit_2|25|2|WASHOUT|2021-01-09|2021-03-18|25|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|LB|ab09e76d-8bbf-4126-a60d-08d6b5292836|5|EPISQCE|Squamous Epithelial Cells|CHEMISTRY|||[?]|[?]|POSITIVE|1|uSiemens|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|PARAFFIN-EMBEDDED|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|3|Visit_3|40|5|FOLLOW-UP|2021-01-24|2021-02-19|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|ab09e76d-8bbf-4126-a60d-08d6b5292836|6|PDGFAB|Platelet Derived Growth Factor IsoformAB|URINALYSIS|[?]|mJoule/cm2|[?]|[?]|INDETERMINATE|1|PIPE|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED||SURFACE PLASMON RESONANCE|MDRD 4 VARIABLE FORMULA|||U||3|Visit_3|40|2|FOLLOW-UP|2021-01-24|2021-02-07|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|ab09e76d-8bbf-4126-a60d-08d6b5292836|7|ANPPRONT|N-Terminal ProA-type Natriuretic Peptide|HEMATOLOGY|[?]|PLUG|[?]|[?]|INDETERMINATE|1|mL/kg/min|1|1|[?]|HIGH|ERYTHROCYTES|AUTOLYZED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|GMI MMOL/MOL FORMULA|||N||4|Visit_4|65|7|SCREENING|2021-02-18|2021-02-19|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|ab09e76d-8bbf-4126-a60d-08d6b5292836|8|INSAAB|Insulin Autoantibody|HEMATOLOGY|[?]|nmol|[?]|[?]|INVALID|1|nmol/L/h|1|1|[?]|LOW|PLASMA|FRESH||HPLC/MS/MS|FIBROMETER FORMULA|Y||Y||4|Visit_4|65|6|TREATMENT|2021-02-18|2021-02-19|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|ab09e76d-8bbf-4126-a60d-08d6b5292836|9|HALPRZLM|Hydroxyalprazolam|URINALYSIS|[?]|/wk|[?]|[?]|INDETERMINATE|1|pg/dL|1|1|[?]|LOW|CORD BLOOD|AUTOLYZED||TEMPLATE INCISION METHOD|GMI % FORMULA|||NA||5|Visit_5|90|5|FOLLOW-UP|2021-03-15|2021-03-18|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|ab09e76d-8bbf-4126-a60d-08d6b5292836|10|C165937|Zea mays IgE AB RAST Score|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Gy/min|1|1|[?]|HIGH|SKIN TISSUE|ROOM TEMPERATURE|N|DISK DIFFUSION|MDRD 4 VARIABLE FORMULA||Y|U|Y|5|Visit_5|90|4|TREATMENT|2021-03-15|2021-03-19|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|8b7e3909-4115-4736-b07a-e0b6c382aa7e|1|TRIM38|Tripartite Motif Containing Protein 38|CHEMISTRY|[?]|F|[?]|[?]|INDETERMINATE|1|WAFER|1|1|[?]|NORMAL|INFRANATANT, SERUM|FRESH||LIQUID SCINTILLATION COUNTING|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|1|WASHOUT|2020-07-11|2020-09-09|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|8b7e3909-4115-4736-b07a-e0b6c382aa7e|2|CD40L|CD40 Ligand|CHEMISTRY|[?]|U/m2/day|[?]|[?]|TRACE|1|fmol/L/sec|1|1|[?]|ABNORMAL|PLEURAL FLUID|CONTAMINATED||SPIROMETRY|ASH FIBROSURE FORMULA|Y||N||1|Visit_1|10|3|TREATMENT|2020-07-11|2020-07-25|10|24|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|8b7e3909-4115-4736-b07a-e0b6c382aa7e|3|ANTHRMA|Antithrombin Activity|HEMATOLOGY|[?]|cd|[?]|[?]|INVALID|1|Frames/s|1|1|[?]|ABNORMAL|BILE|LIPEMIC|N|GC/MS|CKD-EPI FORMULA|Y||NA||2|Visit_2|25|7|TREATMENT|2020-07-26|2020-08-07|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|8b7e3909-4115-4736-b07a-e0b6c382aa7e|4|PEPSNG|Pepsinogen|URINALYSIS|[?]|TRACE|[?]|[?]|INVALID|1|SYRINGE|1|1|[?]|ABNORMAL|LYSATE|LACTESCENT||JAEGER EYE CHART|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|5|FOLLOW-UP|2020-07-26|2020-09-06|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|8b7e3909-4115-4736-b07a-e0b6c382aa7e|5|WDR26|WD Repeat-Containing Protein 26|URINALYSIS|[?]|PRESSOR UNITS|[?]|[?]|POSITIVE|1|usec|1|1|[?]|NORMAL|SYNOVIAL FLUID|FRESH|N|DUKE INCISION METHOD|CKD-EPI FORMULA|Y||N||3|Visit_3|40|4|SCREENING|2020-08-10|2020-09-17|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|8b7e3909-4115-4736-b07a-e0b6c382aa7e|6|C130082|Orchard Grass Pollen IgG|CHEMISTRY|[?]|10^8 PFU|[?]|[?]|BORDERLINE|1|DISK|1|1|[?]|LOW|SYNOVIAL FLUID|LACTESCENT||ERGOSPIROMETRY|FIBROMETER FORMULA|||NA||3|Visit_3|40|2|SCREENING|2020-08-10|2020-09-13|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|8b7e3909-4115-4736-b07a-e0b6c382aa7e|7|EPINSQE|Epi Cells/Non-Squam Epi Cells|URINALYSIS|[?]|/200 HPFs|[?]|[?]|INDETERMINATE|1|atm|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|ROOM TEMPERATURE||IMMUNOFIXATION ELECTROPHORESIS|FIBROSIS 4 FORMULA|Y||U||4|Visit_4|65|3|WASHOUT|2020-09-04|2020-09-19|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|8b7e3909-4115-4736-b07a-e0b6c382aa7e|8|PLAT|Platelets|URINALYSIS|[?]|BU|[?]|[?]|NEGATIVE|1|APS U|1|1|[?]|HIGH|VENOUS PLASMA|FRESH||LASER CAPTURE MICRODISSECTION|NASH FIBROSURE FORMULA|||NA||4|Visit_4|65|4|WASHOUT|2020-09-04|2020-09-21|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|8b7e3909-4115-4736-b07a-e0b6c382aa7e|9|VITD3|Vitamin D3|URINALYSIS|||[?]|[?]|TRACE|1|10^4 CFU/mL|1|1|[?]|ABNORMAL|SERUM|FRESH||STATIC PERIMETRY|GMI % FORMULA|Y||Y|Y|5|Visit_5|90|7|WASHOUT|2020-09-29|2020-10-04|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|8b7e3909-4115-4736-b07a-e0b6c382aa7e|10|PC3MPSAM|PCA3 mRNA/PSA mRNA|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Ci/L|1|1|[?]|ABNORMAL|PLEURAL TISSUE|ROOM TEMPERATURE||NUCLEIC ACID HYBRIDIZATION|GMI % FORMULA|||NA|Y|5|Visit_5|90|7|TREATMENT|2020-09-29|2020-10-08|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|187b2279-526f-4978-89d4-d2da56cc2257|1|TBG|Thyroxine Binding Globulin|URINALYSIS|||[?]|[?]|NEGATIVE|1|log10 TCID 50/dose|1|1|[?]|NORMAL|EXUDATE|CLOTTED||PALPATION|COCKCROFT-GAULT FORMULA|Y|Y|U|Y|1|Visit_1|10|7|WASHOUT|2020-06-21|2020-09-04|10|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|187b2279-526f-4978-89d4-d2da56cc2257|2|CA2729AG|Cancer Antigen 27-29|URINALYSIS|||[?]|[?]|POSITIVE|1|umol/dL|1|1|[?]|NORMAL|PLEURAL FLUID|FROZEN|N|SANGER SEQUENCING|FIBROMETER FORMULA|||U|Y|1|Visit_1|10|1|SCREENING|2020-06-21|2020-08-18|10|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|187b2279-526f-4978-89d4-d2da56cc2257|3|APOE4|Apolipoprotein E4|URINALYSIS|||[?]|[?]|POSITIVE|1|PACKAGE|1|1|[?]|NORMAL|PLATELET|REFRIGERATED|N|TEMPLATE INCISION METHOD|GMI MMOL/MOL FORMULA|||NA|Y|2|Visit_2|25|7|FOLLOW-UP|2020-07-06|2020-09-11|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|187b2279-526f-4978-89d4-d2da56cc2257|4|TRIG|Triglycerides|URINALYSIS|[?]|10^9 CFU/mL|[?]|[?]|NEGATIVE|1|nm|1|1|[?]|NORMAL|ISOLATE|ICTERIC||MOUSE PROTECTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|5|TREATMENT|2020-07-06|2020-07-09|25|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|LB|187b2279-526f-4978-89d4-d2da56cc2257|5|ESTFR|Estradiol, Free|CHEMISTRY|[?]|dpm/0.5 mL|[?]|[?]|TRACE|1|SQU/mL|1|1|[?]|NORMAL|ISOLATE|CONTAMINATED||WEBER GREEN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||3|Visit_3|40|3|FOLLOW-UP|2020-07-21|2020-09-08|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|187b2279-526f-4978-89d4-d2da56cc2257|6|LKM1IAAB|Liver Kidney Microsomal Type 1 IgA Ab|HEMATOLOGY|[?]|Bq/L|[?]|[?]|INVALID|1|mkat|1|1|[?]|NORMAL|SOFT TISSUE|FRESH||MICROBIAL CULTURE, SOLID|ASH FIBROSURE FORMULA|Y||U||3|Visit_3|40|6|TREATMENT|2020-07-21|2020-09-13|40|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|187b2279-526f-4978-89d4-d2da56cc2257|7|ATPVITE|Alpha Tocopherol/Vitamin E|CHEMISTRY|[?]|lx|[?]|[?]|POSITIVE|1|APL U/mL|1|1|[?]|ABNORMAL|LOCHIA|AUTOLYZED||HEMATOXYLIN AND EOSIN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||4|Visit_4|65|1|TREATMENT|2020-08-15|2020-08-25|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|187b2279-526f-4978-89d4-d2da56cc2257|8|MSPIKEXR|Monoclonal Protein Spike Excretion Rate|CHEMISTRY|||[?]|[?]|POSITIVE|1|Tbsp|1|1|[?]|ABNORMAL|LUNG SURFACTANT|HEMOLYZED|N|SPECT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N|Y|4|Visit_4|65|3|TREATMENT|2020-08-15|2020-08-22|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|LB|187b2279-526f-4978-89d4-d2da56cc2257|9|VITB6|Vitamin B6|CHEMISTRY|[?]|CAN|[?]|[?]|INVALID|1|BAR|1|1|[?]|NORMAL|BILE|CONTAMINATED||REFLECTANCE SPECTROSCOPY|CKD-EPI FORMULA|||U||5|Visit_5|90|5|TREATMENT|2020-09-09|2020-09-16|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|LB|187b2279-526f-4978-89d4-d2da56cc2257|10|TIMM10|Translocase Inner Mitochondrial Membr 10|URINALYSIS|||[?]|[?]|TRACE|1|g|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|DRIED||PALPATION|ASH FIBROSURE FORMULA|||NA|Y|5|Visit_5|90|5|TREATMENT|2020-09-09|2020-09-11|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|LB|53506a04-dedb-495b-8e35-0576cdf1b323|1|CDCACM|Chenodeoxycholate Compounds|URINALYSIS|[?]|mL/kg|[?]|[?]|BORDERLINE|1|10^9/dose|1|1|[?]|HIGH|GASTRIC CONTENTS|CLOTTED|N|HEMOCYTOMETRY|GMI MMOL/MOL FORMULA|Y|Y|N||1|Visit_1|10|7|TREATMENT|2020-11-07|2021-01-20|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|53506a04-dedb-495b-8e35-0576cdf1b323|2|PRINSINS|Proinsulin/Insulin Ratio|URINALYSIS|[?]|DDU|[?]|[?]|NEGATIVE|1|mg/m2|1|1|[?]|HIGH|DIALYSIS FLUID|NON-HEMOLYZED||GC/MS|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-11-07|2021-02-04|10|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|53506a04-dedb-495b-8e35-0576cdf1b323|3|PSELECT|P-Selectin|CHEMISTRY|[?]|ngEq/L|[?]|[?]|TRACE|1|BEAM BREAKS|1|1|[?]|HIGH|MUSCLE TISSUE|LACTESCENT||CLAUSS METHOD|FIBROTEST FORMULA|Y||NA||2|Visit_2|25|4|TREATMENT|2020-11-22|2021-01-01|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|53506a04-dedb-495b-8e35-0576cdf1b323|4|DNA|Deoxyribonucleic Acid|CHEMISTRY|[?]|BISCUIT|[?]|[?]|INVALID|1|%/min|1|1|[?]|NORMAL|HAIR FOLLICLE|GELLED||SNELLEN EYE CHART|FIBROTEST FORMULA||Y|U||2|Visit_2|25|5|FOLLOW-UP|2020-11-22|2020-12-14|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|LB|53506a04-dedb-495b-8e35-0576cdf1b323|5|IGF1|Insulin-like Growth Factor-1|URINALYSIS|[?]|MPL U|[?]|[?]|TRACE|1|mmol2/L2|1|1|[?]|HIGH|CELL PELLET|PARAFFIN-EMBEDDED|N|VENTILATION PERFUSION LUNG SCAN|MDRD 4 VARIABLE FORMULA||Y|N||3|Visit_3|40|2|WASHOUT|2020-12-07|2020-12-20|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|53506a04-dedb-495b-8e35-0576cdf1b323|6|VLDLTCT|VLDL Triglyceride + Chylomicron Triglyceride|CHEMISTRY|||[?]|[?]|NEGATIVE|1|ug/dL|1|1|[?]|HIGH|BONE|ROOM TEMPERATURE||THERMAL IONIZATION MASS SPECTROMETRY|MDRD FORMULA|||U|Y|3|Visit_3|40|5|TREATMENT|2020-12-07|2021-01-16|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|53506a04-dedb-495b-8e35-0576cdf1b323|7|HLADR53A|HLA-DR53 Antibody|URINALYSIS|[?]|ng/dL|[?]|[?]|BORDERLINE|1|h*%|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|CONCENTRATED|N|ACID FAST STAIN|MDRD ENZYMATIC FORMULA|||U||4|Visit_4|65|4|FOLLOW-UP|2021-01-01|2021-01-10|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|53506a04-dedb-495b-8e35-0576cdf1b323|8|AST|Aspartate Aminotransferase|URINALYSIS|[?]|pmol/L/h|[?]|[?]|INVALID|1|ms2|1|1|[?]|HIGH|BREAST MILK|FROZEN||LC/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|4|WASHOUT|2021-01-01|2021-02-04|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|53506a04-dedb-495b-8e35-0576cdf1b323|9|CHOL|Cholesterol|CHEMISTRY|[?]|mL/min/mmHg|[?]|[?]|NEGATIVE|1|ag|1|1|[?]|HIGH|BASAL TEAR|UNEXPECTED ODOR|N|WRIGHT-GIEMSA STAIN|HEPASCORE FORMULA|Y||U||5|Visit_5|90|2|FOLLOW-UP|2021-01-26|2021-01-30|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|53506a04-dedb-495b-8e35-0576cdf1b323|10|NSPMTSPM|Normal Sperm/Total Sperm|URINALYSIS|[?]|dL|[?]|[?]|NEGATIVE|1|BAR|1|1|[?]|HIGH|SKIN TISSUE|LIPEMIC||MODIFIED ACID FAST STAIN|FIBROTEST FORMULA|Y||Y||5|Visit_5|90|3|TREATMENT|2021-01-26|2021-01-29|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|defa600c-4205-476e-a40c-690cb16769b3|1|CD4|CD4|URINALYSIS|[?]|/mm2|[?]|[?]|NEGATIVE|1|mL/cm3/min|1|1|[?]|HIGH|SYNOVIAL FLUID|LIPEMIC||IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|2|FOLLOW-UP|2021-01-24|2021-04-09|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|defa600c-4205-476e-a40c-690cb16769b3|2|CYCASULF|Calcium Sulfate Crystals|URINALYSIS|[?]|mmol/mol|[?]|[?]|TRACE|1|days/month|1|1|[?]|NORMAL|AQUEOUS HUMOR|PARAFFIN-EMBEDDED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|2|TREATMENT|2021-01-24|2021-02-08|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|defa600c-4205-476e-a40c-690cb16769b3|3|PCNAG|Proliferating Cell Nuclear Antigen|URINALYSIS|[?]|%(v/v)|[?]|[?]|TRACE|1|10^12/L|1|1|[?]|HIGH|SKIN TISSUE|THAWED||HEMATOXYLIN AND EOSIN STAIN|FIBROTEST FORMULA|||NA||2|Visit_2|25|4|TREATMENT|2021-02-08|2021-03-05|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|defa600c-4205-476e-a40c-690cb16769b3|4|GRWHIH|Growth Hormone Inhibiting Hormone|HEMATOLOGY|[?]|g/L|[?]|[?]|TRACE|1|deg2|1|1|[?]|ABNORMAL|SOFT TISSUE|HEMOLYZED||SXA SCAN|GMI % FORMULA|Y||N||2|Visit_2|25|4|FOLLOW-UP|2021-02-08|2021-03-23|25|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|defa600c-4205-476e-a40c-690cb16769b3|5|CANNAB|Cannabinoids|URINALYSIS|[?]|umol/kg/min|[?]|[?]|TRACE|1|10^6 organisms/g|1|1|[?]|HIGH|CALCULUS|ROOM TEMPERATURE||CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE FORMULA|Y||N||3|Visit_3|40|2|TREATMENT|2021-02-23|2021-04-03|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|defa600c-4205-476e-a40c-690cb16769b3|6|LSELS|Soluble L-Selectin|CHEMISTRY|[?]|mL/animal/wk|[?]|[?]|INDETERMINATE|1|s/h|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|DRIED|N|IRON HEMATOXYLIN STAIN|MDRD 5 VARIABLE FORMULA|||N||3|Visit_3|40|5|TREATMENT|2021-02-23|2021-04-19|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|LB|defa600c-4205-476e-a40c-690cb16769b3|7|PHOSLPD|Phospholipid|HEMATOLOGY|[?]|SBE/mL|[?]|[?]|BORDERLINE|1|mL/(min*100mL)|1|1|[?]|HIGH|VENOUS CORD BLOOD|ROOM TEMPERATURE||REBOUND TONOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||N||4|Visit_4|65|2|WASHOUT|2021-03-20|2021-04-21|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|defa600c-4205-476e-a40c-690cb16769b3|8|NEUTMM|Neutrophilic Metamyelocytes|CHEMISTRY|[?]|FEU|[?]|[?]|BORDERLINE|1|g|1|1|[?]|HIGH|EMESIS|ROOM TEMPERATURE|N|DOUBLE IMMUNODIFFUSION|HEPASCORE FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2021-03-20|2021-03-29|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|LB|defa600c-4205-476e-a40c-690cb16769b3|9|ERCEPPOL|Erythroid Proliferation Pool|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|STRIP|1|1|[?]|ABNORMAL|MUCUS|CLOTTED|N|DYNAMIC LIGHT SCATTERING|HEPASCORE FORMULA|||NA|Y|5|Visit_5|90|2|WASHOUT|2021-04-14|2021-04-18|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-22
e|LB|defa600c-4205-476e-a40c-690cb16769b3|10|O2CT|Oxygen Content|CHEMISTRY|[?]|fmol/L|[?]|[?]|INVALID|1|Log10 ELISA unit|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|GELLED|N|CONTRAST ENHANCED SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA|Y|Y|N||5|Visit_5|90|6|SCREENING|2021-04-14|2021-04-16|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-22
e|LB|e5092583-4259-40ba-a6a2-eeef6607263b|1|C130085|English Plantain Pollen IgA|CHEMISTRY|[?]|mm3/mm2/year|[?]|[?]|INVALID|1|mg/kg/week|1|1|[?]|NORMAL|SWABBED MATERIAL|LACTESCENT||SNP ARRAY|MDRD 5 VARIABLE FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-09-16|2020-10-03|10|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|LB|e5092583-4259-40ba-a6a2-eeef6607263b|2|C130082|Orchard Grass Pollen IgG|HEMATOLOGY|[?]|pt_br|[?]|[?]|NEGATIVE|1|MASK|1|1|[?]|HIGH|MIXED VENOUS BLOOD|UNEXPECTED ODOR||HPLC-UV|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|5|TREATMENT|2020-09-16|2020-11-30|10|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|LB|e5092583-4259-40ba-a6a2-eeef6607263b|3|ENAAB|Extractable Nuclear Antigen Antibody|CHEMISTRY|[?]|SQU/mL|[?]|[?]|NEGATIVE|1|PUFF|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|AUTOLYZED|N|MASS SPECTROMETRY|MDRD FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-10-01|2020-11-11|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|e5092583-4259-40ba-a6a2-eeef6607263b|4|TRP|Tryptophan|HEMATOLOGY|||[?]|[?]|TRACE|1|CUP|1|1|[?]|NORMAL|SPUTUM|HEMOLYZED||ELECTROPHORESIS|CKD-EPI CREATININE FORMULA|Y|Y|N|Y|2|Visit_2|25|3|TREATMENT|2020-10-01|2020-11-25|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|e5092583-4259-40ba-a6a2-eeef6607263b|5|FRTNLC|Ferritin Light Chain|URINALYSIS|[?]|g/m2|[?]|[?]|POSITIVE|1|mol|1|1|[?]|HIGH|PLATELET RICH PLASMA|THAWED||IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-10-16|2020-11-15|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|e5092583-4259-40ba-a6a2-eeef6607263b|6|APLIGGAB|Anti-Phospholipid IgG Antibody|URINALYSIS|[?]|mEq/kg|[?]|[?]|TRACE|1|IU/g|1|1|[?]|ABNORMAL|URINE|ICTERIC||HPLC/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-10-16|2020-11-29|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|LB|e5092583-4259-40ba-a6a2-eeef6607263b|7|RBCAGGLU|Erythrocyte Agglutination|CHEMISTRY|[?]|U/mL|[?]|[?]|POSITIVE|1|fmol/L|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|REFRIGERATED|N|ACRIDINE ORANGE STAIN|HEPASCORE FORMULA|||N||4|Visit_4|65|7|FOLLOW-UP|2020-11-10|2020-11-25|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|e5092583-4259-40ba-a6a2-eeef6607263b|8|FACTXII|Factor XII|URINALYSIS|||[?]|[?]|NEGATIVE|1|v/v|1|1|[?]|HIGH|ABSCESS FLUID|UNEXPECTED ODOR||IMMUNOTURBIDIMETRY|MDRD 4 VARIABLE FORMULA|||U|Y|4|Visit_4|65|3|WASHOUT|2020-11-10|2020-11-30|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|e5092583-4259-40ba-a6a2-eeef6607263b|9|RLP|RLP Cholesterol|CHEMISTRY|[?]|mg/mL/day|[?]|[?]|INVALID|1|PACK|1|1|[?]|HIGH|INTERSTITIAL FLUID|LACTESCENT|N|SPIRAL CT|FIBROMETER FORMULA||Y|U||5|Visit_5|90|3|WASHOUT|2020-12-05|2020-12-11|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|e5092583-4259-40ba-a6a2-eeef6607263b|10|A2MACG|Alpha-2 Macroglobulin|CHEMISTRY|[?]|mm/h|[?]|[?]|NEGATIVE|1|PELLET|1|1|[?]|LOW|CERUMEN|REFRIGERATED||NUCLEIC ACID AMPLIFICATION TEST|ASH FIBROSURE FORMULA||Y|NA||5|Visit_5|90|2|TREATMENT|2020-12-05|2020-12-11|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|461196d1-1213-4e5f-9bac-71f097b6cfdb|1|TCDCA|Taurochenodeoxycholate|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|DISK|1|1|[?]|LOW|PROSTATIC FLUID|HEMOLYZED||SPIROMETRY|GMI % FORMULA||Y|U|Y|1|Visit_1|10|3|WASHOUT|2020-11-13|2021-01-16|10|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|461196d1-1213-4e5f-9bac-71f097b6cfdb|2|STSA|Steroid Sulfatase Activity|URINALYSIS|[?]|/VF|[?]|[?]|POSITIVE|1|mL/g/min|1|1|[?]|LOW|COLOSTRUM|UNEXPECTED ODOR||POLYGRAPHY|COCKCROFT-GAULT FORMULA||Y|N||1|Visit_1|10|2|SCREENING|2020-11-13|2020-11-23|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|461196d1-1213-4e5f-9bac-71f097b6cfdb|3|PAP|Prostatic Acid Phosphatase|URINALYSIS|[?]|mL/kg/day|[?]|[?]|POSITIVE|1|mmol/min/kPa/L|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|FRESH||PH METER MEASUREMENT METHOD|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-11-28|2020-12-20|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|461196d1-1213-4e5f-9bac-71f097b6cfdb|4|HLADR53A|HLA-DR53 Antibody|HEMATOLOGY|[?]|mL/g/min|[?]|[?]|POSITIVE|1|kV|1|1|[?]|LOW|BLOOD|CALCIFIED||ENZYMATIC COLORIMETRY|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-11-28|2020-12-26|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|461196d1-1213-4e5f-9bac-71f097b6cfdb|5|CYLEUC|Leucine Crystals|URINALYSIS|[?]|U/m2/h|[?]|[?]|BORDERLINE|1|kg/L|1|1|[?]|NORMAL|EPITHELIAL CELL|CONCENTRATED||IVY INCISION METHOD|MDRD 6 VARIABLE FORMULA|Y|Y|N||3|Visit_3|40|1|TREATMENT|2020-12-13|2020-12-17|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|LB|461196d1-1213-4e5f-9bac-71f097b6cfdb|6|BDNF|Brain-Derived Neurotrophic Factor|HEMATOLOGY|[?]|mL*cmH2O|[?]|[?]|TRACE|1|Joule|1|1|[?]|NORMAL|PROSTATIC FLUID|HEMOLYZED||CRYOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|N||3|Visit_3|40|3|FOLLOW-UP|2020-12-13|2021-01-19|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|LB|461196d1-1213-4e5f-9bac-71f097b6cfdb|7|YEAST|Yeast Cells|URINALYSIS|[?]|VIRTUAL PIXEL|[?]|[?]|TRACE|1|uL|1|1|[?]|NORMAL|STOOL|HEMOLYZED||RYAN BLUE STAIN|MDRD 5 VARIABLE FORMULA||Y|NA||4|Visit_4|65|3|TREATMENT|2021-01-07|2021-01-30|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|461196d1-1213-4e5f-9bac-71f097b6cfdb|8|HGBAHGB|Hemoglobin A/Total Hemoglobin|HEMATOLOGY|||[?]|[?]|POSITIVE|1|DRUM|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|FRESH||PET/MRI SCAN|MDRD 4 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|3|TREATMENT|2021-01-07|2021-01-17|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|461196d1-1213-4e5f-9bac-71f097b6cfdb|9|VITDBP|Vitamin D Binding Protein|URINALYSIS|[?]|kg/L|[?]|[?]|BORDERLINE|1|Bq/uL|1|1|[?]|HIGH|VITREOUS HUMOR|CALCIFIED||GRADIENT DIFFUSION|NASH FIBROSURE FORMULA|||U||5|Visit_5|90|2|TREATMENT|2021-02-01|2021-02-09|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|461196d1-1213-4e5f-9bac-71f097b6cfdb|10|RBCAGGLU|Erythrocyte Agglutination|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mL/beat|1|1|[?]|NORMAL|EXPIRED AIR|HEMOLYZED||POPULATION SEQUENCING|FIBROTEST FORMULA|||NA|Y|5|Visit_5|90|3|TREATMENT|2021-02-01|2021-02-09|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|LB|4c82922a-55d0-45b9-a7bb-4edac32b0f68|1|COCAM|Cocaine Metabolites|HEMATOLOGY|[?]|uV|[?]|[?]|INVALID|1|10^9 organisms|1|1|[?]|HIGH|SMEGMA|HEMOLYZED||CORONARY ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|NA||1|Visit_1|10|4|SCREENING|2020-12-09|2020-12-22|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|4c82922a-55d0-45b9-a7bb-4edac32b0f68|2|TNF|Tumor Necrosis Factor|URINALYSIS|||[?]|[?]|POSITIVE|1|mV*min|1|1|[?]|ABNORMAL|PLEURAL TISSUE|AGGLUTINATED|N|IHC|MDRD 5 VARIABLE FORMULA|Y||U|Y|1|Visit_1|10|3|TREATMENT|2020-12-09|2021-02-19|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|4c82922a-55d0-45b9-a7bb-4edac32b0f68|3|IFI6|Interferon Alpha-Inducible Protein 6|URINALYSIS|[?]|mV|[?]|[?]|BORDERLINE|1|mol/L|1|1|[?]|NORMAL|LYMPH|REFRIGERATED||MAGNETIC RESONANCE ELASTOGRAPHY|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-12-24|2021-02-06|25|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|4c82922a-55d0-45b9-a7bb-4edac32b0f68|4|TTAC|Thrombin Time Actual/Control|CHEMISTRY|[?]|g/cage|[?]|[?]|INDETERMINATE|1|IU/L|1|1|[?]|ABNORMAL|PERSPIRATION|DRIED||SCANNING ELECTRON MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|5|WASHOUT|2020-12-24|2021-01-22|25|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|4c82922a-55d0-45b9-a7bb-4edac32b0f68|5|CPEPTIDE|C-peptide|HEMATOLOGY|||[?]|[?]|POSITIVE|1|copies/ug|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|AUTOLYZED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|3|Visit_3|40|1|TREATMENT|2021-01-08|2021-02-17|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|4c82922a-55d0-45b9-a7bb-4edac32b0f68|6|C130093|Western Ragweed Pollen IgA|HEMATOLOGY|[?]|nmol/L/h|[?]|[?]|INVALID|1|/mm|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|CLOTTED||CINEANGIOGRAPHY|MDRD FORMULA|||N||3|Visit_3|40|1|WASHOUT|2021-01-08|2021-02-03|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|4c82922a-55d0-45b9-a7bb-4edac32b0f68|7|BASEDEF|Base Deficit|URINALYSIS|[?]|10^7/L|[?]|[?]|NEGATIVE|1|vg/kg|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|CONTAMINATED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA|||NA||4|Visit_4|65|7|SCREENING|2021-02-02|2021-02-28|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|4c82922a-55d0-45b9-a7bb-4edac32b0f68|8|HEINZRBC|Heinz Bodies/Erythrocytes|URINALYSIS|||[?]|[?]|INVALID|1|psi|1|1|[?]|LOW|PLATELET RICH PLASMA|LACTESCENT||CALIPER MEASUREMENT METHOD|CKD-EPI FORMULA|||Y|Y|4|Visit_4|65|2|TREATMENT|2021-02-02|2021-02-05|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|LB|4c82922a-55d0-45b9-a7bb-4edac32b0f68|9|FLRZPM|Flurazepam|CHEMISTRY|[?]|Absorbance U/min|[?]|[?]|INDETERMINATE|1|MHz|1|1|[?]|NORMAL|MENSTRUAL BLOOD|CLOTTED||COLORIMETRY|CKD-EPI CYSTATIN C FORMULA|||N||5|Visit_5|90|1|WASHOUT|2021-02-27|2021-03-01|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|4c82922a-55d0-45b9-a7bb-4edac32b0f68|10|METARUB|Metarubricyte|CHEMISTRY|||[?]|[?]|BORDERLINE|1|APPLICATION|1|1|[?]|HIGH|PERSPIRATION|HEMOLYZED||FLUORESCENT SPOT TEST|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|5|Visit_5|90|5|TREATMENT|2021-02-27|2021-03-04|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|57971bdc-14df-4d9e-a59a-2665703c12ab|1|CORTFR|Cortisol, Free|CHEMISTRY|[?]|amu|[?]|[?]|TRACE|1|mV2/Hz|1|1|[?]|HIGH|LOCHIA|ROOM TEMPERATURE||LIQUID SCINTILLATION COUNTING|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||1|Visit_1|10|4|TREATMENT|2020-05-30|2020-08-12|10|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|57971bdc-14df-4d9e-a59a-2665703c12ab|2|RPTLTIME|Reptilase Time|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|PFU/animal|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|CALCIFIED||DROPLET DIGITAL PCR|NASH FIBROSURE FORMULA|||NA|Y|1|Visit_1|10|5|SCREENING|2020-05-30|2020-06-08|10|19|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|57971bdc-14df-4d9e-a59a-2665703c12ab|3|HIST4AB|Histone 4 Antibody|HEMATOLOGY|[?]|10^6 IU/mL|[?]|[?]|BORDERLINE|1|L|1|1|[?]|NORMAL|CELL PELLET|SOLIDIFIED|N|NON-INVASIVE DIELECTRIC SENSING|FIBROTEST FORMULA|Y||NA||2|Visit_2|25|3|WASHOUT|2020-06-14|2020-08-24|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|57971bdc-14df-4d9e-a59a-2665703c12ab|4|ALA1ALB|Apolipoprotein A1/Apolipoprotein B|URINALYSIS|[?]|deg/mm|[?]|[?]|NEGATIVE|1|ug/m2/h|1|1|[?]|LOW|ISOLATE|DRIED||GRAM STAIN|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-06-14|2020-07-10|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|57971bdc-14df-4d9e-a59a-2665703c12ab|5|LCN2|Lipocalin-2|CHEMISTRY|[?]|10^6 organisms|[?]|[?]|INDETERMINATE|1|dmol|1|1|[?]|ABNORMAL|TISSUE|AGGLUTINATED||CHROMATOGRAPHY|NASH FIBROSURE FORMULA|||U||3|Visit_3|40|2|TREATMENT|2020-06-29|2020-07-27|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|57971bdc-14df-4d9e-a59a-2665703c12ab|6|RETIRBC|Reticulocytes/Erythrocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|cmH2O*s2/mL|1|1|[?]|LOW|PERSPIRATION|LACTESCENT||ELASTOGRAPHY|NASH FIBROSURE FORMULA|||N|Y|3|Visit_3|40|5|TREATMENT|2020-06-29|2020-07-29|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|57971bdc-14df-4d9e-a59a-2665703c12ab|7|NKCE|Natural Killer Cells|HEMATOLOGY|[?]|days/month|[?]|[?]|INVALID|1|kPa|1|1|[?]|NORMAL|EMOTIONAL TEAR|REFRIGERATED||BIOPSY|FIBROTEST FORMULA|||NA||4|Visit_4|65|4|FOLLOW-UP|2020-07-24|2020-08-24|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|57971bdc-14df-4d9e-a59a-2665703c12ab|8|FACTXIII|Factor XIII|CHEMISTRY|||[?]|[?]|NEGATIVE|1|10^8 PFU|1|1|[?]|HIGH|BASAL TEAR|CLOTTED|N|TOTAL BODY RADIOGRAPHY|FIBROTEST FORMULA|Y||U|Y|4|Visit_4|65|1|TREATMENT|2020-07-24|2020-08-15|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|57971bdc-14df-4d9e-a59a-2665703c12ab|9|ACH|Acetylcholine|URINALYSIS|||[?]|[?]|POSITIVE|1|ppm|1|1|[?]|ABNORMAL|RETICULOCYTES|REFRIGERATED||LANDOLT RING|MDRD 6 VARIABLE FORMULA||Y|U|Y|5|Visit_5|90|2|WASHOUT|2020-08-18|2020-08-22|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|LB|57971bdc-14df-4d9e-a59a-2665703c12ab|10|ASTAG|Aspartate Aminotransferase Antigen|HEMATOLOGY|[?]|cycle/min|[?]|[?]|TRACE|1|mmol/L|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|FRESH|N|TOTAL BODY RADIOGRAPHY|CKD-EPI FORMULA|||U||5|Visit_5|90|7|TREATMENT|2020-08-18|2020-08-19|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|LB|dacea2da-9101-41e9-97aa-1cb8445b1320|1|CXCL11|Chemokine (C-X-C Motif) Ligand 11|URINALYSIS|[?]|cd|[?]|[?]|TRACE|1|usec|1|1|[?]|NORMAL|PERSPIRATION|FROZEN|N|OLIGO ACGH|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||1|Visit_1|10|7|SCREENING|2020-10-09|2020-12-03|10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|dacea2da-9101-41e9-97aa-1cb8445b1320|2|MUCTHR|Mucous Threads|URINALYSIS|[?]|10^9 organisms/mL|[?]|[?]|BORDERLINE|1|tuberculin unit/mL|1|1|[?]|LOW|BASAL TEAR|FROZEN||SURFACE PLASMON RESONANCE|HEPASCORE FORMULA|||U||1|Visit_1|10|3|TREATMENT|2020-10-09|2020-10-25|10|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|LB|dacea2da-9101-41e9-97aa-1cb8445b1320|3|CYCAOXA|Calcium Oxalate Crystals|HEMATOLOGY|[?]|fmol|[?]|[?]|BORDERLINE|1|10^6/g|1|1|[?]|LOW|CORD SERUM|CONTAMINATED||ELECTROCHEMILUMINESCENCE|FIBROMETER FORMULA|Y|Y|NA||2|Visit_2|25|5|SCREENING|2020-10-24|2020-12-19|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|dacea2da-9101-41e9-97aa-1cb8445b1320|4|NSPMTSPM|Normal Sperm/Total Sperm|URINALYSIS|[?]|AgU/mL|[?]|[?]|BORDERLINE|1|10^3 organisms|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|CONTAMINATED||CLIP|CKD-EPI CREATININE FORMULA||Y|U||2|Visit_2|25|7|TREATMENT|2020-10-24|2020-11-11|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|dacea2da-9101-41e9-97aa-1cb8445b1320|5|AMYLB40|Amyloid Beta 1-40|CHEMISTRY|[?]|NEBULE|[?]|[?]|INDETERMINATE|1|ppb|1|1|[?]|HIGH|MUSCLE TISSUE|GELLED|N|ELECTROMYOGRAPHY|FIBROTEST FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-11-08|2020-11-25|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|dacea2da-9101-41e9-97aa-1cb8445b1320|6|DTPACLR|DTPA Clearance|HEMATOLOGY|[?]|10^6 IU|[?]|[?]|BORDERLINE|1|mph|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|AUTOLYZED||ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD ENZYMATIC FORMULA|Y||U||3|Visit_3|40|6|WASHOUT|2020-11-08|2020-11-19|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|dacea2da-9101-41e9-97aa-1cb8445b1320|7|HE4|Human Epididymis Protein 4|CHEMISTRY|[?]|log10 CFU/mL|[?]|[?]|POSITIVE|1|lx|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|CALCIFIED||MICROARRAY|MDRD FORMULA|Y|Y|Y||4|Visit_4|65|7|TREATMENT|2020-12-03|2020-12-23|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|dacea2da-9101-41e9-97aa-1cb8445b1320|8|OXZPM|Oxazepam|HEMATOLOGY|[?]|mg/g/h|[?]|[?]|POSITIVE|1|ng/dL|1|1|[?]|NORMAL|VENOUS CORD BLOOD|CONTAMINATED|N|ELECTRICAL IMPEDANCE MYOGRAPHY|CKD-EPI FORMULA|Y|Y|U||4|Visit_4|65|1|TREATMENT|2020-12-03|2020-12-25|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|dacea2da-9101-41e9-97aa-1cb8445b1320|9|C130118|Bee Mix Antigen IgG4 Antibody|URINALYSIS|[?]|CYLINDER|[?]|[?]|POSITIVE|1|nsec|1|1|[?]|LOW|SMEGMA|AGGLUTINATED||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|FIBROTEST FORMULA|||NA||5|Visit_5|90|5|WASHOUT|2020-12-28|2020-12-29|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|dacea2da-9101-41e9-97aa-1cb8445b1320|10|PLP|Pyridoxal Phosphate|URINALYSIS|[?]|10^9 organisms/mL|[?]|[?]|INDETERMINATE|1|Roentgen|1|1|[?]|NORMAL|ALVEOLAR AIR|FROZEN|N|LC/MS|MDRD 4 VARIABLE FORMULA|Y||NA||5|Visit_5|90|5|FOLLOW-UP|2020-12-28|2021-01-02|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|LB|cbf5d05e-e934-4946-b991-5fef63a01888|1|C130126|Cat Dander Antigen IgA Antibody|URINALYSIS|[?]|PUFF|[?]|[?]|NEGATIVE|1|cycle/min|1|1|[?]|ABNORMAL|FLUID|DRIED||CALCOFLUOR WHITE STAIN|FIBROSIS 4 FORMULA|||Y||1|Visit_1|10|5|SCREENING|2020-11-06|2021-01-04|10|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|cbf5d05e-e934-4946-b991-5fef63a01888|2|NEUTMM|Neutrophilic Metamyelocytes|CHEMISTRY|[?]|CIGAR|[?]|[?]|INDETERMINATE|1|km|1|1|[?]|LOW|KERATINOCYTE|CLOTTED||MAPH|HEPASCORE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-11-06|2020-12-15|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|cbf5d05e-e934-4946-b991-5fef63a01888|3|EOSMM|Eosinophilic Metamyelocytes|CHEMISTRY|||[?]|[?]|INVALID|1|mg/m2|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|CALCIFIED||CALIPER MEASUREMENT METHOD|MDRD ENZYMATIC FORMULA|Y||NA|Y|2|Visit_2|25|1|FOLLOW-UP|2020-11-21|2020-11-30|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|cbf5d05e-e934-4946-b991-5fef63a01888|4|PERIOSTN|Periostin|URINALYSIS|[?]|mEq/day|[?]|[?]|BORDERLINE|1|CIGAR|1|1|[?]|HIGH|MECONIUM|NON-HEMOLYZED|N|BIOPSY|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|5|WASHOUT|2020-11-21|2020-12-13|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|cbf5d05e-e934-4946-b991-5fef63a01888|5|CRNTESTR|Carnitine Esters|CHEMISTRY|[?]|10^3 CFU|[?]|[?]|TRACE|1|Hz|1|1|[?]|NORMAL|NAIL|REFRIGERATED||HEMATOXYLIN AND EOSIN STAIN|FIBROMETER FORMULA|Y||Y||3|Visit_3|40|2|TREATMENT|2020-12-06|2020-12-27|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|cbf5d05e-e934-4946-b991-5fef63a01888|6|IGFBP3|Insulin-Like Growth Factor Binding Prot3|CHEMISTRY|[?]|/100 HPFs|[?]|[?]|BORDERLINE|1|ks|1|1|[?]|LOW|CORD BLOOD|DRIED||SLIT LAMP|GMI % FORMULA|||U||3|Visit_3|40|3|TREATMENT|2020-12-06|2021-01-23|40|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|cbf5d05e-e934-4946-b991-5fef63a01888|7|METHPHEN|Methylphenidate|CHEMISTRY|[?]|cs|[?]|[?]|INVALID|1|umol/mol|1|1|[?]|LOW|SKELETAL MUSCLE TISSUE|PARAFFIN-EMBEDDED||SLOAN LETTER EYE CHART 100%|CKD-EPI CYSTATIN C FORMULA||Y|U||4|Visit_4|65|5|TREATMENT|2020-12-31|2021-01-28|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|cbf5d05e-e934-4946-b991-5fef63a01888|8|GSTCREAT|Glutathione-S-Transferase/Creatinine|HEMATOLOGY|[?]|fmol/g|[?]|[?]|NEGATIVE|1|/500 WBC|1|1|[?]|HIGH|AMNIOTIC FLUID|ICTERIC||KNEMOMETRY|HEPASCORE FORMULA||Y|U||4|Visit_4|65|6|TREATMENT|2020-12-31|2021-01-18|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|cbf5d05e-e934-4946-b991-5fef63a01888|9|HLADRAGT|HLA-DR Antigen Type|URINALYSIS|[?]|msec|[?]|[?]|TRACE|1|10^3 organisms/g|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|NON-HEMOLYZED|N|PET/CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC FORMULA|Y||NA||5|Visit_5|90|5|TREATMENT|2021-01-25|2021-01-30|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|cbf5d05e-e934-4946-b991-5fef63a01888|10|AMYLASE|Amylase|CHEMISTRY|||[?]|[?]|POSITIVE|1|g/cm2|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|SOLIDIFIED||WESTERN BLOT|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|5|Visit_5|90|5|FOLLOW-UP|2021-01-25|2021-02-01|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|be18633c-0ff9-4775-9737-dc8a9524fd2c|1|C165928|Industrial Mix IgE AB RAST Score|CHEMISTRY|[?]|STEPS|[?]|[?]|INDETERMINATE|1|mg/mL/min|1|1|[?]|HIGH|CAPILLARY PLASMA|AGGLUTINATED||HPLC-FL|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|5|WASHOUT|2020-10-18|2020-12-26|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|be18633c-0ff9-4775-9737-dc8a9524fd2c|2|TGFB|Transforming Growth Factor Beta|URINALYSIS|||[?]|[?]|INVALID|1|PATCH|1|1|[?]|ABNORMAL|CELL PELLET|AUTOLYZED||SXA SCAN|GMI MMOL/MOL FORMULA|||N|Y|1|Visit_1|10|4|FOLLOW-UP|2020-10-18|2020-12-07|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|be18633c-0ff9-4775-9737-dc8a9524fd2c|3|MET|Methionine|HEMATOLOGY|[?]|uL/dose|[?]|[?]|BORDERLINE|1|VIRTUAL PIXEL|1|1|[?]|NORMAL|BUFFY COAT|NON-HEMOLYZED||MRI|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|5|TREATMENT|2020-11-02|2021-01-12|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|be18633c-0ff9-4775-9737-dc8a9524fd2c|4|INTLK7|Interleukin 7|HEMATOLOGY|||[?]|[?]|INVALID|1|BOX|1|1|[?]|LOW|LAVAGE FLUID|FROZEN|N|IVY INCISION METHOD|FIBROMETER FORMULA|Y|Y|NA|Y|2|Visit_2|25|1|TREATMENT|2020-11-02|2020-11-27|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|be18633c-0ff9-4775-9737-dc8a9524fd2c|5|NAGASEXR|NAGASE Excretion Rate|URINALYSIS|[?]|Log10 ELISA unit|[?]|[?]|INVALID|1|Enzyme U/L|1|1|[?]|NORMAL|SPERMATOZOON|SOLIDIFIED||CLOT DETECTION|FIBROSIS 4 FORMULA||Y|NA||3|Visit_3|40|2|TREATMENT|2020-11-17|2021-01-06|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|LB|be18633c-0ff9-4775-9737-dc8a9524fd2c|6|AMYLB38|Amyloid Beta 1-38|CHEMISTRY|[?]|10^3 organisms|[?]|[?]|TRACE|1|POINT|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|HEMOLYZED|N|LISSAMINE GREEN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-11-17|2020-12-24|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|LB|be18633c-0ff9-4775-9737-dc8a9524fd2c|7|IDLP|IDL Particles|CHEMISTRY|[?]|ft2|[?]|[?]|NEGATIVE|1|U/kg|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|HEMOLYZED||PHOTOMETRY|HEPASCORE FORMULA|||NA||4|Visit_4|65|3|TREATMENT|2020-12-12|2020-12-14|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|be18633c-0ff9-4775-9737-dc8a9524fd2c|8|NUCSWELL|Nuclear Swelling|HEMATOLOGY|[?]|PELLET|[?]|[?]|POSITIVE|1|nmol BCE/L|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|ICTERIC||GRAM STAIN|MDRD 5 VARIABLE FORMULA|||U||4|Visit_4|65|7|FOLLOW-UP|2020-12-12|2021-01-06|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|be18633c-0ff9-4775-9737-dc8a9524fd2c|9|CD20|CD20|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|v/v|1|1|[?]|NORMAL|BUFFY COAT|ICTERIC||ENZYMATIC ULTRACENTRIFUGATION|FIBROMETER FORMULA|||NA|Y|5|Visit_5|90|6|TREATMENT|2021-01-06|2021-01-08|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|be18633c-0ff9-4775-9737-dc8a9524fd2c|10|STROPONI|Skeletal Troponin I|CHEMISTRY|[?]|MnFI|[?]|[?]|POSITIVE|1|anti-Xa IU/mL|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|LIPEMIC||THIN SMEAR|MDRD 5 VARIABLE FORMULA|Y||N||5|Visit_5|90|6|TREATMENT|2021-01-06|2021-01-09|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|LB|f7eba9b8-94fb-46b8-842a-0322eb68a355|1|PAPPEN|Pappenheimer Bodies|URINALYSIS|||[?]|[?]|TRACE|1|Bq|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|LIPEMIC|N|MECHANICAL CLOT DETECTION|CKD-EPI CREATININE FORMULA||Y|U|Y|1|Visit_1|10|1|TREATMENT|2020-05-12|2020-06-13|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-14
e|LB|f7eba9b8-94fb-46b8-842a-0322eb68a355|2|TUDCA|Tauroursodeoxycholate|CHEMISTRY|[?]|DNA copies/mL|[?]|[?]|TRACE|1|%/min|1|1|[?]|LOW|MIXED VENOUS BLOOD|CONTAMINATED|N|ELLA|HEPASCORE FORMULA|||U||1|Visit_1|10|5|WASHOUT|2020-05-12|2020-07-03|10|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-14
e|LB|f7eba9b8-94fb-46b8-842a-0322eb68a355|3|EAGLUC|Glucose, Estimated Average|CHEMISTRY|[?]|CAPLET|[?]|[?]|TRACE|1|ug/m2/day|1|1|[?]|ABNORMAL|DERMAL TISSUE|FROZEN||DROPLET DIGITAL PCR|FIBROTEST FORMULA|Y|Y|NA||2|Visit_2|25|6|WASHOUT|2020-05-27|2020-08-09|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|f7eba9b8-94fb-46b8-842a-0322eb68a355|4|C130083|Orchard Grass Pollen IgG4|HEMATOLOGY|[?]|fmol/g|[?]|[?]|INVALID|1|SACHET|1|1|[?]|HIGH|DISCHARGE|GELLED||HPLC-UV|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|5|WASHOUT|2020-05-27|2020-06-28|25|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|f7eba9b8-94fb-46b8-842a-0322eb68a355|5|NAGCREAT|N-Acetyl Glucosamide/Creatinine|CHEMISTRY|||[?]|[?]|POSITIVE|1|GBq/mg|1|1|[?]|HIGH|VENOUS CORD BLOOD|GELLED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|HEPASCORE FORMULA|||N|Y|3|Visit_3|40|3|WASHOUT|2020-06-11|2020-06-24|40|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|f7eba9b8-94fb-46b8-842a-0322eb68a355|6|CARNIT|Carnitine|URINALYSIS|[?]|gtt|[?]|[?]|TRACE|1|fraction of 1|1|1|[?]|NORMAL|DISCHARGE|CLOTTED||TARGETED GENOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||3|Visit_3|40|3|SCREENING|2020-06-11|2020-07-08|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|f7eba9b8-94fb-46b8-842a-0322eb68a355|7|FCT8INH|Factor VIII Inhibitor|CHEMISTRY|[?]|FEU|[?]|[?]|BORDERLINE|1|fg|1|1|[?]|LOW|KERATINOCYTE|PARAFFIN-EMBEDDED||TOTAL BODY IRRADIATION|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|6|FOLLOW-UP|2020-07-06|2020-07-18|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|f7eba9b8-94fb-46b8-842a-0322eb68a355|8|PROTSFR|Protein S, Free|HEMATOLOGY|[?]|TRACE|[?]|[?]|INVALID|1|MBq|1|1|[?]|HIGH|TISSUE|LIPEMIC||MICROBIAL CULTURE|HEPASCORE FORMULA||Y|N||4|Visit_4|65|6|TREATMENT|2020-07-06|2020-07-09|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|LB|f7eba9b8-94fb-46b8-842a-0322eb68a355|9|C147283|White Elm Pollen IgG Antibody|HEMATOLOGY|[?]|uL/mL|[?]|[?]|BORDERLINE|1|foz_br|1|1|[?]|LOW|MECONIUM|HEMOLYZED||CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI FORMULA|Y||N||5|Visit_5|90|2|FOLLOW-UP|2020-07-31|2020-08-07|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|f7eba9b8-94fb-46b8-842a-0322eb68a355|10|PDW|Platelet Distribution Width|CHEMISTRY|[?]|mm/min|[?]|[?]|INDETERMINATE|1|BLOCKS|1|1|[?]|NORMAL|RETICULOCYTES|CONTAMINATED||ELASTOGRAPHY|FIBROMETER FORMULA||Y|U||5|Visit_5|90|3|TREATMENT|2020-07-31|2020-08-09|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|LB|903199e2-56e1-41e4-8904-d33cc6846ee3|1|LLCFR|Lambda Light Chain, Free|CHEMISTRY|[?]|MHz|[?]|[?]|BORDERLINE|1|PACK|1|1|[?]|LOW|SERUM|DRIED||IODINE STAIN|CKD-EPI CYSTATIN C FORMULA|Y||N||1|Visit_1|10|1|WASHOUT|2021-01-18|2021-01-19|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|903199e2-56e1-41e4-8904-d33cc6846ee3|2|PF2AI8CR|8-Iso-PGF2alpha/Creatinine|CHEMISTRY|[?]|pmol/10^9 cells|[?]|[?]|BORDERLINE|1|lm|1|1|[?]|NORMAL|EXPIRED AIR|ROOM TEMPERATURE||DYNAMIC LIGHT SCATTERING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2021-01-18|2021-01-19|10|11|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|LB|903199e2-56e1-41e4-8904-d33cc6846ee3|3|OPG|Osteoprotegerin|HEMATOLOGY|[?]|ug|[?]|[?]|POSITIVE|1|mEq/ug|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|THAWED||NEXT GENERATION SEQUENCING|FIBROTEST FORMULA|Y|Y|U||2|Visit_2|25|1|TREATMENT|2021-02-02|2021-03-11|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-28
e|LB|903199e2-56e1-41e4-8904-d33cc6846ee3|4|GRWHIH|Growth Hormone Inhibiting Hormone|URINALYSIS|[?]|vg/kg|[?]|[?]|INVALID|1|EIA unit|1|1|[?]|LOW|INTERSTITIAL FLUID|AUTOLYZED||CLIP SEQUENCING|MDRD 5 VARIABLE FORMULA|||N||2|Visit_2|25|2|TREATMENT|2021-02-02|2021-02-23|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-28
e|LB|903199e2-56e1-41e4-8904-d33cc6846ee3|5|ANGLOBDR|Antiglobulin Test, Direct|CHEMISTRY|[?]|Torr|[?]|[?]|TRACE|1|U/g|1|1|[?]|LOW|PLASMA|REFRIGERATED||IMMUNOPRECIPITATION|MDRD ENZYMATIC JAPANESE FORMULA|||NA||3|Visit_3|40|1|FOLLOW-UP|2021-02-17|2021-03-30|40|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-23
e|LB|903199e2-56e1-41e4-8904-d33cc6846ee3|6|CAFFEINE|Caffeine|CHEMISTRY|[?]|log10 TCID 50/mL|[?]|[?]|NEGATIVE|1|U/dL|1|1|[?]|HIGH|MECONIUM|PARAFFIN-EMBEDDED|N|SXA SCAN|MDRD 5 VARIABLE FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2021-02-17|2021-03-15|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-23
e|LB|903199e2-56e1-41e4-8904-d33cc6846ee3|7|GLDH|Glutamate Dehydrogenase|CHEMISTRY|[?]|ft3|[?]|[?]|NEGATIVE|1|BOWL|1|1|[?]|NORMAL|RETICULOCYTES|ROOM TEMPERATURE||CONTRAST ENHANCED MRI|HEPASCORE FORMULA|Y||Y||4|Visit_4|65|5|TREATMENT|2021-03-14|2021-03-30|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|903199e2-56e1-41e4-8904-d33cc6846ee3|8|IFNG|Interferon Gamma|HEMATOLOGY|[?]|10^4/hpf|[?]|[?]|NEGATIVE|1|HOURS|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|LIPEMIC||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|NASH FIBROSURE FORMULA||Y|U||4|Visit_4|65|6|TREATMENT|2021-03-14|2021-04-06|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|903199e2-56e1-41e4-8904-d33cc6846ee3|9|GFRBSB2M|GFR from B-2 Microglobulin Adj for BSA|CHEMISTRY|||[?]|[?]|BORDERLINE|1|cP|1|1|[?]|ABNORMAL|BASAL TEAR|FRESH|N|CLOT DETECTION|MDRD FORMULA||Y|Y|Y|5|Visit_5|90|6|TREATMENT|2021-04-08|2021-04-14|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-02
e|LB|903199e2-56e1-41e4-8904-d33cc6846ee3|10|MASTCE|Mast Cells|HEMATOLOGY|||[?]|[?]|INVALID|1|kDa|1|1|[?]|HIGH|HAIR FOLLICLE|GELLED||CLIP SEQUENCING|GMI % FORMULA||Y|N|Y|5|Visit_5|90|5|WASHOUT|2021-04-08|2021-04-16|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-02
e|LB|32567f8d-e746-44e1-a269-d95ba3bb0b11|1|ATHPIDX|Atherogenic Index of Plasma|HEMATOLOGY|||[?]|[?]|POSITIVE|1|JDF Unit|1|1|[?]|LOW|DERMAL TISSUE|NON-HEMOLYZED||CRYOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y|Y|1|Visit_1|10|4|FOLLOW-UP|2020-11-02|2021-01-25|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|LB|32567f8d-e746-44e1-a269-d95ba3bb0b11|2|ELA2|Neutrophil Elastase|HEMATOLOGY|[?]|mOsm/L|[?]|[?]|INVALID|1|10^6 copies/mL|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|SOLIDIFIED||IHC|HEPASCORE FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2020-11-02|2021-01-14|10|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|LB|32567f8d-e746-44e1-a269-d95ba3bb0b11|3|C130084|English Plantain Pollen IgE|HEMATOLOGY|[?]|BP|[?]|[?]|BORDERLINE|1|10^3 CFU/g|1|1|[?]|ABNORMAL|RETICULOCYTES|THAWED|N|PATHOLOGICAL EVALUATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||2|Visit_2|25|7|TREATMENT|2020-11-17|2021-01-02|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|32567f8d-e746-44e1-a269-d95ba3bb0b11|4|IGGCREAT|Immunoglobulin G/Creatinine|HEMATOLOGY|[?]|LB|[?]|[?]|INVALID|1|PLUG|1|1|[?]|NORMAL|SKIN TISSUE|CALCIFIED||KNEMOMETRY|MDRD FORMULA||Y|N||2|Visit_2|25|2|FOLLOW-UP|2020-11-17|2021-01-27|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|32567f8d-e746-44e1-a269-d95ba3bb0b11|5|ERCECE|Erythroid Cells/Total Cells|CHEMISTRY|[?]|Bq/uL|[?]|[?]|NEGATIVE|1|oz|1|1|[?]|HIGH|PUS|NON-HEMOLYZED||ELASTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||3|Visit_3|40|5|WASHOUT|2020-12-02|2020-12-15|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|32567f8d-e746-44e1-a269-d95ba3bb0b11|6|LDH4|LDH Isoenzyme 4|HEMATOLOGY|[?]|mol/mL|[?]|[?]|POSITIVE|1|%/s|1|1|[?]|HIGH|ERYTHROCYTES|AGGLUTINATED||SURFACE PLASMON RESONANCE|FIBROMETER FORMULA|Y||NA||3|Visit_3|40|2|FOLLOW-UP|2020-12-02|2020-12-14|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|LB|32567f8d-e746-44e1-a269-d95ba3bb0b11|7|SODIUM|Sodium|URINALYSIS|[?]|/10^5|[?]|[?]|INDETERMINATE|1|gtt|1|1|[?]|LOW|SOFT TISSUE|CONCENTRATED||FLUORESCENT ENZYME IMMUNOASSAY|FIBROTEST FORMULA|||N||4|Visit_4|65|6|FOLLOW-UP|2020-12-27|2021-01-26|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|32567f8d-e746-44e1-a269-d95ba3bb0b11|8|HCGFR|Choriogonadotropin Beta, Free|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|pg/L|1|1|[?]|HIGH|MONOCYTE|PARAFFIN-EMBEDDED||PERFUSION MRI|MDRD 4 VARIABLE FORMULA||Y|U|Y|4|Visit_4|65|4|TREATMENT|2020-12-27|2021-01-27|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|LB|32567f8d-e746-44e1-a269-d95ba3bb0b11|9|HLABMSC|HLA-B Mismatch Count|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mOsm/L|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|FROZEN||MICROSCOPY|CKD-EPI CREATININE FORMULA|||NA|Y|5|Visit_5|90|4|SCREENING|2021-01-21|2021-01-25|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|32567f8d-e746-44e1-a269-d95ba3bb0b11|10|COL4|Collagen Type IV|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mmol/min/kPa|1|1|[?]|NORMAL|ISOLATE|ICTERIC||IMPULSE OSCILLOMETRY|CKD-EPI CREATININE FORMULA|||U|Y|5|Visit_5|90|6|TREATMENT|2021-01-21|2021-01-29|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|ecdc54eb-c02f-4112-8e85-8a3352470b3b|1|VITB17|Vitamin B17|URINALYSIS|[?]|10^6 U|[?]|[?]|TRACE|1|days/wk|1|1|[?]|NORMAL|ERYTHROCYTES|PARAFFIN-EMBEDDED||FARR ASSAY|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-11-11|2021-01-20|10|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|ecdc54eb-c02f-4112-8e85-8a3352470b3b|2|MPO|Myeloperoxidase|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mL/dL|1|1|[?]|ABNORMAL|REFLEX TEAR|THAWED||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD 6 VARIABLE FORMULA|||U|Y|1|Visit_1|10|4|TREATMENT|2020-11-11|2020-12-27|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|ecdc54eb-c02f-4112-8e85-8a3352470b3b|3|LKM1IAAB|Liver Kidney Microsomal Type 1 IgA Ab|CHEMISTRY|[?]|BOTTLE|[?]|[?]|BORDERLINE|1|TRACE|1|1|[?]|LOW|GASTRIC FLUID|AUTOLYZED||SXA SCAN|GMI MMOL/MOL FORMULA|Y||Y||2|Visit_2|25|7|WASHOUT|2020-11-26|2020-12-08|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|ecdc54eb-c02f-4112-8e85-8a3352470b3b|4|MERCURY|Mercury|URINALYSIS|[?]|copies/mL|[?]|[?]|BORDERLINE|1|U/g/day|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|FRESH|N|PANENDOSCOPY|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|2|FOLLOW-UP|2020-11-26|2020-12-06|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|ecdc54eb-c02f-4112-8e85-8a3352470b3b|5|C130093|Western Ragweed Pollen IgA|HEMATOLOGY|[?]|g/animal/wk|[?]|[?]|INVALID|1|mol/mL|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|REFRIGERATED||IMMUNODIFFUSION|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||NA||3|Visit_3|40|7|SCREENING|2020-12-11|2021-02-01|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|LB|ecdc54eb-c02f-4112-8e85-8a3352470b3b|6|CARNITAT|Carnitine Acetyl Transferase|URINALYSIS|[?]|psec|[?]|[?]|TRACE|1|mg/dL|1|1|[?]|LOW|EMESIS|LACTESCENT||BAC ACGH|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|7|SCREENING|2020-12-11|2020-12-28|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|LB|ecdc54eb-c02f-4112-8e85-8a3352470b3b|7|TNFR5S|Soluble TNF Receptor Superfamily Mem 5|HEMATOLOGY|[?]|h*%|[?]|[?]|INVALID|1|mg/min|1|1|[?]|NORMAL|INFRANATANT, PLASMA|REFRIGERATED|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|7|FOLLOW-UP|2021-01-05|2021-02-08|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|ecdc54eb-c02f-4112-8e85-8a3352470b3b|8|MYBLALE|Myeloblasts/Leukocytes|HEMATOLOGY|[?]|Bq/ug|[?]|[?]|BORDERLINE|1|%(w/w)|1|1|[?]|NORMAL|CELL PELLET|REFRIGERATED||ACCELERATOR MASS SPECTROMETRY|MDRD FORMULA|Y||Y||4|Visit_4|65|2|FOLLOW-UP|2021-01-05|2021-01-06|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|ecdc54eb-c02f-4112-8e85-8a3352470b3b|9|LDLP|LDL Particles|HEMATOLOGY|[?]|genEq|[?]|[?]|TRACE|1|U.CARR|1|1|[?]|HIGH|REFLEX TEAR|AUTOLYZED|N|URANYL ACETATE STAIN|COCKCROFT-GAULT FORMULA||Y|U||5|Visit_5|90|5|FOLLOW-UP|2021-01-30|2021-02-06|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|ecdc54eb-c02f-4112-8e85-8a3352470b3b|10|ANGLBIND|Antiglobulin Test, Indirect|URINALYSIS|[?]|pg|[?]|[?]|INVALID|1|ng|1|1|[?]|HIGH|MUCUS|ICTERIC|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|HEPASCORE FORMULA|||U||5|Visit_5|90|7|FOLLOW-UP|2021-01-30|2021-02-02|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|LB|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|1|CYCHOL|Cholesterol Crystals|HEMATOLOGY|[?]|mN|[?]|[?]|TRACE|1|MBq|1|1|[?]|ABNORMAL|ISOLATE|DRIED||SPECT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||1|Visit_1|10|5|TREATMENT|2020-07-09|2020-08-07|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|2|C165940|Boxelder Pollen IgE AB RAST Score|CHEMISTRY|[?]|mL*cmH2O|[?]|[?]|INDETERMINATE|1|SBE/mL|1|1|[?]|NORMAL|AQUEOUS HUMOR|AGGLUTINATED|N|ATOMIC ABSORPTION SPECTROMETRY|ASH FIBROSURE FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-07-09|2020-08-24|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|3|C165890|Timothy Grass Pollen IgE AB RAST Score|CHEMISTRY|[?]|/mm|[?]|[?]|TRACE|1|mAmp|1|1|[?]|HIGH|PLASMA ULTRAFILTRATE|DRIED||OPTICAL DENSITY MEASUREMENT|MDRD FORMULA|Y||Y||2|Visit_2|25|5|TREATMENT|2020-07-24|2020-09-03|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|4|MMP1|Matrix Metalloproteinase 1|HEMATOLOGY|[?]|mmHg|[?]|[?]|NEGATIVE|1|pmol|1|1|[?]|NORMAL|PLATELET POOR PLASMA|HEMOLYZED||ANTIBIOTIC AGAR SCREEN|CKD-EPI CYSTATIN C FORMULA|Y||N||2|Visit_2|25|1|TREATMENT|2020-07-24|2020-09-28|25|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|5|C165939|Egg White IgE AB RAST Score|CHEMISTRY|[?]|/sec|[?]|[?]|TRACE|1|U.CARR|1|1|[?]|HIGH|PLATELET POOR PLASMA|LACTESCENT||PHYSICAL EXAMINATION|MDRD FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2020-08-08|2020-09-19|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|6|ETPPH|ETP Peak Height|HEMATOLOGY|[?]|DNA copies/ug|[?]|[?]|POSITIVE|1|SQU/mL|1|1|[?]|NORMAL|WHITE MATTER TISSUE|AGGLUTINATED||DC SHEATH FLOW|MDRD 5 VARIABLE FORMULA|Y||Y||3|Visit_3|40|7|TREATMENT|2020-08-08|2020-09-04|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|LB|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|7|RETIMRTC|Medium Absorption Retic/Reticulocytes|CHEMISTRY|[?]|ka_u/dL|[?]|[?]|POSITIVE|1|Enzyme U/g Hb|1|1|[?]|HIGH|MIXED VENOUS BLOOD|LACTESCENT||HPLC/MS/MS|GMI MMOL/MOL FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-09-02|2020-09-08|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|8|PCA3MRNA|Prostate Cancer Antigen 3 mRNA|CHEMISTRY|[?]|Hz|[?]|[?]|INDETERMINATE|1|gpELISA unit/mL|1|1|[?]|NORMAL|LAVAGE FLUID|HEMOLYZED||CONGO RED STAIN|FIBROTEST FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-09-02|2020-09-12|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|9|C165889|Russian Thistle Pollen IgE AB RAST Score|HEMATOLOGY|||[?]|[?]|POSITIVE|1|nkat|1|1|[?]|HIGH|CELL PELLET|DRIED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA|||NA|Y|5|Visit_5|90|1|TREATMENT|2020-09-27|2020-09-30|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|10|ALDOLASE|Aldolase|HEMATOLOGY|[?]|Farad|[?]|[?]|TRACE|1|/10^4|1|1|[?]|NORMAL|SPERMATOZOON|AGGLUTINATED|N|DUKE INCISION METHOD|HEPASCORE FORMULA|||U||5|Visit_5|90|6|TREATMENT|2020-09-27|2020-09-30|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|5d7241ec-120d-486d-ab39-b9e14ab4ce90|1|CD19LY|CD19/Lymphocytes|HEMATOLOGY|||[?]|[?]|POSITIVE|1|kBq|1|1|[?]|LOW|ENDOTRACHEAL FLUID|DRIED||CONTRAST ENHANCED SPIRAL CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA|Y||U|Y|1|Visit_1|10|7|TREATMENT|2020-08-01|2020-08-04|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|5d7241ec-120d-486d-ab39-b9e14ab4ce90|2|MICA|MHC Class I Chain Related Protein A|HEMATOLOGY|[?]|EP U|[?]|[?]|INVALID|1|tsp eq|1|1|[?]|ABNORMAL|PROSTATIC FLUID|CALCIFIED||WHOLE EXOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||1|Visit_1|10|3|TREATMENT|2020-08-01|2020-08-29|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|LB|5d7241ec-120d-486d-ab39-b9e14ab4ce90|3|MYCEPIDX|Myeloid Proliferation Index|HEMATOLOGY|[?]|CCID 50/mL|[?]|[?]|NEGATIVE|1|grain|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|HEMOLYZED||CRYOSCOPY|ASH FIBROSURE FORMULA|Y||NA||2|Visit_2|25|4|TREATMENT|2020-08-16|2020-10-29|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|5d7241ec-120d-486d-ab39-b9e14ab4ce90|4|BASOLE|Basophils/Leukocytes|HEMATOLOGY|[?]|L|[?]|[?]|INDETERMINATE|1|DNA copies/ug|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|CALCIFIED||LYMPHANGIOGRAPHY|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|2|SCREENING|2020-08-16|2020-09-15|25|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|5d7241ec-120d-486d-ab39-b9e14ab4ce90|5|LTD4|Leukotriene D4|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mmol/L|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|REFRIGERATED||MICRO BROTH DILUTION|FIBROMETER FORMULA|Y||Y|Y|3|Visit_3|40|3|TREATMENT|2020-08-31|2020-09-08|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|5d7241ec-120d-486d-ab39-b9e14ab4ce90|6|NAGASEXR|NAGASE Excretion Rate|CHEMISTRY|[?]|mg/kg/min|[?]|[?]|BORDERLINE|1|mL/h|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|UNEXPECTED ODOR||PUPILLOMETRY|ASH FIBROSURE FORMULA|||NA||3|Visit_3|40|6|TREATMENT|2020-08-31|2020-09-15|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|LB|5d7241ec-120d-486d-ab39-b9e14ab4ce90|7|RETI|Reticulocytes|HEMATOLOGY|[?]|mg/kg/dose|[?]|[?]|INDETERMINATE|1|CYLINDER|1|1|[?]|HIGH|CERUMEN|HEMOLYZED||TEMPLATE INCISION METHOD|GMI % FORMULA||Y|NA||4|Visit_4|65|1|SCREENING|2020-09-25|2020-10-22|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|5d7241ec-120d-486d-ab39-b9e14ab4ce90|8|ERCEPPOL|Erythroid Proliferation Pool|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|nmol/mL/min|1|1|[?]|HIGH|PLATELET|ROOM TEMPERATURE||THICK SMEAR|MDRD 6 VARIABLE FORMULA|Y|Y|Y|Y|4|Visit_4|65|6|FOLLOW-UP|2020-09-25|2020-10-19|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|5d7241ec-120d-486d-ab39-b9e14ab4ce90|9|NONHDL|Non-HDL Cholesterol|HEMATOLOGY|||[?]|[?]|INVALID|1|vg/kg|1|1|[?]|LOW|URINE SEDIMENT|ROOM TEMPERATURE||LIQUID SCINTILLATION COUNTING|MDRD 4 VARIABLE FORMULA|||Y|Y|5|Visit_5|90|7|TREATMENT|2020-10-20|2020-10-22|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|5d7241ec-120d-486d-ab39-b9e14ab4ce90|10|LYMPLLE|Plasmacytoid Lymphocytes/Leukocytes|URINALYSIS|[?]|MONTHS|[?]|[?]|TRACE|1|eq|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|UNEXPECTED ODOR||DUKE INCISION METHOD|CKD-EPI CYSTATIN C FORMULA|||U||5|Visit_5|90|6|TREATMENT|2020-10-20|2020-10-22|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|1|GOLD|Gold|CHEMISTRY|[?]|BU/mL|[?]|[?]|TRACE|1|L/s/kPa|1|1|[?]|LOW|URINE SEDIMENT|SOLIDIFIED|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|4|FOLLOW-UP|2020-06-01|2020-08-20|10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|2|NPY|Neuropeptide Y|HEMATOLOGY|[?]|log10 CCID 50/dose|[?]|[?]|INVALID|1|mg/g/min|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|ICTERIC||MAGNETIC RESONANCE ENTEROGRAPHY|MDRD 4 VARIABLE FORMULA|Y||N||1|Visit_1|10|7|TREATMENT|2020-06-01|2020-07-30|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|LB|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|3|VITB2|Riboflavin|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|mL/g/day|1|1|[?]|HIGH|TRANSUDATE|CONCENTRATED|N|PATHOLOGICAL EVALUATION|MDRD 6 VARIABLE FORMULA|Y||U|Y|2|Visit_2|25|3|TREATMENT|2020-06-16|2020-07-04|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|4|MYPC|Myeloid Progenitor Cells|URINALYSIS|||[?]|[?]|BORDERLINE|1|10^9 CFU/mL|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|LACTESCENT||CELLULAR PROLIFERATION ASSAY|MDRD 6 VARIABLE FORMULA|||NA|Y|2|Visit_2|25|6|WASHOUT|2020-06-16|2020-06-17|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|LB|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|5|GLOBB1BP|Beta-1 Globulin/Beta Protein|HEMATOLOGY|[?]|10^6 CFU/mL|[?]|[?]|INVALID|1|10^9 CFU/g|1|1|[?]|NORMAL|SMEGMA|CONTAMINATED|N|ELASTOGRAPHY|MDRD 6 VARIABLE FORMULA|||U||3|Visit_3|40|1|SCREENING|2020-07-01|2020-07-13|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|6|GBP2|Guanylate Binding Protein 2|URINALYSIS|[?]|nmol/L/min|[?]|[?]|INDETERMINATE|1|%(v/v)|1|1|[?]|HIGH|ALVEOLAR AIR|FRESH||LC-FL|FIBROMETER FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-07-01|2020-08-14|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|7|CD5|CD5|CHEMISTRY|[?]|pt_br|[?]|[?]|POSITIVE|1|pmol/L|1|1|[?]|LOW|DIALYSIS FLUID|GELLED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|Y||N||4|Visit_4|65|2|WASHOUT|2020-07-26|2020-08-26|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|8|PRORUB|Prorubricyte|CHEMISTRY|[?]|mOsm|[?]|[?]|POSITIVE|1|BU|1|1|[?]|HIGH|LAVAGE FLUID|THAWED||AMSLER GRID|ASH FIBROSURE FORMULA|||NA||4|Visit_4|65|2|WASHOUT|2020-07-26|2020-07-28|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|9|FACTXIV|Factor XIV|URINALYSIS|[?]|uCi|[?]|[?]|NEGATIVE|1|MdFI|1|1|[?]|LOW|VENOUS CORD BLOOD|PARAFFIN-EMBEDDED||AUTOMATED COUNT|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||5|Visit_5|90|5|WASHOUT|2020-08-20|2020-08-29|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|10|NAGASE|N-acetyl-beta-D-glucosaminidase|HEMATOLOGY|[?]|nmol/day|[?]|[?]|NEGATIVE|1|U/g|1|1|[?]|HIGH|MONOCYTE|CLOTTED||IMPULSE OSCILLOMETRY|MDRD 5 VARIABLE FORMULA|||U||5|Visit_5|90|2|TREATMENT|2020-08-20|2020-08-28|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|1|CYCAPHOS|Calcium Phosphate Crystals|HEMATOLOGY|[?]|mol/mg|[?]|[?]|POSITIVE|1|Ejaculate U|1|1|[?]|NORMAL|WHITE MATTER TISSUE|DRIED||SPECTROPHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-07-04|2020-08-28|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|2|GLOBB1|Beta-1 Globulin|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mL/m2/min|1|1|[?]|NORMAL|SWABBED MATERIAL|FROZEN||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CYSTATIN C FORMULA|Y|Y|NA|Y|1|Visit_1|10|3|TREATMENT|2020-07-04|2020-08-20|10|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|3|HCHT|Hyocholate|URINALYSIS|[?]|DIP|[?]|[?]|INDETERMINATE|1|umol/dL|1|1|[?]|ABNORMAL|DISCHARGE|CONCENTRATED|N|MEDIASTINOSCOPY|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-07-19|2020-08-05|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|4|ETPAUC|ETP Area Under Curve|URINALYSIS|[?]|oz|[?]|[?]|INDETERMINATE|1|dpm/100mg|1|1|[?]|LOW|CORD SERUM|HEMOLYZED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-07-19|2020-08-22|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|5|EOTAXIN2|Eotaxin-2|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|/4.0 mL|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|REFRIGERATED|N|CONFOCAL MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|3|Visit_3|40|1|TREATMENT|2020-08-03|2020-09-15|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|6|THRCREAT|Threonine/Creatinine|HEMATOLOGY|||[?]|[?]|POSITIVE|1|TAMPON|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|FRESH||ENZYMATIC COLORIMETRY|CKD-EPI CYSTATIN C FORMULA|Y||N|Y|3|Visit_3|40|2|WASHOUT|2020-08-03|2020-08-14|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|7|ASP|Aspartic Acid|URINALYSIS|[?]|ug/h|[?]|[?]|INDETERMINATE|1|mEq/L|1|1|[?]|LOW|BILE|FROZEN||IN VITRO GENE EXPRESSION ASSAY|FIBROTEST FORMULA|||Y||4|Visit_4|65|2|FOLLOW-UP|2020-08-28|2020-09-11|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|LB|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|8|HBA1A|Hemoglobin A1A|CHEMISTRY|||[?]|[?]|BORDERLINE|1|BAU/mL|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|THAWED||MYELOPEROXIDASE STAIN|MDRD 5 VARIABLE FORMULA|||N|Y|4|Visit_4|65|7|WASHOUT|2020-08-28|2020-09-12|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|LB|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|9|MYCYLE|Myelocytes/Leukocytes|CHEMISTRY|[?]|cmol|[?]|[?]|TRACE|1|mg/dL|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|ROOM TEMPERATURE|N|LYMPHANGIOGRAPHY|GMI MMOL/MOL FORMULA|Y||NA||5|Visit_5|90|3|TREATMENT|2020-09-22|2020-09-27|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|10|ERCEPPOL|Erythroid Proliferation Pool|HEMATOLOGY|[?]|mEq/L|[?]|[?]|INVALID|1|ft3|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|SOLIDIFIED|N|GRADIENT DIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||5|Visit_5|90|3|TREATMENT|2020-09-22|2020-09-28|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|a69c6182-9c35-4365-b732-b238e0584ba7|1|HYPRLN|Hydroxyproline|HEMATOLOGY|[?]|LB|[?]|[?]|NEGATIVE|1|10^5/L|1|1|[?]|ABNORMAL|SERUM|LACTESCENT|N|OPTICAL DENSITY MEASUREMENT|COCKCROFT-GAULT FORMULA||Y|Y||1|Visit_1|10|1|TREATMENT|2020-08-07|2020-09-20|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|a69c6182-9c35-4365-b732-b238e0584ba7|2|CYP2C9|Cytochrome P450 2C9|HEMATOLOGY|[?]|APS U|[?]|[?]|BORDERLINE|1|log10 CCID 50/dose|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|NON-HEMOLYZED||TELLER ACUITY CARDS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||1|Visit_1|10|3|TREATMENT|2020-08-07|2020-09-27|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|a69c6182-9c35-4365-b732-b238e0584ba7|3|CD19|CD19|CHEMISTRY|||[?]|[?]|INVALID|1|U/cL|1|1|[?]|NORMAL|EXPIRED AIR|CONTAMINATED|N|PELLI-ROBSON EYE CHART|MDRD 4 VARIABLE FORMULA|||U|Y|2|Visit_2|25|1|WASHOUT|2020-08-22|2020-09-08|25|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|a69c6182-9c35-4365-b732-b238e0584ba7|4|BTKFR|Bruton's Tyrosine Kinase, Free|HEMATOLOGY|[?]|vp/dose|[?]|[?]|BORDERLINE|1|gMFI|1|1|[?]|HIGH|SERUM OR PLASMA|AGGLUTINATED|N|SNP ARRAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||2|Visit_2|25|6|FOLLOW-UP|2020-08-22|2020-09-26|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|LB|a69c6182-9c35-4365-b732-b238e0584ba7|5|FACTII|Factor II|URINALYSIS|||[?]|[?]|NEGATIVE|1|DNA copies/ug|1|1|[?]|LOW|INFRANATANT, PLASMA|REFRIGERATED|N|ELLA|ASH FIBROSURE FORMULA||Y|N|Y|3|Visit_3|40|6|SCREENING|2020-09-06|2020-10-22|40|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|a69c6182-9c35-4365-b732-b238e0584ba7|6|HGFR|Hepatocyte Growth Factor Receptor|HEMATOLOGY|[?]|gpELISA unit/mL|[?]|[?]|INDETERMINATE|1|mOsm|1|1|[?]|NORMAL|SERUM OR PLASMA|UNEXPECTED ODOR||NUCLEIC ACID SEQUENCING|FIBROTEST FORMULA||Y|N||3|Visit_3|40|1|TREATMENT|2020-09-06|2020-10-17|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|LB|a69c6182-9c35-4365-b732-b238e0584ba7|7|FRUMCRTP|Fructosamine Corrected for Total Protein|HEMATOLOGY|[?]|nmol/kg/day|[?]|[?]|INVALID|1|10^6 organisms/mL|1|1|[?]|HIGH|SERUM|CONTAMINATED||MYELOPEROXIDASE STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||U||4|Visit_4|65|6|TREATMENT|2020-10-01|2020-10-02|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|a69c6182-9c35-4365-b732-b238e0584ba7|8|C1INH|Complement C1 Esterase Inhibitor|URINALYSIS|[?]|mL/breath|[?]|[?]|TRACE|1|um2|1|1|[?]|LOW|SALIVA|DRIED|N|SLIT LAMP PHOTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||4|Visit_4|65|5|WASHOUT|2020-10-01|2020-10-12|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|LB|a69c6182-9c35-4365-b732-b238e0584ba7|9|RBCDIPOP|Dimorphic Erythrocyte Population|HEMATOLOGY|[?]|U/mg|[?]|[?]|BORDERLINE|1|VIRTUAL PIXEL|1|1|[?]|HIGH|COLOSTRUM|UNEXPECTED ODOR||PERIPHERAL ANGIOGRAPHY|FIBROMETER FORMULA|||U||5|Visit_5|90|7|TREATMENT|2020-10-26|2020-11-04|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|a69c6182-9c35-4365-b732-b238e0584ba7|10|GFRBSA|Glomerular Filtration Rate Adj for BSA|CHEMISTRY|||[?]|[?]|NEGATIVE|1|ug/min|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR||MICROBIAL BIOCHEMICAL IDENTIFICATION|FIBROSIS 4 FORMULA|Y||U|Y|5|Visit_5|90|2|TREATMENT|2020-10-26|2020-11-03|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|1b9896cf-160e-4a56-8737-9759cd83e784|1|METHQLDN|Methaqualone|URINALYSIS|||[?]|[?]|BORDERLINE|1|bel|1|1|[?]|LOW|CELL PELLET|FROZEN||MICROSCOPY|MDRD 5 VARIABLE FORMULA||Y|NA|Y|1|Visit_1|10|5|TREATMENT|2020-12-11|2021-01-29|10|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|1b9896cf-160e-4a56-8737-9759cd83e784|2|IOTCLRBS|Iothalamate Clearance Adjusted for BSA|HEMATOLOGY|[?]|amp|[?]|[?]|NEGATIVE|1|ug/L/h|1|1|[?]|HIGH|EPIDERMAL TISSUE|DRIED||SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||1|Visit_1|10|1|SCREENING|2020-12-11|2021-03-05|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|LB|1b9896cf-160e-4a56-8737-9759cd83e784|3|VEGFA|Vascular Endothelial Growth Factor A|URINALYSIS|||[?]|[?]|INDETERMINATE|1|gtt|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|GELLED||NEXT GENERATION TARGETED SEQUENCING|HEPASCORE FORMULA|Y|Y|N|Y|2|Visit_2|25|5|TREATMENT|2020-12-26|2021-01-14|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|1b9896cf-160e-4a56-8737-9759cd83e784|4|GLDIGAAB|Gliadin IgA Antibody|HEMATOLOGY|||[?]|[?]|POSITIVE|1|PRESSOR UNITS|1|1|[?]|NORMAL|SWABBED MATERIAL|CLOTTED||ULTRASONOGRAPHIC ELASTOGRAPHY|CKD-EPI CREATININE FORMULA|||NA|Y|2|Visit_2|25|1|TREATMENT|2020-12-26|2021-01-30|25|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|1b9896cf-160e-4a56-8737-9759cd83e784|5|CIT|Citrulline|URINALYSIS|[?]|mL/animal|[?]|[?]|BORDERLINE|1|nL|1|1|[?]|HIGH|PLATELET|LIPEMIC||MICRODENSITOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|2|SCREENING|2021-01-10|2021-01-18|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|1b9896cf-160e-4a56-8737-9759cd83e784|6|APPA|Amyloid Alpha Precursor Protein|URINALYSIS|[?]|m|[?]|[?]|POSITIVE|1|g/mol|1|1|[?]|ABNORMAL|URINE|FRESH||OSCILLOMETRY|CKD-EPI CREATININE FORMULA|||NA||3|Visit_3|40|2|TREATMENT|2021-01-10|2021-01-17|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|LB|1b9896cf-160e-4a56-8737-9759cd83e784|7|LH|Luteinizing Hormone|HEMATOLOGY|[?]|WAFER|[?]|[?]|BORDERLINE|1|10^9/dose|1|1|[?]|LOW|BASAL TEAR|ICTERIC||ROMANOWSKY STAIN|CKD-EPI CYSTATIN C FORMULA|Y||U||4|Visit_4|65|4|TREATMENT|2021-02-04|2021-03-06|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|1b9896cf-160e-4a56-8737-9759cd83e784|8|BLASTLM|Leukemic Blasts|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mEq/day|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED||STATIC PERIMETRY|CKD-EPI CREATININE FORMULA|||U|Y|4|Visit_4|65|3|TREATMENT|2021-02-04|2021-03-01|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|LB|1b9896cf-160e-4a56-8737-9759cd83e784|9|MONOCE|Monocytes/Total Cells|HEMATOLOGY|[?]|uV*sec|[?]|[?]|BORDERLINE|1|min|1|1|[?]|HIGH|SOFT TISSUE|CLOTTED|N|MANUAL COUNT|COCKCROFT-GAULT FORMULA|Y||U||5|Visit_5|90|5|TREATMENT|2021-03-01|2021-03-02|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|1b9896cf-160e-4a56-8737-9759cd83e784|10|C130110|Mold Mix Antigen IgG Antibody|URINALYSIS|[?]|lm|[?]|[?]|INVALID|1|U/g Hb|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|AUTOLYZED|N|SINGLE-MOLECULE ARRAY|COCKCROFT-GAULT FORMULA|||N||5|Visit_5|90|3|TREATMENT|2021-03-01|2021-03-02|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|LB|ea87b553-e331-40cf-bd86-d2bd22694476|1|MUCTHR|Mucous Threads|URINALYSIS|||[?]|[?]|TRACE|1|cmH2O/mL|1|1|[?]|LOW|BLOOD|ICTERIC||TEMPLATE INCISION METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|1|Visit_1|10|3|FOLLOW-UP|2020-08-05|2020-09-25|10|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|ea87b553-e331-40cf-bd86-d2bd22694476|2|PHOSLPD|Phospholipid|CHEMISTRY|[?]|/2500 WBC|[?]|[?]|POSITIVE|1|cm|1|1|[?]|NORMAL|LOCHIA|FRESH|N|AUTOREFRACTION|FIBROSIS 4 FORMULA|Y||U||1|Visit_1|10|2|TREATMENT|2020-08-05|2020-10-06|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|ea87b553-e331-40cf-bd86-d2bd22694476|3|ICAM3|Intercellular Adhesion Molecule 3|CHEMISTRY|[?]|BAU/mL|[?]|[?]|POSITIVE|1|mOsm/kg|1|1|[?]|LOW|TUMOR TISSUE|LACTESCENT||ARTERIAL SPIN LABELING FUNCTIONAL MRI|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-08-20|2020-10-04|25|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|ea87b553-e331-40cf-bd86-d2bd22694476|4|PHOSCLR|Phosphate Clearance|URINALYSIS|[?]|ug/m2/h|[?]|[?]|INVALID|1|CAPSULE|1|1|[?]|NORMAL|SUPERNATANT, SERUM|LIPEMIC||DUCTOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|5|FOLLOW-UP|2020-08-20|2020-09-24|25|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|LB|ea87b553-e331-40cf-bd86-d2bd22694476|5|PCT|Procalcitonin|HEMATOLOGY|[?]|g/day|[?]|[?]|TRACE|1|ukat/10^12 RBC|1|1|[?]|LOW|PLATELET|REFRIGERATED||PUPILLOMETRY|MDRD 5 VARIABLE FORMULA|Y||U||3|Visit_3|40|6|WASHOUT|2020-09-04|2020-10-17|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|ea87b553-e331-40cf-bd86-d2bd22694476|6|NEUTMY|Neutrophilic Myelocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|fmol/g|1|1|[?]|HIGH|COLOSTRUM|REFRIGERATED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||NA|Y|3|Visit_3|40|3|TREATMENT|2020-09-04|2020-09-24|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|ea87b553-e331-40cf-bd86-d2bd22694476|7|C130114|Industrial Mix Antigen IgE Antibody|CHEMISTRY|[?]|MnFI|[?]|[?]|BORDERLINE|1|mL/m2/day|1|1|[?]|LOW|PLATELET|LIPEMIC||ISHIHARA COLOR PLATES|FIBROSIS 4 FORMULA|Y||NA||4|Visit_4|65|3|SCREENING|2020-09-29|2020-11-01|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|ea87b553-e331-40cf-bd86-d2bd22694476|8|PMYCECE|Proliferating Myeloid Cells/Total Cells|URINALYSIS|[?]|RING|[?]|[?]|NEGATIVE|1|/2000 RBC|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|DRIED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC FORMULA|Y||U||4|Visit_4|65|1|TREATMENT|2020-09-29|2020-10-23|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|LB|ea87b553-e331-40cf-bd86-d2bd22694476|9|P3NP|Procollagen 3 N-Terminal Propeptide|CHEMISTRY|[?]|uCi/L|[?]|[?]|INVALID|1|mg/animal|1|1|[?]|NORMAL|SEMEN|REFRIGERATED|N|VIRUS PLAQUE ASSAY|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|1|FOLLOW-UP|2020-10-24|2020-10-30|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|LB|ea87b553-e331-40cf-bd86-d2bd22694476|10|CYBILI|Bilirubin Crystals|HEMATOLOGY|[?]|PFU/animal|[?]|[?]|INVALID|1|mg/min|1|1|[?]|LOW|VENOUS CORD BLOOD|AGGLUTINATED||IMMUNOBLOT|MDRD ENZYMATIC FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2020-10-24|2020-10-25|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|LB|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|1|SOMATRO|Somatotrophin|CHEMISTRY|[?]|DIP|[?]|[?]|INVALID|1|TABLET|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED||TRANSCRIPTION-MEDIATED AMPLIFICATION|COCKCROFT-GAULT FORMULA|Y|Y|Y||1|Visit_1|10|5|SCREENING|2020-07-30|2020-09-09|10|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|2|LIQUFT|Liquefaction Time|CHEMISTRY|||[?]|[?]|TRACE|1|fL|1|1|[?]|HIGH|TRANSUDATE|CONCENTRATED||SINGLE-MOLECULE ARRAY|ASH FIBROSURE FORMULA|||NA|Y|1|Visit_1|10|4|WASHOUT|2020-07-30|2020-09-25|10|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|3|GUDCA|Glycoursodeoxycholate|URINALYSIS|[?]|DNA copies/ug|[?]|[?]|INVALID|1|CAPSULE|1|1|[?]|HIGH|MECONIUM|AGGLUTINATED||PLETHYSMOGRAPHY|GMI MMOL/MOL FORMULA||Y|N||2|Visit_2|25|4|FOLLOW-UP|2020-08-14|2020-08-19|25|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|4|RNPSMAB|Ribonucleoprotein Smith Complex Antibody|HEMATOLOGY|[?]|10^9/g|[?]|[?]|BORDERLINE|1|g/mol|1|1|[?]|ABNORMAL|PLASMA|ROOM TEMPERATURE|N|RULER MEASUREMENT METHOD|MDRD ENZYMATIC FORMULA|Y|Y|NA||2|Visit_2|25|2|TREATMENT|2020-08-14|2020-08-18|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|5|C130110|Mold Mix Antigen IgG Antibody|URINALYSIS|[?]|kg/cm2|[?]|[?]|INVALID|1|mg/m2/day|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|GELLED|N|LC/MS|MDRD FORMULA|Y||U||3|Visit_3|40|2|TREATMENT|2020-08-29|2020-08-31|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|6|IAA5OH|5-Hydroxyindoleacetic Acid|HEMATOLOGY|[?]|BP|[?]|[?]|POSITIVE|1|mmHg|1|1|[?]|LOW|MUCUS|REFRIGERATED||HEMATOXYLIN AND EOSIN STAIN|FIBROTEST FORMULA|||U||3|Visit_3|40|2|WASHOUT|2020-08-29|2020-10-18|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|7|PYRIDNLN|Pyridinoline|CHEMISTRY|||[?]|[?]|POSITIVE|1|amp|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|ICTERIC||MODIFIED ACID FAST STAIN|MDRD 5 VARIABLE FORMULA|||U|Y|4|Visit_4|65|5|FOLLOW-UP|2020-09-23|2020-10-16|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|8|TNF|Tumor Necrosis Factor|HEMATOLOGY|[?]|/wk|[?]|[?]|TRACE|1|%|1|1|[?]|NORMAL|PLATELET RICH PLASMA|CLOTTED||ELISA|ASH FIBROSURE FORMULA|||Y||4|Visit_4|65|5|SCREENING|2020-09-23|2020-10-27|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|9|AXL|AXL Receptor Tyrosine Kinase|URINALYSIS|[?]|SCOOPFUL|[?]|[?]|INDETERMINATE|1|%(w/w)|1|1|[?]|ABNORMAL|DIALYSIS FLUID|REFRIGERATED||IMMUNOPRECIPITATION|FIBROSIS 4 FORMULA|||U||5|Visit_5|90|7|SCREENING|2020-10-18|2020-10-22|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|10|MONOIM|Immature Monocytes|CHEMISTRY|[?]|Ci/g|[?]|[?]|TRACE|1|PUFF|1|1|[?]|ABNORMAL|BONE|CONTAMINATED||CLINICAL EVALUATION|CKD-EPI CREATININE FORMULA||Y|N||5|Visit_5|90|2|TREATMENT|2020-10-18|2020-10-21|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|051dc064-be6f-43eb-aa51-7ed8634d6e23|1|C130134|D. pteronyssinus Antigen IgE Antibody|HEMATOLOGY|[?]|log10 PFU|[?]|[?]|TRACE|1|g|1|1|[?]|NORMAL|EXPIRED AIR|CONCENTRATED||PYROSEQUENCING|FIBROMETER FORMULA|||U||1|Visit_1|10|4|SCREENING|2020-07-08|2020-09-08|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|051dc064-be6f-43eb-aa51-7ed8634d6e23|2|GLUCPED|Plasma Equivalent Glucose Distribution|HEMATOLOGY|[?]|mL/beat|[?]|[?]|BORDERLINE|1|uCi/kg|1|1|[?]|ABNORMAL|KERATINOCYTE|ICTERIC||NEURAMINIDASE INHIBITION ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|U||1|Visit_1|10|5|WASHOUT|2020-07-08|2020-08-17|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|LB|051dc064-be6f-43eb-aa51-7ed8634d6e23|3|DKK1|Dickkopf WNT Signaling Path Inhibitor 1|CHEMISTRY|[?]|Absorbance U|[?]|[?]|POSITIVE|1|Absorbance U/mL|1|1|[?]|ABNORMAL|SEMINAL FLUID|CALCIFIED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|FIBROTEST FORMULA|Y||N||2|Visit_2|25|1|WASHOUT|2020-07-23|2020-09-06|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|LB|051dc064-be6f-43eb-aa51-7ed8634d6e23|4|ALT|Alanine Aminotransferase|URINALYSIS|||[?]|[?]|INDETERMINATE|1|AgU/mL|1|1|[?]|LOW|EPITHELIAL CELL|FRESH||FLUOROSCOPY|FIBROMETER FORMULA||Y|Y|Y|2|Visit_2|25|4|SCREENING|2020-07-23|2020-09-24|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|LB|051dc064-be6f-43eb-aa51-7ed8634d6e23|5|CD38|CD38|HEMATOLOGY|[?]|Bq/mg|[?]|[?]|TRACE|1|mL/beat|1|1|[?]|HIGH|CALCULUS|DRIED||HPLC/MS|MDRD 6 VARIABLE FORMULA|||U||3|Visit_3|40|2|SCREENING|2020-08-07|2020-09-13|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|051dc064-be6f-43eb-aa51-7ed8634d6e23|6|VITB2|Riboflavin|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^3 organisms/mL|1|1|[?]|ABNORMAL|SEMINAL FLUID|DRIED|N|HPLC-FL|FIBROSIS 4 FORMULA||Y|U|Y|3|Visit_3|40|3|TREATMENT|2020-08-07|2020-08-27|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|051dc064-be6f-43eb-aa51-7ed8634d6e23|7|PGF1A|Prostaglandin F1 Alpha|URINALYSIS|[?]|mAmp|[?]|[?]|INVALID|1|FEU|1|1|[?]|ABNORMAL|CELL PELLET|FROZEN||AMSLER GRID|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|6|WASHOUT|2020-09-01|2020-09-28|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|051dc064-be6f-43eb-aa51-7ed8634d6e23|8|ASTCK|AST/Creatine Kinase|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mL/cm3/min|1|1|[?]|ABNORMAL|LUNG SURFACTANT|SOLIDIFIED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|||Y|Y|4|Visit_4|65|3|TREATMENT|2020-09-01|2020-09-16|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|051dc064-be6f-43eb-aa51-7ed8634d6e23|9|NHMCE|Nonhematic Cells|CHEMISTRY|[?]|GPL U|[?]|[?]|INVALID|1|Osm|1|1|[?]|NORMAL|LOCHIA|PARAFFIN-EMBEDDED||HANSEL STAIN|FIBROSIS 4 FORMULA|||N||5|Visit_5|90|7|FOLLOW-UP|2020-09-26|2020-09-30|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|051dc064-be6f-43eb-aa51-7ed8634d6e23|10|TROPONI3|Troponin I Type 3|CHEMISTRY|[?]|atm|[?]|[?]|INDETERMINATE|1|tsp eq|1|1|[?]|HIGH|SUPERNATANT, SERUM|LACTESCENT||POPULATION SEQUENCING|MDRD 5 VARIABLE FORMULA|||Y||5|Visit_5|90|6|WASHOUT|2020-09-26|2020-10-04|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|1|PCNAG|Proliferating Cell Nuclear Antigen|URINALYSIS|||[?]|[?]|NEGATIVE|1|mmol/s|1|1|[?]|HIGH|LOCHIA|NON-HEMOLYZED||FLUORIMETRY|MDRD 5 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|6|SCREENING|2020-06-03|2020-06-28|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|2|SPMMSPM|Motile Sperm/Total Sperm|CHEMISTRY|[?]|Farad|[?]|[?]|NEGATIVE|1|dyn|1|1|[?]|HIGH|PROSTATIC FLUID|CONTAMINATED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI FORMULA|Y||Y||1|Visit_1|10|7|TREATMENT|2020-06-03|2020-06-29|10|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|3|GRAN|Granulocytes|URINALYSIS|[?]|nL|[?]|[?]|NEGATIVE|1|Ci/kg|1|1|[?]|HIGH|LAVAGE FLUID|ICTERIC||PHOTOMETRIC CLOT DETECTION|CKD-EPI CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|3|FOLLOW-UP|2020-06-18|2020-07-11|25|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|4|PEPSNG|Pepsinogen|CHEMISTRY|[?]|1/(s*kPa)|[?]|[?]|POSITIVE|1|mg/kg|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|DRIED||TRIPLE-PHASE MRI SCAN|HEPASCORE FORMULA|Y|Y|NA||2|Visit_2|25|1|TREATMENT|2020-06-18|2020-08-12|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|5|EPIN|Epinephrine|URINALYSIS|||[?]|[?]|POSITIVE|1|mL/kg/min|1|1|[?]|NORMAL|RETICULOCYTES|PARAFFIN-EMBEDDED|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 5 VARIABLE FORMULA||Y|Y|Y|3|Visit_3|40|5|TREATMENT|2020-07-03|2020-07-06|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|6|TRPCRT|Tryptophan/Creatinine|HEMATOLOGY|||[?]|[?]|TRACE|1|Sv|1|1|[?]|LOW|SPERMATOZOON|ICTERIC|N|ELECTRONEUROGRAPHY|CKD-EPI FORMULA|||Y|Y|3|Visit_3|40|2|FOLLOW-UP|2020-07-03|2020-07-20|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|7|CHOLATE|Cholate|CHEMISTRY|[?]|IU/mL|[?]|[?]|INVALID|1|Pack Year|1|1|[?]|NORMAL|MONOCYTE|CALCIFIED||ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|NA||4|Visit_4|65|2|TREATMENT|2020-07-28|2020-08-21|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|8|C165936|Glycine max IgE AB RAST Score|HEMATOLOGY|[?]|pL|[?]|[?]|NEGATIVE|1|MET*h|1|1|[?]|LOW|URINE SEDIMENT|GELLED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI FORMULA|Y||Y||4|Visit_4|65|1|WASHOUT|2020-07-28|2020-08-30|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|9|INHIBINB|Inhibin B|URINALYSIS|[?]|Bq/uL|[?]|[?]|NEGATIVE|1|10^6 organisms/mL|1|1|[?]|LOW|CAPILLARY PLASMA|FROZEN||ENZYMATIC COLORIMETRY|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|2|SCREENING|2020-08-22|2020-08-24|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|LB|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|10|PBGCREAT|Porphobilinogen/Creatinine|URINALYSIS|[?]|MHz|[?]|[?]|TRACE|1|log10 TCID 50/uL|1|1|[?]|HIGH|ABSCESS FLUID|UNEXPECTED ODOR|N|DOUBLE IMMUNODIFFUSION|FIBROTEST FORMULA|||U||5|Visit_5|90|4|FOLLOW-UP|2020-08-22|2020-08-28|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|LB|7a17fe21-b640-4bc5-bf19-b1bceb393dab|1|MONOBL|Monoblasts|HEMATOLOGY|||[?]|[?]|INVALID|1|Absorbance U/mL|1|1|[?]|NORMAL|LAVAGE FLUID|UNEXPECTED ODOR||THIN SMEAR|FIBROSIS 4 FORMULA|Y||N|Y|1|Visit_1|10|4|WASHOUT|2020-09-02|2020-11-22|10|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|7a17fe21-b640-4bc5-bf19-b1bceb393dab|2|DRVTSCPD|dRVVT Screen to Confirm Pct Difference|CHEMISTRY|[?]|g/m2|[?]|[?]|NEGATIVE|1|hPa|1|1|[?]|LOW|VENOUS BLOOD|UNEXPECTED ODOR||INFRARED SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-09-02|2020-11-07|10|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|7a17fe21-b640-4bc5-bf19-b1bceb393dab|3|HETRPH|Heterophils|URINALYSIS|[?]|foz_br|[?]|[?]|TRACE|1|log10 IU/mL|1|1|[?]|HIGH|TRANSUDATE|UNEXPECTED ODOR||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROTEST FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-09-17|2020-10-03|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|7a17fe21-b640-4bc5-bf19-b1bceb393dab|4|CYCAPHOS|Calcium Phosphate Crystals|CHEMISTRY|||[?]|[?]|INVALID|1|BOLUS|1|1|[?]|HIGH|BLOOD|AUTOLYZED||BIOPSY|COCKCROFT-GAULT FORMULA|||N|Y|2|Visit_2|25|1|FOLLOW-UP|2020-09-17|2020-09-22|25|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|7a17fe21-b640-4bc5-bf19-b1bceb393dab|5|RT3|Triiodothyronine, Reverse|URINALYSIS|[?]|Log10 ELISA unit|[?]|[?]|TRACE|1|mL/min/mmHg|1|1|[?]|HIGH|BREAST MILK|LACTESCENT|N|NUCLEIC ACID BASED METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U||3|Visit_3|40|3|SCREENING|2020-10-02|2020-11-08|40|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|7a17fe21-b640-4bc5-bf19-b1bceb393dab|6|CACLR|Calcium Clearance|CHEMISTRY|[?]|cg|[?]|[?]|BORDERLINE|1|BOTTLE|1|1|[?]|HIGH|MUCUS|AGGLUTINATED|N|ACRIDINE ORANGE STAIN|HEPASCORE FORMULA|Y||NA||3|Visit_3|40|6|FOLLOW-UP|2020-10-02|2020-11-19|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|7a17fe21-b640-4bc5-bf19-b1bceb393dab|7|CD4LY|CD4/Lymphocytes|URINALYSIS|[?]|BU|[?]|[?]|BORDERLINE|1|U/mmol|1|1|[?]|ABNORMAL|SEMINAL FLUID|NON-HEMOLYZED||IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD 5 VARIABLE FORMULA|||N||4|Visit_4|65|3|SCREENING|2020-10-27|2020-11-07|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|7a17fe21-b640-4bc5-bf19-b1bceb393dab|8|CREATCLR|Creatinine Clearance|URINALYSIS|[?]|ug/m2/day|[?]|[?]|NEGATIVE|1|Gravitational Unit|1|1|[?]|HIGH|ISOLATE|PARAFFIN-EMBEDDED|N|CONTRAST ENHANCED SPIRAL CT SCAN|GMI MMOL/MOL FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-10-27|2020-11-06|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|7a17fe21-b640-4bc5-bf19-b1bceb393dab|9|C4|Complement C4|URINALYSIS|[?]|mOsm|[?]|[?]|POSITIVE|1|10^9 organisms/g|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|DRIED||AUTOREFRACTION|ASH FIBROSURE FORMULA|Y||U||5|Visit_5|90|7|TREATMENT|2020-11-21|2020-11-25|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|7a17fe21-b640-4bc5-bf19-b1bceb393dab|10|CSGRANC|Granular Coarse Casts|CHEMISTRY|||[?]|[?]|BORDERLINE|1|umol/mg/min|1|1|[?]|HIGH|SWABBED MATERIAL|CLOTTED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|NASH FIBROSURE FORMULA|Y||U|Y|5|Visit_5|90|2|TREATMENT|2020-11-21|2020-11-23|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|1|INSLNFR|Insulin, Free|CHEMISTRY|[?]|mol/mol|[?]|[?]|NEGATIVE|1|log10 PFU/mL|1|1|[?]|LOW|SEMINAL FLUID|CALCIFIED||URANYL ACETATE STAIN|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|5|TREATMENT|2021-01-20|2021-02-21|10|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-02
e|LB|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|2|PLSIMCE|Immature Plasma Cells|CHEMISTRY|[?]|10^8 PFU|[?]|[?]|INVALID|1|ELISA unit/dose|1|1|[?]|NORMAL|SOFT TISSUE|FROZEN||RADIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||1|Visit_1|10|3|TREATMENT|2021-01-20|2021-03-01|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-02
e|LB|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|3|EUDCA|Epimerized Ursodeoxycholate|HEMATOLOGY|[?]|kHz|[?]|[?]|INDETERMINATE|1|log10 TCID 50/mL|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|NON-HEMOLYZED|N|GC/MS-EI|FIBROTEST FORMULA|Y||NA||2|Visit_2|25|4|WASHOUT|2021-02-04|2021-03-03|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|4|C165891|Western Ragweed Pollen IgE AB RAST Score|HEMATOLOGY|[?]|kHz|[?]|[?]|INDETERMINATE|1|10^3 organisms/mL|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|FROZEN||WEBER GREEN STAIN|ASH FIBROSURE FORMULA|||U||2|Visit_2|25|3|TREATMENT|2021-02-04|2021-03-13|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|5|CD3LY|CD3/Lymphocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|EU|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|UNEXPECTED ODOR|N|ELECTROMYOGRAPHY|HEPASCORE FORMULA|||Y|Y|3|Visit_3|40|7|TREATMENT|2021-02-19|2021-03-05|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|6|TSP1|Thrombospondin 1|URINALYSIS|[?]|LOZENGE|[?]|[?]|TRACE|1|nmol/L|1|1|[?]|ABNORMAL|SEMINAL FLUID|THAWED||VIRUS PLAQUE ASSAY|HEPASCORE FORMULA|||U||3|Visit_3|40|3|TREATMENT|2021-02-19|2021-03-24|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|7|DZPM|Diazepam|URINALYSIS|[?]|ng|[?]|[?]|POSITIVE|1|BU/mL|1|1|[?]|LOW|CEREBROSPINAL FLUID|CLOTTED|N|POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2021-03-16|2021-03-31|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|8|ETPTPR|ETP Time to Peak Relative|HEMATOLOGY|||[?]|[?]|TRACE|1|ngEq/L|1|1|[?]|LOW|PERITONEAL FLUID|CONTAMINATED||TARGETED TRANSCRIPTOME SEQUENCING|GMI MMOL/MOL FORMULA||Y|NA|Y|4|Visit_4|65|5|WASHOUT|2021-03-16|2021-04-08|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|LB|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|9|MCV|Ery. Mean Corpuscular Volume|CHEMISTRY|||[?]|[?]|NEGATIVE|1|nmol BCE/mmol|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|CALCIFIED||DNA MICROARRAY|CKD-EPI FORMULA||Y|NA|Y|5|Visit_5|90|3|TREATMENT|2021-04-10|2021-04-13|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|LB|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|10|PLSPCELY|Precursor Plasma Cells/Lymphocytes|URINALYSIS|||[?]|[?]|INVALID|1|10^4/L|1|1|[?]|NORMAL|WHITE MATTER TISSUE|CLOTTED|N|POLYSOMNOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||Y|Y|5|Visit_5|90|5|WASHOUT|2021-04-10|2021-04-19|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|LB|f1d0daec-aa97-4838-9c53-e16dae3e17b2|1|PMYCECE|Proliferating Myeloid Cells/Total Cells|URINALYSIS|[?]|mg2/dL2|[?]|[?]|BORDERLINE|1|pg/cell|1|1|[?]|ABNORMAL|LUNG SURFACTANT|ROOM TEMPERATURE||CALCULATION|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-06-23|2020-06-26|10|13|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|f1d0daec-aa97-4838-9c53-e16dae3e17b2|2|UNSPCECE|Unspecified Cells/Total Cells|URINALYSIS|[?]|ug/animal|[?]|[?]|TRACE|1|mg/h|1|1|[?]|NORMAL|PLATELET RICH PLASMA|AGGLUTINATED|N|ELISPOT|GMI MMOL/MOL FORMULA|||NA||1|Visit_1|10|6|FOLLOW-UP|2020-06-23|2020-07-20|10|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|LB|f1d0daec-aa97-4838-9c53-e16dae3e17b2|3|BASOCE|Basophils/Total Cells|CHEMISTRY|[?]|RING|[?]|[?]|BORDERLINE|1|/100 WBC|1|1|[?]|ABNORMAL|ISOLATE|DRIED||ELISA|FIBROMETER FORMULA||Y|N||2|Visit_2|25|6|TREATMENT|2020-07-08|2020-09-04|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|f1d0daec-aa97-4838-9c53-e16dae3e17b2|4|CD4|CD4|URINALYSIS|||[?]|[?]|TRACE|1|umol/L/sec|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|ROOM TEMPERATURE|N|CHROMATOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N|Y|2|Visit_2|25|6|SCREENING|2020-07-08|2020-07-27|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|LB|f1d0daec-aa97-4838-9c53-e16dae3e17b2|5|BLSTLMLY|Leukemic Blasts/Lymphocytes|CHEMISTRY|[?]|foz_us|[?]|[?]|TRACE|1|RING|1|1|[?]|HIGH|BONE|FRESH|N|MANUAL COUNT|MDRD ENZYMATIC JAPANESE FORMULA|||NA||3|Visit_3|40|4|SCREENING|2020-07-23|2020-09-05|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|LB|f1d0daec-aa97-4838-9c53-e16dae3e17b2|6|VEGF|Vascular Endothelial Growth Factor|URINALYSIS|||[?]|[?]|INDETERMINATE|1|copies/mL|1|1|[?]|ABNORMAL|PERSPIRATION|ROOM TEMPERATURE||DC SHEATH FLOW|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|3|Visit_3|40|6|FOLLOW-UP|2020-07-23|2020-08-20|40|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|LB|f1d0daec-aa97-4838-9c53-e16dae3e17b2|7|RETIH|High Absorption Reticulocytes|URINALYSIS|||[?]|[?]|BORDERLINE|1|kg/mol|1|1|[?]|NORMAL|BONE|CONCENTRATED||RIA|MDRD ENZYMATIC FORMULA|Y|Y|NA|Y|4|Visit_4|65|3|FOLLOW-UP|2020-08-17|2020-09-15|65|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|f1d0daec-aa97-4838-9c53-e16dae3e17b2|8|AMYLB40|Amyloid Beta 1-40|URINALYSIS|[?]|ft|[?]|[?]|INVALID|1|mol|1|1|[?]|HIGH|LAVAGE FLUID|DRIED||WESTERN BLOT|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|1|FOLLOW-UP|2020-08-17|2020-09-14|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|f1d0daec-aa97-4838-9c53-e16dae3e17b2|9|NEUTSG|Neutrophils, Segmented|HEMATOLOGY|[?]|GPS U|[?]|[?]|INDETERMINATE|1|TAMPON|1|1|[?]|ABNORMAL|PERITONEAL FLUID|CALCIFIED||DUCTOGRAPHY|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2020-09-11|2020-09-19|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|f1d0daec-aa97-4838-9c53-e16dae3e17b2|10|C130123|Nut Mix Antigen IgG Antibody|HEMATOLOGY|[?]|10^9/dose|[?]|[?]|TRACE|1|mm3/mm2/year|1|1|[?]|ABNORMAL|SEMINAL FLUID|AGGLUTINATED||DOPPLER ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|1|TREATMENT|2020-09-11|2020-09-12|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|LB|835594ab-e93c-402b-8129-6af659be5ae1|1|CSAB|Cathepsin Antibody|HEMATOLOGY|[?]|L/s|[?]|[?]|NEGATIVE|1|MAC50|1|1|[?]|ABNORMAL|PERSPIRATION|CONTAMINATED||SCINTIGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||1|Visit_1|10|6|TREATMENT|2020-11-01|2020-11-29|10|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|835594ab-e93c-402b-8129-6af659be5ae1|2|GHBP|Growth Hormone Binding Protein|URINALYSIS|||[?]|[?]|INVALID|1|hPa|1|1|[?]|LOW|EMESIS|ROOM TEMPERATURE||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD ENZYMATIC FORMULA|||Y|Y|1|Visit_1|10|7|TREATMENT|2020-11-01|2021-01-27|10|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|835594ab-e93c-402b-8129-6af659be5ae1|3|EPIN|Epinephrine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ug/animal|1|1|[?]|LOW|MECONIUM|AGGLUTINATED|N|STRESS ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA|||U|Y|2|Visit_2|25|6|TREATMENT|2020-11-16|2020-11-18|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|835594ab-e93c-402b-8129-6af659be5ae1|4|ALUMINUM|Aluminum|URINALYSIS|[?]|um/day|[?]|[?]|INVALID|1|pptr|1|1|[?]|ABNORMAL|ABSCESS FLUID|UNEXPECTED ODOR||SCINTIGRAPHY|COCKCROFT-GAULT FORMULA|Y|Y|NA||2|Visit_2|25|7|SCREENING|2020-11-16|2021-01-28|25|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|835594ab-e93c-402b-8129-6af659be5ae1|5|SLTFRNRC|Soluble Transferrin Receptor|CHEMISTRY|[?]|ng/dL|[?]|[?]|BORDERLINE|1|L/min/m2|1|1|[?]|HIGH|MIXED VENOUS BLOOD|NON-HEMOLYZED||PLAQUE REDUCTION NEUTRALIZATION ASSAY|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|6|FOLLOW-UP|2020-12-01|2021-01-12|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|835594ab-e93c-402b-8129-6af659be5ae1|6|PSIGMAB|Phosphatidylserine IgM Antibody|CHEMISTRY|[?]|ug/dL|[?]|[?]|INVALID|1|Henry|1|1|[?]|HIGH|SUPERNATANT, SERUM|UNEXPECTED ODOR|N|PALPATION|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-12-01|2020-12-26|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|835594ab-e93c-402b-8129-6af659be5ae1|7|WBCCE|Leukocytes/Total Cells|URINALYSIS|[?]|CAPSULE|[?]|[?]|INDETERMINATE|1|umol/min|1|1|[?]|HIGH|MECONIUM|THAWED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA||Y|Y||4|Visit_4|65|4|TREATMENT|2020-12-26|2021-01-24|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|835594ab-e93c-402b-8129-6af659be5ae1|8|C130123|Nut Mix Antigen IgG Antibody|HEMATOLOGY|[?]|BOX|[?]|[?]|BORDERLINE|1|10^6 organisms/mg|1|1|[?]|ABNORMAL|CELL PELLET|SOLIDIFIED||FLUORESCEIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||4|Visit_4|65|5|TREATMENT|2020-12-26|2021-01-06|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|835594ab-e93c-402b-8129-6af659be5ae1|9|PO2|Partial Pressure Oxygen|CHEMISTRY|[?]|CCID 50/dose|[?]|[?]|BORDERLINE|1|mL/beat|1|1|[?]|NORMAL|AMNIOTIC FLUID|CLOTTED||COLORIMETRY|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|5|SCREENING|2021-01-20|2021-01-26|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|835594ab-e93c-402b-8129-6af659be5ae1|10|LDLOXI|Oxidized LDL Cholesterol|URINALYSIS|[?]|ug/m2|[?]|[?]|NEGATIVE|1|cg|1|1|[?]|LOW|CAPILLARY BLOOD|NON-HEMOLYZED||FLUORESCENT ENZYME IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|6|TREATMENT|2021-01-20|2021-01-23|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|LB|c3c85786-d24b-4620-9ee0-c13b1cc4f951|1|BLSTLYLE|Lymphoblasts/Leukocytes|URINALYSIS|||[?]|[?]|POSITIVE|1|mL/mmHg/min/L|1|1|[?]|HIGH|GASTRIC CONTENTS|AGGLUTINATED||COMPLEMENT FIXATION|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|1|Visit_1|10|6|TREATMENT|2020-10-07|2020-11-07|10|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|c3c85786-d24b-4620-9ee0-c13b1cc4f951|2|CANNAB|Cannabinoids|URINALYSIS|[?]|10^3 RNA copies/mL|[?]|[?]|BORDERLINE|1|10^7 CFU|1|1|[?]|ABNORMAL|URINE SEDIMENT|SOLIDIFIED||ICP-MS|ASH FIBROSURE FORMULA|||Y||1|Visit_1|10|4|WASHOUT|2020-10-07|2021-01-02|10|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|c3c85786-d24b-4620-9ee0-c13b1cc4f951|3|LACTICAC|Lactic Acid|CHEMISTRY|[?]|mg/min|[?]|[?]|NEGATIVE|1|L/s/kPa|1|1|[?]|ABNORMAL|LYSATE|HEMOLYZED||LIGHT SCATTERING SPECTROSCOPY|MDRD 6 VARIABLE FORMULA||Y|U||2|Visit_2|25|3|TREATMENT|2020-10-22|2020-12-02|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|c3c85786-d24b-4620-9ee0-c13b1cc4f951|4|LDH2|LDH Isoenzyme 2|CHEMISTRY|||[?]|[?]|BORDERLINE|1|/200 HPFs|1|1|[?]|NORMAL|SYNOVIAL FLUID|FRESH||ACCELERATOR MASS SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U|Y|2|Visit_2|25|7|WASHOUT|2020-10-22|2020-12-20|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|LB|c3c85786-d24b-4620-9ee0-c13b1cc4f951|5|TRICH|Trichomonas|CHEMISTRY|[?]|mL/animal/wk|[?]|[?]|TRACE|1|VIAL|1|1|[?]|NORMAL|SPERMATOZOON|GELLED||LANDOLT RING|MDRD 6 VARIABLE FORMULA|Y||NA||3|Visit_3|40|2|TREATMENT|2020-11-06|2020-12-15|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|c3c85786-d24b-4620-9ee0-c13b1cc4f951|6|HAMAB|Human Anti-Mouse Antibody|CHEMISTRY|[?]|umol/L|[?]|[?]|INVALID|1|m/sec|1|1|[?]|LOW|EPITHELIAL CELL|SOLIDIFIED|N|PHOTOMETRY|HEPASCORE FORMULA|||U||3|Visit_3|40|5|WASHOUT|2020-11-06|2020-11-08|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|c3c85786-d24b-4620-9ee0-c13b1cc4f951|7|C165905|Grass Mix Pollen IgG AB RAST Score|URINALYSIS|[?]|1/(s*kPa)|[?]|[?]|BORDERLINE|1|Ci/kg|1|1|[?]|LOW|BONE MARROW|ROOM TEMPERATURE||IMMUNOTURBIDIMETRY|COCKCROFT-GAULT FORMULA|Y||U||4|Visit_4|65|4|TREATMENT|2020-12-01|2020-12-31|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|c3c85786-d24b-4620-9ee0-c13b1cc4f951|8|GAD2AB|Glutamic Acid Decarboxylase 2 Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|/40 HPFs|1|1|[?]|HIGH|CAPILLARY PLASMA|LACTESCENT|N|STRESS ECHOCARDIOGRAPHY|GMI % FORMULA||Y|N|Y|4|Visit_4|65|4|TREATMENT|2020-12-01|2020-12-11|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|c3c85786-d24b-4620-9ee0-c13b1cc4f951|9|CXCL9|Chemokine (C-X-C Motif) Ligand 9|CHEMISTRY|[?]|ug/mol|[?]|[?]|BORDERLINE|1|ug/mol|1|1|[?]|LOW|DIALYSIS FLUID|CONCENTRATED||MYELOPEROXIDASE STAIN|GMI MMOL/MOL FORMULA|||NA||5|Visit_5|90|1|FOLLOW-UP|2020-12-26|2020-12-28|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|c3c85786-d24b-4620-9ee0-c13b1cc4f951|10|HDW|Hemoglobin Distribution Width|URINALYSIS|[?]|DROP|[?]|[?]|BORDERLINE|1|GBq/g|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|LIPEMIC||SLIT LAMP PHOTOGRAPHY|FIBROSIS 4 FORMULA|Y||U||5|Visit_5|90|2|TREATMENT|2020-12-26|2021-01-03|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|5354e3c4-4106-4e4c-85c3-2dbbd001688c|1|VITK|Vitamin K|CHEMISTRY|||[?]|[?]|BORDERLINE|1|MnFI|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|THAWED||MACRO BROTH DILUTION|MDRD FORMULA|||U|Y|1|Visit_1|10|6|TREATMENT|2020-11-15|2020-12-03|10|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|LB|5354e3c4-4106-4e4c-85c3-2dbbd001688c|2|CREATCLR|Creatinine Clearance|URINALYSIS|[?]|g/cage/day|[?]|[?]|TRACE|1|/100 HPFs|1|1|[?]|HIGH|HAIR FOLLICLE|FROZEN||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|FIBROMETER FORMULA|Y||Y||1|Visit_1|10|7|FOLLOW-UP|2020-11-15|2021-01-10|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|LB|5354e3c4-4106-4e4c-85c3-2dbbd001688c|3|BNP|Brain Natriuretic Peptide|URINALYSIS|[?]|Enzyme U/m2|[?]|[?]|TRACE|1|ft|1|1|[?]|HIGH|HAIR|HEMOLYZED||LIGHT SCATTERING SPECTROSCOPY|HEPASCORE FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-11-30|2021-01-24|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|5354e3c4-4106-4e4c-85c3-2dbbd001688c|4|EUDCA|Epimerized Ursodeoxycholate|CHEMISTRY|[?]|CIGARETTE|[?]|[?]|INDETERMINATE|1|mg/kg/dose|1|1|[?]|LOW|SEBUM|AGGLUTINATED|N|ELISA|CKD-EPI CYSTATIN C FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-11-30|2020-12-09|25|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|5354e3c4-4106-4e4c-85c3-2dbbd001688c|5|CHOLATE|Cholate|HEMATOLOGY|[?]|tsp eq|[?]|[?]|POSITIVE|1|BAG|1|1|[?]|HIGH|PROSTATIC FLUID|REFRIGERATED|N|AUTOMATED COUNT|FIBROTEST FORMULA|Y||U||3|Visit_3|40|6|TREATMENT|2020-12-15|2020-12-22|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|5354e3c4-4106-4e4c-85c3-2dbbd001688c|6|INTLK21|Interleukin 21|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|PA|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|AGGLUTINATED||RAJI CELL EIA|FIBROMETER FORMULA|||N|Y|3|Visit_3|40|1|WASHOUT|2020-12-15|2020-12-24|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|LB|5354e3c4-4106-4e4c-85c3-2dbbd001688c|7|RBCFRAG|Erythrocyte Fragment|HEMATOLOGY|[?]|log10 PFU/mL|[?]|[?]|INDETERMINATE|1|%|1|1|[?]|HIGH|DIALYSIS FLUID|AUTOLYZED|N|FLUORESCENT ENZYME IMMUNOASSAY|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|2|TREATMENT|2021-01-09|2021-01-20|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|5354e3c4-4106-4e4c-85c3-2dbbd001688c|8|GLOBB2PT|Beta-2 Globulin/Total Protein|HEMATOLOGY|[?]|cmH2O*s2/mL|[?]|[?]|INDETERMINATE|1|/HPF|1|1|[?]|NORMAL|PLATELET RICH PLASMA|LACTESCENT||ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|ASH FIBROSURE FORMULA|||NA||4|Visit_4|65|3|SCREENING|2021-01-09|2021-01-10|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|LB|5354e3c4-4106-4e4c-85c3-2dbbd001688c|9|C165910|Bee Mix IgG AB RAST Score|HEMATOLOGY|[?]|Bq/ug|[?]|[?]|INDETERMINATE|1|mg/mL/day|1|1|[?]|NORMAL|EXUDATE|HEMOLYZED|N|STRESS ECHOCARDIOGRAPHY|MDRD FORMULA|||N||5|Visit_5|90|5|FOLLOW-UP|2021-02-03|2021-02-10|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|5354e3c4-4106-4e4c-85c3-2dbbd001688c|10|CKMB|Creatine Kinase MB|CHEMISTRY|||[?]|[?]|TRACE|1|Bq/L|1|1|[?]|NORMAL|EMOTIONAL TEAR|AGGLUTINATED||MECHANICAL CLOT DETECTION|MDRD FORMULA|||U|Y|5|Visit_5|90|1|TREATMENT|2021-02-03|2021-02-10|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|LB|f10e9188-ef7b-46f9-a80a-0669436eb4dd|1|LAP|Leucine Aminopeptidase|HEMATOLOGY|[?]|pmol/10^10 cells|[?]|[?]|BORDERLINE|1|g/cage|1|1|[?]|LOW|AQUEOUS HUMOR|NON-HEMOLYZED||PAP STAIN|MDRD 5 VARIABLE FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-06-24|2020-08-31|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|f10e9188-ef7b-46f9-a80a-0669436eb4dd|2|DRVTSCPD|dRVVT Screen to Confirm Pct Difference|HEMATOLOGY|||[?]|[?]|INVALID|1|tuberculin unit/mL|1|1|[?]|ABNORMAL|MUCUS|AGGLUTINATED||IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|U|Y|1|Visit_1|10|3|FOLLOW-UP|2020-06-24|2020-08-27|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|f10e9188-ef7b-46f9-a80a-0669436eb4dd|3|ANPPROMR|Mid-Reg Pro-Atrial Natriuretic Peptide|HEMATOLOGY|[?]|NEEDLE GAUGE|[?]|[?]|NEGATIVE|1|/min|1|1|[?]|NORMAL|HAIR|FRESH||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||2|Visit_2|25|1|WASHOUT|2020-07-09|2020-08-30|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|f10e9188-ef7b-46f9-a80a-0669436eb4dd|4|AMPHETD|Dextroamphetamine|URINALYSIS|[?]|CAN|[?]|[?]|NEGATIVE|1|copies/ug|1|1|[?]|NORMAL|PUS|CLOTTED||MIGET|CKD-EPI FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-07-09|2020-08-23|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|LB|f10e9188-ef7b-46f9-a80a-0669436eb4dd|5|EUDCA|Epimerized Ursodeoxycholate|URINALYSIS|[?]|INHALATION|[?]|[?]|INDETERMINATE|1|kg/mol|1|1|[?]|ABNORMAL|SYNOVIAL FLUID|AGGLUTINATED||HANSEL STAIN|COCKCROFT-GAULT FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-07-24|2020-09-01|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|f10e9188-ef7b-46f9-a80a-0669436eb4dd|6|DKK1|Dickkopf WNT Signaling Path Inhibitor 1|HEMATOLOGY|[?]|mol/mg|[?]|[?]|NEGATIVE|1|IU/kg|1|1|[?]|HIGH|ABSCESS FLUID|LIPEMIC||ACRIDINE ORANGE STAIN|CKD-EPI FORMULA|||U||3|Visit_3|40|3|TREATMENT|2020-07-24|2020-08-04|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|LB|f10e9188-ef7b-46f9-a80a-0669436eb4dd|7|PROMYCE|Promyelocytes/Total Cells|URINALYSIS|[?]|10^9 CFU/g|[?]|[?]|TRACE|1|ug/kg/min|1|1|[?]|HIGH|PLEURAL FLUID|LACTESCENT||DUKE INCISION METHOD|COCKCROFT-GAULT FORMULA|||NA||4|Visit_4|65|3|SCREENING|2020-08-18|2020-08-31|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|f10e9188-ef7b-46f9-a80a-0669436eb4dd|8|CSCYL|Cylindroid Casts|HEMATOLOGY|||[?]|[?]|POSITIVE|1|pmol/10^10 cells|1|1|[?]|LOW|VITREOUS HUMOR|LACTESCENT||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|HEPASCORE FORMULA|||Y|Y|4|Visit_4|65|7|TREATMENT|2020-08-18|2020-09-07|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|f10e9188-ef7b-46f9-a80a-0669436eb4dd|9|ALA|Alanine|URINALYSIS|[?]|uL|[?]|[?]|TRACE|1|GBq/mg|1|1|[?]|ABNORMAL|SEBUM|CLOTTED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|5|TREATMENT|2020-09-12|2020-09-21|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|LB|f10e9188-ef7b-46f9-a80a-0669436eb4dd|10|CSEPIRT|Renal Tubular Epithelial Casts|CHEMISTRY|||[?]|[?]|POSITIVE|1|cal|1|1|[?]|ABNORMAL|SKIN TISSUE|HEMOLYZED||STRESS ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA|||NA|Y|5|Visit_5|90|3|SCREENING|2020-09-12|2020-09-13|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|LB|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|1|PHNBRBTL|Phenobarbital|URINALYSIS|||[?]|[?]|NEGATIVE|1|10^8/L|1|1|[?]|LOW|SEBUM|CONCENTRATED||COMPLEMENT FIXATION|GMI MMOL/MOL FORMULA|||U|Y|1|Visit_1|10|6|TREATMENT|2020-08-13|2020-10-08|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|2|CCL13|Chemokine (C-C Motif) Ligand 13|URINALYSIS|||[?]|[?]|INVALID|1|PIXEL|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|CALCIFIED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD FORMULA|Y||N|Y|1|Visit_1|10|6|TREATMENT|2020-08-13|2020-08-23|10|20|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|3|TAP1|Peptide Transporter TAP1|CHEMISTRY|[?]|ECL unit|[?]|[?]|BORDERLINE|1|MdFI|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|FROZEN||OLIGO ACGH|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|6|WASHOUT|2020-08-28|2020-09-23|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|4|C165911|Dairy Mix IgG AB RAST Score|CHEMISTRY|[?]|mMU/mL|[?]|[?]|INDETERMINATE|1|ft3|1|1|[?]|HIGH|NAIL|ICTERIC||PHOTOMETRY|CKD-EPI CREATININE FORMULA||Y|Y||2|Visit_2|25|3|TREATMENT|2020-08-28|2020-10-14|25|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|5|HGBMHGB|Methemoglobin/Total Hemoglobin|URINALYSIS|||[?]|[?]|POSITIVE|1|Rad|1|1|[?]|NORMAL|SEMEN|FRESH||PH METER MEASUREMENT METHOD|MDRD 6 VARIABLE FORMULA||Y|U|Y|3|Visit_3|40|4|TREATMENT|2020-09-12|2020-10-07|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|6|EOSBLE|Eosinophils Band Form/Leukocytes|HEMATOLOGY|[?]|/mm2|[?]|[?]|NEGATIVE|1|log10 CCID 50/dose|1|1|[?]|NORMAL|MECONIUM|FROZEN||THERMAL IONIZATION MASS SPECTROMETRY|FIBROTEST FORMULA|||Y||3|Visit_3|40|7|FOLLOW-UP|2020-09-12|2020-10-28|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|7|CD10|CD10|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|VOXEL|1|1|[?]|ABNORMAL|DISCHARGE|PARAFFIN-EMBEDDED|N|DIGITAL PCR|CKD-EPI CREATININE FORMULA|||Y|Y|4|Visit_4|65|4|FOLLOW-UP|2020-10-07|2020-10-30|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|8|C130083|Orchard Grass Pollen IgG4|CHEMISTRY|[?]|mmol/min/kPa/L|[?]|[?]|NEGATIVE|1|mOsm|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|NON-HEMOLYZED||ICP-MS|MDRD ENZYMATIC FORMULA|||N||4|Visit_4|65|7|SCREENING|2020-10-07|2020-10-31|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|9|CARNITF|Carnitine, Free|URINALYSIS|[?]|BOLUS|[?]|[?]|TRACE|1|mm/2h|1|1|[?]|NORMAL|SUPERNATANT, SERUM|LIPEMIC|N|KINETIC CHROMOGENIC ASSAY|FIBROTEST FORMULA|Y|Y|N||5|Visit_5|90|6|SCREENING|2020-11-01|2020-11-08|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|10|LEIMLE|Immature Leukocytes/Leukocytes|URINALYSIS|[?]|mN|[?]|[?]|BORDERLINE|1|10^6 U|1|1|[?]|ABNORMAL|TUMOR TISSUE|REFRIGERATED|N|LISSAMINE GREEN STAIN|NASH FIBROSURE FORMULA|||N||5|Visit_5|90|4|TREATMENT|2020-11-01|2020-11-04|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|LB|000b5b99-a92d-4c84-9edc-ee08930d8a2e|1|GRWHIH|Growth Hormone Inhibiting Hormone|CHEMISTRY|[?]|nmol/g|[?]|[?]|INDETERMINATE|1|ms/mmHg|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED||ANTIBIOTIC AGAR SCREEN|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-10-15|2020-11-29|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|000b5b99-a92d-4c84-9edc-ee08930d8a2e|2|C165878|German Cockroach IgE AB RAST Score|CHEMISTRY|||[?]|[?]|INVALID|1|kcal/day|1|1|[?]|LOW|PLATELET RICH PLASMA|FROZEN||ANTIMICROBIAL COMBINATION TESTING|MDRD 6 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|6|TREATMENT|2020-10-15|2020-10-23|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|000b5b99-a92d-4c84-9edc-ee08930d8a2e|3|MPO|Myeloperoxidase|HEMATOLOGY|[?]|10^9 organisms|[?]|[?]|INDETERMINATE|1|mL|1|1|[?]|ABNORMAL|DERMAL TISSUE|CONCENTRATED||RADIOGRAPHY|COCKCROFT-GAULT FORMULA|||Y||2|Visit_2|25|7|WASHOUT|2020-10-30|2021-01-09|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|000b5b99-a92d-4c84-9edc-ee08930d8a2e|4|GLYCREAT|Glycine/Creatinine|CHEMISTRY|[?]|10^3 RNA copies/mL|[?]|[?]|POSITIVE|1|vp/mL|1|1|[?]|ABNORMAL|EXPIRED AIR|SOLIDIFIED|N|MAMMOGRAPHY|HEPASCORE FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2020-10-30|2020-11-23|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|000b5b99-a92d-4c84-9edc-ee08930d8a2e|5|TTGIGGAB|Tissue Transglutaminase IgG Antibody|URINALYSIS|[?]|10^9 organisms/mg|[?]|[?]|INDETERMINATE|1|Bq/ug|1|1|[?]|LOW|AMNIOTIC FLUID|HEMOLYZED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD FORMULA|||N||3|Visit_3|40|4|WASHOUT|2020-11-14|2020-12-20|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|000b5b99-a92d-4c84-9edc-ee08930d8a2e|6|PRTN3AB|Proteinase 3 Antibody|CHEMISTRY|[?]|SYRINGE|[?]|[?]|INDETERMINATE|1|IU/g Hb|1|1|[?]|ABNORMAL|LYSATE|FROZEN|N|BAC ACGH|GMI MMOL/MOL FORMULA||Y|Y||3|Visit_3|40|2|FOLLOW-UP|2020-11-14|2020-12-13|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|LB|000b5b99-a92d-4c84-9edc-ee08930d8a2e|7|ANGTNS1|Angiotensin I|URINALYSIS|[?]|%(w/v)|[?]|[?]|POSITIVE|1|BAG|1|1|[?]|NORMAL|URINE SEDIMENT|GELLED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||4|Visit_4|65|3|FOLLOW-UP|2020-12-09|2020-12-28|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|000b5b99-a92d-4c84-9edc-ee08930d8a2e|8|IGGALB|Immunoglobulin G/Albumin|URINALYSIS|[?]|ug/m2/min|[?]|[?]|BORDERLINE|1|mol/mg|1|1|[?]|HIGH|RETICULOCYTES|THAWED||ULTRASONOGRAPHIC ELASTOGRAPHY|GMI MMOL/MOL FORMULA||Y|N||4|Visit_4|65|6|TREATMENT|2020-12-09|2020-12-30|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|LB|000b5b99-a92d-4c84-9edc-ee08930d8a2e|9|INTLK1|Interleukin 1|HEMATOLOGY|[?]|STEPS|[?]|[?]|BORDERLINE|1|umol|1|1|[?]|NORMAL|ALVEOLAR AIR|PARAFFIN-EMBEDDED||CHROMATOGRAPHY|MDRD 5 VARIABLE FORMULA|||NA||5|Visit_5|90|1|WASHOUT|2021-01-03|2021-01-09|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|000b5b99-a92d-4c84-9edc-ee08930d8a2e|10|LDH5LDH|LDH Isoenzyme 5/LDH|HEMATOLOGY|[?]|U/g/min|[?]|[?]|POSITIVE|1|ms2|1|1|[?]|HIGH|BONE MARROW|FRESH||VENTILATION PERFUSION LUNG SCAN|ASH FIBROSURE FORMULA|Y||N||5|Visit_5|90|3|SCREENING|2021-01-03|2021-01-05|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|1|CD8LY|CD8/Lymphocytes|CHEMISTRY|||[?]|[?]|NEGATIVE|1|10^9 organisms/g|1|1|[?]|HIGH|PLATELET POOR PLASMA|PARAFFIN-EMBEDDED||IMMUNO-PET SCAN|FIBROSIS 4 FORMULA|||Y|Y|1|Visit_1|10|1|WASHOUT|2020-06-01|2020-06-13|10|22|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|2|ADSDNA|Anti-Double Stranded DNA|CHEMISTRY|[?]|GLOBULE|[?]|[?]|INVALID|1|10^6 IU|1|1|[?]|LOW|PLATELET POOR PLASMA|CONCENTRATED|N|PULMONARY ANGIOGRAPHY|NASH FIBROSURE FORMULA|Y|Y|Y||1|Visit_1|10|2|TREATMENT|2020-06-01|2020-08-25|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|LB|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|3|FXAC|Factor X Actual/Control|CHEMISTRY|[?]|U/kg/h|[?]|[?]|POSITIVE|1|IU/kg|1|1|[?]|NORMAL|PERITONEAL FLUID|CONCENTRATED||DOUBLE IMMUNODIFFUSION|FIBROTEST FORMULA|||U||2|Visit_2|25|5|TREATMENT|2020-06-16|2020-07-07|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|4|PHOSEXR|Phosphorus Excretion Rate|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mL/cm3/min|1|1|[?]|HIGH|LOCHIA|UNEXPECTED ODOR||PULSE OXIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|2|Visit_2|25|2|FOLLOW-UP|2020-06-16|2020-08-13|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|5|TAURCRT|Taurine/Creatinine|CHEMISTRY|[?]|hr/day|[?]|[?]|INDETERMINATE|1|C|1|1|[?]|LOW|EPIDERMAL TISSUE|THAWED|N|THICK SMEAR|FIBROTEST FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-07-01|2020-07-28|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|6|CD79A|CD79A|CHEMISTRY|[?]|/500 WBC|[?]|[?]|INVALID|1|mEq/g|1|1|[?]|NORMAL|MUSCLE TISSUE|PARAFFIN-EMBEDDED||LC/MS/MS|MDRD 4 VARIABLE FORMULA|Y||NA||3|Visit_3|40|1|TREATMENT|2020-07-01|2020-08-21|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|7|PAF|Platelet Activating Factor|URINALYSIS|[?]|/HPF|[?]|[?]|TRACE|1|nkat/g Hb|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|GELLED||SPECT SCAN|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|3|TREATMENT|2020-07-26|2020-08-01|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|8|INTLK10|Interleukin 10|CHEMISTRY|[?]|Bq/mL|[?]|[?]|INVALID|1|dB|1|1|[?]|HIGH|STOOL|AGGLUTINATED||LISSAMINE GREEN STAIN|FIBROTEST FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-07-26|2020-08-16|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|9|GLOBGPT|Gamma Globulin/Total Protein|URINALYSIS|[?]|Henry|[?]|[?]|BORDERLINE|1|uL/dose|1|1|[?]|HIGH|COLOSTRUM|PARAFFIN-EMBEDDED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROTEST FORMULA|||NA||5|Visit_5|90|7|SCREENING|2020-08-20|2020-08-28|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|10|CTC|Circulating Tumor Cells|URINALYSIS|||[?]|[?]|INDETERMINATE|1|kV|1|1|[?]|LOW|SYNOVIAL FLUID|PARAFFIN-EMBEDDED||RAJI CELL EIA|CKD-EPI CREATININE FORMULA|||Y|Y|5|Visit_5|90|3|WASHOUT|2020-08-20|2020-08-27|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|11b2b359-d4a1-411d-a676-075b26e1453c|1|FATACFR|Free Fatty Acid|URINALYSIS|[?]|GPL U/mL|[?]|[?]|INDETERMINATE|1|dpm/0.5 mL|1|1|[?]|HIGH|MIXED VENOUS BLOOD|CONCENTRATED|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|CKD-EPI CREATININE FORMULA|||Y||1|Visit_1|10|6|FOLLOW-UP|2020-09-20|2020-12-06|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|11b2b359-d4a1-411d-a676-075b26e1453c|2|DNASEBAB|DNase-B Antibody|HEMATOLOGY|[?]|Bq/mL|[?]|[?]|NEGATIVE|1|ug/m2/h|1|1|[?]|NORMAL|MUCUS|FROZEN||SPIRAL CT|NASH FIBROSURE FORMULA|Y||U||1|Visit_1|10|1|FOLLOW-UP|2020-09-20|2020-11-05|10|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|11b2b359-d4a1-411d-a676-075b26e1453c|3|HDLCCHOL|HDL Cholesterol/Total Cholesterol|CHEMISTRY|[?]|BEAM BREAKS|[?]|[?]|INVALID|1|AMPULE|1|1|[?]|NORMAL|LOCHIA|CONCENTRATED||OLIGO ACGH|MDRD ENZYMATIC FORMULA|||NA||2|Visit_2|25|7|TREATMENT|2020-10-05|2020-11-27|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|11b2b359-d4a1-411d-a676-075b26e1453c|4|HSP70|Heat Shock Protein 70|URINALYSIS|[?]|GPL U/mL|[?]|[?]|INVALID|1|ELISA unit|1|1|[?]|NORMAL|SERUM OR PLASMA|THAWED||FLUOROSCOPY|FIBROMETER FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-10-05|2020-11-21|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|11b2b359-d4a1-411d-a676-075b26e1453c|5|GLDIGAAB|Gliadin IgA Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|DIOPTER|1|1|[?]|NORMAL|CALCULUS|CLOTTED||FLUOROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|3|Visit_3|40|5|TREATMENT|2020-10-20|2020-11-22|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|11b2b359-d4a1-411d-a676-075b26e1453c|6|C165918|American Cockroach IgG AB RAST Score|HEMATOLOGY|[?]|C|[?]|[?]|NEGATIVE|1|DAgU|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|CALCIFIED|N|ENZYMATIC ULTRACENTRIFUGATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|6|SCREENING|2020-10-20|2020-12-14|40|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|11b2b359-d4a1-411d-a676-075b26e1453c|7|CSWBC|WBC Casts|CHEMISTRY|[?]|10^4 CFU/mL|[?]|[?]|BORDERLINE|1|SACHET|1|1|[?]|ABNORMAL|COLOSTRUM|ROOM TEMPERATURE||PHYSICAL EXAMINATION|MDRD 5 VARIABLE FORMULA|||Y||4|Visit_4|65|4|TREATMENT|2020-11-14|2020-11-18|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|11b2b359-d4a1-411d-a676-075b26e1453c|8|FACTXIIA|Factor XII Activity|CHEMISTRY|[?]|Ci/kg|[?]|[?]|TRACE|1|mg/kg/day|1|1|[?]|NORMAL|SWABBED MATERIAL|FRESH||CYSTOMETRY|NASH FIBROSURE FORMULA|Y||NA||4|Visit_4|65|4|SCREENING|2020-11-14|2020-12-10|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|11b2b359-d4a1-411d-a676-075b26e1453c|9|IAA5OH|5-Hydroxyindoleacetic Acid|URINALYSIS|[?]|mg/kg/week|[?]|[?]|BORDERLINE|1|mg/min|1|1|[?]|ABNORMAL|STRIATED MUSCLE TISSUE|FROZEN||IMMUNOFIXATION ELECTROPHORESIS|GMI MMOL/MOL FORMULA|Y||N||5|Visit_5|90|6|SCREENING|2020-12-09|2020-12-12|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|11b2b359-d4a1-411d-a676-075b26e1453c|10|VITECHOL|Vitamin E/Cholesterol|CHEMISTRY|||[?]|[?]|TRACE|1|aMFI|1|1|[?]|ABNORMAL|KERATINOCYTE|AGGLUTINATED||LC-FL|ASH FIBROSURE FORMULA|||U|Y|5|Visit_5|90|1|TREATMENT|2020-12-09|2020-12-15|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|293f673d-af6a-473e-8bce-118bb85bbd9e|1|C130111|Mold Mix Antigen IgA Antibody|CHEMISTRY|[?]|SUPPOSITORY|[?]|[?]|NEGATIVE|1|nmol/L/h|1|1|[?]|ABNORMAL|PROSTATIC FLUID|DRIED||ALCIAN BLUE STAIN|NASH FIBROSURE FORMULA|||U||1|Visit_1|10|4|WASHOUT|2020-10-19|2021-01-16|10|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|293f673d-af6a-473e-8bce-118bb85bbd9e|2|TTGIGGAB|Tissue Transglutaminase IgG Antibody|CHEMISTRY|[?]|beats/min|[?]|[?]|TRACE|1|10^8 PFU|1|1|[?]|LOW|VITREOUS HUMOR|NON-HEMOLYZED||COULOMETRIC TITRATION|MDRD 4 VARIABLE FORMULA||Y|Y||1|Visit_1|10|3|SCREENING|2020-10-19|2020-12-22|10|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|293f673d-af6a-473e-8bce-118bb85bbd9e|3|BLSTLYLE|Lymphoblasts/Leukocytes|URINALYSIS|[?]|mL/s/m2|[?]|[?]|INVALID|1|m|1|1|[?]|LOW|MECONIUM|FROZEN||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-11-03|2020-12-07|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|293f673d-af6a-473e-8bce-118bb85bbd9e|4|CD34|CD34|URINALYSIS|[?]|breaths/30s|[?]|[?]|TRACE|1|g/kg/day|1|1|[?]|LOW|COLOSTRUM|FRESH||MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|NASH FIBROSURE FORMULA||Y|Y||2|Visit_2|25|3|SCREENING|2020-11-03|2021-01-02|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|293f673d-af6a-473e-8bce-118bb85bbd9e|5|LEAD|Lead|HEMATOLOGY|[?]|10^7 TCID 50/dose|[?]|[?]|TRACE|1|1/(s*kPa)|1|1|[?]|HIGH|DERMAL TISSUE|THAWED||SIZE EXCLUSION CHROMATOGRAPHY|HEPASCORE FORMULA|Y||Y||3|Visit_3|40|5|WASHOUT|2020-11-18|2021-01-05|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|293f673d-af6a-473e-8bce-118bb85bbd9e|6|BNZDZPN|Benzodiazepine|URINALYSIS|[?]|um/s|[?]|[?]|INVALID|1|10^9 organisms|1|1|[?]|NORMAL|VENOUS CORD BLOOD|ICTERIC||IMMUNOCHROMATOGRAPHY|FIBROMETER FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2020-11-18|2020-11-19|40|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|293f673d-af6a-473e-8bce-118bb85bbd9e|7|MYCY|Myelocytes|CHEMISTRY|[?]|10^9/dose|[?]|[?]|NEGATIVE|1|ks|1|1|[?]|NORMAL|LAVAGE FLUID|FRESH|N|TEMPLATE INCISION METHOD|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|3|WASHOUT|2020-12-13|2021-01-04|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|293f673d-af6a-473e-8bce-118bb85bbd9e|8|APOH|Apolipoprotein H|HEMATOLOGY|[?]|mL/breath|[?]|[?]|NEGATIVE|1|log10 TCID 50/uL|1|1|[?]|LOW|PLEURAL FLUID|REFRIGERATED||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|ASH FIBROSURE FORMULA|||U||4|Visit_4|65|7|FOLLOW-UP|2020-12-13|2020-12-16|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|293f673d-af6a-473e-8bce-118bb85bbd9e|9|MIP1G|Macrophage Inflammatory Protein 1 Gamma|CHEMISTRY|[?]|kV|[?]|[?]|BORDERLINE|1|ng/L|1|1|[?]|HIGH|URINE SEDIMENT|FROZEN||SIZE EXCLUSION CHROMATOGRAPHY|NASH FIBROSURE FORMULA||Y|N||5|Visit_5|90|2|TREATMENT|2021-01-07|2021-01-16|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|293f673d-af6a-473e-8bce-118bb85bbd9e|10|APRI|AST to Platelet Ratio Index|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|APL U/mL|1|1|[?]|ABNORMAL|MUSCLE TISSUE|NON-HEMOLYZED||TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA||Y|N|Y|5|Visit_5|90|1|SCREENING|2021-01-07|2021-01-08|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|0f60ab31-ee13-4846-93d2-6bcac139006f|1|SCL70GAB|Scl-70 IgG Antibody|HEMATOLOGY|[?]|10^3 DNA copies/mL|[?]|[?]|BORDERLINE|1|Henry|1|1|[?]|ABNORMAL|ISOLATE|CALCIFIED|N|IMMUNORADIOMETRIC ASSAY|COCKCROFT-GAULT FORMULA|Y|Y|U||1|Visit_1|10|7|TREATMENT|2020-07-02|2020-08-06|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|0f60ab31-ee13-4846-93d2-6bcac139006f|2|PSIGGAB|Phosphatidylserine IgG Antibody|CHEMISTRY|[?]|PNU/mL|[?]|[?]|TRACE|1|PHERESIS UNIT|1|1|[?]|LOW|AQUEOUS HUMOR|GELLED||PERCUSSION|HEPASCORE FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-07-02|2020-08-26|10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|0f60ab31-ee13-4846-93d2-6bcac139006f|3|CLCTONN|Calcitonin|URINALYSIS|[?]|ug/g/day|[?]|[?]|TRACE|1|nmol/day|1|1|[?]|LOW|DISCHARGE|CONCENTRATED||AURAMINE STAIN|GMI MMOL/MOL FORMULA||Y|NA||2|Visit_2|25|2|TREATMENT|2020-07-17|2020-09-15|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|0f60ab31-ee13-4846-93d2-6bcac139006f|4|ANTHRMA|Antithrombin Activity|HEMATOLOGY|[?]|MPS U|[?]|[?]|POSITIVE|1|GBq/g|1|1|[?]|ABNORMAL|RETICULOCYTES|FROZEN||IMMUNO-PET SCAN|MDRD FORMULA|||NA||2|Visit_2|25|7|FOLLOW-UP|2020-07-17|2020-08-31|25|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|0f60ab31-ee13-4846-93d2-6bcac139006f|5|APOBAPA1|Apolipoprotein B/Apolipoprotein A1|URINALYSIS|[?]|10^6 CFU/g|[?]|[?]|INVALID|1|nCi|1|1|[?]|ABNORMAL|CORD SERUM|CONCENTRATED||SANGER SEQUENCING|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-08-01|2020-09-05|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|0f60ab31-ee13-4846-93d2-6bcac139006f|6|IDL|IDL Cholesterol|URINALYSIS|[?]|s^-1(%O2)^-1|[?]|[?]|INDETERMINATE|1|mL/m2/min|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|NON-HEMOLYZED|N|JAEGER EYE CHART|NASH FIBROSURE FORMULA|Y|Y|Y||3|Visit_3|40|7|SCREENING|2020-08-01|2020-09-19|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|0f60ab31-ee13-4846-93d2-6bcac139006f|7|ATP|Adenosine Triphosphate|CHEMISTRY|[?]|10^3 CFU|[?]|[?]|TRACE|1|GBq/ug|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|DRIED||HPLC/IEX|CKD-EPI FORMULA|||NA||4|Visit_4|65|5|SCREENING|2020-08-26|2020-09-15|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|0f60ab31-ee13-4846-93d2-6bcac139006f|8|METHANOL|Methanol|CHEMISTRY|[?]|U/mg|[?]|[?]|BORDERLINE|1|10^7/L|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|ROOM TEMPERATURE|N|HPLC/IEX|GMI % FORMULA|Y|Y|Y||4|Visit_4|65|2|WASHOUT|2020-08-26|2020-08-28|65|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|0f60ab31-ee13-4846-93d2-6bcac139006f|9|C130085|English Plantain Pollen IgA|CHEMISTRY|||[?]|[?]|TRACE|1|EID 50/dose|1|1|[?]|LOW|RETICULOCYTES|FRESH|N|AURAMINE STAIN|ASH FIBROSURE FORMULA|Y||NA|Y|5|Visit_5|90|6|SCREENING|2020-09-20|2020-09-26|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|LB|0f60ab31-ee13-4846-93d2-6bcac139006f|10|ABNCELE|Abnormal Cells/Leukocytes|CHEMISTRY|[?]|CFU/mL|[?]|[?]|INDETERMINATE|1|mg/m2/day|1|1|[?]|LOW|COLOSTRUM|LIPEMIC||SURFACE PLASMON RESONANCE|FIBROMETER FORMULA|Y||Y||5|Visit_5|90|1|TREATMENT|2020-09-20|2020-09-26|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|LB|d49f37ce-2d6e-4ebb-91af-7ed32322f824|1|ALPIS|Intestinal Specific Alkaline Phosphatase|HEMATOLOGY|[?]|% INHIBITION|[?]|[?]|TRACE|1|m/sec|1|1|[?]|HIGH|MECONIUM|SOLIDIFIED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|4|TREATMENT|2020-08-31|2020-09-29|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|d49f37ce-2d6e-4ebb-91af-7ed32322f824|2|SPERMMTL|Sperm Motility|CHEMISTRY|[?]|V|[?]|[?]|INVALID|1|VIAL|1|1|[?]|LOW|WHITE MATTER TISSUE|CALCIFIED||DUCTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||U||1|Visit_1|10|3|TREATMENT|2020-08-31|2020-11-12|10|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|d49f37ce-2d6e-4ebb-91af-7ed32322f824|3|FXAAC|Factor X Activity Actual/Control|CHEMISTRY|[?]|fg|[?]|[?]|INVALID|1|mol|1|1|[?]|ABNORMAL|EMESIS|HEMOLYZED|N|MANUAL COUNT|MDRD 4 VARIABLE FORMULA|Y||NA||2|Visit_2|25|3|FOLLOW-UP|2020-09-15|2020-11-24|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|d49f37ce-2d6e-4ebb-91af-7ed32322f824|4|PEMAB|Pemphigoid Antibodies|HEMATOLOGY|[?]|fmol/g|[?]|[?]|BORDERLINE|1|F|1|1|[?]|ABNORMAL|BASAL TEAR|REFRIGERATED||QUANTITATIVE COMPUTED TOMOGRAPHY|NASH FIBROSURE FORMULA||Y|U||2|Visit_2|25|4|WASHOUT|2020-09-15|2020-10-19|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|d49f37ce-2d6e-4ebb-91af-7ed32322f824|5|IFI44|Interferon-Induced Protein 44|URINALYSIS|||[?]|[?]|TRACE|1|MET*min|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE||GC/MS-CI|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|2|FOLLOW-UP|2020-09-30|2020-10-01|40|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|d49f37ce-2d6e-4ebb-91af-7ed32322f824|6|PCDW|Platelet Component Distribution Width|CHEMISTRY|[?]|ugEq|[?]|[?]|TRACE|1|cs|1|1|[?]|ABNORMAL|ABSCESS FLUID|HEMOLYZED|N|ENDOSCOPY|MDRD ENZYMATIC FORMULA|||Y||3|Visit_3|40|2|FOLLOW-UP|2020-09-30|2020-11-20|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|d49f37ce-2d6e-4ebb-91af-7ed32322f824|7|GBP1|Guanylate Binding Protein 1|HEMATOLOGY|[?]|VIRTUAL PIXEL|[?]|[?]|INVALID|1|nL|1|1|[?]|NORMAL|GASTRIC CONTENTS|GELLED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|FIBROSIS 4 FORMULA||Y|U||4|Visit_4|65|2|WASHOUT|2020-10-25|2020-11-14|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|d49f37ce-2d6e-4ebb-91af-7ed32322f824|8|HLADR51A|HLA-DR51 Antibody|URINALYSIS|[?]|mL/min/mmHg|[?]|[?]|POSITIVE|1|mN|1|1|[?]|LOW|LOCHIA|DRIED||FARR ASSAY|MDRD 5 VARIABLE FORMULA|Y||NA||4|Visit_4|65|6|TREATMENT|2020-10-25|2020-11-20|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|d49f37ce-2d6e-4ebb-91af-7ed32322f824|9|CSFIGIDX|CSF IgG Index|CHEMISTRY|[?]|pg/cell|[?]|[?]|INDETERMINATE|1|/7.5 mL|1|1|[?]|LOW|MENSTRUAL BLOOD|CONTAMINATED|N|TELLER ACUITY CARDS|GMI % FORMULA|||NA||5|Visit_5|90|5|FOLLOW-UP|2020-11-19|2020-11-22|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|d49f37ce-2d6e-4ebb-91af-7ed32322f824|10|DCCARNIT|Decanoylcarnitine|URINALYSIS|[?]|uL/mL|[?]|[?]|POSITIVE|1|10^7 PFU|1|1|[?]|NORMAL|EXPIRED AIR|FROZEN||PERIODIC ACID SCHIFF STAIN|FIBROSIS 4 FORMULA|||NA||5|Visit_5|90|5|FOLLOW-UP|2020-11-19|2020-11-22|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|LB|76dd2fe2-bc9e-48e4-870c-af7ece70009a|1|MSTHCE|Mesothelial Cells|CHEMISTRY|[?]|mU|[?]|[?]|POSITIVE|1|Bq/kg|1|1|[?]|HIGH|CERUMEN|AGGLUTINATED||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|CKD-EPI FORMULA|||NA||1|Visit_1|10|5|WASHOUT|2020-07-06|2020-08-27|10|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|76dd2fe2-bc9e-48e4-870c-af7ece70009a|2|GLOBB2PT|Beta-2 Globulin/Total Protein|HEMATOLOGY|[?]|tuberculin unit/mL|[?]|[?]|POSITIVE|1|Bq|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|ROOM TEMPERATURE||OPHTHALMOSCOPY|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|1|WASHOUT|2020-07-06|2020-07-31|10|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|76dd2fe2-bc9e-48e4-870c-af7ece70009a|3|STAT3|STAT3|URINALYSIS|||[?]|[?]|INVALID|1|ug/g/h|1|1|[?]|NORMAL|DISCHARGE|CONTAMINATED||DC SHEATH FLOW|MDRD 6 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|1|TREATMENT|2020-07-21|2020-08-12|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|76dd2fe2-bc9e-48e4-870c-af7ece70009a|4|SPMMSPM|Motile Sperm/Total Sperm|URINALYSIS|[?]|CFU/mL|[?]|[?]|NEGATIVE|1|ngEq/L|1|1|[?]|NORMAL|URINE SEDIMENT|LIPEMIC||SPECT/CT SCAN|MDRD 5 VARIABLE FORMULA||Y|N||2|Visit_2|25|2|TREATMENT|2020-07-21|2020-08-28|25|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|LB|76dd2fe2-bc9e-48e4-870c-af7ece70009a|5|BNZLCGN|Benzoylecgonine|CHEMISTRY|[?]|BISCUIT|[?]|[?]|BORDERLINE|1|ug/kg/min|1|1|[?]|HIGH|EXPIRED AIR|REFRIGERATED||AUSCULTATION|GMI % FORMULA|Y||Y||3|Visit_3|40|2|SCREENING|2020-08-05|2020-09-09|40|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|76dd2fe2-bc9e-48e4-870c-af7ece70009a|6|CTXIICRT|Type II Collagen C-Telopeptides/Creat|URINALYSIS|||[?]|[?]|INDETERMINATE|1|CYLINDER|1|1|[?]|HIGH|MECONIUM|DRIED||LASER CAPTURE MICRODISSECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U|Y|3|Visit_3|40|5|TREATMENT|2020-08-05|2020-08-09|40|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|LB|76dd2fe2-bc9e-48e4-870c-af7ece70009a|7|FIO2|Fraction of Inspired Oxygen|URINALYSIS|[?]|pmol/10^9 cells|[?]|[?]|INDETERMINATE|1|kPa|1|1|[?]|NORMAL|KERATINOCYTE|ICTERIC||PET/CT SCAN|FIBROMETER FORMULA|||U||4|Visit_4|65|2|SCREENING|2020-08-30|2020-09-02|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|76dd2fe2-bc9e-48e4-870c-af7ece70009a|8|EPICCE|Epithelial Cells/Total Cells|URINALYSIS|||[?]|[?]|POSITIVE|1|CAPLET|1|1|[?]|ABNORMAL|DERMAL TISSUE|CALCIFIED||ACCELERATOR MASS SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|4|Visit_4|65|3|WASHOUT|2020-08-30|2020-09-14|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|76dd2fe2-bc9e-48e4-870c-af7ece70009a|9|PRINSINS|Proinsulin/Insulin Ratio|URINALYSIS|[?]|pt_us|[?]|[?]|INDETERMINATE|1|NEEDLE GAUGE|1|1|[?]|LOW|ISOLATE|CONCENTRATED||TWO-COLOR MICROARRAY|CKD-EPI CYSTATIN C FORMULA|||U||5|Visit_5|90|6|SCREENING|2020-09-24|2020-10-01|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|76dd2fe2-bc9e-48e4-870c-af7ece70009a|10|UROTHCE|Urothelial Cells|CHEMISTRY|||[?]|[?]|NEGATIVE|1|umol/L|1|1|[?]|LOW|SMEGMA|SOLIDIFIED|N|MACRO BROTH DILUTION|MDRD ENZYMATIC FORMULA|||N|Y|5|Visit_5|90|6|SCREENING|2020-09-24|2020-09-26|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|1|SMDGCE|Smudge Cells|CHEMISTRY|[?]|/100 WBC|[?]|[?]|INVALID|1|cm/s|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|NON-HEMOLYZED||SLOAN LETTER EYE CHART 2.5%|FIBROMETER FORMULA||Y|U||1|Visit_1|10|6|FOLLOW-UP|2020-11-24|2020-12-14|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|2|CACRALB|Calcium Corrected for Albumin|CHEMISTRY|[?]|AFU|[?]|[?]|POSITIVE|1|Shock Wave|1|1|[?]|HIGH|GASTRIC FLUID|ICTERIC||EIA|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|4|WASHOUT|2020-11-24|2021-02-17|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|LB|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|3|PCA3MRNA|Prostate Cancer Antigen 3 mRNA|URINALYSIS|[?]|mV|[?]|[?]|INVALID|1|PHERESIS UNIT|1|1|[?]|HIGH|TUMOR TISSUE|NON-HEMOLYZED|N|IMMUNOCHEMILUMINOMETRIC ASSAY|HEPASCORE FORMULA|Y||U||2|Visit_2|25|6|TREATMENT|2020-12-09|2021-02-10|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|4|AUERRODS|Auer Rods|CHEMISTRY|[?]|EIA unit|[?]|[?]|NEGATIVE|1|uL/kg/day|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|ICTERIC||OPTICAL MAPPING|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-12-09|2020-12-17|25|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|5|IGHG4|Immunoglobulin Heavy Constant Gamma 4|CHEMISTRY|||[?]|[?]|NEGATIVE|1|10^5/hpf|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||NA|Y|3|Visit_3|40|1|TREATMENT|2020-12-24|2021-01-02|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|6|KLCLLCFR|Kappa Lt Chain,Free/Lambda Lt Chain,Free|HEMATOLOGY|[?]|10^12/L|[?]|[?]|INDETERMINATE|1|GPL U/mL|1|1|[?]|HIGH|URINE|CALCIFIED|N|SPECULAR MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||3|Visit_3|40|2|WASHOUT|2020-12-24|2021-01-22|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|LB|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|7|AMYLOIDP|Amyloid P|CHEMISTRY|||[?]|[?]|POSITIVE|1|FIU|1|1|[?]|NORMAL|INFRANATANT, PLASMA|LACTESCENT|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC FORMULA|||Y|Y|4|Visit_4|65|2|TREATMENT|2021-01-18|2021-02-21|65|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|8|APOA|Apolipoprotein A|HEMATOLOGY|[?]|mmol2/L2|[?]|[?]|TRACE|1|cmH2O/mL|1|1|[?]|LOW|BILE|SOLIDIFIED||THIN SMEAR|MDRD 6 VARIABLE FORMULA||Y|Y||4|Visit_4|65|6|WASHOUT|2021-01-18|2021-01-27|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|LB|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|9|CD20|CD20|URINALYSIS|[?]|ngEq/L|[?]|[?]|TRACE|1|grain|1|1|[?]|LOW|DISCHARGE|CONTAMINATED|N|IMMUNOFIXATION ELECTROPHORESIS|FIBROSIS 4 FORMULA|Y||NA||5|Visit_5|90|5|TREATMENT|2021-02-12|2021-02-21|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|10|C130123|Nut Mix Antigen IgG Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|mg/animal|1|1|[?]|ABNORMAL|CERUMEN|REFRIGERATED||EPSILOMETER|GMI MMOL/MOL FORMULA|||NA|Y|5|Visit_5|90|3|FOLLOW-UP|2021-02-12|2021-02-13|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|78778706-6b5b-4ad8-90af-f56d602863ae|1|OSM|Oncostatin M|CHEMISTRY|||[?]|[?]|BORDERLINE|1|MPS U|1|1|[?]|NORMAL|EXUDATE|DRIED||GC/MS|MDRD 4 VARIABLE FORMULA|||NA|Y|1|Visit_1|10|5|TREATMENT|2020-05-13|2020-07-11|10|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|LB|78778706-6b5b-4ad8-90af-f56d602863ae|2|RBCCLMP|Erythrocyte Cell Clumps|URINALYSIS|[?]|FEU|[?]|[?]|BORDERLINE|1|dpm/mg|1|1|[?]|HIGH|LYSATE|PARAFFIN-EMBEDDED||PERFUSION MRI|MDRD 4 VARIABLE FORMULA|||N||1|Visit_1|10|4|SCREENING|2020-05-13|2020-05-23|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|LB|78778706-6b5b-4ad8-90af-f56d602863ae|3|P50OXYGN|P50 Oxygen|HEMATOLOGY|[?]|ng/dL|[?]|[?]|INVALID|1|ug/m2/h|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|DRIED||ELECTRONEUROGRAPHY|CKD-EPI FORMULA|Y||Y||2|Visit_2|25|5|WASHOUT|2020-05-28|2020-06-05|25|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|LB|78778706-6b5b-4ad8-90af-f56d602863ae|4|CTOT|Complement Total|URINALYSIS|[?]|usec|[?]|[?]|INVALID|1|DIOPTER|1|1|[?]|ABNORMAL|SEBUM|LACTESCENT|N|AMSLER GRID|CKD-EPI FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-05-28|2020-07-03|25|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|LB|78778706-6b5b-4ad8-90af-f56d602863ae|5|VLDL2|VLDL Cholesterol Subtype 2|CHEMISTRY|||[?]|[?]|POSITIVE|1|MET*h|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|CLOTTED|N|DYNAMOMETRY|NASH FIBROSURE FORMULA||Y|Y|Y|3|Visit_3|40|4|TREATMENT|2020-06-12|2020-07-23|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|LB|78778706-6b5b-4ad8-90af-f56d602863ae|6|CHDWR|Ret Corpuscular HGB Conc Distr Width|CHEMISTRY|[?]|Gy/min|[?]|[?]|INVALID|1|mL|1|1|[?]|NORMAL|CAPILLARY BLOOD|AGGLUTINATED|N|MAGNETIC RESONANCE ENTEROGRAPHY|ASH FIBROSURE FORMULA|||N||3|Visit_3|40|1|WASHOUT|2020-06-12|2020-07-29|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|LB|78778706-6b5b-4ad8-90af-f56d602863ae|7|IBCU|Unsaturated Iron Binding Capacity|URINALYSIS|||[?]|[?]|NEGATIVE|1|pmol/dL|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|N|NUCLEIC ACID BASED METHOD|GMI % FORMULA|Y|Y|U|Y|4|Visit_4|65|3|TREATMENT|2020-07-07|2020-07-14|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|78778706-6b5b-4ad8-90af-f56d602863ae|8|INSLNFR|Insulin, Free|HEMATOLOGY|[?]|Bq/g|[?]|[?]|INVALID|1|mL/sec/1.73m2|1|1|[?]|ABNORMAL|BONE|CLOTTED||FLUORESCENT ENZYME IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|3|TREATMENT|2020-07-07|2020-08-03|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|LB|78778706-6b5b-4ad8-90af-f56d602863ae|9|ETPLT|ETP Lag Time|URINALYSIS|||[?]|[?]|BORDERLINE|1|mmol/s|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|THAWED||SMEAR|FIBROMETER FORMULA|Y||Y|Y|5|Visit_5|90|5|TREATMENT|2020-08-01|2020-08-10|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|LB|78778706-6b5b-4ad8-90af-f56d602863ae|10|APLIGGAB|Anti-Phospholipid IgG Antibody|CHEMISTRY|[?]|ug/min|[?]|[?]|TRACE|1|TUBE|1|1|[?]|NORMAL|CAPILLARY BLOOD|FRESH||U-HPLC/MS/MS|MDRD 4 VARIABLE FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2020-08-01|2020-08-07|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|LB|a6954aa1-4860-412a-b988-7f708aca2ab2|1|NMP22|Nuclear Matrix Protein 22|CHEMISTRY|||[?]|[?]|BORDERLINE|1|uIU/L|1|1|[?]|LOW|PUS|AGGLUTINATED||ELISA|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|1|Visit_1|10|1|SCREENING|2020-09-17|2020-12-14|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|a6954aa1-4860-412a-b988-7f708aca2ab2|2|TROPONI2|Troponin I Type 2|HEMATOLOGY|[?]|Pack Year|[?]|[?]|INVALID|1|breaths/30s|1|1|[?]|LOW|STOOL|CALCIFIED||URANYL ACETATE STAIN|GMI % FORMULA||Y|NA||1|Visit_1|10|1|WASHOUT|2020-09-17|2020-10-26|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|a6954aa1-4860-412a-b988-7f708aca2ab2|3|OVALCY|Ovalocytes|HEMATOLOGY|[?]|mg/kg/h|[?]|[?]|NEGATIVE|1|HEP|1|1|[?]|LOW|RETICULOCYTES|LACTESCENT||SURFACE PLASMON RESONANCE|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|3|WASHOUT|2020-10-02|2020-10-23|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|a6954aa1-4860-412a-b988-7f708aca2ab2|4|CLCREAT|Chloride/Creatinine|HEMATOLOGY|[?]|mph|[?]|[?]|TRACE|1|ug/cm2|1|1|[?]|LOW|SUPERNATANT, SERUM|LACTESCENT|N|CHROMATOGRAPHY|FIBROSIS 4 FORMULA||Y|Y||2|Visit_2|25|2|TREATMENT|2020-10-02|2020-10-21|25|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|a6954aa1-4860-412a-b988-7f708aca2ab2|5|UNSPCE|Unspecified Cells|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|TRANSDUCING UNIT/mL|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|LACTESCENT|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|FIBROSIS 4 FORMULA|Y||N|Y|3|Visit_3|40|5|TREATMENT|2020-10-17|2020-12-08|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|a6954aa1-4860-412a-b988-7f708aca2ab2|6|DECORIN|Decorin|HEMATOLOGY|[?]|mV/sec|[?]|[?]|INDETERMINATE|1|DAYS|1|1|[?]|HIGH|CORD SERUM|HEMOLYZED||IMMUNOTURBIDIMETRY|GMI % FORMULA||Y|NA||3|Visit_3|40|4|TREATMENT|2020-10-17|2020-10-20|40|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|LB|a6954aa1-4860-412a-b988-7f708aca2ab2|7|DHPG|3,4-Dihydroxyphenylglycol|CHEMISTRY|[?]|AU/mL|[?]|[?]|BORDERLINE|1|MBP|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|THAWED||PET/MRI SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|N||4|Visit_4|65|2|TREATMENT|2020-11-11|2020-11-20|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|a6954aa1-4860-412a-b988-7f708aca2ab2|8|B1BGLP|Beta-1B Glycoprotein|HEMATOLOGY|[?]|IU/mL|[?]|[?]|TRACE|1|tuberculin unit/mL|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|LACTESCENT||PHASE-CONTRAST MRI|CKD-EPI FORMULA||Y|NA||4|Visit_4|65|1|TREATMENT|2020-11-11|2020-12-07|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|a6954aa1-4860-412a-b988-7f708aca2ab2|9|CRYOGLBN|Cryoglobulin|CHEMISTRY|[?]|mOsm/kg|[?]|[?]|INVALID|1|APL U/mL|1|1|[?]|NORMAL|BASAL TEAR|SOLIDIFIED|N|PYROSEQUENCING|ASH FIBROSURE FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2020-12-06|2020-12-15|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|a6954aa1-4860-412a-b988-7f708aca2ab2|10|PLSIMCLY|Immature Plasma Cells/Lymphocytes|HEMATOLOGY|[?]|CONTAINER|[?]|[?]|NEGATIVE|1|ngEq/L|1|1|[?]|LOW|CAPILLARY BLOOD|FRESH||IHC|FIBROSIS 4 FORMULA||Y|U||5|Visit_5|90|7|TREATMENT|2020-12-06|2020-12-09|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|0a970eb4-f958-42ad-ad8b-60bb427c9cba|1|BLASTLM|Leukemic Blasts|CHEMISTRY|[?]|umol/h/mmol|[?]|[?]|INVALID|1|nmol/L/min|1|1|[?]|ABNORMAL|EMESIS|AUTOLYZED||MANUAL COUNT|MDRD 6 VARIABLE FORMULA|||Y||1|Visit_1|10|1|FOLLOW-UP|2020-05-14|2020-07-27|10|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|0a970eb4-f958-42ad-ad8b-60bb427c9cba|2|CYCACAR|Calcium Carbonate Crystals|URINALYSIS|[?]|IMPLANT|[?]|[?]|BORDERLINE|1|mg/m2/day|1|1|[?]|NORMAL|SWABBED MATERIAL|GELLED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|HEPASCORE FORMULA|Y||Y||1|Visit_1|10|4|SCREENING|2020-05-14|2020-07-12|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|0a970eb4-f958-42ad-ad8b-60bb427c9cba|3|NTXII|Type II Collagen N-Telopeptides|URINALYSIS|[?]|umol/day|[?]|[?]|INVALID|1|hPa|1|1|[?]|NORMAL|ARTERIAL BLOOD|LACTESCENT||KINETIC MICROPARTICLE IMMUNOASSAY|CKD-EPI FORMULA||Y|N||2|Visit_2|25|2|TREATMENT|2020-05-29|2020-06-19|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|LB|0a970eb4-f958-42ad-ad8b-60bb427c9cba|4|ASTCREAT|Aspartate Aminotransferase/Creatinine|HEMATOLOGY|[?]|mg/mol|[?]|[?]|INDETERMINATE|1|10^4/hpf|1|1|[?]|LOW|SUPERNATANT, PLASMA|REFRIGERATED|N|MANUAL COUNT|MDRD 5 VARIABLE FORMULA|||U||2|Visit_2|25|5|WASHOUT|2020-05-29|2020-06-09|25|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|LB|0a970eb4-f958-42ad-ad8b-60bb427c9cba|5|PROGEST|Progesterone|CHEMISTRY|[?]|RFU|[?]|[?]|TRACE|1|kIU|1|1|[?]|NORMAL|EXPIRED AIR|THAWED||KINYOUN STAIN|COCKCROFT-GAULT FORMULA|Y||N||3|Visit_3|40|2|TREATMENT|2020-06-13|2020-07-22|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|0a970eb4-f958-42ad-ad8b-60bb427c9cba|6|IFNG|Interferon Gamma|CHEMISTRY|||[?]|[?]|NEGATIVE|1|10^6 copies/mL|1|1|[?]|HIGH|PLATELET RICH PLASMA|AUTOLYZED||SLIT LAMP PHOTOGRAPHY|MDRD 6 VARIABLE FORMULA|Y||NA|Y|3|Visit_3|40|4|TREATMENT|2020-06-13|2020-07-15|40|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|0a970eb4-f958-42ad-ad8b-60bb427c9cba|7|TSTFTSTT|Testosterone, Free/Testosterone|HEMATOLOGY|[?]|mg/m2/h|[?]|[?]|NEGATIVE|1|10^6 organisms/mg|1|1|[?]|NORMAL|ADIPOSE TISSUE|ROOM TEMPERATURE|N|PHOTOMETRIC CLOT DETECTION|HEPASCORE FORMULA|Y|Y|U||4|Visit_4|65|5|SCREENING|2020-07-08|2020-08-01|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|0a970eb4-f958-42ad-ad8b-60bb427c9cba|8|BLSTMGK|Megakaryoblasts|CHEMISTRY|[?]|mg/L|[?]|[?]|NEGATIVE|1|mEq/day|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|GELLED||ECHOCARDIOGRAPHY|ASH FIBROSURE FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-07-08|2020-07-28|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|0a970eb4-f958-42ad-ad8b-60bb427c9cba|9|CXCR3|Chemokine (C-X-C Motif) Receptor 3|HEMATOLOGY|[?]|CIGARETTE|[?]|[?]|POSITIVE|1|mL/h|1|1|[?]|HIGH|SPERMATOZOON|CONCENTRATED||ELISPOT|CKD-EPI FORMULA|||N||5|Visit_5|90|2|TREATMENT|2020-08-02|2020-08-10|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|0a970eb4-f958-42ad-ad8b-60bb427c9cba|10|CA72_4AG|Cancer Antigen 72-4|URINALYSIS|[?]|uEq/L|[?]|[?]|POSITIVE|1|10^9 organisms/mg|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|UNEXPECTED ODOR||TRANSVAGINAL ULTRASOUND|FIBROSIS 4 FORMULA|||N||5|Visit_5|90|6|SCREENING|2020-08-02|2020-08-05|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|1|PTAC|Prothrombin Time Actual/Control|HEMATOLOGY|||[?]|[?]|INVALID|1|mmAL|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|FRESH||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA||Y|Y|Y|1|Visit_1|10|3|TREATMENT|2021-01-26|2021-02-14|10|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|2|TRIM21|Tripartite Motif Containing Protein 21|URINALYSIS|[?]|10^12/L|[?]|[?]|POSITIVE|1|kg/m2|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED||CELL BASED BIOASSAY|MDRD ENZYMATIC FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2021-01-26|2021-04-03|10|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|LB|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|3|CH50|Complement CH50|URINALYSIS|[?]|cL|[?]|[?]|BORDERLINE|1|uEq/L|1|1|[?]|NORMAL|AQUEOUS HUMOR|NON-HEMOLYZED||CLAUSS METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||2|Visit_2|25|7|TREATMENT|2021-02-10|2021-03-16|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|LB|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|4|NEUTSGBP|Neutrophils, Seg + Band Form + Precursor|URINALYSIS|||[?]|[?]|POSITIVE|1|mOsm/L|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|LIPEMIC||X-RAY|MDRD ENZYMATIC JAPANESE FORMULA|Y||N|Y|2|Visit_2|25|1|SCREENING|2021-02-10|2021-04-16|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|LB|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|5|FAT|Fat|CHEMISTRY|[?]|uV|[?]|[?]|POSITIVE|1|IU|1|1|[?]|LOW|SERUM OR PLASMA|CALCIFIED||MICROBIAL CULTURE, SOLID|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2021-02-25|2021-02-27|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|6|NFHP|Phosphorylated Neurofilament Heavy Chain|HEMATOLOGY|[?]|anti-Xa IU/mL|[?]|[?]|INDETERMINATE|1|mEq/dL|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|AUTOLYZED||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD FORMULA|Y||Y||3|Visit_3|40|4|SCREENING|2021-02-25|2021-03-24|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|7|CRYGLBSR|Cryoglobulin Volume/Serum Volume|URINALYSIS|[?]|mL/m2|[?]|[?]|INDETERMINATE|1|mL/mmHg/min/L|1|1|[?]|HIGH|ISOLATE|NON-HEMOLYZED||TWO-COLOR MICROARRAY|HEPASCORE FORMULA|Y||NA||4|Visit_4|65|6|TREATMENT|2021-03-22|2021-03-27|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|8|COCAAOM|Cocaine and/or Metabolites|CHEMISTRY|||[?]|[?]|POSITIVE|1|ugEq/L|1|1|[?]|ABNORMAL|SMEGMA|LIPEMIC||AUTOMATED COUNT|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|4|Visit_4|65|2|WASHOUT|2021-03-22|2021-04-07|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|9|HEMOLYSI|Hemolytic Index|HEMATOLOGY|[?]|U/10^12 RBC|[?]|[?]|INVALID|1|mL/sec/1.73m2|1|1|[?]|LOW|INTERSTITIAL FLUID|ICTERIC||MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2021-04-16|2021-04-21|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-15
e|LB|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|10|MMP9|Matrix Metalloproteinase 9|CHEMISTRY|[?]|g/day|[?]|[?]|BORDERLINE|1|Enzyme U|1|1|[?]|HIGH|AQUEOUS HUMOR|CALCIFIED||CELLULOSE TAPE|MDRD 6 VARIABLE FORMULA|||Y||5|Visit_5|90|3|FOLLOW-UP|2021-04-16|2021-04-20|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-15
e|LB|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|1|IL18EXR|Interleukin 18 Excretion Rate|CHEMISTRY|[?]|Shock Wave|[?]|[?]|NEGATIVE|1|10^12/L|1|1|[?]|LOW|AMNIOTIC FLUID|AUTOLYZED||POTENTIOMETRY|FIBROSIS 4 FORMULA|Y||N||1|Visit_1|10|7|TREATMENT|2020-08-24|2020-10-28|10|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|2|CYAMMBIU|Ammonium Biurate Crystals|URINALYSIS|[?]|mL/animal|[?]|[?]|BORDERLINE|1|K|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR||ELECTRONEUROGRAPHY|MDRD ENZYMATIC FORMULA|Y|Y|NA||1|Visit_1|10|7|TREATMENT|2020-08-24|2020-10-02|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|3|PROMONO|Promonocytes|HEMATOLOGY|[?]|LOZENGE|[?]|[?]|INVALID|1|BOLUS|1|1|[?]|LOW|INFRANATANT, PLASMA|CONCENTRATED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|FIBROTEST FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-09-08|2020-09-20|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|4|IGG2|Immunoglobulin G Subclass 2|HEMATOLOGY|[?]|ms/mmHg|[?]|[?]|POSITIVE|1|Enzyme U/L|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|CONTAMINATED||POLYGRAPHY|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2020-09-08|2020-10-30|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|5|MONOCE|Monocytes/Total Cells|URINALYSIS|[?]|mL/beat|[?]|[?]|BORDERLINE|1|PHERESIS UNIT|1|1|[?]|LOW|PLEURAL FLUID|SOLIDIFIED||ELECTRICAL IMPEDANCE MYOGRAPHY|FIBROTEST FORMULA|||NA||3|Visit_3|40|2|FOLLOW-UP|2020-09-23|2020-10-29|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|6|PSDEPHD|Pseudoephedrine|CHEMISTRY|[?]|ug/m2|[?]|[?]|BORDERLINE|1|GPS U|1|1|[?]|NORMAL|INTERSTITIAL FLUID|NON-HEMOLYZED|N|NUCLEIC ACID AMPLIFICATION TEST|COCKCROFT-GAULT FORMULA|Y||U||3|Visit_3|40|2|WASHOUT|2020-09-23|2020-11-14|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|LB|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|7|PTAUAB42|Phosphorylated Tau Prot/Amyloid Beta1-42|CHEMISTRY|[?]|kDa|[?]|[?]|NEGATIVE|1|IMPLANT|1|1|[?]|ABNORMAL|REFLEX TEAR|UNEXPECTED ODOR|N|IMMUNODIFFUSION|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|1|TREATMENT|2020-10-18|2020-11-19|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|8|HGBS|Hemoglobin S|HEMATOLOGY|[?]|mgEq|[?]|[?]|INDETERMINATE|1|INHALATION|1|1|[?]|HIGH|LYMPH|LACTESCENT|N|IODINE STAIN|MDRD 6 VARIABLE FORMULA||Y|U||4|Visit_4|65|3|FOLLOW-UP|2020-10-18|2020-11-03|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|9|MIP1|Macrophage Inflammatory Protein 1|HEMATOLOGY|[?]|sec|[?]|[?]|POSITIVE|1|genEq/mL|1|1|[?]|HIGH|INTERSTITIAL FLUID|ICTERIC||CHROMATOGRAPHY|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2020-11-12|2020-11-21|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|10|ANTHRMAG|Antithrombin Antigen|URINALYSIS|[?]|Tbsp|[?]|[?]|INVALID|1|kg/cm2|1|1|[?]|NORMAL|ARTERIAL BLOOD|PARAFFIN-EMBEDDED|N|ACRIDINE ORANGE STAIN|MDRD 6 VARIABLE FORMULA|||Y||5|Visit_5|90|2|WASHOUT|2020-11-12|2020-11-13|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|9b268a13-dc40-4eb6-8729-c131ac302dd3|1|S100A8|S100 Calcium Binding Protein A8|HEMATOLOGY|[?]|Arbitrary U|[?]|[?]|NEGATIVE|1|/10^5|1|1|[?]|NORMAL|EMESIS|CALCIFIED|N|MAGNETIC RESONANCE ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-05-15|2020-08-07|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|9b268a13-dc40-4eb6-8729-c131ac302dd3|2|KYNURNN|Kynurenine|HEMATOLOGY|[?]|mg2/dL2|[?]|[?]|BORDERLINE|1|nmol BCE/mmol|1|1|[?]|LOW|WHITE MATTER TISSUE|GELLED||X-RAY FLUORESCENCE SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-05-15|2020-05-31|10|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|9b268a13-dc40-4eb6-8729-c131ac302dd3|3|CARTP|Cocaine Amphetamine-Reg Transcript Prot|CHEMISTRY|[?]|mL/(min*100mL)|[?]|[?]|INVALID|1|tsp eq|1|1|[?]|HIGH|LUNG SURFACTANT|REFRIGERATED|N|ENZYMATIC COLORIMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|7|TREATMENT|2020-05-30|2020-06-03|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|LB|9b268a13-dc40-4eb6-8729-c131ac302dd3|4|TLYMXM|T-lymphocyte Crossmatch|URINALYSIS|[?]|Mile|[?]|[?]|TRACE|1|g/kg|1|1|[?]|HIGH|BONE|AUTOLYZED||CONTRAST ENHANCED CT SCAN|MDRD FORMULA|||N||2|Visit_2|25|2|FOLLOW-UP|2020-05-30|2020-07-19|25|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|LB|9b268a13-dc40-4eb6-8729-c131ac302dd3|5|CARBXHGB|Carboxyhemoglobin|HEMATOLOGY|[?]|10^6 CFU/mL|[?]|[?]|TRACE|1|L/s/kPa|1|1|[?]|HIGH|PLATELET RICH PLASMA|AGGLUTINATED||BIOPSY|HEPASCORE FORMULA|Y||NA||3|Visit_3|40|6|WASHOUT|2020-06-14|2020-06-15|40|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|9b268a13-dc40-4eb6-8729-c131ac302dd3|6|C130124|Cat Dander Antigen IgE Antibody|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|Gauss|1|1|[?]|LOW|ARTERIAL CORD BLOOD|CLOTTED|N|LIQUID SCINTILLATION COUNTING|MDRD 4 VARIABLE FORMULA|||Y|Y|3|Visit_3|40|1|SCREENING|2020-06-14|2020-06-16|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|LB|9b268a13-dc40-4eb6-8729-c131ac302dd3|7|ENA78|Epith Neutrophil-Activating Peptide 78|CHEMISTRY|[?]|BU/mL|[?]|[?]|POSITIVE|1|log10 copies/mL|1|1|[?]|ABNORMAL|GASTRIC FLUID|FRESH|N|NEXT GENERATION TARGETED SEQUENCING|MDRD 4 VARIABLE FORMULA|||N||4|Visit_4|65|7|WASHOUT|2020-07-09|2020-07-26|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|LB|9b268a13-dc40-4eb6-8729-c131ac302dd3|8|GRAN|Granulocytes|URINALYSIS|[?]|mEq/kg|[?]|[?]|POSITIVE|1|%(v/v)|1|1|[?]|HIGH|PERITONEAL FLUID|LIPEMIC||IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|2|FOLLOW-UP|2020-07-09|2020-08-08|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|LB|9b268a13-dc40-4eb6-8729-c131ac302dd3|9|ANTHRMAG|Antithrombin Antigen|HEMATOLOGY|[?]|mL/cm|[?]|[?]|BORDERLINE|1|LOZENGE|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|FRESH||TARGETED TRANSCRIPTOME SEQUENCING|MDRD 4 VARIABLE FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-08-03|2020-08-05|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|9b268a13-dc40-4eb6-8729-c131ac302dd3|10|TSTFTSTT|Testosterone, Free/Testosterone|HEMATOLOGY|[?]|nmol/kg/day|[?]|[?]|NEGATIVE|1|10^4 CFU/mL|1|1|[?]|NORMAL|TISSUE|ROOM TEMPERATURE||FLUORESCENT IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|4|SCREENING|2020-08-03|2020-08-04|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|fa11534a-92f9-4887-828b-25b7637b8f57|1|T3|Triiodothyronine|CHEMISTRY|[?]|uU/dL|[?]|[?]|BORDERLINE|1|mL/m2/day|1|1|[?]|NORMAL|LAVAGE FLUID|HEMOLYZED||CELL OF ORIGIN ASSAY|NASH FIBROSURE FORMULA|||Y||1|Visit_1|10|1|WASHOUT|2020-12-13|2021-01-12|10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|fa11534a-92f9-4887-828b-25b7637b8f57|2|GDF8|Growth Differentiation Factor 8|HEMATOLOGY|[?]|mg2/dL2|[?]|[?]|POSITIVE|1|g|1|1|[?]|HIGH|HAIR FOLLICLE|CONTAMINATED||ENZYMATIC ULTRACENTRIFUGATION|MDRD FORMULA|||U||1|Visit_1|10|2|WASHOUT|2020-12-13|2021-02-15|10|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|LB|fa11534a-92f9-4887-828b-25b7637b8f57|3|C130102|Tree Mix Pollen Antigen IgG Antibody|HEMATOLOGY|[?]|mL/day|[?]|[?]|TRACE|1|pmol|1|1|[?]|HIGH|ISOLATE|FROZEN||PET SCAN|CKD-EPI CYSTATIN C FORMULA|Y||NA||2|Visit_2|25|7|TREATMENT|2020-12-28|2021-02-21|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|LB|fa11534a-92f9-4887-828b-25b7637b8f57|4|APLIGMAB|Anti-Phospholipid IgM Antibody|CHEMISTRY|[?]|BOX|[?]|[?]|INDETERMINATE|1|deg2|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|GELLED||SLOAN LETTER EYE CHART 1.25%|FIBROTEST FORMULA|||NA||2|Visit_2|25|3|FOLLOW-UP|2020-12-28|2021-02-19|25|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|LB|fa11534a-92f9-4887-828b-25b7637b8f57|5|ESTRCPT|Estrogen Receptor|CHEMISTRY|[?]|mL/m2/day|[?]|[?]|POSITIVE|1|mL/mmHg|1|1|[?]|HIGH|LAVAGE FLUID|ICTERIC|N|MAGNETIC RESONANCE ENTEROGRAPHY|FIBROMETER FORMULA|||NA||3|Visit_3|40|4|WASHOUT|2021-01-12|2021-01-22|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|fa11534a-92f9-4887-828b-25b7637b8f57|6|CCL13|Chemokine (C-C Motif) Ligand 13|HEMATOLOGY|[?]|mEq/kg|[?]|[?]|POSITIVE|1|10^3 organisms/mL|1|1|[?]|NORMAL|PROSTATIC FLUID|SOLIDIFIED||CRYOSCOPY|MDRD 5 VARIABLE FORMULA|||N||3|Visit_3|40|5|WASHOUT|2021-01-12|2021-02-14|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|fa11534a-92f9-4887-828b-25b7637b8f57|7|GATCPHRL|Gamma Tocopherol|HEMATOLOGY|[?]|10^6/L|[?]|[?]|TRACE|1|Antibody Unit|1|1|[?]|LOW|ENDOTRACHEAL FLUID|CLOTTED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|FIBROMETER FORMULA|||N||4|Visit_4|65|6|TREATMENT|2021-02-06|2021-02-25|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|fa11534a-92f9-4887-828b-25b7637b8f57|8|EPSTI1|Epithelial Stromal Interaction Protein 1|URINALYSIS|[?]|ukat/10^12 RBC|[?]|[?]|NEGATIVE|1|DNA copies/mL|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|AGGLUTINATED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|3|FOLLOW-UP|2021-02-06|2021-03-12|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|fa11534a-92f9-4887-828b-25b7637b8f57|9|FECL|Fractional Chloride Excretion|URINALYSIS|||[?]|[?]|INVALID|1|cycle/min|1|1|[?]|LOW|LEUKOCYTE|AGGLUTINATED|N|ELLA|FIBROSIS 4 FORMULA|||Y|Y|5|Visit_5|90|1|TREATMENT|2021-03-03|2021-03-10|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|fa11534a-92f9-4887-828b-25b7637b8f57|10|TLYMXM|T-lymphocyte Crossmatch|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|PATCH|1|1|[?]|LOW|HAIR|FRESH||HPLC/MS|CKD-EPI FORMULA|||Y|Y|5|Visit_5|90|7|TREATMENT|2021-03-03|2021-03-04|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|f305f7a3-8c8b-4eca-afb2-4a376f811170|1|MOCYCELE|Monocytoid Cells/Leukocytes|CHEMISTRY|||[?]|[?]|TRACE|1|g/kg|1|1|[?]|HIGH|STOOL|LIPEMIC||CELLULAR PROLIFERATION ASSAY|MDRD ENZYMATIC FORMULA|Y|Y|NA|Y|1|Visit_1|10|3|TREATMENT|2020-10-04|2020-12-27|10|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|f305f7a3-8c8b-4eca-afb2-4a376f811170|2|FABP3|Fatty Acid Binding Protein 3|URINALYSIS|[?]|%(w/v)|[?]|[?]|NEGATIVE|1|mCi/kg|1|1|[?]|NORMAL|ABSCESS FLUID|PARAFFIN-EMBEDDED||AUDIOMETRY|COCKCROFT-GAULT FORMULA||Y|Y||1|Visit_1|10|6|TREATMENT|2020-10-04|2020-11-21|10|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|f305f7a3-8c8b-4eca-afb2-4a376f811170|3|C165915|Dog Dander IgG AB RAST Score|CHEMISTRY|[?]|mg/mol|[?]|[?]|NEGATIVE|1|dram|1|1|[?]|LOW|PLATELET RICH PLASMA|GELLED|N|IMMUNOPRECIPITATION|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|5|SCREENING|2020-10-19|2020-10-31|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|f305f7a3-8c8b-4eca-afb2-4a376f811170|4|C130104|Grass Mix Pollen Antigen IgG Antibody|HEMATOLOGY|[?]|nmol/L|[?]|[?]|POSITIVE|1|pmol/g|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|CONCENTRATED||AGAR PROPORTION|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||2|Visit_2|25|2|WASHOUT|2020-10-19|2020-11-28|25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|f305f7a3-8c8b-4eca-afb2-4a376f811170|5|VITB2|Riboflavin|CHEMISTRY|[?]|BEAM BREAKS|[?]|[?]|NEGATIVE|1|ng/day|1|1|[?]|ABNORMAL|CORD SERUM|SOLIDIFIED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||3|Visit_3|40|1|TREATMENT|2020-11-03|2020-12-13|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|f305f7a3-8c8b-4eca-afb2-4a376f811170|6|LIPASLAL|Lipase, Lysosomal Acid|CHEMISTRY|[?]|VIRTUAL PIXEL|[?]|[?]|INVALID|1|U/g/h|1|1|[?]|LOW|CIRCULATING TUMOR CELL|DRIED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA|||U||3|Visit_3|40|2|TREATMENT|2020-11-03|2020-11-24|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|f305f7a3-8c8b-4eca-afb2-4a376f811170|7|FIO2|Fraction of Inspired Oxygen|URINALYSIS|[?]|g/kg|[?]|[?]|INDETERMINATE|1|dpm/mL|1|1|[?]|HIGH|VENOUS CORD BLOOD|LIPEMIC||ELECTROCHEMILUMINESCENCE|MDRD 4 VARIABLE FORMULA|||Y||4|Visit_4|65|5|WASHOUT|2020-11-28|2020-12-22|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|f305f7a3-8c8b-4eca-afb2-4a376f811170|8|OH8DXG2|8-Hydroxy-2'-Deoxyguanosine|URINALYSIS|||[?]|[?]|INDETERMINATE|1|ugEq|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE||X-RAY|GMI MMOL/MOL FORMULA|||NA|Y|4|Visit_4|65|7|WASHOUT|2020-11-28|2020-12-10|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|LB|f305f7a3-8c8b-4eca-afb2-4a376f811170|9|GLCHT|Glycolithocholate|CHEMISTRY|[?]|psec|[?]|[?]|POSITIVE|1|Joule|1|1|[?]|NORMAL|BUFFY COAT|PARAFFIN-EMBEDDED||CONTRAST ENHANCED PET SCAN|MDRD 5 VARIABLE FORMULA|Y|Y|N||5|Visit_5|90|2|FOLLOW-UP|2020-12-23|2020-12-24|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|f305f7a3-8c8b-4eca-afb2-4a376f811170|10|TIMP1CRE|TIMP1/Creatinine|HEMATOLOGY|[?]|cg|[?]|[?]|INVALID|1|DRUM|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|THAWED||SANGER SEQUENCING|CKD-EPI CYSTATIN C FORMULA|Y|Y|U||5|Visit_5|90|5|WASHOUT|2020-12-23|2020-12-28|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|LB|6e4ed6b3-e419-464c-a40e-f100a6894baa|1|RBCDYSM|Dysmorphic Erythrocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|h/wk|1|1|[?]|NORMAL|VENOUS CORD BLOOD|SOLIDIFIED||TRICHROME STAIN|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|1|Visit_1|10|7|TREATMENT|2020-06-07|2020-08-02|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|6e4ed6b3-e419-464c-a40e-f100a6894baa|2|PNTBRBTL|Pentobarbital|CHEMISTRY|[?]|DRINK|[?]|[?]|INVALID|1|psec|1|1|[?]|NORMAL|CELL PELLET|GELLED||ELECTROCHEMILUMINESCENCE|CKD-EPI CYSTATIN C FORMULA|Y||Y||1|Visit_1|10|1|TREATMENT|2020-06-07|2020-08-25|10|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|6e4ed6b3-e419-464c-a40e-f100a6894baa|3|NEUTGT|Giant Neutrophils|HEMATOLOGY|[?]|Ci|[?]|[?]|NEGATIVE|1|nmol|1|1|[?]|NORMAL|SOFT TISSUE|PARAFFIN-EMBEDDED|N|ERGOSPIROMETRY|GMI % FORMULA|||U||2|Visit_2|25|7|TREATMENT|2020-06-22|2020-08-07|25|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|LB|6e4ed6b3-e419-464c-a40e-f100a6894baa|4|PLTAGAMP|Platelet Aggregation Amplitude|URINALYSIS|||[?]|[?]|TRACE|1|/2500 WBC|1|1|[?]|NORMAL|LYMPH|ICTERIC||OPTICAL COHERENCE TOMOGRAPHY|MDRD ENZYMATIC FORMULA|||U|Y|2|Visit_2|25|2|SCREENING|2020-06-22|2020-07-07|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|LB|6e4ed6b3-e419-464c-a40e-f100a6894baa|5|C130072|Birch Pollen IgE|CHEMISTRY|[?]|dyn|[?]|[?]|INVALID|1|10^3 organisms/g|1|1|[?]|HIGH|BILE|NON-HEMOLYZED||SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|CKD-EPI CREATININE FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-07-07|2020-08-28|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|6e4ed6b3-e419-464c-a40e-f100a6894baa|6|TCHT|Taurocholate|URINALYSIS|[?]|MPL U/mL|[?]|[?]|BORDERLINE|1|mL/mmHg/min/L|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED||MRI|FIBROMETER FORMULA|||Y||3|Visit_3|40|1|WASHOUT|2020-07-07|2020-09-03|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|LB|6e4ed6b3-e419-464c-a40e-f100a6894baa|7|HGB|Hemoglobin|HEMATOLOGY|[?]|mol/mol|[?]|[?]|INDETERMINATE|1|ms/mmHg|1|1|[?]|LOW|PUS|AGGLUTINATED||U-HPLC/MS/MS|FIBROMETER FORMULA||Y|U||4|Visit_4|65|3|FOLLOW-UP|2020-08-01|2020-08-21|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|6e4ed6b3-e419-464c-a40e-f100a6894baa|8|C165936|Glycine max IgE AB RAST Score|HEMATOLOGY|[?]|mL/min/mmHg|[?]|[?]|NEGATIVE|1|cmH2O*s/mL|1|1|[?]|LOW|TRANSUDATE|CLOTTED||TOTAL BODY IRRADIATION|MDRD 6 VARIABLE FORMULA|||NA||4|Visit_4|65|2|WASHOUT|2020-08-01|2020-09-02|65|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|LB|6e4ed6b3-e419-464c-a40e-f100a6894baa|9|MONOIM|Immature Monocytes|HEMATOLOGY|[?]|mN|[?]|[?]|INDETERMINATE|1|ng/mol|1|1|[?]|LOW|ISOLATE|FROZEN||GEL ELECTROPHORESIS|FIBROMETER FORMULA|||Y||5|Visit_5|90|6|TREATMENT|2020-08-26|2020-08-28|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|6e4ed6b3-e419-464c-a40e-f100a6894baa|10|PCDW|Platelet Component Distribution Width|URINALYSIS|||[?]|[?]|TRACE|1|Bq/mL|1|1|[?]|ABNORMAL|SERUM|THAWED|N|RIA|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|5|Visit_5|90|1|TREATMENT|2020-08-26|2020-08-27|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|LB|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|1|FATBODOV|Fat Bodies, Oval|URINALYSIS|[?]|L/h/m2|[?]|[?]|INVALID|1|dpm/100mg|1|1|[?]|LOW|LYMPH|ICTERIC|N|TONOMETRY|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|4|WASHOUT|2020-08-08|2020-09-12|10|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|2|GLUCEXR|Glucose Excretion Rate|HEMATOLOGY|[?]|mmol/min/kPa|[?]|[?]|BORDERLINE|1|cd*s/m2|1|1|[?]|NORMAL|ISOLATE|DRIED||GC/MS-CI|COCKCROFT-GAULT FORMULA||Y|N||1|Visit_1|10|7|WASHOUT|2020-08-08|2020-09-17|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|LB|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|3|ETPPHR|ETP Peak Height Relative|CHEMISTRY|[?]|umol|[?]|[?]|BORDERLINE|1|/sec|1|1|[?]|HIGH|PERSPIRATION|PARAFFIN-EMBEDDED||POTENTIOMETRY|CKD-EPI FORMULA|||N||2|Visit_2|25|2|SCREENING|2020-08-23|2020-11-01|25|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|4|SCN|Thiocyanate|URINALYSIS|[?]|mL/min/1.73m2|[?]|[?]|TRACE|1|mL/cage/day|1|1|[?]|ABNORMAL|BONE|GELLED||REFRACTOMETRY|FIBROSIS 4 FORMULA|Y||NA||2|Visit_2|25|7|TREATMENT|2020-08-23|2020-11-03|25|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|LB|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|5|COCAAOM|Cocaine and/or Metabolites|URINALYSIS|||[?]|[?]|INVALID|1|ohm|1|1|[?]|LOW|MUSCLE TISSUE|GELLED||ECHOCARDIOGRAPHY|MDRD FORMULA|||U|Y|3|Visit_3|40|2|TREATMENT|2020-09-07|2020-10-28|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|6|CKMB|Creatine Kinase MB|CHEMISTRY|[?]|mOsm|[?]|[?]|INDETERMINATE|1|10^6 RNA copies/mL|1|1|[?]|HIGH|PLEURAL FLUID|SOLIDIFIED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||3|Visit_3|40|2|TREATMENT|2020-09-07|2020-11-02|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|LB|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|7|GFRBSBTP|GFR from Beta-Trace Protein Adj for BSA|URINALYSIS|[?]|mEq/dL|[?]|[?]|INDETERMINATE|1|uL/kg/day|1|1|[?]|HIGH|BASAL TEAR|SOLIDIFIED|N|ERGOSPIROMETRY|CKD-EPI FORMULA|Y||Y||4|Visit_4|65|5|WASHOUT|2020-10-02|2020-10-21|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|8|AMYLASEP|Amylase, Pancreatic|URINALYSIS|[?]|BE/mL|[?]|[?]|TRACE|1|ug/dL|1|1|[?]|NORMAL|ALVEOLAR AIR|THAWED||MANUAL COUNT|CKD-EPI CREATININE FORMULA||Y|Y||4|Visit_4|65|2|SCREENING|2020-10-02|2020-10-04|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|9|PLTLPLT|Large Platelets/Total Platelets|HEMATOLOGY|[?]|umol/dL|[?]|[?]|POSITIVE|1|/cmH2O|1|1|[?]|NORMAL|LEUKOCYTE|UNEXPECTED ODOR|N|ELISPOT|GMI % FORMULA|Y||U||5|Visit_5|90|3|FOLLOW-UP|2020-10-27|2020-11-04|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|10|GSTCREAT|Glutathione-S-Transferase/Creatinine|URINALYSIS|||[?]|[?]|POSITIVE|1|uEq/L|1|1|[?]|HIGH|RETICULOCYTES|LIPEMIC||DROPLET DIGITAL PCR|FIBROMETER FORMULA|Y|Y|Y|Y|5|Visit_5|90|3|TREATMENT|2020-10-27|2020-11-04|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|5d25ac6d-428d-41eb-9549-c23df035a54e|1|TRP1TRG1|Trypsin 1 and Trypsinogen 1|CHEMISTRY|||[?]|[?]|POSITIVE|1|kPa|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|HEMOLYZED|N|IODINE STAIN|MDRD 4 VARIABLE FORMULA|||Y|Y|1|Visit_1|10|4|TREATMENT|2020-05-13|2020-07-21|10|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|5d25ac6d-428d-41eb-9549-c23df035a54e|2|ABO|ABO Blood Group|CHEMISTRY|[?]|mg/g/h|[?]|[?]|NEGATIVE|1|mL/mmHg|1|1|[?]|NORMAL|BUFFY COAT|CONCENTRATED||IMMUNOFLUORESCENT STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|7|FOLLOW-UP|2020-05-13|2020-05-20|10|17|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|LB|5d25ac6d-428d-41eb-9549-c23df035a54e|3|PTAC|Prothrombin Time Actual/Control|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|APPLICATION|1|1|[?]|HIGH|LYSATE|GELLED||CLINICAL EVALUATION|HEPASCORE FORMULA|||NA|Y|2|Visit_2|25|5|WASHOUT|2020-05-28|2020-07-16|25|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|5d25ac6d-428d-41eb-9549-c23df035a54e|4|ACYLCAOX|Acyl Coenzyme A Oxidase|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|psec|1|1|[?]|LOW|INTERSTITIAL FLUID|CALCIFIED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|FIBROSIS 4 FORMULA|Y||NA|Y|2|Visit_2|25|1|TREATMENT|2020-05-28|2020-07-29|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|LB|5d25ac6d-428d-41eb-9549-c23df035a54e|5|BLYCECE|B-Lymphocytes/Total Cells|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|vp/mL|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|CLOTTED||ETDRS EYE CHART|FIBROMETER FORMULA||Y|Y|Y|3|Visit_3|40|3|TREATMENT|2020-06-12|2020-07-25|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-07
e|LB|5d25ac6d-428d-41eb-9549-c23df035a54e|6|APROTCRS|Activated Protein C Resistance|URINALYSIS|[?]|Absorbance U/min|[?]|[?]|INDETERMINATE|1|mL/min/mmHg|1|1|[?]|LOW|ENDOMETRIAL TISSUE|PARAFFIN-EMBEDDED||ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA||Y|N||3|Visit_3|40|2|WASHOUT|2020-06-12|2020-06-18|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-07
e|LB|5d25ac6d-428d-41eb-9549-c23df035a54e|7|TDTAG|Terminal Deoxynucleotidyl Transferase Ag|URINALYSIS|||[?]|[?]|INDETERMINATE|1|CAPFUL|1|1|[?]|HIGH|BONE MARROW|CONCENTRATED||EPSILOMETER|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|4|Visit_4|65|4|WASHOUT|2020-07-07|2020-07-15|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-11
e|LB|5d25ac6d-428d-41eb-9549-c23df035a54e|8|VITDIT|25-Hydroxyvitamin D|HEMATOLOGY|[?]|POUCH|[?]|[?]|INVALID|1|mg/kg/day|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|FROZEN||LC/MS/MS|FIBROSIS 4 FORMULA|Y||NA||4|Visit_4|65|5|FOLLOW-UP|2020-07-07|2020-07-20|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-11
e|LB|5d25ac6d-428d-41eb-9549-c23df035a54e|9|CXCL11|Chemokine (C-X-C Motif) Ligand 11|URINALYSIS|[?]|mL/(min*100mL)|[?]|[?]|INDETERMINATE|1|log10 TCID 50/mL|1|1|[?]|LOW|LYSATE|HEMOLYZED|N|HPLC/IEX|FIBROMETER FORMULA|||U||5|Visit_5|90|7|TREATMENT|2020-08-01|2020-08-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|5d25ac6d-428d-41eb-9549-c23df035a54e|10|ANGPT1|Angiopoietin 1|URINALYSIS|[?]|CONTAINER|[?]|[?]|NEGATIVE|1|mEq/kg|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|ROOM TEMPERATURE||IMPEDANCE CONDUCTIVITY|MDRD FORMULA|Y||NA||5|Visit_5|90|5|WASHOUT|2020-08-01|2020-08-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|1|HYPERCHR|Hyperchromia|CHEMISTRY|[?]|kcal|[?]|[?]|BORDERLINE|1|dpm/mg|1|1|[?]|HIGH|CORD BLOOD|GELLED||POTENTIOMETRY|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|3|FOLLOW-UP|2020-10-30|2020-12-06|10|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|2|EOSLE|Eosinophils/Leukocytes|URINALYSIS|[?]|Bq|[?]|[?]|POSITIVE|1|dpm/mL|1|1|[?]|HIGH|FLUID|CONCENTRATED||SPECT/CT SCAN|FIBROTEST FORMULA|Y||N||1|Visit_1|10|1|WASHOUT|2020-10-30|2021-01-16|10|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|3|OH8DXG2|8-Hydroxy-2'-Deoxyguanosine|CHEMISTRY|[?]|kcal/day|[?]|[?]|TRACE|1|cup eq|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|HEMOLYZED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|1|TREATMENT|2020-11-14|2020-12-18|25|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|4|MET|Methionine|URINALYSIS|[?]|g/kg/day|[?]|[?]|INVALID|1|10^7 CFU|1|1|[?]|NORMAL|MENSTRUAL BLOOD|PARAFFIN-EMBEDDED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|FIBROTEST FORMULA|Y||Y||2|Visit_2|25|2|TREATMENT|2020-11-14|2021-01-17|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|LB|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|5|INDICAN|Indican|URINALYSIS|[?]|/sec|[?]|[?]|NEGATIVE|1|MdFI|1|1|[?]|HIGH|LEUKOCYTE|CLOTTED|N|NUCLEAR RADIOLOGY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||3|Visit_3|40|7|TREATMENT|2020-11-29|2021-01-14|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|6|FPP|Protoporphyrin, Free|CHEMISTRY|[?]|10^6 CFU/g|[?]|[?]|INDETERMINATE|1|pt_us|1|1|[?]|LOW|DISCHARGE|UNEXPECTED ODOR|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|FIBROTEST FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2020-11-29|2020-12-30|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|LB|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|7|LYMA|Lymphocytes Activated|CHEMISTRY|[?]|PATCH|[?]|[?]|NEGATIVE|1|mV/sec|1|1|[?]|ABNORMAL|SEMINAL FLUID|GELLED||TOTAL BODY IRRADIATION|MDRD FORMULA|||Y||4|Visit_4|65|3|WASHOUT|2020-12-24|2020-12-28|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|8|TIMP1CRE|TIMP1/Creatinine|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mOsm|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR||IMPULSE OSCILLOMETRY|NASH FIBROSURE FORMULA|Y|Y|Y|Y|4|Visit_4|65|1|SCREENING|2020-12-24|2021-01-17|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|LB|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|9|NEUTCYBS|Cytoplasmic Basophilia Neutrophil|URINALYSIS|[?]|PA|[?]|[?]|TRACE|1|10^4/L|1|1|[?]|ABNORMAL|EMESIS|CONTAMINATED||PHYSICAL EXAMINATION|CKD-EPI FORMULA|Y|Y|NA||5|Visit_5|90|5|TREATMENT|2021-01-18|2021-01-19|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|10|NICOTINE|Nicotine|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|HOURS|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|ROOM TEMPERATURE||ELECTROCHEMILUMINESCENCE|FIBROTEST FORMULA|||NA|Y|5|Visit_5|90|5|SCREENING|2021-01-18|2021-01-22|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|173aea61-964d-4f4a-8d48-56a1a58de6d8|1|RBCNURBC|Nucleated Erythrocytes/Erythrocytes|URINALYSIS|[?]|MET|[?]|[?]|INVALID|1|uL/dose|1|1|[?]|LOW|BONE MARROW|CONTAMINATED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y||Y||1|Visit_1|10|5|TREATMENT|2020-10-13|2020-10-29|10|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|173aea61-964d-4f4a-8d48-56a1a58de6d8|2|ELA2|Neutrophil Elastase|HEMATOLOGY|[?]|mL/m2/day|[?]|[?]|TRACE|1|mmol/kg|1|1|[?]|NORMAL|PERSPIRATION|ROOM TEMPERATURE||MICROBIAL CONCENTRATION|HEPASCORE FORMULA|||NA||1|Visit_1|10|5|FOLLOW-UP|2020-10-13|2020-12-24|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|173aea61-964d-4f4a-8d48-56a1a58de6d8|3|PC3MPSAM|PCA3 mRNA/PSA mRNA|URINALYSIS|[?]|C|[?]|[?]|INDETERMINATE|1|pmol/L/h|1|1|[?]|LOW|SPERMATOZOON|LIPEMIC|N|ELECTROCHEMILUMINESCENCE|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|4|TREATMENT|2020-10-28|2020-11-24|25|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|173aea61-964d-4f4a-8d48-56a1a58de6d8|4|GLYCRL|Glycerol|URINALYSIS|[?]|10^3 organisms/g|[?]|[?]|INVALID|1|g/cm2|1|1|[?]|NORMAL|ABSCESS FLUID|CLOTTED||COULOMETRIC TITRATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-10-28|2020-12-28|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|173aea61-964d-4f4a-8d48-56a1a58de6d8|5|VLDL2|VLDL Cholesterol Subtype 2|HEMATOLOGY|[?]|10^4/L|[?]|[?]|INDETERMINATE|1|mg/dL|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE||BAC ACGH|MDRD 6 VARIABLE FORMULA|||N||3|Visit_3|40|4|TREATMENT|2020-11-12|2020-12-05|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|173aea61-964d-4f4a-8d48-56a1a58de6d8|6|LDL|LDL Cholesterol|HEMATOLOGY|[?]|Henry|[?]|[?]|NEGATIVE|1|Bq/uL|1|1|[?]|NORMAL|SOFT TISSUE|LIPEMIC||RAJI CELL RIA|CKD-EPI FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-11-12|2020-12-12|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|LB|173aea61-964d-4f4a-8d48-56a1a58de6d8|7|T4FRIND|Thyroxine, Free, Indirect|CHEMISTRY|[?]|kg|[?]|[?]|TRACE|1|nkat/g Hb|1|1|[?]|HIGH|VITREOUS HUMOR|LIPEMIC||FLUORESCENT IMMUNOASSAY|CKD-EPI FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-12-07|2020-12-19|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|173aea61-964d-4f4a-8d48-56a1a58de6d8|8|INCLBOD|Inclusion Bodies|HEMATOLOGY|[?]|cmH2O*s2/mL|[?]|[?]|POSITIVE|1|umol/day|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED||TRANSCRIPTION-MEDIATED AMPLIFICATION|COCKCROFT-GAULT FORMULA|||U||4|Visit_4|65|2|FOLLOW-UP|2020-12-07|2020-12-29|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|LB|173aea61-964d-4f4a-8d48-56a1a58de6d8|9|PLATLRG|Large Platelets|CHEMISTRY|[?]|mg/day|[?]|[?]|BORDERLINE|1|g/day|1|1|[?]|ABNORMAL|ISOLATE|REFRIGERATED||INTRAVASCULAR ULTRASOUND|FIBROSIS 4 FORMULA|||NA||5|Visit_5|90|1|WASHOUT|2021-01-01|2021-01-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|173aea61-964d-4f4a-8d48-56a1a58de6d8|10|BLSTLY|Lymphoblasts|HEMATOLOGY|||[?]|[?]|INVALID|1|U/L|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED|N|MULTI-SLICE SPIRAL CT|ASH FIBROSURE FORMULA|||NA|Y|5|Visit_5|90|4|SCREENING|2021-01-01|2021-01-02|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|LB|45d1adb8-9b3b-4f06-87cb-740205448680|1|UBQN|Ubiquitin Protein|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|nmol BCE/L|1|1|[?]|HIGH|SUPERNATANT, PLASMA|SOLIDIFIED||CISH|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|1|Visit_1|10|3|FOLLOW-UP|2020-07-17|2020-09-26|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|45d1adb8-9b3b-4f06-87cb-740205448680|2|INTLK2|Interleukin 2|HEMATOLOGY|[?]|KALLIKREIN INHIBITOR UNIT|[?]|[?]|BORDERLINE|1|ug/kg/h|1|1|[?]|HIGH|WHITE MATTER TISSUE|HEMOLYZED||FLUORESCENT IMMUNOASSAY|HEPASCORE FORMULA|Y||NA||1|Visit_1|10|1|WASHOUT|2020-07-17|2020-08-29|10|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|45d1adb8-9b3b-4f06-87cb-740205448680|3|FPP|Protoporphyrin, Free|URINALYSIS|||[?]|[?]|INVALID|1|Absorbance U/min|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|HEMOLYZED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|FIBROTEST FORMULA|||Y|Y|2|Visit_2|25|5|TREATMENT|2020-08-01|2020-10-11|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|45d1adb8-9b3b-4f06-87cb-740205448680|4|EDMIGAAB|Endomysial IgA Antibody|URINALYSIS|[?]|g/cage/wk|[?]|[?]|POSITIVE|1|/7.5 mL|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|FRESH||PHOTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|4|WASHOUT|2020-08-01|2020-08-26|25|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|45d1adb8-9b3b-4f06-87cb-740205448680|5|NEUTSG|Neutrophils, Segmented|URINALYSIS|[?]|fg|[?]|[?]|NEGATIVE|1|mg/mol|1|1|[?]|HIGH|PROSTATIC FLUID|AGGLUTINATED||MACRO BROTH DILUTION|COCKCROFT-GAULT FORMULA|||NA||3|Visit_3|40|4|FOLLOW-UP|2020-08-16|2020-10-10|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|45d1adb8-9b3b-4f06-87cb-740205448680|6|PROMYLE|Promyelocytes/Leukocytes|CHEMISTRY|[?]|Bq/kg|[?]|[?]|INDETERMINATE|1|/2500 WBC|1|1|[?]|NORMAL|BILE|SOLIDIFIED||HEMAGGLUTINATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-08-16|2020-09-28|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|45d1adb8-9b3b-4f06-87cb-740205448680|7|KIM1S|Soluble Kidney Injury Molecule-1|URINALYSIS|||[?]|[?]|BORDERLINE|1|titer|1|1|[?]|LOW|SWABBED MATERIAL|PARAFFIN-EMBEDDED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI CREATININE FORMULA|||NA|Y|4|Visit_4|65|7|WASHOUT|2020-09-10|2020-09-29|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|45d1adb8-9b3b-4f06-87cb-740205448680|8|THCCOOH|11-Nor-Delta9-THC-9-Carboxylic Acid|HEMATOLOGY|||[?]|[?]|INVALID|1|cd*s/m2|1|1|[?]|NORMAL|VENOUS PLASMA|LACTESCENT||TOTAL BODY IRRADIATION|MDRD ENZYMATIC JAPANESE FORMULA|||Y|Y|4|Visit_4|65|2|FOLLOW-UP|2020-09-10|2020-10-08|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|45d1adb8-9b3b-4f06-87cb-740205448680|9|NEUTNSQE|Neutrophils/Non-Squam Epi Cells|URINALYSIS|[?]|U/kg/h|[?]|[?]|INVALID|1|mg/day|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|GELLED||MICRO BROTH DILUTION|FIBROMETER FORMULA|Y||N||5|Visit_5|90|5|WASHOUT|2020-10-05|2020-10-11|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|45d1adb8-9b3b-4f06-87cb-740205448680|10|OAS1|2-5-Oligoadenylate Synthase 1|HEMATOLOGY|[?]|MnFI|[?]|[?]|TRACE|1|msec|1|1|[?]|LOW|ARTERIAL CORD BLOOD|CALCIFIED||DIFFUSION TENSOR MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-10-05|2020-10-06|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|LB|7403ad67-7ed5-4716-a874-c360429845bc|1|C165919|German Cockroach IgG AB RAST Score|URINALYSIS|||[?]|[?]|TRACE|1|%/s|1|1|[?]|HIGH|VENOUS BLOOD|GELLED||ENDOSCOPY|CKD-EPI CYSTATIN C FORMULA|||N|Y|1|Visit_1|10|1|WASHOUT|2020-05-30|2020-07-01|10|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|7403ad67-7ed5-4716-a874-c360429845bc|2|EPISCECE|Squamous Epithelial Cells/Total Cells|URINALYSIS|[?]|g/dL|[?]|[?]|NEGATIVE|1|kBq|1|1|[?]|NORMAL|BILE|FROZEN||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|3|FOLLOW-UP|2020-05-30|2020-08-06|10|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|7403ad67-7ed5-4716-a874-c360429845bc|3|C165878|German Cockroach IgE AB RAST Score|CHEMISTRY|[?]|CFU/mL|[?]|[?]|NEGATIVE|1|10^10/L|1|1|[?]|LOW|STOOL|FROZEN||MALDI|NASH FIBROSURE FORMULA|Y|Y|N||2|Visit_2|25|5|FOLLOW-UP|2020-06-14|2020-08-20|25|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|7403ad67-7ed5-4716-a874-c360429845bc|4|DDIMER|D-Dimer|URINALYSIS|[?]|PACKET|[?]|[?]|BORDERLINE|1|pmol/L/h|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|CALCIFIED|N|REBOUND TONOMETRY|CKD-EPI CYSTATIN C FORMULA||Y|U||2|Visit_2|25|1|WASHOUT|2020-06-14|2020-06-24|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|7403ad67-7ed5-4716-a874-c360429845bc|5|IGGCALBC|IgG Clearance/Albumin Clearance|HEMATOLOGY|[?]|10^3 RNA copies/mL|[?]|[?]|INVALID|1|Farad|1|1|[?]|LOW|RETICULOCYTES|LIPEMIC|N|LC/MS|CKD-EPI CREATININE FORMULA||Y|Y||3|Visit_3|40|5|TREATMENT|2020-06-29|2020-07-18|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|LB|7403ad67-7ed5-4716-a874-c360429845bc|6|VMAEXR|Vanillyl Mandelic Acid Excretion Rate|URINALYSIS|||[?]|[?]|TRACE|1|mU/L|1|1|[?]|HIGH|AQUEOUS HUMOR|CLOTTED||DXA SCAN|MDRD 4 VARIABLE FORMULA|||N|Y|3|Visit_3|40|3|SCREENING|2020-06-29|2020-07-13|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|LB|7403ad67-7ed5-4716-a874-c360429845bc|7|SMUSCAB|Smooth Muscle Antibody|HEMATOLOGY|[?]|TRANSDUCING UNIT/mL|[?]|[?]|INVALID|1|mL/beat|1|1|[?]|HIGH|VENOUS PLASMA|CLOTTED||CONTRAST ENHANCED PET/CT SCAN|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|1|FOLLOW-UP|2020-07-24|2020-08-07|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|LB|7403ad67-7ed5-4716-a874-c360429845bc|8|C130081|Orchard Grass Pollen IgA|URINALYSIS|[?]|mmol/kg|[?]|[?]|INVALID|1|10^6 CFU/mL|1|1|[?]|NORMAL|DISCHARGE|DRIED||SLOAN LETTER EYE CHART 2.5%|MDRD 5 VARIABLE FORMULA|||NA||4|Visit_4|65|1|WASHOUT|2020-07-24|2020-08-07|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|LB|7403ad67-7ed5-4716-a874-c360429845bc|9|CYURIAC|Uric Acid Crystals|URINALYSIS|[?]|um/day|[?]|[?]|BORDERLINE|1|VOXEL|1|1|[?]|HIGH|SKIN TISSUE|PARAFFIN-EMBEDDED||LC/MS/MS|GMI % FORMULA|||U||5|Visit_5|90|3|SCREENING|2020-08-18|2020-08-22|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|7403ad67-7ed5-4716-a874-c360429845bc|10|P50OXYGN|P50 Oxygen|HEMATOLOGY|[?]|aMFI|[?]|[?]|TRACE|1|in2|1|1|[?]|NORMAL|ALVEOLAR AIR|GELLED||PLETHYSMOGRAPHY|ASH FIBROSURE FORMULA||Y|N||5|Visit_5|90|3|TREATMENT|2020-08-18|2020-08-20|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|8be919ce-34da-4e49-ac7a-3679c7af632d|1|LDH5LDH|LDH Isoenzyme 5/LDH|URINALYSIS|||[?]|[?]|POSITIVE|1|cy/cm|1|1|[?]|ABNORMAL|EXUDATE|PARAFFIN-EMBEDDED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|HEPASCORE FORMULA|Y||NA|Y|1|Visit_1|10|1|SCREENING|2021-01-13|2021-01-18|10|15|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|8be919ce-34da-4e49-ac7a-3679c7af632d|2|ARG|Arginine|HEMATOLOGY|[?]|10^3 organisms|[?]|[?]|BORDERLINE|1|1/(s*kPa)|1|1|[?]|HIGH|HAIR FOLLICLE|FROZEN||THERMAL IONIZATION MASS SPECTROMETRY|MDRD 5 VARIABLE FORMULA||Y|N||1|Visit_1|10|5|SCREENING|2021-01-13|2021-01-29|10|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|LB|8be919ce-34da-4e49-ac7a-3679c7af632d|3|GLDH|Glutamate Dehydrogenase|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|dpm/100mg|1|1|[?]|ABNORMAL|TUMOR TISSUE|CLOTTED||KINETIC MICROPARTICLE IMMUNOASSAY|HEPASCORE FORMULA|||N|Y|2|Visit_2|25|3|FOLLOW-UP|2021-01-28|2021-04-04|25|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|LB|8be919ce-34da-4e49-ac7a-3679c7af632d|4|CKMB|Creatine Kinase MB|CHEMISTRY|||[?]|[?]|BORDERLINE|1|TRANSDUCING UNIT|1|1|[?]|HIGH|LEUKOCYTE|CONCENTRATED||PH METER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA||Y|N|Y|2|Visit_2|25|1|TREATMENT|2021-01-28|2021-04-01|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|LB|8be919ce-34da-4e49-ac7a-3679c7af632d|5|ASTALT|AST/ALT|CHEMISTRY|[?]|Pa|[?]|[?]|INVALID|1|mL/animal/day|1|1|[?]|LOW|PLEURAL TISSUE|REFRIGERATED||QUANTITATIVE CORONARY ANGIOGRAPHY|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|4|TREATMENT|2021-02-12|2021-03-01|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|8be919ce-34da-4e49-ac7a-3679c7af632d|6|FCTVIIAA|Factor VIIa Activity|URINALYSIS|[?]|mOsm/kg|[?]|[?]|POSITIVE|1|mL/cm3/min|1|1|[?]|LOW|PLATELET RICH PLASMA|LACTESCENT||RAJI CELL EIA|GMI MMOL/MOL FORMULA||Y|NA||3|Visit_3|40|1|WASHOUT|2021-02-12|2021-03-19|40|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|LB|8be919ce-34da-4e49-ac7a-3679c7af632d|7|NACREAT|Sodium/Creatinine|URINALYSIS|[?]|oz eq|[?]|[?]|POSITIVE|1|Weber|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED||NUCLEAR RADIOLOGY|FIBROMETER FORMULA|||Y||4|Visit_4|65|6|TREATMENT|2021-03-09|2021-03-12|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|8be919ce-34da-4e49-ac7a-3679c7af632d|8|LAG3S|Soluble Lymphocyte Activation Gene-3|HEMATOLOGY|[?]|ug/kg/day|[?]|[?]|NEGATIVE|1|V|1|1|[?]|HIGH|DIALYSIS FLUID|AGGLUTINATED||PULMONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA|Y|Y|U||4|Visit_4|65|7|TREATMENT|2021-03-09|2021-04-01|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|8be919ce-34da-4e49-ac7a-3679c7af632d|9|SMDGCE|Smudge Cells|URINALYSIS|[?]|deg/mm|[?]|[?]|TRACE|1|um/s|1|1|[?]|ABNORMAL|SEBUM|HEMOLYZED||PET/SPECT SCAN|HEPASCORE FORMULA|Y|Y|Y||5|Visit_5|90|2|TREATMENT|2021-04-03|2021-04-09|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|8be919ce-34da-4e49-ac7a-3679c7af632d|10|PLSMCECE|Mature Plasma Cells/Total Cells|HEMATOLOGY|[?]|EID 50/mL|[?]|[?]|NEGATIVE|1|kN/cm2|1|1|[?]|LOW|ISOLATE|PARAFFIN-EMBEDDED||RADIOGRAPHY|CKD-EPI CREATININE FORMULA|Y||U||5|Visit_5|90|4|TREATMENT|2021-04-03|2021-04-08|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|9c44967b-914e-43d5-be1e-6829804e04ab|1|GFRBSB2M|GFR from B-2 Microglobulin Adj for BSA|URINALYSIS|[?]|mg/min|[?]|[?]|INVALID|1|ug/L/h|1|1|[?]|NORMAL|ALVEOLAR AIR|HEMOLYZED||MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2021-01-24|2021-04-12|10|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|LB|9c44967b-914e-43d5-be1e-6829804e04ab|2|THBD|Thrombomodulin|HEMATOLOGY|[?]|beats/min|[?]|[?]|INVALID|1|mL/kg/min|1|1|[?]|LOW|RETICULOCYTES|NON-HEMOLYZED||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|6|WASHOUT|2021-01-24|2021-02-28|10|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|LB|9c44967b-914e-43d5-be1e-6829804e04ab|3|EAGLUC|Glucose, Estimated Average|HEMATOLOGY|||[?]|[?]|INVALID|1|cP|1|1|[?]|HIGH|URINE SEDIMENT|ROOM TEMPERATURE||IMMUNOFIXATION ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA|||U|Y|2|Visit_2|25|1|WASHOUT|2021-02-08|2021-02-16|25|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|9c44967b-914e-43d5-be1e-6829804e04ab|4|INTLK3|Interleukin 3|HEMATOLOGY|[?]|cd|[?]|[?]|INVALID|1|ng/dL|1|1|[?]|LOW|CAPILLARY PLASMA|CALCIFIED|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2021-02-08|2021-02-13|25|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|LB|9c44967b-914e-43d5-be1e-6829804e04ab|5|CITCREAT|Citrate/Creatinine|HEMATOLOGY|[?]|ug/g/day|[?]|[?]|POSITIVE|1|PNU/mL|1|1|[?]|ABNORMAL|RETICULOCYTES|PARAFFIN-EMBEDDED||FLOW MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|U||3|Visit_3|40|2|TREATMENT|2021-02-23|2021-03-24|40|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|9c44967b-914e-43d5-be1e-6829804e04ab|6|GLUC|Glucose|URINALYSIS|||[?]|[?]|POSITIVE|1|ng/L|1|1|[?]|LOW|PLATELET POOR PLASMA|AGGLUTINATED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD FORMULA||Y|U|Y|3|Visit_3|40|6|TREATMENT|2021-02-23|2021-04-14|40|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|9c44967b-914e-43d5-be1e-6829804e04ab|7|PRABC|Calculated Panel Reactive Antibody|URINALYSIS|||[?]|[?]|INVALID|1|um|1|1|[?]|HIGH|BASAL TEAR|ICTERIC|N|VIRUS PLAQUE ASSAY|CKD-EPI CREATININE FORMULA||Y|Y|Y|4|Visit_4|65|6|FOLLOW-UP|2021-03-20|2021-03-23|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|LB|9c44967b-914e-43d5-be1e-6829804e04ab|8|FIO2|Fraction of Inspired Oxygen|CHEMISTRY|[?]|uIU/L|[?]|[?]|INDETERMINATE|1|U/m2/day|1|1|[?]|HIGH|TRANSUDATE|AGGLUTINATED||IMMUNOFIXATION ELECTROPHORESIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U||4|Visit_4|65|7|TREATMENT|2021-03-20|2021-04-05|65|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|LB|9c44967b-914e-43d5-be1e-6829804e04ab|9|HIS|Histidine|CHEMISTRY|[?]|/min|[?]|[?]|INVALID|1|kDa|1|1|[?]|LOW|MUCUS|REFRIGERATED|N|FARR ASSAY|COCKCROFT-GAULT FORMULA||Y|NA||5|Visit_5|90|3|WASHOUT|2021-04-14|2021-04-18|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|9c44967b-914e-43d5-be1e-6829804e04ab|10|PROGRP|Pro-gastrin Releasing Peptide|URINALYSIS|[?]|10^8 PFU|[?]|[?]|INVALID|1|Joule|1|1|[?]|ABNORMAL|CALCULUS|THAWED||DC SHEATH FLOW|FIBROMETER FORMULA|Y||NA||5|Visit_5|90|3|TREATMENT|2021-04-14|2021-04-21|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|LB|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|1|B2MICG|Beta-2 Microglobulin|URINALYSIS|[?]|mmol/kg|[?]|[?]|INVALID|1|ft3|1|1|[?]|NORMAL|PROSTATIC FLUID|CALCIFIED||PERIODIC ACID SCHIFF STAIN|CKD-EPI FORMULA||Y|U||1|Visit_1|10|1|FOLLOW-UP|2020-07-31|2020-10-11|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|2|FACTXIV|Factor XIV|HEMATOLOGY|[?]|CIGAR|[?]|[?]|INDETERMINATE|1|10^6/g|1|1|[?]|HIGH|PLEURAL TISSUE|DRIED||ULTRASOUND|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|5|SCREENING|2020-07-31|2020-09-15|10|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|LB|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|3|ALBGLYCA|Glycated Albumin|HEMATOLOGY|[?]|/sec|[?]|[?]|NEGATIVE|1|mAnson U/mL|1|1|[?]|HIGH|SKIN TISSUE|FROZEN||GEL ELECTROPHORESIS|MDRD FORMULA|Y||Y||2|Visit_2|25|6|WASHOUT|2020-08-15|2020-08-16|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|4|OH8DXG2|8-Hydroxy-2'-Deoxyguanosine|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|ECL unit|1|1|[?]|NORMAL|BUFFY COAT|FROZEN||TONOMETRY|CKD-EPI CYSTATIN C FORMULA|||U|Y|2|Visit_2|25|4|TREATMENT|2020-08-15|2020-10-23|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|5|ALPBALP|Alk Phos, Bone/Total Alk Phos|CHEMISTRY|[?]|Ci/mg|[?]|[?]|INVALID|1|mg/kg|1|1|[?]|ABNORMAL|CARDIAC MUSCLE TISSUE|REFRIGERATED||FLUORESCENT LIFETIME IMAGING MICROSCOPY|FIBROTEST FORMULA|||U||3|Visit_3|40|1|WASHOUT|2020-08-30|2020-10-27|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|6|FRFEABS|Fractional Iron Absorption|URINALYSIS|[?]|cm H2O|[?]|[?]|POSITIVE|1|g/animal|1|1|[?]|HIGH|KERATINOCYTE|FRESH||MAGNETIC RESONANCE ELASTOGRAPHY|GMI % FORMULA|||NA||3|Visit_3|40|3|FOLLOW-UP|2020-08-30|2020-09-26|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|7|CCL19|Chemokine (C-C Motif) Ligand 19|URINALYSIS|||[?]|[?]|INVALID|1|U.CARR|1|1|[?]|LOW|LOCHIA|ICTERIC|N|PALPATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|4|Visit_4|65|6|TREATMENT|2020-09-24|2020-10-25|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|8|TRP|Tryptophan|CHEMISTRY|[?]|ug/kg/day|[?]|[?]|INDETERMINATE|1|ug/m2/day|1|1|[?]|HIGH|SKIN TISSUE|CLOTTED||RYAN BLUE STAIN|CKD-EPI FORMULA|Y||NA||4|Visit_4|65|6|TREATMENT|2020-09-24|2020-10-05|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|9|ESTROGEN|Estrogen|CHEMISTRY|[?]|STEPS|[?]|[?]|POSITIVE|1|bel|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|CALCIFIED||ENDOSCOPY|GMI MMOL/MOL FORMULA|Y||U||5|Visit_5|90|2|FOLLOW-UP|2020-10-19|2020-10-28|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|10|GLOBB1|Beta-1 Globulin|CHEMISTRY|[?]|umol/mg/min|[?]|[?]|INVALID|1|ug/animal|1|1|[?]|NORMAL|DIALYSIS FLUID|CONTAMINATED|N|NEXT GENERATION SEQUENCING|MDRD ENZYMATIC FORMULA|||U||5|Visit_5|90|7|SCREENING|2020-10-19|2020-10-21|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|cad8c553-739f-4046-a898-d939eb286dba|1|PRLYMLE|Prolymphocytes/Leukocytes|HEMATOLOGY|[?]|g/cage|[?]|[?]|INVALID|1|mmHg/L/min|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|CKD-EPI FORMULA|||N||1|Visit_1|10|3|WASHOUT|2020-05-17|2020-05-28|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|cad8c553-739f-4046-a898-d939eb286dba|2|TK2|Thymidine Kinase 2|URINALYSIS|||[?]|[?]|INDETERMINATE|1|umol/mg/min|1|1|[?]|ABNORMAL|EXPIRED AIR|DRIED|N|LIQUID SCINTILLATION COUNTING|CKD-EPI CREATININE FORMULA|Y||NA|Y|1|Visit_1|10|4|TREATMENT|2020-05-17|2020-06-15|10|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|cad8c553-739f-4046-a898-d939eb286dba|3|ASN|Asparagine|URINALYSIS|||[?]|[?]|INDETERMINATE|1|U/m2/min|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|CLOTTED||LC-FL|GMI MMOL/MOL FORMULA|||Y|Y|2|Visit_2|25|4|TREATMENT|2020-06-01|2020-07-27|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|cad8c553-739f-4046-a898-d939eb286dba|4|C130074|Birch Pollen IgG|URINALYSIS|[?]|L/day|[?]|[?]|INDETERMINATE|1|s/h|1|1|[?]|LOW|LUNG SURFACTANT|HEMOLYZED||TURBIDIMETRY|MDRD 6 VARIABLE FORMULA|||NA||2|Visit_2|25|7|TREATMENT|2020-06-01|2020-07-19|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|cad8c553-739f-4046-a898-d939eb286dba|5|OCCBLD|Occult Blood|CHEMISTRY|[?]|IU/mmol|[?]|[?]|NEGATIVE|1|km|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|CLOTTED|N|TEST STRIP|CKD-EPI CREATININE FORMULA||Y|Y||3|Visit_3|40|3|WASHOUT|2020-06-16|2020-07-17|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|cad8c553-739f-4046-a898-d939eb286dba|6|LYMPL|Plasmacytoid Lymphocytes|CHEMISTRY|[?]|CARTRIDGE|[?]|[?]|TRACE|1|mmHg*min/L|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|FRESH||MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 4 VARIABLE FORMULA|Y||N||3|Visit_3|40|6|TREATMENT|2020-06-16|2020-08-13|40|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|cad8c553-739f-4046-a898-d939eb286dba|7|A1MCREAT|Alpha-1 Microglobulin/Creatinine|URINALYSIS|[?]|Osm|[?]|[?]|NEGATIVE|1|kDa|1|1|[?]|NORMAL|KERATINOCYTE|LIPEMIC||HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD FORMULA||Y|N||4|Visit_4|65|3|TREATMENT|2020-07-11|2020-07-19|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|cad8c553-739f-4046-a898-d939eb286dba|8|BLASTNCE|Blasts/Nucleated Cells|HEMATOLOGY|[?]|mL/cm H2O|[?]|[?]|POSITIVE|1|L/s|1|1|[?]|HIGH|BLOOD|NON-HEMOLYZED||ENZYMATIC SPECTROPHOTOMETRY|MDRD 4 VARIABLE FORMULA|||U||4|Visit_4|65|2|TREATMENT|2020-07-11|2020-08-09|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|LB|cad8c553-739f-4046-a898-d939eb286dba|9|TATC|Thrombin Antithrombin Complex|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|dL|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|ROOM TEMPERATURE||PET SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|Y|Y|5|Visit_5|90|4|WASHOUT|2020-08-05|2020-08-09|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-12
e|LB|cad8c553-739f-4046-a898-d939eb286dba|10|EPISCECE|Squamous Epithelial Cells/Total Cells|CHEMISTRY|[?]|mmHg|[?]|[?]|INVALID|1|/7.5 mL|1|1|[?]|LOW|CORD SERUM|ROOM TEMPERATURE||POPULATION SEQUENCING|GMI % FORMULA|Y|Y|Y||5|Visit_5|90|5|SCREENING|2020-08-05|2020-08-10|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-12
e|LB|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|1|CGMP|Cyclic Guanosine Monophosphate|CHEMISTRY|[?]|genEq/mL|[?]|[?]|POSITIVE|1|amol|1|1|[?]|NORMAL|PLEURAL FLUID|NON-HEMOLYZED||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|FIBROTEST FORMULA||Y|U||1|Visit_1|10|3|TREATMENT|2020-09-11|2020-10-17|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|2|PD1S|Soluble Programmed Death-1|HEMATOLOGY|||[?]|[?]|TRACE|1|dpm/mg|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|PARAFFIN-EMBEDDED||IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|||U|Y|1|Visit_1|10|1|TREATMENT|2020-09-11|2020-10-31|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|3|SICAM1|Soluble Intercell Adhesion Molecule 1|HEMATOLOGY|[?]|breaths/min|[?]|[?]|INVALID|1|%/s|1|1|[?]|ABNORMAL|SWABBED MATERIAL|THAWED||KINETIC MICROPARTICLE IMMUNOASSAY|NASH FIBROSURE FORMULA|||NA||2|Visit_2|25|5|SCREENING|2020-09-26|2020-11-29|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|4|PICP|Procollagen Type I Carboxy Term Peptide|URINALYSIS|[?]|10^6 IU|[?]|[?]|NEGATIVE|1|CAPLET|1|1|[?]|ABNORMAL|MECONIUM|CONCENTRATED|N|TOTAL BODY RADIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||U||2|Visit_2|25|1|TREATMENT|2020-09-26|2020-10-15|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|5|PRO|Proline|CHEMISTRY|[?]|mV/sec|[?]|[?]|BORDERLINE|1|1/(s*kPa)|1|1|[?]|LOW|SPUTUM|HEMOLYZED||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|ASH FIBROSURE FORMULA|||U||3|Visit_3|40|5|SCREENING|2020-10-11|2020-11-02|40|62|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|6|ESELECT|E-Selectin|CHEMISTRY|[?]|U.CARR|[?]|[?]|INDETERMINATE|1|EID 50/dose|1|1|[?]|HIGH|LAVAGE FLUID|LACTESCENT||AUTOREFRACTION|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|4|WASHOUT|2020-10-11|2020-12-02|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|LB|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|7|PSIGAAB|Phosphatidylserine IgA Antibody|HEMATOLOGY|[?]|ug/g/h|[?]|[?]|NEGATIVE|1|GLOBULE|1|1|[?]|ABNORMAL|NAIL|SOLIDIFIED||MAGNETIC RESONANCE ENTEROGRAPHY|MDRD 5 VARIABLE FORMULA|Y||Y||4|Visit_4|65|1|WASHOUT|2020-11-05|2020-11-18|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|8|BLASTERY|Basophilic Erythroblast|URINALYSIS|[?]|mol|[?]|[?]|INVALID|1|GPS U|1|1|[?]|HIGH|PROSTATIC FLUID|REFRIGERATED|N|AUTOMATED COUNT|FIBROSIS 4 FORMULA|Y||Y||4|Visit_4|65|3|SCREENING|2020-11-05|2020-11-27|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|9|GHRELIN|Ghrelin|HEMATOLOGY|[?]|pptr|[?]|[?]|TRACE|1|mmol2/L2|1|1|[?]|NORMAL|GASTRIC FLUID|CALCIFIED||ELISA|ASH FIBROSURE FORMULA||Y|Y||5|Visit_5|90|3|TREATMENT|2020-11-30|2020-12-07|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|10|FATACFR|Free Fatty Acid|HEMATOLOGY|[?]|Ci/mg|[?]|[?]|INVALID|1|U/m2/day|1|1|[?]|NORMAL|TISSUE|CONCENTRATED||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2020-11-30|2020-12-06|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|81e934f8-7bcc-48d2-8d15-5270e51f2870|1|NEUTLS|Left Shift Neutrophils|URINALYSIS|[?]|DIP|[?]|[?]|NEGATIVE|1|10^8/L|1|1|[?]|ABNORMAL|BUFFY COAT|ICTERIC||CONTACT SPECULAR MICROSCOPY|CKD-EPI CREATININE FORMULA||Y|U||1|Visit_1|10|1|TREATMENT|2021-01-24|2021-03-09|10|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|LB|81e934f8-7bcc-48d2-8d15-5270e51f2870|2|LEU|Leucine|CHEMISTRY|[?]|cm2|[?]|[?]|BORDERLINE|1|dpm/100mg|1|1|[?]|NORMAL|URINE|CALCIFIED|N|IMMUNOBLOT|FIBROSIS 4 FORMULA||Y|Y||1|Visit_1|10|7|TREATMENT|2021-01-24|2021-03-21|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|LB|81e934f8-7bcc-48d2-8d15-5270e51f2870|3|SPMPSPM|Spermatozoa, Progressive/Spermatozoa|URINALYSIS|||[?]|[?]|NEGATIVE|1|um/day|1|1|[?]|HIGH|CALCULUS|REFRIGERATED||KINETIC MICROPARTICLE IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA|Y|2|Visit_2|25|1|TREATMENT|2021-02-08|2021-02-20|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|81e934f8-7bcc-48d2-8d15-5270e51f2870|4|C147280|Cow Milk Protein Antigen IgE Antibody|CHEMISTRY|[?]|Torr|[?]|[?]|TRACE|1|vp/mL|1|1|[?]|ABNORMAL|SPUTUM|LACTESCENT||ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD 6 VARIABLE FORMULA|||N||2|Visit_2|25|6|TREATMENT|2021-02-08|2021-04-23|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|81e934f8-7bcc-48d2-8d15-5270e51f2870|5|C130101|Tree Mix Pollen Antigen IgE Antibody|HEMATOLOGY|[?]|cal|[?]|[?]|TRACE|1|10^8/L|1|1|[?]|LOW|MENSTRUAL BLOOD|THAWED|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI MMOL/MOL FORMULA|Y||U||3|Visit_3|40|4|FOLLOW-UP|2021-02-23|2021-04-19|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|81e934f8-7bcc-48d2-8d15-5270e51f2870|6|C130090|Timothy Grass Pollen IgG|HEMATOLOGY|[?]|eq|[?]|[?]|NEGATIVE|1|g/g/day|1|1|[?]|ABNORMAL|RETICULOCYTES|HEMOLYZED||DISK DIFFUSION|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|3|WASHOUT|2021-02-23|2021-04-03|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|LB|81e934f8-7bcc-48d2-8d15-5270e51f2870|7|SMDGCELE|Smudge Cells/Leukocytes|CHEMISTRY|[?]|pkat|[?]|[?]|INDETERMINATE|1|CCID 50/mL|1|1|[?]|ABNORMAL|EXUDATE|GELLED||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|GMI % FORMULA||Y|Y||4|Visit_4|65|7|TREATMENT|2021-03-20|2021-04-06|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|LB|81e934f8-7bcc-48d2-8d15-5270e51f2870|8|LDH2|LDH Isoenzyme 2|URINALYSIS|[?]|/10^3|[?]|[?]|INDETERMINATE|1|ms2|1|1|[?]|LOW|LYMPH|CONTAMINATED||SPIRAL CT|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-03-20|2021-04-09|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|LB|81e934f8-7bcc-48d2-8d15-5270e51f2870|9|LDH5|LDH Isoenzyme 5|URINALYSIS|[?]|TUBE|[?]|[?]|POSITIVE|1|mL/m2|1|1|[?]|LOW|PERITONEAL FLUID|SOLIDIFIED|N|URANYL ACETATE STAIN|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2021-04-14|2021-04-19|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|81e934f8-7bcc-48d2-8d15-5270e51f2870|10|CYDCPHOS|Dicalcium Phosphate Crystals|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mAnson U/mL|1|1|[?]|ABNORMAL|SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR||ETDRS EYE CHART|MDRD FORMULA||Y|Y|Y|5|Visit_5|90|6|SCREENING|2021-04-14|2021-04-21|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|LB|5713cabe-4d79-4f77-8ddc-daad1242a837|1|IAA5OHCR|5-Hydroxyindoleacetic Acid/Creatinine|HEMATOLOGY|[?]|mU/L|[?]|[?]|POSITIVE|1|uOsm|1|1|[?]|HIGH|LAVAGE FLUID|HEMOLYZED||SPIRAL CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U||1|Visit_1|10|7|TREATMENT|2020-09-09|2020-11-08|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|5713cabe-4d79-4f77-8ddc-daad1242a837|2|TESTOSFR|Testosterone, Free|HEMATOLOGY|[?]|MBP|[?]|[?]|NEGATIVE|1|Newton|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|CONCENTRATED|N|HIGH RESOLUTION MELT ANALYSIS|ASH FIBROSURE FORMULA|Y||N||1|Visit_1|10|6|FOLLOW-UP|2020-09-09|2020-11-26|10|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|LB|5713cabe-4d79-4f77-8ddc-daad1242a837|3|PAH|P-Aminohippurate Sodium|CHEMISTRY|[?]|L|[?]|[?]|INVALID|1|Linear ft*LB|1|1|[?]|ABNORMAL|MUCUS|DRIED||CALCOFLUOR WHITE STAIN|MDRD 4 VARIABLE FORMULA|Y||U||2|Visit_2|25|7|SCREENING|2020-09-24|2020-11-16|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|5713cabe-4d79-4f77-8ddc-daad1242a837|4|C165930|Shellfish Mix IgE AB RAST Score|CHEMISTRY|[?]|cm|[?]|[?]|INVALID|1|mEq/kg|1|1|[?]|HIGH|SALIVA|HEMOLYZED|N|PHASE CONTRAST MICROSCOPY|NASH FIBROSURE FORMULA|Y||U||2|Visit_2|25|3|FOLLOW-UP|2020-09-24|2020-10-20|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|5713cabe-4d79-4f77-8ddc-daad1242a837|5|THMBAAC|Thrombin Activity Actual/Control|HEMATOLOGY|[?]|vg/kg|[?]|[?]|INDETERMINATE|1|mU/g|1|1|[?]|HIGH|STOOL|CONCENTRATED||POLYSOMNOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|3|WASHOUT|2020-10-09|2020-11-25|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|LB|5713cabe-4d79-4f77-8ddc-daad1242a837|6|DNA|Deoxyribonucleic Acid|HEMATOLOGY|[?]|FINGERTIP UNIT|[?]|[?]|BORDERLINE|1|kBq/uL|1|1|[?]|LOW|ERYTHROCYTES|LIPEMIC||IMMUNOASSAY|GMI % FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2020-10-09|2020-11-27|40|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|LB|5713cabe-4d79-4f77-8ddc-daad1242a837|7|HYPGST17|17-Hydroxyprogesterone|CHEMISTRY|[?]|Absorbance U/min|[?]|[?]|TRACE|1|umol/min|1|1|[?]|LOW|ENDOTRACHEAL FLUID|THAWED||DYNAMIC CONTRAST ENHANCED MRI|MDRD FORMULA|||Y||4|Visit_4|65|4|FOLLOW-UP|2020-11-03|2020-11-29|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|5713cabe-4d79-4f77-8ddc-daad1242a837|8|ALPLS|Liver Specific Alkaline Phosphatase|URINALYSIS|[?]|10^6/hpf|[?]|[?]|POSITIVE|1|m3|1|1|[?]|HIGH|CAPILLARY PLASMA|NON-HEMOLYZED|N|DIFFUSION TENSOR MRI|COCKCROFT-GAULT FORMULA|||Y||4|Visit_4|65|5|TREATMENT|2020-11-03|2020-11-26|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|5713cabe-4d79-4f77-8ddc-daad1242a837|9|PROTEXR|Protein Excretion Rate|CHEMISTRY|[?]|Ci/mg|[?]|[?]|INDETERMINATE|1|10^6 organisms/mg|1|1|[?]|HIGH|RETICULOCYTES|AGGLUTINATED||TARGETED GENOME SEQUENCING|MDRD ENZYMATIC FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-11-28|2020-11-30|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|5713cabe-4d79-4f77-8ddc-daad1242a837|10|CELLULAR|Cellularity|HEMATOLOGY|[?]|V/sec|[?]|[?]|TRACE|1|nL|1|1|[?]|NORMAL|BUFFY COAT|ICTERIC||REBOUND TONOMETRY|MDRD 6 VARIABLE FORMULA|||U||5|Visit_5|90|5|TREATMENT|2020-11-28|2020-12-06|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|414d20c7-8dc8-49ad-8ae9-f113b9610109|1|DZPM|Diazepam|URINALYSIS|[?]|/sec|[?]|[?]|NEGATIVE|1|%(v/v)|1|1|[?]|HIGH|SERUM OR PLASMA|FROZEN||IN SITU HYBRIDIZATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||1|Visit_1|10|1|TREATMENT|2020-07-10|2020-09-05|10|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|414d20c7-8dc8-49ad-8ae9-f113b9610109|2|CSFIGIDX|CSF IgG Index|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ukat/L|1|1|[?]|LOW|GASTRIC CONTENTS|PARAFFIN-EMBEDDED||LASER CAPTURE MICRODISSECTION|GMI % FORMULA|Y||NA|Y|1|Visit_1|10|7|SCREENING|2020-07-10|2020-10-07|10|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|LB|414d20c7-8dc8-49ad-8ae9-f113b9610109|3|SMDGCELE|Smudge Cells/Leukocytes|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|ug/kg/day|1|1|[?]|HIGH|STOOL|REFRIGERATED||MICROBIAL CULTURE, SOLID|GMI % FORMULA|||Y|Y|2|Visit_2|25|4|FOLLOW-UP|2020-07-25|2020-08-06|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|414d20c7-8dc8-49ad-8ae9-f113b9610109|4|VLDLPSZ|VLDL Particle Size|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|cmH2O*s2/mL|1|1|[?]|HIGH|SEBUM|ICTERIC||ANGIOGRAPHY|GMI MMOL/MOL FORMULA|Y||U|Y|2|Visit_2|25|4|TREATMENT|2020-07-25|2020-08-04|25|35|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|LB|414d20c7-8dc8-49ad-8ae9-f113b9610109|5|C165936|Glycine max IgE AB RAST Score|URINALYSIS|[?]|Bq/mL|[?]|[?]|TRACE|1|pt_br|1|1|[?]|LOW|LOCHIA|THAWED||LEAD CITRATE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||3|Visit_3|40|6|TREATMENT|2020-08-09|2020-09-22|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|414d20c7-8dc8-49ad-8ae9-f113b9610109|6|OSMLTY|Osmolality|HEMATOLOGY|[?]|BP|[?]|[?]|INVALID|1|sec|1|1|[?]|HIGH|INTERSTITIAL FLUID|NON-HEMOLYZED||PELLI-ROBSON EYE CHART|MDRD FORMULA|||N||3|Visit_3|40|3|FOLLOW-UP|2020-08-09|2020-08-10|40|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|414d20c7-8dc8-49ad-8ae9-f113b9610109|7|DKK1|Dickkopf WNT Signaling Path Inhibitor 1|CHEMISTRY|[?]|CCID 50/mL|[?]|[?]|INVALID|1|/500 WBC|1|1|[?]|ABNORMAL|DISCHARGE|GELLED||DOPPLER ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|6|WASHOUT|2020-09-03|2020-09-12|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|414d20c7-8dc8-49ad-8ae9-f113b9610109|8|SCHISTO|Schistocytes|CHEMISTRY|[?]|APL U|[?]|[?]|INDETERMINATE|1|cd|1|1|[?]|LOW|SEMEN|CLOTTED||CALCULATION|FIBROSIS 4 FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-09-03|2020-09-22|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|414d20c7-8dc8-49ad-8ae9-f113b9610109|9|VITB17|Vitamin B17|URINALYSIS|[?]|10^3 DNA copies/mL|[?]|[?]|POSITIVE|1|lx|1|1|[?]|LOW|DIALYSIS FLUID|THAWED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA|||N||5|Visit_5|90|6|SCREENING|2020-09-28|2020-10-01|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|414d20c7-8dc8-49ad-8ae9-f113b9610109|10|BASOMM|Basophilic Metamyelocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mol/mL|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|CALCIFIED||COMPLEMENT FIXATION|ASH FIBROSURE FORMULA|Y||U|Y|5|Visit_5|90|6|TREATMENT|2020-09-28|2020-09-30|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|21e16094-23bd-4d20-b5f8-10d45858160e|1|INTLK12B|Interleukin 12 Beta|URINALYSIS|[?]|Gravitational Unit|[?]|[?]|BORDERLINE|1|umol/L/h|1|1|[?]|ABNORMAL|LEUKOCYTE|PARAFFIN-EMBEDDED||PHASE-CONTRAST MRI|GMI % FORMULA||Y|U||1|Visit_1|10|5|SCREENING|2020-09-17|2020-11-27|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|21e16094-23bd-4d20-b5f8-10d45858160e|2|CACREAT|Calcium/Creatinine|URINALYSIS|[?]|psi|[?]|[?]|INVALID|1|STEPS|1|1|[?]|LOW|EMESIS|LIPEMIC||TELLER ACUITY CARDS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|5|WASHOUT|2020-09-17|2020-09-28|10|21|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|21e16094-23bd-4d20-b5f8-10d45858160e|3|DENSITY|Density|HEMATOLOGY|[?]|/ms|[?]|[?]|INDETERMINATE|1|kIU|1|1|[?]|LOW|PLATELET RICH PLASMA|CLOTTED||CLIP SEQUENCING|CKD-EPI CREATININE FORMULA|Y||Y||2|Visit_2|25|2|TREATMENT|2020-10-02|2020-10-31|25|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|21e16094-23bd-4d20-b5f8-10d45858160e|4|HBCOHGB|Carboxyhemoglobin/Total Hemoglobin|URINALYSIS|[?]|DAYS|[?]|[?]|TRACE|1|ug/L FEU|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|CONTAMINATED|N|STRESS ECHOCARDIOGRAPHY|MDRD FORMULA|Y||U||2|Visit_2|25|6|TREATMENT|2020-10-02|2020-12-13|25|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|LB|21e16094-23bd-4d20-b5f8-10d45858160e|5|PGAG|Platelet-Granulocyte Agg|HEMATOLOGY|[?]|mL/cage|[?]|[?]|INDETERMINATE|1|10^5/L|1|1|[?]|ABNORMAL|VENOUS PLASMA|AUTOLYZED|N|CHROMATOGRAPHY|FIBROMETER FORMULA||Y|NA||3|Visit_3|40|6|WASHOUT|2020-10-17|2020-11-07|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|21e16094-23bd-4d20-b5f8-10d45858160e|6|BLYCELY|B-Lymphocytes/Lymphocytes|HEMATOLOGY|[?]|Bq/ug|[?]|[?]|INVALID|1|cal|1|1|[?]|LOW|PLATELET RICH PLASMA|CONCENTRATED||CT SCAN|FIBROMETER FORMULA|||U||3|Visit_3|40|7|FOLLOW-UP|2020-10-17|2020-11-22|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|21e16094-23bd-4d20-b5f8-10d45858160e|7|LIPASET|Lipase|URINALYSIS|[?]|10^3 organisms|[?]|[?]|BORDERLINE|1|ug/L FEU|1|1|[?]|NORMAL|URINE SEDIMENT|ROOM TEMPERATURE||DYNAMOMETRY|MDRD 4 VARIABLE FORMULA|||U||4|Visit_4|65|6|FOLLOW-UP|2020-11-11|2020-11-20|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|21e16094-23bd-4d20-b5f8-10d45858160e|8|C165907|Mold Mix IgG AB RAST Score|CHEMISTRY|[?]|U/mg|[?]|[?]|INVALID|1|Shock Wave|1|1|[?]|HIGH|MUCUS|CONCENTRATED||MAMMOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||4|Visit_4|65|3|SCREENING|2020-11-11|2020-11-19|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|LB|21e16094-23bd-4d20-b5f8-10d45858160e|9|RFIGMAB|Rheumatoid Factor IgM Antibody|HEMATOLOGY|||[?]|[?]|TRACE|1|ft3|1|1|[?]|NORMAL|SOFT TISSUE|FROZEN||DIGITAL PCR|MDRD 4 VARIABLE FORMULA|||U|Y|5|Visit_5|90|6|SCREENING|2020-12-06|2020-12-11|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|21e16094-23bd-4d20-b5f8-10d45858160e|10|HLAIIAB|HLA Class II Antibody|URINALYSIS|||[?]|[?]|BORDERLINE|1|POINT|1|1|[?]|ABNORMAL|GASTRIC FLUID|REFRIGERATED||SIZE EXCLUSION CHROMATOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|5|Visit_5|90|4|TREATMENT|2020-12-06|2020-12-07|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|2346613e-6734-476a-a414-511606c2d753|1|GFRBSCUA|GFR from Creat,UreaN,Alb Adj BSA|HEMATOLOGY|[?]|PACKET|[?]|[?]|BORDERLINE|1|ug/mol|1|1|[?]|LOW|BILE|CALCIFIED||FLOW MICROSCOPY|FIBROMETER FORMULA|Y||Y||1|Visit_1|10|3|WASHOUT|2020-09-22|2020-12-14|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|2346613e-6734-476a-a414-511606c2d753|2|RBCGHOST|Erythrocyte Ghosts|HEMATOLOGY|[?]|mg/m2/day|[?]|[?]|INVALID|1|pkat|1|1|[?]|HIGH|DISCHARGE|CONCENTRATED||ULTRASOUND|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|5|WASHOUT|2020-09-22|2020-09-25|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|2346613e-6734-476a-a414-511606c2d753|3|IA2AB|Insulinoma-Associated Protein 2 Antibody|URINALYSIS|[?]|CARTRIDGE|[?]|[?]|INVALID|1|mEq/ug|1|1|[?]|LOW|ABSCESS FLUID|GELLED||ENZYMATIC SPECTROPHOTOMETRY|COCKCROFT-GAULT FORMULA|||NA||2|Visit_2|25|2|WASHOUT|2020-10-07|2020-12-18|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|2346613e-6734-476a-a414-511606c2d753|4|TOXGRAN|Toxic Granulation|URINALYSIS|[?]|EID 50/mL|[?]|[?]|INDETERMINATE|1|kV|1|1|[?]|HIGH|CERUMEN|FROZEN|N|APPLANATION TONOMETRY|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2020-10-07|2020-10-14|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|LB|2346613e-6734-476a-a414-511606c2d753|5|GLY|Glycine|URINALYSIS|[?]|EU|[?]|[?]|INDETERMINATE|1|pmol/dL|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|CALCIFIED||NUCLEAR RADIOLOGY|FIBROMETER FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-10-22|2020-11-17|40|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|LB|2346613e-6734-476a-a414-511606c2d753|6|HGF|Hepatocyte Growth Factor|CHEMISTRY|[?]|mmHg/L/min|[?]|[?]|INVALID|1|10^7 CFU/mL|1|1|[?]|LOW|SUPERNATANT, PLASMA|GELLED||RADIOIMMUNOPRECIPITATION ASSAY|NASH FIBROSURE FORMULA||Y|Y||3|Visit_3|40|3|TREATMENT|2020-10-22|2020-11-16|40|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|LB|2346613e-6734-476a-a414-511606c2d753|7|PHOSCLR|Phosphate Clearance|URINALYSIS|[?]|PACKAGE|[?]|[?]|BORDERLINE|1|STEPS|1|1|[?]|HIGH|LEUKOCYTE|CALCIFIED||CLAUSS METHOD|FIBROSIS 4 FORMULA||Y|NA||4|Visit_4|65|3|TREATMENT|2020-11-16|2020-12-12|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|2346613e-6734-476a-a414-511606c2d753|8|UREANCRT|Urea Nitrogen/Creatinine|HEMATOLOGY|[?]|mL/g/min|[?]|[?]|POSITIVE|1|Bq|1|1|[?]|HIGH|PLATELET POOR PLASMA|HEMOLYZED||CELLULAR PROLIFERATION ASSAY|CKD-EPI CYSTATIN C FORMULA|||N||4|Visit_4|65|2|FOLLOW-UP|2020-11-16|2020-11-30|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|LB|2346613e-6734-476a-a414-511606c2d753|9|FLUVOXAM|Fluvoxamine|CHEMISTRY|[?]|log10 CFU/g|[?]|[?]|INVALID|1|nkat/g Hb|1|1|[?]|LOW|CAPILLARY PLASMA|SOLIDIFIED||WRIGHT-GIEMSA STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|NA||5|Visit_5|90|2|TREATMENT|2020-12-11|2020-12-18|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|2346613e-6734-476a-a414-511606c2d753|10|DIHYDCDN|Dihydrocodeine|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|nL|1|1|[?]|LOW|INTERSTITIAL FLUID|CONCENTRATED|N|BETA LACTAMASE|ASH FIBROSURE FORMULA|||Y|Y|5|Visit_5|90|3|SCREENING|2020-12-11|2020-12-14|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|6a8bda83-1b5a-481e-af4f-77fe74bc37be|1|THR|Threonine|URINALYSIS|[?]|APL U/mL|[?]|[?]|POSITIVE|1|BOTTLE|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|LACTESCENT||RYAN BLUE STAIN|MDRD 4 VARIABLE FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-11-26|2020-12-11|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|6a8bda83-1b5a-481e-af4f-77fe74bc37be|2|ERCEMPOL|Erythroid Maturation Pool|CHEMISTRY|[?]|10^6 copies/mL|[?]|[?]|BORDERLINE|1|pptr|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|SOLIDIFIED|N|PERFUSION MRI|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U||1|Visit_1|10|4|TREATMENT|2020-11-26|2021-01-19|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|LB|6a8bda83-1b5a-481e-af4f-77fe74bc37be|3|IGF1|Insulin-like Growth Factor-1|CHEMISTRY|[?]|mg/cm2|[?]|[?]|BORDERLINE|1|dyn|1|1|[?]|LOW|PLATELET POOR PLASMA|GELLED||X-RAY|HEPASCORE FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-12-11|2021-01-03|25|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|6a8bda83-1b5a-481e-af4f-77fe74bc37be|4|FCTVIIAA|Factor VIIa Activity|URINALYSIS|[?]|cd/m2|[?]|[?]|TRACE|1|%(w/w)|1|1|[?]|ABNORMAL|BASAL TEAR|CLOTTED||IN SITU HYBRIDIZATION|FIBROTEST FORMULA|||NA||2|Visit_2|25|4|SCREENING|2020-12-11|2021-02-01|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|LB|6a8bda83-1b5a-481e-af4f-77fe74bc37be|5|LIPASEG|Lipase, Gastric|URINALYSIS|[?]|Sv|[?]|[?]|BORDERLINE|1|mU|1|1|[?]|LOW|DIALYSIS FLUID|AGGLUTINATED|N|NEURAMINIDASE INHIBITION ASSAY|MDRD 4 VARIABLE FORMULA||Y|U||3|Visit_3|40|1|FOLLOW-UP|2020-12-26|2021-01-23|40|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|6a8bda83-1b5a-481e-af4f-77fe74bc37be|6|V25HD2|25-Hydroxyvitamin D2|URINALYSIS|[?]|umol/L/min|[?]|[?]|POSITIVE|1|log10 copies/mL|1|1|[?]|HIGH|HAIR FOLLICLE|NON-HEMOLYZED|N|CELL BASED BIOASSAY|FIBROSIS 4 FORMULA|Y||U||3|Visit_3|40|2|WASHOUT|2020-12-26|2021-02-07|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|LB|6a8bda83-1b5a-481e-af4f-77fe74bc37be|7|ABNCELE|Abnormal Cells/Leukocytes|CHEMISTRY|[?]|mg/min|[?]|[?]|INDETERMINATE|1|dpm/0.5 mL|1|1|[?]|NORMAL|PLATELET|AGGLUTINATED||AUDIOMETRY|FIBROMETER FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-01-20|2021-01-29|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|6a8bda83-1b5a-481e-af4f-77fe74bc37be|8|HDLPSZ|HDL Particle Size|HEMATOLOGY|[?]|10^6 U|[?]|[?]|BORDERLINE|1|MET*h|1|1|[?]|LOW|CAPILLARY BLOOD|ICTERIC||ANALYTICAL ULTRACENTRIFUGATION|FIBROMETER FORMULA|||U||4|Visit_4|65|2|TREATMENT|2021-01-20|2021-01-29|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|6a8bda83-1b5a-481e-af4f-77fe74bc37be|9|NAGASEXR|NAGASE Excretion Rate|URINALYSIS|[?]|mg/L FEU|[?]|[?]|NEGATIVE|1|ng/day|1|1|[?]|HIGH|EMOTIONAL TEAR|FROZEN||TRYPAN BLUE STAIN|MDRD FORMULA||Y|N||5|Visit_5|90|5|FOLLOW-UP|2021-02-14|2021-02-15|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|6a8bda83-1b5a-481e-af4f-77fe74bc37be|10|CX3CL1|Chemokine (C-X3-C Motif) Ligand 1|URINALYSIS|[?]|mEq/g|[?]|[?]|INVALID|1|100 IU/mL|1|1|[?]|HIGH|VITREOUS HUMOR|GELLED||PHOTOGRAPHY|MDRD FORMULA|Y||N||5|Visit_5|90|1|SCREENING|2021-02-14|2021-02-23|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|LB|748ef401-3def-4674-8d5e-4a198709d672|1|BLAST|Blasts|HEMATOLOGY|||[?]|[?]|POSITIVE|1|deg/mm|1|1|[?]|NORMAL|INFRANATANT, PLASMA|FRESH||DOUBLE IMMUNODIFFUSION|CKD-EPI CREATININE FORMULA|||N|Y|1|Visit_1|10|3|SCREENING|2020-06-08|2020-07-08|10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-01
e|LB|748ef401-3def-4674-8d5e-4a198709d672|2|ADMA|Asymmetric Dimethylarginine|URINALYSIS|||[?]|[?]|INDETERMINATE|1|MBq|1|1|[?]|ABNORMAL|REFLEX TEAR|FRESH||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|1|Visit_1|10|5|SCREENING|2020-06-08|2020-08-29|10|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-01
e|LB|748ef401-3def-4674-8d5e-4a198709d672|3|AMABARAB|ACH Receptor Modulatn Ab/ACH Receptor Ab|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|EVENTS|1|1|[?]|NORMAL|BLOOD|CLOTTED||PET/CT SCAN|FIBROSIS 4 FORMULA|||Y|Y|2|Visit_2|25|6|SCREENING|2020-06-23|2020-07-24|25|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|748ef401-3def-4674-8d5e-4a198709d672|4|C165903|Western Ragweed Pollen IgG AB RAST Score|CHEMISTRY|||[?]|[?]|POSITIVE|1|mol|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|SOLIDIFIED|N|DIGITAL PCR|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|2|Visit_2|25|6|SCREENING|2020-06-23|2020-08-21|25|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|748ef401-3def-4674-8d5e-4a198709d672|5|GRANIMLE|Immature Granulocytes/Leukocytes|CHEMISTRY|[?]|um/s|[?]|[?]|INVALID|1|cm2|1|1|[?]|LOW|SERUM|FRESH|N|SLOAN LETTER EYE CHART 2.5%|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|5|WASHOUT|2020-07-08|2020-08-24|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|748ef401-3def-4674-8d5e-4a198709d672|6|PHOSCRT|Phosphate/Creatinine|CHEMISTRY|||[?]|[?]|NEGATIVE|1|LOZENGE|1|1|[?]|LOW|CERUMEN|AUTOLYZED||HEMAGGLUTINATION ASSAY|MDRD FORMULA|||N|Y|3|Visit_3|40|4|FOLLOW-UP|2020-07-08|2020-07-26|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|748ef401-3def-4674-8d5e-4a198709d672|7|HGBDHGB|Hemoglobin D/Total Hemoglobin|CHEMISTRY|[?]|Enzyme U|[?]|[?]|INDETERMINATE|1|L/h|1|1|[?]|HIGH|EPITHELIAL CELL|UNEXPECTED ODOR|N|VENTILATION PERFUSION LUNG SCAN|CKD-EPI CYSTATIN C FORMULA||Y|U||4|Visit_4|65|7|TREATMENT|2020-08-02|2020-08-16|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|748ef401-3def-4674-8d5e-4a198709d672|8|CAMP|Cyclic Adenosine 3,5-Monophosphate|CHEMISTRY|[?]|log10 TCID 50/mL|[?]|[?]|TRACE|1|uEq|1|1|[?]|LOW|ADIPOSE TISSUE|THAWED||INTERRUPTER TECHNIQUE|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||4|Visit_4|65|4|WASHOUT|2020-08-02|2020-08-24|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|748ef401-3def-4674-8d5e-4a198709d672|9|ALBCREAT|Albumin/Creatinine|URINALYSIS|[?]|1/(s*kPa)|[?]|[?]|NEGATIVE|1|mL/cm3/min|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH||IN SITU HYBRIDIZATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||5|Visit_5|90|5|FOLLOW-UP|2020-08-27|2020-09-05|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|LB|748ef401-3def-4674-8d5e-4a198709d672|10|CD1|CD1|URINALYSIS|[?]|in|[?]|[?]|NEGATIVE|1|10^9 organisms/g|1|1|[?]|ABNORMAL|SERUM|HEMOLYZED||IVY INCISION METHOD|MDRD 4 VARIABLE FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2020-08-27|2020-08-29|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|LB|03c399c1-77b9-4879-a6e8-42ba58ca68d4|1|INTLK31|Interleukin 31|URINALYSIS|||[?]|[?]|INVALID|1|PFU/dose|1|1|[?]|NORMAL|SEMEN|UNEXPECTED ODOR|N|MEDIASTINOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N|Y|1|Visit_1|10|4|FOLLOW-UP|2020-07-15|2020-08-08|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|03c399c1-77b9-4879-a6e8-42ba58ca68d4|2|HYPERCHR|Hyperchromia|URINALYSIS|||[?]|[?]|TRACE|1|oz|1|1|[?]|LOW|CERVICOVAGINAL SECRETION|NON-HEMOLYZED|N|SCINTIGRAPHY|FIBROTEST FORMULA|||N|Y|1|Visit_1|10|3|TREATMENT|2020-07-15|2020-09-11|10|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|LB|03c399c1-77b9-4879-a6e8-42ba58ca68d4|3|RPA1|Renal Papillary Antigen 1|HEMATOLOGY|[?]|/2500 WBC|[?]|[?]|BORDERLINE|1|U/kg/min|1|1|[?]|NORMAL|NAIL|THAWED|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-07-30|2020-09-20|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|03c399c1-77b9-4879-a6e8-42ba58ca68d4|4|IMMGLC|Immunoglobulin Light Chains|CHEMISTRY|[?]|Absorbance U/mL|[?]|[?]|INDETERMINATE|1|U/10^12 RBC|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|AGGLUTINATED||LASER CAPTURE MICRODISSECTION|MDRD 6 VARIABLE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-07-30|2020-10-08|25|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|03c399c1-77b9-4879-a6e8-42ba58ca68d4|5|LDLOXI|Oxidized LDL Cholesterol|HEMATOLOGY|[?]|uEq|[?]|[?]|POSITIVE|1|ft|1|1|[?]|NORMAL|SPUTUM|CALCIFIED|N|TONOMETRY|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-08-14|2020-10-12|40|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|03c399c1-77b9-4879-a6e8-42ba58ca68d4|6|ALTCPHRL|Alpha Tocopherol|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|pmol/10^10 cells|1|1|[?]|ABNORMAL|SMEGMA|UNEXPECTED ODOR||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA|||N|Y|3|Visit_3|40|5|SCREENING|2020-08-14|2020-09-08|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|LB|03c399c1-77b9-4879-a6e8-42ba58ca68d4|7|CA2729AG|Cancer Antigen 27-29|URINALYSIS|[?]|POINT|[?]|[?]|INDETERMINATE|1|ft|1|1|[?]|HIGH|TRANSUDATE|CONTAMINATED||LYMPHANGIOGRAPHY|MDRD FORMULA|||U||4|Visit_4|65|2|TREATMENT|2020-09-08|2020-09-11|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|03c399c1-77b9-4879-a6e8-42ba58ca68d4|8|INTLK5|Interleukin 5|URINALYSIS|||[?]|[?]|POSITIVE|1|DROP|1|1|[?]|NORMAL|PERITONEAL FLUID|GELLED|N|OPHTHALMOSCOPY|HEPASCORE FORMULA||Y|NA|Y|4|Visit_4|65|6|TREATMENT|2020-09-08|2020-09-13|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|03c399c1-77b9-4879-a6e8-42ba58ca68d4|9|CYCAPHOS|Calcium Phosphate Crystals|CHEMISTRY|[?]|s/h|[?]|[?]|INVALID|1|10^9/g|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|FRESH||QUANTITATIVE COMPUTED TOMOGRAPHY|HEPASCORE FORMULA||Y|Y||5|Visit_5|90|6|WASHOUT|2020-10-03|2020-10-12|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|03c399c1-77b9-4879-a6e8-42ba58ca68d4|10|PTSAC|Protein S Actual/Control|URINALYSIS|[?]|log10 IU/mL|[?]|[?]|POSITIVE|1|10^11/L|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|UNEXPECTED ODOR|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI FORMULA|||U||5|Visit_5|90|2|WASHOUT|2020-10-03|2020-10-08|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|b8afdaf1-5c4d-408f-b8ba-381461f15bde|1|OHF6B|6 Beta-Hydroxycortisol|HEMATOLOGY|[?]|GPL U|[?]|[?]|TRACE|1|10^7 CFU/mL|1|1|[?]|LOW|LYSATE|REFRIGERATED|N|ETDRS EYE CHART|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||1|Visit_1|10|6|TREATMENT|2020-11-13|2021-01-22|10|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|LB|b8afdaf1-5c4d-408f-b8ba-381461f15bde|2|C130128|Dog Dander Antigen IgE Antibody|CHEMISTRY|||[?]|[?]|TRACE|1|pg/cell|1|1|[?]|ABNORMAL|CELL PELLET|PARAFFIN-EMBEDDED||REFRACTOMETRY|GMI % FORMULA|||NA|Y|1|Visit_1|10|5|TREATMENT|2020-11-13|2020-12-22|10|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|LB|b8afdaf1-5c4d-408f-b8ba-381461f15bde|3|DRUGSCR|Drug Screen|CHEMISTRY|||[?]|[?]|NEGATIVE|1|copies/uL|1|1|[?]|HIGH|PERIPHERAL BLOOD MONONUCLEAR CELL|SOLIDIFIED||PLAQUE REDUCTION NEUTRALIZATION ASSAY|NASH FIBROSURE FORMULA|||N|Y|2|Visit_2|25|5|WASHOUT|2020-11-28|2020-12-06|25|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|b8afdaf1-5c4d-408f-b8ba-381461f15bde|4|C130120|Shellfish Mix Antigen IgE Antibody|HEMATOLOGY|[?]|mph|[?]|[?]|INVALID|1|MHz|1|1|[?]|NORMAL|MONOCYTE|GELLED||PERFUSION MRI|FIBROTEST FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-11-28|2021-01-23|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|b8afdaf1-5c4d-408f-b8ba-381461f15bde|5|CCL13|Chemokine (C-C Motif) Ligand 13|HEMATOLOGY|[?]|nmol/kg/day|[?]|[?]|INDETERMINATE|1|Tbsp|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|DRIED|N|ANALYTICAL ULTRACENTRIFUGATION|HEPASCORE FORMULA||Y|NA||3|Visit_3|40|3|FOLLOW-UP|2020-12-13|2020-12-20|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|b8afdaf1-5c4d-408f-b8ba-381461f15bde|6|MYCY|Myelocytes|URINALYSIS|[?]|DAgU|[?]|[?]|BORDERLINE|1|in|1|1|[?]|NORMAL|CORD BLOOD|CONCENTRATED||MAGNETIC RESONANCE ELASTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA||3|Visit_3|40|4|TREATMENT|2020-12-13|2021-01-06|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|b8afdaf1-5c4d-408f-b8ba-381461f15bde|7|AMACR|Alpha-Methylacyl Coenzyme A Racemase|URINALYSIS|[?]|NEEDLE GAUGE|[?]|[?]|POSITIVE|1|10^4/hpf|1|1|[?]|LOW|SUPERNATANT, SERUM|DRIED||HEMATOXYLIN AND EOSIN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|2|FOLLOW-UP|2021-01-07|2021-01-17|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|b8afdaf1-5c4d-408f-b8ba-381461f15bde|8|PLSIMCCE|Immature Plasma Cells/Total Cells|CHEMISTRY|||[?]|[?]|INVALID|1|mmol/min/kPa/L|1|1|[?]|ABNORMAL|SALIVA|FRESH||LIGHT SCATTERING SPECTROSCOPY|GMI MMOL/MOL FORMULA||Y|Y|Y|4|Visit_4|65|2|TREATMENT|2021-01-07|2021-02-07|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|b8afdaf1-5c4d-408f-b8ba-381461f15bde|9|INTLK13|Interleukin 13|CHEMISTRY|||[?]|[?]|POSITIVE|1|ngEq/L|1|1|[?]|ABNORMAL|SMEGMA|FRESH||RAJI CELL RIA|GMI % FORMULA|||NA|Y|5|Visit_5|90|2|SCREENING|2021-02-01|2021-02-04|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|b8afdaf1-5c4d-408f-b8ba-381461f15bde|10|INTLK12B|Interleukin 12 Beta|HEMATOLOGY|[?]|10^3 organisms/g|[?]|[?]|BORDERLINE|1|PELLET|1|1|[?]|NORMAL|VENOUS BLOOD|GELLED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA|Y||Y||5|Visit_5|90|1|WASHOUT|2021-02-01|2021-02-05|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|8115d6e8-0908-4491-a82a-08f43ccf1f0d|1|NFLP|Neurofilament Light Chain Protein|URINALYSIS|[?]|V|[?]|[?]|BORDERLINE|1|VIAL|1|1|[?]|HIGH|KERATINOCYTE|CONCENTRATED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|FIBROTEST FORMULA|||N||1|Visit_1|10|2|TREATMENT|2020-11-28|2020-12-13|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|8115d6e8-0908-4491-a82a-08f43ccf1f0d|2|DRVVTSCR|DRVVT Screen to Confirm Ratio|CHEMISTRY|||[?]|[?]|BORDERLINE|1|nmol BCE/nmol|1|1|[?]|ABNORMAL|BONE MARROW|THAWED||OPTICAL COHERENCE TOMOGRAPHY|MDRD 4 VARIABLE FORMULA|Y||Y|Y|1|Visit_1|10|2|TREATMENT|2020-11-28|2021-02-15|10|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|8115d6e8-0908-4491-a82a-08f43ccf1f0d|3|TLCHT|Taurolithocholate|CHEMISTRY|[?]|pkat/L|[?]|[?]|POSITIVE|1|10^6 IU/mL|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|ROOM TEMPERATURE||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|COCKCROFT-GAULT FORMULA|||U||2|Visit_2|25|1|TREATMENT|2020-12-13|2021-02-04|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|8115d6e8-0908-4491-a82a-08f43ccf1f0d|4|TXB2_D11|11-Dehydro-Thromboxane B2|URINALYSIS|[?]|CAPSULE|[?]|[?]|INVALID|1|10^6 DNA copies/mL|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|LIPEMIC||IMMUNORADIOMETRIC ASSAY|FIBROTEST FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-12-13|2021-02-21|25|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|8115d6e8-0908-4491-a82a-08f43ccf1f0d|5|CTXII|Type II Collagen C-Telopeptides|HEMATOLOGY|[?]|cs|[?]|[?]|INVALID|1|ug/g/day|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|PARAFFIN-EMBEDDED||IMMUNOCHROMATOGRAPHY|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-12-28|2021-01-12|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|8115d6e8-0908-4491-a82a-08f43ccf1f0d|6|MDA|3,4-methylenedioxyamphetamine|HEMATOLOGY|[?]|10^8 PFU|[?]|[?]|INDETERMINATE|1|log10 copies/mL|1|1|[?]|NORMAL|EPIDERMAL TISSUE|CONTAMINATED||SICKLE CELL SOLUBILITY TEST|FIBROMETER FORMULA|Y||Y||3|Visit_3|40|6|WASHOUT|2020-12-28|2021-02-22|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|LB|8115d6e8-0908-4491-a82a-08f43ccf1f0d|7|INSLNFR|Insulin, Free|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^6 RNA copies/mL|1|1|[?]|ABNORMAL|COLOSTRUM|HEMOLYZED||TRYPAN BLUE STAIN|MDRD 4 VARIABLE FORMULA|Y||N|Y|4|Visit_4|65|5|TREATMENT|2021-01-22|2021-02-05|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|8115d6e8-0908-4491-a82a-08f43ccf1f0d|8|CD33|CD33|URINALYSIS|[?]|OD Unit|[?]|[?]|BORDERLINE|1|pmol/L|1|1|[?]|HIGH|CORD SERUM|CONCENTRATED||IMMUNOASSAY|GMI % FORMULA|Y||U||4|Visit_4|65|6|FOLLOW-UP|2021-01-22|2021-01-30|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|8115d6e8-0908-4491-a82a-08f43ccf1f0d|9|INTLK12B|Interleukin 12 Beta|URINALYSIS|||[?]|[?]|TRACE|1|ug/L/h|1|1|[?]|NORMAL|INFRANATANT, PLASMA|CONTAMINATED||U-HPLC/MS/MS|HEPASCORE FORMULA|Y||Y|Y|5|Visit_5|90|3|TREATMENT|2021-02-16|2021-02-18|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|8115d6e8-0908-4491-a82a-08f43ccf1f0d|10|GLOBB1|Beta-1 Globulin|URINALYSIS|||[?]|[?]|TRACE|1|umol/h/mmol|1|1|[?]|LOW|TRANSUDATE|CONCENTRATED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|GMI MMOL/MOL FORMULA|||NA|Y|5|Visit_5|90|7|TREATMENT|2021-02-16|2021-02-25|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|fbd7ecb2-905f-40a9-babc-ebaf310cc372|1|IGGCALBC|IgG Clearance/Albumin Clearance|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|U/mg|1|1|[?]|HIGH|REFLEX TEAR|ROOM TEMPERATURE|N|JAFFE REACTION|ASH FIBROSURE FORMULA|||Y|Y|1|Visit_1|10|2|WASHOUT|2020-06-30|2020-08-31|10|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|LB|fbd7ecb2-905f-40a9-babc-ebaf310cc372|2|PO2FIO2|PP Arterial O2/Fraction Inspired O2|HEMATOLOGY|[?]|mg/kg/h|[?]|[?]|NEGATIVE|1|PHERESIS UNIT|1|1|[?]|LOW|CAPILLARY PLASMA|AUTOLYZED||HIGH RESOLUTION MELT ANALYSIS|MDRD FORMULA|Y||U||1|Visit_1|10|2|FOLLOW-UP|2020-06-30|2020-08-11|10|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|LB|fbd7ecb2-905f-40a9-babc-ebaf310cc372|3|LDH3LDH|LDH Isoenzyme 3/LDH|HEMATOLOGY|[?]|10^6 CFU/mL|[?]|[?]|POSITIVE|1|Bq/uL|1|1|[?]|LOW|EMESIS|THAWED||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD FORMULA|Y|Y|Y||2|Visit_2|25|5|SCREENING|2020-07-15|2020-08-29|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|fbd7ecb2-905f-40a9-babc-ebaf310cc372|4|CDT|Carbohydrate-Deficient Transferrin|CHEMISTRY|[?]|mmol2/L2|[?]|[?]|NEGATIVE|1|U|1|1|[?]|ABNORMAL|HAIR|SOLIDIFIED||HPLC/MS|CKD-EPI FORMULA|Y||NA||2|Visit_2|25|3|WASHOUT|2020-07-15|2020-08-21|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|fbd7ecb2-905f-40a9-babc-ebaf310cc372|5|THCCOOH|11-Nor-Delta9-THC-9-Carboxylic Acid|URINALYSIS|[?]|uCi/kg|[?]|[?]|INVALID|1|/VF|1|1|[?]|HIGH|URINE|DRIED||CHROMATOGRAPHY|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2020-07-30|2020-09-22|40|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|fbd7ecb2-905f-40a9-babc-ebaf310cc372|6|CSUNCLA|Unclassified Casts|HEMATOLOGY|[?]|NEBULE|[?]|[?]|NEGATIVE|1|grain|1|1|[?]|LOW|MONOCYTE|HEMOLYZED|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 5 VARIABLE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-07-30|2020-08-18|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|fbd7ecb2-905f-40a9-babc-ebaf310cc372|7|MACROBLD|Macroscopic Blood|CHEMISTRY|[?]|Sv|[?]|[?]|INVALID|1|dyn|1|1|[?]|HIGH|ISOLATE|CALCIFIED||MALDI-TOF|FIBROTEST FORMULA|||Y||4|Visit_4|65|6|WASHOUT|2020-08-24|2020-09-24|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|fbd7ecb2-905f-40a9-babc-ebaf310cc372|8|APLSMA2A|Alpha-2 Antiplasmin Activity|CHEMISTRY|[?]|JAR|[?]|[?]|INDETERMINATE|1|tsp eq|1|1|[?]|ABNORMAL|SALIVA|CONTAMINATED||PANENDOSCOPY|CKD-EPI CYSTATIN C FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2020-08-24|2020-09-16|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|LB|fbd7ecb2-905f-40a9-babc-ebaf310cc372|9|CODEINE|Codeine|HEMATOLOGY|[?]|mg/animal|[?]|[?]|NEGATIVE|1|10^3 CFU/g|1|1|[?]|LOW|WHITE MATTER TISSUE|FRESH||ELECTROPHORESIS|GMI % FORMULA||Y|U||5|Visit_5|90|2|SCREENING|2020-09-18|2020-09-26|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|LB|fbd7ecb2-905f-40a9-babc-ebaf310cc372|10|FIBRINO|Fibrinogen|URINALYSIS|[?]|PFU/dose|[?]|[?]|TRACE|1|STEPS|1|1|[?]|NORMAL|VITREOUS HUMOR|ICTERIC|N|SXA SCAN|FIBROMETER FORMULA|||N||5|Visit_5|90|2|SCREENING|2020-09-18|2020-09-25|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|LB|1a0e1a66-82dd-4945-9c9f-179fba9d781e|1|CD4|CD4|HEMATOLOGY|[?]|cup eq|[?]|[?]|INDETERMINATE|1|EU|1|1|[?]|LOW|BONE|NON-HEMOLYZED|N|RADIATION DOSIMETRY|MDRD 5 VARIABLE FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-12-09|2021-02-01|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|1a0e1a66-82dd-4945-9c9f-179fba9d781e|2|CTXII|Type II Collagen C-Telopeptides|CHEMISTRY|[?]|PACKAGE|[?]|[?]|BORDERLINE|1|ug/m2|1|1|[?]|LOW|REFLEX TEAR|ICTERIC||MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-12-09|2021-02-09|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|LB|1a0e1a66-82dd-4945-9c9f-179fba9d781e|3|KEXR|Potassium Excretion Rate|HEMATOLOGY|[?]|Watt|[?]|[?]|INVALID|1|uU/dL|1|1|[?]|LOW|BREAST MILK|ROOM TEMPERATURE||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|MDRD 6 VARIABLE FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-12-24|2021-01-06|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|1a0e1a66-82dd-4945-9c9f-179fba9d781e|4|FATDROP|Fat Droplet|HEMATOLOGY|[?]|nmol/L/h|[?]|[?]|NEGATIVE|1|g/cm2|1|1|[?]|NORMAL|SMEGMA|HEMOLYZED|N|TRICHROME STAIN|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|5|WASHOUT|2020-12-24|2021-02-19|25|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|1a0e1a66-82dd-4945-9c9f-179fba9d781e|5|GRANSGCE|Granulocytes Segmented/Total Cells|HEMATOLOGY|[?]|uV*sec|[?]|[?]|BORDERLINE|1|mL/m2/day|1|1|[?]|HIGH|SUPERNATANT, PLASMA|PARAFFIN-EMBEDDED||GIEMSA STAIN|HEPASCORE FORMULA|||U||3|Visit_3|40|4|TREATMENT|2021-01-08|2021-02-20|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|1a0e1a66-82dd-4945-9c9f-179fba9d781e|6|CA125AG|Cancer Antigen 125|HEMATOLOGY|[?]|ug/L DDU|[?]|[?]|BORDERLINE|1|anti-Xa IU/mL|1|1|[?]|NORMAL|BILE|THAWED||MICRODENSITOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||3|Visit_3|40|4|TREATMENT|2021-01-08|2021-01-31|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|1a0e1a66-82dd-4945-9c9f-179fba9d781e|7|GSTY1|Glutathione S-Transferase, Y1|HEMATOLOGY|[?]|cy/cm|[?]|[?]|INVALID|1|ppth|1|1|[?]|LOW|SERUM OR PLASMA|CLOTTED||SPECTROPHOTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2021-02-02|2021-02-14|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|1a0e1a66-82dd-4945-9c9f-179fba9d781e|8|VEGF|Vascular Endothelial Growth Factor|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|grain|1|1|[?]|LOW|LOCHIA|PARAFFIN-EMBEDDED|N|FLOW MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|4|Visit_4|65|3|TREATMENT|2021-02-02|2021-02-25|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|1a0e1a66-82dd-4945-9c9f-179fba9d781e|9|MYCYCE|Myelocytes/Total Cells|URINALYSIS|[?]|F|[?]|[?]|INVALID|1|10^11/L|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|DRIED|N|ACCELERATOR MASS SPECTROMETRY|FIBROSIS 4 FORMULA|||Y||5|Visit_5|90|6|FOLLOW-UP|2021-02-27|2021-03-08|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|1a0e1a66-82dd-4945-9c9f-179fba9d781e|10|TPRONP|Non-Phosphorylated Tau Protein|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mL/s/m2|1|1|[?]|NORMAL|ISOLATE|PARAFFIN-EMBEDDED||INTRAVASCULAR ULTRASOUND|GMI % FORMULA|||NA|Y|5|Visit_5|90|7|FOLLOW-UP|2021-02-27|2021-02-28|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|LB|b3ab1879-3dc7-41fa-be53-f4484af21fbd|1|NEUTMY|Neutrophilic Myelocytes|HEMATOLOGY|[?]|mL/m2|[?]|[?]|POSITIVE|1|10^7/L|1|1|[?]|HIGH|INTERSTITIAL FLUID|ROOM TEMPERATURE||VIRUS PLAQUE ASSAY|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|6|TREATMENT|2020-11-19|2020-12-04|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|b3ab1879-3dc7-41fa-be53-f4484af21fbd|2|MPM|Mean Platelet Dry Mass|HEMATOLOGY|[?]|mL/min/1.73m2|[?]|[?]|INDETERMINATE|1|kcal|1|1|[?]|HIGH|CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|N|INDIA INK STAIN|HEPASCORE FORMULA|Y||U||1|Visit_1|10|7|WASHOUT|2020-11-19|2020-12-31|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|b3ab1879-3dc7-41fa-be53-f4484af21fbd|3|FLUORIDE|Fluoride|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^3/hpf|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|UNEXPECTED ODOR||IVY INCISION METHOD|MDRD FORMULA|||U|Y|2|Visit_2|25|2|TREATMENT|2020-12-04|2021-02-13|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|b3ab1879-3dc7-41fa-be53-f4484af21fbd|4|MMP2|Matrix Metalloproteinase 2|CHEMISTRY|[?]|Gy/min|[?]|[?]|INDETERMINATE|1|10^3 organisms/mL|1|1|[?]|LOW|KERATINOCYTE|AUTOLYZED||ACCELERATOR MASS SPECTROMETRY|CKD-EPI FORMULA|||N||2|Visit_2|25|1|FOLLOW-UP|2020-12-04|2021-02-09|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|LB|b3ab1879-3dc7-41fa-be53-f4484af21fbd|5|EOSB|Eosinophils Band Form|URINALYSIS|[?]|L/h|[?]|[?]|INVALID|1|cm/s|1|1|[?]|ABNORMAL|ENDOTRACHEAL FLUID|REFRIGERATED||CT SCAN|CKD-EPI CYSTATIN C FORMULA|Y||Y||3|Visit_3|40|3|TREATMENT|2020-12-19|2021-01-22|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|b3ab1879-3dc7-41fa-be53-f4484af21fbd|6|SAMETH|S-Adenosylmethionine|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|titer|1|1|[?]|NORMAL|PROSTATIC FLUID|LIPEMIC||RADIOGRAPHY|CKD-EPI FORMULA|||Y|Y|3|Visit_3|40|1|FOLLOW-UP|2020-12-19|2021-01-26|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|b3ab1879-3dc7-41fa-be53-f4484af21fbd|7|BAFF|B-Cell Activating Factor|URINALYSIS|[?]|km|[?]|[?]|BORDERLINE|1|PACKAGE|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|AGGLUTINATED||GIEMSA STAIN|GMI MMOL/MOL FORMULA||Y|U||4|Visit_4|65|3|TREATMENT|2021-01-13|2021-01-14|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|b3ab1879-3dc7-41fa-be53-f4484af21fbd|8|CSFAT|Fatty Casts|CHEMISTRY|||[?]|[?]|POSITIVE|1|WEEKS|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|AUTOLYZED||ANALYTICAL ULTRACENTRIFUGATION|FIBROTEST FORMULA|Y||U|Y|4|Visit_4|65|5|TREATMENT|2021-01-13|2021-01-16|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|b3ab1879-3dc7-41fa-be53-f4484af21fbd|9|MEPRDN|Meperidine|HEMATOLOGY|[?]|log10 copies/mL|[?]|[?]|NEGATIVE|1|psec|1|1|[?]|HIGH|CAPILLARY PLASMA|UNEXPECTED ODOR||ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||5|Visit_5|90|3|TREATMENT|2021-02-07|2021-02-15|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|LB|b3ab1879-3dc7-41fa-be53-f4484af21fbd|10|ANTHRMA|Antithrombin Activity|HEMATOLOGY|[?]|L/h/m2|[?]|[?]|TRACE|1|BOTTLE|1|1|[?]|NORMAL|LEUKOCYTE|ROOM TEMPERATURE||NON-INVASIVE DIELECTRIC SENSING|CKD-EPI FORMULA|||NA||5|Visit_5|90|1|SCREENING|2021-02-07|2021-02-16|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|LB|bc71ddfa-c71c-447b-9684-005e4c112172|1|FCT8INH|Factor VIII Inhibitor|CHEMISTRY|[?]|mAmp|[?]|[?]|NEGATIVE|1|U|1|1|[?]|LOW|SUPERNATANT, PLASMA|LACTESCENT|N|PHASE-CONTRAST MRI|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-07-11|2020-07-31|10|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|bc71ddfa-c71c-447b-9684-005e4c112172|2|C165886|White Oak Pollen IgE AB RAST Score|HEMATOLOGY|[?]|IU/g Hb|[?]|[?]|TRACE|1|vp/dose|1|1|[?]|ABNORMAL|SEBUM|REFRIGERATED||CORONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|6|FOLLOW-UP|2020-07-11|2020-08-05|10|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|bc71ddfa-c71c-447b-9684-005e4c112172|3|RDWR|Ret Volume Distribution Width|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|umol/mol|1|1|[?]|LOW|EPITHELIAL CELL|REFRIGERATED||GC/MS|COCKCROFT-GAULT FORMULA|||Y|Y|2|Visit_2|25|1|TREATMENT|2020-07-26|2020-08-12|25|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|bc71ddfa-c71c-447b-9684-005e4c112172|4|NCTD5P|5 Prime Nucleotidase|HEMATOLOGY|[?]|uL/dose|[?]|[?]|INVALID|1|umol/mol|1|1|[?]|LOW|VENOUS PLASMA|GELLED||IMMUNOASSAY|FIBROSIS 4 FORMULA||Y|Y||2|Visit_2|25|3|SCREENING|2020-07-26|2020-09-26|25|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|bc71ddfa-c71c-447b-9684-005e4c112172|5|AMACR|Alpha-Methylacyl Coenzyme A Racemase|CHEMISTRY|[?]|ms2|[?]|[?]|INVALID|1|kcal/day|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|GELLED||SPECTROPHOTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|7|TREATMENT|2020-08-10|2020-09-30|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|bc71ddfa-c71c-447b-9684-005e4c112172|6|HLADRMSC|HLA-DR Mismatch Count|CHEMISTRY|[?]|CAPSULE|[?]|[?]|TRACE|1|Ci/mL|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|FROZEN||GC/MS|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-08-10|2020-10-06|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|bc71ddfa-c71c-447b-9684-005e4c112172|7|HBOXHGB|Oxyhemoglobin/Total Hemoglobin|HEMATOLOGY|||[?]|[?]|POSITIVE|1|NFIU|1|1|[?]|ABNORMAL|HAIR|REFRIGERATED||MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|4|Visit_4|65|5|WASHOUT|2020-09-04|2020-09-14|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|bc71ddfa-c71c-447b-9684-005e4c112172|8|FACTV|Factor V|URINALYSIS|[?]|CARTRIDGE|[?]|[?]|INVALID|1|TCID 50/dose|1|1|[?]|HIGH|LAVAGE FLUID|UNEXPECTED ODOR||LC-FL|ASH FIBROSURE FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-09-04|2020-09-11|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|bc71ddfa-c71c-447b-9684-005e4c112172|9|DDNAIGAB|Anti-Double Stranded DNA IgG|CHEMISTRY|[?]|ug/g/min|[?]|[?]|POSITIVE|1|kg|1|1|[?]|LOW|NAIL|ICTERIC||COLORIMETRY|MDRD 6 VARIABLE FORMULA||Y|Y||5|Visit_5|90|3|SCREENING|2020-09-29|2020-09-30|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|bc71ddfa-c71c-447b-9684-005e4c112172|10|ELA1PMN|Pancreatic Elastase 1, Polymorphonuclear|HEMATOLOGY|[?]|mL/animal|[?]|[?]|INDETERMINATE|1|Bq/kg|1|1|[?]|ABNORMAL|PLEURAL TISSUE|SOLIDIFIED||MODIFIED ACID FAST STAIN|COCKCROFT-GAULT FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2020-09-29|2020-10-02|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|1|INTLK7|Interleukin 7|HEMATOLOGY|[?]|oz|[?]|[?]|NEGATIVE|1|um/day|1|1|[?]|HIGH|HAIR FOLLICLE|ROOM TEMPERATURE||CENTRIFUGATION|MDRD 5 VARIABLE FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-12-09|2021-02-06|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|2|VITB2|Riboflavin|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|BAU|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|FRESH||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|NASH FIBROSURE FORMULA||Y|NA|Y|1|Visit_1|10|7|FOLLOW-UP|2020-12-09|2020-12-13|10|14|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|3|DOPAMEXR|Dopamine Excretion Rate|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|U/animal|1|1|[?]|ABNORMAL|SALIVA|AUTOLYZED||ANALYTICAL ULTRACENTRIFUGATION|FIBROMETER FORMULA|Y||N|Y|2|Visit_2|25|6|WASHOUT|2020-12-24|2021-01-22|25|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|4|POLYCHR|Polychromasia|CHEMISTRY|[?]|kBq/uL|[?]|[?]|INVALID|1|nCi|1|1|[?]|HIGH|KERATINOCYTE|DRIED||FLUORESCENCE ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-12-24|2021-02-14|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|5|FRTNLC|Ferritin Light Chain|CHEMISTRY|[?]|Frames/s|[?]|[?]|TRACE|1|v/v|1|1|[?]|LOW|SERUM OR PLASMA|DRIED|N|IMPEDANCE CONDUCTIVITY|GMI MMOL/MOL FORMULA|Y||N||3|Visit_3|40|4|WASHOUT|2021-01-08|2021-01-23|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|6|RNA|Ribonucleic Acid|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Shock Wave|1|1|[?]|NORMAL|EPITHELIAL CELL|AGGLUTINATED||MICROBIAL CONCENTRATION|CKD-EPI CREATININE FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2021-01-08|2021-01-26|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|7|TSTFTSTT|Testosterone, Free/Testosterone|URINALYSIS|[?]|U/g|[?]|[?]|TRACE|1|nkat/g Hb|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|ICTERIC||NEXT GENERATION TARGETED SEQUENCING|MDRD FORMULA|||NA||4|Visit_4|65|4|WASHOUT|2021-02-02|2021-02-23|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|8|ANGPT1|Angiopoietin 1|HEMATOLOGY|||[?]|[?]|INVALID|1|dpm/mg|1|1|[?]|ABNORMAL|CORD SERUM|GELLED||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD FORMULA|||Y|Y|4|Visit_4|65|3|SCREENING|2021-02-02|2021-02-23|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|LB|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|9|HBA1A|Hemoglobin A1A|HEMATOLOGY|||[?]|[?]|TRACE|1|10^6 IU|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|CLOTTED||CALCOFLUOR WHITE STAIN|ASH FIBROSURE FORMULA|Y||U|Y|5|Visit_5|90|3|TREATMENT|2021-02-27|2021-03-05|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|10|LYMPLLE|Plasmacytoid Lymphocytes/Leukocytes|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|/MBP|1|1|[?]|ABNORMAL|LYSATE|PARAFFIN-EMBEDDED||BRDU CELLULAR PROLIFERATION ASSAY|MDRD 5 VARIABLE FORMULA|||Y|Y|5|Visit_5|90|5|TREATMENT|2021-02-27|2021-03-03|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|1|C130069|Bermuda Grass Pollen IgA|URINALYSIS|[?]|cm/s|[?]|[?]|INDETERMINATE|1|umol/h/mmol|1|1|[?]|HIGH|MUSCLE TISSUE|FRESH||NON-INVASIVE DIELECTRIC SENSING|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-09-06|2020-11-30|10|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|2|PLATIM|Immature Platelets|HEMATOLOGY|[?]|in|[?]|[?]|NEGATIVE|1|AgU/mL|1|1|[?]|ABNORMAL|BILE|DRIED|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|FIBROSIS 4 FORMULA||Y|U||1|Visit_1|10|3|TREATMENT|2020-09-06|2020-11-11|10|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|3|CRH|Corticotropin Releasing Hormone|CHEMISTRY|[?]|nkat/L|[?]|[?]|NEGATIVE|1|10^6 organisms|1|1|[?]|ABNORMAL|MUCUS|AGGLUTINATED||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA|Y|Y|U||2|Visit_2|25|1|WASHOUT|2020-09-21|2020-11-05|25|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|4|CAIONPH|Calcium, Ionized pH Adjusted|CHEMISTRY|[?]|uV2|[?]|[?]|INDETERMINATE|1|tsp eq|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|FROZEN||CELLULOSE TAPE|MDRD 4 VARIABLE FORMULA||Y|NA||2|Visit_2|25|2|WASHOUT|2020-09-21|2020-11-02|25|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|5|EOSIMLE|Immature Eosinophils/Leukocytes|CHEMISTRY|[?]|IU/mg|[?]|[?]|TRACE|1|mL/cage/day|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|FROZEN||DROPLET DIGITAL PCR|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U||3|Visit_3|40|5|TREATMENT|2020-10-06|2020-10-23|40|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|6|ALPBS|Bone Specific Alkaline Phosphatase|URINALYSIS|[?]|ug/L DDU|[?]|[?]|NEGATIVE|1|mU/L|1|1|[?]|ABNORMAL|VENOUS BLOOD|CONCENTRATED||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|5|TREATMENT|2020-10-06|2020-11-24|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|7|TOXVAC|Toxic Vacuolation|HEMATOLOGY|[?]|nmol BCE/nmol|[?]|[?]|TRACE|1|gpELISA unit/mL|1|1|[?]|NORMAL|URINE SEDIMENT|REFRIGERATED||BALLPOINT PEN TECHNIQUE|ASH FIBROSURE FORMULA|||N||4|Visit_4|65|3|FOLLOW-UP|2020-10-31|2020-11-06|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|8|CLUECE|Clue Cells|CHEMISTRY|[?]|sec|[?]|[?]|NEGATIVE|1|mm/2h|1|1|[?]|LOW|STOOL|PARAFFIN-EMBEDDED||SMEAR|MDRD FORMULA|Y||NA||4|Visit_4|65|4|TREATMENT|2020-10-31|2020-11-20|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|9|C130073|Birch Pollen IgA|CHEMISTRY|||[?]|[?]|NEGATIVE|1|LENS|1|1|[?]|ABNORMAL|FLUID|LIPEMIC||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|HEPASCORE FORMULA|Y||N|Y|5|Visit_5|90|4|FOLLOW-UP|2020-11-25|2020-12-03|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|10|ESTRDIOL|Estradiol|CHEMISTRY|||[?]|[?]|BORDERLINE|1|ug/L FEU|1|1|[?]|NORMAL|LYSATE|UNEXPECTED ODOR||TRIPLE-PHASE MRI SCAN|CKD-EPI CREATININE FORMULA|Y|Y|NA|Y|5|Visit_5|90|4|SCREENING|2020-11-25|2020-11-27|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|LB|b1b3e113-8c73-4446-8095-3341f8912bd7|1|MSPIKE|Monoclonal Protein Spike|URINALYSIS|[?]|CCID 50/dose|[?]|[?]|POSITIVE|1|TRANSDUCING UNIT|1|1|[?]|HIGH|HAIR|AGGLUTINATED||CONTRAST ENHANCED SPIRAL CT SCAN|FIBROSIS 4 FORMULA|||N||1|Visit_1|10|2|TREATMENT|2021-01-27|2021-04-11|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|LB|b1b3e113-8c73-4446-8095-3341f8912bd7|2|CD40|CD40|URINALYSIS|[?]|10^6 CFU/g|[?]|[?]|INVALID|1|km/h|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|AUTOLYZED||HIGH RESOLUTION MELT ANALYSIS|COCKCROFT-GAULT FORMULA||Y|N||1|Visit_1|10|7|WASHOUT|2021-01-27|2021-03-28|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|LB|b1b3e113-8c73-4446-8095-3341f8912bd7|3|NEUTMM|Neutrophilic Metamyelocytes|HEMATOLOGY|[?]|MESF|[?]|[?]|INVALID|1|mL/beat|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|CONTAMINATED||CARDIAC THERMODILUTION|MDRD FORMULA|||U||2|Visit_2|25|7|TREATMENT|2021-02-11|2021-04-09|25|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|LB|b1b3e113-8c73-4446-8095-3341f8912bd7|4|HLAA|HLA Class IA Antigen|HEMATOLOGY|[?]|U/L|[?]|[?]|INVALID|1|mOsm|1|1|[?]|ABNORMAL|MONOCYTE|ICTERIC|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD ENZYMATIC FORMULA|Y|Y|U||2|Visit_2|25|5|TREATMENT|2021-02-11|2021-04-21|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|LB|b1b3e113-8c73-4446-8095-3341f8912bd7|5|HCHT|Hyocholate|URINALYSIS|[?]|mCi/L|[?]|[?]|BORDERLINE|1|cmH2O*s/mL|1|1|[?]|NORMAL|PROSTATIC FLUID|GELLED||FUNDUS PHOTOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||U||3|Visit_3|40|2|TREATMENT|2021-02-26|2021-04-18|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|b1b3e113-8c73-4446-8095-3341f8912bd7|6|IFIT1|Interferon-Induced 56 kDa Protein|HEMATOLOGY|[?]|kIU|[?]|[?]|POSITIVE|1|ng/day|1|1|[?]|LOW|EPIDERMAL TISSUE|DRIED|N|NEURAMINIDASE INHIBITION ASSAY|FIBROMETER FORMULA|||N||3|Visit_3|40|3|SCREENING|2021-02-26|2021-03-04|40|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|b1b3e113-8c73-4446-8095-3341f8912bd7|7|BNZDZPN|Benzodiazepine|URINALYSIS|[?]|ng/mol|[?]|[?]|BORDERLINE|1|mmol/g|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|PARAFFIN-EMBEDDED||DOUBLE IMMUNODIFFUSION|MDRD ENZYMATIC FORMULA|||U||4|Visit_4|65|7|FOLLOW-UP|2021-03-23|2021-04-11|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|LB|b1b3e113-8c73-4446-8095-3341f8912bd7|8|PGES|Prostaglandin E Synthase|HEMATOLOGY|[?]|TRANSDUCING UNIT/mL|[?]|[?]|POSITIVE|1|ukat|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|CONCENTRATED||TOTAL BODY RADIOGRAPHY|FIBROSIS 4 FORMULA|||NA||4|Visit_4|65|2|SCREENING|2021-03-23|2021-03-24|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|LB|b1b3e113-8c73-4446-8095-3341f8912bd7|9|PLSPCE|Precursor Plasma Cells|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|pg/L|1|1|[?]|NORMAL|ERYTHROCYTES|LIPEMIC||DIGITAL PCR ARRAY|FIBROMETER FORMULA|Y||N|Y|5|Visit_5|90|1|SCREENING|2021-04-17|2021-04-24|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|b1b3e113-8c73-4446-8095-3341f8912bd7|10|FSH|Follicle Stimulating Hormone|CHEMISTRY|[?]|ug/mL/h|[?]|[?]|TRACE|1|STEPS|1|1|[?]|LOW|MUCUS|ICTERIC||POLYMERASE CHAIN REACTION|FIBROMETER FORMULA|Y|Y|Y||5|Visit_5|90|2|TREATMENT|2021-04-17|2021-04-22|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|1|LYMVAC|Vacuolated Lymphocytes|HEMATOLOGY|[?]|mmHg*min/L|[?]|[?]|INVALID|1|V/sec|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|SOLIDIFIED||INTERRUPTER TECHNIQUE|COCKCROFT-GAULT FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-11-22|2020-12-09|10|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|2|PROTCRT|Protein/Creatinine|CHEMISTRY|[?]|Gy/h|[?]|[?]|NEGATIVE|1|EID 50/dose|1|1|[?]|ABNORMAL|MUSCLE TISSUE|DRIED||MYELOPEROXIDASE STAIN|MDRD 6 VARIABLE FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-11-22|2020-11-28|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|3|CCL23|Chemokine (C-C Motif) Ligand 23|HEMATOLOGY|[?]|BP|[?]|[?]|INDETERMINATE|1|mol/day|1|1|[?]|LOW|PLATELET POOR PLASMA|ICTERIC||PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|2|FOLLOW-UP|2020-12-07|2020-12-31|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|4|PLATLRG|Large Platelets|HEMATOLOGY|[?]|breaths/min|[?]|[?]|POSITIVE|1|CAPSULE|1|1|[?]|LOW|SALIVA|UNEXPECTED ODOR||TOTAL BODY RADIOGRAPHY|MDRD FORMULA||Y|U||2|Visit_2|25|6|FOLLOW-UP|2020-12-07|2021-02-17|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|5|AMABARAB|ACH Receptor Modulatn Ab/ACH Receptor Ab|URINALYSIS|[?]|ukat|[?]|[?]|NEGATIVE|1|10^9 organisms/mL|1|1|[?]|LOW|FLUID|LIPEMIC||SLOAN LETTER EYE CHART 2.5%|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-12-22|2021-01-09|40|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|6|LAP|Leucine Aminopeptidase|HEMATOLOGY|[?]|IU/kg|[?]|[?]|POSITIVE|1|Hz/s|1|1|[?]|LOW|MONOCYTE|ICTERIC|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-12-22|2021-01-12|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|LB|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|7|ETPLT|ETP Lag Time|URINALYSIS|[?]|10^9 organisms/mg|[?]|[?]|INVALID|1|mEq/uL|1|1|[?]|LOW|SUPERNATANT, PLASMA|NON-HEMOLYZED||MICROPARTICLE ENZYME IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U||4|Visit_4|65|1|TREATMENT|2021-01-16|2021-01-17|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|8|PCA3MRNA|Prostate Cancer Antigen 3 mRNA|HEMATOLOGY|[?]|uIU/dL|[?]|[?]|INDETERMINATE|1|YEARS|1|1|[?]|LOW|ISOLATE|DRIED||IMMUNOCHROMATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|7|TREATMENT|2021-01-16|2021-01-22|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|9|SECRETIN|Secretin|HEMATOLOGY|[?]|mmol/min/kPa/L|[?]|[?]|NEGATIVE|1|usec|1|1|[?]|NORMAL|REFLEX TEAR|AGGLUTINATED|N|GC/MS/MS|FIBROMETER FORMULA|||Y||5|Visit_5|90|2|WASHOUT|2021-02-10|2021-02-18|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|10|DTPACLR|DTPA Clearance|CHEMISTRY|[?]|rpm|[?]|[?]|POSITIVE|1|Shock Wave|1|1|[?]|LOW|PLATELET|AUTOLYZED||PET/CT SCAN|FIBROMETER FORMULA||Y|N||5|Visit_5|90|4|TREATMENT|2021-02-10|2021-02-15|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|1|PYRUVATE|Pyruvate|CHEMISTRY|[?]|kPa|[?]|[?]|BORDERLINE|1|pmol/10^9 cells|1|1|[?]|LOW|PLATELET RICH PLASMA|CONCENTRATED||SCINTIGRAPHY|MDRD 6 VARIABLE FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-08-06|2020-09-19|10|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|2|PROTEXR|Protein Excretion Rate|CHEMISTRY|[?]|Ci/uL|[?]|[?]|BORDERLINE|1|Absorbance U/min|1|1|[?]|LOW|SERUM|AUTOLYZED||TRANSMISSION ELECTRON MICROSCOPY|COCKCROFT-GAULT FORMULA|Y||N||1|Visit_1|10|5|TREATMENT|2020-08-06|2020-10-27|10|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|LB|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|3|AMPHETD|Dextroamphetamine|URINALYSIS|||[?]|[?]|TRACE|1|POINT|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|REFRIGERATED||DUKE INCISION METHOD|HEPASCORE FORMULA|Y||Y|Y|2|Visit_2|25|3|TREATMENT|2020-08-21|2020-08-28|25|32|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|4|PROMYLE|Promyelocytes/Leukocytes|HEMATOLOGY|||[?]|[?]|TRACE|1|10^6 IU/mL|1|1|[?]|HIGH|VENOUS CORD BLOOD|UNEXPECTED ODOR||DNA MICROARRAY|FIBROTEST FORMULA|||N|Y|2|Visit_2|25|3|TREATMENT|2020-08-21|2020-08-25|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|LB|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|5|TPRONP|Non-Phosphorylated Tau Protein|URINALYSIS|||[?]|[?]|NEGATIVE|1|kg/cm|1|1|[?]|NORMAL|SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED||RAJI CELL RIA|ASH FIBROSURE FORMULA||Y|U|Y|3|Visit_3|40|1|FOLLOW-UP|2020-09-05|2020-10-24|40|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|6|IGG3|Immunoglobulin G Subclass 3|HEMATOLOGY|[?]|umol/L/sec|[?]|[?]|POSITIVE|1|IMPLANT|1|1|[?]|NORMAL|BREAST MILK|PARAFFIN-EMBEDDED||QUANTITATIVE COMPUTED TOMOGRAPHY|MDRD FORMULA|||NA||3|Visit_3|40|1|WASHOUT|2020-09-05|2020-10-11|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|LB|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|7|ZPP|Zinc Protoporphyrin|URINALYSIS|[?]|mmHg/sec|[?]|[?]|INVALID|1|DAYS|1|1|[?]|LOW|SOFT TISSUE|LIPEMIC||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI CREATININE FORMULA|||Y||4|Visit_4|65|6|SCREENING|2020-09-30|2020-10-07|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|8|ADAM8|ADAM Metallopeptidase Domain 8|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mL/h|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|CONTAMINATED||LINE PROBE ASSAY|CKD-EPI CREATININE FORMULA|Y||U|Y|4|Visit_4|65|7|SCREENING|2020-09-30|2020-10-14|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|9|ALBIDX|Albumin Index|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|ug/m2/h|1|1|[?]|ABNORMAL|NAIL|DRIED|N|IMPULSE OSCILLOMETRY|FIBROMETER FORMULA|||NA|Y|5|Visit_5|90|3|SCREENING|2020-10-25|2020-10-28|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|LB|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|10|COAGIDX|Coagulation Index|HEMATOLOGY|[?]|MdFI|[?]|[?]|POSITIVE|1|kHz|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|FRESH|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|3|TREATMENT|2020-10-25|2020-11-01|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|LB|3b83c7a0-e22b-45b1-b065-71971f014039|1|APOJCRT|Apolipoprotein J/Creatinine|URINALYSIS|[?]|U/L|[?]|[?]|INDETERMINATE|1|mOsm|1|1|[?]|HIGH|MUCUS|ROOM TEMPERATURE||ANTIMICROBIAL COMBINATION TESTING|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|1|TREATMENT|2020-09-01|2020-10-17|10|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|3b83c7a0-e22b-45b1-b065-71971f014039|2|FATLVIDX|Fatty Liver Index|URINALYSIS|[?]|VOXEL|[?]|[?]|INDETERMINATE|1|Rad|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|REFRIGERATED||MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y||1|Visit_1|10|2|FOLLOW-UP|2020-09-01|2020-10-26|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|LB|3b83c7a0-e22b-45b1-b065-71971f014039|3|ENRAGE|Extracell Newly Ident RAGE Bind Protein|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|g/kg|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|CLOTTED||ELECTRICAL IMPEDANCE MYOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|2|Visit_2|25|2|FOLLOW-UP|2020-09-16|2020-09-18|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|3b83c7a0-e22b-45b1-b065-71971f014039|4|ALS|Acid Labile Subunit|CHEMISTRY|[?]|pmol/dL|[?]|[?]|NEGATIVE|1|mL/cm H2O|1|1|[?]|LOW|SERUM OR PLASMA|NON-HEMOLYZED||MAPH|CKD-EPI FORMULA|||Y||2|Visit_2|25|5|FOLLOW-UP|2020-09-16|2020-10-04|25|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|LB|3b83c7a0-e22b-45b1-b065-71971f014039|5|RENINA|Renin Activity|CHEMISTRY|[?]|deg|[?]|[?]|NEGATIVE|1|SQU/mL|1|1|[?]|HIGH|BILE|CONTAMINATED||LASER CAPTURE MICRODISSECTION|CKD-EPI CYSTATIN C FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-10-01|2020-10-24|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|3b83c7a0-e22b-45b1-b065-71971f014039|6|CLCLR|Chloride Clearance|URINALYSIS|[?]|dpm/0.5 mL|[?]|[?]|POSITIVE|1|kg/m2|1|1|[?]|HIGH|DERMAL TISSUE|DRIED|N|WHOLE GENOME SEQUENCING|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-10-01|2020-11-15|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|3b83c7a0-e22b-45b1-b065-71971f014039|7|GSTAL|Alpha Glutathione-S-Transferase|URINALYSIS|[?]|APL U|[?]|[?]|BORDERLINE|1|GPL U|1|1|[?]|LOW|CEREBROSPINAL FLUID|SOLIDIFIED||CONFOCAL MICROSCOPY|NASH FIBROSURE FORMULA|||Y||4|Visit_4|65|4|SCREENING|2020-10-26|2020-11-04|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|3b83c7a0-e22b-45b1-b065-71971f014039|8|GLBCREAT|Globulin/Creatinine|CHEMISTRY|||[?]|[?]|POSITIVE|1|/10^5|1|1|[?]|HIGH|PLEURAL TISSUE|LACTESCENT||NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC FORMULA|||N|Y|4|Visit_4|65|7|FOLLOW-UP|2020-10-26|2020-11-02|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|3b83c7a0-e22b-45b1-b065-71971f014039|9|LTFAB|Lactoferrin Antibody|CHEMISTRY|[?]|umol/dL|[?]|[?]|INVALID|1|MPS U|1|1|[?]|NORMAL|ALVEOLAR AIR|AUTOLYZED||WESTERN BLOT|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|5|TREATMENT|2020-11-20|2020-11-22|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|3b83c7a0-e22b-45b1-b065-71971f014039|10|BPIAB|Bactericidal/Permeability-Inc Protein Ab|CHEMISTRY|[?]|ug/g/min|[?]|[?]|TRACE|1|fmol/L|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|CONCENTRATED||SMEAR|GMI MMOL/MOL FORMULA|||U||5|Visit_5|90|3|TREATMENT|2020-11-20|2020-11-28|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|92c849ce-12b8-4c38-baab-f91c44a007b9|1|CRDIGAAB|Cardiolipin IgA Antibody|CHEMISTRY|[?]|umol/L|[?]|[?]|BORDERLINE|1|10^9/L|1|1|[?]|ABNORMAL|ALVEOLAR AIR|REFRIGERATED|N|IRON HEMATOXYLIN STAIN|GMI % FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-11-12|2021-01-14|10|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|92c849ce-12b8-4c38-baab-f91c44a007b9|2|WBCMORPH|Leukocyte Cell Morphology|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mIU/L|1|1|[?]|LOW|CORD BLOOD|UNEXPECTED ODOR||MECHANICAL CLOT DETECTION|CKD-EPI CYSTATIN C FORMULA|||NA|Y|1|Visit_1|10|2|TREATMENT|2020-11-12|2020-12-03|10|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|LB|92c849ce-12b8-4c38-baab-f91c44a007b9|3|ACRNCRNF|Acylcarnitine/Carnitine, Free|CHEMISTRY|||[?]|[?]|NEGATIVE|1|nmol/L/h|1|1|[?]|HIGH|PLEURAL TISSUE|DRIED|N|AURAMINE STAIN|MDRD 5 VARIABLE FORMULA||Y|U|Y|2|Visit_2|25|4|TREATMENT|2020-11-27|2021-01-01|25|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|92c849ce-12b8-4c38-baab-f91c44a007b9|4|C130115|Industrial Mix Antigen IgG Antibody|CHEMISTRY|[?]|IU/day|[?]|[?]|POSITIVE|1|ug/dL|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|FROZEN||VENTILATION PERFUSION LUNG SCAN|GMI % FORMULA|||Y||2|Visit_2|25|2|TREATMENT|2020-11-27|2020-12-18|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|LB|92c849ce-12b8-4c38-baab-f91c44a007b9|5|AMCRMRNA|AMACR mRNA|CHEMISTRY|||[?]|[?]|INVALID|1|POUCH|1|1|[?]|LOW|KERATINOCYTE|CONTAMINATED||CINEANGIOGRAPHY|CKD-EPI CREATININE FORMULA|Y||NA|Y|3|Visit_3|40|7|WASHOUT|2020-12-12|2021-01-21|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|92c849ce-12b8-4c38-baab-f91c44a007b9|6|ENDOTH1|Endothelin-1|HEMATOLOGY|[?]|10^3 organisms/mL|[?]|[?]|INVALID|1|dpm/mg|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|SOLIDIFIED|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|ASH FIBROSURE FORMULA|Y||N||3|Visit_3|40|7|TREATMENT|2020-12-12|2020-12-31|40|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|LB|92c849ce-12b8-4c38-baab-f91c44a007b9|7|FABP3|Fatty Acid Binding Protein 3|URINALYSIS|[?]|g/cm2|[?]|[?]|BORDERLINE|1|grain|1|1|[?]|LOW|BREAST MILK|AUTOLYZED||TRANSCRIPTION-MEDIATED AMPLIFICATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||4|Visit_4|65|1|FOLLOW-UP|2021-01-06|2021-01-31|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|92c849ce-12b8-4c38-baab-f91c44a007b9|8|CH50|Complement CH50|URINALYSIS|[?]|EID 50/mL|[?]|[?]|POSITIVE|1|IU/kg|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|LIPEMIC||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA|Y|Y|Y||4|Visit_4|65|1|TREATMENT|2021-01-06|2021-01-31|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|LB|92c849ce-12b8-4c38-baab-f91c44a007b9|9|CXCL7|Chemokine (C-X-C Motif) Ligand 7|CHEMISTRY|[?]|mL/day|[?]|[?]|TRACE|1|10^3 CFU/g|1|1|[?]|LOW|EMESIS|AUTOLYZED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROMETER FORMULA|||N||5|Visit_5|90|7|TREATMENT|2021-01-31|2021-02-04|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|92c849ce-12b8-4c38-baab-f91c44a007b9|10|PERIOSTN|Periostin|URINALYSIS|[?]|cm H2O|[?]|[?]|INDETERMINATE|1|TROCHE|1|1|[?]|LOW|PLATELET|DRIED|N|IVY INCISION METHOD|GMI MMOL/MOL FORMULA|||U||5|Visit_5|90|3|TREATMENT|2021-01-31|2021-02-06|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|f2101018-c983-435e-a453-148f182388f7|1|C130134|D. pteronyssinus Antigen IgE Antibody|URINALYSIS|[?]|Joule|[?]|[?]|BORDERLINE|1|IU/g|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|UNEXPECTED ODOR||ANTIBIOTIC AGAR SCREEN|GMI MMOL/MOL FORMULA|||Y||1|Visit_1|10|3|FOLLOW-UP|2020-09-01|2020-10-01|10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|f2101018-c983-435e-a453-148f182388f7|2|FLT3L|FMS-like Tyrosine Kinase 3 Ligand|URINALYSIS|||[?]|[?]|NEGATIVE|1|PIXELS/cm|1|1|[?]|HIGH|BREAST MILK|FRESH||COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI FORMULA|Y||U|Y|1|Visit_1|10|5|TREATMENT|2020-09-01|2020-10-13|10|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|f2101018-c983-435e-a453-148f182388f7|3|EPIRCE|Renal Epithelial Cells|CHEMISTRY|[?]|ka_u/dL|[?]|[?]|INVALID|1|oz|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|AGGLUTINATED|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|GMI MMOL/MOL FORMULA|||NA||2|Visit_2|25|5|WASHOUT|2020-09-16|2020-11-23|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|f2101018-c983-435e-a453-148f182388f7|4|CD11A|CD11A|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|FFU|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|ICTERIC|N|IHC|GMI % FORMULA|Y||N|Y|2|Visit_2|25|6|WASHOUT|2020-09-16|2020-10-07|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|LB|f2101018-c983-435e-a453-148f182388f7|5|FBNCTFT|Fibronectin, Fetal|CHEMISTRY|[?]|copies/ug|[?]|[?]|NEGATIVE|1|nmol|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|ROOM TEMPERATURE||IMMUNOCHROMATOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|NA||3|Visit_3|40|5|SCREENING|2020-10-01|2020-10-10|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|f2101018-c983-435e-a453-148f182388f7|6|PO2ADJT|Partial Pressure Oxygen Adj for Temp|URINALYSIS|[?]|pmol/g|[?]|[?]|NEGATIVE|1|ug/h|1|1|[?]|LOW|EMESIS|ROOM TEMPERATURE||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD ENZYMATIC JAPANESE FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2020-10-01|2020-11-08|40|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|f2101018-c983-435e-a453-148f182388f7|7|ANA|Antinuclear Antibodies|CHEMISTRY|[?]|/sec|[?]|[?]|INVALID|1|mol/g|1|1|[?]|LOW|EPIDERMAL TISSUE|THAWED||MAGNETIC RESONANCE ANGIOGRAPHY|ASH FIBROSURE FORMULA||Y|NA||4|Visit_4|65|1|FOLLOW-UP|2020-10-26|2020-11-17|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|f2101018-c983-435e-a453-148f182388f7|8|CEMORPH|Cell Morphology|URINALYSIS|[?]|m|[?]|[?]|NEGATIVE|1|cP|1|1|[?]|HIGH|LAVAGE FLUID|DRIED||SCANNING ELECTRON MICROSCOPY|HEPASCORE FORMULA||Y|N||4|Visit_4|65|4|TREATMENT|2020-10-26|2020-11-25|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|LB|f2101018-c983-435e-a453-148f182388f7|9|INCLBOD|Inclusion Bodies|CHEMISTRY|||[?]|[?]|POSITIVE|1|CIGARETTE|1|1|[?]|NORMAL|SEBUM|GELLED||MECHANICAL CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N|Y|5|Visit_5|90|3|WASHOUT|2020-11-20|2020-11-27|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|f2101018-c983-435e-a453-148f182388f7|10|TURB|Turbidity|CHEMISTRY|[?]|mL/m2/min|[?]|[?]|INVALID|1|mkat|1|1|[?]|LOW|GASTRIC CONTENTS|AUTOLYZED||FLUORESCENCE ANGIOGRAPHY|FIBROSIS 4 FORMULA||Y|N||5|Visit_5|90|6|WASHOUT|2020-11-20|2020-11-27|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|613284eb-edbe-446b-b4fe-f96f1510e626|1|LPPLA2|Lipoprotein Associated Phospholipase A2|CHEMISTRY|||[?]|[?]|NEGATIVE|1|/cmH2O|1|1|[?]|LOW|MIXED VENOUS BLOOD|PARAFFIN-EMBEDDED||NEPHELOMETRY|GMI % FORMULA|||N|Y|1|Visit_1|10|5|WASHOUT|2020-11-07|2021-01-22|10|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|613284eb-edbe-446b-b4fe-f96f1510e626|2|PO2FIO2|PP Arterial O2/Fraction Inspired O2|URINALYSIS|[?]|g/cage/day|[?]|[?]|POSITIVE|1|cup eq|1|1|[?]|ABNORMAL|KERATINOCYTE|AUTOLYZED||ECHOCARDIOGRAPHY|MDRD 4 VARIABLE FORMULA|Y|Y|NA||1|Visit_1|10|2|TREATMENT|2020-11-07|2020-12-06|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|LB|613284eb-edbe-446b-b4fe-f96f1510e626|3|NFHP|Phosphorylated Neurofilament Heavy Chain|HEMATOLOGY|[?]|10^6 U|[?]|[?]|INVALID|1|10^9 organisms|1|1|[?]|LOW|PLATELET RICH PLASMA|LIPEMIC||HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|7|WASHOUT|2020-11-22|2021-01-28|25|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|613284eb-edbe-446b-b4fe-f96f1510e626|4|FLUOXTN|Fluoxetine|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mg/m2/h|1|1|[?]|LOW|EMESIS|GELLED||COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|Y|Y|2|Visit_2|25|2|WASHOUT|2020-11-22|2020-12-27|25|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|613284eb-edbe-446b-b4fe-f96f1510e626|5|THRCREAT|Threonine/Creatinine|CHEMISTRY|||[?]|[?]|INVALID|1|fmol|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|LACTESCENT||STRESS ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|3|Visit_3|40|6|TREATMENT|2020-12-07|2020-12-30|40|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|613284eb-edbe-446b-b4fe-f96f1510e626|6|PRAB|Panel Reactive Antibody|URINALYSIS|[?]|MHz|[?]|[?]|POSITIVE|1|log10 TCID 50/dose|1|1|[?]|LOW|MUCUS|AUTOLYZED|N|CENTRIFUGATION|FIBROMETER FORMULA|||NA||3|Visit_3|40|6|WASHOUT|2020-12-07|2020-12-17|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|613284eb-edbe-446b-b4fe-f96f1510e626|7|CRLPLSMN|Ceruloplasmin|HEMATOLOGY|[?]|L/min|[?]|[?]|POSITIVE|1|ug/kg/h|1|1|[?]|NORMAL|PLASMA|UNEXPECTED ODOR||MOUSE PROTECTION ASSAY|FIBROSIS 4 FORMULA|||N||4|Visit_4|65|1|SCREENING|2021-01-01|2021-01-31|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|613284eb-edbe-446b-b4fe-f96f1510e626|8|RMNTLP|Remnant Lipoprotein|HEMATOLOGY|[?]|nmol/L/min|[?]|[?]|NEGATIVE|1|pL|1|1|[?]|ABNORMAL|DIALYSIS FLUID, PERITONEAL|GELLED||CHROMOGENIC ASSAY|FIBROMETER FORMULA|||U||4|Visit_4|65|2|WASHOUT|2021-01-01|2021-01-28|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|613284eb-edbe-446b-b4fe-f96f1510e626|9|CELLULAR|Cellularity|CHEMISTRY|[?]|Gy/h|[?]|[?]|TRACE|1|log10 CCID 50/dose|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED||COMPUTERIZED CORNEAL TOPOGRAPHY|FIBROMETER FORMULA|||NA||5|Visit_5|90|6|TREATMENT|2021-01-26|2021-02-03|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|613284eb-edbe-446b-b4fe-f96f1510e626|10|UREANEXR|Urea Nitrogen Excretion Rate|URINALYSIS|[?]|vg/kg|[?]|[?]|INDETERMINATE|1|mL/g/day|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|CLOTTED|N|MAPH|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||5|Visit_5|90|1|FOLLOW-UP|2021-01-26|2021-02-04|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|65e8391b-0c34-4687-a0ab-cb291a4cdf36|1|HBHIB|Hemoglobin H Inclusion Bodies|CHEMISTRY|[?]|mph|[?]|[?]|POSITIVE|1|uV*sec|1|1|[?]|NORMAL|ADIPOSE TISSUE|LIPEMIC||CAPILLARY ELECTROPHORESIS|CKD-EPI CREATININE FORMULA||Y|Y||1|Visit_1|10|7|SCREENING|2020-07-15|2020-07-29|10|24|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|65e8391b-0c34-4687-a0ab-cb291a4cdf36|2|TLCHT|Taurolithocholate|HEMATOLOGY|[?]|10^4/L|[?]|[?]|BORDERLINE|1|IU/kg/h|1|1|[?]|HIGH|BONE|LIPEMIC|N|DROPLET DIGITAL PCR|HEPASCORE FORMULA|Y|Y|Y||1|Visit_1|10|4|TREATMENT|2020-07-15|2020-08-21|10|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|LB|65e8391b-0c34-4687-a0ab-cb291a4cdf36|3|HLADR53A|HLA-DR53 Antibody|URINALYSIS|[?]|keV|[?]|[?]|BORDERLINE|1|10^11/L|1|1|[?]|NORMAL|CORD BLOOD|NON-HEMOLYZED||THERMAL IONIZATION MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA|||NA||2|Visit_2|25|5|WASHOUT|2020-07-30|2020-08-10|25|36|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|65e8391b-0c34-4687-a0ab-cb291a4cdf36|4|UNSPCELE|Unspecified Cells/Leukocytes|URINALYSIS|[?]|/cmH2O|[?]|[?]|NEGATIVE|1|ft|1|1|[?]|NORMAL|PUS|LACTESCENT||MAGNETIC RESONANCE ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U||2|Visit_2|25|1|WASHOUT|2020-07-30|2020-08-03|25|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|65e8391b-0c34-4687-a0ab-cb291a4cdf36|5|ANDSTNDN|Androstenedione|CHEMISTRY|[?]|mL/g/min|[?]|[?]|NEGATIVE|1|IU/dL|1|1|[?]|NORMAL|NAIL|NON-HEMOLYZED||IMMUNOCHROMATOGRAPHY|MDRD 5 VARIABLE FORMULA|Y||U||3|Visit_3|40|2|WASHOUT|2020-08-14|2020-09-26|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|65e8391b-0c34-4687-a0ab-cb291a4cdf36|6|TPAG|Tissue Polypeptide Antigen|URINALYSIS|[?]|ngEq/L|[?]|[?]|INVALID|1|%(v/v)|1|1|[?]|LOW|CALCULUS|LIPEMIC||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|COCKCROFT-GAULT FORMULA|||N||3|Visit_3|40|3|TREATMENT|2020-08-14|2020-09-10|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|LB|65e8391b-0c34-4687-a0ab-cb291a4cdf36|7|SPGRAV|Specific Gravity|CHEMISTRY|[?]|10^11/L|[?]|[?]|POSITIVE|1|umol/L|1|1|[?]|HIGH|BASAL TEAR|HEMOLYZED||STRESS ECHOCARDIOGRAPHY|MDRD FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-09-08|2020-10-08|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|65e8391b-0c34-4687-a0ab-cb291a4cdf36|8|LTE4|Leukotriene E4|CHEMISTRY|||[?]|[?]|BORDERLINE|1|nmol/g|1|1|[?]|NORMAL|PLEURAL FLUID|AUTOLYZED||PERIODIC ACID SCHIFF STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N|Y|4|Visit_4|65|3|TREATMENT|2020-09-08|2020-10-03|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|LB|65e8391b-0c34-4687-a0ab-cb291a4cdf36|9|BLYCELE|B-Lymphocytes/Leukocytes|URINALYSIS|[?]|breaths/min|[?]|[?]|TRACE|1|pL|1|1|[?]|NORMAL|SKIN TISSUE|AGGLUTINATED|N|HPLC-FL|GMI % FORMULA||Y|U||5|Visit_5|90|5|TREATMENT|2020-10-03|2020-10-07|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|65e8391b-0c34-4687-a0ab-cb291a4cdf36|10|FATACVLC|Fatty Acids, Very Long Chain|CHEMISTRY|[?]|kg/cm2|[?]|[?]|NEGATIVE|1|/7.5 mL|1|1|[?]|NORMAL|EMOTIONAL TEAR|UNEXPECTED ODOR||EPSILOMETER|COCKCROFT-GAULT FORMULA|||U||5|Visit_5|90|4|FOLLOW-UP|2020-10-03|2020-10-09|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|LB|2350438a-0bc8-4da5-b6c9-99a6c012b454|1|HLAIIAB|HLA Class II Antibody|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|copies/mL|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|SOLIDIFIED|N|ICC|CKD-EPI CYSTATIN C FORMULA||Y|U|Y|1|Visit_1|10|2|TREATMENT|2020-08-21|2020-08-29|10|18|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|2350438a-0bc8-4da5-b6c9-99a6c012b454|2|PCP|Phencyclidine|CHEMISTRY|[?]|10^4 CFU/mL|[?]|[?]|INDETERMINATE|1|mg/kg/min|1|1|[?]|ABNORMAL|EMESIS|AUTOLYZED||POPULATION SEQUENCING|COCKCROFT-GAULT FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2020-08-21|2020-10-01|10|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|2350438a-0bc8-4da5-b6c9-99a6c012b454|3|T4|Thyroxine|URINALYSIS|[?]|10^9 organisms/g|[?]|[?]|NEGATIVE|1|HOMEOPATHIC DILUTION|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|LACTESCENT|N|REFRACTOMETRY|MDRD ENZYMATIC FORMULA|Y||NA||2|Visit_2|25|2|TREATMENT|2020-09-05|2020-10-30|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|2350438a-0bc8-4da5-b6c9-99a6c012b454|4|C130103|Grass Mix Pollen Antigen IgE Antibody|URINALYSIS|[?]|umol/L|[?]|[?]|INVALID|1|10^9 organisms/g|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|AUTOLYZED||HANSEL STAIN|MDRD 4 VARIABLE FORMULA|Y|Y|U||2|Visit_2|25|2|SCREENING|2020-09-05|2020-09-12|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|2350438a-0bc8-4da5-b6c9-99a6c012b454|5|NEUTSGLE|Neutrophils, Segmented/Leukocytes|HEMATOLOGY|[?]|nmol/day|[?]|[?]|TRACE|1|10^6 CFU/g|1|1|[?]|ABNORMAL|BONE|CONCENTRATED||ICP-MS|FIBROTEST FORMULA|||U||3|Visit_3|40|5|TREATMENT|2020-09-20|2020-10-30|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|2350438a-0bc8-4da5-b6c9-99a6c012b454|6|TT|Thrombin Time|URINALYSIS|[?]|10^7 CFU|[?]|[?]|NEGATIVE|1|mL/g/day|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|AGGLUTINATED|N|RADIOGRAPHY|HEPASCORE FORMULA|||U||3|Visit_3|40|6|TREATMENT|2020-09-20|2020-10-08|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|2350438a-0bc8-4da5-b6c9-99a6c012b454|7|HLAA2AB|HLA-A2 Antibody|URINALYSIS|[?]|uV|[?]|[?]|BORDERLINE|1|Log10 ELISA unit|1|1|[?]|ABNORMAL|URINE|SOLIDIFIED|N|OPHTHALMOSCOPY|CKD-EPI CREATININE FORMULA|Y||N||4|Visit_4|65|6|WASHOUT|2020-10-15|2020-10-29|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|2350438a-0bc8-4da5-b6c9-99a6c012b454|8|RBC|Erythrocytes|URINALYSIS|[?]|V/sec|[?]|[?]|BORDERLINE|1|vg/mL|1|1|[?]|NORMAL|ADIPOSE TISSUE|GELLED||CALIPER MEASUREMENT METHOD|MDRD ENZYMATIC JAPANESE FORMULA|||N||4|Visit_4|65|5|FOLLOW-UP|2020-10-15|2020-11-17|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|LB|2350438a-0bc8-4da5-b6c9-99a6c012b454|9|PLSIMCE|Immature Plasma Cells|HEMATOLOGY|[?]|km/h|[?]|[?]|TRACE|1|uV*sec|1|1|[?]|NORMAL|SYNOVIAL FLUID|GELLED|N|DXA SCAN|FIBROTEST FORMULA||Y|Y||5|Visit_5|90|2|TREATMENT|2020-11-09|2020-11-14|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|2350438a-0bc8-4da5-b6c9-99a6c012b454|10|HLADR52A|HLA-DR52 Antibody|CHEMISTRY|[?]|log10 CFU/mL|[?]|[?]|NEGATIVE|1|TAMPON|1|1|[?]|LOW|EMESIS|ROOM TEMPERATURE|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD FORMULA||Y|U||5|Visit_5|90|2|FOLLOW-UP|2020-11-09|2020-11-17|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|1|FACTXI|Factor XI|CHEMISTRY|[?]|/mm|[?]|[?]|POSITIVE|1|BAG|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|SOLIDIFIED||FARR ASSAY|GMI MMOL/MOL FORMULA||Y|N||1|Visit_1|10|5|TREATMENT|2020-11-16|2020-11-24|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|2|LKM1IGAB|Liver Kidney Microsomal Type 1 IgG Ab|HEMATOLOGY|[?]|BOLUS|[?]|[?]|BORDERLINE|1|TRANSDUCING UNIT/mL|1|1|[?]|HIGH|BASAL TEAR|HEMOLYZED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|1|TREATMENT|2020-11-16|2020-11-22|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|3|BALA|Beta Alanine|URINALYSIS|||[?]|[?]|TRACE|1|TRANSDUCING UNIT/mL|1|1|[?]|NORMAL|SKIN TISSUE|CONCENTRATED||FLUORESCENT SPOT TEST|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|2|Visit_2|25|6|WASHOUT|2020-12-01|2021-01-30|25|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|4|IGG4|Immunoglobulin G Subclass 4|URINALYSIS|[?]|steps/min|[?]|[?]|BORDERLINE|1|mL/s/m2|1|1|[?]|NORMAL|PERITONEAL FLUID|SOLIDIFIED||DIFFUSION WEIGHTED MRI|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2020-12-01|2020-12-25|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|5|MX1|Interferon-Induced Protein p78|CHEMISTRY|||[?]|[?]|INVALID|1|nmol BCE/L|1|1|[?]|LOW|BONE|DRIED||PHYSICAL EXAMINATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA|Y|3|Visit_3|40|4|FOLLOW-UP|2020-12-16|2021-01-07|40|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|6|HYALUAC|Hyaluronic Acid|URINALYSIS|[?]|HOURS|[?]|[?]|TRACE|1|mg/min|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|FROZEN||AUDIOMETRY|MDRD 5 VARIABLE FORMULA||Y|Y||3|Visit_3|40|4|WASHOUT|2020-12-16|2021-01-21|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|LB|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|7|C165932|Dog Dander IgE AB RAST Score|CHEMISTRY|[?]|mL/min/1.73m2|[?]|[?]|INDETERMINATE|1|kg/L|1|1|[?]|HIGH|EPIDERMAL TISSUE|GELLED||SXA SCAN|MDRD 4 VARIABLE FORMULA|Y|Y|U||4|Visit_4|65|4|SCREENING|2021-01-10|2021-02-02|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|8|TNFSR2|Soluble TNF Receptor Type II|URINALYSIS|[?]|10^6 DNA copies/mL|[?]|[?]|INDETERMINATE|1|10^3 organisms/g|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|CALCIFIED||LASER CAPTURE MICRODISSECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||4|Visit_4|65|6|SCREENING|2021-01-10|2021-01-31|65|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|9|NORMEEXR|Normetanephrine Excretion Rate|HEMATOLOGY|||[?]|[?]|TRACE|1|L/s/kPa|1|1|[?]|NORMAL|SMEGMA|UNEXPECTED ODOR||OPHTHALMOSCOPY|MDRD ENZYMATIC FORMULA||Y|N|Y|5|Visit_5|90|1|TREATMENT|2021-02-04|2021-02-13|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|10|IC512AG|Islet Cell 512 Antigen|HEMATOLOGY|[?]|um|[?]|[?]|TRACE|1|mU|1|1|[?]|HIGH|CALCULUS|PARAFFIN-EMBEDDED||EEG|NASH FIBROSURE FORMULA|Y|Y|Y||5|Visit_5|90|4|TREATMENT|2021-02-04|2021-02-10|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|LB|416fe99b-1258-4e72-b1df-48b989f8f8ed|1|IL1EXR|Interleukin 1 Excretion Rate|HEMATOLOGY|[?]|vg/dose|[?]|[?]|TRACE|1|Log10 ELISA unit/dose|1|1|[?]|LOW|MECONIUM|SOLIDIFIED|N|ZIEHL NEELSEN ACID FAST STAIN|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|3|SCREENING|2020-08-28|2020-09-15|10|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|416fe99b-1258-4e72-b1df-48b989f8f8ed|2|INSULINR|Insulin Resistance|URINALYSIS|[?]|/4.0 mL|[?]|[?]|BORDERLINE|1|mg/mL/day|1|1|[?]|HIGH|MONOCYTE|DRIED|N|SLOAN LETTER EYE CHART 1.25%|MDRD 6 VARIABLE FORMULA|||N||1|Visit_1|10|7|TREATMENT|2020-08-28|2020-09-30|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|416fe99b-1258-4e72-b1df-48b989f8f8ed|3|EPINSQCE|Non-Squamous Epithelial Cells|HEMATOLOGY|[?]|10^6 copies/mL|[?]|[?]|NEGATIVE|1|mL/cage/wk|1|1|[?]|HIGH|LEUKOCYTE|AUTOLYZED|N|ELECTROGASTROGRAPHY|COCKCROFT-GAULT FORMULA|||N||2|Visit_2|25|6|FOLLOW-UP|2020-09-12|2020-11-20|25|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|416fe99b-1258-4e72-b1df-48b989f8f8ed|4|ZPP|Zinc Protoporphyrin|CHEMISTRY|[?]|nkat/L|[?]|[?]|INVALID|1|log10 TCID 50/dose|1|1|[?]|NORMAL|SEBUM|AUTOLYZED||STRESS ECHOCARDIOGRAPHY|HEPASCORE FORMULA|||NA||2|Visit_2|25|7|SCREENING|2020-09-12|2020-10-28|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|LB|416fe99b-1258-4e72-b1df-48b989f8f8ed|5|LRZPM|Lorazepam|HEMATOLOGY|[?]|10^9/g|[?]|[?]|BORDERLINE|1|JAR|1|1|[?]|ABNORMAL|BONE MARROW|NON-HEMOLYZED||TRANSMISSION ELECTRON MICROSCOPY|MDRD 5 VARIABLE FORMULA|Y|Y|Y||3|Visit_3|40|6|TREATMENT|2020-09-27|2020-10-11|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|416fe99b-1258-4e72-b1df-48b989f8f8ed|6|CSGRANF|Granular Fine Casts|CHEMISTRY|[?]|TUBE|[?]|[?]|INDETERMINATE|1|mPa|1|1|[?]|LOW|ENDOMETRIAL TISSUE|NON-HEMOLYZED||SLIT LAMP|MDRD FORMULA|||N||3|Visit_3|40|4|WASHOUT|2020-09-27|2020-10-08|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|LB|416fe99b-1258-4e72-b1df-48b989f8f8ed|7|HLAB27AG|HLA-B27 Antigen|CHEMISTRY|||[?]|[?]|INVALID|1|pkat/L|1|1|[?]|ABNORMAL|VENOUS BLOOD|REFRIGERATED|N|ROMANOWSKY STAIN|MDRD 5 VARIABLE FORMULA|||U|Y|4|Visit_4|65|3|FOLLOW-UP|2020-10-22|2020-10-31|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|416fe99b-1258-4e72-b1df-48b989f8f8ed|8|FRFEABS|Fractional Iron Absorption|CHEMISTRY|[?]|VOXEL|[?]|[?]|TRACE|1|mmHg/sec|1|1|[?]|LOW|ABSCESS FLUID|NON-HEMOLYZED||SLOAN LETTER EYE CHART 2.5%|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|3|FOLLOW-UP|2020-10-22|2020-10-23|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|416fe99b-1258-4e72-b1df-48b989f8f8ed|9|FATBODOV|Fat Bodies, Oval|URINALYSIS|[?]|lm|[?]|[?]|POSITIVE|1|/mm2|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|NON-HEMOLYZED|N|ACRIDINE ORANGE STAIN|CKD-EPI CYSTATIN C FORMULA||Y|Y||5|Visit_5|90|2|TREATMENT|2020-11-16|2020-11-18|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|416fe99b-1258-4e72-b1df-48b989f8f8ed|10|EPINSQCE|Non-Squamous Epithelial Cells|URINALYSIS|[?]|Bq/g|[?]|[?]|TRACE|1|ug/cm2|1|1|[?]|LOW|GASTRIC CONTENTS|FRESH||HEMAGGLUTINATION ASSAY|HEPASCORE FORMULA|||U||5|Visit_5|90|7|WASHOUT|2020-11-16|2020-11-22|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|16a9e070-3e5d-444c-9ac1-6a1abfac0370|1|ASP|Aspartic Acid|HEMATOLOGY|[?]|MONTHS|[?]|[?]|BORDERLINE|1|%/min|1|1|[?]|ABNORMAL|SERUM|CLOTTED||HIGH LEVEL AMINOGLYCOSIDE SCREEN|HEPASCORE FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-05-26|2020-08-11|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|16a9e070-3e5d-444c-9ac1-6a1abfac0370|2|ALPLALP|Alk Phos, Liver/Total Alk Phos|HEMATOLOGY|[?]|umol/kg/min|[?]|[?]|TRACE|1|mCi/kg|1|1|[?]|ABNORMAL|MONOCYTE|AGGLUTINATED||PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|NA||1|Visit_1|10|5|TREATMENT|2020-05-26|2020-07-01|10|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|16a9e070-3e5d-444c-9ac1-6a1abfac0370|3|CHCNT|Corpuscular Hemoglobin Content|URINALYSIS|[?]|Enzyme U/g Hb|[?]|[?]|BORDERLINE|1|BP|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|SOLIDIFIED||FLUORESCEIN STAIN|FIBROMETER FORMULA|Y||N||2|Visit_2|25|7|TREATMENT|2020-06-10|2020-07-06|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|LB|16a9e070-3e5d-444c-9ac1-6a1abfac0370|4|NEUTCYBS|Cytoplasmic Basophilia Neutrophil|CHEMISTRY|[?]|L/day|[?]|[?]|POSITIVE|1|U/m2/h|1|1|[?]|LOW|GASTRIC CONTENTS|AGGLUTINATED|N|SLIT LAMP|NASH FIBROSURE FORMULA||Y|U||2|Visit_2|25|5|WASHOUT|2020-06-10|2020-07-18|25|63|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|LB|16a9e070-3e5d-444c-9ac1-6a1abfac0370|5|HDL|HDL Cholesterol|URINALYSIS|[?]|ug/mol|[?]|[?]|INDETERMINATE|1|PACKET|1|1|[?]|ABNORMAL|PLEURAL TISSUE|FRESH|N|FLUORESCENCE ANGIOGRAPHY|FIBROTEST FORMULA|||U||3|Visit_3|40|4|TREATMENT|2020-06-25|2020-07-28|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|16a9e070-3e5d-444c-9ac1-6a1abfac0370|6|NMH|N-methylhistamine|URINALYSIS|[?]|RFU|[?]|[?]|NEGATIVE|1|TUBE|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|AUTOLYZED||SLIT LAMP|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-06-25|2020-08-20|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|16a9e070-3e5d-444c-9ac1-6a1abfac0370|7|C165925|Weed Mix Pollen IgE AB RAST Score|CHEMISTRY|[?]|mg/kg/dose|[?]|[?]|BORDERLINE|1|L/L|1|1|[?]|ABNORMAL|EPITHELIAL CELL|UNEXPECTED ODOR||DISK DIFFUSION|MDRD 6 VARIABLE FORMULA|Y||U||4|Visit_4|65|3|SCREENING|2020-07-20|2020-08-09|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|16a9e070-3e5d-444c-9ac1-6a1abfac0370|8|VITD2425|24,25-Dihydroxyvitamin D|CHEMISTRY|[?]|Ci/ug|[?]|[?]|POSITIVE|1|%/s|1|1|[?]|HIGH|SWABBED MATERIAL|CONTAMINATED||LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|FIBROMETER FORMULA|Y||NA||4|Visit_4|65|6|SCREENING|2020-07-20|2020-07-21|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|16a9e070-3e5d-444c-9ac1-6a1abfac0370|9|SMTHAB|Smith Antibody|HEMATOLOGY|[?]|cmol/L|[?]|[?]|INVALID|1|LB|1|1|[?]|HIGH|BLOOD|DRIED|N|TARGETED TRANSCRIPTOME SEQUENCING|CKD-EPI CREATININE FORMULA|||N||5|Visit_5|90|3|FOLLOW-UP|2020-08-14|2020-08-16|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|16a9e070-3e5d-444c-9ac1-6a1abfac0370|10|CBB|Complement Bb|HEMATOLOGY|[?]|IU|[?]|[?]|INDETERMINATE|1|IU/g Hb|1|1|[?]|NORMAL|PLATELET|FRESH||BIOPSY|MDRD FORMULA|||N||5|Visit_5|90|2|SCREENING|2020-08-14|2020-08-23|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|LB|1497a00d-55b1-4e02-a957-cf15e3d15512|1|LVTRCTM|Levetiracetam|URINALYSIS|[?]|ELISA unit/mL|[?]|[?]|TRACE|1|10^7 PFU|1|1|[?]|LOW|ATHEROSCLEROTIC PLAQUE|THAWED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2021-01-25|2021-03-13|10|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|1497a00d-55b1-4e02-a957-cf15e3d15512|2|FAS|Fas Cell Surface Death Receptor|URINALYSIS|[?]|10^6 organisms/mg|[?]|[?]|INDETERMINATE|1|um|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|FRESH||ICC|NASH FIBROSURE FORMULA|Y||Y||1|Visit_1|10|2|SCREENING|2021-01-25|2021-03-03|10|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|LB|1497a00d-55b1-4e02-a957-cf15e3d15512|3|ANA|Antinuclear Antibodies|URINALYSIS|[?]|mMU/mL|[?]|[?]|INVALID|1|ugEq/L|1|1|[?]|ABNORMAL|EMESIS|FROZEN||GC/MS/MS|MDRD ENZYMATIC JAPANESE FORMULA|||U||2|Visit_2|25|7|TREATMENT|2021-02-09|2021-03-12|25|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-12
e|LB|1497a00d-55b1-4e02-a957-cf15e3d15512|4|FAT|Fat|CHEMISTRY|[?]|mL/dL|[?]|[?]|INDETERMINATE|1|mg/kg/min|1|1|[?]|HIGH|SMEGMA|ICTERIC||FLOCCULATION, CHARCOAL ENHANCED|MDRD ENZYMATIC JAPANESE FORMULA|||NA||2|Visit_2|25|5|WASHOUT|2021-02-09|2021-02-14|25|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-12
e|LB|1497a00d-55b1-4e02-a957-cf15e3d15512|5|PLATBIZ|Bizarre Platelets|CHEMISTRY|[?]|L|[?]|[?]|NEGATIVE|1|U/mmol|1|1|[?]|NORMAL|ALVEOLAR AIR|ICTERIC||JAFFE REACTION|MDRD 6 VARIABLE FORMULA|||U||3|Visit_3|40|6|TREATMENT|2021-02-24|2021-03-17|40|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-17
e|LB|1497a00d-55b1-4e02-a957-cf15e3d15512|6|MACROBLD|Macroscopic Blood|HEMATOLOGY|[?]|ug/kg/min|[?]|[?]|INDETERMINATE|1|DIP|1|1|[?]|ABNORMAL|SPUTUM|CONCENTRATED|N|RULER MEASUREMENT METHOD|GMI % FORMULA|||U||3|Visit_3|40|7|SCREENING|2021-02-24|2021-02-28|40|44|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-17
e|LB|1497a00d-55b1-4e02-a957-cf15e3d15512|7|SPERMMTL|Sperm Motility|URINALYSIS|||[?]|[?]|TRACE|1|gpELISA unit/mL|1|1|[?]|LOW|ENDOTRACHEAL FLUID|UNEXPECTED ODOR||HPLC/IEX|MDRD FORMULA|||N|Y|4|Visit_4|65|4|TREATMENT|2021-03-21|2021-03-30|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-09
e|LB|1497a00d-55b1-4e02-a957-cf15e3d15512|8|CASTS|Casts|URINALYSIS|[?]|cL|[?]|[?]|INVALID|1|genEq|1|1|[?]|LOW|TISSUE|SOLIDIFIED|N|AUTOMATED COUNT|MDRD 5 VARIABLE FORMULA|Y||Y||4|Visit_4|65|7|TREATMENT|2021-03-21|2021-04-05|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-09
e|LB|1497a00d-55b1-4e02-a957-cf15e3d15512|9|LIPASEG|Lipase, Gastric|CHEMISTRY|[?]|scm|[?]|[?]|POSITIVE|1|/5x10^4 WBC|1|1|[?]|ABNORMAL|EPITHELIAL CELL|PARAFFIN-EMBEDDED||IMMUNOBLOT|FIBROTEST FORMULA|||N||5|Visit_5|90|5|WASHOUT|2021-04-15|2021-04-24|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|1497a00d-55b1-4e02-a957-cf15e3d15512|10|TTGIGAAB|Tissue Transglutaminase IgA Antibody|HEMATOLOGY|[?]|TUBE|[?]|[?]|NEGATIVE|1|BU/mL|1|1|[?]|ABNORMAL|PLEURAL TISSUE|AUTOLYZED||PLAQUE REDUCTION NEUTRALIZATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||5|Visit_5|90|5|WASHOUT|2021-04-15|2021-04-21|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|1|CA125AG|Cancer Antigen 125|URINALYSIS|||[?]|[?]|INDETERMINATE|1|uOsm|1|1|[?]|ABNORMAL|DISCHARGE|CONTAMINATED||SPECTROPHOTOMETRY|MDRD 5 VARIABLE FORMULA||Y|U|Y|1|Visit_1|10|7|SCREENING|2020-07-21|2020-10-17|10|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|LB|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|2|APOE|Apolipoprotein E|URINALYSIS|[?]|v/v|[?]|[?]|BORDERLINE|1|GPL U/mL|1|1|[?]|HIGH|SEMEN|CONTAMINATED|N|CONTRAST ENHANCED CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-07-21|2020-09-27|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|LB|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|3|C130084|English Plantain Pollen IgE|URINALYSIS|||[?]|[?]|NEGATIVE|1|umol/L/sec|1|1|[?]|HIGH|GASTRIC FLUID|AUTOLYZED|N|RAJI CELL EIA|MDRD 4 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|5|TREATMENT|2020-08-05|2020-09-12|25|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|4|AMBRBTL|Amobarbital|HEMATOLOGY|[?]|/MBP|[?]|[?]|BORDERLINE|1|g/cage/day|1|1|[?]|NORMAL|PLATELET|CONTAMINATED||ICP-MS|FIBROSIS 4 FORMULA|Y||Y||2|Visit_2|25|5|TREATMENT|2020-08-05|2020-09-21|25|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|5|TTAC|Thrombin Time Actual/Control|CHEMISTRY|[?]|U|[?]|[?]|POSITIVE|1|APPLICATION|1|1|[?]|HIGH|SKIN TISSUE|FRESH||PANENDOSCOPY|COCKCROFT-GAULT FORMULA||Y|NA||3|Visit_3|40|1|SCREENING|2020-08-20|2020-09-19|40|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|6|GLUCCLR|Glucose Clearance|CHEMISTRY|[?]|FIU|[?]|[?]|BORDERLINE|1|kcal/day|1|1|[?]|NORMAL|LYSATE|DRIED|N|IMMUNOFIXATION ELECTROPHORESIS|FIBROSIS 4 FORMULA|||NA||3|Visit_3|40|4|TREATMENT|2020-08-20|2020-10-04|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|7|HGBFPATN|Hemoglobin Fraction Pattern|CHEMISTRY|||[?]|[?]|TRACE|1|10^3 RNA copies/mL|1|1|[?]|LOW|STOOL|ROOM TEMPERATURE||TRICHROME STAIN|CKD-EPI FORMULA|||Y|Y|4|Visit_4|65|6|TREATMENT|2020-09-14|2020-10-14|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|8|RANKL|Receptor Activator Nuclear KappaB Ligand|CHEMISTRY|[?]|U/dL|[?]|[?]|TRACE|1|amu|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|GELLED||ELECTROMYOGRAPHY|MDRD 4 VARIABLE FORMULA|||Y||4|Visit_4|65|3|FOLLOW-UP|2020-09-14|2020-10-18|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|LB|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|9|ANAG|Alpha-N-acetylglucosaminidase|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|lx|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|DRIED|N|HPLC/IEX|GMI % FORMULA|||U|Y|5|Visit_5|90|7|SCREENING|2020-10-09|2020-10-18|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|LB|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|10|APOE4|Apolipoprotein E4|URINALYSIS|||[?]|[?]|NEGATIVE|1|V/sec|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED||DUKE INCISION METHOD|MDRD 6 VARIABLE FORMULA||Y|NA|Y|5|Visit_5|90|6|TREATMENT|2020-10-09|2020-10-13|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|LB|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|1|STBSEXCS|Standard Base Excess|CHEMISTRY|[?]|mOsm/L|[?]|[?]|INVALID|1|GBq/ug|1|1|[?]|ABNORMAL|SERUM OR PLASMA|HEMOLYZED||TURBIDIMETRY|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|6|TREATMENT|2020-12-09|2020-12-11|10|12|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|2|PICP|Procollagen Type I Carboxy Term Peptide|HEMATOLOGY|||[?]|[?]|INVALID|1|100 IU/mL|1|1|[?]|LOW|PERSPIRATION|CONTAMINATED||WHOLE TRANSCRIPTOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|1|Visit_1|10|7|WASHOUT|2020-12-09|2021-01-31|10|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|3|PLATLRG|Large Platelets|URINALYSIS|[?]|MBP|[?]|[?]|POSITIVE|1|DIP|1|1|[?]|ABNORMAL|SALIVA|GELLED|N|CONFOCAL MICROSCOPY|CKD-EPI CREATININE FORMULA|||U||2|Visit_2|25|7|FOLLOW-UP|2020-12-24|2021-02-17|25|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|4|IDL|IDL Cholesterol|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mg/kg/week|1|1|[?]|NORMAL|RETICULOCYTES|GELLED|N|TRANSMISSION ELECTRON MICROSCOPY|COCKCROFT-GAULT FORMULA||Y|N|Y|2|Visit_2|25|7|WASHOUT|2020-12-24|2021-03-06|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|5|FBNCTCE|Fibronectin, Cellular|HEMATOLOGY|[?]|CAN|[?]|[?]|BORDERLINE|1|EID 50/dose|1|1|[?]|ABNORMAL|LAVAGE FLUID|GELLED||LEAD CITRATE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||3|Visit_3|40|1|TREATMENT|2021-01-08|2021-02-19|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|6|C165918|American Cockroach IgG AB RAST Score|CHEMISTRY|||[?]|[?]|POSITIVE|1|Ci/ug|1|1|[?]|ABNORMAL|KERATINOCYTE|NON-HEMOLYZED|N|CONTRAST ENHANCED X-RAY|MDRD 5 VARIABLE FORMULA|||U|Y|3|Visit_3|40|1|FOLLOW-UP|2021-01-08|2021-01-18|40|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|7|BCEFNCTN|Beta-cell Function|HEMATOLOGY|[?]|breaths/30s|[?]|[?]|INVALID|1|ug/m2/min|1|1|[?]|ABNORMAL|STOOL|UNEXPECTED ODOR||MOUSE PROTECTION ASSAY|MDRD 4 VARIABLE FORMULA|Y||U||4|Visit_4|65|1|SCREENING|2021-02-02|2021-02-05|65|68|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|8|ICAM1|Intercellular Adhesion Molecule 1|CHEMISTRY|[?]|PIPE|[?]|[?]|BORDERLINE|1|VIRTUAL PIXEL|1|1|[?]|ABNORMAL|BONE MARROW|ICTERIC||CONGO RED STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||N||4|Visit_4|65|7|SCREENING|2021-02-02|2021-02-15|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|9|PDW|Platelet Distribution Width|HEMATOLOGY|[?]|s*kPa|[?]|[?]|NEGATIVE|1|kDa|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|DRIED||TRICHROME STAIN|FIBROTEST FORMULA|Y||Y||5|Visit_5|90|1|TREATMENT|2021-02-27|2021-03-07|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|10|C130068|Bermuda Grass Pollen IgE|HEMATOLOGY|[?]|mN|[?]|[?]|INVALID|1|U/g|1|1|[?]|ABNORMAL|URINE|CONCENTRATED|N|SPIROMETRY|HEPASCORE FORMULA|||N||5|Visit_5|90|6|TREATMENT|2021-02-27|2021-03-02|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|1|FECL|Fractional Chloride Excretion|CHEMISTRY|[?]|Henry|[?]|[?]|BORDERLINE|1|APL U|1|1|[?]|LOW|INTERSTITIAL FLUID|ROOM TEMPERATURE||QUANTITATIVE ULTRASOUND|MDRD ENZYMATIC FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-11-05|2021-01-16|10|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|2|VEGFR2|Vasc Endothelial Growth Factor Rec 2|CHEMISTRY|[?]|PFU/mL|[?]|[?]|TRACE|1|pkat|1|1|[?]|HIGH|ALVEOLAR AIR|CALCIFIED||SCANNING ELECTRON MICROSCOPY|MDRD 6 VARIABLE FORMULA|Y|Y|N||1|Visit_1|10|7|TREATMENT|2020-11-05|2020-11-19|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|LB|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|3|CATNINB|Beta Catenin|HEMATOLOGY|[?]|10^6 U|[?]|[?]|INVALID|1|IU/L|1|1|[?]|HIGH|SKIN TISSUE|LIPEMIC||FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|GMI % FORMULA|Y||N||2|Visit_2|25|2|TREATMENT|2020-11-20|2020-11-25|25|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|4|C130095|Western Ragweed Pollen IgG4|HEMATOLOGY|[?]|pt_us|[?]|[?]|INDETERMINATE|1|PACKET|1|1|[?]|NORMAL|LEUKOCYTE|DRIED||SMEAR|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||2|Visit_2|25|2|TREATMENT|2020-11-20|2020-12-23|25|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|5|MANNITOL|Mannitol|CHEMISTRY|[?]|10^6/L|[?]|[?]|NEGATIVE|1|K|1|1|[?]|LOW|CAPILLARY BLOOD|CONTAMINATED|N|REVERSE TRANSCRIPTASE PCR|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-12-05|2020-12-13|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|6|ESTRIOL|Estriol|URINALYSIS|||[?]|[?]|POSITIVE|1|DIOPTER|1|1|[?]|HIGH|INFRANATANT, SERUM|NON-HEMOLYZED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|3|Visit_3|40|1|FOLLOW-UP|2020-12-05|2020-12-19|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|LB|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|7|NFHP|Phosphorylated Neurofilament Heavy Chain|CHEMISTRY|[?]|/2500 WBC|[?]|[?]|BORDERLINE|1|100 IU/mL|1|1|[?]|LOW|CAPILLARY BLOOD|PARAFFIN-EMBEDDED||SLIT LAMP PHOTOGRAPHY|COCKCROFT-GAULT FORMULA|Y|Y|U||4|Visit_4|65|6|WASHOUT|2020-12-30|2021-01-21|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|LB|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|8|CSBACT|Bacterial Casts|HEMATOLOGY|||[?]|[?]|INVALID|1|pmol/dL|1|1|[?]|HIGH|CORD BLOOD|THAWED||IMPEDANCE CONDUCTIVITY|MDRD 4 VARIABLE FORMULA||Y|Y|Y|4|Visit_4|65|5|TREATMENT|2020-12-30|2020-12-31|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|LB|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|9|HCGFR|Choriogonadotropin Beta, Free|HEMATOLOGY|[?]|log10 PFU/mL|[?]|[?]|BORDERLINE|1|cy/cm|1|1|[?]|NORMAL|PROSTATIC FLUID|UNEXPECTED ODOR||ELECTROMYOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|6|FOLLOW-UP|2021-01-24|2021-02-02|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|10|LDH4LDH|LDH Isoenzyme 4/LDH|HEMATOLOGY|[?]|10^3 DNA copies/mL|[?]|[?]|TRACE|1|cm H2O|1|1|[?]|HIGH|KERATINOCYTE|NON-HEMOLYZED||VIRUS PLAQUE ASSAY|MDRD 6 VARIABLE FORMULA|Y|Y|N||5|Visit_5|90|3|TREATMENT|2021-01-24|2021-01-31|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|LB|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|1|EOSBLE|Eosinophils Band Form/Leukocytes|CHEMISTRY|[?]|nm|[?]|[?]|NEGATIVE|1|BAR|1|1|[?]|HIGH|EMESIS|CONCENTRATED||LASER CAPTURE MICRODISSECTION|MDRD ENZYMATIC FORMULA|||Y||1|Visit_1|10|3|TREATMENT|2020-05-27|2020-06-11|10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|2|APLSMA2A|Alpha-2 Antiplasmin Activity|URINALYSIS|||[?]|[?]|BORDERLINE|1|mL/dose|1|1|[?]|NORMAL|ERYTHROCYTES|AUTOLYZED|N|POTENTIOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|1|Visit_1|10|2|TREATMENT|2020-05-27|2020-07-23|10|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|3|PNCTPP|Pancreatic Polypeptide|URINALYSIS|[?]|ug/animal|[?]|[?]|TRACE|1|EVENTS|1|1|[?]|LOW|BILE|AGGLUTINATED||NEPHELOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-06-11|2020-07-18|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|LB|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|4|CLCREAT|Chloride/Creatinine|HEMATOLOGY|[?]|Gravitational Unit|[?]|[?]|INVALID|1|mL/animal/wk|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|THAWED|N|RADIAL IMMUNODIFFUSION|MDRD 6 VARIABLE FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2020-06-11|2020-07-07|25|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|LB|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|5|FERRITIN|Ferritin|URINALYSIS|[?]|pmol/dL|[?]|[?]|NEGATIVE|1|10^6/hpf|1|1|[?]|LOW|MENSTRUAL BLOOD|AUTOLYZED||AMSLER GRID|MDRD 4 VARIABLE FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2020-06-26|2020-08-08|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|6|HCGFR|Choriogonadotropin Beta, Free|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mg/day|1|1|[?]|NORMAL|VITREOUS HUMOR|DRIED||HIGH RESOLUTION CT|CKD-EPI CREATININE FORMULA|||NA|Y|3|Visit_3|40|3|TREATMENT|2020-06-26|2020-08-04|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|LB|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|7|PHOSCLR|Phosphate Clearance|CHEMISTRY|[?]|mmHg/L/min|[?]|[?]|TRACE|1|ug/mol|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|CONCENTRATED||CONTRAST ENHANCED MRI|HEPASCORE FORMULA|Y||N||4|Visit_4|65|7|TREATMENT|2020-07-21|2020-08-12|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|8|LDH2|LDH Isoenzyme 2|URINALYSIS|[?]|mL/mmHg/min/L|[?]|[?]|TRACE|1|mL/sec/1.73m2|1|1|[?]|LOW|CALCULUS|CONCENTRATED|N|ISHIHARA COLOR PLATES|HEPASCORE FORMULA||Y|N||4|Visit_4|65|3|SCREENING|2020-07-21|2020-08-09|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|LB|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|9|C5A|Complement C5a|HEMATOLOGY|[?]|log10 PFU|[?]|[?]|BORDERLINE|1|U/m2|1|1|[?]|ABNORMAL|LYSATE|CONCENTRATED|N|CLIP SEQUENCING|NASH FIBROSURE FORMULA||Y|Y||5|Visit_5|90|3|SCREENING|2020-08-15|2020-08-23|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|10|HBOARBHB|Hemoglobin O-Arab/Total Hemoglobin|CHEMISTRY|[?]|mL/m2/min|[?]|[?]|INDETERMINATE|1|10^7 CFU/mL|1|1|[?]|ABNORMAL|PLATELET|LACTESCENT||RADIOIMMUNOPRECIPITATION ASSAY|COCKCROFT-GAULT FORMULA||Y|N||5|Visit_5|90|5|TREATMENT|2020-08-15|2020-08-22|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|LB|2216086b-197e-4780-8e10-28123eb090c5|1|CARNIT|Carnitine|CHEMISTRY|[?]|mol/g|[?]|[?]|POSITIVE|1|CFU/g|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|CLOTTED||ACRIDINE ORANGE STAIN|FIBROSIS 4 FORMULA||Y|Y||1|Visit_1|10|7|FOLLOW-UP|2020-12-12|2021-03-11|10|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|2216086b-197e-4780-8e10-28123eb090c5|2|CD19|CD19|CHEMISTRY|[?]|um/day|[?]|[?]|TRACE|1|m3|1|1|[?]|HIGH|VITREOUS HUMOR|CLOTTED|N|EIA|GMI MMOL/MOL FORMULA|||U||1|Visit_1|10|6|SCREENING|2020-12-12|2020-12-31|10|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|LB|2216086b-197e-4780-8e10-28123eb090c5|3|CD40|CD40|URINALYSIS|[?]|um|[?]|[?]|INDETERMINATE|1|ug/L/h|1|1|[?]|LOW|SUPERNATANT, SERUM OR PLASMA|ROOM TEMPERATURE||CONTRAST ENHANCED MRI|ASH FIBROSURE FORMULA|||Y||2|Visit_2|25|6|SCREENING|2020-12-27|2021-03-01|25|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|2216086b-197e-4780-8e10-28123eb090c5|4|MYCY|Myelocytes|HEMATOLOGY|[?]|nmol/mol|[?]|[?]|BORDERLINE|1|ugEq|1|1|[?]|NORMAL|SERUM|CALCIFIED||WRIGHT-GIEMSA STAIN|COCKCROFT-GAULT FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-12-27|2021-02-13|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|LB|2216086b-197e-4780-8e10-28123eb090c5|5|HLABAGT|HLA-B Antigen Type|CHEMISTRY|||[?]|[?]|POSITIVE|1|g/m2|1|1|[?]|ABNORMAL|SEMINAL FLUID|LACTESCENT||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|ASH FIBROSURE FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2021-01-11|2021-01-22|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|2216086b-197e-4780-8e10-28123eb090c5|6|KLHIGGAB|Keyhole Limpet Hemocyanin IgG Antibody|URINALYSIS|[?]|lm|[?]|[?]|BORDERLINE|1|PFU|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|DRIED|N|CELL OF ORIGIN ASSAY|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2021-01-11|2021-02-22|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|LB|2216086b-197e-4780-8e10-28123eb090c5|7|HOWJOL|Howell-Jolly Bodies|CHEMISTRY|||[?]|[?]|TRACE|1|beats/min|1|1|[?]|LOW|SUPERNATANT, SERUM|FRESH||CONTACT SPECULAR MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|4|Visit_4|65|7|SCREENING|2021-02-05|2021-02-28|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|2216086b-197e-4780-8e10-28123eb090c5|8|MASTCECE|Mast Cells/Total Cells|HEMATOLOGY|[?]|Ejaculate U|[?]|[?]|TRACE|1|BU/mL|1|1|[?]|NORMAL|PLATELET|NON-HEMOLYZED||IMMUNOCHROMATOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||U||4|Visit_4|65|2|SCREENING|2021-02-05|2021-02-25|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|LB|2216086b-197e-4780-8e10-28123eb090c5|9|PLSTCE|Total Plasma Cells|HEMATOLOGY|[?]|pmol/L|[?]|[?]|POSITIVE|1|U/mmol|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|AUTOLYZED||MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||5|Visit_5|90|5|TREATMENT|2021-03-02|2021-03-05|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|2216086b-197e-4780-8e10-28123eb090c5|10|IOTCLR|Iothalamate Clearance|HEMATOLOGY|[?]|10^6/L|[?]|[?]|POSITIVE|1|mg/m2/h|1|1|[?]|LOW|HAIR|UNEXPECTED ODOR||TRIPLE-PHASE MRI SCAN|FIBROMETER FORMULA||Y|N||5|Visit_5|90|1|TREATMENT|2021-03-02|2021-03-08|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|LB|7280f69c-a0f4-48b5-b714-1e272193168c|1|LYMCLF|Lymphocytes, Clefted|URINALYSIS|[?]|%/s|[?]|[?]|INVALID|1|nmol/g|1|1|[?]|NORMAL|EMOTIONAL TEAR|THAWED||SINGLE-SLICE SPIRAL CT|HEPASCORE FORMULA||Y|NA||1|Visit_1|10|4|WASHOUT|2020-08-19|2020-09-16|10|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|7280f69c-a0f4-48b5-b714-1e272193168c|2|PAH|P-Aminohippurate Sodium|HEMATOLOGY|||[?]|[?]|INVALID|1|% INHIBITION|1|1|[?]|HIGH|RETICULOCYTES|DRIED||MYELOPEROXIDASE STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||N|Y|1|Visit_1|10|7|WASHOUT|2020-08-19|2020-09-04|10|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|LB|7280f69c-a0f4-48b5-b714-1e272193168c|3|KETONEBD|Ketone Bodies|URINALYSIS|[?]|EU|[?]|[?]|TRACE|1|FINGERTIP UNIT|1|1|[?]|LOW|URINE|FRESH||IMMUNORADIOMETRIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|2|TREATMENT|2020-09-03|2020-11-05|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|7280f69c-a0f4-48b5-b714-1e272193168c|4|HCGNDI|Choriogonadotropin, Intact|URINALYSIS|[?]|TRACE|[?]|[?]|BORDERLINE|1|nkat|1|1|[?]|NORMAL|CAPILLARY BLOOD|CALCIFIED||PET/MRI SCAN|GMI MMOL/MOL FORMULA|Y|Y|NA||2|Visit_2|25|5|SCREENING|2020-09-03|2020-10-09|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|7280f69c-a0f4-48b5-b714-1e272193168c|5|CSCYL|Cylindroid Casts|CHEMISTRY|||[?]|[?]|POSITIVE|1|cL|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|FRESH||REFRACTOMETRY|FIBROMETER FORMULA|||U|Y|3|Visit_3|40|4|FOLLOW-UP|2020-09-18|2020-10-29|40|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|7280f69c-a0f4-48b5-b714-1e272193168c|6|TIMP1CRE|TIMP1/Creatinine|URINALYSIS|||[?]|[?]|TRACE|1|DRINK|1|1|[?]|NORMAL|VENOUS PLASMA|LIPEMIC||MS/MS|CKD-EPI FORMULA|||Y|Y|3|Visit_3|40|3|TREATMENT|2020-09-18|2020-10-28|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|7280f69c-a0f4-48b5-b714-1e272193168c|7|COQ10|Ubiquinone 10|URINALYSIS|||[?]|[?]|NEGATIVE|1|PFU/animal|1|1|[?]|ABNORMAL|ARTERIAL CORD BLOOD|GELLED||ANTIMICROBIAL COMBINATION TESTING|MDRD 5 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|3|TREATMENT|2020-10-13|2020-11-04|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|7280f69c-a0f4-48b5-b714-1e272193168c|8|CCL16|Chemokine (C-C Motif) Ligand 16|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mL/h|1|1|[?]|ABNORMAL|CERUMEN|LIPEMIC||APPLANATION TONOMETRY|MDRD FORMULA|Y||Y|Y|4|Visit_4|65|2|TREATMENT|2020-10-13|2020-11-06|65|89|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|LB|7280f69c-a0f4-48b5-b714-1e272193168c|9|TK2|Thymidine Kinase 2|HEMATOLOGY|||[?]|[?]|POSITIVE|1|U/mg|1|1|[?]|NORMAL|CERUMEN|ROOM TEMPERATURE||CALCULATION|CKD-EPI FORMULA||Y|U|Y|5|Visit_5|90|3|WASHOUT|2020-11-07|2020-11-16|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|7280f69c-a0f4-48b5-b714-1e272193168c|10|INTLK29|Interleukin 29|HEMATOLOGY|[?]|fmol/L/sec|[?]|[?]|TRACE|1|ng/mol|1|1|[?]|HIGH|STOOL|CALCIFIED||GC/FID|GMI % FORMULA|Y||N||5|Visit_5|90|3|TREATMENT|2020-11-07|2020-11-15|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|LB|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|1|AMA|Antimitochondrial Antibodies|URINALYSIS|||[?]|[?]|BORDERLINE|1|SACHET|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|HEMOLYZED||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA|||N|Y|1|Visit_1|10|6|FOLLOW-UP|2020-08-01|2020-09-11|10|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|2|SMTHAB|Smith Antibody|URINALYSIS|||[?]|[?]|INVALID|1|fraction of 1|1|1|[?]|LOW|EXPIRED AIR|AGGLUTINATED|N|FISH|COCKCROFT-GAULT FORMULA|Y||NA|Y|1|Visit_1|10|7|FOLLOW-UP|2020-08-01|2020-10-08|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|LB|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|3|RBC|Erythrocytes|CHEMISTRY|||[?]|[?]|TRACE|1|nsec|1|1|[?]|LOW|SPERMATOZOON|NON-HEMOLYZED|N|FLUORESCENT IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|Y|Y|U|Y|2|Visit_2|25|6|TREATMENT|2020-08-16|2020-09-22|25|62|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|4|SPMMSPM|Motile Sperm/Total Sperm|CHEMISTRY|||[?]|[?]|INVALID|1|AMPULE|1|1|[?]|HIGH|SALIVA|PARAFFIN-EMBEDDED||CONFOCAL MICROSCOPY|MDRD 6 VARIABLE FORMULA|||N|Y|2|Visit_2|25|2|TREATMENT|2020-08-16|2020-09-07|25|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|5|CYAMPPH|Amorphous Phosphate Crystals|URINALYSIS|||[?]|[?]|POSITIVE|1|ms2|1|1|[?]|ABNORMAL|TISSUE|AUTOLYZED||MEDIASTINOSCOPY|CKD-EPI FORMULA|||Y|Y|3|Visit_3|40|2|SCREENING|2020-08-31|2020-09-03|40|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|6|BPIAB|Bactericidal/Permeability-Inc Protein Ab|CHEMISTRY|[?]|mL/m2/h|[?]|[?]|POSITIVE|1|ug/kg|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|CLOTTED||MICROARRAY|CKD-EPI FORMULA|Y||Y||3|Visit_3|40|1|WASHOUT|2020-08-31|2020-10-03|40|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|LB|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|7|PSIGGAB|Phosphatidylserine IgG Antibody|URINALYSIS|[?]|U/kg/h|[?]|[?]|INVALID|1|CIGAR|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|CONTAMINATED||SURFACE PLASMON RESONANCE|HEPASCORE FORMULA|||NA||4|Visit_4|65|1|WASHOUT|2020-09-25|2020-10-07|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|8|NEUTTOXC|Neutrophilic Toxic Change|URINALYSIS|[?]|mg/kg/dose|[?]|[?]|NEGATIVE|1|ug/L DDU|1|1|[?]|HIGH|PLATELET POOR PLASMA|SOLIDIFIED|N|QUANTITATIVE ULTRASOUND|CKD-EPI FORMULA|||N||4|Visit_4|65|6|SCREENING|2020-09-25|2020-10-01|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|LB|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|9|BLSTLMLY|Leukemic Blasts/Lymphocytes|HEMATOLOGY|[?]|mEq/ug|[?]|[?]|BORDERLINE|1|log EID 50/dose|1|1|[?]|LOW|DIALYSIS FLUID|AUTOLYZED||PULMONARY ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||5|Visit_5|90|5|TREATMENT|2020-10-20|2020-10-26|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|10|ANIONG4|Anion Gap 4|HEMATOLOGY|[?]|s*kPa|[?]|[?]|NEGATIVE|1|h*%|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|ICTERIC||CENTRIFUGATION|FIBROSIS 4 FORMULA|Y||N||5|Visit_5|90|1|WASHOUT|2020-10-20|2020-10-22|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|LB|25c6812b-9200-4dc4-a954-6879183a2c54|1|CD161ALY|CD161a/Lymphocytes|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|foz_us|1|1|[?]|HIGH|PERSPIRATION|THAWED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|FIBROMETER FORMULA|||NA|Y|1|Visit_1|10|1|SCREENING|2020-12-24|2021-01-06|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|25c6812b-9200-4dc4-a954-6879183a2c54|2|PAP|Prostatic Acid Phosphatase|HEMATOLOGY|[?]|nm|[?]|[?]|INDETERMINATE|1|10^6 organisms/mL|1|1|[?]|NORMAL|HAIR FOLLICLE|ROOM TEMPERATURE||IMMUNOASSAY|FIBROMETER FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2020-12-24|2021-02-18|10|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|LB|25c6812b-9200-4dc4-a954-6879183a2c54|3|NEUTNSQE|Neutrophils/Non-Squam Epi Cells|HEMATOLOGY|[?]|BOWL|[?]|[?]|TRACE|1|10^6 DNA copies/mL|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|FRESH||THICK SMEAR|MDRD ENZYMATIC FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2021-01-08|2021-01-21|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|25c6812b-9200-4dc4-a954-6879183a2c54|4|MCH|Ery. Mean Corpuscular Hemoglobin|URINALYSIS|[?]|mph|[?]|[?]|INDETERMINATE|1|mg/g/min|1|1|[?]|LOW|SPERMATOZOON|NON-HEMOLYZED|N|NUCLEAR RADIOLOGY|MDRD FORMULA||Y|N||2|Visit_2|25|1|WASHOUT|2021-01-08|2021-02-16|25|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|LB|25c6812b-9200-4dc4-a954-6879183a2c54|5|MDMA|3,4-methylenedioxymethamphetamine|CHEMISTRY|[?]|AFU|[?]|[?]|BORDERLINE|1|mmHg/L/min|1|1|[?]|ABNORMAL|PLASMA|CONCENTRATED||MICROBIAL BIOCHEMICAL IDENTIFICATION|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|5|FOLLOW-UP|2021-01-23|2021-02-06|40|54|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|LB|25c6812b-9200-4dc4-a954-6879183a2c54|6|C130090|Timothy Grass Pollen IgG|URINALYSIS|[?]|Ejaculate U|[?]|[?]|TRACE|1|BAU/mL|1|1|[?]|HIGH|LEUKOCYTE|FRESH||FLUORESCEIN STAIN|HEPASCORE FORMULA|Y||N||3|Visit_3|40|4|TREATMENT|2021-01-23|2021-01-25|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|LB|25c6812b-9200-4dc4-a954-6879183a2c54|7|DPPIVA|Dipeptidyl Peptidase-4 Activity|CHEMISTRY|[?]|Osm|[?]|[?]|NEGATIVE|1|L/h/m2|1|1|[?]|NORMAL|DISCHARGE|DRIED||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|COCKCROFT-GAULT FORMULA|||Y||4|Visit_4|65|3|WASHOUT|2021-02-17|2021-03-22|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|LB|25c6812b-9200-4dc4-a954-6879183a2c54|8|MCPHGCE|Macrophages/Total Cells|CHEMISTRY|[?]|CCID 50/dose|[?]|[?]|NEGATIVE|1|TUBE|1|1|[?]|LOW|PLATELET POOR PLASMA|CONCENTRATED||QUANTITATIVE CORONARY ANGIOGRAPHY|COCKCROFT-GAULT FORMULA|Y||N||4|Visit_4|65|4|SCREENING|2021-02-17|2021-03-14|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|LB|25c6812b-9200-4dc4-a954-6879183a2c54|9|ANDSTNDN|Androstenedione|CHEMISTRY|[?]|pmol/dL|[?]|[?]|POSITIVE|1|Frames/s|1|1|[?]|HIGH|STOOL|SOLIDIFIED|N|ELISA|GMI % FORMULA|Y|Y|Y||5|Visit_5|90|7|WASHOUT|2021-03-14|2021-03-21|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|25c6812b-9200-4dc4-a954-6879183a2c54|10|MONONSQE|Monocytes/Non-Squam Epi Cells|URINALYSIS|||[?]|[?]|POSITIVE|1|10^3 copies/mL|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|CLOTTED||KINETIC CHROMOGENIC ASSAY|CKD-EPI CREATININE FORMULA||Y|Y|Y|5|Visit_5|90|1|TREATMENT|2021-03-14|2021-03-16|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|10dca475-f364-42f3-9192-faf762832adf|1|EOSNSQE|Eosinophils/Non-Squam Epi Cells|URINALYSIS|[?]|ELISA unit/mL|[?]|[?]|BORDERLINE|1|AgU/mL|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|N|ELLA|NASH FIBROSURE FORMULA||Y|N||1|Visit_1|10|6|TREATMENT|2020-09-25|2020-11-09|10|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|10dca475-f364-42f3-9192-faf762832adf|2|ERCECE|Erythroid Cells/Total Cells|URINALYSIS|[?]|U/dL|[?]|[?]|NEGATIVE|1|U/kg|1|1|[?]|HIGH|ABSCESS FLUID|AGGLUTINATED|N|TELLER ACUITY CARDS|HEPASCORE FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-09-25|2020-12-18|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|10dca475-f364-42f3-9192-faf762832adf|3|ENRAGE|Extracell Newly Ident RAGE Bind Protein|CHEMISTRY|[?]|g/L|[?]|[?]|TRACE|1|uU/L|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|HEMOLYZED||CHROMOGENIC ASSAY|GMI % FORMULA|||NA||2|Visit_2|25|5|FOLLOW-UP|2020-10-10|2020-11-01|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|10dca475-f364-42f3-9192-faf762832adf|4|ATHPIDX|Atherogenic Index of Plasma|URINALYSIS|[?]|IU/mmol|[?]|[?]|BORDERLINE|1|damol/L|1|1|[?]|LOW|AQUEOUS HUMOR|UNEXPECTED ODOR||ANALYTICAL ULTRACENTRIFUGATION|MDRD ENZYMATIC FORMULA||Y|Y||2|Visit_2|25|5|FOLLOW-UP|2020-10-10|2020-11-29|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|LB|10dca475-f364-42f3-9192-faf762832adf|5|NORMEEXR|Normetanephrine Excretion Rate|HEMATOLOGY|[?]|BAU/mL|[?]|[?]|BORDERLINE|1|/LPF|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|N|NUCLEIC ACID BASED METHOD|CKD-EPI FORMULA|||Y||3|Visit_3|40|6|TREATMENT|2020-10-25|2020-12-16|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|10dca475-f364-42f3-9192-faf762832adf|6|WBC|Leukocytes|CHEMISTRY|[?]|U/kg/day|[?]|[?]|TRACE|1|Tesla|1|1|[?]|ABNORMAL|URINE SEDIMENT|DRIED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|GMI MMOL/MOL FORMULA|||N||3|Visit_3|40|3|SCREENING|2020-10-25|2020-11-25|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|LB|10dca475-f364-42f3-9192-faf762832adf|7|PBGCREAT|Porphobilinogen/Creatinine|HEMATOLOGY|[?]|mL/cm|[?]|[?]|TRACE|1|GPS U|1|1|[?]|NORMAL|EMOTIONAL TEAR|THAWED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|FIBROSIS 4 FORMULA||Y|N||4|Visit_4|65|2|TREATMENT|2020-11-19|2020-12-04|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|10dca475-f364-42f3-9192-faf762832adf|8|FIBRINO|Fibrinogen|URINALYSIS|||[?]|[?]|INVALID|1|uU/L|1|1|[?]|ABNORMAL|SERUM OR PLASMA|AUTOLYZED|N|DISK DIFFUSION|MDRD 4 VARIABLE FORMULA|||U|Y|4|Visit_4|65|1|TREATMENT|2020-11-19|2020-12-14|65|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|LB|10dca475-f364-42f3-9192-faf762832adf|9|PLSNCE|Neoplastic Plasma Cells|URINALYSIS|[?]|IU/mmol|[?]|[?]|INDETERMINATE|1|L/kg|1|1|[?]|NORMAL|INFRANATANT, PLASMA|DRIED||INDIRECT IMMUNOFLUORESCENCE|MDRD ENZYMATIC FORMULA||Y|Y||5|Visit_5|90|5|FOLLOW-UP|2020-12-14|2020-12-16|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|10dca475-f364-42f3-9192-faf762832adf|10|GCDCA|Glycochenodeoxycholate|CHEMISTRY|[?]|mEq/ug|[?]|[?]|TRACE|1|%(w/w)|1|1|[?]|ABNORMAL|VENOUS CORD BLOOD|FRESH||RAJI CELL EIA|MDRD ENZYMATIC JAPANESE FORMULA|||Y||5|Visit_5|90|3|FOLLOW-UP|2020-12-14|2020-12-20|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|LB|caf54095-56c3-428f-8342-ce45c6c9a287|1|TIMP1|Tissue Inhibitor of Metalloproteinase 1|URINALYSIS|[?]|Log10 ELISA unit|[?]|[?]|TRACE|1|uEq/L|1|1|[?]|ABNORMAL|BILE|HEMOLYZED|N|SPECULAR MICROSCOPY|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-12-20|2021-03-06|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|caf54095-56c3-428f-8342-ce45c6c9a287|2|FBNCTCE|Fibronectin, Cellular|CHEMISTRY|[?]|hr/day|[?]|[?]|INDETERMINATE|1|mL/cage|1|1|[?]|HIGH|MONOCYTE|THAWED||TRIPLE-PHASE MRI SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||1|Visit_1|10|1|FOLLOW-UP|2020-12-20|2020-12-23|10|13|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|caf54095-56c3-428f-8342-ce45c6c9a287|3|INTLK28|Interleukin 28|URINALYSIS|||[?]|[?]|INVALID|1|Bq/ug|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|NON-HEMOLYZED||CRYOSCOPY|COCKCROFT-GAULT FORMULA||Y|NA|Y|2|Visit_2|25|4|WASHOUT|2021-01-04|2021-02-21|25|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|caf54095-56c3-428f-8342-ce45c6c9a287|4|HGBSHGB|Hemoglobin S/Total Hemoglobin|URINALYSIS|[?]|s^-1(%O2)^-1|[?]|[?]|NEGATIVE|1|APL U/mL|1|1|[?]|LOW|EMOTIONAL TEAR|CALCIFIED||IMMUNOBLOT|ASH FIBROSURE FORMULA|||NA||2|Visit_2|25|3|SCREENING|2021-01-04|2021-01-16|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|caf54095-56c3-428f-8342-ce45c6c9a287|5|APTT|Activated Partial Thromboplastin Time|CHEMISTRY|[?]|pmol/dL|[?]|[?]|BORDERLINE|1|uCi/L|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|FROZEN|N|ULTRASONOGRAPHIC ELASTOGRAPHY|HEPASCORE FORMULA||Y|NA||3|Visit_3|40|2|TREATMENT|2021-01-19|2021-03-06|40|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|caf54095-56c3-428f-8342-ce45c6c9a287|6|SCL70GAB|Scl-70 IgG Antibody|HEMATOLOGY|||[?]|[?]|POSITIVE|1|pg|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|LACTESCENT||COLORIMETRY|FIBROMETER FORMULA|Y||NA|Y|3|Visit_3|40|2|TREATMENT|2021-01-19|2021-03-03|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|LB|caf54095-56c3-428f-8342-ce45c6c9a287|7|SJSA60AB|Sjogrens SS-A60 Antibody|HEMATOLOGY|[?]|mg/kg/min|[?]|[?]|NEGATIVE|1|mEq|1|1|[?]|HIGH|SYNOVIAL FLUID|SOLIDIFIED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|FIBROTEST FORMULA|||NA||4|Visit_4|65|3|TREATMENT|2021-02-13|2021-03-17|65|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|caf54095-56c3-428f-8342-ce45c6c9a287|8|NEUTIM|Immature Neutrophils|URINALYSIS|[?]|dram|[?]|[?]|BORDERLINE|1|ks|1|1|[?]|HIGH|PLATELET RICH PLASMA|HEMOLYZED||SLOAN LETTER EYE CHART 1.25%|MDRD ENZYMATIC FORMULA|Y||Y||4|Visit_4|65|3|TREATMENT|2021-02-13|2021-02-19|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|caf54095-56c3-428f-8342-ce45c6c9a287|9|ERCECE|Erythroid Cells/Total Cells|HEMATOLOGY|||[?]|[?]|TRACE|1|10^3 DNA copies/mL|1|1|[?]|HIGH|VENOUS CORD BLOOD|PARAFFIN-EMBEDDED||SMEAR|NASH FIBROSURE FORMULA|||U|Y|5|Visit_5|90|6|TREATMENT|2021-03-10|2021-03-17|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|caf54095-56c3-428f-8342-ce45c6c9a287|10|IL1R2|Interleukin 1 Receptor Type 2|HEMATOLOGY|[?]|AU/mL|[?]|[?]|INDETERMINATE|1|kg/cm2|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|ROOM TEMPERATURE||CONTRAST ENHANCED PET SCAN|ASH FIBROSURE FORMULA|||N||5|Visit_5|90|4|TREATMENT|2021-03-10|2021-03-18|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|LB|f833ca56-d426-420b-a6d3-fedeabc02734|1|APOJ|Apolipoprotein J|HEMATOLOGY|[?]|WEEKS|[?]|[?]|POSITIVE|1|/2000 RBC|1|1|[?]|HIGH|BASAL TEAR|LACTESCENT||PERIPHERAL ANGIOGRAPHY|GMI % FORMULA|||U||1|Visit_1|10|6|SCREENING|2020-06-20|2020-08-09|10|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|f833ca56-d426-420b-a6d3-fedeabc02734|2|CALB|Calbindin|HEMATOLOGY|[?]|log10 TCID 50/uL|[?]|[?]|POSITIVE|1|STRIP|1|1|[?]|ABNORMAL|EXUDATE|REFRIGERATED|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|CKD-EPI CREATININE FORMULA|Y|Y|NA||1|Visit_1|10|1|TREATMENT|2020-06-20|2020-06-26|10|16|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|f833ca56-d426-420b-a6d3-fedeabc02734|3|BD2|Beta-defensin 2|URINALYSIS|[?]|mmol/mol|[?]|[?]|NEGATIVE|1|%(v/v)|1|1|[?]|NORMAL|WHITE MATTER TISSUE|CONCENTRATED|N|HANSEL STAIN|NASH FIBROSURE FORMULA|||NA||2|Visit_2|25|2|WASHOUT|2020-07-05|2020-07-25|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|f833ca56-d426-420b-a6d3-fedeabc02734|4|STIPBASO|Basophilic Stippling|CHEMISTRY|||[?]|[?]|INVALID|1|nU/cL|1|1|[?]|LOW|STOOL|GELLED|N|TARGETED TRANSCRIPTOME SEQUENCING|MDRD 4 VARIABLE FORMULA|||NA|Y|2|Visit_2|25|6|SCREENING|2020-07-05|2020-08-23|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|LB|f833ca56-d426-420b-a6d3-fedeabc02734|5|C165883|Orchard Grass Pollen IgE AB RAST Score|HEMATOLOGY|[?]|10^6 IU|[?]|[?]|TRACE|1|Farad|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|LACTESCENT|N|IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|||N||3|Visit_3|40|6|FOLLOW-UP|2020-07-20|2020-09-03|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|LB|f833ca56-d426-420b-a6d3-fedeabc02734|6|ABO|ABO Blood Group|URINALYSIS|[?]|mL/g/day|[?]|[?]|INDETERMINATE|1|mmHg/L/min|1|1|[?]|ABNORMAL|GASTRIC FLUID|CONCENTRATED||ELISPOT|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-07-20|2020-08-03|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|LB|f833ca56-d426-420b-a6d3-fedeabc02734|7|V25HD3|25-Hydroxyvitamin D3|HEMATOLOGY|[?]|VOXEL|[?]|[?]|POSITIVE|1|Log10 ELISA unit/dose|1|1|[?]|NORMAL|KERATINOCYTE|CONTAMINATED||JAEGER EYE CHART|CKD-EPI CREATININE FORMULA|Y||U||4|Visit_4|65|4|TREATMENT|2020-08-14|2020-08-31|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|f833ca56-d426-420b-a6d3-fedeabc02734|8|FAS|Fas Cell Surface Death Receptor|HEMATOLOGY|[?]|Joule|[?]|[?]|INVALID|1|dpm/mg|1|1|[?]|NORMAL|ALVEOLAR AIR|NON-HEMOLYZED||FLOW CYTOMETRY|MDRD ENZYMATIC FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2020-08-14|2020-09-13|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|f833ca56-d426-420b-a6d3-fedeabc02734|9|RPTLAAC|Reptilase Activity Actual/Control|URINALYSIS|[?]|mL/sec/1.73m2|[?]|[?]|NEGATIVE|1|um2|1|1|[?]|HIGH|BASAL TEAR|AUTOLYZED||AUTOMATED COUNT|MDRD ENZYMATIC JAPANESE FORMULA|||U||5|Visit_5|90|1|FOLLOW-UP|2020-09-08|2020-09-09|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|f833ca56-d426-420b-a6d3-fedeabc02734|10|C165917|D. pteronyssinus IgG AB RAST Score|HEMATOLOGY|[?]|Enzyme U/m2|[?]|[?]|TRACE|1|umol|1|1|[?]|LOW|CALCULUS|FRESH||KLEIHAUER-BETKE|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||N||5|Visit_5|90|5|FOLLOW-UP|2020-09-08|2020-09-14|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|LB|03c8e2c7-b70d-4d46-8064-c99370eab232|1|C165899|Silver Birch Pollen IgG AB RAST Score|URINALYSIS|[?]|DAYS|[?]|[?]|BORDERLINE|1|U/m2/h|1|1|[?]|HIGH|PROSTATIC FLUID|CONCENTRATED||PULMONARY ANGIOGRAPHY|GMI MMOL/MOL FORMULA|Y||U||1|Visit_1|10|2|FOLLOW-UP|2020-11-29|2020-12-12|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|03c8e2c7-b70d-4d46-8064-c99370eab232|2|PKM2|Pyruvate Kinase Isozyme M2|HEMATOLOGY|[?]|PACK|[?]|[?]|TRACE|1|oz eq|1|1|[?]|HIGH|VENOUS CORD BLOOD|LIPEMIC||GC/FID|MDRD 5 VARIABLE FORMULA|Y||U||1|Visit_1|10|5|WASHOUT|2020-11-29|2021-02-26|10|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|03c8e2c7-b70d-4d46-8064-c99370eab232|3|BLSTMBCE|Myeloblasts/Total Cells|CHEMISTRY|[?]|mg/mol|[?]|[?]|BORDERLINE|1|mmHg*min/L|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|CALCIFIED||KINYOUN STAIN|MDRD 6 VARIABLE FORMULA|Y||Y||2|Visit_2|25|7|FOLLOW-UP|2020-12-14|2020-12-30|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|03c8e2c7-b70d-4d46-8064-c99370eab232|4|ETPAUC|ETP Area Under Curve|CHEMISTRY|||[?]|[?]|POSITIVE|1|MONTHS|1|1|[?]|HIGH|VENOUS CORD BLOOD|LIPEMIC|N|CELLULAR PROLIFERATION ASSAY|FIBROTEST FORMULA||Y|U|Y|2|Visit_2|25|3|TREATMENT|2020-12-14|2021-02-26|25|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|LB|03c8e2c7-b70d-4d46-8064-c99370eab232|5|CCL7|Chemokine (C-C Motif) Ligand 7|CHEMISTRY|[?]|deg|[?]|[?]|INVALID|1|DISK|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|GELLED|N|PALPATION|FIBROSIS 4 FORMULA|||N||3|Visit_3|40|7|SCREENING|2020-12-29|2021-01-13|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|03c8e2c7-b70d-4d46-8064-c99370eab232|6|WBC|Leukocytes|HEMATOLOGY|[?]|DAgU/mL|[?]|[?]|INVALID|1|g/animal/day|1|1|[?]|NORMAL|WHITE MATTER TISSUE|PARAFFIN-EMBEDDED|N|CT SCAN WITHOUT CONTRAST|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y||3|Visit_3|40|1|WASHOUT|2020-12-29|2021-01-07|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|LB|03c8e2c7-b70d-4d46-8064-c99370eab232|7|EPIRCE|Renal Epithelial Cells|CHEMISTRY|[?]|FFU|[?]|[?]|TRACE|1|10^3 organisms|1|1|[?]|HIGH|VENOUS BLOOD|AUTOLYZED||PHASE CONTRAST MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA||4|Visit_4|65|5|WASHOUT|2021-01-23|2021-01-30|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|03c8e2c7-b70d-4d46-8064-c99370eab232|8|GNRH|Gonadotropin Releasing Hormone|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|PATCH|1|1|[?]|NORMAL|ARTERIALIZED CAPILLARY BLOOD|LIPEMIC||ELECTROGASTROGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|Y|Y|4|Visit_4|65|5|TREATMENT|2021-01-23|2021-02-02|65|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|LB|03c8e2c7-b70d-4d46-8064-c99370eab232|9|RBCDYSM|Dysmorphic Erythrocytes|CHEMISTRY|[?]|RNA copies/mL|[?]|[?]|NEGATIVE|1|ug|1|1|[?]|HIGH|DERMAL TISSUE|CONCENTRATED|N|CYSTOSCOPY|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2021-02-17|2021-02-26|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|03c8e2c7-b70d-4d46-8064-c99370eab232|10|CCL13|Chemokine (C-C Motif) Ligand 13|HEMATOLOGY|||[?]|[?]|POSITIVE|1|in|1|1|[?]|LOW|TUMOR TISSUE|ICTERIC||ACRIDINE ORANGE STAIN|MDRD FORMULA|||N|Y|5|Visit_5|90|5|TREATMENT|2021-02-17|2021-02-21|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|LB|944617c7-c5e6-4e06-b114-499c3020dbbd|1|P3NP|Procollagen 3 N-Terminal Propeptide|URINALYSIS|[?]|Coulomb|[?]|[?]|TRACE|1|DNA copies/mL|1|1|[?]|NORMAL|EMOTIONAL TEAR|GELLED||DIFFUSION TENSOR MRI|NASH FIBROSURE FORMULA||Y|Y||1|Visit_1|10|5|TREATMENT|2020-10-22|2020-11-12|10|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|944617c7-c5e6-4e06-b114-499c3020dbbd|2|NOREPIN|Norepinephrine|URINALYSIS|[?]|POUCH|[?]|[?]|BORDERLINE|1|L/kg|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|DRIED||TARGETED GENOME SEQUENCING|HEPASCORE FORMULA|||NA||1|Visit_1|10|3|FOLLOW-UP|2020-10-22|2020-11-11|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|LB|944617c7-c5e6-4e06-b114-499c3020dbbd|3|FIBRINO|Fibrinogen|HEMATOLOGY|[?]|KALLIKREIN INHIBITOR UNIT|[?]|[?]|INVALID|1|mOsm/kg|1|1|[?]|ABNORMAL|BASAL TEAR|THAWED||ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD ENZYMATIC FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-11-06|2020-11-20|25|39|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|944617c7-c5e6-4e06-b114-499c3020dbbd|4|KCREAT|Potassium/Creatinine|CHEMISTRY|[?]|log10 copies/mL|[?]|[?]|INDETERMINATE|1|IU|1|1|[?]|ABNORMAL|ABSCESS FLUID|PARAFFIN-EMBEDDED||CLAUSS METHOD|GMI MMOL/MOL FORMULA|||Y||2|Visit_2|25|5|TREATMENT|2020-11-06|2021-01-06|25|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|944617c7-c5e6-4e06-b114-499c3020dbbd|5|IGGC|IgG Clearance|HEMATOLOGY|[?]|IU/mg|[?]|[?]|NEGATIVE|1|BOTTLE|1|1|[?]|ABNORMAL|FLUID|CLOTTED||INCISION-INDUCED BLEEDING METHOD|MDRD 4 VARIABLE FORMULA||Y|NA||3|Visit_3|40|5|TREATMENT|2020-11-21|2020-12-25|40|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|944617c7-c5e6-4e06-b114-499c3020dbbd|6|HLAC|HLA Class IC Antigen|CHEMISTRY|[?]|lx|[?]|[?]|NEGATIVE|1|TCID 50/dose|1|1|[?]|HIGH|MIXED VENOUS BLOOD|CONCENTRATED||REBOUND TONOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||3|Visit_3|40|2|WASHOUT|2020-11-21|2021-01-10|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|LB|944617c7-c5e6-4e06-b114-499c3020dbbd|7|CD27|CD27|HEMATOLOGY|[?]|mEq|[?]|[?]|BORDERLINE|1|ks|1|1|[?]|ABNORMAL|BUFFY COAT|THAWED||WESTERGREN|FIBROSIS 4 FORMULA|Y|Y|U||4|Visit_4|65|6|TREATMENT|2020-12-16|2021-01-10|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|944617c7-c5e6-4e06-b114-499c3020dbbd|8|HSP70|Heat Shock Protein 70|HEMATOLOGY|||[?]|[?]|TRACE|1|anti-Xa IU|1|1|[?]|ABNORMAL|SERUM OR PLASMA|AGGLUTINATED||HPLC/MS/MS|CKD-EPI CREATININE FORMULA|Y||NA|Y|4|Visit_4|65|7|SCREENING|2020-12-16|2021-01-16|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|944617c7-c5e6-4e06-b114-499c3020dbbd|9|PSELECTS|Soluble P-Selectin|CHEMISTRY|[?]|log10 CFU/mL|[?]|[?]|BORDERLINE|1|cm|1|1|[?]|HIGH|LUNG SURFACTANT|ROOM TEMPERATURE||CLIP SEQUENCING|MDRD ENZYMATIC FORMULA||Y|Y||5|Visit_5|90|7|TREATMENT|2021-01-10|2021-01-14|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|944617c7-c5e6-4e06-b114-499c3020dbbd|10|KEXR|Potassium Excretion Rate|CHEMISTRY|||[?]|[?]|BORDERLINE|1|IU/mmol|1|1|[?]|NORMAL|URINE|NON-HEMOLYZED||GC/MS/MS|FIBROMETER FORMULA||Y|NA|Y|5|Visit_5|90|1|TREATMENT|2021-01-10|2021-01-12|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|LB|e4878c66-1e2b-49bb-838e-85139d160dd4|1|ALDSTRN|Aldosterone|URINALYSIS|[?]|Ci|[?]|[?]|INVALID|1|mV|1|1|[?]|ABNORMAL|ALVEOLAR AIR|CONTAMINATED|N|MICRODENSITOMETRY|CKD-EPI CYSTATIN C FORMULA|||Y||1|Visit_1|10|1|SCREENING|2020-10-21|2020-11-03|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|e4878c66-1e2b-49bb-838e-85139d160dd4|2|CD11A|CD11A|CHEMISTRY|[?]|uL/mL|[?]|[?]|TRACE|1|JDF Unit|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|ROOM TEMPERATURE|N|PYROSEQUENCING|NASH FIBROSURE FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-10-21|2020-12-29|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|e4878c66-1e2b-49bb-838e-85139d160dd4|3|CACR|Calcium Corrected|URINALYSIS|||[?]|[?]|TRACE|1|GPL U/mL|1|1|[?]|ABNORMAL|ABSCESS FLUID|LIPEMIC|N|ELISA|ASH FIBROSURE FORMULA|||N|Y|2|Visit_2|25|4|TREATMENT|2020-11-05|2020-12-20|25|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|e4878c66-1e2b-49bb-838e-85139d160dd4|4|HIST1AB|Histone 1 Antibody|URINALYSIS|[?]|deg2|[?]|[?]|POSITIVE|1|BLOCKS|1|1|[?]|LOW|MONOCYTE|HEMOLYZED||PET/MRI SCAN|MDRD 6 VARIABLE FORMULA|||U||2|Visit_2|25|3|TREATMENT|2020-11-05|2021-01-12|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|LB|e4878c66-1e2b-49bb-838e-85139d160dd4|5|MDZPM|Medazepam|CHEMISTRY|[?]|Enzyme U/g Hb|[?]|[?]|TRACE|1|mL/cm H2O|1|1|[?]|NORMAL|CIRCULATING TUMOR CELL|LIPEMIC||MUGA|MDRD FORMULA|Y||U||3|Visit_3|40|1|TREATMENT|2020-11-20|2020-12-30|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|e4878c66-1e2b-49bb-838e-85139d160dd4|6|APAPCYS|Acetaminophen-Cysteine Adduct|URINALYSIS|[?]|nmol/mL/min|[?]|[?]|TRACE|1|DPM|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|AUTOLYZED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI FORMULA|||U||3|Visit_3|40|4|SCREENING|2020-11-20|2021-01-04|40|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|LB|e4878c66-1e2b-49bb-838e-85139d160dd4|7|FVAAC|Factor V Activity Actual/Control|CHEMISTRY|[?]|cmH2O*s2/mL|[?]|[?]|NEGATIVE|1|QUANTITY SUFFICIENT|1|1|[?]|ABNORMAL|CERUMEN|LIPEMIC||IMMUNOCHEMILUMINOMETRIC ASSAY|FIBROMETER FORMULA|||U||4|Visit_4|65|7|FOLLOW-UP|2020-12-15|2021-01-07|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|e4878c66-1e2b-49bb-838e-85139d160dd4|8|OPG|Osteoprotegerin|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|DNA copies/ug|1|1|[?]|HIGH|INTERSTITIAL FLUID|ICTERIC|N|SCANNING ELECTRON MICROSCOPY|COCKCROFT-GAULT FORMULA|Y|Y|NA|Y|4|Visit_4|65|2|WASHOUT|2020-12-15|2021-01-05|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|LB|e4878c66-1e2b-49bb-838e-85139d160dd4|9|ZPP|Zinc Protoporphyrin|CHEMISTRY|[?]|%/s|[?]|[?]|INVALID|1|EP U|1|1|[?]|ABNORMAL|DIALYSIS FLUID|NON-HEMOLYZED||PEAK FLOWMETRY|CKD-EPI CYSTATIN C FORMULA|||NA||5|Visit_5|90|3|WASHOUT|2021-01-09|2021-01-13|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|e4878c66-1e2b-49bb-838e-85139d160dd4|10|ABNCECE|Abnormal Cells/Total Cells|CHEMISTRY|[?]|10^6/L|[?]|[?]|NEGATIVE|1|mg/h|1|1|[?]|ABNORMAL|BASAL TEAR|DRIED||DYNAMIC LIGHT SCATTERING|GMI MMOL/MOL FORMULA|||NA||5|Visit_5|90|5|TREATMENT|2021-01-09|2021-01-16|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|6873e227-baef-4d6e-8600-0bb61d60fe49|1|MGB|Myoglobin|CHEMISTRY|[?]|Bq/mg|[?]|[?]|BORDERLINE|1|pmol/10^10 cells|1|1|[?]|LOW|PROSTATIC FLUID|LACTESCENT||IMMUNOBLOT|CKD-EPI CREATININE FORMULA||Y|U||1|Visit_1|10|4|WASHOUT|2020-06-06|2020-07-11|10|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|6873e227-baef-4d6e-8600-0bb61d60fe49|2|MNC|Mononuclear Cells|URINALYSIS|||[?]|[?]|NEGATIVE|1|APL U|1|1|[?]|LOW|GASTRIC FLUID|REFRIGERATED|N|APPLANATION TONOMETRY|ASH FIBROSURE FORMULA|||U|Y|1|Visit_1|10|2|TREATMENT|2020-06-06|2020-08-16|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|6873e227-baef-4d6e-8600-0bb61d60fe49|3|OSMLTY|Osmolality|CHEMISTRY|[?]|L/L|[?]|[?]|TRACE|1|10^3 organisms|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|LACTESCENT||REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||2|Visit_2|25|6|SCREENING|2020-06-21|2020-08-15|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|6873e227-baef-4d6e-8600-0bb61d60fe49|4|C130110|Mold Mix Antigen IgG Antibody|CHEMISTRY|||[?]|[?]|POSITIVE|1|nmol/L|1|1|[?]|NORMAL|SEBUM|FRESH||PUPILLOMETRY|MDRD 4 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|3|FOLLOW-UP|2020-06-21|2020-08-20|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|LB|6873e227-baef-4d6e-8600-0bb61d60fe49|5|DSVLFXN|Desvenlafaxine|HEMATOLOGY|[?]|mg/kg/min|[?]|[?]|TRACE|1|Farad|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|FROZEN||SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA|||U||3|Visit_3|40|3|SCREENING|2020-07-06|2020-08-31|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|6873e227-baef-4d6e-8600-0bb61d60fe49|6|ALB|Albumin|URINALYSIS|[?]|Shock Wave|[?]|[?]|TRACE|1|mL/min|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|PARAFFIN-EMBEDDED||TRANSVAGINAL ULTRASOUND|CKD-EPI FORMULA|Y||NA||3|Visit_3|40|7|WASHOUT|2020-07-06|2020-08-27|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|6873e227-baef-4d6e-8600-0bb61d60fe49|7|STROPONI|Skeletal Troponin I|URINALYSIS|||[?]|[?]|NEGATIVE|1|Rad|1|1|[?]|HIGH|FLUID|CALCIFIED||ACRIDINE ORANGE STAIN|FIBROMETER FORMULA|Y||U|Y|4|Visit_4|65|1|FOLLOW-UP|2020-07-31|2020-08-04|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|6873e227-baef-4d6e-8600-0bb61d60fe49|8|PLSPCELY|Precursor Plasma Cells/Lymphocytes|CHEMISTRY|[?]|VIRTUAL PIXEL|[?]|[?]|TRACE|1|mL/s/m2|1|1|[?]|ABNORMAL|BUFFY COAT|CONTAMINATED||GC/FID|MDRD ENZYMATIC FORMULA||Y|NA||4|Visit_4|65|6|TREATMENT|2020-07-31|2020-08-09|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|LB|6873e227-baef-4d6e-8600-0bb61d60fe49|9|PLAGGCVT|Platelet Aggregation Curve Type|HEMATOLOGY|[?]|DROP|[?]|[?]|POSITIVE|1|mL/kg/min|1|1|[?]|NORMAL|CELL PELLET|FRESH|N|HPLC-FL|NASH FIBROSURE FORMULA|||Y||5|Visit_5|90|6|FOLLOW-UP|2020-08-25|2020-08-26|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|6873e227-baef-4d6e-8600-0bb61d60fe49|10|HLZPM|Halazepam|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|RATIO|1|1|[?]|ABNORMAL|ATHEROSCLEROTIC PLAQUE|DRIED|N|EPSILOMETER|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||U|Y|5|Visit_5|90|6|TREATMENT|2020-08-25|2020-08-31|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|LB|bad01879-9b97-4d9c-9eec-58871168bd57|1|GFRBSB2M|GFR from B-2 Microglobulin Adj for BSA|URINALYSIS|[?]|nmol/L/min|[?]|[?]|BORDERLINE|1|mmol/mol|1|1|[?]|HIGH|DISCHARGE|REFRIGERATED||ENZYMATIC COLORIMETRY|MDRD FORMULA|||NA||1|Visit_1|10|7|TREATMENT|2020-10-15|2021-01-06|10|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|bad01879-9b97-4d9c-9eec-58871168bd57|2|GDF11|Growth Differentiation Factor 11|URINALYSIS|||[?]|[?]|INDETERMINATE|1|nm|1|1|[?]|NORMAL|SKELETAL MUSCLE TISSUE|HEMOLYZED||POTENTIOMETRY|HEPASCORE FORMULA||Y|U|Y|1|Visit_1|10|2|TREATMENT|2020-10-15|2020-10-19|10|14|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|LB|bad01879-9b97-4d9c-9eec-58871168bd57|3|CSHYGR|Hyalogranular Casts|CHEMISTRY|[?]|tsp|[?]|[?]|POSITIVE|1|cm/s|1|1|[?]|ABNORMAL|GASTRIC FLUID|LACTESCENT|N|HIGH RESOLUTION MELT ANALYSIS|FIBROMETER FORMULA|||N||2|Visit_2|25|4|SCREENING|2020-10-30|2020-11-29|25|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|LB|bad01879-9b97-4d9c-9eec-58871168bd57|4|IL1R2|Interleukin 1 Receptor Type 2|HEMATOLOGY|[?]|10^7 TCID 50/dose|[?]|[?]|TRACE|1|uEq|1|1|[?]|LOW|SUPERNATANT, PLASMA|LIPEMIC||WHOLE GENOME SEQUENCING|FIBROTEST FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-10-30|2021-01-04|25|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|LB|bad01879-9b97-4d9c-9eec-58871168bd57|5|C130093|Western Ragweed Pollen IgA|HEMATOLOGY|||[?]|[?]|TRACE|1|CAN|1|1|[?]|HIGH|ABSCESS FLUID|THAWED||GC/MS-EI|MDRD FORMULA||Y|NA|Y|3|Visit_3|40|4|TREATMENT|2020-11-14|2021-01-11|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|bad01879-9b97-4d9c-9eec-58871168bd57|6|NEUTTOXC|Neutrophilic Toxic Change|CHEMISTRY|[?]|/LPF|[?]|[?]|INVALID|1|GPS U|1|1|[?]|HIGH|TRANSUDATE|CONTAMINATED||HEMAGGLUTINATION ASSAY|MDRD FORMULA|||N||3|Visit_3|40|7|SCREENING|2020-11-14|2020-11-30|40|56|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|LB|bad01879-9b97-4d9c-9eec-58871168bd57|7|PROLYM|Prolymphocytes|CHEMISTRY|[?]|g/L|[?]|[?]|BORDERLINE|1|mg/kg/dose|1|1|[?]|ABNORMAL|BUFFY COAT|FRESH||ELISPOT|MDRD 4 VARIABLE FORMULA||Y|Y||4|Visit_4|65|1|FOLLOW-UP|2020-12-09|2020-12-23|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|bad01879-9b97-4d9c-9eec-58871168bd57|8|C130121|Shellfish Mix Antigen IgG Antibody|HEMATOLOGY|[?]|kg/cm2|[?]|[?]|NEGATIVE|1|ng|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|CLOTTED||SIZE EXCLUSION CHROMATOGRAPHY|FIBROTEST FORMULA|||U||4|Visit_4|65|2|FOLLOW-UP|2020-12-09|2021-01-11|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|bad01879-9b97-4d9c-9eec-58871168bd57|9|SDH|Sorbitol Dehydrogenase|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|DIP|1|1|[?]|LOW|PLASMA ULTRAFILTRATE|FROZEN||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 4 VARIABLE FORMULA|||N|Y|5|Visit_5|90|2|WASHOUT|2021-01-03|2021-01-09|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|bad01879-9b97-4d9c-9eec-58871168bd57|10|MONOBL|Monoblasts|HEMATOLOGY|||[?]|[?]|POSITIVE|1|pptr|1|1|[?]|LOW|CORD SERUM|UNEXPECTED ODOR||QUANTITATIVE ULTRASOUND|FIBROTEST FORMULA|||NA|Y|5|Visit_5|90|6|WASHOUT|2021-01-03|2021-01-12|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|LB|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|1|G6PDRBC|G6PD-Deficient Erythrocytes|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mm|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|NON-HEMOLYZED||DIGITAL PCR|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|1|Visit_1|10|6|SCREENING|2020-11-05|2021-01-17|10|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|2|HRYCELY|Hairy Cells/Lymphocytes|URINALYSIS|||[?]|[?]|TRACE|1|mg/m2|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|GELLED||MRI WITHOUT CONTRAST|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|1|Visit_1|10|3|TREATMENT|2020-11-05|2021-01-13|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|LB|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|3|HYDMDZ1|1-Hydroxymidazolam|URINALYSIS|[?]|h/wk|[?]|[?]|INDETERMINATE|1|mV*min|1|1|[?]|LOW|CAPILLARY PLASMA|GELLED||MICROBIAL CULTURE, LIQUID|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N||2|Visit_2|25|5|WASHOUT|2020-11-20|2020-11-30|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|4|ETG|Ethyl Glucuronide|URINALYSIS|[?]|U/L|[?]|[?]|POSITIVE|1|Weber|1|1|[?]|NORMAL|TRANSUDATE|SOLIDIFIED|N|SPECT/CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||2|Visit_2|25|5|TREATMENT|2020-11-20|2020-12-21|25|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|LB|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|5|SER|Serine|URINALYSIS|[?]|PUFF|[?]|[?]|BORDERLINE|1|dpm/100mg|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|LACTESCENT||LINE PROBE ASSAY|ASH FIBROSURE FORMULA|||Y||3|Visit_3|40|4|WASHOUT|2020-12-05|2021-02-01|40|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|6|LYMATLE|Lymphocytes Atypical/Leukocytes|HEMATOLOGY|[?]|ng/mol|[?]|[?]|INDETERMINATE|1|SUPPOSITORY|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|ICTERIC|N|IMMUNOCHEMILUMINOMETRIC ASSAY|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|7|TREATMENT|2020-12-05|2020-12-26|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|7|TCDCA|Taurochenodeoxycholate|URINALYSIS|[?]|mL/day|[?]|[?]|NEGATIVE|1|mL/breath|1|1|[?]|HIGH|STOOL|PARAFFIN-EMBEDDED||CELL OF ORIGIN ASSAY|FIBROSIS 4 FORMULA||Y|N||4|Visit_4|65|1|FOLLOW-UP|2020-12-30|2021-01-30|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|8|CD23|CD23|HEMATOLOGY|||[?]|[?]|POSITIVE|1|BAR|1|1|[?]|ABNORMAL|VENOUS BLOOD|CONCENTRATED||PET SCAN|MDRD 5 VARIABLE FORMULA||Y|N|Y|4|Visit_4|65|3|TREATMENT|2020-12-30|2021-01-15|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|LB|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|9|TRIGHDL|Triglycerides/HDL Cholesterol|URINALYSIS|[?]|mL/min|[?]|[?]|POSITIVE|1|g/kg|1|1|[?]|LOW|WHITE MATTER TISSUE|AUTOLYZED||DARK FIELD MICROSCOPY|FIBROMETER FORMULA|||U||5|Visit_5|90|5|SCREENING|2021-01-24|2021-01-25|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|10|AMYLASES|Amylase, Salivary|CHEMISTRY|[?]|TRACE|[?]|[?]|BORDERLINE|1|PFU/animal|1|1|[?]|NORMAL|LOCHIA|DRIED||ANTIMICROBIAL COMBINATION TESTING|ASH FIBROSURE FORMULA|||U||5|Visit_5|90|2|TREATMENT|2021-01-24|2021-01-25|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|LB|0df77775-6e65-4f77-9f8f-7faaa1471141|1|CD4|CD4|URINALYSIS|||[?]|[?]|INVALID|1|Joule|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|CONTAMINATED||LIQUID SCINTILLATION COUNTING|MDRD FORMULA||Y|Y|Y|1|Visit_1|10|1|FOLLOW-UP|2020-08-24|2020-09-07|10|24|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|0df77775-6e65-4f77-9f8f-7faaa1471141|2|PNTBRBTL|Pentobarbital|URINALYSIS|[?]|10^6 U|[?]|[?]|TRACE|1|pmol|1|1|[?]|LOW|PUS|CALCIFIED||AUTOMATED COUNT|GMI % FORMULA||Y|N||1|Visit_1|10|4|TREATMENT|2020-08-24|2020-11-13|10|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|LB|0df77775-6e65-4f77-9f8f-7faaa1471141|3|NORNCTN|Nornicotine|CHEMISTRY|[?]|pptr|[?]|[?]|BORDERLINE|1|ug/mol|1|1|[?]|HIGH|DISCHARGE|LIPEMIC||HIGH LEVEL AMINOGLYCOSIDE SCREEN|GMI MMOL/MOL FORMULA||Y|NA||2|Visit_2|25|7|TREATMENT|2020-09-08|2020-09-18|25|35|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|0df77775-6e65-4f77-9f8f-7faaa1471141|4|MASTCECE|Mast Cells/Total Cells|HEMATOLOGY|[?]|g/U|[?]|[?]|POSITIVE|1|mL/kg/h|1|1|[?]|ABNORMAL|PERSPIRATION|CONTAMINATED||ELECTRONEUROGRAPHY|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|5|WASHOUT|2020-09-08|2020-10-19|25|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|LB|0df77775-6e65-4f77-9f8f-7faaa1471141|5|IGG1|Immunoglobulin G Subclass 1|HEMATOLOGY|||[?]|[?]|INVALID|1|PUFF|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|ICTERIC||MULTIPLE BREATH WASHOUT|CKD-EPI CREATININE FORMULA|Y|Y|NA|Y|3|Visit_3|40|2|TREATMENT|2020-09-23|2020-09-30|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|0df77775-6e65-4f77-9f8f-7faaa1471141|6|VITK|Vitamin K|CHEMISTRY|[?]|/kg|[?]|[?]|TRACE|1|RNA copies/mL|1|1|[?]|NORMAL|KERATINOCYTE|ICTERIC||ALCIAN BLUE STAIN|CKD-EPI FORMULA|Y|Y|NA||3|Visit_3|40|2|TREATMENT|2020-09-23|2020-11-07|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|LB|0df77775-6e65-4f77-9f8f-7faaa1471141|7|GLOBUL|Globulin|CHEMISTRY|[?]|HOURS|[?]|[?]|INVALID|1|DDU|1|1|[?]|LOW|WHITE MATTER TISSUE|NON-HEMOLYZED||NEXT GENERATION TARGETED SEQUENCING|FIBROTEST FORMULA|Y||NA||4|Visit_4|65|5|TREATMENT|2020-10-18|2020-10-25|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|0df77775-6e65-4f77-9f8f-7faaa1471141|8|KLHIGMAB|Keyhole Limpet Hemocyanin IgM Antibody|CHEMISTRY|[?]|nmol/g|[?]|[?]|BORDERLINE|1|IU/day|1|1|[?]|NORMAL|AQUEOUS HUMOR|HEMOLYZED|N|LANDOLT RING|FIBROSIS 4 FORMULA|Y|Y|U||4|Visit_4|65|6|SCREENING|2020-10-18|2020-11-04|65|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|LB|0df77775-6e65-4f77-9f8f-7faaa1471141|9|OLIGBAND|Oligoclonal Bands|URINALYSIS|||[?]|[?]|TRACE|1|keV|1|1|[?]|ABNORMAL|CORD BLOOD|FRESH|N|IN VITRO GENE EXPRESSION ASSAY|FIBROMETER FORMULA|||U|Y|5|Visit_5|90|2|TREATMENT|2020-11-12|2020-11-19|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|0df77775-6e65-4f77-9f8f-7faaa1471141|10|CDT|Carbohydrate-Deficient Transferrin|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Mile|1|1|[?]|ABNORMAL|SUPERNATANT, CEREBROSPINAL FLUID|AGGLUTINATED||HIGH RESOLUTION CT|MDRD 4 VARIABLE FORMULA|Y|Y|Y|Y|5|Visit_5|90|7|WASHOUT|2020-11-12|2020-11-19|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|LB|adc5359a-f1d5-428b-97d8-fce67cfeeaea|1|SPERMMTL|Sperm Motility|HEMATOLOGY|[?]|CAPFUL|[?]|[?]|INDETERMINATE|1|m/sec|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|DRIED||FISH|CKD-EPI CYSTATIN C FORMULA|Y||U||1|Visit_1|10|5|TREATMENT|2020-08-22|2020-11-04|10|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|adc5359a-f1d5-428b-97d8-fce67cfeeaea|2|ANGPT2|Angiopoietin 2|CHEMISTRY|[?]|umol/L/h|[?]|[?]|INVALID|1|kg/mol|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|DRIED||CARDIAC THERMODILUTION|GMI MMOL/MOL FORMULA|||Y||1|Visit_1|10|6|TREATMENT|2020-08-22|2020-09-30|10|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|LB|adc5359a-f1d5-428b-97d8-fce67cfeeaea|3|STAT3|STAT3|CHEMISTRY|[?]|Pa|[?]|[?]|TRACE|1|mU/g|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|CONCENTRATED||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|FIBROMETER FORMULA|||Y||2|Visit_2|25|3|TREATMENT|2020-09-06|2020-11-05|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|adc5359a-f1d5-428b-97d8-fce67cfeeaea|4|FIBRINO|Fibrinogen|HEMATOLOGY|[?]|%(w/w)|[?]|[?]|TRACE|1|fg|1|1|[?]|LOW|STOOL|THAWED||MANUAL COUNT|MDRD 5 VARIABLE FORMULA|Y||N||2|Visit_2|25|5|TREATMENT|2020-09-06|2020-10-06|25|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|LB|adc5359a-f1d5-428b-97d8-fce67cfeeaea|5|C165910|Bee Mix IgG AB RAST Score|URINALYSIS|[?]|mmol/kg|[?]|[?]|INVALID|1|mol/mg|1|1|[?]|HIGH|SMOOTH MUSCLE TISSUE|FROZEN||SNELLEN EYE CHART|COCKCROFT-GAULT FORMULA|Y||NA||3|Visit_3|40|7|WASHOUT|2020-09-21|2020-10-12|40|61|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|adc5359a-f1d5-428b-97d8-fce67cfeeaea|6|EOTAXIN3|Eotaxin-3|URINALYSIS|[?]|BE/mL|[?]|[?]|TRACE|1|ug|1|1|[?]|LOW|TISSUE|CONCENTRATED||IMMUNOASSAY|FIBROSIS 4 FORMULA|Y||N||3|Visit_3|40|6|TREATMENT|2020-09-21|2020-09-23|40|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|adc5359a-f1d5-428b-97d8-fce67cfeeaea|7|RBCDIPOP|Dimorphic Erythrocyte Population|HEMATOLOGY|[?]|mL/cm3/min|[?]|[?]|TRACE|1|foz_br|1|1|[?]|NORMAL|CAPILLARY BLOOD|REFRIGERATED||MULTI-SLICE SPIRAL CT|MDRD 5 VARIABLE FORMULA|Y||U||4|Visit_4|65|5|FOLLOW-UP|2020-10-16|2020-10-22|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|adc5359a-f1d5-428b-97d8-fce67cfeeaea|8|FAT|Fat|URINALYSIS|[?]|Roentgen|[?]|[?]|NEGATIVE|1|mL/(min*100mL)|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|CONCENTRATED||LASER CAPTURE MICRODISSECTION|GMI % FORMULA||Y|U||4|Visit_4|65|4|TREATMENT|2020-10-16|2020-10-17|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|LB|adc5359a-f1d5-428b-97d8-fce67cfeeaea|9|GRWHRH|Growth Hormone Releasing Hormone|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|beats/min|1|1|[?]|LOW|ARTERIAL BLOOD|LIPEMIC|N|CONTRAST ENHANCED MRI|COCKCROFT-GAULT FORMULA||Y|U|Y|5|Visit_5|90|3|TREATMENT|2020-11-10|2020-11-14|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|adc5359a-f1d5-428b-97d8-fce67cfeeaea|10|GDA|Guanine Deaminase|CHEMISTRY|||[?]|[?]|INVALID|1|mmol|1|1|[?]|NORMAL|PERITONEAL FLUID|REFRIGERATED||KNEMOMETRY|ASH FIBROSURE FORMULA|Y||N|Y|5|Visit_5|90|6|SCREENING|2020-11-10|2020-11-12|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|cd68296c-95d4-489e-8b64-b2404f16316c|1|PPI|Inorganic Pyrophosphate|HEMATOLOGY|[?]|mm3/mm2/year|[?]|[?]|NEGATIVE|1|/LSQN|1|1|[?]|HIGH|CALCULUS|HEMOLYZED||TOTAL BODY IRRADIATION|CKD-EPI FORMULA||Y|U||1|Visit_1|10|1|TREATMENT|2020-12-20|2021-03-10|10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|cd68296c-95d4-489e-8b64-b2404f16316c|2|C130137|American Cockroach Antigen IgA Antibody|URINALYSIS|[?]|mg/m2/day|[?]|[?]|POSITIVE|1|GPS U|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|PARAFFIN-EMBEDDED||COLORIMETRY|MDRD 5 VARIABLE FORMULA|||N||1|Visit_1|10|1|SCREENING|2020-12-20|2021-01-15|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|LB|cd68296c-95d4-489e-8b64-b2404f16316c|3|RF|Rheumatoid Factor|URINALYSIS|[?]|uL|[?]|[?]|NEGATIVE|1|MPS U|1|1|[?]|HIGH|EXUDATE|GELLED|N|POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA|||U||2|Visit_2|25|1|TREATMENT|2021-01-04|2021-01-24|25|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|cd68296c-95d4-489e-8b64-b2404f16316c|4|APOC1|Apolipoprotein CI|HEMATOLOGY|[?]|psi|[?]|[?]|TRACE|1|foz_br|1|1|[?]|HIGH|MECONIUM|HEMOLYZED||AUTOREFRACTION|CKD-EPI CREATININE FORMULA|||Y||2|Visit_2|25|1|SCREENING|2021-01-04|2021-02-27|25|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|LB|cd68296c-95d4-489e-8b64-b2404f16316c|5|GLBCREAT|Globulin/Creatinine|CHEMISTRY|[?]|/VF|[?]|[?]|BORDERLINE|1|IU/mmol|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT|N|PHOTOMETRIC CLOT DETECTION|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|U||3|Visit_3|40|4|FOLLOW-UP|2021-01-19|2021-01-26|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|cd68296c-95d4-489e-8b64-b2404f16316c|6|C130069|Bermuda Grass Pollen IgA|URINALYSIS|||[?]|[?]|TRACE|1|mL/breath|1|1|[?]|ABNORMAL|LOCHIA|NON-HEMOLYZED|N|PHYSICAL EXAMINATION|MDRD 4 VARIABLE FORMULA|||N|Y|3|Visit_3|40|6|TREATMENT|2021-01-19|2021-02-03|40|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|LB|cd68296c-95d4-489e-8b64-b2404f16316c|7|TAURINE|Taurine|CHEMISTRY|[?]|cm|[?]|[?]|INDETERMINATE|1|uEq|1|1|[?]|HIGH|VITREOUS HUMOR|LACTESCENT||MAGNETIC RESONANCE ENTEROGRAPHY|HEPASCORE FORMULA||Y|N||4|Visit_4|65|3|FOLLOW-UP|2021-02-13|2021-03-04|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|cd68296c-95d4-489e-8b64-b2404f16316c|8|BASOCE|Basophils/Total Cells|URINALYSIS|[?]|mL/mmHg/min/L|[?]|[?]|NEGATIVE|1|EID 50/dose|1|1|[?]|LOW|EXUDATE|CONTAMINATED||PLETHYSMOGRAPHY|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|5|SCREENING|2021-02-13|2021-02-25|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|cd68296c-95d4-489e-8b64-b2404f16316c|9|SPERMMTL|Sperm Motility|HEMATOLOGY|[?]|STRIP|[?]|[?]|INVALID|1|Tbsp|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|CONCENTRATED|N|BAC ACGH|FIBROSIS 4 FORMULA||Y|Y||5|Visit_5|90|3|FOLLOW-UP|2021-03-10|2021-03-16|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|cd68296c-95d4-489e-8b64-b2404f16316c|10|SULFATE|Sulfate|CHEMISTRY|[?]|mEq/uL|[?]|[?]|POSITIVE|1|FFU|1|1|[?]|ABNORMAL|HAIR|FRESH||MASS SPECTROMETRY|MDRD FORMULA|||N||5|Visit_5|90|2|TREATMENT|2021-03-10|2021-03-17|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|fe137506-d1ce-4b08-a043-9366d86c421e|1|LLCFR|Lambda Light Chain, Free|URINALYSIS|[?]|Bq/mL|[?]|[?]|POSITIVE|1|cm/s|1|1|[?]|ABNORMAL|PLASMA|CALCIFIED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|CKD-EPI CYSTATIN C FORMULA|||Y||1|Visit_1|10|4|TREATMENT|2020-07-03|2020-08-21|10|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|fe137506-d1ce-4b08-a043-9366d86c421e|2|CRNTESTR|Carnitine Esters|URINALYSIS|[?]|mmol/g|[?]|[?]|INVALID|1|IU/g|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|DRIED||PUPILLOMETRY|FIBROTEST FORMULA||Y|Y||1|Visit_1|10|5|WASHOUT|2020-07-03|2020-07-24|10|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|fe137506-d1ce-4b08-a043-9366d86c421e|3|DMG|Dimethylglycine|HEMATOLOGY|||[?]|[?]|INVALID|1|anti-Xa IU/mL|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|GELLED||FLOCCULATION|HEPASCORE FORMULA|||Y|Y|2|Visit_2|25|4|SCREENING|2020-07-18|2020-09-17|25|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|fe137506-d1ce-4b08-a043-9366d86c421e|4|ZPP|Zinc Protoporphyrin|URINALYSIS|[?]|yd|[?]|[?]|INDETERMINATE|1|mg/mL/day|1|1|[?]|LOW|LAVAGE FLUID|LACTESCENT||CHROMOGENIC ASSAY|FIBROSIS 4 FORMULA|||Y||2|Visit_2|25|1|TREATMENT|2020-07-18|2020-09-05|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|LB|fe137506-d1ce-4b08-a043-9366d86c421e|5|MMA|Methylmalonic Acid|CHEMISTRY|[?]|/wk|[?]|[?]|NEGATIVE|1|msec|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|LACTESCENT|N|CONGO RED STAIN|GMI % FORMULA||Y|N||3|Visit_3|40|1|TREATMENT|2020-08-02|2020-09-02|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|fe137506-d1ce-4b08-a043-9366d86c421e|6|LTE4|Leukotriene E4|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|ug/g/day|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|LACTESCENT|N|ICC|ASH FIBROSURE FORMULA|||U|Y|3|Visit_3|40|2|TREATMENT|2020-08-02|2020-09-01|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|LB|fe137506-d1ce-4b08-a043-9366d86c421e|7|SJSA52AB|Sjogrens SS-A52 Antibody|HEMATOLOGY|[?]|umol/L/h|[?]|[?]|INVALID|1|ug|1|1|[?]|LOW|DIALYSIS FLUID|FROZEN||CLIP SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA|||NA||4|Visit_4|65|1|FOLLOW-UP|2020-08-27|2020-09-30|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|fe137506-d1ce-4b08-a043-9366d86c421e|8|CTLPRM|Citalopram|CHEMISTRY|[?]|m2|[?]|[?]|POSITIVE|1|nmol/kg/day|1|1|[?]|ABNORMAL|PLEURAL FLUID|NON-HEMOLYZED|N|GC/MS-CI|HEPASCORE FORMULA|Y||U||4|Visit_4|65|7|TREATMENT|2020-08-27|2020-09-08|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|LB|fe137506-d1ce-4b08-a043-9366d86c421e|9|GLCHT|Glycolithocholate|CHEMISTRY|[?]|Farad|[?]|[?]|BORDERLINE|1|/day|1|1|[?]|LOW|CERUMEN|HEMOLYZED||QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROTEST FORMULA|||U||5|Visit_5|90|4|TREATMENT|2020-09-21|2020-09-22|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|LB|fe137506-d1ce-4b08-a043-9366d86c421e|10|C147281|Egg White Antigen IgE Antibody|CHEMISTRY|||[?]|[?]|NEGATIVE|1|cm/min|1|1|[?]|ABNORMAL|DISCHARGE|FRESH||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U|Y|5|Visit_5|90|2|FOLLOW-UP|2020-09-21|2020-09-22|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|LB|b112c524-42c8-4e9e-8699-209e739972a7|1|RDW|Erythrocytes Distribution Width|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|mL/g/h|1|1|[?]|LOW|SUPERNATANT, PLASMA|NON-HEMOLYZED|N|ENZYMATIC ULTRACENTRIFUGATION|CKD-EPI FORMULA|Y||N|Y|1|Visit_1|10|4|WASHOUT|2021-01-03|2021-01-25|10|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|b112c524-42c8-4e9e-8699-209e739972a7|2|AMPHETD|Dextroamphetamine|HEMATOLOGY|[?]|U/m2|[?]|[?]|POSITIVE|1|LENS|1|1|[?]|NORMAL|PLATELET|ICTERIC||ACCELERATOR MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA|||Y||1|Visit_1|10|6|SCREENING|2021-01-03|2021-01-04|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|LB|b112c524-42c8-4e9e-8699-209e739972a7|3|LYMMCELE|Lymphoma Cells/Leukocytes|CHEMISTRY|||[?]|[?]|TRACE|1|JDF Unit|1|1|[?]|LOW|PROSTATIC FLUID|CALCIFIED||ROMANOWSKY STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||NA|Y|2|Visit_2|25|1|TREATMENT|2021-01-18|2021-01-22|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|LB|b112c524-42c8-4e9e-8699-209e739972a7|4|CYMSU|Monosodium Urate Crystals|URINALYSIS|[?]|kat|[?]|[?]|POSITIVE|1|pg|1|1|[?]|LOW|ARTERIAL BLOOD|LACTESCENT||TWO-COLOR MICROARRAY|MDRD 5 VARIABLE FORMULA|||U||2|Visit_2|25|2|SCREENING|2021-01-18|2021-03-24|25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|LB|b112c524-42c8-4e9e-8699-209e739972a7|5|HYPGST17|17-Hydroxyprogesterone|URINALYSIS|||[?]|[?]|NEGATIVE|1|/100 HPFs|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED||ELECTROPHORESIS|NASH FIBROSURE FORMULA||Y|NA|Y|3|Visit_3|40|6|TREATMENT|2021-02-02|2021-03-14|40|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|LB|b112c524-42c8-4e9e-8699-209e739972a7|6|PROGEST|Progesterone|HEMATOLOGY|[?]|mL/cm H2O|[?]|[?]|NEGATIVE|1|L/s/kPa|1|1|[?]|NORMAL|CALCULUS|PARAFFIN-EMBEDDED||ETDRS EYE CHART|CKD-EPI CREATININE FORMULA|||N||3|Visit_3|40|7|WASHOUT|2021-02-02|2021-03-01|40|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|LB|b112c524-42c8-4e9e-8699-209e739972a7|7|ALPISOE|Alkaline Phosphatase Isoenzyme|URINALYSIS|[?]|min/day|[?]|[?]|INVALID|1|Antibody Unit|1|1|[?]|LOW|PLEURAL FLUID|DRIED||SANGER SEQUENCING|MDRD 6 VARIABLE FORMULA|Y||N||4|Visit_4|65|1|TREATMENT|2021-02-27|2021-03-21|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|b112c524-42c8-4e9e-8699-209e739972a7|8|MYBLAT2|Type II Myeloblasts|CHEMISTRY|||[?]|[?]|BORDERLINE|1|PFU/animal|1|1|[?]|LOW|GASTRIC FLUID|CONCENTRATED||PANENDOSCOPY|FIBROMETER FORMULA|||Y|Y|4|Visit_4|65|5|TREATMENT|2021-02-27|2021-03-28|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|LB|b112c524-42c8-4e9e-8699-209e739972a7|9|CD4LY|CD4/Lymphocytes|CHEMISTRY|||[?]|[?]|TRACE|1|gpELISA unit/mL|1|1|[?]|HIGH|SUPERNATANT, PLASMA|CONTAMINATED||IMMUNORADIOMETRIC ASSAY|FIBROMETER FORMULA|||U|Y|5|Visit_5|90|6|FOLLOW-UP|2021-03-24|2021-03-25|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|b112c524-42c8-4e9e-8699-209e739972a7|10|FATACFR|Free Fatty Acid|URINALYSIS|||[?]|[?]|BORDERLINE|1|Absorbance U/mL|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|LIPEMIC|N|IRON HEMATOXYLIN STAIN|GMI % FORMULA|||U|Y|5|Visit_5|90|3|TREATMENT|2021-03-24|2021-03-31|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|LB|e6e32df8-8b66-49a5-a626-fd385297dd6f|1|GDIGA1|Galactose-Deficient IgA1|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^7 PFU|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|AUTOLYZED||SCANNING ELECTRON MICROSCOPY|CKD-EPI FORMULA|||NA|Y|1|Visit_1|10|4|TREATMENT|2020-09-02|2020-10-12|10|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|e6e32df8-8b66-49a5-a626-fd385297dd6f|2|ETPLT|ETP Lag Time|URINALYSIS|[?]|mm/2h|[?]|[?]|TRACE|1|oz eq|1|1|[?]|NORMAL|TRANSUDATE|NON-HEMOLYZED||ATOMIC ABSORPTION SPECTROMETRY|GMI % FORMULA|Y|Y|NA||1|Visit_1|10|5|WASHOUT|2020-09-02|2020-10-26|10|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|e6e32df8-8b66-49a5-a626-fd385297dd6f|3|BLSTLMLY|Leukemic Blasts/Lymphocytes|HEMATOLOGY|[?]|anti-Xa IU/mL|[?]|[?]|INVALID|1|dmol|1|1|[?]|LOW|PLATELET RICH PLASMA|FRESH|N|DIFFUSION WEIGHTED MRI|MDRD 4 VARIABLE FORMULA||Y|NA||2|Visit_2|25|6|FOLLOW-UP|2020-09-17|2020-11-18|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|e6e32df8-8b66-49a5-a626-fd385297dd6f|4|BASOIMLE|Immature Basophils/Leukocytes|URINALYSIS|[?]|pmol/10^9 cells|[?]|[?]|POSITIVE|1|mol|1|1|[?]|HIGH|NAIL|FRESH||ICP-MS|MDRD ENZYMATIC JAPANESE FORMULA|||N||2|Visit_2|25|5|FOLLOW-UP|2020-09-17|2020-11-27|25|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|e6e32df8-8b66-49a5-a626-fd385297dd6f|5|FACTXIA|Factor XI Activity|URINALYSIS|[?]|pptr|[?]|[?]|INDETERMINATE|1|uL/kg/day|1|1|[?]|ABNORMAL|COLOSTRUM|REFRIGERATED||MAGNETIC RESONANCE ELASTOGRAPHY|GMI MMOL/MOL FORMULA|||NA||3|Visit_3|40|1|FOLLOW-UP|2020-10-02|2020-10-26|40|64|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|e6e32df8-8b66-49a5-a626-fd385297dd6f|6|CXCL12|Chemokine (C-X-C Motif) Ligand 12|URINALYSIS|[?]|mol/mg|[?]|[?]|NEGATIVE|1|vg/dose|1|1|[?]|HIGH|ISOLATE|DRIED||DIGITAL PCR|MDRD ENZYMATIC JAPANESE FORMULA|||N||3|Visit_3|40|6|TREATMENT|2020-10-02|2020-11-05|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|LB|e6e32df8-8b66-49a5-a626-fd385297dd6f|7|HEXK|Hexokinase|HEMATOLOGY|||[?]|[?]|INVALID|1|10^7 TCID 50/dose|1|1|[?]|HIGH|VENOUS CORD BLOOD|DRIED||RULER MEASUREMENT METHOD|NASH FIBROSURE FORMULA||Y|Y|Y|4|Visit_4|65|1|SCREENING|2020-10-27|2020-11-02|65|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|e6e32df8-8b66-49a5-a626-fd385297dd6f|8|HDLCCHOL|HDL Cholesterol/Total Cholesterol|URINALYSIS|[?]|TUBE|[?]|[?]|BORDERLINE|1|dB|1|1|[?]|NORMAL|LUNG SURFACTANT|CLOTTED||CALCOFLUOR WHITE STAIN|MDRD FORMULA|||U||4|Visit_4|65|1|FOLLOW-UP|2020-10-27|2020-11-08|65|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|LB|e6e32df8-8b66-49a5-a626-fd385297dd6f|9|IL6SR|Soluble Interleukin 6 Receptor|CHEMISTRY|[?]|PIPE|[?]|[?]|INVALID|1|kPa/L/sec|1|1|[?]|NORMAL|LUNG SURFACTANT|CLOTTED|N|FLUORESCENT MICROSCOPY|MDRD FORMULA|Y||N||5|Visit_5|90|2|TREATMENT|2020-11-21|2020-11-26|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|e6e32df8-8b66-49a5-a626-fd385297dd6f|10|C130134|D. pteronyssinus Antigen IgE Antibody|URINALYSIS|[?]|cmH2O/mL|[?]|[?]|TRACE|1|10^9 organisms|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|CALCIFIED||QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA|Y||NA||5|Visit_5|90|5|FOLLOW-UP|2020-11-21|2020-11-22|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|LB|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|1|AMPHETD|Dextroamphetamine|URINALYSIS|[?]|deg2|[?]|[?]|INDETERMINATE|1|Bq/mg|1|1|[?]|NORMAL|WHITE MATTER TISSUE|HEMOLYZED||INTRAVASCULAR ULTRASOUND|FIBROMETER FORMULA|||Y||1|Visit_1|10|1|SCREENING|2020-09-18|2020-11-26|10|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|2|RPTLTIME|Reptilase Time|CHEMISTRY|[?]|BU/mL|[?]|[?]|INVALID|1|10^3 CFU|1|1|[?]|LOW|EMESIS|UNEXPECTED ODOR||NON-INVASIVE DIELECTRIC SENSING|GMI MMOL/MOL FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-09-18|2020-10-12|10|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|3|GRANSGCE|Granulocytes Segmented/Total Cells|URINALYSIS|||[?]|[?]|INVALID|1|HOURS|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|ICTERIC||SANGER SEQUENCING|COCKCROFT-GAULT FORMULA|Y||U|Y|2|Visit_2|25|4|FOLLOW-UP|2020-10-03|2020-12-14|25|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|4|GAMBTAC|Gamma-Aminobutyric Acid|CHEMISTRY|||[?]|[?]|NEGATIVE|1|APS U|1|1|[?]|HIGH|DISCHARGE|FRESH||POLYGRAPHY|NASH FIBROSURE FORMULA||Y|U|Y|2|Visit_2|25|1|TREATMENT|2020-10-03|2020-10-15|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|LB|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|5|CLUECE|Clue Cells|URINALYSIS|[?]|10^8/L|[?]|[?]|POSITIVE|1|/200 HPFs|1|1|[?]|ABNORMAL|WHITE MATTER TISSUE|HEMOLYZED||VENTILATION PERFUSION LUNG SCAN|FIBROSIS 4 FORMULA|Y|Y|Y||3|Visit_3|40|3|TREATMENT|2020-10-18|2020-10-27|40|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|6|GRANULIN|Granulin|URINALYSIS|||[?]|[?]|TRACE|1|ms/mmHg|1|1|[?]|ABNORMAL|URINE|SOLIDIFIED||ANTIMICROBIAL COMBINATION TESTING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|3|Visit_3|40|6|WASHOUT|2020-10-18|2020-11-21|40|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|LB|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|7|KRCYMGLE|Megakaryocytes/Leukocytes|CHEMISTRY|[?]|pmol/L/h|[?]|[?]|BORDERLINE|1|MET*h|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|CONCENTRATED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 5 VARIABLE FORMULA|Y||NA||4|Visit_4|65|1|FOLLOW-UP|2020-11-12|2020-11-15|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|8|DZPM|Diazepam|CHEMISTRY|[?]|g/animal|[?]|[?]|INVALID|1|Enzyme U|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|CONCENTRATED|N|KLEIHAUER-BETKE|FIBROTEST FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-11-12|2020-11-26|65|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|LB|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|9|AMMONIA|Ammonia|HEMATOLOGY|[?]|Sv|[?]|[?]|NEGATIVE|1|amu|1|1|[?]|NORMAL|INFRANATANT, SERUM|CONCENTRATED||CLIP SEQUENCING|CKD-EPI FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2020-12-07|2020-12-12|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|10|CLRDZPXD|Chlordiazepoxide|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|CFU/mL|1|1|[?]|NORMAL|RETICULOCYTES|UNEXPECTED ODOR||MICROARRAY|FIBROMETER FORMULA|||Y|Y|5|Visit_5|90|2|WASHOUT|2020-12-07|2020-12-09|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|LB|5002de57-45df-4525-a6b7-b6cc33c22229|1|C130138|American Cockroach Antigen IgG Antibody|URINALYSIS|[?]|L/day|[?]|[?]|BORDERLINE|1|mL/m2|1|1|[?]|ABNORMAL|VENOUS PLASMA|UNEXPECTED ODOR||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|GMI % FORMULA|||U||1|Visit_1|10|3|TREATMENT|2021-01-12|2021-03-22|10|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|5002de57-45df-4525-a6b7-b6cc33c22229|2|EPSTI1|Epithelial Stromal Interaction Protein 1|URINALYSIS|[?]|/MBP|[?]|[?]|NEGATIVE|1|days/wk|1|1|[?]|ABNORMAL|LAVAGE FLUID|ICTERIC||PHYSICAL EXAMINATION|HEPASCORE FORMULA||Y|Y||1|Visit_1|10|6|TREATMENT|2021-01-12|2021-02-13|10|42|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|5002de57-45df-4525-a6b7-b6cc33c22229|3|IGF2|Insulin-like Growth Factor-2|CHEMISTRY|||[?]|[?]|TRACE|1|10^6 organisms|1|1|[?]|NORMAL|CORD SERUM|FRESH||MRI|MDRD 4 VARIABLE FORMULA||Y|N|Y|2|Visit_2|25|7|FOLLOW-UP|2021-01-27|2021-02-18|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|5002de57-45df-4525-a6b7-b6cc33c22229|4|RHD|RhD Factor|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|amp|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|LACTESCENT||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|ASH FIBROSURE FORMULA|Y||NA|Y|2|Visit_2|25|2|TREATMENT|2021-01-27|2021-02-12|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|LB|5002de57-45df-4525-a6b7-b6cc33c22229|5|PROLYM|Prolymphocytes|URINALYSIS|||[?]|[?]|NEGATIVE|1|mL/min/1.73m2|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|FROZEN||AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD FORMULA||Y|U|Y|3|Visit_3|40|3|TREATMENT|2021-02-11|2021-03-10|40|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|5002de57-45df-4525-a6b7-b6cc33c22229|6|NEUTGT|Giant Neutrophils|CHEMISTRY|||[?]|[?]|BORDERLINE|1|uV2|1|1|[?]|LOW|HAIR FOLLICLE|GELLED||CT SCAN|FIBROSIS 4 FORMULA|||N|Y|3|Visit_3|40|4|SCREENING|2021-02-11|2021-02-23|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|5002de57-45df-4525-a6b7-b6cc33c22229|7|GSTMUCRT|Mu Glutathione-S-Transferase/Creatinine|HEMATOLOGY|[?]|IU/L|[?]|[?]|TRACE|1|titer|1|1|[?]|LOW|EXPIRED AIR|FRESH||CONTRAST ENHANCED PET/CT SCAN|MDRD ENZYMATIC FORMULA|Y||N||4|Visit_4|65|4|TREATMENT|2021-03-08|2021-03-31|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|5002de57-45df-4525-a6b7-b6cc33c22229|8|CHCM|Corpuscular HGB Concentration Mean|CHEMISTRY|[?]|mg/m2/day|[?]|[?]|BORDERLINE|1|U/m2|1|1|[?]|NORMAL|REFLEX TEAR|CONTAMINATED|N|GC/MS-EI|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||4|Visit_4|65|5|FOLLOW-UP|2021-03-08|2021-03-12|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|5002de57-45df-4525-a6b7-b6cc33c22229|9|C165911|Dairy Mix IgG AB RAST Score|HEMATOLOGY|[?]|mL/m2|[?]|[?]|NEGATIVE|1|Gy|1|1|[?]|ABNORMAL|TISSUE|LACTESCENT||HPLC/IEX|FIBROSIS 4 FORMULA|Y|Y|N||5|Visit_5|90|3|WASHOUT|2021-04-02|2021-04-09|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|5002de57-45df-4525-a6b7-b6cc33c22229|10|PGF2A|Prostaglandin F2 Alpha|HEMATOLOGY|[?]|%(v/v)|[?]|[?]|INDETERMINATE|1|CAPFUL|1|1|[?]|HIGH|PLATELET|THAWED||LIGHT SCATTERING SPECTROSCOPY|CKD-EPI FORMULA|||U||5|Visit_5|90|3|SCREENING|2021-04-02|2021-04-07|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|298f2081-bb11-4856-9e88-4be3b9b2250d|1|MONOCE|Monocytes/Total Cells|CHEMISTRY|[?]|ELISA unit|[?]|[?]|INVALID|1|nmol/g|1|1|[?]|LOW|SUPERNATANT, PLEURAL FLUID|LACTESCENT||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|GMI % FORMULA|Y|Y|N||1|Visit_1|10|6|WASHOUT|2020-10-05|2020-12-12|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|298f2081-bb11-4856-9e88-4be3b9b2250d|2|BASEEXCS|Base Excess|CHEMISTRY|[?]|keV|[?]|[?]|BORDERLINE|1|mMU/mL|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|THAWED||PH METER MEASUREMENT METHOD|GMI MMOL/MOL FORMULA|Y||N||1|Visit_1|10|6|SCREENING|2020-10-05|2020-12-13|10|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|LB|298f2081-bb11-4856-9e88-4be3b9b2250d|3|HSP90A|Heat Shock Protein 90 Alpha|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mL/m2/day|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|ICTERIC|N|BIOPSY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y||Y|Y|2|Visit_2|25|5|TREATMENT|2020-10-20|2020-11-15|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|298f2081-bb11-4856-9e88-4be3b9b2250d|4|LDH3LDH|LDH Isoenzyme 3/LDH|CHEMISTRY|[?]|ug/kg|[?]|[?]|POSITIVE|1|/h|1|1|[?]|NORMAL|ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR||MOUSE PROTECTION ASSAY|FIBROMETER FORMULA|||Y||2|Visit_2|25|5|SCREENING|2020-10-20|2020-10-22|25|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|298f2081-bb11-4856-9e88-4be3b9b2250d|5|DDX58|DEAD Box Protein 58|HEMATOLOGY|[?]|uCi/L|[?]|[?]|POSITIVE|1|MBq|1|1|[?]|LOW|SEMEN|LIPEMIC|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD 5 VARIABLE FORMULA|||Y||3|Visit_3|40|5|SCREENING|2020-11-04|2020-12-05|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|298f2081-bb11-4856-9e88-4be3b9b2250d|6|HETRPHLE|Heterophils/Leukocytes|HEMATOLOGY|[?]|mg/dL|[?]|[?]|INVALID|1|mg2/dL2|1|1|[?]|NORMAL|STOOL|REFRIGERATED|N|STATIC PERIMETRY|CKD-EPI CREATININE FORMULA|Y|Y|N||3|Visit_3|40|6|SCREENING|2020-11-04|2020-12-17|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|LB|298f2081-bb11-4856-9e88-4be3b9b2250d|7|MMIF|Macrophage Migration Inhibitory Factor|CHEMISTRY|[?]|DROP|[?]|[?]|NEGATIVE|1|pmol/10^9 cells|1|1|[?]|LOW|BLOOD|DRIED||PET SCAN|MDRD 4 VARIABLE FORMULA||Y|N||4|Visit_4|65|6|TREATMENT|2020-11-29|2020-12-12|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|298f2081-bb11-4856-9e88-4be3b9b2250d|8|NRP1|Neuropilin-1|CHEMISTRY|[?]|MONTHS|[?]|[?]|INDETERMINATE|1|ELISA unit|1|1|[?]|LOW|INFRANATANT, SERUM|GELLED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|7|TREATMENT|2020-11-29|2020-12-05|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|LB|298f2081-bb11-4856-9e88-4be3b9b2250d|9|LACTULOS|Lactulose|HEMATOLOGY|[?]|PLUG|[?]|[?]|TRACE|1|10^9 organisms/mL|1|1|[?]|HIGH|SEMEN|THAWED||CALCULATION|MDRD ENZYMATIC FORMULA|||N||5|Visit_5|90|4|FOLLOW-UP|2020-12-24|2020-12-27|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|298f2081-bb11-4856-9e88-4be3b9b2250d|10|CRNTESTR|Carnitine Esters|HEMATOLOGY|[?]|ug/m2/min|[?]|[?]|INDETERMINATE|1|Coulomb|1|1|[?]|NORMAL|TISSUE|LACTESCENT|N|SISH|CKD-EPI CREATININE FORMULA||Y|N||5|Visit_5|90|3|FOLLOW-UP|2020-12-24|2020-12-30|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|LB|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|1|PHOSEXR|Phosphorus Excretion Rate|URINALYSIS|[?]|umol/L/h|[?]|[?]|INVALID|1|U/cL|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|ROOM TEMPERATURE||SLOAN LETTER EYE CHART 1.25%|HEPASCORE FORMULA||Y|N||1|Visit_1|10|1|FOLLOW-UP|2020-12-29|2021-01-27|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|2|C165941|Common Ragweed Pollen IgE AB RAST Score|CHEMISTRY|[?]|mL/dL|[?]|[?]|NEGATIVE|1|dram|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|LACTESCENT||ELECTROCHEMILUMINESCENCE|MDRD 6 VARIABLE FORMULA||Y|N||1|Visit_1|10|6|WASHOUT|2020-12-29|2021-02-27|10|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|LB|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|3|VEGFA|Vascular Endothelial Growth Factor A|URINALYSIS|||[?]|[?]|NEGATIVE|1|mL/breath|1|1|[?]|ABNORMAL|SOFT TISSUE|GELLED||ATOMIC ABSORPTION SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA|||U|Y|2|Visit_2|25|3|TREATMENT|2021-01-13|2021-02-25|25|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|4|APPB|Amyloid Beta Precursor Protein|URINALYSIS|[?]|GPL U/mL|[?]|[?]|INVALID|1|%(w/v)|1|1|[?]|ABNORMAL|CERUMEN|ROOM TEMPERATURE||FLUORESCENT ENZYME IMMUNOASSAY|NASH FIBROSURE FORMULA|||N||2|Visit_2|25|4|SCREENING|2021-01-13|2021-03-23|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|LB|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|5|GGTCREAT|Gamma Glutamyl Transferase/Creatinine|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|min*mg/mL|1|1|[?]|ABNORMAL|BUFFY COAT|FRESH||SMEAR|MDRD ENZYMATIC FORMULA||Y|Y|Y|3|Visit_3|40|1|WASHOUT|2021-01-28|2021-03-13|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|6|CELLULAR|Cellularity|HEMATOLOGY|[?]|mL/dL|[?]|[?]|TRACE|1|mg/dose|1|1|[?]|NORMAL|SOFT TISSUE|CONCENTRATED||PET SCAN|MDRD FORMULA|||N||3|Visit_3|40|7|TREATMENT|2021-01-28|2021-02-08|40|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|7|FXIVAC|Factor XIV Actual/Control|HEMATOLOGY|[?]|amp|[?]|[?]|NEGATIVE|1|mL|1|1|[?]|HIGH|WHITE MATTER TISSUE|DRIED||PALPATION|NASH FIBROSURE FORMULA|||NA||4|Visit_4|65|3|FOLLOW-UP|2021-02-22|2021-03-12|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|LB|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|8|INTLK13|Interleukin 13|URINALYSIS|[?]|kUSP|[?]|[?]|BORDERLINE|1|Sv|1|1|[?]|HIGH|PUS|NON-HEMOLYZED||JAFFE REACTION|FIBROTEST FORMULA|||Y||4|Visit_4|65|2|FOLLOW-UP|2021-02-22|2021-03-02|65|73|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|LB|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|9|IBCT|Total Iron Binding Capacity|HEMATOLOGY|[?]|PELLET|[?]|[?]|POSITIVE|1|cy/cm|1|1|[?]|NORMAL|BREAST MILK|GELLED||STATIC PERIMETRY|MDRD FORMULA||Y|U||5|Visit_5|90|2|WASHOUT|2021-03-19|2021-03-28|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|10|A1AGLP|Alpha-1 Acid Glycoprotein|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^7 PFU|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|ICTERIC||PET SCAN|HEPASCORE FORMULA|||NA|Y|5|Visit_5|90|6|TREATMENT|2021-03-19|2021-03-23|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|LB|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|1|SOST|Sclerostin|HEMATOLOGY|[?]|SPRAY|[?]|[?]|NEGATIVE|1|kIU|1|1|[?]|NORMAL|BONE MARROW|ICTERIC|N|IN VITRO GENE EXPRESSION ASSAY|FIBROSIS 4 FORMULA|||NA||1|Visit_1|10|4|TREATMENT|2020-05-12|2020-06-17|10|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|LB|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|2|HAPTOG|Haptoglobin|URINALYSIS|[?]|mL/kg/h|[?]|[?]|NEGATIVE|1|/min|1|1|[?]|LOW|HAIR|AUTOLYZED||HPLC-UV|FIBROTEST FORMULA||Y|N||1|Visit_1|10|7|TREATMENT|2020-05-12|2020-05-24|10|22|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|LB|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|3|HPOCROM|Hypochromia|HEMATOLOGY|[?]|U/cL|[?]|[?]|INVALID|1|Linear ft*LB|1|1|[?]|NORMAL|FLUID|LIPEMIC||INDIRECT IMMUNOFLUORESCENCE|GMI % FORMULA|Y||NA||2|Visit_2|25|7|WASHOUT|2020-05-27|2020-07-02|25|61|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|4|INTLK19|Interleukin 19|HEMATOLOGY|[?]|DAgU/mL|[?]|[?]|POSITIVE|1|10^6 organisms/mg|1|1|[?]|LOW|PLATELET RICH PLASMA|LIPEMIC||CONTRAST ENHANCED PET SCAN|MDRD ENZYMATIC FORMULA|Y||N||2|Visit_2|25|7|SCREENING|2020-05-27|2020-05-30|25|28|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|LB|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|5|MCP1|Monocyte Chemotactic Protein 1|HEMATOLOGY|[?]|/kg|[?]|[?]|INDETERMINATE|1|mol/L|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|CONTAMINATED||IMPULSE OSCILLOMETRY|GMI MMOL/MOL FORMULA|||U||3|Visit_3|40|3|FOLLOW-UP|2020-06-11|2020-07-05|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|6|TNFSR2|Soluble TNF Receptor Type II|URINALYSIS|[?]|/day|[?]|[?]|POSITIVE|1|mL/cage|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|LIPEMIC||SANGER SEQUENCING|GMI % FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-06-11|2020-08-02|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|7|EDMIGAAB|Endomysial IgA Antibody|HEMATOLOGY|[?]|MPL U/mL|[?]|[?]|INDETERMINATE|1|LENS|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|CLOTTED||SXA SCAN|ASH FIBROSURE FORMULA||Y|NA||4|Visit_4|65|2|WASHOUT|2020-07-06|2020-07-26|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|8|IRF|Immature Reticulocyte Fraction|CHEMISTRY|[?]|pmol/10^9 cells|[?]|[?]|POSITIVE|1|L/s/kPa|1|1|[?]|NORMAL|NAIL|CONCENTRATED||RIA|ASH FIBROSURE FORMULA||Y|U||4|Visit_4|65|1|SCREENING|2020-07-06|2020-07-31|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|9|PCO2|Partial Pressure Carbon Dioxide|URINALYSIS|[?]|mol/mol|[?]|[?]|TRACE|1|GPL U/mL|1|1|[?]|LOW|PLEURAL FLUID|CLOTTED||HEMAGGLUTINATION ASSAY|CKD-EPI FORMULA|||N||5|Visit_5|90|1|WASHOUT|2020-07-31|2020-08-01|90|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-04
e|LB|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|10|OHDG8|8-Hydroxydeoxyguanosine|URINALYSIS|[?]|ng/L|[?]|[?]|BORDERLINE|1|10^3 DNA copies/mL|1|1|[?]|HIGH|EPITHELIAL CELL|REFRIGERATED||ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CYSTATIN C FORMULA|||U||5|Visit_5|90|5|TREATMENT|2020-07-31|2020-08-07|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-04
e|LB|18c21176-db5e-4650-a1af-beb2042c31d8|1|GOLD|Gold|HEMATOLOGY|[?]|Ejaculate U|[?]|[?]|INVALID|1|dpm/mL|1|1|[?]|ABNORMAL|BUFFY COAT|AUTOLYZED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROMETER FORMULA|Y||U||1|Visit_1|10|5|WASHOUT|2020-08-30|2020-11-14|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|18c21176-db5e-4650-a1af-beb2042c31d8|2|GLUCPE|Plasma Equivalent Glucose|URINALYSIS|[?]|mg/kg|[?]|[?]|TRACE|1|RNA copies/mL|1|1|[?]|HIGH|SWABBED MATERIAL|AGGLUTINATED|N|MEDIASTINOSCOPY|FIBROSIS 4 FORMULA|||NA||1|Visit_1|10|7|WASHOUT|2020-08-30|2020-10-25|10|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|18c21176-db5e-4650-a1af-beb2042c31d8|3|WBCCE|Leukocytes/Total Cells|CHEMISTRY|||[?]|[?]|BORDERLINE|1|L|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|REFRIGERATED||CONFOCAL MICROSCOPY|FIBROMETER FORMULA|||N|Y|2|Visit_2|25|4|TREATMENT|2020-09-14|2020-09-23|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|18c21176-db5e-4650-a1af-beb2042c31d8|4|HASIGGAB|Human Anti-Sheep IgG Antibody|URINALYSIS|[?]|IU|[?]|[?]|INVALID|1|mol/mg|1|1|[?]|NORMAL|CORD BLOOD|LACTESCENT||CONTRAST ENHANCED X-RAY|CKD-EPI CYSTATIN C FORMULA|Y||Y||2|Visit_2|25|6|TREATMENT|2020-09-14|2020-10-17|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|LB|18c21176-db5e-4650-a1af-beb2042c31d8|5|FACTXI|Factor XI|CHEMISTRY|||[?]|[?]|POSITIVE|1|kV|1|1|[?]|HIGH|LEUKOCYTE|GELLED||MS/MS|FIBROMETER FORMULA|||NA|Y|3|Visit_3|40|1|TREATMENT|2020-09-29|2020-10-13|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|18c21176-db5e-4650-a1af-beb2042c31d8|6|GLUCEXR|Glucose Excretion Rate|URINALYSIS|[?]|CONTAINER|[?]|[?]|TRACE|1|Bq/g|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|LACTESCENT|N|CONFOCAL MICROSCOPY|MDRD 4 VARIABLE FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-09-29|2020-10-11|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|LB|18c21176-db5e-4650-a1af-beb2042c31d8|7|THYPXDAB|Thyroperoxidase Antibody|HEMATOLOGY|||[?]|[?]|POSITIVE|1|mm3/mm2/year|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|AUTOLYZED||DYNAMIC LIGHT SCATTERING|MDRD 6 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|4|WASHOUT|2020-10-24|2020-11-24|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|18c21176-db5e-4650-a1af-beb2042c31d8|8|PSIGGAB|Phosphatidylserine IgG Antibody|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|/ms|1|1|[?]|ABNORMAL|FLUID|ICTERIC||SLOAN LETTER EYE CHART 2.5%|FIBROSIS 4 FORMULA|||U|Y|4|Visit_4|65|4|TREATMENT|2020-10-24|2020-11-17|65|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|LB|18c21176-db5e-4650-a1af-beb2042c31d8|9|LYMLG|Large Lymphocytes|URINALYSIS|[?]|um|[?]|[?]|POSITIVE|1|IU/day|1|1|[?]|HIGH|COLOSTRUM|ROOM TEMPERATURE||NUCLEIC ACID HYBRIDIZATION|CKD-EPI FORMULA|Y||Y||5|Visit_5|90|6|TREATMENT|2020-11-18|2020-11-21|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|18c21176-db5e-4650-a1af-beb2042c31d8|10|IL6SR|Soluble Interleukin 6 Receptor|URINALYSIS|[?]|Absorbance U/min|[?]|[?]|NEGATIVE|1|mL/kg/min|1|1|[?]|LOW|SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED||MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|2|FOLLOW-UP|2020-11-18|2020-11-24|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|LB|7808abd1-7d6f-4090-aa08-916a804c95f5|1|C165900|Orchard Grass Pollen IgG AB RAST Score|HEMATOLOGY|[?]|SYRINGE|[?]|[?]|INDETERMINATE|1|mIU/L|1|1|[?]|LOW|MUSCLE TISSUE|ICTERIC|N|SPECT/CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-06-20|2020-08-07|10|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|7808abd1-7d6f-4090-aa08-916a804c95f5|2|TDTAG|Terminal Deoxynucleotidyl Transferase Ag|HEMATOLOGY|[?]|cP|[?]|[?]|INVALID|1|psi|1|1|[?]|HIGH|VENOUS PLASMA|AGGLUTINATED||TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD ENZYMATIC FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-06-20|2020-07-01|10|21|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|LB|7808abd1-7d6f-4090-aa08-916a804c95f5|3|METARUB|Metarubricyte|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|F|1|1|[?]|ABNORMAL|PLATELET|ROOM TEMPERATURE|N|EPSILOMETER|FIBROTEST FORMULA|||NA|Y|2|Visit_2|25|5|FOLLOW-UP|2020-07-05|2020-09-10|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|7808abd1-7d6f-4090-aa08-916a804c95f5|4|CSBACT|Bacterial Casts|HEMATOLOGY|[?]|ag|[?]|[?]|INDETERMINATE|1|uEq|1|1|[?]|HIGH|EXPIRED AIR|UNEXPECTED ODOR||TRICHROME STAIN|FIBROTEST FORMULA|||U||2|Visit_2|25|2|SCREENING|2020-07-05|2020-07-26|25|46|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|7808abd1-7d6f-4090-aa08-916a804c95f5|5|FECA|Fractional Calcium Excretion|HEMATOLOGY|[?]|pmol|[?]|[?]|INVALID|1|Newton|1|1|[?]|ABNORMAL|PUS|FRESH||MICROBIAL CULTURE, SOLID|MDRD ENZYMATIC FORMULA|||Y||3|Visit_3|40|4|SCREENING|2020-07-20|2020-09-14|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|7808abd1-7d6f-4090-aa08-916a804c95f5|6|PAPPA|Pregnancy-Associated Plasma Protein-A|HEMATOLOGY|||[?]|[?]|TRACE|1|log10 CFU/g|1|1|[?]|ABNORMAL|KERATINOCYTE|FROZEN|N|MS/MS|NASH FIBROSURE FORMULA|Y|Y|Y|Y|3|Visit_3|40|3|SCREENING|2020-07-20|2020-08-05|40|56|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|LB|7808abd1-7d6f-4090-aa08-916a804c95f5|7|CCL21|Chemokine (C-C Motif) Ligand 21|CHEMISTRY|||[?]|[?]|POSITIVE|1|%/min|1|1|[?]|ABNORMAL|NAIL|FROZEN|N|MICROBIAL CULTURE, LIQUID|ASH FIBROSURE FORMULA|Y||NA|Y|4|Visit_4|65|5|SCREENING|2020-08-14|2020-08-16|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|LB|7808abd1-7d6f-4090-aa08-916a804c95f5|8|NMH|N-methylhistamine|URINALYSIS|[?]|scm|[?]|[?]|TRACE|1|mL/s|1|1|[?]|LOW|ENDOMETRIAL TISSUE|GELLED||POTENTIOMETRY|FIBROTEST FORMULA|||NA||4|Visit_4|65|4|TREATMENT|2020-08-14|2020-09-14|65|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|LB|7808abd1-7d6f-4090-aa08-916a804c95f5|9|MLATONIN|Melatonin|CHEMISTRY|[?]|CCID 50/dose|[?]|[?]|INVALID|1|ug/L FEU|1|1|[?]|NORMAL|LEUKOCYTE|HEMOLYZED||SISH|NASH FIBROSURE FORMULA|Y||Y||5|Visit_5|90|4|FOLLOW-UP|2020-09-08|2020-09-14|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|7808abd1-7d6f-4090-aa08-916a804c95f5|10|SPERMP|Spermatozoa, Progressive|HEMATOLOGY|[?]|U/mg|[?]|[?]|BORDERLINE|1|10^3 RNA copies/mL|1|1|[?]|HIGH|RETICULOCYTES|CALCIFIED|N|WHOLE TRANSCRIPTOME SEQUENCING|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|3|FOLLOW-UP|2020-09-08|2020-09-13|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|57553b78-e761-4577-aae2-5c693a2dc303|1|CARBXHGB|Carboxyhemoglobin|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Log10 ELISA unit/dose|1|1|[?]|NORMAL|CAPILLARY BLOOD|FRESH||PHOROPTER|HEPASCORE FORMULA|||Y|Y|1|Visit_1|10|5|SCREENING|2021-01-01|2021-03-03|10|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|57553b78-e761-4577-aae2-5c693a2dc303|2|BLASTCE|Blasts/Total Cells|HEMATOLOGY|||[?]|[?]|INVALID|1|mm2|1|1|[?]|ABNORMAL|SERUM OR PLASMA OR BLOOD|AGGLUTINATED||MULTI-SLICE SPIRAL CT|COCKCROFT-GAULT FORMULA|Y||Y|Y|1|Visit_1|10|3|FOLLOW-UP|2021-01-01|2021-03-17|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|LB|57553b78-e761-4577-aae2-5c693a2dc303|3|PBGCREAT|Porphobilinogen/Creatinine|URINALYSIS|[?]|dpm/mL|[?]|[?]|POSITIVE|1|10^5/L|1|1|[?]|LOW|PLEURAL TISSUE|NON-HEMOLYZED||NON-INVASIVE DIELECTRIC SENSING|GMI % FORMULA||Y|NA||2|Visit_2|25|4|WASHOUT|2021-01-16|2021-01-23|25|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|57553b78-e761-4577-aae2-5c693a2dc303|4|AMH|Anti-Mullerian Hormone|URINALYSIS|[?]|kUSP|[?]|[?]|NEGATIVE|1|lm|1|1|[?]|NORMAL|CAPILLARY BLOOD|REFRIGERATED|N|IMMUNOBLOT|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|7|TREATMENT|2021-01-16|2021-02-12|25|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|57553b78-e761-4577-aae2-5c693a2dc303|5|HBOARBHB|Hemoglobin O-Arab/Total Hemoglobin|HEMATOLOGY|||[?]|[?]|TRACE|1|um/s|1|1|[?]|HIGH|EPITHELIAL CELL|UNEXPECTED ODOR|N|PERIODIC ACID SCHIFF STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|3|Visit_3|40|7|TREATMENT|2021-01-31|2021-03-20|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|LB|57553b78-e761-4577-aae2-5c693a2dc303|6|ASN|Asparagine|URINALYSIS|[?]|genEq/mL|[?]|[?]|INDETERMINATE|1|mg/dose|1|1|[?]|LOW|LEUKOCYTE|CONTAMINATED||ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CREATININE FORMULA||Y|U||3|Visit_3|40|3|SCREENING|2021-01-31|2021-02-08|40|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|LB|57553b78-e761-4577-aae2-5c693a2dc303|7|CBANH9|Carbonic Anhydrase 9|CHEMISTRY|[?]|PUFF|[?]|[?]|BORDERLINE|1|nmol/L|1|1|[?]|LOW|SOFT TISSUE|AUTOLYZED||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA|Y||U||4|Visit_4|65|1|SCREENING|2021-02-25|2021-02-28|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|57553b78-e761-4577-aae2-5c693a2dc303|8|C165905|Grass Mix Pollen IgG AB RAST Score|CHEMISTRY|[?]|lx|[?]|[?]|TRACE|1|WEEKS|1|1|[?]|NORMAL|BASAL TEAR|THAWED||CALCULATION|MDRD FORMULA|Y||Y||4|Visit_4|65|1|WASHOUT|2021-02-25|2021-02-26|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|LB|57553b78-e761-4577-aae2-5c693a2dc303|9|FACTXII|Factor XII|CHEMISTRY|[?]|ELISA unit/mL|[?]|[?]|NEGATIVE|1|10^4 CFU|1|1|[?]|NORMAL|BASAL TEAR|UNEXPECTED ODOR||GC/MS|GMI MMOL/MOL FORMULA|||Y||5|Visit_5|90|4|WASHOUT|2021-03-22|2021-03-28|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|57553b78-e761-4577-aae2-5c693a2dc303|10|EPIRCE|Renal Epithelial Cells|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Watt|1|1|[?]|HIGH|SPUTUM|SOLIDIFIED|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|NASH FIBROSURE FORMULA|Y||N|Y|5|Visit_5|90|1|TREATMENT|2021-03-22|2021-03-25|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|LB|40883550-4627-4f92-974a-7eeb5bde74c5|1|CD19|CD19|URINALYSIS|[?]|mL/cage|[?]|[?]|INVALID|1|IU/dL|1|1|[?]|NORMAL|EMOTIONAL TEAR|DRIED||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|3|WASHOUT|2020-10-13|2020-11-15|10|43|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|40883550-4627-4f92-974a-7eeb5bde74c5|2|GATCPHRL|Gamma Tocopherol|HEMATOLOGY|[?]|Weber|[?]|[?]|TRACE|1|STEPS|1|1|[?]|ABNORMAL|DERMAL TISSUE|SOLIDIFIED||DIGITAL PCR|FIBROMETER FORMULA|Y||U||1|Visit_1|10|3|TREATMENT|2020-10-13|2020-11-22|10|50|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|LB|40883550-4627-4f92-974a-7eeb5bde74c5|3|LIPASEG|Lipase, Gastric|HEMATOLOGY|[?]|ukat/10^12 RBC|[?]|[?]|INDETERMINATE|1|GLOBULE|1|1|[?]|HIGH|SPERMATOZOON|ICTERIC|N|NUCLEIC ACID HYBRIDIZATION|FIBROSIS 4 FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-10-28|2020-11-23|25|51|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|40883550-4627-4f92-974a-7eeb5bde74c5|4|IGGCALBC|IgG Clearance/Albumin Clearance|URINALYSIS|[?]|CFU/g|[?]|[?]|TRACE|1|uV2|1|1|[?]|HIGH|URINE|SOLIDIFIED||MULTI-SLICE SPIRAL CT|GMI % FORMULA|||Y||2|Visit_2|25|1|SCREENING|2020-10-28|2020-12-30|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|LB|40883550-4627-4f92-974a-7eeb5bde74c5|5|GLDIGAAB|Gliadin IgA Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|100 IU/mL|1|1|[?]|NORMAL|LAVAGE FLUID|UNEXPECTED ODOR||KINETIC CHROMOGENIC ASSAY|MDRD FORMULA||Y|NA|Y|3|Visit_3|40|2|TREATMENT|2020-11-12|2020-11-24|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|40883550-4627-4f92-974a-7eeb5bde74c5|6|FAT|Fat|URINALYSIS|[?]|mmol/g|[?]|[?]|INDETERMINATE|1|uU/L|1|1|[?]|HIGH|MUCUS|PARAFFIN-EMBEDDED||SURFACE PLASMON RESONANCE|MDRD 5 VARIABLE FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-11-12|2020-11-17|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|40883550-4627-4f92-974a-7eeb5bde74c5|7|CHOLINES|Cholinesterase|CHEMISTRY|[?]|mmol/L|[?]|[?]|POSITIVE|1|cP|1|1|[?]|LOW|BREAST MILK|THAWED|N|POPULATION SEQUENCING|CKD-EPI FORMULA|||NA||4|Visit_4|65|5|SCREENING|2020-12-07|2020-12-18|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|40883550-4627-4f92-974a-7eeb5bde74c5|8|NITRITE|Nitrite|URINALYSIS|[?]|mL/(min*100mL)|[?]|[?]|BORDERLINE|1|10^6 CFU/mL|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|SOLIDIFIED|N|IMMUNOPRECIPITATION|MDRD ENZYMATIC JAPANESE FORMULA|Y||N||4|Visit_4|65|5|TREATMENT|2020-12-07|2020-12-29|65|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|LB|40883550-4627-4f92-974a-7eeb5bde74c5|9|C165901|EnglishPlantain Pollen IgG AB RAST Score|HEMATOLOGY|[?]|mL/m2/h|[?]|[?]|NEGATIVE|1|U/mmol|1|1|[?]|NORMAL|SEMINAL FLUID|SOLIDIFIED|N|MODIFIED ACID FAST STAIN|MDRD 5 VARIABLE FORMULA|||Y||5|Visit_5|90|5|SCREENING|2021-01-01|2021-01-08|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|40883550-4627-4f92-974a-7eeb5bde74c5|10|C130122|Nut Mix Antigen IgE Antibody|CHEMISTRY|[?]|GPS U|[?]|[?]|NEGATIVE|1|Ci/mL|1|1|[?]|HIGH|BONE|NON-HEMOLYZED||MUGA|COCKCROFT-GAULT FORMULA|||Y||5|Visit_5|90|2|SCREENING|2021-01-01|2021-01-05|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|4199b549-d021-4bfd-97e6-95630d407183|1|LDLOXAB|Oxidized LDL Cholesterol Antibody|URINALYSIS|[?]|mg/L|[?]|[?]|INVALID|1|10^4/hpf|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|PARAFFIN-EMBEDDED||CT SCAN WITHOUT CONTRAST|GMI % FORMULA|||Y||1|Visit_1|10|5|TREATMENT|2020-12-02|2021-01-09|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|4199b549-d021-4bfd-97e6-95630d407183|2|PROMY|Promyelocytes|HEMATOLOGY|||[?]|[?]|INVALID|1|Gy/h|1|1|[?]|ABNORMAL|EXPIRED AIR|NON-HEMOLYZED||RAJI CELL EIA|MDRD ENZYMATIC FORMULA|Y||NA|Y|1|Visit_1|10|1|FOLLOW-UP|2020-12-02|2021-02-16|10|86|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|LB|4199b549-d021-4bfd-97e6-95630d407183|3|PYY|Peptide YY|CHEMISTRY|[?]|U/L|[?]|[?]|TRACE|1|Bq|1|1|[?]|ABNORMAL|ERYTHROCYTES|CONCENTRATED||LISSAMINE GREEN STAIN|GMI MMOL/MOL FORMULA|||N||2|Visit_2|25|1|WASHOUT|2020-12-17|2020-12-25|25|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|LB|4199b549-d021-4bfd-97e6-95630d407183|4|INLCLR|Inulin Clearance|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|log10 CFU/g|1|1|[?]|NORMAL|SALIVA|AUTOLYZED||MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD 6 VARIABLE FORMULA|||N|Y|2|Visit_2|25|2|TREATMENT|2020-12-17|2021-02-07|25|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|LB|4199b549-d021-4bfd-97e6-95630d407183|5|INTLK20|Interleukin 20|CHEMISTRY|||[?]|[?]|TRACE|1|um|1|1|[?]|LOW|CIRCULATING TUMOR CELL|FROZEN||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|ASH FIBROSURE FORMULA||Y|U|Y|3|Visit_3|40|7|FOLLOW-UP|2021-01-01|2021-02-21|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|4199b549-d021-4bfd-97e6-95630d407183|6|MONOBLLE|Monoblasts/Leukocytes|URINALYSIS|[?]|PA|[?]|[?]|INVALID|1|mg/kg/min|1|1|[?]|LOW|SOFT TISSUE|PARAFFIN-EMBEDDED||WHOLE TRANSCRIPTOME SEQUENCING|CKD-EPI FORMULA||Y|Y||3|Visit_3|40|7|SCREENING|2021-01-01|2021-01-29|40|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|LB|4199b549-d021-4bfd-97e6-95630d407183|7|UREANEXR|Urea Nitrogen Excretion Rate|URINALYSIS|[?]|USP U|[?]|[?]|POSITIVE|1|BEAM BREAKS|1|1|[?]|ABNORMAL|PLEURAL FLUID|AUTOLYZED||CHROMOGENIC ASSAY|GMI % FORMULA|||U||4|Visit_4|65|6|FOLLOW-UP|2021-01-26|2021-02-10|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|4199b549-d021-4bfd-97e6-95630d407183|8|IGG4|Immunoglobulin G Subclass 4|URINALYSIS|[?]|mL/s|[?]|[?]|INVALID|1|Ci/ug|1|1|[?]|ABNORMAL|RETICULOCYTES|LIPEMIC|N|CONTRAST ENHANCED CT SCAN|CKD-EPI FORMULA|||N||4|Visit_4|65|1|TREATMENT|2021-01-26|2021-02-28|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|LB|4199b549-d021-4bfd-97e6-95630d407183|9|TOXVAC|Toxic Vacuolation|URINALYSIS|[?]|mL/m2/min|[?]|[?]|POSITIVE|1|cpm|1|1|[?]|NORMAL|ISOLATE|CLOTTED||QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD FORMULA|||N||5|Visit_5|90|3|TREATMENT|2021-02-20|2021-02-28|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|4199b549-d021-4bfd-97e6-95630d407183|10|DTPACLR|DTPA Clearance|CHEMISTRY|||[?]|[?]|TRACE|1|mL/s/m2|1|1|[?]|LOW|SMOOTH MUSCLE TISSUE|FROZEN||NEPHELOMETRY|MDRD 5 VARIABLE FORMULA|||N|Y|5|Visit_5|90|4|TREATMENT|2021-02-20|2021-02-22|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|6366647f-62fa-48dc-9d77-1677fce62fc7|1|ACTH|Adrenocorticotropic Hormone|CHEMISTRY|||[?]|[?]|BORDERLINE|1|cL|1|1|[?]|LOW|AQUEOUS HUMOR|LACTESCENT||PEAK FLOWMETRY|MDRD FORMULA|||N|Y|1|Visit_1|10|3|TREATMENT|2020-07-14|2020-09-27|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|6366647f-62fa-48dc-9d77-1677fce62fc7|2|CSMIX|Mixed Casts|CHEMISTRY|[?]|mL/g/min|[?]|[?]|NEGATIVE|1|pmol/day|1|1|[?]|ABNORMAL|VITREOUS HUMOR|LACTESCENT||CT SCAN WITHOUT CONTRAST|CKD-EPI FORMULA||Y|NA||1|Visit_1|10|1|TREATMENT|2020-07-14|2020-08-06|10|33|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|6366647f-62fa-48dc-9d77-1677fce62fc7|3|LYMVAC|Vacuolated Lymphocytes|HEMATOLOGY|[?]|kHz|[?]|[?]|BORDERLINE|1|kIU|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|FROZEN||PHOTOGRAPHY|MDRD FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-07-29|2020-08-14|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|6366647f-62fa-48dc-9d77-1677fce62fc7|4|CANNABM|Cannabinoid Metabolites|CHEMISTRY|||[?]|[?]|POSITIVE|1|U/dL|1|1|[?]|LOW|SPERMATOZOON|ICTERIC||BAC ACGH|FIBROMETER FORMULA|||NA|Y|2|Visit_2|25|7|FOLLOW-UP|2020-07-29|2020-09-20|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|LB|6366647f-62fa-48dc-9d77-1677fce62fc7|5|IBCU|Unsaturated Iron Binding Capacity|URINALYSIS|[?]|U/g/day|[?]|[?]|INVALID|1|U/g|1|1|[?]|ABNORMAL|VENOUS BLOOD|THAWED|N|HILLMEN COLOR CHART|MDRD 6 VARIABLE FORMULA||Y|U||3|Visit_3|40|4|FOLLOW-UP|2020-08-13|2020-09-24|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|6366647f-62fa-48dc-9d77-1677fce62fc7|6|BLYCELY|B-Lymphocytes/Lymphocytes|CHEMISTRY|[?]|ng|[?]|[?]|NEGATIVE|1|ukat/L|1|1|[?]|HIGH|SKIN TISSUE|THAWED||AUDIOMETRY|NASH FIBROSURE FORMULA||Y|U||3|Visit_3|40|1|FOLLOW-UP|2020-08-13|2020-09-25|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|6366647f-62fa-48dc-9d77-1677fce62fc7|7|WBCCLMP|Leukocyte Cell Clumps|CHEMISTRY|||[?]|[?]|BORDERLINE|1|cP|1|1|[?]|HIGH|GASTRIC FLUID|ROOM TEMPERATURE|N|SICKLE CELL SOLUBILITY TEST|ASH FIBROSURE FORMULA|Y||U|Y|4|Visit_4|65|1|SCREENING|2020-09-07|2020-09-26|65|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|6366647f-62fa-48dc-9d77-1677fce62fc7|8|APOJ|Apolipoprotein J|CHEMISTRY|[?]|mL/100g/min|[?]|[?]|INDETERMINATE|1|mL/m2/day|1|1|[?]|NORMAL|BREAST MILK|AGGLUTINATED|N|TEST STRIP|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|6|TREATMENT|2020-09-07|2020-09-16|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|LB|6366647f-62fa-48dc-9d77-1677fce62fc7|9|METHDN|Methadone|URINALYSIS|[?]|SFC/10^6 PBMC|[?]|[?]|BORDERLINE|1|mL/m2/day|1|1|[?]|ABNORMAL|CIRCULATING TUMOR CELL|DRIED||LINE PROBE ASSAY|HEPASCORE FORMULA|||NA||5|Visit_5|90|4|WASHOUT|2020-10-02|2020-10-09|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|6366647f-62fa-48dc-9d77-1677fce62fc7|10|ERCENC|Erythroid Cells/Nucleated Cells|URINALYSIS|||[?]|[?]|TRACE|1|U/10^12 RBC|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|CONCENTRATED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N|Y|5|Visit_5|90|1|TREATMENT|2020-10-02|2020-10-04|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|LB|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|1|FATACFRS|Free Fatty Acid, Saturated|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Rad|1|1|[?]|LOW|REFLEX TEAR|NON-HEMOLYZED|N|PERIPHERAL ANGIOGRAPHY|CKD-EPI FORMULA|||U|Y|1|Visit_1|10|1|SCREENING|2020-05-13|2020-06-25|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|2|MDZPM|Medazepam|CHEMISTRY|||[?]|[?]|POSITIVE|1|ug/dL|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM|ROOM TEMPERATURE||NO INFORMATION|HEPASCORE FORMULA|||Y|Y|1|Visit_1|10|3|FOLLOW-UP|2020-05-13|2020-05-27|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|LB|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|3|RNPAB|Ribonucleoprotein Antibody|CHEMISTRY|[?]|mmAL|[?]|[?]|TRACE|1|Gy/h|1|1|[?]|NORMAL|PLATELET RICH PLASMA|REFRIGERATED|N|IMMUNOCHROMATOGRAPHY|MDRD 6 VARIABLE FORMULA|||Y||2|Visit_2|25|6|TREATMENT|2020-05-28|2020-07-23|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|4|DPPIVA|Dipeptidyl Peptidase-4 Activity|HEMATOLOGY|[?]|BAU/mL|[?]|[?]|BORDERLINE|1|SACHET|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|CALCIFIED|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|GMI % FORMULA|Y||N||2|Visit_2|25|1|TREATMENT|2020-05-28|2020-07-22|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|LB|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|5|IGSOL|Soluble Immunoglobulin|URINALYSIS|[?]|SQU/mL|[?]|[?]|BORDERLINE|1|lm|1|1|[?]|LOW|PLEURAL TISSUE|FRESH||FARR ASSAY|COCKCROFT-GAULT FORMULA|||Y||3|Visit_3|40|2|SCREENING|2020-06-12|2020-07-26|40|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|6|C130086|English Plantain Pollen IgG|CHEMISTRY|||[?]|[?]|INVALID|1|Ci|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|FRESH||TRANSVAGINAL ULTRASOUND|MDRD 4 VARIABLE FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2020-06-12|2020-06-24|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|LB|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|7|PIVKAII|Protein Induced by Vitamin K Absence-II|HEMATOLOGY|[?]|ug/kg/day|[?]|[?]|TRACE|1|VIRTUAL PIXEL|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|HEMOLYZED||TRIPLE-PHASE SPIRAL CT SCAN|MDRD ENZYMATIC FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-07-07|2020-07-10|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|8|RBCAGGLU|Erythrocyte Agglutination|CHEMISTRY|[?]|CAPFUL|[?]|[?]|NEGATIVE|1|mL*cmH2O|1|1|[?]|HIGH|SEMINAL FLUID|UNEXPECTED ODOR|N|TWO-COLOR MICROARRAY|MDRD 4 VARIABLE FORMULA||Y|Y||4|Visit_4|65|4|TREATMENT|2020-07-07|2020-07-27|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|LB|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|9|BLYMXM|B-lymphocyte Crossmatch|URINALYSIS|[?]|scm|[?]|[?]|INDETERMINATE|1|BAU/mL|1|1|[?]|NORMAL|EXUDATE|REFRIGERATED||MALDI|FIBROTEST FORMULA|||U||5|Visit_5|90|6|TREATMENT|2020-08-01|2020-08-07|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|10|VITK|Vitamin K|CHEMISTRY|[?]|TABLET|[?]|[?]|TRACE|1|g/dL|1|1|[?]|NORMAL|CORD BLOOD|LIPEMIC||ELECTRONEUROGRAPHY|MDRD ENZYMATIC FORMULA|||Y||5|Visit_5|90|3|SCREENING|2020-08-01|2020-08-06|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|LB|637d7d5f-78d3-47fb-b6dc-d877d92b9001|1|EOSCE|Eosinophils/Total Cells|CHEMISTRY|[?]|kPa/L/sec|[?]|[?]|TRACE|1|mJoule/cm2|1|1|[?]|NORMAL|ISOLATE|CONTAMINATED||FLUOROSCOPY|CKD-EPI CYSTATIN C FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-06-03|2020-08-09|10|77|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|637d7d5f-78d3-47fb-b6dc-d877d92b9001|2|PRINSINS|Proinsulin/Insulin Ratio|URINALYSIS|[?]|/LSQN|[?]|[?]|BORDERLINE|1|10^3 RNA copies/mL|1|1|[?]|HIGH|PROSTATIC FLUID|CALCIFIED|N|WHOLE GENOME SEQUENCING|COCKCROFT-GAULT FORMULA||Y|U||1|Visit_1|10|3|SCREENING|2020-06-03|2020-08-24|10|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|LB|637d7d5f-78d3-47fb-b6dc-d877d92b9001|3|PCA3MRNA|Prostate Cancer Antigen 3 mRNA|CHEMISTRY|[?]|/2500 WBC|[?]|[?]|TRACE|1|CONTAINER|1|1|[?]|ABNORMAL|ABSCESS FLUID|FROZEN||SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA|Y||NA||2|Visit_2|25|1|TREATMENT|2020-06-18|2020-06-20|25|27|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|637d7d5f-78d3-47fb-b6dc-d877d92b9001|4|NEUTIM|Immature Neutrophils|URINALYSIS|[?]|ohm|[?]|[?]|TRACE|1|mg/g/h|1|1|[?]|HIGH|SPERMATOZOON|CALCIFIED|N|SLIT LAMP|CKD-EPI CREATININE FORMULA|||N||2|Visit_2|25|6|TREATMENT|2020-06-18|2020-08-07|25|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|LB|637d7d5f-78d3-47fb-b6dc-d877d92b9001|5|EOSNSQE|Eosinophils/Non-Squam Epi Cells|HEMATOLOGY|[?]|APS U|[?]|[?]|POSITIVE|1|ng|1|1|[?]|LOW|PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|N|PALM METHOD|FIBROTEST FORMULA|||Y||3|Visit_3|40|6|FOLLOW-UP|2020-07-03|2020-08-10|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|637d7d5f-78d3-47fb-b6dc-d877d92b9001|6|DOPAC|3,4-Dihydroxyphenylacetic Acid|URINALYSIS|[?]|mmHg/L/min|[?]|[?]|NEGATIVE|1|Farad|1|1|[?]|ABNORMAL|RETICULOCYTES|NON-HEMOLYZED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROMETER FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-07-03|2020-08-09|40|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-28
e|LB|637d7d5f-78d3-47fb-b6dc-d877d92b9001|7|CEMORPH|Cell Morphology|CHEMISTRY|||[?]|[?]|BORDERLINE|1|lm|1|1|[?]|LOW|ENDOMETRIAL TISSUE|ICTERIC||LEAD CITRATE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U|Y|4|Visit_4|65|4|SCREENING|2020-07-28|2020-08-14|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|637d7d5f-78d3-47fb-b6dc-d877d92b9001|8|MSPIKEPT|Monoclonal Protein Spike/Total Protein|URINALYSIS|[?]|10^3 RNA copies/mL|[?]|[?]|BORDERLINE|1|10^6 IU|1|1|[?]|LOW|ARTERIALIZED CAPILLARY BLOOD|LACTESCENT|N|SPECTROPHOTOMETRY|CKD-EPI FORMULA|||NA||4|Visit_4|65|3|WASHOUT|2020-07-28|2020-08-01|65|69|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|LB|637d7d5f-78d3-47fb-b6dc-d877d92b9001|9|RETPALM|Retinyl Palmitate|URINALYSIS|[?]|CARTRIDGE|[?]|[?]|INVALID|1|10^9 CFU/g|1|1|[?]|HIGH|SKIN TISSUE|HEMOLYZED||SIZE EXCLUSION CHROMATOGRAPHY|FIBROTEST FORMULA||Y|U||5|Visit_5|90|7|WASHOUT|2020-08-22|2020-08-31|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|LB|637d7d5f-78d3-47fb-b6dc-d877d92b9001|10|NONHDL|Non-HDL Cholesterol|HEMATOLOGY|||[?]|[?]|TRACE|1|L/s/kPa|1|1|[?]|NORMAL|TISSUE|CONCENTRATED||SISH|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|5|Visit_5|90|2|TREATMENT|2020-08-22|2020-08-26|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|LB|696cd04a-cde7-4481-b5e2-fad1877ec284|1|GDF11|Growth Differentiation Factor 11|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mL/cage/day|1|1|[?]|NORMAL|STRIATED MUSCLE TISSUE|GELLED||SLIT LAMP|COCKCROFT-GAULT FORMULA|||NA|Y|1|Visit_1|10|7|WASHOUT|2020-08-31|2020-09-06|10|16|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|696cd04a-cde7-4481-b5e2-fad1877ec284|2|GBP2|Guanylate Binding Protein 2|HEMATOLOGY|[?]|cm H2O|[?]|[?]|INVALID|1|DPM|1|1|[?]|NORMAL|CERVICOVAGINAL SECRETION|REFRIGERATED|N|KARYOTYPING|FIBROTEST FORMULA|||NA||1|Visit_1|10|6|WASHOUT|2020-08-31|2020-09-16|10|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|696cd04a-cde7-4481-b5e2-fad1877ec284|3|CBA|Complement Ba|CHEMISTRY|||[?]|[?]|POSITIVE|1|/5x10^4 WBC|1|1|[?]|HIGH|INFRANATANT, PLASMA|AUTOLYZED||SCINTIGRAPHY|COCKCROFT-GAULT FORMULA|Y||NA|Y|2|Visit_2|25|5|TREATMENT|2020-09-15|2020-09-21|25|31|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|696cd04a-cde7-4481-b5e2-fad1877ec284|4|KLCLLCFR|Kappa Lt Chain,Free/Lambda Lt Chain,Free|URINALYSIS|[?]|mEq|[?]|[?]|INVALID|1|g/cage|1|1|[?]|HIGH|LOCHIA|CALCIFIED||NON-INVASIVE DIELECTRIC SENSING|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|7|FOLLOW-UP|2020-09-15|2020-10-20|25|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|LB|696cd04a-cde7-4481-b5e2-fad1877ec284|5|URATEEXR|Urate Excretion Rate|CHEMISTRY|||[?]|[?]|NEGATIVE|1|EP U|1|1|[?]|LOW|MONOCYTE|CLOTTED||IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|Y||U|Y|3|Visit_3|40|3|TREATMENT|2020-09-30|2020-10-12|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|696cd04a-cde7-4481-b5e2-fad1877ec284|6|RETIL|Low Absorption Reticulocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|Tbsp|1|1|[?]|LOW|EXUDATE|GELLED||ANTIMICROBIAL COMBINATION TESTING|MDRD ENZYMATIC FORMULA|||NA|Y|3|Visit_3|40|5|TREATMENT|2020-09-30|2020-10-02|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|LB|696cd04a-cde7-4481-b5e2-fad1877ec284|7|TCDCA|Taurochenodeoxycholate|CHEMISTRY|[?]|PIXEL|[?]|[?]|TRACE|1|BAG|1|1|[?]|ABNORMAL|NAIL|ICTERIC||FLOCCULATION|MDRD 5 VARIABLE FORMULA|||N||4|Visit_4|65|3|SCREENING|2020-10-25|2020-11-07|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|696cd04a-cde7-4481-b5e2-fad1877ec284|8|RETPALM|Retinyl Palmitate|URINALYSIS|[?]|mg/kg/min|[?]|[?]|POSITIVE|1|cmH2O*s/mL|1|1|[?]|HIGH|BONE MARROW|FROZEN||NEXT GENERATION TARGETED SEQUENCING|MDRD ENZYMATIC FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-10-25|2020-11-13|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|LB|696cd04a-cde7-4481-b5e2-fad1877ec284|9|C165923|Tree Mix Pollen IgE AB RAST Score|URINALYSIS|||[?]|[?]|BORDERLINE|1|IU/kg|1|1|[?]|NORMAL|PLATELET RICH PLASMA|GELLED||CONTRAST ENHANCED PET/CT SCAN|MDRD 4 VARIABLE FORMULA|Y||Y|Y|5|Visit_5|90|1|FOLLOW-UP|2020-11-19|2020-11-20|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|696cd04a-cde7-4481-b5e2-fad1877ec284|10|VITC|Vitamin C|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|g/animal/day|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|THAWED||MACRO BROTH DILUTION|FIBROMETER FORMULA|Y||U|Y|5|Visit_5|90|4|WASHOUT|2020-11-19|2020-11-27|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|LB|ce4699cb-66f1-4c13-8428-84064255b765|1|C130114|Industrial Mix Antigen IgE Antibody|CHEMISTRY|[?]|PIXELS/in|[?]|[?]|INVALID|1|anti-Xa IU|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|ROOM TEMPERATURE|N|MAMMOGRAPHY|CKD-EPI CREATININE FORMULA|Y||N||1|Visit_1|10|6|TREATMENT|2020-12-02|2020-12-17|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|ce4699cb-66f1-4c13-8428-84064255b765|2|PKM|Pyruvate Kinase Muscle Isozyme|CHEMISTRY|[?]|nmol BCE/nmol|[?]|[?]|BORDERLINE|1|g/mol|1|1|[?]|HIGH|BONE MARROW MONONUCLEAR CELL|REFRIGERATED|N|CONTRAST ENHANCED CT SCAN|CKD-EPI CYSTATIN C FORMULA|||Y||1|Visit_1|10|2|TREATMENT|2020-12-02|2020-12-04|10|12|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|LB|ce4699cb-66f1-4c13-8428-84064255b765|3|IC512AB|Islet Cell 512 Antibody|CHEMISTRY|[?]|CARTRIDGE|[?]|[?]|INDETERMINATE|1|mL/100g/min|1|1|[?]|LOW|ALVEOLAR AIR|THAWED||KINYOUN STAIN|HEPASCORE FORMULA|||NA||2|Visit_2|25|6|TREATMENT|2020-12-17|2021-01-15|25|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|ce4699cb-66f1-4c13-8428-84064255b765|4|CYSTHION|Cystathionine|HEMATOLOGY|[?]|ug/L|[?]|[?]|INVALID|1|U/g/h|1|1|[?]|LOW|SERUM OR PLASMA|CONCENTRATED||SLIT LAMP|FIBROTEST FORMULA|Y||NA||2|Visit_2|25|6|TREATMENT|2020-12-17|2021-02-11|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|ce4699cb-66f1-4c13-8428-84064255b765|5|PKM|Pyruvate Kinase Muscle Isozyme|URINALYSIS|[?]|BU|[?]|[?]|BORDERLINE|1|/h|1|1|[?]|ABNORMAL|INFRANATANT, SERUM|HEMOLYZED||FLOW CYTOMETRY|MDRD FORMULA|||Y||3|Visit_3|40|5|TREATMENT|2021-01-01|2021-02-22|40|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|ce4699cb-66f1-4c13-8428-84064255b765|6|INSAAB|Insulin Autoantibody|URINALYSIS|[?]|mmol/kg|[?]|[?]|NEGATIVE|1|mL/mmHg|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH||CT SCAN WITHOUT CONTRAST|HEPASCORE FORMULA|Y||N||3|Visit_3|40|1|FOLLOW-UP|2021-01-01|2021-01-24|40|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|LB|ce4699cb-66f1-4c13-8428-84064255b765|7|APTTLAAC|APTT-LA Actual/Control|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|PFU/animal|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|HEMOLYZED||PET/CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE FORMULA|Y|Y|NA|Y|4|Visit_4|65|3|TREATMENT|2021-01-26|2021-02-23|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|ce4699cb-66f1-4c13-8428-84064255b765|8|CYSCREAT|Cystatin C/Creatinine|HEMATOLOGY|[?]|log10 PFU|[?]|[?]|POSITIVE|1|ft3|1|1|[?]|LOW|GASTRIC FLUID|HEMOLYZED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD 4 VARIABLE FORMULA|Y||NA||4|Visit_4|65|7|TREATMENT|2021-01-26|2021-02-05|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|LB|ce4699cb-66f1-4c13-8428-84064255b765|9|CHCNT|Corpuscular Hemoglobin Content|HEMATOLOGY|[?]|MHz|[?]|[?]|INDETERMINATE|1|Arbitrary U|1|1|[?]|NORMAL|PLEURAL FLUID|FRESH||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI CYSTATIN C FORMULA|||U||5|Visit_5|90|3|WASHOUT|2021-02-20|2021-02-24|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|ce4699cb-66f1-4c13-8428-84064255b765|10|KLCLLC|Kappa Light Chain/Lambda Light Chain|HEMATOLOGY|[?]|MHz|[?]|[?]|INVALID|1|100 IU/mL|1|1|[?]|NORMAL|COLOSTRUM|CALCIFIED||IMMUNOCHROMATOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA|Y|Y|U||5|Visit_5|90|4|TREATMENT|2021-02-20|2021-02-22|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|015b391b-23c7-478d-b9d1-226d3cb9edcf|1|INTLK14|Interleukin 14|CHEMISTRY|[?]|nmol/L/h|[?]|[?]|INVALID|1|mg/animal|1|1|[?]|LOW|EMOTIONAL TEAR|AGGLUTINATED||INDIA INK STAIN|GMI % FORMULA|Y||U||1|Visit_1|10|7|FOLLOW-UP|2020-11-29|2021-02-01|10|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|015b391b-23c7-478d-b9d1-226d3cb9edcf|2|CARTP|Cocaine Amphetamine-Reg Transcript Prot|CHEMISTRY|||[?]|[?]|INVALID|1|pkat/L|1|1|[?]|LOW|BLOOD|ICTERIC||PET/CT SCAN WITHOUT CONTRAST|NASH FIBROSURE FORMULA||Y|N|Y|1|Visit_1|10|5|FOLLOW-UP|2020-11-29|2020-12-19|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|LB|015b391b-23c7-478d-b9d1-226d3cb9edcf|3|MCHC|Ery. Mean Corpuscular HGB Concentration|HEMATOLOGY|[?]|g/kg|[?]|[?]|NEGATIVE|1|ug/m2|1|1|[?]|NORMAL|INTERSTITIAL FLUID|CALCIFIED||MANUAL CLOT DETECTION|GMI % FORMULA|||Y||2|Visit_2|25|2|WASHOUT|2020-12-14|2021-02-22|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|015b391b-23c7-478d-b9d1-226d3cb9edcf|4|FABP1|Fatty Acid Binding Protein 1|URINALYSIS|||[?]|[?]|POSITIVE|1|mg/kg/week|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|LACTESCENT||DYNAMOMETRY|FIBROMETER FORMULA|||N|Y|2|Visit_2|25|3|WASHOUT|2020-12-14|2021-01-04|25|46|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|LB|015b391b-23c7-478d-b9d1-226d3cb9edcf|5|PROMONO|Promonocytes|HEMATOLOGY|[?]|TUBE|[?]|[?]|INVALID|1|MPS U|1|1|[?]|NORMAL|ERYTHROCYTES|THAWED||PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC FORMULA|||N||3|Visit_3|40|5|TREATMENT|2020-12-29|2021-01-05|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|LB|015b391b-23c7-478d-b9d1-226d3cb9edcf|6|GALM|Galactose Mutarotase|HEMATOLOGY|||[?]|[?]|INVALID|1|mL/h|1|1|[?]|HIGH|WHITE MATTER TISSUE|ICTERIC||PATHOLOGICAL EVALUATION|FIBROMETER FORMULA|Y||Y|Y|3|Visit_3|40|5|TREATMENT|2020-12-29|2021-01-10|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|LB|015b391b-23c7-478d-b9d1-226d3cb9edcf|7|VITB17|Vitamin B17|CHEMISTRY|||[?]|[?]|NEGATIVE|1|m|1|1|[?]|LOW|LYSATE|AGGLUTINATED||PHYSICAL EXAMINATION|NASH FIBROSURE FORMULA|||Y|Y|4|Visit_4|65|5|WASHOUT|2021-01-23|2021-02-22|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|015b391b-23c7-478d-b9d1-226d3cb9edcf|8|TPROT|Tau Protein|CHEMISTRY|[?]|TUBE|[?]|[?]|NEGATIVE|1|uCi|1|1|[?]|ABNORMAL|ARTERIALIZED CAPILLARY BLOOD|PARAFFIN-EMBEDDED||CAPILLARY ELECTROPHORESIS|FIBROMETER FORMULA|Y||U||4|Visit_4|65|6|TREATMENT|2021-01-23|2021-02-26|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|LB|015b391b-23c7-478d-b9d1-226d3cb9edcf|9|BASOCE|Basophils/Total Cells|URINALYSIS|[?]|GBq/mg|[?]|[?]|INDETERMINATE|1|LENS|1|1|[?]|ABNORMAL|CORD SERUM|PARAFFIN-EMBEDDED||THICK SMEAR|FIBROMETER FORMULA|Y||U||5|Visit_5|90|3|TREATMENT|2021-02-17|2021-02-18|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|015b391b-23c7-478d-b9d1-226d3cb9edcf|10|PRORUB|Prorubricyte|HEMATOLOGY|[?]|POUCH|[?]|[?]|INDETERMINATE|1|cal|1|1|[?]|LOW|SUPERNATANT, SERUM|THAWED||DROPLET DIGITAL PCR|MDRD ENZYMATIC FORMULA|||NA||5|Visit_5|90|6|FOLLOW-UP|2021-02-17|2021-02-24|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|LB|b510a277-c5ee-4a32-b111-b2dbc72c8a27|1|PLSIMCCE|Immature Plasma Cells/Total Cells|HEMATOLOGY|[?]|mL/mmHg|[?]|[?]|INVALID|1|U/L|1|1|[?]|NORMAL|PLATELET POOR PLASMA|REFRIGERATED||HPLC/IEX|ASH FIBROSURE FORMULA|||Y||1|Visit_1|10|3|SCREENING|2020-06-07|2020-08-29|10|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|LB|b510a277-c5ee-4a32-b111-b2dbc72c8a27|2|CYSCREAT|Cystatin C/Creatinine|HEMATOLOGY|[?]|CARTRIDGE|[?]|[?]|POSITIVE|1|10^9 organisms/mL|1|1|[?]|ABNORMAL|STOOL|SOLIDIFIED|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|HEPASCORE FORMULA||Y|N||1|Visit_1|10|1|TREATMENT|2020-06-07|2020-08-17|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|LB|b510a277-c5ee-4a32-b111-b2dbc72c8a27|3|ESTRIOL|Estriol|HEMATOLOGY|[?]|mL/cage|[?]|[?]|TRACE|1|kBq/uL|1|1|[?]|NORMAL|LYSATE|REFRIGERATED||DUKE INCISION METHOD|CKD-EPI CYSTATIN C FORMULA||Y|N||2|Visit_2|25|7|TREATMENT|2020-06-22|2020-07-22|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|b510a277-c5ee-4a32-b111-b2dbc72c8a27|4|FABP1|Fatty Acid Binding Protein 1|URINALYSIS|[?]|CAPLET|[?]|[?]|INVALID|1|L/s|1|1|[?]|HIGH|ADIPOSE TISSUE|UNEXPECTED ODOR|N|IMMUNE REPERTOIRE DEEP SEQUENCING|COCKCROFT-GAULT FORMULA||Y|Y||2|Visit_2|25|3|TREATMENT|2020-06-22|2020-06-23|25|26|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|b510a277-c5ee-4a32-b111-b2dbc72c8a27|5|FIBRINO|Fibrinogen|HEMATOLOGY|[?]|FIU|[?]|[?]|TRACE|1|U/m2/min|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|FRESH||RAJI CELL EIA|MDRD 6 VARIABLE FORMULA|Y||U||3|Visit_3|40|1|TREATMENT|2020-07-07|2020-07-25|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|b510a277-c5ee-4a32-b111-b2dbc72c8a27|6|ASP|Aspartic Acid|CHEMISTRY|||[?]|[?]|INVALID|1|POINT|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|REFRIGERATED|N|TELLER ACUITY CARDS|FIBROMETER FORMULA|Y||N|Y|3|Visit_3|40|3|FOLLOW-UP|2020-07-07|2020-08-23|40|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|LB|b510a277-c5ee-4a32-b111-b2dbc72c8a27|7|METANEXR|Metanephrine Excretion Rate|URINALYSIS|||[?]|[?]|INDETERMINATE|1|oz eq|1|1|[?]|NORMAL|SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR||X-RAY|NASH FIBROSURE FORMULA|||U|Y|4|Visit_4|65|3|WASHOUT|2020-08-01|2020-08-08|65|72|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|b510a277-c5ee-4a32-b111-b2dbc72c8a27|8|AMYLASEM|Macroamylase|URINALYSIS|[?]|P|[?]|[?]|INDETERMINATE|1|BU|1|1|[?]|HIGH|MUSCLE TISSUE|REFRIGERATED||CONTRAST ENHANCED X-RAY|MDRD 6 VARIABLE FORMULA|Y||NA||4|Visit_4|65|4|SCREENING|2020-08-01|2020-08-20|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|b510a277-c5ee-4a32-b111-b2dbc72c8a27|9|TRP1TRG1|Trypsin 1 and Trypsinogen 1|HEMATOLOGY|[?]|nmol/L|[?]|[?]|BORDERLINE|1|mm|1|1|[?]|ABNORMAL|ERYTHROCYTES|ROOM TEMPERATURE||PET/CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||5|Visit_5|90|3|FOLLOW-UP|2020-08-26|2020-08-31|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|b510a277-c5ee-4a32-b111-b2dbc72c8a27|10|CLCTRIOL|Calcitriol|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|TUBE|1|1|[?]|HIGH|SEMEN|CALCIFIED||DYNAMOMETRY|MDRD 4 VARIABLE FORMULA|Y||Y|Y|5|Visit_5|90|5|WASHOUT|2020-08-26|2020-09-02|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|LB|9e9acf6b-d29a-4c11-96d6-b580c721f462|1|MDA|3,4-methylenedioxyamphetamine|HEMATOLOGY|[?]|U/m2|[?]|[?]|INDETERMINATE|1|/10^5|1|1|[?]|ABNORMAL|SUPERNATANT, PLASMA|CONCENTRATED|N|ELLA|FIBROTEST FORMULA|||Y||1|Visit_1|10|7|TREATMENT|2020-08-20|2020-11-01|10|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|9e9acf6b-d29a-4c11-96d6-b580c721f462|2|OHF6B|6 Beta-Hydroxycortisol|CHEMISTRY|[?]|amu|[?]|[?]|NEGATIVE|1|BOWL|1|1|[?]|ABNORMAL|SERUM OR PLASMA|LIPEMIC||DIFFUSION WEIGHTED MRI|CKD-EPI FORMULA|Y||Y||1|Visit_1|10|1|FOLLOW-UP|2020-08-20|2020-10-14|10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|LB|9e9acf6b-d29a-4c11-96d6-b580c721f462|3|INTLK32|Interleukin 32|URINALYSIS|[?]|10^4 CFU/mL|[?]|[?]|INVALID|1|s*kPa|1|1|[?]|LOW|EXUDATE|CALCIFIED|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||Y||2|Visit_2|25|4|SCREENING|2020-09-04|2020-11-12|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|9e9acf6b-d29a-4c11-96d6-b580c721f462|4|MYCYCE|Myelocytes/Total Cells|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/cm H2O|1|1|[?]|LOW|DIALYSIS FLUID, PERITONEAL|ICTERIC||DXA SCAN|MDRD 6 VARIABLE FORMULA|||Y|Y|2|Visit_2|25|7|TREATMENT|2020-09-04|2020-09-23|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|LB|9e9acf6b-d29a-4c11-96d6-b580c721f462|5|AFPL3|Alpha Fetoprotein L3|HEMATOLOGY|[?]|umol/mol|[?]|[?]|INDETERMINATE|1|CFU/mL|1|1|[?]|HIGH|CORD SERUM|HEMOLYZED||POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA|||NA||3|Visit_3|40|2|FOLLOW-UP|2020-09-19|2020-09-24|40|45|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|9e9acf6b-d29a-4c11-96d6-b580c721f462|6|PLAT|Platelets|CHEMISTRY|[?]|10^4/L|[?]|[?]|POSITIVE|1|%/min|1|1|[?]|NORMAL|CAPILLARY BLOOD|HEMOLYZED|N|TOLUIDINE BLUE STAIN|CKD-EPI FORMULA||Y|N||3|Visit_3|40|5|FOLLOW-UP|2020-09-19|2020-09-20|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|LB|9e9acf6b-d29a-4c11-96d6-b580c721f462|7|METARUB|Metarubricyte|HEMATOLOGY|[?]|cm H2O|[?]|[?]|INDETERMINATE|1|Bq/mg|1|1|[?]|NORMAL|LEUKOCYTE|LACTESCENT||FLAME PHOTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||4|Visit_4|65|2|FOLLOW-UP|2020-10-14|2020-11-04|65|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|9e9acf6b-d29a-4c11-96d6-b580c721f462|8|CREAT|Creatinine|CHEMISTRY|[?]|mL/min|[?]|[?]|NEGATIVE|1|/kg|1|1|[?]|ABNORMAL|BUFFY COAT|FRESH||KINETIC MICROPARTICLE IMMUNOASSAY|FIBROSIS 4 FORMULA||Y|NA||4|Visit_4|65|7|TREATMENT|2020-10-14|2020-10-27|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|9e9acf6b-d29a-4c11-96d6-b580c721f462|9|YEASTBUD|Yeast Budding|URINALYSIS|||[?]|[?]|POSITIVE|1|log10 copies/mL|1|1|[?]|NORMAL|MONOCYTE|CONCENTRATED||SPIROMETRY|MDRD 6 VARIABLE FORMULA|||U|Y|5|Visit_5|90|2|FOLLOW-UP|2020-11-08|2020-11-17|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|9e9acf6b-d29a-4c11-96d6-b580c721f462|10|ANISOCHR|Anisochromia|HEMATOLOGY|[?]|/month|[?]|[?]|POSITIVE|1|10^6 IU/mL|1|1|[?]|HIGH|TUMOR TISSUE|CONTAMINATED||ERGOSPIROMETRY|FIBROMETER FORMULA|||U||5|Visit_5|90|7|WASHOUT|2020-11-08|2020-11-11|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|LB|da69b157-7dab-49c5-b8fb-bd312a21fcf0|1|CD8LY|CD8/Lymphocytes|HEMATOLOGY|[?]|mEq/mL|[?]|[?]|NEGATIVE|1|kV|1|1|[?]|LOW|PROSTATIC FLUID|CALCIFIED||MANUAL COUNT|ASH FIBROSURE FORMULA|||NA||1|Visit_1|10|7|FOLLOW-UP|2020-07-18|2020-07-20|10|12|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|da69b157-7dab-49c5-b8fb-bd312a21fcf0|2|PERCECE|Proliferating Erythroid/Total Cells|CHEMISTRY|||[?]|[?]|INVALID|1|m|1|1|[?]|NORMAL|PROSTATIC FLUID|ICTERIC||PELLI-ROBSON EYE CHART|GMI MMOL/MOL FORMULA|||U|Y|1|Visit_1|10|1|SCREENING|2020-07-18|2020-10-12|10|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|LB|da69b157-7dab-49c5-b8fb-bd312a21fcf0|3|FOLHMRNA|Folate Hydrolase mRNA|HEMATOLOGY|[?]|pg/L|[?]|[?]|TRACE|1|foz_us|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|NON-HEMOLYZED||WHOLE GENOME SEQUENCING|MDRD 6 VARIABLE FORMULA|||NA||2|Visit_2|25|2|WASHOUT|2020-08-02|2020-10-06|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|da69b157-7dab-49c5-b8fb-bd312a21fcf0|4|INTLK26|Interleukin 26|HEMATOLOGY|||[?]|[?]|POSITIVE|1|kg/mol|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|ROOM TEMPERATURE||ELISA|HEPASCORE FORMULA|||Y|Y|2|Visit_2|25|5|SCREENING|2020-08-02|2020-08-27|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|LB|da69b157-7dab-49c5-b8fb-bd312a21fcf0|5|CIC|Circulating Immune Complexes|HEMATOLOGY|[?]|IU/mg|[?]|[?]|INDETERMINATE|1|ugEq/L|1|1|[?]|ABNORMAL|CORD BLOOD|LIPEMIC|N|INTERRUPTER TECHNIQUE|FIBROMETER FORMULA|||U||3|Visit_3|40|1|WASHOUT|2020-08-17|2020-10-06|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|da69b157-7dab-49c5-b8fb-bd312a21fcf0|6|TOXVAC|Toxic Vacuolation|CHEMISTRY|[?]|MBq|[?]|[?]|INVALID|1|nkat/g Hb|1|1|[?]|LOW|EXPIRED AIR|ICTERIC||TRICHROME STAIN|GMI % FORMULA|||Y||3|Visit_3|40|3|TREATMENT|2020-08-17|2020-08-24|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|LB|da69b157-7dab-49c5-b8fb-bd312a21fcf0|7|GCHT|Glycocholate|CHEMISTRY|||[?]|[?]|INVALID|1|mL/m2/min|1|1|[?]|HIGH|ADIPOSE TISSUE|NON-HEMOLYZED||GRADIENT DIFFUSION|MDRD 5 VARIABLE FORMULA|||U|Y|4|Visit_4|65|1|WASHOUT|2020-09-11|2020-09-24|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|da69b157-7dab-49c5-b8fb-bd312a21fcf0|8|ANGTNS2|Angiotensin II|URINALYSIS|||[?]|[?]|INDETERMINATE|1|cm2|1|1|[?]|ABNORMAL|MENSTRUAL BLOOD|LIPEMIC||FREEZING POINT DEPRESSION|MDRD 5 VARIABLE FORMULA||Y|N|Y|4|Visit_4|65|4|SCREENING|2020-09-11|2020-10-14|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|LB|da69b157-7dab-49c5-b8fb-bd312a21fcf0|9|HBA1CHGB|Hemoglobin A1C/Hemoglobin|URINALYSIS|[?]|10^6/hpf|[?]|[?]|NEGATIVE|1|beats/min|1|1|[?]|LOW|PLEURAL TISSUE|DRIED||ORCHIDOMETERY|CKD-EPI CYSTATIN C FORMULA|Y||NA||5|Visit_5|90|3|WASHOUT|2020-10-06|2020-10-09|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|da69b157-7dab-49c5-b8fb-bd312a21fcf0|10|RUBCE|Rubricyte/Total Cells|CHEMISTRY|[?]|g/g|[?]|[?]|POSITIVE|1|Watt|1|1|[?]|ABNORMAL|PERITONEAL FLUID|THAWED|N|AURAMINE STAIN|FIBROTEST FORMULA|Y|Y|NA||5|Visit_5|90|5|TREATMENT|2020-10-06|2020-10-13|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|LB|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|1|EPISCECE|Squamous Epithelial Cells/Total Cells|URINALYSIS|[?]|U/g|[?]|[?]|POSITIVE|1|umol/L/h|1|1|[?]|LOW|HAIR FOLLICLE|PARAFFIN-EMBEDDED||LYMPHANGIOGRAPHY|ASH FIBROSURE FORMULA||Y|U||1|Visit_1|10|7|FOLLOW-UP|2020-05-29|2020-07-01|10|43|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|2|LEUKCRBC|Leuks Corrected for Nucl Erythrocytes|HEMATOLOGY|[?]|g/mol|[?]|[?]|INDETERMINATE|1|CFU/g|1|1|[?]|HIGH|PLEURAL FLUID|LACTESCENT||CONTACT SPECULAR MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||1|Visit_1|10|1|SCREENING|2020-05-29|2020-07-11|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|LB|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|3|NEUTCYBS|Cytoplasmic Basophilia Neutrophil|URINALYSIS|[?]|RATIO|[?]|[?]|BORDERLINE|1|cGy|1|1|[?]|NORMAL|AQUEOUS HUMOR|SOLIDIFIED|N|FLUORESCENT MICROSCOPY|CKD-EPI CREATININE FORMULA|||NA||2|Visit_2|25|2|TREATMENT|2020-06-13|2020-06-28|25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|LB|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|4|INHIBINA|Inhibin A|HEMATOLOGY|[?]|10^9 CFU/mL|[?]|[?]|POSITIVE|1|kIU|1|1|[?]|HIGH|SEMEN|CONCENTRATED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|GMI MMOL/MOL FORMULA|||U||2|Visit_2|25|4|SCREENING|2020-06-13|2020-07-28|25|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|LB|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|5|PLATHCT|Platelet Hematocrit|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|10^3 organisms|1|1|[?]|ABNORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD FORMULA|||N|Y|3|Visit_3|40|5|TREATMENT|2020-06-28|2020-08-23|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-24
e|LB|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|6|KLHIGGAB|Keyhole Limpet Hemocyanin IgG Antibody|HEMATOLOGY|[?]|/10^5|[?]|[?]|NEGATIVE|1|umol/day|1|1|[?]|ABNORMAL|INTERSTITIAL FLUID|ROOM TEMPERATURE||ETDRS EYE CHART|GMI % FORMULA|||N||3|Visit_3|40|6|FOLLOW-UP|2020-06-28|2020-07-27|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-24
e|LB|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|7|OAS3|2-5-Oligoadenylate Synthase 3|URINALYSIS|[?]|TRANSDUCING UNIT|[?]|[?]|INDETERMINATE|1|genEq|1|1|[?]|ABNORMAL|SUPERNATANT, PLEURAL FLUID|REFRIGERATED||MULTIPLEXED BEAD BASED IMMUNOASSAY|FIBROSIS 4 FORMULA|||U||4|Visit_4|65|7|TREATMENT|2020-07-23|2020-08-12|65|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|LB|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|8|INTLK14|Interleukin 14|URINALYSIS|[?]|PFU/mL|[?]|[?]|NEGATIVE|1|100 IU/mL|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|GELLED||FISH|COCKCROFT-GAULT FORMULA|Y||NA||4|Visit_4|65|4|SCREENING|2020-07-23|2020-08-03|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|LB|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|9|VCAM1|Vascular Cell Adhesion Molecule 1|CHEMISTRY|||[?]|[?]|POSITIVE|1|Roentgen|1|1|[?]|LOW|CORD SERUM|PARAFFIN-EMBEDDED||FLUORESCENT IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||Y|Y|Y|5|Visit_5|90|3|TREATMENT|2020-08-17|2020-08-19|90|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|10|HGBAHGB|Hemoglobin A/Total Hemoglobin|URINALYSIS|||[?]|[?]|TRACE|1|pmol/L/h|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|GELLED||CARDIAC THERMODILUTION|MDRD 6 VARIABLE FORMULA|Y||U|Y|5|Visit_5|90|6|TREATMENT|2020-08-17|2020-08-24|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|77c97d1e-e223-4485-b2de-59daa4e5b01f|1|C130122|Nut Mix Antigen IgE Antibody|HEMATOLOGY|[?]|mol/mL|[?]|[?]|INDETERMINATE|1|ug/g/min|1|1|[?]|ABNORMAL|HAIR FOLLICLE|ROOM TEMPERATURE||SURFACE PLASMON RESONANCE|MDRD ENZYMATIC JAPANESE FORMULA|||N||1|Visit_1|10|3|TREATMENT|2020-06-19|2020-08-01|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|77c97d1e-e223-4485-b2de-59daa4e5b01f|2|CELLULAR|Cellularity|CHEMISTRY|[?]|10^4 CFU/mL|[?]|[?]|INDETERMINATE|1|mOsm|1|1|[?]|NORMAL|SYNOVIAL FLUID|REFRIGERATED||ELECTRONEUROGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y|Y|Y||1|Visit_1|10|3|TREATMENT|2020-06-19|2020-08-26|10|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|77c97d1e-e223-4485-b2de-59daa4e5b01f|3|C147281|Egg White Antigen IgE Antibody|HEMATOLOGY|[?]|uSiemens|[?]|[?]|POSITIVE|1|LOZENGE|1|1|[?]|LOW|SEBUM|FROZEN||MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI FORMULA|||U||2|Visit_2|25|2|TREATMENT|2020-07-04|2020-07-29|25|50|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|77c97d1e-e223-4485-b2de-59daa4e5b01f|4|VITD23OH|Vitamin D2 D3 25-OH|URINALYSIS|[?]|cm H2O|[?]|[?]|NEGATIVE|1|CAPLET|1|1|[?]|LOW|EPIDERMAL TISSUE|ICTERIC||LYMPHANGIOGRAPHY|MDRD FORMULA||Y|Y||2|Visit_2|25|3|TREATMENT|2020-07-04|2020-07-17|25|38|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|77c97d1e-e223-4485-b2de-59daa4e5b01f|5|TGFB|Transforming Growth Factor Beta|URINALYSIS|||[?]|[?]|POSITIVE|1|PHERESIS UNIT|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|FROZEN||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|ASH FIBROSURE FORMULA||Y|N|Y|3|Visit_3|40|1|WASHOUT|2020-07-19|2020-07-20|40|41|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|77c97d1e-e223-4485-b2de-59daa4e5b01f|6|PPI|Inorganic Pyrophosphate|URINALYSIS|[?]|mL/min|[?]|[?]|NEGATIVE|1|OD Unit|1|1|[?]|HIGH|LUNG SURFACTANT|THAWED||FLUORESCENT MICROSCOPY|MDRD ENZYMATIC FORMULA|Y||Y||3|Visit_3|40|7|SCREENING|2020-07-19|2020-08-05|40|57|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|LB|77c97d1e-e223-4485-b2de-59daa4e5b01f|7|RPTLAAC|Reptilase Activity Actual/Control|URINALYSIS|[?]|mAmp|[?]|[?]|INVALID|1|BU|1|1|[?]|LOW|PERSPIRATION|DRIED|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|FIBROMETER FORMULA|||NA||4|Visit_4|65|3|TREATMENT|2020-08-13|2020-08-27|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|LB|77c97d1e-e223-4485-b2de-59daa4e5b01f|8|BILDIR|Direct Bilirubin|HEMATOLOGY|[?]|amp|[?]|[?]|POSITIVE|1|RFU|1|1|[?]|HIGH|SERUM OR PLASMA OR BLOOD|FRESH||PLETHYSMOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||Y||4|Visit_4|65|6|FOLLOW-UP|2020-08-13|2020-09-04|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|LB|77c97d1e-e223-4485-b2de-59daa4e5b01f|9|PO2FIO2|PP Arterial O2/Fraction Inspired O2|HEMATOLOGY|[?]|umol/mol|[?]|[?]|INVALID|1|ug/m2/h|1|1|[?]|HIGH|FLUID|GELLED||DUCTOGRAPHY|GMI MMOL/MOL FORMULA||Y|U||5|Visit_5|90|7|WASHOUT|2020-09-07|2020-09-16|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|LB|77c97d1e-e223-4485-b2de-59daa4e5b01f|10|HYPSEGCE|Hypersegmented Cells|URINALYSIS|||[?]|[?]|INDETERMINATE|1|/100 WBC|1|1|[?]|LOW|INFRANATANT, PLEURAL FLUID|GELLED||KINYOUN STAIN|GMI % FORMULA|||N|Y|5|Visit_5|90|3|TREATMENT|2020-09-07|2020-09-08|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|LB|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|1|INTLK13|Interleukin 13|CHEMISTRY|[?]|JDF Unit|[?]|[?]|INDETERMINATE|1|dpm/mg|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|CONCENTRATED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|COCKCROFT-GAULT FORMULA|Y||U||1|Visit_1|10|6|TREATMENT|2020-10-14|2021-01-08|10|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|2|C165927|Animal Mix IgE AB RAST Score|URINALYSIS|||[?]|[?]|TRACE|1|ug/h|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|CONTAMINATED|N|SLIT LAMP|MDRD 5 VARIABLE FORMULA|Y|Y|Y|Y|1|Visit_1|10|1|TREATMENT|2020-10-14|2020-11-09|10|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|LB|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|3|FACTVWA|von Willebrand Factor Activity|HEMATOLOGY|[?]|m/sec2|[?]|[?]|POSITIVE|1|foz_us|1|1|[?]|ABNORMAL|ARTERIAL BLOOD|CONCENTRATED||SPIRAL CT|CKD-EPI CREATININE FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-10-29|2020-11-14|25|41|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|4|CFA|Coefficient of Fat Absorption|CHEMISTRY|||[?]|[?]|BORDERLINE|1|mL/g/min|1|1|[?]|HIGH|SEBUM|NON-HEMOLYZED||IMMUNOFLUORESCENT STAIN|CKD-EPI CREATININE FORMULA|||N|Y|2|Visit_2|25|6|WASHOUT|2020-10-29|2020-11-11|25|38|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|LB|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|5|NOREPIN|Norepinephrine|HEMATOLOGY|[?]|/mm2|[?]|[?]|NEGATIVE|1|m|1|1|[?]|HIGH|PLASMA|ROOM TEMPERATURE||MICROSCOPY|MDRD FORMULA||Y|Y||3|Visit_3|40|5|SCREENING|2020-11-13|2020-12-07|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|6|C130113|Animal Mix Antigen IgG Antibody|URINALYSIS|[?]|mg/L|[?]|[?]|POSITIVE|1|ELISA unit/mL|1|1|[?]|HIGH|HAIR|AGGLUTINATED||IMMUNOBLOT|CKD-EPI FORMULA||Y|Y||3|Visit_3|40|6|WASHOUT|2020-11-13|2020-11-25|40|52|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|7|TNFSR1|Soluble TNF Receptor Type I|CHEMISTRY|[?]|Log10 ELISA unit/dose|[?]|[?]|INVALID|1|mmol/kg|1|1|[?]|LOW|REFLEX TEAR|AGGLUTINATED||CT SCAN WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA|||U||4|Visit_4|65|7|WASHOUT|2020-12-08|2021-01-10|65|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|8|SODIUM|Sodium|CHEMISTRY|[?]|anti-Xa IU/mL|[?]|[?]|INDETERMINATE|1|U/animal|1|1|[?]|ABNORMAL|LEUKOCYTE|AUTOLYZED||AUTOREFRACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|6|TREATMENT|2020-12-08|2020-12-20|65|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|LB|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|9|CLRZPT|Clorazepate|URINALYSIS|[?]|um2|[?]|[?]|NEGATIVE|1|PNU/mL|1|1|[?]|NORMAL|SMEGMA|GELLED||MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|6|TREATMENT|2021-01-02|2021-01-05|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|10|C165910|Bee Mix IgG AB RAST Score|CHEMISTRY|[?]|CYLINDER|[?]|[?]|NEGATIVE|1|/ms|1|1|[?]|LOW|CAPILLARY BLOOD|AGGLUTINATED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD 5 VARIABLE FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2021-01-02|2021-01-06|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|LB|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|1|TNF5S|Soluble TNF Superfamily Member 5|CHEMISTRY|||[?]|[?]|INVALID|1|cmHg|1|1|[?]|ABNORMAL|DIALYSIS FLUID|FROZEN|N|APPLANATION TONOMETRY|MDRD 4 VARIABLE FORMULA|||U|Y|1|Visit_1|10|5|WASHOUT|2020-11-01|2020-11-20|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|2|CRYOFBRN|Cryofibrinogen|CHEMISTRY|[?]|mg/kg|[?]|[?]|INVALID|1|ug/L FEU|1|1|[?]|HIGH|PLASMA ULTRAFILTRATE|AGGLUTINATED|N|IMMUNODIFFUSION|MDRD FORMULA|Y||Y||1|Visit_1|10|7|TREATMENT|2020-11-01|2020-11-08|10|17|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|LB|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|3|CRDIGMAB|Cardiolipin IgM Antibody|URINALYSIS|[?]|TUBE|[?]|[?]|INDETERMINATE|1|Hz/s|1|1|[?]|LOW|SALIVA|ICTERIC||MECHANICAL CLOT DETECTION|FIBROTEST FORMULA|||N||2|Visit_2|25|3|WASHOUT|2020-11-16|2021-01-06|25|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|4|NEUTB|Neutrophils Band Form|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|g|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|CLOTTED||CLOT DETECTION|MDRD 4 VARIABLE FORMULA|||U|Y|2|Visit_2|25|3|SCREENING|2020-11-16|2020-12-21|25|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|LB|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|5|PLTMORPH|Platelet Morphology|HEMATOLOGY|[?]|gMFI|[?]|[?]|POSITIVE|1|dpm/0.5 mL|1|1|[?]|HIGH|LYMPH|PARAFFIN-EMBEDDED|N|SLIT LAMP|CKD-EPI FORMULA|Y||U||3|Visit_3|40|3|FOLLOW-UP|2020-12-01|2021-01-01|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|6|ALB|Albumin|URINALYSIS|[?]|Hz|[?]|[?]|NEGATIVE|1|MESF|1|1|[?]|ABNORMAL|RETICULOCYTES|HEMOLYZED||REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 6 VARIABLE FORMULA|Y||Y||3|Visit_3|40|6|TREATMENT|2020-12-01|2020-12-26|40|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|LB|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|7|NPAP|Non-Prostatic Acid Phosphatase|CHEMISTRY|||[?]|[?]|INVALID|1|10^6 organisms/mL|1|1|[?]|NORMAL|PLEURAL TISSUE|DRIED||PHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|Y||U|Y|4|Visit_4|65|4|FOLLOW-UP|2020-12-26|2021-01-14|65|84|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|8|TCHT|Taurocholate|URINALYSIS|||[?]|[?]|TRACE|1|mL/cm3/min|1|1|[?]|HIGH|REFLEX TEAR|REFRIGERATED||TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 4 VARIABLE FORMULA|||NA|Y|4|Visit_4|65|5|SCREENING|2020-12-26|2020-12-28|65|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|LB|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|9|HIST2BAB|Histone 2B Antibody|HEMATOLOGY|[?]|kg/cm2|[?]|[?]|BORDERLINE|1|mL/cage/wk|1|1|[?]|HIGH|LOCHIA|NON-HEMOLYZED||FLUORESCENCE ANGIOGRAPHY|FIBROTEST FORMULA||Y|N||5|Visit_5|90|5|TREATMENT|2021-01-20|2021-01-22|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|10|MONOMA|Monocytes/Macrocytes|CHEMISTRY|[?]|hr/day|[?]|[?]|TRACE|1|/mm|1|1|[?]|NORMAL|PROSTATIC FLUID|AGGLUTINATED||FLUORESCENT MICROSCOPY|MDRD 4 VARIABLE FORMULA||Y|U||5|Visit_5|90|3|FOLLOW-UP|2021-01-20|2021-01-21|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|LB|9eb6e591-d266-4e05-85b6-230e8a02d494|1|PTF1_2|Prothrombin Fragments 1 + 2|URINALYSIS|||[?]|[?]|INDETERMINATE|1|min*mg/mL|1|1|[?]|ABNORMAL|AQUEOUS HUMOR|CALCIFIED||DYNAMOMETRY|NASH FIBROSURE FORMULA|||N|Y|1|Visit_1|10|3|SCREENING|2020-06-28|2020-07-03|10|15|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|9eb6e591-d266-4e05-85b6-230e8a02d494|2|ALBGLOB|Albumin/Globulin|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|Ci/ug|1|1|[?]|NORMAL|BONE MARROW|CLOTTED||NUCLEIC ACID AMPLIFICATION TEST|COCKCROFT-GAULT FORMULA|Y||N|Y|1|Visit_1|10|2|WASHOUT|2020-06-28|2020-09-24|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|9eb6e591-d266-4e05-85b6-230e8a02d494|3|CSGRAN|Granular Casts|HEMATOLOGY|[?]|mEq/g|[?]|[?]|TRACE|1|APL U/mL|1|1|[?]|ABNORMAL|PLASMA|DRIED||MAMMOGRAPHY|MDRD ENZYMATIC FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-07-13|2020-07-14|25|26|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|9eb6e591-d266-4e05-85b6-230e8a02d494|4|ISOPRF2|F2-Isoprostane|CHEMISTRY|[?]|mg/animal|[?]|[?]|NEGATIVE|1|ug/L DDU|1|1|[?]|ABNORMAL|VENOUS PLASMA|REFRIGERATED||ATOMIC ABSORPTION SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-07-13|2020-09-05|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|LB|9eb6e591-d266-4e05-85b6-230e8a02d494|5|PPA|Phenylpropanolamine|HEMATOLOGY|[?]|mol/mL|[?]|[?]|BORDERLINE|1|10^3 organisms/mL|1|1|[?]|HIGH|SUPERNATANT, SERUM OR PLASMA|REFRIGERATED||ELECTROPHORESIS|FIBROTEST FORMULA|||Y||3|Visit_3|40|2|TREATMENT|2020-07-28|2020-09-09|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|LB|9eb6e591-d266-4e05-85b6-230e8a02d494|6|HRYCELY|Hairy Cells/Lymphocytes|CHEMISTRY|[?]|lx|[?]|[?]|INDETERMINATE|1|ug/mol|1|1|[?]|NORMAL|PUS|CONCENTRATED|N|HIGH LEVEL AMINOGLYCOSIDE SCREEN|CKD-EPI FORMULA|||Y||3|Visit_3|40|4|FOLLOW-UP|2020-07-28|2020-09-09|40|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|LB|9eb6e591-d266-4e05-85b6-230e8a02d494|7|COQ10|Ubiquinone 10|URINALYSIS|[?]|mmol/s|[?]|[?]|INDETERMINATE|1|g/day|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|ICTERIC||VIRUS PLAQUE ASSAY|GMI % FORMULA|Y||Y||4|Visit_4|65|1|FOLLOW-UP|2020-08-22|2020-09-21|65|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|9eb6e591-d266-4e05-85b6-230e8a02d494|8|INSULINR|Insulin Resistance|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|cs|1|1|[?]|LOW|VITREOUS HUMOR|AGGLUTINATED||MIGET|MDRD ENZYMATIC JAPANESE FORMULA|||NA|Y|4|Visit_4|65|3|TREATMENT|2020-08-22|2020-08-31|65|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|LB|9eb6e591-d266-4e05-85b6-230e8a02d494|9|MYELINAB|Myelin Antibodies|CHEMISTRY|[?]|mg/g/h|[?]|[?]|TRACE|1|ug/g/day|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|CALCIFIED|N|GRAM STAIN|CKD-EPI CREATININE FORMULA||Y|NA||5|Visit_5|90|2|TREATMENT|2020-09-16|2020-09-19|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|9eb6e591-d266-4e05-85b6-230e8a02d494|10|UROTHCE|Urothelial Cells|HEMATOLOGY|[?]|U/mmol|[?]|[?]|NEGATIVE|1|cd*s/m2|1|1|[?]|HIGH|SMEGMA|CLOTTED|N|DOUBLE IMMUNODIFFUSION|MDRD FORMULA||Y|N||5|Visit_5|90|3|WASHOUT|2020-09-16|2020-09-23|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|LB|6a6e040d-6a09-4004-9fab-f4f82ba00eae|1|LDH4|LDH Isoenzyme 4|CHEMISTRY|[?]|IU/mL|[?]|[?]|INDETERMINATE|1|DISK|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED||INDIA INK STAIN|CKD-EPI CREATININE FORMULA||Y|U||1|Visit_1|10|6|FOLLOW-UP|2020-06-30|2020-09-09|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|6a6e040d-6a09-4004-9fab-f4f82ba00eae|2|TLCHT|Taurolithocholate|URINALYSIS|[?]|kcal/day|[?]|[?]|INVALID|1|pL|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|LACTESCENT||FARR ASSAY|GMI MMOL/MOL FORMULA|Y|Y|U||1|Visit_1|10|1|WASHOUT|2020-06-30|2020-08-19|10|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|LB|6a6e040d-6a09-4004-9fab-f4f82ba00eae|3|SULFATE|Sulfate|CHEMISTRY|[?]|uL/dose|[?]|[?]|NEGATIVE|1|10^12 IU/L|1|1|[?]|HIGH|ALVEOLAR AIR|FROZEN||IMMUNOTURBIDIMETRY|FIBROTEST FORMULA|||N||2|Visit_2|25|4|TREATMENT|2020-07-15|2020-09-14|25|86|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|6a6e040d-6a09-4004-9fab-f4f82ba00eae|4|INTLK10|Interleukin 10|URINALYSIS|[?]|DAgU|[?]|[?]|BORDERLINE|1|ug/min|1|1|[?]|NORMAL|HAIR FOLLICLE|UNEXPECTED ODOR||MEDIASTINOSCOPY|FIBROMETER FORMULA|||Y||2|Visit_2|25|7|WASHOUT|2020-07-15|2020-09-16|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|LB|6a6e040d-6a09-4004-9fab-f4f82ba00eae|5|RETIM|Medium Absorption Reticulocytes|URINALYSIS|[?]|U/dL|[?]|[?]|INDETERMINATE|1|mol/L|1|1|[?]|NORMAL|PERITONEAL FLUID|DRIED||ATOMIC ABSORPTION SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA|Y|Y|U||3|Visit_3|40|3|FOLLOW-UP|2020-07-30|2020-08-25|40|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|6a6e040d-6a09-4004-9fab-f4f82ba00eae|6|TEARDCY|Dacryocytes|CHEMISTRY|||[?]|[?]|NEGATIVE|1|amp|1|1|[?]|NORMAL|ENDOMETRIAL TISSUE|THAWED||NUCLEAR RADIOLOGY|MDRD 4 VARIABLE FORMULA|||N|Y|3|Visit_3|40|1|TREATMENT|2020-07-30|2020-08-28|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|LB|6a6e040d-6a09-4004-9fab-f4f82ba00eae|7|GFRBSBTP|GFR from Beta-Trace Protein Adj for BSA|CHEMISTRY|[?]|/cmH2O|[?]|[?]|INDETERMINATE|1|10^4/hpf|1|1|[?]|NORMAL|DERMAL TISSUE|FROZEN||OLIGO ACGH|MDRD ENZYMATIC FORMULA|||Y||4|Visit_4|65|7|FOLLOW-UP|2020-08-24|2020-09-08|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|6a6e040d-6a09-4004-9fab-f4f82ba00eae|8|ESTFREST|Estradiol, Free/Estradiol|CHEMISTRY|||[?]|[?]|TRACE|1|DRINK|1|1|[?]|HIGH|SOFT TISSUE|THAWED||ANALYTICAL ULTRACENTRIFUGATION|COCKCROFT-GAULT FORMULA|Y|Y|U|Y|4|Visit_4|65|5|TREATMENT|2020-08-24|2020-08-25|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|6a6e040d-6a09-4004-9fab-f4f82ba00eae|9|BLYCE|B-Lymphocytes|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|Bq/L|1|1|[?]|LOW|EMOTIONAL TEAR|LIPEMIC||MYELOPEROXIDASE STAIN|CKD-EPI FORMULA|||N|Y|5|Visit_5|90|7|FOLLOW-UP|2020-09-18|2020-09-24|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|6a6e040d-6a09-4004-9fab-f4f82ba00eae|10|BILI|Bilirubin|URINALYSIS|[?]|BU|[?]|[?]|INDETERMINATE|1|pkat/L|1|1|[?]|ABNORMAL|SERUM OR PLASMA|CONTAMINATED||SXA SCAN|FIBROSIS 4 FORMULA|||Y||5|Visit_5|90|2|TREATMENT|2020-09-18|2020-09-24|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|1|S100B|S100 Calcium-Binding Protein B|CHEMISTRY|[?]|umol|[?]|[?]|INVALID|1|10^9 CFU/mL|1|1|[?]|HIGH|BASAL TEAR|CALCIFIED|N|IMPEDANCE CONDUCTIVITY|MDRD 6 VARIABLE FORMULA||Y|U||1|Visit_1|10|3|FOLLOW-UP|2020-08-17|2020-09-29|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|2|FIBRINOF|Fibrinogen, Functional|CHEMISTRY|[?]|gtt|[?]|[?]|BORDERLINE|1|nmol/day|1|1|[?]|ABNORMAL|URINE|UNEXPECTED ODOR||DIGITAL PCR|CKD-EPI FORMULA|Y||N||1|Visit_1|10|1|SCREENING|2020-08-17|2020-10-05|10|59|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|LB|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|3|YEASTBUD|Yeast Budding|CHEMISTRY|[?]|mPa|[?]|[?]|NEGATIVE|1|uCi|1|1|[?]|NORMAL|DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED|N|CONTRAST ENHANCED CT SCAN|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|6|FOLLOW-UP|2020-09-01|2020-11-12|25|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|4|SCBRBTL|Secobarbital|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|/day|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|CALCIFIED||NUCLEIC ACID BASED METHOD|CKD-EPI CYSTATIN C FORMULA|Y|Y|Y|Y|2|Visit_2|25|1|WASHOUT|2020-09-01|2020-10-17|25|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|LB|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|5|RBPCREAT|Retinol Binding Protein/Creatinine|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|mmHg*min/L|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|NON-HEMOLYZED||PANENDOSCOPY|FIBROSIS 4 FORMULA|||U|Y|3|Visit_3|40|1|SCREENING|2020-09-16|2020-11-06|40|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|6|CORCREAT|Cortisol/Creatinine|CHEMISTRY|[?]|kg/L|[?]|[?]|INDETERMINATE|1|10^11/L|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|LIPEMIC|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA|Y||U||3|Visit_3|40|3|TREATMENT|2020-09-16|2020-10-19|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|7|CH100|Complement CH100|HEMATOLOGY|[?]|C|[?]|[?]|NEGATIVE|1|g/animal/day|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|SOLIDIFIED||FUNCTIONAL MRI|CKD-EPI CREATININE FORMULA|Y||Y||4|Visit_4|65|6|TREATMENT|2020-10-11|2020-10-29|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|8|IGG|Immunoglobulin G|HEMATOLOGY|[?]|KALLIKREIN INHIBITOR UNIT|[?]|[?]|TRACE|1|g/kg|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|LIPEMIC||TELLER ACUITY CARDS|HEPASCORE FORMULA|||Y||4|Visit_4|65|2|SCREENING|2020-10-11|2020-10-19|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|LB|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|9|C130072|Birch Pollen IgE|HEMATOLOGY|[?]|DISK|[?]|[?]|POSITIVE|1|dmol|1|1|[?]|ABNORMAL|ABSCESS FLUID|CALCIFIED||IRON HEMATOXYLIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA|||Y||5|Visit_5|90|5|FOLLOW-UP|2020-11-05|2020-11-10|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|10|INULIN|Inulin|HEMATOLOGY|[?]|SYRINGE|[?]|[?]|POSITIVE|1|ks|1|1|[?]|HIGH|CALCULUS|CONTAMINATED|N|LIGHT MICROSCOPY|COCKCROFT-GAULT FORMULA||Y|NA||5|Visit_5|90|4|WASHOUT|2020-11-05|2020-11-11|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|LB|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|1|FGF19|Fibroblast Growth Factor 19|CHEMISTRY|[?]|10^3 CFU/mL|[?]|[?]|NEGATIVE|1|uL/kg/day|1|1|[?]|HIGH|PLASMA|THAWED||SPECTROPHOTOMETRY|MDRD FORMULA||Y|U||1|Visit_1|10|6|TREATMENT|2021-01-19|2021-03-17|10|67|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-10
e|LB|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|2|HCGFR|Choriogonadotropin Beta, Free|HEMATOLOGY|||[?]|[?]|TRACE|1|mL/day|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|GELLED|N|ETDRS EYE CHART|CKD-EPI CREATININE-CYSTATIN C FORMULA|Y||U|Y|1|Visit_1|10|2|TREATMENT|2021-01-19|2021-01-29|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-10
e|LB|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|3|MPO|Myeloperoxidase|HEMATOLOGY|[?]|anti-Xa IU|[?]|[?]|POSITIVE|1|ka_u/dL|1|1|[?]|ABNORMAL|CORD BLOOD|FROZEN||CONTRAST ENHANCED PET SCAN|GMI MMOL/MOL FORMULA|Y||Y||2|Visit_2|25|2|TREATMENT|2021-02-03|2021-04-07|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|LB|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|4|ANTIDPRS|Antidepressants|CHEMISTRY|[?]|kPa|[?]|[?]|BORDERLINE|1|g/day|1|1|[?]|LOW|MIXED VENOUS BLOOD|LIPEMIC|N|IODINE STAIN|COCKCROFT-GAULT FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2021-02-03|2021-02-27|25|49|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|LB|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|5|CD4LY|CD4/Lymphocytes|CHEMISTRY|[?]|/2500 WBC|[?]|[?]|INVALID|1|PIXELS/cm|1|1|[?]|HIGH|PUS|SOLIDIFIED||AUSCULTATION|MDRD ENZYMATIC JAPANESE FORMULA|||NA||3|Visit_3|40|4|WASHOUT|2021-02-18|2021-04-04|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|6|COQ10|Ubiquinone 10|CHEMISTRY|[?]|mg/h|[?]|[?]|INDETERMINATE|1|/5x10^4 WBC|1|1|[?]|ABNORMAL|RETICULOCYTES|NON-HEMOLYZED|N|INTERRUPTER TECHNIQUE|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|6|WASHOUT|2021-02-18|2021-02-27|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|7|KERAT|Keratocyte|URINALYSIS|[?]|CAN|[?]|[?]|INDETERMINATE|1|fmol/g|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|FRESH|N|AURAMINE STAIN|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|6|SCREENING|2021-03-15|2021-04-10|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|8|ETG|Ethyl Glucuronide|HEMATOLOGY|[?]|OD Unit|[?]|[?]|INVALID|1|Sv|1|1|[?]|HIGH|TUMOR TISSUE|ROOM TEMPERATURE||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||Y|NA||4|Visit_4|65|7|FOLLOW-UP|2021-03-15|2021-04-17|65|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|LB|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|9|RBCAGGLU|Erythrocyte Agglutination|CHEMISTRY|[?]|kUSP|[?]|[?]|BORDERLINE|1|yd|1|1|[?]|NORMAL|TUMOR TISSUE|UNEXPECTED ODOR||DXA SCAN|MDRD 6 VARIABLE FORMULA|||NA||5|Visit_5|90|4|TREATMENT|2021-04-09|2021-04-16|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|10|CTXII|Type II Collagen C-Telopeptides|CHEMISTRY|[?]|uSiemens|[?]|[?]|POSITIVE|1|10^8 PFU|1|1|[?]|ABNORMAL|DIALYSIS FLUID|FROZEN||SEQUENCING|ASH FIBROSURE FORMULA|||NA||5|Visit_5|90|6|WASHOUT|2021-04-09|2021-04-13|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|LB|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|1|RBCAGGLU|Erythrocyte Agglutination|URINALYSIS|[?]|FFU|[?]|[?]|POSITIVE|1|mmHg/L/min|1|1|[?]|HIGH|SKIN TISSUE|ROOM TEMPERATURE||CYSTOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|1|WASHOUT|2020-05-12|2020-05-25|10|23|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|2|DNAAB|Anti-DNA Antibodies|CHEMISTRY|[?]|MPL U/mL|[?]|[?]|INDETERMINATE|1|nmol/L|1|1|[?]|ABNORMAL|CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED||HPLC/MS|COCKCROFT-GAULT FORMULA|||N||1|Visit_1|10|1|TREATMENT|2020-05-12|2020-06-18|10|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|LB|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|3|LEPTO|Leptocytes|CHEMISTRY|[?]|Weber|[?]|[?]|BORDERLINE|1|BAR|1|1|[?]|NORMAL|MONOCYTE|GELLED||SLIT LAMP PHOTOGRAPHY|HEPASCORE FORMULA|||N||2|Visit_2|25|3|SCREENING|2020-05-27|2020-07-29|25|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|LB|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|4|CD27|CD27|URINALYSIS|[?]|/mm|[?]|[?]|INVALID|1|psec|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|ICTERIC||CALCOFLUOR WHITE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA||2|Visit_2|25|7|WASHOUT|2020-05-27|2020-07-24|25|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|LB|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|5|NCTD5P|5 Prime Nucleotidase|URINALYSIS|[?]|mEq/L|[?]|[?]|POSITIVE|1|MPL U|1|1|[?]|ABNORMAL|LYMPH|REFRIGERATED||JAFFE REACTION|ASH FIBROSURE FORMULA|Y||NA||3|Visit_3|40|2|TREATMENT|2020-06-11|2020-07-12|40|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|LB|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|6|MONOIMLE|Immature Monocytes/Leukocytes|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|cg|1|1|[?]|HIGH|TISSUE|REFRIGERATED||APPLANATION TONOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|3|Visit_3|40|3|FOLLOW-UP|2020-06-11|2020-06-18|40|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|LB|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|7|GLBCREAT|Globulin/Creatinine|CHEMISTRY|[?]|mol/L|[?]|[?]|INDETERMINATE|1|h/wk|1|1|[?]|ABNORMAL|SMEGMA|NON-HEMOLYZED||COULOMETRIC TITRATION|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-07-06|2020-07-11|65|70|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|8|CXCL1|Chemokine (C-X-C Motif) Ligand 1|CHEMISTRY|[?]|kat|[?]|[?]|INDETERMINATE|1|vg/mL|1|1|[?]|ABNORMAL|SALIVA|ROOM TEMPERATURE||INDIA INK STAIN|CKD-EPI CREATININE FORMULA||Y|Y||4|Visit_4|65|7|TREATMENT|2020-07-06|2020-08-03|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|LB|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|9|LYMNSQE|Lymphocytes/Non-Squam Epi Cells|CHEMISTRY|||[?]|[?]|POSITIVE|1|usec|1|1|[?]|HIGH|REFLEX TEAR|CONCENTRATED||SANGER SEQUENCING|CKD-EPI FORMULA|||NA|Y|5|Visit_5|90|5|TREATMENT|2020-07-31|2020-08-09|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-20
e|LB|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|10|LEIM|Immature Leukocytes|CHEMISTRY|||[?]|[?]|TRACE|1|deg|1|1|[?]|LOW|MUSCLE TISSUE|SOLIDIFIED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y|Y|5|Visit_5|90|1|TREATMENT|2020-07-31|2020-08-04|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-20
e|LB|ba99022a-d398-4c60-828c-876f119459e1|1|GDIGA1|Galactose-Deficient IgA1|CHEMISTRY|[?]|umol/L/h|[?]|[?]|POSITIVE|1|10^9 organisms/g|1|1|[?]|LOW|VENOUS CORD BLOOD|CLOTTED|N|FLUORESCENCE ANGIOGRAPHY|MDRD FORMULA|||NA||1|Visit_1|10|2|TREATMENT|2020-12-01|2020-12-19|10|28|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|LB|ba99022a-d398-4c60-828c-876f119459e1|2|DHPG|3,4-Dihydroxyphenylglycol|HEMATOLOGY|[?]|fg|[?]|[?]|TRACE|1|mg2/dL2|1|1|[?]|ABNORMAL|CORD SERUM|FRESH|N|WHOLE GENOME SEQUENCING|FIBROTEST FORMULA|Y||Y||1|Visit_1|10|7|TREATMENT|2020-12-01|2020-12-03|10|12|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|LB|ba99022a-d398-4c60-828c-876f119459e1|3|FRFEABS|Fractional Iron Absorption|HEMATOLOGY|||[?]|[?]|INVALID|1|/month|1|1|[?]|NORMAL|EXHALED BREATH CONDENSATE|SOLIDIFIED||PATHOLOGICAL EVALUATION|ASH FIBROSURE FORMULA|Y||U|Y|2|Visit_2|25|1|SCREENING|2020-12-16|2021-02-28|25|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|ba99022a-d398-4c60-828c-876f119459e1|4|PRORUBCE|Prorubricyte/Total Cells|URINALYSIS|[?]|m/sec2|[?]|[?]|INDETERMINATE|1|/4.0 mL|1|1|[?]|HIGH|HAIR FOLLICLE|DRIED||CLOT DETECTION|NASH FIBROSURE FORMULA|||Y||2|Visit_2|25|5|FOLLOW-UP|2020-12-16|2021-01-14|25|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|LB|ba99022a-d398-4c60-828c-876f119459e1|5|CRH|Corticotropin Releasing Hormone|URINALYSIS|[?]|U/dL|[?]|[?]|INVALID|1|SYRINGE|1|1|[?]|HIGH|GASTRIC FLUID|ICTERIC|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||3|Visit_3|40|2|TREATMENT|2020-12-31|2021-02-24|40|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|LB|ba99022a-d398-4c60-828c-876f119459e1|6|ALPIS|Intestinal Specific Alkaline Phosphatase|CHEMISTRY|[?]|MET|[?]|[?]|INDETERMINATE|1|U/g/day|1|1|[?]|NORMAL|MONOCYTE|GELLED|N|CONTRAST ENHANCED MRI|HEPASCORE FORMULA|||NA||3|Visit_3|40|7|TREATMENT|2020-12-31|2021-01-15|40|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|LB|ba99022a-d398-4c60-828c-876f119459e1|7|CD2|CD2|CHEMISTRY|[?]|APL U|[?]|[?]|INVALID|1|log10 CCID 50/dose|1|1|[?]|HIGH|PLEURAL FLUID|CONTAMINATED||KINYOUN STAIN|GMI % FORMULA|||U||4|Visit_4|65|7|TREATMENT|2021-01-25|2021-02-12|65|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|ba99022a-d398-4c60-828c-876f119459e1|8|TRYPSIN|Trypsin|HEMATOLOGY|[?]|mL/kg/h|[?]|[?]|INDETERMINATE|1|mm3/mm2/year|1|1|[?]|LOW|HAIR|CONCENTRATED||CLOT DETECTION|GMI MMOL/MOL FORMULA|||Y||4|Visit_4|65|3|TREATMENT|2021-01-25|2021-01-28|65|68|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|LB|ba99022a-d398-4c60-828c-876f119459e1|9|PAPPA|Pregnancy-Associated Plasma Protein-A|CHEMISTRY|||[?]|[?]|INVALID|1|ugEq/L|1|1|[?]|ABNORMAL|BONE MARROW|ICTERIC||IRON HEMATOXYLIN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N|Y|5|Visit_5|90|3|TREATMENT|2021-02-19|2021-02-22|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|ba99022a-d398-4c60-828c-876f119459e1|10|C147281|Egg White Antigen IgE Antibody|CHEMISTRY|[?]|CAN|[?]|[?]|NEGATIVE|1|10^6/Ejaculate U|1|1|[?]|NORMAL|AMNIOTIC FLUID|ICTERIC||CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD FORMULA|||N||5|Visit_5|90|3|TREATMENT|2021-02-19|2021-02-27|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|d713869e-061c-4e95-8a50-da2e1ec47b3c|1|SPWEIGHT|Specimen Weight|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|log10 CFU/g|1|1|[?]|LOW|NAIL|ICTERIC|N|VIRUS PLAQUE ASSAY|GMI MMOL/MOL FORMULA|||U|Y|1|Visit_1|10|6|SCREENING|2020-06-06|2020-08-12|10|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|LB|d713869e-061c-4e95-8a50-da2e1ec47b3c|2|RENIN|Renin|CHEMISTRY|[?]|/mm2|[?]|[?]|BORDERLINE|1|g/U|1|1|[?]|HIGH|GASTRIC CONTENTS|SOLIDIFIED|N|FARR ASSAY|GMI % FORMULA|||NA||1|Visit_1|10|6|SCREENING|2020-06-06|2020-08-23|10|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|LB|d713869e-061c-4e95-8a50-da2e1ec47b3c|3|HGBEHGB|Hemoglobin E/Total Hemoglobin|CHEMISTRY|||[?]|[?]|TRACE|1|mOsm|1|1|[?]|HIGH|ARTERIAL CORD BLOOD|REFRIGERATED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|CKD-EPI FORMULA|||U|Y|2|Visit_2|25|7|TREATMENT|2020-06-21|2020-08-29|25|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|d713869e-061c-4e95-8a50-da2e1ec47b3c|4|MPV|Mean Platelet Volume|CHEMISTRY|[?]|MET*min|[?]|[?]|INDETERMINATE|1|uCi|1|1|[?]|LOW|LUNG SURFACTANT|ROOM TEMPERATURE||MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CREATININE FORMULA|||NA||2|Visit_2|25|5|FOLLOW-UP|2020-06-21|2020-07-24|25|58|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|LB|d713869e-061c-4e95-8a50-da2e1ec47b3c|5|CCL18|Chemokine (C-C Motif) Ligand 18|CHEMISTRY|||[?]|[?]|INVALID|1|SUPPOSITORY|1|1|[?]|ABNORMAL|ABSCESS FLUID|CONCENTRATED||PERIODIC ACID SCHIFF STAIN|GMI % FORMULA|Y|Y|Y|Y|3|Visit_3|40|7|WASHOUT|2020-07-06|2020-07-11|40|45|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|d713869e-061c-4e95-8a50-da2e1ec47b3c|6|THYAB|Thyroid Antibodies|HEMATOLOGY|[?]|PIXEL|[?]|[?]|BORDERLINE|1|mOsm|1|1|[?]|HIGH|GASTRIC CONTENTS|REFRIGERATED||GC/MS/MS|FIBROTEST FORMULA|||U||3|Visit_3|40|4|SCREENING|2020-07-06|2020-08-31|40|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|LB|d713869e-061c-4e95-8a50-da2e1ec47b3c|7|PORPH|Porphyrin|CHEMISTRY|[?]|mEq/dL|[?]|[?]|BORDERLINE|1|Ci/g|1|1|[?]|HIGH|GASTRIC CONTENTS|GELLED||BIOIMPEDANCE SPECTROSCOPY|GMI % FORMULA||Y|N||4|Visit_4|65|5|TREATMENT|2020-07-31|2020-08-16|65|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|d713869e-061c-4e95-8a50-da2e1ec47b3c|8|HYDMDZ4|4-Hydroxymidazolam|CHEMISTRY|[?]|mmol/L|[?]|[?]|POSITIVE|1|h*%|1|1|[?]|HIGH|ERYTHROCYTES|ROOM TEMPERATURE||HEMAGGLUTINATION INHIBITION ASSAY|MDRD ENZYMATIC FORMULA|||N||4|Visit_4|65|1|TREATMENT|2020-07-31|2020-08-10|65|75|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|LB|d713869e-061c-4e95-8a50-da2e1ec47b3c|9|BLYCELE|B-Lymphocytes/Leukocytes|CHEMISTRY|||[?]|[?]|NEGATIVE|1|s*kPa|1|1|[?]|LOW|BASAL TEAR|HEMOLYZED||BIOIMPEDANCE SPECTROSCOPY|MDRD 6 VARIABLE FORMULA|Y|Y|Y|Y|5|Visit_5|90|3|TREATMENT|2020-08-25|2020-09-02|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|d713869e-061c-4e95-8a50-da2e1ec47b3c|10|LTD4|Leukotriene D4|CHEMISTRY|[?]|pmol/10^9 cells|[?]|[?]|POSITIVE|1|DRUM|1|1|[?]|HIGH|LYMPH|PARAFFIN-EMBEDDED||DUKE INCISION METHOD|GMI % FORMULA|||NA||5|Visit_5|90|1|WASHOUT|2020-08-25|2020-09-03|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|LB|fcebb64c-e0e6-4f29-9c52-15fa91f60018|1|PSP100AB|P100 Polymyositis-scleroderma Autoag Ab|CHEMISTRY|[?]|/HPF|[?]|[?]|NEGATIVE|1|IU|1|1|[?]|LOW|VITREOUS HUMOR|NON-HEMOLYZED||MRI WITHOUT CONTRAST|CKD-EPI CREATININE FORMULA||Y|Y||1|Visit_1|10|1|WASHOUT|2020-07-11|2020-08-07|10|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|fcebb64c-e0e6-4f29-9c52-15fa91f60018|2|ROM|Reactive Oxygen Metabolite|URINALYSIS|||[?]|[?]|POSITIVE|1|PFU/animal|1|1|[?]|NORMAL|BILE|GELLED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|COCKCROFT-GAULT FORMULA|||Y|Y|1|Visit_1|10|1|FOLLOW-UP|2020-07-11|2020-10-07|10|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|LB|fcebb64c-e0e6-4f29-9c52-15fa91f60018|3|GCDCA|Glycochenodeoxycholate|HEMATOLOGY|[?]|C|[?]|[?]|POSITIVE|1|mV*min|1|1|[?]|HIGH|PLATELET RICH PLASMA|ICTERIC||MICROBIAL CULTURE, LIQUID|CKD-EPI FORMULA|Y||N||2|Visit_2|25|7|TREATMENT|2020-07-26|2020-10-04|25|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|fcebb64c-e0e6-4f29-9c52-15fa91f60018|4|CSWAX|Waxy Casts|HEMATOLOGY|[?]|mmHg*min/L|[?]|[?]|BORDERLINE|1|log10 copies/mL|1|1|[?]|LOW|PLATELET|CONCENTRATED||SEQUENCING|NASH FIBROSURE FORMULA|Y||Y||2|Visit_2|25|6|WASHOUT|2020-07-26|2020-08-19|25|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|LB|fcebb64c-e0e6-4f29-9c52-15fa91f60018|5|FIBRINOF|Fibrinogen, Functional|URINALYSIS|||[?]|[?]|TRACE|1|mg/mL/min|1|1|[?]|NORMAL|SEMEN|CONTAMINATED||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD FORMULA|Y||NA|Y|3|Visit_3|40|5|TREATMENT|2020-08-10|2020-09-08|40|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|fcebb64c-e0e6-4f29-9c52-15fa91f60018|6|CD3|CD3|CHEMISTRY|[?]|pmol/L/h|[?]|[?]|BORDERLINE|1|mg/g/h|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|ICTERIC|N|HIGH LEVEL AMINOGLYCOSIDE SCREEN|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||3|Visit_3|40|2|TREATMENT|2020-08-10|2020-08-18|40|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|LB|fcebb64c-e0e6-4f29-9c52-15fa91f60018|7|VEGFR3S|Soluble Vasc Endoth Growth Factor Rec3|URINALYSIS|[?]|lx|[?]|[?]|POSITIVE|1|ng/mol|1|1|[?]|NORMAL|MUSCLE TISSUE|ROOM TEMPERATURE|N|NEXT GENERATION SEQUENCING|FIBROTEST FORMULA|||NA||4|Visit_4|65|6|WASHOUT|2020-09-04|2020-09-09|65|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|fcebb64c-e0e6-4f29-9c52-15fa91f60018|8|PGAG|Platelet-Granulocyte Agg|URINALYSIS|[?]|Enzyme U/L|[?]|[?]|INDETERMINATE|1|mL/min/mmHg|1|1|[?]|LOW|AQUEOUS HUMOR|FROZEN||GEL ELECTROPHORESIS|COCKCROFT-GAULT FORMULA|||Y||4|Visit_4|65|3|SCREENING|2020-09-04|2020-09-27|65|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|LB|fcebb64c-e0e6-4f29-9c52-15fa91f60018|9|PGF2AI8|8-Iso-Prostaglandin F2 Alpha|CHEMISTRY|||[?]|[?]|BORDERLINE|1|10^5/L|1|1|[?]|HIGH|LEUKOCYTE|ROOM TEMPERATURE||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA|Y||Y|Y|5|Visit_5|90|3|TREATMENT|2020-09-29|2020-10-08|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|fcebb64c-e0e6-4f29-9c52-15fa91f60018|10|C130138|American Cockroach Antigen IgG Antibody|CHEMISTRY|[?]|mgEq|[?]|[?]|TRACE|1|RATIO|1|1|[?]|HIGH|PERSPIRATION|HEMOLYZED||SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||Y|NA||5|Visit_5|90|5|FOLLOW-UP|2020-09-29|2020-10-01|90|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|LB|e443f82e-43a8-4710-bff4-fd2b2f4d512f|1|ADAM8|ADAM Metallopeptidase Domain 8|HEMATOLOGY|[?]|dpm/mg|[?]|[?]|NEGATIVE|1|ks|1|1|[?]|NORMAL|EXUDATE|CLOTTED||INFRARED SPECTROMETRY|GMI MMOL/MOL FORMULA||Y|U||1|Visit_1|10|4|TREATMENT|2021-01-01|2021-01-11|10|20|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|LB|e443f82e-43a8-4710-bff4-fd2b2f4d512f|2|TGFA|Transforming Growth Factor Alpha|URINALYSIS|[?]|Anson U|[?]|[?]|TRACE|1|/kg|1|1|[?]|ABNORMAL|SOFT TISSUE|GELLED||ELLA|FIBROSIS 4 FORMULA||Y|U||1|Visit_1|10|1|FOLLOW-UP|2021-01-01|2021-01-14|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|LB|e443f82e-43a8-4710-bff4-fd2b2f4d512f|3|HLADRMSC|HLA-DR Mismatch Count|HEMATOLOGY|[?]|log10 PFU|[?]|[?]|INDETERMINATE|1|U/mg|1|1|[?]|ABNORMAL|DERMAL TISSUE|LIPEMIC|N|REBOUND TONOMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||2|Visit_2|25|2|WASHOUT|2021-01-16|2021-02-26|25|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|e443f82e-43a8-4710-bff4-fd2b2f4d512f|4|PERCECE|Proliferating Erythroid/Total Cells|URINALYSIS|||[?]|[?]|BORDERLINE|1|DAgU/mL|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|CONTAMINATED|N|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CREATININE FORMULA||Y|N|Y|2|Visit_2|25|2|TREATMENT|2021-01-16|2021-01-28|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|LB|e443f82e-43a8-4710-bff4-fd2b2f4d512f|5|A1ANTRYP|Alpha-1 Antitrypsin|CHEMISTRY|||[?]|[?]|INVALID|1|BE/mL|1|1|[?]|NORMAL|VENOUS PLASMA|LIPEMIC||AURAMINE STAIN|COCKCROFT-GAULT FORMULA|||U|Y|3|Visit_3|40|5|WASHOUT|2021-01-31|2021-03-04|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|LB|e443f82e-43a8-4710-bff4-fd2b2f4d512f|6|HYPRLN|Hydroxyproline|CHEMISTRY|[?]|cs|[?]|[?]|INDETERMINATE|1|mL/cm3/min|1|1|[?]|HIGH|ISOLATE|PARAFFIN-EMBEDDED||HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||Y||3|Visit_3|40|1|TREATMENT|2021-01-31|2021-03-05|40|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|LB|e443f82e-43a8-4710-bff4-fd2b2f4d512f|7|MORPHINE|Morphine|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Mile|1|1|[?]|NORMAL|PLATELET POOR PLASMA|PARAFFIN-EMBEDDED||CONGO RED STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y||NA|Y|4|Visit_4|65|3|FOLLOW-UP|2021-02-25|2021-03-01|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-19
e|LB|e443f82e-43a8-4710-bff4-fd2b2f4d512f|8|NTXI|Type I Collagen N-Telopeptides|URINALYSIS|[?]|DRINK|[?]|[?]|INVALID|1|umol/min|1|1|[?]|ABNORMAL|PLASMA|UNEXPECTED ODOR||PET/MRI SCAN|MDRD 6 VARIABLE FORMULA|Y|Y|Y||4|Visit_4|65|2|TREATMENT|2021-02-25|2021-03-04|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-19
e|LB|e443f82e-43a8-4710-bff4-fd2b2f4d512f|9|EOSCE|Eosinophils/Total Cells|HEMATOLOGY|[?]|10^4 CFU|[?]|[?]|INDETERMINATE|1|copies/mL|1|1|[?]|NORMAL|SMEGMA|HEMOLYZED||EPSILOMETER|HEPASCORE FORMULA|||NA||5|Visit_5|90|1|TREATMENT|2021-03-22|2021-03-31|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|e443f82e-43a8-4710-bff4-fd2b2f4d512f|10|TGFA|Transforming Growth Factor Alpha|HEMATOLOGY|[?]|bel|[?]|[?]|POSITIVE|1|TUBE|1|1|[?]|ABNORMAL|CAPILLARY PLASMA|DRIED||COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2021-03-22|2021-03-23|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|LB|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|1|BLYMXM|B-lymphocyte Crossmatch|URINALYSIS|[?]|10^3 RNA copies/mL|[?]|[?]|NEGATIVE|1|rpm|1|1|[?]|HIGH|DIALYSIS FLUID, PERITONEAL|AGGLUTINATED||DARK FIELD MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-06-22|2020-08-23|10|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|2|CSCYL|Cylindroid Casts|CHEMISTRY|[?]|g/dL|[?]|[?]|INVALID|1|V|1|1|[?]|ABNORMAL|GASTRIC FLUID|NON-HEMOLYZED||PHOTOGRAPHY|MDRD 6 VARIABLE FORMULA|||Y||1|Visit_1|10|6|WASHOUT|2020-06-22|2020-09-11|10|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|LB|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|3|ANTIDPRS|Antidepressants|URINALYSIS|[?]|KALLIKREIN INHIBITOR UNIT|[?]|[?]|POSITIVE|1|nm|1|1|[?]|HIGH|DERMAL TISSUE|CLOTTED||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD ENZYMATIC FORMULA|||U||2|Visit_2|25|4|WASHOUT|2020-07-07|2020-09-03|25|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|4|MECONIUM|Meconium|CHEMISTRY|[?]|vg/kg|[?]|[?]|NEGATIVE|1|CAN|1|1|[?]|ABNORMAL|TISSUE|CONCENTRATED||COMPLEMENT FIXATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||2|Visit_2|25|1|TREATMENT|2020-07-07|2020-07-16|25|34|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|5|C147281|Egg White Antigen IgE Antibody|HEMATOLOGY|[?]|kPa|[?]|[?]|POSITIVE|1|umol/mg/min|1|1|[?]|HIGH|PLEURAL TISSUE|THAWED|N|PHOTOMETRY|FIBROSIS 4 FORMULA|Y||Y||3|Visit_3|40|7|TREATMENT|2020-07-22|2020-09-05|40|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|LB|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|6|DCA|Deoxycholate|URINALYSIS|[?]|DNA copies/ug|[?]|[?]|NEGATIVE|1|10^6 organisms/mg|1|1|[?]|NORMAL|KERATINOCYTE|LACTESCENT||POLYGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA|Y||U||3|Visit_3|40|3|WASHOUT|2020-07-22|2020-08-05|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|LB|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|7|METHAMPH|Methamphetamine|CHEMISTRY|[?]|m3|[?]|[?]|NEGATIVE|1|ug/L FEU|1|1|[?]|LOW|REFLEX TEAR|AUTOLYZED||IODINE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||4|Visit_4|65|2|TREATMENT|2020-08-16|2020-08-20|65|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|8|RBCCLMP|Erythrocyte Cell Clumps|HEMATOLOGY|[?]|mAmp|[?]|[?]|INVALID|1|uU/dL|1|1|[?]|ABNORMAL|EXPIRED AIR|FROZEN||ELECTRONEUROGRAPHY|MDRD FORMULA|||NA||4|Visit_4|65|5|TREATMENT|2020-08-16|2020-09-15|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|9|NEUTLE|Neutrophils/Leukocytes|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^6 organisms|1|1|[?]|NORMAL|GASTRIC CONTENTS|GELLED||STRESS ECHOCARDIOGRAPHY|FIBROMETER FORMULA||Y|Y|Y|5|Visit_5|90|7|WASHOUT|2020-09-10|2020-09-17|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|10|OSMRTY|Osmolarity|URINALYSIS|[?]|uIU/L|[?]|[?]|BORDERLINE|1|JDF Unit|1|1|[?]|NORMAL|REFLEX TEAR|AUTOLYZED||ATOMIC ABSORPTION SPECTROMETRY|MDRD FORMULA|Y||NA||5|Visit_5|90|7|TREATMENT|2020-09-10|2020-09-19|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|8a2147b1-2deb-410e-a298-d028a5efc555|1|NRP1|Neuropilin-1|CHEMISTRY|[?]|BEAM BREAKS|[?]|[?]|TRACE|1|pkat|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|PARAFFIN-EMBEDDED||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-10-30|2020-12-28|10|69|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|8a2147b1-2deb-410e-a298-d028a5efc555|2|ARA|Arachidonic Acid|CHEMISTRY|[?]|ug/kg/h|[?]|[?]|INDETERMINATE|1|mV2/Hz|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|DRIED||MOUSE PROTECTION ASSAY|FIBROMETER FORMULA|Y||U||1|Visit_1|10|2|TREATMENT|2020-10-30|2020-11-14|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|LB|8a2147b1-2deb-410e-a298-d028a5efc555|3|SJSA52AB|Sjogrens SS-A52 Antibody|URINALYSIS|[?]|PACKET|[?]|[?]|INVALID|1|10^4/L|1|1|[?]|NORMAL|BONE MARROW|UNEXPECTED ODOR||FARNSWORTH-MUNSELL 100 HUE TEST|GMI % FORMULA|Y||NA||2|Visit_2|25|1|WASHOUT|2020-11-14|2020-12-26|25|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|8a2147b1-2deb-410e-a298-d028a5efc555|4|PTHFG|Parathyroid Hormone, Fragmented|HEMATOLOGY|[?]|gMFI|[?]|[?]|INDETERMINATE|1|umol|1|1|[?]|LOW|DISCHARGE|PARAFFIN-EMBEDDED|N|SISH|MDRD 4 VARIABLE FORMULA|||NA||2|Visit_2|25|5|TREATMENT|2020-11-14|2021-01-17|25|89|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|8a2147b1-2deb-410e-a298-d028a5efc555|5|GFRBSA|Glomerular Filtration Rate Adj for BSA|CHEMISTRY|||[?]|[?]|NEGATIVE|1|Joule|1|1|[?]|NORMAL|CELL PELLET|SOLIDIFIED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|GMI MMOL/MOL FORMULA|Y||U|Y|3|Visit_3|40|6|TREATMENT|2020-11-29|2020-12-30|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|8a2147b1-2deb-410e-a298-d028a5efc555|6|GSTAL|Alpha Glutathione-S-Transferase|HEMATOLOGY|[?]|ppb|[?]|[?]|INVALID|1|ngEq/L|1|1|[?]|ABNORMAL|PLASMA|LACTESCENT||ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|N||3|Visit_3|40|5|TREATMENT|2020-11-29|2020-12-30|40|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|LB|8a2147b1-2deb-410e-a298-d028a5efc555|7|ETPTP|ETP Time to Peak|HEMATOLOGY|[?]|U/mL|[?]|[?]|INVALID|1|g/L|1|1|[?]|ABNORMAL|SERUM|LIPEMIC||FLUORESCEIN STAIN|MDRD ENZYMATIC FORMULA||Y|N||4|Visit_4|65|4|SCREENING|2020-12-24|2021-01-08|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|8a2147b1-2deb-410e-a298-d028a5efc555|8|SCKCERBC|Sickle Cells/Erythrocytes|URINALYSIS|[?]|mL/(min*100mL)|[?]|[?]|INVALID|1|mOsm/kg|1|1|[?]|ABNORMAL|PLATELET POOR PLASMA|THAWED||CALCULATION|NASH FIBROSURE FORMULA|||NA||4|Visit_4|65|2|TREATMENT|2020-12-24|2021-01-21|65|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|LB|8a2147b1-2deb-410e-a298-d028a5efc555|9|ADPNHMW|Adiponectin, High Molecular Weight|URINALYSIS|[?]|mg/mL/day|[?]|[?]|INVALID|1|AgU/mL|1|1|[?]|LOW|LAVAGE FLUID|DRIED||SNP ARRAY|ASH FIBROSURE FORMULA|||U||5|Visit_5|90|2|TREATMENT|2021-01-18|2021-01-23|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|8a2147b1-2deb-410e-a298-d028a5efc555|10|HGBMET|Methemoglobin|HEMATOLOGY|[?]|Bq/ug|[?]|[?]|INVALID|1|Siemens|1|1|[?]|LOW|LUNG SURFACTANT|LIPEMIC||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|FIBROMETER FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2021-01-18|2021-01-21|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|LB|033db3bf-17fb-4872-afdb-1eea3dac6d85|1|LCN2|Lipocalin-2|CHEMISTRY|[?]|NEBULE|[?]|[?]|TRACE|1|g/g/day|1|1|[?]|HIGH|EMESIS|NON-HEMOLYZED||FARNSWORTH-MUNSELL 100 HUE TEST|CKD-EPI CREATININE FORMULA|||U||1|Visit_1|10|4|TREATMENT|2020-07-05|2020-09-04|10|71|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|033db3bf-17fb-4872-afdb-1eea3dac6d85|2|MYPCERPC|Myeloid/Erythroid Ratio|URINALYSIS|[?]|Hounsfield Unit|[?]|[?]|TRACE|1|umol/kg/min|1|1|[?]|HIGH|MENSTRUAL BLOOD|LACTESCENT|N|GC/MS|MDRD 4 VARIABLE FORMULA|||Y||1|Visit_1|10|3|FOLLOW-UP|2020-07-05|2020-07-20|10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|LB|033db3bf-17fb-4872-afdb-1eea3dac6d85|3|THYPXDAB|Thyroperoxidase Antibody|HEMATOLOGY|[?]|/10^4|[?]|[?]|INDETERMINATE|1|ug/h|1|1|[?]|ABNORMAL|BREAST MILK|ROOM TEMPERATURE||PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI % FORMULA|Y|Y|N||2|Visit_2|25|3|TREATMENT|2020-07-20|2020-09-20|25|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|LB|033db3bf-17fb-4872-afdb-1eea3dac6d85|4|VITB1|Thiamine|CHEMISTRY|||[?]|[?]|NEGATIVE|1|APL U/mL|1|1|[?]|ABNORMAL|BONE|HEMOLYZED||SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|ASH FIBROSURE FORMULA||Y|N|Y|2|Visit_2|25|5|TREATMENT|2020-07-20|2020-07-25|25|30|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|LB|033db3bf-17fb-4872-afdb-1eea3dac6d85|5|HYXLYS|Hydroxylysine|CHEMISTRY|[?]|umol/dL|[?]|[?]|NEGATIVE|1|pm|1|1|[?]|NORMAL|LYMPH|UNEXPECTED ODOR||BIOIMPEDANCE SPECTROSCOPY|NASH FIBROSURE FORMULA|||N||3|Visit_3|40|2|TREATMENT|2020-08-04|2020-09-13|40|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|033db3bf-17fb-4872-afdb-1eea3dac6d85|6|NPY|Neuropeptide Y|HEMATOLOGY|[?]|L/min/m2|[?]|[?]|TRACE|1|mMU/mL|1|1|[?]|NORMAL|HAIR FOLLICLE|LIPEMIC|N|POLYSOMNOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||U||3|Visit_3|40|2|TREATMENT|2020-08-04|2020-09-21|40|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|LB|033db3bf-17fb-4872-afdb-1eea3dac6d85|7|TURB|Turbidity|URINALYSIS|[?]|10^7 TCID 50/dose|[?]|[?]|POSITIVE|1|mL/animal|1|1|[?]|ABNORMAL|DIALYSIS FLUID|NON-HEMOLYZED||POLYMERASE CHAIN REACTION|MDRD FORMULA|||NA||4|Visit_4|65|5|FOLLOW-UP|2020-08-29|2020-09-09|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|033db3bf-17fb-4872-afdb-1eea3dac6d85|8|LKM1AB|Liver Kidney Microsomal Type 1 Antibody|CHEMISTRY|||[?]|[?]|NEGATIVE|1|mmol|1|1|[?]|ABNORMAL|ISOLATE|SOLIDIFIED||IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|CKD-EPI CREATININE FORMULA|Y||NA|Y|4|Visit_4|65|4|WASHOUT|2020-08-29|2020-09-21|65|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|033db3bf-17fb-4872-afdb-1eea3dac6d85|9|DNASEBAB|DNase-B Antibody|HEMATOLOGY|[?]|BISCUIT|[?]|[?]|INVALID|1|mg/kg/week|1|1|[?]|LOW|AQUEOUS HUMOR|LIPEMIC||IN SITU HYBRIDIZATION|MDRD 4 VARIABLE FORMULA|||N||5|Visit_5|90|4|WASHOUT|2020-09-23|2020-09-29|90|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|033db3bf-17fb-4872-afdb-1eea3dac6d85|10|MDZLM|Midazolam|URINALYSIS|[?]|hr/day|[?]|[?]|POSITIVE|1|Farad|1|1|[?]|ABNORMAL|VITREOUS HUMOR|GELLED||IN VITRO GENE EXPRESSION ASSAY|MDRD 4 VARIABLE FORMULA|Y|Y|Y||5|Visit_5|90|3|SCREENING|2020-09-23|2020-09-26|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|LB|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|1|VMAEXR|Vanillyl Mandelic Acid Excretion Rate|HEMATOLOGY|[?]|mV2/Hz|[?]|[?]|BORDERLINE|1|Weber|1|1|[?]|HIGH|CIRCULATING TUMOR CELL|REFRIGERATED||COULOMETRIC TITRATION|MDRD 4 VARIABLE FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-06-19|2020-08-01|10|53|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|2|HETRPH|Heterophils|CHEMISTRY|[?]|mL/cm3/min|[?]|[?]|BORDERLINE|1|VOXEL|1|1|[?]|NORMAL|INFRANATANT, PLEURAL FLUID|HEMOLYZED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|7|SCREENING|2020-06-19|2020-07-04|10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|LB|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|3|EOSMM|Eosinophilic Metamyelocytes|HEMATOLOGY|[?]|kIU|[?]|[?]|TRACE|1|amol|1|1|[?]|HIGH|PLATELET POOR PLASMA|PARAFFIN-EMBEDDED||FLUORIMETRY|MDRD 6 VARIABLE FORMULA||Y|U||2|Visit_2|25|2|TREATMENT|2020-07-04|2020-08-26|25|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|4|ECT|Ecarin Clotting Time|HEMATOLOGY|[?]|sec|[?]|[?]|INDETERMINATE|1|/LPF|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|GELLED|N|ERGOSPIROMETRY|MDRD ENZYMATIC JAPANESE FORMULA|||Y||2|Visit_2|25|4|TREATMENT|2020-07-04|2020-08-28|25|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|LB|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|5|ERCENC|Erythroid Cells/Nucleated Cells|URINALYSIS|[?]|Ci/L|[?]|[?]|INVALID|1|uL/mL|1|1|[?]|NORMAL|PLASMA ULTRAFILTRATE|CONCENTRATED||MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI FORMULA|||N||3|Visit_3|40|1|TREATMENT|2020-07-19|2020-09-04|40|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|6|PERCECE|Proliferating Erythroid/Total Cells|CHEMISTRY|[?]|kDa|[?]|[?]|TRACE|1|ELISA unit/dose|1|1|[?]|NORMAL|MIXED VENOUS BLOOD|AUTOLYZED||PHOROPTER|GMI % FORMULA|||Y||3|Visit_3|40|5|FOLLOW-UP|2020-07-19|2020-08-27|40|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|LB|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|7|ARGSAC|Argininosuccinic Acid|CHEMISTRY|[?]|cpm|[?]|[?]|NEGATIVE|1|ug/L FEU|1|1|[?]|ABNORMAL|EPIDERMAL TISSUE|REFRIGERATED|N|FLOW CYTOMETRY|GMI MMOL/MOL FORMULA|Y||U||4|Visit_4|65|1|TREATMENT|2020-08-13|2020-09-02|65|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|8|HCG|Choriogonadotropin Beta|CHEMISTRY|[?]|log10 CCID 50/dose|[?]|[?]|TRACE|1|ppb|1|1|[?]|LOW|URINE|ROOM TEMPERATURE|N|PHOTOMETRY|GMI MMOL/MOL FORMULA|Y||Y||4|Visit_4|65|4|WASHOUT|2020-08-13|2020-09-16|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|9|PLSMCECE|Mature Plasma Cells/Total Cells|CHEMISTRY|[?]|DIOPTER|[?]|[?]|POSITIVE|1|mL/cm H2O|1|1|[?]|HIGH|AQUEOUS HUMOR|SOLIDIFIED||PHASE CONTRAST MICROSCOPY|GMI % FORMULA|||NA||5|Visit_5|90|1|FOLLOW-UP|2020-09-07|2020-09-15|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|10|SLAIGGAB|Soluble Liver Antigen IgG Antibody|URINALYSIS|[?]|MPL U|[?]|[?]|POSITIVE|1|mEq/kg|1|1|[?]|NORMAL|LUNG SURFACTANT|THAWED||ALCIAN BLUE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA|||N||5|Visit_5|90|5|SCREENING|2020-09-07|2020-09-11|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|LB|8dd493b7-a892-4cab-8f69-701471c51d99|1|TRIM21|Tripartite Motif Containing Protein 21|URINALYSIS|[?]|U/animal|[?]|[?]|TRACE|1|CARTRIDGE|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|NON-HEMOLYZED||CINEANGIOGRAPHY|NASH FIBROSURE FORMULA|||N||1|Visit_1|10|2|SCREENING|2021-01-12|2021-03-24|10|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|8dd493b7-a892-4cab-8f69-701471c51d99|2|FERRITIN|Ferritin|HEMATOLOGY|[?]|100 IU/mL|[?]|[?]|BORDERLINE|1|PUFF|1|1|[?]|NORMAL|STOOL|DRIED||MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD ENZYMATIC FORMULA||Y|NA||1|Visit_1|10|5|TREATMENT|2021-01-12|2021-01-29|10|27|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|LB|8dd493b7-a892-4cab-8f69-701471c51d99|3|GFRBSCU|GFR from Creat and UreaN Adj BSA|CHEMISTRY|[?]|mm3/mm2/year|[?]|[?]|POSITIVE|1|kIU|1|1|[?]|ABNORMAL|SUPERNATANT, SERUM OR PLASMA|AUTOLYZED||X-RAY FLUORESCENCE SPECTROMETRY|CKD-EPI FORMULA|||NA||2|Visit_2|25|1|TREATMENT|2021-01-27|2021-03-27|25|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|8dd493b7-a892-4cab-8f69-701471c51d99|4|CANNABM|Cannabinoid Metabolites|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|mEq/ug|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|HEMOLYZED||LANDOLT RING|MDRD FORMULA||Y|Y|Y|2|Visit_2|25|3|TREATMENT|2021-01-27|2021-03-30|25|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|LB|8dd493b7-a892-4cab-8f69-701471c51d99|5|CSEPI|Epithelial Casts|HEMATOLOGY|[?]|SYRINGE|[?]|[?]|TRACE|1|U/mL|1|1|[?]|NORMAL|BREAST MILK|NON-HEMOLYZED||MODIFIED ACID FAST STAIN|COCKCROFT-GAULT FORMULA|||NA||3|Visit_3|40|1|TREATMENT|2021-02-11|2021-03-22|40|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|8dd493b7-a892-4cab-8f69-701471c51d99|6|C130069|Bermuda Grass Pollen IgA|HEMATOLOGY|[?]|ug/L DDU|[?]|[?]|POSITIVE|1|Ci/g|1|1|[?]|LOW|PLATELET POOR PLASMA|THAWED||NON-INVASIVE DIELECTRIC SENSING|MDRD 5 VARIABLE FORMULA||Y|Y||3|Visit_3|40|4|WASHOUT|2021-02-11|2021-04-04|40|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|LB|8dd493b7-a892-4cab-8f69-701471c51d99|7|CELLS|Cells|URINALYSIS|[?]|/5x10^4 WBC|[?]|[?]|TRACE|1|U/g/day|1|1|[?]|LOW|CARDIAC MUSCLE TISSUE|AGGLUTINATED||SCANNING ELECTRON MICROSCOPY|COCKCROFT-GAULT FORMULA|||N||4|Visit_4|65|4|WASHOUT|2021-03-08|2021-03-14|65|71|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|8dd493b7-a892-4cab-8f69-701471c51d99|8|CARNITF|Carnitine, Free|CHEMISTRY|[?]|ft3|[?]|[?]|INVALID|1|10^6 IU/mL|1|1|[?]|ABNORMAL|PLEURAL FLUID|AUTOLYZED||CONTRAST ENHANCED CT SCAN|FIBROMETER FORMULA|||Y||4|Visit_4|65|5|SCREENING|2021-03-08|2021-03-30|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|LB|8dd493b7-a892-4cab-8f69-701471c51d99|9|HLABAGT|HLA-B Antigen Type|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|uIU/L|1|1|[?]|NORMAL|PROSTATIC FLUID|NON-HEMOLYZED||IMMUNOPRECIPITATION|NASH FIBROSURE FORMULA||Y|Y|Y|5|Visit_5|90|7|TREATMENT|2021-04-02|2021-04-09|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|LB|8dd493b7-a892-4cab-8f69-701471c51d99|10|TNF|Tumor Necrosis Factor|CHEMISTRY|[?]|kIU|[?]|[?]|INDETERMINATE|1|U/mg|1|1|[?]|NORMAL|WHITE MATTER TISSUE|ICTERIC||IMMUNOFIXATION ELECTROPHORESIS|MDRD FORMULA|Y||NA||5|Visit_5|90|2|TREATMENT|2021-04-02|2021-04-08|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|LB|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|1|FCTVIIIA|Factor VIII Activity|HEMATOLOGY|[?]|ug/mol|[?]|[?]|BORDERLINE|1|ks|1|1|[?]|ABNORMAL|ADIPOSE TISSUE|SOLIDIFIED||PANENDOSCOPY|CKD-EPI FORMULA||Y|U||1|Visit_1|10|3|TREATMENT|2020-11-07|2021-01-23|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|2|RPPAB|Ribosomal P Protein Antibody|HEMATOLOGY|[?]|kg/m2|[?]|[?]|TRACE|1|uL|1|1|[?]|HIGH|URINE|ROOM TEMPERATURE||INFRARED SPECTROMETRY|CKD-EPI CREATININE FORMULA|||NA||1|Visit_1|10|3|TREATMENT|2020-11-07|2020-11-21|10|24|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|3|LIF|Leukemia Inhibitory Factor|URINALYSIS|[?]|MONTHS|[?]|[?]|INVALID|1|ug/h|1|1|[?]|ABNORMAL|PERITONEAL FLUID|GELLED||IMMUNO-PET SCAN|MDRD ENZYMATIC FORMULA|||N||2|Visit_2|25|2|SCREENING|2020-11-22|2021-01-24|25|88|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|4|AFACTXAA|Anti-Factor Xa Activity|HEMATOLOGY|[?]|deg/mm|[?]|[?]|POSITIVE|1|ug/L FEU|1|1|[?]|NORMAL|CEREBROSPINAL FLUID|CONTAMINATED||FLUOROSCOPY|FIBROSIS 4 FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-11-22|2021-01-15|25|79|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|LB|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|5|ANTHRMA|Antithrombin Activity|HEMATOLOGY|||[?]|[?]|NEGATIVE|1|GBq|1|1|[?]|LOW|CORD SERUM|THAWED||FISH|NASH FIBROSURE FORMULA|||N|Y|3|Visit_3|40|3|TREATMENT|2020-12-07|2021-01-08|40|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|LB|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|6|RBC|Erythrocytes|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|nmol/day|1|1|[?]|LOW|VENOUS BLOOD|GELLED||MRI WITHOUT CONTRAST|GMI % FORMULA|||U|Y|3|Visit_3|40|2|TREATMENT|2020-12-07|2021-01-12|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|LB|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|7|NTXII|Type II Collagen N-Telopeptides|HEMATOLOGY|[?]|WEEKS|[?]|[?]|POSITIVE|1|DROP|1|1|[?]|HIGH|PROSTATIC FLUID|NON-HEMOLYZED||MICROARRAY|GMI MMOL/MOL FORMULA||Y|NA||4|Visit_4|65|1|SCREENING|2021-01-01|2021-01-29|65|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|8|COQ10|Ubiquinone 10|URINALYSIS|||[?]|[?]|POSITIVE|1|IMPLANT|1|1|[?]|ABNORMAL|PLASMA ULTRAFILTRATE|HEMOLYZED||ELISA|MDRD 5 VARIABLE FORMULA|Y||Y|Y|4|Visit_4|65|2|TREATMENT|2021-01-01|2021-02-01|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|LB|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|9|KRCYMG|Megakaryocytes|HEMATOLOGY|[?]|mL/g/day|[?]|[?]|TRACE|1|fg|1|1|[?]|HIGH|STRIATED MUSCLE TISSUE|FROZEN|N|U-HPLC/MS/MS|GMI % FORMULA|Y|Y|U||5|Visit_5|90|7|TREATMENT|2021-01-26|2021-02-04|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|10|CANNABM|Cannabinoid Metabolites|CHEMISTRY|[?]|cs|[?]|[?]|BORDERLINE|1|GBq|1|1|[?]|HIGH|CARDIAC MUSCLE TISSUE|AGGLUTINATED||PERFUSION MRI|FIBROSIS 4 FORMULA||Y|N||5|Visit_5|90|1|TREATMENT|2021-01-26|2021-02-03|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|LB|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|1|C4D|Complement C4d|CHEMISTRY|[?]|L/min/m2|[?]|[?]|TRACE|1|deg/s|1|1|[?]|NORMAL|SALIVA|LACTESCENT|N|RADIATION DOSIMETRY|GMI % FORMULA|||NA||1|Visit_1|10|6|TREATMENT|2020-09-04|2020-09-24|10|30|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|2|HCT|Hematocrit|URINALYSIS|[?]|ELISA unit/mL|[?]|[?]|POSITIVE|1|mL/cage/day|1|1|[?]|ABNORMAL|BILE|CONTAMINATED||RIA|MDRD FORMULA||Y|U||1|Visit_1|10|3|FOLLOW-UP|2020-09-04|2020-10-12|10|48|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|3|PSDGLSRF|Phosphatidylglycerol/Lung Surfactant|URINALYSIS|[?]|lm|[?]|[?]|INDETERMINATE|1|dpm/100mg|1|1|[?]|LOW|EXUDATE|THAWED||PERIPHERAL ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|Y||NA||2|Visit_2|25|7|TREATMENT|2020-09-19|2020-09-23|25|29|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|4|VITB1|Thiamine|HEMATOLOGY|[?]|MPL U/mL|[?]|[?]|INDETERMINATE|1|MAC50|1|1|[?]|ABNORMAL|PLATELET RICH PLASMA|FRESH|N|CRYOSCOPY|MDRD 6 VARIABLE FORMULA|Y||Y||2|Visit_2|25|2|TREATMENT|2020-09-19|2020-10-27|25|63|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|LB|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|5|DRUGSCR|Drug Screen|HEMATOLOGY|||[?]|[?]|TRACE|1|gMFI|1|1|[?]|HIGH|TUMOR TISSUE|LACTESCENT||CONTRAST ENHANCED PET/CT SCAN|CKD-EPI CREATININE FORMULA||Y|N|Y|3|Visit_3|40|2|TREATMENT|2020-10-04|2020-10-22|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|6|PLATSAT|Platelet Satellitism|URINALYSIS|[?]|Enzyme U/m2|[?]|[?]|TRACE|1|grain|1|1|[?]|HIGH|MECONIUM|SOLIDIFIED|N|PET/SPECT SCAN|MDRD 4 VARIABLE FORMULA|Y||N||3|Visit_3|40|1|FOLLOW-UP|2020-10-04|2020-10-18|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|LB|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|7|PLP|Pyridoxal Phosphate|URINALYSIS|[?]|kcal/day|[?]|[?]|NEGATIVE|1|Tesla|1|1|[?]|NORMAL|SOFT TISSUE|CONCENTRATED||DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|FIBROTEST FORMULA||Y|U||4|Visit_4|65|2|WASHOUT|2020-10-29|2020-11-12|65|79|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|8|BLYCELE|B-Lymphocytes/Leukocytes|URINALYSIS|[?]|atm|[?]|[?]|TRACE|1|ug/g/min|1|1|[?]|HIGH|ARTERIALIZED CAPILLARY BLOOD|THAWED||TRYPAN BLUE STAIN|COCKCROFT-GAULT FORMULA|||Y||4|Visit_4|65|1|TREATMENT|2020-10-29|2020-11-25|65|92|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|LB|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|9|BALA|Beta Alanine|URINALYSIS|[?]|cGy|[?]|[?]|BORDERLINE|1|mEq/kg|1|1|[?]|LOW|ENDOMETRIAL TISSUE|ROOM TEMPERATURE||MEDIASTINOSCOPY|CKD-EPI CYSTATIN C FORMULA|||NA||5|Visit_5|90|7|TREATMENT|2020-11-23|2020-11-27|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|10|CKMT2CK|CK, Macromolecular Type 2/Total CK|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Hz/s|1|1|[?]|NORMAL|LEUKOCYTE|FROZEN||INDIA INK STAIN|MDRD ENZYMATIC JAPANESE FORMULA|Y||N|Y|5|Visit_5|90|2|TREATMENT|2020-11-23|2020-12-01|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|LB|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|1|RETIMRTC|Medium Absorption Retic/Reticulocytes|HEMATOLOGY|[?]|ugEq|[?]|[?]|NEGATIVE|1|Enzyme U|1|1|[?]|HIGH|ABSCESS FLUID|REFRIGERATED||HPLC/MS/MS|FIBROMETER FORMULA||Y|NA||1|Visit_1|10|6|FOLLOW-UP|2020-11-20|2020-11-28|10|18|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|2|CHRMTNAB|Chromatin Antibodies|HEMATOLOGY|[?]|mL/m2|[?]|[?]|INDETERMINATE|1|ft3|1|1|[?]|LOW|EPIDERMAL TISSUE|GELLED||STATIC PERIMETRY|MDRD FORMULA||Y|U||1|Visit_1|10|2|FOLLOW-UP|2020-11-20|2021-02-06|10|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|LB|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|3|BLASTRUB|Rubriblast|HEMATOLOGY|||[?]|[?]|POSITIVE|1|/LSQN|1|1|[?]|LOW|HAIR FOLLICLE|REFRIGERATED|N|SISH|FIBROSIS 4 FORMULA|||NA|Y|2|Visit_2|25|4|TREATMENT|2020-12-05|2020-12-16|25|36|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|4|C130102|Tree Mix Pollen Antigen IgG Antibody|CHEMISTRY|||[?]|[?]|BORDERLINE|1|Joule|1|1|[?]|NORMAL|SUPERNATANT, PLASMA|HEMOLYZED||IMMUNO-PET SCAN|FIBROMETER FORMULA|||N|Y|2|Visit_2|25|2|TREATMENT|2020-12-05|2021-01-02|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|LB|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|5|COPPER|Copper|HEMATOLOGY|[?]|mL/cage/wk|[?]|[?]|POSITIVE|1|MASK|1|1|[?]|NORMAL|EXPIRED AIR|UNEXPECTED ODOR||IMMUNOFIXATION ELECTROPHORESIS|HEPASCORE FORMULA|Y||Y||3|Visit_3|40|1|TREATMENT|2020-12-20|2020-12-31|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|6|TSI|Thyroid Stimulating Immunoglobulin|CHEMISTRY|[?]|mL/(min*100mL)|[?]|[?]|INVALID|1|mL/dL|1|1|[?]|LOW|EPIDERMAL TISSUE|NON-HEMOLYZED|N|JAEGER EYE CHART|CKD-EPI CREATININE FORMULA|||Y||3|Visit_3|40|7|WASHOUT|2020-12-20|2021-01-31|40|82|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|LB|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|7|TROPONT|Troponin T|CHEMISTRY|||[?]|[?]|BORDERLINE|1|GPS U|1|1|[?]|LOW|KERATINOCYTE|CALCIFIED||AUDIOMETRY|HEPASCORE FORMULA|Y||U|Y|4|Visit_4|65|3|SCREENING|2021-01-14|2021-01-25|65|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|8|CARNITF|Carnitine, Free|URINALYSIS|[?]|mL/cage|[?]|[?]|INVALID|1|mEq/ug|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|CONCENTRATED||OLIGO ACGH|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y||4|Visit_4|65|4|TREATMENT|2021-01-14|2021-02-09|65|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|LB|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|9|LDLPSZ|LDL Particle Size|URINALYSIS|[?]|IU/mL|[?]|[?]|BORDERLINE|1|deg/s|1|1|[?]|HIGH|ERYTHROCYTES|AUTOLYZED||RULER MEASUREMENT METHOD|FIBROSIS 4 FORMULA|||N||5|Visit_5|90|2|FOLLOW-UP|2021-02-08|2021-02-17|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|10|PSIGAAB|Phosphatidylserine IgA Antibody|URINALYSIS|[?]|L/min|[?]|[?]|TRACE|1|um/s|1|1|[?]|NORMAL|BLOOD|FRESH||RADIOGRAPHY|MDRD FORMULA||Y|NA||5|Visit_5|90|4|TREATMENT|2021-02-08|2021-02-17|90|99|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|LB|b49ef90c-a17e-4554-9fa6-af72b4d56a06|1|HDL3|HDL-Cholesterol Subclass 3|CHEMISTRY|[?]|copies/ug|[?]|[?]|BORDERLINE|1|SYRINGE|1|1|[?]|HIGH|EXUDATE|CONTAMINATED||CAPILLARY ELECTROPHORESIS|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y||1|Visit_1|10|6|TREATMENT|2021-01-05|2021-02-12|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|b49ef90c-a17e-4554-9fa6-af72b4d56a06|2|C130110|Mold Mix Antigen IgG Antibody|URINALYSIS|||[?]|[?]|NEGATIVE|1|SYRINGE|1|1|[?]|ABNORMAL|VENOUS PLASMA|FROZEN||PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|CKD-EPI CYSTATIN C FORMULA|||Y|Y|1|Visit_1|10|6|TREATMENT|2021-01-05|2021-03-03|10|67|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|LB|b49ef90c-a17e-4554-9fa6-af72b4d56a06|3|NEUTSGBP|Neutrophils, Seg + Band Form + Precursor|CHEMISTRY|||[?]|[?]|INVALID|1|mg/g/min|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|LIPEMIC||DROPLET DIGITAL PCR|GMI % FORMULA||Y|Y|Y|2|Visit_2|25|3|TREATMENT|2021-01-20|2021-03-23|25|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|b49ef90c-a17e-4554-9fa6-af72b4d56a06|4|STAT3|STAT3|CHEMISTRY|[?]|titer|[?]|[?]|BORDERLINE|1|kat|1|1|[?]|LOW|STOOL|AGGLUTINATED||SLOAN LETTER EYE CHART 2.5%|CKD-EPI FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2021-01-20|2021-04-03|25|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|LB|b49ef90c-a17e-4554-9fa6-af72b4d56a06|5|INSLNFR|Insulin, Free|URINALYSIS|[?]|copies/ug|[?]|[?]|INVALID|1|/kg|1|1|[?]|HIGH|AMNIOTIC FLUID|NON-HEMOLYZED||DYNAMIC LIGHT SCATTERING|GMI MMOL/MOL FORMULA|||Y||3|Visit_3|40|2|SCREENING|2021-02-04|2021-02-15|40|51|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|b49ef90c-a17e-4554-9fa6-af72b4d56a06|6|THROMNUC|Thrombocytes|URINALYSIS|||[?]|[?]|INDETERMINATE|1|mL/kg/min|1|1|[?]|NORMAL|LYSATE|SOLIDIFIED|N|THICK SMEAR|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U|Y|3|Visit_3|40|7|TREATMENT|2021-02-04|2021-03-14|40|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|LB|b49ef90c-a17e-4554-9fa6-af72b4d56a06|7|PCA3MRNA|Prostate Cancer Antigen 3 mRNA|CHEMISTRY|[?]|MBq|[?]|[?]|BORDERLINE|1|mL/cm|1|1|[?]|LOW|PLATELET RICH PLASMA|PARAFFIN-EMBEDDED||CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI FORMULA|||N||4|Visit_4|65|2|TREATMENT|2021-03-01|2021-03-23|65|87|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|b49ef90c-a17e-4554-9fa6-af72b4d56a06|8|RFIGAAB|Rheumatoid Factor IgA Antibody|CHEMISTRY|[?]|APL U|[?]|[?]|POSITIVE|1|U/animal|1|1|[?]|NORMAL|PERITONEAL FLUID|SOLIDIFIED||CONGO RED STAIN|ASH FIBROSURE FORMULA|Y||N||4|Visit_4|65|4|TREATMENT|2021-03-01|2021-03-16|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|LB|b49ef90c-a17e-4554-9fa6-af72b4d56a06|9|FATACFRU|Free Fatty Acid, Unsaturated|CHEMISTRY|||[?]|[?]|INVALID|1|mg/g/min|1|1|[?]|NORMAL|ERYTHROCYTES|FRESH|N|CINEANGIOGRAPHY|FIBROMETER FORMULA|Y||U|Y|5|Visit_5|90|1|SCREENING|2021-03-26|2021-03-30|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|b49ef90c-a17e-4554-9fa6-af72b4d56a06|10|HGBMET|Methemoglobin|URINALYSIS|||[?]|[?]|INDETERMINATE|1|pt_us|1|1|[?]|LOW|ENDOMETRIAL TISSUE|ROOM TEMPERATURE|N|PUPILLOMETRY|FIBROMETER FORMULA|||Y|Y|5|Visit_5|90|7|TREATMENT|2021-03-26|2021-04-02|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|LB|df041193-ee4e-4835-8db9-5be9b832ded0|1|PT|Prothrombin Time|URINALYSIS|[?]|kcal/day|[?]|[?]|BORDERLINE|1|GPS U|1|1|[?]|ABNORMAL|BONE MARROW MONONUCLEAR CELL|CLOTTED||SLOAN LETTER EYE CHART 100%|FIBROSIS 4 FORMULA|||NA||1|Visit_1|10|5|TREATMENT|2020-11-25|2020-12-24|10|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|df041193-ee4e-4835-8db9-5be9b832ded0|2|INTLK13|Interleukin 13|URINALYSIS|[?]|ug/g/min|[?]|[?]|TRACE|1|mm|1|1|[?]|HIGH|SERUM OR PLASMA|THAWED|N|VIRUS PLAQUE ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA||1|Visit_1|10|6|SCREENING|2020-11-25|2020-12-08|10|23|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|LB|df041193-ee4e-4835-8db9-5be9b832ded0|3|TLYMXM|T-lymphocyte Crossmatch|URINALYSIS|||[?]|[?]|NEGATIVE|1|mg/mL/min|1|1|[?]|NORMAL|SUPERNATANT, SERUM|LIPEMIC||KLEIHAUER-BETKE|GMI % FORMULA|Y|Y|N|Y|2|Visit_2|25|1|TREATMENT|2020-12-10|2020-12-29|25|44|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|df041193-ee4e-4835-8db9-5be9b832ded0|4|CA19_9AG|Cancer Antigen 19-9|URINALYSIS|[?]|1/(s*kPa)|[?]|[?]|BORDERLINE|1|Log10 ELISA unit/dose|1|1|[?]|LOW|KERATINOCYTE|AGGLUTINATED||CHROMATOGRAPHY|ASH FIBROSURE FORMULA|Y||N||2|Visit_2|25|4|WASHOUT|2020-12-10|2020-12-24|25|39|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|LB|df041193-ee4e-4835-8db9-5be9b832ded0|5|LIPEMIAI|Lipemic Index|HEMATOLOGY|[?]|fraction of 1|[?]|[?]|INVALID|1|SQU/mL|1|1|[?]|HIGH|EXHALED BREATH CONDENSATE|ROOM TEMPERATURE||SLIT LAMP|CKD-EPI FORMULA|Y||NA||3|Visit_3|40|2|TREATMENT|2020-12-25|2021-01-03|40|49|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|df041193-ee4e-4835-8db9-5be9b832ded0|6|APLSMA2A|Alpha-2 Antiplasmin Activity|URINALYSIS|[?]|MPL U/mL|[?]|[?]|TRACE|1|U/g|1|1|[?]|NORMAL|WHITE MATTER TISSUE|DRIED||CONTRAST ENHANCED PET SCAN|COCKCROFT-GAULT FORMULA|||U||3|Visit_3|40|2|TREATMENT|2020-12-25|2021-01-08|40|54|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|LB|df041193-ee4e-4835-8db9-5be9b832ded0|7|IL1RL1|Interleukin 1 Receptor-Like 1|HEMATOLOGY|[?]|APL U/mL|[?]|[?]|INVALID|1|mL/cage|1|1|[?]|LOW|SEMEN|CLOTTED||HEMATOXYLIN AND EOSIN STAIN|CKD-EPI FORMULA||Y|N||4|Visit_4|65|1|TREATMENT|2021-01-19|2021-02-01|65|78|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|df041193-ee4e-4835-8db9-5be9b832ded0|8|MCPROT|Monoclonal Protein|HEMATOLOGY|[?]|PHERESIS UNIT|[?]|[?]|TRACE|1|cm/min|1|1|[?]|LOW|PROSTATIC FLUID|DRIED||PEAK FLOWMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||U||4|Visit_4|65|6|FOLLOW-UP|2021-01-19|2021-01-26|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|LB|df041193-ee4e-4835-8db9-5be9b832ded0|9|CFA|Coefficient of Fat Absorption|CHEMISTRY|[?]|PNU/mL|[?]|[?]|POSITIVE|1|kDa|1|1|[?]|NORMAL|PERSPIRATION|CONCENTRATED||CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROTEST FORMULA|||U||5|Visit_5|90|5|SCREENING|2021-02-13|2021-02-22|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|df041193-ee4e-4835-8db9-5be9b832ded0|10|INTLK3|Interleukin 3|URINALYSIS|[?]|ng/dL|[?]|[?]|POSITIVE|1|nL|1|1|[?]|NORMAL|DISCHARGE|UNEXPECTED ODOR|N|RAJI CELL EIA|CKD-EPI CREATININE FORMULA||Y|NA||5|Visit_5|90|1|FOLLOW-UP|2021-02-13|2021-02-18|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|LB|e41a4505-a5aa-4cac-895b-04fe85737ca9|1|C130140|German Cockroach Antigen IgE Antibody|HEMATOLOGY|[?]|Absorbance U/min|[?]|[?]|TRACE|1|ug/animal|1|1|[?]|LOW|SEMINAL FLUID|NON-HEMOLYZED|N|PHOTOGRAPHY|HEPASCORE FORMULA||Y|Y||1|Visit_1|10|2|SCREENING|2021-01-13|2021-03-18|10|74|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|LB|e41a4505-a5aa-4cac-895b-04fe85737ca9|2|IGG|Immunoglobulin G|URINALYSIS|[?]|ug/dose|[?]|[?]|POSITIVE|1|mg/m2|1|1|[?]|HIGH|SUPERNATANT, PLEURAL FLUID|GELLED||CLINICAL EVALUATION|MDRD ENZYMATIC FORMULA||Y|U||1|Visit_1|10|6|SCREENING|2021-01-13|2021-03-29|10|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|LB|e41a4505-a5aa-4cac-895b-04fe85737ca9|3|VLDLTCT|VLDL Triglyceride + Chylomicron Triglyceride|CHEMISTRY|[?]|keV|[?]|[?]|POSITIVE|1|Osm|1|1|[?]|LOW|GASTRIC FLUID|CLOTTED||RIA|SCHWARTZ METHOD FOR CHILDREN FORMULA|||N||2|Visit_2|25|7|TREATMENT|2021-01-28|2021-03-25|25|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|e41a4505-a5aa-4cac-895b-04fe85737ca9|4|KERAT|Keratocyte|HEMATOLOGY|[?]|MBq/uL|[?]|[?]|TRACE|1|10^7 CFU|1|1|[?]|ABNORMAL|CERVICOVAGINAL SECRETION|HEMOLYZED|N|CALCULATION|ASH FIBROSURE FORMULA|||N||2|Visit_2|25|7|SCREENING|2021-01-28|2021-03-21|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|e41a4505-a5aa-4cac-895b-04fe85737ca9|5|DHEA|Dehydroepiandrosterone|HEMATOLOGY|[?]|MAC50|[?]|[?]|POSITIVE|1|L/s/kPa|1|1|[?]|LOW|BILE|GELLED||LINE PROBE ASSAY|NASH FIBROSURE FORMULA|||NA||3|Visit_3|40|7|SCREENING|2021-02-12|2021-02-14|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|e41a4505-a5aa-4cac-895b-04fe85737ca9|6|C130103|Grass Mix Pollen Antigen IgE Antibody|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|ELISA unit/mL|1|1|[?]|HIGH|LYSATE|AUTOLYZED||FREEZING POINT DEPRESSION|GMI MMOL/MOL FORMULA|Y|Y|N|Y|3|Visit_3|40|3|TREATMENT|2021-02-12|2021-03-02|40|58|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|LB|e41a4505-a5aa-4cac-895b-04fe85737ca9|7|PROGEST|Progesterone|URINALYSIS|[?]|BOWL|[?]|[?]|INDETERMINATE|1|km|1|1|[?]|ABNORMAL|EXHALED BREATH CONDENSATE|CONCENTRATED|N|HIGH RESOLUTION MELT ANALYSIS|CKD-EPI FORMULA|||NA||4|Visit_4|65|6|TREATMENT|2021-03-09|2021-04-03|65|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|e41a4505-a5aa-4cac-895b-04fe85737ca9|8|GFRBSCU|GFR from Creat and UreaN Adj BSA|URINALYSIS|[?]|g/animal/day|[?]|[?]|INDETERMINATE|1|kg/cm|1|1|[?]|ABNORMAL|SPUTUM|THAWED|N|PHOTOMETRY|GMI % FORMULA|Y||Y||4|Visit_4|65|5|TREATMENT|2021-03-09|2021-03-18|65|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|LB|e41a4505-a5aa-4cac-895b-04fe85737ca9|9|PROTCRT|Protein/Creatinine|URINALYSIS|[?]|ms2|[?]|[?]|TRACE|1|pmol/L/h|1|1|[?]|NORMAL|RETICULOCYTES|AGGLUTINATED|N|GC/FID|GMI % FORMULA||Y|N||5|Visit_5|90|5|TREATMENT|2021-04-03|2021-04-08|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|e41a4505-a5aa-4cac-895b-04fe85737ca9|10|DRVTSCPD|dRVVT Screen to Confirm Pct Difference|URINALYSIS|[?]|log10 PFU|[?]|[?]|POSITIVE|1|DISK|1|1|[?]|LOW|LAVAGE FLUID|ICTERIC|N|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|NASH FIBROSURE FORMULA|Y||Y||5|Visit_5|90|6|TREATMENT|2021-04-03|2021-04-07|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|1|PCNAG|Proliferating Cell Nuclear Antigen|URINALYSIS|[?]|10^12 IU/L|[?]|[?]|POSITIVE|1|pg/L|1|1|[?]|NORMAL|BILE|REFRIGERATED|N|BRDU CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE FORMULA|||N||1|Visit_1|10|2|TREATMENT|2021-01-15|2021-03-30|10|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|2|C130134|D. pteronyssinus Antigen IgE Antibody|URINALYSIS|[?]|/4.0 mL|[?]|[?]|INDETERMINATE|1|Bq/uL|1|1|[?]|HIGH|STOOL|FROZEN||RADIATION DOSIMETRY|FIBROTEST FORMULA|Y||N||1|Visit_1|10|6|TREATMENT|2021-01-15|2021-03-11|10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|LB|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|3|PHENYTN|Phenytoin|CHEMISTRY|[?]|Ci/kg|[?]|[?]|BORDERLINE|1|BE/mL|1|1|[?]|HIGH|CELL PELLET|FRESH||WHOLE TRANSCRIPTOME SEQUENCING|MDRD 5 VARIABLE FORMULA|Y||Y||2|Visit_2|25|3|FOLLOW-UP|2021-01-30|2021-03-01|25|55|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|4|OXYSAT|Oxygen Saturation|CHEMISTRY|[?]|10^7/L|[?]|[?]|POSITIVE|1|10^7 CFU|1|1|[?]|LOW|TRANSUDATE|ICTERIC||IN SITU HYBRIDIZATION|CKD-EPI CYSTATIN C FORMULA||Y|N||2|Visit_2|25|7|WASHOUT|2021-01-30|2021-02-21|25|47|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|LB|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|5|C165927|Animal Mix IgE AB RAST Score|HEMATOLOGY|[?]|log10 TCID 50/uL|[?]|[?]|BORDERLINE|1|mg/mL/day|1|1|[?]|LOW|HAIR FOLLICLE|AGGLUTINATED||DIFFUSION WEIGHTED MRI|FIBROTEST FORMULA|||NA||3|Visit_3|40|3|TREATMENT|2021-02-14|2021-02-27|40|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|LB|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|6|PD1S|Soluble Programmed Death-1|HEMATOLOGY|||[?]|[?]|POSITIVE|1|/mm2|1|1|[?]|HIGH|CEREBROSPINAL FLUID|CONCENTRATED|N|CONTRAST ENHANCED PET/CT SCAN|MDRD ENZYMATIC FORMULA|Y||U|Y|3|Visit_3|40|3|TREATMENT|2021-02-14|2021-04-12|40|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|LB|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|7|GDIGA1|Galactose-Deficient IgA1|HEMATOLOGY|[?]|mCi/L|[?]|[?]|POSITIVE|1|usec|1|1|[?]|NORMAL|EXUDATE|REFRIGERATED||PULMONARY ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||N||4|Visit_4|65|6|TREATMENT|2021-03-11|2021-03-12|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|LB|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|8|ERCEPIDX|Erythroid Proliferation Index|HEMATOLOGY|[?]|Henry|[?]|[?]|POSITIVE|1|IU|1|1|[?]|LOW|EXHALED BREATH CONDENSATE|ROOM TEMPERATURE|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CYSTATIN C FORMULA|||Y||4|Visit_4|65|7|SCREENING|2021-03-11|2021-04-14|65|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|LB|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|9|GLUCPE|Plasma Equivalent Glucose|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|U/kg/h|1|1|[?]|HIGH|PLATELET RICH PLASMA|CLOTTED||TELLER ACUITY CARDS|MDRD 4 VARIABLE FORMULA||Y|U|Y|5|Visit_5|90|7|SCREENING|2021-04-05|2021-04-12|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|10|IRON|Iron|CHEMISTRY|[?]|dpm/0.5 mL|[?]|[?]|BORDERLINE|1|mg/g/min|1|1|[?]|LOW|MONOCYTE|CONTAMINATED|N|PET SCAN|ASH FIBROSURE FORMULA||Y|U||5|Visit_5|90|3|TREATMENT|2021-04-05|2021-04-11|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|LB|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|1|TRP|Tryptophan|HEMATOLOGY|||[?]|[?]|TRACE|1|lm|1|1|[?]|NORMAL|HAIR|THAWED||DIRECT SEQUENCING|GMI MMOL/MOL FORMULA|||NA|Y|1|Visit_1|10|3|TREATMENT|2020-12-12|2021-02-21|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|2|HCT|Hematocrit|URINALYSIS|[?]|usec|[?]|[?]|TRACE|1|PFU|1|1|[?]|NORMAL|LYMPH|CALCIFIED|N|FARR ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA|||NA||1|Visit_1|10|3|SCREENING|2020-12-12|2021-02-17|10|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|LB|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|3|HCG|Choriogonadotropin Beta|CHEMISTRY|[?]|dL|[?]|[?]|BORDERLINE|1|kUSP|1|1|[?]|NORMAL|RETICULOCYTES|FRESH||CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA|Y||N||2|Visit_2|25|6|FOLLOW-UP|2020-12-27|2021-01-04|25|33|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|4|UDCA|Ursodeoxycholate|HEMATOLOGY|[?]|U/m2/h|[?]|[?]|BORDERLINE|1|/7.5 mL|1|1|[?]|LOW|MECONIUM|PARAFFIN-EMBEDDED||IN SITU HYBRIDIZATION|MDRD 6 VARIABLE FORMULA||Y|N||2|Visit_2|25|1|TREATMENT|2020-12-27|2021-02-25|25|85|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|LB|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|5|PHNBRBTL|Phenobarbital|CHEMISTRY|[?]|cmH2O/mL|[?]|[?]|TRACE|1|PFU/animal|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|LACTESCENT|N|ELECTRONEUROGRAPHY|GMI MMOL/MOL FORMULA|||U||3|Visit_3|40|3|TREATMENT|2021-01-11|2021-02-16|40|76|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|6|PTHW|Parathyroid Hormone, Whole|HEMATOLOGY|[?]|mMU/mL|[?]|[?]|TRACE|1|atm|1|1|[?]|HIGH|CERUMEN|UNEXPECTED ODOR||PET SCAN|FIBROTEST FORMULA|||NA||3|Visit_3|40|4|SCREENING|2021-01-11|2021-02-10|40|70|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|LB|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|7|GLOBBPT|Beta Globulin/Total Protein|URINALYSIS|||[?]|[?]|INVALID|1|/min|1|1|[?]|HIGH|RETICULOCYTES|THAWED||CONTRAST ENHANCED PET/CT SCAN|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|4|Visit_4|65|5|TREATMENT|2021-02-05|2021-02-06|65|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|8|DHEAS|Dehydroepiandrosterone Sulfate|URINALYSIS|[?]|log10 TCID 50/uL|[?]|[?]|POSITIVE|1|uU/dL|1|1|[?]|NORMAL|SWABBED MATERIAL|NON-HEMOLYZED||MALDI|MDRD ENZYMATIC JAPANESE FORMULA||Y|N||4|Visit_4|65|2|TREATMENT|2021-02-05|2021-02-13|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|LB|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|9|NMP22|Nuclear Matrix Protein 22|URINALYSIS|[?]|ug/day|[?]|[?]|NEGATIVE|1|PRESSOR UNITS|1|1|[?]|NORMAL|PUS|ICTERIC|N|MIGET|GMI MMOL/MOL FORMULA|Y||U||5|Visit_5|90|2|TREATMENT|2021-03-02|2021-03-07|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|10|RBCCLMP|Erythrocyte Cell Clumps|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|MBq/uL|1|1|[?]|ABNORMAL|SEMEN|LIPEMIC|N|DOPPLER ULTRASOUND|MDRD 4 VARIABLE FORMULA|||U|Y|5|Visit_5|90|3|TREATMENT|2021-03-02|2021-03-05|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|LB|5abbbb78-2eeb-4d21-85ac-f5d18294c603|1|HGBFR|Hemoglobin, Free|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|kcal/day|1|1|[?]|ABNORMAL|GASTRIC CONTENTS|FRESH||FLUORESCENT LIFETIME IMAGING MICROSCOPY|FIBROMETER FORMULA|||NA|Y|1|Visit_1|10|3|WASHOUT|2021-01-25|2021-02-24|10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|5abbbb78-2eeb-4d21-85ac-f5d18294c603|2|CARTP|Cocaine Amphetamine-Reg Transcript Prot|CHEMISTRY|||[?]|[?]|INVALID|1|ug/L DDU|1|1|[?]|HIGH|MONOCYTE|NON-HEMOLYZED||SNELLEN EYE CHART|GMI % FORMULA|Y|Y|N|Y|1|Visit_1|10|7|TREATMENT|2021-01-25|2021-04-06|10|81|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|LB|5abbbb78-2eeb-4d21-85ac-f5d18294c603|3|NEUTBNE|Neutrophils Band Form/ Neutrophils|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|10^3 DNA copies/mL|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|CONCENTRATED||PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|FIBROTEST FORMULA||Y|NA|Y|2|Visit_2|25|1|SCREENING|2021-02-09|2021-02-21|25|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|5abbbb78-2eeb-4d21-85ac-f5d18294c603|4|PSDGLSRF|Phosphatidylglycerol/Lung Surfactant|URINALYSIS|[?]|Watt|[?]|[?]|TRACE|1|/2500 WBC|1|1|[?]|NORMAL|PLATELET POOR PLASMA|CLOTTED|N|COULOMETRIC TITRATION|NASH FIBROSURE FORMULA|Y|Y|Y||2|Visit_2|25|1|WASHOUT|2021-02-09|2021-03-31|25|75|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|LB|5abbbb78-2eeb-4d21-85ac-f5d18294c603|5|HGBC|Hemoglobin C|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|umol|1|1|[?]|ABNORMAL|CAPILLARY BLOOD|THAWED|N|ELECTROPHORESIS|NASH FIBROSURE FORMULA|||N|Y|3|Visit_3|40|3|FOLLOW-UP|2021-02-24|2021-02-26|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|LB|5abbbb78-2eeb-4d21-85ac-f5d18294c603|6|GDA|Guanine Deaminase|CHEMISTRY|[?]|kHz|[?]|[?]|TRACE|1|mg/mol|1|1|[?]|HIGH|SERUM OR PLASMA|NON-HEMOLYZED||IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CREATININE FORMULA|Y|Y|N||3|Visit_3|40|5|FOLLOW-UP|2021-02-24|2021-03-03|40|47|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|LB|5abbbb78-2eeb-4d21-85ac-f5d18294c603|7|NEUTAGR|Agranular Neutrophils|URINALYSIS|||[?]|[?]|INVALID|1|IU/kg|1|1|[?]|HIGH|ATHEROSCLEROTIC PLAQUE|ROOM TEMPERATURE|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA|||N|Y|4|Visit_4|65|5|SCREENING|2021-03-21|2021-04-05|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|LB|5abbbb78-2eeb-4d21-85ac-f5d18294c603|8|INTLK12|Interleukin 12|CHEMISTRY|[?]|/LSQN|[?]|[?]|INDETERMINATE|1|CFU/mL|1|1|[?]|LOW|EXUDATE|LACTESCENT||MICROBIAL CULTURE, SOLID|FIBROMETER FORMULA|||NA||4|Visit_4|65|5|WASHOUT|2021-03-21|2021-04-05|65|80|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|LB|5abbbb78-2eeb-4d21-85ac-f5d18294c603|9|SEZCE|Sezary Cells|URINALYSIS|||[?]|[?]|INVALID|1|ugEq/L|1|1|[?]|NORMAL|SERUM OR PLASMA OR BLOOD|NON-HEMOLYZED||PULMONARY ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|Y|Y|5|Visit_5|90|2|FOLLOW-UP|2021-04-15|2021-04-16|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|5abbbb78-2eeb-4d21-85ac-f5d18294c603|10|MYBLAT3|Type III Myeloblasts|CHEMISTRY|[?]|mmAL|[?]|[?]|INDETERMINATE|1|/200 HPFs|1|1|[?]|NORMAL|RETICULOCYTES|FROZEN|N|MAPH|ASH FIBROSURE FORMULA|Y||U||5|Visit_5|90|6|SCREENING|2021-04-15|2021-04-18|90|93|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|LB|109fe46d-ac1f-47fe-8ecb-6049a577d38c|1|VOLUME|Volume|HEMATOLOGY|[?]|PACKAGE|[?]|[?]|NEGATIVE|1|CFU/g|1|1|[?]|HIGH|ALVEOLAR AIR|AUTOLYZED||FARR ASSAY|ASH FIBROSURE FORMULA|||U||1|Visit_1|10|1|TREATMENT|2020-05-20|2020-06-16|10|37|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-17
e|LB|109fe46d-ac1f-47fe-8ecb-6049a577d38c|2|FATACFRU|Free Fatty Acid, Unsaturated|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|ng/L|1|1|[?]|NORMAL|ARTERIAL CORD BLOOD|CALCIFIED||PHOROPTER|MDRD 6 VARIABLE FORMULA|||U|Y|1|Visit_1|10|6|WASHOUT|2020-05-20|2020-07-31|10|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-17
e|LB|109fe46d-ac1f-47fe-8ecb-6049a577d38c|3|PSIGGAB|Phosphatidylserine IgG Antibody|CHEMISTRY|[?]|/2500 WBC|[?]|[?]|POSITIVE|1|BOWL|1|1|[?]|LOW|REFLEX TEAR|SOLIDIFIED|N|TRIPLE-PHASE MRI SCAN|FIBROTEST FORMULA|||N||2|Visit_2|25|3|TREATMENT|2020-06-04|2020-06-10|25|31|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|LB|109fe46d-ac1f-47fe-8ecb-6049a577d38c|4|CHLMCRN|Chylomicrons|HEMATOLOGY|||[?]|[?]|INDETERMINATE|1|PATCH|1|1|[?]|NORMAL|INFRANATANT, PLASMA|DRIED||PHOTOGRAPHY|MDRD ENZYMATIC FORMULA|||N|Y|2|Visit_2|25|4|FOLLOW-UP|2020-06-04|2020-07-02|25|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|LB|109fe46d-ac1f-47fe-8ecb-6049a577d38c|5|TLYMXM|T-lymphocyte Crossmatch|CHEMISTRY|[?]|U/m2/min|[?]|[?]|TRACE|1|Joule|1|1|[?]|LOW|CIRCULATING TUMOR CELL|CALCIFIED|N|PHOTOGRAPHY|ASH FIBROSURE FORMULA|||N||3|Visit_3|40|5|FOLLOW-UP|2020-06-19|2020-08-09|40|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|109fe46d-ac1f-47fe-8ecb-6049a577d38c|6|HASIGMAB|Human Anti-Sheep IgM Antibody|URINALYSIS|[?]|CFU/mL|[?]|[?]|BORDERLINE|1|pkat|1|1|[?]|LOW|SYNOVIAL FLUID|THAWED||ICC|COCKCROFT-GAULT FORMULA||Y|NA||3|Visit_3|40|7|TREATMENT|2020-06-19|2020-07-08|40|59|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|LB|109fe46d-ac1f-47fe-8ecb-6049a577d38c|7|MONONSQE|Monocytes/Non-Squam Epi Cells|HEMATOLOGY|[?]|mV*min|[?]|[?]|NEGATIVE|1|ELISA unit/mL|1|1|[?]|LOW|CAPILLARY PLASMA|THAWED||MICROBIAL CULTURE, LIQUID|NASH FIBROSURE FORMULA||Y|Y||4|Visit_4|65|6|WASHOUT|2020-07-14|2020-08-13|65|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|109fe46d-ac1f-47fe-8ecb-6049a577d38c|8|NKCE|Natural Killer Cells|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|/sec|1|1|[?]|HIGH|SALIVA|SOLIDIFIED|N|DARK FIELD MICROSCOPY|ASH FIBROSURE FORMULA|||N|Y|4|Visit_4|65|6|TREATMENT|2020-07-14|2020-07-22|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|LB|109fe46d-ac1f-47fe-8ecb-6049a577d38c|9|CD40|CD40|URINALYSIS|[?]|cm/min|[?]|[?]|INDETERMINATE|1|kBq|1|1|[?]|HIGH|CERVICOVAGINAL SECRETION|LIPEMIC||LC/MS/MS|MDRD 6 VARIABLE FORMULA|||NA||5|Visit_5|90|6|SCREENING|2020-08-08|2020-08-17|90|99|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|LB|109fe46d-ac1f-47fe-8ecb-6049a577d38c|10|PROMYLE|Promyelocytes/Leukocytes|HEMATOLOGY|[?]|uSiemens|[?]|[?]|INVALID|1|cm|1|1|[?]|LOW|ENDOTRACHEAL FLUID|REFRIGERATED|N|HEMOCYTOMETRY|CKD-EPI CREATININE FORMULA|||Y||5|Visit_5|90|7|TREATMENT|2020-08-08|2020-08-12|90|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|LB|cdb18d0a-5fca-4437-9b6e-0e46b0930521|1|INTLK1B|Interleukin 1 Beta|CHEMISTRY|[?]|MBP|[?]|[?]|NEGATIVE|1|Absorbance U|1|1|[?]|LOW|SERUM OR PLASMA OR BLOOD|AGGLUTINATED||TELLER ACUITY CARDS|CKD-EPI CREATININE FORMULA|||Y||1|Visit_1|10|2|FOLLOW-UP|2020-09-03|2020-11-12|10|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|cdb18d0a-5fca-4437-9b6e-0e46b0930521|2|ISOPRF2|F2-Isoprostane|HEMATOLOGY|[?]|MASK|[?]|[?]|BORDERLINE|1|ug/m2/h|1|1|[?]|LOW|STRIATED MUSCLE TISSUE|CONCENTRATED||IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD 5 VARIABLE FORMULA|||U||1|Visit_1|10|7|TREATMENT|2020-09-03|2020-09-22|10|29|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|LB|cdb18d0a-5fca-4437-9b6e-0e46b0930521|3|FACTXIIA|Factor XII Activity|URINALYSIS|[?]|SUPPOSITORY|[?]|[?]|INDETERMINATE|1|Bq/kg|1|1|[?]|NORMAL|AQUEOUS HUMOR|PARAFFIN-EMBEDDED||STATIC PERIMETRY|MDRD 4 VARIABLE FORMULA|||Y||2|Visit_2|25|7|TREATMENT|2020-09-18|2020-10-29|25|66|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|cdb18d0a-5fca-4437-9b6e-0e46b0930521|4|TRAP|Total Radical-Trap Antioxidant Potential|URINALYSIS|[?]|mg/m2|[?]|[?]|TRACE|1|g/mol|1|1|[?]|ABNORMAL|LOCHIA|CLOTTED||MALDI-TOF|HEPASCORE FORMULA|||Y||2|Visit_2|25|6|WASHOUT|2020-09-18|2020-10-18|25|55|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|LB|cdb18d0a-5fca-4437-9b6e-0e46b0930521|5|CD79A|CD79A|HEMATOLOGY|[?]|mm2|[?]|[?]|POSITIVE|1|ug/m2|1|1|[?]|NORMAL|CARDIAC MUSCLE TISSUE|HEMOLYZED||FUNDUS PHOTOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||N||3|Visit_3|40|7|FOLLOW-UP|2020-10-03|2020-11-15|40|83|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|cdb18d0a-5fca-4437-9b6e-0e46b0930521|6|C147276|Arachis hypogaea Antigen IgE Antibody|CHEMISTRY|[?]|mEq/L|[?]|[?]|BORDERLINE|1|kg/m2|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|LACTESCENT||TRYPAN BLUE STAIN|CKD-EPI CREATININE FORMULA|Y||NA||3|Visit_3|40|7|WASHOUT|2020-10-03|2020-11-22|40|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|LB|cdb18d0a-5fca-4437-9b6e-0e46b0930521|7|AMYLASES|Amylase, Salivary|HEMATOLOGY|[?]|mg/mol|[?]|[?]|BORDERLINE|1|10^3 RNA copies/mL|1|1|[?]|LOW|FLUID|ICTERIC|N|CAPILLARY ELECTROPHORESIS|FIBROMETER FORMULA|||U||4|Visit_4|65|4|TREATMENT|2020-10-28|2020-11-26|65|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|cdb18d0a-5fca-4437-9b6e-0e46b0930521|8|APOA1|Apolipoprotein A1|CHEMISTRY|[?]|LB|[?]|[?]|TRACE|1|DIOPTER|1|1|[?]|ABNORMAL|NAIL|LACTESCENT||PET SCAN|MDRD 4 VARIABLE FORMULA||Y|NA||4|Visit_4|65|5|WASHOUT|2020-10-28|2020-11-04|65|72|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|LB|cdb18d0a-5fca-4437-9b6e-0e46b0930521|9|GBP1|Guanylate Binding Protein 1|CHEMISTRY|||[?]|[?]|POSITIVE|1|ft3|1|1|[?]|NORMAL|SEMEN|CONCENTRATED||PHOTOMETRIC CLOT DETECTION|CKD-EPI FORMULA|||Y|Y|5|Visit_5|90|2|WASHOUT|2020-11-22|2020-11-29|90|97|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|cdb18d0a-5fca-4437-9b6e-0e46b0930521|10|CD45RALY|CD45RA/Lymphocytes|URINALYSIS|[?]|mol/mg|[?]|[?]|INDETERMINATE|1|Sv|1|1|[?]|LOW|SEMEN|GELLED||GC/MS/MS|GMI MMOL/MOL FORMULA|||N||5|Visit_5|90|2|TREATMENT|2020-11-22|2020-11-23|90|91|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|LB|e515b916-5d28-4236-8835-2ff43b498ab3|1|HBBARTHB|Hemoglobin Barts/Total Hemoglobin|CHEMISTRY|[?]|Rad|[?]|[?]|INDETERMINATE|1|umol/day|1|1|[?]|LOW|LYMPH|SOLIDIFIED||LEAD CITRATE STAIN|MDRD 4 VARIABLE FORMULA|Y||Y||1|Visit_1|10|2|SCREENING|2020-05-23|2020-06-16|10|34|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|e515b916-5d28-4236-8835-2ff43b498ab3|2|MCHC|Ery. Mean Corpuscular HGB Concentration|URINALYSIS|[?]|mL/cage/wk|[?]|[?]|INVALID|1|DDU|1|1|[?]|ABNORMAL|INFRANATANT, PLASMA|AGGLUTINATED||THICK SMEAR|MDRD 4 VARIABLE FORMULA|||Y||1|Visit_1|10|3|WASHOUT|2020-05-23|2020-05-28|10|15|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|LB|e515b916-5d28-4236-8835-2ff43b498ab3|3|METAMYLE|Metamyelocytes/Leukocytes|CHEMISTRY|[?]|umol/h/mmol|[?]|[?]|BORDERLINE|1|g|1|1|[?]|HIGH|MECONIUM|ROOM TEMPERATURE||IRON HEMATOXYLIN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N||2|Visit_2|25|5|TREATMENT|2020-06-07|2020-07-17|25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|LB|e515b916-5d28-4236-8835-2ff43b498ab3|4|PSIGMAB|Phosphatidylserine IgM Antibody|HEMATOLOGY|[?]|vg/dose|[?]|[?]|INDETERMINATE|1|mol/mg|1|1|[?]|LOW|DISCHARGE|GELLED||RAJI CELL EIA|CKD-EPI CYSTATIN C FORMULA|Y||N||2|Visit_2|25|1|WASHOUT|2020-06-07|2020-08-02|25|81|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|LB|e515b916-5d28-4236-8835-2ff43b498ab3|5|CENTROAB|Centromere B Antibodies|URINALYSIS|||[?]|[?]|POSITIVE|1|PA|1|1|[?]|HIGH|SUPERNATANT, CEREBROSPINAL FLUID|ROOM TEMPERATURE|N|CAPILLARY ELECTROPHORESIS|HEPASCORE FORMULA|||N|Y|3|Visit_3|40|4|WASHOUT|2020-06-22|2020-08-17|40|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|LB|e515b916-5d28-4236-8835-2ff43b498ab3|6|TROPONI3|Troponin I Type 3|URINALYSIS|[?]|kN/cm2|[?]|[?]|BORDERLINE|1|log10 CFU/mL|1|1|[?]|NORMAL|SUPERNATANT, PLEURAL FLUID|AUTOLYZED||AUTOREFRACTION|MDRD 5 VARIABLE FORMULA|Y||U||3|Visit_3|40|7|TREATMENT|2020-06-22|2020-08-05|40|84|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|LB|e515b916-5d28-4236-8835-2ff43b498ab3|7|PHNBRBTL|Phenobarbital|HEMATOLOGY|[?]|nL|[?]|[?]|BORDERLINE|1|MET*min|1|1|[?]|LOW|TUMOR TISSUE|GELLED|N|SPIRAL CT SCAN WITHOUT CONTRAST|GMI MMOL/MOL FORMULA|||U||4|Visit_4|65|5|SCREENING|2020-07-17|2020-07-25|65|73|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|LB|e515b916-5d28-4236-8835-2ff43b498ab3|8|C130143|German Cockroach Antigen IgG4 Antibody|URINALYSIS|||[?]|[?]|INVALID|1|mEq/L|1|1|[?]|ABNORMAL|INFRANATANT, PLEURAL FLUID|DRIED|N|KNEMOMETRY|ASH FIBROSURE FORMULA|Y||Y|Y|4|Visit_4|65|4|SCREENING|2020-07-17|2020-08-12|65|91|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|LB|e515b916-5d28-4236-8835-2ff43b498ab3|9|GSTAL|Alpha Glutathione-S-Transferase|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|kg/L|1|1|[?]|LOW|LUNG SURFACTANT|CLOTTED||CONTRAST ENHANCED PET/CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA|||U|Y|5|Visit_5|90|7|TREATMENT|2020-08-11|2020-08-17|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|LB|e515b916-5d28-4236-8835-2ff43b498ab3|10|CAPHOS|Calcium/Phosphorus|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|RING|1|1|[?]|NORMAL|BREAST MILK|SOLIDIFIED||REVERSE TRANSCRIPTASE PCR|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|5|Visit_5|90|4|WASHOUT|2020-08-11|2020-08-17|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|LB|158af2a8-d447-45e5-8c58-3b950f1bd889|1|FAI|Free Androgen Index|CHEMISTRY|[?]|GLOBULE|[?]|[?]|INVALID|1|KIT|1|1|[?]|LOW|CEREBROSPINAL FLUID|FROZEN||FLAME PHOTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA|||U||1|Visit_1|10|2|TREATMENT|2020-05-30|2020-08-15|10|87|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|LB|158af2a8-d447-45e5-8c58-3b950f1bd889|2|EOSCE|Eosinophils/Total Cells|HEMATOLOGY|[?]|IMPLANT|[?]|[?]|BORDERLINE|1|mg/cm2|1|1|[?]|HIGH|MUSCLE TISSUE|AGGLUTINATED||CELL BASED BIOASSAY|MDRD ENZYMATIC JAPANESE FORMULA|Y|Y|Y||1|Visit_1|10|2|TREATMENT|2020-05-30|2020-07-12|10|53|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|LB|158af2a8-d447-45e5-8c58-3b950f1bd889|3|WBCCLMP|Leukocyte Cell Clumps|URINALYSIS|[?]|g/dL|[?]|[?]|POSITIVE|1|Osm|1|1|[?]|NORMAL|ENDOTRACHEAL FLUID|CONTAMINATED||APPLANATION TONOMETRY|MDRD 6 VARIABLE FORMULA||Y|U||2|Visit_2|25|5|TREATMENT|2020-06-14|2020-08-20|25|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|158af2a8-d447-45e5-8c58-3b950f1bd889|4|PRLYMLE|Prolymphocytes/Leukocytes|CHEMISTRY|[?]|PNU/mL|[?]|[?]|BORDERLINE|1|ug/mol|1|1|[?]|NORMAL|AQUEOUS HUMOR|FRESH||TONOMETRY|NASH FIBROSURE FORMULA|Y|Y|Y||2|Visit_2|25|7|WASHOUT|2020-06-14|2020-07-16|25|57|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|LB|158af2a8-d447-45e5-8c58-3b950f1bd889|5|CBB|Complement Bb|HEMATOLOGY|[?]|gpELISA unit/mL|[?]|[?]|INVALID|1|10^6 U|1|1|[?]|LOW|ABSCESS FLUID|DRIED||INCISION-INDUCED BLEEDING METHOD|MDRD ENZYMATIC FORMULA|||N||3|Visit_3|40|7|TREATMENT|2020-06-29|2020-07-19|40|60|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|158af2a8-d447-45e5-8c58-3b950f1bd889|6|NEUTIMLE|Immature Neutrophils/Leukocytes|CHEMISTRY|[?]|mol/day|[?]|[?]|INVALID|1|%|1|1|[?]|ABNORMAL|EMOTIONAL TEAR|FROZEN||ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|COCKCROFT-GAULT FORMULA||Y|Y||3|Visit_3|40|1|TREATMENT|2020-06-29|2020-08-04|40|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|LB|158af2a8-d447-45e5-8c58-3b950f1bd889|7|CTOT|Complement Total|CHEMISTRY|[?]|days/wk|[?]|[?]|TRACE|1|mL/min|1|1|[?]|NORMAL|INTERSTITIAL FLUID|NON-HEMOLYZED||CONTRAST ENHANCED SPIRAL CT SCAN|ASH FIBROSURE FORMULA|Y|Y|NA||4|Visit_4|65|7|TREATMENT|2020-07-24|2020-08-06|65|78|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|158af2a8-d447-45e5-8c58-3b950f1bd889|8|HIS|Histidine|CHEMISTRY|[?]|mL/m2|[?]|[?]|BORDERLINE|1|Hounsfield Unit|1|1|[?]|ABNORMAL|ABSCESS FLUID|THAWED||MULTI-SLICE SPIRAL CT|NASH FIBROSURE FORMULA|||Y||4|Visit_4|65|2|WASHOUT|2020-07-24|2020-08-20|65|92|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|LB|158af2a8-d447-45e5-8c58-3b950f1bd889|9|NTXI|Type I Collagen N-Telopeptides|HEMATOLOGY|[?]|BE/mL|[?]|[?]|TRACE|1|IU/dL|1|1|[?]|NORMAL|PERIPHERAL BLOOD MONONUCLEAR CELL|ICTERIC||FLUORESCEIN STAIN|MDRD 6 VARIABLE FORMULA||Y|NA||5|Visit_5|90|3|TREATMENT|2020-08-18|2020-08-23|90|95|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|158af2a8-d447-45e5-8c58-3b950f1bd889|10|GDA|Guanine Deaminase|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|10^3/L|1|1|[?]|NORMAL|DISCHARGE|REFRIGERATED|N|MECHANICAL CLOT DETECTION|HEPASCORE FORMULA|||N|Y|5|Visit_5|90|4|FOLLOW-UP|2020-08-18|2020-08-25|90|97|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|LB|e9a930d5-ca57-4069-8251-c164273df082|1|TNF12S|Soluble TNF Superfamily Member 12|HEMATOLOGY|[?]|PIXELS/in|[?]|[?]|TRACE|1|mEq/day|1|1|[?]|NORMAL|SMEGMA|CONCENTRATED|N|TEMPLATE INCISION METHOD|MDRD FORMULA||Y|Y||1|Visit_1|10|7|SCREENING|2020-05-21|2020-06-28|10|48|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|e9a930d5-ca57-4069-8251-c164273df082|2|HCHT|Hyocholate|URINALYSIS|[?]|mL/animal/wk|[?]|[?]|TRACE|1|/mm|1|1|[?]|NORMAL|SMEGMA|CALCIFIED||AGAR DILUTION|HEPASCORE FORMULA|||U||1|Visit_1|10|6|SCREENING|2020-05-21|2020-08-13|10|94|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|LB|e9a930d5-ca57-4069-8251-c164273df082|3|VIP|Vasoactive Intestinal Polypeptide|CHEMISTRY|[?]|mEq/g|[?]|[?]|BORDERLINE|1|IMPLANT|1|1|[?]|LOW|CIRCULATING TUMOR CELL|LIPEMIC|N|POTENTIOMETRY|FIBROSIS 4 FORMULA||Y|U||2|Visit_2|25|6|FOLLOW-UP|2020-06-05|2020-07-24|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-25
e|LB|e9a930d5-ca57-4069-8251-c164273df082|4|CD5|CD5|CHEMISTRY|[?]|vp/mL|[?]|[?]|POSITIVE|1|uL|1|1|[?]|HIGH|EXPIRED AIR|HEMOLYZED|N|TRANSMISSION ELECTRON MICROSCOPY|FIBROSIS 4 FORMULA|Y|Y|NA||2|Visit_2|25|7|TREATMENT|2020-06-05|2020-08-12|25|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-25
e|LB|e9a930d5-ca57-4069-8251-c164273df082|5|ANTHRMAG|Antithrombin Antigen|URINALYSIS|[?]|/sec|[?]|[?]|TRACE|1|EU|1|1|[?]|NORMAL|CALCULUS|SOLIDIFIED||SPECTROPHOTOMETRY|HEPASCORE FORMULA||Y|N||3|Visit_3|40|2|TREATMENT|2020-06-20|2020-06-22|40|42|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|e9a930d5-ca57-4069-8251-c164273df082|6|BLYCELE|B-Lymphocytes/Leukocytes|HEMATOLOGY|[?]|RATIO|[?]|[?]|BORDERLINE|1|cmH2O*s/mL|1|1|[?]|NORMAL|SMOOTH MUSCLE TISSUE|CONTAMINATED|N|CENTRIFUGATION|COCKCROFT-GAULT FORMULA||Y|NA||3|Visit_3|40|5|WASHOUT|2020-06-20|2020-08-09|40|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|LB|e9a930d5-ca57-4069-8251-c164273df082|7|VITDBP|Vitamin D Binding Protein|CHEMISTRY|||[?]|[?]|INDETERMINATE|1|CYLINDER|1|1|[?]|ABNORMAL|MONOCYTE|PARAFFIN-EMBEDDED||MICROSCOPY|ASH FIBROSURE FORMULA|||U|Y|4|Visit_4|65|1|SCREENING|2020-07-15|2020-08-02|65|83|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|e9a930d5-ca57-4069-8251-c164273df082|8|TFRRNSAT|Transferrin Saturation|URINALYSIS|[?]|g/cage/wk|[?]|[?]|POSITIVE|1|BE/mL|1|1|[?]|LOW|EXUDATE|LIPEMIC||PALM METHOD|GMI % FORMULA||Y|NA||4|Visit_4|65|3|WASHOUT|2020-07-15|2020-07-26|65|76|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|LB|e9a930d5-ca57-4069-8251-c164273df082|9|TRIGHDL|Triglycerides/HDL Cholesterol|CHEMISTRY|[?]|mg/kg|[?]|[?]|INVALID|1|CFU/mL|1|1|[?]|HIGH|SEMEN|GELLED|N|CONTRAST ENHANCED PET SCAN|FIBROMETER FORMULA|||U||5|Visit_5|90|7|WASHOUT|2020-08-09|2020-08-17|90|98|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|e9a930d5-ca57-4069-8251-c164273df082|10|GLUCEXR|Glucose Excretion Rate|CHEMISTRY|[?]|mg/kg/day|[?]|[?]|POSITIVE|1|oz eq|1|1|[?]|ABNORMAL|SMOOTH MUSCLE TISSUE|CALCIFIED|N|SEQUENCING|NASH FIBROSURE FORMULA||Y|U||5|Visit_5|90|4|TREATMENT|2020-08-09|2020-08-12|90|93|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|LB|e654e37e-1c95-4f25-83b1-9233186626c6|1|TROPONIN|Troponin|HEMATOLOGY|[?]|AFU|[?]|[?]|INDETERMINATE|1|U/kg/day|1|1|[?]|LOW|VENOUS PLASMA|LACTESCENT||NEXT GENERATION SEQUENCING|COCKCROFT-GAULT FORMULA|Y|Y|U||1|Visit_1|10|7|WASHOUT|2020-08-04|2020-08-05|10|11|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|e654e37e-1c95-4f25-83b1-9233186626c6|2|TK1|Thymidine Kinase 1|HEMATOLOGY|||[?]|[?]|BORDERLINE|1|Pack Year|1|1|[?]|HIGH|CAPILLARY BLOOD|GELLED||PALM METHOD|HEPASCORE FORMULA|||Y|Y|1|Visit_1|10|1|FOLLOW-UP|2020-08-04|2020-08-18|10|24|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|LB|e654e37e-1c95-4f25-83b1-9233186626c6|3|PTAC|Prothrombin Time Actual/Control|HEMATOLOGY|[?]|kcal/day|[?]|[?]|NEGATIVE|1|KIT|1|1|[?]|NORMAL|TISSUE|THAWED||HPLC/IEX|FIBROTEST FORMULA||Y|N||2|Visit_2|25|3|SCREENING|2020-08-19|2020-08-31|25|37|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|e654e37e-1c95-4f25-83b1-9233186626c6|4|DHEAS|Dehydroepiandrosterone Sulfate|CHEMISTRY|[?]|ug/m2/min|[?]|[?]|INVALID|1|10^3 DNA copies/mL|1|1|[?]|NORMAL|SEMINAL FLUID|SOLIDIFIED||REVERSE TRANSCRIPTASE PCR|MDRD FORMULA|||U||2|Visit_2|25|2|TREATMENT|2020-08-19|2020-10-07|25|74|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|LB|e654e37e-1c95-4f25-83b1-9233186626c6|5|CSMIX|Mixed Casts|HEMATOLOGY|[?]|PHERESIS UNIT|[?]|[?]|POSITIVE|1|mmol/L|1|1|[?]|ABNORMAL|HAIR|CONTAMINATED||CYSTOMETRY|GMI % FORMULA|Y||Y||3|Visit_3|40|3|TREATMENT|2020-09-03|2020-10-21|40|88|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|e654e37e-1c95-4f25-83b1-9233186626c6|6|FATACFRU|Free Fatty Acid, Unsaturated|URINALYSIS|[?]|/100 HPFs|[?]|[?]|INVALID|1|kPa|1|1|[?]|NORMAL|BONE MARROW MONONUCLEAR CELL|REFRIGERATED||IMMUNORADIOMETRIC ASSAY|FIBROSIS 4 FORMULA|||Y||3|Visit_3|40|1|FOLLOW-UP|2020-09-03|2020-09-27|40|64|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|LB|e654e37e-1c95-4f25-83b1-9233186626c6|7|FEPI|Fractional Phosphorus Excretion|HEMATOLOGY|[?]|VOXEL|[?]|[?]|BORDERLINE|1|aMFI|1|1|[?]|HIGH|SEBUM|DRIED||RYAN BLUE STAIN|NASH FIBROSURE FORMULA|||N||4|Visit_4|65|7|TREATMENT|2020-09-28|2020-10-15|65|82|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|e654e37e-1c95-4f25-83b1-9233186626c6|8|ABOA1|ABO A1 Subtype|CHEMISTRY|||[?]|[?]|BORDERLINE|1|uCi|1|1|[?]|NORMAL|EMOTIONAL TEAR|AGGLUTINATED||MAMMOGRAPHY|MDRD ENZYMATIC FORMULA|||Y|Y|4|Visit_4|65|4|SCREENING|2020-09-28|2020-09-29|65|66|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|LB|e654e37e-1c95-4f25-83b1-9233186626c6|9|RENIN|Renin|HEMATOLOGY|||[?]|[?]|POSITIVE|1|10^4/hpf|1|1|[?]|LOW|SWABBED MATERIAL|LACTESCENT|N|IMMUNOBLOT|MDRD 6 VARIABLE FORMULA|Y||Y|Y|5|Visit_5|90|1|SCREENING|2020-10-23|2020-10-27|90|94|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|e654e37e-1c95-4f25-83b1-9233186626c6|10|HYPGST17|17-Hydroxyprogesterone|CHEMISTRY|[?]|ug/kg/min|[?]|[?]|NEGATIVE|1|s/h|1|1|[?]|ABNORMAL|AMNIOTIC FLUID|CONCENTRATED|N|MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2020-10-23|2020-10-29|90|96|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|LB|808ee0ac-e668-4e8e-aa0a-889476cbe631|1|LTB4|Leukotriene B4|CHEMISTRY|[?]|ug/dose|[?]|[?]|TRACE|1|mm3/mm2/year|1|1|[?]|NORMAL|VITREOUS HUMOR|GELLED||LUXOL FAST BLUE AND CRESYL VIOLET STAIN|FIBROMETER FORMULA|Y||U||1|Visit_1|10|4|TREATMENT|2020-06-19|2020-09-02|10|85|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|808ee0ac-e668-4e8e-aa0a-889476cbe631|2|DSG1AB|Desmoglein 1 Antibody|URINALYSIS|||[?]|[?]|POSITIVE|1|mL/mmHg|1|1|[?]|ABNORMAL|MIXED VENOUS BLOOD|SOLIDIFIED||TWO-COLOR MICROARRAY|HEPASCORE FORMULA|||Y|Y|1|Visit_1|10|6|FOLLOW-UP|2020-06-19|2020-07-11|10|32|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|LB|808ee0ac-e668-4e8e-aa0a-889476cbe631|3|MONOPTPT|Monoclonal Protein/Total Protein|URINALYSIS|[?]|fL|[?]|[?]|BORDERLINE|1|/5x10^4 WBC|1|1|[?]|HIGH|PLASMA|CLOTTED||PAP STAIN|CKD-EPI CREATININE FORMULA|||NA||2|Visit_2|25|3|TREATMENT|2020-07-04|2020-09-07|25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|808ee0ac-e668-4e8e-aa0a-889476cbe631|4|VLDLPSZ|VLDL Particle Size|CHEMISTRY|[?]|kHz|[?]|[?]|NEGATIVE|1|uOsm|1|1|[?]|HIGH|VITREOUS HUMOR|CONCENTRATED||THIN SMEAR|FIBROMETER FORMULA|Y|Y|NA||2|Visit_2|25|5|TREATMENT|2020-07-04|2020-08-25|25|77|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|LB|808ee0ac-e668-4e8e-aa0a-889476cbe631|5|CEMORPH|Cell Morphology|HEMATOLOGY|[?]|mL/kg/min|[?]|[?]|INDETERMINATE|1|mmHg/L/min|1|1|[?]|NORMAL|URINE SEDIMENT|LACTESCENT|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|FIBROTEST FORMULA|||NA||3|Visit_3|40|3|FOLLOW-UP|2020-07-19|2020-08-08|40|60|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|LB|808ee0ac-e668-4e8e-aa0a-889476cbe631|6|CSEPIR|Renal Epithelial Casts|URINALYSIS|||[?]|[?]|INDETERMINATE|1|log10 IU/mL|1|1|[?]|NORMAL|ISOLATE|ROOM TEMPERATURE||CARDIAC THERMODILUTION|CKD-EPI CREATININE FORMULA|||N|Y|3|Visit_3|40|6|TREATMENT|2020-07-19|2020-07-31|40|52|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|LB|808ee0ac-e668-4e8e-aa0a-889476cbe631|7|C130095|Western Ragweed Pollen IgG4|CHEMISTRY|[?]|mEq/dL|[?]|[?]|INVALID|1|mg2/dL2|1|1|[?]|LOW|EXPIRED AIR|AGGLUTINATED||PET/SPECT SCAN|MDRD 4 VARIABLE FORMULA|||NA||4|Visit_4|65|7|TREATMENT|2020-08-13|2020-09-13|65|96|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|808ee0ac-e668-4e8e-aa0a-889476cbe631|8|INTLK12|Interleukin 12|URINALYSIS|[?]|U/10^12 RBC|[?]|[?]|TRACE|1|10^6 IU/mL|1|1|[?]|HIGH|SKELETAL MUSCLE TISSUE|SOLIDIFIED||MECHANICAL CLOT DETECTION|GMI MMOL/MOL FORMULA||Y|Y||4|Visit_4|65|6|TREATMENT|2020-08-13|2020-08-28|65|80|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|LB|808ee0ac-e668-4e8e-aa0a-889476cbe631|9|MERCURY|Mercury|HEMATOLOGY|[?]|/200 HPFs|[?]|[?]|BORDERLINE|1|Bq/mg|1|1|[?]|HIGH|ENDOTRACHEAL FLUID|UNEXPECTED ODOR||QUANTITATIVE ULTRASOUND|NASH FIBROSURE FORMULA|||NA||5|Visit_5|90|2|TREATMENT|2020-09-07|2020-09-12|90|95|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|LB|808ee0ac-e668-4e8e-aa0a-889476cbe631|10|PSDEPHD|Pseudoephedrine|URINALYSIS|[?]|mmol/kg|[?]|[?]|TRACE|1|kHz|1|1|[?]|LOW|BONE MARROW MONONUCLEAR CELL|FROZEN||CHROMATOGRAPHY|MDRD 4 VARIABLE FORMULA|Y||Y||5|Visit_5|90|3|WASHOUT|2020-09-07|2020-09-15|90|98|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
